#	ABILIFY MAINTENA	2281
1	Dosage	_	NOUN	NN	_	2	compound	_	_
2	adjustments	_	NOUN	NNS	_	0	root	_	_
3	for	_	ADP	IN	_	4	case	_	_
4	patients	_	NOUN	NNS	_	2	nmod	_	_
5	taking	_	VERB	VBG	_	4	acl	_	_
6	CYP2D6	_	NOUN	NN	_	7	compound	_	_
7	inhibitors	_	NOUN	NNS	_	5	dobj	_	_
8	,	_	.	,	_	7	punct	_	_
9	CYP3A4	_	NOUN	NN	_	10	compound	_	_
10	inhibitors	_	NOUN	NNS	_	7	conj	_	_
11	,	_	.	,	_	7	punct	_	_
12	or	_	CONJ	CC	_	7	cc	_	_
13	CYP3A4	_	NOUN	NN	_	14	compound	_	_
14	inducers	_	NOUN	NNS	_	7	conj	_	_
15	for	_	ADP	IN	_	19	case	_	_
16	greater	_	ADJ	JJ	_	18	advmod	_	_
17	than	_	ADP	IN	_	18	advmod	_	_
18	14	_	NUM	CD	_	19	nummod	_	_
19	days	_	NOUN	NNS	_	7	nmod	_	_

#	ABILIFY MAINTENA	2282
1	Patients	_	NOUN	NNS	_	0	root	_	_
2	Taking	_	VERB	VBG	_	1	acl	_	_
3	400	_	NUM	CD	_	4	nummod	_	_
4	mg	_	NOUN	NN	_	2	dobj	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	DRUG	_	NOUN	NN	_	8	compound	_	_
7	Strong	_	ADJ	JJ	_	8	amod	_	_
8	CYP2D6	_	NOUN	NN	_	4	nmod	_	_
9	or	_	CONJ	CC	_	8	cc	_	_
10	CYP3A4	_	NOUN	NN	_	11	compound	_	_
11	inhibitors	_	NOUN	NNS	_	8	conj	_	_
12	300	_	NUM	CD	_	14	nummod	_	_
13	mg	_	NOUN	NN	_	14	compound	_	_
14	CYP2D6	_	NOUN	NN	_	11	dep	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	CYP3A4	_	NOUN	NN	_	17	compound	_	_
17	inhibitors	_	NOUN	NNS	_	21	dep	_	_
18	200	_	NUM	CD	_	20	nummod	_	_
19	mg	_	NOUN	NN	_	20	compound	_	_
20	CYP3A4	_	NOUN	NN	_	21	dep	_	_
21	inducers	_	NOUN	NNS	_	14	conj	_	_
22	Avoid	_	ADJ	JJ	_	24	amod	_	_
23	use	_	NOUN	NN	_	24	compound	_	_
24	Patients	_	NOUN	NNS	_	8	dep	_	_
25	Taking	_	VERB	VBG	_	8	acl	_	_
26	300	_	NUM	CD	_	27	nummod	_	_
27	mg	_	NOUN	NN	_	25	dobj	_	_
28	of	_	ADP	IN	_	31	case	_	_
29	DRUG	_	NOUN	NN	_	31	compound	_	_
30	Strong	_	ADJ	JJ	_	31	amod	_	_
31	CYP2D6	_	NOUN	NN	_	27	nmod	_	_
32	or	_	CONJ	CC	_	31	cc	_	_
33	CYP3A4	_	NOUN	NN	_	34	compound	_	_
34	inhibitors	_	NOUN	NNS	_	31	conj	_	_
35	200	_	NUM	CD	_	37	nummod	_	_
36	mg	_	NOUN	NN	_	37	compound	_	_
37	CYP2D6	_	NOUN	NN	_	34	dep	_	_
38	and	_	CONJ	CC	_	37	cc	_	_
39	CYP3A4	_	NOUN	NN	_	40	compound	_	_
40	inhibitors	_	NOUN	NNS	_	37	conj	_	_
41	160	_	NUM	CD	_	44	nummod	_	_
42	mg	_	NOUN	NN	_	44	compound	_	_
43	CYP3A4	_	NOUN	NN	_	44	compound	_	_
44	inducers	_	NOUN	NNS	_	40	dep	_	_

#	ABILIFY MAINTENA	2283
1	With	_	ADP	IN	_	3	case	_	_
2	concomitant	_	ADJ	JJ	_	3	amod	_	_
3	use	_	NOUN	NN	_	20	nmod	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	with	_	ADP	IN	_	10	case	_	_
7	a	_	DET	DT	_	10	det	_	_
8	strong	_	ADJ	JJ	_	10	amod	_	_
9	CYP3A4	_	NOUN	NN	_	10	compound	_	_
10	inhibitor	_	NOUN	NN	_	3	nmod	_	_
11	or	_	CONJ	CC	_	10	cc	_	_
12	CYP2D6	_	NOUN	NN	_	13	compound	_	_
13	inhibitor	_	NOUN	NN	_	10	conj	_	_
14	for	_	ADP	IN	_	18	case	_	_
15	more	_	ADV	RB	_	17	advmod	_	_
16	than	_	ADP	IN	_	15	mwe	_	_
17	14	_	NUM	CD	_	18	nummod	_	_
18	days	_	NOUN	NNS	_	3	nmod	_	_
19	,	_	.	,	_	20	punct	_	_
20	reduce	_	VERB	VBP	_	0	root	_	_
21	the	_	DET	DT	_	23	det	_	_
22	DRUG	_	NOUN	NN	_	23	compound	_	_
23	dosage	_	NOUN	NN	_	20	dobj	_	_

#	ABILIFY MAINTENA	2284
1	Strong	_	ADJ	JJ	_	3	amod	_	_
2	CYP3A4	_	NOUN	NN	_	3	compound	_	_
3	Inducers	_	NOUN	NNS	_	15	nsubj	_	_
4	e.g	_	NOUN	NN	_	3	dep	_	_
5	,	_	.	,	_	3	punct	_	_
6	carbamazepine	_	NOUN	NN	_	3	appos	_	_
7	The	_	DET	DT	_	9	det	_	_
8	concomitant	_	ADJ	JJ	_	9	amod	_	_
9	use	_	NOUN	NN	_	6	dep	_	_
10	of	_	ADP	IN	_	12	case	_	_
11	oral	_	ADJ	JJ	_	12	amod	_	_
12	DRUG	_	NOUN	NN	_	9	nmod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	carbamazepine	_	NOUN	NN	_	12	conj	_	_
15	decreased	_	VERB	VBD	_	0	root	_	_
16	the	_	DET	DT	_	17	det	_	_
17	exposure	_	NOUN	NN	_	15	dobj	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	DRUG	_	NOUN	NN	_	17	nmod	_	_

#	ABILIFY MAINTENA	2285
1	Avoid	_	X	FW	_	2	amod	_	_
2	use	_	NOUN	NN	_	0	root	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	in	_	ADP	IN	_	6	case	_	_
6	combination	_	NOUN	NN	_	2	nmod	_	_
7	with	_	ADP	IN	_	8	case	_	_
8	carbamazepine	_	NOUN	NN	_	6	nmod	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	other	_	ADJ	JJ	_	11	amod	_	_
11	inducers	_	NOUN	NNS	_	8	conj	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	CYP3A4	_	NOUN	NN	_	8	nmod	_	_
14	for	_	ADP	IN	_	15	case	_	_
15	greater	_	ADJ	JJ	_	13	nmod	_	_
16	than	_	ADP	IN	_	17	case	_	_
17	14days	_	NOUN	NNS	_	15	nmod	_	_

#	ABILIFY MAINTENA	2286
1	Antihypertensive	_	ADJ	JJ	_	2	amod	_	_
2	Drugs	_	NOUN	NNS	_	3	nsubj	_	_
3	Due	_	VERB	VBP	_	11	advcl	_	_
4	to	_	PRT	TO	_	8	case	_	_
5	its	_	PRON	PRP$	_	8	nmod:poss	_	_
6	alpha	_	NOUN	NN	_	8	compound	_	_
7	adrenergic	_	ADJ	JJ	_	8	amod	_	_
8	antagonism	_	NOUN	NN	_	3	nmod	_	_
9	,	_	.	,	_	11	punct	_	_
10	DRUG	_	NOUN	NN	_	11	nsubj	_	_
11	has	_	VERB	VBZ	_	0	root	_	_
12	the	_	DET	DT	_	13	det	_	_
13	potential	_	NOUN	NN	_	11	dobj	_	_
14	to	_	PRT	TO	_	15	mark	_	_
15	enhance	_	VERB	VB	_	11	xcomp	_	_
16	the	_	DET	DT	_	17	det	_	_
17	effect	_	NOUN	NN	_	15	dobj	_	_
18	of	_	ADP	IN	_	21	case	_	_
19	certain	_	ADJ	JJ	_	21	amod	_	_
20	antihypertensive	_	ADJ	JJ	_	21	amod	_	_
21	agents	_	NOUN	NNS	_	17	nmod	_	_

#	ABILIFY MAINTENA	2287
1	Monitor	_	NOUN	NN	_	3	compound	_	_
2	blood	_	NOUN	NN	_	3	compound	_	_
3	pressure	_	NOUN	NN	_	0	root	_	_
4	and	_	CONJ	CC	_	3	cc	_	_
5	adjust	_	ADJ	JJ	_	6	amod	_	_
6	dose	_	NOUN	NN	_	3	conj	_	_
7	accordingly	_	ADV	RB	_	3	root	_	_

#	ABILIFY MAINTENA	2288
1	Benzodiazepines	_	NOUN	NNS	_	0	root	_	_
2	e.g	_	NOUN	NN	_	1	dep	_	_
3	,	_	.	,	_	2	punct	_	_
4	lorazepam	_	NOUN	NN	_	6	compound	_	_
5	The	_	DET	DT	_	6	det	_	_
6	intensity	_	NOUN	NN	_	10	nsubj	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	sedation	_	NOUN	NN	_	6	nmod	_	_
9	was	_	VERB	VBD	_	10	cop	_	_
10	greater	_	ADJ	JJ	_	2	dep	_	_
11	with	_	ADP	IN	_	13	case	_	_
12	the	_	DET	DT	_	13	det	_	_
13	combination	_	NOUN	NN	_	10	nmod	_	_
14	of	_	ADP	IN	_	16	case	_	_
15	oral	_	ADJ	JJ	_	16	amod	_	_
16	DRUG	_	NOUN	NN	_	13	nmod	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	lorazepam	_	NOUN	NN	_	16	conj	_	_
19	as	_	ADP	IN	_	20	mark	_	_
20	compared	_	VERB	VBN	_	10	advcl	_	_
21	to	_	PRT	TO	_	22	case	_	_
22	that	_	DET	WDT	_	20	nmod	_	_
23	observed	_	VERB	VBN	_	22	acl	_	_
24	with	_	ADP	IN	_	25	case	_	_
25	DRUG	_	NOUN	NN	_	23	nmod	_	_
26	alone	_	ADV	RB	_	25	advmod	_	_

#	ABILIFY MAINTENA	2289
1	The	_	DET	DT	_	3	det	_	_
2	orthostatic	_	ADJ	JJ	_	3	amod	_	_
3	hypotension	_	NOUN	NN	_	6	nsubj	_	_
4	observed	_	VERB	VBN	_	3	acl	_	_
5	was	_	VERB	VBD	_	6	cop	_	_
6	greater	_	ADJ	JJ	_	0	root	_	_
7	with	_	ADP	IN	_	9	case	_	_
8	the	_	DET	DT	_	9	det	_	_
9	combination	_	NOUN	NN	_	6	nmod	_	_
10	as	_	ADP	IN	_	11	mark	_	_
11	compared	_	VERB	VBN	_	6	advcl	_	_
12	to	_	PRT	TO	_	13	case	_	_
13	that	_	DET	WDT	_	11	nmod	_	_
14	observed	_	VERB	VBN	_	13	acl	_	_
15	with	_	ADP	IN	_	16	case	_	_
16	lorazepam	_	NOUN	NN	_	14	nmod	_	_
17	alone	_	ADV	RB	_	16	advmod	_	_

#	ABILIFY MAINTENA	2290
1	Based	_	VERB	VBN	_	15	advcl	_	_
2	on	_	ADP	IN	_	4	case	_	_
3	pharmacokinetic	_	ADJ	JJ	_	4	amod	_	_
4	studies	_	NOUN	NNS	_	1	nmod	_	_
5	with	_	ADP	IN	_	7	case	_	_
6	oral	_	ADJ	JJ	_	7	amod	_	_
7	DRUG	_	NOUN	NN	_	4	nmod	_	_
8	,	_	.	,	_	15	punct	_	_
9	no	_	DET	DT	_	11	neg	_	_
10	dosage	_	NOUN	NN	_	11	amod	_	_
11	adjustment	_	NOUN	NN	_	15	nsubjpass	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	DRUG	_	NOUN	NN	_	11	nmod	_	_
14	is	_	VERB	VBZ	_	15	auxpass	_	_
15	required	_	VERB	VBN	_	0	root	_	_
16	when	_	ADV	WRB	_	17	advmod	_	_
17	administered	_	VERB	VBN	_	15	advcl	_	_
18	concomitantly	_	ADV	RB	_	17	advmod	_	_
19	with	_	ADP	IN	_	20	case	_	_
20	famotidine	_	NOUN	NN	_	17	nmod	_	_
21	,	_	.	,	_	20	punct	_	_
22	valproate	_	NOUN	NN	_	20	conj	_	_
23	,	_	.	,	_	20	punct	_	_
24	lithium	_	NOUN	NN	_	20	conj	_	_
25	,	_	.	,	_	20	punct	_	_
26	lorazepam	_	NOUN	NN	_	20	appos	_	_

#	ABILIFY MAINTENA	2291
1	In	_	ADP	IN	_	2	case	_	_
2	addition	_	NOUN	NN	_	8	nmod	_	_
3	,	_	.	,	_	8	punct	_	_
4	no	_	DET	DT	_	6	neg	_	_
5	dosage	_	NOUN	NN	_	6	compound	_	_
6	adjustment	_	NOUN	NN	_	8	nsubj	_	_
7	is	_	VERB	VBZ	_	8	cop	_	_
8	necessary	_	ADJ	JJ	_	0	root	_	_
9	for	_	ADP	IN	_	10	case	_	_
10	substrates	_	NOUN	NNS	_	8	nmod	_	_
11	of	_	ADP	IN	_	13	case	_	_
12	CYP2D6	_	NOUN	NN	_	13	compound	_	_
13	e.g	_	NOUN	NN	_	10	nmod	_	_
14	,	_	.	,	_	13	punct	_	_
15	dextromethorphan	_	NOUN	NN	_	13	conj	_	_
16	,	_	.	,	_	13	punct	_	_
17	fluoxetine	_	NOUN	NN	_	13	conj	_	_
18	,	_	.	,	_	13	punct	_	_
19	paroxetine	_	NOUN	NN	_	13	conj	_	_
20	,	_	.	,	_	13	punct	_	_
21	or	_	CONJ	CC	_	13	cc	_	_
22	venlafaxine	_	NOUN	NN	_	13	conj	_	_
23	,	_	.	,	_	13	punct	_	_
24	CYP2C9	_	NOUN	NN	_	25	compound	_	_
25	e.g	_	NOUN	NN	_	13	conj	_	_
26	,	_	.	,	_	13	punct	_	_
27	warfarin	_	NOUN	NN	_	13	conj	_	_
28	,	_	.	,	_	13	punct	_	_
29	CYP2C19	_	NOUN	NN	_	30	compound	_	_
30	e.g	_	NOUN	NN	_	13	conj	_	_
31	,	_	.	,	_	13	punct	_	_
32	omeprazole	_	ADJ	JJ	_	13	conj	_	_
33	,	_	.	,	_	13	punct	_	_
34	warfarin	_	NOUN	NN	_	13	conj	_	_
35	,	_	.	,	_	13	punct	_	_
36	or	_	CONJ	CC	_	13	cc	_	_
37	CYP3A4	_	NOUN	NN	_	38	compound	_	_
38	e.g	_	NOUN	NN	_	13	conj	_	_
39	,	_	.	,	_	8	punct	_	_
40	dextromethorphan	_	NOUN	NN	_	8	dobj	_	_
41	when	_	ADV	WRB	_	40	advmod	_	_
42	co	_	.	,	_	41	nmod	_	_
43	administered	_	VERB	VBN	_	42	conj	_	_
44	with	_	ADP	IN	_	45	case	_	_
45	DRUG	_	NOUN	NN	_	43	nmod	_	_

#	ABILIFY MAINTENA	2292
1	Additionally	_	ADV	RB	_	7	advmod	_	_
2	,	_	.	,	_	7	punct	_	_
3	no	_	DET	DT	_	5	neg	_	_
4	dosage	_	NOUN	NN	_	5	compound	_	_
5	adjustment	_	NOUN	NN	_	7	nsubj	_	_
6	is	_	VERB	VBZ	_	7	cop	_	_
7	necessary	_	ADJ	JJ	_	0	root	_	_
8	for	_	ADP	IN	_	9	case	_	_
9	valproate	_	NOUN	NN	_	7	nmod	_	_
10	,	_	.	,	_	9	punct	_	_
11	lithium	_	NOUN	NN	_	9	conj	_	_
12	,	_	.	,	_	9	punct	_	_
13	lamotrigine	_	NOUN	NN	_	9	conj	_	_
14	,	_	.	,	_	9	punct	_	_
15	lorazepam	_	NOUN	NN	_	9	conj	_	_
16	,	_	.	,	_	9	punct	_	_
17	or	_	CONJ	CC	_	9	cc	_	_
18	sertraline	_	NOUN	NN	_	9	conj	_	_
19	when	_	ADV	WRB	_	7	advmod	_	_
20	co	_	.	,	_	19	nmod	_	_
21	administered	_	VERB	VBN	_	20	root	_	_
22	with	_	ADP	IN	_	23	case	_	_
23	DRUG	_	NOUN	NN	_	21	nmod	_	_

#	ABILIFY MAINTENA	2293
1	The	_	DET	DT	_	2	det	_	_
2	mechanism	_	NOUN	NN	_	17	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	action	_	NOUN	NN	_	2	nmod	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	in	_	ADP	IN	_	9	case	_	_
8	the	_	DET	DT	_	9	det	_	_
9	treatment	_	NOUN	NN	_	2	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	schizophrenia	_	NOUN	NN	_	9	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	bipolar	_	ADJ	JJ	_	15	amod	_	_
14	I	_	NOUN	NN	_	15	compound	_	_
15	disorder	_	NOUN	NN	_	11	conj	_	_
16	is	_	VERB	VBZ	_	17	auxpass	_	_
17	unknown	_	ADJ	JJ	_	0	root	_	_

#	ABILIFY MAINTENA	2294
1	The	_	DET	DT	_	2	det	_	_
2	efficacy	_	NOUN	NN	_	7	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	could	_	VERB	MD	_	7	aux	_	_
6	be	_	VERB	VB	_	7	auxpass	_	_
7	mediated	_	VERB	VBN	_	0	root	_	_
8	through	_	ADP	IN	_	10	case	_	_
9	a	_	DET	DT	_	10	det	_	_
10	combination	_	NOUN	NN	_	7	nmod	_	_
11	of	_	ADP	IN	_	14	case	_	_
12	partial	_	ADJ	JJ	_	14	amod	_	_
13	agonist	_	NOUN	NN	_	14	compound	_	_
14	activity	_	NOUN	NN	_	10	nmod	_	_
15	at	_	ADP	IN	_	17	case	_	_
16	dopamine	_	NOUN	NN	_	17	compound	_	_
17	D2	_	NOUN	NN	_	10	nmod	_	_
18	and	_	CONJ	CC	_	17	cc	_	_
19	serotonin	_	NOUN	NN	_	22	compound	_	_
20	5	_	NUM	CD	_	22	nummod	_	_
21	HT1A	_	NOUN	NN	_	22	compound	_	_
22	receptors	_	NOUN	NNS	_	17	conj	_	_
23	and	_	CONJ	CC	_	10	cc	_	_
24	antagonist	_	NOUN	NN	_	25	compound	_	_
25	activity	_	NOUN	NN	_	10	conj	_	_
26	at	_	ADP	IN	_	29	case	_	_
27	5	_	NUM	CD	_	29	nummod	_	_
28	HT2A	_	NOUN	NN	_	29	compound	_	_
29	receptors	_	NOUN	NNS	_	25	nmod	_	_

#	ABILIFY MAINTENA	2295
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	exhibits	_	VERB	VBZ	_	0	root	_	_
3	high	_	ADJ	JJ	_	4	amod	_	_
4	affinity	_	NOUN	NN	_	2	dobj	_	_
5	for	_	ADP	IN	_	7	case	_	_
6	dopamine	_	NOUN	NN	_	7	compound	_	_
7	D2	_	NOUN	NN	_	4	nmod	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	D3	_	NOUN	NN	_	10	compound	_	_
10	Kis	_	NOUN	NN	_	7	conj	_	_
11	0.34	_	NUM	CD	_	10	nummod	_	_
12	and	_	CONJ	CC	_	7	cc	_	_
13	0.8	_	NUM	CD	_	14	nummod	_	_
14	nM	_	NOUN	NN	_	7	conj	_	_
15	respectively	_	ADV	RB	_	19	advmod	_	_
16	,	_	.	,	_	19	punct	_	_
17	serotonin	_	NOUN	NN	_	19	compound	_	_
18	5	_	NUM	CD	_	19	nummod	_	_
19	HT1A	_	NOUN	NN	_	2	nmod	_	_
20	and	_	CONJ	CC	_	19	cc	_	_
21	5	_	NUM	CD	_	23	nummod	_	_
22	HT2A	_	NOUN	NN	_	23	compound	_	_
23	receptors	_	NOUN	NNS	_	19	conj	_	_
24	Kis	_	NOUN	NN	_	23	dep	_	_
25	1.7	_	NUM	CD	_	24	nummod	_	_
26	and	_	CONJ	CC	_	24	cc	_	_
27	3.4	_	NUM	CD	_	28	nummod	_	_
28	nM	_	NOUN	NN	_	24	conj	_	_
29	respectively	_	ADV	RB	_	19	advmod	_	_
30	,	_	.	,	_	19	punct	_	_
31	moderate	_	ADJ	JJ	_	32	amod	_	_
32	affinity	_	NOUN	NN	_	30	root	_	_
33	for	_	ADP	IN	_	35	case	_	_
34	dopamine	_	NOUN	NN	_	35	compound	_	_
35	D4	_	NOUN	NN	_	32	nmod	_	_
36	,	_	.	,	_	35	punct	_	_
37	serotonin	_	NOUN	NN	_	39	compound	_	_
38	5	_	NUM	CD	_	39	nummod	_	_
39	HT2C	_	NOUN	NN	_	35	conj	_	_
40	and	_	CONJ	CC	_	35	cc	_	_
41	5	_	NUM	CD	_	42	nummod	_	_
42	HT7	_	NOUN	NN	_	35	conj	_	_
43	,	_	.	,	_	35	punct	_	_
44	alpha1	_	NOUN	NN	_	45	compound	_	_
45	adrenergic	_	ADJ	JJ	_	35	conj	_	_
46	and	_	CONJ	CC	_	35	cc	_	_
47	histamine	_	NOUN	NN	_	49	compound	_	_
48	H1	_	NOUN	NN	_	49	compound	_	_
49	receptors	_	NOUN	NNS	_	35	conj	_	_
50	Kis	_	NOUN	NN	_	52	compound	_	_
51	44	_	NUM	CD	_	52	nummod	_	_
52	nM	_	NOUN	NN	_	35	dep	_	_
53	,	_	.	,	_	52	punct	_	_
54	15	_	NUM	CD	_	55	nummod	_	_
55	nM	_	NOUN	NN	_	52	conj	_	_
56	,	_	.	,	_	52	punct	_	_
57	39	_	NUM	CD	_	58	nummod	_	_
58	nM	_	NOUN	NN	_	52	conj	_	_
59	,	_	.	,	_	52	punct	_	_
60	57	_	NUM	CD	_	61	nummod	_	_
61	nM	_	NOUN	NN	_	52	conj	_	_
62	,	_	.	,	_	52	punct	_	_
63	and	_	CONJ	CC	_	52	cc	_	_
64	61	_	NUM	CD	_	65	nummod	_	_
65	nM	_	NOUN	NN	_	52	conj	_	_
66	,	_	.	,	_	32	punct	_	_
67	respectively	_	ADV	RB	_	32	advmod	_	_
68	,	_	.	,	_	32	punct	_	_
69	and	_	CONJ	CC	_	32	cc	_	_
70	moderate	_	ADJ	JJ	_	71	amod	_	_
71	affinity	_	NOUN	NN	_	32	conj	_	_
72	for	_	ADP	IN	_	79	case	_	_
73	the	_	DET	DT	_	79	det	_	_
74	serotonin	_	NOUN	NN	_	79	compound	_	_
75	reuptake	_	NOUN	NN	_	79	compound	_	_
76	site	_	NOUN	NN	_	79	compound	_	_
77	Ki	_	NOUN	NN	_	79	compound	_	_
78	98	_	NUM	CD	_	79	nummod	_	_
79	nM	_	NOUN	NN	_	71	nmod	_	_

#	ABILIFY MAINTENA	2296
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	has	_	VERB	VBZ	_	0	root	_	_
3	no	_	DET	DT	_	5	neg	_	_
4	appreciable	_	ADJ	JJ	_	5	amod	_	_
5	affinity	_	NOUN	NN	_	2	dobj	_	_
6	for	_	ADP	IN	_	9	case	_	_
7	cholinergic	_	ADJ	JJ	_	9	amod	_	_
8	muscarinic	_	ADJ	JJ	_	9	amod	_	_
9	receptors	_	NOUN	NNS	_	5	nmod	_	_
10	IC50>1000nM	_	NOUN	NN	_	9	dep	_	_

#	ABILIFY MAINTENA	2297
1	Actions	_	NOUN	NNS	_	15	nsubj	_	_
2	at	_	ADP	IN	_	3	case	_	_
3	receptors	_	NOUN	NNS	_	1	nmod	_	_
4	other	_	ADJ	JJ	_	6	case	_	_
5	than	_	ADP	IN	_	4	mwe	_	_
6	D2	_	NOUN	NN	_	3	nmod	_	_
7	,	_	.	,	_	6	punct	_	_
8	5	_	NUM	CD	_	9	nummod	_	_
9	HT1A	_	NOUN	NN	_	6	conj	_	_
10	,	_	.	,	_	6	punct	_	_
11	and	_	CONJ	CC	_	6	cc	_	_
12	5	_	NUM	CD	_	13	nummod	_	_
13	HT2A	_	NOUN	NN	_	6	conj	_	_
14	may	_	VERB	MD	_	15	aux	_	_
15	explain	_	VERB	VB	_	0	root	_	_
16	some	_	DET	DT	_	15	dobj	_	_
17	of	_	ADP	IN	_	21	case	_	_
18	the	_	DET	DT	_	21	det	_	_
19	other	_	ADJ	JJ	_	21	amod	_	_
20	adverse	_	ADJ	JJ	_	21	amod	_	_
21	reactions	_	NOUN	NNS	_	16	nmod	_	_
22	of	_	ADP	IN	_	24	case	_	_
23	DRUG	_	NOUN	NN	_	24	compound	_	_
24	e.g	_	NOUN	NN	_	21	nmod	_	_
25	,	_	.	,	_	15	punct	_	_
26	the	_	DET	DT	_	28	det	_	_
27	orthostatic	_	ADJ	JJ	_	28	amod	_	_
28	hypotension	_	NOUN	NN	_	34	nsubjpass	_	_
29	observed	_	VERB	VBN	_	28	acl	_	_
30	with	_	ADP	IN	_	31	case	_	_
31	DRUG	_	NOUN	NN	_	29	nmod	_	_
32	may	_	VERB	MD	_	34	aux	_	_
33	be	_	VERB	VB	_	34	auxpass	_	_
34	explained	_	VERB	VBN	_	15	parataxis	_	_
35	by	_	ADP	IN	_	38	case	_	_
36	its	_	PRON	PRP$	_	38	nmod:poss	_	_
37	antagonist	_	NOUN	NN	_	38	compound	_	_
38	activity	_	NOUN	NN	_	34	nmod	_	_
39	at	_	ADP	IN	_	42	case	_	_
40	adrenergic	_	ADJ	JJ	_	42	amod	_	_
41	alpha1	_	NOUN	NN	_	42	compound	_	_
42	receptors	_	NOUN	NNS	_	38	nmod	_	_

#	ABILIFY MAINTENA	2298
1	Alcohol	_	NOUN	NN	_	6	nsubj	_	_
2	There	_	NUM	CD	_	1	nummod	_	_
3	was	_	VERB	VBD	_	6	cop	_	_
4	no	_	DET	DT	_	6	neg	_	_
5	significant	_	ADJ	JJ	_	6	amod	_	_
6	difference	_	NOUN	NN	_	0	root	_	_
7	between	_	ADP	IN	_	9	case	_	_
8	oral	_	ADJ	JJ	_	9	amod	_	_
9	DRUG	_	NOUN	NN	_	6	nmod	_	_
10	co	_	PRT	TO	_	11	mark	_	_
11	administered	_	VERB	VBN	_	6	acl	_	_
12	with	_	ADP	IN	_	13	case	_	_
13	ethanol	_	NOUN	NN	_	11	nmod	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	placebo	_	NOUN	NN	_	13	conj	_	_
16	co	_	.	,	_	13	punct	_	_
17	administered	_	VERB	VBN	_	13	acl	_	_
18	with	_	ADP	IN	_	19	case	_	_
19	ethanol	_	NOUN	NN	_	17	nmod	_	_
20	on	_	ADP	IN	_	21	case	_	_
21	performance	_	NOUN	NN	_	17	nmod	_	_
22	of	_	ADP	IN	_	25	case	_	_
23	gross	_	ADJ	JJ	_	25	amod	_	_
24	motor	_	NOUN	NN	_	25	compound	_	_
25	skills	_	NOUN	NNS	_	21	nmod	_	_
26	or	_	CONJ	CC	_	25	cc	_	_
27	stimulus	_	NOUN	NN	_	28	compound	_	_
28	response	_	NOUN	NN	_	25	conj	_	_
29	in	_	ADP	IN	_	31	case	_	_
30	healthy	_	ADJ	JJ	_	31	amod	_	_
31	subjects	_	NOUN	NNS	_	21	nmod	_	_

#	ABILIFY MAINTENA	2299
1	As	_	ADP	IN	_	5	case	_	_
2	with	_	ADP	IN	_	5	case	_	_
3	most	_	ADV	RB	_	4	advmod	_	_
4	psychoactive	_	ADJ	JJ	_	5	amod	_	_
5	medications	_	NOUN	NNS	_	10	nmod	_	_
6	,	_	.	,	_	10	punct	_	_
7	patients	_	NOUN	NNS	_	10	nsubjpass	_	_
8	should	_	VERB	MD	_	10	aux	_	_
9	be	_	VERB	VB	_	10	auxpass	_	_
10	advised	_	VERB	VBN	_	0	root	_	_
11	to	_	PRT	TO	_	12	mark	_	_
12	avoid	_	VERB	VB	_	10	xcomp	_	_
13	alcohol	_	NOUN	NN	_	12	dobj	_	_
14	while	_	ADP	IN	_	15	mark	_	_
15	taking	_	VERB	VBG	_	12	advcl	_	_
16	DRUG	_	NOUN	NN	_	15	dobj	_	_

#	ABILIFY MAINTENA	2300
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	activity	_	NOUN	NN	_	6	nsubj	_	_
3	is	_	VERB	VBZ	_	6	cop	_	_
4	presumably	_	ADV	RB	_	5	advmod	_	_
5	primarily	_	ADV	RB	_	6	advmod	_	_
6	due	_	ADJ	JJ	_	0	root	_	_
7	to	_	PRT	TO	_	10	case	_	_
8	the	_	DET	DT	_	10	det	_	_
9	parent	_	NOUN	NN	_	10	compound	_	_
10	drug	_	NOUN	NN	_	6	nmod	_	_
11	,	_	.	,	_	10	punct	_	_
12	DRUG	_	NOUN	NN	_	10	conj	_	_
13	,	_	.	,	_	10	punct	_	_
14	and	_	CONJ	CC	_	10	cc	_	_
15	to	_	PRT	TO	_	18	case	_	_
16	a	_	DET	DT	_	18	det	_	_
17	lesser	_	ADJ	JJ	_	18	amod	_	_
18	extent	_	NOUN	NN	_	10	conj	_	_
19	,	_	.	,	_	18	punct	_	_
20	to	_	PRT	TO	_	23	case	_	_
21	its	_	PRON	PRP$	_	23	nmod:poss	_	_
22	major	_	ADJ	JJ	_	23	amod	_	_
23	metabolite	_	NOUN	NN	_	18	nmod	_	_
24	,	_	.	,	_	23	punct	_	_
25	dehydro	_	VERB	VBD	_	23	acl	_	_
26	DRUG	_	NOUN	NN	_	25	xcomp	_	_
27	,	_	.	,	_	23	punct	_	_
28	which	_	DET	WDT	_	31	nsubjpass	_	_
29	has	_	VERB	VBZ	_	31	aux	_	_
30	been	_	VERB	VBN	_	31	auxpass	_	_
31	shown	_	VERB	VBN	_	23	acl:relcl	_	_
32	to	_	PRT	TO	_	33	mark	_	_
33	have	_	VERB	VB	_	31	xcomp	_	_
34	affinities	_	NOUN	NNS	_	33	dobj	_	_
35	for	_	ADP	IN	_	37	case	_	_
36	D2	_	NOUN	NN	_	37	compound	_	_
37	receptors	_	NOUN	NNS	_	34	nmod	_	_
38	similar	_	ADJ	JJ	_	37	amod	_	_
39	to	_	PRT	TO	_	42	case	_	_
40	the	_	DET	DT	_	42	det	_	_
41	parent	_	NOUN	NN	_	42	compound	_	_
42	drug	_	NOUN	NN	_	38	nmod	_	_
43	and	_	CONJ	CC	_	31	cc	_	_
44	represents	_	VERB	VBZ	_	31	conj	_	_
45	about	_	ADV	RB	_	46	advmod	_	_
46	29%	_	NOUN	NN	_	44	dobj	_	_
47	of	_	ADP	IN	_	51	case	_	_
48	the	_	DET	DT	_	51	det	_	_
49	parent	_	NOUN	NN	_	51	compound	_	_
50	drug	_	NOUN	NN	_	51	compound	_	_
51	exposure	_	NOUN	NN	_	46	nmod	_	_
52	in	_	ADP	IN	_	53	case	_	_
53	plasma	_	NOUN	NN	_	51	nmod	_	_

#	ABILIFY MAINTENA	2301
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	absorption	_	NOUN	NN	_	8	nsubj	_	_
3	into	_	ADP	IN	_	6	case	_	_
4	the	_	DET	DT	_	6	det	_	_
5	systemic	_	ADJ	JJ	_	6	amod	_	_
6	circulation	_	NOUN	NN	_	2	nmod	_	_
7	is	_	VERB	VBZ	_	8	cop	_	_
8	slow	_	ADJ	JJ	_	0	root	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	prolonged	_	VERB	VBN	_	8	conj	_	_
11	following	_	ADP	IN	_	13	case	_	_
12	intramuscular	_	ADJ	JJ	_	13	amod	_	_
13	injection	_	NOUN	NN	_	10	nmod	_	_
14	due	_	ADJ	JJ	_	17	case	_	_
15	to	_	PRT	TO	_	17	case	_	_
16	low	_	ADJ	JJ	_	17	amod	_	_
17	solubility	_	NOUN	NN	_	10	nmod	_	_
18	of	_	ADP	IN	_	20	case	_	_
19	DRUG	_	NOUN	NN	_	20	compound	_	_
20	particles	_	NOUN	NNS	_	17	nmod	_	_

#	ABILIFY MAINTENA	2302
1	Following	_	ADP	IN	_	5	case	_	_
2	a	_	DET	DT	_	5	det	_	_
3	single	_	ADJ	JJ	_	5	amod	_	_
4	dose	_	NOUN	NN	_	5	compound	_	_
5	administration	_	NOUN	NN	_	39	nmod	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	in	_	ADP	IN	_	13	case	_	_
9	the	_	DET	DT	_	13	det	_	_
10	deltoid	_	ADJ	JJ	_	13	amod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	gluteal	_	ADJ	JJ	_	10	conj	_	_
13	muscle	_	NOUN	NN	_	5	nmod	_	_
14	,	_	.	,	_	39	punct	_	_
15	the	_	DET	DT	_	16	det	_	_
16	extent	_	NOUN	NN	_	39	nsubj	_	_
17	of	_	ADP	IN	_	19	case	_	_
18	absorption	_	NOUN	NN	_	19	compound	_	_
19	AUCt	_	NOUN	NN	_	16	nmod	_	_
20	,	_	.	,	_	16	punct	_	_
21	AUC*	_	NOUN	NN	_	25	nsubj	_	_
22	of	_	ADP	IN	_	23	case	_	_
23	DRUG	_	NOUN	NN	_	21	nmod	_	_
24	was	_	VERB	VBD	_	25	cop	_	_
25	similar	_	ADJ	JJ	_	16	acl:relcl	_	_
26	for	_	ADP	IN	_	29	case	_	_
27	both	_	CONJ	CC	_	29	det	_	_
28	injection	_	NOUN	NN	_	29	compound	_	_
29	sites	_	NOUN	NNS	_	25	nmod	_	_
30	,	_	.	,	_	16	punct	_	_
31	but	_	CONJ	CC	_	16	cc	_	_
32	the	_	DET	DT	_	33	det	_	_
33	rate	_	NOUN	NN	_	16	conj	_	_
34	of	_	ADP	IN	_	36	case	_	_
35	absorption	_	NOUN	NN	_	36	compound	_	_
36	Cmax	_	NOUN	NN	_	33	nmod	_	_
37	was	_	VERB	VBD	_	39	cop	_	_
38	31%	_	ADJ	JJ	_	39	advmod	_	_
39	higher	_	ADJ	JJ	_	0	root	_	_
40	following	_	ADP	IN	_	41	case	_	_
41	administration	_	NOUN	NN	_	39	nmod	_	_
42	to	_	PRT	TO	_	44	case	_	_
43	the	_	DET	DT	_	44	det	_	_
44	deltoid	_	NOUN	NN	_	41	nmod	_	_
45	compared	_	VERB	VBN	_	39	dep	_	_
46	to	_	PRT	TO	_	49	case	_	_
47	the	_	DET	DT	_	49	det	_	_
48	gluteal	_	ADJ	JJ	_	49	amod	_	_
49	site	_	NOUN	NN	_	45	nmod	_	_

#	ABILIFY MAINTENA	2303
1	However	_	ADV	RB	_	11	advmod	_	_
2	,	_	.	,	_	11	punct	_	_
3	at	_	ADP	IN	_	5	case	_	_
4	steady	_	ADJ	JJ	_	5	amod	_	_
5	state	_	NOUN	NN	_	11	nmod	_	_
6	,	_	.	,	_	11	punct	_	_
7	AUC	_	NOUN	NN	_	11	nsubj	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	Cmax	_	NOUN	NN	_	7	conj	_	_
10	were	_	VERB	VBD	_	11	cop	_	_
11	similar	_	ADJ	JJ	_	0	root	_	_
12	for	_	ADP	IN	_	14	case	_	_
13	both	_	DET	DT	_	14	det	_	_
14	sites	_	NOUN	NNS	_	11	nmod	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	injection	_	NOUN	NN	_	14	nmod	_	_

#	ABILIFY MAINTENA	2304
1	Following	_	VERB	VBG	_	4	case	_	_
2	multiple	_	ADJ	JJ	_	4	amod	_	_
3	intramuscular	_	ADJ	JJ	_	4	amod	_	_
4	doses	_	NOUN	NNS	_	12	nmod	_	_
5	,	_	.	,	_	12	punct	_	_
6	the	_	DET	DT	_	8	det	_	_
7	plasma	_	NOUN	NN	_	8	compound	_	_
8	concentrations	_	NOUN	NNS	_	12	nsubj	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	gradually	_	ADV	RB	_	12	advmod	_	_
12	rise	_	VERB	VBP	_	0	root	_	_
13	to	_	PRT	TO	_	16	case	_	_
14	maximum	_	ADJ	JJ	_	16	compound	_	_
15	plasma	_	NOUN	NN	_	16	compound	_	_
16	concentrations	_	NOUN	NNS	_	12	nmod	_	_
17	at	_	ADP	IN	_	20	case	_	_
18	a	_	DET	DT	_	20	det	_	_
19	median	_	ADJ	JJ	_	20	amod	_	_
20	Tmax	_	NOUN	NN	_	12	nmod	_	_
21	of	_	ADP	IN	_	24	case	_	_
22	5	_	NUM	CD	_	24	nummod	_	_
23	7	_	NUM	CD	_	24	nummod	_	_
24	days	_	NOUN	NNS	_	20	nmod	_	_
25	for	_	ADP	IN	_	28	case	_	_
26	the	_	DET	DT	_	28	det	_	_
27	gluteal	_	ADJ	JJ	_	28	amod	_	_
28	muscle	_	NOUN	NN	_	24	nmod	_	_
29	and	_	CONJ	CC	_	20	cc	_	_
30	4	_	NUM	CD	_	31	nummod	_	_
31	days	_	NOUN	NNS	_	20	conj	_	_
32	for	_	ADP	IN	_	35	case	_	_
33	the	_	DET	DT	_	35	det	_	_
34	deltoid	_	ADJ	JJ	_	35	amod	_	_
35	muscle	_	NOUN	NN	_	31	nmod	_	_

#	ABILIFY MAINTENA	2305
1	After	_	ADP	IN	_	3	case	_	_
2	gluteal	_	ADJ	JJ	_	3	amod	_	_
3	administration	_	NOUN	NN	_	15	nmod	_	_
4	,	_	.	,	_	15	punct	_	_
5	the	_	DET	DT	_	12	det	_	_
6	mean	_	NOUN	NN	_	12	compound	_	_
7	apparent	_	ADJ	JJ	_	12	amod	_	_
8	DRUG	_	NOUN	NN	_	12	compound	_	_
9	terminal	_	ADJ	JJ	_	12	amod	_	_
10	elimination	_	NOUN	NN	_	12	compound	_	_
11	half	_	NOUN	NN	_	12	compound	_	_
12	life	_	NOUN	NN	_	15	nsubj	_	_
13	was	_	VERB	VBD	_	15	cop	_	_
14	29.9	_	NUM	CD	_	15	nummod	_	_
15	days	_	NOUN	NNS	_	0	root	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	46.5	_	NUM	CD	_	18	nummod	_	_
18	days	_	NOUN	NNS	_	15	conj	_	_
19	after	_	ADP	IN	_	21	case	_	_
20	multiple	_	ADJ	JJ	_	21	amod	_	_
21	injections	_	NOUN	NNS	_	15	nmod	_	_
22	for	_	ADP	IN	_	26	case	_	_
23	every	_	ADV	RB	_	24	advmod	_	_
24	4	_	NUM	CD	_	26	nummod	_	_
25	week	_	NOUN	NN	_	26	compound	_	_
26	injection	_	NOUN	NN	_	21	nmod	_	_
27	of	_	ADP	IN	_	30	case	_	_
28	DRUG	_	NOUN	NN	_	30	compound	_	_
29	300	_	NUM	CD	_	30	nummod	_	_
30	mg	_	NOUN	NN	_	26	nmod	_	_
31	and	_	CONJ	CC	_	30	cc	_	_
32	400	_	NUM	CD	_	33	nummod	_	_
33	mg	_	NOUN	NN	_	30	conj	_	_
34	,	_	.	,	_	15	punct	_	_
35	respectively	_	ADV	RB	_	15	advmod	_	_

#	ABILIFY MAINTENA	2306
1	Steady	_	ADJ	JJ	_	3	amod	_	_
2	state	_	NOUN	NN	_	3	compound	_	_
3	concentrations	_	NOUN	NNS	_	9	nsubjpass	_	_
4	for	_	ADP	IN	_	7	case	_	_
5	the	_	DET	DT	_	7	det	_	_
6	typical	_	ADJ	JJ	_	7	amod	_	_
7	subject	_	NOUN	NN	_	3	nmod	_	_
8	were	_	VERB	VBD	_	9	auxpass	_	_
9	attained	_	VERB	VBN	_	0	root	_	_
10	by	_	ADP	IN	_	13	case	_	_
11	the	_	DET	DT	_	13	det	_	_
12	fourth	_	ADJ	JJ	_	13	amod	_	_
13	dose	_	NOUN	NN	_	9	nmod	_	_
14	for	_	ADP	IN	_	16	case	_	_
15	both	_	DET	DT	_	16	det	_	_
16	sites	_	NOUN	NNS	_	13	nmod	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	administration	_	NOUN	NN	_	16	nmod	_	_

#	ABILIFY MAINTENA	2307
1	Approximate	_	ADJ	JJ	_	4	amod	_	_
2	dose	_	NOUN	NN	_	4	compound	_	_
3	proportional	_	ADJ	JJ	_	4	amod	_	_
4	increases	_	NOUN	NNS	_	12	nsubjpass	_	_
5	in	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	dehydro	_	ADJ	JJ	_	10	amod	_	_
9	DRUG	_	NOUN	NN	_	10	compound	_	_
10	exposure	_	NOUN	NN	_	6	conj	_	_
11	were	_	VERB	VBD	_	12	auxpass	_	_
12	observed	_	VERB	VBN	_	0	root	_	_
13	after	_	ADP	IN	_	18	case	_	_
14	every	_	ADV	RB	_	15	advmod	_	_
15	four	_	NUM	CD	_	18	nummod	_	_
16	week	_	NOUN	NN	_	18	compound	_	_
17	DRUG	_	NOUN	NN	_	18	compound	_	_
18	injections	_	NOUN	NNS	_	12	nmod	_	_
19	of	_	ADP	IN	_	21	case	_	_
20	300	_	NUM	CD	_	21	nummod	_	_
21	mg	_	NOUN	NN	_	18	nmod	_	_
22	and	_	CONJ	CC	_	21	cc	_	_
23	400	_	NUM	CD	_	24	nummod	_	_
24	mg	_	NOUN	NNS	_	21	conj	_	_

#	ABILIFY MAINTENA	2308
1	Elimination	_	NOUN	NN	_	8	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	is	_	VERB	VBZ	_	8	cop	_	_
5	mainly	_	ADV	RB	_	8	advmod	_	_
6	through	_	ADP	IN	_	8	case	_	_
7	hepatic	_	ADJ	JJ	_	8	amod	_	_
8	metabolism	_	NOUN	NN	_	0	root	_	_
9	involving	_	VERB	VBG	_	8	acl	_	_
10	two	_	NUM	CD	_	12	nummod	_	_
11	P450	_	NOUN	NN	_	12	compound	_	_
12	isozymes	_	NOUN	NNS	_	9	dobj	_	_
13	,	_	.	,	_	12	punct	_	_
14	CYP2D6	_	NOUN	NN	_	12	appos	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	CYP3A4	_	NOUN	NN	_	14	conj	_	_

#	ABILIFY MAINTENA	2309
1	DRUG	_	NOUN	NN	_	5	nsubj	_	_
2	is	_	VERB	VBZ	_	5	cop	_	_
3	not	_	ADV	RB	_	5	neg	_	_
4	a	_	DET	DT	_	5	det	_	_
5	substrate	_	NOUN	NN	_	0	root	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	CYP1A1	_	NOUN	NN	_	5	nmod	_	_
8	,	_	.	,	_	7	punct	_	_
9	CYP1A2	_	NOUN	NN	_	7	conj	_	_
10	,	_	.	,	_	7	punct	_	_
11	CYP2A6	_	NOUN	NN	_	7	conj	_	_
12	,	_	.	,	_	7	punct	_	_
13	CYP2B6	_	NOUN	NN	_	7	conj	_	_
14	,	_	.	,	_	7	punct	_	_
15	CYP2C8	_	NOUN	NN	_	7	conj	_	_
16	,	_	.	,	_	7	punct	_	_
17	CYP2C9	_	NOUN	NN	_	7	conj	_	_
18	,	_	.	,	_	7	punct	_	_
19	CYP2C19	_	NOUN	NN	_	7	conj	_	_
20	,	_	.	,	_	7	punct	_	_
21	or	_	CONJ	CC	_	7	cc	_	_
22	CYP2E1	_	NOUN	NN	_	23	compound	_	_
23	enzymes	_	NOUN	NNS	_	7	conj	_	_

#	ABILIFY MAINTENA	2310
1	DRUG	_	NOUN	NN	_	5	nsubj	_	_
2	also	_	ADV	RB	_	5	advmod	_	_
3	does	_	VERB	VBZ	_	5	aux	_	_
4	not	_	ADV	RB	_	5	neg	_	_
5	undergo	_	VERB	VB	_	0	root	_	_
6	direct	_	ADJ	JJ	_	7	amod	_	_
7	glucuronidation	_	NOUN	NN	_	5	dobj	_	_

#	ABILIFY MAINTENA	2311
1	Drug	_	NOUN	NN	_	3	compound	_	_
2	Interaction	_	NOUN	NN	_	3	compound	_	_
3	Studies	_	NOUN	NNS	_	11	nsubjpass	_	_
4	No	_	X	FW	_	8	compound	_	_
5	specific	_	ADJ	JJ	_	8	amod	_	_
6	drug	_	NOUN	NN	_	8	compound	_	_
7	interaction	_	NOUN	NN	_	8	compound	_	_
8	studies	_	NOUN	NNS	_	3	nmod	_	_
9	have	_	VERB	VBP	_	11	aux	_	_
10	been	_	VERB	VBN	_	11	auxpass	_	_
11	performed	_	VERB	VBN	_	0	root	_	_
12	with	_	ADP	IN	_	13	case	_	_
13	DRUG	_	NOUN	NN	_	11	nmod	_	_

#	ABILIFY MAINTENA	2312
1	The	_	DET	DT	_	3	det	_	_
2	information	_	NOUN	NN	_	3	compound	_	_
3	below	_	NOUN	NN	_	5	nsubjpass	_	_
4	is	_	VERB	VBZ	_	5	auxpass	_	_
5	obtained	_	VERB	VBN	_	0	root	_	_
6	from	_	ADP	IN	_	7	case	_	_
7	studies	_	NOUN	NNS	_	5	nmod	_	_
8	with	_	ADP	IN	_	10	case	_	_
9	oral	_	ADJ	JJ	_	10	amod	_	_
10	DRUG	_	NOUN	NN	_	7	nmod	_	_

#	ABILIFY MAINTENA	2313
1	Effects	_	NOUN	NNS	_	14	nsubjpass	_	_
2	of	_	ADP	IN	_	4	case	_	_
3	other	_	ADJ	JJ	_	4	amod	_	_
4	drugs	_	NOUN	NNS	_	1	nmod	_	_
5	on	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	exposures	_	NOUN	NNS	_	1	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	and	_	CONJ	CC	_	1	cc	_	_
11	dehydro	_	ADJ	JJ	_	12	amod	_	_
12	DRUG	_	NOUN	NN	_	1	conj	_	_
13	are	_	VERB	VBP	_	14	auxpass	_	_
14	summarized	_	VERB	VBN	_	0	root	_	_
15	in	_	ADP	IN	_	16	case	_	_
16	Figure	_	NOUN	NN	_	14	nmod	_	_
17	19	_	NUM	CD	_	16	nummod	_	_
18	and	_	CONJ	CC	_	16	cc	_	_
19	Figure	_	NOUN	NN	_	16	conj	_	_
20	20	_	NUM	CD	_	19	nummod	_	_
21	,	_	.	,	_	14	punct	_	_
22	respectively	_	ADV	RB	_	14	advmod	_	_

#	ABILIFY MAINTENA	2314
1	Based	_	VERB	VBN	_	19	advcl	_	_
2	on	_	ADP	IN	_	3	case	_	_
3	simulation	_	NOUN	NN	_	1	nmod	_	_
4	,	_	.	,	_	19	punct	_	_
5	a	_	DET	DT	_	8	det	_	_
6	4.5	_	NUM	CD	_	7	compound	_	_
7	fold	_	NOUN	NN	_	8	amod	_	_
8	increase	_	NOUN	NN	_	19	nsubjpass	_	_
9	in	_	ADP	IN	_	11	case	_	_
10	mean	_	ADJ	JJ	_	11	amod	_	_
11	Cmax	_	NOUN	NN	_	8	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	AUC	_	NOUN	NN	_	14	compound	_	_
14	values	_	NOUN	NNS	_	11	conj	_	_
15	at	_	ADP	IN	_	17	case	_	_
16	steady	_	ADJ	JJ	_	17	amod	_	_
17	state	_	NOUN	NN	_	8	nmod	_	_
18	is	_	VERB	VBZ	_	19	auxpass	_	_
19	expected	_	VERB	VBN	_	0	root	_	_
20	when	_	ADV	WRB	_	26	advmod	_	_
21	extensive	_	ADJ	JJ	_	22	amod	_	_
22	metabolizers	_	NOUN	NNS	_	26	nsubjpass	_	_
23	of	_	ADP	IN	_	24	case	_	_
24	CYP2D6	_	NOUN	NN	_	22	nmod	_	_
25	are	_	VERB	VBP	_	26	auxpass	_	_
26	administered	_	VERB	VBN	_	19	ccomp	_	_
27	with	_	ADP	IN	_	30	case	_	_
28	both	_	CONJ	CC	_	30	cc:preconj	_	_
29	strong	_	ADJ	JJ	_	30	amod	_	_
30	CYP2D6	_	NOUN	NN	_	26	nmod	_	_
31	and	_	CONJ	CC	_	30	cc	_	_
32	CYP3A4	_	NOUN	NN	_	33	compound	_	_
33	inhibitors	_	NOUN	NNS	_	30	conj	_	_

#	ABILIFY MAINTENA	2315
1	After	_	ADP	IN	_	3	case	_	_
2	oral	_	ADJ	JJ	_	3	amod	_	_
3	administration	_	NOUN	NN	_	19	nmod	_	_
4	,	_	.	,	_	19	punct	_	_
5	a	_	DET	DT	_	8	det	_	_
6	3	_	NUM	CD	_	8	nummod	_	_
7	fold	_	NOUN	NN	_	8	amod	_	_
8	increase	_	NOUN	NN	_	19	nsubjpass	_	_
9	in	_	ADP	IN	_	11	case	_	_
10	mean	_	ADJ	JJ	_	11	amod	_	_
11	Cmax	_	NOUN	NN	_	8	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	AUC	_	NOUN	NN	_	11	conj	_	_
14	values	_	NOUN	NNS	_	11	dep	_	_
15	at	_	ADP	IN	_	17	case	_	_
16	steady	_	ADJ	JJ	_	17	amod	_	_
17	state	_	NOUN	NN	_	8	nmod	_	_
18	is	_	VERB	VBZ	_	19	auxpass	_	_
19	expected	_	VERB	VBN	_	0	root	_	_
20	in	_	ADP	IN	_	22	case	_	_
21	poor	_	ADJ	JJ	_	22	amod	_	_
22	metabolizers	_	NOUN	NNS	_	19	nmod	_	_
23	of	_	ADP	IN	_	24	case	_	_
24	CYP2D6	_	NOUN	NN	_	22	nmod	_	_
25	administered	_	VERB	VBN	_	24	acl	_	_
26	with	_	ADP	IN	_	29	case	_	_
27	strong	_	ADJ	JJ	_	29	amod	_	_
28	CYP3A4	_	NOUN	NN	_	29	compound	_	_
29	inhibitors	_	NOUN	NNS	_	25	nmod	_	_

#	ABILIFY MAINTENA	2316
1	Figure	_	NOUN	NN	_	0	root	_	_
2	19	_	NUM	CD	_	1	nummod	_	_
3	:	_	.	:	_	1	punct	_	_
4	The	_	DET	DT	_	5	det	_	_
5	effects	_	NOUN	NNS	_	1	dep	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	other	_	ADJ	JJ	_	8	amod	_	_
8	drugs	_	NOUN	NNS	_	5	nmod	_	_
9	on	_	ADP	IN	_	11	case	_	_
10	DRUG	_	NOUN	NN	_	11	compound	_	_
11	pharmacokinetics	_	NOUN	NNS	_	5	nmod	_	_
12	Figure	_	NOUN	NN	_	11	dep	_	_
13	20	_	NUM	CD	_	12	nummod	_	_
14	:	_	.	:	_	1	punct	_	_
15	The	_	DET	DT	_	16	det	_	_
16	effects	_	NOUN	NNS	_	35	nmod	_	_
17	of	_	ADP	IN	_	19	case	_	_
18	other	_	ADJ	JJ	_	19	amod	_	_
19	drugs	_	NOUN	NNS	_	16	nmod	_	_
20	on	_	ADP	IN	_	23	case	_	_
21	dehydro	_	ADJ	JJ	_	23	amod	_	_
22	DRUG	_	NOUN	NN	_	23	compound	_	_
23	pharmacokinetics	_	NOUN	NNS	_	16	nmod	_	_
24	The	_	DET	DT	_	25	det	_	_
25	effects	_	NOUN	NNS	_	35	nsubjpass	_	_
26	of	_	ADP	IN	_	27	case	_	_
27	ABILIFY	_	NOUN	NN	_	25	nmod	_	_
28	on	_	ADP	IN	_	30	case	_	_
29	the	_	DET	DT	_	30	det	_	_
30	exposures	_	NOUN	NNS	_	25	nmod	_	_
31	of	_	ADP	IN	_	33	case	_	_
32	other	_	ADJ	JJ	_	33	amod	_	_
33	drugs	_	NOUN	NNS	_	30	nmod	_	_
34	are	_	VERB	VBP	_	35	auxpass	_	_
35	summarized	_	VERB	VBN	_	1	dep	_	_
36	in	_	ADP	IN	_	37	case	_	_
37	Figure	_	NOUN	NN	_	35	nmod	_	_
38	21	_	NUM	CD	_	37	nummod	_	_

#	ABILIFY MAINTENA	2317
1	A	_	DET	DT	_	4	det	_	_
2	population	_	NOUN	NN	_	4	compound	_	_
3	PK	_	NOUN	NN	_	4	compound	_	_
4	analysis	_	NOUN	NN	_	11	nsubj	_	_
5	in	_	ADP	IN	_	6	case	_	_
6	patients	_	NOUN	NNS	_	4	nmod	_	_
7	with	_	ADP	IN	_	10	case	_	_
8	major	_	ADJ	JJ	_	10	amod	_	_
9	depressive	_	ADJ	JJ	_	10	amod	_	_
10	disorder	_	NOUN	NN	_	6	nmod	_	_
11	showed	_	VERB	VBD	_	0	root	_	_
12	no	_	DET	DT	_	14	neg	_	_
13	substantial	_	ADJ	JJ	_	14	amod	_	_
14	change	_	NOUN	NN	_	11	dobj	_	_
15	in	_	ADP	IN	_	17	case	_	_
16	plasma	_	NOUN	NN	_	17	compound	_	_
17	concentrations	_	NOUN	NNS	_	14	nmod	_	_
18	of	_	ADP	IN	_	21	case	_	_
19	fluoxetine	_	NOUN	NN	_	21	compound	_	_
20	20	_	NUM	CD	_	21	nummod	_	_
21	mg	_	NOUN	NN	_	17	nmod	_	_
22	/	_	.	:	_	23	punct	_	_
23	day	_	NOUN	NN	_	14	nmod	_	_
24	or	_	CONJ	CC	_	23	cc	_	_
25	40	_	NUM	CD	_	26	nummod	_	_
26	mg	_	NOUN	NN	_	23	conj	_	_
27	/	_	.	:	_	26	punct	_	_
28	day	_	NOUN	NN	_	26	dep	_	_
29	,	_	.	,	_	26	punct	_	_
30	paroxetine	_	NOUN	NN	_	33	compound	_	_
31	CR	_	NOUN	NN	_	33	compound	_	_
32	37.5	_	NUM	CD	_	33	nummod	_	_
33	mg	_	NOUN	NN	_	26	conj	_	_
34	/	_	.	:	_	26	punct	_	_
35	day	_	NOUN	NN	_	26	dep	_	_
36	or	_	CONJ	CC	_	26	cc	_	_
37	50	_	NUM	CD	_	38	nummod	_	_
38	mg	_	NOUN	NN	_	26	conj	_	_
39	/	_	.	:	_	26	punct	_	_
40	day	_	NOUN	NN	_	26	dep	_	_
41	,	_	.	,	_	11	punct	_	_
42	or	_	CONJ	CC	_	11	cc	_	_
43	sertraline	_	NOUN	NN	_	45	compound	_	_
44	100	_	NUM	CD	_	45	nummod	_	_
45	mg	_	NOUN	NN	_	11	conj	_	_
46	/	_	.	:	_	45	punct	_	_
47	day	_	NOUN	NN	_	45	dep	_	_
48	or	_	CONJ	CC	_	47	cc	_	_
49	150	_	NUM	CD	_	50	nummod	_	_
50	mg	_	NOUN	NN	_	47	conj	_	_
51	/	_	.	:	_	45	punct	_	_
52	day	_	NOUN	NN	_	45	dep	_	_
53	dosed	_	VERB	VBN	_	52	acl	_	_
54	to	_	PRT	TO	_	56	case	_	_
55	steady	_	ADJ	JJ	_	56	amod	_	_
56	state	_	NOUN	NN	_	53	nmod	_	_

#	ABILIFY MAINTENA	2318
1	The	_	DET	DT	_	5	det	_	_
2	steady	_	ADJ	JJ	_	5	amod	_	_
3	state	_	NOUN	NN	_	5	compound	_	_
4	plasma	_	NOUN	NN	_	5	compound	_	_
5	concentrations	_	NOUN	NNS	_	10	nsubj	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	fluoxetine	_	NOUN	NN	_	5	nmod	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	norfluoxetine	_	NOUN	NN	_	7	conj	_	_
10	increased	_	VERB	VBD	_	0	root	_	_
11	by	_	ADP	IN	_	13	case	_	_
12	about	_	ADV	RB	_	13	advmod	_	_
13	18%	_	ADJ	JJ	_	10	nmod	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	36%	_	NOUN	NN	_	13	conj	_	_
16	,	_	.	,	_	13	punct	_	_
17	respectively	_	ADV	RB	_	13	advmod	_	_
18	,	_	.	,	_	10	punct	_	_
19	and	_	CONJ	CC	_	10	cc	_	_
20	concentrations	_	NOUN	NNS	_	23	nsubj	_	_
21	of	_	ADP	IN	_	22	case	_	_
22	paroxetine	_	NOUN	NN	_	20	nmod	_	_
23	decreased	_	VERB	VBD	_	10	conj	_	_
24	by	_	ADP	IN	_	26	case	_	_
25	about	_	ADV	RB	_	26	advmod	_	_
26	27%	_	ADJ	JJ	_	23	nmod	_	_

#	ABILIFY MAINTENA	2319
1	The	_	DET	DT	_	5	det	_	_
2	steady	_	ADJ	JJ	_	5	amod	_	_
3	state	_	NOUN	NN	_	5	compound	_	_
4	plasma	_	NOUN	NN	_	5	compound	_	_
5	concentrations	_	NOUN	NNS	_	13	nsubjpass	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	sertraline	_	NOUN	NN	_	5	nmod	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	desmethylsertraline	_	NOUN	NN	_	7	conj	_	_
10	were	_	VERB	VBD	_	13	auxpass	_	_
11	not	_	ADV	RB	_	13	neg	_	_
12	substantially	_	ADV	RB	_	13	advmod	_	_
13	changed	_	VERB	VBN	_	0	root	_	_
14	when	_	ADV	WRB	_	19	advmod	_	_
15	these	_	DET	DT	_	17	det	_	_
16	antidepressant	_	ADJ	JJ	_	17	amod	_	_
17	therapies	_	NOUN	NNS	_	19	nsubjpass	_	_
18	were	_	VERB	VBD	_	19	auxpass	_	_
19	coadministered	_	VERB	VBN	_	13	ccomp	_	_
20	with	_	ADP	IN	_	21	case	_	_
21	DRUG	_	NOUN	NN	_	19	nmod	_	_

#	ABILIFY MAINTENA	2320
1	Figure	_	NOUN	NN	_	0	root	_	_
2	21	_	NUM	CD	_	1	nummod	_	_
3	:	_	.	:	_	1	punct	_	_
4	The	_	DET	DT	_	5	det	_	_
5	effects	_	NOUN	NNS	_	1	dep	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	oral	_	ADJ	JJ	_	8	amod	_	_
8	DRUG	_	NOUN	NN	_	5	nmod	_	_
9	on	_	ADP	IN	_	10	case	_	_
10	pharmacokinetics	_	NOUN	NNS	_	5	nmod	_	_
11	of	_	ADP	IN	_	13	case	_	_
12	other	_	ADJ	JJ	_	13	amod	_	_
13	drugs	_	NOUN	NNS	_	10	nmod	_	_
14	Figure19	_	NOUN	NN	_	19	compound	_	_
15	Figure	_	NOUN	NN	_	19	compound	_	_
16	20	_	NUM	CD	_	19	nummod	_	_
17	Figure	_	NOUN	NN	_	19	compound	_	_
18	21	_	NUM	CD	_	19	nummod	_	_
19	Studies	_	NOUN	NNS	_	13	dep	_	_
20	in	_	ADP	IN	_	22	case	_	_
21	Specific	_	ADJ	JJ	_	22	amod	_	_
22	Populations	_	NOUN	NNS	_	29	nmod	_	_
23	No	_	NOUN	NN	_	26	compound	_	_
24	specific	_	ADJ	JJ	_	26	amod	_	_
25	pharmacokinetic	_	ADJ	JJ	_	26	amod	_	_
26	studies	_	NOUN	NNS	_	29	nsubjpass	_	_
27	have	_	VERB	VBP	_	29	aux	_	_
28	been	_	VERB	VBN	_	29	auxpass	_	_
29	performed	_	VERB	VBN	_	19	acl:relcl	_	_
30	with	_	ADP	IN	_	31	case	_	_
31	DRUG	_	NOUN	NN	_	29	nmod	_	_
32	in	_	ADP	IN	_	34	case	_	_
33	specific	_	ADJ	JJ	_	34	amod	_	_
34	populations	_	NOUN	NNS	_	29	nmod	_	_

#	ABILIFY MAINTENA	2321
1	All	_	DET	DT	_	5	advmod	_	_
2	the	_	DET	DT	_	3	det	_	_
3	information	_	NOUN	NN	_	5	nsubjpass	_	_
4	is	_	VERB	VBZ	_	5	auxpass	_	_
5	obtained	_	VERB	VBN	_	0	root	_	_
6	from	_	ADP	IN	_	7	case	_	_
7	studies	_	NOUN	NNS	_	5	nmod	_	_
8	with	_	ADP	IN	_	10	case	_	_
9	oral	_	ADJ	JJ	_	10	amod	_	_
10	DRUG	_	NOUN	NN	_	7	nmod	_	_

#	ABILIFY MAINTENA	2322
1	Exposures	_	NOUN	NNS	_	11	nsubjpass	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	and	_	CONJ	CC	_	1	cc	_	_
5	dehydro	_	VERB	VBD	_	6	amod	_	_
6	DRUG	_	NOUN	NN	_	1	conj	_	_
7	in	_	ADP	IN	_	9	case	_	_
8	specific	_	ADJ	JJ	_	9	amod	_	_
9	populations	_	NOUN	NNS	_	1	nmod	_	_
10	are	_	VERB	VBP	_	11	auxpass	_	_
11	summarized	_	VERB	VBN	_	0	root	_	_
12	in	_	ADP	IN	_	13	case	_	_
13	Figure	_	NOUN	NN	_	11	nmod	_	_
14	22	_	NUM	CD	_	13	nummod	_	_
15	and	_	CONJ	CC	_	13	cc	_	_
16	Figure	_	NOUN	NN	_	13	conj	_	_
17	23	_	NUM	CD	_	16	nummod	_	_
18	,	_	.	,	_	11	punct	_	_
19	respectively	_	ADV	RB	_	11	advmod	_	_

#	ABILIFY MAINTENA	2323
1	In	_	ADP	IN	_	2	case	_	_
2	addition	_	NOUN	NN	_	26	nmod	_	_
3	,	_	.	,	_	26	punct	_	_
4	in	_	ADP	IN	_	6	case	_	_
5	pediatric	_	ADJ	JJ	_	6	amod	_	_
6	patients	_	NOUN	NNS	_	26	nmod	_	_
7	10	_	NUM	CD	_	9	compound	_	_
8	to	_	PRT	TO	_	9	dep	_	_
9	17	_	NUM	CD	_	10	nummod	_	_
10	years	_	NOUN	NNS	_	6	dep	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	age	_	NOUN	NN	_	10	nmod	_	_
13	administered	_	VERB	VBN	_	12	acl	_	_
14	with	_	ADP	IN	_	18	case	_	_
15	oral	_	ADJ	JJ	_	18	amod	_	_
16	DRUG	_	NOUN	NN	_	18	compound	_	_
17	20	_	NUM	CD	_	18	nummod	_	_
18	mg	_	NOUN	NN	_	13	nmod	_	_
19	to	_	PRT	TO	_	21	case	_	_
20	30	_	NUM	CD	_	21	nummod	_	_
21	mg	_	NOUN	NN	_	13	nmod	_	_
22	,	_	.	,	_	26	punct	_	_
23	the	_	DET	DT	_	25	det	_	_
24	body	_	NOUN	NN	_	25	compound	_	_
25	weight	_	NOUN	NN	_	26	nsubj	_	_
26	corrected	_	VERB	VBD	_	0	root	_	_
27	DRUG	_	NOUN	NN	_	28	compound	_	_
28	clearance	_	NOUN	NN	_	26	dobj	_	_
29	was	_	VERB	VBD	_	30	cop	_	_
30	similar	_	ADJ	JJ	_	26	parataxis	_	_
31	to	_	PRT	TO	_	33	case	_	_
32	the	_	DET	DT	_	33	det	_	_
33	adults	_	NOUN	NNS	_	30	nmod	_	_

#	ABILIFY MAINTENA	2324
1	Figure	_	NOUN	NN	_	3	compound	_	_
2	22	_	NUM	CD	_	3	nummod	_	_
3	Effects	_	NOUN	NNS	_	0	root	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	intrinsic	_	ADJ	JJ	_	6	amod	_	_
6	factors	_	NOUN	NNS	_	3	nmod	_	_
7	on	_	ADP	IN	_	10	case	_	_
8	DRUG	_	NOUN	NN	_	10	compound	_	_
9	pharmacokinetics	_	NOUN	NNS	_	10	compound	_	_
10	Figure	_	NOUN	NN	_	3	nmod	_	_
11	23	_	NUM	CD	_	10	nummod	_	_
12	:	_	.	:	_	3	punct	_	_
13	Effects	_	NOUN	NNS	_	3	dep	_	_
14	of	_	ADP	IN	_	16	case	_	_
15	intrinsic	_	ADJ	JJ	_	16	amod	_	_
16	factors	_	NOUN	NNS	_	13	nmod	_	_
17	on	_	ADP	IN	_	20	case	_	_
18	dehydro	_	ADJ	JJ	_	20	amod	_	_
19	DRUG	_	NOUN	NN	_	20	compound	_	_
20	pharmacokinetics	_	NOUN	NNS	_	13	nmod	_	_
21	:	_	.	:	_	13	punct	_	_
22	Figure	_	NOUN	NN	_	24	compound	_	_
23	22	_	NUM	CD	_	24	nummod	_	_
24	Figure	_	NOUN	NN	_	13	dep	_	_
25	23	_	NUM	CD	_	24	nummod	_	_

#	Adasuve	2761
1	DRUG	_	NOUN	NN	_	8	nsubj	_	_
2	is	_	VERB	VBZ	_	8	cop	_	_
3	a	_	DET	DT	_	8	det	_	_
4	central	_	ADJ	JJ	_	8	amod	_	_
5	nervous	_	ADJ	JJ	_	8	amod	_	_
6	system	_	NOUN	NN	_	8	compound	_	_
7	CNS	_	NOUN	NN	_	8	compound	_	_
8	depressant	_	ADJ	JJ	_	0	root	_	_

#	Adasuve	2762
1	The	_	DET	DT	_	3	det	_	_
2	concurrent	_	ADJ	JJ	_	3	amod	_	_
3	use	_	NOUN	NN	_	41	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	with	_	ADP	IN	_	9	case	_	_
7	other	_	ADJ	JJ	_	9	amod	_	_
8	CNS	_	NOUN	NN	_	9	compound	_	_
9	depressants	_	NOUN	NNS	_	3	nmod	_	_
10	e.g	_	NOUN	NN	_	9	dep	_	_
11	,	_	.	,	_	10	punct	_	_
12	alcohol	_	NOUN	NN	_	10	conj	_	_
13	,	_	.	,	_	10	punct	_	_
14	opioid	_	ADJ	JJ	_	15	amod	_	_
15	analgesics	_	NOUN	NNS	_	10	conj	_	_
16	,	_	.	,	_	10	punct	_	_
17	benzodiazepines	_	NOUN	NNS	_	10	conj	_	_
18	,	_	.	,	_	10	punct	_	_
19	tricyclic	_	ADJ	JJ	_	20	amod	_	_
20	antidepressants	_	NOUN	NNS	_	10	conj	_	_
21	,	_	.	,	_	10	punct	_	_
22	general	_	ADJ	JJ	_	23	amod	_	_
23	anesthetics	_	NOUN	NNS	_	10	conj	_	_
24	,	_	.	,	_	10	punct	_	_
25	phenothiazines	_	NOUN	NNS	_	10	conj	_	_
26	,	_	.	,	_	10	punct	_	_
27	sedative	_	ADJ	JJ	_	29	amod	_	_
28	/	_	.	:	_	29	punct	_	_
29	hypnotics	_	NOUN	NNS	_	10	conj	_	_
30	,	_	.	,	_	10	punct	_	_
31	muscle	_	NOUN	NN	_	32	compound	_	_
32	relaxants	_	NOUN	NNS	_	10	conj	_	_
33	,	_	.	,	_	10	punct	_	_
34	and	_	CONJ	CC	_	10	cc	_	_
35	/	_	NUM	CD	_	39	compound	_	_
36	or	_	CONJ	CC	_	35	cc	_	_
37	illicit	_	ADJ	JJ	_	35	conj	_	_
38	CNS	_	NOUN	NN	_	39	compound	_	_
39	depressants	_	NOUN	NNS	_	10	conj	_	_
40	can	_	VERB	MD	_	41	aux	_	_
41	increase	_	VERB	VB	_	0	root	_	_
42	the	_	DET	DT	_	43	det	_	_
43	risk	_	NOUN	NN	_	41	dobj	_	_
44	of	_	ADP	IN	_	46	case	_	_
45	respiratory	_	ADJ	JJ	_	46	amod	_	_
46	depression	_	NOUN	NN	_	43	nmod	_	_
47	,	_	.	,	_	46	punct	_	_
48	hypotension	_	NOUN	NN	_	46	conj	_	_
49	,	_	.	,	_	46	punct	_	_
50	profound	_	ADJ	JJ	_	51	amod	_	_
51	sedation	_	NOUN	NN	_	46	conj	_	_
52	,	_	.	,	_	46	punct	_	_
53	and	_	CONJ	CC	_	46	cc	_	_
54	syncope	_	NOUN	NN	_	46	conj	_	_

#	Adasuve	2763
1	Therefore	_	ADV	RB	_	0	root	_	_
2	,	_	.	,	_	1	punct	_	_
3	consider	_	NOUN	NN	_	2	root	_	_
4	reducing	_	VERB	VBG	_	3	acl	_	_
5	the	_	DET	DT	_	6	det	_	_
6	dose	_	NOUN	NN	_	4	dobj	_	_
7	of	_	ADP	IN	_	9	case	_	_
8	CNS	_	NOUN	NN	_	9	compound	_	_
9	depressants	_	NOUN	NNS	_	6	nmod	_	_
10	if	_	DET	WDT	_	11	nsubj	_	_
11	used	_	VERB	VBN	_	6	acl	_	_
12	concomitantly	_	ADV	RB	_	11	advmod	_	_
13	with	_	ADP	IN	_	14	case	_	_
14	DRUG	_	NOUN	NN	_	11	nmod	_	_

#	Adasuve	2764
1	The	_	DET	DT	_	3	det	_	_
2	concomitant	_	ADJ	JJ	_	3	amod	_	_
3	use	_	NOUN	NN	_	11	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	other	_	ADJ	JJ	_	9	amod	_	_
8	anticholinergic	_	ADJ	JJ	_	9	amod	_	_
9	drugs	_	NOUN	NNS	_	5	conj	_	_
10	can	_	VERB	MD	_	11	aux	_	_
11	increase	_	VERB	VB	_	0	root	_	_
12	the	_	DET	DT	_	13	det	_	_
13	risk	_	NOUN	NN	_	11	dobj	_	_
14	of	_	ADP	IN	_	17	case	_	_
15	anticholinergic	_	ADJ	JJ	_	17	amod	_	_
16	adverse	_	ADJ	JJ	_	17	amod	_	_
17	reactions	_	NOUN	NNS	_	13	nmod	_	_
18	including	_	ADP	IN	_	19	case	_	_
19	exacerbation	_	NOUN	NN	_	17	nmod	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	glaucoma	_	NOUN	NN	_	19	nmod	_	_
22	and	_	CONJ	CC	_	21	cc	_	_
23	urinary	_	ADJ	JJ	_	24	amod	_	_
24	retention	_	NOUN	NN	_	21	conj	_	_

#	Adasuve	2765
1	Mean	_	NOUN	NN	_	3	compound	_	_
2	Plasma	_	NOUN	NN	_	3	compound	_	_
3	Concentrations	_	NOUN	NNS	_	31	nsubjpass	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	following	_	VERB	VBG	_	12	case	_	_
7	Single	_	ADJ	JJ	_	12	amod	_	_
8	Dose	_	NOUN	NN	_	12	compound	_	_
9	Administration	_	NOUN	NN	_	12	compound	_	_
10	DRUG	_	NOUN	NN	_	12	compound	_	_
11	10	_	NUM	CD	_	12	nummod	_	_
12	mg	_	NOUN	NN	_	3	nmod	_	_
13	in	_	ADP	IN	_	15	case	_	_
14	Healthy	_	ADJ	JJ	_	15	amod	_	_
15	Subjects	_	NOUN	NNS	_	3	nmod	_	_
16	The	_	DET	DT	_	17	det	_	_
17	mechanism	_	NOUN	NN	_	31	nsubj	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	action	_	NOUN	NN	_	17	nmod	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	DRUG	_	NOUN	NN	_	19	nmod	_	_
22	in	_	ADP	IN	_	24	case	_	_
23	the	_	DET	DT	_	24	det	_	_
24	treatment	_	NOUN	NN	_	17	nmod	_	_
25	of	_	ADP	IN	_	26	case	_	_
26	agitation	_	NOUN	NN	_	24	nmod	_	_
27	associated	_	VERB	VBN	_	26	acl	_	_
28	with	_	ADP	IN	_	29	case	_	_
29	schizophrenia	_	NOUN	NN	_	27	nmod	_	_
30	is	_	VERB	VBZ	_	31	auxpass	_	_
31	unknown	_	ADJ	JJ	_	0	root	_	_

#	Adasuve	2766
1	However	_	ADV	RB	_	7	advmod	_	_
2	,	_	.	,	_	7	punct	_	_
3	its	_	PRON	PRP$	_	4	nmod:poss	_	_
4	efficacy	_	NOUN	NN	_	7	nsubjpass	_	_
5	could	_	VERB	MD	_	7	aux	_	_
6	be	_	VERB	VB	_	7	auxpass	_	_
7	mediated	_	VERB	VBN	_	0	root	_	_
8	through	_	ADP	IN	_	10	case	_	_
9	a	_	DET	DT	_	10	det	_	_
10	combination	_	NOUN	NN	_	7	nmod	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	antagonism	_	NOUN	NN	_	10	nmod	_	_
13	of	_	ADP	IN	_	16	case	_	_
14	central	_	ADJ	JJ	_	16	amod	_	_
15	dopamine	_	NOUN	NN	_	16	compound	_	_
16	D2	_	NOUN	NN	_	12	nmod	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	serotonin	_	NOUN	NN	_	21	compound	_	_
19	5	_	NUM	CD	_	21	nummod	_	_
20	HT2A	_	NOUN	NN	_	21	compound	_	_
21	receptors	_	NOUN	NNS	_	16	conj	_	_

#	Adasuve	2767
1	The	_	DET	DT	_	2	det	_	_
2	mechanism	_	NOUN	NN	_	18	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	action	_	NOUN	NN	_	2	nmod	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	in	_	ADP	IN	_	9	case	_	_
8	the	_	DET	DT	_	9	det	_	_
9	treatment	_	NOUN	NN	_	2	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	agitation	_	NOUN	NN	_	9	nmod	_	_
12	associated	_	VERB	VBN	_	11	acl	_	_
13	with	_	ADP	IN	_	16	case	_	_
14	bipolar	_	ADJ	JJ	_	16	amod	_	_
15	I	_	NOUN	NN	_	16	compound	_	_
16	disorder	_	NOUN	NN	_	12	nmod	_	_
17	is	_	VERB	VBZ	_	18	auxpass	_	_
18	unknown	_	ADJ	JJ	_	0	root	_	_

#	Adasuve	2768
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	acts	_	VERB	VBZ	_	0	root	_	_
3	as	_	ADP	IN	_	5	case	_	_
4	an	_	DET	DT	_	5	det	_	_
5	antagonist	_	NOUN	NN	_	2	nmod	_	_
6	at	_	ADP	IN	_	8	case	_	_
7	central	_	ADJ	JJ	_	8	amod	_	_
8	serotonin	_	NOUN	NN	_	5	nmod	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	dopamine	_	NOUN	NN	_	8	conj	_	_
11	receptors	_	NOUN	NNS	_	8	dep	_	_
12	,	_	.	,	_	2	punct	_	_
13	with	_	ADP	IN	_	15	case	_	_
14	high	_	ADJ	JJ	_	15	amod	_	_
15	affinity	_	NOUN	NN	_	2	nmod	_	_
16	for	_	ADP	IN	_	19	case	_	_
17	serotonin	_	NOUN	NN	_	19	compound	_	_
18	5	_	NUM	CD	_	19	nummod	_	_
19	HT2A	_	NOUN	NN	_	15	nmod	_	_
20	and	_	CONJ	CC	_	19	cc	_	_
21	dopamine	_	NOUN	NN	_	22	compound	_	_
22	D1	_	NOUN	NN	_	19	conj	_	_
23	,	_	.	,	_	19	punct	_	_
24	D2	_	NOUN	NN	_	19	conj	_	_
25	,	_	.	,	_	19	punct	_	_
26	D3	_	NOUN	NN	_	19	conj	_	_
27	,	_	.	,	_	19	punct	_	_
28	and	_	CONJ	CC	_	19	cc	_	_
29	D4	_	NOUN	NN	_	30	compound	_	_
30	receptors	_	NOUN	NNS	_	19	conj	_	_
31	Ki	_	NOUN	NN	_	32	compound	_	_
32	values	_	NOUN	NNS	_	19	dep	_	_
33	of	_	ADP	IN	_	35	case	_	_
34	2	_	NUM	CD	_	35	nummod	_	_
35	nM	_	NOUN	NN	_	32	nmod	_	_
36	,	_	.	,	_	35	punct	_	_
37	18	_	NUM	CD	_	38	nummod	_	_
38	nM	_	NOUN	NN	_	35	conj	_	_
39	,	_	.	,	_	35	punct	_	_
40	10	_	NUM	CD	_	41	nummod	_	_
41	nM	_	NOUN	NN	_	35	conj	_	_
42	,	_	.	,	_	35	punct	_	_
43	21	_	NUM	CD	_	44	nummod	_	_
44	nM	_	NOUN	NN	_	35	conj	_	_
45	,	_	.	,	_	35	punct	_	_
46	9	_	NUM	CD	_	47	nummod	_	_
47	nM	_	NOUN	NN	_	35	appos	_	_
48	,	_	.	,	_	35	punct	_	_
49	respectively	_	ADV	RB	_	35	advmod	_	_

#	Adasuve	2769
1	Some	_	DET	DT	_	10	nsubj	_	_
2	of	_	ADP	IN	_	5	case	_	_
3	the	_	DET	DT	_	5	det	_	_
4	adverse	_	ADJ	JJ	_	5	amod	_	_
5	effects	_	NOUN	NNS	_	1	nmod	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	may	_	VERB	MD	_	10	aux	_	_
9	be	_	VERB	VB	_	10	cop	_	_
10	related	_	ADJ	JJ	_	0	root	_	_
11	to	_	PRT	TO	_	13	case	_	_
12	the	_	DET	DT	_	13	det	_	_
13	antagonism	_	NOUN	NN	_	10	nmod	_	_
14	of	_	ADP	IN	_	17	case	_	_
15	histamine	_	NOUN	NN	_	17	compound	_	_
16	H1	_	NOUN	NN	_	17	compound	_	_
17	somnolence	_	NOUN	NN	_	13	nmod	_	_
18	,	_	.	,	_	17	punct	_	_
19	muscarinic	_	ADJ	JJ	_	21	amod	_	_
20	M1	_	NOUN	NN	_	21	nmod:npmod	_	_
21	anticholinergic	_	ADJ	JJ	_	17	conj	_	_
22	,	_	.	,	_	17	punct	_	_
23	and	_	CONJ	CC	_	17	cc	_	_
24	adrenergic	_	ADJ	JJ	_	28	amod	_	_
25	A2	_	NOUN	NN	_	28	compound	_	_
26	orthostatic	_	ADJ	JJ	_	28	amod	_	_
27	hypotension	_	NOUN	NN	_	28	compound	_	_
28	receptors	_	NOUN	NNS	_	17	conj	_	_
29	Ki	_	NOUN	NN	_	30	compound	_	_
30	values	_	NOUN	NNS	_	28	dep	_	_
31	of	_	ADP	IN	_	33	case	_	_
32	15	_	NUM	CD	_	33	nummod	_	_
33	nM	_	NOUN	NN	_	30	nmod	_	_
34	,	_	.	,	_	33	punct	_	_
35	117	_	NUM	CD	_	36	nummod	_	_
36	nM	_	NOUN	NN	_	33	appos	_	_
37	and	_	CONJ	CC	_	36	cc	_	_
38	250	_	NUM	CD	_	39	nummod	_	_
39	nM	_	NOUN	NN	_	36	conj	_	_
40	,	_	.	,	_	33	punct	_	_
41	respectively	_	ADV	RB	_	10	advmod	_	_

#	Adasuve	2770
1	Thorough	_	ADP	IN	_	7	mark	_	_
2	QTc	_	NOUN	NN	_	4	compound	_	_
3	Study	_	NOUN	NN	_	4	compound	_	_
4	DRUG	_	NOUN	NN	_	7	nsubj	_	_
5	did	_	VERB	VBD	_	7	aux	_	_
6	not	_	ADV	RB	_	7	neg	_	_
7	prolong	_	VERB	VB	_	0	root	_	_
8	the	_	DET	DT	_	10	det	_	_
9	QTc	_	NOUN	NN	_	10	nmod:npmod	_	_
10	interval	_	ADJ	JJ	_	7	dobj	_	_

#	Adasuve	2771
1	The	_	DET	DT	_	2	det	_	_
2	effect	_	NOUN	NN	_	9	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	on	_	ADP	IN	_	7	case	_	_
6	QTc	_	NOUN	NN	_	7	compound	_	_
7	prolongation	_	NOUN	NN	_	2	nmod	_	_
8	was	_	VERB	VBD	_	9	auxpass	_	_
9	evaluated	_	VERB	VBN	_	0	root	_	_
10	in	_	ADP	IN	_	20	case	_	_
11	a	_	DET	DT	_	20	det	_	_
12	randomized	_	ADJ	JJ	_	15	amod	_	_
13	,	_	.	,	_	12	punct	_	_
14	double	_	ADJ	JJ	_	12	dep	_	_
15	blinded	_	VERB	VBN	_	20	amod	_	_
16	,	_	.	,	_	15	punct	_	_
17	positive	_	ADJ	JJ	_	15	dep	_	_
18	moxifloxacin	_	NOUN	NN	_	20	compound	_	_
19	400	_	NUM	CD	_	20	nummod	_	_
20	mg	_	NOUN	NN	_	9	nmod	_	_
21	and	_	CONJ	CC	_	20	cc	_	_
22	placebo	_	NOUN	NN	_	25	compound	_	_
23	controlled	_	VERB	VBN	_	25	amod	_	_
24	parallel	_	ADJ	JJ	_	25	amod	_	_
25	study	_	NOUN	NN	_	20	conj	_	_
26	in	_	ADP	IN	_	28	case	_	_
27	healthy	_	ADJ	JJ	_	28	amod	_	_
28	subjects	_	NOUN	NNS	_	20	nmod	_	_

#	Adasuve	2772
1	A	_	DET	DT	_	2	det	_	_
2	total	_	NOUN	NN	_	8	nsubjpass	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	48	_	NUM	CD	_	6	nummod	_	_
5	healthy	_	ADJ	JJ	_	6	amod	_	_
6	subjects	_	NOUN	NNS	_	2	nmod	_	_
7	were	_	VERB	VBD	_	8	auxpass	_	_
8	administered	_	VERB	VBN	_	0	root	_	_
9	DRUG	_	NOUN	NN	_	11	compound	_	_
10	10	_	NUM	CD	_	11	nummod	_	_
11	mg	_	NOUN	NNS	_	8	dobj	_	_

#	Adasuve	2773
1	In	_	ADP	IN	_	3	case	_	_
2	this	_	DET	DT	_	3	det	_	_
3	study	_	NOUN	NN	_	0	root	_	_
4	with	_	ADP	IN	_	7	case	_	_
5	a	_	DET	DT	_	7	det	_	_
6	demonstrated	_	VERB	VBN	_	7	amod	_	_
7	ability	_	NOUN	NN	_	3	nmod	_	_
8	to	_	PRT	TO	_	9	mark	_	_
9	detect	_	VERB	VB	_	7	acl	_	_
10	small	_	ADJ	JJ	_	11	amod	_	_
11	effects	_	NOUN	NNS	_	9	dobj	_	_
12	,	_	.	,	_	3	punct	_	_
13	the	_	DET	DT	_	14	det	_	_
14	upper	_	NOUN	NN	_	12	root	_	_
15	bound	_	VERB	VBN	_	14	acl	_	_
16	of	_	ADP	IN	_	21	case	_	_
17	the	_	DET	DT	_	21	det	_	_
18	90%	_	ADJ	JJ	_	21	amod	_	_
19	confidence	_	NOUN	NN	_	21	compound	_	_
20	interval	_	ADJ	JJ	_	21	amod	_	_
21	CI	_	NOUN	NN	_	15	nmod	_	_
22	for	_	ADP	IN	_	25	case	_	_
23	the	_	DET	DT	_	25	det	_	_
24	largest	_	ADJ	JJ	_	25	amod	_	_
25	placebo	_	NOUN	NN	_	21	nmod	_	_
26	adjusted	_	VERB	VBN	_	25	acl	_	_
27	,	_	.	,	_	14	punct	_	_
28	baseline	_	NOUN	NN	_	30	compound	_	_
29	corrected	_	VERB	VBD	_	30	amod	_	_
30	QTc	_	NOUN	NN	_	37	nsubj	_	_
31	based	_	VERB	VBN	_	30	acl	_	_
32	on	_	ADP	IN	_	35	case	_	_
33	individual	_	ADJ	JJ	_	35	amod	_	_
34	correction	_	NOUN	NN	_	35	compound	_	_
35	method	_	NOUN	NN	_	31	nmod	_	_
36	was	_	VERB	VBD	_	37	cop	_	_
37	below	_	VERB	VB	_	14	acl:relcl	_	_
38	10	_	NUM	CD	_	39	nummod	_	_
39	milliseconds	_	NOUN	NNS	_	37	dobj	_	_
40	,	_	.	,	_	14	punct	_	_
41	the	_	DET	DT	_	42	det	_	_
42	threshold	_	NOUN	NN	_	14	appos	_	_
43	for	_	ADP	IN	_	45	case	_	_
44	regulatory	_	ADJ	JJ	_	45	amod	_	_
45	concern	_	NOUN	NNS	_	42	nmod	_	_

#	Adasuve	2774
1	Absorption	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	The	_	DET	DT	_	7	det	_	_
4	single	_	ADJ	JJ	_	7	amod	_	_
5	dose	_	NOUN	NN	_	7	compound	_	_
6	pharmacokinetic	_	ADJ	JJ	_	7	amod	_	_
7	parameters	_	NOUN	NNS	_	24	nsubjpass	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	following	_	VERB	VBG	_	11	case	_	_
11	administration	_	NOUN	NN	_	7	nmod	_	_
12	of	_	ADP	IN	_	14	case	_	_
13	single	_	ADJ	JJ	_	14	amod	_	_
14	doses	_	NOUN	NNS	_	11	nmod	_	_
15	of	_	ADP	IN	_	18	case	_	_
16	DRUG	_	NOUN	NN	_	18	compound	_	_
17	10	_	NUM	CD	_	18	nummod	_	_
18	mg	_	NOUN	NN	_	14	nmod	_	_
19	in	_	ADP	IN	_	22	case	_	_
20	healthy	_	ADJ	JJ	_	22	amod	_	_
21	adult	_	ADJ	JJ	_	22	amod	_	_
22	subjects	_	NOUN	NNS	_	11	nmod	_	_
23	are	_	VERB	VBP	_	24	auxpass	_	_
24	presented	_	VERB	VBN	_	1	dep	_	_
25	in	_	ADP	IN	_	26	case	_	_
26	Table	_	ADJ	JJ	_	24	nmod	_	_
27	3	_	NUM	CD	_	26	dep	_	_
28	and	_	CONJ	CC	_	27	cc	_	_
29	Figure	_	NOUN	NN	_	27	conj	_	_
30	8	_	NUM	CD	_	29	nummod	_	_

#	Adasuve	2775
1	Administration	_	NOUN	NN	_	4	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	resulted	_	VERB	VBD	_	0	root	_	_
5	in	_	ADP	IN	_	7	case	_	_
6	rapid	_	ADJ	JJ	_	7	amod	_	_
7	absorption	_	NOUN	NN	_	4	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	,	_	.	,	_	4	punct	_	_
11	with	_	ADP	IN	_	14	case	_	_
12	a	_	DET	DT	_	14	det	_	_
13	median	_	ADJ	JJ	_	14	amod	_	_
14	time	_	NOUN	NN	_	4	nmod	_	_
15	of	_	ADP	IN	_	19	case	_	_
16	maximum	_	NOUN	NN	_	19	compound	_	_
17	plasma	_	NOUN	NN	_	19	compound	_	_
18	concentration	_	NOUN	NN	_	19	compound	_	_
19	Tmax	_	NOUN	NN	_	14	nmod	_	_
20	of	_	ADP	IN	_	22	case	_	_
21	2	_	NUM	CD	_	22	nummod	_	_
22	minutes	_	NOUN	NNS	_	19	nmod	_	_

#	Adasuve	2776
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	exposure	_	NOUN	NN	_	14	nsubj	_	_
3	in	_	ADP	IN	_	7	case	_	_
4	the	_	DET	DT	_	7	det	_	_
5	first	_	ADJ	JJ	_	7	amod	_	_
6	2	_	NUM	CD	_	7	nummod	_	_
7	hours	_	NOUN	NNS	_	2	nmod	_	_
8	after	_	ADP	IN	_	11	case	_	_
9	administration	_	NOUN	NN	_	11	compound	_	_
10	AUC0	_	NOUN	NN	_	11	compound	_	_
11	2h	_	NOUN	NN	_	2	nmod	_	_
12	was	_	VERB	VBD	_	14	cop	_	_
13	66.7	_	NUM	CD	_	14	nummod	_	_
14	ng*h	_	NOUN	NN	_	0	root	_	_
15	/	_	.	:	_	14	punct	_	_
16	mL	_	NOUN	NN	_	14	dep	_	_
17	for	_	ADP	IN	_	21	case	_	_
18	the	_	DET	DT	_	21	det	_	_
19	10	_	NUM	CD	_	21	nummod	_	_
20	mg	_	NOUN	NN	_	21	compound	_	_
21	dose	_	NOUN	NN	_	16	nmod	_	_

#	Adasuve	2777
1	As	_	ADP	IN	_	3	case	_	_
2	a	_	DET	DT	_	3	det	_	_
3	consequence	_	NOUN	NN	_	16	nmod	_	_
4	of	_	ADP	IN	_	8	case	_	_
5	the	_	DET	DT	_	8	det	_	_
6	very	_	ADV	RB	_	7	advmod	_	_
7	rapid	_	ADJ	JJ	_	8	amod	_	_
8	absorption	_	NOUN	NN	_	3	nmod	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	after	_	ADP	IN	_	13	case	_	_
12	oral	_	ADJ	JJ	_	13	amod	_	_
13	inhalation	_	NOUN	NN	_	3	nmod	_	_
14	,	_	.	,	_	16	punct	_	_
15	there	_	DET	EX	_	16	expl	_	_
16	is	_	VERB	VBZ	_	0	root	_	_
17	substantial	_	ADJ	JJ	_	18	amod	_	_
18	variability	_	NOUN	NN	_	16	nsubj	_	_
19	in	_	ADP	IN	_	23	case	_	_
20	the	_	DET	DT	_	23	det	_	_
21	early	_	ADJ	JJ	_	23	amod	_	_
22	plasma	_	NOUN	NN	_	23	compound	_	_
23	concentrations	_	NOUN	NNS	_	16	nmod	_	_
24	of	_	ADP	IN	_	25	case	_	_
25	DRUG	_	NOUN	NN	_	23	nmod	_	_

#	Adasuve	2778
1	The	_	DET	DT	_	5	det	_	_
2	mean	_	ADJ	JJ	_	5	compound	_	_
3	plasma	_	NOUN	NN	_	5	compound	_	_
4	DRUG	_	NOUN	NN	_	5	compound	_	_
5	concentrations	_	NOUN	NNS	_	11	nsubj	_	_
6	following	_	VERB	VBG	_	7	case	_	_
7	administration	_	NOUN	NN	_	5	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	were	_	VERB	VBD	_	11	cop	_	_
11	linear	_	ADJ	JJ	_	0	root	_	_
12	over	_	ADP	IN	_	16	case	_	_
13	the	_	DET	DT	_	16	det	_	_
14	clinical	_	ADJ	JJ	_	16	amod	_	_
15	dose	_	NOUN	NN	_	16	compound	_	_
16	range	_	NOUN	NN	_	11	nmod	_	_

#	Adasuve	2779
1	AUC0	_	NOUN	NN	_	2	compound	_	_
2	2h	_	NOUN	NN	_	8	nsubj	_	_
3	,	_	.	,	_	2	punct	_	_
4	AUCinf	_	NOUN	NN	_	2	conj	_	_
5	,	_	.	,	_	2	punct	_	_
6	and	_	CONJ	CC	_	2	cc	_	_
7	Cmax	_	NOUN	NN	_	2	conj	_	_
8	increased	_	VERB	VBD	_	0	root	_	_
9	in	_	ADP	IN	_	13	case	_	_
10	a	_	DET	DT	_	13	det	_	_
11	dose	_	NOUN	NN	_	13	compound	_	_
12	dependent	_	ADJ	JJ	_	13	amod	_	_
13	manner	_	NOUN	NN	_	8	nmod	_	_

#	Adasuve	2780
1	Pharmacokinetics	_	NOUN	NNS	_	6	nsubj	_	_
2	in	_	ADP	IN	_	5	case	_	_
3	Healthy	_	ADJ	JJ	_	5	amod	_	_
4	Adult	_	NOUN	NN	_	5	compound	_	_
5	Subjects	_	NOUN	NNS	_	1	nmod	_	_
6	Administered	_	VERB	VBD	_	0	root	_	_
7	a	_	DET	DT	_	9	det	_	_
8	Single	_	ADJ	JJ	_	9	amod	_	_
9	Dose	_	NOUN	NN	_	6	dobj	_	_
10	of	_	ADP	IN	_	16	case	_	_
11	DRUG	_	NOUN	NN	_	16	compound	_	_
12	10	_	NUM	CD	_	16	nummod	_	_
13	mg	_	NOUN	NN	_	16	compound	_	_
14	Parameter	_	NOUN	NN	_	16	compound	_	_
15	Healthy	_	ADJ	JJ	_	16	amod	_	_
16	Subjects	_	NOUN	NNS	_	9	nmod	_	_
17	DRUG	_	NOUN	NN	_	23	compound	_	_
18	10	_	NUM	CD	_	23	nummod	_	_
19	mg	_	NOUN	NN	_	23	compound	_	_
20	N=114	_	NOUN	NN	_	23	compound	_	_
21	AUC0	_	NOUN	NN	_	23	compound	_	_
22	2h	_	ADJ	JJ	_	23	amod	_	_
23	ng*h	_	NOUN	NN	_	16	dep	_	_
24	/	_	.	:	_	23	punct	_	_
25	mL	_	NOUN	NN	_	23	appos	_	_
26	,	_	.	,	_	6	punct	_	_
27	mean	_	VERB	VBP	_	6	conj	_	_
28	*	_	CONJ	CC	_	34	cc:preconj	_	_
29	SD	_	NOUN	NN	_	34	compound	_	_
30	66.7	_	NUM	CD	_	32	compound	_	_
31	*	_	ADJ	JJ	_	32	advmod	_	_
32	18.2	_	NUM	CD	_	34	nummod	_	_
33	AUCinf	_	NOUN	NN	_	34	compound	_	_
34	ng*h	_	NOUN	NN	_	27	dobj	_	_
35	/	_	.	:	_	6	punct	_	_
36	mL	_	NOUN	NN	_	38	nsubj	_	_
37	,	_	.	,	_	36	punct	_	_
38	mean	_	VERB	VBP	_	6	parataxis	_	_
39	*	_	CONJ	CC	_	47	amod	_	_
40	SD	_	NOUN	NN	_	47	compound	_	_
41	188	_	NUM	CD	_	42	nummod	_	_
42	*	_	ADJ	JJ	_	47	amod	_	_
43	47	_	NUM	CD	_	45	nummod	_	_
44	Cmax	_	NOUN	NN	_	45	compound	_	_
45	ng	_	NOUN	NN	_	42	dep	_	_
46	/	_	.	:	_	47	punct	_	_
47	mL	_	NOUN	NN	_	38	dobj	_	_
48	,	_	.	,	_	38	punct	_	_
49	mean	_	VERB	VBP	_	38	dep	_	_
50	*	_	CONJ	CC	_	56	amod	_	_
51	SD	_	NOUN	NN	_	56	compound	_	_
52	257	_	NUM	CD	_	56	nummod	_	_
53	*	_	ADJ	JJ	_	56	amod	_	_
54	219	_	NUM	CD	_	56	nummod	_	_
55	Tmax	_	NOUN	NN	_	56	compound	_	_
56	minutes	_	NOUN	NNS	_	49	dobj	_	_
57	,	_	.	,	_	56	punct	_	_
58	median	_	ADJ	JJ	_	59	amod	_	_
59	25%	_	NOUN	NN	_	56	conj	_	_
60	,	_	.	,	_	56	punct	_	_
61	75%	_	NOUN	NN	_	56	conj	_	_
62	1.13	_	NUM	CD	_	63	nummod	_	_
63	1	_	NUM	CD	_	61	dep	_	_
64	,	_	.	,	_	56	punct	_	_
65	2	_	NUM	CD	_	67	nummod	_	_
66	Half	_	NOUN	NN	_	67	amod	_	_
67	life(h	_	NOUN	NN	_	56	appos	_	_
68	,	_	.	,	_	56	punct	_	_
69	mean	_	NOUN	NN	_	71	compound	_	_
70	*	_	ADJ	JJ	_	71	amod	_	_
71	SD	_	NOUN	NN	_	56	appos	_	_
72	7.61	_	NUM	CD	_	71	nummod	_	_
73	*	_	ADJ	JJ	_	71	cc	_	_
74	1.87	_	NUM	CD	_	75	nummod	_	_
75	Figure	_	NOUN	NN	_	71	conj	_	_
76	8	_	NUM	CD	_	75	nummod	_	_

#	Adasuve	2781
1	Mean	_	NOUN	NN	_	3	compound	_	_
2	Plasma	_	NOUN	NN	_	3	compound	_	_
3	Concentrations	_	NOUN	NNS	_	0	root	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	following	_	VERB	VBG	_	12	case	_	_
7	Single	_	ADJ	JJ	_	12	compound	_	_
8	Dose	_	NOUN	NN	_	12	compound	_	_
9	Administration	_	NOUN	NN	_	12	compound	_	_
10	DRUG	_	NOUN	NN	_	12	compound	_	_
11	10	_	NUM	CD	_	12	nummod	_	_
12	mg	_	NOUN	NN	_	3	nmod	_	_
13	in	_	ADP	IN	_	16	case	_	_
14	Healthy	_	ADJ	JJ	_	16	amod	_	_
15	Subjects	_	NOUN	NNS	_	16	compound	_	_
16	Distribution	_	NOUN	NN	_	3	nmod	_	_
17	:	_	.	:	_	3	punct	_	_
18	DRUG	_	NOUN	NN	_	20	nsubjpass	_	_
19	is	_	VERB	VBZ	_	20	auxpass	_	_
20	removed	_	VERB	VBN	_	3	dep	_	_
21	rapidly	_	ADV	RB	_	20	advmod	_	_
22	from	_	ADP	IN	_	24	case	_	_
23	the	_	DET	DT	_	24	det	_	_
24	plasma	_	NOUN	NN	_	20	nmod	_	_
25	and	_	CONJ	CC	_	20	cc	_	_
26	distributed	_	VERB	VBN	_	20	conj	_	_
27	in	_	ADP	IN	_	28	case	_	_
28	tissues	_	NOUN	NNS	_	26	nmod	_	_

#	Adasuve	2782
1	Animal	_	ADJ	JJ	_	2	amod	_	_
2	studies	_	NOUN	NNS	_	6	nsubj	_	_
3	following	_	VERB	VBG	_	5	case	_	_
4	oral	_	ADJ	JJ	_	5	amod	_	_
5	administration	_	NOUN	NN	_	2	nmod	_	_
6	suggest	_	VERB	VBP	_	0	root	_	_
7	an	_	DET	DT	_	10	det	_	_
8	initial	_	ADJ	JJ	_	10	amod	_	_
9	preferential	_	ADJ	JJ	_	10	amod	_	_
10	distribution	_	NOUN	NN	_	6	dobj	_	_
11	in	_	ADP	IN	_	13	case	_	_
12	the	_	DET	DT	_	13	det	_	_
13	lungs	_	NOUN	NNS	_	10	nmod	_	_
14	,	_	.	,	_	13	punct	_	_
15	brain	_	NOUN	NN	_	13	conj	_	_
16	,	_	.	,	_	13	punct	_	_
17	spleen	_	NOUN	NN	_	13	conj	_	_
18	,	_	.	,	_	13	punct	_	_
19	heart	_	NOUN	NN	_	13	conj	_	_
20	,	_	.	,	_	13	punct	_	_
21	and	_	CONJ	CC	_	13	cc	_	_
22	kidney	_	NOUN	NN	_	13	conj	_	_

#	Adasuve	2783
1	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
2	is	_	VERB	VBZ	_	4	auxpass	_	_
3	96.6%	_	ADJ	JJ	_	4	advmod	_	_
4	bound	_	VERB	VBN	_	0	root	_	_
5	to	_	PRT	TO	_	8	case	_	_
6	human	_	ADJ	JJ	_	8	amod	_	_
7	plasma	_	NOUN	NN	_	8	compound	_	_
8	proteins	_	NOUN	NNS	_	4	nmod	_	_

#	Adasuve	2784
1	Metabolism	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	DRUG	_	NOUN	NN	_	5	nsubjpass	_	_
4	is	_	VERB	VBZ	_	5	auxpass	_	_
5	metabolized	_	VERB	VBN	_	1	dep	_	_
6	extensively	_	ADV	RB	_	5	advmod	_	_
7	in	_	ADP	IN	_	9	case	_	_
8	the	_	DET	DT	_	9	det	_	_
9	liver	_	NOUN	NN	_	5	nmod	_	_
10	following	_	VERB	VBG	_	12	case	_	_
11	oral	_	ADJ	JJ	_	12	amod	_	_
12	administration	_	NOUN	NN	_	5	nmod	_	_
13	,	_	.	,	_	5	punct	_	_
14	with	_	ADP	IN	_	16	case	_	_
15	multiple	_	ADJ	JJ	_	16	amod	_	_
16	metabolites	_	NOUN	NNS	_	5	nmod	_	_
17	formed	_	VERB	VBN	_	16	acl	_	_

#	Adasuve	2785
1	The	_	DET	DT	_	4	det	_	_
2	main	_	ADJ	JJ	_	4	amod	_	_
3	metabolic	_	ADJ	JJ	_	4	amod	_	_
4	pathways	_	NOUN	NNS	_	5	nsubj	_	_
5	include	_	VERB	VBP	_	0	root	_	_
6	:	_	.	:	_	5	punct	_	_
7	1	_	NUM	CD	_	8	nummod	_	_
8	hydroxylation	_	NOUN	NN	_	5	dobj	_	_
9	to	_	PRT	TO	_	10	mark	_	_
10	form	_	VERB	VB	_	8	acl	_	_
11	8	_	NUM	CD	_	13	nummod	_	_
12	OH	_	NOUN	NN	_	13	compound	_	_
13	DRUG	_	NOUN	NN	_	10	dobj	_	_
14	by	_	ADP	IN	_	15	case	_	_
15	CYP1A2	_	NOUN	NN	_	10	nmod	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	7	_	NUM	CD	_	19	nummod	_	_
18	OH	_	NOUN	NN	_	19	compound	_	_
19	DRUG	_	NOUN	NN	_	15	conj	_	_
20	by	_	ADP	IN	_	21	case	_	_
21	CYP3A4	_	NOUN	NN	_	10	nmod	_	_
22	and	_	CONJ	CC	_	21	cc	_	_
23	CYP2D6	_	NOUN	NN	_	21	conj	_	_
24	,	_	.	,	_	21	punct	_	_
25	2	_	NUM	CD	_	27	nummod	_	_
26	N	_	NOUN	NN	_	27	compound	_	_
27	oxidation	_	NOUN	NN	_	21	appos	_	_
28	to	_	PRT	TO	_	29	mark	_	_
29	form	_	VERB	VB	_	27	acl	_	_
30	DRUG	_	NOUN	NN	_	32	compound	_	_
31	N	_	NOUN	NN	_	32	compound	_	_
32	oxide	_	NOUN	NN	_	29	dobj	_	_
33	by	_	ADP	IN	_	36	case	_	_
34	flavanoid	_	ADJ	JJ	_	36	amod	_	_
35	monoamine	_	NOUN	NN	_	36	compound	_	_
36	oxidases	_	NOUN	NNS	_	29	nmod	_	_
37	FMOs	_	NOUN	NNS	_	36	dep	_	_
38	,	_	.	,	_	37	punct	_	_
39	and	_	CONJ	CC	_	37	cc	_	_
40	3	_	NUM	CD	_	42	nummod	_	_
41	de	_	NOUN	NN	_	42	amod	_	_
42	methylation	_	NOUN	NN	_	37	conj	_	_
43	to	_	PRT	TO	_	44	mark	_	_
44	form	_	VERB	VB	_	42	acl	_	_
45	amoxapine	_	NOUN	NN	_	44	dobj	_	_

#	Adasuve	2786
1	Because	_	ADP	IN	_	3	mark	_	_
2	there	_	DET	EX	_	3	expl	_	_
3	are	_	VERB	VBP	_	22	advcl	_	_
4	multiple	_	ADJ	JJ	_	6	amod	_	_
5	metabolic	_	ADJ	JJ	_	6	amod	_	_
6	pathways	_	NOUN	NNS	_	3	nsubj	_	_
7	,	_	.	,	_	22	punct	_	_
8	the	_	DET	DT	_	9	det	_	_
9	risk	_	NOUN	NN	_	22	nsubj	_	_
10	of	_	ADP	IN	_	12	case	_	_
11	metabolic	_	ADJ	JJ	_	12	amod	_	_
12	interactions	_	NOUN	NNS	_	9	nmod	_	_
13	caused	_	VERB	VBN	_	12	acl	_	_
14	by	_	ADP	IN	_	16	case	_	_
15	an	_	DET	DT	_	16	det	_	_
16	effect	_	NOUN	NN	_	13	nmod	_	_
17	on	_	ADP	IN	_	20	case	_	_
18	an	_	DET	DT	_	20	det	_	_
19	individual	_	ADJ	JJ	_	20	amod	_	_
20	isoform	_	NOUN	NN	_	16	nmod	_	_
21	is	_	VERB	VBZ	_	22	auxpass	_	_
22	minimal	_	ADJ	JJ	_	0	root	_	_

#	Adasuve	2787
1	For	_	ADP	IN	_	2	case	_	_
2	DRUG	_	NOUN	NN	_	22	nmod	_	_
3	,	_	.	,	_	22	punct	_	_
4	the	_	DET	DT	_	5	det	_	_
5	order	_	NOUN	NN	_	22	nsubj	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	metabolites	_	NOUN	NNS	_	5	nmod	_	_
8	observed	_	VERB	VBN	_	7	acl	_	_
9	in	_	ADP	IN	_	10	case	_	_
10	humans	_	NOUN	NNS	_	8	nmod	_	_
11	based	_	VERB	VBN	_	10	acl	_	_
12	on	_	ADP	IN	_	14	case	_	_
13	systemic	_	ADJ	JJ	_	14	amod	_	_
14	exposure	_	NOUN	NN	_	11	nmod	_	_
15	was	_	VERB	VBD	_	22	cop	_	_
16	8	_	NUM	CD	_	22	nummod	_	_
17	OH	_	NOUN	NN	_	22	compound	_	_
18	DRUG	_	NOUN	NN	_	22	compound	_	_
19	>>	_	NUM	CD	_	22	nummod	_	_
20	DRUG	_	NOUN	NN	_	22	compound	_	_
21	N	_	NOUN	NN	_	22	compound	_	_
22	oxide	_	NOUN	NN	_	0	root	_	_
23	,	_	.	,	_	22	punct	_	_
24	7	_	NUM	CD	_	28	nummod	_	_
25	OH	_	NOUN	NN	_	28	compound	_	_
26	DRUG	_	NOUN	NN	_	28	compound	_	_
27	>	_	NUM	CD	_	28	nummod	_	_
28	amoxapine	_	NOUN	NN	_	22	appos	_	_

#	Adasuve	2788
1	Plasma	_	NOUN	NN	_	2	compound	_	_
2	levels	_	NOUN	NNS	_	8	nsubj	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	8	_	NUM	CD	_	6	nummod	_	_
5	OH	_	NOUN	NN	_	6	compound	_	_
6	DRUG	_	NOUN	NN	_	2	nmod	_	_
7	are	_	VERB	VBP	_	8	cop	_	_
8	similar	_	ADJ	JJ	_	0	root	_	_
9	to	_	PRT	TO	_	10	case	_	_
10	those	_	DET	DT	_	8	nmod	_	_
11	of	_	ADP	IN	_	14	case	_	_
12	the	_	DET	DT	_	14	det	_	_
13	parent	_	NOUN	NN	_	14	compound	_	_
14	compound	_	NOUN	NN	_	10	nmod	_	_

#	Adasuve	2789
1	Excretion	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Excretion	_	NOUN	NN	_	4	nsubj	_	_
4	occurs	_	VERB	VBZ	_	1	dep	_	_
5	mainly	_	ADV	RB	_	4	advmod	_	_
6	in	_	ADP	IN	_	10	case	_	_
7	the	_	DET	DT	_	10	det	_	_
8	first	_	ADJ	JJ	_	10	amod	_	_
9	24	_	NUM	CD	_	10	nummod	_	_
10	hours	_	NOUN	NNS	_	4	nmod	_	_

#	Adasuve	2790
1	Metabolites	_	NOUN	NNS	_	3	nsubjpass	_	_
2	are	_	VERB	VBP	_	3	auxpass	_	_
3	excreted	_	VERB	VBN	_	0	root	_	_
4	in	_	ADP	IN	_	6	case	_	_
5	the	_	DET	DT	_	6	det	_	_
6	urine	_	ADJ	JJ	_	3	nmod	_	_
7	in	_	ADP	IN	_	9	case	_	_
8	the	_	DET	DT	_	9	det	_	_
9	form	_	NOUN	NN	_	6	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	conjugates	_	NOUN	NNS	_	9	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	in	_	ADP	IN	_	15	case	_	_
14	the	_	DET	DT	_	15	det	_	_
15	feces	_	NOUN	NNS	_	11	conj	_	_
16	unconjugated	_	VERB	VBN	_	3	parataxis	_	_

#	Adasuve	2791
1	The	_	DET	DT	_	6	det	_	_
2	terminal	_	ADJ	JJ	_	6	amod	_	_
3	elimination	_	NOUN	NN	_	6	compound	_	_
4	half	_	NOUN	NN	_	6	compound	_	_
5	life	_	NOUN	NN	_	6	compound	_	_
6	T1	_	NOUN	NN	_	0	root	_	_
7	/	_	.	:	_	6	punct	_	_
8	2	_	NUM	CD	_	6	dep	_	_
9	ranged	_	VERB	VBN	_	8	dep	_	_
10	from	_	ADP	IN	_	14	case	_	_
11	6	_	NUM	CD	_	13	compound	_	_
12	to	_	PRT	TO	_	13	dep	_	_
13	8	_	NUM	CD	_	14	nummod	_	_
14	hours	_	NOUN	NNS	_	9	nmod	_	_

#	Adasuve	2792
1	Transporter	_	NOUN	NN	_	2	compound	_	_
2	Interaction	_	NOUN	NN	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	In	_	X	FW	_	6	amod	_	_
5	vitro	_	X	FW	_	4	dep	_	_
6	studies	_	NOUN	NNS	_	7	nsubj	_	_
7	indicated	_	VERB	VBD	_	2	dep	_	_
8	that	_	ADP	IN	_	13	mark	_	_
9	DRUG	_	NOUN	NN	_	13	nsubj	_	_
10	was	_	VERB	VBD	_	13	cop	_	_
11	not	_	ADV	RB	_	13	neg	_	_
12	a	_	DET	DT	_	13	det	_	_
13	substrate	_	NOUN	NN	_	7	ccomp	_	_
14	for	_	ADP	IN	_	18	case	_	_
15	p	_	NOUN	NN	_	18	compound	_	_
16	glycoprotein	_	NOUN	NN	_	18	compound	_	_
17	P	_	NOUN	NN	_	18	compound	_	_
18	gp	_	NOUN	NN	_	13	nmod	_	_
19	:	_	.	:	_	2	punct	_	_
20	however	_	ADV	RB	_	23	advmod	_	_
21	,	_	.	,	_	23	punct	_	_
22	DRUG	_	NOUN	NN	_	23	nsubj	_	_
23	inhibited	_	VERB	VBD	_	2	dep	_	_
24	P	_	NOUN	NN	_	25	compound	_	_
25	gp	_	NOUN	NN	_	23	dobj	_	_

#	Adasuve	2793
1	Special	_	ADJ	JJ	_	2	amod	_	_
2	Populations	_	NOUN	NNS	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	Pharmacokinetics	_	NOUN	NNS	_	2	dep	_	_
5	in	_	ADP	IN	_	6	case	_	_
6	Smokers	_	NOUN	NNS	_	4	nmod	_	_
7	:	_	.	:	_	2	punct	_	_
8	DRUG	_	NOUN	NN	_	9	compound	_	_
9	exposures	_	NOUN	NNS	_	15	nsubj	_	_
10	in	_	ADP	IN	_	11	case	_	_
11	nonsmokers	_	NOUN	NNS	_	9	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	smokers	_	NOUN	NNS	_	11	conj	_	_
14	are	_	VERB	VBP	_	15	cop	_	_
15	similar	_	ADJ	JJ	_	2	dep	_	_
16	,	_	.	,	_	15	punct	_	_
17	with	_	ADP	IN	_	20	case	_	_
18	geometric	_	ADJ	JJ	_	20	amod	_	_
19	mean	_	NOUN	NN	_	20	compound	_	_
20	ratios	_	NOUN	NNS	_	15	nmod	_	_
21	of	_	ADP	IN	_	22	case	_	_
22	92%	_	NOUN	NN	_	20	nmod	_	_
23	,	_	.	,	_	22	punct	_	_
24	85%	_	NOUN	NN	_	22	conj	_	_
25	,	_	.	,	_	22	punct	_	_
26	and	_	CONJ	CC	_	22	cc	_	_
27	99%	_	NOUN	NN	_	22	conj	_	_
28	for	_	ADP	IN	_	30	case	_	_
29	AUC0	_	NOUN	NN	_	30	compound	_	_
30	2h	_	NOUN	NN	_	20	nmod	_	_
31	,	_	.	,	_	30	punct	_	_
32	AUCinf	_	NOUN	NN	_	30	conj	_	_
33	,	_	.	,	_	30	punct	_	_
34	and	_	CONJ	CC	_	30	cc	_	_
35	Cmax	_	NOUN	NN	_	30	conj	_	_
36	respectively	_	ADV	RB	_	20	advmod	_	_

#	Adasuve	2794
1	No	_	DET	DT	_	3	neg	_	_
2	dosage	_	NOUN	NN	_	3	compound	_	_
3	adjustment	_	NOUN	NN	_	5	nsubjpass	_	_
4	is	_	VERB	VBZ	_	5	auxpass	_	_
5	recommended	_	VERB	VBN	_	0	root	_	_
6	based	_	VERB	VBN	_	5	xcomp	_	_
7	on	_	ADP	IN	_	9	case	_	_
8	smoking	_	VERB	VBG	_	9	amod	_	_
9	status	_	NOUN	NN	_	6	nmod	_	_

#	Adasuve	2795
1	Demographic	_	ADJ	JJ	_	2	amod	_	_
2	Effects	_	NOUN	NNS	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	There	_	DET	EX	_	5	expl	_	_
5	were	_	VERB	VBD	_	2	dep	_	_
6	no	_	DET	DT	_	9	neg	_	_
7	clinically	_	ADV	RB	_	8	advmod	_	_
8	significant	_	ADJ	JJ	_	9	amod	_	_
9	differences	_	NOUN	NNS	_	5	nsubj	_	_
10	in	_	ADP	IN	_	12	case	_	_
11	DRUG	_	NOUN	NN	_	12	compound	_	_
12	pharmacokinetics	_	NOUN	NNS	_	9	nmod	_	_
13	following	_	VERB	VBG	_	14	case	_	_
14	administration	_	NOUN	NN	_	5	nmod	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	14	nmod	_	_
17	in	_	ADP	IN	_	18	case	_	_
18	subgroups	_	NOUN	NNS	_	14	nmod	_	_
19	based	_	VERB	VBN	_	18	acl	_	_
20	on	_	ADP	IN	_	21	case	_	_
21	age	_	NOUN	NN	_	19	nmod	_	_
22	,	_	.	,	_	21	punct	_	_
23	weight	_	NOUN	NN	_	21	conj	_	_
24	,	_	.	,	_	21	punct	_	_
25	body	_	NOUN	NN	_	27	compound	_	_
26	mass	_	NOUN	NN	_	27	compound	_	_
27	index	_	NOUN	NN	_	21	conj	_	_
28	,	_	.	,	_	21	punct	_	_
29	gender	_	NOUN	NN	_	21	conj	_	_
30	,	_	.	,	_	21	punct	_	_
31	or	_	CONJ	CC	_	21	cc	_	_
32	race	_	DET	DT	_	21	root	_	_

#	Amitriptyline Hydrochloride	1181
1	Some	_	DET	DT	_	2	det	_	_
2	patients	_	NOUN	NNS	_	4	nsubj	_	_
3	may	_	VERB	MD	_	4	aux	_	_
4	experience	_	VERB	VB	_	0	root	_	_
5	a	_	DET	DT	_	7	det	_	_
6	large	_	ADJ	JJ	_	7	amod	_	_
7	increase	_	NOUN	NN	_	4	dobj	_	_
8	in	_	ADP	IN	_	10	case	_	_
9	DRUG	_	NOUN	NN	_	10	compound	_	_
10	concentration	_	NOUN	NN	_	7	nmod	_	_
11	in	_	ADP	IN	_	13	case	_	_
12	the	_	DET	DT	_	13	det	_	_
13	presence	_	NOUN	NN	_	7	nmod	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	topiramate	_	NOUN	NN	_	13	nmod	_	_
16	and	_	CONJ	CC	_	13	cc	_	_
17	any	_	DET	DT	_	18	det	_	_
18	adjustments	_	NOUN	NNS	_	13	conj	_	_
19	in	_	ADP	IN	_	21	case	_	_
20	DRUG	_	NOUN	NN	_	21	compound	_	_
21	dose	_	NOUN	NN	_	18	nmod	_	_
22	should	_	VERB	MD	_	24	aux	_	_
23	be	_	VERB	VB	_	24	auxpass	_	_
24	made	_	VERB	VBN	_	4	parataxis	_	_
25	according	_	VERB	VBG	_	28	case	_	_
26	to	_	PRT	TO	_	25	mwe	_	_
27	the	_	DET	DT	_	28	det	_	_
28	patient's	_	NOUN	NNS	_	24	nmod	_	_
29	clinical	_	ADJ	JJ	_	30	amod	_	_
30	response	_	NOUN	NN	_	28	dep	_	_
31	and	_	CONJ	CC	_	32	cc	_	_
32	not	_	ADV	RB	_	30	cc	_	_
33	on	_	ADP	IN	_	35	case	_	_
34	the	_	DET	DT	_	35	det	_	_
35	basis	_	NOUN	NN	_	30	conj	_	_
36	of	_	ADP	IN	_	38	case	_	_
37	plasma	_	NOUN	NN	_	38	compound	_	_
38	levels	_	NOUN	NNS	_	35	nmod	_	_

#	Amitriptyline Hydrochloride	1182
1	The	_	DET	DT	_	3	det	_	_
2	biochemical	_	ADJ	JJ	_	3	amod	_	_
3	activity	_	NOUN	NN	_	15	nsubjpass	_	_
4	of	_	ADP	IN	_	13	case	_	_
5	the	_	DET	DT	_	13	det	_	_
6	drug	_	NOUN	NN	_	13	compound	_	_
7	metabolizing	_	VERB	VBG	_	13	compound	_	_
8	isozyme	_	NOUN	NN	_	13	compound	_	_
9	cytochrome	_	NOUN	NN	_	13	compound	_	_
10	P450	_	NOUN	NN	_	13	compound	_	_
11	2D6	_	NOUN	NN	_	13	compound	_	_
12	debrisoquin	_	NOUN	NN	_	13	compound	_	_
13	hydroxylase	_	NOUN	NN	_	3	nmod	_	_
14	is	_	VERB	VBZ	_	15	auxpass	_	_
15	reduced	_	VERB	VBN	_	0	root	_	_
16	in	_	ADP	IN	_	18	case	_	_
17	a	_	DET	DT	_	18	det	_	_
18	subset	_	NOUN	NN	_	15	nmod	_	_
19	of	_	ADP	IN	_	22	case	_	_
20	the	_	DET	DT	_	22	det	_	_
21	caucasian	_	ADJ	JJ	_	22	amod	_	_
22	population	_	NOUN	NN	_	18	nmod	_	_
23	about	_	ADV	RB	_	24	advmod	_	_
24	7%	_	NOUN	NN	_	18	nmod	_	_
25	to	_	PRT	TO	_	26	case	_	_
26	10%	_	NOUN	NN	_	24	nmod	_	_
27	of	_	ADP	IN	_	28	case	_	_
28	Caucasians	_	NOUN	NNS	_	26	nmod	_	_
29	are	_	VERB	VBP	_	31	auxpass	_	_
30	so	_	ADV	RB	_	31	advmod	_	_
31	called	_	VERB	VBN	_	15	parataxis	_	_
32	"poor	_	ADJ	JJ	_	35	amod	_	_
33	metabolizers"	_	NOUN	NN	_	35	compound	_	_
34	reliable	_	ADJ	JJ	_	35	amod	_	_
35	estimates	_	NOUN	NNS	_	31	dobj	_	_
36	of	_	ADP	IN	_	38	case	_	_
37	the	_	DET	DT	_	38	det	_	_
38	prevalence	_	NOUN	NN	_	35	nmod	_	_
39	of	_	ADP	IN	_	44	case	_	_
40	reduced	_	VERB	VBN	_	44	amod	_	_
41	P450	_	NOUN	NN	_	44	compound	_	_
42	2D6	_	NOUN	NN	_	44	compound	_	_
43	isozyme	_	NOUN	NN	_	44	compound	_	_
44	activity	_	NOUN	NN	_	38	nmod	_	_
45	among	_	ADP	IN	_	46	case	_	_
46	Asian	_	NOUN	NN	_	35	nmod	_	_
47	,	_	.	,	_	46	punct	_	_
48	African	_	NOUN	NN	_	46	conj	_	_
49	,	_	.	,	_	46	punct	_	_
50	and	_	CONJ	CC	_	46	cc	_	_
51	other	_	ADJ	JJ	_	46	conj	_	_
52	populations	_	NOUN	NNS	_	46	dep	_	_
53	are	_	VERB	VBP	_	56	auxpass	_	_
54	not	_	ADV	RB	_	56	neg	_	_
55	yet	_	ADV	RB	_	56	advmod	_	_
56	available	_	ADJ	JJ	_	31	parataxis	_	_

#	Amitriptyline Hydrochloride	1183
1	Poor	_	ADJ	JJ	_	2	amod	_	_
2	metabolizers	_	NOUN	NNS	_	4	nsubj	_	_
3	have	_	VERB	VBP	_	4	aux	_	_
4	higher	_	ADJ	JJ	_	0	root	_	_
5	than	_	ADP	IN	_	8	case	_	_
6	expected	_	VERB	VBN	_	8	amod	_	_
7	plasma	_	NOUN	NN	_	8	compound	_	_
8	concentrations	_	NOUN	NNS	_	4	nmod	_	_
9	of	_	ADP	IN	_	12	case	_	_
10	tricyclic	_	ADJ	JJ	_	12	amod	_	_
11	antidepressants	_	NOUN	NNS	_	12	compound	_	_
12	TCAs	_	NOUN	NNS	_	8	nmod	_	_
13	when	_	ADV	WRB	_	14	advmod	_	_
14	given	_	VERB	VBN	_	4	advcl	_	_
15	usual	_	ADJ	JJ	_	16	amod	_	_
16	doses	_	NOUN	NNS	_	14	dobj	_	_

#	Amitriptyline Hydrochloride	1184
1	Depending	_	VERB	VBG	_	4	case	_	_
2	on	_	ADP	IN	_	4	case	_	_
3	the	_	DET	DT	_	4	det	_	_
4	fraction	_	NOUN	NN	_	19	nmod	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	drug	_	NOUN	NN	_	4	nmod	_	_
7	metabolized	_	VERB	VBN	_	6	acl	_	_
8	by	_	ADP	IN	_	10	case	_	_
9	P450	_	NOUN	NN	_	10	compound	_	_
10	2D6	_	NOUN	NN	_	7	nmod	_	_
11	,	_	.	,	_	19	punct	_	_
12	the	_	DET	DT	_	13	det	_	_
13	increase	_	NOUN	NN	_	19	nsubj	_	_
14	in	_	ADP	IN	_	16	case	_	_
15	plasma	_	NOUN	NN	_	16	compound	_	_
16	concentration	_	NOUN	NN	_	13	nmod	_	_
17	may	_	VERB	MD	_	19	aux	_	_
18	be	_	VERB	VB	_	19	cop	_	_
19	small	_	ADJ	JJ	_	0	root	_	_
20	,	_	.	,	_	19	punct	_	_
21	or	_	CONJ	CC	_	19	cc	_	_
22	quite	_	ADV	RB	_	23	advmod	_	_
23	large	_	ADJ	JJ	_	26	amod	_	_
24	8	_	NUM	CD	_	26	nummod	_	_
25	fold	_	NOUN	NN	_	26	amod	_	_
26	increase	_	NOUN	NN	_	19	conj	_	_
27	in	_	ADP	IN	_	29	case	_	_
28	plasma	_	NOUN	NN	_	29	compound	_	_
29	AUC	_	NOUN	NN	_	26	nmod	_	_
30	of	_	ADP	IN	_	32	case	_	_
31	the	_	DET	DT	_	32	det	_	_
32	TCA	_	NOUN	NN	_	29	nmod	_	_

#	Amitriptyline Hydrochloride	1185
1	In	_	ADP	IN	_	2	case	_	_
2	addition	_	NOUN	NN	_	6	nmod	_	_
3	,	_	.	,	_	6	punct	_	_
4	certain	_	ADJ	JJ	_	5	amod	_	_
5	drugs	_	NOUN	NNS	_	6	nsubj	_	_
6	inhibit	_	VERB	VBP	_	0	root	_	_
7	the	_	DET	DT	_	8	det	_	_
8	activity	_	NOUN	NN	_	6	dobj	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	this	_	DET	DT	_	11	det	_	_
11	isozyme	_	NOUN	NN	_	8	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	make	_	ADJ	JJ	_	15	amod	_	_
14	normal	_	ADJ	JJ	_	15	amod	_	_
15	metabolizers	_	NOUN	NNS	_	11	conj	_	_
16	resemble	_	ADJ	JJ	_	6	xcomp	_	_
17	poor	_	ADJ	JJ	_	18	amod	_	_
18	metabolizers	_	NOUN	NNS	_	16	dobj	_	_

#	Amitriptyline Hydrochloride	1186
1	An	_	DET	DT	_	2	det	_	_
2	individual	_	NOUN	NN	_	13	nsubj	_	_
3	who	_	DET	WDT	_	5	nsubj	_	_
4	is	_	VERB	VBZ	_	5	cop	_	_
5	stable	_	ADJ	JJ	_	2	acl:relcl	_	_
6	on	_	ADP	IN	_	9	case	_	_
7	a	_	DET	DT	_	9	det	_	_
8	given	_	VERB	VBN	_	9	amod	_	_
9	dose	_	NOUN	NN	_	5	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	TCA	_	NOUN	NN	_	9	nmod	_	_
12	may	_	VERB	MD	_	13	aux	_	_
13	become	_	VERB	VB	_	0	root	_	_
14	abruptly	_	ADV	RB	_	15	advmod	_	_
15	toxic	_	ADJ	JJ	_	13	xcomp	_	_
16	when	_	ADV	WRB	_	17	advmod	_	_
17	given	_	VERB	VBN	_	15	dep	_	_
18	one	_	NUM	CD	_	17	dobj	_	_
19	of	_	ADP	IN	_	22	case	_	_
20	these	_	DET	DT	_	22	det	_	_
21	inhibiting	_	VERB	VBG	_	22	amod	_	_
22	drugs	_	NOUN	NNS	_	18	nmod	_	_
23	as	_	ADP	IN	_	25	case	_	_
24	concomitant	_	ADJ	JJ	_	25	amod	_	_
25	therapy	_	NOUN	NN	_	17	nmod	_	_

#	Amitriptyline Hydrochloride	1187
1	The	_	DET	DT	_	2	det	_	_
2	drugs	_	NOUN	NNS	_	8	nsubj	_	_
3	that	_	DET	WDT	_	4	nsubj	_	_
4	inhibit	_	VERB	VBP	_	2	acl:relcl	_	_
5	cytochrome	_	NOUN	NN	_	7	compound	_	_
6	P450	_	NOUN	NN	_	7	compound	_	_
7	2D6	_	NOUN	NN	_	4	dobj	_	_
8	include	_	VERB	VBP	_	0	root	_	_
9	some	_	DET	DT	_	8	dobj	_	_
10	that	_	DET	WDT	_	13	nsubjpass	_	_
11	are	_	VERB	VBP	_	13	auxpass	_	_
12	not	_	ADV	RB	_	13	neg	_	_
13	metabolized	_	VERB	VBN	_	9	root	_	_
14	by	_	ADP	IN	_	18	case	_	_
15	the	_	DET	DT	_	18	det	_	_
16	enzyme	_	NOUN	NN	_	18	compound	_	_
17	quinidine	_	NOUN	NN	_	18	compound	_	_
18	cimetidine	_	NOUN	NN	_	13	nmod	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	many	_	NOUN	NN	_	18	conj	_	_
21	that	_	DET	WDT	_	23	nsubj	_	_
22	are	_	VERB	VBP	_	23	cop	_	_
23	substrates	_	NOUN	NNS	_	18	acl:relcl	_	_
24	for	_	ADP	IN	_	29	case	_	_
25	P450	_	NOUN	NN	_	29	compound	_	_
26	2D6	_	NOUN	NN	_	29	compound	_	_
27	many	_	ADJ	JJ	_	29	amod	_	_
28	other	_	ADJ	JJ	_	29	amod	_	_
29	antidepressants	_	NOUN	NNS	_	23	nmod	_	_
30	,	_	.	,	_	29	punct	_	_
31	phenothiazines	_	NOUN	NNS	_	29	conj	_	_
32	,	_	.	,	_	29	punct	_	_
33	and	_	CONJ	CC	_	29	cc	_	_
34	the	_	DET	DT	_	37	det	_	_
35	Type	_	NOUN	NN	_	37	compound	_	_
36	1C	_	NOUN	NN	_	37	compound	_	_
37	antiarrhythmics	_	NOUN	NNS	_	29	conj	_	_
38	propafenone	_	NOUN	NN	_	37	dep	_	_
39	and	_	CONJ	CC	_	38	cc	_	_
40	flecainide	_	NOUN	NN	_	38	conj	_	_

#	Amitriptyline Hydrochloride	1188
1	While	_	ADP	IN	_	19	mark	_	_
2	all	_	CONJ	CC	_	7	cc:preconj	_	_
3	the	_	DET	DT	_	7	det	_	_
4	selective	_	ADJ	JJ	_	7	amod	_	_
5	serotonin	_	NOUN	NN	_	7	compound	_	_
6	reuptake	_	NOUN	NN	_	7	compound	_	_
7	inhibitors	_	NOUN	NNS	_	19	nsubj	_	_
8	SSRIs	_	NOUN	NNS	_	7	dep	_	_
9	,	_	.	,	_	8	punct	_	_
10	e.g	_	NOUN	NN	_	8	conj	_	_
11	,	_	.	,	_	8	punct	_	_
12	fluoxetine	_	NOUN	NN	_	8	conj	_	_
13	,	_	.	,	_	8	punct	_	_
14	sertraline	_	NOUN	NN	_	8	conj	_	_
15	,	_	.	,	_	8	punct	_	_
16	and	_	CONJ	CC	_	8	cc	_	_
17	paroxetine	_	NOUN	NN	_	8	conj	_	_
18	,	_	.	,	_	7	punct	_	_
19	inhibit	_	VERB	VBP	_	25	advcl	_	_
20	P450	_	NOUN	NN	_	21	compound	_	_
21	2D6	_	NOUN	NN	_	19	dobj	_	_
22	,	_	.	,	_	25	punct	_	_
23	they	_	PRON	PRP	_	25	nsubj	_	_
24	may	_	VERB	MD	_	25	aux	_	_
25	vary	_	VERB	VB	_	0	root	_	_
26	in	_	ADP	IN	_	28	case	_	_
27	the	_	DET	DT	_	28	det	_	_
28	extent	_	NOUN	NN	_	25	nmod	_	_
29	of	_	ADP	IN	_	30	case	_	_
30	inhibition	_	NOUN	NN	_	28	nmod	_	_

#	Amitriptyline Hydrochloride	1189
1	The	_	DET	DT	_	2	det	_	_
2	extent	_	NOUN	NN	_	13	nsubj	_	_
3	to	_	PRT	TO	_	4	case	_	_
4	which	_	DET	WDT	_	9	nmod	_	_
5	SSRI	_	NOUN	NN	_	7	compound	_	_
6	TCA	_	NOUN	NN	_	7	compound	_	_
7	interactions	_	NOUN	NNS	_	9	nsubj	_	_
8	may	_	VERB	MD	_	9	aux	_	_
9	pose	_	VERB	VB	_	2	acl:relcl	_	_
10	clinical	_	ADJ	JJ	_	11	amod	_	_
11	problems	_	NOUN	NNS	_	9	dobj	_	_
12	will	_	VERB	MD	_	13	aux	_	_
13	depend	_	VERB	VB	_	0	root	_	_
14	on	_	ADP	IN	_	16	case	_	_
15	the	_	DET	DT	_	16	det	_	_
16	degree	_	NOUN	NN	_	13	nmod	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	inhibition	_	NOUN	NN	_	16	nmod	_	_
19	and	_	CONJ	CC	_	13	cc	_	_
20	the	_	DET	DT	_	21	det	_	_
21	pharmacokinetics	_	NOUN	NNS	_	13	conj	_	_
22	of	_	ADP	IN	_	24	case	_	_
23	the	_	DET	DT	_	24	det	_	_
24	SSRI	_	NOUN	NN	_	21	nmod	_	_
25	involved	_	VERB	VBN	_	24	acl	_	_

#	Amitriptyline Hydrochloride	1190
1	Nevertheless	_	ADV	RB	_	5	advmod	_	_
2	,	_	.	,	_	5	punct	_	_
3	caution	_	NOUN	NN	_	5	nsubjpass	_	_
4	is	_	VERB	VBZ	_	5	auxpass	_	_
5	indicated	_	VERB	VBN	_	0	root	_	_
6	in	_	ADP	IN	_	8	case	_	_
7	the	_	DET	DT	_	8	det	_	_
8	coadministration	_	NOUN	NN	_	5	nmod	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	TCAs	_	NOUN	NNS	_	8	nmod	_	_
11	with	_	ADP	IN	_	12	case	_	_
12	any	_	DET	DT	_	8	nmod	_	_
13	of	_	ADP	IN	_	15	case	_	_
14	the	_	DET	DT	_	15	det	_	_
15	SSRIs	_	NOUN	NNS	_	12	nmod	_	_
16	and	_	CONJ	CC	_	8	cc	_	_
17	also	_	ADV	RB	_	19	advmod	_	_
18	in	_	ADP	IN	_	19	case	_	_
19	switching	_	NOUN	NN	_	8	conj	_	_
20	from	_	ADP	IN	_	22	case	_	_
21	one	_	NUM	CD	_	22	nummod	_	_
22	class	_	NOUN	NN	_	19	nmod	_	_
23	to	_	PRT	TO	_	25	case	_	_
24	the	_	DET	DT	_	25	det	_	_
25	other	_	ADJ	JJ	_	19	nmod	_	_

#	Amitriptyline Hydrochloride	1191
1	Of	_	ADP	IN	_	3	case	_	_
2	particular	_	ADJ	JJ	_	3	amod	_	_
3	importance	_	NOUN	NN	_	8	nmod	_	_
4	,	_	.	,	_	8	punct	_	_
5	sufficient	_	ADJ	JJ	_	6	amod	_	_
6	time	_	NOUN	NN	_	8	nsubj	_	_
7	must	_	VERB	MD	_	8	aux	_	_
8	elapse	_	VERB	VB	_	17	aux	_	_
9	before	_	ADP	IN	_	10	mark	_	_
10	initiating	_	VERB	VBG	_	8	advcl	_	_
11	TCA	_	NOUN	NN	_	12	compound	_	_
12	treatment	_	NOUN	NN	_	10	dobj	_	_
13	in	_	ADP	IN	_	15	case	_	_
14	a	_	DET	DT	_	15	det	_	_
15	patient	_	NOUN	NN	_	10	nmod	_	_
16	being	_	VERB	VBD	_	17	cop	_	_
17	withdrawn	_	ADJ	JJ	_	0	root	_	_
18	from	_	ADP	IN	_	19	case	_	_
19	fluoxetine	_	NOUN	NN	_	17	nmod	_	_
20	,	_	.	,	_	17	punct	_	_
21	given	_	VERB	VBN	_	17	parataxis	_	_
22	the	_	DET	DT	_	25	det	_	_
23	long	_	ADJ	JJ	_	25	amod	_	_
24	half	_	NOUN	NN	_	25	amod	_	_
25	life	_	NOUN	NN	_	21	dobj	_	_
26	of	_	ADP	IN	_	28	case	_	_
27	the	_	DET	DT	_	28	det	_	_
28	parent	_	NOUN	NN	_	25	nmod	_	_
29	and	_	CONJ	CC	_	28	cc	_	_
30	active	_	ADJ	JJ	_	31	amod	_	_
31	metabolite	_	NOUN	NN	_	28	conj	_	_
32	at	_	ADP	IN	_	33	case	_	_
33	least	_	ADJ	JJS	_	34	nmod:npmod	_	_
34	5	_	NUM	CD	_	35	nummod	_	_
35	weeks	_	NOUN	NNS	_	25	nmod	_	_
36	may	_	VERB	MD	_	38	aux	_	_
37	be	_	VERB	VB	_	38	auxpass	_	_
38	necessary	_	ADJ	JJ	_	21	dep	_	_

#	Amitriptyline Hydrochloride	1192
1	Concomitant	_	ADJ	JJ	_	2	amod	_	_
2	use	_	NOUN	NN	_	15	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	tricyclic	_	ADJ	JJ	_	5	amod	_	_
5	antidepressants	_	NOUN	NNS	_	2	nmod	_	_
6	with	_	ADP	IN	_	7	case	_	_
7	drugs	_	NOUN	NNS	_	2	nmod	_	_
8	that	_	DET	WDT	_	10	nsubj	_	_
9	can	_	VERB	MD	_	10	aux	_	_
10	inhibit	_	VERB	VB	_	7	acl:relcl	_	_
11	cytochrome	_	NOUN	NN	_	13	compound	_	_
12	P450	_	NOUN	NN	_	13	compound	_	_
13	2D6	_	NOUN	NN	_	10	dobj	_	_
14	may	_	VERB	MD	_	15	aux	_	_
15	require	_	VERB	VB	_	0	root	_	_
16	lower	_	ADJ	JJ	_	17	amod	_	_
17	doses	_	NOUN	NNS	_	15	dobj	_	_
18	than	_	ADP	IN	_	20	mark	_	_
19	usually	_	ADV	RB	_	20	advmod	_	_
20	prescribed	_	VERB	VBN	_	15	advcl	_	_
21	for	_	ADP	IN	_	25	case	_	_
22	either	_	CONJ	CC	_	25	cc:preconj	_	_
23	the	_	DET	DT	_	25	det	_	_
24	tricyclic	_	ADJ	JJ	_	25	amod	_	_
25	antidepressant	_	NOUN	NN	_	20	nmod	_	_
26	or	_	CONJ	CC	_	25	cc	_	_
27	the	_	DET	DT	_	29	det	_	_
28	other	_	ADJ	JJ	_	29	amod	_	_
29	drug	_	NOUN	NN	_	25	conj	_	_

#	Amitriptyline Hydrochloride	1193
1	Furthermore	_	ADV	RB	_	22	advmod	_	_
2	,	_	.	,	_	22	punct	_	_
3	whenever	_	ADP	IN	_	10	mark	_	_
4	one	_	NUM	CD	_	10	nsubj	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	these	_	DET	DT	_	8	det	_	_
7	other	_	ADJ	JJ	_	8	amod	_	_
8	drugs	_	NOUN	NNS	_	4	nmod	_	_
9	is	_	VERB	VBZ	_	10	cop	_	_
10	withdrawn	_	ADJ	JJ	_	22	advcl	_	_
11	from	_	ADP	IN	_	12	case	_	_
12	cotherapy	_	NOUN	NN	_	10	nmod	_	_
13	,	_	.	,	_	22	punct	_	_
14	an	_	DET	DT	_	16	det	_	_
15	increased	_	VERB	VBN	_	16	amod	_	_
16	dose	_	NOUN	NN	_	22	nsubjpass	_	_
17	of	_	ADP	IN	_	19	case	_	_
18	tricyclic	_	ADJ	JJ	_	19	amod	_	_
19	antidepressant	_	NOUN	NN	_	16	nmod	_	_
20	may	_	VERB	MD	_	22	aux	_	_
21	be	_	VERB	VB	_	22	auxpass	_	_
22	required	_	VERB	VBN	_	0	root	_	_

#	Amitriptyline Hydrochloride	1194
1	It	_	PRON	PRP	_	3	nsubj	_	_
2	is	_	VERB	VBZ	_	3	cop	_	_
3	desirable	_	ADJ	JJ	_	0	root	_	_
4	to	_	PRT	TO	_	5	mark	_	_
5	monitor	_	VERB	VB	_	3	xcomp	_	_
6	TCA	_	NOUN	NN	_	8	compound	_	_
7	plasma	_	NOUN	NN	_	8	compound	_	_
8	levels	_	NOUN	NNS	_	5	dobj	_	_
9	whenever	_	ADV	WRB	_	13	advmod	_	_
10	a	_	DET	DT	_	11	det	_	_
11	TCA	_	NOUN	NN	_	13	nsubj	_	_
12	is	_	VERB	VBZ	_	13	cop	_	_
13	going	_	VERB	VBG	_	5	advcl	_	_
14	to	_	PRT	TO	_	16	mark	_	_
15	be	_	VERB	VB	_	16	auxpass	_	_
16	coadministered	_	VERB	VBN	_	13	xcomp	_	_
17	with	_	ADP	IN	_	19	case	_	_
18	another	_	DET	DT	_	19	det	_	_
19	drug	_	NOUN	NN	_	16	nmod	_	_
20	known	_	VERB	VBN	_	19	acl	_	_
21	to	_	PRT	TO	_	24	mark	_	_
22	be	_	VERB	VB	_	24	cop	_	_
23	an	_	DET	DT	_	24	det	_	_
24	inhibitor	_	NOUN	NN	_	20	xcomp	_	_
25	of	_	ADP	IN	_	27	case	_	_
26	P450	_	NOUN	NN	_	27	compound	_	_
27	2D6	_	NOUN	NN	_	24	nmod	_	_

#	Amitriptyline Hydrochloride	1195
1	Guanethidine	_	NOUN	NN	_	10	nsubj	_	_
2	or	_	CONJ	CC	_	1	cc	_	_
3	similarly	_	ADV	RB	_	4	advmod	_	_
4	acting	_	VERB	VBG	_	1	conj	_	_
5	compounds	_	NOUN	NNS	_	8	compound	_	_
6	thyroid	_	NOUN	NN	_	8	compound	_	_
7	medication	_	NOUN	NN	_	8	compound	_	_
8	alcohol	_	NOUN	NN	_	4	dobj	_	_
9	,	_	.	,	_	1	punct	_	_
10	barbiturates	_	VERB	VBZ	_	0	root	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	other	_	ADJ	JJ	_	14	amod	_	_
13	CNS	_	NOUN	NN	_	14	compound	_	_
14	depressants	_	NOUN	NNS	_	10	conj	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	disulfiram	_	NOUN	NN	_	14	conj	_	_

#	Amitriptyline Hydrochloride	1196
1	When	_	ADV	WRB	_	4	advmod	_	_
2	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
3	is	_	VERB	VBZ	_	4	auxpass	_	_
4	given	_	VERB	VBN	_	27	advcl	_	_
5	with	_	ADP	IN	_	7	case	_	_
6	anticholinergic	_	ADJ	JJ	_	7	amod	_	_
7	agents	_	NOUN	NNS	_	4	nmod	_	_
8	or	_	CONJ	CC	_	7	cc	_	_
9	sympathomimetic	_	ADJ	JJ	_	10	amod	_	_
10	drugs	_	NOUN	NNS	_	7	conj	_	_
11	,	_	.	,	_	27	punct	_	_
12	including	_	VERB	VBG	_	13	case	_	_
13	epinephrine	_	NOUN	NN	_	27	nmod	_	_
14	combined	_	VERB	VBN	_	13	acl	_	_
15	with	_	ADP	IN	_	17	case	_	_
16	local	_	ADJ	JJ	_	17	amod	_	_
17	anesthetics	_	NOUN	NNS	_	14	nmod	_	_
18	,	_	.	,	_	27	punct	_	_
19	close	_	ADJ	JJ	_	20	amod	_	_
20	supervision	_	NOUN	NN	_	27	nsubjpass	_	_
21	and	_	CONJ	CC	_	20	cc	_	_
22	careful	_	ADJ	JJ	_	23	amod	_	_
23	adjustment	_	NOUN	NN	_	20	conj	_	_
24	of	_	ADP	IN	_	25	case	_	_
25	dosages	_	NOUN	NNS	_	20	nmod	_	_
26	are	_	VERB	VBP	_	27	auxpass	_	_
27	required	_	VERB	VBN	_	0	root	_	_

#	Amitriptyline Hydrochloride	1197
1	Hyperpyrexia	_	NOUN	NN	_	4	nsubjpass	_	_
2	has	_	VERB	VBZ	_	4	aux	_	_
3	been	_	VERB	VBN	_	4	auxpass	_	_
4	reported	_	VERB	VBN	_	0	root	_	_
5	when	_	ADV	WRB	_	8	advmod	_	_
6	DRUG	_	NOUN	NN	_	8	nsubjpass	_	_
7	is	_	VERB	VBZ	_	8	auxpass	_	_
8	administered	_	VERB	VBN	_	4	advcl	_	_
9	with	_	ADP	IN	_	11	case	_	_
10	anticholinergic	_	ADJ	JJ	_	11	amod	_	_
11	agents	_	NOUN	NNS	_	8	nmod	_	_
12	or	_	CONJ	CC	_	11	cc	_	_
13	with	_	ADP	IN	_	15	case	_	_
14	neuroleptic	_	ADJ	JJ	_	15	amod	_	_
15	drugs	_	NOUN	NNS	_	11	conj	_	_
16	,	_	.	,	_	4	punct	_	_
17	particularly	_	ADV	RB	_	20	advmod	_	_
18	during	_	ADP	IN	_	20	case	_	_
19	hot	_	PRON	PRP$	_	20	advmod	_	_
20	weather	_	CONJ	CC	_	4	nmod	_	_

#	Amitriptyline Hydrochloride	1198
1	Paralytic	_	ADJ	JJ	_	2	amod	_	_
2	ileus	_	NOUN	NN	_	4	nsubj	_	_
3	may	_	VERB	MD	_	4	aux	_	_
4	occur	_	VERB	VB	_	0	root	_	_
5	in	_	ADP	IN	_	6	case	_	_
6	patients	_	NOUN	NNS	_	4	nmod	_	_
7	taking	_	VERB	VBG	_	6	acl	_	_
8	tricyclic	_	ADJ	JJ	_	9	amod	_	_
9	antidepressants	_	NOUN	NNS	_	7	dobj	_	_
10	in	_	ADP	IN	_	11	case	_	_
11	combination	_	NOUN	NN	_	7	nmod	_	_
12	with	_	ADP	IN	_	15	case	_	_
13	anticholinergic	_	ADJ	JJ	_	15	amod	_	_
14	type	_	NOUN	NN	_	15	compound	_	_
15	drugs	_	NOUN	NNS	_	11	nmod	_	_

#	Amitriptyline Hydrochloride	1199
1	Cimetidine	_	NOUN	NN	_	3	nsubjpass	_	_
2	is	_	VERB	VBZ	_	3	auxpass	_	_
3	reported	_	VERB	VBN	_	0	root	_	_
4	to	_	PRT	TO	_	5	mark	_	_
5	reduce	_	VERB	VB	_	3	xcomp	_	_
6	hepatic	_	ADJ	JJ	_	7	amod	_	_
7	metabolism	_	NOUN	NN	_	5	dobj	_	_
8	of	_	ADP	IN	_	11	case	_	_
9	certain	_	ADJ	JJ	_	11	amod	_	_
10	tricyclic	_	ADJ	JJ	_	11	amod	_	_
11	antidepressants	_	NOUN	NNS	_	7	nmod	_	_
12	,	_	.	,	_	3	punct	_	_
13	thereby	_	ADV	RB	_	14	advmod	_	_
14	delaying	_	VERB	VBG	_	3	advcl	_	_
15	elimination	_	NOUN	NN	_	14	dobj	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	increasing	_	VERB	VBG	_	20	amod	_	_
18	steady	_	ADJ	JJ	_	20	amod	_	_
19	state	_	NOUN	NN	_	20	compound	_	_
20	concentrations	_	NOUN	NNS	_	15	conj	_	_
21	of	_	ADP	IN	_	23	case	_	_
22	these	_	DET	DT	_	23	det	_	_
23	drugs	_	NOUN	NNS	_	15	nmod	_	_

#	Amitriptyline Hydrochloride	1200
1	Clinically	_	ADV	RB	_	6	advmod	_	_
2	significant	_	ADJ	JJ	_	3	amod	_	_
3	effects	_	NOUN	NNS	_	6	nsubjpass	_	_
4	have	_	VERB	VBP	_	6	aux	_	_
5	been	_	VERB	VBN	_	6	auxpass	_	_
6	reported	_	VERB	VBN	_	0	root	_	_
7	with	_	ADP	IN	_	10	case	_	_
8	the	_	DET	DT	_	10	det	_	_
9	tricyclic	_	ADJ	JJ	_	10	amod	_	_
10	antidepressants	_	NOUN	NNS	_	6	nmod	_	_
11	when	_	ADV	WRB	_	12	advmod	_	_
12	used	_	VERB	VBN	_	6	advcl	_	_
13	concomitantly	_	ADV	RB	_	12	advmod	_	_
14	with	_	ADP	IN	_	15	case	_	_
15	cimetidine	_	NOUN	NN	_	12	nmod	_	_

#	Amitriptyline Hydrochloride	1201
1	Increases	_	NOUN	NNS	_	24	nsubjpass	_	_
2	in	_	ADP	IN	_	4	case	_	_
3	plasma	_	NOUN	NN	_	4	compound	_	_
4	levels	_	NOUN	NNS	_	1	nmod	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	tricyclic	_	ADJ	JJ	_	7	amod	_	_
7	antidepressants	_	NOUN	NNS	_	4	nmod	_	_
8	,	_	.	,	_	1	punct	_	_
9	and	_	CONJ	CC	_	1	cc	_	_
10	in	_	ADP	IN	_	12	case	_	_
11	the	_	DET	DT	_	12	det	_	_
12	frequency	_	NOUN	NN	_	1	conj	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	severity	_	NOUN	NN	_	12	conj	_	_
15	of	_	ADP	IN	_	17	case	_	_
16	side	_	ADJ	JJ	_	17	amod	_	_
17	effects	_	NOUN	NNS	_	12	nmod	_	_
18	,	_	.	,	_	12	punct	_	_
19	particularly	_	ADV	RB	_	20	advmod	_	_
20	anticholinergic	_	ADJ	JJ	_	12	amod	_	_
21	,	_	.	,	_	12	punct	_	_
22	have	_	VERB	VBP	_	24	aux	_	_
23	been	_	VERB	VBN	_	24	auxpass	_	_
24	reported	_	VERB	VBN	_	0	root	_	_
25	when	_	ADV	WRB	_	28	advmod	_	_
26	cimetidine	_	NOUN	NN	_	28	nsubjpass	_	_
27	was	_	VERB	VBD	_	28	auxpass	_	_
28	added	_	VERB	VBN	_	24	ccomp	_	_
29	to	_	PRT	TO	_	32	case	_	_
30	the	_	DET	DT	_	32	det	_	_
31	drug	_	NOUN	NN	_	32	compound	_	_
32	regimen	_	NOUN	NNS	_	28	nmod	_	_

#	Amitriptyline Hydrochloride	1202
1	Discontinuation	_	NOUN	NN	_	14	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	cimetidine	_	NOUN	NN	_	1	nmod	_	_
4	in	_	ADP	IN	_	7	case	_	_
5	well	_	ADV	RB	_	6	advmod	_	_
6	controlled	_	VERB	VBN	_	7	amod	_	_
7	patients	_	NOUN	NNS	_	3	nmod	_	_
8	receiving	_	VERB	VBG	_	7	acl	_	_
9	tricyclic	_	ADJ	JJ	_	10	amod	_	_
10	antidepressants	_	NOUN	NNS	_	8	dobj	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	cimetidine	_	NOUN	NN	_	10	conj	_	_
13	may	_	VERB	MD	_	14	aux	_	_
14	decrease	_	VERB	VB	_	0	root	_	_
15	the	_	DET	DT	_	17	det	_	_
16	plasma	_	NOUN	NN	_	17	compound	_	_
17	levels	_	NOUN	NNS	_	14	dobj	_	_
18	and	_	CONJ	CC	_	17	cc	_	_
19	efficacy	_	NOUN	NN	_	17	conj	_	_
20	of	_	ADP	IN	_	22	case	_	_
21	the	_	DET	DT	_	22	det	_	_
22	antidepressants	_	NOUN	NNS	_	17	nmod	_	_

#	Amitriptyline Hydrochloride	1203
1	Caution	_	NOUN	NN	_	3	nsubjpass	_	_
2	is	_	VERB	VBZ	_	3	auxpass	_	_
3	advised	_	VERB	VBN	_	0	root	_	_
4	if	_	ADP	IN	_	6	mark	_	_
5	patients	_	NOUN	NNS	_	6	nsubj	_	_
6	receive	_	VERB	VBP	_	3	root	_	_
7	large	_	ADJ	JJ	_	8	amod	_	_
8	doses	_	NOUN	NNS	_	6	dobj	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	ethchlorvynol	_	NOUN	NN	_	8	nmod	_	_
11	concurrently	_	ADV	RB	_	6	advmod	_	_

#	Amitriptyline Hydrochloride	1204
1	Transient	_	ADJ	JJ	_	2	amod	_	_
2	delirium	_	NOUN	NN	_	5	nsubjpass	_	_
3	has	_	VERB	VBZ	_	5	aux	_	_
4	been	_	VERB	VBN	_	5	auxpass	_	_
5	reported	_	VERB	VBN	_	0	root	_	_
6	in	_	ADP	IN	_	7	case	_	_
7	patients	_	NOUN	NNS	_	5	nmod	_	_
8	who	_	DET	WDT	_	10	nsubjpass	_	_
9	were	_	VERB	VBD	_	10	auxpass	_	_
10	treated	_	VERB	VBN	_	7	acl:relcl	_	_
11	with	_	ADP	IN	_	13	case	_	_
12	one	_	NUM	CD	_	13	nummod	_	_
13	gram	_	NOUN	NN	_	10	nmod	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	ethchlorvynol	_	NOUN	NN	_	13	nmod	_	_
16	and	_	CONJ	CC	_	13	cc	_	_
17	75	_	NUM	CD	_	18	nummod	_	_
18	mg	_	NOUN	NN	_	20	advmod	_	_
19	to	_	PRT	TO	_	20	dep	_	_
20	150	_	NUM	CD	_	21	nummod	_	_
21	mg	_	NOUN	NN	_	13	conj	_	_
22	of	_	ADP	IN	_	23	case	_	_
23	DRUG	_	NOUN	NN	_	21	nmod	_	_

#	Amitriptyline Hydrochloride	1205
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	is	_	VERB	VBZ	_	4	cop	_	_
3	an	_	DET	DT	_	4	det	_	_
4	antidepressant	_	ADJ	JJ	_	0	root	_	_
5	with	_	ADP	IN	_	7	case	_	_
6	sedative	_	ADJ	JJ	_	7	amod	_	_
7	effects	_	NOUN	NNS	_	4	nmod	_	_

#	Amitriptyline Hydrochloride	1206
1	Its	_	PRON	PRP$	_	2	nmod:poss	_	_
2	mechanism	_	NOUN	NN	_	9	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	action	_	NOUN	NN	_	2	nmod	_	_
5	in	_	ADP	IN	_	6	case	_	_
6	man	_	VERB	MD	_	4	nmod	_	_
7	is	_	VERB	VB	_	9	auxpass	_	_
8	not	_	ADV	RB	_	9	neg	_	_
9	known	_	VERB	VBN	_	0	root	_	_

#	Amitriptyline Hydrochloride	1207
1	It	_	PRON	PRP	_	7	nsubj	_	_
2	is	_	VERB	VBZ	_	7	cop	_	_
3	not	_	ADV	RB	_	7	neg	_	_
4	a	_	DET	DT	_	7	det	_	_
5	monoamine	_	NOUN	NN	_	7	compound	_	_
6	oxidase	_	NOUN	NN	_	7	compound	_	_
7	inhibitor	_	NOUN	NN	_	0	root	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	it	_	PRON	PRP	_	12	nsubj	_	_
10	does	_	VERB	VBZ	_	12	aux	_	_
11	not	_	ADV	RB	_	12	neg	_	_
12	act	_	VERB	VB	_	7	conj	_	_
13	primarily	_	ADV	RB	_	12	advmod	_	_
14	by	_	ADP	IN	_	15	case	_	_
15	stimulation	_	NOUN	NN	_	12	nmod	_	_
16	of	_	ADP	IN	_	20	case	_	_
17	the	_	DET	DT	_	20	det	_	_
18	central	_	ADJ	JJ	_	20	amod	_	_
19	nervous	_	ADJ	JJ	_	20	amod	_	_
20	system	_	NOUN	NN	_	15	nmod	_	_

#	Amitriptyline Hydrochloride	1208
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	inhibits	_	VERB	VBZ	_	0	root	_	_
3	the	_	DET	DT	_	6	det	_	_
4	membrane	_	NOUN	NN	_	6	compound	_	_
5	pump	_	NOUN	NN	_	6	compound	_	_
6	mechanism	_	NOUN	NN	_	2	dobj	_	_
7	responsible	_	ADJ	JJ	_	6	amod	_	_
8	for	_	ADP	IN	_	9	case	_	_
9	uptake	_	NOUN	NN	_	7	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	norepinephrine	_	NOUN	NN	_	9	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	serotonin	_	NOUN	NN	_	11	conj	_	_
14	in	_	ADP	IN	_	18	case	_	_
15	adrenergic	_	ADJ	JJ	_	18	amod	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	serotonergic	_	ADJ	JJ	_	15	conj	_	_
18	neurons	_	NOUN	NNS	_	9	nmod	_	_

#	Amitriptyline Hydrochloride	1209
1	Pharmacologically	_	ADV	RB	_	5	advmod	_	_
2	this	_	DET	DT	_	3	det	_	_
3	action	_	NOUN	NN	_	5	nsubj	_	_
4	may	_	VERB	MD	_	5	aux	_	_
5	potentiate	_	VERB	VB	_	0	root	_	_
6	or	_	CONJ	CC	_	5	cc	_	_
7	prolong	_	ADJ	JJ	_	5	conj	_	_
8	neuronal	_	ADJ	JJ	_	9	amod	_	_
9	activity	_	NOUN	NN	_	7	dobj	_	_
10	since	_	ADP	IN	_	17	mark	_	_
11	reuptake	_	NOUN	NN	_	17	nsubj	_	_
12	of	_	ADP	IN	_	15	case	_	_
13	these	_	DET	DT	_	15	det	_	_
14	biogenic	_	ADJ	JJ	_	15	amod	_	_
15	amines	_	NOUN	NNS	_	11	nmod	_	_
16	is	_	VERB	VBZ	_	17	cop	_	_
17	important	_	ADJ	JJ	_	5	ccomp	_	_
18	physiologically	_	ADV	RB	_	17	advmod	_	_
19	in	_	ADP	IN	_	20	mark	_	_
20	terminating	_	VERB	VBG	_	17	advcl	_	_
21	transmitting	_	NOUN	NN	_	22	case	_	_
22	activity	_	NOUN	NN	_	20	dobj	_	_

#	Amitriptyline Hydrochloride	1210
1	This	_	DET	DT	_	2	det	_	_
2	interference	_	NOUN	NN	_	12	nsubjpass	_	_
3	with	_	ADP	IN	_	4	case	_	_
4	reuptake	_	NOUN	NN	_	2	nmod	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	norepinephrine	_	NOUN	NN	_	4	nmod	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	/	_	NOUN	NN	_	6	conj	_	_
9	or	_	CONJ	CC	_	6	cc	_	_
10	serotonin	_	NOUN	NN	_	6	conj	_	_
11	is	_	VERB	VBZ	_	12	auxpass	_	_
12	believed	_	VERB	VBN	_	0	root	_	_
13	by	_	ADP	IN	_	14	case	_	_
14	some	_	DET	DT	_	12	nmod	_	_
15	to	_	PRT	TO	_	16	mark	_	_
16	underlie	_	VERB	VB	_	12	xcomp	_	_
17	the	_	DET	DT	_	19	det	_	_
18	antidepressant	_	ADJ	JJ	_	19	amod	_	_
19	activity	_	NOUN	NN	_	16	dobj	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	DRUG	_	NOUN	NN	_	19	nmod	_	_

#	Amoxapine	3401
1	See	_	ADJ	JJ	_	2	amod	_	_
2	CONTRAINDICATIONS	_	NOUN	NN	_	0	root	_	_
3	about	_	ADV	RB	_	5	case	_	_
4	concurrent	_	ADJ	JJ	_	5	amod	_	_
5	usage	_	NOUN	NN	_	2	nmod	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	tricyclic	_	ADJ	JJ	_	8	amod	_	_
8	antidepressants	_	NOUN	NNS	_	5	nmod	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	monoamine	_	NOUN	NN	_	12	compound	_	_
11	oxidase	_	NOUN	NN	_	12	compound	_	_
12	inhibitors	_	NOUN	NNS	_	8	conj	_	_

#	Amoxapine	3402
1	Paralytic	_	ADJ	JJ	_	2	amod	_	_
2	ileus	_	NOUN	NN	_	4	nsubj	_	_
3	may	_	VERB	MD	_	4	aux	_	_
4	occur	_	VERB	VB	_	0	root	_	_
5	in	_	ADP	IN	_	6	case	_	_
6	patients	_	NOUN	NNS	_	4	nmod	_	_
7	taking	_	VERB	VBG	_	6	acl	_	_
8	tricyclic	_	ADJ	JJ	_	9	amod	_	_
9	antidepressants	_	NOUN	NNS	_	7	dobj	_	_
10	in	_	ADP	IN	_	11	case	_	_
11	combination	_	NOUN	NN	_	7	nmod	_	_
12	with	_	ADP	IN	_	14	case	_	_
13	anticholinergic	_	ADJ	JJ	_	14	amod	_	_
14	drugs	_	NOUN	NNS	_	11	nmod	_	_

#	Amoxapine	3403
1	DRUG	_	NOUN	NN	_	3	nsubj	_	_
2	may	_	VERB	MD	_	3	aux	_	_
3	enhance	_	VERB	VB	_	0	root	_	_
4	the	_	DET	DT	_	5	det	_	_
5	response	_	NOUN	NN	_	3	dobj	_	_
6	to	_	PRT	TO	_	7	case	_	_
7	alcohol	_	NOUN	NN	_	5	nmod	_	_
8	and	_	CONJ	CC	_	3	cc	_	_
9	the	_	DET	DT	_	10	det	_	_
10	effects	_	NOUN	NNS	_	3	conj	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	barbiturates	_	NOUN	NNS	_	10	nmod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	other	_	ADJ	JJ	_	16	amod	_	_
15	CNS	_	NOUN	NN	_	16	compound	_	_
16	depressants	_	NOUN	NNS	_	12	conj	_	_

#	Amoxapine	3404
1	Serum	_	NOUN	NN	_	2	compound	_	_
2	levels	_	NOUN	NNS	_	9	nsubjpass	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	several	_	ADJ	JJ	_	6	amod	_	_
5	tricyclic	_	ADJ	JJ	_	6	amod	_	_
6	antidepressants	_	NOUN	NNS	_	2	nmod	_	_
7	have	_	VERB	VBP	_	9	aux	_	_
8	been	_	VERB	VBN	_	9	auxpass	_	_
9	reported	_	VERB	VBN	_	0	root	_	_
10	to	_	PRT	TO	_	13	mark	_	_
11	be	_	VERB	VB	_	13	auxpass	_	_
12	significantly	_	ADV	RB	_	13	advmod	_	_
13	increased	_	VERB	VBN	_	9	xcomp	_	_
14	when	_	ADV	WRB	_	17	advmod	_	_
15	cimetidine	_	NOUN	NN	_	17	nsubjpass	_	_
16	is	_	VERB	VBZ	_	17	auxpass	_	_
17	administered	_	VERB	VBN	_	13	ccomp	_	_
18	concurrently	_	ADV	RB	_	17	advmod	_	_

#	Amoxapine	3405
1	Although	_	ADP	IN	_	8	mark	_	_
2	such	_	ADJ	JJ	_	4	amod	_	_
3	an	_	DET	DT	_	4	det	_	_
4	interaction	_	NOUN	NN	_	8	nsubjpass	_	_
5	has	_	VERB	VBZ	_	8	aux	_	_
6	not	_	ADV	RB	_	8	neg	_	_
7	been	_	VERB	VBN	_	8	auxpass	_	_
8	reported	_	VERB	VBN	_	20	advcl	_	_
9	to	_	PRT	TO	_	10	case	_	_
10	date	_	NOUN	NNS	_	8	nmod	_	_
11	with	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_
13	,	_	.	,	_	20	punct	_	_
14	specific	_	ADJ	JJ	_	16	amod	_	_
15	interaction	_	NOUN	NN	_	16	compound	_	_
16	studies	_	NOUN	NNS	_	20	nsubj	_	_
17	have	_	VERB	VBP	_	20	aux	_	_
18	not	_	ADV	RB	_	20	neg	_	_
19	been	_	VERB	VBN	_	20	cop	_	_
20	done	_	ADJ	JJ	_	0	root	_	_
21	,	_	.	,	_	20	punct	_	_
22	and	_	CONJ	CC	_	20	cc	_	_
23	the	_	DET	DT	_	24	det	_	_
24	possibility	_	NOUN	NN	_	27	nsubjpass	_	_
25	should	_	VERB	MD	_	27	aux	_	_
26	be	_	VERB	VB	_	27	auxpass	_	_
27	considered	_	VERB	VBN	_	20	conj	_	_

#	Amoxapine	3406
1	Drugs	_	NOUN	NNS	_	20	nsubjpass	_	_
2	Metabolized	_	VERB	VBN	_	1	acl	_	_
3	by	_	ADP	IN	_	5	case	_	_
4	P450	_	NOUN	NN	_	5	compound	_	_
5	2D6	_	NOUN	NN	_	2	nmod	_	_
6	The	_	DET	DT	_	8	det	_	_
7	biochemical	_	ADJ	JJ	_	8	amod	_	_
8	activity	_	NOUN	NN	_	1	dep	_	_
9	of	_	ADP	IN	_	18	case	_	_
10	the	_	DET	DT	_	18	det	_	_
11	drug	_	NOUN	NN	_	18	compound	_	_
12	metabolizing	_	NOUN	NN	_	18	compound	_	_
13	isozyme	_	NOUN	NN	_	18	compound	_	_
14	cytochrome	_	NOUN	NN	_	18	compound	_	_
15	P450	_	NOUN	NN	_	18	compound	_	_
16	2D6	_	NOUN	NN	_	18	compound	_	_
17	debrisoquin	_	NOUN	NN	_	18	compound	_	_
18	hydroxylase	_	NOUN	NN	_	8	nmod	_	_
19	is	_	VERB	VBZ	_	20	auxpass	_	_
20	reduced	_	VERB	VBN	_	0	root	_	_
21	in	_	ADP	IN	_	23	case	_	_
22	a	_	DET	DT	_	23	det	_	_
23	subset	_	NOUN	NN	_	20	nmod	_	_
24	of	_	ADP	IN	_	27	case	_	_
25	the	_	DET	DT	_	27	det	_	_
26	Caucasian	_	ADJ	JJ	_	27	amod	_	_
27	population	_	NOUN	NN	_	23	nmod	_	_
28	about	_	ADV	RB	_	29	advmod	_	_
29	7%	_	NOUN	NN	_	23	nmod	_	_
30	to	_	PRT	TO	_	31	case	_	_
31	10%	_	NOUN	NN	_	29	nmod	_	_
32	of	_	ADP	IN	_	33	case	_	_
33	Caucasians	_	NOUN	NNS	_	31	nmod	_	_
34	are	_	VERB	VBP	_	36	auxpass	_	_
35	so	_	ADV	RB	_	36	advmod	_	_
36	called	_	VERB	VBN	_	20	parataxis	_	_
37	"poor	_	ADJ	JJ	_	40	amod	_	_
38	metabolizers"	_	NOUN	NN	_	40	compound	_	_
39	reliable	_	ADJ	JJ	_	40	amod	_	_
40	estimates	_	NOUN	NNS	_	36	dobj	_	_
41	of	_	ADP	IN	_	43	case	_	_
42	the	_	DET	DT	_	43	det	_	_
43	prevalence	_	NOUN	NN	_	40	nmod	_	_
44	of	_	ADP	IN	_	49	case	_	_
45	reduced	_	VERB	VBN	_	49	amod	_	_
46	P450	_	NOUN	NN	_	49	compound	_	_
47	2D6	_	NOUN	NN	_	49	compound	_	_
48	isozyme	_	NOUN	NN	_	49	compound	_	_
49	activity	_	NOUN	NN	_	43	nmod	_	_
50	among	_	ADP	IN	_	51	case	_	_
51	Asian	_	NOUN	NN	_	40	nmod	_	_
52	,	_	.	,	_	51	punct	_	_
53	African	_	NOUN	NN	_	51	conj	_	_
54	and	_	CONJ	CC	_	51	cc	_	_
55	other	_	ADJ	JJ	_	51	conj	_	_
56	populations	_	NOUN	NNS	_	51	dep	_	_
57	are	_	VERB	VBP	_	60	auxpass	_	_
58	not	_	ADV	RB	_	60	neg	_	_
59	yet	_	ADV	RB	_	60	advmod	_	_
60	available	_	ADJ	JJ	_	36	parataxis	_	_

#	Amoxapine	3407
1	Poor	_	ADJ	JJ	_	2	amod	_	_
2	metabolizers	_	NOUN	NNS	_	4	nsubj	_	_
3	have	_	VERB	VBP	_	4	aux	_	_
4	higher	_	ADJ	JJ	_	0	root	_	_
5	than	_	ADP	IN	_	8	case	_	_
6	expected	_	VERB	VBN	_	8	amod	_	_
7	plasma	_	NOUN	NN	_	8	compound	_	_
8	concentrations	_	NOUN	NNS	_	4	nmod	_	_
9	of	_	ADP	IN	_	12	case	_	_
10	tricyclic	_	ADJ	JJ	_	12	amod	_	_
11	antidepressants	_	NOUN	NNS	_	12	compound	_	_
12	TCAs	_	NOUN	NNS	_	8	nmod	_	_
13	when	_	ADV	WRB	_	14	advmod	_	_
14	given	_	VERB	VBN	_	4	advcl	_	_
15	usual	_	ADJ	JJ	_	16	amod	_	_
16	doses	_	NOUN	NNS	_	14	dobj	_	_

#	Amoxapine	3408
1	Depending	_	VERB	VBG	_	4	case	_	_
2	on	_	ADP	IN	_	4	case	_	_
3	the	_	DET	DT	_	4	det	_	_
4	fraction	_	NOUN	NN	_	19	nmod	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	drug	_	NOUN	NN	_	4	nmod	_	_
7	metabolized	_	VERB	VBN	_	6	acl	_	_
8	by	_	ADP	IN	_	10	case	_	_
9	P450	_	NOUN	NN	_	10	compound	_	_
10	2D6	_	NOUN	NN	_	7	nmod	_	_
11	,	_	.	,	_	19	punct	_	_
12	the	_	DET	DT	_	13	det	_	_
13	increase	_	NOUN	NN	_	19	nsubj	_	_
14	in	_	ADP	IN	_	16	case	_	_
15	plasma	_	NOUN	NN	_	16	compound	_	_
16	concentration	_	NOUN	NN	_	13	nmod	_	_
17	may	_	VERB	MD	_	19	aux	_	_
18	be	_	VERB	VB	_	19	cop	_	_
19	small	_	ADJ	JJ	_	0	root	_	_
20	,	_	.	,	_	19	punct	_	_
21	or	_	CONJ	CC	_	19	cc	_	_
22	quite	_	ADV	RB	_	23	advmod	_	_
23	large	_	ADJ	JJ	_	26	amod	_	_
24	8	_	NUM	CD	_	26	nummod	_	_
25	fold	_	NOUN	NN	_	26	amod	_	_
26	increase	_	NOUN	NN	_	19	conj	_	_
27	in	_	ADP	IN	_	29	case	_	_
28	plasma	_	NOUN	NN	_	29	compound	_	_
29	AUC	_	NOUN	NN	_	26	nmod	_	_
30	of	_	ADP	IN	_	32	case	_	_
31	the	_	DET	DT	_	32	det	_	_
32	TCA	_	NOUN	NN	_	29	nmod	_	_

#	Amoxapine	3409
1	In	_	ADP	IN	_	2	case	_	_
2	addition	_	NOUN	NN	_	6	nmod	_	_
3	,	_	.	,	_	6	punct	_	_
4	certain	_	ADJ	JJ	_	5	amod	_	_
5	drugs	_	NOUN	NNS	_	6	nsubj	_	_
6	inhibit	_	VERB	VBP	_	0	root	_	_
7	the	_	DET	DT	_	8	det	_	_
8	activity	_	NOUN	NN	_	6	dobj	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	this	_	DET	DT	_	11	det	_	_
11	isozyme	_	NOUN	NN	_	8	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	make	_	ADJ	JJ	_	15	amod	_	_
14	normal	_	ADJ	JJ	_	15	amod	_	_
15	metabolizers	_	NOUN	NNS	_	11	conj	_	_
16	resemble	_	ADJ	JJ	_	6	xcomp	_	_
17	poor	_	ADJ	JJ	_	18	amod	_	_
18	metabolizers	_	NOUN	NNS	_	16	dobj	_	_

#	Amoxapine	3410
1	An	_	DET	DT	_	2	det	_	_
2	individual	_	NOUN	NN	_	13	nsubj	_	_
3	who	_	DET	WDT	_	5	nsubj	_	_
4	is	_	VERB	VBZ	_	5	cop	_	_
5	stable	_	ADJ	JJ	_	2	acl:relcl	_	_
6	on	_	ADP	IN	_	9	case	_	_
7	a	_	DET	DT	_	9	det	_	_
8	given	_	VERB	VBN	_	9	amod	_	_
9	dose	_	NOUN	NN	_	5	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	TCA	_	NOUN	NN	_	9	nmod	_	_
12	may	_	VERB	MD	_	13	aux	_	_
13	become	_	VERB	VB	_	0	root	_	_
14	abruptly	_	ADV	RB	_	15	advmod	_	_
15	toxic	_	ADJ	JJ	_	13	xcomp	_	_
16	when	_	ADV	WRB	_	17	advmod	_	_
17	given	_	VERB	VBN	_	15	dep	_	_
18	one	_	NUM	CD	_	17	dobj	_	_
19	of	_	ADP	IN	_	22	case	_	_
20	these	_	DET	DT	_	22	det	_	_
21	inhibiting	_	VERB	VBG	_	22	amod	_	_
22	drugs	_	NOUN	NNS	_	18	nmod	_	_
23	as	_	ADP	IN	_	25	case	_	_
24	concomitant	_	ADJ	JJ	_	25	amod	_	_
25	therapy	_	NOUN	NN	_	17	nmod	_	_

#	Amoxapine	3411
1	The	_	DET	DT	_	2	det	_	_
2	drugs	_	NOUN	NNS	_	8	nsubj	_	_
3	that	_	DET	WDT	_	4	nsubj	_	_
4	inhibit	_	VERB	VBP	_	2	acl:relcl	_	_
5	cytochrome	_	NOUN	NN	_	7	compound	_	_
6	P450	_	NOUN	NN	_	7	compound	_	_
7	2D6	_	NOUN	NN	_	4	dobj	_	_
8	include	_	VERB	VBP	_	0	root	_	_
9	some	_	DET	DT	_	8	dobj	_	_
10	that	_	DET	WDT	_	13	nsubjpass	_	_
11	are	_	VERB	VBP	_	13	auxpass	_	_
12	not	_	ADV	RB	_	13	neg	_	_
13	metabolized	_	VERB	VBN	_	9	root	_	_
14	by	_	ADP	IN	_	18	case	_	_
15	the	_	DET	DT	_	18	det	_	_
16	enzyme	_	NOUN	NN	_	18	compound	_	_
17	quinidine	_	NOUN	NN	_	18	compound	_	_
18	cimetidine	_	NOUN	NN	_	13	nmod	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	many	_	NOUN	NN	_	18	conj	_	_
21	that	_	DET	WDT	_	23	nsubj	_	_
22	are	_	VERB	VBP	_	23	cop	_	_
23	substrates	_	NOUN	NNS	_	18	acl:relcl	_	_
24	for	_	ADP	IN	_	29	case	_	_
25	P450	_	NOUN	NN	_	29	compound	_	_
26	2D6	_	NOUN	NN	_	29	compound	_	_
27	many	_	ADJ	JJ	_	29	amod	_	_
28	other	_	ADJ	JJ	_	29	amod	_	_
29	antidepressants	_	NOUN	NNS	_	23	nmod	_	_
30	,	_	.	,	_	29	punct	_	_
31	phenothiazines	_	NOUN	NNS	_	29	conj	_	_
32	,	_	.	,	_	29	punct	_	_
33	and	_	CONJ	CC	_	29	cc	_	_
34	the	_	DET	DT	_	37	det	_	_
35	Type	_	NOUN	NN	_	37	compound	_	_
36	1C	_	NOUN	NN	_	37	compound	_	_
37	antiarrhythmics	_	NOUN	NNS	_	29	conj	_	_
38	propafenone	_	NOUN	NN	_	37	dep	_	_
39	and	_	CONJ	CC	_	38	cc	_	_
40	flecainide	_	NOUN	NN	_	38	conj	_	_

#	Amoxapine	3412
1	While	_	ADP	IN	_	17	mark	_	_
2	all	_	CONJ	CC	_	6	cc:preconj	_	_
3	the	_	DET	DT	_	6	det	_	_
4	selective	_	ADJ	JJ	_	6	amod	_	_
5	DRUGS	_	NOUN	NN	_	6	compound	_	_
6	SSRIs	_	NOUN	NNS	_	17	nsubj	_	_
7	,	_	.	,	_	6	punct	_	_
8	e.g	_	NOUN	NN	_	6	conj	_	_
9	,	_	.	,	_	6	punct	_	_
10	fluoxetine	_	NOUN	NN	_	6	conj	_	_
11	,	_	.	,	_	6	punct	_	_
12	sertraline	_	NOUN	NN	_	6	conj	_	_
13	,	_	.	,	_	6	punct	_	_
14	and	_	CONJ	CC	_	6	cc	_	_
15	paroxetine	_	NOUN	NN	_	6	conj	_	_
16	,	_	.	,	_	6	punct	_	_
17	inhibit	_	VERB	VBP	_	23	advcl	_	_
18	P450	_	NOUN	NN	_	19	compound	_	_
19	2D6	_	NOUN	NN	_	17	dobj	_	_
20	,	_	.	,	_	23	punct	_	_
21	they	_	PRON	PRP	_	23	nsubj	_	_
22	may	_	VERB	MD	_	23	aux	_	_
23	vary	_	VERB	VB	_	0	root	_	_
24	in	_	ADP	IN	_	26	case	_	_
25	the	_	DET	DT	_	26	det	_	_
26	extent	_	NOUN	NN	_	23	nmod	_	_
27	of	_	ADP	IN	_	28	case	_	_
28	inhibition	_	NOUN	NN	_	26	nmod	_	_

#	Amoxapine	3413
1	The	_	DET	DT	_	2	det	_	_
2	extent	_	NOUN	NN	_	13	nsubj	_	_
3	to	_	PRT	TO	_	4	case	_	_
4	which	_	DET	WDT	_	9	nmod	_	_
5	SSRI	_	NOUN	NN	_	7	compound	_	_
6	TCA	_	NOUN	NN	_	7	compound	_	_
7	interactions	_	NOUN	NNS	_	9	nsubj	_	_
8	may	_	VERB	MD	_	9	aux	_	_
9	pose	_	VERB	VB	_	2	acl:relcl	_	_
10	clinical	_	ADJ	JJ	_	11	amod	_	_
11	problems	_	NOUN	NNS	_	9	dobj	_	_
12	will	_	VERB	MD	_	13	aux	_	_
13	depend	_	VERB	VB	_	0	root	_	_
14	on	_	ADP	IN	_	16	case	_	_
15	the	_	DET	DT	_	16	det	_	_
16	degree	_	NOUN	NN	_	13	nmod	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	inhibition	_	NOUN	NN	_	16	nmod	_	_
19	and	_	CONJ	CC	_	13	cc	_	_
20	the	_	DET	DT	_	21	det	_	_
21	pharmacokinetics	_	NOUN	NNS	_	13	conj	_	_
22	of	_	ADP	IN	_	24	case	_	_
23	the	_	DET	DT	_	24	det	_	_
24	SSRI	_	NOUN	NN	_	21	nmod	_	_
25	involved	_	VERB	VBN	_	24	acl	_	_

#	Amoxapine	3414
1	Nevertheless	_	ADV	RB	_	5	advmod	_	_
2	,	_	.	,	_	5	punct	_	_
3	caution	_	NOUN	NN	_	5	nsubjpass	_	_
4	is	_	VERB	VBZ	_	5	auxpass	_	_
5	indicated	_	VERB	VBN	_	0	root	_	_
6	in	_	ADP	IN	_	9	case	_	_
7	the	_	DET	DT	_	9	det	_	_
8	co	_	DET	DT	_	9	det	_	_
9	administration	_	NOUN	NN	_	5	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	TCAs	_	NOUN	NNS	_	9	nmod	_	_
12	with	_	ADP	IN	_	13	case	_	_
13	any	_	DET	DT	_	9	nmod	_	_
14	of	_	ADP	IN	_	16	case	_	_
15	the	_	DET	DT	_	16	det	_	_
16	SSRIs	_	NOUN	NNS	_	13	nmod	_	_
17	and	_	CONJ	CC	_	9	cc	_	_
18	also	_	ADV	RB	_	20	advmod	_	_
19	in	_	ADP	IN	_	20	case	_	_
20	switching	_	NOUN	NN	_	9	conj	_	_
21	from	_	ADP	IN	_	23	case	_	_
22	one	_	NUM	CD	_	23	nummod	_	_
23	class	_	NOUN	NN	_	20	nmod	_	_
24	to	_	PRT	TO	_	26	case	_	_
25	the	_	DET	DT	_	26	det	_	_
26	other	_	ADJ	JJ	_	20	nmod	_	_

#	Amoxapine	3415
1	Of	_	ADP	IN	_	3	case	_	_
2	particular	_	ADJ	JJ	_	3	amod	_	_
3	importance	_	NOUN	NN	_	8	nmod	_	_
4	,	_	.	,	_	8	punct	_	_
5	sufficient	_	ADJ	JJ	_	6	amod	_	_
6	time	_	NOUN	NN	_	8	nsubj	_	_
7	must	_	VERB	MD	_	8	aux	_	_
8	elapse	_	VERB	VB	_	17	aux	_	_
9	before	_	ADP	IN	_	10	mark	_	_
10	initiating	_	VERB	VBG	_	8	advcl	_	_
11	TCA	_	NOUN	NN	_	12	compound	_	_
12	treatment	_	NOUN	NN	_	10	dobj	_	_
13	in	_	ADP	IN	_	15	case	_	_
14	a	_	DET	DT	_	15	det	_	_
15	patient	_	NOUN	NN	_	10	nmod	_	_
16	being	_	VERB	VBD	_	17	cop	_	_
17	withdrawn	_	ADJ	JJ	_	0	root	_	_
18	from	_	ADP	IN	_	19	case	_	_
19	fluoxetine	_	NOUN	NN	_	17	nmod	_	_
20	,	_	.	,	_	17	punct	_	_
21	given	_	VERB	VBN	_	17	parataxis	_	_
22	the	_	DET	DT	_	25	det	_	_
23	long	_	ADJ	JJ	_	25	amod	_	_
24	half	_	NOUN	NN	_	25	amod	_	_
25	life	_	NOUN	NN	_	21	dobj	_	_
26	of	_	ADP	IN	_	28	case	_	_
27	the	_	DET	DT	_	28	det	_	_
28	parent	_	NOUN	NN	_	25	nmod	_	_
29	and	_	CONJ	CC	_	28	cc	_	_
30	active	_	ADJ	JJ	_	31	amod	_	_
31	metabolite	_	NOUN	NN	_	28	conj	_	_
32	at	_	ADP	IN	_	33	case	_	_
33	least	_	ADJ	JJS	_	34	nmod:npmod	_	_
34	5	_	NUM	CD	_	35	nummod	_	_
35	weeks	_	NOUN	NNS	_	25	nmod	_	_
36	may	_	VERB	MD	_	38	aux	_	_
37	be	_	VERB	VB	_	38	auxpass	_	_
38	necessary	_	ADJ	JJ	_	21	dep	_	_

#	Amoxapine	3416
1	Concomitant	_	ADJ	JJ	_	2	amod	_	_
2	use	_	NOUN	NN	_	15	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	tricyclic	_	ADJ	JJ	_	5	amod	_	_
5	antidepressants	_	NOUN	NNS	_	2	nmod	_	_
6	with	_	ADP	IN	_	7	case	_	_
7	drugs	_	NOUN	NNS	_	2	nmod	_	_
8	that	_	DET	WDT	_	10	nsubj	_	_
9	can	_	VERB	MD	_	10	aux	_	_
10	inhibit	_	VERB	VB	_	7	acl:relcl	_	_
11	cytochrome	_	NOUN	NN	_	13	compound	_	_
12	P450	_	NOUN	NN	_	13	compound	_	_
13	2D6	_	NOUN	NN	_	10	dobj	_	_
14	may	_	VERB	MD	_	15	aux	_	_
15	require	_	VERB	VB	_	0	root	_	_
16	lower	_	ADJ	JJ	_	17	amod	_	_
17	doses	_	NOUN	NNS	_	15	dobj	_	_
18	than	_	ADP	IN	_	20	mark	_	_
19	usually	_	ADV	RB	_	20	advmod	_	_
20	prescribed	_	VERB	VBN	_	15	advcl	_	_
21	for	_	ADP	IN	_	25	case	_	_
22	either	_	CONJ	CC	_	25	cc:preconj	_	_
23	the	_	DET	DT	_	25	det	_	_
24	tricyclic	_	ADJ	JJ	_	25	amod	_	_
25	antidepressant	_	NOUN	NN	_	20	nmod	_	_
26	or	_	CONJ	CC	_	25	cc	_	_
27	the	_	DET	DT	_	29	det	_	_
28	other	_	ADJ	JJ	_	29	amod	_	_
29	drug	_	NOUN	NN	_	25	conj	_	_

#	Amoxapine	3417
1	Furthermore	_	ADV	RB	_	23	advmod	_	_
2	,	_	.	,	_	23	punct	_	_
3	whenever	_	ADP	IN	_	10	mark	_	_
4	one	_	NUM	CD	_	10	nsubj	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	these	_	DET	DT	_	8	det	_	_
7	other	_	ADJ	JJ	_	8	amod	_	_
8	drugs	_	NOUN	NNS	_	4	nmod	_	_
9	is	_	VERB	VBZ	_	10	cop	_	_
10	withdrawn	_	ADJ	JJ	_	23	advcl	_	_
11	from	_	ADP	IN	_	13	case	_	_
12	co	_	PRT	TO	_	13	case	_	_
13	therapy	_	NOUN	NN	_	10	nmod	_	_
14	,	_	.	,	_	23	punct	_	_
15	an	_	DET	DT	_	17	det	_	_
16	increased	_	VERB	VBN	_	17	amod	_	_
17	dose	_	NOUN	NN	_	23	nsubjpass	_	_
18	of	_	ADP	IN	_	20	case	_	_
19	tricyclic	_	ADJ	JJ	_	20	amod	_	_
20	antidepressant	_	NOUN	NN	_	17	nmod	_	_
21	may	_	VERB	MD	_	23	aux	_	_
22	be	_	VERB	VB	_	23	auxpass	_	_
23	required	_	VERB	VBN	_	0	root	_	_

#	Amoxapine	3418
1	It	_	PRON	PRP	_	3	nsubj	_	_
2	is	_	VERB	VBZ	_	3	cop	_	_
3	desirable	_	ADJ	JJ	_	0	root	_	_
4	to	_	PRT	TO	_	5	mark	_	_
5	monitor	_	VERB	VB	_	3	xcomp	_	_
6	TCA	_	NOUN	NN	_	8	compound	_	_
7	plasma	_	NOUN	NN	_	8	compound	_	_
8	levels	_	NOUN	NNS	_	5	dobj	_	_
9	whenever	_	ADV	WRB	_	13	advmod	_	_
10	a	_	DET	DT	_	11	det	_	_
11	TCA	_	NOUN	NN	_	13	nsubj	_	_
12	is	_	VERB	VBZ	_	13	cop	_	_
13	going	_	VERB	VBG	_	5	advcl	_	_
14	to	_	PRT	TO	_	17	mark	_	_
15	be	_	VERB	VB	_	17	auxpass	_	_
16	co	_	PRT	TO	_	17	dep	_	_
17	administered	_	VERB	VBN	_	13	xcomp	_	_
18	with	_	ADP	IN	_	20	case	_	_
19	another	_	DET	DT	_	20	det	_	_
20	drug	_	NOUN	NN	_	17	nmod	_	_
21	known	_	VERB	VBN	_	20	acl	_	_
22	to	_	PRT	TO	_	25	mark	_	_
23	be	_	VERB	VB	_	25	cop	_	_
24	an	_	DET	DT	_	25	det	_	_
25	inhibitor	_	NOUN	NN	_	21	xcomp	_	_
26	of	_	ADP	IN	_	28	case	_	_
27	P450	_	NOUN	NN	_	28	compound	_	_
28	2D6	_	NOUN	NN	_	25	nmod	_	_

#	Amoxapine	3419
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	is	_	VERB	VBZ	_	4	cop	_	_
3	an	_	DET	DT	_	4	det	_	_
4	antidepressant	_	ADJ	JJ	_	0	root	_	_
5	with	_	ADP	IN	_	9	case	_	_
6	a	_	DET	DT	_	9	det	_	_
7	mild	_	ADJ	JJ	_	9	amod	_	_
8	sedative	_	ADJ	JJ	_	9	amod	_	_
9	component	_	NOUN	NN	_	4	nmod	_	_
10	to	_	PRT	TO	_	12	case	_	_
11	its	_	PRON	PRP$	_	12	nmod:poss	_	_
12	action	_	NOUN	NN	_	9	nmod	_	_

#	Amoxapine	3420
1	The	_	DET	DT	_	2	det	_	_
2	mechanism	_	NOUN	NN	_	0	root	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	its	_	PRON	PRP$	_	6	nmod:poss	_	_
5	clinical	_	ADJ	JJ	_	6	amod	_	_
6	action	_	NOUN	NN	_	2	nmod	_	_
7	in	_	ADP	IN	_	8	case	_	_
8	man	_	VERB	MD	_	12	aux	_	_
9	is	_	VERB	VB	_	12	auxpass	_	_
10	not	_	ADV	RB	_	12	neg	_	_
11	well	_	ADV	RB	_	12	advmod	_	_
12	understood	_	VERB	VBN	_	6	acl:relcl	_	_

#	Amoxapine	3421
1	In	_	ADP	IN	_	2	case	_	_
2	animals	_	NOUN	NNS	_	5	nmod	_	_
3	,	_	.	,	_	5	punct	_	_
4	DRUG	_	NOUN	NN	_	5	nsubj	_	_
5	reduced	_	VERB	VBD	_	0	root	_	_
6	the	_	DET	DT	_	7	det	_	_
7	uptake	_	NOUN	NN	_	5	dobj	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	norepinephrine	_	NOUN	NN	_	7	nmod	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	serotonin	_	NOUN	NN	_	9	conj	_	_
12	and	_	CONJ	CC	_	5	cc	_	_
13	blocked	_	VERB	VBD	_	5	conj	_	_
14	the	_	DET	DT	_	15	det	_	_
15	response	_	NOUN	NN	_	13	dobj	_	_
16	of	_	ADP	IN	_	18	case	_	_
17	dopamine	_	NOUN	NN	_	18	compound	_	_
18	receptors	_	NOUN	NNS	_	15	nmod	_	_
19	to	_	PRT	TO	_	20	case	_	_
20	dopamine	_	NOUN	NN	_	15	nmod	_	_

#	Amoxapine	3422
1	DRUG	_	NOUN	NN	_	7	nsubj	_	_
2	is	_	VERB	VBZ	_	7	cop	_	_
3	not	_	ADV	RB	_	7	neg	_	_
4	a	_	DET	DT	_	7	det	_	_
5	monoamine	_	NOUN	NN	_	7	compound	_	_
6	oxidase	_	NOUN	NN	_	7	compound	_	_
7	inhibitor	_	NOUN	NN	_	0	root	_	_

#	Amoxapine	3423
1	DRUG	_	NOUN	NN	_	3	nsubjpass	_	_
2	is	_	VERB	VBZ	_	3	auxpass	_	_
3	absorbed	_	VERB	VBN	_	0	root	_	_
4	rapidly	_	ADV	RB	_	3	advmod	_	_
5	and	_	CONJ	CC	_	3	cc	_	_
6	reaches	_	VERB	VBZ	_	3	conj	_	_
7	peak	_	ADJ	JJ	_	9	amod	_	_
8	blood	_	NOUN	NN	_	9	compound	_	_
9	levels	_	NOUN	NNS	_	6	dobj	_	_
10	approximately	_	ADV	RB	_	11	advmod	_	_
11	90	_	NUM	CD	_	12	nummod	_	_
12	minutes	_	NOUN	NNS	_	6	nmod	_	_
13	after	_	ADP	IN	_	14	case	_	_
14	ingestion	_	NOUN	NN	_	12	nmod	_	_

#	Amoxapine	3424
1	The	_	DET	DT	_	3	det	_	_
2	main	_	ADJ	JJ	_	3	amod	_	_
3	route	_	NOUN	NN	_	8	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	excretion	_	NOUN	NN	_	3	nmod	_	_
6	is	_	VERB	VBZ	_	8	cop	_	_
7	the	_	DET	DT	_	8	det	_	_
8	kidney	_	NOUN	NN	_	0	root	_	_

#	Amoxapine	3425
1	In	_	X	FW	_	3	amod	_	_
2	vitro	_	X	FW	_	1	dep	_	_
3	tests	_	NOUN	NNS	_	4	nsubj	_	_
4	show	_	VERB	VBP	_	0	root	_	_
5	that	_	ADP	IN	_	13	mark	_	_
6	DRUG	_	NOUN	NN	_	7	compound	_	_
7	binding	_	NOUN	NN	_	13	nsubj	_	_
8	to	_	PRT	TO	_	10	case	_	_
9	human	_	ADJ	JJ	_	10	amod	_	_
10	serum	_	NOUN	NN	_	7	nmod	_	_
11	is	_	VERB	VBZ	_	13	cop	_	_
12	approximately	_	ADV	RB	_	13	advmod	_	_
13	90%	_	ADJ	JJ	_	4	ccomp	_	_

#	Amoxapine	3426
1	In	_	ADP	IN	_	2	case	_	_
2	man	_	X	FW	_	7	nmod	_	_
3	,	_	.	,	_	7	punct	_	_
4	DRUG	_	NOUN	NN	_	6	compound	_	_
5	serum	_	NOUN	NN	_	6	compound	_	_
6	concentration	_	NOUN	NN	_	7	nsubj	_	_
7	declines	_	VERB	VBZ	_	0	root	_	_
8	with	_	ADP	IN	_	11	case	_	_
9	a	_	DET	DT	_	11	det	_	_
10	half	_	ADJ	JJ	_	11	amod	_	_
11	life	_	NOUN	NN	_	7	nmod	_	_
12	of	_	ADP	IN	_	14	case	_	_
13	eight	_	NUM	CD	_	14	nummod	_	_
14	hours	_	NOUN	NNS	_	11	nmod	_	_

#	Amoxapine	3427
1	However	_	ADV	RB	_	11	advmod	_	_
2	,	_	.	,	_	11	punct	_	_
3	the	_	DET	DT	_	5	det	_	_
4	major	_	ADJ	JJ	_	5	amod	_	_
5	metabolite	_	NOUN	NN	_	11	nsubj	_	_
6	,	_	.	,	_	5	punct	_	_
7	8	_	NUM	CD	_	9	nummod	_	_
8	hydroxy	_	NOUN	NN	_	9	compound	_	_
9	DRUG	_	NOUN	NN	_	5	appos	_	_
10	,	_	.	,	_	5	punct	_	_
11	has	_	VERB	VBZ	_	0	root	_	_
12	a	_	DET	DT	_	15	det	_	_
13	biologic	_	ADJ	JJ	_	15	amod	_	_
14	half	_	ADJ	JJ	_	15	amod	_	_
15	life	_	NOUN	NN	_	11	dobj	_	_
16	of	_	ADP	IN	_	18	case	_	_
17	30	_	NUM	CD	_	18	nummod	_	_
18	hours	_	NOUN	NNS	_	15	nmod	_	_

#	Amoxapine	3428
1	Metabolites	_	NOUN	NNS	_	3	nsubjpass	_	_
2	are	_	VERB	VBP	_	3	auxpass	_	_
3	excreted	_	VERB	VBN	_	0	root	_	_
4	in	_	ADP	IN	_	6	case	_	_
5	the	_	DET	DT	_	6	det	_	_
6	urine	_	ADJ	JJ	_	3	nmod	_	_
7	in	_	ADP	IN	_	9	case	_	_
8	conjugated	_	VERB	VBN	_	9	amod	_	_
9	form	_	NOUN	NN	_	6	nmod	_	_
10	as	_	ADP	IN	_	11	case	_	_
11	glucuronides	_	NOUN	NNS	_	3	nmod	_	_

#	Amoxapine	3429
1	Clinical	_	ADJ	JJ	_	2	amod	_	_
2	studies	_	NOUN	NNS	_	4	nsubj	_	_
3	have	_	VERB	VBP	_	4	aux	_	_
4	demonstrated	_	VERB	VBN	_	0	root	_	_
5	that	_	ADP	IN	_	7	mark	_	_
6	DRUG	_	NOUN	NN	_	7	nsubj	_	_
7	has	_	VERB	VBZ	_	4	ccomp	_	_
8	a	_	DET	DT	_	11	det	_	_
9	more	_	ADV	RB	_	10	advmod	_	_
10	rapid	_	ADJ	JJ	_	11	amod	_	_
11	onset	_	NOUN	NN	_	7	dobj	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	action	_	NOUN	NN	_	11	nmod	_	_
14	than	_	ADP	IN	_	16	case	_	_
15	either	_	CONJ	CC	_	16	cc:preconj	_	_
16	amitriptyline	_	NOUN	NN	_	7	nmod	_	_
17	or	_	CONJ	CC	_	16	cc	_	_
18	imipramine	_	NOUN	NN	_	16	conj	_	_

#	Amoxapine	3430
1	The	_	DET	DT	_	4	det	_	_
2	initial	_	ADJ	JJ	_	4	amod	_	_
3	clinical	_	ADJ	JJ	_	4	amod	_	_
4	effect	_	NOUN	NN	_	6	nsubj	_	_
5	may	_	VERB	MD	_	6	aux	_	_
6	occur	_	VERB	VB	_	0	root	_	_
7	within	_	ADP	IN	_	11	case	_	_
8	four	_	NUM	CD	_	10	compound	_	_
9	to	_	PRT	TO	_	10	dep	_	_
10	seven	_	NUM	CD	_	11	nummod	_	_
11	days	_	NOUN	NNS	_	6	nmod	_	_
12	and	_	CONJ	CC	_	6	cc	_	_
13	occurs	_	VERB	VBZ	_	6	conj	_	_
14	within	_	ADP	IN	_	16	case	_	_
15	two	_	NUM	CD	_	16	nummod	_	_
16	weeks	_	NOUN	NNS	_	13	nmod	_	_
17	in	_	ADP	IN	_	19	case	_	_
18	over	_	ADP	IN	_	19	case	_	_
19	80%	_	NOUN	NN	_	13	nmod	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	responders	_	NOUN	NNS	_	19	nmod	_	_

#	Apixaban	1211
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	is	_	VERB	VBZ	_	4	cop	_	_
3	a	_	DET	DT	_	4	det	_	_
4	substrate	_	NOUN	NN	_	0	root	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	both	_	CONJ	CC	_	7	cc:preconj	_	_
7	CYP3A4	_	NOUN	NN	_	4	nmod	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	P	_	NOUN	NN	_	10	compound	_	_
10	gp	_	NOUN	NN	_	7	conj	_	_

#	Apixaban	1212
1	Inhibitors	_	NOUN	NNS	_	7	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	CYP3A4	_	NOUN	NN	_	1	nmod	_	_
4	and	_	CONJ	CC	_	3	cc	_	_
5	P	_	NOUN	NN	_	6	compound	_	_
6	gp	_	NOUN	NN	_	3	conj	_	_
7	increase	_	NOUN	NN	_	0	root	_	_
8	exposure	_	NOUN	NN	_	7	dobj	_	_
9	to	_	PRT	TO	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	and	_	CONJ	CC	_	7	cc	_	_
12	increase	_	VERB	VBP	_	7	conj	_	_
13	the	_	DET	DT	_	14	det	_	_
14	risk	_	NOUN	NN	_	12	dobj	_	_
15	of	_	ADP	IN	_	16	mark	_	_
16	bleeding	_	VERB	VBG	_	14	nmod	_	_

#	Apixaban	1213
1	Inducers	_	NOUN	NNS	_	7	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	CYP3A4	_	NOUN	NN	_	1	nmod	_	_
4	and	_	CONJ	CC	_	3	cc	_	_
5	P	_	NOUN	NN	_	6	compound	_	_
6	gp	_	NOUN	NN	_	3	conj	_	_
7	decrease	_	NOUN	NN	_	0	root	_	_
8	exposure	_	NOUN	NN	_	7	dobj	_	_
9	to	_	PRT	TO	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	and	_	CONJ	CC	_	7	cc	_	_
12	increase	_	VERB	VBP	_	7	conj	_	_
13	the	_	DET	DT	_	14	det	_	_
14	risk	_	NOUN	NN	_	12	dobj	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	stroke	_	NOUN	NN	_	14	nmod	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	other	_	ADJ	JJ	_	20	amod	_	_
19	thromboembolic	_	ADJ	JJ	_	20	amod	_	_
20	events	_	NOUN	NNS	_	16	conj	_	_

#	Apixaban	1214
1	Combined	_	ADJ	JJ	_	3	amod	_	_
2	P	_	NOUN	NN	_	3	compound	_	_
3	gp	_	NOUN	NN	_	8	nsubj	_	_
4	and	_	CONJ	CC	_	3	cc	_	_
5	strong	_	ADJ	JJ	_	7	amod	_	_
6	CYP3A4	_	NOUN	NN	_	7	compound	_	_
7	inhibitors	_	NOUN	NNS	_	3	conj	_	_
8	increase	_	VERB	VBP	_	0	root	_	_
9	blood	_	NOUN	NN	_	10	compound	_	_
10	levels	_	NOUN	NNS	_	8	dobj	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_

#	Apixaban	1215
1	Reduce	_	VERB	VBP	_	0	root	_	_
2	ELIQUIS	_	NOUN	NN	_	3	compound	_	_
3	dose	_	NOUN	NN	_	1	dobj	_	_
4	or	_	CONJ	CC	_	3	cc	_	_
5	avoid	_	NOUN	NN	_	6	compound	_	_
6	coadministration	_	NOUN	NN	_	3	conj	_	_

#	Apixaban	1216
1	Simultaneous	_	ADJ	JJ	_	2	amod	_	_
2	use	_	NOUN	NN	_	12	nsubj	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	strong	_	ADJ	JJ	_	6	amod	_	_
5	dual	_	ADJ	JJ	_	6	amod	_	_
6	inducers	_	NOUN	NNS	_	2	nmod	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	CYP3A4	_	NOUN	NN	_	6	nmod	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	P	_	NOUN	NN	_	11	compound	_	_
11	gp	_	NOUN	NN	_	8	conj	_	_
12	reduces	_	VERB	VBZ	_	0	root	_	_
13	blood	_	NOUN	NN	_	14	compound	_	_
14	levels	_	NOUN	NNS	_	12	dobj	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	14	nmod	_	_
17	:	_	.	:	_	12	punct	_	_
18	Avoid	_	ADJ	JJ	_	20	amod	_	_
19	concomitant	_	ADJ	JJ	_	20	amod	_	_
20	use	_	NOUN	NN	_	12	parataxis	_	_

#	Apixaban	1217
1	For	_	ADP	IN	_	2	case	_	_
2	patients	_	NOUN	NNS	_	19	nmod	_	_
3	receiving	_	VERB	VBG	_	2	acl	_	_
4	ELIQUIS	_	NOUN	NN	_	6	compound	_	_
5	5	_	NUM	CD	_	6	nummod	_	_
6	mg	_	NOUN	NN	_	3	dobj	_	_
7	or	_	CONJ	CC	_	6	cc	_	_
8	10	_	NUM	CD	_	9	nummod	_	_
9	mg	_	NOUN	NN	_	6	conj	_	_
10	twice	_	ADV	RB	_	11	advmod	_	_
11	daily	_	ADV	RB	_	2	advmod	_	_
12	,	_	.	,	_	19	punct	_	_
13	the	_	DET	DT	_	14	det	_	_
14	dose	_	NOUN	NN	_	19	nsubjpass	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	ELIQUIS	_	NOUN	NN	_	14	nmod	_	_
17	should	_	VERB	MD	_	19	aux	_	_
18	be	_	VERB	VB	_	19	auxpass	_	_
19	decreased	_	VERB	VBN	_	0	root	_	_
20	by	_	ADP	IN	_	21	case	_	_
21	50%	_	NOUN	NN	_	19	nmod	_	_
22	when	_	ADV	WRB	_	23	advmod	_	_
23	coadministered	_	VERB	VBN	_	19	advcl	_	_
24	with	_	ADP	IN	_	25	case	_	_
25	drugs	_	NOUN	NNS	_	23	nmod	_	_
26	that	_	DET	WDT	_	28	nsubjpass	_	_
27	are	_	VERB	VBP	_	28	auxpass	_	_
28	combined	_	VERB	VBN	_	25	acl:relcl	_	_
29	P	_	NOUN	NN	_	30	compound	_	_
30	gp	_	NOUN	NN	_	28	dobj	_	_
31	and	_	CONJ	CC	_	30	cc	_	_
32	strong	_	ADJ	JJ	_	34	amod	_	_
33	CYP3A4	_	NOUN	NN	_	34	compound	_	_
34	inhibitors	_	NOUN	NNS	_	30	conj	_	_
35	e.g	_	NOUN	NN	_	34	dep	_	_
36	,	_	.	,	_	35	punct	_	_
37	ketoconazole	_	NOUN	NN	_	35	conj	_	_
38	,	_	.	,	_	35	punct	_	_
39	itraconazole	_	NOUN	NN	_	35	conj	_	_
40	,	_	.	,	_	35	punct	_	_
41	ritonavir	_	ADJ	JJ	_	35	root	_	_

#	Apixaban	1218
1	For	_	ADP	IN	_	2	case	_	_
2	patients	_	NOUN	NNS	_	0	root	_	_
3	receiving	_	VERB	VBG	_	2	acl	_	_
4	ELIQUIS	_	NOUN	NN	_	3	dobj	_	_
5	at	_	ADP	IN	_	7	case	_	_
6	a	_	DET	DT	_	7	det	_	_
7	dose	_	NOUN	NN	_	3	nmod	_	_
8	of	_	ADP	IN	_	10	case	_	_
9	2.5	_	NUM	CD	_	10	nummod	_	_
10	mg	_	NOUN	NN	_	7	nmod	_	_
11	twice	_	ADV	RB	_	12	advmod	_	_
12	daily	_	ADV	RB	_	2	advmod	_	_
13	,	_	.	,	_	2	punct	_	_
14	avoid	_	ADJ	JJ	_	15	amod	_	_
15	coadministration	_	NOUN	NN	_	13	root	_	_
16	with	_	ADP	IN	_	19	case	_	_
17	combined	_	VERB	VBN	_	19	amod	_	_
18	P	_	NOUN	NN	_	19	compound	_	_
19	gp	_	NOUN	NN	_	15	nmod	_	_
20	and	_	CONJ	CC	_	19	cc	_	_
21	strong	_	ADJ	JJ	_	23	amod	_	_
22	CYP3A4	_	NOUN	NN	_	23	compound	_	_
23	inhibitors	_	NOUN	NNS	_	19	conj	_	_

#	Apixaban	1219
1	Although	_	ADP	IN	_	7	mark	_	_
2	clarithromycin	_	NOUN	NN	_	7	nsubj	_	_
3	is	_	VERB	VBZ	_	7	cop	_	_
4	a	_	DET	DT	_	7	det	_	_
5	combined	_	VERB	VBN	_	7	amod	_	_
6	P	_	NOUN	NN	_	7	compound	_	_
7	gp	_	NOUN	NN	_	15	advcl	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	strong	_	ADJ	JJ	_	11	amod	_	_
10	CYP3A4	_	NOUN	NN	_	11	compound	_	_
11	inhibitor	_	NOUN	NN	_	7	conj	_	_
12	,	_	.	,	_	15	punct	_	_
13	pharmacokinetic	_	ADJ	JJ	_	14	amod	_	_
14	data	_	NOUN	NNS	_	15	nsubj	_	_
15	suggest	_	VERB	VBP	_	0	root	_	_
16	that	_	ADP	IN	_	21	mark	_	_
17	no	_	DET	DT	_	19	neg	_	_
18	dose	_	NOUN	NN	_	19	compound	_	_
19	adjustment	_	NOUN	NN	_	21	nsubj	_	_
20	is	_	VERB	VBZ	_	21	cop	_	_
21	necessary	_	ADJ	JJ	_	15	ccomp	_	_
22	with	_	ADP	IN	_	24	case	_	_
23	concomitant	_	ADJ	JJ	_	24	amod	_	_
24	administration	_	NOUN	NN	_	21	nmod	_	_
25	with	_	ADP	IN	_	26	case	_	_
26	ELIQUIS	_	NOUN	NN	_	24	nmod	_	_

#	Apixaban	1220
1	Avoid	_	ADP	IN	_	3	case	_	_
2	concomitant	_	ADJ	JJ	_	3	amod	_	_
3	use	_	NOUN	NN	_	25	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	ELIQUIS	_	NOUN	NN	_	3	nmod	_	_
6	with	_	ADP	IN	_	9	case	_	_
7	strong	_	ADJ	JJ	_	9	amod	_	_
8	dual	_	ADJ	JJ	_	9	amod	_	_
9	inducers	_	NOUN	NNS	_	3	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	CYP3A4	_	NOUN	NN	_	9	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	P	_	NOUN	NN	_	15	compound	_	_
14	gp	_	NOUN	NN	_	15	compound	_	_
15	e.g	_	NOUN	NN	_	11	conj	_	_
16	,	_	.	,	_	11	punct	_	_
17	rifampin	_	NOUN	NN	_	11	conj	_	_
18	,	_	.	,	_	11	punct	_	_
19	carbamazepine	_	NOUN	NN	_	11	conj	_	_
20	,	_	.	,	_	11	punct	_	_
21	phenytoin	_	NOUN	NN	_	11	conj	_	_
22	,	_	.	,	_	11	punct	_	_
23	St	_	NOUN	NN	_	24	compound	_	_
24	John's	_	NOUN	NNS	_	11	appos	_	_
25	wort	_	VERB	VBP	_	0	root	_	_
26	because	_	ADP	IN	_	30	mark	_	_
27	such	_	ADJ	JJ	_	28	amod	_	_
28	drugs	_	NOUN	NNS	_	30	nsubj	_	_
29	will	_	VERB	MD	_	30	aux	_	_
30	decrease	_	VERB	VB	_	25	ccomp	_	_
31	exposure	_	NOUN	NN	_	30	dobj	_	_
32	to	_	PRT	TO	_	33	case	_	_
33	DRUG	_	NOUN	NN	_	31	nmod	_	_

#	Apixaban	1224
1	In	_	ADP	IN	_	2	case	_	_
2	ARISTOTLE	_	NOUN	NN	_	8	nmod	_	_
3	,	_	.	,	_	8	punct	_	_
4	concomitant	_	ADJ	JJ	_	5	amod	_	_
5	use	_	NOUN	NN	_	8	nsubj	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	aspirin	_	NOUN	NN	_	5	nmod	_	_
8	increased	_	VERB	VBD	_	0	root	_	_
9	the	_	DET	DT	_	11	det	_	_
10	bleeding	_	VERB	VBG	_	11	amod	_	_
11	risk	_	NOUN	NN	_	8	dobj	_	_
12	on	_	ADP	IN	_	13	case	_	_
13	ELIQUIS	_	NOUN	NN	_	11	nmod	_	_
14	from	_	ADP	IN	_	15	case	_	_
15	1.8%	_	NOUN	NN	_	11	nmod	_	_
16	per	_	ADP	IN	_	17	case	_	_
17	year	_	NOUN	NN	_	15	nmod	_	_
18	to	_	PRT	TO	_	19	case	_	_
19	3.4%	_	NOUN	NN	_	17	nmod	_	_
20	per	_	ADP	IN	_	21	case	_	_
21	year	_	NOUN	NN	_	17	nmod	_	_
22	and	_	CONJ	CC	_	8	cc	_	_
23	concomitant	_	ADJ	JJ	_	24	amod	_	_
24	use	_	NOUN	NN	_	29	nsubj	_	_
25	of	_	ADP	IN	_	26	case	_	_
26	aspirin	_	NOUN	NN	_	24	nmod	_	_
27	and	_	CONJ	CC	_	26	cc	_	_
28	warfarin	_	NOUN	NN	_	26	conj	_	_
29	increased	_	VERB	VBD	_	8	conj	_	_
30	the	_	DET	DT	_	32	det	_	_
31	bleeding	_	VERB	VBG	_	32	amod	_	_
32	risk	_	NOUN	NN	_	29	dobj	_	_
33	from	_	ADP	IN	_	34	case	_	_
34	2.7%	_	NOUN	NN	_	32	nmod	_	_
35	per	_	ADP	IN	_	36	case	_	_
36	year	_	NOUN	NN	_	32	nmod	_	_
37	to	_	PRT	TO	_	38	case	_	_
38	4.6%	_	NOUN	NN	_	36	nmod	_	_
39	per	_	ADP	IN	_	40	case	_	_
40	year	_	NOUN	NN	_	38	nmod	_	_

#	Apixaban	1225
1	In	_	ADP	IN	_	4	case	_	_
2	this	_	DET	DT	_	4	det	_	_
3	clinical	_	ADJ	JJ	_	4	amod	_	_
4	trial	_	NOUN	NN	_	7	nmod	_	_
5	,	_	.	,	_	7	punct	_	_
6	there	_	DET	EX	_	7	expl	_	_
7	was	_	VERB	VBD	_	0	root	_	_
8	limited	_	ADJ	JJ	_	10	amod	_	_
9	2.3%	_	ADJ	JJ	_	10	amod	_	_
10	use	_	NOUN	NN	_	7	dobj	_	_
11	of	_	ADP	IN	_	14	case	_	_
12	dual	_	ADJ	JJ	_	14	amod	_	_
13	antiplatelet	_	ADJ	JJ	_	14	amod	_	_
14	therapy	_	NOUN	NN	_	10	nmod	_	_
15	with	_	ADP	IN	_	16	case	_	_
16	ELIQUIS	_	NOUN	NN	_	14	nmod	_	_

#	Apixaban	1230
1	Coadministration	_	NOUN	NN	_	14	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	DRUGS	_	NOUN	NN	_	1	nmod	_	_
4	,	_	.	,	_	3	punct	_	_
5	fibrinolytics	_	NOUN	NNS	_	3	conj	_	_
6	,	_	.	,	_	3	punct	_	_
7	heparin	_	NOUN	NN	_	3	conj	_	_
8	,	_	.	,	_	3	punct	_	_
9	aspirin	_	NOUN	NN	_	3	conj	_	_
10	,	_	.	,	_	3	punct	_	_
11	and	_	CONJ	CC	_	3	cc	_	_
12	chronic	_	ADJ	JJ	_	13	amod	_	_
13	NSAID	_	NOUN	NN	_	3	conj	_	_
14	use	_	NOUN	NN	_	15	nsubj	_	_
15	increases	_	VERB	VBZ	_	0	root	_	_
16	the	_	DET	DT	_	17	det	_	_
17	risk	_	NOUN	NN	_	15	dobj	_	_
18	of	_	ADP	IN	_	19	mark	_	_
19	bleeding	_	VERB	VBG	_	17	acl	_	_

#	Apixaban	1231
1	APPRAISE	_	NOUN	NN	_	32	nsubjpass	_	_
2	2	_	NUM	CD	_	1	nummod	_	_
3	,	_	.	,	_	1	punct	_	_
4	a	_	DET	DT	_	5	det	_	_
5	placebo	_	NOUN	NN	_	6	nsubj	_	_
6	controlled	_	VERB	VBD	_	1	acl:relcl	_	_
7	clinical	_	ADJ	JJ	_	8	amod	_	_
8	trial	_	NOUN	NN	_	6	dobj	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	in	_	ADP	IN	_	13	case	_	_
12	high	_	ADJ	JJ	_	13	amod	_	_
13	risk	_	NOUN	NN	_	8	nmod	_	_
14	,	_	.	,	_	6	punct	_	_
15	post	_	VERB	VBP	_	6	conj	_	_
16	acute	_	ADJ	JJ	_	19	amod	_	_
17	coronary	_	ADJ	JJ	_	19	amod	_	_
18	syndrome	_	NOUN	NN	_	19	compound	_	_
19	patients	_	NOUN	NNS	_	15	dobj	_	_
20	treated	_	VERB	VBN	_	19	acl	_	_
21	with	_	ADP	IN	_	22	case	_	_
22	aspirin	_	NOUN	NN	_	20	nmod	_	_
23	or	_	CONJ	CC	_	22	cc	_	_
24	the	_	DET	DT	_	25	det	_	_
25	combination	_	NOUN	NN	_	22	conj	_	_
26	of	_	ADP	IN	_	27	case	_	_
27	aspirin	_	NOUN	NN	_	25	nmod	_	_
28	and	_	CONJ	CC	_	27	cc	_	_
29	clopidogrel	_	NOUN	NN	_	27	conj	_	_
30	,	_	.	,	_	1	punct	_	_
31	was	_	VERB	VBD	_	32	auxpass	_	_
32	terminated	_	VERB	VBN	_	0	root	_	_
33	early	_	ADJ	JJ	_	32	xcomp	_	_
34	due	_	ADJ	JJ	_	38	case	_	_
35	to	_	PRT	TO	_	34	mwe	_	_
36	a	_	DET	DT	_	38	det	_	_
37	higher	_	ADJ	JJ	_	38	amod	_	_
38	rate	_	NOUN	NN	_	33	nmod	_	_
39	of	_	ADP	IN	_	40	mark	_	_
40	bleeding	_	VERB	VBG	_	38	acl	_	_
41	with	_	ADP	IN	_	42	case	_	_
42	DRUG	_	NOUN	NN	_	40	nmod	_	_
43	compared	_	VERB	VBN	_	33	dep	_	_
44	to	_	PRT	TO	_	45	case	_	_
45	placebo	_	NOUN	NN	_	43	nmod	_	_

#	Apixaban	1232
1	The	_	DET	DT	_	2	det	_	_
2	rate	_	NOUN	NN	_	8	nsubj	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	ISTH	_	NOUN	NN	_	6	compound	_	_
5	major	_	ADJ	JJ	_	6	amod	_	_
6	bleeding	_	NOUN	NN	_	2	nmod	_	_
7	was	_	VERB	VBD	_	8	cop	_	_
8	2.8%	_	ADJ	JJ	_	0	root	_	_
9	per	_	ADP	IN	_	10	case	_	_
10	year	_	NOUN	NN	_	8	nmod	_	_
11	with	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_
13	versus	_	CONJ	CC	_	12	cc	_	_
14	0.6%	_	NOUN	NN	_	12	conj	_	_
15	per	_	ADP	IN	_	16	case	_	_
16	year	_	NOUN	NN	_	10	nmod	_	_
17	with	_	ADP	IN	_	18	case	_	_
18	placebo	_	NOUN	NN	_	16	nmod	_	_
19	in	_	ADP	IN	_	20	case	_	_
20	patients	_	NOUN	NNS	_	18	nmod	_	_
21	receiving	_	VERB	VBG	_	20	acl	_	_
22	single	_	ADJ	JJ	_	24	amod	_	_
23	antiplatelet	_	ADJ	JJ	_	24	amod	_	_
24	therapy	_	NOUN	NN	_	21	dobj	_	_
25	and	_	CONJ	CC	_	8	cc	_	_
26	was	_	VERB	VBD	_	27	cop	_	_
27	5.9%	_	ADJ	JJ	_	8	conj	_	_
28	per	_	ADP	IN	_	29	case	_	_
29	year	_	NOUN	NN	_	27	nmod	_	_
30	with	_	ADP	IN	_	31	case	_	_
31	DRUG	_	NOUN	NN	_	29	nmod	_	_
32	versus	_	CONJ	CC	_	31	cc	_	_
33	2.5%	_	NOUN	NN	_	31	conj	_	_
34	per	_	ADP	IN	_	35	case	_	_
35	year	_	NOUN	NN	_	29	nmod	_	_
36	with	_	ADP	IN	_	37	case	_	_
37	placebo	_	NOUN	NN	_	35	nmod	_	_
38	in	_	ADP	IN	_	39	case	_	_
39	those	_	DET	DT	_	37	nmod	_	_
40	receiving	_	VERB	VBG	_	39	acl	_	_
41	dual	_	ADJ	JJ	_	43	amod	_	_
42	antiplatelet	_	ADJ	JJ	_	43	compound	_	_
43	therapy	_	NOUN	NN	_	40	dobj	_	_

#	Apixaban	1235
1	DRUG	_	NOUN	NN	_	5	nsubj	_	_
2	is	_	VERB	VBZ	_	5	cop	_	_
3	a	_	DET	DT	_	5	det	_	_
4	selective	_	ADJ	JJ	_	5	amod	_	_
5	inhibitor	_	NOUN	NN	_	0	root	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	FXa	_	NOUN	NN	_	5	nmod	_	_

#	Apixaban	1236
1	It	_	PRON	PRP	_	4	nsubj	_	_
2	does	_	VERB	VBZ	_	4	aux	_	_
3	not	_	ADV	RB	_	4	neg	_	_
4	require	_	VERB	VB	_	0	root	_	_
5	antithrombin	_	NOUN	NN	_	4	dobj	_	_
6	III	_	NUM	CD	_	5	nummod	_	_
7	for	_	ADP	IN	_	9	case	_	_
8	antithrombotic	_	ADJ	JJ	_	9	amod	_	_
9	activity	_	NOUN	NN	_	4	nmod	_	_

#	Apixaban	1237
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	inhibits	_	VERB	VBZ	_	0	root	_	_
3	free	_	ADJ	JJ	_	7	amod	_	_
4	and	_	CONJ	CC	_	3	cc	_	_
5	clot	_	NOUN	NN	_	3	conj	_	_
6	bound	_	VERB	VBD	_	7	amod	_	_
7	FXa	_	NOUN	NN	_	2	dobj	_	_
8	,	_	.	,	_	2	punct	_	_
9	and	_	CONJ	CC	_	2	cc	_	_
10	prothrombinase	_	NOUN	NN	_	11	compound	_	_
11	activity	_	NOUN	NN	_	2	conj	_	_

#	Apixaban	1238
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	has	_	VERB	VBZ	_	0	root	_	_
3	no	_	DET	DT	_	5	neg	_	_
4	direct	_	ADJ	JJ	_	5	amod	_	_
5	effect	_	NOUN	NN	_	2	dobj	_	_
6	on	_	ADP	IN	_	8	case	_	_
7	platelet	_	NOUN	NN	_	8	compound	_	_
8	aggregation	_	NOUN	NN	_	2	nmod	_	_
9	,	_	.	,	_	2	punct	_	_
10	but	_	CONJ	CC	_	2	cc	_	_
11	indirectly	_	ADV	RB	_	12	advmod	_	_
12	inhibits	_	VERB	VBZ	_	2	conj	_	_
13	platelet	_	NOUN	NN	_	14	compound	_	_
14	aggregation	_	NOUN	NN	_	12	dobj	_	_
15	induced	_	VERB	VBN	_	14	acl	_	_
16	by	_	ADP	IN	_	17	case	_	_
17	thrombin	_	NOUN	NN	_	15	nmod	_	_

#	Apixaban	1239
1	By	_	ADP	IN	_	2	mark	_	_
2	inhibiting	_	VERB	VBG	_	6	advcl	_	_
3	FXa	_	NOUN	NN	_	2	dobj	_	_
4	,	_	.	,	_	6	punct	_	_
5	DRUG	_	NOUN	NN	_	6	nsubj	_	_
6	decreases	_	VERB	VBZ	_	0	root	_	_
7	thrombin	_	NOUN	NN	_	8	compound	_	_
8	generation	_	NOUN	NN	_	6	dobj	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	thrombus	_	NOUN	NN	_	11	compound	_	_
11	development	_	NOUN	NN	_	8	conj	_	_

#	Apixaban	1240
1	As	_	ADP	IN	_	3	case	_	_
2	a	_	DET	DT	_	3	det	_	_
3	result	_	NOUN	NN	_	9	nmod	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	FXa	_	NOUN	NN	_	6	compound	_	_
6	inhibition	_	NOUN	NN	_	3	nmod	_	_
7	,	_	.	,	_	9	punct	_	_
8	DRUG	_	NOUN	NN	_	9	nsubj	_	_
9	prolongs	_	VERB	VBZ	_	0	root	_	_
10	clotting	_	VERB	VBG	_	11	amod	_	_
11	tests	_	NOUN	NNS	_	9	dobj	_	_
12	such	_	ADJ	JJ	_	16	case	_	_
13	as	_	ADP	IN	_	12	mwe	_	_
14	prothrombin	_	NOUN	NN	_	16	compound	_	_
15	time	_	NOUN	NN	_	16	compound	_	_
16	PT	_	NOUN	NN	_	11	nmod	_	_
17	,	_	.	,	_	16	punct	_	_
18	INR	_	NOUN	NN	_	16	conj	_	_
19	,	_	.	,	_	16	punct	_	_
20	and	_	CONJ	CC	_	16	cc	_	_
21	activated	_	VERB	VBN	_	25	amod	_	_
22	partial	_	ADJ	JJ	_	25	amod	_	_
23	thromboplastin	_	NOUN	NN	_	25	compound	_	_
24	time	_	NOUN	NN	_	25	compound	_	_
25	aPTT	_	NOUN	NN	_	16	conj	_	_

#	Apixaban	1241
1	Changes	_	NOUN	NNS	_	16	nsubj	_	_
2	observed	_	VERB	VBN	_	1	acl	_	_
3	in	_	ADP	IN	_	6	case	_	_
4	these	_	DET	DT	_	6	det	_	_
5	clotting	_	VERB	VBG	_	6	amod	_	_
6	tests	_	NOUN	NNS	_	2	nmod	_	_
7	at	_	ADP	IN	_	11	case	_	_
8	the	_	DET	DT	_	11	det	_	_
9	expected	_	VERB	VBN	_	11	amod	_	_
10	therapeutic	_	ADJ	JJ	_	11	amod	_	_
11	dose	_	NOUN	NN	_	6	nmod	_	_
12	,	_	.	,	_	1	punct	_	_
13	however	_	ADV	RB	_	16	advmod	_	_
14	,	_	.	,	_	16	punct	_	_
15	are	_	VERB	VBP	_	16	cop	_	_
16	small	_	ADJ	JJ	_	0	root	_	_
17	,	_	.	,	_	16	punct	_	_
18	subject	_	NOUN	NN	_	16	conj	_	_
19	to	_	PRT	TO	_	22	case	_	_
20	a	_	DET	DT	_	22	det	_	_
21	high	_	ADJ	JJ	_	22	amod	_	_
22	degree	_	NOUN	NN	_	18	nmod	_	_
23	of	_	ADP	IN	_	24	case	_	_
24	variability	_	NOUN	NN	_	22	nmod	_	_
25	,	_	.	,	_	16	punct	_	_
26	and	_	CONJ	CC	_	27	cc	_	_
27	not	_	ADV	RB	_	16	cc	_	_
28	useful	_	ADJ	JJ	_	16	conj	_	_
29	in	_	ADP	IN	_	30	mark	_	_
30	monitoring	_	VERB	VBG	_	28	advcl	_	_
31	the	_	DET	DT	_	33	det	_	_
32	anticoagulation	_	NOUN	NN	_	33	compound	_	_
33	effect	_	NOUN	NN	_	30	dobj	_	_
34	of	_	ADP	IN	_	35	case	_	_
35	DRUG	_	NOUN	NN	_	33	nmod	_	_

#	Apixaban	1242
1	The	_	DET	DT	_	5	det	_	_
2	Rotachrom*	_	NOUN	NN	_	5	compound	_	_
3	Heparin	_	NOUN	NN	_	5	compound	_	_
4	chromogenic	_	ADJ	JJ	_	5	amod	_	_
5	assay	_	NOUN	NN	_	7	nsubjpass	_	_
6	was	_	VERB	VBD	_	7	auxpass	_	_
7	used	_	VERB	VBN	_	0	root	_	_
8	to	_	PRT	TO	_	9	mark	_	_
9	measure	_	VERB	VB	_	7	xcomp	_	_
10	the	_	DET	DT	_	11	det	_	_
11	effect	_	NOUN	NN	_	9	dobj	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	DRUG	_	NOUN	NN	_	11	nmod	_	_
14	on	_	ADP	IN	_	16	case	_	_
15	FXa	_	NOUN	NN	_	16	compound	_	_
16	activity	_	NOUN	NN	_	11	nmod	_	_
17	in	_	ADP	IN	_	18	case	_	_
18	humans	_	NOUN	NNS	_	16	nmod	_	_
19	during	_	ADP	IN	_	23	case	_	_
20	the	_	DET	DT	_	23	det	_	_
21	DRUG	_	NOUN	NN	_	23	compound	_	_
22	development	_	NOUN	NN	_	23	compound	_	_
23	program	_	NOUN	NN	_	11	nmod	_	_

#	Apixaban	1243
1	A	_	DET	DT	_	4	det	_	_
2	concentration	_	NOUN	NN	_	4	compound	_	_
3	dependent	_	ADJ	JJ	_	4	amod	_	_
4	increase	_	NOUN	NN	_	10	nsubjpass	_	_
5	in	_	ADP	IN	_	8	case	_	_
6	anti	_	ADJ	JJ	_	8	amod	_	_
7	FXa	_	NOUN	NN	_	8	compound	_	_
8	activity	_	NOUN	NN	_	4	nmod	_	_
9	was	_	VERB	VBD	_	10	auxpass	_	_
10	observed	_	VERB	VBN	_	0	root	_	_
11	in	_	ADP	IN	_	14	case	_	_
12	the	_	DET	DT	_	14	det	_	_
13	dose	_	NOUN	NN	_	14	compound	_	_
14	range	_	NOUN	NN	_	10	nmod	_	_
15	tested	_	VERB	VBN	_	14	acl	_	_
16	and	_	CONJ	CC	_	10	cc	_	_
17	was	_	VERB	VBD	_	18	cop	_	_
18	similar	_	ADJ	JJ	_	10	conj	_	_
19	in	_	ADP	IN	_	21	case	_	_
20	healthy	_	ADJ	JJ	_	21	amod	_	_
21	subjects	_	NOUN	NNS	_	18	nmod	_	_
22	and	_	CONJ	CC	_	21	cc	_	_
23	patients	_	NOUN	NNS	_	21	conj	_	_
24	with	_	ADP	IN	_	25	case	_	_
25	AF	_	NOUN	NN	_	21	nmod	_	_

#	Apixaban	1244
1	This	_	DET	DT	_	2	det	_	_
2	test	_	NOUN	NN	_	5	nsubjpass	_	_
3	is	_	VERB	VBZ	_	5	auxpass	_	_
4	not	_	ADV	RB	_	5	neg	_	_
5	recommended	_	VERB	VBN	_	0	root	_	_
6	for	_	ADP	IN	_	7	mark	_	_
7	assessing	_	VERB	VBG	_	5	advcl	_	_
8	the	_	DET	DT	_	10	det	_	_
9	anticoagulant	_	ADJ	JJ	_	10	amod	_	_
10	effect	_	NOUN	NN	_	7	dobj	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_

#	Apixaban	1245
1	There	_	DET	EX	_	2	expl	_	_
2	is	_	VERB	VBZ	_	0	root	_	_
3	no	_	DET	DT	_	5	neg	_	_
4	clinical	_	ADJ	JJ	_	5	amod	_	_
5	experience	_	NOUN	NN	_	2	nsubj	_	_
6	to	_	PRT	TO	_	7	mark	_	_
7	reverse	_	VERB	VB	_	5	acl	_	_
8	bleeding	_	NOUN	NN	_	7	dobj	_	_
9	with	_	ADP	IN	_	11	case	_	_
10	the	_	DET	DT	_	11	det	_	_
11	use	_	NOUN	NN	_	8	nmod	_	_
12	of	_	ADP	IN	_	16	case	_	_
13	4	_	NUM	CD	_	16	nummod	_	_
14	factor	_	NOUN	NN	_	16	compound	_	_
15	PCC	_	NOUN	NN	_	16	compound	_	_
16	products	_	NOUN	NNS	_	11	nmod	_	_
17	in	_	ADP	IN	_	18	case	_	_
18	individuals	_	NOUN	NNS	_	16	nmod	_	_
19	who	_	DET	WDT	_	21	nsubj	_	_
20	have	_	VERB	VBP	_	21	aux	_	_
21	received	_	VERB	VBN	_	18	acl:relcl	_	_
22	ELIQUIS	_	NOUN	NN	_	21	dobj	_	_

#	Apixaban	1246
1	Effects	_	NOUN	NNS	_	12	nsubjpass	_	_
2	of	_	ADP	IN	_	5	case	_	_
3	4	_	NUM	CD	_	5	nummod	_	_
4	factor	_	NOUN	NN	_	5	compound	_	_
5	PCCs	_	NOUN	NNS	_	1	nmod	_	_
6	on	_	ADP	IN	_	8	case	_	_
7	the	_	DET	DT	_	8	det	_	_
8	pharmacodynamics	_	NOUN	NNS	_	1	nmod	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	were	_	VERB	VBD	_	12	auxpass	_	_
12	studied	_	VERB	VBN	_	0	root	_	_
13	in	_	ADP	IN	_	15	case	_	_
14	healthy	_	ADJ	JJ	_	15	amod	_	_
15	subjects	_	NOUN	NNS	_	12	nmod	_	_

#	Apixaban	1247
1	Following	_	VERB	VBG	_	2	case	_	_
2	administration	_	NOUN	NN	_	14	nmod	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	dosed	_	VERB	VBD	_	2	acl	_	_
6	to	_	PRT	TO	_	8	case	_	_
7	steady	_	ADJ	JJ	_	8	amod	_	_
8	state	_	NOUN	NN	_	5	nmod	_	_
9	,	_	.	,	_	14	punct	_	_
10	endogenous	_	ADJ	JJ	_	13	amod	_	_
11	thrombin	_	NOUN	NN	_	13	compound	_	_
12	potential	_	ADJ	JJ	_	13	amod	_	_
13	ETP	_	NOUN	NN	_	14	nsubj	_	_
14	returned	_	VERB	VBD	_	0	root	_	_
15	to	_	PRT	TO	_	18	case	_	_
16	pre	_	VERB	VB	_	18	compound	_	_
17	DRUG	_	NOUN	NN	_	18	compound	_	_
18	levels	_	NOUN	NNS	_	14	nmod	_	_
19	4	_	NUM	CD	_	20	nummod	_	_
20	hours	_	NOUN	NNS	_	18	dep	_	_
21	after	_	ADP	IN	_	23	case	_	_
22	the	_	DET	DT	_	23	det	_	_
23	initiation	_	NOUN	NN	_	14	nmod	_	_
24	of	_	ADP	IN	_	29	case	_	_
25	a	_	DET	DT	_	29	det	_	_
26	30	_	NUM	CD	_	29	nummod	_	_
27	minute	_	NOUN	NN	_	29	amod	_	_
28	PCC	_	NOUN	NN	_	29	compound	_	_
29	infusion	_	NOUN	NN	_	23	nmod	_	_
30	,	_	.	,	_	14	punct	_	_
31	compared	_	VERB	VBD	_	14	parataxis	_	_
32	to	_	PRT	TO	_	34	case	_	_
33	45	_	NUM	CD	_	34	nummod	_	_
34	hours	_	NOUN	NNS	_	31	nmod	_	_
35	with	_	ADP	IN	_	36	case	_	_
36	placebo	_	NOUN	NN	_	34	nmod	_	_

#	Apixaban	1248
1	Mean	_	NOUN	NN	_	3	compound	_	_
2	ETP	_	NOUN	NN	_	3	compound	_	_
3	levels	_	NOUN	NNS	_	4	nsubj	_	_
4	continued	_	VERB	VBD	_	0	root	_	_
5	to	_	PRT	TO	_	6	mark	_	_
6	increase	_	VERB	VB	_	4	xcomp	_	_
7	and	_	CONJ	CC	_	4	cc	_	_
8	exceeded	_	VERB	VBD	_	4	conj	_	_
9	pre	_	NOUN	NN	_	11	compound	_	_
10	DRUG	_	NOUN	NN	_	11	compound	_	_
11	levels	_	NOUN	NNS	_	8	dobj	_	_
12	reaching	_	VERB	VBG	_	11	acl	_	_
13	a	_	DET	DT	_	17	det	_	_
14	maximum	_	ADJ	JJ	_	17	amod	_	_
15	34%	_	ADJ	JJ	_	17	amod	_	_
16	51%	_	ADJ	JJ	_	17	amod	_	_
17	increase	_	NOUN	NN	_	12	dobj	_	_
18	over	_	ADP	IN	_	21	case	_	_
19	pre	_	NOUN	NN	_	21	compound	_	_
20	DRUG	_	NOUN	NN	_	21	compound	_	_
21	levels	_	NOUN	NNS	_	12	nmod	_	_
22	at	_	ADP	IN	_	24	case	_	_
23	21	_	NUM	CD	_	24	nummod	_	_
24	hours	_	NOUN	NNS	_	12	nmod	_	_
25	after	_	ADP	IN	_	26	mark	_	_
26	initiating	_	VERB	VBG	_	12	advcl	_	_
27	PCC	_	NOUN	NN	_	26	dobj	_	_
28	and	_	CONJ	CC	_	4	cc	_	_
29	remained	_	VERB	VBD	_	4	conj	_	_
30	elevated	_	ADJ	JJ	_	33	amod	_	_
31	21%	_	ADJ	JJ	_	33	amod	_	_
32	27%	_	ADJ	JJ	_	33	amod	_	_
33	increase	_	NOUN	NN	_	29	dobj	_	_
34	at	_	ADP	IN	_	36	case	_	_
35	the	_	DET	DT	_	36	det	_	_
36	end	_	NOUN	NN	_	29	nmod	_	_
37	of	_	ADP	IN	_	41	case	_	_
38	the	_	DET	DT	_	41	det	_	_
39	study	_	NOUN	NN	_	41	compound	_	_
40	69	_	NUM	CD	_	41	nummod	_	_
41	hours	_	NOUN	NNS	_	36	nmod	_	_
42	after	_	ADP	IN	_	43	case	_	_
43	initiation	_	NOUN	NN	_	29	nmod	_	_
44	of	_	ADP	IN	_	45	case	_	_
45	PCC	_	NOUN	NN	_	43	nmod	_	_

#	Apixaban	1249
1	The	_	DET	DT	_	3	det	_	_
2	clinical	_	ADJ	JJ	_	3	amod	_	_
3	relevance	_	NOUN	NN	_	10	nsubj	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	this	_	DET	DT	_	6	det	_	_
6	increase	_	NOUN	NN	_	3	nmod	_	_
7	in	_	ADP	IN	_	8	case	_	_
8	ETP	_	NOUN	NN	_	6	nmod	_	_
9	is	_	VERB	VBZ	_	10	auxpass	_	_
10	unknown	_	ADJ	JJ	_	0	root	_	_

#	Apixaban	1250
1	Pharmacodynamic	_	ADJ	JJ	_	4	amod	_	_
2	drug	_	NOUN	NN	_	4	compound	_	_
3	interaction	_	NOUN	NN	_	4	compound	_	_
4	studies	_	NOUN	NNS	_	21	nsubjpass	_	_
5	with	_	ADP	IN	_	6	case	_	_
6	aspirin	_	NOUN	NN	_	4	nmod	_	_
7	,	_	.	,	_	6	punct	_	_
8	clopidogrel	_	NOUN	NN	_	6	conj	_	_
9	,	_	.	,	_	6	punct	_	_
10	aspirin	_	NOUN	NN	_	6	conj	_	_
11	and	_	CONJ	CC	_	6	cc	_	_
12	clopidogrel	_	NOUN	NN	_	6	conj	_	_
13	,	_	.	,	_	6	punct	_	_
14	prasugrel	_	NOUN	NN	_	6	conj	_	_
15	,	_	.	,	_	6	punct	_	_
16	enoxaparin	_	NOUN	NN	_	6	conj	_	_
17	,	_	.	,	_	6	punct	_	_
18	and	_	CONJ	CC	_	6	cc	_	_
19	naproxen	_	NOUN	NN	_	6	conj	_	_
20	were	_	VERB	VBD	_	21	auxpass	_	_
21	conducted	_	VERB	VBN	_	0	root	_	_

#	Apixaban	1251
1	No	_	DET	DT	_	3	neg	_	_
2	pharmacodynamic	_	ADJ	JJ	_	3	amod	_	_
3	interactions	_	NOUN	NNS	_	5	nsubjpass	_	_
4	were	_	VERB	VBD	_	5	auxpass	_	_
5	observed	_	VERB	VBN	_	0	root	_	_
6	with	_	ADP	IN	_	7	case	_	_
7	aspirin	_	NOUN	NN	_	5	nmod	_	_
8	,	_	.	,	_	7	punct	_	_
9	clopidogrel	_	NOUN	NN	_	7	conj	_	_
10	,	_	.	,	_	7	punct	_	_
11	or	_	CONJ	CC	_	7	cc	_	_
12	prasugrel	_	NOUN	NN	_	7	conj	_	_

#	Apixaban	1252
1	A	_	DET	DT	_	2	det	_	_
2	50%	_	ADJ	JJ	_	11	nsubjpass	_	_
3	to	_	PRT	TO	_	5	case	_	_
4	60%	_	ADJ	JJ	_	5	amod	_	_
5	increase	_	NOUN	NN	_	2	nmod	_	_
6	in	_	ADP	IN	_	9	case	_	_
7	anti	_	ADJ	JJ	_	9	amod	_	_
8	FXa	_	NOUN	NN	_	9	compound	_	_
9	activity	_	NOUN	NN	_	5	nmod	_	_
10	was	_	VERB	VBD	_	11	auxpass	_	_
11	observed	_	VERB	VBN	_	0	root	_	_
12	when	_	ADV	WRB	_	15	advmod	_	_
13	DRUG	_	NOUN	NN	_	15	nsubjpass	_	_
14	was	_	VERB	VBD	_	15	auxpass	_	_
15	coadministered	_	VERB	VBN	_	11	advcl	_	_
16	with	_	ADP	IN	_	17	case	_	_
17	enoxaparin	_	NOUN	NN	_	15	nmod	_	_
18	or	_	CONJ	CC	_	17	cc	_	_
19	naproxen	_	NOUN	NN	_	17	conj	_	_

#	Apixaban	1253
1	Renal	_	ADJ	JJ	_	2	amod	_	_
2	impairment	_	NOUN	NN	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	Anti	_	NOUN	NN	_	6	compound	_	_
5	FXa	_	NOUN	NN	_	6	compound	_	_
6	activity	_	NOUN	NN	_	13	nsubj	_	_
7	adjusted	_	VERB	VBN	_	6	acl	_	_
8	for	_	ADP	IN	_	9	case	_	_
9	exposure	_	NOUN	NN	_	7	nmod	_	_
10	to	_	PRT	TO	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_
12	was	_	VERB	VBD	_	13	cop	_	_
13	similar	_	ADJ	JJ	_	2	dep	_	_
14	across	_	ADP	IN	_	17	case	_	_
15	renal	_	ADJ	JJ	_	17	amod	_	_
16	function	_	NOUN	NN	_	17	compound	_	_
17	categories	_	NOUN	NNS	_	13	nmod	_	_

#	Apixaban	1254
1	Hepatic	_	ADJ	JJ	_	2	amod	_	_
2	impairment	_	NOUN	NN	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	Changes	_	NOUN	NNS	_	10	nsubj	_	_
5	in	_	ADP	IN	_	8	case	_	_
6	anti	_	ADJ	JJ	_	8	amod	_	_
7	FXa	_	NOUN	NN	_	8	compound	_	_
8	activity	_	NOUN	NN	_	4	nmod	_	_
9	were	_	VERB	VBD	_	10	cop	_	_
10	similar	_	ADJ	JJ	_	2	dep	_	_
11	in	_	ADP	IN	_	12	case	_	_
12	patients	_	NOUN	NNS	_	10	nmod	_	_
13	with	_	ADP	IN	_	14	case	_	_
14	mild	_	ADJ	JJ	_	12	nmod	_	_
15	to	_	PRT	TO	_	18	case	_	_
16	moderate	_	ADJ	JJ	_	18	amod	_	_
17	hepatic	_	ADJ	JJ	_	18	amod	_	_
18	impairment	_	NOUN	NN	_	12	nmod	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	healthy	_	ADJ	JJ	_	21	amod	_	_
21	subjects	_	NOUN	NNS	_	18	conj	_	_

#	Apixaban	1255
1	However	_	ADV	RB	_	11	advmod	_	_
2	,	_	.	,	_	11	punct	_	_
3	in	_	ADP	IN	_	4	case	_	_
4	patients	_	NOUN	NNS	_	11	nmod	_	_
5	with	_	ADP	IN	_	8	case	_	_
6	moderate	_	ADJ	JJ	_	8	amod	_	_
7	hepatic	_	ADJ	JJ	_	8	amod	_	_
8	impairment	_	NOUN	NN	_	4	nmod	_	_
9	,	_	.	,	_	11	punct	_	_
10	there	_	DET	EX	_	11	expl	_	_
11	is	_	VERB	VBZ	_	0	root	_	_
12	no	_	DET	DT	_	14	neg	_	_
13	clear	_	ADJ	JJ	_	14	amod	_	_
14	understanding	_	NOUN	NN	_	11	dobj	_	_
15	of	_	ADP	IN	_	17	case	_	_
16	the	_	DET	DT	_	17	det	_	_
17	impact	_	NOUN	NN	_	14	nmod	_	_
18	of	_	ADP	IN	_	20	case	_	_
19	this	_	DET	DT	_	20	det	_	_
20	degree	_	NOUN	NN	_	17	nmod	_	_
21	of	_	ADP	IN	_	24	case	_	_
22	hepatic	_	ADJ	JJ	_	24	amod	_	_
23	function	_	NOUN	NN	_	24	compound	_	_
24	impairment	_	NOUN	NN	_	20	nmod	_	_
25	on	_	ADP	IN	_	28	case	_	_
26	the	_	DET	DT	_	28	det	_	_
27	coagulation	_	NOUN	NN	_	28	compound	_	_
28	cascade	_	NOUN	NN	_	20	nmod	_	_
29	and	_	CONJ	CC	_	14	cc	_	_
30	its	_	PRON	PRP$	_	31	nmod:poss	_	_
31	relationship	_	NOUN	NN	_	14	conj	_	_
32	to	_	PRT	TO	_	33	case	_	_
33	efficacy	_	NOUN	NN	_	31	nmod	_	_
34	and	_	CONJ	CC	_	31	cc	_	_
35	bleeding	_	VERB	VBG	_	31	conj	_	_

#	Apixaban	1256
1	Patients	_	NOUN	NNS	_	8	nsubjpass	_	_
2	with	_	ADP	IN	_	5	case	_	_
3	severe	_	ADJ	JJ	_	5	amod	_	_
4	hepatic	_	ADJ	JJ	_	5	amod	_	_
5	impairment	_	NOUN	NN	_	1	nmod	_	_
6	were	_	VERB	VBD	_	8	auxpass	_	_
7	not	_	ADV	RB	_	8	neg	_	_
8	studied	_	VERB	VBN	_	0	root	_	_

#	Apixaban	1257
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	has	_	VERB	VBZ	_	0	root	_	_
3	no	_	DET	DT	_	4	neg	_	_
4	effect	_	NOUN	NN	_	2	dobj	_	_
5	on	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	QTc	_	NOUN	NN	_	4	nmod	_	_
8	interval	_	ADJ	JJ	_	7	amod	_	_
9	in	_	ADP	IN	_	10	case	_	_
10	humans	_	NOUN	NNS	_	8	nmod	_	_
11	at	_	ADP	IN	_	12	case	_	_
12	doses	_	NOUN	NNS	_	10	nmod	_	_
13	up	_	ADV	RB	_	15	advmod	_	_
14	to	_	PRT	TO	_	13	mwe	_	_
15	50	_	NUM	CD	_	17	nummod	_	_
16	mg	_	NOUN	NN	_	17	compound	_	_
17	DRUG	_	NOUN	NN	_	12	nmod	_	_
18	demonstrates	_	VERB	VBZ	_	2	parataxis	_	_
19	linear	_	ADJ	JJ	_	20	amod	_	_
20	pharmacokinetics	_	NOUN	NNS	_	18	dobj	_	_
21	with	_	ADP	IN	_	24	case	_	_
22	dose	_	NOUN	NN	_	24	compound	_	_
23	proportional	_	ADJ	JJ	_	24	amod	_	_
24	increases	_	NOUN	NNS	_	20	nmod	_	_
25	in	_	ADP	IN	_	26	case	_	_
26	exposure	_	NOUN	NN	_	24	nmod	_	_
27	for	_	ADP	IN	_	29	case	_	_
28	oral	_	ADJ	JJ	_	29	amod	_	_
29	doses	_	NOUN	NNS	_	26	nmod	_	_
30	up	_	ADV	RB	_	32	advmod	_	_
31	to	_	PRT	TO	_	30	mwe	_	_
32	10	_	NUM	CD	_	26	nmod	_	_
33	mg	_	NOUN	NN	_	32	dep	_	_

#	Apixaban	1258
1	The	_	DET	DT	_	3	det	_	_
2	absolute	_	ADJ	JJ	_	3	amod	_	_
3	bioavailability	_	NOUN	NN	_	8	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	is	_	VERB	VBZ	_	8	cop	_	_
7	approximately	_	ADV	RB	_	8	advmod	_	_
8	50%	_	ADJ	JJ	_	0	root	_	_
9	for	_	ADP	IN	_	10	case	_	_
10	doses	_	NOUN	NNS	_	8	nmod	_	_
11	up	_	ADV	RB	_	13	advmod	_	_
12	to	_	PRT	TO	_	11	mwe	_	_
13	10	_	NUM	CD	_	14	nummod	_	_
14	mg	_	NOUN	NN	_	10	nmod	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	ELIQUIS	_	NOUN	NN	_	14	nmod	_	_

#	Apixaban	1259
1	Food	_	NOUN	NN	_	4	nsubj	_	_
2	does	_	VERB	VBZ	_	4	aux	_	_
3	not	_	ADV	RB	_	4	neg	_	_
4	affect	_	VERB	VB	_	0	root	_	_
5	the	_	DET	DT	_	6	det	_	_
6	bioavailability	_	NOUN	NN	_	4	dobj	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_

#	Apixaban	1260
1	Maximum	_	NOUN	NN	_	2	compound	_	_
2	concentrations	_	NOUN	NNS	_	6	nsubj	_	_
3	Cmax	_	NOUN	NN	_	2	dep	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	appear	_	VERB	VBZ	_	0	root	_	_
7	3	_	NUM	CD	_	9	compound	_	_
8	to	_	PRT	TO	_	9	dep	_	_
9	4	_	NUM	CD	_	10	nummod	_	_
10	hours	_	NOUN	NNS	_	6	dobj	_	_
11	after	_	ADP	IN	_	13	case	_	_
12	oral	_	ADJ	JJ	_	13	amod	_	_
13	administration	_	NOUN	NN	_	6	nmod	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	ELIQUIS	_	NOUN	NN	_	13	nmod	_	_

#	Apixaban	1261
1	At	_	ADP	IN	_	2	case	_	_
2	doses	_	NOUN	NNS	_	7	nmod	_	_
3	>25	_	NUM	CD	_	4	nummod	_	_
4	mg	_	NOUN	NN	_	2	dep	_	_
5	,	_	.	,	_	7	punct	_	_
6	DRUG	_	NOUN	NN	_	7	nsubj	_	_
7	displays	_	VERB	VBZ	_	0	root	_	_
8	dissolution	_	NOUN	NN	_	10	compound	_	_
9	limited	_	ADJ	JJ	_	10	amod	_	_
10	absorption	_	NOUN	NN	_	7	dobj	_	_
11	with	_	ADP	IN	_	13	case	_	_
12	decreased	_	VERB	VBN	_	13	amod	_	_
13	bioavailability	_	NOUN	NN	_	10	nmod	_	_

#	Apixaban	1262
1	Following	_	VERB	VBG	_	3	case	_	_
2	oral	_	ADJ	JJ	_	3	amod	_	_
3	administration	_	NOUN	NN	_	15	nsubj	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	10	_	NUM	CD	_	6	nummod	_	_
6	mg	_	NOUN	NN	_	3	nmod	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	as	_	ADP	IN	_	14	case	_	_
10	2	_	NUM	CD	_	14	nummod	_	_
11	crushed	_	VERB	VBD	_	14	amod	_	_
12	5	_	NUM	CD	_	14	nummod	_	_
13	mg	_	NOUN	NN	_	14	compound	_	_
14	tablets	_	NOUN	NNS	_	3	nmod	_	_
15	suspended	_	VERB	VBD	_	24	advcl	_	_
16	in	_	ADP	IN	_	18	case	_	_
17	30	_	NUM	CD	_	18	nummod	_	_
18	mL	_	NOUN	NN	_	15	nmod	_	_
19	of	_	ADP	IN	_	20	case	_	_
20	water	_	NOUN	NN	_	18	nmod	_	_
21	,	_	.	,	_	24	punct	_	_
22	exposure	_	NOUN	NN	_	24	nsubj	_	_
23	was	_	VERB	VBD	_	24	cop	_	_
24	similar	_	ADJ	JJ	_	0	root	_	_
25	to	_	PRT	TO	_	26	case	_	_
26	that	_	ADP	IN	_	24	nmod	_	_
27	after	_	ADP	IN	_	29	case	_	_
28	oral	_	ADJ	JJ	_	29	amod	_	_
29	administration	_	NOUN	NN	_	26	nmod	_	_
30	of	_	ADP	IN	_	35	case	_	_
31	2	_	NUM	CD	_	35	nummod	_	_
32	intact	_	ADJ	JJ	_	35	amod	_	_
33	5	_	NUM	CD	_	35	nummod	_	_
34	mg	_	NOUN	NN	_	35	compound	_	_
35	tablets	_	NOUN	NNS	_	29	nmod	_	_

#	Apixaban	1263
1	Following	_	VERB	VBG	_	3	case	_	_
2	oral	_	ADJ	JJ	_	3	amod	_	_
3	administration	_	NOUN	NN	_	27	nmod	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	10	_	NUM	CD	_	6	nummod	_	_
6	mg	_	NOUN	NN	_	3	nmod	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	as	_	ADP	IN	_	14	case	_	_
10	2	_	NUM	CD	_	14	nummod	_	_
11	crushed	_	VERB	VBD	_	14	amod	_	_
12	5	_	NUM	CD	_	14	nummod	_	_
13	mg	_	NOUN	NN	_	14	compound	_	_
14	tablets	_	NOUN	NNS	_	3	nmod	_	_
15	mixed	_	VERB	VBN	_	14	acl	_	_
16	with	_	ADP	IN	_	18	case	_	_
17	30	_	NUM	CD	_	18	nummod	_	_
18	g	_	NOUN	NN	_	15	nmod	_	_
19	of	_	ADP	IN	_	20	case	_	_
20	applesauce	_	NOUN	NN	_	18	nmod	_	_
21	,	_	.	,	_	27	punct	_	_
22	the	_	DET	DT	_	23	det	_	_
23	Cmax	_	NOUN	NN	_	27	nsubj	_	_
24	and	_	CONJ	CC	_	23	cc	_	_
25	AUC	_	NOUN	NN	_	23	conj	_	_
26	were	_	VERB	VBD	_	27	cop	_	_
27	20%	_	ADJ	JJ	_	0	root	_	_
28	and	_	CONJ	CC	_	27	cc	_	_
29	16%	_	ADJ	JJ	_	30	nmod:npmod	_	_
30	lower	_	ADJ	JJ	_	27	conj	_	_
31	,	_	.	,	_	27	punct	_	_
32	respectively	_	ADV	RB	_	27	advmod	_	_
33	,	_	.	,	_	27	punct	_	_
34	when	_	ADV	RB	_	35	advmod	_	_
35	compared	_	VERB	VBN	_	27	advcl	_	_
36	to	_	PRT	TO	_	37	case	_	_
37	administration	_	NOUN	NN	_	35	nmod	_	_
38	of	_	ADP	IN	_	43	case	_	_
39	2	_	NUM	CD	_	43	nummod	_	_
40	intact	_	ADJ	JJ	_	43	amod	_	_
41	5	_	NUM	CD	_	43	nummod	_	_
42	mg	_	NOUN	NN	_	43	compound	_	_
43	tablets	_	NOUN	NNS	_	37	nmod	_	_

#	Apixaban	1264
1	Following	_	ADP	IN	_	2	case	_	_
2	administration	_	NOUN	NN	_	27	nmod	_	_
3	of	_	ADP	IN	_	9	case	_	_
4	a	_	DET	DT	_	9	det	_	_
5	crushed	_	VERB	VBN	_	9	amod	_	_
6	5	_	NUM	CD	_	9	nummod	_	_
7	mg	_	NOUN	NN	_	9	compound	_	_
8	ELIQUIS	_	NOUN	NN	_	9	compound	_	_
9	tablet	_	NOUN	NN	_	2	nmod	_	_
10	that	_	DET	WDT	_	12	nsubjpass	_	_
11	was	_	VERB	VBD	_	12	auxpass	_	_
12	suspended	_	VERB	VBN	_	9	acl:relcl	_	_
13	in	_	ADP	IN	_	16	case	_	_
14	60	_	NUM	CD	_	16	nummod	_	_
15	mL	_	NOUN	NN	_	16	compound	_	_
16	D5W	_	NOUN	NN	_	12	nmod	_	_
17	and	_	CONJ	CC	_	12	cc	_	_
18	delivered	_	VERB	VBN	_	12	conj	_	_
19	through	_	ADP	IN	_	23	case	_	_
20	a	_	DET	DT	_	23	det	_	_
21	nasogastric	_	ADJ	JJ	_	23	amod	_	_
22	tube	_	NOUN	NN	_	23	compound	_	_
23	NGT	_	NOUN	NN	_	18	nmod	_	_
24	,	_	.	,	_	27	punct	_	_
25	exposure	_	NOUN	NN	_	27	nsubj	_	_
26	was	_	VERB	VBD	_	27	cop	_	_
27	similar	_	ADJ	JJ	_	0	root	_	_
28	to	_	PRT	TO	_	29	case	_	_
29	that	_	DET	WDT	_	27	nmod	_	_
30	seen	_	VERB	VBN	_	29	acl	_	_
31	in	_	ADP	IN	_	34	case	_	_
32	other	_	ADJ	JJ	_	34	amod	_	_
33	clinical	_	ADJ	JJ	_	34	amod	_	_
34	trials	_	NOUN	NNS	_	30	nmod	_	_
35	involving	_	VERB	VBG	_	34	acl	_	_
36	healthy	_	ADJ	JJ	_	37	amod	_	_
37	volunteers	_	NOUN	NNS	_	35	dobj	_	_
38	receiving	_	VERB	VBG	_	37	acl	_	_
39	a	_	DET	DT	_	45	det	_	_
40	single	_	ADJ	JJ	_	45	amod	_	_
41	oral	_	ADJ	JJ	_	45	amod	_	_
42	5	_	NUM	CD	_	45	nummod	_	_
43	mg	_	NOUN	NN	_	45	compound	_	_
44	tablet	_	NOUN	NN	_	45	compound	_	_
45	dose	_	NOUN	NN	_	38	dobj	_	_

#	Apixaban	1265
1	Plasma	_	NOUN	NN	_	3	compound	_	_
2	protein	_	NOUN	NN	_	3	compound	_	_
3	binding	_	NOUN	NN	_	8	nsubj	_	_
4	in	_	ADP	IN	_	5	case	_	_
5	humans	_	NOUN	NNS	_	3	nmod	_	_
6	is	_	VERB	VBZ	_	8	auxpass	_	_
7	approximately	_	ADV	RB	_	8	advmod	_	_
8	87%	_	ADJ	JJ	_	0	root	_	_

#	Apixaban	1266
1	The	_	DET	DT	_	2	det	_	_
2	volume	_	NOUN	NN	_	9	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	distribution	_	NOUN	NN	_	5	compound	_	_
5	Vss	_	NOUN	NN	_	2	nmod	_	_
6	is	_	VERB	VBZ	_	9	cop	_	_
7	approximately	_	ADV	RB	_	9	advmod	_	_
8	21	_	NUM	CD	_	9	nummod	_	_
9	liters	_	NOUN	NNS	_	0	root	_	_

#	Apixaban	1267
1	Approximately	_	ADV	RB	_	10	advmod	_	_
2	25%	_	NOUN	NN	_	10	nsubjpass	_	_
3	of	_	ADP	IN	_	8	case	_	_
4	an	_	DET	DT	_	8	det	_	_
5	orally	_	ADV	RB	_	6	advmod	_	_
6	administered	_	VERB	VBN	_	8	amod	_	_
7	DRUG	_	NOUN	NN	_	8	compound	_	_
8	dose	_	NOUN	NN	_	2	nmod	_	_
9	is	_	VERB	VBZ	_	10	auxpass	_	_
10	recovered	_	VERB	VBN	_	0	root	_	_
11	in	_	ADP	IN	_	12	case	_	_
12	urine	_	ADJ	JJ	_	10	nmod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	feces	_	NOUN	NNS	_	12	conj	_	_
15	as	_	ADP	IN	_	16	case	_	_
16	metabolites	_	NOUN	NNS	_	10	nmod	_	_

#	Apixaban	1268
1	DRUG	_	NOUN	NN	_	3	nsubjpass	_	_
2	is	_	VERB	VBZ	_	3	auxpass	_	_
3	metabolized	_	VERB	VBN	_	0	root	_	_
4	mainly	_	ADV	RB	_	3	advmod	_	_
5	via	_	ADP	IN	_	6	case	_	_
6	CYP3A4	_	NOUN	NN	_	3	nmod	_	_
7	with	_	ADP	IN	_	9	case	_	_
8	minor	_	ADJ	JJ	_	9	amod	_	_
9	contributions	_	NOUN	NNS	_	3	nmod	_	_
10	from	_	ADP	IN	_	11	case	_	_
11	CYP1A2	_	NOUN	NN	_	9	nmod	_	_
12	,	_	.	,	_	11	punct	_	_
13	2C8	_	NOUN	NN	_	11	conj	_	_
14	,	_	.	,	_	11	punct	_	_
15	2C9	_	NOUN	NN	_	11	conj	_	_
16	,	_	.	,	_	11	punct	_	_
17	2C19	_	NOUN	NN	_	11	conj	_	_
18	,	_	.	,	_	11	punct	_	_
19	and	_	CONJ	CC	_	11	cc	_	_
20	2J2	_	NOUN	NN	_	11	conj	_	_

#	Apixaban	1269
1	O	_	NOUN	NN	_	2	compound	_	_
2	demethylation	_	NOUN	NN	_	13	nsubj	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	hydroxylation	_	NOUN	NN	_	2	conj	_	_
5	at	_	ADP	IN	_	9	case	_	_
6	the	_	DET	DT	_	9	det	_	_
7	3	_	NUM	CD	_	9	nummod	_	_
8	oxopiperidinyl	_	NOUN	NN	_	9	compound	_	_
9	moiety	_	NOUN	NN	_	2	nmod	_	_
10	are	_	VERB	VBP	_	13	cop	_	_
11	the	_	DET	DT	_	13	det	_	_
12	major	_	ADJ	JJ	_	13	amod	_	_
13	sites	_	NOUN	NNS	_	0	root	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	biotransformation	_	NOUN	NN	_	13	nmod	_	_

#	Apixaban	1270
1	Unchanged	_	ADJ	JJ	_	2	amod	_	_
2	DRUG	_	NOUN	NN	_	8	nsubj	_	_
3	is	_	VERB	VBZ	_	8	cop	_	_
4	the	_	DET	DT	_	8	det	_	_
5	major	_	ADJ	JJ	_	8	amod	_	_
6	drug	_	NOUN	NN	_	8	compound	_	_
7	related	_	ADJ	JJ	_	8	amod	_	_
8	component	_	NOUN	NN	_	0	root	_	_
9	in	_	ADP	IN	_	11	case	_	_
10	human	_	ADJ	JJ	_	11	amod	_	_
11	plasma	_	NOUN	NN	_	8	nmod	_	_
12	there	_	PRON	PRP$	_	13	expl	_	_
13	are	_	VERB	VBP	_	11	acl:relcl	_	_
14	no	_	DET	DT	_	17	neg	_	_
15	active	_	ADJ	JJ	_	17	amod	_	_
16	circulating	_	ADJ	JJ	_	17	amod	_	_
17	metabolites	_	NOUN	NNS	_	13	conj	_	_

#	Apixaban	1271
1	DRUG	_	NOUN	NN	_	3	nsubjpass	_	_
2	is	_	VERB	VBZ	_	3	auxpass	_	_
3	eliminated	_	VERB	VBN	_	0	root	_	_
4	in	_	ADP	IN	_	6	case	_	_
5	both	_	CONJ	CC	_	6	cc:preconj	_	_
6	urine	_	ADJ	JJ	_	3	nmod	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	feces	_	NOUN	NNS	_	6	conj	_	_

#	Apixaban	1272
1	Renal	_	ADJ	JJ	_	2	amod	_	_
2	excretion	_	NOUN	NN	_	3	nsubj	_	_
3	accounts	_	VERB	VBZ	_	0	root	_	_
4	for	_	ADP	IN	_	6	case	_	_
5	about	_	ADV	RB	_	6	advmod	_	_
6	27%	_	NOUN	NN	_	3	nmod	_	_
7	of	_	ADP	IN	_	9	case	_	_
8	total	_	ADJ	JJ	_	9	amod	_	_
9	clearance	_	NOUN	NN	_	6	nmod	_	_

#	Apixaban	1273
1	Biliary	_	ADJ	JJ	_	5	amod	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	direct	_	ADJ	JJ	_	1	conj	_	_
4	intestinal	_	ADJ	JJ	_	5	amod	_	_
5	excretion	_	NOUN	NN	_	6	nsubj	_	_
6	contributes	_	VERB	VBZ	_	0	root	_	_
7	to	_	PRT	TO	_	8	case	_	_
8	elimination	_	NOUN	NN	_	6	nmod	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	in	_	ADP	IN	_	13	case	_	_
12	the	_	DET	DT	_	13	det	_	_
13	feces	_	NOUN	NNS	_	8	nmod	_	_

#	Apixaban	1274
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	has	_	VERB	VBZ	_	0	root	_	_
3	a	_	DET	DT	_	5	det	_	_
4	total	_	ADJ	JJ	_	5	amod	_	_
5	clearance	_	NOUN	NN	_	2	dobj	_	_
6	of	_	ADP	IN	_	9	case	_	_
7	approximately	_	ADV	RB	_	8	advmod	_	_
8	3.3	_	NUM	CD	_	9	nummod	_	_
9	L	_	NOUN	NN	_	5	nmod	_	_
10	/	_	.	:	_	5	punct	_	_
11	hour	_	NUM	CD	_	5	dep	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	an	_	DET	DT	_	16	det	_	_
14	apparent	_	ADJ	JJ	_	16	amod	_	_
15	half	_	NOUN	NN	_	16	compound	_	_
16	life	_	NOUN	NN	_	11	conj	_	_
17	of	_	ADP	IN	_	20	case	_	_
18	approximately	_	ADV	RB	_	19	advmod	_	_
19	12	_	NUM	CD	_	20	nummod	_	_
20	hours	_	NOUN	NNS	_	11	nmod	_	_
21	following	_	ADP	IN	_	23	case	_	_
22	oral	_	ADJ	JJ	_	23	amod	_	_
23	administration	_	NOUN	NN	_	11	nmod	_	_

#	Apixaban	1275
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	is	_	VERB	VBZ	_	4	cop	_	_
3	a	_	DET	DT	_	4	det	_	_
4	substrate	_	NOUN	NN	_	0	root	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	transport	_	NOUN	NN	_	7	compound	_	_
7	proteins	_	NOUN	NNS	_	4	nmod	_	_
8	:	_	.	:	_	4	punct	_	_
9	P	_	NOUN	NN	_	10	compound	_	_
10	gp	_	NOUN	NN	_	4	dep	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	breast	_	NOUN	NN	_	15	compound	_	_
13	cancer	_	NOUN	NN	_	15	compound	_	_
14	resistance	_	NOUN	NN	_	15	compound	_	_
15	protein	_	NOUN	NN	_	10	conj	_	_

#	Apixaban	1276
1	In	_	X	FW	_	4	amod	_	_
2	vitro	_	X	FW	_	1	dep	_	_
3	DRUG	_	NOUN	NN	_	4	compound	_	_
4	studies	_	NOUN	NNS	_	55	nsubjpass	_	_
5	at	_	ADP	IN	_	6	case	_	_
6	concentrations	_	NOUN	NNS	_	4	nmod	_	_
7	significantly	_	ADV	RB	_	8	advmod	_	_
8	greater	_	ADJ	JJ	_	6	amod	_	_
9	than	_	ADP	IN	_	11	case	_	_
10	therapeutic	_	ADJ	JJ	_	11	amod	_	_
11	exposures	_	NOUN	NNS	_	8	nmod	_	_
12	,	_	.	,	_	4	punct	_	_
13	no	_	DET	DT	_	15	neg	_	_
14	inhibitory	_	ADJ	JJ	_	15	amod	_	_
15	effect	_	NOUN	NN	_	4	conj	_	_
16	on	_	ADP	IN	_	18	case	_	_
17	the	_	DET	DT	_	18	det	_	_
18	activity	_	NOUN	NN	_	15	nmod	_	_
19	of	_	ADP	IN	_	20	case	_	_
20	CYP1A2	_	NOUN	NN	_	18	nmod	_	_
21	,	_	.	,	_	20	punct	_	_
22	CYP2A6	_	NOUN	NN	_	20	conj	_	_
23	,	_	.	,	_	20	punct	_	_
24	CYP2B6	_	NOUN	NN	_	20	conj	_	_
25	,	_	.	,	_	20	punct	_	_
26	CYP2C8	_	NOUN	NN	_	20	conj	_	_
27	,	_	.	,	_	20	punct	_	_
28	CYP2C9	_	NOUN	NN	_	20	conj	_	_
29	,	_	.	,	_	20	punct	_	_
30	CYP2D6	_	NOUN	NN	_	20	conj	_	_
31	,	_	.	,	_	20	punct	_	_
32	CYP3A4	_	NOUN	NN	_	20	conj	_	_
33	/	_	.	-RRB-	_	20	punct	_	_
34	5	_	NUM	CD	_	20	nummod	_	_
35	,	_	.	,	_	20	punct	_	_
36	or	_	CONJ	CC	_	20	cc	_	_
37	CYP2C19	_	NOUN	NN	_	20	conj	_	_
38	,	_	.	,	_	4	punct	_	_
39	nor	_	CONJ	CC	_	4	cc	_	_
40	induction	_	NOUN	NN	_	41	compound	_	_
41	effect	_	NOUN	NN	_	4	conj	_	_
42	on	_	ADP	IN	_	44	case	_	_
43	the	_	DET	DT	_	44	det	_	_
44	activity	_	NOUN	NN	_	4	nmod	_	_
45	of	_	ADP	IN	_	46	case	_	_
46	CYP1A2	_	NOUN	NN	_	44	nmod	_	_
47	,	_	.	,	_	46	punct	_	_
48	CYP2B6	_	NOUN	NN	_	46	conj	_	_
49	,	_	.	,	_	46	punct	_	_
50	or	_	CONJ	CC	_	46	cc	_	_
51	CYP3A4	_	NOUN	NN	_	46	conj	_	_
52	/	_	.	:	_	53	punct	_	_
53	5	_	NUM	CD	_	4	nmod	_	_
54	were	_	VERB	VBD	_	55	auxpass	_	_
55	observed	_	VERB	VBN	_	0	root	_	_

#	Apixaban	1277
1	Therefore	_	ADV	RB	_	6	advmod	_	_
2	,	_	.	,	_	6	punct	_	_
3	DRUG	_	NOUN	NN	_	6	nsubjpass	_	_
4	is	_	VERB	VBZ	_	6	auxpass	_	_
5	not	_	ADV	RB	_	6	neg	_	_
6	expected	_	VERB	VBN	_	0	root	_	_
7	to	_	PRT	TO	_	8	mark	_	_
8	alter	_	VERB	VB	_	6	xcomp	_	_
9	the	_	DET	DT	_	11	det	_	_
10	metabolic	_	ADJ	JJ	_	11	amod	_	_
11	clearance	_	NOUN	NN	_	8	dobj	_	_
12	of	_	ADP	IN	_	14	case	_	_
13	coadministered	_	VERB	VBN	_	14	amod	_	_
14	drugs	_	NOUN	NNS	_	11	nmod	_	_
15	that	_	DET	WDT	_	17	nsubjpass	_	_
16	are	_	VERB	VBP	_	17	auxpass	_	_
17	metabolized	_	VERB	VBN	_	14	acl:relcl	_	_
18	by	_	ADP	IN	_	20	case	_	_
19	these	_	DET	DT	_	20	det	_	_
20	enzymes	_	NOUN	NNS	_	17	nmod	_	_

#	Apixaban	1278
1	DRUG	_	NOUN	NN	_	6	nsubj	_	_
2	is	_	VERB	VBZ	_	6	cop	_	_
3	not	_	ADV	RB	_	6	neg	_	_
4	a	_	DET	DT	_	6	det	_	_
5	significant	_	ADJ	JJ	_	6	amod	_	_
6	inhibitor	_	NOUN	NN	_	0	root	_	_
7	of	_	ADP	IN	_	9	case	_	_
8	P	_	NOUN	NN	_	9	compound	_	_
9	gp	_	NOUN	NN	_	6	nmod	_	_

#	Apixaban	1279
1	The	_	DET	DT	_	2	det	_	_
2	effects	_	NOUN	NNS	_	12	nsubjpass	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	coadministered	_	VERB	VBN	_	5	amod	_	_
5	drugs	_	NOUN	NNS	_	2	nmod	_	_
6	on	_	ADP	IN	_	8	case	_	_
7	the	_	DET	DT	_	8	det	_	_
8	pharmacokinetics	_	NOUN	NNS	_	2	nmod	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	are	_	VERB	VBP	_	12	auxpass	_	_
12	summarized	_	VERB	VBN	_	0	root	_	_
13	in	_	ADP	IN	_	14	case	_	_
14	Figure	_	NOUN	NN	_	12	nmod	_	_
15	2	_	NUM	CD	_	14	nummod	_	_

#	Apixaban	1280
1	Figure	_	NOUN	NN	_	0	root	_	_
2	2	_	NUM	CD	_	1	nummod	_	_
3	:	_	.	:	_	1	punct	_	_
4	Effect	_	NOUN	NN	_	32	nsubj	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	Coadministered	_	ADJ	JJ	_	7	amod	_	_
7	Drugs	_	NOUN	NNS	_	4	nmod	_	_
8	on	_	ADP	IN	_	10	case	_	_
9	the	_	DET	DT	_	10	det	_	_
10	Pharmacokinetics	_	NOUN	NNS	_	4	nmod	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_
13	In	_	ADP	IN	_	15	case	_	_
14	dedicated	_	VERB	VBN	_	15	amod	_	_
15	studies	_	NOUN	NNS	_	10	nmod	_	_
16	conducted	_	VERB	VBN	_	15	acl	_	_
17	in	_	ADP	IN	_	19	case	_	_
18	healthy	_	ADJ	JJ	_	19	amod	_	_
19	subjects	_	NOUN	NNS	_	16	nmod	_	_
20	,	_	.	,	_	19	punct	_	_
21	famotidine	_	NOUN	NN	_	19	conj	_	_
22	,	_	.	,	_	19	punct	_	_
23	atenolol	_	NOUN	NN	_	19	conj	_	_
24	,	_	.	,	_	19	punct	_	_
25	prasugrel	_	NOUN	NN	_	19	conj	_	_
26	,	_	.	,	_	19	punct	_	_
27	and	_	CONJ	CC	_	19	cc	_	_
28	enoxaparin	_	NOUN	NN	_	19	conj	_	_
29	did	_	VERB	VBD	_	32	aux	_	_
30	not	_	ADV	RB	_	32	neg	_	_
31	meaningfully	_	ADV	RB	_	32	advmod	_	_
32	alter	_	VERB	VB	_	1	dep	_	_
33	the	_	DET	DT	_	34	det	_	_
34	pharmacokinetics	_	NOUN	NNS	_	32	dobj	_	_
35	of	_	ADP	IN	_	36	case	_	_
36	DRUG	_	NOUN	NN	_	34	nmod	_	_

#	Apixaban	1281
1	In	_	ADP	IN	_	2	case	_	_
2	studies	_	NOUN	NNS	_	12	nmod	_	_
3	conducted	_	VERB	VBN	_	2	acl	_	_
4	in	_	ADP	IN	_	6	case	_	_
5	healthy	_	ADJ	JJ	_	6	amod	_	_
6	subjects	_	NOUN	NNS	_	3	nmod	_	_
7	,	_	.	,	_	12	punct	_	_
8	DRUG	_	NOUN	NN	_	12	nsubj	_	_
9	did	_	VERB	MD	_	12	aux	_	_
10	not	_	ADV	RB	_	12	neg	_	_
11	meaningfully	_	ADV	RB	_	12	advmod	_	_
12	alter	_	VERB	VB	_	0	root	_	_
13	the	_	DET	DT	_	14	det	_	_
14	pharmacokinetics	_	NOUN	NNS	_	12	dobj	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	digoxin	_	NOUN	NN	_	14	nmod	_	_
17	,	_	.	,	_	16	punct	_	_
18	naproxen	_	NOUN	NN	_	16	conj	_	_
19	,	_	.	,	_	16	punct	_	_
20	atenolol	_	NOUN	NN	_	16	conj	_	_
21	,	_	.	,	_	16	punct	_	_
22	prasugrel	_	NOUN	NN	_	16	conj	_	_
23	,	_	.	,	_	16	punct	_	_
24	or	_	CONJ	CC	_	16	cc	_	_
25	acetylsalicylic	_	ADJ	JJ	_	26	amod	_	_
26	acid	_	NOUN	NN	_	16	conj	_	_

#	Apixaban	1282
1	Effect	_	NOUN	NN	_	33	nsubjpass	_	_
2	of	_	ADP	IN	_	4	case	_	_
3	Coadministered	_	ADJ	JJ	_	4	amod	_	_
4	Drugs	_	NOUN	NNS	_	1	nmod	_	_
5	on	_	ADP	IN	_	6	case	_	_
6	Pharmacokinetics	_	NOUN	NNS	_	1	nmod	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	The	_	DET	DT	_	10	det	_	_
10	effects	_	NOUN	NNS	_	6	dep	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	level	_	NOUN	NN	_	10	nmod	_	_
13	of	_	ADP	IN	_	15	case	_	_
14	renal	_	ADJ	JJ	_	15	amod	_	_
15	impairment	_	NOUN	NN	_	12	nmod	_	_
16	,	_	.	,	_	15	punct	_	_
17	age	_	NOUN	NN	_	15	conj	_	_
18	,	_	.	,	_	15	punct	_	_
19	body	_	NOUN	NN	_	20	compound	_	_
20	weight	_	NOUN	NN	_	15	conj	_	_
21	,	_	.	,	_	15	punct	_	_
22	and	_	CONJ	CC	_	15	cc	_	_
23	level	_	NOUN	NN	_	15	conj	_	_
24	of	_	ADP	IN	_	26	case	_	_
25	hepatic	_	ADJ	JJ	_	26	amod	_	_
26	impairment	_	NOUN	NN	_	15	nmod	_	_
27	on	_	ADP	IN	_	29	case	_	_
28	the	_	DET	DT	_	29	det	_	_
29	pharmacokinetics	_	NOUN	NNS	_	10	nmod	_	_
30	of	_	ADP	IN	_	31	case	_	_
31	DRUG	_	NOUN	NN	_	29	nmod	_	_
32	are	_	VERB	VBP	_	33	auxpass	_	_
33	summarized	_	VERB	VBN	_	0	root	_	_
34	in	_	ADP	IN	_	35	case	_	_
35	Figure	_	NOUN	NN	_	33	nmod	_	_
36	3	_	NUM	CD	_	35	nummod	_	_

#	Apixaban	1283
1	Figure	_	NOUN	NN	_	0	root	_	_
2	3	_	NUM	CD	_	1	nummod	_	_
3	:	_	.	:	_	1	punct	_	_
4	Effect	_	NOUN	NN	_	26	nsubj	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	Specific	_	ADJ	JJ	_	7	amod	_	_
7	Populations	_	NOUN	NNS	_	4	nmod	_	_
8	on	_	ADP	IN	_	10	case	_	_
9	the	_	DET	DT	_	10	det	_	_
10	Pharmacokinetics	_	NOUN	NNS	_	4	nmod	_	_
11	of	_	ADP	IN	_	15	case	_	_
12	DRUG	_	NOUN	NN	_	15	compound	_	_
13	*	_	NUM	CD	_	15	nummod	_	_
14	ESRD	_	NOUN	NN	_	15	compound	_	_
15	subjects	_	NOUN	NNS	_	10	nmod	_	_
16	treated	_	VERB	VBN	_	15	acl	_	_
17	with	_	ADP	IN	_	22	case	_	_
18	intermittent	_	ADJ	JJ	_	22	amod	_	_
19	hemodialysis	_	NOUN	NN	_	22	compound	_	_
20	reported	_	VERB	VBN	_	22	amod	_	_
21	PK	_	NOUN	NN	_	22	compound	_	_
22	findings	_	NOUN	NNS	_	16	nmod	_	_
23	are	_	VERB	VBP	_	26	cop	_	_
24	following	_	VERB	VBG	_	26	case	_	_
25	single	_	ADJ	JJ	_	26	amod	_	_
26	dose	_	NOUN	NN	_	1	dep	_	_
27	of	_	ADP	IN	_	30	case	_	_
28	DRUG	_	NOUN	NN	_	30	compound	_	_
29	post	_	NOUN	NN	_	30	compound	_	_
30	hemodialysis	_	NOUN	NN	_	26	nmod	_	_

#	Apixaban	1284
1	*	_	NOUN	NN	_	2	compound	_	_
2	Results	_	NOUN	NNS	_	3	nsubj	_	_
3	reflect	_	VERB	VBP	_	0	root	_	_
4	CrCl	_	NOUN	NN	_	3	dobj	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	15	_	NUM	CD	_	7	nummod	_	_
7	mL	_	NOUN	NN	_	4	nmod	_	_
8	/	_	.	:	_	3	punct	_	_
9	min	_	NOUN	NN	_	3	parataxis	_	_
10	based	_	VERB	VBN	_	9	acl	_	_
11	on	_	ADP	IN	_	13	case	_	_
12	regression	_	NOUN	NN	_	13	compound	_	_
13	analysis	_	NOUN	NN	_	10	nmod	_	_

#	Apixaban	1285
1	*	_	NOUN	NN	_	4	compound	_	_
2	Dashed	_	ADJ	JJ	_	4	amod	_	_
3	vertical	_	ADJ	JJ	_	4	amod	_	_
4	lines	_	NOUN	NNS	_	5	nsubj	_	_
5	illustrate	_	VERB	VBP	_	0	root	_	_
6	pharmacokinetic	_	ADJ	JJ	_	7	amod	_	_
7	changes	_	NOUN	NNS	_	5	dobj	_	_
8	that	_	DET	WDT	_	10	nsubjpass	_	_
9	were	_	VERB	VBD	_	10	auxpass	_	_
10	used	_	VERB	VBN	_	7	acl:relcl	_	_
11	to	_	PRT	TO	_	14	case	_	_
12	inform	_	ADJ	JJ	_	14	amod	_	_
13	dosing	_	NOUN	NN	_	14	compound	_	_
14	recommendations	_	NOUN	NNS	_	10	nmod	_	_

#	Apixaban	1286
1	No	_	DET	DT	_	3	neg	_	_
2	dose	_	NOUN	NN	_	3	compound	_	_
3	adjustment	_	NOUN	NN	_	5	nsubjpass	_	_
4	is	_	VERB	VBZ	_	5	auxpass	_	_
5	recommended	_	VERB	VBN	_	0	root	_	_
6	for	_	ADP	IN	_	10	case	_	_
7	nonvalvular	_	ADJ	JJ	_	10	amod	_	_
8	atrial	_	ADJ	JJ	_	10	amod	_	_
9	fibrillation	_	NOUN	NN	_	10	compound	_	_
10	patients	_	NOUN	NNS	_	5	nmod	_	_
11	unless	_	ADP	IN	_	21	mark	_	_
12	at	_	ADP	IN	_	13	case	_	_
13	least	_	ADJ	JJS	_	14	nmod:npmod	_	_
14	2	_	NUM	CD	_	21	nsubj	_	_
15	of	_	ADP	IN	_	19	case	_	_
16	the	_	DET	DT	_	19	det	_	_
17	following	_	VERB	VBG	_	19	amod	_	_
18	patient	_	NOUN	NN	_	19	compound	_	_
19	characteristics	_	NOUN	NNS	_	14	nmod	_	_
20	are	_	VERB	VBP	_	21	cop	_	_
21	present	_	ADJ	JJ	_	5	advcl	_	_
22	:	_	.	:	_	5	punct	_	_
23	age	_	NOUN	NN	_	26	compound	_	_
24	>	_	NUM	CD	_	26	nummod	_	_
25	79	_	NUM	CD	_	26	nummod	_	_
26	years	_	NOUN	NNS	_	5	parataxis	_	_
27	,	_	.	,	_	26	punct	_	_
28	body	_	NOUN	NN	_	32	compound	_	_
29	weight	_	NOUN	NN	_	32	compound	_	_
30	<	_	NUM	CD	_	32	nummod	_	_
31	61	_	NUM	CD	_	32	nummod	_	_
32	kg	_	NOUN	NN	_	26	conj	_	_
33	,	_	.	,	_	26	punct	_	_
34	or	_	CONJ	CC	_	26	cc	_	_
35	serum	_	NOUN	NN	_	39	compound	_	_
36	creatinine	_	NOUN	NN	_	39	compound	_	_
37	>	_	NUM	CD	_	39	nummod	_	_
38	1.4	_	NUM	CD	_	39	nummod	_	_
39	mg	_	NOUN	NN	_	26	conj	_	_
40	/	_	.	:	_	26	punct	_	_
41	dL	_	ADP	IN	_	26	punct	_	_

#	Apixaban	1287
1	Gender	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	A	_	PRON	PRP$	_	4	nmod:poss	_	_
4	study	_	NOUN	NN	_	15	nsubj	_	_
5	in	_	ADP	IN	_	7	case	_	_
6	healthy	_	ADJ	JJ	_	7	amod	_	_
7	subjects	_	NOUN	NNS	_	4	nmod	_	_
8	comparing	_	VERB	VBG	_	7	acl	_	_
9	the	_	DET	DT	_	10	det	_	_
10	pharmacokinetics	_	NOUN	NNS	_	8	dobj	_	_
11	in	_	ADP	IN	_	12	case	_	_
12	males	_	NOUN	NNS	_	10	nmod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	females	_	NOUN	NNS	_	12	conj	_	_
15	showed	_	VERB	VBD	_	1	dep	_	_
16	no	_	DET	DT	_	18	neg	_	_
17	meaningful	_	ADJ	JJ	_	18	amod	_	_
18	difference	_	NOUN	NN	_	15	dobj	_	_

#	Apixaban	1288
1	Race	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	The	_	DET	DT	_	4	det	_	_
4	results	_	NOUN	NNS	_	11	nsubj	_	_
5	across	_	ADP	IN	_	7	case	_	_
6	pharmacokinetic	_	ADJ	JJ	_	7	amod	_	_
7	studies	_	NOUN	NNS	_	4	nmod	_	_
8	in	_	ADP	IN	_	10	case	_	_
9	normal	_	ADJ	JJ	_	10	amod	_	_
10	subjects	_	NOUN	NNS	_	7	nmod	_	_
11	showed	_	VERB	VBD	_	1	dep	_	_
12	no	_	DET	DT	_	13	neg	_	_
13	differences	_	NOUN	NNS	_	11	dobj	_	_
14	in	_	ADP	IN	_	16	case	_	_
15	DRUG	_	NOUN	NN	_	16	compound	_	_
16	pharmacokinetics	_	NOUN	NNS	_	13	nmod	_	_
17	among	_	ADP	IN	_	20	case	_	_
18	White	_	ADJ	JJ	_	20	amod	_	_
19	/	_	.	:	_	20	punct	_	_
20	Caucasian	_	NOUN	NN	_	13	nmod	_	_
21	,	_	.	,	_	20	punct	_	_
22	Asian	_	NOUN	NN	_	20	conj	_	_
23	,	_	.	,	_	20	punct	_	_
24	and	_	CONJ	CC	_	20	cc	_	_
25	Black	_	NOUN	NN	_	20	conj	_	_
26	/	_	.	:	_	20	punct	_	_
27	African	_	NOUN	NN	_	29	compound	_	_
28	American	_	NOUN	NN	_	29	compound	_	_
29	subjects	_	NOUN	NNS	_	20	dep	_	_

#	Apixaban	1289
1	No	_	DET	DT	_	3	neg	_	_
2	dose	_	NOUN	NN	_	3	compound	_	_
3	adjustment	_	NOUN	NN	_	5	nsubjpass	_	_
4	is	_	VERB	VBZ	_	5	auxpass	_	_
5	required	_	VERB	VBN	_	0	root	_	_
6	based	_	VERB	VBN	_	5	xcomp	_	_
7	on	_	ADP	IN	_	10	case	_	_
8	race	_	ADJ	JJ	_	10	amod	_	_
9	/	_	.	.	_	10	punct	_	_
10	ethnicity	_	NOUN	NN	_	6	nmod	_	_

#	Apixaban	1290
1	Hemodialysis	_	NOUN	NN	_	0	root	_	_
2	in	_	ADP	IN	_	4	case	_	_
3	ESRD	_	NOUN	NN	_	4	compound	_	_
4	subjects	_	NOUN	NNS	_	1	nmod	_	_
5	:	_	.	:	_	1	punct	_	_
6	Systemic	_	ADJ	JJ	_	7	amod	_	_
7	exposure	_	NOUN	NN	_	20	nsubj	_	_
8	to	_	PRT	TO	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	administered	_	VERB	VBN	_	9	acl	_	_
11	as	_	ADP	IN	_	16	case	_	_
12	a	_	DET	DT	_	16	det	_	_
13	single	_	ADJ	JJ	_	16	amod	_	_
14	5	_	NUM	CD	_	16	nummod	_	_
15	mg	_	NOUN	NN	_	16	compound	_	_
16	dose	_	NOUN	NN	_	10	nmod	_	_
17	in	_	ADP	IN	_	19	case	_	_
18	ESRD	_	NOUN	NN	_	19	compound	_	_
19	subjects	_	NOUN	NNS	_	16	nmod	_	_
20	dosed	_	VERB	VBD	_	1	dep	_	_
21	immediately	_	ADV	RB	_	20	advmod	_	_
22	after	_	ADP	IN	_	24	case	_	_
23	the	_	DET	DT	_	24	det	_	_
24	completion	_	NOUN	NN	_	20	nmod	_	_
25	of	_	ADP	IN	_	32	case	_	_
26	a	_	DET	DT	_	32	det	_	_
27	4	_	NUM	CD	_	32	nummod	_	_
28	hour	_	NUM	CD	_	32	nummod	_	_
29	hemodialysis	_	NOUN	NN	_	32	compound	_	_
30	session	_	NOUN	NN	_	32	compound	_	_
31	post	_	ADJ	JJ	_	32	amod	_	_
32	dialysis	_	NOUN	NN	_	24	nmod	_	_
33	is	_	VERB	VBZ	_	35	cop	_	_
34	36%	_	ADJ	JJ	_	35	advmod	_	_
35	higher	_	ADJ	JJ	_	20	parataxis	_	_
36	when	_	ADV	WRB	_	37	advmod	_	_
37	compared	_	VERB	VBN	_	35	advcl	_	_
38	to	_	PRT	TO	_	39	case	_	_
39	subjects	_	NOUN	NNS	_	37	nmod	_	_
40	with	_	ADP	IN	_	43	case	_	_
41	normal	_	ADJ	JJ	_	43	amod	_	_
42	renal	_	ADJ	JJ	_	43	amod	_	_
43	function	_	NOUN	NN	_	39	nmod	_	_

#	Apixaban	1291
1	The	_	DET	DT	_	3	det	_	_
2	systemic	_	ADJ	JJ	_	3	amod	_	_
3	exposure	_	NOUN	NN	_	6	nsubj	_	_
4	to	_	PRT	TO	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	administered	_	VERB	VBD	_	0	root	_	_
7	2	_	NUM	CD	_	8	nummod	_	_
8	hours	_	NOUN	NNS	_	6	dobj	_	_
9	prior	_	ADJ	JJ	_	15	case	_	_
10	to	_	PRT	TO	_	9	mwe	_	_
11	a	_	DET	DT	_	15	det	_	_
12	4	_	NUM	CD	_	15	nummod	_	_
13	hour	_	NUM	CD	_	15	nummod	_	_
14	hemodialysis	_	NOUN	NN	_	15	compound	_	_
15	session	_	NOUN	NN	_	8	nmod	_	_
16	with	_	ADP	IN	_	20	case	_	_
17	a	_	DET	DT	_	20	det	_	_
18	dialysate	_	ADJ	JJ	_	20	amod	_	_
19	flow	_	NOUN	NN	_	20	compound	_	_
20	rate	_	NOUN	NN	_	15	nmod	_	_
21	of	_	ADP	IN	_	23	case	_	_
22	500	_	NUM	CD	_	23	nummod	_	_
23	mL	_	NOUN	NN	_	20	nmod	_	_
24	/	_	.	:	_	6	punct	_	_
25	min	_	NOUN	NN	_	6	parataxis	_	_
26	and	_	CONJ	CC	_	25	cc	_	_
27	a	_	DET	DT	_	30	det	_	_
28	blood	_	NOUN	NN	_	30	compound	_	_
29	flow	_	NOUN	NN	_	30	compound	_	_
30	rate	_	NOUN	NN	_	25	conj	_	_
31	in	_	ADP	IN	_	33	case	_	_
32	the	_	DET	DT	_	33	det	_	_
33	range	_	NOUN	NN	_	25	nmod	_	_
34	of	_	ADP	IN	_	38	case	_	_
35	350	_	NUM	CD	_	37	compound	_	_
36	to	_	PRT	TO	_	37	dep	_	_
37	500	_	NUM	CD	_	38	nummod	_	_
38	mL	_	NOUN	NN	_	33	nmod	_	_
39	/	_	.	:	_	25	punct	_	_
40	min	_	NOUN	NN	_	43	nsubj	_	_
41	is	_	VERB	VBZ	_	43	cop	_	_
42	17%	_	ADJ	JJ	_	43	amod	_	_
43	higher	_	ADJ	JJ	_	25	dep	_	_
44	compared	_	VERB	VBN	_	43	acl	_	_
45	to	_	PRT	TO	_	46	case	_	_
46	those	_	DET	DT	_	44	nmod	_	_
47	with	_	ADP	IN	_	50	case	_	_
48	normal	_	ADJ	JJ	_	50	amod	_	_
49	renal	_	ADJ	JJ	_	50	amod	_	_
50	function	_	NOUN	NN	_	46	nmod	_	_

#	Apixaban	1292
1	The	_	DET	DT	_	3	det	_	_
2	dialysis	_	NOUN	NN	_	3	compound	_	_
3	clearance	_	NOUN	NN	_	9	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	is	_	VERB	VBZ	_	9	cop	_	_
7	approximately	_	ADV	RB	_	9	advmod	_	_
8	18	_	NUM	CD	_	9	nummod	_	_
9	mL	_	NOUN	NN	_	0	root	_	_
10	/	_	.	:	_	9	punct	_	_
11	min	_	NOUN	NN	_	9	dep	_	_

#	Apixaban	1293
1	The	_	DET	DT	_	3	det	_	_
2	systemic	_	ADJ	JJ	_	3	amod	_	_
3	exposure	_	NOUN	NN	_	8	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	is	_	VERB	VBZ	_	8	cop	_	_
7	14%	_	ADJ	JJ	_	8	advmod	_	_
8	lower	_	ADJ	JJ	_	0	root	_	_
9	on	_	ADP	IN	_	10	case	_	_
10	dialysis	_	NOUN	NN	_	8	nmod	_	_
11	when	_	ADV	WRB	_	12	advmod	_	_
12	compared	_	VERB	VBN	_	8	advcl	_	_
13	to	_	PRT	TO	_	16	case	_	_
14	not	_	ADV	RB	_	16	neg	_	_
15	on	_	ADP	IN	_	16	case	_	_
16	dialysis	_	NOUN	NN	_	12	nmod	_	_

#	Apixaban	1294
1	Protein	_	NOUN	NN	_	2	compound	_	_
2	binding	_	NOUN	NN	_	6	nsubj	_	_
3	was	_	VERB	VBD	_	6	cop	_	_
4	similar	_	ADJ	JJ	_	6	amod	_	_
5	92%	_	ADJ	JJ	_	6	amod	_	_
6	94%	_	NOUN	NN	_	0	root	_	_
7	between	_	ADP	IN	_	9	case	_	_
8	healthy	_	ADJ	JJ	_	9	amod	_	_
9	controls	_	NOUN	NNS	_	6	nmod	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	ESRD	_	NOUN	NN	_	12	compound	_	_
12	subjects	_	NOUN	NNS	_	9	conj	_	_
13	during	_	ADP	IN	_	16	case	_	_
14	the	_	DET	DT	_	16	dep	_	_
15	on	_	ADP	IN	_	16	case	_	_
16	dialysis	_	NOUN	NN	_	6	nmod	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	off	_	NUM	CD	_	20	nummod	_	_
19	dialysis	_	NOUN	NN	_	20	compound	_	_
20	periods	_	NOUN	NNS	_	16	conj	_	_

#	Apixaban	1295
1	O:\E	_	NOUN	NN	_	2	compound	_	_
2	Submissions\PBO\PRODUCTS\Eliquis	_	NOUN	NNS	_	0	root	_	_
3	202155\08	_	NUM	CD	_	2	nummod	_	_

#	Apixaban	1296
1	Orig	_	NOUN	NN	_	2	compound	_	_
2	Submission\Source\eliquis	_	NOUN	NNS	_	0	root	_	_
3	pkplot	_	ADJ	JJ	_	2	acl	_	_
4	pop	_	NOUN	NN	_	5	compound	_	_
5	fig3.jpg	_	NOUN	NN	_	3	dobj	_	_

#	Aubagio	3148
1	Drugs	_	NOUN	NNS	_	0	root	_	_
2	metabolized	_	VERB	VBN	_	1	acl	_	_
3	by	_	ADP	IN	_	4	case	_	_
4	CYP2C8	_	NOUN	NN	_	2	nmod	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	OAT3	_	NOUN	NN	_	4	conj	_	_
7	transporters	_	NOUN	NNS	_	4	dep	_	_
8	:	_	.	:	_	1	punct	_	_
9	Monitor	_	NOUN	NN	_	10	compound	_	_
10	patients	_	NOUN	NNS	_	22	nsubj	_	_
11	because	_	ADP	IN	_	14	mark	_	_
12	DRUG	_	NOUN	NN	_	14	nsubj	_	_
13	may	_	VERB	MD	_	14	aux	_	_
14	increase	_	VERB	VB	_	10	acl:relcl	_	_
15	exposure	_	NOUN	NN	_	14	dobj	_	_
16	of	_	ADP	IN	_	18	case	_	_
17	these	_	DET	DT	_	18	det	_	_
18	drugs	_	NOUN	NNS	_	15	nmod	_	_
19	7	_	NUM	CD	_	20	nummod	_	_
20	DRUG	_	NOUN	NN	_	18	dep	_	_
21	may	_	VERB	MD	_	22	aux	_	_
22	increase	_	VERB	VB	_	1	dep	_	_
23	exposure	_	NOUN	NN	_	22	dobj	_	_
24	of	_	ADP	IN	_	25	case	_	_
25	ethinylestradiol	_	NOUN	NN	_	23	nmod	_	_
26	and	_	CONJ	CC	_	25	cc	_	_
27	levonorgestrel	_	NOUN	NN	_	25	conj	_	_

#	Aubagio	3149
1	Choose	_	ADP	IN	_	0	root	_	_
2	an	_	DET	DT	_	7	det	_	_
3	appropriate	_	ADJ	JJ	_	7	amod	_	_
4	oral	_	ADJ	JJ	_	7	amod	_	_
5	contraceptive	_	ADJ	JJ	_	7	amod	_	_
6	7	_	NUM	CD	_	7	nummod	_	_
7	Drugs	_	NOUN	NNS	_	1	dobj	_	_
8	metabolized	_	VERB	VBN	_	7	acl	_	_
9	by	_	ADP	IN	_	10	case	_	_
10	CYP1A2	_	NOUN	NN	_	8	nmod	_	_
11	:	_	.	:	_	1	punct	_	_
12	Monitor	_	NOUN	NN	_	13	compound	_	_
13	patients	_	NOUN	NNS	_	11	root	_	_
14	because	_	ADP	IN	_	17	mark	_	_
15	DRUG	_	NOUN	NN	_	17	nsubj	_	_
16	may	_	VERB	MD	_	17	aux	_	_
17	decrease	_	VERB	VB	_	13	acl:relcl	_	_
18	exposure	_	NOUN	NN	_	17	dobj	_	_
19	of	_	ADP	IN	_	21	case	_	_
20	these	_	DET	DT	_	21	det	_	_
21	drugs	_	NOUN	NNS	_	18	nmod	_	_
22	7	_	NUM	CD	_	23	nummod	_	_
23	Warfarin	_	NOUN	NN	_	21	dep	_	_
24	:	_	.	:	_	13	punct	_	_
25	Monitor	_	NOUN	NN	_	26	compound	_	_
26	INR	_	NOUN	NN	_	30	nsubj	_	_
27	as	_	ADP	IN	_	28	case	_	_
28	DRUG	_	NOUN	NN	_	26	nmod	_	_
29	may	_	VERB	MD	_	30	aux	_	_
30	decrease	_	VERB	VB	_	13	dep	_	_
31	INR	_	NOUN	NN	_	33	compound	_	_
32	7	_	NUM	CD	_	33	nummod	_	_
33	Drugs	_	NOUN	NNS	_	30	dobj	_	_
34	metabolized	_	VERB	VBN	_	33	acl	_	_
35	by	_	ADP	IN	_	36	case	_	_
36	BCRP	_	NOUN	NN	_	34	nmod	_	_
37	and	_	CONJ	CC	_	36	cc	_	_
38	OATP1B1	_	NOUN	NN	_	36	conj	_	_
39	/	_	.	:	_	33	punct	_	_
40	B3	_	NOUN	NN	_	41	compound	_	_
41	transporters	_	NOUN	NNS	_	33	dep	_	_
42	:	_	.	:	_	13	punct	_	_
43	Monitor	_	NOUN	NN	_	44	compound	_	_
44	patients	_	NOUN	NNS	_	13	dep	_	_
45	because	_	ADP	IN	_	48	mark	_	_
46	DRUG	_	NOUN	NN	_	48	nsubj	_	_
47	may	_	VERB	MD	_	48	aux	_	_
48	increase	_	VERB	VB	_	44	acl:relcl	_	_
49	exposure	_	NOUN	NN	_	48	dobj	_	_
50	of	_	ADP	IN	_	52	case	_	_
51	these	_	DET	DT	_	52	det	_	_
52	drugs	_	NOUN	NNS	_	49	nmod	_	_
53	7	_	NUM	CD	_	54	nummod	_	_
54	Rosuvastatin	_	NOUN	NN	_	52	dep	_	_
55	:	_	.	:	_	13	punct	_	_
56	The	_	DET	DT	_	57	det	_	_
57	dose	_	NOUN	NN	_	62	nsubj	_	_
58	of	_	ADP	IN	_	59	case	_	_
59	rosuvastatin	_	NOUN	NN	_	57	nmod	_	_
60	should	_	VERB	MD	_	62	aux	_	_
61	not	_	ADV	RB	_	62	neg	_	_
62	exceed	_	VERB	VBN	_	13	dep	_	_
63	10	_	NUM	CD	_	64	nummod	_	_
64	mg	_	NOUN	NN	_	62	dobj	_	_
65	once	_	ADV	RB	_	66	advmod	_	_
66	daily	_	ADV	RB	_	81	advmod	_	_
67	in	_	ADP	IN	_	68	case	_	_
68	patients	_	NOUN	NNS	_	66	nmod	_	_
69	taking	_	VERB	VBG	_	68	acl	_	_
70	DRUG	_	NOUN	NN	_	72	compound	_	_
71	7	_	NUM	CD	_	72	nummod	_	_
72	Effect	_	NOUN	NN	_	69	dobj	_	_
73	of	_	ADP	IN	_	74	case	_	_
74	DRUG	_	NOUN	NN	_	72	nmod	_	_
75	on	_	ADP	IN	_	77	case	_	_
76	CYP2C8	_	NOUN	NN	_	77	compound	_	_
77	substrates	_	NOUN	NNS	_	72	nmod	_	_
78	DRUG	_	NOUN	NN	_	77	dep	_	_
79	is	_	VERB	VBZ	_	81	cop	_	_
80	an	_	DET	DT	_	81	det	_	_
81	inhibitor	_	NOUN	NN	_	62	xcomp	_	_
82	of	_	ADP	IN	_	83	case	_	_
83	CYP2C8	_	NOUN	NN	_	81	nmod	_	_
84	in	_	X	FW	_	85	compound	_	_
85	vivo	_	X	FW	_	81	advmod	_	_

#	Aubagio	3150
1	In	_	ADP	IN	_	2	case	_	_
2	patients	_	NOUN	NNS	_	23	nmod	_	_
3	taking	_	VERB	VBG	_	2	acl	_	_
4	DRUG	_	NOUN	NN	_	3	dobj	_	_
5	,	_	.	,	_	23	punct	_	_
6	exposure	_	NOUN	NN	_	23	nsubjpass	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	drugs	_	NOUN	NNS	_	6	nmod	_	_
9	metabolized	_	VERB	VBN	_	8	acl	_	_
10	by	_	ADP	IN	_	12	case	_	_
11	CYP2C8	_	NOUN	NN	_	12	compound	_	_
12	e.g	_	NOUN	NN	_	9	nmod	_	_
13	,	_	.	,	_	12	punct	_	_
14	paclitaxel	_	NOUN	NN	_	12	conj	_	_
15	,	_	.	,	_	12	punct	_	_
16	pioglitazone	_	NOUN	NN	_	12	conj	_	_
17	,	_	.	,	_	12	punct	_	_
18	repaglinide	_	NOUN	NN	_	12	appos	_	_
19	,	_	.	,	_	12	punct	_	_
20	rosiglitazone	_	NOUN	NN	_	12	appos	_	_
21	may	_	VERB	MD	_	23	aux	_	_
22	be	_	VERB	VB	_	23	auxpass	_	_
23	increased	_	VERB	VBN	_	0	root	_	_

#	Aubagio	3151
1	Monitor	_	VERB	VB	_	0	root	_	_
2	these	_	DET	DT	_	3	det	_	_
3	patients	_	NOUN	NNS	_	1	dobj	_	_
4	and	_	CONJ	CC	_	1	cc	_	_
5	adjust	_	ADV	RB	_	1	conj	_	_
6	the	_	DET	DT	_	7	det	_	_
7	dose	_	NOUN	NN	_	5	dobj	_	_
8	of	_	ADP	IN	_	11	case	_	_
9	the	_	DET	DT	_	11	det	_	_
10	concomitant	_	ADJ	JJ	_	11	amod	_	_
11	drug(s	_	NOUN	NNS	_	7	nmod	_	_
12	metabolized	_	VERB	VBN	_	11	acl	_	_
13	by	_	ADP	IN	_	14	case	_	_
14	CYP2C8	_	NOUN	NN	_	12	nmod	_	_
15	as	_	ADP	IN	_	16	mark	_	_
16	required	_	VERB	VBN	_	5	advcl	_	_

#	Aubagio	3152
1	Effect	_	NOUN	NN	_	11	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	on	_	ADP	IN	_	6	case	_	_
5	warfarin	_	NOUN	NN	_	6	compound	_	_
6	Coadministration	_	NOUN	NN	_	1	nmod	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	with	_	ADP	IN	_	10	case	_	_
10	warfarin	_	NOUN	NN	_	1	nmod	_	_
11	requires	_	VERB	VBZ	_	0	root	_	_
12	close	_	ADJ	JJ	_	13	amod	_	_
13	monitoring	_	NOUN	NN	_	11	dobj	_	_
14	of	_	ADP	IN	_	19	case	_	_
15	the	_	DET	DT	_	19	det	_	_
16	international	_	ADJ	JJ	_	19	amod	_	_
17	normalized	_	ADJ	JJ	_	19	amod	_	_
18	ratio	_	NOUN	NN	_	19	compound	_	_
19	INR	_	NOUN	NN	_	13	nmod	_	_
20	because	_	ADP	IN	_	23	mark	_	_
21	DRUG	_	NOUN	NN	_	23	nsubj	_	_
22	may	_	VERB	MD	_	23	aux	_	_
23	decrease	_	VERB	VB	_	11	advcl	_	_
24	peak	_	ADJ	JJ	_	25	amod	_	_
25	INR	_	NOUN	NN	_	23	dobj	_	_
26	by	_	ADP	IN	_	28	case	_	_
27	approximately	_	ADV	RB	_	28	advmod	_	_
28	25%	_	ADJ	JJ	_	23	nmod	_	_

#	Aubagio	3153
1	Effect	_	NOUN	NN	_	9	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	on	_	ADP	IN	_	6	case	_	_
5	oral	_	ADJ	JJ	_	6	amod	_	_
6	contraceptives	_	NOUN	NNS	_	1	nmod	_	_
7	DRUG	_	NOUN	NN	_	6	dep	_	_
8	may	_	VERB	MD	_	9	aux	_	_
9	increase	_	VERB	VB	_	0	root	_	_
10	the	_	DET	DT	_	12	det	_	_
11	systemic	_	ADJ	JJ	_	12	amod	_	_
12	exposures	_	NOUN	NNS	_	9	dobj	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	ethinylestradiol	_	NOUN	NN	_	12	nmod	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	levonorgestrel	_	NOUN	NN	_	14	conj	_	_

#	Aubagio	3154
1	Consideration	_	NOUN	NN	_	4	nsubjpass	_	_
2	should	_	VERB	MD	_	4	aux	_	_
3	be	_	VERB	VB	_	4	auxpass	_	_
4	given	_	VERB	VBN	_	0	root	_	_
5	to	_	PRT	TO	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	type	_	NOUN	NN	_	4	nmod	_	_
8	or	_	CONJ	CC	_	7	cc	_	_
9	dose	_	NOUN	NN	_	7	conj	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	contraceptives	_	NOUN	NNS	_	7	nmod	_	_
12	used	_	VERB	VBN	_	11	acl	_	_
13	in	_	ADP	IN	_	14	case	_	_
14	combination	_	NOUN	NN	_	12	nmod	_	_
15	with	_	ADP	IN	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	14	nmod	_	_

#	Aubagio	3155
1	Effect	_	NOUN	NN	_	12	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	on	_	ADP	IN	_	6	case	_	_
5	CYP1A2	_	NOUN	NN	_	6	compound	_	_
6	substrates	_	NOUN	NNS	_	1	nmod	_	_
7	DRUG	_	NOUN	NN	_	6	dep	_	_
8	may	_	VERB	MD	_	12	aux	_	_
9	be	_	VERB	VB	_	12	cop	_	_
10	a	_	DET	DT	_	12	det	_	_
11	weak	_	ADJ	JJ	_	12	amod	_	_
12	inducer	_	NOUN	NN	_	0	root	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	CYP1A2	_	NOUN	NN	_	12	nmod	_	_
15	in	_	X	FW	_	16	compound	_	_
16	vivo	_	X	FW	_	14	advmod	_	_

#	Aubagio	3156
1	In	_	ADP	IN	_	2	case	_	_
2	patients	_	NOUN	NNS	_	23	nmod	_	_
3	taking	_	VERB	VBG	_	2	acl	_	_
4	DRUG	_	NOUN	NN	_	3	dobj	_	_
5	,	_	.	,	_	23	punct	_	_
6	exposure	_	NOUN	NN	_	23	nsubjpass	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	drugs	_	NOUN	NNS	_	6	nmod	_	_
9	metabolized	_	VERB	VBN	_	8	acl	_	_
10	by	_	ADP	IN	_	12	case	_	_
11	CYP1A2	_	NOUN	NN	_	12	compound	_	_
12	e.g	_	NOUN	NN	_	9	nmod	_	_
13	,	_	.	,	_	12	punct	_	_
14	alosetron	_	NOUN	NN	_	12	conj	_	_
15	,	_	.	,	_	12	punct	_	_
16	duloxetine	_	NOUN	NN	_	12	conj	_	_
17	,	_	.	,	_	12	punct	_	_
18	theophylline	_	NOUN	NN	_	12	appos	_	_
19	,	_	.	,	_	12	punct	_	_
20	tizanidine	_	NOUN	NN	_	12	appos	_	_
21	may	_	VERB	MD	_	23	aux	_	_
22	be	_	VERB	VB	_	23	auxpass	_	_
23	reduced	_	VERB	VBN	_	0	root	_	_

#	Aubagio	3157
1	Monitor	_	VERB	VB	_	0	root	_	_
2	these	_	DET	DT	_	3	det	_	_
3	patients	_	NOUN	NNS	_	1	dobj	_	_
4	and	_	CONJ	CC	_	1	cc	_	_
5	adjust	_	ADV	RB	_	1	conj	_	_
6	the	_	DET	DT	_	7	det	_	_
7	dose	_	NOUN	NN	_	5	dobj	_	_
8	of	_	ADP	IN	_	11	case	_	_
9	the	_	DET	DT	_	11	det	_	_
10	concomitant	_	ADJ	JJ	_	11	amod	_	_
11	drug(s	_	NOUN	NNS	_	7	nmod	_	_
12	metabolized	_	VERB	VBN	_	11	acl	_	_
13	by	_	ADP	IN	_	14	case	_	_
14	CYP1A2	_	NOUN	NN	_	12	nmod	_	_
15	as	_	ADP	IN	_	16	mark	_	_
16	required	_	VERB	VBN	_	5	advcl	_	_

#	Aubagio	3158
1	Effect	_	NOUN	NN	_	12	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	on	_	ADP	IN	_	10	case	_	_
5	organic	_	ADJ	JJ	_	10	amod	_	_
6	anion	_	NOUN	NN	_	10	compound	_	_
7	transporter	_	NOUN	NN	_	10	compound	_	_
8	3	_	NUM	CD	_	10	nummod	_	_
9	OAT3	_	NOUN	NN	_	10	compound	_	_
10	substrates	_	NOUN	NNS	_	1	nmod	_	_
11	DRUG	_	NOUN	NN	_	10	dep	_	_
12	inhibits	_	VERB	VBZ	_	0	root	_	_
13	the	_	DET	DT	_	14	det	_	_
14	activity	_	NOUN	NN	_	12	dobj	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	OAT3	_	NOUN	NN	_	14	nmod	_	_
17	in	_	NOUN	NN	_	18	compound	_	_
18	vivo	_	X	FW	_	14	advmod	_	_

#	Aubagio	3159
1	In	_	ADP	IN	_	2	case	_	_
2	patients	_	NOUN	NNS	_	0	root	_	_
3	taking	_	VERB	VBG	_	2	acl	_	_
4	DRUG	_	NOUN	NN	_	3	dobj	_	_
5	,	_	.	,	_	2	punct	_	_
6	exposure	_	NOUN	NN	_	5	root	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	drugs	_	NOUN	NNS	_	6	nmod	_	_
9	which	_	DET	WDT	_	12	nsubj	_	_
10	are	_	VERB	VBP	_	12	cop	_	_
11	OAT3	_	NOUN	NN	_	12	compound	_	_
12	substrates	_	NOUN	NNS	_	8	acl:relcl	_	_
13	e.g	_	NOUN	NN	_	33	nsubjpass	_	_
14	,	_	.	,	_	13	punct	_	_
15	cefaclor	_	NOUN	NN	_	13	conj	_	_
16	,	_	.	,	_	13	punct	_	_
17	cimetidine	_	NOUN	NN	_	13	conj	_	_
18	,	_	.	,	_	13	punct	_	_
19	ciprofloxacin	_	NOUN	NN	_	13	conj	_	_
20	,	_	.	,	_	13	punct	_	_
21	penicillin	_	NOUN	NN	_	22	compound	_	_
22	DRUGS	_	NOUN	NN	_	13	conj	_	_
23	,	_	.	,	_	13	punct	_	_
24	ketoprofen	_	NOUN	NN	_	13	conj	_	_
25	,	_	.	,	_	13	punct	_	_
26	furosemide	_	NOUN	NN	_	13	conj	_	_
27	,	_	.	,	_	13	punct	_	_
28	methotrexate	_	NOUN	NN	_	13	appos	_	_
29	,	_	.	,	_	13	punct	_	_
30	zidovudine	_	NOUN	NN	_	13	appos	_	_
31	may	_	VERB	MD	_	33	aux	_	_
32	be	_	VERB	VB	_	33	auxpass	_	_
33	increased	_	VERB	VBN	_	12	root	_	_

#	Aubagio	3160
1	Monitor	_	VERB	VB	_	0	root	_	_
2	these	_	DET	DT	_	3	det	_	_
3	patients	_	NOUN	NNS	_	1	dobj	_	_
4	and	_	CONJ	CC	_	1	cc	_	_
5	adjust	_	VERB	VBP	_	1	conj	_	_
6	the	_	DET	DT	_	7	det	_	_
7	dose	_	NOUN	NN	_	5	dobj	_	_
8	of	_	ADP	IN	_	11	case	_	_
9	the	_	DET	DT	_	11	det	_	_
10	concomitant	_	ADJ	JJ	_	11	amod	_	_
11	drug(s	_	NOUN	NNS	_	7	nmod	_	_
12	which	_	DET	WDT	_	15	nsubj	_	_
13	are	_	VERB	VBP	_	15	cop	_	_
14	OAT3	_	NOUN	NN	_	15	compound	_	_
15	substrates	_	NOUN	NNS	_	11	acl:relcl	_	_
16	as	_	ADP	IN	_	17	mark	_	_
17	required	_	VERB	VBN	_	15	acl:relcl	_	_

#	Aubagio	3161
1	Effect	_	NOUN	NN	_	0	root	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	on	_	ADP	IN	_	5	case	_	_
5	BCRP	_	NOUN	NN	_	1	nmod	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	organic	_	ADJ	JJ	_	8	amod	_	_
8	anion	_	NOUN	NN	_	5	conj	_	_
9	transporting	_	VERB	VBG	_	8	acl	_	_
10	polypeptide	_	NOUN	NN	_	11	compound	_	_
11	B1	_	NOUN	NN	_	9	dobj	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	B3	_	NOUN	NN	_	14	compound	_	_
14	OATP1B1	_	NOUN	NN	_	11	conj	_	_
15	/	_	.	:	_	1	punct	_	_
16	1B3	_	NOUN	NN	_	17	compound	_	_
17	substrates	_	NOUN	NNS	_	19	nsubj	_	_
18	DRUG	_	NOUN	NN	_	17	dep	_	_
19	inhibits	_	VERB	VBZ	_	1	dep	_	_
20	the	_	DET	DT	_	21	det	_	_
21	activity	_	NOUN	NN	_	19	dobj	_	_
22	of	_	ADP	IN	_	23	case	_	_
23	BCRP	_	NOUN	NN	_	21	nmod	_	_
24	and	_	CONJ	CC	_	23	cc	_	_
25	OATP1B1	_	NOUN	NN	_	23	conj	_	_
26	/	_	.	:	_	27	punct	_	_
27	1B3	_	NOUN	NN	_	21	nmod	_	_
28	in	_	X	FW	_	29	compound	_	_
29	vivo	_	X	FW	_	27	dep	_	_

#	Aubagio	3162
1	For	_	ADP	IN	_	3	case	_	_
2	a	_	DET	DT	_	3	det	_	_
3	patient	_	NOUN	NN	_	13	nmod	_	_
4	taking	_	VERB	VBG	_	3	acl	_	_
5	DRUG	_	NOUN	NN	_	4	dobj	_	_
6	,	_	.	,	_	13	punct	_	_
7	the	_	DET	DT	_	8	det	_	_
8	dose	_	NOUN	NN	_	13	nsubj	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	rosuvastatin	_	NOUN	NN	_	8	nmod	_	_
11	should	_	VERB	MD	_	13	aux	_	_
12	not	_	ADV	RB	_	13	neg	_	_
13	exceed	_	VERB	VBN	_	0	root	_	_
14	10	_	NUM	CD	_	15	nummod	_	_
15	mg	_	NOUN	NN	_	13	dobj	_	_
16	once	_	ADV	RB	_	13	advmod	_	_
17	daily	_	ADV	RB	_	16	dep	_	_

#	Aubagio	3163
1	For	_	ADP	IN	_	3	case	_	_
2	other	_	ADJ	JJ	_	3	amod	_	_
3	substrates	_	NOUN	NNS	_	0	root	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	BCRP	_	NOUN	NN	_	6	compound	_	_
6	e.g	_	NOUN	NN	_	3	nmod	_	_
7	,	_	.	,	_	6	punct	_	_
8	mitoxantrone	_	NOUN	NN	_	6	conj	_	_
9	and	_	CONJ	CC	_	6	cc	_	_
10	drugs	_	NOUN	NNS	_	6	conj	_	_
11	in	_	ADP	IN	_	15	case	_	_
12	the	_	DET	DT	_	15	det	_	_
13	OATP	_	NOUN	NN	_	15	compound	_	_
14	family	_	NOUN	NN	_	15	compound	_	_
15	e.g	_	NOUN	NN	_	3	nmod	_	_
16	,	_	.	,	_	15	punct	_	_
17	methotrexate	_	NOUN	NN	_	15	conj	_	_
18	,	_	.	,	_	15	punct	_	_
19	rifampin	_	NOUN	NN	_	15	conj	_	_
20	,	_	.	,	_	15	punct	_	_
21	especially	_	ADV	RB	_	25	advmod	_	_
22	HMG	_	NOUN	NN	_	25	compound	_	_
23	Co	_	NOUN	NN	_	25	compound	_	_
24	reductase	_	NOUN	NN	_	25	compound	_	_
25	inhibitors	_	NOUN	NNS	_	15	appos	_	_
26	e.g	_	NOUN	NN	_	25	dep	_	_
27	,	_	.	,	_	26	punct	_	_
28	atorvastatin	_	NOUN	NN	_	26	conj	_	_
29	,	_	.	,	_	26	punct	_	_
30	nateglinide	_	NOUN	NN	_	26	conj	_	_
31	,	_	.	,	_	26	punct	_	_
32	pravastatin	_	NOUN	NN	_	26	conj	_	_
33	,	_	.	,	_	26	punct	_	_
34	repaglinide	_	NOUN	NN	_	26	conj	_	_
35	,	_	.	,	_	26	punct	_	_
36	and	_	CONJ	CC	_	26	cc	_	_
37	simvastatin	_	NOUN	NN	_	26	conj	_	_
38	,	_	.	,	_	15	punct	_	_
39	consider	_	VERB	VBP	_	15	acl	_	_
40	reducing	_	VERB	VBG	_	15	acl	_	_
41	the	_	DET	DT	_	42	det	_	_
42	dose	_	NOUN	NN	_	40	dobj	_	_
43	of	_	ADP	IN	_	45	case	_	_
44	these	_	DET	DT	_	45	det	_	_
45	drugs	_	NOUN	NNS	_	42	nmod	_	_
46	and	_	CONJ	CC	_	45	cc	_	_
47	monitor	_	NOUN	NN	_	48	compound	_	_
48	patients	_	NOUN	NNS	_	45	conj	_	_
49	closely	_	ADV	RB	_	51	advmod	_	_
50	for	_	ADP	IN	_	51	case	_	_
51	signs	_	NOUN	NNS	_	40	nmod	_	_
52	and	_	CONJ	CC	_	51	cc	_	_
53	symptoms	_	NOUN	NNS	_	51	conj	_	_
54	of	_	ADP	IN	_	56	case	_	_
55	increased	_	VERB	VBN	_	56	amod	_	_
56	exposures	_	NOUN	NNS	_	51	nmod	_	_
57	to	_	PRT	TO	_	59	case	_	_
58	the	_	DET	DT	_	59	det	_	_
59	drugs	_	NOUN	NNS	_	51	nmod	_	_
60	while	_	ADP	IN	_	63	mark	_	_
61	patients	_	NOUN	NNS	_	63	nsubj	_	_
62	are	_	VERB	VBP	_	63	cop	_	_
63	taking	_	VERB	VBG	_	40	advcl	_	_
64	DRUG	_	NOUN	NN	_	63	dobj	_	_

#	Aubagio	3164
1	DRUG	_	NOUN	NN	_	11	nsubj	_	_
2	,	_	.	,	_	1	punct	_	_
3	an	_	DET	DT	_	5	det	_	_
4	immunomodulatory	_	ADJ	JJ	_	5	amod	_	_
5	agent	_	NOUN	NN	_	1	appos	_	_
6	with	_	ADP	IN	_	9	case	_	_
7	anti	_	ADJ	JJ	_	9	amod	_	_
8	inflammatory	_	ADJ	JJ	_	9	amod	_	_
9	properties	_	NOUN	NNS	_	5	nmod	_	_
10	,	_	.	,	_	1	punct	_	_
11	inhibits	_	VERB	VBZ	_	0	root	_	_
12	dihydroorotate	_	NOUN	NN	_	13	compound	_	_
13	dehydrogenase	_	NOUN	NN	_	11	dobj	_	_
14	,	_	.	,	_	13	punct	_	_
15	a	_	DET	DT	_	17	det	_	_
16	mitochondrial	_	ADJ	JJ	_	17	amod	_	_
17	enzyme	_	NOUN	NN	_	13	appos	_	_
18	involved	_	VERB	VBN	_	17	acl	_	_
19	in	_	ADP	IN	_	23	case	_	_
20	de	_	X	FW	_	23	amod	_	_
21	novo	_	X	FW	_	20	dep	_	_
22	pyrimidine	_	NOUN	NN	_	23	compound	_	_
23	synthesis	_	NOUN	NN	_	18	nmod	_	_

#	Aubagio	3165
1	The	_	DET	DT	_	3	det	_	_
2	exact	_	ADJ	JJ	_	3	amod	_	_
3	mechanism	_	NOUN	NN	_	15	nsubj	_	_
4	by	_	ADP	IN	_	5	case	_	_
5	which	_	DET	WDT	_	7	nmod	_	_
6	DRUG	_	NOUN	NN	_	7	nsubj	_	_
7	exerts	_	VERB	VBZ	_	3	acl:relcl	_	_
8	its	_	PRON	PRP$	_	10	nmod:poss	_	_
9	therapeutic	_	ADJ	JJ	_	10	amod	_	_
10	effect	_	NOUN	NN	_	7	dobj	_	_
11	in	_	ADP	IN	_	13	case	_	_
12	multiple	_	ADJ	JJ	_	13	amod	_	_
13	sclerosis	_	NOUN	NN	_	10	nmod	_	_
14	is	_	VERB	VBZ	_	15	cop	_	_
15	unknown	_	ADJ	JJ	_	0	root	_	_
16	but	_	CONJ	CC	_	15	cc	_	_
17	may	_	VERB	MD	_	18	aux	_	_
18	involve	_	VERB	VB	_	15	conj	_	_
19	a	_	DET	DT	_	20	det	_	_
20	reduction	_	NOUN	NN	_	18	dobj	_	_
21	in	_	ADP	IN	_	23	case	_	_
22	the	_	DET	DT	_	23	det	_	_
23	number	_	NOUN	NN	_	20	nmod	_	_
24	of	_	ADP	IN	_	26	case	_	_
25	activated	_	VERB	VBN	_	26	amod	_	_
26	lymphocytes	_	NOUN	NNS	_	23	nmod	_	_
27	in	_	ADP	IN	_	28	case	_	_
28	CNS	_	NOUN	NN	_	23	nmod	_	_

#	Aubagio	3166
1	Potential	_	ADJ	JJ	_	20	advmod	_	_
2	to	_	PRT	TO	_	3	mark	_	_
3	prolong	_	VERB	VB	_	1	acl	_	_
4	the	_	DET	DT	_	5	det	_	_
5	QT	_	NOUN	NN	_	3	dobj	_	_
6	interval	_	ADJ	JJ	_	5	amod	_	_
7	In	_	ADP	IN	_	9	case	_	_
8	a	_	DET	DT	_	9	det	_	_
9	placebo	_	NOUN	NN	_	6	nmod	_	_
10	controlled	_	VERB	VBN	_	9	acl	_	_
11	thorough	_	ADP	IN	_	13	case	_	_
12	QT	_	NOUN	NN	_	13	compound	_	_
13	study	_	NOUN	NN	_	10	nmod	_	_
14	performed	_	VERB	VBN	_	13	acl	_	_
15	in	_	ADP	IN	_	17	case	_	_
16	healthy	_	ADJ	JJ	_	17	amod	_	_
17	subjects	_	NOUN	NNS	_	14	nmod	_	_
18	,	_	.	,	_	20	punct	_	_
19	there	_	DET	EX	_	20	expl	_	_
20	was	_	VERB	VBD	_	0	root	_	_
21	no	_	DET	DT	_	22	neg	_	_
22	evidence	_	NOUN	NN	_	20	dobj	_	_
23	that	_	ADP	IN	_	25	mark	_	_
24	DRUG	_	NOUN	NN	_	25	nsubj	_	_
25	caused	_	VERB	VBD	_	22	ccomp	_	_
26	QT	_	NOUN	NN	_	28	compound	_	_
27	interval	_	ADJ	JJ	_	28	amod	_	_
28	prolongation	_	NOUN	NN	_	25	dobj	_	_
29	of	_	ADP	IN	_	31	case	_	_
30	clinical	_	ADJ	JJ	_	31	amod	_	_
31	significance	_	NOUN	NN	_	28	nmod	_	_
32	i.e	_	ADJ	JJ	_	25	advmod	_	_
33	,	_	.	,	_	25	punct	_	_
34	the	_	DET	DT	_	35	det	_	_
35	upper	_	NOUN	NN	_	25	dobj	_	_
36	bound	_	VERB	VBN	_	35	acl	_	_
37	of	_	ADP	IN	_	40	case	_	_
38	the	_	DET	DT	_	40	det	_	_
39	90%	_	ADJ	JJ	_	40	amod	_	_
40	confidence	_	NOUN	NN	_	36	nmod	_	_
41	interval	_	ADJ	JJ	_	40	amod	_	_
42	for	_	ADP	IN	_	45	case	_	_
43	the	_	DET	DT	_	45	det	_	_
44	largest	_	ADJ	JJ	_	45	amod	_	_
45	placebo	_	NOUN	NN	_	41	nmod	_	_
46	adjusted	_	VERB	VBN	_	45	acl	_	_
47	,	_	.	,	_	35	punct	_	_
48	baseline	_	NOUN	NN	_	50	compound	_	_
49	corrected	_	VERB	VBD	_	50	amod	_	_
50	QTc	_	NOUN	NN	_	52	nsubjpass	_	_
51	was	_	VERB	VBD	_	52	auxpass	_	_
52	below	_	VERB	VB	_	35	dep	_	_
53	10	_	NUM	CD	_	54	nummod	_	_
54	ms	_	NOUN	NNS	_	52	dobj	_	_

#	Aubagio	3167
1	DRUG	_	NOUN	NN	_	6	nsubj	_	_
2	is	_	VERB	VBZ	_	6	cop	_	_
3	the	_	DET	DT	_	6	det	_	_
4	principal	_	ADJ	JJ	_	6	amod	_	_
5	active	_	ADJ	JJ	_	6	amod	_	_
6	metabolite	_	NOUN	NN	_	0	root	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	leflunomide	_	NOUN	NN	_	6	nmod	_	_
9	and	_	CONJ	CC	_	6	cc	_	_
10	is	_	VERB	VBZ	_	11	cop	_	_
11	responsible	_	ADJ	JJ	_	6	conj	_	_
12	for	_	ADP	IN	_	14	case	_	_
13	leflunomide's	_	NOUN	NNS	_	14	compound	_	_
14	activity	_	NOUN	NN	_	11	nmod	_	_
15	in	_	X	FW	_	16	compound	_	_
16	vivo	_	X	FW	_	14	advmod	_	_

#	Aubagio	3168
1	At	_	ADP	IN	_	3	case	_	_
2	recommended	_	VERB	VBN	_	3	amod	_	_
3	doses	_	NOUN	NNS	_	8	nmod	_	_
4	,	_	.	,	_	8	punct	_	_
5	DRUG	_	NOUN	NN	_	8	nsubj	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	leflunomide	_	NOUN	NN	_	5	conj	_	_
8	result	_	VERB	VBP	_	0	root	_	_
9	in	_	ADP	IN	_	12	case	_	_
10	a	_	DET	DT	_	12	det	_	_
11	similar	_	ADJ	JJ	_	12	amod	_	_
12	range	_	NOUN	NN	_	8	nmod	_	_
13	of	_	ADP	IN	_	15	case	_	_
14	plasma	_	NOUN	NN	_	15	compound	_	_
15	concentrations	_	NOUN	NNS	_	12	nmod	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	DRUG	_	NOUN	NN	_	15	nmod	_	_

#	Aubagio	3169
1	Based	_	VERB	VBN	_	24	advcl	_	_
2	on	_	ADP	IN	_	5	case	_	_
3	a	_	DET	DT	_	5	det	_	_
4	population	_	NOUN	NN	_	5	compound	_	_
5	analysis	_	NOUN	NN	_	1	nmod	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	in	_	ADP	IN	_	10	case	_	_
9	healthy	_	ADJ	JJ	_	10	amod	_	_
10	volunteers	_	NOUN	NNS	_	5	nmod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	MS	_	NOUN	NN	_	13	compound	_	_
13	patients	_	NOUN	NNS	_	10	conj	_	_
14	,	_	.	,	_	24	punct	_	_
15	median	_	ADJ	JJ	_	24	dep	_	_
16	t1	_	NUM	CD	_	18	nummod	_	_
17	/	_	.	:	_	18	punct	_	_
18	2	_	NUM	CD	_	24	nsubj	_	_
19	was	_	VERB	VBD	_	24	cop	_	_
20	approximately	_	ADV	RB	_	21	advmod	_	_
21	18	_	NUM	CD	_	24	nummod	_	_
22	and	_	CONJ	CC	_	21	cc	_	_
23	19	_	NUM	CD	_	21	conj	_	_
24	days	_	NOUN	NNS	_	0	root	_	_
25	after	_	ADP	IN	_	27	case	_	_
26	repeated	_	ADJ	JJ	_	27	amod	_	_
27	doses	_	NOUN	NNS	_	24	nmod	_	_
28	of	_	ADP	IN	_	30	case	_	_
29	7	_	NUM	CD	_	30	nummod	_	_
30	mg	_	NOUN	NN	_	27	nmod	_	_
31	and	_	CONJ	CC	_	30	cc	_	_
32	14	_	NUM	CD	_	33	nummod	_	_
33	mg	_	NOUN	NN	_	30	conj	_	_
34	respectively	_	ADV	RB	_	24	neg	_	_

#	Aubagio	3170
1	It	_	PRON	PRP	_	2	nsubj	_	_
2	takes	_	VERB	VBZ	_	0	root	_	_
3	approximately	_	ADV	RB	_	4	advmod	_	_
4	3	_	NUM	CD	_	5	nummod	_	_
5	months	_	NOUN	NNS	_	2	dobj	_	_
6	respectively	_	ADV	RB	_	8	advmod	_	_
7	to	_	PRT	TO	_	8	mark	_	_
8	reach	_	VERB	VB	_	2	xcomp	_	_
9	steady	_	ADJ	JJ	_	11	amod	_	_
10	state	_	NOUN	NN	_	11	compound	_	_
11	concentrations	_	NOUN	NNS	_	8	dobj	_	_

#	Aubagio	3171
1	The	_	DET	DT	_	5	det	_	_
2	estimated	_	VERB	VBN	_	5	amod	_	_
3	AUC	_	NOUN	NN	_	5	compound	_	_
4	accumulation	_	NOUN	NN	_	5	compound	_	_
5	ratio	_	NOUN	NN	_	8	nsubj	_	_
6	is	_	VERB	VBZ	_	8	cop	_	_
7	approximately	_	ADV	RB	_	8	advmod	_	_
8	30	_	NUM	CD	_	30	nsubj	_	_
9	after	_	ADP	IN	_	11	case	_	_
10	repeated	_	ADJ	JJ	_	11	amod	_	_
11	doses	_	NOUN	NNS	_	8	nmod	_	_
12	of	_	ADP	IN	_	19	case	_	_
13	7	_	NUM	CD	_	19	nummod	_	_
14	or	_	CONJ	CC	_	13	cc	_	_
15	14	_	NUM	CD	_	13	conj	_	_
16	mg	_	NOUN	NN	_	19	compound	_	_
17	Absorption	_	NOUN	NN	_	19	compound	_	_
18	Median	_	ADJ	JJ	_	19	amod	_	_
19	time	_	NOUN	NN	_	11	nmod	_	_
20	to	_	PRT	TO	_	21	mark	_	_
21	reach	_	VERB	VB	_	11	acl	_	_
22	maximum	_	NOUN	NN	_	24	compound	_	_
23	plasma	_	NOUN	NN	_	24	compound	_	_
24	concentrations	_	NOUN	NNS	_	21	dobj	_	_
25	is	_	VERB	VBZ	_	30	cop	_	_
26	between	_	ADP	IN	_	30	case	_	_
27	1	_	NUM	CD	_	29	compound	_	_
28	to	_	PRT	TO	_	29	dep	_	_
29	4	_	NUM	CD	_	30	nummod	_	_
30	hours	_	NOUN	NNS	_	0	root	_	_
31	post	_	ADJ	JJ	_	32	amod	_	_
32	dose	_	NOUN	NN	_	30	dep	_	_
33	following	_	VERB	VBG	_	35	case	_	_
34	oral	_	ADJ	JJ	_	35	amod	_	_
35	administration	_	NOUN	NN	_	32	nmod	_	_
36	of	_	ADP	IN	_	37	case	_	_
37	DRUG	_	NOUN	NN	_	35	nmod	_	_

#	Aubagio	3172
1	Food	_	NOUN	NN	_	4	nsubj	_	_
2	does	_	VERB	VBZ	_	4	aux	_	_
3	not	_	ADV	RB	_	4	neg	_	_
4	have	_	VERB	VB	_	0	root	_	_
5	a	_	DET	DT	_	8	det	_	_
6	clinically	_	ADV	RB	_	7	advmod	_	_
7	relevant	_	ADJ	JJ	_	8	amod	_	_
8	effect	_	NOUN	NN	_	4	dobj	_	_
9	on	_	ADP	IN	_	11	case	_	_
10	DRUG	_	NOUN	NN	_	11	compound	_	_
11	pharmacokinetics	_	NOUN	NNS	_	8	nmod	_	_

#	Aubagio	3173
1	Distribution	_	NOUN	NN	_	2	compound	_	_
2	DRUG	_	NOUN	NN	_	5	nsubjpass	_	_
3	is	_	VERB	VBZ	_	5	auxpass	_	_
4	extensively	_	ADV	RB	_	5	advmod	_	_
5	bound	_	VERB	VBN	_	0	root	_	_
6	to	_	PRT	TO	_	9	case	_	_
7	plasma	_	NOUN	NN	_	9	compound	_	_
8	protein	_	NOUN	NN	_	9	compound	_	_
9	>99%	_	NOUN	NN	_	5	nmod	_	_
10	and	_	CONJ	CC	_	5	cc	_	_
11	is	_	VERB	VBZ	_	13	auxpass	_	_
12	mainly	_	ADV	RB	_	13	advmod	_	_
13	distributed	_	VERB	VBN	_	5	conj	_	_
14	in	_	ADP	IN	_	15	case	_	_
15	plasma	_	NOUN	NN	_	13	nmod	_	_

#	Aubagio	3174
1	The	_	DET	DT	_	2	det	_	_
2	volume	_	NOUN	NN	_	7	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	distribution	_	NOUN	NN	_	2	nmod	_	_
5	is	_	VERB	VBZ	_	7	cop	_	_
6	11	_	NUM	CD	_	7	nummod	_	_
7	L	_	NOUN	NN	_	0	root	_	_
8	after	_	ADP	IN	_	13	case	_	_
9	a	_	DET	DT	_	13	det	_	_
10	single	_	ADJ	JJ	_	13	amod	_	_
11	intravenous	_	ADJ	JJ	_	13	amod	_	_
12	IV	_	NOUN	NN	_	13	compound	_	_
13	administration	_	NOUN	NN	_	7	nmod	_	_

#	Aubagio	3175
1	Metabolism	_	NOUN	NN	_	2	compound	_	_
2	DRUG	_	NOUN	NN	_	7	nsubj	_	_
3	is	_	VERB	VBZ	_	7	cop	_	_
4	the	_	DET	DT	_	7	det	_	_
5	major	_	ADJ	JJ	_	7	amod	_	_
6	circulating	_	ADJ	JJ	_	7	amod	_	_
7	moiety	_	NOUN	NN	_	0	root	_	_
8	detected	_	VERB	VBN	_	7	acl	_	_
9	in	_	ADP	IN	_	10	case	_	_
10	plasma	_	NOUN	NN	_	8	nmod	_	_

#	Aubagio	3176
1	The	_	DET	DT	_	4	det	_	_
2	primary	_	ADJ	JJ	_	4	amod	_	_
3	biotransformation	_	NOUN	NN	_	4	compound	_	_
4	pathway	_	NOUN	NN	_	11	nsubj	_	_
5	to	_	PRT	TO	_	7	case	_	_
6	minor	_	ADJ	JJ	_	7	amod	_	_
7	metabolites	_	NOUN	NNS	_	4	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	is	_	VERB	VBZ	_	11	cop	_	_
11	hydrolysis	_	NOUN	NN	_	0	root	_	_
12	,	_	.	,	_	11	punct	_	_
13	with	_	ADP	IN	_	14	case	_	_
14	oxidation	_	NOUN	NN	_	18	nsubj	_	_
15	being	_	VERB	VBD	_	18	cop	_	_
16	a	_	DET	DT	_	18	det	_	_
17	minor	_	ADJ	JJ	_	18	amod	_	_
18	pathway	_	NOUN	NN	_	11	advcl	_	_

#	Aubagio	3177
1	Secondary	_	ADJ	JJ	_	2	amod	_	_
2	pathways	_	NOUN	NNS	_	3	nsubj	_	_
3	involve	_	VERB	VBP	_	0	root	_	_
4	oxidation	_	NOUN	NN	_	3	dobj	_	_
5	,	_	.	,	_	4	punct	_	_
6	N	_	NOUN	NN	_	7	compound	_	_
7	acetylation	_	NOUN	NN	_	4	conj	_	_
8	and	_	CONJ	CC	_	4	cc	_	_
9	sulfate	_	NOUN	NN	_	10	compound	_	_
10	conjugation	_	NOUN	NN	_	4	conj	_	_

#	Aubagio	3178
1	Elimination	_	NOUN	NN	_	2	compound	_	_
2	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
3	is	_	VERB	VBZ	_	4	auxpass	_	_
4	eliminated	_	VERB	VBN	_	0	root	_	_
5	mainly	_	ADV	RB	_	4	advmod	_	_
6	through	_	ADP	IN	_	9	case	_	_
7	direct	_	ADJ	JJ	_	9	amod	_	_
8	biliary	_	ADJ	JJ	_	9	amod	_	_
9	excretion	_	NOUN	NN	_	4	nmod	_	_
10	of	_	ADP	IN	_	12	case	_	_
11	unchanged	_	ADJ	JJ	_	12	amod	_	_
12	drug	_	NOUN	NN	_	9	nmod	_	_
13	as	_	ADV	RB	_	9	cc	_	_
14	well	_	ADV	RB	_	13	mwe	_	_
15	as	_	ADP	IN	_	13	mwe	_	_
16	renal	_	ADJ	JJ	_	17	amod	_	_
17	excretion	_	NOUN	NN	_	9	conj	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	metabolites	_	NOUN	NNS	_	17	nmod	_	_

#	Aubagio	3179
1	Over	_	ADP	IN	_	3	case	_	_
2	21	_	NUM	CD	_	3	nummod	_	_
3	days	_	NOUN	NNS	_	11	nmod	_	_
4	,	_	.	,	_	11	punct	_	_
5	60.1%	_	NOUN	NN	_	11	nsubjpass	_	_
6	of	_	ADP	IN	_	9	case	_	_
7	the	_	DET	DT	_	9	det	_	_
8	administered	_	VERB	VBN	_	9	amod	_	_
9	dose	_	NOUN	NN	_	5	nmod	_	_
10	is	_	VERB	VBZ	_	11	auxpass	_	_
11	excreted	_	VERB	VBN	_	0	root	_	_
12	via	_	ADP	IN	_	14	case	_	_
13	feces	_	NOUN	NNS	_	14	compound	_	_
14	37.5%	_	ADJ	JJ	_	11	nmod	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	urine	_	VERB	VBG	_	14	conj	_	_
17	22.6%	_	ADJ	JJ	_	16	dobj	_	_

#	Aubagio	3180
1	After	_	ADP	IN	_	5	case	_	_
2	an	_	DET	DT	_	5	det	_	_
3	accelerated	_	VERB	VBN	_	5	amod	_	_
4	elimination	_	NOUN	NN	_	5	compound	_	_
5	procedure	_	NOUN	NN	_	13	nmod	_	_
6	with	_	ADP	IN	_	7	case	_	_
7	cholestyramine	_	NOUN	NN	_	5	nmod	_	_
8	,	_	.	,	_	13	punct	_	_
9	an	_	DET	DT	_	11	det	_	_
10	additional	_	ADJ	JJ	_	11	amod	_	_
11	23.1%	_	NOUN	NN	_	13	nsubjpass	_	_
12	was	_	VERB	VBD	_	13	auxpass	_	_
13	recovered	_	VERB	VBN	_	0	root	_	_
14	mostly	_	ADV	RB	_	13	advmod	_	_
15	in	_	ADP	IN	_	16	case	_	_
16	feces	_	NOUN	NNS	_	13	nmod	_	_

#	Aubagio	3181
1	After	_	ADP	IN	_	5	case	_	_
2	a	_	DET	DT	_	5	det	_	_
3	single	_	ADJ	JJ	_	5	amod	_	_
4	IV	_	NUM	CD	_	5	nummod	_	_
5	administration	_	NOUN	NN	_	15	nmod	_	_
6	,	_	.	,	_	15	punct	_	_
7	the	_	DET	DT	_	10	det	_	_
8	total	_	ADJ	JJ	_	10	amod	_	_
9	body	_	NOUN	NN	_	10	compound	_	_
10	clearance	_	NOUN	NN	_	15	nsubj	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_
13	is	_	VERB	VBZ	_	15	cop	_	_
14	30.5	_	NUM	CD	_	15	nummod	_	_
15	mL	_	NOUN	NN	_	0	root	_	_
16	/	_	.	:	_	15	punct	_	_
17	h	_	NOUN	NN	_	15	dep	_	_

#	Aubagio	3182
1	Drug	_	NOUN	NN	_	3	compound	_	_
2	Interaction	_	NOUN	NN	_	3	compound	_	_
3	Studies	_	NOUN	NNS	_	7	nsubjpass	_	_
4	DRUG	_	NOUN	NN	_	3	dep	_	_
5	is	_	VERB	VBZ	_	7	auxpass	_	_
6	not	_	ADV	RB	_	7	neg	_	_
7	metabolized	_	VERB	VBN	_	0	root	_	_
8	by	_	ADP	IN	_	10	case	_	_
9	Cytochrome	_	NOUN	NN	_	10	compound	_	_
10	P450	_	NOUN	NN	_	7	nmod	_	_
11	or	_	CONJ	CC	_	10	cc	_	_
12	flavin	_	NOUN	NN	_	15	compound	_	_
13	monoamine	_	NOUN	NN	_	15	compound	_	_
14	oxidase	_	NOUN	NN	_	15	compound	_	_
15	enzymes	_	NOUN	NNS	_	10	conj	_	_

#	Aubagio	3183
1	The	_	DET	DT	_	3	det	_	_
2	Potential	_	ADJ	JJ	_	3	amod	_	_
3	Effect	_	NOUN	NN	_	24	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	on	_	ADP	IN	_	8	case	_	_
7	Other	_	ADJ	JJ	_	8	amod	_	_
8	Drugs	_	NOUN	NNS	_	14	nmod	_	_
9	CYP2C8	_	NOUN	NN	_	10	compound	_	_
10	Substrates	_	NOUN	NNS	_	14	nsubj	_	_
11	There	_	DET	EX	_	10	nummod	_	_
12	was	_	VERB	VBD	_	14	cop	_	_
13	an	_	DET	DT	_	14	det	_	_
14	increase	_	NOUN	NN	_	3	acl	_	_
15	in	_	ADP	IN	_	18	case	_	_
16	mean	_	NOUN	NN	_	18	compound	_	_
17	repaglinide	_	NOUN	NN	_	18	compound	_	_
18	Cmax	_	NOUN	NN	_	14	nmod	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	AUC	_	NOUN	NN	_	18	conj	_	_
21	1.7	_	NUM	CD	_	20	nummod	_	_
22	and	_	CONJ	CC	_	20	cc	_	_
23	2.4	_	NUM	CD	_	20	conj	_	_
24	fold	_	NOUN	NN	_	0	root	_	_
25	,	_	.	,	_	24	punct	_	_
26	respectively	_	ADV	RB	_	24	advmod	_	_
27	,	_	.	,	_	24	punct	_	_
28	following	_	VERB	VBG	_	30	case	_	_
29	repeated	_	VERB	VBN	_	30	amod	_	_
30	doses	_	NOUN	NNS	_	24	nmod	_	_
31	of	_	ADP	IN	_	32	case	_	_
32	DRUG	_	NOUN	NN	_	30	nmod	_	_
33	and	_	CONJ	CC	_	30	cc	_	_
34	a	_	DET	DT	_	36	det	_	_
35	single	_	ADJ	JJ	_	36	amod	_	_
36	dose	_	NOUN	NN	_	30	conj	_	_
37	of	_	ADP	IN	_	40	case	_	_
38	0.25	_	NUM	CD	_	40	nummod	_	_
39	mg	_	NOUN	NN	_	40	compound	_	_
40	repaglinide	_	NOUN	NN	_	36	nmod	_	_
41	,	_	.	,	_	24	punct	_	_
42	suggesting	_	VERB	VBG	_	24	acl	_	_
43	that	_	ADP	IN	_	47	mark	_	_
44	DRUG	_	NOUN	NN	_	47	nsubj	_	_
45	is	_	VERB	VBZ	_	47	cop	_	_
46	an	_	DET	DT	_	47	det	_	_
47	inhibitor	_	NOUN	NN	_	42	ccomp	_	_
48	of	_	ADP	IN	_	49	case	_	_
49	CYP2C8	_	NOUN	NN	_	47	nmod	_	_
50	in	_	X	FW	_	51	compound	_	_
51	vivo	_	X	FW	_	47	advmod	_	_

#	Aubagio	3184
1	The	_	DET	DT	_	2	det	_	_
2	magnitude	_	NOUN	NN	_	7	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	interaction	_	NOUN	NN	_	2	nmod	_	_
5	could	_	VERB	MD	_	7	aux	_	_
6	be	_	VERB	VB	_	7	cop	_	_
7	higher	_	ADJ	JJ	_	0	root	_	_
8	at	_	ADP	IN	_	12	case	_	_
9	the	_	DET	DT	_	12	det	_	_
10	recommended	_	VERB	VBN	_	12	amod	_	_
11	repaglinide	_	NOUN	NN	_	12	compound	_	_
12	dose	_	NOUN	NN	_	7	nmod	_	_

#	Aubagio	3185
1	CYP1A2	_	NOUN	NN	_	2	compound	_	_
2	Substrates	_	NOUN	NNS	_	3	nsubj	_	_
3	Repeated	_	ADJ	JJ	_	0	root	_	_
4	doses	_	NOUN	NNS	_	3	dobj	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	decreased	_	VERB	VBD	_	3	parataxis	_	_
8	mean	_	NOUN	NN	_	9	compound	_	_
9	Cmax	_	NOUN	NN	_	7	dobj	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	AUC	_	NOUN	NN	_	9	conj	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	caffeine	_	NOUN	NN	_	9	nmod	_	_
14	by	_	ADP	IN	_	15	case	_	_
15	18%	_	NOUN	NN	_	13	nmod	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	55%	_	NOUN	NN	_	15	conj	_	_
18	,	_	.	,	_	7	punct	_	_
19	respectively	_	ADV	RB	_	7	advmod	_	_
20	,	_	.	,	_	7	punct	_	_
21	suggesting	_	VERB	VBG	_	7	advcl	_	_
22	that	_	ADP	IN	_	28	mark	_	_
23	DRUG	_	NOUN	NN	_	28	nsubj	_	_
24	may	_	VERB	MD	_	28	aux	_	_
25	be	_	VERB	VB	_	28	cop	_	_
26	a	_	DET	DT	_	28	det	_	_
27	weak	_	ADJ	JJ	_	28	amod	_	_
28	inducer	_	NOUN	NN	_	21	ccomp	_	_
29	of	_	ADP	IN	_	30	case	_	_
30	CYP1A2	_	NOUN	NN	_	28	nmod	_	_
31	in	_	X	FW	_	32	compound	_	_
32	vivo	_	X	FW	_	28	advmod	_	_

#	Aubagio	3186
1	OAT3	_	NOUN	NN	_	2	compound	_	_
2	Substrates	_	NOUN	NNS	_	0	root	_	_
3	There	_	DET	EX	_	4	expl	_	_
4	was	_	VERB	VBD	_	2	acl:relcl	_	_
5	an	_	DET	DT	_	6	det	_	_
6	increase	_	NOUN	NN	_	4	nsubj	_	_
7	in	_	ADP	IN	_	10	case	_	_
8	mean	_	NOUN	NN	_	10	compound	_	_
9	cefaclor	_	NOUN	NN	_	10	compound	_	_
10	Cmax	_	NOUN	NN	_	6	nmod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	AUC	_	NOUN	NN	_	10	conj	_	_
13	1.43	_	NUM	CD	_	12	nummod	_	_
14	and	_	CONJ	CC	_	12	cc	_	_
15	1.54	_	NUM	CD	_	12	conj	_	_
16	fold	_	NOUN	NN	_	6	advmod	_	_
17	,	_	.	,	_	2	punct	_	_
18	respectively	_	ADV	RB	_	26	advmod	_	_
19	,	_	.	,	_	26	punct	_	_
20	following	_	VERB	VBG	_	22	case	_	_
21	repeated	_	VERB	VBN	_	22	amod	_	_
22	doses	_	NOUN	NNS	_	26	nmod	_	_
23	of	_	ADP	IN	_	24	case	_	_
24	DRUG	_	NOUN	NN	_	22	nmod	_	_
25	,	_	.	,	_	26	punct	_	_
26	suggesting	_	VERB	VBG	_	2	acl	_	_
27	that	_	ADP	IN	_	31	mark	_	_
28	DRUG	_	NOUN	NN	_	31	nsubj	_	_
29	is	_	VERB	VBZ	_	31	cop	_	_
30	an	_	DET	DT	_	31	det	_	_
31	inhibitor	_	NOUN	NN	_	26	ccomp	_	_
32	of	_	ADP	IN	_	37	case	_	_
33	organic	_	ADJ	JJ	_	37	amod	_	_
34	anion	_	NOUN	NN	_	37	compound	_	_
35	transporter	_	NOUN	NN	_	37	compound	_	_
36	3	_	NUM	CD	_	37	nummod	_	_
37	OAT3	_	NOUN	NN	_	31	nmod	_	_
38	in	_	NOUN	NN	_	39	compound	_	_
39	vivo	_	X	FW	_	31	advmod	_	_

#	Aubagio	3187
1	BCRP	_	NOUN	NN	_	0	root	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	OATP1B1	_	NOUN	NN	_	1	conj	_	_
4	/	_	.	:	_	1	punct	_	_
5	1B3	_	NOUN	NN	_	6	compound	_	_
6	Substrates	_	NOUN	NNS	_	10	nsubj	_	_
7	There	_	DET	EX	_	6	nummod	_	_
8	was	_	VERB	VBD	_	10	cop	_	_
9	an	_	DET	DT	_	10	det	_	_
10	increase	_	NOUN	NN	_	1	dep	_	_
11	in	_	ADP	IN	_	14	case	_	_
12	mean	_	ADJ	JJ	_	14	amod	_	_
13	rosuvastatin	_	NOUN	NN	_	14	compound	_	_
14	Cmax	_	NOUN	NN	_	10	nmod	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	AUC	_	NOUN	NN	_	14	conj	_	_
17	2.65	_	NUM	CD	_	16	nummod	_	_
18	and	_	CONJ	CC	_	16	cc	_	_
19	2.51	_	NUM	CD	_	16	conj	_	_
20	fold	_	NOUN	NN	_	10	advmod	_	_
21	,	_	.	,	_	1	punct	_	_
22	respectively	_	ADV	RB	_	30	advmod	_	_
23	,	_	.	,	_	30	punct	_	_
24	following	_	VERB	VBG	_	26	case	_	_
25	repeated	_	VERB	VBN	_	26	amod	_	_
26	doses	_	NOUN	NNS	_	30	nmod	_	_
27	of	_	ADP	IN	_	28	case	_	_
28	DRUG	_	NOUN	NN	_	26	nmod	_	_
29	,	_	.	,	_	30	punct	_	_
30	suggesting	_	VERB	VBG	_	1	dep	_	_
31	that	_	ADP	IN	_	35	mark	_	_
32	DRUG	_	NOUN	NN	_	35	nsubj	_	_
33	is	_	VERB	VBZ	_	35	cop	_	_
34	an	_	DET	DT	_	35	det	_	_
35	inhibitor	_	NOUN	NN	_	30	ccomp	_	_
36	of	_	ADP	IN	_	38	case	_	_
37	BCRP	_	NOUN	NN	_	38	compound	_	_
38	transporter	_	NOUN	NN	_	35	nmod	_	_
39	and	_	CONJ	CC	_	38	cc	_	_
40	organic	_	ADJ	JJ	_	44	amod	_	_
41	anion	_	NOUN	NN	_	44	compound	_	_
42	transporting	_	VERB	VBG	_	44	compound	_	_
43	polypeptide	_	NOUN	NN	_	44	compound	_	_
44	1B1	_	NOUN	NN	_	38	conj	_	_
45	and	_	CONJ	CC	_	44	cc	_	_
46	1B3	_	NOUN	NN	_	47	compound	_	_
47	OATP1B1	_	NOUN	NN	_	44	conj	_	_
48	/	_	.	:	_	44	punct	_	_
49	1B3	_	NOUN	NN	_	44	appos	_	_

#	Aubagio	3188
1	Oral	_	ADJ	JJ	_	2	amod	_	_
2	Contraceptives	_	NOUN	NNS	_	0	root	_	_
3	There	_	DET	EX	_	4	expl	_	_
4	was	_	VERB	VBD	_	2	acl:relcl	_	_
5	an	_	DET	DT	_	6	det	_	_
6	increase	_	NOUN	NN	_	4	nsubj	_	_
7	in	_	ADP	IN	_	10	case	_	_
8	mean	_	NOUN	NN	_	10	compound	_	_
9	ethinylestradiol	_	NOUN	NN	_	10	compound	_	_
10	Cmax	_	NOUN	NN	_	6	nmod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	AUC0	_	NOUN	NN	_	17	compound	_	_
13	24	_	NUM	CD	_	14	nummod	_	_
14	1.58	_	NUM	CD	_	17	nummod	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	1.54	_	NUM	CD	_	14	conj	_	_
17	fold	_	NOUN	NN	_	10	conj	_	_
18	,	_	.	,	_	10	punct	_	_
19	respectively	_	ADV	RB	_	20	advmod	_	_
20	and	_	CONJ	CC	_	10	advmod	_	_
21	levonorgestrel	_	NOUN	NN	_	22	compound	_	_
22	Cmax	_	NOUN	NN	_	20	conj	_	_
23	and	_	CONJ	CC	_	22	cc	_	_
24	AUC0	_	NOUN	NN	_	29	compound	_	_
25	24	_	NUM	CD	_	26	nummod	_	_
26	1.33	_	NUM	CD	_	29	nummod	_	_
27	and	_	CONJ	CC	_	26	cc	_	_
28	1.41	_	NUM	CD	_	26	conj	_	_
29	fold	_	NOUN	NN	_	22	conj	_	_
30	,	_	.	,	_	2	punct	_	_
31	respectively	_	ADV	RB	_	34	advmod	_	_
32	following	_	VERB	VBG	_	34	case	_	_
33	repeated	_	VERB	VBN	_	34	amod	_	_
34	doses	_	NOUN	NNS	_	2	nmod	_	_
35	of	_	ADP	IN	_	36	case	_	_
36	DRUG	_	NOUN	NN	_	34	nmod	_	_

#	Aubagio	3189
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	did	_	VERB	VBD	_	4	aux	_	_
3	not	_	ADV	RB	_	4	neg	_	_
4	affect	_	VERB	VB	_	0	root	_	_
5	the	_	DET	DT	_	6	det	_	_
6	pharmacokinetics	_	NOUN	NNS	_	4	dobj	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	bupropion	_	NOUN	NN	_	6	nmod	_	_
9	a	_	DET	DT	_	11	det	_	_
10	CYP2B6	_	NOUN	NN	_	11	compound	_	_
11	substrate	_	NOUN	NN	_	8	dep	_	_
12	,	_	.	,	_	11	punct	_	_
13	midazolam	_	VERB	VBP	_	16	compound	_	_
14	a	_	DET	DT	_	16	det	_	_
15	CYP3A4	_	NOUN	NN	_	16	compound	_	_
16	substrate	_	NOUN	NN	_	11	conj	_	_
17	,	_	.	,	_	11	punct	_	_
18	S	_	NOUN	NN	_	19	compound	_	_
19	warfarin	_	NOUN	NN	_	11	appos	_	_
20	a	_	DET	DT	_	22	det	_	_
21	CYP2C9	_	NOUN	NN	_	22	compound	_	_
22	substrate	_	NOUN	NN	_	19	dep	_	_
23	,	_	.	,	_	22	punct	_	_
24	omeprazole	_	ADJ	JJ	_	22	conj	_	_
25	a	_	DET	DT	_	27	det	_	_
26	CYP2C19	_	NOUN	NN	_	27	compound	_	_
27	substrate	_	NOUN	NN	_	24	dobj	_	_
28	,	_	.	,	_	22	punct	_	_
29	and	_	CONJ	CC	_	22	cc	_	_
30	metoprolol	_	NOUN	NN	_	33	compound	_	_
31	a	_	DET	DT	_	33	det	_	_
32	CYP2D6	_	NOUN	NN	_	33	compound	_	_
33	substrate	_	NOUN	NN	_	22	conj	_	_

#	Aubagio	3190
1	The	_	DET	DT	_	3	det	_	_
2	Potential	_	ADJ	JJ	_	3	amod	_	_
3	Effect	_	NOUN	NN	_	0	root	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	Other	_	ADJ	JJ	_	6	amod	_	_
6	Drugs	_	NOUN	NNS	_	3	nmod	_	_
7	on	_	ADP	IN	_	10	case	_	_
8	DRUG	_	NOUN	NN	_	10	compound	_	_
9	Potent	_	ADJ	JJ	_	10	amod	_	_
10	CYP	_	NOUN	NN	_	3	nmod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	transporter	_	NOUN	NN	_	13	compound	_	_
13	inducers	_	NOUN	NNS	_	10	conj	_	_
14	:	_	.	:	_	3	punct	_	_
15	Rifampin	_	NOUN	NN	_	18	nsubj	_	_
16	did	_	VERB	VBD	_	18	aux	_	_
17	not	_	ADV	RB	_	18	neg	_	_
18	affect	_	VERB	VB	_	3	dep	_	_
19	the	_	DET	DT	_	20	det	_	_
20	pharmacokinetics	_	NOUN	NNS	_	18	dobj	_	_
21	of	_	ADP	IN	_	22	case	_	_
22	DRUG	_	NOUN	NN	_	20	nmod	_	_

#	Aubagio	3191
1	Specific	_	ADJ	JJ	_	2	amod	_	_
2	populations	_	NOUN	NNS	_	10	nsubj	_	_
3	Hepatic	_	ADJ	JJ	_	5	amod	_	_
4	Impairment	_	NOUN	NN	_	5	compound	_	_
5	Mild	_	NOUN	NN	_	2	dep	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	moderate	_	ADJ	JJ	_	9	amod	_	_
8	hepatic	_	ADJ	JJ	_	9	amod	_	_
9	impairment	_	NOUN	NN	_	5	conj	_	_
10	had	_	VERB	VBD	_	0	root	_	_
11	no	_	DET	DT	_	12	neg	_	_
12	impact	_	VERB	VB	_	10	ccomp	_	_
13	on	_	ADP	IN	_	15	case	_	_
14	the	_	DET	DT	_	15	det	_	_
15	pharmacokinetics	_	NOUN	NNS	_	12	nmod	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	DRUG	_	NOUN	NN	_	15	nmod	_	_

#	Aubagio	3192
1	The	_	DET	DT	_	2	det	_	_
2	pharmacokinetics	_	NOUN	NNS	_	12	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	in	_	ADP	IN	_	8	case	_	_
6	severe	_	ADJ	JJ	_	8	amod	_	_
7	hepatic	_	ADJ	JJ	_	8	amod	_	_
8	impairment	_	NOUN	NN	_	2	nmod	_	_
9	have	_	VERB	MD	_	12	aux	_	_
10	not	_	ADV	RB	_	12	neg	_	_
11	been	_	VERB	VBN	_	12	auxpass	_	_
12	evaluated	_	VERB	VBN	_	0	root	_	_

#	Aubagio	3193
1	Renal	_	ADJ	JJ	_	5	amod	_	_
2	Impairment	_	NOUN	NN	_	5	compound	_	_
3	Severe	_	ADJ	JJ	_	5	amod	_	_
4	renal	_	ADJ	JJ	_	5	amod	_	_
5	impairment	_	NOUN	NN	_	6	nsubj	_	_
6	had	_	VERB	VBD	_	0	root	_	_
7	no	_	DET	DT	_	8	neg	_	_
8	impact	_	VERB	VB	_	6	dobj	_	_
9	on	_	ADP	IN	_	11	case	_	_
10	the	_	DET	DT	_	11	det	_	_
11	pharmacokinetics	_	NOUN	NNS	_	8	nmod	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	DRUG	_	NOUN	NN	_	11	nmod	_	_

#	Aubagio	3194
1	Gender	_	NOUN	NN	_	13	advcl	_	_
2	In	_	ADP	IN	_	5	case	_	_
3	a	_	DET	DT	_	5	det	_	_
4	population	_	NOUN	NN	_	5	compound	_	_
5	analysis	_	NOUN	NN	_	1	nmod	_	_
6	,	_	.	,	_	13	punct	_	_
7	the	_	DET	DT	_	9	det	_	_
8	clearance	_	NOUN	NN	_	9	compound	_	_
9	rate	_	NOUN	NN	_	13	nsubj	_	_
10	for	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_
12	is	_	VERB	VBZ	_	13	cop	_	_
13	23%	_	ADJ	JJ	_	0	root	_	_
14	less	_	ADV	RB	_	13	advmod	_	_
15	in	_	ADP	IN	_	16	case	_	_
16	females	_	NOUN	NNS	_	13	nmod	_	_
17	than	_	ADP	IN	_	19	case	_	_
18	in	_	ADP	IN	_	19	case	_	_
19	males	_	NOUN	NNS	_	13	nmod	_	_

#	Aubagio	3195
1	Race	_	ADJ	JJ	_	2	amod	_	_
2	Effect	_	NOUN	NN	_	13	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	race	_	NOUN	NN	_	2	nmod	_	_
5	on	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	pharmacokinetics	_	NOUN	NNS	_	2	nmod	_	_
8	of	_	ADP	IN	_	10	case	_	_
9	DRUG	_	NOUN	NN	_	10	compound	_	_
10	cannot	_	NOUN	NN	_	7	nmod	_	_
11	be	_	VERB	VBZ	_	13	auxpass	_	_
12	adequately	_	ADV	RB	_	13	advmod	_	_
13	assessed	_	VERB	VBN	_	0	root	_	_
14	due	_	ADJ	JJ	_	18	case	_	_
15	to	_	PRT	TO	_	14	mwe	_	_
16	a	_	DET	DT	_	18	det	_	_
17	low	_	ADJ	JJ	_	18	amod	_	_
18	number	_	NOUN	NN	_	13	nmod	_	_
19	of	_	ADP	IN	_	22	case	_	_
20	non	_	ADJ	JJ	_	22	amod	_	_
21	white	_	ADJ	JJ	_	22	amod	_	_
22	patients	_	NOUN	NNS	_	18	nmod	_	_
23	in	_	ADP	IN	_	26	case	_	_
24	the	_	DET	DT	_	26	det	_	_
25	clinical	_	ADJ	JJ	_	26	amod	_	_
26	trials	_	NOUN	NNS	_	22	nmod	_	_

#	Bicalutamide	4901
1	Clinical	_	ADJ	JJ	_	2	amod	_	_
2	studies	_	NOUN	NNS	_	5	nsubj	_	_
3	have	_	VERB	VBP	_	5	aux	_	_
4	not	_	ADV	RB	_	5	neg	_	_
5	shown	_	VERB	VBN	_	0	root	_	_
6	any	_	DET	DT	_	8	det	_	_
7	drug	_	NOUN	NN	_	8	compound	_	_
8	interactions	_	NOUN	NNS	_	5	dobj	_	_
9	between	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	LHRH	_	NOUN	NN	_	10	conj	_	_
13	analogs	_	NOUN	NNS	_	10	dep	_	_
14	goserelin	_	NOUN	NN	_	10	dep	_	_
15	or	_	CONJ	CC	_	14	cc	_	_
16	leuprolide	_	NOUN	NN	_	14	conj	_	_

#	Bicalutamide	4902
1	There	_	DET	EX	_	2	expl	_	_
2	is	_	VERB	VBZ	_	0	root	_	_
3	no	_	DET	DT	_	4	neg	_	_
4	evidence	_	NOUN	NN	_	2	nsubj	_	_
5	that	_	ADP	IN	_	7	mark	_	_
6	DRUG	_	NOUN	NN	_	7	nsubj	_	_
7	induces	_	VERB	VBZ	_	4	ccomp	_	_
8	hepatic	_	ADJ	JJ	_	9	amod	_	_
9	enzymes	_	NOUN	NNS	_	7	dobj	_	_

#	Bicalutamide	4903
1	In	_	X	FW	_	3	amod	_	_
2	vitro	_	X	FW	_	1	dep	_	_
3	studies	_	NOUN	NNS	_	5	nsubj	_	_
4	have	_	VERB	VBP	_	5	aux	_	_
5	shown	_	VERB	VBN	_	0	root	_	_
6	that	_	ADP	IN	_	11	mark	_	_
7	R	_	NOUN	NN	_	8	compound	_	_
8	DRUG	_	NOUN	NN	_	11	nsubj	_	_
9	is	_	VERB	VBZ	_	11	cop	_	_
10	an	_	DET	DT	_	11	det	_	_
11	inhibitor	_	NOUN	NN	_	5	ccomp	_	_
12	of	_	ADP	IN	_	14	case	_	_
13	CYP	_	NOUN	NN	_	14	compound	_	_
14	3A4	_	NOUN	NN	_	11	nmod	_	_
15	with	_	ADP	IN	_	18	case	_	_
16	lesser	_	ADJ	JJ	_	18	amod	_	_
17	inhibitory	_	ADJ	JJ	_	18	amod	_	_
18	effects	_	NOUN	NNS	_	11	nmod	_	_
19	on	_	ADP	IN	_	21	case	_	_
20	CYP	_	NOUN	NN	_	21	compound	_	_
21	2C9	_	NOUN	NN	_	18	nmod	_	_
22	,	_	.	,	_	21	punct	_	_
23	2C19	_	NOUN	NN	_	21	conj	_	_
24	and	_	CONJ	CC	_	21	cc	_	_
25	2D6	_	NOUN	NN	_	26	compound	_	_
26	activity	_	NOUN	NN	_	21	conj	_	_

#	Bicalutamide	4904
1	Clinical	_	ADJ	JJ	_	2	amod	_	_
2	studies	_	NOUN	NNS	_	4	nsubj	_	_
3	have	_	VERB	VBP	_	4	aux	_	_
4	shown	_	VERB	VBN	_	0	root	_	_
5	that	_	ADP	IN	_	21	mark	_	_
6	with	_	ADP	IN	_	8	case	_	_
7	co	_	PRT	TO	_	8	nmod:poss	_	_
8	administration	_	NOUN	NN	_	21	nmod	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	,	_	.	,	_	21	punct	_	_
12	mean	_	ADJ	JJ	_	13	compound	_	_
13	midazolam	_	NOUN	NN	_	21	nmod	_	_
14	a	_	DET	DT	_	18	det	_	_
15	CYP	_	NOUN	NN	_	18	compound	_	_
16	3A4	_	NOUN	NN	_	18	compound	_	_
17	substrate	_	NOUN	NN	_	18	compound	_	_
18	levels	_	NOUN	NNS	_	21	nsubjpass	_	_
19	may	_	VERB	MD	_	21	aux	_	_
20	be	_	VERB	VB	_	21	auxpass	_	_
21	increased	_	VERB	VBN	_	4	ccomp	_	_
22	1.5	_	NUM	CD	_	23	nummod	_	_
23	fold	_	NOUN	NN	_	21	dobj	_	_
24	for	_	ADP	IN	_	26	case	_	_
25	C	_	NOUN	NN	_	26	compound	_	_
26	max	_	NOUN	NN	_	23	nmod	_	_
27	and	_	CONJ	CC	_	23	cc	_	_
28	1.9	_	NUM	CD	_	29	nummod	_	_
29	fold	_	NOUN	NN	_	23	conj	_	_
30	for	_	ADP	IN	_	31	case	_	_
31	AUC	_	NOUN	NN	_	29	nmod	_	_

#	Bicalutamide	4905
1	Hence	_	ADV	RB	_	6	advmod	_	_
2	,	_	.	,	_	6	punct	_	_
3	caution	_	NOUN	NN	_	6	nsubjpass	_	_
4	should	_	VERB	MD	_	6	aux	_	_
5	be	_	VERB	VB	_	6	auxpass	_	_
6	exercised	_	VERB	VBN	_	0	root	_	_
7	when	_	ADV	WRB	_	11	advmod	_	_
8	DRUG	_	NOUN	NN	_	11	nsubjpass	_	_
9	is	_	VERB	VBZ	_	11	auxpass	_	_
10	co	_	PRT	TO	_	11	mark	_	_
11	administered	_	VERB	VBN	_	6	ccomp	_	_
12	with	_	ADP	IN	_	15	case	_	_
13	CYP	_	NOUN	NN	_	15	compound	_	_
14	3A4	_	NOUN	NN	_	15	compound	_	_
15	substrates	_	NOUN	NNS	_	11	nmod	_	_

#	Bicalutamide	4906
1	In	_	X	FW	_	5	amod	_	_
2	vitro	_	X	FW	_	1	dep	_	_
3	protein	_	NOUN	NN	_	5	compound	_	_
4	binding	_	NOUN	NN	_	5	compound	_	_
5	studies	_	NOUN	NNS	_	7	nsubj	_	_
6	have	_	VERB	VBP	_	7	aux	_	_
7	shown	_	VERB	VBN	_	0	root	_	_
8	that	_	ADP	IN	_	11	mark	_	_
9	DRUG	_	NOUN	NN	_	11	nsubj	_	_
10	can	_	VERB	MD	_	11	aux	_	_
11	displace	_	VERB	VB	_	7	ccomp	_	_
12	coumarin	_	NOUN	NN	_	13	compound	_	_
13	anticoagulants	_	NOUN	NNS	_	11	dobj	_	_
14	from	_	ADP	IN	_	16	case	_	_
15	binding	_	VERB	VBG	_	16	compound	_	_
16	sites	_	NOUN	NNS	_	13	nmod	_	_

#	Bicalutamide	4907
1	Prothrombin	_	NOUN	NN	_	2	compound	_	_
2	times	_	NOUN	NNS	_	6	nsubjpass	_	_
3	should	_	VERB	MD	_	6	aux	_	_
4	be	_	VERB	VB	_	6	auxpass	_	_
5	closely	_	ADV	RB	_	6	advmod	_	_
6	monitored	_	VERB	VBN	_	0	root	_	_
7	in	_	ADP	IN	_	8	case	_	_
8	patients	_	NOUN	NNS	_	6	nmod	_	_
9	already	_	ADV	RB	_	10	advmod	_	_
10	receiving	_	VERB	VBG	_	8	acl	_	_
11	coumarin	_	NOUN	NN	_	12	compound	_	_
12	anticoagulants	_	NOUN	NNS	_	10	dobj	_	_
13	who	_	DET	WDT	_	15	nsubjpass	_	_
14	are	_	VERB	VBP	_	15	auxpass	_	_
15	started	_	VERB	VBN	_	12	acl:relcl	_	_
16	on	_	ADP	IN	_	17	case	_	_
17	DRUG	_	NOUN	NN	_	15	nmod	_	_
18	and	_	CONJ	CC	_	15	cc	_	_
19	adjustment	_	NOUN	NN	_	26	nsubj	_	_
20	of	_	ADP	IN	_	23	case	_	_
21	the	_	DET	DT	_	23	det	_	_
22	anticoagulant	_	ADJ	JJ	_	23	amod	_	_
23	dose	_	NOUN	NN	_	19	nmod	_	_
24	may	_	VERB	MD	_	26	aux	_	_
25	be	_	VERB	VB	_	26	auxpass	_	_
26	necessary	_	ADJ	JJ	_	15	conj	_	_

#	Bicalutamide	4908
1	R	_	NOUN	NN	_	2	compound	_	_
2	DRUG	_	NOUN	NN	_	5	nsubj	_	_
3	is	_	VERB	VBZ	_	5	cop	_	_
4	an	_	DET	DT	_	5	det	_	_
5	inhibitor	_	NOUN	NN	_	0	root	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	CYP	_	NOUN	NN	_	8	compound	_	_
8	3A4	_	NOUN	NN	_	5	nmod	_	_
9	therefore	_	ADV	RB	_	5	advmod	_	_
10	,	_	.	,	_	5	punct	_	_
11	caution	_	NOUN	NN	_	14	nsubjpass	_	_
12	should	_	VERB	MD	_	14	aux	_	_
13	be	_	VERB	VB	_	14	auxpass	_	_
14	used	_	VERB	VBN	_	5	dep	_	_
15	when	_	ADV	WRB	_	19	advmod	_	_
16	DRUG	_	NOUN	NN	_	19	nsubjpass	_	_
17	is	_	VERB	VBZ	_	19	auxpass	_	_
18	co	_	PRT	TO	_	19	mark	_	_
19	administered	_	VERB	VBN	_	14	advcl	_	_
20	with	_	ADP	IN	_	23	case	_	_
21	CYP	_	NOUN	NN	_	23	compound	_	_
22	3A4	_	NOUN	NN	_	23	compound	_	_
23	substrates	_	NOUN	NNS	_	19	nmod	_	_

#	Bicalutamide	4909
1	Prothrombin	_	NOUN	NN	_	2	compound	_	_
2	times	_	NOUN	NNS	_	6	nsubjpass	_	_
3	should	_	VERB	MD	_	6	aux	_	_
4	be	_	VERB	VB	_	6	auxpass	_	_
5	closely	_	ADV	RB	_	6	advmod	_	_
6	monitored	_	VERB	VBN	_	0	root	_	_
7	in	_	ADP	IN	_	8	case	_	_
8	patient	_	NOUN	NN	_	6	nmod	_	_
9	already	_	ADV	RB	_	10	advmod	_	_
10	receiving	_	VERB	VBG	_	8	acl	_	_
11	coumarin	_	NOUN	NN	_	12	compound	_	_
12	anticoagulants	_	NOUN	NNS	_	10	dobj	_	_
13	who	_	DET	WDT	_	15	nsubjpass	_	_
14	are	_	VERB	VBP	_	15	auxpass	_	_
15	started	_	VERB	VBN	_	12	acl:relcl	_	_
16	on	_	ADP	IN	_	17	case	_	_
17	DRUG	_	NOUN	NN	_	15	nmod	_	_

#	Bicalutamide	4910
1	DRUG	_	NOUN	NN	_	8	nsubj	_	_
2	is	_	VERB	VBZ	_	8	cop	_	_
3	a	_	DET	DT	_	8	det	_	_
4	non	_	ADJ	JJ	_	8	amod	_	_
5	steroidal	_	ADJ	JJ	_	8	amod	_	_
6	androgen	_	NOUN	NN	_	8	compound	_	_
7	receptor	_	NOUN	NN	_	8	compound	_	_
8	inhibitor	_	NOUN	NN	_	0	root	_	_

#	Bicalutamide	4911
1	It	_	PRON	PRP	_	3	nsubj	_	_
2	competitively	_	ADV	RB	_	3	advmod	_	_
3	inhibits	_	VERB	VBZ	_	0	root	_	_
4	the	_	DET	DT	_	5	det	_	_
5	action	_	NOUN	NN	_	3	dobj	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	androgens	_	NOUN	NNS	_	5	nmod	_	_
8	by	_	ADP	IN	_	9	mark	_	_
9	binding	_	VERB	VBG	_	3	advcl	_	_
10	to	_	PRT	TO	_	13	case	_	_
11	cytosol	_	NOUN	NN	_	13	compound	_	_
12	androgen	_	NOUN	NN	_	13	compound	_	_
13	receptors	_	NOUN	NNS	_	9	nmod	_	_
14	in	_	ADP	IN	_	17	case	_	_
15	the	_	DET	DT	_	17	det	_	_
16	target	_	NOUN	NN	_	17	compound	_	_
17	tissue	_	NOUN	NN	_	13	nmod	_	_

#	Bicalutamide	4912
1	Prostatic	_	ADJ	JJ	_	2	amod	_	_
2	carcinoma	_	NOUN	NN	_	4	nsubjpass	_	_
3	is	_	VERB	VBZ	_	4	auxpass	_	_
4	known	_	VERB	VBN	_	0	root	_	_
5	to	_	PRT	TO	_	8	mark	_	_
6	be	_	VERB	VB	_	8	cop	_	_
7	androgen	_	NOUN	NN	_	8	nmod:npmod	_	_
8	sensitive	_	ADJ	JJ	_	4	xcomp	_	_
9	and	_	CONJ	CC	_	4	cc	_	_
10	responds	_	VERB	VBZ	_	4	conj	_	_
11	to	_	PRT	TO	_	12	case	_	_
12	treatment	_	NOUN	NN	_	10	nmod	_	_
13	that	_	DET	WDT	_	14	nsubj	_	_
14	counteracts	_	VERB	VBZ	_	12	acl:relcl	_	_
15	the	_	DET	DT	_	16	det	_	_
16	effect	_	NOUN	NN	_	14	dobj	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	androgen	_	NOUN	NN	_	16	nmod	_	_
19	and	_	CONJ	CC	_	16	cc	_	_
20	/	_	NOUN	NN	_	16	conj	_	_
21	or	_	CONJ	CC	_	14	cc	_	_
22	removes	_	VERB	VBZ	_	14	conj	_	_
23	the	_	DET	DT	_	24	det	_	_
24	source	_	NOUN	NN	_	22	dobj	_	_
25	of	_	ADP	IN	_	26	case	_	_
26	androgen	_	NOUN	NN	_	24	nmod	_	_

#	Bicalutamide	4913
1	When	_	ADV	WRB	_	4	advmod	_	_
2	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
3	is	_	VERB	VBZ	_	4	auxpass	_	_
4	combined	_	VERB	VBN	_	22	advcl	_	_
5	with	_	ADP	IN	_	8	case	_	_
6	LHRH	_	NOUN	NN	_	8	compound	_	_
7	analog	_	NOUN	NN	_	8	compound	_	_
8	therapy	_	NOUN	NN	_	4	nmod	_	_
9	,	_	.	,	_	22	punct	_	_
10	the	_	DET	DT	_	11	det	_	_
11	suppression	_	NOUN	NN	_	22	nsubjpass	_	_
12	of	_	ADP	IN	_	14	case	_	_
13	serum	_	NOUN	NN	_	14	compound	_	_
14	testosterone	_	NOUN	NN	_	11	nmod	_	_
15	induced	_	VERB	VBN	_	14	acl	_	_
16	by	_	ADP	IN	_	19	case	_	_
17	the	_	DET	DT	_	19	det	_	_
18	LHRH	_	NOUN	NN	_	19	compound	_	_
19	analog	_	NOUN	NN	_	15	nmod	_	_
20	is	_	VERB	VBZ	_	22	auxpass	_	_
21	not	_	ADV	RB	_	22	neg	_	_
22	affected	_	VERB	VBN	_	0	root	_	_

#	Bicalutamide	4914
1	However	_	ADV	RB	_	24	advmod	_	_
2	,	_	.	,	_	24	punct	_	_
3	in	_	ADP	IN	_	5	case	_	_
4	clinical	_	ADJ	JJ	_	5	amod	_	_
5	trials	_	NOUN	NNS	_	24	nmod	_	_
6	with	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	as	_	ADP	IN	_	11	case	_	_
9	a	_	DET	DT	_	11	det	_	_
10	single	_	ADJ	JJ	_	11	amod	_	_
11	agent	_	NOUN	NN	_	5	nmod	_	_
12	for	_	ADP	IN	_	14	case	_	_
13	prostate	_	NOUN	NN	_	14	compound	_	_
14	cancer	_	NOUN	NN	_	11	nmod	_	_
15	,	_	.	,	_	24	punct	_	_
16	rises	_	NOUN	NNS	_	24	nsubjpass	_	_
17	in	_	ADP	IN	_	18	case	_	_
18	serum	_	NOUN	NN	_	16	nmod	_	_
19	testosterone	_	NOUN	NN	_	18	dep	_	_
20	and	_	CONJ	CC	_	18	cc	_	_
21	estradiol	_	NOUN	NN	_	18	conj	_	_
22	have	_	VERB	VBP	_	24	aux	_	_
23	been	_	VERB	VBN	_	24	auxpass	_	_
24	noted	_	VERB	VBN	_	0	root	_	_

#	Bicalutamide	4915
1	In	_	ADP	IN	_	3	case	_	_
2	a	_	DET	DT	_	3	det	_	_
3	subset	_	NOUN	NN	_	0	root	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	patients	_	NOUN	NNS	_	3	nmod	_	_
6	who	_	DET	WDT	_	9	nsubjpass	_	_
7	have	_	VERB	VBP	_	9	aux	_	_
8	been	_	VERB	VBN	_	9	auxpass	_	_
9	treated	_	VERB	VBN	_	5	acl:relcl	_	_
10	with	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	an	_	DET	DT	_	15	det	_	_
14	LHRH	_	NOUN	NN	_	15	compound	_	_
15	agonist	_	NOUN	NN	_	11	conj	_	_
16	,	_	.	,	_	3	punct	_	_
17	and	_	CONJ	CC	_	3	cc	_	_
18	who	_	ADP	IN	_	3	conj	_	_
19	discontinue	_	ADJ	JJ	_	21	amod	_	_
20	DRUG	_	NOUN	NN	_	21	compound	_	_
21	therapy	_	NOUN	NN	_	18	root	_	_
22	due	_	ADJ	JJ	_	27	case	_	_
23	to	_	PRT	TO	_	22	mwe	_	_
24	progressive	_	ADJ	JJ	_	27	amod	_	_
25	advanced	_	VERB	VBN	_	27	amod	_	_
26	prostate	_	NOUN	NN	_	27	compound	_	_
27	cancer	_	NOUN	NN	_	21	nmod	_	_
28	,	_	.	,	_	21	punct	_	_
29	a	_	DET	DT	_	30	det	_	_
30	reduction	_	NOUN	NN	_	46	nsubjpass	_	_
31	in	_	ADP	IN	_	35	case	_	_
32	Prostate	_	NOUN	NN	_	35	compound	_	_
33	Specific	_	ADJ	JJ	_	35	amod	_	_
34	Antigen	_	NOUN	NN	_	35	compound	_	_
35	PSA	_	NOUN	NN	_	30	nmod	_	_
36	and	_	CONJ	CC	_	35	cc	_	_
37	/	_	NUM	CD	_	35	conj	_	_
38	or	_	CONJ	CC	_	37	cc	_	_
39	clinical	_	ADJ	JJ	_	43	amod	_	_
40	improvement	_	NOUN	NN	_	43	compound	_	_
41	antiandrogen	_	ADJ	JJ	_	43	amod	_	_
42	withdrawal	_	NOUN	NN	_	43	compound	_	_
43	phenomenon	_	NOUN	NN	_	37	conj	_	_
44	may	_	VERB	MD	_	46	aux	_	_
45	be	_	VERB	VB	_	46	auxpass	_	_
46	observed	_	VERB	VBN	_	21	dep	_	_

#	Bicalutamide	4916
1	Absorption	_	NOUN	NN	_	2	compound	_	_
2	DRUG	_	NOUN	NN	_	5	nsubjpass	_	_
3	is	_	VERB	VBZ	_	5	auxpass	_	_
4	well	_	ADV	RB	_	5	advmod	_	_
5	absorbed	_	VERB	VBN	_	0	root	_	_
6	following	_	ADP	IN	_	8	case	_	_
7	oral	_	ADJ	JJ	_	8	amod	_	_
8	administration	_	NOUN	NN	_	5	nmod	_	_
9	,	_	.	,	_	5	punct	_	_
10	although	_	ADP	IN	_	15	mark	_	_
11	the	_	DET	DT	_	13	det	_	_
12	absolute	_	NOUN	NN	_	13	amod	_	_
13	bioavailability	_	NOUN	NN	_	15	nsubj	_	_
14	is	_	VERB	VBZ	_	15	auxpass	_	_
15	unknown	_	ADJ	JJ	_	5	advcl	_	_

#	Bicalutamide	4917
1	Co	_	PRT	TO	_	2	case	_	_
2	administration	_	NOUN	NN	_	7	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	with	_	ADP	IN	_	6	case	_	_
6	food	_	NOUN	NN	_	2	nmod	_	_
7	has	_	VERB	VBZ	_	0	root	_	_
8	no	_	DET	DT	_	11	neg	_	_
9	clinically	_	ADV	RB	_	10	advmod	_	_
10	significant	_	ADJ	JJ	_	11	amod	_	_
11	effect	_	NOUN	NN	_	7	dobj	_	_
12	on	_	ADP	IN	_	13	case	_	_
13	rate	_	NOUN	NN	_	7	nmod	_	_
14	or	_	CONJ	CC	_	13	cc	_	_
15	extent	_	NOUN	NN	_	13	conj	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	absorption	_	NOUN	NN	_	13	nmod	_	_

#	Bicalutamide	4918
1	Distribution	_	NOUN	NN	_	2	compound	_	_
2	DRUG	_	NOUN	NN	_	6	nsubj	_	_
3	is	_	VERB	VBZ	_	6	auxpass	_	_
4	highly	_	ADV	RB	_	5	advmod	_	_
5	protein	_	NOUN	NN	_	6	nsubj	_	_
6	bound	_	VERB	VBN	_	0	root	_	_
7	96%	_	ADJ	JJ	_	6	xcomp	_	_

#	Bicalutamide	4919
1	Metabolism	_	NOUN	NN	_	0	root	_	_
2	/	_	.	:	_	1	punct	_	_
3	Elimination	_	NOUN	NN	_	4	compound	_	_
4	DRUG	_	NOUN	NN	_	5	nsubj	_	_
5	undergoes	_	VERB	VBZ	_	1	dep	_	_
6	stereospecific	_	ADJ	JJ	_	7	amod	_	_
7	metabolism	_	NOUN	NN	_	5	dobj	_	_

#	Bicalutamide	4920
1	The	_	DET	DT	_	4	det	_	_
2	S	_	NOUN	NN	_	4	compound	_	_
3	inactive	_	ADJ	JJ	_	4	amod	_	_
4	isomer	_	NOUN	NN	_	6	nsubjpass	_	_
5	is	_	VERB	VBZ	_	6	auxpass	_	_
6	metabolized	_	VERB	VBN	_	0	root	_	_
7	primarily	_	ADV	RB	_	6	advmod	_	_
8	by	_	ADP	IN	_	9	case	_	_
9	glucuronidation	_	NOUN	NN	_	6	nmod	_	_

#	Bicalutamide	4921
1	The	_	DET	DT	_	4	det	_	_
2	R	_	NOUN	NN	_	4	compound	_	_
3	active	_	ADJ	JJ	_	4	amod	_	_
4	isomer	_	NOUN	NN	_	6	nsubj	_	_
5	also	_	ADV	RB	_	6	advmod	_	_
6	undergoes	_	VERB	VBZ	_	0	root	_	_
7	glucuronidation	_	NOUN	NN	_	6	dobj	_	_
8	but	_	CONJ	CC	_	6	cc	_	_
9	is	_	VERB	VBZ	_	11	auxpass	_	_
10	predominantly	_	ADV	RB	_	11	advmod	_	_
11	oxidized	_	VERB	VBN	_	6	conj	_	_
12	to	_	PRT	TO	_	15	case	_	_
13	an	_	DET	DT	_	15	det	_	_
14	inactive	_	ADJ	JJ	_	15	amod	_	_
15	metabolite	_	NOUN	NN	_	11	nmod	_	_
16	followed	_	VERB	VBN	_	15	acl	_	_
17	by	_	ADP	IN	_	18	case	_	_
18	glucuronidation	_	NOUN	NN	_	16	nmod	_	_

#	Bicalutamide	4922
1	Both	_	CONJ	CC	_	3	cc:preconj	_	_
2	the	_	DET	DT	_	3	dep	_	_
3	parent	_	NOUN	NN	_	8	nsubjpass	_	_
4	and	_	CONJ	CC	_	3	cc	_	_
5	metabolite	_	NOUN	NN	_	3	conj	_	_
6	glucuronides	_	NOUN	NNS	_	3	dep	_	_
7	are	_	VERB	VBP	_	8	auxpass	_	_
8	eliminated	_	VERB	VBN	_	0	root	_	_
9	in	_	ADP	IN	_	11	case	_	_
10	the	_	DET	DT	_	11	det	_	_
11	urine	_	ADJ	JJ	_	8	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	feces	_	NOUN	NNS	_	11	conj	_	_

#	Bicalutamide	4923
1	The	_	DET	DT	_	3	det	_	_
2	S	_	NOUN	NN	_	3	compound	_	_
3	enantiomer	_	NOUN	NN	_	6	nsubjpass	_	_
4	is	_	VERB	VBZ	_	6	auxpass	_	_
5	rapidly	_	ADV	RB	_	6	advmod	_	_
6	cleared	_	VERB	VBN	_	0	root	_	_
7	relative	_	ADJ	JJ	_	6	advmod	_	_
8	to	_	PRT	TO	_	11	case	_	_
9	the	_	DET	DT	_	11	det	_	_
10	R	_	NOUN	NN	_	11	compound	_	_
11	enantiomer	_	NOUN	NN	_	7	nmod	_	_
12	,	_	.	,	_	6	punct	_	_
13	with	_	ADP	IN	_	16	case	_	_
14	the	_	DET	DT	_	16	det	_	_
15	R	_	NOUN	NN	_	16	compound	_	_
16	enantiomer	_	NOUN	NN	_	6	nmod	_	_
17	accounting	_	VERB	VBG	_	16	acl	_	_
18	for	_	ADP	IN	_	20	case	_	_
19	about	_	ADV	RB	_	20	advmod	_	_
20	99%	_	NOUN	NN	_	17	nmod	_	_
21	of	_	ADP	IN	_	26	case	_	_
22	total	_	ADJ	JJ	_	26	amod	_	_
23	steady	_	ADJ	JJ	_	26	amod	_	_
24	state	_	NOUN	NN	_	26	compound	_	_
25	plasma	_	NOUN	NN	_	26	compound	_	_
26	levels	_	NOUN	NNS	_	20	nmod	_	_

#	Bicalutamide	4924
1	Pharmacokinetics	_	NOUN	NNS	_	17	nsubjpass	_	_
2	of	_	ADP	IN	_	5	case	_	_
3	the	_	DET	DT	_	5	det	_	_
4	active	_	ADJ	JJ	_	5	amod	_	_
5	enantiomer	_	NOUN	NN	_	1	nmod	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	in	_	ADP	IN	_	10	case	_	_
9	normal	_	ADJ	JJ	_	10	amod	_	_
10	males	_	NOUN	NNS	_	1	nmod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	patients	_	NOUN	NNS	_	10	conj	_	_
13	with	_	ADP	IN	_	15	case	_	_
14	prostate	_	NOUN	NN	_	15	compound	_	_
15	cancer	_	NOUN	NN	_	10	nmod	_	_
16	are	_	VERB	VBP	_	17	auxpass	_	_
17	presented	_	VERB	VBN	_	0	root	_	_
18	in	_	ADP	IN	_	19	case	_	_
19	Table	_	ADJ	JJ	_	17	nmod	_	_
20	3	_	NUM	CD	_	19	dep	_	_

#	Bicalutamide	4925
1	Parameter	_	NOUN	NN	_	6	compound	_	_
2	Mean	_	NOUN	NN	_	6	compound	_	_
3	Standard	_	NOUN	NN	_	6	compound	_	_
4	Deviation	_	NOUN	NN	_	6	compound	_	_
5	Normal	_	ADJ	JJ	_	6	amod	_	_
6	Males	_	NOUN	NNS	_	0	root	_	_
7	n=30	_	NOUN	NN	_	11	compound	_	_
8	Apparent	_	ADJ	JJ	_	11	amod	_	_
9	Oral	_	ADJ	JJ	_	11	amod	_	_
10	Clearance	_	NOUN	NN	_	11	compound	_	_
11	L	_	NOUN	NN	_	6	dep	_	_
12	/	_	.	:	_	17	punct	_	_
13	hr	_	NOUN	NN	_	17	compound	_	_
14	0.320	_	NUM	CD	_	17	nummod	_	_
15	0.103	_	NUM	CD	_	17	nummod	_	_
16	Single	_	ADJ	JJ	_	17	amod	_	_
17	Dose	_	NOUN	NN	_	11	dep	_	_
18	Peak	_	ADJ	JJ	_	17	dep	_	_

#	Brintellix	5130
1	Strong	_	ADJ	JJ	_	2	amod	_	_
2	inhibitors	_	NOUN	NNS	_	6	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	CYP2D6	_	NOUN	NN	_	2	nmod	_	_
5	:	_	.	:	_	2	punct	_	_
6	Reduce	_	VERB	VBP	_	0	root	_	_
7	DRUG	_	NOUN	NN	_	8	compound	_	_
8	dose	_	NOUN	NN	_	6	dobj	_	_
9	by	_	ADP	IN	_	10	case	_	_
10	half	_	NOUN	NN	_	6	nmod	_	_
11	when	_	ADV	WRB	_	27	advmod	_	_
12	a	_	DET	DT	_	16	det	_	_
13	strong	_	ADJ	JJ	_	16	amod	_	_
14	CYP2D6	_	NOUN	NN	_	16	compound	_	_
15	inhibitor	_	NOUN	NN	_	16	compound	_	_
16	e.g	_	NOUN	NN	_	27	nsubjpass	_	_
17	,	_	.	,	_	16	punct	_	_
18	bupropion	_	NOUN	NN	_	16	conj	_	_
19	,	_	.	,	_	16	punct	_	_
20	fluoxetine	_	NOUN	NN	_	16	conj	_	_
21	,	_	.	,	_	16	punct	_	_
22	paroxetine	_	NOUN	NN	_	16	conj	_	_
23	,	_	.	,	_	16	punct	_	_
24	or	_	CONJ	CC	_	16	cc	_	_
25	quinidine	_	NOUN	NN	_	16	conj	_	_
26	is	_	VERB	VBZ	_	27	auxpass	_	_
27	coadministered	_	VERB	VBN	_	6	advcl	_	_
28	2.6	_	NUM	CD	_	27	neg	_	_
29	and	_	CONJ	CC	_	28	cc	_	_
30	7.3	_	NUM	CD	_	28	conj	_	_

#	Brintellix	5131
1	Strong	_	ADJ	JJ	_	3	amod	_	_
2	CYP	_	NOUN	NN	_	3	compound	_	_
3	Inducers	_	NOUN	NNS	_	0	root	_	_
4	:	_	.	:	_	3	punct	_	_
5	Consider	_	VERB	VBP	_	6	advmod	_	_
6	increasing	_	VERB	VBG	_	3	dep	_	_
7	DRUG	_	NOUN	NN	_	8	compound	_	_
8	dose	_	NOUN	NN	_	6	dobj	_	_
9	when	_	ADV	WRB	_	23	advmod	_	_
10	a	_	DET	DT	_	14	det	_	_
11	strong	_	ADJ	JJ	_	14	amod	_	_
12	CYP	_	NOUN	NN	_	14	compound	_	_
13	inducer	_	NOUN	NN	_	14	compound	_	_
14	e.g	_	NOUN	NN	_	23	nsubjpass	_	_
15	,	_	.	,	_	14	punct	_	_
16	rifampin	_	NOUN	NN	_	14	conj	_	_
17	,	_	.	,	_	14	punct	_	_
18	carbamazepine	_	NOUN	NN	_	14	conj	_	_
19	,	_	.	,	_	14	punct	_	_
20	or	_	CONJ	CC	_	14	cc	_	_
21	phenytoin	_	NOUN	NN	_	14	conj	_	_
22	is	_	VERB	VBZ	_	23	auxpass	_	_
23	coadministered	_	VERB	VBN	_	6	advcl	_	_
24	for	_	ADP	IN	_	28	case	_	_
25	more	_	ADV	RB	_	27	advmod	_	_
26	than	_	ADP	IN	_	25	mwe	_	_
27	14	_	NUM	CD	_	28	nummod	_	_
28	days	_	NOUN	NNS	_	23	nmod	_	_

#	Brintellix	5132
1	The	_	DET	DT	_	4	det	_	_
2	maximum	_	NOUN	NN	_	4	compound	_	_
3	recommended	_	ADJ	JJ	_	4	amod	_	_
4	dose	_	NOUN	NN	_	7	nsubj	_	_
5	should	_	VERB	MD	_	7	aux	_	_
6	not	_	ADV	RB	_	7	neg	_	_
7	exceed	_	VERB	VBN	_	0	root	_	_
8	3	_	NUM	CD	_	9	nummod	_	_
9	times	_	NOUN	NNS	_	7	dobj	_	_
10	the	_	DET	DT	_	11	det	_	_
11	original	_	ADJ	JJ	_	9	dep	_	_
12	dose	_	NOUN	NN	_	11	dep	_	_
13	2.7	_	NUM	CD	_	12	dep	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	7.3	_	NUM	CD	_	13	conj	_	_

#	Brintellix	5133
1	Monoamine	_	NOUN	NN	_	3	compound	_	_
2	Oxidase	_	NOUN	NN	_	3	compound	_	_
3	Inhibitors	_	NOUN	NNS	_	16	nsubj	_	_
4	Adverse	_	ADJ	JJ	_	5	amod	_	_
5	reactions	_	NOUN	NNS	_	3	dep	_	_
6	,	_	.	,	_	5	punct	_	_
7	some	_	DET	DT	_	11	nsubj	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	which	_	DET	WDT	_	7	nmod	_	_
10	are	_	VERB	VBP	_	11	cop	_	_
11	serious	_	ADJ	JJ	_	5	acl:relcl	_	_
12	or	_	CONJ	CC	_	11	cc	_	_
13	fatal	_	ADJ	JJ	_	11	conj	_	_
14	,	_	.	,	_	3	punct	_	_
15	can	_	VERB	MD	_	16	aux	_	_
16	develop	_	VERB	VB	_	0	root	_	_
17	in	_	ADP	IN	_	18	case	_	_
18	patients	_	NOUN	NNS	_	16	nmod	_	_
19	who	_	DET	WDT	_	20	nsubj	_	_
20	use	_	VERB	VBP	_	18	acl:relcl	_	_
21	MAOIs	_	NOUN	NNS	_	20	dobj	_	_
22	or	_	CONJ	CC	_	20	cc	_	_
23	who	_	DET	WDT	_	27	nsubjpass	_	_
24	have	_	VERB	VBP	_	27	aux	_	_
25	recently	_	ADV	RB	_	27	advmod	_	_
26	been	_	VERB	VBN	_	27	auxpass	_	_
27	discontinued	_	VERB	VBN	_	20	conj	_	_
28	from	_	ADP	IN	_	30	case	_	_
29	an	_	DET	DT	_	30	det	_	_
30	MAOI	_	NOUN	NN	_	27	nmod	_	_
31	and	_	CONJ	CC	_	27	cc	_	_
32	started	_	VERB	VBN	_	27	conj	_	_
33	on	_	ADP	IN	_	36	case	_	_
34	a	_	DET	DT	_	36	det	_	_
35	serotonergic	_	ADJ	JJ	_	36	amod	_	_
36	antidepressant(s	_	NOUN	NNS	_	32	nmod	_	_
37	or	_	CONJ	CC	_	27	cc	_	_
38	who	_	DET	WDT	_	41	nsubj	_	_
39	have	_	VERB	VBP	_	41	aux	_	_
40	recently	_	ADV	RB	_	41	advmod	_	_
41	had	_	VERB	VB	_	27	conj	_	_
42	SSRI	_	NOUN	NN	_	41	dobj	_	_
43	or	_	CONJ	CC	_	42	cc	_	_
44	SNRI	_	NOUN	NN	_	42	conj	_	_
45	therapy	_	NOUN	NN	_	42	dep	_	_
46	discontinued	_	VERB	VBN	_	42	acl	_	_
47	prior	_	ADJ	JJ	_	46	xcomp	_	_
48	to	_	PRT	TO	_	49	case	_	_
49	initiation	_	NOUN	NN	_	47	nmod	_	_
50	of	_	ADP	IN	_	52	case	_	_
51	an	_	DET	DT	_	52	det	_	_
52	MAOI	_	NOUN	NN	_	49	nmod	_	_

#	Brintellix	5134
1	Serotonergic	_	ADJ	JJ	_	2	amod	_	_
2	Drugs	_	NOUN	NNS	_	3	nsubj	_	_
3	Based	_	VERB	VBD	_	21	advcl	_	_
4	on	_	ADP	IN	_	6	case	_	_
5	the	_	DET	DT	_	6	det	_	_
6	mechanism	_	NOUN	NN	_	3	nmod	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	action	_	NOUN	NN	_	6	nmod	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	and	_	CONJ	CC	_	6	cc	_	_
12	the	_	DET	DT	_	13	det	_	_
13	potential	_	NOUN	NN	_	6	conj	_	_
14	for	_	ADP	IN	_	16	case	_	_
15	serotonin	_	NOUN	NN	_	16	compound	_	_
16	toxicity	_	NOUN	NN	_	13	nmod	_	_
17	,	_	.	,	_	21	punct	_	_
18	serotonin	_	NOUN	NN	_	19	compound	_	_
19	syndrome	_	NOUN	NN	_	21	nsubj	_	_
20	may	_	VERB	MD	_	21	aux	_	_
21	occur	_	VERB	VB	_	0	root	_	_
22	when	_	ADV	WRB	_	25	advmod	_	_
23	DRUG	_	NOUN	NN	_	25	nsubjpass	_	_
24	is	_	VERB	VBZ	_	25	auxpass	_	_
25	coadministered	_	VERB	VBN	_	21	ccomp	_	_
26	with	_	ADP	IN	_	28	case	_	_
27	other	_	ADJ	JJ	_	28	amod	_	_
28	drugs	_	NOUN	NNS	_	25	nmod	_	_
29	that	_	DET	WDT	_	31	nsubj	_	_
30	may	_	VERB	MD	_	31	aux	_	_
31	affect	_	VERB	VB	_	28	acl:relcl	_	_
32	the	_	DET	DT	_	35	det	_	_
33	serotonergic	_	ADJ	JJ	_	35	amod	_	_
34	neurotransmitter	_	ADJ	JJ	_	35	amod	_	_
35	systems	_	NOUN	NNS	_	31	dobj	_	_
36	e.g	_	NOUN	NN	_	35	dep	_	_
37	,	_	.	,	_	36	punct	_	_
38	SSRIs	_	NOUN	NNS	_	36	conj	_	_
39	,	_	.	,	_	36	punct	_	_
40	SNRIs	_	NOUN	NNS	_	36	conj	_	_
41	,	_	.	,	_	36	punct	_	_
42	triptans	_	NOUN	NNS	_	36	conj	_	_
43	,	_	.	,	_	36	punct	_	_
44	buspirone	_	NOUN	NN	_	36	conj	_	_
45	,	_	.	,	_	36	punct	_	_
46	tramadol	_	NOUN	NN	_	36	conj	_	_
47	,	_	.	,	_	36	punct	_	_
48	and	_	CONJ	CC	_	36	cc	_	_
49	tryptophan	_	NOUN	NN	_	51	compound	_	_
50	products	_	NOUN	NNS	_	51	compound	_	_
51	etc	_	NOUN	NN	_	36	conj	_	_

#	Brintellix	5135
1	Closely	_	ADV	RB	_	2	advmod	_	_
2	monitor	_	VERB	VBP	_	3	amod	_	_
3	symptoms	_	NOUN	NNS	_	0	root	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	serotonin	_	NOUN	NN	_	6	compound	_	_
6	syndrome	_	NOUN	NN	_	3	nmod	_	_
7	if	_	ADP	IN	_	11	mark	_	_
8	DRUG	_	NOUN	NN	_	11	nsubjpass	_	_
9	is	_	VERB	VBZ	_	11	auxpass	_	_
10	co	_	PRT	TO	_	11	mark	_	_
11	administered	_	VERB	VBN	_	3	acl	_	_
12	with	_	ADP	IN	_	15	case	_	_
13	other	_	ADJ	JJ	_	15	amod	_	_
14	serotonergic	_	ADJ	JJ	_	15	amod	_	_
15	drugs	_	NOUN	NNS	_	11	nmod	_	_

#	Brintellix	5136
1	Treatment	_	NOUN	NN	_	11	nsubjpass	_	_
2	with	_	ADP	IN	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	and	_	CONJ	CC	_	1	cc	_	_
5	any	_	DET	DT	_	8	det	_	_
6	concomitant	_	ADJ	JJ	_	8	amod	_	_
7	serotonergic	_	ADJ	JJ	_	8	amod	_	_
8	agents	_	NOUN	NNS	_	1	conj	_	_
9	should	_	VERB	MD	_	11	aux	_	_
10	be	_	VERB	VB	_	11	auxpass	_	_
11	discontinued	_	VERB	VBN	_	0	root	_	_
12	immediately	_	ADV	RB	_	11	advmod	_	_
13	if	_	ADP	IN	_	16	mark	_	_
14	serotonin	_	NOUN	NN	_	15	compound	_	_
15	syndrome	_	NOUN	NN	_	16	nsubj	_	_
16	occurs	_	VERB	VBZ	_	11	root	_	_

#	Brintellix	5137
1	Other	_	ADJ	JJ	_	4	amod	_	_
2	CNS	_	NOUN	NN	_	4	compound	_	_
3	Active	_	ADJ	JJ	_	4	amod	_	_
4	Agents	_	NOUN	NNS	_	10	nsubjpass	_	_
5	No	_	VERB	VBP	_	8	compound	_	_
6	clinically	_	ADV	RB	_	7	advmod	_	_
7	relevant	_	ADJ	JJ	_	8	amod	_	_
8	effect	_	NOUN	NN	_	4	nmod	_	_
9	was	_	VERB	VBD	_	10	auxpass	_	_
10	observed	_	VERB	VBN	_	0	root	_	_
11	on	_	ADP	IN	_	15	case	_	_
12	steady	_	ADJ	JJ	_	15	amod	_	_
13	state	_	NOUN	NN	_	15	compound	_	_
14	lithium	_	NOUN	NN	_	15	compound	_	_
15	exposure	_	NOUN	NN	_	10	nmod	_	_
16	following	_	ADP	IN	_	17	case	_	_
17	coadministration	_	NOUN	NN	_	10	nmod	_	_
18	with	_	ADP	IN	_	21	case	_	_
19	multiple	_	ADJ	JJ	_	21	amod	_	_
20	daily	_	ADJ	JJ	_	21	amod	_	_
21	doses	_	NOUN	NNS	_	17	nmod	_	_
22	of	_	ADP	IN	_	23	case	_	_
23	DRUG	_	NOUN	NN	_	21	nmod	_	_

#	Brintellix	5138
1	Multiple	_	ADJ	JJ	_	2	amod	_	_
2	doses	_	NOUN	NNS	_	7	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	did	_	VERB	VBD	_	7	aux	_	_
6	not	_	ADV	RB	_	7	neg	_	_
7	affect	_	VERB	VB	_	0	root	_	_
8	the	_	DET	DT	_	9	det	_	_
9	pharmacokinetics	_	NOUN	NNS	_	7	dobj	_	_
10	or	_	CONJ	CC	_	9	cc	_	_
11	pharmacodynamics	_	NOUN	NNS	_	14	compound	_	_
12	composite	_	ADJ	JJ	_	14	amod	_	_
13	cognitive	_	ADJ	JJ	_	14	amod	_	_
14	score	_	NOUN	NN	_	9	conj	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	diazepam	_	NOUN	NN	_	9	nmod	_	_

#	Brintellix	5139
1	A	_	DET	DT	_	3	det	_	_
2	clinical	_	ADJ	JJ	_	3	amod	_	_
3	study	_	NOUN	NN	_	5	nsubj	_	_
4	has	_	VERB	VBZ	_	5	aux	_	_
5	shown	_	VERB	VBN	_	0	root	_	_
6	that	_	ADP	IN	_	17	mark	_	_
7	DRUG	_	NOUN	NN	_	9	compound	_	_
8	single	_	ADJ	JJ	_	9	amod	_	_
9	dose	_	NOUN	NN	_	17	nsubj	_	_
10	of	_	ADP	IN	_	14	case	_	_
11	20	_	NUM	CD	_	14	nummod	_	_
12	or	_	CONJ	CC	_	11	cc	_	_
13	40	_	NUM	CD	_	11	conj	_	_
14	mg	_	NOUN	NN	_	9	nmod	_	_
15	did	_	VERB	VBD	_	17	aux	_	_
16	not	_	ADV	RB	_	17	neg	_	_
17	increase	_	VERB	VB	_	5	ccomp	_	_
18	the	_	DET	DT	_	19	det	_	_
19	impairment	_	NOUN	NN	_	17	dobj	_	_
20	of	_	ADP	IN	_	24	case	_	_
21	mental	_	ADJ	JJ	_	24	amod	_	_
22	and	_	CONJ	CC	_	21	cc	_	_
23	motor	_	NOUN	NN	_	21	conj	_	_
24	skills	_	NOUN	NNS	_	19	nmod	_	_
25	caused	_	VERB	VBN	_	24	acl	_	_
26	by	_	ADP	IN	_	29	case	_	_
27	alcohol	_	NOUN	NN	_	29	compound	_	_
28	single	_	ADJ	JJ	_	29	amod	_	_
29	dose	_	NOUN	NN	_	25	nmod	_	_
30	of	_	ADP	IN	_	32	case	_	_
31	0.6	_	NUM	CD	_	32	nummod	_	_
32	g	_	NOUN	NN	_	34	compound	_	_
33	/	_	.	:	_	34	punct	_	_
34	kg	_	NOUN	NN	_	29	nmod	_	_

#	Brintellix	5140
1	Details	_	NOUN	NNS	_	13	nsubjpass	_	_
2	on	_	ADP	IN	_	6	case	_	_
3	the	_	DET	DT	_	6	det	_	_
4	potential	_	ADJ	JJ	_	6	amod	_	_
5	pharmacokinetic	_	ADJ	JJ	_	6	amod	_	_
6	interactions	_	NOUN	NNS	_	1	nmod	_	_
7	between	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	bupropion	_	NOUN	NN	_	8	conj	_	_
11	can	_	VERB	MD	_	13	aux	_	_
12	be	_	VERB	VB	_	13	auxpass	_	_
13	found	_	VERB	VBN	_	0	root	_	_
14	in	_	ADP	IN	_	15	case	_	_
15	Section	_	NOUN	NN	_	13	nmod	_	_
16	7.3	_	NUM	CD	_	15	nummod	_	_

#	Brintellix	5141
1	Serotonin	_	NOUN	NN	_	2	compound	_	_
2	release	_	NOUN	NN	_	5	nsubj	_	_
3	by	_	ADP	IN	_	4	case	_	_
4	platelets	_	NOUN	NNS	_	2	nmod	_	_
5	plays	_	VERB	VBZ	_	0	root	_	_
6	an	_	DET	DT	_	8	det	_	_
7	important	_	ADJ	JJ	_	8	amod	_	_
8	role	_	NOUN	NN	_	5	dobj	_	_
9	in	_	ADP	IN	_	10	case	_	_
10	hemostasis	_	NOUN	NN	_	8	nmod	_	_

#	Brintellix	5142
1	Epidemiological	_	ADJ	JJ	_	2	amod	_	_
2	studies	_	NOUN	NNS	_	10	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	case	_	NOUN	NN	_	5	compound	_	_
5	control	_	NOUN	NN	_	2	nmod	_	_
6	and	_	CONJ	CC	_	2	cc	_	_
7	cohort	_	NOUN	NN	_	8	compound	_	_
8	design	_	NOUN	NN	_	2	conj	_	_
9	have	_	VERB	VBP	_	10	aux	_	_
10	demonstrated	_	VERB	VBN	_	0	root	_	_
11	an	_	DET	DT	_	12	det	_	_
12	association	_	NOUN	NN	_	10	dobj	_	_
13	between	_	ADP	IN	_	14	case	_	_
14	use	_	NOUN	NN	_	12	nmod	_	_
15	of	_	ADP	IN	_	17	case	_	_
16	psychotropic	_	ADJ	JJ	_	17	amod	_	_
17	drugs	_	NOUN	NNS	_	14	nmod	_	_
18	that	_	DET	WDT	_	19	nsubj	_	_
19	interfere	_	VERB	VBP	_	17	acl:relcl	_	_
20	with	_	ADP	IN	_	22	case	_	_
21	serotonin	_	NOUN	NN	_	22	compound	_	_
22	reuptake	_	NOUN	NN	_	19	nmod	_	_
23	and	_	CONJ	CC	_	19	cc	_	_
24	the	_	DET	DT	_	25	det	_	_
25	occurrence	_	NOUN	NN	_	19	conj	_	_
26	of	_	ADP	IN	_	27	mark	_	_
27	upper	_	VERB	VBG	_	25	acl	_	_
28	gastrointestinal	_	ADJ	JJ	_	29	amod	_	_
29	bleeding	_	NOUN	NN	_	27	dobj	_	_

#	Brintellix	5143
1	These	_	DET	DT	_	2	det	_	_
2	studies	_	NOUN	NNS	_	5	nsubj	_	_
3	have	_	VERB	VBP	_	5	aux	_	_
4	also	_	ADV	RB	_	5	advmod	_	_
5	shown	_	VERB	VBN	_	0	root	_	_
6	that	_	ADP	IN	_	15	mark	_	_
7	concurrent	_	ADJ	JJ	_	8	amod	_	_
8	use	_	NOUN	NN	_	15	nsubj	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	an	_	DET	DT	_	11	det	_	_
11	NSAID	_	NOUN	NN	_	8	nmod	_	_
12	or	_	CONJ	CC	_	11	cc	_	_
13	aspirin	_	NOUN	NN	_	11	conj	_	_
14	may	_	VERB	MD	_	15	aux	_	_
15	potentiate	_	VERB	VB	_	5	ccomp	_	_
16	this	_	DET	DT	_	17	det	_	_
17	risk	_	NOUN	NN	_	15	dobj	_	_
18	of	_	ADP	IN	_	19	mark	_	_
19	bleeding	_	VERB	VBG	_	17	nmod	_	_

#	Brintellix	5144
1	Altered	_	VERB	VBN	_	3	amod	_	_
2	anticoagulant	_	ADJ	JJ	_	3	amod	_	_
3	effects	_	NOUN	NNS	_	11	nsubjpass	_	_
4	,	_	.	,	_	3	punct	_	_
5	including	_	VERB	VBG	_	7	case	_	_
6	increased	_	VERB	VBN	_	7	amod	_	_
7	bleeding	_	NOUN	NN	_	3	nmod	_	_
8	,	_	.	,	_	3	punct	_	_
9	have	_	VERB	VBP	_	11	aux	_	_
10	been	_	VERB	VBN	_	11	auxpass	_	_
11	reported	_	VERB	VBN	_	0	root	_	_
12	when	_	ADV	WRB	_	17	advmod	_	_
13	SSRIs	_	NOUN	NNS	_	17	nsubjpass	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	SNRIs	_	NOUN	NNS	_	13	conj	_	_
16	are	_	VERB	VBP	_	17	auxpass	_	_
17	coadministered	_	VERB	VBN	_	11	advcl	_	_
18	with	_	ADP	IN	_	19	case	_	_
19	warfarin	_	NOUN	NN	_	17	nmod	_	_

#	Brintellix	5145
1	Following	_	VERB	VBG	_	2	case	_	_
2	coadministration	_	NOUN	NN	_	25	nmod	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	stable	_	ADJ	JJ	_	5	amod	_	_
5	doses	_	NOUN	NNS	_	2	nmod	_	_
6	of	_	ADP	IN	_	11	case	_	_
7	warfarin	_	NOUN	NN	_	11	compound	_	_
8	1	_	NUM	CD	_	10	compound	_	_
9	to	_	PRT	TO	_	10	dep	_	_
10	10	_	NUM	CD	_	11	nummod	_	_
11	mg	_	NOUN	NN	_	5	nmod	_	_
12	/	_	.	:	_	13	punct	_	_
13	day	_	NOUN	NN	_	2	dep	_	_
14	with	_	ADP	IN	_	17	case	_	_
15	multiple	_	ADJ	JJ	_	17	amod	_	_
16	daily	_	ADV	RB	_	17	amod	_	_
17	doses	_	NOUN	NNS	_	13	nmod	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	DRUG	_	NOUN	NN	_	17	nmod	_	_
20	,	_	.	,	_	25	punct	_	_
21	no	_	DET	DT	_	23	neg	_	_
22	significant	_	ADJ	JJ	_	23	amod	_	_
23	effects	_	NOUN	NNS	_	25	nsubjpass	_	_
24	were	_	VERB	VBD	_	25	auxpass	_	_
25	observed	_	VERB	VBN	_	0	root	_	_
26	in	_	ADP	IN	_	27	case	_	_
27	INR	_	NOUN	NN	_	25	nmod	_	_
28	,	_	.	,	_	27	punct	_	_
29	prothrombin	_	NOUN	NN	_	30	compound	_	_
30	values	_	NOUN	NNS	_	27	conj	_	_
31	or	_	CONJ	CC	_	27	cc	_	_
32	total	_	ADJ	JJ	_	34	amod	_	_
33	warfarin	_	NOUN	NN	_	34	compound	_	_
34	protein	_	NOUN	NN	_	27	conj	_	_
35	bound	_	VERB	VBN	_	34	acl	_	_
36	plus	_	CONJ	CC	_	35	cc	_	_
37	free	_	ADJ	JJ	_	39	amod	_	_
38	drug	_	NOUN	NN	_	39	compound	_	_
39	pharmacokinetics	_	NOUN	NNS	_	35	conj	_	_
40	for	_	ADP	IN	_	42	case	_	_
41	both	_	CONJ	CC	_	42	cc:preconj	_	_
42	R	_	NOUN	NN	_	35	nmod	_	_
43	and	_	CONJ	CC	_	42	cc	_	_
44	S	_	NOUN	NN	_	45	compound	_	_
45	warfarin	_	NOUN	NN	_	42	conj	_	_

#	Brintellix	5146
1	Coadministration	_	NOUN	NN	_	0	root	_	_
2	of	_	ADP	IN	_	5	case	_	_
3	aspirin	_	NOUN	NN	_	5	compound	_	_
4	150	_	NUM	CD	_	5	nummod	_	_
5	mg	_	NOUN	NN	_	1	nmod	_	_
6	/	_	.	:	_	1	punct	_	_
7	day	_	NOUN	NN	_	14	nsubj	_	_
8	with	_	ADP	IN	_	11	case	_	_
9	multiple	_	ADJ	JJ	_	11	amod	_	_
10	daily	_	ADJ	JJ	_	11	amod	_	_
11	doses	_	NOUN	NNS	_	7	nmod	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	DRUG	_	NOUN	NN	_	11	nmod	_	_
14	had	_	VERB	VBD	_	1	dep	_	_
15	no	_	DET	DT	_	18	neg	_	_
16	significant	_	ADJ	JJ	_	18	amod	_	_
17	inhibitory	_	ADJ	JJ	_	18	amod	_	_
18	effect	_	NOUN	NN	_	14	dobj	_	_
19	on	_	ADP	IN	_	21	case	_	_
20	platelet	_	NOUN	NN	_	21	compound	_	_
21	aggregation	_	NOUN	NN	_	18	nmod	_	_
22	or	_	CONJ	CC	_	21	cc	_	_
23	pharmacokinetics	_	NOUN	NNS	_	21	conj	_	_
24	of	_	ADP	IN	_	25	case	_	_
25	aspirin	_	NOUN	NN	_	21	nmod	_	_
26	and	_	CONJ	CC	_	25	cc	_	_
27	salicylic	_	ADJ	JJ	_	28	amod	_	_
28	acid	_	NOUN	NN	_	25	conj	_	_

#	Brintellix	5147
1	Patients	_	NOUN	NNS	_	12	nsubjpass	_	_
2	receiving	_	VERB	VBG	_	1	acl	_	_
3	other	_	ADJ	JJ	_	4	amod	_	_
4	drugs	_	NOUN	NNS	_	2	dobj	_	_
5	that	_	DET	WDT	_	6	nsubj	_	_
6	interfere	_	VERB	VBP	_	4	acl:relcl	_	_
7	with	_	ADP	IN	_	8	case	_	_
8	hemostasis	_	NOUN	NN	_	6	nmod	_	_
9	should	_	VERB	MD	_	12	aux	_	_
10	be	_	VERB	VB	_	12	auxpass	_	_
11	carefully	_	ADV	RB	_	12	advmod	_	_
12	monitored	_	VERB	VBN	_	0	root	_	_
13	when	_	ADV	WRB	_	16	advmod	_	_
14	DRUG	_	NOUN	NN	_	16	nsubjpass	_	_
15	is	_	VERB	VBZ	_	16	auxpass	_	_
16	initiated	_	VERB	VBN	_	12	ccomp	_	_
17	or	_	CONJ	CC	_	16	cc	_	_
18	discontinued	_	VERB	VBN	_	16	conj	_	_

#	Brintellix	5148
1	Reduce	_	VERB	VB	_	0	root	_	_
2	DRUG	_	NOUN	NN	_	3	compound	_	_
3	dose	_	NOUN	NN	_	1	dobj	_	_
4	by	_	ADP	IN	_	5	case	_	_
5	half	_	NOUN	NN	_	1	nmod	_	_
6	when	_	ADV	WRB	_	21	advmod	_	_
7	a	_	DET	DT	_	11	det	_	_
8	strong	_	ADJ	JJ	_	11	amod	_	_
9	CYP2D6	_	NOUN	NN	_	11	compound	_	_
10	inhibitor	_	NOUN	NN	_	11	compound	_	_
11	e.g	_	NOUN	NN	_	21	nsubjpass	_	_
12	,	_	.	,	_	11	punct	_	_
13	bupropion	_	NOUN	NN	_	11	conj	_	_
14	,	_	.	,	_	11	punct	_	_
15	fluoxetine	_	NOUN	NN	_	11	conj	_	_
16	,	_	.	,	_	11	punct	_	_
17	paroxetine	_	NOUN	NN	_	11	appos	_	_
18	,	_	.	,	_	11	punct	_	_
19	quinidine	_	NOUN	NN	_	11	appos	_	_
20	is	_	VERB	VBZ	_	21	auxpass	_	_
21	coadministered	_	VERB	VBN	_	1	advcl	_	_

#	Brintellix	5149
1	Consider	_	NOUN	NN	_	0	root	_	_
2	increasing	_	VERB	VBG	_	1	acl	_	_
3	the	_	DET	DT	_	5	det	_	_
4	DRUG	_	NOUN	NN	_	5	compound	_	_
5	dose	_	NOUN	NN	_	2	dobj	_	_
6	when	_	ADV	WRB	_	19	advmod	_	_
7	a	_	DET	DT	_	11	det	_	_
8	strong	_	ADJ	JJ	_	11	amod	_	_
9	CYP	_	NOUN	NN	_	11	compound	_	_
10	inducer	_	NOUN	NN	_	11	compound	_	_
11	e.g	_	NOUN	NN	_	19	nsubjpass	_	_
12	,	_	.	,	_	11	punct	_	_
13	rifampicin	_	NOUN	NN	_	11	appos	_	_
14	,	_	.	,	_	11	punct	_	_
15	carbamazepine	_	NOUN	NN	_	11	appos	_	_
16	,	_	.	,	_	11	punct	_	_
17	phenytoin	_	NOUN	NN	_	11	appos	_	_
18	is	_	VERB	VBZ	_	19	auxpass	_	_
19	coadministered	_	VERB	VBN	_	2	advcl	_	_

#	Brintellix	5150
1	The	_	DET	DT	_	3	det	_	_
2	maximum	_	NOUN	NN	_	3	compound	_	_
3	dose	_	NOUN	NN	_	6	nsubjpass	_	_
4	is	_	VERB	VBZ	_	6	auxpass	_	_
5	not	_	ADV	RB	_	6	neg	_	_
6	recommended	_	VERB	VBN	_	0	root	_	_
7	to	_	PRT	TO	_	8	mark	_	_
8	exceed	_	VERB	VB	_	6	xcomp	_	_
9	three	_	NUM	CD	_	10	nummod	_	_
10	times	_	NOUN	NNS	_	13	compound	_	_
11	the	_	DET	DT	_	13	det	_	_
12	original	_	ADJ	JJ	_	13	amod	_	_
13	dose	_	NOUN	NN	_	8	dobj	_	_

#	Brintellix	5151
1	Impact	_	NOUN	NN	_	16	nsubjpass	_	_
2	of	_	ADP	IN	_	4	case	_	_
3	Other	_	ADJ	JJ	_	4	amod	_	_
4	Drugs	_	NOUN	NNS	_	1	nmod	_	_
5	on	_	ADP	IN	_	11	case	_	_
6	DRUG	_	NOUN	NN	_	11	compound	_	_
7	PK	_	NOUN	NN	_	11	compound	_	_
8	Figure1.jpg	_	NOUN	NN	_	11	compound	_	_
9	No	_	NOUN	NN	_	11	compound	_	_
10	dose	_	NOUN	NN	_	11	compound	_	_
11	adjustment	_	NOUN	NN	_	1	nmod	_	_
12	for	_	ADP	IN	_	14	case	_	_
13	the	_	DET	DT	_	14	det	_	_
14	comedications	_	NOUN	NNS	_	11	nmod	_	_
15	is	_	VERB	VBZ	_	16	auxpass	_	_
16	needed	_	VERB	VBN	_	0	root	_	_
17	when	_	ADV	WRB	_	20	advmod	_	_
18	DRUG	_	NOUN	NN	_	20	nsubjpass	_	_
19	is	_	VERB	VBZ	_	20	auxpass	_	_
20	coadministered	_	VERB	VBN	_	16	advcl	_	_
21	with	_	ADP	IN	_	23	case	_	_
22	a	_	DET	DT	_	23	det	_	_
23	substrate	_	NOUN	NN	_	20	nmod	_	_
24	of	_	ADP	IN	_	26	case	_	_
25	CYP1A2	_	NOUN	NN	_	26	compound	_	_
26	e.g	_	NOUN	NN	_	23	nmod	_	_
27	,	_	.	,	_	26	punct	_	_
28	duloxetine	_	NOUN	NN	_	26	conj	_	_
29	,	_	.	,	_	26	punct	_	_
30	CYP2A6	_	NOUN	NN	_	26	conj	_	_
31	,	_	.	,	_	26	punct	_	_
32	CYP2B6	_	NOUN	NN	_	33	compound	_	_
33	e.g	_	NOUN	NN	_	26	conj	_	_
34	,	_	.	,	_	26	punct	_	_
35	bupropion	_	NOUN	NN	_	26	conj	_	_
36	,	_	.	,	_	26	punct	_	_
37	CYP2C8	_	NOUN	NN	_	38	compound	_	_
38	e.g	_	NOUN	NN	_	26	conj	_	_
39	,	_	.	,	_	26	punct	_	_
40	repaglinide	_	NOUN	NN	_	26	conj	_	_
41	,	_	.	,	_	26	punct	_	_
42	CYP2C9	_	NOUN	NN	_	43	compound	_	_
43	e.g	_	NOUN	NN	_	26	conj	_	_
44	,	_	.	,	_	26	punct	_	_
45	S	_	NOUN	NN	_	46	compound	_	_
46	warfarin	_	NOUN	NN	_	26	conj	_	_
47	,	_	.	,	_	26	punct	_	_
48	CYP2C19	_	NOUN	NN	_	49	compound	_	_
49	e.g	_	NOUN	NN	_	26	conj	_	_
50	,	_	.	,	_	26	punct	_	_
51	diazepam	_	NOUN	NN	_	26	conj	_	_
52	,	_	.	,	_	26	punct	_	_
53	CYP2D6	_	NOUN	NN	_	54	compound	_	_
54	e.g	_	NOUN	NN	_	26	conj	_	_
55	,	_	.	,	_	26	punct	_	_
56	venlafaxine	_	NOUN	NN	_	26	conj	_	_
57	,	_	.	,	_	26	punct	_	_
58	CYP3A4	_	NOUN	NN	_	26	conj	_	_
59	/	_	.	-RRB-	_	26	punct	_	_
60	5	_	NUM	CD	_	61	nummod	_	_
61	e.g	_	NOUN	NN	_	26	conj	_	_
62	,	_	.	,	_	26	punct	_	_
63	budesonide	_	NOUN	NN	_	26	conj	_	_
64	,	_	.	,	_	26	punct	_	_
65	and	_	CONJ	CC	_	26	cc	_	_
66	P	_	NOUN	NN	_	68	compound	_	_
67	gp	_	NOUN	NN	_	68	compound	_	_
68	e.g	_	NOUN	NN	_	26	conj	_	_
69	,	_	.	,	_	16	punct	_	_
70	digoxin	_	NOUN	NN	_	16	root	_	_

#	Brintellix	5152
1	In	_	ADP	IN	_	2	case	_	_
2	addition	_	NOUN	NN	_	15	nmod	_	_
3	,	_	.	,	_	15	punct	_	_
4	no	_	DET	DT	_	6	neg	_	_
5	dose	_	NOUN	NN	_	6	compound	_	_
6	adjustment	_	NOUN	NN	_	15	nsubj	_	_
7	for	_	ADP	IN	_	8	case	_	_
8	lithium	_	NOUN	NN	_	6	nmod	_	_
9	,	_	.	,	_	8	punct	_	_
10	aspirin	_	NOUN	NN	_	8	conj	_	_
11	,	_	.	,	_	8	punct	_	_
12	and	_	CONJ	CC	_	8	cc	_	_
13	warfarin	_	NOUN	NN	_	8	conj	_	_
14	is	_	VERB	VBZ	_	15	auxpass	_	_
15	necessary	_	ADJ	JJ	_	0	root	_	_

#	Brintellix	5153
1	DRUG	_	NOUN	NN	_	6	nsubj	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	its	_	PRON	PRP$	_	4	nmod:poss	_	_
4	metabolites	_	NOUN	NNS	_	1	conj	_	_
5	are	_	VERB	VBP	_	6	cop	_	_
6	unlikely	_	ADJ	JJ	_	0	root	_	_
7	to	_	PRT	TO	_	8	mark	_	_
8	inhibit	_	VERB	VB	_	6	xcomp	_	_
9	the	_	DET	DT	_	12	det	_	_
10	following	_	VERB	VBG	_	12	amod	_	_
11	CYP	_	NOUN	NN	_	12	compound	_	_
12	enzymes	_	NOUN	NNS	_	8	dobj	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	transporter	_	NOUN	NN	_	12	conj	_	_
15	based	_	VERB	VBN	_	12	acl	_	_
16	on	_	ADP	IN	_	19	case	_	_
17	in	_	X	FW	_	19	amod	_	_
18	vitro	_	X	FW	_	17	dep	_	_
19	data	_	NOUN	NNS	_	15	nmod	_	_
20	:	_	.	:	_	6	punct	_	_
21	CYP1A2	_	NOUN	NN	_	6	dep	_	_
22	,	_	.	,	_	21	punct	_	_
23	CYP2A6	_	NOUN	NN	_	21	conj	_	_
24	,	_	.	,	_	21	punct	_	_
25	CYP2B6	_	NOUN	NN	_	21	conj	_	_
26	,	_	.	,	_	21	punct	_	_
27	CYP2C8	_	NOUN	NN	_	21	conj	_	_
28	,	_	.	,	_	21	punct	_	_
29	CYP2C9	_	NOUN	NN	_	21	conj	_	_
30	,	_	.	,	_	21	punct	_	_
31	CYP2C19	_	NOUN	NN	_	21	conj	_	_
32	,	_	.	,	_	21	punct	_	_
33	CYP2D6	_	NOUN	NN	_	21	conj	_	_
34	,	_	.	,	_	21	punct	_	_
35	CYP2E1	_	NOUN	NN	_	21	conj	_	_
36	,	_	.	,	_	21	punct	_	_
37	CYP3A4	_	NOUN	NN	_	21	conj	_	_
38	/	_	.	-RRB-	_	21	punct	_	_
39	5	_	NUM	CD	_	21	nummod	_	_
40	,	_	.	,	_	21	punct	_	_
41	and	_	CONJ	CC	_	21	cc	_	_
42	P	_	NOUN	NN	_	43	compound	_	_
43	gp	_	NOUN	NN	_	21	conj	_	_

#	Brintellix	5154
1	As	_	ADP	IN	_	2	case	_	_
2	such	_	ADJ	JJ	_	17	nmod	_	_
3	,	_	.	,	_	17	punct	_	_
4	no	_	DET	DT	_	7	neg	_	_
5	clinically	_	ADV	RB	_	6	advmod	_	_
6	relevant	_	ADJ	JJ	_	7	amod	_	_
7	interactions	_	NOUN	NNS	_	17	nsubjpass	_	_
8	with	_	ADP	IN	_	9	case	_	_
9	drugs	_	NOUN	NNS	_	7	nmod	_	_
10	metabolized	_	VERB	VBN	_	9	acl	_	_
11	by	_	ADP	IN	_	14	case	_	_
12	these	_	DET	DT	_	14	det	_	_
13	CYP	_	NOUN	NN	_	14	compound	_	_
14	enzymes	_	NOUN	NNS	_	10	nmod	_	_
15	would	_	VERB	MD	_	17	aux	_	_
16	be	_	VERB	VB	_	17	auxpass	_	_
17	expected	_	VERB	VBN	_	0	root	_	_

#	Brintellix	5155
1	In	_	ADP	IN	_	2	case	_	_
2	addition	_	NOUN	NN	_	7	nmod	_	_
3	,	_	.	,	_	7	punct	_	_
4	DRUG	_	NOUN	NN	_	7	nsubj	_	_
5	did	_	VERB	VBD	_	7	aux	_	_
6	not	_	ADV	RB	_	7	neg	_	_
7	induce	_	VERB	VB	_	0	root	_	_
8	CYP1A2	_	NOUN	NN	_	7	dobj	_	_
9	,	_	.	,	_	8	punct	_	_
10	CYP2A6	_	NOUN	NN	_	8	conj	_	_
11	,	_	.	,	_	8	punct	_	_
12	CYP2B6	_	NOUN	NN	_	8	conj	_	_
13	,	_	.	,	_	8	punct	_	_
14	CYP2C8	_	NOUN	NN	_	8	conj	_	_
15	,	_	.	,	_	8	punct	_	_
16	CYP2C9	_	NOUN	NN	_	8	conj	_	_
17	,	_	.	,	_	8	punct	_	_
18	CYP2C19	_	NOUN	NN	_	8	conj	_	_
19	,	_	.	,	_	8	punct	_	_
20	and	_	CONJ	CC	_	8	cc	_	_
21	CYP3A4	_	NOUN	NN	_	8	conj	_	_
22	/	_	.	:	_	7	punct	_	_
23	5	_	NUM	CD	_	7	parataxis	_	_
24	in	_	ADP	IN	_	28	case	_	_
25	an	_	DET	DT	_	28	det	_	_
26	in	_	X	FW	_	28	amod	_	_
27	vitro	_	X	FW	_	26	dep	_	_
28	study	_	NOUN	NN	_	23	nmod	_	_
29	in	_	ADP	IN	_	32	case	_	_
30	cultured	_	VERB	VBN	_	32	amod	_	_
31	human	_	ADJ	JJ	_	32	amod	_	_
32	hepatocytes	_	NOUN	NNS	_	28	nmod	_	_

#	Brintellix	5156
1	Chronic	_	ADJ	JJ	_	2	amod	_	_
2	administration	_	NOUN	NN	_	6	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	is	_	VERB	VBZ	_	6	cop	_	_
6	unlikely	_	ADJ	JJ	_	0	root	_	_
7	to	_	PRT	TO	_	8	mark	_	_
8	induce	_	VERB	VB	_	6	xcomp	_	_
9	the	_	DET	DT	_	10	det	_	_
10	metabolism	_	NOUN	NN	_	8	dobj	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	drugs	_	NOUN	NNS	_	10	nmod	_	_
13	metabolized	_	VERB	VBN	_	12	acl	_	_
14	by	_	ADP	IN	_	17	case	_	_
15	these	_	DET	DT	_	17	det	_	_
16	CYP	_	NOUN	NN	_	17	compound	_	_
17	isoforms	_	NOUN	NNS	_	13	nmod	_	_

#	Brintellix	5157
1	Furthermore	_	ADV	RB	_	34	advmod	_	_
2	,	_	.	,	_	34	punct	_	_
3	in	_	ADP	IN	_	5	case	_	_
4	a	_	DET	DT	_	5	det	_	_
5	series	_	NOUN	NNS	_	34	nmod	_	_
6	of	_	ADP	IN	_	10	case	_	_
7	clinical	_	ADJ	JJ	_	10	amod	_	_
8	drug	_	NOUN	NN	_	10	compound	_	_
9	interaction	_	NOUN	NN	_	10	compound	_	_
10	studies	_	NOUN	NNS	_	5	nmod	_	_
11	,	_	.	,	_	34	punct	_	_
12	coadministration	_	NOUN	NN	_	34	nsubj	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	DRUG	_	NOUN	NN	_	12	nmod	_	_
15	with	_	ADP	IN	_	16	case	_	_
16	substrates	_	NOUN	NNS	_	12	nmod	_	_
17	for	_	ADP	IN	_	19	case	_	_
18	CYP2B6	_	NOUN	NN	_	19	compound	_	_
19	e.g	_	NOUN	NN	_	16	nmod	_	_
20	,	_	.	,	_	19	punct	_	_
21	bupropion	_	NOUN	NN	_	19	conj	_	_
22	,	_	.	,	_	19	punct	_	_
23	CYP2C9	_	NOUN	NN	_	24	compound	_	_
24	e.g	_	NOUN	NN	_	19	conj	_	_
25	,	_	.	,	_	19	punct	_	_
26	warfarin	_	NOUN	NN	_	19	conj	_	_
27	,	_	.	,	_	19	punct	_	_
28	and	_	CONJ	CC	_	19	cc	_	_
29	CYP2C19	_	NOUN	NN	_	30	compound	_	_
30	e.g	_	NOUN	NN	_	19	conj	_	_
31	,	_	.	,	_	19	punct	_	_
32	diazepam	_	NOUN	NN	_	19	appos	_	_
33	,	_	.	,	_	19	punct	_	_
34	had	_	VERB	VBD	_	0	root	_	_
35	no	_	DET	DT	_	38	neg	_	_
36	clinical	_	ADJ	JJ	_	38	amod	_	_
37	meaningful	_	ADJ	JJ	_	38	amod	_	_
38	effect	_	NOUN	NN	_	34	dobj	_	_
39	on	_	ADP	IN	_	41	case	_	_
40	the	_	DET	DT	_	41	det	_	_
41	pharmacokinetics	_	NOUN	NNS	_	34	nmod	_	_
42	of	_	ADP	IN	_	44	case	_	_
43	these	_	DET	DT	_	44	det	_	_
44	substrates	_	NOUN	NNS	_	41	nmod	_	_
45	Figure	_	NOUN	NN	_	44	dep	_	_
46	2	_	NUM	CD	_	45	nummod	_	_

#	Brintellix	5158
1	Because	_	ADP	IN	_	5	mark	_	_
2	DRUG	_	NOUN	NN	_	5	nsubjpass	_	_
3	is	_	VERB	VBZ	_	5	auxpass	_	_
4	highly	_	ADV	RB	_	5	advmod	_	_
5	bound	_	VERB	VBN	_	22	advcl	_	_
6	to	_	PRT	TO	_	8	case	_	_
7	plasma	_	NOUN	NN	_	8	compound	_	_
8	protein	_	NOUN	NN	_	5	nmod	_	_
9	,	_	.	,	_	22	punct	_	_
10	coadministration	_	NOUN	NN	_	22	nsubj	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_
13	with	_	ADP	IN	_	15	case	_	_
14	another	_	DET	DT	_	15	det	_	_
15	drug	_	NOUN	NN	_	10	nmod	_	_
16	that	_	DET	WDT	_	19	nsubj	_	_
17	is	_	VERB	VBZ	_	19	cop	_	_
18	highly	_	ADV	RB	_	19	advmod	_	_
19	protein	_	NOUN	NN	_	15	acl:relcl	_	_
20	bound	_	VERB	VBN	_	19	acl	_	_
21	may	_	VERB	MD	_	22	aux	_	_
22	increase	_	VERB	VB	_	0	root	_	_
23	free	_	ADJ	JJ	_	24	amod	_	_
24	concentrations	_	NOUN	NNS	_	22	dobj	_	_
25	of	_	ADP	IN	_	28	case	_	_
26	the	_	DET	DT	_	28	det	_	_
27	other	_	ADJ	JJ	_	28	amod	_	_
28	drug	_	NOUN	NN	_	24	nmod	_	_

#	Brintellix	5159
1	However	_	ADV	RB	_	2	advmod	_	_
2	,	_	.	,	_	0	root	_	_
3	in	_	ADP	IN	_	6	case	_	_
4	a	_	DET	DT	_	6	det	_	_
5	clinical	_	ADJ	JJ	_	6	amod	_	_
6	study	_	NOUN	NN	_	2	root	_	_
7	with	_	ADP	IN	_	8	case	_	_
8	coadministration	_	NOUN	NN	_	6	nmod	_	_
9	of	_	ADP	IN	_	12	case	_	_
10	DRUG	_	NOUN	NN	_	12	compound	_	_
11	10	_	NUM	CD	_	12	nummod	_	_
12	mg	_	NOUN	NN	_	8	nmod	_	_
13	/	_	.	:	_	14	punct	_	_
14	day	_	NOUN	NN	_	6	nmod	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	warfarin	_	NOUN	NN	_	18	compound	_	_
17	1	_	NUM	CD	_	18	nummod	_	_
18	mg	_	NOUN	NN	_	14	conj	_	_
19	/	_	.	:	_	14	punct	_	_
20	day	_	NOUN	NN	_	14	dep	_	_
21	to	_	PRT	TO	_	23	case	_	_
22	10	_	NUM	CD	_	23	nummod	_	_
23	mg	_	NOUN	NN	_	20	nmod	_	_
24	/	_	.	:	_	14	punct	_	_
25	day	_	NOUN	NN	_	14	dep	_	_
26	,	_	.	,	_	25	punct	_	_
27	a	_	DET	DT	_	29	det	_	_
28	highly	_	ADV	RB	_	29	advmod	_	_
29	protein	_	NOUN	NN	_	25	appos	_	_
30	bound	_	VERB	VBD	_	31	amod	_	_
31	drug	_	NOUN	NN	_	29	dep	_	_
32	,	_	.	,	_	25	punct	_	_
33	no	_	DET	DT	_	35	neg	_	_
34	significant	_	ADJ	JJ	_	35	amod	_	_
35	change	_	NOUN	NN	_	39	nsubjpass	_	_
36	in	_	ADP	IN	_	37	case	_	_
37	INR	_	NOUN	NN	_	35	nmod	_	_
38	was	_	VERB	VBD	_	39	auxpass	_	_
39	observed	_	VERB	VBN	_	25	dep	_	_

#	Brintellix	5160
1	Impact	_	NOUN	NN	_	0	root	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	on	_	ADP	IN	_	5	case	_	_
5	PK	_	NOUN	NN	_	1	nmod	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	Other	_	ADJ	JJ	_	8	amod	_	_
8	Drugs	_	NOUN	NNS	_	5	nmod	_	_
9	Figure2.jpg	_	NOUN	NN	_	8	dep	_	_

#	Brintellix	5161
1	The	_	DET	DT	_	2	det	_	_
2	mechanism	_	NOUN	NN	_	12	nsubjpass	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	the	_	DET	DT	_	6	det	_	_
5	antidepressant	_	ADJ	JJ	_	6	amod	_	_
6	effect	_	NOUN	NN	_	2	nmod	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	is	_	VERB	VBZ	_	12	auxpass	_	_
10	not	_	ADV	RB	_	12	neg	_	_
11	fully	_	ADV	RB	_	12	advmod	_	_
12	understood	_	VERB	VBN	_	0	root	_	_
13	,	_	.	,	_	12	punct	_	_
14	but	_	CONJ	CC	_	12	cc	_	_
15	is	_	VERB	VBZ	_	16	auxpass	_	_
16	thought	_	VERB	VBN	_	12	conj	_	_
17	to	_	PRT	TO	_	19	mark	_	_
18	be	_	VERB	VB	_	19	cop	_	_
19	related	_	ADJ	JJ	_	16	xcomp	_	_
20	to	_	PRT	TO	_	22	case	_	_
21	its	_	PRON	PRP$	_	22	nmod:poss	_	_
22	enhancement	_	NOUN	NN	_	19	nmod	_	_
23	of	_	ADP	IN	_	25	case	_	_
24	serotonergic	_	ADJ	JJ	_	25	amod	_	_
25	activity	_	NOUN	NN	_	22	nmod	_	_
26	in	_	ADP	IN	_	28	case	_	_
27	the	_	DET	DT	_	28	det	_	_
28	CNS	_	NOUN	NN	_	25	nmod	_	_
29	through	_	ADP	IN	_	30	case	_	_
30	inhibition	_	NOUN	NN	_	22	nmod	_	_
31	of	_	ADP	IN	_	33	case	_	_
32	the	_	DET	DT	_	33	det	_	_
33	reuptake	_	NOUN	NN	_	30	nmod	_	_
34	of	_	ADP	IN	_	37	case	_	_
35	serotonin	_	NOUN	NN	_	37	compound	_	_
36	5	_	NUM	CD	_	37	nummod	_	_
37	HT	_	NOUN	NN	_	33	nmod	_	_

#	Brintellix	5162
1	It	_	PRON	PRP	_	3	nsubj	_	_
2	also	_	ADV	RB	_	3	advmod	_	_
3	has	_	VERB	VBZ	_	0	root	_	_
4	several	_	ADJ	JJ	_	6	amod	_	_
5	other	_	ADJ	JJ	_	6	amod	_	_
6	activities	_	NOUN	NNS	_	3	dobj	_	_
7	including	_	ADP	IN	_	11	case	_	_
8	5	_	NUM	CD	_	11	nummod	_	_
9	HT3	_	NOUN	NN	_	11	compound	_	_
10	receptor	_	NOUN	NN	_	11	compound	_	_
11	antagonism	_	NOUN	NN	_	6	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	5	_	NUM	CD	_	16	nummod	_	_
14	HT1A	_	NOUN	NN	_	16	compound	_	_
15	receptor	_	NOUN	NN	_	16	compound	_	_
16	agonism	_	NOUN	NN	_	11	conj	_	_

#	Brintellix	5163
1	The	_	DET	DT	_	2	det	_	_
2	contribution	_	NOUN	NN	_	14	nsubjpass	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	these	_	DET	DT	_	5	det	_	_
5	activities	_	NOUN	NNS	_	2	nmod	_	_
6	to	_	PRT	TO	_	10	case	_	_
7	DRUG	_	NOUN	NN	_	10	nmod:poss	_	_
8	's	_	PRT	POS	_	7	case	_	_
9	antidepressant	_	ADJ	JJ	_	10	amod	_	_
10	effect	_	NOUN	NN	_	2	nmod	_	_
11	has	_	VERB	VBZ	_	14	aux	_	_
12	not	_	ADV	RB	_	14	neg	_	_
13	been	_	VERB	VBN	_	14	auxpass	_	_
14	established	_	VERB	VBN	_	0	root	_	_

#	Brintellix	5164
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	binds	_	VERB	VBZ	_	0	root	_	_
3	with	_	ADP	IN	_	5	case	_	_
4	high	_	ADJ	JJ	_	5	amod	_	_
5	affinity	_	NOUN	NN	_	2	nmod	_	_
6	to	_	PRT	TO	_	12	case	_	_
7	the	_	DET	DT	_	12	det	_	_
8	human	_	ADJ	JJ	_	12	amod	_	_
9	serotonin	_	NOUN	NN	_	12	compound	_	_
10	transporter	_	NOUN	NN	_	12	compound	_	_
11	Ki=1.6	_	NOUN	NN	_	12	compound	_	_
12	nM	_	NOUN	NN	_	5	nmod	_	_
13	,	_	.	,	_	5	punct	_	_
14	but	_	CONJ	CC	_	15	cc	_	_
15	not	_	ADV	RB	_	5	cc	_	_
16	to	_	PRT	TO	_	20	case	_	_
17	the	_	DET	DT	_	20	det	_	_
18	norepinephrine	_	NOUN	NN	_	20	compound	_	_
19	Ki=113	_	NOUN	NN	_	20	compound	_	_
20	nM	_	NOUN	NN	_	5	conj	_	_
21	or	_	CONJ	CC	_	20	cc	_	_
22	dopamine	_	NOUN	NN	_	25	compound	_	_
23	Ki>1000	_	NOUN	NN	_	25	compound	_	_
24	nM	_	NOUN	NN	_	25	compound	_	_
25	transporters	_	NOUN	NNS	_	20	conj	_	_

#	Brintellix	5165
1	DRUG	_	NOUN	NN	_	5	nsubj	_	_
2	potently	_	ADV	RB	_	3	advmod	_	_
3	and	_	CONJ	CC	_	5	advmod	_	_
4	selectively	_	ADV	RB	_	3	advmod	_	_
5	inhibits	_	VERB	VBZ	_	0	root	_	_
6	reuptake	_	NOUN	NN	_	5	dobj	_	_
7	of	_	ADP	IN	_	10	case	_	_
8	serotonin	_	NOUN	NN	_	10	compound	_	_
9	IC50=5.4	_	NOUN	NN	_	10	compound	_	_
10	nM	_	NOUN	NN	_	6	nmod	_	_

#	Brintellix	5166
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	binds	_	VERB	VBZ	_	0	root	_	_
3	to	_	PRT	TO	_	7	case	_	_
4	5	_	NUM	CD	_	7	nummod	_	_
5	HT3	_	NOUN	NN	_	7	compound	_	_
6	Ki=3.7	_	NOUN	NN	_	7	compound	_	_
7	nM	_	NOUN	NN	_	2	nmod	_	_
8	,	_	.	,	_	7	punct	_	_
9	5	_	NUM	CD	_	12	nummod	_	_
10	HT1A	_	NOUN	NN	_	12	compound	_	_
11	Ki=15	_	NOUN	NN	_	12	compound	_	_
12	nM	_	NOUN	NN	_	7	conj	_	_
13	,	_	.	,	_	7	punct	_	_
14	5	_	NUM	CD	_	17	nummod	_	_
15	HT7	_	NOUN	NN	_	17	compound	_	_
16	Ki=19	_	NOUN	NN	_	17	compound	_	_
17	nM	_	NOUN	NN	_	7	conj	_	_
18	,	_	.	,	_	7	punct	_	_
19	5	_	NUM	CD	_	22	nummod	_	_
20	HT1D	_	NOUN	NN	_	22	compound	_	_
21	Ki=54	_	NOUN	NN	_	22	compound	_	_
22	nM	_	NOUN	NN	_	7	conj	_	_
23	,	_	.	,	_	7	punct	_	_
24	and	_	CONJ	CC	_	7	cc	_	_
25	5	_	NUM	CD	_	28	nummod	_	_
26	HT1B	_	NOUN	NN	_	28	compound	_	_
27	Ki=33	_	NOUN	NN	_	28	compound	_	_
28	nM	_	NOUN	NN	_	7	conj	_	_
29	,	_	.	,	_	7	punct	_	_
30	receptors	_	NOUN	NNS	_	7	conj	_	_
31	and	_	CONJ	CC	_	2	cc	_	_
32	is	_	VERB	VBZ	_	35	cop	_	_
33	a	_	DET	DT	_	35	det	_	_
34	5	_	NUM	CD	_	35	nummod	_	_
35	HT3	_	NOUN	NN	_	2	conj	_	_
36	,	_	.	,	_	35	punct	_	_
37	5	_	NUM	CD	_	38	nummod	_	_
38	HT1D	_	NOUN	NN	_	35	conj	_	_
39	,	_	.	,	_	35	punct	_	_
40	and	_	CONJ	CC	_	35	cc	_	_
41	5	_	NUM	CD	_	44	nummod	_	_
42	HT7	_	NOUN	NN	_	44	compound	_	_
43	receptor	_	NOUN	NN	_	44	compound	_	_
44	antagonist	_	NOUN	NN	_	35	conj	_	_
45	,	_	.	,	_	35	punct	_	_
46	5	_	NUM	CD	_	50	nummod	_	_
47	HT1B	_	NOUN	NN	_	50	compound	_	_
48	receptor	_	NOUN	NN	_	50	compound	_	_
49	partial	_	ADJ	JJ	_	50	amod	_	_
50	agonist	_	NOUN	NN	_	35	conj	_	_
51	,	_	.	,	_	35	punct	_	_
52	and	_	CONJ	CC	_	35	cc	_	_
53	5	_	NUM	CD	_	56	nummod	_	_
54	HT1A	_	NOUN	NN	_	56	compound	_	_
55	receptor	_	NOUN	NN	_	56	compound	_	_
56	agonist	_	NOUN	NN	_	35	conj	_	_

#	Brintellix	5167
1	In	_	ADP	IN	_	2	case	_	_
2	humans	_	NOUN	NNS	_	11	nmod	_	_
3	,	_	.	,	_	11	punct	_	_
4	the	_	DET	DT	_	9	det	_	_
5	mean	_	NOUN	NN	_	9	compound	_	_
6	5	_	NUM	CD	_	9	nummod	_	_
7	HT	_	NOUN	NN	_	9	compound	_	_
8	transporter	_	NOUN	NN	_	9	compound	_	_
9	occupancy	_	NOUN	NN	_	11	nsubj	_	_
10	,	_	.	,	_	9	punct	_	_
11	based	_	VERB	VBD	_	0	root	_	_
12	on	_	ADP	IN	_	14	case	_	_
13	the	_	DET	DT	_	14	det	_	_
14	results	_	NOUN	NNS	_	11	nmod	_	_
15	from	_	ADP	IN	_	19	case	_	_
16	2	_	NUM	CD	_	19	nummod	_	_
17	clinical	_	ADJ	JJ	_	19	amod	_	_
18	PET	_	NOUN	NN	_	19	compound	_	_
19	studies	_	NOUN	NNS	_	14	nmod	_	_
20	using	_	VERB	VBG	_	11	xcomp	_	_
21	5	_	NUM	CD	_	23	nummod	_	_
22	HTT	_	NOUN	NN	_	23	compound	_	_
23	ligands	_	NOUN	NNS	_	20	dobj	_	_
24	11C	_	NOUN	NN	_	25	compound	_	_
25	MADAM	_	NOUN	NN	_	23	dep	_	_
26	or	_	CONJ	CC	_	25	cc	_	_
27	11C	_	NOUN	NN	_	28	compound	_	_
28	DASB	_	NOUN	NN	_	25	conj	_	_
29	,	_	.	,	_	11	punct	_	_
30	was	_	VERB	VBD	_	32	cop	_	_
31	approximately	_	ADV	RB	_	32	advmod	_	_
32	50%	_	ADJ	JJ	_	11	parataxis	_	_
33	at	_	ADP	IN	_	35	case	_	_
34	5	_	NUM	CD	_	35	nummod	_	_
35	mg	_	NOUN	NN	_	32	nmod	_	_
36	/	_	.	:	_	32	punct	_	_
37	day	_	NOUN	NN	_	32	nmod	_	_
38	,	_	.	,	_	37	punct	_	_
39	65%	_	NOUN	NN	_	37	appos	_	_
40	at	_	ADP	IN	_	42	case	_	_
41	10	_	NUM	CD	_	42	nummod	_	_
42	mg	_	NOUN	NN	_	39	nmod	_	_
43	/	_	.	:	_	37	punct	_	_
44	day	_	NOUN	NN	_	37	dep	_	_
45	and	_	CONJ	CC	_	44	cc	_	_
46	approximately	_	ADV	RB	_	47	advmod	_	_
47	80%	_	ADJ	JJ	_	44	conj	_	_
48	at	_	ADP	IN	_	52	case	_	_
49	20	_	NUM	CD	_	50	nummod	_	_
50	mg	_	NOUN	NN	_	52	amod	_	_
51	/	_	.	:	_	52	punct	_	_
52	day	_	NOUN	NN	_	47	nmod	_	_
53	in	_	ADP	IN	_	55	case	_	_
54	the	_	DET	DT	_	55	det	_	_
55	regions	_	NOUN	NNS	_	52	nmod	_	_
56	of	_	ADP	IN	_	57	case	_	_
57	interest	_	ADJ	JJ	_	55	nmod	_	_

#	Brintellix	5168
1	Effect	_	NOUN	NN	_	0	root	_	_
2	on	_	ADP	IN	_	4	case	_	_
3	Cardiac	_	ADJ	JJ	_	4	amod	_	_
4	Repolarization	_	NOUN	NN	_	1	nmod	_	_
5	The	_	DET	DT	_	6	det	_	_
6	effect	_	NOUN	NN	_	21	nsubjpass	_	_
7	of	_	ADP	IN	_	10	case	_	_
8	DRUG	_	NOUN	NN	_	10	compound	_	_
9	10	_	NUM	CD	_	10	nummod	_	_
10	mg	_	NOUN	NN	_	6	nmod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	40	_	NUM	CD	_	13	nummod	_	_
13	mg	_	NOUN	NN	_	10	conj	_	_
14	administered	_	VERB	VBN	_	10	acl	_	_
15	once	_	ADV	RB	_	16	advmod	_	_
16	daily	_	ADV	RB	_	14	advmod	_	_
17	on	_	ADP	IN	_	19	case	_	_
18	QTc	_	NOUN	NN	_	19	compound	_	_
19	interval	_	NOUN	NN	_	14	nmod	_	_
20	was	_	VERB	VBD	_	21	auxpass	_	_
21	evaluated	_	VERB	VBN	_	1	acl:relcl	_	_
22	in	_	ADP	IN	_	27	case	_	_
23	a	_	DET	DT	_	27	det	_	_
24	randomized	_	ADJ	JJ	_	27	amod	_	_
25	,	_	.	,	_	24	punct	_	_
26	double	_	ADJ	JJ	_	24	dep	_	_
27	blind	_	NOUN	NN	_	21	nmod	_	_
28	,	_	.	,	_	27	punct	_	_
29	placebo	_	NOUN	NN	_	27	conj	_	_
30	,	_	.	,	_	27	punct	_	_
31	and	_	CONJ	CC	_	27	cc	_	_
32	active	_	ADJ	JJ	_	36	amod	_	_
33	controlled	_	VERB	VBN	_	36	amod	_	_
34	moxifloxacin	_	NOUN	NN	_	36	compound	_	_
35	400	_	NUM	CD	_	36	nummod	_	_
36	mg	_	NOUN	NN	_	27	conj	_	_
37	,	_	.	,	_	1	punct	_	_
38	four	_	NUM	CD	_	39	nummod	_	_
39	treatment	_	NOUN	NN	_	42	compound	_	_
40	arm	_	NOUN	NN	_	42	compound	_	_
41	parallel	_	ADJ	JJ	_	42	amod	_	_
42	study	_	NOUN	NN	_	1	appos	_	_
43	in	_	ADP	IN	_	46	case	_	_
44	340	_	NUM	CD	_	46	nummod	_	_
45	male	_	ADJ	JJ	_	46	amod	_	_
46	subjects	_	NOUN	NNS	_	42	nmod	_	_

#	Brintellix	5169
1	In	_	ADP	IN	_	3	case	_	_
2	the	_	DET	DT	_	3	det	_	_
3	study	_	NOUN	NN	_	18	nmod	_	_
4	the	_	DET	DT	_	5	det	_	_
5	upper	_	NOUN	NN	_	18	nsubj	_	_
6	bound	_	VERB	VBN	_	5	acl	_	_
7	of	_	ADP	IN	_	12	case	_	_
8	the	_	DET	DT	_	12	det	_	_
9	one	_	NUM	CD	_	12	nummod	_	_
10	sided	_	ADJ	JJ	_	12	amod	_	_
11	95%	_	ADJ	JJ	_	12	amod	_	_
12	confidence	_	NOUN	NN	_	6	nmod	_	_
13	interval	_	ADJ	JJ	_	12	amod	_	_
14	for	_	ADP	IN	_	16	case	_	_
15	the	_	DET	DT	_	16	det	_	_
16	QTc	_	NOUN	NN	_	13	nmod	_	_
17	was	_	VERB	VBD	_	18	cop	_	_
18	below	_	VERB	VB	_	0	root	_	_
19	10	_	NUM	CD	_	20	nummod	_	_
20	ms	_	NOUN	NNS	_	18	dobj	_	_
21	,	_	.	,	_	18	punct	_	_
22	the	_	DET	DT	_	23	det	_	_
23	threshold	_	NOUN	NN	_	21	root	_	_
24	for	_	ADP	IN	_	26	case	_	_
25	regulatory	_	ADJ	JJ	_	26	amod	_	_
26	concern	_	NOUN	NNS	_	23	nmod	_	_

#	Brintellix	5170
1	The	_	DET	DT	_	3	det	_	_
2	oral	_	ADJ	JJ	_	3	amod	_	_
3	dose	_	NOUN	NN	_	8	nsubj	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	40	_	NUM	CD	_	6	nummod	_	_
6	mg	_	NOUN	NN	_	3	nmod	_	_
7	is	_	VERB	VBZ	_	8	cop	_	_
8	sufficient	_	ADJ	JJ	_	0	root	_	_
9	to	_	PRT	TO	_	10	mark	_	_
10	assess	_	VERB	VB	_	8	xcomp	_	_
11	the	_	DET	DT	_	12	det	_	_
12	effect	_	NOUN	NN	_	10	dobj	_	_
13	of	_	ADP	IN	_	15	case	_	_
14	metabolic	_	ADJ	JJ	_	15	amod	_	_
15	inhibition	_	NOUN	NN	_	12	nmod	_	_

#	Brintellix	5171
1	Effect	_	NOUN	NN	_	16	nsubj	_	_
2	on	_	ADP	IN	_	4	case	_	_
3	Driving	_	ADJ	JJ	_	4	amod	_	_
4	Performance	_	NOUN	NN	_	1	nmod	_	_
5	In	_	ADP	IN	_	8	case	_	_
6	a	_	DET	DT	_	8	det	_	_
7	clinical	_	ADJ	JJ	_	8	amod	_	_
8	study	_	NOUN	NN	_	1	nmod	_	_
9	in	_	ADP	IN	_	11	case	_	_
10	healthy	_	ADJ	JJ	_	11	amod	_	_
11	subjects	_	NOUN	NNS	_	8	nmod	_	_
12	,	_	.	,	_	16	punct	_	_
13	DRUG	_	NOUN	NN	_	16	nsubj	_	_
14	did	_	VERB	VBD	_	16	aux	_	_
15	not	_	ADV	RB	_	16	neg	_	_
16	impair	_	VERB	VB	_	0	root	_	_
17	driving	_	VERB	VBG	_	16	xcomp	_	_
18	performance	_	NOUN	NN	_	17	dobj	_	_
19	,	_	.	,	_	16	punct	_	_
20	or	_	CONJ	CC	_	16	cc	_	_
21	have	_	VERB	VBP	_	16	conj	_	_
22	adverse	_	ADJ	JJ	_	23	amod	_	_
23	psychomotor	_	NOUN	NN	_	21	dobj	_	_
24	or	_	CONJ	CC	_	23	cc	_	_
25	cognitive	_	ADJ	JJ	_	26	amod	_	_
26	effects	_	NOUN	NNS	_	23	conj	_	_
27	following	_	VERB	VBG	_	31	case	_	_
28	single	_	ADJ	JJ	_	31	amod	_	_
29	and	_	CONJ	CC	_	28	cc	_	_
30	multiple	_	ADJ	JJ	_	28	conj	_	_
31	doses	_	NOUN	NNS	_	21	nmod	_	_
32	of	_	ADP	IN	_	36	case	_	_
33	10	_	NUM	CD	_	36	nummod	_	_
34	mg	_	NOUN	NN	_	36	compound	_	_
35	/	_	NUM	CD	_	36	compound	_	_
36	day	_	NOUN	NN	_	31	nmod	_	_

#	Brintellix	5172
1	Because	_	ADP	IN	_	6	mark	_	_
2	any	_	DET	DT	_	4	det	_	_
3	psychoactive	_	ADJ	JJ	_	4	amod	_	_
4	drug	_	NOUN	NN	_	6	nsubj	_	_
5	may	_	VERB	MD	_	6	aux	_	_
6	impair	_	VERB	VB	_	20	advcl	_	_
7	judgment	_	NOUN	NN	_	6	dobj	_	_
8	,	_	.	,	_	7	punct	_	_
9	thinking	_	NOUN	NN	_	7	conj	_	_
10	,	_	.	,	_	7	punct	_	_
11	or	_	CONJ	CC	_	7	cc	_	_
12	motor	_	NOUN	NN	_	13	compound	_	_
13	skills	_	NOUN	NNS	_	7	conj	_	_
14	,	_	.	,	_	20	punct	_	_
15	however	_	ADV	RB	_	20	advmod	_	_
16	,	_	.	,	_	20	punct	_	_
17	patients	_	NOUN	NNS	_	20	nsubjpass	_	_
18	should	_	VERB	MD	_	20	aux	_	_
19	be	_	VERB	VB	_	20	auxpass	_	_
20	cautioned	_	VERB	VBN	_	0	root	_	_
21	about	_	ADV	RB	_	22	advmod	_	_
22	operating	_	VERB	VBG	_	20	advcl	_	_
23	hazardous	_	ADJ	JJ	_	24	amod	_	_
24	machinery	_	NOUN	NN	_	22	dobj	_	_
25	,	_	.	,	_	24	punct	_	_
26	including	_	VERB	VBG	_	27	case	_	_
27	automobiles	_	NOUN	NNS	_	24	nmod	_	_
28	,	_	.	,	_	20	punct	_	_
29	until	_	ADP	IN	_	33	mark	_	_
30	they	_	PRON	PRP	_	33	nsubj	_	_
31	are	_	VERB	VBP	_	33	cop	_	_
32	reasonably	_	ADV	RB	_	33	advmod	_	_
33	certain	_	ADJ	JJ	_	20	advcl	_	_
34	that	_	ADP	IN	_	39	mark	_	_
35	DRUG	_	NOUN	NN	_	36	compound	_	_
36	therapy	_	NOUN	NN	_	39	nsubj	_	_
37	does	_	VERB	VBZ	_	39	aux	_	_
38	not	_	ADV	RB	_	39	neg	_	_
39	affect	_	VERB	VB	_	33	ccomp	_	_
40	their	_	PRON	PRP$	_	41	nmod:poss	_	_
41	ability	_	NOUN	NN	_	39	dobj	_	_
42	to	_	PRT	TO	_	43	mark	_	_
43	engage	_	VERB	VB	_	41	acl	_	_
44	in	_	ADP	IN	_	46	case	_	_
45	such	_	ADJ	JJ	_	46	amod	_	_
46	activities	_	NOUN	NNS	_	43	nmod	_	_

#	Brintellix	5173
1	DRUG	_	NOUN	NN	_	3	compound	_	_
2	pharmacological	_	ADJ	JJ	_	3	amod	_	_
3	activity	_	NOUN	NN	_	9	nsubj	_	_
4	is	_	VERB	VBZ	_	9	cop	_	_
5	due	_	ADJ	JJ	_	9	case	_	_
6	to	_	PRT	TO	_	5	mwe	_	_
7	the	_	DET	DT	_	9	det	_	_
8	parent	_	NOUN	NN	_	9	compound	_	_
9	drug	_	NOUN	NN	_	0	root	_	_

#	Brintellix	5174
1	The	_	DET	DT	_	2	det	_	_
2	pharmacokinetics	_	NOUN	NNS	_	11	nsubj	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	DRUG	_	NOUN	NN	_	6	compound	_	_
5	2.5	_	NUM	CD	_	6	nummod	_	_
6	mg	_	NOUN	NN	_	2	nmod	_	_
7	to	_	PRT	TO	_	9	case	_	_
8	60	_	NUM	CD	_	9	nummod	_	_
9	mg	_	NOUN	NN	_	2	nmod	_	_
10	are	_	VERB	VBP	_	11	cop	_	_
11	linear	_	ADJ	JJ	_	0	root	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	dose	_	NOUN	NN	_	14	compound	_	_
14	proportional	_	ADJ	JJ	_	11	conj	_	_
15	when	_	ADV	WRB	_	18	advmod	_	_
16	DRUG	_	NOUN	NN	_	18	nsubjpass	_	_
17	is	_	VERB	VBZ	_	18	auxpass	_	_
18	administered	_	VERB	VBN	_	11	ccomp	_	_
19	once	_	ADV	RB	_	18	advmod	_	_
20	daily	_	ADV	RB	_	19	dep	_	_

#	Brintellix	5175
1	The	_	DET	DT	_	5	det	_	_
2	mean	_	ADJ	JJ	_	5	amod	_	_
3	terminal	_	ADJ	JJ	_	5	amod	_	_
4	half	_	NOUN	NN	_	5	compound	_	_
5	life	_	NOUN	NN	_	9	nsubj	_	_
6	is	_	VERB	VBZ	_	9	cop	_	_
7	approximately	_	ADV	RB	_	8	advmod	_	_
8	66	_	NUM	CD	_	9	nummod	_	_
9	hours	_	NOUN	NNS	_	0	root	_	_
10	,	_	.	,	_	9	punct	_	_
11	and	_	CONJ	CC	_	9	cc	_	_
12	steady	_	ADJ	JJ	_	15	amod	_	_
13	state	_	NOUN	NN	_	15	compound	_	_
14	plasma	_	NOUN	NN	_	15	compound	_	_
15	concentrations	_	NOUN	NNS	_	18	nsubjpass	_	_
16	are	_	VERB	VBP	_	18	auxpass	_	_
17	typically	_	ADV	RB	_	18	advmod	_	_
18	achieved	_	VERB	VBN	_	9	conj	_	_
19	within	_	ADP	IN	_	21	case	_	_
20	two	_	NUM	CD	_	21	nummod	_	_
21	weeks	_	NOUN	NNS	_	18	nmod	_	_
22	of	_	ADP	IN	_	23	mark	_	_
23	dosing	_	VERB	VBG	_	21	acl	_	_

#	Brintellix	5176
1	Absorption	_	NOUN	NN	_	11	nsubjpass	_	_
2	The	_	DET	DT	_	7	det	_	_
3	maximal	_	ADJ	JJ	_	7	amod	_	_
4	plasma	_	NOUN	NN	_	7	compound	_	_
5	DRUG	_	NOUN	NN	_	7	compound	_	_
6	concentration	_	NOUN	NN	_	7	compound	_	_
7	Cmax	_	NOUN	NN	_	1	dobj	_	_
8	after	_	ADP	IN	_	9	case	_	_
9	dosing	_	NOUN	NN	_	1	nmod	_	_
10	is	_	VERB	VBZ	_	11	auxpass	_	_
11	reached	_	VERB	VBN	_	0	root	_	_
12	within	_	ADP	IN	_	16	case	_	_
13	7	_	NUM	CD	_	15	compound	_	_
14	to	_	PRT	TO	_	15	dep	_	_
15	11	_	NUM	CD	_	16	nummod	_	_
16	hours	_	NOUN	NNS	_	11	nmod	_	_
17	postdose	_	NOUN	NN	_	18	case	_	_
18	Tmax	_	NOUN	NN	_	16	dep	_	_

#	Brintellix	5177
1	Steady	_	ADJ	JJ	_	5	amod	_	_
2	state	_	NOUN	NN	_	5	compound	_	_
3	mean	_	NOUN	NN	_	5	compound	_	_
4	Cmax	_	NOUN	NN	_	5	compound	_	_
5	values	_	NOUN	NNS	_	9	nsubj	_	_
6	were	_	VERB	VBD	_	9	cop	_	_
7	9	_	NUM	CD	_	9	nummod	_	_
8	,	_	.	,	_	9	punct	_	_
9	18	_	NUM	CD	_	0	root	_	_
10	,	_	.	,	_	9	punct	_	_
11	and	_	CONJ	CC	_	9	cc	_	_
12	33	_	NUM	CD	_	13	nummod	_	_
13	ng	_	NOUN	NN	_	9	conj	_	_
14	/	_	.	:	_	9	punct	_	_
15	mL	_	NOUN	NN	_	9	dep	_	_
16	following	_	VERB	VBG	_	17	case	_	_
17	doses	_	NOUN	NNS	_	15	nmod	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	5	_	NUM	CD	_	17	nmod	_	_
20	,	_	.	,	_	19	punct	_	_
21	10	_	NUM	CD	_	19	conj	_	_
22	,	_	.	,	_	19	punct	_	_
23	and	_	CONJ	CC	_	19	cc	_	_
24	20	_	NUM	CD	_	19	conj	_	_
25	mg	_	NOUN	NN	_	27	compound	_	_
26	/	_	.	:	_	27	punct	_	_
27	day	_	NOUN	NN	_	19	dep	_	_

#	Brintellix	5178
1	No	_	DET	DT	_	2	neg	_	_
2	effect	_	NOUN	NN	_	9	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	food	_	NOUN	NN	_	2	nmod	_	_
5	on	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	pharmacokinetics	_	NOUN	NNS	_	2	nmod	_	_
8	was	_	VERB	VBD	_	9	auxpass	_	_
9	observed	_	VERB	VBN	_	0	root	_	_

#	Brintellix	5179
1	Distribution	_	NOUN	NN	_	11	nsubj	_	_
2	The	_	DET	DT	_	4	det	_	_
3	apparent	_	ADJ	JJ	_	4	amod	_	_
4	volume	_	NOUN	NN	_	1	dobj	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	distribution	_	NOUN	NN	_	4	nmod	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	is	_	VERB	VBZ	_	11	cop	_	_
10	approximately	_	ADV	RB	_	11	advmod	_	_
11	2600L	_	NOUN	NN	_	0	root	_	_
12	,	_	.	,	_	11	punct	_	_
13	indicating	_	VERB	VBG	_	11	acl	_	_
14	extensive	_	ADJ	JJ	_	16	amod	_	_
15	extravascular	_	ADJ	JJ	_	16	amod	_	_
16	distribution	_	NOUN	NN	_	13	dobj	_	_

#	Brintellix	5180
1	The	_	DET	DT	_	4	det	_	_
2	plasma	_	NOUN	NN	_	4	compound	_	_
3	protein	_	NOUN	NN	_	4	compound	_	_
4	binding	_	NOUN	NN	_	10	nsubj	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	in	_	ADP	IN	_	8	case	_	_
8	humans	_	NOUN	NNS	_	4	nmod	_	_
9	is	_	VERB	VBZ	_	10	cop	_	_
10	98%	_	ADJ	JJ	_	0	root	_	_
11	,	_	.	,	_	10	punct	_	_
12	independent	_	ADJ	JJ	_	10	xcomp	_	_
13	of	_	ADP	IN	_	15	case	_	_
14	plasma	_	NOUN	NN	_	15	compound	_	_
15	concentrations	_	NOUN	NNS	_	12	nmod	_	_

#	Brintellix	5181
1	No	_	DET	DT	_	3	neg	_	_
2	apparent	_	ADJ	JJ	_	3	amod	_	_
3	difference	_	NOUN	NN	_	30	nsubjpass	_	_
4	in	_	ADP	IN	_	8	case	_	_
5	the	_	DET	DT	_	8	det	_	_
6	plasma	_	NOUN	NN	_	8	compound	_	_
7	protein	_	NOUN	NN	_	8	compound	_	_
8	binding	_	NOUN	NN	_	3	nmod	_	_
9	between	_	ADP	IN	_	11	case	_	_
10	healthy	_	ADJ	JJ	_	11	amod	_	_
11	subjects	_	NOUN	NNS	_	8	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	subjects	_	NOUN	NNS	_	11	conj	_	_
14	with	_	ADP	IN	_	16	case	_	_
15	hepatic	_	ADJ	JJ	_	16	amod	_	_
16	mild	_	ADJ	JJ	_	11	nmod	_	_
17	,	_	.	,	_	16	punct	_	_
18	moderate	_	ADJ	JJ	_	16	conj	_	_
19	or	_	CONJ	CC	_	16	cc	_	_
20	renal	_	ADJ	JJ	_	21	amod	_	_
21	mild	_	ADJ	JJ	_	16	conj	_	_
22	,	_	.	,	_	16	punct	_	_
23	moderate	_	ADJ	JJ	_	16	conj	_	_
24	,	_	.	,	_	16	punct	_	_
25	severe	_	ADJ	JJ	_	16	conj	_	_
26	,	_	.	,	_	16	punct	_	_
27	ESRD	_	NOUN	NN	_	28	compound	_	_
28	impairment	_	NOUN	NN	_	16	appos	_	_
29	is	_	VERB	VBZ	_	30	auxpass	_	_
30	observed	_	VERB	VBN	_	0	root	_	_

#	Brintellix	5182
1	Metabolism	_	NOUN	NN	_	7	nsubjpass	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	Elimination	_	NOUN	NN	_	4	compound	_	_
4	DRUG	_	NOUN	NN	_	1	conj	_	_
5	is	_	VERB	VBZ	_	7	auxpass	_	_
6	extensively	_	ADV	RB	_	7	advmod	_	_
7	metabolized	_	VERB	VBN	_	0	root	_	_
8	primarily	_	ADV	RB	_	7	advmod	_	_
9	through	_	ADP	IN	_	10	case	_	_
10	oxidation	_	NOUN	NN	_	7	nmod	_	_
11	via	_	ADP	IN	_	14	case	_	_
12	cytochrome	_	NOUN	NN	_	14	compound	_	_
13	P450	_	NOUN	NN	_	14	compound	_	_
14	isozymes	_	NOUN	NNS	_	10	nmod	_	_
15	CYP2D6	_	NOUN	NN	_	14	dep	_	_
16	,	_	.	,	_	15	punct	_	_
17	CYP3A4	_	NOUN	NN	_	15	conj	_	_
18	/	_	.	:	_	15	punct	_	_
19	5,CYP2C19	_	NOUN	NN	_	15	conj	_	_
20	,	_	.	,	_	15	punct	_	_
21	CYP2C9	_	NOUN	NN	_	15	conj	_	_
22	,	_	.	,	_	15	punct	_	_
23	CYP2A6	_	NOUN	NN	_	15	conj	_	_
24	,	_	.	,	_	15	punct	_	_
25	CYP2C8	_	NOUN	NN	_	15	conj	_	_
26	and	_	CONJ	CC	_	15	cc	_	_
27	CYP2B6	_	NOUN	NN	_	15	conj	_	_
28	and	_	CONJ	CC	_	15	cc	_	_
29	subsequent	_	ADJ	JJ	_	32	amod	_	_
30	glucuronic	_	ADJ	JJ	_	32	amod	_	_
31	acid	_	NOUN	NN	_	32	compound	_	_
32	conjugation	_	NOUN	NN	_	15	conj	_	_

#	Brintellix	5183
1	CYP2D6	_	NOUN	NN	_	5	nsubj	_	_
2	is	_	VERB	VBZ	_	5	cop	_	_
3	the	_	DET	DT	_	5	det	_	_
4	primary	_	ADJ	JJ	_	5	amod	_	_
5	enzyme	_	NOUN	NN	_	27	nsubj	_	_
6	catalyzing	_	VERB	VBG	_	5	acl	_	_
7	the	_	DET	DT	_	8	det	_	_
8	metabolism	_	NOUN	NN	_	6	dobj	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	to	_	PRT	TO	_	13	case	_	_
12	its	_	PRON	PRP$	_	13	nmod:poss	_	_
13	major	_	ADJ	JJ	_	8	nmod	_	_
14	,	_	.	,	_	13	punct	_	_
15	pharmacologically	_	ADV	RB	_	16	advmod	_	_
16	inactive	_	ADJ	JJ	_	13	conj	_	_
17	,	_	.	,	_	13	punct	_	_
18	carboxylic	_	ADJ	JJ	_	20	amod	_	_
19	acid	_	NOUN	NN	_	20	compound	_	_
20	metabolite	_	NOUN	NN	_	13	conj	_	_
21	,	_	.	,	_	13	punct	_	_
22	and	_	CONJ	CC	_	13	cc	_	_
23	poor	_	ADJ	JJ	_	24	amod	_	_
24	metabolizers	_	NOUN	NNS	_	13	conj	_	_
25	of	_	ADP	IN	_	26	case	_	_
26	CYP2D6	_	NOUN	NN	_	24	nmod	_	_
27	have	_	VERB	VBP	_	0	root	_	_
28	approximately	_	ADV	RB	_	27	root	_	_
29	twice	_	ADV	WRB	_	28	dep	_	_
30	the	_	DET	DT	_	33	det	_	_
31	DRUG	_	NOUN	NN	_	33	compound	_	_
32	plasma	_	NOUN	NN	_	33	compound	_	_
33	concentration	_	NOUN	NN	_	29	root	_	_
34	of	_	ADP	IN	_	36	case	_	_
35	extensive	_	ADJ	JJ	_	36	amod	_	_
36	metabolizers	_	NOUN	NNS	_	33	nmod	_	_

#	Brintellix	5184
1	Following	_	ADP	IN	_	5	case	_	_
2	a	_	DET	DT	_	5	det	_	_
3	single	_	ADJ	JJ	_	5	amod	_	_
4	oral	_	ADJ	JJ	_	5	amod	_	_
5	dose	_	NOUN	NN	_	20	nmod	_	_
6	of	_	ADP	IN	_	9	case	_	_
7	14C	_	NOUN	NN	_	9	compound	_	_
8	labeled	_	VERB	VBN	_	9	amod	_	_
9	DRUG	_	NOUN	NN	_	5	nmod	_	_
10	,	_	.	,	_	20	punct	_	_
11	approximately	_	ADV	RB	_	12	advmod	_	_
12	59%	_	ADJ	JJ	_	20	nsubjpass	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	26%	_	NOUN	NN	_	12	conj	_	_
15	of	_	ADP	IN	_	18	case	_	_
16	the	_	DET	DT	_	18	det	_	_
17	administered	_	ADJ	JJ	_	18	amod	_	_
18	radioactivity	_	NOUN	NN	_	12	nmod	_	_
19	was	_	VERB	VBD	_	20	auxpass	_	_
20	recovered	_	VERB	VBN	_	0	root	_	_
21	in	_	ADP	IN	_	23	case	_	_
22	the	_	DET	DT	_	23	det	_	_
23	urine	_	ADJ	JJ	_	20	nmod	_	_
24	and	_	CONJ	CC	_	23	cc	_	_
25	feces	_	NOUN	NNS	_	23	conj	_	_
26	,	_	.	,	_	23	punct	_	_
27	respectively	_	ADV	RB	_	23	advmod	_	_
28	as	_	ADP	IN	_	29	case	_	_
29	metabolites	_	NOUN	NNS	_	27	nmod	_	_

#	Brintellix	5185
1	Negligible	_	ADJ	JJ	_	2	amod	_	_
2	amounts	_	NOUN	NNS	_	7	nsubjpass	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	unchanged	_	ADJ	JJ	_	5	amod	_	_
5	DRUG	_	NOUN	NN	_	2	nmod	_	_
6	were	_	VERB	VBD	_	7	auxpass	_	_
7	excreted	_	VERB	VBN	_	0	root	_	_
8	in	_	ADP	IN	_	11	case	_	_
9	the	_	DET	DT	_	11	det	_	_
10	urine	_	ADJ	JJ	_	11	amod	_	_
11	up	_	ADJ	JJ	_	7	nmod	_	_
12	to	_	PRT	TO	_	14	case	_	_
13	48	_	NUM	CD	_	14	nummod	_	_
14	hours	_	NOUN	NNS	_	11	nmod	_	_

#	Brintellix	5186
1	The	_	DET	DT	_	2	det	_	_
2	presence	_	NOUN	NN	_	20	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	hepatic	_	ADJ	JJ	_	5	amod	_	_
5	mild	_	ADJ	JJ	_	2	nmod	_	_
6	or	_	CONJ	CC	_	5	cc	_	_
7	moderate	_	ADJ	JJ	_	5	conj	_	_
8	or	_	CONJ	CC	_	5	cc	_	_
9	renal	_	ADJ	JJ	_	5	conj	_	_
10	impairment	_	NOUN	NN	_	11	compound	_	_
11	mild	_	ADJ	JJ	_	5	dep	_	_
12	,	_	.	,	_	5	punct	_	_
13	moderate	_	ADJ	JJ	_	5	conj	_	_
14	,	_	.	,	_	5	punct	_	_
15	severe	_	ADJ	JJ	_	5	conj	_	_
16	and	_	CONJ	CC	_	5	cc	_	_
17	ESRD	_	NOUN	NN	_	5	conj	_	_
18	did	_	VERB	VBD	_	20	aux	_	_
19	not	_	ADV	RB	_	20	neg	_	_
20	affect	_	VERB	VB	_	0	root	_	_
21	the	_	DET	DT	_	23	det	_	_
22	apparent	_	ADJ	JJ	_	23	amod	_	_
23	clearance	_	NOUN	NN	_	20	dobj	_	_
24	of	_	ADP	IN	_	25	case	_	_
25	DRUG	_	NOUN	NN	_	23	nmod	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2796
1	The	_	DET	DT	_	2	det	_	_
2	risks	_	NOUN	NNS	_	15	nsubjpass	_	_
3	of	_	ADP	IN	_	4	mark	_	_
4	using	_	VERB	VBG	_	2	acl	_	_
5	DRUG	_	NOUN	NN	_	4	dobj	_	_
6	in	_	ADP	IN	_	7	case	_	_
7	combination	_	NOUN	NN	_	4	nmod	_	_
8	with	_	ADP	IN	_	10	case	_	_
9	other	_	ADJ	JJ	_	10	amod	_	_
10	drugs	_	NOUN	NNS	_	7	nmod	_	_
11	have	_	VERB	VBP	_	15	aux	_	_
12	not	_	ADV	RB	_	15	neg	_	_
13	been	_	VERB	VBN	_	15	auxpass	_	_
14	systematically	_	ADV	RB	_	15	advmod	_	_
15	evaluated	_	VERB	VBN	_	0	root	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2797
1	Given	_	ADP	IN	_	5	case	_	_
2	the	_	DET	DT	_	5	det	_	_
3	primary	_	ADJ	JJ	_	5	amod	_	_
4	CNS	_	NOUN	NN	_	5	compound	_	_
5	effects	_	NOUN	NNS	_	11	nmod	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	,	_	.	,	_	11	punct	_	_
9	caution	_	NOUN	NN	_	11	nsubjpass	_	_
10	is	_	VERB	VBZ	_	11	auxpass	_	_
11	advised	_	VERB	VBN	_	0	root	_	_
12	in	_	ADP	IN	_	13	mark	_	_
13	using	_	VERB	VBG	_	11	advcl	_	_
14	it	_	PRON	PRP	_	13	dobj	_	_
15	concomitantly	_	ADV	RB	_	13	advmod	_	_
16	with	_	ADP	IN	_	20	case	_	_
17	other	_	ADJ	JJ	_	20	amod	_	_
18	CNS	_	NOUN	NN	_	20	compound	_	_
19	active	_	ADJ	JJ	_	20	amod	_	_
20	drugs	_	NOUN	NNS	_	15	nmod	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2798
1	DRUG	_	NOUN	NN	_	5	nsubjpass	_	_
2	should	_	VERB	MD	_	5	aux	_	_
3	not	_	ADV	RB	_	5	neg	_	_
4	be	_	VERB	VB	_	5	auxpass	_	_
5	used	_	VERB	VBN	_	0	root	_	_
6	with	_	ADP	IN	_	8	case	_	_
7	MAO	_	NOUN	NN	_	8	compound	_	_
8	inhibitors	_	NOUN	NNS	_	5	nmod	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2799
1	Close	_	ADJ	JJ	_	2	compound	_	_
2	supervision	_	NOUN	NN	_	9	nsubjpass	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	careful	_	ADJ	JJ	_	5	amod	_	_
5	adjustment	_	NOUN	NN	_	2	conj	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	dosage	_	NOUN	NN	_	2	nmod	_	_
8	are	_	VERB	VBP	_	9	auxpass	_	_
9	required	_	VERB	VBN	_	0	root	_	_
10	when	_	ADV	WRB	_	13	advmod	_	_
11	DRUG	_	NOUN	NN	_	13	nsubjpass	_	_
12	is	_	VERB	VBZ	_	13	auxpass	_	_
13	administered	_	VERB	VBN	_	9	ccomp	_	_
14	with	_	ADP	IN	_	18	case	_	_
15	anticholinergic	_	ADJ	JJ	_	18	amod	_	_
16	or	_	CONJ	CC	_	15	cc	_	_
17	sympathomimetic	_	ADJ	JJ	_	15	conj	_	_
18	drugs	_	NOUN	NNS	_	13	nmod	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2800
1	Several	_	ADJ	JJ	_	3	amod	_	_
2	tricyclic	_	ADJ	JJ	_	3	amod	_	_
3	antidepressants	_	NOUN	NNS	_	6	nsubjpass	_	_
4	have	_	VERB	VBP	_	6	aux	_	_
5	been	_	VERB	VBN	_	6	auxpass	_	_
6	reported	_	VERB	VBN	_	0	root	_	_
7	to	_	PRT	TO	_	8	mark	_	_
8	block	_	VERB	VB	_	6	xcomp	_	_
9	the	_	DET	DT	_	11	det	_	_
10	pharmacologic	_	ADJ	JJ	_	11	amod	_	_
11	effects	_	NOUN	NNS	_	8	dobj	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	guanethidine	_	NOUN	NN	_	11	nmod	_	_
14	,	_	.	,	_	13	punct	_	_
15	clonidine	_	NOUN	NN	_	13	conj	_	_
16	,	_	.	,	_	13	punct	_	_
17	or	_	CONJ	CC	_	13	cc	_	_
18	similar	_	ADJ	JJ	_	19	amod	_	_
19	agents	_	NOUN	NNS	_	13	conj	_	_
20	,	_	.	,	_	6	punct	_	_
21	and	_	CONJ	CC	_	6	cc	_	_
22	such	_	ADJ	JJ	_	27	advmod	_	_
23	an	_	DET	DT	_	24	det	_	_
24	effect	_	NOUN	NN	_	27	nsubjpass	_	_
25	may	_	VERB	MD	_	27	aux	_	_
26	be	_	VERB	VB	_	27	auxpass	_	_
27	anticipated	_	VERB	VBN	_	6	conj	_	_
28	with	_	ADP	IN	_	29	case	_	_
29	CMI	_	NOUN	NN	_	27	nmod	_	_
30	because	_	ADP	IN	_	34	case	_	_
31	of	_	ADP	IN	_	34	case	_	_
32	its	_	PRON	PRP$	_	34	nmod:poss	_	_
33	structural	_	ADJ	JJ	_	34	amod	_	_
34	similarity	_	NOUN	NN	_	27	nmod	_	_
35	to	_	PRT	TO	_	38	case	_	_
36	other	_	ADJ	JJ	_	38	amod	_	_
37	tricyclic	_	ADJ	JJ	_	38	amod	_	_
38	antidepressants	_	NOUN	NNS	_	34	nmod	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2801
1	The	_	DET	DT	_	3	det	_	_
2	plasma	_	NOUN	NN	_	3	compound	_	_
3	concentration	_	NOUN	NN	_	8	nsubjpass	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	CMI	_	NOUN	NN	_	3	nmod	_	_
6	has	_	VERB	VBZ	_	8	aux	_	_
7	been	_	VERB	VBN	_	8	auxpass	_	_
8	reported	_	VERB	VBN	_	0	root	_	_
9	to	_	PRT	TO	_	11	mark	_	_
10	be	_	VERB	VB	_	11	auxpass	_	_
11	increased	_	VERB	VBN	_	8	xcomp	_	_
12	by	_	ADP	IN	_	15	case	_	_
13	the	_	DET	DT	_	15	det	_	_
14	concomitant	_	ADJ	JJ	_	15	amod	_	_
15	administration	_	NOUN	NN	_	11	nmod	_	_
16	of	_	ADP	IN	_	19	case	_	_
17	haloperidol	_	NOUN	NN	_	19	compound	_	_
18	plasma	_	NOUN	NN	_	19	compound	_	_
19	levels	_	NOUN	NNS	_	15	nmod	_	_
20	of	_	ADP	IN	_	25	case	_	_
21	several	_	ADJ	JJ	_	25	amod	_	_
22	closely	_	ADV	RB	_	23	advmod	_	_
23	related	_	ADJ	JJ	_	25	amod	_	_
24	tricyclic	_	ADJ	JJ	_	25	amod	_	_
25	antidepressants	_	NOUN	NNS	_	19	nmod	_	_
26	have	_	VERB	VBP	_	28	aux	_	_
27	been	_	VERB	VBN	_	28	auxpass	_	_
28	reported	_	VERB	VBN	_	8	parataxis	_	_
29	to	_	PRT	TO	_	31	mark	_	_
30	be	_	VERB	VB	_	31	auxpass	_	_
31	increased	_	VERB	VBN	_	28	xcomp	_	_
32	by	_	ADP	IN	_	35	case	_	_
33	the	_	DET	DT	_	35	det	_	_
34	concomitant	_	ADJ	JJ	_	35	amod	_	_
35	administration	_	NOUN	NN	_	31	nmod	_	_
36	of	_	ADP	IN	_	37	case	_	_
37	methylphenidate	_	NOUN	NN	_	35	nmod	_	_
38	or	_	CONJ	CC	_	37	cc	_	_
39	hepatic	_	ADJ	JJ	_	41	amod	_	_
40	enzyme	_	NOUN	NN	_	41	compound	_	_
41	inhibitors	_	NOUN	NNS	_	37	conj	_	_
42	e.g	_	NOUN	NN	_	37	dep	_	_
43	,	_	.	,	_	42	punct	_	_
44	cimetidine	_	NOUN	NN	_	42	conj	_	_
45	,	_	.	,	_	42	punct	_	_
46	fluoxetine	_	NOUN	NN	_	42	conj	_	_
47	and	_	CONJ	CC	_	31	cc	_	_
48	decreased	_	VERB	VBD	_	31	conj	_	_
49	by	_	ADP	IN	_	52	case	_	_
50	the	_	DET	DT	_	52	det	_	_
51	concomitant	_	ADJ	JJ	_	52	amod	_	_
52	administration	_	NOUN	NN	_	48	nmod	_	_
53	of	_	ADP	IN	_	56	case	_	_
54	hepatic	_	ADJ	JJ	_	56	amod	_	_
55	enzyme	_	NOUN	NN	_	56	compound	_	_
56	inducers	_	NOUN	NNS	_	52	nmod	_	_
57	e.g	_	NOUN	NN	_	56	dep	_	_
58	,	_	.	,	_	57	punct	_	_
59	barbiturates	_	VERB	VBZ	_	57	conj	_	_
60	,	_	.	,	_	57	punct	_	_
61	phenytoin	_	NOUN	NN	_	57	conj	_	_
62	,	_	.	,	_	57	punct	_	_
63	and	_	CONJ	CC	_	57	cc	_	_
64	such	_	ADJ	JJ	_	66	amod	_	_
65	an	_	DET	DT	_	66	det	_	_
66	effect	_	NOUN	NN	_	57	conj	_	_
67	may	_	VERB	MD	_	69	aux	_	_
68	be	_	VERB	VB	_	69	auxpass	_	_
69	anticipated	_	VERB	VBN	_	31	parataxis	_	_
70	with	_	ADP	IN	_	71	case	_	_
71	CMI	_	NOUN	NN	_	69	nmod	_	_
72	as	_	ADV	RB	_	73	advmod	_	_
73	well	_	ADV	RB	_	69	advmod	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2802
1	Administration	_	NOUN	NN	_	6	nsubjpass	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	CMI	_	NOUN	NN	_	1	nmod	_	_
4	has	_	VERB	VBZ	_	6	aux	_	_
5	been	_	VERB	VBN	_	6	auxpass	_	_
6	reported	_	VERB	VBN	_	0	root	_	_
7	to	_	PRT	TO	_	8	mark	_	_
8	increase	_	VERB	VB	_	6	xcomp	_	_
9	the	_	DET	DT	_	11	det	_	_
10	plasma	_	NOUN	NN	_	11	compound	_	_
11	levels	_	NOUN	NNS	_	8	dobj	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	phenobarbital	_	ADJ	JJ	_	11	nmod	_	_
14	,	_	.	,	_	8	punct	_	_
15	if	_	DET	WDT	_	16	nsubj	_	_
16	given	_	VERB	VBN	_	8	parataxis	_	_
17	concomitantly	_	ADV	RB	_	16	advmod	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2803
1	The	_	DET	DT	_	3	det	_	_
2	biochemical	_	ADJ	JJ	_	3	amod	_	_
3	activity	_	NOUN	NN	_	15	nsubjpass	_	_
4	of	_	ADP	IN	_	13	case	_	_
5	the	_	DET	DT	_	13	det	_	_
6	drug	_	NOUN	NN	_	13	compound	_	_
7	metabolizing	_	VERB	VBG	_	13	compound	_	_
8	isozyme	_	NOUN	NN	_	13	compound	_	_
9	cytochrome	_	NOUN	NN	_	13	compound	_	_
10	P450	_	NOUN	NN	_	13	compound	_	_
11	2D6	_	NOUN	NN	_	13	compound	_	_
12	debrisoquin	_	NOUN	NN	_	13	compound	_	_
13	hydroxylase	_	NOUN	NN	_	3	nmod	_	_
14	is	_	VERB	VBZ	_	15	auxpass	_	_
15	reduced	_	VERB	VBN	_	0	root	_	_
16	in	_	ADP	IN	_	18	case	_	_
17	a	_	DET	DT	_	18	det	_	_
18	subset	_	NOUN	NN	_	15	nmod	_	_
19	of	_	ADP	IN	_	22	case	_	_
20	the	_	DET	DT	_	22	det	_	_
21	caucasian	_	ADJ	JJ	_	22	amod	_	_
22	population	_	NOUN	NN	_	18	nmod	_	_
23	about	_	ADV	RB	_	24	advmod	_	_
24	7%	_	NOUN	NN	_	18	nmod	_	_
25	to	_	PRT	TO	_	26	case	_	_
26	10%	_	NOUN	NN	_	24	nmod	_	_
27	of	_	ADP	IN	_	28	case	_	_
28	Caucasians	_	NOUN	NNS	_	26	nmod	_	_
29	are	_	VERB	VBP	_	31	auxpass	_	_
30	so	_	ADV	RB	_	31	advmod	_	_
31	called	_	VERB	VBN	_	15	parataxis	_	_
32	"poor	_	ADJ	JJ	_	35	amod	_	_
33	metabolizers"	_	NOUN	NN	_	35	compound	_	_
34	reliable	_	ADJ	JJ	_	35	amod	_	_
35	estimates	_	NOUN	NNS	_	31	dobj	_	_
36	of	_	ADP	IN	_	38	case	_	_
37	the	_	DET	DT	_	38	det	_	_
38	prevalence	_	NOUN	NN	_	35	nmod	_	_
39	of	_	ADP	IN	_	44	case	_	_
40	reduced	_	VERB	VBN	_	44	amod	_	_
41	P450	_	NOUN	NN	_	44	compound	_	_
42	2D6	_	NOUN	NN	_	44	compound	_	_
43	isozyme	_	NOUN	NN	_	44	compound	_	_
44	activity	_	NOUN	NN	_	38	nmod	_	_
45	among	_	ADP	IN	_	46	case	_	_
46	Asian	_	NOUN	NN	_	35	nmod	_	_
47	,	_	.	,	_	46	punct	_	_
48	African	_	NOUN	NN	_	46	conj	_	_
49	,	_	.	,	_	46	punct	_	_
50	and	_	CONJ	CC	_	46	cc	_	_
51	other	_	ADJ	JJ	_	46	conj	_	_
52	populations	_	NOUN	NNS	_	46	dep	_	_
53	are	_	VERB	VBP	_	56	auxpass	_	_
54	not	_	ADV	RB	_	56	neg	_	_
55	yet	_	ADV	RB	_	56	advmod	_	_
56	available	_	ADJ	JJ	_	31	parataxis	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2804
1	Poor	_	ADJ	JJ	_	2	amod	_	_
2	metabolizers	_	NOUN	NNS	_	4	nsubj	_	_
3	have	_	VERB	VBP	_	4	aux	_	_
4	higher	_	ADJ	JJ	_	0	root	_	_
5	than	_	ADP	IN	_	8	case	_	_
6	expected	_	VERB	VBN	_	8	amod	_	_
7	plasma	_	NOUN	NN	_	8	compound	_	_
8	concentrations	_	NOUN	NNS	_	4	nmod	_	_
9	of	_	ADP	IN	_	12	case	_	_
10	tricyclic	_	ADJ	JJ	_	12	amod	_	_
11	antidepressants	_	NOUN	NNS	_	12	compound	_	_
12	TCAs	_	NOUN	NNS	_	8	nmod	_	_
13	when	_	ADV	WRB	_	14	advmod	_	_
14	given	_	VERB	VBN	_	4	advcl	_	_
15	usual	_	ADJ	JJ	_	16	amod	_	_
16	doses	_	NOUN	NNS	_	14	dobj	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2805
1	Depending	_	VERB	VBG	_	4	case	_	_
2	on	_	ADP	IN	_	4	case	_	_
3	the	_	DET	DT	_	4	det	_	_
4	fraction	_	NOUN	NN	_	19	nmod	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	drug	_	NOUN	NN	_	4	nmod	_	_
7	metabolized	_	VERB	VBN	_	6	acl	_	_
8	by	_	ADP	IN	_	10	case	_	_
9	P450	_	NOUN	NN	_	10	compound	_	_
10	2D6	_	NOUN	NN	_	7	nmod	_	_
11	,	_	.	,	_	19	punct	_	_
12	the	_	DET	DT	_	13	det	_	_
13	increase	_	NOUN	NN	_	19	nsubj	_	_
14	in	_	ADP	IN	_	16	case	_	_
15	plasma	_	NOUN	NN	_	16	compound	_	_
16	concentration	_	NOUN	NN	_	13	nmod	_	_
17	may	_	VERB	MD	_	19	aux	_	_
18	be	_	VERB	VB	_	19	cop	_	_
19	small	_	ADJ	JJ	_	0	root	_	_
20	,	_	.	,	_	19	punct	_	_
21	or	_	CONJ	CC	_	19	cc	_	_
22	quite	_	ADV	RB	_	23	advmod	_	_
23	large	_	ADJ	JJ	_	26	amod	_	_
24	8	_	NUM	CD	_	26	nummod	_	_
25	fold	_	NOUN	NN	_	26	amod	_	_
26	increase	_	NOUN	NN	_	19	conj	_	_
27	in	_	ADP	IN	_	29	case	_	_
28	plasma	_	NOUN	NN	_	29	compound	_	_
29	AUC	_	NOUN	NN	_	26	nmod	_	_
30	of	_	ADP	IN	_	32	case	_	_
31	the	_	DET	DT	_	32	det	_	_
32	TCA	_	NOUN	NN	_	29	nmod	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2806
1	In	_	ADP	IN	_	2	case	_	_
2	addition	_	NOUN	NN	_	6	nmod	_	_
3	,	_	.	,	_	6	punct	_	_
4	certain	_	ADJ	JJ	_	5	amod	_	_
5	drugs	_	NOUN	NNS	_	6	nsubj	_	_
6	inhibit	_	VERB	VBP	_	0	root	_	_
7	the	_	DET	DT	_	8	det	_	_
8	activity	_	NOUN	NN	_	6	dobj	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	this	_	DET	DT	_	11	det	_	_
11	isozyme	_	NOUN	NN	_	8	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	make	_	ADJ	JJ	_	15	amod	_	_
14	normal	_	ADJ	JJ	_	15	amod	_	_
15	metabolizers	_	NOUN	NNS	_	11	conj	_	_
16	resemble	_	ADJ	JJ	_	6	xcomp	_	_
17	poor	_	ADJ	JJ	_	18	amod	_	_
18	metabolizers	_	NOUN	NNS	_	16	dobj	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2807
1	An	_	DET	DT	_	2	det	_	_
2	individual	_	NOUN	NN	_	13	nsubj	_	_
3	who	_	DET	WDT	_	5	nsubj	_	_
4	is	_	VERB	VBZ	_	5	cop	_	_
5	stable	_	ADJ	JJ	_	2	acl:relcl	_	_
6	on	_	ADP	IN	_	9	case	_	_
7	a	_	DET	DT	_	9	det	_	_
8	given	_	VERB	VBN	_	9	amod	_	_
9	dose	_	NOUN	NN	_	5	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	TCA	_	NOUN	NN	_	9	nmod	_	_
12	may	_	VERB	MD	_	13	aux	_	_
13	become	_	VERB	VB	_	0	root	_	_
14	abruptly	_	ADV	RB	_	15	advmod	_	_
15	toxic	_	ADJ	JJ	_	13	xcomp	_	_
16	when	_	ADV	WRB	_	17	advmod	_	_
17	given	_	VERB	VBN	_	15	dep	_	_
18	one	_	NUM	CD	_	17	dobj	_	_
19	of	_	ADP	IN	_	22	case	_	_
20	these	_	DET	DT	_	22	det	_	_
21	inhibiting	_	VERB	VBG	_	22	amod	_	_
22	drugs	_	NOUN	NNS	_	18	nmod	_	_
23	as	_	ADP	IN	_	25	case	_	_
24	concomitant	_	ADJ	JJ	_	25	amod	_	_
25	therapy	_	NOUN	NN	_	17	nmod	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2808
1	The	_	DET	DT	_	2	det	_	_
2	drugs	_	NOUN	NNS	_	8	nsubj	_	_
3	that	_	DET	WDT	_	4	nsubj	_	_
4	inhibit	_	VERB	VBP	_	2	acl:relcl	_	_
5	cytochrome	_	NOUN	NN	_	7	compound	_	_
6	P450	_	NOUN	NN	_	7	compound	_	_
7	2D6	_	NOUN	NN	_	4	dobj	_	_
8	include	_	VERB	VBP	_	0	root	_	_
9	some	_	DET	DT	_	8	dobj	_	_
10	that	_	DET	WDT	_	13	nsubjpass	_	_
11	are	_	VERB	VBP	_	13	auxpass	_	_
12	not	_	ADV	RB	_	13	neg	_	_
13	metabolized	_	VERB	VBN	_	9	root	_	_
14	by	_	ADP	IN	_	18	case	_	_
15	the	_	DET	DT	_	18	det	_	_
16	enzyme	_	NOUN	NN	_	18	compound	_	_
17	quinidine	_	NOUN	NN	_	18	compound	_	_
18	cimetidine	_	NOUN	NN	_	13	nmod	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	many	_	NOUN	NN	_	18	conj	_	_
21	that	_	DET	WDT	_	23	nsubj	_	_
22	are	_	VERB	VBP	_	23	cop	_	_
23	substrates	_	NOUN	NNS	_	18	acl:relcl	_	_
24	for	_	ADP	IN	_	29	case	_	_
25	P450	_	NOUN	NN	_	29	compound	_	_
26	2D6	_	NOUN	NN	_	29	compound	_	_
27	many	_	ADJ	JJ	_	29	amod	_	_
28	other	_	ADJ	JJ	_	29	amod	_	_
29	antidepressants	_	NOUN	NNS	_	23	nmod	_	_
30	,	_	.	,	_	29	punct	_	_
31	phenothiazines	_	NOUN	NNS	_	29	conj	_	_
32	,	_	.	,	_	29	punct	_	_
33	and	_	CONJ	CC	_	29	cc	_	_
34	the	_	DET	DT	_	37	det	_	_
35	Type	_	NOUN	NN	_	37	compound	_	_
36	1C	_	NOUN	NN	_	37	compound	_	_
37	antiarrhythmics	_	NOUN	NNS	_	29	conj	_	_
38	propafenone	_	NOUN	NN	_	37	dep	_	_
39	and	_	CONJ	CC	_	38	cc	_	_
40	flecainide	_	NOUN	NN	_	38	conj	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2809
1	While	_	ADP	IN	_	19	mark	_	_
2	all	_	CONJ	CC	_	6	cc:preconj	_	_
3	the	_	DET	DT	_	6	det	_	_
4	selective	_	ADJ	JJ	_	6	amod	_	_
5	DRUGS	_	NOUN	NN	_	6	compound	_	_
6	SSRIs	_	NOUN	NNS	_	19	nsubj	_	_
7	,	_	.	,	_	6	punct	_	_
8	e.g	_	NOUN	NN	_	6	conj	_	_
9	,	_	.	,	_	6	punct	_	_
10	fluoxetine	_	NOUN	NN	_	6	conj	_	_
11	,	_	.	,	_	6	punct	_	_
12	sertraline	_	NOUN	NN	_	6	conj	_	_
13	,	_	.	,	_	6	punct	_	_
14	paroxetine	_	NOUN	NN	_	6	conj	_	_
15	,	_	.	,	_	6	punct	_	_
16	and	_	CONJ	CC	_	6	cc	_	_
17	fluvoxamine	_	NOUN	NN	_	6	conj	_	_
18	,	_	.	,	_	6	punct	_	_
19	inhibit	_	VERB	VBP	_	25	advcl	_	_
20	P450	_	NOUN	NN	_	21	compound	_	_
21	2D6	_	NOUN	NN	_	19	dobj	_	_
22	,	_	.	,	_	25	punct	_	_
23	they	_	PRON	PRP	_	25	nsubj	_	_
24	may	_	VERB	MD	_	25	aux	_	_
25	vary	_	VERB	VB	_	0	root	_	_
26	in	_	ADP	IN	_	28	case	_	_
27	the	_	DET	DT	_	28	det	_	_
28	extent	_	NOUN	NN	_	25	nmod	_	_
29	of	_	ADP	IN	_	30	case	_	_
30	inhibition	_	NOUN	NN	_	28	nmod	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2810
1	Fluvoxamine	_	NOUN	NN	_	5	nsubjpass	_	_
2	has	_	VERB	VBZ	_	5	aux	_	_
3	also	_	ADV	RB	_	5	advmod	_	_
4	been	_	VERB	VBN	_	5	auxpass	_	_
5	shown	_	VERB	VBN	_	0	root	_	_
6	to	_	PRT	TO	_	7	mark	_	_
7	inhibit	_	VERB	VB	_	5	xcomp	_	_
8	P450	_	NOUN	NN	_	9	compound	_	_
9	1A2	_	NOUN	NN	_	7	dobj	_	_
10	,	_	.	,	_	7	punct	_	_
11	an	_	DET	DT	_	12	det	_	_
12	isoform	_	NOUN	NN	_	7	dobj	_	_
13	also	_	ADV	RB	_	14	advmod	_	_
14	involved	_	VERB	VBN	_	12	acl	_	_
15	in	_	ADP	IN	_	17	case	_	_
16	TCA	_	NOUN	NN	_	17	compound	_	_
17	metabolism	_	NOUN	NN	_	14	nmod	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2811
1	The	_	DET	DT	_	2	det	_	_
2	extent	_	NOUN	NN	_	13	nsubj	_	_
3	to	_	PRT	TO	_	4	case	_	_
4	which	_	DET	WDT	_	9	nmod	_	_
5	SSRI	_	NOUN	NN	_	7	compound	_	_
6	TCA	_	NOUN	NN	_	7	compound	_	_
7	interactions	_	NOUN	NNS	_	9	nsubj	_	_
8	may	_	VERB	MD	_	9	aux	_	_
9	pose	_	VERB	VB	_	2	acl:relcl	_	_
10	clinical	_	ADJ	JJ	_	11	amod	_	_
11	problems	_	NOUN	NNS	_	9	dobj	_	_
12	will	_	VERB	MD	_	13	aux	_	_
13	depend	_	VERB	VB	_	0	root	_	_
14	on	_	ADP	IN	_	16	case	_	_
15	the	_	DET	DT	_	16	det	_	_
16	degree	_	NOUN	NN	_	13	nmod	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	inhibition	_	NOUN	NN	_	16	nmod	_	_
19	and	_	CONJ	CC	_	13	cc	_	_
20	the	_	DET	DT	_	21	det	_	_
21	pharmacokinetics	_	NOUN	NNS	_	13	conj	_	_
22	of	_	ADP	IN	_	24	case	_	_
23	the	_	DET	DT	_	24	det	_	_
24	SSRI	_	NOUN	NN	_	21	nmod	_	_
25	involved	_	VERB	VBN	_	24	acl	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2812
1	Nevertheless	_	ADV	RB	_	5	advmod	_	_
2	,	_	.	,	_	5	punct	_	_
3	caution	_	NOUN	NN	_	5	nsubjpass	_	_
4	is	_	VERB	VBZ	_	5	auxpass	_	_
5	indicated	_	VERB	VBN	_	0	root	_	_
6	in	_	ADP	IN	_	9	case	_	_
7	the	_	DET	DT	_	9	det	_	_
8	co	_	DET	DT	_	9	det	_	_
9	administration	_	NOUN	NN	_	5	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	TCAs	_	NOUN	NNS	_	9	nmod	_	_
12	with	_	ADP	IN	_	13	case	_	_
13	any	_	DET	DT	_	9	nmod	_	_
14	of	_	ADP	IN	_	16	case	_	_
15	the	_	DET	DT	_	16	det	_	_
16	SSRIs	_	NOUN	NNS	_	13	nmod	_	_
17	and	_	CONJ	CC	_	9	cc	_	_
18	also	_	ADV	RB	_	20	advmod	_	_
19	in	_	ADP	IN	_	20	case	_	_
20	switching	_	NOUN	NN	_	9	conj	_	_
21	from	_	ADP	IN	_	23	case	_	_
22	one	_	NUM	CD	_	23	nummod	_	_
23	class	_	NOUN	NN	_	20	nmod	_	_
24	to	_	PRT	TO	_	26	case	_	_
25	the	_	DET	DT	_	26	det	_	_
26	other	_	ADJ	JJ	_	20	nmod	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2813
1	Of	_	ADP	IN	_	3	case	_	_
2	particular	_	ADJ	JJ	_	3	amod	_	_
3	importance	_	NOUN	NN	_	8	nmod	_	_
4	,	_	.	,	_	8	punct	_	_
5	sufficient	_	ADJ	JJ	_	6	amod	_	_
6	time	_	NOUN	NN	_	8	nsubj	_	_
7	must	_	VERB	MD	_	8	aux	_	_
8	elapse	_	VERB	VB	_	17	aux	_	_
9	before	_	ADP	IN	_	10	mark	_	_
10	initiating	_	VERB	VBG	_	8	advcl	_	_
11	TCA	_	NOUN	NN	_	12	compound	_	_
12	treatment	_	NOUN	NN	_	10	dobj	_	_
13	in	_	ADP	IN	_	15	case	_	_
14	a	_	DET	DT	_	15	det	_	_
15	patient	_	NOUN	NN	_	10	nmod	_	_
16	being	_	VERB	VBD	_	17	cop	_	_
17	withdrawn	_	ADJ	JJ	_	0	root	_	_
18	from	_	ADP	IN	_	19	case	_	_
19	fluoxetine	_	NOUN	NN	_	17	nmod	_	_
20	,	_	.	,	_	17	punct	_	_
21	given	_	VERB	VBN	_	17	parataxis	_	_
22	the	_	DET	DT	_	25	det	_	_
23	long	_	ADJ	JJ	_	25	amod	_	_
24	half	_	NOUN	NN	_	25	amod	_	_
25	life	_	NOUN	NN	_	21	dobj	_	_
26	of	_	ADP	IN	_	28	case	_	_
27	the	_	DET	DT	_	28	det	_	_
28	parent	_	NOUN	NN	_	25	nmod	_	_
29	and	_	CONJ	CC	_	28	cc	_	_
30	active	_	ADJ	JJ	_	31	amod	_	_
31	metabolite	_	NOUN	NN	_	28	conj	_	_
32	at	_	ADP	IN	_	33	case	_	_
33	least	_	ADJ	JJS	_	34	nmod:npmod	_	_
34	5	_	NUM	CD	_	35	nummod	_	_
35	weeks	_	NOUN	NNS	_	25	nmod	_	_
36	may	_	VERB	MD	_	38	aux	_	_
37	be	_	VERB	VB	_	38	auxpass	_	_
38	necessary	_	ADJ	JJ	_	21	dep	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2814
1	Concomitant	_	ADJ	JJ	_	2	amod	_	_
2	use	_	NOUN	NN	_	21	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	agents	_	NOUN	NNS	_	2	nmod	_	_
5	in	_	ADP	IN	_	8	case	_	_
6	tricyclic	_	ADJ	JJ	_	8	amod	_	_
7	antidepressant	_	ADJ	JJ	_	8	amod	_	_
8	class	_	NOUN	NN	_	4	nmod	_	_
9	which	_	DET	WDT	_	10	nsubj	_	_
10	includes	_	VERB	VBZ	_	8	acl:relcl	_	_
11	DRUG	_	NOUN	NN	_	10	dobj	_	_
12	with	_	ADP	IN	_	13	case	_	_
13	drugs	_	NOUN	NNS	_	10	nmod	_	_
14	that	_	DET	WDT	_	16	nsubj	_	_
15	can	_	VERB	MD	_	16	aux	_	_
16	inhibit	_	VERB	VB	_	13	acl:relcl	_	_
17	cytochrome	_	NOUN	NN	_	19	compound	_	_
18	P450	_	NOUN	NN	_	19	compound	_	_
19	2D6	_	NOUN	NN	_	16	dobj	_	_
20	may	_	VERB	MD	_	21	aux	_	_
21	require	_	VERB	VB	_	0	root	_	_
22	lower	_	ADJ	JJ	_	23	amod	_	_
23	doses	_	NOUN	NNS	_	21	dobj	_	_
24	than	_	ADP	IN	_	26	mark	_	_
25	usually	_	ADV	RB	_	26	advmod	_	_
26	prescribed	_	VERB	VBN	_	21	advcl	_	_
27	for	_	ADP	IN	_	32	case	_	_
28	either	_	CONJ	CC	_	32	cc:preconj	_	_
29	the	_	DET	DT	_	32	det	_	_
30	tricyclic	_	ADJ	JJ	_	32	amod	_	_
31	antidepressant	_	ADJ	JJ	_	32	amod	_	_
32	agent	_	NOUN	NN	_	26	nmod	_	_
33	or	_	CONJ	CC	_	32	cc	_	_
34	the	_	DET	DT	_	36	det	_	_
35	other	_	ADJ	JJ	_	36	amod	_	_
36	drug	_	NOUN	NN	_	32	conj	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2815
1	Furthermore	_	ADV	RB	_	23	advmod	_	_
2	,	_	.	,	_	23	punct	_	_
3	whenever	_	ADP	IN	_	9	mark	_	_
4	one	_	NUM	CD	_	9	nsubj	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	these	_	DET	DT	_	7	det	_	_
7	drugs	_	NOUN	NNS	_	4	nmod	_	_
8	is	_	VERB	VBZ	_	9	cop	_	_
9	withdrawn	_	ADJ	JJ	_	23	advcl	_	_
10	from	_	ADP	IN	_	12	case	_	_
11	co	_	PRT	TO	_	12	case	_	_
12	therapy	_	NOUN	NN	_	9	nmod	_	_
13	,	_	.	,	_	23	punct	_	_
14	an	_	DET	DT	_	16	det	_	_
15	increased	_	VERB	VBN	_	16	amod	_	_
16	dose	_	NOUN	NN	_	23	nsubjpass	_	_
17	of	_	ADP	IN	_	20	case	_	_
18	tricyclic	_	ADJ	JJ	_	20	amod	_	_
19	antidepressant	_	ADJ	JJ	_	20	amod	_	_
20	agent	_	NOUN	NN	_	16	nmod	_	_
21	may	_	VERB	MD	_	23	aux	_	_
22	be	_	VERB	VB	_	23	auxpass	_	_
23	required	_	VERB	VBN	_	0	root	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2816
1	It	_	PRON	PRP	_	3	nsubj	_	_
2	is	_	VERB	VBZ	_	3	cop	_	_
3	desirable	_	ADJ	JJ	_	0	root	_	_
4	to	_	PRT	TO	_	5	mark	_	_
5	monitor	_	VERB	VB	_	3	xcomp	_	_
6	TCA	_	NOUN	NN	_	8	compound	_	_
7	plasma	_	NOUN	NN	_	8	compound	_	_
8	levels	_	NOUN	NNS	_	5	dobj	_	_
9	whenever	_	ADV	WRB	_	20	advmod	_	_
10	an	_	DET	DT	_	11	det	_	_
11	agent	_	NOUN	NN	_	20	nsubj	_	_
12	of	_	ADP	IN	_	16	case	_	_
13	the	_	DET	DT	_	16	det	_	_
14	tricyclic	_	ADJ	JJ	_	16	amod	_	_
15	antidepressant	_	ADJ	JJ	_	16	amod	_	_
16	class	_	NOUN	NN	_	11	nmod	_	_
17	including	_	ADP	IN	_	18	case	_	_
18	DRUG	_	NOUN	NN	_	16	nmod	_	_
19	is	_	VERB	VBZ	_	20	cop	_	_
20	going	_	VERB	VBG	_	5	advcl	_	_
21	to	_	PRT	TO	_	24	mark	_	_
22	be	_	VERB	VB	_	24	auxpass	_	_
23	co	_	PRT	TO	_	24	dep	_	_
24	administered	_	VERB	VBN	_	20	xcomp	_	_
25	with	_	ADP	IN	_	27	case	_	_
26	another	_	DET	DT	_	27	det	_	_
27	drug	_	NOUN	NN	_	24	nmod	_	_
28	known	_	VERB	VBN	_	27	acl	_	_
29	to	_	PRT	TO	_	32	mark	_	_
30	be	_	VERB	VB	_	32	cop	_	_
31	an	_	DET	DT	_	32	det	_	_
32	inhibitor	_	NOUN	NN	_	28	xcomp	_	_
33	of	_	ADP	IN	_	35	case	_	_
34	P450	_	NOUN	NN	_	35	compound	_	_
35	2D6	_	NOUN	NN	_	32	nmod	_	_
36	and	_	CONJ	CC	_	35	cc	_	_
37	/	_	.	:	_	35	conj	_	_
38	or	_	CONJ	CC	_	37	cc	_	_
39	P450	_	NOUN	NN	_	40	compound	_	_
40	1A2	_	NOUN	NN	_	37	conj	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2817
1	Because	_	ADP	IN	_	5	mark	_	_
2	DRUG	_	NOUN	NN	_	5	nsubjpass	_	_
3	is	_	VERB	VBZ	_	5	auxpass	_	_
4	highly	_	ADV	RB	_	5	advmod	_	_
5	bound	_	VERB	VBN	_	31	advcl	_	_
6	to	_	PRT	TO	_	8	case	_	_
7	serum	_	NOUN	NN	_	8	compound	_	_
8	protein	_	NOUN	NN	_	5	nmod	_	_
9	,	_	.	,	_	31	punct	_	_
10	the	_	DET	DT	_	11	det	_	_
11	administration	_	NOUN	NN	_	31	nsubj	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	DRUG	_	NOUN	NN	_	11	nmod	_	_
14	to	_	PRT	TO	_	15	case	_	_
15	patients	_	NOUN	NNS	_	11	nmod	_	_
16	taking	_	VERB	VBG	_	15	acl	_	_
17	other	_	ADJ	JJ	_	18	amod	_	_
18	drugs	_	NOUN	NNS	_	16	dobj	_	_
19	that	_	DET	WDT	_	22	nsubjpass	_	_
20	are	_	VERB	VBP	_	22	auxpass	_	_
21	highly	_	ADV	RB	_	22	advmod	_	_
22	bound	_	VERB	VBN	_	18	acl:relcl	_	_
23	to	_	PRT	TO	_	25	case	_	_
24	protein	_	NOUN	NN	_	25	compound	_	_
25	e.g	_	NOUN	NN	_	22	nmod	_	_
26	,	_	.	,	_	25	punct	_	_
27	warfarin	_	NOUN	NN	_	25	appos	_	_
28	,	_	.	,	_	25	punct	_	_
29	digoxin	_	NOUN	NN	_	25	appos	_	_
30	may	_	VERB	MD	_	31	aux	_	_
31	cause	_	VERB	VB	_	0	root	_	_
32	an	_	DET	DT	_	33	det	_	_
33	increase	_	NOUN	NN	_	31	dobj	_	_
34	in	_	ADP	IN	_	36	case	_	_
35	plasma	_	NOUN	NN	_	36	compound	_	_
36	concentrations	_	NOUN	NNS	_	33	nmod	_	_
37	of	_	ADP	IN	_	39	case	_	_
38	these	_	DET	DT	_	39	det	_	_
39	drugs	_	NOUN	NNS	_	36	nmod	_	_
40	,	_	.	,	_	31	punct	_	_
41	potentially	_	ADV	RB	_	42	advmod	_	_
42	resulting	_	VERB	VBG	_	31	advcl	_	_
43	in	_	ADP	IN	_	45	case	_	_
44	adverse	_	ADJ	JJ	_	45	amod	_	_
45	effects	_	NOUN	NNS	_	42	nmod	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2818
1	Conversely	_	ADV	RB	_	6	advmod	_	_
2	,	_	.	,	_	6	punct	_	_
3	adverse	_	ADJ	JJ	_	4	amod	_	_
4	effects	_	NOUN	NNS	_	6	nsubj	_	_
5	may	_	VERB	MD	_	6	aux	_	_
6	result	_	VERB	VB	_	0	root	_	_
7	from	_	ADP	IN	_	8	case	_	_
8	displacement	_	NOUN	NN	_	6	nmod	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	protein	_	NOUN	NN	_	8	nmod	_	_
11	bound	_	VERB	VBN	_	12	amod	_	_
12	DRUG	_	NOUN	NN	_	10	dep	_	_
13	by	_	ADP	IN	_	17	case	_	_
14	other	_	ADJ	JJ	_	17	amod	_	_
15	highly	_	ADV	RB	_	16	advmod	_	_
16	bound	_	VERB	VBN	_	17	amod	_	_
17	drugs	_	NOUN	NNS	_	8	nmod	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2821
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	CMI	_	NOUN	NN	_	4	nsubjpass	_	_
3	is	_	VERB	VBZ	_	4	auxpass	_	_
4	presumed	_	VERB	VBN	_	0	root	_	_
5	to	_	PRT	TO	_	6	mark	_	_
6	influence	_	VERB	VB	_	4	xcomp	_	_
7	obsessive	_	ADJ	JJ	_	10	amod	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	compulsive	_	ADJ	JJ	_	7	conj	_	_
10	behaviors	_	NOUN	NNS	_	6	dobj	_	_
11	through	_	ADP	IN	_	13	case	_	_
12	its	_	PRON	PRP$	_	13	nmod:poss	_	_
13	effects	_	NOUN	NNS	_	6	nmod	_	_
14	on	_	ADP	IN	_	17	case	_	_
15	serotonergic	_	ADJ	JJ	_	17	amod	_	_
16	neuronal	_	ADJ	JJ	_	17	amod	_	_
17	transmission	_	NOUN	NN	_	13	nmod	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2822
1	The	_	DET	DT	_	4	det	_	_
2	actual	_	ADJ	JJ	_	4	amod	_	_
3	neurochemical	_	ADJ	JJ	_	4	amod	_	_
4	mechanism	_	NOUN	NN	_	6	nsubj	_	_
5	is	_	VERB	VBZ	_	6	cop	_	_
6	unknown	_	ADJ	JJ	_	0	root	_	_
7	,	_	.	,	_	6	punct	_	_
8	but	_	CONJ	CC	_	6	cc	_	_
9	CMI's	_	NOUN	NNS	_	10	compound	_	_
10	capacity	_	NOUN	NN	_	20	nsubjpass	_	_
11	to	_	PRT	TO	_	12	mark	_	_
12	inhibit	_	VERB	VB	_	10	acl	_	_
13	the	_	DET	DT	_	14	det	_	_
14	reuptake	_	NOUN	NN	_	12	dobj	_	_
15	of	_	ADP	IN	_	18	case	_	_
16	serotonin	_	NOUN	NN	_	18	compound	_	_
17	5	_	NUM	CD	_	18	nummod	_	_
18	HT	_	NOUN	NN	_	14	nmod	_	_
19	is	_	VERB	VBZ	_	20	auxpass	_	_
20	thought	_	VERB	VBN	_	6	conj	_	_
21	to	_	PRT	TO	_	23	mark	_	_
22	be	_	VERB	VB	_	23	cop	_	_
23	important	_	ADJ	JJ	_	20	xcomp	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2823
1	CMI	_	NOUN	NN	_	7	nsubj	_	_
2	from	_	ADP	IN	_	4	case	_	_
3	DRUG	_	NOUN	NN	_	4	compound	_	_
4	capsules	_	NOUN	NNS	_	1	nmod	_	_
5	is	_	VERB	VBZ	_	7	cop	_	_
6	as	_	ADV	RB	_	7	advmod	_	_
7	bioavailable	_	ADJ	JJ	_	0	root	_	_
8	as	_	ADP	IN	_	9	case	_	_
9	CMI	_	NOUN	NN	_	7	nmod	_	_
10	from	_	ADP	IN	_	12	case	_	_
11	a	_	DET	DT	_	12	det	_	_
12	solution	_	NOUN	NN	_	9	nmod	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2824
1	The	_	DET	DT	_	2	det	_	_
2	bioavailability	_	NOUN	NN	_	10	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	CMI	_	NOUN	NN	_	2	nmod	_	_
5	from	_	ADP	IN	_	6	case	_	_
6	capsules	_	NOUN	NNS	_	2	nmod	_	_
7	is	_	VERB	VBZ	_	10	auxpass	_	_
8	not	_	ADV	RB	_	10	neg	_	_
9	significantly	_	ADV	RB	_	10	advmod	_	_
10	affected	_	VERB	VBN	_	0	root	_	_
11	by	_	ADP	IN	_	12	case	_	_
12	food	_	NOUN	NN	_	10	nmod	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2825
1	In	_	ADP	IN	_	5	case	_	_
2	a	_	DET	DT	_	5	det	_	_
3	dose	_	NOUN	NN	_	5	compound	_	_
4	proportionality	_	NOUN	NN	_	5	compound	_	_
5	study	_	NOUN	NN	_	22	nmod	_	_
6	involving	_	VERB	VBG	_	5	acl	_	_
7	multiple	_	ADJ	JJ	_	9	amod	_	_
8	CMI	_	NOUN	NN	_	9	compound	_	_
9	doses	_	NOUN	NNS	_	6	dobj	_	_
10	,	_	.	,	_	22	punct	_	_
11	steady	_	ADJ	JJ	_	14	amod	_	_
12	state	_	NOUN	NN	_	14	compound	_	_
13	plasma	_	NOUN	NN	_	14	compound	_	_
14	concentrations	_	NOUN	NNS	_	22	nsubj	_	_
15	Css	_	NOUN	NN	_	14	dep	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	area	_	NOUN	NN	_	15	conj	_	_
18	under	_	ADP	IN	_	21	case	_	_
19	plasma	_	NOUN	NN	_	21	compound	_	_
20	concentration	_	NOUN	NN	_	21	compound	_	_
21	time	_	NOUN	NN	_	14	nmod	_	_
22	curves	_	VERB	VBZ	_	38	aux	_	_
23	AUC	_	NOUN	NN	_	22	dobj	_	_
24	of	_	ADP	IN	_	25	case	_	_
25	CMI	_	NOUN	NN	_	23	nmod	_	_
26	and	_	CONJ	CC	_	25	cc	_	_
27	CMI's	_	NOUN	NNS	_	30	compound	_	_
28	major	_	ADJ	JJ	_	30	amod	_	_
29	active	_	ADJ	JJ	_	30	amod	_	_
30	metabolite	_	NOUN	NN	_	25	conj	_	_
31	,	_	.	,	_	25	punct	_	_
32	desmethyl	_	ADJ	JJ	_	34	compound	_	_
33	DRUG	_	NOUN	NN	_	34	compound	_	_
34	DMI	_	NOUN	NN	_	25	appos	_	_
35	,	_	.	,	_	25	punct	_	_
36	were	_	VERB	VBD	_	38	cop	_	_
37	not	_	ADV	RB	_	38	neg	_	_
38	proportional	_	ADJ	JJ	_	0	root	_	_
39	to	_	PRT	TO	_	40	case	_	_
40	dose	_	NOUN	NN	_	38	nmod	_	_
41	over	_	ADP	IN	_	43	case	_	_
42	the	_	DET	DT	_	43	det	_	_
43	ranges	_	NOUN	NNS	_	38	nmod	_	_
44	evaluated	_	VERB	VBN	_	43	acl	_	_
45	,	_	.	,	_	43	punct	_	_
46	i.e	_	ADJ	JJ	_	54	advmod	_	_
47	,	_	.	,	_	54	punct	_	_
48	between	_	ADP	IN	_	52	case	_	_
49	25	_	NUM	CD	_	51	compound	_	_
50	to	_	PRT	TO	_	51	dep	_	_
51	100	_	NUM	CD	_	52	nummod	_	_
52	mg	_	NOUN	NN	_	54	compound	_	_
53	/	_	.	:	_	54	punct	_	_
54	day	_	NOUN	NN	_	43	nmod	_	_
55	and	_	CONJ	CC	_	54	cc	_	_
56	between	_	ADP	IN	_	60	case	_	_
57	25	_	NUM	CD	_	59	compound	_	_
58	to	_	PRT	TO	_	59	dep	_	_
59	150	_	NUM	CD	_	60	nummod	_	_
60	mg	_	NOUN	NN	_	54	conj	_	_
61	/	_	.	:	_	43	punct	_	_
62	day	_	NOUN	NN	_	43	dep	_	_
63	,	_	.	,	_	38	punct	_	_
64	although	_	ADP	IN	_	71	mark	_	_
65	Css	_	NOUN	NN	_	71	nsubj	_	_
66	and	_	CONJ	CC	_	65	cc	_	_
67	AUC	_	NOUN	NN	_	65	conj	_	_
68	are	_	VERB	VBP	_	71	cop	_	_
69	approximately	_	ADV	RB	_	71	advmod	_	_
70	linearly	_	ADV	RB	_	71	advmod	_	_
71	related	_	ADJ	JJ	_	38	advcl	_	_
72	to	_	PRT	TO	_	73	case	_	_
73	dose	_	NOUN	NN	_	71	nmod	_	_
74	between	_	ADP	IN	_	80	case	_	_
75	100	_	NUM	CD	_	77	compound	_	_
76	to	_	PRT	TO	_	77	dep	_	_
77	150	_	NUM	CD	_	78	nummod	_	_
78	mg	_	NOUN	NN	_	80	compound	_	_
79	/	_	NUM	CD	_	80	punct	_	_
80	day	_	NOUN	NN	_	73	nmod	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2826
1	The	_	DET	DT	_	2	det	_	_
2	relationship	_	NOUN	NN	_	0	root	_	_
3	between	_	ADP	IN	_	4	case	_	_
4	dose	_	NOUN	NN	_	2	nmod	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	CMI	_	NOUN	NN	_	4	conj	_	_
7	/	_	.	:	_	2	punct	_	_
8	DMI	_	NOUN	NN	_	9	compound	_	_
9	concentrations	_	NOUN	NNS	_	18	nsubjpass	_	_
10	at	_	ADP	IN	_	13	case	_	_
11	higher	_	ADJ	JJ	_	13	amod	_	_
12	daily	_	ADV	RB	_	13	amod	_	_
13	doses	_	NOUN	NNS	_	9	nmod	_	_
14	has	_	VERB	VBZ	_	18	aux	_	_
15	not	_	ADV	RB	_	18	neg	_	_
16	been	_	VERB	VBN	_	18	auxpass	_	_
17	systematically	_	ADV	RB	_	18	advmod	_	_
18	assessed	_	VERB	VBN	_	2	dep	_	_
19	,	_	.	,	_	18	punct	_	_
20	but	_	CONJ	CC	_	18	cc	_	_
21	if	_	ADP	IN	_	23	mark	_	_
22	there	_	DET	EX	_	23	expl	_	_
23	is	_	VERB	VBZ	_	18	conj	_	_
24	significant	_	ADJ	JJ	_	26	amod	_	_
25	dose	_	NOUN	NN	_	26	compound	_	_
26	dependency	_	NOUN	NN	_	23	nsubj	_	_
27	at	_	ADP	IN	_	28	case	_	_
28	doses	_	NOUN	NNS	_	23	nmod	_	_
29	above	_	ADP	IN	_	33	case	_	_
30	150	_	NUM	CD	_	31	nummod	_	_
31	mg	_	NOUN	NN	_	33	amod	_	_
32	/	_	.	:	_	33	punct	_	_
33	day	_	NOUN	NN	_	28	nmod	_	_
34	,	_	.	,	_	18	punct	_	_
35	there	_	DET	EX	_	36	expl	_	_
36	is	_	VERB	VBZ	_	18	parataxis	_	_
37	the	_	DET	DT	_	38	det	_	_
38	potential	_	NOUN	NN	_	36	nsubj	_	_
39	for	_	ADP	IN	_	42	case	_	_
40	dramatically	_	ADV	RB	_	41	advmod	_	_
41	higher	_	ADJ	JJ	_	42	amod	_	_
42	Css	_	NOUN	NN	_	38	nmod	_	_
43	and	_	CONJ	CC	_	42	cc	_	_
44	AUC	_	NOUN	NN	_	42	conj	_	_
45	even	_	ADV	RB	_	47	advmod	_	_
46	for	_	ADP	IN	_	47	case	_	_
47	patients	_	NOUN	NNS	_	36	nmod	_	_
48	dosed	_	VERB	VBN	_	47	acl	_	_
49	within	_	ADP	IN	_	52	case	_	_
50	the	_	DET	DT	_	52	det	_	_
51	recommended	_	ADJ	JJ	_	52	amod	_	_
52	range	_	NOUN	NN	_	48	nmod	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2827
1	This	_	DET	DT	_	3	nsubj	_	_
2	may	_	VERB	MD	_	3	aux	_	_
3	pose	_	VERB	VB	_	0	root	_	_
4	a	_	DET	DT	_	6	det	_	_
5	potential	_	ADJ	JJ	_	6	amod	_	_
6	risk	_	NOUN	NN	_	3	dobj	_	_
7	to	_	PRT	TO	_	9	case	_	_
8	some	_	DET	DT	_	9	det	_	_
9	patients	_	NOUN	NNS	_	6	nmod	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2828
1	After	_	ADP	IN	_	7	case	_	_
2	a	_	DET	DT	_	7	det	_	_
3	single	_	ADJ	JJ	_	7	amod	_	_
4	50	_	NUM	CD	_	7	nummod	_	_
5	mg	_	NOUN	NN	_	7	compound	_	_
6	oral	_	ADJ	JJ	_	7	amod	_	_
7	dose	_	NOUN	NN	_	14	nmod	_	_
8	,	_	.	,	_	14	punct	_	_
9	maximum	_	NOUN	NN	_	11	compound	_	_
10	plasma	_	NOUN	NN	_	11	compound	_	_
11	concentrations	_	NOUN	NNS	_	14	nsubj	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	CMI	_	NOUN	NN	_	11	nmod	_	_
14	occur	_	VERB	VBP	_	0	root	_	_
15	within	_	ADP	IN	_	19	case	_	_
16	2	_	NUM	CD	_	18	compound	_	_
17	to	_	PRT	TO	_	18	dep	_	_
18	6	_	NUM	CD	_	19	nummod	_	_
19	hours	_	NOUN	NNS	_	14	nmod	_	_
20	mean	_	NOUN	NN	_	19	amod	_	_
21	,	_	.	,	_	19	punct	_	_
22	4.7	_	NUM	CD	_	23	nummod	_	_
23	hr	_	NOUN	NN	_	19	conj	_	_
24	and	_	CONJ	CC	_	19	cc	_	_
25	range	_	NOUN	NN	_	19	conj	_	_
26	from	_	ADP	IN	_	28	case	_	_
27	56	_	NUM	CD	_	28	nummod	_	_
28	ng	_	NOUN	NN	_	25	nmod	_	_
29	/	_	.	:	_	14	punct	_	_
30	mL	_	NOUN	NN	_	14	parataxis	_	_
31	to	_	PRT	TO	_	33	case	_	_
32	154	_	NUM	CD	_	33	nummod	_	_
33	ng	_	NOUN	NN	_	30	nmod	_	_
34	/	_	.	:	_	30	punct	_	_
35	mL	_	NOUN	NN	_	36	compound	_	_
36	mean	_	NOUN	NN	_	30	dep	_	_
37	,	_	.	,	_	36	punct	_	_
38	92	_	NUM	CD	_	39	nummod	_	_
39	ng	_	NOUN	NN	_	36	appos	_	_
40	/	_	.	:	_	36	punct	_	_
41	mL	_	NOUN	NN	_	36	dep	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2829
1	After	_	ADP	IN	_	4	case	_	_
2	multiple	_	ADJ	JJ	_	4	amod	_	_
3	daily	_	ADJ	JJ	_	4	amod	_	_
4	doses	_	NOUN	NNS	_	16	nmod	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	150	_	NUM	CD	_	7	nummod	_	_
7	mg	_	NOUN	NN	_	4	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	,	_	.	,	_	16	punct	_	_
11	steady	_	ADJ	JJ	_	15	amod	_	_
12	state	_	NOUN	NN	_	15	compound	_	_
13	maximum	_	NOUN	NN	_	15	compound	_	_
14	plasma	_	NOUN	NN	_	15	compound	_	_
15	concentrations	_	NOUN	NNS	_	16	nsubj	_	_
16	range	_	VERB	VBP	_	0	root	_	_
17	from	_	ADP	IN	_	19	case	_	_
18	94	_	NUM	CD	_	19	nummod	_	_
19	ng	_	NOUN	NN	_	16	nmod	_	_
20	/	_	.	:	_	19	punct	_	_
21	mL	_	NOUN	NN	_	19	dep	_	_
22	to	_	PRT	TO	_	24	case	_	_
23	339	_	NUM	CD	_	24	nummod	_	_
24	ng	_	NOUN	NN	_	21	nmod	_	_
25	/	_	.	:	_	19	punct	_	_
26	mL	_	NOUN	NN	_	27	compound	_	_
27	mean	_	NOUN	NN	_	19	dep	_	_
28	,	_	.	,	_	27	punct	_	_
29	218	_	NUM	CD	_	30	nummod	_	_
30	ng	_	NOUN	NN	_	27	appos	_	_
31	/	_	.	:	_	27	punct	_	_
32	mL	_	NOUN	NN	_	27	dep	_	_
33	for	_	ADP	IN	_	34	case	_	_
34	CMI	_	NOUN	NN	_	32	nmod	_	_
35	and	_	CONJ	CC	_	32	cc	_	_
36	from	_	ADP	IN	_	38	case	_	_
37	134	_	NUM	CD	_	38	nummod	_	_
38	ng	_	NOUN	NN	_	32	conj	_	_
39	/	_	.	:	_	27	punct	_	_
40	mL	_	NOUN	NN	_	42	advmod	_	_
41	to	_	PRT	TO	_	42	dep	_	_
42	532	_	NUM	CD	_	43	nummod	_	_
43	ng	_	NOUN	NN	_	27	dep	_	_
44	/	_	.	:	_	19	punct	_	_
45	mL	_	NOUN	NN	_	46	compound	_	_
46	mean	_	NOUN	NN	_	19	dep	_	_
47	,	_	.	,	_	19	punct	_	_
48	274	_	NUM	CD	_	49	nummod	_	_
49	ng	_	NOUN	NN	_	19	appos	_	_
50	/	_	.	:	_	19	punct	_	_
51	mL	_	NOUN	NN	_	19	dep	_	_
52	for	_	ADP	IN	_	53	case	_	_
53	DMI	_	NOUN	NN	_	51	nmod	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2830
1	Additional	_	ADJ	JJ	_	2	amod	_	_
2	information	_	NOUN	NN	_	14	nsubj	_	_
3	from	_	ADP	IN	_	7	case	_	_
4	a	_	DET	DT	_	7	det	_	_
5	rising	_	VERB	VBG	_	7	amod	_	_
6	dose	_	NOUN	NN	_	7	compound	_	_
7	study	_	NOUN	NN	_	2	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	doses	_	NOUN	NNS	_	7	nmod	_	_
10	up	_	ADV	RB	_	12	advmod	_	_
11	to	_	PRT	TO	_	10	mwe	_	_
12	250	_	NUM	CD	_	13	nummod	_	_
13	mg	_	NOUN	NN	_	2	nmod	_	_
14	suggests	_	VERB	VBZ	_	0	root	_	_
15	that	_	ADP	IN	_	18	mark	_	_
16	DMI	_	NOUN	NN	_	18	nsubj	_	_
17	may	_	VERB	MD	_	18	aux	_	_
18	exhibit	_	VERB	VB	_	14	ccomp	_	_
19	nonlinear	_	ADJ	JJ	_	20	amod	_	_
20	pharmacokinetics	_	NOUN	NNS	_	18	dobj	_	_
21	over	_	ADP	IN	_	25	case	_	_
22	the	_	DET	DT	_	25	det	_	_
23	usual	_	ADJ	JJ	_	25	amod	_	_
24	dosing	_	NOUN	NN	_	25	compound	_	_
25	range	_	NOUN	NN	_	18	nmod	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2831
1	At	_	ADP	IN	_	3	case	_	_
2	a	_	DET	DT	_	3	det	_	_
3	dose	_	NOUN	NN	_	32	nmod	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	DRUG	_	NOUN	NN	_	6	compound	_	_
6	Capsules	_	NOUN	NNS	_	3	nmod	_	_
7	,	_	.	,	_	6	punct	_	_
8	200	_	NUM	CD	_	9	nummod	_	_
9	mg	_	NOUN	NN	_	6	appos	_	_
10	,	_	.	,	_	6	punct	_	_
11	subjects	_	NOUN	NNS	_	6	appos	_	_
12	who	_	DET	WDT	_	13	nsubj	_	_
13	had	_	VERB	VBD	_	11	acl:relcl	_	_
14	a	_	DET	DT	_	17	det	_	_
15	single	_	ADJ	JJ	_	17	amod	_	_
16	blood	_	NOUN	NN	_	17	compound	_	_
17	sample	_	NOUN	NN	_	13	dobj	_	_
18	taken	_	VERB	VBN	_	17	acl	_	_
19	approximately	_	ADV	RB	_	20	advmod	_	_
20	9	_	NUM	CD	_	22	compound	_	_
21	to	_	PRT	TO	_	22	dep	_	_
22	22	_	NUM	CD	_	23	nummod	_	_
23	hours	_	NOUN	NNS	_	18	nmod	_	_
24	,	_	.	,	_	23	punct	_	_
25	median	_	ADJ	JJ	_	27	amod	_	_
26	16	_	NUM	CD	_	27	nummod	_	_
27	hours	_	NOUN	NNS	_	23	appos	_	_
28	,	_	.	,	_	32	punct	_	_
29	after	_	ADP	IN	_	31	case	_	_
30	the	_	DET	DT	_	31	det	_	_
31	dose	_	NOUN	NN	_	32	nmod	_	_
32	had	_	VERB	VBD	_	0	root	_	_
33	plasma	_	NOUN	NN	_	34	compound	_	_
34	concentrations	_	NOUN	NNS	_	32	dobj	_	_
35	of	_	ADP	IN	_	39	case	_	_
36	up	_	ADJ	JJ	_	38	advmod	_	_
37	to	_	PRT	TO	_	38	dep	_	_
38	605	_	NUM	CD	_	39	nummod	_	_
39	ng	_	NOUN	NN	_	34	nmod	_	_
40	/	_	.	:	_	32	punct	_	_
41	mL	_	NOUN	NN	_	32	parataxis	_	_
42	for	_	ADP	IN	_	43	case	_	_
43	CMI	_	NOUN	NN	_	41	nmod	_	_
44	,	_	.	,	_	43	punct	_	_
45	781	_	NUM	CD	_	46	nummod	_	_
46	ng	_	NOUN	NN	_	43	appos	_	_
47	/	_	.	:	_	43	punct	_	_
48	mL	_	NOUN	NN	_	43	conj	_	_
49	for	_	ADP	IN	_	50	case	_	_
50	DMI	_	NOUN	NN	_	48	nmod	_	_
51	,	_	.	,	_	43	punct	_	_
52	and	_	CONJ	CC	_	43	cc	_	_
53	1386	_	NUM	CD	_	54	nummod	_	_
54	ng	_	NOUN	NN	_	43	conj	_	_
55	/	_	.	:	_	41	punct	_	_
56	mL	_	NOUN	NN	_	41	dep	_	_
57	for	_	ADP	IN	_	58	case	_	_
58	both	_	CONJ	CC	_	56	dep	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2832
1	CMI	_	NOUN	NN	_	2	nsubj	_	_
2	distributes	_	VERB	VBZ	_	0	root	_	_
3	into	_	ADP	IN	_	6	case	_	_
4	cerebrospinal	_	ADJ	JJ	_	6	amod	_	_
5	fluid	_	NOUN	NN	_	6	compound	_	_
6	CSF	_	NOUN	NN	_	2	nmod	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	brain	_	NOUN	NN	_	6	conj	_	_
9	and	_	CONJ	CC	_	6	cc	_	_
10	into	_	ADP	IN	_	12	case	_	_
11	breast	_	NOUN	NN	_	12	compound	_	_
12	milk	_	NOUN	NNS	_	6	conj	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2833
1	DMI	_	NOUN	NN	_	3	nsubj	_	_
2	also	_	ADV	RB	_	3	advmod	_	_
3	distributes	_	VERB	VBZ	_	0	root	_	_
4	into	_	ADP	IN	_	5	case	_	_
5	CSF	_	NOUN	NN	_	3	nmod	_	_
6	,	_	.	,	_	3	punct	_	_
7	with	_	ADP	IN	_	10	case	_	_
8	a	_	DET	DT	_	10	det	_	_
9	mean	_	ADJ	JJ	_	10	amod	_	_
10	CSF	_	NOUN	NN	_	3	nmod	_	_
11	/	_	.	-LRB-	_	13	punct	_	_
12	plasma	_	NOUN	NN	_	13	compound	_	_
13	ratio	_	NOUN	NN	_	10	dep	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	2.6	_	NUM	CD	_	13	nmod	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2834
1	The	_	DET	DT	_	3	det	_	_
2	protein	_	NOUN	NN	_	3	compound	_	_
3	binding	_	NOUN	NN	_	8	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	CMI	_	NOUN	NN	_	3	nmod	_	_
6	is	_	VERB	VBZ	_	8	cop	_	_
7	approximately	_	ADV	RB	_	8	advmod	_	_
8	97%	_	ADJ	JJ	_	0	root	_	_
9	,	_	.	,	_	8	punct	_	_
10	principally	_	ADV	RB	_	12	advmod	_	_
11	to	_	PRT	TO	_	12	case	_	_
12	albumin	_	NOUN	NN	_	8	nmod	_	_
13	,	_	.	,	_	8	punct	_	_
14	and	_	CONJ	CC	_	8	cc	_	_
15	is	_	VERB	VBZ	_	16	cop	_	_
16	independent	_	ADJ	JJ	_	8	conj	_	_
17	of	_	ADP	IN	_	19	case	_	_
18	CMI	_	NOUN	NN	_	19	compound	_	_
19	concentration	_	NOUN	NN	_	16	nmod	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2835
1	The	_	DET	DT	_	2	det	_	_
2	interaction	_	NOUN	NN	_	15	nsubjpass	_	_
3	between	_	ADP	IN	_	4	case	_	_
4	CMI	_	NOUN	NN	_	2	nmod	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	other	_	ADJ	JJ	_	10	amod	_	_
7	highly	_	ADV	RB	_	10	advmod	_	_
8	protein	_	NOUN	NN	_	10	compound	_	_
9	bound	_	ADJ	JJ	_	10	amod	_	_
10	drugs	_	NOUN	NNS	_	4	conj	_	_
11	has	_	VERB	VBZ	_	15	aux	_	_
12	not	_	ADV	RB	_	15	neg	_	_
13	been	_	VERB	VBN	_	15	auxpass	_	_
14	fully	_	ADV	RB	_	15	advmod	_	_
15	evaluated	_	VERB	VBN	_	0	root	_	_
16	,	_	.	,	_	15	punct	_	_
17	but	_	CONJ	CC	_	15	cc	_	_
18	may	_	VERB	MD	_	20	aux	_	_
19	be	_	VERB	VB	_	20	auxpass	_	_
20	important	_	ADJ	JJ	_	15	conj	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2836
1	CMI	_	NOUN	NN	_	4	nsubj	_	_
2	is	_	VERB	VBZ	_	4	cop	_	_
3	extensively	_	ADV	RB	_	4	advmod	_	_
4	biotransformed	_	ADJ	JJ	_	0	root	_	_
5	to	_	PRT	TO	_	6	case	_	_
6	DMI	_	NOUN	NN	_	4	nmod	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	other	_	ADJ	JJ	_	9	amod	_	_
9	metabolites	_	NOUN	NNS	_	6	conj	_	_
10	and	_	CONJ	CC	_	4	cc	_	_
11	their	_	PRON	PRP$	_	12	nmod:poss	_	_
12	glucuronide	_	NOUN	NN	_	13	nsubj	_	_
13	conjugates	_	VERB	VBZ	_	4	conj	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2837
1	DMI	_	NOUN	NN	_	4	nsubj	_	_
2	is	_	VERB	VBZ	_	4	cop	_	_
3	pharmacologically	_	ADV	RB	_	4	advmod	_	_
4	active	_	ADJ	JJ	_	0	root	_	_
5	,	_	.	,	_	4	punct	_	_
6	but	_	CONJ	CC	_	4	cc	_	_
7	its	_	PRON	PRP$	_	8	nmod:poss	_	_
8	effects	_	NOUN	NNS	_	13	nsubj	_	_
9	on	_	ADP	IN	_	11	case	_	_
10	OCD	_	NOUN	NN	_	11	compound	_	_
11	behaviors	_	NOUN	NNS	_	8	nmod	_	_
12	are	_	VERB	VBP	_	13	auxpass	_	_
13	unknown	_	ADJ	JJ	_	4	conj	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2838
1	These	_	DET	DT	_	2	det	_	_
2	metabolites	_	NOUN	NNS	_	4	nsubjpass	_	_
3	are	_	VERB	VBP	_	4	auxpass	_	_
4	excreted	_	VERB	VBN	_	0	root	_	_
5	in	_	ADP	IN	_	6	case	_	_
6	urine	_	ADJ	JJ	_	4	nmod	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	feces	_	NOUN	NNS	_	6	conj	_	_
9	,	_	.	,	_	4	punct	_	_
10	following	_	VERB	VBG	_	12	case	_	_
11	biliary	_	ADJ	JJ	_	12	amod	_	_
12	elimination	_	NOUN	NN	_	4	nmod	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2839
1	After	_	ADP	IN	_	4	case	_	_
2	a	_	DET	DT	_	4	det	_	_
3	25	_	NUM	CD	_	4	nummod	_	_
4	mg	_	NOUN	NN	_	23	nmod	_	_
5	radiolabeled	_	ADJ	JJ	_	6	amod	_	_
6	dose	_	NOUN	NN	_	4	dep	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	CMI	_	NOUN	NN	_	6	nmod	_	_
9	in	_	ADP	IN	_	11	case	_	_
10	two	_	NUM	CD	_	11	nummod	_	_
11	subjects	_	NOUN	NNS	_	6	nmod	_	_
12	,	_	.	,	_	11	punct	_	_
13	60%	_	NOUN	NN	_	11	appos	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	51%	_	NOUN	NN	_	13	conj	_	_
16	,	_	.	,	_	23	punct	_	_
17	respectively	_	ADV	RB	_	23	advmod	_	_
18	,	_	.	,	_	23	punct	_	_
19	of	_	ADP	IN	_	21	case	_	_
20	the	_	DET	DT	_	21	det	_	_
21	dose	_	NOUN	NN	_	23	nsubjpass	_	_
22	were	_	VERB	VBD	_	23	auxpass	_	_
23	recovered	_	VERB	VBN	_	0	root	_	_
24	in	_	ADP	IN	_	26	case	_	_
25	the	_	DET	DT	_	26	det	_	_
26	urine	_	ADJ	JJ	_	23	nmod	_	_
27	and	_	CONJ	CC	_	26	cc	_	_
28	32%	_	NOUN	NN	_	26	conj	_	_
29	and	_	CONJ	CC	_	26	cc	_	_
30	24%	_	NOUN	NN	_	26	conj	_	_
31	,	_	.	,	_	23	punct	_	_
32	respectively	_	ADV	RB	_	23	advmod	_	_
33	,	_	.	,	_	23	punct	_	_
34	in	_	ADP	IN	_	35	case	_	_
35	feces	_	NOUN	NNS	_	23	nmod	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2840
1	In	_	ADP	IN	_	4	case	_	_
2	the	_	DET	DT	_	4	det	_	_
3	same	_	ADJ	JJ	_	4	amod	_	_
4	study	_	NOUN	NN	_	17	nmod	_	_
5	,	_	.	,	_	17	punct	_	_
6	the	_	DET	DT	_	9	det	_	_
7	combined	_	VERB	VBN	_	9	amod	_	_
8	urinary	_	ADJ	JJ	_	9	amod	_	_
9	recoveries	_	NOUN	NNS	_	17	nsubj	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	CMI	_	NOUN	NN	_	9	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	DMI	_	NOUN	NN	_	11	conj	_	_
14	were	_	VERB	VBD	_	17	cop	_	_
15	only	_	ADV	RB	_	17	advmod	_	_
16	about	_	ADV	RB	_	17	advmod	_	_
17	0.8%	_	ADJ	JJ	_	0	root	_	_
18	to	_	PRT	TO	_	19	case	_	_
19	1.3%	_	NOUN	NN	_	17	nmod	_	_
20	of	_	ADP	IN	_	22	case	_	_
21	the	_	DET	DT	_	22	det	_	_
22	dose	_	NOUN	NN	_	19	nmod	_	_
23	administered	_	VERB	VBN	_	22	acl	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2841
1	CMI	_	NOUN	NN	_	4	nsubj	_	_
2	does	_	VERB	VBZ	_	4	aux	_	_
3	not	_	ADV	RB	_	4	neg	_	_
4	induce	_	VERB	VB	_	0	root	_	_
5	drug	_	NOUN	NN	_	7	compound	_	_
6	metabolizing	_	NOUN	NN	_	7	compound	_	_
7	enzymes	_	NOUN	NNS	_	4	dobj	_	_
8	,	_	.	,	_	4	punct	_	_
9	as	_	ADP	IN	_	10	mark	_	_
10	measured	_	VERB	VBN	_	4	advcl	_	_
11	by	_	ADP	IN	_	14	case	_	_
12	antipyrine	_	NOUN	NN	_	14	compound	_	_
13	half	_	NOUN	NN	_	14	compound	_	_
14	life	_	NOUN	NN	_	10	nmod	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2842
1	Evidence	_	NOUN	NN	_	19	nsubj	_	_
2	that	_	ADP	IN	_	13	mark	_	_
3	the	_	DET	DT	_	5	det	_	_
4	C	_	NOUN	NN	_	5	compound	_	_
5	ss	_	NOUN	NN	_	13	nsubj	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	AUC	_	NOUN	NN	_	5	conj	_	_
8	for	_	ADP	IN	_	9	case	_	_
9	CMI	_	NOUN	NN	_	5	nmod	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	DMI	_	NOUN	NN	_	9	conj	_	_
12	may	_	VERB	MD	_	13	aux	_	_
13	increase	_	VERB	VB	_	1	ccomp	_	_
14	disproportionately	_	ADV	RB	_	13	advmod	_	_
15	with	_	ADP	IN	_	16	mark	_	_
16	increasing	_	VERB	VBG	_	13	advcl	_	_
17	oral	_	ADJ	JJ	_	18	amod	_	_
18	doses	_	NOUN	NNS	_	16	dobj	_	_
19	suggests	_	VERB	VBZ	_	0	root	_	_
20	that	_	ADP	IN	_	30	mark	_	_
21	the	_	DET	DT	_	22	det	_	_
22	metabolism	_	NOUN	NN	_	30	nsubj	_	_
23	of	_	ADP	IN	_	24	case	_	_
24	CMI	_	NOUN	NN	_	22	nmod	_	_
25	and	_	CONJ	CC	_	24	cc	_	_
26	DMI	_	NOUN	NN	_	24	conj	_	_
27	may	_	VERB	MD	_	30	aux	_	_
28	be	_	VERB	VB	_	30	cop	_	_
29	capacity	_	VERB	VB	_	30	nmod:npmod	_	_
30	limited	_	ADJ	JJ	_	19	ccomp	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2843
1	This	_	DET	DT	_	2	det	_	_
2	fact	_	NOUN	NN	_	5	nsubjpass	_	_
3	must	_	VERB	MD	_	5	aux	_	_
4	be	_	VERB	VB	_	5	auxpass	_	_
5	considered	_	VERB	VBN	_	0	root	_	_
6	in	_	ADP	IN	_	7	mark	_	_
7	assessing	_	VERB	VBG	_	5	advcl	_	_
8	the	_	DET	DT	_	9	det	_	_
9	estimates	_	NOUN	NNS	_	7	dobj	_	_
10	of	_	ADP	IN	_	13	case	_	_
11	the	_	DET	DT	_	13	det	_	_
12	pharmacokinetic	_	ADJ	JJ	_	13	amod	_	_
13	parameters	_	NOUN	NNS	_	9	nmod	_	_
14	presented	_	VERB	VBN	_	13	acl	_	_
15	below	_	NOUN	NN	_	14	xcomp	_	_
16	,	_	.	,	_	5	punct	_	_
17	as	_	ADP	IN	_	20	mark	_	_
18	these	_	DET	DT	_	20	nsubjpass	_	_
19	were	_	VERB	VBD	_	20	auxpass	_	_
20	obtained	_	VERB	VBN	_	5	advcl	_	_
21	in	_	ADP	IN	_	22	case	_	_
22	individuals	_	NOUN	NNS	_	20	nmod	_	_
23	exposed	_	VERB	VBN	_	22	acl	_	_
24	to	_	PRT	TO	_	25	case	_	_
25	doses	_	NOUN	NNS	_	23	nmod	_	_
26	of	_	ADP	IN	_	28	case	_	_
27	150	_	NUM	CD	_	28	nummod	_	_
28	mg	_	NOUN	NNS	_	25	nmod	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2844
1	If	_	ADP	IN	_	3	case	_	_
2	the	_	DET	DT	_	3	det	_	_
3	pharmacokinetics	_	NOUN	NNS	_	9	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	CMI	_	NOUN	NN	_	3	nmod	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	DMI	_	NOUN	NN	_	5	conj	_	_
8	are	_	VERB	VBP	_	9	cop	_	_
9	nonlinear	_	ADJ	JJ	_	23	advcl	_	_
10	at	_	ADP	IN	_	11	case	_	_
11	doses	_	NOUN	NNS	_	9	nmod	_	_
12	above	_	ADP	IN	_	14	case	_	_
13	150	_	NUM	CD	_	14	nummod	_	_
14	mg	_	NOUN	NN	_	11	nmod	_	_
15	,	_	.	,	_	23	punct	_	_
16	their	_	PRON	PRP$	_	19	nmod:poss	_	_
17	elimination	_	NOUN	NN	_	19	compound	_	_
18	half	_	NOUN	NN	_	19	compound	_	_
19	lives	_	NOUN	NNS	_	23	nsubjpass	_	_
20	may	_	VERB	MD	_	23	aux	_	_
21	be	_	VERB	VB	_	23	auxpass	_	_
22	considerably	_	ADV	RB	_	23	advmod	_	_
23	lengthened	_	VERB	VBN	_	0	root	_	_
24	at	_	ADP	IN	_	25	case	_	_
25	doses	_	NOUN	NNS	_	23	nmod	_	_
26	near	_	ADP	IN	_	29	case	_	_
27	the	_	DET	DT	_	29	det	_	_
28	upper	_	ADJ	JJ	_	29	amod	_	_
29	end	_	NOUN	NN	_	25	nmod	_	_
30	of	_	ADP	IN	_	34	case	_	_
31	the	_	DET	DT	_	34	det	_	_
32	recommended	_	VERB	VBN	_	34	amod	_	_
33	dosing	_	NOUN	NN	_	34	amod	_	_
34	range	_	NOUN	NN	_	29	nmod	_	_
35	i.e	_	ADV	RB	_	29	advmod	_	_
36	,	_	.	,	_	23	punct	_	_
37	200	_	NUM	CD	_	38	nummod	_	_
38	mg	_	NOUN	NN	_	23	dep	_	_
39	/	_	.	:	_	38	punct	_	_
40	day	_	NOUN	NN	_	38	dep	_	_
41	to	_	PRT	TO	_	45	case	_	_
42	250	_	NUM	CD	_	43	nummod	_	_
43	mg	_	NOUN	NN	_	45	compound	_	_
44	/	_	NUM	CD	_	45	punct	_	_
45	day	_	NOUN	NN	_	40	nmod	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2845
1	Consequently	_	ADV	RB	_	7	advmod	_	_
2	,	_	.	,	_	7	punct	_	_
3	CMI	_	NOUN	NN	_	7	nsubj	_	_
4	and	_	CONJ	CC	_	3	cc	_	_
5	DMI	_	NOUN	NN	_	3	conj	_	_
6	may	_	VERB	MD	_	7	aux	_	_
7	accumulate	_	VERB	VB	_	0	root	_	_
8	,	_	.	,	_	7	punct	_	_
9	and	_	CONJ	CC	_	7	cc	_	_
10	this	_	DET	DT	_	11	det	_	_
11	accumulation	_	NOUN	NN	_	13	nsubj	_	_
12	may	_	VERB	MD	_	13	aux	_	_
13	increase	_	VERB	VB	_	7	conj	_	_
14	the	_	DET	DT	_	15	det	_	_
15	incidence	_	NOUN	NN	_	13	dobj	_	_
16	of	_	ADP	IN	_	18	case	_	_
17	any	_	DET	DT	_	18	dep	_	_
18	dose	_	NOUN	NN	_	15	nmod	_	_
19	or	_	CONJ	CC	_	18	cc	_	_
20	plasma	_	NOUN	NN	_	24	compound	_	_
21	concentration	_	NOUN	NN	_	24	compound	_	_
22	dependent	_	ADJ	JJ	_	24	amod	_	_
23	adverse	_	ADJ	JJ	_	24	amod	_	_
24	reactions	_	NOUN	NNS	_	18	conj	_	_
25	,	_	.	,	_	7	punct	_	_
26	in	_	ADP	IN	_	28	case	_	_
27	particular	_	ADJ	JJ	_	28	amod	_	_
28	seizures	_	NOUN	NNS	_	7	nmod	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2846
1	After	_	ADP	IN	_	5	case	_	_
2	a	_	DET	DT	_	5	det	_	_
3	150	_	NUM	CD	_	5	nummod	_	_
4	mg	_	NOUN	NN	_	5	compound	_	_
5	dose	_	NOUN	NN	_	12	nmod	_	_
6	,	_	.	,	_	12	punct	_	_
7	the	_	DET	DT	_	9	det	_	_
8	half	_	ADJ	JJ	_	9	amod	_	_
9	life	_	NOUN	NN	_	12	nsubj	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	CMI	_	NOUN	NN	_	9	nmod	_	_
12	ranges	_	NOUN	NNS	_	0	root	_	_
13	from	_	ADP	IN	_	15	case	_	_
14	19	_	NUM	CD	_	15	nummod	_	_
15	hours	_	NOUN	NNS	_	12	nmod	_	_
16	to	_	PRT	TO	_	18	case	_	_
17	37	_	NUM	CD	_	18	nummod	_	_
18	hours	_	NOUN	NNS	_	12	nmod	_	_
19	mean	_	NOUN	NN	_	18	amod	_	_
20	,	_	.	,	_	18	punct	_	_
21	32	_	NUM	CD	_	22	nummod	_	_
22	hr	_	NOUN	NN	_	18	conj	_	_
23	and	_	CONJ	CC	_	18	cc	_	_
24	that	_	DET	WDT	_	18	conj	_	_
25	of	_	ADP	IN	_	27	case	_	_
26	DMI	_	NOUN	NN	_	27	compound	_	_
27	ranges	_	NOUN	NNS	_	24	nmod	_	_
28	from	_	ADP	IN	_	30	case	_	_
29	54	_	NUM	CD	_	30	nummod	_	_
30	hours	_	NOUN	NNS	_	24	nmod	_	_
31	to	_	PRT	TO	_	33	case	_	_
32	77	_	NUM	CD	_	33	nummod	_	_
33	hours	_	NOUN	NNS	_	24	nmod	_	_
34	mean	_	NOUN	NN	_	33	amod	_	_
35	,	_	.	,	_	18	punct	_	_
36	69	_	NUM	CD	_	37	nummod	_	_
37	hr	_	NOUN	NN	_	18	appos	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2847
1	Steady	_	ADJ	JJ	_	3	amod	_	_
2	state	_	NOUN	NN	_	3	compound	_	_
3	levels	_	NOUN	NNS	_	9	nsubjpass	_	_
4	after	_	ADP	IN	_	6	case	_	_
5	multiple	_	ADJ	JJ	_	6	amod	_	_
6	dosing	_	NOUN	NN	_	3	nmod	_	_
7	are	_	VERB	VBP	_	9	auxpass	_	_
8	typically	_	ADV	RB	_	9	advmod	_	_
9	reached	_	VERB	VBN	_	0	root	_	_
10	within	_	ADP	IN	_	14	case	_	_
11	7	_	NUM	CD	_	13	compound	_	_
12	to	_	PRT	TO	_	13	dep	_	_
13	14	_	NUM	CD	_	14	nummod	_	_
14	days	_	NOUN	NNS	_	9	nmod	_	_
15	for	_	ADP	IN	_	16	case	_	_
16	CMI	_	NOUN	NN	_	14	nmod	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2848
1	Plasma	_	NOUN	NN	_	2	compound	_	_
2	concentrations	_	NOUN	NNS	_	6	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	the	_	DET	DT	_	5	det	_	_
5	metabolite	_	NOUN	NN	_	2	nmod	_	_
6	exceed	_	VERB	VBD	_	0	root	_	_
7	the	_	DET	DT	_	9	det	_	_
8	parent	_	NOUN	NN	_	9	compound	_	_
9	drug	_	NOUN	NN	_	6	dobj	_	_
10	on	_	ADP	IN	_	12	case	_	_
11	multiple	_	ADJ	JJ	_	12	amod	_	_
12	dosing	_	VERB	VBG	_	6	advcl	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2849
1	After	_	ADP	IN	_	3	case	_	_
2	multiple	_	ADJ	JJ	_	3	amod	_	_
3	dosing	_	NOUN	NN	_	0	root	_	_
4	with	_	ADP	IN	_	6	case	_	_
5	150	_	NUM	CD	_	6	nummod	_	_
6	mg	_	NOUN	NN	_	3	nmod	_	_
7	/	_	.	:	_	8	punct	_	_
8	day	_	NOUN	NN	_	22	nsubj	_	_
9	,	_	.	,	_	8	punct	_	_
10	the	_	DET	DT	_	12	det	_	_
11	accumulation	_	NOUN	NN	_	12	compound	_	_
12	factor	_	NOUN	NN	_	17	nsubj	_	_
13	for	_	ADP	IN	_	14	case	_	_
14	CMI	_	NOUN	NN	_	12	nmod	_	_
15	is	_	VERB	VBZ	_	17	cop	_	_
16	approximately	_	ADV	RB	_	17	advmod	_	_
17	2.5	_	NUM	CD	_	8	appos	_	_
18	and	_	CONJ	CC	_	17	cc	_	_
19	for	_	ADP	IN	_	20	case	_	_
20	DMI	_	NOUN	NN	_	17	conj	_	_
21	is	_	VERB	VBZ	_	22	cop	_	_
22	4.6	_	NUM	CD	_	3	neg	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2850
1	Importantly	_	ADV	RB	_	5	advmod	_	_
2	,	_	.	,	_	5	punct	_	_
3	it	_	PRON	PRP	_	5	nsubj	_	_
4	may	_	VERB	MD	_	5	aux	_	_
5	take	_	VERB	VB	_	0	root	_	_
6	two	_	NUM	CD	_	7	nummod	_	_
7	weeks	_	NOUN	NNS	_	5	dobj	_	_
8	or	_	CONJ	CC	_	5	cc	_	_
9	longer	_	ADV	RB	_	5	conj	_	_
10	to	_	PRT	TO	_	11	mark	_	_
11	achieve	_	VERB	VB	_	9	xcomp	_	_
12	this	_	DET	DT	_	13	det	_	_
13	extent	_	NOUN	NN	_	11	dobj	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	accumulation	_	NOUN	NN	_	13	nmod	_	_
16	at	_	ADP	IN	_	18	case	_	_
17	constant	_	ADJ	JJ	_	18	amod	_	_
18	dosing	_	NOUN	NN	_	13	nmod	_	_
19	because	_	ADP	IN	_	11	nmod	_	_
20	of	_	ADP	IN	_	26	case	_	_
21	the	_	DET	DT	_	26	det	_	_
22	relatively	_	ADV	RB	_	23	advmod	_	_
23	long	_	ADJ	JJ	_	26	amod	_	_
24	elimination	_	NOUN	NN	_	26	compound	_	_
25	half	_	ADJ	JJ	_	26	amod	_	_
26	lives	_	NOUN	NNS	_	19	nmod	_	_
27	of	_	ADP	IN	_	28	case	_	_
28	CMI	_	NOUN	NN	_	26	nmod	_	_
29	and	_	CONJ	CC	_	28	cc	_	_
30	DMI	_	NOUN	NN	_	28	conj	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2851
1	The	_	DET	DT	_	2	det	_	_
2	effects	_	NOUN	NNS	_	16	nsubjpass	_	_
3	of	_	ADP	IN	_	7	case	_	_
4	hepatic	_	ADJ	JJ	_	7	amod	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	renal	_	ADJ	JJ	_	4	conj	_	_
7	impairment	_	NOUN	NN	_	2	nmod	_	_
8	on	_	ADP	IN	_	10	case	_	_
9	the	_	DET	DT	_	10	det	_	_
10	disposition	_	NOUN	NN	_	2	nmod	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_
13	have	_	VERB	MD	_	16	aux	_	_
14	not	_	ADV	RB	_	16	neg	_	_
15	been	_	VERB	VBN	_	16	auxpass	_	_
16	determined	_	VERB	VBN	_	0	root	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2852
1	Co	_	PRT	TO	_	2	case	_	_
2	administration	_	NOUN	NN	_	7	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	haloperidol	_	NOUN	NN	_	2	nmod	_	_
5	with	_	ADP	IN	_	6	case	_	_
6	CMI	_	NOUN	NN	_	2	nmod	_	_
7	increases	_	VERB	VBZ	_	0	root	_	_
8	plasma	_	NOUN	NN	_	9	compound	_	_
9	concentrations	_	NOUN	NNS	_	7	dobj	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	CMI	_	NOUN	NN	_	9	nmod	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2853
1	Co	_	PRT	TO	_	2	case	_	_
2	administration	_	NOUN	NN	_	7	nmod	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	CMI	_	NOUN	NN	_	2	nmod	_	_
5	with	_	ADP	IN	_	6	case	_	_
6	phenobarbital	_	ADJ	JJ	_	2	nmod	_	_
7	increases	_	VERB	VBZ	_	0	root	_	_
8	plasma	_	NOUN	NN	_	9	compound	_	_
9	concentrations	_	NOUN	NNS	_	7	dobj	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	phenobarbital	_	ADJ	JJ	_	9	nmod	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2854
1	Younger	_	ADJ	JJ	_	2	amod	_	_
2	subjects	_	NOUN	NNS	_	9	nsubj	_	_
3	18	_	NUM	CD	_	5	compound	_	_
4	to	_	PRT	TO	_	5	dep	_	_
5	40	_	NUM	CD	_	6	nummod	_	_
6	years	_	NOUN	NNS	_	2	nmod	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	age	_	NOUN	NN	_	6	nmod	_	_
9	tolerated	_	VERB	VBD	_	0	root	_	_
10	CMI	_	NOUN	NN	_	9	dobj	_	_
11	better	_	ADV	RB	_	9	advmod	_	_
12	and	_	CONJ	CC	_	9	cc	_	_
13	had	_	VERB	VBD	_	9	conj	_	_
14	significantly	_	ADV	RB	_	15	advmod	_	_
15	lower	_	ADJ	JJ	_	19	amod	_	_
16	steady	_	ADJ	JJ	_	19	amod	_	_
17	state	_	NOUN	NN	_	19	compound	_	_
18	plasma	_	NOUN	NN	_	19	compound	_	_
19	concentrations	_	NOUN	NNS	_	13	dobj	_	_
20	,	_	.	,	_	9	punct	_	_
21	compared	_	VERB	VBN	_	9	xcomp	_	_
22	with	_	ADP	IN	_	23	case	_	_
23	subjects	_	NOUN	NNS	_	21	nmod	_	_
24	over	_	ADP	IN	_	26	case	_	_
25	65	_	NUM	CD	_	26	nummod	_	_
26	years	_	NOUN	NNS	_	21	nmod	_	_
27	of	_	ADP	IN	_	28	case	_	_
28	age	_	NOUN	NN	_	26	nmod	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2855
1	Children	_	NUM	CD	_	7	nsubj	_	_
2	under	_	ADP	IN	_	4	case	_	_
3	15	_	NUM	CD	_	4	nummod	_	_
4	years	_	NOUN	NNS	_	1	nmod	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	age	_	NOUN	NN	_	4	nmod	_	_
7	had	_	VERB	VBD	_	0	root	_	_
8	significantly	_	ADV	RB	_	9	advmod	_	_
9	lower	_	ADJ	JJ	_	11	amod	_	_
10	plasma	_	NOUN	NN	_	11	compound	_	_
11	concentration	_	NOUN	NN	_	7	dobj	_	_
12	/	_	.	:	_	7	punct	_	_
13	dose	_	NOUN	NN	_	14	compound	_	_
14	ratios	_	NOUN	NNS	_	7	parataxis	_	_
15	,	_	.	,	_	14	punct	_	_
16	compared	_	VERB	VBN	_	14	acl	_	_
17	with	_	ADP	IN	_	18	case	_	_
18	adults	_	NOUN	NNS	_	16	nmod	_	_

#	CLOMIPRAMINE HYDROCHLORIDE	2856
1	Plasma	_	NOUN	NN	_	2	compound	_	_
2	concentrations	_	NOUN	NNS	_	7	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	CMI	_	NOUN	NN	_	2	nmod	_	_
5	were	_	VERB	VBD	_	7	cop	_	_
6	significantly	_	ADV	RB	_	7	advmod	_	_
7	lower	_	ADJ	JJ	_	0	root	_	_
8	in	_	ADP	IN	_	9	case	_	_
9	smokers	_	NOUN	NNS	_	7	nmod	_	_
10	than	_	ADP	IN	_	12	case	_	_
11	in	_	ADP	IN	_	12	case	_	_
12	nonsmokers	_	NOUN	NNS	_	7	nmod	_	_

#	COUMADIN	2021
1	Drugs	_	NOUN	NNS	_	3	nsubj	_	_
2	may	_	VERB	MD	_	3	aux	_	_
3	interact	_	VERB	VB	_	0	root	_	_
4	with	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	through	_	ADP	IN	_	10	case	_	_
7	pharmacodynamic	_	ADJ	JJ	_	10	amod	_	_
8	or	_	CONJ	CC	_	7	cc	_	_
9	pharmacokinetic	_	ADJ	JJ	_	7	conj	_	_
10	mechanisms	_	NOUN	NNS	_	3	nmod	_	_

#	COUMADIN	2022
1	Pharmacodynamic	_	ADJ	JJ	_	2	amod	_	_
2	mechanisms	_	NOUN	NNS	_	11	nsubj	_	_
3	for	_	ADP	IN	_	5	case	_	_
4	drug	_	NOUN	NN	_	5	compound	_	_
5	interactions	_	NOUN	NNS	_	2	nmod	_	_
6	with	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	are	_	VERB	VBP	_	11	cop	_	_
9	synergism	_	VERB	VB	_	11	amod	_	_
10	impaired	_	ADJ	JJ	_	11	amod	_	_
11	hemostasis	_	NOUN	NN	_	0	root	_	_
12	,	_	.	,	_	11	punct	_	_
13	reduced	_	VERB	VBN	_	11	acl	_	_
14	clotting	_	VERB	VBG	_	16	amod	_	_
15	factor	_	NOUN	NN	_	16	compound	_	_
16	synthesis	_	NOUN	NN	_	13	nmod	_	_
17	,	_	.	,	_	16	punct	_	_
18	competitive	_	ADJ	JJ	_	21	amod	_	_
19	antagonism	_	NOUN	NN	_	21	compound	_	_
20	vitamin	_	NOUN	NN	_	21	compound	_	_
21	K	_	NOUN	NN	_	16	conj	_	_
22	,	_	.	,	_	16	punct	_	_
23	and	_	CONJ	CC	_	16	cc	_	_
24	alteration	_	NOUN	NN	_	16	conj	_	_
25	of	_	ADP	IN	_	29	case	_	_
26	the	_	DET	DT	_	29	det	_	_
27	physiologic	_	ADJ	JJ	_	29	amod	_	_
28	control	_	NOUN	NN	_	29	compound	_	_
29	loop	_	NOUN	NN	_	24	nmod	_	_
30	for	_	ADP	IN	_	35	case	_	_
31	vitamin	_	NOUN	NN	_	35	compound	_	_
32	K	_	NOUN	NN	_	35	compound	_	_
33	metabolism	_	NOUN	NN	_	35	compound	_	_
34	hereditary	_	ADJ	JJ	_	35	amod	_	_
35	resistance	_	NOUN	NN	_	24	nmod	_	_

#	COUMADIN	2023
1	Pharmacokinetic	_	ADJ	JJ	_	2	amod	_	_
2	mechanisms	_	NOUN	NNS	_	11	nsubj	_	_
3	for	_	ADP	IN	_	5	case	_	_
4	drug	_	NOUN	NN	_	5	compound	_	_
5	interactions	_	NOUN	NNS	_	2	nmod	_	_
6	with	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	are	_	VERB	VBP	_	11	cop	_	_
9	mainly	_	ADV	RB	_	11	advmod	_	_
10	enzyme	_	NOUN	NN	_	11	compound	_	_
11	induction	_	NOUN	NN	_	0	root	_	_
12	,	_	.	,	_	11	punct	_	_
13	enzyme	_	NOUN	NN	_	14	compound	_	_
14	inhibition	_	NOUN	NN	_	11	conj	_	_
15	,	_	.	,	_	11	punct	_	_
16	and	_	CONJ	CC	_	11	cc	_	_
17	reduced	_	VERB	VBD	_	11	conj	_	_
18	plasma	_	NOUN	NN	_	20	compound	_	_
19	protein	_	NOUN	NN	_	20	compound	_	_
20	binding	_	NOUN	NN	_	17	dobj	_	_

#	COUMADIN	2024
1	It	_	PRON	PRP	_	3	nsubj	_	_
2	is	_	VERB	VBZ	_	3	cop	_	_
3	important	_	ADJ	JJ	_	0	root	_	_
4	to	_	PRT	TO	_	5	mark	_	_
5	note	_	VERB	VB	_	3	xcomp	_	_
6	that	_	ADP	IN	_	10	mark	_	_
7	some	_	DET	DT	_	8	det	_	_
8	drugs	_	NOUN	NNS	_	10	nsubj	_	_
9	may	_	VERB	MD	_	10	aux	_	_
10	interact	_	VERB	VB	_	5	ccomp	_	_
11	by	_	ADP	IN	_	15	case	_	_
12	more	_	ADJ	JJR	_	14	advmod	_	_
13	than	_	ADP	IN	_	12	mwe	_	_
14	one	_	NUM	CD	_	15	nummod	_	_
15	mechanism	_	NOUN	NN	_	10	nmod	_	_

#	COUMADIN	2025
1	More	_	ADV	RB	_	2	advmod	_	_
2	frequent	_	ADJ	JJ	_	4	amod	_	_
3	INR	_	NOUN	NN	_	4	compound	_	_
4	monitoring	_	NOUN	NN	_	7	nsubjpass	_	_
5	should	_	VERB	MD	_	7	aux	_	_
6	be	_	VERB	VB	_	7	auxpass	_	_
7	performed	_	VERB	VBN	_	0	root	_	_
8	when	_	ADV	WRB	_	9	advmod	_	_
9	starting	_	VERB	VBG	_	7	advcl	_	_
10	or	_	CONJ	CC	_	9	cc	_	_
11	stopping	_	VERB	VBG	_	9	conj	_	_
12	other	_	ADJ	JJ	_	13	amod	_	_
13	drugs	_	NOUN	NNS	_	11	dobj	_	_
14	,	_	.	,	_	13	punct	_	_
15	including	_	VERB	VBG	_	16	case	_	_
16	botanicals	_	NOUN	NNS	_	13	nmod	_	_
17	,	_	.	,	_	7	punct	_	_
18	or	_	CONJ	CC	_	7	cc	_	_
19	when	_	ADV	RB	_	20	advmod	_	_
20	changing	_	VERB	VBG	_	7	conj	_	_
21	dosages	_	NOUN	NNS	_	20	dobj	_	_
22	of	_	ADP	IN	_	24	case	_	_
23	other	_	ADJ	JJ	_	24	amod	_	_
24	drugs	_	NOUN	NNS	_	21	nmod	_	_
25	,	_	.	,	_	20	punct	_	_
26	including	_	VERB	VBG	_	27	case	_	_
27	drugs	_	NOUN	NNS	_	20	nmod	_	_
28	intended	_	VERB	VBN	_	27	acl	_	_
29	for	_	ADP	IN	_	33	case	_	_
30	short	_	ADJ	JJ	_	33	amod	_	_
31	term	_	NOUN	NN	_	33	compound	_	_
32	use	_	NOUN	NN	_	33	compound	_	_
33	e.g	_	NOUN	NN	_	28	nmod	_	_
34	,	_	.	,	_	33	punct	_	_
35	antibiotics	_	NOUN	NNS	_	33	conj	_	_
36	,	_	.	,	_	33	punct	_	_
37	antifungals	_	NOUN	NNS	_	33	conj	_	_
38	,	_	.	,	_	33	punct	_	_
39	corticosteroids	_	NOUN	NNS	_	33	conj	_	_

#	COUMADIN	2026
1	Consult	_	VERB	VB	_	0	root	_	_
2	the	_	DET	DT	_	3	det	_	_
3	labeling	_	NOUN	NN	_	1	dobj	_	_
4	of	_	ADP	IN	_	8	case	_	_
5	all	_	DET	DT	_	8	det	_	_
6	concurrently	_	ADV	RB	_	7	advmod	_	_
7	used	_	VERB	VBN	_	8	amod	_	_
8	drugs	_	NOUN	NNS	_	3	nmod	_	_
9	to	_	PRT	TO	_	10	mark	_	_
10	obtain	_	VERB	VB	_	3	acl	_	_
11	further	_	ADJ	JJ	_	12	amod	_	_
12	information	_	NOUN	NN	_	10	dobj	_	_
13	about	_	ADP	IN	_	14	case	_	_
14	interactions	_	NOUN	NNS	_	10	nmod	_	_
15	with	_	ADP	IN	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	14	nmod	_	_
17	or	_	CONJ	CC	_	16	cc	_	_
18	adverse	_	ADJ	JJ	_	19	amod	_	_
19	reactions	_	NOUN	NNS	_	16	conj	_	_
20	pertaining	_	VERB	VBG	_	16	acl	_	_
21	to	_	PRT	TO	_	22	mark	_	_
22	bleeding	_	VERB	VBG	_	20	advcl	_	_

#	COUMADIN	2027
1	Concomitant	_	ADJ	JJ	_	2	amod	_	_
2	use	_	NOUN	NN	_	0	root	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	drugs	_	NOUN	NNS	_	2	nmod	_	_
5	that	_	DET	WDT	_	6	nsubj	_	_
6	increase	_	VERB	VBP	_	4	acl:relcl	_	_
7	bleeding	_	VERB	VBG	_	8	amod	_	_
8	risk	_	NOUN	NN	_	6	dobj	_	_
9	,	_	.	,	_	8	punct	_	_
10	antibiotics	_	NOUN	NNS	_	8	conj	_	_
11	,	_	.	,	_	8	punct	_	_
12	antifungals	_	NOUN	NNS	_	8	conj	_	_
13	,	_	.	,	_	8	punct	_	_
14	botanical	_	ADJ	JJ	_	16	amod	_	_
15	herbal	_	ADJ	JJ	_	16	amod	_	_
16	products	_	NOUN	NNS	_	8	conj	_	_
17	,	_	.	,	_	8	punct	_	_
18	and	_	CONJ	CC	_	8	cc	_	_
19	inhibitors	_	NOUN	NNS	_	8	conj	_	_
20	and	_	CONJ	CC	_	8	cc	_	_
21	inducers	_	NOUN	NNS	_	8	conj	_	_
22	of	_	ADP	IN	_	23	case	_	_
23	CYP2C9	_	NOUN	NN	_	21	nmod	_	_
24	,	_	.	,	_	23	punct	_	_
25	1A2	_	NOUN	NN	_	23	conj	_	_
26	,	_	.	,	_	23	punct	_	_
27	or	_	CONJ	CC	_	23	cc	_	_
28	3A4	_	NOUN	NN	_	23	conj	_	_
29	7	_	NUM	CD	_	28	nummod	_	_

#	COUMADIN	2028
1	Consult	_	NOUN	NN	_	2	compound	_	_
2	labeling	_	NOUN	NN	_	0	root	_	_
3	of	_	ADP	IN	_	7	case	_	_
4	all	_	DET	DT	_	7	det	_	_
5	concurrently	_	ADV	RB	_	6	advmod	_	_
6	used	_	VERB	VBN	_	7	amod	_	_
7	drugs	_	NOUN	NNS	_	2	nmod	_	_
8	for	_	ADP	IN	_	10	case	_	_
9	complete	_	ADJ	JJ	_	10	amod	_	_
10	information	_	NOUN	NN	_	2	nmod	_	_
11	about	_	ADP	IN	_	12	case	_	_
12	interactions	_	NOUN	NNS	_	10	nmod	_	_
13	with	_	ADP	IN	_	14	case	_	_
14	DRUG	_	NOUN	NN	_	12	nmod	_	_
15	or	_	CONJ	CC	_	2	cc	_	_
16	increased	_	VERB	VBD	_	17	amod	_	_
17	risks	_	NOUN	NNS	_	2	conj	_	_
18	for	_	ADP	IN	_	19	mark	_	_
19	bleeding	_	VERB	VBG	_	17	acl	_	_

#	COUMADIN	2029
1	CYP450	_	NOUN	NN	_	2	compound	_	_
2	isozymes	_	NOUN	NNS	_	9	nsubj	_	_
3	involved	_	VERB	VBN	_	2	acl	_	_
4	in	_	ADP	IN	_	6	case	_	_
5	the	_	DET	DT	_	6	det	_	_
6	metabolism	_	NOUN	NN	_	3	nmod	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	include	_	VERB	VBP	_	0	root	_	_
10	CYP2C9	_	NOUN	NN	_	9	dobj	_	_
11	,	_	.	,	_	10	punct	_	_
12	2C19	_	NOUN	NN	_	10	conj	_	_
13	,	_	.	,	_	10	punct	_	_
14	2C8	_	NOUN	NN	_	10	conj	_	_
15	,	_	.	,	_	10	punct	_	_
16	2C18	_	NOUN	NN	_	10	conj	_	_
17	,	_	.	,	_	10	punct	_	_
18	1A2	_	NOUN	NN	_	10	conj	_	_
19	,	_	.	,	_	10	punct	_	_
20	and	_	CONJ	CC	_	10	cc	_	_
21	3A4	_	NOUN	NN	_	10	conj	_	_

#	COUMADIN	2030
1	The	_	DET	DT	_	6	det	_	_
2	more	_	ADV	RB	_	3	advmod	_	_
3	potent	_	ADJ	JJ	_	6	amod	_	_
4	DRUG	_	NOUN	NN	_	6	compound	_	_
5	S	_	NOUN	NN	_	6	compound	_	_
6	enantiomer	_	NOUN	NN	_	8	nsubjpass	_	_
7	is	_	VERB	VBZ	_	8	auxpass	_	_
8	metabolized	_	VERB	VBN	_	0	root	_	_
9	by	_	ADP	IN	_	10	case	_	_
10	CYP2C9	_	NOUN	NN	_	8	nmod	_	_
11	while	_	ADP	IN	_	16	mark	_	_
12	the	_	DET	DT	_	14	det	_	_
13	R	_	NOUN	NN	_	14	compound	_	_
14	enantiomer	_	NOUN	NN	_	16	nsubjpass	_	_
15	is	_	VERB	VBZ	_	16	auxpass	_	_
16	metabolized	_	VERB	VBN	_	8	advcl	_	_
17	by	_	ADP	IN	_	18	case	_	_
18	CYP1A2	_	NOUN	NN	_	16	nmod	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	3A4	_	NOUN	NN	_	18	conj	_	_

#	COUMADIN	2031
1	Inhibitors	_	NOUN	NNS	_	11	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	CYP2C9	_	NOUN	NN	_	1	nmod	_	_
4	,	_	.	,	_	3	punct	_	_
5	1A2	_	NOUN	NN	_	3	conj	_	_
6	,	_	.	,	_	3	punct	_	_
7	and	_	CONJ	CC	_	3	cc	_	_
8	/	_	NOUN	NN	_	3	conj	_	_
9	or	_	CONJ	CC	_	3	cc	_	_
10	3A4	_	NOUN	NN	_	3	conj	_	_
11	have	_	VERB	VBP	_	0	root	_	_
12	the	_	DET	DT	_	13	det	_	_
13	potential	_	NOUN	NN	_	11	dobj	_	_
14	to	_	PRT	TO	_	15	mark	_	_
15	increase	_	VERB	VB	_	11	xcomp	_	_
16	the	_	DET	DT	_	17	det	_	_
17	effect	_	NOUN	NN	_	15	dobj	_	_
18	increase	_	VERB	VBP	_	19	amod	_	_
19	INR	_	NOUN	NN	_	15	dobj	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	DRUG	_	NOUN	NN	_	19	nmod	_	_
22	by	_	ADP	IN	_	23	mark	_	_
23	increasing	_	VERB	VBG	_	15	advcl	_	_
24	the	_	DET	DT	_	25	det	_	_
25	exposure	_	NOUN	NN	_	23	dobj	_	_
26	of	_	ADP	IN	_	27	case	_	_
27	DRUG	_	NOUN	NN	_	25	nmod	_	_

#	COUMADIN	2032
1	Inducers	_	NOUN	NNS	_	11	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	CYP2C9	_	NOUN	NN	_	1	nmod	_	_
4	,	_	.	,	_	3	punct	_	_
5	1A2	_	NOUN	NN	_	3	conj	_	_
6	,	_	.	,	_	3	punct	_	_
7	and	_	CONJ	CC	_	3	cc	_	_
8	/	_	NOUN	NN	_	3	conj	_	_
9	or	_	CONJ	CC	_	3	cc	_	_
10	3A4	_	NOUN	NN	_	3	conj	_	_
11	have	_	VERB	VBP	_	0	root	_	_
12	the	_	DET	DT	_	13	det	_	_
13	potential	_	NOUN	NN	_	11	dobj	_	_
14	to	_	PRT	TO	_	15	mark	_	_
15	decrease	_	VERB	VB	_	11	xcomp	_	_
16	the	_	DET	DT	_	17	det	_	_
17	effect	_	NOUN	NN	_	15	dobj	_	_
18	decrease	_	NOUN	NN	_	19	compound	_	_
19	INR	_	NOUN	NN	_	15	dobj	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	DRUG	_	NOUN	NN	_	19	nmod	_	_
22	by	_	ADP	IN	_	23	mark	_	_
23	decreasing	_	VERB	VBG	_	15	advcl	_	_
24	the	_	DET	DT	_	25	det	_	_
25	exposure	_	NOUN	NN	_	23	dobj	_	_
26	of	_	ADP	IN	_	27	case	_	_
27	DRUG	_	NOUN	NN	_	25	nmod	_	_

#	COUMADIN	2033
1	Examples	_	NOUN	NNS	_	14	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	inhibitors	_	NOUN	NNS	_	1	nmod	_	_
4	and	_	CONJ	CC	_	3	cc	_	_
5	inducers	_	NOUN	NNS	_	3	conj	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	CYP2C9	_	NOUN	NN	_	3	nmod	_	_
8	,	_	.	,	_	7	punct	_	_
9	1A2	_	NOUN	NN	_	7	conj	_	_
10	,	_	.	,	_	7	punct	_	_
11	and	_	CONJ	CC	_	7	cc	_	_
12	3A4	_	NOUN	NN	_	7	conj	_	_
13	are	_	VERB	VBP	_	14	auxpass	_	_
14	below	_	VERB	VB	_	0	root	_	_
15	in	_	ADP	IN	_	17	case	_	_
16	Table	_	ADJ	JJ	_	17	amod	_	_
17	2	_	NUM	CD	_	14	nmod	_	_
18	however	_	ADV	RB	_	14	advmod	_	_
19	,	_	.	,	_	14	punct	_	_
20	this	_	DET	DT	_	21	det	_	_
21	list	_	NOUN	NN	_	25	nsubjpass	_	_
22	should	_	VERB	MD	_	25	aux	_	_
23	not	_	ADV	RB	_	25	neg	_	_
24	be	_	VERB	VB	_	25	auxpass	_	_
25	considered	_	VERB	VBN	_	14	parataxis	_	_
26	all	_	DET	DT	_	27	det	_	_
27	inclusive	_	ADJ	JJ	_	25	conj	_	_

#	COUMADIN	2034
1	Consult	_	VERB	VB	_	0	root	_	_
2	the	_	DET	DT	_	3	det	_	_
3	labeling	_	NOUN	NN	_	1	dobj	_	_
4	of	_	ADP	IN	_	8	case	_	_
5	all	_	DET	DT	_	8	det	_	_
6	concurrently	_	ADV	RB	_	7	advmod	_	_
7	used	_	VERB	VBN	_	8	amod	_	_
8	drugs	_	NOUN	NNS	_	3	nmod	_	_
9	to	_	PRT	TO	_	10	mark	_	_
10	obtain	_	VERB	VB	_	3	acl	_	_
11	further	_	ADJ	JJ	_	12	amod	_	_
12	information	_	NOUN	NN	_	10	dobj	_	_
13	about	_	ADV	RB	_	16	case	_	_
14	CYP450	_	NOUN	NN	_	16	compound	_	_
15	interaction	_	NOUN	NN	_	16	compound	_	_
16	potential	_	ADJ	JJ	_	12	nmod	_	_

#	COUMADIN	2035
1	The	_	DET	DT	_	3	det	_	_
2	CYP450	_	NOUN	NN	_	3	compound	_	_
3	inhibition	_	NOUN	NN	_	9	nsubjpass	_	_
4	and	_	CONJ	CC	_	3	cc	_	_
5	induction	_	NOUN	NN	_	6	compound	_	_
6	potential	_	NOUN	NN	_	3	conj	_	_
7	should	_	VERB	MD	_	9	aux	_	_
8	be	_	VERB	VB	_	9	auxpass	_	_
9	considered	_	VERB	VBN	_	0	root	_	_
10	when	_	ADV	WRB	_	11	advmod	_	_
11	starting	_	VERB	VBG	_	9	ccomp	_	_
12	,	_	.	,	_	11	punct	_	_
13	stopping	_	NOUN	NN	_	11	conj	_	_
14	,	_	.	,	_	11	punct	_	_
15	or	_	CONJ	CC	_	11	cc	_	_
16	changing	_	VERB	VBG	_	17	amod	_	_
17	dose	_	NOUN	NN	_	11	conj	_	_
18	of	_	ADP	IN	_	20	case	_	_
19	concomitant	_	ADJ	JJ	_	20	amod	_	_
20	medications	_	NOUN	NNS	_	17	nmod	_	_

#	COUMADIN	2036
1	Closely	_	ADV	RB	_	2	advmod	_	_
2	monitor	_	VERB	VBP	_	3	amod	_	_
3	INR	_	NOUN	NN	_	0	root	_	_
4	if	_	ADP	IN	_	10	mark	_	_
5	a	_	DET	DT	_	7	det	_	_
6	concomitant	_	ADJ	JJ	_	7	amod	_	_
7	drug	_	NOUN	NN	_	10	nsubj	_	_
8	is	_	VERB	VBZ	_	10	cop	_	_
9	a	_	DET	DT	_	10	det	_	_
10	CYP2C9	_	NOUN	NN	_	3	nmod	_	_
11	,	_	.	,	_	10	punct	_	_
12	1A2	_	NOUN	NN	_	10	conj	_	_
13	,	_	.	,	_	10	punct	_	_
14	and	_	CONJ	CC	_	10	cc	_	_
15	/	_	NOUN	NN	_	10	conj	_	_
16	or	_	CONJ	CC	_	10	cc	_	_
17	3A4	_	NOUN	NN	_	18	compound	_	_
18	inhibitor	_	NOUN	NN	_	10	conj	_	_
19	or	_	CONJ	CC	_	3	cc	_	_
20	inducer	_	NOUN	NN	_	3	root	_	_

#	COUMADIN	2037
1	Table	_	ADJ	JJ	_	0	root	_	_
2	2	_	NUM	CD	_	1	dep	_	_
3	:	_	.	:	_	1	punct	_	_
4	Examples	_	NOUN	NNS	_	12	nsubj	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	CYP450	_	NOUN	NN	_	7	compound	_	_
7	Interactions	_	NOUN	NNS	_	4	nmod	_	_
8	with	_	ADP	IN	_	11	case	_	_
9	DRUG	_	NOUN	NN	_	11	compound	_	_
10	Enzyme	_	NOUN	NN	_	11	compound	_	_
11	Inhibitors	_	NOUN	NNS	_	7	nmod	_	_
12	Inducers	_	NOUN	NNS	_	1	dep	_	_
13	CYP2C9	_	NOUN	NN	_	14	compound	_	_
14	amiodarone	_	NOUN	NN	_	12	dobj	_	_
15	,	_	.	,	_	14	punct	_	_
16	capecitabine	_	NOUN	NN	_	14	conj	_	_
17	,	_	.	,	_	14	punct	_	_
18	cotrimoxazole	_	NOUN	NN	_	14	conj	_	_
19	,	_	.	,	_	14	punct	_	_
20	etravirine	_	NOUN	NN	_	14	conj	_	_
21	,	_	.	,	_	14	punct	_	_
22	fluconazole	_	NOUN	NN	_	14	conj	_	_
23	,	_	.	,	_	14	punct	_	_
24	fluvastatin	_	NOUN	NN	_	14	conj	_	_
25	,	_	.	,	_	14	punct	_	_
26	fluvoxamine	_	NOUN	NN	_	14	conj	_	_
27	,	_	.	,	_	14	punct	_	_
28	metronidazole	_	NOUN	NN	_	14	conj	_	_
29	,	_	.	,	_	14	punct	_	_
30	miconazole	_	NOUN	NN	_	14	conj	_	_
31	,	_	.	,	_	14	punct	_	_
32	oxandrolone	_	NOUN	NN	_	14	conj	_	_
33	,	_	.	,	_	14	punct	_	_
34	sulfinpyrazone	_	NOUN	NN	_	14	conj	_	_
35	,	_	.	,	_	14	punct	_	_
36	tigecycline	_	NOUN	NN	_	14	conj	_	_
37	,	_	.	,	_	14	punct	_	_
38	voriconazole	_	NOUN	NN	_	14	conj	_	_
39	,	_	.	,	_	14	punct	_	_
40	zafirlukast	_	NOUN	NN	_	41	nmod:npmod	_	_
41	aprepitant	_	ADJ	JJ	_	14	conj	_	_
42	,	_	.	,	_	14	punct	_	_
43	bosentan	_	NOUN	NN	_	14	conj	_	_
44	,	_	.	,	_	14	punct	_	_
45	carbamazepine	_	NOUN	NN	_	14	conj	_	_
46	,	_	.	,	_	14	punct	_	_
47	phenobarbital	_	ADJ	JJ	_	14	conj	_	_
48	,	_	.	,	_	14	punct	_	_
49	rifampin	_	NOUN	NN	_	51	compound	_	_
50	CYP1A2	_	NOUN	NN	_	51	compound	_	_
51	acyclovir	_	NOUN	NN	_	14	conj	_	_
52	,	_	.	,	_	14	punct	_	_
53	allopurinol	_	NOUN	NN	_	14	conj	_	_
54	,	_	.	,	_	14	punct	_	_
55	caffeine	_	NOUN	NN	_	14	conj	_	_
56	,	_	.	,	_	14	punct	_	_
57	cimetidine	_	NOUN	NN	_	14	conj	_	_
58	,	_	.	,	_	14	punct	_	_
59	ciprofloxacin	_	NOUN	NN	_	14	conj	_	_
60	,	_	.	,	_	14	punct	_	_
61	disulfiram	_	NOUN	NN	_	14	conj	_	_
62	,	_	.	,	_	14	punct	_	_
63	enoxacin	_	NOUN	NN	_	14	conj	_	_
64	,	_	.	,	_	14	punct	_	_
65	famotidine	_	NOUN	NN	_	14	conj	_	_
66	,	_	.	,	_	14	punct	_	_
67	fluvoxamine	_	NOUN	NN	_	14	conj	_	_
68	,	_	.	,	_	14	punct	_	_
69	methoxsalen	_	NOUN	NN	_	14	conj	_	_
70	,	_	.	,	_	14	punct	_	_
71	mexiletine	_	NOUN	NN	_	14	conj	_	_
72	,	_	.	,	_	14	punct	_	_
73	norfloxacin	_	NOUN	NN	_	14	conj	_	_
74	,	_	.	,	_	14	punct	_	_
75	oral	_	ADJ	JJ	_	76	amod	_	_
76	contraceptives	_	NOUN	NNS	_	14	conj	_	_
77	,	_	.	,	_	14	punct	_	_
78	phenylpropanolamine	_	NOUN	NN	_	14	conj	_	_
79	,	_	.	,	_	14	punct	_	_
80	propafenone	_	NOUN	NN	_	14	conj	_	_
81	,	_	.	,	_	14	punct	_	_
82	propranolol	_	NOUN	NN	_	14	conj	_	_
83	,	_	.	,	_	14	punct	_	_
84	terbinafine	_	NOUN	NN	_	14	conj	_	_
85	,	_	.	,	_	14	punct	_	_
86	thiabendazole	_	NOUN	NN	_	14	conj	_	_
87	,	_	.	,	_	14	punct	_	_
88	ticlopidine	_	NOUN	NN	_	14	conj	_	_
89	,	_	.	,	_	14	punct	_	_
90	verapamil	_	NOUN	NN	_	14	conj	_	_
91	,	_	.	,	_	14	punct	_	_
92	zileuton	_	NOUN	NN	_	93	compound	_	_
93	montelukast	_	NOUN	NN	_	14	conj	_	_
94	,	_	.	,	_	14	punct	_	_
95	moricizine	_	NOUN	NN	_	14	conj	_	_
96	,	_	.	,	_	14	punct	_	_
97	omeprazole	_	ADJ	JJ	_	14	conj	_	_
98	,	_	.	,	_	14	punct	_	_
99	phenobarbital	_	ADJ	JJ	_	14	conj	_	_
100	,	_	.	,	_	14	punct	_	_
101	phenytoin	_	NOUN	NN	_	14	conj	_	_
102	,	_	.	,	_	14	punct	_	_
103	cigarette	_	NOUN	NN	_	14	appos	_	_
104	smoking	_	VERB	VBG	_	103	acl	_	_
105	CYP3A4	_	NOUN	NN	_	106	compound	_	_
106	alprazolam	_	NOUN	NN	_	104	dobj	_	_
107	,	_	.	,	_	106	punct	_	_
108	amiodarone	_	NOUN	NN	_	106	conj	_	_
109	,	_	.	,	_	106	punct	_	_
110	amlodipine	_	NOUN	NN	_	106	conj	_	_
111	,	_	.	,	_	106	punct	_	_
112	amprenavir	_	NOUN	NN	_	106	conj	_	_
113	,	_	.	,	_	106	punct	_	_
114	aprepitant	_	ADJ	JJ	_	106	conj	_	_
115	,	_	.	,	_	106	punct	_	_
116	atorvastatin	_	NOUN	NN	_	106	conj	_	_
117	,	_	.	,	_	106	punct	_	_
118	atazanavir	_	NOUN	NN	_	106	conj	_	_
119	,	_	.	,	_	106	punct	_	_
120	bicalutamide	_	NOUN	NN	_	106	conj	_	_
121	,	_	.	,	_	106	punct	_	_
122	cilostazol	_	NOUN	NN	_	106	conj	_	_
123	,	_	.	,	_	106	punct	_	_
124	cimetidine	_	NOUN	NN	_	106	conj	_	_
125	,	_	.	,	_	106	punct	_	_
126	ciprofloxacin	_	NOUN	NN	_	106	conj	_	_
127	,	_	.	,	_	106	punct	_	_
128	clarithromycin	_	NOUN	NN	_	106	conj	_	_
129	,	_	.	,	_	106	punct	_	_
130	conivaptan	_	NOUN	NN	_	106	conj	_	_
131	,	_	.	,	_	106	punct	_	_
132	cyclosporine	_	NOUN	NN	_	106	conj	_	_
133	,	_	.	,	_	106	punct	_	_
134	darunavir	_	NOUN	NN	_	106	appos	_	_
135	/	_	.	:	_	106	punct	_	_
136	ritonavir	_	NOUN	NN	_	106	conj	_	_
137	,	_	.	,	_	106	punct	_	_
138	diltiazem	_	NOUN	NN	_	106	conj	_	_
139	,	_	.	,	_	106	punct	_	_
140	erythromycin	_	NOUN	NN	_	106	conj	_	_
141	,	_	.	,	_	106	punct	_	_
142	fluconazole	_	NOUN	NN	_	106	conj	_	_
143	,	_	.	,	_	106	punct	_	_
144	fluoxetine	_	NOUN	NN	_	106	conj	_	_
145	,	_	.	,	_	106	punct	_	_
146	fluvoxamine	_	NOUN	NN	_	106	conj	_	_
147	,	_	.	,	_	106	punct	_	_
148	fosamprenavir	_	NOUN	NN	_	106	conj	_	_
149	,	_	.	,	_	106	punct	_	_
150	imatinib	_	NOUN	NN	_	106	conj	_	_
151	,	_	.	,	_	106	punct	_	_
152	indinavir	_	NOUN	NN	_	106	conj	_	_
153	,	_	.	,	_	106	punct	_	_
154	isoniazid	_	NOUN	NN	_	106	conj	_	_
155	,	_	.	,	_	106	punct	_	_
156	itraconazole	_	NOUN	NN	_	106	conj	_	_
157	,	_	.	,	_	106	punct	_	_
158	ketoconazole	_	NOUN	NN	_	106	conj	_	_
159	,	_	.	,	_	106	punct	_	_
160	lopinavir	_	ADJ	JJ	_	106	appos	_	_
161	/	_	.	-RRB-	_	14	punct	_	_
162	ritonavir	_	NOUN	NN	_	14	dep	_	_
163	,	_	.	,	_	162	punct	_	_
164	nefazodone	_	NOUN	NN	_	162	conj	_	_
165	,	_	.	,	_	162	punct	_	_
166	nelfinavir	_	NOUN	NN	_	162	conj	_	_
167	,	_	.	,	_	162	punct	_	_
168	nilotinib	_	NOUN	NN	_	162	conj	_	_
169	,	_	.	,	_	162	punct	_	_
170	oral	_	ADJ	JJ	_	171	amod	_	_
171	contraceptives	_	NOUN	NNS	_	162	conj	_	_
172	,	_	.	,	_	162	punct	_	_
173	posaconazole	_	NOUN	NN	_	162	conj	_	_
174	,	_	.	,	_	162	punct	_	_
175	ranitidine	_	NOUN	NN	_	162	conj	_	_
176	,	_	.	,	_	162	punct	_	_
177	ranolazine	_	NOUN	NN	_	162	conj	_	_
178	,	_	.	,	_	162	punct	_	_
179	ritonavir	_	NOUN	NN	_	162	conj	_	_
180	,	_	.	,	_	162	punct	_	_
181	saquinavir	_	NOUN	NN	_	162	conj	_	_
182	,	_	.	,	_	162	punct	_	_
183	telithromycin	_	NOUN	NN	_	162	conj	_	_
184	,	_	.	,	_	162	punct	_	_
185	tipranavir	_	NOUN	NN	_	162	conj	_	_
186	,	_	.	,	_	162	punct	_	_
187	voriconazole	_	NOUN	NN	_	162	conj	_	_
188	,	_	.	,	_	162	punct	_	_
189	zileuton	_	NOUN	NN	_	190	compound	_	_
190	armodafinil	_	NOUN	NN	_	162	conj	_	_
191	,	_	.	,	_	162	punct	_	_
192	amprenavir	_	NOUN	NN	_	162	conj	_	_
193	,	_	.	,	_	162	punct	_	_
194	aprepitant	_	ADJ	JJ	_	162	conj	_	_
195	,	_	.	,	_	162	punct	_	_
196	bosentan	_	NOUN	NN	_	162	conj	_	_
197	,	_	.	,	_	162	punct	_	_
198	carbamazepine	_	NOUN	NN	_	162	conj	_	_
199	,	_	.	,	_	162	punct	_	_
200	efavirenz	_	NOUN	NN	_	162	conj	_	_
201	,	_	.	,	_	162	punct	_	_
202	etravirine	_	NOUN	NN	_	162	conj	_	_
203	,	_	.	,	_	162	punct	_	_
204	modafinil	_	NOUN	NN	_	162	conj	_	_
205	,	_	.	,	_	162	punct	_	_
206	nafcillin	_	NOUN	NN	_	162	conj	_	_
207	,	_	.	,	_	162	punct	_	_
208	phenytoin	_	NOUN	NN	_	162	conj	_	_
209	,	_	.	,	_	162	punct	_	_
210	pioglitazone	_	NOUN	NN	_	162	conj	_	_
211	,	_	.	,	_	162	punct	_	_
212	prednisone	_	NOUN	NN	_	162	conj	_	_
213	,	_	.	,	_	162	punct	_	_
214	rifampin	_	NOUN	NN	_	162	conj	_	_
215	,	_	.	,	_	162	punct	_	_
216	rufinamide	_	NOUN	NN	_	217	compound	_	_
217	Examples	_	NOUN	NNS	_	228	nsubjpass	_	_
218	of	_	ADP	IN	_	219	case	_	_
219	drugs	_	NOUN	NNS	_	217	nmod	_	_
220	known	_	VERB	VBN	_	219	acl	_	_
221	to	_	PRT	TO	_	222	mark	_	_
222	increase	_	VERB	VB	_	220	xcomp	_	_
223	the	_	DET	DT	_	224	det	_	_
224	risk	_	NOUN	NN	_	222	dobj	_	_
225	of	_	ADP	IN	_	226	case	_	_
226	bleeding	_	NOUN	NN	_	224	nmod	_	_
227	are	_	VERB	VBP	_	228	auxpass	_	_
228	presented	_	VERB	VBN	_	162	dep	_	_
229	in	_	ADP	IN	_	230	case	_	_
230	Table	_	ADJ	JJ	_	228	nmod	_	_
231	3	_	NUM	CD	_	230	dep	_	_

#	COUMADIN	2038
1	Because	_	ADP	IN	_	5	mark	_	_
2	bleeding	_	VERB	VBG	_	3	amod	_	_
3	risk	_	NOUN	NN	_	5	nsubjpass	_	_
4	is	_	VERB	VBZ	_	5	auxpass	_	_
5	increased	_	VERB	VBN	_	0	root	_	_
6	when	_	ADV	WRB	_	10	advmod	_	_
7	these	_	DET	DT	_	8	det	_	_
8	drugs	_	NOUN	NNS	_	10	nsubjpass	_	_
9	are	_	VERB	VBP	_	10	auxpass	_	_
10	used	_	VERB	VBN	_	5	advcl	_	_
11	concomitantly	_	ADV	RB	_	10	advmod	_	_
12	with	_	ADP	IN	_	13	case	_	_
13	DRUG	_	NOUN	NN	_	10	nmod	_	_
14	,	_	.	,	_	5	punct	_	_
15	closely	_	ADV	RB	_	16	advmod	_	_
16	monitor	_	NOUN	NN	_	17	amod	_	_
17	patients	_	NOUN	NNS	_	14	root	_	_
18	receiving	_	VERB	VBG	_	17	acl	_	_
19	any	_	DET	DT	_	21	det	_	_
20	such	_	ADJ	JJ	_	21	amod	_	_
21	drug	_	NOUN	NN	_	18	dobj	_	_
22	with	_	ADP	IN	_	23	case	_	_
23	DRUG	_	NOUN	NN	_	21	nmod	_	_

#	COUMADIN	2039
1	Table	_	ADJ	JJ	_	0	root	_	_
2	3	_	NUM	CD	_	1	dep	_	_
3	:	_	.	:	_	1	punct	_	_
4	Drugs	_	NOUN	NNS	_	1	dep	_	_
5	that	_	DET	WDT	_	7	mark	_	_
6	Can	_	NOUN	NN	_	7	nsubj	_	_
7	Increase	_	VERB	VBP	_	4	acl:relcl	_	_
8	the	_	DET	DT	_	9	det	_	_
9	Risk	_	NOUN	NN	_	7	dobj	_	_
10	of	_	ADP	IN	_	15	case	_	_
11	Bleeding	_	VERB	VBG	_	15	amod	_	_
12	Drug	_	NOUN	NN	_	15	compound	_	_
13	Class	_	NOUN	NN	_	15	compound	_	_
14	Specific	_	ADJ	JJ	_	15	amod	_	_
15	Drugs	_	NOUN	NNS	_	9	nmod	_	_
16	DRUGS	_	NOUN	NN	_	17	compound	_	_
17	argatroban	_	NOUN	NN	_	15	dep	_	_
18	,	_	.	,	_	17	punct	_	_
19	dabigatran	_	NOUN	NN	_	17	conj	_	_
20	,	_	.	,	_	17	punct	_	_
21	bivalirudin	_	NOUN	NN	_	17	conj	_	_
22	,	_	.	,	_	17	punct	_	_
23	desirudin	_	NOUN	NN	_	17	conj	_	_
24	,	_	.	,	_	17	punct	_	_
25	heparin	_	NOUN	NN	_	17	conj	_	_
26	,	_	.	,	_	17	punct	_	_
27	lepirudin	_	NOUN	NN	_	29	compound	_	_
28	Antiplatelet	_	NOUN	NN	_	29	compound	_	_
29	Agents	_	NOUN	NNS	_	17	appos	_	_
30	aspirin	_	NOUN	NN	_	118	nsubj	_	_
31	,	_	.	,	_	30	punct	_	_
32	cilostazol	_	NOUN	NN	_	30	conj	_	_
33	,	_	.	,	_	30	punct	_	_
34	clopidogrel	_	NOUN	NN	_	30	conj	_	_
35	,	_	.	,	_	30	punct	_	_
36	dipyridamole	_	NOUN	NN	_	30	conj	_	_
37	,	_	.	,	_	30	punct	_	_
38	prasugrel	_	NOUN	NN	_	30	conj	_	_
39	,	_	.	,	_	30	punct	_	_
40	ticlopidine	_	NOUN	NN	_	44	compound	_	_
41	Nonsteroidal	_	ADJ	JJ	_	44	amod	_	_
42	Anti	_	NOUN	NN	_	44	compound	_	_
43	Inflammatory	_	ADJ	JJ	_	44	amod	_	_
44	Agents	_	NOUN	NNS	_	30	appos	_	_
45	celecoxib	_	NOUN	NN	_	44	nmod	_	_
46	,	_	.	,	_	45	punct	_	_
47	diclofenac	_	ADJ	JJ	_	45	conj	_	_
48	,	_	.	,	_	45	punct	_	_
49	diflunisal	_	ADJ	JJ	_	45	conj	_	_
50	,	_	.	,	_	45	punct	_	_
51	fenoprofen	_	NOUN	NN	_	45	conj	_	_
52	,	_	.	,	_	45	punct	_	_
53	ibuprofen	_	NOUN	NN	_	45	conj	_	_
54	,	_	.	,	_	45	punct	_	_
55	indomethacin	_	NOUN	NN	_	45	conj	_	_
56	,	_	.	,	_	45	punct	_	_
57	ketoprofen	_	NOUN	NN	_	45	conj	_	_
58	,	_	.	,	_	45	punct	_	_
59	ketorolac	_	ADJ	JJ	_	45	conj	_	_
60	,	_	.	,	_	45	punct	_	_
61	mefenamic	_	ADJ	JJ	_	62	amod	_	_
62	acid	_	NOUN	NN	_	45	conj	_	_
63	,	_	.	,	_	45	punct	_	_
64	naproxen	_	NOUN	NN	_	45	conj	_	_
65	,	_	.	,	_	45	punct	_	_
66	oxaprozin	_	NOUN	NN	_	45	conj	_	_
67	,	_	.	,	_	45	punct	_	_
68	piroxicam	_	NOUN	NN	_	45	conj	_	_
69	,	_	.	,	_	45	punct	_	_
70	sulindac	_	ADJ	JJ	_	73	amod	_	_
71	Serotonin	_	NOUN	NN	_	73	compound	_	_
72	Reuptake	_	NOUN	NN	_	73	compound	_	_
73	Inhibitors	_	NOUN	NNS	_	45	appos	_	_
74	citalopram	_	NOUN	NN	_	73	dep	_	_
75	,	_	.	,	_	74	punct	_	_
76	desvenlafaxine	_	NOUN	NN	_	74	conj	_	_
77	,	_	.	,	_	74	punct	_	_
78	duloxetine	_	NOUN	NN	_	74	conj	_	_
79	,	_	.	,	_	74	punct	_	_
80	escitalopram	_	NOUN	NN	_	74	conj	_	_
81	,	_	.	,	_	74	punct	_	_
82	fluoxetine	_	NOUN	NN	_	74	conj	_	_
83	,	_	.	,	_	74	punct	_	_
84	fluvoxamine	_	NOUN	NN	_	74	conj	_	_
85	,	_	.	,	_	74	punct	_	_
86	milnacipran	_	NOUN	NN	_	74	conj	_	_
87	,	_	.	,	_	74	punct	_	_
88	paroxetine	_	NOUN	NN	_	74	conj	_	_
89	,	_	.	,	_	74	punct	_	_
90	sertraline	_	NOUN	NN	_	74	conj	_	_
91	,	_	.	,	_	74	punct	_	_
92	venlafaxine	_	NOUN	NN	_	74	appos	_	_
93	,	_	.	,	_	74	punct	_	_
94	vilazodone	_	NOUN	NN	_	98	nsubj	_	_
95	There	_	NUM	CD	_	94	nummod	_	_
96	have	_	VERB	VBP	_	98	aux	_	_
97	been	_	VERB	VBN	_	98	cop	_	_
98	reports	_	NOUN	NNS	_	74	conj	_	_
99	of	_	ADP	IN	_	100	case	_	_
100	changes	_	NOUN	NNS	_	98	nmod	_	_
101	in	_	ADP	IN	_	102	case	_	_
102	INR	_	NOUN	NN	_	100	nmod	_	_
103	in	_	ADP	IN	_	104	case	_	_
104	patients	_	NOUN	NNS	_	100	nmod	_	_
105	taking	_	VERB	VBG	_	104	acl	_	_
106	DRUG	_	NOUN	NN	_	105	dobj	_	_
107	and	_	CONJ	CC	_	106	cc	_	_
108	antibiotics	_	NOUN	NNS	_	106	conj	_	_
109	or	_	CONJ	CC	_	106	cc	_	_
110	antifungals	_	NOUN	NNS	_	106	conj	_	_
111	,	_	.	,	_	74	punct	_	_
112	but	_	CONJ	CC	_	74	cc	_	_
113	clinical	_	ADJ	JJ	_	115	amod	_	_
114	pharmacokinetic	_	ADJ	JJ	_	115	amod	_	_
115	studies	_	NOUN	NNS	_	74	conj	_	_
116	have	_	VERB	VBP	_	118	aux	_	_
117	not	_	ADV	RB	_	118	neg	_	_
118	shown	_	VERB	VBN	_	29	acl	_	_
119	consistent	_	ADJ	JJ	_	120	amod	_	_
120	effects	_	NOUN	NNS	_	118	dobj	_	_
121	of	_	ADP	IN	_	123	case	_	_
122	these	_	DET	DT	_	123	det	_	_
123	agents	_	NOUN	NNS	_	120	nmod	_	_
124	on	_	ADP	IN	_	126	case	_	_
125	plasma	_	NOUN	NN	_	126	compound	_	_
126	concentrations	_	NOUN	NNS	_	120	nmod	_	_
127	of	_	ADP	IN	_	128	case	_	_
128	DRUG	_	NOUN	NN	_	126	nmod	_	_

#	COUMADIN	2040
1	Closely	_	ADV	RB	_	2	advmod	_	_
2	monitor	_	VERB	VBP	_	0	root	_	_
3	INR	_	NOUN	NN	_	2	dobj	_	_
4	when	_	ADV	WRB	_	5	advmod	_	_
5	starting	_	VERB	VBG	_	2	advcl	_	_
6	or	_	CONJ	CC	_	5	cc	_	_
7	stopping	_	VERB	VBG	_	5	conj	_	_
8	any	_	DET	DT	_	9	det	_	_
9	antibiotic	_	ADJ	JJ	_	5	dobj	_	_
10	or	_	CONJ	CC	_	9	cc	_	_
11	antifungal	_	ADJ	JJ	_	9	conj	_	_
12	in	_	ADP	IN	_	13	case	_	_
13	patients	_	NOUN	NNS	_	9	nmod	_	_
14	taking	_	VERB	VBG	_	13	acl	_	_
15	DRUG	_	NOUN	NN	_	14	nmod	_	_

#	COUMADIN	2041
1	More	_	ADV	RB	_	2	advmod	_	_
2	frequent	_	ADJ	JJ	_	4	amod	_	_
3	INR	_	NOUN	NN	_	4	compound	_	_
4	monitoring	_	NOUN	NN	_	7	nsubjpass	_	_
5	should	_	VERB	MD	_	7	aux	_	_
6	be	_	VERB	VB	_	7	auxpass	_	_
7	performed	_	VERB	VBN	_	0	root	_	_
8	when	_	ADV	WRB	_	9	advmod	_	_
9	starting	_	VERB	VBG	_	7	advcl	_	_
10	or	_	CONJ	CC	_	9	cc	_	_
11	stopping	_	NOUN	NN	_	9	conj	_	_
12	botanicals	_	NOUN	NNS	_	9	dobj	_	_

#	COUMADIN	2042
1	Few	_	ADJ	JJ	_	2	amod	_	_
2	adequate	_	NOUN	NN	_	0	root	_	_
3	,	_	.	,	_	2	punct	_	_
4	well	_	ADV	RB	_	5	advmod	_	_
5	controlled	_	VERB	VBN	_	6	amod	_	_
6	studies	_	NOUN	NNS	_	21	nsubj	_	_
7	evaluating	_	VERB	VBG	_	6	acl	_	_
8	the	_	DET	DT	_	9	det	_	_
9	potential	_	NOUN	NN	_	7	dobj	_	_
10	for	_	ADP	IN	_	16	case	_	_
11	metabolic	_	ADJ	JJ	_	16	amod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	/	_	NOUN	NN	_	11	conj	_	_
14	or	_	CONJ	CC	_	11	cc	_	_
15	pharmacologic	_	ADJ	JJ	_	11	conj	_	_
16	interactions	_	NOUN	NNS	_	9	nmod	_	_
17	between	_	ADP	IN	_	18	case	_	_
18	botanicals	_	NOUN	NNS	_	16	nmod	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	DRUG	_	NOUN	NN	_	18	conj	_	_
21	exist	_	VERB	VBZ	_	2	dep	_	_

#	COUMADIN	2043
1	Due	_	ADP	IN	_	4	case	_	_
2	to	_	PRT	TO	_	1	mwe	_	_
3	a	_	DET	DT	_	4	det	_	_
4	lack	_	NOUN	NN	_	19	nmod	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	manufacturing	_	ADJ	JJ	_	7	amod	_	_
7	standardization	_	NOUN	NN	_	4	nmod	_	_
8	with	_	ADP	IN	_	11	case	_	_
9	botanical	_	ADJ	JJ	_	11	amod	_	_
10	medicinal	_	ADJ	JJ	_	11	amod	_	_
11	preparations	_	NOUN	NNS	_	7	nmod	_	_
12	,	_	.	,	_	19	punct	_	_
13	the	_	DET	DT	_	14	det	_	_
14	amount	_	NOUN	NN	_	19	nsubjpass	_	_
15	of	_	ADP	IN	_	17	case	_	_
16	active	_	ADJ	JJ	_	17	amod	_	_
17	ingredients	_	NOUN	NNS	_	14	nmod	_	_
18	may	_	VERB	MD	_	19	aux	_	_
19	vary	_	VERB	VB	_	0	root	_	_

#	COUMADIN	2044
1	This	_	DET	DT	_	4	nsubj	_	_
2	could	_	VERB	MD	_	4	aux	_	_
3	further	_	ADV	RB	_	4	advmod	_	_
4	confound	_	VERB	VB	_	0	root	_	_
5	the	_	DET	DT	_	6	det	_	_
6	ability	_	NOUN	NN	_	4	dobj	_	_
7	to	_	PRT	TO	_	8	mark	_	_
8	assess	_	VERB	VB	_	6	acl	_	_
9	potential	_	ADJ	JJ	_	10	amod	_	_
10	interactions	_	NOUN	NNS	_	8	dobj	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	effects	_	NOUN	NNS	_	10	conj	_	_
13	on	_	ADP	IN	_	14	case	_	_
14	anticoagulation	_	NOUN	NN	_	10	nmod	_	_

#	COUMADIN	2045
1	Some	_	DET	DT	_	2	det	_	_
2	botanicals	_	NOUN	NNS	_	4	nsubj	_	_
3	may	_	VERB	MD	_	4	aux	_	_
4	cause	_	VERB	VB	_	0	root	_	_
5	bleeding	_	VERB	VBG	_	6	amod	_	_
6	events	_	NOUN	NNS	_	4	dobj	_	_
7	when	_	ADV	WRB	_	8	advmod	_	_
8	taken	_	VERB	VBN	_	4	advcl	_	_
9	alone	_	ADV	RB	_	10	advmod	_	_
10	e.g	_	NOUN	NN	_	8	dobj	_	_
11	,	_	.	,	_	10	punct	_	_
12	garlic	_	ADJ	JJ	_	10	conj	_	_
13	and	_	CONJ	CC	_	10	cc	_	_
14	Ginkgo	_	NOUN	NN	_	15	compound	_	_
15	biloba	_	NOUN	NN	_	10	conj	_	_
16	and	_	CONJ	CC	_	4	cc	_	_
17	may	_	VERB	MD	_	18	aux	_	_
18	have	_	VERB	VB	_	4	conj	_	_
19	anticoagulant	_	ADJ	JJ	_	18	dobj	_	_
20	,	_	.	,	_	19	punct	_	_
21	antiplatelet	_	ADJ	JJ	_	19	conj	_	_
22	,	_	.	,	_	19	punct	_	_
23	and	_	CONJ	CC	_	19	cc	_	_
24	/	_	NUM	CD	_	19	conj	_	_
25	or	_	CONJ	CC	_	19	cc	_	_
26	fibrinolytic	_	ADJ	JJ	_	19	conj	_	_
27	properties	_	NOUN	NNS	_	19	dep	_	_

#	COUMADIN	2046
1	These	_	DET	DT	_	2	det	_	_
2	effects	_	NOUN	NNS	_	5	nsubjpass	_	_
3	would	_	VERB	MD	_	5	aux	_	_
4	be	_	VERB	VB	_	5	auxpass	_	_
5	expected	_	VERB	VBN	_	0	root	_	_
6	to	_	PRT	TO	_	8	mark	_	_
7	be	_	VERB	VB	_	8	cop	_	_
8	additive	_	ADJ	JJ	_	5	xcomp	_	_
9	to	_	PRT	TO	_	12	case	_	_
10	the	_	DET	DT	_	12	det	_	_
11	anticoagulant	_	ADJ	JJ	_	12	amod	_	_
12	effects	_	NOUN	NNS	_	8	nmod	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	DRUG	_	NOUN	NN	_	12	nmod	_	_

#	COUMADIN	2047
1	Conversely	_	ADV	RB	_	6	advmod	_	_
2	,	_	.	,	_	6	punct	_	_
3	some	_	DET	DT	_	4	det	_	_
4	botanicals	_	NOUN	NNS	_	6	nsubj	_	_
5	may	_	VERB	MD	_	6	aux	_	_
6	decrease	_	VERB	VB	_	0	root	_	_
7	the	_	DET	DT	_	8	det	_	_
8	effects	_	NOUN	NNS	_	6	dobj	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	DRUG	_	NOUN	NN	_	11	compound	_	_
11	e.g	_	NOUN	NN	_	8	nmod	_	_
12	,	_	.	,	_	11	punct	_	_
13	co	_	PRT	TO	_	15	case	_	_
14	enzyme	_	NOUN	NN	_	15	compound	_	_
15	Q10	_	NOUN	NN	_	11	conj	_	_
16	,	_	.	,	_	11	punct	_	_
17	St	_	NOUN	NN	_	18	compound	_	_
18	John's	_	NOUN	NNS	_	11	conj	_	_
19	wort	_	ADV	RB	_	6	advmod	_	_
20	,	_	.	,	_	6	punct	_	_
21	ginseng	_	VERB	VBG	_	6	xcomp	_	_

#	COUMADIN	2048
1	Some	_	DET	DT	_	2	det	_	_
2	botanicals	_	NOUN	NNS	_	6	nsubj	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	foods	_	NOUN	NNS	_	2	conj	_	_
5	can	_	VERB	MD	_	6	aux	_	_
6	interact	_	VERB	VB	_	0	root	_	_
7	with	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	through	_	ADP	IN	_	11	case	_	_
10	CYP450	_	NOUN	NN	_	11	compound	_	_
11	interactions	_	NOUN	NNS	_	6	nmod	_	_
12	e.g	_	NOUN	NN	_	11	dep	_	_
13	,	_	.	,	_	12	punct	_	_
14	echinacea	_	NOUN	NN	_	12	conj	_	_
15	,	_	.	,	_	12	punct	_	_
16	grapefruit	_	ADJ	JJ	_	17	amod	_	_
17	juice	_	NOUN	NN	_	12	conj	_	_
18	,	_	.	,	_	12	punct	_	_
19	ginkgo	_	NOUN	NN	_	12	conj	_	_
20	,	_	.	,	_	12	punct	_	_
21	goldenseal	_	ADJ	JJ	_	12	conj	_	_
22	,	_	.	,	_	12	punct	_	_
23	St	_	NOUN	NN	_	24	compound	_	_
24	John's	_	NOUN	NNS	_	12	appos	_	_
25	wort	_	VERB	VBZ	_	6	parataxis	_	_

#	COUMADIN	2049
1	The	_	DET	DT	_	2	det	_	_
2	amount	_	NOUN	NN	_	9	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	vitamin	_	NOUN	NN	_	5	compound	_	_
5	K	_	NOUN	NN	_	2	nmod	_	_
6	in	_	ADP	IN	_	7	case	_	_
7	food	_	NOUN	NN	_	2	nmod	_	_
8	may	_	VERB	MD	_	9	aux	_	_
9	affect	_	VERB	VB	_	0	root	_	_
10	therapy	_	NOUN	NN	_	9	dobj	_	_
11	with	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_

#	COUMADIN	2050
1	Advise	_	ADJ	JJ	_	2	case	_	_
2	patients	_	NOUN	NNS	_	23	nsubj	_	_
3	taking	_	VERB	VBG	_	2	acl	_	_
4	DRUG	_	NOUN	NN	_	3	dobj	_	_
5	to	_	PRT	TO	_	11	mark	_	_
6	eat	_	VERB	VB	_	11	cop	_	_
7	a	_	DET	DT	_	11	det	_	_
8	normal	_	ADJ	JJ	_	11	amod	_	_
9	,	_	.	,	_	8	punct	_	_
10	balanced	_	ADJ	JJ	_	8	dep	_	_
11	diet	_	NOUN	NN	_	3	dobj	_	_
12	maintaining	_	VERB	VBG	_	11	acl	_	_
13	a	_	DET	DT	_	15	det	_	_
14	consistent	_	ADJ	JJ	_	15	amod	_	_
15	amount	_	NOUN	NN	_	12	dobj	_	_
16	of	_	ADP	IN	_	19	case	_	_
17	vitamin	_	NOUN	NN	_	19	compound	_	_
18	K	_	NOUN	NN	_	19	compound	_	_
19	Patients	_	NOUN	NNS	_	15	nmod	_	_
20	taking	_	VERB	VBG	_	19	acl	_	_
21	DRUG	_	NOUN	NN	_	20	dobj	_	_
22	should	_	VERB	MD	_	23	aux	_	_
23	avoid	_	ADP	IN	_	0	root	_	_
24	drastic	_	ADJ	JJ	_	25	amod	_	_
25	changes	_	NOUN	NNS	_	23	dobj	_	_
26	in	_	ADP	IN	_	28	case	_	_
27	dietary	_	ADJ	JJ	_	28	amod	_	_
28	habits	_	NOUN	NNS	_	25	nmod	_	_
29	,	_	.	,	_	23	punct	_	_
30	such	_	ADJ	JJ	_	23	nmod	_	_
31	as	_	ADP	IN	_	30	mwe	_	_
32	eating	_	VERB	VBG	_	30	dep	_	_
33	large	_	ADJ	JJ	_	34	amod	_	_
34	amounts	_	NOUN	NNS	_	32	dobj	_	_
35	of	_	ADP	IN	_	38	case	_	_
36	green	_	ADJ	JJ	_	38	amod	_	_
37	leafy	_	ADJ	JJ	_	38	amod	_	_
38	vegetables	_	NOUN	NNS	_	34	nmod	_	_

#	COUMADIN	2051
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	acts	_	VERB	VBZ	_	0	root	_	_
3	by	_	ADP	IN	_	4	mark	_	_
4	inhibiting	_	VERB	VBG	_	2	advcl	_	_
5	the	_	DET	DT	_	6	det	_	_
6	synthesis	_	NOUN	NN	_	4	dobj	_	_
7	of	_	ADP	IN	_	12	case	_	_
8	vitamin	_	NOUN	NN	_	12	compound	_	_
9	K	_	NOUN	NN	_	12	compound	_	_
10	dependent	_	ADJ	JJ	_	12	amod	_	_
11	clotting	_	NOUN	NN	_	12	compound	_	_
12	factors	_	NOUN	NNS	_	6	nmod	_	_
13	,	_	.	,	_	12	punct	_	_
14	which	_	DET	WDT	_	15	nsubj	_	_
15	include	_	VERB	VBP	_	12	acl:relcl	_	_
16	Factors	_	NOUN	NNS	_	15	dobj	_	_
17	II	_	NUM	CD	_	16	nummod	_	_
18	,	_	.	,	_	16	punct	_	_
19	VII	_	NOUN	NN	_	16	conj	_	_
20	,	_	.	,	_	16	punct	_	_
21	IX	_	NOUN	NN	_	16	conj	_	_
22	,	_	.	,	_	16	punct	_	_
23	and	_	CONJ	CC	_	16	cc	_	_
24	DRUG	_	NOUN	NN	_	16	conj	_	_
25	,	_	.	,	_	2	punct	_	_
26	and	_	CONJ	CC	_	2	cc	_	_
27	the	_	DET	DT	_	29	det	_	_
28	anticoagulant	_	ADJ	JJ	_	29	amod	_	_
29	proteins	_	NOUN	NNS	_	38	nsubj	_	_
30	C	_	NOUN	NN	_	29	dep	_	_
31	and	_	CONJ	CC	_	30	cc	_	_
32	S	_	NOUN	NN	_	34	compound	_	_
33	Vitamin	_	NOUN	NN	_	34	compound	_	_
34	K	_	NOUN	NN	_	30	conj	_	_
35	is	_	VERB	VBZ	_	38	cop	_	_
36	an	_	DET	DT	_	38	det	_	_
37	essential	_	ADJ	JJ	_	38	amod	_	_
38	cofactor	_	NOUN	NN	_	2	conj	_	_
39	for	_	ADP	IN	_	43	case	_	_
40	the	_	DET	DT	_	43	det	_	_
41	post	_	ADJ	JJ	_	43	amod	_	_
42	ribosomal	_	ADJ	JJ	_	43	amod	_	_
43	synthesis	_	NOUN	NN	_	38	nmod	_	_
44	of	_	ADP	IN	_	50	case	_	_
45	the	_	DET	DT	_	50	det	_	_
46	vitamin	_	NOUN	NN	_	50	compound	_	_
47	K	_	NOUN	NN	_	50	compound	_	_
48	dependent	_	ADJ	JJ	_	50	amod	_	_
49	clotting	_	NOUN	NN	_	50	compound	_	_
50	factors	_	NOUN	NNS	_	43	nmod	_	_

#	COUMADIN	2052
1	Vitamin	_	NOUN	NN	_	2	compound	_	_
2	K	_	NOUN	NN	_	3	nsubj	_	_
3	promotes	_	VERB	VBZ	_	0	root	_	_
4	the	_	DET	DT	_	5	det	_	_
5	biosynthesis	_	NOUN	NN	_	3	dobj	_	_
6	of	_	ADP	IN	_	10	case	_	_
7	DRUGS	_	NOUN	NN	_	10	compound	_	_
8	carboxyglutamic	_	ADJ	JJ	_	10	amod	_	_
9	acid	_	NOUN	NN	_	10	compound	_	_
10	residues	_	NOUN	NNS	_	5	nmod	_	_
11	in	_	ADP	IN	_	13	case	_	_
12	the	_	DET	DT	_	13	det	_	_
13	proteins	_	NOUN	NNS	_	5	nmod	_	_
14	that	_	DET	WDT	_	16	nsubj	_	_
15	are	_	VERB	VBP	_	16	cop	_	_
16	essential	_	ADJ	JJ	_	13	acl:relcl	_	_
17	for	_	ADP	IN	_	19	case	_	_
18	biological	_	ADJ	JJ	_	19	amod	_	_
19	activity	_	NOUN	NN	_	16	nmod	_	_

#	COUMADIN	2053
1	DRUG	_	NOUN	NN	_	3	nsubjpass	_	_
2	is	_	VERB	VBZ	_	3	auxpass	_	_
3	thought	_	VERB	VBN	_	0	root	_	_
4	to	_	PRT	TO	_	5	mark	_	_
5	interfere	_	VERB	VB	_	3	xcomp	_	_
6	with	_	ADP	IN	_	7	mark	_	_
7	clotting	_	VERB	VBG	_	5	advcl	_	_
8	factor	_	NOUN	NN	_	9	compound	_	_
9	synthesis	_	NOUN	NN	_	7	dobj	_	_
10	by	_	ADP	IN	_	11	case	_	_
11	inhibition	_	NOUN	NN	_	7	nmod	_	_
12	of	_	ADP	IN	_	15	case	_	_
13	the	_	DET	DT	_	15	det	_	_
14	C1	_	NOUN	NN	_	15	compound	_	_
15	subunit	_	NOUN	NN	_	11	nmod	_	_
16	of	_	ADP	IN	_	23	case	_	_
17	vitamin	_	NOUN	NN	_	23	compound	_	_
18	K	_	NOUN	NN	_	23	compound	_	_
19	epoxide	_	NOUN	NN	_	23	compound	_	_
20	reductase	_	NOUN	NN	_	23	compound	_	_
21	VKORC1	_	NOUN	NN	_	23	compound	_	_
22	enzyme	_	NOUN	NN	_	23	compound	_	_
23	complex	_	NOUN	NN	_	15	nmod	_	_
24	,	_	.	,	_	3	punct	_	_
25	thereby	_	ADV	RB	_	26	advmod	_	_
26	reducing	_	VERB	VBG	_	3	advcl	_	_
27	the	_	DET	DT	_	28	det	_	_
28	regeneration	_	NOUN	NN	_	26	dobj	_	_
29	of	_	ADP	IN	_	32	case	_	_
30	vitamin	_	NOUN	NN	_	32	compound	_	_
31	K1	_	NOUN	NN	_	32	compound	_	_
32	epoxide	_	NOUN	NN	_	28	nmod	_	_

#	COUMADIN	2054
1	An	_	DET	DT	_	3	det	_	_
2	anticoagulation	_	NOUN	NN	_	3	compound	_	_
3	effect	_	NOUN	NN	_	5	nsubj	_	_
4	generally	_	ADV	RB	_	5	advmod	_	_
5	occurs	_	VERB	VBZ	_	0	root	_	_
6	within	_	ADP	IN	_	8	case	_	_
7	24	_	NUM	CD	_	8	nummod	_	_
8	hours	_	NOUN	NNS	_	5	nmod	_	_
9	after	_	ADP	IN	_	11	case	_	_
10	DRUG	_	NOUN	NN	_	11	compound	_	_
11	administration	_	NOUN	NN	_	5	nmod	_	_

#	COUMADIN	2055
1	However	_	ADV	RB	_	8	advmod	_	_
2	,	_	.	,	_	8	punct	_	_
3	peak	_	ADJ	JJ	_	5	amod	_	_
4	anticoagulant	_	ADJ	JJ	_	5	amod	_	_
5	effect	_	NOUN	NN	_	8	nsubjpass	_	_
6	may	_	VERB	MD	_	8	aux	_	_
7	be	_	VERB	VB	_	8	auxpass	_	_
8	delayed	_	VERB	VBN	_	0	root	_	_
9	72	_	NUM	CD	_	11	compound	_	_
10	to	_	PRT	TO	_	11	dep	_	_
11	96	_	NUM	CD	_	12	nummod	_	_
12	hours	_	NOUN	NNS	_	8	dobj	_	_

#	COUMADIN	2056
1	The	_	DET	DT	_	2	det	_	_
2	duration	_	NOUN	NN	_	16	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	action	_	NOUN	NN	_	2	nmod	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	a	_	DET	DT	_	8	det	_	_
7	single	_	ADJ	JJ	_	8	amod	_	_
8	dose	_	NOUN	NN	_	4	nmod	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	racemic	_	ADJ	JJ	_	11	amod	_	_
11	DRUG	_	NOUN	NN	_	8	nmod	_	_
12	is	_	VERB	VBZ	_	16	cop	_	_
13	2	_	NUM	CD	_	15	compound	_	_
14	to	_	PRT	TO	_	15	dep	_	_
15	5	_	NUM	CD	_	16	nummod	_	_
16	days	_	NOUN	NNS	_	0	root	_	_

#	COUMADIN	2057
1	The	_	DET	DT	_	2	det	_	_
2	effects	_	NOUN	NNS	_	6	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	may	_	VERB	MD	_	6	aux	_	_
6	become	_	VERB	VB	_	0	root	_	_
7	more	_	ADV	RB	_	8	advmod	_	_
8	pronounced	_	ADJ	JJ	_	6	xcomp	_	_
9	as	_	ADP	IN	_	10	case	_	_
10	effects	_	NOUN	NNS	_	8	nmod	_	_
11	of	_	ADP	IN	_	14	case	_	_
12	daily	_	ADV	RB	_	14	advmod	_	_
13	maintenance	_	NOUN	NN	_	14	compound	_	_
14	doses	_	NOUN	NNS	_	10	nmod	_	_
15	overlap	_	VERB	VBP	_	6	parataxis	_	_

#	COUMADIN	2058
1	This	_	DET	DT	_	3	nsubj	_	_
2	is	_	VERB	VBZ	_	3	cop	_	_
3	consistent	_	ADJ	JJ	_	0	root	_	_
4	with	_	ADP	IN	_	7	case	_	_
5	the	_	DET	DT	_	7	det	_	_
6	half	_	ADJ	JJ	_	7	amod	_	_
7	lives	_	NOUN	NNS	_	3	nmod	_	_
8	of	_	ADP	IN	_	15	case	_	_
9	the	_	DET	DT	_	15	det	_	_
10	affected	_	VERB	VBN	_	15	amod	_	_
11	vitamin	_	NOUN	NN	_	15	compound	_	_
12	K	_	NOUN	NN	_	15	compound	_	_
13	dependent	_	ADJ	JJ	_	15	amod	_	_
14	clotting	_	NOUN	NN	_	15	compound	_	_
15	factors	_	NOUN	NNS	_	7	nmod	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	anticoagulation	_	NOUN	NN	_	18	compound	_	_
18	proteins	_	NOUN	NNS	_	15	conj	_	_
19	:	_	.	:	_	3	punct	_	_
20	Factor	_	NOUN	NN	_	23	compound	_	_
21	II	_	NUM	CD	_	23	nummod	_	_
22	60	_	NUM	CD	_	23	nummod	_	_
23	hours	_	NOUN	NNS	_	49	nsubj	_	_
24	,	_	.	,	_	23	punct	_	_
25	VII	_	NOUN	NN	_	29	compound	_	_
26	4	_	NUM	CD	_	28	compound	_	_
27	to	_	PRT	TO	_	28	dep	_	_
28	6	_	NUM	CD	_	29	nummod	_	_
29	hours	_	NOUN	NNS	_	23	conj	_	_
30	,	_	.	,	_	23	punct	_	_
31	IX	_	NOUN	NN	_	33	compound	_	_
32	24	_	NUM	CD	_	33	nummod	_	_
33	hours	_	NOUN	NNS	_	23	conj	_	_
34	,	_	.	,	_	33	punct	_	_
35	DRUG	_	NOUN	NN	_	39	compound	_	_
36	48	_	NUM	CD	_	38	compound	_	_
37	to	_	PRT	TO	_	38	dep	_	_
38	72	_	NUM	CD	_	39	nummod	_	_
39	hours	_	NOUN	NNS	_	33	conj	_	_
40	,	_	.	,	_	23	punct	_	_
41	and	_	CONJ	CC	_	23	cc	_	_
42	proteins	_	NOUN	NNS	_	23	conj	_	_
43	C	_	NOUN	NN	_	42	dep	_	_
44	and	_	CONJ	CC	_	43	cc	_	_
45	S	_	NOUN	NN	_	43	conj	_	_
46	are	_	VERB	VBP	_	49	cop	_	_
47	approximately	_	ADV	RB	_	48	advmod	_	_
48	8	_	NUM	CD	_	49	nummod	_	_
49	hours	_	NOUN	NNS	_	3	parataxis	_	_
50	and	_	CONJ	CC	_	49	cc	_	_
51	30	_	NUM	CD	_	52	nummod	_	_
52	hours	_	NOUN	NNS	_	49	conj	_	_
53	,	_	.	,	_	49	punct	_	_
54	respectively	_	ADV	RB	_	49	neg	_	_

#	COUMADIN	2059
1	DRUG	_	NOUN	NN	_	5	nsubj	_	_
2	is	_	VERB	VBZ	_	5	cop	_	_
3	a	_	DET	DT	_	5	det	_	_
4	racemic	_	ADJ	JJ	_	5	amod	_	_
5	mixture	_	NOUN	NN	_	0	root	_	_
6	of	_	ADP	IN	_	11	case	_	_
7	the	_	DET	DT	_	11	det	_	_
8	R	_	NOUN	NN	_	11	compound	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	S	_	NOUN	NN	_	8	conj	_	_
11	enantiomers	_	NOUN	NNS	_	5	nmod	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	DRUG	_	NOUN	NN	_	11	nmod	_	_

#	COUMADIN	2060
1	The	_	DET	DT	_	3	det	_	_
2	S	_	NOUN	NN	_	3	compound	_	_
3	enantiomer	_	NOUN	NN	_	4	nsubj	_	_
4	exhibits	_	VERB	VBZ	_	0	root	_	_
5	2	_	NUM	CD	_	7	compound	_	_
6	to	_	PRT	TO	_	7	dep	_	_
7	5	_	NUM	CD	_	8	nummod	_	_
8	times	_	NOUN	NNS	_	4	dobj	_	_
9	more	_	ADV	RB	_	10	advmod	_	_
10	anticoagulant	_	ADJ	JJ	_	11	amod	_	_
11	activity	_	NOUN	NN	_	4	dobj	_	_
12	than	_	ADP	IN	_	15	case	_	_
13	the	_	DET	DT	_	15	det	_	_
14	R	_	NOUN	NN	_	15	compound	_	_
15	enantiomer	_	NOUN	NN	_	11	nmod	_	_
16	in	_	ADP	IN	_	17	case	_	_
17	humans	_	NOUN	NNS	_	15	nmod	_	_
18	,	_	.	,	_	4	punct	_	_
19	but	_	CONJ	CC	_	4	cc	_	_
20	generally	_	ADV	RB	_	21	advmod	_	_
21	has	_	VERB	VBZ	_	4	conj	_	_
22	a	_	DET	DT	_	25	det	_	_
23	more	_	ADV	RB	_	24	advmod	_	_
24	rapid	_	ADJ	JJ	_	25	amod	_	_
25	clearance	_	NOUN	NN	_	21	dobj	_	_

#	COUMADIN	2061
1	DRUG	_	NOUN	NN	_	5	nsubjpass	_	_
2	is	_	VERB	VBZ	_	5	auxpass	_	_
3	essentially	_	ADV	RB	_	5	advmod	_	_
4	completely	_	ADV	RB	_	5	advmod	_	_
5	absorbed	_	VERB	VBN	_	0	root	_	_
6	after	_	ADP	IN	_	8	case	_	_
7	oral	_	ADJ	JJ	_	8	amod	_	_
8	administration	_	NOUN	NN	_	5	nmod	_	_
9	,	_	.	,	_	5	punct	_	_
10	with	_	ADP	IN	_	12	case	_	_
11	peak	_	ADJ	JJ	_	12	amod	_	_
12	concentration	_	NOUN	NN	_	5	nmod	_	_
13	generally	_	ADV	RB	_	14	advmod	_	_
14	attained	_	VERB	VBN	_	12	acl	_	_
15	within	_	ADP	IN	_	19	case	_	_
16	the	_	DET	DT	_	19	det	_	_
17	first	_	ADJ	JJ	_	19	amod	_	_
18	4	_	NUM	CD	_	19	nummod	_	_
19	hours	_	NOUN	NNS	_	14	nmod	_	_

#	COUMADIN	2062
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	shows	_	VERB	VBZ	_	0	root	_	_
3	a	_	DET	DT	_	4	det	_	_
4	volume	_	NOUN	NN	_	2	dobj	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	distribution	_	NOUN	NN	_	4	nmod	_	_
7	of	_	ADP	IN	_	10	case	_	_
8	about	_	ADV	RB	_	9	advmod	_	_
9	0.14	_	NUM	CD	_	10	nummod	_	_
10	L	_	NOUN	NN	_	6	nmod	_	_
11	/	_	.	:	_	10	punct	_	_
12	kg	_	NOUN	NN	_	10	dep	_	_

#	COUMADIN	2063
1	Approximately	_	ADV	RB	_	7	advmod	_	_
2	99%	_	NOUN	NN	_	7	nsubjpass	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	the	_	DET	DT	_	5	det	_	_
5	drug	_	NOUN	NN	_	2	nmod	_	_
6	is	_	VERB	VBZ	_	7	auxpass	_	_
7	bound	_	VERB	VBN	_	0	root	_	_
8	to	_	PRT	TO	_	10	case	_	_
9	plasma	_	NOUN	NN	_	10	compound	_	_
10	proteins	_	NOUN	NNS	_	7	nmod	_	_

#	COUMADIN	2064
1	The	_	DET	DT	_	2	det	_	_
2	elimination	_	NOUN	NN	_	7	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	is	_	VERB	VBZ	_	7	cop	_	_
6	almost	_	ADV	RB	_	7	advmod	_	_
7	entirely	_	ADV	RB	_	0	root	_	_
8	by	_	ADP	IN	_	9	case	_	_
9	metabolism	_	NOUN	NN	_	7	nmod	_	_

#	COUMADIN	2065
1	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
2	is	_	VERB	VBZ	_	4	auxpass	_	_
3	stereoselectively	_	ADV	RB	_	4	advmod	_	_
4	metabolized	_	VERB	VBN	_	0	root	_	_
5	by	_	ADP	IN	_	12	case	_	_
6	hepatic	_	ADJ	JJ	_	12	amod	_	_
7	cytochrome	_	NOUN	NN	_	12	compound	_	_
8	P	_	NOUN	NN	_	12	compound	_	_
9	450	_	NUM	CD	_	12	nummod	_	_
10	CYP450	_	NOUN	NN	_	12	compound	_	_
11	microsomal	_	ADJ	JJ	_	12	amod	_	_
12	enzymes	_	NOUN	NNS	_	4	nmod	_	_
13	to	_	PRT	TO	_	16	case	_	_
14	inactive	_	ADJ	JJ	_	16	amod	_	_
15	hydroxylated	_	ADJ	JJ	_	16	amod	_	_
16	metabolites	_	NOUN	NNS	_	12	nmod	_	_
17	predominant	_	ADJ	JJ	_	18	amod	_	_
18	route	_	NOUN	NN	_	16	dep	_	_
19	and	_	CONJ	CC	_	12	cc	_	_
20	by	_	ADP	IN	_	21	case	_	_
21	reductases	_	NOUN	NNS	_	12	conj	_	_
22	to	_	PRT	TO	_	24	case	_	_
23	reduced	_	VERB	VBN	_	24	amod	_	_
24	metabolites	_	NOUN	NNS	_	21	nmod	_	_
25	DRUG	_	NOUN	NN	_	26	compound	_	_
26	alcohols	_	NOUN	NNS	_	24	dep	_	_
27	with	_	ADP	IN	_	30	case	_	_
28	minimal	_	ADJ	JJ	_	30	amod	_	_
29	anticoagulant	_	ADJ	JJ	_	30	amod	_	_
30	activity	_	NOUN	NN	_	24	nmod	_	_

#	COUMADIN	2066
1	Identified	_	VERB	VBN	_	2	amod	_	_
2	metabolites	_	NOUN	NNS	_	5	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	include	_	VERB	VBP	_	0	root	_	_
6	dehydro	_	VERB	VBN	_	7	amod	_	_
7	DRUG	_	NOUN	NN	_	5	dobj	_	_
8	,	_	.	,	_	7	punct	_	_
9	two	_	NUM	CD	_	11	nummod	_	_
10	diastereoisomer	_	NOUN	NN	_	11	compound	_	_
11	alcohols	_	NOUN	NNS	_	7	conj	_	_
12	,	_	.	,	_	7	punct	_	_
13	and	_	CONJ	CC	_	7	cc	_	_
14	4'	_	ADJ	JJ	_	7	conj	_	_
15	,	_	.	,	_	14	punct	_	_
16	6	_	NUM	CD	_	14	conj	_	_
17	,	_	.	,	_	14	punct	_	_
18	7	_	NUM	CD	_	14	conj	_	_
19	,	_	.	,	_	14	punct	_	_
20	8	_	NUM	CD	_	14	conj	_	_
21	,	_	.	,	_	14	punct	_	_
22	and	_	CONJ	CC	_	14	cc	_	_
23	10	_	NUM	CD	_	14	conj	_	_
24	hydroxy	_	NOUN	NN	_	25	compound	_	_
25	DRUG	_	NOUN	NN	_	14	dep	_	_

#	COUMADIN	2067
1	The	_	DET	DT	_	3	det	_	_
2	CYP450	_	NOUN	NN	_	3	compound	_	_
3	isozymes	_	NOUN	NNS	_	10	nsubj	_	_
4	involved	_	VERB	VBN	_	3	acl	_	_
5	in	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	metabolism	_	NOUN	NN	_	4	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	include	_	VERB	VBP	_	0	root	_	_
11	CYP2C9	_	NOUN	NN	_	10	dobj	_	_
12	,	_	.	,	_	11	punct	_	_
13	2C19	_	NOUN	NN	_	11	conj	_	_
14	,	_	.	,	_	11	punct	_	_
15	2C8	_	NOUN	NN	_	11	conj	_	_
16	,	_	.	,	_	11	punct	_	_
17	2C18	_	NOUN	NN	_	11	conj	_	_
18	,	_	.	,	_	11	punct	_	_
19	1A2	_	NOUN	NN	_	11	conj	_	_
20	,	_	.	,	_	11	punct	_	_
21	and	_	CONJ	CC	_	11	cc	_	_
22	3A4	_	NOUN	NN	_	11	conj	_	_

#	COUMADIN	2068
1	CYP2C9	_	NOUN	NN	_	8	nsubj	_	_
2	,	_	.	,	_	1	punct	_	_
3	a	_	DET	DT	_	5	det	_	_
4	polymorphic	_	ADJ	JJ	_	5	amod	_	_
5	enzyme	_	NOUN	NN	_	1	appos	_	_
6	,	_	.	,	_	1	punct	_	_
7	is	_	VERB	VBZ	_	8	cop	_	_
8	likely	_	ADJ	JJ	_	0	root	_	_
9	to	_	PRT	TO	_	13	mark	_	_
10	be	_	VERB	VB	_	13	cop	_	_
11	the	_	DET	DT	_	13	det	_	_
12	principal	_	ADJ	JJ	_	13	amod	_	_
13	form	_	NOUN	NN	_	8	xcomp	_	_
14	of	_	ADP	IN	_	17	case	_	_
15	human	_	ADJ	JJ	_	17	amod	_	_
16	liver	_	NOUN	NN	_	17	compound	_	_
17	CYP450	_	NOUN	NN	_	13	nmod	_	_
18	that	_	DET	WDT	_	19	nsubj	_	_
19	modulates	_	VERB	VBZ	_	17	acl:relcl	_	_
20	the	_	DET	DT	_	24	det	_	_
21	in	_	ADJ	JJ	_	24	amod	_	_
22	vivo	_	X	FW	_	21	dep	_	_
23	anticoagulant	_	ADJ	JJ	_	24	amod	_	_
24	activity	_	NOUN	NN	_	19	dobj	_	_
25	of	_	ADP	IN	_	26	case	_	_
26	DRUG	_	NOUN	NN	_	24	nmod	_	_

#	COUMADIN	2069
1	Patients	_	NOUN	NNS	_	10	nsubj	_	_
2	with	_	ADP	IN	_	8	case	_	_
3	one	_	NUM	CD	_	8	nummod	_	_
4	or	_	CONJ	CC	_	3	cc	_	_
5	more	_	ADV	RB	_	3	conj	_	_
6	variant	_	ADJ	JJ	_	8	amod	_	_
7	CYP2C9	_	NOUN	NN	_	8	compound	_	_
8	alleles	_	NOUN	NNS	_	1	nmod	_	_
9	have	_	VERB	VBP	_	10	aux	_	_
10	decreased	_	VERB	VBN	_	0	root	_	_
11	S	_	NOUN	NN	_	13	compound	_	_
12	DRUG	_	NOUN	NN	_	13	compound	_	_
13	clearance	_	NOUN	NN	_	10	dobj	_	_

#	COUMADIN	2070
1	The	_	DET	DT	_	4	det	_	_
2	terminal	_	ADJ	JJ	_	4	amod	_	_
3	half	_	ADJ	JJ	_	4	amod	_	_
4	life	_	NOUN	NN	_	15	nsubj	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	after	_	ADP	IN	_	10	case	_	_
8	a	_	DET	DT	_	10	det	_	_
9	single	_	ADJ	JJ	_	10	amod	_	_
10	dose	_	NOUN	NN	_	4	nmod	_	_
11	is	_	VERB	VBZ	_	15	cop	_	_
12	approximately	_	ADV	RB	_	13	advmod	_	_
13	1	_	NUM	CD	_	14	nummod	_	_
14	week	_	NOUN	NN	_	15	nmod:npmod	_	_
15	however	_	ADV	RB	_	0	root	_	_
16	,	_	.	,	_	15	punct	_	_
17	the	_	DET	DT	_	21	det	_	_
18	effective	_	ADJ	JJ	_	21	amod	_	_
19	half	_	NOUN	NN	_	21	compound	_	_
20	life	_	NOUN	NN	_	21	compound	_	_
21	ranges	_	NOUN	NNS	_	16	root	_	_
22	from	_	ADP	IN	_	26	case	_	_
23	20	_	NUM	CD	_	25	compound	_	_
24	to	_	PRT	TO	_	25	dep	_	_
25	60	_	NUM	CD	_	26	nummod	_	_
26	hours	_	NOUN	NNS	_	21	nmod	_	_
27	,	_	.	,	_	21	punct	_	_
28	with	_	ADP	IN	_	30	case	_	_
29	a	_	DET	DT	_	30	det	_	_
30	mean	_	NOUN	NN	_	21	nmod	_	_
31	of	_	ADP	IN	_	34	case	_	_
32	about	_	ADV	RB	_	33	advmod	_	_
33	40	_	NUM	CD	_	34	nummod	_	_
34	hours	_	NOUN	NNS	_	30	nmod	_	_

#	COUMADIN	2071
1	The	_	DET	DT	_	2	det	_	_
2	clearance	_	NOUN	NN	_	8	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	R	_	NOUN	NN	_	5	compound	_	_
5	DRUG	_	NOUN	NN	_	2	nmod	_	_
6	is	_	VERB	VBZ	_	8	cop	_	_
7	generally	_	ADV	RB	_	8	advmod	_	_
8	half	_	VERB	VB	_	0	root	_	_
9	that	_	ADP	IN	_	21	nsubj	_	_
10	of	_	ADP	IN	_	12	case	_	_
11	S	_	NOUN	NN	_	12	compound	_	_
12	DRUG	_	NOUN	NN	_	9	nmod	_	_
13	,	_	.	,	_	9	punct	_	_
14	thus	_	ADV	RB	_	17	advmod	_	_
15	as	_	ADP	IN	_	17	case	_	_
16	the	_	DET	DT	_	17	det	_	_
17	volumes	_	NOUN	NNS	_	9	nmod	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	distribution	_	NOUN	NN	_	17	nmod	_	_
20	are	_	VERB	VBP	_	21	cop	_	_
21	similar	_	ADJ	JJ	_	8	ccomp	_	_
22	,	_	.	,	_	21	punct	_	_
23	the	_	DET	DT	_	25	det	_	_
24	half	_	ADJ	JJ	_	25	amod	_	_
25	life	_	NOUN	NN	_	30	nsubj	_	_
26	of	_	ADP	IN	_	28	case	_	_
27	R	_	NOUN	NN	_	28	compound	_	_
28	DRUG	_	NOUN	NN	_	25	nmod	_	_
29	is	_	VERB	VBZ	_	30	cop	_	_
30	longer	_	ADV	RB	_	21	parataxis	_	_
31	than	_	ADP	IN	_	32	case	_	_
32	that	_	DET	DT	_	30	nmod	_	_
33	of	_	ADP	IN	_	35	case	_	_
34	S	_	NOUN	NN	_	35	compound	_	_
35	DRUG	_	NOUN	NN	_	32	nmod	_	_

#	COUMADIN	2072
1	The	_	DET	DT	_	3	det	_	_
2	half	_	ADJ	JJ	_	3	amod	_	_
3	life	_	NOUN	NN	_	7	nsubj	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	R	_	NOUN	NN	_	6	compound	_	_
6	DRUG	_	NOUN	NN	_	3	nmod	_	_
7	ranges	_	NOUN	NNS	_	0	root	_	_
8	from	_	ADP	IN	_	12	case	_	_
9	37	_	NUM	CD	_	11	compound	_	_
10	to	_	PRT	TO	_	11	dep	_	_
11	89	_	NUM	CD	_	12	nummod	_	_
12	hours	_	NOUN	NNS	_	7	nmod	_	_
13	,	_	.	,	_	7	punct	_	_
14	while	_	ADP	IN	_	7	dep	_	_
15	that	_	DET	WDT	_	14	root	_	_
16	of	_	ADP	IN	_	19	case	_	_
17	S	_	NOUN	NN	_	19	compound	_	_
18	DRUG	_	NOUN	NN	_	19	compound	_	_
19	ranges	_	NOUN	NNS	_	15	nmod	_	_
20	from	_	ADP	IN	_	24	case	_	_
21	21	_	NUM	CD	_	23	compound	_	_
22	to	_	PRT	TO	_	23	dep	_	_
23	43	_	NUM	CD	_	24	nummod	_	_
24	hours	_	NOUN	NNS	_	19	nmod	_	_

#	COUMADIN	2073
1	Studies	_	NOUN	NNS	_	6	nsubj	_	_
2	with	_	ADP	IN	_	4	case	_	_
3	radiolabeled	_	VERB	VBN	_	4	amod	_	_
4	drug	_	NOUN	NN	_	1	nmod	_	_
5	have	_	VERB	MD	_	6	aux	_	_
6	demonstrated	_	VERB	VBN	_	0	root	_	_
7	that	_	ADP	IN	_	17	mark	_	_
8	up	_	ADJ	JJ	_	10	advmod	_	_
9	to	_	PRT	TO	_	10	case	_	_
10	92%	_	NOUN	NN	_	17	nsubjpass	_	_
11	of	_	ADP	IN	_	15	case	_	_
12	the	_	DET	DT	_	15	det	_	_
13	orally	_	ADV	RB	_	14	advmod	_	_
14	administered	_	VERB	VBN	_	15	amod	_	_
15	dose	_	NOUN	NN	_	10	nmod	_	_
16	is	_	VERB	VBZ	_	17	auxpass	_	_
17	recovered	_	VERB	VBN	_	6	ccomp	_	_
18	in	_	ADP	IN	_	19	mark	_	_
19	urine	_	VERB	VBG	_	17	advcl	_	_

#	COUMADIN	2074
1	Very	_	ADV	RB	_	2	advmod	_	_
2	little	_	ADJ	JJ	_	3	amod	_	_
3	DRUG	_	NOUN	NN	_	5	nsubjpass	_	_
4	is	_	VERB	VBZ	_	5	auxpass	_	_
5	excreted	_	VERB	VBN	_	0	root	_	_
6	unchanged	_	ADJ	JJ	_	5	xcomp	_	_
7	in	_	ADP	IN	_	8	mark	_	_
8	urine	_	VERB	VBG	_	5	advcl	_	_

#	COUMADIN	2075
1	Urinary	_	ADJ	JJ	_	2	amod	_	_
2	excretion	_	NOUN	NN	_	6	nsubj	_	_
3	is	_	VERB	VBZ	_	6	cop	_	_
4	in	_	ADP	IN	_	6	case	_	_
5	the	_	DET	DT	_	6	det	_	_
6	form	_	NOUN	NN	_	0	root	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	metabolites	_	NOUN	NNS	_	6	nmod	_	_

#	COUMADIN	2076
1	Patients	_	NOUN	NNS	_	3	compound	_	_
2	60	_	NUM	CD	_	3	nummod	_	_
3	years	_	NOUN	NNS	_	0	root	_	_
4	or	_	CONJ	CC	_	3	cc	_	_
5	older	_	ADV	RB	_	6	advmod	_	_
6	appear	_	VERB	VBP	_	3	conj	_	_
7	to	_	PRT	TO	_	8	mark	_	_
8	exhibit	_	VERB	VB	_	6	xcomp	_	_
9	greater	_	ADJ	JJ	_	8	dobj	_	_
10	than	_	ADP	IN	_	13	case	_	_
11	expected	_	VERB	VBN	_	13	amod	_	_
12	INR	_	NOUN	NN	_	13	compound	_	_
13	response	_	NOUN	NN	_	9	nmod	_	_
14	to	_	PRT	TO	_	17	case	_	_
15	the	_	DET	DT	_	17	det	_	_
16	anticoagulant	_	ADJ	JJ	_	17	amod	_	_
17	effects	_	NOUN	NNS	_	13	nmod	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	DRUG	_	NOUN	NN	_	17	nmod	_	_

#	COUMADIN	2077
1	The	_	DET	DT	_	2	det	_	_
2	cause	_	NOUN	NN	_	18	nsubj	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	the	_	DET	DT	_	6	det	_	_
5	increased	_	ADJ	JJ	_	6	amod	_	_
6	sensitivity	_	NOUN	NN	_	2	nmod	_	_
7	to	_	PRT	TO	_	10	case	_	_
8	the	_	DET	DT	_	10	det	_	_
9	anticoagulant	_	ADJ	JJ	_	10	amod	_	_
10	effects	_	NOUN	NNS	_	2	nmod	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_
13	in	_	ADP	IN	_	16	case	_	_
14	this	_	DET	DT	_	16	det	_	_
15	age	_	NOUN	NN	_	16	compound	_	_
16	group	_	NOUN	NN	_	10	nmod	_	_
17	is	_	VERB	VBZ	_	18	cop	_	_
18	unknown	_	ADJ	JJ	_	0	root	_	_
19	but	_	CONJ	CC	_	18	cc	_	_
20	may	_	VERB	MD	_	25	aux	_	_
21	be	_	VERB	VB	_	25	cop	_	_
22	due	_	ADJ	JJ	_	25	case	_	_
23	to	_	PRT	TO	_	22	mwe	_	_
24	a	_	DET	DT	_	25	det	_	_
25	combination	_	NOUN	NN	_	18	conj	_	_
26	of	_	ADP	IN	_	30	case	_	_
27	pharmacokinetic	_	ADJ	JJ	_	30	amod	_	_
28	and	_	CONJ	CC	_	27	cc	_	_
29	pharmacodynamic	_	ADJ	JJ	_	27	conj	_	_
30	factors	_	NOUN	NNS	_	25	nmod	_	_

#	COUMADIN	2078
1	Limited	_	ADJ	JJ	_	2	amod	_	_
2	information	_	NOUN	NN	_	3	nsubj	_	_
3	suggests	_	VERB	VBZ	_	0	root	_	_
4	there	_	PRON	PRP$	_	5	expl	_	_
5	is	_	VERB	VBZ	_	3	ccomp	_	_
6	no	_	DET	DT	_	7	neg	_	_
7	difference	_	NOUN	NN	_	5	nsubj	_	_
8	in	_	ADP	IN	_	10	case	_	_
9	the	_	DET	DT	_	10	det	_	_
10	clearance	_	NOUN	NN	_	7	nmod	_	_
11	of	_	ADP	IN	_	13	case	_	_
12	S	_	NOUN	NN	_	13	compound	_	_
13	DRUG	_	NOUN	NN	_	10	nmod	_	_
14	however	_	ADV	RB	_	5	advmod	_	_
15	,	_	.	,	_	3	punct	_	_
16	there	_	DET	EX	_	21	nsubj	_	_
17	may	_	VERB	MD	_	21	aux	_	_
18	be	_	VERB	VB	_	21	cop	_	_
19	a	_	DET	DT	_	21	det	_	_
20	slight	_	ADJ	JJ	_	21	amod	_	_
21	decrease	_	NOUN	NN	_	3	parataxis	_	_
22	in	_	ADP	IN	_	24	case	_	_
23	the	_	DET	DT	_	24	det	_	_
24	clearance	_	NOUN	NN	_	21	nmod	_	_
25	of	_	ADP	IN	_	27	case	_	_
26	R	_	NOUN	NN	_	27	compound	_	_
27	DRUG	_	NOUN	NN	_	24	nmod	_	_
28	in	_	ADP	IN	_	30	case	_	_
29	the	_	DET	DT	_	30	det	_	_
30	elderly	_	NOUN	NN	_	24	nmod	_	_
31	as	_	ADP	IN	_	32	mark	_	_
32	compared	_	VERB	VBN	_	21	acl	_	_
33	to	_	PRT	TO	_	35	case	_	_
34	the	_	DET	DT	_	35	det	_	_
35	young	_	ADJ	JJ	_	32	nmod	_	_

#	COUMADIN	2079
1	Therefore	_	ADV	RB	_	15	advmod	_	_
2	,	_	.	,	_	15	punct	_	_
3	as	_	ADP	IN	_	6	mark	_	_
4	patient	_	NOUN	NN	_	5	compound	_	_
5	age	_	NOUN	NN	_	6	nsubj	_	_
6	increases	_	VERB	VBZ	_	15	advcl	_	_
7	,	_	.	,	_	15	punct	_	_
8	a	_	DET	DT	_	10	det	_	_
9	lower	_	ADJ	JJ	_	10	amod	_	_
10	dose	_	NOUN	NN	_	15	nsubjpass	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_
13	is	_	VERB	VBZ	_	15	auxpass	_	_
14	usually	_	ADV	RB	_	15	advmod	_	_
15	required	_	VERB	VBN	_	0	root	_	_
16	to	_	PRT	TO	_	17	mark	_	_
17	produce	_	VERB	VB	_	15	xcomp	_	_
18	a	_	DET	DT	_	20	det	_	_
19	therapeutic	_	ADJ	JJ	_	20	amod	_	_
20	level	_	NOUN	NN	_	17	dobj	_	_
21	of	_	ADP	IN	_	22	case	_	_
22	anticoagulation	_	NOUN	NN	_	20	nmod	_	_

#	COUMADIN	2080
1	Asian	_	ADJ	JJ	_	2	amod	_	_
2	patients	_	NOUN	NNS	_	4	nsubj	_	_
3	may	_	VERB	MD	_	4	aux	_	_
4	require	_	VERB	VB	_	0	root	_	_
5	lower	_	ADJ	JJ	_	6	amod	_	_
6	initiation	_	NOUN	NN	_	4	dobj	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	maintenance	_	NOUN	NN	_	9	compound	_	_
9	doses	_	NOUN	NNS	_	6	conj	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	6	nmod	_	_

#	COUMADIN	2081
1	A	_	DET	DT	_	4	det	_	_
2	non	_	ADJ	JJ	_	4	amod	_	_
3	controlled	_	VERB	VBN	_	4	amod	_	_
4	study	_	NOUN	NN	_	15	nsubj	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	151	_	NUM	CD	_	8	nummod	_	_
7	Chinese	_	ADJ	JJ	_	8	amod	_	_
8	outpatients	_	NOUN	NNS	_	4	nmod	_	_
9	stabilized	_	VERB	VBN	_	8	acl	_	_
10	on	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_
12	for	_	ADP	IN	_	14	case	_	_
13	various	_	ADJ	JJ	_	14	amod	_	_
14	indications	_	NOUN	NNS	_	11	nmod	_	_
15	reported	_	VERB	VBD	_	0	root	_	_
16	a	_	DET	DT	_	20	det	_	_
17	mean	_	ADJ	JJ	_	20	amod	_	_
18	daily	_	ADV	RB	_	20	advmod	_	_
19	DRUG	_	NOUN	NN	_	20	compound	_	_
20	requirement	_	NOUN	NN	_	15	dobj	_	_
21	of	_	ADP	IN	_	25	case	_	_
22	3.3	_	NUM	CD	_	24	compound	_	_
23	*	_	ADJ	JJ	_	24	advmod	_	_
24	1.4	_	NUM	CD	_	25	nummod	_	_
25	mg	_	NOUN	NN	_	20	nmod	_	_
26	to	_	PRT	TO	_	27	mark	_	_
27	achieve	_	VERB	VB	_	15	xcomp	_	_
28	an	_	DET	DT	_	29	det	_	_
29	INR	_	NOUN	NN	_	27	dobj	_	_
30	of	_	ADP	IN	_	33	case	_	_
31	2	_	NUM	CD	_	33	compound	_	_
32	to	_	PRT	TO	_	33	dep	_	_
33	2.5	_	NUM	CD	_	29	nmod	_	_

#	COUMADIN	2082
1	Patient	_	NOUN	NN	_	2	compound	_	_
2	age	_	NOUN	NN	_	7	nsubj	_	_
3	was	_	VERB	VBD	_	7	cop	_	_
4	the	_	DET	DT	_	7	det	_	_
5	most	_	ADV	RB	_	6	advmod	_	_
6	important	_	ADJ	JJ	_	7	amod	_	_
7	determinant	_	NOUN	NN	_	0	root	_	_
8	of	_	ADP	IN	_	10	case	_	_
9	DRUG	_	NOUN	NN	_	10	compound	_	_
10	requirement	_	NOUN	NN	_	7	nmod	_	_
11	in	_	ADP	IN	_	13	case	_	_
12	these	_	DET	DT	_	13	det	_	_
13	patients	_	NOUN	NNS	_	10	nmod	_	_
14	,	_	.	,	_	7	punct	_	_
15	with	_	ADP	IN	_	20	case	_	_
16	a	_	DET	DT	_	20	det	_	_
17	progressively	_	ADV	RB	_	18	advmod	_	_
18	lower	_	ADJ	JJ	_	20	amod	_	_
19	DRUG	_	NOUN	NN	_	20	compound	_	_
20	requirement	_	NOUN	NN	_	7	nmod	_	_
21	with	_	ADP	IN	_	23	case	_	_
22	increasing	_	VERB	VBG	_	23	amod	_	_
23	age	_	NOUN	NN	_	20	nmod	_	_

#	COUMADIN	2083
1	The	_	DET	DT	_	3	det	_	_
2	S	_	NOUN	NN	_	3	compound	_	_
3	enantiomer	_	NOUN	NN	_	8	nsubjpass	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	is	_	VERB	VBZ	_	8	auxpass	_	_
7	mainly	_	ADV	RB	_	8	advmod	_	_
8	metabolized	_	VERB	VBN	_	0	root	_	_
9	to	_	PRT	TO	_	12	case	_	_
10	7	_	NUM	CD	_	11	compound	_	_
11	hydroxy	_	NOUN	NN	_	12	amod	_	_
12	DRUG	_	NOUN	NN	_	8	nmod	_	_
13	by	_	ADP	IN	_	14	case	_	_
14	CYP2C9	_	NOUN	NN	_	8	nmod	_	_
15	,	_	.	,	_	14	punct	_	_
16	a	_	DET	DT	_	18	det	_	_
17	polymorphic	_	ADJ	JJ	_	18	amod	_	_
18	enzyme	_	NOUN	NN	_	14	appos	_	_

#	COUMADIN	2084
1	The	_	DET	DT	_	3	det	_	_
2	variant	_	ADJ	JJ	_	3	amod	_	_
3	alleles	_	NOUN	NNS	_	9	nsubj	_	_
4	,	_	.	,	_	3	punct	_	_
5	CYP2C9*2	_	NOUN	NN	_	3	appos	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	CYP2C9*3	_	NOUN	NN	_	5	conj	_	_
8	,	_	.	,	_	3	punct	_	_
9	result	_	VERB	VBP	_	0	root	_	_
10	in	_	ADP	IN	_	17	case	_	_
11	decreased	_	VERB	VBN	_	17	amod	_	_
12	in	_	X	FW	_	17	amod	_	_
13	vitro	_	X	FW	_	12	dep	_	_
14	CYP2C9	_	NOUN	NN	_	17	compound	_	_
15	enzymatic	_	ADJ	JJ	_	17	amod	_	_
16	7	_	NUM	CD	_	17	nummod	_	_
17	hydroxylation	_	NOUN	NN	_	9	nmod	_	_
18	of	_	ADP	IN	_	20	case	_	_
19	S	_	NOUN	NN	_	20	compound	_	_
20	DRUG	_	NOUN	NN	_	17	nmod	_	_

#	COUMADIN	2085
1	The	_	DET	DT	_	2	det	_	_
2	frequencies	_	NOUN	NNS	_	10	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	these	_	DET	DT	_	5	det	_	_
5	alleles	_	NOUN	NNS	_	2	nmod	_	_
6	in	_	ADP	IN	_	7	case	_	_
7	Caucasians	_	NOUN	NNS	_	5	nmod	_	_
8	are	_	VERB	VBP	_	10	cop	_	_
9	approximately	_	ADV	RB	_	10	advmod	_	_
10	11%	_	ADJ	JJ	_	0	root	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	7%	_	NOUN	NN	_	10	conj	_	_
13	for	_	ADP	IN	_	14	case	_	_
14	CYP2C9*2	_	NOUN	NN	_	12	nmod	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	CYP2C9*3	_	NOUN	NN	_	14	conj	_	_
17	,	_	.	,	_	10	punct	_	_
18	respectively	_	ADV	RB	_	10	advmod	_	_

#	COUMADIN	2086
1	Other	_	ADJ	JJ	_	3	amod	_	_
2	CYP2C9	_	NOUN	NN	_	3	compound	_	_
3	alleles	_	NOUN	NNS	_	9	nsubj	_	_
4	associated	_	VERB	VBN	_	3	acl	_	_
5	with	_	ADP	IN	_	8	case	_	_
6	reduced	_	VERB	VBN	_	8	amod	_	_
7	enzymatic	_	ADJ	JJ	_	8	amod	_	_
8	activity	_	NOUN	NN	_	4	nmod	_	_
9	occur	_	VERB	VBP	_	0	root	_	_
10	at	_	ADP	IN	_	12	case	_	_
11	lower	_	ADJ	JJ	_	12	amod	_	_
12	frequencies	_	NOUN	NNS	_	9	nmod	_	_
13	,	_	.	,	_	12	punct	_	_
14	including	_	VERB	VBG	_	15	case	_	_
15	5	_	NUM	CD	_	12	nmod	_	_
16	,	_	.	,	_	15	punct	_	_
17	6	_	NUM	CD	_	15	conj	_	_
18	,	_	.	,	_	15	punct	_	_
19	and	_	CONJ	CC	_	15	cc	_	_
20	11	_	NUM	CD	_	15	conj	_	_
21	alleles	_	NOUN	NNS	_	15	dep	_	_
22	in	_	ADP	IN	_	23	case	_	_
23	populations	_	NOUN	NNS	_	15	nmod	_	_
24	of	_	ADP	IN	_	26	case	_	_
25	African	_	NOUN	NN	_	26	compound	_	_
26	ancestry	_	NOUN	NN	_	23	nmod	_	_
27	and	_	CONJ	CC	_	26	cc	_	_
28	5	_	NUM	CD	_	26	conj	_	_
29	,	_	.	,	_	26	punct	_	_
30	9	_	NUM	CD	_	26	conj	_	_
31	,	_	.	,	_	26	punct	_	_
32	and	_	CONJ	CC	_	26	cc	_	_
33	11	_	NUM	CD	_	34	nummod	_	_
34	alleles	_	NOUN	NNS	_	26	conj	_	_
35	in	_	ADP	IN	_	36	case	_	_
36	Caucasians	_	NOUN	NNS	_	26	nmod	_	_

#	COUMADIN	2087
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	reduces	_	VERB	VBZ	_	0	root	_	_
3	the	_	DET	DT	_	4	det	_	_
4	regeneration	_	NOUN	NN	_	2	dobj	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	vitamin	_	NOUN	NN	_	7	compound	_	_
7	K	_	NOUN	NN	_	4	nmod	_	_
8	from	_	ADP	IN	_	11	case	_	_
9	vitamin	_	NOUN	NN	_	11	compound	_	_
10	K	_	NOUN	NN	_	11	compound	_	_
11	epoxide	_	NOUN	NN	_	4	nmod	_	_
12	in	_	ADP	IN	_	16	case	_	_
13	the	_	DET	DT	_	16	det	_	_
14	vitamin	_	NOUN	NN	_	16	compound	_	_
15	K	_	NOUN	NN	_	16	compound	_	_
16	cycle	_	NOUN	NN	_	4	nmod	_	_
17	through	_	ADP	IN	_	18	case	_	_
18	inhibition	_	NOUN	NN	_	2	nmod	_	_
19	of	_	ADP	IN	_	20	case	_	_
20	VKOR	_	NOUN	NN	_	18	nmod	_	_
21	,	_	.	,	_	20	punct	_	_
22	a	_	DET	DT	_	25	det	_	_
23	multiprotein	_	ADJ	JJ	_	25	amod	_	_
24	enzyme	_	NOUN	NN	_	25	compound	_	_
25	complex	_	NOUN	NNS	_	20	appos	_	_

#	COUMADIN	2088
1	Certain	_	ADJ	JJ	_	4	amod	_	_
2	single	_	ADJ	JJ	_	4	amod	_	_
3	nucleotide	_	NOUN	NN	_	4	compound	_	_
4	polymorphisms	_	NOUN	NNS	_	0	root	_	_
5	in	_	ADP	IN	_	9	case	_	_
6	the	_	DET	DT	_	9	det	_	_
7	VKORC1	_	NOUN	NN	_	9	compound	_	_
8	gene	_	NOUN	NN	_	9	compound	_	_
9	e.g	_	NOUN	NN	_	4	nmod	_	_
10	,	_	.	,	_	4	punct	_	_
11	1639G>A	_	NOUN	NN	_	14	nsubjpass	_	_
12	have	_	VERB	VBP	_	14	aux	_	_
13	been	_	VERB	VBN	_	14	auxpass	_	_
14	associated	_	VERB	VBN	_	4	dep	_	_
15	with	_	ADP	IN	_	19	case	_	_
16	variable	_	ADJ	JJ	_	19	amod	_	_
17	DRUG	_	NOUN	NN	_	19	compound	_	_
18	dose	_	NOUN	NN	_	19	compound	_	_
19	requirements	_	NOUN	NNS	_	14	nmod	_	_

#	COUMADIN	2089
1	VKORC1	_	NOUN	NN	_	7	nsubj	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	CYP2C9	_	NOUN	NN	_	1	conj	_	_
4	gene	_	NOUN	NN	_	5	compound	_	_
5	variants	_	NOUN	NNS	_	1	dep	_	_
6	generally	_	ADV	RB	_	7	advmod	_	_
7	explain	_	VERB	VBP	_	0	root	_	_
8	the	_	DET	DT	_	10	det	_	_
9	largest	_	ADJ	JJ	_	10	amod	_	_
10	proportion	_	NOUN	NN	_	7	dobj	_	_
11	of	_	ADP	IN	_	13	case	_	_
12	known	_	VERB	VBN	_	13	amod	_	_
13	variability	_	NOUN	NN	_	10	nmod	_	_
14	in	_	ADP	IN	_	17	case	_	_
15	DRUG	_	NOUN	NN	_	17	compound	_	_
16	dose	_	NOUN	NN	_	17	compound	_	_
17	requirements	_	NOUN	NNS	_	13	nmod	_	_

#	COUMADIN	2090
1	CYP2C9	_	NOUN	NN	_	5	compound	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	VKORC1	_	NOUN	NN	_	1	conj	_	_
4	genotype	_	NOUN	NN	_	5	compound	_	_
5	information	_	NOUN	NN	_	11	nsubj	_	_
6	,	_	.	,	_	5	punct	_	_
7	when	_	ADV	RB	_	8	advmod	_	_
8	available	_	ADJ	JJ	_	11	nsubj	_	_
9	,	_	.	,	_	8	punct	_	_
10	can	_	VERB	MD	_	11	aux	_	_
11	assist	_	VERB	VB	_	0	root	_	_
12	in	_	ADP	IN	_	13	case	_	_
13	selection	_	NOUN	NN	_	11	nmod	_	_
14	of	_	ADP	IN	_	17	case	_	_
15	the	_	DET	DT	_	17	det	_	_
16	initial	_	ADJ	JJ	_	17	amod	_	_
17	dose	_	NOUN	NN	_	13	nmod	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	DRUG	_	NOUN	NN	_	17	nmod	_	_

#	CRESTOR	5995
1	*	_	NOUN	NN	_	2	compound	_	_
2	Cyclosporine	_	NOUN	NN	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	Combination	_	NOUN	NN	_	5	nsubj	_	_
5	increases	_	VERB	VBZ	_	2	dep	_	_
6	DRUG	_	NOUN	NN	_	7	compound	_	_
7	exposure	_	NOUN	NN	_	5	dobj	_	_

#	CRESTOR	5996
1	*	_	NOUN	NN	_	2	compound	_	_
2	Gemfibrozil	_	NOUN	NN	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	Combination	_	NOUN	NN	_	7	nsubjpass	_	_
5	should	_	VERB	MD	_	7	aux	_	_
6	be	_	VERB	VB	_	7	auxpass	_	_
7	avoided	_	VERB	VBN	_	2	dep	_	_

#	CRESTOR	5997
1	If	_	ADP	IN	_	2	mark	_	_
2	used	_	VERB	VBN	_	0	root	_	_
3	together	_	ADV	RB	_	2	advmod	_	_
4	,	_	.	,	_	2	punct	_	_
5	limit	_	VERB	VBP	_	7	amod	_	_
6	DRUG	_	NOUN	NN	_	7	compound	_	_
7	dose	_	NOUN	NN	_	4	root	_	_
8	to	_	PRT	TO	_	9	case	_	_
9	10mg	_	ADJ	JJ	_	7	nmod	_	_
10	once	_	ADV	RB	_	9	advmod	_	_
11	daily	_	ADV	RB	_	7	root	_	_

#	CRESTOR	5998
1	*	_	NOUN	NN	_	2	compound	_	_
2	Lopinavir	_	ADJ	JJ	_	0	root	_	_
3	/	_	.	:	_	2	punct	_	_
4	Ritonavir	_	NOUN	NN	_	2	dep	_	_
5	or	_	CONJ	CC	_	4	cc	_	_
6	atazanavir	_	NOUN	NN	_	4	conj	_	_
7	/	_	.	:	_	4	punct	_	_
8	ritonavir	_	NOUN	NN	_	4	dep	_	_
9	:	_	.	:	_	2	punct	_	_
10	Combination	_	NOUN	NN	_	11	nsubj	_	_
11	increases	_	VERB	VBZ	_	2	dep	_	_
12	DRUG	_	NOUN	NN	_	13	compound	_	_
13	exposure	_	NOUN	NN	_	11	dobj	_	_

#	CRESTOR	5999
1	*	_	NOUN	NN	_	3	compound	_	_
2	Coumarin	_	NOUN	NN	_	3	compound	_	_
3	anticoagulants	_	NOUN	NNS	_	0	root	_	_
4	:	_	.	:	_	3	punct	_	_
5	Combination	_	NOUN	NN	_	6	nsubj	_	_
6	prolongs	_	VERB	VBZ	_	3	dep	_	_
7	INR	_	NOUN	NN	_	6	dobj	_	_

#	CRESTOR	6000
1	Achieve	_	ADJ	JJ	_	0	root	_	_
2	stable	_	ADJ	JJ	_	3	amod	_	_
3	INR	_	NOUN	NN	_	1	dobj	_	_
4	prior	_	ADJ	JJ	_	3	amod	_	_
5	to	_	PRT	TO	_	6	mark	_	_
6	starting	_	VERB	VBG	_	4	advcl	_	_
7	DRUG	_	NOUN	NN	_	6	dobj	_	_

#	CRESTOR	6001
1	Monitor	_	NOUN	NN	_	2	compound	_	_
2	INR	_	NOUN	NN	_	0	root	_	_
3	frequently	_	ADV	RB	_	5	advmod	_	_
4	until	_	ADP	IN	_	5	case	_	_
5	stable	_	ADJ	JJ	_	2	nmod	_	_
6	upon	_	ADP	IN	_	7	case	_	_
7	initiation	_	NOUN	NN	_	5	nmod	_	_
8	or	_	CONJ	CC	_	7	cc	_	_
9	alteration	_	NOUN	NN	_	7	conj	_	_
10	of	_	ADP	IN	_	12	case	_	_
11	DRUG	_	NOUN	NN	_	12	compound	_	_
12	therapy	_	NOUN	NN	_	7	nmod	_	_

#	CRESTOR	6002
1	*	_	NOUN	NN	_	5	compound	_	_
2	Concomitant	_	ADJ	JJ	_	5	amod	_	_
3	lipid	_	NOUN	NN	_	5	compound	_	_
4	lowering	_	NOUN	NN	_	5	compound	_	_
5	therapies	_	NOUN	NNS	_	0	root	_	_
6	:	_	.	:	_	5	punct	_	_
7	use	_	VERB	VBP	_	5	dep	_	_
8	with	_	ADP	IN	_	9	case	_	_
9	fibrates	_	NOUN	NNS	_	7	nmod	_	_
10	or	_	CONJ	CC	_	9	cc	_	_
11	lipid	_	NOUN	NN	_	13	compound	_	_
12	modifying	_	VERB	VBG	_	13	compound	_	_
13	doses	_	NOUN	NNS	_	16	compound	_	_
14	>	_	NUM	CD	_	16	nummod	_	_
15	1	_	NUM	CD	_	16	nummod	_	_
16	g	_	NOUN	NN	_	9	conj	_	_
17	/	_	.	:	_	5	punct	_	_
18	day	_	NOUN	NN	_	21	nsubj	_	_
19	of	_	ADP	IN	_	20	case	_	_
20	niacin	_	NOUN	NN	_	18	nmod	_	_
21	increases	_	VERB	VBZ	_	5	dep	_	_
22	the	_	DET	DT	_	23	det	_	_
23	risk	_	NOUN	NN	_	21	dobj	_	_
24	of	_	ADP	IN	_	28	case	_	_
25	adverse	_	ADJ	JJ	_	28	amod	_	_
26	skeletal	_	ADJ	JJ	_	28	amod	_	_
27	muscle	_	NOUN	NN	_	28	compound	_	_
28	effects	_	NOUN	NNS	_	23	nmod	_	_

#	CRESTOR	6003
1	Caution	_	NOUN	NN	_	4	nsubjpass	_	_
2	should	_	VERB	MD	_	4	aux	_	_
3	be	_	VERB	VB	_	4	auxpass	_	_
4	used	_	VERB	VBN	_	0	root	_	_
5	when	_	ADV	WRB	_	6	advmod	_	_
6	prescribing	_	VERB	VBG	_	4	advcl	_	_
7	with	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_

#	CRESTOR	6004
1	Cyclosporine	_	NOUN	NN	_	2	nsubj	_	_
2	increased	_	VERB	VBD	_	0	root	_	_
3	DRUG	_	NOUN	NN	_	5	compound	_	_
4	exposure	_	NOUN	NN	_	5	compound	_	_
5	AUC	_	NOUN	NN	_	2	dobj	_	_
6	7	_	NUM	CD	_	5	nummod	_	_
7	fold	_	VERB	MD	_	2	punct	_	_

#	CRESTOR	6005
1	Therefore	_	ADV	RB	_	14	advmod	_	_
2	,	_	.	,	_	14	punct	_	_
3	in	_	ADP	IN	_	4	case	_	_
4	patients	_	NOUN	NNS	_	14	nmod	_	_
5	taking	_	VERB	VBG	_	4	acl	_	_
6	cyclosporine	_	NOUN	NN	_	5	dobj	_	_
7	,	_	.	,	_	14	punct	_	_
8	the	_	DET	DT	_	9	det	_	_
9	dose	_	NOUN	NN	_	14	nsubj	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_
12	should	_	VERB	MD	_	14	aux	_	_
13	not	_	ADV	RB	_	14	neg	_	_
14	exceed	_	VERB	VBN	_	0	root	_	_
15	5mg	_	NOUN	NN	_	14	dobj	_	_
16	once	_	ADV	RB	_	14	advmod	_	_
17	daily	_	ADV	RB	_	16	dep	_	_

#	CRESTOR	6006
1	Gemfibrozil	_	NOUN	NN	_	3	nsubj	_	_
2	significantly	_	ADV	RB	_	3	advmod	_	_
3	increased	_	VERB	VBD	_	0	root	_	_
4	DRUG	_	NOUN	NN	_	5	compound	_	_
5	exposure	_	NOUN	NN	_	3	dobj	_	_

#	CRESTOR	6007
1	Due	_	ADP	IN	_	6	case	_	_
2	to	_	PRT	TO	_	1	mwe	_	_
3	an	_	DET	DT	_	6	det	_	_
4	observed	_	VERB	VBN	_	6	amod	_	_
5	increased	_	VERB	VBN	_	6	amod	_	_
6	risk	_	NOUN	NN	_	20	nmod	_	_
7	of	_	ADP	IN	_	10	case	_	_
8	myopathy	_	NOUN	NN	_	10	compound	_	_
9	/	_	.	:	_	10	punct	_	_
10	rhabdomyolysis	_	NOUN	NN	_	6	nmod	_	_
11	,	_	.	,	_	20	punct	_	_
12	combination	_	NOUN	NN	_	13	compound	_	_
13	therapy	_	NOUN	NN	_	20	nsubjpass	_	_
14	with	_	ADP	IN	_	15	case	_	_
15	DRUG	_	NOUN	NN	_	13	nmod	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	gemfibrozil	_	NOUN	NN	_	15	conj	_	_
18	should	_	VERB	MD	_	20	aux	_	_
19	be	_	VERB	VB	_	20	auxpass	_	_
20	avoided	_	VERB	VBN	_	0	root	_	_

#	CRESTOR	6008
1	If	_	ADP	IN	_	2	mark	_	_
2	used	_	VERB	VBN	_	11	advcl	_	_
3	together	_	ADV	RB	_	2	advmod	_	_
4	,	_	.	,	_	11	punct	_	_
5	the	_	DET	DT	_	6	det	_	_
6	dose	_	NOUN	NN	_	11	nsubj	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	should	_	VERB	MD	_	11	aux	_	_
10	not	_	ADV	RB	_	11	neg	_	_
11	exceed	_	VERB	VBN	_	0	root	_	_
12	10mg	_	ADJ	JJ	_	11	dobj	_	_
13	once	_	ADV	RB	_	12	dep	_	_
14	daily	_	ADV	RB	_	13	dep	_	_

#	CRESTOR	6009
1	Coadministration	_	NOUN	NN	_	14	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	with	_	ADP	IN	_	7	case	_	_
5	certain	_	ADJ	JJ	_	7	amod	_	_
6	protease	_	NOUN	NN	_	7	compound	_	_
7	inhibitors	_	NOUN	NNS	_	1	nmod	_	_
8	given	_	VERB	VBN	_	7	acl	_	_
9	in	_	ADP	IN	_	10	case	_	_
10	combination	_	NOUN	NN	_	8	nmod	_	_
11	with	_	ADP	IN	_	12	case	_	_
12	ritonavir	_	NOUN	NN	_	10	nmod	_	_
13	has	_	VERB	VBZ	_	14	aux	_	_
14	differing	_	VERB	VBG	_	0	root	_	_
15	effects	_	NOUN	NNS	_	14	dobj	_	_
16	on	_	ADP	IN	_	18	case	_	_
17	DRUG	_	NOUN	NN	_	18	compound	_	_
18	exposure	_	NOUN	NN	_	15	nmod	_	_

#	CRESTOR	6010
1	The	_	DET	DT	_	4	det	_	_
2	protease	_	NOUN	NN	_	4	compound	_	_
3	inhibitor	_	NOUN	NN	_	4	compound	_	_
4	combinations	_	NOUN	NNS	_	0	root	_	_
5	lopinavir	_	ADJ	JJ	_	4	amod	_	_
6	/	_	.	:	_	4	punct	_	_
7	ritonavir	_	NOUN	NN	_	4	dep	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	atazanavir	_	NOUN	NN	_	7	conj	_	_
10	/	_	.	:	_	4	punct	_	_
11	ritonavir	_	NOUN	NN	_	12	nsubj	_	_
12	increase	_	VERB	VBP	_	4	dep	_	_
13	DRUG	_	NOUN	NN	_	15	compound	_	_
14	exposure	_	NOUN	NN	_	15	compound	_	_
15	AUC	_	NOUN	NN	_	12	dobj	_	_
16	up	_	ADV	RB	_	12	advmod	_	_
17	to	_	PRT	TO	_	18	case	_	_
18	threefold	_	ADV	RB	_	16	dep	_	_

#	CRESTOR	6011
1	For	_	ADP	IN	_	3	case	_	_
2	these	_	DET	DT	_	3	det	_	_
3	combinations	_	NOUN	NNS	_	10	nmod	_	_
4	the	_	DET	DT	_	5	det	_	_
5	dose	_	NOUN	NN	_	10	nsubj	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	should	_	VERB	MD	_	10	aux	_	_
9	not	_	ADV	RB	_	10	neg	_	_
10	exceed	_	VERB	VBN	_	0	root	_	_
11	10mg	_	ADJ	JJ	_	10	dobj	_	_
12	once	_	ADV	RB	_	11	dep	_	_
13	daily	_	ADV	RB	_	12	dep	_	_

#	CRESTOR	6012
1	The	_	DET	DT	_	2	det	_	_
2	combinations	_	NOUN	NNS	_	0	root	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	tipranavir	_	NOUN	NN	_	6	compound	_	_
5	/	_	.	:	_	6	punct	_	_
6	ritonavir	_	NOUN	NN	_	2	nmod	_	_
7	or	_	CONJ	CC	_	6	cc	_	_
8	fosamprenavir	_	NOUN	NN	_	6	conj	_	_
9	/	_	.	:	_	2	punct	_	_
10	ritonavir	_	NOUN	NN	_	11	nsubj	_	_
11	produce	_	VERB	VBP	_	2	dep	_	_
12	little	_	ADJ	JJ	_	15	amod	_	_
13	or	_	CONJ	CC	_	12	cc	_	_
14	no	_	DET	DT	_	12	conj	_	_
15	change	_	NOUN	NN	_	11	dobj	_	_
16	in	_	ADP	IN	_	18	case	_	_
17	DRUG	_	NOUN	NN	_	18	compound	_	_
18	exposure	_	NOUN	NN	_	15	nmod	_	_

#	CRESTOR	6013
1	Caution	_	NOUN	NN	_	4	nsubjpass	_	_
2	should	_	VERB	MD	_	4	aux	_	_
3	be	_	VERB	VB	_	4	auxpass	_	_
4	exercised	_	VERB	VBN	_	0	root	_	_
5	when	_	ADV	WRB	_	8	advmod	_	_
6	DRUG	_	NOUN	NN	_	8	nsubjpass	_	_
7	is	_	VERB	VBZ	_	8	auxpass	_	_
8	coadministered	_	VERB	VBN	_	4	ccomp	_	_
9	with	_	ADP	IN	_	11	case	_	_
10	protease	_	NOUN	NN	_	11	compound	_	_
11	inhibitors	_	NOUN	NNS	_	8	nmod	_	_
12	given	_	VERB	VBN	_	11	acl	_	_
13	in	_	ADP	IN	_	14	case	_	_
14	combination	_	NOUN	NN	_	12	nmod	_	_
15	with	_	ADP	IN	_	16	case	_	_
16	ritonavir	_	ADJ	JJ	_	14	nmod	_	_

#	CRESTOR	6014
1	DRUG	_	NOUN	NN	_	3	nsubj	_	_
2	significantly	_	ADV	RB	_	3	advmod	_	_
3	increased	_	VERB	VBD	_	0	root	_	_
4	INR	_	NOUN	NN	_	3	dobj	_	_
5	in	_	ADP	IN	_	6	case	_	_
6	patients	_	NOUN	NNS	_	3	nmod	_	_
7	receiving	_	VERB	VBG	_	6	acl	_	_
8	coumarin	_	NOUN	NN	_	9	compound	_	_
9	anticoagulants	_	NOUN	NNS	_	7	dobj	_	_

#	CRESTOR	6015
1	Therefore	_	ADV	RB	_	6	advmod	_	_
2	,	_	.	,	_	6	punct	_	_
3	caution	_	NOUN	NN	_	6	nsubjpass	_	_
4	should	_	VERB	MD	_	6	aux	_	_
5	be	_	VERB	VB	_	6	auxpass	_	_
6	exercised	_	VERB	VBN	_	0	root	_	_
7	when	_	ADV	WRB	_	11	advmod	_	_
8	coumarin	_	NOUN	NN	_	9	compound	_	_
9	anticoagulants	_	NOUN	NNS	_	11	nsubjpass	_	_
10	are	_	VERB	VBP	_	11	auxpass	_	_
11	given	_	VERB	VBN	_	6	ccomp	_	_
12	in	_	ADP	IN	_	13	case	_	_
13	conjunction	_	NOUN	NN	_	11	nmod	_	_
14	with	_	ADP	IN	_	15	case	_	_
15	DRUG	_	NOUN	NN	_	13	nmod	_	_

#	CRESTOR	6016
1	In	_	ADP	IN	_	2	case	_	_
2	patients	_	NOUN	NNS	_	13	nmod	_	_
3	taking	_	VERB	VBG	_	2	acl	_	_
4	coumarin	_	NOUN	NN	_	5	compound	_	_
5	anticoagulants	_	NOUN	NNS	_	3	dobj	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	DRUG	_	NOUN	NN	_	5	conj	_	_
8	concomitantly	_	ADV	RB	_	2	advmod	_	_
9	,	_	.	,	_	13	punct	_	_
10	INR	_	NOUN	NN	_	13	nsubjpass	_	_
11	should	_	VERB	MD	_	13	aux	_	_
12	be	_	VERB	VB	_	13	auxpass	_	_
13	determined	_	VERB	VBN	_	0	root	_	_
14	before	_	ADP	IN	_	15	mark	_	_
15	starting	_	VERB	VBG	_	13	advcl	_	_
16	DRUG	_	NOUN	NN	_	15	dobj	_	_
17	and	_	CONJ	CC	_	15	cc	_	_
18	frequently	_	ADV	RB	_	19	advmod	_	_
19	enough	_	VERB	VB	_	15	conj	_	_
20	during	_	ADP	IN	_	22	case	_	_
21	early	_	ADJ	JJ	_	22	amod	_	_
22	therapy	_	NOUN	NN	_	19	nmod	_	_
23	to	_	PRT	TO	_	24	mark	_	_
24	ensure	_	VERB	VB	_	19	xcomp	_	_
25	that	_	ADP	IN	_	31	mark	_	_
26	no	_	DET	DT	_	28	neg	_	_
27	significant	_	ADJ	JJ	_	28	amod	_	_
28	alteration	_	NOUN	NN	_	31	nsubj	_	_
29	of	_	ADP	IN	_	30	case	_	_
30	INR	_	NOUN	NN	_	28	nmod	_	_
31	occurs	_	VERB	VBZ	_	24	ccomp	_	_

#	CRESTOR	6017
1	The	_	DET	DT	_	2	det	_	_
2	risk	_	NOUN	NN	_	9	nsubjpass	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	skeletal	_	ADJ	JJ	_	6	amod	_	_
5	muscle	_	NOUN	NN	_	6	compound	_	_
6	effects	_	NOUN	NNS	_	2	nmod	_	_
7	may	_	VERB	MD	_	9	aux	_	_
8	be	_	VERB	VB	_	9	auxpass	_	_
9	enhanced	_	VERB	VBN	_	0	root	_	_
10	when	_	ADV	WRB	_	13	advmod	_	_
11	DRUG	_	NOUN	NN	_	13	nsubjpass	_	_
12	is	_	VERB	VBZ	_	13	auxpass	_	_
13	used	_	VERB	VBN	_	9	advcl	_	_
14	in	_	ADP	IN	_	15	case	_	_
15	combination	_	NOUN	NN	_	13	nmod	_	_
16	with	_	ADP	IN	_	19	case	_	_
17	lipid	_	NOUN	NN	_	19	compound	_	_
18	modifying	_	VERB	VBG	_	19	compound	_	_
19	doses	_	NOUN	NNS	_	15	nmod	_	_
20	>1g	_	NOUN	NN	_	19	dep	_	_
21	/	_	.	:	_	9	punct	_	_
22	day	_	NOUN	NN	_	28	nsubjpass	_	_
23	of	_	ADP	IN	_	25	case	_	_
24	niacin	_	NOUN	NN	_	25	compound	_	_
25	caution	_	NOUN	NN	_	22	nmod	_	_
26	should	_	VERB	MD	_	28	aux	_	_
27	be	_	VERB	VB	_	28	auxpass	_	_
28	used	_	VERB	VBN	_	9	parataxis	_	_
29	when	_	ADV	WRB	_	30	advmod	_	_
30	prescribing	_	VERB	VBG	_	28	advcl	_	_
31	with	_	ADP	IN	_	32	case	_	_
32	DRUG	_	NOUN	NN	_	30	nmod	_	_

#	CRESTOR	6018
1	When	_	ADV	WRB	_	4	advmod	_	_
2	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
3	was	_	VERB	VBD	_	4	auxpass	_	_
4	coadministered	_	VERB	VBN	_	20	advcl	_	_
5	with	_	ADP	IN	_	6	case	_	_
6	fenofibrate	_	NOUN	NN	_	4	nmod	_	_
7	,	_	.	,	_	20	punct	_	_
8	no	_	DET	DT	_	11	neg	_	_
9	clinically	_	ADV	RB	_	10	advmod	_	_
10	significant	_	ADJ	JJ	_	11	amod	_	_
11	increase	_	NOUN	NN	_	20	nsubjpass	_	_
12	in	_	ADP	IN	_	14	case	_	_
13	the	_	DET	DT	_	14	det	_	_
14	AUC	_	NOUN	NN	_	11	nmod	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	14	nmod	_	_
17	or	_	CONJ	CC	_	16	cc	_	_
18	fenofibrate	_	NOUN	NN	_	16	conj	_	_
19	was	_	VERB	VBD	_	20	auxpass	_	_
20	observed	_	VERB	VBN	_	0	root	_	_

#	CRESTOR	6019
1	Because	_	ADP	IN	_	4	mark	_	_
2	it	_	PRON	PRP	_	4	nsubjpass	_	_
3	is	_	VERB	VBZ	_	4	auxpass	_	_
4	known	_	VERB	VBN	_	28	advcl	_	_
5	that	_	ADP	IN	_	18	mark	_	_
6	the	_	DET	DT	_	7	det	_	_
7	risk	_	NOUN	NN	_	18	nsubjpass	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	myopathy	_	NOUN	NN	_	7	nmod	_	_
10	during	_	ADP	IN	_	11	case	_	_
11	treatment	_	NOUN	NN	_	7	nmod	_	_
12	with	_	ADP	IN	_	16	case	_	_
13	HMG	_	NOUN	NN	_	16	compound	_	_
14	CoA	_	NOUN	NN	_	16	compound	_	_
15	reductase	_	NOUN	NN	_	16	compound	_	_
16	inhibitors	_	NOUN	NNS	_	11	nmod	_	_
17	is	_	VERB	VBZ	_	18	auxpass	_	_
18	increased	_	VERB	VBN	_	4	ccomp	_	_
19	with	_	ADP	IN	_	21	case	_	_
20	concomitant	_	ADJ	JJ	_	21	amod	_	_
21	use	_	NOUN	NN	_	18	nmod	_	_
22	of	_	ADP	IN	_	23	case	_	_
23	fenofibrates	_	NOUN	NNS	_	21	nmod	_	_
24	,	_	.	,	_	28	punct	_	_
25	caution	_	NOUN	NN	_	28	nsubjpass	_	_
26	should	_	VERB	MD	_	28	aux	_	_
27	be	_	VERB	VB	_	28	auxpass	_	_
28	used	_	VERB	VBN	_	0	root	_	_
29	when	_	ADV	WRB	_	30	advmod	_	_
30	prescribing	_	VERB	VBG	_	28	advcl	_	_
31	fenofibrates	_	NOUN	NNS	_	30	dobj	_	_
32	with	_	ADP	IN	_	33	case	_	_
33	DRUG	_	NOUN	NN	_	31	nmod	_	_

#	CRESTOR	6020
1	Cases	_	NOUN	NNS	_	10	nsubjpass	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	myopathy	_	NOUN	NN	_	1	nmod	_	_
4	,	_	.	,	_	3	punct	_	_
5	including	_	VERB	VBG	_	6	case	_	_
6	rhabdomyolysis	_	NOUN	NN	_	3	nmod	_	_
7	,	_	.	,	_	1	punct	_	_
8	have	_	VERB	VBP	_	10	aux	_	_
9	been	_	VERB	VBN	_	10	auxpass	_	_
10	reported	_	VERB	VBN	_	0	root	_	_
11	with	_	ADP	IN	_	15	case	_	_
12	HMG	_	NOUN	NN	_	15	compound	_	_
13	CoA	_	NOUN	NN	_	15	compound	_	_
14	reductase	_	NOUN	NN	_	15	compound	_	_
15	inhibitors	_	NOUN	NNS	_	10	nmod	_	_
16	,	_	.	,	_	15	punct	_	_
17	including	_	VERB	VBG	_	18	case	_	_
18	DRUG	_	NOUN	NN	_	15	nmod	_	_
19	,	_	.	,	_	15	punct	_	_
20	coadministered	_	VERB	VBN	_	15	acl	_	_
21	with	_	ADP	IN	_	22	case	_	_
22	colchicine	_	NOUN	NN	_	20	nmod	_	_
23	,	_	.	,	_	10	punct	_	_
24	and	_	CONJ	CC	_	10	cc	_	_
25	caution	_	NOUN	NN	_	28	nsubjpass	_	_
26	should	_	VERB	MD	_	28	aux	_	_
27	be	_	VERB	VB	_	28	auxpass	_	_
28	exercised	_	VERB	VBN	_	10	conj	_	_
29	when	_	ADV	WRB	_	30	advmod	_	_
30	prescribing	_	VERB	VBG	_	28	advcl	_	_
31	DRUG	_	NOUN	NN	_	30	dobj	_	_
32	with	_	ADP	IN	_	33	case	_	_
33	colchicine	_	NOUN	NN	_	30	nmod	_	_

#	CRESTOR	6021
1	DRUG	_	NOUN	NN	_	7	nsubj	_	_
2	is	_	VERB	VBZ	_	7	cop	_	_
3	a	_	DET	DT	_	7	det	_	_
4	selective	_	ADJ	JJ	_	7	amod	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	competitive	_	ADJ	JJ	_	4	conj	_	_
7	inhibitor	_	NOUN	NN	_	0	root	_	_
8	of	_	ADP	IN	_	11	case	_	_
9	HMG	_	NOUN	NN	_	11	compound	_	_
10	CoA	_	NOUN	NN	_	11	compound	_	_
11	reductase	_	NOUN	NN	_	7	nmod	_	_
12	,	_	.	,	_	11	punct	_	_
13	the	_	DET	DT	_	16	det	_	_
14	rate	_	ADJ	JJ	_	16	amod	_	_
15	limiting	_	VERB	VBG	_	16	compound	_	_
16	enzyme	_	NOUN	NN	_	11	appos	_	_
17	that	_	DET	WDT	_	18	nsubj	_	_
18	converts	_	VERB	VBZ	_	16	acl:relcl	_	_
19	3	_	NUM	CD	_	24	nummod	_	_
20	hydroxy	_	NOUN	NN	_	24	compound	_	_
21	3	_	NUM	CD	_	24	nummod	_	_
22	methylglutaryl	_	NOUN	NN	_	24	amod	_	_
23	coenzyme	_	NOUN	NN	_	24	compound	_	_
24	A	_	NOUN	NN	_	18	dobj	_	_
25	to	_	PRT	TO	_	26	mark	_	_
26	mevalonate	_	VERB	VB	_	18	xcomp	_	_
27	,	_	.	,	_	11	punct	_	_
28	a	_	DET	DT	_	29	det	_	_
29	precursor	_	NOUN	NN	_	11	appos	_	_
30	of	_	ADP	IN	_	31	case	_	_
31	cholesterol	_	NOUN	NN	_	29	nmod	_	_

#	CRESTOR	6022
1	In	_	X	FW	_	3	amod	_	_
2	vivo	_	X	FW	_	1	dep	_	_
3	studies	_	NOUN	NNS	_	18	nsubj	_	_
4	in	_	ADP	IN	_	5	case	_	_
5	animals	_	NOUN	NNS	_	3	nmod	_	_
6	,	_	.	,	_	3	punct	_	_
7	and	_	CONJ	CC	_	3	cc	_	_
8	in	_	X	FW	_	10	amod	_	_
9	vitro	_	X	FW	_	8	dep	_	_
10	studies	_	NOUN	NNS	_	3	conj	_	_
11	in	_	ADP	IN	_	13	case	_	_
12	cultured	_	VERB	VBN	_	13	amod	_	_
13	animal	_	NOUN	NN	_	10	nmod	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	human	_	ADJ	JJ	_	16	amod	_	_
16	cells	_	NOUN	NNS	_	13	conj	_	_
17	have	_	VERB	VBP	_	18	aux	_	_
18	shown	_	VERB	VBN	_	0	root	_	_
19	DRUG	_	NOUN	NN	_	18	dobj	_	_
20	to	_	PRT	TO	_	21	mark	_	_
21	have	_	VERB	VB	_	18	xcomp	_	_
22	a	_	DET	DT	_	24	det	_	_
23	high	_	ADJ	JJ	_	24	amod	_	_
24	uptake	_	NOUN	NN	_	21	dobj	_	_
25	into	_	ADP	IN	_	31	case	_	_
26	,	_	.	,	_	25	punct	_	_
27	and	_	CONJ	CC	_	25	cc	_	_
28	selectivity	_	NOUN	NN	_	25	conj	_	_
29	for	_	ADP	IN	_	31	case	_	_
30	,	_	.	,	_	31	punct	_	_
31	action	_	NOUN	NN	_	21	nmod	_	_
32	in	_	ADP	IN	_	34	case	_	_
33	the	_	DET	DT	_	34	det	_	_
34	liver	_	NOUN	NN	_	31	nmod	_	_
35	,	_	.	,	_	34	punct	_	_
36	the	_	DET	DT	_	38	det	_	_
37	target	_	NOUN	NN	_	38	compound	_	_
38	organ	_	NOUN	NN	_	34	appos	_	_
39	for	_	ADP	IN	_	41	case	_	_
40	cholesterol	_	NOUN	NN	_	41	compound	_	_
41	lowering	_	VERB	VBG	_	38	nmod	_	_

#	CRESTOR	6023
1	In	_	ADP	IN	_	7	case	_	_
2	in	_	X	FW	_	3	compound	_	_
3	vivo	_	X	FW	_	4	advmod	_	_
4	and	_	CONJ	CC	_	7	amod	_	_
5	in	_	X	FW	_	4	conj	_	_
6	vitro	_	X	FW	_	5	dep	_	_
7	studies	_	NOUN	NNS	_	10	nmod	_	_
8	,	_	.	,	_	10	punct	_	_
9	DRUG	_	NOUN	NN	_	10	nsubj	_	_
10	produces	_	VERB	VBZ	_	0	root	_	_
11	its	_	PRON	PRP$	_	14	nmod:poss	_	_
12	lipid	_	NOUN	NN	_	14	compound	_	_
13	modifying	_	NOUN	NN	_	14	compound	_	_
14	effects	_	NOUN	NNS	_	10	dobj	_	_
15	in	_	ADP	IN	_	17	case	_	_
16	two	_	NUM	CD	_	17	nummod	_	_
17	ways	_	NOUN	NNS	_	14	nmod	_	_

#	CRESTOR	6024
1	First	_	ADV	RB	_	4	advmod	_	_
2	,	_	.	,	_	4	punct	_	_
3	it	_	PRON	PRP	_	4	nsubj	_	_
4	increases	_	VERB	VBZ	_	0	root	_	_
5	the	_	DET	DT	_	6	det	_	_
6	number	_	NOUN	NN	_	4	dobj	_	_
7	of	_	ADP	IN	_	10	case	_	_
8	hepatic	_	ADJ	JJ	_	10	amod	_	_
9	LDL	_	NOUN	NN	_	10	compound	_	_
10	receptors	_	NOUN	NNS	_	6	nmod	_	_
11	on	_	ADP	IN	_	14	case	_	_
12	the	_	DET	DT	_	14	det	_	_
13	cell	_	NOUN	NN	_	14	compound	_	_
14	surface	_	NOUN	NN	_	6	nmod	_	_
15	to	_	PRT	TO	_	16	mark	_	_
16	enhance	_	VERB	VB	_	6	acl	_	_
17	uptake	_	NOUN	NN	_	16	dobj	_	_
18	and	_	CONJ	CC	_	16	cc	_	_
19	catabolism	_	NOUN	NN	_	16	conj	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	LDL	_	NOUN	NN	_	19	nmod	_	_

#	CRESTOR	6025
1	Second	_	ADV	RB	_	4	advmod	_	_
2	,	_	.	,	_	4	punct	_	_
3	DRUG	_	NOUN	NN	_	4	nsubj	_	_
4	inhibits	_	VERB	VBZ	_	0	root	_	_
5	hepatic	_	ADJ	JJ	_	6	amod	_	_
6	synthesis	_	NOUN	NN	_	4	dobj	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	VLDL	_	NOUN	NN	_	6	nmod	_	_
9	,	_	.	,	_	6	punct	_	_
10	which	_	DET	WDT	_	11	nsubj	_	_
11	reduces	_	VERB	VBZ	_	6	acl:relcl	_	_
12	the	_	DET	DT	_	14	det	_	_
13	total	_	ADJ	JJ	_	14	amod	_	_
14	number	_	NOUN	NN	_	11	dobj	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	VLDL	_	NOUN	NN	_	14	nmod	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	LDL	_	NOUN	NN	_	16	conj	_	_
19	particles	_	NOUN	NNS	_	16	dep	_	_

#	CRESTOR	6026
1	*	_	NOUN	NN	_	2	compound	_	_
2	Absorption	_	NOUN	NN	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	In	_	ADP	IN	_	7	case	_	_
5	clinical	_	ADJ	JJ	_	7	amod	_	_
6	pharmacology	_	NOUN	NN	_	7	compound	_	_
7	studies	_	NOUN	NNS	_	2	nmod	_	_
8	in	_	ADP	IN	_	9	case	_	_
9	man	_	X	FW	_	7	nmod	_	_
10	,	_	.	,	_	2	punct	_	_
11	peak	_	ADJ	JJ	_	13	amod	_	_
12	plasma	_	NOUN	NN	_	13	compound	_	_
13	concentrations	_	NOUN	NNS	_	17	nsubjpass	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	DRUG	_	NOUN	NN	_	13	nmod	_	_
16	were	_	VERB	VBD	_	17	auxpass	_	_
17	reached	_	VERB	VBN	_	2	dep	_	_
18	3	_	NUM	CD	_	20	nummod	_	_
19	to	_	PRT	TO	_	20	case	_	_
20	5hours	_	VERB	VB	_	17	xcomp	_	_
21	following	_	VERB	VBG	_	23	case	_	_
22	oral	_	ADJ	JJ	_	23	amod	_	_
23	dosing	_	VERB	VBG	_	20	nmod	_	_

#	CRESTOR	6027
1	Both	_	CONJ	CC	_	2	cc:preconj	_	_
2	Cmax	_	NOUN	NN	_	5	nsubj	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	AUC	_	NOUN	NN	_	2	conj	_	_
5	increased	_	VERB	VBD	_	0	root	_	_
6	in	_	ADP	IN	_	8	case	_	_
7	approximate	_	ADJ	JJ	_	8	amod	_	_
8	proportion	_	NOUN	NN	_	5	nmod	_	_
9	to	_	PRT	TO	_	11	case	_	_
10	DRUG	_	NOUN	NN	_	11	compound	_	_
11	dose	_	NOUN	NN	_	8	nmod	_	_

#	CRESTOR	6028
1	The	_	DET	DT	_	3	det	_	_
2	absolute	_	ADJ	JJ	_	3	amod	_	_
3	bioavailability	_	NOUN	NN	_	8	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	is	_	VERB	VBZ	_	8	auxpass	_	_
7	approximately	_	ADV	RB	_	8	advmod	_	_
8	20%	_	ADJ	JJ	_	0	root	_	_

#	CRESTOR	6029
1	Administration	_	NOUN	NN	_	8	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	with	_	ADP	IN	_	5	case	_	_
5	food	_	NOUN	NN	_	1	nmod	_	_
6	did	_	VERB	VBD	_	8	aux	_	_
7	not	_	ADV	RB	_	8	neg	_	_
8	affect	_	VERB	VB	_	0	root	_	_
9	the	_	DET	DT	_	10	det	_	_
10	AUC	_	NOUN	NN	_	8	dobj	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_

#	CRESTOR	6030
1	The	_	DET	DT	_	2	det	_	_
2	AUC	_	NOUN	NN	_	7	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	does	_	VERB	VBZ	_	7	aux	_	_
6	not	_	ADV	RB	_	7	neg	_	_
7	differ	_	VERB	VB	_	0	root	_	_
8	following	_	ADP	IN	_	9	case	_	_
9	evening	_	NOUN	NN	_	7	nmod	_	_
10	or	_	CONJ	CC	_	9	cc	_	_
11	morning	_	NOUN	NN	_	13	compound	_	_
12	drug	_	NOUN	NN	_	13	compound	_	_
13	administration	_	NOUN	NN	_	9	conj	_	_

#	CRESTOR	6031
1	*	_	NOUN	NN	_	2	compound	_	_
2	Distribution	_	NOUN	NN	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	Mean	_	ADJ	JJ	_	5	amod	_	_
5	volume	_	NOUN	NN	_	16	nsubj	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	distribution	_	NOUN	NN	_	5	nmod	_	_
8	at	_	ADP	IN	_	10	case	_	_
9	steady	_	ADJ	JJ	_	10	amod	_	_
10	state	_	NOUN	NN	_	5	nmod	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_
13	is	_	VERB	VBZ	_	16	cop	_	_
14	approximately	_	ADV	RB	_	15	advmod	_	_
15	134	_	NUM	CD	_	16	nummod	_	_
16	liters	_	NOUN	NNS	_	2	dep	_	_

#	CRESTOR	6032
1	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
2	is	_	VERB	VBZ	_	4	auxpass	_	_
3	88%	_	ADJ	JJ	_	4	advmod	_	_
4	bound	_	VERB	VBN	_	0	root	_	_
5	to	_	PRT	TO	_	7	case	_	_
6	plasma	_	NOUN	NN	_	7	compound	_	_
7	proteins	_	NOUN	NNS	_	4	nmod	_	_
8	,	_	.	,	_	7	punct	_	_
9	mostly	_	ADV	RB	_	10	advmod	_	_
10	albumin	_	NOUN	NN	_	7	appos	_	_

#	CRESTOR	6033
1	This	_	DET	DT	_	2	det	_	_
2	binding	_	NOUN	NN	_	4	nsubj	_	_
3	is	_	VERB	VBZ	_	4	cop	_	_
4	reversible	_	ADJ	JJ	_	0	root	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	independent	_	ADJ	JJ	_	4	conj	_	_
7	of	_	ADP	IN	_	9	case	_	_
8	plasma	_	NOUN	NN	_	9	compound	_	_
9	concentrations	_	NOUN	NNS	_	4	nmod	_	_

#	CRESTOR	6034
1	*	_	NOUN	NN	_	2	compound	_	_
2	Metabolism	_	NOUN	NN	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	DRUG	_	NOUN	NN	_	8	nsubjpass	_	_
5	is	_	VERB	VBZ	_	8	auxpass	_	_
6	not	_	ADV	RB	_	8	neg	_	_
7	extensively	_	ADV	RB	_	8	advmod	_	_
8	metabolized	_	VERB	VBN	_	2	dep	_	_
9	approximately	_	ADV	RB	_	10	advmod	_	_
10	10%	_	NOUN	NN	_	8	dobj	_	_
11	of	_	ADP	IN	_	14	case	_	_
12	a	_	DET	DT	_	14	det	_	_
13	radiolabeled	_	ADJ	JJ	_	14	amod	_	_
14	dose	_	NOUN	NN	_	10	nmod	_	_
15	is	_	VERB	VBZ	_	16	auxpass	_	_
16	recovered	_	VERB	VBN	_	8	parataxis	_	_
17	as	_	ADP	IN	_	18	case	_	_
18	metabolite	_	NOUN	NN	_	16	nmod	_	_

#	CRESTOR	6035
1	The	_	DET	DT	_	3	det	_	_
2	major	_	ADJ	JJ	_	3	amod	_	_
3	metabolite	_	NOUN	NN	_	7	nsubj	_	_
4	is	_	VERB	VBZ	_	7	cop	_	_
5	N	_	NOUN	NN	_	7	compound	_	_
6	desmethyl	_	NOUN	NN	_	7	compound	_	_
7	DRUG	_	NOUN	NN	_	0	root	_	_
8	,	_	.	,	_	7	punct	_	_
9	which	_	DET	WDT	_	11	nsubjpass	_	_
10	is	_	VERB	VBZ	_	11	auxpass	_	_
11	formed	_	VERB	VBN	_	7	acl:relcl	_	_
12	principally	_	ADV	RB	_	11	advmod	_	_
13	by	_	ADP	IN	_	16	case	_	_
14	cytochrome	_	NOUN	NN	_	16	compound	_	_
15	P450	_	NOUN	NN	_	16	compound	_	_
16	\2C9	_	NOUN	NN	_	11	nmod	_	_
17	,	_	.	,	_	7	punct	_	_
18	and	_	CONJ	CC	_	7	cc	_	_
19	in	_	X	FW	_	21	amod	_	_
20	vitro	_	X	FW	_	19	dep	_	_
21	studies	_	NOUN	NNS	_	23	nsubj	_	_
22	have	_	VERB	VBP	_	23	aux	_	_
23	demonstrated	_	VERB	VBN	_	7	conj	_	_
24	that	_	ADP	IN	_	28	mark	_	_
25	N	_	NOUN	NN	_	27	compound	_	_
26	desmethyl	_	NOUN	NN	_	27	compound	_	_
27	DRUG	_	NOUN	NN	_	28	nsubj	_	_
28	has	_	VERB	VBZ	_	23	ccomp	_	_
29	approximately	_	ADV	RB	_	30	advmod	_	_
30	one	_	NUM	CD	_	28	dobj	_	_
31	sixth	_	ADJ	JJ	_	30	dep	_	_
32	to	_	PRT	TO	_	34	case	_	_
33	one	_	NUM	CD	_	34	nummod	_	_
34	half	_	NOUN	NN	_	31	nmod	_	_
35	the	_	DET	DT	_	40	det	_	_
36	HMG	_	NOUN	NN	_	40	compound	_	_
37	CoA	_	NOUN	NN	_	40	compound	_	_
38	reductase	_	NOUN	NN	_	40	compound	_	_
39	inhibitory	_	ADJ	JJ	_	40	amod	_	_
40	activity	_	NOUN	NN	_	31	dobj	_	_
41	of	_	ADP	IN	_	44	case	_	_
42	the	_	DET	DT	_	44	det	_	_
43	parent	_	NOUN	NN	_	44	compound	_	_
44	compound	_	NOUN	NN	_	40	nmod	_	_

#	CRESTOR	6036
1	Overall	_	ADV	RB	_	15	advmod	_	_
2	,	_	.	,	_	15	punct	_	_
3	greater	_	ADJ	JJ	_	5	case	_	_
4	than	_	ADP	IN	_	3	mwe	_	_
5	90%	_	NOUN	NN	_	15	nsubjpass	_	_
6	of	_	ADP	IN	_	13	case	_	_
7	active	_	ADJ	JJ	_	13	amod	_	_
8	plasma	_	NOUN	NN	_	13	compound	_	_
9	HMG	_	NOUN	NN	_	13	compound	_	_
10	CoA	_	NOUN	NN	_	13	compound	_	_
11	reductase	_	NOUN	NN	_	13	compound	_	_
12	inhibitory	_	ADJ	JJ	_	13	amod	_	_
13	activity	_	NOUN	NN	_	5	nmod	_	_
14	is	_	VERB	VBZ	_	15	auxpass	_	_
15	accounted	_	VERB	VBN	_	0	root	_	_
16	for	_	ADP	IN	_	20	case	_	_
17	by	_	ADP	IN	_	20	case	_	_
18	the	_	DET	DT	_	20	det	_	_
19	parent	_	NOUN	NN	_	20	compound	_	_
20	compound	_	NOUN	NN	_	15	nmod	_	_

#	CRESTOR	6037
1	*	_	NOUN	NN	_	2	compound	_	_
2	Excretion	_	NOUN	NN	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	Following	_	VERB	VBG	_	6	case	_	_
5	oral	_	ADJ	JJ	_	6	amod	_	_
6	administration	_	NOUN	NN	_	14	nmod	_	_
7	,	_	.	,	_	14	punct	_	_
8	DRUG	_	NOUN	NN	_	14	nsubjpass	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	its	_	PRON	PRP$	_	11	nmod:poss	_	_
11	metabolites	_	NOUN	NNS	_	8	conj	_	_
12	are	_	VERB	VBP	_	14	auxpass	_	_
13	primarily	_	ADV	RB	_	14	advmod	_	_
14	excreted	_	VERB	VBN	_	2	dep	_	_
15	in	_	ADP	IN	_	18	case	_	_
16	the	_	DET	DT	_	18	det	_	_
17	feces	_	NOUN	NNS	_	18	compound	_	_
18	90%	_	ADJ	JJ	_	14	nmod	_	_

#	CRESTOR	6038
1	The	_	DET	DT	_	4	det	_	_
2	elimination	_	NOUN	NN	_	4	compound	_	_
3	half	_	NOUN	NN	_	4	compound	_	_
4	life	_	NOUN	NN	_	13	nsubj	_	_
5	t1	_	NUM	CD	_	4	nummod	_	_
6	/	_	.	:	_	4	punct	_	_
7	2	_	NUM	CD	_	4	dep	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	is	_	VERB	VBZ	_	13	cop	_	_
11	approximately	_	ADV	RB	_	13	advmod	_	_
12	19	_	NUM	CD	_	13	nummod	_	_
13	hours	_	NOUN	NNS	_	0	root	_	_

#	CRESTOR	6039
1	After	_	ADP	IN	_	4	case	_	_
2	an	_	DET	DT	_	4	det	_	_
3	intravenous	_	ADJ	JJ	_	4	amod	_	_
4	dose	_	NOUN	NN	_	16	nmod	_	_
5	,	_	.	,	_	16	punct	_	_
6	approximately	_	ADV	RB	_	7	advmod	_	_
7	28%	_	NOUN	NN	_	16	nsubj	_	_
8	of	_	ADP	IN	_	11	case	_	_
9	total	_	ADJ	JJ	_	11	amod	_	_
10	body	_	NOUN	NN	_	11	compound	_	_
11	clearance	_	NOUN	NN	_	7	nmod	_	_
12	was	_	VERB	VBD	_	16	cop	_	_
13	via	_	ADP	IN	_	16	case	_	_
14	the	_	DET	DT	_	16	det	_	_
15	renal	_	ADJ	JJ	_	16	amod	_	_
16	route	_	NOUN	NN	_	0	root	_	_
17	,	_	.	,	_	16	punct	_	_
18	and	_	CONJ	CC	_	16	cc	_	_
19	72%	_	NOUN	NN	_	16	conj	_	_
20	by	_	ADP	IN	_	23	case	_	_
21	the	_	DET	DT	_	23	det	_	_
22	hepatic	_	ADJ	JJ	_	23	amod	_	_
23	route	_	NOUN	NNS	_	19	nmod	_	_

#	CRESTOR	6040
1	*	_	NOUN	NN	_	2	compound	_	_
2	Race	_	NOUN	NN	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	A	_	NOUN	NN	_	7	compound	_	_
5	population	_	NOUN	NN	_	7	compound	_	_
6	pharmacokinetic	_	ADJ	JJ	_	7	amod	_	_
7	analysis	_	NOUN	NN	_	8	nsubj	_	_
8	revealed	_	VERB	VBD	_	2	dep	_	_
9	no	_	DET	DT	_	12	neg	_	_
10	clinically	_	ADV	RB	_	11	advmod	_	_
11	relevant	_	ADJ	JJ	_	12	amod	_	_
12	differences	_	NOUN	NNS	_	8	dobj	_	_
13	in	_	ADP	IN	_	14	case	_	_
14	pharmacokinetics	_	NOUN	NNS	_	12	nmod	_	_
15	among	_	ADP	IN	_	16	case	_	_
16	Caucasian	_	ADJ	JJ	_	12	nmod	_	_
17	,	_	.	,	_	16	punct	_	_
18	Hispanic	_	ADJ	JJ	_	16	conj	_	_
19	,	_	.	,	_	16	punct	_	_
20	and	_	CONJ	CC	_	16	cc	_	_
21	Black	_	NOUN	NN	_	16	conj	_	_
22	or	_	CONJ	CC	_	16	cc	_	_
23	Afro	_	NOUN	NN	_	25	compound	_	_
24	Caribbean	_	ADJ	JJ	_	25	compound	_	_
25	groups	_	NOUN	NNS	_	16	conj	_	_

#	CRESTOR	6041
1	However	_	ADV	RB	_	14	advmod	_	_
2	,	_	.	,	_	14	punct	_	_
3	pharmacokinetic	_	ADJ	JJ	_	4	amod	_	_
4	studies	_	NOUN	NNS	_	14	nsubj	_	_
5	,	_	.	,	_	4	punct	_	_
6	including	_	VERB	VBG	_	7	case	_	_
7	one	_	NUM	CD	_	4	nmod	_	_
8	conducted	_	VERB	VBN	_	7	acl	_	_
9	in	_	ADP	IN	_	11	case	_	_
10	the	_	DET	DT	_	11	det	_	_
11	US	_	NOUN	NN	_	8	nmod	_	_
12	,	_	.	,	_	4	punct	_	_
13	have	_	VERB	VBP	_	14	aux	_	_
14	demonstrated	_	VERB	VBN	_	0	root	_	_
15	an	_	DET	DT	_	19	det	_	_
16	approximate	_	ADJ	JJ	_	19	amod	_	_
17	2	_	NUM	CD	_	19	nummod	_	_
18	fold	_	NOUN	NN	_	19	amod	_	_
19	elevation	_	NOUN	NN	_	14	dobj	_	_
20	in	_	ADP	IN	_	23	case	_	_
21	median	_	ADJ	JJ	_	23	amod	_	_
22	exposure	_	NOUN	NN	_	23	compound	_	_
23	AUC	_	NOUN	NN	_	19	nmod	_	_
24	and	_	CONJ	CC	_	23	cc	_	_
25	Cmax	_	NOUN	NN	_	23	conj	_	_
26	in	_	ADP	IN	_	28	case	_	_
27	Asian	_	ADJ	JJ	_	28	amod	_	_
28	subjects	_	NOUN	NNS	_	19	nmod	_	_
29	when	_	ADV	WRB	_	30	advmod	_	_
30	compared	_	VERB	VBN	_	14	advcl	_	_
31	with	_	ADP	IN	_	35	case	_	_
32	a	_	DET	DT	_	35	det	_	_
33	Caucasian	_	ADJ	JJ	_	35	amod	_	_
34	control	_	NOUN	NN	_	35	compound	_	_
35	group	_	NOUN	NN	_	30	nmod	_	_

#	CRESTOR	6042
1	*	_	NOUN	NN	_	2	compound	_	_
2	Gender	_	NOUN	NN	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	There	_	DET	EX	_	5	expl	_	_
5	were	_	VERB	VBD	_	2	dep	_	_
6	no	_	DET	DT	_	7	neg	_	_
7	differences	_	NOUN	NNS	_	5	nsubj	_	_
8	in	_	ADP	IN	_	10	case	_	_
9	plasma	_	NOUN	NN	_	10	compound	_	_
10	concentrations	_	NOUN	NNS	_	7	nmod	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_
13	between	_	ADP	IN	_	14	case	_	_
14	men	_	NOUN	NN	_	10	nmod	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	women	_	NOUN	NNS	_	14	conj	_	_

#	CRESTOR	6043
1	*	_	NOUN	NN	_	2	compound	_	_
2	Geriatric	_	ADJ	JJ	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	There	_	DET	EX	_	5	expl	_	_
5	were	_	VERB	VBD	_	2	parataxis	_	_
6	no	_	DET	DT	_	7	neg	_	_
7	differences	_	NOUN	NNS	_	5	nsubj	_	_
8	in	_	ADP	IN	_	10	case	_	_
9	plasma	_	NOUN	NN	_	10	compound	_	_
10	concentrations	_	NOUN	NNS	_	7	nmod	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_
13	between	_	ADP	IN	_	18	case	_	_
14	the	_	DET	DT	_	18	det	_	_
15	nonelderly	_	ADJ	JJ	_	18	amod	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	elderly	_	ADJ	JJ	_	15	conj	_	_
18	populations	_	NOUN	NNS	_	10	nmod	_	_
19	age	_	NOUN	NN	_	20	compound	_	_
20	>65years	_	NOUN	NNS	_	18	dep	_	_

#	CRESTOR	6044
1	*	_	NOUN	NN	_	3	compound	_	_
2	Renal	_	ADJ	JJ	_	3	amod	_	_
3	Impairment	_	NOUN	NN	_	0	root	_	_
4	:	_	.	:	_	3	punct	_	_
5	Mild	_	NOUN	NN	_	3	dep	_	_
6	to	_	PRT	TO	_	10	case	_	_
7	moderate	_	ADJ	JJ	_	10	amod	_	_
8	renal	_	ADJ	JJ	_	10	amod	_	_
9	impairment	_	NOUN	NN	_	10	compound	_	_
10	CLcr>30mL	_	NOUN	NN	_	5	nmod	_	_
11	/	_	.	:	_	3	punct	_	_
12	min	_	NOUN	NN	_	16	nsubj	_	_
13	/	_	.	:	_	12	punct	_	_
14	1.73	_	NUM	CD	_	15	nummod	_	_
15	m2	_	NOUN	NN	_	12	dep	_	_
16	had	_	VERB	VBD	_	3	dep	_	_
17	no	_	DET	DT	_	18	neg	_	_
18	influence	_	VERB	VB	_	16	dobj	_	_
19	on	_	ADP	IN	_	21	case	_	_
20	plasma	_	NOUN	NN	_	21	compound	_	_
21	concentrations	_	NOUN	NNS	_	18	nmod	_	_
22	of	_	ADP	IN	_	23	case	_	_
23	DRUG	_	NOUN	NN	_	21	nmod	_	_

#	CRESTOR	6045
1	However	_	ADV	RB	_	7	advmod	_	_
2	,	_	.	,	_	7	punct	_	_
3	plasma	_	NOUN	NN	_	4	compound	_	_
4	concentrations	_	NOUN	NNS	_	7	nsubj	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	increased	_	VERB	VBD	_	0	root	_	_
8	to	_	PRT	TO	_	12	case	_	_
9	a	_	DET	DT	_	12	det	_	_
10	clinically	_	ADV	RB	_	11	advmod	_	_
11	significant	_	ADJ	JJ	_	12	amod	_	_
12	extent	_	NOUN	NN	_	7	nmod	_	_
13	about	_	ADP	IN	_	14	advmod	_	_
14	3	_	NUM	CD	_	15	nummod	_	_
15	fold	_	NOUN	NN	_	7	nmod	_	_
16	in	_	ADP	IN	_	17	case	_	_
17	patients	_	NOUN	NNS	_	15	nmod	_	_
18	with	_	ADP	IN	_	23	case	_	_
19	severe	_	ADJ	JJ	_	23	amod	_	_
20	renal	_	ADJ	JJ	_	23	amod	_	_
21	impairment	_	NOUN	NN	_	23	compound	_	_
22	CLcr<30	_	NOUN	NN	_	23	compound	_	_
23	mL	_	NOUN	NN	_	17	nmod	_	_
24	/	_	.	:	_	7	punct	_	_
25	min	_	NOUN	NN	_	7	parataxis	_	_
26	/	_	.	:	_	25	punct	_	_
27	1.73	_	NUM	CD	_	28	nummod	_	_
28	m2	_	NOUN	NN	_	32	nsubj	_	_
29	not	_	ADV	RB	_	30	neg	_	_
30	receiving	_	VERB	VBG	_	28	acl	_	_
31	hemodialysis	_	NOUN	NN	_	30	dobj	_	_
32	compared	_	VERB	VBN	_	25	dep	_	_
33	with	_	ADP	IN	_	35	case	_	_
34	healthy	_	ADJ	JJ	_	35	amod	_	_
35	subjects	_	NOUN	NNS	_	32	nmod	_	_
36	CLcr>	_	NOUN	NN	_	37	compound	_	_
37	80mL	_	NOUN	NN	_	35	dep	_	_
38	/	_	.	:	_	37	punct	_	_
39	min	_	NOUN	NN	_	37	dep	_	_
40	/	_	.	,	_	39	punct	_	_
41	1.73m2	_	NUM	CD	_	39	nummod	_	_

#	CRESTOR	6046
1	*	_	NOUN	NN	_	2	compound	_	_
2	Hemodialysis	_	NOUN	NN	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	Steady	_	ADJ	JJ	_	7	amod	_	_
5	state	_	NOUN	NN	_	7	compound	_	_
6	plasma	_	NOUN	NN	_	7	compound	_	_
7	concentrations	_	NOUN	NNS	_	17	nsubj	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	in	_	ADP	IN	_	11	case	_	_
11	patients	_	NOUN	NNS	_	7	nmod	_	_
12	on	_	ADP	IN	_	14	case	_	_
13	chronic	_	ADJ	JJ	_	14	amod	_	_
14	hemodialysis	_	NOUN	NN	_	11	nmod	_	_
15	were	_	VERB	VBD	_	17	cop	_	_
16	approximately	_	ADV	RB	_	17	advmod	_	_
17	50%	_	ADJ	JJ	_	2	dep	_	_
18	greater	_	ADJ	JJ	_	17	dep	_	_
19	compared	_	VERB	VBN	_	18	dep	_	_
20	with	_	ADP	IN	_	23	case	_	_
21	healthy	_	ADJ	JJ	_	23	amod	_	_
22	volunteer	_	ADJ	JJ	_	23	amod	_	_
23	subjects	_	NOUN	NNS	_	19	nmod	_	_
24	with	_	ADP	IN	_	27	case	_	_
25	normal	_	ADJ	JJ	_	27	amod	_	_
26	renal	_	ADJ	JJ	_	27	amod	_	_
27	function	_	NOUN	NN	_	23	nmod	_	_

#	CRESTOR	6047
1	*	_	NOUN	NN	_	3	compound	_	_
2	Hepatic	_	ADJ	JJ	_	3	amod	_	_
3	Impairment	_	NOUN	NN	_	0	root	_	_
4	:	_	.	:	_	3	punct	_	_
5	In	_	ADP	IN	_	6	case	_	_
6	patients	_	NOUN	NNS	_	3	nmod	_	_
7	with	_	ADP	IN	_	11	case	_	_
8	chronic	_	ADJ	JJ	_	11	amod	_	_
9	alcohol	_	NOUN	NN	_	11	compound	_	_
10	liver	_	NOUN	NN	_	11	compound	_	_
11	disease	_	NOUN	NN	_	6	nmod	_	_
12	,	_	.	,	_	3	punct	_	_
13	plasma	_	NOUN	NN	_	14	compound	_	_
14	concentrations	_	NOUN	NNS	_	19	nsubjpass	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	14	nmod	_	_
17	were	_	VERB	VBD	_	19	auxpass	_	_
18	modestly	_	ADV	RB	_	19	advmod	_	_
19	increased	_	VERB	VBN	_	3	dep	_	_

#	CRESTOR	6048
1	In	_	ADP	IN	_	2	case	_	_
2	patients	_	NOUN	NNS	_	13	nmod	_	_
3	with	_	ADP	IN	_	7	case	_	_
4	Child	_	NOUN	NN	_	7	compound	_	_
5	Pugh	_	NOUN	NN	_	7	compound	_	_
6	A	_	NOUN	NN	_	7	compound	_	_
7	disease	_	NOUN	NN	_	2	nmod	_	_
8	,	_	.	,	_	13	punct	_	_
9	Cmax	_	NOUN	NN	_	13	nsubjpass	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	AUC	_	NOUN	NN	_	9	conj	_	_
12	were	_	VERB	VBD	_	13	auxpass	_	_
13	increased	_	VERB	VBN	_	0	root	_	_
14	by	_	ADP	IN	_	15	case	_	_
15	60%	_	NOUN	NN	_	13	nmod	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	5%	_	NOUN	NN	_	15	conj	_	_
18	,	_	.	,	_	13	punct	_	_
19	respectively	_	ADV	RB	_	13	advmod	_	_
20	,	_	.	,	_	13	punct	_	_
21	as	_	ADP	IN	_	22	mark	_	_
22	compared	_	VERB	VBN	_	13	advcl	_	_
23	with	_	ADP	IN	_	24	case	_	_
24	patients	_	NOUN	NNS	_	22	nmod	_	_
25	with	_	ADP	IN	_	28	case	_	_
26	normal	_	ADJ	JJ	_	28	amod	_	_
27	liver	_	NOUN	NN	_	28	compound	_	_
28	function	_	NOUN	NN	_	24	nmod	_	_

#	CRESTOR	6049
1	In	_	ADP	IN	_	2	case	_	_
2	patients	_	NOUN	NNS	_	13	nmod	_	_
3	with	_	ADP	IN	_	7	case	_	_
4	Child	_	ADJ	JJ	_	7	compound	_	_
5	Pugh	_	NOUN	NN	_	7	compound	_	_
6	B	_	NOUN	NN	_	7	compound	_	_
7	disease	_	NOUN	NN	_	2	nmod	_	_
8	,	_	.	,	_	13	punct	_	_
9	Cmax	_	NOUN	NN	_	13	nsubjpass	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	AUC	_	NOUN	NN	_	9	conj	_	_
12	were	_	VERB	VBD	_	13	auxpass	_	_
13	increased	_	VERB	VBN	_	0	root	_	_
14	100%	_	NOUN	NN	_	13	xcomp	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	21%	_	NOUN	NN	_	14	conj	_	_
17	,	_	.	,	_	13	punct	_	_
18	respectively	_	ADV	RB	_	13	advmod	_	_
19	,	_	.	,	_	13	punct	_	_
20	compared	_	VERB	VBN	_	13	xcomp	_	_
21	with	_	ADP	IN	_	22	case	_	_
22	patients	_	NOUN	NNS	_	20	nmod	_	_
23	with	_	ADP	IN	_	26	case	_	_
24	normal	_	ADJ	JJ	_	26	amod	_	_
25	liver	_	NOUN	NN	_	26	compound	_	_
26	function	_	NOUN	NN	_	22	nmod	_	_

#	CRESTOR	6050
1	Drug	_	NOUN	NN	_	3	compound	_	_
2	Drug	_	NOUN	NN	_	3	compound	_	_
3	Interactions	_	NOUN	NNS	_	0	root	_	_
4	:	_	.	:	_	3	punct	_	_
5	DRUG	_	NOUN	NN	_	6	compound	_	_
6	clearance	_	NOUN	NN	_	9	nsubj	_	_
7	is	_	VERB	VBZ	_	9	cop	_	_
8	not	_	ADV	RB	_	9	neg	_	_
9	dependent	_	ADJ	JJ	_	3	dep	_	_
10	on	_	ADP	IN	_	11	case	_	_
11	metabolism	_	NOUN	NN	_	9	nmod	_	_
12	by	_	ADP	IN	_	15	case	_	_
13	cytochrome	_	NOUN	NN	_	15	compound	_	_
14	P450	_	NOUN	NN	_	15	compound	_	_
15	3A4	_	NOUN	NN	_	11	nmod	_	_
16	to	_	PRT	TO	_	20	case	_	_
17	a	_	DET	DT	_	20	det	_	_
18	clinically	_	ADV	RB	_	19	advmod	_	_
19	significant	_	ADJ	JJ	_	20	amod	_	_
20	extent	_	NOUN	NN	_	11	nmod	_	_

#	CRESTOR	6051
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	is	_	VERB	VBZ	_	4	cop	_	_
3	a	_	DET	DT	_	4	det	_	_
4	substrate	_	NOUN	NN	_	0	root	_	_
5	for	_	ADP	IN	_	8	case	_	_
6	certain	_	ADJ	JJ	_	8	amod	_	_
7	transporter	_	NOUN	NN	_	8	compound	_	_
8	proteins	_	NOUN	NNS	_	4	nmod	_	_
9	including	_	ADP	IN	_	15	case	_	_
10	the	_	DET	DT	_	15	det	_	_
11	hepatic	_	ADJ	JJ	_	15	amod	_	_
12	uptake	_	NOUN	NN	_	15	compound	_	_
13	transporter	_	NOUN	NN	_	15	compound	_	_
14	organic	_	ADJ	JJ	_	15	amod	_	_
15	anion	_	NOUN	NN	_	8	nmod	_	_
16	transporting	_	VERB	VBG	_	15	acl	_	_
17	polyprotein	_	NOUN	NN	_	19	compound	_	_
18	1B1	_	NOUN	NN	_	19	compound	_	_
19	OATP1B1	_	NOUN	NN	_	16	dobj	_	_
20	and	_	CONJ	CC	_	19	cc	_	_
21	efflux	_	NOUN	NN	_	26	compound	_	_
22	transporter	_	NOUN	NN	_	26	compound	_	_
23	breast	_	NOUN	NN	_	26	compound	_	_
24	cancer	_	NOUN	NN	_	26	compound	_	_
25	resistance	_	NOUN	NN	_	26	compound	_	_
26	protein	_	NOUN	NN	_	27	compound	_	_
27	BCRP	_	NOUN	NN	_	19	conj	_	_

#	CRESTOR	6052
1	Concomitant	_	ADJ	JJ	_	2	amod	_	_
2	administration	_	NOUN	NN	_	22	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	with	_	ADP	IN	_	6	case	_	_
6	medications	_	NOUN	NNS	_	2	nmod	_	_
7	that	_	DET	WDT	_	9	nsubj	_	_
8	are	_	VERB	VBP	_	9	cop	_	_
9	inhibitors	_	NOUN	NNS	_	6	acl:relcl	_	_
10	of	_	ADP	IN	_	13	case	_	_
11	these	_	DET	DT	_	13	det	_	_
12	transporter	_	NOUN	NN	_	13	compound	_	_
13	proteins	_	NOUN	NNS	_	9	nmod	_	_
14	e.g	_	X	FW	_	15	case	_	_
15	cyclosporine	_	NOUN	NN	_	13	nmod	_	_
16	,	_	.	,	_	2	punct	_	_
17	certain	_	ADJ	JJ	_	20	amod	_	_
18	HIV	_	NOUN	NN	_	20	compound	_	_
19	protease	_	NOUN	NN	_	20	compound	_	_
20	inhibitors	_	NOUN	NNS	_	2	appos	_	_
21	may	_	VERB	MD	_	22	aux	_	_
22	result	_	VERB	VB	_	0	root	_	_
23	in	_	ADP	IN	_	27	case	_	_
24	increased	_	VERB	VBN	_	27	amod	_	_
25	DRUG	_	NOUN	NN	_	27	compound	_	_
26	plasma	_	NOUN	NN	_	27	compound	_	_
27	concentrations	_	NOUN	NNS	_	22	nmod	_	_
28	and	_	CONJ	CC	_	22	cc	_	_
29	an	_	DET	DT	_	31	det	_	_
30	increased	_	VERB	VBN	_	31	amod	_	_
31	risk	_	NOUN	NN	_	22	conj	_	_
32	of	_	ADP	IN	_	33	case	_	_
33	myopathy	_	NOUN	NN	_	31	nmod	_	_

#	CRESTOR	6053
1	Effect	_	NOUN	NN	_	0	root	_	_
2	of	_	ADP	IN	_	4	case	_	_
3	Coadministered	_	ADJ	JJ	_	4	amod	_	_
4	Drugs	_	NOUN	NNS	_	1	nmod	_	_
5	on	_	ADP	IN	_	10	case	_	_
6	DRUG	_	NOUN	NN	_	10	compound	_	_
7	Systemic	_	ADJ	JJ	_	10	amod	_	_
8	Exposure	_	NOUN	NN	_	10	compound	_	_
9	Coadministered	_	ADJ	JJ	_	10	amod	_	_
10	drug	_	NOUN	NN	_	1	nmod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	dosing	_	VERB	VBG	_	18	amod	_	_
13	regimen	_	NOUN	NN	_	18	compound	_	_
14	DRUG	_	NOUN	NN	_	18	compound	_	_
15	Dose	_	NOUN	NN	_	18	compound	_	_
16	mg	_	NOUN	NN	_	18	compound	_	_
17	Single	_	ADJ	JJ	_	18	amod	_	_
18	dose	_	NOUN	NN	_	10	conj	_	_
19	unless	_	ADP	IN	_	21	mark	_	_
20	otherwise	_	ADV	RB	_	21	advmod	_	_
21	noted	_	VERB	VBN	_	1	acl	_	_

#	CRESTOR	6054
1	Change	_	NOUN	NN	_	4	nsubj	_	_
2	in	_	ADP	IN	_	3	case	_	_
3	AUC	_	NOUN	NN	_	1	nmod	_	_
4	Mean	_	VERB	VBP	_	0	root	_	_
5	ratio	_	NOUN	NN	_	4	dobj	_	_
6	with	_	ADP	IN	_	7	case	_	_
7	/	_	.	-RRB-	_	5	nmod	_	_
8	without	_	ADP	IN	_	10	case	_	_
9	coadministered	_	VERB	VBN	_	10	amod	_	_
10	drug	_	NOUN	NN	_	5	nmod	_	_
11	and	_	CONJ	CC	_	5	cc	_	_
12	no	_	DET	DT	_	15	neg	_	_
13	change	_	NOUN	NN	_	15	compound	_	_
14	=	_	ADJ	JJ	_	15	amod	_	_
15	1fold	_	NOUN	NN	_	18	amod	_	_
16	or	_	CONJ	CC	_	15	cc	_	_
17	%	_	NOUN	NN	_	15	conj	_	_
18	change	_	NOUN	NN	_	5	conj	_	_
19	with	_	ADP	IN	_	20	case	_	_
20	/	_	.	-RRB-	_	18	nmod	_	_
21	without	_	ADP	IN	_	23	case	_	_
22	coadministered	_	VERB	VBN	_	23	amod	_	_
23	drug	_	NOUN	NN	_	18	nmod	_	_
24	and	_	CONJ	CC	_	23	cc	_	_
25	no	_	DET	DT	_	26	neg	_	_
26	change	_	NOUN	NN	_	23	conj	_	_
27	=	_	CONJ	CC	_	29	amod	_	_
28	0%	_	ADJ	JJ	_	29	amod	_	_
29	symbols	_	NOUN	NNS	_	26	dep	_	_
30	of	_	ADP	IN	_	31	case	_	_
31	*	_	NOUN	NN	_	29	nmod	_	_
32	and	_	CONJ	CC	_	29	cc	_	_
33	*	_	NUM	CD	_	34	nsubj	_	_
34	indicate	_	VERB	VBP	_	29	conj	_	_
35	the	_	DET	DT	_	36	det	_	_
36	exposure	_	NOUN	NN	_	34	dobj	_	_
37	increase	_	NOUN	NN	_	36	dep	_	_
38	and	_	CONJ	CC	_	37	cc	_	_
39	decrease	_	NOUN	NN	_	37	conj	_	_
40	,	_	.	,	_	4	punct	_	_
41	respectively	_	ADV	RB	_	4	advmod	_	_

#	CRESTOR	6055
1	Change	_	NOUN	NN	_	7	nsubj	_	_
2	in	_	ADP	IN	_	6	case	_	_
3	Cmax	_	NOUN	NN	_	6	compound	_	_
4	Cyclosporine	_	NOUN	NN	_	6	compound	_	_
5	stable	_	ADJ	JJ	_	6	amod	_	_
6	dose	_	NOUN	NN	_	1	nmod	_	_
7	required	_	VERB	VBD	_	0	root	_	_
8	75mg	_	ADJ	JJ	_	11	amod	_	_
9	200mgBID	_	NOUN	NN	_	11	compound	_	_
10	10mg	_	ADJ	JJ	_	11	amod	_	_
11	QD	_	NOUN	NN	_	7	dobj	_	_
12	for	_	ADP	IN	_	13	case	_	_
13	10days	_	NOUN	NNS	_	11	nmod	_	_
14	*	_	ADV	RB	_	15	advmod	_	_
15	7.1	_	NUM	CD	_	21	nummod	_	_
16	foldClinically	_	ADV	RB	_	17	advmod	_	_
17	significant	_	ADJ	JJ	_	21	amod	_	_
18	*	_	ADJ	JJ	_	21	amod	_	_
19	11	_	NUM	CD	_	21	nummod	_	_
20	fold	_	NOUN	NN	_	21	compound	_	_
21	Atazanavir	_	NOUN	NN	_	87	dep	_	_
22	/	_	.	:	_	21	punct	_	_
23	ritonavir	_	ADJ	JJ	_	25	compound	_	_
24	combination	_	NOUN	NN	_	25	compound	_	_
25	300mg	_	ADJ	JJ	_	21	dep	_	_
26	/	_	.	:	_	21	punct	_	_
27	100mgQD	_	NOUN	NN	_	21	dep	_	_
28	for	_	ADP	IN	_	43	case	_	_
29	8days	_	NOUN	NN	_	43	amod	_	_
30	10mg	_	ADJ	JJ	_	43	amod	_	_
31	*	_	ADJ	JJ	_	37	amod	_	_
32	3.1	_	NUM	CD	_	33	nummod	_	_
33	fold	_	NOUN	NN	_	35	advmod	_	_
34	*	_	CONJ	CC	_	35	advmod	_	_
35	7	_	NUM	CD	_	37	nummod	_	_
36	fold	_	NOUN	NN	_	37	compound	_	_
37	Lopinavir	_	ADJ	JJ	_	30	dep	_	_
38	/	_	.	:	_	37	punct	_	_
39	ritonavir	_	ADJ	JJ	_	41	compound	_	_
40	combination	_	NOUN	NN	_	41	compound	_	_
41	400mg	_	ADJ	JJ	_	37	dep	_	_
42	/	_	.	:	_	37	punct	_	_
43	100mgBID	_	NOUN	NN	_	27	nmod	_	_
44	for	_	ADP	IN	_	46	case	_	_
45	17days	_	NOUN	NN	_	46	compound	_	_
46	20mgQD	_	NOUN	NN	_	43	nmod	_	_
47	for	_	ADP	IN	_	56	case	_	_
48	7days	_	NOUN	NNS	_	50	compound	_	_
49	*	_	ADV	RB	_	50	advmod	_	_
50	2.1	_	NUM	CD	_	51	nummod	_	_
51	fold	_	NOUN	NN	_	53	advmod	_	_
52	*	_	CONJ	CC	_	53	advmod	_	_
53	5	_	NUM	CD	_	56	nummod	_	_
54	fold	_	NOUN	NN	_	56	compound	_	_
55	Gemfibrozil	_	NOUN	NN	_	56	compound	_	_
56	600mgBID	_	NOUN	NN	_	46	nmod	_	_
57	for	_	ADP	IN	_	69	case	_	_
58	7days	_	ADJ	JJ	_	69	compound	_	_
59	80mg	_	ADJ	JJ	_	69	amod	_	_
60	*	_	ADJ	JJ	_	69	amod	_	_
61	1.9	_	NUM	CD	_	62	nummod	_	_
62	fold	_	NOUN	NN	_	64	advmod	_	_
63	*	_	CONJ	CC	_	64	advmod	_	_
64	2.2	_	NUM	CD	_	69	nummod	_	_
65	fold	_	NOUN	NN	_	69	amod	_	_
66	Eltrombopag	_	ADJ	JJ	_	69	amod	_	_
67	75	_	NUM	CD	_	69	nummod	_	_
68	mg	_	NOUN	NN	_	69	compound	_	_
69	QD	_	NOUN	NN	_	56	nmod	_	_
70	,	_	.	,	_	27	punct	_	_
71	5	_	NUM	CD	_	72	nummod	_	_
72	days	_	NOUN	NNS	_	77	dep	_	_
73	10	_	NUM	CD	_	74	nummod	_	_
74	mg	_	NOUN	NN	_	77	compound	_	_
75	*	_	ADJ	JJ	_	76	advmod	_	_
76	1.6	_	NUM	CD	_	77	nummod	_	_
77	fold	_	NOUN	NN	_	79	advmod	_	_
78	*	_	CONJ	CC	_	79	advmod	_	_
79	2	_	NUM	CD	_	83	nummod	_	_
80	fold	_	NOUN	NN	_	83	compound	_	_
81	Darunavir	_	NOUN	NN	_	83	amod	_	_
82	600	_	NUM	CD	_	83	nummod	_	_
83	mg	_	NOUN	NN	_	27	appos	_	_
84	/	_	.	:	_	21	punct	_	_
85	ritonavir	_	NOUN	NN	_	86	advmod	_	_
86	100	_	NUM	CD	_	87	compound	_	_
87	mg	_	NOUN	NN	_	176	dep	_	_
88	BID	_	NOUN	NN	_	87	dep	_	_
89	,	_	.	,	_	87	punct	_	_
90	7	_	NUM	CD	_	91	nummod	_	_
91	days	_	NOUN	NNS	_	93	dep	_	_
92	10	_	NUM	CD	_	93	compound	_	_
93	mg	_	NOUN	NN	_	94	amod	_	_
94	QD	_	NOUN	NN	_	87	appos	_	_
95	for	_	ADP	IN	_	97	case	_	_
96	7	_	NUM	CD	_	97	nummod	_	_
97	days	_	NOUN	NNS	_	94	nmod	_	_
98	*	_	CONJ	CC	_	99	advmod	_	_
99	1.5	_	NUM	CD	_	100	nummod	_	_
100	fold	_	NOUN	NN	_	102	advmod	_	_
101	*	_	CONJ	CC	_	102	advmod	_	_
102	2.4	_	NUM	CD	_	104	nummod	_	_
103	fold	_	NOUN	NN	_	104	compound	_	_
104	Tipranavir	_	NOUN	NN	_	94	dep	_	_
105	/	_	.	:	_	87	punct	_	_
106	ritonavir	_	ADJ	JJ	_	108	compound	_	_
107	combination	_	NOUN	NN	_	108	compound	_	_
108	500mg	_	ADJ	JJ	_	87	dep	_	_
109	/	_	.	:	_	87	punct	_	_
110	200mgBID	_	NOUN	NN	_	87	dep	_	_
111	for	_	ADP	IN	_	124	case	_	_
112	11days	_	ADJ	JJ	_	124	compound	_	_
113	10mg	_	ADJ	JJ	_	124	amod	_	_
114	*	_	CONJ	CC	_	124	amod	_	_
115	26%	_	NOUN	NN	_	124	amod	_	_
116	*	_	CONJ	CC	_	124	amod	_	_
117	2.2	_	NUM	CD	_	124	nummod	_	_
118	fold	_	NOUN	NN	_	124	compound	_	_
119	Dronedarone	_	NOUN	NN	_	124	compound	_	_
120	400	_	NUM	CD	_	124	nummod	_	_
121	mg	_	NOUN	NN	_	124	compound	_	_
122	BID	_	NOUN	NN	_	124	compound	_	_
123	10	_	NUM	CD	_	124	nummod	_	_
124	mg	_	NOUN	NN	_	110	nmod	_	_
125	*	_	CONJ	CC	_	110	cc	_	_
126	1.4	_	NUM	CD	_	131	nummod	_	_
127	fold	_	NOUN	NN	_	131	compound	_	_
128	Itraconazole	_	NOUN	NN	_	131	compound	_	_
129	200	_	NUM	CD	_	131	nummod	_	_
130	mg	_	NOUN	NN	_	131	compound	_	_
131	QD	_	NOUN	NN	_	110	conj	_	_
132	,	_	.	,	_	110	punct	_	_
133	5	_	NUM	CD	_	134	nummod	_	_
134	days	_	NOUN	NNS	_	110	appos	_	_
135	10	_	NUM	CD	_	136	nummod	_	_
136	mg	_	NOUN	NN	_	134	dep	_	_
137	or	_	CONJ	CC	_	136	cc	_	_
138	80mg	_	ADJ	JJ	_	150	amod	_	_
139	*	_	CONJ	CC	_	150	amod	_	_
140	39%	_	ADJ	JJ	_	150	amod	_	_
141	*	_	CONJ	CC	_	150	amod	_	_
142	28%	_	ADJ	JJ	_	150	amod	_	_
143	*	_	CONJ	CC	_	150	amod	_	_
144	36%	_	ADJ	JJ	_	150	amod	_	_
145	*	_	NUM	CD	_	150	amod	_	_
146	15%	_	ADJ	JJ	_	150	amod	_	_
147	Ezetimibe	_	NOUN	NN	_	150	compound	_	_
148	10	_	NUM	CD	_	150	nummod	_	_
149	mg	_	NOUN	NN	_	150	compound	_	_
150	QD	_	NOUN	NN	_	136	conj	_	_
151	,	_	.	,	_	110	punct	_	_
152	14	_	NUM	CD	_	153	nummod	_	_
153	days	_	NOUN	NNS	_	110	appos	_	_
154	10	_	NUM	CD	_	156	nummod	_	_
155	mg	_	NOUN	NN	_	156	compound	_	_
156	QD	_	NOUN	NN	_	153	dep	_	_
157	for	_	ADP	IN	_	159	case	_	_
158	14	_	NUM	CD	_	159	nummod	_	_
159	days	_	NOUN	NNS	_	153	nmod	_	_
160	*	_	CONJ	CC	_	161	advmod	_	_
161	1.2	_	NUM	CD	_	153	nmod	_	_
162	fold	_	NOUN	NN	_	163	compound	_	_
163	Fosamprenavir	_	ADJ	JJ	_	161	conj	_	_
164	/	_	.	:	_	87	punct	_	_
165	ritonavir	_	ADJ	JJ	_	166	amod	_	_
166	700mg	_	ADJ	JJ	_	87	dep	_	_
167	/	_	.	:	_	87	punct	_	_
168	100mgBID	_	NOUN	NN	_	176	nsubj	_	_
169	for	_	ADP	IN	_	175	case	_	_
170	7days	_	ADJ	JJ	_	175	compound	_	_
171	10mg	_	ADJ	JJ	_	175	amod	_	_
172	*	_	CONJ	CC	_	175	nummod	_	_
173	8%	_	ADJ	JJ	_	175	amod	_	_
174	*	_	CONJ	CC	_	175	nummod	_	_
175	45%	_	NOUN	NN	_	168	nmod	_	_
176	Fenofibrate	_	NOUN	NN	_	7	advcl	_	_
177	67mgTID	_	NOUN	NN	_	176	dobj	_	_
178	for	_	ADP	IN	_	187	case	_	_
179	7days	_	ADJ	JJ	_	187	amod	_	_
180	10mg	_	ADJ	JJ	_	187	amod	_	_
181	*	_	CONJ	CC	_	187	amod	_	_
182	*	_	CONJ	CC	_	187	amod	_	_
183	21%	_	ADJ	JJ	_	187	amod	_	_
184	Rifampicin	_	NOUN	NN	_	187	compound	_	_
185	450	_	NUM	CD	_	187	nummod	_	_
186	mg	_	NOUN	NN	_	187	compound	_	_
187	QD	_	NOUN	NN	_	177	nmod	_	_
188	,	_	.	,	_	7	punct	_	_
189	7	_	NUM	CD	_	190	nummod	_	_
190	days	_	NOUN	NNS	_	199	compound	_	_
191	20	_	NUM	CD	_	192	nummod	_	_
192	mg	_	NOUN	NN	_	193	dep	_	_
193	*	_	CONJ	CC	_	199	amod	_	_
194	Aluminum	_	NOUN	NN	_	199	compound	_	_
195	&	_	NOUN	NN	_	199	compound	_	_
196	magnesium	_	NOUN	NN	_	199	compound	_	_
197	hydroxide	_	NOUN	NN	_	199	compound	_	_
198	combination	_	NOUN	NN	_	199	compound	_	_
199	antacid	_	NOUN	NN	_	200	nsubj	_	_
200	Administered	_	VERB	VBN	_	7	parataxis	_	_
201	simultaneouslyAdministered	_	ADJ	JJ	_	202	amod	_	_
202	2hours	_	NOUN	NNS	_	200	dobj	_	_
203	apart	_	ADJ	JJ	_	214	amod	_	_
204	40mg40mg	_	NOUN	NN	_	214	compound	_	_
205	*	_	NUM	CD	_	214	nummod	_	_
206	54%	_	NOUN	NN	_	214	amod	_	_
207	*	_	CONJ	CC	_	214	amod	_	_
208	22%	_	ADJ	JJ	_	214	amod	_	_
209	*	_	CONJ	CC	_	214	amod	_	_
210	50%	_	ADJ	JJ	_	214	amod	_	_
211	*	_	NUM	CD	_	214	amod	_	_
212	16%	_	ADJ	JJ	_	214	amod	_	_
213	Ketoconazole	_	NOUN	NN	_	214	compound	_	_
214	200mgBID	_	NOUN	NN	_	202	dep	_	_
215	for	_	ADP	IN	_	224	case	_	_
216	7days	_	ADJ	JJ	_	224	amod	_	_
217	80mg	_	ADJ	JJ	_	224	amod	_	_
218	*	_	NUM	CD	_	224	amod	_	_
219	2%	_	ADJ	JJ	_	224	amod	_	_
220	*	_	CONJ	CC	_	224	nummod	_	_
221	5%	_	ADJ	JJ	_	224	amod	_	_
222	Fluconazole	_	NOUN	NN	_	224	compound	_	_
223	200mg	_	ADJ	JJ	_	224	amod	_	_
224	QD	_	NOUN	NN	_	214	nmod	_	_
225	for	_	ADP	IN	_	233	case	_	_
226	11days	_	ADJ	JJ	_	233	amod	_	_
227	80mg	_	ADJ	JJ	_	233	amod	_	_
228	*	_	CONJ	CC	_	233	amod	_	_
229	14%	_	ADJ	JJ	_	233	amod	_	_
230	*	_	NUM	CD	_	233	amod	_	_
231	9%	_	ADJ	JJ	_	233	amod	_	_
232	Erythromycin	_	NOUN	NN	_	233	compound	_	_
233	500mgQID	_	NOUN	NN	_	224	nmod	_	_
234	for	_	ADP	IN	_	242	case	_	_
235	7days	_	NOUN	NN	_	242	compound	_	_
236	80mg	_	ADJ	JJ	_	242	compound	_	_
237	*	_	ADJ	JJ	_	242	compound	_	_
238	20%	_	ADJ	JJ	_	242	compound	_	_
239	*	_	CONJ	CC	_	242	compound	_	_
240	31%	_	ADJ	JJ	_	242	compound	_	_
241	Table	_	ADJ	JJ	_	242	compound	_	_
242	5	_	NUM	CD	_	233	nmod	_	_

#	CRESTOR	6056
1	Effect	_	NOUN	NN	_	31	nsubj	_	_
2	of	_	ADP	IN	_	4	case	_	_
3	DRUG	_	NOUN	NN	_	4	compound	_	_
4	Coadministration	_	NOUN	NN	_	1	nmod	_	_
5	on	_	ADP	IN	_	7	case	_	_
6	Systemic	_	ADJ	JJ	_	7	amod	_	_
7	Exposure	_	NOUN	NN	_	1	nmod	_	_
8	To	_	PRT	TO	_	10	case	_	_
9	Other	_	ADJ	JJ	_	10	amod	_	_
10	Drugs	_	NOUN	NNS	_	7	nmod	_	_
11	DRUG	_	NOUN	NN	_	16	compound	_	_
12	Dosage	_	NOUN	NN	_	16	compound	_	_
13	Regimen	_	NOUN	NN	_	16	compound	_	_
14	Coadministered	_	ADJ	JJ	_	16	amod	_	_
15	Drug	_	NOUN	NN	_	16	compound	_	_
16	Name	_	NOUN	NN	_	10	dep	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	Dose	_	NOUN	NN	_	19	compound	_	_
19	Change	_	NOUN	NN	_	16	conj	_	_
20	in	_	ADP	IN	_	22	case	_	_
21	AUC	_	NOUN	NN	_	22	compound	_	_
22	Change	_	NOUN	NN	_	10	nmod	_	_
23	in	_	ADP	IN	_	26	case	_	_
24	Cmax	_	NOUN	NN	_	26	compound	_	_
25	40mg	_	ADJ	JJ	_	26	amod	_	_
26	QD	_	NOUN	NN	_	22	nmod	_	_
27	for	_	ADP	IN	_	29	case	_	_
28	10	_	NUM	CD	_	29	nummod	_	_
29	days	_	NOUN	NNS	_	22	nmod	_	_
30	WarfarinClinically	_	ADV	RB	_	31	advmod	_	_
31	significant	_	ADJ	JJ	_	0	root	_	_
32	pharmacodynamic	_	ADJ	JJ	_	33	amod	_	_
33	effects	_	NOUN	NNS	_	34	compound	_	_
34	QD	_	NOUN	NN	_	31	dobj	_	_
35	for	_	ADP	IN	_	44	case	_	_
36	21	_	NUM	CD	_	44	nummod	_	_
37	Days	_	NOUN	NNS	_	44	compound	_	_
38	EE	_	NOUN	NN	_	44	compound	_	_
39	*	_	CONJ	CC	_	44	nummod	_	_
40	26%	_	ADJ	JJ	_	44	amod	_	_
41	NG	_	NOUN	NN	_	44	compound	_	_
42	*	_	CONJ	CC	_	44	nummod	_	_
43	34%	_	ADJ	JJ	_	44	amod	_	_
44	EE	_	NOUN	NN	_	34	nmod	_	_
45	*	_	CONJ	CC	_	50	nummod	_	_
46	25%	_	ADJ	JJ	_	50	amod	_	_
47	NG	_	NOUN	NN	_	50	compound	_	_
48	*	_	NUM	CD	_	50	nummod	_	_
49	23%	_	ADJ	JJ	_	50	amod	_	_
50	EE	_	NOUN	NN	_	44	dep	_	_
51	=	_	ADJ	JJ	_	53	amod	_	_
52	ethinyl	_	NOUN	NN	_	53	amod	_	_
53	estradiol	_	NOUN	NN	_	50	dep	_	_
54	,	_	.	,	_	31	punct	_	_
55	NG	_	NOUN	NN	_	56	nsubj	_	_
56	=	_	ADJ	JJ	_	31	dep	_	_
57	norgestrel	_	NOUN	NN	_	56	dobj	_	_

#	Celexa	807
1	Serotonergic	_	ADJ	JJ	_	2	amod	_	_
2	Drugs	_	NOUN	NNS	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	See	_	VERB	VBP	_	5	amod	_	_
5	CONTRAINDICATIONS	_	NOUN	NN	_	2	dep	_	_
6	,	_	.	,	_	5	punct	_	_
7	WARNINGS	_	NOUN	NN	_	5	conj	_	_
8	,	_	.	,	_	5	punct	_	_
9	and	_	CONJ	CC	_	5	cc	_	_
10	DOSAGE	_	NOUN	NN	_	5	conj	_	_
11	AND	_	CONJ	CC	_	10	cc	_	_
12	ADMINISTRATION	_	NOUN	NN	_	10	conj	_	_

#	Celexa	808
1	Triptans	_	NOUN	NNS	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	There	_	DET	EX	_	8	nsubj	_	_
4	have	_	VERB	VBP	_	8	aux	_	_
5	been	_	VERB	VBN	_	8	cop	_	_
6	rare	_	ADJ	JJ	_	8	amod	_	_
7	postmarketing	_	ADJ	JJ	_	8	amod	_	_
8	reports	_	NOUN	NNS	_	1	dep	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	serotonin	_	NOUN	NN	_	11	compound	_	_
11	syndrome	_	NOUN	NN	_	8	nmod	_	_
12	with	_	ADP	IN	_	13	case	_	_
13	use	_	NOUN	NN	_	8	nmod	_	_
14	of	_	ADP	IN	_	16	case	_	_
15	an	_	DET	DT	_	16	det	_	_
16	SSRI	_	NOUN	NN	_	13	nmod	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	a	_	DET	DT	_	19	det	_	_
19	triptan	_	NOUN	NN	_	16	conj	_	_

#	Celexa	809
1	If	_	ADP	IN	_	3	case	_	_
2	concomitant	_	ADJ	JJ	_	3	amod	_	_
3	treatment	_	NOUN	NN	_	11	nsubjpass	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	with	_	ADP	IN	_	8	case	_	_
7	a	_	DET	DT	_	8	det	_	_
8	triptan	_	NOUN	NN	_	3	nmod	_	_
9	is	_	VERB	VBZ	_	11	auxpass	_	_
10	clinically	_	ADV	RB	_	11	advmod	_	_
11	warranted	_	VERB	VBN	_	19	advcl	_	_
12	,	_	.	,	_	19	punct	_	_
13	careful	_	ADJ	JJ	_	14	amod	_	_
14	observation	_	NOUN	NN	_	19	nsubjpass	_	_
15	of	_	ADP	IN	_	17	case	_	_
16	the	_	DET	DT	_	17	det	_	_
17	patient	_	NOUN	NN	_	14	nmod	_	_
18	is	_	VERB	VBZ	_	19	auxpass	_	_
19	advised	_	VERB	VBN	_	0	root	_	_
20	,	_	.	,	_	19	punct	_	_
21	particularly	_	ADV	RB	_	23	advmod	_	_
22	during	_	ADP	IN	_	23	case	_	_
23	treatment	_	NOUN	NN	_	19	nmod	_	_
24	initiation	_	NOUN	NN	_	23	dep	_	_
25	and	_	CONJ	CC	_	24	cc	_	_
26	dose	_	NOUN	NN	_	24	conj	_	_
27	increases	_	VERB	VBZ	_	19	root	_	_

#	Celexa	810
1	CNS	_	NOUN	NN	_	2	compound	_	_
2	Drugs	_	NOUN	NNS	_	3	nsubj	_	_
3	Given	_	VERB	VBP	_	0	root	_	_
4	the	_	DET	DT	_	7	det	_	_
5	primary	_	ADJ	JJ	_	7	amod	_	_
6	CNS	_	NOUN	NN	_	7	compound	_	_
7	effects	_	NOUN	NNS	_	3	dobj	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	,	_	.	,	_	3	punct	_	_
11	caution	_	NOUN	NN	_	14	nsubjpass	_	_
12	should	_	VERB	MD	_	14	aux	_	_
13	be	_	VERB	VB	_	14	auxpass	_	_
14	used	_	VERB	VBN	_	3	parataxis	_	_
15	when	_	ADV	WRB	_	18	advmod	_	_
16	it	_	PRON	PRP	_	18	nsubjpass	_	_
17	is	_	VERB	VBZ	_	18	auxpass	_	_
18	taken	_	VERB	VBN	_	14	advcl	_	_
19	in	_	ADP	IN	_	20	case	_	_
20	combination	_	NOUN	NN	_	18	nmod	_	_
21	with	_	ADP	IN	_	25	case	_	_
22	other	_	ADJ	JJ	_	25	amod	_	_
23	centrally	_	ADV	RB	_	24	advmod	_	_
24	acting	_	VERB	VBG	_	25	amod	_	_
25	drugs	_	NOUN	NNS	_	20	nmod	_	_

#	Celexa	811
1	Alcohol	_	NOUN	NN	_	36	nsubjpass	_	_
2	Although	_	ADP	IN	_	6	mark	_	_
3	DRUG	_	NOUN	NN	_	6	nsubj	_	_
4	did	_	VERB	VBD	_	6	aux	_	_
5	not	_	ADV	RB	_	6	neg	_	_
6	potentiate	_	VERB	VB	_	1	acl:relcl	_	_
7	the	_	DET	DT	_	11	det	_	_
8	cognitive	_	ADJ	JJ	_	11	amod	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	motor	_	NOUN	NN	_	8	conj	_	_
11	effects	_	NOUN	NNS	_	6	dobj	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	alcohol	_	NOUN	NN	_	11	nmod	_	_
14	in	_	ADP	IN	_	17	case	_	_
15	a	_	DET	DT	_	17	det	_	_
16	clinical	_	ADJ	JJ	_	17	amod	_	_
17	trial	_	NOUN	NN	_	11	nmod	_	_
18	,	_	.	,	_	1	punct	_	_
19	as	_	ADP	IN	_	23	case	_	_
20	with	_	ADP	IN	_	23	case	_	_
21	other	_	ADJ	JJ	_	23	amod	_	_
22	psychotropic	_	ADJ	JJ	_	23	amod	_	_
23	medications	_	NOUN	NNS	_	1	nmod	_	_
24	,	_	.	,	_	36	punct	_	_
25	the	_	DET	DT	_	26	det	_	_
26	use	_	NOUN	NN	_	36	nsubjpass	_	_
27	of	_	ADP	IN	_	28	case	_	_
28	alcohol	_	NOUN	NN	_	26	nmod	_	_
29	by	_	ADP	IN	_	31	case	_	_
30	depressed	_	VERB	VBN	_	31	amod	_	_
31	patients	_	NOUN	NNS	_	26	nmod	_	_
32	taking	_	VERB	VBG	_	31	acl	_	_
33	DRUG	_	NOUN	NN	_	32	dobj	_	_
34	is	_	VERB	VBZ	_	36	auxpass	_	_
35	not	_	ADV	RB	_	36	neg	_	_
36	recommended	_	VERB	VBN	_	0	root	_	_

#	Celexa	812
1	Monoamine	_	NOUN	NN	_	3	compound	_	_
2	Oxidase	_	NOUN	NN	_	3	compound	_	_
3	Inhibitors	_	NOUN	NNS	_	5	nsubj	_	_
4	MAOIs	_	NOUN	NNS	_	3	dep	_	_
5	See	_	VERB	VBP	_	0	root	_	_
6	CONTRAINDICATIONS	_	NOUN	NN	_	5	dobj	_	_
7	,	_	.	,	_	6	punct	_	_
8	WARNINGS	_	NOUN	NN	_	6	conj	_	_
9	and	_	CONJ	CC	_	6	cc	_	_
10	DOSAGE	_	NOUN	NN	_	6	conj	_	_
11	AND	_	CONJ	CC	_	10	cc	_	_
12	ADMINISTRATION	_	NOUN	NN	_	10	conj	_	_

#	Celexa	813
1	Drugs	_	NOUN	NNS	_	0	root	_	_
2	That	_	DET	WDT	_	3	nsubj	_	_
3	Interfere	_	VERB	VBP	_	1	acl:relcl	_	_
4	With	_	ADP	IN	_	6	case	_	_
5	Hemostasis	_	NOUN	NN	_	6	compound	_	_
6	NSAIDs	_	NOUN	NNS	_	3	nmod	_	_
7	,	_	.	,	_	6	punct	_	_
8	Aspirin	_	NOUN	NN	_	6	conj	_	_
9	,	_	.	,	_	6	punct	_	_
10	Warfarin	_	NOUN	NN	_	6	appos	_	_
11	,	_	.	,	_	6	punct	_	_
12	etc	_	NOUN	NN	_	6	root	_	_

#	Celexa	815
1	Epidemiological	_	ADJ	JJ	_	2	amod	_	_
2	studies	_	NOUN	NNS	_	0	root	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	the	_	DET	DT	_	6	det	_	_
5	case	_	NOUN	NN	_	6	compound	_	_
6	control	_	NOUN	NN	_	2	nmod	_	_
7	and	_	CONJ	CC	_	2	cc	_	_
8	cohort	_	NOUN	NN	_	2	conj	_	_
9	design	_	NOUN	NN	_	8	dobj	_	_
10	that	_	DET	WDT	_	12	nsubj	_	_
11	have	_	VERB	VBP	_	12	aux	_	_
12	demonstrated	_	VERB	VBN	_	9	dep	_	_
13	an	_	DET	DT	_	14	det	_	_
14	association	_	NOUN	NN	_	12	dobj	_	_
15	between	_	ADP	IN	_	16	case	_	_
16	use	_	NOUN	NN	_	14	nmod	_	_
17	of	_	ADP	IN	_	19	case	_	_
18	psychotropic	_	ADJ	JJ	_	19	amod	_	_
19	drugs	_	NOUN	NNS	_	16	nmod	_	_
20	that	_	DET	WDT	_	21	nsubj	_	_
21	interfere	_	VERB	VBP	_	19	acl:relcl	_	_
22	with	_	ADP	IN	_	24	case	_	_
23	serotonin	_	NOUN	NN	_	24	compound	_	_
24	reuptake	_	NOUN	NN	_	21	nmod	_	_
25	and	_	CONJ	CC	_	21	cc	_	_
26	the	_	DET	DT	_	27	det	_	_
27	occurrence	_	NOUN	NN	_	34	nsubj	_	_
28	of	_	ADP	IN	_	31	case	_	_
29	upper	_	VERB	VBG	_	31	amod	_	_
30	gastrointestinal	_	ADJ	JJ	_	31	amod	_	_
31	bleeding	_	NOUN	NN	_	27	nmod	_	_
32	have	_	VERB	MD	_	34	aux	_	_
33	also	_	ADV	RB	_	34	advmod	_	_
34	shown	_	VERB	VBN	_	21	conj	_	_
35	that	_	ADP	IN	_	44	mark	_	_
36	concurrent	_	ADJ	JJ	_	37	amod	_	_
37	use	_	NOUN	NN	_	44	nsubj	_	_
38	of	_	ADP	IN	_	40	case	_	_
39	an	_	DET	DT	_	40	det	_	_
40	NSAID	_	NOUN	NN	_	37	nmod	_	_
41	or	_	CONJ	CC	_	40	cc	_	_
42	aspirin	_	NOUN	NN	_	40	conj	_	_
43	may	_	VERB	MD	_	44	aux	_	_
44	potentiate	_	VERB	VB	_	34	ccomp	_	_
45	this	_	DET	DT	_	46	det	_	_
46	risk	_	NOUN	NN	_	44	dobj	_	_
47	of	_	ADP	IN	_	48	mark	_	_
48	bleeding	_	VERB	VBG	_	46	nmod	_	_

#	Celexa	816
1	Altered	_	VERB	VBN	_	3	amod	_	_
2	anticoagulant	_	ADJ	JJ	_	3	amod	_	_
3	effects	_	NOUN	NNS	_	11	nsubjpass	_	_
4	,	_	.	,	_	3	punct	_	_
5	including	_	VERB	VBG	_	7	case	_	_
6	increased	_	VERB	VBN	_	7	amod	_	_
7	bleeding	_	NOUN	NN	_	3	nmod	_	_
8	,	_	.	,	_	3	punct	_	_
9	have	_	VERB	VBP	_	11	aux	_	_
10	been	_	VERB	VBN	_	11	auxpass	_	_
11	reported	_	VERB	VBN	_	0	root	_	_
12	when	_	ADV	WRB	_	17	advmod	_	_
13	SSRIs	_	NOUN	NNS	_	17	nsubjpass	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	SNRIs	_	NOUN	NNS	_	13	conj	_	_
16	are	_	VERB	VBP	_	17	auxpass	_	_
17	coadministered	_	VERB	VBN	_	11	advcl	_	_
18	with	_	ADP	IN	_	19	case	_	_
19	warfarin	_	NOUN	NN	_	17	nmod	_	_

#	Celexa	817
1	Patients	_	NOUN	NNS	_	8	nsubjpass	_	_
2	receiving	_	VERB	VBG	_	1	acl	_	_
3	warfarin	_	NOUN	NN	_	4	compound	_	_
4	therapy	_	NOUN	NN	_	2	dobj	_	_
5	should	_	VERB	MD	_	8	aux	_	_
6	be	_	VERB	VB	_	8	auxpass	_	_
7	carefully	_	ADV	RB	_	8	advmod	_	_
8	monitored	_	VERB	VBN	_	0	root	_	_
9	when	_	ADV	WRB	_	12	advmod	_	_
10	DRUG	_	NOUN	NN	_	12	nsubjpass	_	_
11	is	_	VERB	VBZ	_	12	auxpass	_	_
12	initiated	_	VERB	VBN	_	8	ccomp	_	_
13	or	_	CONJ	CC	_	12	cc	_	_
14	discontinued	_	VERB	VBN	_	12	conj	_	_

#	Celexa	818
1	Cimetidine	_	NOUN	NN	_	16	nsubj	_	_
2	In	_	ADP	IN	_	3	case	_	_
3	subjects	_	NOUN	NNS	_	1	nmod	_	_
4	who	_	DET	WDT	_	6	nsubj	_	_
5	had	_	VERB	MD	_	6	aux	_	_
6	received	_	VERB	VBN	_	3	acl:relcl	_	_
7	21	_	NUM	CD	_	8	nummod	_	_
8	days	_	NOUN	NNS	_	6	dobj	_	_
9	of	_	ADP	IN	_	14	case	_	_
10	40	_	NUM	CD	_	11	nummod	_	_
11	mg	_	NOUN	NN	_	14	compound	_	_
12	/	_	.	:	_	14	punct	_	_
13	day	_	NOUN	NN	_	14	compound	_	_
14	DRUG	_	NOUN	NN	_	8	nmod	_	_
15	,	_	.	,	_	1	punct	_	_
16	combined	_	VERB	VBN	_	0	root	_	_
17	administration	_	NOUN	NN	_	16	dobj	_	_
18	of	_	ADP	IN	_	20	case	_	_
19	400	_	NUM	CD	_	20	nummod	_	_
20	mg	_	NOUN	NN	_	17	nmod	_	_
21	twice	_	ADV	WRB	_	28	advmod	_	_
22	a	_	DET	DT	_	24	det	_	_
23	day	_	NOUN	NN	_	24	compound	_	_
24	cimetidine	_	NOUN	NN	_	28	nsubj	_	_
25	for	_	ADP	IN	_	27	case	_	_
26	8	_	NUM	CD	_	27	nummod	_	_
27	days	_	NOUN	NNS	_	24	nmod	_	_
28	resulted	_	VERB	VBD	_	16	advcl	_	_
29	in	_	ADP	IN	_	31	case	_	_
30	an	_	DET	DT	_	31	det	_	_
31	increase	_	NOUN	NN	_	28	nmod	_	_
32	in	_	ADP	IN	_	34	case	_	_
33	DRUG	_	NOUN	NN	_	34	compound	_	_
34	AUC	_	NOUN	NN	_	31	nmod	_	_
35	and	_	CONJ	CC	_	34	cc	_	_
36	Cmax	_	NOUN	NN	_	34	conj	_	_
37	of	_	ADP	IN	_	38	case	_	_
38	43%	_	NOUN	NN	_	34	nmod	_	_
39	and	_	CONJ	CC	_	38	cc	_	_
40	39%	_	NOUN	NN	_	38	conj	_	_
41	,	_	.	,	_	16	punct	_	_
42	respectively	_	ADV	RB	_	16	advmod	_	_

#	Celexa	819
1	DRUG	_	NOUN	NN	_	3	compound	_	_
2	20	_	NUM	CD	_	3	nummod	_	_
3	mg	_	NOUN	NN	_	0	root	_	_
4	/	_	.	:	_	3	punct	_	_
5	day	_	NOUN	NN	_	10	nsubj	_	_
6	is	_	VERB	VBZ	_	10	cop	_	_
7	the	_	DET	DT	_	10	det	_	_
8	maximum	_	NOUN	NN	_	10	compound	_	_
9	recommended	_	VERB	VBN	_	10	amod	_	_
10	dose	_	NOUN	NN	_	3	dep	_	_
11	for	_	ADP	IN	_	12	case	_	_
12	patients	_	NOUN	NNS	_	10	nmod	_	_
13	taking	_	VERB	VBG	_	12	acl	_	_
14	concomitant	_	ADJ	JJ	_	15	amod	_	_
15	cimetidine	_	NOUN	NN	_	13	dobj	_	_
16	because	_	ADP	IN	_	19	case	_	_
17	of	_	ADP	IN	_	19	case	_	_
18	the	_	DET	DT	_	19	det	_	_
19	risk	_	NOUN	NN	_	10	nmod	_	_
20	of	_	ADP	IN	_	22	case	_	_
21	QT	_	NOUN	NN	_	22	compound	_	_
22	prolongation	_	NOUN	NN	_	19	nmod	_	_

#	Celexa	820
1	Digoxin	_	NOUN	NN	_	0	root	_	_
2	In	_	ADP	IN	_	3	case	_	_
3	subjects	_	NOUN	NNS	_	1	nmod	_	_
4	who	_	DET	WDT	_	6	nsubj	_	_
5	had	_	VERB	MD	_	6	aux	_	_
6	received	_	VERB	VBN	_	3	acl:relcl	_	_
7	21	_	NUM	CD	_	8	nummod	_	_
8	days	_	NOUN	NNS	_	6	dobj	_	_
9	of	_	ADP	IN	_	14	case	_	_
10	40	_	NUM	CD	_	11	nummod	_	_
11	mg	_	NOUN	NN	_	14	compound	_	_
12	/	_	.	:	_	14	punct	_	_
13	day	_	NOUN	NN	_	14	compound	_	_
14	DRUG	_	NOUN	NN	_	8	nmod	_	_
15	,	_	.	,	_	1	punct	_	_
16	combined	_	VERB	VBN	_	17	amod	_	_
17	administration	_	NOUN	NN	_	30	nsubj	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	DRUG	_	NOUN	NN	_	17	nmod	_	_
20	and	_	CONJ	CC	_	19	cc	_	_
21	digoxin	_	NOUN	NN	_	23	compound	_	_
22	single	_	ADJ	JJ	_	23	amod	_	_
23	dose	_	NOUN	NN	_	19	conj	_	_
24	of	_	ADP	IN	_	26	case	_	_
25	1	_	NUM	CD	_	26	nummod	_	_
26	mg	_	NOUN	NN	_	19	nmod	_	_
27	did	_	VERB	VBD	_	30	aux	_	_
28	not	_	ADV	RB	_	30	neg	_	_
29	significantly	_	ADV	RB	_	30	advmod	_	_
30	affect	_	VERB	VB	_	1	dep	_	_
31	the	_	DET	DT	_	32	det	_	_
32	pharmacokinetics	_	NOUN	NNS	_	30	dobj	_	_
33	of	_	ADP	IN	_	35	case	_	_
34	either	_	CONJ	CC	_	35	cc:preconj	_	_
35	DRUG	_	NOUN	NN	_	32	nmod	_	_
36	or	_	CONJ	CC	_	35	cc	_	_
37	digoxin	_	NOUN	NN	_	35	conj	_	_

#	Celexa	821
1	Lithium	_	NOUN	NN	_	2	compound	_	_
2	Coadministration	_	NOUN	NN	_	0	root	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	DRUG	_	NOUN	NN	_	6	compound	_	_
5	40	_	NUM	CD	_	6	nummod	_	_
6	mg	_	NOUN	NN	_	2	nmod	_	_
7	/	_	.	:	_	2	punct	_	_
8	day	_	NOUN	NN	_	2	dep	_	_
9	for	_	ADP	IN	_	11	case	_	_
10	10	_	NUM	CD	_	11	nummod	_	_
11	days	_	NOUN	NNS	_	8	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	lithium	_	NOUN	NN	_	15	compound	_	_
14	30	_	NUM	CD	_	15	nummod	_	_
15	mmol	_	NOUN	NN	_	11	conj	_	_
16	/	_	.	:	_	2	punct	_	_
17	day	_	NOUN	NN	_	21	nsubj	_	_
18	for	_	ADP	IN	_	20	case	_	_
19	5	_	NUM	CD	_	20	nummod	_	_
20	days	_	NOUN	NNS	_	17	nmod	_	_
21	had	_	VERB	VBD	_	2	dep	_	_
22	no	_	DET	DT	_	24	neg	_	_
23	significant	_	ADJ	JJ	_	24	amod	_	_
24	effect	_	NOUN	NN	_	21	dobj	_	_
25	on	_	ADP	IN	_	27	case	_	_
26	the	_	DET	DT	_	27	det	_	_
27	pharmacokinetics	_	NOUN	NNS	_	24	nmod	_	_
28	of	_	ADP	IN	_	29	case	_	_
29	DRUG	_	NOUN	NN	_	27	nmod	_	_
30	or	_	CONJ	CC	_	29	cc	_	_
31	lithium	_	NOUN	NN	_	29	conj	_	_

#	Celexa	822
1	Nevertheless	_	ADV	RB	_	8	advmod	_	_
2	,	_	.	,	_	8	punct	_	_
3	plasma	_	NOUN	NN	_	5	compound	_	_
4	lithium	_	NOUN	NN	_	5	compound	_	_
5	levels	_	NOUN	NNS	_	8	nsubjpass	_	_
6	should	_	VERB	MD	_	8	aux	_	_
7	be	_	VERB	VB	_	8	auxpass	_	_
8	monitored	_	VERB	VBN	_	0	root	_	_
9	with	_	ADP	IN	_	11	case	_	_
10	appropriate	_	ADJ	JJ	_	11	amod	_	_
11	adjustment	_	NOUN	NN	_	8	nmod	_	_
12	to	_	PRT	TO	_	15	case	_	_
13	the	_	DET	DT	_	15	det	_	_
14	lithium	_	NOUN	NN	_	15	compound	_	_
15	dose	_	NOUN	NN	_	11	nmod	_	_
16	in	_	ADP	IN	_	17	case	_	_
17	accordance	_	NOUN	NN	_	11	nmod	_	_
18	with	_	ADP	IN	_	21	case	_	_
19	standard	_	ADJ	JJ	_	21	amod	_	_
20	clinical	_	ADJ	JJ	_	21	amod	_	_
21	practice	_	NOUN	NN	_	17	nmod	_	_

#	Celexa	823
1	Because	_	ADP	IN	_	4	mark	_	_
2	lithium	_	NOUN	NN	_	4	nsubj	_	_
3	may	_	VERB	MD	_	4	aux	_	_
4	enhance	_	VERB	VB	_	14	advcl	_	_
5	the	_	DET	DT	_	7	det	_	_
6	serotonergic	_	ADJ	JJ	_	7	amod	_	_
7	effects	_	NOUN	NNS	_	4	dobj	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	,	_	.	,	_	14	punct	_	_
11	caution	_	NOUN	NN	_	14	nsubjpass	_	_
12	should	_	VERB	MD	_	14	aux	_	_
13	be	_	VERB	VB	_	14	auxpass	_	_
14	exercised	_	VERB	VBN	_	0	root	_	_
15	when	_	ADV	WRB	_	20	advmod	_	_
16	DRUG	_	NOUN	NN	_	20	nsubjpass	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	lithium	_	NOUN	NN	_	16	conj	_	_
19	are	_	VERB	VBP	_	20	auxpass	_	_
20	coadministered	_	VERB	VBN	_	14	root	_	_

#	Celexa	824
1	Pimozide	_	NOUN	NN	_	27	nsubjpass	_	_
2	In	_	ADP	IN	_	5	case	_	_
3	a	_	DET	DT	_	5	det	_	_
4	controlled	_	VERB	VBN	_	5	amod	_	_
5	study	_	NOUN	NN	_	1	nmod	_	_
6	,	_	.	,	_	1	punct	_	_
7	a	_	DET	DT	_	9	det	_	_
8	single	_	ADJ	JJ	_	9	amod	_	_
9	dose	_	NOUN	NN	_	1	appos	_	_
10	of	_	ADP	IN	_	13	case	_	_
11	pimozide	_	NOUN	NN	_	13	compound	_	_
12	2	_	NUM	CD	_	13	nummod	_	_
13	mg	_	NOUN	NN	_	9	nmod	_	_
14	co	_	PRT	TO	_	15	mark	_	_
15	administered	_	VERB	VBN	_	9	acl	_	_
16	with	_	ADP	IN	_	19	case	_	_
17	DRUG	_	NOUN	NN	_	19	compound	_	_
18	40	_	NUM	CD	_	19	nummod	_	_
19	mg	_	NOUN	NN	_	15	nmod	_	_
20	given	_	VERB	VBN	_	19	acl	_	_
21	once	_	ADV	RB	_	22	advmod	_	_
22	daily	_	ADV	RB	_	20	advmod	_	_
23	for	_	ADP	IN	_	25	case	_	_
24	11	_	NUM	CD	_	25	nummod	_	_
25	days	_	NOUN	NNS	_	20	nmod	_	_
26	was	_	VERB	VBD	_	27	auxpass	_	_
27	associated	_	VERB	VBN	_	0	root	_	_
28	with	_	ADP	IN	_	31	case	_	_
29	a	_	DET	DT	_	31	det	_	_
30	mean	_	ADJ	JJ	_	31	amod	_	_
31	increase	_	NOUN	NN	_	27	nmod	_	_
32	in	_	ADP	IN	_	34	case	_	_
33	QTc	_	NOUN	NN	_	34	compound	_	_
34	values	_	NOUN	NNS	_	31	nmod	_	_
35	of	_	ADP	IN	_	38	case	_	_
36	approximately	_	ADV	RB	_	37	advmod	_	_
37	10	_	NUM	CD	_	38	nummod	_	_
38	msec	_	NOUN	NN	_	34	nmod	_	_
39	compared	_	VERB	VBN	_	27	xcomp	_	_
40	to	_	PRT	TO	_	41	case	_	_
41	pimozide	_	NOUN	NN	_	39	nmod	_	_
42	given	_	VERB	VBN	_	41	acl	_	_
43	alone	_	ADV	RB	_	42	advmod	_	_

#	Celexa	825
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	did	_	VERB	VBD	_	4	aux	_	_
3	not	_	ADV	RB	_	4	neg	_	_
4	alter	_	VERB	VB	_	0	root	_	_
5	the	_	DET	DT	_	7	det	_	_
6	mean	_	NOUN	NN	_	7	amod	_	_
7	AUC	_	NOUN	NN	_	4	dobj	_	_
8	or	_	CONJ	CC	_	7	cc	_	_
9	Cmax	_	NOUN	NN	_	7	conj	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	pimozide	_	NOUN	NN	_	7	nmod	_	_

#	Celexa	826
1	The	_	DET	DT	_	2	det	_	_
2	mechanism	_	NOUN	NN	_	9	nsubjpass	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	this	_	DET	DT	_	6	det	_	_
5	pharmacodynamic	_	ADJ	JJ	_	6	amod	_	_
6	interaction	_	NOUN	NN	_	2	nmod	_	_
7	is	_	VERB	VBZ	_	9	auxpass	_	_
8	not	_	ADV	RB	_	9	neg	_	_
9	known	_	VERB	VBN	_	0	root	_	_

#	Celexa	827
1	Theophylline	_	NOUN	NN	_	3	compound	_	_
2	Combined	_	ADJ	JJ	_	3	amod	_	_
3	administration	_	NOUN	NN	_	0	root	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	DRUG	_	NOUN	NN	_	7	compound	_	_
6	40	_	NUM	CD	_	7	nummod	_	_
7	mg	_	NOUN	NN	_	3	nmod	_	_
8	/	_	.	:	_	3	punct	_	_
9	day	_	NOUN	NN	_	25	nsubj	_	_
10	for	_	ADP	IN	_	12	case	_	_
11	21	_	NUM	CD	_	12	nummod	_	_
12	days	_	NOUN	NNS	_	9	nmod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	the	_	DET	DT	_	19	det	_	_
15	CYP1A2	_	NOUN	NN	_	19	compound	_	_
16	substrate	_	NOUN	NN	_	19	compound	_	_
17	theophylline	_	NOUN	NN	_	19	compound	_	_
18	single	_	ADJ	JJ	_	19	amod	_	_
19	dose	_	NOUN	NN	_	12	conj	_	_
20	of	_	ADP	IN	_	22	case	_	_
21	300	_	NUM	CD	_	22	nummod	_	_
22	mg	_	NOUN	NN	_	19	nmod	_	_
23	did	_	VERB	VBD	_	25	aux	_	_
24	not	_	ADV	RB	_	25	neg	_	_
25	affect	_	VERB	VB	_	3	dep	_	_
26	the	_	DET	DT	_	27	det	_	_
27	pharmacokinetics	_	NOUN	NNS	_	25	dobj	_	_
28	of	_	ADP	IN	_	29	case	_	_
29	theophylline	_	NOUN	NN	_	27	nmod	_	_

#	Celexa	828
1	The	_	DET	DT	_	2	det	_	_
2	effect	_	NOUN	NN	_	12	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	theophylline	_	NOUN	NN	_	2	nmod	_	_
5	on	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	pharmacokinetics	_	NOUN	NNS	_	2	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	was	_	VERB	VBD	_	12	auxpass	_	_
11	not	_	ADV	RB	_	12	neg	_	_
12	evaluated	_	VERB	VBN	_	0	root	_	_

#	Celexa	829
1	Sumatriptan	_	NOUN	NN	_	7	nsubj	_	_
2	There	_	NUM	CD	_	1	nummod	_	_
3	have	_	VERB	VBP	_	7	aux	_	_
4	been	_	VERB	VBN	_	7	cop	_	_
5	rare	_	ADJ	JJ	_	7	amod	_	_
6	postmarketing	_	VERB	VBG	_	7	amod	_	_
7	reports	_	NOUN	NNS	_	0	root	_	_
8	describing	_	VERB	VBG	_	7	acl	_	_
9	patients	_	NOUN	NNS	_	8	dobj	_	_
10	with	_	ADP	IN	_	11	case	_	_
11	weakness	_	NOUN	NN	_	9	nmod	_	_
12	,	_	.	,	_	11	punct	_	_
13	hyperreflexia	_	NOUN	NN	_	11	conj	_	_
14	,	_	.	,	_	11	punct	_	_
15	and	_	CONJ	CC	_	11	cc	_	_
16	incoordination	_	NOUN	NN	_	11	conj	_	_
17	following	_	ADP	IN	_	19	case	_	_
18	the	_	DET	DT	_	19	det	_	_
19	use	_	NOUN	NN	_	8	nmod	_	_
20	of	_	ADP	IN	_	22	case	_	_
21	a	_	DET	DT	_	22	det	_	_
22	SSRI	_	NOUN	NN	_	19	nmod	_	_
23	and	_	CONJ	CC	_	22	cc	_	_
24	sumatriptan	_	NOUN	NN	_	22	conj	_	_

#	Celexa	830
1	If	_	ADP	IN	_	3	case	_	_
2	concomitant	_	ADJ	JJ	_	3	amod	_	_
3	treatment	_	NOUN	NN	_	22	nsubjpass	_	_
4	with	_	ADP	IN	_	5	case	_	_
5	sumatriptan	_	NOUN	NN	_	3	nmod	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	an	_	DET	DT	_	9	det	_	_
8	SSRI	_	NOUN	NN	_	9	compound	_	_
9	e.g	_	NOUN	NN	_	5	conj	_	_
10	,	_	.	,	_	9	punct	_	_
11	fluoxetine	_	NOUN	NN	_	9	conj	_	_
12	,	_	.	,	_	9	punct	_	_
13	fluvoxamine	_	NOUN	NN	_	9	conj	_	_
14	,	_	.	,	_	9	punct	_	_
15	paroxetine	_	NOUN	NN	_	9	conj	_	_
16	,	_	.	,	_	9	punct	_	_
17	sertraline	_	NOUN	NN	_	9	appos	_	_
18	,	_	.	,	_	9	punct	_	_
19	DRUG	_	NOUN	NN	_	9	appos	_	_
20	is	_	VERB	VBZ	_	22	auxpass	_	_
21	clinically	_	ADV	RB	_	22	advmod	_	_
22	warranted	_	VERB	VBN	_	0	root	_	_
23	,	_	.	,	_	22	punct	_	_
24	appropriate	_	ADJ	JJ	_	25	amod	_	_
25	observation	_	NOUN	NN	_	30	nsubjpass	_	_
26	of	_	ADP	IN	_	28	case	_	_
27	the	_	DET	DT	_	28	det	_	_
28	patient	_	NOUN	NN	_	25	nmod	_	_
29	is	_	VERB	VBZ	_	30	auxpass	_	_
30	advised	_	VERB	VBN	_	22	parataxis	_	_

#	Celexa	831
1	Warfarin	_	NOUN	NN	_	2	compound	_	_
2	Administration	_	NOUN	NN	_	0	root	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	40	_	NUM	CD	_	5	nummod	_	_
5	mg	_	NOUN	NN	_	2	nmod	_	_
6	/	_	.	:	_	2	punct	_	_
7	day	_	NOUN	NN	_	8	compound	_	_
8	DRUG	_	NOUN	NN	_	14	nsubj	_	_
9	for	_	ADP	IN	_	11	case	_	_
10	21	_	NUM	CD	_	11	nummod	_	_
11	days	_	NOUN	NNS	_	8	nmod	_	_
12	did	_	VERB	VBD	_	14	aux	_	_
13	not	_	ADV	RB	_	14	neg	_	_
14	affect	_	VERB	VB	_	2	dep	_	_
15	the	_	DET	DT	_	16	det	_	_
16	pharmacokinetics	_	NOUN	NNS	_	14	dobj	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	warfarin	_	NOUN	NN	_	16	nmod	_	_
19	,	_	.	,	_	18	punct	_	_
20	a	_	DET	DT	_	22	det	_	_
21	CYP3A4	_	NOUN	NN	_	22	compound	_	_
22	substrate	_	NOUN	NN	_	18	appos	_	_

#	Celexa	832
1	Prothrombin	_	NOUN	NN	_	2	compound	_	_
2	time	_	NOUN	NN	_	4	nsubjpass	_	_
3	was	_	VERB	VBD	_	4	auxpass	_	_
4	increased	_	VERB	VBN	_	0	root	_	_
5	by	_	ADP	IN	_	6	case	_	_
6	5%	_	NOUN	NN	_	4	nmod	_	_
7	,	_	.	,	_	6	punct	_	_
8	the	_	DET	DT	_	10	det	_	_
9	clinical	_	ADJ	JJ	_	10	amod	_	_
10	significance	_	NOUN	NN	_	14	nsubj	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	which	_	DET	WDT	_	10	nmod	_	_
13	is	_	VERB	VBZ	_	14	auxpass	_	_
14	unknown	_	ADJ	JJ	_	6	dep	_	_

#	Celexa	833
1	Carbamazepine	_	NOUN	NN	_	3	compound	_	_
2	Combined	_	ADJ	JJ	_	3	amod	_	_
3	administration	_	NOUN	NN	_	0	root	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	DRUG	_	NOUN	NN	_	7	compound	_	_
6	40	_	NUM	CD	_	7	nummod	_	_
7	mg	_	NOUN	NN	_	3	nmod	_	_
8	/	_	.	:	_	3	punct	_	_
9	day	_	NOUN	NN	_	3	dep	_	_
10	for	_	ADP	IN	_	12	case	_	_
11	14	_	NUM	CD	_	12	nummod	_	_
12	days	_	NOUN	NNS	_	9	nmod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	carbamazepine	_	NOUN	NN	_	12	conj	_	_
15	titrated	_	VERB	VBN	_	12	acl	_	_
16	to	_	PRT	TO	_	18	case	_	_
17	400	_	NUM	CD	_	18	nummod	_	_
18	mg	_	NOUN	NN	_	15	nmod	_	_
19	/	_	.	:	_	3	punct	_	_
20	day	_	NOUN	NN	_	27	nsubj	_	_
21	for	_	ADP	IN	_	23	case	_	_
22	35	_	NUM	CD	_	23	nummod	_	_
23	days	_	NOUN	NNS	_	20	nmod	_	_
24	did	_	VERB	VBD	_	27	aux	_	_
25	not	_	ADV	RB	_	27	neg	_	_
26	significantly	_	ADV	RB	_	27	advmod	_	_
27	affect	_	VERB	VB	_	3	dep	_	_
28	the	_	DET	DT	_	29	det	_	_
29	pharmacokinetics	_	NOUN	NNS	_	27	dobj	_	_
30	of	_	ADP	IN	_	31	case	_	_
31	carbamazepine	_	NOUN	NN	_	29	nmod	_	_
32	,	_	.	,	_	31	punct	_	_
33	a	_	DET	DT	_	35	det	_	_
34	CYP3A4	_	NOUN	NN	_	35	compound	_	_
35	substrate	_	NOUN	NN	_	31	appos	_	_

#	Celexa	834
1	Although	_	ADP	IN	_	7	mark	_	_
2	trough	_	VERB	VBP	_	7	aux	_	_
3	DRUG	_	NOUN	NN	_	5	compound	_	_
4	plasma	_	NOUN	NN	_	5	compound	_	_
5	levels	_	NOUN	NNS	_	7	nsubj	_	_
6	were	_	VERB	VBD	_	7	cop	_	_
7	unaffected	_	ADJ	JJ	_	9	advcl	_	_
8	,	_	.	,	_	9	punct	_	_
9	given	_	VERB	VBD	_	0	root	_	_
10	the	_	DET	DT	_	11	det	_	_
11	enzyme	_	NOUN	NN	_	9	dobj	_	_
12	inducing	_	VERB	VBG	_	11	acl	_	_
13	properties	_	NOUN	NNS	_	12	dobj	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	carbamazepine	_	NOUN	NN	_	13	nmod	_	_
16	,	_	.	,	_	9	punct	_	_
17	the	_	DET	DT	_	18	det	_	_
18	possibility	_	NOUN	NN	_	29	nsubjpass	_	_
19	that	_	ADP	IN	_	22	mark	_	_
20	carbamazepine	_	NOUN	NN	_	22	nsubj	_	_
21	might	_	VERB	MD	_	22	aux	_	_
22	increase	_	VERB	VB	_	18	acl:relcl	_	_
23	the	_	DET	DT	_	24	det	_	_
24	clearance	_	NOUN	NN	_	22	dobj	_	_
25	of	_	ADP	IN	_	26	case	_	_
26	DRUG	_	NOUN	NN	_	24	nmod	_	_
27	should	_	VERB	MD	_	29	aux	_	_
28	be	_	VERB	VB	_	29	auxpass	_	_
29	considered	_	VERB	VBN	_	9	parataxis	_	_
30	if	_	ADP	IN	_	35	mark	_	_
31	the	_	DET	DT	_	33	det	_	_
32	two	_	NUM	CD	_	33	nummod	_	_
33	drugs	_	NOUN	NNS	_	35	nsubjpass	_	_
34	are	_	VERB	VBP	_	35	auxpass	_	_
35	coadministered	_	VERB	VBN	_	29	ccomp	_	_

#	Celexa	835
1	Triazolam	_	NOUN	NN	_	3	compound	_	_
2	Combined	_	ADJ	JJ	_	3	amod	_	_
3	administration	_	NOUN	NN	_	0	root	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	titrated	_	VERB	VBN	_	5	acl	_	_
7	to	_	PRT	TO	_	9	case	_	_
8	40	_	NUM	CD	_	9	nummod	_	_
9	mg	_	NOUN	NN	_	6	nmod	_	_
10	/	_	.	:	_	3	punct	_	_
11	day	_	NOUN	NN	_	28	nsubj	_	_
12	for	_	ADP	IN	_	14	case	_	_
13	28	_	NUM	CD	_	14	nummod	_	_
14	days	_	NOUN	NNS	_	11	nmod	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	the	_	DET	DT	_	21	det	_	_
17	CYP3A4	_	NOUN	NN	_	21	compound	_	_
18	substrate	_	NOUN	NN	_	21	compound	_	_
19	triazolam	_	NOUN	NN	_	21	compound	_	_
20	single	_	ADJ	JJ	_	21	amod	_	_
21	dose	_	NOUN	NN	_	14	conj	_	_
22	of	_	ADP	IN	_	24	case	_	_
23	0.25	_	NUM	CD	_	24	nummod	_	_
24	mg	_	NOUN	NN	_	21	nmod	_	_
25	did	_	VERB	VBD	_	28	aux	_	_
26	not	_	ADV	RB	_	28	neg	_	_
27	significantly	_	ADV	RB	_	28	advmod	_	_
28	affect	_	VERB	VB	_	3	dep	_	_
29	the	_	DET	DT	_	30	det	_	_
30	pharmacokinetics	_	NOUN	NNS	_	28	dobj	_	_
31	of	_	ADP	IN	_	33	case	_	_
32	either	_	CONJ	CC	_	33	cc:preconj	_	_
33	DRUG	_	NOUN	NN	_	30	nmod	_	_
34	or	_	CONJ	CC	_	33	cc	_	_
35	triazolam	_	NOUN	NN	_	33	conj	_	_

#	Celexa	836
1	Ketoconazole	_	NOUN	NN	_	3	compound	_	_
2	Combined	_	ADJ	JJ	_	3	amod	_	_
3	administration	_	NOUN	NN	_	12	nsubj	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	DRUG	_	NOUN	NN	_	7	compound	_	_
6	40	_	NUM	CD	_	7	nummod	_	_
7	mg	_	NOUN	NN	_	3	nmod	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	ketoconazole	_	NOUN	NN	_	11	compound	_	_
10	200	_	NUM	CD	_	11	nummod	_	_
11	mg	_	NOUN	NN	_	7	conj	_	_
12	decreased	_	VERB	VBD	_	0	root	_	_
13	the	_	DET	DT	_	14	det	_	_
14	Cmax	_	NOUN	NN	_	12	dobj	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	AUC	_	NOUN	NN	_	14	conj	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	ketoconazole	_	NOUN	NN	_	14	nmod	_	_
19	by	_	ADP	IN	_	20	case	_	_
20	21%	_	NOUN	NN	_	12	nmod	_	_
21	and	_	CONJ	CC	_	20	cc	_	_
22	10%	_	NOUN	NN	_	20	conj	_	_
23	,	_	.	,	_	12	punct	_	_
24	respectively	_	ADV	RB	_	12	advmod	_	_
25	,	_	.	,	_	12	punct	_	_
26	and	_	CONJ	CC	_	12	cc	_	_
27	did	_	VERB	MD	_	30	aux	_	_
28	not	_	ADV	RB	_	30	neg	_	_
29	significantly	_	ADV	RB	_	30	advmod	_	_
30	affect	_	VERB	VB	_	12	conj	_	_
31	the	_	DET	DT	_	32	det	_	_
32	pharmacokinetics	_	NOUN	NNS	_	30	dobj	_	_
33	of	_	ADP	IN	_	34	case	_	_
34	DRUG	_	NOUN	NN	_	32	nmod	_	_

#	Celexa	837
1	CYP2C19	_	NOUN	NN	_	2	compound	_	_
2	Inhibitors	_	NOUN	NNS	_	12	nsubj	_	_
3	DRUG	_	NOUN	NN	_	5	compound	_	_
4	20	_	NUM	CD	_	5	nummod	_	_
5	mg	_	NOUN	NN	_	2	nmod	_	_
6	/	_	.	:	_	5	punct	_	_
7	day	_	NOUN	NN	_	5	dep	_	_
8	is	_	VERB	VBZ	_	12	cop	_	_
9	the	_	DET	DT	_	12	det	_	_
10	maximum	_	NOUN	NN	_	12	compound	_	_
11	recommended	_	VERB	VBN	_	12	amod	_	_
12	dose	_	NOUN	NN	_	0	root	_	_
13	for	_	ADP	IN	_	14	case	_	_
14	patients	_	NOUN	NNS	_	12	nmod	_	_
15	taking	_	VERB	VBG	_	14	acl	_	_
16	concomitant	_	ADJ	JJ	_	18	amod	_	_
17	CYP2C19	_	NOUN	NN	_	18	compound	_	_
18	inhibitors	_	NOUN	NNS	_	15	dobj	_	_
19	because	_	ADP	IN	_	22	case	_	_
20	of	_	ADP	IN	_	22	case	_	_
21	the	_	DET	DT	_	22	det	_	_
22	risk	_	NOUN	NN	_	12	nmod	_	_
23	of	_	ADP	IN	_	25	case	_	_
24	QT	_	NOUN	NN	_	25	compound	_	_
25	prolongation	_	NOUN	NN	_	22	nmod	_	_

#	Celexa	838
1	Metoprolol	_	NOUN	NN	_	2	compound	_	_
2	Administration	_	NOUN	NN	_	0	root	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	40	_	NUM	CD	_	5	nummod	_	_
5	mg	_	NOUN	NN	_	2	nmod	_	_
6	/	_	.	:	_	2	punct	_	_
7	day	_	NOUN	NN	_	8	compound	_	_
8	DRUG	_	NOUN	NN	_	12	nsubj	_	_
9	for	_	ADP	IN	_	11	case	_	_
10	22	_	NUM	CD	_	11	nummod	_	_
11	days	_	NOUN	NNS	_	8	nmod	_	_
12	resulted	_	VERB	VBD	_	2	dep	_	_
13	in	_	ADP	IN	_	17	case	_	_
14	a	_	DET	DT	_	17	det	_	_
15	two	_	NUM	CD	_	16	compound	_	_
16	fold	_	NOUN	NN	_	17	amod	_	_
17	increase	_	NOUN	NN	_	12	nmod	_	_
18	in	_	ADP	IN	_	21	case	_	_
19	the	_	DET	DT	_	21	det	_	_
20	plasma	_	NOUN	NN	_	21	compound	_	_
21	levels	_	NOUN	NNS	_	17	nmod	_	_
22	of	_	ADP	IN	_	27	case	_	_
23	the	_	DET	DT	_	27	det	_	_
24	beta	_	NOUN	NN	_	27	compound	_	_
25	adrenergic	_	ADJ	JJ	_	27	amod	_	_
26	blocker	_	NOUN	NN	_	27	compound	_	_
27	metoprolol	_	NOUN	NN	_	21	nmod	_	_

#	Celexa	839
1	Increased	_	VERB	VBN	_	4	amod	_	_
2	metoprolol	_	NOUN	NN	_	4	compound	_	_
3	plasma	_	NOUN	NN	_	4	compound	_	_
4	levels	_	NOUN	NNS	_	7	nsubjpass	_	_
5	have	_	VERB	VBP	_	7	aux	_	_
6	been	_	VERB	VBN	_	7	auxpass	_	_
7	associated	_	VERB	VBN	_	0	root	_	_
8	with	_	ADP	IN	_	10	case	_	_
9	decreased	_	VERB	VBN	_	10	amod	_	_
10	cardioselectivity	_	NOUN	NN	_	7	nmod	_	_

#	Celexa	840
1	Coadministration	_	NOUN	NN	_	6	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	and	_	CONJ	CC	_	3	cc	_	_
5	metoprolol	_	NOUN	NN	_	3	conj	_	_
6	had	_	VERB	VBD	_	0	root	_	_
7	no	_	DET	DT	_	10	neg	_	_
8	clinically	_	ADV	RB	_	9	advmod	_	_
9	significant	_	ADJ	JJ	_	10	amod	_	_
10	effects	_	NOUN	NNS	_	6	dobj	_	_
11	on	_	ADP	IN	_	13	case	_	_
12	blood	_	NOUN	NN	_	13	compound	_	_
13	pressure	_	NOUN	NN	_	10	nmod	_	_
14	or	_	CONJ	CC	_	13	cc	_	_
15	heart	_	NOUN	NN	_	16	compound	_	_
16	rate	_	NOUN	NN	_	13	conj	_	_

#	Celexa	841
1	Imipramine	_	NOUN	NN	_	10	nsubj	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	Other	_	ADJ	JJ	_	5	amod	_	_
4	Tricyclic	_	ADJ	JJ	_	5	amod	_	_
5	Antidepressants	_	NOUN	NNS	_	1	conj	_	_
6	TCAs	_	NOUN	NNS	_	9	compound	_	_
7	In	_	X	FW	_	9	amod	_	_
8	vitro	_	X	FW	_	7	dep	_	_
9	studies	_	NOUN	NNS	_	1	dep	_	_
10	suggest	_	VERB	VBP	_	0	root	_	_
11	that	_	ADP	IN	_	17	mark	_	_
12	DRUG	_	NOUN	NN	_	17	nsubj	_	_
13	is	_	VERB	VBZ	_	17	cop	_	_
14	a	_	DET	DT	_	17	det	_	_
15	relatively	_	ADV	RB	_	16	advmod	_	_
16	weak	_	ADJ	JJ	_	17	amod	_	_
17	inhibitor	_	NOUN	NN	_	10	ccomp	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	CYP2D6	_	NOUN	NN	_	17	nmod	_	_

#	Celexa	842
1	Coadministration	_	NOUN	NN	_	0	root	_	_
2	of	_	ADP	IN	_	5	case	_	_
3	DRUG	_	NOUN	NN	_	5	compound	_	_
4	40	_	NUM	CD	_	5	nummod	_	_
5	mg	_	NOUN	NN	_	1	nmod	_	_
6	/	_	.	:	_	1	punct	_	_
7	day	_	NOUN	NN	_	29	nsubj	_	_
8	for	_	ADP	IN	_	10	case	_	_
9	10	_	NUM	CD	_	10	nummod	_	_
10	days	_	NOUN	NNS	_	7	nmod	_	_
11	with	_	ADP	IN	_	16	case	_	_
12	the	_	DET	DT	_	16	det	_	_
13	TCA	_	NOUN	NN	_	16	compound	_	_
14	imipramine	_	NOUN	NN	_	16	compound	_	_
15	single	_	ADJ	JJ	_	16	amod	_	_
16	dose	_	NOUN	NN	_	10	nmod	_	_
17	of	_	ADP	IN	_	19	case	_	_
18	100	_	NUM	CD	_	19	nummod	_	_
19	mg	_	NOUN	NN	_	16	nmod	_	_
20	,	_	.	,	_	19	punct	_	_
21	a	_	DET	DT	_	22	det	_	_
22	substrate	_	NOUN	NN	_	19	appos	_	_
23	for	_	ADP	IN	_	24	case	_	_
24	CYP2D6	_	NOUN	NN	_	22	nmod	_	_
25	,	_	.	,	_	7	punct	_	_
26	did	_	VERB	MD	_	29	aux	_	_
27	not	_	ADV	RB	_	29	neg	_	_
28	significantly	_	ADV	RB	_	29	advmod	_	_
29	affect	_	VERB	VB	_	1	dep	_	_
30	the	_	DET	DT	_	32	det	_	_
31	plasma	_	NOUN	NN	_	32	compound	_	_
32	concentrations	_	NOUN	NNS	_	29	dobj	_	_
33	of	_	ADP	IN	_	34	case	_	_
34	imipramine	_	NOUN	NN	_	32	nmod	_	_
35	or	_	CONJ	CC	_	34	cc	_	_
36	DRUG	_	NOUN	NN	_	34	conj	_	_

#	Celexa	843
1	However	_	ADV	RB	_	11	advmod	_	_
2	,	_	.	,	_	11	punct	_	_
3	the	_	DET	DT	_	4	det	_	_
4	concentration	_	NOUN	NN	_	11	nsubjpass	_	_
5	of	_	ADP	IN	_	9	case	_	_
6	the	_	DET	DT	_	9	det	_	_
7	imipramine	_	NOUN	NN	_	9	compound	_	_
8	metabolite	_	NOUN	NN	_	9	compound	_	_
9	desipramine	_	NOUN	NN	_	4	nmod	_	_
10	was	_	VERB	VBD	_	11	auxpass	_	_
11	increased	_	VERB	VBN	_	0	root	_	_
12	by	_	ADP	IN	_	14	case	_	_
13	approximately	_	ADV	RB	_	14	advmod	_	_
14	50%	_	ADJ	JJ	_	11	nmod	_	_

#	Celexa	844
1	The	_	DET	DT	_	3	det	_	_
2	clinical	_	ADJ	JJ	_	3	amod	_	_
3	significance	_	NOUN	NN	_	9	nsubj	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	the	_	DET	DT	_	7	det	_	_
6	desipramine	_	NOUN	NN	_	7	compound	_	_
7	change	_	NOUN	NN	_	3	nmod	_	_
8	is	_	VERB	VBZ	_	9	auxpass	_	_
9	unknown	_	ADJ	JJ	_	0	root	_	_

#	Celexa	845
1	Nevertheless	_	ADV	RB	_	5	advmod	_	_
2	,	_	.	,	_	5	punct	_	_
3	caution	_	NOUN	NN	_	5	nsubjpass	_	_
4	is	_	VERB	VBZ	_	5	auxpass	_	_
5	indicated	_	VERB	VBN	_	0	root	_	_
6	in	_	ADP	IN	_	8	case	_	_
7	the	_	DET	DT	_	8	det	_	_
8	coadministration	_	NOUN	NN	_	5	nmod	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	TCAs	_	NOUN	NNS	_	8	nmod	_	_
11	with	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	8	nmod	_	_

#	Celexa	846
1	Electroconvulsive	_	ADJ	JJ	_	3	amod	_	_
2	Therapy	_	NOUN	NN	_	3	compound	_	_
3	ECT	_	NOUN	NN	_	8	nsubj	_	_
4	There	_	DET	EX	_	3	nummod	_	_
5	are	_	VERB	VBP	_	8	cop	_	_
6	no	_	DET	DT	_	8	neg	_	_
7	clinical	_	ADJ	JJ	_	8	amod	_	_
8	studies	_	NOUN	NNS	_	0	root	_	_
9	of	_	ADP	IN	_	12	case	_	_
10	the	_	DET	DT	_	12	det	_	_
11	combined	_	ADJ	JJ	_	12	amod	_	_
12	use	_	NOUN	NN	_	8	nmod	_	_
13	of	_	ADP	IN	_	16	case	_	_
14	electroconvulsive	_	ADJ	JJ	_	16	amod	_	_
15	therapy	_	NOUN	NN	_	16	compound	_	_
16	ECT	_	NOUN	NN	_	12	nmod	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	DRUG	_	NOUN	NN	_	16	conj	_	_

#	Celexa	847
1	The	_	DET	DT	_	2	det	_	_
2	mechanism	_	NOUN	NN	_	12	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	action	_	NOUN	NN	_	2	nmod	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	DRUG	_	NOUN	NN	_	7	compound	_	_
7	HBr	_	NOUN	NN	_	4	nmod	_	_
8	as	_	ADP	IN	_	10	case	_	_
9	an	_	DET	DT	_	10	det	_	_
10	antidepressant	_	NOUN	NN	_	2	nmod	_	_
11	is	_	VERB	VBZ	_	12	auxpass	_	_
12	presumed	_	VERB	VBN	_	0	root	_	_
13	to	_	PRT	TO	_	15	mark	_	_
14	be	_	VERB	VB	_	15	auxpass	_	_
15	linked	_	VERB	VBN	_	12	xcomp	_	_
16	to	_	PRT	TO	_	17	case	_	_
17	potentiation	_	NOUN	NN	_	15	nmod	_	_
18	of	_	ADP	IN	_	20	case	_	_
19	serotonergic	_	ADJ	JJ	_	20	amod	_	_
20	activity	_	NOUN	NN	_	17	nmod	_	_
21	in	_	ADP	IN	_	26	case	_	_
22	the	_	DET	DT	_	26	det	_	_
23	central	_	ADJ	JJ	_	26	amod	_	_
24	nervous	_	ADJ	JJ	_	26	amod	_	_
25	system	_	NOUN	NN	_	26	compound	_	_
26	CNS	_	NOUN	NN	_	20	nmod	_	_
27	resulting	_	VERB	VBG	_	26	acl	_	_
28	from	_	ADP	IN	_	30	case	_	_
29	its	_	PRON	PRP$	_	30	nmod:poss	_	_
30	inhibition	_	NOUN	NN	_	27	nmod	_	_
31	of	_	ADP	IN	_	34	case	_	_
32	CNS	_	NOUN	NN	_	34	compound	_	_
33	neuronal	_	ADJ	JJ	_	34	amod	_	_
34	reuptake	_	NOUN	NN	_	30	nmod	_	_
35	of	_	ADP	IN	_	38	case	_	_
36	serotonin	_	NOUN	NN	_	38	compound	_	_
37	5	_	NUM	CD	_	38	nummod	_	_
38	HT	_	NOUN	NN	_	34	nmod	_	_

#	Celexa	848
1	In	_	X	FW	_	2	compound	_	_
2	vitro	_	X	FW	_	3	advmod	_	_
3	and	_	CONJ	CC	_	6	amod	_	_
4	in	_	X	FW	_	3	conj	_	_
5	vivo	_	X	FW	_	4	dep	_	_
6	studies	_	NOUN	NNS	_	9	nsubj	_	_
7	in	_	ADP	IN	_	8	case	_	_
8	animals	_	NOUN	NNS	_	6	nmod	_	_
9	suggest	_	VERB	VBP	_	0	root	_	_
10	that	_	ADP	IN	_	19	mark	_	_
11	DRUG	_	NOUN	NN	_	19	nsubj	_	_
12	is	_	VERB	VBZ	_	19	cop	_	_
13	a	_	DET	DT	_	19	det	_	_
14	highly	_	ADV	RB	_	15	advmod	_	_
15	selective	_	ADJ	JJ	_	19	amod	_	_
16	serotonin	_	NOUN	NN	_	19	compound	_	_
17	reuptake	_	NOUN	NN	_	19	compound	_	_
18	inhibitor	_	NOUN	NN	_	19	compound	_	_
19	SSRI	_	NOUN	NN	_	9	ccomp	_	_
20	with	_	ADP	IN	_	22	case	_	_
21	minimal	_	ADJ	JJ	_	22	amod	_	_
22	effects	_	NOUN	NNS	_	19	nmod	_	_
23	on	_	ADP	IN	_	25	case	_	_
24	norepinephrine	_	NOUN	NN	_	25	compound	_	_
25	NE	_	NOUN	NN	_	22	nmod	_	_
26	and	_	CONJ	CC	_	25	cc	_	_
27	dopamine	_	NOUN	NN	_	30	compound	_	_
28	DA	_	NOUN	NN	_	30	compound	_	_
29	neuronal	_	ADJ	JJ	_	30	amod	_	_
30	reuptake	_	NOUN	NN	_	25	conj	_	_

#	Celexa	849
1	Tolerance	_	NOUN	NN	_	11	nsubjpass	_	_
2	to	_	PRT	TO	_	4	case	_	_
3	the	_	DET	DT	_	4	det	_	_
4	inhibition	_	NOUN	NN	_	1	nmod	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	5	_	NUM	CD	_	8	nummod	_	_
7	HT	_	NOUN	NN	_	8	compound	_	_
8	uptake	_	NOUN	NN	_	4	nmod	_	_
9	is	_	VERB	VBZ	_	11	auxpass	_	_
10	not	_	ADV	RB	_	11	neg	_	_
11	induced	_	VERB	VBN	_	0	root	_	_
12	by	_	ADP	IN	_	17	case	_	_
13	long	_	ADJ	JJ	_	17	amod	_	_
14	term	_	NOUN	NN	_	17	compound	_	_
15	14	_	NUM	CD	_	17	nummod	_	_
16	day	_	NOUN	NN	_	17	compound	_	_
17	treatment	_	NOUN	NN	_	11	nmod	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	rats	_	NOUN	NNS	_	17	nmod	_	_
20	with	_	ADP	IN	_	21	case	_	_
21	DRUG	_	NOUN	NN	_	19	nmod	_	_

#	Celexa	850
1	DRUG	_	NOUN	NN	_	5	nsubj	_	_
2	is	_	VERB	VBZ	_	5	cop	_	_
3	a	_	DET	DT	_	5	det	_	_
4	racemic	_	ADJ	JJ	_	5	amod	_	_
5	mixture	_	NOUN	NN	_	0	root	_	_
6	50	_	NUM	CD	_	8	nummod	_	_
7	/	_	.	:	_	8	punct	_	_
8	50	_	NUM	CD	_	5	nummod	_	_
9	,	_	.	,	_	5	punct	_	_
10	and	_	CONJ	CC	_	5	cc	_	_
11	the	_	DET	DT	_	12	det	_	_
12	inhibition	_	NOUN	NN	_	21	nsubj	_	_
13	of	_	ADP	IN	_	16	case	_	_
14	5	_	NUM	CD	_	16	nummod	_	_
15	HT	_	NOUN	NN	_	16	compound	_	_
16	reuptake	_	NOUN	NN	_	12	nmod	_	_
17	by	_	ADP	IN	_	18	case	_	_
18	DRUG	_	NOUN	NN	_	12	nmod	_	_
19	is	_	VERB	VBZ	_	21	cop	_	_
20	primarily	_	ADV	RB	_	21	advmod	_	_
21	due	_	ADJ	JJ	_	5	conj	_	_
22	to	_	PRT	TO	_	25	case	_	_
23	the	_	DET	DT	_	25	det	_	_
24	S	_	NOUN	NN	_	25	compound	_	_
25	enantiomer	_	ADJ	JJ	_	21	nmod	_	_

#	Celexa	851
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	has	_	VERB	VBZ	_	0	root	_	_
3	no	_	NUM	CD	_	7	nummod	_	_
4	or	_	CONJ	CC	_	3	cc	_	_
5	very	_	ADV	RB	_	3	conj	_	_
6	low	_	ADJ	JJ	_	7	amod	_	_
7	affinity	_	NOUN	NN	_	2	dobj	_	_
8	for	_	ADP	IN	_	10	case	_	_
9	5	_	NUM	CD	_	10	nummod	_	_
10	HT1A	_	NOUN	NN	_	7	nmod	_	_
11	,	_	.	,	_	10	punct	_	_
12	5	_	NUM	CD	_	13	nummod	_	_
13	HT2A	_	NOUN	NN	_	10	conj	_	_
14	,	_	.	,	_	10	punct	_	_
15	dopamine	_	NOUN	NN	_	16	compound	_	_
16	D1	_	NOUN	NN	_	10	conj	_	_
17	and	_	CONJ	CC	_	10	cc	_	_
18	D2	_	NOUN	NN	_	10	conj	_	_
19	,	_	.	,	_	10	punct	_	_
20	A1	_	NOUN	NN	_	10	conj	_	_
21	,	_	.	,	_	10	punct	_	_
22	A2	_	NOUN	NN	_	10	conj	_	_
23	,	_	.	,	_	10	punct	_	_
24	and	_	CONJ	CC	_	10	cc	_	_
25	B	_	NOUN	NN	_	26	compound	_	_
26	adrenergic	_	ADJ	JJ	_	10	conj	_	_
27	,	_	.	,	_	10	punct	_	_
28	histamine	_	NOUN	NN	_	29	compound	_	_
29	H1	_	NOUN	NN	_	10	conj	_	_
30	,	_	.	,	_	10	punct	_	_
31	gamma	_	NOUN	NN	_	34	compound	_	_
32	aminobutyric	_	ADJ	JJ	_	34	amod	_	_
33	acid	_	NOUN	NN	_	34	compound	_	_
34	GABA	_	NOUN	NN	_	10	conj	_	_
35	,	_	.	,	_	10	punct	_	_
36	muscarinic	_	ADJ	JJ	_	37	amod	_	_
37	cholinergic	_	ADJ	JJ	_	10	conj	_	_
38	,	_	.	,	_	10	punct	_	_
39	and	_	CONJ	CC	_	10	cc	_	_
40	benzodiazepine	_	NOUN	NN	_	41	compound	_	_
41	receptors	_	NOUN	NNS	_	10	conj	_	_

#	Celexa	852
1	Antagonism	_	NOUN	NN	_	12	nsubjpass	_	_
2	of	_	ADP	IN	_	9	case	_	_
3	muscarinic	_	ADJ	JJ	_	9	amod	_	_
4	,	_	.	,	_	3	punct	_	_
5	histaminergic	_	ADJ	JJ	_	3	conj	_	_
6	,	_	.	,	_	3	punct	_	_
7	and	_	CONJ	CC	_	3	cc	_	_
8	adrenergic	_	ADJ	JJ	_	3	conj	_	_
9	receptors	_	NOUN	NNS	_	1	nmod	_	_
10	has	_	VERB	VBZ	_	12	aux	_	_
11	been	_	VERB	VBN	_	12	auxpass	_	_
12	hypothesized	_	VERB	VBN	_	0	root	_	_
13	to	_	PRT	TO	_	15	mark	_	_
14	be	_	VERB	VB	_	15	auxpass	_	_
15	associated	_	VERB	VBN	_	12	xcomp	_	_
16	with	_	ADP	IN	_	18	case	_	_
17	various	_	ADJ	JJ	_	18	amod	_	_
18	anticholinergic	_	ADJ	JJ	_	15	nmod	_	_
19	,	_	.	,	_	18	punct	_	_
20	sedative	_	ADJ	JJ	_	18	conj	_	_
21	,	_	.	,	_	18	punct	_	_
22	and	_	CONJ	CC	_	18	cc	_	_
23	cardiovascular	_	ADJ	JJ	_	18	conj	_	_
24	effects	_	NOUN	NNS	_	18	dep	_	_
25	of	_	ADP	IN	_	28	case	_	_
26	other	_	ADJ	JJ	_	28	amod	_	_
27	psychotropic	_	ADJ	JJ	_	28	amod	_	_
28	drugs	_	NOUN	NNS	_	18	nmod	_	_

#	Celexa	853
1	The	_	DET	DT	_	6	det	_	_
2	single	_	ADJ	JJ	_	6	amod	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	multiple	_	ADJ	JJ	_	2	conj	_	_
5	dose	_	NOUN	NN	_	6	compound	_	_
6	pharmacokinetics	_	NOUN	NNS	_	10	nsubj	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	are	_	VERB	VBP	_	10	cop	_	_
10	linear	_	ADJ	JJ	_	0	root	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	dose	_	NOUN	NN	_	10	conj	_	_
13	proportional	_	ADJ	JJ	_	12	amod	_	_
14	in	_	ADP	IN	_	17	case	_	_
15	a	_	DET	DT	_	17	det	_	_
16	dose	_	NOUN	NN	_	17	compound	_	_
17	range	_	NOUN	NN	_	13	nmod	_	_
18	of	_	ADP	IN	_	23	case	_	_
19	10	_	NUM	CD	_	23	nummod	_	_
20	60	_	NUM	CD	_	23	nummod	_	_
21	mg	_	NOUN	NN	_	23	compound	_	_
22	/	_	NUM	CD	_	23	compound	_	_
23	day	_	NOUN	NN	_	17	nmod	_	_

#	Celexa	854
1	Biotransformation	_	NOUN	NN	_	6	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	is	_	VERB	VBZ	_	6	cop	_	_
5	mainly	_	ADV	RB	_	6	advmod	_	_
6	hepatic	_	ADJ	JJ	_	0	root	_	_
7	,	_	.	,	_	6	punct	_	_
8	with	_	ADP	IN	_	13	case	_	_
9	a	_	DET	DT	_	13	det	_	_
10	mean	_	ADJ	JJ	_	13	amod	_	_
11	terminal	_	ADJ	JJ	_	13	amod	_	_
12	half	_	ADJ	JJ	_	13	amod	_	_
13	life	_	NOUN	NN	_	6	nmod	_	_
14	of	_	ADP	IN	_	17	case	_	_
15	about	_	ADV	RB	_	16	advmod	_	_
16	35	_	NUM	CD	_	17	nummod	_	_
17	hours	_	NOUN	NNS	_	13	nmod	_	_

#	Celexa	855
1	With	_	ADP	IN	_	4	case	_	_
2	once	_	ADV	RB	_	3	advmod	_	_
3	daily	_	ADV	RB	_	4	advmod	_	_
4	dosing	_	NOUN	NN	_	11	nmod	_	_
5	,	_	.	,	_	11	punct	_	_
6	steady	_	ADJ	JJ	_	9	amod	_	_
7	state	_	NOUN	NN	_	9	compound	_	_
8	plasma	_	NOUN	NN	_	9	compound	_	_
9	concentrations	_	NOUN	NNS	_	11	nsubjpass	_	_
10	are	_	VERB	VBP	_	11	auxpass	_	_
11	achieved	_	VERB	VBN	_	0	root	_	_
12	within	_	ADP	IN	_	15	case	_	_
13	approximately	_	ADV	RB	_	14	advmod	_	_
14	one	_	NUM	CD	_	15	nummod	_	_
15	week	_	NOUN	NN	_	11	nmod	_	_

#	Celexa	856
1	At	_	ADP	IN	_	3	case	_	_
2	steady	_	ADJ	JJ	_	3	amod	_	_
3	state	_	NOUN	NN	_	14	nmod	_	_
4	,	_	.	,	_	14	punct	_	_
5	the	_	DET	DT	_	6	det	_	_
6	extent	_	NOUN	NN	_	14	nsubj	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	accumulation	_	NOUN	NN	_	6	nmod	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	in	_	ADP	IN	_	12	case	_	_
12	plasma	_	NOUN	NN	_	8	nmod	_	_
13	,	_	.	,	_	6	punct	_	_
14	based	_	VERB	VBN	_	0	root	_	_
15	on	_	ADP	IN	_	18	case	_	_
16	the	_	DET	DT	_	18	det	_	_
17	half	_	ADJ	JJ	_	18	amod	_	_
18	life	_	NOUN	NN	_	14	nmod	_	_
19	,	_	.	,	_	14	punct	_	_
20	is	_	VERB	VBZ	_	21	auxpass	_	_
21	expected	_	VERB	VBN	_	14	parataxis	_	_
22	to	_	PRT	TO	_	25	mark	_	_
23	be	_	VERB	VB	_	25	cop	_	_
24	2.5	_	NUM	CD	_	25	nummod	_	_
25	times	_	NOUN	NNS	_	21	nmod	_	_
26	the	_	DET	DT	_	28	det	_	_
27	plasma	_	NOUN	NN	_	28	compound	_	_
28	concentrations	_	NOUN	NNS	_	25	dobj	_	_
29	observed	_	VERB	VBN	_	28	acl	_	_
30	after	_	ADP	IN	_	33	case	_	_
31	a	_	DET	DT	_	33	det	_	_
32	single	_	ADJ	JJ	_	33	amod	_	_
33	dose	_	NOUN	NN	_	29	nmod	_	_

#	Celexa	857
1	Following	_	ADP	IN	_	8	case	_	_
2	a	_	DET	DT	_	8	det	_	_
3	single	_	ADJ	JJ	_	8	amod	_	_
4	oral	_	ADJ	JJ	_	8	amod	_	_
5	dose	_	NOUN	NN	_	8	compound	_	_
6	40	_	NUM	CD	_	8	nummod	_	_
7	mg	_	NOUN	NN	_	8	compound	_	_
8	tablet	_	NOUN	NN	_	15	nmod	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	,	_	.	,	_	15	punct	_	_
12	peak	_	ADJ	JJ	_	14	amod	_	_
13	blood	_	NOUN	NN	_	14	compound	_	_
14	levels	_	NOUN	NNS	_	15	nsubj	_	_
15	occur	_	VERB	VBP	_	0	root	_	_
16	at	_	ADP	IN	_	19	case	_	_
17	about	_	ADV	RB	_	18	advmod	_	_
18	4	_	NUM	CD	_	19	nummod	_	_
19	hours	_	NOUN	NNS	_	15	nmod	_	_

#	Celexa	858
1	The	_	DET	DT	_	3	det	_	_
2	absolute	_	ADJ	JJ	_	3	amod	_	_
3	bioavailability	_	NOUN	NN	_	8	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	was	_	VERB	VBD	_	8	cop	_	_
7	about	_	ADV	RB	_	8	advmod	_	_
8	80%	_	ADJ	JJ	_	0	root	_	_
9	relative	_	ADJ	JJ	_	8	advmod	_	_
10	to	_	PRT	TO	_	13	case	_	_
11	an	_	DET	DT	_	13	det	_	_
12	intravenous	_	ADJ	JJ	_	13	amod	_	_
13	dose	_	NOUN	NN	_	9	nmod	_	_
14	,	_	.	,	_	8	punct	_	_
15	and	_	CONJ	CC	_	8	cc	_	_
16	absorption	_	NOUN	NN	_	19	nsubjpass	_	_
17	is	_	VERB	VBZ	_	19	auxpass	_	_
18	not	_	ADV	RB	_	19	neg	_	_
19	affected	_	VERB	VBN	_	8	conj	_	_
20	by	_	ADP	IN	_	21	case	_	_
21	food	_	NOUN	NN	_	19	nmod	_	_

#	Celexa	859
1	The	_	DET	DT	_	2	det	_	_
2	volume	_	NOUN	NN	_	10	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	distribution	_	NOUN	NN	_	2	nmod	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	is	_	VERB	VBZ	_	10	cop	_	_
8	about	_	ADV	RB	_	10	advmod	_	_
9	12	_	NUM	CD	_	10	nummod	_	_
10	L	_	NOUN	NN	_	0	root	_	_
11	/	_	.	:	_	10	punct	_	_
12	kg	_	NOUN	NN	_	33	nsubj	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	the	_	DET	DT	_	15	det	_	_
15	binding	_	NOUN	NN	_	12	conj	_	_
16	of	_	ADP	IN	_	18	case	_	_
17	DRUG	_	NOUN	NN	_	18	compound	_	_
18	CT	_	NOUN	NN	_	15	nmod	_	_
19	,	_	.	,	_	12	punct	_	_
20	demethyl	_	NOUN	NN	_	22	compound	_	_
21	DRUG	_	NOUN	NN	_	22	compound	_	_
22	DCT	_	NOUN	NN	_	12	conj	_	_
23	and	_	CONJ	CC	_	12	cc	_	_
24	didemethyl	_	ADJ	JJ	_	26	amod	_	_
25	DRUG	_	NOUN	NN	_	26	compound	_	_
26	DDCT	_	NOUN	NN	_	12	conj	_	_
27	to	_	PRT	TO	_	30	case	_	_
28	human	_	ADJ	JJ	_	30	amod	_	_
29	plasma	_	NOUN	NN	_	30	compound	_	_
30	proteins	_	NOUN	NNS	_	26	nmod	_	_
31	is	_	VERB	VBZ	_	33	cop	_	_
32	about	_	ADV	RB	_	33	advmod	_	_
33	80%	_	ADJ	JJ	_	10	dep	_	_

#	Celexa	860
1	Following	_	VERB	VBG	_	3	case	_	_
2	intravenous	_	ADJ	JJ	_	3	amod	_	_
3	administrations	_	NOUN	NNS	_	21	nmod	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	,	_	.	,	_	21	punct	_	_
7	the	_	DET	DT	_	8	det	_	_
8	fraction	_	NOUN	NN	_	21	nsubj	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	drug	_	NOUN	NN	_	8	nmod	_	_
11	recovered	_	VERB	VBN	_	10	acl	_	_
12	in	_	ADP	IN	_	14	case	_	_
13	the	_	DET	DT	_	14	det	_	_
14	urine	_	ADJ	JJ	_	11	nmod	_	_
15	as	_	ADP	IN	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	11	nmod	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	DCT	_	NOUN	NN	_	16	conj	_	_
19	was	_	VERB	VBD	_	21	cop	_	_
20	about	_	ADV	RB	_	21	advmod	_	_
21	10%	_	ADJ	JJ	_	0	root	_	_
22	and	_	CONJ	CC	_	21	cc	_	_
23	5%	_	NOUN	NN	_	21	conj	_	_
24	,	_	.	,	_	21	punct	_	_
25	respectively	_	ADV	RB	_	21	advmod	_	_

#	Celexa	861
1	The	_	DET	DT	_	3	det	_	_
2	systemic	_	ADJ	JJ	_	3	amod	_	_
3	clearance	_	NOUN	NN	_	8	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	was	_	VERB	VBD	_	8	cop	_	_
7	330	_	NUM	CD	_	8	nummod	_	_
8	mL	_	NOUN	NN	_	0	root	_	_
9	/	_	.	:	_	8	punct	_	_
10	min	_	NOUN	NN	_	8	dep	_	_
11	,	_	.	,	_	10	punct	_	_
12	with	_	ADP	IN	_	14	case	_	_
13	approximately	_	ADV	RB	_	14	advmod	_	_
14	20%	_	NOUN	NN	_	10	nmod	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	that	_	DET	WDT	_	14	nmod	_	_
17	due	_	ADJ	JJ	_	16	nmod	_	_
18	to	_	PRT	TO	_	20	case	_	_
19	renal	_	ADJ	JJ	_	20	amod	_	_
20	clearance	_	NOUN	NN	_	17	nmod	_	_

#	Celexa	862
1	DRUG	_	NOUN	NN	_	3	nsubjpass	_	_
2	is	_	VERB	VBZ	_	3	auxpass	_	_
3	metabolized	_	VERB	VBN	_	0	root	_	_
4	to	_	PRT	TO	_	5	mark	_	_
5	demethyl	_	VERB	VB	_	3	xcomp	_	_
6	DRUG	_	NOUN	NN	_	7	compound	_	_
7	DCT	_	NOUN	NN	_	5	dobj	_	_
8	,	_	.	,	_	7	punct	_	_
9	didemethyl	_	ADJ	JJ	_	11	compound	_	_
10	DRUG	_	NOUN	NN	_	11	compound	_	_
11	DDCT	_	NOUN	NN	_	7	conj	_	_
12	,	_	.	,	_	7	punct	_	_
13	DRUG	_	NOUN	NN	_	15	compound	_	_
14	N	_	NOUN	NN	_	15	compound	_	_
15	oxide	_	NOUN	NN	_	7	conj	_	_
16	,	_	.	,	_	7	punct	_	_
17	and	_	CONJ	CC	_	7	cc	_	_
18	a	_	DET	DT	_	22	det	_	_
19	deaminated	_	VERB	VBN	_	22	amod	_	_
20	propionic	_	ADJ	JJ	_	22	amod	_	_
21	acid	_	NOUN	NN	_	22	compound	_	_
22	derivative	_	ADJ	JJ	_	7	root	_	_

#	Celexa	863
1	In	_	ADP	IN	_	2	case	_	_
2	humans	_	NOUN	NNS	_	9	nmod	_	_
3	,	_	.	,	_	9	punct	_	_
4	unchanged	_	ADJ	JJ	_	5	amod	_	_
5	DRUG	_	NOUN	NN	_	9	nsubj	_	_
6	is	_	VERB	VBZ	_	9	cop	_	_
7	the	_	DET	DT	_	9	det	_	_
8	predominant	_	ADJ	JJ	_	9	amod	_	_
9	compound	_	NOUN	NN	_	0	root	_	_
10	in	_	ADP	IN	_	11	case	_	_
11	plasma	_	NOUN	NN	_	9	nmod	_	_

#	Celexa	864
1	At	_	ADP	IN	_	3	case	_	_
2	steady	_	ADJ	JJ	_	3	amod	_	_
3	state	_	NOUN	NN	_	21	nmod	_	_
4	,	_	.	,	_	21	punct	_	_
5	the	_	DET	DT	_	6	det	_	_
6	concentrations	_	NOUN	NNS	_	21	nsubj	_	_
7	of	_	ADP	IN	_	10	case	_	_
8	DRUG	_	NOUN	NN	_	10	nmod:poss	_	_
9	's	_	PRT	POS	_	8	case	_	_
10	metabolites	_	NOUN	NNS	_	6	nmod	_	_
11	,	_	.	,	_	10	punct	_	_
12	DCT	_	NOUN	NN	_	10	appos	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	DDCT	_	NOUN	NN	_	12	conj	_	_
15	,	_	.	,	_	6	punct	_	_
16	in	_	ADP	IN	_	17	case	_	_
17	plasma	_	NOUN	NN	_	6	nmod	_	_
18	are	_	VERB	VBP	_	21	cop	_	_
19	approximately	_	ADV	RB	_	20	advmod	_	_
20	one	_	NUM	CD	_	21	nummod	_	_
21	half	_	NOUN	NN	_	0	root	_	_
22	and	_	CONJ	CC	_	21	cc	_	_
23	one	_	NUM	CD	_	24	nummod	_	_
24	tenth	_	NOUN	NN	_	21	conj	_	_
25	,	_	.	,	_	21	punct	_	_
26	respectively	_	ADV	RB	_	21	advmod	_	_
27	,	_	.	,	_	21	punct	_	_
28	that	_	DET	WDT	_	21	appos	_	_
29	of	_	ADP	IN	_	32	case	_	_
30	the	_	DET	DT	_	32	det	_	_
31	parent	_	NOUN	NN	_	32	compound	_	_
32	drug	_	NOUN	NN	_	28	nmod	_	_

#	Celexa	865
1	In	_	X	FW	_	3	amod	_	_
2	vitro	_	X	FW	_	1	dep	_	_
3	studies	_	NOUN	NNS	_	4	nsubj	_	_
4	show	_	VERB	VBP	_	0	root	_	_
5	that	_	ADP	IN	_	11	mark	_	_
6	DRUG	_	NOUN	NN	_	11	nsubj	_	_
7	is	_	VERB	VBZ	_	11	cop	_	_
8	at	_	ADP	IN	_	9	case	_	_
9	least	_	ADJ	JJS	_	10	nmod:npmod	_	_
10	8	_	NUM	CD	_	11	nummod	_	_
11	times	_	NOUN	NNS	_	4	ccomp	_	_
12	more	_	ADV	RB	_	13	advmod	_	_
13	potent	_	ADJ	JJ	_	11	amod	_	_
14	than	_	ADP	IN	_	16	case	_	_
15	its	_	PRON	PRP$	_	16	nmod:poss	_	_
16	metabolites	_	NOUN	NNS	_	13	nmod	_	_
17	in	_	ADP	IN	_	19	case	_	_
18	the	_	DET	DT	_	19	det	_	_
19	inhibition	_	NOUN	NN	_	16	nmod	_	_
20	of	_	ADP	IN	_	22	case	_	_
21	serotonin	_	NOUN	NN	_	22	compound	_	_
22	reuptake	_	NOUN	NN	_	19	nmod	_	_
23	,	_	.	,	_	11	punct	_	_
24	suggesting	_	VERB	VBG	_	11	acl	_	_
25	that	_	ADP	IN	_	32	mark	_	_
26	the	_	DET	DT	_	27	det	_	_
27	metabolites	_	NOUN	NNS	_	32	nsubj	_	_
28	evaluated	_	VERB	VBN	_	27	acl	_	_
29	do	_	VERB	MD	_	32	aux	_	_
30	not	_	ADV	RB	_	32	neg	_	_
31	likely	_	ADV	RB	_	32	advmod	_	_
32	contribute	_	VERB	VB	_	24	ccomp	_	_
33	significantly	_	ADV	RB	_	32	advmod	_	_
34	to	_	PRT	TO	_	37	case	_	_
35	the	_	DET	DT	_	37	det	_	_
36	antidepressant	_	ADJ	JJ	_	37	amod	_	_
37	actions	_	NOUN	NNS	_	32	nmod	_	_
38	of	_	ADP	IN	_	39	case	_	_
39	DRUG	_	NOUN	NN	_	37	nmod	_	_

#	Celexa	866
1	In	_	X	FW	_	3	amod	_	_
2	vitro	_	X	FW	_	1	dep	_	_
3	studies	_	NOUN	NNS	_	8	nsubj	_	_
4	using	_	VERB	VBG	_	3	acl	_	_
5	human	_	ADJ	JJ	_	7	amod	_	_
6	liver	_	NOUN	NN	_	7	compound	_	_
7	microsomes	_	NOUN	NNS	_	4	dobj	_	_
8	indicated	_	VERB	VBD	_	0	root	_	_
9	that	_	ADP	IN	_	16	mark	_	_
10	CYP3A4	_	NOUN	NN	_	16	nsubj	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	CYP2C19	_	NOUN	NN	_	10	conj	_	_
13	are	_	VERB	VBP	_	16	cop	_	_
14	the	_	DET	DT	_	16	det	_	_
15	primary	_	ADJ	JJ	_	16	amod	_	_
16	isozymes	_	NOUN	NNS	_	8	ccomp	_	_
17	involved	_	VERB	VBN	_	16	acl	_	_
18	in	_	ADP	IN	_	21	case	_	_
19	the	_	DET	DT	_	21	det	_	_
20	N	_	NOUN	NN	_	21	compound	_	_
21	demethylation	_	NOUN	NN	_	17	nmod	_	_
22	of	_	ADP	IN	_	23	case	_	_
23	DRUG	_	NOUN	NN	_	21	nmod	_	_

#	Celexa	867
1	Age	_	VERB	VBG	_	3	amod	_	_
2	DRUG	_	NOUN	NN	_	3	compound	_	_
3	pharmacokinetics	_	NOUN	NNS	_	0	root	_	_
4	in	_	ADP	IN	_	5	case	_	_
5	subjects	_	NOUN	NNS	_	12	nmod	_	_
6	>	_	NUM	CD	_	8	nummod	_	_
7	60	_	NUM	CD	_	8	nummod	_	_
8	years	_	NOUN	NNS	_	12	nsubjpass	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	age	_	NOUN	NN	_	8	nmod	_	_
11	were	_	VERB	VBD	_	12	auxpass	_	_
12	compared	_	VERB	VBN	_	3	acl:relcl	_	_
13	to	_	PRT	TO	_	15	case	_	_
14	younger	_	ADJ	JJ	_	15	amod	_	_
15	subjects	_	NOUN	NNS	_	12	nmod	_	_
16	in	_	ADP	IN	_	20	case	_	_
17	two	_	NUM	CD	_	20	nummod	_	_
18	normal	_	ADJ	JJ	_	20	amod	_	_
19	volunteer	_	ADJ	JJ	_	20	amod	_	_
20	studies	_	NOUN	NNS	_	15	nmod	_	_

#	Celexa	868
1	In	_	ADP	IN	_	5	case	_	_
2	a	_	DET	DT	_	5	det	_	_
3	single	_	ADJ	JJ	_	5	amod	_	_
4	dose	_	NOUN	NN	_	5	compound	_	_
5	study	_	NOUN	NN	_	13	nmod	_	_
6	,	_	.	,	_	13	punct	_	_
7	DRUG	_	NOUN	NN	_	8	compound	_	_
8	AUC	_	NOUN	NN	_	13	nsubjpass	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	half	_	ADJ	JJ	_	11	amod	_	_
11	life	_	NOUN	NN	_	8	conj	_	_
12	were	_	VERB	VBD	_	13	auxpass	_	_
13	increased	_	VERB	VBN	_	0	root	_	_
14	in	_	ADP	IN	_	16	case	_	_
15	the	_	DET	DT	_	16	det	_	_
16	subjects	_	NOUN	NNS	_	13	nmod	_	_
17	>	_	NUM	CD	_	19	nummod	_	_
18	60	_	NUM	CD	_	19	nummod	_	_
19	years	_	NOUN	NNS	_	16	dep	_	_
20	old	_	ADJ	JJ	_	16	amod	_	_
21	by	_	ADP	IN	_	22	case	_	_
22	30%	_	NOUN	NN	_	20	nmod	_	_
23	and	_	CONJ	CC	_	22	cc	_	_
24	50%	_	NOUN	NN	_	22	conj	_	_
25	,	_	.	,	_	13	punct	_	_
26	respectively	_	ADV	RB	_	13	advmod	_	_
27	,	_	.	,	_	13	punct	_	_
28	whereas	_	ADP	IN	_	36	mark	_	_
29	in	_	ADP	IN	_	33	case	_	_
30	a	_	DET	DT	_	33	det	_	_
31	multiple	_	ADJ	JJ	_	33	amod	_	_
32	dose	_	NOUN	NN	_	33	compound	_	_
33	study	_	NOUN	NN	_	36	nmod	_	_
34	they	_	PRON	PRP	_	36	nsubjpass	_	_
35	were	_	VERB	VBD	_	36	auxpass	_	_
36	increased	_	VERB	VBN	_	13	advcl	_	_
37	by	_	ADP	IN	_	38	case	_	_
38	23%	_	NOUN	NN	_	36	nmod	_	_
39	and	_	CONJ	CC	_	38	cc	_	_
40	30%	_	NOUN	NN	_	38	conj	_	_
41	,	_	.	,	_	13	punct	_	_
42	respectively	_	ADV	RB	_	13	advmod	_	_

#	Celexa	869
1	20	_	NUM	CD	_	2	nummod	_	_
2	mg	_	NOUN	NN	_	9	dep	_	_
3	/	_	.	:	_	2	punct	_	_
4	day	_	NOUN	NN	_	9	nsubj	_	_
5	is	_	VERB	VBZ	_	9	cop	_	_
6	the	_	DET	DT	_	9	det	_	_
7	maximum	_	NOUN	NN	_	9	compound	_	_
8	recommended	_	VERB	VBN	_	9	amod	_	_
9	dose	_	NOUN	NN	_	0	root	_	_
10	for	_	ADP	IN	_	11	case	_	_
11	patients	_	NOUN	NNS	_	9	nmod	_	_
12	who	_	DET	WDT	_	14	nsubj	_	_
13	are	_	VERB	VBP	_	14	cop	_	_
14	greater	_	ADJ	JJ	_	11	acl:relcl	_	_
15	than	_	ADP	IN	_	17	case	_	_
16	60	_	NUM	CD	_	17	nummod	_	_
17	years	_	NOUN	NNS	_	14	nmod	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	age	_	NOUN	NN	_	17	nmod	_	_
20	,	_	.	,	_	9	punct	_	_
21	due	_	ADJ	JJ	_	24	case	_	_
22	to	_	PRT	TO	_	21	mwe	_	_
23	the	_	DET	DT	_	24	det	_	_
24	risk	_	NOUN	NN	_	9	nmod	_	_
25	of	_	ADP	IN	_	27	case	_	_
26	QT	_	NOUN	NN	_	27	compound	_	_
27	prolongation	_	NOUN	NN	_	24	nmod	_	_

#	Celexa	870
1	Gender	_	NOUN	NN	_	14	nmod	_	_
2	In	_	ADP	IN	_	5	case	_	_
3	three	_	NUM	CD	_	5	nummod	_	_
4	pharmacokinetic	_	ADJ	JJ	_	5	amod	_	_
5	studies	_	NOUN	NNS	_	1	nmod	_	_
6	total	_	ADJ	JJ	_	7	amod	_	_
7	N=32	_	NOUN	NN	_	5	dep	_	_
8	,	_	.	,	_	14	punct	_	_
9	DRUG	_	NOUN	NN	_	10	compound	_	_
10	AUC	_	NOUN	NN	_	14	nsubj	_	_
11	in	_	ADP	IN	_	12	case	_	_
12	women	_	NOUN	NNS	_	10	nmod	_	_
13	was	_	VERB	VBD	_	14	cop	_	_
14	one	_	NUM	CD	_	0	root	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	a	_	DET	DT	_	17	det	_	_
17	half	_	NOUN	NN	_	14	conj	_	_
18	to	_	PRT	TO	_	20	case	_	_
19	two	_	NUM	CD	_	20	nummod	_	_
20	times	_	NOUN	NNS	_	17	nmod	_	_
21	that	_	DET	WDT	_	20	dep	_	_
22	in	_	ADP	IN	_	23	case	_	_
23	men	_	NOUN	NN	_	21	nmod	_	_

#	Celexa	871
1	This	_	DET	DT	_	2	det	_	_
2	difference	_	NOUN	NN	_	5	nsubjpass	_	_
3	was	_	VERB	VBD	_	5	auxpass	_	_
4	not	_	ADV	RB	_	5	neg	_	_
5	observed	_	VERB	VBN	_	0	root	_	_
6	in	_	ADP	IN	_	10	case	_	_
7	five	_	NUM	CD	_	10	nummod	_	_
8	other	_	ADJ	JJ	_	10	amod	_	_
9	pharmacokinetic	_	ADJ	JJ	_	10	amod	_	_
10	studies	_	NOUN	NNS	_	5	nmod	_	_
11	total	_	ADJ	JJ	_	12	amod	_	_
12	N=114	_	NOUN	NN	_	10	dep	_	_

#	Celexa	872
1	In	_	ADP	IN	_	3	case	_	_
2	clinical	_	ADJ	JJ	_	3	amod	_	_
3	studies	_	NOUN	NNS	_	14	nmod	_	_
4	,	_	.	,	_	14	punct	_	_
5	no	_	DET	DT	_	6	neg	_	_
6	differences	_	NOUN	NNS	_	14	nsubjpass	_	_
7	in	_	ADP	IN	_	12	case	_	_
8	steady	_	ADJ	JJ	_	12	amod	_	_
9	state	_	NOUN	NN	_	12	compound	_	_
10	serum	_	NOUN	NN	_	12	compound	_	_
11	DRUG	_	NOUN	NN	_	12	compound	_	_
12	levels	_	NOUN	NNS	_	6	nmod	_	_
13	were	_	VERB	VBD	_	14	auxpass	_	_
14	seen	_	VERB	VBN	_	0	root	_	_
15	between	_	ADP	IN	_	17	case	_	_
16	men	_	NOUN	NN	_	17	compound	_	_
17	N=237	_	NOUN	NN	_	14	nmod	_	_
18	and	_	CONJ	CC	_	17	cc	_	_
19	women	_	NOUN	NNS	_	20	compound	_	_
20	N=388	_	NOUN	NN	_	17	conj	_	_

#	Celexa	873
1	There	_	DET	EX	_	2	expl	_	_
2	were	_	VERB	VBD	_	0	root	_	_
3	no	_	DET	DT	_	5	neg	_	_
4	gender	_	NOUN	NN	_	5	amod	_	_
5	differences	_	NOUN	NNS	_	2	nsubj	_	_
6	in	_	ADP	IN	_	8	case	_	_
7	the	_	DET	DT	_	8	det	_	_
8	pharmacokinetics	_	NOUN	NNS	_	2	nmod	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	DCT	_	NOUN	NN	_	8	nmod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	DDCT	_	NOUN	NN	_	10	conj	_	_

#	Celexa	874
1	No	_	DET	DT	_	2	neg	_	_
2	adjustment	_	NOUN	NN	_	11	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	dosage	_	NOUN	NN	_	2	nmod	_	_
5	on	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	basis	_	NOUN	NN	_	2	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	gender	_	NOUN	NN	_	7	nmod	_	_
10	is	_	VERB	VBZ	_	11	auxpass	_	_
11	recommended	_	VERB	VBN	_	0	root	_	_

#	Celexa	875
1	Reduced	_	VERB	VBN	_	6	amod	_	_
2	hepatic	_	ADJ	JJ	_	6	amod	_	_
3	function	_	NOUN	NN	_	6	compound	_	_
4	DRUG	_	NOUN	NN	_	6	compound	_	_
5	oral	_	ADJ	JJ	_	6	amod	_	_
6	clearance	_	NOUN	NN	_	8	nsubjpass	_	_
7	was	_	VERB	VBD	_	8	auxpass	_	_
8	reduced	_	VERB	VBN	_	0	root	_	_
9	by	_	ADP	IN	_	13	case	_	_
10	37%	_	ADJ	JJ	_	13	amod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	half	_	ADJ	JJ	_	10	conj	_	_
13	life	_	NOUN	NN	_	8	nmod	_	_
14	was	_	VERB	VBD	_	15	auxpass	_	_
15	doubled	_	VERB	VBN	_	8	parataxis	_	_
16	in	_	ADP	IN	_	17	case	_	_
17	patients	_	NOUN	NNS	_	15	nmod	_	_
18	with	_	ADP	IN	_	21	case	_	_
19	reduced	_	VERB	VBN	_	21	amod	_	_
20	hepatic	_	ADJ	JJ	_	21	amod	_	_
21	function	_	NOUN	NN	_	17	nmod	_	_
22	compared	_	VERB	VBN	_	25	case	_	_
23	to	_	PRT	TO	_	25	case	_	_
24	normal	_	ADJ	JJ	_	25	amod	_	_
25	subjects	_	NOUN	NNS	_	15	nmod	_	_

#	Celexa	876
1	20	_	NUM	CD	_	2	nummod	_	_
2	mg	_	NOUN	NN	_	0	root	_	_
3	/	_	.	:	_	2	punct	_	_
4	day	_	NOUN	NN	_	7	nsubj	_	_
5	is	_	VERB	VBZ	_	7	cop	_	_
6	the	_	DET	DT	_	7	det	_	_
7	maximum	_	NOUN	NN	_	2	dep	_	_
8	recommended	_	VERB	VBN	_	9	amod	_	_
9	dose	_	NOUN	NN	_	7	dep	_	_
10	for	_	ADP	IN	_	13	case	_	_
11	hepatically	_	ADV	RB	_	12	advmod	_	_
12	impaired	_	ADJ	JJ	_	13	amod	_	_
13	patients	_	NOUN	NNS	_	9	nmod	_	_
14	,	_	.	,	_	2	punct	_	_
15	due	_	ADJ	JJ	_	18	case	_	_
16	to	_	PRT	TO	_	15	mwe	_	_
17	the	_	DET	DT	_	18	det	_	_
18	risk	_	NOUN	NN	_	2	nmod	_	_
19	of	_	ADP	IN	_	21	case	_	_
20	QT	_	NOUN	NN	_	21	compound	_	_
21	prolongation	_	NOUN	NN	_	18	nmod	_	_

#	Celexa	877
1	CYP2C19	_	NOUN	NN	_	3	compound	_	_
2	poor	_	ADJ	JJ	_	3	amod	_	_
3	metabolizers	_	NOUN	NNS	_	16	nsubjpass	_	_
4	In	_	ADP	IN	_	7	case	_	_
5	CYP2C19	_	NOUN	NN	_	7	compound	_	_
6	poor	_	ADJ	JJ	_	7	amod	_	_
7	metabolizers	_	NOUN	NNS	_	3	nmod	_	_
8	,	_	.	,	_	3	punct	_	_
9	DRUG	_	NOUN	NN	_	11	compound	_	_
10	steady	_	ADJ	JJ	_	11	amod	_	_
11	state	_	NOUN	NN	_	3	appos	_	_
12	Cmax	_	NOUN	NN	_	11	dep	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	AUC	_	NOUN	NN	_	12	conj	_	_
15	was	_	VERB	VBD	_	16	auxpass	_	_
16	increased	_	VERB	VBN	_	0	root	_	_
17	by	_	ADP	IN	_	18	case	_	_
18	68%	_	NOUN	NN	_	16	nmod	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	107%	_	NOUN	NN	_	18	conj	_	_
21	,	_	.	,	_	16	punct	_	_
22	respectively	_	ADV	RB	_	16	advmod	_	_

#	Celexa	878
1	DRUG	_	NOUN	NN	_	3	compound	_	_
2	20	_	NUM	CD	_	3	nummod	_	_
3	mg	_	NOUN	NN	_	0	root	_	_
4	/	_	.	:	_	3	punct	_	_
5	day	_	NOUN	NN	_	10	nsubj	_	_
6	is	_	VERB	VBZ	_	10	cop	_	_
7	the	_	DET	DT	_	10	det	_	_
8	maximum	_	NOUN	NN	_	10	compound	_	_
9	recommended	_	VERB	VBN	_	10	amod	_	_
10	dose	_	NOUN	NN	_	3	dep	_	_
11	in	_	ADP	IN	_	14	case	_	_
12	CYP2C19	_	NOUN	NN	_	14	compound	_	_
13	poor	_	ADJ	JJ	_	14	amod	_	_
14	metabolizers	_	NOUN	NNS	_	10	nmod	_	_
15	due	_	ADJ	JJ	_	18	case	_	_
16	to	_	PRT	TO	_	15	mwe	_	_
17	the	_	DET	DT	_	18	det	_	_
18	risk	_	NOUN	NN	_	10	nmod	_	_
19	of	_	ADP	IN	_	21	case	_	_
20	QT	_	NOUN	NN	_	21	compound	_	_
21	prolongation	_	NOUN	NN	_	18	nmod	_	_

#	Celexa	879
1	CYP2D6	_	NOUN	NN	_	3	compound	_	_
2	poor	_	ADJ	JJ	_	3	amod	_	_
3	metabolizers	_	NOUN	NNS	_	7	compound	_	_
4	DRUG	_	NOUN	NN	_	7	compound	_	_
5	steady	_	ADJ	JJ	_	7	amod	_	_
6	state	_	NOUN	NN	_	7	compound	_	_
7	levels	_	NOUN	NNS	_	11	nsubj	_	_
8	were	_	VERB	VBD	_	11	cop	_	_
9	not	_	ADV	RB	_	11	neg	_	_
10	significantly	_	ADV	RB	_	11	advmod	_	_
11	different	_	ADJ	JJ	_	0	root	_	_
12	in	_	ADP	IN	_	14	case	_	_
13	poor	_	ADJ	JJ	_	14	amod	_	_
14	metabolizers	_	NOUN	NNS	_	11	nmod	_	_
15	and	_	CONJ	CC	_	11	cc	_	_
16	extensive	_	ADJ	JJ	_	17	amod	_	_
17	metabolizers	_	NOUN	NNS	_	11	conj	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	CYP2D6	_	NOUN	NN	_	17	nmod	_	_

#	Celexa	880
1	Reduced	_	VERB	VBN	_	3	amod	_	_
2	renal	_	ADJ	JJ	_	3	amod	_	_
3	function	_	NOUN	NN	_	19	nsubjpass	_	_
4	In	_	ADP	IN	_	5	case	_	_
5	patients	_	NOUN	NNS	_	3	nmod	_	_
6	with	_	ADP	IN	_	7	case	_	_
7	mild	_	ADJ	JJ	_	5	nmod	_	_
8	to	_	PRT	TO	_	9	mark	_	_
9	moderate	_	ADJ	JJ	_	3	acl	_	_
10	renal	_	ADJ	JJ	_	12	amod	_	_
11	function	_	NOUN	NN	_	12	compound	_	_
12	impairment	_	NOUN	NN	_	9	dobj	_	_
13	,	_	.	,	_	19	punct	_	_
14	oral	_	ADJ	JJ	_	15	amod	_	_
15	clearance	_	NOUN	NN	_	19	nsubjpass	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	DRUG	_	NOUN	NN	_	15	nmod	_	_
18	was	_	VERB	VBD	_	19	auxpass	_	_
19	reduced	_	VERB	VBN	_	0	root	_	_
20	by	_	ADP	IN	_	21	case	_	_
21	17%	_	NOUN	NN	_	19	nmod	_	_
22	compared	_	VERB	VBN	_	25	case	_	_
23	to	_	PRT	TO	_	25	case	_	_
24	normal	_	ADJ	JJ	_	25	amod	_	_
25	subjects	_	NOUN	NNS	_	19	nmod	_	_

#	Celexa	881
1	No	_	DET	DT	_	2	neg	_	_
2	adjustment	_	NOUN	NN	_	9	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	dosage	_	NOUN	NN	_	2	nmod	_	_
5	for	_	ADP	IN	_	7	case	_	_
6	such	_	ADJ	JJ	_	7	amod	_	_
7	patients	_	NOUN	NNS	_	4	nmod	_	_
8	is	_	VERB	VBZ	_	9	auxpass	_	_
9	recommended	_	VERB	VBN	_	0	root	_	_

#	Celexa	882
1	No	_	DET	DT	_	2	neg	_	_
2	information	_	NOUN	NN	_	4	nsubj	_	_
3	is	_	VERB	VBZ	_	4	cop	_	_
4	available	_	ADJ	JJ	_	0	root	_	_
5	about	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	pharmacokinetics	_	NOUN	NNS	_	4	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	in	_	ADP	IN	_	11	case	_	_
11	patients	_	NOUN	NNS	_	7	nmod	_	_
12	with	_	ADP	IN	_	21	case	_	_
13	severely	_	ADV	RB	_	14	advmod	_	_
14	reduced	_	VERB	VBN	_	21	amod	_	_
15	renal	_	ADJ	JJ	_	21	amod	_	_
16	function	_	NOUN	NN	_	21	compound	_	_
17	creatinine	_	NOUN	NN	_	21	compound	_	_
18	clearance	_	NOUN	NN	_	21	compound	_	_
19	<	_	NUM	CD	_	21	nummod	_	_
20	20	_	NUM	CD	_	21	nummod	_	_
21	mL	_	NOUN	NN	_	11	nmod	_	_
22	/	_	.	:	_	21	punct	_	_
23	min	_	NOUN	NN	_	21	dep	_	_

#	Celexa	883
1	In	_	X	FW	_	5	amod	_	_
2	vitro	_	X	FW	_	1	dep	_	_
3	enzyme	_	NOUN	NN	_	5	compound	_	_
4	inhibition	_	NOUN	NN	_	5	compound	_	_
5	data	_	NOUN	NNS	_	8	nsubj	_	_
6	did	_	VERB	VBD	_	8	aux	_	_
7	not	_	ADV	RB	_	8	neg	_	_
8	reveal	_	VERB	VB	_	0	root	_	_
9	an	_	DET	DT	_	11	det	_	_
10	inhibitory	_	ADJ	JJ	_	11	amod	_	_
11	effect	_	NOUN	NN	_	8	dobj	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	DRUG	_	NOUN	NN	_	11	nmod	_	_
14	on	_	ADP	IN	_	15	case	_	_
15	CYP3A4	_	NOUN	NN	_	11	nmod	_	_
16	,	_	.	,	_	15	punct	_	_
17	2C9	_	NOUN	NN	_	15	conj	_	_
18	,	_	.	,	_	15	punct	_	_
19	or	_	CONJ	CC	_	15	cc	_	_
20	2E1	_	NOUN	NN	_	15	conj	_	_
21	,	_	.	,	_	8	punct	_	_
22	but	_	CONJ	CC	_	8	cc	_	_
23	did	_	VERB	MD	_	24	aux	_	_
24	suggest	_	VERB	VB	_	8	conj	_	_
25	that	_	ADP	IN	_	30	mark	_	_
26	it	_	PRON	PRP	_	30	nsubj	_	_
27	is	_	VERB	VBZ	_	30	cop	_	_
28	a	_	DET	DT	_	30	det	_	_
29	weak	_	ADJ	JJ	_	30	amod	_	_
30	inhibitor	_	NOUN	NN	_	24	ccomp	_	_
31	of	_	ADP	IN	_	32	case	_	_
32	CYP1A2	_	NOUN	NN	_	30	nmod	_	_
33	,	_	.	,	_	32	punct	_	_
34	2D6	_	NOUN	NN	_	32	conj	_	_
35	,	_	.	,	_	32	punct	_	_
36	and	_	CONJ	CC	_	32	cc	_	_
37	2C19	_	NOUN	NN	_	32	conj	_	_

#	Celexa	884
1	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
2	would	_	VERB	MD	_	4	aux	_	_
3	be	_	VERB	VB	_	4	auxpass	_	_
4	expected	_	VERB	VBN	_	0	root	_	_
5	to	_	PRT	TO	_	6	mark	_	_
6	have	_	VERB	VB	_	4	xcomp	_	_
7	little	_	ADJ	JJ	_	9	amod	_	_
8	inhibitory	_	ADJ	JJ	_	9	amod	_	_
9	effect	_	NOUN	NN	_	6	dobj	_	_
10	on	_	ADP	IN	_	13	case	_	_
11	in	_	X	FW	_	13	amod	_	_
12	vivo	_	X	FW	_	11	dep	_	_
13	metabolism	_	NOUN	NN	_	6	nmod	_	_
14	mediated	_	VERB	VBN	_	13	acl	_	_
15	by	_	ADP	IN	_	17	case	_	_
16	these	_	DET	DT	_	17	det	_	_
17	enzymes	_	NOUN	NNS	_	14	nmod	_	_

#	Celexa	885
1	However	_	ADV	RB	_	11	advmod	_	_
2	,	_	.	,	_	11	punct	_	_
3	in	_	X	FW	_	5	amod	_	_
4	vivo	_	X	FW	_	3	dep	_	_
5	data	_	NOUN	NNS	_	11	nsubj	_	_
6	to	_	PRT	TO	_	7	mark	_	_
7	address	_	VERB	VB	_	5	acl	_	_
8	this	_	DET	DT	_	9	det	_	_
9	question	_	NOUN	NN	_	7	dobj	_	_
10	are	_	VERB	VBP	_	11	auxpass	_	_
11	limited	_	ADJ	JJ	_	0	root	_	_

#	Celexa	886
1	CYP3A4	_	NOUN	NN	_	0	root	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	CYP	_	NOUN	NN	_	1	conj	_	_
4	2C19	_	NOUN	NN	_	5	compound	_	_
5	inhibitors	_	NOUN	NNS	_	1	dep	_	_
6	:	_	.	:	_	1	punct	_	_
7	Since	_	ADP	IN	_	15	mark	_	_
8	CYP3A4	_	NOUN	NN	_	15	nsubj	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	CYP	_	NOUN	NN	_	8	conj	_	_
11	2C19	_	NOUN	NN	_	8	dep	_	_
12	are	_	VERB	VBP	_	15	cop	_	_
13	the	_	DET	DT	_	15	det	_	_
14	primary	_	ADJ	JJ	_	15	amod	_	_
15	enzymes	_	NOUN	NNS	_	25	advcl	_	_
16	involved	_	VERB	VBN	_	15	acl	_	_
17	in	_	ADP	IN	_	19	case	_	_
18	the	_	DET	DT	_	19	det	_	_
19	metabolism	_	NOUN	NN	_	16	nmod	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	DRUG	_	NOUN	NN	_	19	nmod	_	_
22	,	_	.	,	_	25	punct	_	_
23	it	_	PRON	PRP	_	25	nsubjpass	_	_
24	is	_	VERB	VBZ	_	25	auxpass	_	_
25	expected	_	VERB	VBN	_	1	dep	_	_
26	that	_	ADP	IN	_	49	mark	_	_
27	potent	_	ADJ	JJ	_	28	amod	_	_
28	inhibitors	_	NOUN	NNS	_	49	nsubj	_	_
29	of	_	ADP	IN	_	31	case	_	_
30	CYP3A4	_	NOUN	NN	_	31	compound	_	_
31	e.g	_	NOUN	NN	_	28	nmod	_	_
32	,	_	.	,	_	31	punct	_	_
33	ketoconazole	_	NOUN	NN	_	31	conj	_	_
34	,	_	.	,	_	31	punct	_	_
35	itraconazole	_	NOUN	NN	_	31	conj	_	_
36	,	_	.	,	_	31	punct	_	_
37	and	_	CONJ	CC	_	31	cc	_	_
38	macrolide	_	NOUN	NN	_	39	compound	_	_
39	antibiotics	_	NOUN	NNS	_	31	conj	_	_
40	and	_	CONJ	CC	_	31	cc	_	_
41	potent	_	ADJ	JJ	_	42	amod	_	_
42	inhibitors	_	NOUN	NNS	_	31	conj	_	_
43	of	_	ADP	IN	_	45	case	_	_
44	CYP2C19	_	NOUN	NN	_	45	compound	_	_
45	e.g	_	NOUN	NN	_	31	nmod	_	_
46	,	_	.	,	_	28	punct	_	_
47	omeprazole	_	NOUN	NN	_	28	appos	_	_
48	might	_	VERB	MD	_	49	aux	_	_
49	decrease	_	VERB	VB	_	25	ccomp	_	_
50	the	_	DET	DT	_	51	det	_	_
51	clearance	_	NOUN	NN	_	49	dobj	_	_
52	of	_	ADP	IN	_	53	case	_	_
53	DRUG	_	NOUN	NN	_	51	nmod	_	_

#	Celexa	887
1	However	_	ADV	RB	_	15	advmod	_	_
2	,	_	.	,	_	15	punct	_	_
3	coadministration	_	NOUN	NN	_	15	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	and	_	CONJ	CC	_	3	cc	_	_
7	the	_	DET	DT	_	11	det	_	_
8	potent	_	ADJ	JJ	_	11	amod	_	_
9	CYP3A4	_	NOUN	NN	_	11	compound	_	_
10	inhibitor	_	NOUN	NN	_	11	compound	_	_
11	ketoconazole	_	NOUN	NN	_	3	conj	_	_
12	did	_	VERB	VBD	_	15	aux	_	_
13	not	_	ADV	RB	_	15	neg	_	_
14	significantly	_	ADV	RB	_	15	advmod	_	_
15	affect	_	VERB	VB	_	0	root	_	_
16	the	_	DET	DT	_	17	det	_	_
17	pharmacokinetics	_	NOUN	NNS	_	15	dobj	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	DRUG	_	NOUN	NN	_	17	nmod	_	_

#	Celexa	888
1	DRUG	_	NOUN	NN	_	3	compound	_	_
2	20	_	NUM	CD	_	3	nummod	_	_
3	mg	_	NOUN	NN	_	0	root	_	_
4	/	_	.	:	_	3	punct	_	_
5	day	_	NOUN	NN	_	10	nsubj	_	_
6	is	_	VERB	VBZ	_	10	cop	_	_
7	the	_	DET	DT	_	10	det	_	_
8	maximum	_	NOUN	NN	_	10	compound	_	_
9	recommended	_	VERB	VBN	_	10	amod	_	_
10	dose	_	NOUN	NN	_	3	dep	_	_
11	in	_	ADP	IN	_	12	case	_	_
12	patients	_	NOUN	NNS	_	10	nmod	_	_
13	taking	_	VERB	VBG	_	12	acl	_	_
14	concomitant	_	ADJ	JJ	_	15	amod	_	_
15	cimetidine	_	NOUN	NN	_	13	dobj	_	_
16	or	_	CONJ	CC	_	15	cc	_	_
17	another	_	DET	DT	_	19	det	_	_
18	CYP2C19	_	NOUN	NN	_	19	compound	_	_
19	inhibitor	_	NOUN	NN	_	15	conj	_	_
20	,	_	.	,	_	3	punct	_	_
21	because	_	ADP	IN	_	24	case	_	_
22	of	_	ADP	IN	_	24	case	_	_
23	the	_	DET	DT	_	24	det	_	_
24	risk	_	NOUN	NN	_	3	nmod	_	_
25	of	_	ADP	IN	_	27	case	_	_
26	QT	_	NOUN	NN	_	27	compound	_	_
27	prolongation	_	NOUN	NN	_	24	nmod	_	_

#	Celexa	889
1	CYP2D6	_	NOUN	NN	_	2	compound	_	_
2	Inhibitors	_	NOUN	NNS	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	Coadministration	_	NOUN	NN	_	14	nsubj	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	a	_	DET	DT	_	7	det	_	_
7	drug	_	NOUN	NN	_	4	nmod	_	_
8	that	_	DET	WDT	_	9	nsubj	_	_
9	inhibits	_	VERB	VBZ	_	7	acl:relcl	_	_
10	CYP2D6	_	NOUN	NN	_	9	dobj	_	_
11	with	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	9	nmod	_	_
13	is	_	VERB	VBZ	_	14	cop	_	_
14	unlikely	_	ADJ	JJ	_	2	dep	_	_
15	to	_	PRT	TO	_	16	mark	_	_
16	have	_	VERB	VB	_	14	xcomp	_	_
17	clinically	_	ADV	RB	_	18	advmod	_	_
18	significant	_	ADJ	JJ	_	19	amod	_	_
19	effects	_	NOUN	NNS	_	16	dobj	_	_
20	on	_	ADP	IN	_	22	case	_	_
21	DRUG	_	NOUN	NN	_	22	compound	_	_
22	metabolism	_	NOUN	NN	_	16	nmod	_	_
23	,	_	.	,	_	14	punct	_	_
24	based	_	VERB	VBN	_	14	xcomp	_	_
25	on	_	ADP	IN	_	28	case	_	_
26	the	_	DET	DT	_	28	det	_	_
27	study	_	NOUN	NN	_	28	compound	_	_
28	results	_	NOUN	NNS	_	24	nmod	_	_
29	in	_	ADP	IN	_	32	case	_	_
30	CYP2D6	_	NOUN	NN	_	32	compound	_	_
31	poor	_	ADJ	JJ	_	32	amod	_	_
32	metabolizers	_	NOUN	NNS	_	28	nmod	_	_

#	Celexa	890
1	The	_	DET	DT	_	2	det	_	_
2	efficacy	_	NOUN	NN	_	11	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	as	_	ADP	IN	_	7	case	_	_
6	a	_	DET	DT	_	7	det	_	_
7	treatment	_	NOUN	NN	_	2	nmod	_	_
8	for	_	ADP	IN	_	9	case	_	_
9	depression	_	NOUN	NN	_	7	nmod	_	_
10	was	_	VERB	VBD	_	11	auxpass	_	_
11	established	_	VERB	VBN	_	0	root	_	_
12	in	_	ADP	IN	_	16	case	_	_
13	two	_	NUM	CD	_	14	nummod	_	_
14	placebo	_	NOUN	NN	_	16	amod	_	_
15	controlled	_	VERB	VBN	_	16	amod	_	_
16	studies	_	NOUN	NNS	_	11	nmod	_	_
17	of	_	ADP	IN	_	21	case	_	_
18	4	_	NUM	CD	_	20	compound	_	_
19	to	_	PRT	TO	_	20	dep	_	_
20	6	_	NUM	CD	_	21	nummod	_	_
21	weeks	_	NOUN	NNS	_	16	nmod	_	_
22	in	_	ADP	IN	_	23	case	_	_
23	duration	_	NOUN	NN	_	16	nmod	_	_
24	in	_	ADP	IN	_	26	case	_	_
25	adult	_	ADJ	JJ	_	26	amod	_	_
26	outpatients	_	NOUN	NNS	_	23	nmod	_	_
27	ages	_	VERB	VBZ	_	11	parataxis	_	_
28	18	_	NUM	CD	_	29	nummod	_	_
29	66	_	NUM	CD	_	27	neg	_	_
30	meeting	_	VERB	VBG	_	29	acl	_	_
31	DSM	_	NOUN	NN	_	30	dobj	_	_
32	III	_	NUM	CD	_	31	nummod	_	_
33	or	_	CONJ	CC	_	31	cc	_	_
34	DSM	_	NOUN	NN	_	37	compound	_	_
35	III	_	NUM	CD	_	37	nummod	_	_
36	R	_	NOUN	NN	_	37	compound	_	_
37	criteria	_	NOUN	NN	_	31	conj	_	_
38	for	_	ADP	IN	_	40	case	_	_
39	major	_	ADJ	JJ	_	40	amod	_	_
40	depression	_	NOUN	NN	_	30	nmod	_	_

#	Celexa	891
1	Study	_	NOUN	NN	_	28	nsubj	_	_
2	1	_	NUM	CD	_	1	nummod	_	_
3	,	_	.	,	_	1	punct	_	_
4	a	_	DET	DT	_	7	det	_	_
5	6	_	NUM	CD	_	7	nummod	_	_
6	week	_	NOUN	NN	_	7	compound	_	_
7	trial	_	NOUN	NN	_	1	appos	_	_
8	in	_	ADP	IN	_	9	case	_	_
9	which	_	DET	WDT	_	11	nmod	_	_
10	patients	_	NOUN	NNS	_	11	nsubj	_	_
11	received	_	VERB	VBD	_	7	acl:relcl	_	_
12	fixed	_	VERB	VBN	_	14	amod	_	_
13	DRUG	_	NOUN	NN	_	14	compound	_	_
14	doses	_	NOUN	NNS	_	11	dobj	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	10	_	NUM	CD	_	14	nmod	_	_
17	,	_	.	,	_	16	punct	_	_
18	20	_	NUM	CD	_	16	conj	_	_
19	,	_	.	,	_	16	punct	_	_
20	40	_	NUM	CD	_	16	conj	_	_
21	,	_	.	,	_	16	punct	_	_
22	and	_	CONJ	CC	_	16	cc	_	_
23	60	_	NUM	CD	_	16	conj	_	_
24	mg	_	NOUN	NN	_	26	compound	_	_
25	/	_	.	:	_	26	punct	_	_
26	day	_	NOUN	NN	_	16	dep	_	_
27	,	_	.	,	_	1	punct	_	_
28	showed	_	VERB	VBD	_	0	root	_	_
29	that	_	ADP	IN	_	41	mark	_	_
30	DRUG	_	NOUN	NN	_	41	nsubj	_	_
31	at	_	ADP	IN	_	32	case	_	_
32	doses	_	NOUN	NNS	_	30	nmod	_	_
33	of	_	ADP	IN	_	39	case	_	_
34	40	_	NUM	CD	_	37	nummod	_	_
35	and	_	CONJ	CC	_	34	cc	_	_
36	60	_	NUM	CD	_	34	conj	_	_
37	mg	_	NOUN	NN	_	39	amod	_	_
38	/	_	.	:	_	39	punct	_	_
39	day	_	NOUN	NN	_	32	nmod	_	_
40	was	_	VERB	VBD	_	41	cop	_	_
41	effective	_	ADJ	JJ	_	28	ccomp	_	_
42	as	_	ADP	IN	_	43	mark	_	_
43	measured	_	VERB	VBN	_	41	advcl	_	_
44	by	_	ADP	IN	_	47	case	_	_
45	the	_	DET	DT	_	47	det	_	_
46	Hamilton	_	NOUN	NN	_	47	compound	_	_
47	Depression	_	NOUN	NN	_	43	nmod	_	_
48	Rating	_	VERB	VBG	_	47	acl	_	_
49	Scale	_	NOUN	NN	_	52	compound	_	_
50	HAMD	_	NOUN	NN	_	52	compound	_	_
51	total	_	ADJ	JJ	_	52	amod	_	_
52	score	_	NOUN	NN	_	48	dobj	_	_
53	,	_	.	,	_	41	punct	_	_
54	the	_	DET	DT	_	55	det	_	_
55	HAMD	_	NOUN	NN	_	56	nsubj	_	_
56	depressed	_	VERB	VBD	_	41	conj	_	_
57	mood	_	NOUN	NN	_	59	compound	_	_
58	item	_	NOUN	NN	_	59	compound	_	_
59	Item	_	NOUN	NN	_	56	dobj	_	_
60	1	_	NUM	CD	_	59	nummod	_	_
61	,	_	.	,	_	59	punct	_	_
62	the	_	DET	DT	_	65	det	_	_
63	Montgomery	_	NOUN	NN	_	65	compound	_	_
64	Asberg	_	NOUN	NN	_	65	compound	_	_
65	Depression	_	NOUN	NN	_	59	appos	_	_
66	Rating	_	VERB	VBG	_	65	acl	_	_
67	Scale	_	NOUN	NN	_	66	dobj	_	_
68	,	_	.	,	_	41	punct	_	_
69	and	_	CONJ	CC	_	41	cc	_	_
70	the	_	DET	DT	_	76	det	_	_
71	Clinical	_	ADJ	JJ	_	76	amod	_	_
72	Global	_	ADJ	JJ	_	76	amod	_	_
73	Impression	_	NOUN	NN	_	76	compound	_	_
74	CGI	_	NOUN	NN	_	76	compound	_	_
75	Severity	_	NOUN	NN	_	76	compound	_	_
76	scale	_	NOUN	NN	_	41	conj	_	_

#	Celexa	892
1	This	_	DET	DT	_	2	det	_	_
2	study	_	NOUN	NN	_	3	nsubj	_	_
3	showed	_	VERB	VBD	_	0	root	_	_
4	no	_	DET	DT	_	6	neg	_	_
5	clear	_	ADJ	JJ	_	6	amod	_	_
6	effect	_	NOUN	NN	_	3	dobj	_	_
7	of	_	ADP	IN	_	12	case	_	_
8	the	_	DET	DT	_	12	det	_	_
9	10	_	NUM	CD	_	12	nummod	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	20	_	NUM	CD	_	9	conj	_	_
12	mg	_	NOUN	NN	_	6	nmod	_	_
13	/	_	.	:	_	12	punct	_	_
14	day	_	NOUN	NN	_	15	compound	_	_
15	doses	_	NOUN	NNS	_	12	conj	_	_
16	,	_	.	,	_	3	punct	_	_
17	and	_	CONJ	CC	_	3	cc	_	_
18	the	_	DET	DT	_	23	det	_	_
19	60	_	NUM	CD	_	23	nummod	_	_
20	mg	_	NOUN	NN	_	23	compound	_	_
21	/	_	.	:	_	23	punct	_	_
22	day	_	NOUN	NN	_	23	compound	_	_
23	dose	_	NOUN	NN	_	27	nsubj	_	_
24	was	_	VERB	VBD	_	27	cop	_	_
25	not	_	ADV	RB	_	27	neg	_	_
26	more	_	ADV	RB	_	27	advmod	_	_
27	effective	_	ADJ	JJ	_	3	conj	_	_
28	than	_	ADP	IN	_	34	case	_	_
29	the	_	DET	DT	_	34	det	_	_
30	40	_	NUM	CD	_	31	nummod	_	_
31	mg	_	NOUN	NN	_	34	compound	_	_
32	/	_	.	:	_	34	punct	_	_
33	day	_	NOUN	NN	_	34	compound	_	_
34	dose	_	NOUN	NN	_	27	nmod	_	_

#	Celexa	893
1	In	_	ADP	IN	_	2	case	_	_
2	study	_	NOUN	NN	_	0	root	_	_
3	2	_	NUM	CD	_	2	nummod	_	_
4	,	_	.	,	_	2	punct	_	_
5	a	_	DET	DT	_	7	det	_	_
6	4	_	NUM	CD	_	7	nummod	_	_
7	week	_	NOUN	NN	_	4	root	_	_
8	,	_	.	,	_	7	punct	_	_
9	placebo	_	NOUN	NN	_	7	appos	_	_
10	controlled	_	VERB	VBD	_	9	acl	_	_
11	trial	_	ADJ	JJ	_	10	xcomp	_	_
12	in	_	ADP	IN	_	14	case	_	_
13	depressed	_	VERB	VBN	_	14	amod	_	_
14	patients	_	NOUN	NNS	_	11	nmod	_	_
15	,	_	.	,	_	7	punct	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	whom	_	ADP	IN	_	7	nmod	_	_
18	85%	_	ADJ	JJ	_	20	amod	_	_
19	met	_	X	FW	_	18	cc	_	_
20	criteria	_	NOUN	NN	_	17	root	_	_
21	for	_	ADP	IN	_	22	case	_	_
22	melancholia	_	NOUN	NN	_	20	nmod	_	_
23	,	_	.	,	_	20	punct	_	_
24	the	_	DET	DT	_	26	det	_	_
25	initial	_	ADJ	JJ	_	26	amod	_	_
26	dose	_	NOUN	NN	_	29	nsubj	_	_
27	was	_	VERB	VBD	_	29	cop	_	_
28	20	_	NUM	CD	_	29	nummod	_	_
29	mg	_	NOUN	NN	_	20	appos	_	_
30	/	_	.	:	_	29	punct	_	_
31	day	_	NOUN	NN	_	29	dep	_	_
32	,	_	.	,	_	20	punct	_	_
33	followed	_	VERB	VBN	_	20	acl	_	_
34	by	_	ADP	IN	_	35	case	_	_
35	titration	_	NOUN	NN	_	33	nmod	_	_
36	to	_	PRT	TO	_	40	case	_	_
37	the	_	DET	DT	_	40	det	_	_
38	maximum	_	NOUN	NN	_	40	compound	_	_
39	tolerated	_	ADJ	JJ	_	40	amod	_	_
40	dose	_	NOUN	NN	_	35	nmod	_	_
41	or	_	CONJ	CC	_	40	cc	_	_
42	a	_	DET	DT	_	44	det	_	_
43	maximum	_	NOUN	NN	_	44	compound	_	_
44	dose	_	NOUN	NN	_	40	conj	_	_
45	of	_	ADP	IN	_	49	case	_	_
46	80	_	NUM	CD	_	49	nummod	_	_
47	mg	_	NOUN	NN	_	49	compound	_	_
48	/	_	NUM	CD	_	49	compound	_	_
49	day	_	NOUN	NN	_	44	nmod	_	_

#	Celexa	894
1	Patients	_	NOUN	NNS	_	5	nsubj	_	_
2	treated	_	VERB	VBN	_	1	acl	_	_
3	with	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	showed	_	VERB	VBD	_	0	root	_	_
6	significantly	_	ADV	RB	_	7	advmod	_	_
7	greater	_	ADJ	JJ	_	8	amod	_	_
8	improvement	_	NOUN	NN	_	5	dobj	_	_
9	than	_	ADP	IN	_	11	case	_	_
10	placebo	_	NOUN	NN	_	11	compound	_	_
11	patients	_	NOUN	NNS	_	5	nmod	_	_
12	on	_	ADP	IN	_	16	case	_	_
13	the	_	DET	DT	_	16	det	_	_
14	HAMD	_	NOUN	NN	_	16	compound	_	_
15	total	_	ADJ	JJ	_	16	amod	_	_
16	score	_	NOUN	NN	_	11	nmod	_	_
17	,	_	.	,	_	16	punct	_	_
18	HAMD	_	NOUN	NN	_	19	compound	_	_
19	item	_	NOUN	NN	_	16	conj	_	_
20	1	_	NUM	CD	_	19	nummod	_	_
21	,	_	.	,	_	16	punct	_	_
22	and	_	CONJ	CC	_	16	cc	_	_
23	the	_	DET	DT	_	26	det	_	_
24	CGI	_	NOUN	NN	_	26	compound	_	_
25	Severity	_	NOUN	NN	_	26	compound	_	_
26	score	_	NOUN	NN	_	16	conj	_	_

#	Celexa	895
1	In	_	ADP	IN	_	7	case	_	_
2	three	_	NUM	CD	_	7	nummod	_	_
3	additional	_	ADJ	JJ	_	7	amod	_	_
4	placebo	_	NOUN	NN	_	7	compound	_	_
5	controlled	_	VERB	VBN	_	7	amod	_	_
6	depression	_	NOUN	NN	_	7	compound	_	_
7	trials	_	NOUN	NNS	_	26	nmod	_	_
8	,	_	.	,	_	26	punct	_	_
9	the	_	DET	DT	_	10	det	_	_
10	difference	_	NOUN	NN	_	26	nsubj	_	_
11	in	_	ADP	IN	_	12	case	_	_
12	response	_	NOUN	NN	_	10	nmod	_	_
13	to	_	PRT	TO	_	14	case	_	_
14	treatment	_	NOUN	NN	_	12	nmod	_	_
15	between	_	ADP	IN	_	16	case	_	_
16	patients	_	NOUN	NNS	_	14	nmod	_	_
17	receiving	_	VERB	VBG	_	16	acl	_	_
18	DRUG	_	NOUN	NN	_	17	dobj	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	patients	_	NOUN	NNS	_	18	conj	_	_
21	receiving	_	VERB	VBG	_	18	acl	_	_
22	placebo	_	NOUN	NN	_	21	dobj	_	_
23	was	_	VERB	VBD	_	26	cop	_	_
24	not	_	ADV	RB	_	26	neg	_	_
25	statistically	_	ADV	RB	_	26	advmod	_	_
26	significant	_	ADJ	JJ	_	0	root	_	_
27	,	_	.	,	_	26	punct	_	_
28	possibly	_	ADV	RB	_	29	advmod	_	_
29	due	_	ADJ	JJ	_	26	dep	_	_
30	to	_	PRT	TO	_	34	case	_	_
31	high	_	ADJ	JJ	_	34	amod	_	_
32	spontaneous	_	ADJ	JJ	_	34	amod	_	_
33	response	_	NOUN	NN	_	34	compound	_	_
34	rate	_	NOUN	NN	_	29	nmod	_	_
35	,	_	.	,	_	34	punct	_	_
36	smaller	_	ADJ	JJ	_	38	amod	_	_
37	sample	_	ADJ	JJ	_	38	amod	_	_
38	size	_	NOUN	NN	_	34	conj	_	_
39	,	_	.	,	_	34	punct	_	_
40	or	_	CONJ	CC	_	34	cc	_	_
41	,	_	.	,	_	34	punct	_	_
42	in	_	ADP	IN	_	44	case	_	_
43	the	_	DET	DT	_	44	det	_	_
44	case	_	NOUN	NN	_	50	nmod	_	_
45	of	_	ADP	IN	_	47	case	_	_
46	one	_	NUM	CD	_	47	nummod	_	_
47	study	_	NOUN	NN	_	44	nmod	_	_
48	,	_	.	,	_	50	punct	_	_
49	too	_	X	FW	_	50	advmod	_	_
50	low	_	ADJ	JJ	_	34	conj	_	_
51	a	_	DET	DT	_	52	det	_	_
52	dose	_	NOUN	NN	_	50	nmod	_	_

#	Celexa	896
1	In	_	ADP	IN	_	5	case	_	_
2	two	_	NUM	CD	_	5	nummod	_	_
3	long	_	ADJ	JJ	_	5	amod	_	_
4	term	_	NOUN	NN	_	5	compound	_	_
5	studies	_	NOUN	NNS	_	0	root	_	_
6	,	_	.	,	_	5	punct	_	_
7	depressed	_	VERB	VBN	_	8	amod	_	_
8	patients	_	NOUN	NNS	_	6	root	_	_
9	who	_	DET	WDT	_	11	nsubj	_	_
10	had	_	VERB	MD	_	11	aux	_	_
11	responded	_	VERB	VBN	_	8	acl:relcl	_	_
12	to	_	PRT	TO	_	13	case	_	_
13	DRUG	_	NOUN	NN	_	11	nmod	_	_
14	during	_	ADP	IN	_	17	case	_	_
15	an	_	DET	DT	_	17	dep	_	_
16	initial	_	ADJ	JJ	_	17	amod	_	_
17	6	_	NUM	CD	_	11	nmod	_	_
18	or	_	CONJ	CC	_	17	cc	_	_
19	8	_	NUM	CD	_	17	conj	_	_
20	weeks	_	NOUN	NNS	_	17	dep	_	_
21	of	_	ADP	IN	_	25	case	_	_
22	acute	_	ADJ	JJ	_	25	amod	_	_
23	treatment	_	NOUN	NN	_	25	compound	_	_
24	fixed	_	ADJ	JJ	_	25	amod	_	_
25	doses	_	NOUN	NNS	_	17	nmod	_	_
26	of	_	ADP	IN	_	30	case	_	_
27	20	_	NUM	CD	_	30	nummod	_	_
28	or	_	CONJ	CC	_	27	cc	_	_
29	40	_	NUM	CD	_	27	conj	_	_
30	mg	_	NOUN	NN	_	25	nmod	_	_
31	/	_	.	:	_	8	punct	_	_
32	day	_	NOUN	NN	_	8	dep	_	_
33	in	_	ADP	IN	_	35	case	_	_
34	one	_	NUM	CD	_	35	nummod	_	_
35	study	_	NOUN	NN	_	32	nmod	_	_
36	and	_	CONJ	CC	_	32	cc	_	_
37	flexible	_	ADJ	JJ	_	38	amod	_	_
38	doses	_	NOUN	NNS	_	32	conj	_	_
39	of	_	ADP	IN	_	42	case	_	_
40	20	_	NUM	CD	_	42	nummod	_	_
41	60	_	NUM	CD	_	42	nummod	_	_
42	mg	_	NOUN	NN	_	38	nmod	_	_
43	/	_	.	:	_	8	punct	_	_
44	day	_	NOUN	NN	_	50	nsubjpass	_	_
45	in	_	ADP	IN	_	48	case	_	_
46	the	_	DET	DT	_	48	det	_	_
47	second	_	ADJ	JJ	_	48	amod	_	_
48	study	_	NOUN	NN	_	44	nmod	_	_
49	were	_	VERB	VBD	_	50	auxpass	_	_
50	randomized	_	VERB	VBN	_	8	dep	_	_
51	to	_	PRT	TO	_	52	case	_	_
52	continuation	_	NOUN	NN	_	50	nmod	_	_
53	of	_	ADP	IN	_	54	case	_	_
54	DRUG	_	NOUN	NN	_	52	nmod	_	_
55	or	_	CONJ	CC	_	54	cc	_	_
56	to	_	PRT	TO	_	57	case	_	_
57	placebo	_	NOUN	NN	_	54	conj	_	_

#	Celexa	897
1	In	_	ADP	IN	_	3	case	_	_
2	both	_	DET	DT	_	3	det	_	_
3	studies	_	NOUN	NNS	_	10	nmod	_	_
4	,	_	.	,	_	10	punct	_	_
5	patients	_	NOUN	NNS	_	10	nsubj	_	_
6	receiving	_	VERB	VBG	_	5	acl	_	_
7	continued	_	VERB	VBN	_	9	amod	_	_
8	DRUG	_	NOUN	NN	_	9	compound	_	_
9	treatment	_	NOUN	NN	_	6	dobj	_	_
10	experienced	_	VERB	VBN	_	0	root	_	_
11	significantly	_	ADV	RB	_	12	advmod	_	_
12	lower	_	ADJ	JJ	_	14	amod	_	_
13	relapse	_	ADJ	JJ	_	14	amod	_	_
14	rates	_	NOUN	NNS	_	10	dobj	_	_
15	over	_	ADP	IN	_	19	case	_	_
16	the	_	DET	DT	_	19	det	_	_
17	subsequent	_	ADJ	JJ	_	19	amod	_	_
18	6	_	NUM	CD	_	19	nummod	_	_
19	months	_	NOUN	NNS	_	10	nmod	_	_
20	compared	_	VERB	VBN	_	10	xcomp	_	_
21	to	_	PRT	TO	_	22	case	_	_
22	those	_	DET	DT	_	20	nmod	_	_
23	receiving	_	VERB	VBG	_	22	acl	_	_
24	placebo	_	NOUN	NN	_	23	nmod	_	_

#	Celexa	898
1	In	_	ADP	IN	_	5	case	_	_
2	the	_	DET	DT	_	5	det	_	_
3	fixed	_	VERB	VBN	_	5	amod	_	_
4	dose	_	NOUN	NN	_	5	compound	_	_
5	study	_	NOUN	NN	_	14	nmod	_	_
6	,	_	.	,	_	14	punct	_	_
7	the	_	DET	DT	_	9	det	_	_
8	decreased	_	VERB	VBN	_	9	amod	_	_
9	rate	_	NOUN	NN	_	14	nsubj	_	_
10	of	_	ADP	IN	_	12	case	_	_
11	depression	_	NOUN	NN	_	12	compound	_	_
12	relapse	_	NOUN	NN	_	9	nmod	_	_
13	was	_	VERB	VBD	_	14	cop	_	_
14	similar	_	ADJ	JJ	_	0	root	_	_
15	in	_	ADP	IN	_	16	case	_	_
16	patients	_	NOUN	NNS	_	14	nmod	_	_
17	receiving	_	VERB	VBG	_	16	acl	_	_
18	20	_	NUM	CD	_	21	nummod	_	_
19	or	_	CONJ	CC	_	18	cc	_	_
20	40	_	NUM	CD	_	18	conj	_	_
21	mg	_	NOUN	NN	_	17	dobj	_	_
22	/	_	.	:	_	14	punct	_	_
23	day	_	NOUN	NN	_	14	parataxis	_	_
24	of	_	ADP	IN	_	25	case	_	_
25	DRUG	_	NOUN	NN	_	23	nmod	_	_

#	Celexa	899
1	Analyses	_	NOUN	NNS	_	17	nsubj	_	_
2	of	_	ADP	IN	_	4	case	_	_
3	the	_	DET	DT	_	4	det	_	_
4	relationship	_	NOUN	NN	_	1	nmod	_	_
5	between	_	ADP	IN	_	7	case	_	_
6	treatment	_	NOUN	NN	_	7	compound	_	_
7	outcome	_	NOUN	NN	_	4	nmod	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	age	_	NOUN	NN	_	7	conj	_	_
10	,	_	.	,	_	7	punct	_	_
11	gender	_	NOUN	NN	_	7	conj	_	_
12	,	_	.	,	_	7	punct	_	_
13	and	_	CONJ	CC	_	7	cc	_	_
14	race	_	NOUN	NN	_	7	conj	_	_
15	did	_	VERB	VBD	_	17	aux	_	_
16	not	_	ADV	RB	_	17	neg	_	_
17	suggest	_	VERB	VB	_	0	root	_	_
18	any	_	DET	DT	_	20	det	_	_
19	differential	_	ADJ	JJ	_	20	amod	_	_
20	responsiveness	_	NOUN	NN	_	17	dobj	_	_
21	on	_	ADP	IN	_	23	case	_	_
22	the	_	DET	DT	_	23	det	_	_
23	basis	_	NOUN	NN	_	17	nmod	_	_
24	of	_	ADP	IN	_	27	case	_	_
25	these	_	DET	DT	_	27	det	_	_
26	patient	_	NOUN	NN	_	27	compound	_	_
27	characteristics	_	NOUN	NNS	_	23	nmod	_	_

#	Celexa	900
1	Highly	_	ADV	RB	_	2	advmod	_	_
2	variable	_	ADJ	JJ	_	3	amod	_	_
3	results	_	NOUN	NNS	_	6	nsubjpass	_	_
4	have	_	VERB	VBP	_	6	aux	_	_
5	been	_	VERB	VBN	_	6	auxpass	_	_
6	seen	_	VERB	VBN	_	0	root	_	_
7	in	_	ADP	IN	_	10	case	_	_
8	the	_	DET	DT	_	10	det	_	_
9	clinical	_	ADJ	JJ	_	10	amod	_	_
10	development	_	NOUN	NN	_	6	nmod	_	_
11	of	_	ADP	IN	_	14	case	_	_
12	all	_	DET	DT	_	14	det	_	_
13	antidepressant	_	ADJ	JJ	_	14	amod	_	_
14	drugs	_	NOUN	NNS	_	10	nmod	_	_

#	Celexa	901
1	Furthermore	_	ADV	RB	_	36	advmod	_	_
2	,	_	.	,	_	36	punct	_	_
3	in	_	ADP	IN	_	5	case	_	_
4	those	_	DET	DT	_	5	det	_	_
5	circumstances	_	NOUN	NNS	_	36	nmod	_	_
6	when	_	ADV	WRB	_	12	advmod	_	_
7	the	_	DET	DT	_	8	det	_	_
8	drugs	_	NOUN	NNS	_	12	nsubjpass	_	_
9	have	_	VERB	VBP	_	12	aux	_	_
10	not	_	ADV	RB	_	12	neg	_	_
11	been	_	VERB	VBN	_	12	auxpass	_	_
12	studied	_	VERB	VBN	_	5	acl:relcl	_	_
13	in	_	ADP	IN	_	18	case	_	_
14	the	_	DET	DT	_	18	det	_	_
15	same	_	ADJ	JJ	_	18	amod	_	_
16	controlled	_	VERB	VBN	_	18	amod	_	_
17	clinical	_	ADJ	JJ	_	18	amod	_	_
18	trial(s	_	NOUN	NNS	_	12	nmod	_	_
19	,	_	.	,	_	36	punct	_	_
20	comparisons	_	NOUN	NNS	_	36	nsubj	_	_
21	among	_	ADP	IN	_	23	case	_	_
22	the	_	DET	DT	_	23	det	_	_
23	results	_	NOUN	NNS	_	20	nmod	_	_
24	of	_	ADP	IN	_	25	case	_	_
25	studies	_	NOUN	NNS	_	23	nmod	_	_
26	evaluating	_	VERB	VBG	_	25	acl	_	_
27	the	_	DET	DT	_	28	det	_	_
28	effectiveness	_	NOUN	NN	_	26	dobj	_	_
29	of	_	ADP	IN	_	33	case	_	_
30	different	_	ADJ	JJ	_	33	amod	_	_
31	antidepressant	_	ADJ	JJ	_	33	amod	_	_
32	drug	_	NOUN	NN	_	33	compound	_	_
33	products	_	NOUN	NNS	_	28	nmod	_	_
34	are	_	VERB	VBP	_	36	auxpass	_	_
35	inherently	_	ADV	RB	_	36	advmod	_	_
36	unreliable	_	ADJ	JJ	_	0	root	_	_

#	Celexa	902
1	Because	_	ADP	IN	_	31	mark	_	_
2	conditions	_	NOUN	NNS	_	31	nsubj	_	_
3	of	_	ADP	IN	_	4	mark	_	_
4	testing	_	VERB	VBG	_	2	acl	_	_
5	e.g	_	NOUN	NN	_	21	compound	_	_
6	,	_	.	,	_	5	punct	_	_
7	patient	_	NOUN	NN	_	8	compound	_	_
8	samples	_	NOUN	NNS	_	5	conj	_	_
9	,	_	.	,	_	5	punct	_	_
10	investigators	_	NOUN	NNS	_	5	conj	_	_
11	,	_	.	,	_	5	punct	_	_
12	doses	_	NOUN	NNS	_	5	appos	_	_
13	of	_	ADP	IN	_	15	case	_	_
14	the	_	DET	DT	_	15	det	_	_
15	treatments	_	NOUN	NNS	_	12	nmod	_	_
16	administered	_	VERB	VBN	_	15	acl	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	compared	_	VERB	VBD	_	16	conj	_	_
19	,	_	.	,	_	5	punct	_	_
20	outcome	_	NOUN	NN	_	5	conj	_	_
21	measures	_	NOUN	NNS	_	4	dobj	_	_
22	,	_	.	,	_	2	punct	_	_
23	etc	_	NOUN	NN	_	2	appos	_	_
24	vary	_	ADJ	JJR	_	23	amod	_	_
25	among	_	ADP	IN	_	26	case	_	_
26	trials	_	NOUN	NNS	_	24	nmod	_	_
27	,	_	.	,	_	2	punct	_	_
28	it	_	PRON	PRP	_	31	nsubj	_	_
29	is	_	VERB	VBZ	_	31	cop	_	_
30	virtually	_	ADV	RB	_	31	advmod	_	_
31	impossible	_	ADJ	JJ	_	0	root	_	_
32	to	_	PRT	TO	_	33	mark	_	_
33	distinguish	_	VERB	VB	_	31	xcomp	_	_
34	a	_	DET	DT	_	35	det	_	_
35	difference	_	NOUN	NN	_	33	dobj	_	_
36	in	_	ADP	IN	_	38	case	_	_
37	drug	_	NOUN	NN	_	38	compound	_	_
38	effect	_	NOUN	NN	_	35	nmod	_	_
39	from	_	ADP	IN	_	41	case	_	_
40	a	_	DET	DT	_	41	det	_	_
41	difference	_	NOUN	NN	_	35	nmod	_	_
42	due	_	ADJ	JJ	_	44	case	_	_
43	to	_	PRT	TO	_	42	mwe	_	_
44	one	_	NUM	CD	_	41	nmod	_	_
45	or	_	CONJ	CC	_	41	cc	_	_
46	more	_	NOUN	NN	_	41	conj	_	_
47	of	_	ADP	IN	_	50	case	_	_
48	the	_	DET	DT	_	50	det	_	_
49	confounding	_	VERB	VBG	_	50	amod	_	_
50	factors	_	NOUN	NNS	_	46	nmod	_	_
51	just	_	ADV	RB	_	52	advmod	_	_
52	enumerated	_	VERB	VBN	_	33	parataxis	_	_

#	Clozapine	2980
1	Concomitant	_	ADJ	JJ	_	2	amod	_	_
2	use	_	NOUN	NN	_	8	nsubj	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	Strong	_	ADJ	JJ	_	6	amod	_	_
5	CYP1A2	_	NOUN	NN	_	6	compound	_	_
6	Inhibitors	_	NOUN	NNS	_	2	nmod	_	_
7	:	_	.	:	_	2	punct	_	_
8	Reduce	_	VERB	VBP	_	0	root	_	_
9	CLOZARIL	_	NOUN	NN	_	10	compound	_	_
10	dose	_	NOUN	NN	_	8	dobj	_	_
11	to	_	PRT	TO	_	13	case	_	_
12	one	_	NUM	CD	_	13	nummod	_	_
13	third	_	NOUN	NN	_	8	nmod	_	_
14	when	_	ADV	WRB	_	15	advmod	_	_
15	coadministered	_	VERB	VBN	_	8	advcl	_	_
16	with	_	ADP	IN	_	19	case	_	_
17	strong	_	ADJ	JJ	_	19	amod	_	_
18	CYP1A2	_	NOUN	NN	_	19	compound	_	_
19	inhibitors	_	NOUN	NNS	_	15	nmod	_	_
20	e.g	_	NOUN	NN	_	19	dep	_	_
21	,	_	.	,	_	20	punct	_	_
22	fluvoxamine	_	NOUN	NN	_	20	conj	_	_
23	,	_	.	,	_	20	punct	_	_
24	ciprofloxacin	_	NOUN	NN	_	20	conj	_	_
25	,	_	.	,	_	20	punct	_	_
26	enoxacin	_	NOUN	NN	_	20	appos	_	_

#	Clozapine	2981
1	Concomitant	_	ADJ	JJ	_	2	amod	_	_
2	use	_	NOUN	NN	_	9	nsubjpass	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	Strong	_	ADJ	JJ	_	6	amod	_	_
5	CYP3A4	_	NOUN	NN	_	6	compound	_	_
6	Inducers	_	NOUN	NNS	_	2	nmod	_	_
7	is	_	VERB	VBZ	_	9	auxpass	_	_
8	not	_	ADV	RB	_	9	neg	_	_
9	recommended	_	VERB	VBN	_	0	root	_	_

#	Clozapine	2982
1	Discontinuation	_	NOUN	NN	_	0	root	_	_
2	of	_	ADP	IN	_	6	case	_	_
3	CYP1A2	_	NOUN	NN	_	6	compound	_	_
4	or	_	CONJ	CC	_	3	cc	_	_
5	CYP3A4	_	NOUN	NN	_	3	conj	_	_
6	Inducers	_	NOUN	NNS	_	1	nmod	_	_
7	:	_	.	:	_	1	punct	_	_
8	Consider	_	VERB	VBP	_	9	advmod	_	_
9	reducing	_	VERB	VBG	_	1	dep	_	_
10	CLOZARIL	_	NOUN	NN	_	11	compound	_	_
11	dose	_	NOUN	NN	_	9	dobj	_	_
12	when	_	ADV	WRB	_	14	advmod	_	_
13	CYP1A2	_	NOUN	NN	_	14	nsubj	_	_
14	inducers	_	NOUN	NNS	_	9	nmod	_	_
15	e.g	_	NOUN	NN	_	26	nsubjpass	_	_
16	,	_	.	,	_	15	punct	_	_
17	tobacco	_	ADP	IN	_	18	case	_	_
18	smoke	_	NOUN	NN	_	15	nmod	_	_
19	or	_	CONJ	CC	_	18	cc	_	_
20	CYP3A4	_	NOUN	NN	_	18	conj	_	_
21	inducers	_	NOUN	NNS	_	22	compound	_	_
22	e.g	_	NOUN	NN	_	18	dep	_	_
23	,	_	.	,	_	15	punct	_	_
24	carbamazepine	_	NOUN	NN	_	15	appos	_	_
25	are	_	VERB	VBP	_	26	auxpass	_	_
26	discontinued	_	VERB	VBN	_	14	ccomp	_	_

#	Clozapine	2983
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	is	_	VERB	VBZ	_	4	cop	_	_
3	a	_	DET	DT	_	4	det	_	_
4	substrate	_	NOUN	NN	_	0	root	_	_
5	for	_	ADP	IN	_	9	case	_	_
6	many	_	ADJ	JJ	_	9	amod	_	_
7	cytochrome	_	NOUN	NN	_	9	compound	_	_
8	P450	_	NOUN	NN	_	9	compound	_	_
9	isozymes	_	NOUN	NNS	_	4	nmod	_	_
10	,	_	.	,	_	4	punct	_	_
11	in	_	ADP	IN	_	13	case	_	_
12	particular	_	ADJ	JJ	_	13	amod	_	_
13	CYP1A2	_	NOUN	NN	_	4	nmod	_	_
14	,	_	.	,	_	13	punct	_	_
15	CYP3A4	_	NOUN	NN	_	13	conj	_	_
16	,	_	.	,	_	13	punct	_	_
17	and	_	CONJ	CC	_	13	cc	_	_
18	CYP2D6	_	NOUN	NN	_	13	conj	_	_

#	Clozapine	2984
1	Use	_	NOUN	NN	_	2	compound	_	_
2	caution	_	NOUN	NN	_	0	root	_	_
3	when	_	ADV	WRB	_	4	advmod	_	_
4	administering	_	VERB	VBG	_	2	acl	_	_
5	CLOZARIL	_	NOUN	NN	_	4	dobj	_	_
6	concomitantly	_	ADV	RB	_	8	advmod	_	_
7	with	_	ADP	IN	_	8	case	_	_
8	drugs	_	NOUN	NNS	_	2	nmod	_	_
9	that	_	DET	WDT	_	11	nsubj	_	_
10	are	_	VERB	VBP	_	11	cop	_	_
11	inducers	_	NOUN	NNS	_	8	acl:relcl	_	_
12	or	_	CONJ	CC	_	11	cc	_	_
13	inhibitors	_	NOUN	NNS	_	11	conj	_	_
14	of	_	ADP	IN	_	16	case	_	_
15	these	_	DET	DT	_	16	det	_	_
16	enzymes	_	NOUN	NNS	_	13	nmod	_	_

#	Clozapine	2985
1	CYP1A2	_	NOUN	NN	_	2	compound	_	_
2	Inhibitors	_	NOUN	NNS	_	11	nsubj	_	_
3	Concomitant	_	ADJ	JJ	_	4	amod	_	_
4	use	_	NOUN	NN	_	2	dep	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	CLOZARIL	_	NOUN	NN	_	4	nmod	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	CYP1A2	_	NOUN	NN	_	6	conj	_	_
9	inhibitors	_	NOUN	NNS	_	6	dep	_	_
10	can	_	VERB	MD	_	11	aux	_	_
11	increase	_	VERB	VB	_	0	root	_	_
12	plasma	_	NOUN	NN	_	13	compound	_	_
13	levels	_	NOUN	NNS	_	11	dobj	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	DRUG	_	NOUN	NN	_	13	nmod	_	_
16	,	_	.	,	_	11	punct	_	_
17	potentially	_	ADV	RB	_	18	advmod	_	_
18	resulting	_	VERB	VBG	_	11	advcl	_	_
19	in	_	ADP	IN	_	21	case	_	_
20	adverse	_	ADJ	JJ	_	21	amod	_	_
21	reactions	_	NOUN	NNS	_	18	nmod	_	_

#	Clozapine	2986
1	Reduce	_	VERB	VB	_	0	root	_	_
2	the	_	DET	DT	_	4	det	_	_
3	CLOZARIL	_	NOUN	NN	_	4	compound	_	_
4	dose	_	NOUN	NN	_	1	dobj	_	_
5	to	_	PRT	TO	_	7	case	_	_
6	one	_	NUM	CD	_	7	nummod	_	_
7	third	_	NOUN	NN	_	1	nmod	_	_
8	of	_	ADP	IN	_	11	case	_	_
9	the	_	DET	DT	_	11	det	_	_
10	original	_	ADJ	JJ	_	11	amod	_	_
11	dose	_	NOUN	NN	_	7	nmod	_	_
12	when	_	ADV	WRB	_	15	advmod	_	_
13	CLOZARIL	_	NOUN	NN	_	15	nsubjpass	_	_
14	is	_	VERB	VBZ	_	15	auxpass	_	_
15	coadministered	_	VERB	VBN	_	1	advcl	_	_
16	with	_	ADP	IN	_	19	case	_	_
17	strong	_	ADJ	JJ	_	19	amod	_	_
18	CYP1A2	_	NOUN	NN	_	19	compound	_	_
19	inhibitors	_	NOUN	NNS	_	15	nmod	_	_
20	e.g	_	NOUN	NN	_	19	dep	_	_
21	,	_	.	,	_	20	punct	_	_
22	fluvoxamine	_	NOUN	NN	_	20	conj	_	_
23	,	_	.	,	_	20	punct	_	_
24	ciprofloxacin	_	NOUN	NN	_	20	conj	_	_
25	,	_	.	,	_	20	punct	_	_
26	or	_	CONJ	CC	_	20	cc	_	_
27	enoxacin	_	NOUN	NN	_	20	conj	_	_

#	Clozapine	2987
1	The	_	DET	DT	_	3	det	_	_
2	CLOZARIL	_	NOUN	NN	_	3	compound	_	_
3	dose	_	NOUN	NN	_	6	nsubjpass	_	_
4	should	_	VERB	MD	_	6	aux	_	_
5	be	_	VERB	VB	_	6	auxpass	_	_
6	increased	_	VERB	VBN	_	0	root	_	_
7	to	_	PRT	TO	_	10	case	_	_
8	the	_	DET	DT	_	10	det	_	_
9	original	_	ADJ	JJ	_	10	amod	_	_
10	dose	_	NOUN	NN	_	6	nmod	_	_
11	when	_	ADV	WRB	_	18	advmod	_	_
12	coadministration	_	NOUN	NN	_	18	nsubjpass	_	_
13	of	_	ADP	IN	_	16	case	_	_
14	strong	_	ADJ	JJ	_	16	amod	_	_
15	CYP1A2	_	NOUN	NN	_	16	compound	_	_
16	inhibitors	_	NOUN	NNS	_	12	nmod	_	_
17	is	_	VERB	VBZ	_	18	auxpass	_	_
18	discontinued	_	VERB	VBN	_	6	advcl	_	_

#	Clozapine	2988
1	Moderate	_	ADJ	JJ	_	5	amod	_	_
2	or	_	CONJ	CC	_	1	cc	_	_
3	weak	_	ADJ	JJ	_	1	conj	_	_
4	CYP1A2	_	NOUN	NN	_	5	compound	_	_
5	inhibitors	_	NOUN	NNS	_	6	nsubj	_	_
6	include	_	VERB	VBP	_	0	root	_	_
7	oral	_	ADJ	JJ	_	8	amod	_	_
8	contraceptives	_	NOUN	NNS	_	6	dobj	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	caffeine	_	NOUN	NN	_	8	conj	_	_

#	Clozapine	2989
1	Monitor	_	NOUN	NN	_	2	compound	_	_
2	patients	_	NOUN	NNS	_	0	root	_	_
3	closely	_	ADV	RB	_	4	advmod	_	_
4	when	_	ADV	WRB	_	7	advmod	_	_
5	CLOZARIL	_	NOUN	NN	_	7	nsubjpass	_	_
6	is	_	VERB	VBZ	_	7	auxpass	_	_
7	coadministered	_	VERB	VBN	_	2	acl:relcl	_	_
8	with	_	ADP	IN	_	10	case	_	_
9	these	_	DET	DT	_	10	det	_	_
10	inhibitors	_	NOUN	NNS	_	7	nmod	_	_

#	Clozapine	2990
1	Consider	_	NOUN	NN	_	0	root	_	_
2	reducing	_	VERB	VBG	_	1	acl	_	_
3	the	_	DET	DT	_	5	det	_	_
4	CLOZARIL	_	NOUN	NN	_	5	compound	_	_
5	dosage	_	NOUN	NN	_	2	dobj	_	_
6	if	_	ADP	IN	_	5	dep	_	_
7	necessary	_	ADJ	JJ	_	6	root	_	_

#	Clozapine	2991
1	CYP2D6	_	NOUN	NN	_	4	compound	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	CYP3A4	_	NOUN	NN	_	1	conj	_	_
4	Inhibitors	_	NOUN	NNS	_	37	nsubj	_	_
5	Concomitant	_	ADJ	JJ	_	6	amod	_	_
6	treatment	_	NOUN	NN	_	4	dep	_	_
7	with	_	ADP	IN	_	8	case	_	_
8	CLOZARIL	_	NOUN	NN	_	6	nmod	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	CYP2D6	_	NOUN	NN	_	8	conj	_	_
11	or	_	CONJ	CC	_	8	cc	_	_
12	CYP3A4	_	NOUN	NN	_	13	compound	_	_
13	inhibitors	_	NOUN	NNS	_	8	conj	_	_
14	e.g	_	NOUN	NN	_	13	dep	_	_
15	,	_	.	,	_	8	punct	_	_
16	cimetidine	_	NOUN	NN	_	8	conj	_	_
17	,	_	.	,	_	8	punct	_	_
18	escitalopram	_	NOUN	NN	_	8	conj	_	_
19	,	_	.	,	_	8	punct	_	_
20	erythromycin	_	NOUN	NN	_	8	conj	_	_
21	,	_	.	,	_	8	punct	_	_
22	paroxetine	_	NOUN	NN	_	8	conj	_	_
23	,	_	.	,	_	8	punct	_	_
24	bupropion	_	NOUN	NN	_	8	conj	_	_
25	,	_	.	,	_	8	punct	_	_
26	fluoxetine	_	NOUN	NN	_	8	conj	_	_
27	,	_	.	,	_	8	punct	_	_
28	quinidine	_	NOUN	NN	_	8	conj	_	_
29	,	_	.	,	_	8	punct	_	_
30	duloxetine	_	NOUN	NN	_	8	conj	_	_
31	,	_	.	,	_	8	punct	_	_
32	terbinafine	_	NOUN	NN	_	8	conj	_	_
33	,	_	.	,	_	8	punct	_	_
34	or	_	CONJ	CC	_	8	cc	_	_
35	sertraline	_	NOUN	NN	_	8	conj	_	_
36	can	_	VERB	MD	_	37	aux	_	_
37	increase	_	VERB	VB	_	0	root	_	_
38	DRUG	_	NOUN	NN	_	39	compound	_	_
39	levels	_	NOUN	NNS	_	37	dobj	_	_
40	and	_	CONJ	CC	_	37	cc	_	_
41	lead	_	VERB	VBP	_	37	conj	_	_
42	to	_	PRT	TO	_	44	case	_	_
43	adverse	_	ADJ	JJ	_	44	amod	_	_
44	reactions	_	NOUN	NNS	_	41	nmod	_	_

#	Clozapine	2992
1	Use	_	NOUN	NN	_	2	compound	_	_
2	caution	_	NOUN	NN	_	0	root	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	monitor	_	NOUN	NN	_	5	compound	_	_
5	patients	_	NOUN	NNS	_	2	conj	_	_
6	closely	_	ADV	RB	_	7	advmod	_	_
7	when	_	ADV	RB	_	8	advmod	_	_
8	using	_	VERB	VBG	_	2	acl	_	_
9	such	_	ADJ	JJ	_	10	amod	_	_
10	inhibitors	_	NOUN	NNS	_	8	dobj	_	_

#	Clozapine	2993
1	Consider	_	NOUN	NN	_	0	root	_	_
2	reducing	_	VERB	VBG	_	1	acl	_	_
3	the	_	DET	DT	_	5	det	_	_
4	CLOZARIL	_	NOUN	NN	_	5	compound	_	_
5	dose	_	NOUN	NN	_	2	dobj	_	_

#	Clozapine	2994
1	CYP1A2	_	NOUN	NN	_	4	nsubj	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	CYP3A4	_	NOUN	NN	_	1	conj	_	_
4	Inducers	_	VERB	VBZ	_	15	aux	_	_
5	Concomitant	_	ADJ	JJ	_	6	amod	_	_
6	treatment	_	NOUN	NN	_	4	dobj	_	_
7	with	_	ADP	IN	_	8	case	_	_
8	drugs	_	NOUN	NNS	_	6	nmod	_	_
9	that	_	DET	WDT	_	10	nsubj	_	_
10	induce	_	VERB	VBP	_	8	acl:relcl	_	_
11	CYP1A2	_	NOUN	NN	_	10	dobj	_	_
12	or	_	CONJ	CC	_	11	cc	_	_
13	CYP3A4	_	NOUN	NN	_	11	conj	_	_
14	can	_	VERB	MD	_	15	aux	_	_
15	decrease	_	VERB	VB	_	0	root	_	_
16	the	_	DET	DT	_	18	det	_	_
17	plasma	_	NOUN	NN	_	18	compound	_	_
18	concentration	_	NOUN	NN	_	15	dobj	_	_
19	of	_	ADP	IN	_	20	case	_	_
20	DRUG	_	NOUN	NN	_	18	nmod	_	_
21	,	_	.	,	_	15	punct	_	_
22	resulting	_	VERB	VBG	_	15	advcl	_	_
23	in	_	ADP	IN	_	25	case	_	_
24	decreased	_	VERB	VBN	_	25	amod	_	_
25	effectiveness	_	NOUN	NN	_	22	nmod	_	_
26	of	_	ADP	IN	_	27	case	_	_
27	CLOZARIL	_	NOUN	NN	_	25	nmod	_	_

#	Clozapine	2995
1	Tobacco	_	NOUN	NN	_	2	compound	_	_
2	smoke	_	NOUN	NN	_	6	nsubj	_	_
3	is	_	VERB	VBZ	_	6	cop	_	_
4	a	_	DET	DT	_	6	det	_	_
5	moderate	_	ADJ	JJ	_	6	amod	_	_
6	inducer	_	NOUN	NN	_	0	root	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	CYP1A2	_	NOUN	NN	_	6	nmod	_	_

#	Clozapine	2996
1	Strong	_	ADJ	JJ	_	3	amod	_	_
2	CYP3A4	_	NOUN	NN	_	3	compound	_	_
3	inducers	_	NOUN	NNS	_	4	nsubj	_	_
4	include	_	VERB	VBP	_	0	root	_	_
5	carbamazepine	_	NOUN	NN	_	11	compound	_	_
6	,	_	.	,	_	5	punct	_	_
7	phenytoin	_	NOUN	NN	_	5	conj	_	_
8	,	_	.	,	_	5	punct	_	_
9	St	_	NOUN	NN	_	10	compound	_	_
10	John's	_	NOUN	NNS	_	5	conj	_	_
11	wort	_	VERB	VBP	_	4	ccomp	_	_
12	,	_	.	,	_	11	punct	_	_
13	and	_	CONJ	CC	_	11	cc	_	_
14	rifampin	_	NOUN	NN	_	11	conj	_	_

#	Clozapine	2997
1	It	_	PRON	PRP	_	4	nsubj	_	_
2	may	_	VERB	MD	_	4	aux	_	_
3	be	_	VERB	VB	_	4	cop	_	_
4	necessary	_	ADJ	JJ	_	0	root	_	_
5	to	_	PRT	TO	_	6	mark	_	_
6	increase	_	VERB	VB	_	4	xcomp	_	_
7	the	_	DET	DT	_	9	det	_	_
8	CLOZARIL	_	NOUN	NN	_	9	compound	_	_
9	dose	_	NOUN	NN	_	6	dobj	_	_
10	if	_	DET	WDT	_	11	nsubj	_	_
11	used	_	VERB	VBN	_	9	acl	_	_
12	concomitantly	_	ADV	RB	_	11	advmod	_	_
13	with	_	ADP	IN	_	14	case	_	_
14	inducers	_	NOUN	NNS	_	11	nmod	_	_
15	of	_	ADP	IN	_	17	case	_	_
16	these	_	DET	DT	_	17	det	_	_
17	enzymes	_	NOUN	NNS	_	14	nmod	_	_

#	Clozapine	2998
1	However	_	ADV	RB	_	13	advmod	_	_
2	,	_	.	,	_	13	punct	_	_
3	concomitant	_	ADJ	JJ	_	4	amod	_	_
4	use	_	NOUN	NN	_	13	nsubjpass	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	CLOZARIL	_	NOUN	NN	_	4	nmod	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	strong	_	ADJ	JJ	_	10	amod	_	_
9	CYP3A4	_	NOUN	NN	_	10	compound	_	_
10	inducers	_	NOUN	NNS	_	6	conj	_	_
11	is	_	VERB	VBZ	_	13	auxpass	_	_
12	not	_	ADV	RB	_	13	neg	_	_
13	recommended	_	VERB	VBN	_	0	root	_	_

#	Clozapine	2999
1	Consider	_	NOUN	NN	_	0	root	_	_
2	reducing	_	VERB	VBG	_	1	acl	_	_
3	the	_	DET	DT	_	5	det	_	_
4	CLOZARIL	_	NOUN	NN	_	5	compound	_	_
5	dosage	_	NOUN	NN	_	2	dobj	_	_
6	when	_	ADV	WRB	_	7	advmod	_	_
7	discontinuing	_	VERB	VBG	_	2	advcl	_	_
8	coadministered	_	VERB	VBN	_	10	amod	_	_
9	enzyme	_	NOUN	NN	_	10	compound	_	_
10	inducers	_	NOUN	NNS	_	7	dobj	_	_
11	because	_	ADP	IN	_	16	mark	_	_
12	discontinuation	_	NOUN	NN	_	16	nsubj	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	inducers	_	NOUN	NNS	_	12	nmod	_	_
15	can	_	VERB	MD	_	16	aux	_	_
16	result	_	VERB	VB	_	7	parataxis	_	_
17	in	_	ADP	IN	_	21	case	_	_
18	increased	_	VERB	VBN	_	21	amod	_	_
19	DRUG	_	NOUN	NN	_	21	compound	_	_
20	plasma	_	NOUN	NN	_	21	compound	_	_
21	levels	_	NOUN	NNS	_	16	nmod	_	_
22	and	_	CONJ	CC	_	16	cc	_	_
23	an	_	DET	DT	_	25	det	_	_
24	increased	_	ADJ	JJ	_	25	amod	_	_
25	risk	_	NOUN	NN	_	16	conj	_	_
26	of	_	ADP	IN	_	28	case	_	_
27	adverse	_	ADJ	JJ	_	28	amod	_	_
28	reactions	_	NOUN	NNS	_	25	nmod	_	_

#	Clozapine	3000
1	Drugs	_	NOUN	NNS	_	0	root	_	_
2	that	_	DET	WDT	_	3	nsubj	_	_
3	Cause	_	VERB	VBP	_	1	acl:relcl	_	_
4	QT	_	NOUN	NN	_	8	compound	_	_
5	Interval	_	ADJ	JJ	_	8	amod	_	_
6	Prolongation	_	NOUN	NN	_	8	compound	_	_
7	Use	_	NOUN	NN	_	8	compound	_	_
8	caution	_	NOUN	NN	_	3	dobj	_	_
9	when	_	ADV	WRB	_	10	advmod	_	_
10	administering	_	VERB	VBG	_	3	advcl	_	_
11	concomitant	_	ADJ	JJ	_	12	amod	_	_
12	medications	_	NOUN	NNS	_	10	dobj	_	_
13	that	_	DET	WDT	_	14	nsubj	_	_
14	prolong	_	VERB	VBP	_	12	acl:relcl	_	_
15	the	_	DET	DT	_	17	det	_	_
16	QT	_	NOUN	NN	_	17	compound	_	_
17	interval	_	ADJ	JJ	_	14	dobj	_	_
18	or	_	CONJ	CC	_	14	cc	_	_
19	inhibit	_	VERB	VBP	_	14	conj	_	_
20	the	_	DET	DT	_	21	det	_	_
21	metabolism	_	NOUN	NN	_	19	dobj	_	_
22	of	_	ADP	IN	_	23	case	_	_
23	DRUG	_	NOUN	NN	_	21	nmod	_	_

#	Clozapine	3001
1	Drugs	_	NOUN	NNS	_	6	nsubj	_	_
2	that	_	DET	WDT	_	3	nsubj	_	_
3	cause	_	VERB	VBP	_	1	acl:relcl	_	_
4	QT	_	NOUN	NN	_	5	compound	_	_
5	prolongation	_	NOUN	NN	_	3	dobj	_	_
6	include	_	VERB	VBP	_	0	root	_	_
7	:	_	.	:	_	6	punct	_	_
8	specific	_	ADJ	JJ	_	9	amod	_	_
9	antipsychotics	_	NOUN	NNS	_	6	dep	_	_
10	e.g	_	NOUN	NN	_	9	dep	_	_
11	,	_	.	,	_	10	punct	_	_
12	ziprasidone	_	NOUN	NN	_	10	conj	_	_
13	,	_	.	,	_	10	punct	_	_
14	iloperidone	_	NOUN	NN	_	10	conj	_	_
15	,	_	.	,	_	10	punct	_	_
16	chlorpromazine	_	NOUN	NN	_	10	conj	_	_
17	,	_	.	,	_	10	punct	_	_
18	thioridazine	_	NOUN	NN	_	10	conj	_	_
19	,	_	.	,	_	10	punct	_	_
20	mesoridazine	_	NOUN	NN	_	10	conj	_	_
21	,	_	.	,	_	10	punct	_	_
22	droperidol	_	NOUN	NN	_	10	conj	_	_
23	,	_	.	,	_	10	punct	_	_
24	and	_	CONJ	CC	_	10	cc	_	_
25	pimozide	_	NOUN	NN	_	10	conj	_	_
26	,	_	.	,	_	9	punct	_	_
27	specific	_	ADJ	JJ	_	28	amod	_	_
28	antibiotics	_	NOUN	NNS	_	9	appos	_	_
29	e.g	_	NOUN	NN	_	28	dep	_	_
30	,	_	.	,	_	29	punct	_	_
31	erythromycin	_	NOUN	NN	_	29	conj	_	_
32	,	_	.	,	_	29	punct	_	_
33	gatifloxacin	_	NOUN	NN	_	29	conj	_	_
34	,	_	.	,	_	29	punct	_	_
35	moxifloxacin	_	NOUN	NN	_	29	conj	_	_
36	,	_	.	,	_	29	punct	_	_
37	sparfloxacin	_	NOUN	NN	_	29	conj	_	_
38	,	_	.	,	_	29	punct	_	_
39	Class	_	NOUN	NN	_	41	compound	_	_
40	1A	_	NOUN	NN	_	41	compound	_	_
41	antiarrhythmics	_	NOUN	NNS	_	29	appos	_	_
42	e.g	_	NOUN	NN	_	41	dep	_	_
43	,	_	.	,	_	42	punct	_	_
44	quinidine	_	NOUN	NN	_	42	conj	_	_
45	,	_	.	,	_	42	punct	_	_
46	procainamide	_	NOUN	NN	_	42	conj	_	_
47	or	_	CONJ	CC	_	42	cc	_	_
48	Class	_	NOUN	NN	_	50	compound	_	_
49	III	_	NUM	CD	_	50	nummod	_	_
50	antiarrhythmics	_	NOUN	NNS	_	42	conj	_	_
51	e.g	_	NOUN	NN	_	50	dep	_	_
52	,	_	.	,	_	42	punct	_	_
53	amiodarone	_	NOUN	NN	_	42	conj	_	_
54	,	_	.	,	_	42	punct	_	_
55	sotalol	_	NOUN	NN	_	42	conj	_	_
56	,	_	.	,	_	42	punct	_	_
57	and	_	CONJ	CC	_	42	cc	_	_
58	others	_	NOUN	NNS	_	59	compound	_	_
59	e.g	_	NOUN	NN	_	42	conj	_	_
60	,	_	.	,	_	42	punct	_	_
61	pentamidine	_	NOUN	NN	_	42	conj	_	_
62	,	_	.	,	_	42	punct	_	_
63	levomethadyl	_	NOUN	NN	_	64	compound	_	_
64	acetate	_	NOUN	NN	_	42	conj	_	_
65	,	_	.	,	_	42	punct	_	_
66	methadone	_	NOUN	NN	_	42	conj	_	_
67	,	_	.	,	_	42	punct	_	_
68	halofantrine	_	NOUN	NN	_	42	conj	_	_
69	,	_	.	,	_	42	punct	_	_
70	mefloquine	_	NOUN	NN	_	42	conj	_	_
71	,	_	.	,	_	42	punct	_	_
72	dolasetron	_	NOUN	NN	_	73	compound	_	_
73	mesylate	_	NOUN	NN	_	42	conj	_	_
74	,	_	.	,	_	42	punct	_	_
75	probucol	_	NOUN	NN	_	42	conj	_	_
76	or	_	CONJ	CC	_	42	cc	_	_
77	tacrolimus	_	NOUN	NN	_	42	conj	_	_

#	Clozapine	3002
1	Concomitant	_	ADJ	JJ	_	2	amod	_	_
2	use	_	NOUN	NN	_	12	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	CLOZARIL	_	NOUN	NN	_	2	nmod	_	_
5	with	_	ADP	IN	_	7	case	_	_
6	other	_	ADJ	JJ	_	7	amod	_	_
7	drugs	_	NOUN	NNS	_	2	nmod	_	_
8	metabolized	_	VERB	VBN	_	7	acl	_	_
9	by	_	ADP	IN	_	10	case	_	_
10	CYP2D6	_	NOUN	NN	_	8	nmod	_	_
11	can	_	VERB	MD	_	12	aux	_	_
12	increase	_	VERB	VB	_	0	root	_	_
13	levels	_	NOUN	NNS	_	12	dobj	_	_
14	of	_	ADP	IN	_	17	case	_	_
15	these	_	DET	DT	_	17	det	_	_
16	CYP2D6	_	NOUN	NN	_	17	compound	_	_
17	substrates	_	NOUN	NNS	_	13	nmod	_	_

#	Clozapine	3003
1	Use	_	NOUN	NN	_	2	compound	_	_
2	caution	_	NOUN	NN	_	0	root	_	_
3	when	_	ADV	WRB	_	4	advmod	_	_
4	coadministering	_	VERB	VBG	_	2	acl	_	_
5	CLOZARIL	_	NOUN	NN	_	4	dobj	_	_
6	with	_	ADP	IN	_	8	case	_	_
7	other	_	ADJ	JJ	_	8	amod	_	_
8	drugs	_	NOUN	NNS	_	4	nmod	_	_
9	that	_	DET	WDT	_	11	nsubjpass	_	_
10	are	_	VERB	VBP	_	11	auxpass	_	_
11	metabolized	_	VERB	VBN	_	8	acl:relcl	_	_
12	by	_	ADP	IN	_	13	case	_	_
13	CYP2D6	_	NOUN	NN	_	11	nmod	_	_

#	Clozapine	3004
1	It	_	PRON	PRP	_	4	nsubj	_	_
2	may	_	VERB	MD	_	4	aux	_	_
3	be	_	VERB	VB	_	4	cop	_	_
4	necessary	_	ADJ	JJ	_	0	root	_	_
5	to	_	PRT	TO	_	6	mark	_	_
6	use	_	VERB	VB	_	4	xcomp	_	_
7	lower	_	ADJ	JJ	_	8	amod	_	_
8	doses	_	NOUN	NNS	_	6	dobj	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	such	_	ADJ	JJ	_	11	amod	_	_
11	drugs	_	NOUN	NNS	_	8	nmod	_	_
12	than	_	ADP	IN	_	14	mark	_	_
13	usually	_	ADV	RB	_	14	advmod	_	_
14	prescribed	_	VERB	VBN	_	6	advcl	_	_

#	Clozapine	3005
1	Such	_	ADJ	JJ	_	2	amod	_	_
2	drugs	_	NOUN	NNS	_	3	nsubj	_	_
3	include	_	VERB	VBP	_	0	root	_	_
4	specific	_	ADJ	JJ	_	5	amod	_	_
5	antidepressants	_	NOUN	NNS	_	3	dobj	_	_
6	,	_	.	,	_	5	punct	_	_
7	phenothiazines	_	NOUN	NNS	_	5	conj	_	_
8	,	_	.	,	_	5	punct	_	_
9	carbamazepine	_	NOUN	NN	_	5	conj	_	_
10	,	_	.	,	_	5	punct	_	_
11	and	_	CONJ	CC	_	5	cc	_	_
12	Type	_	NOUN	NN	_	14	compound	_	_
13	1C	_	NOUN	NN	_	14	compound	_	_
14	antiarrhythmics	_	NOUN	NNS	_	5	conj	_	_
15	e.g	_	NOUN	NN	_	14	dep	_	_
16	,	_	.	,	_	15	punct	_	_
17	propafenone	_	NOUN	NN	_	15	conj	_	_
18	,	_	.	,	_	15	punct	_	_
19	flecainide	_	NOUN	NN	_	15	conj	_	_
20	,	_	.	,	_	15	punct	_	_
21	and	_	CONJ	CC	_	15	cc	_	_
22	encainide	_	NOUN	NN	_	15	conj	_	_

#	Clozapine	3006
1	The	_	DET	DT	_	2	det	_	_
2	mechanism	_	NOUN	NN	_	8	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	action	_	NOUN	NN	_	2	nmod	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	is	_	VERB	VBZ	_	8	auxpass	_	_
8	unknown	_	ADJ	JJ	_	0	root	_	_

#	Clozapine	3007
1	However	_	ADV	RB	_	6	advmod	_	_
2	,	_	.	,	_	6	punct	_	_
3	it	_	PRON	PRP	_	6	nsubjpass	_	_
4	has	_	VERB	VBZ	_	6	aux	_	_
5	been	_	VERB	VBN	_	6	auxpass	_	_
6	proposed	_	VERB	VBN	_	0	root	_	_
7	that	_	ADP	IN	_	16	mark	_	_
8	the	_	DET	DT	_	10	det	_	_
9	therapeutic	_	ADJ	JJ	_	10	amod	_	_
10	efficacy	_	NOUN	NN	_	16	nsubjpass	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_
13	in	_	ADP	IN	_	14	case	_	_
14	schizophrenia	_	NOUN	NN	_	10	nmod	_	_
15	is	_	VERB	VBZ	_	16	auxpass	_	_
16	mediated	_	VERB	VBN	_	6	ccomp	_	_
17	through	_	ADP	IN	_	18	case	_	_
18	antagonism	_	NOUN	NN	_	16	nmod	_	_
19	of	_	ADP	IN	_	24	case	_	_
20	the	_	DET	DT	_	24	det	_	_
21	dopamine	_	NOUN	NN	_	24	compound	_	_
22	type	_	NOUN	NN	_	24	compound	_	_
23	2	_	NUM	CD	_	24	nummod	_	_
24	D2	_	NOUN	NN	_	18	nmod	_	_
25	and	_	CONJ	CC	_	24	cc	_	_
26	the	_	DET	DT	_	32	det	_	_
27	serotonin	_	NOUN	NN	_	32	compound	_	_
28	type	_	NOUN	NN	_	32	compound	_	_
29	2A	_	NOUN	NN	_	32	compound	_	_
30	5	_	NUM	CD	_	32	nummod	_	_
31	HT2A	_	NOUN	NN	_	32	compound	_	_
32	receptors	_	NOUN	NNS	_	24	conj	_	_

#	Clozapine	3008
1	CLOZARIL	_	NOUN	NN	_	3	nsubj	_	_
2	also	_	ADV	RB	_	3	advmod	_	_
3	acts	_	VERB	VBZ	_	0	root	_	_
4	as	_	ADP	IN	_	6	case	_	_
5	an	_	DET	DT	_	6	det	_	_
6	antagonist	_	NOUN	NN	_	3	nmod	_	_
7	at	_	ADP	IN	_	15	case	_	_
8	adrenergic	_	ADJ	JJ	_	15	amod	_	_
9	,	_	.	,	_	8	punct	_	_
10	cholinergic	_	ADJ	JJ	_	8	conj	_	_
11	,	_	.	,	_	8	punct	_	_
12	histaminergic	_	ADJ	JJ	_	8	conj	_	_
13	and	_	CONJ	CC	_	8	cc	_	_
14	other	_	ADJ	JJ	_	8	conj	_	_
15	dopaminergic	_	ADJ	JJ	_	6	nmod	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	serotonergic	_	ADJ	JJ	_	15	conj	_	_
18	receptors	_	NOUN	NNS	_	15	dep	_	_

#	Clozapine	3009
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	demonstrated	_	VERB	VBD	_	0	root	_	_
3	binding	_	NOUN	NN	_	4	compound	_	_
4	affinity	_	NOUN	NN	_	2	dobj	_	_
5	to	_	PRT	TO	_	8	case	_	_
6	the	_	DET	DT	_	8	det	_	_
7	following	_	VERB	VBG	_	8	amod	_	_
8	receptors	_	NOUN	NNS	_	4	nmod	_	_
9	:	_	.	:	_	2	punct	_	_
10	histamine	_	NOUN	NN	_	14	compound	_	_
11	H1	_	NOUN	NN	_	14	compound	_	_
12	Ki	_	NOUN	NN	_	14	compound	_	_
13	1.1	_	NUM	CD	_	14	nummod	_	_
14	nM	_	NOUN	NN	_	2	parataxis	_	_
15	,	_	.	,	_	14	punct	_	_
16	adrenergic	_	ADJ	JJ	_	20	amod	_	_
17	A1A	_	NOUN	NN	_	20	compound	_	_
18	Ki	_	NOUN	NN	_	20	compound	_	_
19	1.6	_	NUM	CD	_	20	nummod	_	_
20	nM	_	NOUN	NN	_	14	appos	_	_
21	,	_	.	,	_	14	punct	_	_
22	serotonin	_	NOUN	NN	_	27	compound	_	_
23	5	_	NUM	CD	_	27	nummod	_	_
24	HT6	_	NOUN	NN	_	27	compound	_	_
25	Ki	_	NOUN	NN	_	27	compound	_	_
26	4	_	NUM	CD	_	27	nummod	_	_
27	nM	_	NOUN	NN	_	14	appos	_	_
28	,	_	.	,	_	14	punct	_	_
29	serotonin	_	NOUN	NN	_	34	compound	_	_
30	5	_	NUM	CD	_	34	nummod	_	_
31	HT2A	_	NOUN	NN	_	34	compound	_	_
32	Ki	_	NOUN	NN	_	34	compound	_	_
33	5.4	_	NUM	CD	_	34	nummod	_	_
34	nM	_	NOUN	NN	_	14	conj	_	_
35	,	_	.	,	_	14	punct	_	_
36	muscarinic	_	ADJ	JJ	_	40	amod	_	_
37	M1	_	NOUN	NN	_	40	compound	_	_
38	Ki	_	NOUN	NN	_	40	compound	_	_
39	6.2	_	NUM	CD	_	40	nummod	_	_
40	nM	_	NOUN	NN	_	14	appos	_	_
41	,	_	.	,	_	14	punct	_	_
42	serotonin	_	NOUN	NN	_	47	compound	_	_
43	5	_	NUM	CD	_	47	nummod	_	_
44	HT7	_	NOUN	NN	_	47	compound	_	_
45	Ki	_	NOUN	NN	_	47	compound	_	_
46	6.3	_	NUM	CD	_	47	nummod	_	_
47	nM	_	NOUN	NN	_	14	conj	_	_
48	,	_	.	,	_	14	punct	_	_
49	serotonin	_	NOUN	NN	_	54	compound	_	_
50	5	_	NUM	CD	_	54	nummod	_	_
51	HT2C	_	NOUN	NN	_	54	compound	_	_
52	Ki	_	NOUN	NN	_	54	compound	_	_
53	9.4	_	NUM	CD	_	54	nummod	_	_
54	nM	_	NOUN	NN	_	14	conj	_	_
55	,	_	.	,	_	14	punct	_	_
56	dopamine	_	NOUN	NN	_	60	compound	_	_
57	D4	_	NOUN	NN	_	60	compound	_	_
58	Ki	_	NOUN	NN	_	60	compound	_	_
59	24	_	NUM	CD	_	60	nummod	_	_
60	nM	_	NOUN	NN	_	14	conj	_	_
61	,	_	.	,	_	14	punct	_	_
62	adrenergic	_	ADJ	JJ	_	66	amod	_	_
63	A2A	_	NOUN	NN	_	66	compound	_	_
64	Ki	_	NOUN	NN	_	66	compound	_	_
65	90	_	NUM	CD	_	66	nummod	_	_
66	nM	_	NOUN	NN	_	14	conj	_	_
67	,	_	.	,	_	14	punct	_	_
68	serotonin	_	NOUN	NN	_	73	compound	_	_
69	5	_	NUM	CD	_	73	nummod	_	_
70	HT3	_	NOUN	NN	_	73	compound	_	_
71	Ki	_	NOUN	NN	_	73	compound	_	_
72	95	_	NUM	CD	_	73	nummod	_	_
73	nM	_	NOUN	NN	_	14	conj	_	_
74	,	_	.	,	_	14	punct	_	_
75	serotonin	_	NOUN	NN	_	80	compound	_	_
76	5	_	NUM	CD	_	80	nummod	_	_
77	HT1A	_	NOUN	NN	_	80	compound	_	_
78	Ki	_	NOUN	NN	_	80	compound	_	_
79	120	_	NUM	CD	_	80	nummod	_	_
80	nM	_	NOUN	NN	_	14	conj	_	_
81	,	_	.	,	_	14	punct	_	_
82	dopamine	_	NOUN	NN	_	86	compound	_	_
83	D2	_	NOUN	NN	_	86	compound	_	_
84	Ki	_	NOUN	NN	_	86	compound	_	_
85	160	_	NUM	CD	_	86	nummod	_	_
86	nM	_	NOUN	NN	_	14	conj	_	_
87	,	_	.	,	_	14	punct	_	_
88	dopamine	_	NOUN	NN	_	92	compound	_	_
89	D1	_	NOUN	NN	_	92	compound	_	_
90	Ki	_	NOUN	NN	_	92	compound	_	_
91	270	_	NUM	CD	_	92	nummod	_	_
92	nM	_	NOUN	NN	_	14	conj	_	_
93	,	_	.	,	_	14	punct	_	_
94	dopamine	_	NOUN	NN	_	98	compound	_	_
95	D5	_	NOUN	NN	_	98	compound	_	_
96	Ki	_	NOUN	NN	_	98	compound	_	_
97	454	_	NUM	CD	_	98	nummod	_	_
98	nM	_	NOUN	NN	_	14	conj	_	_
99	,	_	.	,	_	14	punct	_	_
100	and	_	CONJ	CC	_	14	cc	_	_
101	dopamine	_	NOUN	NN	_	105	compound	_	_
102	D3	_	NOUN	NN	_	105	compound	_	_
103	Ki	_	NOUN	NN	_	105	compound	_	_
104	555	_	NUM	CD	_	105	nummod	_	_
105	nM	_	NOUN	NN	_	14	conj	_	_

#	Clozapine	3010
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	causes	_	VERB	VBZ	_	0	root	_	_
3	little	_	ADJ	JJ	_	2	dobj	_	_
4	or	_	CONJ	CC	_	3	cc	_	_
5	no	_	DET	DT	_	3	conj	_	_
6	prolactin	_	NOUN	NN	_	7	compound	_	_
7	elevation	_	NOUN	NN	_	3	dep	_	_

#	Clozapine	3011
1	Clinical	_	ADJ	JJ	_	4	amod	_	_
2	electroencephalogram	_	NOUN	NN	_	4	compound	_	_
3	EEG	_	NOUN	NN	_	4	compound	_	_
4	studies	_	NOUN	NNS	_	5	nsubj	_	_
5	demonstrated	_	VERB	VBD	_	0	root	_	_
6	that	_	ADP	IN	_	8	mark	_	_
7	DRUG	_	NOUN	NN	_	8	nsubj	_	_
8	increases	_	VERB	VBZ	_	5	ccomp	_	_
9	delta	_	NOUN	NN	_	8	dobj	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	theta	_	PRON	PRP$	_	12	nmod:poss	_	_
12	activity	_	NOUN	NN	_	9	conj	_	_
13	and	_	CONJ	CC	_	8	cc	_	_
14	slows	_	VERB	VBZ	_	8	conj	_	_
15	dominant	_	ADJ	JJ	_	17	amod	_	_
16	alpha	_	NOUN	NN	_	17	compound	_	_
17	frequencies	_	NOUN	NNS	_	14	dobj	_	_

#	Clozapine	3012
1	Sharp	_	NOUN	NN	_	3	compound	_	_
2	wave	_	NOUN	NN	_	3	compound	_	_
3	activity	_	NOUN	NN	_	11	nsubj	_	_
4	and	_	CONJ	CC	_	3	cc	_	_
5	spike	_	NOUN	NN	_	8	compound	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	wave	_	ADJ	JJ	_	5	conj	_	_
8	complexes	_	NOUN	NNS	_	3	conj	_	_
9	may	_	VERB	MD	_	11	aux	_	_
10	also	_	ADV	RB	_	11	advmod	_	_
11	develop	_	VERB	VB	_	0	root	_	_

#	Clozapine	3013
1	Patients	_	NOUN	NNS	_	3	nsubj	_	_
2	have	_	VERB	VBP	_	3	aux	_	_
3	reported	_	VERB	VBN	_	0	root	_	_
4	an	_	DET	DT	_	5	det	_	_
5	intensification	_	NOUN	NN	_	3	dobj	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	dream	_	NOUN	NN	_	8	compound	_	_
8	activity	_	NOUN	NN	_	5	nmod	_	_
9	during	_	ADP	IN	_	11	case	_	_
10	DRUG	_	NOUN	NN	_	11	compound	_	_
11	therapy	_	NOUN	NN	_	5	nmod	_	_

#	Clozapine	3014
1	REM	_	NOUN	NN	_	2	compound	_	_
2	sleep	_	NOUN	NN	_	4	nsubjpass	_	_
3	was	_	VERB	VBD	_	4	auxpass	_	_
4	found	_	VERB	VBN	_	0	root	_	_
5	to	_	PRT	TO	_	7	mark	_	_
6	be	_	VERB	VB	_	7	auxpass	_	_
7	increased	_	VERB	VBN	_	4	xcomp	_	_
8	to	_	PRT	TO	_	9	case	_	_
9	85%	_	NOUN	NN	_	7	nmod	_	_
10	of	_	ADP	IN	_	14	case	_	_
11	the	_	DET	DT	_	14	det	_	_
12	total	_	ADJ	JJ	_	14	amod	_	_
13	sleep	_	NOUN	NN	_	14	compound	_	_
14	time	_	NOUN	NN	_	9	nmod	_	_

#	Clozapine	3015
1	In	_	ADP	IN	_	3	case	_	_
2	these	_	DET	DT	_	3	det	_	_
3	patients	_	NOUN	NNS	_	10	nmod	_	_
4	,	_	.	,	_	10	punct	_	_
5	the	_	DET	DT	_	6	det	_	_
6	onset	_	NOUN	NN	_	10	nsubj	_	_
7	of	_	ADP	IN	_	9	case	_	_
8	REM	_	NOUN	NN	_	9	compound	_	_
9	sleep	_	NOUN	NN	_	6	nmod	_	_
10	occurred	_	VERB	VBD	_	0	root	_	_
11	almost	_	ADV	RB	_	10	advmod	_	_
12	immediately	_	ADV	RB	_	10	advmod	_	_
13	after	_	ADP	IN	_	14	mark	_	_
14	falling	_	VERB	VBG	_	10	advcl	_	_
15	asleep	_	NOUN	NN	_	14	ccomp	_	_

#	Clozapine	3016
1	Absorption	_	NOUN	NN	_	14	nsubj	_	_
2	In	_	ADP	IN	_	3	case	_	_
3	humans	_	NOUN	NNS	_	1	nmod	_	_
4	,	_	.	,	_	1	punct	_	_
5	CLOZARIL	_	NOUN	NN	_	6	compound	_	_
6	tablets	_	NOUN	NNS	_	1	appos	_	_
7	25	_	NUM	CD	_	8	nummod	_	_
8	mg	_	NOUN	NN	_	6	dep	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	100	_	NUM	CD	_	11	nummod	_	_
11	mg	_	NOUN	NN	_	8	conj	_	_
12	are	_	VERB	VBP	_	14	cop	_	_
13	equally	_	ADV	RB	_	14	advmod	_	_
14	bioavailable	_	ADJ	JJ	_	0	root	_	_
15	relative	_	ADJ	JJ	_	14	advmod	_	_
16	to	_	PRT	TO	_	19	case	_	_
17	a	_	DET	DT	_	19	det	_	_
18	CLOZARIL	_	NOUN	NN	_	19	compound	_	_
19	solution	_	NOUN	NN	_	15	nmod	_	_

#	Clozapine	3017
1	Following	_	VERB	VBG	_	3	case	_	_
2	oral	_	ADJ	JJ	_	3	amod	_	_
3	administration	_	NOUN	NN	_	20	nmod	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	CLOZARIL	_	NOUN	NN	_	7	compound	_	_
6	100	_	NUM	CD	_	7	nummod	_	_
7	mg	_	NOUN	NN	_	3	nmod	_	_
8	twice	_	ADV	RB	_	9	advmod	_	_
9	daily	_	ADV	RB	_	3	advmod	_	_
10	,	_	.	,	_	20	punct	_	_
11	the	_	DET	DT	_	17	det	_	_
12	average	_	ADJ	JJ	_	17	amod	_	_
13	steady	_	ADJ	JJ	_	17	amod	_	_
14	state	_	NOUN	NN	_	17	compound	_	_
15	peak	_	ADJ	JJ	_	17	amod	_	_
16	plasma	_	NOUN	NN	_	17	compound	_	_
17	concentration	_	NOUN	NN	_	20	nsubj	_	_
18	was	_	VERB	VBD	_	20	cop	_	_
19	319	_	NUM	CD	_	20	nummod	_	_
20	ng	_	NOUN	NN	_	0	root	_	_
21	/	_	.	:	_	20	punct	_	_
22	mL	_	NOUN	NN	_	23	compound	_	_
23	range	_	NOUN	NN	_	20	dep	_	_
24	:	_	.	:	_	20	punct	_	_
25	102	_	NUM	CD	_	27	compound	_	_
26	to	_	PRT	TO	_	27	dep	_	_
27	771	_	NUM	CD	_	28	nummod	_	_
28	ng	_	NOUN	NN	_	20	dep	_	_
29	/	_	.	:	_	28	punct	_	_
30	mL	_	NOUN	NN	_	28	dep	_	_
31	,	_	.	,	_	20	punct	_	_
32	occurring	_	VERB	VBG	_	20	acl	_	_
33	at	_	ADP	IN	_	35	case	_	_
34	the	_	DET	DT	_	35	det	_	_
35	average	_	NOUN	NN	_	32	nmod	_	_
36	of	_	ADP	IN	_	39	case	_	_
37	2.5	_	NUM	CD	_	39	nummod	_	_
38	hours	_	NOUN	NNS	_	39	compound	_	_
39	range	_	NOUN	NN	_	35	nmod	_	_
40	:	_	.	:	_	20	punct	_	_
41	1	_	NUM	CD	_	43	compound	_	_
42	to	_	PRT	TO	_	43	dep	_	_
43	6	_	NUM	CD	_	44	nummod	_	_
44	hours	_	NOUN	NNS	_	20	dep	_	_
45	after	_	ADP	IN	_	46	mark	_	_
46	dosing	_	VERB	VBG	_	44	acl	_	_

#	Clozapine	3018
1	The	_	DET	DT	_	4	det	_	_
2	average	_	ADJ	JJ	_	4	amod	_	_
3	minimum	_	ADJ	JJ	_	4	amod	_	_
4	concentration	_	NOUN	NN	_	10	nsubj	_	_
5	at	_	ADP	IN	_	7	case	_	_
6	steady	_	ADJ	JJ	_	7	amod	_	_
7	state	_	NOUN	NN	_	4	nmod	_	_
8	was	_	VERB	VBD	_	10	cop	_	_
9	122	_	NUM	CD	_	10	nummod	_	_
10	ng	_	NOUN	NN	_	0	root	_	_
11	/	_	.	:	_	10	punct	_	_
12	mL	_	NOUN	NN	_	13	compound	_	_
13	range	_	NOUN	NN	_	10	dep	_	_
14	:	_	.	:	_	10	punct	_	_
15	41	_	NUM	CD	_	17	compound	_	_
16	to	_	PRT	TO	_	17	dep	_	_
17	343	_	NUM	CD	_	18	nummod	_	_
18	ng	_	NOUN	NN	_	10	dep	_	_
19	/	_	.	:	_	18	punct	_	_
20	mL	_	NOUN	NN	_	18	dep	_	_
21	,	_	.	,	_	10	punct	_	_
22	after	_	ADP	IN	_	24	case	_	_
23	100	_	NUM	CD	_	24	nummod	_	_
24	mg	_	NOUN	NN	_	10	nmod	_	_
25	twice	_	ADV	RB	_	26	advmod	_	_
26	daily	_	ADV	RB	_	27	advmod	_	_
27	dosing	_	VERB	VBG	_	10	advcl	_	_

#	Clozapine	3019
1	Food	_	NOUN	NN	_	4	nsubj	_	_
2	does	_	VERB	VBZ	_	4	aux	_	_
3	not	_	ADV	RB	_	4	neg	_	_
4	appear	_	VERB	VB	_	0	root	_	_
5	to	_	PRT	TO	_	6	mark	_	_
6	affect	_	VERB	VB	_	4	xcomp	_	_
7	the	_	DET	DT	_	9	det	_	_
8	systemic	_	ADJ	JJ	_	9	amod	_	_
9	bioavailability	_	NOUN	NN	_	6	dobj	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	CLOZARIL	_	NOUN	NN	_	9	nmod	_	_

#	Clozapine	3020
1	Thus	_	ADV	RB	_	6	advmod	_	_
2	,	_	.	,	_	6	punct	_	_
3	CLOZARIL	_	NOUN	NN	_	6	nsubjpass	_	_
4	may	_	VERB	MD	_	6	aux	_	_
5	be	_	VERB	VB	_	6	auxpass	_	_
6	administered	_	VERB	VBN	_	0	root	_	_
7	with	_	ADP	IN	_	6	nmod	_	_
8	or	_	CONJ	CC	_	7	cc	_	_
9	without	_	ADP	IN	_	7	conj	_	_
10	food	_	NOUN	NN	_	7	dep	_	_

#	Clozapine	3021
1	Distribution	_	NOUN	NN	_	2	compound	_	_
2	DRUG	_	NOUN	NN	_	5	nsubj	_	_
3	is	_	VERB	VBZ	_	5	cop	_	_
4	approximately	_	ADV	RB	_	5	advmod	_	_
5	97%	_	ADJ	JJ	_	0	root	_	_
6	bound	_	VERB	VBN	_	5	acl	_	_
7	to	_	PRT	TO	_	9	case	_	_
8	serum	_	NOUN	NN	_	9	compound	_	_
9	proteins	_	NOUN	NNS	_	6	nmod	_	_

#	Clozapine	3022
1	The	_	DET	DT	_	2	det	_	_
2	interaction	_	NOUN	NN	_	15	nsubjpass	_	_
3	between	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	other	_	ADJ	JJ	_	10	amod	_	_
7	highly	_	ADV	RB	_	10	advmod	_	_
8	protein	_	NOUN	NN	_	10	compound	_	_
9	bound	_	ADJ	JJ	_	10	amod	_	_
10	drugs	_	NOUN	NNS	_	4	conj	_	_
11	has	_	VERB	VBZ	_	15	aux	_	_
12	not	_	ADV	RB	_	15	neg	_	_
13	been	_	VERB	VBN	_	15	auxpass	_	_
14	fully	_	ADV	RB	_	15	advmod	_	_
15	evaluated	_	VERB	VBN	_	0	root	_	_
16	but	_	CONJ	CC	_	15	cc	_	_
17	may	_	VERB	MD	_	19	aux	_	_
18	be	_	VERB	VB	_	19	auxpass	_	_
19	important	_	ADJ	JJ	_	15	conj	_	_

#	Clozapine	3023
1	Metabolism	_	NOUN	NN	_	8	nsubjpass	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	Excretion	_	NOUN	NN	_	4	compound	_	_
4	DRUG	_	NOUN	NN	_	1	conj	_	_
5	is	_	VERB	VBZ	_	8	auxpass	_	_
6	almost	_	ADV	RB	_	8	advmod	_	_
7	completely	_	ADV	RB	_	8	advmod	_	_
8	metabolized	_	VERB	VBN	_	0	root	_	_
9	prior	_	ADJ	JJ	_	11	case	_	_
10	to	_	PRT	TO	_	11	case	_	_
11	excretion	_	NOUN	NN	_	8	nmod	_	_
12	,	_	.	,	_	8	punct	_	_
13	and	_	CONJ	CC	_	8	cc	_	_
14	only	_	ADV	RB	_	16	advmod	_	_
15	trace	_	NOUN	NN	_	16	compound	_	_
16	amounts	_	NOUN	NNS	_	21	nsubjpass	_	_
17	of	_	ADP	IN	_	19	case	_	_
18	unchanged	_	ADJ	JJ	_	19	amod	_	_
19	drug	_	NOUN	NN	_	16	nmod	_	_
20	are	_	VERB	VBP	_	21	auxpass	_	_
21	detected	_	VERB	VBN	_	8	conj	_	_
22	in	_	ADP	IN	_	24	case	_	_
23	the	_	DET	DT	_	24	det	_	_
24	urine	_	ADJ	JJ	_	21	nmod	_	_
25	and	_	CONJ	CC	_	24	cc	_	_
26	feces	_	NOUN	NNS	_	24	conj	_	_

#	Clozapine	3024
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	is	_	VERB	VBZ	_	4	cop	_	_
3	a	_	DET	DT	_	4	det	_	_
4	substrate	_	NOUN	NN	_	0	root	_	_
5	for	_	ADP	IN	_	9	case	_	_
6	many	_	ADJ	JJ	_	9	amod	_	_
7	cytochrome	_	NOUN	NN	_	9	compound	_	_
8	P450	_	NOUN	NN	_	9	compound	_	_
9	isozymes	_	NOUN	NNS	_	4	nmod	_	_
10	,	_	.	,	_	4	punct	_	_
11	in	_	ADP	IN	_	13	case	_	_
12	particular	_	ADJ	JJ	_	13	amod	_	_
13	CYP1A2	_	NOUN	NN	_	4	nmod	_	_
14	,	_	.	,	_	13	punct	_	_
15	CYP2D6	_	NOUN	NN	_	13	conj	_	_
16	,	_	.	,	_	13	punct	_	_
17	and	_	CONJ	CC	_	13	cc	_	_
18	CYP3A4	_	NOUN	NN	_	13	conj	_	_

#	Clozapine	3025
1	Approximately	_	ADV	RB	_	8	advmod	_	_
2	50%	_	NOUN	NN	_	8	nsubjpass	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	the	_	DET	DT	_	6	det	_	_
5	administered	_	VERB	VBN	_	6	amod	_	_
6	dose	_	NOUN	NN	_	2	nmod	_	_
7	is	_	VERB	VBZ	_	8	auxpass	_	_
8	excreted	_	VERB	VBN	_	0	root	_	_
9	in	_	ADP	IN	_	11	case	_	_
10	the	_	DET	DT	_	11	det	_	_
11	urine	_	NOUN	NN	_	8	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	30%	_	NOUN	NN	_	11	conj	_	_
14	in	_	ADP	IN	_	16	case	_	_
15	the	_	DET	DT	_	16	det	_	_
16	feces	_	NOUN	NNS	_	8	nmod	_	_

#	Clozapine	3026
1	The	_	DET	DT	_	9	det	_	_
2	demethylated	_	VERB	VBN	_	9	amod	_	_
3	,	_	.	,	_	2	punct	_	_
4	hydroxylated	_	VERB	VBN	_	2	conj	_	_
5	,	_	.	,	_	2	punct	_	_
6	and	_	CONJ	CC	_	2	cc	_	_
7	N	_	NOUN	NN	_	2	conj	_	_
8	oxide	_	NOUN	NN	_	9	compound	_	_
9	derivatives	_	NOUN	NNS	_	11	nsubj	_	_
10	are	_	VERB	VBP	_	11	cop	_	_
11	components	_	NOUN	NNS	_	0	root	_	_
12	in	_	ADP	IN	_	14	case	_	_
13	both	_	CONJ	CC	_	14	cc:preconj	_	_
14	urine	_	ADJ	JJ	_	11	dep	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	feces	_	NOUN	NNS	_	14	conj	_	_

#	Clozapine	3027
1	Pharmacological	_	ADJ	JJ	_	2	amod	_	_
2	testing	_	NOUN	NN	_	4	nsubj	_	_
3	has	_	VERB	VBZ	_	4	aux	_	_
4	shown	_	VERB	VBN	_	0	root	_	_
5	the	_	DET	DT	_	7	det	_	_
6	desmethyl	_	NOUN	NN	_	7	compound	_	_
7	metabolite	_	NOUN	NN	_	4	dobj	_	_
8	nor	_	CONJ	CC	_	7	cc	_	_
9	DRUG	_	NOUN	NN	_	7	conj	_	_
10	to	_	PRT	TO	_	11	mark	_	_
11	have	_	VERB	VB	_	4	xcomp	_	_
12	only	_	ADV	RB	_	13	advmod	_	_
13	limited	_	ADJ	JJ	_	14	amod	_	_
14	activity	_	NOUN	NN	_	11	dobj	_	_
15	,	_	.	,	_	4	punct	_	_
16	while	_	ADP	IN	_	24	mark	_	_
17	the	_	DET	DT	_	22	det	_	_
18	hydroxylated	_	ADJ	JJ	_	22	amod	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	N	_	NOUN	NN	_	18	conj	_	_
21	oxide	_	NOUN	NN	_	22	compound	_	_
22	derivatives	_	NOUN	NNS	_	24	nsubj	_	_
23	were	_	VERB	VBD	_	24	auxpass	_	_
24	inactive	_	ADJ	JJ	_	4	advcl	_	_

#	Clozapine	3028
1	The	_	DET	DT	_	5	det	_	_
2	mean	_	ADJ	JJ	_	5	compound	_	_
3	elimination	_	NOUN	NN	_	5	compound	_	_
4	half	_	NOUN	NN	_	5	compound	_	_
5	life	_	NOUN	NN	_	17	nsubj	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	after	_	ADP	IN	_	13	case	_	_
9	a	_	DET	DT	_	13	det	_	_
10	single	_	ADJ	JJ	_	13	amod	_	_
11	75	_	NUM	CD	_	13	nummod	_	_
12	mg	_	NOUN	NN	_	13	compound	_	_
13	dose	_	NOUN	NN	_	5	nmod	_	_
14	was	_	VERB	VBD	_	17	cop	_	_
15	8	_	NUM	CD	_	17	nummod	_	_
16	hours	_	NOUN	NNS	_	17	compound	_	_
17	range	_	NOUN	NN	_	0	root	_	_
18	:	_	.	:	_	17	punct	_	_
19	4	_	NUM	CD	_	21	nummod	_	_
20	to12	_	NUM	CD	_	21	nummod	_	_
21	hours	_	NOUN	NNS	_	23	nsubj	_	_
22	,	_	.	,	_	21	punct	_	_
23	compared	_	VERB	VBD	_	17	parataxis	_	_
24	to	_	PRT	TO	_	29	case	_	_
25	a	_	DET	DT	_	29	det	_	_
26	mean	_	ADJ	JJ	_	29	amod	_	_
27	elimination	_	NOUN	NN	_	29	compound	_	_
28	half	_	NOUN	NN	_	29	compound	_	_
29	life	_	NOUN	NN	_	23	nmod	_	_
30	of	_	ADP	IN	_	33	case	_	_
31	12	_	NUM	CD	_	33	nummod	_	_
32	hours	_	NOUN	NNS	_	33	compound	_	_
33	range	_	NOUN	NN	_	29	nmod	_	_
34	:	_	.	:	_	23	punct	_	_
35	4	_	NUM	CD	_	37	compound	_	_
36	to	_	PRT	TO	_	37	dep	_	_
37	66	_	NUM	CD	_	38	nummod	_	_
38	hours	_	NOUN	NNS	_	23	dobj	_	_
39	,	_	.	,	_	23	punct	_	_
40	after	_	ADP	IN	_	41	mark	_	_
41	achieving	_	VERB	VBG	_	23	advcl	_	_
42	steady	_	ADJ	JJ	_	43	amod	_	_
43	state	_	NOUN	NN	_	41	dobj	_	_
44	with	_	ADP	IN	_	46	case	_	_
45	100	_	NUM	CD	_	46	nummod	_	_
46	mg	_	NOUN	NN	_	41	nmod	_	_
47	twice	_	ADV	RB	_	48	advmod	_	_
48	daily	_	ADV	RB	_	49	advmod	_	_
49	dosing	_	VERB	VBG	_	41	advcl	_	_

#	Clozapine	3029
1	A	_	DET	DT	_	2	det	_	_
2	comparison	_	NOUN	NN	_	12	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	single	_	ADJ	JJ	_	5	amod	_	_
5	dose	_	NOUN	NN	_	2	nmod	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	multiple	_	ADJ	JJ	_	9	amod	_	_
8	dose	_	NOUN	NN	_	9	compound	_	_
9	administration	_	NOUN	NN	_	5	conj	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	5	nmod	_	_
12	demonstrated	_	VERB	VBD	_	0	root	_	_
13	that	_	ADP	IN	_	18	mark	_	_
14	the	_	DET	DT	_	17	det	_	_
15	elimination	_	NOUN	NN	_	17	compound	_	_
16	half	_	NOUN	NN	_	17	compound	_	_
17	life	_	NOUN	NN	_	18	nsubj	_	_
18	increased	_	VERB	VBD	_	12	ccomp	_	_
19	significantly	_	ADV	RB	_	18	advmod	_	_
20	after	_	ADP	IN	_	22	case	_	_
21	multiple	_	ADJ	JJ	_	22	amod	_	_
22	dosing	_	NOUN	NN	_	18	nmod	_	_
23	relative	_	ADJ	JJ	_	22	amod	_	_
24	to	_	PRT	TO	_	25	case	_	_
25	that	_	DET	WDT	_	23	nmod	_	_
26	after	_	ADP	IN	_	29	case	_	_
27	single	_	ADJ	JJ	_	29	amod	_	_
28	dose	_	NOUN	NN	_	29	compound	_	_
29	administration	_	NOUN	NN	_	25	nmod	_	_
30	,	_	.	,	_	18	punct	_	_
31	suggesting	_	VERB	VBG	_	18	advcl	_	_
32	the	_	DET	DT	_	33	det	_	_
33	possibility	_	NOUN	NN	_	31	dobj	_	_
34	of	_	ADP	IN	_	37	case	_	_
35	concentration	_	NOUN	NN	_	37	compound	_	_
36	dependent	_	ADJ	JJ	_	37	amod	_	_
37	pharmacokinetics	_	NOUN	NNS	_	33	nmod	_	_

#	Clozapine	3030
1	However	_	ADV	RB	_	28	advmod	_	_
2	,	_	.	,	_	28	punct	_	_
3	at	_	ADP	IN	_	5	case	_	_
4	steady	_	ADJ	JJ	_	5	amod	_	_
5	state	_	NOUN	NN	_	28	nmod	_	_
6	,	_	.	,	_	28	punct	_	_
7	approximately	_	ADV	RB	_	8	advmod	_	_
8	dose	_	NOUN	NN	_	10	compound	_	_
9	proportional	_	ADJ	JJ	_	10	amod	_	_
10	changes	_	NOUN	NNS	_	28	nsubjpass	_	_
11	with	_	ADP	IN	_	12	case	_	_
12	respect	_	NOUN	NN	_	10	nmod	_	_
13	to	_	PRT	TO	_	15	case	_	_
14	AUC	_	NOUN	NN	_	15	compound	_	_
15	area	_	NOUN	NN	_	12	nmod	_	_
16	under	_	ADP	IN	_	26	case	_	_
17	the	_	DET	DT	_	26	det	_	_
18	curve	_	ADJ	JJ	_	26	amod	_	_
19	,	_	.	,	_	18	punct	_	_
20	peak	_	ADJ	JJ	_	18	conj	_	_
21	,	_	.	,	_	18	punct	_	_
22	and	_	CONJ	CC	_	18	cc	_	_
23	minimum	_	ADJ	JJ	_	18	conj	_	_
24	DRUG	_	NOUN	NN	_	26	compound	_	_
25	plasma	_	NOUN	NN	_	26	compound	_	_
26	concentrations	_	NOUN	NNS	_	12	nmod	_	_
27	were	_	VERB	VBD	_	28	auxpass	_	_
28	observed	_	VERB	VBN	_	0	root	_	_
29	after	_	ADP	IN	_	30	case	_	_
30	administration	_	NOUN	NN	_	28	nmod	_	_
31	of	_	ADP	IN	_	32	case	_	_
32	37.5	_	NUM	CD	_	30	nmod	_	_
33	,	_	.	,	_	32	punct	_	_
34	75	_	NUM	CD	_	32	conj	_	_
35	,	_	.	,	_	32	punct	_	_
36	and	_	CONJ	CC	_	32	cc	_	_
37	150	_	NUM	CD	_	32	conj	_	_
38	mg	_	NOUN	NN	_	32	dep	_	_
39	twice	_	ADV	RB	_	40	advmod	_	_
40	daily	_	ADV	RB	_	28	advmod	_	_

#	Clozapine	3031
1	Drug	_	NOUN	NN	_	4	compound	_	_
2	Drug	_	NOUN	NN	_	4	compound	_	_
3	Interaction	_	NOUN	NN	_	4	compound	_	_
4	Studies	_	NOUN	NNS	_	10	nsubjpass	_	_
5	Fluvoxamine	_	NOUN	NN	_	8	compound	_	_
6	A	_	NOUN	NN	_	8	compound	_	_
7	pharmacokinetic	_	ADJ	JJ	_	8	amod	_	_
8	study	_	NOUN	NN	_	4	dep	_	_
9	was	_	VERB	VBD	_	10	auxpass	_	_
10	conducted	_	VERB	VBN	_	0	root	_	_
11	in	_	ADP	IN	_	14	case	_	_
12	16	_	NUM	CD	_	14	nummod	_	_
13	schizophrenic	_	ADJ	JJ	_	14	amod	_	_
14	patients	_	NOUN	NNS	_	10	nmod	_	_
15	who	_	DET	WDT	_	16	nsubj	_	_
16	received	_	VERB	VBD	_	14	acl:relcl	_	_
17	DRUG	_	NOUN	NN	_	16	dobj	_	_
18	under	_	ADP	IN	_	21	case	_	_
19	steady	_	ADJ	JJ	_	21	amod	_	_
20	state	_	NOUN	NN	_	21	compound	_	_
21	conditions	_	NOUN	NNS	_	16	nmod	_	_

#	Clozapine	3032
1	After	_	ADP	IN	_	2	case	_	_
2	coadministration	_	NOUN	NN	_	27	nmod	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	fluvoxamine	_	NOUN	NN	_	2	nmod	_	_
5	for	_	ADP	IN	_	7	case	_	_
6	14	_	NUM	CD	_	7	nummod	_	_
7	days	_	NOUN	NNS	_	2	nmod	_	_
8	,	_	.	,	_	27	punct	_	_
9	mean	_	ADJ	JJ	_	11	amod	_	_
10	trough	_	NOUN	NN	_	11	compound	_	_
11	concentrations	_	NOUN	NNS	_	27	nsubj	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	DRUG	_	NOUN	NN	_	11	nmod	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	its	_	PRON	PRP$	_	16	nmod:poss	_	_
16	metabolites	_	NOUN	NNS	_	13	conj	_	_
17	,	_	.	,	_	13	punct	_	_
18	N	_	NOUN	NN	_	20	compound	_	_
19	desmethyl	_	NOUN	NN	_	20	compound	_	_
20	DRUG	_	NOUN	NN	_	13	conj	_	_
21	and	_	CONJ	CC	_	13	cc	_	_
22	DRUG	_	NOUN	NN	_	24	compound	_	_
23	N	_	NOUN	NN	_	24	compound	_	_
24	oxide	_	NOUN	NN	_	13	conj	_	_
25	,	_	.	,	_	11	punct	_	_
26	were	_	VERB	VBD	_	27	cop	_	_
27	elevated	_	ADJ	JJ	_	0	root	_	_
28	about	_	ADV	RB	_	29	advmod	_	_
29	3	_	NUM	CD	_	30	nummod	_	_
30	fold	_	NOUN	NN	_	27	nmod	_	_
31	compared	_	VERB	VBN	_	30	acl	_	_
32	to	_	PRT	TO	_	36	case	_	_
33	baseline	_	NOUN	NN	_	36	compound	_	_
34	steady	_	ADJ	JJ	_	36	amod	_	_
35	state	_	NOUN	NN	_	36	compound	_	_
36	concentrations	_	NOUN	NNS	_	31	nmod	_	_

#	Clozapine	3033
1	Paroxetine	_	NOUN	NN	_	0	root	_	_
2	,	_	.	,	_	1	punct	_	_
3	Fluoxetine	_	NOUN	NN	_	1	conj	_	_
4	,	_	.	,	_	1	punct	_	_
5	and	_	CONJ	CC	_	1	cc	_	_
6	Sertraline	_	NOUN	NN	_	1	conj	_	_
7	In	_	ADP	IN	_	9	case	_	_
8	a	_	DET	DT	_	9	det	_	_
9	study	_	NOUN	NN	_	1	nmod	_	_
10	of	_	ADP	IN	_	12	case	_	_
11	schizophrenic	_	ADJ	JJ	_	12	amod	_	_
12	patients	_	NOUN	NNS	_	9	nmod	_	_
13	n=14	_	NOUN	NN	_	12	dep	_	_
14	who	_	DET	WDT	_	15	nsubj	_	_
15	received	_	VERB	VBD	_	13	acl:relcl	_	_
16	DRUG	_	NOUN	NN	_	15	dobj	_	_
17	under	_	ADP	IN	_	20	case	_	_
18	steady	_	ADJ	JJ	_	20	amod	_	_
19	state	_	NOUN	NN	_	20	compound	_	_
20	conditions	_	NOUN	NNS	_	15	nmod	_	_
21	,	_	.	,	_	1	punct	_	_
22	coadministration	_	NOUN	NN	_	25	nsubj	_	_
23	of	_	ADP	IN	_	24	case	_	_
24	paroxetine	_	NOUN	NN	_	22	nmod	_	_
25	produced	_	VERB	VBD	_	1	dep	_	_
26	only	_	ADV	RB	_	27	advmod	_	_
27	minor	_	ADJ	JJ	_	28	amod	_	_
28	changes	_	NOUN	NNS	_	25	dobj	_	_
29	in	_	ADP	IN	_	31	case	_	_
30	the	_	DET	DT	_	31	det	_	_
31	levels	_	NOUN	NNS	_	28	nmod	_	_
32	of	_	ADP	IN	_	33	case	_	_
33	DRUG	_	NOUN	NN	_	31	nmod	_	_
34	and	_	CONJ	CC	_	33	cc	_	_
35	its	_	PRON	PRP$	_	36	nmod:poss	_	_
36	metabolites	_	NOUN	NNS	_	33	conj	_	_

#	Clozapine	3034
1	However	_	ADV	RB	_	6	advmod	_	_
2	,	_	.	,	_	6	punct	_	_
3	other	_	ADJ	JJ	_	5	amod	_	_
4	published	_	VERB	VBN	_	5	amod	_	_
5	reports	_	NOUN	NNS	_	6	nsubj	_	_
6	describe	_	VERB	VBP	_	0	root	_	_
7	modest	_	ADJ	JJ	_	8	amod	_	_
8	elevations	_	NOUN	NNS	_	6	dobj	_	_
9	less	_	ADV	RB	_	11	advmod	_	_
10	than	_	ADP	IN	_	11	advmod	_	_
11	2	_	NUM	CD	_	12	nummod	_	_
12	fold	_	NOUN	NN	_	6	nmod	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	DRUG	_	NOUN	NN	_	12	nmod	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	metabolite	_	NOUN	NN	_	14	conj	_	_
17	concentrations	_	NOUN	NNS	_	14	dep	_	_
18	when	_	ADV	WRB	_	21	advmod	_	_
19	DRUG	_	NOUN	NN	_	21	nsubjpass	_	_
20	was	_	VERB	VBD	_	21	auxpass	_	_
21	taken	_	VERB	VBN	_	6	advcl	_	_
22	with	_	ADP	IN	_	23	case	_	_
23	paroxetine	_	NOUN	NN	_	21	nmod	_	_
24	,	_	.	,	_	23	punct	_	_
25	fluoxetine	_	NOUN	NN	_	23	conj	_	_
26	,	_	.	,	_	23	punct	_	_
27	and	_	CONJ	CC	_	23	cc	_	_
28	sertraline	_	NOUN	NN	_	23	conj	_	_

#	Clozapine	3035
1	Specific	_	ADJ	JJ	_	3	amod	_	_
2	Population	_	NOUN	NN	_	3	compound	_	_
3	Studies	_	NOUN	NNS	_	13	nsubjpass	_	_
4	Renal	_	ADJ	JJ	_	11	amod	_	_
5	or	_	CONJ	CC	_	4	cc	_	_
6	Hepatic	_	ADJ	JJ	_	4	conj	_	_
7	Impairment	_	NOUN	NN	_	11	compound	_	_
8	No	_	NOUN	NN	_	11	compound	_	_
9	specific	_	ADJ	JJ	_	11	amod	_	_
10	pharmacokinetic	_	ADJ	JJ	_	11	amod	_	_
11	studies	_	NOUN	NNS	_	3	dep	_	_
12	were	_	VERB	VBD	_	13	auxpass	_	_
13	conducted	_	VERB	VBN	_	0	root	_	_
14	to	_	PRT	TO	_	15	mark	_	_
15	investigate	_	VERB	VB	_	13	xcomp	_	_
16	the	_	DET	DT	_	17	det	_	_
17	effects	_	NOUN	NNS	_	15	dobj	_	_
18	of	_	ADP	IN	_	22	case	_	_
19	renal	_	ADJ	JJ	_	22	amod	_	_
20	or	_	CONJ	CC	_	19	cc	_	_
21	hepatic	_	ADJ	JJ	_	19	conj	_	_
22	impairment	_	NOUN	NN	_	17	nmod	_	_
23	on	_	ADP	IN	_	25	case	_	_
24	the	_	DET	DT	_	25	det	_	_
25	pharmacokinetics	_	NOUN	NNS	_	17	nmod	_	_
26	of	_	ADP	IN	_	27	case	_	_
27	DRUG	_	NOUN	NN	_	25	nmod	_	_

#	Clozapine	3036
1	Higher	_	ADJ	JJ	_	4	amod	_	_
2	DRUG	_	NOUN	NN	_	4	compound	_	_
3	plasma	_	NOUN	NN	_	4	compound	_	_
4	concentrations	_	NOUN	NNS	_	6	nsubj	_	_
5	are	_	VERB	VBP	_	6	cop	_	_
6	likely	_	ADV	RB	_	0	root	_	_
7	in	_	ADP	IN	_	8	case	_	_
8	patients	_	NOUN	NNS	_	6	nmod	_	_
9	with	_	ADP	IN	_	11	case	_	_
10	significant	_	ADJ	JJ	_	11	amod	_	_
11	renal	_	ADJ	JJ	_	8	nmod	_	_
12	or	_	CONJ	CC	_	11	cc	_	_
13	hepatic	_	ADJ	JJ	_	11	conj	_	_
14	impairment	_	NOUN	NN	_	11	dep	_	_
15	when	_	ADV	WRB	_	6	advmod	_	_
16	given	_	VERB	VBN	_	18	amod	_	_
17	usual	_	ADJ	JJ	_	18	amod	_	_
18	doses	_	NOUN	NNS	_	15	nmod	_	_

#	Clozapine	3037
1	CYP2D6	_	NOUN	NN	_	3	compound	_	_
2	Poor	_	ADJ	JJ	_	3	amod	_	_
3	Metabolizers	_	NOUN	NNS	_	12	nsubj	_	_
4	A	_	NOUN	NN	_	7	compound	_	_
5	subset	_	NOUN	NN	_	7	compound	_	_
6	3%	_	ADJ	JJ	_	7	amod	_	_
7	10%	_	NOUN	NN	_	3	dep	_	_
8	of	_	ADP	IN	_	10	case	_	_
9	the	_	DET	DT	_	10	det	_	_
10	population	_	NOUN	NN	_	7	nmod	_	_
11	has	_	VERB	VBZ	_	12	aux	_	_
12	reduced	_	VERB	VBN	_	0	root	_	_
13	activity	_	NOUN	NN	_	12	dobj	_	_
14	of	_	ADP	IN	_	18	case	_	_
15	CYP2D6	_	NOUN	NN	_	18	compound	_	_
16	CYP2D6	_	NOUN	NN	_	18	compound	_	_
17	poor	_	ADJ	JJ	_	18	amod	_	_
18	metabolizers	_	NOUN	NNS	_	13	nmod	_	_

#	Clozapine	3038
1	These	_	DET	DT	_	2	det	_	_
2	individuals	_	NOUN	NNS	_	4	nsubj	_	_
3	may	_	VERB	MD	_	4	aux	_	_
4	develop	_	VERB	VB	_	0	root	_	_
5	higher	_	ADJ	JJ	_	4	xcomp	_	_
6	than	_	ADP	IN	_	9	case	_	_
7	expected	_	VERB	VBN	_	9	amod	_	_
8	plasma	_	NOUN	NN	_	9	compound	_	_
9	concentrations	_	NOUN	NNS	_	5	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_
12	when	_	ADV	WRB	_	4	advmod	_	_
13	given	_	VERB	VBN	_	15	amod	_	_
14	usual	_	ADJ	JJ	_	15	amod	_	_
15	doses	_	NOUN	NNS	_	12	nmod	_	_

#	Dabigatran	1911
1	P	_	NOUN	NN	_	4	compound	_	_
2	gp	_	NOUN	NN	_	4	compound	_	_
3	inducers	_	VERB	VBZ	_	4	compound	_	_
4	rifampin	_	NOUN	NN	_	24	nsubj	_	_
5	:	_	.	:	_	4	punct	_	_
6	Avoid	_	ADJ	JJ	_	7	amod	_	_
7	coadministration	_	NOUN	NN	_	4	dep	_	_
8	with	_	ADP	IN	_	13	case	_	_
9	PRADAXA	_	NOUN	NN	_	13	compound	_	_
10	5.5	_	NUM	CD	_	13	nummod	_	_
11	P	_	NOUN	NN	_	13	compound	_	_
12	gp	_	NOUN	NN	_	13	compound	_	_
13	inhibitors	_	NOUN	NNS	_	7	nmod	_	_
14	in	_	ADP	IN	_	15	case	_	_
15	patients	_	NOUN	NNS	_	7	nmod	_	_
16	with	_	ADP	IN	_	20	case	_	_
17	CrCl	_	NOUN	NN	_	20	compound	_	_
18	30	_	NUM	CD	_	20	nummod	_	_
19	50	_	NUM	CD	_	20	nummod	_	_
20	mL	_	NOUN	NN	_	15	nmod	_	_
21	/	_	.	:	_	7	punct	_	_
22	min	_	NOUN	NN	_	7	dep	_	_
23	:	_	.	:	_	4	punct	_	_
24	Reduce	_	VERB	VBP	_	0	root	_	_
25	dose	_	NOUN	NN	_	24	dobj	_	_
26	or	_	CONJ	CC	_	25	cc	_	_
27	avoid	_	ADP	IN	_	31	case	_	_
28	7	_	NUM	CD	_	31	nummod	_	_
29	P	_	NOUN	NN	_	31	compound	_	_
30	gp	_	NOUN	NN	_	31	compound	_	_
31	inhibitors	_	NOUN	NNS	_	25	conj	_	_
32	in	_	ADP	IN	_	33	case	_	_
33	patients	_	NOUN	NNS	_	24	nmod	_	_
34	with	_	ADP	IN	_	37	case	_	_
35	CrCl	_	NOUN	NN	_	37	compound	_	_
36	<30	_	NUM	CD	_	37	nummod	_	_
37	mL	_	NOUN	NN	_	33	nmod	_	_
38	/	_	.	:	_	24	punct	_	_
39	min	_	NOUN	NN	_	24	dep	_	_
40	:	_	.	:	_	24	punct	_	_
41	Not	_	ADV	RB	_	42	neg	_	_
42	recommended	_	VERB	VBD	_	24	parataxis	_	_
43	7	_	NUM	CD	_	46	nummod	_	_
44	The	_	DET	DT	_	46	det	_	_
45	concomitant	_	ADJ	JJ	_	46	amod	_	_
46	use	_	NOUN	NN	_	42	dobj	_	_
47	of	_	ADP	IN	_	48	case	_	_
48	PRADAXA	_	NOUN	NN	_	46	nmod	_	_
49	with	_	ADP	IN	_	52	case	_	_
50	P	_	NOUN	NN	_	52	compound	_	_
51	gp	_	NOUN	NN	_	52	compound	_	_
52	inducers	_	NOUN	NNS	_	46	nmod	_	_
53	e.g	_	NOUN	NN	_	52	dep	_	_
54	,	_	.	,	_	42	punct	_	_
55	rifampin	_	NOUN	NN	_	56	nsubj	_	_
56	reduces	_	VERB	VBZ	_	42	parataxis	_	_
57	exposure	_	NOUN	NN	_	56	dobj	_	_
58	to	_	PRT	TO	_	59	case	_	_
59	DRUG	_	NOUN	NN	_	57	nmod	_	_
60	and	_	CONJ	CC	_	56	cc	_	_
61	should	_	VERB	MD	_	64	aux	_	_
62	generally	_	ADV	RB	_	64	advmod	_	_
63	be	_	VERB	VB	_	64	auxpass	_	_
64	avoided	_	VERB	VBN	_	56	conj	_	_

#	Dabigatran	1912
1	P	_	NOUN	NN	_	3	compound	_	_
2	gp	_	NOUN	NN	_	3	compound	_	_
3	inhibition	_	NOUN	NN	_	12	nsubj	_	_
4	and	_	CONJ	CC	_	3	cc	_	_
5	impaired	_	ADJ	JJ	_	7	amod	_	_
6	renal	_	ADJ	JJ	_	7	amod	_	_
7	function	_	NOUN	NN	_	3	conj	_	_
8	are	_	VERB	VBP	_	12	cop	_	_
9	the	_	DET	DT	_	12	det	_	_
10	major	_	ADJ	JJ	_	12	amod	_	_
11	independent	_	ADJ	JJ	_	12	amod	_	_
12	factors	_	NOUN	NNS	_	0	root	_	_
13	that	_	DET	WDT	_	14	nsubj	_	_
14	result	_	VERB	VBP	_	12	acl:relcl	_	_
15	in	_	ADP	IN	_	17	case	_	_
16	increased	_	VERB	VBN	_	17	amod	_	_
17	exposure	_	NOUN	NN	_	14	nmod	_	_
18	to	_	PRT	TO	_	19	case	_	_
19	DRUG	_	NOUN	NN	_	17	nmod	_	_

#	Dabigatran	1913
1	Concomitant	_	ADJ	JJ	_	2	amod	_	_
2	use	_	NOUN	NN	_	13	nsubjpass	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	P	_	NOUN	NN	_	6	compound	_	_
5	gp	_	NOUN	NN	_	6	compound	_	_
6	inhibitors	_	NOUN	NNS	_	2	nmod	_	_
7	in	_	ADP	IN	_	8	case	_	_
8	patients	_	NOUN	NNS	_	2	nmod	_	_
9	with	_	ADP	IN	_	11	case	_	_
10	renal	_	ADJ	JJ	_	11	amod	_	_
11	impairment	_	NOUN	NN	_	8	nmod	_	_
12	is	_	VERB	VBZ	_	13	auxpass	_	_
13	expected	_	VERB	VBN	_	0	root	_	_
14	to	_	PRT	TO	_	15	mark	_	_
15	produce	_	VERB	VB	_	13	xcomp	_	_
16	increased	_	ADJ	JJ	_	17	amod	_	_
17	exposure	_	NOUN	NN	_	15	dobj	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	DRUG	_	NOUN	NN	_	17	nmod	_	_
20	compared	_	VERB	VBN	_	13	xcomp	_	_
21	to	_	PRT	TO	_	22	case	_	_
22	that	_	DET	WDT	_	20	nmod	_	_
23	seen	_	VERB	VBN	_	22	acl	_	_
24	with	_	ADP	IN	_	26	case	_	_
25	either	_	CONJ	CC	_	26	det	_	_
26	factor	_	NOUN	NN	_	23	nmod	_	_
27	alone	_	ADV	RB	_	26	advmod	_	_

#	Dabigatran	1914
1	In	_	ADP	IN	_	2	case	_	_
2	patients	_	NOUN	NNS	_	14	nmod	_	_
3	with	_	ADP	IN	_	10	case	_	_
4	moderate	_	ADJ	JJ	_	10	amod	_	_
5	renal	_	ADJ	JJ	_	10	amod	_	_
6	impairment	_	NOUN	NN	_	10	compound	_	_
7	CrCl	_	NOUN	NN	_	10	compound	_	_
8	30	_	NUM	CD	_	10	nummod	_	_
9	50	_	NUM	CD	_	10	nummod	_	_
10	mL	_	NOUN	NN	_	2	nmod	_	_
11	/	_	.	:	_	12	punct	_	_
12	min	_	NOUN	NN	_	14	nsubj	_	_
13	,	_	.	,	_	12	punct	_	_
14	reduce	_	VERB	VBP	_	0	root	_	_
15	the	_	DET	DT	_	16	det	_	_
16	dose	_	NOUN	NN	_	14	dobj	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	PRADAXA	_	NOUN	NN	_	16	nmod	_	_
19	to	_	PRT	TO	_	21	case	_	_
20	75	_	NUM	CD	_	21	nummod	_	_
21	mg	_	NOUN	NN	_	16	nmod	_	_
22	twice	_	ADV	RB	_	23	advmod	_	_
23	daily	_	ADV	RB	_	24	advmod	_	_
24	when	_	ADV	WRB	_	25	advmod	_	_
25	administered	_	VERB	VBN	_	14	advcl	_	_
26	concomitantly	_	ADV	RB	_	25	advmod	_	_
27	with	_	ADP	IN	_	31	case	_	_
28	the	_	DET	DT	_	31	det	_	_
29	P	_	NOUN	NN	_	31	compound	_	_
30	gp	_	NOUN	NN	_	31	compound	_	_
31	inhibitors	_	NOUN	NNS	_	25	nmod	_	_
32	dronedarone	_	NOUN	NN	_	31	dep	_	_
33	or	_	CONJ	CC	_	32	cc	_	_
34	systemic	_	ADJ	JJ	_	35	amod	_	_
35	ketoconazole	_	NOUN	NN	_	32	conj	_	_

#	Dabigatran	1915
1	The	_	DET	DT	_	2	det	_	_
2	use	_	NOUN	NN	_	20	nsubj	_	_
3	of	_	ADP	IN	_	7	case	_	_
4	the	_	DET	DT	_	7	det	_	_
5	P	_	NOUN	NN	_	7	compound	_	_
6	gp	_	NOUN	NN	_	7	compound	_	_
7	inhibitors	_	NOUN	NNS	_	2	nmod	_	_
8	verapamil	_	NOUN	NN	_	7	dep	_	_
9	,	_	.	,	_	8	punct	_	_
10	amiodarone	_	NOUN	NN	_	8	conj	_	_
11	,	_	.	,	_	8	punct	_	_
12	quinidine	_	NOUN	NN	_	8	conj	_	_
13	,	_	.	,	_	8	punct	_	_
14	clarithromycin	_	NOUN	NN	_	8	conj	_	_
15	,	_	.	,	_	8	punct	_	_
16	and	_	CONJ	CC	_	8	cc	_	_
17	ticagrelor	_	NOUN	NN	_	8	conj	_	_
18	does	_	VERB	VBZ	_	20	aux	_	_
19	not	_	ADV	RB	_	20	neg	_	_
20	require	_	VERB	VB	_	0	root	_	_
21	a	_	DET	DT	_	23	det	_	_
22	dose	_	NOUN	NN	_	23	compound	_	_
23	adjustment	_	NOUN	NN	_	20	dobj	_	_
24	of	_	ADP	IN	_	25	case	_	_
25	PRADAXA	_	NOUN	NN	_	23	nmod	_	_

#	Dabigatran	1916
1	These	_	DET	DT	_	2	det	_	_
2	results	_	NOUN	NNS	_	6	nsubjpass	_	_
3	should	_	VERB	MD	_	6	aux	_	_
4	not	_	ADV	RB	_	6	neg	_	_
5	be	_	VERB	VB	_	6	auxpass	_	_
6	extrapolated	_	VERB	VBN	_	0	root	_	_
7	to	_	PRT	TO	_	11	case	_	_
8	other	_	ADJ	JJ	_	11	amod	_	_
9	P	_	NOUN	NN	_	11	compound	_	_
10	gp	_	NOUN	NN	_	11	compound	_	_
11	inhibitors	_	NOUN	NNS	_	6	nmod	_	_

#	Dabigatran	1917
1	The	_	DET	DT	_	3	det	_	_
2	concomitant	_	ADJ	JJ	_	3	amod	_	_
3	use	_	NOUN	NN	_	24	nsubjpass	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	PRADAXA	_	NOUN	NN	_	3	nmod	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	P	_	NOUN	NN	_	9	compound	_	_
8	gp	_	NOUN	NN	_	9	compound	_	_
9	inhibitors	_	NOUN	NNS	_	5	conj	_	_
10	in	_	ADP	IN	_	11	case	_	_
11	patients	_	NOUN	NNS	_	3	nmod	_	_
12	with	_	ADP	IN	_	21	case	_	_
13	severe	_	ADJ	JJ	_	21	amod	_	_
14	renal	_	ADJ	JJ	_	21	amod	_	_
15	impairment	_	NOUN	NN	_	21	compound	_	_
16	CrCl	_	NOUN	NN	_	21	compound	_	_
17	15	_	NUM	CD	_	21	nummod	_	_
18	30	_	NUM	CD	_	21	nummod	_	_
19	mL	_	NOUN	NN	_	21	compound	_	_
20	/	_	.	:	_	21	punct	_	_
21	min	_	NOUN	NN	_	11	nmod	_	_
22	should	_	VERB	MD	_	24	aux	_	_
23	be	_	VERB	VB	_	24	auxpass	_	_
24	avoided	_	VERB	VBN	_	0	root	_	_

#	Dabigatran	1918
1	Avoid	_	X	FW	_	2	amod	_	_
2	use	_	NOUN	NN	_	0	root	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	PRADAXA	_	NOUN	NN	_	2	nmod	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	P	_	NOUN	NN	_	8	compound	_	_
7	gp	_	NOUN	NN	_	8	compound	_	_
8	inhibitors	_	NOUN	NNS	_	4	conj	_	_
9	in	_	ADP	IN	_	10	case	_	_
10	patients	_	NOUN	NNS	_	2	nmod	_	_
11	with	_	ADP	IN	_	14	case	_	_
12	CrCl	_	NOUN	NN	_	14	compound	_	_
13	<50	_	NUM	CD	_	14	nummod	_	_
14	mL	_	NOUN	NN	_	10	nmod	_	_
15	/	_	.	:	_	16	punct	_	_
16	min	_	NOUN	NN	_	2	nmod	_	_

#	Dabigatran	1919
1	In	_	ADP	IN	_	2	case	_	_
2	patients	_	NOUN	NNS	_	27	nmod	_	_
3	with	_	ADP	IN	_	6	case	_	_
4	CrCl	_	NOUN	NN	_	6	compound	_	_
5	>50	_	NUM	CD	_	6	nummod	_	_
6	mL	_	NOUN	NN	_	2	nmod	_	_
7	/	_	.	:	_	8	punct	_	_
8	min	_	NOUN	NN	_	2	nmod	_	_
9	who	_	DET	WDT	_	10	nsubj	_	_
10	have	_	VERB	VBP	_	8	acl:relcl	_	_
11	concomitant	_	ADJ	JJ	_	12	amod	_	_
12	administration	_	NOUN	NN	_	10	dobj	_	_
13	of	_	ADP	IN	_	16	case	_	_
14	P	_	NOUN	NN	_	16	compound	_	_
15	gp	_	NOUN	NN	_	16	compound	_	_
16	inhibitors	_	NOUN	NNS	_	12	nmod	_	_
17	such	_	ADJ	JJ	_	19	case	_	_
18	as	_	ADP	IN	_	17	mwe	_	_
19	dronedarone	_	NOUN	NN	_	16	nmod	_	_
20	or	_	CONJ	CC	_	19	cc	_	_
21	systemic	_	ADJ	JJ	_	22	amod	_	_
22	ketoconazole	_	NOUN	NN	_	19	conj	_	_
23	,	_	.	,	_	27	punct	_	_
24	it	_	PRON	PRP	_	27	nsubj	_	_
25	may	_	VERB	MD	_	27	aux	_	_
26	be	_	VERB	VB	_	27	cop	_	_
27	helpful	_	ADJ	JJ	_	0	root	_	_
28	to	_	PRT	TO	_	29	mark	_	_
29	separate	_	VERB	VB	_	27	xcomp	_	_
30	the	_	DET	DT	_	31	det	_	_
31	timing	_	NOUN	NN	_	29	dobj	_	_
32	of	_	ADP	IN	_	33	case	_	_
33	administration	_	NOUN	NN	_	31	nmod	_	_
34	of	_	ADP	IN	_	35	case	_	_
35	DRUG	_	NOUN	NN	_	33	nmod	_	_
36	and	_	CONJ	CC	_	33	cc	_	_
37	the	_	DET	DT	_	40	det	_	_
38	P	_	NOUN	NN	_	40	compound	_	_
39	gp	_	NOUN	NN	_	40	compound	_	_
40	inhibitor	_	NOUN	NN	_	33	conj	_	_
41	by	_	ADP	IN	_	43	case	_	_
42	several	_	ADJ	JJ	_	43	amod	_	_
43	hours	_	NOUN	NNS	_	31	nmod	_	_

#	Dabigatran	1920
1	The	_	DET	DT	_	3	det	_	_
2	concomitant	_	ADJ	JJ	_	3	amod	_	_
3	use	_	NOUN	NN	_	0	root	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	PRADAXA	_	NOUN	NN	_	3	nmod	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	P	_	NOUN	NN	_	9	compound	_	_
8	gp	_	NOUN	NN	_	9	compound	_	_
9	inhibitors	_	NOUN	NNS	_	5	conj	_	_
10	in	_	ADP	IN	_	11	case	_	_
11	patients	_	NOUN	NNS	_	3	nmod	_	_
12	with	_	ADP	IN	_	15	case	_	_
13	CrCl	_	NOUN	NN	_	15	compound	_	_
14	<50	_	NUM	CD	_	15	nummod	_	_
15	mL	_	NOUN	NN	_	11	nmod	_	_
16	/	_	.	:	_	3	punct	_	_
17	min	_	NOUN	NN	_	20	nsubjpass	_	_
18	should	_	VERB	MD	_	20	aux	_	_
19	be	_	VERB	VB	_	20	auxpass	_	_
20	avoided	_	VERB	VBN	_	3	dep	_	_

#	Dabigatran	1921
1	DRUG	_	NOUN	NN	_	7	nsubj	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	its	_	PRON	PRP$	_	5	nmod:poss	_	_
4	acyl	_	NOUN	NN	_	5	compound	_	_
5	glucuronides	_	NOUN	NNS	_	1	conj	_	_
6	are	_	VERB	VBP	_	7	cop	_	_
7	competitive	_	ADJ	JJ	_	0	root	_	_
8	,	_	.	,	_	7	punct	_	_
9	direct	_	ADJ	JJ	_	7	dep	_	_
10	thrombin	_	NOUN	NN	_	11	compound	_	_
11	inhibitors	_	NOUN	NNS	_	7	dep	_	_

#	Dabigatran	1922
1	Because	_	ADP	IN	_	5	mark	_	_
2	thrombin	_	NOUN	NN	_	4	compound	_	_
3	serine	_	NOUN	NN	_	4	compound	_	_
4	protease	_	NOUN	NN	_	5	nsubj	_	_
5	enables	_	VERB	VBZ	_	19	advcl	_	_
6	the	_	DET	DT	_	7	det	_	_
7	conversion	_	NOUN	NN	_	5	dobj	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	fibrinogen	_	NOUN	NN	_	7	nmod	_	_
10	into	_	ADP	IN	_	11	case	_	_
11	fibrin	_	NOUN	NN	_	7	nmod	_	_
12	during	_	ADP	IN	_	15	case	_	_
13	the	_	DET	DT	_	15	det	_	_
14	coagulation	_	NOUN	NN	_	15	compound	_	_
15	cascade	_	NOUN	NN	_	7	nmod	_	_
16	,	_	.	,	_	19	punct	_	_
17	its	_	PRON	PRP$	_	18	nmod:poss	_	_
18	inhibition	_	NOUN	NN	_	19	nsubj	_	_
19	prevents	_	VERB	VBZ	_	0	root	_	_
20	the	_	DET	DT	_	21	det	_	_
21	development	_	NOUN	NN	_	19	dobj	_	_
22	of	_	ADP	IN	_	24	case	_	_
23	a	_	DET	DT	_	24	det	_	_
24	thrombus	_	NOUN	NN	_	21	nmod	_	_

#	Dabigatran	1923
1	Both	_	CONJ	CC	_	2	cc:preconj	_	_
2	free	_	ADJ	JJ	_	5	nsubj	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	clot	_	NOUN	NN	_	2	conj	_	_
5	bound	_	VERB	VBD	_	0	root	_	_
6	thrombin	_	NOUN	NN	_	5	dobj	_	_
7	,	_	.	,	_	5	punct	_	_
8	and	_	CONJ	CC	_	5	cc	_	_
9	thrombin	_	NOUN	NN	_	10	nmod:npmod	_	_
10	induced	_	ADJ	JJ	_	12	amod	_	_
11	platelet	_	NOUN	NN	_	12	compound	_	_
12	aggregation	_	NOUN	NN	_	14	nsubjpass	_	_
13	are	_	VERB	VBP	_	14	auxpass	_	_
14	inhibited	_	VERB	VBN	_	5	conj	_	_
15	by	_	ADP	IN	_	18	case	_	_
16	the	_	DET	DT	_	18	det	_	_
17	active	_	ADJ	JJ	_	18	amod	_	_
18	moieties	_	NOUN	NNS	_	14	nmod	_	_

#	Dabigatran	1924
1	At	_	ADP	IN	_	4	case	_	_
2	recommended	_	VERB	VBN	_	4	amod	_	_
3	therapeutic	_	ADJ	JJ	_	4	amod	_	_
4	doses	_	NOUN	NNS	_	8	nmod	_	_
5	,	_	.	,	_	8	punct	_	_
6	DRUG	_	NOUN	NN	_	7	compound	_	_
7	etexilate	_	NOUN	NN	_	8	nsubj	_	_
8	prolongs	_	VERB	VBZ	_	0	root	_	_
9	the	_	DET	DT	_	11	det	_	_
10	coagulation	_	NOUN	NN	_	11	compound	_	_
11	markers	_	NOUN	NNS	_	8	dobj	_	_
12	such	_	ADJ	JJ	_	14	case	_	_
13	as	_	ADP	IN	_	12	mwe	_	_
14	aPTT	_	NOUN	NN	_	11	nmod	_	_
15	,	_	.	,	_	14	punct	_	_
16	ECT	_	NOUN	NN	_	14	conj	_	_
17	,	_	.	,	_	14	punct	_	_
18	and	_	CONJ	CC	_	14	cc	_	_
19	TT	_	NOUN	NN	_	14	conj	_	_

#	Dabigatran	1925
1	INR	_	NOUN	NN	_	4	nsubj	_	_
2	is	_	VERB	VBZ	_	4	cop	_	_
3	relatively	_	ADV	RB	_	4	advmod	_	_
4	insensitive	_	ADJ	JJ	_	0	root	_	_
5	to	_	PRT	TO	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	exposure	_	NOUN	NN	_	4	nmod	_	_
8	to	_	PRT	TO	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	cannot	_	NOUN	NN	_	9	conj	_	_
12	be	_	VERB	VBZ	_	13	auxpass	_	_
13	interpreted	_	VERB	VBN	_	4	parataxis	_	_
14	the	_	DET	DT	_	16	det	_	_
15	same	_	ADJ	JJ	_	16	amod	_	_
16	way	_	NOUN	NNS	_	13	dobj	_	_
17	as	_	ADP	IN	_	18	mark	_	_
18	used	_	VERB	VBN	_	13	advcl	_	_
19	for	_	ADP	IN	_	20	case	_	_
20	warfarin	_	NOUN	NN	_	18	nmod	_	_
21	monitoring	_	VERB	VBG	_	20	acl	_	_

#	Dabigatran	1926
1	The	_	DET	DT	_	3	det	_	_
2	aPTT	_	NOUN	NN	_	3	compound	_	_
3	test	_	NOUN	NN	_	4	nsubj	_	_
4	provides	_	VERB	VBZ	_	0	root	_	_
5	an	_	DET	DT	_	6	det	_	_
6	approximation	_	NOUN	NN	_	4	dobj	_	_
7	of	_	ADP	IN	_	10	case	_	_
8	PRADAXA's	_	NOUN	NN	_	10	compound	_	_
9	anticoagulant	_	ADJ	JJ	_	10	amod	_	_
10	effect	_	NOUN	NN	_	6	nmod	_	_

#	Dabigatran	1927
1	The	_	DET	DT	_	4	det	_	_
2	average	_	ADJ	JJ	_	4	amod	_	_
3	time	_	NOUN	NN	_	4	compound	_	_
4	course	_	NOUN	NN	_	23	nsubjpass	_	_
5	for	_	ADP	IN	_	6	case	_	_
6	effects	_	NOUN	NNS	_	4	nmod	_	_
7	on	_	ADP	IN	_	8	case	_	_
8	aPTT	_	NOUN	NN	_	4	nmod	_	_
9	,	_	.	,	_	4	punct	_	_
10	following	_	VERB	VBG	_	13	case	_	_
11	approved	_	VERB	VBN	_	13	amod	_	_
12	dosing	_	VERB	VBG	_	13	amod	_	_
13	regimens	_	NOUN	NNS	_	4	nmod	_	_
14	in	_	ADP	IN	_	15	case	_	_
15	patients	_	NOUN	NNS	_	13	nmod	_	_
16	with	_	ADP	IN	_	18	case	_	_
17	various	_	ADJ	JJ	_	18	amod	_	_
18	degrees	_	NOUN	NNS	_	15	nmod	_	_
19	of	_	ADP	IN	_	21	case	_	_
20	renal	_	ADJ	JJ	_	21	amod	_	_
21	impairment	_	NOUN	NN	_	18	nmod	_	_
22	is	_	VERB	VBZ	_	23	auxpass	_	_
23	shown	_	VERB	VBN	_	0	root	_	_
24	in	_	ADP	IN	_	25	case	_	_
25	Figure	_	NOUN	NN	_	23	nmod	_	_
26	2	_	NUM	CD	_	25	nummod	_	_

#	Dabigatran	1928
1	The	_	DET	DT	_	2	det	_	_
2	curves	_	NOUN	NNS	_	3	nsubj	_	_
3	represent	_	VERB	VBP	_	0	root	_	_
4	mean	_	ADJ	JJ	_	5	amod	_	_
5	levels	_	NOUN	NNS	_	3	dobj	_	_
6	without	_	ADP	IN	_	9	case	_	_
7	confidence	_	NOUN	NN	_	9	compound	_	_
8	intervals	_	VERB	VBZ	_	9	compound	_	_
9	variations	_	NOUN	NNS	_	3	nmod	_	_
10	should	_	VERB	MD	_	12	aux	_	_
11	be	_	VERB	VB	_	12	auxpass	_	_
12	expected	_	VERB	VBN	_	3	parataxis	_	_
13	when	_	ADV	WRB	_	14	advmod	_	_
14	measuring	_	VERB	VBG	_	12	advcl	_	_
15	aPTT	_	NOUN	NN	_	14	dobj	_	_

#	Dabigatran	1929
1	While	_	ADP	IN	_	5	mark	_	_
2	advice	_	NOUN	NN	_	5	mark	_	_
3	cannot	_	NOUN	NN	_	5	nsubjpass	_	_
4	be	_	VERB	VBZ	_	5	auxpass	_	_
5	provided	_	VERB	VBN	_	24	advcl	_	_
6	on	_	ADP	IN	_	8	case	_	_
7	the	_	DET	DT	_	8	det	_	_
8	level	_	NOUN	NN	_	5	nmod	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	recovery	_	NOUN	NN	_	8	nmod	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	aPTT	_	NOUN	NN	_	10	nmod	_	_
13	needed	_	VERB	VBN	_	10	acl	_	_
14	in	_	ADP	IN	_	18	case	_	_
15	any	_	DET	DT	_	18	det	_	_
16	particular	_	ADJ	JJ	_	18	amod	_	_
17	clinical	_	ADJ	JJ	_	18	amod	_	_
18	setting	_	NOUN	NN	_	13	nmod	_	_
19	,	_	.	,	_	24	punct	_	_
20	the	_	DET	DT	_	21	det	_	_
21	curves	_	NOUN	NNS	_	24	nsubjpass	_	_
22	can	_	VERB	MD	_	24	aux	_	_
23	be	_	VERB	VB	_	24	auxpass	_	_
24	used	_	VERB	VBN	_	0	root	_	_
25	to	_	PRT	TO	_	26	mark	_	_
26	estimate	_	VERB	VB	_	24	xcomp	_	_
27	the	_	DET	DT	_	28	det	_	_
28	time	_	NOUN	NN	_	26	dobj	_	_
29	to	_	PRT	TO	_	30	mark	_	_
30	get	_	VERB	VB	_	26	xcomp	_	_
31	to	_	PRT	TO	_	34	case	_	_
32	a	_	DET	DT	_	34	det	_	_
33	particular	_	ADJ	JJ	_	34	amod	_	_
34	level	_	NOUN	NN	_	30	nmod	_	_
35	of	_	ADP	IN	_	36	case	_	_
36	recovery	_	NOUN	NN	_	34	nmod	_	_
37	,	_	.	,	_	24	punct	_	_
38	even	_	ADV	RB	_	39	advmod	_	_
39	when	_	ADV	WRB	_	24	advmod	_	_
40	the	_	DET	DT	_	41	det	_	_
41	time	_	NOUN	NN	_	39	root	_	_
42	since	_	ADP	IN	_	51	mark	_	_
43	the	_	DET	DT	_	45	det	_	_
44	last	_	ADJ	JJ	_	45	amod	_	_
45	dose	_	NOUN	NN	_	51	nsubjpass	_	_
46	of	_	ADP	IN	_	47	case	_	_
47	PRADAXA	_	NOUN	NN	_	45	nmod	_	_
48	is	_	VERB	VBZ	_	51	auxpass	_	_
49	not	_	ADV	RB	_	51	neg	_	_
50	precisely	_	ADV	RB	_	51	advmod	_	_
51	known	_	VERB	VBN	_	41	acl:relcl	_	_

#	Dabigatran	1930
1	In	_	ADP	IN	_	5	case	_	_
2	the	_	DET	DT	_	5	det	_	_
3	RE	_	NOUN	NN	_	5	compound	_	_
4	LY	_	NOUN	NN	_	5	compound	_	_
5	trial	_	NOUN	NN	_	23	nmod	_	_
6	,	_	.	,	_	23	punct	_	_
7	the	_	DET	DT	_	9	det	_	_
8	median	_	ADJ	JJ	_	9	amod	_	_
9	10th	_	NOUN	NN	_	23	nsubj	_	_
10	to	_	PRT	TO	_	14	case	_	_
11	90th	_	ADJ	JJ	_	14	amod	_	_
12	percentile	_	ADJ	JJ	_	14	amod	_	_
13	trough	_	NOUN	NN	_	14	compound	_	_
14	aPTT	_	NOUN	NN	_	9	nmod	_	_
15	in	_	ADP	IN	_	16	case	_	_
16	patients	_	NOUN	NNS	_	14	nmod	_	_
17	receiving	_	VERB	VBG	_	16	acl	_	_
18	the	_	DET	DT	_	21	det	_	_
19	150	_	NUM	CD	_	21	nummod	_	_
20	mg	_	NOUN	NN	_	21	compound	_	_
21	dose	_	NOUN	NN	_	17	dobj	_	_
22	was	_	VERB	VBD	_	23	cop	_	_
23	52	_	NUM	CD	_	0	root	_	_
24	40	_	NUM	CD	_	23	nummod	_	_
25	to	_	PRT	TO	_	27	case	_	_
26	76	_	NUM	CD	_	27	nummod	_	_
27	seconds	_	NOUN	NNS	_	23	nmod	_	_

#	Dabigatran	1931
1	Figure	_	NOUN	NN	_	5	compound	_	_
2	2	_	NUM	CD	_	5	nummod	_	_
3	Average	_	NOUN	NN	_	5	compound	_	_
4	Time	_	NOUN	NN	_	5	compound	_	_
5	Course	_	NOUN	NN	_	0	root	_	_
6	for	_	ADP	IN	_	7	case	_	_
7	Effects	_	NOUN	NNS	_	5	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	on	_	ADP	IN	_	11	case	_	_
11	aPTT	_	NOUN	NN	_	5	nmod	_	_
12	,	_	.	,	_	5	punct	_	_
13	Following	_	VERB	VBG	_	17	case	_	_
14	Approved	_	ADJ	JJ	_	17	amod	_	_
15	PRADAXA	_	NOUN	NN	_	17	compound	_	_
16	Dosing	_	VERB	VBG	_	17	compound	_	_
17	Regimens	_	NOUN	NNS	_	5	nmod	_	_
18	in	_	ADP	IN	_	19	case	_	_
19	Patients	_	NOUN	NNS	_	17	nmod	_	_
20	with	_	ADP	IN	_	22	case	_	_
21	Various	_	ADJ	JJ	_	22	amod	_	_
22	Degrees	_	NOUN	NNS	_	19	nmod	_	_
23	of	_	ADP	IN	_	26	case	_	_
24	Renal	_	ADJ	JJ	_	26	amod	_	_
25	Impairment*	_	NOUN	NN	_	26	compound	_	_
26	Simulations	_	NOUN	NNS	_	22	nmod	_	_
27	based	_	VERB	VBN	_	26	acl	_	_
28	on	_	ADP	IN	_	30	case	_	_
29	PK	_	NOUN	NN	_	30	compound	_	_
30	data	_	NOUN	NNS	_	27	nmod	_	_
31	from	_	ADP	IN	_	33	case	_	_
32	a	_	DET	DT	_	33	det	_	_
33	study	_	NOUN	NN	_	30	nmod	_	_
34	in	_	ADP	IN	_	35	case	_	_
35	subjects	_	NOUN	NNS	_	33	nmod	_	_
36	with	_	ADP	IN	_	38	case	_	_
37	renal	_	ADJ	JJ	_	38	amod	_	_
38	impairment	_	NOUN	NN	_	35	nmod	_	_
39	and	_	CONJ	CC	_	38	cc	_	_
40	PK	_	NOUN	NN	_	38	conj	_	_
41	/	_	.	:	_	40	punct	_	_
42	aPTT	_	NOUN	NN	_	43	compound	_	_
43	relationships	_	NOUN	NNS	_	56	nsubjpass	_	_
44	derived	_	VERB	VBN	_	43	acl	_	_
45	from	_	ADP	IN	_	51	case	_	_
46	the	_	DET	DT	_	51	det	_	_
47	RE	_	NOUN	NN	_	51	compound	_	_
48	LY	_	NOUN	NN	_	51	compound	_	_
49	study	_	NOUN	NN	_	51	compound	_	_
50	aPTT	_	NOUN	NN	_	51	compound	_	_
51	prolongation	_	NOUN	NN	_	44	nmod	_	_
52	in	_	ADP	IN	_	54	case	_	_
53	RE	_	NOUN	NN	_	54	compound	_	_
54	LY	_	NOUN	NN	_	51	nmod	_	_
55	was	_	VERB	VBD	_	56	auxpass	_	_
56	measured	_	VERB	VBN	_	40	dep	_	_
57	centrally	_	ADV	RB	_	56	advmod	_	_
58	in	_	ADP	IN	_	60	case	_	_
59	citrate	_	NOUN	NN	_	60	amod	_	_
60	plasma	_	NOUN	NN	_	56	nmod	_	_
61	using	_	VERB	VBG	_	56	xcomp	_	_
62	PTT	_	NOUN	NN	_	65	compound	_	_
63	Reagent	_	ADJ	JJ	_	65	amod	_	_
64	Roche	_	NOUN	NN	_	65	compound	_	_
65	Diagnostics	_	NOUN	NNS	_	61	dobj	_	_
66	GmbH	_	NOUN	NN	_	65	dep	_	_
67	,	_	.	,	_	66	punct	_	_
68	Mannheim	_	NOUN	NN	_	66	conj	_	_
69	,	_	.	,	_	66	punct	_	_
70	Germany	_	ADJ	JJ	_	66	root	_	_

#	Dabigatran	1932
1	There	_	DET	EX	_	5	nsubj	_	_
2	may	_	VERB	MD	_	5	aux	_	_
3	be	_	VERB	VB	_	5	cop	_	_
4	quantitative	_	ADJ	JJ	_	5	amod	_	_
5	differences	_	NOUN	NNS	_	0	root	_	_
6	between	_	ADP	IN	_	9	case	_	_
7	various	_	ADJ	JJ	_	9	amod	_	_
8	established	_	VERB	VBN	_	9	amod	_	_
9	methods	_	NOUN	NNS	_	5	nmod	_	_
10	for	_	ADP	IN	_	12	case	_	_
11	aPTT	_	NOUN	NN	_	12	compound	_	_
12	assessment	_	NOUN	NN	_	9	nmod	_	_

#	Dabigatran	1933
1	The	_	DET	DT	_	2	det	_	_
2	degree	_	NOUN	NN	_	9	nsubjpass	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	anticoagulant	_	ADJ	JJ	_	5	amod	_	_
5	activity	_	NOUN	NN	_	2	nmod	_	_
6	can	_	VERB	MD	_	9	aux	_	_
7	also	_	ADV	RB	_	9	advmod	_	_
8	be	_	VERB	VB	_	9	auxpass	_	_
9	assessed	_	VERB	VBN	_	0	root	_	_
10	by	_	ADP	IN	_	12	case	_	_
11	the	_	DET	DT	_	12	det	_	_
12	ecarin	_	NOUN	NN	_	9	nmod	_	_
13	clotting	_	VERB	VBG	_	12	acl	_	_
14	time	_	NOUN	NN	_	15	compound	_	_
15	ECT	_	NOUN	NN	_	13	dobj	_	_

#	Dabigatran	1934
1	This	_	DET	DT	_	2	det	_	_
2	test	_	NOUN	NN	_	7	nsubj	_	_
3	is	_	VERB	VBZ	_	7	cop	_	_
4	a	_	DET	DT	_	7	det	_	_
5	more	_	ADV	RB	_	6	advmod	_	_
6	specific	_	ADJ	JJ	_	7	amod	_	_
7	measure	_	NOUN	NN	_	0	root	_	_
8	of	_	ADP	IN	_	10	case	_	_
9	the	_	DET	DT	_	10	det	_	_
10	effect	_	NOUN	NN	_	7	nmod	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_
13	than	_	ADP	IN	_	18	case	_	_
14	activated	_	VERB	VBN	_	18	amod	_	_
15	partial	_	ADJ	JJ	_	18	amod	_	_
16	thromboplastin	_	NOUN	NN	_	18	compound	_	_
17	time	_	NOUN	NN	_	18	compound	_	_
18	aPTT	_	NOUN	NN	_	10	nmod	_	_

#	Dabigatran	1935
1	In	_	ADP	IN	_	5	case	_	_
2	the	_	DET	DT	_	5	det	_	_
3	RE	_	NOUN	NN	_	5	compound	_	_
4	LY	_	NOUN	NN	_	5	compound	_	_
5	trial	_	NOUN	NN	_	23	nmod	_	_
6	,	_	.	,	_	23	punct	_	_
7	the	_	DET	DT	_	9	det	_	_
8	median	_	ADJ	JJ	_	9	amod	_	_
9	10th	_	NOUN	NN	_	23	nsubj	_	_
10	to	_	PRT	TO	_	14	case	_	_
11	90th	_	ADJ	JJ	_	14	amod	_	_
12	percentile	_	ADJ	JJ	_	14	amod	_	_
13	trough	_	NOUN	NN	_	14	compound	_	_
14	ECT	_	NOUN	NN	_	9	nmod	_	_
15	in	_	ADP	IN	_	16	case	_	_
16	patients	_	NOUN	NNS	_	9	nmod	_	_
17	receiving	_	VERB	VBG	_	16	acl	_	_
18	the	_	DET	DT	_	21	det	_	_
19	150	_	NUM	CD	_	21	nummod	_	_
20	mg	_	NOUN	NN	_	21	compound	_	_
21	dose	_	NOUN	NN	_	17	dobj	_	_
22	was	_	VERB	VBD	_	23	cop	_	_
23	63	_	NUM	CD	_	0	root	_	_
24	44	_	NUM	CD	_	26	compound	_	_
25	to	_	PRT	TO	_	26	dep	_	_
26	103	_	NUM	CD	_	27	nummod	_	_
27	seconds	_	NOUN	NNS	_	23	dep	_	_

#	Dabigatran	1936
1	In	_	ADP	IN	_	5	case	_	_
2	orthopedic	_	ADJ	JJ	_	5	amod	_	_
3	hip	_	NOUN	NN	_	5	compound	_	_
4	surgery	_	NOUN	NN	_	5	compound	_	_
5	patients	_	NOUN	NNS	_	17	nmod	_	_
6	,	_	.	,	_	17	punct	_	_
7	maximum	_	NOUN	NN	_	9	compound	_	_
8	aPTT	_	NOUN	NN	_	9	compound	_	_
9	response	_	NOUN	NN	_	17	nsubj	_	_
10	Emax	_	NOUN	NN	_	9	dep	_	_
11	to	_	PRT	TO	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	baseline	_	NOUN	NN	_	15	compound	_	_
15	aPTT	_	NOUN	NN	_	12	conj	_	_
16	were	_	VERB	VBD	_	17	cop	_	_
17	higher	_	ADJ	JJ	_	0	root	_	_
18	shortly	_	ADV	RB	_	17	advmod	_	_
19	after	_	ADP	IN	_	20	case	_	_
20	surgery	_	NOUN	NN	_	17	nmod	_	_
21	than	_	ADP	IN	_	25	case	_	_
22	at	_	ADP	IN	_	25	case	_	_
23	later	_	ADJ	JJ	_	25	amod	_	_
24	time	_	NOUN	NN	_	25	compound	_	_
25	points	_	NOUN	NNS	_	17	nmod	_	_
26	e.g	_	.	.	_	25	punct	_	_

#	Dabigatran	1937
1	Cardiac	_	ADJ	JJ	_	4	amod	_	_
2	Electrophysiology	_	NOUN	NN	_	4	compound	_	_
3	No	_	NOUN	NN	_	4	compound	_	_
4	prolongation	_	NOUN	NN	_	10	nsubjpass	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	the	_	DET	DT	_	8	det	_	_
7	QTc	_	NOUN	NN	_	8	compound	_	_
8	interval	_	NOUN	NN	_	4	nmod	_	_
9	was	_	VERB	VBD	_	10	auxpass	_	_
10	observed	_	VERB	VBN	_	0	root	_	_
11	with	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_
13	etexilate	_	VERB	VBP	_	10	advcl	_	_
14	at	_	ADP	IN	_	15	case	_	_
15	doses	_	NOUN	NNS	_	13	nmod	_	_
16	up	_	ADV	RB	_	18	advmod	_	_
17	to	_	PRT	TO	_	16	mwe	_	_
18	600	_	NUM	CD	_	15	nmod	_	_
19	mg	_	NOUN	NNS	_	18	dep	_	_

#	Dabigatran	1938
1	Figure	_	NOUN	NN	_	3	compound	_	_
2	2	_	NUM	CD	_	3	nummod	_	_
3	DRUG	_	NOUN	NN	_	4	nsubj	_	_
4	etexilate	_	NOUN	NN	_	7	nsubjpass	_	_
5	mesylate	_	NOUN	NN	_	4	dobj	_	_
6	is	_	VERB	VBZ	_	7	auxpass	_	_
7	absorbed	_	VERB	VBN	_	0	root	_	_
8	as	_	ADP	IN	_	12	case	_	_
9	the	_	DET	DT	_	12	det	_	_
10	DRUG	_	NOUN	NN	_	12	compound	_	_
11	etexilate	_	NOUN	NN	_	12	compound	_	_
12	ester	_	NOUN	NN	_	7	nmod	_	_

#	Dabigatran	1939
1	The	_	DET	DT	_	2	det	_	_
2	ester	_	NOUN	NN	_	5	nsubjpass	_	_
3	is	_	VERB	VBZ	_	5	auxpass	_	_
4	then	_	ADV	RB	_	5	advmod	_	_
5	hydrolyzed	_	VERB	VBN	_	0	root	_	_
6	,	_	.	,	_	5	punct	_	_
7	forming	_	VERB	VBG	_	5	xcomp	_	_
8	DRUG	_	NOUN	NN	_	7	dobj	_	_
9	,	_	.	,	_	5	punct	_	_
10	the	_	DET	DT	_	12	det	_	_
11	active	_	ADJ	JJ	_	12	amod	_	_
12	moiety	_	NOUN	NN	_	5	root	_	_

#	Dabigatran	1940
1	DRUG	_	NOUN	NN	_	3	nsubjpass	_	_
2	is	_	VERB	VBZ	_	3	auxpass	_	_
3	metabolized	_	VERB	VBN	_	0	root	_	_
4	to	_	PRT	TO	_	8	case	_	_
5	four	_	NUM	CD	_	8	nummod	_	_
6	different	_	ADJ	JJ	_	8	amod	_	_
7	acyl	_	NOUN	NN	_	8	compound	_	_
8	glucuronides	_	NOUN	NNS	_	3	nmod	_	_
9	and	_	CONJ	CC	_	3	cc	_	_
10	both	_	CONJ	CC	_	12	cc:preconj	_	_
11	the	_	DET	DT	_	12	det	_	_
12	glucuronides	_	NOUN	NNS	_	15	nsubj	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	DRUG	_	NOUN	NN	_	12	conj	_	_
15	have	_	VERB	VBP	_	3	conj	_	_
16	similar	_	ADJ	JJ	_	18	amod	_	_
17	pharmacological	_	ADJ	JJ	_	18	amod	_	_
18	activity	_	NOUN	NN	_	15	dobj	_	_

#	Dabigatran	1941
1	Pharmacokinetics	_	NOUN	NNS	_	4	nsubj	_	_
2	described	_	VERB	VBN	_	1	acl	_	_
3	here	_	ADV	RB	_	2	advmod	_	_
4	refer	_	VERB	VBP	_	0	root	_	_
5	to	_	PRT	TO	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	sum	_	NOUN	NN	_	4	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	and	_	CONJ	CC	_	7	cc	_	_
11	its	_	PRON	PRP$	_	12	nmod:poss	_	_
12	glucuronides	_	NOUN	NNS	_	7	conj	_	_

#	Dabigatran	1942
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	displays	_	VERB	VBZ	_	0	root	_	_
3	dose	_	NOUN	NN	_	5	compound	_	_
4	proportional	_	ADJ	JJ	_	5	amod	_	_
5	pharmacokinetics	_	NOUN	NNS	_	2	dobj	_	_
6	in	_	ADP	IN	_	8	case	_	_
7	healthy	_	ADJ	JJ	_	8	amod	_	_
8	subjects	_	NOUN	NNS	_	2	nmod	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	patients	_	NOUN	NNS	_	8	conj	_	_
11	in	_	ADP	IN	_	13	case	_	_
12	the	_	DET	DT	_	13	det	_	_
13	range	_	NOUN	NN	_	8	nmod	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	doses	_	NOUN	NNS	_	13	nmod	_	_
16	from	_	ADP	IN	_	21	case	_	_
17	10	_	NUM	CD	_	19	compound	_	_
18	to	_	PRT	TO	_	19	dep	_	_
19	400	_	NUM	CD	_	21	nummod	_	_
20	mg	_	NOUN	NN	_	21	compound	_	_
21	Absorption	_	NOUN	NN	_	13	nmod	_	_
22	The	_	DET	DT	_	24	det	_	_
23	absolute	_	NOUN	NN	_	24	amod	_	_
24	bioavailability	_	NOUN	NN	_	37	nsubj	_	_
25	of	_	ADP	IN	_	26	case	_	_
26	DRUG	_	NOUN	NN	_	24	nmod	_	_
27	following	_	VERB	VBG	_	29	case	_	_
28	oral	_	ADJ	JJ	_	29	amod	_	_
29	administration	_	NOUN	NN	_	24	nmod	_	_
30	of	_	ADP	IN	_	32	case	_	_
31	DRUG	_	NOUN	NN	_	32	compound	_	_
32	etexilate	_	NOUN	NN	_	29	nmod	_	_
33	is	_	VERB	VBZ	_	37	cop	_	_
34	approximately	_	ADV	RB	_	35	advmod	_	_
35	3	_	NUM	CD	_	37	compound	_	_
36	to	_	PRT	TO	_	37	case	_	_
37	7%	_	ADJ	JJ	_	2	parataxis	_	_

#	Dabigatran	1943
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	etexilate	_	NOUN	NN	_	5	nsubj	_	_
3	is	_	VERB	VBZ	_	5	cop	_	_
4	a	_	DET	DT	_	5	det	_	_
5	substrate	_	NOUN	NN	_	0	root	_	_
6	of	_	ADP	IN	_	11	case	_	_
7	the	_	DET	DT	_	11	det	_	_
8	efflux	_	NOUN	NN	_	11	compound	_	_
9	transporter	_	NOUN	NN	_	11	compound	_	_
10	P	_	NOUN	NN	_	11	compound	_	_
11	gp	_	NOUN	NN	_	5	nmod	_	_

#	Dabigatran	1944
1	After	_	ADP	IN	_	3	case	_	_
2	oral	_	ADJ	JJ	_	3	amod	_	_
3	administration	_	NOUN	NN	_	6	nmod	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	etexilate	_	VERB	VBP	_	12	advcl	_	_
7	in	_	ADP	IN	_	9	case	_	_
8	healthy	_	ADJ	JJ	_	9	amod	_	_
9	volunteers	_	NOUN	NNS	_	6	nmod	_	_
10	,	_	.	,	_	12	punct	_	_
11	Cmax	_	NOUN	NN	_	12	nsubj	_	_
12	occurs	_	VERB	VBZ	_	0	root	_	_
13	at	_	ADP	IN	_	17	case	_	_
14	1	_	NUM	CD	_	17	nummod	_	_
15	hour	_	NUM	CD	_	17	nummod	_	_
16	post	_	ADJ	JJ	_	17	amod	_	_
17	administration	_	NOUN	NN	_	12	nmod	_	_
18	in	_	ADP	IN	_	21	case	_	_
19	the	_	DET	DT	_	21	det	_	_
20	fasted	_	ADJ	JJ	_	21	amod	_	_
21	state	_	NOUN	NN	_	17	nmod	_	_

#	Dabigatran	1945
1	Coadministration	_	NOUN	NN	_	9	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	PRADAXA	_	NOUN	NN	_	1	nmod	_	_
4	with	_	ADP	IN	_	8	case	_	_
5	a	_	DET	DT	_	8	det	_	_
6	high	_	ADJ	JJ	_	8	amod	_	_
7	fat	_	NOUN	NN	_	8	compound	_	_
8	meal	_	NOUN	NN	_	1	nmod	_	_
9	delays	_	VERB	VBZ	_	0	root	_	_
10	the	_	DET	DT	_	11	det	_	_
11	time	_	NOUN	NN	_	9	dobj	_	_
12	to	_	PRT	TO	_	13	case	_	_
13	Cmax	_	NOUN	NN	_	11	nmod	_	_
14	by	_	ADP	IN	_	17	case	_	_
15	approximately	_	ADV	RB	_	16	advmod	_	_
16	2	_	NUM	CD	_	17	nummod	_	_
17	hours	_	NOUN	NNS	_	9	nmod	_	_
18	but	_	CONJ	CC	_	9	cc	_	_
19	has	_	VERB	VBZ	_	30	aux	_	_
20	no	_	DET	DT	_	21	neg	_	_
21	effect	_	NOUN	NN	_	19	dobj	_	_
22	on	_	ADP	IN	_	24	case	_	_
23	the	_	DET	DT	_	24	det	_	_
24	bioavailability	_	NOUN	NN	_	19	nmod	_	_
25	of	_	ADP	IN	_	27	case	_	_
26	DRUG	_	NOUN	NN	_	27	compound	_	_
27	PRADAXA	_	NOUN	NN	_	24	nmod	_	_
28	may	_	VERB	MD	_	30	aux	_	_
29	be	_	VERB	VB	_	30	auxpass	_	_
30	administered	_	VERB	VBN	_	9	conj	_	_
31	with	_	ADP	IN	_	30	nmod	_	_
32	or	_	CONJ	CC	_	31	cc	_	_
33	without	_	ADP	IN	_	31	conj	_	_
34	food	_	NOUN	NN	_	31	dep	_	_

#	Dabigatran	1946
1	The	_	DET	DT	_	3	det	_	_
2	oral	_	ADJ	JJ	_	3	amod	_	_
3	bioavailability	_	NOUN	NN	_	6	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	etexilate	_	VERB	VBP	_	0	root	_	_
7	increases	_	NOUN	NNS	_	6	dobj	_	_
8	by	_	ADP	IN	_	9	case	_	_
9	75%	_	NOUN	NN	_	6	nmod	_	_
10	when	_	ADV	WRB	_	14	advmod	_	_
11	the	_	DET	DT	_	12	det	_	_
12	pellets	_	NOUN	NNS	_	14	nsubjpass	_	_
13	are	_	VERB	VBP	_	14	auxpass	_	_
14	taken	_	VERB	VBN	_	6	advcl	_	_
15	without	_	ADP	IN	_	17	case	_	_
16	the	_	DET	DT	_	17	det	_	_
17	capsule	_	NOUN	NN	_	14	nmod	_	_
18	shell	_	ADV	RB	_	19	advmod	_	_
19	compared	_	VERB	VBD	_	6	advcl	_	_
20	to	_	PRT	TO	_	24	case	_	_
21	the	_	DET	DT	_	24	det	_	_
22	intact	_	ADJ	JJ	_	24	amod	_	_
23	capsule	_	NOUN	NN	_	24	compound	_	_
24	formulation	_	NOUN	NN	_	19	nmod	_	_

#	Dabigatran	1947
1	PRADAXA	_	NOUN	NN	_	2	compound	_	_
2	capsules	_	NOUN	NNS	_	7	nsubjpass	_	_
3	should	_	VERB	MD	_	7	aux	_	_
4	therefore	_	ADV	RB	_	7	advmod	_	_
5	not	_	ADV	RB	_	7	neg	_	_
6	be	_	VERB	VB	_	7	auxpass	_	_
7	broken	_	VERB	VBN	_	0	root	_	_
8	,	_	.	,	_	7	punct	_	_
9	chewed	_	VERB	VBN	_	7	conj	_	_
10	,	_	.	,	_	7	punct	_	_
11	or	_	CONJ	CC	_	7	cc	_	_
12	opened	_	VERB	VBN	_	7	conj	_	_
13	before	_	ADP	IN	_	14	case	_	_
14	administration	_	NOUN	NN	_	12	nmod	_	_

#	Dabigatran	1948
1	Distribution	_	NOUN	NN	_	2	compound	_	_
2	DRUG	_	NOUN	NN	_	5	nsubj	_	_
3	is	_	VERB	VBZ	_	5	cop	_	_
4	approximately	_	ADV	RB	_	5	advmod	_	_
5	35%	_	ADJ	JJ	_	0	root	_	_
6	bound	_	VERB	VBN	_	5	acl	_	_
7	to	_	PRT	TO	_	10	case	_	_
8	human	_	ADJ	JJ	_	10	amod	_	_
9	plasma	_	NOUN	NN	_	10	compound	_	_
10	proteins	_	NOUN	NNS	_	6	nmod	_	_

#	Dabigatran	1949
1	The	_	DET	DT	_	4	det	_	_
2	red	_	ADJ	JJ	_	4	amod	_	_
3	blood	_	NOUN	NN	_	4	compound	_	_
4	cell	_	NOUN	NN	_	0	root	_	_
5	to	_	PRT	TO	_	7	case	_	_
6	plasma	_	NOUN	NN	_	7	compound	_	_
7	partitioning	_	NOUN	NN	_	4	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	measured	_	VERB	VBN	_	9	acl	_	_
11	as	_	ADP	IN	_	13	case	_	_
12	total	_	ADJ	JJ	_	13	amod	_	_
13	radioactivity	_	NOUN	NN	_	10	nmod	_	_
14	is	_	VERB	VBZ	_	17	cop	_	_
15	less	_	ADV	RB	_	17	advmod	_	_
16	than	_	ADP	IN	_	17	case	_	_
17	0.3	_	NUM	CD	_	4	nmod	_	_

#	Dabigatran	1950
1	The	_	DET	DT	_	2	det	_	_
2	volume	_	NOUN	NN	_	13	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	distribution	_	NOUN	NN	_	2	nmod	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	is	_	VERB	VBZ	_	13	cop	_	_
8	50	_	NUM	CD	_	13	nummod	_	_
9	to	_	PRT	TO	_	13	case	_	_
10	70	_	NUM	CD	_	13	nummod	_	_
11	L	_	NOUN	NN	_	13	compound	_	_
12	DRUG	_	NOUN	NN	_	13	compound	_	_
13	pharmacokinetics	_	NOUN	NNS	_	16	nsubj	_	_
14	are	_	VERB	VBP	_	16	cop	_	_
15	dose	_	NOUN	NN	_	16	nmod:npmod	_	_
16	proportional	_	ADJ	JJ	_	0	root	_	_
17	after	_	ADP	IN	_	19	case	_	_
18	single	_	ADJ	JJ	_	19	amod	_	_
19	doses	_	NOUN	NNS	_	16	nmod	_	_
20	of	_	ADP	IN	_	24	case	_	_
21	10	_	NUM	CD	_	23	compound	_	_
22	to	_	PRT	TO	_	23	dep	_	_
23	400	_	NUM	CD	_	24	nummod	_	_
24	mg	_	NOUN	NNS	_	19	nmod	_	_

#	Dabigatran	1951
1	Given	_	ADP	IN	_	3	case	_	_
2	twice	_	ADV	RB	_	3	advmod	_	_
3	daily	_	ADV	RB	_	0	root	_	_
4	,	_	.	,	_	3	punct	_	_
5	DRUG	_	NOUN	NN	_	8	nmod:poss	_	_
6	's	_	PRT	POS	_	8	case	_	_
7	accumulation	_	NOUN	NN	_	8	compound	_	_
8	factor	_	NOUN	NN	_	4	root	_	_
9	is	_	VERB	VBZ	_	11	cop	_	_
10	approximately	_	ADV	RB	_	11	advmod	_	_
11	two	_	NUM	CD	_	8	nmod	_	_

#	Dabigatran	1952
1	Elimination	_	NOUN	NN	_	2	compound	_	_
2	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
3	is	_	VERB	VBZ	_	4	auxpass	_	_
4	eliminated	_	VERB	VBN	_	0	root	_	_
5	primarily	_	ADV	RB	_	4	advmod	_	_
6	in	_	ADP	IN	_	8	case	_	_
7	the	_	DET	DT	_	8	det	_	_
8	urine	_	VERB	VBG	_	4	advcl	_	_

#	Dabigatran	1953
1	Renal	_	ADJ	JJ	_	2	amod	_	_
2	clearance	_	NOUN	NN	_	6	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	is	_	VERB	VBZ	_	6	cop	_	_
6	80%	_	NOUN	NN	_	0	root	_	_
7	of	_	ADP	IN	_	9	case	_	_
8	total	_	ADJ	JJ	_	9	amod	_	_
9	clearance	_	NOUN	NN	_	6	nmod	_	_
10	after	_	ADP	IN	_	12	case	_	_
11	intravenous	_	ADJ	JJ	_	12	amod	_	_
12	administration	_	NOUN	NN	_	9	nmod	_	_

#	Dabigatran	1954
1	After	_	ADP	IN	_	3	case	_	_
2	oral	_	ADJ	JJ	_	3	amod	_	_
3	administration	_	NOUN	NN	_	12	nmod	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	radiolabeled	_	VERB	VBN	_	6	amod	_	_
6	DRUG	_	NOUN	NN	_	3	nmod	_	_
7	,	_	.	,	_	12	punct	_	_
8	7%	_	NOUN	NN	_	12	nsubjpass	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	radioactivity	_	NOUN	NN	_	8	nmod	_	_
11	is	_	VERB	VBZ	_	12	auxpass	_	_
12	recovered	_	VERB	VBN	_	0	root	_	_
13	in	_	ADP	IN	_	14	case	_	_
14	urine	_	ADJ	JJ	_	12	nmod	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	86%	_	NOUN	NN	_	14	conj	_	_
17	in	_	ADP	IN	_	18	case	_	_
18	feces	_	NOUN	NNS	_	12	nmod	_	_

#	Dabigatran	1955
1	The	_	DET	DT	_	3	det	_	_
2	half	_	ADJ	JJ	_	3	amod	_	_
3	life	_	NOUN	NN	_	13	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	in	_	ADP	IN	_	8	case	_	_
7	healthy	_	ADJ	JJ	_	8	amod	_	_
8	subjects	_	NOUN	NNS	_	3	nmod	_	_
9	is	_	VERB	VBZ	_	13	cop	_	_
10	12	_	NUM	CD	_	12	compound	_	_
11	to	_	PRT	TO	_	12	dep	_	_
12	17	_	NUM	CD	_	13	nummod	_	_
13	hours	_	NOUN	NNS	_	0	root	_	_

#	Dabigatran	1956
1	Metabolism	_	NOUN	NN	_	4	compound	_	_
2	After	_	NOUN	NN	_	4	compound	_	_
3	oral	_	ADJ	JJ	_	4	amod	_	_
4	administration	_	NOUN	NN	_	9	nsubjpass	_	_
5	,	_	.	,	_	4	punct	_	_
6	DRUG	_	NOUN	NN	_	7	compound	_	_
7	etexilate	_	VERB	VBP	_	4	appos	_	_
8	is	_	VERB	VBZ	_	9	auxpass	_	_
9	converted	_	VERB	VBN	_	0	root	_	_
10	to	_	PRT	TO	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_

#	Dabigatran	1957
1	The	_	DET	DT	_	2	det	_	_
2	cleavage	_	NOUN	NN	_	6	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	the	_	DET	DT	_	5	det	_	_
5	DRUG	_	NOUN	NN	_	2	nmod	_	_
6	etexilate	_	NOUN	NN	_	20	nsubj	_	_
7	by	_	ADP	IN	_	10	case	_	_
8	esterase	_	NOUN	NN	_	10	compound	_	_
9	catalyzed	_	ADJ	JJ	_	10	amod	_	_
10	hydrolysis	_	NOUN	NN	_	6	nmod	_	_
11	to	_	PRT	TO	_	15	case	_	_
12	the	_	DET	DT	_	15	det	_	_
13	active	_	ADJ	JJ	_	15	amod	_	_
14	principal	_	ADJ	JJ	_	15	amod	_	_
15	DRUG	_	NOUN	NN	_	10	nmod	_	_
16	is	_	VERB	VBZ	_	20	cop	_	_
17	the	_	DET	DT	_	20	det	_	_
18	predominant	_	ADJ	JJ	_	20	amod	_	_
19	metabolic	_	ADJ	JJ	_	20	amod	_	_
20	reaction	_	NOUN	NN	_	0	root	_	_

#	Dabigatran	1958
1	DRUG	_	NOUN	NN	_	5	nsubj	_	_
2	is	_	VERB	VBZ	_	5	cop	_	_
3	not	_	ADV	RB	_	5	neg	_	_
4	a	_	DET	DT	_	5	det	_	_
5	substrate	_	NOUN	NN	_	0	root	_	_
6	,	_	.	,	_	5	punct	_	_
7	inhibitor	_	NOUN	NN	_	5	conj	_	_
8	,	_	.	,	_	5	punct	_	_
9	or	_	CONJ	CC	_	5	cc	_	_
10	inducer	_	NOUN	NN	_	5	conj	_	_
11	of	_	ADP	IN	_	13	case	_	_
12	CYP450	_	NOUN	NN	_	13	compound	_	_
13	enzymes	_	NOUN	NNS	_	10	nmod	_	_

#	Dabigatran	1959
1	DRUG	_	NOUN	NN	_	3	nsubj	_	_
2	is	_	VERB	VBZ	_	3	cop	_	_
3	subject	_	NOUN	NN	_	0	root	_	_
4	to	_	PRT	TO	_	5	case	_	_
5	conjugation	_	NOUN	NN	_	3	nmod	_	_
6	forming	_	VERB	VBG	_	5	acl	_	_
7	pharmacologically	_	ADV	RB	_	8	advmod	_	_
8	active	_	ADJ	JJ	_	10	amod	_	_
9	acyl	_	NOUN	NN	_	10	compound	_	_
10	glucuronides	_	NOUN	NNS	_	6	dobj	_	_

#	Dabigatran	1960
1	Four	_	NUM	CD	_	3	nummod	_	_
2	positional	_	ADJ	JJ	_	3	amod	_	_
3	isomers	_	NOUN	NNS	_	18	nsubj	_	_
4	,	_	.	,	_	3	punct	_	_
5	1	_	NUM	CD	_	6	nummod	_	_
6	O	_	NOUN	NN	_	3	conj	_	_
7	,	_	.	,	_	3	punct	_	_
8	2	_	NUM	CD	_	9	nummod	_	_
9	O	_	NOUN	NN	_	3	conj	_	_
10	,	_	.	,	_	3	punct	_	_
11	3	_	NUM	CD	_	12	nummod	_	_
12	O	_	NOUN	NN	_	3	conj	_	_
13	,	_	.	,	_	3	punct	_	_
14	and	_	CONJ	CC	_	3	cc	_	_
15	4	_	NUM	CD	_	17	nummod	_	_
16	O	_	NOUN	NN	_	17	compound	_	_
17	acylglucuronide	_	NOUN	NN	_	3	conj	_	_
18	exist	_	VERB	VBP	_	0	root	_	_
19	,	_	.	,	_	18	punct	_	_
20	and	_	CONJ	CC	_	18	cc	_	_
21	each	_	DET	DT	_	22	det	_	_
22	accounts	_	NOUN	NNS	_	18	conj	_	_
23	for	_	ADP	IN	_	26	case	_	_
24	less	_	ADV	RB	_	26	advmod	_	_
25	than	_	ADP	IN	_	24	mwe	_	_
26	10%	_	NOUN	NN	_	22	nmod	_	_
27	of	_	ADP	IN	_	29	case	_	_
28	total	_	ADJ	JJ	_	29	amod	_	_
29	DRUG	_	NOUN	NN	_	26	nmod	_	_
30	in	_	ADP	IN	_	31	case	_	_
31	plasma	_	NOUN	NN	_	29	nmod	_	_

#	Dabigatran	1961
1	Renal	_	ADJ	JJ	_	4	amod	_	_
2	Impairment	_	NOUN	NN	_	4	nmod:npmod	_	_
3	An	_	NOUN	NN	_	4	nmod:npmod	_	_
4	open	_	ADJ	JJ	_	0	root	_	_
5	,	_	.	,	_	4	punct	_	_
6	parallel	_	ADJ	JJ	_	10	amod	_	_
7	group	_	NOUN	NN	_	10	compound	_	_
8	single	_	ADJ	JJ	_	10	amod	_	_
9	center	_	NOUN	NN	_	10	compound	_	_
10	study	_	NOUN	NN	_	11	nsubj	_	_
11	compared	_	VERB	VBD	_	4	parataxis	_	_
12	DRUG	_	NOUN	NN	_	13	compound	_	_
13	pharmacokinetics	_	NOUN	NNS	_	11	dobj	_	_
14	in	_	ADP	IN	_	16	case	_	_
15	healthy	_	ADJ	JJ	_	16	amod	_	_
16	subjects	_	NOUN	NNS	_	11	nmod	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	patients	_	NOUN	NNS	_	16	conj	_	_
19	with	_	ADP	IN	_	20	case	_	_
20	mild	_	ADJ	JJ	_	16	nmod	_	_
21	to	_	PRT	TO	_	24	case	_	_
22	moderate	_	ADJ	JJ	_	24	amod	_	_
23	renal	_	ADJ	JJ	_	24	amod	_	_
24	impairment	_	NOUN	NN	_	16	nmod	_	_
25	receiving	_	VERB	VBG	_	24	acl	_	_
26	a	_	DET	DT	_	28	det	_	_
27	single	_	ADJ	JJ	_	28	amod	_	_
28	dose	_	NOUN	NN	_	25	dobj	_	_
29	of	_	ADP	IN	_	32	case	_	_
30	PRADAXA	_	NOUN	NN	_	32	compound	_	_
31	150	_	NUM	CD	_	32	nummod	_	_
32	mg	_	NOUN	NNS	_	28	nmod	_	_

#	Dabigatran	1962
1	Exposure	_	NOUN	NN	_	4	nsubj	_	_
2	to	_	PRT	TO	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	increases	_	VERB	VBZ	_	0	root	_	_
5	with	_	ADP	IN	_	6	case	_	_
6	severity	_	NOUN	NN	_	4	nmod	_	_
7	of	_	ADP	IN	_	10	case	_	_
8	renal	_	ADJ	JJ	_	10	amod	_	_
9	function	_	NOUN	NN	_	10	compound	_	_
10	impairment	_	NOUN	NN	_	6	nmod	_	_
11	Table	_	ADJ	JJ	_	10	dep	_	_
12	8	_	NUM	CD	_	11	nummod	_	_

#	Dabigatran	1963
1	Similar	_	ADJ	JJ	_	2	amod	_	_
2	findings	_	NOUN	NNS	_	4	nsubjpass	_	_
3	were	_	VERB	VBD	_	4	auxpass	_	_
4	observed	_	VERB	VBN	_	0	root	_	_
5	in	_	ADP	IN	_	8	case	_	_
6	the	_	DET	DT	_	8	det	_	_
7	RE	_	NOUN	NN	_	8	compound	_	_
8	LY	_	NOUN	NN	_	4	nmod	_	_
9	,	_	.	,	_	4	punct	_	_
10	RE	_	NOUN	NN	_	11	compound	_	_
11	COVER	_	NOUN	NN	_	4	dep	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	RE	_	NOUN	NN	_	16	compound	_	_
14	NOVATE	_	NOUN	NN	_	16	compound	_	_
15	II	_	NUM	CD	_	16	nummod	_	_
16	trials	_	NOUN	NNS	_	11	conj	_	_

#	Dabigatran	1964
1	Table	_	ADJ	JJ	_	3	amod	_	_
2	6	_	NUM	CD	_	3	nummod	_	_
3	Impact	_	NOUN	NN	_	17	nsubjpass	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	Renal	_	ADJ	JJ	_	6	amod	_	_
6	Impairment	_	NOUN	NN	_	3	nmod	_	_
7	on	_	ADP	IN	_	10	case	_	_
8	DRUG	_	NOUN	NN	_	10	compound	_	_
9	Pharmacokinetics	_	NOUN	NNS	_	10	compound	_	_
10	+Patients	_	NOUN	NNS	_	3	nmod	_	_
11	with	_	ADP	IN	_	14	case	_	_
12	severe	_	ADJ	JJ	_	14	amod	_	_
13	renal	_	ADJ	JJ	_	14	amod	_	_
14	impairment	_	NOUN	NN	_	10	nmod	_	_
15	were	_	VERB	VBD	_	17	auxpass	_	_
16	not	_	ADV	RB	_	17	neg	_	_
17	studied	_	VERB	VBN	_	0	root	_	_
18	in	_	ADP	IN	_	20	case	_	_
19	RE	_	NOUN	NN	_	20	compound	_	_
20	LY	_	NOUN	NN	_	17	nmod	_	_
21	and	_	CONJ	CC	_	20	cc	_	_
22	RE	_	NOUN	NN	_	23	compound	_	_
23	COVER	_	NOUN	NN	_	20	conj	_	_

#	Dabigatran	1965
1	Dosing	_	VERB	VBG	_	2	amod	_	_
2	recommendations	_	NOUN	NNS	_	10	nsubjpass	_	_
3	in	_	ADP	IN	_	4	case	_	_
4	subjects	_	NOUN	NNS	_	2	nmod	_	_
5	with	_	ADP	IN	_	8	case	_	_
6	severe	_	ADJ	JJ	_	8	amod	_	_
7	renal	_	ADJ	JJ	_	8	amod	_	_
8	impairment	_	NOUN	NN	_	4	nmod	_	_
9	are	_	VERB	VBP	_	10	auxpass	_	_
10	based	_	VERB	VBN	_	0	root	_	_
11	on	_	ADP	IN	_	13	case	_	_
12	pharmacokinetic	_	ADJ	JJ	_	13	amod	_	_
13	modeling	_	NOUN	NN	_	10	nmod	_	_

#	Dabigatran	1966
1	Renal	_	ADJ	JJ	_	4	amod	_	_
2	Function	_	NOUN	NN	_	4	compound	_	_
3	CrCl	_	NOUN	NN	_	4	compound	_	_
4	mL	_	NOUN	NN	_	0	root	_	_
5	/	_	.	:	_	4	punct	_	_
6	min	_	NOUN	NN	_	7	compound	_	_
7	Increase	_	NOUN	NN	_	55	nsubj	_	_
8	in	_	ADP	IN	_	10	case	_	_
9	AUC	_	NOUN	NN	_	10	compound	_	_
10	Increase	_	NOUN	NN	_	7	nmod	_	_
11	in	_	ADP	IN	_	12	case	_	_
12	Cmax	_	NOUN	NN	_	10	nmod	_	_
13	t1	_	NUM	CD	_	12	nummod	_	_
14	/	_	.	-LRB-	_	7	punct	_	_
15	2	_	NUM	CD	_	16	nummod	_	_
16	h	_	NOUN	NN	_	7	dep	_	_
17	Normal	_	ADJ	JJ	_	43	amod	_	_
18	>	_	NUM	CD	_	43	nummod	_	_
19	80	_	NUM	CD	_	43	nummod	_	_
20	1x	_	NUM	CD	_	43	nummod	_	_
21	1x	_	NUM	CD	_	43	nummod	_	_
22	13	_	NUM	CD	_	43	nummod	_	_
23	Mild	_	NOUN	NN	_	43	amod	_	_
24	50	_	NUM	CD	_	43	nummod	_	_
25	80	_	NUM	CD	_	43	nummod	_	_
26	1.5x	_	NUM	CD	_	43	nummod	_	_
27	1.1x	_	NUM	CD	_	43	nummod	_	_
28	15	_	NUM	CD	_	43	nummod	_	_
29	Moderate	_	ADJ	JJ	_	43	amod	_	_
30	30	_	NUM	CD	_	43	nummod	_	_
31	50	_	NUM	CD	_	43	nummod	_	_
32	3.2x	_	NUM	CD	_	43	nummod	_	_
33	1.7x	_	NUM	CD	_	43	nummod	_	_
34	18	_	NUM	CD	_	43	nummod	_	_
35	Severe+	_	ADJ	JJ	_	43	amod	_	_
36	15	_	NUM	CD	_	43	nummod	_	_
37	30	_	NUM	CD	_	43	nummod	_	_
38	6.3x	_	NUM	CD	_	43	nummod	_	_
39	2.1x	_	NUM	CD	_	43	nummod	_	_
40	27	_	NUM	CD	_	43	nummod	_	_
41	Hepatic	_	ADJ	JJ	_	43	amod	_	_
42	Impairment	_	NOUN	NN	_	43	compound	_	_
43	Administration	_	NOUN	NN	_	16	dep	_	_
44	of	_	ADP	IN	_	45	case	_	_
45	PRADAXA	_	NOUN	NN	_	43	nmod	_	_
46	in	_	ADP	IN	_	47	case	_	_
47	patients	_	NOUN	NNS	_	43	nmod	_	_
48	with	_	ADP	IN	_	54	case	_	_
49	moderate	_	ADJ	JJ	_	54	amod	_	_
50	hepatic	_	ADJ	JJ	_	54	amod	_	_
51	impairment	_	NOUN	NN	_	54	compound	_	_
52	Child	_	NOUN	NN	_	54	compound	_	_
53	Pugh	_	NOUN	NN	_	54	compound	_	_
54	B	_	NOUN	NN	_	47	nmod	_	_
55	showed	_	VERB	VBD	_	4	dep	_	_
56	a	_	DET	DT	_	60	det	_	_
57	large	_	ADJ	JJ	_	60	amod	_	_
58	inter	_	NOUN	NN	_	60	compound	_	_
59	subject	_	NOUN	NN	_	60	compound	_	_
60	variability	_	NOUN	NN	_	55	dobj	_	_
61	,	_	.	,	_	55	punct	_	_
62	but	_	CONJ	CC	_	55	cc	_	_
63	no	_	DET	DT	_	64	neg	_	_
64	evidence	_	NOUN	NN	_	55	conj	_	_
65	of	_	ADP	IN	_	68	case	_	_
66	a	_	DET	DT	_	68	det	_	_
67	consistent	_	ADJ	JJ	_	68	amod	_	_
68	change	_	NOUN	NN	_	64	nmod	_	_
69	in	_	ADP	IN	_	70	case	_	_
70	exposure	_	NOUN	NN	_	68	nmod	_	_
71	or	_	CONJ	CC	_	70	cc	_	_
72	pharmacodynamics	_	NOUN	NNS	_	70	conj	_	_

#	Dabigatran	1967
1	Drug	_	NOUN	NN	_	2	compound	_	_
2	Interactions	_	NOUN	NNS	_	0	root	_	_
3	A	_	NOUN	NN	_	4	compound	_	_
4	summary	_	NOUN	NN	_	15	nsubjpass	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	effect	_	NOUN	NN	_	4	nmod	_	_
8	of	_	ADP	IN	_	10	case	_	_
9	coadministered	_	VERB	VBN	_	10	amod	_	_
10	drugs	_	NOUN	NNS	_	7	nmod	_	_
11	on	_	ADP	IN	_	13	case	_	_
12	DRUG	_	NOUN	NN	_	13	compound	_	_
13	exposure	_	NOUN	NN	_	7	nmod	_	_
14	is	_	VERB	VBZ	_	15	auxpass	_	_
15	shown	_	VERB	VBN	_	2	acl	_	_
16	in	_	ADP	IN	_	17	case	_	_
17	Figures	_	NOUN	NNS	_	15	nmod	_	_
18	3.1	_	NUM	CD	_	17	nummod	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	3.2	_	NUM	CD	_	18	conj	_	_

#	Dabigatran	1968
1	In	_	ADP	IN	_	6	case	_	_
2	the	_	DET	DT	_	6	det	_	_
3	orthopedic	_	ADJ	JJ	_	6	amod	_	_
4	hip	_	NOUN	NN	_	6	compound	_	_
5	surgery	_	NOUN	NN	_	6	compound	_	_
6	patients	_	NOUN	NNS	_	16	nmod	_	_
7	,	_	.	,	_	16	punct	_	_
8	limited	_	ADJ	JJ	_	10	amod	_	_
9	clinical	_	ADJ	JJ	_	10	amod	_	_
10	data	_	NOUN	NNS	_	16	nsubj	_	_
11	with	_	ADP	IN	_	14	case	_	_
12	P	_	NOUN	NN	_	14	compound	_	_
13	gp	_	NOUN	NN	_	14	compound	_	_
14	inhibitors	_	NOUN	NNS	_	10	nmod	_	_
15	is	_	VERB	VBZ	_	16	auxpass	_	_
16	available	_	ADJ	JJ	_	0	root	_	_

#	Dabigatran	1969
1	Figure	_	NOUN	NN	_	3	compound	_	_
2	3.1	_	NUM	CD	_	3	nummod	_	_
3	Effect	_	NOUN	NN	_	0	root	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	P	_	NOUN	NN	_	7	compound	_	_
6	gp	_	NOUN	NN	_	7	compound	_	_
7	Inhibitor	_	NOUN	NN	_	3	nmod	_	_
8	or	_	CONJ	CC	_	7	cc	_	_
9	Inducer	_	ADJ	JJ	_	11	amod	_	_
10	rifampicin	_	NOUN	NN	_	11	compound	_	_
11	Drugs	_	NOUN	NNS	_	7	conj	_	_
12	on	_	ADP	IN	_	13	case	_	_
13	Peak	_	NOUN	NN	_	3	nmod	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	Total	_	ADJ	JJ	_	13	conj	_	_
16	Exposure	_	NOUN	NN	_	13	dep	_	_
17	to	_	PRT	TO	_	19	case	_	_
18	DRUG	_	NOUN	NN	_	19	compound	_	_
19	Cmax	_	NOUN	NN	_	3	nmod	_	_
20	and	_	CONJ	CC	_	19	cc	_	_
21	AUC	_	NOUN	NN	_	19	conj	_	_

#	Dabigatran	1970
1	Shown	_	VERB	VBN	_	0	root	_	_
2	are	_	VERB	VBP	_	6	cop	_	_
3	the	_	DET	DT	_	6	det	_	_
4	Geometric	_	ADJ	JJ	_	6	amod	_	_
5	Mean	_	NOUN	NN	_	6	compound	_	_
6	Ratios	_	NOUN	NNS	_	1	nmod	_	_
7	Ratio	_	NOUN	NN	_	6	dep	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	90%	_	ADJ	JJ	_	13	amod	_	_
10	Confidence	_	NOUN	NN	_	13	compound	_	_
11	Interval	_	ADJ	JJ	_	13	amod	_	_
12	90%	_	ADJ	JJ	_	13	amod	_	_
13	CI	_	NOUN	NN	_	7	conj	_	_

#	Dabigatran	1971
1	The	_	DET	DT	_	2	dep	_	_
2	Perpetrator	_	NOUN	NN	_	11	nsubjpass	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	DRUG	_	NOUN	NN	_	6	compound	_	_
5	Etexilate	_	NOUN	NN	_	6	compound	_	_
6	Dose	_	NOUN	NN	_	2	conj	_	_
7	and	_	CONJ	CC	_	2	cc	_	_
8	Dosing	_	ADJ	JJ	_	9	amod	_	_
9	Frequency	_	NOUN	NN	_	2	conj	_	_
10	are	_	VERB	VBP	_	11	auxpass	_	_
11	given	_	VERB	VBN	_	0	root	_	_
12	as	_	ADV	RB	_	11	cc	_	_
13	well	_	ADV	RB	_	12	mwe	_	_
14	as	_	ADP	IN	_	12	mwe	_	_
15	the	_	DET	DT	_	16	det	_	_
16	Time	_	NOUN	NN	_	11	conj	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	Perpetrator	_	NOUN	NN	_	16	nmod	_	_
19	Dosing	_	VERB	VBG	_	18	acl	_	_
20	in	_	ADP	IN	_	21	case	_	_
21	Relation	_	NOUN	NN	_	19	nmod	_	_
22	to	_	PRT	TO	_	30	case	_	_
23	DRUG	_	NOUN	NN	_	30	compound	_	_
24	Etexilate	_	NOUN	NN	_	30	compound	_	_
25	Dose	_	NOUN	NN	_	30	compound	_	_
26	Time	_	NOUN	NN	_	30	compound	_	_
27	Difference	_	NOUN	NN	_	30	compound	_	_
28	Figure	_	NOUN	NN	_	30	compound	_	_
29	3.2	_	NUM	CD	_	30	nummod	_	_
30	Effect	_	NOUN	NN	_	21	nmod	_	_
31	of	_	ADP	IN	_	35	case	_	_
32	Non	_	NOUN	NN	_	35	compound	_	_
33	P	_	NOUN	NN	_	35	compound	_	_
34	gp	_	NOUN	NN	_	35	compound	_	_
35	Inhibitor	_	NOUN	NN	_	30	nmod	_	_
36	or	_	CONJ	CC	_	35	cc	_	_
37	Inducer	_	NOUN	NN	_	35	conj	_	_
38	,	_	.	,	_	37	punct	_	_
39	Other	_	ADJ	JJ	_	40	amod	_	_
40	Drugs	_	NOUN	NNS	_	37	appos	_	_
41	,	_	.	,	_	16	punct	_	_
42	on	_	ADP	IN	_	43	case	_	_
43	Peak	_	NOUN	NN	_	16	nmod	_	_
44	and	_	CONJ	CC	_	43	cc	_	_
45	Total	_	ADJ	JJ	_	43	conj	_	_
46	Exposure	_	NOUN	NN	_	43	dep	_	_
47	to	_	PRT	TO	_	49	case	_	_
48	DRUG	_	NOUN	NN	_	49	compound	_	_
49	Cmax	_	NOUN	NN	_	43	nmod	_	_
50	and	_	CONJ	CC	_	49	cc	_	_
51	AUC	_	NOUN	NN	_	49	conj	_	_

#	Dabigatran	1973
1	The	_	DET	DT	_	2	dep	_	_
2	Perpetrator	_	NOUN	NN	_	11	nsubjpass	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	DRUG	_	NOUN	NN	_	6	compound	_	_
5	Etexilate	_	NOUN	NN	_	6	compound	_	_
6	Dose	_	NOUN	NN	_	2	conj	_	_
7	and	_	CONJ	CC	_	2	cc	_	_
8	Dosing	_	ADJ	JJ	_	9	amod	_	_
9	Frequency	_	NOUN	NN	_	2	conj	_	_
10	are	_	VERB	VBP	_	11	auxpass	_	_
11	given	_	VERB	VBN	_	0	root	_	_
12	as	_	ADV	RB	_	11	cc	_	_
13	well	_	ADV	RB	_	12	mwe	_	_
14	as	_	ADP	IN	_	12	mwe	_	_
15	the	_	DET	DT	_	16	det	_	_
16	Time	_	NOUN	NN	_	11	conj	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	Perpetrator	_	NOUN	NN	_	16	nmod	_	_
19	Dosing	_	VERB	VBG	_	18	acl	_	_
20	in	_	ADP	IN	_	21	case	_	_
21	Relation	_	NOUN	NN	_	19	nmod	_	_
22	to	_	PRT	TO	_	28	case	_	_
23	DRUG	_	NOUN	NN	_	28	compound	_	_
24	Etexilate	_	NOUN	NN	_	28	compound	_	_
25	Dose	_	NOUN	NN	_	28	compound	_	_
26	Time	_	NOUN	NN	_	28	compound	_	_
27	Difference	_	NOUN	NN	_	28	compound	_	_
28	Figure	_	NOUN	NN	_	21	nmod	_	_
29	3.1	_	NUM	CD	_	30	nummod	_	_
30	Figure	_	NOUN	NN	_	28	dep	_	_
31	3.2	_	NUM	CD	_	30	nummod	_	_
32	In	_	ADP	IN	_	34	case	_	_
33	RE	_	NOUN	NN	_	34	compound	_	_
34	LY	_	NOUN	NN	_	21	nmod	_	_
35	,	_	.	,	_	11	punct	_	_
36	DRUG	_	NOUN	NN	_	38	compound	_	_
37	plasma	_	NOUN	NN	_	38	compound	_	_
38	samples	_	NOUN	NNS	_	41	nsubjpass	_	_
39	were	_	VERB	VBD	_	41	auxpass	_	_
40	also	_	ADV	RB	_	41	advmod	_	_
41	collected	_	VERB	VBN	_	11	parataxis	_	_

#	Dabigatran	1974
1	The	_	DET	DT	_	3	det	_	_
2	concomitant	_	ADJ	JJ	_	3	amod	_	_
3	use	_	NOUN	NN	_	17	nsubj	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	proton	_	NOUN	NN	_	7	compound	_	_
6	pump	_	NOUN	NN	_	7	compound	_	_
7	inhibitors	_	NOUN	NNS	_	3	nmod	_	_
8	,	_	.	,	_	7	punct	_	_
9	H2	_	NOUN	NN	_	10	compound	_	_
10	antagonists	_	NOUN	NNS	_	7	conj	_	_
11	,	_	.	,	_	7	punct	_	_
12	and	_	CONJ	CC	_	7	cc	_	_
13	digoxin	_	NOUN	NN	_	7	conj	_	_
14	did	_	VERB	VBD	_	17	aux	_	_
15	not	_	ADV	RB	_	17	neg	_	_
16	appreciably	_	ADV	RB	_	17	advmod	_	_
17	change	_	VERB	VB	_	0	root	_	_
18	the	_	DET	DT	_	20	det	_	_
19	trough	_	NOUN	NN	_	20	compound	_	_
20	concentration	_	NOUN	NN	_	17	dobj	_	_
21	of	_	ADP	IN	_	22	case	_	_
22	DRUG	_	NOUN	NN	_	20	nmod	_	_

#	Dabigatran	1975
1	Impact	_	NOUN	NN	_	25	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	on	_	ADP	IN	_	6	case	_	_
5	Other	_	ADJ	JJ	_	6	amod	_	_
6	Drugs	_	NOUN	NNS	_	1	nmod	_	_
7	In	_	ADP	IN	_	9	case	_	_
8	clinical	_	ADJ	JJ	_	9	amod	_	_
9	studies	_	NOUN	NNS	_	1	nmod	_	_
10	exploring	_	VERB	VBG	_	9	acl	_	_
11	CYP3A4	_	NOUN	NN	_	10	dobj	_	_
12	,	_	.	,	_	11	punct	_	_
13	CYP2C9	_	NOUN	NN	_	11	conj	_	_
14	,	_	.	,	_	11	punct	_	_
15	P	_	NOUN	NN	_	16	compound	_	_
16	gp	_	NOUN	NN	_	11	conj	_	_
17	and	_	CONJ	CC	_	11	cc	_	_
18	other	_	ADJ	JJ	_	19	amod	_	_
19	pathways	_	NOUN	NNS	_	11	conj	_	_
20	,	_	.	,	_	25	punct	_	_
21	DRUG	_	NOUN	NN	_	25	nsubj	_	_
22	did	_	VERB	MD	_	25	aux	_	_
23	not	_	ADV	RB	_	25	neg	_	_
24	meaningfully	_	ADV	RB	_	25	advmod	_	_
25	alter	_	VERB	VB	_	0	root	_	_
26	the	_	DET	DT	_	27	det	_	_
27	pharmacokinetics	_	NOUN	NNS	_	25	dobj	_	_
28	of	_	ADP	IN	_	29	case	_	_
29	amiodarone	_	NOUN	NN	_	27	nmod	_	_
30	,	_	.	,	_	29	punct	_	_
31	atorvastatin	_	NOUN	NN	_	29	conj	_	_
32	,	_	.	,	_	29	punct	_	_
33	clarithromycin	_	NOUN	NN	_	29	conj	_	_
34	,	_	.	,	_	29	punct	_	_
35	diclofenac	_	ADJ	JJ	_	29	conj	_	_
36	,	_	.	,	_	29	punct	_	_
37	clopidogrel	_	NOUN	NN	_	29	conj	_	_
38	,	_	.	,	_	29	punct	_	_
39	digoxin	_	NOUN	NN	_	29	conj	_	_
40	,	_	.	,	_	29	punct	_	_
41	pantoprazole	_	NOUN	NN	_	29	conj	_	_
42	,	_	.	,	_	29	punct	_	_
43	or	_	CONJ	CC	_	29	cc	_	_
44	ranitidine	_	NOUN	NN	_	29	conj	_	_

#	Doxepin	119
1	Studies	_	NOUN	NNS	_	5	nsubjpass	_	_
2	have	_	VERB	VBP	_	5	aux	_	_
3	not	_	ADV	RB	_	5	neg	_	_
4	been	_	VERB	VBN	_	5	auxpass	_	_
5	performed	_	VERB	VBN	_	0	root	_	_
6	examining	_	VERB	VBG	_	5	xcomp	_	_
7	drug	_	NOUN	NN	_	8	compound	_	_
8	interactions	_	NOUN	NNS	_	6	dobj	_	_
9	with	_	ADP	IN	_	10	case	_	_
10	PRUDOXIN	_	NOUN	NN	_	8	nmod	_	_
11	Cream	_	NOUN	NN	_	5	parataxis	_	_

#	Doxepin	120
1	However	_	ADV	RB	_	29	advmod	_	_
2	,	_	.	,	_	29	punct	_	_
3	since	_	ADP	IN	_	15	mark	_	_
4	plasma	_	NOUN	NN	_	5	compound	_	_
5	levels	_	NOUN	NNS	_	15	nsubj	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	following	_	VERB	VBG	_	10	case	_	_
9	topical	_	ADJ	JJ	_	10	amod	_	_
10	application	_	NOUN	NN	_	5	nmod	_	_
11	of	_	ADP	IN	_	13	case	_	_
12	PRUDOXIN	_	NOUN	NN	_	13	compound	_	_
13	Cream	_	NOUN	NN	_	10	nmod	_	_
14	can	_	VERB	MD	_	15	aux	_	_
15	reach	_	VERB	VB	_	29	advcl	_	_
16	levels	_	NOUN	NNS	_	15	dobj	_	_
17	obtained	_	VERB	VBN	_	16	acl	_	_
18	with	_	ADP	IN	_	22	case	_	_
19	oral	_	ADJ	JJ	_	22	amod	_	_
20	DRUG	_	NOUN	NN	_	22	compound	_	_
21	HCl	_	NOUN	NN	_	22	compound	_	_
22	therapy	_	NOUN	NN	_	17	nmod	_	_
23	,	_	.	,	_	29	punct	_	_
24	the	_	DET	DT	_	27	det	_	_
25	following	_	VERB	VBG	_	27	amod	_	_
26	drug	_	NOUN	NN	_	27	compound	_	_
27	interactions	_	NOUN	NNS	_	29	nsubj	_	_
28	are	_	VERB	VBP	_	29	cop	_	_
29	possible	_	ADJ	JJ	_	0	root	_	_
30	following	_	ADP	IN	_	34	case	_	_
31	topical	_	ADJ	JJ	_	34	amod	_	_
32	PRUDOXIN	_	NOUN	NN	_	34	compound	_	_
33	Cream	_	NOUN	NN	_	34	compound	_	_
34	application	_	NOUN	NN	_	29	nmod	_	_
35	:	_	.	:	_	29	punct	_	_
36	Drugs	_	NOUN	NNS	_	29	dep	_	_
37	Metabolized	_	VERB	VBN	_	36	acl	_	_
38	by	_	ADP	IN	_	40	case	_	_
39	P450	_	NOUN	NN	_	40	compound	_	_
40	2D6	_	NOUN	NN	_	37	nmod	_	_
41	:	_	.	:	_	29	punct	_	_
42	The	_	DET	DT	_	44	det	_	_
43	biochemical	_	ADJ	JJ	_	44	amod	_	_
44	activity	_	NOUN	NN	_	56	nsubjpass	_	_
45	of	_	ADP	IN	_	54	case	_	_
46	the	_	DET	DT	_	54	det	_	_
47	drug	_	NOUN	NN	_	54	compound	_	_
48	metabolizing	_	VERB	VBG	_	54	compound	_	_
49	isozyme	_	NOUN	NN	_	54	compound	_	_
50	cytochrome	_	NOUN	NN	_	54	compound	_	_
51	P450	_	NOUN	NN	_	54	compound	_	_
52	2D6	_	NOUN	NN	_	54	compound	_	_
53	debrisoquin	_	NOUN	NN	_	54	compound	_	_
54	hydroxylase	_	NOUN	NN	_	44	nmod	_	_
55	is	_	VERB	VBZ	_	56	auxpass	_	_
56	reduced	_	VERB	VBN	_	29	parataxis	_	_
57	in	_	ADP	IN	_	59	case	_	_
58	a	_	DET	DT	_	59	det	_	_
59	subset	_	NOUN	NN	_	56	nmod	_	_
60	of	_	ADP	IN	_	63	case	_	_
61	the	_	DET	DT	_	63	det	_	_
62	Caucasian	_	ADJ	JJ	_	63	amod	_	_
63	population	_	NOUN	NN	_	59	nmod	_	_
64	about	_	ADP	IN	_	65	advmod	_	_
65	7	_	NUM	CD	_	66	nummod	_	_
66	10%	_	NOUN	NN	_	59	nmod	_	_
67	of	_	ADP	IN	_	68	case	_	_
68	Caucasians	_	NOUN	NNS	_	66	nmod	_	_
69	are	_	VERB	VBP	_	71	auxpass	_	_
70	so	_	ADV	RB	_	71	advmod	_	_
71	called	_	VERB	VBN	_	56	parataxis	_	_
72	"poor	_	ADJ	JJ	_	75	amod	_	_
73	metabolizers"	_	NOUN	NN	_	75	compound	_	_
74	reliable	_	ADJ	JJ	_	75	amod	_	_
75	estimates	_	NOUN	NNS	_	71	dobj	_	_
76	of	_	ADP	IN	_	78	case	_	_
77	the	_	DET	DT	_	78	det	_	_
78	prevalence	_	NOUN	NN	_	75	nmod	_	_
79	of	_	ADP	IN	_	84	case	_	_
80	reduced	_	VERB	VBN	_	84	amod	_	_
81	P450	_	NOUN	NN	_	84	compound	_	_
82	2D6	_	NOUN	NN	_	84	compound	_	_
83	isozyme	_	NOUN	NN	_	84	compound	_	_
84	activity	_	NOUN	NN	_	78	nmod	_	_
85	among	_	ADP	IN	_	86	case	_	_
86	Asian	_	NOUN	NN	_	75	nmod	_	_
87	,	_	.	,	_	86	punct	_	_
88	African	_	NOUN	NN	_	86	conj	_	_
89	and	_	CONJ	CC	_	86	cc	_	_
90	other	_	ADJ	JJ	_	86	conj	_	_
91	populations	_	NOUN	NNS	_	86	dep	_	_
92	are	_	VERB	VBP	_	95	auxpass	_	_
93	not	_	ADV	RB	_	95	neg	_	_
94	yet	_	ADV	RB	_	95	advmod	_	_
95	available	_	ADJ	JJ	_	71	parataxis	_	_

#	Doxepin	121
1	Poor	_	ADJ	JJ	_	2	amod	_	_
2	metabolizers	_	NOUN	NNS	_	4	nsubj	_	_
3	have	_	VERB	VBP	_	4	aux	_	_
4	higher	_	ADJ	JJ	_	0	root	_	_
5	than	_	ADP	IN	_	8	case	_	_
6	expected	_	VERB	VBN	_	8	amod	_	_
7	plasma	_	NOUN	NN	_	8	compound	_	_
8	concentrations	_	NOUN	NNS	_	4	nmod	_	_
9	of	_	ADP	IN	_	12	case	_	_
10	tricyclic	_	ADJ	JJ	_	12	amod	_	_
11	DRUGS	_	NOUN	NN	_	12	compound	_	_
12	TCAs	_	NOUN	NNS	_	8	nmod	_	_
13	when	_	ADV	WRB	_	14	advmod	_	_
14	given	_	VERB	VBN	_	4	advcl	_	_
15	usual	_	ADJ	JJ	_	16	amod	_	_
16	doses	_	NOUN	NNS	_	14	dobj	_	_

#	Doxepin	122
1	Depending	_	VERB	VBG	_	4	case	_	_
2	on	_	ADP	IN	_	4	case	_	_
3	the	_	DET	DT	_	4	det	_	_
4	fraction	_	NOUN	NN	_	19	nmod	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	drug	_	NOUN	NN	_	4	nmod	_	_
7	metabolized	_	VERB	VBN	_	6	acl	_	_
8	by	_	ADP	IN	_	10	case	_	_
9	P450	_	NOUN	NN	_	10	compound	_	_
10	2D6	_	NOUN	NN	_	7	nmod	_	_
11	,	_	.	,	_	19	punct	_	_
12	the	_	DET	DT	_	13	det	_	_
13	increase	_	NOUN	NN	_	19	nsubj	_	_
14	in	_	ADP	IN	_	16	case	_	_
15	plasma	_	NOUN	NN	_	16	compound	_	_
16	concentration	_	NOUN	NN	_	13	nmod	_	_
17	may	_	VERB	MD	_	19	aux	_	_
18	be	_	VERB	VB	_	19	cop	_	_
19	small	_	ADJ	JJ	_	0	root	_	_
20	,	_	.	,	_	19	punct	_	_
21	or	_	CONJ	CC	_	19	cc	_	_
22	quite	_	ADV	RB	_	23	advmod	_	_
23	large	_	ADJ	JJ	_	26	amod	_	_
24	8	_	NUM	CD	_	26	nummod	_	_
25	fold	_	NOUN	NN	_	26	amod	_	_
26	increase	_	NOUN	NN	_	19	conj	_	_
27	in	_	ADP	IN	_	29	case	_	_
28	plasma	_	NOUN	NN	_	29	compound	_	_
29	AUC	_	NOUN	NN	_	26	nmod	_	_
30	of	_	ADP	IN	_	32	case	_	_
31	the	_	DET	DT	_	32	det	_	_
32	TCA	_	NOUN	NN	_	29	nmod	_	_

#	Doxepin	123
1	In	_	ADP	IN	_	2	case	_	_
2	addition	_	NOUN	NN	_	6	nmod	_	_
3	,	_	.	,	_	6	punct	_	_
4	certain	_	ADJ	JJ	_	5	amod	_	_
5	drugs	_	NOUN	NNS	_	6	nsubj	_	_
6	inhibit	_	VERB	VBP	_	0	root	_	_
7	the	_	DET	DT	_	8	det	_	_
8	activity	_	NOUN	NN	_	6	dobj	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	this	_	DET	DT	_	11	det	_	_
11	isozyme	_	NOUN	NN	_	8	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	make	_	ADJ	JJ	_	15	amod	_	_
14	normal	_	ADJ	JJ	_	15	amod	_	_
15	metabolizers	_	NOUN	NNS	_	11	conj	_	_
16	resemble	_	ADJ	JJ	_	6	xcomp	_	_
17	poor	_	ADJ	JJ	_	18	amod	_	_
18	metabolizers	_	NOUN	NNS	_	16	dobj	_	_

#	Doxepin	124
1	An	_	DET	DT	_	2	det	_	_
2	individual	_	NOUN	NN	_	15	nsubj	_	_
3	who	_	DET	WDT	_	5	nsubj	_	_
4	is	_	VERB	VBZ	_	5	cop	_	_
5	stable	_	ADJ	JJ	_	2	acl:relcl	_	_
6	on	_	ADP	IN	_	10	case	_	_
7	a	_	DET	DT	_	10	det	_	_
8	given	_	VERB	VBN	_	10	amod	_	_
9	dosage	_	NOUN	NN	_	10	compound	_	_
10	regimen	_	NOUN	NN	_	5	nmod	_	_
11	of	_	ADP	IN	_	13	case	_	_
12	a	_	DET	DT	_	13	det	_	_
13	TCA	_	NOUN	NN	_	10	nmod	_	_
14	may	_	VERB	MD	_	15	aux	_	_
15	become	_	VERB	VB	_	0	root	_	_
16	abruptly	_	ADV	RB	_	17	advmod	_	_
17	toxic	_	ADJ	JJ	_	15	xcomp	_	_
18	when	_	ADV	WRB	_	19	advmod	_	_
19	given	_	VERB	VBN	_	17	dep	_	_
20	one	_	NUM	CD	_	19	dobj	_	_
21	of	_	ADP	IN	_	24	case	_	_
22	these	_	DET	DT	_	24	det	_	_
23	inhibiting	_	VERB	VBG	_	24	amod	_	_
24	drugs	_	NOUN	NNS	_	20	nmod	_	_
25	as	_	ADP	IN	_	27	case	_	_
26	concomitant	_	ADJ	JJ	_	27	amod	_	_
27	therapy	_	NOUN	NN	_	19	nmod	_	_

#	Doxepin	125
1	The	_	DET	DT	_	2	det	_	_
2	drugs	_	NOUN	NNS	_	8	nsubj	_	_
3	that	_	DET	WDT	_	4	nsubj	_	_
4	inhibit	_	VERB	VBP	_	2	acl:relcl	_	_
5	cytochrome	_	NOUN	NN	_	7	compound	_	_
6	P450	_	NOUN	NN	_	7	compound	_	_
7	2D6	_	NOUN	NN	_	4	dobj	_	_
8	include	_	VERB	VBP	_	0	root	_	_
9	some	_	DET	DT	_	8	dobj	_	_
10	that	_	DET	WDT	_	13	nsubjpass	_	_
11	are	_	VERB	VBP	_	13	auxpass	_	_
12	not	_	ADV	RB	_	13	neg	_	_
13	metabolized	_	VERB	VBN	_	9	root	_	_
14	by	_	ADP	IN	_	18	case	_	_
15	the	_	DET	DT	_	18	det	_	_
16	enzyme	_	NOUN	NN	_	18	compound	_	_
17	quinidine	_	NOUN	NN	_	18	compound	_	_
18	cimetidine	_	NOUN	NN	_	13	nmod	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	many	_	NOUN	NN	_	18	conj	_	_
21	that	_	DET	WDT	_	23	nsubj	_	_
22	are	_	VERB	VBP	_	23	cop	_	_
23	substrates	_	NOUN	NNS	_	18	acl:relcl	_	_
24	for	_	ADP	IN	_	29	case	_	_
25	P450	_	NOUN	NN	_	29	compound	_	_
26	2D6	_	NOUN	NN	_	29	compound	_	_
27	many	_	ADJ	JJ	_	29	amod	_	_
28	other	_	ADJ	JJ	_	29	amod	_	_
29	DRUGS	_	NOUN	NN	_	23	nmod	_	_
30	,	_	.	,	_	29	punct	_	_
31	phenothiazines	_	NOUN	NNS	_	29	conj	_	_
32	,	_	.	,	_	29	punct	_	_
33	and	_	CONJ	CC	_	29	cc	_	_
34	the	_	DET	DT	_	37	det	_	_
35	Type	_	NOUN	NN	_	37	compound	_	_
36	1C	_	NOUN	NN	_	37	compound	_	_
37	antiarrhythmics	_	NOUN	NNS	_	29	conj	_	_
38	propafenone	_	NOUN	NN	_	37	dep	_	_
39	and	_	CONJ	CC	_	38	cc	_	_
40	flecainide	_	NOUN	NN	_	38	conj	_	_

#	Doxepin	126
1	While	_	ADP	IN	_	19	mark	_	_
2	all	_	CONJ	CC	_	7	cc:preconj	_	_
3	the	_	DET	DT	_	7	det	_	_
4	selective	_	ADJ	JJ	_	7	amod	_	_
5	serotonin	_	NOUN	NN	_	7	compound	_	_
6	reuptake	_	NOUN	NN	_	7	compound	_	_
7	inhibitors	_	NOUN	NNS	_	19	nsubj	_	_
8	SSRIs	_	NOUN	NNS	_	7	dep	_	_
9	,	_	.	,	_	8	punct	_	_
10	e.g	_	NOUN	NN	_	8	conj	_	_
11	,	_	.	,	_	8	punct	_	_
12	fluoxetine	_	NOUN	NN	_	8	conj	_	_
13	,	_	.	,	_	8	punct	_	_
14	sertraline	_	NOUN	NN	_	8	conj	_	_
15	,	_	.	,	_	8	punct	_	_
16	and	_	CONJ	CC	_	8	cc	_	_
17	paroxetine	_	NOUN	NN	_	8	conj	_	_
18	,	_	.	,	_	7	punct	_	_
19	inhibit	_	VERB	VBP	_	25	advcl	_	_
20	P450	_	NOUN	NN	_	21	compound	_	_
21	2D6	_	NOUN	NN	_	19	dobj	_	_
22	,	_	.	,	_	25	punct	_	_
23	they	_	PRON	PRP	_	25	nsubj	_	_
24	may	_	VERB	MD	_	25	aux	_	_
25	vary	_	VERB	VB	_	0	root	_	_
26	in	_	ADP	IN	_	28	case	_	_
27	the	_	DET	DT	_	28	det	_	_
28	extent	_	NOUN	NN	_	25	nmod	_	_
29	of	_	ADP	IN	_	30	case	_	_
30	inhibition	_	NOUN	NN	_	28	nmod	_	_

#	Doxepin	127
1	The	_	DET	DT	_	2	det	_	_
2	extent	_	NOUN	NN	_	13	nsubj	_	_
3	to	_	PRT	TO	_	4	case	_	_
4	which	_	DET	WDT	_	9	nmod	_	_
5	SSRI	_	NOUN	NN	_	7	compound	_	_
6	TCA	_	NOUN	NN	_	7	compound	_	_
7	interactions	_	NOUN	NNS	_	9	nsubj	_	_
8	may	_	VERB	MD	_	9	aux	_	_
9	pose	_	VERB	VB	_	2	acl:relcl	_	_
10	clinical	_	ADJ	JJ	_	11	amod	_	_
11	problems	_	NOUN	NNS	_	9	dobj	_	_
12	will	_	VERB	MD	_	13	aux	_	_
13	depend	_	VERB	VB	_	0	root	_	_
14	on	_	ADP	IN	_	16	case	_	_
15	the	_	DET	DT	_	16	det	_	_
16	degree	_	NOUN	NN	_	13	nmod	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	inhibition	_	NOUN	NN	_	16	nmod	_	_
19	and	_	CONJ	CC	_	13	cc	_	_
20	the	_	DET	DT	_	21	det	_	_
21	pharmacokinetics	_	NOUN	NNS	_	13	conj	_	_
22	of	_	ADP	IN	_	24	case	_	_
23	the	_	DET	DT	_	24	det	_	_
24	SSRI	_	NOUN	NN	_	21	nmod	_	_
25	involved	_	VERB	VBN	_	24	acl	_	_

#	Doxepin	128
1	Nevertheless	_	ADV	RB	_	5	advmod	_	_
2	,	_	.	,	_	5	punct	_	_
3	caution	_	NOUN	NN	_	5	nsubjpass	_	_
4	is	_	VERB	VBZ	_	5	auxpass	_	_
5	indicated	_	VERB	VBN	_	0	root	_	_
6	in	_	ADP	IN	_	9	case	_	_
7	the	_	DET	DT	_	9	det	_	_
8	co	_	DET	DT	_	9	det	_	_
9	administration	_	NOUN	NN	_	5	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	TCAs	_	NOUN	NNS	_	9	nmod	_	_
12	with	_	ADP	IN	_	13	case	_	_
13	any	_	DET	DT	_	9	nmod	_	_
14	of	_	ADP	IN	_	16	case	_	_
15	the	_	DET	DT	_	16	det	_	_
16	SSRIs	_	NOUN	NNS	_	13	nmod	_	_

#	Doxepin	129
1	Of	_	ADP	IN	_	3	case	_	_
2	particular	_	ADJ	JJ	_	3	amod	_	_
3	importance	_	NOUN	NN	_	8	nmod	_	_
4	,	_	.	,	_	8	punct	_	_
5	sufficient	_	ADJ	JJ	_	6	amod	_	_
6	time	_	NOUN	NN	_	8	nsubj	_	_
7	must	_	VERB	MD	_	8	aux	_	_
8	elapse	_	VERB	VB	_	17	aux	_	_
9	before	_	ADP	IN	_	10	mark	_	_
10	initiating	_	VERB	VBG	_	8	advcl	_	_
11	TCA	_	NOUN	NN	_	12	compound	_	_
12	treatment	_	NOUN	NN	_	10	dobj	_	_
13	in	_	ADP	IN	_	15	case	_	_
14	a	_	DET	DT	_	15	det	_	_
15	patient	_	NOUN	NN	_	10	nmod	_	_
16	being	_	VERB	VBD	_	17	cop	_	_
17	withdrawn	_	ADJ	JJ	_	0	root	_	_
18	from	_	ADP	IN	_	19	case	_	_
19	fluoxetine	_	NOUN	NN	_	17	nmod	_	_
20	,	_	.	,	_	17	punct	_	_
21	given	_	VERB	VBN	_	17	parataxis	_	_
22	the	_	DET	DT	_	25	det	_	_
23	long	_	ADJ	JJ	_	25	amod	_	_
24	half	_	NOUN	NN	_	25	amod	_	_
25	life	_	NOUN	NN	_	21	dobj	_	_
26	of	_	ADP	IN	_	28	case	_	_
27	the	_	DET	DT	_	28	det	_	_
28	parent	_	NOUN	NN	_	25	nmod	_	_
29	and	_	CONJ	CC	_	28	cc	_	_
30	active	_	ADJ	JJ	_	31	amod	_	_
31	metabolite	_	NOUN	NN	_	28	conj	_	_
32	at	_	ADP	IN	_	33	case	_	_
33	least	_	ADJ	JJS	_	34	nmod:npmod	_	_
34	5	_	NUM	CD	_	35	nummod	_	_
35	weeks	_	NOUN	NNS	_	25	nmod	_	_
36	may	_	VERB	MD	_	38	aux	_	_
37	be	_	VERB	VB	_	38	auxpass	_	_
38	necessary	_	ADJ	JJ	_	21	dep	_	_

#	Doxepin	130
1	Concomitant	_	ADJ	JJ	_	2	amod	_	_
2	use	_	NOUN	NN	_	15	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	tricyclic	_	ADJ	JJ	_	5	amod	_	_
5	DRUGS	_	NOUN	NN	_	2	nmod	_	_
6	with	_	ADP	IN	_	7	case	_	_
7	drugs	_	NOUN	NNS	_	2	nmod	_	_
8	that	_	DET	WDT	_	10	nsubj	_	_
9	can	_	VERB	MD	_	10	aux	_	_
10	inhibit	_	VERB	VB	_	7	acl:relcl	_	_
11	cytochrome	_	NOUN	NN	_	13	compound	_	_
12	P450	_	NOUN	NN	_	13	compound	_	_
13	2D6	_	NOUN	NN	_	10	dobj	_	_
14	may	_	VERB	MD	_	15	aux	_	_
15	require	_	VERB	VB	_	0	root	_	_
16	lower	_	ADJ	JJ	_	17	amod	_	_
17	doses	_	NOUN	NNS	_	15	dobj	_	_
18	than	_	ADP	IN	_	20	mark	_	_
19	usually	_	ADV	RB	_	20	advmod	_	_
20	prescribed	_	VERB	VBN	_	15	advcl	_	_
21	for	_	ADP	IN	_	25	case	_	_
22	either	_	CONJ	CC	_	25	cc:preconj	_	_
23	the	_	DET	DT	_	25	det	_	_
24	tricyclic	_	ADJ	JJ	_	25	amod	_	_
25	antidepressant	_	NOUN	NN	_	20	nmod	_	_
26	or	_	CONJ	CC	_	25	cc	_	_
27	the	_	DET	DT	_	29	det	_	_
28	other	_	ADJ	JJ	_	29	amod	_	_
29	drug	_	NOUN	NN	_	25	conj	_	_

#	Doxepin	131
1	It	_	PRON	PRP	_	3	nsubj	_	_
2	is	_	VERB	VBZ	_	3	cop	_	_
3	desirable	_	ADJ	JJ	_	0	root	_	_
4	to	_	PRT	TO	_	5	mark	_	_
5	monitor	_	VERB	VB	_	3	xcomp	_	_
6	TCA	_	NOUN	NN	_	8	compound	_	_
7	plasma	_	NOUN	NN	_	8	compound	_	_
8	levels	_	NOUN	NNS	_	5	dobj	_	_
9	whenever	_	ADV	WRB	_	13	advmod	_	_
10	a	_	DET	DT	_	11	det	_	_
11	TCA	_	NOUN	NN	_	13	nsubj	_	_
12	is	_	VERB	VBZ	_	13	cop	_	_
13	going	_	VERB	VBG	_	5	advcl	_	_
14	to	_	PRT	TO	_	17	mark	_	_
15	be	_	VERB	VB	_	17	auxpass	_	_
16	co	_	PRT	TO	_	17	dep	_	_
17	administered	_	VERB	VBN	_	13	xcomp	_	_
18	with	_	ADP	IN	_	20	case	_	_
19	another	_	DET	DT	_	20	det	_	_
20	drug	_	NOUN	NN	_	17	nmod	_	_
21	known	_	VERB	VBN	_	20	acl	_	_
22	to	_	PRT	TO	_	25	mark	_	_
23	be	_	VERB	VB	_	25	cop	_	_
24	an	_	DET	DT	_	25	det	_	_
25	inhibitor	_	NOUN	NN	_	21	xcomp	_	_
26	of	_	ADP	IN	_	28	case	_	_
27	P450	_	NOUN	NN	_	28	compound	_	_
28	2D6	_	NOUN	NN	_	25	nmod	_	_

#	Doxepin	132
1	MAO	_	NOUN	NN	_	2	compound	_	_
2	Inhibitors	_	NOUN	NNS	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	Serious	_	ADJ	JJ	_	6	amod	_	_
5	side	_	ADJ	JJ	_	6	amod	_	_
6	effects	_	NOUN	NNS	_	12	nsubjpass	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	even	_	ADV	RB	_	9	advmod	_	_
9	death	_	NOUN	NN	_	6	conj	_	_
10	have	_	VERB	VBP	_	12	aux	_	_
11	been	_	VERB	VBN	_	12	auxpass	_	_
12	reported	_	VERB	VBN	_	2	dep	_	_
13	following	_	ADP	IN	_	16	case	_	_
14	the	_	DET	DT	_	16	det	_	_
15	concomitant	_	ADJ	JJ	_	16	amod	_	_
16	use	_	NOUN	NN	_	12	nmod	_	_
17	of	_	ADP	IN	_	19	case	_	_
18	certain	_	ADJ	JJ	_	19	amod	_	_
19	drugs	_	NOUN	NNS	_	16	nmod	_	_
20	with	_	ADP	IN	_	22	case	_	_
21	MAO	_	NOUN	NN	_	22	compound	_	_
22	inhibitors	_	NOUN	NNS	_	16	nmod	_	_

#	Doxepin	133
1	Therefore	_	ADV	RB	_	7	advmod	_	_
2	,	_	.	,	_	7	punct	_	_
3	MAO	_	NOUN	NN	_	4	compound	_	_
4	inhibitors	_	NOUN	NNS	_	7	nsubjpass	_	_
5	should	_	VERB	MD	_	7	aux	_	_
6	be	_	VERB	VB	_	7	auxpass	_	_
7	discontinued	_	VERB	VBN	_	0	root	_	_
8	at	_	ADP	IN	_	9	case	_	_
9	least	_	ADJ	JJS	_	10	nmod:npmod	_	_
10	two	_	NUM	CD	_	11	nummod	_	_
11	weeks	_	NOUN	NNS	_	7	dobj	_	_
12	prior	_	ADJ	JJ	_	11	amod	_	_
13	to	_	PRT	TO	_	16	case	_	_
14	the	_	DET	DT	_	16	det	_	_
15	cautious	_	ADJ	JJ	_	16	amod	_	_
16	initiation	_	NOUN	NN	_	12	nmod	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	therapy	_	NOUN	NN	_	16	nmod	_	_
19	with	_	ADP	IN	_	20	case	_	_
20	PRUDOXIN	_	NOUN	NN	_	16	nmod	_	_
21	Cream	_	NOUN	NN	_	7	xcomp	_	_

#	Doxepin	134
1	The	_	DET	DT	_	3	det	_	_
2	exact	_	ADJ	JJ	_	3	amod	_	_
3	length	_	NOUN	NN	_	7	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	time	_	NOUN	NN	_	3	nmod	_	_
6	may	_	VERB	MD	_	7	aux	_	_
7	vary	_	VERB	VB	_	17	aux	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	is	_	VERB	VBZ	_	10	cop	_	_
10	dependent	_	ADJ	JJ	_	7	conj	_	_
11	upon	_	ADP	IN	_	15	case	_	_
12	the	_	DET	DT	_	15	det	_	_
13	particular	_	ADJ	JJ	_	15	amod	_	_
14	MAO	_	NOUN	NN	_	15	compound	_	_
15	inhibitor	_	NOUN	NN	_	10	nmod	_	_
16	being	_	VERB	VBD	_	17	auxpass	_	_
17	used	_	VERB	VBN	_	0	root	_	_
18	,	_	.	,	_	17	punct	_	_
19	the	_	DET	DT	_	20	det	_	_
20	length	_	NOUN	NN	_	26	nsubjpass	_	_
21	of	_	ADP	IN	_	22	case	_	_
22	time	_	NOUN	NN	_	20	nmod	_	_
23	it	_	PRON	PRP	_	26	nsubjpass	_	_
24	has	_	VERB	VBZ	_	26	aux	_	_
25	been	_	VERB	VBN	_	26	auxpass	_	_
26	administered	_	VERB	VBN	_	17	conj	_	_
27	,	_	.	,	_	17	punct	_	_
28	and	_	CONJ	CC	_	17	cc	_	_
29	the	_	DET	DT	_	30	det	_	_
30	dosage	_	NOUN	NN	_	31	nsubj	_	_
31	involved	_	VERB	VBN	_	17	conj	_	_

#	Doxepin	135
1	Cimetidine	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Serious	_	ADJ	JJ	_	5	amod	_	_
4	anticholinergic	_	ADJ	JJ	_	5	amod	_	_
5	symptoms	_	NOUN	NNS	_	19	nsubjpass	_	_
6	i.e	_	ADJ	JJ	_	5	amod	_	_
7	,	_	.	,	_	6	punct	_	_
8	severe	_	ADJ	JJ	_	10	amod	_	_
9	dry	_	NOUN	NN	_	10	compound	_	_
10	mouth	_	NOUN	NN	_	6	conj	_	_
11	,	_	.	,	_	6	punct	_	_
12	urinary	_	ADJ	JJ	_	13	amod	_	_
13	retention	_	NOUN	NN	_	6	conj	_	_
14	and	_	CONJ	CC	_	6	cc	_	_
15	blurred	_	ADJ	JJ	_	16	amod	_	_
16	vision	_	NOUN	NN	_	6	conj	_	_
17	have	_	VERB	VBP	_	19	aux	_	_
18	been	_	VERB	VBN	_	19	auxpass	_	_
19	associated	_	VERB	VBN	_	1	dep	_	_
20	with	_	ADP	IN	_	21	case	_	_
21	elevations	_	NOUN	NNS	_	19	nmod	_	_
22	in	_	ADP	IN	_	25	case	_	_
23	the	_	DET	DT	_	25	det	_	_
24	serum	_	NOUN	NN	_	25	compound	_	_
25	levels	_	NOUN	NNS	_	21	nmod	_	_
26	of	_	ADP	IN	_	28	case	_	_
27	tricyclic	_	ADJ	JJ	_	28	amod	_	_
28	antidepressant	_	NOUN	NN	_	25	nmod	_	_
29	when	_	ADV	WRB	_	33	advmod	_	_
30	cimetidine	_	NOUN	NN	_	31	compound	_	_
31	therapy	_	NOUN	NN	_	33	nsubjpass	_	_
32	is	_	VERB	VBZ	_	33	auxpass	_	_
33	initiated	_	VERB	VBN	_	19	advcl	_	_

#	Doxepin	136
1	Additionally	_	ADV	RB	_	11	advmod	_	_
2	,	_	.	,	_	11	punct	_	_
3	higher	_	ADJ	JJ	_	11	nsubjpass	_	_
4	than	_	ADP	IN	_	8	case	_	_
5	expected	_	VERB	VBN	_	8	amod	_	_
6	tricyclic	_	ADJ	JJ	_	8	amod	_	_
7	antidepressant	_	ADJ	JJ	_	8	amod	_	_
8	levels	_	NOUN	NNS	_	3	nmod	_	_
9	have	_	VERB	VBP	_	11	aux	_	_
10	been	_	VERB	VBN	_	11	auxpass	_	_
11	observed	_	VERB	VBN	_	0	root	_	_
12	when	_	ADV	WRB	_	15	advmod	_	_
13	they	_	PRON	PRP	_	15	nsubjpass	_	_
14	are	_	VERB	VBP	_	15	auxpass	_	_
15	begun	_	VERB	VBN	_	11	ccomp	_	_
16	in	_	ADP	IN	_	17	case	_	_
17	patients	_	NOUN	NNS	_	15	nmod	_	_
18	already	_	ADV	RB	_	19	advmod	_	_
19	taking	_	VERB	VBG	_	17	acl	_	_
20	cimetidine	_	NOUN	NN	_	19	nmod	_	_

#	Doxepin	137
1	Alcohol	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Alcohol	_	NOUN	NN	_	4	compound	_	_
4	ingestion	_	NOUN	NN	_	6	nsubj	_	_
5	may	_	VERB	MD	_	6	aux	_	_
6	exacerbate	_	VERB	VB	_	1	dep	_	_
7	the	_	DET	DT	_	10	det	_	_
8	potential	_	ADJ	JJ	_	10	amod	_	_
9	sedative	_	ADJ	JJ	_	10	amod	_	_
10	effects	_	NOUN	NNS	_	6	dobj	_	_
11	of	_	ADP	IN	_	13	case	_	_
12	PRUDOXIN	_	NOUN	NN	_	13	compound	_	_
13	Cream	_	NOUN	NN	_	10	nmod	_	_

#	Doxepin	138
1	This	_	DET	DT	_	4	nsubj	_	_
2	is	_	VERB	VBZ	_	4	cop	_	_
3	especially	_	ADV	RB	_	4	advmod	_	_
4	important	_	ADJ	JJ	_	0	root	_	_
5	in	_	ADP	IN	_	6	case	_	_
6	patients	_	NOUN	NNS	_	4	nmod	_	_
7	who	_	DET	WDT	_	9	nsubj	_	_
8	may	_	VERB	MD	_	9	aux	_	_
9	use	_	VERB	VB	_	6	acl:relcl	_	_
10	alcohol	_	NOUN	NN	_	9	dobj	_	_
11	excessively	_	ADV	RB	_	9	advmod	_	_

#	Doxepin	139
1	Tolazamide	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	A	_	PRON	PRP$	_	4	det	_	_
4	case	_	NOUN	NN	_	10	nsubjpass	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	severe	_	ADJ	JJ	_	7	amod	_	_
7	hypoglycemia	_	NOUN	NN	_	4	nmod	_	_
8	has	_	VERB	VBZ	_	10	aux	_	_
9	been	_	VERB	VBN	_	10	auxpass	_	_
10	reported	_	VERB	VBN	_	1	dep	_	_
11	in	_	ADP	IN	_	16	case	_	_
12	a	_	DET	DT	_	16	det	_	_
13	type	_	NOUN	NN	_	16	compound	_	_
14	II	_	NUM	CD	_	16	nummod	_	_
15	diabetic	_	ADJ	JJ	_	16	amod	_	_
16	patient	_	NOUN	NN	_	10	nmod	_	_
17	maintained	_	VERB	VBN	_	16	acl	_	_
18	on	_	ADP	IN	_	21	case	_	_
19	tolazamide	_	NOUN	NN	_	21	compound	_	_
20	1	_	NUM	CD	_	21	nummod	_	_
21	gm	_	NOUN	NN	_	17	nmod	_	_
22	/	_	.	:	_	25	punct	_	_
23	day	_	NOUN	NN	_	25	compound	_	_
24	11	_	NUM	CD	_	25	nummod	_	_
25	days	_	NOUN	NNS	_	10	nmod	_	_
26	after	_	ADP	IN	_	28	case	_	_
27	the	_	DET	DT	_	28	det	_	_
28	addition	_	NOUN	NN	_	25	nmod	_	_
29	of	_	ADP	IN	_	35	case	_	_
30	oral	_	ADJ	JJ	_	35	amod	_	_
31	DRUG	_	NOUN	NN	_	35	compound	_	_
32	75	_	NUM	CD	_	35	nummod	_	_
33	mg	_	NOUN	NN	_	35	compound	_	_
34	/	_	NUM	CD	_	35	compound	_	_
35	day	_	NOUN	NN	_	28	nmod	_	_

#	Doxepin	140
1	Although	_	ADP	IN	_	5	mark	_	_
2	DRUG	_	NOUN	NN	_	3	compound	_	_
3	HCl	_	NOUN	NN	_	5	nsubj	_	_
4	does	_	VERB	MD	_	5	aux	_	_
5	have	_	VERB	VB	_	25	advcl	_	_
6	H1	_	NOUN	NN	_	12	compound	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	H2	_	NOUN	NN	_	6	conj	_	_
9	histamine	_	NOUN	NN	_	12	compound	_	_
10	receptor	_	NOUN	NN	_	12	compound	_	_
11	blocking	_	VERB	VBG	_	12	compound	_	_
12	actions	_	NOUN	NNS	_	5	dobj	_	_
13	,	_	.	,	_	25	punct	_	_
14	the	_	DET	DT	_	16	det	_	_
15	exact	_	ADJ	JJ	_	16	amod	_	_
16	mechanism	_	NOUN	NN	_	25	nsubj	_	_
17	by	_	ADP	IN	_	18	case	_	_
18	which	_	DET	WDT	_	20	nmod	_	_
19	DRUG	_	NOUN	NN	_	20	nsubj	_	_
20	exerts	_	VERB	VBZ	_	16	acl:relcl	_	_
21	its	_	PRON	PRP$	_	23	nmod:poss	_	_
22	antipruritic	_	ADJ	JJ	_	23	amod	_	_
23	effect	_	NOUN	NN	_	20	dobj	_	_
24	is	_	VERB	VBZ	_	25	auxpass	_	_
25	unknown	_	ADJ	JJ	_	0	root	_	_

#	Doxepin	141
1	PRUDOXIN	_	NOUN	NN	_	2	compound	_	_
2	Cream	_	NOUN	NN	_	4	nsubj	_	_
3	can	_	VERB	MD	_	4	aux	_	_
4	produce	_	VERB	VB	_	0	root	_	_
5	drowsiness	_	NOUN	NN	_	4	dobj	_	_
6	which	_	DET	WDT	_	8	nsubj	_	_
7	may	_	VERB	MD	_	8	aux	_	_
8	reduce	_	VERB	VB	_	5	acl:relcl	_	_
9	awareness	_	NOUN	NN	_	8	dobj	_	_
10	,	_	.	,	_	4	punct	_	_
11	including	_	VERB	VBG	_	12	case	_	_
12	awareness	_	NOUN	NN	_	4	nmod	_	_
13	of	_	ADP	IN	_	15	case	_	_
14	pruritic	_	ADJ	JJ	_	15	amod	_	_
15	symptoms	_	NOUN	NNS	_	12	nmod	_	_

#	Doxepin	142
1	In	_	ADP	IN	_	5	case	_	_
2	19	_	NUM	CD	_	5	nummod	_	_
3	pruritic	_	ADJ	JJ	_	5	amod	_	_
4	eczema	_	NOUN	NN	_	5	compound	_	_
5	patients	_	NOUN	NNS	_	14	nmod	_	_
6	treated	_	VERB	VBN	_	5	acl	_	_
7	with	_	ADP	IN	_	9	case	_	_
8	PRUDOXIN	_	NOUN	NN	_	9	compound	_	_
9	Cream	_	NOUN	NN	_	6	nmod	_	_
10	,	_	.	,	_	14	punct	_	_
11	plasma	_	NOUN	NN	_	13	compound	_	_
12	DRUG	_	NOUN	NN	_	13	compound	_	_
13	concentrations	_	NOUN	NNS	_	14	nsubj	_	_
14	ranged	_	VERB	VBD	_	0	root	_	_
15	from	_	ADP	IN	_	19	case	_	_
16	nondetectable	_	ADJ	JJ	_	18	advmod	_	_
17	to	_	PRT	TO	_	18	dep	_	_
18	47	_	NUM	CD	_	19	nummod	_	_
19	ng	_	NOUN	NN	_	14	nmod	_	_
20	/	_	.	:	_	14	punct	_	_
21	mL	_	NOUN	NN	_	14	parataxis	_	_
22	from	_	ADP	IN	_	24	case	_	_
23	percutaneous	_	ADJ	JJ	_	24	amod	_	_
24	absorption	_	NOUN	NN	_	21	nmod	_	_

#	Doxepin	143
1	Plasma	_	NOUN	NN	_	2	compound	_	_
2	levels	_	NOUN	NNS	_	10	nsubj	_	_
3	from	_	ADP	IN	_	5	case	_	_
4	topical	_	ADJ	JJ	_	5	amod	_	_
5	application	_	NOUN	NN	_	2	nmod	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	PRUDOXIN	_	NOUN	NN	_	8	compound	_	_
8	Cream	_	NOUN	NN	_	5	nmod	_	_
9	can	_	VERB	MD	_	10	aux	_	_
10	result	_	VERB	VB	_	0	root	_	_
11	in	_	ADP	IN	_	12	case	_	_
12	CNS	_	NOUN	NN	_	10	nmod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	other	_	ADJ	JJ	_	17	amod	_	_
15	systemic	_	ADJ	JJ	_	17	amod	_	_
16	side	_	ADJ	JJ	_	17	amod	_	_
17	effects	_	NOUN	NNS	_	12	conj	_	_

#	Doxepin	144
1	Once	_	ADP	IN	_	2	mark	_	_
2	absorbed	_	VERB	VBN	_	9	advcl	_	_
3	into	_	ADP	IN	_	6	case	_	_
4	the	_	DET	DT	_	6	det	_	_
5	systemic	_	ADJ	JJ	_	6	amod	_	_
6	circulation	_	NOUN	NN	_	2	nmod	_	_
7	,	_	.	,	_	9	punct	_	_
8	DRUG	_	NOUN	NN	_	9	nsubj	_	_
9	undergoes	_	VERB	VBZ	_	0	root	_	_
10	hepatic	_	ADJ	JJ	_	11	amod	_	_
11	metabolism	_	NOUN	NN	_	9	dobj	_	_
12	that	_	DET	WDT	_	13	nsubj	_	_
13	results	_	VERB	VBZ	_	11	acl:relcl	_	_
14	in	_	ADP	IN	_	15	case	_	_
15	conversion	_	NOUN	NN	_	13	nmod	_	_
16	to	_	PRT	TO	_	20	case	_	_
17	pharmacologically	_	ADV	RB	_	18	advmod	_	_
18	active	_	ADJ	JJ	_	20	amod	_	_
19	desmethyl	_	NOUN	NN	_	20	compound	_	_
20	DRUG	_	NOUN	NN	_	15	nmod	_	_

#	Doxepin	145
1	Further	_	ADJ	JJ	_	2	amod	_	_
2	glucuronidation	_	NOUN	NN	_	3	nsubj	_	_
3	results	_	VERB	VBZ	_	0	root	_	_
4	in	_	ADP	IN	_	6	case	_	_
5	urinary	_	ADJ	JJ	_	6	amod	_	_
6	excretion	_	NOUN	NN	_	3	nmod	_	_
7	of	_	ADP	IN	_	10	case	_	_
8	the	_	DET	DT	_	10	det	_	_
9	parent	_	NOUN	NN	_	10	compound	_	_
10	drug	_	NOUN	NN	_	6	nmod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	its	_	PRON	PRP$	_	13	nmod:poss	_	_
13	metabolites	_	NOUN	NNS	_	10	conj	_	_

#	Doxepin	146
1	Desmethyl	_	NOUN	NN	_	2	compound	_	_
2	DRUG	_	NOUN	NN	_	3	nsubj	_	_
3	has	_	VERB	VBZ	_	0	root	_	_
4	a	_	DET	DT	_	6	det	_	_
5	half	_	ADJ	JJ	_	6	amod	_	_
6	life	_	NOUN	NN	_	3	dobj	_	_
7	that	_	DET	WDT	_	8	nsubj	_	_
8	ranges	_	VERB	VBZ	_	6	acl:relcl	_	_
9	from	_	ADP	IN	_	13	case	_	_
10	28	_	NUM	CD	_	12	compound	_	_
11	to	_	PRT	TO	_	12	dep	_	_
12	52	_	NUM	CD	_	13	nummod	_	_
13	hours	_	NOUN	NNS	_	8	nmod	_	_
14	and	_	CONJ	CC	_	8	cc	_	_
15	is	_	VERB	VBZ	_	17	auxpass	_	_
16	not	_	ADV	RB	_	17	neg	_	_
17	affected	_	VERB	VBN	_	8	conj	_	_
18	by	_	ADP	IN	_	20	case	_	_
19	multiple	_	ADJ	JJ	_	20	amod	_	_
20	dosing	_	VERB	VBG	_	17	nmod	_	_

#	Doxepin	147
1	Plasma	_	NOUN	NN	_	2	compound	_	_
2	levels	_	NOUN	NNS	_	11	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	both	_	CONJ	CC	_	5	cc:preconj	_	_
5	DRUG	_	NOUN	NN	_	2	nmod	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	desmethyl	_	NOUN	NN	_	8	compound	_	_
8	DRUG	_	NOUN	NN	_	5	conj	_	_
9	are	_	VERB	VBP	_	11	cop	_	_
10	highly	_	ADV	RB	_	11	advmod	_	_
11	variable	_	ADJ	JJ	_	0	root	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	are	_	VERB	VBP	_	15	auxpass	_	_
14	poorly	_	ADV	RB	_	15	advmod	_	_
15	correlated	_	VERB	VBN	_	11	conj	_	_
16	with	_	ADP	IN	_	17	case	_	_
17	dosage	_	NOUN	NN	_	15	nmod	_	_

#	Doxepin	148
1	Wide	_	ADJ	JJ	_	2	amod	_	_
2	distribution	_	NOUN	NN	_	3	nsubj	_	_
3	occurs	_	VERB	VBZ	_	0	root	_	_
4	in	_	ADP	IN	_	6	case	_	_
5	body	_	NOUN	NN	_	6	compound	_	_
6	tissues	_	NOUN	NNS	_	3	nmod	_	_
7	including	_	ADP	IN	_	8	case	_	_
8	lungs	_	NOUN	NNS	_	6	nmod	_	_
9	,	_	.	,	_	8	punct	_	_
10	heart	_	NOUN	NN	_	8	conj	_	_
11	,	_	.	,	_	8	punct	_	_
12	brain	_	NOUN	NN	_	8	conj	_	_
13	,	_	.	,	_	8	punct	_	_
14	and	_	CONJ	CC	_	8	cc	_	_
15	liver	_	NOUN	NN	_	8	conj	_	_

#	Doxepin	149
1	Renal	_	ADJ	JJ	_	2	amod	_	_
2	disease	_	NOUN	NN	_	12	nsubj	_	_
3	,	_	.	,	_	2	punct	_	_
4	genetic	_	ADJ	JJ	_	5	amod	_	_
5	factors	_	NOUN	NNS	_	2	conj	_	_
6	,	_	.	,	_	2	punct	_	_
7	age	_	NOUN	NN	_	2	conj	_	_
8	,	_	.	,	_	2	punct	_	_
9	and	_	CONJ	CC	_	2	cc	_	_
10	other	_	ADJ	JJ	_	11	amod	_	_
11	medications	_	NOUN	NNS	_	2	conj	_	_
12	affect	_	VERB	VBP	_	0	root	_	_
13	the	_	DET	DT	_	14	det	_	_
14	metabolism	_	NOUN	NN	_	12	dobj	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	subsequent	_	ADJ	JJ	_	17	amod	_	_
17	elimination	_	NOUN	NN	_	14	conj	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	DRUG	_	NOUN	NN	_	14	nmod	_	_

#	Duloxetine	328
1	Potent	_	ADJ	JJ	_	2	amod	_	_
2	inhibitors	_	NOUN	NNS	_	7	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	CYP1A2	_	NOUN	NN	_	2	nmod	_	_
5	should	_	VERB	MD	_	7	aux	_	_
6	be	_	VERB	VB	_	7	auxpass	_	_
7	avoided	_	VERB	VBN	_	0	root	_	_
8	7.1	_	NUM	CD	_	7	neg	_	_

#	Duloxetine	329
1	Potent	_	ADJ	JJ	_	2	amod	_	_
2	inhibitors	_	NOUN	NNS	_	6	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	CYP2D6	_	NOUN	NN	_	2	nmod	_	_
5	may	_	VERB	MD	_	6	aux	_	_
6	increase	_	VERB	VB	_	0	root	_	_
7	DRUG	_	NOUN	NN	_	8	compound	_	_
8	concentrations	_	NOUN	NNS	_	6	dobj	_	_
9	7.2	_	NUM	CD	_	8	nummod	_	_

#	Duloxetine	330
1	DRUG	_	NOUN	NN	_	5	nsubj	_	_
2	is	_	VERB	VBZ	_	5	cop	_	_
3	a	_	DET	DT	_	5	det	_	_
4	moderate	_	ADJ	JJ	_	5	amod	_	_
5	inhibitor	_	NOUN	NN	_	0	root	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	CYP2D6	_	NOUN	NN	_	5	nmod	_	_
8	7.9	_	NUM	CD	_	7	nummod	_	_

#	Duloxetine	331
1	Both	_	CONJ	CC	_	2	cc:preconj	_	_
2	CYP1A2	_	NOUN	NN	_	6	nsubj	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	CYP2D6	_	NOUN	NN	_	2	conj	_	_
5	are	_	VERB	VBP	_	6	cop	_	_
6	responsible	_	ADJ	JJ	_	0	root	_	_
7	for	_	ADP	IN	_	9	case	_	_
8	DRUG	_	NOUN	NN	_	9	compound	_	_
9	metabolism	_	NOUN	NN	_	6	nmod	_	_

#	Duloxetine	332
1	When	_	ADV	WRB	_	6	advmod	_	_
2	DRUG	_	NOUN	NN	_	3	compound	_	_
3	60mg	_	NOUN	NN	_	6	nsubjpass	_	_
4	was	_	VERB	VBD	_	6	auxpass	_	_
5	co	_	PRT	TO	_	6	mark	_	_
6	administered	_	VERB	VBN	_	23	advcl	_	_
7	with	_	ADP	IN	_	9	case	_	_
8	fluvoxamine	_	NOUN	NN	_	9	compound	_	_
9	100mg	_	NOUN	NN	_	6	nmod	_	_
10	,	_	.	,	_	9	punct	_	_
11	a	_	DET	DT	_	14	det	_	_
12	potent	_	ADJ	JJ	_	14	amod	_	_
13	CYP1A2	_	NOUN	NN	_	14	compound	_	_
14	inhibitor	_	NOUN	NN	_	9	appos	_	_
15	,	_	.	,	_	23	punct	_	_
16	to	_	PRT	TO	_	18	case	_	_
17	male	_	ADJ	JJ	_	18	amod	_	_
18	subjects	_	NOUN	NNS	_	23	nmod	_	_
19	n=14	_	NOUN	NN	_	21	compound	_	_
20	DRUG	_	NOUN	NN	_	21	compound	_	_
21	AUC	_	NOUN	NN	_	23	nsubjpass	_	_
22	was	_	VERB	VBD	_	23	auxpass	_	_
23	increased	_	VERB	VBN	_	0	root	_	_
24	approximately	_	ADV	RB	_	25	advmod	_	_
25	6	_	NUM	CD	_	26	nummod	_	_
26	fold	_	NOUN	NN	_	23	dobj	_	_
27	,	_	.	,	_	23	punct	_	_
28	the	_	DET	DT	_	29	det	_	_
29	Cmax	_	NOUN	NN	_	31	nsubjpass	_	_
30	was	_	VERB	VBD	_	31	auxpass	_	_
31	increased	_	VERB	VBN	_	23	conj	_	_
32	about	_	ADV	RB	_	33	advmod	_	_
33	2.5	_	NUM	CD	_	34	nummod	_	_
34	fold	_	NOUN	NN	_	31	nmod	_	_
35	,	_	.	,	_	23	punct	_	_
36	and	_	CONJ	CC	_	23	cc	_	_
37	DRUG	_	NOUN	NN	_	42	nsubjpass	_	_
38	t1	_	NUM	CD	_	37	nummod	_	_
39	/	_	.	:	_	37	punct	_	_
40	2	_	NUM	CD	_	37	nummod	_	_
41	was	_	VERB	VBD	_	42	auxpass	_	_
42	increased	_	VERB	VBN	_	23	conj	_	_
43	approximately	_	ADV	RB	_	45	advmod	_	_
44	3	_	NUM	CD	_	45	nummod	_	_
45	fold	_	VERB	MD	_	42	advmod	_	_

#	Duloxetine	333
1	Other	_	ADJ	JJ	_	2	amod	_	_
2	drugs	_	NOUN	NNS	_	7	nsubj	_	_
3	that	_	DET	WDT	_	4	nsubj	_	_
4	inhibit	_	VERB	VBP	_	2	acl:relcl	_	_
5	CYP1A2	_	NOUN	NN	_	6	compound	_	_
6	metabolism	_	NOUN	NN	_	4	dobj	_	_
7	include	_	VERB	VBP	_	0	root	_	_
8	cimetidine	_	NOUN	NN	_	7	dobj	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	quinolone	_	NOUN	NN	_	8	conj	_	_
11	antimicrobials	_	NOUN	NNS	_	8	dep	_	_
12	such	_	ADJ	JJ	_	14	case	_	_
13	as	_	ADP	IN	_	12	mwe	_	_
14	ciprofloxacin	_	NOUN	NN	_	8	nmod	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	enoxacin	_	NOUN	NN	_	14	conj	_	_

#	Duloxetine	334
1	Concomitant	_	ADJ	JJ	_	2	amod	_	_
2	use	_	NOUN	NN	_	15	nsubj	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	DRUG	_	NOUN	NN	_	6	compound	_	_
5	40	_	NUM	CD	_	6	nummod	_	_
6	mg	_	NOUN	NN	_	2	nmod	_	_
7	once	_	ADV	RB	_	8	advmod	_	_
8	daily	_	ADV	RB	_	15	advmod	_	_
9	with	_	ADP	IN	_	12	case	_	_
10	paroxetine	_	NOUN	NN	_	12	compound	_	_
11	20	_	NUM	CD	_	12	nummod	_	_
12	mg	_	NOUN	NN	_	8	nmod	_	_
13	once	_	ADV	RB	_	15	advmod	_	_
14	daily	_	ADV	RB	_	15	advmod	_	_
15	increased	_	VERB	VBD	_	0	root	_	_
16	the	_	DET	DT	_	17	det	_	_
17	concentration	_	NOUN	NN	_	15	dobj	_	_
18	of	_	ADP	IN	_	20	case	_	_
19	DRUG	_	NOUN	NN	_	20	compound	_	_
20	AUC	_	NOUN	NN	_	17	nmod	_	_
21	by	_	ADP	IN	_	23	case	_	_
22	about	_	ADV	RB	_	23	advmod	_	_
23	60%	_	ADJ	JJ	_	15	nmod	_	_
24	,	_	.	,	_	15	punct	_	_
25	and	_	CONJ	CC	_	15	cc	_	_
26	greater	_	ADJ	JJ	_	27	amod	_	_
27	degrees	_	NOUN	NNS	_	31	nsubjpass	_	_
28	of	_	ADP	IN	_	29	case	_	_
29	inhibition	_	NOUN	NN	_	27	nmod	_	_
30	are	_	VERB	VBP	_	31	auxpass	_	_
31	expected	_	VERB	VBN	_	15	conj	_	_
32	with	_	ADP	IN	_	34	case	_	_
33	higher	_	ADJ	JJ	_	34	amod	_	_
34	doses	_	NOUN	NNS	_	31	nmod	_	_
35	of	_	ADP	IN	_	36	case	_	_
36	paroxetine	_	NOUN	NN	_	34	nmod	_	_

#	Duloxetine	335
1	Similar	_	ADJ	JJ	_	2	amod	_	_
2	effects	_	NOUN	NNS	_	5	nsubjpass	_	_
3	would	_	VERB	MD	_	5	aux	_	_
4	be	_	VERB	VB	_	5	auxpass	_	_
5	expected	_	VERB	VBN	_	0	root	_	_
6	with	_	ADP	IN	_	10	case	_	_
7	other	_	ADJ	JJ	_	10	amod	_	_
8	potent	_	ADJ	JJ	_	10	amod	_	_
9	CYP2D6	_	NOUN	NN	_	10	compound	_	_
10	inhibitors	_	NOUN	NNS	_	5	nmod	_	_
11	e.g	_	NOUN	NN	_	10	dep	_	_
12	,	_	.	,	_	11	punct	_	_
13	fluoxetine	_	NOUN	NN	_	11	conj	_	_
14	,	_	.	,	_	11	punct	_	_
15	quinidine	_	NOUN	NN	_	11	appos	_	_

#	Duloxetine	336
1	Concomitant	_	ADJ	JJ	_	2	amod	_	_
2	administration	_	NOUN	NN	_	0	root	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	DRUG	_	NOUN	NN	_	6	compound	_	_
5	40	_	NUM	CD	_	6	nummod	_	_
6	mg	_	NOUN	NN	_	2	nmod	_	_
7	twice	_	ADV	RB	_	8	advmod	_	_
8	daily	_	ADV	RB	_	2	advmod	_	_
9	with	_	ADP	IN	_	12	case	_	_
10	fluvoxamine	_	NOUN	NN	_	12	compound	_	_
11	100	_	NUM	CD	_	12	nummod	_	_
12	mg	_	NOUN	NN	_	8	nmod	_	_
13	,	_	.	,	_	8	punct	_	_
14	a	_	DET	DT	_	17	det	_	_
15	potent	_	ADJ	JJ	_	17	amod	_	_
16	CYP1A2	_	NOUN	NN	_	17	compound	_	_
17	inhibitor	_	NOUN	NN	_	8	dep	_	_
18	,	_	.	,	_	17	punct	_	_
19	to	_	PRT	TO	_	23	case	_	_
20	CYP2D6	_	NOUN	NN	_	23	compound	_	_
21	poor	_	ADJ	JJ	_	23	amod	_	_
22	metabolizer	_	ADJ	JJ	_	23	amod	_	_
23	subjects	_	NOUN	NNS	_	25	nmod	_	_
24	n=14	_	NOUN	NN	_	25	nsubj	_	_
25	resulted	_	VERB	VBD	_	17	dep	_	_
26	in	_	ADP	IN	_	30	case	_	_
27	a	_	DET	DT	_	30	det	_	_
28	6	_	NUM	CD	_	29	compound	_	_
29	fold	_	NOUN	NN	_	30	amod	_	_
30	increase	_	NOUN	NN	_	25	nmod	_	_
31	in	_	ADP	IN	_	33	case	_	_
32	DRUG	_	NOUN	NN	_	33	compound	_	_
33	AUC	_	NOUN	NN	_	30	nmod	_	_
34	and	_	CONJ	CC	_	33	cc	_	_
35	Cmax	_	NOUN	NN	_	33	conj	_	_

#	Duloxetine	337
1	Serotonin	_	NOUN	NN	_	2	compound	_	_
2	release	_	NOUN	NN	_	5	nsubj	_	_
3	by	_	ADP	IN	_	4	case	_	_
4	platelets	_	NOUN	NNS	_	2	nmod	_	_
5	plays	_	VERB	VBZ	_	0	root	_	_
6	an	_	DET	DT	_	8	det	_	_
7	important	_	ADJ	JJ	_	8	amod	_	_
8	role	_	NOUN	NN	_	5	dobj	_	_
9	in	_	ADP	IN	_	10	case	_	_
10	hemostasis	_	NOUN	NN	_	8	nmod	_	_

#	Duloxetine	338
1	Epidemiological	_	ADJ	JJ	_	2	amod	_	_
2	studies	_	NOUN	NNS	_	0	root	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	the	_	DET	DT	_	6	det	_	_
5	case	_	NOUN	NN	_	6	compound	_	_
6	control	_	NOUN	NN	_	2	nmod	_	_
7	and	_	CONJ	CC	_	2	cc	_	_
8	cohort	_	NOUN	NN	_	2	conj	_	_
9	design	_	NOUN	NN	_	8	dobj	_	_
10	that	_	DET	WDT	_	12	nsubj	_	_
11	have	_	VERB	VBP	_	12	aux	_	_
12	demonstrated	_	VERB	VBN	_	9	dep	_	_
13	an	_	DET	DT	_	14	det	_	_
14	association	_	NOUN	NN	_	12	dobj	_	_
15	between	_	ADP	IN	_	16	case	_	_
16	use	_	NOUN	NN	_	14	nmod	_	_
17	of	_	ADP	IN	_	19	case	_	_
18	psychotropic	_	ADJ	JJ	_	19	amod	_	_
19	drugs	_	NOUN	NNS	_	16	nmod	_	_
20	that	_	DET	WDT	_	21	nsubj	_	_
21	interfere	_	VERB	VBP	_	19	acl:relcl	_	_
22	with	_	ADP	IN	_	24	case	_	_
23	serotonin	_	NOUN	NN	_	24	compound	_	_
24	reuptake	_	NOUN	NN	_	21	nmod	_	_
25	and	_	CONJ	CC	_	21	cc	_	_
26	the	_	DET	DT	_	27	det	_	_
27	occurrence	_	NOUN	NN	_	34	nsubj	_	_
28	of	_	ADP	IN	_	31	case	_	_
29	upper	_	VERB	VBG	_	31	amod	_	_
30	gastrointestinal	_	ADJ	JJ	_	31	amod	_	_
31	bleeding	_	NOUN	NN	_	27	nmod	_	_
32	have	_	VERB	MD	_	34	aux	_	_
33	also	_	ADV	RB	_	34	advmod	_	_
34	shown	_	VERB	VBN	_	21	conj	_	_
35	that	_	ADP	IN	_	44	mark	_	_
36	concurrent	_	ADJ	JJ	_	37	amod	_	_
37	use	_	NOUN	NN	_	44	nsubj	_	_
38	of	_	ADP	IN	_	40	case	_	_
39	an	_	DET	DT	_	40	det	_	_
40	NSAID	_	NOUN	NN	_	37	nmod	_	_
41	or	_	CONJ	CC	_	40	cc	_	_
42	aspirin	_	NOUN	NN	_	40	conj	_	_
43	may	_	VERB	MD	_	44	aux	_	_
44	potentiate	_	VERB	VB	_	34	ccomp	_	_
45	this	_	DET	DT	_	46	det	_	_
46	risk	_	NOUN	NN	_	44	dobj	_	_
47	of	_	ADP	IN	_	48	mark	_	_
48	bleeding	_	VERB	VBG	_	46	nmod	_	_

#	Duloxetine	339
1	Altered	_	VERB	VBN	_	3	amod	_	_
2	anticoagulant	_	ADJ	JJ	_	3	amod	_	_
3	effects	_	NOUN	NNS	_	11	nsubjpass	_	_
4	,	_	.	,	_	3	punct	_	_
5	including	_	VERB	VBG	_	7	case	_	_
6	increased	_	VERB	VBN	_	7	amod	_	_
7	bleeding	_	NOUN	NN	_	3	nmod	_	_
8	,	_	.	,	_	3	punct	_	_
9	have	_	VERB	VBP	_	11	aux	_	_
10	been	_	VERB	VBN	_	11	auxpass	_	_
11	reported	_	VERB	VBN	_	0	root	_	_
12	when	_	ADV	WRB	_	18	advmod	_	_
13	SSRIs	_	NOUN	NNS	_	18	nsubjpass	_	_
14	or	_	CONJ	CC	_	13	cc	_	_
15	SNRIs	_	NOUN	NNS	_	13	conj	_	_
16	are	_	VERB	VBP	_	18	auxpass	_	_
17	co	_	PRT	TO	_	18	mark	_	_
18	administered	_	VERB	VBN	_	11	advcl	_	_
19	with	_	ADP	IN	_	20	case	_	_
20	warfarin	_	NOUN	NN	_	18	nmod	_	_

#	Duloxetine	340
1	Concomitant	_	ADJ	JJ	_	2	amod	_	_
2	administration	_	NOUN	NN	_	35	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	warfarin	_	NOUN	NN	_	2	nmod	_	_
5	2	_	NUM	CD	_	4	nummod	_	_
6	to	_	PRT	TO	_	8	case	_	_
7	9	_	NUM	CD	_	8	nummod	_	_
8	mg	_	NOUN	NN	_	2	nmod	_	_
9	once	_	ADV	RB	_	10	advmod	_	_
10	daily	_	ADV	RB	_	35	advmod	_	_
11	under	_	ADP	IN	_	14	case	_	_
12	steady	_	ADJ	JJ	_	14	amod	_	_
13	state	_	NOUN	NN	_	14	compound	_	_
14	conditions	_	NOUN	NNS	_	35	nsubj	_	_
15	with	_	ADP	IN	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	14	nmod	_	_
17	60	_	NUM	CD	_	16	nummod	_	_
18	or	_	CONJ	CC	_	16	cc	_	_
19	120	_	NUM	CD	_	20	nummod	_	_
20	mg	_	NOUN	NN	_	16	conj	_	_
21	once	_	ADV	RB	_	22	advmod	_	_
22	daily	_	ADV	RB	_	35	advmod	_	_
23	for	_	ADP	IN	_	27	case	_	_
24	up	_	ADJ	JJ	_	26	advmod	_	_
25	to	_	PRT	TO	_	26	dep	_	_
26	14	_	NUM	CD	_	27	nummod	_	_
27	days	_	NOUN	NNS	_	22	nmod	_	_
28	in	_	ADP	IN	_	30	case	_	_
29	healthy	_	ADJ	JJ	_	30	amod	_	_
30	subjects	_	NOUN	NNS	_	27	nmod	_	_
31	n=15	_	NOUN	NN	_	30	dep	_	_
32	did	_	VERB	VBD	_	35	aux	_	_
33	not	_	ADV	RB	_	35	neg	_	_
34	significantly	_	ADV	RB	_	35	advmod	_	_
35	change	_	VERB	VB	_	0	root	_	_
36	INR	_	NOUN	NN	_	35	dobj	_	_
37	from	_	ADP	IN	_	41	case	_	_
38	baseline	_	NOUN	NN	_	41	compound	_	_
39	mean	_	NOUN	NN	_	41	compound	_	_
40	INR	_	NOUN	NN	_	41	compound	_	_
41	changes	_	NOUN	NNS	_	35	nmod	_	_
42	ranged	_	VERB	VBN	_	41	acl	_	_
43	from	_	ADP	IN	_	46	case	_	_
44	0.05	_	NUM	CD	_	46	compound	_	_
45	to	_	PRT	TO	_	46	dep	_	_
46	+0.07	_	NUM	CD	_	42	nmod	_	_

#	Duloxetine	341
1	The	_	DET	DT	_	4	det	_	_
2	total	_	ADJ	JJ	_	4	amod	_	_
3	warfarin	_	NOUN	NN	_	4	compound	_	_
4	protein	_	NOUN	NN	_	5	nsubj	_	_
5	bound	_	VERB	VBN	_	0	root	_	_
6	plus	_	CONJ	CC	_	5	cc	_	_
7	free	_	ADJ	JJ	_	9	amod	_	_
8	drug	_	NOUN	NN	_	9	compound	_	_
9	pharmacokinetics	_	NOUN	NNS	_	5	conj	_	_
10	AUCT,ss	_	NOUN	NN	_	9	amod	_	_
11	,	_	.	,	_	5	punct	_	_
12	Cmax,ss	_	NOUN	NN	_	23	nsubjpass	_	_
13	or	_	CONJ	CC	_	12	cc	_	_
14	tmax,ss	_	NOUN	NN	_	12	conj	_	_
15	for	_	ADP	IN	_	17	case	_	_
16	both	_	CONJ	CC	_	17	cc:preconj	_	_
17	R	_	NOUN	NN	_	12	nmod	_	_
18	and	_	CONJ	CC	_	17	cc	_	_
19	S	_	NOUN	NN	_	17	conj	_	_
20	warfarin	_	NOUN	NN	_	17	dep	_	_
21	were	_	VERB	VBD	_	23	auxpass	_	_
22	not	_	ADV	RB	_	23	neg	_	_
23	altered	_	VERB	VBN	_	5	parataxis	_	_
24	by	_	ADP	IN	_	25	case	_	_
25	DRUG	_	NOUN	NN	_	23	nmod	_	_

#	Duloxetine	342
1	Because	_	ADP	IN	_	5	case	_	_
2	of	_	ADP	IN	_	5	case	_	_
3	the	_	DET	DT	_	5	det	_	_
4	potential	_	ADJ	JJ	_	5	amod	_	_
5	effect	_	NOUN	NN	_	18	nmod	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	on	_	ADP	IN	_	9	case	_	_
9	platelets	_	NOUN	NNS	_	5	nmod	_	_
10	,	_	.	,	_	18	punct	_	_
11	patients	_	NOUN	NNS	_	18	nsubjpass	_	_
12	receiving	_	VERB	VBG	_	11	acl	_	_
13	warfarin	_	NOUN	NN	_	14	compound	_	_
14	therapy	_	NOUN	NN	_	12	dobj	_	_
15	should	_	VERB	MD	_	18	aux	_	_
16	be	_	VERB	VB	_	18	auxpass	_	_
17	carefully	_	ADV	RB	_	18	advmod	_	_
18	monitored	_	VERB	VBN	_	0	root	_	_
19	when	_	ADV	WRB	_	22	advmod	_	_
20	DRUG	_	NOUN	NN	_	22	nsubjpass	_	_
21	is	_	VERB	VBZ	_	22	auxpass	_	_
22	initiated	_	VERB	VBN	_	18	ccomp	_	_
23	or	_	CONJ	CC	_	22	cc	_	_
24	discontinued	_	VERB	VBN	_	22	conj	_	_

#	Duloxetine	343
1	Under	_	ADP	IN	_	4	case	_	_
2	steady	_	ADJ	JJ	_	4	amod	_	_
3	state	_	NOUN	NN	_	4	compound	_	_
4	conditions	_	NOUN	NNS	_	26	nmod	_	_
5	for	_	ADP	IN	_	11	case	_	_
6	DRUG	_	NOUN	NN	_	11	compound	_	_
7	60	_	NUM	CD	_	11	nummod	_	_
8	mg	_	NOUN	NN	_	11	compound	_	_
9	Q	_	NOUN	NN	_	11	compound	_	_
10	12	_	NUM	CD	_	11	nummod	_	_
11	hours	_	NOUN	NNS	_	4	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	lorazepam	_	NOUN	NN	_	18	compound	_	_
14	2	_	NUM	CD	_	18	nummod	_	_
15	mg	_	NOUN	NN	_	18	compound	_	_
16	Q	_	NOUN	NN	_	18	compound	_	_
17	12	_	NUM	CD	_	18	nummod	_	_
18	hours	_	NOUN	NNS	_	11	conj	_	_
19	,	_	.	,	_	26	punct	_	_
20	the	_	DET	DT	_	21	det	_	_
21	pharmacokinetics	_	NOUN	NNS	_	26	nsubjpass	_	_
22	of	_	ADP	IN	_	23	case	_	_
23	DRUG	_	NOUN	NN	_	21	nmod	_	_
24	were	_	VERB	VBD	_	26	auxpass	_	_
25	not	_	ADV	RB	_	26	neg	_	_
26	affected	_	VERB	VBN	_	0	root	_	_
27	by	_	ADP	IN	_	29	case	_	_
28	co	_	ADP	IN	_	29	case	_	_
29	administration	_	NOUN	NN	_	26	nmod	_	_

#	Duloxetine	344
1	Under	_	ADP	IN	_	4	case	_	_
2	steady	_	ADJ	JJ	_	4	amod	_	_
3	state	_	NOUN	NN	_	4	compound	_	_
4	conditions	_	NOUN	NNS	_	22	nmod	_	_
5	for	_	ADP	IN	_	8	case	_	_
6	DRUG	_	NOUN	NN	_	8	compound	_	_
7	20	_	NUM	CD	_	8	nummod	_	_
8	mg	_	NOUN	NN	_	4	nmod	_	_
9	qhs	_	ADP	IN	_	4	nmod	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	temazepam	_	NOUN	NN	_	13	compound	_	_
12	30	_	NUM	CD	_	13	nummod	_	_
13	mg	_	NOUN	NN	_	9	conj	_	_
14	qhs	_	ADP	IN	_	4	advmod	_	_
15	,	_	.	,	_	22	punct	_	_
16	the	_	DET	DT	_	17	det	_	_
17	pharmacokinetics	_	NOUN	NNS	_	22	nsubjpass	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	DRUG	_	NOUN	NN	_	17	nmod	_	_
20	were	_	VERB	VBD	_	22	auxpass	_	_
21	not	_	ADV	RB	_	22	neg	_	_
22	affected	_	VERB	VBN	_	0	root	_	_
23	by	_	ADP	IN	_	25	case	_	_
24	co	_	ADP	IN	_	25	case	_	_
25	administration	_	NOUN	NN	_	22	nmod	_	_

#	Duloxetine	345
1	DRUG	_	NOUN	NN	_	4	compound	_	_
2	delayed	_	ADJ	JJ	_	4	amod	_	_
3	release	_	NOUN	NN	_	4	compound	_	_
4	capsules	_	NOUN	NNS	_	5	nsubj	_	_
5	have	_	VERB	VBP	_	0	root	_	_
6	an	_	DET	DT	_	8	det	_	_
7	enteric	_	ADJ	JJ	_	8	amod	_	_
8	coating	_	NOUN	NN	_	5	dobj	_	_
9	that	_	DET	WDT	_	10	nsubj	_	_
10	resists	_	VERB	VBZ	_	8	ccomp	_	_
11	dissolution	_	NOUN	NN	_	10	dobj	_	_
12	until	_	ADP	IN	_	13	mark	_	_
13	reaching	_	VERB	VBG	_	10	advcl	_	_
14	a	_	DET	DT	_	15	det	_	_
15	segment	_	NOUN	NN	_	13	dobj	_	_
16	of	_	ADP	IN	_	19	case	_	_
17	the	_	DET	DT	_	19	det	_	_
18	gastrointestinal	_	ADJ	JJ	_	19	amod	_	_
19	tract	_	NOUN	NN	_	15	nmod	_	_
20	where	_	ADV	WRB	_	23	advmod	_	_
21	the	_	DET	DT	_	22	det	_	_
22	pH	_	NOUN	NN	_	23	nsubj	_	_
23	exceeds	_	VERB	VBZ	_	19	acl:relcl	_	_
24	5.5	_	NUM	CD	_	23	neg	_	_

#	Duloxetine	346
1	In	_	ADP	IN	_	4	case	_	_
2	extremely	_	ADV	RB	_	3	advmod	_	_
3	acidic	_	ADJ	JJ	_	4	amod	_	_
4	conditions	_	NOUN	NNS	_	15	nmod	_	_
5	,	_	.	,	_	15	punct	_	_
6	DRUG	_	NOUN	NN	_	15	nsubj	_	_
7	,	_	.	,	_	6	punct	_	_
8	unprotected	_	ADJ	JJ	_	6	amod	_	_
9	by	_	ADP	IN	_	12	case	_	_
10	the	_	DET	DT	_	12	det	_	_
11	enteric	_	ADJ	JJ	_	12	amod	_	_
12	coating	_	NOUN	NN	_	8	nmod	_	_
13	,	_	.	,	_	6	punct	_	_
14	may	_	VERB	MD	_	15	aux	_	_
15	undergo	_	VERB	VB	_	0	root	_	_
16	hydrolysis	_	NOUN	NN	_	15	dobj	_	_
17	to	_	PRT	TO	_	18	mark	_	_
18	form	_	VERB	VB	_	16	acl	_	_
19	naphthol	_	NOUN	NN	_	18	dobj	_	_

#	Duloxetine	347
1	Caution	_	NOUN	NN	_	3	nsubjpass	_	_
2	is	_	VERB	VBZ	_	3	auxpass	_	_
3	advised	_	VERB	VBN	_	0	root	_	_
4	in	_	ADP	IN	_	5	mark	_	_
5	using	_	VERB	VBG	_	3	advcl	_	_
6	DRUG	_	NOUN	NN	_	5	dobj	_	_
7	in	_	ADP	IN	_	8	case	_	_
8	patients	_	NOUN	NNS	_	5	nmod	_	_
9	with	_	ADP	IN	_	10	case	_	_
10	conditions	_	NOUN	NNS	_	8	nmod	_	_
11	that	_	DET	WDT	_	13	nsubj	_	_
12	may	_	VERB	MD	_	13	aux	_	_
13	slow	_	VERB	VB	_	10	acl:relcl	_	_
14	gastric	_	ADJ	JJ	_	16	amod	_	_
15	emptying	_	VERB	VBG	_	16	amod	_	_
16	e.g	_	NOUN	NN	_	13	dobj	_	_
17	,	_	.	,	_	3	punct	_	_
18	some	_	DET	DT	_	19	det	_	_
19	diabetics	_	NOUN	NNS	_	17	root	_	_

#	Duloxetine	348
1	Drugs	_	NOUN	NNS	_	8	nsubj	_	_
2	that	_	DET	WDT	_	3	nsubj	_	_
3	raise	_	VERB	VBP	_	1	acl:relcl	_	_
4	the	_	DET	DT	_	6	det	_	_
5	gastrointestinal	_	ADJ	JJ	_	6	amod	_	_
6	pH	_	NOUN	NN	_	3	dobj	_	_
7	may	_	VERB	MD	_	8	aux	_	_
8	lead	_	VERB	VB	_	0	root	_	_
9	to	_	PRT	TO	_	12	case	_	_
10	an	_	DET	DT	_	12	det	_	_
11	earlier	_	ADJ	JJ	_	12	amod	_	_
12	release	_	NOUN	NN	_	8	nmod	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	DRUG	_	NOUN	NN	_	12	nmod	_	_

#	Duloxetine	349
1	However	_	ADV	RB	_	20	advmod	_	_
2	,	_	.	,	_	20	punct	_	_
3	co	_	PRT	TO	_	4	case	_	_
4	administration	_	NOUN	NN	_	20	nsubj	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	with	_	ADP	IN	_	8	case	_	_
8	aluminum	_	NOUN	NN	_	4	nmod	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	magnesium	_	NOUN	NN	_	8	conj	_	_
11	containing	_	VERB	VBG	_	8	acl	_	_
12	antacids	_	NOUN	NNS	_	11	dobj	_	_
13	51	_	NUM	CD	_	14	nummod	_	_
14	mEq	_	NOUN	NN	_	12	dep	_	_
15	or	_	CONJ	CC	_	14	cc	_	_
16	DRUG	_	NOUN	NN	_	14	conj	_	_
17	with	_	ADP	IN	_	18	case	_	_
18	famotidine	_	NOUN	NN	_	11	nmod	_	_
19	,	_	.	,	_	4	punct	_	_
20	had	_	VERB	VBD	_	0	root	_	_
21	no	_	DET	DT	_	23	neg	_	_
22	significant	_	ADJ	JJ	_	23	amod	_	_
23	effect	_	NOUN	NN	_	20	dobj	_	_
24	on	_	ADP	IN	_	26	case	_	_
25	the	_	DET	DT	_	26	det	_	_
26	rate	_	NOUN	NN	_	20	nmod	_	_
27	or	_	CONJ	CC	_	26	cc	_	_
28	extent	_	NOUN	NN	_	26	conj	_	_
29	of	_	ADP	IN	_	31	case	_	_
30	DRUG	_	NOUN	NN	_	31	compound	_	_
31	absorption	_	NOUN	NN	_	26	nmod	_	_
32	after	_	ADP	IN	_	33	case	_	_
33	administration	_	NOUN	NN	_	20	nmod	_	_
34	of	_	ADP	IN	_	39	case	_	_
35	a	_	DET	DT	_	39	det	_	_
36	40	_	NUM	CD	_	39	nummod	_	_
37	mg	_	NOUN	NN	_	39	compound	_	_
38	oral	_	ADJ	JJ	_	39	amod	_	_
39	dose	_	NOUN	NN	_	33	nmod	_	_

#	Duloxetine	350
1	It	_	PRON	PRP	_	3	nsubj	_	_
2	is	_	VERB	VBZ	_	3	cop	_	_
3	unknown	_	ADJ	JJ	_	0	root	_	_
4	whether	_	ADP	IN	_	12	mark	_	_
5	the	_	DET	DT	_	7	det	_	_
6	concomitant	_	ADJ	JJ	_	7	amod	_	_
7	administration	_	NOUN	NN	_	12	nsubj	_	_
8	of	_	ADP	IN	_	11	case	_	_
9	proton	_	NOUN	NN	_	11	compound	_	_
10	pump	_	NOUN	NN	_	11	compound	_	_
11	inhibitors	_	NOUN	NNS	_	7	nmod	_	_
12	affects	_	VERB	VBZ	_	3	ccomp	_	_
13	DRUG	_	NOUN	NN	_	14	compound	_	_
14	absorption	_	NOUN	NN	_	12	dobj	_	_

#	Duloxetine	351
1	In	_	X	FW	_	5	amod	_	_
2	vitro	_	X	FW	_	1	dep	_	_
3	drug	_	NOUN	NN	_	5	compound	_	_
4	interaction	_	NOUN	NN	_	5	compound	_	_
5	studies	_	NOUN	NNS	_	6	nsubj	_	_
6	demonstrate	_	VERB	VBP	_	0	root	_	_
7	that	_	ADP	IN	_	11	mark	_	_
8	DRUG	_	NOUN	NN	_	11	nsubj	_	_
9	does	_	VERB	VBZ	_	11	aux	_	_
10	not	_	ADV	RB	_	11	neg	_	_
11	induce	_	VERB	VB	_	6	ccomp	_	_
12	CYP1A2	_	NOUN	NN	_	13	compound	_	_
13	activity	_	NOUN	NN	_	11	dobj	_	_

#	Duloxetine	352
1	Therefore	_	ADV	RB	_	0	root	_	_
2	,	_	.	,	_	1	punct	_	_
3	an	_	DET	DT	_	4	det	_	_
4	increase	_	NOUN	NN	_	2	root	_	_
5	in	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	metabolism	_	NOUN	NN	_	4	nmod	_	_
8	of	_	ADP	IN	_	10	case	_	_
9	CYP1A2	_	NOUN	NN	_	10	compound	_	_
10	substrates	_	NOUN	NNS	_	21	nmod	_	_
11	e.g	_	NOUN	NN	_	21	nsubjpass	_	_
12	,	_	.	,	_	11	punct	_	_
13	theophylline	_	NOUN	NN	_	11	appos	_	_
14	,	_	.	,	_	11	punct	_	_
15	caffeine	_	NOUN	NN	_	11	appos	_	_
16	resulting	_	VERB	VBG	_	15	acl	_	_
17	from	_	ADP	IN	_	18	case	_	_
18	induction	_	NOUN	NN	_	16	nmod	_	_
19	is	_	VERB	VBZ	_	21	auxpass	_	_
20	not	_	ADV	RB	_	21	neg	_	_
21	anticipated	_	VERB	VBN	_	7	acl	_	_
22	,	_	.	,	_	4	punct	_	_
23	although	_	ADP	IN	_	31	mark	_	_
24	clinical	_	ADJ	JJ	_	25	amod	_	_
25	studies	_	NOUN	NNS	_	31	nsubjpass	_	_
26	of	_	ADP	IN	_	27	case	_	_
27	induction	_	NOUN	NN	_	25	nmod	_	_
28	have	_	VERB	MD	_	31	aux	_	_
29	not	_	ADV	RB	_	31	neg	_	_
30	been	_	VERB	VBN	_	31	auxpass	_	_
31	performed	_	VERB	VBN	_	4	root	_	_

#	Duloxetine	353
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	is	_	VERB	VBZ	_	4	cop	_	_
3	an	_	DET	DT	_	4	det	_	_
4	inhibitor	_	NOUN	NN	_	0	root	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	the	_	DET	DT	_	8	det	_	_
7	CYP1A2	_	NOUN	NN	_	8	compound	_	_
8	isoform	_	NOUN	NN	_	4	nmod	_	_
9	in	_	ADP	IN	_	12	case	_	_
10	in	_	X	FW	_	12	amod	_	_
11	vitro	_	X	FW	_	10	dep	_	_
12	studies	_	NOUN	NNS	_	4	nmod	_	_
13	,	_	.	,	_	4	punct	_	_
14	and	_	CONJ	CC	_	4	cc	_	_
15	in	_	ADP	IN	_	18	case	_	_
16	two	_	NUM	CD	_	18	nummod	_	_
17	clinical	_	ADJ	JJ	_	18	amod	_	_
18	studies	_	NOUN	NNS	_	29	nmod	_	_
19	the	_	DET	DT	_	24	det	_	_
20	average	_	ADJ	JJ	_	24	amod	_	_
21	90%	_	ADJ	JJ	_	24	amod	_	_
22	confidence	_	NOUN	NN	_	24	compound	_	_
23	interval	_	ADJ	JJ	_	24	amod	_	_
24	increase	_	NOUN	NN	_	29	nsubj	_	_
25	in	_	ADP	IN	_	27	case	_	_
26	theophylline	_	NOUN	NN	_	27	compound	_	_
27	AUC	_	NOUN	NN	_	24	nmod	_	_
28	was	_	VERB	VBD	_	29	cop	_	_
29	7%	_	ADJ	JJ	_	4	conj	_	_
30	1%	_	NOUN	NN	_	29	dobj	_	_
31	to	_	PRT	TO	_	32	case	_	_
32	15%	_	ADJ	JJ	_	30	nmod	_	_
33	and	_	CONJ	CC	_	32	cc	_	_
34	20%	_	ADJ	JJ	_	32	conj	_	_
35	13%	_	NOUN	NN	_	32	dep	_	_
36	to	_	PRT	TO	_	37	case	_	_
37	27%	_	NOUN	NN	_	32	nmod	_	_
38	when	_	ADV	WRB	_	29	advmod	_	_
39	co	_	PRT	TO	_	38	nmod	_	_
40	administered	_	VERB	VBN	_	39	dep	_	_
41	with	_	ADP	IN	_	44	case	_	_
42	DRUG	_	NOUN	NN	_	44	compound	_	_
43	60	_	NUM	CD	_	44	nummod	_	_
44	mg	_	NOUN	NN	_	40	nmod	_	_
45	twice	_	ADV	RB	_	40	advmod	_	_
46	daily	_	ADV	RB	_	40	neg	_	_

#	Duloxetine	354
1	DRUG	_	NOUN	NN	_	5	nsubj	_	_
2	is	_	VERB	VBZ	_	5	cop	_	_
3	a	_	DET	DT	_	5	det	_	_
4	moderate	_	ADJ	JJ	_	5	amod	_	_
5	inhibitor	_	NOUN	NN	_	0	root	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	CYP2D6	_	NOUN	NN	_	5	nmod	_	_

#	Duloxetine	355
1	When	_	ADV	WRB	_	4	advmod	_	_
2	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
3	was	_	VERB	VBD	_	4	auxpass	_	_
4	administered	_	VERB	VBN	_	32	advcl	_	_
5	at	_	ADP	IN	_	7	case	_	_
6	a	_	DET	DT	_	7	det	_	_
7	dose	_	NOUN	NN	_	4	nmod	_	_
8	of	_	ADP	IN	_	10	case	_	_
9	60	_	NUM	CD	_	10	nummod	_	_
10	mg	_	NOUN	NN	_	7	nmod	_	_
11	twice	_	ADV	RB	_	12	advmod	_	_
12	daily	_	ADV	RB	_	4	advmod	_	_
13	in	_	ADP	IN	_	14	case	_	_
14	conjunction	_	NOUN	NN	_	12	nmod	_	_
15	with	_	ADP	IN	_	20	case	_	_
16	a	_	DET	DT	_	20	det	_	_
17	single	_	ADJ	JJ	_	20	amod	_	_
18	50	_	NUM	CD	_	20	nummod	_	_
19	mg	_	NOUN	NN	_	20	compound	_	_
20	dose	_	NOUN	NN	_	14	nmod	_	_
21	of	_	ADP	IN	_	22	case	_	_
22	desipramine	_	NOUN	NN	_	20	nmod	_	_
23	,	_	.	,	_	22	punct	_	_
24	a	_	DET	DT	_	26	det	_	_
25	CYP2D6	_	NOUN	NN	_	26	compound	_	_
26	substrate	_	NOUN	NN	_	22	appos	_	_
27	,	_	.	,	_	32	punct	_	_
28	the	_	DET	DT	_	29	det	_	_
29	AUC	_	NOUN	NN	_	32	nsubj	_	_
30	of	_	ADP	IN	_	31	case	_	_
31	desipramine	_	NOUN	NN	_	29	nmod	_	_
32	increased	_	VERB	VBD	_	0	root	_	_
33	3	_	NUM	CD	_	34	nummod	_	_
34	fold	_	VERB	MD	_	32	advmod	_	_

#	Duloxetine	356
1	Results	_	NOUN	NNS	_	6	nsubj	_	_
2	of	_	ADP	IN	_	5	case	_	_
3	in	_	X	FW	_	5	amod	_	_
4	vitro	_	X	FW	_	3	dep	_	_
5	studies	_	NOUN	NNS	_	1	nmod	_	_
6	demonstrate	_	VERB	VBP	_	0	root	_	_
7	that	_	ADP	IN	_	11	mark	_	_
8	DRUG	_	NOUN	NN	_	11	nsubj	_	_
9	does	_	VERB	VBZ	_	11	aux	_	_
10	not	_	ADV	RB	_	11	neg	_	_
11	inhibit	_	VERB	VB	_	6	ccomp	_	_
12	activity	_	NOUN	NN	_	11	dobj	_	_

#	Duloxetine	357
1	In	_	ADP	IN	_	4	case	_	_
2	a	_	DET	DT	_	4	det	_	_
3	clinical	_	ADJ	JJ	_	4	amod	_	_
4	study	_	NOUN	NN	_	19	nmod	_	_
5	,	_	.	,	_	19	punct	_	_
6	the	_	DET	DT	_	7	det	_	_
7	pharmacokinetics	_	NOUN	NNS	_	19	nsubjpass	_	_
8	of	_	ADP	IN	_	10	case	_	_
9	S	_	NOUN	NN	_	10	compound	_	_
10	warfarin	_	NOUN	NN	_	7	nmod	_	_
11	,	_	.	,	_	10	punct	_	_
12	a	_	DET	DT	_	14	det	_	_
13	CYP2C9	_	NOUN	NN	_	14	compound	_	_
14	substrate	_	NOUN	NN	_	10	appos	_	_
15	,	_	.	,	_	7	punct	_	_
16	were	_	VERB	VBD	_	19	auxpass	_	_
17	not	_	ADV	RB	_	19	neg	_	_
18	significantly	_	ADV	RB	_	19	advmod	_	_
19	affected	_	VERB	VBN	_	0	root	_	_
20	by	_	ADP	IN	_	21	case	_	_
21	DRUG	_	NOUN	NN	_	19	nmod	_	_

#	Duloxetine	358
1	Results	_	NOUN	NNS	_	6	nsubj	_	_
2	of	_	ADP	IN	_	5	case	_	_
3	in	_	X	FW	_	5	amod	_	_
4	vitro	_	X	FW	_	3	dep	_	_
5	studies	_	NOUN	NNS	_	1	nmod	_	_
6	demonstrate	_	VERB	VBP	_	0	root	_	_
7	that	_	ADP	IN	_	11	mark	_	_
8	DRUG	_	NOUN	NN	_	11	nsubj	_	_
9	does	_	VERB	VBZ	_	11	aux	_	_
10	not	_	ADV	RB	_	11	neg	_	_
11	inhibit	_	VERB	VB	_	6	ccomp	_	_
12	or	_	CONJ	CC	_	11	cc	_	_
13	induce	_	VERB	VB	_	11	conj	_	_
14	CYP3A	_	NOUN	NN	_	15	compound	_	_
15	activity	_	NOUN	NN	_	13	dobj	_	_

#	Duloxetine	359
1	Therefore	_	ADV	RB	_	28	advmod	_	_
2	,	_	.	,	_	28	punct	_	_
3	an	_	DET	DT	_	4	det	_	_
4	increase	_	NOUN	NN	_	28	nsubjpass	_	_
5	or	_	CONJ	CC	_	4	cc	_	_
6	decrease	_	NOUN	NN	_	4	conj	_	_
7	in	_	ADP	IN	_	9	case	_	_
8	the	_	DET	DT	_	9	det	_	_
9	metabolism	_	NOUN	NN	_	4	nmod	_	_
10	of	_	ADP	IN	_	12	case	_	_
11	CYP3A	_	NOUN	NN	_	12	compound	_	_
12	substrates	_	NOUN	NNS	_	9	nmod	_	_
13	e.g	_	NOUN	NN	_	12	dep	_	_
14	,	_	.	,	_	4	punct	_	_
15	oral	_	ADJ	JJ	_	16	amod	_	_
16	contraceptives	_	NOUN	NNS	_	4	conj	_	_
17	and	_	CONJ	CC	_	4	cc	_	_
18	other	_	ADJ	JJ	_	20	amod	_	_
19	steroidal	_	ADJ	JJ	_	20	amod	_	_
20	agents	_	NOUN	NNS	_	4	conj	_	_
21	resulting	_	VERB	VBG	_	20	acl	_	_
22	from	_	ADP	IN	_	23	case	_	_
23	induction	_	NOUN	NN	_	21	nmod	_	_
24	or	_	CONJ	CC	_	23	cc	_	_
25	inhibition	_	NOUN	NN	_	23	conj	_	_
26	is	_	VERB	VBZ	_	28	auxpass	_	_
27	not	_	ADV	RB	_	28	neg	_	_
28	anticipated	_	VERB	VBN	_	0	root	_	_
29	,	_	.	,	_	28	punct	_	_
30	although	_	ADP	IN	_	36	mark	_	_
31	clinical	_	ADJ	JJ	_	32	amod	_	_
32	studies	_	NOUN	NNS	_	36	nsubjpass	_	_
33	have	_	VERB	VBP	_	36	aux	_	_
34	not	_	ADV	RB	_	36	neg	_	_
35	been	_	VERB	VBN	_	36	auxpass	_	_
36	performed	_	VERB	VBN	_	28	advcl	_	_

#	Duloxetine	360
1	Results	_	NOUN	NNS	_	6	nsubj	_	_
2	of	_	ADP	IN	_	5	case	_	_
3	in	_	X	FW	_	5	amod	_	_
4	vitro	_	X	FW	_	3	dep	_	_
5	studies	_	NOUN	NNS	_	1	nmod	_	_
6	demonstrate	_	VERB	VBP	_	0	root	_	_
7	that	_	ADP	IN	_	11	mark	_	_
8	DRUG	_	NOUN	NN	_	11	nsubj	_	_
9	does	_	VERB	VBZ	_	11	aux	_	_
10	not	_	ADV	RB	_	11	neg	_	_
11	inhibit	_	VERB	VB	_	6	ccomp	_	_
12	CYP2C19	_	NOUN	NN	_	13	compound	_	_
13	activity	_	NOUN	NN	_	11	dobj	_	_
14	at	_	ADP	IN	_	16	case	_	_
15	therapeutic	_	ADJ	JJ	_	16	amod	_	_
16	concentrations	_	NOUN	NNS	_	11	nmod	_	_

#	Duloxetine	361
1	Inhibition	_	NOUN	NN	_	11	nsubjpass	_	_
2	of	_	ADP	IN	_	4	case	_	_
3	the	_	DET	DT	_	4	det	_	_
4	metabolism	_	NOUN	NN	_	1	nmod	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	CYP2C19	_	NOUN	NN	_	7	compound	_	_
7	substrates	_	NOUN	NNS	_	4	nmod	_	_
8	is	_	VERB	VBZ	_	11	auxpass	_	_
9	therefore	_	ADV	RB	_	11	advmod	_	_
10	not	_	ADV	RB	_	11	neg	_	_
11	anticipated	_	VERB	VBN	_	0	root	_	_
12	,	_	.	,	_	11	punct	_	_
13	although	_	ADP	IN	_	19	mark	_	_
14	clinical	_	ADJ	JJ	_	15	amod	_	_
15	studies	_	NOUN	NNS	_	19	nsubjpass	_	_
16	have	_	VERB	VBP	_	19	aux	_	_
17	not	_	ADV	RB	_	19	neg	_	_
18	been	_	VERB	VBN	_	19	auxpass	_	_
19	performed	_	VERB	VBN	_	11	advcl	_	_

#	Duloxetine	364
1	When	_	ADV	WRB	_	6	advmod	_	_
2	DRUG	_	NOUN	NN	_	6	nsubjpass	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	ethanol	_	NOUN	NN	_	2	conj	_	_
5	were	_	VERB	VBD	_	6	auxpass	_	_
6	administered	_	VERB	VBN	_	0	root	_	_
7	several	_	ADJ	JJ	_	8	amod	_	_
8	hours	_	NOUN	NNS	_	6	dobj	_	_
9	apart	_	ADJ	JJ	_	8	dep	_	_
10	so	_	ADV	RB	_	9	advmod	_	_
11	that	_	ADP	IN	_	22	mark	_	_
12	peak	_	ADJ	JJ	_	13	amod	_	_
13	concentrations	_	NOUN	NNS	_	22	nsubj	_	_
14	of	_	ADP	IN	_	17	case	_	_
15	each	_	DET	DT	_	17	det	_	_
16	would	_	VERB	MD	_	17	advmod	_	_
17	coincide	_	VERB	VB	_	13	nmod	_	_
18	,	_	.	,	_	22	punct	_	_
19	DRUG	_	NOUN	NN	_	22	nsubj	_	_
20	did	_	VERB	VBD	_	22	aux	_	_
21	not	_	ADV	RB	_	22	neg	_	_
22	increase	_	VERB	VB	_	9	ccomp	_	_
23	the	_	DET	DT	_	24	det	_	_
24	impairment	_	NOUN	NN	_	22	dobj	_	_
25	of	_	ADP	IN	_	29	case	_	_
26	mental	_	ADJ	JJ	_	29	amod	_	_
27	and	_	CONJ	CC	_	26	cc	_	_
28	motor	_	NOUN	NN	_	26	conj	_	_
29	skills	_	NOUN	NNS	_	24	nmod	_	_
30	caused	_	VERB	VBN	_	29	acl	_	_
31	by	_	ADP	IN	_	32	case	_	_
32	alcohol	_	NOUN	NN	_	30	nmod	_	_

#	Duloxetine	365
1	In	_	ADP	IN	_	6	case	_	_
2	the	_	DET	DT	_	6	det	_	_
3	DRUG	_	NOUN	NN	_	6	compound	_	_
4	clinical	_	ADJ	JJ	_	6	amod	_	_
5	trials	_	NOUN	NNS	_	6	compound	_	_
6	database	_	NOUN	NN	_	12	nmod	_	_
7	,	_	.	,	_	12	punct	_	_
8	three	_	NUM	CD	_	11	nummod	_	_
9	DRUG	_	NOUN	NN	_	11	compound	_	_
10	treated	_	ADJ	JJ	_	11	amod	_	_
11	patients	_	NOUN	NNS	_	12	nsubj	_	_
12	had	_	VERB	VBD	_	0	root	_	_
13	liver	_	NOUN	NN	_	14	compound	_	_
14	injury	_	NOUN	NN	_	12	dobj	_	_
15	as	_	ADP	IN	_	16	mark	_	_
16	manifested	_	VERB	VBN	_	12	advcl	_	_
17	by	_	ADP	IN	_	18	case	_	_
18	ALT	_	NOUN	NN	_	16	nmod	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	total	_	ADJ	JJ	_	22	amod	_	_
21	bilirubin	_	NOUN	NN	_	22	compound	_	_
22	elevations	_	NOUN	NNS	_	18	conj	_	_
23	,	_	.	,	_	12	punct	_	_
24	with	_	ADP	IN	_	25	case	_	_
25	evidence	_	NOUN	NN	_	12	nmod	_	_
26	of	_	ADP	IN	_	27	case	_	_
27	obstruction	_	NOUN	NN	_	25	nmod	_	_

#	Duloxetine	366
1	Substantial	_	ADJ	JJ	_	4	amod	_	_
2	intercurrent	_	ADJ	JJ	_	4	amod	_	_
3	ethanol	_	NOUN	NN	_	4	compound	_	_
4	use	_	NOUN	NN	_	6	nsubj	_	_
5	was	_	VERB	VBD	_	6	cop	_	_
6	present	_	ADJ	JJ	_	0	root	_	_
7	in	_	ADP	IN	_	8	case	_	_
8	each	_	DET	DT	_	6	nmod	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	these	_	DET	DT	_	11	det	_	_
11	cases	_	NOUN	NNS	_	8	nmod	_	_
12	,	_	.	,	_	6	punct	_	_
13	and	_	CONJ	CC	_	6	cc	_	_
14	this	_	DET	DT	_	17	nsubj	_	_
15	may	_	VERB	MD	_	17	aux	_	_
16	have	_	VERB	VB	_	17	aux	_	_
17	contributed	_	VERB	VBN	_	6	conj	_	_
18	to	_	PRT	TO	_	20	case	_	_
19	the	_	DET	DT	_	20	det	_	_
20	abnormalities	_	NOUN	NNS	_	17	nmod	_	_
21	seen	_	VERB	VBN	_	17	parataxis	_	_

#	Duloxetine	367
1	Because	_	ADP	IN	_	5	mark	_	_
2	DRUG	_	NOUN	NN	_	5	nsubjpass	_	_
3	is	_	VERB	VBZ	_	5	auxpass	_	_
4	highly	_	ADV	RB	_	5	advmod	_	_
5	bound	_	VERB	VBN	_	25	advcl	_	_
6	to	_	PRT	TO	_	8	case	_	_
7	plasma	_	NOUN	NN	_	8	compound	_	_
8	protein	_	NOUN	NN	_	5	nmod	_	_
9	,	_	.	,	_	25	punct	_	_
10	administration	_	NOUN	NN	_	25	nsubj	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_
13	to	_	PRT	TO	_	15	case	_	_
14	a	_	DET	DT	_	15	det	_	_
15	patient	_	NOUN	NN	_	10	nmod	_	_
16	taking	_	VERB	VBG	_	15	acl	_	_
17	another	_	DET	DT	_	18	det	_	_
18	drug	_	NOUN	NN	_	16	dobj	_	_
19	that	_	DET	WDT	_	23	nsubjpass	_	_
20	is	_	VERB	VBZ	_	23	auxpass	_	_
21	highly	_	ADV	RB	_	22	advmod	_	_
22	protein	_	NOUN	NN	_	23	nsubjpass	_	_
23	bound	_	VERB	VBN	_	18	acl:relcl	_	_
24	may	_	VERB	MD	_	25	aux	_	_
25	cause	_	VERB	VB	_	0	root	_	_
26	increased	_	VERB	VBN	_	28	amod	_	_
27	free	_	ADJ	JJ	_	28	amod	_	_
28	concentrations	_	NOUN	NNS	_	25	dobj	_	_
29	of	_	ADP	IN	_	32	case	_	_
30	the	_	DET	DT	_	32	det	_	_
31	other	_	ADJ	JJ	_	32	amod	_	_
32	drug	_	NOUN	NN	_	28	nmod	_	_
33	,	_	.	,	_	25	punct	_	_
34	potentially	_	ADV	RB	_	35	advmod	_	_
35	resulting	_	VERB	VBG	_	25	advcl	_	_
36	in	_	ADP	IN	_	38	case	_	_
37	adverse	_	ADJ	JJ	_	38	amod	_	_
38	reactions	_	NOUN	NNS	_	35	nmod	_	_

#	Duloxetine	368
1	However	_	ADV	RB	_	26	advmod	_	_
2	,	_	.	,	_	26	punct	_	_
3	co	_	PRT	TO	_	4	case	_	_
4	administration	_	NOUN	NN	_	26	nsubj	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	60	_	NUM	CD	_	6	nummod	_	_
8	or	_	CONJ	CC	_	6	cc	_	_
9	120	_	NUM	CD	_	10	nummod	_	_
10	mg	_	NOUN	NN	_	6	conj	_	_
11	with	_	ADP	IN	_	12	case	_	_
12	warfarin	_	NOUN	NN	_	4	nmod	_	_
13	2	_	NUM	CD	_	12	nummod	_	_
14	to	_	PRT	TO	_	16	case	_	_
15	9	_	NUM	CD	_	16	nummod	_	_
16	mg	_	NOUN	NN	_	4	nmod	_	_
17	,	_	.	,	_	16	punct	_	_
18	a	_	DET	DT	_	20	det	_	_
19	highly	_	ADV	RB	_	20	advmod	_	_
20	protein	_	NOUN	NN	_	16	appos	_	_
21	bound	_	VERB	VBN	_	20	acl	_	_
22	drug	_	NOUN	NN	_	21	xcomp	_	_
23	,	_	.	,	_	4	punct	_	_
24	did	_	VERB	MD	_	26	aux	_	_
25	not	_	ADV	RB	_	26	neg	_	_
26	result	_	VERB	VB	_	0	root	_	_
27	in	_	ADP	IN	_	29	case	_	_
28	significant	_	ADJ	JJ	_	29	amod	_	_
29	changes	_	NOUN	NNS	_	26	nmod	_	_
30	in	_	ADP	IN	_	31	case	_	_
31	INR	_	NOUN	NN	_	29	nmod	_	_
32	and	_	CONJ	CC	_	31	cc	_	_
33	in	_	ADP	IN	_	35	case	_	_
34	the	_	DET	DT	_	35	det	_	_
35	pharmacokinetics	_	NOUN	NNS	_	31	conj	_	_
36	of	_	ADP	IN	_	39	case	_	_
37	either	_	CONJ	CC	_	39	cc:preconj	_	_
38	total	_	ADJ	JJ	_	39	amod	_	_
39	S	_	NOUN	NN	_	35	nmod	_	_
40	or	_	CONJ	CC	_	39	cc	_	_
41	total	_	ADJ	JJ	_	44	amod	_	_
42	R	_	NOUN	NN	_	44	compound	_	_
43	warfarin	_	NOUN	NN	_	44	compound	_	_
44	protein	_	NOUN	NN	_	39	conj	_	_
45	bound	_	VERB	VBN	_	44	dep	_	_
46	plus	_	CONJ	CC	_	45	cc	_	_
47	free	_	ADJ	JJ	_	48	amod	_	_
48	drug	_	NOUN	NN	_	45	conj	_	_

#	Duloxetine	369
1	Although	_	ADP	IN	_	20	mark	_	_
2	the	_	DET	DT	_	4	det	_	_
3	exact	_	ADJ	JJ	_	4	amod	_	_
4	mechanisms	_	NOUN	NNS	_	20	nmod	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	antidepressant	_	ADJ	JJ	_	4	nmod	_	_
8	,	_	.	,	_	20	punct	_	_
9	central	_	ADJ	JJ	_	11	amod	_	_
10	pain	_	NOUN	NN	_	11	compound	_	_
11	inhibitory	_	ADJ	JJ	_	14	amod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	anxiolytic	_	ADJ	JJ	_	11	conj	_	_
14	actions	_	NOUN	NNS	_	20	nsubj	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	14	nmod	_	_
17	in	_	ADP	IN	_	18	case	_	_
18	humans	_	NOUN	NNS	_	14	nmod	_	_
19	are	_	VERB	VBP	_	20	cop	_	_
20	unknown	_	ADJ	JJ	_	25	advcl	_	_
21	,	_	.	,	_	25	punct	_	_
22	these	_	DET	DT	_	23	det	_	_
23	actions	_	NOUN	NNS	_	25	nsubjpass	_	_
24	are	_	VERB	VBP	_	25	auxpass	_	_
25	believed	_	VERB	VBN	_	0	root	_	_
26	to	_	PRT	TO	_	28	mark	_	_
27	be	_	VERB	VB	_	28	cop	_	_
28	related	_	ADJ	JJ	_	25	xcomp	_	_
29	to	_	PRT	TO	_	31	case	_	_
30	its	_	PRON	PRP$	_	31	nmod:poss	_	_
31	potentiation	_	NOUN	NN	_	28	nmod	_	_
32	of	_	ADP	IN	_	36	case	_	_
33	serotonergic	_	ADJ	JJ	_	36	amod	_	_
34	and	_	CONJ	CC	_	33	cc	_	_
35	noradrenergic	_	ADJ	JJ	_	33	conj	_	_
36	activity	_	NOUN	NN	_	31	nmod	_	_
37	in	_	ADP	IN	_	39	case	_	_
38	the	_	DET	DT	_	39	det	_	_
39	CNS	_	NOUN	NN	_	36	nmod	_	_

#	Duloxetine	370
1	Preclinical	_	ADJ	JJ	_	2	amod	_	_
2	studies	_	NOUN	NNS	_	4	nsubj	_	_
3	have	_	VERB	VBP	_	4	aux	_	_
4	shown	_	VERB	VBN	_	0	root	_	_
5	that	_	ADP	IN	_	10	mark	_	_
6	DRUG	_	NOUN	NN	_	10	nsubj	_	_
7	is	_	VERB	VBZ	_	10	cop	_	_
8	a	_	DET	DT	_	10	det	_	_
9	potent	_	ADJ	JJ	_	10	amod	_	_
10	inhibitor	_	NOUN	NN	_	4	ccomp	_	_
11	of	_	ADP	IN	_	13	case	_	_
12	neuronal	_	ADJ	JJ	_	13	amod	_	_
13	serotonin	_	NOUN	NN	_	10	nmod	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	norepinephrine	_	NOUN	NN	_	16	compound	_	_
16	reuptake	_	NOUN	NN	_	13	conj	_	_
17	and	_	CONJ	CC	_	10	cc	_	_
18	a	_	DET	DT	_	21	det	_	_
19	less	_	ADV	RB	_	20	advmod	_	_
20	potent	_	ADJ	JJ	_	21	amod	_	_
21	inhibitor	_	NOUN	NN	_	10	conj	_	_
22	of	_	ADP	IN	_	24	case	_	_
23	dopamine	_	NOUN	NN	_	24	compound	_	_
24	reuptake	_	NOUN	NN	_	21	nmod	_	_

#	Duloxetine	371
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	has	_	VERB	VBZ	_	0	root	_	_
3	no	_	DET	DT	_	5	neg	_	_
4	significant	_	ADJ	JJ	_	5	amod	_	_
5	affinity	_	NOUN	NN	_	2	dobj	_	_
6	for	_	ADP	IN	_	21	case	_	_
7	dopaminergic	_	ADJ	JJ	_	21	amod	_	_
8	,	_	.	,	_	7	punct	_	_
9	adrenergic	_	ADJ	JJ	_	7	conj	_	_
10	,	_	.	,	_	7	punct	_	_
11	cholinergic	_	ADJ	JJ	_	7	conj	_	_
12	,	_	.	,	_	7	punct	_	_
13	histaminergic	_	ADJ	JJ	_	7	conj	_	_
14	,	_	.	,	_	7	punct	_	_
15	opioid	_	ADJ	JJ	_	7	conj	_	_
16	,	_	.	,	_	7	punct	_	_
17	glutamate	_	NOUN	NN	_	7	conj	_	_
18	,	_	.	,	_	7	punct	_	_
19	and	_	CONJ	CC	_	7	cc	_	_
20	GABA	_	NOUN	NN	_	7	conj	_	_
21	receptors	_	NOUN	NNS	_	5	nmod	_	_
22	in	_	X	FW	_	23	compound	_	_
23	vitro	_	X	FW	_	2	advmod	_	_

#	Duloxetine	372
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	does	_	VERB	VBZ	_	4	aux	_	_
3	not	_	ADV	RB	_	4	neg	_	_
4	inhibit	_	VERB	VB	_	0	root	_	_
5	monoamine	_	NOUN	NN	_	7	compound	_	_
6	oxidase	_	NOUN	NN	_	7	compound	_	_
7	MAO	_	NOUN	NN	_	4	dobj	_	_

#	Duloxetine	373
1	DRUG	_	NOUN	NN	_	5	nsubj	_	_
2	is	_	VERB	VBZ	_	5	cop	_	_
3	in	_	ADP	IN	_	5	case	_	_
4	a	_	DET	DT	_	5	det	_	_
5	class	_	NOUN	NN	_	0	root	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	drugs	_	NOUN	NNS	_	5	nmod	_	_
8	known	_	VERB	VBN	_	7	acl	_	_
9	to	_	PRT	TO	_	10	mark	_	_
10	affect	_	VERB	VB	_	8	xcomp	_	_
11	urethral	_	ADJ	JJ	_	12	amod	_	_
12	resistance	_	NOUN	NN	_	10	dobj	_	_

#	Duloxetine	374
1	If	_	ADP	IN	_	2	case	_	_
2	symptoms	_	NOUN	NNS	_	6	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	urinary	_	ADJ	JJ	_	5	amod	_	_
5	hesitation	_	NOUN	NN	_	2	nmod	_	_
6	develop	_	VERB	VBP	_	15	advcl	_	_
7	during	_	ADP	IN	_	8	case	_	_
8	treatment	_	NOUN	NN	_	6	nmod	_	_
9	with	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	,	_	.	,	_	15	punct	_	_
12	consideration	_	NOUN	NN	_	15	nsubjpass	_	_
13	should	_	VERB	MD	_	15	aux	_	_
14	be	_	VERB	VB	_	15	auxpass	_	_
15	given	_	VERB	VBN	_	0	root	_	_
16	to	_	PRT	TO	_	18	case	_	_
17	the	_	DET	DT	_	18	det	_	_
18	possibility	_	NOUN	NN	_	15	nmod	_	_
19	that	_	ADP	IN	_	24	mark	_	_
20	they	_	PRON	PRP	_	24	nsubj	_	_
21	might	_	VERB	MD	_	24	aux	_	_
22	be	_	VERB	VB	_	24	cop	_	_
23	drug	_	NOUN	NN	_	24	nmod:npmod	_	_
24	related	_	ADJ	JJ	_	18	ccomp	_	_

#	Duloxetine	375
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	has	_	VERB	VBZ	_	0	root	_	_
3	an	_	DET	DT	_	6	det	_	_
4	elimination	_	NOUN	NN	_	6	compound	_	_
5	half	_	NOUN	NN	_	6	compound	_	_
6	life	_	NOUN	NN	_	2	dobj	_	_
7	of	_	ADP	IN	_	10	case	_	_
8	about	_	ADV	RB	_	9	advmod	_	_
9	12	_	NUM	CD	_	10	nummod	_	_
10	hours	_	NOUN	NNS	_	6	nmod	_	_
11	range	_	NOUN	NN	_	14	advmod	_	_
12	8	_	NUM	CD	_	14	compound	_	_
13	to	_	PRT	TO	_	14	dep	_	_
14	17	_	NUM	CD	_	15	nummod	_	_
15	hours	_	NOUN	NNS	_	6	dep	_	_
16	and	_	CONJ	CC	_	2	cc	_	_
17	its	_	PRON	PRP$	_	18	nmod:poss	_	_
18	pharmacokinetics	_	NOUN	NNS	_	21	nsubj	_	_
19	are	_	VERB	VBP	_	21	cop	_	_
20	dose	_	NOUN	NN	_	21	nmod:npmod	_	_
21	proportional	_	ADJ	JJ	_	2	conj	_	_
22	over	_	ADP	IN	_	25	case	_	_
23	the	_	DET	DT	_	25	det	_	_
24	therapeutic	_	ADJ	JJ	_	25	amod	_	_
25	range	_	NOUN	NN	_	21	nmod	_	_

#	Duloxetine	376
1	Steady	_	ADJ	JJ	_	4	amod	_	_
2	state	_	NOUN	NN	_	4	compound	_	_
3	plasma	_	NOUN	NN	_	4	compound	_	_
4	concentrations	_	NOUN	NNS	_	7	nsubjpass	_	_
5	are	_	VERB	VBP	_	7	auxpass	_	_
6	typically	_	ADV	RB	_	7	advmod	_	_
7	achieved	_	VERB	VBN	_	0	root	_	_
8	after	_	ADP	IN	_	10	case	_	_
9	3	_	NUM	CD	_	10	nummod	_	_
10	days	_	NOUN	NNS	_	7	nmod	_	_
11	of	_	ADP	IN	_	12	mark	_	_
12	dosing	_	VERB	VBG	_	10	acl	_	_

#	Duloxetine	377
1	Elimination	_	NOUN	NN	_	8	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	is	_	VERB	VBZ	_	8	cop	_	_
5	mainly	_	ADV	RB	_	8	advmod	_	_
6	through	_	ADP	IN	_	8	case	_	_
7	hepatic	_	ADJ	JJ	_	8	amod	_	_
8	metabolism	_	NOUN	NN	_	0	root	_	_
9	involving	_	VERB	VBG	_	8	acl	_	_
10	two	_	NUM	CD	_	12	nummod	_	_
11	P450	_	NOUN	NN	_	12	compound	_	_
12	isozymes	_	NOUN	NNS	_	9	dobj	_	_
13	,	_	.	,	_	12	punct	_	_
14	CYP1A2	_	NOUN	NN	_	12	appos	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	CYP2D6	_	NOUN	NN	_	14	conj	_	_

#	Duloxetine	378
1	Absorption	_	NOUN	NN	_	5	nsubj	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	Distribution	_	NOUN	NN	_	1	conj	_	_
4	Orally	_	ADV	RB	_	5	advmod	_	_
5	administered	_	VERB	VBD	_	10	nsubjpass	_	_
6	DRUG	_	NOUN	NN	_	7	compound	_	_
7	hydrochloride	_	NOUN	NN	_	5	dobj	_	_
8	is	_	VERB	VBZ	_	10	auxpass	_	_
9	well	_	ADV	RB	_	10	advmod	_	_
10	absorbed	_	VERB	VBN	_	0	root	_	_

#	Duloxetine	379
1	There	_	DET	EX	_	2	expl	_	_
2	is	_	VERB	VBZ	_	0	root	_	_
3	a	_	DET	DT	_	7	det	_	_
4	median	_	ADJ	JJ	_	7	amod	_	_
5	2	_	NUM	CD	_	7	nummod	_	_
6	hour	_	NUM	CD	_	7	nummod	_	_
7	lag	_	NOUN	NN	_	2	nsubj	_	_
8	until	_	ADP	IN	_	9	case	_	_
9	absorption	_	NOUN	NN	_	2	nmod	_	_
10	begins	_	VERB	VBZ	_	11	amod	_	_
11	Tlag	_	NOUN	NN	_	2	nsubj	_	_
12	,	_	.	,	_	2	punct	_	_
13	with	_	ADP	IN	_	16	case	_	_
14	maximal	_	ADJ	JJ	_	16	amod	_	_
15	plasma	_	NOUN	NN	_	16	compound	_	_
16	concentrations	_	NOUN	NNS	_	2	nmod	_	_
17	Cmax	_	NOUN	NN	_	16	dep	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	DRUG	_	NOUN	NN	_	17	nmod	_	_
20	occurring	_	VERB	VBG	_	19	acl	_	_
21	6	_	NUM	CD	_	22	nummod	_	_
22	hours	_	NOUN	NNS	_	20	dobj	_	_
23	post	_	ADJ	JJ	_	24	compound	_	_
24	dose	_	NOUN	NN	_	22	dep	_	_

#	Duloxetine	380
1	Food	_	NOUN	NN	_	4	nsubj	_	_
2	does	_	VERB	VBZ	_	4	aux	_	_
3	not	_	ADV	RB	_	4	neg	_	_
4	affect	_	VERB	VB	_	0	root	_	_
5	the	_	DET	DT	_	6	det	_	_
6	Cmax	_	NOUN	NN	_	4	dobj	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	,	_	.	,	_	4	punct	_	_
10	but	_	CONJ	CC	_	4	cc	_	_
11	delays	_	VERB	VBZ	_	4	conj	_	_
12	the	_	DET	DT	_	13	det	_	_
13	time	_	NOUN	NN	_	11	dobj	_	_
14	to	_	PRT	TO	_	15	mark	_	_
15	reach	_	VERB	VB	_	11	xcomp	_	_
16	peak	_	ADJ	JJ	_	17	amod	_	_
17	concentration	_	NOUN	NN	_	15	dobj	_	_
18	from	_	ADP	IN	_	22	case	_	_
19	6	_	NUM	CD	_	21	compound	_	_
20	to	_	PRT	TO	_	21	dep	_	_
21	10	_	NUM	CD	_	22	nummod	_	_
22	hours	_	NOUN	NNS	_	17	nmod	_	_
23	and	_	CONJ	CC	_	11	cc	_	_
24	it	_	PRON	PRP	_	26	nsubj	_	_
25	marginally	_	ADV	RB	_	26	advmod	_	_
26	decreases	_	VERB	VBZ	_	11	conj	_	_
27	the	_	DET	DT	_	28	det	_	_
28	extent	_	NOUN	NN	_	26	dobj	_	_
29	of	_	ADP	IN	_	31	case	_	_
30	absorption	_	NOUN	NN	_	31	compound	_	_
31	AUC	_	NOUN	NN	_	28	nmod	_	_
32	by	_	ADP	IN	_	34	case	_	_
33	about	_	ADV	RB	_	34	advmod	_	_
34	10%	_	ADJ	JJ	_	28	nmod	_	_

#	Duloxetine	381
1	There	_	DET	EX	_	2	expl	_	_
2	is	_	VERB	VBZ	_	0	root	_	_
3	a	_	DET	DT	_	6	det	_	_
4	3	_	NUM	CD	_	6	nummod	_	_
5	hour	_	NUM	CD	_	6	nummod	_	_
6	delay	_	NOUN	NN	_	2	nsubj	_	_
7	in	_	ADP	IN	_	8	case	_	_
8	absorption	_	NOUN	NN	_	2	nmod	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	a	_	DET	DT	_	13	det	_	_
11	one	_	NUM	CD	_	13	nummod	_	_
12	third	_	ADJ	JJ	_	13	amod	_	_
13	increase	_	NOUN	NN	_	8	conj	_	_
14	in	_	ADP	IN	_	16	case	_	_
15	apparent	_	ADJ	JJ	_	16	amod	_	_
16	clearance	_	NOUN	NN	_	8	nmod	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	DRUG	_	NOUN	NN	_	16	nmod	_	_
19	after	_	ADP	IN	_	22	case	_	_
20	an	_	DET	DT	_	22	det	_	_
21	evening	_	VERB	VBG	_	22	amod	_	_
22	dose	_	NOUN	NN	_	16	nmod	_	_
23	as	_	ADP	IN	_	24	mark	_	_
24	compared	_	VERB	VBN	_	2	advcl	_	_
25	to	_	PRT	TO	_	28	case	_	_
26	a	_	DET	DT	_	28	det	_	_
27	morning	_	NOUN	NN	_	28	compound	_	_
28	dose	_	NOUN	NN	_	24	nmod	_	_

#	Duloxetine	382
1	The	_	DET	DT	_	3	det	_	_
2	apparent	_	ADJ	JJ	_	3	amod	_	_
3	volume	_	NOUN	NN	_	6	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	distribution	_	NOUN	NN	_	3	nmod	_	_
6	averages	_	VERB	VBZ	_	12	aux	_	_
7	about	_	ADV	RB	_	9	advmod	_	_
8	1640L	_	NOUN	NN	_	9	compound	_	_
9	DRUG	_	NOUN	NN	_	6	nmod	_	_
10	is	_	VERB	VBZ	_	12	auxpass	_	_
11	highly	_	ADV	RB	_	12	advmod	_	_
12	bound	_	VERB	VBN	_	0	root	_	_
13	>90%	_	NOUN	NN	_	12	xcomp	_	_
14	to	_	PRT	TO	_	15	case	_	_
15	proteins	_	NOUN	NNS	_	13	nmod	_	_
16	in	_	ADP	IN	_	18	case	_	_
17	human	_	ADJ	JJ	_	18	amod	_	_
18	plasma	_	NOUN	NN	_	15	nmod	_	_
19	,	_	.	,	_	12	punct	_	_
20	binding	_	VERB	VBG	_	12	xcomp	_	_
21	primarily	_	ADV	RB	_	23	advmod	_	_
22	to	_	PRT	TO	_	23	case	_	_
23	albumin	_	NOUN	NN	_	20	nmod	_	_
24	and	_	CONJ	CC	_	23	cc	_	_
25	A1	_	NOUN	NN	_	27	compound	_	_
26	acid	_	NOUN	NN	_	27	compound	_	_
27	glycoprotein	_	NOUN	NN	_	23	conj	_	_

#	Duloxetine	383
1	The	_	DET	DT	_	2	det	_	_
2	interaction	_	NOUN	NN	_	15	nsubjpass	_	_
3	between	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	other	_	ADJ	JJ	_	10	amod	_	_
7	highly	_	ADV	RB	_	10	advmod	_	_
8	protein	_	NOUN	NN	_	10	compound	_	_
9	bound	_	ADJ	JJ	_	10	amod	_	_
10	drugs	_	NOUN	NNS	_	4	conj	_	_
11	has	_	VERB	VBZ	_	15	aux	_	_
12	not	_	ADV	RB	_	15	neg	_	_
13	been	_	VERB	VBN	_	15	auxpass	_	_
14	fully	_	ADV	RB	_	15	advmod	_	_
15	evaluated	_	VERB	VBN	_	0	root	_	_

#	Duloxetine	384
1	Plasma	_	NOUN	NN	_	3	compound	_	_
2	protein	_	NOUN	NN	_	3	compound	_	_
3	binding	_	NOUN	NN	_	8	nsubjpass	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	is	_	VERB	VBZ	_	8	auxpass	_	_
7	not	_	ADV	RB	_	8	neg	_	_
8	affected	_	VERB	VBN	_	0	root	_	_
9	by	_	ADP	IN	_	13	case	_	_
10	renal	_	ADJ	JJ	_	13	amod	_	_
11	or	_	CONJ	CC	_	10	cc	_	_
12	hepatic	_	ADJ	JJ	_	10	conj	_	_
13	impairment	_	NOUN	NN	_	8	nmod	_	_

#	Duloxetine	385
1	Metabolism	_	NOUN	NN	_	13	nsubjpass	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	Elimination	_	NOUN	NN	_	4	compound	_	_
4	Biotransformation	_	NOUN	NN	_	1	conj	_	_
5	and	_	CONJ	CC	_	1	cc	_	_
6	disposition	_	NOUN	NN	_	1	conj	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	in	_	ADP	IN	_	10	case	_	_
10	humans	_	NOUN	NNS	_	1	nmod	_	_
11	have	_	VERB	VBP	_	13	aux	_	_
12	been	_	VERB	VBN	_	13	auxpass	_	_
13	determined	_	VERB	VBN	_	0	root	_	_
14	following	_	VERB	VBG	_	16	case	_	_
15	oral	_	ADJ	JJ	_	16	amod	_	_
16	administration	_	NOUN	NN	_	13	nmod	_	_
17	of	_	ADP	IN	_	20	case	_	_
18	14C	_	NOUN	NN	_	20	compound	_	_
19	labeled	_	VERB	VBN	_	20	amod	_	_
20	DRUG	_	NOUN	NN	_	16	nmod	_	_

#	Duloxetine	386
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	comprises	_	VERB	VBZ	_	0	root	_	_
3	about	_	ADV	RB	_	4	advmod	_	_
4	3%	_	NOUN	NN	_	2	dobj	_	_
5	of	_	ADP	IN	_	9	case	_	_
6	the	_	DET	DT	_	9	det	_	_
7	total	_	ADJ	JJ	_	9	amod	_	_
8	radiolabeled	_	VERB	VBN	_	9	amod	_	_
9	material	_	NOUN	NN	_	4	nmod	_	_
10	in	_	ADP	IN	_	12	case	_	_
11	the	_	DET	DT	_	12	det	_	_
12	plasma	_	NOUN	NN	_	9	nmod	_	_
13	,	_	.	,	_	2	punct	_	_
14	indicating	_	VERB	VBG	_	2	advcl	_	_
15	that	_	ADP	IN	_	17	mark	_	_
16	it	_	PRON	PRP	_	17	nsubj	_	_
17	undergoes	_	VERB	VBZ	_	14	ccomp	_	_
18	extensive	_	ADJ	JJ	_	19	amod	_	_
19	metabolism	_	NOUN	NN	_	17	dobj	_	_
20	to	_	PRT	TO	_	22	case	_	_
21	numerous	_	ADJ	JJ	_	22	amod	_	_
22	metabolites	_	NOUN	NNS	_	19	nmod	_	_

#	Duloxetine	387
1	The	_	DET	DT	_	4	det	_	_
2	major	_	ADJ	JJ	_	4	amod	_	_
3	biotransformation	_	NOUN	NN	_	4	compound	_	_
4	pathways	_	NOUN	NNS	_	7	nsubj	_	_
5	for	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	involve	_	VERB	VBP	_	0	root	_	_
8	oxidation	_	NOUN	NN	_	7	dobj	_	_
9	of	_	ADP	IN	_	12	case	_	_
10	the	_	DET	DT	_	12	det	_	_
11	naphthyl	_	ADJ	JJ	_	12	amod	_	_
12	ring	_	NOUN	NN	_	8	nmod	_	_
13	followed	_	VERB	VBN	_	12	acl	_	_
14	by	_	ADP	IN	_	15	case	_	_
15	conjugation	_	NOUN	NN	_	13	nmod	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	further	_	ADJ	JJ	_	18	amod	_	_
18	oxidation	_	NOUN	NN	_	15	conj	_	_

#	Duloxetine	388
1	Both	_	CONJ	CC	_	2	cc:preconj	_	_
2	CYP1A2	_	NOUN	NN	_	5	nsubj	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	CYP2D6	_	NOUN	NN	_	2	conj	_	_
5	catalyze	_	VERB	VBP	_	0	root	_	_
6	the	_	DET	DT	_	7	det	_	_
7	oxidation	_	NOUN	NN	_	5	dobj	_	_
8	of	_	ADP	IN	_	11	case	_	_
9	the	_	DET	DT	_	11	det	_	_
10	naphthyl	_	ADJ	JJ	_	11	amod	_	_
11	ring	_	NOUN	NN	_	7	nmod	_	_
12	in	_	NOUN	NN	_	13	compound	_	_
13	vitro	_	X	FW	_	7	advmod	_	_

#	Duloxetine	389
1	Metabolites	_	NOUN	NNS	_	5	nsubj	_	_
2	found	_	VERB	VBN	_	1	acl	_	_
3	in	_	ADP	IN	_	4	case	_	_
4	plasma	_	NOUN	NN	_	2	nmod	_	_
5	include	_	VERB	VBP	_	0	root	_	_
6	4	_	NUM	CD	_	9	nummod	_	_
7	hydroxy	_	NOUN	NN	_	9	amod	_	_
8	DRUG	_	NOUN	NN	_	9	compound	_	_
9	glucuronide	_	NOUN	NN	_	5	dobj	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	5	_	NUM	CD	_	12	nummod	_	_
12	hydroxy	_	NOUN	NN	_	9	conj	_	_
13	,	_	.	,	_	9	punct	_	_
14	6	_	NUM	CD	_	17	nummod	_	_
15	methoxy	_	NOUN	NN	_	17	compound	_	_
16	DRUG	_	NOUN	NN	_	17	compound	_	_
17	sulfate	_	NOUN	NN	_	9	appos	_	_

#	Duloxetine	390
1	Many	_	ADJ	JJ	_	3	amod	_	_
2	additional	_	ADJ	JJ	_	3	amod	_	_
3	metabolites	_	NOUN	NNS	_	6	nsubjpass	_	_
4	have	_	VERB	VBP	_	6	aux	_	_
5	been	_	VERB	VBN	_	6	auxpass	_	_
6	identified	_	VERB	VBN	_	0	root	_	_
7	in	_	ADP	IN	_	8	case	_	_
8	urine	_	ADJ	JJ	_	6	nmod	_	_
9	,	_	.	,	_	8	punct	_	_
10	some	_	DET	DT	_	14	det	_	_
11	representing	_	VERB	VBG	_	14	amod	_	_
12	only	_	ADV	RB	_	13	advmod	_	_
13	minor	_	ADJ	JJ	_	14	amod	_	_
14	pathways	_	NOUN	NNS	_	8	appos	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	elimination	_	NOUN	NN	_	14	nmod	_	_

#	Duloxetine	391
1	Only	_	ADV	RB	_	3	advmod	_	_
2	trace	_	NOUN	NN	_	3	compound	_	_
3	<1%	_	NOUN	NN	_	12	nsubj	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	the	_	DET	DT	_	7	det	_	_
6	dose	_	NOUN	NN	_	7	compound	_	_
7	amounts	_	NOUN	NNS	_	3	nmod	_	_
8	of	_	ADP	IN	_	10	case	_	_
9	unchanged	_	ADJ	JJ	_	10	amod	_	_
10	DRUG	_	NOUN	NN	_	7	nmod	_	_
11	are	_	VERB	VBP	_	12	cop	_	_
12	present	_	ADJ	JJ	_	0	root	_	_
13	in	_	ADP	IN	_	15	case	_	_
14	the	_	DET	DT	_	15	det	_	_
15	urine	_	VERB	VBG	_	12	nmod	_	_

#	Duloxetine	392
1	Most	_	ADV	RB	_	2	advmod	_	_
2	about	_	ADV	RB	_	3	advmod	_	_
3	70%	_	NOUN	NN	_	8	nsubj	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	the	_	DET	DT	_	7	det	_	_
6	DRUG	_	NOUN	NN	_	7	compound	_	_
7	dose	_	NOUN	NN	_	3	nmod	_	_
8	appears	_	VERB	VBZ	_	0	root	_	_
9	in	_	ADP	IN	_	11	case	_	_
10	the	_	DET	DT	_	11	det	_	_
11	urine	_	ADJ	JJ	_	8	nmod	_	_
12	as	_	ADP	IN	_	13	case	_	_
13	metabolites	_	NOUN	NNS	_	8	nmod	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	DRUG	_	NOUN	NN	_	13	nmod	_	_
16	about	_	ADV	RB	_	17	case	_	_
17	20%	_	NOUN	NN	_	13	nmod	_	_
18	is	_	VERB	VBZ	_	19	auxpass	_	_
19	excreted	_	VERB	VBN	_	8	parataxis	_	_
20	in	_	ADP	IN	_	22	case	_	_
21	the	_	DET	DT	_	22	det	_	_
22	feces	_	NOUN	NNS	_	19	nmod	_	_

#	Duloxetine	393
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	undergoes	_	VERB	VBZ	_	0	root	_	_
3	extensive	_	ADJ	JJ	_	4	amod	_	_
4	metabolism	_	NOUN	NN	_	2	dobj	_	_
5	,	_	.	,	_	2	punct	_	_
6	but	_	CONJ	CC	_	2	cc	_	_
7	the	_	DET	DT	_	10	det	_	_
8	major	_	ADJ	JJ	_	10	amod	_	_
9	circulating	_	ADJ	JJ	_	10	amod	_	_
10	metabolites	_	NOUN	NNS	_	14	nsubjpass	_	_
11	have	_	VERB	VBP	_	14	aux	_	_
12	not	_	ADV	RB	_	14	neg	_	_
13	been	_	VERB	VBN	_	14	auxpass	_	_
14	shown	_	VERB	VBN	_	2	conj	_	_
15	to	_	PRT	TO	_	16	mark	_	_
16	contribute	_	VERB	VB	_	14	xcomp	_	_
17	significantly	_	ADV	RB	_	16	advmod	_	_
18	to	_	PRT	TO	_	21	case	_	_
19	the	_	DET	DT	_	21	det	_	_
20	pharmacologic	_	ADJ	JJ	_	21	amod	_	_
21	activity	_	NOUN	NN	_	16	nmod	_	_
22	of	_	ADP	IN	_	23	case	_	_
23	DRUG	_	NOUN	NN	_	21	nmod	_	_

#	Duloxetine	394
1	Pediatric	_	ADJ	JJ	_	3	amod	_	_
2	use	_	NOUN	NN	_	3	compound	_	_
3	information	_	NOUN	NN	_	6	nsubj	_	_
4	for	_	ADP	IN	_	5	case	_	_
5	patients	_	NOUN	NNS	_	3	nmod	_	_
6	ages	_	VERB	VBZ	_	0	root	_	_
7	7	_	NUM	CD	_	9	compound	_	_
8	to	_	PRT	TO	_	9	dep	_	_
9	17	_	NUM	CD	_	10	nummod	_	_
10	years	_	NOUN	NNS	_	6	dobj	_	_
11	is	_	VERB	VBZ	_	12	auxpass	_	_
12	approved	_	VERB	VBN	_	6	advcl	_	_
13	for	_	ADP	IN	_	15	case	_	_
14	Eli	_	NOUN	NN	_	15	compound	_	_
15	Lilly	_	NOUN	NN	_	12	nmod	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	Company	_	ADJ	JJ	_	15	conj	_	_
18	,	_	.	,	_	6	punct	_	_
19	Inc.'s	_	NOUN	NNS	_	6	dobj	_	_
20	CYMBALTA	_	NOUN	NN	_	25	compound	_	_
21	*	_	NUM	CD	_	25	nummod	_	_
22	DRUG	_	NOUN	NN	_	25	compound	_	_
23	delayed	_	ADJ	JJ	_	25	amod	_	_
24	release	_	NOUN	NN	_	25	compound	_	_
25	capsules	_	NOUN	NNS	_	19	nmod	_	_

#	Duloxetine	395
1	However	_	ADV	RB	_	20	advmod	_	_
2	,	_	.	,	_	20	punct	_	_
3	due	_	ADJ	JJ	_	6	case	_	_
4	to	_	PRT	TO	_	3	mwe	_	_
5	Eli	_	NOUN	NN	_	6	compound	_	_
6	Lilly	_	NOUN	NN	_	20	nmod	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	Company	_	NOUN	NN	_	6	conj	_	_
9	,	_	.	,	_	20	punct	_	_
10	Inc.'s	_	NOUN	NNS	_	20	nmod	_	_
11	marketing	_	VERB	VBG	_	10	acl	_	_
12	exclusivity	_	NOUN	NN	_	13	compound	_	_
13	rights	_	NOUN	NNS	_	11	dobj	_	_
14	,	_	.	,	_	20	punct	_	_
15	this	_	DET	DT	_	17	det	_	_
16	drug	_	NOUN	NN	_	17	compound	_	_
17	product	_	NOUN	NN	_	20	nsubjpass	_	_
18	is	_	VERB	VBZ	_	20	auxpass	_	_
19	not	_	ADV	RB	_	20	neg	_	_
20	labeled	_	VERB	VBN	_	0	root	_	_
21	with	_	ADP	IN	_	22	case	_	_
22	that	_	ADP	IN	_	20	nmod	_	_
23	pediatric	_	ADJ	JJ	_	24	amod	_	_
24	information	_	NOUN	NN	_	22	root	_	_

#	EMSAM	16
1	Serious	_	ADJ	JJ	_	3	advmod	_	_
2	,	_	.	,	_	3	punct	_	_
3	sometimes	_	VERB	VBZ	_	0	root	_	_
4	fatal	_	ADJ	JJ	_	10	amod	_	_
5	,	_	.	,	_	4	punct	_	_
6	central	_	ADJ	JJ	_	4	dep	_	_
7	nervous	_	ADJ	JJ	_	10	amod	_	_
8	system	_	NOUN	NN	_	10	compound	_	_
9	CNS	_	NOUN	NN	_	10	compound	_	_
10	toxicity	_	NOUN	NN	_	3	dobj	_	_
11	referred	_	VERB	VBN	_	10	acl	_	_
12	to	_	PRT	TO	_	16	case	_	_
13	as	_	ADP	IN	_	16	case	_	_
14	the	_	DET	DT	_	16	det	_	_
15	"serotonin	_	NOUN	NN	_	16	compound	_	_
16	syndrome"	_	NOUN	NN	_	11	nmod	_	_
17	has	_	VERB	VBZ	_	19	aux	_	_
18	been	_	VERB	VBN	_	19	auxpass	_	_
19	reported	_	VERB	VBN	_	3	parataxis	_	_
20	with	_	ADP	IN	_	22	case	_	_
21	the	_	DET	DT	_	22	det	_	_
22	combination	_	NOUN	NN	_	19	nmod	_	_
23	of	_	ADP	IN	_	25	case	_	_
24	nonselective	_	ADJ	JJ	_	25	amod	_	_
25	MAOIs	_	NOUN	NNS	_	22	nmod	_	_
26	and	_	CONJ	CC	_	25	cc	_	_
27	serotonergic	_	ADJ	JJ	_	28	amod	_	_
28	drugs	_	NOUN	NNS	_	25	conj	_	_

#	EMSAM	17
1	Use	_	NOUN	NN	_	8	nsubjpass	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	with	_	ADP	IN	_	6	case	_	_
5	these	_	DET	DT	_	6	det	_	_
6	drugs	_	NOUN	NNS	_	1	nmod	_	_
7	is	_	VERB	VBZ	_	8	auxpass	_	_
8	contraindicated	_	VERB	VBN	_	0	root	_	_

#	EMSAM	18
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	has	_	VERB	VBZ	_	0	root	_	_
3	the	_	DET	DT	_	4	det	_	_
4	capacity	_	NOUN	NN	_	2	dobj	_	_
5	to	_	PRT	TO	_	6	mark	_	_
6	inhibit	_	VERB	VB	_	4	acl	_	_
7	intestinal	_	ADJ	JJ	_	8	amod	_	_
8	MAO	_	NOUN	NN	_	6	dobj	_	_
9	,	_	.	,	_	8	punct	_	_
10	which	_	DET	WDT	_	12	nsubj	_	_
11	is	_	VERB	VBZ	_	12	cop	_	_
12	responsible	_	ADJ	JJ	_	8	acl:relcl	_	_
13	for	_	ADP	IN	_	15	case	_	_
14	the	_	DET	DT	_	15	det	_	_
15	catabolism	_	NOUN	NN	_	12	nmod	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	tyramine	_	NOUN	NN	_	15	nmod	_	_
18	in	_	ADP	IN	_	19	case	_	_
19	food	_	NOUN	NN	_	15	nmod	_	_
20	and	_	CONJ	CC	_	19	cc	_	_
21	beverages	_	NOUN	NNS	_	19	conj	_	_

#	EMSAM	19
1	As	_	ADP	IN	_	3	case	_	_
2	a	_	DET	DT	_	3	det	_	_
3	result	_	NOUN	NN	_	13	nmod	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	this	_	DET	DT	_	6	det	_	_
6	inhibition	_	NOUN	NN	_	3	nmod	_	_
7	,	_	.	,	_	13	punct	_	_
8	large	_	ADJ	JJ	_	9	amod	_	_
9	amounts	_	NOUN	NNS	_	13	nsubj	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	tyramine	_	NOUN	NN	_	9	nmod	_	_
12	may	_	VERB	MD	_	13	aux	_	_
13	enter	_	VERB	VB	_	0	root	_	_
14	the	_	DET	DT	_	16	det	_	_
15	systemic	_	ADJ	JJ	_	16	amod	_	_
16	circulation	_	NOUN	NN	_	13	dobj	_	_
17	and	_	CONJ	CC	_	13	cc	_	_
18	precipitate	_	VERB	VBP	_	13	conj	_	_
19	a	_	DET	DT	_	20	det	_	_
20	sudden	_	NOUN	NN	_	18	dobj	_	_
21	,	_	.	,	_	13	punct	_	_
22	large	_	ADJ	JJ	_	23	amod	_	_
23	rise	_	NOUN	NN	_	13	dobj	_	_
24	in	_	ADP	IN	_	26	case	_	_
25	blood	_	NOUN	NN	_	26	compound	_	_
26	pressure	_	NOUN	NN	_	23	nmod	_	_
27	or	_	CONJ	CC	_	26	cc	_	_
28	hypertensive	_	ADJ	JJ	_	29	amod	_	_
29	crisis	_	NOUN	NNS	_	26	conj	_	_

#	EMSAM	20
1	A	_	DET	DT	_	2	det	_	_
2	diet	_	NOUN	NN	_	9	nsubj	_	_
3	low	_	ADJ	JJ	_	2	amod	_	_
4	in	_	ADP	IN	_	6	case	_	_
5	tyramine	_	NOUN	NN	_	6	compound	_	_
6	content	_	NOUN	NN	_	3	nmod	_	_
7	may	_	VERB	MD	_	9	aux	_	_
8	be	_	VERB	VB	_	9	cop	_	_
9	necessary	_	ADJ	JJ	_	0	root	_	_
10	to	_	PRT	TO	_	11	mark	_	_
11	avoid	_	ADP	IN	_	9	xcomp	_	_
12	this	_	DET	DT	_	13	det	_	_
13	interaction	_	NOUN	NN	_	11	dobj	_	_

#	EMSAM	21
1	Studies	_	NOUN	NNS	_	14	nsubjpass	_	_
2	to	_	PRT	TO	_	3	mark	_	_
3	evaluate	_	VERB	VB	_	1	acl	_	_
4	the	_	DET	DT	_	5	det	_	_
5	potential	_	NOUN	NN	_	3	dobj	_	_
6	for	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	to	_	PRT	TO	_	9	mark	_	_
9	inhibit	_	VERB	VB	_	3	xcomp	_	_
10	tyramine	_	NOUN	NN	_	11	compound	_	_
11	metabolism	_	NOUN	NN	_	9	dobj	_	_
12	have	_	VERB	VBP	_	14	aux	_	_
13	been	_	VERB	VBN	_	14	auxpass	_	_
14	conducted	_	VERB	VBN	_	0	root	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	,	_	.	,	_	14	punct	_	_
17	overall	_	ADV	RB	_	14	advmod	_	_
18	,	_	.	,	_	14	punct	_	_
19	the	_	DET	DT	_	20	det	_	_
20	data	_	NOUN	NNS	_	27	nsubj	_	_
21	for	_	ADP	IN	_	23	case	_	_
22	DRUG	_	NOUN	NN	_	23	compound	_	_
23	6mg	_	NOUN	NN	_	20	nmod	_	_
24	per	_	ADP	IN	_	26	case	_	_
25	24	_	NUM	CD	_	26	nummod	_	_
26	hours	_	NOUN	NNS	_	20	nmod	_	_
27	support	_	VERB	VBP	_	14	parataxis	_	_
28	a	_	DET	DT	_	29	det	_	_
29	recommendation	_	NOUN	NN	_	27	dobj	_	_
30	that	_	ADP	IN	_	36	mark	_	_
31	a	_	DET	DT	_	33	det	_	_
32	modified	_	VERB	VBN	_	33	amod	_	_
33	diet	_	NOUN	NN	_	36	nsubjpass	_	_
34	is	_	VERB	VBZ	_	36	auxpass	_	_
35	not	_	ADV	RB	_	36	neg	_	_
36	required	_	VERB	VBN	_	29	ccomp	_	_
37	at	_	ADP	IN	_	39	case	_	_
38	this	_	DET	DT	_	39	det	_	_
39	dose	_	NOUN	NN	_	36	nmod	_	_

#	EMSAM	22
1	Due	_	ADJ	JJ	_	6	case	_	_
2	to	_	PRT	TO	_	1	mwe	_	_
3	the	_	DET	DT	_	6	det	_	_
4	more	_	ADV	RB	_	5	advmod	_	_
5	limited	_	ADJ	JJ	_	6	amod	_	_
6	data	_	NOUN	NNS	_	27	nsubj	_	_
7	available	_	ADJ	JJ	_	6	amod	_	_
8	for	_	ADP	IN	_	10	case	_	_
9	DRUG	_	NOUN	NN	_	10	compound	_	_
10	9mg	_	NOUN	NN	_	7	nmod	_	_
11	per	_	ADP	IN	_	13	case	_	_
12	24	_	NUM	CD	_	13	nummod	_	_
13	hours	_	NOUN	NNS	_	7	nmod	_	_
14	and	_	CONJ	CC	_	6	cc	_	_
15	the	_	DET	DT	_	16	det	_	_
16	results	_	NOUN	NNS	_	6	conj	_	_
17	from	_	ADP	IN	_	23	case	_	_
18	the	_	DET	DT	_	23	det	_	_
19	Phase	_	NOUN	NN	_	23	compound	_	_
20	I	_	NUM	CD	_	23	nummod	_	_
21	tyramine	_	NOUN	NN	_	23	compound	_	_
22	challenge	_	NOUN	NN	_	23	compound	_	_
23	study	_	NOUN	NN	_	16	nmod	_	_
24	in	_	ADP	IN	_	26	case	_	_
25	fed	_	ADJ	JJ	_	26	amod	_	_
26	volunteers	_	NOUN	NNS	_	23	nmod	_	_
27	administered	_	VERB	VBD	_	39	advcl	_	_
28	DRUG	_	NOUN	NN	_	29	compound	_	_
29	12mg	_	NOUN	NN	_	27	dobj	_	_
30	per	_	ADP	IN	_	32	case	_	_
31	24	_	NUM	CD	_	32	nummod	_	_
32	hours	_	NOUN	NNS	_	27	nmod	_	_
33	,	_	.	,	_	39	punct	_	_
34	patients	_	NOUN	NNS	_	39	nsubj	_	_
35	receiving	_	VERB	VBG	_	34	acl	_	_
36	these	_	DET	DT	_	37	det	_	_
37	doses	_	NOUN	NNS	_	35	dobj	_	_
38	should	_	VERB	MD	_	39	aux	_	_
39	follow	_	VERB	VB	_	0	root	_	_
40	Dietary	_	NOUN	NN	_	41	compound	_	_
41	Modifications	_	NOUN	NNS	_	39	dobj	_	_
42	Required	_	VERB	VBN	_	41	acl	_	_
43	for	_	ADP	IN	_	44	case	_	_
44	Patients	_	NOUN	NNS	_	42	nmod	_	_
45	Taking	_	VERB	VBG	_	44	acl	_	_
46	DRUG	_	NOUN	NN	_	47	compound	_	_
47	9mg	_	NOUN	NN	_	45	dobj	_	_
48	per	_	ADP	IN	_	50	case	_	_
49	24	_	NUM	CD	_	50	nummod	_	_
50	hours	_	NOUN	NNS	_	45	nmod	_	_
51	and	_	CONJ	CC	_	50	cc	_	_
52	12mg	_	NOUN	NN	_	50	conj	_	_
53	per	_	ADP	IN	_	55	case	_	_
54	24	_	NUM	CD	_	55	nummod	_	_
55	hours	_	NOUN	NNS	_	45	nmod	_	_
56	below	_	VERB	VBP	_	39	parataxis	_	_

#	EMSAM	23
1	The	_	DET	DT	_	2	det	_	_
2	foods	_	NOUN	NNS	_	11	nsubjpass	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	beverages	_	NOUN	NNS	_	2	conj	_	_
5	listed	_	VERB	VBN	_	2	acl	_	_
6	in	_	ADP	IN	_	7	case	_	_
7	Table	_	ADJ	JJ	_	5	nmod	_	_
8	5	_	NUM	CD	_	7	nummod	_	_
9	should	_	VERB	MD	_	11	aux	_	_
10	be	_	VERB	VB	_	11	auxpass	_	_
11	avoided	_	VERB	VBN	_	0	root	_	_
12	beginning	_	VERB	VBG	_	11	xcomp	_	_
13	on	_	ADP	IN	_	16	case	_	_
14	the	_	DET	DT	_	16	det	_	_
15	first	_	ADJ	JJ	_	16	amod	_	_
16	day	_	NOUN	NN	_	12	nmod	_	_
17	of	_	ADP	IN	_	19	case	_	_
18	DRUG	_	NOUN	NN	_	19	compound	_	_
19	9mg	_	NOUN	NN	_	16	nmod	_	_
20	per	_	ADP	IN	_	22	case	_	_
21	24	_	NUM	CD	_	22	nummod	_	_
22	hours	_	NOUN	NNS	_	16	nmod	_	_
23	or	_	CONJ	CC	_	22	cc	_	_
24	12mg	_	ADJ	JJ	_	22	conj	_	_
25	per	_	ADP	IN	_	28	case	_	_
26	24	_	NUM	CD	_	28	nummod	_	_
27	hours	_	NOUN	NNS	_	28	compound	_	_
28	treatment	_	NOUN	NN	_	16	nmod	_	_
29	,	_	.	,	_	11	punct	_	_
30	and	_	CONJ	CC	_	11	cc	_	_
31	should	_	VERB	MD	_	32	aux	_	_
32	continue	_	VERB	VB	_	11	conj	_	_
33	to	_	PRT	TO	_	35	mark	_	_
34	be	_	VERB	VB	_	35	auxpass	_	_
35	avoided	_	VERB	VBN	_	32	xcomp	_	_
36	for	_	ADP	IN	_	38	case	_	_
37	2	_	NUM	CD	_	38	nummod	_	_
38	weeks	_	NOUN	NNS	_	35	nmod	_	_
39	after	_	ADP	IN	_	42	case	_	_
40	a	_	DET	DT	_	42	det	_	_
41	dose	_	NOUN	NN	_	42	compound	_	_
42	reduction	_	NOUN	NN	_	35	nmod	_	_
43	to	_	PRT	TO	_	45	case	_	_
44	DRUG	_	NOUN	NN	_	45	compound	_	_
45	6mg	_	NOUN	NN	_	42	nmod	_	_
46	per	_	ADP	IN	_	48	case	_	_
47	24	_	NUM	CD	_	48	nummod	_	_
48	hours	_	NOUN	NNS	_	42	nmod	_	_
49	or	_	CONJ	CC	_	42	cc	_	_
50	following	_	VERB	VBG	_	52	case	_	_
51	the	_	DET	DT	_	52	det	_	_
52	discontinuation	_	NOUN	NN	_	42	conj	_	_
53	of	_	ADP	IN	_	55	case	_	_
54	DRUG	_	NOUN	NN	_	55	compound	_	_
55	9mg	_	NOUN	NN	_	52	nmod	_	_
56	per	_	ADP	IN	_	58	case	_	_
57	24	_	NUM	CD	_	58	nummod	_	_
58	hours	_	NOUN	NNS	_	52	nmod	_	_
59	or	_	CONJ	CC	_	58	cc	_	_
60	12mg	_	ADJ	JJ	_	58	conj	_	_
61	per	_	ADP	IN	_	63	case	_	_
62	24	_	NUM	CD	_	63	nummod	_	_
63	hours	_	NOUN	NNS	_	52	nmod	_	_

#	EMSAM	24
1	Food	_	NOUN	NN	_	58	nsubjpass	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	Beverages	_	VERB	VBZ	_	1	conj	_	_
4	to	_	PRT	TO	_	5	case	_	_
5	Avoid	_	ADJ	JJ	_	1	nmod	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	Those	_	NOUN	NN	_	5	conj	_	_
8	which	_	DET	WDT	_	13	nsubj	_	_
9	are	_	VERB	VBP	_	13	cop	_	_
10	Acceptable	_	ADJ	JJ	_	13	amod	_	_
11	All	_	NOUN	NN	_	13	compound	_	_
12	other	_	ADJ	JJ	_	13	amod	_	_
13	vegetables	_	NOUN	NNS	_	5	acl:relcl	_	_
14	Dairy	_	NOUN	NN	_	16	compound	_	_
15	Aged	_	ADJ	JJ	_	16	amod	_	_
16	cheeses	_	NOUN	NNS	_	13	dobj	_	_
17	Processed	_	VERB	VBN	_	18	amod	_	_
18	cheeses	_	NOUN	NNS	_	16	dep	_	_
19	,	_	.	,	_	18	punct	_	_
20	mozzarella	_	NOUN	NN	_	18	conj	_	_
21	,	_	.	,	_	18	punct	_	_
22	ricotta	_	NOUN	NN	_	23	compound	_	_
23	cheese	_	NOUN	NN	_	18	conj	_	_
24	,	_	.	,	_	18	punct	_	_
25	cottage	_	NOUN	NN	_	26	compound	_	_
26	cheese	_	NOUN	NN	_	18	conj	_	_
27	,	_	.	,	_	18	punct	_	_
28	and	_	CONJ	CC	_	18	cc	_	_
29	yogurt	_	NOUN	NN	_	32	compound	_	_
30	Beverages	_	VERB	VBZ	_	32	amod	_	_
31	All	_	NUM	CD	_	32	nummod	_	_
32	varieties	_	NOUN	NNS	_	18	conj	_	_
33	of	_	ADP	IN	_	34	case	_	_
34	tap	_	NOUN	NN	_	32	nmod	_	_
35	beer	_	VERB	VBD	_	58	auxpass	_	_
36	and	_	CONJ	CC	_	58	cc	_	_
37	beers	_	VERB	VBZ	_	58	nsubjpass	_	_
38	that	_	DET	WDT	_	42	nsubjpass	_	_
39	have	_	VERB	VBP	_	42	aux	_	_
40	not	_	ADV	RB	_	42	neg	_	_
41	been	_	VERB	VBN	_	42	auxpass	_	_
42	pasteurized	_	VERB	VBN	_	37	conj	_	_
43	so	_	ADV	RB	_	42	advmod	_	_
44	as	_	ADP	IN	_	46	mark	_	_
45	to	_	PRT	TO	_	46	mark	_	_
46	allow	_	VERB	VB	_	42	xcomp	_	_
47	for	_	ADP	IN	_	51	case	_	_
48	ongoing	_	ADJ	JJ	_	51	amod	_	_
49	fermentation	_	NOUN	NN	_	51	compound	_	_
50	Concomitant	_	ADJ	JJ	_	51	amod	_	_
51	use	_	NOUN	NN	_	46	nmod	_	_
52	of	_	ADP	IN	_	53	case	_	_
53	alcohol	_	NOUN	NN	_	51	nmod	_	_
54	with	_	ADP	IN	_	55	case	_	_
55	DRUG	_	NOUN	NN	_	51	nmod	_	_
56	is	_	VERB	VBZ	_	58	auxpass	_	_
57	not	_	ADV	RB	_	58	neg	_	_
58	recommended	_	VERB	VBN	_	0	root	_	_

#	EMSAM	25
1	Bottled	_	VERB	VBN	_	4	amod	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	canned	_	VERB	VBN	_	1	conj	_	_
4	beers	_	NOUN	NNS	_	7	nsubj	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	wines	_	NOUN	NNS	_	4	conj	_	_
7	contain	_	VERB	VBP	_	0	root	_	_
8	little	_	ADJ	JJ	_	7	dobj	_	_
9	or	_	CONJ	CC	_	8	cc	_	_
10	no	_	DET	DT	_	8	conj	_	_
11	tyramine	_	NOUN	NN	_	8	dep	_	_

#	EMSAM	26
1	Miscellaneous	_	ADJ	JJ	_	5	amod	_	_
2	Concentrated	_	ADJ	JJ	_	5	amod	_	_
3	yeast	_	NOUN	NN	_	5	compound	_	_
4	extract	_	NOUN	NN	_	5	compound	_	_
5	e.g	_	NOUN	NN	_	0	root	_	_
6	,	_	.	,	_	5	punct	_	_
7	Marmite	_	NOUN	NN	_	5	conj	_	_
8	,	_	.	,	_	5	punct	_	_
9	sauerkraut	_	NOUN	NN	_	5	conj	_	_
10	,	_	.	,	_	5	punct	_	_
11	most	_	ADV	RB	_	12	advmod	_	_
12	soybean	_	ADJ	JJ	_	13	amod	_	_
13	products	_	NOUN	NNS	_	5	conj	_	_
14	including	_	ADP	IN	_	16	case	_	_
15	soy	_	NOUN	NN	_	16	compound	_	_
16	sauce	_	NOUN	NN	_	13	nmod	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	tofu	_	ADV	RB	_	16	conj	_	_
19	,	_	.	,	_	5	punct	_	_
20	OTC	_	NOUN	NN	_	21	compound	_	_
21	supplements	_	NOUN	NNS	_	5	conj	_	_
22	containing	_	VERB	VBG	_	21	acl	_	_
23	tyramine	_	NOUN	NN	_	25	compound	_	_
24	Brewer's	_	VERB	VBZ	_	25	compound	_	_
25	yeast	_	NOUN	NN	_	22	dobj	_	_
26	,	_	.	,	_	25	punct	_	_
27	baker's	_	VERB	VBZ	_	28	compound	_	_
28	yeast	_	NOUN	NN	_	25	conj	_	_
29	,	_	.	,	_	25	punct	_	_
30	soy	_	ADP	IN	_	31	case	_	_
31	milk	_	NOUN	NN	_	25	conj	_	_
32	,	_	.	,	_	5	punct	_	_
33	commercial	_	ADJ	JJ	_	36	amod	_	_
34	chain	_	NOUN	NN	_	36	compound	_	_
35	restaurant	_	ADJ	JJ	_	36	amod	_	_
36	pizzas	_	NOUN	NNS	_	5	appos	_	_
37	prepared	_	VERB	VBN	_	53	advcl	_	_
38	with	_	ADP	IN	_	39	case	_	_
39	cheeses	_	NOUN	NNS	_	37	nmod	_	_
40	low	_	ADJ	JJ	_	39	amod	_	_
41	in	_	ADP	IN	_	42	case	_	_
42	tyramine	_	NOUN	NN	_	40	nmod	_	_
43	The	_	DET	DT	_	44	det	_	_
44	use	_	NOUN	NN	_	53	nsubj	_	_
45	of	_	ADP	IN	_	46	case	_	_
46	DRUG	_	NOUN	NN	_	44	nmod	_	_
47	with	_	ADP	IN	_	49	case	_	_
48	sympathomimetic	_	ADJ	JJ	_	49	amod	_	_
49	amines	_	NOUN	NNS	_	44	nmod	_	_
50	or	_	CONJ	CC	_	49	cc	_	_
51	buspirone	_	NOUN	NN	_	49	conj	_	_
52	may	_	VERB	MD	_	53	aux	_	_
53	produce	_	VERB	VB	_	36	acl	_	_
54	substantial	_	ADJ	JJ	_	55	amod	_	_
55	elevations	_	NOUN	NNS	_	53	dobj	_	_
56	in	_	ADP	IN	_	58	case	_	_
57	blood	_	NOUN	NN	_	58	compound	_	_
58	pressure	_	NOUN	NN	_	55	nmod	_	_

#	EMSAM	27
1	Therefore	_	ADV	RB	_	5	advmod	_	_
2	,	_	.	,	_	5	punct	_	_
3	monitor	_	NOUN	NN	_	5	compound	_	_
4	blood	_	NOUN	NN	_	5	compound	_	_
5	pressure	_	NOUN	NN	_	0	root	_	_
6	if	_	ADP	IN	_	9	mark	_	_
7	DRUG	_	NOUN	NN	_	9	nsubjpass	_	_
8	is	_	VERB	VBZ	_	9	auxpass	_	_
9	used	_	VERB	VBN	_	5	acl:relcl	_	_
10	with	_	ADP	IN	_	11	case	_	_
11	any	_	DET	DT	_	9	nmod	_	_
12	of	_	ADP	IN	_	15	case	_	_
13	the	_	DET	DT	_	15	det	_	_
14	following	_	VERB	VBG	_	15	amod	_	_
15	drugs	_	NOUN	NNS	_	11	nmod	_	_
16	:	_	.	:	_	5	punct	_	_
17	buspirone	_	NOUN	NN	_	5	dep	_	_
18	,	_	.	,	_	17	punct	_	_
19	amphetamines	_	NOUN	NNS	_	17	conj	_	_
20	,	_	.	,	_	17	punct	_	_
21	and	_	CONJ	CC	_	17	cc	_	_
22	cold	_	ADJ	JJ	_	23	amod	_	_
23	products	_	NOUN	NNS	_	17	conj	_	_
24	or	_	CONJ	CC	_	23	cc	_	_
25	weight	_	NOUN	NN	_	27	compound	_	_
26	reducing	_	NOUN	NN	_	27	compound	_	_
27	preparations	_	NOUN	NNS	_	23	conj	_	_
28	that	_	DET	WDT	_	29	nsubj	_	_
29	contain	_	VERB	VBP	_	17	acl:relcl	_	_
30	sympathomimetic	_	ADJ	JJ	_	31	amod	_	_
31	amines	_	NOUN	NNS	_	29	dobj	_	_
32	e.g	_	NOUN	NN	_	31	dep	_	_
33	,	_	.	,	_	32	punct	_	_
34	pseudoephedrine	_	NOUN	NN	_	32	conj	_	_
35	,	_	.	,	_	32	punct	_	_
36	phenylephrine	_	NOUN	NN	_	32	conj	_	_
37	,	_	.	,	_	32	punct	_	_
38	phenylpropanolamine	_	NOUN	NN	_	32	conj	_	_
39	,	_	.	,	_	32	punct	_	_
40	and	_	CONJ	CC	_	32	cc	_	_
41	ephedrine	_	NOUN	NN	_	32	conj	_	_

#	EMSAM	28
1	Carbamazepine	_	NOUN	NN	_	3	nsubjpass	_	_
2	is	_	VERB	VBZ	_	3	auxpass	_	_
3	contraindicated	_	VERB	VBN	_	0	root	_	_
4	with	_	ADP	IN	_	5	case	_	_
5	MAOIs	_	NOUN	NNS	_	3	nmod	_	_
6	,	_	.	,	_	5	punct	_	_
7	including	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	5	nmod	_	_

#	EMSAM	29
1	No	_	DET	DT	_	3	neg	_	_
2	dose	_	NOUN	NN	_	3	compound	_	_
3	adjustment	_	NOUN	NN	_	7	nsubjpass	_	_
4	for	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	is	_	VERB	VBZ	_	7	auxpass	_	_
7	needed	_	VERB	VBN	_	0	root	_	_
8	when	_	ADV	WRB	_	11	advmod	_	_
9	DRUG	_	NOUN	NN	_	11	nsubjpass	_	_
10	is	_	VERB	VBZ	_	11	auxpass	_	_
11	used	_	VERB	VBN	_	7	ccomp	_	_
12	concomitantly	_	ADV	RB	_	11	advmod	_	_
13	with	_	ADP	IN	_	14	case	_	_
14	alcohol	_	NOUN	NN	_	11	nmod	_	_
15	,	_	.	,	_	14	punct	_	_
16	alprazolam	_	NOUN	NN	_	14	conj	_	_
17	,	_	.	,	_	14	punct	_	_
18	ibuprofen	_	NOUN	NN	_	14	conj	_	_
19	,	_	.	,	_	14	punct	_	_
20	olanzapine	_	NOUN	NN	_	14	conj	_	_
21	,	_	.	,	_	14	punct	_	_
22	risperidone	_	NOUN	NN	_	14	conj	_	_
23	,	_	.	,	_	14	punct	_	_
24	levothyroxine	_	NOUN	NN	_	14	conj	_	_
25	,	_	.	,	_	14	punct	_	_
26	and	_	CONJ	CC	_	14	cc	_	_
27	CYP3A4	_	NOUN	NN	_	28	compound	_	_
28	inhibitors	_	NOUN	NNS	_	14	conj	_	_
29	e.g	_	NOUN	NN	_	28	dep	_	_
30	,	_	.	,	_	14	punct	_	_
31	ketoconazole	_	NOUN	NN	_	14	appos	_	_

#	EMSAM	30
1	No	_	DET	DT	_	4	neg	_	_
2	clinically	_	ADV	RB	_	3	advmod	_	_
3	meaningful	_	ADJ	JJ	_	4	amod	_	_
4	change	_	NOUN	NN	_	9	nsubjpass	_	_
5	in	_	ADP	IN	_	7	case	_	_
6	DRUG	_	NOUN	NN	_	7	compound	_	_
7	exposure	_	NOUN	NN	_	4	nmod	_	_
8	was	_	VERB	VBD	_	9	auxpass	_	_
9	seen	_	VERB	VBN	_	0	root	_	_
10	when	_	ADV	WRB	_	14	advmod	_	_
11	DRUG	_	NOUN	NN	_	14	nsubjpass	_	_
12	was	_	VERB	VBD	_	14	auxpass	_	_
13	co	_	PRT	TO	_	14	dep	_	_
14	administered	_	VERB	VBN	_	9	advcl	_	_
15	with	_	ADP	IN	_	16	case	_	_
16	alcohol	_	NOUN	NN	_	14	nmod	_	_
17	,	_	.	,	_	16	punct	_	_
18	alprazolam	_	NOUN	NN	_	16	conj	_	_
19	,	_	.	,	_	16	punct	_	_
20	ibuprofen	_	NOUN	NN	_	16	conj	_	_
21	,	_	.	,	_	16	punct	_	_
22	olanzapine	_	NOUN	NN	_	16	conj	_	_
23	,	_	.	,	_	16	punct	_	_
24	risperidone	_	NOUN	NN	_	16	conj	_	_
25	,	_	.	,	_	16	punct	_	_
26	levothyroxine	_	NOUN	NN	_	16	conj	_	_
27	,	_	.	,	_	16	punct	_	_
28	and	_	CONJ	CC	_	16	cc	_	_
29	ketoconazole	_	NOUN	NN	_	16	conj	_	_

#	EMSAM	31
1	Use	_	NOUN	NN	_	9	nsubjpass	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	alcohol	_	NOUN	NN	_	1	nmod	_	_
4	while	_	ADP	IN	_	5	mark	_	_
5	taking	_	VERB	VBG	_	1	acl	_	_
6	DRUG	_	NOUN	NN	_	5	dobj	_	_
7	is	_	VERB	VBZ	_	9	auxpass	_	_
8	not	_	ADV	RB	_	9	neg	_	_
9	recommended	_	VERB	VBN	_	0	root	_	_
10	,	_	.	,	_	9	punct	_	_
11	even	_	ADV	RB	_	17	advmod	_	_
12	though	_	ADP	IN	_	17	mark	_	_
13	DRUG	_	NOUN	NN	_	17	nsubjpass	_	_
14	has	_	VERB	VBZ	_	17	aux	_	_
15	not	_	ADV	RB	_	17	neg	_	_
16	been	_	VERB	VBN	_	17	auxpass	_	_
17	shown	_	VERB	VBN	_	9	parataxis	_	_
18	to	_	PRT	TO	_	19	mark	_	_
19	increase	_	VERB	VB	_	17	xcomp	_	_
20	the	_	DET	DT	_	21	det	_	_
21	impairment	_	NOUN	NN	_	19	dobj	_	_
22	of	_	ADP	IN	_	26	case	_	_
23	mental	_	ADJ	JJ	_	26	amod	_	_
24	and	_	CONJ	CC	_	23	cc	_	_
25	motor	_	NOUN	NN	_	23	conj	_	_
26	skills	_	NOUN	NNS	_	21	nmod	_	_
27	caused	_	VERB	VBN	_	26	acl	_	_
28	by	_	ADP	IN	_	30	case	_	_
29	alcohol	_	NOUN	NN	_	30	compound	_	_
30	0.75mg	_	NOUN	NN	_	27	nmod	_	_
31	per	_	ADP	IN	_	32	case	_	_
32	kg	_	NOUN	NN	_	30	nmod	_	_

#	EMSAM	32
1	Monitor	_	NOUN	NN	_	3	compound	_	_
2	blood	_	NOUN	NN	_	3	compound	_	_
3	pressure	_	NOUN	NN	_	0	root	_	_
4	if	_	ADP	IN	_	14	mark	_	_
5	sympathomimetic	_	ADJ	JJ	_	6	amod	_	_
6	agents	_	NOUN	NNS	_	14	nsubjpass	_	_
7	e.g	_	NOUN	NN	_	6	dep	_	_
8	,	_	.	,	_	7	punct	_	_
9	phenylpropanolamine	_	NOUN	NN	_	10	compound	_	_
10	PPA	_	NOUN	NN	_	7	conj	_	_
11	or	_	CONJ	CC	_	7	cc	_	_
12	pseudoephedrine	_	NOUN	NN	_	7	conj	_	_
13	are	_	VERB	VBP	_	14	auxpass	_	_
14	used	_	VERB	VBN	_	3	acl:relcl	_	_
15	with	_	ADP	IN	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	14	nmod	_	_
17	,	_	.	,	_	3	punct	_	_
18	even	_	ADV	RB	_	23	advmod	_	_
19	though	_	ADP	IN	_	23	mark	_	_
20	DRUG	_	NOUN	NN	_	23	nsubj	_	_
21	does	_	VERB	VBZ	_	23	aux	_	_
22	not	_	ADV	RB	_	23	neg	_	_
23	appear	_	VERB	VB	_	3	advcl	_	_
24	to	_	PRT	TO	_	25	mark	_	_
25	affect	_	VERB	VB	_	23	xcomp	_	_
26	the	_	DET	DT	_	27	det	_	_
27	pharmacokinetics	_	NOUN	NNS	_	25	dobj	_	_
28	of	_	ADP	IN	_	29	case	_	_
29	PPA	_	NOUN	NN	_	27	nmod	_	_
30	or	_	CONJ	CC	_	29	cc	_	_
31	pseudoephedrine	_	NOUN	NN	_	29	conj	_	_

#	EMSAM	33
1	No	_	DET	DT	_	3	neg	_	_
2	dose	_	NOUN	NN	_	3	compound	_	_
3	adjustment	_	NOUN	NN	_	25	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	alprazolam	_	NOUN	NN	_	3	nmod	_	_
6	,	_	.	,	_	5	punct	_	_
7	ibuprofen	_	NOUN	NN	_	5	conj	_	_
8	,	_	.	,	_	5	punct	_	_
9	levothyroxine	_	NOUN	NN	_	5	conj	_	_
10	,	_	.	,	_	5	punct	_	_
11	olanzapine	_	NOUN	NN	_	5	conj	_	_
12	,	_	.	,	_	5	punct	_	_
13	risperdione	_	NOUN	NN	_	5	conj	_	_
14	,	_	.	,	_	5	punct	_	_
15	warfarin	_	NOUN	NN	_	5	conj	_	_
16	,	_	.	,	_	5	punct	_	_
17	or	_	CONJ	CC	_	5	cc	_	_
18	strong	_	ADJ	JJ	_	20	amod	_	_
19	CYP3A4	_	NOUN	NN	_	20	compound	_	_
20	inhibitors	_	NOUN	NNS	_	5	conj	_	_
21	e.g	_	NOUN	NN	_	3	amod	_	_
22	,	_	.	,	_	3	punct	_	_
23	ketoconazole	_	NOUN	NN	_	3	appos	_	_
24	is	_	VERB	VBZ	_	25	cop	_	_
25	necessary	_	ADJ	JJ	_	0	root	_	_
26	when	_	ADV	WRB	_	30	advmod	_	_
27	these	_	DET	DT	_	28	det	_	_
28	drugs	_	NOUN	NNS	_	30	nsubjpass	_	_
29	are	_	VERB	VBP	_	30	auxpass	_	_
30	used	_	VERB	VBN	_	25	ccomp	_	_
31	in	_	ADP	IN	_	32	case	_	_
32	combination	_	NOUN	NN	_	30	nmod	_	_
33	with	_	ADP	IN	_	34	case	_	_
34	DRUG	_	NOUN	NN	_	32	nmod	_	_

#	EMSAM	34
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	had	_	VERB	VBD	_	0	root	_	_
3	no	_	DET	DT	_	6	neg	_	_
4	clinically	_	ADV	RB	_	5	advmod	_	_
5	relevant	_	ADJ	JJ	_	6	amod	_	_
6	effect	_	NOUN	NN	_	2	dobj	_	_
7	on	_	ADP	IN	_	8	case	_	_
8	pharmacokinetics	_	NOUN	NNS	_	6	nmod	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	these	_	DET	DT	_	11	det	_	_
11	drugs	_	NOUN	NNS	_	8	nmod	_	_

#	EMSAM	35
1	The	_	DET	DT	_	2	det	_	_
2	mechanism	_	NOUN	NN	_	18	nmod	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	action	_	NOUN	NN	_	2	nmod	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	the	_	DET	DT	_	9	det	_	_
8	drug	_	NOUN	NN	_	9	compound	_	_
9	substance	_	NOUN	NN	_	18	nsubjpass	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_
12	as	_	ADP	IN	_	14	case	_	_
13	an	_	DET	DT	_	14	det	_	_
14	antidepressant	_	NOUN	NN	_	9	nmod	_	_
15	is	_	VERB	VBZ	_	18	auxpass	_	_
16	not	_	ADV	RB	_	18	neg	_	_
17	fully	_	ADV	RB	_	18	advmod	_	_
18	understood	_	VERB	VBN	_	0	root	_	_
19	,	_	.	,	_	18	punct	_	_
20	but	_	CONJ	CC	_	18	cc	_	_
21	is	_	VERB	VBZ	_	22	auxpass	_	_
22	presumed	_	VERB	VBN	_	18	conj	_	_
23	to	_	PRT	TO	_	25	mark	_	_
24	be	_	VERB	VB	_	25	auxpass	_	_
25	linked	_	VERB	VBN	_	22	xcomp	_	_
26	to	_	PRT	TO	_	27	case	_	_
27	potentiation	_	NOUN	NN	_	25	nmod	_	_
28	of	_	ADP	IN	_	31	case	_	_
29	monoamine	_	NOUN	NN	_	31	compound	_	_
30	neurotransmitter	_	ADJ	JJ	_	31	amod	_	_
31	activity	_	NOUN	NN	_	27	nmod	_	_
32	in	_	ADP	IN	_	37	case	_	_
33	the	_	DET	DT	_	37	det	_	_
34	central	_	ADJ	JJ	_	37	amod	_	_
35	nervous	_	ADJ	JJ	_	37	amod	_	_
36	system	_	NOUN	NN	_	37	compound	_	_
37	CNS	_	NOUN	NN	_	31	nmod	_	_
38	resulting	_	VERB	VBG	_	37	acl	_	_
39	from	_	ADP	IN	_	42	case	_	_
40	its	_	PRON	PRP$	_	42	nmod:poss	_	_
41	irreversible	_	ADJ	JJ	_	42	amod	_	_
42	inhibition	_	NOUN	NN	_	38	nmod	_	_
43	of	_	ADP	IN	_	48	case	_	_
44	the	_	DET	DT	_	48	det	_	_
45	enzyme	_	NOUN	NN	_	48	compound	_	_
46	monoamine	_	NOUN	NN	_	48	compound	_	_
47	oxidase	_	NOUN	NN	_	48	compound	_	_
48	MAO	_	NOUN	NN	_	42	nmod	_	_

#	EMSAM	36
1	MAO	_	NOUN	NN	_	2	nsubj	_	_
2	exists	_	VERB	VBZ	_	0	root	_	_
3	as	_	ADP	IN	_	5	case	_	_
4	two	_	NUM	CD	_	5	nummod	_	_
5	isoenzymes	_	NOUN	NNS	_	2	nmod	_	_
6	,	_	.	,	_	5	punct	_	_
7	referred	_	VERB	VBN	_	5	acl	_	_
8	to	_	PRT	TO	_	11	case	_	_
9	as	_	ADP	IN	_	11	case	_	_
10	MAO	_	NOUN	NN	_	11	compound	_	_
11	A	_	NOUN	NN	_	7	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	MAO	_	NOUN	NN	_	14	compound	_	_
14	B	_	NOUN	NN	_	11	conj	_	_

#	EMSAM	37
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	has	_	VERB	VBZ	_	0	root	_	_
3	a	_	DET	DT	_	5	det	_	_
4	greater	_	ADJ	JJ	_	5	amod	_	_
5	affinity	_	NOUN	NN	_	2	dobj	_	_
6	for	_	ADP	IN	_	8	case	_	_
7	MAO	_	NOUN	NN	_	8	compound	_	_
8	B	_	NOUN	NN	_	5	nmod	_	_
9	,	_	.	,	_	2	punct	_	_
10	compared	_	VERB	VBN	_	2	dep	_	_
11	to	_	PRT	TO	_	13	case	_	_
12	MAO	_	NOUN	NN	_	13	compound	_	_
13	A	_	NOUN	NN	_	10	nmod	_	_

#	EMSAM	38
1	However	_	ADV	RB	_	8	advmod	_	_
2	,	_	.	,	_	8	punct	_	_
3	at	_	ADP	IN	_	5	case	_	_
4	antidepressant	_	ADJ	JJ	_	5	amod	_	_
5	doses	_	NOUN	NNS	_	8	nmod	_	_
6	,	_	.	,	_	8	punct	_	_
7	DRUG	_	NOUN	NN	_	8	nsubj	_	_
8	inhibits	_	VERB	VBZ	_	0	root	_	_
9	both	_	DET	DT	_	10	det	_	_
10	isoenzymes	_	NOUN	NNS	_	8	dobj	_	_

#	EMSAM	39
1	In	_	ADP	IN	_	6	case	_	_
2	an	_	DET	DT	_	6	det	_	_
3	in	_	ADJ	JJ	_	6	amod	_	_
4	vivo	_	X	FW	_	3	dep	_	_
5	animal	_	NOUN	NN	_	6	compound	_	_
6	model	_	NOUN	NN	_	22	nmod	_	_
7	used	_	VERB	VBN	_	6	acl	_	_
8	to	_	PRT	TO	_	9	mark	_	_
9	test	_	VERB	VB	_	7	xcomp	_	_
10	for	_	ADP	IN	_	15	case	_	_
11	antidepressant	_	ADJ	JJ	_	15	amod	_	_
12	activity	_	NOUN	NN	_	15	compound	_	_
13	Forced	_	ADJ	JJ	_	15	amod	_	_
14	Swim	_	NOUN	NN	_	15	compound	_	_
15	Test	_	NOUN	NN	_	9	nmod	_	_
16	,	_	.	,	_	22	punct	_	_
17	DRUG	_	NOUN	NN	_	22	nsubj	_	_
18	administered	_	VERB	VBN	_	17	acl	_	_
19	by	_	ADP	IN	_	21	case	_	_
20	transdermal	_	ADJ	JJ	_	21	amod	_	_
21	system	_	NOUN	NN	_	18	nmod	_	_
22	exhibited	_	VERB	VBD	_	0	root	_	_
23	antidepressant	_	ADJ	JJ	_	24	amod	_	_
24	properties	_	NOUN	NNS	_	22	dobj	_	_
25	only	_	ADV	RB	_	27	advmod	_	_
26	at	_	ADP	IN	_	27	case	_	_
27	doses	_	NOUN	NNS	_	22	nmod	_	_
28	that	_	DET	WDT	_	29	nsubj	_	_
29	inhibited	_	VERB	VBD	_	27	acl:relcl	_	_
30	both	_	CONJ	CC	_	32	cc:preconj	_	_
31	MAO	_	NOUN	NN	_	32	compound	_	_
32	A	_	NOUN	NN	_	29	dobj	_	_
33	and	_	CONJ	CC	_	32	cc	_	_
34	MAO	_	NOUN	NN	_	36	compound	_	_
35	B	_	NOUN	NN	_	36	compound	_	_
36	activity	_	NOUN	NN	_	32	conj	_	_
37	in	_	ADP	IN	_	39	case	_	_
38	the	_	DET	DT	_	39	det	_	_
39	brain	_	NOUN	NN	_	32	nmod	_	_

#	EMSAM	40
1	In	_	ADP	IN	_	3	case	_	_
2	the	_	DET	DT	_	3	det	_	_
3	CNS	_	NOUN	NN	_	10	nmod	_	_
4	,	_	.	,	_	10	punct	_	_
5	MAO	_	NOUN	NN	_	6	compound	_	_
6	A	_	NOUN	NN	_	10	nsubj	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	MAO	_	NOUN	NN	_	9	compound	_	_
9	B	_	NOUN	NN	_	6	conj	_	_
10	play	_	VERB	VBP	_	0	root	_	_
11	important	_	ADJ	JJ	_	12	amod	_	_
12	roles	_	NOUN	NNS	_	10	dobj	_	_
13	in	_	ADP	IN	_	15	case	_	_
14	the	_	DET	DT	_	15	det	_	_
15	catabolism	_	NOUN	NN	_	10	nmod	_	_
16	of	_	ADP	IN	_	18	case	_	_
17	neurotransmitter	_	ADJ	JJ	_	18	amod	_	_
18	amines	_	NOUN	NNS	_	15	nmod	_	_
19	such	_	ADJ	JJ	_	21	case	_	_
20	as	_	ADP	IN	_	19	mwe	_	_
21	norepinephrine	_	NOUN	NN	_	18	nmod	_	_
22	,	_	.	,	_	21	punct	_	_
23	dopamine	_	NOUN	NN	_	21	conj	_	_
24	,	_	.	,	_	21	punct	_	_
25	and	_	CONJ	CC	_	21	cc	_	_
26	serotonin	_	NOUN	NN	_	21	conj	_	_
27	,	_	.	,	_	21	punct	_	_
28	as	_	ADV	RB	_	21	cc	_	_
29	well	_	ADV	RB	_	28	mwe	_	_
30	as	_	ADP	IN	_	28	mwe	_	_
31	neuromodulators	_	NOUN	NNS	_	21	conj	_	_
32	such	_	ADJ	JJ	_	34	case	_	_
33	as	_	ADP	IN	_	32	mwe	_	_
34	phenylethylamine	_	NOUN	NN	_	31	nmod	_	_

#	EMSAM	41
1	In	_	ADP	IN	_	6	case	_	_
2	in	_	X	FW	_	6	amod	_	_
3	vitro	_	X	FW	_	2	dep	_	_
4	receptor	_	NOUN	NN	_	6	compound	_	_
5	binding	_	NOUN	NN	_	6	compound	_	_
6	assays	_	NOUN	NNS	_	10	nmod	_	_
7	,	_	.	,	_	10	punct	_	_
8	DRUG	_	NOUN	NN	_	10	nsubj	_	_
9	has	_	VERB	VBZ	_	10	aux	_	_
10	demonstrated	_	VERB	VBN	_	0	root	_	_
11	affinity	_	NOUN	NN	_	10	dobj	_	_
12	for	_	ADP	IN	_	19	case	_	_
13	the	_	DET	DT	_	19	det	_	_
14	human	_	ADJ	JJ	_	19	amod	_	_
15	recombinant	_	ADJ	JJ	_	19	amod	_	_
16	adrenergic	_	ADJ	JJ	_	19	amod	_	_
17	A2B	_	NOUN	NN	_	19	compound	_	_
18	receptor	_	NOUN	NN	_	19	compound	_	_
19	Ki	_	NOUN	NN	_	11	nmod	_	_
20	=	_	ADJ	JJ	_	21	case	_	_
21	0.3mcM	_	NOUN	NN	_	19	dep	_	_

#	EMSAM	42
1	No	_	DET	DT	_	3	neg	_	_
2	affinity	_	NOUN	NN	_	3	compound	_	_
3	Ki	_	NOUN	NN	_	8	nsubjpass	_	_
4	greater	_	ADJ	JJ	_	3	amod	_	_
5	than	_	ADP	IN	_	6	case	_	_
6	10mcM	_	NOUN	NN	_	4	nmod	_	_
7	was	_	VERB	VBD	_	8	auxpass	_	_
8	noted	_	VERB	VBN	_	0	root	_	_
9	at	_	ADP	IN	_	11	case	_	_
10	dopamine	_	NOUN	NN	_	11	compound	_	_
11	receptors	_	NOUN	NNS	_	8	nmod	_	_
12	,	_	.	,	_	11	punct	_	_
13	adrenergic	_	ADJ	JJ	_	14	amod	_	_
14	B3	_	NOUN	NN	_	11	appos	_	_
15	,	_	.	,	_	14	punct	_	_
16	glutamate	_	NOUN	NN	_	14	conj	_	_
17	,	_	.	,	_	14	punct	_	_
18	muscarinic	_	ADJ	JJ	_	20	amod	_	_
19	M1	_	NOUN	NN	_	20	compound	_	_
20	M5	_	NOUN	NN	_	14	conj	_	_
21	,	_	.	,	_	14	punct	_	_
22	nicotinic	_	ADJ	JJ	_	14	conj	_	_
23	,	_	.	,	_	14	punct	_	_
24	or	_	CONJ	CC	_	14	cc	_	_
25	rolipram	_	NOUN	NN	_	26	compound	_	_
26	receptor	_	NOUN	NN	_	14	conj	_	_
27	/	_	NUM	CD	_	11	punct	_	_
28	sites	_	NOUN	NNS	_	11	root	_	_

#	EMSAM	43
1	DRUG	_	NOUN	NN	_	10	nsubj	_	_
2	the	_	DET	DT	_	4	det	_	_
3	drug	_	NOUN	NN	_	4	compound	_	_
4	substance	_	NOUN	NN	_	10	nsubj	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	is	_	VERB	VBZ	_	10	cop	_	_
8	an	_	DET	DT	_	10	det	_	_
9	irreversible	_	ADJ	JJ	_	10	amod	_	_
10	inhibitor	_	NOUN	NN	_	0	root	_	_
11	of	_	ADP	IN	_	14	case	_	_
12	monoamine	_	NOUN	NN	_	14	compound	_	_
13	oxidase	_	NOUN	NN	_	14	compound	_	_
14	MAO	_	NOUN	NN	_	10	nmod	_	_
15	,	_	.	,	_	14	punct	_	_
16	a	_	DET	DT	_	19	det	_	_
17	ubiquitous	_	ADJ	JJ	_	19	amod	_	_
18	intracellular	_	ADJ	JJ	_	19	amod	_	_
19	enzyme	_	NOUN	NN	_	14	appos	_	_

#	EMSAM	45
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	shows	_	VERB	VBZ	_	0	root	_	_
3	greater	_	ADJ	JJ	_	4	amod	_	_
4	affinity	_	NOUN	NN	_	2	dobj	_	_
5	for	_	ADP	IN	_	7	case	_	_
6	MAO	_	NOUN	NN	_	7	compound	_	_
7	B	_	NOUN	NN	_	4	nmod	_	_
8	however	_	ADV	RB	_	2	advmod	_	_
9	,	_	.	,	_	2	punct	_	_
10	as	_	ADP	IN	_	13	mark	_	_
11	DRUG	_	NOUN	NN	_	12	compound	_	_
12	concentration	_	NOUN	NN	_	13	nsubj	_	_
13	increases	_	VERB	VBZ	_	2	advcl	_	_
14	,	_	.	,	_	2	punct	_	_
15	this	_	DET	DT	_	16	det	_	_
16	selectivity	_	NOUN	NN	_	18	nsubjpass	_	_
17	is	_	VERB	VBZ	_	18	auxpass	_	_
18	lost	_	VERB	VBN	_	2	parataxis	_	_
19	with	_	ADP	IN	_	20	mark	_	_
20	resulting	_	VERB	VBG	_	18	advcl	_	_
21	dose	_	NOUN	NN	_	23	compound	_	_
22	related	_	ADJ	JJ	_	23	amod	_	_
23	inhibition	_	NOUN	NN	_	20	dobj	_	_
24	of	_	ADP	IN	_	26	case	_	_
25	MAO	_	NOUN	NN	_	26	compound	_	_
26	A	_	NOUN	NN	_	23	nmod	_	_

#	EMSAM	46
1	Intestinal	_	ADJ	JJ	_	2	amod	_	_
2	MAO	_	NOUN	NN	_	6	nsubj	_	_
3	is	_	VERB	VBZ	_	6	cop	_	_
4	predominantly	_	ADV	RB	_	6	advmod	_	_
5	type	_	NOUN	NN	_	6	compound	_	_
6	A	_	NOUN	NN	_	0	root	_	_
7	,	_	.	,	_	6	punct	_	_
8	while	_	ADP	IN	_	14	mark	_	_
9	in	_	ADP	IN	_	11	case	_	_
10	the	_	DET	DT	_	11	det	_	_
11	brain	_	NOUN	NN	_	14	nmod	_	_
12	both	_	DET	DT	_	13	det	_	_
13	isoenzymes	_	NOUN	NNS	_	14	nsubj	_	_
14	exist	_	VERB	VBZ	_	6	advcl	_	_

#	EMSAM	47
1	MAO	_	NOUN	NN	_	2	nsubj	_	_
2	plays	_	VERB	VBZ	_	0	root	_	_
3	a	_	DET	DT	_	6	det	_	_
4	vital	_	ADJ	JJ	_	6	amod	_	_
5	physiological	_	ADJ	JJ	_	6	amod	_	_
6	role	_	NOUN	NN	_	2	dobj	_	_
7	in	_	ADP	IN	_	8	mark	_	_
8	terminating	_	VERB	VBG	_	2	advcl	_	_
9	the	_	DET	DT	_	11	det	_	_
10	biological	_	ADJ	JJ	_	11	amod	_	_
11	activity	_	NOUN	NN	_	8	dobj	_	_
12	of	_	ADP	IN	_	14	case	_	_
13	both	_	CONJ	CC	_	14	cc:preconj	_	_
14	endogenous	_	ADJ	JJ	_	11	nmod	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	exogenous	_	ADJ	JJ	_	14	conj	_	_
17	amines	_	NOUN	NNS	_	14	dep	_	_

#	EMSAM	48
1	In	_	ADP	IN	_	2	case	_	_
2	addition	_	NOUN	NN	_	18	nmod	_	_
3	to	_	PRT	TO	_	5	case	_	_
4	their	_	PRON	PRP$	_	5	nmod:poss	_	_
5	role	_	NOUN	NN	_	2	nmod	_	_
6	in	_	ADP	IN	_	8	case	_	_
7	the	_	DET	DT	_	8	det	_	_
8	catabolism	_	NOUN	NN	_	5	nmod	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	monoamines	_	NOUN	NNS	_	8	nmod	_	_
11	in	_	ADP	IN	_	13	case	_	_
12	the	_	DET	DT	_	13	det	_	_
13	CNS	_	NOUN	NN	_	8	nmod	_	_
14	,	_	.	,	_	18	punct	_	_
15	MAOs	_	NOUN	NNS	_	18	nsubj	_	_
16	are	_	VERB	VBP	_	18	cop	_	_
17	also	_	ADV	RB	_	18	advmod	_	_
18	important	_	ADJ	JJ	_	0	root	_	_
19	in	_	ADP	IN	_	21	case	_	_
20	the	_	DET	DT	_	21	det	_	_
21	catabolism	_	NOUN	NN	_	18	nmod	_	_
22	of	_	ADP	IN	_	24	case	_	_
23	exogenous	_	ADJ	JJ	_	24	amod	_	_
24	amines	_	NOUN	NNS	_	21	nmod	_	_
25	found	_	VERB	VBN	_	24	acl	_	_
26	in	_	ADP	IN	_	28	case	_	_
27	a	_	DET	DT	_	28	det	_	_
28	variety	_	NOUN	NN	_	25	nmod	_	_
29	of	_	ADP	IN	_	30	case	_	_
30	foods	_	NOUN	NNS	_	28	nmod	_	_
31	and	_	CONJ	CC	_	30	cc	_	_
32	drugs	_	NOUN	NNS	_	30	conj	_	_

#	EMSAM	49
1	MAO	_	NOUN	NN	_	9	nsubj	_	_
2	in	_	ADP	IN	_	5	case	_	_
3	the	_	DET	DT	_	5	det	_	_
4	gastrointestinal	_	ADJ	JJ	_	5	amod	_	_
5	tract	_	NOUN	NN	_	1	nmod	_	_
6	primarily	_	ADV	RB	_	8	advmod	_	_
7	type	_	NOUN	NN	_	8	compound	_	_
8	A	_	NOUN	NN	_	9	nsubj	_	_
9	provides	_	VERB	VBZ	_	0	root	_	_
10	protection	_	NOUN	NN	_	9	dobj	_	_
11	from	_	ADP	IN	_	13	case	_	_
12	exogenous	_	ADJ	JJ	_	13	amod	_	_
13	amines	_	NOUN	NNS	_	10	nmod	_	_
14	with	_	ADP	IN	_	16	case	_	_
15	vasopressor	_	NOUN	NN	_	16	compound	_	_
16	actions	_	NOUN	NNS	_	10	nmod	_	_
17	,	_	.	,	_	16	punct	_	_
18	such	_	ADJ	JJ	_	20	case	_	_
19	as	_	ADP	IN	_	18	mwe	_	_
20	tyramine	_	NOUN	NN	_	16	nmod	_	_
21	,	_	.	,	_	20	punct	_	_
22	which	_	DET	WDT	_	27	nsubj	_	_
23	if	_	DET	WDT	_	24	nsubj	_	_
24	absorbed	_	VERB	VBD	_	22	acl:relcl	_	_
25	intact	_	ADJ	JJ	_	24	dobj	_	_
26	can	_	VERB	MD	_	27	aux	_	_
27	cause	_	VERB	VB	_	20	acl:relcl	_	_
28	a	_	DET	DT	_	30	det	_	_
29	hypertensive	_	ADJ	JJ	_	30	amod	_	_
30	crisis	_	NOUN	NN	_	27	dobj	_	_
31	,	_	.	,	_	30	punct	_	_
32	the	_	DET	DT	_	35	det	_	_
33	so	_	ADV	RB	_	34	advmod	_	_
34	called	_	VERB	VBN	_	35	amod	_	_
35	"cheese	_	NOUN	NN	_	30	appos	_	_
36	reaction"	_	NOUN	NN	_	35	dep	_	_

#	EMSAM	50
1	If	_	ADP	IN	_	4	case	_	_
2	a	_	DET	DT	_	4	det	_	_
3	large	_	ADJ	JJ	_	4	amod	_	_
4	amount	_	NOUN	NN	_	8	nsubjpass	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	tyramine	_	NOUN	NN	_	4	nmod	_	_
7	is	_	VERB	VBZ	_	8	auxpass	_	_
8	absorbed	_	VERB	VBN	_	13	advcl	_	_
9	systemically	_	ADV	RB	_	8	advmod	_	_
10	,	_	.	,	_	13	punct	_	_
11	it	_	PRON	PRP	_	13	nsubjpass	_	_
12	is	_	VERB	VBZ	_	13	auxpass	_	_
13	taken	_	VERB	VBN	_	0	root	_	_
14	up	_	ADV	RB	_	13	advmod	_	_
15	by	_	ADP	IN	_	17	case	_	_
16	adrenergic	_	ADJ	JJ	_	17	amod	_	_
17	neurons	_	NOUN	NNS	_	13	nmod	_	_
18	and	_	CONJ	CC	_	13	cc	_	_
19	causes	_	VERB	VBZ	_	13	conj	_	_
20	norepinephrine	_	NOUN	NN	_	21	compound	_	_
21	release	_	NOUN	NN	_	19	dobj	_	_
22	from	_	ADP	IN	_	25	case	_	_
23	neuronal	_	ADJ	JJ	_	25	amod	_	_
24	storage	_	NOUN	NN	_	25	compound	_	_
25	sites	_	NOUN	NNS	_	21	nmod	_	_
26	with	_	ADP	IN	_	28	case	_	_
27	resultant	_	ADJ	JJ	_	28	amod	_	_
28	elevation	_	NOUN	NN	_	21	nmod	_	_
29	of	_	ADP	IN	_	31	case	_	_
30	blood	_	NOUN	NN	_	31	compound	_	_
31	pressure	_	NOUN	NN	_	28	nmod	_	_

#	EMSAM	51
1	While	_	ADP	IN	_	4	mark	_	_
2	most	_	ADV	RB	_	3	amod	_	_
3	foods	_	NOUN	NNS	_	4	nsubj	_	_
4	contain	_	VERB	VBP	_	15	advcl	_	_
5	negligible	_	ADJ	JJ	_	6	amod	_	_
6	amounts	_	NOUN	NNS	_	4	dobj	_	_
7	or	_	CONJ	CC	_	6	cc	_	_
8	no	_	ADV	RB	_	9	neg	_	_
9	tyramine	_	NOUN	NN	_	6	conj	_	_
10	,	_	.	,	_	15	punct	_	_
11	certain	_	ADJ	JJ	_	13	amod	_	_
12	food	_	NOUN	NN	_	13	compound	_	_
13	products	_	NOUN	NNS	_	15	nsubj	_	_
14	may	_	VERB	MD	_	15	aux	_	_
15	contain	_	VERB	VB	_	0	root	_	_
16	large	_	ADJ	JJ	_	17	amod	_	_
17	amounts	_	NOUN	NNS	_	15	dobj	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	tyramine	_	NOUN	NN	_	17	nmod	_	_
20	that	_	DET	WDT	_	21	nsubj	_	_
21	represent	_	VERB	VBP	_	19	acl:relcl	_	_
22	a	_	DET	DT	_	24	det	_	_
23	potential	_	ADJ	JJ	_	24	amod	_	_
24	risk	_	NOUN	NN	_	21	dobj	_	_
25	for	_	ADP	IN	_	27	case	_	_
26	hypertensive	_	ADJ	JJ	_	27	amod	_	_
27	crisis	_	NOUN	NNS	_	24	nmod	_	_

#	EMSAM	52
1	To	_	PRT	TO	_	2	mark	_	_
2	define	_	VERB	VB	_	20	advcl	_	_
3	the	_	DET	DT	_	4	det	_	_
4	risk	_	NOUN	NN	_	2	dobj	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	hypertensive	_	ADJ	JJ	_	7	amod	_	_
7	crises	_	NOUN	NNS	_	4	nmod	_	_
8	with	_	ADP	IN	_	9	case	_	_
9	use	_	NOUN	NN	_	4	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_
12	,	_	.	,	_	20	punct	_	_
13	several	_	ADJ	JJ	_	18	amod	_	_
14	Phase	_	NOUN	NN	_	18	compound	_	_
15	I	_	NUM	CD	_	18	nummod	_	_
16	tyramine	_	NOUN	NN	_	18	compound	_	_
17	challenge	_	NOUN	NN	_	18	compound	_	_
18	studies	_	NOUN	NNS	_	20	nsubjpass	_	_
19	were	_	VERB	VBD	_	20	auxpass	_	_
20	conducted	_	VERB	VBN	_	0	root	_	_
21	both	_	CONJ	CC	_	20	advmod	_	_
22	with	_	ADP	IN	_	25	case	_	_
23	and	_	CONJ	CC	_	22	cc	_	_
24	without	_	ADP	IN	_	22	conj	_	_
25	food	_	NOUN	NN	_	21	nmod	_	_

#	EMSAM	53
1	Fourteen	_	NUM	CD	_	4	nummod	_	_
2	tyramine	_	NOUN	NN	_	4	compound	_	_
3	challenge	_	NOUN	NN	_	4	compound	_	_
4	studies	_	NOUN	NNS	_	23	nsubjpass	_	_
5	including	_	ADP	IN	_	8	case	_	_
6	214	_	NUM	CD	_	8	nummod	_	_
7	healthy	_	ADJ	JJ	_	8	amod	_	_
8	subjects	_	NOUN	NNS	_	4	nmod	_	_
9	age	_	VERB	VBP	_	10	case	_	_
10	range	_	NOUN	NN	_	4	nmod	_	_
11	18	_	NUM	CD	_	15	nummod	_	_
12	to	_	PRT	TO	_	15	case	_	_
13	65	_	NUM	CD	_	14	compound	_	_
14	31	_	NUM	CD	_	15	nummod	_	_
15	subjects	_	NOUN	NNS	_	19	compound	_	_
16	greater	_	ADJ	JJ	_	18	advmod	_	_
17	than	_	ADP	IN	_	16	mwe	_	_
18	50	_	NUM	CD	_	19	nummod	_	_
19	years	_	NOUN	NNS	_	10	nmod	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	age	_	NOUN	NN	_	19	nmod	_	_
22	were	_	VERB	VBD	_	23	auxpass	_	_
23	conducted	_	VERB	VBN	_	0	root	_	_
24	to	_	PRT	TO	_	25	mark	_	_
25	determine	_	VERB	VB	_	23	xcomp	_	_
26	the	_	DET	DT	_	28	det	_	_
27	pressor	_	ADJ	JJ	_	28	amod	_	_
28	effects	_	NOUN	NNS	_	25	dobj	_	_
29	of	_	ADP	IN	_	31	case	_	_
30	oral	_	ADJ	JJ	_	31	amod	_	_
31	tyramine	_	NOUN	NN	_	28	nmod	_	_
32	with	_	ADP	IN	_	36	case	_	_
33	concurrent	_	ADJ	JJ	_	36	amod	_	_
34	DRUG	_	NOUN	NN	_	36	compound	_	_
35	treatment	_	NOUN	NN	_	36	compound	_	_
36	6mg	_	NOUN	NN	_	31	nmod	_	_
37	per	_	ADP	IN	_	39	case	_	_
38	24	_	NUM	CD	_	39	nummod	_	_
39	hours	_	NOUN	NNS	_	25	nmod	_	_
40	to	_	PRT	TO	_	41	case	_	_
41	12mg	_	ADJ	JJ	_	39	amod	_	_
42	per	_	ADP	IN	_	44	case	_	_
43	24	_	NUM	CD	_	44	nummod	_	_
44	hours	_	NOUN	NNS	_	41	nmod	_	_
45	,	_	.	,	_	25	punct	_	_
46	measured	_	VERB	VBN	_	25	xcomp	_	_
47	as	_	ADP	IN	_	49	case	_	_
48	the	_	DET	DT	_	49	det	_	_
49	dose	_	NOUN	NN	_	46	nmod	_	_
50	of	_	ADP	IN	_	51	case	_	_
51	tyramine	_	NOUN	NN	_	49	nmod	_	_
52	required	_	VERB	VBN	_	51	acl	_	_
53	to	_	PRT	TO	_	54	mark	_	_
54	raise	_	VERB	VB	_	52	xcomp	_	_
55	systolic	_	ADJ	JJ	_	57	amod	_	_
56	blood	_	NOUN	NN	_	57	compound	_	_
57	pressure	_	NOUN	NN	_	54	dobj	_	_
58	by	_	ADP	IN	_	60	case	_	_
59	30mmHg	_	NOUN	NN	_	60	compound	_	_
60	TYR30	_	NOUN	NN	_	54	nmod	_	_

#	EMSAM	54
1	Studies	_	NOUN	NNS	_	3	nsubjpass	_	_
2	were	_	VERB	VBD	_	3	auxpass	_	_
3	conducted	_	VERB	VBN	_	0	root	_	_
4	with	_	ADP	IN	_	3	nmod	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	without	_	ADP	IN	_	8	case	_	_
7	concomitant	_	ADJ	JJ	_	8	amod	_	_
8	administration	_	NOUN	NN	_	4	conj	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	food	_	NOUN	NN	_	8	nmod	_	_

#	EMSAM	55
1	Studies	_	NOUN	NNS	_	7	nsubj	_	_
2	conducted	_	VERB	VBN	_	1	acl	_	_
3	with	_	ADP	IN	_	4	case	_	_
4	food	_	NOUN	NN	_	2	nmod	_	_
5	are	_	VERB	VBP	_	7	cop	_	_
6	most	_	ADV	RB	_	7	advmod	_	_
7	relevant	_	ADJ	JJ	_	0	root	_	_
8	to	_	PRT	TO	_	10	case	_	_
9	clinical	_	ADJ	JJ	_	10	amod	_	_
10	practice	_	NOUN	NN	_	7	nmod	_	_
11	since	_	ADP	IN	_	16	mark	_	_
12	tyramine	_	NOUN	NN	_	16	nsubjpass	_	_
13	typically	_	ADV	RB	_	16	advmod	_	_
14	will	_	VERB	MD	_	16	aux	_	_
15	be	_	VERB	VB	_	16	auxpass	_	_
16	consumed	_	VERB	VBN	_	7	advcl	_	_
17	in	_	ADP	IN	_	18	case	_	_
18	food	_	NOUN	NN	_	16	nmod	_	_

#	EMSAM	56
1	A	_	DET	DT	_	4	det	_	_
2	high	_	ADJ	JJ	_	4	amod	_	_
3	tyramine	_	NOUN	NN	_	4	compound	_	_
4	meal	_	NOUN	NN	_	6	nsubjpass	_	_
5	is	_	VERB	VBZ	_	6	auxpass	_	_
6	considered	_	VERB	VBN	_	0	root	_	_
7	to	_	PRT	TO	_	8	mark	_	_
8	contain	_	VERB	VB	_	6	xcomp	_	_
9	up	_	ADV	RB	_	11	advmod	_	_
10	to	_	PRT	TO	_	11	case	_	_
11	40mg	_	NOUN	NN	_	8	nmod	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	tyramine	_	NOUN	NN	_	11	nmod	_	_

#	EMSAM	57
1	One	_	NUM	CD	_	2	nummod	_	_
2	study	_	NOUN	NN	_	10	nsubj	_	_
3	using	_	VERB	VBG	_	2	acl	_	_
4	a	_	DET	DT	_	6	det	_	_
5	crossover	_	ADJ	JJ	_	6	amod	_	_
6	design	_	NOUN	NN	_	3	dobj	_	_
7	in	_	ADP	IN	_	9	case	_	_
8	13	_	NUM	CD	_	9	nummod	_	_
9	subjects	_	NOUN	NNS	_	6	nmod	_	_
10	investigated	_	VERB	VBD	_	0	root	_	_
11	tyramine	_	NOUN	NN	_	13	compound	_	_
12	pressor	_	NOUN	NN	_	13	compound	_	_
13	doses	_	NOUN	NNS	_	10	dobj	_	_
14	TYR30	_	NOUN	NN	_	13	dep	_	_
15	after	_	ADP	IN	_	16	case	_	_
16	administration	_	NOUN	NN	_	10	nmod	_	_
17	of	_	ADP	IN	_	19	case	_	_
18	DRUG	_	NOUN	NN	_	19	compound	_	_
19	6mg	_	NOUN	NN	_	16	nmod	_	_
20	per	_	ADP	IN	_	22	case	_	_
21	24	_	NUM	CD	_	22	nummod	_	_
22	hours	_	NOUN	NNS	_	16	nmod	_	_
23	and	_	CONJ	CC	_	22	cc	_	_
24	oral	_	ADJ	JJ	_	26	amod	_	_
25	DRUG	_	NOUN	NN	_	26	compound	_	_
26	5mg	_	NOUN	NN	_	22	conj	_	_
27	twice	_	ADV	RB	_	28	advmod	_	_
28	daily	_	ADV	RB	_	16	advmod	_	_
29	for	_	ADP	IN	_	30	case	_	_
30	9days	_	NOUN	NNS	_	28	nmod	_	_

#	EMSAM	58
1	Mean	_	NOUN	NN	_	3	compound	_	_
2	pressor	_	NOUN	NN	_	3	compound	_	_
3	doses	_	NOUN	NNS	_	12	nsubj	_	_
4	TYR30	_	NOUN	NN	_	3	dep	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	tyramine	_	NOUN	NN	_	7	compound	_	_
7	capsules	_	NOUN	NNS	_	4	nmod	_	_
8	administered	_	VERB	VBN	_	7	acl	_	_
9	without	_	ADP	IN	_	10	case	_	_
10	food	_	NOUN	NN	_	8	nmod	_	_
11	were	_	VERB	VBD	_	12	cop	_	_
12	338mg	_	ADJ	JJ	_	0	root	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	385mg	_	NOUN	NN	_	12	conj	_	_
15	in	_	ADP	IN	_	16	case	_	_
16	subjects	_	NOUN	NNS	_	12	nmod	_	_
17	treated	_	VERB	VBN	_	16	acl	_	_
18	with	_	ADP	IN	_	19	case	_	_
19	DRUG	_	NOUN	NN	_	17	nmod	_	_
20	and	_	CONJ	CC	_	19	cc	_	_
21	oral	_	ADJ	JJ	_	22	amod	_	_
22	DRUG	_	NOUN	NN	_	19	conj	_	_
23	,	_	.	,	_	12	punct	_	_
24	respectively	_	ADV	RB	_	12	advmod	_	_

#	EMSAM	59
1	Another	_	DET	DT	_	2	det	_	_
2	study	_	NOUN	NN	_	10	nsubj	_	_
3	using	_	VERB	VBG	_	2	acl	_	_
4	a	_	DET	DT	_	6	det	_	_
5	crossover	_	ADJ	JJ	_	6	amod	_	_
6	design	_	NOUN	NN	_	3	dobj	_	_
7	in	_	ADP	IN	_	9	case	_	_
8	10	_	NUM	CD	_	9	nummod	_	_
9	subjects	_	NOUN	NNS	_	6	nmod	_	_
10	investigated	_	VERB	VBD	_	0	root	_	_
11	tyramine	_	NOUN	NN	_	13	compound	_	_
12	pressor	_	NOUN	NN	_	13	compound	_	_
13	doses	_	NOUN	NNS	_	10	dobj	_	_
14	after	_	ADP	IN	_	15	case	_	_
15	administration	_	NOUN	NN	_	10	nmod	_	_
16	of	_	ADP	IN	_	18	case	_	_
17	DRUG	_	NOUN	NN	_	18	compound	_	_
18	6mg	_	NOUN	NN	_	15	nmod	_	_
19	per	_	ADP	IN	_	21	case	_	_
20	24	_	NUM	CD	_	21	nummod	_	_
21	hours	_	NOUN	NNS	_	15	nmod	_	_
22	or	_	CONJ	CC	_	21	cc	_	_
23	tranylcypromine	_	NOUN	NN	_	24	compound	_	_
24	30mg	_	ADJ	JJ	_	21	conj	_	_
25	per	_	ADP	IN	_	26	case	_	_
26	day	_	NOUN	NN	_	15	nmod	_	_
27	for	_	ADP	IN	_	29	case	_	_
28	10	_	NUM	CD	_	29	nummod	_	_
29	days	_	NOUN	NNS	_	26	nmod	_	_

#	EMSAM	60
1	Mean	_	NOUN	NN	_	3	compound	_	_
2	pressor	_	NOUN	NN	_	3	compound	_	_
3	doses	_	NOUN	NNS	_	12	nsubj	_	_
4	TYR30	_	NOUN	NN	_	3	dep	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	tyramine	_	NOUN	NN	_	7	compound	_	_
7	capsules	_	NOUN	NNS	_	4	nmod	_	_
8	administered	_	VERB	VBN	_	7	acl	_	_
9	without	_	ADP	IN	_	10	case	_	_
10	food	_	NOUN	NN	_	8	nmod	_	_
11	were	_	VERB	VBD	_	12	cop	_	_
12	270mg	_	ADJ	JJ	_	0	root	_	_
13	in	_	ADP	IN	_	14	case	_	_
14	subjects	_	NOUN	NNS	_	12	nmod	_	_
15	treated	_	VERB	VBN	_	14	acl	_	_
16	with	_	ADP	IN	_	18	case	_	_
17	DRUG	_	NOUN	NN	_	18	compound	_	_
18	6mg	_	NOUN	NN	_	15	nmod	_	_
19	per	_	ADP	IN	_	21	case	_	_
20	24	_	NUM	CD	_	21	nummod	_	_
21	hours	_	NOUN	NNS	_	15	nmod	_	_
22	and	_	CONJ	CC	_	21	cc	_	_
23	10mg	_	NOUN	NN	_	21	conj	_	_
24	in	_	ADP	IN	_	25	case	_	_
25	subjects	_	NOUN	NNS	_	21	nmod	_	_
26	treated	_	VERB	VBN	_	25	acl	_	_
27	with	_	ADP	IN	_	28	case	_	_
28	tranylcypromine	_	NOUN	NN	_	26	nmod	_	_

#	EMSAM	61
1	In	_	ADP	IN	_	5	case	_	_
2	a	_	DET	DT	_	5	det	_	_
3	third	_	ADJ	JJ	_	5	amod	_	_
4	crossover	_	ADJ	JJ	_	5	amod	_	_
5	study	_	NOUN	NN	_	11	nmod	_	_
6	,	_	.	,	_	11	punct	_	_
7	tyramine	_	NOUN	NN	_	11	nsubjpass	_	_
8	without	_	ADP	IN	_	9	case	_	_
9	food	_	NOUN	NN	_	7	nmod	_	_
10	was	_	VERB	VBD	_	11	auxpass	_	_
11	administered	_	VERB	VBN	_	0	root	_	_
12	to	_	PRT	TO	_	14	case	_	_
13	12	_	NUM	CD	_	14	nummod	_	_
14	subjects	_	NOUN	NNS	_	11	nmod	_	_

#	EMSAM	62
1	The	_	DET	DT	_	5	det	_	_
2	mean	_	ADJ	JJ	_	5	compound	_	_
3	tyramine	_	NOUN	NN	_	5	compound	_	_
4	pressor	_	NOUN	NN	_	5	compound	_	_
5	doses	_	NOUN	NNS	_	21	nsubj	_	_
6	TYR30	_	NOUN	NN	_	5	dep	_	_
7	after	_	ADP	IN	_	8	case	_	_
8	administration	_	NOUN	NN	_	5	nmod	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	DRUG	_	NOUN	NN	_	11	compound	_	_
11	6mg	_	NOUN	NN	_	8	nmod	_	_
12	per	_	ADP	IN	_	14	case	_	_
13	24	_	NUM	CD	_	14	nummod	_	_
14	hours	_	NOUN	NNS	_	8	nmod	_	_
15	for	_	ADP	IN	_	19	case	_	_
16	9	_	NUM	CD	_	19	nummod	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	33	_	NUM	CD	_	16	conj	_	_
19	days	_	NOUN	NNS	_	8	nmod	_	_
20	were	_	VERB	VBD	_	21	cop	_	_
21	292mg	_	ADJ	JJ	_	0	root	_	_
22	and	_	CONJ	CC	_	21	cc	_	_
23	204mg	_	NOUN	NN	_	21	conj	_	_
24	,	_	.	,	_	21	punct	_	_
25	respectively	_	ADV	RB	_	21	advmod	_	_

#	EMSAM	63
1	The	_	DET	DT	_	4	det	_	_
2	lowest	_	ADJ	JJ	_	4	amod	_	_
3	pressor	_	NOUN	NN	_	4	compound	_	_
4	dose	_	NOUN	NN	_	6	nsubj	_	_
5	was	_	VERB	VBD	_	6	cop	_	_
6	50mg	_	ADJ	JJ	_	0	root	_	_
7	in	_	ADP	IN	_	9	case	_	_
8	one	_	NUM	CD	_	9	nummod	_	_
9	subject	_	NOUN	NN	_	6	nmod	_	_
10	in	_	ADP	IN	_	14	case	_	_
11	the	_	DET	DT	_	14	det	_	_
12	33	_	NUM	CD	_	14	nummod	_	_
13	day	_	NOUN	NN	_	14	compound	_	_
14	group	_	NOUN	NN	_	9	nmod	_	_

#	EMSAM	64
1	Tyramine	_	NOUN	NN	_	3	compound	_	_
2	pressor	_	NOUN	NN	_	3	compound	_	_
3	doses	_	NOUN	NNS	_	6	nsubjpass	_	_
4	were	_	VERB	VBD	_	6	auxpass	_	_
5	also	_	ADV	RB	_	6	advmod	_	_
6	studied	_	VERB	VBN	_	0	root	_	_
7	in	_	ADP	IN	_	9	case	_	_
8	11	_	NUM	CD	_	9	nummod	_	_
9	subjects	_	NOUN	NNS	_	6	nmod	_	_
10	after	_	ADP	IN	_	12	case	_	_
11	extended	_	VERB	VBN	_	12	amod	_	_
12	treatment	_	NOUN	NN	_	6	nmod	_	_
13	with	_	ADP	IN	_	15	case	_	_
14	DRUG	_	NOUN	NN	_	15	compound	_	_
15	12mg	_	NOUN	NN	_	12	nmod	_	_
16	per	_	ADP	IN	_	18	case	_	_
17	24	_	NUM	CD	_	18	nummod	_	_
18	hours	_	NOUN	NNS	_	12	nmod	_	_

#	EMSAM	65
1	At	_	ADP	IN	_	2	case	_	_
2	30	_	NUM	CD	_	21	nmod	_	_
3	,	_	.	,	_	2	punct	_	_
4	60	_	NUM	CD	_	2	conj	_	_
5	,	_	.	,	_	2	punct	_	_
6	and	_	CONJ	CC	_	2	cc	_	_
7	90	_	NUM	CD	_	2	conj	_	_
8	days	_	NOUN	NNS	_	2	dep	_	_
9	,	_	.	,	_	21	punct	_	_
10	the	_	DET	DT	_	13	det	_	_
11	mean	_	NOUN	NN	_	13	compound	_	_
12	pressor	_	NOUN	NN	_	13	compound	_	_
13	doses	_	NOUN	NNS	_	21	nsubj	_	_
14	TYR30	_	NOUN	NN	_	13	dep	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	tyramine	_	NOUN	NN	_	14	nmod	_	_
17	administered	_	VERB	VBN	_	16	acl	_	_
18	without	_	ADP	IN	_	19	case	_	_
19	food	_	NOUN	NN	_	17	nmod	_	_
20	were	_	VERB	VBD	_	21	cop	_	_
21	95mg	_	ADJ	JJ	_	0	root	_	_
22	,	_	.	,	_	21	punct	_	_
23	72mg	_	NOUN	NN	_	21	conj	_	_
24	,	_	.	,	_	21	punct	_	_
25	and	_	CONJ	CC	_	21	cc	_	_
26	88mg	_	NOUN	NN	_	21	conj	_	_
27	,	_	.	,	_	21	punct	_	_
28	respectively	_	ADV	RB	_	21	advmod	_	_

#	EMSAM	66
1	The	_	DET	DT	_	4	det	_	_
2	lowest	_	ADJ	JJ	_	4	amod	_	_
3	pressor	_	NOUN	NN	_	4	amod	_	_
4	dose	_	NOUN	NN	_	8	nsubj	_	_
5	without	_	ADP	IN	_	6	case	_	_
6	food	_	NOUN	NN	_	4	nmod	_	_
7	was	_	VERB	VBD	_	8	cop	_	_
8	25mg	_	ADJ	JJ	_	0	root	_	_
9	in	_	ADP	IN	_	11	case	_	_
10	three	_	NUM	CD	_	11	nummod	_	_
11	subjects	_	NOUN	NNS	_	8	nmod	_	_
12	at	_	ADP	IN	_	13	case	_	_
13	day	_	NOUN	NN	_	11	nmod	_	_
14	30	_	NUM	CD	_	13	nummod	_	_
15	while	_	ADP	IN	_	8	dep	_	_
16	on	_	ADP	IN	_	18	case	_	_
17	DRUG	_	NOUN	NN	_	18	compound	_	_
18	12mg	_	NOUN	NN	_	15	nmod	_	_
19	per	_	ADP	IN	_	21	case	_	_
20	24	_	NUM	CD	_	21	nummod	_	_
21	hours	_	NOUN	NNS	_	18	nmod	_	_

#	EMSAM	67
1	Eight	_	NUM	CD	_	2	nummod	_	_
2	subjects	_	NOUN	NNS	_	21	nsubjpass	_	_
3	from	_	ADP	IN	_	5	case	_	_
4	this	_	DET	DT	_	5	det	_	_
5	study	_	NOUN	NN	_	2	nmod	_	_
6	,	_	.	,	_	2	punct	_	_
7	with	_	ADP	IN	_	12	case	_	_
8	a	_	DET	DT	_	12	det	_	_
9	mean	_	ADJ	JJ	_	12	amod	_	_
10	tyramine	_	NOUN	NN	_	12	compound	_	_
11	pressor	_	NOUN	NN	_	12	compound	_	_
12	dose	_	NOUN	NN	_	2	nmod	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	64mg	_	NOUN	NN	_	12	nmod	_	_
15	at	_	ADP	IN	_	17	case	_	_
16	90	_	NUM	CD	_	17	nummod	_	_
17	days	_	NOUN	NNS	_	12	nmod	_	_
18	,	_	.	,	_	2	punct	_	_
19	were	_	VERB	VBD	_	21	auxpass	_	_
20	subsequently	_	ADV	RB	_	21	advmod	_	_
21	administered	_	VERB	VBN	_	0	root	_	_
22	tyramine	_	NOUN	NN	_	21	xcomp	_	_
23	with	_	ADP	IN	_	24	case	_	_
24	food	_	NOUN	NN	_	22	nmod	_	_
25	,	_	.	,	_	21	punct	_	_
26	resulting	_	VERB	VBG	_	21	xcomp	_	_
27	in	_	ADP	IN	_	31	case	_	_
28	a	_	DET	DT	_	31	det	_	_
29	mean	_	ADJ	JJ	_	31	amod	_	_
30	pressor	_	NOUN	NN	_	31	compound	_	_
31	dose	_	NOUN	NN	_	26	nmod	_	_
32	of	_	ADP	IN	_	35	case	_	_
33	172mg	_	ADJ	JJ	_	35	amod	_	_
34	2.7	_	NUM	CD	_	35	nummod	_	_
35	times	_	NOUN	NNS	_	31	nmod	_	_
36	the	_	DET	DT	_	39	det	_	_
37	mean	_	NOUN	NN	_	39	compound	_	_
38	pressor	_	NOUN	NN	_	39	compound	_	_
39	dose	_	NOUN	NN	_	31	dep	_	_
40	observed	_	VERB	VBN	_	39	acl	_	_
41	without	_	ADP	IN	_	42	case	_	_
42	food	_	NOUN	NN	_	40	nmod	_	_
43	,	_	.	,	_	39	punct	_	_
44	p	_	NOUN	NN	_	39	appos	_	_
45	less	_	ADV	RB	_	44	nmod	_	_
46	than	_	ADP	IN	_	47	case	_	_
47	0.003	_	NUM	CD	_	45	nmod	_	_

#	EMSAM	68
1	With	_	ADP	IN	_	3	case	_	_
2	the	_	DET	DT	_	3	det	_	_
3	exception	_	NOUN	NN	_	18	nmod	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	one	_	NUM	CD	_	7	nummod	_	_
6	study	_	NOUN	NN	_	7	compound	_	_
7	N	_	NOUN	NN	_	3	nmod	_	_
8	=	_	ADJ	JJ	_	7	amod	_	_
9	153	_	NUM	CD	_	8	dep	_	_
10	,	_	.	,	_	18	punct	_	_
11	the	_	DET	DT	_	16	det	_	_
12	Phase	_	NOUN	NN	_	16	compound	_	_
13	III	_	NUM	CD	_	16	nummod	_	_
14	clinical	_	ADJ	JJ	_	16	amod	_	_
15	development	_	NOUN	NN	_	16	compound	_	_
16	program	_	NOUN	NN	_	18	nsubjpass	_	_
17	was	_	VERB	VBD	_	18	auxpass	_	_
18	conducted	_	VERB	VBN	_	0	root	_	_
19	without	_	ADP	IN	_	20	mark	_	_
20	requiring	_	VERB	VBG	_	18	advcl	_	_
21	a	_	DET	DT	_	24	det	_	_
22	modified	_	VERB	VBN	_	24	amod	_	_
23	diet	_	NOUN	NN	_	24	compound	_	_
24	N	_	NOUN	NN	_	20	dobj	_	_
25	=	_	ADJ	JJ	_	24	amod	_	_
26	2,553	_	NUM	CD	_	25	dep	_	_
27	,	_	.	,	_	24	punct	_	_
28	1,606	_	NUM	CD	_	30	nummod	_	_
29	at	_	ADP	IN	_	30	case	_	_
30	6mg	_	NOUN	NN	_	24	conj	_	_
31	per	_	ADP	IN	_	33	case	_	_
32	24	_	NUM	CD	_	33	nummod	_	_
33	hours	_	NOUN	NNS	_	30	nmod	_	_
34	,	_	.	,	_	24	punct	_	_
35	and	_	CONJ	CC	_	24	cc	_	_
36	947	_	NUM	CD	_	38	nummod	_	_
37	at	_	ADP	IN	_	38	case	_	_
38	9mg	_	NOUN	NN	_	24	conj	_	_
39	per	_	ADP	IN	_	41	case	_	_
40	24	_	NUM	CD	_	41	nummod	_	_
41	hours	_	NOUN	NNS	_	38	nmod	_	_
42	or	_	CONJ	CC	_	41	cc	_	_
43	12mg	_	ADJ	JJ	_	41	conj	_	_
44	per	_	ADP	IN	_	46	case	_	_
45	24	_	NUM	CD	_	46	nummod	_	_
46	hours	_	NOUN	NNS	_	38	nmod	_	_

#	EMSAM	69
1	No	_	DET	DT	_	3	neg	_	_
2	hypertensive	_	ADJ	JJ	_	3	amod	_	_
3	crises	_	NOUN	NNS	_	5	nsubjpass	_	_
4	were	_	VERB	VBD	_	5	auxpass	_	_
5	reported	_	VERB	VBN	_	0	root	_	_
6	in	_	ADP	IN	_	8	case	_	_
7	any	_	DET	DT	_	8	det	_	_
8	patient	_	NOUN	NN	_	5	nmod	_	_
9	receiving	_	VERB	VBG	_	8	acl	_	_
10	DRUG	_	NOUN	NN	_	9	nmod	_	_

#	EMSAM	70
1	Overall	_	ADV	RB	_	11	advmod	_	_
2	,	_	.	,	_	11	punct	_	_
3	the	_	DET	DT	_	4	det	_	_
4	data	_	NOUN	NNS	_	11	nsubj	_	_
5	for	_	ADP	IN	_	7	case	_	_
6	DRUG	_	NOUN	NN	_	7	compound	_	_
7	6mg	_	NOUN	NN	_	4	nmod	_	_
8	per	_	ADP	IN	_	10	case	_	_
9	24	_	NUM	CD	_	10	nummod	_	_
10	hours	_	NOUN	NNS	_	4	nmod	_	_
11	support	_	VERB	VBP	_	0	root	_	_
12	a	_	DET	DT	_	13	det	_	_
13	recommendation	_	NOUN	NN	_	11	dobj	_	_
14	that	_	ADP	IN	_	20	mark	_	_
15	a	_	DET	DT	_	17	det	_	_
16	modified	_	VERB	VBN	_	17	amod	_	_
17	diet	_	NOUN	NN	_	20	nsubjpass	_	_
18	is	_	VERB	VBZ	_	20	auxpass	_	_
19	not	_	ADV	RB	_	20	neg	_	_
20	required	_	VERB	VBN	_	13	ccomp	_	_
21	at	_	ADP	IN	_	23	case	_	_
22	this	_	DET	DT	_	23	det	_	_
23	dose	_	NOUN	NN	_	20	nmod	_	_

#	EMSAM	72
1	Following	_	VERB	VBG	_	3	case	_	_
2	dermal	_	ADJ	JJ	_	3	amod	_	_
3	application	_	NOUN	NN	_	19	nmod	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	to	_	PRT	TO	_	7	case	_	_
7	humans	_	NOUN	NNS	_	3	nmod	_	_
8	,	_	.	,	_	19	punct	_	_
9	25%	_	NOUN	NN	_	19	nsubjpass	_	_
10	to	_	PRT	TO	_	11	case	_	_
11	30%	_	NOUN	NN	_	9	nmod	_	_
12	of	_	ADP	IN	_	15	case	_	_
13	the	_	DET	DT	_	15	det	_	_
14	DRUG	_	NOUN	NN	_	15	compound	_	_
15	content	_	NOUN	NN	_	11	nmod	_	_
16	on	_	ADP	IN	_	17	case	_	_
17	average	_	NOUN	NN	_	9	nmod	_	_
18	is	_	VERB	VBZ	_	19	auxpass	_	_
19	delivered	_	VERB	VBN	_	0	root	_	_
20	systemically	_	ADV	RB	_	19	advmod	_	_
21	over	_	ADP	IN	_	24	case	_	_
22	24	_	NUM	CD	_	23	nummod	_	_
23	hours	_	NOUN	NNS	_	24	compound	_	_
24	range	_	NOUN	NN	_	19	nmod	_	_
25	approximately	_	ADV	RB	_	26	advmod	_	_
26	10%	_	ADJ	JJ	_	24	nmod	_	_
27	to	_	PRT	TO	_	28	case	_	_
28	40%	_	ADJ	JJ	_	26	nmod	_	_

#	EMSAM	73
1	Consequently	_	ADV	RB	_	13	advmod	_	_
2	,	_	.	,	_	13	punct	_	_
3	the	_	DET	DT	_	4	det	_	_
4	degree	_	NOUN	NN	_	13	nsubj	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	drug	_	NOUN	NN	_	7	compound	_	_
7	absorption	_	NOUN	NN	_	4	nmod	_	_
8	may	_	VERB	MD	_	13	aux	_	_
9	be	_	VERB	VB	_	13	cop	_	_
10	1	_	NUM	CD	_	13	nummod	_	_
11	/	_	NUM	CD	_	13	punct	_	_
12	3	_	NUM	CD	_	13	nummod	_	_
13	higher	_	ADJ	JJ	_	0	root	_	_
14	than	_	ADP	IN	_	17	case	_	_
15	the	_	DET	DT	_	17	det	_	_
16	average	_	ADJ	JJ	_	17	amod	_	_
17	amounts	_	NOUN	NNS	_	13	nmod	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	6mg	_	NOUN	NN	_	17	nmod	_	_
20	to	_	PRT	TO	_	21	case	_	_
21	12mg	_	ADJ	JJ	_	17	nmod	_	_
22	per	_	ADP	IN	_	24	case	_	_
23	24	_	NUM	CD	_	24	nummod	_	_
24	hours	_	NOUN	NNS	_	21	nmod	_	_

#	EMSAM	74
1	Transdermal	_	ADJ	JJ	_	2	amod	_	_
2	dosing	_	NOUN	NN	_	3	nsubj	_	_
3	results	_	VERB	VBZ	_	0	root	_	_
4	in	_	ADP	IN	_	7	case	_	_
5	significantly	_	ADV	RB	_	6	advmod	_	_
6	higher	_	ADJ	JJ	_	7	amod	_	_
7	exposure	_	NOUN	NN	_	3	nmod	_	_
8	to	_	PRT	TO	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	with	_	ADP	IN	_	13	case	_	_
11	significantly	_	ADV	RB	_	12	advmod	_	_
12	lower	_	ADJ	JJ	_	13	amod	_	_
13	exposure	_	NOUN	NN	_	7	nmod	_	_
14	for	_	ADP	IN	_	16	case	_	_
15	all	_	DET	DT	_	16	det	_	_
16	metabolites	_	NOUN	NNS	_	13	nmod	_	_
17	when	_	ADV	WRB	_	18	advmod	_	_
18	compared	_	VERB	VBD	_	3	advcl	_	_
19	to	_	PRT	TO	_	21	case	_	_
20	oral	_	ADJ	JJ	_	21	amod	_	_
21	dosing	_	NOUN	NN	_	18	nmod	_	_
22	,	_	.	,	_	3	punct	_	_
23	due	_	ADJ	JJ	_	28	case	_	_
24	to	_	PRT	TO	_	23	mwe	_	_
25	extensive	_	ADJ	JJ	_	28	amod	_	_
26	first	_	ADJ	JJ	_	28	amod	_	_
27	pass	_	NOUN	NN	_	28	compound	_	_
28	metabolism	_	NOUN	NN	_	3	nmod	_	_

#	EMSAM	75
1	In	_	ADP	IN	_	5	case	_	_
2	a	_	DET	DT	_	5	det	_	_
3	10	_	NUM	CD	_	5	nummod	_	_
4	day	_	NOUN	NN	_	5	compound	_	_
5	study	_	NOUN	NN	_	23	nmod	_	_
6	with	_	ADP	IN	_	8	case	_	_
7	daily	_	ADV	RB	_	8	advmod	_	_
8	administration	_	NOUN	NN	_	5	nmod	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	to	_	PRT	TO	_	13	case	_	_
12	healthy	_	ADJ	JJ	_	13	amod	_	_
13	male	_	ADJ	JJ	_	8	nmod	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	female	_	ADJ	JJ	_	13	conj	_	_
16	volunteers	_	NOUN	NNS	_	13	dep	_	_
17	,	_	.	,	_	23	punct	_	_
18	steady	_	ADJ	JJ	_	22	amod	_	_
19	state	_	NOUN	NN	_	22	compound	_	_
20	DRUG	_	NOUN	NN	_	22	compound	_	_
21	plasma	_	NOUN	NN	_	22	compound	_	_
22	concentrations	_	NOUN	NNS	_	23	nsubj	_	_
23	indicated	_	VERB	VBD	_	0	root	_	_
24	DRUG	_	NOUN	NN	_	27	compound	_	_
25	concentration	_	NOUN	NN	_	27	compound	_	_
26	time	_	NOUN	NN	_	27	compound	_	_
27	profiles	_	NOUN	NNS	_	23	dobj	_	_
28	were	_	VERB	VBD	_	29	cop	_	_
29	comparable	_	ADJ	JJ	_	23	parataxis	_	_
30	when	_	ADV	WRB	_	33	advmod	_	_
31	DRUG	_	NOUN	NN	_	33	nsubjpass	_	_
32	is	_	VERB	VBZ	_	33	auxpass	_	_
33	applied	_	VERB	VBN	_	29	advcl	_	_
34	to	_	PRT	TO	_	37	case	_	_
35	the	_	DET	DT	_	37	det	_	_
36	upper	_	NOUN	NN	_	37	amod	_	_
37	torso	_	NOUN	NN	_	33	nmod	_	_
38	or	_	CONJ	CC	_	37	cc	_	_
39	upper	_	VERB	VBG	_	40	case	_	_
40	thigh	_	NOUN	NN	_	37	conj	_	_
41	,	_	.	,	_	29	punct	_	_
42	and	_	CONJ	CC	_	29	cc	_	_
43	absorption	_	NOUN	NN	_	51	nsubj	_	_
44	from	_	ADP	IN	_	47	case	_	_
45	these	_	DET	DT	_	47	det	_	_
46	two	_	NUM	CD	_	47	nummod	_	_
47	sites	_	NOUN	NNS	_	43	nmod	_	_
48	of	_	ADP	IN	_	49	case	_	_
49	administration	_	NOUN	NN	_	47	nmod	_	_
50	was	_	VERB	VBD	_	51	auxpass	_	_
51	equivalent	_	ADJ	JJ	_	29	conj	_	_

#	EMSAM	76
1	Following	_	VERB	VBG	_	3	case	_	_
2	dermal	_	ADJ	JJ	_	3	amod	_	_
3	application	_	NOUN	NN	_	14	nmod	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	radiolabeled	_	VERB	VBN	_	6	amod	_	_
6	DRUG	_	NOUN	NN	_	3	nmod	_	_
7	to	_	PRT	TO	_	9	case	_	_
8	laboratory	_	ADJ	JJ	_	9	amod	_	_
9	animals	_	NOUN	NNS	_	3	nmod	_	_
10	,	_	.	,	_	14	punct	_	_
11	DRUG	_	NOUN	NN	_	14	nsubjpass	_	_
12	is	_	VERB	VBZ	_	14	auxpass	_	_
13	rapidly	_	ADV	RB	_	14	advmod	_	_
14	distributed	_	VERB	VBN	_	0	root	_	_
15	to	_	PRT	TO	_	18	case	_	_
16	all	_	DET	DT	_	18	det	_	_
17	body	_	NOUN	NN	_	18	compound	_	_
18	tissues	_	NOUN	NNS	_	14	nmod	_	_

#	EMSAM	77
1	DRUG	_	NOUN	NN	_	3	nsubj	_	_
2	rapidly	_	ADV	RB	_	3	advmod	_	_
3	penetrates	_	VERB	VBZ	_	0	root	_	_
4	the	_	DET	DT	_	6	det	_	_
5	blood	_	NOUN	NN	_	6	compound	_	_
6	brain	_	NOUN	NN	_	3	dobj	_	_
7	barrier	_	ADJ	JJ	_	6	dep	_	_

#	EMSAM	78
1	In	_	ADP	IN	_	2	case	_	_
2	humans	_	NOUN	NNS	_	7	nmod	_	_
3	,	_	.	,	_	7	punct	_	_
4	DRUG	_	NOUN	NN	_	7	nsubj	_	_
5	is	_	VERB	VBZ	_	7	cop	_	_
6	approximately	_	ADV	RB	_	7	advmod	_	_
7	90%	_	ADJ	JJ	_	0	root	_	_
8	bound	_	VERB	VBN	_	7	acl	_	_
9	to	_	PRT	TO	_	11	case	_	_
10	plasma	_	NOUN	NN	_	11	compound	_	_
11	protein	_	NOUN	NN	_	8	nmod	_	_
12	over	_	ADP	IN	_	16	case	_	_
13	a	_	DET	DT	_	16	det	_	_
14	2	_	NUM	CD	_	16	nummod	_	_
15	to	_	PRT	TO	_	16	case	_	_
16	500ng	_	ADJ	JJ	_	8	nmod	_	_
17	per	_	ADP	IN	_	20	case	_	_
18	mL	_	NOUN	NN	_	20	compound	_	_
19	concentration	_	NOUN	NN	_	20	compound	_	_
20	range	_	NOUN	NN	_	16	nmod	_	_

#	EMSAM	79
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	does	_	VERB	VBZ	_	4	aux	_	_
3	not	_	ADV	RB	_	4	neg	_	_
4	accumulate	_	VERB	VB	_	0	root	_	_
5	in	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	skin	_	NOUN	NN	_	4	nmod	_	_

#	EMSAM	80
1	Transdermally	_	ADV	RB	_	2	advmod	_	_
2	absorbed	_	VERB	VBN	_	3	amod	_	_
3	DRUG	_	NOUN	NN	_	8	nsubjpass	_	_
4	via	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	is	_	VERB	VBZ	_	8	auxpass	_	_
7	not	_	ADV	RB	_	8	neg	_	_
8	metabolized	_	VERB	VBN	_	0	root	_	_
9	in	_	ADP	IN	_	11	case	_	_
10	human	_	ADJ	JJ	_	11	amod	_	_
11	skin	_	NOUN	NN	_	8	nmod	_	_
12	and	_	CONJ	CC	_	8	cc	_	_
13	does	_	VERB	VBZ	_	15	aux	_	_
14	not	_	ADV	RB	_	15	neg	_	_
15	undergo	_	VERB	VB	_	8	conj	_	_
16	extensive	_	ADJ	JJ	_	19	amod	_	_
17	first	_	ADJ	JJ	_	19	amod	_	_
18	pass	_	NOUN	NN	_	19	compound	_	_
19	metabolism	_	NOUN	NN	_	15	dobj	_	_

#	EMSAM	81
1	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
2	is	_	VERB	VBZ	_	4	auxpass	_	_
3	extensively	_	ADV	RB	_	4	advmod	_	_
4	metabolized	_	VERB	VBN	_	0	root	_	_
5	by	_	ADP	IN	_	10	case	_	_
6	several	_	ADJ	JJ	_	10	amod	_	_
7	CYP450	_	NOUN	NN	_	10	compound	_	_
8	dependent	_	ADJ	JJ	_	10	amod	_	_
9	enzyme	_	NOUN	NN	_	10	compound	_	_
10	systems	_	NOUN	NNS	_	4	nmod	_	_

#	EMSAM	82
1	DRUG	_	NOUN	NN	_	3	nsubjpass	_	_
2	is	_	VERB	VBZ	_	3	auxpass	_	_
3	metabolized	_	VERB	VBN	_	0	root	_	_
4	initially	_	ADV	RB	_	3	advmod	_	_
5	via	_	ADP	IN	_	7	case	_	_
6	N	_	NOUN	NN	_	7	compound	_	_
7	dealkylation	_	NOUN	NN	_	3	nmod	_	_
8	or	_	CONJ	CC	_	7	cc	_	_
9	N	_	NOUN	NN	_	10	compound	_	_
10	depropargylation	_	NOUN	NN	_	7	conj	_	_
11	to	_	PRT	TO	_	12	mark	_	_
12	form	_	VERB	VB	_	3	xcomp	_	_
13	N	_	NOUN	NN	_	15	compound	_	_
14	desmethyl	_	NOUN	NN	_	15	compound	_	_
15	DRUG	_	NOUN	NN	_	12	dobj	_	_
16	or	_	CONJ	CC	_	15	cc	_	_
17	R	_	NOUN	NN	_	18	compound	_	_
18	methamphetamine	_	NOUN	NN	_	15	conj	_	_
19	,	_	.	,	_	3	punct	_	_
20	respectively	_	ADV	RB	_	3	advmod	_	_

#	EMSAM	83
1	Both	_	DET	DT	_	8	nsubjpass	_	_
2	of	_	ADP	IN	_	4	case	_	_
3	these	_	DET	DT	_	4	det	_	_
4	metabolites	_	NOUN	NNS	_	1	nmod	_	_
5	can	_	VERB	MD	_	8	aux	_	_
6	be	_	VERB	VB	_	8	auxpass	_	_
7	further	_	ADV	RB	_	8	advmod	_	_
8	metabolized	_	VERB	VBN	_	0	root	_	_
9	to	_	PRT	TO	_	10	case	_	_
10	R	_	NOUN	NN	_	8	nmod	_	_
11	amphetamine	_	NOUN	NN	_	10	dep	_	_

#	EMSAM	84
1	These	_	DET	DT	_	2	det	_	_
2	metabolites	_	NOUN	NNS	_	7	nsubj	_	_
3	are	_	VERB	VBP	_	7	cop	_	_
4	all	_	DET	DT	_	7	det	_	_
5	levorotatory	_	ADJ	JJ	_	7	amod	_	_
6	l	_	NOUN	NN	_	7	compound	_	_
7	enantiomers	_	NOUN	NNS	_	0	root	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	no	_	ADV	RB	_	11	neg	_	_
10	racemic	_	ADJ	JJ	_	11	amod	_	_
11	biotransformation	_	NOUN	NN	_	7	conj	_	_
12	to	_	PRT	TO	_	16	case	_	_
13	the	_	DET	DT	_	16	det	_	_
14	dextrorotatory	_	ADJ	JJ	_	16	amod	_	_
15	form	_	NOUN	NN	_	16	compound	_	_
16	i.e	_	ADJ	JJ	_	11	nmod	_	_
17	,	_	.	,	_	7	punct	_	_
18	S(+	_	ADJ	JJ	_	19	amod	_	_
19	amphetamine	_	NOUN	NN	_	23	nsubj	_	_
20	or	_	CONJ	CC	_	19	cc	_	_
21	S(+	_	ADJ	JJ	_	22	amod	_	_
22	methamphetamine	_	NOUN	NN	_	19	conj	_	_
23	occurs	_	VERB	VBZ	_	7	parataxis	_	_

#	EMSAM	85
1	R	_	NOUN	NN	_	2	compound	_	_
2	methamphetamine	_	NOUN	NN	_	8	nsubjpass	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	R	_	NOUN	NN	_	5	compound	_	_
5	amphetamine	_	NOUN	NN	_	2	conj	_	_
6	are	_	VERB	VBP	_	8	auxpass	_	_
7	mainly	_	ADV	RB	_	8	advmod	_	_
8	excreted	_	VERB	VBN	_	0	root	_	_
9	unchanged	_	ADJ	JJ	_	8	xcomp	_	_
10	in	_	ADP	IN	_	11	mark	_	_
11	urine	_	VERB	VBG	_	8	advcl	_	_

#	EMSAM	86
1	In	_	X	FW	_	3	amod	_	_
2	vitro	_	X	FW	_	1	dep	_	_
3	studies	_	NOUN	NNS	_	8	nsubj	_	_
4	utilizing	_	VERB	VBG	_	3	acl	_	_
5	human	_	ADJ	JJ	_	7	amod	_	_
6	liver	_	NOUN	NN	_	7	compound	_	_
7	microsomes	_	NOUN	NNS	_	4	dobj	_	_
8	demonstrated	_	VERB	VBD	_	0	root	_	_
9	that	_	ADP	IN	_	15	mark	_	_
10	several	_	ADJ	JJ	_	13	amod	_	_
11	CYP450	_	NOUN	NN	_	13	compound	_	_
12	dependent	_	ADJ	JJ	_	13	amod	_	_
13	enzymes	_	NOUN	NNS	_	15	nsubjpass	_	_
14	are	_	VERB	VBP	_	15	auxpass	_	_
15	involved	_	VERB	VBN	_	8	ccomp	_	_
16	in	_	ADP	IN	_	18	case	_	_
17	the	_	DET	DT	_	18	det	_	_
18	metabolism	_	NOUN	NN	_	15	nmod	_	_
19	of	_	ADP	IN	_	20	case	_	_
20	DRUG	_	NOUN	NN	_	18	nmod	_	_
21	and	_	CONJ	CC	_	18	cc	_	_
22	its	_	PRON	PRP$	_	23	nmod:poss	_	_
23	metabolites	_	NOUN	NNS	_	18	conj	_	_

#	EMSAM	87
1	CYP2B6	_	NOUN	NN	_	8	nsubj	_	_
2	,	_	.	,	_	1	punct	_	_
3	CYP2C9	_	NOUN	NN	_	1	conj	_	_
4	,	_	.	,	_	1	punct	_	_
5	CYP3A4	_	NOUN	NN	_	1	conj	_	_
6	and	_	CONJ	CC	_	1	cc	_	_
7	CYP3A5	_	NOUN	NN	_	1	conj	_	_
8	appeared	_	VERB	VBD	_	0	root	_	_
9	to	_	PRT	TO	_	14	mark	_	_
10	be	_	VERB	VB	_	14	cop	_	_
11	the	_	DET	DT	_	14	det	_	_
12	major	_	ADJ	JJ	_	14	amod	_	_
13	contributing	_	VERB	VBG	_	14	amod	_	_
14	enzymes	_	NOUN	NNS	_	8	xcomp	_	_
15	in	_	ADP	IN	_	17	case	_	_
16	the	_	DET	DT	_	17	det	_	_
17	formation	_	NOUN	NN	_	14	nmod	_	_
18	of	_	ADP	IN	_	20	case	_	_
19	R	_	NOUN	NN	_	20	compound	_	_
20	methamphetamine	_	NOUN	NN	_	17	nmod	_	_
21	from	_	ADP	IN	_	22	case	_	_
22	DRUG	_	NOUN	NN	_	17	nmod	_	_
23	,	_	.	,	_	8	punct	_	_
24	with	_	ADP	IN	_	25	case	_	_
25	CYP2A6	_	NOUN	NN	_	8	nmod	_	_
26	having	_	VERB	VBG	_	25	acl	_	_
27	a	_	DET	DT	_	29	det	_	_
28	minor	_	ADJ	JJ	_	29	amod	_	_
29	role	_	NOUN	NN	_	26	dobj	_	_

#	EMSAM	88
1	CYP2A6	_	NOUN	NN	_	8	nsubj	_	_
2	,	_	.	,	_	1	punct	_	_
3	CYP2B6	_	NOUN	NN	_	1	conj	_	_
4	,	_	.	,	_	1	punct	_	_
5	CYP3A4	_	NOUN	NN	_	1	conj	_	_
6	and	_	CONJ	CC	_	1	cc	_	_
7	CYP3A5	_	NOUN	NN	_	1	conj	_	_
8	appeared	_	VERB	VBD	_	0	root	_	_
9	to	_	PRT	TO	_	10	mark	_	_
10	contribute	_	VERB	VB	_	8	xcomp	_	_
11	to	_	PRT	TO	_	13	case	_	_
12	the	_	DET	DT	_	13	det	_	_
13	formation	_	NOUN	NN	_	10	nmod	_	_
14	of	_	ADP	IN	_	16	case	_	_
15	R	_	NOUN	NN	_	16	compound	_	_
16	amphetamine	_	NOUN	NN	_	13	nmod	_	_
17	from	_	ADP	IN	_	20	case	_	_
18	N	_	NOUN	NN	_	20	compound	_	_
19	desmethyl	_	NOUN	NN	_	20	compound	_	_
20	DRUG	_	NOUN	NN	_	16	nmod	_	_

#	EMSAM	89
1	The	_	DET	DT	_	2	det	_	_
2	potential	_	NOUN	NN	_	18	nsubjpass	_	_
3	for	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	or	_	CONJ	CC	_	4	cc	_	_
6	N	_	NOUN	NN	_	8	compound	_	_
7	desmethyl	_	NOUN	NN	_	8	compound	_	_
8	DRUG	_	NOUN	NN	_	4	conj	_	_
9	to	_	PRT	TO	_	10	mark	_	_
10	inhibit	_	VERB	VB	_	2	acl	_	_
11	individual	_	ADJ	JJ	_	15	amod	_	_
12	CYP450	_	NOUN	NN	_	15	compound	_	_
13	dependent	_	ADJ	JJ	_	15	amod	_	_
14	enzyme	_	NOUN	NN	_	15	compound	_	_
15	pathways	_	NOUN	NNS	_	10	dobj	_	_
16	was	_	VERB	VBD	_	18	auxpass	_	_
17	also	_	ADV	RB	_	18	advmod	_	_
18	examined	_	VERB	VBN	_	0	root	_	_
19	in	_	X	FW	_	20	compound	_	_
20	vitro	_	X	FW	_	18	advmod	_	_
21	with	_	ADP	IN	_	24	case	_	_
22	human	_	ADJ	JJ	_	24	amod	_	_
23	liver	_	NOUN	NN	_	24	compound	_	_
24	microsomes	_	NOUN	NNS	_	18	nmod	_	_

#	EMSAM	90
1	Each	_	DET	DT	_	2	det	_	_
2	substrate	_	NOUN	NN	_	4	nsubjpass	_	_
3	was	_	VERB	VBD	_	4	auxpass	_	_
4	examined	_	VERB	VBN	_	0	root	_	_
5	over	_	ADP	IN	_	8	case	_	_
6	a	_	DET	DT	_	8	det	_	_
7	concentration	_	NOUN	NN	_	8	compound	_	_
8	range	_	NOUN	NN	_	4	nmod	_	_
9	of	_	ADP	IN	_	12	case	_	_
10	2.5	_	NUM	CD	_	12	nummod	_	_
11	to	_	PRT	TO	_	12	case	_	_
12	250mcM	_	NOUN	NN	_	8	nmod	_	_

#	EMSAM	91
1	Consistent	_	ADJ	JJ	_	12	advmod	_	_
2	with	_	ADP	IN	_	4	case	_	_
3	competitive	_	ADJ	JJ	_	4	amod	_	_
4	inhibition	_	NOUN	NN	_	1	nmod	_	_
5	,	_	.	,	_	12	punct	_	_
6	both	_	CONJ	CC	_	7	cc:preconj	_	_
7	DRUG	_	NOUN	NN	_	12	nsubj	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	N	_	NOUN	NN	_	11	compound	_	_
10	desmethyl	_	NOUN	NN	_	11	compound	_	_
11	DRUG	_	NOUN	NN	_	7	conj	_	_
12	caused	_	VERB	VBD	_	0	root	_	_
13	a	_	DET	DT	_	16	det	_	_
14	concentration	_	NOUN	NN	_	16	compound	_	_
15	dependent	_	ADJ	JJ	_	16	amod	_	_
16	inhibition	_	NOUN	NN	_	12	dobj	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	CYP2D6	_	NOUN	NN	_	16	nmod	_	_
19	at	_	ADP	IN	_	22	case	_	_
20	10	_	NUM	CD	_	22	nummod	_	_
21	to	_	PRT	TO	_	22	case	_	_
22	250mcM	_	NOUN	NN	_	16	nmod	_	_
23	and	_	CONJ	CC	_	22	cc	_	_
24	CYP3A4	_	NOUN	NN	_	22	conj	_	_
25	and	_	CONJ	CC	_	22	cc	_	_
26	CYP3A5	_	NOUN	NN	_	22	conj	_	_
27	at	_	ADP	IN	_	30	case	_	_
28	25	_	NUM	CD	_	30	compound	_	_
29	to	_	PRT	TO	_	30	case	_	_
30	250mcM	_	NOUN	NN	_	16	nmod	_	_

#	EMSAM	92
1	CYP2C19	_	NOUN	NN	_	6	nsubjpass	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	CYP2B6	_	NOUN	NN	_	1	conj	_	_
4	were	_	VERB	VBD	_	6	auxpass	_	_
5	also	_	ADV	RB	_	6	advmod	_	_
6	inhibited	_	VERB	VBN	_	0	root	_	_
7	at	_	ADP	IN	_	8	case	_	_
8	concentrations	_	NOUN	NNS	_	6	nmod	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	100mcM	_	NOUN	NN	_	8	nmod	_	_
11	or	_	CONJ	CC	_	10	cc	_	_
12	greater	_	ADJ	JJ	_	10	conj	_	_

#	EMSAM	93
1	All	_	DET	DT	_	3	det	_	_
2	inhibitory	_	ADJ	JJ	_	3	amod	_	_
3	effects	_	NOUN	NNS	_	10	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	N	_	NOUN	NN	_	9	compound	_	_
8	desmethyl	_	NOUN	NN	_	9	compound	_	_
9	DRUG	_	NOUN	NN	_	5	conj	_	_
10	occurred	_	VERB	VBD	_	0	root	_	_
11	at	_	ADP	IN	_	12	case	_	_
12	concentrations	_	NOUN	NNS	_	10	nmod	_	_
13	that	_	DET	WDT	_	16	nsubj	_	_
14	are	_	VERB	VBP	_	16	cop	_	_
15	several	_	ADJ	JJ	_	16	amod	_	_
16	orders	_	NOUN	NNS	_	12	acl:relcl	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	magnitude	_	NOUN	NN	_	16	nmod	_	_
19	higher	_	ADJ	JJ	_	18	amod	_	_
20	than	_	ADP	IN	_	21	case	_	_
21	concentrations	_	NOUN	NNS	_	19	nmod	_	_
22	seen	_	VERB	VBN	_	21	acl	_	_
23	clinically	_	ADV	RB	_	24	advmod	_	_
24	highest	_	ADJ	JJ	_	26	amod	_	_
25	predose	_	NOUN	NN	_	26	compound	_	_
26	concentration	_	NOUN	NN	_	22	dobj	_	_
27	observed	_	VERB	VBN	_	26	acl	_	_
28	at	_	ADP	IN	_	30	case	_	_
29	a	_	DET	DT	_	30	det	_	_
30	dose	_	NOUN	NN	_	27	nmod	_	_
31	of	_	ADP	IN	_	32	case	_	_
32	12mg	_	ADJ	JJ	_	30	nmod	_	_
33	per	_	ADP	IN	_	35	case	_	_
34	24	_	NUM	CD	_	35	nummod	_	_
35	hours	_	NOUN	NNS	_	30	nmod	_	_
36	at	_	ADP	IN	_	38	case	_	_
37	steady	_	ADJ	JJ	_	38	amod	_	_
38	state	_	NOUN	NN	_	30	nmod	_	_
39	was	_	VERB	VBD	_	40	auxpass	_	_
40	0.046mcM	_	NOUN	NN	_	10	advcl	_	_

#	EMSAM	94
1	Approximately	_	ADV	RB	_	9	advmod	_	_
2	10%	_	ADJ	JJ	_	9	nsubj	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	2%	_	NOUN	NN	_	2	conj	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	a	_	DET	DT	_	8	det	_	_
7	radiolabeled	_	ADJ	JJ	_	8	amod	_	_
8	dose	_	NOUN	NN	_	2	nmod	_	_
9	applied	_	VERB	VBD	_	0	root	_	_
10	dermally	_	ADV	RB	_	9	advmod	_	_
11	,	_	.	,	_	9	punct	_	_
12	as	_	ADP	IN	_	15	case	_	_
13	a	_	DET	DT	_	15	det	_	_
14	DMSO	_	NOUN	NN	_	15	compound	_	_
15	solution	_	NOUN	NN	_	9	nmod	_	_
16	,	_	.	,	_	9	punct	_	_
17	was	_	VERB	VBD	_	18	auxpass	_	_
18	recovered	_	VERB	VBN	_	9	parataxis	_	_
19	in	_	ADP	IN	_	20	case	_	_
20	urine	_	ADJ	JJ	_	18	nmod	_	_
21	and	_	CONJ	CC	_	20	cc	_	_
22	feces	_	NOUN	NNS	_	20	conj	_	_
23	respectively	_	ADV	RB	_	18	advmod	_	_
24	,	_	.	,	_	18	punct	_	_
25	with	_	ADP	IN	_	28	case	_	_
26	at	_	ADP	IN	_	28	amod	_	_
27	least	_	ADJ	JJS	_	26	dep	_	_
28	63%	_	NOUN	NN	_	18	nmod	_	_
29	of	_	ADP	IN	_	31	case	_	_
30	the	_	DET	DT	_	31	det	_	_
31	dose	_	NOUN	NN	_	28	nmod	_	_
32	remaining	_	VERB	VBG	_	31	acl	_	_
33	unabsorbed	_	ADJ	JJ	_	32	nmod	_	_

#	EMSAM	95
1	The	_	DET	DT	_	3	det	_	_
2	remaining	_	VERB	VBG	_	3	amod	_	_
3	25%	_	NOUN	NN	_	8	nsubj	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	the	_	DET	DT	_	6	det	_	_
6	dose	_	NOUN	NN	_	3	nmod	_	_
7	was	_	VERB	VBD	_	8	cop	_	_
8	unaccounted	_	ADJ	JJ	_	0	root	_	_
9	for	_	ADP	IN	_	8	root	_	_

#	EMSAM	96
1	Urinary	_	ADJ	JJ	_	2	amod	_	_
2	excretion	_	NOUN	NN	_	0	root	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	unchanged	_	ADJ	JJ	_	5	amod	_	_
5	DRUG	_	NOUN	NN	_	2	nmod	_	_
6	accounted	_	VERB	VBN	_	2	acl	_	_
7	for	_	ADP	IN	_	8	case	_	_
8	0.1%	_	NOUN	NN	_	6	nmod	_	_
9	of	_	ADP	IN	_	12	case	_	_
10	the	_	DET	DT	_	12	det	_	_
11	applied	_	ADJ	JJ	_	12	amod	_	_
12	dose	_	NOUN	NN	_	8	nmod	_	_
13	with	_	ADP	IN	_	15	case	_	_
14	the	_	DET	DT	_	15	det	_	_
15	remainder	_	NOUN	NN	_	6	nmod	_	_
16	of	_	ADP	IN	_	18	case	_	_
17	the	_	DET	DT	_	18	det	_	_
18	dose	_	NOUN	NN	_	15	nmod	_	_
19	recovered	_	VERB	VBN	_	18	acl	_	_
20	in	_	ADP	IN	_	23	case	_	_
21	urine	_	ADJ	JJ	_	23	compound	_	_
22	being	_	VERB	VBZ	_	23	compound	_	_
23	metabolites	_	NOUN	NNS	_	19	nmod	_	_

#	EMSAM	97
1	The	_	DET	DT	_	3	det	_	_
2	systemic	_	ADJ	JJ	_	3	amod	_	_
3	clearance	_	NOUN	NN	_	11	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	after	_	ADP	IN	_	8	case	_	_
7	intravenous	_	ADJ	JJ	_	8	amod	_	_
8	administration	_	NOUN	NN	_	3	nmod	_	_
9	was	_	VERB	VBD	_	11	cop	_	_
10	1.4	_	NUM	CD	_	11	nummod	_	_
11	L	_	NOUN	NN	_	0	root	_	_
12	per	_	ADP	IN	_	13	case	_	_
13	min	_	NOUN	NN	_	11	nmod	_	_
14	,	_	.	,	_	11	punct	_	_
15	and	_	CONJ	CC	_	11	cc	_	_
16	the	_	DET	DT	_	19	det	_	_
17	mean	_	ADJ	JJ	_	19	amod	_	_
18	half	_	ADJ	JJ	_	19	amod	_	_
19	lives	_	NOUN	NNS	_	11	conj	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	DRUG	_	NOUN	NN	_	19	nmod	_	_
22	and	_	CONJ	CC	_	19	cc	_	_
23	its	_	PRON	PRP$	_	25	nmod:poss	_	_
24	three	_	NUM	CD	_	25	nummod	_	_
25	metabolites	_	NOUN	NNS	_	19	conj	_	_
26	,	_	.	,	_	25	punct	_	_
27	R	_	NOUN	NN	_	30	compound	_	_
28	N	_	NOUN	NN	_	30	compound	_	_
29	desmethyl	_	NOUN	NN	_	30	compound	_	_
30	DRUG	_	NOUN	NN	_	25	conj	_	_
31	,	_	.	,	_	25	punct	_	_
32	R	_	NOUN	NN	_	33	compound	_	_
33	amphetamine	_	NOUN	NN	_	25	conj	_	_
34	,	_	.	,	_	25	punct	_	_
35	and	_	CONJ	CC	_	25	cc	_	_
36	R	_	NOUN	NN	_	37	compound	_	_
37	methamphetamine	_	NOUN	NN	_	25	conj	_	_
38	,	_	.	,	_	19	punct	_	_
39	ranged	_	VERB	VBN	_	19	acl	_	_
40	from	_	ADP	IN	_	44	case	_	_
41	18	_	NUM	CD	_	43	compound	_	_
42	to	_	PRT	TO	_	43	dep	_	_
43	25	_	NUM	CD	_	44	nummod	_	_
44	hours	_	NOUN	NNS	_	39	nmod	_	_

#	EMSAM	98
1	DRUG	_	NOUN	NN	_	5	nsubjpass	_	_
2	should	_	VERB	MD	_	5	aux	_	_
3	not	_	ADV	RB	_	5	neg	_	_
4	be	_	VERB	VB	_	5	auxpass	_	_
5	used	_	VERB	VBN	_	0	root	_	_
6	in	_	ADP	IN	_	7	case	_	_
7	patients	_	NOUN	NNS	_	5	nmod	_	_
8	less	_	ADV	RB	_	10	advmod	_	_
9	than	_	ADP	IN	_	8	mwe	_	_
10	18	_	NUM	CD	_	11	nummod	_	_
11	years	_	NOUN	NNS	_	5	nmod	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	age	_	NOUN	NN	_	11	nmod	_	_

#	EMSAM	99
1	Stratification	_	NOUN	NN	_	9	nsubj	_	_
2	of	_	ADP	IN	_	4	case	_	_
3	exposure	_	NOUN	NN	_	4	compound	_	_
4	data	_	NOUN	NNS	_	1	nmod	_	_
5	following	_	VERB	VBG	_	6	case	_	_
6	treatment	_	NOUN	NN	_	1	nmod	_	_
7	with	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	indicated	_	VERB	VBD	_	0	root	_	_
10	that	_	ADP	IN	_	20	mark	_	_
11	pre	_	NOUN	NN	_	16	compound	_	_
12	dose	_	NOUN	NN	_	16	compound	_	_
13	trough	_	NOUN	NN	_	16	compound	_	_
14	DRUG	_	NOUN	NN	_	16	compound	_	_
15	plasma	_	NOUN	NN	_	16	compound	_	_
16	concentrations	_	NOUN	NNS	_	20	nsubj	_	_
17	at	_	ADP	IN	_	19	case	_	_
18	steady	_	ADJ	JJ	_	19	amod	_	_
19	state	_	NOUN	NN	_	16	nmod	_	_
20	appeared	_	VERB	VBD	_	9	ccomp	_	_
21	higher	_	ADJ	JJ	_	22	amod	_	_
22	p	_	NOUN	NN	_	20	dobj	_	_
23	=	_	ADJ	JJ	_	22	amod	_	_
24	0.12	_	NUM	CD	_	23	dep	_	_
25	in	_	ADP	IN	_	30	case	_	_
26	children	_	NOUN	NN	_	30	compound	_	_
27	aged	_	ADJ	JJ	_	30	amod	_	_
28	<	_	NUM	CD	_	30	nummod	_	_
29	12	_	NUM	CD	_	30	nummod	_	_
30	years	_	NOUN	NNS	_	23	nmod	_	_
31	old	_	ADJ	JJ	_	20	advmod	_	_
32	,	_	.	,	_	20	punct	_	_
33	compared	_	VERB	VBD	_	20	advcl	_	_
34	to	_	PRT	TO	_	35	case	_	_
35	adolescents	_	NOUN	NNS	_	33	nmod	_	_
36	aged	_	ADJ	JJ	_	39	amod	_	_
37	>	_	NUM	CD	_	39	nummod	_	_
38	12	_	NUM	CD	_	39	nummod	_	_
39	years	_	NOUN	NNS	_	35	dep	_	_
40	as	_	ADP	IN	_	41	mark	_	_
41	shown	_	VERB	VBN	_	33	advcl	_	_
42	in	_	ADP	IN	_	43	case	_	_
43	Table	_	ADJ	JJ	_	41	nmod	_	_
44	6	_	NUM	CD	_	43	dep	_	_

#	EMSAM	100
1	Steady	_	ADJ	JJ	_	5	amod	_	_
2	State	_	NOUN	NN	_	5	compound	_	_
3	DRUG	_	NOUN	NN	_	5	compound	_	_
4	Trough	_	NOUN	NN	_	5	compound	_	_
5	Concentrations	_	NOUN	NNS	_	0	root	_	_
6	Associated	_	VERB	VBN	_	5	acl	_	_
7	with	_	ADP	IN	_	8	case	_	_
8	Administration	_	NOUN	NN	_	6	nmod	_	_
9	of	_	ADP	IN	_	12	case	_	_
10	DRUG	_	NOUN	NN	_	12	compound	_	_
11	15	_	NUM	CD	_	12	nummod	_	_
12	mg	_	NOUN	NN	_	8	nmod	_	_
13	/	_	.	:	_	5	punct	_	_
14	15	_	NUM	CD	_	15	nummod	_	_
15	cm2	_	NOUN	NN	_	5	dep	_	_
16	Daily	_	ADV	RB	_	15	amod	_	_
17	for	_	ADP	IN	_	21	case	_	_
18	7	_	NUM	CD	_	21	nummod	_	_
19	Days	_	NOUN	NN	_	21	compound	_	_
20	Trough	_	NOUN	NN	_	21	compound	_	_
21	Concentration	_	NOUN	NN	_	16	nmod	_	_
22	,	_	.	,	_	15	punct	_	_
23	pg	_	NOUN	NN	_	25	compound	_	_
24	/	_	.	:	_	25	punct	_	_
25	mL	_	NOUN	NN	_	15	appos	_	_
26	6	_	NUM	CD	_	25	nummod	_	_
27	to	_	PRT	TO	_	32	case	_	_
28	11	_	NUM	CD	_	32	nummod	_	_
29	year	_	NOUN	NN	_	32	compound	_	_
30	old	_	ADJ	JJ	_	32	amod	_	_
31	age	_	NOUN	NN	_	32	compound	_	_
32	group	_	NOUN	NN	_	25	nmod	_	_
33	12	_	NUM	CD	_	32	nummod	_	_
34	to	_	PRT	TO	_	40	case	_	_
35	14	_	NUM	CD	_	36	nummod	_	_
36	year	_	NOUN	NN	_	40	amod	_	_
37	old	_	ADJ	JJ	_	40	amod	_	_
38	age	_	NOUN	NN	_	40	compound	_	_
39	group	_	NOUN	NN	_	40	compound	_	_
40	N	_	NOUN	NN	_	25	nmod	_	_
41	=	_	ADJ	JJ	_	25	dep	_	_
42	6	_	NUM	CD	_	43	nummod	_	_
43	N	_	NOUN	NN	_	44	nsubj	_	_
44	=	_	ADJ	JJ	_	41	dep	_	_
45	4	_	NUM	CD	_	53	nummod	_	_
46	Mean	_	NOUN	NN	_	53	compound	_	_
47	SD	_	NOUN	NN	_	53	compound	_	_
48	2,562	_	NUM	CD	_	53	nummod	_	_
49	974	_	NUM	CD	_	53	nummod	_	_
50	1,821	_	NUM	CD	_	53	nummod	_	_
51	146	_	NUM	CD	_	53	nummod	_	_
52	The	_	DET	DT	_	53	det	_	_
53	pharmacokinetics	_	NOUN	NNS	_	44	dobj	_	_
54	and	_	CONJ	CC	_	53	cc	_	_
55	pharmacodynamics	_	NOUN	NNS	_	53	conj	_	_
56	of	_	ADP	IN	_	58	case	_	_
57	alcohol	_	NOUN	NN	_	58	compound	_	_
58	0.75mg	_	NOUN	NN	_	53	nmod	_	_
59	per	_	ADP	IN	_	60	case	_	_
60	kg	_	NOUN	NN	_	53	nmod	_	_
61	alone	_	ADV	RB	_	60	advmod	_	_
62	or	_	CONJ	CC	_	44	cc	_	_
63	in	_	ADP	IN	_	64	case	_	_
64	combination	_	NOUN	NN	_	77	nsubjpass	_	_
65	with	_	ADP	IN	_	67	case	_	_
66	DRUG	_	NOUN	NN	_	67	compound	_	_
67	6mg	_	NOUN	NN	_	64	nmod	_	_
68	per	_	ADP	IN	_	70	case	_	_
69	24	_	NUM	CD	_	70	nummod	_	_
70	hours	_	NOUN	NNS	_	64	nmod	_	_
71	for	_	ADP	IN	_	73	case	_	_
72	7	_	NUM	CD	_	73	nummod	_	_
73	days	_	NOUN	NNS	_	64	nmod	_	_
74	of	_	ADP	IN	_	75	case	_	_
75	treatment	_	NOUN	NN	_	73	nmod	_	_
76	was	_	VERB	VBD	_	77	auxpass	_	_
77	examined	_	VERB	VBN	_	44	conj	_	_
78	in	_	ADP	IN	_	81	case	_	_
79	16	_	NUM	CD	_	81	nummod	_	_
80	healthy	_	ADJ	JJ	_	81	amod	_	_
81	volunteers	_	NOUN	NNS	_	77	nmod	_	_

#	EMSAM	101
1	No	_	DET	DT	_	4	neg	_	_
2	clinically	_	ADV	RB	_	3	advmod	_	_
3	significant	_	ADJ	JJ	_	4	amod	_	_
4	differences	_	NOUN	NNS	_	6	nsubjpass	_	_
5	were	_	VERB	VBD	_	6	auxpass	_	_
6	observed	_	VERB	VBN	_	0	root	_	_
7	in	_	ADP	IN	_	9	case	_	_
8	the	_	DET	DT	_	9	det	_	_
9	pharmacokinetics	_	NOUN	NNS	_	6	nmod	_	_
10	or	_	CONJ	CC	_	9	cc	_	_
11	pharmacodynamics	_	NOUN	NNS	_	9	conj	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	alcohol	_	NOUN	NN	_	9	nmod	_	_
14	or	_	CONJ	CC	_	9	cc	_	_
15	the	_	DET	DT	_	16	det	_	_
16	pharmacokinetics	_	NOUN	NNS	_	9	conj	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	DRUG	_	NOUN	NN	_	16	nmod	_	_
19	during	_	ADP	IN	_	21	case	_	_
20	co	_	ADP	IN	_	21	case	_	_
21	administration	_	NOUN	NN	_	16	nmod	_	_

#	EMSAM	102
1	Although	_	ADP	IN	_	6	mark	_	_
2	DRUG	_	NOUN	NN	_	6	nsubjpass	_	_
3	has	_	VERB	VBZ	_	6	aux	_	_
4	not	_	ADV	RB	_	6	neg	_	_
5	been	_	VERB	VBN	_	6	auxpass	_	_
6	shown	_	VERB	VBN	_	35	advcl	_	_
7	to	_	PRT	TO	_	8	mark	_	_
8	increase	_	VERB	VB	_	6	xcomp	_	_
9	the	_	DET	DT	_	10	det	_	_
10	impairment	_	NOUN	NN	_	8	dobj	_	_
11	of	_	ADP	IN	_	15	case	_	_
12	mental	_	ADJ	JJ	_	15	amod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	motor	_	NOUN	NN	_	12	conj	_	_
15	skills	_	NOUN	NNS	_	10	nmod	_	_
16	caused	_	VERB	VBN	_	15	acl	_	_
17	by	_	ADP	IN	_	19	case	_	_
18	alcohol	_	NOUN	NN	_	19	compound	_	_
19	0.75mg	_	NOUN	NN	_	16	nmod	_	_
20	per	_	ADP	IN	_	21	case	_	_
21	kg	_	NOUN	NN	_	19	nmod	_	_
22	and	_	CONJ	CC	_	6	cc	_	_
23	failed	_	VERB	VBD	_	6	conj	_	_
24	to	_	PRT	TO	_	25	mark	_	_
25	alter	_	VERB	VB	_	23	xcomp	_	_
26	the	_	DET	DT	_	28	det	_	_
27	pharmacokinetic	_	ADJ	JJ	_	28	amod	_	_
28	properties	_	NOUN	NNS	_	25	dobj	_	_
29	of	_	ADP	IN	_	30	case	_	_
30	alcohol	_	NOUN	NN	_	28	nmod	_	_
31	,	_	.	,	_	35	punct	_	_
32	patients	_	NOUN	NNS	_	35	nsubjpass	_	_
33	should	_	VERB	MD	_	35	aux	_	_
34	be	_	VERB	VB	_	35	auxpass	_	_
35	advised	_	VERB	VBN	_	0	root	_	_
36	that	_	ADP	IN	_	43	mark	_	_
37	the	_	DET	DT	_	38	det	_	_
38	use	_	NOUN	NN	_	43	nsubjpass	_	_
39	of	_	ADP	IN	_	40	case	_	_
40	alcohol	_	NOUN	NN	_	38	nmod	_	_
41	is	_	VERB	VBZ	_	43	auxpass	_	_
42	not	_	ADV	RB	_	43	neg	_	_
43	recommended	_	VERB	VBN	_	35	ccomp	_	_
44	while	_	ADP	IN	_	45	mark	_	_
45	taking	_	VERB	VBG	_	43	advcl	_	_
46	DRUG	_	NOUN	NN	_	45	dobj	_	_

#	EMSAM	103
1	In	_	ADP	IN	_	2	case	_	_
2	subjects	_	NOUN	NNS	_	33	nmod	_	_
3	who	_	DET	WDT	_	5	nsubj	_	_
4	had	_	VERB	MD	_	5	aux	_	_
5	received	_	VERB	VBN	_	2	acl:relcl	_	_
6	DRUG	_	NOUN	NN	_	8	compound	_	_
7	6	_	NUM	CD	_	8	nummod	_	_
8	mg	_	NOUN	NN	_	5	dobj	_	_
9	per	_	ADP	IN	_	11	case	_	_
10	24	_	NUM	CD	_	11	nummod	_	_
11	hours	_	NOUN	NNS	_	5	nmod	_	_
12	for	_	ADP	IN	_	14	case	_	_
13	7	_	NUM	CD	_	14	nummod	_	_
14	days	_	NOUN	NNS	_	11	nmod	_	_
15	,	_	.	,	_	33	punct	_	_
16	co	_	PRT	TO	_	17	case	_	_
17	administration	_	NOUN	NN	_	33	nsubj	_	_
18	with	_	ADP	IN	_	21	case	_	_
19	alprazolam	_	NOUN	NN	_	21	compound	_	_
20	15	_	NUM	CD	_	21	nummod	_	_
21	mg	_	NOUN	NN	_	17	nmod	_	_
22	per	_	ADP	IN	_	23	case	_	_
23	day	_	NOUN	NN	_	17	nmod	_	_
24	,	_	.	,	_	23	punct	_	_
25	a	_	DET	DT	_	26	dep	_	_
26	CYP3A4	_	NOUN	NN	_	23	appos	_	_
27	and	_	CONJ	CC	_	26	cc	_	_
28	CYP3A5	_	NOUN	NN	_	26	conj	_	_
29	substrate	_	NOUN	NN	_	26	dep	_	_
30	,	_	.	,	_	17	punct	_	_
31	did	_	VERB	MD	_	33	aux	_	_
32	not	_	ADV	RB	_	33	neg	_	_
33	affect	_	VERB	VB	_	0	root	_	_
34	the	_	DET	DT	_	35	det	_	_
35	pharmacokinetics	_	NOUN	NNS	_	33	dobj	_	_
36	of	_	ADP	IN	_	37	case	_	_
37	alprazolam	_	NOUN	NN	_	35	nmod	_	_
38	or	_	CONJ	CC	_	37	cc	_	_
39	DRUG	_	NOUN	NN	_	37	conj	_	_

#	EMSAM	104
1	Carbamazepine	_	NOUN	NN	_	5	nsubj	_	_
2	is	_	VERB	VBZ	_	5	cop	_	_
3	an	_	DET	DT	_	5	det	_	_
4	enzyme	_	NOUN	NN	_	5	compound	_	_
5	inducer	_	NOUN	NN	_	0	root	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	typically	_	ADV	RB	_	8	advmod	_	_
8	causes	_	VERB	VBZ	_	5	conj	_	_
9	decreases	_	NOUN	NNS	_	8	dobj	_	_
10	in	_	ADP	IN	_	12	case	_	_
11	drug	_	NOUN	NN	_	12	compound	_	_
12	exposure	_	NOUN	NN	_	9	nmod	_	_
13	however	_	ADV	RB	_	5	advmod	_	_
14	,	_	.	,	_	5	punct	_	_
15	approximately	_	ADV	RB	_	16	advmod	_	_
16	2	_	NUM	CD	_	17	nummod	_	_
17	fold	_	NOUN	NN	_	18	nsubj	_	_
18	increased	_	VERB	VBD	_	5	conj	_	_
19	systemic	_	ADJ	JJ	_	20	amod	_	_
20	exposure	_	NOUN	NN	_	18	dobj	_	_
21	of	_	ADP	IN	_	22	case	_	_
22	DRUG	_	NOUN	NN	_	20	nmod	_	_
23	and	_	CONJ	CC	_	22	cc	_	_
24	its	_	PRON	PRP$	_	25	nmod:poss	_	_
25	metabolites	_	NOUN	NNS	_	22	conj	_	_
26	,	_	.	,	_	5	punct	_	_
27	L	_	NOUN	NN	_	28	compound	_	_
28	amphetamine	_	NOUN	NN	_	33	nsubjpass	_	_
29	and	_	CONJ	CC	_	28	cc	_	_
30	L	_	NOUN	NN	_	31	compound	_	_
31	methamphetamine	_	NOUN	NN	_	28	conj	_	_
32	were	_	VERB	VBD	_	33	auxpass	_	_
33	seen	_	VERB	VBN	_	5	dep	_	_
34	after	_	ADP	IN	_	36	case	_	_
35	single	_	ADJ	JJ	_	36	amod	_	_
36	application	_	NOUN	NN	_	33	nmod	_	_
37	of	_	ADP	IN	_	40	case	_	_
38	DRUG	_	NOUN	NN	_	40	compound	_	_
39	6	_	NUM	CD	_	40	nummod	_	_
40	mg	_	NOUN	NN	_	36	nmod	_	_
41	per	_	ADP	IN	_	43	case	_	_
42	24	_	NUM	CD	_	43	nummod	_	_
43	hours	_	NOUN	NNS	_	36	nmod	_	_
44	in	_	ADP	IN	_	45	case	_	_
45	subjects	_	NOUN	NNS	_	43	nmod	_	_
46	who	_	DET	WDT	_	48	nsubj	_	_
47	had	_	VERB	MD	_	48	aux	_	_
48	received	_	VERB	VBN	_	45	acl:relcl	_	_
49	carbamazepine	_	NOUN	NN	_	50	compound	_	_
50	400mg	_	NOUN	NN	_	48	dobj	_	_
51	per	_	ADP	IN	_	52	case	_	_
52	day	_	NOUN	NN	_	48	nmod	_	_
53	for	_	ADP	IN	_	55	case	_	_
54	14	_	NUM	CD	_	55	nummod	_	_
55	days	_	NOUN	NNS	_	52	nmod	_	_

#	EMSAM	105
1	Changes	_	NOUN	NNS	_	9	nsubj	_	_
2	in	_	ADP	IN	_	5	case	_	_
3	plasma	_	NOUN	NN	_	5	compound	_	_
4	DRUG	_	NOUN	NN	_	5	compound	_	_
5	concentrations	_	NOUN	NNS	_	1	nmod	_	_
6	were	_	VERB	VBD	_	9	cop	_	_
7	nearly	_	ADV	RB	_	8	advmod	_	_
8	2	_	NUM	CD	_	9	nummod	_	_
9	fold	_	NOUN	NN	_	0	root	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	variable	_	ADJ	JJ	_	9	conj	_	_
12	across	_	ADP	IN	_	15	case	_	_
13	the	_	DET	DT	_	15	det	_	_
14	subject	_	NOUN	NN	_	15	compound	_	_
15	population	_	NOUN	NN	_	11	nmod	_	_

#	EMSAM	106
1	Such	_	ADJ	JJ	_	2	amod	_	_
2	increases	_	NOUN	NNS	_	4	nsubj	_	_
3	may	_	VERB	MD	_	4	aux	_	_
4	increase	_	VERB	VB	_	0	root	_	_
5	the	_	DET	DT	_	6	det	_	_
6	risk	_	NOUN	NN	_	4	dobj	_	_
7	of	_	ADP	IN	_	10	case	_	_
8	a	_	DET	DT	_	10	det	_	_
9	hypertensive	_	ADJ	JJ	_	10	amod	_	_
10	crisis	_	NOUN	NN	_	6	nmod	_	_
11	when	_	ADV	WRB	_	14	advmod	_	_
12	carbamazepine	_	NOUN	NN	_	14	nsubjpass	_	_
13	is	_	VERB	VBZ	_	14	auxpass	_	_
14	used	_	VERB	VBN	_	4	advcl	_	_
15	with	_	ADP	IN	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	14	nmod	_	_
17	at	_	ADP	IN	_	19	case	_	_
18	any	_	DET	DT	_	19	det	_	_
19	dose	_	NOUN	NN	_	14	nmod	_	_

#	EMSAM	107
1	In	_	ADP	IN	_	2	case	_	_
2	subjects	_	NOUN	NNS	_	27	nmod	_	_
3	who	_	DET	WDT	_	5	nsubj	_	_
4	had	_	VERB	MD	_	5	aux	_	_
5	received	_	VERB	VBN	_	2	acl:relcl	_	_
6	DRUG	_	NOUN	NN	_	7	compound	_	_
7	6mg	_	NOUN	NN	_	5	dobj	_	_
8	per	_	ADP	IN	_	10	case	_	_
9	24	_	NUM	CD	_	10	nummod	_	_
10	hours	_	NOUN	NNS	_	5	nmod	_	_
11	for	_	ADP	IN	_	13	case	_	_
12	11	_	NUM	CD	_	13	nummod	_	_
13	days	_	NOUN	NNS	_	10	nmod	_	_
14	,	_	.	,	_	27	punct	_	_
15	combined	_	VERB	VBN	_	16	amod	_	_
16	administration	_	NOUN	NN	_	27	nsubj	_	_
17	with	_	ADP	IN	_	24	case	_	_
18	the	_	DET	DT	_	24	det	_	_
19	CYP2C9	_	NOUN	NN	_	24	compound	_	_
20	substrate	_	NOUN	NN	_	24	compound	_	_
21	ibuprofen	_	NOUN	NN	_	24	compound	_	_
22	800mg	_	ADJ	JJ	_	24	amod	_	_
23	single	_	ADJ	JJ	_	24	amod	_	_
24	dose	_	NOUN	NN	_	16	nmod	_	_
25	did	_	VERB	VBD	_	27	aux	_	_
26	not	_	ADV	RB	_	27	neg	_	_
27	affect	_	VERB	VB	_	0	root	_	_
28	the	_	DET	DT	_	29	det	_	_
29	pharmacokinetics	_	NOUN	NNS	_	27	dobj	_	_
30	of	_	ADP	IN	_	32	case	_	_
31	either	_	CONJ	CC	_	32	cc:preconj	_	_
32	DRUG	_	NOUN	NN	_	29	nmod	_	_
33	or	_	CONJ	CC	_	32	cc	_	_
34	ibuprofen	_	NOUN	NN	_	32	conj	_	_

#	EMSAM	108
1	Seven	_	NUM	CD	_	3	nummod	_	_
2	day	_	NOUN	NN	_	3	compound	_	_
3	treatment	_	NOUN	NN	_	18	nsubj	_	_
4	with	_	ADP	IN	_	6	case	_	_
5	ketoconazole	_	NOUN	NN	_	6	compound	_	_
6	200mg	_	NOUN	NN	_	3	nmod	_	_
7	per	_	ADP	IN	_	8	case	_	_
8	day	_	NOUN	NN	_	3	nmod	_	_
9	,	_	.	,	_	8	punct	_	_
10	a	_	DET	DT	_	12	det	_	_
11	potent	_	ADJ	JJ	_	12	amod	_	_
12	inhibitor	_	NOUN	NN	_	8	appos	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	CYP3A4	_	NOUN	NN	_	12	nmod	_	_
15	,	_	.	,	_	3	punct	_	_
16	did	_	VERB	MD	_	18	aux	_	_
17	not	_	ADV	RB	_	18	neg	_	_
18	affect	_	VERB	VB	_	0	root	_	_
19	the	_	DET	DT	_	22	det	_	_
20	steady	_	ADJ	JJ	_	22	amod	_	_
21	state	_	NOUN	NN	_	22	compound	_	_
22	pharmacokinetics	_	NOUN	NNS	_	18	dobj	_	_
23	of	_	ADP	IN	_	24	case	_	_
24	DRUG	_	NOUN	NN	_	22	nmod	_	_
25	in	_	ADP	IN	_	26	case	_	_
26	subjects	_	NOUN	NNS	_	22	nmod	_	_
27	who	_	DET	WDT	_	28	nsubj	_	_
28	received	_	VERB	VBD	_	26	acl:relcl	_	_
29	DRUG	_	NOUN	NN	_	30	compound	_	_
30	6mg	_	NOUN	NN	_	28	dobj	_	_
31	per	_	ADP	IN	_	33	case	_	_
32	24	_	NUM	CD	_	33	nummod	_	_
33	hours	_	NOUN	NNS	_	28	nmod	_	_
34	for	_	ADP	IN	_	36	case	_	_
35	7	_	NUM	CD	_	36	nummod	_	_
36	days	_	NOUN	NNS	_	33	nmod	_	_
37	and	_	CONJ	CC	_	28	cc	_	_
38	no	_	DET	DT	_	39	neg	_	_
39	differences	_	NOUN	NNS	_	46	nsubjpass	_	_
40	in	_	ADP	IN	_	42	case	_	_
41	the	_	DET	DT	_	42	det	_	_
42	pharmacokinetics	_	NOUN	NNS	_	39	nmod	_	_
43	of	_	ADP	IN	_	44	case	_	_
44	ketoconazole	_	NOUN	NN	_	42	nmod	_	_
45	were	_	VERB	VBD	_	46	auxpass	_	_
46	observed	_	VERB	VBN	_	28	conj	_	_

#	EMSAM	109
1	In	_	ADP	IN	_	3	case	_	_
2	healthy	_	ADJ	JJ	_	3	amod	_	_
3	subjects	_	NOUN	NNS	_	25	nmod	_	_
4	who	_	DET	WDT	_	6	nsubj	_	_
5	had	_	VERB	MD	_	6	aux	_	_
6	received	_	VERB	VBN	_	3	acl:relcl	_	_
7	DRUG	_	NOUN	NN	_	8	compound	_	_
8	6mg	_	NOUN	NN	_	6	dobj	_	_
9	per	_	ADP	IN	_	11	case	_	_
10	24	_	NUM	CD	_	11	nummod	_	_
11	hours	_	NOUN	NNS	_	6	nmod	_	_
12	for	_	ADP	IN	_	14	case	_	_
13	10	_	NUM	CD	_	14	nummod	_	_
14	days	_	NOUN	NNS	_	11	nmod	_	_
15	,	_	.	,	_	25	punct	_	_
16	single	_	ADJ	JJ	_	18	amod	_	_
17	dose	_	NOUN	NN	_	18	compound	_	_
18	administration	_	NOUN	NN	_	25	nsubj	_	_
19	with	_	ADP	IN	_	22	case	_	_
20	levothyroxine	_	NOUN	NN	_	22	compound	_	_
21	150	_	NUM	CD	_	22	nummod	_	_
22	mcg	_	NOUN	NN	_	18	nmod	_	_
23	did	_	VERB	VBD	_	25	aux	_	_
24	not	_	ADV	RB	_	25	neg	_	_
25	alter	_	VERB	VB	_	0	root	_	_
26	the	_	DET	DT	_	27	det	_	_
27	pharmacokinetics	_	NOUN	NNS	_	25	dobj	_	_
28	of	_	ADP	IN	_	30	case	_	_
29	either	_	CONJ	CC	_	30	cc:preconj	_	_
30	DRUG	_	NOUN	NN	_	27	nmod	_	_
31	or	_	CONJ	CC	_	30	cc	_	_
32	levothyroxine	_	NOUN	NN	_	30	conj	_	_

#	EMSAM	110
1	In	_	ADP	IN	_	2	case	_	_
2	subjects	_	NOUN	NNS	_	33	nmod	_	_
3	who	_	DET	WDT	_	5	nsubj	_	_
4	had	_	VERB	MD	_	5	aux	_	_
5	received	_	VERB	VBN	_	2	acl:relcl	_	_
6	DRUG	_	NOUN	NN	_	7	compound	_	_
7	6mg	_	NOUN	NN	_	5	dobj	_	_
8	per	_	ADP	IN	_	10	case	_	_
9	24	_	NUM	CD	_	10	nummod	_	_
10	hours	_	NOUN	NNS	_	5	nmod	_	_
11	for	_	ADP	IN	_	13	case	_	_
12	10	_	NUM	CD	_	13	nummod	_	_
13	days	_	NOUN	NNS	_	10	nmod	_	_
14	,	_	.	,	_	33	punct	_	_
15	co	_	PRT	TO	_	16	case	_	_
16	administration	_	NOUN	NN	_	33	nsubj	_	_
17	with	_	ADP	IN	_	18	case	_	_
18	olanzapine	_	NOUN	NN	_	16	nmod	_	_
19	,	_	.	,	_	18	punct	_	_
20	a	_	DET	DT	_	21	det	_	_
21	substrate	_	NOUN	NN	_	18	appos	_	_
22	for	_	ADP	IN	_	23	case	_	_
23	CYP1A2	_	NOUN	NN	_	21	nmod	_	_
24	,	_	.	,	_	23	punct	_	_
25	CYP2D6	_	NOUN	NN	_	23	conj	_	_
26	,	_	.	,	_	23	punct	_	_
27	and	_	CONJ	CC	_	23	cc	_	_
28	possibly	_	ADV	RB	_	29	advmod	_	_
29	CYP2A6	_	NOUN	NN	_	23	conj	_	_
30	,	_	.	,	_	16	punct	_	_
31	did	_	VERB	MD	_	33	aux	_	_
32	not	_	ADV	RB	_	33	neg	_	_
33	affect	_	VERB	VB	_	0	root	_	_
34	the	_	DET	DT	_	35	det	_	_
35	pharmacokinetics	_	NOUN	NNS	_	33	dobj	_	_
36	of	_	ADP	IN	_	37	case	_	_
37	DRUG	_	NOUN	NN	_	35	nmod	_	_
38	or	_	CONJ	CC	_	37	cc	_	_
39	olanzapine	_	NOUN	NN	_	37	conj	_	_

#	EMSAM	111
1	In	_	ADP	IN	_	2	case	_	_
2	subjects	_	NOUN	NNS	_	28	nmod	_	_
3	who	_	DET	WDT	_	5	nsubj	_	_
4	had	_	VERB	MD	_	5	aux	_	_
5	received	_	VERB	VBN	_	2	acl:relcl	_	_
6	DRUG	_	NOUN	NN	_	7	compound	_	_
7	6mg	_	NOUN	NN	_	5	dobj	_	_
8	per	_	ADP	IN	_	10	case	_	_
9	24	_	NUM	CD	_	10	nummod	_	_
10	hours	_	NOUN	NNS	_	5	nmod	_	_
11	for	_	ADP	IN	_	13	case	_	_
12	9	_	NUM	CD	_	13	nummod	_	_
13	days	_	NOUN	NNS	_	5	nmod	_	_
14	,	_	.	,	_	28	punct	_	_
15	co	_	PRT	TO	_	16	case	_	_
16	administration	_	NOUN	NN	_	28	nsubj	_	_
17	with	_	ADP	IN	_	22	case	_	_
18	PPA	_	NOUN	NN	_	22	compound	_	_
19	25mg	_	ADJ	JJ	_	22	amod	_	_
20	every	_	ADV	RB	_	21	advmod	_	_
21	4	_	NUM	CD	_	22	nummod	_	_
22	hours	_	NOUN	NNS	_	16	nmod	_	_
23	for	_	ADP	IN	_	25	case	_	_
24	24	_	NUM	CD	_	25	nummod	_	_
25	hours	_	NOUN	NNS	_	16	nmod	_	_
26	did	_	VERB	VBD	_	28	aux	_	_
27	not	_	ADV	RB	_	28	neg	_	_
28	affect	_	VERB	VB	_	0	root	_	_
29	the	_	DET	DT	_	30	det	_	_
30	pharmacokinetics	_	NOUN	NNS	_	28	dobj	_	_
31	of	_	ADP	IN	_	32	case	_	_
32	PPA	_	NOUN	NN	_	30	nmod	_	_

#	EMSAM	112
1	There	_	DET	EX	_	2	expl	_	_
2	was	_	VERB	VBD	_	0	root	_	_
3	a	_	DET	DT	_	5	det	_	_
4	higher	_	ADJ	JJ	_	5	amod	_	_
5	incidence	_	NOUN	NN	_	2	nsubj	_	_
6	of	_	ADP	IN	_	10	case	_	_
7	significant	_	ADJ	JJ	_	10	amod	_	_
8	blood	_	NOUN	NN	_	10	compound	_	_
9	pressure	_	NOUN	NN	_	10	compound	_	_
10	elevations	_	NOUN	NNS	_	5	nmod	_	_
11	with	_	ADP	IN	_	14	case	_	_
12	the	_	DET	DT	_	14	det	_	_
13	co	_	PRT	TO	_	14	det	_	_
14	administration	_	NOUN	NN	_	5	nmod	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	14	nmod	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	PPA	_	NOUN	NN	_	16	conj	_	_
19	than	_	ADP	IN	_	21	case	_	_
20	with	_	ADP	IN	_	21	case	_	_
21	PPA	_	NOUN	NN	_	2	nmod	_	_
22	alone	_	ADV	RB	_	21	advmod	_	_
23	,	_	.	,	_	2	punct	_	_
24	suggesting	_	VERB	VBG	_	2	advcl	_	_
25	a	_	DET	DT	_	28	det	_	_
26	possible	_	ADJ	JJ	_	28	amod	_	_
27	pharmacodynamic	_	ADJ	JJ	_	28	amod	_	_
28	interaction	_	NOUN	NN	_	24	root	_	_

#	EMSAM	113
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	6mg	_	NOUN	NN	_	0	root	_	_
3	per	_	ADP	IN	_	5	case	_	_
4	24	_	NUM	CD	_	5	nummod	_	_
5	hours	_	NOUN	NNS	_	2	nmod	_	_
6	for	_	ADP	IN	_	8	case	_	_
7	10	_	NUM	CD	_	8	nummod	_	_
8	days	_	NOUN	NNS	_	2	nmod	_	_
9	,	_	.	,	_	2	punct	_	_
10	co	_	PRT	TO	_	11	mark	_	_
11	administered	_	VERB	VBN	_	2	acl	_	_
12	with	_	ADP	IN	_	14	case	_	_
13	pseudoephedrine	_	NOUN	NN	_	14	compound	_	_
14	60mg	_	NOUN	NN	_	11	nmod	_	_
15	,	_	.	,	_	2	punct	_	_
16	3	_	NUM	CD	_	17	nummod	_	_
17	times	_	NOUN	NNS	_	22	nsubj	_	_
18	a	_	DET	DT	_	19	det	_	_
19	day	_	NOUN	NN	_	22	nsubj	_	_
20	did	_	VERB	VBD	_	22	aux	_	_
21	not	_	ADV	RB	_	22	neg	_	_
22	affect	_	VERB	VB	_	2	dep	_	_
23	the	_	DET	DT	_	24	det	_	_
24	pharmacokinetics	_	NOUN	NNS	_	22	dobj	_	_
25	of	_	ADP	IN	_	26	case	_	_
26	pseudoephedrine	_	NOUN	NN	_	24	nmod	_	_

#	EMSAM	114
1	There	_	DET	EX	_	2	expl	_	_
2	were	_	VERB	VBD	_	0	root	_	_
3	no	_	DET	DT	_	6	neg	_	_
4	clinically	_	ADV	RB	_	5	advmod	_	_
5	significant	_	ADJ	JJ	_	6	amod	_	_
6	changes	_	NOUN	NNS	_	2	nsubj	_	_
7	in	_	ADP	IN	_	9	case	_	_
8	blood	_	NOUN	NN	_	9	compound	_	_
9	pressure	_	NOUN	NN	_	6	nmod	_	_
10	during	_	ADP	IN	_	12	case	_	_
11	pseudoephedrine	_	NOUN	NN	_	12	compound	_	_
12	administration	_	NOUN	NN	_	2	nmod	_	_
13	alone	_	ADV	RB	_	12	advmod	_	_
14	,	_	.	,	_	2	punct	_	_
15	or	_	CONJ	CC	_	2	cc	_	_
16	in	_	ADP	IN	_	17	case	_	_
17	combination	_	NOUN	NN	_	2	conj	_	_
18	with	_	ADP	IN	_	19	case	_	_
19	DRUG	_	NOUN	NN	_	17	nmod	_	_

#	EMSAM	115
1	In	_	ADP	IN	_	2	case	_	_
2	subjects	_	NOUN	NNS	_	33	nmod	_	_
3	who	_	DET	WDT	_	5	nsubj	_	_
4	had	_	VERB	MD	_	5	aux	_	_
5	received	_	VERB	VBN	_	2	acl:relcl	_	_
6	DRUG	_	NOUN	NN	_	7	compound	_	_
7	6mg	_	NOUN	NN	_	5	dobj	_	_
8	per	_	ADP	IN	_	10	case	_	_
9	24	_	NUM	CD	_	10	nummod	_	_
10	hours	_	NOUN	NNS	_	5	nmod	_	_
11	for	_	ADP	IN	_	13	case	_	_
12	10	_	NUM	CD	_	13	nummod	_	_
13	days	_	NOUN	NNS	_	5	nmod	_	_
14	,	_	.	,	_	33	punct	_	_
15	co	_	PRT	TO	_	16	case	_	_
16	administration	_	NOUN	NN	_	33	nsubj	_	_
17	with	_	ADP	IN	_	19	case	_	_
18	risperidone	_	NOUN	NN	_	19	compound	_	_
19	2mg	_	NOUN	NN	_	16	nmod	_	_
20	per	_	ADP	IN	_	21	case	_	_
21	day	_	NOUN	NN	_	16	nmod	_	_
22	for	_	ADP	IN	_	24	case	_	_
23	7	_	NUM	CD	_	24	nummod	_	_
24	days	_	NOUN	NNS	_	21	nmod	_	_
25	,	_	.	,	_	24	punct	_	_
26	a	_	DET	DT	_	27	det	_	_
27	substrate	_	NOUN	NN	_	24	appos	_	_
28	for	_	ADP	IN	_	29	case	_	_
29	CYP2D6	_	NOUN	NN	_	27	nmod	_	_
30	,	_	.	,	_	16	punct	_	_
31	did	_	VERB	MD	_	33	aux	_	_
32	not	_	ADV	RB	_	33	neg	_	_
33	affect	_	VERB	VB	_	0	root	_	_
34	the	_	DET	DT	_	35	det	_	_
35	pharmacokinetics	_	NOUN	NNS	_	33	dobj	_	_
36	of	_	ADP	IN	_	37	case	_	_
37	DRUG	_	NOUN	NN	_	35	nmod	_	_
38	or	_	CONJ	CC	_	37	cc	_	_
39	risperidone	_	NOUN	NN	_	37	conj	_	_

#	EMSAM	116
1	Warfarin	_	NOUN	NN	_	4	nsubj	_	_
2	is	_	VERB	VBZ	_	4	cop	_	_
3	a	_	DET	DT	_	4	det	_	_
4	substrate	_	NOUN	NN	_	0	root	_	_
5	for	_	ADP	IN	_	10	case	_	_
6	CYP2C9	_	NOUN	NN	_	10	compound	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	CYP3A4	_	NOUN	NN	_	6	conj	_	_
9	metabolism	_	NOUN	NN	_	10	compound	_	_
10	pathways	_	NOUN	NNS	_	4	nmod	_	_

#	EMSAM	117
1	In	_	ADP	IN	_	3	case	_	_
2	healthy	_	ADJ	JJ	_	3	amod	_	_
3	volunteers	_	NOUN	NNS	_	33	nmod	_	_
4	titrated	_	VERB	VBN	_	3	acl	_	_
5	with	_	ADP	IN	_	8	case	_	_
6	Coumadin*#	_	NOUN	NN	_	8	compound	_	_
7	warfarin	_	NOUN	NN	_	8	compound	_	_
8	sodium	_	NOUN	NN	_	4	nmod	_	_
9	to	_	PRT	TO	_	11	case	_	_
10	clinical	_	ADJ	JJ	_	11	amod	_	_
11	levels	_	NOUN	NNS	_	4	nmod	_	_
12	of	_	ADP	IN	_	14	case	_	_
13	anticoagulation	_	NOUN	NN	_	14	compound	_	_
14	INR	_	NOUN	NN	_	11	nmod	_	_
15	of	_	ADP	IN	_	18	case	_	_
16	1.5	_	NUM	CD	_	18	nummod	_	_
17	to	_	PRT	TO	_	18	case	_	_
18	2	_	NUM	CD	_	14	nmod	_	_
19	,	_	.	,	_	33	punct	_	_
20	co	_	PRT	TO	_	21	case	_	_
21	administration	_	NOUN	NN	_	33	nsubj	_	_
22	with	_	ADP	IN	_	24	case	_	_
23	DRUG	_	NOUN	NN	_	24	compound	_	_
24	6mg	_	NOUN	NN	_	21	nmod	_	_
25	per	_	ADP	IN	_	27	case	_	_
26	24	_	NUM	CD	_	27	nummod	_	_
27	hours	_	NOUN	NNS	_	21	nmod	_	_
28	for	_	ADP	IN	_	30	case	_	_
29	7	_	NUM	CD	_	30	nummod	_	_
30	days	_	NOUN	NNS	_	21	nmod	_	_
31	did	_	VERB	VBD	_	33	aux	_	_
32	not	_	ADV	RB	_	33	neg	_	_
33	affect	_	VERB	VB	_	0	root	_	_
34	the	_	DET	DT	_	35	det	_	_
35	pharmacokinetics	_	NOUN	NNS	_	33	dobj	_	_
36	of	_	ADP	IN	_	40	case	_	_
37	the	_	DET	DT	_	40	det	_	_
38	individual	_	ADJ	JJ	_	40	amod	_	_
39	warfarin	_	NOUN	NN	_	40	compound	_	_
40	enantiomers	_	NOUN	NNS	_	35	nmod	_	_

#	EMSAM	118
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	did	_	VERB	VBD	_	4	aux	_	_
3	not	_	ADV	RB	_	4	neg	_	_
4	alter	_	VERB	VB	_	0	root	_	_
5	the	_	DET	DT	_	8	det	_	_
6	clinical	_	ADJ	JJ	_	8	amod	_	_
7	pharmacodynamic	_	ADJ	JJ	_	8	amod	_	_
8	effects	_	NOUN	NNS	_	4	dobj	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	warfarin	_	NOUN	NN	_	8	nmod	_	_
11	as	_	ADP	IN	_	12	mark	_	_
12	measured	_	VERB	VBN	_	4	advcl	_	_
13	by	_	ADP	IN	_	14	case	_	_
14	INR	_	NOUN	NN	_	12	nmod	_	_
15	,	_	.	,	_	14	punct	_	_
16	Factor	_	NOUN	NN	_	17	compound	_	_
17	VII	_	NOUN	NN	_	14	conj	_	_
18	or	_	CONJ	CC	_	14	cc	_	_
19	Factor	_	NOUN	NN	_	21	compound	_	_
20	DRUG	_	NOUN	NN	_	21	compound	_	_
21	levels	_	NOUN	NNS	_	14	conj	_	_

#	Estazolam	3201
1	If	_	ADP	IN	_	4	mark	_	_
2	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
3	is	_	VERB	VBZ	_	4	auxpass	_	_
4	given	_	VERB	VBN	_	20	advcl	_	_
5	concomitantly	_	ADV	RB	_	4	advmod	_	_
6	with	_	ADP	IN	_	8	case	_	_
7	other	_	ADJ	JJ	_	8	amod	_	_
8	drugs	_	NOUN	NNS	_	4	nmod	_	_
9	acting	_	VERB	VBG	_	8	acl	_	_
10	on	_	ADP	IN	_	14	case	_	_
11	the	_	DET	DT	_	14	det	_	_
12	central	_	ADJ	JJ	_	14	amod	_	_
13	nervous	_	ADJ	JJ	_	14	amod	_	_
14	system	_	NOUN	NN	_	9	nmod	_	_
15	,	_	.	,	_	20	punct	_	_
16	careful	_	ADJ	JJ	_	17	amod	_	_
17	consideration	_	NOUN	NN	_	20	nsubjpass	_	_
18	should	_	VERB	MD	_	20	aux	_	_
19	be	_	VERB	VB	_	20	auxpass	_	_
20	given	_	VERB	VBN	_	0	root	_	_
21	to	_	PRT	TO	_	23	case	_	_
22	the	_	DET	DT	_	23	det	_	_
23	pharmacology	_	NOUN	NN	_	20	nmod	_	_
24	of	_	ADP	IN	_	26	case	_	_
25	all	_	DET	DT	_	26	det	_	_
26	agents	_	NOUN	NNS	_	23	nmod	_	_

#	Estazolam	3202
1	The	_	DET	DT	_	2	det	_	_
2	action	_	NOUN	NN	_	8	nsubjpass	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	the	_	DET	DT	_	5	det	_	_
5	benzodiazepines	_	NOUN	NNS	_	2	nmod	_	_
6	may	_	VERB	MD	_	8	aux	_	_
7	be	_	VERB	VB	_	8	auxpass	_	_
8	potentiated	_	VERB	VBN	_	0	root	_	_
9	by	_	ADP	IN	_	10	case	_	_
10	DRUGS	_	NOUN	NN	_	8	nmod	_	_
11	,	_	.	,	_	10	punct	_	_
12	antihistamines	_	NOUN	NNS	_	10	conj	_	_
13	,	_	.	,	_	10	punct	_	_
14	alcohol	_	NOUN	NN	_	10	conj	_	_
15	,	_	.	,	_	10	punct	_	_
16	barbiturates	_	VERB	VBZ	_	10	conj	_	_
17	,	_	.	,	_	10	punct	_	_
18	monoamine	_	NOUN	NN	_	20	compound	_	_
19	oxidase	_	NOUN	NN	_	20	compound	_	_
20	inhibitors	_	NOUN	NNS	_	10	conj	_	_
21	,	_	.	,	_	10	punct	_	_
22	narcotics	_	NOUN	NNS	_	10	conj	_	_
23	,	_	.	,	_	10	punct	_	_
24	phenothiazines	_	NOUN	NNS	_	10	conj	_	_
25	,	_	.	,	_	10	punct	_	_
26	psychotropic	_	ADJ	JJ	_	27	amod	_	_
27	medications	_	NOUN	NNS	_	10	conj	_	_
28	,	_	.	,	_	10	punct	_	_
29	or	_	CONJ	CC	_	10	cc	_	_
30	other	_	ADJ	JJ	_	31	amod	_	_
31	drugs	_	NOUN	NNS	_	10	conj	_	_
32	that	_	DET	WDT	_	33	nsubj	_	_
33	produce	_	VERB	VBP	_	31	acl:relcl	_	_
34	CNS	_	NOUN	NN	_	35	compound	_	_
35	depression	_	NOUN	NN	_	33	dobj	_	_

#	Estazolam	3203
1	Smokers	_	NOUN	NNS	_	2	nsubj	_	_
2	have	_	VERB	VBP	_	0	root	_	_
3	an	_	DET	DT	_	5	det	_	_
4	increased	_	VERB	VBN	_	5	amod	_	_
5	clearance	_	NOUN	NN	_	2	dobj	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	benzodiazepines	_	NOUN	NNS	_	5	nmod	_	_
8	as	_	ADP	IN	_	9	mark	_	_
9	compared	_	VERB	VBN	_	14	advcl	_	_
10	to	_	PRT	TO	_	11	case	_	_
11	nonsmokers	_	NOUN	NNS	_	9	nmod	_	_
12	this	_	DET	DT	_	14	nsubjpass	_	_
13	was	_	VERB	VBD	_	14	auxpass	_	_
14	seen	_	VERB	VBN	_	2	advcl	_	_
15	in	_	ADP	IN	_	16	case	_	_
16	studies	_	NOUN	NNS	_	14	nmod	_	_
17	with	_	ADP	IN	_	18	case	_	_
18	DRUG	_	NOUN	NN	_	16	nmod	_	_

#	Estazolam	3204
1	While	_	ADP	IN	_	10	mark	_	_
2	no	_	DET	DT	_	8	neg	_	_
3	in	_	X	FW	_	8	amod	_	_
4	vivo	_	X	FW	_	3	dep	_	_
5	drug	_	NOUN	NN	_	8	compound	_	_
6	drug	_	NOUN	NN	_	8	compound	_	_
7	interaction	_	NOUN	NN	_	8	compound	_	_
8	studies	_	NOUN	NNS	_	10	nsubjpass	_	_
9	were	_	VERB	VBD	_	10	auxpass	_	_
10	conducted	_	VERB	VBN	_	36	advcl	_	_
11	between	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	inducers	_	NOUN	NNS	_	12	conj	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	CYP3A	_	NOUN	NN	_	12	nmod	_	_
17	,	_	.	,	_	36	punct	_	_
18	compounds	_	NOUN	NNS	_	36	nsubjpass	_	_
19	that	_	DET	WDT	_	23	nsubj	_	_
20	are	_	VERB	VBP	_	23	cop	_	_
21	potent	_	ADJ	JJ	_	23	amod	_	_
22	CYP3A	_	NOUN	NN	_	23	compound	_	_
23	inhibitors	_	NOUN	NNS	_	18	acl:relcl	_	_
24	such	_	ADJ	JJ	_	26	case	_	_
25	as	_	ADP	IN	_	24	mwe	_	_
26	carbamazepine	_	NOUN	NN	_	23	nmod	_	_
27	,	_	.	,	_	26	punct	_	_
28	phenytoin	_	NOUN	NN	_	26	conj	_	_
29	,	_	.	,	_	26	punct	_	_
30	rifampin	_	NOUN	NN	_	26	conj	_	_
31	,	_	.	,	_	26	punct	_	_
32	and	_	CONJ	CC	_	26	cc	_	_
33	barbiturates	_	VERB	VBZ	_	26	conj	_	_
34	would	_	VERB	MD	_	36	aux	_	_
35	be	_	VERB	VB	_	36	auxpass	_	_
36	expected	_	VERB	VBN	_	0	root	_	_
37	to	_	PRT	TO	_	38	mark	_	_
38	decrease	_	VERB	VB	_	36	xcomp	_	_
39	DRUG	_	NOUN	NN	_	40	compound	_	_
40	concentrations	_	NOUN	NNS	_	38	dobj	_	_

#	Estazolam	3205
1	The	_	DET	DT	_	2	det	_	_
2	metabolism	_	NOUN	NN	_	20	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	to	_	PRT	TO	_	12	case	_	_
6	the	_	DET	DT	_	12	det	_	_
7	major	_	ADJ	JJ	_	12	amod	_	_
8	circulating	_	ADJ	JJ	_	12	amod	_	_
9	metabolite	_	NOUN	NN	_	12	compound	_	_
10	4	_	NUM	CD	_	12	nummod	_	_
11	hydroxy	_	NOUN	NN	_	12	compound	_	_
12	DRUG	_	NOUN	NN	_	2	nmod	_	_
13	and	_	CONJ	CC	_	2	cc	_	_
14	the	_	DET	DT	_	15	det	_	_
15	metabolism	_	NOUN	NN	_	2	conj	_	_
16	of	_	ADP	IN	_	18	case	_	_
17	other	_	ADJ	JJ	_	18	amod	_	_
18	triazolobenzodiazepines	_	NOUN	NNS	_	15	nmod	_	_
19	is	_	VERB	VBZ	_	20	auxpass	_	_
20	catalyzed	_	VERB	VBN	_	0	root	_	_
21	by	_	ADP	IN	_	22	case	_	_
22	CYP3A	_	NOUN	NN	_	20	nmod	_	_

#	Estazolam	3206
1	Consequently	_	ADV	RB	_	6	advmod	_	_
2	,	_	.	,	_	6	punct	_	_
3	DRUG	_	NOUN	NN	_	6	nsubjpass	_	_
4	should	_	VERB	MD	_	6	aux	_	_
5	be	_	VERB	VB	_	6	auxpass	_	_
6	avoided	_	VERB	VBN	_	0	root	_	_
7	in	_	ADP	IN	_	8	case	_	_
8	patients	_	NOUN	NNS	_	6	nmod	_	_
9	receiving	_	VERB	VBG	_	8	acl	_	_
10	ketoconazole	_	NOUN	NN	_	9	dobj	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	itraconazole	_	NOUN	NN	_	10	conj	_	_
13	,	_	.	,	_	10	punct	_	_
14	which	_	DET	WDT	_	18	nsubj	_	_
15	are	_	VERB	VBP	_	18	cop	_	_
16	very	_	ADV	RB	_	17	advmod	_	_
17	potent	_	ADJ	JJ	_	18	amod	_	_
18	inhibitors	_	NOUN	NNS	_	10	acl:relcl	_	_
19	of	_	ADP	IN	_	20	case	_	_
20	CYP3A	_	NOUN	NN	_	18	nmod	_	_

#	Estazolam	3207
1	With	_	ADP	IN	_	2	case	_	_
2	drugs	_	NOUN	NNS	_	17	nmod	_	_
3	inhibiting	_	VERB	VBG	_	2	acl	_	_
4	CYP3A	_	NOUN	NN	_	3	dobj	_	_
5	to	_	PRT	TO	_	12	case	_	_
6	a	_	DET	DT	_	12	det	_	_
7	lesser	_	ADJ	JJ	_	12	amod	_	_
8	,	_	.	,	_	7	punct	_	_
9	but	_	CONJ	CC	_	7	cc	_	_
10	still	_	ADV	RB	_	11	advmod	_	_
11	significant	_	ADJ	JJ	_	7	conj	_	_
12	degree	_	NOUN	NN	_	3	nmod	_	_
13	,	_	.	,	_	17	punct	_	_
14	DRUG	_	NOUN	NN	_	17	nsubjpass	_	_
15	should	_	VERB	MD	_	17	aux	_	_
16	be	_	VERB	VB	_	17	auxpass	_	_
17	used	_	VERB	VBN	_	0	root	_	_
18	only	_	ADV	RB	_	17	advmod	_	_
19	with	_	ADP	IN	_	20	case	_	_
20	caution	_	NOUN	NN	_	17	nmod	_	_
21	and	_	CONJ	CC	_	20	cc	_	_
22	consideration	_	NOUN	NN	_	20	conj	_	_
23	of	_	ADP	IN	_	26	case	_	_
24	appropriate	_	ADJ	JJ	_	26	amod	_	_
25	dosage	_	NOUN	NN	_	26	compound	_	_
26	reduction	_	NOUN	NN	_	20	nmod	_	_

#	Estazolam	3208
1	The	_	DET	DT	_	4	det	_	_
2	following	_	VERB	VBG	_	4	amod	_	_
3	are	_	VERB	VBP	_	4	compound	_	_
4	examples	_	NOUN	NNS	_	0	root	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	drugs	_	NOUN	NNS	_	4	nmod	_	_
7	known	_	VERB	VBN	_	6	acl	_	_
8	to	_	PRT	TO	_	9	mark	_	_
9	inhibit	_	VERB	VB	_	7	xcomp	_	_
10	the	_	DET	DT	_	11	det	_	_
11	metabolism	_	NOUN	NN	_	9	dobj	_	_
12	of	_	ADP	IN	_	15	case	_	_
13	other	_	ADJ	JJ	_	15	amod	_	_
14	related	_	ADJ	JJ	_	15	amod	_	_
15	benzodiazepines	_	NOUN	NNS	_	11	nmod	_	_
16	,	_	.	,	_	4	punct	_	_
17	presumably	_	ADV	RB	_	19	advmod	_	_
18	through	_	ADP	IN	_	19	case	_	_
19	inhibition	_	NOUN	NN	_	4	nmod	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	CYP3A	_	NOUN	NN	_	19	nmod	_	_
22	:	_	.	:	_	4	punct	_	_
23	nefazodone	_	NOUN	NN	_	4	dep	_	_
24	,	_	.	,	_	23	punct	_	_
25	fluvoxamine	_	NOUN	NN	_	23	conj	_	_
26	,	_	.	,	_	23	punct	_	_
27	cimetidine	_	NOUN	NN	_	23	conj	_	_
28	,	_	.	,	_	23	punct	_	_
29	diltiazem	_	NOUN	NN	_	23	conj	_	_
30	,	_	.	,	_	23	punct	_	_
31	isoniazide	_	NOUN	NN	_	23	conj	_	_
32	,	_	.	,	_	23	punct	_	_
33	and	_	CONJ	CC	_	23	cc	_	_
34	some	_	DET	DT	_	36	det	_	_
35	macrolide	_	NOUN	NN	_	36	compound	_	_
36	antibiotics	_	NOUN	NNS	_	23	conj	_	_

#	Estazolam	3209
1	A	_	DET	DT	_	4	det	_	_
2	multiple	_	ADJ	JJ	_	4	amod	_	_
3	dose	_	NOUN	NN	_	4	compound	_	_
4	study	_	NOUN	NN	_	6	nsubjpass	_	_
5	was	_	VERB	VBD	_	6	auxpass	_	_
6	conducted	_	VERB	VBN	_	0	root	_	_
7	to	_	PRT	TO	_	8	mark	_	_
8	assess	_	VERB	VB	_	6	xcomp	_	_
9	the	_	DET	DT	_	10	det	_	_
10	effect	_	NOUN	NN	_	8	dobj	_	_
11	of	_	ADP	IN	_	15	case	_	_
12	fluoxetine	_	NOUN	NN	_	15	compound	_	_
13	20	_	NUM	CD	_	15	nummod	_	_
14	mg	_	NOUN	NN	_	15	compound	_	_
15	BID	_	NOUN	NN	_	10	nmod	_	_
16	on	_	ADP	IN	_	18	case	_	_
17	the	_	DET	DT	_	18	det	_	_
18	pharmacokinetics	_	NOUN	NNS	_	10	nmod	_	_
19	of	_	ADP	IN	_	23	case	_	_
20	DRUG	_	NOUN	NN	_	23	compound	_	_
21	2	_	NUM	CD	_	23	nummod	_	_
22	mg	_	NOUN	NN	_	23	compound	_	_
23	QHS	_	NOUN	NN	_	18	nmod	_	_
24	after	_	ADP	IN	_	26	case	_	_
25	seven	_	NUM	CD	_	26	nummod	_	_
26	days	_	NOUN	NNS	_	10	nmod	_	_

#	Estazolam	3210
1	The	_	DET	DT	_	2	det	_	_
2	pharmacokinetics	_	NOUN	NNS	_	10	nsubjpass	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	DRUG	_	NOUN	NN	_	5	compound	_	_
5	Cmax	_	NOUN	NN	_	2	nmod	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	AUC	_	NOUN	NN	_	5	conj	_	_
8	were	_	VERB	VBD	_	10	auxpass	_	_
9	not	_	ADV	RB	_	10	neg	_	_
10	affected	_	VERB	VBN	_	0	root	_	_
11	during	_	ADP	IN	_	14	case	_	_
12	multiple	_	ADJ	JJ	_	14	amod	_	_
13	dose	_	NOUN	NN	_	14	compound	_	_
14	fluoxetine	_	NOUN	NN	_	10	nmod	_	_
15	,	_	.	,	_	10	punct	_	_
16	suggesting	_	VERB	VBG	_	10	xcomp	_	_
17	no	_	DET	DT	_	21	neg	_	_
18	clinically	_	ADV	RB	_	19	advmod	_	_
19	significant	_	ADJ	JJ	_	21	amod	_	_
20	pharmacokinetic	_	ADJ	JJ	_	21	amod	_	_
21	interaction	_	NOUN	NN	_	16	root	_	_

#	Estazolam	3211
1	At	_	ADP	IN	_	4	case	_	_
2	clinically	_	ADV	RB	_	3	advmod	_	_
3	relevant	_	ADJ	JJ	_	4	amod	_	_
4	concentrations	_	NOUN	NNS	_	9	nmod	_	_
5	,	_	.	,	_	9	punct	_	_
6	in	_	X	FW	_	8	amod	_	_
7	vitro	_	X	FW	_	6	dep	_	_
8	studies	_	NOUN	NNS	_	9	nsubj	_	_
9	indicate	_	VERB	VBP	_	0	root	_	_
10	that	_	ADP	IN	_	15	mark	_	_
11	DRUG	_	NOUN	NN	_	12	compound	_	_
12	0.6uM	_	NOUN	NN	_	15	nsubj	_	_
13	was	_	VERB	VBD	_	15	cop	_	_
14	not	_	ADV	RB	_	15	neg	_	_
15	inhibitory	_	ADJ	JJ	_	9	ccomp	_	_
16	towards	_	ADP	IN	_	21	case	_	_
17	the	_	DET	DT	_	21	det	_	_
18	major	_	ADJ	JJ	_	21	amod	_	_
19	cytochrome	_	NOUN	NN	_	21	compound	_	_
20	P450	_	NOUN	NN	_	21	compound	_	_
21	isoforms	_	NOUN	NNS	_	15	nmod	_	_
22	CYP1A2	_	NOUN	NN	_	21	dep	_	_
23	,	_	.	,	_	22	punct	_	_
24	CYP2A6	_	NOUN	NN	_	22	conj	_	_
25	,	_	.	,	_	22	punct	_	_
26	CYP2C9	_	NOUN	NN	_	22	conj	_	_
27	,	_	.	,	_	22	punct	_	_
28	CYP2C19	_	NOUN	NN	_	22	conj	_	_
29	,	_	.	,	_	22	punct	_	_
30	CYP2D6	_	NOUN	NN	_	22	conj	_	_
31	,	_	.	,	_	22	punct	_	_
32	CYP2E1	_	NOUN	NN	_	22	conj	_	_
33	,	_	.	,	_	22	punct	_	_
34	and	_	CONJ	CC	_	22	cc	_	_
35	CYP3A	_	NOUN	NN	_	22	conj	_	_

#	Estazolam	3212
1	Therefore	_	ADV	RB	_	13	advmod	_	_
2	,	_	.	,	_	13	punct	_	_
3	based	_	VERB	VBN	_	13	advcl	_	_
4	on	_	ADP	IN	_	8	case	_	_
5	these	_	DET	DT	_	8	det	_	_
6	in	_	X	FW	_	8	amod	_	_
7	vitro	_	X	FW	_	6	dep	_	_
8	data	_	NOUN	NNS	_	3	nmod	_	_
9	,	_	.	,	_	13	punct	_	_
10	DRUG	_	NOUN	NN	_	13	nsubj	_	_
11	is	_	VERB	VBZ	_	13	cop	_	_
12	very	_	ADV	RB	_	13	advmod	_	_
13	unlikely	_	ADJ	JJ	_	0	root	_	_
14	to	_	PRT	TO	_	15	mark	_	_
15	inhibit	_	VERB	VB	_	13	xcomp	_	_
16	the	_	DET	DT	_	17	det	_	_
17	biotransformation	_	NOUN	NN	_	15	dobj	_	_
18	of	_	ADP	IN	_	20	case	_	_
19	other	_	ADJ	JJ	_	20	amod	_	_
20	drugs	_	NOUN	NNS	_	17	nmod	_	_
21	metabolized	_	VERB	VBN	_	20	acl	_	_
22	by	_	ADP	IN	_	25	case	_	_
23	these	_	DET	DT	_	25	det	_	_
24	CYP	_	NOUN	NN	_	25	compound	_	_
25	isoforms	_	NOUN	NNS	_	21	nmod	_	_

#	Estazolam	3213
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	tablets	_	NOUN	NNS	_	5	nsubjpass	_	_
3	have	_	VERB	VBP	_	5	aux	_	_
4	been	_	VERB	VBN	_	5	auxpass	_	_
5	found	_	VERB	VBN	_	0	root	_	_
6	to	_	PRT	TO	_	8	mark	_	_
7	be	_	VERB	VB	_	8	cop	_	_
8	equivalent	_	ADJ	JJ	_	5	xcomp	_	_
9	in	_	ADP	IN	_	10	case	_	_
10	absorption	_	NOUN	NN	_	8	nmod	_	_
11	to	_	PRT	TO	_	15	case	_	_
12	an	_	DET	DT	_	15	det	_	_
13	orally	_	ADV	RB	_	14	advmod	_	_
14	administered	_	VERB	VBN	_	15	amod	_	_
15	solution	_	NOUN	NN	_	10	nmod	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	DRUG	_	NOUN	NN	_	15	nmod	_	_

#	Estazolam	3214
1	In	_	ADP	IN	_	3	case	_	_
2	healthy	_	ADJ	JJ	_	3	amod	_	_
3	subjects	_	NOUN	NNS	_	20	nmod	_	_
4	who	_	DET	WDT	_	5	nsubj	_	_
5	received	_	VERB	VBD	_	3	acl:relcl	_	_
6	up	_	ADV	RB	_	5	advmod	_	_
7	to	_	PRT	TO	_	9	case	_	_
8	three	_	NUM	CD	_	9	nummod	_	_
9	times	_	NOUN	NNS	_	5	nmod	_	_
10	the	_	DET	DT	_	12	det	_	_
11	recommended	_	VERB	VBN	_	12	amod	_	_
12	dose	_	NOUN	NN	_	5	dobj	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	DRUG	_	NOUN	NN	_	12	nmod	_	_
15	,	_	.	,	_	20	punct	_	_
16	peak	_	ADJ	JJ	_	19	amod	_	_
17	DRUG	_	NOUN	NN	_	19	compound	_	_
18	plasma	_	NOUN	NN	_	19	compound	_	_
19	concentrations	_	NOUN	NNS	_	20	nsubj	_	_
20	occurred	_	VERB	VBD	_	0	root	_	_
21	within	_	ADP	IN	_	23	case	_	_
22	two	_	NUM	CD	_	23	nummod	_	_
23	hours	_	NOUN	NNS	_	20	nmod	_	_
24	after	_	ADP	IN	_	25	mark	_	_
25	dosing	_	VERB	VBG	_	20	advcl	_	_
26	range	_	NOUN	NN	_	30	compound	_	_
27	0.5	_	NUM	CD	_	29	compound	_	_
28	to	_	PRT	TO	_	29	dep	_	_
29	6.0	_	NUM	CD	_	30	nummod	_	_
30	hours	_	NOUN	NNS	_	25	dobj	_	_
31	and	_	CONJ	CC	_	20	cc	_	_
32	were	_	VERB	VBD	_	33	cop	_	_
33	proportional	_	ADJ	JJ	_	20	conj	_	_
34	to	_	PRT	TO	_	37	case	_	_
35	the	_	DET	DT	_	37	det	_	_
36	administered	_	VERB	VBN	_	37	amod	_	_
37	dose	_	NOUN	NN	_	33	nmod	_	_
38	,	_	.	,	_	20	punct	_	_
39	suggesting	_	VERB	VBG	_	20	xcomp	_	_
40	linear	_	ADJ	JJ	_	41	amod	_	_
41	pharmacokinetics	_	NOUN	NNS	_	39	dobj	_	_
42	over	_	ADP	IN	_	45	case	_	_
43	the	_	DET	DT	_	45	det	_	_
44	dosage	_	NOUN	NN	_	45	compound	_	_
45	range	_	NOUN	NN	_	41	nmod	_	_
46	tested	_	VERB	VBN	_	45	acl	_	_

#	Estazolam	3215
1	Independent	_	ADV	RB	_	10	advmod	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	concentration	_	NOUN	NN	_	1	nmod	_	_
4	,	_	.	,	_	10	punct	_	_
5	DRUG	_	NOUN	NN	_	10	nsubj	_	_
6	in	_	ADP	IN	_	7	case	_	_
7	plasma	_	NOUN	NN	_	5	nmod	_	_
8	is	_	VERB	VBZ	_	10	cop	_	_
9	93%	_	ADJ	JJ	_	10	amod	_	_
10	protein	_	NOUN	NN	_	0	root	_	_
11	bound	_	VERB	VBN	_	10	root	_	_

#	Estazolam	3216
1	Only	_	ADV	RB	_	2	advmod	_	_
2	two	_	NUM	CD	_	3	nummod	_	_
3	metabolites	_	NOUN	NNS	_	12	nsubjpass	_	_
4	1	_	NUM	CD	_	5	compound	_	_
5	oxo	_	ADV	RB	_	10	amod	_	_
6	DRUG	_	NOUN	NN	_	10	compound	_	_
7	&	_	CONJ	CC	_	8	dep	_	_
8	4	_	NUM	CD	_	10	nummod	_	_
9	hydroxy	_	NOUN	NN	_	10	amod	_	_
10	DRUG	_	NOUN	NN	_	3	nmod	_	_
11	were	_	VERB	VBD	_	12	auxpass	_	_
12	detected	_	VERB	VBN	_	0	root	_	_
13	in	_	ADP	IN	_	15	case	_	_
14	human	_	ADJ	JJ	_	15	amod	_	_
15	plasma	_	NOUN	NN	_	12	nmod	_	_
16	up	_	ADV	RB	_	12	nmod	_	_
17	to	_	PRT	TO	_	19	case	_	_
18	18	_	NUM	CD	_	19	nummod	_	_
19	hrs	_	PRON	PRP	_	16	nmod	_	_

#	Estazolam	3217
1	The	_	DET	DT	_	3	det	_	_
2	pharmacologic	_	ADJ	JJ	_	3	amod	_	_
3	activity	_	NOUN	NN	_	11	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	is	_	VERB	VBZ	_	11	cop	_	_
7	primarily	_	ADV	RB	_	11	advmod	_	_
8	from	_	ADP	IN	_	11	case	_	_
9	the	_	DET	DT	_	11	det	_	_
10	parent	_	NOUN	NN	_	11	compound	_	_
11	drug	_	NOUN	NN	_	0	root	_	_

#	Estazolam	3218
1	The	_	DET	DT	_	2	det	_	_
2	elimination	_	NOUN	NN	_	7	nsubj	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	the	_	DET	DT	_	6	det	_	_
5	parent	_	NOUN	NN	_	6	compound	_	_
6	drug	_	NOUN	NN	_	2	nmod	_	_
7	takes	_	VERB	VBZ	_	0	root	_	_
8	place	_	NOUN	NN	_	7	dobj	_	_
9	via	_	ADP	IN	_	11	case	_	_
10	hepatic	_	ADJ	JJ	_	11	amod	_	_
11	metabolism	_	NOUN	NN	_	7	nmod	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	DRUG	_	NOUN	NN	_	11	nmod	_	_
14	to	_	PRT	TO	_	18	case	_	_
15	hydroxylated	_	ADJ	JJ	_	18	amod	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	other	_	ADJ	JJ	_	15	conj	_	_
18	metabolites	_	NOUN	NNS	_	11	nmod	_	_
19	that	_	DET	WDT	_	21	nsubjpass	_	_
20	are	_	VERB	VBP	_	21	auxpass	_	_
21	eliminated	_	VERB	VBN	_	18	acl:relcl	_	_
22	largely	_	ADV	RB	_	21	advmod	_	_
23	in	_	ADP	IN	_	27	case	_	_
24	the	_	DET	DT	_	27	det	_	_
25	urine	_	VERB	VBG	_	27	amod	_	_
26	both	_	CONJ	CC	_	27	cc:preconj	_	_
27	free	_	ADJ	JJ	_	21	nmod	_	_
28	and	_	CONJ	CC	_	21	cc	_	_
29	conjugated	_	VERB	VBN	_	21	conj	_	_

#	Estazolam	3219
1	In	_	ADP	IN	_	2	case	_	_
2	humans	_	NOUN	NNS	_	14	nmod	_	_
3	,	_	.	,	_	14	punct	_	_
4	greater	_	ADJ	JJ	_	6	case	_	_
5	than	_	ADP	IN	_	4	mwe	_	_
6	70%	_	NOUN	NN	_	14	nsubjpass	_	_
7	of	_	ADP	IN	_	10	case	_	_
8	a	_	DET	DT	_	10	det	_	_
9	single	_	ADJ	JJ	_	10	amod	_	_
10	dose	_	NOUN	NN	_	6	nmod	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_
13	was	_	VERB	VBD	_	14	auxpass	_	_
14	recovered	_	VERB	VBN	_	0	root	_	_
15	in	_	ADP	IN	_	17	case	_	_
16	the	_	DET	DT	_	17	det	_	_
17	urine	_	NOUN	NN	_	14	nmod	_	_
18	as	_	ADP	IN	_	19	case	_	_
19	metabolites	_	NOUN	NNS	_	17	nmod	_	_

#	Estazolam	3220
1	Less	_	ADV	RB	_	3	case	_	_
2	than	_	ADP	IN	_	1	mwe	_	_
3	5%	_	NOUN	NN	_	12	nsubjpass	_	_
4	of	_	ADP	IN	_	8	case	_	_
5	a	_	DET	DT	_	8	det	_	_
6	2	_	NUM	CD	_	8	nummod	_	_
7	mg	_	NOUN	NN	_	8	compound	_	_
8	dose	_	NOUN	NN	_	3	nmod	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	was	_	VERB	VBD	_	12	auxpass	_	_
12	excreted	_	VERB	VBN	_	0	root	_	_
13	unchanged	_	ADJ	JJ	_	12	xcomp	_	_
14	in	_	ADP	IN	_	16	case	_	_
15	the	_	DET	DT	_	16	det	_	_
16	urine	_	ADJ	JJ	_	13	nmod	_	_
17	,	_	.	,	_	12	punct	_	_
18	with	_	ADP	IN	_	20	case	_	_
19	only	_	ADV	RB	_	20	advmod	_	_
20	4%	_	NOUN	NN	_	12	nmod	_	_
21	of	_	ADP	IN	_	23	case	_	_
22	the	_	DET	DT	_	23	det	_	_
23	dose	_	NOUN	NN	_	20	nmod	_	_
24	appearing	_	VERB	VBG	_	23	acl	_	_
25	in	_	ADP	IN	_	27	case	_	_
26	the	_	DET	DT	_	27	det	_	_
27	feces	_	NOUN	NNS	_	24	nmod	_	_

#	Estazolam	3221
1	The	_	DET	DT	_	5	det	_	_
2	principal	_	ADJ	JJ	_	5	amod	_	_
3	urinary	_	ADJ	JJ	_	5	amod	_	_
4	excretion	_	NOUN	NN	_	5	compound	_	_
5	product	_	NOUN	NN	_	9	nsubj	_	_
6	is	_	VERB	VBZ	_	9	cop	_	_
7	an	_	DET	DT	_	9	det	_	_
8	unidentified	_	ADJ	JJ	_	9	amod	_	_
9	metabolite	_	NOUN	NN	_	0	root	_	_
10	,	_	.	,	_	9	punct	_	_
11	presumed	_	VERB	VBN	_	9	acl	_	_
12	to	_	PRT	TO	_	16	mark	_	_
13	be	_	VERB	VB	_	16	cop	_	_
14	a	_	DET	DT	_	16	det	_	_
15	metabolic	_	ADJ	JJ	_	16	amod	_	_
16	product	_	NOUN	NN	_	11	xcomp	_	_
17	of	_	ADP	IN	_	20	case	_	_
18	4	_	NUM	CD	_	20	nummod	_	_
19	hydroxy	_	NOUN	NN	_	20	compound	_	_
20	DRUG	_	NOUN	NN	_	16	nmod	_	_
21	,	_	.	,	_	9	punct	_	_
22	accounting	_	VERB	VBG	_	9	acl	_	_
23	for	_	ADP	IN	_	26	case	_	_
24	at	_	ADP	IN	_	26	amod	_	_
25	least	_	X	FW	_	24	dep	_	_
26	27%	_	NOUN	NN	_	22	nmod	_	_
27	of	_	ADP	IN	_	30	case	_	_
28	the	_	DET	DT	_	30	det	_	_
29	administered	_	VERB	VBN	_	30	amod	_	_
30	dose	_	NOUN	NN	_	26	nmod	_	_

#	Estazolam	3222
1	4	_	NUM	CD	_	3	nummod	_	_
2	hydroxy	_	NOUN	NN	_	3	compound	_	_
3	DRUG	_	NOUN	NN	_	7	nsubj	_	_
4	is	_	VERB	VBZ	_	7	cop	_	_
5	the	_	DET	DT	_	7	det	_	_
6	major	_	ADJ	JJ	_	7	amod	_	_
7	metabolite	_	NOUN	NN	_	0	root	_	_
8	in	_	ADP	IN	_	9	case	_	_
9	plasma	_	NOUN	NN	_	7	nmod	_	_
10	,	_	.	,	_	7	punct	_	_
11	with	_	ADP	IN	_	12	case	_	_
12	concentrations	_	NOUN	NNS	_	7	nmod	_	_
13	approaching	_	VERB	VBG	_	12	acl	_	_
14	12%	_	NOUN	NN	_	13	dobj	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	those	_	DET	DT	_	14	nmod	_	_
17	of	_	ADP	IN	_	21	case	_	_
18	the	_	DET	DT	_	21	det	_	_
19	parent	_	NOUN	NN	_	21	compound	_	_
20	eight	_	NUM	CD	_	21	nummod	_	_
21	hours	_	NOUN	NNS	_	16	nmod	_	_
22	after	_	ADP	IN	_	23	case	_	_
23	administration	_	NOUN	NN	_	14	nmod	_	_

#	Estazolam	3223
1	Urinary	_	ADJ	JJ	_	4	amod	_	_
2	4	_	NUM	CD	_	4	nummod	_	_
3	hydroxy	_	NOUN	NN	_	4	compound	_	_
4	DRUG	_	NOUN	NN	_	9	nsubj	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	1	_	NUM	CD	_	8	nummod	_	_
7	oxo	_	NOUN	NN	_	8	compound	_	_
8	DRUG	_	NOUN	NN	_	4	conj	_	_
9	account	_	VERB	VBP	_	0	root	_	_
10	for	_	ADP	IN	_	11	case	_	_
11	11.9%	_	ADJ	JJ	_	9	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	4.4%	_	NOUN	NN	_	11	conj	_	_
14	of	_	ADP	IN	_	16	case	_	_
15	the	_	DET	DT	_	16	det	_	_
16	dose	_	NOUN	NN	_	11	nmod	_	_
17	respectively	_	ADV	RB	_	9	advmod	_	_

#	Estazolam	3224
1	In	_	X	FW	_	3	amod	_	_
2	vitro	_	X	FW	_	1	dep	_	_
3	studies	_	NOUN	NNS	_	8	nsubj	_	_
4	with	_	ADP	IN	_	7	case	_	_
5	human	_	ADJ	JJ	_	7	amod	_	_
6	liver	_	NOUN	NN	_	7	compound	_	_
7	microsomes	_	NOUN	NNS	_	3	nmod	_	_
8	indicate	_	VERB	VBP	_	0	root	_	_
9	that	_	ADP	IN	_	23	mark	_	_
10	the	_	DET	DT	_	11	det	_	_
11	biotransformation	_	NOUN	NN	_	23	nsubjpass	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	DRUG	_	NOUN	NN	_	11	nmod	_	_
14	to	_	PRT	TO	_	21	case	_	_
15	the	_	DET	DT	_	21	det	_	_
16	major	_	ADJ	JJ	_	21	amod	_	_
17	circulating	_	ADJ	JJ	_	21	amod	_	_
18	metabolite	_	NOUN	NN	_	21	compound	_	_
19	4	_	NUM	CD	_	21	nummod	_	_
20	hydroxy	_	NOUN	NN	_	21	compound	_	_
21	DRUG	_	NOUN	NN	_	11	nmod	_	_
22	is	_	VERB	VBZ	_	23	auxpass	_	_
23	mediated	_	VERB	VBN	_	8	ccomp	_	_
24	by	_	ADP	IN	_	28	case	_	_
25	cytochrome	_	NOUN	NN	_	28	compound	_	_
26	P450	_	NOUN	NN	_	28	compound	_	_
27	3A	_	NOUN	NN	_	28	compound	_	_
28	CYP3A	_	NOUN	NN	_	23	nmod	_	_

#	Estazolam	3225
1	While	_	ADP	IN	_	14	mark	_	_
2	4	_	NUM	CD	_	4	nummod	_	_
3	hydroxy	_	NOUN	NN	_	4	amod	_	_
4	DRUG	_	NOUN	NN	_	14	nsubj	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	the	_	DET	DT	_	8	det	_	_
7	lesser	_	ADJ	JJ	_	8	amod	_	_
8	metabolite	_	NOUN	NN	_	4	conj	_	_
9	,	_	.	,	_	8	punct	_	_
10	1	_	NUM	CD	_	12	nummod	_	_
11	oxo	_	NOUN	NN	_	12	compound	_	_
12	DRUG	_	NOUN	NN	_	8	appos	_	_
13	,	_	.	,	_	4	punct	_	_
14	have	_	VERB	VBP	_	25	advcl	_	_
15	some	_	DET	DT	_	17	det	_	_
16	pharmacologic	_	ADJ	JJ	_	17	amod	_	_
17	activity	_	NOUN	NN	_	14	dobj	_	_
18	,	_	.	,	_	25	punct	_	_
19	their	_	PRON	PRP$	_	21	nmod:poss	_	_
20	low	_	ADJ	JJ	_	21	amod	_	_
21	potencies	_	NOUN	NNS	_	25	nsubj	_	_
22	and	_	CONJ	CC	_	21	cc	_	_
23	low	_	ADJ	JJ	_	24	amod	_	_
24	concentrations	_	NOUN	NNS	_	21	conj	_	_
25	preclude	_	VERB	VBP	_	0	root	_	_
26	any	_	DET	DT	_	28	det	_	_
27	significant	_	ADJ	JJ	_	28	amod	_	_
28	contribution	_	NOUN	NN	_	25	dobj	_	_
29	to	_	PRT	TO	_	32	case	_	_
30	the	_	DET	DT	_	32	det	_	_
31	hypnotic	_	ADJ	JJ	_	32	amod	_	_
32	effect	_	NOUN	NN	_	28	nmod	_	_
33	of	_	ADP	IN	_	34	case	_	_
34	DRUG	_	NOUN	NN	_	32	nmod	_	_

#	Estazolam	3226
1	The	_	DET	DT	_	2	det	_	_
2	range	_	NOUN	NN	_	13	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	estimates	_	NOUN	NNS	_	2	nmod	_	_
5	for	_	ADP	IN	_	10	case	_	_
6	the	_	DET	DT	_	10	det	_	_
7	mean	_	NOUN	NN	_	10	compound	_	_
8	elimination	_	NOUN	NN	_	10	compound	_	_
9	half	_	NOUN	NN	_	10	compound	_	_
10	life	_	NOUN	NN	_	4	nmod	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_
13	varied	_	VERB	VBD	_	0	root	_	_
14	from	_	ADP	IN	_	18	case	_	_
15	10	_	NUM	CD	_	17	compound	_	_
16	to	_	PRT	TO	_	17	dep	_	_
17	24	_	NUM	CD	_	18	nummod	_	_
18	hours	_	NOUN	NNS	_	13	nmod	_	_

#	Estazolam	3227
1	Radiolabel	_	NOUN	NN	_	4	compound	_	_
2	mass	_	NOUN	NN	_	4	compound	_	_
3	balance	_	NOUN	NN	_	4	compound	_	_
4	studies	_	NOUN	NNS	_	5	nsubj	_	_
5	indicate	_	VERB	VBP	_	0	root	_	_
6	that	_	ADP	IN	_	15	mark	_	_
7	the	_	DET	DT	_	9	det	_	_
8	main	_	ADJ	JJ	_	9	amod	_	_
9	route	_	NOUN	NN	_	15	nsubj	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	excretion	_	NOUN	NN	_	9	nmod	_	_
12	is	_	VERB	VBZ	_	15	cop	_	_
13	via	_	ADP	IN	_	15	case	_	_
14	the	_	DET	DT	_	15	det	_	_
15	kidneys	_	NOUN	NNS	_	5	ccomp	_	_

#	Estazolam	3228
1	After	_	ADP	IN	_	3	case	_	_
2	5	_	NUM	CD	_	3	nummod	_	_
3	days	_	NOUN	NNS	_	11	nmod	_	_
4	,	_	.	,	_	11	punct	_	_
5	87%	_	NOUN	NN	_	11	nsubjpass	_	_
6	of	_	ADP	IN	_	9	case	_	_
7	the	_	DET	DT	_	9	det	_	_
8	administered	_	VERB	VBN	_	9	amod	_	_
9	radioactivity	_	NOUN	NN	_	5	nmod	_	_
10	was	_	VERB	VBD	_	11	auxpass	_	_
11	excreted	_	VERB	VBN	_	0	root	_	_
12	in	_	ADP	IN	_	13	case	_	_
13	human	_	ADJ	JJ	_	11	nmod	_	_
14	urine	_	VERB	VBG	_	13	ccomp	_	_

#	Estazolam	3229
1	Less	_	ADV	RB	_	3	case	_	_
2	than	_	ADP	IN	_	1	mwe	_	_
3	4%	_	NOUN	NN	_	8	nsubjpass	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	the	_	DET	DT	_	6	det	_	_
6	dose	_	NOUN	NN	_	3	nmod	_	_
7	was	_	VERB	VBD	_	8	auxpass	_	_
8	excreted	_	VERB	VBN	_	0	root	_	_
9	unchanged	_	ADJ	JJ	_	8	root	_	_

#	Estazolam	3230
1	Four	_	NUM	CD	_	2	nummod	_	_
2	metabolites	_	NOUN	NNS	_	4	nsubjpass	_	_
3	were	_	VERB	VBD	_	4	auxpass	_	_
4	identified	_	VERB	VBN	_	0	root	_	_
5	as	_	ADP	IN	_	8	case	_	_
6	1	_	NUM	CD	_	8	nummod	_	_
7	oxo	_	NOUN	NN	_	8	compound	_	_
8	DRUG	_	NOUN	NN	_	4	nmod	_	_
9	,	_	.	,	_	8	punct	_	_
10	4'	_	ADJ	JJ	_	12	amod	_	_
11	hydroxy	_	NOUN	NN	_	12	compound	_	_
12	DRUG	_	NOUN	NN	_	8	conj	_	_
13	,	_	.	,	_	8	punct	_	_
14	4	_	NUM	CD	_	15	compound	_	_
15	hydroxy	_	NOUN	NN	_	16	amod	_	_
16	DRUG	_	NOUN	NN	_	8	conj	_	_
17	,	_	.	,	_	8	punct	_	_
18	and	_	CONJ	CC	_	8	cc	_	_
19	benzophenone	_	NOUN	NN	_	8	conj	_	_
20	,	_	.	,	_	4	punct	_	_
21	as	_	ADP	IN	_	23	case	_	_
22	free	_	ADJ	JJ	_	23	amod	_	_
23	metabolites	_	NOUN	NNS	_	4	nmod	_	_
24	and	_	CONJ	CC	_	23	cc	_	_
25	glucuronides	_	NOUN	NNS	_	23	conj	_	_

#	Estazolam	3231
1	The	_	DET	DT	_	3	det	_	_
2	predominant	_	ADJ	JJ	_	3	amod	_	_
3	metabolite	_	NOUN	NN	_	14	nsubjpass	_	_
4	in	_	ADP	IN	_	6	case	_	_
5	urine	_	ADJ	JJ	_	6	amod	_	_
6	17%	_	NOUN	NN	_	3	nmod	_	_
7	of	_	ADP	IN	_	10	case	_	_
8	the	_	DET	DT	_	10	det	_	_
9	administered	_	ADJ	JJ	_	10	amod	_	_
10	dose	_	NOUN	NN	_	6	nmod	_	_
11	has	_	VERB	VBZ	_	14	aux	_	_
12	not	_	ADV	RB	_	14	neg	_	_
13	been	_	VERB	VBN	_	14	auxpass	_	_
14	identified	_	VERB	VBN	_	0	root	_	_
15	,	_	.	,	_	14	punct	_	_
16	but	_	CONJ	CC	_	14	cc	_	_
17	is	_	VERB	VBZ	_	18	cop	_	_
18	likely	_	ADJ	JJ	_	14	conj	_	_
19	to	_	PRT	TO	_	22	mark	_	_
20	be	_	VERB	VB	_	22	cop	_	_
21	a	_	DET	DT	_	22	det	_	_
22	metabolite	_	NOUN	NN	_	18	nmod	_	_
23	of	_	ADP	IN	_	26	case	_	_
24	4	_	NUM	CD	_	26	nummod	_	_
25	hydroxy	_	NOUN	NN	_	26	compound	_	_
26	DRUG	_	NOUN	NN	_	22	nmod	_	_

#	Estazolam	3232
1	In	_	ADP	IN	_	5	case	_	_
2	a	_	DET	DT	_	5	det	_	_
3	small	_	ADJ	JJ	_	5	amod	_	_
4	study	_	NOUN	NN	_	5	compound	_	_
5	N	_	NOUN	NN	_	23	nmod	_	_
6	=	_	ADJ	JJ	_	5	amod	_	_
7	8	_	NUM	CD	_	6	dep	_	_
8	using	_	VERB	VBG	_	6	xcomp	_	_
9	various	_	ADJ	JJ	_	10	amod	_	_
10	doses	_	NOUN	NNS	_	8	dobj	_	_
11	in	_	ADP	IN	_	13	case	_	_
12	older	_	ADJ	JJ	_	13	amod	_	_
13	subjects	_	NOUN	NNS	_	10	nmod	_	_
14	59	_	NUM	CD	_	16	compound	_	_
15	to	_	PRT	TO	_	16	dep	_	_
16	68	_	NUM	CD	_	17	nummod	_	_
17	years	_	NOUN	NNS	_	13	dep	_	_
18	,	_	.	,	_	23	punct	_	_
19	peak	_	ADJ	JJ	_	21	amod	_	_
20	DRUG	_	NOUN	NN	_	21	compound	_	_
21	concentrations	_	NOUN	NNS	_	23	nsubjpass	_	_
22	were	_	VERB	VBD	_	23	auxpass	_	_
23	found	_	VERB	VBN	_	0	root	_	_
24	to	_	PRT	TO	_	26	mark	_	_
25	be	_	VERB	VB	_	26	cop	_	_
26	similar	_	ADJ	JJ	_	23	xcomp	_	_
27	to	_	PRT	TO	_	28	case	_	_
28	those	_	DET	DT	_	26	nmod	_	_
29	observed	_	VERB	VBN	_	28	acl	_	_
30	in	_	ADP	IN	_	32	case	_	_
31	younger	_	ADJ	JJ	_	32	amod	_	_
32	subjects	_	NOUN	NNS	_	29	nmod	_	_
33	with	_	ADP	IN	_	38	case	_	_
34	a	_	DET	DT	_	38	det	_	_
35	mean	_	ADJ	JJ	_	38	compound	_	_
36	elimination	_	NOUN	NN	_	38	compound	_	_
37	half	_	NOUN	NN	_	38	compound	_	_
38	life	_	NOUN	NN	_	32	nmod	_	_
39	of	_	ADP	IN	_	41	case	_	_
40	18.4	_	NUM	CD	_	41	nummod	_	_
41	hours	_	NOUN	NNS	_	38	nmod	_	_
42	range	_	NOUN	NN	_	41	dep	_	_
43	13.5	_	NUM	CD	_	42	nummod	_	_
44	to	_	PRT	TO	_	46	case	_	_
45	34.6	_	NUM	CD	_	46	nummod	_	_
46	hours	_	NOUN	NNS	_	38	nmod	_	_

#	Estazolam	3233
1	The	_	DET	DT	_	2	det	_	_
2	influence	_	NOUN	NN	_	16	nsubjpass	_	_
3	of	_	ADP	IN	_	7	case	_	_
4	hepatic	_	ADJ	JJ	_	7	amod	_	_
5	or	_	CONJ	CC	_	4	cc	_	_
6	renal	_	ADJ	JJ	_	4	conj	_	_
7	impairment	_	NOUN	NN	_	2	nmod	_	_
8	on	_	ADP	IN	_	10	case	_	_
9	the	_	DET	DT	_	10	det	_	_
10	pharmacokinetics	_	NOUN	NNS	_	2	nmod	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_
13	has	_	VERB	VBZ	_	16	aux	_	_
14	not	_	ADV	RB	_	16	neg	_	_
15	been	_	VERB	VBN	_	16	auxpass	_	_
16	studied	_	VERB	VBN	_	0	root	_	_

#	Estazolam	3234
1	The	_	DET	DT	_	2	det	_	_
2	pharmacokinetics	_	NOUN	NNS	_	8	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	have	_	VERB	MD	_	8	aux	_	_
6	not	_	ADV	RB	_	8	neg	_	_
7	been	_	VERB	VBN	_	8	auxpass	_	_
8	studied	_	VERB	VBN	_	0	root	_	_
9	in	_	ADP	IN	_	11	case	_	_
10	pediatric	_	ADJ	JJ	_	11	amod	_	_
11	patients	_	NOUN	NNS	_	8	nmod	_	_

#	Estazolam	3235
1	The	_	DET	DT	_	2	det	_	_
2	influence	_	NOUN	NN	_	13	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	race	_	NOUN	NN	_	2	nmod	_	_
5	on	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	pharmacokinetics	_	NOUN	NNS	_	2	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	has	_	VERB	VBZ	_	13	aux	_	_
11	not	_	ADV	RB	_	13	neg	_	_
12	been	_	VERB	VBN	_	13	auxpass	_	_
13	studied	_	VERB	VBN	_	0	root	_	_

#	Estazolam	3236
1	The	_	DET	DT	_	3	det	_	_
2	gender	_	ADJ	JJ	_	3	amod	_	_
3	effect	_	NOUN	NN	_	12	nsubjpass	_	_
4	on	_	ADP	IN	_	6	case	_	_
5	the	_	DET	DT	_	6	det	_	_
6	pharmacokinetics	_	NOUN	NNS	_	3	nmod	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	has	_	VERB	VBZ	_	12	aux	_	_
10	not	_	ADV	RB	_	12	neg	_	_
11	been	_	VERB	VBN	_	12	auxpass	_	_
12	investigated	_	VERB	VBN	_	0	root	_	_

#	Estazolam	3237
1	The	_	DET	DT	_	2	det	_	_
2	clearance	_	NOUN	NN	_	6	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	benzodiazepines	_	NOUN	NNS	_	2	nmod	_	_
5	is	_	VERB	VBZ	_	6	auxpass	_	_
6	accelerated	_	VERB	VBN	_	0	root	_	_
7	in	_	ADP	IN	_	8	case	_	_
8	smokers	_	NOUN	NNS	_	6	nmod	_	_
9	compared	_	VERB	VBN	_	11	case	_	_
10	to	_	PRT	TO	_	11	case	_	_
11	nonsmokers	_	NOUN	NNS	_	6	advcl	_	_
12	,	_	.	,	_	6	punct	_	_
13	and	_	CONJ	CC	_	6	cc	_	_
14	there	_	PRON	PRP$	_	15	expl	_	_
15	is	_	VERB	VBZ	_	6	conj	_	_
16	evidence	_	ADJ	JJ	_	15	ccomp	_	_
17	that	_	ADP	IN	_	19	mark	_	_
18	this	_	DET	DT	_	19	nsubj	_	_
19	occurs	_	VERB	VBZ	_	16	ccomp	_	_
20	with	_	ADP	IN	_	21	case	_	_
21	DRUG	_	NOUN	NN	_	19	nmod	_	_

#	Estazolam	3238
1	This	_	DET	DT	_	2	det	_	_
2	decrease	_	NOUN	NN	_	16	nsubj	_	_
3	in	_	ADP	IN	_	5	case	_	_
4	half	_	ADJ	JJ	_	5	amod	_	_
5	life	_	NOUN	NN	_	2	nmod	_	_
6	,	_	.	,	_	2	punct	_	_
7	presumably	_	ADV	RB	_	8	advmod	_	_
8	due	_	ADJ	JJ	_	11	case	_	_
9	to	_	PRT	TO	_	8	mwe	_	_
10	enzyme	_	NOUN	NN	_	11	compound	_	_
11	induction	_	NOUN	NN	_	2	nmod	_	_
12	by	_	ADP	IN	_	13	case	_	_
13	smoking	_	NOUN	NN	_	11	nmod	_	_
14	,	_	.	,	_	2	punct	_	_
15	is	_	VERB	VBZ	_	16	cop	_	_
16	consistent	_	ADJ	JJ	_	0	root	_	_
17	with	_	ADP	IN	_	19	case	_	_
18	other	_	ADJ	JJ	_	19	amod	_	_
19	drugs	_	NOUN	NNS	_	16	nmod	_	_
20	with	_	ADP	IN	_	24	case	_	_
21	similar	_	ADJ	JJ	_	24	amod	_	_
22	hepatic	_	ADJ	JJ	_	24	amod	_	_
23	clearance	_	NOUN	NN	_	24	compound	_	_
24	characteristics	_	NOUN	NNS	_	19	nmod	_	_

#	Estazolam	3239
1	In	_	ADP	IN	_	3	case	_	_
2	all	_	DET	DT	_	3	det	_	_
3	subjects	_	NOUN	NNS	_	14	nmod	_	_
4	and	_	CONJ	CC	_	3	cc	_	_
5	at	_	ADP	IN	_	7	case	_	_
6	all	_	DET	DT	_	7	det	_	_
7	doses	_	NOUN	NNS	_	3	conj	_	_
8	,	_	.	,	_	14	punct	_	_
9	the	_	DET	DT	_	13	det	_	_
10	mean	_	NOUN	NN	_	13	compound	_	_
11	elimination	_	NOUN	NN	_	13	compound	_	_
12	half	_	NOUN	NN	_	13	compound	_	_
13	life	_	NOUN	NN	_	14	nsubj	_	_
14	appeared	_	VERB	VBD	_	0	root	_	_
15	to	_	PRT	TO	_	17	mark	_	_
16	be	_	VERB	VB	_	17	cop	_	_
17	independent	_	ADJ	JJ	_	14	xcomp	_	_
18	of	_	ADP	IN	_	20	case	_	_
19	the	_	DET	DT	_	20	det	_	_
20	dose	_	NOUN	NN	_	17	nmod	_	_

#	Estazolam	3240
1	The	_	DET	DT	_	2	det	_	_
2	metabolism	_	NOUN	NN	_	14	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	to	_	PRT	TO	_	12	case	_	_
6	the	_	DET	DT	_	12	det	_	_
7	major	_	ADJ	JJ	_	12	amod	_	_
8	circulating	_	ADJ	JJ	_	12	amod	_	_
9	metabolite	_	NOUN	NN	_	12	compound	_	_
10	4	_	NUM	CD	_	12	nummod	_	_
11	hydroxy	_	NOUN	NN	_	12	compound	_	_
12	DRUG	_	NOUN	NN	_	2	nmod	_	_
13	is	_	VERB	VBZ	_	14	auxpass	_	_
14	catalyzed	_	VERB	VBN	_	0	root	_	_
15	by	_	ADP	IN	_	16	case	_	_
16	CYP3A	_	NOUN	NN	_	14	nmod	_	_

#	Estazolam	3241
1	While	_	ADP	IN	_	10	mark	_	_
2	no	_	DET	DT	_	8	neg	_	_
3	in	_	X	FW	_	8	amod	_	_
4	vivo	_	X	FW	_	3	dep	_	_
5	drug	_	NOUN	NN	_	8	compound	_	_
6	drug	_	NOUN	NN	_	8	compound	_	_
7	interaction	_	NOUN	NN	_	8	compound	_	_
8	studies	_	NOUN	NNS	_	10	nsubjpass	_	_
9	were	_	VERB	VBD	_	10	auxpass	_	_
10	conducted	_	VERB	VBN	_	0	root	_	_
11	between	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	inhibitors	_	NOUN	NNS	_	12	conj	_	_
15	/	_	.	:	_	10	punct	_	_
16	inducers	_	NOUN	NNS	_	60	nsubjpass	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	CYP3A	_	NOUN	NN	_	16	nmod	_	_
19	,	_	.	,	_	16	punct	_	_
20	compounds	_	NOUN	NNS	_	40	nsubjpass	_	_
21	that	_	DET	WDT	_	25	nsubj	_	_
22	are	_	VERB	VBP	_	25	cop	_	_
23	potent	_	ADJ	JJ	_	25	amod	_	_
24	CYP3A	_	NOUN	NN	_	25	compound	_	_
25	inhibitors	_	NOUN	NNS	_	20	acl:relcl	_	_
26	such	_	ADJ	JJ	_	28	case	_	_
27	as	_	ADP	IN	_	26	mwe	_	_
28	ketoconazole	_	NOUN	NN	_	25	nmod	_	_
29	,	_	.	,	_	28	punct	_	_
30	itraconazole	_	NOUN	NN	_	28	conj	_	_
31	,	_	.	,	_	28	punct	_	_
32	nefazodone	_	NOUN	NN	_	28	conj	_	_
33	,	_	.	,	_	28	punct	_	_
34	fluvoxamine	_	NOUN	NN	_	28	conj	_	_
35	,	_	.	,	_	28	punct	_	_
36	and	_	CONJ	CC	_	28	cc	_	_
37	erythromycin	_	NOUN	NN	_	28	conj	_	_
38	would	_	VERB	MD	_	40	aux	_	_
39	be	_	VERB	VB	_	40	auxpass	_	_
40	expected	_	VERB	VBN	_	16	acl:relcl	_	_
41	to	_	PRT	TO	_	42	mark	_	_
42	increase	_	VERB	VB	_	40	xcomp	_	_
43	plasma	_	NOUN	NN	_	45	compound	_	_
44	DRUG	_	NOUN	NN	_	45	compound	_	_
45	concentrations	_	NOUN	NNS	_	42	dobj	_	_
46	and	_	CONJ	CC	_	45	cc	_	_
47	CYP3A	_	NOUN	NN	_	48	compound	_	_
48	inducers	_	NOUN	NNS	_	45	conj	_	_
49	such	_	ADJ	JJ	_	51	case	_	_
50	as	_	ADP	IN	_	49	mwe	_	_
51	carbamazepine	_	NOUN	NN	_	48	nmod	_	_
52	,	_	.	,	_	51	punct	_	_
53	phenytoin	_	NOUN	NN	_	51	conj	_	_
54	,	_	.	,	_	51	punct	_	_
55	rifampin	_	NOUN	NN	_	51	conj	_	_
56	and	_	CONJ	CC	_	51	cc	_	_
57	barbiturates	_	VERB	VBZ	_	51	conj	_	_
58	would	_	VERB	MD	_	60	aux	_	_
59	be	_	VERB	VB	_	60	auxpass	_	_
60	expected	_	VERB	VBN	_	10	parataxis	_	_
61	to	_	PRT	TO	_	62	mark	_	_
62	decrease	_	VERB	VB	_	60	xcomp	_	_
63	DRUG	_	NOUN	NN	_	64	compound	_	_
64	concentrations	_	NOUN	NNS	_	62	dobj	_	_

#	Estazolam	3244
1	The	_	DET	DT	_	2	det	_	_
2	results	_	NOUN	NNS	_	10	nsubj	_	_
3	from	_	ADP	IN	_	9	case	_	_
4	in	_	X	FW	_	9	amod	_	_
5	vitro	_	X	FW	_	4	dep	_	_
6	human	_	ADJ	JJ	_	9	amod	_	_
7	liver	_	NOUN	NN	_	9	compound	_	_
8	microsomal	_	ADJ	JJ	_	9	amod	_	_
9	studies	_	NOUN	NNS	_	2	nmod	_	_
10	suggest	_	VERB	VBP	_	0	root	_	_
11	that	_	ADP	IN	_	17	mark	_	_
12	at	_	ADP	IN	_	14	case	_	_
13	therapeutic	_	ADJ	JJ	_	14	amod	_	_
14	concentrations	_	NOUN	NNS	_	17	nmod	_	_
15	,	_	.	,	_	17	punct	_	_
16	DRUG	_	NOUN	NN	_	17	nsubj	_	_
17	has	_	VERB	VBZ	_	10	ccomp	_	_
18	no	_	DET	DT	_	21	neg	_	_
19	significant	_	ADJ	JJ	_	21	amod	_	_
20	inhibitory	_	ADJ	JJ	_	21	amod	_	_
21	effect	_	NOUN	NN	_	17	dobj	_	_
22	on	_	ADP	IN	_	29	case	_	_
23	the	_	DET	DT	_	29	det	_	_
24	major	_	ADJ	JJ	_	29	amod	_	_
25	human	_	ADJ	JJ	_	29	amod	_	_
26	cytochrome	_	NOUN	NN	_	29	compound	_	_
27	P450	_	NOUN	NN	_	29	compound	_	_
28	enzyme	_	NOUN	NN	_	29	compound	_	_
29	activities	_	NOUN	NNS	_	17	nmod	_	_
30	i.e	_	ADJ	JJ	_	29	dep	_	_
31	,	_	.	,	_	30	punct	_	_
32	CYP1A2	_	NOUN	NN	_	30	dep	_	_
33	,	_	.	,	_	32	punct	_	_
34	CYP2A6	_	NOUN	NN	_	32	conj	_	_
35	,	_	.	,	_	32	punct	_	_
36	CYP2C9	_	NOUN	NN	_	32	conj	_	_
37	,	_	.	,	_	32	punct	_	_
38	CYP2C19	_	NOUN	NN	_	32	conj	_	_
39	,	_	.	,	_	32	punct	_	_
40	CYP2D6	_	NOUN	NN	_	32	conj	_	_
41	,	_	.	,	_	32	punct	_	_
42	CYP2E1	_	NOUN	NN	_	32	conj	_	_
43	,	_	.	,	_	32	punct	_	_
44	and	_	CONJ	CC	_	32	cc	_	_
45	CYP3A	_	NOUN	NN	_	32	conj	_	_

#	Estazolam	3245
1	The	_	DET	DT	_	2	det	_	_
2	ability	_	NOUN	NN	_	14	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	to	_	PRT	TO	_	6	mark	_	_
6	induce	_	VERB	VB	_	2	acl	_	_
7	human	_	ADJ	JJ	_	10	amod	_	_
8	hepatic	_	ADJ	JJ	_	10	amod	_	_
9	enzyme	_	NOUN	NN	_	10	compound	_	_
10	systems	_	NOUN	NNS	_	6	dobj	_	_
11	has	_	VERB	VBZ	_	14	aux	_	_
12	not	_	ADV	RB	_	14	neg	_	_
13	been	_	VERB	VBN	_	14	auxpass	_	_
14	determined	_	VERB	VBN	_	0	root	_	_

#	Estazolam	3246
1	Postulated	_	ADJ	JJ	_	2	amod	_	_
2	relationship	_	NOUN	NN	_	0	root	_	_
3	between	_	ADP	IN	_	5	case	_	_
4	elimination	_	NOUN	NN	_	5	compound	_	_
5	rate	_	NOUN	NN	_	2	nmod	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	benzodiazepine	_	NOUN	NN	_	8	compound	_	_
8	hypnotics	_	NOUN	NNS	_	5	nmod	_	_
9	and	_	CONJ	CC	_	2	cc	_	_
10	their	_	PRON	PRP$	_	11	nmod:poss	_	_
11	profile	_	NOUN	NN	_	2	conj	_	_
12	of	_	ADP	IN	_	15	case	_	_
13	common	_	ADJ	JJ	_	15	amod	_	_
14	untoward	_	ADJ	JJ	_	15	amod	_	_
15	effects	_	NOUN	NNS	_	11	nmod	_	_
16	:	_	.	:	_	2	punct	_	_
17	The	_	DET	DT	_	18	det	_	_
18	type	_	NOUN	NN	_	37	nsubjpass	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	duration	_	NOUN	NN	_	18	conj	_	_
21	of	_	ADP	IN	_	23	case	_	_
22	hypnotic	_	ADJ	JJ	_	23	amod	_	_
23	effects	_	NOUN	NNS	_	18	nmod	_	_
24	and	_	CONJ	CC	_	18	cc	_	_
25	the	_	DET	DT	_	26	det	_	_
26	profile	_	NOUN	NN	_	18	conj	_	_
27	of	_	ADP	IN	_	29	case	_	_
28	unwanted	_	ADJ	JJ	_	29	amod	_	_
29	effects	_	NOUN	NNS	_	26	nmod	_	_
30	during	_	ADP	IN	_	31	case	_	_
31	administration	_	NOUN	NN	_	18	nmod	_	_
32	of	_	ADP	IN	_	34	case	_	_
33	benzodiazepine	_	NOUN	NN	_	34	compound	_	_
34	drugs	_	NOUN	NNS	_	31	nmod	_	_
35	may	_	VERB	MD	_	37	aux	_	_
36	be	_	VERB	VB	_	37	auxpass	_	_
37	influenced	_	VERB	VBN	_	2	dep	_	_
38	by	_	ADP	IN	_	42	case	_	_
39	the	_	DET	DT	_	42	det	_	_
40	biologic	_	ADJ	JJ	_	42	amod	_	_
41	half	_	ADJ	JJ	_	42	amod	_	_
42	life	_	NOUN	NN	_	37	nmod	_	_
43	of	_	ADP	IN	_	45	case	_	_
44	administered	_	VERB	VBN	_	45	amod	_	_
45	drug	_	NOUN	NN	_	42	nmod	_	_
46	and	_	CONJ	CC	_	37	cc	_	_
47	any	_	DET	DT	_	49	det	_	_
48	active	_	ADJ	JJ	_	49	amod	_	_
49	metabolites	_	NOUN	NNS	_	50	nsubj	_	_
50	formed	_	VERB	VBN	_	37	conj	_	_

#	Estazolam	3247
1	If	_	ADP	IN	_	3	case	_	_
2	half	_	ADJ	JJ	_	3	amod	_	_
3	lives	_	NOUN	NNS	_	5	nsubj	_	_
4	are	_	VERB	VBP	_	5	cop	_	_
5	long	_	ADJ	JJ	_	11	nsubj	_	_
6	,	_	.	,	_	5	punct	_	_
7	drug	_	NOUN	NN	_	5	conj	_	_
8	or	_	CONJ	CC	_	5	cc	_	_
9	metabolites	_	NOUN	NNS	_	5	conj	_	_
10	may	_	VERB	MD	_	11	aux	_	_
11	accumulate	_	VERB	VB	_	0	root	_	_
12	during	_	ADP	IN	_	13	case	_	_
13	periods	_	NOUN	NNS	_	11	nmod	_	_
14	of	_	ADP	IN	_	16	case	_	_
15	nightly	_	ADV	RB	_	16	advmod	_	_
16	administration	_	NOUN	NN	_	13	nmod	_	_
17	and	_	CONJ	CC	_	11	cc	_	_
18	may	_	VERB	MD	_	20	aux	_	_
19	be	_	VERB	VB	_	20	auxpass	_	_
20	associated	_	VERB	VBN	_	45	advcl	_	_
21	with	_	ADP	IN	_	22	case	_	_
22	impairments	_	NOUN	NNS	_	20	nmod	_	_
23	of	_	ADP	IN	_	29	case	_	_
24	cognitive	_	ADJ	JJ	_	29	amod	_	_
25	and	_	CONJ	CC	_	24	cc	_	_
26	/	_	NUM	CD	_	24	conj	_	_
27	or	_	CONJ	CC	_	24	cc	_	_
28	motor	_	NOUN	NN	_	24	conj	_	_
29	performance	_	NOUN	NN	_	22	nmod	_	_
30	during	_	ADP	IN	_	32	case	_	_
31	waking	_	VERB	VBG	_	32	amod	_	_
32	hours	_	NOUN	NNS	_	20	nmod	_	_
33	the	_	DET	DT	_	34	det	_	_
34	possibility	_	NOUN	NN	_	45	nsubjpass	_	_
35	of	_	ADP	IN	_	36	case	_	_
36	interaction	_	NOUN	NN	_	34	nmod	_	_
37	with	_	ADP	IN	_	40	case	_	_
38	other	_	ADJ	JJ	_	40	amod	_	_
39	psychoactive	_	ADJ	JJ	_	40	amod	_	_
40	drugs	_	NOUN	NNS	_	36	nmod	_	_
41	or	_	CONJ	CC	_	40	cc	_	_
42	alcohol	_	NOUN	NN	_	40	conj	_	_
43	will	_	VERB	MD	_	45	aux	_	_
44	be	_	VERB	VB	_	45	auxpass	_	_
45	increased	_	VERB	VBN	_	11	conj	_	_

#	Estazolam	3248
1	In	_	ADP	IN	_	2	case	_	_
2	contrast	_	NOUN	NN	_	15	nmod	_	_
3	,	_	.	,	_	15	punct	_	_
4	if	_	ADP	IN	_	8	mark	_	_
5	half	_	ADJ	JJ	_	6	amod	_	_
6	lives	_	NOUN	NNS	_	8	nsubj	_	_
7	are	_	VERB	VBP	_	8	cop	_	_
8	short	_	ADJ	JJ	_	15	advcl	_	_
9	,	_	.	,	_	15	punct	_	_
10	drug	_	NOUN	NN	_	15	nsubjpass	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	metabolites	_	NOUN	NNS	_	10	conj	_	_
13	will	_	VERB	MD	_	15	aux	_	_
14	be	_	VERB	VB	_	15	auxpass	_	_
15	cleared	_	VERB	VBN	_	0	root	_	_
16	before	_	ADP	IN	_	19	case	_	_
17	the	_	DET	DT	_	19	det	_	_
18	next	_	ADV	RB	_	19	advmod	_	_
19	dose	_	NOUN	NN	_	15	nmod	_	_
20	is	_	VERB	VBZ	_	21	auxpass	_	_
21	ingested	_	VERB	VBN	_	15	parataxis	_	_
22	,	_	.	,	_	21	punct	_	_
23	and	_	CONJ	CC	_	21	cc	_	_
24	carry	_	VERB	VB	_	36	nsubj	_	_
25	over	_	ADP	IN	_	26	case	_	_
26	effects	_	NOUN	NNS	_	24	nmod	_	_
27	related	_	ADJ	JJ	_	26	amod	_	_
28	to	_	PRT	TO	_	30	case	_	_
29	excessive	_	ADJ	JJ	_	30	amod	_	_
30	sedation	_	NOUN	NN	_	27	nmod	_	_
31	or	_	CONJ	CC	_	30	cc	_	_
32	CNS	_	NOUN	NN	_	33	compound	_	_
33	depression	_	NOUN	NN	_	30	conj	_	_
34	should	_	VERB	MD	_	36	aux	_	_
35	be	_	VERB	VB	_	36	cop	_	_
36	minimal	_	ADJ	JJ	_	21	conj	_	_
37	or	_	CONJ	CC	_	36	cc	_	_
38	absent	_	ADJ	JJ	_	36	conj	_	_

#	Estazolam	3249
1	However	_	ADV	RB	_	22	advmod	_	_
2	,	_	.	,	_	22	punct	_	_
3	during	_	ADP	IN	_	5	case	_	_
4	nightly	_	ADV	RB	_	5	advmod	_	_
5	use	_	NOUN	NN	_	22	nmod	_	_
6	for	_	ADP	IN	_	9	case	_	_
7	an	_	DET	DT	_	9	det	_	_
8	extended	_	VERB	VBN	_	9	amod	_	_
9	period	_	NOUN	NN	_	5	nmod	_	_
10	,	_	.	,	_	22	punct	_	_
11	pharmacodynamic	_	ADJ	JJ	_	12	amod	_	_
12	tolerance	_	NOUN	NN	_	22	nsubj	_	_
13	or	_	CONJ	CC	_	12	cc	_	_
14	adaptation	_	NOUN	NN	_	12	conj	_	_
15	to	_	PRT	TO	_	17	case	_	_
16	some	_	DET	DT	_	17	det	_	_
17	effects	_	NOUN	NNS	_	12	nmod	_	_
18	of	_	ADP	IN	_	20	case	_	_
19	benzodiazepine	_	NOUN	NN	_	20	compound	_	_
20	hypnotics	_	NOUN	NNS	_	17	nmod	_	_
21	may	_	VERB	MD	_	22	aux	_	_
22	develop	_	VERB	VB	_	0	root	_	_

#	Estazolam	3250
1	If	_	ADP	IN	_	3	case	_	_
2	the	_	DET	DT	_	3	det	_	_
3	drug	_	NOUN	NN	_	4	nsubj	_	_
4	has	_	VERB	VBZ	_	13	advcl	_	_
5	a	_	DET	DT	_	9	det	_	_
6	short	_	ADJ	JJ	_	9	amod	_	_
7	elimination	_	NOUN	NN	_	9	compound	_	_
8	half	_	NOUN	NN	_	9	compound	_	_
9	life	_	NOUN	NN	_	4	dobj	_	_
10	,	_	.	,	_	13	punct	_	_
11	it	_	PRON	PRP	_	13	nsubj	_	_
12	is	_	VERB	VBZ	_	13	cop	_	_
13	possible	_	ADJ	JJ	_	0	root	_	_
14	that	_	ADP	IN	_	34	mark	_	_
15	a	_	DET	DT	_	17	det	_	_
16	relative	_	ADJ	JJ	_	17	amod	_	_
17	deficiency	_	NOUN	NN	_	34	nsubj	_	_
18	of	_	ADP	IN	_	20	case	_	_
19	the	_	DET	DT	_	20	det	_	_
20	drug	_	NOUN	NN	_	17	nmod	_	_
21	or	_	CONJ	CC	_	20	cc	_	_
22	its	_	PRON	PRP$	_	24	nmod:poss	_	_
23	active	_	ADJ	JJ	_	24	amod	_	_
24	metabolites	_	NOUN	NNS	_	20	conj	_	_
25	i.e	_	ADJ	JJ	_	34	advmod	_	_
26	,	_	.	,	_	34	punct	_	_
27	in	_	ADP	IN	_	28	case	_	_
28	relationship	_	NOUN	NN	_	34	nmod	_	_
29	to	_	PRT	TO	_	32	case	_	_
30	the	_	DET	DT	_	32	det	_	_
31	receptor	_	NOUN	NN	_	32	compound	_	_
32	site	_	NOUN	NN	_	28	nmod	_	_
33	may	_	VERB	MD	_	34	aux	_	_
34	occur	_	VERB	VB	_	13	ccomp	_	_
35	at	_	ADP	IN	_	37	case	_	_
36	some	_	DET	DT	_	37	det	_	_
37	point	_	NOUN	NN	_	34	nmod	_	_
38	in	_	ADP	IN	_	40	case	_	_
39	the	_	DET	DT	_	40	det	_	_
40	interval	_	ADJ	JJ	_	37	nmod	_	_
41	between	_	ADP	IN	_	43	case	_	_
42	each	_	DET	DT	_	43	det	_	_
43	night's	_	NOUN	NNS	_	40	nmod	_	_
44	use	_	VERB	VBP	_	34	parataxis	_	_

#	Estazolam	3251
1	This	_	DET	DT	_	2	det	_	_
2	sequence	_	NOUN	NN	_	6	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	events	_	NOUN	NNS	_	2	nmod	_	_
5	may	_	VERB	MD	_	6	aux	_	_
6	account	_	VERB	VB	_	0	root	_	_
7	for	_	ADP	IN	_	10	case	_	_
8	two	_	NUM	CD	_	10	nummod	_	_
9	clinical	_	ADJ	JJ	_	10	amod	_	_
10	findings	_	NOUN	NNS	_	6	nmod	_	_
11	reported	_	VERB	VBN	_	10	acl	_	_
12	to	_	PRT	TO	_	13	mark	_	_
13	occur	_	VERB	VB	_	11	xcomp	_	_
14	after	_	ADP	IN	_	16	case	_	_
15	several	_	ADJ	JJ	_	16	amod	_	_
16	weeks	_	NOUN	NNS	_	13	nmod	_	_
17	of	_	ADP	IN	_	19	case	_	_
18	nightly	_	ADV	RB	_	19	advmod	_	_
19	use	_	NOUN	NN	_	16	nmod	_	_
20	of	_	ADP	IN	_	24	case	_	_
21	rapidly	_	ADV	RB	_	22	advmod	_	_
22	eliminated	_	VERB	VBN	_	24	amod	_	_
23	benzodiazepine	_	NOUN	NN	_	24	compound	_	_
24	hypnotics	_	NOUN	NNS	_	19	nmod	_	_
25	,	_	.	,	_	6	punct	_	_
26	namely	_	ADV	RB	_	6	advmod	_	_
27	,	_	.	,	_	6	punct	_	_
28	increased	_	VERB	VBD	_	29	amod	_	_
29	wakefulness	_	NOUN	NN	_	6	dobj	_	_
30	during	_	ADP	IN	_	33	case	_	_
31	the	_	DET	DT	_	33	det	_	_
32	last	_	ADJ	JJ	_	33	amod	_	_
33	third	_	NOUN	NN	_	29	nmod	_	_
34	of	_	ADP	IN	_	40	case	_	_
35	the	_	DET	DT	_	40	det	_	_
36	night	_	VERB	MD	_	40	amod	_	_
37	and	_	CONJ	CC	_	36	cc	_	_
38	increased	_	VERB	VBN	_	36	conj	_	_
39	daytime	_	ADJ	JJ	_	40	amod	_	_
40	anxiety	_	NOUN	NN	_	33	nmod	_	_
41	in	_	ADP	IN	_	43	case	_	_
42	selected	_	VERB	VBN	_	43	amod	_	_
43	patients	_	NOUN	NNS	_	40	nmod	_	_

#	Eszopiclone	268
1	CNS	_	NOUN	NN	_	2	compound	_	_
2	Depressants	_	NOUN	NNS	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	Additive	_	ADJ	JJ	_	7	amod	_	_
5	CNS	_	NOUN	NN	_	7	compound	_	_
6	depressant	_	ADJ	JJ	_	7	amod	_	_
7	effects	_	NOUN	NNS	_	10	nsubj	_	_
8	with	_	ADP	IN	_	9	case	_	_
9	combination	_	NOUN	NN	_	7	nmod	_	_
10	use	_	VERB	VBP	_	2	dep	_	_

#	Eszopiclone	269
1	Use	_	NOUN	NN	_	4	nsubj	_	_
2	with	_	ADP	IN	_	3	case	_	_
3	ethanol	_	NOUN	NN	_	1	nmod	_	_
4	causes	_	VERB	VBZ	_	0	root	_	_
5	additive	_	ADJ	JJ	_	9	amod	_	_
6	psychomotor	_	NOUN	NN	_	9	compound	_	_
7	impairment	_	NOUN	NN	_	9	compound	_	_
8	7.1	_	NUM	CD	_	9	nummod	_	_
9	Rifampicin	_	NOUN	NN	_	4	dobj	_	_
10	:	_	.	:	_	4	punct	_	_
11	Combination	_	NOUN	NN	_	12	compound	_	_
12	use	_	NOUN	NN	_	14	nsubj	_	_
13	may	_	VERB	MD	_	14	aux	_	_
14	decrease	_	VERB	VB	_	4	parataxis	_	_
15	exposure	_	NOUN	NN	_	14	dobj	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	effects	_	NOUN	NNS	_	15	conj	_	_
18	of	_	ADP	IN	_	21	case	_	_
19	LUNESTA	_	NOUN	NN	_	21	compound	_	_
20	7.2	_	NUM	CD	_	21	nummod	_	_
21	Ketoconazole	_	NOUN	NN	_	15	nmod	_	_
22	:	_	.	:	_	4	punct	_	_
23	Combination	_	NOUN	NN	_	24	compound	_	_
24	use	_	NOUN	NN	_	25	nsubj	_	_
25	increases	_	VERB	VBZ	_	4	parataxis	_	_
26	exposure	_	NOUN	NN	_	25	dobj	_	_
27	and	_	CONJ	CC	_	26	cc	_	_
28	effect	_	NOUN	NN	_	26	conj	_	_
29	of	_	ADP	IN	_	30	case	_	_
30	LUNESTA	_	NOUN	NN	_	26	nmod	_	_

#	Eszopiclone	270
1	Dose	_	ADJ	JJ	_	2	compound	_	_
2	reduction	_	NOUN	NN	_	6	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	LUNESTA	_	NOUN	NN	_	2	nmod	_	_
5	is	_	VERB	VBZ	_	6	auxpass	_	_
6	needed	_	VERB	VBN	_	0	root	_	_
7	7.2	_	NUM	CD	_	8	nummod	_	_
8	Ethanol	_	NOUN	NN	_	6	dobj	_	_
9	:	_	.	:	_	6	punct	_	_
10	An	_	DET	DT	_	12	det	_	_
11	additive	_	ADJ	JJ	_	12	amod	_	_
12	effect	_	NOUN	NN	_	17	nsubjpass	_	_
13	on	_	ADP	IN	_	15	case	_	_
14	psychomotor	_	NOUN	NN	_	15	compound	_	_
15	performance	_	NOUN	NN	_	12	nmod	_	_
16	was	_	VERB	VBD	_	17	auxpass	_	_
17	seen	_	VERB	VBN	_	6	parataxis	_	_
18	with	_	ADP	IN	_	19	case	_	_
19	coadministration	_	NOUN	NN	_	17	nmod	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	DRUG	_	NOUN	NN	_	19	nmod	_	_
22	and	_	CONJ	CC	_	21	cc	_	_
23	ethanol	_	NOUN	NN	_	21	conj	_	_

#	Eszopiclone	271
1	Olanzapine	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Coadministration	_	NOUN	NN	_	8	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	olanzapine	_	NOUN	NN	_	5	conj	_	_
8	produced	_	VERB	VBD	_	1	dep	_	_
9	a	_	DET	DT	_	10	det	_	_
10	decrease	_	NOUN	NN	_	8	dobj	_	_
11	in	_	ADP	IN	_	13	case	_	_
12	DSST	_	NOUN	NN	_	13	compound	_	_
13	scores	_	NOUN	NNS	_	10	nmod	_	_

#	Eszopiclone	272
1	The	_	DET	DT	_	2	det	_	_
2	interaction	_	NOUN	NN	_	4	nsubj	_	_
3	was	_	VERB	VBD	_	4	cop	_	_
4	pharmacodynamic	_	ADJ	JJ	_	0	root	_	_
5	there	_	PRON	PRP$	_	6	expl	_	_
6	was	_	VERB	VBD	_	4	ccomp	_	_
7	no	_	DET	DT	_	8	neg	_	_
8	alteration	_	NOUN	NN	_	6	nsubj	_	_
9	in	_	ADP	IN	_	11	case	_	_
10	the	_	DET	DT	_	11	det	_	_
11	pharmacokinetics	_	NOUN	NNS	_	8	nmod	_	_
12	of	_	ADP	IN	_	14	case	_	_
13	either	_	CONJ	CC	_	14	det	_	_
14	drug	_	NOUN	NN	_	11	nmod	_	_

#	Eszopiclone	273
1	Drugs	_	NOUN	NNS	_	11	nsubj	_	_
2	That	_	DET	WDT	_	3	nsubj	_	_
3	Inhibit	_	VERB	VBP	_	1	acl:relcl	_	_
4	CYP3A4	_	NOUN	NN	_	6	compound	_	_
5	Ketoconazole	_	NOUN	NN	_	6	compound	_	_
6	CYP3A4	_	NOUN	NN	_	3	dobj	_	_
7	is	_	VERB	VBZ	_	11	cop	_	_
8	a	_	DET	DT	_	11	det	_	_
9	major	_	ADJ	JJ	_	11	amod	_	_
10	metabolic	_	ADJ	JJ	_	11	amod	_	_
11	pathway	_	NOUN	NN	_	0	root	_	_
12	for	_	ADP	IN	_	13	case	_	_
13	elimination	_	NOUN	NN	_	11	nmod	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	DRUG	_	NOUN	NN	_	13	nmod	_	_

#	Eszopiclone	274
1	The	_	DET	DT	_	2	det	_	_
2	exposure	_	NOUN	NN	_	6	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	was	_	VERB	VBD	_	6	auxpass	_	_
6	increased	_	VERB	VBN	_	0	root	_	_
7	by	_	ADP	IN	_	8	case	_	_
8	coadministration	_	NOUN	NN	_	6	nmod	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	ketoconazole	_	NOUN	NN	_	8	nmod	_	_
11	,	_	.	,	_	6	punct	_	_
12	a	_	DET	DT	_	14	det	_	_
13	potent	_	ADJ	JJ	_	14	amod	_	_
14	inhibitor	_	NOUN	NN	_	6	dobj	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	CYP3A4	_	NOUN	NN	_	14	nmod	_	_

#	Eszopiclone	275
1	Other	_	ADJ	JJ	_	3	amod	_	_
2	strong	_	ADJ	JJ	_	3	amod	_	_
3	inhibitors	_	NOUN	NNS	_	21	nsubjpass	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	CYP3A4	_	NOUN	NN	_	6	compound	_	_
6	e.g	_	NOUN	NN	_	3	nmod	_	_
7	,	_	.	,	_	6	punct	_	_
8	itraconazole	_	NOUN	NN	_	6	conj	_	_
9	,	_	.	,	_	6	punct	_	_
10	clarithromycin	_	NOUN	NN	_	6	conj	_	_
11	,	_	.	,	_	6	punct	_	_
12	nefazodone	_	NOUN	NN	_	6	conj	_	_
13	,	_	.	,	_	6	punct	_	_
14	troleandomycin	_	NOUN	NN	_	6	conj	_	_
15	,	_	.	,	_	6	punct	_	_
16	ritonavir	_	NOUN	NN	_	6	appos	_	_
17	,	_	.	,	_	6	punct	_	_
18	nelfinavir	_	NOUN	NN	_	6	appos	_	_
19	would	_	VERB	MD	_	21	aux	_	_
20	be	_	VERB	VB	_	21	auxpass	_	_
21	expected	_	VERB	VBN	_	0	root	_	_
22	to	_	PRT	TO	_	23	mark	_	_
23	behave	_	NOUN	NN	_	21	nmod	_	_
24	similarly	_	ADV	RB	_	23	advmod	_	_

#	Eszopiclone	276
1	Dose	_	ADJ	JJ	_	2	compound	_	_
2	reduction	_	NOUN	NN	_	6	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	LUNESTA	_	NOUN	NN	_	2	nmod	_	_
5	is	_	VERB	VBZ	_	6	auxpass	_	_
6	needed	_	VERB	VBN	_	0	root	_	_
7	for	_	ADP	IN	_	8	case	_	_
8	patient	_	NOUN	NN	_	6	nmod	_	_
9	co	_	PRT	TO	_	11	case	_	_
10	administered	_	VERB	VBN	_	11	amod	_	_
11	LUNESTA	_	NOUN	NN	_	8	nmod	_	_
12	with	_	ADP	IN	_	15	case	_	_
13	potent	_	ADJ	JJ	_	15	amod	_	_
14	CYP3A4	_	NOUN	NN	_	15	compound	_	_
15	inhibitors	_	NOUN	NNS	_	8	nmod	_	_

#	Eszopiclone	277
1	Drugs	_	NOUN	NNS	_	10	nsubjpass	_	_
2	that	_	DET	WDT	_	3	nsubj	_	_
3	Induce	_	VERB	VBP	_	1	acl:relcl	_	_
4	CYP3A4	_	NOUN	NN	_	8	compound	_	_
5	Rifampicin	_	NOUN	NN	_	8	compound	_	_
6	Racemic	_	ADJ	JJ	_	8	amod	_	_
7	zopiclone	_	NOUN	NN	_	8	compound	_	_
8	exposure	_	NOUN	NN	_	3	dobj	_	_
9	was	_	VERB	VBD	_	10	auxpass	_	_
10	decreased	_	VERB	VBN	_	0	root	_	_
11	80%	_	ADJ	JJ	_	10	dobj	_	_
12	by	_	ADP	IN	_	14	case	_	_
13	concomitant	_	ADJ	JJ	_	14	amod	_	_
14	use	_	NOUN	NN	_	10	nmod	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	rifampicin	_	NOUN	NN	_	14	nmod	_	_
17	,	_	.	,	_	10	punct	_	_
18	a	_	DET	DT	_	20	det	_	_
19	potent	_	ADJ	JJ	_	20	amod	_	_
20	inducer	_	NOUN	NN	_	10	dobj	_	_
21	of	_	ADP	IN	_	22	case	_	_
22	CYP3A4	_	NOUN	NN	_	20	nmod	_	_

#	Eszopiclone	278
1	A	_	DET	DT	_	3	det	_	_
2	similar	_	ADJ	JJ	_	3	amod	_	_
3	effect	_	NOUN	NN	_	6	nsubjpass	_	_
4	would	_	VERB	MD	_	6	aux	_	_
5	be	_	VERB	VB	_	6	auxpass	_	_
6	expected	_	VERB	VBN	_	0	root	_	_
7	with	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_

#	Eszopiclone	279
1	Combination	_	NOUN	NN	_	2	compound	_	_
2	use	_	NOUN	NN	_	7	nsubj	_	_
3	with	_	ADP	IN	_	5	case	_	_
4	CYP3A4	_	NOUN	NN	_	5	compound	_	_
5	inducer	_	NOUN	NN	_	2	nmod	_	_
6	may	_	VERB	MD	_	7	aux	_	_
7	decrease	_	VERB	VB	_	0	root	_	_
8	the	_	DET	DT	_	9	det	_	_
9	exposure	_	NOUN	NN	_	7	dobj	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	effects	_	NOUN	NNS	_	9	conj	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	LUNESTA	_	NOUN	NN	_	9	nmod	_	_

#	Eszopiclone	280
1	The	_	DET	DT	_	3	det	_	_
2	precise	_	ADJ	JJ	_	3	amod	_	_
3	mechanism	_	NOUN	NN	_	12	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	action	_	NOUN	NN	_	3	nmod	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	as	_	ADP	IN	_	10	case	_	_
9	a	_	DET	DT	_	10	det	_	_
10	hypnotic	_	NOUN	NN	_	3	nmod	_	_
11	is	_	VERB	VBZ	_	12	cop	_	_
12	unknown	_	ADJ	JJ	_	0	root	_	_
13	,	_	.	,	_	12	punct	_	_
14	but	_	CONJ	CC	_	12	cc	_	_
15	its	_	PRON	PRP$	_	16	nmod:poss	_	_
16	effect	_	NOUN	NN	_	18	nsubjpass	_	_
17	is	_	VERB	VBZ	_	18	auxpass	_	_
18	believed	_	VERB	VBN	_	12	conj	_	_
19	to	_	PRT	TO	_	20	mark	_	_
20	result	_	VERB	VB	_	18	xcomp	_	_
21	from	_	ADP	IN	_	23	case	_	_
22	its	_	PRON	PRP$	_	23	nmod:poss	_	_
23	interaction	_	NOUN	NN	_	20	nmod	_	_
24	with	_	ADP	IN	_	27	case	_	_
25	GABA	_	NOUN	NN	_	27	compound	_	_
26	receptor	_	NOUN	NN	_	27	compound	_	_
27	complexes	_	NOUN	NNS	_	23	nmod	_	_
28	at	_	ADP	IN	_	30	case	_	_
29	binding	_	VERB	VBG	_	30	amod	_	_
30	domains	_	NOUN	NNS	_	23	nmod	_	_
31	located	_	ADJ	JJ	_	30	amod	_	_
32	close	_	ADJ	JJ	_	31	nmod	_	_
33	to	_	PRT	TO	_	36	mark	_	_
34	or	_	CONJ	CC	_	33	cc	_	_
35	allosterically	_	ADV	RB	_	33	conj	_	_
36	coupled	_	VERB	VBN	_	32	acl	_	_
37	to	_	PRT	TO	_	39	case	_	_
38	benzodiazepine	_	NOUN	NN	_	39	compound	_	_
39	receptors	_	NOUN	NNS	_	36	nmod	_	_

#	Eszopiclone	281
1	DRUG	_	NOUN	NN	_	5	nsubj	_	_
2	is	_	VERB	VBZ	_	5	cop	_	_
3	a	_	DET	DT	_	5	det	_	_
4	nonbenzodiazepine	_	ADJ	JJ	_	5	amod	_	_
5	hypnotic	_	NOUN	NN	_	0	root	_	_
6	that	_	DET	WDT	_	10	nsubj	_	_
7	is	_	VERB	VBZ	_	10	cop	_	_
8	a	_	DET	DT	_	10	det	_	_
9	pyrrolopyrazine	_	NOUN	NN	_	10	compound	_	_
10	derivative	_	NOUN	NN	_	5	ccomp	_	_
11	of	_	ADP	IN	_	14	case	_	_
12	the	_	DET	DT	_	14	det	_	_
13	cyclopyrrolone	_	NOUN	NN	_	14	compound	_	_
14	class	_	NOUN	NN	_	10	nmod	_	_
15	with	_	ADP	IN	_	18	case	_	_
16	a	_	DET	DT	_	18	det	_	_
17	chemical	_	ADJ	JJ	_	18	amod	_	_
18	structure	_	NOUN	NN	_	10	nmod	_	_
19	unrelated	_	ADJ	JJ	_	18	amod	_	_
20	to	_	PRT	TO	_	21	case	_	_
21	pyrazolopyrimidines	_	NOUN	NNS	_	19	nmod	_	_
22	,	_	.	,	_	21	punct	_	_
23	imidazopyridines	_	NOUN	NNS	_	21	conj	_	_
24	,	_	.	,	_	21	punct	_	_
25	benzodiazepines	_	NOUN	NNS	_	21	conj	_	_
26	,	_	.	,	_	21	punct	_	_
27	barbiturates	_	VERB	VBZ	_	21	conj	_	_
28	,	_	.	,	_	10	punct	_	_
29	or	_	CONJ	CC	_	10	cc	_	_
30	other	_	ADJ	JJ	_	31	amod	_	_
31	drugs	_	NOUN	NNS	_	10	conj	_	_
32	with	_	ADP	IN	_	35	case	_	_
33	known	_	VERB	VBN	_	35	amod	_	_
34	hypnotic	_	ADJ	JJ	_	35	amod	_	_
35	properties	_	NOUN	NNS	_	31	nmod	_	_

#	Eszopiclone	282
1	The	_	DET	DT	_	2	det	_	_
2	pharmacokinetics	_	NOUN	NNS	_	7	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	have	_	VERB	VBP	_	7	aux	_	_
6	been	_	VERB	VBN	_	7	auxpass	_	_
7	investigated	_	VERB	VBN	_	0	root	_	_
8	in	_	ADP	IN	_	10	case	_	_
9	healthy	_	ADJ	JJ	_	10	amod	_	_
10	subjects	_	NOUN	NNS	_	7	nmod	_	_
11	adult	_	ADJ	JJ	_	10	dep	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	elderly	_	NOUN	NN	_	11	conj	_	_
14	and	_	CONJ	CC	_	11	cc	_	_
15	in	_	ADP	IN	_	16	case	_	_
16	patients	_	NOUN	NNS	_	11	conj	_	_
17	with	_	ADP	IN	_	19	case	_	_
18	hepatic	_	ADJ	JJ	_	19	amod	_	_
19	disease	_	NOUN	NN	_	16	nmod	_	_
20	or	_	CONJ	CC	_	19	cc	_	_
21	renal	_	ADJ	JJ	_	22	amod	_	_
22	disease	_	NOUN	NN	_	19	conj	_	_

#	Eszopiclone	283
1	In	_	ADP	IN	_	3	case	_	_
2	healthy	_	ADJ	JJ	_	3	amod	_	_
3	subjects	_	NOUN	NNS	_	9	nmod	_	_
4	,	_	.	,	_	9	punct	_	_
5	the	_	DET	DT	_	7	det	_	_
6	pharmacokinetic	_	ADJ	JJ	_	7	amod	_	_
7	profile	_	NOUN	NN	_	9	nsubjpass	_	_
8	was	_	VERB	VBD	_	9	auxpass	_	_
9	examined	_	VERB	VBN	_	0	root	_	_
10	after	_	ADP	IN	_	12	case	_	_
11	single	_	ADJ	JJ	_	12	amod	_	_
12	doses	_	NOUN	NNS	_	9	nmod	_	_
13	of	_	ADP	IN	_	17	case	_	_
14	up	_	ADJ	JJ	_	16	advmod	_	_
15	to	_	PRT	TO	_	16	dep	_	_
16	7.5	_	NUM	CD	_	17	nummod	_	_
17	mg	_	NOUN	NN	_	12	nmod	_	_
18	and	_	CONJ	CC	_	12	cc	_	_
19	after	_	ADP	IN	_	22	case	_	_
20	once	_	ADV	RB	_	21	advmod	_	_
21	daily	_	ADV	RB	_	22	amod	_	_
22	administration	_	NOUN	NN	_	12	conj	_	_
23	of	_	ADP	IN	_	24	case	_	_
24	1	_	NUM	CD	_	22	nmod	_	_
25	,	_	.	,	_	24	punct	_	_
26	3	_	NUM	CD	_	24	conj	_	_
27	,	_	.	,	_	24	punct	_	_
28	and	_	CONJ	CC	_	24	cc	_	_
29	6	_	NUM	CD	_	24	conj	_	_
30	mg	_	NOUN	NN	_	24	dep	_	_
31	for	_	ADP	IN	_	33	case	_	_
32	7	_	NUM	CD	_	33	nummod	_	_
33	days	_	NOUN	NNS	_	22	nmod	_	_

#	Eszopiclone	284
1	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
2	is	_	VERB	VBZ	_	4	auxpass	_	_
3	rapidly	_	ADV	RB	_	4	advmod	_	_
4	absorbed	_	VERB	VBN	_	0	root	_	_
5	,	_	.	,	_	4	punct	_	_
6	with	_	ADP	IN	_	8	case	_	_
7	a	_	DET	DT	_	8	det	_	_
8	time	_	NOUN	NN	_	4	nmod	_	_
9	to	_	PRT	TO	_	10	mark	_	_
10	peak	_	VERB	VB	_	8	acl	_	_
11	concentration	_	NOUN	NN	_	12	compound	_	_
12	tmax	_	NOUN	NN	_	10	dobj	_	_
13	of	_	ADP	IN	_	16	case	_	_
14	approximately	_	ADV	RB	_	15	advmod	_	_
15	1	_	NUM	CD	_	16	nummod	_	_
16	hour	_	NOUN	NN	_	12	nmod	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	a	_	DET	DT	_	23	det	_	_
19	terminal	_	ADJ	JJ	_	23	amod	_	_
20	phase	_	NOUN	NN	_	23	compound	_	_
21	elimination	_	NOUN	NN	_	23	compound	_	_
22	half	_	NOUN	NN	_	23	compound	_	_
23	life	_	NOUN	NN	_	16	conj	_	_
24	t1	_	NUM	CD	_	23	nummod	_	_
25	/	_	.	:	_	8	punct	_	_
26	2	_	NUM	CD	_	8	dep	_	_
27	of	_	ADP	IN	_	30	case	_	_
28	approximately	_	ADV	RB	_	29	advmod	_	_
29	6	_	NUM	CD	_	30	nummod	_	_
30	hours	_	NOUN	NNS	_	26	nmod	_	_

#	Eszopiclone	285
1	In	_	ADP	IN	_	3	case	_	_
2	healthy	_	ADJ	JJ	_	3	amod	_	_
3	adults	_	NOUN	NNS	_	8	nmod	_	_
4	,	_	.	,	_	8	punct	_	_
5	LUNESTA	_	NOUN	NN	_	8	nsubj	_	_
6	does	_	VERB	VBZ	_	8	aux	_	_
7	not	_	ADV	RB	_	8	neg	_	_
8	accumulate	_	VERB	VB	_	0	root	_	_
9	with	_	ADP	IN	_	12	case	_	_
10	once	_	ADV	RB	_	11	advmod	_	_
11	daily	_	ADV	RB	_	12	amod	_	_
12	administration	_	NOUN	NN	_	8	nmod	_	_
13	,	_	.	,	_	8	punct	_	_
14	and	_	CONJ	CC	_	8	cc	_	_
15	its	_	PRON	PRP$	_	16	nmod:poss	_	_
16	exposure	_	NOUN	NN	_	19	nsubj	_	_
17	is	_	VERB	VBZ	_	19	cop	_	_
18	dose	_	NOUN	NN	_	19	nmod:npmod	_	_
19	proportional	_	ADJ	JJ	_	8	conj	_	_
20	over	_	ADP	IN	_	22	case	_	_
21	the	_	DET	DT	_	22	det	_	_
22	range	_	NOUN	NN	_	19	nmod	_	_
23	of	_	ADP	IN	_	28	case	_	_
24	1	_	NUM	CD	_	26	compound	_	_
25	to	_	PRT	TO	_	26	dep	_	_
26	6	_	NUM	CD	_	28	nummod	_	_
27	mg	_	NOUN	NN	_	28	compound	_	_
28	Absorption	_	NOUN	NN	_	22	nmod	_	_
29	and	_	CONJ	CC	_	28	cc	_	_
30	Distribution	_	NOUN	NN	_	31	compound	_	_
31	DRUG	_	NOUN	NN	_	28	conj	_	_
32	is	_	VERB	VBZ	_	34	auxpass	_	_
33	rapidly	_	ADV	RB	_	34	advmod	_	_
34	absorbed	_	VERB	VBN	_	19	parataxis	_	_
35	following	_	ADP	IN	_	37	case	_	_
36	oral	_	ADJ	JJ	_	37	amod	_	_
37	administration	_	NOUN	NN	_	34	nmod	_	_

#	Eszopiclone	286
1	Peak	_	ADJ	JJ	_	3	amod	_	_
2	plasma	_	NOUN	NN	_	3	compound	_	_
3	concentrations	_	NOUN	NNS	_	5	nsubjpass	_	_
4	are	_	VERB	VBP	_	5	auxpass	_	_
5	achieved	_	VERB	VBN	_	0	root	_	_
6	within	_	ADP	IN	_	9	case	_	_
7	approximately	_	ADV	RB	_	8	advmod	_	_
8	1	_	NUM	CD	_	9	nummod	_	_
9	hour	_	NOUN	NN	_	5	nmod	_	_
10	after	_	ADP	IN	_	12	case	_	_
11	oral	_	ADJ	JJ	_	12	amod	_	_
12	administration	_	NOUN	NN	_	5	nmod	_	_

#	Eszopiclone	287
1	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
2	is	_	VERB	VBZ	_	4	auxpass	_	_
3	weakly	_	ADV	RB	_	4	advmod	_	_
4	bound	_	VERB	VBN	_	0	root	_	_
5	to	_	PRT	TO	_	9	case	_	_
6	plasma	_	NOUN	NN	_	9	compound	_	_
7	protein	_	NOUN	NN	_	9	compound	_	_
8	52	_	NUM	CD	_	9	nummod	_	_
9	59%	_	ADJ	JJ	_	4	nmod	_	_

#	Eszopiclone	288
1	The	_	DET	DT	_	4	det	_	_
2	large	_	ADJ	JJ	_	4	amod	_	_
3	free	_	ADJ	JJ	_	4	amod	_	_
4	fraction	_	NOUN	NN	_	5	nsubj	_	_
5	suggests	_	VERB	VBZ	_	0	root	_	_
6	that	_	ADP	IN	_	12	mark	_	_
7	DRUG	_	NOUN	NN	_	8	compound	_	_
8	disposition	_	NOUN	NN	_	12	nsubjpass	_	_
9	should	_	VERB	MD	_	12	aux	_	_
10	not	_	ADV	RB	_	12	neg	_	_
11	be	_	VERB	VB	_	12	auxpass	_	_
12	affected	_	VERB	VBN	_	5	ccomp	_	_
13	by	_	ADP	IN	_	16	case	_	_
14	drug	_	NOUN	NN	_	16	compound	_	_
15	drug	_	NOUN	NN	_	16	compound	_	_
16	interactions	_	NOUN	NNS	_	12	nmod	_	_
17	caused	_	VERB	VBN	_	16	acl	_	_
18	by	_	ADP	IN	_	20	case	_	_
19	protein	_	NOUN	NN	_	20	compound	_	_
20	binding	_	NOUN	NN	_	17	nmod	_	_

#	Eszopiclone	289
1	The	_	DET	DT	_	2	det	_	_
2	blood	_	NOUN	NN	_	9	nsubj	_	_
3	to	_	PRT	TO	_	5	case	_	_
4	plasma	_	NOUN	NN	_	5	compound	_	_
5	ratio	_	NOUN	NN	_	2	nmod	_	_
6	for	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	is	_	VERB	VBZ	_	9	cop	_	_
9	less	_	ADV	RB	_	0	root	_	_
10	than	_	ADP	IN	_	11	case	_	_
11	one	_	NUM	CD	_	9	nmod	_	_
12	,	_	.	,	_	9	punct	_	_
13	indicating	_	VERB	VBG	_	9	advcl	_	_
14	no	_	DET	DT	_	16	neg	_	_
15	selective	_	ADJ	JJ	_	16	amod	_	_
16	uptake	_	NOUN	NN	_	13	dobj	_	_
17	by	_	ADP	IN	_	20	case	_	_
18	red	_	ADJ	JJ	_	20	amod	_	_
19	blood	_	NOUN	NN	_	20	compound	_	_
20	cells	_	NOUN	NNS	_	16	nmod	_	_

#	Eszopiclone	290
1	Metabolism	_	NOUN	NN	_	9	nsubjpass	_	_
2	Following	_	ADP	IN	_	4	case	_	_
3	oral	_	ADJ	JJ	_	4	amod	_	_
4	administration	_	NOUN	NN	_	1	nmod	_	_
5	,	_	.	,	_	1	punct	_	_
6	DRUG	_	NOUN	NN	_	1	appos	_	_
7	is	_	VERB	VBZ	_	9	auxpass	_	_
8	extensively	_	ADV	RB	_	9	advmod	_	_
9	metabolized	_	VERB	VBN	_	0	root	_	_
10	by	_	ADP	IN	_	11	case	_	_
11	oxidation	_	NOUN	NN	_	9	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	demethylation	_	NOUN	NN	_	11	conj	_	_

#	Eszopiclone	291
1	The	_	DET	DT	_	4	det	_	_
2	primary	_	ADJ	JJ	_	4	amod	_	_
3	plasma	_	NOUN	NN	_	4	compound	_	_
4	metabolites	_	NOUN	NNS	_	9	nsubj	_	_
5	are	_	VERB	VBP	_	9	cop	_	_
6	S	_	NOUN	NN	_	9	compound	_	_
7	zopiclone	_	NOUN	NN	_	9	compound	_	_
8	N	_	NOUN	NN	_	9	compound	_	_
9	oxide	_	NOUN	NN	_	0	root	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	S	_	NOUN	NN	_	14	compound	_	_
12	N	_	NOUN	NN	_	14	compound	_	_
13	desmethyl	_	NOUN	NN	_	14	compound	_	_
14	zopiclone	_	NOUN	NN	_	9	conj	_	_
15	the	_	DET	DT	_	17	det	_	_
16	latter	_	ADJ	JJ	_	17	amod	_	_
17	compound	_	NOUN	NN	_	18	nsubj	_	_
18	binds	_	VERB	VBZ	_	9	acl:relcl	_	_
19	to	_	PRT	TO	_	21	case	_	_
20	GABA	_	NOUN	NN	_	21	compound	_	_
21	receptors	_	NOUN	NNS	_	18	nmod	_	_
22	with	_	ADP	IN	_	25	case	_	_
23	substantially	_	ADV	RB	_	24	advmod	_	_
24	lower	_	ADJ	JJ	_	25	amod	_	_
25	potency	_	NOUN	NN	_	18	nmod	_	_
26	than	_	ADP	IN	_	27	case	_	_
27	DRUG	_	NOUN	NN	_	25	nmod	_	_
28	,	_	.	,	_	9	punct	_	_
29	and	_	CONJ	CC	_	9	cc	_	_
30	the	_	DET	DT	_	32	det	_	_
31	former	_	ADJ	JJ	_	32	amod	_	_
32	compound	_	NOUN	NN	_	33	nsubj	_	_
33	shows	_	VERB	VBZ	_	9	conj	_	_
34	no	_	DET	DT	_	36	neg	_	_
35	significant	_	ADJ	JJ	_	36	amod	_	_
36	binding	_	NOUN	NN	_	33	dobj	_	_
37	to	_	PRT	TO	_	39	case	_	_
38	this	_	DET	DT	_	39	det	_	_
39	receptor	_	NOUN	NN	_	36	nmod	_	_

#	Eszopiclone	292
1	In	_	X	FW	_	3	amod	_	_
2	vitro	_	X	FW	_	1	dep	_	_
3	studies	_	NOUN	NNS	_	5	nsubj	_	_
4	have	_	VERB	VBP	_	5	aux	_	_
5	shown	_	VERB	VBN	_	0	root	_	_
6	that	_	ADP	IN	_	12	mark	_	_
7	CYP3A4	_	NOUN	NN	_	10	compound	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	CYP2E1	_	NOUN	NN	_	7	conj	_	_
10	enzymes	_	NOUN	NNS	_	12	nsubjpass	_	_
11	are	_	VERB	VBP	_	12	auxpass	_	_
12	involved	_	VERB	VBN	_	5	ccomp	_	_
13	in	_	ADP	IN	_	15	case	_	_
14	the	_	DET	DT	_	15	det	_	_
15	metabolism	_	NOUN	NN	_	12	nmod	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	DRUG	_	NOUN	NN	_	15	nmod	_	_

#	Eszopiclone	293
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	did	_	VERB	VBD	_	4	aux	_	_
3	not	_	ADV	RB	_	4	neg	_	_
4	show	_	VERB	VB	_	0	root	_	_
5	any	_	DET	DT	_	7	det	_	_
6	inhibitory	_	ADJ	JJ	_	7	amod	_	_
7	potential	_	NOUN	NN	_	4	dobj	_	_
8	on	_	ADP	IN	_	10	case	_	_
9	CYP450	_	NOUN	NN	_	10	compound	_	_
10	1A2	_	NOUN	NN	_	7	nmod	_	_
11	,	_	.	,	_	10	punct	_	_
12	2A6	_	NOUN	NN	_	10	conj	_	_
13	,	_	.	,	_	10	punct	_	_
14	2C9	_	NOUN	NN	_	10	conj	_	_
15	,	_	.	,	_	10	punct	_	_
16	2C19	_	NOUN	NN	_	10	conj	_	_
17	,	_	.	,	_	10	punct	_	_
18	2D6	_	NOUN	NN	_	10	conj	_	_
19	,	_	.	,	_	10	punct	_	_
20	2E1	_	NOUN	NN	_	10	conj	_	_
21	,	_	.	,	_	10	punct	_	_
22	and	_	CONJ	CC	_	10	cc	_	_
23	3A4	_	NOUN	NN	_	10	conj	_	_
24	in	_	ADP	IN	_	27	case	_	_
25	cryopreserved	_	VERB	VBN	_	27	amod	_	_
26	human	_	ADJ	JJ	_	27	amod	_	_
27	hepatocytes	_	NOUN	NNS	_	7	nmod	_	_

#	Eszopiclone	294
1	Elimination	_	NOUN	NN	_	4	compound	_	_
2	After	_	NOUN	NN	_	4	compound	_	_
3	oral	_	ADJ	JJ	_	4	amod	_	_
4	administration	_	NOUN	NN	_	8	nsubjpass	_	_
5	,	_	.	,	_	4	punct	_	_
6	DRUG	_	NOUN	NN	_	4	appos	_	_
7	is	_	VERB	VBZ	_	8	auxpass	_	_
8	eliminated	_	VERB	VBN	_	0	root	_	_
9	with	_	ADP	IN	_	11	case	_	_
10	a	_	DET	DT	_	11	det	_	_
11	mean	_	NOUN	NN	_	8	nmod	_	_
12	t1	_	NUM	CD	_	11	nummod	_	_
13	/	_	.	:	_	11	punct	_	_
14	2	_	NUM	CD	_	11	dep	_	_
15	of	_	ADP	IN	_	18	case	_	_
16	approximately	_	ADV	RB	_	17	advmod	_	_
17	6	_	NUM	CD	_	18	nummod	_	_
18	hours	_	NOUN	NNS	_	14	nmod	_	_

#	Eszopiclone	295
1	Up	_	ADV	RB	_	12	nsubjpass	_	_
2	to	_	PRT	TO	_	3	case	_	_
3	75%	_	NOUN	NN	_	1	nmod	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	an	_	DET	DT	_	7	det	_	_
6	oral	_	ADJ	JJ	_	7	amod	_	_
7	dose	_	NOUN	NN	_	3	nmod	_	_
8	of	_	ADP	IN	_	10	case	_	_
9	racemic	_	ADJ	JJ	_	10	amod	_	_
10	zopiclone	_	NOUN	NN	_	7	nmod	_	_
11	is	_	VERB	VBZ	_	12	auxpass	_	_
12	excreted	_	VERB	VBN	_	0	root	_	_
13	in	_	ADP	IN	_	15	case	_	_
14	the	_	DET	DT	_	15	det	_	_
15	urine	_	NOUN	NN	_	12	nmod	_	_
16	,	_	.	,	_	12	punct	_	_
17	primarily	_	ADV	RB	_	19	advmod	_	_
18	as	_	ADP	IN	_	19	case	_	_
19	metabolites	_	NOUN	NNS	_	12	nmod	_	_

#	Eszopiclone	296
1	A	_	DET	DT	_	4	det	_	_
2	similar	_	ADJ	JJ	_	4	amod	_	_
3	excretion	_	NOUN	NN	_	4	compound	_	_
4	profile	_	NOUN	NN	_	7	nsubjpass	_	_
5	would	_	VERB	MD	_	7	aux	_	_
6	be	_	VERB	VB	_	7	auxpass	_	_
7	expected	_	VERB	VBN	_	0	root	_	_
8	for	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	,	_	.	,	_	7	punct	_	_
11	the	_	DET	DT	_	13	det	_	_
12	S	_	NOUN	NN	_	13	compound	_	_
13	isomer	_	NOUN	NN	_	7	dobj	_	_
14	of	_	ADP	IN	_	16	case	_	_
15	racemic	_	ADJ	JJ	_	16	amod	_	_
16	zopiclone	_	NOUN	NN	_	13	nmod	_	_

#	Eszopiclone	297
1	Less	_	ADV	RB	_	3	case	_	_
2	than	_	ADP	IN	_	1	mwe	_	_
3	10%	_	NOUN	NN	_	11	nsubjpass	_	_
4	of	_	ADP	IN	_	9	case	_	_
5	the	_	DET	DT	_	9	det	_	_
6	orally	_	ADV	RB	_	7	advmod	_	_
7	administered	_	VERB	VBN	_	9	amod	_	_
8	DRUG	_	NOUN	NN	_	9	compound	_	_
9	dose	_	NOUN	NN	_	3	nmod	_	_
10	is	_	VERB	VBZ	_	11	auxpass	_	_
11	excreted	_	VERB	VBN	_	0	root	_	_
12	in	_	ADP	IN	_	14	case	_	_
13	the	_	DET	DT	_	14	det	_	_
14	urine	_	ADJ	JJ	_	11	nmod	_	_
15	as	_	ADP	IN	_	17	case	_	_
16	parent	_	NOUN	NN	_	17	compound	_	_
17	drug	_	NOUN	NN	_	14	nmod	_	_

#	Eszopiclone	298
1	Effect	_	NOUN	NN	_	0	root	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	Food	_	NOUN	NN	_	1	nmod	_	_
4	In	_	ADP	IN	_	6	case	_	_
5	healthy	_	ADJ	JJ	_	6	amod	_	_
6	adults	_	NOUN	NNS	_	1	nmod	_	_
7	,	_	.	,	_	1	punct	_	_
8	administration	_	NOUN	NN	_	21	nsubj	_	_
9	of	_	ADP	IN	_	13	case	_	_
10	a	_	DET	DT	_	13	det	_	_
11	3	_	NUM	CD	_	13	nummod	_	_
12	mg	_	NOUN	NN	_	13	compound	_	_
13	dose	_	NOUN	NN	_	8	nmod	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	DRUG	_	NOUN	NN	_	13	nmod	_	_
16	after	_	ADP	IN	_	20	case	_	_
17	a	_	DET	DT	_	20	det	_	_
18	high	_	ADJ	JJ	_	20	amod	_	_
19	fat	_	NOUN	NN	_	20	compound	_	_
20	meal	_	NOUN	NN	_	8	nmod	_	_
21	resulted	_	VERB	VBD	_	1	dep	_	_
22	in	_	ADP	IN	_	24	case	_	_
23	no	_	DET	DT	_	24	neg	_	_
24	change	_	NOUN	NN	_	21	nmod	_	_
25	in	_	ADP	IN	_	26	case	_	_
26	AUC	_	NOUN	NN	_	24	nmod	_	_
27	,	_	.	,	_	26	punct	_	_
28	a	_	DET	DT	_	29	det	_	_
29	reduction	_	NOUN	NN	_	26	conj	_	_
30	in	_	ADP	IN	_	32	case	_	_
31	mean	_	ADJ	JJ	_	32	amod	_	_
32	Cmax	_	NOUN	NN	_	29	nmod	_	_
33	of	_	ADP	IN	_	34	case	_	_
34	21%	_	NOUN	NN	_	32	nmod	_	_
35	,	_	.	,	_	26	punct	_	_
36	and	_	CONJ	CC	_	26	cc	_	_
37	delayed	_	VERB	VBN	_	38	amod	_	_
38	tmax	_	NOUN	NN	_	26	conj	_	_
39	by	_	ADP	IN	_	42	case	_	_
40	approximately	_	ADV	RB	_	41	advmod	_	_
41	1	_	NUM	CD	_	42	nummod	_	_
42	hour	_	NUM	CD	_	24	nmod	_	_

#	Eszopiclone	299
1	The	_	DET	DT	_	3	det	_	_
2	half	_	ADJ	JJ	_	3	amod	_	_
3	life	_	NOUN	NN	_	4	nsubj	_	_
4	remained	_	VERB	VBD	_	0	root	_	_
5	unchanged	_	ADJ	JJ	_	4	xcomp	_	_
6	,	_	.	,	_	4	punct	_	_
7	approximately	_	ADV	RB	_	9	advmod	_	_
8	6	_	NUM	CD	_	9	nummod	_	_
9	hours	_	NOUN	NNS	_	4	nmod	_	_

#	Eszopiclone	300
1	The	_	DET	DT	_	2	det	_	_
2	effects	_	NOUN	NNS	_	10	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	LUNESTA	_	NOUN	NN	_	2	nmod	_	_
5	on	_	ADP	IN	_	7	case	_	_
6	sleep	_	NOUN	NN	_	7	compound	_	_
7	onset	_	NOUN	NN	_	2	nmod	_	_
8	may	_	VERB	MD	_	10	aux	_	_
9	be	_	VERB	VB	_	10	auxpass	_	_
10	reduced	_	VERB	VBN	_	0	root	_	_
11	if	_	ADP	IN	_	14	mark	_	_
12	it	_	PRON	PRP	_	14	nsubjpass	_	_
13	is	_	VERB	VBZ	_	14	auxpass	_	_
14	taken	_	VERB	VBN	_	10	ccomp	_	_
15	with	_	ADP	IN	_	17	case	_	_
16	or	_	CONJ	CC	_	17	cc	_	_
17	immediately	_	ADV	RB	_	14	advmod	_	_
18	after	_	ADP	IN	_	21	case	_	_
19	a	_	DET	DT	_	21	det	_	_
20	high	_	ADJ	JJ	_	21	amod	_	_
21	fat	_	NOUN	NN	_	14	nmod	_	_
22	/	_	.	:	_	14	punct	_	_
23	heavy	_	ADJ	JJ	_	14	dep	_	_
24	meal	_	ADJ	JJ	_	23	dep	_	_

#	Eszopiclone	301
1	Specific	_	ADJ	JJ	_	2	amod	_	_
2	Populations	_	NOUN	NNS	_	4	nsubj	_	_
3	Age	_	NOUN	NN	_	2	dep	_	_
4	Compared	_	VERB	VBD	_	0	root	_	_
5	with	_	ADP	IN	_	8	case	_	_
6	non	_	ADJ	JJ	_	8	amod	_	_
7	elderly	_	ADJ	JJ	_	8	amod	_	_
8	adults	_	NOUN	NNS	_	4	nmod	_	_
9	,	_	.	,	_	4	punct	_	_
10	subjects	_	NOUN	NNS	_	4	conj	_	_
11	65	_	NUM	CD	_	12	nummod	_	_
12	years	_	NOUN	NNS	_	10	dobj	_	_
13	and	_	CONJ	CC	_	4	cc	_	_
14	older	_	ADV	RB	_	15	advmod	_	_
15	had	_	VERB	VBD	_	4	conj	_	_
16	an	_	DET	DT	_	17	det	_	_
17	increase	_	NOUN	NN	_	15	dobj	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	41%	_	NOUN	NN	_	17	nmod	_	_
20	in	_	ADP	IN	_	23	case	_	_
21	total	_	ADJ	JJ	_	23	amod	_	_
22	exposure	_	NOUN	NN	_	23	compound	_	_
23	AUC	_	NOUN	NN	_	17	nmod	_	_
24	and	_	CONJ	CC	_	15	cc	_	_
25	a	_	DET	DT	_	28	det	_	_
26	slightly	_	ADV	RB	_	27	advmod	_	_
27	prolonged	_	ADJ	JJ	_	28	amod	_	_
28	elimination	_	NOUN	NN	_	15	conj	_	_
29	of	_	ADP	IN	_	33	case	_	_
30	DRUG	_	NOUN	NN	_	33	compound	_	_
31	t1	_	NUM	CD	_	33	nummod	_	_
32	/	_	.	:	_	33	punct	_	_
33	2	_	NUM	CD	_	28	nmod	_	_
34	approximately	_	ADV	RB	_	35	advmod	_	_
35	9hours	_	NOUN	NNS	_	28	nmod	_	_

#	Eszopiclone	302
1	Therefore	_	ADV	RB	_	10	advmod	_	_
2	,	_	.	,	_	10	punct	_	_
3	in	_	ADP	IN	_	5	case	_	_
4	elderly	_	ADJ	JJ	_	5	amod	_	_
5	patients	_	NOUN	NNS	_	10	nmod	_	_
6	the	_	DET	DT	_	7	det	_	_
7	dose	_	NOUN	NN	_	10	nsubj	_	_
8	should	_	VERB	MD	_	10	aux	_	_
9	not	_	ADV	RB	_	10	neg	_	_
10	exceed	_	VERB	VBN	_	0	root	_	_
11	2	_	NUM	CD	_	12	nummod	_	_
12	mg	_	NOUN	NN	_	10	dobj	_	_

#	Eszopiclone	303
1	Gender	_	NOUN	NN	_	0	root	_	_
2	The	_	DET	DT	_	3	det	_	_
3	pharmacokinetics	_	NOUN	NNS	_	11	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	in	_	ADP	IN	_	7	case	_	_
7	men	_	NOUN	NN	_	3	nmod	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	women	_	NOUN	NNS	_	7	conj	_	_
10	are	_	VERB	VBP	_	11	auxpass	_	_
11	similar	_	ADJ	JJ	_	1	dep	_	_

#	Eszopiclone	304
1	Race	_	NOUN	NN	_	24	nmod	_	_
2	In	_	ADP	IN	_	4	case	_	_
3	an	_	DET	DT	_	4	det	_	_
4	analysis	_	NOUN	NN	_	1	nmod	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	data	_	NOUN	NNS	_	4	nmod	_	_
7	on	_	ADP	IN	_	9	case	_	_
8	all	_	DET	DT	_	9	det	_	_
9	subjects	_	NOUN	NNS	_	4	nmod	_	_
10	participating	_	VERB	VBG	_	9	acl	_	_
11	in	_	ADP	IN	_	14	case	_	_
12	Phase	_	NOUN	NN	_	14	compound	_	_
13	1	_	NUM	CD	_	14	nummod	_	_
14	studies	_	NOUN	NNS	_	10	nmod	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	14	nmod	_	_
17	,	_	.	,	_	24	punct	_	_
18	the	_	DET	DT	_	19	det	_	_
19	pharmacokinetics	_	NOUN	NNS	_	24	nsubj	_	_
20	for	_	ADP	IN	_	22	case	_	_
21	all	_	DET	DT	_	22	det	_	_
22	races	_	NOUN	NNS	_	19	nmod	_	_
23	studied	_	VERB	VBN	_	22	acl	_	_
24	appeared	_	VERB	VBD	_	0	root	_	_
25	similar	_	ADJ	JJ	_	24	xcomp	_	_

#	Eszopiclone	305
1	Hepatic	_	ADJ	JJ	_	3	amod	_	_
2	Impairment	_	NOUN	NN	_	3	compound	_	_
3	Pharmacokinetics	_	NOUN	NNS	_	11	nsubjpass	_	_
4	of	_	ADP	IN	_	9	case	_	_
5	a	_	DET	DT	_	9	det	_	_
6	2	_	NUM	CD	_	9	nummod	_	_
7	mg	_	NOUN	NN	_	9	compound	_	_
8	DRUG	_	NOUN	NN	_	9	compound	_	_
9	dose	_	NOUN	NN	_	3	nmod	_	_
10	were	_	VERB	VBD	_	11	auxpass	_	_
11	assessed	_	VERB	VBN	_	0	root	_	_
12	in	_	ADP	IN	_	15	case	_	_
13	16	_	NUM	CD	_	15	nummod	_	_
14	healthy	_	ADJ	JJ	_	15	amod	_	_
15	volunteers	_	NOUN	NNS	_	11	nmod	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	in	_	ADP	IN	_	18	case	_	_
18	8subjects	_	NOUN	NNS	_	15	conj	_	_
19	with	_	ADP	IN	_	27	case	_	_
20	mild	_	ADJ	JJ	_	27	amod	_	_
21	,	_	.	,	_	20	punct	_	_
22	moderate	_	ADJ	JJ	_	20	conj	_	_
23	,	_	.	,	_	20	punct	_	_
24	and	_	CONJ	CC	_	20	cc	_	_
25	severe	_	ADJ	JJ	_	20	conj	_	_
26	liver	_	NOUN	NN	_	27	compound	_	_
27	disease	_	NOUN	NN	_	18	nmod	_	_

#	Eszopiclone	306
1	Exposure	_	NOUN	NN	_	3	nsubjpass	_	_
2	was	_	VERB	VBD	_	3	auxpass	_	_
3	increased	_	VERB	VBN	_	0	root	_	_
4	2	_	NUM	CD	_	5	nummod	_	_
5	fold	_	NOUN	NN	_	3	dobj	_	_
6	in	_	ADP	IN	_	9	case	_	_
7	severely	_	ADV	RB	_	8	advmod	_	_
8	impaired	_	ADJ	JJ	_	9	amod	_	_
9	patients	_	NOUN	NNS	_	5	nmod	_	_
10	compared	_	VERB	VBN	_	14	case	_	_
11	with	_	ADP	IN	_	14	case	_	_
12	the	_	DET	DT	_	14	det	_	_
13	healthy	_	ADJ	JJ	_	14	amod	_	_
14	volunteers	_	NOUN	NNS	_	3	nmod	_	_

#	Eszopiclone	307
1	No	_	DET	DT	_	3	neg	_	_
2	dose	_	NOUN	NN	_	3	compound	_	_
3	adjustment	_	NOUN	NN	_	5	nsubj	_	_
4	is	_	VERB	VBZ	_	5	cop	_	_
5	necessary	_	ADJ	JJ	_	0	root	_	_
6	for	_	ADP	IN	_	7	case	_	_
7	patients	_	NOUN	NNS	_	5	nmod	_	_
8	with	_	ADP	IN	_	9	case	_	_
9	mild	_	ADJ	JJ	_	7	nmod	_	_
10	to	_	PRT	TO	_	13	case	_	_
11	moderate	_	ADJ	JJ	_	13	amod	_	_
12	hepatic	_	ADJ	JJ	_	13	amod	_	_
13	impairment	_	NOUN	NN	_	9	nmod	_	_

#	Eszopiclone	308
1	Dose	_	NOUN	NN	_	2	compound	_	_
2	reduction	_	NOUN	NN	_	4	nsubjpass	_	_
3	is	_	VERB	VBZ	_	4	auxpass	_	_
4	recommended	_	VERB	VBN	_	0	root	_	_
5	for	_	ADP	IN	_	6	case	_	_
6	patients	_	NOUN	NNS	_	4	nmod	_	_
7	with	_	ADP	IN	_	10	case	_	_
8	severe	_	ADJ	JJ	_	10	amod	_	_
9	hepatic	_	ADJ	JJ	_	10	amod	_	_
10	impairment	_	NOUN	NN	_	6	nmod	_	_

#	Eszopiclone	309
1	LUNESTA	_	NOUN	NN	_	4	nsubjpass	_	_
2	should	_	VERB	MD	_	4	aux	_	_
3	be	_	VERB	VB	_	4	auxpass	_	_
4	used	_	VERB	VBN	_	0	root	_	_
5	with	_	ADP	IN	_	6	case	_	_
6	caution	_	NOUN	NN	_	4	nmod	_	_
7	in	_	ADP	IN	_	8	case	_	_
8	patients	_	NOUN	NNS	_	6	nmod	_	_
9	with	_	ADP	IN	_	11	case	_	_
10	hepatic	_	ADJ	JJ	_	11	amod	_	_
11	impairment	_	NOUN	NN	_	8	nmod	_	_

#	Eszopiclone	310
1	Renal	_	ADJ	JJ	_	2	amod	_	_
2	Impairment	_	NOUN	NN	_	0	root	_	_
3	The	_	DET	DT	_	4	det	_	_
4	pharmacokinetics	_	NOUN	NNS	_	8	nsubjpass	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	were	_	VERB	VBD	_	8	auxpass	_	_
8	studied	_	VERB	VBN	_	2	dep	_	_
9	in	_	ADP	IN	_	11	case	_	_
10	24	_	NUM	CD	_	11	nummod	_	_
11	patients	_	NOUN	NNS	_	8	nmod	_	_
12	with	_	ADP	IN	_	20	case	_	_
13	mild	_	ADJ	JJ	_	20	amod	_	_
14	,	_	.	,	_	13	punct	_	_
15	moderate	_	ADJ	JJ	_	13	conj	_	_
16	,	_	.	,	_	13	punct	_	_
17	or	_	CONJ	CC	_	13	cc	_	_
18	severe	_	ADJ	JJ	_	13	conj	_	_
19	renal	_	ADJ	JJ	_	20	amod	_	_
20	impairment	_	NOUN	NN	_	11	nmod	_	_

#	Eszopiclone	311
1	AUC	_	NOUN	NN	_	5	nsubj	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	Cmax	_	NOUN	NN	_	1	conj	_	_
4	were	_	VERB	VBD	_	5	cop	_	_
5	similar	_	ADJ	JJ	_	0	root	_	_
6	in	_	ADP	IN	_	8	case	_	_
7	the	_	DET	DT	_	8	det	_	_
8	patients	_	NOUN	NNS	_	5	nmod	_	_
9	compared	_	VERB	VBN	_	15	case	_	_
10	with	_	ADP	IN	_	15	case	_	_
11	demographically	_	ADV	RB	_	12	advmod	_	_
12	matched	_	VERB	VBN	_	15	amod	_	_
13	healthy	_	ADJ	JJ	_	15	amod	_	_
14	control	_	NOUN	NN	_	15	compound	_	_
15	subjects	_	NOUN	NNS	_	5	nmod	_	_

#	Eszopiclone	312
1	No	_	DET	DT	_	3	neg	_	_
2	dose	_	NOUN	NN	_	3	compound	_	_
3	adjustment	_	NOUN	NN	_	5	nsubj	_	_
4	is	_	VERB	VBZ	_	5	cop	_	_
5	necessary	_	ADJ	JJ	_	0	root	_	_
6	in	_	ADP	IN	_	7	case	_	_
7	patients	_	NOUN	NNS	_	5	nmod	_	_
8	with	_	ADP	IN	_	10	case	_	_
9	renal	_	ADJ	JJ	_	10	amod	_	_
10	impairment	_	NOUN	NN	_	7	nmod	_	_
11	,	_	.	,	_	5	punct	_	_
12	since	_	ADP	IN	_	23	mark	_	_
13	less	_	ADV	RB	_	15	advmod	_	_
14	than	_	ADP	IN	_	13	mwe	_	_
15	10%	_	NOUN	NN	_	23	nsubjpass	_	_
16	of	_	ADP	IN	_	21	case	_	_
17	the	_	DET	DT	_	21	det	_	_
18	orally	_	ADV	RB	_	19	advmod	_	_
19	administered	_	VERB	VBN	_	21	amod	_	_
20	DRUG	_	NOUN	NN	_	21	compound	_	_
21	dose	_	NOUN	NN	_	15	nmod	_	_
22	is	_	VERB	VBZ	_	23	auxpass	_	_
23	excreted	_	VERB	VBN	_	5	advcl	_	_
24	in	_	ADP	IN	_	26	case	_	_
25	the	_	DET	DT	_	26	det	_	_
26	urine	_	ADJ	JJ	_	23	nmod	_	_
27	as	_	ADP	IN	_	29	case	_	_
28	parent	_	NOUN	NN	_	29	compound	_	_
29	drug	_	NOUN	NN	_	23	nmod	_	_

#	Eszopiclone	313
1	Drug	_	NOUN	NN	_	2	compound	_	_
2	Interactions	_	NOUN	NNS	_	5	nsubjpass	_	_
3	DRUG	_	NOUN	NN	_	2	dep	_	_
4	is	_	VERB	VBZ	_	5	auxpass	_	_
5	metabolized	_	VERB	VBN	_	0	root	_	_
6	by	_	ADP	IN	_	7	case	_	_
7	CYP3A4	_	NOUN	NN	_	5	nmod	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	CYP2E1	_	NOUN	NN	_	7	conj	_	_
10	via	_	ADP	IN	_	11	case	_	_
11	demethylation	_	NOUN	NN	_	5	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	oxidation	_	NOUN	NN	_	11	conj	_	_

#	Eszopiclone	314
1	There	_	DET	EX	_	2	expl	_	_
2	were	_	VERB	VBD	_	0	root	_	_
3	no	_	DET	DT	_	7	neg	_	_
4	pharmacokinetic	_	ADJ	JJ	_	7	amod	_	_
5	or	_	CONJ	CC	_	4	cc	_	_
6	pharmacodynamic	_	ADJ	JJ	_	4	conj	_	_
7	interactions	_	NOUN	NNS	_	2	nsubj	_	_
8	between	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	paroxetine	_	NOUN	NN	_	9	conj	_	_

#	Eszopiclone	315
1	When	_	ADV	WRB	_	4	advmod	_	_
2	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
3	was	_	VERB	VBD	_	4	auxpass	_	_
4	coadministered	_	VERB	VBN	_	12	advcl	_	_
5	with	_	ADP	IN	_	6	case	_	_
6	olanzapine	_	NOUN	NN	_	4	nmod	_	_
7	,	_	.	,	_	12	punct	_	_
8	no	_	DET	DT	_	10	neg	_	_
9	pharmacokinetic	_	ADJ	JJ	_	10	amod	_	_
10	interaction	_	NOUN	NN	_	12	nsubjpass	_	_
11	was	_	VERB	VBD	_	12	auxpass	_	_
12	detected	_	VERB	VBN	_	0	root	_	_
13	in	_	ADP	IN	_	14	case	_	_
14	levels	_	NOUN	NNS	_	12	nmod	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	14	nmod	_	_
17	or	_	CONJ	CC	_	16	cc	_	_
18	olanzapine	_	NOUN	NN	_	16	conj	_	_
19	,	_	.	,	_	12	punct	_	_
20	but	_	CONJ	CC	_	12	cc	_	_
21	a	_	DET	DT	_	23	det	_	_
22	pharmacodynamic	_	ADJ	JJ	_	23	amod	_	_
23	interaction	_	NOUN	NN	_	25	nsubjpass	_	_
24	was	_	VERB	VBD	_	25	auxpass	_	_
25	seen	_	VERB	VBN	_	12	conj	_	_
26	on	_	ADP	IN	_	28	case	_	_
27	a	_	DET	DT	_	28	det	_	_
28	measure	_	NOUN	NN	_	25	nmod	_	_
29	of	_	ADP	IN	_	31	case	_	_
30	psychomotor	_	NOUN	NN	_	31	compound	_	_
31	function	_	NOUN	NN	_	28	nmod	_	_

#	Eszopiclone	316
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	lorazepam	_	NOUN	NN	_	1	conj	_	_
4	decreased	_	VERB	VBD	_	0	root	_	_
5	each	_	DET	DT	_	6	det	_	_
6	other's	_	NOUN	NNS	_	4	dobj	_	_
7	Cmax	_	NOUN	NN	_	6	dep	_	_
8	by	_	ADP	IN	_	9	case	_	_
9	22%	_	ADJ	JJ	_	6	nmod	_	_

#	Eszopiclone	317
1	Coadministration	_	NOUN	NN	_	23	nsubj	_	_
2	of	_	ADP	IN	_	5	case	_	_
3	DRUG	_	NOUN	NN	_	5	compound	_	_
4	3	_	NUM	CD	_	5	nummod	_	_
5	mg	_	NOUN	NN	_	1	nmod	_	_
6	to	_	PRT	TO	_	7	case	_	_
7	subjects	_	NOUN	NNS	_	1	nmod	_	_
8	receiving	_	VERB	VBG	_	7	acl	_	_
9	ketoconazole	_	NOUN	NN	_	8	dobj	_	_
10	,	_	.	,	_	9	punct	_	_
11	a	_	DET	DT	_	13	det	_	_
12	potent	_	ADJ	JJ	_	13	amod	_	_
13	inhibitor	_	NOUN	NN	_	9	appos	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	CYP3A4	_	NOUN	NN	_	13	nmod	_	_
16	,	_	.	,	_	9	punct	_	_
17	400mg	_	ADJ	JJ	_	9	amod	_	_
18	daily	_	ADV	RB	_	17	advmod	_	_
19	for	_	ADP	IN	_	21	case	_	_
20	5	_	NUM	CD	_	21	nummod	_	_
21	days	_	NOUN	NNS	_	17	nmod	_	_
22	,	_	.	,	_	1	punct	_	_
23	resulted	_	VERB	VBD	_	0	root	_	_
24	in	_	ADP	IN	_	28	case	_	_
25	a	_	DET	DT	_	28	det	_	_
26	2.2	_	NUM	CD	_	27	compound	_	_
27	fold	_	NOUN	NN	_	28	amod	_	_
28	increase	_	NOUN	NN	_	23	nmod	_	_
29	in	_	ADP	IN	_	30	case	_	_
30	exposure	_	NOUN	NN	_	28	nmod	_	_
31	to	_	PRT	TO	_	32	case	_	_
32	DRUG	_	NOUN	NN	_	30	nmod	_	_

#	Eszopiclone	318
1	Cmax	_	NOUN	NN	_	7	nsubjpass	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	t1	_	NUM	CD	_	1	conj	_	_
4	/	_	.	:	_	1	punct	_	_
5	2	_	NUM	CD	_	1	nummod	_	_
6	were	_	VERB	VBD	_	7	auxpass	_	_
7	increased	_	VERB	VBN	_	0	root	_	_
8	1.4	_	NUM	CD	_	9	nummod	_	_
9	fold	_	NOUN	NN	_	7	nmod	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	1.3	_	NUM	CD	_	12	nummod	_	_
12	fold	_	NOUN	NN	_	9	conj	_	_
13	,	_	.	,	_	9	punct	_	_
14	respectively	_	ADV	RB	_	9	advmod	_	_

#	Eszopiclone	319
1	LUNESTA	_	NOUN	NN	_	5	nsubjpass	_	_
2	would	_	VERB	MD	_	5	aux	_	_
3	not	_	ADV	RB	_	5	neg	_	_
4	be	_	VERB	VB	_	5	auxpass	_	_
5	expected	_	VERB	VBN	_	0	root	_	_
6	to	_	PRT	TO	_	7	mark	_	_
7	alter	_	VERB	VB	_	5	xcomp	_	_
8	the	_	DET	DT	_	9	det	_	_
9	clearance	_	NOUN	NN	_	7	dobj	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	drugs	_	NOUN	NNS	_	9	nmod	_	_
12	metabolized	_	VERB	VBN	_	11	acl	_	_
13	by	_	ADP	IN	_	16	case	_	_
14	common	_	ADJ	JJ	_	16	amod	_	_
15	CYP450	_	NOUN	NN	_	16	compound	_	_
16	enzymes	_	NOUN	NNS	_	12	nmod	_	_

#	Eszopiclone	320
1	Paroxetine	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Coadministration	_	NOUN	NN	_	11	nsubj	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	single	_	ADJ	JJ	_	6	amod	_	_
6	dose	_	NOUN	NN	_	3	nmod	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	paroxetine	_	NOUN	NN	_	8	conj	_	_
11	produced	_	VERB	VBD	_	1	dep	_	_
12	no	_	DET	DT	_	16	neg	_	_
13	pharmacokinetic	_	ADJ	JJ	_	16	amod	_	_
14	or	_	CONJ	CC	_	13	cc	_	_
15	pharmacodynamic	_	ADJ	JJ	_	13	conj	_	_
16	interaction	_	NOUN	NN	_	11	dobj	_	_

#	Eszopiclone	321
1	The	_	DET	DT	_	2	det	_	_
2	lack	_	NOUN	NN	_	13	nsubj	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	a	_	DET	DT	_	6	det	_	_
5	drug	_	NOUN	NN	_	6	compound	_	_
6	interaction	_	NOUN	NN	_	2	nmod	_	_
7	following	_	VERB	VBG	_	10	case	_	_
8	single	_	ADJ	JJ	_	10	amod	_	_
9	dose	_	NOUN	NN	_	10	compound	_	_
10	administration	_	NOUN	NN	_	2	nmod	_	_
11	does	_	VERB	VBZ	_	13	aux	_	_
12	not	_	ADV	RB	_	13	neg	_	_
13	predict	_	VERB	VB	_	0	root	_	_
14	the	_	DET	DT	_	16	det	_	_
15	complete	_	ADJ	JJ	_	16	amod	_	_
16	absence	_	NOUN	NN	_	13	dobj	_	_
17	of	_	ADP	IN	_	20	case	_	_
18	a	_	DET	DT	_	20	det	_	_
19	pharmacodynamic	_	ADJ	JJ	_	20	amod	_	_
20	effect	_	NOUN	NN	_	16	nmod	_	_
21	following	_	ADP	IN	_	23	case	_	_
22	chronic	_	ADJ	JJ	_	23	amod	_	_
23	administration	_	NOUN	NN	_	16	nmod	_	_

#	Eszopiclone	322
1	Lorazepam	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Coadministration	_	NOUN	NN	_	13	nsubj	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	single	_	ADJ	JJ	_	6	amod	_	_
6	doses	_	NOUN	NNS	_	3	nmod	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	lorazepam	_	NOUN	NN	_	8	conj	_	_
11	did	_	VERB	VBD	_	13	aux	_	_
12	not	_	ADV	RB	_	13	neg	_	_
13	have	_	VERB	VB	_	1	dep	_	_
14	clinically	_	ADV	RB	_	15	advmod	_	_
15	relevant	_	ADJ	JJ	_	16	amod	_	_
16	effects	_	NOUN	NNS	_	13	dobj	_	_
17	on	_	ADP	IN	_	19	case	_	_
18	the	_	DET	DT	_	19	det	_	_
19	pharmacodynamics	_	NOUN	NNS	_	13	nmod	_	_
20	or	_	CONJ	CC	_	19	cc	_	_
21	pharmacokinetics	_	NOUN	NNS	_	19	conj	_	_
22	of	_	ADP	IN	_	24	case	_	_
23	either	_	CONJ	CC	_	24	det	_	_
24	drug	_	NOUN	NN	_	19	nmod	_	_

#	Eszopiclone	324
1	Drugs	_	NOUN	NNS	_	0	root	_	_
2	with	_	ADP	IN	_	7	case	_	_
3	a	_	DET	DT	_	7	det	_	_
4	Narrow	_	NOUN	NN	_	7	compound	_	_
5	Therapeutic	_	ADJ	JJ	_	7	amod	_	_
6	Index	_	NOUN	NN	_	7	compound	_	_
7	Digoxin	_	NOUN	NN	_	1	nmod	_	_
8	:	_	.	:	_	1	punct	_	_
9	A	_	PRON	PRP$	_	11	det	_	_
10	single	_	ADJ	JJ	_	11	amod	_	_
11	dose	_	NOUN	NN	_	18	nsubj	_	_
12	of	_	ADP	IN	_	15	case	_	_
13	DRUG	_	NOUN	NN	_	15	compound	_	_
14	3	_	NUM	CD	_	15	nummod	_	_
15	mg	_	NOUN	NN	_	11	nmod	_	_
16	did	_	VERB	VBD	_	18	aux	_	_
17	not	_	ADV	RB	_	18	neg	_	_
18	affect	_	VERB	VB	_	1	dep	_	_
19	the	_	DET	DT	_	20	det	_	_
20	pharmacokinetics	_	NOUN	NNS	_	18	dobj	_	_
21	of	_	ADP	IN	_	22	case	_	_
22	digoxin	_	NOUN	NN	_	20	nmod	_	_
23	measured	_	VERB	VBN	_	22	acl	_	_
24	at	_	ADP	IN	_	26	case	_	_
25	steady	_	ADJ	JJ	_	26	amod	_	_
26	state	_	NOUN	NN	_	23	nmod	_	_
27	following	_	ADP	IN	_	28	case	_	_
28	dosing	_	NOUN	NN	_	23	nmod	_	_
29	of	_	ADP	IN	_	31	case	_	_
30	0.5	_	NUM	CD	_	31	nummod	_	_
31	mg	_	NOUN	NN	_	28	nmod	_	_
32	twice	_	ADV	RB	_	33	advmod	_	_
33	daily	_	ADV	RB	_	18	advmod	_	_
34	for	_	ADP	IN	_	36	case	_	_
35	one	_	NUM	CD	_	36	nummod	_	_
36	day	_	NOUN	NN	_	33	nmod	_	_
37	and	_	CONJ	CC	_	33	cc	_	_
38	0.25	_	NUM	CD	_	39	nummod	_	_
39	mg	_	NOUN	NN	_	33	conj	_	_
40	daily	_	ADV	RB	_	39	advmod	_	_
41	for	_	ADP	IN	_	45	case	_	_
42	the	_	DET	DT	_	45	det	_	_
43	next	_	ADV	RB	_	44	advmod	_	_
44	6	_	NUM	CD	_	45	nummod	_	_
45	days	_	NOUN	NNS	_	39	nmod	_	_

#	Eszopiclone	325
1	Warfarin	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	DRUG	_	NOUN	NN	_	5	compound	_	_
4	3	_	NUM	CD	_	5	nummod	_	_
5	mg	_	NOUN	NN	_	13	nsubj	_	_
6	administered	_	VERB	VBN	_	5	acl	_	_
7	daily	_	ADV	RB	_	6	advmod	_	_
8	for	_	ADP	IN	_	10	case	_	_
9	5	_	NUM	CD	_	10	nummod	_	_
10	days	_	NOUN	NNS	_	6	nmod	_	_
11	did	_	VERB	VBD	_	13	aux	_	_
12	not	_	ADV	RB	_	13	neg	_	_
13	affect	_	VERB	VB	_	1	dep	_	_
14	the	_	DET	DT	_	15	det	_	_
15	pharmacokinetics	_	NOUN	NNS	_	13	dobj	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	R	_	NOUN	NN	_	15	nmod	_	_
18	or	_	CONJ	CC	_	17	cc	_	_
19	S	_	NOUN	NN	_	17	conj	_	_
20	warfarin	_	NOUN	NN	_	17	dep	_	_
21	,	_	.	,	_	13	punct	_	_
22	nor	_	CONJ	CC	_	13	cc	_	_
23	were	_	VERB	VBD	_	26	cop	_	_
24	there	_	PRON	PRP$	_	26	nmod:poss	_	_
25	any	_	DET	DT	_	26	det	_	_
26	changes	_	NOUN	NNS	_	13	conj	_	_
27	in	_	ADP	IN	_	32	case	_	_
28	the	_	DET	DT	_	32	det	_	_
29	pharmacodynamic	_	ADJ	JJ	_	32	amod	_	_
30	profile	_	NOUN	NN	_	32	compound	_	_
31	prothrombin	_	NOUN	NN	_	32	compound	_	_
32	time	_	NOUN	NN	_	26	nmod	_	_
33	following	_	ADP	IN	_	39	case	_	_
34	a	_	DET	DT	_	39	det	_	_
35	single	_	ADJ	JJ	_	39	amod	_	_
36	25	_	NUM	CD	_	39	nummod	_	_
37	mg	_	NOUN	NN	_	39	amod	_	_
38	oral	_	ADJ	JJ	_	39	amod	_	_
39	dose	_	NOUN	NN	_	26	nmod	_	_
40	of	_	ADP	IN	_	41	case	_	_
41	warfarin	_	NOUN	NN	_	39	nmod	_	_

#	Eszopiclone	326
1	Drugs	_	NOUN	NNS	_	11	nsubjpass	_	_
2	Highly	_	ADV	RB	_	3	advmod	_	_
3	Bound	_	VERB	VBN	_	1	acl	_	_
4	to	_	PRT	TO	_	7	case	_	_
5	Plasma	_	NOUN	NN	_	7	compound	_	_
6	Protein	_	NOUN	NN	_	7	compound	_	_
7	DRUG	_	NOUN	NN	_	3	nmod	_	_
8	is	_	VERB	VBZ	_	11	auxpass	_	_
9	not	_	ADV	RB	_	11	neg	_	_
10	highly	_	ADV	RB	_	11	advmod	_	_
11	bound	_	VERB	VBN	_	0	root	_	_
12	to	_	PRT	TO	_	14	case	_	_
13	plasma	_	NOUN	NN	_	14	compound	_	_
14	proteins	_	NOUN	NNS	_	11	nmod	_	_
15	52	_	NUM	CD	_	16	nummod	_	_
16	59%	_	NOUN	NN	_	14	dep	_	_
17	bound	_	VERB	VBN	_	14	acl	_	_
18	therefore	_	ADV	RB	_	17	advmod	_	_
19	,	_	.	,	_	11	punct	_	_
20	the	_	DET	DT	_	21	det	_	_
21	disposition	_	NOUN	NN	_	26	nsubjpass	_	_
22	of	_	ADP	IN	_	23	case	_	_
23	DRUG	_	NOUN	NN	_	21	nmod	_	_
24	is	_	VERB	VBZ	_	26	auxpass	_	_
25	not	_	ADV	RB	_	26	neg	_	_
26	expected	_	VERB	VBN	_	11	parataxis	_	_
27	to	_	PRT	TO	_	29	mark	_	_
28	be	_	VERB	VB	_	29	cop	_	_
29	sensitive	_	ADJ	JJ	_	26	xcomp	_	_
30	to	_	PRT	TO	_	31	case	_	_
31	alterations	_	NOUN	NNS	_	29	nmod	_	_
32	in	_	ADP	IN	_	34	case	_	_
33	protein	_	NOUN	NN	_	34	compound	_	_
34	binding	_	NOUN	NN	_	31	nmod	_	_

#	Eszopiclone	327
1	Administration	_	NOUN	NN	_	20	nsubjpass	_	_
2	of	_	ADP	IN	_	5	case	_	_
3	DRUG	_	NOUN	NN	_	5	compound	_	_
4	3	_	NUM	CD	_	5	nummod	_	_
5	mg	_	NOUN	NN	_	1	nmod	_	_
6	to	_	PRT	TO	_	8	case	_	_
7	a	_	DET	DT	_	8	det	_	_
8	patient	_	NOUN	NN	_	1	nmod	_	_
9	taking	_	VERB	VBG	_	8	acl	_	_
10	another	_	DET	DT	_	11	det	_	_
11	drug	_	NOUN	NN	_	9	dobj	_	_
12	that	_	DET	WDT	_	16	nsubjpass	_	_
13	is	_	VERB	VBZ	_	16	auxpass	_	_
14	highly	_	ADV	RB	_	15	advmod	_	_
15	protein	_	NOUN	NN	_	16	nsubjpass	_	_
16	bound	_	VERB	VBN	_	11	acl:relcl	_	_
17	would	_	VERB	MD	_	20	aux	_	_
18	not	_	ADV	RB	_	20	neg	_	_
19	be	_	VERB	VB	_	20	auxpass	_	_
20	expected	_	VERB	VBN	_	0	root	_	_
21	to	_	PRT	TO	_	22	mark	_	_
22	cause	_	VERB	VB	_	20	xcomp	_	_
23	an	_	DET	DT	_	24	det	_	_
24	alteration	_	NOUN	NN	_	22	dobj	_	_
25	in	_	ADP	IN	_	28	case	_	_
26	the	_	DET	DT	_	28	det	_	_
27	free	_	ADJ	JJ	_	28	amod	_	_
28	concentration	_	NOUN	NN	_	24	nmod	_	_
29	of	_	ADP	IN	_	31	case	_	_
30	either	_	CONJ	CC	_	31	det	_	_
31	drug	_	NOUN	NN	_	28	nmod	_	_

#	Fanapt	3967
1	Given	_	ADP	IN	_	5	case	_	_
2	the	_	DET	DT	_	5	det	_	_
3	primary	_	ADJ	JJ	_	5	amod	_	_
4	CNS	_	NOUN	NN	_	5	compound	_	_
5	effects	_	NOUN	NNS	_	12	nmod	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	,	_	.	,	_	12	punct	_	_
9	caution	_	NOUN	NN	_	12	nsubjpass	_	_
10	should	_	VERB	MD	_	12	aux	_	_
11	be	_	VERB	VB	_	12	auxpass	_	_
12	used	_	VERB	VBN	_	0	root	_	_
13	when	_	ADV	WRB	_	16	advmod	_	_
14	it	_	PRON	PRP	_	16	nsubjpass	_	_
15	is	_	VERB	VBZ	_	16	auxpass	_	_
16	taken	_	VERB	VBN	_	12	ccomp	_	_
17	in	_	ADP	IN	_	18	case	_	_
18	combination	_	NOUN	NN	_	16	nmod	_	_
19	with	_	ADP	IN	_	23	case	_	_
20	other	_	ADJ	JJ	_	23	amod	_	_
21	centrally	_	ADV	RB	_	22	advmod	_	_
22	acting	_	VERB	VBG	_	23	amod	_	_
23	drugs	_	NOUN	NNS	_	18	nmod	_	_
24	and	_	CONJ	CC	_	23	cc	_	_
25	alcohol	_	NOUN	NN	_	23	conj	_	_

#	Fanapt	3968
1	Due	_	ADJ	JJ	_	7	case	_	_
2	to	_	PRT	TO	_	1	mwe	_	_
3	its	_	PRON	PRP$	_	7	nmod:poss	_	_
4	alpha1	_	NOUN	NN	_	7	compound	_	_
5	adrenergic	_	ADJ	JJ	_	7	amod	_	_
6	receptor	_	NOUN	NN	_	7	compound	_	_
7	antagonism	_	NOUN	NN	_	10	nmod	_	_
8	,	_	.	,	_	10	punct	_	_
9	DRUG	_	NOUN	NN	_	10	nsubj	_	_
10	has	_	VERB	VBZ	_	0	root	_	_
11	the	_	DET	DT	_	12	det	_	_
12	potential	_	NOUN	NN	_	10	dobj	_	_
13	to	_	PRT	TO	_	14	mark	_	_
14	enhance	_	VERB	VB	_	10	xcomp	_	_
15	the	_	DET	DT	_	16	det	_	_
16	effect	_	NOUN	NN	_	14	dobj	_	_
17	of	_	ADP	IN	_	20	case	_	_
18	certain	_	ADJ	JJ	_	20	amod	_	_
19	antihypertensive	_	ADJ	JJ	_	20	amod	_	_
20	agents	_	NOUN	NNS	_	16	nmod	_	_

#	Fanapt	3969
1	The	_	DET	DT	_	2	det	_	_
2	dose	_	NOUN	NN	_	7	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	should	_	VERB	MD	_	7	aux	_	_
6	be	_	VERB	VB	_	7	auxpass	_	_
7	reduced	_	VERB	VBN	_	0	root	_	_
8	in	_	ADP	IN	_	9	case	_	_
9	patients	_	NOUN	NNS	_	7	nmod	_	_
10	co	_	PRT	TO	_	11	mark	_	_
11	administered	_	VERB	VBN	_	9	acl	_	_
12	a	_	DET	DT	_	14	det	_	_
13	strong	_	ADJ	JJ	_	14	amod	_	_
14	CYP2D6	_	NOUN	NN	_	11	dobj	_	_
15	or	_	CONJ	CC	_	14	cc	_	_
16	CYP3A4	_	NOUN	NN	_	17	compound	_	_
17	inhibitor	_	NOUN	NN	_	14	conj	_	_

#	Fanapt	3970
1	DRUG	_	NOUN	NN	_	5	nsubj	_	_
2	is	_	VERB	VBZ	_	5	cop	_	_
3	not	_	ADV	RB	_	5	neg	_	_
4	a	_	DET	DT	_	5	det	_	_
5	substrate	_	NOUN	NN	_	0	root	_	_
6	for	_	ADP	IN	_	7	case	_	_
7	CYP1A1	_	NOUN	NN	_	5	nmod	_	_
8	,	_	.	,	_	7	punct	_	_
9	CYP1A2	_	NOUN	NN	_	7	conj	_	_
10	,	_	.	,	_	7	punct	_	_
11	CYP2A6	_	NOUN	NN	_	7	conj	_	_
12	,	_	.	,	_	7	punct	_	_
13	CYP2B6	_	NOUN	NN	_	7	conj	_	_
14	,	_	.	,	_	7	punct	_	_
15	CYP2C8	_	NOUN	NN	_	7	conj	_	_
16	,	_	.	,	_	7	punct	_	_
17	CYP2C9	_	NOUN	NN	_	7	conj	_	_
18	,	_	.	,	_	7	punct	_	_
19	CYP2C19	_	NOUN	NN	_	7	conj	_	_
20	,	_	.	,	_	7	punct	_	_
21	or	_	CONJ	CC	_	7	cc	_	_
22	CYP2E1	_	NOUN	NN	_	23	compound	_	_
23	enzymes	_	NOUN	NNS	_	7	conj	_	_

#	Fanapt	3971
1	This	_	DET	DT	_	2	nsubj	_	_
2	suggests	_	VERB	VBZ	_	0	root	_	_
3	that	_	ADP	IN	_	24	mark	_	_
4	an	_	DET	DT	_	5	det	_	_
5	interaction	_	NOUN	NN	_	24	nsubj	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	with	_	ADP	IN	_	9	case	_	_
9	inhibitors	_	NOUN	NNS	_	5	nmod	_	_
10	or	_	CONJ	CC	_	9	cc	_	_
11	inducers	_	NOUN	NNS	_	9	conj	_	_
12	of	_	ADP	IN	_	14	case	_	_
13	these	_	DET	DT	_	14	det	_	_
14	enzymes	_	NOUN	NNS	_	9	nmod	_	_
15	,	_	.	,	_	14	punct	_	_
16	or	_	CONJ	CC	_	14	cc	_	_
17	other	_	ADJ	JJ	_	18	amod	_	_
18	factors	_	NOUN	NNS	_	14	conj	_	_
19	,	_	.	,	_	5	punct	_	_
20	like	_	ADP	IN	_	21	case	_	_
21	smoking	_	NOUN	NN	_	5	nmod	_	_
22	,	_	.	,	_	5	punct	_	_
23	is	_	VERB	VBZ	_	24	auxpass	_	_
24	unlikely	_	ADV	RB	_	2	ccomp	_	_

#	Fanapt	3972
1	Both	_	CONJ	CC	_	2	cc:preconj	_	_
2	CYP3A4	_	NOUN	NN	_	6	nsubj	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	CYP2D6	_	NOUN	NN	_	2	conj	_	_
5	are	_	VERB	VBP	_	6	cop	_	_
6	responsible	_	ADJ	JJ	_	0	root	_	_
7	for	_	ADP	IN	_	9	case	_	_
8	DRUG	_	NOUN	NN	_	9	compound	_	_
9	metabolism	_	NOUN	NN	_	6	nmod	_	_

#	Fanapt	3973
1	Inhibitors	_	NOUN	NNS	_	15	nsubj	_	_
2	of	_	ADP	IN	_	4	case	_	_
3	CYP3A4	_	NOUN	NN	_	4	compound	_	_
4	e.g	_	NOUN	NN	_	1	nmod	_	_
5	,	_	.	,	_	4	punct	_	_
6	ketoconazole	_	NOUN	NN	_	4	conj	_	_
7	or	_	CONJ	CC	_	4	cc	_	_
8	CYP2D6	_	NOUN	NN	_	9	compound	_	_
9	e.g	_	NOUN	NN	_	4	conj	_	_
10	,	_	.	,	_	4	punct	_	_
11	fluoxetine	_	NOUN	NN	_	4	appos	_	_
12	,	_	.	,	_	4	punct	_	_
13	paroxetine	_	NOUN	NN	_	4	appos	_	_
14	can	_	VERB	MD	_	15	aux	_	_
15	inhibit	_	VERB	VB	_	0	root	_	_
16	DRUG	_	NOUN	NN	_	17	compound	_	_
17	elimination	_	NOUN	NN	_	15	dobj	_	_
18	and	_	CONJ	CC	_	15	cc	_	_
19	cause	_	VERB	VBP	_	15	conj	_	_
20	increased	_	ADJ	JJ	_	22	amod	_	_
21	blood	_	NOUN	NN	_	22	compound	_	_
22	levels	_	NOUN	NNS	_	19	dobj	_	_

#	Fanapt	3974
1	Ketoconazole	_	NOUN	NN	_	40	nsubj	_	_
2	:	_	.	:	_	1	punct	_	_
3	Co	_	NOUN	NN	_	4	compound	_	_
4	administration	_	NOUN	NN	_	34	nsubj	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	ketoconazole	_	NOUN	NN	_	8	compound	_	_
7	200	_	NUM	CD	_	8	nummod	_	_
8	mg	_	NOUN	NN	_	4	nmod	_	_
9	twice	_	ADV	RB	_	10	advmod	_	_
10	daily	_	ADV	RB	_	34	advmod	_	_
11	for	_	ADP	IN	_	13	case	_	_
12	4	_	NUM	CD	_	13	nummod	_	_
13	days	_	NOUN	NNS	_	10	nmod	_	_
14	,	_	.	,	_	34	punct	_	_
15	a	_	DET	DT	_	17	det	_	_
16	potent	_	ADJ	JJ	_	17	amod	_	_
17	inhibitor	_	NOUN	NN	_	34	nsubj	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	CYP3A4	_	NOUN	NN	_	17	nmod	_	_
20	,	_	.	,	_	17	punct	_	_
21	with	_	ADP	IN	_	26	case	_	_
22	a	_	DET	DT	_	26	det	_	_
23	3	_	NUM	CD	_	26	nummod	_	_
24	mg	_	NOUN	NN	_	26	compound	_	_
25	single	_	ADJ	JJ	_	26	amod	_	_
26	dose	_	NOUN	NN	_	17	nmod	_	_
27	of	_	ADP	IN	_	28	case	_	_
28	DRUG	_	NOUN	NN	_	26	nmod	_	_
29	to	_	PRT	TO	_	32	case	_	_
30	19	_	NUM	CD	_	32	nummod	_	_
31	healthy	_	ADJ	JJ	_	32	amod	_	_
32	volunteers	_	NOUN	NNS	_	26	nmod	_	_
33	,	_	.	,	_	17	punct	_	_
34	ages	_	VERB	VBZ	_	1	appos	_	_
35	18	_	NUM	CD	_	37	compound	_	_
36	to	_	PRT	TO	_	37	dep	_	_
37	45	_	NUM	CD	_	38	nummod	_	_
38	years	_	NOUN	NNS	_	34	dobj	_	_
39	,	_	.	,	_	1	punct	_	_
40	increased	_	VERB	VBD	_	0	root	_	_
41	the	_	DET	DT	_	42	det	_	_
42	area	_	NOUN	NN	_	40	dobj	_	_
43	under	_	ADP	IN	_	46	case	_	_
44	the	_	DET	DT	_	46	det	_	_
45	curve	_	ADJ	JJ	_	46	amod	_	_
46	AUC	_	NOUN	NN	_	40	nmod	_	_
47	of	_	ADP	IN	_	48	case	_	_
48	DRUG	_	NOUN	NN	_	46	nmod	_	_
49	and	_	CONJ	CC	_	46	cc	_	_
50	its	_	PRON	PRP$	_	51	nmod:poss	_	_
51	metabolites	_	NOUN	NNS	_	46	conj	_	_
52	P88	_	NOUN	NN	_	51	dep	_	_
53	and	_	CONJ	CC	_	52	cc	_	_
54	P95	_	NOUN	NN	_	52	conj	_	_
55	by	_	ADP	IN	_	56	case	_	_
56	57%	_	NOUN	NN	_	40	nmod	_	_
57	,	_	.	,	_	56	punct	_	_
58	55%	_	NOUN	NN	_	56	conj	_	_
59	and	_	CONJ	CC	_	56	cc	_	_
60	35%	_	NOUN	NN	_	56	conj	_	_
61	,	_	.	,	_	40	punct	_	_
62	respectively	_	ADV	RB	_	40	advmod	_	_

#	Fanapt	3975
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	doses	_	NOUN	NNS	_	5	nsubjpass	_	_
3	should	_	VERB	MD	_	5	aux	_	_
4	be	_	VERB	VB	_	5	auxpass	_	_
5	reduced	_	VERB	VBN	_	0	root	_	_
6	by	_	ADP	IN	_	9	case	_	_
7	about	_	ADV	RB	_	8	advmod	_	_
8	one	_	NUM	CD	_	9	nummod	_	_
9	half	_	NOUN	NN	_	5	nmod	_	_
10	when	_	ADV	WRB	_	11	advmod	_	_
11	administered	_	VERB	VBN	_	5	advcl	_	_
12	with	_	ADP	IN	_	13	case	_	_
13	ketoconazole	_	NOUN	NN	_	11	nmod	_	_
14	or	_	CONJ	CC	_	13	cc	_	_
15	other	_	ADJ	JJ	_	17	amod	_	_
16	strong	_	ADJ	JJ	_	17	amod	_	_
17	inhibitors	_	NOUN	NNS	_	13	conj	_	_
18	of	_	ADP	IN	_	20	case	_	_
19	CYP3A4	_	NOUN	NN	_	20	compound	_	_
20	e.g	_	NOUN	NN	_	13	nmod	_	_
21	,	_	.	,	_	20	punct	_	_
22	itraconazole	_	NOUN	NN	_	20	appos	_	_

#	Fanapt	3976
1	Weaker	_	ADJ	JJ	_	2	amod	_	_
2	inhibitors	_	NOUN	NNS	_	12	nsubjpass	_	_
3	e.g	_	NOUN	NN	_	2	nmod	_	_
4	,	_	.	,	_	3	punct	_	_
5	erythromycin	_	NOUN	NN	_	3	appos	_	_
6	,	_	.	,	_	3	punct	_	_
7	grapefruit	_	ADJ	JJ	_	8	amod	_	_
8	juice	_	NOUN	NN	_	3	appos	_	_
9	have	_	VERB	MD	_	12	aux	_	_
10	not	_	ADV	RB	_	12	neg	_	_
11	been	_	VERB	VBN	_	12	auxpass	_	_
12	studied	_	VERB	VBN	_	0	root	_	_

#	Fanapt	3977
1	When	_	ADV	WRB	_	6	advmod	_	_
2	the	_	DET	DT	_	4	det	_	_
3	CYP3A4	_	NOUN	NN	_	4	compound	_	_
4	inhibitor	_	NOUN	NN	_	6	nsubjpass	_	_
5	is	_	VERB	VBZ	_	6	auxpass	_	_
6	withdrawn	_	ADJ	JJ	_	17	advcl	_	_
7	from	_	ADP	IN	_	10	case	_	_
8	the	_	DET	DT	_	10	det	_	_
9	combination	_	NOUN	NN	_	10	compound	_	_
10	therapy	_	NOUN	NN	_	6	nmod	_	_
11	,	_	.	,	_	17	punct	_	_
12	the	_	DET	DT	_	14	det	_	_
13	DRUG	_	NOUN	NN	_	14	compound	_	_
14	dose	_	NOUN	NN	_	17	nsubjpass	_	_
15	should	_	VERB	MD	_	17	aux	_	_
16	be	_	VERB	VB	_	17	auxpass	_	_
17	returned	_	VERB	VBN	_	0	root	_	_
18	to	_	PRT	TO	_	21	case	_	_
19	the	_	DET	DT	_	21	det	_	_
20	previous	_	ADJ	JJ	_	21	amod	_	_
21	level	_	NOUN	NN	_	17	nmod	_	_

#	Fanapt	3978
1	Fluoxetine	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Co	_	NOUN	NN	_	4	compound	_	_
4	administration	_	NOUN	NN	_	48	nsubj	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	fluoxetine	_	NOUN	NN	_	8	compound	_	_
7	20	_	NUM	CD	_	8	nummod	_	_
8	mg	_	NOUN	NN	_	4	nmod	_	_
9	twice	_	ADV	RB	_	10	advmod	_	_
10	daily	_	ADV	RB	_	4	advmod	_	_
11	for	_	ADP	IN	_	13	case	_	_
12	21	_	NUM	CD	_	13	nummod	_	_
13	days	_	NOUN	NNS	_	10	nmod	_	_
14	,	_	.	,	_	10	punct	_	_
15	a	_	DET	DT	_	17	det	_	_
16	potent	_	ADJ	JJ	_	17	amod	_	_
17	inhibitor	_	NOUN	NN	_	34	nsubj	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	CYP2D6	_	NOUN	NN	_	17	nmod	_	_
20	,	_	.	,	_	17	punct	_	_
21	with	_	ADP	IN	_	26	case	_	_
22	a	_	DET	DT	_	26	det	_	_
23	single	_	ADJ	JJ	_	26	amod	_	_
24	3	_	NUM	CD	_	26	nummod	_	_
25	mg	_	NOUN	NN	_	26	compound	_	_
26	dose	_	NOUN	NN	_	17	nmod	_	_
27	of	_	ADP	IN	_	28	case	_	_
28	DRUG	_	NOUN	NN	_	26	nmod	_	_
29	to	_	PRT	TO	_	32	case	_	_
30	23	_	NUM	CD	_	32	nummod	_	_
31	healthy	_	ADJ	JJ	_	32	amod	_	_
32	volunteers	_	NOUN	NNS	_	26	nmod	_	_
33	,	_	.	,	_	17	punct	_	_
34	ages	_	VERB	VBZ	_	10	dep	_	_
35	29	_	NUM	CD	_	37	compound	_	_
36	to	_	PRT	TO	_	37	dep	_	_
37	44	_	NUM	CD	_	38	nummod	_	_
38	years	_	NOUN	NNS	_	34	dobj	_	_
39	,	_	.	,	_	34	punct	_	_
40	who	_	DET	WDT	_	42	nsubjpass	_	_
41	were	_	VERB	VBD	_	42	auxpass	_	_
42	classified	_	VERB	VBN	_	34	ccomp	_	_
43	as	_	ADP	IN	_	46	case	_	_
44	CYP2D6	_	NOUN	NN	_	46	compound	_	_
45	extensive	_	ADJ	JJ	_	46	amod	_	_
46	metabolizers	_	NOUN	NNS	_	42	nmod	_	_
47	,	_	.	,	_	4	punct	_	_
48	increased	_	VERB	VBD	_	1	dep	_	_
49	the	_	DET	DT	_	50	det	_	_
50	AUC	_	NOUN	NN	_	48	dobj	_	_
51	of	_	ADP	IN	_	52	case	_	_
52	DRUG	_	NOUN	NN	_	50	nmod	_	_
53	and	_	CONJ	CC	_	50	cc	_	_
54	its	_	PRON	PRP$	_	56	nmod:poss	_	_
55	metabolite	_	NOUN	NN	_	56	compound	_	_
56	P88	_	NOUN	NN	_	50	conj	_	_
57	,	_	.	,	_	48	punct	_	_
58	by	_	ADP	IN	_	63	case	_	_
59	about	_	ADV	RB	_	60	advmod	_	_
60	2	_	NUM	CD	_	62	compound	_	_
61	to	_	PRT	TO	_	62	dep	_	_
62	3	_	NUM	CD	_	63	nummod	_	_
63	fold	_	NOUN	NN	_	48	nmod	_	_
64	,	_	.	,	_	48	punct	_	_
65	and	_	CONJ	CC	_	48	cc	_	_
66	decreased	_	VERB	VBD	_	48	conj	_	_
67	the	_	DET	DT	_	68	det	_	_
68	AUC	_	NOUN	NN	_	66	dobj	_	_
69	of	_	ADP	IN	_	72	case	_	_
70	its	_	PRON	PRP$	_	72	nmod:poss	_	_
71	metabolite	_	NOUN	NN	_	72	compound	_	_
72	P95	_	NOUN	NN	_	68	nmod	_	_
73	by	_	ADP	IN	_	74	case	_	_
74	one	_	NUM	CD	_	66	nmod	_	_
75	half	_	VERB	MD	_	48	root	_	_

#	Fanapt	3979
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	doses	_	NOUN	NNS	_	5	nsubjpass	_	_
3	should	_	VERB	MD	_	5	aux	_	_
4	be	_	VERB	VB	_	5	auxpass	_	_
5	reduced	_	VERB	VBN	_	0	root	_	_
6	by	_	ADP	IN	_	8	case	_	_
7	one	_	NUM	CD	_	8	nummod	_	_
8	half	_	NOUN	NN	_	5	nmod	_	_
9	when	_	ADV	WRB	_	10	advmod	_	_
10	administered	_	VERB	VBN	_	5	advcl	_	_
11	with	_	ADP	IN	_	12	case	_	_
12	fluoxetine	_	NOUN	NN	_	10	nmod	_	_

#	Fanapt	3980
1	When	_	ADV	WRB	_	4	advmod	_	_
2	fluoxetine	_	NOUN	NN	_	4	nsubj	_	_
3	is	_	VERB	VBZ	_	4	auxpass	_	_
4	withdrawn	_	ADJ	JJ	_	15	advcl	_	_
5	from	_	ADP	IN	_	8	case	_	_
6	the	_	DET	DT	_	8	det	_	_
7	combination	_	NOUN	NN	_	8	compound	_	_
8	therapy	_	NOUN	NN	_	4	nmod	_	_
9	,	_	.	,	_	15	punct	_	_
10	the	_	DET	DT	_	12	det	_	_
11	DRUG	_	NOUN	NN	_	12	compound	_	_
12	dose	_	NOUN	NN	_	15	nsubjpass	_	_
13	should	_	VERB	MD	_	15	aux	_	_
14	be	_	VERB	VB	_	15	auxpass	_	_
15	returned	_	VERB	VBN	_	0	root	_	_
16	to	_	PRT	TO	_	19	case	_	_
17	the	_	DET	DT	_	19	det	_	_
18	previous	_	ADJ	JJ	_	19	amod	_	_
19	level	_	NOUN	NN	_	15	nmod	_	_

#	Fanapt	3981
1	Other	_	ADJ	JJ	_	3	amod	_	_
2	strong	_	ADJ	JJ	_	3	amod	_	_
3	inhibitors	_	NOUN	NNS	_	8	nsubjpass	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	CYP2D6	_	NOUN	NN	_	3	nmod	_	_
6	would	_	VERB	MD	_	8	aux	_	_
7	be	_	VERB	VB	_	8	auxpass	_	_
8	expected	_	VERB	VBN	_	0	root	_	_
9	to	_	PRT	TO	_	10	mark	_	_
10	have	_	VERB	VB	_	8	xcomp	_	_
11	similar	_	ADJ	JJ	_	12	amod	_	_
12	effects	_	NOUN	NNS	_	10	dobj	_	_
13	and	_	CONJ	CC	_	8	cc	_	_
14	would	_	VERB	MD	_	15	aux	_	_
15	need	_	VERB	VB	_	8	conj	_	_
16	appropriate	_	ADJ	JJ	_	18	amod	_	_
17	dose	_	NOUN	NN	_	18	compound	_	_
18	reductions	_	NOUN	NNS	_	15	dobj	_	_

#	Fanapt	3982
1	When	_	ADV	WRB	_	6	advmod	_	_
2	the	_	DET	DT	_	4	det	_	_
3	CYP2D6	_	NOUN	NN	_	4	compound	_	_
4	inhibitor	_	NOUN	NN	_	6	nsubjpass	_	_
5	is	_	VERB	VBZ	_	6	auxpass	_	_
6	withdrawn	_	ADJ	JJ	_	17	advcl	_	_
7	from	_	ADP	IN	_	10	case	_	_
8	the	_	DET	DT	_	10	det	_	_
9	combination	_	NOUN	NN	_	10	compound	_	_
10	therapy	_	NOUN	NN	_	6	nmod	_	_
11	,	_	.	,	_	17	punct	_	_
12	DRUG	_	NOUN	NN	_	13	compound	_	_
13	dose	_	NOUN	NN	_	17	nsubjpass	_	_
14	could	_	VERB	MD	_	17	aux	_	_
15	then	_	ADV	RB	_	17	advmod	_	_
16	be	_	VERB	VB	_	17	auxpass	_	_
17	increased	_	VERB	VBN	_	0	root	_	_
18	to	_	PRT	TO	_	21	case	_	_
19	the	_	DET	DT	_	21	det	_	_
20	previous	_	ADJ	JJ	_	21	amod	_	_
21	level	_	NOUN	NN	_	17	nmod	_	_

#	Fanapt	3983
1	Paroxetine	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Co	_	NOUN	NN	_	4	compound	_	_
4	administration	_	NOUN	NN	_	73	nsubj	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	paroxetine	_	NOUN	NN	_	8	compound	_	_
7	20	_	NUM	CD	_	8	nummod	_	_
8	mg	_	NOUN	NN	_	4	nmod	_	_
9	/	_	.	:	_	4	punct	_	_
10	day	_	NOUN	NN	_	40	nsubj	_	_
11	for	_	ADP	IN	_	14	case	_	_
12	5	_	NUM	CD	_	14	nummod	_	_
13	8	_	NUM	CD	_	14	nummod	_	_
14	days	_	NOUN	NNS	_	10	nmod	_	_
15	,	_	.	,	_	14	punct	_	_
16	a	_	DET	DT	_	18	det	_	_
17	potent	_	ADJ	JJ	_	18	amod	_	_
18	inhibitor	_	NOUN	NN	_	14	appos	_	_
19	of	_	ADP	IN	_	20	case	_	_
20	CYP2D6	_	NOUN	NN	_	18	nmod	_	_
21	,	_	.	,	_	10	punct	_	_
22	with	_	ADP	IN	_	24	case	_	_
23	multiple	_	ADJ	JJ	_	24	amod	_	_
24	doses	_	NOUN	NNS	_	10	nmod	_	_
25	of	_	ADP	IN	_	26	case	_	_
26	DRUG	_	NOUN	NN	_	24	nmod	_	_
27	8	_	NUM	CD	_	26	nummod	_	_
28	or	_	CONJ	CC	_	26	cc	_	_
29	12	_	NUM	CD	_	30	nummod	_	_
30	mg	_	NOUN	NN	_	26	conj	_	_
31	twice	_	ADV	RB	_	32	advmod	_	_
32	daily	_	ADV	RB	_	10	advmod	_	_
33	to	_	PRT	TO	_	34	case	_	_
34	patients	_	NOUN	NNS	_	32	nmod	_	_
35	with	_	ADP	IN	_	37	case	_	_
36	schizophrenia	_	NOUN	NN	_	37	compound	_	_
37	ages	_	NOUN	NNS	_	34	nmod	_	_
38	18	_	NUM	CD	_	39	nummod	_	_
39	65	_	NUM	CD	_	37	dep	_	_
40	resulted	_	VERB	VBD	_	4	dep	_	_
41	in	_	ADP	IN	_	47	case	_	_
42	increased	_	VERB	VBN	_	47	amod	_	_
43	mean	_	NOUN	NN	_	47	compound	_	_
44	steady	_	ADJ	JJ	_	47	amod	_	_
45	state	_	NOUN	NN	_	47	compound	_	_
46	peak	_	ADJ	JJ	_	47	amod	_	_
47	concentrations	_	NOUN	NNS	_	40	nmod	_	_
48	of	_	ADP	IN	_	49	case	_	_
49	DRUG	_	NOUN	NN	_	47	nmod	_	_
50	and	_	CONJ	CC	_	47	cc	_	_
51	its	_	PRON	PRP$	_	53	nmod:poss	_	_
52	metabolite	_	NOUN	NN	_	53	compound	_	_
53	P88	_	NOUN	NN	_	47	conj	_	_
54	,	_	.	,	_	4	punct	_	_
55	by	_	ADP	IN	_	58	case	_	_
56	about	_	ADV	RB	_	57	advmod	_	_
57	1.6	_	NUM	CD	_	58	nummod	_	_
58	fold	_	NOUN	NN	_	4	nmod	_	_
59	,	_	.	,	_	4	punct	_	_
60	and	_	CONJ	CC	_	4	cc	_	_
61	decreased	_	VERB	VBN	_	66	amod	_	_
62	mean	_	NOUN	NN	_	66	amod	_	_
63	steady	_	ADJ	JJ	_	66	amod	_	_
64	state	_	NOUN	NN	_	66	compound	_	_
65	peak	_	ADJ	JJ	_	66	amod	_	_
66	concentrations	_	NOUN	NNS	_	4	conj	_	_
67	of	_	ADP	IN	_	70	case	_	_
68	its	_	PRON	PRP$	_	70	nmod:poss	_	_
69	metabolite	_	NOUN	NN	_	70	compound	_	_
70	P95	_	NOUN	NN	_	66	nmod	_	_
71	by	_	ADP	IN	_	72	case	_	_
72	one	_	NUM	CD	_	4	nmod	_	_
73	half	_	VERB	MD	_	1	dep	_	_

#	Fanapt	3984
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	doses	_	NOUN	NNS	_	5	nsubjpass	_	_
3	should	_	VERB	MD	_	5	aux	_	_
4	be	_	VERB	VB	_	5	auxpass	_	_
5	reduced	_	VERB	VBN	_	0	root	_	_
6	by	_	ADP	IN	_	8	case	_	_
7	one	_	NUM	CD	_	8	nummod	_	_
8	half	_	NOUN	NN	_	5	nmod	_	_
9	when	_	ADV	WRB	_	10	advmod	_	_
10	administered	_	VERB	VBN	_	5	advcl	_	_
11	with	_	ADP	IN	_	12	case	_	_
12	paroxetine	_	NOUN	NN	_	10	nmod	_	_

#	Fanapt	3985
1	When	_	ADV	WRB	_	4	advmod	_	_
2	paroxetine	_	NOUN	NN	_	4	nsubj	_	_
3	is	_	VERB	VBZ	_	4	cop	_	_
4	withdrawn	_	ADJ	JJ	_	15	advcl	_	_
5	from	_	ADP	IN	_	8	case	_	_
6	the	_	DET	DT	_	8	det	_	_
7	combination	_	NOUN	NN	_	8	compound	_	_
8	therapy	_	NOUN	NN	_	4	nmod	_	_
9	,	_	.	,	_	15	punct	_	_
10	the	_	DET	DT	_	12	det	_	_
11	DRUG	_	NOUN	NN	_	12	compound	_	_
12	dose	_	NOUN	NN	_	15	nsubjpass	_	_
13	should	_	VERB	MD	_	15	aux	_	_
14	be	_	VERB	VB	_	15	auxpass	_	_
15	returned	_	VERB	VBN	_	0	root	_	_
16	to	_	PRT	TO	_	19	case	_	_
17	the	_	DET	DT	_	19	det	_	_
18	previous	_	ADJ	JJ	_	19	amod	_	_
19	level	_	NOUN	NN	_	15	nmod	_	_

#	Fanapt	3987
1	When	_	ADV	WRB	_	6	advmod	_	_
2	the	_	DET	DT	_	4	det	_	_
3	CYP2D6	_	NOUN	NN	_	4	compound	_	_
4	inhibitor	_	NOUN	NN	_	6	nsubjpass	_	_
5	is	_	VERB	VBZ	_	6	auxpass	_	_
6	withdrawn	_	ADJ	JJ	_	17	advcl	_	_
7	from	_	ADP	IN	_	10	case	_	_
8	the	_	DET	DT	_	10	det	_	_
9	combination	_	NOUN	NN	_	10	compound	_	_
10	therapy	_	NOUN	NN	_	6	nmod	_	_
11	,	_	.	,	_	17	punct	_	_
12	DRUG	_	NOUN	NN	_	13	compound	_	_
13	dose	_	NOUN	NN	_	17	nsubjpass	_	_
14	could	_	VERB	MD	_	17	aux	_	_
15	then	_	ADV	RB	_	17	advmod	_	_
16	be	_	VERB	VB	_	17	auxpass	_	_
17	increased	_	VERB	VBN	_	0	root	_	_
18	to	_	PRT	TO	_	20	case	_	_
19	previous	_	ADJ	JJ	_	20	amod	_	_
20	levels	_	NOUN	NNS	_	17	nmod	_	_

#	Fanapt	3988
1	Paroxetine	_	NOUN	NN	_	0	root	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	Ketoconazole	_	NOUN	NN	_	1	conj	_	_
4	:	_	.	:	_	1	punct	_	_
5	Co	_	NOUN	NN	_	6	compound	_	_
6	administration	_	NOUN	NN	_	45	nsubj	_	_
7	of	_	ADP	IN	_	10	case	_	_
8	paroxetine	_	NOUN	NN	_	10	compound	_	_
9	20	_	NUM	CD	_	10	nummod	_	_
10	mg	_	NOUN	NN	_	6	nmod	_	_
11	once	_	ADV	RB	_	12	advmod	_	_
12	daily	_	ADV	RB	_	26	advmod	_	_
13	for	_	ADP	IN	_	15	case	_	_
14	10	_	NUM	CD	_	15	nummod	_	_
15	days	_	NOUN	NNS	_	12	nmod	_	_
16	,	_	.	,	_	15	punct	_	_
17	a	_	DET	DT	_	19	det	_	_
18	CYP2D6	_	NOUN	NN	_	19	compound	_	_
19	inhibitor	_	NOUN	NN	_	15	conj	_	_
20	,	_	.	,	_	15	punct	_	_
21	and	_	CONJ	CC	_	15	cc	_	_
22	ketoconazole	_	NOUN	NN	_	24	compound	_	_
23	200	_	NUM	CD	_	24	nummod	_	_
24	mg	_	NOUN	NN	_	15	conj	_	_
25	twice	_	ADV	RB	_	26	advmod	_	_
26	daily	_	ADV	RB	_	45	advmod	_	_
27	with	_	ADP	IN	_	29	case	_	_
28	multiple	_	ADJ	JJ	_	29	amod	_	_
29	doses	_	NOUN	NNS	_	26	nmod	_	_
30	of	_	ADP	IN	_	31	case	_	_
31	DRUG	_	NOUN	NN	_	29	nmod	_	_
32	8	_	NUM	CD	_	31	nummod	_	_
33	or	_	CONJ	CC	_	31	cc	_	_
34	12	_	NUM	CD	_	35	nummod	_	_
35	mg	_	NOUN	NN	_	31	conj	_	_
36	twice	_	ADV	RB	_	37	advmod	_	_
37	daily	_	ADV	RB	_	26	advmod	_	_
38	to	_	PRT	TO	_	39	case	_	_
39	patients	_	NOUN	NNS	_	37	nmod	_	_
40	with	_	ADP	IN	_	42	case	_	_
41	schizophrenia	_	NOUN	NN	_	42	compound	_	_
42	ages	_	NOUN	NNS	_	39	nmod	_	_
43	18	_	NUM	CD	_	44	nummod	_	_
44	65	_	NUM	CD	_	42	dep	_	_
45	resulted	_	VERB	VBD	_	1	dep	_	_
46	in	_	ADP	IN	_	50	case	_	_
47	a	_	DET	DT	_	50	det	_	_
48	1.4	_	NUM	CD	_	49	compound	_	_
49	fold	_	NOUN	NN	_	50	amod	_	_
50	increase	_	NOUN	NN	_	45	nmod	_	_
51	in	_	ADP	IN	_	54	case	_	_
52	steady	_	ADJ	JJ	_	54	amod	_	_
53	state	_	NOUN	NN	_	54	compound	_	_
54	concentrations	_	NOUN	NNS	_	50	nmod	_	_
55	of	_	ADP	IN	_	56	case	_	_
56	DRUG	_	NOUN	NN	_	54	nmod	_	_
57	and	_	CONJ	CC	_	50	cc	_	_
58	its	_	PRON	PRP$	_	60	nmod:poss	_	_
59	metabolite	_	NOUN	NN	_	60	compound	_	_
60	P88	_	NOUN	NN	_	50	conj	_	_
61	and	_	CONJ	CC	_	60	cc	_	_
62	a	_	DET	DT	_	65	det	_	_
63	1.4	_	NUM	CD	_	64	compound	_	_
64	fold	_	NOUN	NN	_	65	amod	_	_
65	decrease	_	NOUN	NN	_	60	conj	_	_
66	in	_	ADP	IN	_	68	case	_	_
67	the	_	DET	DT	_	68	det	_	_
68	P95	_	NOUN	NN	_	65	nmod	_	_
69	in	_	ADP	IN	_	71	case	_	_
70	the	_	DET	DT	_	71	det	_	_
71	presence	_	NOUN	NN	_	45	nmod	_	_
72	of	_	ADP	IN	_	73	case	_	_
73	paroxetine	_	NOUN	NN	_	71	nmod	_	_

#	Fanapt	3989
1	So	_	DET	DT	_	2	neg	_	_
2	giving	_	VERB	VBG	_	14	nsubj	_	_
3	DRUG	_	NOUN	NN	_	2	dobj	_	_
4	with	_	ADP	IN	_	5	case	_	_
5	inhibitors	_	NOUN	NNS	_	2	nmod	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	both	_	DET	DT	_	5	nmod	_	_
8	of	_	ADP	IN	_	11	case	_	_
9	its	_	PRON	PRP$	_	11	nmod:poss	_	_
10	metabolic	_	ADJ	JJ	_	11	amod	_	_
11	pathways	_	NOUN	NNS	_	7	nmod	_	_
12	did	_	VERB	VBD	_	14	aux	_	_
13	not	_	ADV	RB	_	14	neg	_	_
14	add	_	VERB	VB	_	0	root	_	_
15	to	_	PRT	TO	_	17	case	_	_
16	the	_	DET	DT	_	17	det	_	_
17	effect	_	NOUN	NN	_	14	nmod	_	_
18	of	_	ADP	IN	_	20	case	_	_
19	either	_	CONJ	CC	_	20	det	_	_
20	inhibitor	_	NOUN	NN	_	17	nmod	_	_
21	given	_	VERB	VBN	_	20	acl	_	_
22	alone	_	ADV	RB	_	21	advmod	_	_

#	Fanapt	3990
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	doses	_	NOUN	NNS	_	6	nsubjpass	_	_
3	should	_	VERB	MD	_	6	aux	_	_
4	therefore	_	ADV	RB	_	6	advmod	_	_
5	be	_	VERB	VB	_	6	auxpass	_	_
6	reduced	_	VERB	VBN	_	0	root	_	_
7	by	_	ADP	IN	_	10	case	_	_
8	about	_	ADV	RB	_	9	advmod	_	_
9	one	_	NUM	CD	_	10	nummod	_	_
10	half	_	NOUN	NN	_	6	nmod	_	_
11	if	_	DET	WDT	_	12	nsubj	_	_
12	administered	_	VERB	VBN	_	10	acl	_	_
13	concomitantly	_	ADV	RB	_	12	advmod	_	_
14	with	_	ADP	IN	_	17	case	_	_
15	both	_	CONJ	CC	_	17	cc:preconj	_	_
16	a	_	DET	DT	_	17	dep	_	_
17	CYP2D6	_	NOUN	NN	_	12	nmod	_	_
18	and	_	CONJ	CC	_	17	cc	_	_
19	CYP3A4	_	NOUN	NN	_	20	compound	_	_
20	inhibitor	_	NOUN	NN	_	17	conj	_	_

#	Fanapt	3991
1	In	_	X	FW	_	3	amod	_	_
2	vitro	_	X	FW	_	1	dep	_	_
3	studies	_	NOUN	NNS	_	8	nsubj	_	_
4	in	_	ADP	IN	_	7	case	_	_
5	human	_	ADJ	JJ	_	7	amod	_	_
6	liver	_	NOUN	NN	_	7	compound	_	_
7	microsomes	_	NOUN	NNS	_	3	nmod	_	_
8	showed	_	VERB	VBD	_	0	root	_	_
9	that	_	ADP	IN	_	14	mark	_	_
10	DRUG	_	NOUN	NN	_	14	nsubj	_	_
11	does	_	VERB	VBZ	_	14	aux	_	_
12	not	_	ADV	RB	_	14	neg	_	_
13	substantially	_	ADV	RB	_	14	advmod	_	_
14	inhibit	_	VERB	VB	_	8	ccomp	_	_
15	the	_	DET	DT	_	16	det	_	_
16	metabolism	_	NOUN	NN	_	14	dobj	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	drugs	_	NOUN	NNS	_	16	nmod	_	_
19	metabolized	_	VERB	VBN	_	18	acl	_	_
20	by	_	ADP	IN	_	25	case	_	_
21	the	_	DET	DT	_	25	det	_	_
22	following	_	VERB	VBG	_	25	amod	_	_
23	cytochrome	_	NOUN	NN	_	25	compound	_	_
24	P450	_	NOUN	NN	_	25	compound	_	_
25	isozymes	_	NOUN	NNS	_	19	nmod	_	_
26	:	_	.	:	_	14	punct	_	_
27	CYP1A1	_	NOUN	NN	_	14	dep	_	_
28	,	_	.	,	_	27	punct	_	_
29	CYP1A2	_	NOUN	NN	_	27	conj	_	_
30	,	_	.	,	_	27	punct	_	_
31	CYP2A6	_	NOUN	NN	_	27	conj	_	_
32	,	_	.	,	_	27	punct	_	_
33	CYP2B6	_	NOUN	NN	_	27	conj	_	_
34	,	_	.	,	_	27	punct	_	_
35	CYP2C8	_	NOUN	NN	_	27	conj	_	_
36	,	_	.	,	_	27	punct	_	_
37	CYP2C9	_	NOUN	NN	_	27	conj	_	_
38	,	_	.	,	_	27	punct	_	_
39	or	_	CONJ	CC	_	27	cc	_	_
40	CYP2E1	_	NOUN	NN	_	27	conj	_	_

#	Fanapt	3992
1	Furthermore	_	ADV	RB	_	10	advmod	_	_
2	,	_	.	,	_	10	punct	_	_
3	in	_	X	FW	_	5	amod	_	_
4	vitro	_	X	FW	_	3	dep	_	_
5	studies	_	NOUN	NNS	_	10	nsubj	_	_
6	in	_	ADP	IN	_	9	case	_	_
7	human	_	ADJ	JJ	_	9	amod	_	_
8	liver	_	NOUN	NN	_	9	compound	_	_
9	microsomes	_	NOUN	NNS	_	5	nmod	_	_
10	showed	_	VERB	VBD	_	0	root	_	_
11	that	_	ADP	IN	_	15	mark	_	_
12	DRUG	_	NOUN	NN	_	15	nsubj	_	_
13	does	_	VERB	VBZ	_	15	aux	_	_
14	not	_	ADV	RB	_	15	neg	_	_
15	have	_	VERB	VB	_	10	ccomp	_	_
16	enzyme	_	NOUN	NN	_	18	compound	_	_
17	inducing	_	VERB	VBG	_	18	compound	_	_
18	properties	_	NOUN	NNS	_	15	dobj	_	_
19	,	_	.	,	_	15	punct	_	_
20	specifically	_	ADV	RB	_	26	advmod	_	_
21	for	_	ADP	IN	_	26	case	_	_
22	the	_	DET	DT	_	26	det	_	_
23	following	_	VERB	VBG	_	26	amod	_	_
24	cytochrome	_	NOUN	NN	_	26	compound	_	_
25	P450	_	NOUN	NN	_	26	compound	_	_
26	isozymes	_	NOUN	NNS	_	15	nmod	_	_
27	:	_	.	:	_	15	punct	_	_
28	CYP1A2	_	NOUN	NN	_	15	dep	_	_
29	,	_	.	,	_	28	punct	_	_
30	CYP2C8	_	NOUN	NN	_	28	conj	_	_
31	,	_	.	,	_	28	punct	_	_
32	CYP2C9	_	NOUN	NN	_	28	conj	_	_
33	,	_	.	,	_	28	punct	_	_
34	CYP2C19	_	NOUN	NN	_	28	conj	_	_
35	,	_	.	,	_	28	punct	_	_
36	CYP3A4	_	NOUN	NN	_	28	conj	_	_
37	and	_	CONJ	CC	_	28	cc	_	_
38	CYP3A5	_	NOUN	NN	_	28	conj	_	_

#	Fanapt	3993
1	Dextromethorphan	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	A	_	PRON	PRP$	_	4	det	_	_
4	study	_	NOUN	NN	_	8	nsubj	_	_
5	in	_	ADP	IN	_	7	case	_	_
6	healthy	_	ADJ	JJ	_	7	amod	_	_
7	volunteers	_	NOUN	NNS	_	4	nmod	_	_
8	showed	_	VERB	VBD	_	1	dep	_	_
9	that	_	ADP	IN	_	29	mark	_	_
10	changes	_	NOUN	NNS	_	29	nsubj	_	_
11	in	_	ADP	IN	_	13	case	_	_
12	the	_	DET	DT	_	13	det	_	_
13	pharmacokinetics	_	NOUN	NNS	_	10	nmod	_	_
14	of	_	ADP	IN	_	18	case	_	_
15	dextromethorphan	_	NOUN	NN	_	18	compound	_	_
16	80	_	NUM	CD	_	18	nummod	_	_
17	mg	_	NOUN	NN	_	18	compound	_	_
18	dose	_	NOUN	NN	_	13	nmod	_	_
19	when	_	ADV	WRB	_	28	advmod	_	_
20	a	_	DET	DT	_	23	det	_	_
21	3	_	NUM	CD	_	23	nummod	_	_
22	mg	_	NOUN	NN	_	23	compound	_	_
23	dose	_	NOUN	NN	_	28	nsubjpass	_	_
24	of	_	ADP	IN	_	25	case	_	_
25	DRUG	_	NOUN	NN	_	23	nmod	_	_
26	was	_	VERB	VBD	_	28	auxpass	_	_
27	co	_	PRT	TO	_	28	mark	_	_
28	administered	_	VERB	VBN	_	10	acl	_	_
29	resulted	_	VERB	VBN	_	8	ccomp	_	_
30	in	_	ADP	IN	_	33	case	_	_
31	a	_	DET	DT	_	33	det	_	_
32	17%	_	ADJ	JJ	_	33	amod	_	_
33	increase	_	NOUN	NN	_	29	nmod	_	_
34	in	_	ADP	IN	_	36	case	_	_
35	total	_	ADJ	JJ	_	36	amod	_	_
36	exposure	_	NOUN	NN	_	33	nmod	_	_
37	and	_	CONJ	CC	_	29	cc	_	_
38	a	_	DET	DT	_	40	det	_	_
39	26%	_	ADJ	JJ	_	40	amod	_	_
40	increase	_	NOUN	NN	_	29	conj	_	_
41	in	_	ADP	IN	_	45	case	_	_
42	the	_	DET	DT	_	45	det	_	_
43	maximum	_	NOUN	NN	_	45	compound	_	_
44	plasma	_	NOUN	NN	_	45	compound	_	_
45	concentrations	_	NOUN	NNS	_	40	nmod	_	_
46	Cmax)of	_	NOUN	NN	_	47	compound	_	_
47	dextromethorphan	_	NOUN	NN	_	45	dep	_	_

#	Fanapt	3994
1	Thus	_	ADV	RB	_	12	advmod	_	_
2	,	_	.	,	_	12	punct	_	_
3	an	_	DET	DT	_	4	det	_	_
4	interaction	_	NOUN	NN	_	12	nsubj	_	_
5	between	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	other	_	ADJ	JJ	_	10	amod	_	_
9	CYP2D6	_	NOUN	NN	_	10	compound	_	_
10	substrates	_	NOUN	NNS	_	6	conj	_	_
11	is	_	VERB	VBZ	_	12	auxpass	_	_
12	unlikely	_	ADV	RB	_	0	root	_	_

#	Fanapt	3995
1	Fluoxetine	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	A	_	PRON	PRP$	_	7	det	_	_
4	single	_	ADJ	JJ	_	7	amod	_	_
5	3	_	NUM	CD	_	7	nummod	_	_
6	mg	_	NOUN	NN	_	7	compound	_	_
7	dose	_	NOUN	NN	_	10	nsubj	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	had	_	VERB	VBD	_	1	dep	_	_
11	no	_	DET	DT	_	12	neg	_	_
12	effect	_	NOUN	NN	_	10	dobj	_	_
13	on	_	ADP	IN	_	15	case	_	_
14	the	_	DET	DT	_	15	det	_	_
15	pharmacokinetics	_	NOUN	NNS	_	12	nmod	_	_
16	of	_	ADP	IN	_	19	case	_	_
17	fluoxetine	_	NOUN	NN	_	19	compound	_	_
18	20	_	NUM	CD	_	19	nummod	_	_
19	mg	_	NOUN	NN	_	15	nmod	_	_
20	twice	_	ADV	RB	_	21	advmod	_	_
21	daily	_	ADV	RB	_	10	advmod	_	_

#	Fanapt	3996
1	Midazolam	_	NOUN	NN	_	12	advmod	_	_
2	a	_	DET	DT	_	7	det	_	_
3	sensitive	_	ADJ	JJ	_	7	amod	_	_
4	CYP	_	NOUN	NN	_	7	compound	_	_
5	3A4	_	NOUN	NN	_	7	compound	_	_
6	substrate):A	_	NOUN	NN	_	7	compound	_	_
7	study	_	NOUN	NN	_	12	nsubj	_	_
8	in	_	ADP	IN	_	9	case	_	_
9	patients	_	NOUN	NNS	_	7	nmod	_	_
10	with	_	ADP	IN	_	11	case	_	_
11	schizophrenia	_	NOUN	NN	_	9	nmod	_	_
12	showed	_	VERB	VBD	_	0	root	_	_
13	a	_	DET	DT	_	17	det	_	_
14	less	_	ADV	RB	_	16	advmod	_	_
15	than	_	ADP	IN	_	14	mwe	_	_
16	50%	_	ADJ	JJ	_	17	amod	_	_
17	increase	_	NOUN	NN	_	12	dobj	_	_
18	in	_	ADP	IN	_	21	case	_	_
19	midazolam	_	NOUN	NN	_	21	compound	_	_
20	total	_	ADJ	JJ	_	21	amod	_	_
21	exposure	_	NOUN	NN	_	17	nmod	_	_
22	at	_	ADP	IN	_	27	case	_	_
23	DRUG	_	NOUN	NN	_	27	compound	_	_
24	steady	_	ADJ	JJ	_	27	amod	_	_
25	state	_	NOUN	NN	_	27	compound	_	_
26	14	_	NUM	CD	_	27	nummod	_	_
27	days	_	NOUN	NNS	_	17	nmod	_	_
28	of	_	ADP	IN	_	30	case	_	_
29	oral	_	ADJ	JJ	_	30	amod	_	_
30	dosing	_	NOUN	NN	_	27	nmod	_	_
31	at	_	ADP	IN	_	36	case	_	_
32	up	_	ADJ	JJ	_	34	advmod	_	_
33	to	_	PRT	TO	_	34	dep	_	_
34	10	_	NUM	CD	_	36	nummod	_	_
35	mg	_	NOUN	NN	_	36	compound	_	_
36	DRUG	_	NOUN	NN	_	17	nmod	_	_
37	twice	_	ADV	RB	_	38	advmod	_	_
38	daily	_	ADV	RB	_	39	advmod	_	_
39	and	_	CONJ	CC	_	12	advmod	_	_
40	no	_	DET	DT	_	41	neg	_	_
41	effect	_	NOUN	NN	_	39	conj	_	_
42	on	_	ADP	IN	_	43	case	_	_
43	midazolam	_	NOUN	NN	_	41	nmod	_	_
44	Cmax	_	NOUN	NN	_	43	dep	_	_

#	Fanapt	3997
1	Thus	_	ADV	RB	_	12	advmod	_	_
2	,	_	.	,	_	12	punct	_	_
3	an	_	DET	DT	_	4	det	_	_
4	interaction	_	NOUN	NN	_	12	nsubj	_	_
5	between	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	other	_	ADJ	JJ	_	10	amod	_	_
9	CYP3A4	_	NOUN	NN	_	10	compound	_	_
10	substrates	_	NOUN	NNS	_	6	conj	_	_
11	is	_	VERB	VBZ	_	12	auxpass	_	_
12	unlikely	_	ADV	RB	_	0	root	_	_

#	Fanapt	3998
1	DRUG	_	NOUN	NN	_	5	nsubjpass	_	_
2	should	_	VERB	MD	_	5	aux	_	_
3	not	_	ADV	RB	_	5	neg	_	_
4	be	_	VERB	VB	_	5	auxpass	_	_
5	used	_	VERB	VBN	_	0	root	_	_
6	with	_	ADP	IN	_	9	case	_	_
7	any	_	DET	DT	_	9	det	_	_
8	other	_	ADJ	JJ	_	9	amod	_	_
9	drugs	_	NOUN	NNS	_	5	nmod	_	_
10	that	_	DET	WDT	_	11	nsubj	_	_
11	prolong	_	VERB	VBP	_	9	acl:relcl	_	_
12	the	_	DET	DT	_	14	det	_	_
13	QT	_	NOUN	NN	_	14	nmod:npmod	_	_
14	interval	_	ADJ	JJ	_	11	dobj	_	_

#	Fanapt	3999
1	The	_	DET	DT	_	2	det	_	_
2	mechanism	_	NOUN	NN	_	18	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	action	_	NOUN	NN	_	2	nmod	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	,	_	.	,	_	2	punct	_	_
8	as	_	ADP	IN	_	11	case	_	_
9	with	_	ADP	IN	_	11	case	_	_
10	other	_	ADJ	JJ	_	11	amod	_	_
11	drugs	_	NOUN	NNS	_	2	nmod	_	_
12	having	_	VERB	VBG	_	11	acl	_	_
13	efficacy	_	NOUN	NN	_	12	dobj	_	_
14	in	_	ADP	IN	_	15	case	_	_
15	schizophrenia	_	NOUN	NN	_	13	nmod	_	_
16	,	_	.	,	_	2	punct	_	_
17	is	_	VERB	VBZ	_	18	auxpass	_	_
18	unknown	_	ADJ	JJ	_	0	root	_	_

#	Fanapt	4000
1	However	_	ADV	RB	_	4	advmod	_	_
2	it	_	PRON	PRP	_	4	nsubjpass	_	_
3	is	_	VERB	VBZ	_	4	auxpass	_	_
4	proposed	_	VERB	VBN	_	0	root	_	_
5	that	_	ADP	IN	_	11	mark	_	_
6	the	_	DET	DT	_	7	det	_	_
7	efficacy	_	NOUN	NN	_	11	nsubjpass	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	is	_	VERB	VBZ	_	11	auxpass	_	_
11	mediated	_	VERB	VBN	_	4	ccomp	_	_
12	through	_	ADP	IN	_	14	case	_	_
13	a	_	DET	DT	_	14	det	_	_
14	combination	_	NOUN	NN	_	11	nmod	_	_
15	of	_	ADP	IN	_	19	case	_	_
16	dopamine	_	NOUN	NN	_	19	compound	_	_
17	type	_	NOUN	NN	_	19	compound	_	_
18	2	_	NUM	CD	_	19	nummod	_	_
19	D2	_	NOUN	NN	_	14	nmod	_	_
20	and	_	CONJ	CC	_	19	cc	_	_
21	serotonin	_	NOUN	NN	_	26	compound	_	_
22	type	_	NOUN	NN	_	26	compound	_	_
23	2	_	NUM	CD	_	26	nummod	_	_
24	5	_	NUM	CD	_	26	nummod	_	_
25	HT2	_	NOUN	NN	_	26	compound	_	_
26	antagonisms	_	NOUN	NNS	_	19	conj	_	_

#	Fanapt	4001
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	exhibits	_	VERB	VBZ	_	0	root	_	_
3	high	_	ADJ	JJ	_	5	amod	_	_
4	nM	_	NOUN	NN	_	5	compound	_	_
5	affinity	_	NOUN	NN	_	2	dobj	_	_
6	binding	_	VERB	VBG	_	5	acl	_	_
7	to	_	PRT	TO	_	12	case	_	_
8	serotonin	_	NOUN	NN	_	12	compound	_	_
9	5	_	NUM	CD	_	12	nummod	_	_
10	HT2A	_	NOUN	NN	_	12	compound	_	_
11	dopamine	_	NOUN	NN	_	12	compound	_	_
12	D2	_	NOUN	NN	_	22	compound	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	D3	_	NOUN	NN	_	15	compound	_	_
15	receptors	_	NOUN	NNS	_	12	conj	_	_
16	,	_	.	,	_	12	punct	_	_
17	and	_	CONJ	CC	_	12	cc	_	_
18	norepinephrine	_	NOUN	NN	_	20	compound	_	_
19	NEA1	_	NOUN	NN	_	20	compound	_	_
20	receptors	_	NOUN	NNS	_	12	conj	_	_
21	Ki	_	NOUN	NN	_	22	compound	_	_
22	values	_	NOUN	NNS	_	6	dobj	_	_
23	of	_	ADP	IN	_	24	case	_	_
24	5.6	_	NUM	CD	_	22	nmod	_	_
25	,	_	.	,	_	24	punct	_	_
26	6.3	_	NUM	CD	_	24	conj	_	_
27	,	_	.	,	_	24	punct	_	_
28	7.1	_	NUM	CD	_	24	conj	_	_
29	,	_	.	,	_	24	punct	_	_
30	and	_	CONJ	CC	_	24	cc	_	_
31	0.36	_	NUM	CD	_	24	conj	_	_
32	nM	_	NOUN	NN	_	24	dep	_	_
33	,	_	.	,	_	2	punct	_	_
34	respectively	_	ADV	RB	_	2	advmod	_	_

#	Fanapt	4002
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	has	_	VERB	VBZ	_	0	root	_	_
3	moderate	_	ADJ	JJ	_	4	amod	_	_
4	affinity	_	NOUN	NN	_	2	dobj	_	_
5	for	_	ADP	IN	_	7	case	_	_
6	dopamine	_	NOUN	NN	_	7	compound	_	_
7	D4	_	NOUN	NN	_	4	nmod	_	_
8	,	_	.	,	_	4	punct	_	_
9	and	_	CONJ	CC	_	4	cc	_	_
10	serotonin	_	NOUN	NN	_	12	compound	_	_
11	5	_	NUM	CD	_	12	nummod	_	_
12	HT6	_	NOUN	NN	_	18	compound	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	5	_	NUM	CD	_	16	nummod	_	_
15	HT7	_	NOUN	NN	_	16	compound	_	_
16	receptors	_	NOUN	NNS	_	12	conj	_	_
17	Ki	_	NOUN	NN	_	18	compound	_	_
18	values	_	NOUN	NNS	_	4	conj	_	_
19	of	_	ADP	IN	_	20	case	_	_
20	25	_	NUM	CD	_	18	nmod	_	_
21	,	_	.	,	_	20	punct	_	_
22	43	_	NUM	CD	_	20	conj	_	_
23	,	_	.	,	_	20	punct	_	_
24	and	_	CONJ	CC	_	20	cc	_	_
25	22	_	NUM	CD	_	20	conj	_	_
26	,	_	.	,	_	20	punct	_	_
27	nM	_	NOUN	NN	_	20	conj	_	_
28	respectively	_	ADV	RB	_	27	advmod	_	_
29	,	_	.	,	_	20	punct	_	_
30	and	_	CONJ	CC	_	20	cc	_	_
31	low	_	ADJ	JJ	_	32	amod	_	_
32	affinity	_	NOUN	NN	_	20	conj	_	_
33	for	_	ADP	IN	_	37	case	_	_
34	the	_	DET	DT	_	37	det	_	_
35	serotonin	_	NOUN	NN	_	37	compound	_	_
36	5	_	NUM	CD	_	37	nummod	_	_
37	HT1A	_	NOUN	NN	_	18	nmod	_	_
38	,	_	.	,	_	37	punct	_	_
39	dopamine	_	NOUN	NN	_	40	compound	_	_
40	D1	_	NOUN	NN	_	37	conj	_	_
41	,	_	.	,	_	37	punct	_	_
42	and	_	CONJ	CC	_	37	cc	_	_
43	histamine	_	NOUN	NN	_	45	compound	_	_
44	H1	_	NOUN	NN	_	45	compound	_	_
45	receptors	_	NOUN	NNS	_	37	conj	_	_
46	Ki	_	NOUN	NN	_	47	compound	_	_
47	values	_	NOUN	NNS	_	37	dep	_	_
48	of	_	ADP	IN	_	49	case	_	_
49	168	_	NUM	CD	_	47	nmod	_	_
50	,	_	.	,	_	49	punct	_	_
51	216	_	NUM	CD	_	49	conj	_	_
52	and	_	CONJ	CC	_	49	cc	_	_
53	437	_	NUM	CD	_	49	conj	_	_
54	nM	_	NOUN	NN	_	49	dep	_	_
55	,	_	.	,	_	4	punct	_	_
56	respectively	_	ADV	RB	_	2	advmod	_	_

#	Fanapt	4003
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	has	_	VERB	VBZ	_	0	root	_	_
3	no	_	DET	DT	_	8	neg	_	_
4	appreciable	_	ADJ	JJ	_	8	amod	_	_
5	affinity	_	NOUN	NN	_	8	compound	_	_
6	Ki	_	NOUN	NN	_	8	compound	_	_
7	>1000	_	NUM	CD	_	8	nummod	_	_
8	nM	_	NOUN	NN	_	2	dobj	_	_
9	for	_	ADP	IN	_	12	case	_	_
10	cholinergic	_	ADJ	JJ	_	12	amod	_	_
11	muscarinic	_	ADJ	JJ	_	12	amod	_	_
12	receptors	_	NOUN	NNS	_	8	nmod	_	_

#	Fanapt	4004
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	functions	_	VERB	VBZ	_	0	root	_	_
3	as	_	ADP	IN	_	5	case	_	_
4	an	_	DET	DT	_	5	det	_	_
5	antagonist	_	NOUN	NN	_	2	nmod	_	_
6	at	_	ADP	IN	_	9	case	_	_
7	the	_	DET	DT	_	9	det	_	_
8	dopamine	_	NOUN	NN	_	9	compound	_	_
9	D2	_	NOUN	NN	_	5	nmod	_	_
10	,	_	.	,	_	9	punct	_	_
11	D3	_	NOUN	NN	_	9	conj	_	_
12	,	_	.	,	_	9	punct	_	_
13	serotonin	_	NOUN	NN	_	15	compound	_	_
14	5	_	NUM	CD	_	15	nummod	_	_
15	HT1A	_	NOUN	NN	_	9	conj	_	_
16	and	_	CONJ	CC	_	9	cc	_	_
17	norepinephrine	_	NOUN	NN	_	18	compound	_	_
18	A1	_	NOUN	NN	_	9	conj	_	_
19	/	_	.	:	_	2	punct	_	_
20	A2C	_	NOUN	NN	_	21	compound	_	_
21	receptors	_	NOUN	NNS	_	2	parataxis	_	_

#	Fanapt	4005
1	The	_	DET	DT	_	2	det	_	_
2	affinity	_	NOUN	NN	_	10	nsubj	_	_
3	of	_	ADP	IN	_	7	case	_	_
4	the	_	DET	DT	_	7	det	_	_
5	DRUG	_	NOUN	NN	_	7	compound	_	_
6	metabolite	_	NOUN	NN	_	7	compound	_	_
7	P88	_	NOUN	NN	_	2	nmod	_	_
8	is	_	VERB	VBZ	_	10	cop	_	_
9	generally	_	ADV	RB	_	10	advmod	_	_
10	equal	_	ADJ	JJ	_	0	root	_	_
11	or	_	CONJ	CC	_	10	cc	_	_
12	less	_	ADV	RB	_	10	conj	_	_
13	than	_	ADP	IN	_	14	case	_	_
14	that	_	DET	DT	_	12	nmod	_	_
15	of	_	ADP	IN	_	18	case	_	_
16	the	_	DET	DT	_	18	det	_	_
17	parent	_	NOUN	NN	_	18	compound	_	_
18	compound	_	NOUN	NN	_	14	nmod	_	_

#	Fanapt	4006
1	In	_	ADP	IN	_	2	case	_	_
2	contrast	_	NOUN	NN	_	8	nmod	_	_
3	,	_	.	,	_	8	punct	_	_
4	the	_	DET	DT	_	6	det	_	_
5	metabolite	_	NOUN	NN	_	6	compound	_	_
6	P95	_	NOUN	NN	_	8	nsubj	_	_
7	only	_	ADV	RB	_	8	advmod	_	_
8	shows	_	VERB	VBZ	_	0	root	_	_
9	affinity	_	NOUN	NN	_	8	dobj	_	_
10	for	_	ADP	IN	_	14	case	_	_
11	5	_	NUM	CD	_	14	nummod	_	_
12	HT2A	_	NOUN	NN	_	14	compound	_	_
13	Ki	_	NOUN	NN	_	14	compound	_	_
14	value	_	NOUN	NN	_	9	nmod	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	3.91	_	NUM	CD	_	30	nummod	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	the	_	DET	DT	_	19	det	_	_
19	NEA1A	_	NOUN	NN	_	16	conj	_	_
20	,	_	.	,	_	16	punct	_	_
21	NEA1B	_	NOUN	NN	_	16	conj	_	_
22	,	_	.	,	_	16	punct	_	_
23	NEA1D	_	NOUN	NN	_	16	conj	_	_
24	,	_	.	,	_	16	punct	_	_
25	and	_	CONJ	CC	_	16	cc	_	_
26	NEA2	_	NOUN	NN	_	28	compound	_	_
27	C	_	NOUN	NN	_	28	compound	_	_
28	receptors	_	NOUN	NNS	_	16	conj	_	_
29	Ki	_	NOUN	NN	_	30	compound	_	_
30	values	_	NOUN	NNS	_	14	nmod	_	_
31	of	_	ADP	IN	_	32	case	_	_
32	4.7	_	NUM	CD	_	30	nmod	_	_
33	,	_	.	,	_	32	punct	_	_
34	2.7	_	NUM	CD	_	32	conj	_	_
35	,	_	.	,	_	32	punct	_	_
36	8.8	_	NUM	CD	_	32	conj	_	_
37	,	_	.	,	_	32	punct	_	_
38	and	_	CONJ	CC	_	32	cc	_	_
39	4.7	_	NUM	CD	_	32	conj	_	_
40	nM	_	NOUN	NN	_	32	dep	_	_
41	respectively	_	ADV	RB	_	8	advmod	_	_

#	Fanapt	4007
1	The	_	DET	DT	_	6	det	_	_
2	observed	_	VERB	VBN	_	6	amod	_	_
3	mean	_	NOUN	NN	_	6	compound	_	_
4	elimination	_	NOUN	NN	_	6	compound	_	_
5	half	_	NOUN	NN	_	6	compound	_	_
6	lives	_	NOUN	NNS	_	0	root	_	_
7	for	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	,	_	.	,	_	8	punct	_	_
10	P88	_	NOUN	NN	_	8	conj	_	_
11	and	_	CONJ	CC	_	8	cc	_	_
12	P95	_	NOUN	NN	_	8	conj	_	_
13	in	_	ADP	IN	_	16	case	_	_
14	CYP2D6	_	NOUN	NN	_	16	compound	_	_
15	extensive	_	ADJ	JJ	_	16	amod	_	_
16	metabolizers	_	NOUN	NNS	_	6	nmod	_	_
17	EM)are	_	NOUN	NN	_	16	dep	_	_
18	18	_	NUM	CD	_	17	nummod	_	_
19	,	_	.	,	_	17	punct	_	_
20	26	_	NUM	CD	_	17	conj	_	_
21	,	_	.	,	_	17	punct	_	_
22	and	_	CONJ	CC	_	17	cc	_	_
23	23	_	NUM	CD	_	24	nummod	_	_
24	hours	_	NOUN	NNS	_	17	conj	_	_
25	,	_	.	,	_	16	punct	_	_
26	respectively	_	ADV	RB	_	16	advmod	_	_
27	,	_	.	,	_	6	punct	_	_
28	and	_	CONJ	CC	_	6	cc	_	_
29	in	_	ADP	IN	_	31	case	_	_
30	poor	_	ADJ	JJ	_	31	amod	_	_
31	metabolizers	_	NOUN	NNS	_	6	conj	_	_
32	PM	_	NOUN	NN	_	34	nsubj	_	_
33	are	_	VERB	VBP	_	34	cop	_	_
34	33	_	NUM	CD	_	40	nummod	_	_
35	,	_	.	,	_	34	punct	_	_
36	37	_	NUM	CD	_	34	conj	_	_
37	,	_	.	,	_	34	punct	_	_
38	and	_	CONJ	CC	_	34	cc	_	_
39	31	_	NUM	CD	_	34	conj	_	_
40	hours	_	NOUN	NNS	_	31	dep	_	_
41	,	_	.	,	_	31	punct	_	_
42	respectively	_	ADV	RB	_	31	advmod	_	_

#	Fanapt	4008
1	Steady	_	ADJ	JJ	_	3	amod	_	_
2	state	_	NOUN	NN	_	3	compound	_	_
3	concentrations	_	NOUN	NNS	_	5	nsubjpass	_	_
4	are	_	VERB	VBP	_	5	auxpass	_	_
5	attained	_	VERB	VBN	_	0	root	_	_
6	within	_	ADP	IN	_	9	case	_	_
7	3	_	NUM	CD	_	9	nummod	_	_
8	4	_	NUM	CD	_	9	nummod	_	_
9	days	_	NOUN	NNS	_	5	nmod	_	_
10	of	_	ADP	IN	_	11	mark	_	_
11	dosing	_	VERB	VBG	_	9	acl	_	_

#	Fanapt	4009
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	accumulation	_	NOUN	NN	_	4	nsubj	_	_
3	is	_	VERB	VBZ	_	4	cop	_	_
4	predictable	_	ADJ	JJ	_	0	root	_	_
5	from	_	ADP	IN	_	8	case	_	_
6	single	_	ADJ	JJ	_	8	amod	_	_
7	dose	_	NOUN	NN	_	8	compound	_	_
8	pharmacokinetics	_	NOUN	NNS	_	4	nmod	_	_

#	Fanapt	4010
1	The	_	DET	DT	_	2	det	_	_
2	pharmacokinetics	_	NOUN	NNS	_	9	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	is	_	VERB	VBZ	_	9	cop	_	_
6	more	_	ADV	RB	_	9	advmod	_	_
7	than	_	ADP	IN	_	9	case	_	_
8	dose	_	NOUN	NN	_	9	nmod:npmod	_	_
9	proportional	_	ADJ	JJ	_	0	root	_	_

#	Fanapt	4011
1	Elimination	_	NOUN	NN	_	8	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	is	_	VERB	VBZ	_	8	cop	_	_
5	mainly	_	ADV	RB	_	8	advmod	_	_
6	through	_	ADP	IN	_	8	case	_	_
7	hepatic	_	ADJ	JJ	_	8	amod	_	_
8	metabolism	_	NOUN	NN	_	0	root	_	_
9	involving	_	VERB	VBG	_	8	acl	_	_
10	2	_	NUM	CD	_	12	nummod	_	_
11	P450	_	NOUN	NN	_	12	compound	_	_
12	isozymes	_	NOUN	NNS	_	9	dobj	_	_
13	,	_	.	,	_	12	punct	_	_
14	CYP2D6	_	NOUN	NN	_	12	appos	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	CYP3A4	_	NOUN	NN	_	14	conj	_	_

#	Fanapt	4012
1	Absorption	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	DRUG	_	NOUN	NN	_	6	nsubjpass	_	_
4	is	_	VERB	VBZ	_	6	auxpass	_	_
5	well	_	ADV	RB	_	6	advmod	_	_
6	absorbed	_	VERB	VBN	_	1	dep	_	_
7	after	_	ADP	IN	_	8	case	_	_
8	administration	_	NOUN	NN	_	6	nmod	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	the	_	DET	DT	_	11	det	_	_
11	tablet	_	NOUN	NN	_	8	nmod	_	_
12	with	_	ADP	IN	_	15	case	_	_
13	peak	_	ADJ	JJ	_	15	amod	_	_
14	plasma	_	NOUN	NN	_	15	compound	_	_
15	concentrations	_	NOUN	NNS	_	8	nmod	_	_
16	occurring	_	VERB	VBG	_	15	acl	_	_
17	within	_	ADP	IN	_	21	case	_	_
18	2	_	NUM	CD	_	20	compound	_	_
19	to	_	PRT	TO	_	20	dep	_	_
20	4	_	NUM	CD	_	21	nummod	_	_
21	hours	_	NOUN	NNS	_	16	nmod	_	_
22	while	_	ADP	IN	_	30	mark	_	_
23	the	_	DET	DT	_	25	det	_	_
24	relative	_	ADJ	JJ	_	25	amod	_	_
25	bioavailability	_	NOUN	NN	_	30	nsubj	_	_
26	of	_	ADP	IN	_	29	case	_	_
27	the	_	DET	DT	_	29	det	_	_
28	tablet	_	NOUN	NN	_	29	compound	_	_
29	formulation	_	NOUN	NN	_	25	nmod	_	_
30	compared	_	VERB	VBD	_	6	parataxis	_	_
31	to	_	PRT	TO	_	33	case	_	_
32	oral	_	ADJ	JJ	_	33	amod	_	_
33	solution	_	NOUN	NN	_	30	nmod	_	_
34	is	_	VERB	VBZ	_	35	auxpass	_	_
35	96%	_	ADJ	JJ	_	30	parataxis	_	_

#	Fanapt	4013
1	Administration	_	NOUN	NN	_	13	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	with	_	ADP	IN	_	9	case	_	_
5	a	_	DET	DT	_	9	det	_	_
6	standard	_	ADJ	JJ	_	9	amod	_	_
7	high	_	ADJ	JJ	_	9	amod	_	_
8	fat	_	NOUN	NN	_	9	compound	_	_
9	meal	_	NOUN	NN	_	1	nmod	_	_
10	did	_	VERB	VBD	_	13	aux	_	_
11	not	_	ADV	RB	_	13	neg	_	_
12	significantly	_	ADV	RB	_	13	advmod	_	_
13	affect	_	VERB	VB	_	0	root	_	_
14	the	_	DET	DT	_	15	det	_	_
15	Cmax	_	NOUN	NN	_	13	dobj	_	_
16	or	_	CONJ	CC	_	15	cc	_	_
17	AUC	_	NOUN	NN	_	15	conj	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	DRUG	_	NOUN	NN	_	15	nmod	_	_
20	,	_	.	,	_	19	punct	_	_
21	P88	_	NOUN	NN	_	19	conj	_	_
22	,	_	.	,	_	19	punct	_	_
23	or	_	CONJ	CC	_	19	cc	_	_
24	P95	_	NOUN	NN	_	19	conj	_	_
25	,	_	.	,	_	13	punct	_	_
26	but	_	CONJ	CC	_	13	cc	_	_
27	delayed	_	VERB	VBD	_	13	conj	_	_
28	Tmax	_	NOUN	NN	_	27	dobj	_	_
29	by	_	ADP	IN	_	31	case	_	_
30	1	_	NUM	CD	_	31	nummod	_	_
31	hour	_	NOUN	NN	_	27	nmod	_	_
32	for	_	ADP	IN	_	33	case	_	_
33	DRUG	_	NOUN	NN	_	31	nmod	_	_
34	,	_	.	,	_	13	punct	_	_
35	2	_	NUM	CD	_	36	nummod	_	_
36	hours	_	NOUN	NNS	_	13	dobj	_	_
37	for	_	ADP	IN	_	38	case	_	_
38	P88	_	NOUN	NN	_	36	nmod	_	_
39	and	_	CONJ	CC	_	36	cc	_	_
40	6	_	NUM	CD	_	41	nummod	_	_
41	hours	_	NOUN	NNS	_	36	conj	_	_
42	for	_	ADP	IN	_	43	case	_	_
43	P95	_	NOUN	NN	_	41	nmod	_	_

#	Fanapt	4014
1	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
2	can	_	VERB	MD	_	4	aux	_	_
3	be	_	VERB	VB	_	4	auxpass	_	_
4	administered	_	VERB	VBN	_	0	root	_	_
5	without	_	ADP	IN	_	6	case	_	_
6	regard	_	NOUN	NN	_	4	nmod	_	_
7	to	_	PRT	TO	_	8	case	_	_
8	meals	_	NOUN	NNS	_	6	nmod	_	_

#	Fanapt	4015
1	Distribution	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	DRUG	_	NOUN	NN	_	4	nsubj	_	_
4	has	_	VERB	VBZ	_	1	dep	_	_
5	an	_	DET	DT	_	8	det	_	_
6	apparent	_	ADJ	JJ	_	8	amod	_	_
7	clearance	_	NOUN	NN	_	8	compound	_	_
8	clearance	_	NOUN	NN	_	4	dobj	_	_
9	/	_	.	:	_	4	punct	_	_
10	bioavailability	_	NOUN	NN	_	4	dep	_	_
11	of	_	ADP	IN	_	15	case	_	_
12	47	_	NUM	CD	_	14	compound	_	_
13	to	_	PRT	TO	_	14	dep	_	_
14	102	_	NUM	CD	_	15	nummod	_	_
15	L	_	NOUN	NN	_	10	nmod	_	_
16	/	_	.	:	_	10	punct	_	_
17	h	_	NOUN	NN	_	52	nsubj	_	_
18	,	_	.	,	_	17	punct	_	_
19	with	_	ADP	IN	_	22	case	_	_
20	an	_	DET	DT	_	22	det	_	_
21	apparent	_	ADJ	JJ	_	22	amod	_	_
22	volume	_	NOUN	NN	_	17	nmod	_	_
23	of	_	ADP	IN	_	24	case	_	_
24	distribution	_	NOUN	NN	_	22	nmod	_	_
25	of	_	ADP	IN	_	32	case	_	_
26	1340	_	NUM	CD	_	28	compound	_	_
27	to	_	PRT	TO	_	28	dep	_	_
28	2800	_	NUM	CD	_	32	nummod	_	_
29	L	_	NOUN	NN	_	32	compound	_	_
30	At	_	NOUN	NN	_	32	compound	_	_
31	therapeutic	_	ADJ	JJ	_	32	amod	_	_
32	concentrations	_	NOUN	NNS	_	24	nmod	_	_
33	,	_	.	,	_	17	punct	_	_
34	the	_	DET	DT	_	36	det	_	_
35	unbound	_	ADJ	JJ	_	36	amod	_	_
36	fraction	_	NOUN	NN	_	42	nsubj	_	_
37	of	_	ADP	IN	_	38	case	_	_
38	DRUG	_	NOUN	NN	_	36	nmod	_	_
39	in	_	ADP	IN	_	40	case	_	_
40	plasma	_	NOUN	NN	_	36	nmod	_	_
41	is	_	VERB	VBZ	_	42	cop	_	_
42	~3%	_	ADJ	JJ	_	17	acl:relcl	_	_
43	and	_	CONJ	CC	_	42	cc	_	_
44	of	_	ADP	IN	_	46	case	_	_
45	each	_	DET	DT	_	46	det	_	_
46	metabolite	_	NOUN	NN	_	42	conj	_	_
47	P88	_	NOUN	NN	_	46	dep	_	_
48	and	_	CONJ	CC	_	47	cc	_	_
49	P95	_	NOUN	NN	_	47	conj	_	_
50	it	_	PRON	PRP	_	52	nsubj	_	_
51	is	_	VERB	VBZ	_	52	auxpass	_	_
52	~8%	_	ADJ	JJ	_	10	dep	_	_

#	Fanapt	4016
1	Metabolism	_	NOUN	NN	_	0	root	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	Elimination	_	NOUN	NN	_	1	conj	_	_
4	:	_	.	:	_	1	punct	_	_
5	DRUG	_	NOUN	NN	_	7	nsubjpass	_	_
6	is	_	VERB	VBZ	_	7	auxpass	_	_
7	metabolized	_	VERB	VBN	_	1	dep	_	_
8	primarily	_	ADV	RB	_	7	advmod	_	_
9	by	_	ADP	IN	_	12	case	_	_
10	3	_	NUM	CD	_	12	nummod	_	_
11	biotransformation	_	NOUN	NN	_	12	compound	_	_
12	pathways	_	NOUN	NNS	_	7	nmod	_	_
13	:	_	.	:	_	7	punct	_	_
14	carbonyl	_	NOUN	NN	_	15	compound	_	_
15	reduction	_	NOUN	NN	_	7	parataxis	_	_
16	,	_	.	,	_	15	punct	_	_
17	hydroxylation	_	NOUN	NN	_	15	appos	_	_
18	mediated	_	VERB	VBN	_	17	acl	_	_
19	by	_	ADP	IN	_	20	case	_	_
20	CYP2D6	_	NOUN	NN	_	18	nmod	_	_
21	and	_	CONJ	CC	_	20	cc	_	_
22	O	_	NOUN	NN	_	23	compound	_	_
23	demethylation	_	NOUN	NN	_	20	conj	_	_
24	mediated	_	VERB	VBN	_	20	acl	_	_
25	by	_	ADP	IN	_	26	case	_	_
26	CYP3A4	_	NOUN	NN	_	24	nmod	_	_

#	Fanapt	4017
1	There	_	DET	EX	_	2	expl	_	_
2	are	_	VERB	VBP	_	0	root	_	_
3	2	_	NUM	CD	_	6	nummod	_	_
4	predominant	_	ADJ	JJ	_	6	amod	_	_
5	DRUG	_	NOUN	NN	_	6	compound	_	_
6	metabolites	_	NOUN	NNS	_	2	nsubj	_	_
7	,	_	.	,	_	6	punct	_	_
8	P95	_	NOUN	NN	_	6	appos	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	P88	_	NOUN	NN	_	8	conj	_	_

#	Fanapt	4018
1	The	_	DET	DT	_	4	det	_	_
2	DRUG	_	NOUN	NN	_	4	compound	_	_
3	metabolite	_	NOUN	NN	_	4	compound	_	_
4	P95	_	NOUN	NN	_	5	nsubj	_	_
5	represents	_	VERB	VBZ	_	0	root	_	_
6	47.9%	_	NOUN	NN	_	5	dobj	_	_
7	of	_	ADP	IN	_	9	case	_	_
8	the	_	DET	DT	_	9	det	_	_
9	AUC	_	NOUN	NN	_	6	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_
12	and	_	CONJ	CC	_	5	cc	_	_
13	its	_	PRON	PRP$	_	14	nmod:poss	_	_
14	metabolites	_	NOUN	NNS	_	5	conj	_	_
15	in	_	ADP	IN	_	16	case	_	_
16	plasma	_	NOUN	NN	_	14	nmod	_	_
17	at	_	ADP	IN	_	19	case	_	_
18	steady	_	ADJ	JJ	_	19	amod	_	_
19	state	_	NOUN	NN	_	14	nmod	_	_
20	for	_	ADP	IN	_	22	case	_	_
21	extensive	_	ADJ	JJ	_	22	amod	_	_
22	metabolizers	_	NOUN	NNS	_	19	nmod	_	_
23	EM	_	NOUN	NN	_	22	dep	_	_
24	and	_	CONJ	CC	_	23	cc	_	_
25	25%	_	NOUN	NN	_	23	conj	_	_
26	for	_	ADP	IN	_	28	case	_	_
27	poor	_	ADJ	JJ	_	28	amod	_	_
28	metabolizers	_	NOUN	NNS	_	22	nmod	_	_
29	PM	_	NOUN	NN	_	28	dep	_	_

#	Fanapt	4019
1	The	_	DET	DT	_	4	det	_	_
2	active	_	ADJ	JJ	_	4	amod	_	_
3	metabolite	_	NOUN	NN	_	4	compound	_	_
4	P88	_	NOUN	NN	_	5	nsubj	_	_
5	accounts	_	VERB	VBZ	_	0	root	_	_
6	for	_	ADP	IN	_	7	case	_	_
7	19.5%	_	ADJ	JJ	_	5	nmod	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	34.0%	_	NOUN	NN	_	7	conj	_	_
10	of	_	ADP	IN	_	13	case	_	_
11	total	_	ADJ	JJ	_	13	amod	_	_
12	plasma	_	NOUN	NN	_	13	compound	_	_
13	exposure	_	NOUN	NN	_	7	nmod	_	_
14	in	_	ADP	IN	_	15	case	_	_
15	EM	_	NOUN	NN	_	13	nmod	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	PM	_	NOUN	NN	_	15	conj	_	_
18	,	_	.	,	_	5	punct	_	_
19	respectively	_	ADV	RB	_	5	advmod	_	_

#	Fanapt	4020
1	Approximately	_	ADV	RB	_	3	advmod	_	_
2	7%	_	ADJ	JJ	_	3	amod	_	_
3	10%	_	NOUN	NN	_	14	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	Caucasians	_	NOUN	NNS	_	3	nmod	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	3%	_	ADJ	JJ	_	8	amod	_	_
8	8%	_	NOUN	NN	_	5	conj	_	_
9	of	_	ADP	IN	_	13	case	_	_
10	black	_	ADJ	JJ	_	13	amod	_	_
11	/	_	.	:	_	13	punct	_	_
12	African	_	NOUN	NN	_	13	compound	_	_
13	Americans	_	NOUN	NNS	_	5	nmod	_	_
14	lack	_	VERB	VBP	_	0	root	_	_
15	the	_	DET	DT	_	16	det	_	_
16	capacity	_	NOUN	NN	_	14	dobj	_	_
17	to	_	PRT	TO	_	18	mark	_	_
18	metabolize	_	VERB	VB	_	16	acl	_	_
19	CYP2D6	_	NOUN	NN	_	20	compound	_	_
20	substrates	_	NOUN	NNS	_	18	dobj	_	_
21	and	_	CONJ	CC	_	14	cc	_	_
22	are	_	VERB	VBP	_	23	auxpass	_	_
23	classified	_	VERB	VBN	_	14	conj	_	_
24	as	_	ADP	IN	_	27	case	_	_
25	poor	_	ADJ	JJ	_	27	amod	_	_
26	metabolizers	_	NOUN	NNS	_	27	compound	_	_
27	PM	_	NOUN	NN	_	23	nmod	_	_
28	,	_	.	,	_	14	punct	_	_
29	whereas	_	ADP	IN	_	33	mark	_	_
30	the	_	DET	DT	_	31	det	_	_
31	rest	_	NOUN	NN	_	33	nsubj	_	_
32	are	_	VERB	VBP	_	33	cop	_	_
33	intermediate	_	ADJ	JJ	_	14	advcl	_	_
34	,	_	.	,	_	14	punct	_	_
35	extensive	_	ADJ	JJ	_	14	dep	_	_
36	or	_	CONJ	CC	_	35	cc	_	_
37	ultrarapid	_	NOUN	NN	_	35	conj	_	_
38	metabolizers	_	NOUN	NNS	_	35	dep	_	_

#	Fanapt	4021
1	Co	_	PRT	TO	_	2	case	_	_
2	administration	_	NOUN	NN	_	13	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	with	_	ADP	IN	_	8	case	_	_
6	known	_	VERB	VBN	_	8	amod	_	_
7	strong	_	ADJ	JJ	_	8	amod	_	_
8	inhibitors	_	NOUN	NNS	_	2	nmod	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	CYP2D6	_	NOUN	NN	_	8	nmod	_	_
11	like	_	ADP	IN	_	12	case	_	_
12	fluoxetine	_	NOUN	NN	_	8	nmod	_	_
13	results	_	VERB	VBZ	_	33	advcl	_	_
14	in	_	ADP	IN	_	18	case	_	_
15	a	_	DET	DT	_	18	det	_	_
16	2.3	_	NUM	CD	_	17	compound	_	_
17	fold	_	NOUN	NN	_	18	amod	_	_
18	increase	_	NOUN	NN	_	13	nmod	_	_
19	in	_	ADP	IN	_	22	case	_	_
20	DRUG	_	NOUN	NN	_	22	compound	_	_
21	plasma	_	NOUN	NN	_	22	compound	_	_
22	exposure	_	NOUN	NN	_	18	nmod	_	_
23	,	_	.	,	_	33	punct	_	_
24	andtherefore	_	ADV	RB	_	25	advmod	_	_
25	one	_	NUM	CD	_	26	nummod	_	_
26	half	_	NOUN	NN	_	33	nsubjpass	_	_
27	of	_	ADP	IN	_	30	case	_	_
28	the	_	DET	DT	_	30	det	_	_
29	DRUG	_	NOUN	NN	_	30	compound	_	_
30	dose	_	NOUN	NN	_	26	nmod	_	_
31	should	_	VERB	MD	_	33	aux	_	_
32	be	_	VERB	VB	_	33	auxpass	_	_
33	administered	_	VERB	VBN	_	0	root	_	_

#	Fanapt	4022
1	Similarly	_	ADV	RB	_	6	advmod	_	_
2	,	_	.	,	_	6	punct	_	_
3	PMs	_	NOUN	NN	_	6	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	CYP2D6	_	NOUN	NN	_	3	nmod	_	_
6	have	_	VERB	VBP	_	0	root	_	_
7	higher	_	ADJ	JJ	_	8	amod	_	_
8	exposure	_	NOUN	NN	_	6	dobj	_	_
9	to	_	PRT	TO	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	compared	_	VERB	VBN	_	6	xcomp	_	_
12	with	_	ADP	IN	_	14	case	_	_
13	EMsand	_	NOUN	NN	_	14	compound	_	_
14	PMs	_	NOUN	NNS	_	11	nmod	_	_
15	should	_	VERB	MD	_	16	aux	_	_
16	have	_	VERB	VB	_	6	parataxis	_	_
17	their	_	PRON	PRP$	_	18	nmod:poss	_	_
18	dose	_	NOUN	NN	_	16	dobj	_	_
19	reduced	_	VERB	VBN	_	18	acl	_	_
20	by	_	ADP	IN	_	21	case	_	_
21	one	_	NUM	CD	_	19	nmod	_	_
22	half	_	ADV	RB	_	16	parataxis	_	_

#	Fanapt	4023
1	Laboratory	_	ADJ	JJ	_	2	amod	_	_
2	tests	_	NOUN	NNS	_	4	nsubj	_	_
3	are	_	VERB	VBP	_	4	cop	_	_
4	available	_	ADJ	JJ	_	0	root	_	_
5	to	_	PRT	TO	_	6	mark	_	_
6	identify	_	VERB	VB	_	4	xcomp	_	_
7	CYP2D6	_	NOUN	NN	_	8	compound	_	_
8	PMs	_	NOUN	NNS	_	6	dobj	_	_

#	Fanapt	4024
1	The	_	DET	DT	_	2	det	_	_
2	bulk	_	NOUN	NN	_	8	nsubjpass	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	the	_	DET	DT	_	6	det	_	_
5	radioactive	_	ADJ	JJ	_	6	amod	_	_
6	materials	_	NOUN	NNS	_	2	nmod	_	_
7	were	_	VERB	VBD	_	8	auxpass	_	_
8	recovered	_	VERB	VBN	_	0	root	_	_
9	in	_	ADP	IN	_	13	case	_	_
10	the	_	DET	DT	_	13	det	_	_
11	urine	_	ADJ	JJ	_	13	amod	_	_
12	mean	_	NOUN	NN	_	13	compound	_	_
13	58.2%	_	NOUN	NN	_	8	nmod	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	45.1%	_	NOUN	NN	_	13	conj	_	_
16	in	_	ADP	IN	_	17	case	_	_
17	EM	_	NOUN	NN	_	8	nmod	_	_
18	and	_	CONJ	CC	_	17	cc	_	_
19	PM	_	NOUN	NN	_	17	conj	_	_
20	,	_	.	,	_	8	punct	_	_
21	respectively	_	ADV	RB	_	8	advmod	_	_
22	,	_	.	,	_	8	punct	_	_
23	with	_	ADP	IN	_	24	case	_	_
24	feces	_	NOUN	NNS	_	8	nmod	_	_
25	accounting	_	VERB	VBG	_	24	acl	_	_
26	for	_	ADP	IN	_	28	case	_	_
27	19.9%	_	ADJ	JJ	_	28	amod	_	_
28	EM	_	NOUN	NN	_	25	nmod	_	_
29	to	_	PRT	TO	_	31	case	_	_
30	22.1%	_	ADJ	JJ	_	31	amod	_	_
31	PM	_	NOUN	NN	_	25	nmod	_	_
32	of	_	ADP	IN	_	35	case	_	_
33	the	_	DET	DT	_	35	det	_	_
34	dosed	_	ADJ	JJ	_	35	amod	_	_
35	radioactivity	_	NOUN	NN	_	31	nmod	_	_

#	Fanapt	4025
1	Transporter	_	NOUN	NN	_	2	compound	_	_
2	Interaction	_	NOUN	NN	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	DRUG	_	NOUN	NN	_	9	nsubj	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	P88	_	NOUN	NN	_	4	conj	_	_
7	are	_	VERB	VBP	_	9	cop	_	_
8	not	_	ADV	RB	_	9	neg	_	_
9	substrates	_	NOUN	NNS	_	20	nsubj	_	_
10	of	_	ADP	IN	_	12	case	_	_
11	P	_	NOUN	NN	_	12	compound	_	_
12	gp	_	NOUN	NN	_	9	nmod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	DRUG	_	NOUN	NN	_	12	conj	_	_
15	is	_	VERB	VBZ	_	20	cop	_	_
16	a	_	DET	DT	_	20	det	_	_
17	weak	_	ADJ	JJ	_	20	amod	_	_
18	P	_	NOUN	NN	_	20	compound	_	_
19	gp	_	NOUN	NN	_	20	compound	_	_
20	inhibitor	_	NOUN	NN	_	2	dep	_	_

#	Fetzima	5338
1	Other	_	ADJ	JJ	_	5	case	_	_
2	than	_	ADP	IN	_	1	mwe	_	_
3	CYP3A4	_	NOUN	NN	_	5	compound	_	_
4	drug	_	NOUN	NN	_	5	compound	_	_
5	interactions	_	NOUN	NNS	_	9	nmod	_	_
6	,	_	.	,	_	9	punct	_	_
7	DRUG	_	NOUN	NN	_	9	nsubjpass	_	_
8	is	_	VERB	VBZ	_	9	auxpass	_	_
9	predicted	_	VERB	VBN	_	0	root	_	_
10	,	_	.	,	_	9	punct	_	_
11	based	_	VERB	VBN	_	9	xcomp	_	_
12	on	_	ADP	IN	_	15	case	_	_
13	in	_	X	FW	_	15	amod	_	_
14	vitro	_	X	FW	_	13	dep	_	_
15	studies	_	NOUN	NNS	_	11	nmod	_	_
16	,	_	.	,	_	9	punct	_	_
17	to	_	PRT	TO	_	18	mark	_	_
18	have	_	VERB	VB	_	9	xcomp	_	_
19	a	_	DET	DT	_	21	det	_	_
20	low	_	ADJ	JJ	_	21	amod	_	_
21	potential	_	NOUN	NN	_	18	dobj	_	_
22	to	_	PRT	TO	_	24	mark	_	_
23	be	_	VERB	VB	_	24	auxpass	_	_
24	involved	_	VERB	VBN	_	18	xcomp	_	_
25	in	_	ADP	IN	_	30	case	_	_
26	clinically	_	ADV	RB	_	27	advmod	_	_
27	significant	_	ADJ	JJ	_	30	amod	_	_
28	pharmacokinetic	_	ADJ	JJ	_	30	amod	_	_
29	drug	_	NOUN	NN	_	30	compound	_	_
30	interactions	_	NOUN	NNS	_	24	nmod	_	_

#	Fetzima	5339
1	Strong	_	ADJ	JJ	_	3	amod	_	_
2	CYP3A4	_	NOUN	NN	_	3	compound	_	_
3	inhibitors	_	NOUN	NNS	_	0	root	_	_
4	such	_	ADJ	JJ	_	6	case	_	_
5	as	_	ADP	IN	_	4	mwe	_	_
6	ketoconazole	_	NOUN	NN	_	3	nmod	_	_
7	:	_	.	:	_	3	punct	_	_
8	Do	_	ADV	RB	_	10	advmod	_	_
9	not	_	ADV	RB	_	10	neg	_	_
10	exceed	_	VERB	VBN	_	3	dep	_	_
11	80	_	NUM	CD	_	12	nummod	_	_
12	mg	_	NOUN	NN	_	10	dobj	_	_
13	once	_	ADP	IN	_	15	case	_	_
14	daily	_	ADV	RB	_	15	advmod	_	_
15	7	_	NUM	CD	_	10	nmod	_	_

#	Fetzima	5340
1	Serotonin	_	NOUN	NN	_	2	compound	_	_
2	release	_	NOUN	NN	_	5	nsubj	_	_
3	by	_	ADP	IN	_	4	case	_	_
4	platelets	_	NOUN	NNS	_	2	nmod	_	_
5	plays	_	VERB	VBZ	_	0	root	_	_
6	an	_	DET	DT	_	8	det	_	_
7	important	_	ADJ	JJ	_	8	amod	_	_
8	role	_	NOUN	NN	_	5	dobj	_	_
9	in	_	ADP	IN	_	10	case	_	_
10	hemostasis	_	NOUN	NN	_	8	nmod	_	_

#	Fetzima	5341
1	Epidemiological	_	ADJ	JJ	_	2	amod	_	_
2	studies	_	NOUN	NNS	_	10	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	case	_	NOUN	NN	_	5	compound	_	_
5	control	_	NOUN	NN	_	2	nmod	_	_
6	and	_	CONJ	CC	_	2	cc	_	_
7	cohort	_	NOUN	NN	_	8	compound	_	_
8	design	_	NOUN	NN	_	2	conj	_	_
9	have	_	VERB	VBP	_	10	aux	_	_
10	demonstrated	_	VERB	VBN	_	0	root	_	_
11	an	_	DET	DT	_	12	det	_	_
12	association	_	NOUN	NN	_	10	dobj	_	_
13	between	_	ADP	IN	_	14	case	_	_
14	use	_	NOUN	NN	_	12	nmod	_	_
15	of	_	ADP	IN	_	17	case	_	_
16	psychotropic	_	ADJ	JJ	_	17	amod	_	_
17	drugs	_	NOUN	NNS	_	14	nmod	_	_
18	that	_	DET	WDT	_	19	nsubj	_	_
19	interfere	_	VERB	VBP	_	17	acl:relcl	_	_
20	with	_	ADP	IN	_	22	case	_	_
21	serotonin	_	NOUN	NN	_	22	compound	_	_
22	reuptake	_	NOUN	NN	_	19	nmod	_	_
23	and	_	CONJ	CC	_	19	cc	_	_
24	the	_	DET	DT	_	25	det	_	_
25	occurrence	_	NOUN	NN	_	19	conj	_	_
26	of	_	ADP	IN	_	27	mark	_	_
27	upper	_	VERB	VBG	_	25	acl	_	_
28	gastrointestinal	_	ADJ	JJ	_	29	amod	_	_
29	bleeding	_	NOUN	NN	_	27	dobj	_	_

#	Fetzima	5342
1	These	_	DET	DT	_	2	det	_	_
2	studies	_	NOUN	NNS	_	5	nsubj	_	_
3	have	_	VERB	VBP	_	5	aux	_	_
4	also	_	ADV	RB	_	5	advmod	_	_
5	shown	_	VERB	VBN	_	0	root	_	_
6	that	_	ADP	IN	_	15	mark	_	_
7	concurrent	_	ADJ	JJ	_	8	amod	_	_
8	use	_	NOUN	NN	_	15	nsubj	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	an	_	DET	DT	_	11	det	_	_
11	NSAID	_	NOUN	NN	_	8	nmod	_	_
12	or	_	CONJ	CC	_	11	cc	_	_
13	aspirin	_	NOUN	NN	_	11	conj	_	_
14	may	_	VERB	MD	_	15	aux	_	_
15	potentiate	_	VERB	VB	_	5	ccomp	_	_
16	this	_	DET	DT	_	17	det	_	_
17	risk	_	NOUN	NN	_	15	dobj	_	_
18	of	_	ADP	IN	_	19	mark	_	_
19	bleeding	_	VERB	VBG	_	17	nmod	_	_

#	Fetzima	5343
1	Altered	_	VERB	VBN	_	3	amod	_	_
2	anticoagulant	_	ADJ	JJ	_	3	amod	_	_
3	effects	_	NOUN	NNS	_	11	nsubjpass	_	_
4	,	_	.	,	_	3	punct	_	_
5	including	_	VERB	VBG	_	7	case	_	_
6	increased	_	VERB	VBN	_	7	amod	_	_
7	bleeding	_	NOUN	NN	_	3	nmod	_	_
8	,	_	.	,	_	3	punct	_	_
9	have	_	VERB	VBP	_	11	aux	_	_
10	been	_	VERB	VBN	_	11	auxpass	_	_
11	reported	_	VERB	VBN	_	0	root	_	_
12	when	_	ADV	WRB	_	18	advmod	_	_
13	SSRIs	_	NOUN	NNS	_	18	nsubjpass	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	SNRIs	_	NOUN	NNS	_	13	conj	_	_
16	are	_	VERB	VBP	_	18	auxpass	_	_
17	co	_	PRT	TO	_	18	mark	_	_
18	administered	_	VERB	VBN	_	11	advcl	_	_
19	with	_	ADP	IN	_	20	case	_	_
20	warfarin	_	NOUN	NN	_	18	nmod	_	_

#	Fetzima	5344
1	Patients	_	NOUN	NNS	_	8	nsubjpass	_	_
2	receiving	_	VERB	VBG	_	1	acl	_	_
3	warfarin	_	NOUN	NN	_	4	compound	_	_
4	therapy	_	NOUN	NN	_	2	dobj	_	_
5	should	_	VERB	MD	_	8	aux	_	_
6	be	_	VERB	VB	_	8	auxpass	_	_
7	carefully	_	ADV	RB	_	8	advmod	_	_
8	monitored	_	VERB	VBN	_	0	root	_	_
9	when	_	ADV	WRB	_	12	advmod	_	_
10	DRUG	_	NOUN	NN	_	12	nsubjpass	_	_
11	is	_	VERB	VBZ	_	12	auxpass	_	_
12	initiated	_	VERB	VBN	_	8	ccomp	_	_
13	or	_	CONJ	CC	_	12	cc	_	_
14	discontinued	_	VERB	VBN	_	12	conj	_	_

#	Fetzima	5345
1	Dose	_	NOUN	NN	_	2	compound	_	_
2	adjustment	_	NOUN	NN	_	4	nsubjpass	_	_
3	is	_	VERB	VBZ	_	4	auxpass	_	_
4	recommended	_	VERB	VBN	_	0	root	_	_
5	when	_	ADV	WRB	_	9	advmod	_	_
6	DRUG	_	NOUN	NN	_	9	nsubjpass	_	_
7	is	_	VERB	VBZ	_	9	auxpass	_	_
8	co	_	PRT	TO	_	9	mark	_	_
9	administered	_	VERB	VBN	_	4	advcl	_	_
10	with	_	ADP	IN	_	12	case	_	_
11	strong	_	ADJ	JJ	_	12	amod	_	_
12	inhibitors	_	NOUN	NNS	_	9	nmod	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	CYP3A4	_	NOUN	NN	_	12	nmod	_	_
15	e.g	_	CONJ	CC	_	16	compound	_	_
16	ketoconazole	_	NOUN	NN	_	14	dep	_	_

#	Fetzima	5346
1	An	_	DET	DT	_	4	det	_	_
2	in	_	ADJ	JJ	_	4	amod	_	_
3	vivo	_	X	FW	_	2	dep	_	_
4	study	_	NOUN	NN	_	5	nsubj	_	_
5	showed	_	VERB	VBD	_	0	root	_	_
6	a	_	DET	DT	_	9	det	_	_
7	clinically	_	ADV	RB	_	8	advmod	_	_
8	meaningful	_	ADJ	JJ	_	9	amod	_	_
9	increase	_	NOUN	NN	_	5	dobj	_	_
10	in	_	ADP	IN	_	12	case	_	_
11	DRUG	_	NOUN	NN	_	12	compound	_	_
12	exposure	_	NOUN	NN	_	9	nmod	_	_
13	when	_	ADV	WRB	_	17	advmod	_	_
14	DRUG	_	NOUN	NN	_	17	nsubjpass	_	_
15	was	_	VERB	VBD	_	17	auxpass	_	_
16	co	_	PRT	TO	_	17	dep	_	_
17	administered	_	VERB	VBN	_	5	advcl	_	_
18	with	_	ADP	IN	_	22	case	_	_
19	the	_	DET	DT	_	22	det	_	_
20	CYP3A4	_	NOUN	NN	_	22	compound	_	_
21	inhibitor	_	NOUN	NN	_	22	compound	_	_
22	ketoconazole	_	NOUN	NN	_	17	nmod	_	_

#	Fetzima	5347
1	No	_	DET	DT	_	3	neg	_	_
2	dose	_	NOUN	NN	_	3	compound	_	_
3	adjustment	_	NOUN	NN	_	7	nsubjpass	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	is	_	VERB	VBZ	_	7	auxpass	_	_
7	needed	_	VERB	VBN	_	0	root	_	_
8	when	_	ADV	WRB	_	7	advmod	_	_
9	co	_	PRT	TO	_	8	nmod	_	_
10	administered	_	VERB	VBN	_	9	root	_	_
11	with	_	ADP	IN	_	14	case	_	_
12	a	_	DET	DT	_	14	det	_	_
13	CYP3A4	_	NOUN	NN	_	14	compound	_	_
14	inducer	_	NOUN	NN	_	10	nmod	_	_
15	or	_	CONJ	CC	_	14	cc	_	_
16	substrate	_	NOUN	NN	_	14	conj	_	_

#	Fetzima	5348
1	In	_	X	FW	_	3	amod	_	_
2	vivo	_	X	FW	_	1	dep	_	_
3	studies	_	NOUN	NNS	_	4	nsubj	_	_
4	showed	_	VERB	VBD	_	0	root	_	_
5	no	_	DET	DT	_	8	neg	_	_
6	clinically	_	ADV	RB	_	7	advmod	_	_
7	meaningful	_	ADJ	JJ	_	8	amod	_	_
8	change	_	NOUN	NN	_	4	dobj	_	_
9	in	_	ADP	IN	_	11	case	_	_
10	DRUG	_	NOUN	NN	_	11	compound	_	_
11	exposure	_	NOUN	NN	_	8	nmod	_	_
12	when	_	ADV	WRB	_	4	advmod	_	_
13	co	_	PRT	TO	_	12	nmod	_	_
14	administered	_	VERB	VBN	_	13	dep	_	_
15	with	_	ADP	IN	_	19	case	_	_
16	the	_	DET	DT	_	19	det	_	_
17	CYP3A4	_	NOUN	NN	_	19	compound	_	_
18	inducer	_	NOUN	NN	_	19	compound	_	_
19	carbamazepine	_	NOUN	NN	_	14	nmod	_	_
20	or	_	CONJ	CC	_	19	cc	_	_
21	the	_	DET	DT	_	24	det	_	_
22	CYP3A4	_	NOUN	NN	_	24	compound	_	_
23	substrate	_	NOUN	NN	_	24	compound	_	_
24	alprazolam	_	NOUN	NN	_	19	conj	_	_

#	Fetzima	5349
1	No	_	DET	DT	_	3	neg	_	_
2	dose	_	NOUN	NN	_	3	compound	_	_
3	adjustment	_	NOUN	NN	_	7	nsubjpass	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	is	_	VERB	VBZ	_	7	auxpass	_	_
7	needed	_	VERB	VBN	_	0	root	_	_
8	when	_	ADV	WRB	_	10	advmod	_	_
9	co	_	PRT	TO	_	10	mark	_	_
10	administered	_	VERB	VBN	_	7	advcl	_	_
11	with	_	ADP	IN	_	12	case	_	_
12	inhibitors	_	NOUN	NNS	_	10	nmod	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	CYP2C8	_	NOUN	NN	_	12	nmod	_	_
15	,	_	.	,	_	14	punct	_	_
16	CYP2C19	_	NOUN	NN	_	14	conj	_	_
17	,	_	.	,	_	14	punct	_	_
18	CYP2D6	_	NOUN	NN	_	14	conj	_	_
19	,	_	.	,	_	14	punct	_	_
20	CYP2J2	_	NOUN	NN	_	14	conj	_	_
21	,	_	.	,	_	14	punct	_	_
22	P	_	NOUN	NN	_	23	compound	_	_
23	glycoprotein	_	NOUN	NN	_	14	conj	_	_
24	,	_	.	,	_	14	punct	_	_
25	BCRP	_	NOUN	NN	_	14	conj	_	_
26	,	_	.	,	_	14	punct	_	_
27	OATP1B1	_	NOUN	NN	_	14	conj	_	_
28	,	_	.	,	_	14	punct	_	_
29	OATP1B3	_	NOUN	NN	_	14	conj	_	_
30	,	_	.	,	_	14	punct	_	_
31	OAT1	_	NOUN	NN	_	14	conj	_	_
32	,	_	.	,	_	14	punct	_	_
33	OAT3	_	NOUN	NN	_	14	conj	_	_
34	,	_	.	,	_	14	punct	_	_
35	or	_	CONJ	CC	_	14	cc	_	_
36	OCT2	_	NOUN	NN	_	14	conj	_	_

#	Fetzima	5350
1	In	_	X	FW	_	3	amod	_	_
2	vitro	_	X	FW	_	1	dep	_	_
3	studies	_	NOUN	NNS	_	4	nsubj	_	_
4	suggested	_	VERB	VBD	_	0	root	_	_
5	that	_	ADP	IN	_	14	mark	_	_
6	CYP2C8	_	NOUN	NN	_	14	nsubj	_	_
7	,	_	.	,	_	6	punct	_	_
8	CYP2C19	_	NOUN	NN	_	6	conj	_	_
9	,	_	.	,	_	6	punct	_	_
10	CYP2D6	_	NOUN	NN	_	6	conj	_	_
11	,	_	.	,	_	6	punct	_	_
12	and	_	CONJ	CC	_	6	cc	_	_
13	CYP2J2	_	NOUN	NN	_	6	conj	_	_
14	had	_	VERB	VBD	_	4	ccomp	_	_
15	minimal	_	ADJ	JJ	_	16	amod	_	_
16	contributions	_	NOUN	NNS	_	14	dobj	_	_
17	to	_	PRT	TO	_	18	case	_	_
18	metabolism	_	NOUN	NN	_	14	nmod	_	_
19	of	_	ADP	IN	_	20	case	_	_
20	DRUG	_	NOUN	NN	_	18	nmod	_	_

#	Fetzima	5351
1	In	_	ADP	IN	_	2	case	_	_
2	addition	_	NOUN	NN	_	8	nmod	_	_
3	,	_	.	,	_	8	punct	_	_
4	DRUG	_	NOUN	NN	_	8	nsubj	_	_
5	is	_	VERB	VBZ	_	8	cop	_	_
6	not	_	ADV	RB	_	8	neg	_	_
7	a	_	DET	DT	_	8	det	_	_
8	substrate	_	NOUN	NN	_	0	root	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	BCRP	_	NOUN	NN	_	8	nmod	_	_
11	,	_	.	,	_	10	punct	_	_
12	OATP1B1	_	NOUN	NN	_	10	conj	_	_
13	,	_	.	,	_	10	punct	_	_
14	OATP1B3	_	NOUN	NN	_	10	conj	_	_
15	,	_	.	,	_	10	punct	_	_
16	OAT1	_	NOUN	NN	_	10	conj	_	_
17	,	_	.	,	_	10	punct	_	_
18	OAT3	_	NOUN	NN	_	10	conj	_	_
19	,	_	.	,	_	10	punct	_	_
20	or	_	CONJ	CC	_	10	cc	_	_
21	OCT2	_	NOUN	NN	_	10	conj	_	_
22	and	_	CONJ	CC	_	8	cc	_	_
23	is	_	VERB	VBZ	_	26	cop	_	_
24	a	_	DET	DT	_	26	det	_	_
25	weak	_	ADJ	JJ	_	26	amod	_	_
26	substrate	_	NOUN	NN	_	8	conj	_	_
27	of	_	ADP	IN	_	29	case	_	_
28	P	_	NOUN	NN	_	29	compound	_	_
29	gp	_	NOUN	NN	_	26	nmod	_	_

#	Fetzima	5352
1	Figure	_	NOUN	NN	_	4	compound	_	_
2	1	_	NUM	CD	_	4	nummod	_	_
3	PK	_	NOUN	NN	_	4	compound	_	_
4	Interactions	_	NOUN	NNS	_	21	nsubjpass	_	_
5	between	_	ADP	IN	_	7	case	_	_
6	DRUG	_	NOUN	NN	_	7	compound	_	_
7	LVM	_	NOUN	NN	_	4	nmod	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	Other	_	ADJ	JJ	_	15	amod	_	_
10	Drugs	_	NOUN	NNS	_	15	compound	_	_
11	Figure	_	NOUN	NN	_	15	compound	_	_
12	1	_	NUM	CD	_	15	nummod	_	_
13	No	_	NOUN	NN	_	15	compound	_	_
14	dose	_	NOUN	NN	_	15	compound	_	_
15	adjustment	_	NOUN	NN	_	7	conj	_	_
16	of	_	ADP	IN	_	19	case	_	_
17	the	_	DET	DT	_	19	det	_	_
18	concomitant	_	ADJ	JJ	_	19	amod	_	_
19	medication	_	NOUN	NN	_	7	nmod	_	_
20	is	_	VERB	VBZ	_	21	auxpass	_	_
21	recommended	_	VERB	VBN	_	0	root	_	_
22	when	_	ADV	WRB	_	25	advmod	_	_
23	DRUG	_	NOUN	NN	_	25	nsubjpass	_	_
24	is	_	VERB	VBZ	_	25	auxpass	_	_
25	administered	_	VERB	VBN	_	21	ccomp	_	_
26	with	_	ADP	IN	_	28	case	_	_
27	a	_	DET	DT	_	28	det	_	_
28	substrate	_	NOUN	NN	_	25	nmod	_	_
29	of	_	ADP	IN	_	30	case	_	_
30	CYP3A4	_	NOUN	NN	_	28	nmod	_	_
31	,	_	.	,	_	30	punct	_	_
32	CYP1A2	_	NOUN	NN	_	30	conj	_	_
33	,	_	.	,	_	30	punct	_	_
34	CYP2A6	_	NOUN	NN	_	30	conj	_	_
35	,	_	.	,	_	30	punct	_	_
36	CYP2C8	_	NOUN	NN	_	30	conj	_	_
37	,	_	.	,	_	30	punct	_	_
38	CYP2C9	_	NOUN	NN	_	30	conj	_	_
39	,	_	.	,	_	30	punct	_	_
40	CYP2C19	_	NOUN	NN	_	30	conj	_	_
41	,	_	.	,	_	30	punct	_	_
42	CYP2D6	_	NOUN	NN	_	30	conj	_	_
43	,	_	.	,	_	30	punct	_	_
44	CYP2E1	_	NOUN	NN	_	30	conj	_	_
45	,	_	.	,	_	30	punct	_	_
46	P	_	NOUN	NN	_	47	compound	_	_
47	gp	_	NOUN	NN	_	30	conj	_	_
48	,	_	.	,	_	30	punct	_	_
49	OATP1B1	_	NOUN	NN	_	30	conj	_	_
50	,	_	.	,	_	30	punct	_	_
51	OATP1B3	_	NOUN	NN	_	30	conj	_	_
52	,	_	.	,	_	30	punct	_	_
53	OAT1	_	NOUN	NN	_	30	conj	_	_
54	,	_	.	,	_	30	punct	_	_
55	OAT3	_	NOUN	NN	_	30	conj	_	_
56	,	_	.	,	_	30	punct	_	_
57	or	_	CONJ	CC	_	30	cc	_	_
58	OCT2	_	NOUN	NN	_	30	conj	_	_

#	Fetzima	5353
1	In	_	X	FW	_	3	amod	_	_
2	vitro	_	X	FW	_	1	dep	_	_
3	studies	_	NOUN	NNS	_	5	nsubj	_	_
4	have	_	VERB	VBP	_	5	aux	_	_
5	shown	_	VERB	VBN	_	0	root	_	_
6	that	_	ADP	IN	_	11	mark	_	_
7	DRUG	_	NOUN	NN	_	11	nsubj	_	_
8	is	_	VERB	VBZ	_	11	cop	_	_
9	not	_	ADV	RB	_	11	neg	_	_
10	an	_	DET	DT	_	11	det	_	_
11	inhibitor	_	NOUN	NN	_	5	ccomp	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	CYP1A2	_	NOUN	NN	_	11	nmod	_	_
14	,	_	.	,	_	13	punct	_	_
15	CYP2A6	_	NOUN	NN	_	13	conj	_	_
16	,	_	.	,	_	13	punct	_	_
17	CYP2C8	_	NOUN	NN	_	13	conj	_	_
18	,	_	.	,	_	13	punct	_	_
19	CYP2C9	_	NOUN	NN	_	13	conj	_	_
20	,	_	.	,	_	13	punct	_	_
21	CYP2C19	_	NOUN	NN	_	13	conj	_	_
22	,	_	.	,	_	13	punct	_	_
23	CYP2D6	_	NOUN	NN	_	13	conj	_	_
24	,	_	.	,	_	13	punct	_	_
25	CYP2E1	_	NOUN	NN	_	13	conj	_	_
26	,	_	.	,	_	13	punct	_	_
27	P	_	NOUN	NN	_	28	compound	_	_
28	gp	_	NOUN	NN	_	13	conj	_	_
29	,	_	.	,	_	13	punct	_	_
30	OATP1B1	_	NOUN	NN	_	13	conj	_	_
31	,	_	.	,	_	13	punct	_	_
32	OATP1B3	_	NOUN	NN	_	13	conj	_	_
33	,	_	.	,	_	13	punct	_	_
34	OAT1	_	NOUN	NN	_	13	conj	_	_
35	,	_	.	,	_	13	punct	_	_
36	OAT3	_	NOUN	NN	_	13	conj	_	_
37	,	_	.	,	_	13	punct	_	_
38	or	_	CONJ	CC	_	13	cc	_	_
39	OCT2	_	NOUN	NN	_	13	conj	_	_

#	Fetzima	5354
1	Concomitant	_	ADJ	JJ	_	2	amod	_	_
2	use	_	NOUN	NN	_	14	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	with	_	ADP	IN	_	6	case	_	_
6	alprazolam	_	NOUN	NN	_	2	nmod	_	_
7	or	_	CONJ	CC	_	6	cc	_	_
8	carbamazepine	_	NOUN	NN	_	6	conj	_	_
9	,	_	.	,	_	6	punct	_	_
10	substrates	_	NOUN	NNS	_	6	appos	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	CYP3A4	_	NOUN	NN	_	10	nmod	_	_
13	,	_	.	,	_	2	punct	_	_
14	had	_	VERB	VBD	_	0	root	_	_
15	no	_	DET	DT	_	17	neg	_	_
16	significant	_	ADJ	JJ	_	17	amod	_	_
17	effect	_	NOUN	NN	_	14	dobj	_	_
18	on	_	ADP	IN	_	23	case	_	_
19	alprazolam	_	NOUN	NN	_	23	compound	_	_
20	or	_	CONJ	CC	_	19	cc	_	_
21	carbamazepine	_	NOUN	NN	_	19	conj	_	_
22	plasma	_	NOUN	NN	_	23	compound	_	_
23	concentrations	_	NOUN	NNS	_	17	nmod	_	_

#	Fetzima	5355
1	The	_	DET	DT	_	2	det	_	_
2	risk	_	NOUN	NN	_	17	nsubjpass	_	_
3	of	_	ADP	IN	_	4	mark	_	_
4	using	_	VERB	VBG	_	2	acl	_	_
5	DRUG	_	NOUN	NN	_	4	dobj	_	_
6	in	_	ADP	IN	_	7	case	_	_
7	combination	_	NOUN	NN	_	4	nmod	_	_
8	with	_	ADP	IN	_	12	case	_	_
9	other	_	ADJ	JJ	_	12	amod	_	_
10	CNS	_	NOUN	NN	_	12	compound	_	_
11	active	_	ADJ	JJ	_	12	amod	_	_
12	drugs	_	NOUN	NNS	_	7	nmod	_	_
13	has	_	VERB	VBZ	_	17	aux	_	_
14	not	_	ADV	RB	_	17	neg	_	_
15	been	_	VERB	VBN	_	17	auxpass	_	_
16	systematically	_	ADV	RB	_	17	advmod	_	_
17	evaluated	_	VERB	VBN	_	0	root	_	_

#	Fetzima	5356
1	Consequently	_	ADV	RB	_	5	advmod	_	_
2	,	_	.	,	_	5	punct	_	_
3	caution	_	NOUN	NN	_	5	nsubjpass	_	_
4	is	_	VERB	VBZ	_	5	auxpass	_	_
5	advised	_	VERB	VBN	_	0	root	_	_
6	when	_	ADV	WRB	_	9	advmod	_	_
7	DRUG	_	NOUN	NN	_	9	nsubjpass	_	_
8	is	_	VERB	VBZ	_	9	auxpass	_	_
9	prescribed	_	VERB	VBN	_	5	ccomp	_	_
10	in	_	ADP	IN	_	11	case	_	_
11	combination	_	NOUN	NN	_	9	nmod	_	_
12	with	_	ADP	IN	_	16	case	_	_
13	other	_	ADJ	JJ	_	16	amod	_	_
14	CNS	_	NOUN	NN	_	16	compound	_	_
15	active	_	ADJ	JJ	_	16	amod	_	_
16	drugs	_	NOUN	NNS	_	11	nmod	_	_
17	,	_	.	,	_	9	punct	_	_
18	including	_	VERB	VBG	_	19	case	_	_
19	those	_	DET	DT	_	9	nmod	_	_
20	with	_	ADP	IN	_	23	case	_	_
21	a	_	DET	DT	_	23	det	_	_
22	similar	_	ADJ	JJ	_	23	amod	_	_
23	mechanism	_	NOUN	NN	_	19	nmod	_	_
24	of	_	ADP	IN	_	25	case	_	_
25	action	_	NOUN	NN	_	23	nmod	_	_

#	Fetzima	5357
1	Alcohol	_	NOUN	NN	_	0	root	_	_
2	In	_	ADP	IN	_	6	case	_	_
3	an	_	DET	DT	_	6	det	_	_
4	in	_	X	FW	_	6	amod	_	_
5	vitro	_	X	FW	_	4	dep	_	_
6	study	_	NOUN	NN	_	1	nmod	_	_
7	,	_	.	,	_	1	punct	_	_
8	alcohol	_	NOUN	NN	_	9	nsubj	_	_
9	interacted	_	VERB	VBD	_	1	dep	_	_
10	with	_	ADP	IN	_	14	case	_	_
11	the	_	DET	DT	_	14	det	_	_
12	extended	_	VERB	VBN	_	14	amod	_	_
13	release	_	NOUN	NN	_	14	compound	_	_
14	properties	_	NOUN	NNS	_	9	nmod	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	14	nmod	_	_

#	Fetzima	5358
1	If	_	ADP	IN	_	4	mark	_	_
2	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
3	is	_	VERB	VBZ	_	4	auxpass	_	_
4	taken	_	VERB	VBN	_	14	advcl	_	_
5	with	_	ADP	IN	_	6	case	_	_
6	alcohol	_	NOUN	NN	_	4	nmod	_	_
7	,	_	.	,	_	14	punct	_	_
8	a	_	DET	DT	_	12	det	_	_
9	pronounced	_	ADJ	JJ	_	12	amod	_	_
10	accelerated	_	ADJ	JJ	_	12	amod	_	_
11	drug	_	NOUN	NN	_	12	compound	_	_
12	release	_	NOUN	NN	_	14	nsubj	_	_
13	may	_	VERB	MD	_	14	aux	_	_
14	occur	_	VERB	VB	_	0	root	_	_

#	Fetzima	5359
1	It	_	PRON	PRP	_	3	nsubjpass	_	_
2	is	_	VERB	VBZ	_	3	auxpass	_	_
3	recommended	_	VERB	VBN	_	0	root	_	_
4	that	_	ADP	IN	_	6	mark	_	_
5	DRUG	_	NOUN	NN	_	6	nsubj	_	_
6	extended	_	VERB	VBD	_	3	ccomp	_	_
7	release	_	NOUN	NN	_	8	compound	_	_
8	capsules	_	NOUN	NNS	_	11	nsubjpass	_	_
9	not	_	ADV	RB	_	11	neg	_	_
10	be	_	VERB	VB	_	11	auxpass	_	_
11	taken	_	VERB	VBN	_	6	ccomp	_	_
12	with	_	ADP	IN	_	13	case	_	_
13	alcohol	_	NOUN	NN	_	11	nmod	_	_

#	Fetzima	5360
1	The	_	DET	DT	_	3	det	_	_
2	exact	_	ADJ	JJ	_	3	amod	_	_
3	mechanism	_	NOUN	NN	_	11	nsubj	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	the	_	DET	DT	_	7	det	_	_
6	antidepressant	_	ADJ	JJ	_	7	amod	_	_
7	action	_	NOUN	NN	_	3	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	is	_	VERB	VBZ	_	11	cop	_	_
11	unknown	_	ADJ	JJ	_	0	root	_	_
12	,	_	.	,	_	11	punct	_	_
13	but	_	CONJ	CC	_	11	cc	_	_
14	is	_	VERB	VBZ	_	15	auxpass	_	_
15	thought	_	VERB	VBN	_	11	conj	_	_
16	to	_	PRT	TO	_	18	mark	_	_
17	be	_	VERB	VB	_	18	cop	_	_
18	related	_	ADJ	JJ	_	15	xcomp	_	_
19	to	_	PRT	TO	_	21	case	_	_
20	the	_	DET	DT	_	21	det	_	_
21	potentiation	_	NOUN	NN	_	18	nmod	_	_
22	of	_	ADP	IN	_	23	case	_	_
23	serotonin	_	NOUN	NN	_	21	nmod	_	_
24	and	_	CONJ	CC	_	23	cc	_	_
25	norepinephrine	_	NOUN	NN	_	23	conj	_	_
26	in	_	ADP	IN	_	30	case	_	_
27	the	_	DET	DT	_	30	det	_	_
28	central	_	ADJ	JJ	_	30	amod	_	_
29	nervous	_	ADJ	JJ	_	30	amod	_	_
30	system	_	NOUN	NN	_	21	nmod	_	_
31	,	_	.	,	_	11	punct	_	_
32	through	_	ADP	IN	_	33	case	_	_
33	inhibition	_	NOUN	NN	_	11	nmod	_	_
34	of	_	ADP	IN	_	35	case	_	_
35	reuptake	_	NOUN	NN	_	33	nmod	_	_
36	at	_	ADP	IN	_	37	case	_	_
37	serotonin	_	NOUN	NN	_	33	nmod	_	_
38	and	_	CONJ	CC	_	37	cc	_	_
39	norepinephrine	_	NOUN	NN	_	37	conj	_	_
40	transporters	_	NOUN	NNS	_	37	dep	_	_

#	Fetzima	5361
1	Non	_	CONJ	CC	_	3	amod	_	_
2	clinical	_	ADJ	JJ	_	3	amod	_	_
3	studies	_	NOUN	NNS	_	5	nsubj	_	_
4	have	_	VERB	VBP	_	5	aux	_	_
5	shown	_	VERB	VBN	_	0	root	_	_
6	that	_	ADP	IN	_	13	mark	_	_
7	DRUG	_	NOUN	NN	_	13	nsubj	_	_
8	is	_	VERB	VBZ	_	13	cop	_	_
9	a	_	DET	DT	_	13	det	_	_
10	potent	_	ADJ	JJ	_	13	amod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	selective	_	ADJ	JJ	_	10	conj	_	_
13	serotonin	_	NOUN	NN	_	5	ccomp	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	norepinephrine	_	NOUN	NN	_	18	compound	_	_
16	reuptake	_	NOUN	NN	_	18	compound	_	_
17	inhibitor	_	NOUN	NN	_	18	compound	_	_
18	SNRI	_	NOUN	NN	_	13	conj	_	_

#	Fetzima	5362
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	binds	_	VERB	VBZ	_	0	root	_	_
3	with	_	ADP	IN	_	5	case	_	_
4	high	_	ADJ	JJ	_	5	amod	_	_
5	affinity	_	NOUN	NN	_	2	nmod	_	_
6	to	_	PRT	TO	_	11	case	_	_
7	the	_	DET	DT	_	11	det	_	_
8	human	_	ADJ	JJ	_	11	amod	_	_
9	serotonin	_	NOUN	NN	_	11	compound	_	_
10	5	_	NUM	CD	_	11	nummod	_	_
11	HT	_	NOUN	NN	_	5	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	norepinephrine	_	NOUN	NN	_	15	compound	_	_
14	NE	_	NOUN	NN	_	15	compound	_	_
15	transporters	_	NOUN	NNS	_	11	conj	_	_
16	Ki	_	NOUN	NN	_	17	nsubj	_	_
17	=	_	ADJ	JJ	_	11	amod	_	_
18	11	_	NUM	CD	_	21	nummod	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	91	_	NUM	CD	_	18	conj	_	_
21	nM	_	NOUN	NN	_	17	dobj	_	_
22	,	_	.	,	_	2	punct	_	_
23	respectively	_	ADV	RB	_	24	advmod	_	_
24	and	_	CONJ	CC	_	26	advmod	_	_
25	potently	_	ADV	RB	_	24	advmod	_	_
26	inhibits	_	VERB	VBZ	_	2	parataxis	_	_
27	5	_	NUM	CD	_	28	nummod	_	_
28	HT	_	NOUN	NN	_	26	dobj	_	_
29	and	_	CONJ	CC	_	28	cc	_	_
30	NE	_	NOUN	NN	_	32	compound	_	_
31	reuptake	_	NOUN	NN	_	32	compound	_	_
32	IC50	_	NOUN	NN	_	28	conj	_	_
33	=	_	ADJ	JJ	_	28	amod	_	_
34	16	_	NUM	CD	_	38	nummod	_	_
35	19	_	NUM	CD	_	38	nummod	_	_
36	and	_	CONJ	CC	_	35	cc	_	_
37	11	_	NUM	CD	_	35	conj	_	_
38	nM	_	NOUN	NN	_	33	dep	_	_
39	,	_	.	,	_	26	punct	_	_
40	respectively	_	ADV	RB	_	26	advmod	_	_

#	Fetzima	5363
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	lacks	_	VERB	VBZ	_	0	root	_	_
3	significant	_	ADJ	JJ	_	4	amod	_	_
4	affinity	_	NOUN	NN	_	2	dobj	_	_
5	for	_	ADP	IN	_	8	case	_	_
6	any	_	DET	DT	_	8	det	_	_
7	other	_	ADJ	JJ	_	8	amod	_	_
8	receptors	_	NOUN	NNS	_	4	nmod	_	_
9	,	_	.	,	_	8	punct	_	_
10	ion	_	NOUN	NN	_	11	compound	_	_
11	channels	_	NOUN	NNS	_	8	conj	_	_
12	or	_	CONJ	CC	_	8	cc	_	_
13	transporters	_	NOUN	NNS	_	8	conj	_	_
14	tested	_	VERB	VBN	_	13	acl	_	_
15	in	_	X	FW	_	16	compound	_	_
16	vitro	_	X	FW	_	14	advmod	_	_
17	,	_	.	,	_	8	punct	_	_
18	including	_	VERB	VBG	_	20	case	_	_
19	serotonergic	_	ADJ	JJ	_	20	amod	_	_
20	5HT1	_	NOUN	NN	_	8	nmod	_	_
21	7	_	NUM	CD	_	20	nummod	_	_
22	,	_	.	,	_	20	punct	_	_
23	A	_	NOUN	NN	_	20	conj	_	_
24	and	_	CONJ	CC	_	20	cc	_	_
25	B	_	NOUN	NN	_	26	compound	_	_
26	adrenergic	_	ADJ	JJ	_	20	conj	_	_
27	,	_	.	,	_	20	punct	_	_
28	muscarinic	_	ADJ	JJ	_	20	conj	_	_
29	,	_	.	,	_	20	punct	_	_
30	or	_	CONJ	CC	_	20	cc	_	_
31	histaminergic	_	ADJ	JJ	_	32	amod	_	_
32	receptors	_	NOUN	NNS	_	20	conj	_	_
33	and	_	CONJ	CC	_	32	cc	_	_
34	Ca2+	_	NOUN	NN	_	41	compound	_	_
35	,	_	.	,	_	34	punct	_	_
36	Na+	_	NOUN	NN	_	34	conj	_	_
37	,	_	.	,	_	34	punct	_	_
38	K+	_	NOUN	NN	_	34	conj	_	_
39	or	_	CONJ	CC	_	34	cc	_	_
40	Cl	_	NOUN	NN	_	34	conj	_	_
41	channels	_	NOUN	NNS	_	32	conj	_	_

#	Fetzima	5364
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	did	_	VERB	VBD	_	4	aux	_	_
3	not	_	ADV	RB	_	4	neg	_	_
4	inhibit	_	VERB	VB	_	0	root	_	_
5	monoamine	_	NOUN	NN	_	7	compound	_	_
6	oxidase	_	NOUN	NN	_	7	compound	_	_
7	MAO	_	NOUN	NN	_	4	dobj	_	_

#	Fetzima	5365
1	Cardiovascular	_	ADJ	JJ	_	3	amod	_	_
2	Electrophysiology	_	NOUN	NN	_	3	compound	_	_
3	At	_	NOUN	NN	_	0	root	_	_
4	a	_	DET	DT	_	7	det	_	_
5	dose	_	NOUN	NN	_	7	compound	_	_
6	2.5	_	NUM	CD	_	7	nummod	_	_
7	times	_	NOUN	NNS	_	3	dep	_	_
8	the	_	DET	DT	_	11	det	_	_
9	maximum	_	NOUN	NN	_	11	compound	_	_
10	recommended	_	VERB	VBN	_	11	amod	_	_
11	dose	_	NOUN	NN	_	7	dobj	_	_
12	,	_	.	,	_	3	punct	_	_
13	DRUG	_	NOUN	NN	_	16	nsubj	_	_
14	does	_	VERB	VBZ	_	16	aux	_	_
15	not	_	ADV	RB	_	16	neg	_	_
16	prolong	_	VERB	VB	_	3	dep	_	_
17	QTc	_	NOUN	NN	_	16	dobj	_	_
18	to	_	PRT	TO	_	22	case	_	_
19	any	_	DET	DT	_	22	det	_	_
20	clinically	_	ADV	RB	_	21	advmod	_	_
21	relevant	_	ADJ	JJ	_	22	amod	_	_
22	extent	_	NOUN	NN	_	16	nmod	_	_

#	Fetzima	5366
1	The	_	DET	DT	_	2	det	_	_
2	concentration	_	NOUN	NN	_	9	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	at	_	ADP	IN	_	7	case	_	_
6	steady	_	ADJ	JJ	_	7	amod	_	_
7	state	_	NOUN	NN	_	2	nmod	_	_
8	is	_	VERB	VBZ	_	9	cop	_	_
9	proportional	_	ADJ	JJ	_	0	root	_	_
10	to	_	PRT	TO	_	11	case	_	_
11	dose	_	NOUN	NN	_	9	nmod	_	_
12	when	_	ADV	WRB	_	13	advmod	_	_
13	administered	_	VERB	VBN	_	9	advcl	_	_
14	from	_	ADP	IN	_	18	case	_	_
15	25	_	NUM	CD	_	17	compound	_	_
16	to	_	PRT	TO	_	17	dep	_	_
17	300	_	NUM	CD	_	18	nummod	_	_
18	mg	_	NOUN	NN	_	13	nmod	_	_
19	once	_	ADV	RB	_	13	advmod	_	_
20	daily	_	ADV	RB	_	19	dep	_	_

#	Fetzima	5367
1	Following	_	ADP	IN	_	4	case	_	_
2	an	_	DET	DT	_	4	det	_	_
3	oral	_	ADJ	JJ	_	4	amod	_	_
4	administration	_	NOUN	NN	_	16	nmod	_	_
5	,	_	.	,	_	16	punct	_	_
6	the	_	DET	DT	_	10	det	_	_
7	mean	_	NOUN	NN	_	10	compound	_	_
8	apparent	_	ADJ	JJ	_	10	amod	_	_
9	total	_	ADJ	JJ	_	10	amod	_	_
10	clearance	_	NOUN	NN	_	16	nsubj	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_
13	is	_	VERB	VBZ	_	16	cop	_	_
14	21	_	NUM	CD	_	16	nummod	_	_
15	29	_	NUM	CD	_	16	nummod	_	_
16	L	_	NOUN	NN	_	0	root	_	_
17	/	_	.	:	_	16	punct	_	_
18	h	_	NOUN	NN	_	16	dep	_	_

#	Fetzima	5368
1	Steady	_	ADJ	JJ	_	3	amod	_	_
2	state	_	NOUN	NN	_	3	compound	_	_
3	concentrations	_	NOUN	NNS	_	7	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	are	_	VERB	VBP	_	7	cop	_	_
7	predictable	_	ADJ	JJ	_	0	root	_	_
8	from	_	ADP	IN	_	11	case	_	_
9	single	_	ADJ	JJ	_	11	amod	_	_
10	dose	_	NOUN	NN	_	11	compound	_	_
11	data	_	NOUN	NNS	_	7	nmod	_	_

#	Fetzima	5369
1	The	_	DET	DT	_	6	det	_	_
2	apparent	_	ADJ	JJ	_	6	amod	_	_
3	terminal	_	ADJ	JJ	_	6	amod	_	_
4	elimination	_	NOUN	NN	_	6	compound	_	_
5	half	_	NOUN	NN	_	6	compound	_	_
6	life	_	NOUN	NN	_	12	nsubj	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	is	_	VERB	VBZ	_	12	cop	_	_
10	approximately	_	ADV	RB	_	12	advmod	_	_
11	12	_	NUM	CD	_	12	nummod	_	_
12	hours	_	NOUN	NNS	_	0	root	_	_

#	Fetzima	5370
1	After	_	ADP	IN	_	3	case	_	_
2	daily	_	ADV	RB	_	3	advmod	_	_
3	dosing	_	NOUN	NN	_	15	nmod	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	DRUG	_	NOUN	NN	_	7	compound	_	_
6	120	_	NUM	CD	_	7	nummod	_	_
7	mg	_	NOUN	NN	_	3	nmod	_	_
8	,	_	.	,	_	15	punct	_	_
9	the	_	DET	DT	_	12	det	_	_
10	mean	_	NOUN	NN	_	12	compound	_	_
11	Cmax	_	NOUN	NN	_	12	compound	_	_
12	value	_	NOUN	NN	_	15	nsubj	_	_
13	is	_	VERB	VBZ	_	15	cop	_	_
14	341	_	NUM	CD	_	15	nummod	_	_
15	ng	_	NOUN	NN	_	0	root	_	_
16	/	_	.	:	_	15	punct	_	_
17	mL	_	NOUN	NN	_	15	dep	_	_
18	,	_	.	,	_	17	punct	_	_
19	and	_	CONJ	CC	_	17	cc	_	_
20	the	_	DET	DT	_	25	det	_	_
21	mean	_	ADJ	JJ	_	25	amod	_	_
22	steady	_	ADJ	JJ	_	25	amod	_	_
23	state	_	NOUN	NN	_	25	compound	_	_
24	AUC	_	NOUN	NN	_	25	compound	_	_
25	value	_	NOUN	NN	_	28	nsubj	_	_
26	is	_	VERB	VBZ	_	28	cop	_	_
27	5196	_	NUM	CD	_	28	nummod	_	_
28	ng*h	_	NOUN	NN	_	17	conj	_	_
29	/	_	.	:	_	28	punct	_	_
30	mL	_	NOUN	NN	_	28	dep	_	_

#	Fetzima	5371
1	Interconversion	_	NOUN	NN	_	9	nsubj	_	_
2	between	_	ADP	IN	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	and	_	CONJ	CC	_	1	cc	_	_
5	its	_	PRON	PRP$	_	6	nmod:poss	_	_
6	stereoisomer	_	NOUN	NN	_	1	conj	_	_
7	does	_	VERB	VBZ	_	9	aux	_	_
8	not	_	ADV	RB	_	9	neg	_	_
9	occur	_	VERB	VB	_	0	root	_	_
10	in	_	ADP	IN	_	11	case	_	_
11	humans	_	NOUN	NNS	_	9	nmod	_	_

#	Fetzima	5372
1	Absorption	_	NOUN	NN	_	13	nsubj	_	_
2	The	_	DET	DT	_	4	det	_	_
3	relative	_	ADJ	JJ	_	4	amod	_	_
4	bioavailability	_	NOUN	NN	_	1	dobj	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	after	_	ADP	IN	_	8	case	_	_
8	administration	_	NOUN	NN	_	4	nmod	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	DRUG	_	NOUN	NN	_	11	compound	_	_
11	ER	_	NOUN	NN	_	8	nmod	_	_
12	was	_	VERB	VBD	_	13	cop	_	_
13	92%	_	NOUN	NN	_	0	root	_	_
14	when	_	ADV	WRB	_	15	advmod	_	_
15	compared	_	VERB	VBN	_	13	advcl	_	_
16	to	_	PRT	TO	_	18	case	_	_
17	oral	_	ADJ	JJ	_	18	amod	_	_
18	solution	_	NOUN	NN	_	15	nmod	_	_

#	Fetzima	5373
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	concentration	_	NOUN	NN	_	6	nsubjpass	_	_
3	was	_	VERB	VBD	_	6	auxpass	_	_
4	not	_	ADV	RB	_	6	neg	_	_
5	significantly	_	ADV	RB	_	6	advmod	_	_
6	affected	_	VERB	VBN	_	0	root	_	_
7	when	_	ADV	WRB	_	10	advmod	_	_
8	DRUG	_	NOUN	NN	_	10	nsubjpass	_	_
9	was	_	VERB	VBD	_	10	auxpass	_	_
10	administered	_	VERB	VBN	_	6	advcl	_	_
11	with	_	ADP	IN	_	12	case	_	_
12	food	_	NOUN	NN	_	10	nmod	_	_

#	Fetzima	5374
1	The	_	DET	DT	_	3	det	_	_
2	median	_	ADJ	JJ	_	3	amod	_	_
3	time	_	NOUN	NN	_	13	nsubj	_	_
4	to	_	PRT	TO	_	5	mark	_	_
5	peak	_	VERB	VB	_	3	acl	_	_
6	concentration	_	NOUN	NN	_	7	compound	_	_
7	Tmax	_	NOUN	NN	_	5	dobj	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	is	_	VERB	VBZ	_	13	cop	_	_
11	6	_	NUM	CD	_	13	nummod	_	_
12	8	_	NUM	CD	_	13	nummod	_	_
13	hours	_	NOUN	NNS	_	0	root	_	_
14	after	_	ADP	IN	_	16	case	_	_
15	oral	_	ADJ	JJ	_	16	amod	_	_
16	administration	_	NOUN	NN	_	13	nmod	_	_

#	Fetzima	5375
1	Distribution	_	NOUN	NN	_	2	compound	_	_
2	DRUG	_	NOUN	NN	_	5	nsubjpass	_	_
3	is	_	VERB	VBZ	_	5	auxpass	_	_
4	widely	_	ADV	RB	_	5	advmod	_	_
5	distributed	_	VERB	VBN	_	0	root	_	_
6	with	_	ADP	IN	_	9	case	_	_
7	an	_	DET	DT	_	9	det	_	_
8	apparent	_	ADJ	JJ	_	9	amod	_	_
9	volume	_	NOUN	NN	_	5	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	distribution	_	NOUN	NN	_	9	nmod	_	_
12	of	_	ADP	IN	_	18	case	_	_
13	387	_	NUM	CD	_	18	nummod	_	_
14	473	_	NUM	CD	_	18	nummod	_	_
15	L	_	NOUN	NN	_	18	compound	_	_
16	plasma	_	NOUN	NN	_	18	compound	_	_
17	protein	_	NOUN	NN	_	18	compound	_	_
18	binding	_	NOUN	NN	_	11	nmod	_	_
19	is	_	VERB	VBZ	_	20	cop	_	_
20	22%	_	ADJ	JJ	_	5	parataxis	_	_
21	over	_	ADP	IN	_	23	case	_	_
22	concentration	_	NOUN	NN	_	23	compound	_	_
23	range	_	NOUN	NN	_	20	nmod	_	_
24	of	_	ADP	IN	_	28	case	_	_
25	10	_	NUM	CD	_	27	compound	_	_
26	to	_	PRT	TO	_	27	dep	_	_
27	1000	_	NUM	CD	_	28	nummod	_	_
28	ng	_	NOUN	NN	_	23	nmod	_	_
29	/	_	.	:	_	28	punct	_	_
30	mL	_	NOUN	NN	_	28	dep	_	_

#	Fetzima	5376
1	Metabolism	_	NOUN	NN	_	2	compound	_	_
2	DRUG	_	NOUN	NN	_	3	nsubj	_	_
3	undergoes	_	VERB	VBZ	_	0	root	_	_
4	desethylation	_	NOUN	NN	_	3	dobj	_	_
5	to	_	PRT	TO	_	6	mark	_	_
6	form	_	VERB	VB	_	4	acl	_	_
7	desethyl	_	NOUN	NN	_	8	compound	_	_
8	DRUG	_	NOUN	NN	_	6	dobj	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	hydroxylation	_	NOUN	NN	_	8	conj	_	_
11	to	_	PRT	TO	_	12	mark	_	_
12	form	_	VERB	VB	_	6	xcomp	_	_
13	p	_	NOUN	NN	_	15	compound	_	_
14	hydroxy	_	NOUN	NN	_	15	compound	_	_
15	DRUG	_	NOUN	NN	_	12	dobj	_	_

#	Fetzima	5377
1	Both	_	CONJ	CC	_	3	det	_	_
2	oxidative	_	ADJ	JJ	_	3	amod	_	_
3	metabolites	_	NOUN	NNS	_	4	nsubj	_	_
4	undergo	_	VERB	VBP	_	0	root	_	_
5	further	_	ADJ	JJ	_	6	amod	_	_
6	conjugation	_	NOUN	NN	_	4	dobj	_	_
7	with	_	ADP	IN	_	8	case	_	_
8	glucuronide	_	NOUN	NN	_	6	nmod	_	_
9	to	_	PRT	TO	_	10	case	_	_
10	form	_	NOUN	NN	_	6	nmod	_	_
11	conjugates	_	VERB	VBZ	_	4	parataxis	_	_

#	Fetzima	5378
1	The	_	DET	DT	_	2	det	_	_
2	desethylation	_	NOUN	NN	_	4	nsubjpass	_	_
3	is	_	VERB	VBZ	_	4	auxpass	_	_
4	catalyzed	_	VERB	VBN	_	0	root	_	_
5	primarily	_	ADV	RB	_	4	advmod	_	_
6	by	_	ADP	IN	_	7	case	_	_
7	CYP3A4	_	NOUN	NN	_	4	nmod	_	_
8	with	_	ADP	IN	_	10	case	_	_
9	minor	_	ADJ	JJ	_	10	amod	_	_
10	contribution	_	NOUN	NN	_	4	nmod	_	_
11	by	_	ADP	IN	_	12	case	_	_
12	CYP2C8	_	NOUN	NN	_	10	nmod	_	_
13	,	_	.	,	_	12	punct	_	_
14	2C19	_	NOUN	NN	_	12	conj	_	_
15	,	_	.	,	_	12	punct	_	_
16	2D6	_	NOUN	NN	_	12	conj	_	_
17	,	_	.	,	_	12	punct	_	_
18	and	_	CONJ	CC	_	12	cc	_	_
19	2J2	_	NOUN	NN	_	12	conj	_	_

#	Fetzima	5379
1	Elimination	_	NOUN	NN	_	0	root	_	_
2	/	_	.	:	_	1	punct	_	_
3	Excretion	_	NOUN	NN	_	4	compound	_	_
4	DRUG	_	NOUN	NN	_	9	nsubjpass	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	its	_	PRON	PRP$	_	7	nmod:poss	_	_
7	metabolites	_	NOUN	NNS	_	4	conj	_	_
8	are	_	VERB	VBP	_	9	auxpass	_	_
9	eliminated	_	VERB	VBN	_	1	dep	_	_
10	primarily	_	ADV	RB	_	9	advmod	_	_
11	by	_	ADP	IN	_	13	case	_	_
12	renal	_	ADJ	JJ	_	13	amod	_	_
13	excretion	_	NOUN	NN	_	9	nmod	_	_

#	Fetzima	5380
1	Following	_	VERB	VBG	_	3	case	_	_
2	oral	_	ADJ	JJ	_	3	amod	_	_
3	administration	_	NOUN	NN	_	15	nmod	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	14C	_	NOUN	NN	_	7	compound	_	_
6	DRUG	_	NOUN	NN	_	7	compound	_	_
7	solution	_	NOUN	NN	_	3	nmod	_	_
8	,	_	.	,	_	15	punct	_	_
9	approximately	_	ADV	RB	_	10	advmod	_	_
10	58%	_	NOUN	NN	_	15	nsubjpass	_	_
11	of	_	ADP	IN	_	13	case	_	_
12	the	_	DET	DT	_	13	det	_	_
13	dose	_	NOUN	NN	_	10	nmod	_	_
14	is	_	VERB	VBZ	_	15	auxpass	_	_
15	excreted	_	VERB	VBN	_	0	root	_	_
16	in	_	ADP	IN	_	17	case	_	_
17	urine	_	ADJ	JJ	_	15	nmod	_	_
18	as	_	ADP	IN	_	20	case	_	_
19	unchanged	_	ADJ	JJ	_	20	amod	_	_
20	DRUG	_	NOUN	NN	_	17	nmod	_	_

#	Fetzima	5381
1	N	_	NOUN	NN	_	3	compound	_	_
2	desethyl	_	NOUN	NN	_	3	compound	_	_
3	DRUG	_	NOUN	NN	_	7	nsubj	_	_
4	is	_	VERB	VBZ	_	7	cop	_	_
5	the	_	DET	DT	_	7	det	_	_
6	major	_	ADJ	JJ	_	7	amod	_	_
7	metabolite	_	NOUN	NN	_	0	root	_	_
8	excreted	_	VERB	VBN	_	7	acl	_	_
9	in	_	ADP	IN	_	11	case	_	_
10	the	_	DET	DT	_	11	det	_	_
11	urine	_	ADJ	JJ	_	8	nmod	_	_
12	and	_	CONJ	CC	_	7	cc	_	_
13	accounted	_	VERB	VBN	_	7	conj	_	_
14	for	_	ADP	IN	_	16	case	_	_
15	approximately	_	ADV	RB	_	16	advmod	_	_
16	18%	_	NOUN	NN	_	13	nmod	_	_
17	of	_	ADP	IN	_	19	case	_	_
18	the	_	DET	DT	_	19	det	_	_
19	dose	_	NOUN	NN	_	16	nmod	_	_

#	Fetzima	5382
1	Other	_	ADJ	JJ	_	3	amod	_	_
2	identifiable	_	ADJ	JJ	_	3	amod	_	_
3	metabolites	_	NOUN	NNS	_	11	nsubj	_	_
4	excreted	_	VERB	VBN	_	3	acl	_	_
5	in	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	urine	_	NOUN	NN	_	4	nmod	_	_
8	are	_	VERB	VBP	_	11	cop	_	_
9	DRUG	_	NOUN	NN	_	11	compound	_	_
10	glucuronide	_	NOUN	NN	_	11	compound	_	_
11	4%	_	NOUN	NN	_	0	root	_	_
12	,	_	.	,	_	11	punct	_	_
13	desethyl	_	NOUN	NN	_	16	compound	_	_
14	DRUG	_	NOUN	NN	_	16	compound	_	_
15	glucuronide	_	NOUN	NN	_	16	compound	_	_
16	3%	_	NOUN	NN	_	11	conj	_	_
17	,	_	.	,	_	11	punct	_	_
18	p	_	NOUN	NN	_	22	compound	_	_
19	hydroxy	_	NOUN	NN	_	22	compound	_	_
20	DRUG	_	NOUN	NN	_	22	compound	_	_
21	glucuronide	_	NOUN	NN	_	22	compound	_	_
22	1%	_	NOUN	NN	_	11	conj	_	_
23	,	_	.	,	_	11	punct	_	_
24	and	_	CONJ	CC	_	11	cc	_	_
25	p	_	NOUN	NN	_	28	compound	_	_
26	hydroxy	_	NOUN	NN	_	28	compound	_	_
27	DRUG	_	NOUN	NN	_	28	compound	_	_
28	1%	_	ADJ	JJ	_	11	conj	_	_

#	Fetzima	5383
1	The	_	DET	DT	_	2	det	_	_
2	metabolites	_	NOUN	NNS	_	4	nsubj	_	_
3	are	_	VERB	VBP	_	4	auxpass	_	_
4	inactive	_	ADJ	JJ	_	0	root	_	_

#	Fluphenazine	5721
1	The	_	DET	DT	_	3	det	_	_
2	basic	_	ADJ	JJ	_	3	amod	_	_
3	effects	_	NOUN	NNS	_	7	nsubj	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	DRUG	_	NOUN	NN	_	6	compound	_	_
6	decanoate	_	NOUN	NN	_	3	nmod	_	_
7	appear	_	VERB	VBZ	_	0	root	_	_
8	to	_	PRT	TO	_	11	mark	_	_
9	be	_	VERB	VB	_	11	cop	_	_
10	no	_	ADV	RB	_	11	neg	_	_
11	different	_	ADJ	JJ	_	7	xcomp	_	_
12	from	_	ADP	IN	_	13	case	_	_
13	those	_	DET	DT	_	11	nmod	_	_
14	of	_	ADP	IN	_	16	case	_	_
15	DRUG	_	NOUN	NN	_	16	compound	_	_
16	hydrochloride	_	NOUN	NN	_	13	nmod	_	_
17	,	_	.	,	_	7	punct	_	_
18	with	_	ADP	IN	_	20	case	_	_
19	the	_	DET	DT	_	20	det	_	_
20	exception	_	NOUN	NN	_	7	nmod	_	_
21	of	_	ADP	IN	_	22	case	_	_
22	duration	_	NOUN	NN	_	20	nmod	_	_
23	of	_	ADP	IN	_	24	case	_	_
24	action	_	NOUN	NN	_	22	nmod	_	_

#	Fluphenazine	5722
1	The	_	DET	DT	_	2	det	_	_
2	esterification	_	NOUN	NN	_	6	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	markedly	_	ADV	RB	_	6	advmod	_	_
6	prolongs	_	VERB	VBZ	_	0	root	_	_
7	the	_	DET	DT	_	9	det	_	_
8	drug's	_	NOUN	NNS	_	9	amod	_	_
9	duration	_	NOUN	NN	_	6	dobj	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	effect	_	NOUN	NN	_	9	nmod	_	_
12	without	_	ADP	IN	_	13	case	_	_
13	unduly	_	NOUN	NN	_	9	nmod	_	_
14	attenuating	_	VERB	VBG	_	13	acl	_	_
15	its	_	PRON	PRP$	_	17	nmod:poss	_	_
16	beneficial	_	ADJ	JJ	_	17	amod	_	_
17	action	_	NOUN	NN	_	14	dobj	_	_

#	Fluphenazine	5723
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	decanoate	_	NOUN	NN	_	3	nsubj	_	_
3	has	_	VERB	VBZ	_	0	root	_	_
4	activity	_	NOUN	NN	_	3	dobj	_	_
5	at	_	ADP	IN	_	7	case	_	_
6	all	_	DET	DT	_	7	det	_	_
7	levels	_	NOUN	NNS	_	4	nmod	_	_
8	of	_	ADP	IN	_	13	case	_	_
9	the	_	DET	DT	_	13	det	_	_
10	central	_	ADJ	JJ	_	13	amod	_	_
11	nervous	_	ADJ	JJ	_	13	amod	_	_
12	system	_	NOUN	NN	_	13	compound	_	_
13	CNS	_	NOUN	NN	_	7	nmod	_	_
14	as	_	ADV	RB	_	13	cc	_	_
15	well	_	ADV	RB	_	14	mwe	_	_
16	as	_	ADP	IN	_	14	mwe	_	_
17	on	_	ADP	IN	_	20	case	_	_
18	multiple	_	ADJ	JJ	_	20	amod	_	_
19	organ	_	NOUN	NN	_	20	compound	_	_
20	systems	_	NOUN	NNS	_	13	conj	_	_

#	Fluphenazine	5724
1	The	_	DET	DT	_	2	det	_	_
2	mechanism	_	NOUN	NN	_	10	nsubj	_	_
3	whereby	_	ADV	WRB	_	8	advmod	_	_
4	its	_	PRON	PRP$	_	6	nmod:poss	_	_
5	therapeutic	_	ADJ	JJ	_	6	amod	_	_
6	action	_	NOUN	NN	_	8	nsubjpass	_	_
7	is	_	VERB	VBZ	_	8	auxpass	_	_
8	exerted	_	VERB	VBN	_	2	acl:relcl	_	_
9	is	_	VERB	VBZ	_	10	auxpass	_	_
10	unknown	_	ADJ	JJ	_	0	root	_	_

#	Fluphenazine	5725
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	differs	_	VERB	VBZ	_	0	root	_	_
3	from	_	ADP	IN	_	6	case	_	_
4	other	_	ADJ	JJ	_	6	amod	_	_
5	phenothiazine	_	NOUN	NN	_	6	compound	_	_
6	derivatives	_	NOUN	NNS	_	2	nmod	_	_
7	in	_	ADP	IN	_	9	case	_	_
8	several	_	ADJ	JJ	_	9	amod	_	_
9	respects	_	NOUN	NNS	_	6	nmod	_	_
10	:	_	.	:	_	2	punct	_	_
11	it	_	PRON	PRP	_	14	nsubj	_	_
12	is	_	VERB	VBZ	_	14	cop	_	_
13	more	_	ADV	RB	_	14	advmod	_	_
14	potent	_	ADJ	JJ	_	21	advcl	_	_
15	on	_	ADP	IN	_	18	case	_	_
16	a	_	DET	DT	_	18	det	_	_
17	milligram	_	ADJ	JJ	_	18	amod	_	_
18	basis	_	NOUN	NN	_	14	nmod	_	_
19	,	_	.	,	_	21	punct	_	_
20	it	_	PRON	PRP	_	21	nsubj	_	_
21	has	_	VERB	VBZ	_	2	parataxis	_	_
22	less	_	ADV	RB	_	23	advmod	_	_
23	potentiating	_	VERB	VBG	_	21	xcomp	_	_
24	effect	_	NOUN	NN	_	23	dobj	_	_
25	on	_	ADP	IN	_	27	case	_	_
26	CNS	_	NOUN	NN	_	27	compound	_	_
27	depressants	_	NOUN	NNS	_	23	nmod	_	_
28	and	_	CONJ	CC	_	27	cc	_	_
29	anesthetics	_	NOUN	NNS	_	27	conj	_	_
30	than	_	ADP	IN	_	31	mark	_	_
31	do	_	VERB	VB	_	23	advcl	_	_
32	some	_	DET	DT	_	31	dobj	_	_
33	of	_	ADP	IN	_	35	case	_	_
34	the	_	DET	DT	_	35	det	_	_
35	phenothiazines	_	NOUN	NNS	_	32	nmod	_	_
36	and	_	CONJ	CC	_	21	cc	_	_
37	appears	_	VERB	VBZ	_	21	conj	_	_
38	to	_	PRT	TO	_	41	mark	_	_
39	be	_	VERB	VB	_	41	cop	_	_
40	less	_	ADV	RB	_	41	advmod	_	_
41	sedating	_	NOUN	NN	_	37	xcomp	_	_
42	,	_	.	,	_	21	punct	_	_
43	and	_	CONJ	CC	_	21	cc	_	_
44	it	_	PRON	PRP	_	47	nsubj	_	_
45	is	_	VERB	VBZ	_	47	cop	_	_
46	less	_	ADV	RB	_	47	advmod	_	_
47	likely	_	ADV	RB	_	21	conj	_	_
48	than	_	ADP	IN	_	49	case	_	_
49	some	_	DET	DT	_	47	nmod	_	_
50	of	_	ADP	IN	_	53	case	_	_
51	the	_	DET	DT	_	53	det	_	_
52	older	_	ADJ	JJ	_	53	amod	_	_
53	phenothiazines	_	NOUN	NNS	_	49	nmod	_	_
54	to	_	PRT	TO	_	55	mark	_	_
55	produce	_	VERB	VB	_	49	acl	_	_
56	hypotension	_	NOUN	NN	_	55	dobj	_	_
57	nevertheless	_	ADV	RB	_	55	advmod	_	_
58	,	_	.	,	_	21	punct	_	_
59	appropriate	_	ADJ	JJ	_	60	amod	_	_
60	cautions	_	NOUN	NNS	_	63	nsubjpass	_	_
61	should	_	VERB	MD	_	63	aux	_	_
62	be	_	VERB	VB	_	63	auxpass	_	_
63	observed	_	VERB	VBN	_	21	parataxis	_	_
64	,	_	.	,	_	63	punct	_	_
65	see	_	VERB	VBP	_	63	xcomp	_	_
66	PRECAUTIONS	_	NOUN	NN	_	65	dobj	_	_
67	and	_	CONJ	CC	_	66	cc	_	_
68	ADVERSE	_	NOUN	NN	_	69	compound	_	_
69	REACTIONS	_	NOUN	NN	_	66	conj	_	_

#	Flurazepam Hydrochloride	3039
1	Benzodiazepines	_	NOUN	NNS	_	6	nsubj	_	_
2	,	_	.	,	_	1	punct	_	_
3	including	_	VERB	VBG	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	1	nmod	_	_
5	,	_	.	,	_	1	punct	_	_
6	produce	_	VERB	VBP	_	0	root	_	_
7	additive	_	ADJ	JJ	_	10	amod	_	_
8	CNS	_	NOUN	NN	_	10	compound	_	_
9	depressant	_	ADJ	JJ	_	10	amod	_	_
10	effects	_	NOUN	NNS	_	6	dobj	_	_
11	when	_	ADV	WRB	_	6	advmod	_	_
12	co	_	PRT	TO	_	11	nmod	_	_
13	administered	_	VERB	VBN	_	12	dep	_	_
14	with	_	ADP	IN	_	15	case	_	_
15	ethanol	_	NOUN	NN	_	13	nmod	_	_
16	or	_	CONJ	CC	_	15	cc	_	_
17	other	_	ADJ	JJ	_	19	amod	_	_
18	CNS	_	NOUN	NN	_	19	compound	_	_
19	depressants	_	NOUN	NNS	_	15	conj	_	_
20	e.g	_	NOUN	NN	_	19	dep	_	_
21	,	_	.	,	_	15	punct	_	_
22	psychotropic	_	ADJ	JJ	_	23	amod	_	_
23	medications	_	NOUN	NNS	_	15	conj	_	_
24	,	_	.	,	_	15	punct	_	_
25	anticonvulsants	_	NOUN	NNS	_	15	conj	_	_
26	,	_	.	,	_	15	punct	_	_
27	antihistamines	_	NOUN	NNS	_	15	appos	_	_

#	Flurazepam Hydrochloride	3040
1	Downward	_	ADP	IN	_	3	case	_	_
2	dose	_	NOUN	NN	_	3	compound	_	_
3	adjustment	_	NOUN	NN	_	14	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	/	_	NUM	CD	_	5	conj	_	_
8	or	_	CONJ	CC	_	5	cc	_	_
9	concomitant	_	ADJ	JJ	_	11	amod	_	_
10	CNS	_	NOUN	NN	_	11	compound	_	_
11	depressants	_	NOUN	NNS	_	5	conj	_	_
12	may	_	VERB	MD	_	14	aux	_	_
13	be	_	VERB	VB	_	14	cop	_	_
14	necessary	_	ADJ	JJ	_	0	root	_	_
15	because	_	ADP	IN	_	18	case	_	_
16	of	_	ADP	IN	_	18	case	_	_
17	additive	_	ADJ	JJ	_	18	amod	_	_
18	effects	_	NOUN	NNS	_	14	nmod	_	_

#	Flurazepam Hydrochloride	3041
1	CNS	_	NOUN	NN	_	2	compound	_	_
2	Depressants	_	NOUN	NNS	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	Downward	_	NOUN	NN	_	6	compound	_	_
5	dose	_	NOUN	NN	_	6	compound	_	_
6	adjustment	_	NOUN	NN	_	9	nsubj	_	_
7	may	_	VERB	MD	_	9	aux	_	_
8	be	_	VERB	VB	_	9	cop	_	_
9	necessary	_	ADJ	JJ	_	2	dep	_	_
10	due	_	ADJ	JJ	_	13	case	_	_
11	to	_	PRT	TO	_	13	case	_	_
12	additive	_	ADJ	JJ	_	13	amod	_	_
13	effects	_	NOUN	NNS	_	9	nmod	_	_

#	Flurazepam Hydrochloride	3042
1	Opioids	_	NOUN	NNS	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Limit	_	NOUN	NN	_	4	case	_	_
4	dosage	_	NOUN	NN	_	1	dep	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	duration	_	NOUN	NN	_	4	conj	_	_
7	,	_	.	,	_	4	punct	_	_
8	and	_	CONJ	CC	_	4	cc	_	_
9	follow	_	VERB	VBP	_	10	amod	_	_
10	patients	_	NOUN	NNS	_	4	conj	_	_
11	closely	_	ADV	RB	_	14	advmod	_	_
12	for	_	ADP	IN	_	14	case	_	_
13	respiratory	_	ADJ	JJ	_	14	amod	_	_
14	depression	_	NOUN	NN	_	4	nmod	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	sedation	_	NOUN	NN	_	14	conj	_	_

#	Flurazepam Hydrochloride	3043
1	The	_	DET	DT	_	3	det	_	_
2	concomitant	_	ADJ	JJ	_	3	amod	_	_
3	use	_	NOUN	NN	_	8	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	benzodiazepines	_	NOUN	NNS	_	3	nmod	_	_
6	and	_	CONJ	CC	_	3	cc	_	_
7	opioids	_	NOUN	NNS	_	3	conj	_	_
8	increases	_	VERB	VBZ	_	0	root	_	_
9	the	_	DET	DT	_	10	det	_	_
10	risk	_	NOUN	NN	_	8	dobj	_	_
11	of	_	ADP	IN	_	13	case	_	_
12	respiratory	_	ADJ	JJ	_	13	amod	_	_
13	depression	_	NOUN	NN	_	10	nmod	_	_
14	because	_	ADP	IN	_	16	case	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	actions	_	NOUN	NNS	_	8	nmod	_	_
17	at	_	ADP	IN	_	20	case	_	_
18	different	_	ADJ	JJ	_	20	amod	_	_
19	receptor	_	NOUN	NN	_	20	compound	_	_
20	sites	_	NOUN	NNS	_	16	nmod	_	_
21	in	_	ADP	IN	_	23	case	_	_
22	the	_	DET	DT	_	23	det	_	_
23	CNS	_	NOUN	NN	_	20	nmod	_	_
24	that	_	DET	WDT	_	25	nsubj	_	_
25	control	_	VERB	VBP	_	23	acl:relcl	_	_
26	respiration	_	NOUN	NN	_	25	dobj	_	_

#	Flurazepam Hydrochloride	3044
1	Benzodiazepines	_	NOUN	NNS	_	2	nsubj	_	_
2	interact	_	VERB	VBP	_	0	root	_	_
3	at	_	ADP	IN	_	5	case	_	_
4	GABAA	_	NOUN	NN	_	5	compound	_	_
5	sites	_	NOUN	NNS	_	2	nmod	_	_
6	,	_	.	,	_	2	punct	_	_
7	and	_	CONJ	CC	_	2	cc	_	_
8	opioids	_	NOUN	NNS	_	9	nsubj	_	_
9	interact	_	VERB	VBP	_	2	conj	_	_
10	primarily	_	ADV	RB	_	9	advmod	_	_
11	at	_	ADP	IN	_	13	case	_	_
12	mu	_	NOUN	NN	_	13	compound	_	_
13	receptors	_	NOUN	NNS	_	9	nmod	_	_

#	Flurazepam Hydrochloride	3045
1	When	_	ADV	WRB	_	6	advmod	_	_
2	benzodiazepines	_	NOUN	NNS	_	6	nsubjpass	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	opioids	_	NOUN	NNS	_	2	conj	_	_
5	are	_	VERB	VBP	_	6	auxpass	_	_
6	combined	_	VERB	VBN	_	19	advcl	_	_
7	,	_	.	,	_	19	punct	_	_
8	the	_	DET	DT	_	9	det	_	_
9	potential	_	NOUN	NN	_	19	nsubj	_	_
10	for	_	ADP	IN	_	11	case	_	_
11	benzodiazepines	_	NOUN	NNS	_	9	nmod	_	_
12	to	_	PRT	TO	_	14	mark	_	_
13	significantly	_	ADV	RB	_	14	advmod	_	_
14	worsen	_	NOUN	NN	_	9	acl	_	_
15	opioid	_	ADJ	JJ	_	18	amod	_	_
16	related	_	ADJ	JJ	_	18	amod	_	_
17	respiratory	_	ADJ	JJ	_	18	amod	_	_
18	depression	_	NOUN	NN	_	14	dobj	_	_
19	exists	_	VERB	VBZ	_	0	root	_	_

#	Flurazepam Hydrochloride	3046
1	Limit	_	NOUN	NN	_	2	compound	_	_
2	dosage	_	NOUN	NN	_	0	root	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	duration	_	NOUN	NN	_	2	conj	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	concomitant	_	ADJ	JJ	_	7	amod	_	_
7	use	_	NOUN	NN	_	2	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	benzodiazepines	_	NOUN	NNS	_	7	nmod	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	opioids	_	VERB	VBZ	_	9	conj	_	_
12	,	_	.	,	_	2	punct	_	_
13	and	_	CONJ	CC	_	2	cc	_	_
14	follow	_	VERB	VBP	_	2	conj	_	_
15	patients	_	NOUN	NNS	_	14	dobj	_	_
16	closely	_	ADV	RB	_	15	advmod	_	_
17	for	_	ADP	IN	_	19	case	_	_
18	respiratory	_	ADJ	JJ	_	19	amod	_	_
19	depression	_	NOUN	NN	_	16	nmod	_	_
20	and	_	CONJ	CC	_	19	cc	_	_
21	sedation	_	NOUN	NN	_	19	conj	_	_

#	Flurazepam Hydrochloride	3047
1	DRUG	_	NOUN	NN	_	16	nsubj	_	_
2	,	_	.	,	_	1	punct	_	_
3	like	_	ADP	IN	_	8	case	_	_
4	other	_	ADJ	JJ	_	8	amod	_	_
5	central	_	ADJ	JJ	_	8	amod	_	_
6	nervous	_	ADJ	JJ	_	8	amod	_	_
7	system	_	NOUN	NN	_	8	compound	_	_
8	agents	_	NOUN	NNS	_	1	nmod	_	_
9	of	_	ADP	IN	_	13	case	_	_
10	the	_	DET	DT	_	13	det	_	_
11	1,4	_	NUM	CD	_	13	nummod	_	_
12	benzodiazepine	_	NOUN	NN	_	13	compound	_	_
13	class	_	NOUN	NN	_	8	nmod	_	_
14	,	_	.	,	_	1	punct	_	_
15	presumably	_	ADV	RB	_	16	advmod	_	_
16	exerts	_	VERB	VBZ	_	0	root	_	_
17	its	_	PRON	PRP$	_	18	nmod:poss	_	_
18	effects	_	NOUN	NNS	_	16	dobj	_	_
19	by	_	ADP	IN	_	20	mark	_	_
20	binding	_	VERB	VBG	_	16	advcl	_	_
21	to	_	PRT	TO	_	24	case	_	_
22	stereo	_	VERB	VBN	_	24	amod	_	_
23	specific	_	ADJ	JJ	_	24	amod	_	_
24	receptors	_	NOUN	NNS	_	20	nmod	_	_
25	at	_	ADP	IN	_	27	case	_	_
26	several	_	ADJ	JJ	_	27	amod	_	_
27	sites	_	NOUN	NNS	_	20	nmod	_	_
28	within	_	ADP	IN	_	33	case	_	_
29	the	_	DET	DT	_	33	det	_	_
30	central	_	ADJ	JJ	_	33	amod	_	_
31	nervous	_	ADJ	JJ	_	33	amod	_	_
32	system	_	NOUN	NN	_	33	compound	_	_
33	CNS	_	NOUN	NN	_	27	nmod	_	_

#	Flurazepam Hydrochloride	3048
1	The	_	DET	DT	_	3	det	_	_
2	exact	_	ADJ	JJ	_	3	amod	_	_
3	mechanism	_	NOUN	NN	_	7	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	action	_	NOUN	NN	_	3	nmod	_	_
6	is	_	VERB	VBZ	_	7	auxpass	_	_
7	unknown	_	ADJ	JJ	_	0	root	_	_

#	Flurazepam Hydrochloride	3049
1	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
2	is	_	VERB	VBZ	_	4	auxpass	_	_
3	rapidly	_	ADV	RB	_	4	advmod	_	_
4	absorbed	_	VERB	VBN	_	0	root	_	_
5	from	_	ADP	IN	_	9	case	_	_
6	the	_	DET	DT	_	9	det	_	_
7	gastro	_	NOUN	NN	_	9	compound	_	_
8	intestinal	_	ADJ	JJ	_	9	amod	_	_
9	tract	_	NOUN	NN	_	4	nmod	_	_

#	Flurazepam Hydrochloride	3050
1	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
2	is	_	VERB	VBZ	_	4	auxpass	_	_
3	rapidly	_	ADV	RB	_	4	advmod	_	_
4	metabolized	_	VERB	VBN	_	0	root	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	is	_	VERB	VBZ	_	7	auxpass	_	_
7	excreted	_	VERB	VBN	_	4	conj	_	_
8	primarily	_	ADV	RB	_	7	advmod	_	_
9	in	_	ADP	IN	_	11	case	_	_
10	the	_	DET	DT	_	11	det	_	_
11	urine	_	VERB	VBG	_	7	advcl	_	_

#	Flurazepam Hydrochloride	3051
1	Following	_	ADP	IN	_	5	case	_	_
2	a	_	DET	DT	_	5	det	_	_
3	single	_	ADJ	JJ	_	5	amod	_	_
4	oral	_	ADJ	JJ	_	5	amod	_	_
5	dose	_	NOUN	NN	_	0	root	_	_
6	,	_	.	,	_	5	punct	_	_
7	peak	_	ADJ	JJ	_	10	amod	_	_
8	DRUG	_	NOUN	NN	_	10	compound	_	_
9	plasma	_	NOUN	NN	_	10	compound	_	_
10	concentrations	_	NOUN	NNS	_	6	root	_	_
11	ranging	_	VERB	VBG	_	10	acl	_	_
12	from	_	ADP	IN	_	16	case	_	_
13	0.5	_	NUM	CD	_	15	compound	_	_
14	to	_	PRT	TO	_	15	dep	_	_
15	4.0	_	NUM	CD	_	16	nummod	_	_
16	ng	_	NOUN	NN	_	11	nmod	_	_
17	/	_	.	:	_	10	punct	_	_
18	mL	_	NOUN	NN	_	19	nsubj	_	_
19	occur	_	VERB	VBP	_	10	dep	_	_
20	at	_	ADP	IN	_	24	case	_	_
21	30	_	NUM	CD	_	23	compound	_	_
22	to	_	PRT	TO	_	23	dep	_	_
23	60	_	NUM	CD	_	24	nummod	_	_
24	minutes	_	NOUN	NNS	_	19	nmod	_	_
25	post	_	VERB	VBG	_	19	advcl	_	_
26	dosing	_	VERB	VBG	_	25	ccomp	_	_

#	Flurazepam Hydrochloride	3052
1	The	_	DET	DT	_	6	det	_	_
2	harmonic	_	ADJ	JJ	_	6	amod	_	_
3	mean	_	NOUN	NN	_	6	compound	_	_
4	apparent	_	ADJ	JJ	_	6	amod	_	_
5	half	_	ADJ	JJ	_	6	amod	_	_
6	life	_	NOUN	NN	_	11	nsubj	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	is	_	VERB	VBZ	_	11	cop	_	_
10	2.3	_	NUM	CD	_	11	nummod	_	_
11	hours	_	NOUN	NNS	_	0	root	_	_

#	Flurazepam Hydrochloride	3053
1	The	_	DET	DT	_	4	det	_	_
2	blood	_	NOUN	NN	_	4	compound	_	_
3	level	_	NOUN	NN	_	4	compound	_	_
4	profile	_	NOUN	NN	_	12	nsubjpass	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	and	_	CONJ	CC	_	4	cc	_	_
8	its	_	PRON	PRP$	_	10	nmod:poss	_	_
9	major	_	ADJ	JJ	_	10	amod	_	_
10	metabolites	_	NOUN	NNS	_	4	conj	_	_
11	was	_	VERB	VBD	_	12	auxpass	_	_
12	determined	_	VERB	VBN	_	0	root	_	_
13	in	_	ADP	IN	_	14	case	_	_
14	man	_	VERB	MD	_	12	nmod	_	_
15	following	_	ADP	IN	_	18	case	_	_
16	the	_	DET	DT	_	18	det	_	_
17	oral	_	ADJ	JJ	_	18	amod	_	_
18	administration	_	NOUN	NN	_	14	nmod	_	_
19	of	_	ADP	IN	_	21	case	_	_
20	30	_	NUM	CD	_	21	nummod	_	_
21	mg	_	NOUN	NN	_	18	nmod	_	_
22	daily	_	ADV	RB	_	18	advmod	_	_
23	for	_	ADP	IN	_	25	case	_	_
24	2	_	NUM	CD	_	25	nummod	_	_
25	weeks	_	NOUN	NNS	_	22	nmod	_	_

#	Flurazepam Hydrochloride	3054
1	The	_	DET	DT	_	4	det	_	_
2	N1	_	NOUN	NN	_	4	compound	_	_
3	hydroxyethyl	_	NOUN	NN	_	4	compound	_	_
4	DRUG	_	NOUN	NN	_	6	nsubj	_	_
5	was	_	VERB	VBD	_	6	cop	_	_
6	measurable	_	ADJ	JJ	_	0	root	_	_
7	only	_	ADV	RB	_	6	advmod	_	_
8	during	_	ADP	IN	_	11	case	_	_
9	the	_	DET	DT	_	11	det	_	_
10	early	_	ADJ	JJ	_	11	amod	_	_
11	hours	_	NOUN	NNS	_	6	nmod	_	_
12	after	_	ADP	IN	_	16	case	_	_
13	a	_	DET	DT	_	16	det	_	_
14	30	_	NUM	CD	_	16	nummod	_	_
15	mg	_	NOUN	NN	_	16	compound	_	_
16	dose	_	NOUN	NN	_	11	nmod	_	_
17	and	_	CONJ	CC	_	6	cc	_	_
18	was	_	VERB	VBD	_	20	cop	_	_
19	not	_	ADV	RB	_	20	neg	_	_
20	detectable	_	ADJ	JJ	_	6	conj	_	_
21	after	_	ADP	IN	_	23	case	_	_
22	24	_	NUM	CD	_	23	nummod	_	_
23	hours	_	NOUN	NNS	_	20	nmod	_	_

#	Flurazepam Hydrochloride	3055
1	The	_	DET	DT	_	3	det	_	_
2	major	_	ADJ	JJ	_	3	amod	_	_
3	metabolite	_	NOUN	NN	_	9	nsubj	_	_
4	in	_	ADP	IN	_	5	case	_	_
5	blood	_	NOUN	NN	_	3	nmod	_	_
6	was	_	VERB	VBD	_	9	cop	_	_
7	N1	_	NOUN	NN	_	9	compound	_	_
8	desalkyl	_	NOUN	NN	_	9	compound	_	_
9	DRUG	_	NOUN	NN	_	0	root	_	_
10	,	_	.	,	_	9	punct	_	_
11	which	_	DET	WDT	_	12	nsubj	_	_
12	reached	_	VERB	VBD	_	9	acl:relcl	_	_
13	steady	_	ADJ	JJ	_	16	amod	_	_
14	state	_	NOUN	NN	_	16	compound	_	_
15	plateau	_	NOUN	NN	_	16	compound	_	_
16	levels	_	NOUN	NNS	_	12	dobj	_	_
17	after	_	ADP	IN	_	21	case	_	_
18	7	_	NUM	CD	_	20	compound	_	_
19	to	_	PRT	TO	_	20	dep	_	_
20	10	_	NUM	CD	_	21	nummod	_	_
21	days	_	NOUN	NNS	_	12	nmod	_	_
22	of	_	ADP	IN	_	23	case	_	_
23	dosing	_	NOUN	NN	_	21	nmod	_	_
24	,	_	.	,	_	9	punct	_	_
25	at	_	ADP	IN	_	26	case	_	_
26	levels	_	NOUN	NNS	_	9	nmod	_	_
27	approximately	_	ADV	RB	_	28	advmod	_	_
28	5	_	NUM	CD	_	31	nummod	_	_
29	to	_	PRT	TO	_	28	dep	_	_
30	6	_	NUM	CD	_	31	nummod	_	_
31	fold	_	NOUN	NN	_	26	nmod	_	_
32	greater	_	ADJ	JJ	_	31	amod	_	_
33	than	_	ADP	IN	_	37	case	_	_
34	the	_	DET	DT	_	37	det	_	_
35	24	_	NUM	CD	_	37	nummod	_	_
36	hour	_	NUM	CD	_	37	nummod	_	_
37	levels	_	NOUN	NNS	_	32	nmod	_	_
38	observed	_	VERB	VBN	_	37	acl	_	_
39	on	_	ADP	IN	_	40	case	_	_
40	Day	_	NOUN	NN	_	38	nmod	_	_
41	1	_	NUM	CD	_	40	nummod	_	_

#	Flurazepam Hydrochloride	3056
1	The	_	DET	DT	_	3	det	_	_
2	half	_	ADJ	JJ	_	3	amod	_	_
3	life	_	NOUN	NN	_	0	root	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	elimination	_	NOUN	NN	_	3	nmod	_	_
6	of	_	ADP	IN	_	9	case	_	_
7	N1	_	NOUN	NN	_	9	compound	_	_
8	desalkyl	_	NOUN	NN	_	9	compound	_	_
9	DRUG	_	NOUN	NN	_	5	nmod	_	_
10	ranged	_	VERB	VBN	_	9	acl	_	_
11	from	_	ADP	IN	_	15	case	_	_
12	47	_	NUM	CD	_	14	compound	_	_
13	to	_	PRT	TO	_	14	dep	_	_
14	100	_	NUM	CD	_	15	nummod	_	_
15	hours	_	NOUN	NNS	_	10	nmod	_	_

#	Flurazepam Hydrochloride	3057
1	The	_	DET	DT	_	4	det	_	_
2	major	_	ADJ	JJ	_	4	amod	_	_
3	urinary	_	ADJ	JJ	_	4	amod	_	_
4	metabolite	_	NOUN	NN	_	6	nsubjpass	_	_
5	is	_	VERB	VBZ	_	6	auxpass	_	_
6	conjugated	_	VERB	VBN	_	0	root	_	_
7	N1	_	NOUN	NN	_	9	compound	_	_
8	hydroxyethyl	_	NOUN	NN	_	9	compound	_	_
9	DRUG	_	NOUN	NN	_	6	dobj	_	_
10	which	_	DET	WDT	_	11	nsubj	_	_
11	accounts	_	VERB	VBZ	_	9	acl:relcl	_	_
12	for	_	ADP	IN	_	13	case	_	_
13	22%	_	NOUN	NN	_	11	nmod	_	_
14	to	_	PRT	TO	_	15	case	_	_
15	55%	_	NOUN	NN	_	11	nmod	_	_
16	of	_	ADP	IN	_	18	case	_	_
17	the	_	DET	DT	_	18	det	_	_
18	dose	_	NOUN	NN	_	15	nmod	_	_

#	Flurazepam Hydrochloride	3058
1	Less	_	ADV	RB	_	3	case	_	_
2	than	_	ADP	IN	_	1	mwe	_	_
3	1%	_	NOUN	NN	_	8	nsubjpass	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	the	_	DET	DT	_	6	det	_	_
6	dose	_	NOUN	NN	_	3	nmod	_	_
7	is	_	VERB	VBZ	_	8	auxpass	_	_
8	excreted	_	VERB	VBN	_	0	root	_	_
9	in	_	ADP	IN	_	11	case	_	_
10	the	_	DET	DT	_	11	det	_	_
11	urine	_	ADJ	JJ	_	8	nmod	_	_
12	as	_	ADP	IN	_	15	case	_	_
13	N1	_	NOUN	NN	_	15	compound	_	_
14	desalkyl	_	NOUN	NN	_	15	compound	_	_
15	DRUG	_	NOUN	NN	_	11	nmod	_	_

#	Flurazepam Hydrochloride	3059
1	This	_	DET	DT	_	3	det	_	_
2	pharmacokinetic	_	ADJ	JJ	_	3	amod	_	_
3	profile	_	NOUN	NN	_	6	nsubj	_	_
4	may	_	VERB	MD	_	6	aux	_	_
5	be	_	VERB	VB	_	6	cop	_	_
6	responsible	_	ADJ	JJ	_	0	root	_	_
7	for	_	ADP	IN	_	10	case	_	_
8	the	_	DET	DT	_	10	det	_	_
9	clinical	_	ADJ	JJ	_	10	amod	_	_
10	observation	_	NOUN	NN	_	6	nmod	_	_
11	that	_	ADP	IN	_	15	mark	_	_
12	DRUG	_	NOUN	NN	_	15	nsubj	_	_
13	is	_	VERB	VBZ	_	15	cop	_	_
14	increasingly	_	ADV	RB	_	15	advmod	_	_
15	effective	_	ADJ	JJ	_	10	ccomp	_	_
16	on	_	ADP	IN	_	21	case	_	_
17	the	_	DET	DT	_	21	det	_	_
18	second	_	ADJ	JJ	_	21	amod	_	_
19	or	_	CONJ	CC	_	18	cc	_	_
20	third	_	ADJ	JJ	_	18	conj	_	_
21	night	_	VERB	MD	_	15	nmod	_	_
22	of	_	ADP	IN	_	24	case	_	_
23	consecutive	_	ADJ	JJ	_	24	amod	_	_
24	use	_	NOUN	NN	_	21	nmod	_	_
25	and	_	CONJ	CC	_	15	cc	_	_
26	that	_	ADP	IN	_	36	mark	_	_
27	for	_	ADP	IN	_	31	case	_	_
28	1	_	NUM	CD	_	31	nummod	_	_
29	or	_	CONJ	CC	_	28	cc	_	_
30	2	_	NUM	CD	_	28	conj	_	_
31	nights	_	NOUN	NNS	_	36	nsubjpass	_	_
32	after	_	ADP	IN	_	34	case	_	_
33	the	_	DET	DT	_	34	det	_	_
34	drug	_	NOUN	NN	_	31	nmod	_	_
35	is	_	VERB	VBZ	_	36	auxpass	_	_
36	discontinued	_	VERB	VBN	_	47	nsubjpass	_	_
37	both	_	CONJ	CC	_	39	cc:preconj	_	_
38	sleep	_	NOUN	NN	_	39	compound	_	_
39	latency	_	NOUN	NN	_	36	dobj	_	_
40	and	_	CONJ	CC	_	39	cc	_	_
41	total	_	ADJ	JJ	_	43	amod	_	_
42	wake	_	ADJ	JJ	_	43	amod	_	_
43	time	_	NOUN	NN	_	39	conj	_	_
44	may	_	VERB	MD	_	47	aux	_	_
45	still	_	ADV	RB	_	47	advmod	_	_
46	be	_	VERB	VB	_	47	auxpass	_	_
47	decreased	_	VERB	VBN	_	15	conj	_	_

#	Flurazepam Hydrochloride	3060
1	The	_	DET	DT	_	4	det	_	_
2	single	_	ADJ	JJ	_	4	amod	_	_
3	dose	_	NOUN	NN	_	4	compound	_	_
4	pharmacokinetics	_	NOUN	NNS	_	8	nsubjpass	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	were	_	VERB	VBD	_	8	auxpass	_	_
8	studied	_	VERB	VBN	_	0	root	_	_
9	in	_	ADP	IN	_	13	case	_	_
10	12	_	NUM	CD	_	13	nummod	_	_
11	healthy	_	ADJ	JJ	_	13	amod	_	_
12	geriatric	_	ADJ	JJ	_	13	amod	_	_
13	subjects	_	NOUN	NNS	_	8	nmod	_	_
14	aged	_	ADJ	JJ	_	13	amod	_	_
15	61	_	NUM	CD	_	17	compound	_	_
16	to	_	PRT	TO	_	17	dep	_	_
17	85	_	NUM	CD	_	18	nummod	_	_
18	years	_	NOUN	NNS	_	14	nmod	_	_

#	Flurazepam Hydrochloride	3061
1	The	_	DET	DT	_	5	det	_	_
2	mean	_	ADJ	JJ	_	5	compound	_	_
3	elimination	_	NOUN	NN	_	5	compound	_	_
4	half	_	NOUN	NN	_	5	compound	_	_
5	life	_	NOUN	NN	_	14	nsubj	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	desalkyl	_	ADJ	JJ	_	8	amod	_	_
8	DRUG	_	NOUN	NN	_	5	nmod	_	_
9	was	_	VERB	VBD	_	14	cop	_	_
10	longer	_	ADV	RB	_	14	advmod	_	_
11	in	_	ADP	IN	_	14	case	_	_
12	elderly	_	ADJ	JJ	_	14	amod	_	_
13	male	_	ADJ	JJ	_	14	amod	_	_
14	subjects	_	NOUN	NNS	_	0	root	_	_
15	160	_	NUM	CD	_	16	nummod	_	_
16	hours	_	NOUN	NNS	_	14	dobj	_	_
17	compared	_	VERB	VBD	_	16	acl	_	_
18	with	_	ADP	IN	_	21	case	_	_
19	younger	_	ADJ	JJ	_	21	amod	_	_
20	male	_	ADJ	JJ	_	21	amod	_	_
21	subjects	_	NOUN	NNS	_	17	nmod	_	_
22	74	_	NUM	CD	_	23	nummod	_	_
23	hours	_	NOUN	NNS	_	21	dep	_	_
24	,	_	.	,	_	14	punct	_	_
25	while	_	ADP	IN	_	31	mark	_	_
26	mean	_	ADJ	JJ	_	29	amod	_	_
27	elimination	_	NOUN	NN	_	29	compound	_	_
28	half	_	NOUN	NN	_	29	compound	_	_
29	life	_	NOUN	NN	_	31	nsubj	_	_
30	was	_	VERB	VBD	_	31	cop	_	_
31	similar	_	ADJ	JJ	_	14	advcl	_	_
32	in	_	ADP	IN	_	35	case	_	_
33	geriatric	_	ADJ	JJ	_	35	amod	_	_
34	female	_	ADJ	JJ	_	35	amod	_	_
35	subjects	_	NOUN	NNS	_	31	nmod	_	_
36	120	_	NUM	CD	_	37	nummod	_	_
37	hours	_	NOUN	NNS	_	35	dep	_	_
38	and	_	CONJ	CC	_	37	cc	_	_
39	younger	_	ADJ	JJ	_	41	amod	_	_
40	female	_	ADJ	JJ	_	41	amod	_	_
41	subjects	_	NOUN	NNS	_	37	conj	_	_
42	90	_	NUM	CD	_	43	nummod	_	_
43	hours	_	NOUN	NNS	_	41	dep	_	_

#	Flurazepam Hydrochloride	3062
1	After	_	ADP	IN	_	3	case	_	_
2	multiple	_	ADJ	JJ	_	3	amod	_	_
3	dosing	_	NOUN	NN	_	14	nmod	_	_
4	,	_	.	,	_	14	punct	_	_
5	mean	_	ADJ	JJ	_	9	amod	_	_
6	steady	_	ADJ	JJ	_	9	amod	_	_
7	state	_	NOUN	NN	_	9	compound	_	_
8	plasma	_	NOUN	NN	_	9	compound	_	_
9	levels	_	NOUN	NNS	_	14	nsubj	_	_
10	of	_	ADP	IN	_	12	case	_	_
11	desalkyl	_	ADJ	JJ	_	12	amod	_	_
12	DRUG	_	NOUN	NN	_	9	nmod	_	_
13	were	_	VERB	VBD	_	14	cop	_	_
14	higher	_	ADJ	JJ	_	0	root	_	_
15	in	_	ADP	IN	_	18	case	_	_
16	elderly	_	ADJ	JJ	_	18	amod	_	_
17	male	_	ADJ	JJ	_	18	amod	_	_
18	subjects	_	NOUN	NNS	_	14	nmod	_	_
19	81	_	NUM	CD	_	20	nummod	_	_
20	ng	_	NOUN	NN	_	18	dep	_	_
21	/	_	.	:	_	14	punct	_	_
22	mL	_	NOUN	NN	_	23	nsubj	_	_
23	compared	_	VERB	VBD	_	14	parataxis	_	_
24	with	_	ADP	IN	_	27	case	_	_
25	younger	_	ADJ	JJ	_	27	amod	_	_
26	male	_	ADJ	JJ	_	27	amod	_	_
27	subjects	_	NOUN	NNS	_	23	nmod	_	_
28	53	_	NUM	CD	_	29	nummod	_	_
29	ng	_	NOUN	NN	_	27	dep	_	_
30	/	_	.	:	_	29	punct	_	_
31	mL	_	NOUN	NN	_	29	dep	_	_
32	,	_	.	,	_	23	punct	_	_
33	while	_	ADP	IN	_	36	mark	_	_
34	values	_	NOUN	NNS	_	36	nsubj	_	_
35	were	_	VERB	VBD	_	36	cop	_	_
36	similar	_	ADJ	JJ	_	23	advcl	_	_
37	between	_	ADP	IN	_	40	case	_	_
38	elderly	_	ADJ	JJ	_	40	amod	_	_
39	female	_	ADJ	JJ	_	40	amod	_	_
40	subjects	_	NOUN	NNS	_	36	nmod	_	_
41	85	_	NUM	CD	_	42	nummod	_	_
42	ng	_	NOUN	NN	_	40	dep	_	_
43	/	_	.	:	_	42	punct	_	_
44	mL	_	NOUN	NN	_	42	dep	_	_
45	and	_	CONJ	CC	_	44	cc	_	_
46	younger	_	ADJ	JJ	_	48	amod	_	_
47	female	_	ADJ	JJ	_	48	amod	_	_
48	subjects	_	NOUN	NNS	_	44	conj	_	_
49	86	_	NUM	CD	_	50	nummod	_	_
50	ng	_	NOUN	NN	_	48	dep	_	_
51	/	_	.	:	_	42	punct	_	_
52	mL	_	NOUN	NN	_	42	dep	_	_

#	Flurazepam Hydrochloride	3063
1	The	_	DET	DT	_	2	det	_	_
2	mean	_	NOUN	NN	_	13	nsubj	_	_
3	washout	_	NOUN	NN	_	5	case	_	_
4	half	_	ADJ	JJ	_	5	amod	_	_
5	life	_	NOUN	NN	_	2	nmod	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	desalkyl	_	ADJ	JJ	_	8	amod	_	_
8	DRUG	_	NOUN	NN	_	5	nmod	_	_
9	was	_	VERB	VBD	_	13	cop	_	_
10	longer	_	ADV	RB	_	13	advmod	_	_
11	in	_	ADP	IN	_	13	case	_	_
12	elderly	_	ADJ	JJ	_	13	amod	_	_
13	male	_	ADJ	JJ	_	0	root	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	female	_	ADJ	JJ	_	13	conj	_	_
16	subjects	_	NOUN	NNS	_	13	dep	_	_
17	126	_	NUM	CD	_	20	nummod	_	_
18	and	_	CONJ	CC	_	17	cc	_	_
19	158	_	NUM	CD	_	17	conj	_	_
20	hours	_	NOUN	NNS	_	16	dep	_	_
21	,	_	.	,	_	13	punct	_	_
22	respectively	_	ADV	RB	_	23	advmod	_	_
23	compared	_	VERB	VBD	_	13	parataxis	_	_
24	with	_	ADP	IN	_	26	case	_	_
25	younger	_	ADJ	JJ	_	26	amod	_	_
26	male	_	ADJ	JJ	_	23	nmod	_	_
27	and	_	CONJ	CC	_	26	cc	_	_
28	female	_	ADJ	JJ	_	26	conj	_	_
29	subjects	_	NOUN	NNS	_	33	compound	_	_
30	111	_	NUM	CD	_	33	nummod	_	_
31	and	_	CONJ	CC	_	30	cc	_	_
32	113	_	NUM	CD	_	30	conj	_	_
33	hours	_	NOUN	NNS	_	26	dep	_	_
34	,	_	.	,	_	26	punct	_	_
35	respectively).1	_	NOUN	NN	_	38	compound	_	_
36	1	_	NUM	CD	_	38	nummod	_	_
37	Greenblatt	_	NOUN	NN	_	38	compound	_	_
38	DJ	_	NOUN	NN	_	26	conj	_	_
39	,	_	.	,	_	26	punct	_	_
40	Divoll	_	ADJ	JJ	_	41	amod	_	_
41	M	_	NOUN	NN	_	26	conj	_	_
42	,	_	.	,	_	26	punct	_	_
43	Hammatz	_	NOUN	NN	_	44	compound	_	_
44	JS	_	NOUN	NN	_	26	conj	_	_
45	,	_	.	,	_	26	punct	_	_
46	MacLauglin	_	NOUN	NN	_	47	compound	_	_
47	DS	_	NOUN	NN	_	26	conj	_	_
48	,	_	.	,	_	26	punct	_	_
49	Shader	_	NOUN	NN	_	50	compound	_	_
50	RI	_	NOUN	NN	_	26	conj	_	_
51	:	_	.	:	_	26	punct	_	_
52	Kinetics	_	NOUN	NNS	_	26	conj	_	_
53	and	_	CONJ	CC	_	26	cc	_	_
54	clinical	_	ADJ	JJ	_	55	amod	_	_
55	effects	_	NOUN	NNS	_	26	conj	_	_
56	of	_	ADP	IN	_	57	case	_	_
57	DRUG	_	NOUN	NN	_	55	nmod	_	_
58	in	_	ADP	IN	_	62	case	_	_
59	young	_	ADJ	JJ	_	62	amod	_	_
60	and	_	CONJ	CC	_	59	cc	_	_
61	elderly	_	ADJ	JJ	_	59	conj	_	_
62	noninsomniacs	_	NOUN	NNS	_	23	nmod	_	_

#	Fluvastatin	150
1	Cyclosporine	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Combination	_	NOUN	NN	_	4	nsubj	_	_
4	increases	_	VERB	VBZ	_	1	dep	_	_
5	DRUG	_	NOUN	NN	_	6	compound	_	_
6	exposure	_	NOUN	NN	_	4	dobj	_	_

#	Fluvastatin	151
1	Limit	_	NOUN	NN	_	0	root	_	_
2	DRUG	_	NOUN	NN	_	3	compound	_	_
3	dose	_	NOUN	NN	_	1	dobj	_	_
4	to	_	PRT	TO	_	6	case	_	_
5	20	_	NUM	CD	_	6	nummod	_	_
6	mg	_	NOUN	NN	_	3	nmod	_	_
7	2.4	_	NUM	CD	_	6	nummod	_	_
8	,	_	.	,	_	6	punct	_	_
9	7.1	_	NUM	CD	_	10	nummod	_	_
10	Fluconazole	_	NOUN	NN	_	6	appos	_	_
11	:	_	.	:	_	1	punct	_	_
12	Combination	_	NOUN	NN	_	13	nsubj	_	_
13	increases	_	VERB	VBZ	_	1	parataxis	_	_
14	DRUG	_	NOUN	NN	_	15	compound	_	_
15	exposure	_	NOUN	NN	_	13	dobj	_	_

#	Fluvastatin	152
1	Limit	_	NOUN	NN	_	0	root	_	_
2	DRUG	_	NOUN	NN	_	3	compound	_	_
3	dose	_	NOUN	NN	_	1	dobj	_	_
4	to	_	PRT	TO	_	6	case	_	_
5	20	_	NUM	CD	_	6	nummod	_	_
6	mg	_	NOUN	NN	_	1	nmod	_	_
7	2.5	_	NUM	CD	_	6	nummod	_	_
8	,	_	.	,	_	6	punct	_	_
9	7.2	_	NUM	CD	_	13	nummod	_	_
10	Concomitant	_	ADJ	JJ	_	13	amod	_	_
11	lipid	_	NOUN	NN	_	13	compound	_	_
12	lowering	_	VERB	VBG	_	13	compound	_	_
13	therapies	_	NOUN	NNS	_	6	appos	_	_
14	:	_	.	:	_	1	punct	_	_
15	Use	_	NOUN	NN	_	1	dep	_	_
16	with	_	ADP	IN	_	17	case	_	_
17	fibrates	_	NOUN	NNS	_	15	nmod	_	_
18	or	_	CONJ	CC	_	17	cc	_	_
19	lipid	_	NOUN	NN	_	21	compound	_	_
20	modifying	_	VERB	VBG	_	21	compound	_	_
21	doses	_	NOUN	NNS	_	24	compound	_	_
22	>	_	NUM	CD	_	24	nummod	_	_
23	1	_	NUM	CD	_	24	nummod	_	_
24	g	_	NOUN	NN	_	17	conj	_	_
25	/	_	.	:	_	1	punct	_	_
26	day	_	NOUN	NN	_	29	nsubj	_	_
27	of	_	ADP	IN	_	28	case	_	_
28	niacin	_	NOUN	NN	_	26	nmod	_	_
29	increases	_	VERB	VBZ	_	1	parataxis	_	_
30	the	_	DET	DT	_	31	det	_	_
31	risk	_	NOUN	NN	_	29	dobj	_	_
32	of	_	ADP	IN	_	36	case	_	_
33	adverse	_	ADJ	JJ	_	36	amod	_	_
34	skeletal	_	ADJ	JJ	_	36	amod	_	_
35	muscle	_	NOUN	NN	_	36	compound	_	_
36	effects	_	NOUN	NNS	_	31	nmod	_	_

#	Fluvastatin	153
1	Caution	_	NOUN	NN	_	4	nsubjpass	_	_
2	should	_	VERB	MD	_	4	aux	_	_
3	be	_	VERB	VB	_	4	auxpass	_	_
4	used	_	VERB	VBN	_	0	root	_	_
5	when	_	ADV	WRB	_	6	advmod	_	_
6	prescribing	_	VERB	VBG	_	4	advcl	_	_
7	with	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	5.1	_	NUM	CD	_	8	nummod	_	_
10	,	_	.	,	_	8	punct	_	_
11	7.3	_	NUM	CD	_	8	conj	_	_
12	,	_	.	,	_	8	punct	_	_
13	7.4	_	NUM	CD	_	14	nummod	_	_
14	Glyburide	_	NOUN	NN	_	8	appos	_	_
15	:	_	.	:	_	4	punct	_	_
16	Monitor	_	NOUN	NN	_	19	compound	_	_
17	blood	_	NOUN	NN	_	19	compound	_	_
18	glucose	_	NOUN	NN	_	19	compound	_	_
19	levels	_	NOUN	NNS	_	4	parataxis	_	_
20	when	_	ADV	WRB	_	24	advmod	_	_
21	DRUG	_	NOUN	NN	_	22	compound	_	_
22	dose	_	NOUN	NN	_	24	nsubjpass	_	_
23	is	_	VERB	VBZ	_	24	auxpass	_	_
24	changed	_	VERB	VBN	_	19	acl:relcl	_	_
25	7	_	NUM	CD	_	26	nummod	_	_
26	Phenytoin	_	NOUN	NN	_	24	dobj	_	_
27	:	_	.	:	_	19	punct	_	_
28	Monitor	_	NOUN	NN	_	31	compound	_	_
29	plasma	_	NOUN	NN	_	31	compound	_	_
30	phenytoin	_	NOUN	NN	_	31	compound	_	_
31	levels	_	NOUN	NNS	_	47	nsubj	_	_
32	when	_	ADV	WRB	_	36	advmod	_	_
33	DRUG	_	NOUN	NN	_	34	compound	_	_
34	treatment	_	NOUN	NN	_	36	nsubjpass	_	_
35	is	_	VERB	VBZ	_	36	auxpass	_	_
36	initiated	_	VERB	VBN	_	31	acl:relcl	_	_
37	or	_	CONJ	CC	_	36	cc	_	_
38	when	_	ADV	WRB	_	42	advmod	_	_
39	the	_	DET	DT	_	40	det	_	_
40	dosage	_	NOUN	NN	_	42	nsubjpass	_	_
41	is	_	VERB	VBZ	_	42	auxpass	_	_
42	changed	_	VERB	VBN	_	36	conj	_	_
43	7	_	NUM	CD	_	44	nummod	_	_
44	Warfarin	_	NOUN	NN	_	42	dobj	_	_
45	and	_	CONJ	CC	_	44	cc	_	_
46	coumarin	_	NOUN	NN	_	44	conj	_	_
47	derivates	_	VERB	VBZ	_	19	dep	_	_
48	:	_	.	:	_	19	punct	_	_
49	Monitor	_	ADJ	JJ	_	51	compound	_	_
50	prothrombin	_	NOUN	NN	_	51	compound	_	_
51	times	_	NOUN	NNS	_	67	nsubj	_	_
52	when	_	ADV	WRB	_	56	advmod	_	_
53	DRUG	_	NOUN	NN	_	54	compound	_	_
54	coadministration	_	NOUN	NN	_	56	nsubjpass	_	_
55	is	_	VERB	VBZ	_	56	auxpass	_	_
56	initiated	_	VERB	VBN	_	51	acl:relcl	_	_
57	,	_	.	,	_	51	punct	_	_
58	discontinued	_	VERB	VBN	_	51	acl	_	_
59	,	_	.	,	_	51	punct	_	_
60	or	_	CONJ	CC	_	51	cc	_	_
61	the	_	DET	DT	_	62	det	_	_
62	dosage	_	NOUN	NN	_	63	nsubj	_	_
63	changed	_	VERB	VBN	_	51	conj	_	_
64	7	_	NUM	CD	_	66	nummod	_	_
65	Cyclosporine	_	NOUN	NN	_	66	compound	_	_
66	coadministration	_	NOUN	NN	_	63	dobj	_	_
67	increases	_	VERB	VBZ	_	19	dep	_	_
68	DRUG	_	NOUN	NN	_	69	compound	_	_
69	exposure	_	NOUN	NN	_	67	dobj	_	_

#	Fluvastatin	154
1	Therefore	_	ADV	RB	_	11	advmod	_	_
2	,	_	.	,	_	11	punct	_	_
3	in	_	ADP	IN	_	4	case	_	_
4	patients	_	NOUN	NNS	_	11	nmod	_	_
5	taking	_	VERB	VBG	_	4	acl	_	_
6	cyclosporine	_	NOUN	NN	_	5	dobj	_	_
7	,	_	.	,	_	11	punct	_	_
8	therapy	_	NOUN	NN	_	11	nsubj	_	_
9	should	_	VERB	MD	_	11	aux	_	_
10	be	_	VERB	VB	_	11	cop	_	_
11	limited	_	ADJ	JJ	_	0	root	_	_
12	to	_	PRT	TO	_	15	case	_	_
13	DRUG	_	NOUN	NN	_	15	compound	_	_
14	20	_	NUM	CD	_	15	nummod	_	_
15	mg	_	NOUN	NN	_	11	nmod	_	_
16	twice	_	ADV	RB	_	17	advmod	_	_
17	daily	_	ADV	RB	_	11	advmod	_	_

#	Fluvastatin	155
1	Administration	_	NOUN	NN	_	18	nsubj	_	_
2	of	_	ADP	IN	_	7	case	_	_
3	DRUG	_	NOUN	NN	_	7	compound	_	_
4	40	_	NUM	CD	_	7	nummod	_	_
5	mg	_	NOUN	NN	_	7	amod	_	_
6	single	_	ADJ	JJ	_	7	amod	_	_
7	dose	_	NOUN	NN	_	1	nmod	_	_
8	to	_	PRT	TO	_	10	case	_	_
9	healthy	_	ADJ	JJ	_	10	amod	_	_
10	volunteers	_	NOUN	NNS	_	1	nmod	_	_
11	pre	_	NOUN	NN	_	12	auxpass	_	_
12	treated	_	VERB	VBN	_	1	acl	_	_
13	with	_	ADP	IN	_	14	case	_	_
14	fluconazole	_	NOUN	NN	_	12	nmod	_	_
15	for	_	ADP	IN	_	17	case	_	_
16	4	_	NUM	CD	_	17	nummod	_	_
17	days	_	NOUN	NNS	_	14	nmod	_	_
18	results	_	VERB	VBZ	_	0	root	_	_
19	in	_	ADP	IN	_	21	case	_	_
20	an	_	DET	DT	_	21	det	_	_
21	increase	_	NOUN	NN	_	18	nmod	_	_
22	of	_	ADP	IN	_	24	case	_	_
23	DRUG	_	NOUN	NN	_	24	compound	_	_
24	exposure	_	NOUN	NN	_	21	nmod	_	_

#	Fluvastatin	156
1	Therefore	_	ADV	RB	_	11	advmod	_	_
2	,	_	.	,	_	11	punct	_	_
3	in	_	ADP	IN	_	4	case	_	_
4	patients	_	NOUN	NNS	_	11	nmod	_	_
5	taking	_	VERB	VBG	_	4	acl	_	_
6	fluconazole	_	NOUN	NN	_	5	dobj	_	_
7	,	_	.	,	_	11	punct	_	_
8	therapy	_	NOUN	NN	_	11	nsubj	_	_
9	should	_	VERB	MD	_	11	aux	_	_
10	be	_	VERB	VB	_	11	cop	_	_
11	limited	_	ADJ	JJ	_	0	root	_	_
12	to	_	PRT	TO	_	15	case	_	_
13	DRUG	_	NOUN	NN	_	15	compound	_	_
14	20	_	NUM	CD	_	15	nummod	_	_
15	mg	_	NOUN	NN	_	11	nmod	_	_
16	twice	_	ADV	RB	_	17	advmod	_	_
17	daily	_	ADV	RB	_	11	advmod	_	_

#	Fluvastatin	157
1	Due	_	ADP	IN	_	5	case	_	_
2	to	_	PRT	TO	_	1	mwe	_	_
3	an	_	DET	DT	_	5	det	_	_
4	increased	_	VERB	VBN	_	5	amod	_	_
5	risk	_	NOUN	NN	_	29	nmod	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	myopathy	_	NOUN	NN	_	5	nmod	_	_
8	/	_	.	:	_	5	punct	_	_
9	rhabdomyolysis	_	NOUN	NN	_	29	nsubjpass	_	_
10	when	_	ADV	WRB	_	16	advmod	_	_
11	HMG	_	NOUN	NN	_	14	compound	_	_
12	CoA	_	NOUN	NN	_	14	compound	_	_
13	reductase	_	NOUN	NN	_	14	compound	_	_
14	inhibitors	_	NOUN	NNS	_	16	nsubjpass	_	_
15	are	_	VERB	VBP	_	16	auxpass	_	_
16	coadministered	_	VERB	VBN	_	9	acl:relcl	_	_
17	with	_	ADP	IN	_	18	case	_	_
18	gemfibrozil	_	NOUN	NN	_	16	nmod	_	_
19	,	_	.	,	_	29	punct	_	_
20	concomitant	_	ADJ	JJ	_	21	amod	_	_
21	administration	_	NOUN	NN	_	29	nsubjpass	_	_
22	of	_	ADP	IN	_	24	case	_	_
23	DRUG	_	NOUN	NN	_	24	compound	_	_
24	sodium	_	NOUN	NN	_	21	nmod	_	_
25	with	_	ADP	IN	_	26	case	_	_
26	gemfibrozil	_	NOUN	NN	_	21	nmod	_	_
27	should	_	VERB	MD	_	29	aux	_	_
28	be	_	VERB	VB	_	29	auxpass	_	_
29	avoided	_	VERB	VBN	_	0	root	_	_

#	Fluvastatin	158
1	Because	_	ADP	IN	_	4	mark	_	_
2	it	_	PRON	PRP	_	4	nsubjpass	_	_
3	is	_	VERB	VBZ	_	4	auxpass	_	_
4	known	_	VERB	VBN	_	30	advcl	_	_
5	that	_	ADP	IN	_	18	mark	_	_
6	the	_	DET	DT	_	7	det	_	_
7	risk	_	NOUN	NN	_	18	nsubjpass	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	myopathy	_	NOUN	NN	_	7	nmod	_	_
10	during	_	ADP	IN	_	11	case	_	_
11	treatment	_	NOUN	NN	_	7	nmod	_	_
12	with	_	ADP	IN	_	16	case	_	_
13	HMG	_	NOUN	NN	_	16	compound	_	_
14	CoA	_	NOUN	NN	_	16	compound	_	_
15	reductase	_	NOUN	NN	_	16	compound	_	_
16	inhibitors	_	NOUN	NNS	_	11	nmod	_	_
17	is	_	VERB	VBZ	_	18	auxpass	_	_
18	increased	_	VERB	VBN	_	4	ccomp	_	_
19	with	_	ADP	IN	_	21	case	_	_
20	concurrent	_	ADJ	JJ	_	21	amod	_	_
21	administration	_	NOUN	NN	_	18	nmod	_	_
22	of	_	ADP	IN	_	24	case	_	_
23	other	_	ADJ	JJ	_	24	amod	_	_
24	fibrates	_	NOUN	NNS	_	21	nmod	_	_
25	,	_	.	,	_	30	punct	_	_
26	DRUG	_	NOUN	NN	_	27	compound	_	_
27	sodium	_	NOUN	NN	_	30	nsubjpass	_	_
28	should	_	VERB	MD	_	30	aux	_	_
29	be	_	VERB	VB	_	30	auxpass	_	_
30	administered	_	VERB	VBN	_	0	root	_	_
31	with	_	ADP	IN	_	32	case	_	_
32	caution	_	NOUN	NN	_	30	nmod	_	_
33	when	_	ADV	WRB	_	34	advmod	_	_
34	used	_	VERB	VBN	_	30	advcl	_	_
35	concomitantly	_	ADV	RB	_	34	advmod	_	_
36	with	_	ADP	IN	_	38	case	_	_
37	other	_	ADJ	JJ	_	38	amod	_	_
38	fibrates	_	NOUN	NNS	_	34	nmod	_	_

#	Fluvastatin	159
1	The	_	DET	DT	_	2	det	_	_
2	risk	_	NOUN	NN	_	9	nsubjpass	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	skeletal	_	ADJ	JJ	_	6	amod	_	_
5	muscle	_	NOUN	NN	_	6	compound	_	_
6	effects	_	NOUN	NNS	_	2	nmod	_	_
7	may	_	VERB	MD	_	9	aux	_	_
8	be	_	VERB	VB	_	9	auxpass	_	_
9	enhanced	_	VERB	VBN	_	0	root	_	_
10	when	_	ADV	WRB	_	14	advmod	_	_
11	DRUG	_	NOUN	NN	_	12	compound	_	_
12	sodium	_	NOUN	NN	_	14	nsubjpass	_	_
13	is	_	VERB	VBZ	_	14	auxpass	_	_
14	used	_	VERB	VBN	_	9	advcl	_	_
15	in	_	ADP	IN	_	16	case	_	_
16	combination	_	NOUN	NN	_	14	nmod	_	_
17	with	_	ADP	IN	_	20	case	_	_
18	lipid	_	NOUN	NN	_	20	compound	_	_
19	modifying	_	VERB	VBG	_	20	compound	_	_
20	doses	_	NOUN	NNS	_	16	nmod	_	_
21	>	_	NUM	CD	_	23	nummod	_	_
22	1	_	NUM	CD	_	23	nummod	_	_
23	g	_	NOUN	NN	_	20	dep	_	_
24	/	_	.	:	_	9	punct	_	_
25	day	_	NOUN	NN	_	36	nmod	_	_
26	of	_	ADP	IN	_	27	case	_	_
27	niacin	_	NOUN	NN	_	25	nmod	_	_
28	a	_	DET	DT	_	29	det	_	_
29	reduction	_	NOUN	NN	_	36	nsubjpass	_	_
30	in	_	ADP	IN	_	33	case	_	_
31	DRUG	_	NOUN	NN	_	33	compound	_	_
32	sodium	_	NOUN	NN	_	33	compound	_	_
33	dosage	_	NOUN	NN	_	29	nmod	_	_
34	should	_	VERB	MD	_	36	aux	_	_
35	be	_	VERB	VB	_	36	auxpass	_	_
36	considered	_	VERB	VBN	_	9	parataxis	_	_
37	in	_	ADP	IN	_	39	case	_	_
38	this	_	DET	DT	_	39	det	_	_
39	setting	_	VERB	VBG	_	36	nmod	_	_

#	Fluvastatin	160
1	Concomitant	_	ADJ	JJ	_	2	amod	_	_
2	administration	_	NOUN	NN	_	0	root	_	_
3	of	_	ADP	IN	_	9	case	_	_
4	DRUG	_	NOUN	NN	_	9	compound	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	glyburide	_	NOUN	NN	_	4	conj	_	_
7	increased	_	ADJ	JJ	_	9	amod	_	_
8	glyburide	_	NOUN	NN	_	9	compound	_	_
9	exposures	_	NOUN	NNS	_	2	nmod	_	_

#	Fluvastatin	161
1	Patients	_	NOUN	NNS	_	10	nsubj	_	_
2	on	_	ADP	IN	_	4	case	_	_
3	concomitant	_	ADJ	JJ	_	4	amod	_	_
4	therapy	_	NOUN	NN	_	1	nmod	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	glyburide	_	NOUN	NN	_	4	nmod	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	DRUG	_	NOUN	NN	_	6	conj	_	_
9	should	_	VERB	MD	_	10	aux	_	_
10	continue	_	VERB	VB	_	0	root	_	_
11	to	_	PRT	TO	_	13	mark	_	_
12	be	_	VERB	VB	_	13	auxpass	_	_
13	monitored	_	VERB	VBN	_	10	xcomp	_	_
14	appropriately	_	ADV	RB	_	13	advmod	_	_

#	Fluvastatin	162
1	Concomitant	_	ADJ	JJ	_	2	amod	_	_
2	administration	_	NOUN	NN	_	7	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	phenytoin	_	NOUN	NN	_	4	conj	_	_
7	increased	_	ADJ	JJ	_	0	root	_	_
8	phenytoin	_	NOUN	NN	_	9	compound	_	_
9	exposures	_	NOUN	NNS	_	7	dobj	_	_

#	Fluvastatin	163
1	Patients	_	NOUN	NNS	_	3	nsubj	_	_
2	should	_	VERB	MD	_	3	aux	_	_
3	continue	_	VERB	VB	_	0	root	_	_
4	to	_	PRT	TO	_	6	mark	_	_
5	be	_	VERB	VB	_	6	auxpass	_	_
6	monitored	_	VERB	VBN	_	3	xcomp	_	_
7	appropriately	_	ADV	RB	_	12	advmod	_	_
8	when	_	ADV	WRB	_	12	advmod	_	_
9	DRUG	_	NOUN	NN	_	10	compound	_	_
10	therapy	_	NOUN	NN	_	12	nsubjpass	_	_
11	is	_	VERB	VBZ	_	12	auxpass	_	_
12	initiated	_	VERB	VBN	_	6	ccomp	_	_
13	or	_	CONJ	CC	_	12	cc	_	_
14	when	_	ADV	WRB	_	18	advmod	_	_
15	DRUG	_	NOUN	NN	_	16	compound	_	_
16	dose	_	NOUN	NN	_	18	nsubjpass	_	_
17	is	_	VERB	VBZ	_	18	auxpass	_	_
18	changed	_	VERB	VBN	_	12	conj	_	_

#	Fluvastatin	164
1	Bleeding	_	NOUN	NN	_	10	nsubjpass	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	/	_	NOUN	NN	_	1	conj	_	_
4	or	_	CONJ	CC	_	1	cc	_	_
5	increased	_	VERB	VBN	_	7	amod	_	_
6	prothrombin	_	NOUN	NN	_	7	compound	_	_
7	times	_	NOUN	NNS	_	1	conj	_	_
8	have	_	VERB	VBP	_	10	aux	_	_
9	been	_	VERB	VBN	_	10	auxpass	_	_
10	reported	_	VERB	VBN	_	0	root	_	_
11	in	_	ADP	IN	_	12	case	_	_
12	patients	_	NOUN	NNS	_	10	nmod	_	_
13	taking	_	VERB	VBG	_	12	acl	_	_
14	coumarin	_	NOUN	NN	_	15	compound	_	_
15	anticoagulants	_	NOUN	NNS	_	13	dobj	_	_
16	concomitantly	_	ADV	RB	_	13	advmod	_	_
17	with	_	ADP	IN	_	22	case	_	_
18	other	_	ADJ	JJ	_	22	amod	_	_
19	HMG	_	NOUN	NN	_	22	compound	_	_
20	CoA	_	NOUN	NN	_	22	compound	_	_
21	reductase	_	NOUN	NN	_	22	compound	_	_
22	inhibitors	_	NOUN	NNS	_	13	nmod	_	_

#	Fluvastatin	165
1	Therefore	_	ADV	RB	_	9	advmod	_	_
2	,	_	.	,	_	9	punct	_	_
3	patients	_	NOUN	NNS	_	9	nsubj	_	_
4	receiving	_	VERB	VBG	_	3	acl	_	_
5	warfarin	_	NOUN	NN	_	7	compound	_	_
6	type	_	NOUN	NN	_	7	compound	_	_
7	anticoagulants	_	NOUN	NNS	_	4	dobj	_	_
8	should	_	VERB	MD	_	9	aux	_	_
9	have	_	VERB	VB	_	0	root	_	_
10	their	_	PRON	PRP$	_	12	nmod:poss	_	_
11	prothrombin	_	NOUN	NN	_	12	compound	_	_
12	times	_	NOUN	NNS	_	9	dobj	_	_
13	closely	_	ADV	RB	_	14	advmod	_	_
14	monitored	_	VERB	VBN	_	12	acl	_	_
15	when	_	ADV	WRB	_	19	advmod	_	_
16	DRUG	_	NOUN	NN	_	17	compound	_	_
17	sodium	_	NOUN	NN	_	19	nsubjpass	_	_
18	is	_	VERB	VBZ	_	19	auxpass	_	_
19	initiated	_	VERB	VBN	_	14	ccomp	_	_
20	or	_	CONJ	CC	_	19	cc	_	_
21	the	_	DET	DT	_	22	det	_	_
22	dosage	_	NOUN	NN	_	27	nsubjpass	_	_
23	of	_	ADP	IN	_	25	case	_	_
24	DRUG	_	NOUN	NN	_	25	compound	_	_
25	sodium	_	NOUN	NN	_	22	nmod	_	_
26	is	_	VERB	VBZ	_	27	auxpass	_	_
27	changed	_	VERB	VBN	_	19	conj	_	_

#	Fluvastatin	166
1	Cases	_	NOUN	NNS	_	10	nsubjpass	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	myopathy	_	NOUN	NN	_	1	nmod	_	_
4	,	_	.	,	_	3	punct	_	_
5	including	_	VERB	VBG	_	6	case	_	_
6	rhabdomyolysis	_	NOUN	NN	_	3	nmod	_	_
7	,	_	.	,	_	1	punct	_	_
8	have	_	VERB	VBP	_	10	aux	_	_
9	been	_	VERB	VBN	_	10	auxpass	_	_
10	reported	_	VERB	VBN	_	0	root	_	_
11	with	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_
13	coadministered	_	VERB	VBN	_	12	acl	_	_
14	with	_	ADP	IN	_	15	case	_	_
15	colchicine	_	NOUN	NN	_	13	nmod	_	_
16	,	_	.	,	_	10	punct	_	_
17	and	_	CONJ	CC	_	10	cc	_	_
18	caution	_	NOUN	NN	_	21	nsubjpass	_	_
19	should	_	VERB	MD	_	21	aux	_	_
20	be	_	VERB	VB	_	21	auxpass	_	_
21	exercised	_	VERB	VBN	_	10	conj	_	_
22	when	_	ADV	WRB	_	23	advmod	_	_
23	prescribing	_	VERB	VBG	_	21	advcl	_	_
24	DRUG	_	NOUN	NN	_	23	dobj	_	_
25	with	_	ADP	IN	_	26	case	_	_
26	colchicine	_	NOUN	NN	_	23	nmod	_	_

#	Fluvastatin	167
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	sodium	_	NOUN	NN	_	6	nsubj	_	_
3	is	_	VERB	VBZ	_	6	cop	_	_
4	a	_	DET	DT	_	6	det	_	_
5	competitive	_	ADJ	JJ	_	6	amod	_	_
6	inhibitor	_	NOUN	NN	_	0	root	_	_
7	of	_	ADP	IN	_	10	case	_	_
8	HMG	_	NOUN	NN	_	10	compound	_	_
9	CoA	_	NOUN	NN	_	10	compound	_	_
10	reductase	_	NOUN	NN	_	6	nmod	_	_
11	,	_	.	,	_	10	punct	_	_
12	the	_	DET	DT	_	15	det	_	_
13	rate	_	ADJ	JJ	_	15	amod	_	_
14	limiting	_	VERB	VBG	_	15	compound	_	_
15	enzyme	_	NOUN	NN	_	10	appos	_	_
16	that	_	DET	WDT	_	17	nsubj	_	_
17	converts	_	VERB	VBZ	_	15	acl:relcl	_	_
18	3	_	NUM	CD	_	25	nummod	_	_
19	hydroxy	_	NOUN	NN	_	25	compound	_	_
20	3	_	NUM	CD	_	25	nummod	_	_
21	methylglutaryl	_	NOUN	NN	_	25	compound	_	_
22	coenzyme	_	NOUN	NN	_	25	compound	_	_
23	A	_	NOUN	NN	_	25	compound	_	_
24	HMG	_	NOUN	NN	_	25	compound	_	_
25	CoA	_	NOUN	NN	_	17	dobj	_	_
26	to	_	PRT	TO	_	27	mark	_	_
27	mevalonate	_	VERB	VB	_	17	xcomp	_	_
28	,	_	.	,	_	27	punct	_	_
29	a	_	DET	DT	_	30	det	_	_
30	precursor	_	NOUN	NN	_	27	dobj	_	_
31	of	_	ADP	IN	_	32	case	_	_
32	sterols	_	NOUN	NNS	_	30	nmod	_	_
33	,	_	.	,	_	32	punct	_	_
34	including	_	VERB	VBG	_	35	case	_	_
35	cholesterol	_	NOUN	NN	_	32	nmod	_	_

#	Fluvastatin	168
1	The	_	DET	DT	_	2	det	_	_
2	inhibition	_	NOUN	NN	_	6	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	cholesterol	_	NOUN	NN	_	5	compound	_	_
5	biosynthesis	_	NOUN	NN	_	2	nmod	_	_
6	reduces	_	VERB	VBZ	_	0	root	_	_
7	the	_	DET	DT	_	8	det	_	_
8	cholesterol	_	NOUN	NN	_	6	dobj	_	_
9	in	_	ADP	IN	_	11	case	_	_
10	hepatic	_	ADJ	JJ	_	11	amod	_	_
11	cells	_	NOUN	NNS	_	8	nmod	_	_
12	,	_	.	,	_	11	punct	_	_
13	which	_	DET	WDT	_	14	nsubj	_	_
14	stimulates	_	VERB	VBZ	_	11	acl:relcl	_	_
15	the	_	DET	DT	_	16	det	_	_
16	synthesis	_	NOUN	NN	_	14	dobj	_	_
17	of	_	ADP	IN	_	19	case	_	_
18	LDL	_	NOUN	NN	_	19	compound	_	_
19	receptors	_	NOUN	NNS	_	16	nmod	_	_
20	and	_	CONJ	CC	_	14	cc	_	_
21	thereby	_	ADV	RB	_	22	advmod	_	_
22	increases	_	VERB	VBZ	_	14	conj	_	_
23	the	_	DET	DT	_	24	det	_	_
24	uptake	_	NOUN	NN	_	22	dobj	_	_
25	of	_	ADP	IN	_	27	case	_	_
26	LDL	_	NOUN	NN	_	27	compound	_	_
27	particles	_	NOUN	NNS	_	24	nmod	_	_

#	Fluvastatin	169
1	The	_	DET	DT	_	3	det	_	_
2	end	_	NOUN	NN	_	3	compound	_	_
3	result	_	NOUN	NN	_	10	nsubj	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	these	_	DET	DT	_	7	det	_	_
6	biochemical	_	ADJ	JJ	_	7	amod	_	_
7	processes	_	NOUN	NNS	_	3	nmod	_	_
8	is	_	VERB	VBZ	_	10	cop	_	_
9	a	_	DET	DT	_	10	det	_	_
10	reduction	_	NOUN	NN	_	0	root	_	_
11	of	_	ADP	IN	_	15	case	_	_
12	the	_	DET	DT	_	15	det	_	_
13	plasma	_	NOUN	NN	_	15	compound	_	_
14	cholesterol	_	NOUN	NN	_	15	compound	_	_
15	concentration	_	NOUN	NN	_	10	nmod	_	_

#	Fluvastatin	170
1	Absorption	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Following	_	ADP	IN	_	5	case	_	_
4	oral	_	ADJ	JJ	_	5	amod	_	_
5	administration	_	NOUN	NN	_	1	nmod	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	the	_	DET	DT	_	8	det	_	_
8	capsule	_	NOUN	NN	_	5	nmod	_	_
9	,	_	.	,	_	1	punct	_	_
10	DRUG	_	NOUN	NN	_	11	nsubj	_	_
11	reaches	_	VERB	VBZ	_	1	dep	_	_
12	peak	_	ADJ	JJ	_	13	amod	_	_
13	concentrations	_	NOUN	NNS	_	11	dobj	_	_
14	in	_	ADP	IN	_	18	case	_	_
15	less	_	ADV	RB	_	18	advmod	_	_
16	than	_	ADP	IN	_	18	case	_	_
17	1	_	NUM	CD	_	18	nummod	_	_
18	hour	_	NUM	CD	_	13	nmod	_	_

#	Fluvastatin	171
1	The	_	DET	DT	_	3	det	_	_
2	absolute	_	ADJ	JJ	_	3	amod	_	_
3	bioavailability	_	NOUN	NN	_	6	nsubj	_	_
4	is	_	VERB	VBZ	_	6	cop	_	_
5	24%	_	ADJ	JJ	_	6	amod	_	_
6	range	_	NOUN	NN	_	0	root	_	_
7	9%	_	NOUN	NN	_	6	dobj	_	_
8	to	_	PRT	TO	_	9	case	_	_
9	50%	_	ADJ	JJ	_	7	nmod	_	_
10	after	_	ADP	IN	_	11	case	_	_
11	administration	_	NOUN	NN	_	7	nmod	_	_
12	of	_	ADP	IN	_	16	case	_	_
13	a	_	DET	DT	_	16	det	_	_
14	10	_	NUM	CD	_	16	nummod	_	_
15	mg	_	NOUN	NN	_	16	compound	_	_
16	dose	_	NOUN	NN	_	11	nmod	_	_

#	Fluvastatin	172
1	At	_	ADP	IN	_	3	case	_	_
2	steady	_	ADJ	JJ	_	3	amod	_	_
3	state	_	NOUN	NN	_	0	root	_	_
4	,	_	.	,	_	3	punct	_	_
5	administration	_	NOUN	NN	_	4	root	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	with	_	ADP	IN	_	12	case	_	_
9	the	_	DET	DT	_	12	det	_	_
10	evening	_	VERB	VBG	_	12	amod	_	_
11	meal	_	ADJ	JJ	_	12	amod	_	_
12	results	_	NOUN	NNS	_	5	nmod	_	_
13	in	_	ADP	IN	_	16	case	_	_
14	a	_	DET	DT	_	16	det	_	_
15	50%	_	ADJ	JJ	_	16	amod	_	_
16	decrease	_	NOUN	NN	_	5	nmod	_	_
17	in	_	ADP	IN	_	18	case	_	_
18	Cmax	_	NOUN	NN	_	16	nmod	_	_
19	,	_	.	,	_	18	punct	_	_
20	an	_	DET	DT	_	22	det	_	_
21	11%	_	ADJ	JJ	_	22	amod	_	_
22	decrease	_	NOUN	NN	_	18	conj	_	_
23	in	_	ADP	IN	_	24	case	_	_
24	AUC	_	NOUN	NN	_	22	nmod	_	_
25	,	_	.	,	_	18	punct	_	_
26	and	_	CONJ	CC	_	18	cc	_	_
27	a	_	DET	DT	_	32	det	_	_
28	more	_	ADJ	JJ	_	30	advmod	_	_
29	than	_	ADP	IN	_	30	advmod	_	_
30	two	_	NUM	CD	_	32	nummod	_	_
31	fold	_	NOUN	NN	_	32	amod	_	_
32	increase	_	NOUN	NN	_	18	conj	_	_
33	in	_	ADP	IN	_	34	case	_	_
34	tmax	_	NOUN	NN	_	32	nmod	_	_
35	as	_	ADP	IN	_	36	mark	_	_
36	compared	_	VERB	VBN	_	5	acl	_	_
37	to	_	PRT	TO	_	40	case	_	_
38	administration	_	NOUN	NN	_	40	compound	_	_
39	4	_	NUM	CD	_	40	nummod	_	_
40	hours	_	NOUN	NNS	_	36	nmod	_	_
41	after	_	ADP	IN	_	43	case	_	_
42	the	_	DET	DT	_	43	det	_	_
43	evening	_	VERB	VBG	_	36	nmod	_	_
44	meal	_	ADJ	JJ	_	43	dep	_	_

#	Fluvastatin	173
1	No	_	DET	DT	_	3	neg	_	_
2	significant	_	ADJ	JJ	_	3	amod	_	_
3	differences	_	NOUN	NNS	_	10	nsubjpass	_	_
4	in	_	ADP	IN	_	8	case	_	_
5	the	_	DET	DT	_	8	det	_	_
6	lipid	_	NOUN	NN	_	8	compound	_	_
7	lowering	_	NOUN	NN	_	8	compound	_	_
8	effects	_	NOUN	NNS	_	3	nmod	_	_
9	were	_	VERB	VBD	_	10	auxpass	_	_
10	observed	_	VERB	VBN	_	0	root	_	_
11	between	_	ADP	IN	_	14	case	_	_
12	the	_	DET	DT	_	14	det	_	_
13	two	_	NUM	CD	_	14	nummod	_	_
14	administrations	_	NOUN	NNS	_	10	nmod	_	_

#	Fluvastatin	174
1	After	_	ADP	IN	_	5	case	_	_
2	single	_	ADJ	JJ	_	5	amod	_	_
3	or	_	CONJ	CC	_	2	cc	_	_
4	multiple	_	ADJ	JJ	_	2	conj	_	_
5	doses	_	NOUN	NNS	_	11	nmod	_	_
6	above	_	ADP	IN	_	8	case	_	_
7	20	_	NUM	CD	_	8	nummod	_	_
8	mg	_	NOUN	NN	_	5	nmod	_	_
9	,	_	.	,	_	11	punct	_	_
10	DRUG	_	NOUN	NN	_	11	nsubj	_	_
11	exhibits	_	VERB	VBZ	_	0	root	_	_
12	saturable	_	ADJ	JJ	_	15	amod	_	_
13	first	_	ADJ	JJ	_	15	amod	_	_
14	pass	_	NOUN	NN	_	15	compound	_	_
15	metabolism	_	NOUN	NN	_	11	dobj	_	_
16	resulting	_	VERB	VBG	_	15	acl	_	_
17	in	_	ADP	IN	_	24	case	_	_
18	more	_	ADV	RB	_	24	advmod	_	_
19	than	_	ADP	IN	_	18	mwe	_	_
20	dose	_	NOUN	NN	_	24	compound	_	_
21	proportional	_	ADJ	JJ	_	24	amod	_	_
22	plasma	_	NOUN	NN	_	24	compound	_	_
23	DRUG	_	NOUN	NN	_	24	compound	_	_
24	concentrations	_	NOUN	NNS	_	16	nmod	_	_

#	Fluvastatin	175
1	DRUG	_	NOUN	NN	_	6	nsubj	_	_
2	administered	_	VERB	VBN	_	1	acl	_	_
3	as	_	ADP	IN	_	5	case	_	_
4	DRUG	_	NOUN	NN	_	5	compound	_	_
5	sodium	_	NOUN	NN	_	2	nmod	_	_
6	extended	_	VERB	VBD	_	0	root	_	_
7	release	_	NOUN	NN	_	10	compound	_	_
8	80	_	NUM	CD	_	10	nummod	_	_
9	mg	_	NOUN	NN	_	10	compound	_	_
10	tablets	_	NOUN	NNS	_	6	dobj	_	_
11	reaches	_	VERB	VBZ	_	6	parataxis	_	_
12	peak	_	ADJ	JJ	_	13	amod	_	_
13	concentration	_	NOUN	NN	_	11	dobj	_	_
14	in	_	ADP	IN	_	17	case	_	_
15	approximately	_	ADV	RB	_	16	advmod	_	_
16	3	_	NUM	CD	_	17	nummod	_	_
17	hours	_	NOUN	NNS	_	13	nmod	_	_
18	under	_	ADP	IN	_	19	mark	_	_
19	fasting	_	VERB	VBG	_	11	advcl	_	_
20	conditions	_	NOUN	NNS	_	19	dobj	_	_
21	,	_	.	,	_	11	punct	_	_
22	after	_	ADP	IN	_	26	case	_	_
23	a	_	DET	DT	_	26	det	_	_
24	low	_	ADJ	JJ	_	26	amod	_	_
25	fat	_	NOUN	NN	_	26	compound	_	_
26	meal	_	ADJ	JJ	_	11	nmod	_	_
27	,	_	.	,	_	11	punct	_	_
28	or	_	CONJ	CC	_	11	cc	_	_
29	2.5	_	NUM	CD	_	30	nummod	_	_
30	hours	_	NOUN	NNS	_	11	conj	_	_
31	after	_	ADP	IN	_	35	case	_	_
32	a	_	DET	DT	_	35	det	_	_
33	low	_	ADJ	JJ	_	35	amod	_	_
34	fat	_	NOUN	NN	_	35	compound	_	_
35	meal	_	ADJ	JJ	_	30	nmod	_	_

#	Fluvastatin	176
1	The	_	DET	DT	_	4	det	_	_
2	mean	_	ADJ	JJ	_	4	amod	_	_
3	relative	_	ADJ	JJ	_	4	amod	_	_
4	bioavailability	_	NOUN	NN	_	13	nsubj	_	_
5	of	_	ADP	IN	_	9	case	_	_
6	the	_	DET	DT	_	9	det	_	_
7	extended	_	VERB	VBN	_	9	amod	_	_
8	release	_	NOUN	NN	_	9	compound	_	_
9	tablet	_	NOUN	NN	_	4	nmod	_	_
10	is	_	VERB	VBZ	_	13	cop	_	_
11	approximately	_	ADV	RB	_	12	advmod	_	_
12	29%	_	ADJ	JJ	_	13	amod	_	_
13	range	_	NOUN	NN	_	0	root	_	_
14	:	_	.	:	_	13	punct	_	_
15	9%	_	NOUN	NN	_	18	nsubj	_	_
16	to	_	PRT	TO	_	17	case	_	_
17	66%	_	NOUN	NN	_	15	nmod	_	_
18	compared	_	VERB	VBN	_	13	dep	_	_
19	to	_	PRT	TO	_	20	case	_	_
20	that	_	DET	DT	_	18	nmod	_	_
21	of	_	ADP	IN	_	26	case	_	_
22	the	_	DET	DT	_	26	det	_	_
23	DRUG	_	NOUN	NN	_	26	compound	_	_
24	immediate	_	ADJ	JJ	_	26	amod	_	_
25	release	_	NOUN	NN	_	26	compound	_	_
26	capsule	_	NOUN	NN	_	20	nmod	_	_
27	administered	_	VERB	VBN	_	26	acl	_	_
28	under	_	ADP	IN	_	30	case	_	_
29	fasting	_	VERB	VBG	_	30	amod	_	_
30	conditions	_	NOUN	NNS	_	27	nmod	_	_

#	Fluvastatin	177
1	Administration	_	NOUN	NN	_	7	nsubj	_	_
2	of	_	ADP	IN	_	6	case	_	_
3	a	_	DET	DT	_	6	det	_	_
4	high	_	ADJ	JJ	_	6	amod	_	_
5	fat	_	NOUN	NN	_	6	compound	_	_
6	meal	_	NOUN	NN	_	1	nmod	_	_
7	delayed	_	VERB	VBD	_	0	root	_	_
8	the	_	DET	DT	_	10	det	_	_
9	absorption	_	NOUN	NN	_	10	compound	_	_
10	Tmax	_	NOUN	NN	_	7	dobj	_	_
11	:	_	.	:	_	7	punct	_	_
12	6h	_	ADJ	JJ	_	7	dep	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	increased	_	VERB	VBD	_	12	conj	_	_
15	the	_	DET	DT	_	16	det	_	_
16	bioavailability	_	NOUN	NN	_	14	dobj	_	_
17	of	_	ADP	IN	_	21	case	_	_
18	the	_	DET	DT	_	21	det	_	_
19	extended	_	VERB	VBN	_	21	amod	_	_
20	release	_	NOUN	NN	_	21	compound	_	_
21	tablet	_	NOUN	NN	_	16	nmod	_	_
22	by	_	ADP	IN	_	24	case	_	_
23	approximately	_	ADV	RB	_	24	advmod	_	_
24	50%	_	ADJ	JJ	_	16	nmod	_	_

#	Fluvastatin	178
1	However	_	ADV	RB	_	9	advmod	_	_
2	,	_	.	,	_	9	punct	_	_
3	the	_	DET	DT	_	5	det	_	_
4	maximum	_	NOUN	NN	_	5	compound	_	_
5	concentration	_	NOUN	NN	_	9	nsubj	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	DRUG	_	NOUN	NN	_	8	compound	_	_
8	sodium	_	NOUN	NN	_	5	nmod	_	_
9	extended	_	VERB	VBD	_	0	root	_	_
10	release	_	NOUN	NN	_	11	compound	_	_
11	tablets	_	NOUN	NNS	_	9	dobj	_	_
12	seen	_	VERB	VBN	_	11	acl	_	_
13	after	_	ADP	IN	_	17	case	_	_
14	a	_	DET	DT	_	17	det	_	_
15	high	_	ADJ	JJ	_	17	amod	_	_
16	fat	_	NOUN	NN	_	17	compound	_	_
17	meal	_	NOUN	NN	_	12	nmod	_	_
18	is	_	VERB	VBZ	_	23	cop	_	_
19	less	_	ADV	RB	_	23	advmod	_	_
20	than	_	ADP	IN	_	23	case	_	_
21	the	_	DET	DT	_	23	det	_	_
22	peak	_	ADJ	JJ	_	23	amod	_	_
23	concentration	_	NOUN	NN	_	9	nmod	_	_
24	following	_	ADP	IN	_	27	case	_	_
25	a	_	DET	DT	_	27	det	_	_
26	single	_	ADJ	JJ	_	27	amod	_	_
27	dose	_	NOUN	NN	_	23	nmod	_	_
28	or	_	CONJ	CC	_	23	cc	_	_
29	twice	_	ADV	RB	_	30	advmod	_	_
30	daily	_	ADV	RB	_	31	advmod	_	_
31	dose	_	NOUN	NN	_	23	conj	_	_
32	of	_	ADP	IN	_	37	case	_	_
33	the	_	DET	DT	_	37	det	_	_
34	40	_	NUM	CD	_	37	nummod	_	_
35	mg	_	NOUN	NN	_	37	compound	_	_
36	DRUG	_	NOUN	NN	_	37	compound	_	_
37	capsule	_	NOUN	NN	_	31	nmod	_	_

#	Fluvastatin	179
1	Distribution	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	DRUG	_	NOUN	NN	_	6	nsubjpass	_	_
4	is	_	VERB	VBZ	_	6	auxpass	_	_
5	98%	_	ADJ	JJ	_	6	advmod	_	_
6	bound	_	VERB	VBN	_	1	dep	_	_
7	to	_	PRT	TO	_	9	case	_	_
8	plasma	_	NOUN	NN	_	9	compound	_	_
9	proteins	_	NOUN	NNS	_	6	nmod	_	_

#	Fluvastatin	180
1	The	_	DET	DT	_	3	det	_	_
2	mean	_	ADJ	JJ	_	3	amod	_	_
3	volume	_	NOUN	NN	_	8	nsubjpass	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	distribution	_	NOUN	NN	_	6	compound	_	_
6	VDss	_	NOUN	NN	_	3	nmod	_	_
7	is	_	VERB	VBZ	_	8	auxpass	_	_
8	estimated	_	VERB	VBN	_	0	root	_	_
9	at	_	ADP	IN	_	11	case	_	_
10	0.35	_	NUM	CD	_	11	nummod	_	_
11	L	_	NOUN	NN	_	8	nmod	_	_
12	/	_	.	:	_	11	punct	_	_
13	kg	_	NOUN	NN	_	11	dep	_	_

#	Fluvastatin	181
1	At	_	ADP	IN	_	3	case	_	_
2	therapeutic	_	ADJ	JJ	_	3	amod	_	_
3	concentrations	_	NOUN	NNS	_	12	nmod	_	_
4	,	_	.	,	_	12	punct	_	_
5	the	_	DET	DT	_	7	det	_	_
6	protein	_	NOUN	NN	_	7	compound	_	_
7	binding	_	NOUN	NN	_	12	nsubjpass	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	is	_	VERB	VBZ	_	12	auxpass	_	_
11	not	_	ADV	RB	_	12	neg	_	_
12	affected	_	VERB	VBN	_	0	root	_	_
13	by	_	ADP	IN	_	14	case	_	_
14	warfarin	_	NOUN	NN	_	12	nmod	_	_
15	,	_	.	,	_	14	punct	_	_
16	salicylic	_	ADJ	JJ	_	17	amod	_	_
17	acid	_	NOUN	NN	_	14	conj	_	_
18	and	_	CONJ	CC	_	14	cc	_	_
19	glyburide	_	NOUN	NN	_	14	conj	_	_

#	Fluvastatin	182
1	Metabolism	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	DRUG	_	NOUN	NN	_	5	nsubjpass	_	_
4	is	_	VERB	VBZ	_	5	auxpass	_	_
5	metabolized	_	VERB	VBN	_	1	dep	_	_
6	in	_	ADP	IN	_	8	case	_	_
7	the	_	DET	DT	_	8	det	_	_
8	liver	_	NOUN	NN	_	5	nmod	_	_
9	,	_	.	,	_	5	punct	_	_
10	primarily	_	ADV	RB	_	12	advmod	_	_
11	via	_	ADP	IN	_	12	case	_	_
12	hydroxylation	_	NOUN	NN	_	5	nmod	_	_
13	of	_	ADP	IN	_	16	case	_	_
14	the	_	DET	DT	_	16	det	_	_
15	indole	_	ADJ	JJ	_	16	amod	_	_
16	ring	_	NOUN	NN	_	12	nmod	_	_
17	at	_	ADP	IN	_	22	case	_	_
18	the	_	DET	DT	_	22	det	_	_
19	5	_	NUM	CD	_	22	nummod	_	_
20	and	_	CONJ	CC	_	19	cc	_	_
21	6	_	NUM	CD	_	19	conj	_	_
22	positions	_	NOUN	NNS	_	12	nmod	_	_

#	Fluvastatin	183
1	N	_	NOUN	NN	_	2	compound	_	_
2	dealkylation	_	NOUN	NN	_	11	nsubj	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	beta	_	NOUN	NN	_	5	compound	_	_
5	oxidation	_	NOUN	NN	_	2	conj	_	_
6	of	_	ADP	IN	_	9	case	_	_
7	the	_	DET	DT	_	9	det	_	_
8	side	_	ADJ	JJ	_	9	amod	_	_
9	chain	_	NOUN	NN	_	2	nmod	_	_
10	also	_	ADV	RB	_	11	advmod	_	_
11	occurs	_	VERB	VBZ	_	0	root	_	_

#	Fluvastatin	184
1	The	_	DET	DT	_	3	det	_	_
2	hydroxy	_	ADJ	JJ	_	3	amod	_	_
3	metabolites	_	NOUN	NNS	_	4	nsubj	_	_
4	have	_	VERB	VBP	_	0	root	_	_
5	some	_	DET	DT	_	7	det	_	_
6	pharmacologic	_	ADJ	JJ	_	7	amod	_	_
7	activity	_	NOUN	NN	_	4	dobj	_	_
8	,	_	.	,	_	4	punct	_	_
9	but	_	CONJ	CC	_	4	cc	_	_
10	do	_	VERB	MD	_	12	aux	_	_
11	not	_	ADV	RB	_	12	neg	_	_
12	circulate	_	NOUN	NN	_	4	conj	_	_
13	in	_	ADP	IN	_	15	case	_	_
14	the	_	DET	DT	_	15	det	_	_
15	blood	_	NOUN	NN	_	12	nmod	_	_

#	Fluvastatin	185
1	Both	_	DET	DT	_	2	det	_	_
2	enantiomers	_	NOUN	NNS	_	6	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	are	_	VERB	VBP	_	6	auxpass	_	_
6	metabolized	_	VERB	VBN	_	0	root	_	_
7	in	_	ADP	IN	_	10	case	_	_
8	a	_	DET	DT	_	10	det	_	_
9	similar	_	ADJ	JJ	_	10	amod	_	_
10	manner	_	NOUN	NN	_	6	nmod	_	_

#	Fluvastatin	186
1	In	_	X	FW	_	3	amod	_	_
2	vitro	_	X	FW	_	1	dep	_	_
3	data	_	NOUN	NNS	_	4	nsubj	_	_
4	indicate	_	VERB	VBP	_	0	root	_	_
5	that	_	ADP	IN	_	8	mark	_	_
6	DRUG	_	NOUN	NN	_	7	compound	_	_
7	metabolism	_	NOUN	NN	_	8	nsubj	_	_
8	involves	_	VERB	VBZ	_	4	ccomp	_	_
9	multiple	_	ADJ	JJ	_	13	amod	_	_
10	Cytochrome	_	NOUN	NN	_	13	compound	_	_
11	P450	_	NOUN	NN	_	13	compound	_	_
12	CYP	_	NOUN	NN	_	13	compound	_	_
13	isozymes	_	NOUN	NNS	_	8	dobj	_	_

#	Fluvastatin	187
1	CYP2C9	_	NOUN	NN	_	2	compound	_	_
2	isoenzyme	_	NOUN	NN	_	5	nsubjpass	_	_
3	is	_	VERB	VBZ	_	5	auxpass	_	_
4	primarily	_	ADV	RB	_	5	advmod	_	_
5	involved	_	VERB	VBN	_	0	root	_	_
6	in	_	ADP	IN	_	8	case	_	_
7	the	_	DET	DT	_	8	det	_	_
8	metabolism	_	NOUN	NN	_	5	nmod	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	approximately	_	ADV	RB	_	12	advmod	_	_
12	75%	_	ADJ	JJ	_	5	advmod	_	_
13	,	_	.	,	_	5	punct	_	_
14	while	_	ADP	IN	_	5	dep	_	_
15	CYP2C8	_	NOUN	NN	_	18	compound	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	CYP3A4	_	NOUN	NN	_	15	conj	_	_
18	isoenzymes	_	NOUN	NNS	_	20	nsubjpass	_	_
19	are	_	VERB	VBP	_	20	auxpass	_	_
20	involved	_	VERB	VBN	_	5	parataxis	_	_
21	to	_	PRT	TO	_	25	case	_	_
22	a	_	DET	DT	_	25	det	_	_
23	much	_	ADV	RB	_	24	advmod	_	_
24	less	_	ADV	RB	_	25	amod	_	_
25	extent	_	NOUN	NN	_	20	nmod	_	_
26	,	_	.	,	_	25	punct	_	_
27	i.e	_	ADV	RB	_	30	advmod	_	_
28	,	_	.	,	_	30	punct	_	_
29	approximately	_	ADV	RB	_	30	advmod	_	_
30	5%	_	ADJ	JJ	_	25	appos	_	_
31	and	_	CONJ	CC	_	30	cc	_	_
32	approximately	_	ADV	RB	_	33	advmod	_	_
33	20%	_	NOUN	NN	_	30	conj	_	_
34	,	_	.	,	_	25	punct	_	_
35	respectively	_	ADV	RB	_	25	advmod	_	_

#	Fluvastatin	188
1	Excretion	_	NOUN	NN	_	11	nsubj	_	_
2	:	_	.	:	_	1	punct	_	_
3	Following	_	ADP	IN	_	5	case	_	_
4	oral	_	ADJ	JJ	_	5	amod	_	_
5	administration	_	NOUN	NN	_	1	nmod	_	_
6	,	_	.	,	_	1	punct	_	_
7	DRUG	_	NOUN	NN	_	1	appos	_	_
8	is	_	VERB	VBZ	_	11	cop	_	_
9	primarily	_	ADV	RB	_	11	advmod	_	_
10	about	_	ADV	RB	_	11	advmod	_	_
11	90%	_	NOUN	NN	_	0	root	_	_
12	excreted	_	VERB	VBN	_	11	acl	_	_
13	in	_	ADP	IN	_	15	case	_	_
14	the	_	DET	DT	_	15	det	_	_
15	feces	_	NOUN	NNS	_	12	nmod	_	_
16	as	_	ADP	IN	_	17	case	_	_
17	metabolites	_	NOUN	NNS	_	12	nmod	_	_
18	,	_	.	,	_	11	punct	_	_
19	with	_	ADP	IN	_	22	case	_	_
20	less	_	ADV	RB	_	22	advmod	_	_
21	than	_	ADP	IN	_	20	mwe	_	_
22	2%	_	NOUN	NN	_	11	nmod	_	_
23	present	_	ADJ	JJ	_	22	amod	_	_
24	as	_	ADP	IN	_	26	case	_	_
25	unchanged	_	ADJ	JJ	_	26	amod	_	_
26	drug	_	NOUN	NN	_	23	nmod	_	_

#	Fluvastatin	189
1	Approximately	_	ADV	RB	_	9	advmod	_	_
2	5%	_	NOUN	NN	_	9	nsubjpass	_	_
3	of	_	ADP	IN	_	7	case	_	_
4	a	_	DET	DT	_	7	det	_	_
5	radiolabeled	_	VERB	VBN	_	7	amod	_	_
6	oral	_	ADJ	JJ	_	7	amod	_	_
7	dose	_	NOUN	NN	_	2	nmod	_	_
8	were	_	VERB	VBD	_	9	auxpass	_	_
9	recovered	_	VERB	VBN	_	0	root	_	_
10	in	_	ADP	IN	_	11	mark	_	_
11	urine	_	VERB	VBG	_	9	advcl	_	_

#	Fluvastatin	190
1	The	_	DET	DT	_	4	det	_	_
2	elimination	_	NOUN	NN	_	4	compound	_	_
3	half	_	NOUN	NN	_	4	compound	_	_
4	life	_	NOUN	NN	_	13	nsubj	_	_
5	t1	_	NUM	CD	_	4	nummod	_	_
6	/	_	.	:	_	4	punct	_	_
7	2	_	NUM	CD	_	4	dep	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	is	_	VERB	VBZ	_	13	cop	_	_
11	approximately	_	ADV	RB	_	13	advmod	_	_
12	3	_	NUM	CD	_	13	nummod	_	_
13	hours	_	NOUN	NNS	_	0	root	_	_

#	Fluvastatin	191
1	Specific	_	ADJ	JJ	_	2	amod	_	_
2	Populations	_	NOUN	NNS	_	4	compound	_	_
3	Renal	_	ADJ	JJ	_	4	amod	_	_
4	Impairment	_	NOUN	NN	_	0	root	_	_
5	:	_	.	:	_	4	punct	_	_
6	In	_	ADP	IN	_	7	case	_	_
7	patients	_	NOUN	NNS	_	25	nmod	_	_
8	with	_	ADP	IN	_	9	case	_	_
9	moderate	_	NOUN	NN	_	7	nmod	_	_
10	to	_	PRT	TO	_	14	case	_	_
11	severe	_	ADJ	JJ	_	14	amod	_	_
12	renal	_	ADJ	JJ	_	14	amod	_	_
13	impairment	_	NOUN	NN	_	14	compound	_	_
14	CLCr	_	NOUN	NN	_	9	nmod	_	_
15	10	_	NUM	CD	_	17	compound	_	_
16	to	_	PRT	TO	_	17	dep	_	_
17	40	_	NUM	CD	_	18	nummod	_	_
18	mL	_	NOUN	NN	_	14	dep	_	_
19	/	_	.	:	_	20	punct	_	_
20	min	_	NOUN	NN	_	25	nsubj	_	_
21	,	_	.	,	_	20	punct	_	_
22	AUC	_	NOUN	NN	_	20	conj	_	_
23	and	_	CONJ	CC	_	20	cc	_	_
24	Cmax	_	NOUN	NN	_	20	conj	_	_
25	increased	_	VERB	VBD	_	4	dep	_	_
26	approximately	_	ADV	RB	_	27	advmod	_	_
27	1.2	_	NUM	CD	_	28	nummod	_	_
28	fold	_	NOUN	NN	_	25	dobj	_	_
29	after	_	ADP	IN	_	30	case	_	_
30	administration	_	NOUN	NN	_	25	nmod	_	_
31	of	_	ADP	IN	_	34	case	_	_
32	a	_	DET	DT	_	34	det	_	_
33	single	_	ADJ	JJ	_	34	amod	_	_
34	dose	_	NOUN	NN	_	30	nmod	_	_
35	of	_	ADP	IN	_	38	case	_	_
36	40	_	NUM	CD	_	38	nummod	_	_
37	mg	_	NOUN	NN	_	38	compound	_	_
38	DRUG	_	NOUN	NN	_	34	nmod	_	_
39	compared	_	VERB	VBN	_	42	case	_	_
40	to	_	PRT	TO	_	42	case	_	_
41	healthy	_	ADJ	JJ	_	42	amod	_	_
42	volunteers	_	NOUN	NNS	_	25	nmod	_	_

#	Fluvastatin	192
1	In	_	ADP	IN	_	2	case	_	_
2	patients	_	NOUN	NNS	_	13	nmod	_	_
3	with	_	ADP	IN	_	7	case	_	_
4	end	_	NOUN	NN	_	7	compound	_	_
5	stage	_	NOUN	NN	_	7	compound	_	_
6	renal	_	ADJ	JJ	_	7	amod	_	_
7	disease	_	NOUN	NN	_	2	nmod	_	_
8	on	_	ADP	IN	_	9	case	_	_
9	hemodialysis	_	NOUN	NN	_	2	nmod	_	_
10	,	_	.	,	_	13	punct	_	_
11	the	_	DET	DT	_	12	det	_	_
12	AUC	_	NOUN	NN	_	13	nsubj	_	_
13	increased	_	VERB	VBD	_	0	root	_	_
14	by	_	ADP	IN	_	16	case	_	_
15	approximately	_	ADV	RB	_	16	advmod	_	_
16	1.5	_	NUM	CD	_	13	nmod	_	_
17	fold	_	ADJ	JJR	_	16	dep	_	_

#	Fluvastatin	193
1	DRUG	_	NOUN	NN	_	5	compound	_	_
2	sodium	_	NOUN	NN	_	5	compound	_	_
3	extended	_	VERB	VBD	_	5	amod	_	_
4	release	_	NOUN	NN	_	5	compound	_	_
5	tablets	_	NOUN	NNS	_	8	nsubjpass	_	_
6	were	_	VERB	VBD	_	8	auxpass	_	_
7	not	_	ADV	RB	_	8	neg	_	_
8	evaluated	_	VERB	VBN	_	0	root	_	_
9	in	_	ADP	IN	_	10	case	_	_
10	patients	_	NOUN	NNS	_	8	nmod	_	_
11	with	_	ADP	IN	_	13	case	_	_
12	renal	_	ADJ	JJ	_	13	amod	_	_
13	impairment	_	NOUN	NN	_	10	nmod	_	_

#	Fluvastatin	194
1	However	_	ADV	RB	_	14	advmod	_	_
2	,	_	.	,	_	14	punct	_	_
3	systemic	_	ADJ	JJ	_	4	amod	_	_
4	exposures	_	NOUN	NNS	_	14	nsubj	_	_
5	after	_	ADP	IN	_	6	case	_	_
6	administration	_	NOUN	NN	_	4	nmod	_	_
7	of	_	ADP	IN	_	12	case	_	_
8	DRUG	_	NOUN	NN	_	12	compound	_	_
9	sodium	_	NOUN	NN	_	12	compound	_	_
10	extended	_	ADJ	JJ	_	12	amod	_	_
11	release	_	NOUN	NN	_	12	compound	_	_
12	tablets	_	NOUN	NNS	_	6	nmod	_	_
13	are	_	VERB	VBP	_	14	cop	_	_
14	lower	_	ADJ	JJ	_	0	root	_	_
15	than	_	ADP	IN	_	22	case	_	_
16	after	_	ADP	IN	_	22	case	_	_
17	the	_	DET	DT	_	22	det	_	_
18	40	_	NUM	CD	_	22	nummod	_	_
19	mg	_	NOUN	NN	_	22	compound	_	_
20	immediate	_	ADJ	JJ	_	22	amod	_	_
21	release	_	NOUN	NN	_	22	compound	_	_
22	capsule	_	NOUN	NN	_	14	nmod	_	_

#	Fluvastatin	195
1	Hepatic	_	ADJ	JJ	_	2	amod	_	_
2	Impairment	_	NOUN	NN	_	18	nsubj	_	_
3	:	_	.	:	_	2	punct	_	_
4	In	_	ADP	IN	_	5	case	_	_
5	patients	_	NOUN	NNS	_	2	nmod	_	_
6	with	_	ADP	IN	_	8	case	_	_
7	hepatic	_	ADJ	JJ	_	8	amod	_	_
8	impairment	_	NOUN	NN	_	5	nmod	_	_
9	due	_	ADJ	JJ	_	12	case	_	_
10	to	_	PRT	TO	_	9	mwe	_	_
11	liver	_	NOUN	NN	_	12	compound	_	_
12	cirrhosis	_	NOUN	NN	_	8	nmod	_	_
13	,	_	.	,	_	2	punct	_	_
14	DRUG	_	NOUN	NN	_	15	compound	_	_
15	AUC	_	NOUN	NN	_	2	conj	_	_
16	and	_	CONJ	CC	_	2	cc	_	_
17	Cmax	_	NOUN	NN	_	2	conj	_	_
18	increased	_	VERB	VBD	_	0	root	_	_
19	approximately	_	ADV	RB	_	20	advmod	_	_
20	2.5	_	NUM	CD	_	21	nummod	_	_
21	fold	_	NOUN	NN	_	18	dobj	_	_
22	compared	_	VERB	VBD	_	18	xcomp	_	_
23	to	_	PRT	TO	_	25	case	_	_
24	healthy	_	ADJ	JJ	_	25	amod	_	_
25	subjects	_	NOUN	NNS	_	22	nmod	_	_
26	after	_	ADP	IN	_	27	case	_	_
27	administration	_	NOUN	NN	_	22	nmod	_	_
28	of	_	ADP	IN	_	33	case	_	_
29	a	_	DET	DT	_	33	det	_	_
30	single	_	ADJ	JJ	_	33	amod	_	_
31	40	_	NUM	CD	_	33	nummod	_	_
32	mg	_	NOUN	NN	_	33	compound	_	_
33	dose	_	NOUN	NN	_	27	nmod	_	_

#	Fluvastatin	196
1	The	_	DET	DT	_	3	det	_	_
2	enantiomer	_	ADJ	JJ	_	3	amod	_	_
3	ratios	_	NOUN	NNS	_	15	nsubj	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	the	_	DET	DT	_	7	det	_	_
6	two	_	NUM	CD	_	7	nummod	_	_
7	isomers	_	NOUN	NNS	_	3	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	in	_	ADP	IN	_	13	case	_	_
11	hepatic	_	ADJ	JJ	_	13	amod	_	_
12	impairment	_	NOUN	NN	_	13	compound	_	_
13	patients	_	NOUN	NNS	_	3	nmod	_	_
14	were	_	VERB	VBD	_	15	cop	_	_
15	comparable	_	ADJ	JJ	_	0	root	_	_
16	to	_	PRT	TO	_	17	case	_	_
17	those	_	DET	DT	_	15	nmod	_	_
18	observed	_	VERB	VBN	_	17	acl	_	_
19	in	_	ADP	IN	_	21	case	_	_
20	healthy	_	ADJ	JJ	_	21	amod	_	_
21	subjects	_	NOUN	NNS	_	18	nmod	_	_

#	Fluvastatin	197
1	Geriatric	_	ADJ	JJ	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Plasma	_	NOUN	NN	_	4	compound	_	_
4	levels	_	NOUN	NNS	_	10	nsubj	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	are	_	VERB	VBP	_	10	cop	_	_
8	not	_	ADV	RB	_	10	neg	_	_
9	significantly	_	ADV	RB	_	10	advmod	_	_
10	different	_	ADJ	JJ	_	1	dep	_	_
11	in	_	ADP	IN	_	12	case	_	_
12	patients	_	NOUN	NNS	_	10	nmod	_	_
13	age	_	VERB	VBG	_	16	case	_	_
14	>	_	NUM	CD	_	16	nummod	_	_
15	65	_	NUM	CD	_	16	nummod	_	_
16	years	_	NOUN	NNS	_	10	nmod	_	_
17	compared	_	VERB	VBN	_	10	dep	_	_
18	to	_	PRT	TO	_	19	case	_	_
19	patients	_	NOUN	NNS	_	17	nmod	_	_
20	age	_	NOUN	NN	_	24	compound	_	_
21	21	_	NUM	CD	_	23	compound	_	_
22	to	_	PRT	TO	_	23	dep	_	_
23	49	_	NUM	CD	_	24	nummod	_	_
24	years	_	NOUN	NNS	_	17	nmod	_	_

#	Fluvastatin	198
1	Gender	_	NOUN	NN	_	18	nmod	_	_
2	:	_	.	:	_	1	punct	_	_
3	In	_	ADP	IN	_	5	case	_	_
4	a	_	DET	DT	_	5	det	_	_
5	study	_	NOUN	NN	_	1	nmod	_	_
6	evaluating	_	VERB	VBG	_	5	acl	_	_
7	the	_	DET	DT	_	8	det	_	_
8	effect	_	NOUN	NN	_	6	dobj	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	age	_	NOUN	NN	_	8	nmod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	gender	_	NOUN	NN	_	10	conj	_	_
13	on	_	ADP	IN	_	15	case	_	_
14	DRUG	_	NOUN	NN	_	15	compound	_	_
15	pharmacokinetics	_	NOUN	NNS	_	8	nmod	_	_
16	,	_	.	,	_	18	punct	_	_
17	there	_	DET	EX	_	18	expl	_	_
18	were	_	VERB	VBD	_	0	root	_	_
19	no	_	DET	DT	_	21	neg	_	_
20	significant	_	ADJ	JJ	_	21	amod	_	_
21	differences	_	NOUN	NNS	_	18	nsubj	_	_
22	in	_	ADP	IN	_	24	case	_	_
23	DRUG	_	NOUN	NN	_	24	compound	_	_
24	exposures	_	NOUN	NNS	_	21	nmod	_	_
25	between	_	ADP	IN	_	26	case	_	_
26	males	_	NOUN	NNS	_	24	nmod	_	_
27	and	_	CONJ	CC	_	26	cc	_	_
28	females	_	NOUN	NNS	_	26	conj	_	_
29	,	_	.	,	_	18	punct	_	_
30	except	_	VERB	VBG	_	33	case	_	_
31	between	_	ADP	IN	_	33	case	_	_
32	younger	_	ADJ	JJ	_	33	amod	_	_
33	females	_	NOUN	NNS	_	18	nmod	_	_
34	and	_	CONJ	CC	_	33	cc	_	_
35	younger	_	ADJ	JJ	_	36	amod	_	_
36	males	_	NOUN	NNS	_	38	nsubj	_	_
37	both	_	CONJ	CC	_	38	cc:preconj	_	_
38	ages	_	VERB	VBZ	_	33	conj	_	_
39	21	_	NUM	CD	_	41	compound	_	_
40	to	_	PRT	TO	_	41	dep	_	_
41	49	_	NUM	CD	_	42	nummod	_	_
42	years	_	NOUN	NNS	_	38	dobj	_	_
43	,	_	.	,	_	18	punct	_	_
44	where	_	ADV	WRB	_	46	advmod	_	_
45	there	_	DET	EX	_	46	expl	_	_
46	was	_	VERB	VBD	_	18	dep	_	_
47	an	_	DET	DT	_	50	det	_	_
48	approximate	_	ADJ	JJ	_	50	amod	_	_
49	30%	_	ADJ	JJ	_	50	amod	_	_
50	increase	_	NOUN	NN	_	46	dobj	_	_
51	in	_	ADP	IN	_	52	case	_	_
52	AUC	_	NOUN	NN	_	50	nmod	_	_
53	in	_	ADP	IN	_	54	case	_	_
54	females	_	NOUN	NNS	_	50	nmod	_	_

#	Fluvastatin	199
1	Adjusting	_	VERB	VBG	_	5	csubj	_	_
2	for	_	ADP	IN	_	4	case	_	_
3	body	_	NOUN	NN	_	4	compound	_	_
4	weight	_	NOUN	NN	_	1	nmod	_	_
5	decreases	_	VERB	VBZ	_	0	root	_	_
6	the	_	DET	DT	_	7	det	_	_
7	magnitude	_	NOUN	NN	_	5	dobj	_	_
8	of	_	ADP	IN	_	10	case	_	_
9	the	_	DET	DT	_	10	det	_	_
10	differences	_	NOUN	NNS	_	7	nmod	_	_
11	seen	_	VERB	VBN	_	7	acl	_	_

#	Fluvastatin	200
1	Pediatric	_	ADJ	JJ	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Pharmacokinetic	_	ADJ	JJ	_	4	amod	_	_
4	data	_	NOUN	NNS	_	11	nsubj	_	_
5	in	_	ADP	IN	_	8	case	_	_
6	the	_	DET	DT	_	8	det	_	_
7	pediatric	_	ADJ	JJ	_	8	amod	_	_
8	population	_	NOUN	NN	_	4	nmod	_	_
9	are	_	VERB	VBD	_	11	auxpass	_	_
10	not	_	ADV	RB	_	11	neg	_	_
11	available	_	ADJ	JJ	_	1	dep	_	_

#	Fluvastatin	201
1	Drug	_	NOUN	NN	_	3	compound	_	_
2	Drug	_	NOUN	NN	_	3	compound	_	_
3	Interactions	_	NOUN	NNS	_	0	root	_	_
4	:	_	.	:	_	3	punct	_	_
5	Data	_	NOUN	NN	_	25	nsubj	_	_
6	from	_	ADP	IN	_	9	case	_	_
7	drug	_	NOUN	NN	_	9	compound	_	_
8	drug	_	NOUN	NN	_	9	compound	_	_
9	interactions	_	NOUN	NNS	_	5	nmod	_	_
10	studies	_	NOUN	NNS	_	9	dep	_	_
11	involving	_	VERB	VBG	_	10	acl	_	_
12	coadministration	_	NOUN	NN	_	11	dobj	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	gemfibrozil	_	NOUN	NN	_	12	nmod	_	_
15	,	_	.	,	_	14	punct	_	_
16	niacin	_	NOUN	NN	_	14	conj	_	_
17	,	_	.	,	_	14	punct	_	_
18	itraconazole	_	NOUN	NN	_	14	conj	_	_
19	,	_	.	,	_	14	punct	_	_
20	erythromycin	_	NOUN	NN	_	14	conj	_	_
21	,	_	.	,	_	14	punct	_	_
22	tolbutamide	_	NOUN	NN	_	14	conj	_	_
23	or	_	CONJ	CC	_	14	cc	_	_
24	clopidogrel	_	NOUN	NN	_	14	conj	_	_
25	indicate	_	VERB	VBP	_	3	dep	_	_
26	that	_	ADP	IN	_	35	mark	_	_
27	the	_	DET	DT	_	29	det	_	_
28	PK	_	NOUN	NN	_	29	compound	_	_
29	disposition	_	NOUN	NN	_	35	nsubjpass	_	_
30	of	_	ADP	IN	_	31	case	_	_
31	DRUG	_	NOUN	NN	_	29	nmod	_	_
32	is	_	VERB	VBZ	_	35	auxpass	_	_
33	not	_	ADV	RB	_	35	neg	_	_
34	significantly	_	ADV	RB	_	35	advmod	_	_
35	altered	_	VERB	VBN	_	25	ccomp	_	_
36	when	_	ADV	WRB	_	39	advmod	_	_
37	DRUG	_	NOUN	NN	_	39	nsubjpass	_	_
38	is	_	VERB	VBZ	_	39	auxpass	_	_
39	coadministered	_	VERB	VBN	_	35	ccomp	_	_
40	with	_	ADP	IN	_	41	case	_	_
41	any	_	DET	DT	_	39	nmod	_	_
42	of	_	ADP	IN	_	44	case	_	_
43	these	_	DET	DT	_	44	det	_	_
44	drugs	_	NOUN	NNS	_	41	nmod	_	_

#	Fluvastatin	202
1	The	_	DET	DT	_	6	det	_	_
2	below	_	NOUN	NN	_	6	amod	_	_
3	listed	_	ADJ	JJ	_	6	amod	_	_
4	drug	_	NOUN	NN	_	6	compound	_	_
5	interaction	_	NOUN	NN	_	6	compound	_	_
6	information	_	NOUN	NN	_	8	nsubjpass	_	_
7	is	_	VERB	VBZ	_	8	auxpass	_	_
8	derived	_	VERB	VBN	_	0	root	_	_
9	from	_	ADP	IN	_	10	case	_	_
10	studies	_	NOUN	NNS	_	8	nmod	_	_
11	using	_	VERB	VBG	_	10	acl	_	_
12	DRUG	_	NOUN	NN	_	13	compound	_	_
13	capsules	_	NOUN	NNS	_	11	dobj	_	_

#	Fluvastatin	203
1	Table	_	ADJ	JJ	_	0	root	_	_
2	3	_	NUM	CD	_	1	dep	_	_
3	:	_	.	:	_	1	punct	_	_
4	Effect	_	NOUN	NN	_	1	dep	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	Coadministered	_	ADJ	JJ	_	7	amod	_	_
7	Drugs	_	NOUN	NNS	_	4	nmod	_	_
8	on	_	ADP	IN	_	13	case	_	_
9	DRUG	_	NOUN	NN	_	13	compound	_	_
10	Systemic	_	ADJ	JJ	_	13	amod	_	_
11	Exposure	_	NOUN	NN	_	13	compound	_	_
12	Coadministered	_	ADJ	JJ	_	13	amod	_	_
13	drug	_	NOUN	NN	_	4	nmod	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	dosing	_	VERB	VBG	_	21	amod	_	_
16	regimen	_	NOUN	NN	_	21	compound	_	_
17	DRUG	_	NOUN	NN	_	21	compound	_	_
18	Dose	_	NOUN	NN	_	21	compound	_	_
19	mg	_	NOUN	NN	_	21	compound	_	_
20	Single	_	ADJ	JJ	_	21	amod	_	_
21	dose	_	NOUN	NN	_	13	conj	_	_
22	unless	_	ADP	IN	_	28	mark	_	_
23	otherwise	_	ADV	RB	_	24	advmod	_	_
24	noted	_	VERB	VBN	_	25	amod	_	_
25	Change	_	NOUN	NN	_	28	nsubj	_	_
26	in	_	ADP	IN	_	27	case	_	_
27	AUC	_	NOUN	NN	_	25	nmod	_	_
28	Mean	_	NOUN	NN	_	4	acl:relcl	_	_
29	ratio	_	NOUN	NN	_	28	dobj	_	_
30	with	_	ADP	IN	_	31	case	_	_
31	/	_	.	-RRB-	_	29	nmod	_	_
32	without	_	ADP	IN	_	34	case	_	_
33	coadministered	_	VERB	VBN	_	34	amod	_	_
34	drug	_	NOUN	NN	_	28	nmod	_	_
35	and	_	CONJ	CC	_	28	cc	_	_
36	no	_	DET	DT	_	40	neg	_	_
37	change	_	NOUN	NN	_	40	compound	_	_
38	=	_	ADJ	JJ	_	40	amod	_	_
39	1	_	NUM	CD	_	40	nummod	_	_
40	fold	_	NOUN	NN	_	28	conj	_	_
41	or	_	CONJ	CC	_	40	cc	_	_
42	%	_	NOUN	NN	_	43	nummod	_	_
43	change	_	NOUN	NN	_	40	conj	_	_
44	with	_	ADP	IN	_	45	case	_	_
45	/	_	.	-RRB-	_	40	nmod	_	_
46	without	_	ADP	IN	_	48	case	_	_
47	coadministered	_	VERB	VBN	_	48	amod	_	_
48	drug	_	NOUN	NN	_	45	nmod	_	_
49	and	_	CONJ	CC	_	48	cc	_	_
50	no	_	DET	DT	_	51	neg	_	_
51	change	_	NOUN	NN	_	48	conj	_	_
52	=	_	CONJ	CC	_	54	amod	_	_
53	0%	_	ADJ	JJ	_	54	amod	_	_
54	symbols	_	NOUN	NNS	_	51	dep	_	_
55	of	_	ADP	IN	_	56	case	_	_
56	*	_	NOUN	NN	_	54	nmod	_	_
57	and	_	CONJ	CC	_	54	cc	_	_
58	*	_	NUM	CD	_	59	nsubj	_	_
59	indicate	_	VERB	VBP	_	54	conj	_	_
60	the	_	DET	DT	_	61	det	_	_
61	exposure	_	NOUN	NN	_	59	dobj	_	_
62	increase	_	NOUN	NN	_	61	dep	_	_
63	and	_	CONJ	CC	_	62	cc	_	_
64	decrease	_	NOUN	NN	_	62	conj	_	_
65	,	_	.	,	_	4	punct	_	_
66	respectively	_	ADV	RB	_	4	advmod	_	_

#	Fluvastatin	204
1	Change	_	NOUN	NN	_	0	root	_	_
2	in	_	ADP	IN	_	7	case	_	_
3	Cmax	_	NOUN	NN	_	7	compound	_	_
4	Cyclosporine	_	NOUN	NN	_	7	compound	_	_
5	stable	_	ADJ	JJ	_	7	amod	_	_
6	dose	_	NOUN	NN	_	7	compound	_	_
7	b.i.d	_	NOUN	NN	_	1	nmod	_	_

#	Fluvastatin	205
1	Considered	_	VERB	VBN	_	6	amod	_	_
2	clinically	_	ADV	RB	_	3	advmod	_	_
3	significant	_	ADJ	JJ	_	6	amod	_	_
4	20	_	NUM	CD	_	6	nummod	_	_
5	mg	_	NOUN	NN	_	6	compound	_	_
6	QD	_	NOUN	NN	_	36	nsubj	_	_
7	for	_	ADP	IN	_	20	case	_	_
8	14	_	NUM	CD	_	20	nummod	_	_
9	weeks	_	NOUN	NN	_	20	compound	_	_
10	90%	_	ADJ	JJ	_	20	amod	_	_
11	30%	_	ADJ	JJ	_	20	amod	_	_
12	Fluconazole	_	NOUN	NN	_	20	compound	_	_
13	400	_	NUM	CD	_	20	nummod	_	_
14	mg	_	NOUN	NN	_	20	compound	_	_
15	QD	_	NOUN	NN	_	20	compound	_	_
16	day	_	NOUN	NN	_	20	compound	_	_
17	1,200	_	NUM	CD	_	20	nummod	_	_
18	mg	_	NOUN	NN	_	20	compound	_	_
19	b.i.d	_	NOUN	NN	_	20	compound	_	_
20	day	_	NOUN	NN	_	6	nmod	_	_
21	2	_	NUM	CD	_	20	nummod	_	_
22	to	_	PRT	TO	_	35	case	_	_
23	4	_	NUM	CD	_	35	nummod	_	_
24	40	_	NUM	CD	_	35	nummod	_	_
25	mg	_	NOUN	NN	_	35	amod	_	_
26	QD	_	NOUN	NN	_	35	compound	_	_
27	84%	_	ADJ	JJ	_	35	amod	_	_
28	44%	_	ADJ	JJ	_	35	amod	_	_
29	Cholestyramine	_	NOUN	NN	_	35	compound	_	_
30	8	_	NUM	CD	_	35	nummod	_	_
31	g	_	NOUN	NN	_	35	compound	_	_
32	QD	_	NOUN	NN	_	35	compound	_	_
33	20	_	NUM	CD	_	35	nummod	_	_
34	mg	_	NOUN	NN	_	35	compound	_	_
35	QD	_	NOUN	NN	_	6	nmod	_	_
36	administered	_	VERB	VBD	_	0	root	_	_
37	4	_	NUM	CD	_	38	nummod	_	_
38	hrs	_	NOUN	NNS	_	36	dobj	_	_
39	after	_	ADP	IN	_	49	case	_	_
40	a	_	DET	DT	_	49	det	_	_
41	meal	_	ADJ	JJ	_	49	amod	_	_
42	plus	_	CONJ	CC	_	41	cc	_	_
43	cholestyramine	_	NOUN	NN	_	41	conj	_	_
44	51%	_	ADJ	JJ	_	49	amod	_	_
45	83%	_	ADJ	JJ	_	49	amod	_	_
46	Rifampicin	_	NOUN	NN	_	49	compound	_	_
47	600	_	NUM	CD	_	49	nummod	_	_
48	mg	_	NOUN	NN	_	49	compound	_	_
49	QD	_	NOUN	NN	_	36	nmod	_	_
50	for	_	ADP	IN	_	52	case	_	_
51	6	_	NUM	CD	_	52	nummod	_	_
52	days	_	NOUN	NNS	_	49	nmod	_	_
53	20	_	NUM	CD	_	61	nummod	_	_
54	mg	_	NOUN	NN	_	61	amod	_	_
55	QD	_	NOUN	NN	_	61	compound	_	_
56	53%	_	ADJ	JJ	_	61	amod	_	_
57	42%	_	ADJ	JJ	_	61	amod	_	_
58	Cimetidine	_	NOUN	NN	_	61	compound	_	_
59	400	_	NUM	CD	_	61	nummod	_	_
60	mg	_	NOUN	NN	_	61	compound	_	_
61	b.i.d	_	NOUN	NN	_	52	dep	_	_
62	for	_	ADP	IN	_	64	case	_	_
63	5	_	NUM	CD	_	64	nummod	_	_
64	days	_	NOUN	NNS	_	61	nmod	_	_
65	,	_	.	,	_	36	punct	_	_
66	QD	_	NOUN	NN	_	204	nsubj	_	_
67	on	_	ADP	IN	_	78	case	_	_
68	Day	_	NOUN	NN	_	78	compound	_	_
69	6	_	NUM	CD	_	78	nummod	_	_
70	20	_	NUM	CD	_	78	nummod	_	_
71	mg	_	NOUN	NN	_	78	amod	_	_
72	QD	_	NOUN	NN	_	78	compound	_	_
73	30%	_	ADJ	JJ	_	78	amod	_	_
74	40%	_	ADJ	JJ	_	78	amod	_	_
75	Ranitidine	_	NOUN	NN	_	78	compound	_	_
76	150	_	NUM	CD	_	78	nummod	_	_
77	mg	_	NOUN	NN	_	78	compound	_	_
78	b.i.d	_	NOUN	NN	_	66	nmod	_	_
79	for	_	ADP	IN	_	81	case	_	_
80	5	_	NUM	CD	_	81	nummod	_	_
81	days	_	NOUN	NNS	_	66	nmod	_	_
82	,	_	.	,	_	66	punct	_	_
83	QD	_	NOUN	NN	_	66	appos	_	_
84	on	_	ADP	IN	_	95	case	_	_
85	Day	_	NOUN	NN	_	95	compound	_	_
86	6	_	NUM	CD	_	95	nummod	_	_
87	20	_	NUM	CD	_	95	nummod	_	_
88	mg	_	NOUN	NN	_	95	amod	_	_
89	QD	_	NOUN	NN	_	95	compound	_	_
90	10%	_	ADJ	JJ	_	95	amod	_	_
91	50%	_	ADJ	JJ	_	95	amod	_	_
92	Omeprazole	_	NOUN	NN	_	95	compound	_	_
93	40	_	NUM	CD	_	95	nummod	_	_
94	mg	_	NOUN	NN	_	95	compound	_	_
95	QD	_	NOUN	NN	_	83	nmod	_	_
96	for	_	ADP	IN	_	98	case	_	_
97	6	_	NUM	CD	_	98	nummod	_	_
98	days	_	NOUN	NNS	_	83	nmod	_	_
99	20	_	NUM	CD	_	110	nummod	_	_
100	mg	_	NOUN	NN	_	110	amod	_	_
101	QD	_	NOUN	NN	_	110	compound	_	_
102	20%	_	ADJ	JJ	_	110	amod	_	_
103	37%	_	ADJ	JJ	_	110	amod	_	_
104	Phenytoin	_	NOUN	NN	_	110	compound	_	_
105	300	_	NUM	CD	_	110	nummod	_	_
106	mg	_	NOUN	NN	_	110	compound	_	_
107	QD	_	NOUN	NN	_	110	compound	_	_
108	40	_	NUM	CD	_	110	nummod	_	_
109	mg	_	NOUN	NN	_	110	compound	_	_
110	b.i.d	_	NOUN	NN	_	98	dep	_	_
111	for	_	ADP	IN	_	113	case	_	_
112	5	_	NUM	CD	_	113	nummod	_	_
113	days	_	NOUN	NNS	_	110	nmod	_	_
114	40%	_	ADJ	JJ	_	119	amod	_	_
115	27%	_	ADJ	JJ	_	119	amod	_	_
116	Propranolol	_	NOUN	NN	_	119	compound	_	_
117	40	_	NUM	CD	_	119	nummod	_	_
118	mg	_	NOUN	NN	_	119	compound	_	_
119	b.i.d	_	NOUN	NN	_	113	dep	_	_
120	for	_	ADP	IN	_	122	case	_	_
121	3.5	_	NUM	CD	_	122	nummod	_	_
122	days	_	NOUN	NNS	_	119	nmod	_	_
123	40	_	NUM	CD	_	128	nummod	_	_
124	mg	_	NOUN	NN	_	128	compound	_	_
125	QD	_	NOUN	NN	_	128	compound	_	_
126	5%	_	ADJ	JJ	_	128	amod	_	_
127	No	_	NOUN	NN	_	128	compound	_	_
128	change	_	NOUN	NN	_	129	compound	_	_
129	Digoxin	_	NOUN	NN	_	122	dep	_	_
130	0.1	_	NUM	CD	_	129	nummod	_	_
131	to	_	PRT	TO	_	129	dep	_	_
132	0.5	_	NUM	CD	_	134	nummod	_	_
133	mg	_	NOUN	NN	_	134	compound	_	_
134	QD	_	NOUN	NN	_	129	dep	_	_
135	for	_	ADP	IN	_	150	case	_	_
136	3	_	NUM	CD	_	150	nummod	_	_
137	weeks	_	NOUN	NN	_	150	compound	_	_
138	40	_	NUM	CD	_	150	nummod	_	_
139	mg	_	NOUN	NN	_	150	compound	_	_
140	QD	_	NOUN	NN	_	150	compound	_	_
141	No	_	NOUN	NN	_	150	compound	_	_
142	change	_	NOUN	NN	_	150	compound	_	_
143	11%	_	ADJ	JJ	_	150	amod	_	_
144	Diclofenac	_	ADJ	JJ	_	150	amod	_	_
145	25	_	NUM	CD	_	150	nummod	_	_
146	mg	_	NOUN	NN	_	150	compound	_	_
147	QD	_	NOUN	NN	_	150	compound	_	_
148	40	_	NUM	CD	_	150	nummod	_	_
149	mg	_	NOUN	NN	_	150	compound	_	_
150	QD	_	NOUN	NN	_	129	nmod	_	_
151	for	_	ADP	IN	_	153	case	_	_
152	8	_	NUM	CD	_	153	nummod	_	_
153	days	_	NOUN	NNS	_	129	nmod	_	_
154	50%	_	ADJ	JJ	_	156	amod	_	_
155	80%	_	ADJ	JJ	_	156	amod	_	_
156	Glyburide	_	NOUN	NN	_	153	dep	_	_
157	5	_	NUM	CD	_	156	nummod	_	_
158	to	_	PRT	TO	_	161	case	_	_
159	20	_	NUM	CD	_	160	compound	_	_
160	mg	_	NOUN	NN	_	161	amod	_	_
161	QD	_	NOUN	NN	_	156	nmod	_	_
162	for	_	ADP	IN	_	164	case	_	_
163	22	_	NUM	CD	_	164	nummod	_	_
164	days	_	NOUN	NNS	_	156	nmod	_	_
165	40	_	NUM	CD	_	167	nummod	_	_
166	mg	_	NOUN	NN	_	167	compound	_	_
167	b.i.d	_	NOUN	NN	_	164	dep	_	_
168	for	_	ADP	IN	_	170	case	_	_
169	14	_	NUM	CD	_	170	nummod	_	_
170	days	_	NOUN	NNS	_	167	nmod	_	_
171	51%	_	ADJ	JJ	_	179	amod	_	_
172	44%	_	ADJ	JJ	_	179	amod	_	_
173	Warfarin	_	NOUN	NN	_	179	compound	_	_
174	30	_	NUM	CD	_	179	nummod	_	_
175	mg	_	NOUN	NN	_	179	compound	_	_
176	QD	_	NOUN	NN	_	179	compound	_	_
177	40	_	NUM	CD	_	179	nummod	_	_
178	mg	_	NOUN	NN	_	179	compound	_	_
179	QD	_	NOUN	NN	_	170	dep	_	_
180	for	_	ADP	IN	_	182	case	_	_
181	8	_	NUM	CD	_	182	nummod	_	_
182	days	_	NOUN	NNS	_	179	nmod	_	_
183	30%	_	ADJ	JJ	_	187	amod	_	_
184	67%	_	ADJ	JJ	_	187	amod	_	_
185	Clopidogrel	_	NOUN	NN	_	187	compound	_	_
186	300	_	NUM	CD	_	187	nummod	_	_
187	mg	_	NOUN	NN	_	182	dep	_	_
188	loading	_	VERB	VBG	_	187	acl	_	_
189	dose	_	NOUN	NN	_	188	dobj	_	_
190	on	_	ADP	IN	_	191	case	_	_
191	day	_	NOUN	NN	_	188	nmod	_	_
192	10	_	NUM	CD	_	191	nummod	_	_
193	,	_	.	,	_	66	punct	_	_
194	75	_	NUM	CD	_	195	compound	_	_
195	mg	_	NOUN	NN	_	196	amod	_	_
196	QD	_	NOUN	NN	_	66	appos	_	_
197	on	_	ADP	IN	_	198	case	_	_
198	days	_	NOUN	NNS	_	196	nmod	_	_
199	11	_	NUM	CD	_	201	compound	_	_
200	to	_	PRT	TO	_	201	dep	_	_
201	19	_	NUM	CD	_	203	nummod	_	_
202	DRUG	_	NOUN	NN	_	203	compound	_	_
203	sodium	_	NOUN	NN	_	198	dep	_	_
204	extended	_	VERB	VBD	_	36	parataxis	_	_
205	release	_	NOUN	NN	_	206	compound	_	_
206	tablets	_	NOUN	NNS	_	204	dobj	_	_
207	,	_	.	,	_	206	punct	_	_
208	80	_	NUM	CD	_	210	nummod	_	_
209	mg	_	NOUN	NN	_	210	compound	_	_
210	QD	_	NOUN	NN	_	206	appos	_	_
211	for	_	ADP	IN	_	213	case	_	_
212	19	_	NUM	CD	_	213	nummod	_	_
213	days	_	NOUN	NNS	_	210	nmod	_	_
214	2%	_	ADJ	JJ	_	216	amod	_	_
215	27%	_	ADJ	JJ	_	216	amod	_	_
216	Data	_	NOUN	NN	_	210	dep	_	_
217	from	_	ADP	IN	_	221	case	_	_
218	drug	_	NOUN	NN	_	221	compound	_	_
219	drug	_	NOUN	NN	_	221	compound	_	_
220	interaction	_	NOUN	NN	_	221	compound	_	_
221	studies	_	NOUN	NNS	_	216	nmod	_	_
222	involving	_	VERB	VBG	_	221	acl	_	_
223	DRUG	_	NOUN	NN	_	222	dobj	_	_
224	and	_	CONJ	CC	_	223	cc	_	_
225	coadministration	_	NOUN	NN	_	223	conj	_	_
226	of	_	ADP	IN	_	228	case	_	_
227	either	_	CONJ	CC	_	228	cc:preconj	_	_
228	gemfibrozil	_	NOUN	NN	_	223	nmod	_	_
229	,	_	.	,	_	228	punct	_	_
230	tolbutamide	_	NOUN	NN	_	228	conj	_	_
231	or	_	CONJ	CC	_	228	cc	_	_
232	losartan	_	NOUN	NN	_	228	conj	_	_
233	indicate	_	VERB	VBP	_	204	parataxis	_	_
234	that	_	ADP	IN	_	248	mark	_	_
235	the	_	DET	DT	_	237	det	_	_
236	PK	_	NOUN	NN	_	237	compound	_	_
237	disposition	_	NOUN	NN	_	248	nsubjpass	_	_
238	of	_	ADP	IN	_	240	case	_	_
239	either	_	CONJ	CC	_	240	cc:preconj	_	_
240	gemfibrozil	_	NOUN	NN	_	237	nmod	_	_
241	,	_	.	,	_	240	punct	_	_
242	tolbutamide	_	NOUN	NN	_	240	conj	_	_
243	or	_	CONJ	CC	_	240	cc	_	_
244	losartan	_	NOUN	NN	_	240	conj	_	_
245	is	_	VERB	VBZ	_	248	auxpass	_	_
246	not	_	ADV	RB	_	248	neg	_	_
247	significantly	_	ADV	RB	_	248	advmod	_	_
248	altered	_	VERB	VBN	_	233	ccomp	_	_
249	when	_	ADV	WRB	_	250	advmod	_	_
250	coadministered	_	VERB	VBN	_	248	advcl	_	_
251	with	_	ADP	IN	_	252	case	_	_
252	DRUG	_	NOUN	NN	_	250	nmod	_	_

#	Fluvastatin	206
1	Table	_	ADJ	JJ	_	0	root	_	_
2	4	_	NUM	CD	_	1	dep	_	_
3	:	_	.	:	_	1	punct	_	_
4	Effect	_	NOUN	NN	_	1	dep	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	DRUG	_	NOUN	NN	_	7	compound	_	_
7	Coadministration	_	NOUN	NN	_	4	nmod	_	_
8	on	_	ADP	IN	_	10	case	_	_
9	Systemic	_	ADJ	JJ	_	10	amod	_	_
10	Exposure	_	NOUN	NN	_	4	nmod	_	_
11	of	_	ADP	IN	_	13	case	_	_
12	Other	_	ADJ	JJ	_	13	amod	_	_
13	Drugs	_	NOUN	NNS	_	10	nmod	_	_
14	DRUG	_	NOUN	NN	_	19	compound	_	_
15	dosage	_	NOUN	NN	_	19	compound	_	_
16	regimen	_	NOUN	NN	_	19	compound	_	_
17	Coadministered	_	ADJ	JJ	_	19	amod	_	_
18	drug	_	NOUN	NN	_	19	compound	_	_
19	Name	_	NOUN	NN	_	13	dep	_	_
20	and	_	CONJ	CC	_	19	cc	_	_
21	Dose	_	NOUN	NN	_	24	compound	_	_
22	mg	_	NOUN	NN	_	24	compound	_	_
23	Single	_	ADJ	JJ	_	24	amod	_	_
24	dose	_	NOUN	NN	_	19	conj	_	_
25	unless	_	ADP	IN	_	31	mark	_	_
26	otherwise	_	ADV	RB	_	27	advmod	_	_
27	noted	_	VERB	VBN	_	28	amod	_	_
28	Change	_	NOUN	NN	_	31	nsubj	_	_
29	in	_	ADP	IN	_	30	case	_	_
30	AUC	_	NOUN	NN	_	28	nmod	_	_
31	Mean	_	NOUN	NN	_	4	acl:relcl	_	_
32	ratio	_	NOUN	NN	_	31	dobj	_	_
33	with	_	ADP	IN	_	34	case	_	_
34	/	_	.	-RRB-	_	31	nmod	_	_
35	without	_	ADP	IN	_	37	case	_	_
36	coadministered	_	VERB	VBN	_	37	amod	_	_
37	drug	_	NOUN	NN	_	31	nmod	_	_
38	and	_	CONJ	CC	_	31	cc	_	_
39	no	_	DET	DT	_	43	neg	_	_
40	change	_	NOUN	NN	_	43	compound	_	_
41	=	_	ADJ	JJ	_	43	amod	_	_
42	1	_	NUM	CD	_	43	nummod	_	_
43	fold	_	NOUN	NN	_	31	conj	_	_
44	or	_	CONJ	CC	_	43	cc	_	_
45	%	_	NOUN	NN	_	46	nummod	_	_
46	change	_	NOUN	NN	_	43	conj	_	_
47	with	_	ADP	IN	_	48	case	_	_
48	/	_	.	-RRB-	_	43	nmod	_	_
49	without	_	ADP	IN	_	51	case	_	_
50	coadministered	_	VERB	VBN	_	51	amod	_	_
51	drug	_	NOUN	NN	_	48	nmod	_	_
52	and	_	CONJ	CC	_	51	cc	_	_
53	no	_	DET	DT	_	54	neg	_	_
54	change	_	NOUN	NN	_	51	conj	_	_
55	=	_	CONJ	CC	_	57	amod	_	_
56	0%	_	ADJ	JJ	_	57	amod	_	_
57	symbols	_	NOUN	NNS	_	54	dep	_	_
58	of	_	ADP	IN	_	59	case	_	_
59	*	_	NOUN	NN	_	57	nmod	_	_
60	and	_	CONJ	CC	_	57	cc	_	_
61	*	_	NUM	CD	_	62	nsubj	_	_
62	indicate	_	VERB	VBP	_	57	conj	_	_
63	the	_	DET	DT	_	64	det	_	_
64	exposure	_	NOUN	NN	_	62	dobj	_	_
65	increase	_	NOUN	NN	_	64	dep	_	_
66	and	_	CONJ	CC	_	65	cc	_	_
67	decrease	_	NOUN	NN	_	65	conj	_	_
68	,	_	.	,	_	4	punct	_	_
69	respectively	_	ADV	RB	_	4	advmod	_	_

#	Fluvastatin	207
1	Change	_	NOUN	NN	_	13	nsubj	_	_
2	in	_	ADP	IN	_	6	case	_	_
3	Cmax	_	NOUN	NN	_	6	compound	_	_
4	40	_	NUM	CD	_	6	nummod	_	_
5	mg	_	NOUN	NN	_	6	compound	_	_
6	QD	_	NOUN	NN	_	1	nmod	_	_
7	for	_	ADP	IN	_	9	case	_	_
8	5	_	NUM	CD	_	9	nummod	_	_
9	days	_	NOUN	NNS	_	1	nmod	_	_
10	Phenytoin	_	NOUN	NN	_	12	compound	_	_
11	300	_	NUM	CD	_	12	nummod	_	_
12	mg	_	NOUN	NN	_	9	dep	_	_
13	QDConsidered	_	ADJ	JJ	_	0	root	_	_
14	clinically	_	ADV	RB	_	15	advmod	_	_
15	significant	_	ADJ	JJ	_	20	amod	_	_
16	20%	_	ADJ	JJ	_	20	amod	_	_
17	5%	_	ADJ	JJ	_	20	amod	_	_
18	40	_	NUM	CD	_	20	nummod	_	_
19	mg	_	NOUN	NN	_	20	compound	_	_
20	b.i.d	_	NOUN	NN	_	13	dobj	_	_
21	for	_	ADP	IN	_	23	case	_	_
22	21	_	NUM	CD	_	23	nummod	_	_
23	days	_	NOUN	NNS	_	20	nmod	_	_
24	Glyburide	_	NOUN	NN	_	23	dep	_	_
25	5	_	NUM	CD	_	24	nummod	_	_
26	to	_	PRT	TO	_	29	case	_	_
27	20	_	NUM	CD	_	28	compound	_	_
28	mg	_	NOUN	NN	_	29	amod	_	_
29	QD	_	NOUN	NN	_	20	nmod	_	_
30	for	_	ADP	IN	_	32	case	_	_
31	22	_	NUM	CD	_	32	nummod	_	_
32	days	_	NOUN	NNS	_	20	nmod	_	_
33	70%	_	ADJ	JJ	_	37	amod	_	_
34	50%	_	ADJ	JJ	_	37	amod	_	_
35	40	_	NUM	CD	_	37	nummod	_	_
36	mg	_	NOUN	NN	_	37	compound	_	_
37	QD	_	NOUN	NN	_	32	dep	_	_
38	for	_	ADP	IN	_	40	case	_	_
39	8	_	NUM	CD	_	40	nummod	_	_
40	days	_	NOUN	NNS	_	37	nmod	_	_
41	Diclofenac	_	ADJ	JJ	_	49	amod	_	_
42	25	_	NUM	CD	_	49	nummod	_	_
43	mg	_	NOUN	NN	_	49	compound	_	_
44	QD	_	NOUN	NN	_	49	compound	_	_
45	25%	_	ADJ	JJ	_	49	amod	_	_
46	60%	_	ADJ	JJ	_	49	amod	_	_
47	40	_	NUM	CD	_	49	nummod	_	_
48	mg	_	NOUN	NN	_	49	compound	_	_
49	QD	_	NOUN	NN	_	40	dep	_	_
50	for	_	ADP	IN	_	58	case	_	_
51	8	_	NUM	CD	_	52	nummod	_	_
52	days	_	NOUN	NNS	_	58	compound	_	_
53	Warfarin	_	NOUN	NN	_	58	compound	_	_
54	30	_	NUM	CD	_	58	nummod	_	_
55	mg	_	NOUN	NN	_	58	compound	_	_
56	QD	_	NOUN	NN	_	58	compound	_	_
57	S	_	NOUN	NN	_	58	compound	_	_
58	warfarin	_	NOUN	NN	_	49	nmod	_	_
59	:	_	.	:	_	13	punct	_	_
60	7%	_	ADJ	JJ	_	62	amod	_	_
61	S	_	NOUN	NN	_	62	compound	_	_
62	warfarin	_	NOUN	NN	_	13	dep	_	_
63	:	_	.	:	_	62	punct	_	_
64	10%	_	ADJ	JJ	_	66	amod	_	_
65	R	_	NOUN	NN	_	66	compound	_	_
66	warfarin	_	NOUN	NN	_	62	dep	_	_
67	:	_	.	:	_	66	punct	_	_
68	no	_	DET	DT	_	71	neg	_	_
69	change	_	NOUN	NN	_	71	compound	_	_
70	R	_	NOUN	NN	_	71	compound	_	_
71	warfarin	_	NOUN	NN	_	66	appos	_	_
72	:	_	.	:	_	66	punct	_	_
73	6%	_	ADJ	JJ	_	66	dep	_	_

#	Fluvoxamine Maleate	1394
1	Drug	_	NOUN	NN	_	2	compound	_	_
2	Interactions	_	NOUN	NNS	_	11	nsubj	_	_
3	not	_	ADV	RB	_	4	neg	_	_
4	described	_	VERB	VBN	_	2	acl	_	_
5	in	_	ADP	IN	_	6	case	_	_
6	Contraindications	_	NOUN	NNS	_	4	nmod	_	_
7	or	_	CONJ	CC	_	6	cc	_	_
8	Warnings	_	NOUN	NNS	_	6	conj	_	_
9	and	_	CONJ	CC	_	6	cc	_	_
10	Precautions	_	NOUN	NNS	_	6	conj	_	_
11	include	_	VERB	VBP	_	0	root	_	_
12	the	_	DET	DT	_	13	det	_	_
13	following	_	ADJ	JJ	_	11	dobj	_	_
14	:	_	.	:	_	11	punct	_	_
15	Drugs	_	NOUN	NNS	_	11	dep	_	_
16	Inhibiting	_	VERB	VBG	_	15	acl	_	_
17	or	_	CONJ	CC	_	16	cc	_	_
18	Metabolized	_	VERB	VBN	_	16	conj	_	_
19	by	_	ADP	IN	_	21	case	_	_
20	Cytochrome	_	NOUN	NN	_	21	compound	_	_
21	P450	_	NOUN	NN	_	16	nmod	_	_
22	:	_	.	:	_	11	punct	_	_
23	DRUG	_	NOUN	NN	_	24	nsubj	_	_
24	inhibits	_	VERB	VBZ	_	11	parataxis	_	_
25	several	_	ADJ	JJ	_	28	amod	_	_
26	cytochrome	_	NOUN	NN	_	28	compound	_	_
27	P450	_	NOUN	NN	_	28	compound	_	_
28	isoenzymes	_	NOUN	NNS	_	24	dobj	_	_
29	CYP1A2	_	NOUN	NN	_	28	dep	_	_
30	,	_	.	,	_	29	punct	_	_
31	CYP2C9	_	NOUN	NN	_	29	conj	_	_
32	,	_	.	,	_	29	punct	_	_
33	CYP3A4	_	NOUN	NN	_	29	conj	_	_
34	,	_	.	,	_	29	punct	_	_
35	and	_	CONJ	CC	_	29	cc	_	_
36	CYP2C19	_	NOUN	NN	_	29	conj	_	_

#	Fluvoxamine Maleate	1395
1	Carbamazepine	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Elevated	_	ADJ	JJ	_	5	amod	_	_
4	carbamazepine	_	NOUN	NN	_	5	compound	_	_
5	levels	_	NOUN	NNS	_	1	dep	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	symptoms	_	NOUN	NNS	_	5	conj	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	toxicity	_	NOUN	NN	_	5	nmod	_	_
10	with	_	ADP	IN	_	11	case	_	_
11	coadministration	_	NOUN	NN	_	9	nmod	_	_
12	7.2	_	NUM	CD	_	11	nummod	_	_

#	Fluvoxamine Maleate	1396
1	Sumatriptan	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Rare	_	ADJ	JJ	_	5	amod	_	_
4	postmarketing	_	ADJ	JJ	_	5	amod	_	_
5	reports	_	NOUN	NNS	_	1	dep	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	weakness	_	NOUN	NN	_	5	nmod	_	_
8	,	_	.	,	_	7	punct	_	_
9	hyperreflexia	_	NOUN	NN	_	7	conj	_	_
10	,	_	.	,	_	7	punct	_	_
11	and	_	CONJ	CC	_	7	cc	_	_
12	incoordination	_	NOUN	NN	_	7	conj	_	_
13	following	_	VERB	VBG	_	14	case	_	_
14	use	_	NOUN	NN	_	5	nmod	_	_
15	of	_	ADP	IN	_	17	case	_	_
16	an	_	DET	DT	_	17	det	_	_
17	SSRI	_	NOUN	NN	_	14	nmod	_	_
18	and	_	CONJ	CC	_	17	cc	_	_
19	sumatriptan	_	NOUN	NN	_	17	conj	_	_

#	Fluvoxamine Maleate	1397
1	Monitor	_	NOUN	NN	_	0	root	_	_
2	appropriately	_	ADV	RB	_	1	advmod	_	_
3	if	_	ADP	IN	_	8	mark	_	_
4	concomitant	_	ADJ	JJ	_	5	amod	_	_
5	treatment	_	NOUN	NN	_	8	nsubjpass	_	_
6	is	_	VERB	VBZ	_	8	auxpass	_	_
7	clinically	_	ADV	RB	_	8	advmod	_	_
8	warranted	_	VERB	VBN	_	1	root	_	_
9	7.2	_	NUM	CD	_	8	neg	_	_

#	Fluvoxamine Maleate	1398
1	Tacrine	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Coadministration	_	NOUN	NN	_	4	nsubj	_	_
4	increased	_	VERB	VBD	_	1	dep	_	_
5	tacrine	_	NOUN	NN	_	6	compound	_	_
6	Cmax	_	NOUN	NN	_	4	dobj	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	AUC	_	NOUN	NN	_	6	conj	_	_
9	five	_	NUM	CD	_	8	nummod	_	_
10	and	_	CONJ	CC	_	6	cc	_	_
11	eight	_	NUM	CD	_	12	nummod	_	_
12	fold	_	NOUN	NN	_	6	conj	_	_
13	and	_	CONJ	CC	_	4	cc	_	_
14	caused	_	VERB	VBD	_	4	conj	_	_
15	nausea	_	NOUN	NN	_	14	dobj	_	_
16	,	_	.	,	_	15	punct	_	_
17	vomiting	_	VERB	VBG	_	15	conj	_	_
18	,	_	.	,	_	15	punct	_	_
19	sweating	_	NOUN	NN	_	15	conj	_	_
20	,	_	.	,	_	15	punct	_	_
21	and	_	CONJ	CC	_	15	cc	_	_
22	diarrhea	_	NOUN	NN	_	15	conj	_	_
23	7.2	_	NUM	CD	_	22	nummod	_	_

#	Fluvoxamine Maleate	1399
1	Tricyclic	_	ADJ	JJ	_	2	amod	_	_
2	Antidepressants	_	NOUN	NNS	_	0	root	_	_
3	TCAs	_	NOUN	NNS	_	2	dep	_	_
4	:	_	.	:	_	2	punct	_	_
5	Coadministration	_	NOUN	NN	_	7	nsubj	_	_
6	significantly	_	ADV	RB	_	7	advmod	_	_
7	increased	_	VERB	VBD	_	2	dep	_	_
8	plasma	_	NOUN	NN	_	10	compound	_	_
9	TCA	_	NOUN	NN	_	10	compound	_	_
10	levels	_	NOUN	NNS	_	7	dobj	_	_

#	Fluvoxamine Maleate	1400
1	Use	_	NOUN	NN	_	6	compound	_	_
2	caution	_	NOUN	NN	_	6	compound	_	_
3	monitor	_	NOUN	NN	_	6	compound	_	_
4	plasma	_	NOUN	NN	_	6	compound	_	_
5	TCA	_	NOUN	NN	_	6	compound	_	_
6	levels	_	NOUN	NNS	_	7	nsubj	_	_
7	reduce	_	VERB	VBP	_	0	root	_	_
8	TCA	_	NOUN	NN	_	9	compound	_	_
9	dose	_	NOUN	NN	_	7	dobj	_	_
10	if	_	DET	WDT	_	11	nsubj	_	_
11	indicated	_	VERB	VBD	_	9	acl:relcl	_	_
12	7.2	_	NUM	CD	_	11	neg	_	_

#	Fluvoxamine Maleate	1401
1	Tryptophan	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Severe	_	ADJ	JJ	_	1	dep	_	_
4	vomiting	_	VERB	VBG	_	3	dep	_	_
5	with	_	ADP	IN	_	6	case	_	_
6	coadministration	_	NOUN	NN	_	4	nmod	_	_
7	7.2	_	NUM	CD	_	6	nummod	_	_

#	Fluvoxamine Maleate	1402
1	Diltiazem	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Bradycardia	_	NOUN	NN	_	1	dep	_	_
4	with	_	ADP	IN	_	5	case	_	_
5	coadministration	_	NOUN	NN	_	3	nmod	_	_
6	7.3	_	NUM	CD	_	5	nummod	_	_

#	Fluvoxamine Maleate	1403
1	Propranolol	_	NOUN	NN	_	5	nsubj	_	_
2	or	_	CONJ	CC	_	1	cc	_	_
3	metoprolol	_	NOUN	NN	_	1	conj	_	_
4	:	_	.	:	_	1	punct	_	_
5	Reduce	_	VERB	VBP	_	0	root	_	_
6	dose	_	NOUN	NN	_	5	dobj	_	_
7	if	_	DET	WDT	_	8	nsubj	_	_
8	coadministered	_	VERB	VBD	_	6	dep	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	titrate	_	VERB	VB	_	8	conj	_	_
11	more	_	ADV	RB	_	12	advmod	_	_
12	cautiously	_	ADV	RB	_	13	advmod	_	_
13	7.3	_	NUM	CD	_	10	neg	_	_

#	Fluvoxamine Maleate	1404
1	Multiple	_	ADJ	JJ	_	5	amod	_	_
2	hepatic	_	ADJ	JJ	_	5	amod	_	_
3	cytochrome	_	NOUN	NN	_	5	compound	_	_
4	P450	_	NOUN	NN	_	5	compound	_	_
5	isoenzymes	_	NOUN	NNS	_	7	nsubjpass	_	_
6	are	_	VERB	VBP	_	7	auxpass	_	_
7	involved	_	VERB	VBN	_	0	root	_	_
8	in	_	ADP	IN	_	11	case	_	_
9	the	_	DET	DT	_	11	det	_	_
10	oxidative	_	ADJ	JJ	_	11	amod	_	_
11	biotransformation	_	NOUN	NN	_	7	nmod	_	_
12	of	_	ADP	IN	_	15	case	_	_
13	a	_	DET	DT	_	15	det	_	_
14	large	_	ADJ	JJ	_	15	amod	_	_
15	number	_	NOUN	NN	_	11	nmod	_	_
16	of	_	ADP	IN	_	19	case	_	_
17	structurally	_	ADV	RB	_	18	advmod	_	_
18	different	_	ADJ	JJ	_	19	amod	_	_
19	drugs	_	NOUN	NNS	_	15	nmod	_	_
20	and	_	CONJ	CC	_	19	cc	_	_
21	endogenous	_	ADJ	JJ	_	22	amod	_	_
22	compounds	_	NOUN	NNS	_	19	conj	_	_

#	Fluvoxamine Maleate	1405
1	The	_	DET	DT	_	3	det	_	_
2	available	_	ADJ	JJ	_	3	amod	_	_
3	knowledge	_	NOUN	NN	_	17	nsubjpass	_	_
4	concerning	_	VERB	VBG	_	3	acl	_	_
5	the	_	DET	DT	_	6	det	_	_
6	relationship	_	NOUN	NN	_	4	dobj	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	the	_	DET	DT	_	14	det	_	_
11	cytochrome	_	NOUN	NN	_	14	compound	_	_
12	P450	_	NOUN	NN	_	14	compound	_	_
13	isoenzyme	_	NOUN	NN	_	14	compound	_	_
14	system	_	NOUN	NN	_	8	conj	_	_
15	has	_	VERB	VBZ	_	17	aux	_	_
16	been	_	VERB	VBN	_	17	auxpass	_	_
17	obtained	_	VERB	VBN	_	0	root	_	_
18	mostly	_	ADV	RB	_	17	advmod	_	_
19	from	_	ADP	IN	_	22	case	_	_
20	pharmacokinetic	_	ADJ	JJ	_	22	amod	_	_
21	interaction	_	NOUN	NN	_	22	compound	_	_
22	studies	_	NOUN	NNS	_	17	nmod	_	_
23	conducted	_	VERB	VBN	_	22	acl	_	_
24	in	_	ADP	IN	_	26	case	_	_
25	healthy	_	ADJ	JJ	_	26	amod	_	_
26	volunteers	_	NOUN	NNS	_	23	nmod	_	_
27	,	_	.	,	_	17	punct	_	_
28	but	_	CONJ	CC	_	17	cc	_	_
29	some	_	DET	DT	_	33	det	_	_
30	preliminary	_	ADJ	JJ	_	33	amod	_	_
31	in	_	X	FW	_	33	amod	_	_
32	vitro	_	X	FW	_	31	dep	_	_
33	data	_	NOUN	NNS	_	36	nsubj	_	_
34	are	_	VERB	VBP	_	36	auxpass	_	_
35	also	_	ADV	RB	_	36	advmod	_	_
36	available	_	ADJ	JJ	_	17	conj	_	_

#	Fluvoxamine Maleate	1406
1	Based	_	VERB	VBN	_	0	root	_	_
2	on	_	ADP	IN	_	4	case	_	_
3	a	_	DET	DT	_	4	det	_	_
4	finding	_	NOUN	NN	_	1	nmod	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	substantial	_	ADJ	JJ	_	7	amod	_	_
7	interactions	_	NOUN	NNS	_	4	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	with	_	ADP	IN	_	11	case	_	_
11	certain	_	NOUN	NN	_	4	nmod	_	_
12	of	_	ADP	IN	_	14	case	_	_
13	these	_	DET	DT	_	14	det	_	_
14	drugs	_	NOUN	NNS	_	11	nmod	_	_

#	Fluvoxamine Maleate	1407
1	In	_	X	FW	_	3	amod	_	_
2	vitro	_	X	FW	_	1	dep	_	_
3	data	_	NOUN	NNS	_	4	nsubj	_	_
4	suggest	_	VERB	VBP	_	0	root	_	_
5	that	_	ADP	IN	_	11	mark	_	_
6	DRUG	_	NOUN	NN	_	11	nsubj	_	_
7	is	_	VERB	VBZ	_	11	cop	_	_
8	a	_	DET	DT	_	11	det	_	_
9	relatively	_	ADV	RB	_	10	advmod	_	_
10	weak	_	ADJ	JJ	_	11	amod	_	_
11	inhibitor	_	NOUN	NN	_	4	ccomp	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	CYP2D6	_	NOUN	NN	_	11	nmod	_	_

#	Fluvoxamine Maleate	1408
1	Approximately	_	ADV	RB	_	7	advmod	_	_
2	7%	_	NOUN	NN	_	7	nsubj	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	the	_	DET	DT	_	6	det	_	_
5	normal	_	ADJ	JJ	_	6	amod	_	_
6	population	_	NOUN	NN	_	2	nmod	_	_
7	has	_	VERB	VBZ	_	0	root	_	_
8	a	_	DET	DT	_	10	det	_	_
9	genetic	_	ADJ	JJ	_	10	amod	_	_
10	code	_	NOUN	NN	_	7	dobj	_	_
11	that	_	DET	WDT	_	12	nsubj	_	_
12	leads	_	VERB	VBZ	_	10	acl:relcl	_	_
13	to	_	PRT	TO	_	15	case	_	_
14	reduced	_	VERB	VBN	_	15	amod	_	_
15	levels	_	NOUN	NNS	_	12	nmod	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	activity	_	NOUN	NN	_	15	nmod	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	CYP2D6	_	NOUN	NN	_	17	nmod	_	_

#	Fluvoxamine Maleate	1409
1	Such	_	ADJ	JJ	_	2	amod	_	_
2	individuals	_	NOUN	NNS	_	5	nsubjpass	_	_
3	have	_	VERB	VBP	_	5	aux	_	_
4	been	_	VERB	VBN	_	5	auxpass	_	_
5	referred	_	VERB	VBN	_	0	root	_	_
6	to	_	PRT	TO	_	10	case	_	_
7	as	_	ADP	IN	_	10	case	_	_
8	"poor	_	ADJ	JJ	_	10	amod	_	_
9	metabolizers"	_	NOUN	NN	_	10	compound	_	_
10	PM	_	NOUN	NN	_	5	nmod	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	drugs	_	NOUN	NNS	_	10	nmod	_	_
13	such	_	ADJ	JJ	_	15	case	_	_
14	as	_	ADP	IN	_	13	mwe	_	_
15	debrisoquin	_	NOUN	NN	_	12	nmod	_	_
16	,	_	.	,	_	15	punct	_	_
17	dextromethorphan	_	NOUN	NN	_	15	conj	_	_
18	,	_	.	,	_	15	punct	_	_
19	and	_	CONJ	CC	_	15	cc	_	_
20	tricyclic	_	ADJ	JJ	_	21	amod	_	_
21	antidepressants	_	NOUN	NNS	_	15	conj	_	_

#	Fluvoxamine Maleate	1410
1	While	_	ADP	IN	_	11	mark	_	_
2	none	_	NOUN	NN	_	11	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	the	_	DET	DT	_	5	det	_	_
5	drugs	_	NOUN	NNS	_	2	nmod	_	_
6	studied	_	VERB	VBN	_	5	acl	_	_
7	for	_	ADP	IN	_	9	case	_	_
8	drug	_	NOUN	NN	_	9	compound	_	_
9	interactions	_	NOUN	NNS	_	6	nmod	_	_
10	significantly	_	ADV	RB	_	11	advmod	_	_
11	affected	_	VERB	VBD	_	30	advcl	_	_
12	the	_	DET	DT	_	13	det	_	_
13	pharmacokinetics	_	NOUN	NNS	_	11	dobj	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	DRUG	_	NOUN	NN	_	13	nmod	_	_
16	,	_	.	,	_	30	punct	_	_
17	an	_	DET	DT	_	20	det	_	_
18	in	_	X	FW	_	20	amod	_	_
19	vivo	_	X	FW	_	18	dep	_	_
20	study	_	NOUN	NN	_	30	nsubj	_	_
21	of	_	ADP	IN	_	25	case	_	_
22	DRUG	_	NOUN	NN	_	25	compound	_	_
23	single	_	ADJ	JJ	_	25	amod	_	_
24	dose	_	NOUN	NN	_	25	compound	_	_
25	pharmacokinetics	_	NOUN	NNS	_	20	nmod	_	_
26	in	_	ADP	IN	_	29	case	_	_
27	13	_	NUM	CD	_	29	nummod	_	_
28	PM	_	NOUN	NN	_	29	compound	_	_
29	subjects	_	NOUN	NNS	_	20	nmod	_	_
30	demonstrated	_	VERB	VBD	_	0	root	_	_
31	altered	_	VERB	VBN	_	33	amod	_	_
32	pharmacokinetic	_	ADJ	JJ	_	33	amod	_	_
33	properties	_	NOUN	NNS	_	30	dobj	_	_
34	compared	_	VERB	VBD	_	30	xcomp	_	_
35	to	_	PRT	TO	_	39	case	_	_
36	16	_	NUM	CD	_	39	nummod	_	_
37	"extensive	_	ADJ	JJ	_	39	amod	_	_
38	metabolizers"	_	NOUN	NN	_	39	compound	_	_
39	EM	_	NOUN	NN	_	34	nmod	_	_
40	:	_	.	:	_	30	punct	_	_
41	mean	_	ADJ	JJ	_	42	amod	_	_
42	Cmax	_	NOUN	NN	_	50	nsubjpass	_	_
43	,	_	.	,	_	42	punct	_	_
44	AUC	_	NOUN	NN	_	42	conj	_	_
45	,	_	.	,	_	42	punct	_	_
46	and	_	CONJ	CC	_	42	cc	_	_
47	half	_	ADJ	JJ	_	48	amod	_	_
48	life	_	NOUN	NN	_	42	conj	_	_
49	were	_	VERB	VBD	_	50	auxpass	_	_
50	increased	_	VERB	VBN	_	30	parataxis	_	_
51	by	_	ADP	IN	_	52	case	_	_
52	52%	_	NOUN	NN	_	50	nmod	_	_
53	,	_	.	,	_	52	punct	_	_
54	200%	_	NOUN	NN	_	52	conj	_	_
55	,	_	.	,	_	52	punct	_	_
56	and	_	CONJ	CC	_	52	cc	_	_
57	62%	_	NOUN	NN	_	52	conj	_	_
58	,	_	.	,	_	50	punct	_	_
59	respectively	_	ADV	RB	_	50	advmod	_	_
60	,	_	.	,	_	50	punct	_	_
61	in	_	ADP	IN	_	63	case	_	_
62	the	_	DET	DT	_	63	det	_	_
63	PM	_	NOUN	NN	_	50	nmod	_	_
64	compared	_	VERB	VBN	_	63	acl	_	_
65	to	_	PRT	TO	_	68	case	_	_
66	the	_	DET	DT	_	68	det	_	_
67	EM	_	NOUN	NN	_	68	compound	_	_
68	group	_	NOUN	NN	_	64	nmod	_	_

#	Fluvoxamine Maleate	1411
1	This	_	DET	DT	_	2	nsubj	_	_
2	suggests	_	VERB	VBZ	_	0	root	_	_
3	that	_	ADP	IN	_	6	mark	_	_
4	DRUG	_	NOUN	NN	_	6	nsubjpass	_	_
5	is	_	VERB	VBZ	_	6	auxpass	_	_
6	metabolized	_	VERB	VBN	_	2	ccomp	_	_
7	,	_	.	,	_	6	punct	_	_
8	at	_	ADV	RB	_	11	advmod	_	_
9	least	_	ADV	RB	_	8	mwe	_	_
10	in	_	ADP	IN	_	11	case	_	_
11	part	_	NOUN	NN	_	6	nmod	_	_
12	,	_	.	,	_	6	punct	_	_
13	by	_	ADP	IN	_	14	case	_	_
14	CYP2D6	_	NOUN	NN	_	6	nmod	_	_

#	Fluvoxamine Maleate	1412
1	Caution	_	NOUN	NN	_	3	nsubjpass	_	_
2	is	_	VERB	VBZ	_	3	auxpass	_	_
3	indicated	_	VERB	VBN	_	0	root	_	_
4	in	_	ADP	IN	_	5	case	_	_
5	patients	_	NOUN	NNS	_	3	nmod	_	_
6	known	_	VERB	VBN	_	5	acl	_	_
7	to	_	PRT	TO	_	10	case	_	_
8	have	_	VERB	VB	_	9	aux	_	_
9	reduced	_	VERB	VBN	_	10	amod	_	_
10	levels	_	NOUN	NNS	_	6	nmod	_	_
11	of	_	ADP	IN	_	13	case	_	_
12	CYP2D6	_	NOUN	NN	_	13	compound	_	_
13	activity	_	NOUN	NN	_	10	nmod	_	_
14	and	_	CONJ	CC	_	10	cc	_	_
15	those	_	DET	DT	_	10	conj	_	_
16	receiving	_	VERB	VBG	_	15	acl	_	_
17	concomitant	_	ADJ	JJ	_	18	amod	_	_
18	drugs	_	NOUN	NNS	_	16	dobj	_	_
19	known	_	VERB	VBN	_	18	acl	_	_
20	to	_	PRT	TO	_	21	mark	_	_
21	inhibit	_	VERB	VB	_	19	xcomp	_	_
22	this	_	DET	DT	_	26	det	_	_
23	cytochrome	_	NOUN	NN	_	26	compound	_	_
24	P450	_	NOUN	NN	_	26	compound	_	_
25	isoenzyme	_	NOUN	NN	_	26	compound	_	_
26	e.g	_	NOUN	NN	_	21	dobj	_	_
27	,	_	.	,	_	26	punct	_	_
28	quinidine	_	VERB	VBG	_	26	appos	_	_

#	Fluvoxamine Maleate	1413
1	The	_	DET	DT	_	2	det	_	_
2	metabolism	_	NOUN	NN	_	9	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	has	_	VERB	VBZ	_	9	aux	_	_
6	not	_	ADV	RB	_	9	neg	_	_
7	been	_	VERB	VBN	_	9	auxpass	_	_
8	fully	_	ADV	RB	_	9	advmod	_	_
9	characterized	_	VERB	VBN	_	0	root	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	the	_	DET	DT	_	12	det	_	_
12	effects	_	NOUN	NNS	_	34	nsubjpass	_	_
13	of	_	ADP	IN	_	18	case	_	_
14	potent	_	ADJ	JJ	_	18	amod	_	_
15	cytochrome	_	NOUN	NN	_	18	compound	_	_
16	P450	_	NOUN	NN	_	18	compound	_	_
17	isoenzyme	_	NOUN	NN	_	18	compound	_	_
18	inhibition	_	NOUN	NN	_	12	nmod	_	_
19	,	_	.	,	_	12	punct	_	_
20	such	_	ADJ	JJ	_	24	case	_	_
21	as	_	ADP	IN	_	20	mwe	_	_
22	the	_	DET	DT	_	24	det	_	_
23	ketoconazole	_	NOUN	NN	_	24	compound	_	_
24	inhibition	_	NOUN	NN	_	12	nmod	_	_
25	of	_	ADP	IN	_	26	case	_	_
26	CYP3A4	_	NOUN	NN	_	24	nmod	_	_
27	,	_	.	,	_	12	punct	_	_
28	on	_	ADP	IN	_	30	case	_	_
29	DRUG	_	NOUN	NN	_	30	compound	_	_
30	metabolism	_	NOUN	NN	_	12	nmod	_	_
31	have	_	VERB	MD	_	34	aux	_	_
32	not	_	ADV	RB	_	34	neg	_	_
33	been	_	VERB	VBN	_	34	auxpass	_	_
34	studied	_	VERB	VBN	_	9	conj	_	_

#	Fluvoxamine Maleate	1414
1	A	_	DET	DT	_	5	det	_	_
2	clinically	_	ADV	RB	_	3	advmod	_	_
3	significant	_	ADJ	JJ	_	5	amod	_	_
4	DRUG	_	NOUN	NN	_	5	compound	_	_
5	interaction	_	NOUN	NN	_	7	nsubj	_	_
6	is	_	VERB	VBZ	_	7	cop	_	_
7	possible	_	ADJ	JJ	_	0	root	_	_
8	with	_	ADP	IN	_	9	case	_	_
9	drugs	_	NOUN	NNS	_	7	nmod	_	_
10	having	_	VERB	VBG	_	9	acl	_	_
11	a	_	DET	DT	_	14	det	_	_
12	narrow	_	NOUN	NN	_	14	compound	_	_
13	therapeutic	_	ADJ	JJ	_	14	amod	_	_
14	ratio	_	NOUN	NN	_	10	dobj	_	_
15	such	_	ADJ	JJ	_	17	case	_	_
16	as	_	ADP	IN	_	15	mwe	_	_
17	pimozide	_	NOUN	NN	_	14	nmod	_	_
18	,	_	.	,	_	17	punct	_	_
19	warfarin	_	NOUN	NN	_	17	conj	_	_
20	,	_	.	,	_	17	punct	_	_
21	theophylline	_	NOUN	NN	_	17	conj	_	_
22	,	_	.	,	_	17	punct	_	_
23	certain	_	ADJ	JJ	_	24	amod	_	_
24	benzodiazepines	_	NOUN	NNS	_	17	conj	_	_
25	,	_	.	,	_	17	punct	_	_
26	omeprazole	_	ADJ	JJ	_	17	appos	_	_
27	and	_	CONJ	CC	_	26	cc	_	_
28	phenytoin	_	NOUN	NN	_	26	conj	_	_

#	Fluvoxamine Maleate	1415
1	If	_	ADP	IN	_	4	mark	_	_
2	DRUG	_	NOUN	NN	_	3	compound	_	_
3	tablets	_	NOUN	NNS	_	4	nsubj	_	_
4	are	_	VERB	VBP	_	38	aux	_	_
5	to	_	PRT	TO	_	7	mark	_	_
6	be	_	VERB	VB	_	7	auxpass	_	_
7	administered	_	VERB	VBN	_	4	xcomp	_	_
8	together	_	ADV	RB	_	7	advmod	_	_
9	with	_	ADP	IN	_	11	case	_	_
10	a	_	DET	DT	_	11	det	_	_
11	drug	_	NOUN	NN	_	7	nmod	_	_
12	that	_	DET	WDT	_	14	nsubjpass	_	_
13	is	_	VERB	VBZ	_	14	auxpass	_	_
14	eliminated	_	VERB	VBN	_	11	acl:relcl	_	_
15	via	_	ADP	IN	_	17	case	_	_
16	oxidative	_	ADJ	JJ	_	17	amod	_	_
17	metabolism	_	NOUN	NN	_	14	nmod	_	_
18	and	_	CONJ	CC	_	14	cc	_	_
19	has	_	VERB	VBZ	_	14	conj	_	_
20	a	_	DET	DT	_	23	det	_	_
21	narrow	_	NOUN	NN	_	23	compound	_	_
22	therapeutic	_	ADJ	JJ	_	23	amod	_	_
23	window	_	NOUN	NN	_	19	dobj	_	_
24	,	_	.	,	_	23	punct	_	_
25	plasma	_	NOUN	NN	_	26	compound	_	_
26	levels	_	NOUN	NNS	_	23	conj	_	_
27	and	_	CONJ	CC	_	23	cc	_	_
28	/	_	NUM	CD	_	31	compound	_	_
29	or	_	CONJ	CC	_	28	cc	_	_
30	pharmacodynamic	_	ADJ	JJ	_	28	conj	_	_
31	effects	_	NOUN	NNS	_	23	conj	_	_
32	of	_	ADP	IN	_	35	case	_	_
33	the	_	DET	DT	_	35	det	_	_
34	latter	_	ADJ	JJ	_	35	amod	_	_
35	drug	_	NOUN	NN	_	31	nmod	_	_
36	should	_	VERB	MD	_	38	aux	_	_
37	be	_	VERB	VB	_	38	auxpass	_	_
38	monitored	_	VERB	VBN	_	0	root	_	_
39	closely	_	ADV	RB	_	38	advmod	_	_
40	,	_	.	,	_	38	punct	_	_
41	at	_	ADV	RB	_	48	mark	_	_
42	least	_	ADV	RB	_	41	mwe	_	_
43	until	_	ADP	IN	_	46	case	_	_
44	steady	_	ADJ	JJ	_	46	amod	_	_
45	state	_	NOUN	NN	_	46	compound	_	_
46	conditions	_	NOUN	NNS	_	48	nsubjpass	_	_
47	are	_	VERB	VBP	_	48	auxpass	_	_
48	reached	_	VERB	VBN	_	38	parataxis	_	_

#	Fluvoxamine Maleate	1416
1	A	_	DET	DT	_	2	det	_	_
2	study	_	NOUN	NN	_	0	root	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	multiple	_	ADJ	JJ	_	5	amod	_	_
5	doses	_	NOUN	NNS	_	2	nmod	_	_
6	of	_	ADP	IN	_	10	case	_	_
7	DRUG	_	NOUN	NN	_	10	compound	_	_
8	50	_	NUM	CD	_	10	nummod	_	_
9	mg	_	NOUN	NN	_	10	compound	_	_
10	b.i.d	_	NOUN	NN	_	5	nmod	_	_
11	in	_	ADP	IN	_	14	case	_	_
12	healthy	_	ADJ	JJ	_	14	amod	_	_
13	male	_	ADJ	JJ	_	14	amod	_	_
14	volunteers	_	NOUN	NNS	_	2	nmod	_	_
15	N	_	NOUN	NN	_	16	nsubj	_	_
16	=	_	ADJ	JJ	_	14	dep	_	_
17	12	_	NUM	CD	_	16	dobj	_	_
18	and	_	CONJ	CC	_	16	cc	_	_
19	a	_	DET	DT	_	21	det	_	_
20	single	_	ADJ	JJ	_	21	amod	_	_
21	dose	_	NOUN	NN	_	28	nsubj	_	_
22	of	_	ADP	IN	_	27	case	_	_
23	lorazepam	_	NOUN	NN	_	27	compound	_	_
24	4	_	NUM	CD	_	27	nummod	_	_
25	mg	_	NOUN	NN	_	27	compound	_	_
26	single	_	ADJ	JJ	_	27	amod	_	_
27	dose	_	NOUN	NN	_	21	nmod	_	_
28	indicated	_	VERB	VBD	_	16	conj	_	_
29	no	_	DET	DT	_	32	neg	_	_
30	significant	_	ADJ	JJ	_	32	amod	_	_
31	pharmacokinetic	_	ADJ	JJ	_	32	amod	_	_
32	interaction	_	NOUN	NN	_	28	dobj	_	_

#	Fluvoxamine Maleate	1417
1	On	_	ADP	IN	_	2	case	_	_
2	average	_	NOUN	NN	_	0	root	_	_
3	,	_	.	,	_	2	punct	_	_
4	both	_	CONJ	CC	_	5	cc:preconj	_	_
5	lorazepam	_	NOUN	NN	_	3	root	_	_
6	alone	_	ADV	RB	_	7	advmod	_	_
7	and	_	CONJ	CC	_	5	advmod	_	_
8	lorazepam	_	NOUN	NN	_	11	nsubj	_	_
9	with	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	produced	_	VERB	VBD	_	7	conj	_	_
12	substantial	_	ADJ	JJ	_	13	amod	_	_
13	decrements	_	NOUN	NNS	_	11	dobj	_	_
14	in	_	ADP	IN	_	16	case	_	_
15	cognitive	_	ADJ	JJ	_	16	amod	_	_
16	functioning	_	VERB	VBG	_	11	advcl	_	_
17	however	_	ADV	RB	_	16	advmod	_	_
18	,	_	.	,	_	5	punct	_	_
19	the	_	DET	DT	_	20	det	_	_
20	coadministration	_	NOUN	NN	_	27	nsubj	_	_
21	of	_	ADP	IN	_	22	case	_	_
22	DRUG	_	NOUN	NN	_	20	nmod	_	_
23	and	_	CONJ	CC	_	22	cc	_	_
24	lorazepam	_	NOUN	NN	_	22	conj	_	_
25	did	_	VERB	VBD	_	27	aux	_	_
26	not	_	ADV	RB	_	27	neg	_	_
27	produce	_	VERB	VB	_	5	dep	_	_
28	larger	_	ADJ	JJ	_	30	amod	_	_
29	mean	_	NOUN	NN	_	30	compound	_	_
30	decrements	_	NOUN	NNS	_	27	dobj	_	_
31	compared	_	VERB	VBN	_	27	xcomp	_	_
32	to	_	PRT	TO	_	33	case	_	_
33	lorazepam	_	NOUN	NN	_	31	nmod	_	_
34	alone	_	ADV	RB	_	33	advmod	_	_

#	Fluvoxamine Maleate	1418
1	Studies	_	NOUN	NNS	_	27	nsubj	_	_
2	involving	_	VERB	VBG	_	1	acl	_	_
3	single	_	ADJ	JJ	_	6	amod	_	_
4	40	_	NUM	CD	_	6	nummod	_	_
5	g	_	NOUN	NN	_	6	compound	_	_
6	doses	_	NOUN	NNS	_	2	dobj	_	_
7	of	_	ADP	IN	_	10	case	_	_
8	ethanol	_	NOUN	NN	_	10	compound	_	_
9	oral	_	ADJ	JJ	_	10	amod	_	_
10	administration	_	NOUN	NN	_	6	nmod	_	_
11	in	_	ADP	IN	_	13	case	_	_
12	one	_	NUM	CD	_	13	nummod	_	_
13	study	_	NOUN	NN	_	2	nmod	_	_
14	and	_	CONJ	CC	_	1	cc	_	_
15	intravenous	_	ADJ	JJ	_	1	conj	_	_
16	in	_	ADP	IN	_	21	case	_	_
17	the	_	DET	DT	_	21	det	_	_
18	other	_	ADJ	JJ	_	21	amod	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	multiple	_	ADJ	JJ	_	18	conj	_	_
21	dosing	_	NOUN	NN	_	15	nmod	_	_
22	with	_	ADP	IN	_	26	case	_	_
23	DRUG	_	NOUN	NN	_	26	compound	_	_
24	50	_	NUM	CD	_	26	nummod	_	_
25	mg	_	NOUN	NN	_	26	compound	_	_
26	b.i.d	_	NOUN	NN	_	21	nmod	_	_
27	revealed	_	VERB	VBD	_	0	root	_	_
28	no	_	DET	DT	_	29	neg	_	_
29	effect	_	NOUN	NN	_	27	dobj	_	_
30	of	_	ADP	IN	_	32	case	_	_
31	either	_	CONJ	CC	_	32	det	_	_
32	drug	_	NOUN	NN	_	29	nmod	_	_
33	on	_	ADP	IN	_	35	case	_	_
34	the	_	DET	DT	_	35	det	_	_
35	pharmacokinetics	_	NOUN	NNS	_	29	nmod	_	_
36	or	_	CONJ	CC	_	35	cc	_	_
37	pharmacodynamics	_	NOUN	NNS	_	35	conj	_	_
38	of	_	ADP	IN	_	40	case	_	_
39	the	_	DET	DT	_	40	det	_	_
40	other	_	ADJ	JJ	_	35	nmod	_	_

#	Fluvoxamine Maleate	1419
1	As	_	ADP	IN	_	5	case	_	_
2	with	_	ADP	IN	_	5	case	_	_
3	other	_	ADJ	JJ	_	5	amod	_	_
4	psychotropic	_	ADJ	JJ	_	5	amod	_	_
5	medications	_	NOUN	NNS	_	10	nmod	_	_
6	,	_	.	,	_	10	punct	_	_
7	patients	_	NOUN	NNS	_	10	nsubjpass	_	_
8	should	_	VERB	MD	_	10	aux	_	_
9	be	_	VERB	VB	_	10	auxpass	_	_
10	advised	_	VERB	VBN	_	0	root	_	_
11	to	_	PRT	TO	_	12	mark	_	_
12	avoid	_	VERB	VB	_	10	xcomp	_	_
13	alcohol	_	NOUN	NN	_	12	dobj	_	_
14	while	_	ADP	IN	_	15	mark	_	_
15	taking	_	VERB	VBG	_	12	advcl	_	_
16	DRUG	_	NOUN	NN	_	17	compound	_	_
17	tablets	_	NOUN	NNS	_	15	dobj	_	_

#	Fluvoxamine Maleate	1420
1	Elevated	_	ADJ	JJ	_	3	amod	_	_
2	carbamazepine	_	NOUN	NN	_	3	compound	_	_
3	levels	_	NOUN	NNS	_	10	nsubjpass	_	_
4	and	_	CONJ	CC	_	3	cc	_	_
5	symptoms	_	NOUN	NNS	_	3	conj	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	toxicity	_	NOUN	NN	_	5	nmod	_	_
8	have	_	VERB	VBP	_	10	aux	_	_
9	been	_	VERB	VBN	_	10	auxpass	_	_
10	reported	_	VERB	VBN	_	0	root	_	_
11	with	_	ADP	IN	_	13	case	_	_
12	the	_	DET	DT	_	13	det	_	_
13	coadministration	_	NOUN	NN	_	10	nmod	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	DRUG	_	NOUN	NN	_	13	nmod	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	carbamazepine	_	NOUN	NN	_	15	conj	_	_

#	Fluvoxamine Maleate	1421
1	As	_	ADP	IN	_	5	case	_	_
2	with	_	ADP	IN	_	5	case	_	_
3	other	_	ADJ	JJ	_	5	amod	_	_
4	serotonergic	_	ADJ	JJ	_	5	amod	_	_
5	drugs	_	NOUN	NNS	_	9	nmod	_	_
6	,	_	.	,	_	9	punct	_	_
7	lithium	_	NOUN	NN	_	9	nsubj	_	_
8	may	_	VERB	MD	_	9	aux	_	_
9	enhance	_	VERB	VB	_	0	root	_	_
10	the	_	DET	DT	_	12	det	_	_
11	serotonergic	_	ADJ	JJ	_	12	amod	_	_
12	effects	_	NOUN	NNS	_	9	dobj	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	DRUG	_	NOUN	NN	_	12	nmod	_	_
15	and	_	CONJ	CC	_	9	cc	_	_
16	,	_	.	,	_	9	punct	_	_
17	therefore	_	ADV	RB	_	9	advmod	_	_
18	,	_	.	,	_	9	punct	_	_
19	the	_	DET	DT	_	20	det	_	_
20	combination	_	NOUN	NN	_	23	nsubjpass	_	_
21	should	_	VERB	MD	_	23	aux	_	_
22	be	_	VERB	VB	_	23	auxpass	_	_
23	used	_	VERB	VBN	_	9	parataxis	_	_
24	with	_	ADP	IN	_	25	case	_	_
25	caution	_	NOUN	NN	_	23	nmod	_	_

#	Fluvoxamine Maleate	1422
1	Seizures	_	NOUN	NNS	_	4	nsubjpass	_	_
2	have	_	VERB	VBP	_	4	aux	_	_
3	been	_	VERB	VBN	_	4	auxpass	_	_
4	reported	_	VERB	VBN	_	0	root	_	_
5	with	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	coadministration	_	NOUN	NN	_	4	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	lithium	_	NOUN	NN	_	9	conj	_	_

#	Fluvoxamine Maleate	1423
1	See	_	NOUN	NN	_	2	compound	_	_
2	Dosage	_	NOUN	NN	_	0	root	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	Administration	_	NOUN	NN	_	2	conj	_	_
5	2.5	_	NUM	CD	_	4	nummod	_	_
6	and	_	CONJ	CC	_	2	cc	_	_
7	2.6	_	NUM	CD	_	2	conj	_	_
8	,	_	.	,	_	2	punct	_	_
9	Contraindications	_	NOUN	NNS	_	2	conj	_	_
10	4.2	_	NUM	CD	_	9	nummod	_	_
11	and	_	CONJ	CC	_	2	cc	_	_
12	Warnings	_	NOUN	NNS	_	2	conj	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	Precautions	_	NOUN	NNS	_	12	conj	_	_
15	5.2	_	NUM	CD	_	14	nummod	_	_

#	Fluvoxamine Maleate	1424
1	See	_	NOUN	NN	_	2	compound	_	_
2	Contraindications	_	NOUN	NNS	_	0	root	_	_
3	4.1	_	NUM	CD	_	2	nummod	_	_
4	and	_	CONJ	CC	_	2	cc	_	_
5	Warnings	_	NOUN	NNS	_	2	conj	_	_
6	and	_	CONJ	CC	_	2	cc	_	_
7	Precautions	_	NOUN	NNS	_	2	conj	_	_
8	5.6	_	NUM	CD	_	7	nummod	_	_

#	Fluvoxamine Maleate	1426
1	In	_	ADP	IN	_	3	case	_	_
2	a	_	DET	DT	_	3	det	_	_
3	study	_	NOUN	NN	_	45	nmod	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	13	_	NUM	CD	_	6	nummod	_	_
6	healthy	_	ADJ	JJ	_	3	nmod	_	_
7	,	_	.	,	_	6	punct	_	_
8	male	_	ADJ	JJ	_	6	dep	_	_
9	volunteers	_	NOUN	NNS	_	6	dep	_	_
10	,	_	.	,	_	45	punct	_	_
11	a	_	DET	DT	_	15	det	_	_
12	single	_	ADJ	JJ	_	15	amod	_	_
13	40	_	NUM	CD	_	15	nummod	_	_
14	mg	_	NOUN	NN	_	15	compound	_	_
15	dose	_	NOUN	NN	_	45	nsubj	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	tacrine	_	NOUN	NN	_	15	nmod	_	_
18	added	_	VERB	VBN	_	17	acl	_	_
19	to	_	PRT	TO	_	22	case	_	_
20	DRUG	_	NOUN	NN	_	22	compound	_	_
21	100	_	NUM	CD	_	22	nummod	_	_
22	mg	_	NOUN	NN	_	18	nmod	_	_
23	/	_	.	:	_	15	punct	_	_
24	day	_	NOUN	NN	_	30	nsubjpass	_	_
25	administered	_	VERB	VBN	_	24	acl	_	_
26	at	_	ADP	IN	_	28	case	_	_
27	steady	_	ADJ	JJ	_	28	amod	_	_
28	state	_	NOUN	NN	_	25	nmod	_	_
29	was	_	VERB	VBD	_	30	auxpass	_	_
30	associated	_	VERB	VBN	_	15	acl:relcl	_	_
31	with	_	ADP	IN	_	36	case	_	_
32	5	_	NUM	CD	_	35	compound	_	_
33	and	_	CONJ	CC	_	32	cc	_	_
34	8	_	NUM	CD	_	32	conj	_	_
35	fold	_	NOUN	NN	_	36	dep	_	_
36	increases	_	NOUN	NNS	_	30	nmod	_	_
37	in	_	ADP	IN	_	39	case	_	_
38	tacrine	_	NOUN	NN	_	39	compound	_	_
39	Cmax	_	NOUN	NN	_	36	nmod	_	_
40	and	_	CONJ	CC	_	39	cc	_	_
41	AUC	_	NOUN	NN	_	39	conj	_	_
42	,	_	.	,	_	15	punct	_	_
43	respectively	_	ADV	RB	_	45	advmod	_	_
44	,	_	.	,	_	45	punct	_	_
45	compared	_	VERB	VBD	_	0	root	_	_
46	to	_	PRT	TO	_	48	case	_	_
47	the	_	DET	DT	_	48	det	_	_
48	administration	_	NOUN	NN	_	45	nmod	_	_
49	of	_	ADP	IN	_	50	case	_	_
50	tacrine	_	NOUN	NN	_	48	nmod	_	_
51	alone	_	ADV	RB	_	50	advmod	_	_

#	Fluvoxamine Maleate	1427
1	Five	_	NUM	CD	_	2	nummod	_	_
2	subjects	_	NOUN	NNS	_	3	nsubj	_	_
3	experienced	_	VERB	VBD	_	0	root	_	_
4	nausea	_	NOUN	NN	_	3	dobj	_	_
5	,	_	.	,	_	4	punct	_	_
6	vomiting	_	VERB	VBG	_	4	conj	_	_
7	,	_	.	,	_	4	punct	_	_
8	sweating	_	NOUN	NN	_	4	conj	_	_
9	,	_	.	,	_	4	punct	_	_
10	and	_	CONJ	CC	_	4	cc	_	_
11	diarrhea	_	NOUN	NN	_	4	conj	_	_
12	following	_	ADP	IN	_	13	case	_	_
13	coadministration	_	NOUN	NN	_	3	nmod	_	_
14	,	_	.	,	_	3	punct	_	_
15	consistent	_	ADJ	JJ	_	3	xcomp	_	_
16	with	_	ADP	IN	_	19	case	_	_
17	the	_	DET	DT	_	19	det	_	_
18	cholinergic	_	ADJ	JJ	_	19	amod	_	_
19	effects	_	NOUN	NNS	_	15	nmod	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	tacrine	_	NOUN	NN	_	19	nmod	_	_

#	Fluvoxamine Maleate	1428
1	See	_	NOUN	NN	_	2	compound	_	_
2	Contraindications	_	NOUN	NNS	_	0	root	_	_
3	4.1	_	NUM	CD	_	2	nummod	_	_
4	and	_	CONJ	CC	_	2	cc	_	_
5	Warnings	_	NOUN	NNS	_	2	conj	_	_
6	and	_	CONJ	CC	_	2	cc	_	_
7	Precautions	_	NOUN	NNS	_	2	conj	_	_
8	5.4	_	NUM	CD	_	7	nummod	_	_

#	Fluvoxamine Maleate	1429
1	See	_	NOUN	NN	_	2	compound	_	_
2	Contraindications	_	NOUN	NNS	_	0	root	_	_
3	4.1	_	NUM	CD	_	2	nummod	_	_
4	and	_	CONJ	CC	_	2	cc	_	_
5	Warnings	_	NOUN	NNS	_	2	conj	_	_
6	and	_	CONJ	CC	_	2	cc	_	_
7	Precautions	_	NOUN	NNS	_	2	conj	_	_
8	5.5	_	NUM	CD	_	7	nummod	_	_

#	Fluvoxamine Maleate	1430
1	Significantly	_	ADV	RB	_	2	advmod	_	_
2	increased	_	VERB	VBN	_	5	amod	_	_
3	plasma	_	NOUN	NN	_	5	compound	_	_
4	TCA	_	NOUN	NN	_	5	compound	_	_
5	levels	_	NOUN	NNS	_	8	nsubjpass	_	_
6	have	_	VERB	VBP	_	8	aux	_	_
7	been	_	VERB	VBN	_	8	auxpass	_	_
8	reported	_	VERB	VBN	_	0	root	_	_
9	with	_	ADP	IN	_	11	case	_	_
10	the	_	DET	DT	_	11	det	_	_
11	coadministration	_	NOUN	NN	_	8	nmod	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	DRUG	_	NOUN	NN	_	11	nmod	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	amitriptyline	_	NOUN	NN	_	13	conj	_	_
16	,	_	.	,	_	13	punct	_	_
17	clomipramine	_	NOUN	NN	_	13	conj	_	_
18	or	_	CONJ	CC	_	13	cc	_	_
19	imipramine	_	NOUN	NN	_	13	conj	_	_

#	Fluvoxamine Maleate	1431
1	Caution	_	NOUN	NN	_	3	nsubjpass	_	_
2	is	_	VERB	VBZ	_	3	auxpass	_	_
3	indicated	_	VERB	VBN	_	0	root	_	_
4	with	_	ADP	IN	_	6	case	_	_
5	the	_	DET	DT	_	6	det	_	_
6	coadministration	_	NOUN	NN	_	3	nmod	_	_
7	of	_	ADP	IN	_	9	case	_	_
8	DRUG	_	NOUN	NN	_	9	compound	_	_
9	tablets	_	NOUN	NNS	_	6	nmod	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	TCAs	_	NOUN	NN	_	14	compound	_	_
12	plasma	_	NOUN	NN	_	14	compound	_	_
13	TCA	_	NOUN	NN	_	14	compound	_	_
14	concentrations	_	NOUN	NNS	_	9	conj	_	_
15	may	_	VERB	MD	_	16	aux	_	_
16	need	_	VERB	VB	_	3	parataxis	_	_
17	to	_	PRT	TO	_	19	mark	_	_
18	be	_	VERB	VB	_	19	auxpass	_	_
19	monitored	_	VERB	VBN	_	16	xcomp	_	_
20	,	_	.	,	_	16	punct	_	_
21	and	_	CONJ	CC	_	16	cc	_	_
22	the	_	DET	DT	_	23	det	_	_
23	dose	_	NOUN	NN	_	27	nsubj	_	_
24	of	_	ADP	IN	_	25	case	_	_
25	TCA	_	NOUN	NN	_	23	nmod	_	_
26	may	_	VERB	MD	_	27	aux	_	_
27	need	_	VERB	VB	_	16	conj	_	_
28	to	_	PRT	TO	_	30	mark	_	_
29	be	_	VERB	VB	_	30	auxpass	_	_
30	reduced	_	VERB	VBN	_	27	ccomp	_	_

#	Fluvoxamine Maleate	1432
1	There	_	DET	EX	_	6	nmod:poss	_	_
2	have	_	VERB	VBP	_	6	aux	_	_
3	been	_	VERB	VBN	_	6	cop	_	_
4	rare	_	ADJ	JJ	_	6	amod	_	_
5	postmarketing	_	ADJ	JJ	_	6	amod	_	_
6	reports	_	NOUN	NNS	_	0	root	_	_
7	of	_	ADP	IN	_	9	case	_	_
8	serotonin	_	NOUN	NN	_	9	compound	_	_
9	syndrome	_	NOUN	NN	_	6	nmod	_	_
10	with	_	ADP	IN	_	11	case	_	_
11	use	_	NOUN	NN	_	6	nmod	_	_
12	of	_	ADP	IN	_	14	case	_	_
13	an	_	DET	DT	_	14	det	_	_
14	SSRI	_	NOUN	NN	_	11	nmod	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	a	_	DET	DT	_	17	det	_	_
17	triptan	_	NOUN	NN	_	14	conj	_	_

#	Fluvoxamine Maleate	1433
1	If	_	ADP	IN	_	3	case	_	_
2	concomitant	_	ADJ	JJ	_	3	amod	_	_
3	treatment	_	NOUN	NN	_	11	nsubjpass	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	with	_	ADP	IN	_	8	case	_	_
7	a	_	DET	DT	_	8	det	_	_
8	triptan	_	NOUN	NN	_	3	nmod	_	_
9	is	_	VERB	VBZ	_	11	auxpass	_	_
10	clinically	_	ADV	RB	_	11	advmod	_	_
11	warranted	_	VERB	VBN	_	19	advcl	_	_
12	,	_	.	,	_	19	punct	_	_
13	careful	_	ADJ	JJ	_	14	amod	_	_
14	observation	_	NOUN	NN	_	19	nsubjpass	_	_
15	of	_	ADP	IN	_	17	case	_	_
16	the	_	DET	DT	_	17	det	_	_
17	patient	_	NOUN	NN	_	14	nmod	_	_
18	is	_	VERB	VBZ	_	19	auxpass	_	_
19	advised	_	VERB	VBN	_	0	root	_	_
20	,	_	.	,	_	19	punct	_	_
21	particularly	_	ADV	RB	_	23	advmod	_	_
22	during	_	ADP	IN	_	23	case	_	_
23	treatment	_	NOUN	NN	_	19	nmod	_	_
24	initiation	_	NOUN	NN	_	23	dep	_	_
25	and	_	CONJ	CC	_	24	cc	_	_
26	dose	_	NOUN	NN	_	24	conj	_	_
27	increases	_	VERB	VBZ	_	19	root	_	_

#	Fluvoxamine Maleate	1434
1	There	_	DET	EX	_	6	nmod:poss	_	_
2	have	_	VERB	VBP	_	6	aux	_	_
3	been	_	VERB	VBN	_	6	cop	_	_
4	rare	_	ADJ	JJ	_	6	amod	_	_
5	postmarketing	_	VERB	VBG	_	6	amod	_	_
6	reports	_	NOUN	NNS	_	0	root	_	_
7	describing	_	VERB	VBG	_	6	acl	_	_
8	patients	_	NOUN	NNS	_	7	dobj	_	_
9	with	_	ADP	IN	_	10	case	_	_
10	weakness	_	NOUN	NN	_	8	nmod	_	_
11	,	_	.	,	_	10	punct	_	_
12	hyperreflexia	_	NOUN	NN	_	10	conj	_	_
13	,	_	.	,	_	10	punct	_	_
14	and	_	CONJ	CC	_	10	cc	_	_
15	incoordination	_	NOUN	NN	_	10	conj	_	_
16	following	_	ADP	IN	_	18	case	_	_
17	the	_	DET	DT	_	18	det	_	_
18	use	_	NOUN	NN	_	7	nmod	_	_
19	of	_	ADP	IN	_	24	case	_	_
20	a	_	DET	DT	_	24	det	_	_
21	selective	_	ADJ	JJ	_	24	amod	_	_
22	serotonin	_	NOUN	NN	_	24	compound	_	_
23	reuptake	_	NOUN	NN	_	24	compound	_	_
24	inhibitor	_	NOUN	NN	_	18	nmod	_	_
25	SSRI	_	NOUN	NN	_	24	dep	_	_
26	and	_	CONJ	CC	_	25	cc	_	_
27	sumatriptan	_	NOUN	NN	_	25	conj	_	_

#	Fluvoxamine Maleate	1435
1	If	_	ADP	IN	_	3	case	_	_
2	concomitant	_	ADJ	JJ	_	3	amod	_	_
3	treatment	_	NOUN	NN	_	20	nsubjpass	_	_
4	with	_	ADP	IN	_	5	case	_	_
5	sumatriptan	_	NOUN	NN	_	3	nmod	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	an	_	DET	DT	_	9	det	_	_
8	SSRI	_	NOUN	NN	_	9	compound	_	_
9	e.g	_	NOUN	NN	_	5	conj	_	_
10	,	_	.	,	_	9	punct	_	_
11	fluoxetine	_	NOUN	NN	_	9	conj	_	_
12	,	_	.	,	_	9	punct	_	_
13	DRUG	_	NOUN	NN	_	9	conj	_	_
14	,	_	.	,	_	9	punct	_	_
15	paroxetine	_	NOUN	NN	_	9	appos	_	_
16	,	_	.	,	_	9	punct	_	_
17	sertraline	_	NOUN	NN	_	9	appos	_	_
18	is	_	VERB	VBZ	_	20	auxpass	_	_
19	clinically	_	ADV	RB	_	20	advmod	_	_
20	warranted	_	VERB	VBN	_	0	root	_	_
21	,	_	.	,	_	20	punct	_	_
22	appropriate	_	ADJ	JJ	_	23	amod	_	_
23	observation	_	NOUN	NN	_	28	nsubjpass	_	_
24	of	_	ADP	IN	_	26	case	_	_
25	the	_	DET	DT	_	26	det	_	_
26	patient	_	NOUN	NN	_	23	nmod	_	_
27	is	_	VERB	VBZ	_	28	auxpass	_	_
28	advised	_	VERB	VBN	_	20	parataxis	_	_

#	Fluvoxamine Maleate	1436
1	Tryptophan	_	NOUN	NN	_	3	nsubj	_	_
2	may	_	VERB	MD	_	3	aux	_	_
3	enhance	_	VERB	VB	_	0	root	_	_
4	the	_	DET	DT	_	6	det	_	_
5	serotonergic	_	ADJ	JJ	_	6	amod	_	_
6	effects	_	NOUN	NNS	_	3	dobj	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	,	_	.	,	_	3	punct	_	_
10	and	_	CONJ	CC	_	3	cc	_	_
11	the	_	DET	DT	_	12	det	_	_
12	combination	_	NOUN	NN	_	18	nsubjpass	_	_
13	should	_	VERB	MD	_	18	aux	_	_
14	,	_	.	,	_	18	punct	_	_
15	therefore	_	ADV	RB	_	18	advmod	_	_
16	,	_	.	,	_	18	punct	_	_
17	be	_	VERB	VBZ	_	18	auxpass	_	_
18	used	_	VERB	VBN	_	3	conj	_	_
19	with	_	ADP	IN	_	20	case	_	_
20	caution	_	NOUN	NN	_	18	nmod	_	_

#	Fluvoxamine Maleate	1437
1	Severe	_	ADJ	JJ	_	2	amod	_	_
2	vomiting	_	NOUN	NN	_	5	nsubjpass	_	_
3	has	_	VERB	VBZ	_	5	aux	_	_
4	been	_	VERB	VBN	_	5	auxpass	_	_
5	reported	_	VERB	VBN	_	0	root	_	_
6	with	_	ADP	IN	_	8	case	_	_
7	the	_	DET	DT	_	8	det	_	_
8	coadministration	_	NOUN	NN	_	5	nmod	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	tryptophan	_	NOUN	NN	_	10	conj	_	_

#	Fluvoxamine Maleate	1438
1	See	_	NOUN	NN	_	2	compound	_	_
2	Contraindications	_	NOUN	NNS	_	14	nsubj	_	_
3	4.1	_	NUM	CD	_	2	nummod	_	_
4	,	_	.	,	_	2	punct	_	_
5	Warnings	_	NOUN	NNS	_	2	conj	_	_
6	and	_	CONJ	CC	_	2	cc	_	_
7	Precautions	_	NOUN	NNS	_	2	conj	_	_
8	5.7	_	NUM	CD	_	7	nummod	_	_
9	,	_	.	,	_	2	punct	_	_
10	and	_	CONJ	CC	_	2	cc	_	_
11	Lotronex**	_	NOUN	NN	_	13	compound	_	_
12	alosetron	_	NOUN	NN	_	13	compound	_	_
13	package	_	NOUN	NN	_	2	conj	_	_
14	insert	_	VERB	VBP	_	0	root	_	_

#	Fluvoxamine Maleate	1439
1	Administration	_	NOUN	NN	_	16	nsubj	_	_
2	of	_	ADP	IN	_	5	case	_	_
3	DRUG	_	NOUN	NN	_	5	compound	_	_
4	100	_	NUM	CD	_	5	nummod	_	_
5	mg	_	NOUN	NN	_	1	nmod	_	_
6	daily	_	ADV	RB	_	9	advmod	_	_
7	for	_	ADP	IN	_	9	case	_	_
8	18	_	NUM	CD	_	9	nummod	_	_
9	days	_	NOUN	NNS	_	1	nmod	_	_
10	N	_	NOUN	NN	_	11	nsubj	_	_
11	=	_	ADJ	JJ	_	9	amod	_	_
12	8	_	NUM	CD	_	11	dobj	_	_
13	did	_	VERB	VBD	_	16	aux	_	_
14	not	_	ADV	RB	_	16	neg	_	_
15	significantly	_	ADV	RB	_	16	advmod	_	_
16	affect	_	VERB	VB	_	0	root	_	_
17	the	_	DET	DT	_	18	det	_	_
18	pharmacokinetics	_	NOUN	NNS	_	16	dobj	_	_
19	of	_	ADP	IN	_	25	case	_	_
20	a	_	DET	DT	_	25	det	_	_
21	1.25	_	NUM	CD	_	25	nummod	_	_
22	mg	_	NOUN	NN	_	25	compound	_	_
23	single	_	ADJ	JJ	_	25	amod	_	_
24	intravenous	_	ADJ	JJ	_	25	amod	_	_
25	dose	_	NOUN	NN	_	18	nmod	_	_
26	of	_	ADP	IN	_	27	case	_	_
27	digoxin	_	NOUN	NN	_	25	nmod	_	_

#	Fluvoxamine Maleate	1440
1	Bradycardia	_	NOUN	NN	_	4	nsubjpass	_	_
2	has	_	VERB	VBZ	_	4	aux	_	_
3	been	_	VERB	VBN	_	4	auxpass	_	_
4	reported	_	VERB	VBN	_	0	root	_	_
5	with	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	coadministration	_	NOUN	NN	_	4	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	diltiazem	_	NOUN	NN	_	9	conj	_	_

#	Fluvoxamine Maleate	1441
1	Coadministration	_	NOUN	NN	_	17	nsubj	_	_
2	of	_	ADP	IN	_	5	case	_	_
3	DRUG	_	NOUN	NN	_	5	compound	_	_
4	100	_	NUM	CD	_	5	nummod	_	_
5	mg	_	NOUN	NN	_	1	nmod	_	_
6	per	_	ADP	IN	_	7	case	_	_
7	day	_	NOUN	NN	_	1	nmod	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	propranolol	_	NOUN	NN	_	11	compound	_	_
10	160	_	NUM	CD	_	11	nummod	_	_
11	mg	_	NOUN	NN	_	7	conj	_	_
12	per	_	ADP	IN	_	13	case	_	_
13	day	_	NOUN	NN	_	7	nmod	_	_
14	in	_	ADP	IN	_	16	case	_	_
15	normal	_	ADJ	JJ	_	16	amod	_	_
16	volunteers	_	NOUN	NNS	_	13	nmod	_	_
17	resulted	_	VERB	VBD	_	0	root	_	_
18	in	_	ADP	IN	_	24	case	_	_
19	a	_	DET	DT	_	24	det	_	_
20	mean	_	ADJ	JJ	_	24	amod	_	_
21	five	_	NUM	CD	_	24	nummod	_	_
22	fold	_	NOUN	NN	_	24	amod	_	_
23	increase	_	NOUN	NN	_	24	compound	_	_
24	range	_	NOUN	NN	_	17	nmod	_	_
25	2	_	NUM	CD	_	27	nummod	_	_
26	to	_	PRT	TO	_	27	case	_	_
27	17	_	NUM	CD	_	24	nummod	_	_
28	in	_	ADP	IN	_	32	case	_	_
29	minimum	_	ADJ	JJ	_	32	amod	_	_
30	propranolol	_	ADJ	JJ	_	32	compound	_	_
31	plasma	_	NOUN	NN	_	32	compound	_	_
32	concentrations	_	NOUN	NNS	_	24	nmod	_	_

#	Fluvoxamine Maleate	1442
1	In	_	ADP	IN	_	3	case	_	_
2	this	_	DET	DT	_	3	det	_	_
3	study	_	NOUN	NN	_	6	nmod	_	_
4	,	_	.	,	_	6	punct	_	_
5	there	_	DET	EX	_	6	expl	_	_
6	was	_	VERB	VBD	_	0	root	_	_
7	a	_	DET	DT	_	9	det	_	_
8	slight	_	ADJ	JJ	_	9	amod	_	_
9	potentiation	_	NOUN	NN	_	6	nsubj	_	_
10	of	_	ADP	IN	_	14	case	_	_
11	the	_	DET	DT	_	14	det	_	_
12	propranolol	_	NOUN	NN	_	14	amod	_	_
13	induced	_	VERB	VBN	_	14	amod	_	_
14	reduction	_	NOUN	NN	_	9	nmod	_	_
15	in	_	ADP	IN	_	17	case	_	_
16	heart	_	NOUN	NN	_	17	compound	_	_
17	rate	_	NOUN	NN	_	14	nmod	_	_
18	and	_	CONJ	CC	_	17	cc	_	_
19	reduction	_	NOUN	NN	_	17	conj	_	_
20	in	_	ADP	IN	_	24	case	_	_
21	the	_	DET	DT	_	24	det	_	_
22	exercise	_	ADJ	JJ	_	24	amod	_	_
23	diastolic	_	ADJ	JJ	_	24	amod	_	_
24	pressure	_	NOUN	NN	_	14	nmod	_	_

#	Fluvoxamine Maleate	1443
1	One	_	NUM	CD	_	2	nummod	_	_
2	case	_	NOUN	NN	_	16	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	bradycardia	_	NOUN	NN	_	2	nmod	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	hypotension	_	NOUN	NN	_	4	conj	_	_
7	and	_	CONJ	CC	_	2	cc	_	_
8	a	_	DET	DT	_	10	det	_	_
9	second	_	ADJ	JJ	_	10	amod	_	_
10	case	_	NOUN	NN	_	2	conj	_	_
11	of	_	ADP	IN	_	13	case	_	_
12	orthostatic	_	ADJ	JJ	_	13	amod	_	_
13	hypotension	_	NOUN	NN	_	10	nmod	_	_
14	have	_	VERB	VBP	_	16	aux	_	_
15	been	_	VERB	VBN	_	16	auxpass	_	_
16	reported	_	VERB	VBN	_	0	root	_	_
17	with	_	ADP	IN	_	19	case	_	_
18	the	_	DET	DT	_	19	det	_	_
19	coadministration	_	NOUN	NN	_	16	nmod	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	DRUG	_	NOUN	NN	_	19	nmod	_	_
22	and	_	CONJ	CC	_	21	cc	_	_
23	metoprolol	_	NOUN	NN	_	21	conj	_	_

#	Fluvoxamine Maleate	1444
1	If	_	ADP	IN	_	2	case	_	_
2	propranolol	_	NOUN	NN	_	6	nsubjpass	_	_
3	or	_	CONJ	CC	_	2	cc	_	_
4	metoprolol	_	NOUN	NN	_	2	conj	_	_
5	is	_	VERB	VBZ	_	6	auxpass	_	_
6	coadministered	_	VERB	VBN	_	25	advcl	_	_
7	with	_	ADP	IN	_	9	case	_	_
8	DRUG	_	NOUN	NN	_	9	compound	_	_
9	tablets	_	NOUN	NNS	_	6	nmod	_	_
10	,	_	.	,	_	25	punct	_	_
11	a	_	DET	DT	_	12	det	_	_
12	reduction	_	NOUN	NN	_	25	nsubjpass	_	_
13	in	_	ADP	IN	_	18	case	_	_
14	the	_	DET	DT	_	18	det	_	_
15	initial	_	ADJ	JJ	_	18	amod	_	_
16	beta	_	NOUN	NN	_	18	compound	_	_
17	blocker	_	NOUN	NN	_	18	compound	_	_
18	dose	_	NOUN	NN	_	12	nmod	_	_
19	and	_	CONJ	CC	_	12	cc	_	_
20	more	_	ADV	RB	_	21	advmod	_	_
21	cautious	_	ADJ	JJ	_	23	amod	_	_
22	dose	_	NOUN	NN	_	23	compound	_	_
23	titration	_	NOUN	NN	_	12	conj	_	_
24	are	_	VERB	VBP	_	25	auxpass	_	_
25	recommended	_	VERB	VBN	_	0	root	_	_

#	Fluvoxamine Maleate	1445
1	No	_	DET	DT	_	3	neg	_	_
2	dosage	_	NOUN	NN	_	3	compound	_	_
3	adjustment	_	NOUN	NN	_	5	nsubjpass	_	_
4	is	_	VERB	VBZ	_	5	auxpass	_	_
5	required	_	VERB	VBN	_	0	root	_	_
6	for	_	ADP	IN	_	8	case	_	_
7	DRUG	_	NOUN	NN	_	8	compound	_	_
8	tablets	_	NOUN	NNS	_	5	nmod	_	_

#	Fluvoxamine Maleate	1446
1	Coadministration	_	NOUN	NN	_	15	nsubj	_	_
2	of	_	ADP	IN	_	5	case	_	_
3	DRUG	_	NOUN	NN	_	5	compound	_	_
4	100	_	NUM	CD	_	5	nummod	_	_
5	mg	_	NOUN	NN	_	1	nmod	_	_
6	per	_	ADP	IN	_	7	case	_	_
7	day	_	NOUN	NN	_	1	nmod	_	_
8	with	_	ADP	IN	_	11	case	_	_
9	atenolol	_	NOUN	NN	_	11	compound	_	_
10	100	_	NUM	CD	_	11	nummod	_	_
11	mg	_	NOUN	NN	_	7	nmod	_	_
12	per	_	ADP	IN	_	14	case	_	_
13	day	_	NOUN	NN	_	14	compound	_	_
14	N	_	NOUN	NN	_	7	nmod	_	_
15	=	_	ADJ	JJ	_	0	root	_	_
16	6	_	NUM	CD	_	15	dobj	_	_
17	did	_	VERB	VBD	_	19	aux	_	_
18	not	_	ADV	RB	_	19	neg	_	_
19	affect	_	VERB	VB	_	15	parataxis	_	_
20	the	_	DET	DT	_	22	det	_	_
21	plasma	_	NOUN	NN	_	22	compound	_	_
22	concentrations	_	NOUN	NNS	_	19	dobj	_	_
23	of	_	ADP	IN	_	24	case	_	_
24	atenolol	_	NOUN	NN	_	22	nmod	_	_

#	Fluvoxamine Maleate	1447
1	Unlike	_	ADP	IN	_	2	case	_	_
2	propranolol	_	NOUN	NN	_	12	nmod	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	metoprolol	_	NOUN	NN	_	2	conj	_	_
5	which	_	DET	WDT	_	6	nsubj	_	_
6	undergo	_	VERB	VBP	_	2	acl:relcl	_	_
7	hepatic	_	ADJ	JJ	_	8	amod	_	_
8	metabolism	_	NOUN	NN	_	6	dobj	_	_
9	,	_	.	,	_	12	punct	_	_
10	atenolol	_	NOUN	NN	_	12	nsubjpass	_	_
11	is	_	VERB	VBZ	_	12	auxpass	_	_
12	eliminated	_	VERB	VBN	_	0	root	_	_
13	primarily	_	ADV	RB	_	12	advmod	_	_
14	by	_	ADP	IN	_	16	case	_	_
15	renal	_	ADJ	JJ	_	16	amod	_	_
16	excretion	_	NOUN	NN	_	12	nmod	_	_

#	Fluvoxamine Maleate	1448
1	See	_	NOUN	NN	_	2	compound	_	_
2	Warnings	_	NOUN	NNS	_	0	root	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	Precautions	_	NOUN	NNS	_	2	conj	_	_
5	5.8	_	NUM	CD	_	4	nummod	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	5.10	_	NUM	CD	_	5	conj	_	_

#	Fluvoxamine Maleate	1449
1	Smokers	_	NOUN	NNS	_	2	nsubj	_	_
2	had	_	VERB	VBD	_	0	root	_	_
3	a	_	DET	DT	_	5	det	_	_
4	25%	_	ADJ	JJ	_	5	amod	_	_
5	increase	_	NOUN	NN	_	2	dobj	_	_
6	in	_	ADP	IN	_	8	case	_	_
7	the	_	DET	DT	_	8	det	_	_
8	metabolism	_	NOUN	NN	_	5	nmod	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	compared	_	VERB	VBN	_	13	case	_	_
12	to	_	PRT	TO	_	13	case	_	_
13	nonsmokers	_	NOUN	NNS	_	2	nmod	_	_

#	Fluvoxamine Maleate	1450
1	There	_	DET	EX	_	2	expl	_	_
2	are	_	VERB	VBP	_	0	root	_	_
3	no	_	DET	DT	_	5	neg	_	_
4	clinical	_	ADJ	JJ	_	5	amod	_	_
5	studies	_	NOUN	NNS	_	2	nsubj	_	_
6	establishing	_	VERB	VBG	_	5	acl	_	_
7	the	_	DET	DT	_	8	det	_	_
8	benefits	_	NOUN	NNS	_	6	dobj	_	_
9	or	_	CONJ	CC	_	8	cc	_	_
10	risks	_	NOUN	NNS	_	8	conj	_	_
11	of	_	ADP	IN	_	13	case	_	_
12	combined	_	VERB	VBN	_	13	amod	_	_
13	use	_	NOUN	NN	_	8	nmod	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	ECT	_	NOUN	NN	_	13	nmod	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	DRUG	_	NOUN	NN	_	15	conj	_	_

#	Fluvoxamine Maleate	1451
1	The	_	DET	DT	_	2	det	_	_
2	mechanism	_	NOUN	NN	_	12	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	action	_	NOUN	NN	_	2	nmod	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	in	_	ADP	IN	_	10	case	_	_
8	obsessive	_	ADJ	JJ	_	10	amod	_	_
9	compulsive	_	ADJ	JJ	_	10	amod	_	_
10	disorder	_	NOUN	NN	_	4	nmod	_	_
11	is	_	VERB	VBZ	_	12	auxpass	_	_
12	presumed	_	VERB	VBN	_	0	root	_	_
13	to	_	PRT	TO	_	15	mark	_	_
14	be	_	VERB	VB	_	15	auxpass	_	_
15	linked	_	VERB	VBN	_	12	xcomp	_	_
16	to	_	PRT	TO	_	21	case	_	_
17	its	_	PRON	PRP$	_	21	nmod:poss	_	_
18	specific	_	ADJ	JJ	_	21	amod	_	_
19	serotonin	_	NOUN	NN	_	21	compound	_	_
20	reuptake	_	NOUN	NN	_	21	compound	_	_
21	inhibition	_	NOUN	NN	_	15	nmod	_	_
22	in	_	ADP	IN	_	24	case	_	_
23	brain	_	NOUN	NN	_	24	compound	_	_
24	neurons	_	NOUN	NNS	_	21	nmod	_	_

#	Fluvoxamine Maleate	1452
1	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
2	has	_	VERB	VBZ	_	4	aux	_	_
3	been	_	VERB	VBN	_	4	auxpass	_	_
4	shown	_	VERB	VBN	_	0	root	_	_
5	to	_	PRT	TO	_	9	mark	_	_
6	be	_	VERB	VB	_	9	cop	_	_
7	a	_	DET	DT	_	9	det	_	_
8	potent	_	ADJ	JJ	_	9	amod	_	_
9	inhibitor	_	NOUN	NN	_	4	ccomp	_	_
10	of	_	ADP	IN	_	14	case	_	_
11	the	_	DET	DT	_	14	det	_	_
12	serotonin	_	NOUN	NN	_	14	compound	_	_
13	reuptake	_	NOUN	NN	_	14	compound	_	_
14	transporter	_	NOUN	NN	_	9	nmod	_	_
15	in	_	ADP	IN	_	17	case	_	_
16	preclinical	_	ADJ	JJ	_	17	amod	_	_
17	studies	_	NOUN	NNS	_	14	nmod	_	_
18	,	_	.	,	_	9	punct	_	_
19	both	_	CONJ	CC	_	9	nmod	_	_
20	in	_	X	FW	_	21	compound	_	_
21	vitro	_	X	FW	_	19	dep	_	_
22	and	_	CONJ	CC	_	19	cc	_	_
23	in	_	X	FW	_	24	compound	_	_
24	vivo	_	X	FW	_	19	conj	_	_

#	Fluvoxamine Maleate	1453
1	In	_	ADP	IN	_	4	case	_	_
2	in	_	X	FW	_	4	amod	_	_
3	vitro	_	X	FW	_	2	dep	_	_
4	studies	_	NOUN	NNS	_	7	nmod	_	_
5	,	_	.	,	_	7	punct	_	_
6	DRUG	_	NOUN	NN	_	7	nsubj	_	_
7	had	_	VERB	VBD	_	0	root	_	_
8	no	_	DET	DT	_	10	neg	_	_
9	significant	_	ADJ	JJ	_	10	amod	_	_
10	affinity	_	NOUN	NN	_	7	dobj	_	_
11	for	_	ADP	IN	_	12	case	_	_
12	histaminergic	_	ADJ	JJ	_	10	nmod	_	_
13	,	_	.	,	_	12	punct	_	_
14	alpha	_	NOUN	NN	_	12	conj	_	_
15	or	_	CONJ	CC	_	12	cc	_	_
16	beta	_	NOUN	NN	_	12	conj	_	_
17	adrenergic	_	ADJ	JJ	_	23	amod	_	_
18	,	_	.	,	_	17	punct	_	_
19	muscarinic	_	ADJ	JJ	_	17	conj	_	_
20	,	_	.	,	_	17	punct	_	_
21	or	_	CONJ	CC	_	17	cc	_	_
22	dopaminergic	_	ADJ	JJ	_	17	conj	_	_
23	receptors	_	NOUN	NNS	_	12	dep	_	_

#	Fluvoxamine Maleate	1454
1	Antagonism	_	NOUN	NN	_	8	nsubjpass	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	some	_	DET	DT	_	1	nmod	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	these	_	DET	DT	_	6	det	_	_
6	receptors	_	NOUN	NNS	_	3	nmod	_	_
7	is	_	VERB	VBZ	_	8	auxpass	_	_
8	thought	_	VERB	VBN	_	0	root	_	_
9	to	_	PRT	TO	_	11	mark	_	_
10	be	_	VERB	VB	_	11	auxpass	_	_
11	associated	_	VERB	VBN	_	8	xcomp	_	_
12	with	_	ADP	IN	_	14	case	_	_
13	various	_	ADJ	JJ	_	14	amod	_	_
14	sedative	_	ADJ	JJ	_	11	nmod	_	_
15	,	_	.	,	_	14	punct	_	_
16	cardiovascular	_	ADJ	JJ	_	14	conj	_	_
17	,	_	.	,	_	14	punct	_	_
18	anticholinergic	_	ADJ	JJ	_	14	conj	_	_
19	,	_	.	,	_	14	punct	_	_
20	and	_	CONJ	CC	_	14	cc	_	_
21	extrapyramidal	_	ADJ	JJ	_	14	conj	_	_
22	effects	_	NOUN	NNS	_	14	dep	_	_
23	of	_	ADP	IN	_	26	case	_	_
24	some	_	DET	DT	_	26	det	_	_
25	psychotropic	_	ADJ	JJ	_	26	amod	_	_
26	drugs	_	NOUN	NNS	_	14	nmod	_	_

#	Fluvoxamine Maleate	1455
1	The	_	DET	DT	_	3	det	_	_
2	absolute	_	ADJ	JJ	_	3	amod	_	_
3	bioavailability	_	NOUN	NN	_	7	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	is	_	VERB	VBZ	_	7	auxpass	_	_
7	53%	_	ADJ	JJ	_	0	root	_	_

#	Fluvoxamine Maleate	1456
1	Oral	_	ADJ	JJ	_	2	amod	_	_
2	bioavailability	_	NOUN	NN	_	6	nsubjpass	_	_
3	is	_	VERB	VBZ	_	6	auxpass	_	_
4	not	_	ADV	RB	_	6	neg	_	_
5	significantly	_	ADV	RB	_	6	advmod	_	_
6	affected	_	VERB	VBN	_	0	root	_	_
7	by	_	ADP	IN	_	8	case	_	_
8	food	_	NOUN	NN	_	6	nmod	_	_

#	Fluvoxamine Maleate	1457
1	In	_	ADP	IN	_	5	case	_	_
2	a	_	DET	DT	_	5	det	_	_
3	dose	_	NOUN	NN	_	5	compound	_	_
4	proportionality	_	NOUN	NN	_	5	compound	_	_
5	study	_	NOUN	NN	_	29	nmod	_	_
6	involving	_	VERB	VBG	_	5	acl	_	_
7	DRUG	_	NOUN	NN	_	6	dobj	_	_
8	at	_	ADP	IN	_	9	case	_	_
9	100	_	NUM	CD	_	6	nmod	_	_
10	,	_	.	,	_	9	punct	_	_
11	200	_	NUM	CD	_	9	conj	_	_
12	and	_	CONJ	CC	_	9	cc	_	_
13	300	_	NUM	CD	_	9	conj	_	_
14	mg	_	NOUN	NN	_	9	dep	_	_
15	/	_	.	:	_	5	punct	_	_
16	day	_	NOUN	NN	_	5	dep	_	_
17	for	_	ADP	IN	_	20	case	_	_
18	10	_	NUM	CD	_	20	nummod	_	_
19	consecutive	_	ADJ	JJ	_	20	amod	_	_
20	days	_	NOUN	NNS	_	16	nmod	_	_
21	in	_	ADP	IN	_	24	case	_	_
22	30	_	NUM	CD	_	24	nummod	_	_
23	normal	_	ADJ	JJ	_	24	amod	_	_
24	volunteers	_	NOUN	NNS	_	16	nmod	_	_
25	,	_	.	,	_	29	punct	_	_
26	steady	_	ADJ	JJ	_	27	amod	_	_
27	state	_	NOUN	NN	_	29	nsubjpass	_	_
28	was	_	VERB	VBD	_	29	auxpass	_	_
29	achieved	_	VERB	VBN	_	0	root	_	_
30	after	_	ADP	IN	_	33	case	_	_
31	about	_	ADV	RB	_	33	advmod	_	_
32	a	_	DET	DT	_	33	det	_	_
33	week	_	NOUN	NN	_	29	nmod	_	_
34	of	_	ADP	IN	_	35	mark	_	_
35	dosing	_	VERB	VBG	_	33	acl	_	_

#	Fluvoxamine Maleate	1458
1	Maximum	_	NOUN	NN	_	3	compound	_	_
2	plasma	_	NOUN	NN	_	3	compound	_	_
3	concentrations	_	NOUN	NNS	_	7	nsubj	_	_
4	at	_	ADP	IN	_	6	case	_	_
5	steady	_	ADJ	JJ	_	6	amod	_	_
6	state	_	NOUN	NN	_	3	nmod	_	_
7	occurred	_	VERB	VBD	_	0	root	_	_
8	within	_	ADP	IN	_	12	case	_	_
9	3	_	NUM	CD	_	11	compound	_	_
10	to	_	PRT	TO	_	11	dep	_	_
11	8	_	NUM	CD	_	12	nummod	_	_
12	hours	_	NOUN	NNS	_	7	nmod	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	dosing	_	NOUN	NN	_	12	nmod	_	_
15	and	_	CONJ	CC	_	7	cc	_	_
16	reached	_	VERB	VBN	_	7	conj	_	_
17	concentrations	_	NOUN	NNS	_	16	dobj	_	_
18	averaging	_	VERB	VBG	_	17	acl	_	_
19	88	_	NUM	CD	_	24	nummod	_	_
20	,	_	.	,	_	19	punct	_	_
21	283	_	NUM	CD	_	19	conj	_	_
22	and	_	CONJ	CC	_	19	cc	_	_
23	546	_	NUM	CD	_	19	conj	_	_
24	ng	_	NOUN	NN	_	18	nmod	_	_
25	/	_	.	:	_	24	punct	_	_
26	mL	_	NOUN	NN	_	24	appos	_	_
27	,	_	.	,	_	24	punct	_	_
28	respectively	_	ADV	RB	_	24	advmod	_	_

#	Fluvoxamine Maleate	1459
1	Thus	_	ADV	RB	_	4	advmod	_	_
2	,	_	.	,	_	4	punct	_	_
3	DRUG	_	NOUN	NN	_	4	nsubj	_	_
4	had	_	VERB	VBD	_	0	root	_	_
5	nonlinear	_	ADJ	JJ	_	6	amod	_	_
6	pharmacokinetics	_	NOUN	NNS	_	4	dobj	_	_
7	over	_	ADP	IN	_	10	case	_	_
8	this	_	DET	DT	_	10	det	_	_
9	dose	_	NOUN	NN	_	10	compound	_	_
10	range	_	NOUN	NN	_	4	nmod	_	_
11	,	_	.	,	_	4	punct	_	_
12	i.e	_	ADV	RB	_	4	advmod	_	_
13	,	_	.	,	_	4	punct	_	_
14	higher	_	ADJ	JJ	_	15	amod	_	_
15	doses	_	NOUN	NNS	_	18	nsubj	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	DRUG	_	NOUN	NN	_	15	nmod	_	_
18	produced	_	VERB	VBD	_	4	parataxis	_	_
19	disproportionately	_	ADV	RB	_	20	advmod	_	_
20	higher	_	ADJ	JJ	_	21	amod	_	_
21	concentrations	_	NOUN	NNS	_	18	dobj	_	_
22	than	_	ADP	IN	_	23	mark	_	_
23	predicted	_	VERB	VBN	_	18	advcl	_	_
24	from	_	ADP	IN	_	27	case	_	_
25	the	_	DET	DT	_	27	det	_	_
26	lower	_	ADJ	JJ	_	27	amod	_	_
27	dose	_	NOUN	NN	_	23	nmod	_	_

#	Fluvoxamine Maleate	1460
1	The	_	DET	DT	_	4	det	_	_
2	mean	_	ADJ	JJ	_	4	amod	_	_
3	apparent	_	ADJ	JJ	_	4	amod	_	_
4	volume	_	NOUN	NN	_	12	nsubj	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	distribution	_	NOUN	NN	_	4	nmod	_	_
7	for	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	is	_	VERB	VBZ	_	12	cop	_	_
10	approximately	_	ADV	RB	_	12	advmod	_	_
11	25	_	NUM	CD	_	12	nummod	_	_
12	L	_	NOUN	NN	_	0	root	_	_
13	/	_	.	:	_	12	punct	_	_
14	kg	_	NOUN	NN	_	12	dep	_	_
15	,	_	.	,	_	12	punct	_	_
16	suggesting	_	VERB	VBG	_	12	acl	_	_
17	extensive	_	ADJ	JJ	_	19	amod	_	_
18	tissue	_	NOUN	NN	_	19	compound	_	_
19	distribution	_	NOUN	NN	_	16	dobj	_	_

#	Fluvoxamine Maleate	1461
1	Approximately	_	ADV	RB	_	6	advmod	_	_
2	80%	_	NOUN	NN	_	6	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	is	_	VERB	VBZ	_	6	auxpass	_	_
6	bound	_	VERB	VBN	_	0	root	_	_
7	to	_	PRT	TO	_	9	case	_	_
8	plasma	_	NOUN	NN	_	9	compound	_	_
9	protein	_	NOUN	NN	_	6	nmod	_	_
10	,	_	.	,	_	9	punct	_	_
11	mostly	_	ADV	RB	_	12	advmod	_	_
12	albumin	_	NOUN	NN	_	9	appos	_	_
13	,	_	.	,	_	6	punct	_	_
14	over	_	ADP	IN	_	17	case	_	_
15	a	_	DET	DT	_	17	det	_	_
16	concentration	_	NOUN	NN	_	17	compound	_	_
17	range	_	NOUN	NN	_	6	nmod	_	_
18	of	_	ADP	IN	_	22	case	_	_
19	20	_	NUM	CD	_	21	compound	_	_
20	to	_	PRT	TO	_	21	dep	_	_
21	2000	_	NUM	CD	_	22	nummod	_	_
22	ng	_	NOUN	NN	_	17	nmod	_	_
23	/	_	.	:	_	17	punct	_	_
24	mL	_	NOUN	NN	_	17	root	_	_

#	Fluvoxamine Maleate	1462
1	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
2	is	_	VERB	VBZ	_	4	auxpass	_	_
3	extensively	_	ADV	RB	_	4	advmod	_	_
4	metabolized	_	VERB	VBN	_	0	root	_	_
5	by	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	liver	_	NOUN	NN	_	4	nmod	_	_
8	the	_	DET	DT	_	11	det	_	_
9	main	_	ADJ	JJ	_	11	amod	_	_
10	metabolic	_	ADJ	JJ	_	11	amod	_	_
11	routes	_	NOUN	NNS	_	14	nsubj	_	_
12	are	_	VERB	VBP	_	14	cop	_	_
13	oxidative	_	ADJ	JJ	_	14	amod	_	_
14	demethylation	_	NOUN	NN	_	4	parataxis	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	deamination	_	NOUN	NN	_	14	conj	_	_

#	Fluvoxamine Maleate	1463
1	Nine	_	NOUN	NN	_	2	compound	_	_
2	metabolites	_	NOUN	NNS	_	4	nsubjpass	_	_
3	were	_	VERB	VBD	_	4	auxpass	_	_
4	identified	_	VERB	VBN	_	0	root	_	_
5	following	_	ADP	IN	_	10	case	_	_
6	a	_	DET	DT	_	10	det	_	_
7	5	_	NUM	CD	_	10	nummod	_	_
8	mg	_	NOUN	NN	_	10	compound	_	_
9	radiolabelled	_	VERB	VBN	_	10	amod	_	_
10	dose	_	NOUN	NN	_	4	nmod	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_
13	,	_	.	,	_	4	punct	_	_
14	constituting	_	VERB	VBG	_	4	xcomp	_	_
15	approximately	_	ADV	RB	_	16	advmod	_	_
16	85%	_	NOUN	NN	_	14	dobj	_	_
17	of	_	ADP	IN	_	21	case	_	_
18	the	_	DET	DT	_	21	det	_	_
19	urinary	_	ADJ	JJ	_	21	amod	_	_
20	excretion	_	NOUN	NN	_	21	compound	_	_
21	products	_	NOUN	NNS	_	16	nmod	_	_
22	of	_	ADP	IN	_	23	case	_	_
23	DRUG	_	NOUN	NN	_	21	nmod	_	_

#	Fluvoxamine Maleate	1464
1	The	_	DET	DT	_	4	det	_	_
2	main	_	ADJ	JJ	_	4	amod	_	_
3	human	_	ADJ	JJ	_	4	amod	_	_
4	metabolite	_	NOUN	NN	_	7	nsubj	_	_
5	was	_	VERB	VBD	_	7	cop	_	_
6	DRUG	_	NOUN	NN	_	7	compound	_	_
7	acid	_	NOUN	NN	_	0	root	_	_
8	which	_	DET	WDT	_	17	nsubj	_	_
9	,	_	.	,	_	17	punct	_	_
10	together	_	ADV	RB	_	15	advmod	_	_
11	with	_	ADP	IN	_	15	case	_	_
12	its	_	PRON	PRP$	_	15	nmod:poss	_	_
13	N	_	NOUN	NN	_	15	compound	_	_
14	acetylated	_	ADJ	JJ	_	15	amod	_	_
15	analog	_	NOUN	NN	_	17	nmod	_	_
16	,	_	.	,	_	17	punct	_	_
17	accounted	_	VERB	VBN	_	7	acl	_	_
18	for	_	ADP	IN	_	20	case	_	_
19	about	_	ADV	RB	_	20	advmod	_	_
20	60%	_	NOUN	NN	_	17	nmod	_	_
21	of	_	ADP	IN	_	25	case	_	_
22	the	_	DET	DT	_	25	det	_	_
23	urinary	_	ADJ	JJ	_	25	amod	_	_
24	excretion	_	NOUN	NN	_	25	compound	_	_
25	products	_	NOUN	NNS	_	20	nmod	_	_

#	Fluvoxamine Maleate	1465
1	A	_	DET	DT	_	3	det	_	_
2	third	_	ADJ	JJ	_	3	amod	_	_
3	metabolite	_	NOUN	NN	_	0	root	_	_
4	,	_	.	,	_	3	punct	_	_
5	fluvoxethanol	_	NOUN	NN	_	3	appos	_	_
6	,	_	.	,	_	3	punct	_	_
7	formed	_	VERB	VBN	_	3	acl	_	_
8	by	_	ADP	IN	_	10	case	_	_
9	oxidative	_	ADJ	JJ	_	10	amod	_	_
10	deamination	_	NOUN	NN	_	7	nmod	_	_
11	,	_	.	,	_	3	punct	_	_
12	accounted	_	VERB	VBN	_	3	acl	_	_
13	for	_	ADP	IN	_	15	case	_	_
14	about	_	ADV	RB	_	15	advmod	_	_
15	10%	_	ADJ	JJ	_	12	nmod	_	_

#	Fluvoxamine Maleate	1466
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	acid	_	NOUN	NN	_	6	nsubjpass	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	fluvoxethanol	_	NOUN	NN	_	2	conj	_	_
5	were	_	VERB	VBD	_	6	auxpass	_	_
6	tested	_	VERB	VBN	_	0	root	_	_
7	in	_	ADP	IN	_	11	case	_	_
8	an	_	DET	DT	_	11	det	_	_
9	in	_	ADJ	JJ	_	11	amod	_	_
10	vitro	_	X	FW	_	9	dep	_	_
11	assay	_	NOUN	NN	_	6	nmod	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	serotonin	_	NOUN	NN	_	11	nmod	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	norepinephrine	_	NOUN	NN	_	17	compound	_	_
16	reuptake	_	NOUN	NN	_	17	compound	_	_
17	inhibition	_	NOUN	NN	_	13	conj	_	_
18	in	_	ADP	IN	_	19	case	_	_
19	rats	_	NOUN	NNS	_	11	nmod	_	_
20	they	_	PRON	PRP	_	22	nsubj	_	_
21	were	_	VERB	VBD	_	22	cop	_	_
22	inactive	_	ADJ	JJ	_	6	parataxis	_	_
23	except	_	ADP	IN	_	27	case	_	_
24	for	_	ADP	IN	_	27	case	_	_
25	a	_	DET	DT	_	27	det	_	_
26	weak	_	ADJ	JJ	_	27	amod	_	_
27	effect	_	NOUN	NN	_	22	nmod	_	_
28	of	_	ADP	IN	_	31	case	_	_
29	the	_	DET	DT	_	31	det	_	_
30	former	_	ADJ	JJ	_	31	amod	_	_
31	metabolite	_	NOUN	NN	_	27	nmod	_	_
32	on	_	ADP	IN	_	33	case	_	_
33	inhibition	_	NOUN	NN	_	27	nmod	_	_
34	of	_	ADP	IN	_	36	case	_	_
35	serotonin	_	NOUN	NN	_	36	compound	_	_
36	uptake	_	NOUN	NN	_	33	nmod	_	_
37	1	_	NUM	CD	_	36	nummod	_	_
38	to	_	PRT	TO	_	40	case	_	_
39	2	_	NUM	CD	_	40	nummod	_	_
40	orders	_	NOUN	NNS	_	33	nmod	_	_
41	of	_	ADP	IN	_	42	case	_	_
42	magnitude	_	NOUN	NN	_	40	nmod	_	_
43	less	_	ADV	RB	_	44	advmod	_	_
44	potent	_	ADJ	JJ	_	42	amod	_	_
45	than	_	ADP	IN	_	48	case	_	_
46	the	_	DET	DT	_	48	det	_	_
47	parent	_	NOUN	NN	_	48	compound	_	_
48	compound	_	NOUN	NN	_	44	nmod	_	_

#	Fluvoxamine Maleate	1467
1	Approximately	_	ADV	RB	_	6	advmod	_	_
2	2%	_	NOUN	NN	_	6	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	was	_	VERB	VBD	_	6	auxpass	_	_
6	excreted	_	VERB	VBN	_	0	root	_	_
7	in	_	ADP	IN	_	8	mark	_	_
8	urine	_	VERB	VBG	_	6	advcl	_	_
9	unchanged	_	ADJ	JJ	_	8	dep	_	_

#	Fluvoxamine Maleate	1468
1	Following	_	ADP	IN	_	6	case	_	_
2	a	_	DET	DT	_	6	det	_	_
3	14C	_	NOUN	NN	_	6	compound	_	_
4	labelled	_	VERB	VBN	_	6	amod	_	_
5	oral	_	ADJ	JJ	_	6	amod	_	_
6	dose	_	NOUN	NN	_	21	nmod	_	_
7	of	_	ADP	IN	_	10	case	_	_
8	DRUG	_	NOUN	NN	_	10	compound	_	_
9	5	_	NUM	CD	_	10	nummod	_	_
10	mg	_	NOUN	NN	_	6	nmod	_	_
11	,	_	.	,	_	21	punct	_	_
12	an	_	DET	DT	_	13	det	_	_
13	average	_	NOUN	NN	_	21	nsubjpass	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	94%	_	NOUN	NN	_	13	nmod	_	_
16	of	_	ADP	IN	_	19	case	_	_
17	drug	_	NOUN	NN	_	19	compound	_	_
18	related	_	ADJ	JJ	_	19	amod	_	_
19	products	_	NOUN	NNS	_	15	nmod	_	_
20	was	_	VERB	VBD	_	21	auxpass	_	_
21	recovered	_	VERB	VBN	_	0	root	_	_
22	in	_	ADP	IN	_	24	case	_	_
23	the	_	DET	DT	_	24	det	_	_
24	urine	_	NOUN	NN	_	21	nmod	_	_
25	within	_	ADP	IN	_	27	case	_	_
26	71	_	NUM	CD	_	27	nummod	_	_
27	hours	_	NOUN	NNS	_	24	nmod	_	_

#	Fluvoxamine Maleate	1469
1	The	_	DET	DT	_	5	det	_	_
2	mean	_	ADJ	JJ	_	5	amod	_	_
3	plasma	_	NOUN	NN	_	5	compound	_	_
4	half	_	NOUN	NN	_	5	compound	_	_
5	life	_	NOUN	NN	_	0	root	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	at	_	ADP	IN	_	10	case	_	_
9	steady	_	ADJ	JJ	_	10	amod	_	_
10	state	_	NOUN	NN	_	5	nmod	_	_
11	after	_	ADP	IN	_	14	case	_	_
12	multiple	_	ADJ	JJ	_	14	amod	_	_
13	oral	_	ADJ	JJ	_	14	amod	_	_
14	doses	_	NOUN	NNS	_	5	nmod	_	_
15	of	_	ADP	IN	_	17	case	_	_
16	100	_	NUM	CD	_	17	nummod	_	_
17	mg	_	NOUN	NN	_	14	nmod	_	_
18	/	_	.	:	_	5	punct	_	_
19	day	_	NOUN	NN	_	27	nsubj	_	_
20	in	_	ADP	IN	_	24	case	_	_
21	healthy	_	ADJ	JJ	_	24	amod	_	_
22	,	_	.	,	_	21	punct	_	_
23	young	_	ADJ	JJ	_	21	dep	_	_
24	volunteers	_	NOUN	NNS	_	19	nmod	_	_
25	was	_	VERB	VBD	_	27	cop	_	_
26	15.6	_	NUM	CD	_	27	nummod	_	_
27	hours	_	NOUN	NNS	_	5	dep	_	_

#	Fluvoxamine Maleate	1470
1	In	_	ADP	IN	_	3	case	_	_
2	a	_	DET	DT	_	3	det	_	_
3	study	_	NOUN	NN	_	33	nmod	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	DRUG	_	NOUN	NN	_	6	compound	_	_
6	tablets	_	NOUN	NNS	_	3	nmod	_	_
7	at	_	ADP	IN	_	11	case	_	_
8	50	_	NUM	CD	_	11	nummod	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	100	_	NUM	CD	_	8	conj	_	_
11	mg	_	NOUN	NN	_	3	nmod	_	_
12	comparing	_	VERB	VBG	_	11	acl	_	_
13	elderly	_	ADJ	JJ	_	14	amod	_	_
14	ages	_	NOUN	NNS	_	12	dobj	_	_
15	66	_	NUM	CD	_	16	nummod	_	_
16	73	_	NUM	CD	_	20	nsubj	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	young	_	ADJ	JJ	_	16	conj	_	_
19	subjects	_	NOUN	NNS	_	16	dep	_	_
20	ages	_	VERB	VBZ	_	14	dep	_	_
21	19	_	NUM	CD	_	22	nummod	_	_
22	35	_	NUM	CD	_	20	dobj	_	_
23	,	_	.	,	_	33	punct	_	_
24	mean	_	ADJ	JJ	_	27	amod	_	_
25	maximum	_	NOUN	NN	_	27	compound	_	_
26	plasma	_	NOUN	NN	_	27	compound	_	_
27	concentrations	_	NOUN	NNS	_	33	nsubj	_	_
28	in	_	ADP	IN	_	30	case	_	_
29	the	_	DET	DT	_	30	det	_	_
30	elderly	_	NOUN	NN	_	27	nmod	_	_
31	were	_	VERB	VBD	_	33	cop	_	_
32	40%	_	ADJ	JJ	_	33	advmod	_	_
33	higher	_	ADJ	JJ	_	0	root	_	_

#	Fluvoxamine Maleate	1471
1	The	_	DET	DT	_	6	det	_	_
2	multiple	_	ADJ	JJ	_	6	amod	_	_
3	dose	_	NOUN	NN	_	6	compound	_	_
4	elimination	_	NOUN	NN	_	6	compound	_	_
5	half	_	NOUN	NN	_	6	compound	_	_
6	life	_	NOUN	NN	_	13	nsubj	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	was	_	VERB	VBD	_	13	cop	_	_
10	17.4	_	NUM	CD	_	13	nummod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	25.9	_	NUM	CD	_	10	conj	_	_
13	hours	_	NOUN	NNS	_	17	nsubj	_	_
14	in	_	ADP	IN	_	16	case	_	_
15	the	_	DET	DT	_	16	det	_	_
16	elderly	_	NOUN	NN	_	13	nmod	_	_
17	compared	_	VERB	VBN	_	0	root	_	_
18	to	_	PRT	TO	_	22	case	_	_
19	13.6	_	NUM	CD	_	22	nummod	_	_
20	and	_	CONJ	CC	_	19	cc	_	_
21	15.6	_	NUM	CD	_	19	conj	_	_
22	hours	_	NOUN	NNS	_	17	nmod	_	_
23	in	_	ADP	IN	_	26	case	_	_
24	the	_	DET	DT	_	26	det	_	_
25	young	_	ADJ	JJ	_	26	amod	_	_
26	subjects	_	NOUN	NNS	_	22	nmod	_	_
27	at	_	ADP	IN	_	29	case	_	_
28	steady	_	ADJ	JJ	_	29	amod	_	_
29	state	_	NOUN	NN	_	17	nmod	_	_
30	for	_	ADP	IN	_	35	case	_	_
31	50	_	NUM	CD	_	35	nummod	_	_
32	and	_	CONJ	CC	_	31	cc	_	_
33	100	_	NUM	CD	_	31	conj	_	_
34	mg	_	NOUN	NN	_	35	compound	_	_
35	doses	_	NOUN	NNS	_	29	nmod	_	_
36	,	_	.	,	_	17	punct	_	_
37	respectively	_	ADV	RB	_	17	advmod	_	_

#	Fluvoxamine Maleate	1472
1	In	_	ADP	IN	_	3	case	_	_
2	elderly	_	ADJ	JJ	_	3	amod	_	_
3	patients	_	NOUN	NNS	_	10	nmod	_	_
4	,	_	.	,	_	10	punct	_	_
5	the	_	DET	DT	_	6	det	_	_
6	clearance	_	NOUN	NN	_	10	nsubjpass	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	was	_	VERB	VBD	_	10	auxpass	_	_
10	reduced	_	VERB	VBN	_	23	advcl	_	_
11	by	_	ADP	IN	_	13	case	_	_
12	about	_	ADV	RB	_	13	advmod	_	_
13	50%	_	ADJ	JJ	_	10	nmod	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	,	_	.	,	_	13	punct	_	_
16	therefore	_	ADV	RB	_	13	advmod	_	_
17	,	_	.	,	_	23	punct	_	_
18	DRUG	_	NOUN	NN	_	19	compound	_	_
19	tablets	_	NOUN	NNS	_	23	nsubjpass	_	_
20	should	_	VERB	MD	_	23	aux	_	_
21	be	_	VERB	VB	_	23	auxpass	_	_
22	slowly	_	ADV	RB	_	23	advmod	_	_
23	titrated	_	VERB	VBN	_	0	root	_	_
24	during	_	ADP	IN	_	25	case	_	_
25	initiation	_	NOUN	NN	_	23	nmod	_	_
26	of	_	ADP	IN	_	27	case	_	_
27	therapy	_	NOUN	NN	_	25	nmod	_	_

#	Fluvoxamine Maleate	1473
1	The	_	DET	DT	_	4	det	_	_
2	multiple	_	ADJ	JJ	_	4	amod	_	_
3	dose	_	NOUN	NN	_	4	compound	_	_
4	pharmacokinetics	_	NOUN	NNS	_	8	nsubjpass	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	were	_	VERB	VBD	_	8	auxpass	_	_
8	determined	_	VERB	VBN	_	0	root	_	_
9	in	_	ADP	IN	_	14	case	_	_
10	male	_	ADJ	JJ	_	14	amod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	female	_	ADJ	JJ	_	10	conj	_	_
13	children	_	NOUN	NN	_	14	compound	_	_
14	ages	_	NOUN	NNS	_	8	nmod	_	_
15	6	_	NUM	CD	_	16	nummod	_	_
16	11	_	NUM	CD	_	14	dep	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	adolescents	_	NOUN	NNS	_	16	conj	_	_
19	ages	_	VERB	VBZ	_	14	acl	_	_
20	12	_	NUM	CD	_	21	nummod	_	_
21	17	_	NUM	CD	_	19	neg	_	_

#	Fluvoxamine Maleate	1474
1	Steady	_	ADJ	JJ	_	5	amod	_	_
2	state	_	NOUN	NN	_	5	compound	_	_
3	plasma	_	NOUN	NN	_	5	compound	_	_
4	DRUG	_	NOUN	NN	_	5	compound	_	_
5	concentrations	_	NOUN	NNS	_	10	nsubj	_	_
6	were	_	VERB	VBD	_	10	cop	_	_
7	2	_	NUM	CD	_	9	nummod	_	_
8	3	_	NUM	CD	_	9	nummod	_	_
9	fold	_	NOUN	NN	_	10	nmod:npmod	_	_
10	higher	_	ADJ	JJ	_	0	root	_	_
11	in	_	ADP	IN	_	12	case	_	_
12	children	_	NOUN	NN	_	10	nmod	_	_
13	than	_	ADP	IN	_	15	case	_	_
14	in	_	ADP	IN	_	15	case	_	_
15	adolescents	_	NOUN	NNS	_	10	nmod	_	_

#	Fluvoxamine Maleate	1475
1	AUC	_	NOUN	NN	_	10	nsubj	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	Cmax	_	NOUN	NN	_	1	conj	_	_
4	in	_	ADP	IN	_	5	case	_	_
5	children	_	NOUN	NN	_	1	nmod	_	_
6	were	_	VERB	VBD	_	10	cop	_	_
7	1.5	_	NUM	CD	_	9	compound	_	_
8	to	_	PRT	TO	_	9	dep	_	_
9	2.7	_	NUM	CD	_	10	nummod	_	_
10	fold	_	NOUN	NN	_	0	root	_	_
11	higher	_	ADJ	JJ	_	10	amod	_	_
12	than	_	ADP	IN	_	13	case	_	_
13	that	_	DET	WDT	_	11	nmod	_	_
14	in	_	ADP	IN	_	15	case	_	_
15	adolescents	_	NOUN	NNS	_	13	nmod	_	_

#	Fluvoxamine Maleate	1476
1	As	_	ADP	IN	_	3	case	_	_
2	in	_	ADP	IN	_	3	case	_	_
3	adults	_	NOUN	NNS	_	9	nmod	_	_
4	,	_	.	,	_	9	punct	_	_
5	both	_	CONJ	CC	_	6	cc:preconj	_	_
6	children	_	NOUN	NN	_	9	nsubj	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	adolescents	_	NOUN	NNS	_	6	conj	_	_
9	exhibited	_	VERB	VBD	_	0	root	_	_
10	nonlinear	_	ADJ	JJ	_	13	amod	_	_
11	multiple	_	ADJ	JJ	_	13	amod	_	_
12	dose	_	NOUN	NN	_	13	compound	_	_
13	pharmacokinetics	_	NOUN	NNS	_	9	dobj	_	_

#	Fluvoxamine Maleate	1477
1	Female	_	ADJ	JJ	_	2	amod	_	_
2	children	_	NOUN	NN	_	3	nsubj	_	_
3	showed	_	VERB	VBD	_	0	root	_	_
4	significantly	_	ADV	RB	_	5	advmod	_	_
5	higher	_	ADJ	JJ	_	6	amod	_	_
6	AUC	_	NOUN	NN	_	3	dobj	_	_
7	0	_	NUM	CD	_	8	nummod	_	_
8	12	_	NUM	CD	_	6	dep	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	Cmax	_	NOUN	NN	_	8	conj	_	_
11	compared	_	VERB	VBD	_	3	parataxis	_	_
12	to	_	PRT	TO	_	14	case	_	_
13	male	_	ADJ	JJ	_	14	amod	_	_
14	children	_	NOUN	NN	_	11	nmod	_	_
15	and	_	CONJ	CC	_	11	cc	_	_
16	,	_	.	,	_	11	punct	_	_
17	therefore	_	ADV	RB	_	11	advmod	_	_
18	,	_	.	,	_	11	punct	_	_
19	lower	_	ADJ	JJ	_	20	amod	_	_
20	doses	_	NOUN	NNS	_	25	nsubj	_	_
21	of	_	ADP	IN	_	23	case	_	_
22	DRUG	_	NOUN	NN	_	23	compound	_	_
23	tablets	_	NOUN	NNS	_	20	nmod	_	_
24	may	_	VERB	MD	_	25	aux	_	_
25	produce	_	VERB	VB	_	11	parataxis	_	_
26	therapeutic	_	ADJ	JJ	_	27	amod	_	_
27	benefit	_	NOUN	NN	_	25	dobj	_	_

#	Fluvoxamine Maleate	1478
1	No	_	DET	DT	_	3	neg	_	_
2	gender	_	NOUN	NN	_	3	compound	_	_
3	differences	_	NOUN	NNS	_	5	nsubjpass	_	_
4	were	_	VERB	VBD	_	5	auxpass	_	_
5	observed	_	VERB	VBN	_	0	root	_	_
6	in	_	ADP	IN	_	7	case	_	_
7	adolescents	_	NOUN	NNS	_	5	nmod	_	_

#	Fluvoxamine Maleate	1479
1	Steady	_	ADJ	JJ	_	5	amod	_	_
2	state	_	NOUN	NN	_	5	compound	_	_
3	plasma	_	NOUN	NN	_	5	compound	_	_
4	DRUG	_	NOUN	NN	_	5	compound	_	_
5	concentrations	_	NOUN	NNS	_	7	nsubj	_	_
6	were	_	VERB	VBD	_	7	cop	_	_
7	similar	_	ADJ	JJ	_	0	root	_	_
8	in	_	ADP	IN	_	9	case	_	_
9	adults	_	NOUN	NNS	_	7	nmod	_	_
10	and	_	CONJ	CC	_	7	cc	_	_
11	adolescents	_	NOUN	NNS	_	7	conj	_	_
12	at	_	ADP	IN	_	14	case	_	_
13	a	_	DET	DT	_	14	det	_	_
14	dose	_	NOUN	NN	_	11	nmod	_	_
15	of	_	ADP	IN	_	19	case	_	_
16	300	_	NUM	CD	_	17	nummod	_	_
17	mg	_	NOUN	NN	_	19	compound	_	_
18	/	_	.	:	_	19	punct	_	_
19	day	_	NOUN	NN	_	14	nmod	_	_
20	,	_	.	,	_	7	punct	_	_
21	indicating	_	VERB	VBG	_	7	advcl	_	_
22	that	_	ADP	IN	_	26	mark	_	_
23	DRUG	_	NOUN	NN	_	24	compound	_	_
24	exposure	_	NOUN	NN	_	26	nsubj	_	_
25	was	_	VERB	VBD	_	26	cop	_	_
26	similar	_	ADJ	JJ	_	21	ccomp	_	_
27	in	_	ADP	IN	_	30	case	_	_
28	these	_	DET	DT	_	30	det	_	_
29	two	_	NUM	CD	_	30	nummod	_	_
30	populations	_	NOUN	NNS	_	26	nmod	_	_

#	Fluvoxamine Maleate	1480
1	Dose	_	NOUN	NN	_	2	compound	_	_
2	adjustment	_	NOUN	NN	_	16	nsubjpass	_	_
3	in	_	ADP	IN	_	4	case	_	_
4	adolescents	_	NOUN	NNS	_	2	nmod	_	_
5	up	_	ADV	RB	_	4	cc	_	_
6	to	_	PRT	TO	_	5	mwe	_	_
7	the	_	DET	DT	_	10	det	_	_
8	adult	_	ADJ	JJ	_	10	amod	_	_
9	maximum	_	NOUN	NN	_	10	compound	_	_
10	dose	_	NOUN	NN	_	4	conj	_	_
11	of	_	ADP	IN	_	13	case	_	_
12	300	_	NUM	CD	_	13	nummod	_	_
13	mg	_	NOUN	NN	_	10	nmod	_	_
14	may	_	VERB	MD	_	16	aux	_	_
15	be	_	VERB	VB	_	16	auxpass	_	_
16	indicated	_	VERB	VBN	_	0	root	_	_
17	to	_	PRT	TO	_	18	mark	_	_
18	achieve	_	VERB	VB	_	16	xcomp	_	_
19	therapeutic	_	ADJ	JJ	_	20	amod	_	_
20	benefit	_	NOUN	NN	_	18	dobj	_	_

#	Fluvoxamine Maleate	1481
1	TABLE	_	NOUN	NN	_	0	root	_	_
2	4	_	NUM	CD	_	1	nummod	_	_
3	:	_	.	:	_	1	punct	_	_
4	COMPARISON	_	NOUN	NN	_	10	compound	_	_
5	OF	_	PRT	POS	_	10	neg	_	_
6	MEAN	_	NOUN	NN	_	10	compound	_	_
7	SD	_	NOUN	NN	_	10	compound	_	_
8	DRUG	_	NOUN	NN	_	10	compound	_	_
9	PHARMACOKINETIC	_	NOUN	NN	_	10	compound	_	_
10	PARAMETERS	_	NOUN	NN	_	22	nsubj	_	_
11	BETWEEN	_	VERB	VBG	_	12	amod	_	_
12	CHILDREN	_	NOUN	NN	_	10	dep	_	_
13	,	_	.	,	_	12	punct	_	_
14	ADOLESCENTS	_	NOUN	NN	_	12	conj	_	_
15	,	_	.	,	_	12	punct	_	_
16	AND	_	NOUN	NN	_	21	compound	_	_
17	ADULTS	_	NOUN	NN	_	21	compound	_	_
18	Pharmacokinetic	_	ADJ	JJ	_	21	amod	_	_
19	Parameter	_	NOUN	NN	_	21	compound	_	_
20	body	_	NOUN	NN	_	21	compound	_	_
21	weight	_	NOUN	NN	_	12	appos	_	_
22	corrected	_	VERB	VBD	_	1	dep	_	_
23	Dose	_	NOUN	NN	_	31	compound	_	_
24	=	_	ADJ	JJ	_	26	amod	_	_
25	200	_	NUM	CD	_	26	nummod	_	_
26	mg	_	NOUN	NN	_	31	compound	_	_
27	/	_	.	:	_	31	punct	_	_
28	day	_	NOUN	NN	_	31	compound	_	_
29	100	_	NUM	CD	_	31	nummod	_	_
30	mg	_	NOUN	NN	_	31	compound	_	_
31	b.i.d	_	NOUN	NN	_	22	dobj	_	_

#	Fluvoxamine Maleate	1482
1	Children(N	_	NOUN	NN	_	2	nsubj	_	_
2	=	_	ADJ	JJ	_	0	root	_	_
3	10	_	NUM	CD	_	9	nummod	_	_
4	Adolescent	_	ADJ	JJ	_	9	amod	_	_
5	N	_	NOUN	NN	_	9	compound	_	_
6	=	_	ADJ	JJ	_	9	amod	_	_
7	17	_	NUM	CD	_	9	nummod	_	_
8	Adolescent	_	ADJ	JJ	_	9	amod	_	_
9	N	_	NOUN	NN	_	2	dobj	_	_
10	=	_	ADJ	JJ	_	9	acl	_	_
11	13	_	NUM	CD	_	13	nummod	_	_
12	Adult	_	NOUN	NN	_	13	compound	_	_
13	N	_	NOUN	NN	_	14	nsubj	_	_
14	=	_	ADJ	JJ	_	10	dep	_	_
15	16	_	NUM	CD	_	29	compound	_	_
16	AUC	_	NOUN	NN	_	29	compound	_	_
17	0	_	NUM	CD	_	29	compound	_	_
18	12	_	NUM	CD	_	29	compound	_	_
19	ng*h	_	NOUN	NN	_	29	compound	_	_
20	/	_	.	:	_	29	punct	_	_
21	mL	_	NOUN	NN	_	29	compound	_	_
22	/	_	.	-RRB-	_	29	punct	_	_
23	kg	_	NOUN	NN	_	29	compound	_	_
24	155.1	_	NUM	CD	_	29	compound	_	_
25	160.9	_	NUM	CD	_	29	compound	_	_
26	43.9	_	NUM	CD	_	29	compound	_	_
27	27.9	_	NUM	CD	_	29	compound	_	_
28	69.6	_	NUM	CD	_	29	compound	_	_
29	46.6	_	NUM	CD	_	14	neg	_	_
30	59.4	_	NUM	CD	_	29	conj	_	_
31	40.9	_	NUM	CD	_	33	nummod	_	_
32	Cmax	_	NOUN	NN	_	33	compound	_	_
33	ng	_	NOUN	NN	_	30	dep	_	_
34	/	_	.	:	_	35	punct	_	_
35	mL	_	NOUN	NN	_	33	punct	_	_
36	/	_	.	-RRB-	_	35	punct	_	_
37	kg	_	NOUN	NN	_	68	compound	_	_
38	14.8	_	NUM	CD	_	68	nummod	_	_
39	14.9	_	NUM	CD	_	68	nummod	_	_
40	4.2	_	NUM	CD	_	68	nummod	_	_
41	2.6	_	NUM	CD	_	68	nummod	_	_
42	6.7	_	NUM	CD	_	68	nummod	_	_
43	4.2	_	NUM	CD	_	68	nummod	_	_
44	5.7	_	NUM	CD	_	68	nummod	_	_
45	3.9	_	NUM	CD	_	47	nummod	_	_
46	Cmin	_	NOUN	NN	_	47	compound	_	_
47	ng	_	NOUN	NN	_	68	compound	_	_
48	/	_	.	:	_	49	punct	_	_
49	mL	_	NOUN	NN	_	47	appos	_	_
50	/	_	.	-RRB-	_	49	punct	_	_
51	kg	_	NOUN	NN	_	68	compound	_	_
52	11	_	NUM	CD	_	68	nummod	_	_
53	11.9	_	NUM	CD	_	68	nummod	_	_
54	2.9	_	NUM	CD	_	68	nummod	_	_
55	2	_	NUM	CD	_	68	nummod	_	_
56	4.8	_	NUM	CD	_	68	nummod	_	_
57	3.8	_	NUM	CD	_	68	nummod	_	_
58	4.6	_	NUM	CD	_	62	nummod	_	_
59	3.2	_	NUM	CD	_	62	nummod	_	_
60	TABLE	_	NOUN	NN	_	62	compound	_	_
61	5	_	NUM	CD	_	62	nummod	_	_
62	COMPARISON	_	NOUN	NN	_	68	compound	_	_
63	OF	_	NUM	CD	_	68	nummod	_	_
64	MEAN	_	NOUN	NN	_	68	compound	_	_
65	SD	_	NOUN	NN	_	68	compound	_	_
66	DRUG	_	NOUN	NN	_	68	compound	_	_
67	PHARMACOKINETIC	_	NOUN	NN	_	68	compound	_	_
68	PARAMETERS	_	NOUN	NN	_	70	compound	_	_
69	BETWEEN	_	ADJ	JJ	_	70	amod	_	_
70	MALE	_	NOUN	NN	_	82	nsubj	_	_
71	AND	_	CONJ	CC	_	70	cc	_	_
72	FEMALE	_	NOUN	NN	_	81	compound	_	_
73	CHILDREN	_	NOUN	NN	_	81	compound	_	_
74	6	_	NUM	CD	_	81	nummod	_	_
75	TO	_	NOUN	NN	_	81	compound	_	_
76	11	_	NUM	CD	_	81	nummod	_	_
77	YEARS	_	NOUN	NN	_	81	compound	_	_
78	Pharmacokinetic	_	ADJ	JJ	_	81	amod	_	_
79	Parameter	_	NOUN	NN	_	81	compound	_	_
80	body	_	NOUN	NN	_	81	compound	_	_
81	weight	_	NOUN	NN	_	70	conj	_	_
82	corrected	_	VERB	VBD	_	35	dep	_	_
83	Dose	_	NOUN	NN	_	91	compound	_	_
84	=	_	ADJ	JJ	_	86	amod	_	_
85	200	_	NUM	CD	_	86	nummod	_	_
86	mg	_	NOUN	NN	_	91	compound	_	_
87	/	_	.	:	_	91	punct	_	_
88	day	_	NOUN	NN	_	91	compound	_	_
89	100	_	NUM	CD	_	91	nummod	_	_
90	mg	_	NOUN	NN	_	91	compound	_	_
91	b.i.d	_	NOUN	NN	_	82	dobj	_	_

#	Fluvoxamine Maleate	1483
1	Male	_	ADJ	JJ	_	2	amod	_	_
2	Children(N	_	NOUN	NN	_	3	nsubj	_	_
3	=	_	ADJ	JJ	_	0	root	_	_
4	7	_	NUM	CD	_	6	nummod	_	_
5	Female	_	ADJ	JJ	_	6	amod	_	_
6	Children(N	_	NOUN	NN	_	3	dobj	_	_
7	=	_	ADJ	JJ	_	6	amod	_	_
8	3	_	NUM	CD	_	43	nummod	_	_
9	AUC	_	NOUN	NN	_	43	compound	_	_
10	0	_	NUM	CD	_	43	nummod	_	_
11	12	_	NUM	CD	_	43	nummod	_	_
12	ng*h	_	NOUN	NN	_	43	compound	_	_
13	/	_	.	:	_	43	punct	_	_
14	mL	_	NOUN	NN	_	43	compound	_	_
15	/	_	.	-RRB-	_	43	punct	_	_
16	kg	_	NOUN	NN	_	43	compound	_	_
17	95.8	_	NUM	CD	_	43	nummod	_	_
18	83.9	_	NUM	CD	_	43	nummod	_	_
19	293.5	_	NUM	CD	_	43	nummod	_	_
20	233	_	NUM	CD	_	22	nummod	_	_
21	Cmax	_	NOUN	NN	_	22	compound	_	_
22	ng	_	NOUN	NN	_	43	compound	_	_
23	/	_	.	:	_	43	punct	_	_
24	mL	_	NOUN	NN	_	43	compound	_	_
25	/	_	.	-RRB-	_	43	punct	_	_
26	kg	_	NOUN	NN	_	43	compound	_	_
27	9.1	_	NUM	CD	_	43	nummod	_	_
28	7.6	_	NUM	CD	_	43	nummod	_	_
29	28.1	_	NUM	CD	_	43	nummod	_	_
30	21.1	_	NUM	CD	_	32	nummod	_	_
31	Cmin	_	NOUN	NN	_	32	compound	_	_
32	ng	_	NOUN	NN	_	43	compound	_	_
33	/	_	.	:	_	43	punct	_	_
34	mL	_	NOUN	NN	_	43	compound	_	_
35	/	_	.	-RRB-	_	43	punct	_	_
36	kg	_	NOUN	NN	_	43	compound	_	_
37	6.6	_	NUM	CD	_	43	nummod	_	_
38	6.1	_	NUM	CD	_	43	nummod	_	_
39	21.2	_	NUM	CD	_	43	nummod	_	_
40	17.6	_	NUM	CD	_	43	nummod	_	_
41	A	_	NOUN	NN	_	43	compound	_	_
42	cross	_	ADJ	JJ	_	43	amod	_	_
43	study	_	NOUN	NN	_	46	compound	_	_
44	comparison	_	NOUN	NN	_	46	compound	_	_
45	healthy	_	ADJ	JJ	_	46	amod	_	_
46	subjects	_	NOUN	NNS	_	7	dobj	_	_
47	vs	_	CONJ	CC	_	46	cc	_	_
48	patients	_	NOUN	NNS	_	46	conj	_	_
49	with	_	ADP	IN	_	51	case	_	_
50	hepatic	_	ADJ	JJ	_	51	amod	_	_
51	dysfunction	_	NOUN	NN	_	46	nmod	_	_
52	suggested	_	VERB	VBD	_	3	parataxis	_	_
53	a	_	DET	DT	_	55	det	_	_
54	30%	_	ADJ	JJ	_	55	amod	_	_
55	decrease	_	NOUN	NN	_	52	root	_	_
56	in	_	ADP	IN	_	58	case	_	_
57	DRUG	_	NOUN	NN	_	58	compound	_	_
58	clearance	_	NOUN	NN	_	55	nmod	_	_
59	in	_	ADP	IN	_	60	case	_	_
60	association	_	NOUN	NN	_	55	nmod	_	_
61	with	_	ADP	IN	_	63	case	_	_
62	hepatic	_	ADJ	JJ	_	63	amod	_	_
63	dysfunction	_	NOUN	NN	_	60	nmod	_	_

#	Fluvoxamine Maleate	1484
1	The	_	DET	DT	_	5	det	_	_
2	mean	_	ADJ	JJ	_	5	amod	_	_
3	minimum	_	ADJ	JJ	_	5	amod	_	_
4	plasma	_	NOUN	NN	_	5	compound	_	_
5	concentrations	_	NOUN	NNS	_	0	root	_	_
6	in	_	ADP	IN	_	9	case	_	_
7	renally	_	ADV	RB	_	8	advmod	_	_
8	impaired	_	ADJ	JJ	_	9	amod	_	_
9	patients	_	NOUN	NNS	_	5	nmod	_	_
10	creatinine	_	NOUN	NN	_	11	compound	_	_
11	clearance	_	NOUN	NN	_	9	dep	_	_
12	of	_	ADP	IN	_	16	case	_	_
13	5	_	NUM	CD	_	15	compound	_	_
14	to	_	PRT	TO	_	15	dep	_	_
15	45	_	NUM	CD	_	16	nummod	_	_
16	mL	_	NOUN	NN	_	11	nmod	_	_
17	/	_	.	:	_	11	punct	_	_
18	min	_	NOUN	NN	_	31	nmod	_	_
19	after	_	ADP	IN	_	23	case	_	_
20	4	_	NUM	CD	_	23	nummod	_	_
21	and	_	CONJ	CC	_	20	cc	_	_
22	6	_	NUM	CD	_	20	conj	_	_
23	weeks	_	NOUN	NNS	_	18	nmod	_	_
24	of	_	ADP	IN	_	28	case	_	_
25	treatment	_	NOUN	NN	_	28	compound	_	_
26	50	_	NUM	CD	_	28	nummod	_	_
27	mg	_	NOUN	NN	_	28	compound	_	_
28	b.i.d	_	NOUN	NN	_	23	nmod	_	_
29	,	_	.	,	_	31	punct	_	_
30	N	_	NOUN	NN	_	31	nsubj	_	_
31	=	_	ADJ	JJ	_	34	aux	_	_
32	13	_	NUM	CD	_	31	dobj	_	_
33	were	_	VERB	VBD	_	34	cop	_	_
34	comparable	_	ADJ	JJ	_	11	acl:relcl	_	_
35	to	_	PRT	TO	_	37	case	_	_
36	each	_	DET	DT	_	37	det	_	_
37	other	_	ADJ	JJ	_	34	nmod	_	_
38	,	_	.	,	_	5	punct	_	_
39	suggesting	_	VERB	VBG	_	5	acl	_	_
40	no	_	DET	DT	_	41	neg	_	_
41	accumulation	_	NOUN	NN	_	39	dobj	_	_
42	of	_	ADP	IN	_	43	case	_	_
43	DRUG	_	NOUN	NN	_	41	nmod	_	_
44	in	_	ADP	IN	_	46	case	_	_
45	these	_	DET	DT	_	46	det	_	_
46	patients	_	NOUN	NNS	_	41	nmod	_	_

#	Gilenya	2871
1	Systemic	_	ADJ	JJ	_	2	amod	_	_
2	ketoconazole	_	NOUN	NN	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	Monitor	_	NOUN	NN	_	2	dep	_	_
5	during	_	ADP	IN	_	7	case	_	_
6	concomitant	_	ADJ	JJ	_	7	amod	_	_
7	use	_	NOUN	NN	_	4	nmod	_	_

#	Gilenya	2872
1	Vaccines	_	NOUN	NNS	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Avoid	_	ADJ	JJ	_	6	amod	_	_
4	live	_	ADP	IN	_	6	case	_	_
5	attenuated	_	VERB	VBN	_	6	amod	_	_
6	vaccines	_	NOUN	NNS	_	1	dep	_	_
7	during	_	ADP	IN	_	6	dep	_	_
8	,	_	.	,	_	7	punct	_	_
9	and	_	CONJ	CC	_	7	cc	_	_
10	for	_	ADP	IN	_	12	case	_	_
11	2	_	NUM	CD	_	12	nummod	_	_
12	months	_	NOUN	NNS	_	7	conj	_	_
13	after	_	ADP	IN	_	14	mark	_	_
14	stopping	_	VERB	VBG	_	12	acl	_	_
15	DRUG	_	NOUN	NN	_	16	compound	_	_
16	treatment	_	NOUN	NN	_	14	dobj	_	_

#	Gilenya	2873
1	DRUG	_	NOUN	NN	_	5	nsubjpass	_	_
2	has	_	VERB	VBZ	_	5	aux	_	_
3	not	_	ADV	RB	_	5	neg	_	_
4	been	_	VERB	VBN	_	5	auxpass	_	_
5	studied	_	VERB	VBN	_	0	root	_	_
6	in	_	ADP	IN	_	7	case	_	_
7	patients	_	NOUN	NNS	_	5	nmod	_	_
8	treated	_	VERB	VBN	_	7	acl	_	_
9	with	_	ADP	IN	_	10	case	_	_
10	drugs	_	NOUN	NNS	_	8	nmod	_	_
11	that	_	DET	WDT	_	12	nsubj	_	_
12	prolong	_	VERB	VBP	_	10	acl:relcl	_	_
13	the	_	DET	DT	_	15	det	_	_
14	QT	_	NOUN	NN	_	15	nmod:npmod	_	_
15	interval	_	ADJ	JJ	_	12	dobj	_	_

#	Gilenya	2874
1	Drugs	_	NOUN	NNS	_	9	nsubjpass	_	_
2	that	_	DET	WDT	_	3	nsubj	_	_
3	prolong	_	VERB	VBP	_	1	acl:relcl	_	_
4	the	_	DET	DT	_	6	det	_	_
5	QT	_	NOUN	NN	_	6	compound	_	_
6	interval	_	NOUN	NN	_	3	dobj	_	_
7	have	_	VERB	VBP	_	9	aux	_	_
8	been	_	VERB	VBN	_	9	auxpass	_	_
9	associated	_	VERB	VBN	_	0	root	_	_
10	with	_	ADP	IN	_	11	case	_	_
11	cases	_	NOUN	NNS	_	9	nmod	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	torsades	_	NOUN	NNS	_	11	nmod	_	_
14	de	_	ADP	IN	_	15	case	_	_
15	pointes	_	NOUN	NNS	_	13	nmod	_	_
16	in	_	ADP	IN	_	17	case	_	_
17	patients	_	NOUN	NNS	_	15	nmod	_	_
18	with	_	ADP	IN	_	19	case	_	_
19	bradycardia	_	NOUN	NN	_	17	nmod	_	_

#	Gilenya	2875
1	Since	_	ADP	IN	_	6	mark	_	_
2	initiation	_	NOUN	NN	_	6	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	DRUG	_	NOUN	NN	_	5	compound	_	_
5	treatment	_	NOUN	NN	_	2	nmod	_	_
6	results	_	VERB	VBZ	_	45	advcl	_	_
7	in	_	ADP	IN	_	10	case	_	_
8	decreased	_	VERB	VBN	_	10	amod	_	_
9	heart	_	NOUN	NN	_	10	compound	_	_
10	rate	_	NOUN	NN	_	6	nmod	_	_
11	and	_	CONJ	CC	_	6	cc	_	_
12	may	_	VERB	MD	_	13	aux	_	_
13	prolong	_	VERB	VB	_	6	conj	_	_
14	the	_	DET	DT	_	16	det	_	_
15	QT	_	NOUN	NN	_	16	compound	_	_
16	interval	_	ADJ	JJ	_	13	dobj	_	_
17	,	_	.	,	_	45	punct	_	_
18	patients	_	NOUN	NNS	_	45	nsubj	_	_
19	on	_	ADP	IN	_	22	case	_	_
20	QT	_	NOUN	NN	_	22	compound	_	_
21	prolonging	_	VERB	VBG	_	22	compound	_	_
22	drugs	_	NOUN	NNS	_	18	nmod	_	_
23	with	_	ADP	IN	_	26	case	_	_
24	a	_	DET	DT	_	26	det	_	_
25	known	_	VERB	VBN	_	26	amod	_	_
26	risk	_	NOUN	NN	_	18	nmod	_	_
27	of	_	ADP	IN	_	28	case	_	_
28	torsades	_	NOUN	NNS	_	26	nmod	_	_
29	de	_	ADP	IN	_	30	case	_	_
30	pointes	_	NOUN	NNS	_	44	nmod	_	_
31	e.g	_	NOUN	NN	_	44	nsubjpass	_	_
32	,	_	.	,	_	31	punct	_	_
33	citalopram	_	NOUN	NN	_	31	conj	_	_
34	,	_	.	,	_	31	punct	_	_
35	chlorpromazine	_	NOUN	NN	_	31	conj	_	_
36	,	_	.	,	_	31	punct	_	_
37	haloperidol	_	NOUN	NN	_	31	conj	_	_
38	,	_	.	,	_	31	punct	_	_
39	methadone	_	NOUN	NN	_	31	appos	_	_
40	,	_	.	,	_	31	punct	_	_
41	erythromycin	_	NOUN	NN	_	31	appos	_	_
42	should	_	VERB	MD	_	44	aux	_	_
43	be	_	VERB	VB	_	44	auxpass	_	_
44	monitored	_	VERB	VBN	_	28	acl:relcl	_	_
45	overnight	_	VERB	VBN	_	0	root	_	_
46	with	_	ADP	IN	_	48	case	_	_
47	continuous	_	ADJ	JJ	_	48	amod	_	_
48	ECG	_	NOUN	NN	_	45	nmod	_	_
49	in	_	ADP	IN	_	52	case	_	_
50	a	_	DET	DT	_	52	det	_	_
51	medical	_	ADJ	JJ	_	52	amod	_	_
52	facility	_	NOUN	NN	_	45	nmod	_	_

#	Gilenya	2876
1	The	_	DET	DT	_	3	det	_	_
2	blood	_	NOUN	NN	_	3	compound	_	_
3	levels	_	NOUN	NNS	_	10	nsubjpass	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	DRUG	_	NOUN	NN	_	8	compound	_	_
8	phosphate	_	NOUN	NN	_	5	conj	_	_
9	are	_	VERB	VBP	_	10	auxpass	_	_
10	increased	_	VERB	VBN	_	0	root	_	_
11	by	_	ADP	IN	_	13	case	_	_
12	1.7	_	NUM	CD	_	13	nummod	_	_
13	fold	_	NOUN	NN	_	10	nmod	_	_
14	when	_	ADV	WRB	_	15	advmod	_	_
15	used	_	VERB	VBN	_	10	advcl	_	_
16	concomitantly	_	ADV	RB	_	15	advmod	_	_
17	with	_	ADP	IN	_	18	case	_	_
18	ketoconazole	_	NOUN	NN	_	15	nmod	_	_

#	Gilenya	2878
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	reduces	_	VERB	VBZ	_	0	root	_	_
3	the	_	DET	DT	_	5	det	_	_
4	immune	_	ADJ	JJ	_	5	amod	_	_
5	response	_	NOUN	NN	_	2	dobj	_	_
6	to	_	PRT	TO	_	7	case	_	_
7	vaccination	_	NOUN	NN	_	5	nmod	_	_

#	Gilenya	2879
1	Vaccination	_	NOUN	NN	_	5	nsubj	_	_
2	may	_	VERB	MD	_	5	aux	_	_
3	be	_	VERB	VB	_	5	cop	_	_
4	less	_	ADV	RB	_	5	advmod	_	_
5	effective	_	ADJ	JJ	_	0	root	_	_
6	during	_	ADP	IN	_	5	nmod	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	for	_	ADP	IN	_	9	case	_	_
9	up	_	ADJ	JJ	_	6	conj	_	_
10	to	_	PRT	TO	_	12	case	_	_
11	2	_	NUM	CD	_	12	nummod	_	_
12	months	_	NOUN	NNS	_	9	nmod	_	_
13	after	_	ADP	IN	_	14	case	_	_
14	discontinuation	_	NOUN	NN	_	9	nmod	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	treatment	_	NOUN	NN	_	14	nmod	_	_
17	with	_	ADP	IN	_	18	case	_	_
18	DRUG	_	NOUN	NN	_	16	nmod	_	_

#	Gilenya	2880
1	Avoid	_	ADP	IN	_	3	case	_	_
2	the	_	DET	DT	_	3	det	_	_
3	use	_	NOUN	NN	_	0	root	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	live	_	ADP	IN	_	7	amod	_	_
6	attenuated	_	VERB	VBN	_	7	amod	_	_
7	vaccines	_	NOUN	NNS	_	3	nmod	_	_
8	during	_	ADP	IN	_	14	case	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	for	_	ADP	IN	_	12	case	_	_
11	2	_	NUM	CD	_	12	nummod	_	_
12	months	_	NOUN	NNS	_	8	conj	_	_
13	after	_	ADP	IN	_	14	case	_	_
14	treatment	_	NOUN	NN	_	3	nmod	_	_
15	with	_	ADP	IN	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	14	nmod	_	_
17	because	_	ADP	IN	_	20	case	_	_
18	of	_	ADP	IN	_	20	case	_	_
19	the	_	DET	DT	_	20	det	_	_
20	risk	_	NOUN	NN	_	3	nmod	_	_
21	of	_	ADP	IN	_	22	case	_	_
22	infection	_	NOUN	NN	_	20	nmod	_	_

#	Gilenya	2881
1	Antineoplastic	_	ADJ	JJ	_	8	amod	_	_
2	,	_	.	,	_	1	punct	_	_
3	Immunosuppressive	_	ADJ	JJ	_	1	conj	_	_
4	,	_	.	,	_	1	punct	_	_
5	or	_	CONJ	CC	_	1	cc	_	_
6	Immune	_	ADJ	JJ	_	1	conj	_	_
7	Modulating	_	VERB	VBG	_	8	amod	_	_
8	Therapies	_	NOUN	NNS	_	21	nsubjpass	_	_
9	Antineoplastic	_	ADJ	JJ	_	8	amod	_	_
10	,	_	.	,	_	9	punct	_	_
11	immune	_	ADJ	JJ	_	12	amod	_	_
12	modulating	_	NOUN	NN	_	9	conj	_	_
13	,	_	.	,	_	9	punct	_	_
14	or	_	CONJ	CC	_	9	cc	_	_
15	immunosuppressive	_	ADJ	JJ	_	9	conj	_	_
16	therapies	_	NOUN	NNS	_	9	dep	_	_
17	,	_	.	,	_	8	punct	_	_
18	including	_	VERB	VBG	_	19	case	_	_
19	corticosteroids	_	NOUN	NNS	_	8	nmod	_	_
20	are	_	VERB	VBP	_	21	auxpass	_	_
21	expected	_	VERB	VBN	_	0	root	_	_
22	to	_	PRT	TO	_	23	mark	_	_
23	increase	_	VERB	VB	_	21	xcomp	_	_
24	the	_	DET	DT	_	25	det	_	_
25	risk	_	NOUN	NN	_	23	dobj	_	_
26	of	_	ADP	IN	_	27	case	_	_
27	immunosuppression	_	NOUN	NN	_	25	nmod	_	_
28	,	_	.	,	_	21	punct	_	_
29	and	_	CONJ	CC	_	21	cc	_	_
30	the	_	DET	DT	_	31	det	_	_
31	risk	_	NOUN	NN	_	39	nsubjpass	_	_
32	of	_	ADP	IN	_	36	case	_	_
33	additive	_	ADJ	JJ	_	36	amod	_	_
34	immune	_	ADJ	JJ	_	36	amod	_	_
35	system	_	NOUN	NN	_	36	compound	_	_
36	effects	_	NOUN	NNS	_	31	nmod	_	_
37	must	_	VERB	MD	_	39	aux	_	_
38	be	_	VERB	VB	_	39	auxpass	_	_
39	considered	_	VERB	VBN	_	21	conj	_	_
40	if	_	ADP	IN	_	44	mark	_	_
41	these	_	DET	DT	_	42	det	_	_
42	therapies	_	NOUN	NNS	_	44	nsubjpass	_	_
43	are	_	VERB	VBP	_	44	auxpass	_	_
44	coadministered	_	VERB	VBN	_	39	ccomp	_	_
45	with	_	ADP	IN	_	46	case	_	_
46	DRUG	_	NOUN	NN	_	44	nmod	_	_

#	Gilenya	2882
1	When	_	ADV	WRB	_	29	advmod	_	_
2	switching	_	NOUN	NN	_	29	nmod	_	_
3	from	_	ADP	IN	_	4	case	_	_
4	drugs	_	NOUN	NNS	_	2	nmod	_	_
5	with	_	ADP	IN	_	8	case	_	_
6	prolonged	_	ADJ	JJ	_	8	amod	_	_
7	immune	_	ADJ	JJ	_	8	amod	_	_
8	effects	_	NOUN	NNS	_	4	nmod	_	_
9	,	_	.	,	_	8	punct	_	_
10	such	_	ADJ	JJ	_	12	case	_	_
11	as	_	ADP	IN	_	10	mwe	_	_
12	natalizumab	_	ADJ	JJ	_	8	nmod	_	_
13	,	_	.	,	_	12	punct	_	_
14	teriflunomide	_	NOUN	NN	_	12	conj	_	_
15	or	_	CONJ	CC	_	12	cc	_	_
16	mitoxantrone	_	NOUN	NN	_	12	conj	_	_
17	,	_	.	,	_	29	punct	_	_
18	the	_	DET	DT	_	19	det	_	_
19	duration	_	NOUN	NN	_	29	nsubjpass	_	_
20	and	_	CONJ	CC	_	19	cc	_	_
21	mode	_	NOUN	NN	_	19	conj	_	_
22	of	_	ADP	IN	_	23	case	_	_
23	action	_	NOUN	NN	_	19	nmod	_	_
24	of	_	ADP	IN	_	26	case	_	_
25	these	_	DET	DT	_	26	det	_	_
26	drugs	_	NOUN	NNS	_	23	nmod	_	_
27	must	_	VERB	MD	_	29	aux	_	_
28	be	_	VERB	VB	_	29	auxpass	_	_
29	considered	_	VERB	VBN	_	0	root	_	_
30	to	_	PRT	TO	_	35	case	_	_
31	avoid	_	ADV	RB	_	35	amod	_	_
32	unintended	_	ADJ	JJ	_	35	amod	_	_
33	additive	_	ADJ	JJ	_	35	amod	_	_
34	immunosuppressive	_	ADJ	JJ	_	35	amod	_	_
35	effects	_	NOUN	NNS	_	29	nmod	_	_
36	when	_	ADV	WRB	_	37	advmod	_	_
37	initiating	_	VERB	VBG	_	29	advcl	_	_
38	DRUG	_	NOUN	NN	_	37	dobj	_	_

#	Gilenya	2883
1	Experience	_	NOUN	NN	_	39	nsubj	_	_
2	with	_	ADP	IN	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	in	_	ADP	IN	_	5	case	_	_
5	patients	_	NOUN	NNS	_	1	nmod	_	_
6	receiving	_	VERB	VBG	_	5	acl	_	_
7	concurrent	_	ADJ	JJ	_	8	amod	_	_
8	therapy	_	NOUN	NN	_	6	dobj	_	_
9	with	_	ADP	IN	_	10	case	_	_
10	drugs	_	NOUN	NNS	_	8	nmod	_	_
11	that	_	DET	WDT	_	12	nsubj	_	_
12	slow	_	VERB	VBP	_	10	acl:relcl	_	_
13	the	_	DET	DT	_	15	det	_	_
14	heart	_	NOUN	NN	_	15	compound	_	_
15	rate	_	NOUN	NN	_	12	dobj	_	_
16	or	_	CONJ	CC	_	15	cc	_	_
17	atrioventricular	_	ADJ	JJ	_	19	amod	_	_
18	conduction	_	NOUN	NN	_	19	compound	_	_
19	e.g	_	NOUN	NN	_	15	conj	_	_
20	,	_	.	,	_	15	punct	_	_
21	beta	_	NOUN	NN	_	22	compound	_	_
22	blockers	_	NOUN	NNS	_	15	conj	_	_
23	,	_	.	,	_	15	punct	_	_
24	digoxin	_	NOUN	NN	_	15	conj	_	_
25	,	_	.	,	_	15	punct	_	_
26	or	_	CONJ	CC	_	15	cc	_	_
27	heart	_	NOUN	NN	_	28	compound	_	_
28	rate	_	NOUN	NN	_	15	conj	_	_
29	slowing	_	VERB	VBG	_	15	acl	_	_
30	calcium	_	NOUN	NN	_	32	compound	_	_
31	channel	_	NOUN	NN	_	32	compound	_	_
32	blockers	_	NOUN	NNS	_	29	dobj	_	_
33	such	_	ADJ	JJ	_	35	case	_	_
34	as	_	ADP	IN	_	33	mwe	_	_
35	diltiazem	_	NOUN	NN	_	32	nmod	_	_
36	or	_	CONJ	CC	_	35	cc	_	_
37	verapamil	_	NOUN	NN	_	35	conj	_	_
38	is	_	VERB	VBZ	_	39	auxpass	_	_
39	limited	_	ADJ	JJ	_	0	root	_	_

#	Gilenya	2884
1	Because	_	ADP	IN	_	7	mark	_	_
2	initiation	_	NOUN	NN	_	7	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	DRUG	_	NOUN	NN	_	5	compound	_	_
5	treatment	_	NOUN	NN	_	2	nmod	_	_
6	may	_	VERB	MD	_	7	aux	_	_
7	result	_	VERB	VB	_	26	advcl	_	_
8	in	_	ADP	IN	_	11	case	_	_
9	an	_	DET	DT	_	11	det	_	_
10	additional	_	ADJ	JJ	_	11	amod	_	_
11	decrease	_	NOUN	NN	_	7	nmod	_	_
12	in	_	ADP	IN	_	14	case	_	_
13	heart	_	NOUN	NN	_	14	compound	_	_
14	rate	_	NOUN	NN	_	11	nmod	_	_
15	,	_	.	,	_	26	punct	_	_
16	concomitant	_	ADJ	JJ	_	17	amod	_	_
17	use	_	NOUN	NN	_	26	nsubjpass	_	_
18	of	_	ADP	IN	_	20	case	_	_
19	these	_	DET	DT	_	20	det	_	_
20	drugs	_	NOUN	NNS	_	17	nmod	_	_
21	during	_	ADP	IN	_	23	case	_	_
22	DRUG	_	NOUN	NN	_	23	compound	_	_
23	initiation	_	NOUN	NN	_	17	nmod	_	_
24	may	_	VERB	MD	_	26	aux	_	_
25	be	_	VERB	VB	_	26	auxpass	_	_
26	associated	_	VERB	VBN	_	0	root	_	_
27	with	_	ADP	IN	_	29	case	_	_
28	severe	_	ADJ	JJ	_	29	amod	_	_
29	bradycardia	_	NOUN	NN	_	26	nmod	_	_
30	or	_	CONJ	CC	_	29	cc	_	_
31	heart	_	NOUN	NN	_	29	conj	_	_
32	block	_	VERB	VBP	_	26	parataxis	_	_

#	Gilenya	2885
1	Seek	_	NOUN	NN	_	2	nsubj	_	_
2	advice	_	NOUN	NN	_	0	root	_	_
3	from	_	ADP	IN	_	6	case	_	_
4	the	_	DET	DT	_	6	det	_	_
5	prescribing	_	VERB	VBG	_	6	amod	_	_
6	physician	_	NOUN	NN	_	2	nmod	_	_
7	regarding	_	ADP	IN	_	9	case	_	_
8	the	_	DET	DT	_	9	det	_	_
9	possibility	_	NOUN	NN	_	6	nmod	_	_
10	to	_	PRT	TO	_	11	case	_	_
11	switch	_	NOUN	NN	_	9	nmod	_	_
12	to	_	PRT	TO	_	13	case	_	_
13	drugs	_	NOUN	NNS	_	11	nmod	_	_
14	that	_	DET	WDT	_	17	nsubj	_	_
15	do	_	VERB	MD	_	17	aux	_	_
16	not	_	ADV	RB	_	17	neg	_	_
17	slow	_	VERB	VB	_	13	acl:relcl	_	_
18	the	_	DET	DT	_	20	det	_	_
19	heart	_	NOUN	NN	_	20	compound	_	_
20	rate	_	NOUN	NN	_	17	dobj	_	_
21	or	_	CONJ	CC	_	20	cc	_	_
22	atrioventricular	_	ADJ	JJ	_	23	amod	_	_
23	conduction	_	NOUN	NN	_	20	conj	_	_
24	before	_	ADP	IN	_	25	mark	_	_
25	initiating	_	VERB	VBG	_	17	advcl	_	_
26	DRUG	_	NOUN	NN	_	25	dobj	_	_

#	Gilenya	2886
1	Patients	_	NOUN	NNS	_	8	nsubj	_	_
2	who	_	DET	WDT	_	4	nmod:poss	_	_
3	cannot	_	NOUN	NN	_	4	compound	_	_
4	switch	_	NOUN	NN	_	1	nmod	_	_
5	,	_	.	,	_	4	punct	_	_
6	should	_	VERB	MD	_	8	aux	_	_
7	have	_	VERB	VB	_	8	aux	_	_
8	overnight	_	VERB	VB	_	0	root	_	_
9	continuous	_	ADJ	JJ	_	10	amod	_	_
10	ECG	_	NOUN	NN	_	8	dobj	_	_
11	monitoring	_	VERB	VBG	_	10	acl	_	_
12	after	_	ADP	IN	_	15	case	_	_
13	the	_	DET	DT	_	15	det	_	_
14	first	_	ADJ	JJ	_	15	amod	_	_
15	dose	_	NOUN	NN	_	11	nmod	_	_

#	Gilenya	2887
1	Because	_	ADP	IN	_	3	mark	_	_
2	DRUG	_	NOUN	NN	_	3	nsubj	_	_
3	reduces	_	VERB	VBZ	_	20	advcl	_	_
4	blood	_	NOUN	NN	_	6	compound	_	_
5	lymphocyte	_	NOUN	NN	_	6	compound	_	_
6	counts	_	NOUN	NNS	_	3	dobj	_	_
7	via	_	ADP	IN	_	8	case	_	_
8	redistribution	_	NOUN	NN	_	3	nmod	_	_
9	in	_	ADP	IN	_	12	case	_	_
10	secondary	_	ADJ	JJ	_	12	amod	_	_
11	lymphoid	_	ADJ	JJ	_	12	amod	_	_
12	organs	_	NOUN	NNS	_	8	nmod	_	_
13	,	_	.	,	_	20	punct	_	_
14	peripheral	_	ADJ	JJ	_	17	amod	_	_
15	blood	_	NOUN	NN	_	17	compound	_	_
16	lymphocyte	_	NOUN	NN	_	17	compound	_	_
17	counts	_	NOUN	NNS	_	20	nsubjpass	_	_
18	cannot	_	NOUN	NN	_	17	dep	_	_
19	be	_	VERB	VBZ	_	20	auxpass	_	_
20	utilized	_	VERB	VBN	_	0	root	_	_
21	to	_	PRT	TO	_	22	mark	_	_
22	evaluate	_	VERB	VB	_	20	xcomp	_	_
23	the	_	DET	DT	_	26	det	_	_
24	lymphocyte	_	NOUN	NN	_	26	compound	_	_
25	subset	_	NOUN	NN	_	26	compound	_	_
26	status	_	NOUN	NN	_	22	dobj	_	_
27	of	_	ADP	IN	_	29	case	_	_
28	a	_	DET	DT	_	29	det	_	_
29	patient	_	NOUN	NN	_	26	nmod	_	_
30	treated	_	VERB	VBN	_	29	acl	_	_
31	with	_	ADP	IN	_	32	case	_	_
32	DRUG	_	NOUN	NN	_	30	nmod	_	_

#	Gilenya	2888
1	A	_	DET	DT	_	3	det	_	_
2	recent	_	ADJ	JJ	_	3	amod	_	_
3	CBC	_	NOUN	NN	_	6	nsubj	_	_
4	should	_	VERB	MD	_	6	aux	_	_
5	be	_	VERB	VB	_	6	cop	_	_
6	available	_	ADJ	JJ	_	0	root	_	_
7	before	_	ADP	IN	_	8	mark	_	_
8	initiating	_	VERB	VBG	_	6	advcl	_	_
9	treatment	_	NOUN	NN	_	8	dobj	_	_
10	with	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_

#	Gilenya	2889
1	DRUG	_	NOUN	NN	_	3	nsubjpass	_	_
2	is	_	VERB	VBZ	_	3	auxpass	_	_
3	metabolized	_	VERB	VBN	_	0	root	_	_
4	by	_	ADP	IN	_	6	case	_	_
5	sphingosine	_	NOUN	NN	_	6	compound	_	_
6	kinase	_	NOUN	NN	_	3	nmod	_	_
7	to	_	PRT	TO	_	10	case	_	_
8	the	_	DET	DT	_	10	det	_	_
9	active	_	ADJ	JJ	_	10	amod	_	_
10	metabolite	_	NOUN	NN	_	3	nmod	_	_
11	,	_	.	,	_	3	punct	_	_
12	DRUG	_	NOUN	NN	_	13	compound	_	_
13	phosphate	_	NOUN	NN	_	3	dobj	_	_

#	Gilenya	2890
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	phosphate	_	NOUN	NN	_	9	nsubj	_	_
3	is	_	VERB	VBZ	_	9	cop	_	_
4	a	_	DET	DT	_	9	det	_	_
5	sphingosine	_	NOUN	NN	_	9	compound	_	_
6	1	_	NUM	CD	_	9	nummod	_	_
7	phosphate	_	NOUN	NN	_	9	compound	_	_
8	receptor	_	NOUN	NN	_	9	compound	_	_
9	modulator	_	NOUN	NN	_	0	root	_	_
10	,	_	.	,	_	9	punct	_	_
11	and	_	CONJ	CC	_	9	cc	_	_
12	binds	_	VERB	VBZ	_	9	conj	_	_
13	with	_	ADP	IN	_	15	case	_	_
14	high	_	ADJ	JJ	_	15	amod	_	_
15	affinity	_	NOUN	NN	_	12	nmod	_	_
16	to	_	PRT	TO	_	20	case	_	_
17	sphingosine	_	NOUN	NN	_	20	compound	_	_
18	1	_	NUM	CD	_	20	nummod	_	_
19	phosphate	_	NOUN	NN	_	20	compound	_	_
20	receptors	_	NOUN	NNS	_	15	nmod	_	_
21	1	_	NUM	CD	_	20	nummod	_	_
22	,	_	.	,	_	20	punct	_	_
23	3	_	NUM	CD	_	20	conj	_	_
24	,	_	.	,	_	20	punct	_	_
25	4	_	NUM	CD	_	20	conj	_	_
26	,	_	.	,	_	20	punct	_	_
27	and	_	CONJ	CC	_	20	cc	_	_
28	5	_	NUM	CD	_	20	conj	_	_

#	Gilenya	2891
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	phosphate	_	NOUN	NN	_	3	nsubj	_	_
3	blocks	_	VERB	VBZ	_	0	root	_	_
4	the	_	DET	DT	_	5	det	_	_
5	capacity	_	NOUN	NN	_	3	dobj	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	lymphocytes	_	NOUN	NNS	_	5	nmod	_	_
8	to	_	PRT	TO	_	9	mark	_	_
9	egress	_	VERB	VB	_	5	acl	_	_
10	from	_	ADP	IN	_	12	case	_	_
11	lymph	_	NOUN	NN	_	12	compound	_	_
12	nodes	_	NOUN	NNS	_	9	nmod	_	_
13	,	_	.	,	_	3	punct	_	_
14	reducing	_	VERB	VBG	_	3	advcl	_	_
15	the	_	DET	DT	_	16	det	_	_
16	number	_	NOUN	NN	_	14	dobj	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	lymphocytes	_	NOUN	NNS	_	16	nmod	_	_
19	in	_	ADP	IN	_	21	case	_	_
20	peripheral	_	ADJ	JJ	_	21	amod	_	_
21	blood	_	NOUN	NN	_	16	nmod	_	_

#	Gilenya	2892
1	The	_	DET	DT	_	2	det	_	_
2	mechanism	_	NOUN	NN	_	13	nsubj	_	_
3	by	_	ADP	IN	_	4	case	_	_
4	which	_	DET	WDT	_	6	nmod	_	_
5	DRUG	_	NOUN	NN	_	6	nsubj	_	_
6	exerts	_	VERB	VBZ	_	2	acl:relcl	_	_
7	therapeutic	_	ADJ	JJ	_	8	amod	_	_
8	effects	_	NOUN	NNS	_	6	dobj	_	_
9	in	_	ADP	IN	_	11	case	_	_
10	multiple	_	ADJ	JJ	_	11	amod	_	_
11	sclerosis	_	NOUN	NN	_	8	nmod	_	_
12	is	_	VERB	VBZ	_	13	cop	_	_
13	unknown	_	ADJ	JJ	_	0	root	_	_
14	,	_	.	,	_	13	punct	_	_
15	but	_	CONJ	CC	_	13	cc	_	_
16	may	_	VERB	MD	_	17	aux	_	_
17	involve	_	VERB	VB	_	13	conj	_	_
18	reduction	_	NOUN	NN	_	17	dobj	_	_
19	of	_	ADP	IN	_	21	case	_	_
20	lymphocyte	_	NOUN	NN	_	21	compound	_	_
21	migration	_	NOUN	NN	_	18	nmod	_	_
22	into	_	ADP	IN	_	26	case	_	_
23	the	_	DET	DT	_	26	det	_	_
24	central	_	ADJ	JJ	_	26	amod	_	_
25	nervous	_	ADJ	JJ	_	26	amod	_	_
26	system	_	NOUN	NN	_	21	nmod	_	_

#	Gilenya	2893
1	Heart	_	ADJ	JJ	_	2	compound	_	_
2	Rate	_	NOUN	NN	_	6	nsubj	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	Rhythm	_	NOUN	NN	_	5	compound	_	_
5	DRUG	_	NOUN	NN	_	2	conj	_	_
6	causes	_	VERB	VBZ	_	0	root	_	_
7	a	_	DET	DT	_	9	det	_	_
8	transient	_	ADJ	JJ	_	9	amod	_	_
9	reduction	_	NOUN	NN	_	6	dobj	_	_
10	in	_	ADP	IN	_	12	case	_	_
11	heart	_	NOUN	NN	_	12	compound	_	_
12	rate	_	NOUN	NN	_	9	nmod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	AV	_	NOUN	NN	_	15	compound	_	_
15	conduction	_	NOUN	NN	_	12	conj	_	_
16	at	_	ADP	IN	_	18	case	_	_
17	treatment	_	NOUN	NN	_	18	compound	_	_
18	initiation	_	NOUN	NN	_	9	nmod	_	_

#	Gilenya	2894
1	Heart	_	ADJ	JJ	_	2	amod	_	_
2	rate	_	NOUN	NN	_	4	nsubj	_	_
3	progressively	_	ADV	RB	_	4	advmod	_	_
4	increases	_	VERB	VBZ	_	0	root	_	_
5	after	_	ADP	IN	_	8	case	_	_
6	the	_	DET	DT	_	8	det	_	_
7	first	_	ADJ	JJ	_	8	amod	_	_
8	day	_	NOUN	NN	_	4	nmod	_	_
9	,	_	.	,	_	4	punct	_	_
10	returning	_	VERB	VBG	_	4	advcl	_	_
11	to	_	PRT	TO	_	13	case	_	_
12	baseline	_	NOUN	NN	_	13	compound	_	_
13	values	_	NOUN	NNS	_	10	nmod	_	_
14	within	_	ADP	IN	_	16	case	_	_
15	1	_	NUM	CD	_	16	nummod	_	_
16	month	_	NOUN	NN	_	10	nmod	_	_
17	of	_	ADP	IN	_	19	case	_	_
18	the	_	DET	DT	_	19	det	_	_
19	start	_	NOUN	NN	_	16	nmod	_	_
20	of	_	ADP	IN	_	22	case	_	_
21	chronic	_	ADJ	JJ	_	22	amod	_	_
22	treatment	_	NOUN	NN	_	19	nmod	_	_

#	Gilenya	2895
1	Autonomic	_	ADJ	JJ	_	2	amod	_	_
2	responses	_	NOUN	NNS	_	20	nsubjpass	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	the	_	DET	DT	_	5	det	_	_
5	heart	_	NOUN	NN	_	2	nmod	_	_
6	,	_	.	,	_	5	punct	_	_
7	including	_	VERB	VBG	_	9	case	_	_
8	diurnal	_	ADJ	JJ	_	9	amod	_	_
9	variation	_	NOUN	NN	_	5	nmod	_	_
10	of	_	ADP	IN	_	12	case	_	_
11	heart	_	NOUN	NN	_	12	compound	_	_
12	rate	_	NOUN	NN	_	9	nmod	_	_
13	and	_	CONJ	CC	_	9	cc	_	_
14	response	_	NOUN	NN	_	9	conj	_	_
15	to	_	PRT	TO	_	16	mark	_	_
16	exercise	_	VERB	VB	_	14	acl	_	_
17	,	_	.	,	_	2	punct	_	_
18	are	_	VERB	VBP	_	20	auxpass	_	_
19	not	_	ADV	RB	_	20	neg	_	_
20	affected	_	VERB	VBN	_	0	root	_	_
21	by	_	ADP	IN	_	23	case	_	_
22	DRUG	_	NOUN	NN	_	23	compound	_	_
23	treatment	_	NOUN	NN	_	20	nmod	_	_

#	Gilenya	2896
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	treatment	_	NOUN	NN	_	5	nsubjpass	_	_
3	is	_	VERB	VBZ	_	5	auxpass	_	_
4	not	_	ADV	RB	_	5	neg	_	_
5	associated	_	VERB	VBN	_	0	root	_	_
6	with	_	ADP	IN	_	8	case	_	_
7	a	_	DET	DT	_	8	det	_	_
8	decrease	_	NOUN	NN	_	5	nmod	_	_
9	in	_	ADP	IN	_	11	case	_	_
10	cardiac	_	ADJ	JJ	_	11	amod	_	_
11	output	_	NOUN	NN	_	8	nmod	_	_

#	Gilenya	2897
1	Potential	_	ADJ	JJ	_	38	advmod	_	_
2	to	_	PRT	TO	_	3	mark	_	_
3	Prolong	_	VERB	VB	_	1	acl	_	_
4	the	_	DET	DT	_	5	det	_	_
5	QT	_	NOUN	NN	_	3	dobj	_	_
6	Interval	_	ADJ	JJ	_	5	amod	_	_
7	In	_	ADP	IN	_	12	case	_	_
8	a	_	DET	DT	_	12	det	_	_
9	thorough	_	NOUN	NN	_	12	compound	_	_
10	QT	_	NOUN	NN	_	12	compound	_	_
11	interval	_	ADJ	JJ	_	12	amod	_	_
12	study	_	NOUN	NN	_	6	nmod	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	doses	_	NOUN	NNS	_	12	nmod	_	_
15	of	_	ADP	IN	_	20	case	_	_
16	1.25	_	NUM	CD	_	20	nummod	_	_
17	or	_	CONJ	CC	_	16	cc	_	_
18	2.5	_	NUM	CD	_	16	conj	_	_
19	mg	_	NOUN	NN	_	20	compound	_	_
20	DRUG	_	NOUN	NN	_	14	nmod	_	_
21	at	_	ADP	IN	_	23	case	_	_
22	steady	_	ADJ	JJ	_	23	amod	_	_
23	state	_	NOUN	NN	_	12	nmod	_	_
24	,	_	.	,	_	38	punct	_	_
25	when	_	ADV	WRB	_	34	advmod	_	_
26	a	_	DET	DT	_	29	det	_	_
27	negative	_	ADJ	JJ	_	29	amod	_	_
28	chronotropic	_	ADJ	JJ	_	29	amod	_	_
29	effect	_	NOUN	NN	_	34	nsubj	_	_
30	of	_	ADP	IN	_	31	case	_	_
31	DRUG	_	NOUN	NN	_	29	nmod	_	_
32	was	_	VERB	VBD	_	34	cop	_	_
33	still	_	ADV	RB	_	34	advmod	_	_
34	present	_	ADJ	JJ	_	38	advcl	_	_
35	,	_	.	,	_	38	punct	_	_
36	DRUG	_	NOUN	NN	_	37	compound	_	_
37	treatment	_	NOUN	NN	_	38	nsubj	_	_
38	resulted	_	VERB	VBD	_	0	root	_	_
39	in	_	ADP	IN	_	41	case	_	_
40	a	_	DET	DT	_	41	det	_	_
41	prolongation	_	NOUN	NN	_	38	nmod	_	_
42	of	_	ADP	IN	_	43	case	_	_
43	QTc	_	NOUN	NN	_	41	nmod	_	_
44	,	_	.	,	_	38	punct	_	_
45	with	_	ADP	IN	_	48	case	_	_
46	the	_	DET	DT	_	48	det	_	_
47	upper	_	ADJ	JJ	_	48	amod	_	_
48	boundary	_	NOUN	NN	_	38	nmod	_	_
49	of	_	ADP	IN	_	54	case	_	_
50	the	_	DET	DT	_	54	det	_	_
51	90%	_	ADJ	JJ	_	54	amod	_	_
52	confidence	_	NOUN	NN	_	54	compound	_	_
53	interval	_	ADJ	JJ	_	54	amod	_	_
54	CI	_	NOUN	NN	_	48	nmod	_	_
55	of	_	ADP	IN	_	57	case	_	_
56	14.0	_	NUM	CD	_	57	nummod	_	_
57	msec	_	ADJ	JJ	_	54	nmod	_	_

#	Gilenya	2898
1	There	_	DET	EX	_	2	expl	_	_
2	is	_	VERB	VBZ	_	0	root	_	_
3	no	_	DET	DT	_	5	neg	_	_
4	consistent	_	ADJ	JJ	_	5	amod	_	_
5	signal	_	NOUN	NN	_	2	nsubj	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	increased	_	VERB	VBN	_	8	amod	_	_
8	incidence	_	NOUN	NN	_	5	nmod	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	QTc	_	NOUN	NN	_	11	compound	_	_
11	outliers	_	NOUN	NNS	_	8	nmod	_	_
12	,	_	.	,	_	2	punct	_	_
13	either	_	CONJ	CC	_	14	cc:preconj	_	_
14	absolute	_	VERB	VBP	_	2	dep	_	_
15	or	_	CONJ	CC	_	14	cc	_	_
16	change	_	NOUN	NN	_	14	conj	_	_
17	from	_	ADP	IN	_	18	case	_	_
18	baseline	_	NOUN	NN	_	16	nmod	_	_
19	,	_	.	,	_	14	punct	_	_
20	associated	_	VERB	VBN	_	14	acl	_	_
21	with	_	ADP	IN	_	23	case	_	_
22	DRUG	_	NOUN	NN	_	23	compound	_	_
23	treatment	_	NOUN	NN	_	20	nmod	_	_

#	Gilenya	2899
1	In	_	ADP	IN	_	3	case	_	_
2	MS	_	NOUN	NN	_	3	compound	_	_
3	studies	_	NOUN	NNS	_	6	nmod	_	_
4	,	_	.	,	_	6	punct	_	_
5	there	_	DET	EX	_	6	expl	_	_
6	was	_	VERB	VBD	_	0	root	_	_
7	no	_	DET	DT	_	10	neg	_	_
8	clinically	_	ADV	RB	_	9	advmod	_	_
9	relevant	_	ADJ	JJ	_	10	amod	_	_
10	prolongation	_	NOUN	NN	_	6	nsubj	_	_
11	of	_	ADP	IN	_	14	case	_	_
12	the	_	DET	DT	_	14	det	_	_
13	QT	_	NOUN	NN	_	14	compound	_	_
14	interval	_	ADJ	JJ	_	10	nmod	_	_
15	,	_	.	,	_	6	punct	_	_
16	but	_	CONJ	CC	_	6	cc	_	_
17	patients	_	NOUN	NNS	_	25	nsubjpass	_	_
18	at	_	ADP	IN	_	19	case	_	_
19	risk	_	NOUN	NN	_	17	nmod	_	_
20	for	_	ADP	IN	_	22	case	_	_
21	QT	_	NOUN	NN	_	22	compound	_	_
22	prolongation	_	NOUN	NN	_	19	nmod	_	_
23	were	_	VERB	VBD	_	25	auxpass	_	_
24	not	_	ADV	RB	_	25	neg	_	_
25	included	_	VERB	VBN	_	6	conj	_	_
26	in	_	ADP	IN	_	28	case	_	_
27	clinical	_	ADJ	JJ	_	28	amod	_	_
28	studies	_	NOUN	NNS	_	25	nmod	_	_

#	Gilenya	2900
1	Immune	_	ADJ	JJ	_	3	amod	_	_
2	System	_	NOUN	NN	_	3	compound	_	_
3	Effects	_	NOUN	NNS	_	0	root	_	_
4	on	_	ADP	IN	_	7	case	_	_
5	Immune	_	ADJ	JJ	_	7	amod	_	_
6	Cell	_	NOUN	NN	_	7	compound	_	_
7	Numbers	_	NOUN	NNS	_	3	nmod	_	_
8	in	_	ADP	IN	_	10	case	_	_
9	the	_	DET	DT	_	10	det	_	_
10	Blood	_	NOUN	NN	_	3	nmod	_	_
11	In	_	ADP	IN	_	13	case	_	_
12	a	_	DET	DT	_	13	det	_	_
13	study	_	NOUN	NN	_	3	nmod	_	_
14	in	_	ADP	IN	_	15	case	_	_
15	which	_	DET	WDT	_	18	nmod	_	_
16	12	_	NUM	CD	_	17	nummod	_	_
17	subjects	_	NOUN	NNS	_	18	nsubj	_	_
18	received	_	VERB	VBD	_	13	acl:relcl	_	_
19	DRUG	_	NOUN	NN	_	21	compound	_	_
20	0.5	_	NUM	CD	_	21	nummod	_	_
21	mg	_	NOUN	NN	_	18	dobj	_	_
22	daily	_	ADV	RB	_	18	advmod	_	_
23	,	_	.	,	_	3	punct	_	_
24	the	_	DET	DT	_	26	det	_	_
25	lymphocyte	_	NOUN	NN	_	26	compound	_	_
26	count	_	NOUN	NN	_	27	nsubj	_	_
27	decreased	_	VERB	VBD	_	3	dep	_	_
28	to	_	PRT	TO	_	30	case	_	_
29	approximately	_	ADV	RB	_	30	advmod	_	_
30	60%	_	NOUN	NN	_	27	nmod	_	_
31	of	_	ADP	IN	_	32	case	_	_
32	baseline	_	NOUN	NN	_	30	nmod	_	_
33	within	_	ADP	IN	_	37	case	_	_
34	4	_	NUM	CD	_	36	compound	_	_
35	to	_	PRT	TO	_	36	dep	_	_
36	6	_	NUM	CD	_	37	nummod	_	_
37	hours	_	NOUN	NNS	_	30	nmod	_	_
38	after	_	ADP	IN	_	41	case	_	_
39	the	_	DET	DT	_	41	det	_	_
40	first	_	ADJ	JJ	_	41	amod	_	_
41	dose	_	NOUN	NN	_	30	nmod	_	_

#	Gilenya	2901
1	With	_	ADP	IN	_	4	case	_	_
2	continued	_	VERB	VBN	_	4	amod	_	_
3	daily	_	ADV	RB	_	4	advmod	_	_
4	dosing	_	NOUN	NN	_	9	nmod	_	_
5	,	_	.	,	_	9	punct	_	_
6	the	_	DET	DT	_	8	det	_	_
7	lymphocyte	_	NOUN	NN	_	8	compound	_	_
8	count	_	NOUN	NN	_	9	nsubj	_	_
9	continued	_	VERB	VBD	_	0	root	_	_
10	to	_	PRT	TO	_	11	mark	_	_
11	decrease	_	VERB	VB	_	9	xcomp	_	_
12	over	_	ADP	IN	_	16	case	_	_
13	a	_	DET	DT	_	16	det	_	_
14	2	_	NUM	CD	_	16	nummod	_	_
15	week	_	NOUN	NN	_	16	compound	_	_
16	period	_	NOUN	NN	_	11	nmod	_	_
17	,	_	.	,	_	9	punct	_	_
18	reaching	_	VERB	VBG	_	9	xcomp	_	_
19	a	_	DET	DT	_	21	det	_	_
20	nadir	_	ADJ	JJ	_	21	amod	_	_
21	count	_	NOUN	NN	_	18	dobj	_	_
22	of	_	ADP	IN	_	25	case	_	_
23	approximately	_	ADV	RB	_	24	advmod	_	_
24	500	_	NUM	CD	_	25	nummod	_	_
25	cells	_	NOUN	NNS	_	21	nmod	_	_
26	/	_	.	:	_	9	punct	_	_
27	mcL	_	NOUN	NN	_	9	dep	_	_
28	or	_	CONJ	CC	_	27	cc	_	_
29	approximately	_	ADV	RB	_	30	advmod	_	_
30	30%	_	NOUN	NN	_	27	conj	_	_
31	of	_	ADP	IN	_	32	case	_	_
32	baseline	_	NOUN	NN	_	30	nmod	_	_

#	Gilenya	2902
1	In	_	ADP	IN	_	3	case	_	_
2	a	_	DET	DT	_	3	det	_	_
3	placebo	_	NOUN	NN	_	4	nsubj	_	_
4	controlled	_	VERB	VBD	_	31	advcl	_	_
5	study	_	NOUN	NN	_	4	dobj	_	_
6	in	_	ADP	IN	_	9	case	_	_
7	1272	_	NUM	CD	_	9	nummod	_	_
8	MS	_	NOUN	NN	_	9	compound	_	_
9	patients	_	NOUN	NNS	_	5	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	whom	_	ADP	IN	_	16	nmod	_	_
12	425	_	NUM	CD	_	16	nummod	_	_
13	received	_	VERB	VBN	_	16	amod	_	_
14	DRUG	_	NOUN	NN	_	16	compound	_	_
15	0.5	_	NUM	CD	_	16	nummod	_	_
16	mg	_	NOUN	NN	_	9	nmod	_	_
17	daily	_	ADV	RB	_	18	advmod	_	_
18	and	_	CONJ	CC	_	16	advmod	_	_
19	418	_	NUM	CD	_	21	nummod	_	_
20	received	_	VERB	VBN	_	21	amod	_	_
21	placebo	_	NOUN	NN	_	18	conj	_	_
22	,	_	.	,	_	31	punct	_	_
23	18%	_	ADJ	JJ	_	24	amod	_	_
24	N=78	_	NOUN	NN	_	31	nsubj	_	_
25	of	_	ADP	IN	_	26	case	_	_
26	patients	_	NOUN	NNS	_	24	nmod	_	_
27	on	_	ADP	IN	_	30	case	_	_
28	DRUG	_	NOUN	NN	_	30	compound	_	_
29	0.5	_	NUM	CD	_	30	nummod	_	_
30	mg	_	NOUN	NN	_	24	nmod	_	_
31	reached	_	VERB	VBD	_	0	root	_	_
32	a	_	DET	DT	_	33	det	_	_
33	nadir	_	NOUN	NN	_	31	dobj	_	_
34	of	_	ADP	IN	_	36	case	_	_
35	<200	_	NUM	CD	_	36	nummod	_	_
36	cells	_	NOUN	NNS	_	33	nmod	_	_
37	/	_	.	:	_	31	punct	_	_
38	mcL	_	NOUN	NN	_	31	parataxis	_	_
39	on	_	ADP	IN	_	43	case	_	_
40	at	_	ADP	IN	_	41	case	_	_
41	least	_	ADJ	JJS	_	42	nmod:npmod	_	_
42	1	_	NUM	CD	_	43	nummod	_	_
43	occasion	_	NOUN	NN	_	38	nmod	_	_

#	Gilenya	2903
1	No	_	DET	DT	_	2	neg	_	_
2	patient	_	NOUN	NN	_	5	nsubj	_	_
3	on	_	ADP	IN	_	4	case	_	_
4	placebo	_	NOUN	NN	_	2	nmod	_	_
5	reached	_	VERB	VBD	_	0	root	_	_
6	a	_	DET	DT	_	7	det	_	_
7	nadir	_	NOUN	NN	_	5	dobj	_	_
8	of	_	ADP	IN	_	10	case	_	_
9	<200	_	NUM	CD	_	10	nummod	_	_
10	cells	_	NOUN	NNS	_	7	nmod	_	_
11	/	_	.	:	_	5	punct	_	_
12	mcL	_	NOUN	NN	_	5	parataxis	_	_

#	Gilenya	2904
1	Low	_	ADJ	JJ	_	3	amod	_	_
2	lymphocyte	_	NOUN	NN	_	3	compound	_	_
3	counts	_	NOUN	NNS	_	5	nsubjpass	_	_
4	are	_	VERB	VBP	_	5	auxpass	_	_
5	maintained	_	VERB	VBN	_	0	root	_	_
6	with	_	ADP	IN	_	9	case	_	_
7	chronic	_	ADJ	JJ	_	9	amod	_	_
8	daily	_	ADV	RB	_	9	advmod	_	_
9	dosing	_	NOUN	NN	_	5	nmod	_	_
10	of	_	ADP	IN	_	13	case	_	_
11	DRUG	_	NOUN	NN	_	13	compound	_	_
12	0.5	_	NUM	CD	_	13	nummod	_	_
13	mg	_	NOUN	NN	_	9	nmod	_	_
14	daily	_	ADV	RB	_	5	advmod	_	_

#	Gilenya	2905
1	Chronic	_	ADJ	JJ	_	3	amod	_	_
2	DRUG	_	NOUN	NN	_	3	compound	_	_
3	dosing	_	NOUN	NN	_	4	nsubj	_	_
4	leads	_	VERB	VBZ	_	0	root	_	_
5	to	_	PRT	TO	_	8	case	_	_
6	a	_	DET	DT	_	8	det	_	_
7	mild	_	ADJ	JJ	_	8	amod	_	_
8	decrease	_	NOUN	NN	_	4	nmod	_	_
9	in	_	ADP	IN	_	12	case	_	_
10	the	_	DET	DT	_	12	det	_	_
11	neutrophil	_	NOUN	NN	_	12	compound	_	_
12	count	_	NOUN	NN	_	8	nmod	_	_
13	to	_	PRT	TO	_	15	case	_	_
14	approximately	_	ADV	RB	_	15	advmod	_	_
15	80%	_	NOUN	NN	_	8	nmod	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	baseline	_	NOUN	NN	_	15	nmod	_	_

#	Gilenya	2906
1	Peripheral	_	ADJ	JJ	_	4	amod	_	_
2	lymphocyte	_	NOUN	NN	_	4	compound	_	_
3	count	_	NOUN	NN	_	4	compound	_	_
4	increases	_	NOUN	NNS	_	6	nsubj	_	_
5	are	_	VERB	VBP	_	6	cop	_	_
6	evident	_	ADJ	JJ	_	0	root	_	_
7	within	_	ADP	IN	_	8	case	_	_
8	days	_	NOUN	NNS	_	6	nmod	_	_
9	of	_	ADP	IN	_	10	mark	_	_
10	stopping	_	VERB	VBG	_	8	acl	_	_
11	DRUG	_	NOUN	NN	_	12	compound	_	_
12	treatment	_	NOUN	NN	_	10	dobj	_	_
13	and	_	CONJ	CC	_	6	cc	_	_
14	typically	_	ADV	RB	_	18	advmod	_	_
15	normal	_	ADJ	JJ	_	16	amod	_	_
16	counts	_	NOUN	NNS	_	18	nsubjpass	_	_
17	are	_	VERB	VBP	_	18	auxpass	_	_
18	reached	_	VERB	VBN	_	6	conj	_	_
19	within	_	ADP	IN	_	23	case	_	_
20	1	_	NUM	CD	_	22	compound	_	_
21	to	_	PRT	TO	_	22	dep	_	_
22	2	_	NUM	CD	_	23	nummod	_	_
23	months	_	NOUN	NNS	_	18	nmod	_	_

#	Gilenya	2907
1	Effect	_	NOUN	NN	_	6	nsubj	_	_
2	on	_	ADP	IN	_	5	case	_	_
3	Antibody	_	NOUN	NN	_	5	compound	_	_
4	Response	_	NOUN	NN	_	5	compound	_	_
5	DRUG	_	NOUN	NN	_	1	nmod	_	_
6	reduces	_	VERB	VBZ	_	0	root	_	_
7	the	_	DET	DT	_	9	det	_	_
8	immune	_	ADJ	JJ	_	9	amod	_	_
9	response	_	NOUN	NN	_	6	dobj	_	_
10	to	_	PRT	TO	_	11	case	_	_
11	vaccination	_	NOUN	NN	_	9	nmod	_	_
12	,	_	.	,	_	6	punct	_	_
13	as	_	ADP	IN	_	14	mark	_	_
14	evaluated	_	VERB	VBN	_	6	advcl	_	_
15	in	_	ADP	IN	_	17	case	_	_
16	2	_	NUM	CD	_	17	nummod	_	_
17	studies	_	NOUN	NNS	_	14	nmod	_	_

#	Gilenya	2908
1	In	_	ADP	IN	_	4	case	_	_
2	the	_	DET	DT	_	4	det	_	_
3	first	_	ADJ	JJ	_	4	amod	_	_
4	study	_	NOUN	NN	_	21	nmod	_	_
5	,	_	.	,	_	21	punct	_	_
6	the	_	DET	DT	_	7	det	_	_
7	immunogenicity	_	NOUN	NN	_	21	nsubjpass	_	_
8	of	_	ADP	IN	_	12	case	_	_
9	keyhole	_	NOUN	NN	_	12	compound	_	_
10	limpet	_	NOUN	NN	_	12	compound	_	_
11	hemocyanin	_	NOUN	NN	_	12	compound	_	_
12	KLH	_	NOUN	NN	_	7	nmod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	pneumococcal	_	ADJ	JJ	_	19	amod	_	_
15	polysaccharide	_	NOUN	NN	_	19	compound	_	_
16	vaccine	_	NOUN	NN	_	19	compound	_	_
17	PPV	_	NOUN	NN	_	19	compound	_	_
18	23	_	NUM	CD	_	19	nummod	_	_
19	immunization	_	NOUN	NN	_	12	conj	_	_
20	were	_	VERB	VBD	_	21	auxpass	_	_
21	assessed	_	VERB	VBN	_	0	root	_	_
22	by	_	ADP	IN	_	23	case	_	_
23	IgM	_	NOUN	NN	_	21	nmod	_	_
24	and	_	CONJ	CC	_	23	cc	_	_
25	IgG	_	NOUN	NN	_	23	conj	_	_
26	titers	_	NOUN	NNS	_	23	dep	_	_
27	in	_	ADP	IN	_	30	case	_	_
28	a	_	DET	DT	_	30	det	_	_
29	steady	_	ADJ	JJ	_	30	amod	_	_
30	state	_	NOUN	NN	_	21	nmod	_	_
31	,	_	.	,	_	30	punct	_	_
32	randomized	_	VERB	VBN	_	30	acl	_	_
33	,	_	.	,	_	21	punct	_	_
34	placebo	_	NOUN	NN	_	36	compound	_	_
35	controlled	_	ADJ	JJ	_	36	amod	_	_
36	study	_	NOUN	NN	_	33	root	_	_
37	in	_	ADP	IN	_	39	case	_	_
38	healthy	_	ADJ	JJ	_	39	amod	_	_
39	volunteers	_	NOUN	NNS	_	36	nmod	_	_

#	Gilenya	2909
1	Compared	_	VERB	VBN	_	10	advcl	_	_
2	to	_	PRT	TO	_	3	case	_	_
3	placebo	_	NOUN	NN	_	1	nmod	_	_
4	,	_	.	,	_	10	punct	_	_
5	antigen	_	NOUN	NN	_	8	compound	_	_
6	specific	_	ADJ	JJ	_	8	amod	_	_
7	IgM	_	NOUN	NN	_	8	compound	_	_
8	titers	_	NOUN	NNS	_	10	nsubjpass	_	_
9	were	_	VERB	VBD	_	10	auxpass	_	_
10	decreased	_	VERB	VBN	_	0	root	_	_
11	by	_	ADP	IN	_	12	case	_	_
12	91%	_	NOUN	NN	_	10	nmod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	25%	_	NOUN	NN	_	12	conj	_	_
15	in	_	ADP	IN	_	16	case	_	_
16	response	_	NOUN	NN	_	10	nmod	_	_
17	to	_	PRT	TO	_	18	case	_	_
18	KLH	_	NOUN	NN	_	16	nmod	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	PPV	_	NOUN	NN	_	18	conj	_	_
21	23	_	NUM	CD	_	20	nummod	_	_
22	,	_	.	,	_	10	punct	_	_
23	respectively	_	ADV	RB	_	10	advmod	_	_
24	,	_	.	,	_	10	punct	_	_
25	in	_	ADP	IN	_	26	case	_	_
26	subjects	_	NOUN	NNS	_	10	nmod	_	_
27	on	_	ADP	IN	_	30	case	_	_
28	DRUG	_	NOUN	NN	_	30	compound	_	_
29	0.5	_	NUM	CD	_	30	nummod	_	_
30	mg	_	NOUN	NNS	_	26	nmod	_	_

#	Gilenya	2910
1	Similarly	_	ADV	RB	_	6	advmod	_	_
2	,	_	.	,	_	6	punct	_	_
3	IgG	_	NOUN	NN	_	4	compound	_	_
4	titers	_	NOUN	NNS	_	6	nsubjpass	_	_
5	were	_	VERB	VBD	_	6	auxpass	_	_
6	decreased	_	VERB	VBN	_	0	root	_	_
7	by	_	ADP	IN	_	8	case	_	_
8	45%	_	NOUN	NN	_	6	nmod	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	50%	_	NOUN	NN	_	8	conj	_	_
11	,	_	.	,	_	6	punct	_	_
12	in	_	ADP	IN	_	13	case	_	_
13	response	_	NOUN	NN	_	6	nmod	_	_
14	to	_	PRT	TO	_	15	case	_	_
15	KLH	_	NOUN	NN	_	13	nmod	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	PPV	_	NOUN	NN	_	15	conj	_	_
18	23	_	NUM	CD	_	17	nummod	_	_
19	,	_	.	,	_	6	punct	_	_
20	respectively	_	ADV	RB	_	6	advmod	_	_
21	,	_	.	,	_	6	punct	_	_
22	in	_	ADP	IN	_	23	case	_	_
23	subjects	_	NOUN	NNS	_	6	nmod	_	_
24	on	_	ADP	IN	_	27	case	_	_
25	DRUG	_	NOUN	NN	_	27	compound	_	_
26	0.5	_	NUM	CD	_	27	nummod	_	_
27	mg	_	NOUN	NN	_	23	nmod	_	_
28	daily	_	ADV	RB	_	29	advmod	_	_
29	compared	_	VERB	VBN	_	6	advcl	_	_
30	to	_	PRT	TO	_	31	case	_	_
31	placebo	_	NOUN	NN	_	29	nmod	_	_

#	Gilenya	2911
1	The	_	DET	DT	_	3	det	_	_
2	responder	_	NOUN	NN	_	3	compound	_	_
3	rate	_	NOUN	NN	_	24	nsubj	_	_
4	for	_	ADP	IN	_	7	case	_	_
5	DRUG	_	NOUN	NN	_	7	compound	_	_
6	0.5	_	NUM	CD	_	7	nummod	_	_
7	mg	_	NOUN	NN	_	3	nmod	_	_
8	as	_	ADP	IN	_	9	mark	_	_
9	measured	_	VERB	VBN	_	3	acl	_	_
10	by	_	ADP	IN	_	12	case	_	_
11	the	_	DET	DT	_	12	det	_	_
12	number	_	NOUN	NN	_	9	nmod	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	subjects	_	NOUN	NNS	_	12	nmod	_	_
15	with	_	ADP	IN	_	19	case	_	_
16	a	_	DET	DT	_	19	det	_	_
17	>4	_	NUM	CD	_	18	compound	_	_
18	fold	_	NOUN	NN	_	19	amod	_	_
19	increase	_	NOUN	NN	_	12	nmod	_	_
20	in	_	ADP	IN	_	22	case	_	_
21	KLH	_	NOUN	NN	_	22	compound	_	_
22	IgG	_	NOUN	NN	_	19	nmod	_	_
23	was	_	VERB	VBD	_	24	cop	_	_
24	comparable	_	ADJ	JJ	_	0	root	_	_
25	to	_	PRT	TO	_	26	case	_	_
26	placebo	_	NOUN	NN	_	24	nmod	_	_
27	and	_	CONJ	CC	_	26	cc	_	_
28	25%	_	NOUN	NN	_	26	conj	_	_
29	lower	_	ADJ	JJ	_	26	amod	_	_
30	for	_	ADP	IN	_	33	case	_	_
31	PPV	_	NOUN	NN	_	33	compound	_	_
32	23	_	NUM	CD	_	33	nummod	_	_
33	IgG	_	NOUN	NN	_	29	nmod	_	_
34	,	_	.	,	_	24	punct	_	_
35	while	_	ADP	IN	_	52	mark	_	_
36	the	_	DET	DT	_	37	det	_	_
37	number	_	NOUN	NN	_	52	nsubj	_	_
38	of	_	ADP	IN	_	39	case	_	_
39	subjects	_	NOUN	NNS	_	37	nmod	_	_
40	with	_	ADP	IN	_	44	case	_	_
41	a	_	DET	DT	_	44	det	_	_
42	>4	_	NUM	CD	_	43	compound	_	_
43	fold	_	NOUN	NN	_	44	amod	_	_
44	increase	_	NOUN	NN	_	37	nmod	_	_
45	in	_	ADP	IN	_	46	case	_	_
46	KLH	_	NOUN	NN	_	44	nmod	_	_
47	and	_	CONJ	CC	_	46	cc	_	_
48	PPV	_	NOUN	NN	_	50	compound	_	_
49	23	_	NUM	CD	_	50	nummod	_	_
50	IgM	_	NOUN	NN	_	46	conj	_	_
51	was	_	VERB	VBD	_	52	cop	_	_
52	75%	_	ADJ	JJ	_	24	advcl	_	_
53	and	_	CONJ	CC	_	52	cc	_	_
54	40%	_	ADJ	JJ	_	55	nmod:npmod	_	_
55	lower	_	ADJ	JJ	_	52	conj	_	_
56	,	_	.	,	_	24	punct	_	_
57	respectively	_	ADV	RB	_	24	advmod	_	_
58	,	_	.	,	_	24	punct	_	_
59	compared	_	VERB	VBN	_	24	advcl	_	_
60	to	_	PRT	TO	_	61	case	_	_
61	placebo	_	NOUN	NN	_	59	nmod	_	_

#	Gilenya	2912
1	The	_	DET	DT	_	2	det	_	_
2	capacity	_	NOUN	NN	_	17	nsubjpass	_	_
3	to	_	PRT	TO	_	4	mark	_	_
4	mount	_	VERB	VB	_	2	acl	_	_
5	a	_	DET	DT	_	10	det	_	_
6	skin	_	NOUN	NN	_	10	compound	_	_
7	delayed	_	ADJ	JJ	_	10	amod	_	_
8	type	_	NOUN	NN	_	10	compound	_	_
9	hypersensitivity	_	NOUN	NN	_	10	compound	_	_
10	reaction	_	NOUN	NN	_	4	dobj	_	_
11	to	_	PRT	TO	_	12	case	_	_
12	Candida	_	NOUN	NN	_	10	nmod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	tetanus	_	NOUN	NN	_	15	compound	_	_
15	toxoid	_	NOUN	NN	_	12	conj	_	_
16	was	_	VERB	VBD	_	17	auxpass	_	_
17	decreased	_	VERB	VBN	_	0	root	_	_
18	by	_	ADP	IN	_	20	case	_	_
19	approximately	_	ADV	RB	_	20	advmod	_	_
20	30%	_	NOUN	NN	_	17	nmod	_	_
21	in	_	ADP	IN	_	22	case	_	_
22	subjects	_	NOUN	NNS	_	20	nmod	_	_
23	on	_	ADP	IN	_	26	case	_	_
24	DRUG	_	NOUN	NN	_	26	compound	_	_
25	0.5	_	NUM	CD	_	26	nummod	_	_
26	mg	_	NOUN	NN	_	22	nmod	_	_
27	daily	_	ADV	RB	_	17	advmod	_	_
28	,	_	.	,	_	17	punct	_	_
29	compared	_	VERB	VBN	_	17	xcomp	_	_
30	to	_	PRT	TO	_	31	case	_	_
31	placebo	_	NOUN	NN	_	29	nmod	_	_

#	Gilenya	2913
1	Immunologic	_	ADJ	JJ	_	2	amod	_	_
2	responses	_	NOUN	NNS	_	5	nsubjpass	_	_
3	were	_	VERB	VBD	_	5	auxpass	_	_
4	further	_	ADV	RB	_	5	advmod	_	_
5	decreased	_	VERB	VBN	_	0	root	_	_
6	with	_	ADP	IN	_	9	case	_	_
7	DRUG	_	NOUN	NN	_	9	compound	_	_
8	1.25	_	NUM	CD	_	9	nummod	_	_
9	mg	_	NOUN	NN	_	5	nmod	_	_
10	a	_	DET	DT	_	11	det	_	_
11	dose	_	NOUN	NN	_	9	nmod	_	_
12	higher	_	ADJ	JJ	_	11	amod	_	_
13	than	_	ADP	IN	_	14	mark	_	_
14	recommended	_	VERB	VBN	_	12	advcl	_	_
15	in	_	ADP	IN	_	16	case	_	_
16	MS	_	NOUN	NN	_	14	nmod	_	_

#	Gilenya	2914
1	In	_	ADP	IN	_	4	case	_	_
2	the	_	DET	DT	_	4	det	_	_
3	second	_	ADJ	JJ	_	4	amod	_	_
4	study	_	NOUN	NN	_	18	nmod	_	_
5	,	_	.	,	_	18	punct	_	_
6	the	_	DET	DT	_	7	det	_	_
7	immunogenicity	_	NOUN	NN	_	18	nsubjpass	_	_
8	of	_	ADP	IN	_	12	case	_	_
9	Northern	_	NOUN	NN	_	12	compound	_	_
10	hemisphere	_	NOUN	NN	_	12	compound	_	_
11	seasonal	_	ADJ	JJ	_	12	amod	_	_
12	influenza	_	NOUN	NN	_	7	nmod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	tetanus	_	NOUN	NN	_	16	compound	_	_
15	toxoid	_	NOUN	NN	_	16	compound	_	_
16	vaccination	_	NOUN	NN	_	12	conj	_	_
17	was	_	VERB	VBD	_	18	auxpass	_	_
18	assessed	_	VERB	VBN	_	0	root	_	_
19	in	_	ADP	IN	_	24	case	_	_
20	a	_	DET	DT	_	24	det	_	_
21	12	_	NUM	CD	_	24	nummod	_	_
22	week	_	NOUN	NN	_	24	compound	_	_
23	steady	_	ADJ	JJ	_	24	amod	_	_
24	state	_	NOUN	NN	_	18	nmod	_	_
25	,	_	.	,	_	24	punct	_	_
26	randomized	_	VERB	VBN	_	24	acl	_	_
27	,	_	.	,	_	18	punct	_	_
28	placebo	_	NOUN	NN	_	30	compound	_	_
29	controlled	_	VERB	VBN	_	30	amod	_	_
30	study	_	NOUN	NN	_	18	dobj	_	_
31	of	_	ADP	IN	_	34	case	_	_
32	DRUG	_	NOUN	NN	_	34	compound	_	_
33	0.5	_	NUM	CD	_	34	nummod	_	_
34	mg	_	NOUN	NN	_	30	nmod	_	_
35	in	_	ADP	IN	_	38	case	_	_
36	multiple	_	ADJ	JJ	_	38	amod	_	_
37	sclerosis	_	NOUN	NN	_	38	compound	_	_
38	patients	_	NOUN	NNS	_	30	nmod	_	_
39	n=136	_	NOUN	NN	_	38	root	_	_

#	Gilenya	2915
1	The	_	DET	DT	_	5	det	_	_
2	responder	_	NOUN	NN	_	5	compound	_	_
3	rate	_	NOUN	NN	_	5	compound	_	_
4	3	_	NUM	CD	_	5	nummod	_	_
5	weeks	_	NOUN	NNS	_	31	nsubj	_	_
6	after	_	ADP	IN	_	7	case	_	_
7	vaccination	_	NOUN	NN	_	5	nmod	_	_
8	,	_	.	,	_	5	punct	_	_
9	defined	_	VERB	VBN	_	5	acl	_	_
10	as	_	ADP	IN	_	11	case	_	_
11	seroconversion	_	NOUN	NN	_	9	nmod	_	_
12	or	_	CONJ	CC	_	11	cc	_	_
13	a	_	DET	DT	_	16	det	_	_
14	>4	_	NUM	CD	_	16	nummod	_	_
15	fold	_	NOUN	NN	_	16	amod	_	_
16	increase	_	NOUN	NN	_	11	conj	_	_
17	in	_	ADP	IN	_	18	case	_	_
18	antibody	_	NOUN	NN	_	16	nmod	_	_
19	directed	_	VERB	VBN	_	18	acl	_	_
20	against	_	ADP	IN	_	23	case	_	_
21	at	_	ADP	IN	_	22	case	_	_
22	least	_	ADJ	JJS	_	23	nmod:npmod	_	_
23	1	_	NUM	CD	_	19	nmod	_	_
24	of	_	ADP	IN	_	28	case	_	_
25	the	_	DET	DT	_	28	det	_	_
26	3	_	NUM	CD	_	28	nummod	_	_
27	influenza	_	NOUN	NN	_	28	compound	_	_
28	strains	_	NOUN	NNS	_	23	nmod	_	_
29	,	_	.	,	_	5	punct	_	_
30	was	_	VERB	VBD	_	31	cop	_	_
31	54%	_	ADJ	JJ	_	0	root	_	_
32	for	_	ADP	IN	_	35	case	_	_
33	DRUG	_	NOUN	NN	_	35	compound	_	_
34	0.5	_	NUM	CD	_	35	nummod	_	_
35	mg	_	NOUN	NN	_	31	nmod	_	_
36	and	_	CONJ	CC	_	35	cc	_	_
37	85%	_	NOUN	NN	_	35	conj	_	_
38	in	_	ADP	IN	_	41	case	_	_
39	the	_	DET	DT	_	41	det	_	_
40	placebo	_	NOUN	NN	_	41	compound	_	_
41	group	_	NOUN	NN	_	35	nmod	_	_

#	Gilenya	2916
1	The	_	DET	DT	_	5	det	_	_
2	responder	_	NOUN	NN	_	5	compound	_	_
3	rate	_	NOUN	NN	_	5	compound	_	_
4	3	_	NUM	CD	_	5	nummod	_	_
5	weeks	_	NOUN	NNS	_	24	nsubj	_	_
6	after	_	ADP	IN	_	7	case	_	_
7	vaccination	_	NOUN	NN	_	5	nmod	_	_
8	,	_	.	,	_	5	punct	_	_
9	defined	_	VERB	VBN	_	5	acl	_	_
10	as	_	ADP	IN	_	11	case	_	_
11	seroconversion	_	NOUN	NN	_	9	nmod	_	_
12	or	_	CONJ	CC	_	11	cc	_	_
13	a	_	DET	DT	_	16	det	_	_
14	>4	_	NUM	CD	_	16	nummod	_	_
15	fold	_	NOUN	NN	_	16	amod	_	_
16	increase	_	NOUN	NN	_	11	conj	_	_
17	in	_	ADP	IN	_	18	case	_	_
18	antibody	_	NOUN	NN	_	16	nmod	_	_
19	directed	_	VERB	VBN	_	18	acl	_	_
20	against	_	ADP	IN	_	22	case	_	_
21	tetanus	_	NOUN	NN	_	22	compound	_	_
22	toxoid	_	NOUN	NN	_	19	nmod	_	_
23	was	_	VERB	VBD	_	24	cop	_	_
24	40%	_	ADJ	JJ	_	0	root	_	_
25	for	_	ADP	IN	_	28	case	_	_
26	DRUG	_	NOUN	NN	_	28	compound	_	_
27	0.5	_	NUM	CD	_	28	nummod	_	_
28	mg	_	NOUN	NN	_	24	nmod	_	_
29	and	_	CONJ	CC	_	28	cc	_	_
30	61%	_	NOUN	NN	_	28	conj	_	_
31	in	_	ADP	IN	_	34	case	_	_
32	the	_	DET	DT	_	34	det	_	_
33	placebo	_	NOUN	NN	_	34	compound	_	_
34	group	_	NOUN	NN	_	28	nmod	_	_

#	Gilenya	2917
1	Pulmonary	_	ADJ	JJ	_	5	amod	_	_
2	Function	_	NOUN	NN	_	5	compound	_	_
3	Single	_	ADJ	JJ	_	5	amod	_	_
4	DRUG	_	NOUN	NN	_	5	compound	_	_
5	doses	_	NOUN	NNS	_	12	compound	_	_
6	>5	_	NUM	CD	_	7	nummod	_	_
7	mg	_	NOUN	NN	_	12	compound	_	_
8	10	_	NUM	CD	_	7	nummod	_	_
9	fold	_	NOUN	NN	_	7	dep	_	_
10	the	_	DET	DT	_	12	det	_	_
11	recommended	_	ADJ	JJ	_	12	amod	_	_
12	dose	_	NOUN	NN	_	14	nsubjpass	_	_
13	are	_	VERB	VBP	_	14	auxpass	_	_
14	associated	_	VERB	VBN	_	0	root	_	_
15	with	_	ADP	IN	_	19	case	_	_
16	a	_	DET	DT	_	19	det	_	_
17	dose	_	NOUN	NN	_	19	compound	_	_
18	dependent	_	ADJ	JJ	_	19	amod	_	_
19	increase	_	NOUN	NN	_	14	nmod	_	_
20	in	_	ADP	IN	_	22	case	_	_
21	airway	_	NOUN	NN	_	22	compound	_	_
22	resistance	_	NOUN	NN	_	19	nmod	_	_

#	Gilenya	2918
1	In	_	ADP	IN	_	4	case	_	_
2	a14	_	NUM	CD	_	4	nummod	_	_
3	day	_	NOUN	NN	_	4	compound	_	_
4	study	_	NOUN	NN	_	19	nmod	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	0.5	_	NUM	CD	_	14	nummod	_	_
7	,	_	.	,	_	6	punct	_	_
8	1.25	_	NUM	CD	_	6	conj	_	_
9	,	_	.	,	_	6	punct	_	_
10	or	_	CONJ	CC	_	6	cc	_	_
11	5	_	NUM	CD	_	12	nummod	_	_
12	mg	_	NOUN	NN	_	6	conj	_	_
13	/	_	.	:	_	14	punct	_	_
14	day	_	NOUN	NN	_	4	nmod	_	_
15	,	_	.	,	_	19	punct	_	_
16	DRUG	_	NOUN	NN	_	19	nsubjpass	_	_
17	was	_	VERB	VBD	_	19	auxpass	_	_
18	not	_	ADV	RB	_	19	neg	_	_
19	associated	_	VERB	VBN	_	0	root	_	_
20	with	_	ADP	IN	_	22	case	_	_
21	impaired	_	ADJ	JJ	_	22	amod	_	_
22	oxygenation	_	NOUN	NN	_	19	nmod	_	_
23	or	_	CONJ	CC	_	22	cc	_	_
24	oxygen	_	NOUN	NN	_	25	compound	_	_
25	desaturation	_	NOUN	NN	_	22	conj	_	_
26	with	_	ADP	IN	_	27	case	_	_
27	exercise	_	NOUN	NN	_	22	nmod	_	_
28	or	_	CONJ	CC	_	22	cc	_	_
29	an	_	DET	DT	_	30	det	_	_
30	increase	_	NOUN	NN	_	22	conj	_	_
31	in	_	ADP	IN	_	33	case	_	_
32	airway	_	NOUN	NN	_	33	compound	_	_
33	responsiveness	_	NOUN	NN	_	30	nmod	_	_
34	to	_	PRT	TO	_	35	case	_	_
35	methacholine	_	NOUN	NN	_	33	nmod	_	_

#	Gilenya	2919
1	Subjects	_	NOUN	NNS	_	5	nsubj	_	_
2	on	_	ADP	IN	_	4	case	_	_
3	DRUG	_	NOUN	NN	_	4	compound	_	_
4	treatment	_	NOUN	NN	_	1	nmod	_	_
5	had	_	VERB	VBD	_	0	root	_	_
6	a	_	DET	DT	_	9	det	_	_
7	normal	_	ADJ	JJ	_	9	amod	_	_
8	bronchodilator	_	NOUN	NN	_	9	compound	_	_
9	response	_	NOUN	NN	_	5	dobj	_	_
10	to	_	PRT	TO	_	13	case	_	_
11	inhaled	_	VERB	VBN	_	13	amod	_	_
12	beta	_	NOUN	NN	_	13	compound	_	_
13	agonists	_	NOUN	NNS	_	9	nmod	_	_

#	Gilenya	2920
1	In	_	ADP	IN	_	5	case	_	_
2	a	_	DET	DT	_	5	det	_	_
3	14	_	NUM	CD	_	5	nummod	_	_
4	day	_	NOUN	NN	_	5	compound	_	_
5	placebo	_	NOUN	NN	_	6	nsubj	_	_
6	controlled	_	VERB	VBD	_	17	advcl	_	_
7	study	_	NOUN	NN	_	6	dobj	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	patients	_	NOUN	NNS	_	7	nmod	_	_
10	with	_	ADP	IN	_	12	case	_	_
11	moderate	_	ADJ	JJ	_	12	amod	_	_
12	asthma	_	NOUN	NN	_	9	nmod	_	_
13	,	_	.	,	_	17	punct	_	_
14	no	_	DET	DT	_	15	neg	_	_
15	effect	_	NOUN	NN	_	17	nsubjpass	_	_
16	was	_	VERB	VBD	_	17	auxpass	_	_
17	seen	_	VERB	VBN	_	0	root	_	_
18	for	_	ADP	IN	_	21	case	_	_
19	DRUG	_	NOUN	NN	_	21	compound	_	_
20	0.5	_	NUM	CD	_	21	nummod	_	_
21	mg	_	NOUN	NN	_	17	nmod	_	_
22	recommended	_	VERB	VBN	_	23	amod	_	_
23	dose	_	NOUN	NN	_	17	nmod	_	_
24	in	_	ADP	IN	_	25	case	_	_
25	MS	_	NOUN	NN	_	23	nmod	_	_

#	Gilenya	2921
1	A	_	DET	DT	_	3	det	_	_
2	10%	_	ADJ	JJ	_	3	amod	_	_
3	reduction	_	NOUN	NN	_	13	nsubjpass	_	_
4	in	_	ADP	IN	_	6	case	_	_
5	mean	_	ADJ	JJ	_	6	amod	_	_
6	FEV1	_	NOUN	NN	_	3	nmod	_	_
7	at	_	ADP	IN	_	9	case	_	_
8	6	_	NUM	CD	_	9	nummod	_	_
9	hours	_	NOUN	NNS	_	3	nmod	_	_
10	after	_	ADP	IN	_	11	case	_	_
11	dosing	_	NOUN	NN	_	3	nmod	_	_
12	was	_	VERB	VBD	_	13	auxpass	_	_
13	observed	_	VERB	VBN	_	0	root	_	_
14	in	_	ADP	IN	_	15	case	_	_
15	patients	_	NOUN	NNS	_	13	nmod	_	_
16	receiving	_	VERB	VBG	_	15	acl	_	_
17	DRUG	_	NOUN	NN	_	19	compound	_	_
18	1.25	_	NUM	CD	_	19	nummod	_	_
19	mg	_	NOUN	NN	_	16	nmod	_	_
20	a	_	DET	DT	_	21	det	_	_
21	dose	_	NOUN	NN	_	19	dep	_	_
22	higher	_	ADJ	JJ	_	19	amod	_	_
23	than	_	ADP	IN	_	24	mark	_	_
24	recommended	_	VERB	VBN	_	22	advcl	_	_
25	for	_	ADP	IN	_	26	case	_	_
26	use	_	NOUN	NN	_	24	nmod	_	_
27	in	_	ADP	IN	_	28	case	_	_
28	MS	_	NOUN	NN	_	26	nmod	_	_
29	on	_	ADP	IN	_	30	case	_	_
30	Day	_	NOUN	NN	_	26	nmod	_	_
31	10	_	NUM	CD	_	30	nummod	_	_
32	of	_	ADP	IN	_	33	case	_	_
33	treatment	_	NOUN	NN	_	30	nmod	_	_

#	Gilenya	2922
1	DRUG	_	NOUN	NN	_	3	compound	_	_
2	1.25	_	NUM	CD	_	3	nummod	_	_
3	mg	_	NOUN	NN	_	5	nsubjpass	_	_
4	was	_	VERB	VBD	_	5	auxpass	_	_
5	associated	_	VERB	VBN	_	0	root	_	_
6	with	_	ADP	IN	_	10	case	_	_
7	a	_	DET	DT	_	10	det	_	_
8	5	_	NUM	CD	_	9	compound	_	_
9	fold	_	NOUN	NN	_	10	amod	_	_
10	increase	_	NOUN	NN	_	5	nmod	_	_
11	in	_	ADP	IN	_	13	case	_	_
12	the	_	DET	DT	_	13	det	_	_
13	use	_	NOUN	NN	_	10	nmod	_	_
14	of	_	ADP	IN	_	19	case	_	_
15	rescue	_	NOUN	NN	_	19	compound	_	_
16	short	_	ADJ	JJ	_	19	amod	_	_
17	acting	_	VERB	VBG	_	19	compound	_	_
18	beta	_	NOUN	NN	_	19	compound	_	_
19	agonists	_	NOUN	NNS	_	13	nmod	_	_

#	Gilenya	2923
1	Absorption	_	NOUN	NN	_	8	nsubj	_	_
2	The	_	DET	DT	_	4	det	_	_
3	Tmaxof	_	NOUN	NN	_	4	compound	_	_
4	DRUG	_	NOUN	NN	_	1	nmod	_	_
5	is	_	VERB	VBZ	_	8	cop	_	_
6	12	_	NUM	CD	_	8	nummod	_	_
7	16	_	NUM	CD	_	8	nummod	_	_
8	hours	_	NOUN	NNS	_	0	root	_	_

#	Gilenya	2924
1	The	_	DET	DT	_	6	det	_	_
2	apparent	_	ADJ	JJ	_	6	amod	_	_
3	absolute	_	NOUN	NN	_	6	compound	_	_
4	oral	_	ADJ	JJ	_	6	amod	_	_
5	bioavailabilityis	_	NOUN	NN	_	6	compound	_	_
6	93%	_	ADJ	JJ	_	0	root	_	_

#	Gilenya	2925
1	Food	_	NOUN	NN	_	2	compound	_	_
2	intake	_	NOUN	NN	_	5	nsubj	_	_
3	does	_	VERB	VBZ	_	5	aux	_	_
4	not	_	ADV	RB	_	5	neg	_	_
5	alter	_	VERB	VB	_	0	root	_	_
6	Cmax	_	NOUN	NN	_	5	dobj	_	_
7	or	_	CONJ	CC	_	6	cc	_	_
8	exposure	_	NOUN	NN	_	6	conj	_	_
9	AUC	_	NOUN	NN	_	6	dep	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	6	nmod	_	_
12	or	_	CONJ	CC	_	11	cc	_	_
13	DRUG	_	NOUN	NN	_	14	compound	_	_
14	phosphate	_	NOUN	NN	_	11	conj	_	_

#	Gilenya	2926
1	Therefore	_	ADV	RB	_	5	advmod	_	_
2	DRUG	_	NOUN	NN	_	5	nsubjpass	_	_
3	may	_	VERB	MD	_	5	aux	_	_
4	be	_	VERB	VB	_	5	auxpass	_	_
5	taken	_	VERB	VBN	_	0	root	_	_
6	without	_	ADP	IN	_	7	case	_	_
7	regard	_	NOUN	NN	_	5	nmod	_	_
8	to	_	PRT	TO	_	9	case	_	_
9	meals	_	NOUN	NNS	_	7	nmod	_	_

#	Gilenya	2927
1	Steady	_	ADJ	JJ	_	3	amod	_	_
2	stateblood	_	NOUN	NN	_	3	compound	_	_
3	concentrations	_	NOUN	NNS	_	5	nsubjpass	_	_
4	are	_	VERB	VBP	_	5	auxpass	_	_
5	reached	_	VERB	VBN	_	0	root	_	_
6	within	_	ADP	IN	_	9	case	_	_
7	1	_	NUM	CD	_	9	nummod	_	_
8	to	_	PRT	TO	_	9	case	_	_
9	2months	_	NOUN	NNS	_	5	nmod	_	_
10	following	_	ADP	IN	_	13	case	_	_
11	once	_	ADV	RB	_	12	advmod	_	_
12	daily	_	ADV	RB	_	13	advmod	_	_
13	administration	_	NOUN	NN	_	5	nmod	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	steady	_	ADJ	JJ	_	17	amod	_	_
16	state	_	NOUN	NN	_	17	compound	_	_
17	levels	_	NOUN	NNS	_	13	conj	_	_
18	are	_	VERB	VBP	_	22	cop	_	_
19	approximately	_	ADV	RB	_	20	advmod	_	_
20	10	_	NUM	CD	_	21	nummod	_	_
21	fold	_	NOUN	NN	_	22	nmod:npmod	_	_
22	greater	_	ADJ	JJ	_	5	dep	_	_
23	than	_	ADP	IN	_	27	case	_	_
24	with	_	ADP	IN	_	27	case	_	_
25	the	_	DET	DT	_	27	det	_	_
26	initial	_	ADJ	JJ	_	27	amod	_	_
27	dose	_	NOUN	NN	_	22	nmod	_	_

#	Gilenya	2928
1	Distribution	_	NOUN	NN	_	2	compound	_	_
2	DRUG	_	NOUN	NN	_	5	nsubj	_	_
3	highly	_	ADV	RB	_	4	advmod	_	_
4	86%	_	ADJ	JJ	_	5	advmod	_	_
5	distributes	_	VERB	VBZ	_	0	root	_	_
6	in	_	ADP	IN	_	9	case	_	_
7	red	_	ADJ	JJ	_	9	amod	_	_
8	blood	_	NOUN	NN	_	9	compound	_	_
9	cells	_	NOUN	NNS	_	5	nmod	_	_

#	Gilenya	2929
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	phosphate	_	NOUN	NN	_	3	nsubj	_	_
3	has	_	VERB	VBZ	_	0	root	_	_
4	a	_	DET	DT	_	6	det	_	_
5	smaller	_	ADJ	JJ	_	6	amod	_	_
6	uptake	_	NOUN	NN	_	3	dobj	_	_
7	in	_	ADP	IN	_	9	case	_	_
8	blood	_	NOUN	NN	_	9	compound	_	_
9	cells	_	NOUN	NNS	_	6	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	<17%	_	ADJ	JJ	_	9	nmod	_	_

#	Gilenya	2930
1	DRUG	_	NOUN	NN	_	7	nsubj	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	DRUG	_	NOUN	NN	_	4	compound	_	_
4	phosphate	_	NOUN	NN	_	1	conj	_	_
5	are	_	VERB	VBP	_	7	cop	_	_
6	>99.7%	_	ADJ	JJ	_	7	amod	_	_
7	protein	_	NOUN	NN	_	0	root	_	_
8	bound	_	VERB	VBN	_	7	root	_	_

#	Gilenya	2931
1	DRUG	_	NOUN	NN	_	6	compound	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	DRUG	_	NOUN	NN	_	1	conj	_	_
4	phosphate	_	NOUN	NN	_	6	compound	_	_
5	protein	_	NOUN	NN	_	6	compound	_	_
6	binding	_	NOUN	NN	_	9	nsubjpass	_	_
7	is	_	VERB	VBZ	_	9	auxpass	_	_
8	not	_	ADV	RB	_	9	neg	_	_
9	altered	_	VERB	VBN	_	0	root	_	_
10	by	_	ADP	IN	_	14	case	_	_
11	renal	_	ADJ	JJ	_	14	amod	_	_
12	or	_	CONJ	CC	_	11	cc	_	_
13	hepatic	_	ADJ	JJ	_	11	conj	_	_
14	impairment	_	NOUN	NN	_	9	nmod	_	_

#	Gilenya	2932
1	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
2	is	_	VERB	VBZ	_	4	auxpass	_	_
3	extensively	_	ADV	RB	_	4	advmod	_	_
4	distributed	_	VERB	VBN	_	23	advcl	_	_
5	to	_	PRT	TO	_	7	case	_	_
6	body	_	NOUN	NN	_	7	compound	_	_
7	tissueswith	_	NOUN	NN	_	4	nmod	_	_
8	a	_	DET	DT	_	9	det	_	_
9	volume	_	NOUN	NN	_	4	dobj	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	distribution	_	NOUN	NN	_	9	nmod	_	_
12	of	_	ADP	IN	_	16	case	_	_
13	about	_	ADV	RB	_	14	advmod	_	_
14	1200*260	_	NUM	CD	_	16	nummod	_	_
15	L	_	NOUN	NN	_	16	compound	_	_
16	Metabolism	_	NOUN	NN	_	11	nmod	_	_
17	The	_	DET	DT	_	18	det	_	_
18	biotransformation	_	NOUN	NN	_	23	nsubj	_	_
19	of	_	ADP	IN	_	20	case	_	_
20	DRUG	_	NOUN	NN	_	18	nmod	_	_
21	in	_	ADP	IN	_	22	case	_	_
22	humans	_	NOUN	NNS	_	18	nmod	_	_
23	occurs	_	VERB	VBZ	_	0	root	_	_
24	by	_	ADP	IN	_	27	case	_	_
25	3	_	NUM	CD	_	27	nummod	_	_
26	main	_	ADJ	JJ	_	27	amod	_	_
27	pathways	_	NOUN	NNS	_	23	nmod	_	_
28	:	_	.	:	_	23	punct	_	_
29	by	_	ADP	IN	_	32	case	_	_
30	reversible	_	ADJ	JJ	_	32	amod	_	_
31	stereoselective	_	ADJ	JJ	_	32	amod	_	_
32	phosphorylation	_	NOUN	NN	_	23	parataxis	_	_
33	to	_	PRT	TO	_	38	case	_	_
34	the	_	DET	DT	_	38	det	_	_
35	pharmacologically	_	ADV	RB	_	36	advmod	_	_
36	active	_	ADJ	JJ	_	38	amod	_	_
37	S	_	NOUN	NN	_	38	compound	_	_
38	enantiomer	_	NOUN	NN	_	32	nmod	_	_
39	of	_	ADP	IN	_	41	case	_	_
40	DRUG	_	NOUN	NN	_	41	compound	_	_
41	phosphate	_	NOUN	NN	_	38	nmod	_	_
42	,	_	.	,	_	32	punct	_	_
43	by	_	ADP	IN	_	45	case	_	_
44	oxidative	_	ADJ	JJ	_	45	amod	_	_
45	biotransformation	_	NOUN	NN	_	32	nmod	_	_
46	catalyzed	_	VERB	VBN	_	45	acl	_	_
47	mainly	_	ADV	RB	_	46	advmod	_	_
48	by	_	ADP	IN	_	53	case	_	_
49	the	_	DET	DT	_	53	det	_	_
50	cytochrome	_	NOUN	NN	_	53	compound	_	_
51	P450	_	NOUN	NN	_	53	compound	_	_
52	4F2	_	NOUN	NN	_	53	compound	_	_
53	CYP4F2	_	NOUN	NN	_	46	nmod	_	_
54	and	_	CONJ	CC	_	53	cc	_	_
55	possibly	_	ADV	RB	_	56	advmod	_	_
56	other	_	ADJ	JJ	_	58	amod	_	_
57	CYP4F	_	NOUN	NN	_	58	compound	_	_
58	isoenzymes	_	NOUN	NNS	_	53	conj	_	_
59	with	_	ADP	IN	_	62	case	_	_
60	subsequent	_	ADJ	JJ	_	62	amod	_	_
61	fatty	_	ADJ	JJ	_	62	amod	_	_
62	acid	_	NOUN	NN	_	53	nmod	_	_
63	like	_	ADP	IN	_	64	case	_	_
64	degradation	_	NOUN	NN	_	46	nmod	_	_
65	to	_	PRT	TO	_	67	case	_	_
66	inactive	_	ADJ	JJ	_	67	amod	_	_
67	metabolites	_	NOUN	NNS	_	64	nmod	_	_
68	,	_	.	,	_	32	punct	_	_
69	and	_	CONJ	CC	_	32	cc	_	_
70	by	_	ADP	IN	_	71	case	_	_
71	formation	_	NOUN	NN	_	32	conj	_	_
72	of	_	ADP	IN	_	78	case	_	_
73	pharmacologically	_	ADV	RB	_	74	advmod	_	_
74	inactive	_	ADJ	JJ	_	78	amod	_	_
75	non	_	ADJ	JJ	_	78	amod	_	_
76	polar	_	ADJ	JJ	_	78	amod	_	_
77	ceramide	_	NOUN	NN	_	78	compound	_	_
78	analogs	_	NOUN	NNS	_	71	nmod	_	_
79	of	_	ADP	IN	_	80	case	_	_
80	DRUG	_	NOUN	NN	_	78	nmod	_	_

#	Gilenya	2933
1	Inhibitors	_	NOUN	NNS	_	12	nsubj	_	_
2	or	_	CONJ	CC	_	1	cc	_	_
3	inducers	_	NOUN	NNS	_	1	conj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	CYP4F2	_	NOUN	NN	_	1	nmod	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	possibly	_	ADV	RB	_	8	advmod	_	_
8	other	_	ADJ	JJ	_	10	amod	_	_
9	CYP4F	_	NOUN	NN	_	10	compound	_	_
10	isozymes	_	NOUN	NNS	_	5	conj	_	_
11	might	_	VERB	MD	_	12	aux	_	_
12	alter	_	VERB	VB	_	0	root	_	_
13	the	_	DET	DT	_	14	det	_	_
14	exposure	_	NOUN	NN	_	12	dobj	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	14	nmod	_	_
17	or	_	CONJ	CC	_	16	cc	_	_
18	DRUG	_	NOUN	NN	_	19	compound	_	_
19	phosphate	_	NOUN	NN	_	16	conj	_	_

#	Gilenya	2934
1	In	_	X	FW	_	3	amod	_	_
2	vitro	_	X	FW	_	1	dep	_	_
3	studies	_	NOUN	NNS	_	6	nsubj	_	_
4	in	_	ADP	IN	_	5	case	_	_
5	hepatocytes	_	NOUN	NNS	_	3	nmod	_	_
6	indicated	_	VERB	VBD	_	0	root	_	_
7	that	_	ADP	IN	_	10	mark	_	_
8	CYP3A4	_	NOUN	NN	_	10	nsubj	_	_
9	may	_	VERB	MD	_	10	aux	_	_
10	contribute	_	VERB	VB	_	6	ccomp	_	_
11	to	_	PRT	TO	_	13	case	_	_
12	DRUG	_	NOUN	NN	_	13	compound	_	_
13	metabolism	_	NOUN	NN	_	10	nmod	_	_
14	in	_	ADP	IN	_	16	case	_	_
15	the	_	DET	DT	_	16	det	_	_
16	case	_	NOUN	NN	_	13	nmod	_	_
17	of	_	ADP	IN	_	19	case	_	_
18	strong	_	ADJ	JJ	_	19	amod	_	_
19	induction	_	NOUN	NN	_	16	nmod	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	CYP3A4	_	NOUN	NN	_	19	nmod	_	_

#	Gilenya	2935
1	Following	_	VERB	VBG	_	4	case	_	_
2	single	_	ADJ	JJ	_	4	amod	_	_
3	oral	_	ADJ	JJ	_	4	amod	_	_
4	administration	_	NOUN	NN	_	29	nmod	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	14C	_	NOUN	NN	_	7	compound	_	_
7	DRUG	_	NOUN	NN	_	4	nmod	_	_
8	,	_	.	,	_	7	punct	_	_
9	the	_	DET	DT	_	13	det	_	_
10	major	_	ADJ	JJ	_	13	amod	_	_
11	DRUG	_	NOUN	NN	_	13	compound	_	_
12	related	_	ADJ	JJ	_	13	amod	_	_
13	components	_	NOUN	NNS	_	7	appos	_	_
14	in	_	ADP	IN	_	15	case	_	_
15	blood	_	NOUN	NN	_	13	nmod	_	_
16	,	_	.	,	_	29	punct	_	_
17	as	_	ADP	IN	_	18	mark	_	_
18	judged	_	VERB	VBN	_	29	advcl	_	_
19	from	_	ADP	IN	_	21	case	_	_
20	their	_	PRON	PRP$	_	21	nmod:poss	_	_
21	contribution	_	NOUN	NN	_	18	nmod	_	_
22	to	_	PRT	TO	_	24	case	_	_
23	the	_	DET	DT	_	24	det	_	_
24	AUC	_	NOUN	NN	_	21	nmod	_	_
25	up	_	ADV	RB	_	28	advmod	_	_
26	to	_	PRT	TO	_	28	case	_	_
27	816	_	NUM	CD	_	28	nummod	_	_
28	hours	_	NOUN	NNS	_	21	nmod	_	_
29	post	_	VERB	VBP	_	0	root	_	_
30	dose	_	NOUN	NN	_	29	dobj	_	_
31	of	_	ADP	IN	_	34	case	_	_
32	total	_	ADJ	JJ	_	34	amod	_	_
33	radiolabeled	_	ADJ	JJ	_	34	amod	_	_
34	components	_	NOUN	NNS	_	30	nmod	_	_
35	,	_	.	,	_	29	punct	_	_
36	are	_	VERB	VBP	_	52	cop	_	_
37	DRUG	_	NOUN	NN	_	52	compound	_	_
38	itself	_	CONJ	CC	_	39	cc:preconj	_	_
39	23.3%	_	ADJ	JJ	_	52	amod	_	_
40	,	_	.	,	_	39	punct	_	_
41	DRUG	_	NOUN	NN	_	43	compound	_	_
42	phosphate	_	NOUN	NN	_	43	nmod:npmod	_	_
43	10.3%	_	ADJ	JJ	_	39	conj	_	_
44	,	_	.	,	_	39	punct	_	_
45	and	_	CONJ	CC	_	39	cc	_	_
46	inactive	_	ADJ	JJ	_	39	conj	_	_
47	metabolites	_	NOUN	NNS	_	39	dep	_	_
48	M3	_	NOUN	NN	_	52	compound	_	_
49	carboxylic	_	ADJ	JJ	_	52	amod	_	_
50	acid	_	NOUN	NN	_	52	compound	_	_
51	metabolite	_	NOUN	NN	_	52	compound	_	_
52	8.3%	_	NOUN	NN	_	29	parataxis	_	_
53	,	_	.	,	_	52	punct	_	_
54	M29	_	NOUN	NN	_	57	compound	_	_
55	ceramide	_	NOUN	NN	_	57	compound	_	_
56	metabolite	_	NOUN	NN	_	57	compound	_	_
57	8.9%	_	NOUN	NN	_	52	conj	_	_
58	,	_	.	,	_	52	punct	_	_
59	and	_	CONJ	CC	_	52	cc	_	_
60	M30	_	NOUN	NN	_	63	compound	_	_
61	ceramide	_	NOUN	NN	_	63	compound	_	_
62	metabolite	_	NOUN	NN	_	63	compound	_	_
63	7.3%	_	ADJ	JJ	_	52	conj	_	_

#	Gilenya	2936
1	Elimination	_	NOUN	NN	_	4	compound	_	_
2	DRUG	_	NOUN	NN	_	4	compound	_	_
3	blood	_	NOUN	NN	_	4	compound	_	_
4	clearance	_	NOUN	NN	_	7	nsubj	_	_
5	is	_	VERB	VBZ	_	7	cop	_	_
6	6.3*2.3	_	NUM	CD	_	7	nummod	_	_
7	L	_	NOUN	NN	_	0	root	_	_
8	/	_	.	:	_	7	punct	_	_
9	h	_	NOUN	NN	_	7	dep	_	_
10	,	_	.	,	_	9	punct	_	_
11	and	_	CONJ	CC	_	9	cc	_	_
12	the	_	DET	DT	_	17	det	_	_
13	average	_	ADJ	JJ	_	17	amod	_	_
14	apparent	_	ADJ	JJ	_	17	amod	_	_
15	terminal	_	ADJ	JJ	_	17	amod	_	_
16	half	_	NOUN	NN	_	17	compound	_	_
17	life	_	NOUN	NN	_	9	conj	_	_
18	t1	_	NUM	CD	_	17	nummod	_	_
19	/	_	.	:	_	17	punct	_	_
20	2	_	NUM	CD	_	17	nummod	_	_
21	is	_	VERB	VBZ	_	25	cop	_	_
22	6	_	NUM	CD	_	24	compound	_	_
23	to	_	PRT	TO	_	24	dep	_	_
24	9	_	NUM	CD	_	25	nummod	_	_
25	days	_	NOUN	NNS	_	17	nmod	_	_

#	Gilenya	2937
1	Blood	_	NOUN	NN	_	2	compound	_	_
2	levels	_	NOUN	NNS	_	6	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	DRUG	_	NOUN	NN	_	5	compound	_	_
5	phosphate	_	NOUN	NN	_	2	nmod	_	_
6	decline	_	VERB	VBP	_	0	root	_	_
7	in	_	ADP	IN	_	8	case	_	_
8	parallel	_	NOUN	NN	_	6	nmod	_	_
9	with	_	ADP	IN	_	10	case	_	_
10	those	_	DET	DT	_	8	nmod	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_
13	in	_	ADP	IN	_	16	case	_	_
14	the	_	DET	DT	_	16	det	_	_
15	terminal	_	ADJ	JJ	_	16	amod	_	_
16	phase	_	NOUN	NN	_	10	nmod	_	_
17	,	_	.	,	_	6	punct	_	_
18	yielding	_	VERB	VBG	_	6	xcomp	_	_
19	similar	_	ADJ	JJ	_	21	amod	_	_
20	half	_	ADJ	JJ	_	21	amod	_	_
21	lives	_	NOUN	NNS	_	18	dobj	_	_
22	for	_	ADP	IN	_	23	case	_	_
23	both	_	CONJ	CC	_	21	dep	_	_

#	Gilenya	2938
1	After	_	ADP	IN	_	3	case	_	_
2	oral	_	ADJ	JJ	_	3	amod	_	_
3	administration	_	NOUN	NN	_	12	nmod	_	_
4	,	_	.	,	_	12	punct	_	_
5	about	_	ADV	RB	_	6	advmod	_	_
6	81%	_	NOUN	NN	_	12	nsubjpass	_	_
7	of	_	ADP	IN	_	9	case	_	_
8	the	_	DET	DT	_	9	det	_	_
9	dose	_	NOUN	NN	_	6	nmod	_	_
10	is	_	VERB	VBZ	_	12	auxpass	_	_
11	slowly	_	ADV	RB	_	12	advmod	_	_
12	excreted	_	VERB	VBN	_	0	root	_	_
13	in	_	ADP	IN	_	15	case	_	_
14	the	_	DET	DT	_	15	det	_	_
15	urine	_	ADJ	JJ	_	12	nmod	_	_
16	as	_	ADP	IN	_	18	case	_	_
17	inactive	_	ADJ	JJ	_	18	amod	_	_
18	metabolites	_	NOUN	NNS	_	12	nmod	_	_

#	Gilenya	2939
1	DRUG	_	NOUN	NN	_	4	compound	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	DRUG	_	NOUN	NN	_	1	conj	_	_
4	phosphate	_	NOUN	NN	_	7	nsubjpass	_	_
5	are	_	VERB	VBP	_	7	auxpass	_	_
6	not	_	ADV	RB	_	7	neg	_	_
7	excreted	_	VERB	VBN	_	0	root	_	_
8	intact	_	ADJ	JJ	_	7	xcomp	_	_
9	in	_	ADP	IN	_	10	case	_	_
10	urine	_	ADJ	JJ	_	8	nmod	_	_
11	but	_	CONJ	CC	_	7	cc	_	_
12	are	_	VERB	VBP	_	15	cop	_	_
13	the	_	DET	DT	_	15	det	_	_
14	major	_	ADJ	JJ	_	15	amod	_	_
15	components	_	NOUN	NNS	_	7	conj	_	_
16	in	_	ADP	IN	_	18	case	_	_
17	the	_	DET	DT	_	18	det	_	_
18	feces	_	NOUN	NNS	_	15	nmod	_	_
19	with	_	ADP	IN	_	20	case	_	_
20	amounts	_	NOUN	NNS	_	18	nmod	_	_
21	of	_	ADP	IN	_	23	case	_	_
22	each	_	DET	DT	_	23	det	_	_
23	representing	_	VERB	VBG	_	20	nmod	_	_
24	less	_	ADV	RB	_	26	advmod	_	_
25	than	_	ADP	IN	_	26	case	_	_
26	2.5%	_	NOUN	NN	_	23	nmod	_	_
27	of	_	ADP	IN	_	29	case	_	_
28	the	_	DET	DT	_	29	det	_	_
29	dose	_	NOUN	NN	_	26	nmod	_	_

#	Gilenya	2940
1	Specific	_	ADJ	JJ	_	2	amod	_	_
2	Populations	_	NOUN	NNS	_	14	nsubj	_	_
3	Geriatric	_	ADJ	JJ	_	4	amod	_	_
4	Patients	_	NOUN	NNS	_	2	dep	_	_
5	The	_	DET	DT	_	6	det	_	_
6	mechanism	_	NOUN	NN	_	4	dep	_	_
7	for	_	ADP	IN	_	8	case	_	_
8	elimination	_	NOUN	NN	_	6	nmod	_	_
9	and	_	CONJ	CC	_	6	cc	_	_
10	results	_	NOUN	NNS	_	6	conj	_	_
11	from	_	ADP	IN	_	13	case	_	_
12	population	_	NOUN	NN	_	13	compound	_	_
13	pharmacokinetics	_	NOUN	NNS	_	10	nmod	_	_
14	suggest	_	VERB	VBP	_	0	root	_	_
15	that	_	ADP	IN	_	21	mark	_	_
16	dose	_	NOUN	NN	_	17	compound	_	_
17	adjustment	_	NOUN	NN	_	21	nsubj	_	_
18	would	_	VERB	MD	_	21	aux	_	_
19	not	_	ADV	RB	_	21	neg	_	_
20	be	_	VERB	VB	_	21	cop	_	_
21	necessary	_	ADJ	JJ	_	14	ccomp	_	_
22	in	_	ADP	IN	_	24	case	_	_
23	elderly	_	ADJ	JJ	_	24	amod	_	_
24	patients	_	NOUN	NNS	_	21	nmod	_	_

#	Gilenya	2941
1	However	_	ADV	RB	_	12	advmod	_	_
2	,	_	.	,	_	12	punct	_	_
3	clinical	_	ADJ	JJ	_	4	amod	_	_
4	experience	_	NOUN	NN	_	12	nsubj	_	_
5	in	_	ADP	IN	_	6	case	_	_
6	patients	_	NOUN	NNS	_	4	nmod	_	_
7	aged	_	ADJ	JJ	_	6	amod	_	_
8	above	_	ADP	IN	_	10	case	_	_
9	65	_	NUM	CD	_	10	nummod	_	_
10	years	_	NOUN	NNS	_	7	nmod	_	_
11	is	_	VERB	VBZ	_	12	auxpass	_	_
12	limited	_	ADJ	JJ	_	0	root	_	_

#	Gilenya	2942
1	Gender	_	NOUN	NN	_	2	compound	_	_
2	Gender	_	NOUN	NN	_	3	nsubj	_	_
3	has	_	VERB	VBZ	_	0	root	_	_
4	no	_	DET	DT	_	7	neg	_	_
5	clinically	_	ADV	RB	_	6	advmod	_	_
6	significant	_	ADJ	JJ	_	7	amod	_	_
7	influence	_	NOUN	NN	_	3	dobj	_	_
8	on	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	DRUG	_	NOUN	NN	_	13	compound	_	_
12	phosphate	_	NOUN	NN	_	13	compound	_	_
13	pharmacokinetics	_	NOUN	NNS	_	9	conj	_	_

#	Gilenya	2943
1	Race	_	ADV	RB	_	15	advmod	_	_
2	The	_	DET	DT	_	3	det	_	_
3	effects	_	NOUN	NNS	_	15	nsubjpass	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	race	_	NOUN	NN	_	3	nmod	_	_
6	on	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	3	nmod	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	DRUG	_	NOUN	NN	_	11	compound	_	_
10	phosphate	_	NOUN	NN	_	11	compound	_	_
11	pharmacokinetics	_	NOUN	NNS	_	7	conj	_	_
12	cannot	_	NOUN	NN	_	7	dep	_	_
13	be	_	VERB	VBZ	_	15	auxpass	_	_
14	adequately	_	ADV	RB	_	15	advmod	_	_
15	assessed	_	VERB	VBN	_	0	root	_	_
16	due	_	ADJ	JJ	_	20	case	_	_
17	to	_	PRT	TO	_	16	mwe	_	_
18	a	_	DET	DT	_	20	det	_	_
19	low	_	ADJ	JJ	_	20	amod	_	_
20	number	_	NOUN	NN	_	15	nmod	_	_
21	of	_	ADP	IN	_	24	case	_	_
22	non	_	ADJ	JJ	_	24	amod	_	_
23	white	_	ADJ	JJ	_	24	amod	_	_
24	patients	_	NOUN	NNS	_	20	nmod	_	_
25	in	_	ADP	IN	_	28	case	_	_
26	the	_	DET	DT	_	28	det	_	_
27	clinical	_	ADJ	JJ	_	28	amod	_	_
28	program	_	NOUN	NN	_	24	nmod	_	_

#	Gilenya	2944
1	Renal	_	ADJ	JJ	_	2	amod	_	_
2	Impairment	_	NOUN	NN	_	15	nsubjpass	_	_
3	In	_	ADP	IN	_	4	case	_	_
4	patients	_	NOUN	NNS	_	2	nmod	_	_
5	with	_	ADP	IN	_	8	case	_	_
6	severe	_	ADJ	JJ	_	8	amod	_	_
7	renal	_	ADJ	JJ	_	8	amod	_	_
8	impairment	_	NOUN	NN	_	4	nmod	_	_
9	,	_	.	,	_	2	punct	_	_
10	DRUG	_	NOUN	NN	_	11	compound	_	_
11	Cmax	_	NOUN	NN	_	2	appos	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	AUC	_	NOUN	NN	_	11	conj	_	_
14	are	_	VERB	VBP	_	15	auxpass	_	_
15	increased	_	VERB	VBN	_	0	root	_	_
16	by	_	ADP	IN	_	17	case	_	_
17	32%	_	ADJ	JJ	_	15	nmod	_	_
18	and	_	CONJ	CC	_	17	cc	_	_
19	43%	_	ADJ	JJ	_	17	conj	_	_
20	,	_	.	,	_	17	punct	_	_
21	respectively	_	ADV	RB	_	17	advmod	_	_
22	,	_	.	,	_	17	punct	_	_
23	and	_	CONJ	CC	_	17	cc	_	_
24	DRUG	_	NOUN	NN	_	25	compound	_	_
25	phosphate	_	NOUN	NN	_	17	conj	_	_
26	Cmax	_	NOUN	NN	_	17	dep	_	_
27	and	_	CONJ	CC	_	26	cc	_	_
28	AUC	_	NOUN	NN	_	26	conj	_	_
29	are	_	VERB	VBP	_	30	auxpass	_	_
30	increased	_	VERB	VBN	_	15	parataxis	_	_
31	by	_	ADP	IN	_	32	case	_	_
32	25%	_	NOUN	NN	_	30	nmod	_	_
33	and	_	CONJ	CC	_	32	cc	_	_
34	14%	_	NOUN	NN	_	32	conj	_	_
35	,	_	.	,	_	30	punct	_	_
36	respectively	_	ADV	RB	_	30	advmod	_	_
37	,	_	.	,	_	30	punct	_	_
38	with	_	ADP	IN	_	40	case	_	_
39	no	_	DET	DT	_	40	neg	_	_
40	change	_	NOUN	NN	_	30	nmod	_	_
41	in	_	ADP	IN	_	45	case	_	_
42	apparent	_	ADJ	JJ	_	45	amod	_	_
43	elimination	_	NOUN	NN	_	45	compound	_	_
44	half	_	NOUN	NN	_	45	compound	_	_
45	life	_	NOUN	NN	_	40	nmod	_	_

#	Gilenya	2945
1	Based	_	VERB	VBN	_	12	advcl	_	_
2	on	_	ADP	IN	_	4	case	_	_
3	these	_	DET	DT	_	4	det	_	_
4	findings	_	NOUN	NNS	_	1	nmod	_	_
5	,	_	.	,	_	12	punct	_	_
6	the	_	DET	DT	_	10	det	_	_
7	DRUG	_	NOUN	NN	_	10	compound	_	_
8	0.5	_	NUM	CD	_	10	nummod	_	_
9	mg	_	NOUN	NN	_	10	compound	_	_
10	dose	_	NOUN	NN	_	12	nsubj	_	_
11	is	_	VERB	VBZ	_	12	cop	_	_
12	appropriate	_	ADJ	JJ	_	0	root	_	_
13	for	_	ADP	IN	_	14	case	_	_
14	use	_	NOUN	NN	_	12	nmod	_	_
15	in	_	ADP	IN	_	16	case	_	_
16	patients	_	NOUN	NNS	_	14	nmod	_	_
17	with	_	ADP	IN	_	19	case	_	_
18	renal	_	ADJ	JJ	_	19	amod	_	_
19	impairment	_	NOUN	NN	_	16	nmod	_	_

#	Gilenya	2946
1	The	_	DET	DT	_	3	det	_	_
2	systemic	_	ADJ	JJ	_	3	amod	_	_
3	exposure	_	NOUN	NN	_	11	nsubjpass	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	2	_	NUM	CD	_	6	nummod	_	_
6	metabolites	_	NOUN	NNS	_	3	nmod	_	_
7	M2	_	NOUN	NN	_	6	dep	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	M3	_	NOUN	NN	_	7	conj	_	_
10	is	_	VERB	VBZ	_	11	auxpass	_	_
11	increased	_	VERB	VBN	_	0	root	_	_
12	by	_	ADP	IN	_	16	case	_	_
13	3	_	NUM	CD	_	16	nummod	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	13	_	NUM	CD	_	13	conj	_	_
16	fold	_	NOUN	NN	_	11	nmod	_	_
17	,	_	.	,	_	11	punct	_	_
18	respectively	_	ADV	RB	_	11	advmod	_	_

#	Gilenya	2947
1	The	_	DET	DT	_	2	det	_	_
2	toxicity	_	NOUN	NN	_	10	nsubjpass	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	these	_	DET	DT	_	5	det	_	_
5	metabolites	_	NOUN	NNS	_	2	nmod	_	_
6	has	_	VERB	VBZ	_	10	aux	_	_
7	not	_	ADV	RB	_	10	neg	_	_
8	been	_	VERB	VBN	_	10	auxpass	_	_
9	fully	_	ADV	RB	_	10	advmod	_	_
10	characterized	_	VERB	VBN	_	0	root	_	_

#	Gilenya	2948
1	A	_	DET	DT	_	2	det	_	_
2	study	_	NOUN	NN	_	14	nsubjpass	_	_
3	in	_	ADP	IN	_	4	case	_	_
4	patients	_	NOUN	NNS	_	2	nmod	_	_
5	with	_	ADP	IN	_	10	case	_	_
6	mild	_	ADJ	JJ	_	10	amod	_	_
7	or	_	CONJ	CC	_	6	cc	_	_
8	moderate	_	ADJ	JJ	_	6	conj	_	_
9	renal	_	ADJ	JJ	_	10	amod	_	_
10	impairment	_	NOUN	NN	_	4	nmod	_	_
11	has	_	VERB	VBZ	_	14	aux	_	_
12	not	_	ADV	RB	_	14	neg	_	_
13	been	_	VERB	VBN	_	14	auxpass	_	_
14	conducted	_	VERB	VBN	_	0	root	_	_

#	Gilenya	2949
1	Hepatic	_	ADJ	JJ	_	2	amod	_	_
2	Impairment	_	NOUN	NN	_	37	nsubjpass	_	_
3	In	_	ADP	IN	_	4	case	_	_
4	subjects	_	NOUN	NNS	_	2	nmod	_	_
5	with	_	ADP	IN	_	17	case	_	_
6	mild	_	ADJ	JJ	_	17	amod	_	_
7	,	_	.	,	_	6	punct	_	_
8	moderate	_	ADJ	JJ	_	6	conj	_	_
9	,	_	.	,	_	6	punct	_	_
10	or	_	CONJ	CC	_	6	cc	_	_
11	severe	_	ADJ	JJ	_	6	conj	_	_
12	hepatic	_	ADJ	JJ	_	17	amod	_	_
13	impairment	_	NOUN	NN	_	17	compound	_	_
14	Child	_	NOUN	NN	_	17	compound	_	_
15	Pugh	_	NOUN	NN	_	17	compound	_	_
16	class	_	NOUN	NN	_	17	compound	_	_
17	A	_	NOUN	NN	_	4	nmod	_	_
18	,	_	.	,	_	17	punct	_	_
19	B	_	NOUN	NN	_	17	conj	_	_
20	,	_	.	,	_	17	punct	_	_
21	and	_	CONJ	CC	_	17	cc	_	_
22	C	_	NOUN	NN	_	17	conj	_	_
23	,	_	.	,	_	2	punct	_	_
24	no	_	DET	DT	_	25	neg	_	_
25	change	_	NOUN	NN	_	30	nsubjpass	_	_
26	in	_	ADP	IN	_	28	case	_	_
27	DRUG	_	NOUN	NN	_	28	compound	_	_
28	Cmax	_	NOUN	NN	_	25	nmod	_	_
29	was	_	VERB	VBD	_	30	auxpass	_	_
30	observed	_	VERB	VBN	_	2	conj	_	_
31	,	_	.	,	_	2	punct	_	_
32	but	_	CONJ	CC	_	2	cc	_	_
33	DRUG	_	NOUN	NN	_	34	compound	_	_
34	AUC0	_	NOUN	NN	_	2	conj	_	_
35	*	_	NUM	CD	_	34	nummod	_	_
36	was	_	VERB	VBD	_	37	auxpass	_	_
37	increased	_	VERB	VBN	_	0	root	_	_
38	respectively	_	ADV	RB	_	37	advmod	_	_
39	by	_	ADP	IN	_	40	case	_	_
40	12%	_	ADJ	JJ	_	37	nmod	_	_
41	,	_	.	,	_	40	punct	_	_
42	44%	_	ADJ	JJ	_	40	conj	_	_
43	,	_	.	,	_	40	punct	_	_
44	and	_	CONJ	CC	_	40	cc	_	_
45	103%	_	ADJ	JJ	_	40	conj	_	_

#	Gilenya	2950
1	In	_	ADP	IN	_	2	case	_	_
2	patients	_	NOUN	NNS	_	16	nmod	_	_
3	with	_	ADP	IN	_	10	case	_	_
4	severe	_	ADJ	JJ	_	10	amod	_	_
5	hepatic	_	ADJ	JJ	_	10	amod	_	_
6	impairment	_	NOUN	NN	_	10	compound	_	_
7	Child	_	NOUN	NN	_	10	compound	_	_
8	Pugh	_	NOUN	NN	_	10	compound	_	_
9	class	_	NOUN	NN	_	10	compound	_	_
10	C	_	NOUN	NN	_	2	nmod	_	_
11	,	_	.	,	_	16	punct	_	_
12	DRUG	_	NOUN	NN	_	14	compound	_	_
13	phosphate	_	NOUN	NN	_	14	compound	_	_
14	Cmax	_	NOUN	NN	_	16	nsubjpass	_	_
15	was	_	VERB	VBD	_	16	auxpass	_	_
16	decreased	_	VERB	VBN	_	0	root	_	_
17	by	_	ADP	IN	_	24	mark	_	_
18	22%	_	ADJ	JJ	_	24	nsubjpass	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	AUC0	_	NOUN	NN	_	22	compound	_	_
21	96	_	NUM	CD	_	22	nummod	_	_
22	hours	_	NOUN	NNS	_	18	conj	_	_
23	was	_	VERB	VBD	_	24	auxpass	_	_
24	decreased	_	VERB	VBN	_	16	ccomp	_	_
25	by	_	ADP	IN	_	26	case	_	_
26	29%	_	ADJ	JJ	_	24	nmod	_	_

#	Gilenya	2951
1	The	_	DET	DT	_	2	det	_	_
2	pharmacokinetics	_	NOUN	NNS	_	8	nsubjpass	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	DRUG	_	NOUN	NN	_	5	compound	_	_
5	phosphate	_	NOUN	NN	_	2	nmod	_	_
6	was	_	VERB	VBD	_	8	auxpass	_	_
7	not	_	ADV	RB	_	8	neg	_	_
8	evaluated	_	VERB	VBN	_	0	root	_	_
9	in	_	ADP	IN	_	10	case	_	_
10	patients	_	NOUN	NNS	_	8	nmod	_	_
11	with	_	ADP	IN	_	16	case	_	_
12	mild	_	ADJ	JJ	_	16	amod	_	_
13	or	_	CONJ	CC	_	12	cc	_	_
14	moderate	_	ADJ	JJ	_	12	conj	_	_
15	hepatic	_	ADJ	JJ	_	16	amod	_	_
16	impairment	_	NOUN	NN	_	10	nmod	_	_

#	Gilenya	2952
1	The	_	DET	DT	_	5	det	_	_
2	apparent	_	ADJ	JJ	_	5	amod	_	_
3	elimination	_	NOUN	NN	_	5	compound	_	_
4	half	_	NOUN	NN	_	5	compound	_	_
5	life	_	NOUN	NN	_	9	nsubj	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	is	_	VERB	VBZ	_	9	cop	_	_
9	unchanged	_	ADJ	JJ	_	0	root	_	_
10	in	_	ADP	IN	_	11	case	_	_
11	subjects	_	NOUN	NNS	_	9	nmod	_	_
12	with	_	ADP	IN	_	15	case	_	_
13	mild	_	ADJ	JJ	_	15	amod	_	_
14	hepatic	_	ADJ	JJ	_	15	amod	_	_
15	impairment	_	NOUN	NN	_	11	nmod	_	_
16	,	_	.	,	_	9	punct	_	_
17	but	_	CONJ	CC	_	9	cc	_	_
18	is	_	VERB	VBZ	_	19	auxpass	_	_
19	prolonged	_	VERB	VBN	_	9	conj	_	_
20	by	_	ADP	IN	_	22	case	_	_
21	about	_	ADV	RB	_	22	advmod	_	_
22	50%	_	NOUN	NN	_	19	nmod	_	_
23	in	_	ADP	IN	_	24	case	_	_
24	patients	_	NOUN	NNS	_	22	nmod	_	_
25	with	_	ADP	IN	_	30	case	_	_
26	moderate	_	ADJ	JJ	_	30	amod	_	_
27	or	_	CONJ	CC	_	26	cc	_	_
28	severe	_	ADJ	JJ	_	26	conj	_	_
29	hepatic	_	ADJ	JJ	_	30	amod	_	_
30	impairment	_	NOUN	NN	_	24	nmod	_	_

#	Gilenya	2953
1	Patients	_	NOUN	NNS	_	13	nsubjpass	_	_
2	with	_	ADP	IN	_	9	case	_	_
3	severe	_	ADJ	JJ	_	9	amod	_	_
4	hepatic	_	ADJ	JJ	_	9	amod	_	_
5	impairment	_	NOUN	NN	_	9	compound	_	_
6	Child	_	NOUN	NN	_	9	compound	_	_
7	Pugh	_	NOUN	NN	_	9	compound	_	_
8	class	_	NOUN	NN	_	9	compound	_	_
9	C	_	NOUN	NN	_	1	nmod	_	_
10	should	_	VERB	MD	_	13	aux	_	_
11	be	_	VERB	VB	_	13	auxpass	_	_
12	closely	_	ADV	RB	_	13	advmod	_	_
13	monitored	_	VERB	VBN	_	0	root	_	_
14	,	_	.	,	_	13	punct	_	_
15	as	_	ADP	IN	_	22	mark	_	_
16	the	_	DET	DT	_	17	det	_	_
17	risk	_	NOUN	NN	_	22	nsubj	_	_
18	of	_	ADP	IN	_	20	case	_	_
19	adverse	_	ADJ	JJ	_	20	amod	_	_
20	reactions	_	NOUN	NNS	_	17	nmod	_	_
21	is	_	VERB	VBZ	_	22	auxpass	_	_
22	greater	_	ADJ	JJ	_	13	advcl	_	_

#	Gilenya	2954
1	No	_	DET	DT	_	3	neg	_	_
2	dose	_	NOUN	NN	_	3	compound	_	_
3	adjustment	_	NOUN	NN	_	5	nsubjpass	_	_
4	is	_	VERB	VBZ	_	5	auxpass	_	_
5	needed	_	VERB	VBN	_	0	root	_	_
6	in	_	ADP	IN	_	7	case	_	_
7	patients	_	NOUN	NNS	_	5	nmod	_	_
8	with	_	ADP	IN	_	17	case	_	_
9	mild	_	ADJ	JJ	_	17	amod	_	_
10	or	_	CONJ	CC	_	9	cc	_	_
11	moderate	_	ADJ	JJ	_	9	conj	_	_
12	hepatic	_	ADJ	JJ	_	17	amod	_	_
13	impairment	_	NOUN	NN	_	17	compound	_	_
14	Child	_	NOUN	NN	_	17	compound	_	_
15	Pugh	_	NOUN	NN	_	17	compound	_	_
16	class	_	NOUN	NN	_	17	compound	_	_
17	A	_	NOUN	NN	_	7	nmod	_	_
18	and	_	CONJ	CC	_	17	cc	_	_
19	B	_	NOUN	NN	_	17	conj	_	_

#	Gilenya	2955
1	Drug	_	NOUN	NN	_	2	compound	_	_
2	Interactions	_	NOUN	NNS	_	3	nsubj	_	_
3	Ketoconazole	_	VERB	VBP	_	0	root	_	_
4	The	_	DET	DT	_	5	det	_	_
5	coadministration	_	NOUN	NN	_	3	dobj	_	_
6	of	_	ADP	IN	_	10	case	_	_
7	ketoconazole	_	NOUN	NN	_	10	compound	_	_
8	a	_	DET	DT	_	10	det	_	_
9	potent	_	ADJ	JJ	_	10	amod	_	_
10	inhibitor	_	NOUN	NN	_	5	nmod	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	CYP3A	_	NOUN	NN	_	10	nmod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	CYP4F	_	NOUN	NN	_	16	compound	_	_
15	200	_	NUM	CD	_	16	nummod	_	_
16	mg	_	NOUN	NN	_	12	conj	_	_
17	twice	_	ADV	RB	_	18	advmod	_	_
18	daily	_	ADV	RB	_	3	advmod	_	_
19	at	_	ADP	IN	_	21	case	_	_
20	steady	_	ADJ	JJ	_	21	amod	_	_
21	state	_	NOUN	NN	_	18	nmod	_	_
22	and	_	CONJ	CC	_	18	cc	_	_
23	a	_	DET	DT	_	25	det	_	_
24	single	_	ADJ	JJ	_	25	amod	_	_
25	dose	_	NOUN	NN	_	30	nsubj	_	_
26	of	_	ADP	IN	_	29	case	_	_
27	DRUG	_	NOUN	NN	_	29	compound	_	_
28	5	_	NUM	CD	_	29	nummod	_	_
29	mg	_	NOUN	NN	_	25	nmod	_	_
30	led	_	VERB	VBD	_	18	conj	_	_
31	to	_	PRT	TO	_	34	case	_	_
32	a	_	DET	DT	_	34	det	_	_
33	70%	_	ADJ	JJ	_	34	amod	_	_
34	increase	_	NOUN	NN	_	30	nmod	_	_
35	in	_	ADP	IN	_	36	case	_	_
36	AUC	_	NOUN	NN	_	34	nmod	_	_
37	of	_	ADP	IN	_	38	case	_	_
38	DRUG	_	NOUN	NN	_	36	nmod	_	_
39	and	_	CONJ	CC	_	38	cc	_	_
40	DRUG	_	NOUN	NN	_	41	compound	_	_
41	phosphate	_	NOUN	NN	_	38	conj	_	_

#	Gilenya	2956
1	Patients	_	NOUN	NNS	_	12	nsubjpass	_	_
2	who	_	DET	WDT	_	3	nsubj	_	_
3	use	_	VERB	VBP	_	1	acl:relcl	_	_
4	DRUG	_	NOUN	NN	_	3	dobj	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	systemic	_	ADJ	JJ	_	7	amod	_	_
7	ketoconazole	_	NOUN	NN	_	4	conj	_	_
8	concomitantly	_	ADV	RB	_	12	advmod	_	_
9	should	_	VERB	MD	_	12	aux	_	_
10	be	_	VERB	VB	_	12	auxpass	_	_
11	closely	_	ADV	RB	_	12	advmod	_	_
12	monitored	_	VERB	VBN	_	0	root	_	_
13	,	_	.	,	_	12	punct	_	_
14	as	_	ADP	IN	_	21	mark	_	_
15	the	_	DET	DT	_	16	det	_	_
16	risk	_	NOUN	NN	_	21	nsubj	_	_
17	of	_	ADP	IN	_	19	case	_	_
18	adverse	_	ADJ	JJ	_	19	amod	_	_
19	reactions	_	NOUN	NNS	_	16	nmod	_	_
20	is	_	VERB	VBZ	_	21	auxpass	_	_
21	greater	_	ADJ	JJ	_	12	advcl	_	_

#	Gilenya	2957
1	Carbamazepine	_	NOUN	NN	_	3	compound	_	_
2	The	_	DET	DT	_	3	det	_	_
3	coadministration	_	NOUN	NN	_	0	root	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	carbamazepine	_	NOUN	NN	_	3	nmod	_	_
6	a	_	DET	DT	_	9	det	_	_
7	potent	_	ADJ	JJ	_	9	amod	_	_
8	CYP450	_	NOUN	NN	_	9	compound	_	_
9	enzyme	_	NOUN	NN	_	10	nsubj	_	_
10	inducer	_	VERB	VBP	_	3	dep	_	_
11	600	_	NUM	CD	_	12	nummod	_	_
12	mg	_	NOUN	NN	_	10	dobj	_	_
13	twice	_	ADV	RB	_	14	advmod	_	_
14	daily	_	ADV	RB	_	10	advmod	_	_
15	at	_	ADP	IN	_	17	case	_	_
16	steady	_	ADJ	JJ	_	17	amod	_	_
17	state	_	NOUN	NN	_	14	nmod	_	_
18	and	_	CONJ	CC	_	14	cc	_	_
19	a	_	DET	DT	_	21	det	_	_
20	single	_	ADJ	JJ	_	21	amod	_	_
21	dose	_	NOUN	NN	_	26	nsubj	_	_
22	of	_	ADP	IN	_	25	case	_	_
23	DRUG	_	NOUN	NN	_	25	compound	_	_
24	2	_	NUM	CD	_	25	nummod	_	_
25	mg	_	NOUN	NN	_	21	nmod	_	_
26	decreased	_	VERB	VBD	_	14	conj	_	_
27	blood	_	NOUN	NN	_	28	compound	_	_
28	concentrations	_	NOUN	NNS	_	29	compound	_	_
29	AUC	_	NOUN	NN	_	26	dobj	_	_
30	of	_	ADP	IN	_	31	case	_	_
31	DRUG	_	NOUN	NN	_	29	nmod	_	_
32	and	_	CONJ	CC	_	31	cc	_	_
33	DRUG	_	NOUN	NN	_	34	compound	_	_
34	phosphate	_	NOUN	NN	_	31	conj	_	_
35	by	_	ADP	IN	_	37	case	_	_
36	approximately	_	ADV	RB	_	37	advmod	_	_
37	40%	_	ADJ	JJ	_	29	nmod	_	_

#	Gilenya	2958
1	The	_	DET	DT	_	3	det	_	_
2	clinical	_	ADJ	JJ	_	3	amod	_	_
3	impact	_	NOUN	NN	_	8	nsubj	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	this	_	DET	DT	_	6	det	_	_
6	decrease	_	NOUN	NN	_	3	nmod	_	_
7	is	_	VERB	VBZ	_	8	auxpass	_	_
8	unknown	_	ADJ	JJ	_	0	root	_	_

#	Gilenya	2959
1	Other	_	ADJ	JJ	_	5	amod	_	_
2	strong	_	ADJ	JJ	_	5	amod	_	_
3	CYP450	_	NOUN	NN	_	5	compound	_	_
4	enzyme	_	NOUN	NN	_	5	compound	_	_
5	inducers	_	NOUN	NNS	_	18	nsubj	_	_
6	,	_	.	,	_	5	punct	_	_
7	e.g	_	NOUN	NN	_	5	appos	_	_
8	,	_	.	,	_	7	punct	_	_
9	rifampicin	_	NOUN	NN	_	7	conj	_	_
10	,	_	.	,	_	7	punct	_	_
11	phenytoin	_	NOUN	NN	_	7	conj	_	_
12	,	_	.	,	_	7	punct	_	_
13	phenobarbital	_	ADJ	JJ	_	7	conj	_	_
14	,	_	.	,	_	7	punct	_	_
15	and	_	CONJ	CC	_	7	cc	_	_
16	St	_	NOUN	NN	_	7	conj	_	_
17	John's	_	NOUN	NNS	_	7	dep	_	_
18	wort	_	VERB	VBP	_	0	root	_	_
19	,	_	.	,	_	18	punct	_	_
20	may	_	VERB	MD	_	22	aux	_	_
21	also	_	ADV	RB	_	22	advmod	_	_
22	reduce	_	VERB	VB	_	18	parataxis	_	_
23	AUC	_	NOUN	NN	_	22	dobj	_	_
24	of	_	ADP	IN	_	25	case	_	_
25	DRUG	_	NOUN	NN	_	23	nmod	_	_
26	and	_	CONJ	CC	_	25	cc	_	_
27	DRUG	_	NOUN	NN	_	28	compound	_	_
28	phosphate	_	NOUN	NN	_	25	conj	_	_

#	Gilenya	2960
1	The	_	DET	DT	_	3	det	_	_
2	clinical	_	ADJ	JJ	_	3	amod	_	_
3	impact	_	NOUN	NN	_	9	nsubj	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	this	_	DET	DT	_	7	det	_	_
6	potential	_	ADJ	JJ	_	7	amod	_	_
7	decrease	_	NOUN	NN	_	3	nmod	_	_
8	is	_	VERB	VBZ	_	9	auxpass	_	_
9	unknown	_	ADJ	JJ	_	0	root	_	_

#	Gilenya	2961
1	Potential	_	NOUN	NN	_	27	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	and	_	CONJ	CC	_	3	cc	_	_
5	DRUG	_	NOUN	NN	_	3	conj	_	_
6	phosphate	_	NOUN	NN	_	3	dep	_	_
7	to	_	PRT	TO	_	8	mark	_	_
8	Inhibit	_	VERB	VB	_	1	acl	_	_
9	the	_	DET	DT	_	10	det	_	_
10	Metabolism	_	NOUN	NN	_	8	dobj	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	Comedications	_	NOUN	NNS	_	10	nmod	_	_
13	In	_	X	FW	_	16	amod	_	_
14	vitro	_	X	FW	_	13	dep	_	_
15	inhibition	_	NOUN	NN	_	16	compound	_	_
16	studies	_	NOUN	NNS	_	10	nmod	_	_
17	using	_	VERB	VBG	_	16	acl	_	_
18	pooled	_	VERB	VBN	_	21	amod	_	_
19	human	_	ADJ	JJ	_	21	amod	_	_
20	liver	_	NOUN	NN	_	21	compound	_	_
21	microsomes	_	NOUN	NNS	_	17	dobj	_	_
22	and	_	CONJ	CC	_	21	cc	_	_
23	specific	_	ADJ	JJ	_	26	amod	_	_
24	metabolic	_	ADJ	JJ	_	26	amod	_	_
25	probe	_	NOUN	NN	_	26	compound	_	_
26	substrates	_	NOUN	NNS	_	21	conj	_	_
27	demonstrate	_	VERB	VBP	_	0	root	_	_
28	that	_	ADP	IN	_	30	mark	_	_
29	DRUG	_	NOUN	NN	_	30	nsubj	_	_
30	has	_	VERB	VBZ	_	27	ccomp	_	_
31	little	_	ADJ	JJ	_	34	amod	_	_
32	or	_	CONJ	CC	_	31	cc	_	_
33	no	_	DET	DT	_	31	conj	_	_
34	capacity	_	NOUN	NN	_	30	dobj	_	_
35	to	_	PRT	TO	_	36	mark	_	_
36	inhibit	_	VERB	VB	_	30	xcomp	_	_
37	the	_	DET	DT	_	38	det	_	_
38	activity	_	NOUN	NN	_	36	dobj	_	_
39	of	_	ADP	IN	_	43	case	_	_
40	the	_	DET	DT	_	43	det	_	_
41	following	_	VERB	VBG	_	43	amod	_	_
42	CYP	_	NOUN	NN	_	43	compound	_	_
43	enzymes	_	NOUN	NNS	_	38	nmod	_	_
44	:	_	.	:	_	30	punct	_	_
45	CYP1A2	_	NOUN	NN	_	76	nsubj	_	_
46	,	_	.	,	_	45	punct	_	_
47	CYP2A6	_	NOUN	NN	_	45	conj	_	_
48	,	_	.	,	_	45	punct	_	_
49	CYP2B6	_	NOUN	NN	_	45	conj	_	_
50	,	_	.	,	_	45	punct	_	_
51	CYP2C8	_	NOUN	NN	_	45	conj	_	_
52	,	_	.	,	_	45	punct	_	_
53	CYP2C9	_	NOUN	NN	_	45	conj	_	_
54	,	_	.	,	_	45	punct	_	_
55	CYP2C19	_	NOUN	NN	_	45	conj	_	_
56	,	_	.	,	_	45	punct	_	_
57	CYP2D6	_	NOUN	NN	_	45	conj	_	_
58	,	_	.	,	_	45	punct	_	_
59	CYP2E1	_	NOUN	NN	_	45	conj	_	_
60	,	_	.	,	_	45	punct	_	_
61	CYP3A4	_	NOUN	NN	_	45	conj	_	_
62	/	_	.	-RRB-	_	45	punct	_	_
63	5	_	NUM	CD	_	45	nummod	_	_
64	,	_	.	,	_	45	punct	_	_
65	or	_	CONJ	CC	_	45	cc	_	_
66	CYP4A9	_	NOUN	NN	_	45	conj	_	_
67	/	_	.	:	_	45	punct	_	_
68	11	_	NUM	CD	_	69	nummod	_	_
69	DRUG	_	NOUN	NN	_	45	conj	_	_
70	only	_	ADV	RB	_	69	advmod	_	_
71	,	_	.	,	_	45	punct	_	_
72	and	_	CONJ	CC	_	45	cc	_	_
73	similarly	_	ADV	RB	_	75	advmod	_	_
74	DRUG	_	NOUN	NN	_	75	compound	_	_
75	phosphate	_	NOUN	NN	_	45	conj	_	_
76	has	_	VERB	VBZ	_	30	parataxis	_	_
77	little	_	ADJ	JJ	_	80	amod	_	_
78	or	_	CONJ	CC	_	77	cc	_	_
79	no	_	DET	DT	_	77	conj	_	_
80	capacity	_	NOUN	NN	_	76	dobj	_	_
81	to	_	PRT	TO	_	82	mark	_	_
82	inhibit	_	VERB	VB	_	76	xcomp	_	_
83	the	_	DET	DT	_	84	det	_	_
84	activity	_	NOUN	NN	_	82	dobj	_	_
85	of	_	ADP	IN	_	86	case	_	_
86	CYP1A2	_	NOUN	NN	_	84	nmod	_	_
87	,	_	.	,	_	86	punct	_	_
88	CYP2A6	_	NOUN	NN	_	86	conj	_	_
89	,	_	.	,	_	86	punct	_	_
90	CYP2B6	_	NOUN	NN	_	86	conj	_	_
91	,	_	.	,	_	86	punct	_	_
92	CYP2C8	_	NOUN	NN	_	86	conj	_	_
93	,	_	.	,	_	86	punct	_	_
94	CYP2C9	_	NOUN	NN	_	86	conj	_	_
95	,	_	.	,	_	86	punct	_	_
96	CYP2C19	_	NOUN	NN	_	86	conj	_	_
97	,	_	.	,	_	86	punct	_	_
98	CYP2D6	_	NOUN	NN	_	86	conj	_	_
99	,	_	.	,	_	86	punct	_	_
100	CYP2E1	_	NOUN	NN	_	86	conj	_	_
101	,	_	.	,	_	86	punct	_	_
102	or	_	CONJ	CC	_	86	cc	_	_
103	CYP3A4	_	NOUN	NN	_	86	conj	_	_
104	at	_	ADP	IN	_	105	case	_	_
105	concentrations	_	NOUN	NNS	_	84	nmod	_	_
106	up	_	ADJ	JJ	_	108	advmod	_	_
107	to	_	PRT	TO	_	106	mwe	_	_
108	3	_	NUM	CD	_	109	nummod	_	_
109	orders	_	NOUN	NNS	_	82	nmod	_	_
110	of	_	ADP	IN	_	111	case	_	_
111	magnitude	_	NOUN	NN	_	109	nmod	_	_
112	of	_	ADP	IN	_	114	case	_	_
113	therapeutic	_	ADJ	JJ	_	114	amod	_	_
114	concentrations	_	NOUN	NNS	_	111	nmod	_	_

#	Gilenya	2962
1	Therefore	_	ADV	RB	_	8	advmod	_	_
2	,	_	.	,	_	8	punct	_	_
3	DRUG	_	NOUN	NN	_	6	compound	_	_
4	and	_	CONJ	CC	_	3	cc	_	_
5	DRUG	_	NOUN	NN	_	3	conj	_	_
6	phosphate	_	NOUN	NN	_	8	nsubj	_	_
7	are	_	VERB	VBP	_	8	cop	_	_
8	unlikely	_	ADJ	JJ	_	0	root	_	_
9	to	_	PRT	TO	_	10	mark	_	_
10	reduce	_	VERB	VB	_	8	xcomp	_	_
11	the	_	DET	DT	_	12	det	_	_
12	clearance	_	NOUN	NN	_	10	dobj	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	drugs	_	NOUN	NNS	_	12	nmod	_	_
15	that	_	DET	WDT	_	18	nsubjpass	_	_
16	are	_	VERB	VBP	_	18	auxpass	_	_
17	mainly	_	ADV	RB	_	18	advmod	_	_
18	cleared	_	VERB	VBN	_	14	acl:relcl	_	_
19	through	_	ADP	IN	_	20	case	_	_
20	metabolism	_	NOUN	NN	_	18	nmod	_	_
21	by	_	ADP	IN	_	25	case	_	_
22	the	_	DET	DT	_	25	det	_	_
23	major	_	ADJ	JJ	_	25	amod	_	_
24	CYP	_	NOUN	NN	_	25	compound	_	_
25	isoenzymes	_	NOUN	NNS	_	20	nmod	_	_
26	described	_	VERB	VBN	_	25	acl	_	_
27	above	_	ADV	RB	_	26	advmod	_	_

#	Gilenya	2963
1	Potential	_	NOUN	NN	_	20	nsubjpass	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	and	_	CONJ	CC	_	3	cc	_	_
5	DRUG	_	NOUN	NN	_	3	conj	_	_
6	phosphate	_	NOUN	NN	_	3	dep	_	_
7	to	_	PRT	TO	_	8	mark	_	_
8	Induce	_	VERB	VB	_	1	acl	_	_
9	its	_	PRON	PRP$	_	10	nmod:poss	_	_
10	Own	_	NOUN	NN	_	8	dobj	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	/	_	NOUN	NN	_	10	conj	_	_
13	or	_	CONJ	CC	_	10	cc	_	_
14	the	_	DET	DT	_	15	det	_	_
15	Metabolism	_	NOUN	NN	_	10	conj	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	Comedications	_	NOUN	NNS	_	15	nmod	_	_
18	DRUG	_	NOUN	NN	_	17	dep	_	_
19	was	_	VERB	VBD	_	20	auxpass	_	_
20	examined	_	VERB	VBN	_	0	root	_	_
21	for	_	ADP	IN	_	23	case	_	_
22	its	_	PRON	PRP$	_	23	nmod:poss	_	_
23	potential	_	NOUN	NN	_	20	nmod	_	_
24	to	_	PRT	TO	_	25	mark	_	_
25	induce	_	VERB	VB	_	23	acl	_	_
26	human	_	ADJ	JJ	_	27	amod	_	_
27	CYP3A4	_	NOUN	NN	_	25	dobj	_	_
28	,	_	.	,	_	27	punct	_	_
29	CYP1A2	_	NOUN	NN	_	27	conj	_	_
30	,	_	.	,	_	27	punct	_	_
31	CYP4F2	_	NOUN	NN	_	27	conj	_	_
32	,	_	.	,	_	27	punct	_	_
33	and	_	CONJ	CC	_	27	cc	_	_
34	MDR1	_	NOUN	NN	_	37	compound	_	_
35	P	_	NOUN	NN	_	37	compound	_	_
36	glycoprotein	_	NOUN	NN	_	37	compound	_	_
37	mRNA	_	NOUN	NN	_	27	conj	_	_
38	and	_	CONJ	CC	_	27	cc	_	_
39	CYP3A	_	NOUN	NN	_	27	conj	_	_
40	,	_	.	,	_	27	punct	_	_
41	CYP1A2	_	NOUN	NN	_	27	conj	_	_
42	,	_	.	,	_	27	punct	_	_
43	CYP2B6	_	NOUN	NN	_	27	conj	_	_
44	,	_	.	,	_	27	punct	_	_
45	CYP2C8	_	NOUN	NN	_	27	conj	_	_
46	,	_	.	,	_	27	punct	_	_
47	CYP2C9	_	NOUN	NN	_	27	conj	_	_
48	,	_	.	,	_	27	punct	_	_
49	CYP2C19	_	NOUN	NN	_	27	conj	_	_
50	,	_	.	,	_	27	punct	_	_
51	and	_	CONJ	CC	_	27	cc	_	_
52	CYP4F2	_	NOUN	NN	_	53	compound	_	_
53	activity	_	NOUN	NN	_	27	conj	_	_
54	in	_	ADP	IN	_	57	case	_	_
55	primary	_	ADJ	JJ	_	57	amod	_	_
56	human	_	ADJ	JJ	_	57	amod	_	_
57	hepatocytes	_	NOUN	NNS	_	27	nmod	_	_

#	Gilenya	2964
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	did	_	VERB	VBD	_	4	aux	_	_
3	not	_	ADV	RB	_	4	neg	_	_
4	induce	_	VERB	VB	_	0	root	_	_
5	mRNA	_	NOUN	NN	_	4	dobj	_	_
6	or	_	CONJ	CC	_	5	cc	_	_
7	activity	_	NOUN	NN	_	5	conj	_	_
8	of	_	ADP	IN	_	12	case	_	_
9	the	_	DET	DT	_	12	det	_	_
10	different	_	ADJ	JJ	_	12	amod	_	_
11	CYP	_	NOUN	NN	_	12	compound	_	_
12	enzymes	_	NOUN	NNS	_	5	nmod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	MDR1	_	NOUN	NN	_	12	conj	_	_
15	with	_	ADP	IN	_	16	case	_	_
16	respect	_	NOUN	NN	_	4	nmod	_	_
17	to	_	PRT	TO	_	20	case	_	_
18	the	_	DET	DT	_	20	det	_	_
19	vehicle	_	NOUN	NN	_	20	compound	_	_
20	control	_	NOUN	NN	_	16	nmod	_	_
21	therefore	_	ADV	RB	_	4	advmod	_	_
22	,	_	.	,	_	4	punct	_	_
23	no	_	DET	DT	_	26	neg	_	_
24	clinically	_	ADV	RB	_	25	advmod	_	_
25	relevant	_	ADJ	JJ	_	26	amod	_	_
26	induction	_	NOUN	NN	_	37	nsubjpass	_	_
27	of	_	ADP	IN	_	31	case	_	_
28	the	_	DET	DT	_	31	det	_	_
29	tested	_	VERB	VBN	_	31	amod	_	_
30	CYP	_	NOUN	NN	_	31	compound	_	_
31	enzymes	_	NOUN	NNS	_	26	nmod	_	_
32	or	_	CONJ	CC	_	31	cc	_	_
33	MDR1	_	NOUN	NN	_	31	conj	_	_
34	by	_	ADP	IN	_	35	case	_	_
35	DRUG	_	NOUN	NN	_	26	nmod	_	_
36	are	_	VERB	VBP	_	37	auxpass	_	_
37	expected	_	VERB	VBN	_	4	parataxis	_	_
38	at	_	ADP	IN	_	40	case	_	_
39	therapeutic	_	ADJ	JJ	_	40	amod	_	_
40	concentrations	_	NOUN	NNS	_	37	nmod	_	_

#	Gilenya	2965
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	phosphate	_	NOUN	NN	_	5	nsubjpass	_	_
3	was	_	VERB	VBD	_	5	auxpass	_	_
4	also	_	ADV	RB	_	5	advmod	_	_
5	examined	_	VERB	VBN	_	0	root	_	_
6	for	_	ADP	IN	_	8	case	_	_
7	its	_	PRON	PRP$	_	8	nmod:poss	_	_
8	potential	_	NOUN	NN	_	5	nmod	_	_
9	to	_	PRT	TO	_	10	mark	_	_
10	induce	_	VERB	VB	_	8	acl	_	_
11	mRNA	_	NOUN	NN	_	10	dobj	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	/	_	NOUN	NN	_	11	conj	_	_
14	or	_	CONJ	CC	_	11	cc	_	_
15	activity	_	NOUN	NN	_	11	conj	_	_
16	of	_	ADP	IN	_	18	case	_	_
17	human	_	ADJ	JJ	_	18	amod	_	_
18	CYP1A2	_	NOUN	NN	_	11	nmod	_	_
19	,	_	.	,	_	18	punct	_	_
20	CYP2B6	_	NOUN	NN	_	18	conj	_	_
21	,	_	.	,	_	18	punct	_	_
22	CYP2C8	_	NOUN	NN	_	18	conj	_	_
23	,	_	.	,	_	18	punct	_	_
24	CYP2C9	_	NOUN	NN	_	18	conj	_	_
25	,	_	.	,	_	18	punct	_	_
26	CYP2C19	_	NOUN	NN	_	18	conj	_	_
27	,	_	.	,	_	18	punct	_	_
28	CYP3A	_	NOUN	NN	_	18	conj	_	_
29	,	_	.	,	_	18	punct	_	_
30	CYP4F2	_	NOUN	NN	_	18	conj	_	_
31	,	_	.	,	_	18	punct	_	_
32	CYP4F3B	_	NOUN	NN	_	18	conj	_	_
33	,	_	.	,	_	18	punct	_	_
34	and	_	CONJ	CC	_	18	cc	_	_
35	CYP4F12	_	NOUN	NN	_	18	conj	_	_

#	Gilenya	2966
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	phosphate	_	NOUN	NN	_	5	nsubjpass	_	_
3	is	_	VERB	VBZ	_	5	auxpass	_	_
4	not	_	ADV	RB	_	5	neg	_	_
5	expected	_	VERB	VBN	_	0	root	_	_
6	to	_	PRT	TO	_	7	mark	_	_
7	have	_	VERB	VB	_	5	xcomp	_	_
8	clinically	_	ADV	RB	_	9	advmod	_	_
9	significant	_	ADJ	JJ	_	11	amod	_	_
10	induction	_	NOUN	NN	_	11	compound	_	_
11	effects	_	NOUN	NNS	_	7	dobj	_	_
12	on	_	ADP	IN	_	14	case	_	_
13	these	_	DET	DT	_	14	det	_	_
14	enzymes	_	NOUN	NNS	_	7	nmod	_	_
15	at	_	ADP	IN	_	17	case	_	_
16	therapeutic	_	ADJ	JJ	_	17	amod	_	_
17	dose	_	NOUN	NN	_	14	nmod	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	DRUG	_	NOUN	NN	_	17	nmod	_	_

#	Gilenya	2967
1	In	_	X	FW	_	3	amod	_	_
2	vitro	_	X	FW	_	1	dep	_	_
3	experiments	_	NOUN	NNS	_	6	nsubj	_	_
4	did	_	VERB	VBD	_	6	aux	_	_
5	not	_	ADV	RB	_	6	neg	_	_
6	provide	_	VERB	VB	_	0	root	_	_
7	an	_	DET	DT	_	8	det	_	_
8	indication	_	NOUN	NN	_	6	dobj	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	CYP	_	NOUN	NN	_	11	compound	_	_
11	induction	_	NOUN	NN	_	8	nmod	_	_
12	by	_	ADP	IN	_	14	case	_	_
13	DRUG	_	NOUN	NN	_	14	compound	_	_
14	phosphate	_	NOUN	NN	_	8	nmod	_	_

#	Gilenya	2968
1	Transporters	_	NOUN	NNS	_	16	nsubjpass	_	_
2	Based	_	VERB	VBN	_	1	acl	_	_
3	on	_	ADP	IN	_	6	case	_	_
4	in	_	X	FW	_	6	amod	_	_
5	vitro	_	X	FW	_	4	dep	_	_
6	data	_	NOUN	NNS	_	2	nmod	_	_
7	,	_	.	,	_	1	punct	_	_
8	DRUG	_	NOUN	NN	_	1	appos	_	_
9	as	_	ADV	RB	_	8	cc	_	_
10	well	_	ADV	RB	_	9	mwe	_	_
11	as	_	ADP	IN	_	9	mwe	_	_
12	DRUG	_	NOUN	NN	_	13	compound	_	_
13	phosphate	_	NOUN	NN	_	8	conj	_	_
14	are	_	VERB	VBP	_	16	auxpass	_	_
15	not	_	ADV	RB	_	16	neg	_	_
16	expected	_	VERB	VBN	_	0	root	_	_
17	to	_	PRT	TO	_	18	mark	_	_
18	inhibit	_	VERB	VB	_	16	xcomp	_	_
19	the	_	DET	DT	_	20	det	_	_
20	uptake	_	NOUN	NN	_	18	dobj	_	_
21	of	_	ADP	IN	_	22	case	_	_
22	comedications	_	NOUN	NNS	_	20	nmod	_	_
23	and	_	CONJ	CC	_	22	cc	_	_
24	/	_	NUM	CD	_	22	conj	_	_
25	or	_	CONJ	CC	_	24	cc	_	_
26	biologics	_	NOUN	NNS	_	24	conj	_	_
27	transported	_	VERB	VBN	_	22	acl	_	_
28	by	_	ADP	IN	_	33	case	_	_
29	the	_	DET	DT	_	33	det	_	_
30	organic	_	ADJ	JJ	_	33	amod	_	_
31	anion	_	NOUN	NN	_	33	compound	_	_
32	transporting	_	NOUN	NN	_	33	compound	_	_
33	polypeptides	_	NOUN	NNS	_	27	nmod	_	_
34	OATP1B1	_	NOUN	NN	_	33	dep	_	_
35	,	_	.	,	_	34	punct	_	_
36	OATP1B3	_	NOUN	NN	_	34	conj	_	_
37	,	_	.	,	_	34	punct	_	_
38	or	_	CONJ	CC	_	34	cc	_	_
39	the	_	DET	DT	_	41	det	_	_
40	sodium	_	NOUN	NN	_	41	compound	_	_
41	taurocholate	_	NOUN	NN	_	34	conj	_	_
42	co	_	PRT	TO	_	43	mark	_	_
43	transporting	_	VERB	VBG	_	41	acl	_	_
44	polypeptide	_	NOUN	NN	_	45	compound	_	_
45	NTCP	_	NOUN	NN	_	43	dobj	_	_

#	Gilenya	2969
1	Similarly	_	ADV	RB	_	6	advmod	_	_
2	,	_	.	,	_	6	punct	_	_
3	they	_	PRON	PRP	_	6	nsubjpass	_	_
4	are	_	VERB	VBP	_	6	auxpass	_	_
5	not	_	ADV	RB	_	6	neg	_	_
6	expected	_	VERB	VBN	_	0	root	_	_
7	to	_	PRT	TO	_	8	mark	_	_
8	inhibit	_	VERB	VB	_	6	xcomp	_	_
9	the	_	DET	DT	_	10	det	_	_
10	efflux	_	NOUN	NN	_	8	dobj	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	comedications	_	NOUN	NNS	_	10	nmod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	/	_	NOUN	NN	_	12	conj	_	_
15	or	_	CONJ	CC	_	14	cc	_	_
16	biologics	_	NOUN	NNS	_	14	conj	_	_
17	transported	_	VERB	VBN	_	12	acl	_	_
18	by	_	ADP	IN	_	24	case	_	_
19	the	_	DET	DT	_	24	det	_	_
20	breast	_	NOUN	NN	_	24	compound	_	_
21	cancer	_	NOUN	NN	_	24	compound	_	_
22	resistance	_	NOUN	NN	_	24	compound	_	_
23	protein	_	NOUN	NN	_	24	compound	_	_
24	BCRP	_	NOUN	NN	_	17	nmod	_	_
25	,	_	.	,	_	6	punct	_	_
26	the	_	DET	DT	_	31	det	_	_
27	bile	_	ADJ	JJ	_	31	amod	_	_
28	salt	_	NOUN	NN	_	31	compound	_	_
29	export	_	NOUN	NN	_	31	compound	_	_
30	pump	_	NOUN	NN	_	31	compound	_	_
31	BSEP	_	NOUN	NN	_	25	root	_	_
32	,	_	.	,	_	31	punct	_	_
33	the	_	DET	DT	_	39	det	_	_
34	multidrug	_	ADJ	JJ	_	39	amod	_	_
35	resistance	_	NOUN	NN	_	39	compound	_	_
36	associated	_	VERB	VBN	_	39	amod	_	_
37	protein	_	NOUN	NN	_	39	compound	_	_
38	2	_	NUM	CD	_	39	nummod	_	_
39	MRP2	_	NOUN	NN	_	31	conj	_	_
40	,	_	.	,	_	31	punct	_	_
41	or	_	CONJ	CC	_	31	cc	_	_
42	P	_	NOUN	NN	_	45	compound	_	_
43	glycoprotein	_	NOUN	NN	_	45	compound	_	_
44	P	_	NOUN	NN	_	45	compound	_	_
45	gp	_	NOUN	NN	_	31	conj	_	_
46	at	_	ADP	IN	_	48	case	_	_
47	therapeutic	_	ADJ	JJ	_	48	amod	_	_
48	concentrations	_	NOUN	NNS	_	31	nmod	_	_

#	Gilenya	2970
1	Oral	_	ADJ	JJ	_	2	amod	_	_
2	Contraceptives	_	NOUN	NNS	_	0	root	_	_
3	The	_	DET	DT	_	4	det	_	_
4	coadministration	_	NOUN	NN	_	18	nsubj	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	DRUG	_	NOUN	NN	_	8	compound	_	_
7	0.5	_	NUM	CD	_	8	nummod	_	_
8	mg	_	NOUN	NN	_	4	nmod	_	_
9	daily	_	ADV	RB	_	12	advmod	_	_
10	with	_	ADP	IN	_	12	case	_	_
11	oral	_	ADJ	JJ	_	12	amod	_	_
12	contraceptives	_	NOUN	NNS	_	4	nmod	_	_
13	ethinylestradiol	_	NOUN	NN	_	12	dep	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	levonorgestrel	_	NOUN	NN	_	13	conj	_	_
16	did	_	VERB	VBD	_	18	aux	_	_
17	not	_	ADV	RB	_	18	neg	_	_
18	elicit	_	VERB	VB	_	2	dep	_	_
19	any	_	DET	DT	_	22	det	_	_
20	clinically	_	ADV	RB	_	21	advmod	_	_
21	significant	_	ADJ	JJ	_	22	amod	_	_
22	change	_	NOUN	NN	_	18	dobj	_	_
23	in	_	ADP	IN	_	26	case	_	_
24	oral	_	ADJ	JJ	_	26	amod	_	_
25	contraceptives	_	NOUN	NNS	_	26	compound	_	_
26	exposure	_	NOUN	NN	_	22	nmod	_	_

#	Gilenya	2971
1	DRUG	_	NOUN	NN	_	5	compound	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	DRUG	_	NOUN	NN	_	1	conj	_	_
4	phosphate	_	NOUN	NN	_	5	compound	_	_
5	exposure	_	NOUN	NN	_	7	nsubj	_	_
6	were	_	VERB	VBD	_	7	cop	_	_
7	consistent	_	ADJ	JJ	_	0	root	_	_
8	with	_	ADP	IN	_	9	case	_	_
9	those	_	DET	DT	_	7	nmod	_	_
10	from	_	ADP	IN	_	12	case	_	_
11	previous	_	ADJ	JJ	_	12	amod	_	_
12	studies	_	NOUN	NNS	_	9	nmod	_	_

#	Gilenya	2972
1	No	_	DET	DT	_	3	neg	_	_
2	interaction	_	NOUN	NN	_	3	compound	_	_
3	studies	_	NOUN	NNS	_	6	nsubjpass	_	_
4	have	_	VERB	VBP	_	6	aux	_	_
5	been	_	VERB	VBN	_	6	auxpass	_	_
6	performed	_	VERB	VBN	_	0	root	_	_
7	with	_	ADP	IN	_	9	case	_	_
8	oral	_	ADJ	JJ	_	9	amod	_	_
9	contraceptives	_	NOUN	NNS	_	6	nmod	_	_
10	containing	_	VERB	VBG	_	9	acl	_	_
11	other	_	ADJ	JJ	_	12	amod	_	_
12	progestagens	_	NOUN	NNS	_	10	dobj	_	_
13	however	_	ADV	RB	_	6	advmod	_	_
14	,	_	.	,	_	6	punct	_	_
15	an	_	DET	DT	_	16	det	_	_
16	effect	_	NOUN	NN	_	24	nsubjpass	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	DRUG	_	NOUN	NN	_	16	nmod	_	_
19	on	_	ADP	IN	_	21	case	_	_
20	their	_	PRON	PRP$	_	21	nmod:poss	_	_
21	exposure	_	NOUN	NN	_	16	nmod	_	_
22	is	_	VERB	VBZ	_	24	auxpass	_	_
23	not	_	ADV	RB	_	24	neg	_	_
24	expected	_	VERB	VBN	_	6	parataxis	_	_

#	Gilenya	2973
1	Cyclosporine	_	NOUN	NN	_	3	compound	_	_
2	The	_	DET	DT	_	3	det	_	_
3	pharmacokinetics	_	NOUN	NNS	_	10	nsubjpass	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	single	_	ADJ	JJ	_	7	amod	_	_
6	dose	_	NOUN	NN	_	7	compound	_	_
7	DRUG	_	NOUN	NN	_	3	nmod	_	_
8	was	_	VERB	VBD	_	10	auxpass	_	_
9	not	_	ADV	RB	_	10	neg	_	_
10	altered	_	VERB	VBN	_	0	root	_	_
11	during	_	ADP	IN	_	12	case	_	_
12	coadministration	_	NOUN	NN	_	10	nmod	_	_
13	with	_	ADP	IN	_	14	case	_	_
14	cyclosporine	_	NOUN	NN	_	12	nmod	_	_
15	at	_	ADP	IN	_	17	case	_	_
16	steady	_	ADJ	JJ	_	17	amod	_	_
17	state	_	NOUN	NN	_	12	nmod	_	_
18	,	_	.	,	_	10	punct	_	_
19	nor	_	CONJ	CC	_	10	cc	_	_
20	was	_	VERB	VBD	_	24	cop	_	_
21	cyclosporine	_	NOUN	NN	_	24	compound	_	_
22	steady	_	ADJ	JJ	_	24	amod	_	_
23	state	_	NOUN	NN	_	24	compound	_	_
24	pharmacokinetics	_	NOUN	NNS	_	10	conj	_	_
25	altered	_	VERB	VBN	_	24	acl	_	_
26	by	_	ADP	IN	_	27	case	_	_
27	DRUG	_	NOUN	NN	_	25	nmod	_	_

#	Gilenya	2974
1	These	_	DET	DT	_	2	det	_	_
2	data	_	NOUN	NNS	_	3	nsubj	_	_
3	indicate	_	VERB	VBP	_	0	root	_	_
4	that	_	ADP	IN	_	7	mark	_	_
5	DRUG	_	NOUN	NN	_	7	nsubj	_	_
6	is	_	VERB	VBZ	_	7	cop	_	_
7	unlikely	_	ADJ	JJ	_	3	ccomp	_	_
8	to	_	PRT	TO	_	9	mark	_	_
9	reduce	_	VERB	VB	_	7	xcomp	_	_
10	or	_	CONJ	CC	_	9	cc	_	_
11	increase	_	VERB	VB	_	9	conj	_	_
12	the	_	DET	DT	_	13	det	_	_
13	clearance	_	NOUN	NN	_	9	dobj	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	drugs	_	NOUN	NNS	_	13	nmod	_	_
16	cleared	_	VERB	VBN	_	15	acl	_	_
17	mainly	_	ADV	RB	_	16	advmod	_	_
18	by	_	ADP	IN	_	19	case	_	_
19	CYP3A4	_	NOUN	NN	_	16	nmod	_	_

#	Gilenya	2975
1	Potent	_	ADJ	JJ	_	2	amod	_	_
2	inhibition	_	NOUN	NN	_	16	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	transporters	_	NOUN	NNS	_	2	nmod	_	_
5	MDR1	_	NOUN	NN	_	7	compound	_	_
6	P	_	NOUN	NN	_	7	compound	_	_
7	gp	_	NOUN	NN	_	4	dep	_	_
8	,	_	.	,	_	7	punct	_	_
9	MRP2	_	NOUN	NN	_	7	conj	_	_
10	,	_	.	,	_	7	punct	_	_
11	and	_	CONJ	CC	_	7	cc	_	_
12	OATP	_	NOUN	NN	_	13	compound	_	_
13	1B1	_	NOUN	NN	_	7	conj	_	_
14	does	_	VERB	MD	_	16	aux	_	_
15	not	_	ADV	RB	_	16	neg	_	_
16	influence	_	VERB	VB	_	0	root	_	_
17	DRUG	_	NOUN	NN	_	18	compound	_	_
18	disposition	_	NOUN	NN	_	16	dobj	_	_

#	Gilenya	2976
1	Isoproterenol	_	NOUN	NN	_	18	nsubjpass	_	_
2	,	_	.	,	_	1	punct	_	_
3	Atropine	_	NOUN	NN	_	1	conj	_	_
4	,	_	.	,	_	1	punct	_	_
5	Atenolol	_	NOUN	NN	_	1	conj	_	_
6	,	_	.	,	_	1	punct	_	_
7	and	_	CONJ	CC	_	1	cc	_	_
8	Diltiazem	_	NOUN	NN	_	11	compound	_	_
9	Single	_	ADJ	JJ	_	11	amod	_	_
10	dose	_	NOUN	NN	_	11	compound	_	_
11	DRUG	_	NOUN	NN	_	1	conj	_	_
12	and	_	CONJ	CC	_	1	cc	_	_
13	DRUG	_	NOUN	NN	_	15	compound	_	_
14	phosphate	_	NOUN	NN	_	15	compound	_	_
15	exposure	_	NOUN	NN	_	1	conj	_	_
16	was	_	VERB	VBD	_	18	auxpass	_	_
17	not	_	ADV	RB	_	18	neg	_	_
18	altered	_	VERB	VBN	_	0	root	_	_
19	by	_	ADP	IN	_	21	case	_	_
20	coadministered	_	VERB	VBN	_	21	amod	_	_
21	isoproterenol	_	NOUN	NN	_	18	nmod	_	_
22	or	_	CONJ	CC	_	21	cc	_	_
23	atropine	_	NOUN	NN	_	21	conj	_	_

#	Gilenya	2977
1	Likewise	_	ADV	RB	_	23	advmod	_	_
2	,	_	.	,	_	23	punct	_	_
3	the	_	DET	DT	_	6	det	_	_
4	single	_	ADJ	JJ	_	6	amod	_	_
5	dose	_	NOUN	NN	_	6	compound	_	_
6	pharmacokinetics	_	NOUN	NNS	_	23	nsubj	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	DRUG	_	NOUN	NN	_	11	compound	_	_
11	phosphate	_	NOUN	NN	_	8	conj	_	_
12	and	_	CONJ	CC	_	6	cc	_	_
13	the	_	DET	DT	_	16	det	_	_
14	steady	_	ADJ	JJ	_	16	amod	_	_
15	state	_	NOUN	NN	_	16	compound	_	_
16	pharmacokinetics	_	NOUN	NNS	_	6	conj	_	_
17	of	_	ADP	IN	_	19	case	_	_
18	both	_	CONJ	CC	_	19	cc:preconj	_	_
19	atenolol	_	NOUN	NN	_	16	nmod	_	_
20	and	_	CONJ	CC	_	19	cc	_	_
21	diltiazem	_	NOUN	NN	_	19	conj	_	_
22	were	_	VERB	VBD	_	23	cop	_	_
23	unchanged	_	ADJ	JJ	_	0	root	_	_
24	during	_	ADP	IN	_	26	case	_	_
25	the	_	DET	DT	_	26	det	_	_
26	coadministration	_	NOUN	NN	_	23	nmod	_	_
27	of	_	ADP	IN	_	31	case	_	_
28	the	_	DET	DT	_	31	det	_	_
29	latter	_	ADJ	JJ	_	31	amod	_	_
30	2	_	NUM	CD	_	31	nummod	_	_
31	drugs	_	NOUN	NNS	_	26	nmod	_	_
32	individually	_	ADV	RB	_	26	advmod	_	_
33	with	_	ADP	IN	_	34	case	_	_
34	DRUG	_	NOUN	NN	_	32	nmod	_	_

#	Gilenya	2978
1	Population	_	NOUN	NN	_	2	compound	_	_
2	Pharmacokinetics	_	NOUN	NNS	_	7	compound	_	_
3	Analysis	_	NOUN	NN	_	6	compound	_	_
4	A	_	NOUN	NN	_	6	compound	_	_
5	population	_	NOUN	NN	_	6	compound	_	_
6	pharmacokinetics	_	NOUN	NNS	_	7	compound	_	_
7	evaluation	_	NOUN	NN	_	14	nsubj	_	_
8	performed	_	VERB	VBN	_	7	acl	_	_
9	in	_	ADP	IN	_	11	case	_	_
10	MS	_	NOUN	NN	_	11	compound	_	_
11	patients	_	NOUN	NNS	_	8	nmod	_	_
12	did	_	VERB	VBD	_	14	aux	_	_
13	not	_	ADV	RB	_	14	neg	_	_
14	provide	_	VERB	VB	_	0	root	_	_
15	evidence	_	NOUN	NN	_	14	dobj	_	_
16	for	_	ADP	IN	_	19	case	_	_
17	a	_	DET	DT	_	19	det	_	_
18	significant	_	ADJ	JJ	_	19	amod	_	_
19	effect	_	NOUN	NN	_	15	nmod	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	fluoxetine	_	NOUN	NN	_	19	nmod	_	_
22	and	_	CONJ	CC	_	21	cc	_	_
23	paroxetine	_	NOUN	NN	_	26	compound	_	_
24	strong	_	ADJ	JJ	_	26	amod	_	_
25	CYP2D6	_	NOUN	NN	_	26	compound	_	_
26	inhibitors	_	NOUN	NNS	_	21	conj	_	_
27	on	_	ADP	IN	_	28	case	_	_
28	DRUG	_	NOUN	NN	_	15	nmod	_	_
29	or	_	CONJ	CC	_	28	cc	_	_
30	DRUG	_	NOUN	NN	_	33	compound	_	_
31	phosphate	_	NOUN	NN	_	33	compound	_	_
32	predose	_	NOUN	NN	_	33	compound	_	_
33	concentrations	_	NOUN	NNS	_	28	conj	_	_

#	Gilenya	2979
1	In	_	ADP	IN	_	2	case	_	_
2	addition	_	NOUN	NN	_	9	nmod	_	_
3	,	_	.	,	_	9	punct	_	_
4	the	_	DET	DT	_	8	det	_	_
5	following	_	VERB	VBG	_	8	amod	_	_
6	commonly	_	ADV	RB	_	5	dep	_	_
7	coprescribed	_	VERB	VBN	_	8	amod	_	_
8	substances	_	NOUN	NNS	_	9	nsubj	_	_
9	had	_	VERB	VBD	_	0	root	_	_
10	no	_	DET	DT	_	14	neg	_	_
11	clinically	_	ADV	RB	_	12	advmod	_	_
12	relevant	_	ADJ	JJ	_	14	amod	_	_
13	effect	_	NOUN	NN	_	14	compound	_	_
14	<20%	_	NOUN	NN	_	9	dobj	_	_
15	on	_	ADP	IN	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	9	nmod	_	_
17	or	_	CONJ	CC	_	16	cc	_	_
18	DRUG	_	NOUN	NN	_	21	compound	_	_
19	phosphate	_	NOUN	NN	_	21	compound	_	_
20	predose	_	NOUN	NN	_	21	compound	_	_
21	concentrations	_	NOUN	NNS	_	16	conj	_	_
22	:	_	.	:	_	9	punct	_	_
23	baclofen	_	NOUN	NN	_	9	dep	_	_
24	,	_	.	,	_	23	punct	_	_
25	gabapentin	_	NOUN	NN	_	23	conj	_	_
26	,	_	.	,	_	23	punct	_	_
27	oxybutynin	_	NOUN	NN	_	23	conj	_	_
28	,	_	.	,	_	23	punct	_	_
29	amantadine	_	NOUN	NN	_	23	conj	_	_
30	,	_	.	,	_	23	punct	_	_
31	modafinil	_	NOUN	NN	_	23	conj	_	_
32	,	_	.	,	_	23	punct	_	_
33	amitriptyline	_	NOUN	NN	_	23	conj	_	_
34	,	_	.	,	_	23	punct	_	_
35	pregabalin	_	NOUN	NN	_	23	conj	_	_
36	,	_	.	,	_	23	punct	_	_
37	and	_	CONJ	CC	_	23	cc	_	_
38	corticosteroids	_	NOUN	NNS	_	23	conj	_	_

#	Halcion	5013
1	The	_	DET	DT	_	3	det	_	_
2	concomitant	_	ADJ	JJ	_	3	amod	_	_
3	use	_	NOUN	NN	_	8	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	benzodiazepines	_	NOUN	NNS	_	3	nmod	_	_
6	and	_	CONJ	CC	_	3	cc	_	_
7	opioids	_	NOUN	NNS	_	3	conj	_	_
8	increases	_	VERB	VBZ	_	0	root	_	_
9	the	_	DET	DT	_	10	det	_	_
10	risk	_	NOUN	NN	_	8	dobj	_	_
11	of	_	ADP	IN	_	13	case	_	_
12	respiratory	_	ADJ	JJ	_	13	amod	_	_
13	depression	_	NOUN	NN	_	10	nmod	_	_
14	because	_	ADP	IN	_	16	case	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	actions	_	NOUN	NNS	_	8	nmod	_	_
17	at	_	ADP	IN	_	20	case	_	_
18	different	_	ADJ	JJ	_	20	amod	_	_
19	receptor	_	NOUN	NN	_	20	compound	_	_
20	sites	_	NOUN	NNS	_	16	nmod	_	_
21	in	_	ADP	IN	_	23	case	_	_
22	the	_	DET	DT	_	23	det	_	_
23	CNS	_	NOUN	NN	_	20	nmod	_	_
24	that	_	DET	WDT	_	25	nsubj	_	_
25	control	_	VERB	VBP	_	23	acl:relcl	_	_
26	respiration	_	NOUN	NN	_	25	dobj	_	_

#	Halcion	5014
1	Benzodiazepines	_	NOUN	NNS	_	2	nsubj	_	_
2	interact	_	VERB	VBP	_	0	root	_	_
3	at	_	ADP	IN	_	5	case	_	_
4	GABAA	_	NOUN	NN	_	5	compound	_	_
5	sites	_	NOUN	NNS	_	2	nmod	_	_
6	and	_	CONJ	CC	_	2	cc	_	_
7	opioids	_	NOUN	NNS	_	8	nsubj	_	_
8	interact	_	VERB	VBP	_	2	conj	_	_
9	primarily	_	ADV	RB	_	8	advmod	_	_
10	at	_	ADP	IN	_	12	case	_	_
11	mu	_	NOUN	NN	_	12	compound	_	_
12	receptors	_	NOUN	NNS	_	8	nmod	_	_

#	Halcion	5015
1	When	_	ADV	WRB	_	6	advmod	_	_
2	benzodiazepines	_	NOUN	NNS	_	6	nsubjpass	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	opioids	_	NOUN	NNS	_	2	conj	_	_
5	are	_	VERB	VBP	_	6	auxpass	_	_
6	combined	_	VERB	VBN	_	19	advcl	_	_
7	,	_	.	,	_	19	punct	_	_
8	the	_	DET	DT	_	9	det	_	_
9	potential	_	NOUN	NN	_	19	nsubj	_	_
10	for	_	ADP	IN	_	11	case	_	_
11	benzodiazepines	_	NOUN	NNS	_	9	nmod	_	_
12	to	_	PRT	TO	_	14	mark	_	_
13	significantly	_	ADV	RB	_	14	advmod	_	_
14	worsen	_	NOUN	NN	_	9	acl	_	_
15	opioid	_	ADJ	JJ	_	18	amod	_	_
16	related	_	ADJ	JJ	_	18	amod	_	_
17	respiratory	_	ADJ	JJ	_	18	amod	_	_
18	depression	_	NOUN	NN	_	14	dobj	_	_
19	exists	_	VERB	VBZ	_	0	root	_	_

#	Halcion	5016
1	Limit	_	NOUN	NN	_	2	compound	_	_
2	dosage	_	NOUN	NN	_	0	root	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	duration	_	NOUN	NN	_	2	conj	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	concomitant	_	ADJ	JJ	_	7	amod	_	_
7	use	_	NOUN	NN	_	2	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	benzodiazepines	_	NOUN	NNS	_	7	nmod	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	opioids	_	NOUN	NNS	_	9	conj	_	_
12	,	_	.	,	_	2	punct	_	_
13	and	_	CONJ	CC	_	2	cc	_	_
14	monitor	_	NOUN	NN	_	15	compound	_	_
15	patients	_	NOUN	NNS	_	2	conj	_	_
16	closely	_	ADV	RB	_	19	advmod	_	_
17	for	_	ADP	IN	_	19	case	_	_
18	respiratory	_	ADJ	JJ	_	19	amod	_	_
19	depression	_	NOUN	NN	_	2	nmod	_	_
20	and	_	CONJ	CC	_	19	cc	_	_
21	sedation	_	NOUN	NN	_	19	conj	_	_

#	Halcion	5017
1	Both	_	CONJ	CC	_	2	cc:preconj	_	_
2	pharmacodynamic	_	ADJ	JJ	_	8	nsubjpass	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	pharmacokinetic	_	ADJ	JJ	_	2	conj	_	_
5	interactions	_	NOUN	NNS	_	2	dep	_	_
6	have	_	VERB	VBP	_	8	aux	_	_
7	been	_	VERB	VBN	_	8	auxpass	_	_
8	reported	_	VERB	VBN	_	0	root	_	_
9	with	_	ADP	IN	_	10	case	_	_
10	benzodiazepines	_	NOUN	NNS	_	8	nmod	_	_

#	Halcion	5018
1	In	_	ADP	IN	_	2	case	_	_
2	particular	_	ADJ	JJ	_	5	nmod	_	_
3	,	_	.	,	_	5	punct	_	_
4	DRUG	_	NOUN	NN	_	5	nsubj	_	_
5	produces	_	VERB	VBZ	_	0	root	_	_
6	additive	_	ADJ	JJ	_	9	amod	_	_
7	CNS	_	NOUN	NN	_	9	compound	_	_
8	depressant	_	ADJ	JJ	_	9	amod	_	_
9	effects	_	NOUN	NNS	_	5	dobj	_	_
10	when	_	ADV	WRB	_	11	advmod	_	_
11	coadministered	_	VERB	VBN	_	5	advcl	_	_
12	with	_	ADP	IN	_	15	case	_	_
13	other	_	ADJ	JJ	_	15	amod	_	_
14	psychotropic	_	ADJ	JJ	_	15	amod	_	_
15	medications	_	NOUN	NNS	_	11	nmod	_	_
16	,	_	.	,	_	15	punct	_	_
17	anticonvulsants	_	NOUN	NNS	_	15	conj	_	_
18	,	_	.	,	_	15	punct	_	_
19	antihistamines	_	NOUN	NNS	_	15	conj	_	_
20	,	_	.	,	_	15	punct	_	_
21	ethanol	_	NOUN	NN	_	15	conj	_	_
22	,	_	.	,	_	15	punct	_	_
23	and	_	CONJ	CC	_	15	cc	_	_
24	other	_	ADJ	JJ	_	25	amod	_	_
25	drugs	_	NOUN	NNS	_	15	conj	_	_
26	which	_	DET	WDT	_	27	nsubj	_	_
27	themselves	_	VERB	VBZ	_	25	acl:relcl	_	_
28	produce	_	VERB	VBP	_	5	parataxis	_	_
29	CNS	_	NOUN	NN	_	30	compound	_	_
30	depression	_	NOUN	NN	_	28	dobj	_	_

#	Halcion	5019
1	The	_	DET	DT	_	3	det	_	_
2	initial	_	ADJ	JJ	_	3	amod	_	_
3	step	_	NOUN	NN	_	8	nsubj	_	_
4	in	_	ADP	IN	_	6	case	_	_
5	DRUG	_	NOUN	NN	_	6	compound	_	_
6	metabolism	_	NOUN	NN	_	3	nmod	_	_
7	is	_	VERB	VBZ	_	8	cop	_	_
8	hydroxylation	_	NOUN	NN	_	0	root	_	_
9	catalyzed	_	VERB	VBN	_	8	acl	_	_
10	by	_	ADP	IN	_	15	case	_	_
11	cytochrome	_	NOUN	NN	_	15	compound	_	_
12	P450	_	NOUN	NN	_	15	compound	_	_
13	3A	_	NOUN	NN	_	15	compound	_	_
14	CYP	_	NOUN	NN	_	15	compound	_	_
15	3A	_	NOUN	NN	_	9	nmod	_	_

#	Halcion	5020
1	Drugs	_	NOUN	NNS	_	8	nsubj	_	_
2	which	_	DET	WDT	_	3	nsubj	_	_
3	inhibit	_	VERB	VBP	_	1	acl:relcl	_	_
4	this	_	DET	DT	_	6	det	_	_
5	metabolic	_	ADJ	JJ	_	6	amod	_	_
6	pathway	_	NOUN	NN	_	3	dobj	_	_
7	may	_	VERB	MD	_	8	aux	_	_
8	have	_	VERB	VB	_	0	root	_	_
9	a	_	DET	DT	_	11	det	_	_
10	profound	_	ADJ	JJ	_	11	amod	_	_
11	effect	_	NOUN	NN	_	8	dobj	_	_
12	on	_	ADP	IN	_	14	case	_	_
13	the	_	DET	DT	_	14	det	_	_
14	clearance	_	NOUN	NN	_	11	nmod	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	14	nmod	_	_

#	Halcion	5021
1	DRUG	_	NOUN	NN	_	3	nsubjpass	_	_
2	is	_	VERB	VBZ	_	3	auxpass	_	_
3	contraindicated	_	VERB	VBN	_	0	root	_	_
4	with	_	ADP	IN	_	15	case	_	_
5	ketoconzaole	_	ADJ	JJ	_	15	amod	_	_
6	,	_	.	,	_	5	punct	_	_
7	itraconazole	_	NOUN	NN	_	5	conj	_	_
8	,	_	.	,	_	5	punct	_	_
9	nefazodone	_	NOUN	NN	_	5	conj	_	_
10	,	_	.	,	_	5	punct	_	_
11	and	_	CONJ	CC	_	5	cc	_	_
12	several	_	ADJ	JJ	_	5	conj	_	_
13	HIV	_	NOUN	NN	_	15	compound	_	_
14	protease	_	NOUN	NN	_	15	compound	_	_
15	inhibitors	_	NOUN	NNS	_	3	nmod	_	_

#	Halcion	5022
1	Coadministration	_	NOUN	NN	_	4	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	isoniazid	_	NOUN	NN	_	1	nmod	_	_
4	increased	_	VERB	VBD	_	0	root	_	_
5	the	_	DET	DT	_	8	det	_	_
6	maximum	_	NOUN	NN	_	8	compound	_	_
7	plasma	_	NOUN	NN	_	8	compound	_	_
8	concentration	_	NOUN	NN	_	4	dobj	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	by	_	ADP	IN	_	12	case	_	_
12	20%	_	NOUN	NN	_	4	nmod	_	_
13	,	_	.	,	_	12	punct	_	_
14	decreased	_	VERB	VBN	_	15	amod	_	_
15	clearance	_	NOUN	NN	_	12	conj	_	_
16	by	_	ADP	IN	_	17	case	_	_
17	42%	_	ADJ	JJ	_	15	nmod	_	_
18	,	_	.	,	_	12	punct	_	_
19	and	_	CONJ	CC	_	12	cc	_	_
20	increased	_	VERB	VBN	_	22	amod	_	_
21	half	_	ADJ	JJ	_	22	amod	_	_
22	life	_	NOUN	NN	_	12	conj	_	_
23	by	_	ADP	IN	_	24	case	_	_
24	31%	_	ADJ	JJ	_	4	nmod	_	_

#	Halcion	5023
1	Coadministration	_	NOUN	NN	_	5	nsubj	_	_
2	of	_	ADP	IN	_	4	case	_	_
3	oral	_	ADJ	JJ	_	4	amod	_	_
4	contraceptives	_	NOUN	NNS	_	1	nmod	_	_
5	increased	_	VERB	VBD	_	0	root	_	_
6	maximum	_	NOUN	NN	_	8	compound	_	_
7	plasma	_	NOUN	NN	_	8	compound	_	_
8	concentration	_	NOUN	NN	_	5	dobj	_	_
9	by	_	ADP	IN	_	10	case	_	_
10	6%	_	NOUN	NN	_	5	nmod	_	_
11	,	_	.	,	_	10	punct	_	_
12	decreased	_	VERB	VBN	_	13	amod	_	_
13	clearance	_	NOUN	NN	_	10	conj	_	_
14	by	_	ADP	IN	_	15	case	_	_
15	32%	_	ADJ	JJ	_	13	nmod	_	_
16	,	_	.	,	_	10	punct	_	_
17	and	_	CONJ	CC	_	10	cc	_	_
18	increased	_	VERB	VBN	_	20	amod	_	_
19	half	_	ADJ	JJ	_	20	amod	_	_
20	life	_	NOUN	NN	_	10	conj	_	_
21	by	_	ADP	IN	_	22	case	_	_
22	16%	_	ADJ	JJ	_	5	nmod	_	_

#	Halcion	5024
1	Coadministration	_	NOUN	NN	_	5	nsubj	_	_
2	of	_	ADP	IN	_	4	case	_	_
3	grapefruit	_	ADJ	JJ	_	4	amod	_	_
4	juice	_	NOUN	NN	_	1	nmod	_	_
5	increased	_	VERB	VBD	_	0	root	_	_
6	the	_	DET	DT	_	9	det	_	_
7	maximum	_	ADJ	JJ	_	9	compound	_	_
8	plasma	_	NOUN	NN	_	9	compound	_	_
9	concentration	_	NOUN	NN	_	5	dobj	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_
12	by	_	ADP	IN	_	13	case	_	_
13	25%	_	NOUN	NN	_	5	nmod	_	_
14	,	_	.	,	_	5	punct	_	_
15	increased	_	VERB	VBD	_	5	conj	_	_
16	the	_	DET	DT	_	17	det	_	_
17	area	_	NOUN	NN	_	15	dobj	_	_
18	under	_	ADP	IN	_	20	case	_	_
19	the	_	DET	DT	_	20	det	_	_
20	concentration	_	NOUN	NN	_	15	nmod	_	_
21	curve	_	VERB	VBN	_	20	acl	_	_
22	by	_	ADP	IN	_	23	case	_	_
23	48%	_	ADJ	JJ	_	21	nmod	_	_
24	,	_	.	,	_	5	punct	_	_
25	and	_	CONJ	CC	_	5	cc	_	_
26	increased	_	VERB	VBN	_	28	amod	_	_
27	half	_	ADJ	JJ	_	28	amod	_	_
28	life	_	NOUN	NN	_	5	conj	_	_
29	by	_	ADP	IN	_	30	case	_	_
30	18%	_	ADJ	JJ	_	28	nmod	_	_

#	Halcion	5025
1	Available	_	ADJ	JJ	_	2	amod	_	_
2	data	_	NOUN	NNS	_	11	nsubj	_	_
3	from	_	ADP	IN	_	5	case	_	_
4	clinical	_	ADJ	JJ	_	5	amod	_	_
5	studies	_	NOUN	NNS	_	2	nmod	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	benzodiazepines	_	NOUN	NNS	_	5	nmod	_	_
8	other	_	ADJ	JJ	_	7	amod	_	_
9	than	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	suggest	_	VERB	VBP	_	0	root	_	_
12	a	_	DET	DT	_	15	det	_	_
13	possible	_	ADJ	JJ	_	15	amod	_	_
14	drug	_	NOUN	NN	_	15	compound	_	_
15	interaction	_	NOUN	NN	_	11	dobj	_	_
16	with	_	ADP	IN	_	17	case	_	_
17	DRUG	_	NOUN	NN	_	15	nmod	_	_
18	for	_	ADP	IN	_	20	case	_	_
19	the	_	DET	DT	_	20	det	_	_
20	following	_	ADJ	JJ	_	15	nmod	_	_
21	:	_	.	:	_	20	punct	_	_
22	fluvoxamine	_	NOUN	NN	_	20	conj	_	_
23	,	_	.	,	_	20	punct	_	_
24	diltiazem	_	NOUN	NN	_	20	conj	_	_
25	,	_	.	,	_	20	punct	_	_
26	and	_	CONJ	CC	_	20	cc	_	_
27	verapamil	_	NOUN	NN	_	20	conj	_	_

#	Halcion	5026
1	Data	_	NOUN	NN	_	8	nsubj	_	_
2	from	_	ADP	IN	_	5	case	_	_
3	in	_	X	FW	_	5	amod	_	_
4	vitro	_	X	FW	_	3	dep	_	_
5	studies	_	NOUN	NNS	_	1	nmod	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	suggest	_	VERB	VBP	_	0	root	_	_
9	a	_	DET	DT	_	12	det	_	_
10	possible	_	ADJ	JJ	_	12	amod	_	_
11	drug	_	NOUN	NN	_	12	compound	_	_
12	interaction	_	NOUN	NN	_	8	dobj	_	_
13	with	_	ADP	IN	_	14	case	_	_
14	DRUG	_	NOUN	NN	_	12	nmod	_	_
15	for	_	ADP	IN	_	17	case	_	_
16	the	_	DET	DT	_	17	det	_	_
17	following	_	ADJ	JJ	_	12	nmod	_	_
18	:	_	.	:	_	8	punct	_	_
19	sertraline	_	NOUN	NN	_	8	dep	_	_
20	and	_	CONJ	CC	_	19	cc	_	_
21	paroxetine	_	NOUN	NN	_	19	conj	_	_

#	Halcion	5027
1	Data	_	NOUN	NN	_	11	nsubj	_	_
2	from	_	ADP	IN	_	5	case	_	_
3	in	_	X	FW	_	5	amod	_	_
4	vitro	_	X	FW	_	3	dep	_	_
5	studies	_	NOUN	NNS	_	1	nmod	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	benzodiazepines	_	NOUN	NNS	_	5	nmod	_	_
8	other	_	ADJ	JJ	_	7	amod	_	_
9	than	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	suggest	_	VERB	VBP	_	0	root	_	_
12	a	_	DET	DT	_	15	det	_	_
13	possible	_	ADJ	JJ	_	15	amod	_	_
14	drug	_	NOUN	NN	_	15	compound	_	_
15	interaction	_	NOUN	NN	_	11	dobj	_	_
16	with	_	ADP	IN	_	17	case	_	_
17	DRUG	_	NOUN	NN	_	15	nmod	_	_
18	for	_	ADP	IN	_	22	case	_	_
19	the	_	DET	DT	_	22	det	_	_
20	following	_	ADJ	JJ	_	22	amod	_	_
21	:	_	.	:	_	20	punct	_	_
22	ergotamine	_	NOUN	NN	_	15	nmod	_	_
23	,	_	.	,	_	22	punct	_	_
24	cyclosporine	_	NOUN	NN	_	22	conj	_	_
25	,	_	.	,	_	22	punct	_	_
26	amiodarone	_	NOUN	NN	_	22	conj	_	_
27	,	_	.	,	_	22	punct	_	_
28	nicardipine	_	NOUN	NN	_	22	conj	_	_
29	,	_	.	,	_	22	punct	_	_
30	and	_	CONJ	CC	_	22	cc	_	_
31	nifedipine	_	NOUN	NN	_	22	conj	_	_

#	Halcion	5028
1	Caution	_	NOUN	NN	_	3	nsubjpass	_	_
2	is	_	VERB	VBZ	_	3	auxpass	_	_
3	recommended	_	VERB	VBN	_	0	root	_	_
4	during	_	ADP	IN	_	5	case	_	_
5	coadministration	_	NOUN	NN	_	3	nmod	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	any	_	DET	DT	_	5	nmod	_	_
8	of	_	ADP	IN	_	10	case	_	_
9	these	_	DET	DT	_	10	det	_	_
10	drugs	_	NOUN	NNS	_	7	nmod	_	_
11	with	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_

#	Halcion	5029
1	Coadministration	_	NOUN	NN	_	4	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	ranitidine	_	NOUN	NN	_	1	nmod	_	_
4	increased	_	VERB	VBD	_	0	root	_	_
5	the	_	DET	DT	_	8	det	_	_
6	maximum	_	NOUN	NN	_	8	compound	_	_
7	plasma	_	NOUN	NN	_	8	compound	_	_
8	concentration	_	NOUN	NN	_	4	dobj	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	by	_	ADP	IN	_	12	case	_	_
12	30%	_	NOUN	NN	_	4	nmod	_	_
13	,	_	.	,	_	4	punct	_	_
14	increased	_	VERB	VBD	_	4	conj	_	_
15	the	_	DET	DT	_	16	det	_	_
16	area	_	NOUN	NN	_	14	dobj	_	_
17	under	_	ADP	IN	_	19	case	_	_
18	the	_	DET	DT	_	19	det	_	_
19	concentration	_	NOUN	NN	_	14	nmod	_	_
20	curve	_	VERB	VBN	_	19	acl	_	_
21	by	_	ADP	IN	_	22	case	_	_
22	27%	_	ADJ	JJ	_	20	nmod	_	_
23	,	_	.	,	_	4	punct	_	_
24	and	_	CONJ	CC	_	4	cc	_	_
25	increased	_	VERB	VBN	_	4	conj	_	_
26	half	_	ADJ	JJ	_	27	amod	_	_
27	life	_	NOUN	NN	_	25	dobj	_	_
28	by	_	ADP	IN	_	29	case	_	_
29	3.3%	_	ADJ	JJ	_	25	nmod	_	_

#	Halcion	5030
1	Caution	_	NOUN	NN	_	3	nsubjpass	_	_
2	is	_	VERB	VBZ	_	3	auxpass	_	_
3	recommended	_	VERB	VBN	_	0	root	_	_
4	during	_	ADP	IN	_	5	case	_	_
5	coadministration	_	NOUN	NN	_	3	nmod	_	_
6	with	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_

#	Halcion	5031
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	is	_	VERB	VBZ	_	4	cop	_	_
3	a	_	DET	DT	_	4	det	_	_
4	hypnotic	_	ADJ	JJ	_	0	root	_	_
5	with	_	ADP	IN	_	11	case	_	_
6	a	_	DET	DT	_	11	det	_	_
7	short	_	ADJ	JJ	_	11	amod	_	_
8	mean	_	NOUN	NN	_	11	compound	_	_
9	plasma	_	NOUN	NN	_	11	compound	_	_
10	half	_	NOUN	NN	_	11	compound	_	_
11	life	_	NOUN	NN	_	4	nmod	_	_
12	reported	_	VERB	VBN	_	11	acl	_	_
13	to	_	PRT	TO	_	17	mark	_	_
14	be	_	VERB	VB	_	17	cop	_	_
15	in	_	ADP	IN	_	17	case	_	_
16	the	_	DET	DT	_	17	det	_	_
17	range	_	NOUN	NN	_	12	nmod	_	_
18	of	_	ADP	IN	_	22	case	_	_
19	1.5	_	NUM	CD	_	21	compound	_	_
20	to	_	PRT	TO	_	21	dep	_	_
21	5.5	_	NUM	CD	_	22	nummod	_	_
22	hours	_	NOUN	NNS	_	17	nmod	_	_

#	Halcion	5032
1	In	_	ADP	IN	_	3	case	_	_
2	normal	_	ADJ	JJ	_	3	amod	_	_
3	subjects	_	NOUN	NNS	_	16	nmod	_	_
4	treated	_	VERB	VBN	_	3	acl	_	_
5	for	_	ADP	IN	_	7	case	_	_
6	7	_	NUM	CD	_	7	nummod	_	_
7	days	_	NOUN	NNS	_	4	nmod	_	_
8	with	_	ADP	IN	_	10	case	_	_
9	four	_	NUM	CD	_	10	nummod	_	_
10	times	_	NOUN	NNS	_	7	nmod	_	_
11	the	_	DET	DT	_	13	det	_	_
12	recommended	_	VERB	VBN	_	13	amod	_	_
13	dosage	_	NOUN	NN	_	4	dobj	_	_
14	,	_	.	,	_	16	punct	_	_
15	there	_	DET	EX	_	16	expl	_	_
16	was	_	VERB	VBD	_	0	root	_	_
17	no	_	DET	DT	_	18	neg	_	_
18	evidence	_	NOUN	NN	_	16	nsubj	_	_
19	of	_	ADP	IN	_	22	case	_	_
20	altered	_	VERB	VBN	_	22	amod	_	_
21	systemic	_	ADJ	JJ	_	22	amod	_	_
22	bioavailability	_	NOUN	NN	_	18	nmod	_	_
23	,	_	.	,	_	22	punct	_	_
24	rate	_	NOUN	NN	_	22	conj	_	_
25	of	_	ADP	IN	_	26	case	_	_
26	elimination	_	NOUN	NN	_	24	nmod	_	_
27	,	_	.	,	_	22	punct	_	_
28	or	_	CONJ	CC	_	22	cc	_	_
29	accumulation	_	NOUN	NN	_	22	conj	_	_

#	Halcion	5033
1	Peak	_	ADJ	JJ	_	3	amod	_	_
2	plasma	_	NOUN	NN	_	3	compound	_	_
3	levels	_	NOUN	NNS	_	5	nsubjpass	_	_
4	are	_	VERB	VBP	_	5	auxpass	_	_
5	reached	_	VERB	VBN	_	0	root	_	_
6	within	_	ADP	IN	_	8	case	_	_
7	2	_	NUM	CD	_	8	nummod	_	_
8	hours	_	NOUN	NNS	_	5	nmod	_	_
9	following	_	ADP	IN	_	11	case	_	_
10	oral	_	ADJ	JJ	_	11	amod	_	_
11	administration	_	NOUN	NN	_	5	nmod	_	_

#	Halcion	5034
1	Following	_	ADP	IN	_	3	case	_	_
2	recommended	_	VERB	VBN	_	3	amod	_	_
3	doses	_	NOUN	NNS	_	22	nmod	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	,	_	.	,	_	22	punct	_	_
7	DRUG	_	NOUN	NN	_	10	compound	_	_
8	peak	_	ADJ	JJ	_	10	amod	_	_
9	plasma	_	NOUN	NN	_	10	compound	_	_
10	levels	_	NOUN	NNS	_	22	nsubjpass	_	_
11	in	_	ADP	IN	_	13	case	_	_
12	the	_	DET	DT	_	13	det	_	_
13	range	_	NOUN	NN	_	10	nmod	_	_
14	of	_	ADP	IN	_	20	case	_	_
15	1	_	NUM	CD	_	17	compound	_	_
16	to	_	PRT	TO	_	17	dep	_	_
17	6	_	NUM	CD	_	18	nummod	_	_
18	ng	_	NOUN	NN	_	20	amod	_	_
19	/	_	.	:	_	20	punct	_	_
20	mL	_	NOUN	NN	_	13	nmod	_	_
21	are	_	VERB	VBP	_	22	auxpass	_	_
22	seen	_	VERB	VBN	_	0	root	_	_

#	Halcion	5035
1	The	_	DET	DT	_	3	det	_	_
2	plasma	_	NOUN	NN	_	3	compound	_	_
3	levels	_	NOUN	NNS	_	6	nsubj	_	_
4	achieved	_	VERB	VBN	_	3	acl	_	_
5	are	_	VERB	VBP	_	6	cop	_	_
6	proportional	_	ADJ	JJ	_	0	root	_	_
7	to	_	PRT	TO	_	9	case	_	_
8	the	_	DET	DT	_	9	det	_	_
9	dose	_	NOUN	NN	_	6	nmod	_	_
10	given	_	VERB	VBN	_	9	acl	_	_

#	Halcion	5036
1	DRUG	_	NOUN	NN	_	17	nsubjpass	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	its	_	PRON	PRP$	_	4	nmod:poss	_	_
4	metabolites	_	NOUN	NNS	_	1	conj	_	_
5	,	_	.	,	_	1	punct	_	_
6	principally	_	ADV	RB	_	9	advmod	_	_
7	as	_	ADP	IN	_	9	case	_	_
8	conjugated	_	VERB	VBN	_	9	amod	_	_
9	glucuronides	_	NOUN	NNS	_	1	nmod	_	_
10	,	_	.	,	_	9	punct	_	_
11	which	_	DET	WDT	_	14	nsubj	_	_
12	are	_	VERB	VBP	_	14	cop	_	_
13	presumably	_	ADV	RB	_	14	advmod	_	_
14	inactive	_	ADJ	JJ	_	9	acl:relcl	_	_
15	,	_	.	,	_	1	punct	_	_
16	are	_	VERB	VBP	_	17	auxpass	_	_
17	excreted	_	VERB	VBN	_	0	root	_	_
18	primarily	_	ADV	RB	_	17	advmod	_	_
19	in	_	ADP	IN	_	21	case	_	_
20	the	_	DET	DT	_	21	det	_	_
21	urine	_	VERB	VBG	_	17	advcl	_	_

#	Halcion	5037
1	Only	_	ADV	RB	_	2	advmod	_	_
2	small	_	ADJ	JJ	_	3	amod	_	_
3	amounts	_	NOUN	NNS	_	7	nsubj	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	unmetabolized	_	ADJ	JJ	_	6	amod	_	_
6	DRUG	_	NOUN	NN	_	3	nmod	_	_
7	appear	_	VERB	VBZ	_	0	root	_	_
8	in	_	ADP	IN	_	10	case	_	_
9	the	_	DET	DT	_	10	det	_	_
10	urine	_	VERB	VBG	_	7	nmod	_	_

#	Halcion	5038
1	The	_	DET	DT	_	4	det	_	_
2	two	_	NUM	CD	_	4	nummod	_	_
3	primary	_	ADJ	JJ	_	4	amod	_	_
4	metabolites	_	NOUN	NNS	_	5	nsubj	_	_
5	accounted	_	VERB	VBD	_	0	root	_	_
6	for	_	ADP	IN	_	7	case	_	_
7	79.9%	_	NOUN	NN	_	5	nmod	_	_
8	of	_	ADP	IN	_	10	case	_	_
9	urinary	_	ADJ	JJ	_	10	amod	_	_
10	excretion	_	NOUN	NN	_	7	nmod	_	_

#	Halcion	5039
1	Urinary	_	ADJ	JJ	_	2	amod	_	_
2	excretion	_	NOUN	NN	_	3	nsubj	_	_
3	appeared	_	VERB	VBD	_	0	root	_	_
4	to	_	PRT	TO	_	6	mark	_	_
5	be	_	VERB	VB	_	6	cop	_	_
6	biphasic	_	ADJ	JJ	_	3	xcomp	_	_
7	in	_	ADP	IN	_	10	case	_	_
8	its	_	PRON	PRP$	_	10	nmod:poss	_	_
9	time	_	NOUN	NN	_	10	compound	_	_
10	course	_	NOUN	NN	_	6	nmod	_	_

#	Halcion	5040
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	Tablets	_	NOUN	NNS	_	13	nsubj	_	_
3	0.5	_	NUM	CD	_	4	nummod	_	_
4	mg	_	NOUN	NN	_	2	dep	_	_
5	,	_	.	,	_	2	punct	_	_
6	in	_	ADP	IN	_	9	case	_	_
7	two	_	NUM	CD	_	9	nummod	_	_
8	separate	_	ADJ	JJ	_	9	amod	_	_
9	studies	_	NOUN	NNS	_	2	nmod	_	_
10	,	_	.	,	_	2	punct	_	_
11	did	_	VERB	MD	_	13	aux	_	_
12	not	_	ADV	RB	_	13	neg	_	_
13	affect	_	VERB	VB	_	0	root	_	_
14	the	_	DET	DT	_	16	det	_	_
15	prothrombin	_	NOUN	NN	_	16	compound	_	_
16	times	_	NOUN	NNS	_	13	dobj	_	_
17	or	_	CONJ	CC	_	16	cc	_	_
18	plasma	_	NOUN	NN	_	20	compound	_	_
19	warfarin	_	NOUN	NN	_	20	compound	_	_
20	levels	_	NOUN	NNS	_	16	conj	_	_
21	in	_	ADP	IN	_	23	case	_	_
22	male	_	ADJ	JJ	_	23	amod	_	_
23	volunteers	_	NOUN	NNS	_	16	nmod	_	_
24	administered	_	VERB	VBN	_	23	acl	_	_
25	sodium	_	NOUN	NN	_	26	compound	_	_
26	warfarin	_	NOUN	NN	_	24	dobj	_	_
27	orally	_	ADV	RB	_	13	advmod	_	_

#	Halcion	5041
1	Extremely	_	ADV	RB	_	8	advmod	_	_
2	high	_	ADJ	JJ	_	3	amod	_	_
3	concentrations	_	NOUN	NNS	_	8	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	do	_	VERB	MD	_	8	aux	_	_
7	not	_	ADV	RB	_	8	neg	_	_
8	displace	_	VERB	VB	_	0	root	_	_
9	bilirubin	_	NOUN	NN	_	8	dobj	_	_
10	bound	_	VERB	VBN	_	9	acl	_	_
11	to	_	PRT	TO	_	14	case	_	_
12	human	_	ADJ	JJ	_	14	amod	_	_
13	serum	_	NOUN	NN	_	14	compound	_	_
14	albumin	_	NOUN	NN	_	10	nmod	_	_
15	in	_	NOUN	NN	_	16	compound	_	_
16	vitro	_	X	FW	_	14	advmod	_	_

#	Halcion	5042
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	14C	_	NOUN	NN	_	4	nsubjpass	_	_
3	was	_	VERB	VBD	_	4	auxpass	_	_
4	administered	_	VERB	VBN	_	0	root	_	_
5	orally	_	ADV	RB	_	4	advmod	_	_
6	to	_	PRT	TO	_	8	case	_	_
7	pregnant	_	ADJ	JJ	_	8	amod	_	_
8	mice	_	NOUN	NNS	_	4	nmod	_	_

#	Halcion	5043
1	Drug	_	NOUN	NN	_	3	compound	_	_
2	related	_	ADJ	JJ	_	3	amod	_	_
3	material	_	NOUN	NN	_	4	nsubj	_	_
4	appeared	_	VERB	VBD	_	0	root	_	_
5	uniformly	_	ADV	RB	_	6	advmod	_	_
6	distributed	_	VERB	VBN	_	4	ccomp	_	_
7	in	_	ADP	IN	_	9	case	_	_
8	the	_	DET	DT	_	9	det	_	_
9	fetus	_	NOUN	NN	_	6	nmod	_	_
10	with	_	ADP	IN	_	12	case	_	_
11	14C	_	NOUN	NN	_	12	compound	_	_
12	concentrations	_	NOUN	NNS	_	9	nmod	_	_
13	approximately	_	ADV	RB	_	15	advmod	_	_
14	the	_	DET	DT	_	15	det	_	_
15	same	_	ADJ	JJ	_	6	nmod	_	_
16	as	_	ADP	IN	_	19	case	_	_
17	in	_	ADP	IN	_	19	case	_	_
18	the	_	DET	DT	_	19	det	_	_
19	brain	_	NOUN	NN	_	15	nmod	_	_
20	of	_	ADP	IN	_	22	case	_	_
21	the	_	DET	DT	_	22	det	_	_
22	mother	_	ADJ	JJ	_	19	nmod	_	_

#	Halcion	5044
1	In	_	ADP	IN	_	4	case	_	_
2	sleep	_	NOUN	NN	_	4	amod	_	_
3	laboratory	_	ADJ	JJ	_	4	amod	_	_
4	studies	_	NOUN	NNS	_	9	nmod	_	_
5	,	_	.	,	_	9	punct	_	_
6	DRUG	_	NOUN	NN	_	7	compound	_	_
7	Tablets	_	NOUN	NNS	_	9	nsubj	_	_
8	significantly	_	ADV	RB	_	9	advmod	_	_
9	decreased	_	VERB	VBD	_	0	root	_	_
10	sleep	_	NOUN	NN	_	11	compound	_	_
11	latency	_	NOUN	NN	_	9	dobj	_	_
12	,	_	.	,	_	9	punct	_	_
13	increased	_	VERB	VBD	_	9	conj	_	_
14	the	_	DET	DT	_	15	det	_	_
15	duration	_	NOUN	NN	_	13	dobj	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	sleep	_	NOUN	NN	_	15	nmod	_	_
18	,	_	.	,	_	9	punct	_	_
19	and	_	CONJ	CC	_	9	cc	_	_
20	decreased	_	VERB	VBD	_	9	conj	_	_
21	the	_	DET	DT	_	22	det	_	_
22	number	_	NOUN	NN	_	20	dobj	_	_
23	of	_	ADP	IN	_	25	case	_	_
24	nocturnal	_	ADJ	JJ	_	25	amod	_	_
25	awakenings	_	NOUN	NNS	_	22	nmod	_	_

#	Halcion	5045
1	After	_	ADP	IN	_	3	case	_	_
2	2	_	NUM	CD	_	3	nummod	_	_
3	weeks	_	NOUN	NNS	_	17	nmod	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	consecutive	_	ADJ	JJ	_	7	amod	_	_
6	nightly	_	ADV	RB	_	7	advmod	_	_
7	administration	_	NOUN	NN	_	3	nmod	_	_
8	,	_	.	,	_	17	punct	_	_
9	the	_	DET	DT	_	11	det	_	_
10	drug's	_	NOUN	NNS	_	11	compound	_	_
11	effect	_	NOUN	NN	_	17	nsubjpass	_	_
12	on	_	ADP	IN	_	15	case	_	_
13	total	_	ADJ	JJ	_	15	amod	_	_
14	wake	_	ADJ	JJ	_	15	amod	_	_
15	time	_	NOUN	NN	_	11	nmod	_	_
16	is	_	VERB	VBZ	_	17	auxpass	_	_
17	decreased	_	VERB	VBN	_	0	root	_	_
18	,	_	.	,	_	17	punct	_	_
19	and	_	CONJ	CC	_	17	cc	_	_
20	the	_	DET	DT	_	21	det	_	_
21	values	_	NOUN	NNS	_	17	conj	_	_
22	recorded	_	VERB	VBN	_	21	acl	_	_
23	in	_	ADP	IN	_	26	case	_	_
24	the	_	DET	DT	_	26	det	_	_
25	last	_	ADJ	JJ	_	26	amod	_	_
26	third	_	NOUN	NN	_	22	nmod	_	_
27	of	_	ADP	IN	_	32	case	_	_
28	the	_	DET	DT	_	32	det	_	_
29	night	_	VERB	MD	_	30	advmod	_	_
30	approach	_	NOUN	NN	_	32	compound	_	_
31	baseline	_	NOUN	NN	_	32	compound	_	_
32	levels	_	NOUN	NNS	_	26	nmod	_	_

#	Halcion	5046
1	On	_	ADP	IN	_	12	case	_	_
2	the	_	DET	DT	_	12	dep	_	_
3	first	_	ADJ	JJ	_	12	nsubj	_	_
4	and	_	CONJ	CC	_	3	cc	_	_
5	/	_	NOUN	NN	_	3	conj	_	_
6	or	_	CONJ	CC	_	3	cc	_	_
7	second	_	ADJ	JJ	_	3	conj	_	_
8	night	_	VERB	MD	_	12	aux	_	_
9	after	_	ADP	IN	_	12	case	_	_
10	drug	_	NOUN	NN	_	12	nmod:npmod	_	_
11	discontinuance	_	NOUN	NN	_	12	nmod:npmod	_	_
12	first	_	ADJ	JJ	_	21	nsubj	_	_
13	or	_	CONJ	CC	_	12	cc	_	_
14	second	_	ADJ	JJ	_	16	amod	_	_
15	post	_	ADJ	JJ	_	16	amod	_	_
16	drug	_	NOUN	NN	_	12	conj	_	_
17	night	_	VERB	MD	_	21	aux	_	_
18	,	_	.	,	_	21	punct	_	_
19	total	_	ADJ	JJ	_	21	amod	_	_
20	time	_	NOUN	NN	_	21	compound	_	_
21	asleep	_	NOUN	NN	_	0	root	_	_
22	,	_	.	,	_	21	punct	_	_
23	percentage	_	NOUN	NN	_	21	conj	_	_
24	of	_	ADP	IN	_	27	case	_	_
25	time	_	NOUN	NN	_	27	compound	_	_
26	spent	_	ADJ	JJ	_	27	amod	_	_
27	sleeping	_	NOUN	NN	_	23	nmod	_	_
28	,	_	.	,	_	21	punct	_	_
29	and	_	CONJ	CC	_	21	cc	_	_
30	rapidity	_	NOUN	NN	_	21	conj	_	_
31	of	_	ADP	IN	_	33	case	_	_
32	falling	_	VERB	VBG	_	33	amod	_	_
33	asleep	_	NOUN	NN	_	30	nmod	_	_
34	frequently	_	ADV	RB	_	37	advmod	_	_
35	were	_	VERB	VBD	_	37	cop	_	_
36	significantly	_	ADV	RB	_	37	advmod	_	_
37	less	_	ADV	RB	_	21	dep	_	_
38	than	_	ADP	IN	_	42	case	_	_
39	on	_	ADP	IN	_	42	case	_	_
40	baseline	_	NOUN	NN	_	42	compound	_	_
41	predrug	_	NOUN	NN	_	42	compound	_	_
42	nights	_	NOUN	NNS	_	37	nmod	_	_

#	Halcion	5047
1	This	_	DET	DT	_	2	det	_	_
2	effect	_	NOUN	NN	_	5	nsubjpass	_	_
3	is	_	VERB	VBZ	_	5	auxpass	_	_
4	often	_	ADV	RB	_	5	advmod	_	_
5	called	_	VERB	VBN	_	0	root	_	_
6	"rebound"	_	NOUN	NN	_	7	compound	_	_
7	insomnia	_	NOUN	NN	_	5	xcomp	_	_

#	Halcion	5048
1	The	_	DET	DT	_	2	det	_	_
2	type	_	NOUN	NN	_	21	nsubjpass	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	duration	_	NOUN	NN	_	2	conj	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	hypnotic	_	ADJ	JJ	_	7	amod	_	_
7	effects	_	NOUN	NNS	_	2	nmod	_	_
8	and	_	CONJ	CC	_	2	cc	_	_
9	the	_	DET	DT	_	10	det	_	_
10	profile	_	NOUN	NN	_	2	conj	_	_
11	of	_	ADP	IN	_	13	case	_	_
12	unwanted	_	ADJ	JJ	_	13	amod	_	_
13	effects	_	NOUN	NNS	_	10	nmod	_	_
14	during	_	ADP	IN	_	15	case	_	_
15	administration	_	NOUN	NN	_	2	nmod	_	_
16	of	_	ADP	IN	_	18	case	_	_
17	benzodiazepine	_	NOUN	NN	_	18	compound	_	_
18	drugs	_	NOUN	NNS	_	15	nmod	_	_
19	may	_	VERB	MD	_	21	aux	_	_
20	be	_	VERB	VB	_	21	auxpass	_	_
21	influenced	_	VERB	VBN	_	0	root	_	_
22	by	_	ADP	IN	_	26	case	_	_
23	the	_	DET	DT	_	26	det	_	_
24	biologic	_	ADJ	JJ	_	26	amod	_	_
25	half	_	ADJ	JJ	_	26	amod	_	_
26	life	_	NOUN	NN	_	21	nmod	_	_
27	of	_	ADP	IN	_	29	case	_	_
28	administered	_	VERB	VBN	_	29	amod	_	_
29	drug	_	NOUN	NN	_	26	nmod	_	_
30	and	_	CONJ	CC	_	21	cc	_	_
31	any	_	DET	DT	_	33	det	_	_
32	active	_	ADJ	JJ	_	33	amod	_	_
33	metabolites	_	NOUN	NNS	_	34	nsubj	_	_
34	formed	_	VERB	VBN	_	21	conj	_	_

#	Halcion	5049
1	When	_	ADV	WRB	_	5	advmod	_	_
2	half	_	ADJ	JJ	_	3	amod	_	_
3	lives	_	NOUN	NNS	_	5	nsubj	_	_
4	are	_	VERB	VBP	_	5	cop	_	_
5	long	_	ADJ	JJ	_	12	advcl	_	_
6	,	_	.	,	_	12	punct	_	_
7	the	_	DET	DT	_	8	dep	_	_
8	drug	_	NOUN	NN	_	12	nsubj	_	_
9	or	_	CONJ	CC	_	8	cc	_	_
10	metabolites	_	NOUN	NNS	_	8	conj	_	_
11	may	_	VERB	MD	_	12	aux	_	_
12	accumulate	_	VERB	VB	_	0	root	_	_
13	during	_	ADP	IN	_	14	case	_	_
14	periods	_	NOUN	NNS	_	12	nmod	_	_
15	of	_	ADP	IN	_	17	case	_	_
16	nightly	_	ADV	RB	_	17	advmod	_	_
17	administration	_	NOUN	NN	_	14	nmod	_	_
18	and	_	CONJ	CC	_	12	cc	_	_
19	be	_	VERB	VBZ	_	20	auxpass	_	_
20	associated	_	VERB	VBN	_	43	advcl	_	_
21	with	_	ADP	IN	_	22	case	_	_
22	impairments	_	NOUN	NNS	_	20	nmod	_	_
23	of	_	ADP	IN	_	27	case	_	_
24	cognitive	_	ADJ	JJ	_	27	amod	_	_
25	and	_	CONJ	CC	_	24	cc	_	_
26	motor	_	NOUN	NN	_	24	conj	_	_
27	performance	_	NOUN	NN	_	22	nmod	_	_
28	during	_	ADP	IN	_	30	case	_	_
29	waking	_	VERB	VBG	_	30	amod	_	_
30	hours	_	NOUN	NNS	_	20	nmod	_	_
31	the	_	DET	DT	_	32	det	_	_
32	possibility	_	NOUN	NN	_	43	nsubjpass	_	_
33	of	_	ADP	IN	_	34	case	_	_
34	interaction	_	NOUN	NN	_	32	nmod	_	_
35	with	_	ADP	IN	_	38	case	_	_
36	other	_	ADJ	JJ	_	38	amod	_	_
37	psychoactive	_	ADJ	JJ	_	38	amod	_	_
38	drugs	_	NOUN	NNS	_	34	nmod	_	_
39	or	_	CONJ	CC	_	38	cc	_	_
40	alcohol	_	NOUN	NN	_	38	conj	_	_
41	will	_	VERB	MD	_	43	aux	_	_
42	be	_	VERB	VB	_	43	auxpass	_	_
43	enhanced	_	VERB	VBN	_	12	conj	_	_

#	Halcion	5050
1	In	_	ADP	IN	_	2	case	_	_
2	contrast	_	NOUN	NN	_	16	nmod	_	_
3	,	_	.	,	_	16	punct	_	_
4	if	_	ADP	IN	_	8	mark	_	_
5	half	_	ADJ	JJ	_	6	amod	_	_
6	lives	_	NOUN	NNS	_	8	nsubj	_	_
7	are	_	VERB	VBP	_	8	cop	_	_
8	short	_	ADJ	JJ	_	16	advcl	_	_
9	,	_	.	,	_	16	punct	_	_
10	the	_	DET	DT	_	11	dep	_	_
11	drug	_	NOUN	NN	_	16	nsubjpass	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	metabolites	_	NOUN	NNS	_	11	conj	_	_
14	will	_	VERB	MD	_	16	aux	_	_
15	be	_	VERB	VB	_	16	auxpass	_	_
16	cleared	_	VERB	VBN	_	0	root	_	_
17	before	_	ADP	IN	_	20	case	_	_
18	the	_	DET	DT	_	20	det	_	_
19	next	_	ADV	RB	_	20	advmod	_	_
20	dose	_	NOUN	NN	_	16	nmod	_	_
21	is	_	VERB	VBZ	_	22	auxpass	_	_
22	ingested	_	VERB	VBN	_	16	parataxis	_	_
23	,	_	.	,	_	22	punct	_	_
24	and	_	CONJ	CC	_	22	cc	_	_
25	carry	_	VERB	VB	_	37	nsubj	_	_
26	over	_	ADP	IN	_	27	case	_	_
27	effects	_	NOUN	NNS	_	25	nmod	_	_
28	related	_	ADJ	JJ	_	27	amod	_	_
29	to	_	PRT	TO	_	31	case	_	_
30	excessive	_	ADJ	JJ	_	31	amod	_	_
31	sedation	_	NOUN	NN	_	28	nmod	_	_
32	or	_	CONJ	CC	_	31	cc	_	_
33	CNS	_	NOUN	NN	_	34	compound	_	_
34	depression	_	NOUN	NN	_	31	conj	_	_
35	should	_	VERB	MD	_	37	aux	_	_
36	be	_	VERB	VB	_	37	cop	_	_
37	minimal	_	ADJ	JJ	_	22	conj	_	_
38	or	_	CONJ	CC	_	37	cc	_	_
39	absent	_	ADJ	JJ	_	37	conj	_	_

#	Halcion	5051
1	However	_	ADV	RB	_	21	advmod	_	_
2	,	_	.	,	_	21	punct	_	_
3	during	_	ADP	IN	_	5	case	_	_
4	nightly	_	ADV	RB	_	5	advmod	_	_
5	use	_	NOUN	NN	_	21	nsubj	_	_
6	for	_	ADP	IN	_	11	case	_	_
7	an	_	DET	DT	_	11	det	_	_
8	extended	_	VERB	VBN	_	11	amod	_	_
9	period	_	NOUN	NN	_	11	compound	_	_
10	pharmacodynamic	_	ADJ	JJ	_	11	amod	_	_
11	tolerance	_	NOUN	NN	_	5	nmod	_	_
12	or	_	CONJ	CC	_	11	cc	_	_
13	adaptation	_	NOUN	NN	_	11	conj	_	_
14	to	_	PRT	TO	_	16	case	_	_
15	some	_	DET	DT	_	16	det	_	_
16	effects	_	NOUN	NNS	_	5	nmod	_	_
17	of	_	ADP	IN	_	19	case	_	_
18	benzodiazepine	_	NOUN	NN	_	19	compound	_	_
19	hypnotics	_	NOUN	NNS	_	16	nmod	_	_
20	may	_	VERB	MD	_	21	aux	_	_
21	develop	_	VERB	VB	_	0	root	_	_

#	Halcion	5052
1	If	_	ADP	IN	_	3	case	_	_
2	the	_	DET	DT	_	3	det	_	_
3	drug	_	NOUN	NN	_	4	nsubj	_	_
4	has	_	VERB	VBZ	_	14	advcl	_	_
5	a	_	DET	DT	_	8	det	_	_
6	short	_	ADJ	JJ	_	8	amod	_	_
7	half	_	ADJ	JJ	_	8	amod	_	_
8	life	_	NOUN	NN	_	4	dobj	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	elimination	_	NOUN	NN	_	8	nmod	_	_
11	,	_	.	,	_	14	punct	_	_
12	it	_	PRON	PRP	_	14	nsubj	_	_
13	is	_	VERB	VBZ	_	14	cop	_	_
14	possible	_	ADJ	JJ	_	0	root	_	_
15	that	_	ADP	IN	_	35	mark	_	_
16	a	_	DET	DT	_	18	det	_	_
17	relative	_	ADJ	JJ	_	18	amod	_	_
18	deficiency	_	NOUN	NN	_	35	nsubj	_	_
19	of	_	ADP	IN	_	21	case	_	_
20	the	_	DET	DT	_	21	det	_	_
21	drug	_	NOUN	NN	_	18	nmod	_	_
22	or	_	CONJ	CC	_	21	cc	_	_
23	its	_	PRON	PRP$	_	25	nmod:poss	_	_
24	active	_	ADJ	JJ	_	25	amod	_	_
25	metabolites	_	NOUN	NNS	_	21	conj	_	_
26	ie	_	ADV	RB	_	35	advmod	_	_
27	,	_	.	,	_	35	punct	_	_
28	in	_	ADP	IN	_	29	case	_	_
29	relationship	_	NOUN	NN	_	35	nmod	_	_
30	to	_	PRT	TO	_	33	case	_	_
31	the	_	DET	DT	_	33	det	_	_
32	receptor	_	NOUN	NN	_	33	compound	_	_
33	site	_	NOUN	NN	_	29	nmod	_	_
34	may	_	VERB	MD	_	35	aux	_	_
35	occur	_	VERB	VB	_	14	ccomp	_	_
36	at	_	ADP	IN	_	38	case	_	_
37	some	_	DET	DT	_	38	det	_	_
38	point	_	NOUN	NN	_	35	nmod	_	_
39	in	_	ADP	IN	_	41	case	_	_
40	the	_	DET	DT	_	41	det	_	_
41	interval	_	ADJ	JJ	_	38	nmod	_	_
42	between	_	ADP	IN	_	44	case	_	_
43	each	_	DET	DT	_	44	det	_	_
44	night's	_	NOUN	NNS	_	41	nmod	_	_
45	use	_	VERB	VBP	_	35	parataxis	_	_

#	Halcion	5053
1	This	_	DET	DT	_	2	det	_	_
2	sequence	_	NOUN	NN	_	6	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	events	_	NOUN	NNS	_	2	nmod	_	_
5	may	_	VERB	MD	_	6	aux	_	_
6	account	_	VERB	VB	_	0	root	_	_
7	for	_	ADP	IN	_	10	case	_	_
8	two	_	NUM	CD	_	10	nummod	_	_
9	clinical	_	ADJ	JJ	_	10	amod	_	_
10	findings	_	NOUN	NNS	_	6	nmod	_	_
11	reported	_	VERB	VBN	_	10	acl	_	_
12	to	_	PRT	TO	_	13	mark	_	_
13	occur	_	VERB	VB	_	11	xcomp	_	_
14	after	_	ADP	IN	_	16	case	_	_
15	several	_	ADJ	JJ	_	16	amod	_	_
16	weeks	_	NOUN	NNS	_	13	nmod	_	_
17	of	_	ADP	IN	_	19	case	_	_
18	nightly	_	ADV	RB	_	19	advmod	_	_
19	use	_	NOUN	NN	_	16	nmod	_	_
20	of	_	ADP	IN	_	24	case	_	_
21	rapidly	_	ADV	RB	_	22	advmod	_	_
22	eliminated	_	VERB	VBN	_	24	amod	_	_
23	benzodiazepine	_	NOUN	NN	_	24	compound	_	_
24	hypnotics	_	NOUN	NNS	_	19	nmod	_	_
25	:	_	.	:	_	6	punct	_	_
26	1	_	NUM	CD	_	28	nummod	_	_
27	increased	_	VERB	VBN	_	28	amod	_	_
28	wakefulness	_	NOUN	NN	_	6	parataxis	_	_
29	during	_	ADP	IN	_	32	case	_	_
30	the	_	DET	DT	_	32	det	_	_
31	last	_	ADJ	JJ	_	32	amod	_	_
32	third	_	NOUN	NN	_	28	nmod	_	_
33	of	_	ADP	IN	_	39	case	_	_
34	the	_	DET	DT	_	39	det	_	_
35	night	_	VERB	MD	_	39	dep	_	_
36	and	_	CONJ	CC	_	35	cc	_	_
37	2	_	NUM	CD	_	35	conj	_	_
38	the	_	DET	DT	_	39	det	_	_
39	appearance	_	NOUN	NN	_	32	nmod	_	_
40	of	_	ADP	IN	_	43	case	_	_
41	increased	_	VERB	VBN	_	43	amod	_	_
42	daytime	_	ADJ	JJ	_	43	amod	_	_
43	anxiety	_	NOUN	NN	_	39	nmod	_	_
44	after	_	ADP	IN	_	46	case	_	_
45	10	_	NUM	CD	_	46	nummod	_	_
46	days	_	NOUN	NNS	_	28	nmod	_	_
47	of	_	ADP	IN	_	49	case	_	_
48	continuous	_	ADJ	JJ	_	49	amod	_	_
49	treatment	_	NOUN	NN	_	46	nmod	_	_

#	Halcion	5054
1	In	_	ADP	IN	_	3	case	_	_
2	a	_	DET	DT	_	3	det	_	_
3	study	_	NOUN	NN	_	33	nmod	_	_
4	of	_	ADP	IN	_	8	case	_	_
5	elderly	_	ADJ	JJ	_	8	amod	_	_
6	62	_	NUM	CD	_	8	nummod	_	_
7	83	_	NUM	CD	_	8	nummod	_	_
8	years	_	NOUN	NNS	_	3	nmod	_	_
9	old	_	ADJ	JJ	_	16	nsubj	_	_
10	versus	_	CONJ	CC	_	9	cc	_	_
11	younger	_	ADJ	JJ	_	9	conj	_	_
12	subjects	_	NOUN	NNS	_	15	compound	_	_
13	21	_	NUM	CD	_	15	nummod	_	_
14	41	_	NUM	CD	_	15	nummod	_	_
15	years	_	NOUN	NNS	_	9	dep	_	_
16	old	_	ADJ	JJ	_	8	amod	_	_
17	who	_	DET	WDT	_	18	nsubj	_	_
18	received	_	VERB	VBD	_	16	ccomp	_	_
19	DRUG	_	NOUN	NN	_	18	dobj	_	_
20	at	_	ADP	IN	_	24	case	_	_
21	the	_	DET	DT	_	24	det	_	_
22	same	_	ADJ	JJ	_	24	amod	_	_
23	dose	_	NOUN	NN	_	24	compound	_	_
24	levels	_	NOUN	NNS	_	18	nmod	_	_
25	0.125	_	NUM	CD	_	26	nummod	_	_
26	mg	_	NOUN	NN	_	24	dep	_	_
27	and	_	CONJ	CC	_	26	cc	_	_
28	0.25	_	NUM	CD	_	29	nummod	_	_
29	mg	_	NOUN	NN	_	26	conj	_	_
30	,	_	.	,	_	33	punct	_	_
31	the	_	DET	DT	_	32	det	_	_
32	elderly	_	NOUN	NN	_	33	nsubj	_	_
33	experienced	_	VERB	VBD	_	0	root	_	_
34	both	_	CONJ	CC	_	36	cc:preconj	_	_
35	greater	_	ADJ	JJ	_	36	amod	_	_
36	sedation	_	NOUN	NN	_	33	dobj	_	_
37	and	_	CONJ	CC	_	36	cc	_	_
38	impairment	_	NOUN	NN	_	36	conj	_	_
39	of	_	ADP	IN	_	41	case	_	_
40	psychomotor	_	NOUN	NN	_	41	compound	_	_
41	performance	_	NOUN	NN	_	36	nmod	_	_

#	Halcion	5055
1	These	_	DET	DT	_	2	det	_	_
2	effects	_	NOUN	NNS	_	3	nsubj	_	_
3	resulted	_	VERB	VBD	_	0	root	_	_
4	largely	_	ADV	RB	_	3	advmod	_	_
5	from	_	ADP	IN	_	8	case	_	_
6	higher	_	ADJ	JJ	_	8	amod	_	_
7	plasma	_	NOUN	NN	_	8	compound	_	_
8	concentrations	_	NOUN	NNS	_	3	nmod	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	in	_	ADP	IN	_	13	case	_	_
12	the	_	DET	DT	_	13	det	_	_
13	elderly	_	ADJ	JJ	_	8	nmod	_	_

#	Haloperidol	5129
1	The	_	DET	DT	_	3	det	_	_
2	precise	_	ADJ	JJ	_	3	amod	_	_
3	mechanism	_	NOUN	NN	_	10	nsubjpass	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	action	_	NOUN	NN	_	3	nmod	_	_
6	has	_	VERB	VBZ	_	10	aux	_	_
7	not	_	ADV	RB	_	10	neg	_	_
8	been	_	VERB	VBN	_	10	auxpass	_	_
9	clearly	_	ADV	RB	_	10	advmod	_	_
10	established	_	VERB	VBN	_	0	root	_	_

#	Harvoni	4334
1	Coadministration	_	NOUN	NN	_	5	nsubj	_	_
2	with	_	ADP	IN	_	3	case	_	_
3	amiodarone	_	NOUN	NN	_	1	nmod	_	_
4	may	_	VERB	MD	_	5	aux	_	_
5	result	_	VERB	VB	_	0	root	_	_
6	in	_	ADP	IN	_	9	case	_	_
7	serious	_	ADJ	JJ	_	9	amod	_	_
8	symptomatic	_	ADJ	JJ	_	9	amod	_	_
9	bradycardia	_	NOUN	NN	_	5	nmod	_	_

#	Harvoni	4335
1	Use	_	NOUN	NN	_	8	nsubjpass	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	with	_	ADP	IN	_	5	case	_	_
5	amiodarone	_	NOUN	NN	_	1	nmod	_	_
6	is	_	VERB	VBZ	_	8	auxpass	_	_
7	not	_	ADV	RB	_	8	neg	_	_
8	recommended	_	VERB	VBN	_	0	root	_	_

#	Harvoni	4336
1	P	_	NOUN	NN	_	3	compound	_	_
2	gp	_	NOUN	NN	_	3	compound	_	_
3	inducers	_	NOUN	NNS	_	10	nsubj	_	_
4	e.g	_	NOUN	NN	_	3	dep	_	_
5	,	_	.	,	_	4	punct	_	_
6	rifampin	_	NOUN	NN	_	4	conj	_	_
7	,	_	.	,	_	4	punct	_	_
8	St	_	NOUN	NN	_	9	compound	_	_
9	John's	_	NOUN	NNS	_	4	appos	_	_
10	wort	_	ADV	RB	_	0	root	_	_
11	:	_	.	:	_	10	punct	_	_
12	May	_	NOUN	NN	_	13	nsubj	_	_
13	alter	_	VERB	VBP	_	10	parataxis	_	_
14	concentrations	_	NOUN	NNS	_	13	dobj	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	14	nmod	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	DRUG	_	NOUN	NN	_	16	conj	_	_

#	Harvoni	4337
1	Use	_	NOUN	NN	_	10	nsubjpass	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	with	_	ADP	IN	_	7	case	_	_
5	P	_	NOUN	NN	_	7	compound	_	_
6	gp	_	NOUN	NN	_	7	compound	_	_
7	inducers	_	NOUN	NNS	_	1	nmod	_	_
8	is	_	VERB	VBZ	_	10	auxpass	_	_
9	not	_	ADV	RB	_	10	neg	_	_
10	recommended	_	VERB	VBN	_	0	root	_	_

#	Harvoni	4338
1	Frequent	_	ADJ	JJ	_	2	amod	_	_
2	monitoring	_	NOUN	NN	_	10	nsubjpass	_	_
3	of	_	ADP	IN	_	8	case	_	_
4	international	_	ADJ	JJ	_	8	amod	_	_
5	normalized	_	ADJ	JJ	_	8	amod	_	_
6	ratio	_	NOUN	NN	_	8	compound	_	_
7	INR	_	NOUN	NN	_	8	compound	_	_
8	values	_	NOUN	NNS	_	2	nmod	_	_
9	is	_	VERB	VBZ	_	10	auxpass	_	_
10	recommended	_	VERB	VBN	_	0	root	_	_
11	in	_	ADP	IN	_	12	case	_	_
12	patients	_	NOUN	NNS	_	10	nmod	_	_
13	receiving	_	VERB	VBG	_	12	acl	_	_
14	warfarin	_	NOUN	NN	_	13	nmod	_	_

#	Harvoni	4339
1	Consult	_	VERB	VB	_	0	root	_	_
2	the	_	DET	DT	_	5	det	_	_
3	full	_	ADJ	JJ	_	5	amod	_	_
4	prescribing	_	NOUN	NN	_	5	compound	_	_
5	information	_	NOUN	NN	_	1	dobj	_	_
6	prior	_	ADJ	JJ	_	5	amod	_	_
7	to	_	PRT	TO	_	8	mark	_	_
8	use	_	NOUN	NN	_	6	nmod	_	_
9	for	_	ADP	IN	_	12	case	_	_
10	potential	_	ADJ	JJ	_	12	amod	_	_
11	drug	_	NOUN	NN	_	12	compound	_	_
12	interactions	_	NOUN	NNS	_	8	nmod	_	_

#	Harvoni	4340
1	As	_	ADP	IN	_	3	mark	_	_
2	DRUG	_	NOUN	NN	_	3	nsubj	_	_
3	contains	_	VERB	VBZ	_	19	advcl	_	_
4	DRUG	_	NOUN	NN	_	3	dobj	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	DRUG	_	NOUN	NN	_	4	conj	_	_
7	,	_	.	,	_	19	punct	_	_
8	any	_	DET	DT	_	9	det	_	_
9	interactions	_	NOUN	NNS	_	19	nsubj	_	_
10	that	_	DET	WDT	_	13	nsubjpass	_	_
11	have	_	VERB	VBP	_	13	aux	_	_
12	been	_	VERB	VBN	_	13	auxpass	_	_
13	identified	_	VERB	VBN	_	9	acl:relcl	_	_
14	with	_	ADP	IN	_	16	case	_	_
15	these	_	DET	DT	_	16	det	_	_
16	agents	_	NOUN	NNS	_	13	nmod	_	_
17	individually	_	ADV	RB	_	19	advmod	_	_
18	may	_	VERB	MD	_	19	aux	_	_
19	occur	_	VERB	VB	_	0	root	_	_
20	with	_	ADP	IN	_	21	case	_	_
21	DRUG	_	NOUN	NN	_	19	nmod	_	_

#	Harvoni	4341
1	After	_	ADP	IN	_	3	case	_	_
2	oral	_	ADJ	JJ	_	3	amod	_	_
3	administration	_	NOUN	NN	_	10	nmod	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	,	_	.	,	_	10	punct	_	_
7	DRUG	_	NOUN	NN	_	10	nsubjpass	_	_
8	is	_	VERB	VBZ	_	10	auxpass	_	_
9	rapidly	_	ADV	RB	_	10	advmod	_	_
10	absorbed	_	VERB	VBN	_	0	root	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	subject	_	NOUN	NN	_	10	conj	_	_
13	to	_	PRT	TO	_	18	case	_	_
14	extensive	_	ADJ	JJ	_	18	amod	_	_
15	first	_	ADJ	JJ	_	18	amod	_	_
16	pass	_	NOUN	NN	_	18	compound	_	_
17	hepatic	_	ADJ	JJ	_	18	amod	_	_
18	extraction	_	NOUN	NN	_	12	nmod	_	_

#	Harvoni	4342
1	In	_	ADP	IN	_	4	case	_	_
2	clinical	_	ADJ	JJ	_	4	amod	_	_
3	pharmacology	_	NOUN	NN	_	4	compound	_	_
4	studies	_	NOUN	NNS	_	15	nmod	_	_
5	,	_	.	,	_	15	punct	_	_
6	both	_	CONJ	CC	_	7	cc:preconj	_	_
7	DRUG	_	NOUN	NN	_	15	nsubjpass	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	the	_	DET	DT	_	12	det	_	_
10	inactive	_	ADJ	JJ	_	12	amod	_	_
11	metabolite	_	NOUN	NN	_	12	compound	_	_
12	GS	_	NOUN	NN	_	7	conj	_	_
13	331007	_	NUM	CD	_	12	nummod	_	_
14	were	_	VERB	VBD	_	15	auxpass	_	_
15	monitored	_	VERB	VBN	_	0	root	_	_
16	for	_	ADP	IN	_	17	case	_	_
17	purposes	_	NOUN	NNS	_	15	nmod	_	_
18	of	_	ADP	IN	_	20	case	_	_
19	pharmacokinetic	_	ADJ	JJ	_	20	amod	_	_
20	analyses	_	NOUN	NNS	_	17	nmod	_	_

#	Harvoni	4343
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	is	_	VERB	VBZ	_	4	cop	_	_
3	an	_	DET	DT	_	4	det	_	_
4	inhibitor	_	NOUN	NN	_	0	root	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	the	_	DET	DT	_	8	det	_	_
7	drug	_	NOUN	NN	_	8	compound	_	_
8	transporters	_	NOUN	NNS	_	4	nmod	_	_
9	P	_	NOUN	NN	_	10	compound	_	_
10	gp	_	NOUN	NN	_	8	dep	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	breast	_	NOUN	NN	_	16	compound	_	_
13	cancer	_	NOUN	NN	_	16	compound	_	_
14	resistance	_	NOUN	NN	_	16	compound	_	_
15	protein	_	NOUN	NN	_	16	compound	_	_
16	BCRP	_	NOUN	NN	_	10	conj	_	_
17	and	_	CONJ	CC	_	4	cc	_	_
18	may	_	VERB	MD	_	19	aux	_	_
19	increase	_	VERB	VB	_	4	conj	_	_
20	intestinal	_	ADJ	JJ	_	21	amod	_	_
21	absorption	_	NOUN	NN	_	19	dobj	_	_
22	of	_	ADP	IN	_	24	case	_	_
23	coadministered	_	VERB	VBN	_	24	amod	_	_
24	substrates	_	NOUN	NNS	_	21	nmod	_	_
25	for	_	ADP	IN	_	27	case	_	_
26	these	_	DET	DT	_	27	det	_	_
27	transporters	_	NOUN	NNS	_	24	nmod	_	_

#	Harvoni	4344
1	DRUG	_	NOUN	NN	_	5	nsubj	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	DRUG	_	NOUN	NN	_	1	conj	_	_
4	are	_	VERB	VBP	_	5	cop	_	_
5	substrates	_	NOUN	NNS	_	0	root	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	drug	_	NOUN	NN	_	8	compound	_	_
8	transporters	_	NOUN	NNS	_	5	nmod	_	_
9	P	_	NOUN	NN	_	10	compound	_	_
10	gp	_	NOUN	NN	_	8	dep	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	BCRP	_	NOUN	NN	_	10	conj	_	_
13	while	_	ADP	IN	_	16	mark	_	_
14	GS	_	NOUN	NN	_	16	nsubj	_	_
15	331007	_	NUM	CD	_	14	nummod	_	_
16	is	_	VERB	VBZ	_	5	root	_	_
17	not	_	ADV	RB	_	16	neg	_	_

#	Harvoni	4346
1	Fluctuations	_	NOUN	NNS	_	6	nsubj	_	_
2	in	_	ADP	IN	_	4	case	_	_
3	INR	_	NOUN	NN	_	4	compound	_	_
4	values	_	NOUN	NNS	_	1	nmod	_	_
5	may	_	VERB	MD	_	6	aux	_	_
6	occur	_	VERB	VB	_	0	root	_	_
7	in	_	ADP	IN	_	8	case	_	_
8	patients	_	NOUN	NNS	_	6	nmod	_	_
9	receiving	_	VERB	VBG	_	8	acl	_	_
10	warfarin	_	NOUN	NN	_	9	dobj	_	_
11	concomitant	_	ADJ	JJ	_	10	amod	_	_
12	with	_	ADP	IN	_	14	case	_	_
13	HCV	_	NOUN	NN	_	14	compound	_	_
14	treatment	_	NOUN	NN	_	11	nmod	_	_
15	,	_	.	,	_	6	punct	_	_
16	including	_	VERB	VBG	_	17	case	_	_
17	treatment	_	NOUN	NN	_	6	nmod	_	_
18	with	_	ADP	IN	_	19	case	_	_
19	DRUG	_	NOUN	NN	_	17	nmod	_	_

#	Harvoni	4347
1	Frequent	_	ADJ	JJ	_	2	amod	_	_
2	monitoring	_	NOUN	NN	_	7	nsubjpass	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	INR	_	NOUN	NN	_	5	compound	_	_
5	values	_	NOUN	NNS	_	2	nmod	_	_
6	is	_	VERB	VBZ	_	7	auxpass	_	_
7	recommended	_	VERB	VBN	_	0	root	_	_
8	during	_	ADP	IN	_	9	case	_	_
9	treatment	_	NOUN	NN	_	7	nmod	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	post	_	ADJ	JJ	_	12	amod	_	_
12	treatment	_	NOUN	NN	_	9	conj	_	_
13	follow	_	VERB	VBP	_	7	parataxis	_	_
14	up	_	PRON	PRP$	_	13	neg	_	_

#	Harvoni	4348
1	Table	_	ADJ	JJ	_	3	nsubj	_	_
2	5	_	NUM	CD	_	1	dep	_	_
3	provides	_	VERB	VBZ	_	0	root	_	_
4	a	_	DET	DT	_	5	det	_	_
5	listing	_	NOUN	NN	_	3	dobj	_	_
6	of	_	ADP	IN	_	13	case	_	_
7	established	_	VERB	VBN	_	13	amod	_	_
8	or	_	CONJ	CC	_	7	cc	_	_
9	potentially	_	ADV	RB	_	10	advmod	_	_
10	clinically	_	ADV	RB	_	11	advmod	_	_
11	significant	_	ADJ	JJ	_	7	conj	_	_
12	drug	_	NOUN	NN	_	13	compound	_	_
13	interactions	_	NOUN	NNS	_	5	nmod	_	_

#	Harvoni	4349
1	The	_	DET	DT	_	3	det	_	_
2	drug	_	NOUN	NN	_	3	compound	_	_
3	interactions	_	NOUN	NNS	_	6	nsubjpass	_	_
4	described	_	VERB	VBN	_	3	acl	_	_
5	are	_	VERB	VBP	_	6	auxpass	_	_
6	based	_	VERB	VBN	_	0	root	_	_
7	on	_	ADP	IN	_	8	case	_	_
8	studies	_	NOUN	NNS	_	6	nmod	_	_
9	conducted	_	VERB	VBN	_	8	acl	_	_
10	with	_	ADP	IN	_	12	case	_	_
11	either	_	CONJ	CC	_	12	cc:preconj	_	_
12	DRUG	_	NOUN	NN	_	9	nmod	_	_
13	,	_	.	,	_	12	punct	_	_
14	the	_	DET	DT	_	15	det	_	_
15	components	_	NOUN	NNS	_	12	appos	_	_
16	of	_	ADP	IN	_	18	case	_	_
17	DRUG	_	NOUN	NN	_	18	compound	_	_
18	DRUG	_	NOUN	NN	_	15	nmod	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	DRUG	_	NOUN	NN	_	18	conj	_	_
21	as	_	ADP	IN	_	23	case	_	_
22	individual	_	ADJ	JJ	_	23	amod	_	_
23	agents	_	NOUN	NNS	_	15	nmod	_	_
24	,	_	.	,	_	6	punct	_	_
25	or	_	CONJ	CC	_	6	cc	_	_
26	are	_	VERB	VBP	_	27	auxpass	_	_
27	predicted	_	VERB	VBN	_	6	conj	_	_
28	drug	_	NOUN	NN	_	29	compound	_	_
29	interactions	_	NOUN	NNS	_	27	xcomp	_	_
30	that	_	DET	WDT	_	32	nsubj	_	_
31	may	_	VERB	MD	_	32	aux	_	_
32	occur	_	VERB	VB	_	29	acl:relcl	_	_
33	with	_	ADP	IN	_	34	case	_	_
34	DRUG	_	NOUN	NN	_	32	nmod	_	_

#	Harvoni	4350
1	Table	_	ADJ	JJ	_	6	amod	_	_
2	5	_	NUM	CD	_	6	nummod	_	_
3	Potentially	_	ADV	RB	_	4	advmod	_	_
4	Significant	_	ADJ	JJ	_	6	amod	_	_
5	Drug	_	NOUN	NN	_	6	compound	_	_
6	Interactions	_	NOUN	NNS	_	0	root	_	_
7	:	_	.	:	_	6	punct	_	_
8	Alteration	_	NOUN	NN	_	15	nsubj	_	_
9	in	_	ADP	IN	_	10	case	_	_
10	Dose	_	NOUN	NN	_	8	nmod	_	_
11	or	_	CONJ	CC	_	10	cc	_	_
12	Regimen	_	NOUN	NN	_	14	compound	_	_
13	May	_	NOUN	NN	_	14	compound	_	_
14	Be	_	NOUN	NN	_	10	conj	_	_
15	Recommended	_	VERB	VBN	_	6	dep	_	_
16	Based	_	VERB	VBN	_	15	xcomp	_	_
17	on	_	ADP	IN	_	20	case	_	_
18	Drug	_	NOUN	NN	_	20	compound	_	_
19	Interaction	_	NOUN	NN	_	20	compound	_	_
20	Studies	_	NOUN	NNS	_	16	nmod	_	_
21	or	_	CONJ	CC	_	20	cc	_	_
22	Predicted	_	ADJ	JJ	_	24	amod	_	_
23	InteractionThis	_	NOUN	NN	_	24	compound	_	_
24	table	_	NOUN	NN	_	20	conj	_	_
25	is	_	VERB	VBZ	_	28	cop	_	_
26	not	_	ADV	RB	_	28	neg	_	_
27	all	_	DET	DT	_	28	det	_	_
28	inclusive	_	ADJ	JJ	_	15	dep	_	_

#	Harvoni	4351
1	Concomitant	_	ADJ	JJ	_	3	amod	_	_
2	Drug	_	NOUN	NN	_	3	compound	_	_
3	Class	_	NOUN	NN	_	0	root	_	_
4	:	_	.	:	_	3	punct	_	_
5	Drug	_	NOUN	NN	_	7	compound	_	_
6	Name	_	NOUN	NN	_	7	compound	_	_
7	Effect	_	NOUN	NN	_	3	dep	_	_
8	on	_	ADP	IN	_	11	case	_	_
9	Concentration*	_	NOUN	NN	_	11	compound	_	_
10	=	_	ADJ	JJ	_	11	amod	_	_
11	decrease	_	NOUN	NN	_	7	nmod	_	_
12	,	_	.	,	_	7	punct	_	_
13	*	_	DET	DT	_	15	advmod	_	_
14	=	_	DET	DT	_	15	punct	_	_
15	increase	_	VERB	VBP	_	7	acl:relcl	_	_
16	Clinical	_	ADJ	JJ	_	20	amod	_	_
17	Comment	_	NOUN	NN	_	20	compound	_	_
18	Acid	_	NOUN	NN	_	20	compound	_	_
19	Reducing	_	VERB	VBG	_	20	compound	_	_
20	Agents	_	NOUN	NNS	_	15	dobj	_	_
21	:	_	.	:	_	3	punct	_	_
22	*	_	DET	DT	_	25	det	_	_
23	DRUG	_	NOUN	NN	_	25	compound	_	_
24	DRUG	_	NOUN	NN	_	25	compound	_	_
25	solubility	_	NOUN	NN	_	26	nsubj	_	_
26	decreases	_	VERB	VBZ	_	3	dep	_	_
27	as	_	ADP	IN	_	29	mark	_	_
28	pH	_	NOUN	NN	_	29	nsubj	_	_
29	increases	_	VERB	VBZ	_	26	advcl	_	_

#	Harvoni	4352
1	Drugs	_	NOUN	NNS	_	7	nsubjpass	_	_
2	that	_	DET	WDT	_	3	nsubj	_	_
3	increase	_	VERB	VBP	_	1	acl:relcl	_	_
4	gastric	_	ADJ	JJ	_	5	amod	_	_
5	pH	_	NOUN	NN	_	3	dobj	_	_
6	are	_	VERB	VBP	_	7	auxpass	_	_
7	expected	_	VERB	VBN	_	0	root	_	_
8	to	_	PRT	TO	_	9	mark	_	_
9	decrease	_	VERB	VB	_	7	xcomp	_	_
10	concentration	_	NOUN	NN	_	9	dobj	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_

#	Harvoni	4353
1	Antacids	_	NOUN	NNS	_	10	nsubjpass	_	_
2	e.g	_	NOUN	NN	_	1	dep	_	_
3	,	_	.	,	_	2	punct	_	_
4	aluminum	_	ADJ	JJ	_	2	conj	_	_
5	and	_	CONJ	CC	_	2	cc	_	_
6	magnesium	_	NOUN	NN	_	8	compound	_	_
7	hydroxide	_	NOUN	NN	_	8	compound	_	_
8	It	_	NOUN	NN	_	2	conj	_	_
9	is	_	VERB	VBZ	_	10	auxpass	_	_
10	recommended	_	VERB	VBN	_	0	root	_	_
11	to	_	PRT	TO	_	12	mark	_	_
12	separate	_	VERB	VB	_	10	xcomp	_	_
13	antacid	_	NOUN	NN	_	16	compound	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	DRUG	_	NOUN	NN	_	13	conj	_	_
16	administration	_	NOUN	NN	_	12	dobj	_	_
17	by	_	ADP	IN	_	19	case	_	_
18	4	_	NUM	CD	_	19	nummod	_	_
19	hours	_	NOUN	NNS	_	12	nmod	_	_

#	Harvoni	4354
1	H2	_	NOUN	NN	_	4	compound	_	_
2	receptor	_	NOUN	NN	_	4	compound	_	_
3	antagonistsThese	_	ADJ	JJ	_	4	amod	_	_
4	interactions	_	NOUN	NNS	_	7	nsubjpass	_	_
5	have	_	VERB	VBP	_	7	aux	_	_
6	been	_	VERB	VBN	_	7	auxpass	_	_
7	studied	_	VERB	VBN	_	0	root	_	_
8	in	_	ADP	IN	_	10	case	_	_
9	healthy	_	ADJ	JJ	_	10	amod	_	_
10	adults	_	NOUN	NNS	_	7	nmod	_	_

#	Harvoni	4355
1	e.g	_	CONJ	CC	_	9	advmod	_	_
2	,	_	.	,	_	9	punct	_	_
3	famotidine	_	NOUN	NN	_	6	compound	_	_
4	H2	_	NOUN	NN	_	6	compound	_	_
5	receptor	_	NOUN	NN	_	6	compound	_	_
6	antagonists	_	NOUN	NNS	_	9	nsubjpass	_	_
7	may	_	VERB	MD	_	9	aux	_	_
8	be	_	VERB	VB	_	9	auxpass	_	_
9	administered	_	VERB	VBN	_	0	root	_	_
10	simultaneously	_	ADV	RB	_	9	advmod	_	_
11	with	_	ADP	IN	_	14	case	_	_
12	or	_	CONJ	CC	_	13	cc	_	_
13	12	_	NUM	CD	_	14	nummod	_	_
14	hours	_	NOUN	NNS	_	9	nmod	_	_
15	apart	_	ADJ	JJ	_	14	amod	_	_
16	from	_	ADP	IN	_	17	case	_	_
17	DRUG	_	NOUN	NN	_	15	nmod	_	_
18	at	_	ADP	IN	_	20	case	_	_
19	a	_	DET	DT	_	20	det	_	_
20	dose	_	NOUN	NN	_	9	nmod	_	_
21	that	_	DET	WDT	_	24	nsubj	_	_
22	does	_	VERB	VBZ	_	24	aux	_	_
23	not	_	ADV	RB	_	24	neg	_	_
24	exceed	_	VERB	VBN	_	20	acl:relcl	_	_
25	doses	_	NOUN	NNS	_	24	dobj	_	_
26	comparable	_	ADJ	JJ	_	25	amod	_	_
27	to	_	PRT	TO	_	30	case	_	_
28	famotidine	_	NOUN	NN	_	30	compound	_	_
29	40	_	NUM	CD	_	30	nummod	_	_
30	mg	_	NOUN	NN	_	26	nmod	_	_
31	twice	_	ADV	RB	_	32	advmod	_	_
32	daily	_	ADV	RB	_	24	advmod	_	_

#	Harvoni	4356
1	Proton	_	NOUN	NN	_	3	compound	_	_
2	pump	_	NOUN	NN	_	3	compound	_	_
3	inhibitors	_	NOUN	NNS	_	20	nsubjpass	_	_
4	e.g	_	NOUN	NN	_	3	amod	_	_
5	,	_	.	,	_	3	punct	_	_
6	omeprazole	_	ADJ	JJ	_	10	amod	_	_
7	Proton	_	NOUN	NN	_	10	compound	_	_
8	pump	_	NOUN	NN	_	10	compound	_	_
9	inhibitor	_	NOUN	NN	_	10	compound	_	_
10	doses	_	NOUN	NNS	_	3	appos	_	_
11	comparable	_	ADJ	JJ	_	10	amod	_	_
12	to	_	PRT	TO	_	15	case	_	_
13	omeprazole	_	ADJ	JJ	_	15	amod	_	_
14	20	_	NUM	CD	_	15	nummod	_	_
15	mg	_	NOUN	NN	_	11	nmod	_	_
16	or	_	CONJ	CC	_	15	cc	_	_
17	lower	_	ADJ	JJ	_	15	conj	_	_
18	can	_	VERB	MD	_	20	aux	_	_
19	be	_	VERB	VB	_	20	auxpass	_	_
20	administered	_	VERB	VBN	_	0	root	_	_
21	simultaneously	_	ADV	RB	_	20	advmod	_	_
22	with	_	ADP	IN	_	23	case	_	_
23	DRUG	_	NOUN	NN	_	20	nmod	_	_
24	under	_	ADP	IN	_	26	case	_	_
25	fasted	_	ADJ	JJ	_	26	amod	_	_
26	conditions	_	NOUN	NNS	_	20	nmod	_	_

#	Harvoni	4357
1	Antiarrhythmics	_	NOUN	NNS	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	amiodarone	_	NOUN	NN	_	4	compound	_	_
4	Effect	_	NOUN	NN	_	1	dep	_	_
5	on	_	ADP	IN	_	6	case	_	_
6	amiodarone	_	NOUN	NN	_	20	nmod	_	_
7	,	_	.	,	_	6	punct	_	_
8	DRUG	_	NOUN	NN	_	6	conj	_	_
9	,	_	.	,	_	6	punct	_	_
10	and	_	CONJ	CC	_	6	cc	_	_
11	DRUG	_	NOUN	NN	_	6	conj	_	_
12	concentrations	_	NOUN	NNS	_	6	dep	_	_
13	unknown	_	ADJ	JJ	_	14	amod	_	_
14	Coadministration	_	NOUN	NN	_	20	nsubj	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	amiodarone	_	NOUN	NN	_	14	nmod	_	_
17	with	_	ADP	IN	_	18	case	_	_
18	DRUG	_	NOUN	NN	_	14	nmod	_	_
19	may	_	VERB	MD	_	20	aux	_	_
20	result	_	VERB	VB	_	4	acl	_	_
21	in	_	ADP	IN	_	24	case	_	_
22	serious	_	ADJ	JJ	_	24	amod	_	_
23	symptomatic	_	ADJ	JJ	_	24	amod	_	_
24	bradycardia	_	NOUN	NN	_	20	nmod	_	_

#	Harvoni	4358
1	Coadministration	_	NOUN	NN	_	8	nsubjpass	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	amiodarone	_	NOUN	NN	_	1	nmod	_	_
4	with	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	1	nmod	_	_
6	is	_	VERB	VBZ	_	8	auxpass	_	_
7	not	_	ADV	RB	_	8	neg	_	_
8	recommended	_	VERB	VBN	_	0	root	_	_
9	if	_	ADP	IN	_	12	mark	_	_
10	coadministration	_	NOUN	NN	_	12	nsubjpass	_	_
11	is	_	VERB	VBZ	_	12	auxpass	_	_
12	required	_	VERB	VBN	_	8	ccomp	_	_
13	,	_	.	,	_	12	punct	_	_
14	cardiac	_	ADJ	JJ	_	15	amod	_	_
15	monitoring	_	NOUN	NN	_	21	nsubj	_	_
16	is	_	VERB	VBZ	_	21	cop	_	_
17	recommended	_	VERB	VBN	_	21	amod	_	_
18	digoxin	_	NOUN	NN	_	21	compound	_	_
19	*	_	ADJ	JJ	_	21	nummod	_	_
20	digoxin	_	NOUN	NN	_	21	compound	_	_
21	Coadministration	_	NOUN	NN	_	27	nsubj	_	_
22	of	_	ADP	IN	_	23	case	_	_
23	DRUG	_	NOUN	NN	_	21	nmod	_	_
24	with	_	ADP	IN	_	25	case	_	_
25	digoxin	_	NOUN	NN	_	21	nmod	_	_
26	may	_	VERB	MD	_	27	aux	_	_
27	increase	_	VERB	VB	_	12	parataxis	_	_
28	the	_	DET	DT	_	29	det	_	_
29	concentration	_	NOUN	NN	_	27	dobj	_	_
30	of	_	ADP	IN	_	31	case	_	_
31	digoxin	_	NOUN	NN	_	29	nmod	_	_

#	Harvoni	4359
1	Therapeutic	_	ADJ	JJ	_	3	amod	_	_
2	concentration	_	NOUN	NN	_	3	compound	_	_
3	monitoring	_	NOUN	NN	_	7	nsubjpass	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	digoxin	_	NOUN	NN	_	3	nmod	_	_
6	is	_	VERB	VBZ	_	7	auxpass	_	_
7	recommended	_	VERB	VBN	_	0	root	_	_
8	when	_	ADV	WRB	_	9	advmod	_	_
9	coadministered	_	VERB	VBN	_	7	advcl	_	_
10	with	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_

#	Harvoni	4360
1	Anticonvulsants	_	NOUN	NNS	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	carbamazepine	_	NOUN	NN	_	14	compound	_	_
4	phenytoin	_	NOUN	NN	_	14	compound	_	_
5	phenobarbital	_	ADJ	JJ	_	14	amod	_	_
6	oxcarbazepine	_	NOUN	NN	_	14	compound	_	_
7	*	_	CONJ	CC	_	14	nummod	_	_
8	DRUG	_	NOUN	NN	_	14	compound	_	_
9	*	_	NUM	CD	_	14	nummod	_	_
10	DRUG	_	NOUN	NN	_	14	compound	_	_
11	*	_	NUM	CD	_	14	nummod	_	_
12	GS	_	NOUN	NN	_	14	compound	_	_
13	331007	_	NUM	CD	_	14	nummod	_	_
14	Coadministration	_	NOUN	NN	_	27	nsubjpass	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	14	nmod	_	_
17	with	_	ADP	IN	_	18	case	_	_
18	carbamazepine	_	NOUN	NN	_	14	nmod	_	_
19	,	_	.	,	_	18	punct	_	_
20	phenytoin	_	NOUN	NN	_	18	conj	_	_
21	,	_	.	,	_	18	punct	_	_
22	phenobarbital	_	ADJ	JJ	_	18	conj	_	_
23	,	_	.	,	_	18	punct	_	_
24	or	_	CONJ	CC	_	18	cc	_	_
25	oxcarbazepine	_	NOUN	NN	_	18	conj	_	_
26	is	_	VERB	VBZ	_	27	auxpass	_	_
27	expected	_	VERB	VBN	_	1	dep	_	_
28	to	_	PRT	TO	_	29	mark	_	_
29	decrease	_	VERB	VB	_	27	xcomp	_	_
30	the	_	DET	DT	_	31	det	_	_
31	concentration	_	NOUN	NN	_	29	dobj	_	_
32	of	_	ADP	IN	_	33	case	_	_
33	DRUG	_	NOUN	NN	_	31	nmod	_	_
34	and	_	CONJ	CC	_	33	cc	_	_
35	DRUG	_	NOUN	NN	_	33	conj	_	_
36	,	_	.	,	_	27	punct	_	_
37	leading	_	VERB	VBG	_	27	advcl	_	_
38	to	_	PRT	TO	_	41	case	_	_
39	reduced	_	VERB	VBN	_	41	amod	_	_
40	therapeutic	_	ADJ	JJ	_	41	amod	_	_
41	effect	_	NOUN	NN	_	37	nmod	_	_
42	of	_	ADP	IN	_	43	case	_	_
43	DRUG	_	NOUN	NN	_	41	nmod	_	_

#	Harvoni	4361
1	Antimycobacterials	_	NOUN	NNS	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	rifabutin	_	NOUN	NN	_	5	compound	_	_
4	rifampin	_	NOUN	NN	_	5	compound	_	_
5	rifapentine	_	NOUN	NN	_	21	nsubjpass	_	_
6	*	_	CONJ	CC	_	13	case	_	_
7	DRUG	_	NOUN	NN	_	13	compound	_	_
8	*	_	NUM	CD	_	13	nummod	_	_
9	DRUG	_	NOUN	NN	_	13	compound	_	_
10	*	_	NUM	CD	_	13	nummod	_	_
11	GS	_	NOUN	NN	_	13	compound	_	_
12	331007	_	NUM	CD	_	13	nummod	_	_
13	Coadministration	_	NOUN	NN	_	5	dep	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	DRUG	_	NOUN	NN	_	13	nmod	_	_
16	with	_	ADP	IN	_	17	case	_	_
17	rifabutin	_	NOUN	NN	_	13	nmod	_	_
18	or	_	CONJ	CC	_	17	cc	_	_
19	rifapentine	_	NOUN	NN	_	17	conj	_	_
20	is	_	VERB	VBZ	_	21	auxpass	_	_
21	expected	_	VERB	VBN	_	1	dep	_	_
22	to	_	PRT	TO	_	23	mark	_	_
23	decrease	_	VERB	VB	_	21	xcomp	_	_
24	the	_	DET	DT	_	25	det	_	_
25	concentration	_	NOUN	NN	_	23	dobj	_	_
26	of	_	ADP	IN	_	27	case	_	_
27	DRUG	_	NOUN	NN	_	25	nmod	_	_
28	and	_	CONJ	CC	_	27	cc	_	_
29	DRUG	_	NOUN	NN	_	27	conj	_	_
30	,	_	.	,	_	21	punct	_	_
31	leading	_	VERB	VBG	_	21	advcl	_	_
32	to	_	PRT	TO	_	35	case	_	_
33	reduced	_	VERB	VBN	_	35	amod	_	_
34	therapeutic	_	ADJ	JJ	_	35	amod	_	_
35	effect	_	NOUN	NN	_	31	nmod	_	_
36	of	_	ADP	IN	_	37	case	_	_
37	DRUG	_	NOUN	NN	_	35	nmod	_	_

#	Harvoni	4362
1	Coadministration	_	NOUN	NN	_	4	nsubj	_	_
2	is	_	VERB	VBZ	_	4	cop	_	_
3	not	_	ADV	RB	_	4	neg	_	_
4	recommended.Coadministration	_	NOUN	NN	_	17	nsubjpass	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	with	_	ADP	IN	_	8	case	_	_
8	rifampin	_	NOUN	NN	_	4	nmod	_	_
9	,	_	.	,	_	8	punct	_	_
10	a	_	DET	DT	_	13	det	_	_
11	P	_	NOUN	NN	_	13	compound	_	_
12	gp	_	NOUN	NN	_	13	compound	_	_
13	inducer	_	NOUN	NN	_	8	appos	_	_
14	,	_	.	,	_	4	punct	_	_
15	is	_	VERB	VBZ	_	17	auxpass	_	_
16	not	_	ADV	RB	_	17	neg	_	_
17	recommended	_	VERB	VBN	_	0	root	_	_

#	Harvoni	4363
1	HIV	_	NOUN	NN	_	2	compound	_	_
2	Antiretrovirals	_	NOUN	NNS	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	Regimens	_	NOUN	NNS	_	2	dep	_	_
5	containing	_	VERB	VBG	_	4	acl	_	_
6	tenofovir	_	ADJ	JJ	_	7	amod	_	_
7	DF	_	NOUN	NN	_	5	dobj	_	_
8	without	_	ADP	IN	_	12	case	_	_
9	an	_	DET	DT	_	12	det	_	_
10	HIV	_	NOUN	NN	_	12	compound	_	_
11	protease	_	NOUN	NN	_	12	compound	_	_
12	inhibitor	_	NOUN	NN	_	5	nmod	_	_
13	/	_	.	:	_	4	punct	_	_
14	ritonavir	_	NOUN	NN	_	4	dep	_	_
15	or	_	CONJ	CC	_	14	cc	_	_
16	cobicistat	_	ADJ	JJ	_	18	amod	_	_
17	tenofovir	_	NOUN	NN	_	18	amod	_	_
18	Monitor	_	NOUN	NN	_	14	conj	_	_
19	for	_	ADP	IN	_	23	case	_	_
20	tenofovir	_	NOUN	NN	_	23	amod	_	_
21	associated	_	VERB	VBD	_	23	amod	_	_
22	adverse	_	ADJ	JJ	_	23	amod	_	_
23	reactions	_	NOUN	NNS	_	14	nmod	_	_
24	in	_	ADP	IN	_	25	case	_	_
25	patients	_	NOUN	NNS	_	23	nmod	_	_
26	receiving	_	VERB	VBG	_	25	acl	_	_
27	DRUG	_	NOUN	NN	_	26	dobj	_	_
28	concomitantly	_	ADV	RB	_	31	advmod	_	_
29	with	_	ADP	IN	_	31	case	_	_
30	a	_	DET	DT	_	31	det	_	_
31	regimen	_	NOUN	NN	_	14	nmod	_	_
32	containing	_	VERB	VBG	_	31	acl	_	_
33	tenofovir	_	ADJ	JJ	_	34	amod	_	_
34	DF	_	NOUN	NN	_	32	dobj	_	_
35	without	_	ADP	IN	_	39	case	_	_
36	an	_	DET	DT	_	39	det	_	_
37	HIV	_	NOUN	NN	_	39	compound	_	_
38	protease	_	NOUN	NN	_	39	compound	_	_
39	inhibitor	_	NOUN	NN	_	32	nmod	_	_
40	/	_	.	:	_	4	punct	_	_
41	ritonavir	_	NOUN	NN	_	4	dep	_	_
42	or	_	CONJ	CC	_	41	cc	_	_
43	cobicistat	_	ADJ	JJ	_	41	conj	_	_

#	Harvoni	4364
1	Refer	_	ADV	RB	_	3	case	_	_
2	to	_	PRT	TO	_	1	mwe	_	_
3	VIREAD	_	NOUN	NN	_	0	root	_	_
4	or	_	CONJ	CC	_	3	cc	_	_
5	TRUVADA	_	NOUN	NN	_	3	conj	_	_
6	prescribing	_	NOUN	NN	_	7	compound	_	_
7	information	_	NOUN	NN	_	3	dep	_	_
8	for	_	ADP	IN	_	9	case	_	_
9	recommendations	_	NOUN	NNS	_	3	nmod	_	_
10	on	_	ADP	IN	_	12	case	_	_
11	renal	_	ADJ	JJ	_	12	amod	_	_
12	monitoring	_	VERB	VBG	_	3	nmod	_	_

#	Harvoni	4365
1	Regimens	_	NOUN	NNS	_	0	root	_	_
2	containing	_	VERB	VBG	_	1	acl	_	_
3	tenofovir	_	NOUN	NN	_	4	compound	_	_
4	DF	_	NOUN	NN	_	2	dobj	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	an	_	DET	DT	_	9	det	_	_
7	HIV	_	NOUN	NN	_	9	compound	_	_
8	protease	_	NOUN	NN	_	9	compound	_	_
9	inhibitor	_	NOUN	NN	_	4	conj	_	_
10	/	_	.	:	_	1	punct	_	_
11	ritonavir	_	NOUN	NN	_	1	dep	_	_
12	or	_	CONJ	CC	_	11	cc	_	_
13	cobicistat	_	ADJ	JJ	_	11	conj	_	_

#	Harvoni	4366
1	If	_	ADP	IN	_	2	case	_	_
2	coadministration	_	NOUN	NN	_	4	nsubj	_	_
3	is	_	VERB	VBZ	_	4	cop	_	_
4	necessary	_	ADJ	JJ	_	0	root	_	_
5	,	_	.	,	_	4	punct	_	_
6	monitor	_	NOUN	NN	_	5	root	_	_
7	for	_	ADP	IN	_	11	case	_	_
8	tenofovir	_	ADJ	JJ	_	11	amod	_	_
9	associated	_	ADJ	JJ	_	11	amod	_	_
10	adverse	_	ADJ	JJ	_	11	amod	_	_
11	reactions	_	NOUN	NNS	_	6	nmod	_	_

#	Harvoni	4367
1	Refer	_	ADV	RB	_	3	case	_	_
2	to	_	PRT	TO	_	1	mwe	_	_
3	VIREAD	_	NOUN	NN	_	49	nsubjpass	_	_
4	or	_	CONJ	CC	_	3	cc	_	_
5	TRUVADA	_	NOUN	NN	_	3	conj	_	_
6	prescribing	_	NOUN	NN	_	7	compound	_	_
7	information	_	NOUN	NN	_	3	dep	_	_
8	for	_	ADP	IN	_	9	case	_	_
9	recommendations	_	NOUN	NNS	_	3	nmod	_	_
10	on	_	ADP	IN	_	13	case	_	_
11	renal	_	ADJ	JJ	_	13	amod	_	_
12	monitoring	_	VERB	VBG	_	13	amod	_	_
13	elvitegravir	_	NOUN	NN	_	9	nmod	_	_
14	,	_	.	,	_	13	punct	_	_
15	cobicistat	_	NOUN	NN	_	13	conj	_	_
16	,	_	.	,	_	13	punct	_	_
17	emtricitabine	_	NOUN	NN	_	13	conj	_	_
18	,	_	.	,	_	13	punct	_	_
19	tenofovir	_	ADJ	JJ	_	24	compound	_	_
20	DF	_	NOUN	NN	_	24	compound	_	_
21	*	_	NUM	CD	_	24	nummod	_	_
22	tenofovir	_	NOUN	NN	_	24	compound	_	_
23	The	_	NOUN	NN	_	24	compound	_	_
24	safety	_	NOUN	NN	_	13	conj	_	_
25	of	_	ADP	IN	_	28	case	_	_
26	increased	_	VERB	VBN	_	28	amod	_	_
27	tenofovir	_	ADJ	JJ	_	28	amod	_	_
28	concentrations	_	NOUN	NNS	_	24	nmod	_	_
29	in	_	ADP	IN	_	31	case	_	_
30	the	_	DET	DT	_	31	det	_	_
31	setting	_	NOUN	NN	_	24	nmod	_	_
32	of	_	ADP	IN	_	33	case	_	_
33	DRUG	_	NOUN	NN	_	31	nmod	_	_
34	and	_	CONJ	CC	_	13	cc	_	_
35	the	_	DET	DT	_	36	det	_	_
36	combination	_	NOUN	NN	_	13	conj	_	_
37	of	_	ADP	IN	_	38	case	_	_
38	elvitegravir	_	NOUN	NN	_	36	nmod	_	_
39	,	_	.	,	_	38	punct	_	_
40	cobicistat	_	NOUN	NN	_	38	conj	_	_
41	,	_	.	,	_	38	punct	_	_
42	emtricitabine	_	NOUN	NN	_	38	conj	_	_
43	and	_	CONJ	CC	_	38	cc	_	_
44	tenofovir	_	NOUN	NN	_	45	compound	_	_
45	DF	_	NOUN	NN	_	38	conj	_	_
46	has	_	VERB	VBZ	_	49	aux	_	_
47	not	_	ADV	RB	_	49	neg	_	_
48	been	_	VERB	VBN	_	49	auxpass	_	_
49	established	_	VERB	VBN	_	0	root	_	_
50	tipranavir	_	NOUN	NN	_	49	xcomp	_	_
51	/	_	.	:	_	49	punct	_	_
52	ritonavir	_	NOUN	NN	_	49	parataxis	_	_
53	*	_	CONJ	CC	_	60	cc:preconj	_	_
54	DRUG	_	NOUN	NN	_	60	compound	_	_
55	*	_	NUM	CD	_	60	nummod	_	_
56	DRUG	_	NOUN	NN	_	60	compound	_	_
57	*	_	NUM	CD	_	60	nummod	_	_
58	GS	_	NOUN	NN	_	60	compound	_	_
59	331007	_	NUM	CD	_	60	nummod	_	_
60	Coadministration	_	NOUN	NN	_	52	dobj	_	_
61	of	_	ADP	IN	_	62	case	_	_
62	DRUG	_	NOUN	NN	_	60	nmod	_	_
63	with	_	ADP	IN	_	64	case	_	_
64	tipranavir	_	NOUN	NN	_	60	nmod	_	_
65	/	_	.	:	_	52	punct	_	_
66	ritonavir	_	NOUN	NN	_	68	nsubjpass	_	_
67	is	_	VERB	VBZ	_	68	auxpass	_	_
68	expected	_	VERB	VBN	_	52	parataxis	_	_
69	to	_	PRT	TO	_	70	mark	_	_
70	decrease	_	VERB	VB	_	68	xcomp	_	_
71	the	_	DET	DT	_	72	det	_	_
72	concentration	_	NOUN	NN	_	70	dobj	_	_
73	of	_	ADP	IN	_	74	case	_	_
74	DRUG	_	NOUN	NN	_	72	nmod	_	_
75	and	_	CONJ	CC	_	74	cc	_	_
76	DRUG	_	NOUN	NN	_	74	conj	_	_
77	,	_	.	,	_	68	punct	_	_
78	leading	_	VERB	VBG	_	68	advcl	_	_
79	to	_	PRT	TO	_	82	case	_	_
80	reduced	_	VERB	VBN	_	82	amod	_	_
81	therapeutic	_	ADJ	JJ	_	82	amod	_	_
82	effect	_	NOUN	NN	_	78	nmod	_	_
83	of	_	ADP	IN	_	84	case	_	_
84	DRUG	_	NOUN	NN	_	82	nmod	_	_

#	Harvoni	4368
1	HCV	_	NOUN	NN	_	2	compound	_	_
2	Products	_	NOUN	NNS	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	simeprevir	_	VERB	VBP	_	15	advmod	_	_
5	*	_	DET	DT	_	9	det	_	_
6	DRUG	_	NOUN	NN	_	9	compound	_	_
7	*	_	NUM	CD	_	9	nummod	_	_
8	simeprevir	_	ADJ	JJ	_	9	amod	_	_
9	Concentrations	_	NOUN	NNS	_	15	nsubjpass	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	simeprevir	_	NOUN	NN	_	11	conj	_	_
14	are	_	VERB	VBP	_	15	auxpass	_	_
15	increased	_	VERB	VBN	_	2	dep	_	_
16	when	_	ADV	WRB	_	19	advmod	_	_
17	simeprevir	_	NOUN	NN	_	19	nsubjpass	_	_
18	is	_	VERB	VBZ	_	19	auxpass	_	_
19	coadministered	_	VERB	VBN	_	15	advcl	_	_
20	with	_	ADP	IN	_	21	case	_	_
21	DRUG	_	NOUN	NN	_	19	nmod	_	_

#	Harvoni	4369
1	Coadministration	_	NOUN	NN	_	8	nsubjpass	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	with	_	ADP	IN	_	5	case	_	_
5	simeprevir	_	NOUN	NN	_	1	nmod	_	_
6	is	_	VERB	VBZ	_	8	auxpass	_	_
7	not	_	ADV	RB	_	8	neg	_	_
8	recommended	_	VERB	VBN	_	0	root	_	_

#	Harvoni	4370
1	Herbal	_	ADJ	JJ	_	2	amod	_	_
2	Supplements	_	NOUN	NNS	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	St	_	NOUN	NN	_	5	compound	_	_
5	John's	_	NOUN	NNS	_	6	nsubj	_	_
6	wort	_	VERB	VBP	_	30	advcl	_	_
7	Hypericum	_	NOUN	NN	_	16	compound	_	_
8	perforatum	_	NOUN	NN	_	16	compound	_	_
9	*	_	CONJ	CC	_	16	amod	_	_
10	DRUG	_	NOUN	NN	_	16	compound	_	_
11	*	_	NUM	CD	_	16	nummod	_	_
12	DRUG	_	NOUN	NN	_	16	compound	_	_
13	*	_	NUM	CD	_	16	nummod	_	_
14	GS	_	NOUN	NN	_	16	compound	_	_
15	331007	_	NUM	CD	_	16	nummod	_	_
16	Coadministration	_	NOUN	NN	_	6	dobj	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	DRUG	_	NOUN	NN	_	16	nmod	_	_
19	with	_	ADP	IN	_	21	case	_	_
20	St	_	NOUN	NN	_	21	compound	_	_
21	John's	_	NOUN	NNS	_	16	nmod	_	_
22	wort	_	ADV	RB	_	6	advmod	_	_
23	,	_	.	,	_	30	punct	_	_
24	a	_	DET	DT	_	27	det	_	_
25	P	_	NOUN	NN	_	27	compound	_	_
26	gp	_	NOUN	NN	_	27	compound	_	_
27	inducer	_	NOUN	NN	_	30	nsubjpass	_	_
28	is	_	VERB	VBZ	_	30	auxpass	_	_
29	not	_	ADV	RB	_	30	neg	_	_
30	recommended	_	VERB	VBN	_	2	dep	_	_

#	Harvoni	4371
1	HMG	_	NOUN	NN	_	4	compound	_	_
2	CoA	_	NOUN	NN	_	4	compound	_	_
3	Reductase	_	NOUN	NN	_	4	compound	_	_
4	Inhibitors	_	NOUN	NNS	_	0	root	_	_
5	:	_	.	:	_	4	punct	_	_
6	rosuvastatin	_	NOUN	NN	_	9	compound	_	_
7	*	_	X	FW	_	9	nummod	_	_
8	rosuvastatin	_	NOUN	NN	_	9	compound	_	_
9	Coadministration	_	NOUN	NN	_	16	nsubj	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_
12	with	_	ADP	IN	_	13	case	_	_
13	rosuvastatin	_	NOUN	NN	_	9	nmod	_	_
14	may	_	VERB	MD	_	16	aux	_	_
15	significantly	_	ADV	RB	_	16	advmod	_	_
16	increase	_	VERB	VB	_	4	dep	_	_
17	the	_	DET	DT	_	18	det	_	_
18	concentration	_	NOUN	NN	_	16	dobj	_	_
19	of	_	ADP	IN	_	20	case	_	_
20	rosuvastatin	_	NOUN	NN	_	18	nmod	_	_
21	which	_	DET	WDT	_	23	nsubjpass	_	_
22	is	_	VERB	VBZ	_	23	auxpass	_	_
23	associated	_	VERB	VBN	_	20	acl:relcl	_	_
24	with	_	ADP	IN	_	26	case	_	_
25	increased	_	VERB	VBN	_	26	amod	_	_
26	risk	_	NOUN	NN	_	23	nmod	_	_
27	of	_	ADP	IN	_	28	case	_	_
28	myopathy	_	NOUN	NN	_	26	nmod	_	_
29	,	_	.	,	_	20	punct	_	_
30	including	_	ADP	IN	_	31	case	_	_
31	rhabdomyolysis	_	NOUN	NN	_	20	nmod	_	_

#	Harvoni	4372
1	Coadministration	_	NOUN	NN	_	9	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	with	_	ADP	IN	_	5	case	_	_
5	rosuvastatin	_	NOUN	NN	_	1	nmod	_	_
6	is	_	VERB	VBZ	_	9	cop	_	_
7	not	_	ADV	RB	_	9	neg	_	_
8	recommended.atorvastatin*	_	ADJ	JJ	_	9	amod	_	_
9	atorvastatinCoadministration	_	NOUN	NN	_	16	nsubjpass	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_
12	with	_	ADP	IN	_	13	case	_	_
13	atorvastatin	_	NOUN	NN	_	9	nmod	_	_
14	may	_	VERB	MD	_	16	aux	_	_
15	be	_	VERB	VB	_	16	auxpass	_	_
16	associated	_	VERB	VBN	_	0	root	_	_
17	with	_	ADP	IN	_	19	case	_	_
18	increased	_	VERB	VBN	_	19	amod	_	_
19	risk	_	NOUN	NN	_	16	nmod	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	myopathy	_	NOUN	NN	_	19	nmod	_	_
22	,	_	.	,	_	19	punct	_	_
23	including	_	ADP	IN	_	24	case	_	_
24	rhabdomyolysis	_	NOUN	NN	_	19	nmod	_	_

#	Harvoni	4373
1	Monitor	_	NOUN	NN	_	8	nsubj	_	_
2	closely	_	ADV	RB	_	7	advmod	_	_
3	for	_	ADP	IN	_	7	case	_	_
4	HMG	_	NOUN	NN	_	7	compound	_	_
5	CoA	_	NOUN	NN	_	7	compound	_	_
6	reductase	_	NOUN	NN	_	7	compound	_	_
7	inhibitor	_	NOUN	NN	_	1	nmod	_	_
8	associated	_	VERB	VBD	_	0	root	_	_
9	adverse	_	ADJ	JJ	_	10	amod	_	_
10	reactions	_	NOUN	NNS	_	8	dobj	_	_
11	,	_	.	,	_	10	punct	_	_
12	such	_	ADJ	JJ	_	14	case	_	_
13	as	_	ADP	IN	_	12	mwe	_	_
14	myopathy	_	NOUN	NN	_	10	nmod	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	rhabdomyolysis	_	NOUN	NN	_	14	conj	_	_

#	Harvoni	4374
1	Based	_	VERB	VBN	_	26	advcl	_	_
2	on	_	ADP	IN	_	5	case	_	_
3	drug	_	NOUN	NN	_	5	compound	_	_
4	interaction	_	NOUN	NN	_	5	compound	_	_
5	studies	_	NOUN	NNS	_	1	nmod	_	_
6	conducted	_	VERB	VBN	_	5	acl	_	_
7	with	_	ADP	IN	_	9	case	_	_
8	the	_	DET	DT	_	9	det	_	_
9	components	_	NOUN	NNS	_	6	nmod	_	_
10	of	_	ADP	IN	_	12	case	_	_
11	DRUG	_	NOUN	NN	_	12	compound	_	_
12	DRUG	_	NOUN	NN	_	9	nmod	_	_
13	or	_	CONJ	CC	_	12	cc	_	_
14	DRUG	_	NOUN	NN	_	12	conj	_	_
15	or	_	CONJ	CC	_	14	cc	_	_
16	DRUG	_	NOUN	NN	_	14	conj	_	_
17	,	_	.	,	_	26	punct	_	_
18	no	_	DET	DT	_	22	neg	_	_
19	clinically	_	ADV	RB	_	22	advmod	_	_
20	significant	_	ADJ	JJ	_	22	amod	_	_
21	drug	_	NOUN	NN	_	22	compound	_	_
22	interactions	_	NOUN	NNS	_	26	nsubjpass	_	_
23	have	_	VERB	VBP	_	26	aux	_	_
24	been	_	VERB	VBN	_	26	auxpass	_	_
25	either	_	CONJ	CC	_	26	advmod	_	_
26	observed	_	VERB	VBN	_	0	root	_	_
27	or	_	CONJ	CC	_	26	cc	_	_
28	are	_	VERB	VBP	_	29	auxpass	_	_
29	expected	_	VERB	VBN	_	26	conj	_	_
30	when	_	ADV	WRB	_	33	advmod	_	_
31	DRUG	_	NOUN	NN	_	33	nsubjpass	_	_
32	is	_	VERB	VBZ	_	33	auxpass	_	_
33	used	_	VERB	VBN	_	29	advcl	_	_
34	with	_	ADP	IN	_	37	case	_	_
35	the	_	DET	DT	_	37	det	_	_
36	following	_	VERB	VBG	_	37	amod	_	_
37	drugs	_	NOUN	NNS	_	33	nmod	_	_
38	individually	_	ADV	RB	_	33	advmod	_	_
39	:	_	.	:	_	26	punct	_	_
40	abacavir	_	NOUN	NN	_	26	dep	_	_
41	,	_	.	,	_	40	punct	_	_
42	atazanavir	_	NOUN	NN	_	40	appos	_	_
43	/	_	.	:	_	40	punct	_	_
44	ritonavir	_	NOUN	NN	_	40	dep	_	_
45	,	_	.	,	_	44	punct	_	_
46	cyclosporine	_	NOUN	NN	_	44	conj	_	_
47	,	_	.	,	_	44	punct	_	_
48	darunavir	_	NOUN	NN	_	44	appos	_	_
49	/	_	.	:	_	44	punct	_	_
50	ritonavir	_	NOUN	NN	_	44	conj	_	_
51	,	_	.	,	_	44	punct	_	_
52	efavirenz	_	ADJ	JJ	_	44	conj	_	_
53	,	_	.	,	_	44	punct	_	_
54	emtricitabine	_	NOUN	NN	_	44	conj	_	_
55	,	_	.	,	_	44	punct	_	_
56	lamivudine	_	NOUN	NN	_	44	conj	_	_
57	,	_	.	,	_	44	punct	_	_
58	methadone	_	NOUN	NN	_	44	conj	_	_
59	,	_	.	,	_	44	punct	_	_
60	oral	_	ADJ	JJ	_	61	amod	_	_
61	contraceptives	_	NOUN	NNS	_	44	conj	_	_
62	,	_	.	,	_	44	punct	_	_
63	pravastatin	_	NOUN	NN	_	44	conj	_	_
64	,	_	.	,	_	44	punct	_	_
65	raltegravir	_	NOUN	NN	_	44	conj	_	_
66	,	_	.	,	_	44	punct	_	_
67	rilpivirine	_	NOUN	NN	_	44	conj	_	_
68	,	_	.	,	_	44	punct	_	_
69	tacrolimus	_	NOUN	NN	_	44	conj	_	_
70	,	_	.	,	_	44	punct	_	_
71	tenofovir	_	NOUN	NN	_	73	compound	_	_
72	disoproxil	_	NOUN	NN	_	73	compound	_	_
73	fumarate	_	NOUN	NN	_	44	conj	_	_
74	,	_	.	,	_	44	punct	_	_
75	or	_	CONJ	CC	_	44	cc	_	_
76	verapamil	_	NOUN	NN	_	44	conj	_	_

#	Harvoni	4375
1	See	_	NOUN	NN	_	2	nsubj	_	_
2	Table	_	ADJ	JJ	_	0	root	_	_
3	5	_	NUM	CD	_	2	dobj	_	_
4	for	_	ADP	IN	_	5	case	_	_
5	use	_	NOUN	NN	_	2	nmod	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	with	_	ADP	IN	_	12	case	_	_
9	certain	_	ADJ	JJ	_	12	amod	_	_
10	HIV	_	NOUN	NN	_	12	compound	_	_
11	antiretroviral	_	ADJ	JJ	_	12	amod	_	_
12	regimens	_	NOUN	NNS	_	5	nmod	_	_

#	Harvoni	4376
1	DRUG	_	NOUN	NN	_	6	nsubj	_	_
2	is	_	VERB	VBZ	_	6	cop	_	_
3	a	_	DET	DT	_	6	det	_	_
4	fixed	_	VERB	VBN	_	6	amod	_	_
5	dose	_	NOUN	NN	_	6	compound	_	_
6	combination	_	NOUN	NN	_	0	root	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	DRUG	_	NOUN	NN	_	8	conj	_	_
11	which	_	DET	WDT	_	13	nsubj	_	_
12	are	_	VERB	VBP	_	13	cop	_	_
13	direct	_	ADJ	JJ	_	8	acl:relcl	_	_
14	acting	_	VERB	VBG	_	13	advcl	_	_
15	DRUGS	_	NOUN	NN	_	14	dobj	_	_
16	against	_	ADP	IN	_	20	case	_	_
17	the	_	DET	DT	_	20	det	_	_
18	hepatitis	_	NOUN	NN	_	20	compound	_	_
19	C	_	NOUN	NN	_	20	compound	_	_
20	virus	_	NOUN	NN	_	15	nmod	_	_

#	Harvoni	4377
1	Cardiac	_	ADJ	JJ	_	5	amod	_	_
2	Electrophysiology	_	NOUN	NN	_	5	compound	_	_
3	Thorough	_	NOUN	NN	_	5	compound	_	_
4	QT	_	NOUN	NN	_	5	compound	_	_
5	studies	_	NOUN	NNS	_	8	nsubjpass	_	_
6	have	_	VERB	VBP	_	8	aux	_	_
7	been	_	VERB	VBN	_	8	auxpass	_	_
8	conducted	_	VERB	VBN	_	0	root	_	_
9	for	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	DRUG	_	NOUN	NN	_	10	conj	_	_

#	Harvoni	4378
1	The	_	DET	DT	_	2	det	_	_
2	effect	_	NOUN	NN	_	22	nsubjpass	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	DRUG	_	NOUN	NN	_	6	compound	_	_
5	120	_	NUM	CD	_	6	nummod	_	_
6	mg	_	NOUN	NN	_	2	nmod	_	_
7	twice	_	ADV	RB	_	8	advmod	_	_
8	daily	_	ADV	RB	_	9	advmod	_	_
9	2.67	_	NUM	CD	_	10	nummod	_	_
10	times	_	NOUN	NNS	_	14	dep	_	_
11	the	_	DET	DT	_	12	det	_	_
12	maximum	_	NOUN	NN	_	13	nsubj	_	_
13	recommended	_	VERB	VBN	_	14	amod	_	_
14	dosage	_	NOUN	NN	_	2	dep	_	_
15	for	_	ADP	IN	_	17	case	_	_
16	10	_	NUM	CD	_	17	nummod	_	_
17	days	_	NOUN	NNS	_	14	nmod	_	_
18	on	_	ADP	IN	_	20	case	_	_
19	QTc	_	NOUN	NN	_	20	compound	_	_
20	interval	_	NOUN	NN	_	14	nmod	_	_
21	was	_	VERB	VBD	_	22	auxpass	_	_
22	evaluated	_	VERB	VBN	_	0	root	_	_
23	in	_	ADP	IN	_	28	case	_	_
24	a	_	DET	DT	_	28	det	_	_
25	randomized	_	ADJ	JJ	_	28	amod	_	_
26	,	_	.	,	_	25	punct	_	_
27	multiple	_	ADJ	JJ	_	25	dep	_	_
28	dose	_	NOUN	NN	_	22	nmod	_	_
29	,	_	.	,	_	28	punct	_	_
30	placebo	_	NOUN	NN	_	28	conj	_	_
31	,	_	.	,	_	28	punct	_	_
32	and	_	CONJ	CC	_	28	cc	_	_
33	active	_	ADJ	JJ	_	39	amod	_	_
34	controlled	_	VERB	VBN	_	39	amod	_	_
35	moxifloxacin	_	NOUN	NN	_	39	compound	_	_
36	400	_	NUM	CD	_	39	nummod	_	_
37	mg	_	NOUN	NN	_	39	compound	_	_
38	three	_	NUM	CD	_	39	nummod	_	_
39	period	_	NOUN	NN	_	28	conj	_	_
40	crossover	_	ADV	RB	_	39	amod	_	_
41	thorough	_	ADP	IN	_	43	case	_	_
42	QT	_	NOUN	NN	_	43	compound	_	_
43	trial	_	ADJ	JJ	_	22	nmod	_	_
44	in	_	ADP	IN	_	47	case	_	_
45	59	_	NUM	CD	_	47	nummod	_	_
46	healthy	_	ADJ	JJ	_	47	amod	_	_
47	subjects	_	NOUN	NNS	_	43	nmod	_	_

#	Harvoni	4379
1	At	_	ADP	IN	_	3	case	_	_
2	the	_	DET	DT	_	3	det	_	_
3	dose	_	NOUN	NN	_	19	nmod	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	120	_	NUM	CD	_	6	nummod	_	_
6	mg	_	NOUN	NN	_	3	nmod	_	_
7	twice	_	ADV	RB	_	8	advmod	_	_
8	daily	_	ADV	RB	_	9	advmod	_	_
9	2.67	_	NUM	CD	_	10	nummod	_	_
10	times	_	NOUN	NNS	_	14	dep	_	_
11	the	_	DET	DT	_	14	det	_	_
12	maximum	_	NOUN	NN	_	14	compound	_	_
13	recommended	_	VERB	VBD	_	14	amod	_	_
14	dosage	_	NOUN	NN	_	3	nmod	_	_
15	,	_	.	,	_	19	punct	_	_
16	DRUG	_	NOUN	NN	_	19	nsubj	_	_
17	does	_	VERB	VBZ	_	19	aux	_	_
18	not	_	ADV	RB	_	19	neg	_	_
19	prolong	_	VERB	VB	_	0	root	_	_
20	QTc	_	NOUN	NN	_	19	dobj	_	_
21	interval	_	ADJ	JJ	_	20	amod	_	_
22	to	_	PRT	TO	_	26	case	_	_
23	any	_	DET	DT	_	26	det	_	_
24	clinically	_	ADV	RB	_	25	advmod	_	_
25	relevant	_	ADJ	JJ	_	26	amod	_	_
26	extent	_	NOUN	NN	_	21	nmod	_	_

#	Harvoni	4380
1	The	_	DET	DT	_	2	det	_	_
2	effect	_	NOUN	NN	_	8	nsubj	_	_
3	of	_	ADP	IN	_	7	case	_	_
4	DRUG	_	NOUN	NN	_	7	compound	_	_
5	400	_	NUM	CD	_	7	nummod	_	_
6	mg	_	NOUN	NN	_	7	compound	_	_
7	maximum	_	NOUN	NN	_	2	nmod	_	_
8	recommended	_	VERB	VBD	_	0	root	_	_
9	dosage	_	NOUN	NN	_	8	dobj	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	1200	_	NUM	CD	_	14	nummod	_	_
12	mg	_	NOUN	NN	_	14	compound	_	_
13	three	_	NUM	CD	_	14	nummod	_	_
14	times	_	NOUN	NNS	_	9	conj	_	_
15	the	_	DET	DT	_	18	det	_	_
16	maximum	_	NOUN	NN	_	18	compound	_	_
17	recommended	_	ADJ	JJ	_	18	amod	_	_
18	dosage	_	NOUN	NN	_	23	nsubjpass	_	_
19	on	_	ADP	IN	_	21	case	_	_
20	QTc	_	NOUN	NN	_	21	compound	_	_
21	interval	_	NOUN	NN	_	18	nmod	_	_
22	was	_	VERB	VBD	_	23	auxpass	_	_
23	evaluated	_	VERB	VBN	_	8	parataxis	_	_
24	in	_	ADP	IN	_	29	case	_	_
25	a	_	DET	DT	_	29	det	_	_
26	randomized	_	ADJ	JJ	_	29	amod	_	_
27	,	_	.	,	_	26	punct	_	_
28	single	_	ADJ	JJ	_	26	dep	_	_
29	dose	_	NOUN	NN	_	23	nmod	_	_
30	,	_	.	,	_	29	punct	_	_
31	placebo	_	NOUN	NN	_	29	conj	_	_
32	,	_	.	,	_	29	punct	_	_
33	and	_	CONJ	CC	_	29	cc	_	_
34	active	_	ADJ	JJ	_	40	amod	_	_
35	controlled	_	VERB	VBN	_	40	amod	_	_
36	moxifloxacin	_	NOUN	NN	_	40	compound	_	_
37	400	_	NUM	CD	_	40	nummod	_	_
38	mg	_	NOUN	NN	_	40	compound	_	_
39	four	_	NUM	CD	_	40	nummod	_	_
40	period	_	NOUN	NN	_	29	conj	_	_
41	crossover	_	ADV	RB	_	40	amod	_	_
42	thorough	_	ADP	IN	_	44	case	_	_
43	QT	_	NOUN	NN	_	44	compound	_	_
44	trial	_	ADJ	JJ	_	23	nmod	_	_
45	in	_	ADP	IN	_	48	case	_	_
46	59	_	NUM	CD	_	48	nummod	_	_
47	healthy	_	ADJ	JJ	_	48	amod	_	_
48	subjects	_	NOUN	NNS	_	44	nmod	_	_

#	Harvoni	4381
1	At	_	ADP	IN	_	5	case	_	_
2	a	_	DET	DT	_	5	det	_	_
3	dose	_	NOUN	NN	_	5	compound	_	_
4	three	_	NUM	CD	_	5	nummod	_	_
5	times	_	NOUN	NNS	_	14	nmod	_	_
6	the	_	DET	DT	_	9	det	_	_
7	maximum	_	NOUN	NN	_	9	compound	_	_
8	recommended	_	VERB	VBD	_	9	amod	_	_
9	dose	_	NOUN	NN	_	14	nsubj	_	_
10	,	_	.	,	_	9	punct	_	_
11	DRUG	_	NOUN	NN	_	9	appos	_	_
12	does	_	VERB	VBZ	_	14	aux	_	_
13	not	_	ADV	RB	_	14	neg	_	_
14	prolong	_	VERB	VB	_	0	root	_	_
15	QTc	_	NOUN	NN	_	14	dobj	_	_
16	to	_	PRT	TO	_	20	case	_	_
17	any	_	DET	DT	_	20	det	_	_
18	clinically	_	ADV	RB	_	19	advmod	_	_
19	relevant	_	ADJ	JJ	_	20	amod	_	_
20	extent	_	NOUN	NN	_	14	nmod	_	_

#	Harvoni	4382
1	Absorption	_	NOUN	NN	_	19	nsubjpass	_	_
2	The	_	DET	DT	_	4	det	_	_
3	pharmacokinetic	_	ADJ	JJ	_	4	amod	_	_
4	properties	_	NOUN	NNS	_	1	nmod	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	,	_	.	,	_	6	punct	_	_
8	DRUG	_	NOUN	NN	_	6	conj	_	_
9	,	_	.	,	_	6	punct	_	_
10	and	_	CONJ	CC	_	6	cc	_	_
11	the	_	DET	DT	_	15	det	_	_
12	predominant	_	ADJ	JJ	_	15	amod	_	_
13	circulating	_	ADJ	JJ	_	15	amod	_	_
14	metabolite	_	NOUN	NN	_	15	compound	_	_
15	GS	_	NOUN	NN	_	6	conj	_	_
16	331007	_	NUM	CD	_	15	nummod	_	_
17	have	_	VERB	VBP	_	19	aux	_	_
18	been	_	VERB	VBN	_	19	auxpass	_	_
19	evaluated	_	VERB	VBN	_	42	advcl	_	_
20	in	_	ADP	IN	_	23	case	_	_
21	healthy	_	ADJ	JJ	_	23	amod	_	_
22	adult	_	ADJ	JJ	_	23	amod	_	_
23	subjects	_	NOUN	NNS	_	19	nmod	_	_
24	and	_	CONJ	CC	_	23	cc	_	_
25	in	_	ADP	IN	_	26	case	_	_
26	subjects	_	NOUN	NNS	_	23	conj	_	_
27	with	_	ADP	IN	_	30	case	_	_
28	chronic	_	ADJ	JJ	_	30	amod	_	_
29	hepatitis	_	NOUN	NN	_	30	compound	_	_
30	C	_	NOUN	NN	_	26	nmod	_	_
31	Following	_	ADP	IN	_	33	case	_	_
32	oral	_	ADJ	JJ	_	33	amod	_	_
33	administration	_	NOUN	NN	_	26	nmod	_	_
34	of	_	ADP	IN	_	35	case	_	_
35	DRUG	_	NOUN	NN	_	33	nmod	_	_
36	,	_	.	,	_	42	punct	_	_
37	DRUG	_	NOUN	NN	_	40	compound	_	_
38	median	_	ADJ	JJ	_	40	amod	_	_
39	peak	_	ADJ	JJ	_	40	amod	_	_
40	concentrations	_	NOUN	NNS	_	42	nsubjpass	_	_
41	were	_	VERB	VBD	_	42	auxpass	_	_
42	observed	_	VERB	VBN	_	0	root	_	_
43	4	_	NUM	CD	_	45	compound	_	_
44	to	_	PRT	TO	_	45	dep	_	_
45	4.5	_	NUM	CD	_	46	nummod	_	_
46	hours	_	NOUN	NNS	_	42	nmod	_	_
47	post	_	ADJ	JJ	_	48	compound	_	_
48	dose	_	NOUN	NN	_	46	dep	_	_

#	Harvoni	4383
1	DRUG	_	NOUN	NN	_	3	nsubjpass	_	_
2	was	_	VERB	VBD	_	3	auxpass	_	_
3	absorbed	_	VERB	VBN	_	0	root	_	_
4	quickly	_	ADV	RB	_	3	advmod	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	the	_	DET	DT	_	10	det	_	_
7	peak	_	ADJ	JJ	_	10	amod	_	_
8	median	_	ADJ	JJ	_	10	amod	_	_
9	plasma	_	NOUN	NN	_	10	compound	_	_
10	concentration	_	NOUN	NN	_	12	nsubjpass	_	_
11	was	_	VERB	VBD	_	12	auxpass	_	_
12	observed	_	VERB	VBN	_	4	conj	_	_
13	~0.8	_	NUM	CD	_	18	compound	_	_
14	to	_	PRT	TO	_	18	case	_	_
15	1	_	NUM	CD	_	18	nummod	_	_
16	hour	_	NUM	CD	_	18	compound	_	_
17	post	_	ADJ	JJ	_	18	compound	_	_
18	dose	_	NOUN	NN	_	12	nmod	_	_

#	Harvoni	4384
1	Median	_	ADJ	JJ	_	4	amod	_	_
2	peak	_	ADJ	JJ	_	4	amod	_	_
3	plasma	_	NOUN	NN	_	4	compound	_	_
4	concentration	_	NOUN	NN	_	9	nsubjpass	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	GS	_	NOUN	NN	_	4	nmod	_	_
7	331007	_	NUM	CD	_	6	nummod	_	_
8	was	_	VERB	VBD	_	9	auxpass	_	_
9	observed	_	VERB	VBN	_	0	root	_	_
10	between	_	ADP	IN	_	14	case	_	_
11	3.5	_	NUM	CD	_	13	compound	_	_
12	to	_	PRT	TO	_	13	dep	_	_
13	4	_	NUM	CD	_	14	nummod	_	_
14	hours	_	NOUN	NNS	_	9	nmod	_	_
15	post	_	ADJ	JJ	_	16	case	_	_
16	dose	_	NOUN	NN	_	14	dep	_	_

#	Harvoni	4385
1	Based	_	VERB	VBN	_	0	root	_	_
2	on	_	ADP	IN	_	6	case	_	_
3	the	_	DET	DT	_	6	det	_	_
4	population	_	NOUN	NN	_	6	compound	_	_
5	pharmacokinetic	_	ADJ	JJ	_	6	amod	_	_
6	analysis	_	NOUN	NN	_	1	nmod	_	_
7	in	_	ADP	IN	_	10	case	_	_
8	HCV	_	NOUN	NN	_	10	compound	_	_
9	infected	_	ADJ	JJ	_	10	amod	_	_
10	subjects	_	NOUN	NNS	_	6	nmod	_	_
11	,	_	.	,	_	10	punct	_	_
12	geometric	_	ADJ	JJ	_	16	amod	_	_
13	mean	_	NOUN	NN	_	16	compound	_	_
14	steady	_	ADJ	JJ	_	16	amod	_	_
15	state	_	NOUN	NN	_	16	compound	_	_
16	AUC0	_	NOUN	NN	_	30	nsubj	_	_
17	24	_	NUM	CD	_	16	nummod	_	_
18	for	_	ADP	IN	_	20	case	_	_
19	DRUG	_	NOUN	NN	_	20	compound	_	_
20	N=2113	_	NOUN	NN	_	16	nmod	_	_
21	,	_	.	,	_	20	punct	_	_
22	DRUG	_	NOUN	NN	_	23	compound	_	_
23	N=1542	_	NOUN	NN	_	20	conj	_	_
24	,	_	.	,	_	20	punct	_	_
25	and	_	CONJ	CC	_	20	cc	_	_
26	GS	_	NOUN	NN	_	28	compound	_	_
27	331007	_	NUM	CD	_	28	nummod	_	_
28	N=2113	_	NOUN	NN	_	20	conj	_	_
29	were	_	VERB	VBD	_	30	cop	_	_
30	7290	_	NUM	CD	_	10	appos	_	_
31	,	_	.	,	_	30	punct	_	_
32	1320	_	NUM	CD	_	30	conj	_	_
33	,	_	.	,	_	30	punct	_	_
34	and	_	CONJ	CC	_	30	cc	_	_
35	12,000	_	NUM	CD	_	36	nummod	_	_
36	ng*hr	_	NOUN	NN	_	30	conj	_	_
37	/	_	.	:	_	10	punct	_	_
38	mL	_	NOUN	NN	_	10	appos	_	_
39	,	_	.	,	_	1	punct	_	_
40	respectively	_	ADV	RB	_	1	advmod	_	_

#	Harvoni	4386
1	Steady	_	ADJ	JJ	_	3	amod	_	_
2	state	_	NOUN	NN	_	3	compound	_	_
3	Cmax	_	NOUN	NN	_	13	nsubj	_	_
4	for	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	,	_	.	,	_	5	punct	_	_
7	DRUG	_	NOUN	NN	_	5	conj	_	_
8	,	_	.	,	_	5	punct	_	_
9	and	_	CONJ	CC	_	5	cc	_	_
10	GS	_	NOUN	NN	_	5	conj	_	_
11	331007	_	NUM	CD	_	10	nummod	_	_
12	were	_	VERB	VBD	_	13	cop	_	_
13	323	_	NUM	CD	_	0	root	_	_
14	,	_	.	,	_	13	punct	_	_
15	618	_	NUM	CD	_	13	conj	_	_
16	,	_	.	,	_	13	punct	_	_
17	and	_	CONJ	CC	_	13	cc	_	_
18	707	_	NUM	CD	_	19	nummod	_	_
19	ng	_	NOUN	NN	_	13	conj	_	_
20	/	_	.	:	_	13	punct	_	_
21	mL	_	NOUN	NN	_	13	dep	_	_
22	,	_	.	,	_	21	punct	_	_
23	respectively	_	ADV	RB	_	21	advmod	_	_

#	Harvoni	4387
1	DRUG	_	NOUN	NN	_	10	nsubj	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	GS	_	NOUN	NN	_	5	compound	_	_
4	331007	_	NUM	CD	_	5	nummod	_	_
5	AUC0	_	NOUN	NN	_	1	conj	_	_
6	24	_	NUM	CD	_	5	nummod	_	_
7	and	_	CONJ	CC	_	1	cc	_	_
8	Cmax	_	NOUN	NN	_	1	conj	_	_
9	were	_	VERB	VBD	_	10	cop	_	_
10	similar	_	ADJ	JJ	_	0	root	_	_
11	in	_	ADP	IN	_	14	case	_	_
12	healthy	_	ADJ	JJ	_	14	amod	_	_
13	adult	_	ADJ	JJ	_	14	amod	_	_
14	subjects	_	NOUN	NNS	_	10	nmod	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	subjects	_	NOUN	NNS	_	14	conj	_	_
17	with	_	ADP	IN	_	19	case	_	_
18	HCV	_	NOUN	NN	_	19	compound	_	_
19	infection	_	NOUN	NN	_	14	nmod	_	_

#	Harvoni	4388
1	Relative	_	ADV	RB	_	14	nsubj	_	_
2	to	_	PRT	TO	_	4	case	_	_
3	healthy	_	ADJ	JJ	_	4	amod	_	_
4	subjects	_	NOUN	NNS	_	1	nmod	_	_
5	N=191	_	NOUN	NN	_	4	dep	_	_
6	,	_	.	,	_	5	punct	_	_
7	DRUG	_	NOUN	NN	_	8	compound	_	_
8	AUC0	_	NOUN	NN	_	5	conj	_	_
9	24	_	NUM	CD	_	8	nummod	_	_
10	and	_	CONJ	CC	_	5	cc	_	_
11	Cmax	_	NOUN	NN	_	5	conj	_	_
12	were	_	VERB	VBD	_	14	cop	_	_
13	24%	_	ADJ	JJ	_	14	amod	_	_
14	lower	_	ADJ	JJ	_	0	root	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	32%	_	ADJ	JJ	_	14	conj	_	_
17	lower	_	ADJ	JJ	_	14	dep	_	_
18	,	_	.	,	_	14	punct	_	_
19	respectively	_	ADV	RB	_	14	advmod	_	_
20	,	_	.	,	_	14	punct	_	_
21	in	_	ADP	IN	_	24	case	_	_
22	HCV	_	NOUN	NN	_	24	compound	_	_
23	infected	_	ADJ	JJ	_	24	amod	_	_
24	subjects	_	NOUN	NNS	_	14	nmod	_	_

#	Harvoni	4389
1	Effect	_	NOUN	NN	_	37	nsubj	_	_
2	of	_	ADP	IN	_	4	case	_	_
3	Food	_	ADJ	JJ	_	4	amod	_	_
4	Relative	_	ADJ	JJ	_	1	nmod	_	_
5	to	_	PRT	TO	_	6	mark	_	_
6	fasting	_	VERB	VBG	_	1	acl	_	_
7	conditions	_	NOUN	NNS	_	6	dobj	_	_
8	,	_	.	,	_	7	punct	_	_
9	the	_	DET	DT	_	10	det	_	_
10	administration	_	NOUN	NN	_	7	appos	_	_
11	of	_	ADP	IN	_	14	case	_	_
12	a	_	DET	DT	_	14	det	_	_
13	single	_	ADJ	JJ	_	14	amod	_	_
14	dose	_	NOUN	NN	_	10	nmod	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	14	nmod	_	_
17	with	_	ADP	IN	_	22	case	_	_
18	a	_	DET	DT	_	22	det	_	_
19	moderate	_	ADJ	JJ	_	22	compound	_	_
20	fat	_	NOUN	NN	_	22	compound	_	_
21	~600	_	NUM	CD	_	22	nummod	_	_
22	kcal	_	NOUN	NN	_	10	nmod	_	_
23	,	_	.	,	_	22	punct	_	_
24	25%	_	NOUN	NN	_	22	conj	_	_
25	to	_	PRT	TO	_	27	case	_	_
26	30%	_	ADJ	JJ	_	27	amod	_	_
27	fat	_	NOUN	NN	_	24	nmod	_	_
28	or	_	CONJ	CC	_	22	cc	_	_
29	high	_	ADJ	JJ	_	32	amod	_	_
30	fat	_	NOUN	NN	_	32	compound	_	_
31	~1000	_	NUM	CD	_	32	nummod	_	_
32	kcal	_	ADJ	JJ	_	22	conj	_	_
33	,	_	.	,	_	1	punct	_	_
34	50%	_	ADJ	JJ	_	36	amod	_	_
35	fat	_	NOUN	NN	_	36	compound	_	_
36	meal	_	ADJ	JJ	_	1	amod	_	_
37	increased	_	VERB	VBD	_	0	root	_	_
38	DRUG	_	NOUN	NN	_	40	compound	_	_
39	AUC0	_	NOUN	NN	_	40	compound	_	_
40	inf	_	NOUN	NN	_	37	dobj	_	_
41	by	_	ADP	IN	_	44	case	_	_
42	approximately	_	ADV	RB	_	43	advmod	_	_
43	2	_	NUM	CD	_	44	nummod	_	_
44	fold	_	NOUN	NN	_	37	nmod	_	_
45	,	_	.	,	_	37	punct	_	_
46	but	_	CONJ	CC	_	37	cc	_	_
47	did	_	VERB	MD	_	50	aux	_	_
48	not	_	ADV	RB	_	50	neg	_	_
49	significantly	_	ADV	RB	_	50	advmod	_	_
50	affect	_	VERB	VB	_	37	conj	_	_
51	DRUG	_	NOUN	NN	_	52	compound	_	_
52	Cmax	_	NOUN	NN	_	50	dobj	_	_

#	Harvoni	4390
1	The	_	DET	DT	_	2	det	_	_
2	exposures	_	NOUN	NNS	_	10	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	GS	_	NOUN	NN	_	2	nmod	_	_
5	331007	_	NUM	CD	_	4	nummod	_	_
6	and	_	CONJ	CC	_	4	cc	_	_
7	DRUG	_	NOUN	NN	_	4	conj	_	_
8	were	_	VERB	VBD	_	10	auxpass	_	_
9	not	_	ADV	RB	_	10	neg	_	_
10	altered	_	VERB	VBN	_	0	root	_	_
11	in	_	ADP	IN	_	13	case	_	_
12	the	_	DET	DT	_	13	det	_	_
13	presence	_	NOUN	NN	_	10	nmod	_	_
14	of	_	ADP	IN	_	17	case	_	_
15	either	_	CONJ	CC	_	17	det	_	_
16	meal	_	ADJ	JJ	_	17	amod	_	_
17	type	_	NOUN	NN	_	13	nmod	_	_

#	Harvoni	4391
1	The	_	DET	DT	_	3	det	_	_
2	response	_	NOUN	NN	_	3	compound	_	_
3	rates	_	NOUN	NNS	_	9	nsubj	_	_
4	in	_	ADP	IN	_	7	case	_	_
5	Phase	_	NOUN	NN	_	7	compound	_	_
6	3	_	NUM	CD	_	7	nummod	_	_
7	trials	_	NOUN	NNS	_	3	nmod	_	_
8	were	_	VERB	VBD	_	9	cop	_	_
9	similar	_	ADJ	JJ	_	0	root	_	_
10	in	_	ADP	IN	_	13	case	_	_
11	HCV	_	NOUN	NN	_	13	compound	_	_
12	infected	_	ADJ	JJ	_	13	amod	_	_
13	subjects	_	NOUN	NNS	_	9	nmod	_	_
14	who	_	DET	WDT	_	15	nsubj	_	_
15	received	_	VERB	VBD	_	13	acl:relcl	_	_
16	DRUG	_	NOUN	NN	_	15	dobj	_	_
17	with	_	ADP	IN	_	18	case	_	_
18	food	_	NOUN	NN	_	15	nmod	_	_
19	or	_	CONJ	CC	_	18	cc	_	_
20	without	_	ADP	IN	_	21	case	_	_
21	food	_	NOUN	NN	_	18	conj	_	_

#	Harvoni	4392
1	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
2	can	_	VERB	MD	_	4	aux	_	_
3	be	_	VERB	VB	_	4	auxpass	_	_
4	administered	_	VERB	VBN	_	0	root	_	_
5	without	_	ADP	IN	_	8	case	_	_
6	regard	_	NOUN	NN	_	8	compound	_	_
7	to	_	PRT	TO	_	8	case	_	_
8	food	_	NOUN	NN	_	4	nmod	_	_

#	Harvoni	4393
1	Distribution	_	NOUN	NN	_	2	compound	_	_
2	DRUG	_	NOUN	NN	_	4	nsubj	_	_
3	is	_	VERB	VBZ	_	4	cop	_	_
4	greater	_	ADJ	JJ	_	0	root	_	_
5	than	_	ADP	IN	_	6	case	_	_
6	99.8%	_	NOUN	NN	_	4	nmod	_	_
7	bound	_	VERB	VBN	_	6	acl	_	_
8	to	_	PRT	TO	_	11	case	_	_
9	human	_	ADJ	JJ	_	11	amod	_	_
10	plasma	_	NOUN	NN	_	11	compound	_	_
11	proteins	_	NOUN	NNS	_	7	nmod	_	_

#	Harvoni	4394
1	After	_	ADP	IN	_	6	case	_	_
2	a	_	DET	DT	_	6	det	_	_
3	single	_	ADJ	JJ	_	6	amod	_	_
4	90	_	NUM	CD	_	6	nummod	_	_
5	mg	_	NOUN	NN	_	6	compound	_	_
6	dose	_	NOUN	NN	_	0	root	_	_
7	of	_	ADP	IN	_	9	case	_	_
8	14C	_	NOUN	NN	_	9	compound	_	_
9	DRUG	_	NOUN	NN	_	6	nmod	_	_
10	in	_	ADP	IN	_	12	case	_	_
11	healthy	_	ADJ	JJ	_	12	amod	_	_
12	subjects	_	NOUN	NNS	_	6	nmod	_	_
13	,	_	.	,	_	6	punct	_	_
14	the	_	DET	DT	_	15	det	_	_
15	blood	_	NOUN	NN	_	13	root	_	_
16	to	_	PRT	TO	_	18	case	_	_
17	plasma	_	NOUN	NN	_	18	compound	_	_
18	ratio	_	NOUN	NN	_	15	nmod	_	_
19	of	_	ADP	IN	_	21	case	_	_
20	14C	_	NOUN	NN	_	21	compound	_	_
21	radioactivity	_	NOUN	NN	_	18	nmod	_	_
22	ranged	_	VERB	VBN	_	21	acl	_	_
23	between	_	ADP	IN	_	24	case	_	_
24	0.51	_	NUM	CD	_	22	nmod	_	_
25	and	_	CONJ	CC	_	24	cc	_	_
26	0.66	_	NUM	CD	_	24	conj	_	_

#	Harvoni	4395
1	DRUG	_	NOUN	NN	_	5	nsubj	_	_
2	is	_	VERB	VBZ	_	5	cop	_	_
3	approximately	_	ADV	RB	_	4	advmod	_	_
4	61	_	NUM	CD	_	5	nummod	_	_
5	65%	_	NOUN	NN	_	0	root	_	_
6	bound	_	VERB	VBN	_	5	acl	_	_
7	to	_	PRT	TO	_	10	case	_	_
8	human	_	ADJ	JJ	_	10	amod	_	_
9	plasma	_	NOUN	NN	_	10	compound	_	_
10	proteins	_	NOUN	NNS	_	6	nmod	_	_
11	and	_	CONJ	CC	_	5	cc	_	_
12	the	_	DET	DT	_	13	det	_	_
13	binding	_	NOUN	NN	_	15	nsubj	_	_
14	is	_	VERB	VBZ	_	15	cop	_	_
15	independent	_	ADJ	JJ	_	5	conj	_	_
16	of	_	ADP	IN	_	18	case	_	_
17	drug	_	NOUN	NN	_	18	compound	_	_
18	concentration	_	NOUN	NN	_	15	nmod	_	_
19	over	_	ADP	IN	_	21	case	_	_
20	the	_	DET	DT	_	21	det	_	_
21	range	_	NOUN	NN	_	18	nmod	_	_
22	of	_	ADP	IN	_	24	case	_	_
23	1	_	NUM	CD	_	24	nummod	_	_
24	ug	_	NOUN	NN	_	21	nmod	_	_
25	/	_	.	:	_	5	punct	_	_
26	mL	_	NOUN	NN	_	5	dep	_	_
27	to	_	PRT	TO	_	29	case	_	_
28	20	_	NUM	CD	_	29	nummod	_	_
29	ug	_	ADJ	JJR	_	26	nmod	_	_
30	/	_	.	:	_	5	punct	_	_
31	mL	_	NOUN	NN	_	5	dep	_	_

#	Harvoni	4396
1	Protein	_	NOUN	NN	_	2	compound	_	_
2	binding	_	NOUN	NN	_	7	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	GS	_	NOUN	NN	_	2	nmod	_	_
5	331007	_	NUM	CD	_	4	nummod	_	_
6	was	_	VERB	VBD	_	7	cop	_	_
7	minimal	_	ADJ	JJ	_	0	root	_	_
8	in	_	ADP	IN	_	10	case	_	_
9	human	_	ADJ	JJ	_	10	amod	_	_
10	plasma	_	NOUN	NN	_	7	nmod	_	_

#	Harvoni	4397
1	After	_	ADP	IN	_	6	case	_	_
2	a	_	DET	DT	_	6	det	_	_
3	single	_	ADJ	JJ	_	6	amod	_	_
4	400	_	NUM	CD	_	6	nummod	_	_
5	mg	_	NOUN	NN	_	6	compound	_	_
6	dose	_	NOUN	NN	_	0	root	_	_
7	of	_	ADP	IN	_	9	case	_	_
8	14C	_	NOUN	NN	_	9	compound	_	_
9	DRUG	_	NOUN	NN	_	6	nmod	_	_
10	in	_	ADP	IN	_	12	case	_	_
11	healthy	_	ADJ	JJ	_	12	amod	_	_
12	subjects	_	NOUN	NNS	_	6	nmod	_	_
13	,	_	.	,	_	6	punct	_	_
14	the	_	DET	DT	_	15	det	_	_
15	blood	_	NOUN	NN	_	24	nsubj	_	_
16	to	_	PRT	TO	_	18	case	_	_
17	plasma	_	NOUN	NN	_	18	compound	_	_
18	ratio	_	NOUN	NN	_	15	nmod	_	_
19	of	_	ADP	IN	_	21	case	_	_
20	14C	_	NOUN	NN	_	21	compound	_	_
21	radioactivity	_	NOUN	NN	_	18	nmod	_	_
22	was	_	VERB	VBD	_	24	cop	_	_
23	approximately	_	ADV	RB	_	24	advmod	_	_
24	0.7	_	NUM	CD	_	13	root	_	_

#	Harvoni	4398
1	Metabolism	_	NOUN	NN	_	0	root	_	_
2	In	_	X	FW	_	3	compound	_	_
3	vitro	_	X	FW	_	1	advmod	_	_
4	,	_	.	,	_	1	punct	_	_
5	no	_	DET	DT	_	7	neg	_	_
6	detectable	_	ADJ	JJ	_	7	amod	_	_
7	metabolism	_	NOUN	NN	_	11	nsubjpass	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	was	_	VERB	VBD	_	11	auxpass	_	_
11	observed	_	VERB	VBN	_	1	dep	_	_
12	by	_	ADP	IN	_	14	case	_	_
13	human	_	ADJ	JJ	_	14	amod	_	_
14	CYP1A2	_	NOUN	NN	_	11	nmod	_	_
15	,	_	.	,	_	14	punct	_	_
16	CYP2C8	_	NOUN	NN	_	14	conj	_	_
17	,	_	.	,	_	14	punct	_	_
18	CYP2C9	_	NOUN	NN	_	14	conj	_	_
19	,	_	.	,	_	14	punct	_	_
20	CYP2C19	_	NOUN	NN	_	14	conj	_	_
21	,	_	.	,	_	14	punct	_	_
22	CYP2D6	_	NOUN	NN	_	14	conj	_	_
23	,	_	.	,	_	14	punct	_	_
24	and	_	CONJ	CC	_	14	cc	_	_
25	CYP3A4	_	NOUN	NN	_	14	conj	_	_

#	Harvoni	4399
1	Evidence	_	NOUN	NN	_	12	nsubjpass	_	_
2	of	_	ADP	IN	_	5	case	_	_
3	slow	_	ADJ	JJ	_	5	compound	_	_
4	oxidative	_	ADJ	JJ	_	5	amod	_	_
5	metabolism	_	NOUN	NN	_	1	nmod	_	_
6	via	_	ADP	IN	_	9	case	_	_
7	an	_	DET	DT	_	9	det	_	_
8	unknown	_	ADJ	JJ	_	9	amod	_	_
9	mechanism	_	NOUN	NN	_	1	nmod	_	_
10	has	_	VERB	VBZ	_	12	aux	_	_
11	been	_	VERB	VBN	_	12	auxpass	_	_
12	observed	_	VERB	VBN	_	0	root	_	_

#	Harvoni	4400
1	Following	_	ADP	IN	_	4	case	_	_
2	a	_	DET	DT	_	4	det	_	_
3	single	_	ADJ	JJ	_	4	amod	_	_
4	dose	_	NOUN	NN	_	15	nmod	_	_
5	of	_	ADP	IN	_	9	case	_	_
6	90	_	NUM	CD	_	9	nummod	_	_
7	mg	_	NOUN	NN	_	9	compound	_	_
8	14C	_	NOUN	NN	_	9	compound	_	_
9	DRUG	_	NOUN	NN	_	4	nmod	_	_
10	,	_	.	,	_	15	punct	_	_
11	systemic	_	ADJ	JJ	_	12	amod	_	_
12	exposure	_	NOUN	NN	_	15	nsubj	_	_
13	was	_	VERB	VBD	_	15	cop	_	_
14	almost	_	ADV	RB	_	15	advmod	_	_
15	exclusively	_	ADV	RB	_	0	root	_	_
16	to	_	PRT	TO	_	19	case	_	_
17	the	_	DET	DT	_	19	det	_	_
18	parent	_	NOUN	NN	_	19	compound	_	_
19	drug	_	NOUN	NN	_	15	nmod	_	_
20	greater	_	ADJ	JJ	_	19	amod	_	_
21	than	_	ADP	IN	_	22	case	_	_
22	98%	_	ADJ	JJ	_	20	nmod	_	_

#	Harvoni	4401
1	Unchanged	_	ADJ	JJ	_	2	amod	_	_
2	DRUG	_	NOUN	NN	_	6	nsubj	_	_
3	is	_	VERB	VBZ	_	6	cop	_	_
4	the	_	DET	DT	_	6	det	_	_
5	major	_	ADJ	JJ	_	6	amod	_	_
6	species	_	NOUN	NNS	_	0	root	_	_
7	present	_	ADJ	JJ	_	6	amod	_	_
8	in	_	ADP	IN	_	9	case	_	_
9	feces	_	NOUN	NNS	_	7	nmod	_	_

#	Harvoni	4402
1	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
2	is	_	VERB	VBZ	_	4	auxpass	_	_
3	extensively	_	ADV	RB	_	4	advmod	_	_
4	metabolized	_	VERB	VBN	_	0	root	_	_
5	in	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	liver	_	NOUN	NN	_	4	nmod	_	_
8	to	_	PRT	TO	_	9	mark	_	_
9	form	_	VERB	VB	_	4	xcomp	_	_
10	the	_	DET	DT	_	16	det	_	_
11	pharmacologically	_	ADV	RB	_	12	advmod	_	_
12	active	_	ADJ	JJ	_	16	amod	_	_
13	nucleoside	_	NOUN	NN	_	16	compound	_	_
14	analog	_	NOUN	NN	_	16	compound	_	_
15	triphosphate	_	NOUN	NN	_	16	compound	_	_
16	GS	_	NOUN	NN	_	9	dobj	_	_
17	461203	_	NUM	CD	_	16	nummod	_	_

#	Harvoni	4403
1	The	_	DET	DT	_	4	det	_	_
2	metabolic	_	ADJ	JJ	_	4	amod	_	_
3	activation	_	NOUN	NN	_	4	compound	_	_
4	pathway	_	NOUN	NN	_	5	nsubj	_	_
5	involves	_	VERB	VBZ	_	0	root	_	_
6	sequential	_	ADJ	JJ	_	7	amod	_	_
7	hydrolysis	_	NOUN	NN	_	5	dobj	_	_
8	of	_	ADP	IN	_	12	case	_	_
9	the	_	DET	DT	_	12	det	_	_
10	carboxyl	_	NOUN	NN	_	12	compound	_	_
11	ester	_	NOUN	NN	_	12	compound	_	_
12	moiety	_	NOUN	NN	_	7	nmod	_	_
13	catalyzed	_	VERB	VBN	_	12	acl	_	_
14	by	_	ADP	IN	_	18	case	_	_
15	human	_	ADJ	JJ	_	18	amod	_	_
16	cathepsin	_	NOUN	NN	_	18	compound	_	_
17	A	_	NOUN	NN	_	18	compound	_	_
18	CatA	_	NOUN	NN	_	13	nmod	_	_
19	or	_	CONJ	CC	_	18	cc	_	_
20	carboxylesterase	_	NOUN	NN	_	22	compound	_	_
21	1	_	NUM	CD	_	22	nummod	_	_
22	CES1	_	NOUN	NN	_	18	conj	_	_
23	and	_	CONJ	CC	_	7	cc	_	_
24	phosphoramidate	_	ADJ	JJ	_	25	compound	_	_
25	cleavage	_	NOUN	NN	_	7	conj	_	_
26	by	_	ADP	IN	_	33	case	_	_
27	histidine	_	NOUN	NN	_	33	compound	_	_
28	triad	_	ADJ	JJ	_	33	amod	_	_
29	nucleotide	_	NOUN	NN	_	33	compound	_	_
30	binding	_	NOUN	NN	_	33	compound	_	_
31	protein	_	NOUN	NN	_	33	compound	_	_
32	1	_	NUM	CD	_	33	nummod	_	_
33	HINT1	_	NOUN	NN	_	5	nmod	_	_
34	followed	_	VERB	VBN	_	33	acl	_	_
35	by	_	ADP	IN	_	36	case	_	_
36	phosphorylation	_	NOUN	NN	_	34	nmod	_	_
37	by	_	ADP	IN	_	42	case	_	_
38	the	_	DET	DT	_	42	det	_	_
39	pyrimidine	_	NOUN	NN	_	42	compound	_	_
40	nucleotide	_	NOUN	NN	_	42	compound	_	_
41	biosynthesis	_	NOUN	NN	_	42	compound	_	_
42	pathway	_	NOUN	NN	_	36	nmod	_	_

#	Harvoni	4404
1	Dephosphorylation	_	NOUN	NN	_	2	nsubj	_	_
2	results	_	VERB	VBZ	_	0	root	_	_
3	in	_	ADP	IN	_	5	case	_	_
4	the	_	DET	DT	_	5	det	_	_
5	formation	_	NOUN	NN	_	2	nmod	_	_
6	of	_	ADP	IN	_	9	case	_	_
7	nucleoside	_	NOUN	NN	_	9	compound	_	_
8	metabolite	_	NOUN	NN	_	9	compound	_	_
9	GS	_	NOUN	NN	_	5	nmod	_	_
10	331007	_	NUM	CD	_	9	nummod	_	_
11	that	_	DET	WDT	_	15	mark	_	_
12	cannot	_	NOUN	NN	_	15	nsubjpass	_	_
13	be	_	VERB	VBZ	_	15	auxpass	_	_
14	efficiently	_	ADV	RB	_	15	advmod	_	_
15	rephosphorylated	_	VERB	VBN	_	5	acl:relcl	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	lacks	_	VERB	VBZ	_	15	conj	_	_
18	anti	_	ADJ	JJ	_	20	amod	_	_
19	HCV	_	NOUN	NN	_	20	compound	_	_
20	activity	_	NOUN	NN	_	17	dobj	_	_
21	in	_	X	FW	_	22	compound	_	_
22	vitro	_	X	FW	_	17	advmod	_	_

#	Harvoni	4405
1	After	_	ADP	IN	_	7	case	_	_
2	a	_	DET	DT	_	7	det	_	_
3	single	_	ADJ	JJ	_	7	amod	_	_
4	400	_	NUM	CD	_	7	nummod	_	_
5	mg	_	NOUN	NN	_	7	compound	_	_
6	oral	_	ADJ	JJ	_	7	amod	_	_
7	dose	_	NOUN	NN	_	14	nmod	_	_
8	of	_	ADP	IN	_	10	case	_	_
9	14C	_	NOUN	NN	_	10	compound	_	_
10	DRUG	_	NOUN	NN	_	7	nmod	_	_
11	,	_	.	,	_	14	punct	_	_
12	GS	_	NOUN	NN	_	14	nsubj	_	_
13	331007	_	NUM	CD	_	12	nummod	_	_
14	accounted	_	VERB	VBD	_	0	root	_	_
15	for	_	ADP	IN	_	17	case	_	_
16	approximately	_	ADV	RB	_	17	advmod	_	_
17	greater	_	ADJ	JJ	_	14	nmod	_	_
18	than	_	ADP	IN	_	19	case	_	_
19	90%	_	NOUN	NN	_	17	nmod	_	_
20	of	_	ADP	IN	_	23	case	_	_
21	total	_	ADJ	JJ	_	23	amod	_	_
22	systemic	_	ADJ	JJ	_	23	amod	_	_
23	exposure	_	NOUN	NN	_	19	nmod	_	_

#	Harvoni	4406
1	Elimination	_	NOUN	NN	_	13	nsubj	_	_
2	Following	_	ADP	IN	_	8	case	_	_
3	a	_	DET	DT	_	8	det	_	_
4	single	_	ADJ	JJ	_	8	amod	_	_
5	90	_	NUM	CD	_	8	nummod	_	_
6	mg	_	NOUN	NN	_	8	compound	_	_
7	oral	_	ADJ	JJ	_	8	amod	_	_
8	dose	_	NOUN	NN	_	1	nmod	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	14C	_	NOUN	NN	_	11	compound	_	_
11	DRUG	_	NOUN	NN	_	8	nmod	_	_
12	,	_	.	,	_	1	punct	_	_
13	mean	_	VERB	VBP	_	0	root	_	_
14	total	_	ADJ	JJ	_	15	amod	_	_
15	recovery	_	NOUN	NN	_	13	dobj	_	_
16	of	_	ADP	IN	_	19	case	_	_
17	the	_	DET	DT	_	19	det	_	_
18	14C	_	NOUN	NN	_	19	compound	_	_
19	radioactivity	_	NOUN	NN	_	15	nmod	_	_
20	in	_	ADP	IN	_	21	case	_	_
21	feces	_	NOUN	NNS	_	15	nmod	_	_
22	and	_	CONJ	CC	_	13	cc	_	_
23	urine	_	NOUN	NN	_	26	nsubj	_	_
24	was	_	VERB	VBD	_	26	cop	_	_
25	approximately	_	ADV	RB	_	26	advmod	_	_
26	87%	_	ADJ	JJ	_	13	conj	_	_
27	,	_	.	,	_	13	punct	_	_
28	with	_	ADP	IN	_	29	case	_	_
29	most	_	NOUN	NN	_	13	nmod	_	_
30	of	_	ADP	IN	_	33	case	_	_
31	the	_	DET	DT	_	33	det	_	_
32	radioactive	_	ADJ	JJ	_	33	amod	_	_
33	dose	_	NOUN	NN	_	29	nmod	_	_
34	recovered	_	VERB	VBN	_	33	acl	_	_
35	from	_	ADP	IN	_	36	case	_	_
36	feces	_	NOUN	NNS	_	34	nmod	_	_
37	approximately	_	ADV	RB	_	38	advmod	_	_
38	86%	_	ADJ	JJ	_	36	dep	_	_

#	Harvoni	4407
1	Unchanged	_	ADJ	JJ	_	2	amod	_	_
2	DRUG	_	NOUN	NN	_	6	nsubj	_	_
3	excreted	_	VERB	VBN	_	2	acl	_	_
4	in	_	ADP	IN	_	5	case	_	_
5	feces	_	NOUN	NNS	_	3	nmod	_	_
6	accounted	_	VERB	VBN	_	0	root	_	_
7	for	_	ADP	IN	_	9	case	_	_
8	a	_	DET	DT	_	9	det	_	_
9	mean	_	NOUN	NN	_	6	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	70%	_	NOUN	NN	_	9	nmod	_	_
12	of	_	ADP	IN	_	15	case	_	_
13	the	_	DET	DT	_	15	det	_	_
14	administered	_	ADJ	JJ	_	15	amod	_	_
15	dose	_	NOUN	NN	_	11	nmod	_	_
16	and	_	CONJ	CC	_	6	cc	_	_
17	the	_	DET	DT	_	20	det	_	_
18	oxidative	_	ADJ	JJ	_	20	amod	_	_
19	metabolite	_	NOUN	NN	_	20	compound	_	_
20	M19	_	NOUN	NN	_	21	nsubj	_	_
21	accounted	_	VERB	VBN	_	6	conj	_	_
22	for	_	ADP	IN	_	23	case	_	_
23	2.2%	_	NOUN	NN	_	21	nmod	_	_
24	of	_	ADP	IN	_	26	case	_	_
25	the	_	DET	DT	_	26	det	_	_
26	dose	_	NOUN	NN	_	23	nmod	_	_

#	Harvoni	4408
1	These	_	DET	DT	_	2	det	_	_
2	data	_	NOUN	NNS	_	3	nsubj	_	_
3	indicate	_	VERB	VBP	_	0	root	_	_
4	that	_	ADP	IN	_	13	mark	_	_
5	biliary	_	ADJ	JJ	_	6	amod	_	_
6	excretion	_	NOUN	NN	_	13	nsubj	_	_
7	of	_	ADP	IN	_	9	case	_	_
8	unchanged	_	ADJ	JJ	_	9	amod	_	_
9	DRUG	_	NOUN	NN	_	6	nmod	_	_
10	is	_	VERB	VBZ	_	13	cop	_	_
11	a	_	DET	DT	_	13	det	_	_
12	major	_	ADJ	JJ	_	13	amod	_	_
13	route	_	NOUN	NN	_	3	ccomp	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	elimination	_	NOUN	NN	_	13	nmod	_	_
16	,	_	.	,	_	13	punct	_	_
17	with	_	ADP	IN	_	19	case	_	_
18	renal	_	ADJ	JJ	_	19	amod	_	_
19	excretion	_	NOUN	NN	_	23	nsubj	_	_
20	being	_	VERB	VBD	_	23	cop	_	_
21	a	_	DET	DT	_	23	det	_	_
22	minor	_	ADJ	JJ	_	23	amod	_	_
23	pathway	_	NOUN	NN	_	13	advcl	_	_
24	approximately	_	ADV	RB	_	25	advmod	_	_
25	1%	_	ADJ	JJ	_	23	dep	_	_

#	Harvoni	4409
1	The	_	DET	DT	_	5	det	_	_
2	median	_	ADJ	JJ	_	5	amod	_	_
3	terminal	_	ADJ	JJ	_	5	amod	_	_
4	half	_	ADJ	JJ	_	5	amod	_	_
5	life	_	NOUN	NN	_	14	nsubj	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	following	_	VERB	VBG	_	9	case	_	_
9	administration	_	NOUN	NN	_	5	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_
12	was	_	VERB	VBD	_	14	cop	_	_
13	47	_	NUM	CD	_	14	nummod	_	_
14	hours	_	NOUN	NNS	_	0	root	_	_

#	Harvoni	4410
1	Following	_	ADP	IN	_	7	case	_	_
2	a	_	DET	DT	_	7	det	_	_
3	single	_	ADJ	JJ	_	7	amod	_	_
4	400	_	NUM	CD	_	7	nummod	_	_
5	mg	_	NOUN	NN	_	7	compound	_	_
6	oral	_	ADJ	JJ	_	7	amod	_	_
7	dose	_	NOUN	NN	_	19	nmod	_	_
8	of	_	ADP	IN	_	10	case	_	_
9	14C	_	NOUN	NN	_	10	compound	_	_
10	DRUG	_	NOUN	NN	_	7	nmod	_	_
11	,	_	.	,	_	19	punct	_	_
12	mean	_	ADJ	JJ	_	14	amod	_	_
13	total	_	ADJ	JJ	_	14	amod	_	_
14	recovery	_	NOUN	NN	_	19	nsubj	_	_
15	of	_	ADP	IN	_	17	case	_	_
16	the	_	DET	DT	_	17	det	_	_
17	dose	_	NOUN	NN	_	14	nmod	_	_
18	was	_	VERB	VBD	_	19	cop	_	_
19	greater	_	ADJ	JJ	_	0	root	_	_
20	than	_	ADP	IN	_	21	case	_	_
21	92%	_	NOUN	NN	_	19	nmod	_	_
22	,	_	.	,	_	19	punct	_	_
23	consisting	_	VERB	VBG	_	19	xcomp	_	_
24	of	_	ADP	IN	_	26	case	_	_
25	approximately	_	ADV	RB	_	26	advmod	_	_
26	80%	_	ADJ	JJ	_	23	nmod	_	_
27	,	_	.	,	_	26	punct	_	_
28	14%	_	NOUN	NN	_	26	conj	_	_
29	,	_	.	,	_	26	punct	_	_
30	and	_	CONJ	CC	_	26	cc	_	_
31	2.5%	_	NOUN	NN	_	26	conj	_	_
32	recovered	_	VERB	VBN	_	26	acl	_	_
33	in	_	ADP	IN	_	34	case	_	_
34	urine	_	ADJ	JJ	_	32	nmod	_	_
35	,	_	.	,	_	34	punct	_	_
36	feces	_	NOUN	NNS	_	34	conj	_	_
37	,	_	.	,	_	34	punct	_	_
38	and	_	CONJ	CC	_	34	cc	_	_
39	expired	_	VERB	VBN	_	34	conj	_	_
40	air	_	NOUN	NN	_	34	dep	_	_
41	,	_	.	,	_	19	punct	_	_
42	respectively	_	ADV	RB	_	19	advmod	_	_

#	Harvoni	4411
1	The	_	DET	DT	_	2	det	_	_
2	majority	_	NOUN	NN	_	13	nsubj	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	the	_	DET	DT	_	6	det	_	_
5	DRUG	_	NOUN	NN	_	6	compound	_	_
6	dose	_	NOUN	NN	_	2	nmod	_	_
7	recovered	_	VERB	VBN	_	6	acl	_	_
8	in	_	ADP	IN	_	9	case	_	_
9	urine	_	NOUN	NN	_	7	nmod	_	_
10	was	_	VERB	VBD	_	13	cop	_	_
11	GS	_	NOUN	NN	_	13	compound	_	_
12	331007	_	NUM	CD	_	13	nummod	_	_
13	78%	_	NOUN	NN	_	0	root	_	_
14	while	_	ADP	IN	_	17	mark	_	_
15	3.5%	_	NOUN	NN	_	17	nsubjpass	_	_
16	was	_	VERB	VBD	_	17	auxpass	_	_
17	recovered	_	VERB	VBN	_	13	advcl	_	_
18	as	_	ADP	IN	_	19	case	_	_
19	DRUG	_	NOUN	NN	_	17	nmod	_	_

#	Harvoni	4412
1	These	_	DET	DT	_	2	det	_	_
2	data	_	NOUN	NNS	_	3	nsubj	_	_
3	indicate	_	VERB	VBP	_	0	root	_	_
4	that	_	ADP	IN	_	11	mark	_	_
5	renal	_	ADJ	JJ	_	6	amod	_	_
6	clearance	_	NOUN	NN	_	11	nsubj	_	_
7	is	_	VERB	VBZ	_	11	cop	_	_
8	the	_	DET	DT	_	11	det	_	_
9	major	_	ADJ	JJ	_	11	amod	_	_
10	elimination	_	NOUN	NN	_	11	compound	_	_
11	pathway	_	NOUN	NN	_	3	ccomp	_	_
12	for	_	ADP	IN	_	13	case	_	_
13	GS	_	NOUN	NN	_	11	nmod	_	_
14	331007	_	NUM	CD	_	13	nummod	_	_

#	Harvoni	4413
1	The	_	DET	DT	_	5	det	_	_
2	median	_	ADJ	JJ	_	5	amod	_	_
3	terminal	_	ADJ	JJ	_	5	amod	_	_
4	half	_	ADJ	JJ	_	5	amod	_	_
5	lives	_	NOUN	NNS	_	19	nsubj	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	GS	_	NOUN	NN	_	7	conj	_	_
10	331007	_	NUM	CD	_	9	nummod	_	_
11	following	_	VERB	VBG	_	12	case	_	_
12	administration	_	NOUN	NN	_	5	nmod	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	DRUG	_	NOUN	NN	_	12	nmod	_	_
15	were	_	VERB	VBD	_	19	cop	_	_
16	0.5	_	NUM	CD	_	19	nummod	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	27	_	NUM	CD	_	16	conj	_	_
19	hours	_	NOUN	NNS	_	0	root	_	_
20	,	_	.	,	_	19	punct	_	_
21	respectively	_	ADV	RB	_	19	advmod	_	_

#	Harvoni	4414
1	Specific	_	ADJ	JJ	_	2	amod	_	_
2	Populations	_	NOUN	NNS	_	0	root	_	_
3	Race	_	ADJ	JJ	_	2	amod	_	_
4	:	_	.	:	_	2	punct	_	_
5	Population	_	NOUN	NN	_	7	compound	_	_
6	pharmacokinetics	_	NOUN	NNS	_	7	compound	_	_
7	analysis	_	NOUN	NN	_	12	nsubj	_	_
8	in	_	ADP	IN	_	11	case	_	_
9	HCV	_	NOUN	NN	_	11	compound	_	_
10	infected	_	ADJ	JJ	_	11	amod	_	_
11	subjects	_	NOUN	NNS	_	7	nmod	_	_
12	indicated	_	VERB	VBD	_	2	dep	_	_
13	that	_	ADP	IN	_	15	mark	_	_
14	race	_	NOUN	NN	_	15	nsubj	_	_
15	had	_	VERB	VBD	_	12	ccomp	_	_
16	no	_	DET	DT	_	19	neg	_	_
17	clinically	_	ADV	RB	_	18	advmod	_	_
18	relevant	_	ADJ	JJ	_	19	amod	_	_
19	effect	_	NOUN	NN	_	15	dobj	_	_
20	on	_	ADP	IN	_	22	case	_	_
21	the	_	DET	DT	_	22	det	_	_
22	exposure	_	NOUN	NN	_	15	nmod	_	_
23	of	_	ADP	IN	_	24	case	_	_
24	DRUG	_	NOUN	NN	_	22	nmod	_	_
25	,	_	.	,	_	24	punct	_	_
26	DRUG	_	NOUN	NN	_	24	conj	_	_
27	,	_	.	,	_	24	punct	_	_
28	and	_	CONJ	CC	_	24	cc	_	_
29	GS	_	NOUN	NN	_	24	conj	_	_
30	331007	_	NUM	CD	_	29	nummod	_	_

#	Harvoni	4415
1	Gender	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Population	_	NOUN	NN	_	5	compound	_	_
4	pharmacokinetics	_	NOUN	NNS	_	5	compound	_	_
5	analysis	_	NOUN	NN	_	10	nsubj	_	_
6	in	_	ADP	IN	_	9	case	_	_
7	HCV	_	NOUN	NN	_	9	compound	_	_
8	infected	_	ADJ	JJ	_	9	amod	_	_
9	subjects	_	NOUN	NNS	_	5	nmod	_	_
10	indicated	_	VERB	VBD	_	1	dep	_	_
11	that	_	ADP	IN	_	13	mark	_	_
12	gender	_	NOUN	NN	_	13	nsubj	_	_
13	had	_	VERB	VBD	_	10	ccomp	_	_
14	no	_	DET	DT	_	17	neg	_	_
15	clinically	_	ADV	RB	_	16	advmod	_	_
16	relevant	_	ADJ	JJ	_	17	amod	_	_
17	effect	_	NOUN	NN	_	13	dobj	_	_
18	on	_	ADP	IN	_	20	case	_	_
19	the	_	DET	DT	_	20	det	_	_
20	exposure	_	NOUN	NN	_	13	nmod	_	_
21	of	_	ADP	IN	_	22	case	_	_
22	DRUG	_	NOUN	NN	_	20	nmod	_	_
23	and	_	CONJ	CC	_	22	cc	_	_
24	GS	_	NOUN	NN	_	22	conj	_	_
25	331007	_	NUM	CD	_	24	nummod	_	_

#	Harvoni	4416
1	AUC	_	NOUN	NN	_	7	nsubj	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	Cmax	_	NOUN	NN	_	1	conj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	1	nmod	_	_
6	were	_	VERB	VBD	_	7	cop	_	_
7	77%	_	ADJ	JJ	_	29	advcl	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	58%	_	ADJ	JJ	_	10	nmod:npmod	_	_
10	higher	_	ADJ	JJ	_	7	conj	_	_
11	,	_	.	,	_	7	punct	_	_
12	respectively	_	ADV	RB	_	7	advmod	_	_
13	,	_	.	,	_	7	punct	_	_
14	in	_	ADP	IN	_	15	case	_	_
15	females	_	NOUN	NNS	_	7	nmod	_	_
16	than	_	ADP	IN	_	17	case	_	_
17	males	_	NOUN	NNS	_	15	nmod	_	_
18	however	_	ADV	RB	_	17	advmod	_	_
19	,	_	.	,	_	29	punct	_	_
20	the	_	DET	DT	_	21	det	_	_
21	relationship	_	NOUN	NN	_	29	nsubjpass	_	_
22	between	_	ADP	IN	_	23	case	_	_
23	gender	_	NOUN	NN	_	21	nmod	_	_
24	and	_	CONJ	CC	_	23	cc	_	_
25	DRUG	_	NOUN	NN	_	23	conj	_	_
26	exposures	_	NOUN	NNS	_	23	dep	_	_
27	was	_	VERB	VBD	_	29	auxpass	_	_
28	not	_	ADV	RB	_	29	neg	_	_
29	considered	_	VERB	VBN	_	0	root	_	_
30	clinically	_	ADV	RB	_	31	advmod	_	_
31	relevant	_	ADJ	JJ	_	29	xcomp	_	_
32	,	_	.	,	_	29	punct	_	_
33	as	_	ADP	IN	_	40	mark	_	_
34	high	_	ADJ	JJ	_	36	amod	_	_
35	response	_	NOUN	NN	_	36	compound	_	_
36	rates	_	NOUN	NNS	_	38	compound	_	_
37	SVR	_	NOUN	NN	_	38	compound	_	_
38	>90%	_	NOUN	NN	_	40	nsubjpass	_	_
39	were	_	VERB	VBD	_	40	auxpass	_	_
40	achieved	_	VERB	VBN	_	29	parataxis	_	_
41	in	_	ADP	IN	_	45	case	_	_
42	male	_	ADJ	JJ	_	45	amod	_	_
43	and	_	CONJ	CC	_	42	cc	_	_
44	female	_	ADJ	JJ	_	42	conj	_	_
45	subjects	_	NOUN	NNS	_	40	nmod	_	_
46	across	_	ADP	IN	_	50	case	_	_
47	the	_	DET	DT	_	50	det	_	_
48	Phase	_	NOUN	NN	_	50	compound	_	_
49	3	_	NUM	CD	_	50	nummod	_	_
50	studies	_	NOUN	NNS	_	45	nmod	_	_
51	and	_	CONJ	CC	_	40	cc	_	_
52	the	_	DET	DT	_	54	det	_	_
53	safety	_	NOUN	NN	_	54	compound	_	_
54	profiles	_	NOUN	NNS	_	56	nsubj	_	_
55	are	_	VERB	VBP	_	56	cop	_	_
56	similar	_	ADJ	JJ	_	40	conj	_	_
57	in	_	ADP	IN	_	58	case	_	_
58	females	_	NOUN	NNS	_	56	nmod	_	_
59	and	_	CONJ	CC	_	56	cc	_	_
60	males	_	NOUN	NNS	_	56	conj	_	_

#	Harvoni	4417
1	Pediatric	_	ADJ	JJ	_	2	amod	_	_
2	Patients	_	NOUN	NNS	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	The	_	DET	DT	_	5	det	_	_
5	pharmacokinetics	_	NOUN	NNS	_	15	nsubjpass	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	,	_	.	,	_	7	punct	_	_
9	DRUG	_	NOUN	NN	_	7	conj	_	_
10	,	_	.	,	_	7	punct	_	_
11	and	_	CONJ	CC	_	7	cc	_	_
12	GS	_	NOUN	NN	_	7	conj	_	_
13	331007	_	NUM	CD	_	12	nummod	_	_
14	were	_	VERB	VBD	_	15	auxpass	_	_
15	determined	_	VERB	VBN	_	2	dep	_	_
16	in	_	ADP	IN	_	19	case	_	_
17	100	_	NUM	CD	_	19	nummod	_	_
18	pediatric	_	ADJ	JJ	_	19	amod	_	_
19	subjects	_	NOUN	NNS	_	15	nmod	_	_
20	12	_	NUM	CD	_	21	nummod	_	_
21	years	_	NOUN	NNS	_	19	dep	_	_
22	of	_	ADP	IN	_	23	case	_	_
23	age	_	NOUN	NN	_	21	nmod	_	_
24	and	_	CONJ	CC	_	15	cc	_	_
25	older	_	ADV	RB	_	26	advmod	_	_
26	infected	_	VERB	VBN	_	15	conj	_	_
27	with	_	ADP	IN	_	29	case	_	_
28	HCV	_	NOUN	NN	_	29	compound	_	_
29	genotype	_	NOUN	NN	_	26	nmod	_	_
30	1	_	NUM	CD	_	29	nummod	_	_
31	receiving	_	VERB	VBG	_	29	acl	_	_
32	a	_	DET	DT	_	34	det	_	_
33	daily	_	ADV	RB	_	34	amod	_	_
34	dose	_	NOUN	NN	_	31	dobj	_	_
35	of	_	ADP	IN	_	39	case	_	_
36	DRUG	_	NOUN	NN	_	39	compound	_	_
37	90	_	NUM	CD	_	39	nummod	_	_
38	mg	_	NOUN	NN	_	39	compound	_	_
39	DRUG	_	NOUN	NN	_	34	nmod	_	_
40	and	_	CONJ	CC	_	39	cc	_	_
41	400	_	NUM	CD	_	43	nummod	_	_
42	mg	_	NOUN	NN	_	43	compound	_	_
43	DRUG	_	NOUN	NN	_	39	conj	_	_

#	Harvoni	4418
1	The	_	DET	DT	_	3	det	_	_
2	pharmacokinetic	_	ADJ	JJ	_	3	amod	_	_
3	properties	_	NOUN	NNS	_	0	root	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	,	_	.	,	_	5	punct	_	_
7	DRUG	_	NOUN	NN	_	5	conj	_	_
8	,	_	.	,	_	5	punct	_	_
9	and	_	CONJ	CC	_	5	cc	_	_
10	GS	_	NOUN	NN	_	5	conj	_	_
11	331007	_	NUM	CD	_	10	nummod	_	_
12	in	_	ADP	IN	_	14	case	_	_
13	pediatric	_	ADJ	JJ	_	14	amod	_	_
14	subjects	_	NOUN	NNS	_	3	nmod	_	_
15	12	_	NUM	CD	_	16	nummod	_	_
16	years	_	NOUN	NNS	_	14	dep	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	age	_	NOUN	NN	_	16	nmod	_	_
19	and	_	CONJ	CC	_	3	cc	_	_
20	older	_	ADV	RB	_	22	advmod	_	_
21	are	_	VERB	VBP	_	22	auxpass	_	_
22	provided	_	VERB	VBN	_	3	conj	_	_
23	in	_	ADP	IN	_	24	case	_	_
24	Table	_	ADJ	JJ	_	22	nmod	_	_
25	6	_	NUM	CD	_	24	dep	_	_

#	Harvoni	4419
1	Exposures	_	NOUN	NNS	_	6	nsubj	_	_
2	in	_	ADP	IN	_	4	case	_	_
3	pediatric	_	ADJ	JJ	_	4	amod	_	_
4	subjects	_	NOUN	NNS	_	1	nmod	_	_
5	were	_	VERB	VBD	_	6	cop	_	_
6	similar	_	ADJ	JJ	_	0	root	_	_
7	to	_	PRT	TO	_	8	case	_	_
8	those	_	DET	DT	_	6	nmod	_	_
9	observed	_	VERB	VBN	_	8	acl	_	_
10	in	_	ADP	IN	_	11	case	_	_
11	adults	_	NOUN	NNS	_	9	nmod	_	_

#	Harvoni	4420
1	Table	_	ADJ	JJ	_	4	amod	_	_
2	6	_	NUM	CD	_	4	nummod	_	_
3	Pharmacokinetic	_	ADJ	JJ	_	4	amod	_	_
4	Properties	_	NOUN	NNS	_	0	root	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	Components	_	NOUN	NNS	_	4	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	in	_	ADP	IN	_	12	case	_	_
11	Pediatric	_	ADJ	JJ	_	12	amod	_	_
12	Subjects	_	NOUN	NNS	_	4	nmod	_	_
13	12	_	NUM	CD	_	14	nummod	_	_
14	Years	_	NOUN	NNS	_	12	dep	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	Age	_	NOUN	NN	_	14	nmod	_	_
17	and	_	CONJ	CC	_	14	cc	_	_
18	Older	_	ADJ	JJ	_	14	root	_	_

#	Harvoni	4421
1	Geriatric	_	ADJ	JJ	_	2	amod	_	_
2	Patients	_	NOUN	NNS	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	Population	_	NOUN	NN	_	6	compound	_	_
5	pharmacokinetic	_	ADJ	JJ	_	6	amod	_	_
6	analysis	_	NOUN	NN	_	11	nsubj	_	_
7	in	_	ADP	IN	_	10	case	_	_
8	HCV	_	NOUN	NN	_	10	compound	_	_
9	infected	_	ADJ	JJ	_	10	amod	_	_
10	subjects	_	NOUN	NNS	_	6	nmod	_	_
11	showed	_	VERB	VBD	_	2	dep	_	_
12	that	_	ADP	IN	_	26	mark	_	_
13	within	_	ADP	IN	_	16	case	_	_
14	the	_	DET	DT	_	16	det	_	_
15	age	_	NOUN	NN	_	16	compound	_	_
16	range	_	NOUN	NN	_	26	nmod	_	_
17	18	_	NUM	CD	_	19	compound	_	_
18	to	_	PRT	TO	_	19	dep	_	_
19	80	_	NUM	CD	_	20	nummod	_	_
20	years	_	NOUN	NNS	_	16	dep	_	_
21	analyzed	_	VERB	VBN	_	20	acl	_	_
22	,	_	.	,	_	26	punct	_	_
23	age	_	NOUN	NN	_	26	nsubj	_	_
24	did	_	VERB	VBD	_	26	aux	_	_
25	not	_	ADV	RB	_	26	neg	_	_
26	have	_	VERB	VB	_	11	ccomp	_	_
27	a	_	DET	DT	_	30	det	_	_
28	clinically	_	ADV	RB	_	29	advmod	_	_
29	relevant	_	ADJ	JJ	_	30	amod	_	_
30	effect	_	NOUN	NN	_	26	dobj	_	_
31	on	_	ADP	IN	_	33	case	_	_
32	the	_	DET	DT	_	33	det	_	_
33	exposure	_	NOUN	NN	_	26	nmod	_	_
34	to	_	PRT	TO	_	35	case	_	_
35	DRUG	_	NOUN	NN	_	33	nmod	_	_
36	,	_	.	,	_	35	punct	_	_
37	DRUG	_	NOUN	NN	_	35	conj	_	_
38	,	_	.	,	_	35	punct	_	_
39	and	_	CONJ	CC	_	35	cc	_	_
40	GS	_	NOUN	NN	_	35	conj	_	_
41	331007	_	NUM	CD	_	40	nummod	_	_

#	Harvoni	4422
1	Patients	_	NOUN	NNS	_	0	root	_	_
2	with	_	ADP	IN	_	4	case	_	_
3	Renal	_	ADJ	JJ	_	4	amod	_	_
4	Impairment	_	NOUN	NN	_	1	nmod	_	_
5	:	_	.	:	_	1	punct	_	_
6	The	_	DET	DT	_	7	det	_	_
7	pharmacokinetics	_	NOUN	NNS	_	11	nsubjpass	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	were	_	VERB	VBD	_	11	auxpass	_	_
11	studied	_	VERB	VBN	_	1	dep	_	_
12	with	_	ADP	IN	_	15	case	_	_
13	a	_	DET	DT	_	15	det	_	_
14	single	_	ADJ	JJ	_	15	amod	_	_
15	dose	_	NOUN	NN	_	11	nmod	_	_
16	of	_	ADP	IN	_	19	case	_	_
17	90	_	NUM	CD	_	19	nummod	_	_
18	mg	_	NOUN	NN	_	19	compound	_	_
19	DRUG	_	NOUN	NN	_	15	nmod	_	_
20	in	_	ADP	IN	_	23	case	_	_
21	HCV	_	NOUN	NN	_	23	compound	_	_
22	negative	_	ADJ	JJ	_	23	amod	_	_
23	subjects	_	NOUN	NNS	_	15	nmod	_	_
24	with	_	ADP	IN	_	28	case	_	_
25	severe	_	ADJ	JJ	_	28	amod	_	_
26	renal	_	ADJ	JJ	_	28	amod	_	_
27	impairment	_	NOUN	NN	_	28	compound	_	_
28	eGFR	_	NOUN	NN	_	23	nmod	_	_
29	less	_	ADV	RB	_	31	advmod	_	_
30	than	_	ADP	IN	_	29	mwe	_	_
31	30	_	NUM	CD	_	32	nummod	_	_
32	mL	_	NOUN	NN	_	23	nmod	_	_
33	/	_	.	:	_	11	punct	_	_
34	min	_	NOUN	NN	_	11	parataxis	_	_
35	by	_	ADP	IN	_	37	case	_	_
36	Cockcroft	_	NOUN	NN	_	37	compound	_	_
37	Gault	_	NOUN	NN	_	34	nmod	_	_

#	Harvoni	4423
1	No	_	DET	DT	_	4	neg	_	_
2	clinically	_	ADV	RB	_	3	advmod	_	_
3	relevant	_	ADJ	JJ	_	4	amod	_	_
4	differences	_	NOUN	NNS	_	9	nsubjpass	_	_
5	in	_	ADP	IN	_	7	case	_	_
6	DRUG	_	NOUN	NN	_	7	compound	_	_
7	pharmacokinetics	_	NOUN	NNS	_	4	nmod	_	_
8	were	_	VERB	VBD	_	9	auxpass	_	_
9	observed	_	VERB	VBN	_	0	root	_	_
10	between	_	ADP	IN	_	12	case	_	_
11	healthy	_	ADJ	JJ	_	12	amod	_	_
12	subjects	_	NOUN	NNS	_	9	nmod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	subjects	_	NOUN	NNS	_	12	conj	_	_
15	with	_	ADP	IN	_	18	case	_	_
16	severe	_	ADJ	JJ	_	18	amod	_	_
17	renal	_	ADJ	JJ	_	18	amod	_	_
18	impairment	_	NOUN	NN	_	12	nmod	_	_

#	Harvoni	4424
1	The	_	DET	DT	_	2	det	_	_
2	pharmacokinetics	_	NOUN	NNS	_	6	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	were	_	VERB	VBD	_	6	auxpass	_	_
6	studied	_	VERB	VBN	_	0	root	_	_
7	in	_	ADP	IN	_	10	case	_	_
8	HCV	_	NOUN	NN	_	10	compound	_	_
9	negative	_	ADJ	JJ	_	10	amod	_	_
10	subjects	_	NOUN	NNS	_	6	nmod	_	_
11	with	_	ADP	IN	_	13	case	_	_
12	mild	_	ADJ	JJ	_	13	amod	_	_
13	eGFR	_	NOUN	NN	_	10	nmod	_	_
14	between	_	ADP	IN	_	20	case	_	_
15	50	_	NUM	CD	_	17	nummod	_	_
16	to	_	PRT	TO	_	17	dep	_	_
17	less	_	ADV	RB	_	19	advmod	_	_
18	than	_	ADP	IN	_	17	mwe	_	_
19	80	_	NUM	CD	_	20	nummod	_	_
20	mL	_	NOUN	NN	_	10	nmod	_	_
21	/	_	.	:	_	10	punct	_	_
22	min	_	NOUN	NN	_	10	dep	_	_
23	/	_	.	:	_	22	punct	_	_
24	1.73	_	NUM	CD	_	25	nummod	_	_
25	m2	_	NOUN	NN	_	22	conj	_	_
26	,	_	.	,	_	22	punct	_	_
27	moderate	_	ADJ	JJ	_	28	amod	_	_
28	eGFR	_	NOUN	NN	_	22	appos	_	_
29	between	_	ADP	IN	_	37	case	_	_
30	30	_	NUM	CD	_	32	nummod	_	_
31	to	_	PRT	TO	_	32	dep	_	_
32	less	_	ADV	RB	_	34	advmod	_	_
33	than	_	ADP	IN	_	32	mwe	_	_
34	50	_	NUM	CD	_	35	nummod	_	_
35	mL	_	NOUN	NN	_	37	compound	_	_
36	/	_	.	:	_	37	punct	_	_
37	min	_	NOUN	NN	_	28	nmod	_	_
38	/	_	.	:	_	22	punct	_	_
39	1.73	_	NUM	CD	_	40	nummod	_	_
40	m2	_	NOUN	NN	_	22	conj	_	_
41	,	_	.	,	_	22	punct	_	_
42	severe	_	ADJ	JJ	_	45	amod	_	_
43	renal	_	ADJ	JJ	_	45	amod	_	_
44	impairment	_	NOUN	NN	_	45	compound	_	_
45	eGFR	_	NOUN	NN	_	22	appos	_	_
46	less	_	ADV	RB	_	48	advmod	_	_
47	than	_	ADP	IN	_	46	mwe	_	_
48	30	_	NUM	CD	_	49	nummod	_	_
49	mL	_	NOUN	NN	_	45	nmod	_	_
50	/	_	.	:	_	22	punct	_	_
51	min	_	NOUN	NN	_	22	dep	_	_
52	/	_	.	:	_	51	punct	_	_
53	1.73	_	NUM	CD	_	54	nummod	_	_
54	m2	_	NOUN	NN	_	51	conj	_	_
55	,	_	.	,	_	51	punct	_	_
56	and	_	CONJ	CC	_	51	cc	_	_
57	subjects	_	NOUN	NNS	_	51	conj	_	_
58	with	_	ADP	IN	_	59	case	_	_
59	ESRD	_	NOUN	NN	_	57	nmod	_	_
60	requiring	_	VERB	VBG	_	59	acl	_	_
61	hemodialysis	_	NOUN	NN	_	60	dobj	_	_
62	following	_	ADP	IN	_	67	case	_	_
63	a	_	DET	DT	_	67	det	_	_
64	single	_	ADJ	JJ	_	67	amod	_	_
65	400	_	NUM	CD	_	67	nummod	_	_
66	mg	_	NOUN	NN	_	67	compound	_	_
67	dose	_	NOUN	NN	_	60	nmod	_	_
68	of	_	ADP	IN	_	69	case	_	_
69	DRUG	_	NOUN	NN	_	67	nmod	_	_

#	Harvoni	4425
1	Relative	_	ADV	RB	_	0	root	_	_
2	to	_	PRT	TO	_	3	case	_	_
3	subjects	_	NOUN	NNS	_	1	nmod	_	_
4	with	_	ADP	IN	_	10	case	_	_
5	normal	_	ADJ	JJ	_	10	amod	_	_
6	renal	_	ADJ	JJ	_	10	amod	_	_
7	function	_	NOUN	NN	_	10	compound	_	_
8	eGFR	_	NOUN	NN	_	10	compound	_	_
9	>80	_	NUM	CD	_	10	nummod	_	_
10	mL	_	NOUN	NN	_	3	nmod	_	_
11	/	_	.	:	_	12	punct	_	_
12	min	_	NOUN	NN	_	1	nmod	_	_
13	/	_	.	-RRB-	_	12	punct	_	_
14	1.73m2	_	NUM	CD	_	12	nummod	_	_
15	,	_	.	,	_	12	punct	_	_
16	the	_	DET	DT	_	19	det	_	_
17	DRUG	_	NOUN	NN	_	19	compound	_	_
18	AUC0	_	NOUN	NN	_	19	compound	_	_
19	inf	_	NOUN	NN	_	21	nsubj	_	_
20	was	_	VERB	VBD	_	21	cop	_	_
21	61%	_	ADJ	JJ	_	12	appos	_	_
22	,	_	.	,	_	21	punct	_	_
23	107%	_	NOUN	NN	_	21	conj	_	_
24	,	_	.	,	_	21	punct	_	_
25	and	_	CONJ	CC	_	21	cc	_	_
26	171%	_	NOUN	NN	_	27	nmod:npmod	_	_
27	higher	_	ADJ	JJ	_	21	conj	_	_
28	in	_	ADP	IN	_	36	case	_	_
29	mild	_	ADJ	JJ	_	36	amod	_	_
30	,	_	.	,	_	29	punct	_	_
31	moderate	_	ADJ	JJ	_	29	conj	_	_
32	,	_	.	,	_	29	punct	_	_
33	and	_	CONJ	CC	_	29	cc	_	_
34	severe	_	ADJ	JJ	_	29	conj	_	_
35	renal	_	ADJ	JJ	_	36	amod	_	_
36	impairment	_	NOUN	NN	_	27	nmod	_	_
37	,	_	.	,	_	12	punct	_	_
38	while	_	ADP	IN	_	45	mark	_	_
39	the	_	DET	DT	_	43	det	_	_
40	GS	_	NOUN	NN	_	43	compound	_	_
41	331007	_	NUM	CD	_	43	nummod	_	_
42	AUC0	_	NOUN	NN	_	43	compound	_	_
43	inf	_	NOUN	NN	_	45	nsubj	_	_
44	was	_	VERB	VBD	_	45	cop	_	_
45	55%	_	NOUN	NN	_	1	advcl	_	_
46	,	_	.	,	_	45	punct	_	_
47	88%	_	NOUN	NN	_	45	conj	_	_
48	,	_	.	,	_	45	punct	_	_
49	and	_	CONJ	CC	_	45	cc	_	_
50	451%	_	NOUN	NN	_	51	nmod:npmod	_	_
51	higher	_	ADJ	JJ	_	45	conj	_	_
52	,	_	.	,	_	1	punct	_	_
53	respectively	_	ADV	RB	_	1	neg	_	_

#	Harvoni	4426
1	In	_	ADP	IN	_	2	case	_	_
2	subjects	_	NOUN	NNS	_	21	nmod	_	_
3	with	_	ADP	IN	_	4	case	_	_
4	ESRD	_	NOUN	NN	_	2	nmod	_	_
5	,	_	.	,	_	21	punct	_	_
6	relative	_	ADJ	JJ	_	21	advmod	_	_
7	to	_	PRT	TO	_	8	case	_	_
8	subjects	_	NOUN	NNS	_	6	nmod	_	_
9	with	_	ADP	IN	_	12	case	_	_
10	normal	_	ADJ	JJ	_	12	amod	_	_
11	renal	_	ADJ	JJ	_	12	amod	_	_
12	function	_	NOUN	NN	_	8	nmod	_	_
13	,	_	.	,	_	21	punct	_	_
14	DRUG	_	NOUN	NN	_	21	nsubj	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	GS	_	NOUN	NN	_	19	compound	_	_
17	331007	_	NUM	CD	_	19	nummod	_	_
18	AUC0	_	NOUN	NN	_	19	compound	_	_
19	inf	_	NOUN	NN	_	14	conj	_	_
20	was	_	VERB	VBD	_	21	cop	_	_
21	28%	_	ADJ	JJ	_	0	root	_	_
22	and	_	CONJ	CC	_	21	cc	_	_
23	1280%	_	ADJ	JJ	_	24	compound	_	_
24	higher	_	ADJ	JJ	_	21	conj	_	_
25	when	_	ADV	WRB	_	28	advmod	_	_
26	DRUG	_	NOUN	NN	_	28	nsubjpass	_	_
27	was	_	VERB	VBD	_	28	auxpass	_	_
28	dosed	_	VERB	VBN	_	21	root	_	_
29	1	_	NUM	CD	_	30	nummod	_	_
30	hour	_	NUM	CD	_	28	dobj	_	_
31	before	_	ADP	IN	_	32	case	_	_
32	hemodialysis	_	NOUN	NN	_	28	nmod	_	_
33	compared	_	VERB	VBN	_	28	parataxis	_	_
34	with	_	ADP	IN	_	35	case	_	_
35	60%	_	ADJ	JJ	_	33	nmod	_	_
36	and	_	CONJ	CC	_	35	cc	_	_
37	2070%	_	ADJ	JJ	_	35	conj	_	_
38	higher	_	ADJ	JJ	_	35	dep	_	_
39	when	_	ADV	WRB	_	42	advmod	_	_
40	DRUG	_	NOUN	NN	_	42	nsubjpass	_	_
41	was	_	VERB	VBD	_	42	auxpass	_	_
42	dosed	_	VERB	VBN	_	33	advcl	_	_
43	1	_	NUM	CD	_	44	nummod	_	_
44	hour	_	NUM	CD	_	42	dobj	_	_
45	after	_	ADP	IN	_	46	case	_	_
46	hemodialysis	_	NOUN	NN	_	42	nmod	_	_
47	,	_	.	,	_	33	punct	_	_
48	respectively	_	ADV	RB	_	33	advmod	_	_

#	Harvoni	4427
1	A	_	DET	DT	_	5	det	_	_
2	4	_	NUM	CD	_	5	nummod	_	_
3	hour	_	NUM	CD	_	5	nummod	_	_
4	hemodialysis	_	NOUN	NN	_	5	compound	_	_
5	session	_	NOUN	NN	_	6	nsubj	_	_
6	removed	_	VERB	VBD	_	0	root	_	_
7	approximately	_	ADV	RB	_	8	advmod	_	_
8	18%	_	NOUN	NN	_	6	dobj	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	administered	_	VERB	VBN	_	11	amod	_	_
11	dose	_	NOUN	NN	_	8	nmod	_	_

#	Harvoni	4428
1	Patients	_	NOUN	NNS	_	0	root	_	_
2	with	_	ADP	IN	_	4	case	_	_
3	Hepatic	_	ADJ	JJ	_	4	amod	_	_
4	Impairment	_	NOUN	NN	_	1	nmod	_	_
5	:	_	.	:	_	1	punct	_	_
6	The	_	DET	DT	_	7	det	_	_
7	pharmacokinetics	_	NOUN	NNS	_	11	nsubjpass	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	were	_	VERB	VBD	_	11	auxpass	_	_
11	studied	_	VERB	VBN	_	1	dep	_	_
12	with	_	ADP	IN	_	15	case	_	_
13	a	_	DET	DT	_	15	det	_	_
14	single	_	ADJ	JJ	_	15	amod	_	_
15	dose	_	NOUN	NN	_	11	nmod	_	_
16	of	_	ADP	IN	_	19	case	_	_
17	90	_	NUM	CD	_	19	nummod	_	_
18	mg	_	NOUN	NN	_	19	compound	_	_
19	DRUG	_	NOUN	NN	_	15	nmod	_	_
20	in	_	ADP	IN	_	23	case	_	_
21	HCV	_	NOUN	NN	_	23	compound	_	_
22	negative	_	ADJ	JJ	_	23	amod	_	_
23	subjects	_	NOUN	NNS	_	15	nmod	_	_
24	with	_	ADP	IN	_	31	case	_	_
25	severe	_	ADJ	JJ	_	31	amod	_	_
26	hepatic	_	ADJ	JJ	_	31	amod	_	_
27	impairment	_	NOUN	NN	_	31	compound	_	_
28	Child	_	NOUN	NN	_	31	compound	_	_
29	Pugh	_	NOUN	NN	_	31	compound	_	_
30	Class	_	NOUN	NN	_	31	compound	_	_
31	C	_	NOUN	NN	_	23	nmod	_	_

#	Harvoni	4429
1	DRUG	_	NOUN	NN	_	5	compound	_	_
2	plasma	_	NOUN	NN	_	5	compound	_	_
3	exposure	_	NOUN	NN	_	5	compound	_	_
4	AUC0	_	NOUN	NN	_	5	compound	_	_
5	inf	_	NOUN	NN	_	7	nsubj	_	_
6	was	_	VERB	VBD	_	7	cop	_	_
7	similar	_	ADJ	JJ	_	0	root	_	_
8	in	_	ADP	IN	_	9	case	_	_
9	subjects	_	NOUN	NNS	_	7	nmod	_	_
10	with	_	ADP	IN	_	13	case	_	_
11	severe	_	ADJ	JJ	_	13	amod	_	_
12	hepatic	_	ADJ	JJ	_	13	amod	_	_
13	impairment	_	NOUN	NN	_	9	nmod	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	control	_	ADJ	JJ	_	16	amod	_	_
16	subjects	_	NOUN	NNS	_	13	conj	_	_
17	with	_	ADP	IN	_	20	case	_	_
18	normal	_	ADJ	JJ	_	20	amod	_	_
19	hepatic	_	ADJ	JJ	_	20	amod	_	_
20	function	_	NOUN	NN	_	13	nmod	_	_

#	Harvoni	4430
1	Population	_	NOUN	NN	_	3	compound	_	_
2	pharmacokinetics	_	NOUN	NNS	_	3	compound	_	_
3	analysis	_	NOUN	NN	_	8	nsubj	_	_
4	in	_	ADP	IN	_	7	case	_	_
5	HCV	_	NOUN	NN	_	7	compound	_	_
6	infected	_	ADJ	JJ	_	7	amod	_	_
7	subjects	_	NOUN	NNS	_	3	nmod	_	_
8	indicated	_	VERB	VBD	_	0	root	_	_
9	that	_	ADP	IN	_	14	mark	_	_
10	cirrhosis	_	NOUN	NN	_	14	nsubj	_	_
11	including	_	ADP	IN	_	13	case	_	_
12	decompensated	_	VERB	VBN	_	13	amod	_	_
13	cirrhosis	_	NOUN	NN	_	10	nmod	_	_
14	had	_	VERB	VBD	_	8	ccomp	_	_
15	no	_	DET	DT	_	18	neg	_	_
16	clinically	_	ADV	RB	_	17	advmod	_	_
17	relevant	_	ADJ	JJ	_	18	amod	_	_
18	effect	_	NOUN	NN	_	14	dobj	_	_
19	on	_	ADP	IN	_	21	case	_	_
20	the	_	DET	DT	_	21	det	_	_
21	exposure	_	NOUN	NN	_	14	nmod	_	_
22	of	_	ADP	IN	_	23	case	_	_
23	DRUG	_	NOUN	NN	_	21	nmod	_	_

#	Harvoni	4431
1	The	_	DET	DT	_	2	det	_	_
2	pharmacokinetics	_	NOUN	NNS	_	6	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	were	_	VERB	VBD	_	6	auxpass	_	_
6	studied	_	VERB	VBN	_	0	root	_	_
7	following	_	ADP	IN	_	10	case	_	_
8	7	_	NUM	CD	_	10	nummod	_	_
9	day	_	NOUN	NN	_	10	compound	_	_
10	dosing	_	NOUN	NN	_	6	nmod	_	_
11	of	_	ADP	IN	_	14	case	_	_
12	400	_	NUM	CD	_	14	nummod	_	_
13	mg	_	NOUN	NN	_	14	compound	_	_
14	DRUG	_	NOUN	NN	_	10	nmod	_	_
15	in	_	ADP	IN	_	18	case	_	_
16	HCV	_	NOUN	NN	_	18	compound	_	_
17	infected	_	ADJ	JJ	_	18	amod	_	_
18	subjects	_	NOUN	NNS	_	10	nmod	_	_
19	with	_	ADP	IN	_	28	case	_	_
20	moderate	_	ADJ	JJ	_	28	amod	_	_
21	and	_	CONJ	CC	_	20	cc	_	_
22	severe	_	ADJ	JJ	_	20	conj	_	_
23	hepatic	_	ADJ	JJ	_	28	amod	_	_
24	impairment	_	NOUN	NN	_	28	compound	_	_
25	Child	_	NOUN	NN	_	28	compound	_	_
26	Pugh	_	NOUN	NN	_	28	compound	_	_
27	Class	_	NOUN	NN	_	28	compound	_	_
28	B	_	NOUN	NN	_	18	nmod	_	_
29	and	_	CONJ	CC	_	28	cc	_	_
30	C	_	NOUN	NN	_	28	conj	_	_

#	Harvoni	4432
1	Relative	_	ADV	RB	_	14	advmod	_	_
2	to	_	PRT	TO	_	3	case	_	_
3	subjects	_	NOUN	NNS	_	1	nmod	_	_
4	with	_	ADP	IN	_	7	case	_	_
5	normal	_	ADJ	JJ	_	7	amod	_	_
6	hepatic	_	ADJ	JJ	_	7	amod	_	_
7	function	_	NOUN	NN	_	3	nmod	_	_
8	,	_	.	,	_	14	punct	_	_
9	the	_	DET	DT	_	11	det	_	_
10	DRUG	_	NOUN	NN	_	11	compound	_	_
11	AUC0	_	NOUN	NN	_	14	nsubj	_	_
12	24	_	NUM	CD	_	11	nummod	_	_
13	were	_	VERB	VBD	_	14	cop	_	_
14	126%	_	ADJ	JJ	_	0	root	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	143%	_	NOUN	NN	_	14	conj	_	_
17	higher	_	ADJ	JJ	_	16	amod	_	_
18	in	_	ADP	IN	_	23	case	_	_
19	moderate	_	ADJ	JJ	_	23	amod	_	_
20	and	_	CONJ	CC	_	19	cc	_	_
21	severe	_	ADJ	JJ	_	19	conj	_	_
22	hepatic	_	ADJ	JJ	_	23	amod	_	_
23	impairment	_	NOUN	NN	_	17	nmod	_	_
24	,	_	.	,	_	14	punct	_	_
25	while	_	ADP	IN	_	32	mark	_	_
26	the	_	DET	DT	_	29	det	_	_
27	GS	_	NOUN	NN	_	29	compound	_	_
28	331007	_	NUM	CD	_	29	nummod	_	_
29	AUC0	_	NOUN	NN	_	32	nsubj	_	_
30	24	_	NUM	CD	_	29	nummod	_	_
31	were	_	VERB	VBD	_	32	cop	_	_
32	18%	_	ADJ	JJ	_	14	advcl	_	_
33	and	_	CONJ	CC	_	32	cc	_	_
34	9%	_	NOUN	NN	_	35	nmod:npmod	_	_
35	higher	_	ADJ	JJ	_	32	conj	_	_
36	,	_	.	,	_	14	punct	_	_
37	respectively	_	ADV	RB	_	14	advmod	_	_

#	Harvoni	4433
1	Population	_	NOUN	NN	_	3	compound	_	_
2	pharmacokinetics	_	NOUN	NNS	_	3	compound	_	_
3	analysis	_	NOUN	NN	_	8	nsubj	_	_
4	in	_	ADP	IN	_	7	case	_	_
5	HCV	_	NOUN	NN	_	7	compound	_	_
6	infected	_	ADJ	JJ	_	7	amod	_	_
7	subjects	_	NOUN	NNS	_	3	nmod	_	_
8	indicated	_	VERB	VBD	_	0	root	_	_
9	that	_	ADP	IN	_	14	mark	_	_
10	cirrhosis	_	NOUN	NN	_	14	nsubj	_	_
11	including	_	ADP	IN	_	13	case	_	_
12	decompensated	_	VERB	VBN	_	13	amod	_	_
13	cirrhosis	_	NOUN	NN	_	10	nmod	_	_
14	had	_	VERB	VBD	_	8	ccomp	_	_
15	no	_	DET	DT	_	18	neg	_	_
16	clinically	_	ADV	RB	_	17	advmod	_	_
17	relevant	_	ADJ	JJ	_	18	amod	_	_
18	effect	_	NOUN	NN	_	14	dobj	_	_
19	on	_	ADP	IN	_	21	case	_	_
20	the	_	DET	DT	_	21	det	_	_
21	exposure	_	NOUN	NN	_	14	nmod	_	_
22	of	_	ADP	IN	_	23	case	_	_
23	DRUG	_	NOUN	NN	_	21	nmod	_	_
24	and	_	CONJ	CC	_	23	cc	_	_
25	GS	_	NOUN	NN	_	23	conj	_	_
26	331007	_	NUM	CD	_	25	nummod	_	_

#	Harvoni	4434
1	Drug	_	NOUN	NN	_	3	compound	_	_
2	Interaction	_	NOUN	NN	_	3	compound	_	_
3	Studies	_	NOUN	NNS	_	8	nsubj	_	_
4	DRUG	_	NOUN	NN	_	3	dep	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	DRUG	_	NOUN	NN	_	4	conj	_	_
7	are	_	VERB	VBP	_	8	cop	_	_
8	substrates	_	NOUN	NNS	_	0	root	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	drug	_	NOUN	NN	_	11	compound	_	_
11	transporters	_	NOUN	NNS	_	8	nmod	_	_
12	P	_	NOUN	NN	_	13	compound	_	_
13	gp	_	NOUN	NN	_	11	dep	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	BCRP	_	NOUN	NN	_	13	conj	_	_
16	while	_	ADP	IN	_	19	mark	_	_
17	GS	_	NOUN	NN	_	19	nsubj	_	_
18	331007	_	NUM	CD	_	17	nummod	_	_
19	is	_	VERB	VBZ	_	8	root	_	_
20	not	_	ADV	RB	_	19	neg	_	_

#	Harvoni	4435
1	P	_	NOUN	NN	_	3	compound	_	_
2	gp	_	NOUN	NN	_	3	compound	_	_
3	inducers	_	NOUN	NNS	_	12	nsubj	_	_
4	e.g	_	NOUN	NN	_	3	dep	_	_
5	,	_	.	,	_	4	punct	_	_
6	rifampin	_	NOUN	NN	_	4	conj	_	_
7	or	_	CONJ	CC	_	4	cc	_	_
8	St	_	NOUN	NN	_	9	compound	_	_
9	John's	_	NOUN	NNS	_	4	conj	_	_
10	wort	_	VERB	VBP	_	3	acl	_	_
11	may	_	VERB	MD	_	12	aux	_	_
12	decrease	_	VERB	VB	_	0	root	_	_
13	DRUG	_	NOUN	NN	_	12	dobj	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	DRUG	_	NOUN	NN	_	13	conj	_	_
16	plasma	_	NOUN	NN	_	17	compound	_	_
17	concentrations	_	NOUN	NNS	_	13	dep	_	_
18	,	_	.	,	_	12	punct	_	_
19	leading	_	VERB	VBG	_	12	advcl	_	_
20	to	_	PRT	TO	_	23	case	_	_
21	reduced	_	VERB	VBN	_	23	amod	_	_
22	therapeutic	_	ADJ	JJ	_	23	amod	_	_
23	effect	_	NOUN	NN	_	19	nmod	_	_
24	of	_	ADP	IN	_	25	case	_	_
25	DRUG	_	NOUN	NN	_	23	nmod	_	_
26	,	_	.	,	_	12	punct	_	_
27	and	_	CONJ	CC	_	12	cc	_	_
28	the	_	DET	DT	_	29	det	_	_
29	use	_	NOUN	NN	_	36	nsubjpass	_	_
30	with	_	ADP	IN	_	33	case	_	_
31	P	_	NOUN	NN	_	33	compound	_	_
32	gp	_	NOUN	NN	_	33	compound	_	_
33	inducers	_	NOUN	NNS	_	29	nmod	_	_
34	is	_	VERB	VBZ	_	36	auxpass	_	_
35	not	_	ADV	RB	_	36	neg	_	_
36	recommended	_	VERB	VBN	_	12	conj	_	_
37	with	_	ADP	IN	_	38	case	_	_
38	DRUG	_	NOUN	NN	_	36	nmod	_	_

#	Harvoni	4436
1	Coadministration	_	NOUN	NN	_	13	nsubj	_	_
2	with	_	ADP	IN	_	3	case	_	_
3	drugs	_	NOUN	NNS	_	1	nmod	_	_
4	that	_	DET	WDT	_	5	nsubj	_	_
5	inhibit	_	VERB	VBP	_	3	acl:relcl	_	_
6	P	_	NOUN	NN	_	7	compound	_	_
7	gp	_	NOUN	NN	_	5	dobj	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	/	_	NOUN	NN	_	7	conj	_	_
10	or	_	CONJ	CC	_	9	cc	_	_
11	BCRP	_	NOUN	NN	_	9	conj	_	_
12	may	_	VERB	MD	_	13	aux	_	_
13	increase	_	VERB	VB	_	0	root	_	_
14	DRUG	_	NOUN	NN	_	13	dobj	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	DRUG	_	NOUN	NN	_	14	conj	_	_
17	plasma	_	NOUN	NN	_	18	compound	_	_
18	concentrations	_	NOUN	NNS	_	14	dep	_	_
19	without	_	ADP	IN	_	20	mark	_	_
20	increasing	_	VERB	VBG	_	13	advcl	_	_
21	GS	_	NOUN	NN	_	25	compound	_	_
22	331007	_	NUM	CD	_	25	nummod	_	_
23	plasma	_	NOUN	NN	_	25	compound	_	_
24	concentration	_	NOUN	NN	_	25	compound	_	_
25	DRUG	_	NOUN	NN	_	20	dobj	_	_
26	may	_	VERB	MD	_	28	aux	_	_
27	be	_	VERB	VB	_	28	auxpass	_	_
28	coadministered	_	VERB	VBN	_	13	parataxis	_	_
29	with	_	ADP	IN	_	31	case	_	_
30	P	_	NOUN	NN	_	31	compound	_	_
31	gp	_	NOUN	NN	_	28	nmod	_	_
32	and	_	CONJ	CC	_	31	cc	_	_
33	/	_	NUM	CD	_	31	conj	_	_
34	or	_	CONJ	CC	_	33	cc	_	_
35	BCRP	_	NOUN	NN	_	33	conj	_	_
36	inhibitors	_	NOUN	NNS	_	31	dep	_	_

#	Harvoni	4437
1	Neither	_	CONJ	CC	_	2	cc:preconj	_	_
2	DRUG	_	NOUN	NN	_	7	nsubj	_	_
3	nor	_	CONJ	CC	_	2	cc	_	_
4	DRUG	_	NOUN	NN	_	2	conj	_	_
5	is	_	VERB	VBZ	_	7	cop	_	_
6	a	_	DET	DT	_	7	det	_	_
7	substrate	_	NOUN	NN	_	0	root	_	_
8	for	_	ADP	IN	_	11	case	_	_
9	hepatic	_	ADJ	JJ	_	11	amod	_	_
10	uptake	_	NOUN	NN	_	11	compound	_	_
11	transporters	_	NOUN	NNS	_	7	nmod	_	_
12	OCT1	_	NOUN	NN	_	11	dep	_	_
13	,	_	.	,	_	12	punct	_	_
14	OATP1B1	_	NOUN	NN	_	12	conj	_	_
15	,	_	.	,	_	12	punct	_	_
16	or	_	CONJ	CC	_	12	cc	_	_
17	OATP1B3	_	NOUN	NN	_	12	conj	_	_

#	Harvoni	4438
1	GS	_	NOUN	NN	_	6	nsubj	_	_
2	331007	_	NUM	CD	_	1	nummod	_	_
3	is	_	VERB	VBZ	_	6	cop	_	_
4	not	_	ADV	RB	_	6	neg	_	_
5	a	_	DET	DT	_	6	det	_	_
6	substrate	_	NOUN	NN	_	0	root	_	_
7	for	_	ADP	IN	_	9	case	_	_
8	renal	_	ADJ	JJ	_	9	amod	_	_
9	transporters	_	NOUN	NNS	_	6	nmod	_	_
10	,	_	.	,	_	9	punct	_	_
11	including	_	VERB	VBG	_	15	case	_	_
12	organic	_	ADJ	JJ	_	15	amod	_	_
13	anion	_	NOUN	NN	_	15	compound	_	_
14	transporter	_	NOUN	NN	_	15	compound	_	_
15	OAT1	_	NOUN	NN	_	9	nmod	_	_
16	or	_	CONJ	CC	_	15	cc	_	_
17	OAT3	_	NOUN	NN	_	15	conj	_	_
18	,	_	.	,	_	6	punct	_	_
19	or	_	CONJ	CC	_	6	cc	_	_
20	organic	_	ADJ	JJ	_	22	amod	_	_
21	cation	_	NOUN	NN	_	22	compound	_	_
22	transporter	_	NOUN	NN	_	6	conj	_	_
23	OCT2	_	NOUN	NN	_	22	dep	_	_

#	Harvoni	4439
1	DRUG	_	NOUN	NN	_	3	nsubj	_	_
2	is	_	VERB	VBZ	_	3	cop	_	_
3	subject	_	NOUN	NN	_	0	root	_	_
4	to	_	PRT	TO	_	5	mark	_	_
5	slow	_	VERB	VB	_	3	xcomp	_	_
6	oxidative	_	ADJ	JJ	_	7	amod	_	_
7	metabolism	_	NOUN	NN	_	5	dobj	_	_
8	via	_	ADP	IN	_	11	case	_	_
9	an	_	DET	DT	_	11	det	_	_
10	unknown	_	ADJ	JJ	_	11	amod	_	_
11	mechanism	_	NOUN	NN	_	5	nmod	_	_

#	Harvoni	4440
1	In	_	X	FW	_	2	compound	_	_
2	vitro	_	X	FW	_	14	advmod	_	_
3	,	_	.	,	_	14	punct	_	_
4	no	_	DET	DT	_	6	neg	_	_
5	detectable	_	ADJ	JJ	_	6	amod	_	_
6	metabolism	_	NOUN	NN	_	14	nsubjpass	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	by	_	ADP	IN	_	11	case	_	_
10	CYP	_	NOUN	NN	_	11	compound	_	_
11	enzymes	_	NOUN	NNS	_	6	nmod	_	_
12	has	_	VERB	VBZ	_	14	aux	_	_
13	been	_	VERB	VBN	_	14	auxpass	_	_
14	observed	_	VERB	VBN	_	0	root	_	_

#	Harvoni	4441
1	Biliary	_	ADJ	JJ	_	2	amod	_	_
2	excretion	_	NOUN	NN	_	9	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	unchanged	_	ADJ	JJ	_	5	amod	_	_
5	DRUG	_	NOUN	NN	_	2	nmod	_	_
6	is	_	VERB	VBZ	_	9	cop	_	_
7	a	_	DET	DT	_	9	det	_	_
8	major	_	ADJ	JJ	_	9	amod	_	_
9	route	_	NOUN	NN	_	0	root	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	elimination	_	NOUN	NN	_	9	nmod	_	_

#	Harvoni	4442
1	DRUG	_	NOUN	NN	_	5	nsubj	_	_
2	is	_	VERB	VBZ	_	5	cop	_	_
3	not	_	ADV	RB	_	5	neg	_	_
4	a	_	DET	DT	_	5	det	_	_
5	substrate	_	NOUN	NN	_	0	root	_	_
6	for	_	ADP	IN	_	7	case	_	_
7	CYP	_	NOUN	NN	_	5	nmod	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	UGT1A1	_	NOUN	NN	_	7	conj	_	_
10	enzymes	_	NOUN	NNS	_	7	dep	_	_

#	Harvoni	4443
1	Clinically	_	ADV	RB	_	15	advmod	_	_
2	significant	_	ADJ	JJ	_	4	amod	_	_
3	drug	_	NOUN	NN	_	4	compound	_	_
4	interactions	_	NOUN	NNS	_	15	nsubjpass	_	_
5	with	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	mediated	_	VERB	VBN	_	6	acl	_	_
8	by	_	ADP	IN	_	9	case	_	_
9	CYP	_	NOUN	NN	_	7	nmod	_	_
10	or	_	CONJ	CC	_	9	cc	_	_
11	UGT1A1	_	NOUN	NN	_	9	conj	_	_
12	enzymes	_	NOUN	NNS	_	9	dep	_	_
13	are	_	VERB	VBP	_	15	auxpass	_	_
14	not	_	ADV	RB	_	15	neg	_	_
15	expected	_	VERB	VBN	_	0	root	_	_

#	Harvoni	4444
1	The	_	DET	DT	_	2	det	_	_
2	effects	_	NOUN	NNS	_	18	nsubjpass	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	coadministered	_	VERB	VBN	_	5	amod	_	_
5	drugs	_	NOUN	NNS	_	2	nmod	_	_
6	on	_	ADP	IN	_	8	case	_	_
7	the	_	DET	DT	_	8	det	_	_
8	exposure	_	NOUN	NN	_	2	nmod	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	,	_	.	,	_	10	punct	_	_
12	DRUG	_	NOUN	NN	_	10	conj	_	_
13	,	_	.	,	_	10	punct	_	_
14	and	_	CONJ	CC	_	10	cc	_	_
15	GS	_	NOUN	NN	_	10	conj	_	_
16	331007	_	NUM	CD	_	15	nummod	_	_
17	are	_	VERB	VBP	_	18	auxpass	_	_
18	shown	_	VERB	VBN	_	0	root	_	_
19	in	_	ADP	IN	_	20	case	_	_
20	Table	_	ADJ	JJ	_	18	nmod	_	_
21	7	_	NUM	CD	_	20	dep	_	_

#	Harvoni	4445
1	Table	_	ADJ	JJ	_	4	amod	_	_
2	7	_	NUM	CD	_	4	nummod	_	_
3	Drug	_	NOUN	NN	_	4	compound	_	_
4	Interactions	_	NOUN	NNS	_	0	root	_	_
5	:	_	.	:	_	4	punct	_	_
6	Changes	_	NOUN	NNS	_	4	dep	_	_
7	in	_	ADP	IN	_	9	case	_	_
8	Pharmacokinetic	_	ADJ	JJ	_	9	amod	_	_
9	Parameters	_	NOUN	NNS	_	6	nmod	_	_
10	for	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_
12	,	_	.	,	_	11	punct	_	_
13	DRUG	_	NOUN	NN	_	11	conj	_	_
14	,	_	.	,	_	11	punct	_	_
15	and	_	CONJ	CC	_	11	cc	_	_
16	the	_	DET	DT	_	20	det	_	_
17	Predominant	_	ADJ	JJ	_	20	amod	_	_
18	Circulating	_	ADJ	JJ	_	20	amod	_	_
19	Metabolite	_	NOUN	NN	_	20	compound	_	_
20	GS	_	NOUN	NN	_	11	conj	_	_
21	331007	_	NUM	CD	_	20	nummod	_	_
22	in	_	ADP	IN	_	24	case	_	_
23	the	_	DET	DT	_	24	det	_	_
24	Presence	_	NOUN	NN	_	6	nmod	_	_
25	of	_	ADP	IN	_	30	case	_	_
26	the	_	DET	DT	_	30	det	_	_
27	Coadministered	_	ADJ	JJ	_	30	amod	_	_
28	DrugAll	_	NOUN	NN	_	30	compound	_	_
29	interaction	_	NOUN	NN	_	30	compound	_	_
30	studies	_	NOUN	NNS	_	24	nmod	_	_
31	conducted	_	VERB	VBN	_	30	acl	_	_
32	in	_	ADP	IN	_	34	case	_	_
33	healthy	_	ADJ	JJ	_	34	amod	_	_
34	volunteers	_	NOUN	NNS	_	31	nmod	_	_

#	Harvoni	4446
1	Co	_	PRT	TO	_	4	case	_	_
2	administered	_	VERB	VBN	_	4	amod	_	_
3	Drug	_	NOUN	NN	_	4	compound	_	_
4	Dose	_	NOUN	NN	_	0	root	_	_
5	of	_	ADP	IN	_	18	case	_	_
6	Co	_	NOUN	NN	_	18	compound	_	_
7	administered	_	VERB	VBN	_	18	amod	_	_
8	Drug	_	NOUN	NN	_	18	compound	_	_
9	mg	_	NOUN	NN	_	18	compound	_	_
10	DRUG	_	NOUN	NN	_	18	compound	_	_
11	Dose(mg	_	NOUN	NN	_	18	compound	_	_
12	DRUG	_	NOUN	NN	_	18	compound	_	_
13	Dose(mg	_	NOUN	NN	_	18	compound	_	_
14	N	_	NOUN	NN	_	18	compound	_	_
15	Mean	_	NOUN	NN	_	18	compound	_	_
16	Ratio	_	NOUN	NN	_	18	compound	_	_
17	90%	_	ADJ	JJ	_	18	amod	_	_
18	CI	_	NOUN	NN	_	4	nmod	_	_
19	of	_	ADP	IN	_	20	case	_	_
20	DRUG	_	NOUN	NN	_	18	nmod	_	_
21	,	_	.	,	_	20	punct	_	_
22	DRUG	_	NOUN	NN	_	20	conj	_	_
23	,	_	.	,	_	20	punct	_	_
24	and	_	CONJ	CC	_	20	cc	_	_
25	GS	_	NOUN	NN	_	27	compound	_	_
26	331007	_	NUM	CD	_	27	nummod	_	_
27	PK	_	NOUN	NN	_	20	conj	_	_
28	With	_	ADP	IN	_	29	case	_	_
29	/	_	.	-RRB-	_	4	punct	_	_
30	Without	_	ADP	IN	_	37	case	_	_
31	Coadministered	_	ADJ	JJ	_	37	amod	_	_
32	DrugNo	_	NOUN	NN	_	37	compound	_	_
33	Effect=1.00	_	NOUN	NN	_	37	compound	_	_
34	Cmax	_	NOUN	NN	_	37	compound	_	_
35	AUC	_	NOUN	NN	_	37	compound	_	_
36	Cmin	_	NOUN	NN	_	37	compound	_	_
37	NA	_	NOUN	NN	_	38	nmod	_	_
38	=	_	VERB	VBD	_	29	root	_	_
39	not	_	ADV	RB	_	40	neg	_	_
40	available	_	ADJ	JJ	_	38	dep	_	_
41	/	_	.	-LRB-	_	40	punct	_	_
42	not	_	ADV	RB	_	43	neg	_	_
43	applicable	_	ADJ	JJ	_	40	dep	_	_
44	,	_	.	,	_	40	punct	_	_
45	ND	_	NOUN	NN	_	48	nsubj	_	_
46	=	_	VERB	VBD	_	48	auxpass	_	_
47	not	_	ADV	RB	_	48	neg	_	_
48	dosed	_	VERB	VBN	_	40	dep	_	_

#	Harvoni	4447
1	Staggered	_	VERB	VBN	_	4	amod	_	_
2	administration	_	NOUN	NN	_	4	compound	_	_
3	12	_	NUM	CD	_	4	nummod	_	_
4	hours	_	NOUN	NNS	_	0	root	_	_
5	apart	_	ADJ	JJ	_	4	amod	_	_
6	of	_	ADP	IN	_	28	case	_	_
7	atazanavir	_	NOUN	NN	_	28	compound	_	_
8	/	_	.	:	_	7	punct	_	_
9	ritonavir	_	NOUN	NN	_	7	conj	_	_
10	+	_	CONJ	CC	_	7	cc	_	_
11	emtricitabine	_	NOUN	NN	_	7	conj	_	_
12	/	_	.	:	_	7	punct	_	_
13	tenofovir	_	NOUN	NN	_	14	compound	_	_
14	DF	_	NOUN	NN	_	7	conj	_	_
15	or	_	CONJ	CC	_	7	cc	_	_
16	darunavir	_	NOUN	NN	_	7	conj	_	_
17	/	_	.	:	_	7	punct	_	_
18	ritonavir	_	NOUN	NN	_	7	appos	_	_
19	+	_	CONJ	CC	_	18	cc	_	_
20	emtricitabine	_	NOUN	NN	_	18	conj	_	_
21	/	_	.	:	_	7	punct	_	_
22	tenofovir	_	NOUN	NN	_	23	compound	_	_
23	DF	_	NOUN	NN	_	7	conj	_	_
24	and	_	CONJ	CC	_	7	cc	_	_
25	DRUG	_	NOUN	NN	_	7	conj	_	_
26	provided	_	VERB	VBD	_	28	amod	_	_
27	similar	_	ADJ	JJ	_	28	amod	_	_
28	results	_	NOUN	NNS	_	5	nmod	_	_

#	Harvoni	4448
1	,	_	PRT	TO	_	3	case	_	_
2	The	_	DET	DT	_	3	det	_	_
3	effects	_	NOUN	NNS	_	0	root	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	atazanavir	_	NOUN	NN	_	3	nmod	_	_
6	/	_	.	:	_	3	punct	_	_
7	ritonavir	_	NOUN	NN	_	13	nsubj	_	_
8	on	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	DRUG	_	NOUN	NN	_	9	conj	_	_
12	are	_	VERB	VBP	_	13	cop	_	_
13	similar	_	ADJ	JJ	_	3	dep	_	_
14	with	_	ADP	IN	_	13	nmod	_	_
15	or	_	CONJ	CC	_	14	cc	_	_
16	without	_	ADP	IN	_	20	case	_	_
17	the	_	DET	DT	_	20	dep	_	_
18	presence	_	NOUN	NN	_	20	dep	_	_
19	of	_	ADP	IN	_	20	case	_	_
20	emtricitabine	_	NOUN	NN	_	14	conj	_	_
21	/	_	.	:	_	13	punct	_	_
22	tenofovir	_	NOUN	NN	_	23	compound	_	_
23	DF	_	NOUN	NN	_	13	dep	_	_

#	Harvoni	4449
1	300	_	NUM	CD	_	0	root	_	_
2	/	_	.	-RRB-	_	1	punct	_	_
3	100	_	NUM	CD	_	1	dep	_	_
4	+	_	CONJ	CC	_	3	cc	_	_
5	200	_	NUM	CD	_	3	conj	_	_
6	/	_	.	:	_	3	punct	_	_
7	300	_	NUM	CD	_	3	dep	_	_
8	once	_	ADV	RB	_	7	advmod	_	_
9	daily	_	ADV	RB	_	3	advmod	_	_

#	Harvoni	4450
1	600	_	NUM	CD	_	0	root	_	_
2	/	_	.	-RRB-	_	1	punct	_	_
3	200	_	NUM	CD	_	1	dep	_	_
4	/	_	.	-RRB-	_	3	punct	_	_
5	300	_	NUM	CD	_	3	dep	_	_
6	once	_	ADV	RB	_	7	advmod	_	_
7	daily	_	ADV	RB	_	8	advmod	_	_
8	90	_	NUM	CD	_	5	dep	_	_
9	once	_	ADV	RB	_	10	advmod	_	_
10	daily	_	ADV	RB	_	11	advmod	_	_
11	400	_	NUM	CD	_	15	nummod	_	_
12	once	_	ADV	RB	_	13	advmod	_	_
13	daily	_	ADV	RB	_	14	advmod	_	_
14	14	_	NUM	CD	_	15	nummod	_	_
15	DRUG	_	NOUN	NN	_	8	dep	_	_
16	0.66	_	NUM	CD	_	15	dep	_	_
17	0.59	_	NUM	CD	_	16	dep	_	_
18	,	_	.	,	_	15	punct	_	_
19	0.75	_	NUM	CD	_	20	nummod	_	_
20	0.66(0.59	_	NUM	CD	_	15	appos	_	_
21	,	_	.	,	_	15	punct	_	_
22	0.75	_	NUM	CD	_	23	nummod	_	_
23	0.66(0.57	_	NUM	CD	_	15	appos	_	_
24	,	_	.	,	_	15	punct	_	_
25	0.76	_	NUM	CD	_	26	nummod	_	_
26	DRUG	_	NOUN	NN	_	15	appos	_	_
27	1.03	_	NUM	CD	_	28	nummod	_	_
28	0.87	_	NUM	CD	_	26	dep	_	_
29	,	_	.	,	_	15	punct	_	_
30	1.23	_	NUM	CD	_	31	nummod	_	_
31	0.94	_	NUM	CD	_	15	appos	_	_
32	0.81	_	NUM	CD	_	31	dep	_	_
33	,	_	.	,	_	15	punct	_	_
34	1.10	_	NUM	CD	_	36	nummod	_	_
35	NA	_	NOUN	NN	_	36	compound	_	_
36	GS	_	NOUN	NN	_	15	appos	_	_
37	331007	_	NUM	CD	_	38	nummod	_	_
38	0.86	_	NUM	CD	_	36	nummod	_	_
39	0.76	_	NUM	CD	_	38	dep	_	_
40	,	_	.	,	_	15	punct	_	_
41	0.96	_	NUM	CD	_	42	nummod	_	_
42	0.90	_	NUM	CD	_	15	appos	_	_
43	0.83	_	NUM	CD	_	42	dep	_	_
44	,	_	.	,	_	15	punct	_	_
45	0.97	_	NUM	CD	_	46	nummod	_	_
46	1.07	_	NUM	CD	_	15	appos	_	_
47	1.02	_	NUM	CD	_	46	dep	_	_
48	,	_	.	,	_	15	punct	_	_
49	1.13	_	NUM	CD	_	50	nummod	_	_
50	Elvitegravir	_	NOUN	NN	_	15	appos	_	_
51	/	_	.	:	_	15	punct	_	_
52	cobicistat	_	NOUN	NN	_	15	dep	_	_
53	150	_	NUM	CD	_	52	nummod	_	_
54	/	_	.	:	_	52	punct	_	_
55	150	_	NUM	CD	_	58	nummod	_	_
56	once	_	ADV	RB	_	57	advmod	_	_
57	daily	_	ADV	RB	_	58	advmod	_	_
58	90	_	NUM	CD	_	52	dep	_	_
59	once	_	ADV	RB	_	60	advmod	_	_
60	daily	_	ADV	RB	_	61	advmod	_	_
61	400	_	NUM	CD	_	65	nummod	_	_
62	once	_	ADV	RB	_	63	advmod	_	_
63	daily	_	ADV	RB	_	64	advmod	_	_
64	29	_	NUM	CD	_	65	nummod	_	_
65	DRUG	_	NOUN	NN	_	58	dep	_	_
66	1.63	_	NUM	CD	_	65	dep	_	_
67	1.51	_	NUM	CD	_	66	dep	_	_
68	,	_	.	,	_	65	punct	_	_
69	1.75	_	NUM	CD	_	70	nummod	_	_
70	1.78	_	NUM	CD	_	65	appos	_	_
71	1.64	_	NUM	CD	_	70	dep	_	_
72	,	_	.	,	_	65	punct	_	_
73	1.94	_	NUM	CD	_	74	nummod	_	_
74	1.91	_	NUM	CD	_	65	appos	_	_
75	1.76	_	NUM	CD	_	74	dep	_	_
76	,	_	.	,	_	65	punct	_	_
77	2.08	_	NUM	CD	_	78	nummod	_	_
78	DRUG	_	NOUN	NN	_	65	appos	_	_
79	1.33	_	NUM	CD	_	80	nummod	_	_
80	1.14	_	NUM	CD	_	78	dep	_	_
81	,	_	.	,	_	65	punct	_	_
82	1.56	_	NUM	CD	_	83	nummod	_	_
83	1.36	_	NUM	CD	_	65	appos	_	_
84	1.21	_	NUM	CD	_	83	dep	_	_
85	,	_	.	,	_	65	punct	_	_
86	1.52	_	NUM	CD	_	88	nummod	_	_
87	NA	_	NOUN	NN	_	88	compound	_	_
88	GS	_	NOUN	NN	_	65	appos	_	_
89	331007	_	NUM	CD	_	90	nummod	_	_
90	1.33	_	NUM	CD	_	88	nummod	_	_
91	1.22	_	NUM	CD	_	90	dep	_	_
92	,	_	.	,	_	65	punct	_	_
93	1.44	_	NUM	CD	_	94	nummod	_	_
94	1.44	_	NUM	CD	_	65	appos	_	_
95	1.41	_	NUM	CD	_	94	dep	_	_
96	,	_	.	,	_	65	punct	_	_
97	1.48	_	NUM	CD	_	98	nummod	_	_
98	1.53	_	NUM	CD	_	65	appos	_	_
99	1.47	_	NUM	CD	_	98	dep	_	_
100	,	_	.	,	_	65	punct	_	_
101	1.59	_	NUM	CD	_	105	nummod	_	_
102	Famotidine	_	NOUN	NN	_	105	compound	_	_
103	40	_	NUM	CD	_	105	nummod	_	_
104	single	_	ADJ	JJ	_	105	amod	_	_
105	dose	_	NOUN	NN	_	65	appos	_	_
106	simultaneously	_	ADV	RB	_	114	advmod	_	_
107	with	_	ADP	IN	_	114	case	_	_
108	DRUG	_	NOUN	NN	_	114	compound	_	_
109	90	_	NUM	CD	_	114	nummod	_	_
110	single	_	ADJ	JJ	_	114	amod	_	_
111	dose	_	NOUN	NN	_	114	compound	_	_
112	400	_	NUM	CD	_	114	nummod	_	_
113	single	_	ADJ	JJ	_	114	amod	_	_
114	dose	_	NOUN	NN	_	105	nmod	_	_
115	12	_	NUM	CD	_	116	nummod	_	_
116	DRUG	_	NOUN	NN	_	114	dep	_	_
117	0.80	_	NUM	CD	_	118	nummod	_	_
118	0.69	_	NUM	CD	_	116	dep	_	_
119	,	_	.	,	_	114	punct	_	_
120	0.93	_	NUM	CD	_	121	nummod	_	_
121	0.89	_	NUM	CD	_	114	appos	_	_
122	0.76	_	NUM	CD	_	121	dep	_	_
123	,	_	.	,	_	114	punct	_	_
124	1.06	_	NUM	CD	_	126	nummod	_	_
125	NA	_	NOUN	NN	_	126	compound	_	_
126	DRUG	_	NOUN	NN	_	114	appos	_	_
127	1.15	_	NUM	CD	_	128	nummod	_	_
128	0.88	_	NUM	CD	_	126	dep	_	_
129	,	_	.	,	_	114	punct	_	_
130	1.50	_	NUM	CD	_	131	nummod	_	_
131	1.11	_	NUM	CD	_	114	appos	_	_
132	1.00	_	NUM	CD	_	131	dep	_	_
133	,	_	.	,	_	114	punct	_	_
134	1.24	_	NUM	CD	_	136	nummod	_	_
135	NA	_	NOUN	NN	_	136	compound	_	_
136	GS	_	NOUN	NN	_	114	appos	_	_
137	331007	_	NUM	CD	_	136	nummod	_	_
138	1.06	_	NUM	CD	_	137	dep	_	_
139	0.97	_	NUM	CD	_	138	dep	_	_
140	,	_	.	,	_	138	punct	_	_
141	1.14	_	NUM	CD	_	138	conj	_	_
142	1.06	_	NUM	CD	_	141	dep	_	_
143	1.02	_	NUM	CD	_	142	dep	_	_
144	,	_	.	,	_	138	punct	_	_
145	1.11	_	NUM	CD	_	151	nummod	_	_
146	NA	_	NOUN	NN	_	151	compound	_	_
147	40	_	NUM	CD	_	151	nummod	_	_
148	single	_	ADJ	JJ	_	151	amod	_	_
149	dose	_	NOUN	NN	_	151	compound	_	_
150	12	_	NUM	CD	_	151	nummod	_	_
151	hours	_	NOUN	NNS	_	138	appos	_	_
152	prior	_	ADJ	JJ	_	154	case	_	_
153	to	_	PRT	TO	_	152	mwe	_	_
154	DRUG	_	NOUN	NN	_	151	nmod	_	_
155	12	_	NUM	CD	_	154	nummod	_	_
156	DRUG	_	NOUN	NN	_	154	dep	_	_
157	0.83	_	NUM	CD	_	156	dep	_	_
158	0.69	_	NUM	CD	_	157	dep	_	_
159	,	_	.	,	_	154	punct	_	_
160	1.00	_	NUM	CD	_	161	nummod	_	_
161	0.98	_	NUM	CD	_	154	appos	_	_
162	0.80	_	NUM	CD	_	161	dep	_	_
163	,	_	.	,	_	154	punct	_	_
164	1.20	_	NUM	CD	_	166	nummod	_	_
165	NA	_	NOUN	NN	_	166	compound	_	_
166	DRUG	_	NOUN	NN	_	154	appos	_	_
167	1.00	_	NUM	CD	_	168	nummod	_	_
168	0.76	_	NUM	CD	_	166	dep	_	_
169	,	_	.	,	_	154	punct	_	_
170	1.32	_	NUM	CD	_	171	nummod	_	_
171	0.95	_	NUM	CD	_	154	appos	_	_
172	0.82	_	NUM	CD	_	171	dep	_	_
173	,	_	.	,	_	154	punct	_	_
174	1.10	_	NUM	CD	_	176	nummod	_	_
175	NA	_	NOUN	NN	_	176	compound	_	_
176	GS	_	NOUN	NN	_	154	appos	_	_
177	331007	_	NUM	CD	_	178	nummod	_	_
178	1.13	_	NUM	CD	_	176	nummod	_	_
179	1.07	_	NUM	CD	_	178	dep	_	_
180	,	_	.	,	_	154	punct	_	_
181	1.20	_	NUM	CD	_	182	nummod	_	_
182	1.06	_	NUM	CD	_	154	appos	_	_
183	1.01	_	NUM	CD	_	182	dep	_	_
184	,	_	.	,	_	154	punct	_	_
185	1.12	_	NUM	CD	_	187	nummod	_	_
186	NA	_	NOUN	NN	_	187	compound	_	_
187	Methadone	_	NOUN	NN	_	154	appos	_	_
188	30	_	NUM	CD	_	187	nummod	_	_
189	to	_	PRT	TO	_	187	dep	_	_
190	130	_	NUM	CD	_	187	nummod	_	_
191	daily	_	ADV	RB	_	192	advmod	_	_
192	ND	_	NOUN	NN	_	187	nmod	_	_
193	400	_	NUM	CD	_	192	nummod	_	_
194	once	_	ADV	RB	_	195	advmod	_	_
195	daily	_	ADV	RB	_	196	advmod	_	_
196	14	_	NUM	CD	_	197	nummod	_	_
197	DRUG	_	NOUN	NN	_	187	dep	_	_
198	0.95(0.68	_	NUM	CD	_	197	nummod	_	_
199	,	_	.	,	_	197	punct	_	_
200	1.33	_	NUM	CD	_	201	nummod	_	_
201	1.30	_	NUM	CD	_	197	appos	_	_
202	1.00	_	NUM	CD	_	201	dep	_	_
203	,	_	.	,	_	197	punct	_	_
204	1.69	_	NUM	CD	_	206	nummod	_	_
205	NA	_	NOUN	NN	_	206	compound	_	_
206	GS	_	NOUN	NN	_	197	appos	_	_
207	331007	_	NUM	CD	_	208	nummod	_	_
208	0.73(0.65	_	NUM	CD	_	206	dep	_	_
209	,	_	.	,	_	197	punct	_	_
210	0.83	_	NUM	CD	_	211	nummod	_	_
211	1.04	_	NUM	CD	_	197	appos	_	_
212	0.89	_	NUM	CD	_	211	dep	_	_
213	,	_	.	,	_	197	punct	_	_
214	1.22	_	NUM	CD	_	216	nummod	_	_
215	NA	_	NOUN	NN	_	216	compound	_	_
216	Omeprazole	_	NOUN	NN	_	197	appos	_	_
217	20	_	NUM	CD	_	216	nummod	_	_
218	once	_	ADV	RB	_	219	advmod	_	_
219	daily	_	ADV	RB	_	220	advmod	_	_
220	simultaneously	_	ADV	RB	_	216	advmod	_	_
221	with	_	ADP	IN	_	228	case	_	_
222	DRUG	_	NOUN	NN	_	228	compound	_	_
223	90	_	NUM	CD	_	228	nummod	_	_
224	single	_	ADJ	JJ	_	228	amod	_	_
225	dose	_	NOUN	NN	_	228	compound	_	_
226	400	_	NUM	CD	_	228	nummod	_	_
227	single	_	ADJ	JJ	_	228	amod	_	_
228	dose	_	NOUN	NN	_	220	nmod	_	_
229	16	_	NUM	CD	_	230	nummod	_	_
230	DRUG	_	NOUN	NN	_	228	dep	_	_
231	0.89	_	NUM	CD	_	232	nummod	_	_
232	0.61	_	NUM	CD	_	230	dep	_	_
233	,	_	.	,	_	228	punct	_	_
234	1.30	_	NUM	CD	_	235	nummod	_	_
235	0.96	_	NUM	CD	_	228	appos	_	_
236	0.66	_	NUM	CD	_	235	dep	_	_
237	,	_	.	,	_	228	punct	_	_
238	1.39	_	NUM	CD	_	240	nummod	_	_
239	NA	_	NOUN	NN	_	240	compound	_	_
240	DRUG	_	NOUN	NN	_	228	appos	_	_
241	1.12	_	NUM	CD	_	242	nummod	_	_
242	0.88	_	NUM	CD	_	240	dep	_	_
243	,	_	.	,	_	228	punct	_	_
244	1.42	_	NUM	CD	_	245	nummod	_	_
245	1.00	_	NUM	CD	_	228	appos	_	_
246	0.80	_	NUM	CD	_	245	dep	_	_
247	,	_	.	,	_	228	punct	_	_
248	1.25	_	NUM	CD	_	250	nummod	_	_
249	NA	_	NOUN	NN	_	250	compound	_	_
250	GS	_	NOUN	NN	_	228	appos	_	_
251	331007	_	NUM	CD	_	250	nummod	_	_
252	1.14	_	NUM	CD	_	251	dep	_	_
253	1.01	_	NUM	CD	_	252	dep	_	_
254	,	_	.	,	_	252	punct	_	_
255	1.29	_	NUM	CD	_	252	conj	_	_
256	1.03	_	NUM	CD	_	255	dep	_	_
257	0.96	_	NUM	CD	_	256	dep	_	_
258	,	_	.	,	_	252	punct	_	_
259	1.12	_	NUM	CD	_	260	nummod	_	_
260	NA	_	NOUN	NN	_	265	compound	_	_
261	20	_	NUM	CD	_	260	nummod	_	_
262	once	_	ADV	RB	_	263	advmod	_	_
263	daily	_	ADV	RB	_	264	advmod	_	_
264	2	_	NUM	CD	_	265	nummod	_	_
265	hours	_	NOUN	NNS	_	252	dep	_	_
266	prior	_	ADJ	JJ	_	272	case	_	_
267	to	_	PRT	TO	_	266	mwe	_	_
268	DRUG	_	NOUN	NN	_	272	compound	_	_
269	30	_	NUM	CD	_	272	nummod	_	_
270	single	_	ADJ	JJ	_	272	amod	_	_
271	dose	_	NOUN	NN	_	272	compound	_	_
272	ND	_	NOUN	NN	_	265	nmod	_	_
273	17	_	NUM	CD	_	272	nummod	_	_
274	DRUG	_	NOUN	NN	_	272	dep	_	_
275	0.52(0.41	_	NUM	CD	_	274	nummod	_	_
276	,	_	.	,	_	272	punct	_	_
277	0.66	_	NUM	CD	_	278	nummod	_	_
278	0.58(0.48	_	NUM	CD	_	272	appos	_	_
279	,	_	.	,	_	272	punct	_	_
280	0.71	_	NUM	CD	_	283	nummod	_	_
281	NA	_	NOUN	NN	_	283	compound	_	_
282	RifampinThis	_	NOUN	NN	_	283	compound	_	_
283	study	_	NOUN	NN	_	285	nsubjpass	_	_
284	was	_	VERB	VBD	_	285	auxpass	_	_
285	conducted	_	VERB	VBN	_	272	dep	_	_
286	in	_	ADP	IN	_	288	case	_	_
287	the	_	DET	DT	_	288	det	_	_
288	presence	_	NOUN	NN	_	285	nmod	_	_
289	of	_	ADP	IN	_	296	case	_	_
290	two	_	NUM	CD	_	296	nummod	_	_
291	other	_	ADJ	JJ	_	296	amod	_	_
292	investigational	_	ADJ	JJ	_	296	amod	_	_
293	HCV	_	NOUN	NN	_	296	compound	_	_
294	direct	_	ADJ	JJ	_	296	amod	_	_
295	acting	_	VERB	VBG	_	296	compound	_	_
296	agents	_	NOUN	NNS	_	288	nmod	_	_

#	Harvoni	4451
1	ND	_	NOUN	NN	_	3	compound	_	_
2	31	_	NUM	CD	_	3	nummod	_	_
3	DRUG	_	NOUN	NN	_	0	root	_	_
4	0.65	_	NUM	CD	_	5	nummod	_	_
5	0.56	_	NUM	CD	_	3	dep	_	_
6	,	_	.	,	_	3	punct	_	_
7	0.76	_	NUM	CD	_	8	nummod	_	_
8	0.41	_	NUM	CD	_	3	conj	_	_
9	0.36	_	NUM	CD	_	8	dep	_	_
10	,	_	.	,	_	3	punct	_	_
11	0.48	_	NUM	CD	_	16	nummod	_	_
12	NA	_	NOUN	NN	_	16	compound	_	_
13	ND	_	NOUN	NN	_	16	compound	_	_
14	400	_	NUM	CD	_	16	nummod	_	_
15	single	_	ADJ	JJ	_	16	amod	_	_
16	dose	_	NOUN	NN	_	3	appos	_	_
17	17	_	NUM	CD	_	18	nummod	_	_
18	DRUG	_	NOUN	NN	_	16	dep	_	_
19	0.23	_	NUM	CD	_	20	nummod	_	_
20	0.19	_	NUM	CD	_	18	dep	_	_
21	,	_	.	,	_	18	punct	_	_
22	0.29	_	NUM	CD	_	23	nummod	_	_
23	0.28	_	NUM	CD	_	18	appos	_	_
24	0.24	_	NUM	CD	_	23	dep	_	_
25	,	_	.	,	_	18	punct	_	_
26	0.32	_	NUM	CD	_	28	nummod	_	_
27	NA	_	NOUN	NN	_	28	compound	_	_
28	GS	_	NOUN	NN	_	18	appos	_	_
29	331007	_	NUM	CD	_	28	nummod	_	_
30	1.23	_	NUM	CD	_	29	dep	_	_
31	1.14	_	NUM	CD	_	30	dep	_	_
32	,	_	.	,	_	30	punct	_	_
33	1.34	_	NUM	CD	_	30	appos	_	_
34	0.95	_	NUM	CD	_	33	dep	_	_
35	0.88	_	NUM	CD	_	34	dep	_	_
36	,	_	.	,	_	30	punct	_	_
37	1.03	_	NUM	CD	_	38	nummod	_	_
38	NA	_	NOUN	NN	_	39	nsubj	_	_
39	Simeprevir	_	VERB	VBP	_	30	appos	_	_
40	150	_	NUM	CD	_	48	nummod	_	_
41	once	_	ADV	RB	_	42	advmod	_	_
42	daily	_	ADV	RB	_	43	advmod	_	_
43	30	_	NUM	CD	_	48	nummod	_	_
44	once	_	ADV	RB	_	45	advmod	_	_
45	daily	_	ADV	RB	_	48	advmod	_	_
46	ND	_	NOUN	NN	_	48	compound	_	_
47	22	_	NUM	CD	_	48	nummod	_	_
48	DRUG	_	NOUN	NN	_	39	dobj	_	_
49	1.81	_	NUM	CD	_	50	nummod	_	_
50	1.69	_	NUM	CD	_	48	dep	_	_
51	,	_	.	,	_	48	punct	_	_
52	2.94	_	NUM	CD	_	53	nummod	_	_
53	1.92	_	NUM	CD	_	48	appos	_	_
54	1.77	_	NUM	CD	_	53	dep	_	_
55	,	_	.	,	_	48	punct	_	_
56	2.07	_	NUM	CD	_	65	nummod	_	_
57	NA	_	NOUN	NN	_	65	compound	_	_
58	Tacrolimus	_	NOUN	NN	_	65	compound	_	_
59	5	_	NUM	CD	_	65	nummod	_	_
60	single	_	ADJ	JJ	_	65	amod	_	_
61	dose	_	NOUN	NN	_	65	compound	_	_
62	ND	_	NOUN	NN	_	65	compound	_	_
63	400	_	NUM	CD	_	65	nummod	_	_
64	single	_	ADJ	JJ	_	65	amod	_	_
65	dose	_	NOUN	NN	_	48	appos	_	_
66	16	_	NUM	CD	_	67	nummod	_	_
67	DRUG	_	NOUN	NN	_	65	dep	_	_
68	0.97	_	NUM	CD	_	67	dep	_	_
69	0.65	_	NUM	CD	_	68	dep	_	_
70	,	_	.	,	_	67	punct	_	_
71	1.43	_	NUM	CD	_	72	nummod	_	_
72	1.13	_	NUM	CD	_	67	appos	_	_
73	0.81	_	NUM	CD	_	72	dep	_	_
74	,	_	.	,	_	67	punct	_	_
75	1.57	_	NUM	CD	_	77	nummod	_	_
76	NA	_	NOUN	NN	_	77	compound	_	_
77	GS	_	NOUN	NN	_	67	appos	_	_
78	331007	_	NUM	CD	_	77	nummod	_	_
79	0.97	_	NUM	CD	_	78	dep	_	_
80	0.83	_	NUM	CD	_	79	dep	_	_
81	,	_	.	,	_	79	punct	_	_
82	1.14	_	NUM	CD	_	79	appos	_	_
83	1.00	_	NUM	CD	_	82	dep	_	_
84	0.87	_	NUM	CD	_	83	dep	_	_
85	,	_	.	,	_	79	punct	_	_
86	1.13	_	NUM	CD	_	79	conj	_	_

#	Harvoni	4452
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	is	_	VERB	VBZ	_	4	cop	_	_
3	an	_	DET	DT	_	4	det	_	_
4	inhibitor	_	NOUN	NN	_	0	root	_	_
5	of	_	ADP	IN	_	9	case	_	_
6	drug	_	NOUN	NN	_	9	compound	_	_
7	transporter	_	NOUN	NN	_	9	compound	_	_
8	P	_	NOUN	NN	_	9	compound	_	_
9	gp	_	NOUN	NN	_	4	nmod	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	breast	_	NOUN	NN	_	15	compound	_	_
12	cancer	_	NOUN	NN	_	15	compound	_	_
13	resistance	_	NOUN	NN	_	15	compound	_	_
14	protein	_	NOUN	NN	_	15	compound	_	_
15	BCRP	_	NOUN	NN	_	9	conj	_	_
16	and	_	CONJ	CC	_	4	cc	_	_
17	may	_	VERB	MD	_	18	aux	_	_
18	increase	_	VERB	VB	_	4	conj	_	_
19	intestinal	_	ADJ	JJ	_	20	amod	_	_
20	absorption	_	NOUN	NN	_	18	dobj	_	_
21	of	_	ADP	IN	_	23	case	_	_
22	coadministered	_	VERB	VBN	_	23	amod	_	_
23	substrates	_	NOUN	NNS	_	20	nmod	_	_
24	for	_	ADP	IN	_	26	case	_	_
25	these	_	DET	DT	_	26	det	_	_
26	transporters	_	NOUN	NNS	_	23	nmod	_	_

#	Harvoni	4453
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	is	_	VERB	VBZ	_	4	cop	_	_
3	an	_	DET	DT	_	4	det	_	_
4	inhibitor	_	NOUN	NN	_	0	root	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	transporters	_	NOUN	NNS	_	4	nmod	_	_
7	OATP1B1	_	NOUN	NN	_	6	dep	_	_
8	,	_	.	,	_	7	punct	_	_
9	OATP1B3	_	NOUN	NN	_	7	conj	_	_
10	,	_	.	,	_	7	punct	_	_
11	and	_	CONJ	CC	_	7	cc	_	_
12	BSEP	_	NOUN	NN	_	7	conj	_	_
13	only	_	ADV	RB	_	15	advmod	_	_
14	at	_	ADP	IN	_	15	case	_	_
15	concentrations	_	NOUN	NNS	_	4	nmod	_	_
16	exceeding	_	VERB	VBG	_	15	acl	_	_
17	those	_	DET	DT	_	16	dobj	_	_
18	achieved	_	VERB	VBN	_	17	acl	_	_
19	in	_	ADP	IN	_	20	case	_	_
20	clinic	_	ADJ	JJ	_	18	nmod	_	_

#	Harvoni	4454
1	DRUG	_	NOUN	NN	_	5	nsubj	_	_
2	is	_	VERB	VBZ	_	5	cop	_	_
3	not	_	ADV	RB	_	5	neg	_	_
4	an	_	DET	DT	_	5	det	_	_
5	inhibitor	_	NOUN	NN	_	0	root	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	transporters	_	NOUN	NNS	_	5	nmod	_	_
8	MRP2	_	NOUN	NN	_	7	dep	_	_
9	,	_	.	,	_	8	punct	_	_
10	MRP4	_	NOUN	NN	_	8	conj	_	_
11	,	_	.	,	_	8	punct	_	_
12	OCT2	_	NOUN	NN	_	8	conj	_	_
13	,	_	.	,	_	8	punct	_	_
14	OAT1	_	NOUN	NN	_	8	conj	_	_
15	,	_	.	,	_	8	punct	_	_
16	OAT3	_	NOUN	NN	_	8	conj	_	_
17	,	_	.	,	_	8	punct	_	_
18	MATE1	_	NOUN	NN	_	8	conj	_	_
19	,	_	.	,	_	8	punct	_	_
20	and	_	CONJ	CC	_	8	cc	_	_
21	OCT1	_	NOUN	NN	_	8	conj	_	_

#	Harvoni	4455
1	The	_	DET	DT	_	5	det	_	_
2	drug	_	NOUN	NN	_	5	compound	_	_
3	drug	_	NOUN	NN	_	5	compound	_	_
4	interaction	_	NOUN	NN	_	5	compound	_	_
5	potential	_	NOUN	NN	_	10	nsubj	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	is	_	VERB	VBZ	_	10	cop	_	_
9	primarily	_	ADV	RB	_	10	advmod	_	_
10	limited	_	ADJ	JJ	_	0	root	_	_
11	to	_	PRT	TO	_	14	case	_	_
12	the	_	DET	DT	_	14	det	_	_
13	intestinal	_	ADJ	JJ	_	14	amod	_	_
14	inhibition	_	NOUN	NN	_	10	nmod	_	_
15	of	_	ADP	IN	_	17	case	_	_
16	P	_	NOUN	NN	_	17	compound	_	_
17	gp	_	NOUN	NN	_	14	nmod	_	_
18	and	_	CONJ	CC	_	17	cc	_	_
19	BCRP	_	NOUN	NN	_	17	conj	_	_

#	Harvoni	4456
1	Clinically	_	ADV	RB	_	2	advmod	_	_
2	relevant	_	ADJ	JJ	_	4	amod	_	_
3	transporter	_	NOUN	NN	_	4	compound	_	_
4	inhibition	_	NOUN	NN	_	13	nsubjpass	_	_
5	by	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	in	_	ADP	IN	_	10	case	_	_
8	the	_	DET	DT	_	10	det	_	_
9	systemic	_	ADJ	JJ	_	10	amod	_	_
10	circulation	_	NOUN	NN	_	4	nmod	_	_
11	is	_	VERB	VBZ	_	13	auxpass	_	_
12	not	_	ADV	RB	_	13	neg	_	_
13	expected	_	VERB	VBN	_	0	root	_	_
14	due	_	ADJ	JJ	_	19	case	_	_
15	to	_	PRT	TO	_	19	case	_	_
16	its	_	PRON	PRP$	_	19	nmod:poss	_	_
17	high	_	ADJ	JJ	_	19	amod	_	_
18	protein	_	NOUN	NN	_	19	compound	_	_
19	binding	_	NOUN	NN	_	13	nmod	_	_

#	Harvoni	4457
1	DRUG	_	NOUN	NN	_	7	nsubj	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	GS	_	NOUN	NN	_	1	conj	_	_
4	331007	_	NUM	CD	_	3	nummod	_	_
5	are	_	VERB	VBP	_	7	cop	_	_
6	not	_	ADV	RB	_	7	neg	_	_
7	inhibitors	_	NOUN	NNS	_	0	root	_	_
8	of	_	ADP	IN	_	10	case	_	_
9	drug	_	NOUN	NN	_	10	compound	_	_
10	transporters	_	NOUN	NNS	_	7	nmod	_	_
11	P	_	NOUN	NN	_	12	compound	_	_
12	gp	_	NOUN	NN	_	10	dep	_	_
13	,	_	.	,	_	12	punct	_	_
14	BCRP	_	NOUN	NN	_	12	conj	_	_
15	,	_	.	,	_	12	punct	_	_
16	MRP2	_	NOUN	NN	_	12	conj	_	_
17	,	_	.	,	_	12	punct	_	_
18	BSEP	_	NOUN	NN	_	12	conj	_	_
19	,	_	.	,	_	12	punct	_	_
20	OATP1B1	_	NOUN	NN	_	12	conj	_	_
21	,	_	.	,	_	12	punct	_	_
22	OATP1B3	_	NOUN	NN	_	12	conj	_	_
23	,	_	.	,	_	12	punct	_	_
24	and	_	CONJ	CC	_	12	cc	_	_
25	OCT1	_	NOUN	NN	_	12	conj	_	_
26	,	_	.	,	_	7	punct	_	_
27	and	_	CONJ	CC	_	7	cc	_	_
28	GS	_	NOUN	NN	_	33	nsubj	_	_
29	331007	_	NUM	CD	_	28	nummod	_	_
30	is	_	VERB	VBZ	_	33	cop	_	_
31	not	_	ADV	RB	_	33	neg	_	_
32	an	_	DET	DT	_	33	det	_	_
33	inhibitor	_	NOUN	NN	_	7	conj	_	_
34	of	_	ADP	IN	_	35	case	_	_
35	OAT1	_	NOUN	NN	_	33	nmod	_	_
36	,	_	.	,	_	35	punct	_	_
37	OCT2	_	NOUN	NN	_	35	conj	_	_
38	,	_	.	,	_	35	punct	_	_
39	and	_	CONJ	CC	_	35	cc	_	_
40	MATE1	_	NOUN	NN	_	35	conj	_	_

#	Harvoni	4458
1	DRUG	_	NOUN	NN	_	10	nsubj	_	_
2	,	_	.	,	_	1	punct	_	_
3	DRUG	_	NOUN	NN	_	1	conj	_	_
4	,	_	.	,	_	1	punct	_	_
5	and	_	CONJ	CC	_	1	cc	_	_
6	GS	_	NOUN	NN	_	1	conj	_	_
7	331007	_	NUM	CD	_	6	nummod	_	_
8	are	_	VERB	VBP	_	10	cop	_	_
9	not	_	ADV	RB	_	10	neg	_	_
10	inhibitors	_	NOUN	NNS	_	0	root	_	_
11	or	_	CONJ	CC	_	10	cc	_	_
12	inducers	_	NOUN	NNS	_	10	conj	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	CYP	_	NOUN	NN	_	12	nmod	_	_
15	or	_	CONJ	CC	_	14	cc	_	_
16	UGT1A1	_	NOUN	NN	_	14	conj	_	_
17	enzymes	_	NOUN	NNS	_	14	dep	_	_

#	Harvoni	4459
1	The	_	DET	DT	_	2	det	_	_
2	effects	_	NOUN	NNS	_	14	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	or	_	CONJ	CC	_	4	cc	_	_
6	DRUG	_	NOUN	NN	_	4	conj	_	_
7	on	_	ADP	IN	_	9	case	_	_
8	the	_	DET	DT	_	9	det	_	_
9	exposure	_	NOUN	NN	_	2	nmod	_	_
10	of	_	ADP	IN	_	12	case	_	_
11	coadministered	_	VERB	VBN	_	12	amod	_	_
12	drugs	_	NOUN	NNS	_	9	nmod	_	_
13	are	_	VERB	VBP	_	14	auxpass	_	_
14	shown	_	VERB	VBN	_	0	root	_	_
15	in	_	ADP	IN	_	16	case	_	_
16	Table	_	ADJ	JJ	_	14	nmod	_	_
17	8	_	NUM	CD	_	16	dep	_	_

#	Harvoni	4460
1	Table	_	ADJ	JJ	_	4	amod	_	_
2	8	_	NUM	CD	_	4	nummod	_	_
3	Drug	_	NOUN	NN	_	4	compound	_	_
4	Interactions	_	NOUN	NNS	_	0	root	_	_
5	:	_	.	:	_	4	punct	_	_
6	Changes	_	NOUN	NNS	_	4	dep	_	_
7	in	_	ADP	IN	_	9	case	_	_
8	Pharmacokinetic	_	ADJ	JJ	_	9	amod	_	_
9	Parameters	_	NOUN	NNS	_	6	nmod	_	_
10	for	_	ADP	IN	_	12	case	_	_
11	Coadministered	_	ADJ	JJ	_	12	amod	_	_
12	Drug	_	NOUN	NN	_	9	nmod	_	_
13	in	_	ADP	IN	_	15	case	_	_
14	the	_	DET	DT	_	15	det	_	_
15	Presence	_	NOUN	NN	_	6	nmod	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	DRUG	_	NOUN	NN	_	15	nmod	_	_
18	,	_	.	,	_	17	punct	_	_
19	DRUG	_	NOUN	NN	_	17	conj	_	_
20	,	_	.	,	_	17	punct	_	_
21	or	_	CONJ	CC	_	17	cc	_	_
22	DRUG	_	NOUN	NN	_	25	compound	_	_
23	All	_	NOUN	NN	_	25	compound	_	_
24	interaction	_	NOUN	NN	_	25	compound	_	_
25	studies	_	NOUN	NNS	_	17	conj	_	_
26	conducted	_	VERB	VBN	_	17	acl	_	_
27	in	_	ADP	IN	_	29	case	_	_
28	healthy	_	ADJ	JJ	_	29	amod	_	_
29	volunteers	_	NOUN	NNS	_	26	nmod	_	_

#	Harvoni	4461
1	Co	_	PRT	TO	_	4	case	_	_
2	administered	_	VERB	VBN	_	4	amod	_	_
3	Drug	_	NOUN	NN	_	4	compound	_	_
4	Dose	_	NOUN	NN	_	0	root	_	_
5	of	_	ADP	IN	_	14	case	_	_
6	Co	_	NOUN	NN	_	14	compound	_	_
7	administered	_	VERB	VBN	_	14	amod	_	_
8	Drug	_	NOUN	NN	_	14	compound	_	_
9	mg	_	NOUN	NN	_	14	compound	_	_
10	DRUG	_	NOUN	NN	_	14	compound	_	_
11	Dose(mg	_	NOUN	NN	_	14	compound	_	_
12	DRUG	_	NOUN	NN	_	14	compound	_	_
13	Dose(mg	_	NOUN	NN	_	14	compound	_	_
14	N	_	NOUN	NN	_	4	nmod	_	_
15	Mean	_	NOUN	NN	_	4	nmod	_	_
16	Ratio	_	NOUN	NN	_	18	compound	_	_
17	90%	_	ADJ	JJ	_	18	amod	_	_
18	CI	_	NOUN	NN	_	15	dobj	_	_
19	of	_	ADP	IN	_	22	case	_	_
20	Coadministered	_	ADJ	JJ	_	22	amod	_	_
21	Drug	_	NOUN	NN	_	22	compound	_	_
22	PK	_	NOUN	NN	_	18	nmod	_	_
23	With	_	ADP	IN	_	24	case	_	_
24	/	_	.	-LRB-	_	15	nmod	_	_
25	Without	_	ADP	IN	_	26	case	_	_
26	DRUG	_	NOUN	NN	_	24	root	_	_
27	,	_	.	,	_	26	punct	_	_
28	DRUG	_	NOUN	NN	_	26	conj	_	_
29	,	_	.	,	_	26	punct	_	_
30	or	_	CONJ	CC	_	26	cc	_	_
31	DRUG	_	NOUN	NN	_	37	compound	_	_
32	No	_	NOUN	NN	_	37	compound	_	_
33	Effect=1.00	_	NOUN	NN	_	37	compound	_	_
34	Cmax	_	NOUN	NN	_	37	compound	_	_
35	AUC	_	NOUN	NN	_	37	compound	_	_
36	Cmin	_	NOUN	NN	_	37	compound	_	_
37	NA	_	NOUN	NN	_	26	conj	_	_
38	=	_	VERB	VBD	_	26	dep	_	_
39	not	_	ADV	RB	_	40	neg	_	_
40	available	_	ADJ	JJ	_	38	dep	_	_
41	/	_	.	-LRB-	_	40	punct	_	_
42	not	_	ADV	RB	_	43	neg	_	_
43	applicable	_	ADJ	JJ	_	40	dep	_	_
44	,	_	.	,	_	40	punct	_	_
45	ND	_	NOUN	NN	_	48	nsubj	_	_
46	=	_	VERB	VBD	_	48	auxpass	_	_
47	not	_	ADV	RB	_	48	neg	_	_
48	dosed	_	VERB	VBN	_	40	dep	_	_

#	Harvoni	4463
1	,	_	PRT	TO	_	3	case	_	_
2	The	_	DET	DT	_	3	det	_	_
3	effects	_	NOUN	NNS	_	11	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	on	_	ADP	IN	_	7	case	_	_
7	atazanavir	_	NOUN	NN	_	3	nmod	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	ritonavir	_	NOUN	NN	_	7	conj	_	_
10	are	_	VERB	VBP	_	11	cop	_	_
11	similar	_	ADJ	JJ	_	0	root	_	_
12	with	_	ADP	IN	_	11	dep	_	_
13	or	_	CONJ	CC	_	12	cc	_	_
14	without	_	ADP	IN	_	18	case	_	_
15	the	_	DET	DT	_	18	dep	_	_
16	presence	_	NOUN	NN	_	18	dep	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	emtricitabine	_	NOUN	NN	_	12	conj	_	_
19	/	_	.	:	_	11	punct	_	_
20	tenofovir	_	NOUN	NN	_	21	compound	_	_
21	DF	_	NOUN	NN	_	11	dep	_	_

#	Harvoni	4464
1	This	_	DET	DT	_	2	det	_	_
2	magnitude	_	NOUN	NN	_	10	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	change	_	NOUN	NN	_	2	nmod	_	_
5	in	_	ADP	IN	_	7	case	_	_
6	tenofovir	_	NOUN	NN	_	7	compound	_	_
7	exposure	_	NOUN	NN	_	4	nmod	_	_
8	does	_	VERB	VBZ	_	10	aux	_	_
9	not	_	ADV	RB	_	10	neg	_	_
10	reflect	_	VERB	VB	_	0	root	_	_
11	the	_	DET	DT	_	15	det	_	_
12	approximately	_	ADV	RB	_	13	advmod	_	_
13	60	_	NUM	CD	_	15	nummod	_	_
14	80%	_	ADJ	JJ	_	15	amod	_	_
15	increase	_	NOUN	NN	_	10	dobj	_	_
16	caused	_	VERB	VBN	_	15	acl	_	_
17	by	_	ADP	IN	_	19	case	_	_
18	the	_	DET	DT	_	19	det	_	_
19	effects	_	NOUN	NNS	_	16	nmod	_	_
20	of	_	ADP	IN	_	23	case	_	_
21	an	_	DET	DT	_	23	det	_	_
22	HIV	_	NOUN	NN	_	23	compound	_	_
23	PI	_	NOUN	NN	_	19	nmod	_	_
24	/	_	.	:	_	10	punct	_	_
25	ritonavir	_	NOUN	NN	_	10	parataxis	_	_
26	and	_	CONJ	CC	_	25	cc	_	_
27	the	_	DET	DT	_	28	det	_	_
28	effect	_	NOUN	NN	_	25	conj	_	_
29	of	_	ADP	IN	_	30	case	_	_
30	food	_	NOUN	NN	_	28	nmod	_	_

#	Harvoni	4465
1	Therefore	_	ADV	RB	_	7	advmod	_	_
2	,	_	.	,	_	7	punct	_	_
3	tenofovir	_	ADJ	JJ	_	4	compound	_	_
4	exposure	_	NOUN	NN	_	7	nsubj	_	_
5	is	_	VERB	VBZ	_	7	cop	_	_
6	approximately	_	ADV	RB	_	7	advmod	_	_
7	130%	_	ADJ	JJ	_	0	root	_	_
8	higher	_	ADJ	JJ	_	7	xcomp	_	_
9	when	_	ADV	WRB	_	10	advmod	_	_
10	administered	_	VERB	VBN	_	8	advcl	_	_
11	as	_	ADP	IN	_	13	case	_	_
12	tenofovir	_	ADJ	JJ	_	13	amod	_	_
13	DF	_	NOUN	NN	_	10	nmod	_	_
14	+	_	CONJ	CC	_	13	cc	_	_
15	atazanavir	_	NOUN	NN	_	13	conj	_	_
16	/	_	.	:	_	7	punct	_	_
17	ritonavir	_	NOUN	NN	_	7	dep	_	_
18	+	_	CONJ	CC	_	17	cc	_	_
19	DRUG	_	NOUN	NN	_	17	conj	_	_
20	or	_	CONJ	CC	_	17	cc	_	_
21	tenofovir	_	ADJ	JJ	_	22	compound	_	_
22	DF	_	NOUN	NN	_	17	conj	_	_
23	+	_	CONJ	CC	_	22	cc	_	_
24	darunavir	_	NOUN	NN	_	22	conj	_	_
25	/	_	.	:	_	7	punct	_	_
26	ritonavir	_	NOUN	NN	_	7	dep	_	_
27	+	_	CONJ	CC	_	26	cc	_	_
28	DRUG	_	NOUN	NN	_	26	conj	_	_
29	and	_	CONJ	CC	_	26	cc	_	_
30	with	_	ADP	IN	_	31	case	_	_
31	food	_	NOUN	NN	_	26	conj	_	_
32	as	_	ADP	IN	_	33	mark	_	_
33	compared	_	VERB	VBN	_	26	acl	_	_
34	to	_	PRT	TO	_	37	case	_	_
35	the	_	DET	DT	_	37	det	_	_
36	tenofovir	_	NOUN	NN	_	37	compound	_	_
37	exposure	_	NOUN	NN	_	33	nmod	_	_
38	observed	_	VERB	VBN	_	37	acl	_	_
39	following	_	VERB	VBG	_	41	case	_	_
40	fasted	_	VERB	VBN	_	41	amod	_	_
41	administration	_	NOUN	NN	_	38	nmod	_	_
42	of	_	ADP	IN	_	46	case	_	_
43	tenofovir	_	ADJ	JJ	_	46	amod	_	_
44	DF	_	NOUN	NN	_	46	compound	_	_
45	based	_	ADJ	JJ	_	46	amod	_	_
46	regimens	_	NOUN	NNS	_	41	nmod	_	_
47	that	_	DET	WDT	_	50	nsubj	_	_
48	do	_	VERB	MD	_	50	aux	_	_
49	not	_	ADV	RB	_	50	neg	_	_
50	contain	_	VERB	VB	_	46	acl:relcl	_	_
51	an	_	DET	DT	_	53	det	_	_
52	HIV	_	NOUN	NN	_	53	compound	_	_
53	PI	_	NOUN	NN	_	50	dobj	_	_
54	/	_	.	:	_	53	punct	_	_
55	ritonavir	_	NOUN	NN	_	53	dep	_	_
56	and	_	CONJ	CC	_	55	cc	_	_
57	DRUG	_	NOUN	NN	_	55	conj	_	_

#	Harvoni	4466
1	The	_	DET	DT	_	2	det	_	_
2	effects	_	NOUN	NNS	_	9	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	on	_	ADP	IN	_	7	case	_	_
6	tenofovir	_	NOUN	NN	_	7	compound	_	_
7	exposures	_	NOUN	NNS	_	2	nmod	_	_
8	are	_	VERB	VBP	_	9	cop	_	_
9	similar	_	ADJ	JJ	_	0	root	_	_
10	when	_	ADV	WRB	_	13	advmod	_	_
11	tenofovir	_	NOUN	NN	_	13	nsubjpass	_	_
12	is	_	VERB	VBZ	_	13	auxpass	_	_
13	administered	_	VERB	VBN	_	9	ccomp	_	_
14	as	_	ADP	IN	_	15	case	_	_
15	ATRIPLA	_	NOUN	NN	_	13	nmod	_	_
16	,	_	.	,	_	15	punct	_	_
17	COMPLERA	_	NOUN	NN	_	15	conj	_	_
18	,	_	.	,	_	15	punct	_	_
19	or	_	CONJ	CC	_	15	cc	_	_
20	TRUVADA	_	NOUN	NN	_	15	conj	_	_
21	+	_	CONJ	CC	_	15	cc	_	_
22	dolutegravir	_	ADJ	JJ	_	15	conj	_	_

#	Harvoni	4467
1	90	_	NUM	CD	_	0	root	_	_
2	once	_	ADV	RB	_	3	advmod	_	_
3	daily	_	ADV	RB	_	4	advmod	_	_
4	400	_	NUM	CD	_	1	dep	_	_
5	once	_	ADV	RB	_	6	advmod	_	_
6	daily	_	ADV	RB	_	7	advmod	_	_
7	15	_	NUM	CD	_	4	dep	_	_
8	1.79	_	NUM	CD	_	7	dep	_	_
9	1.56	_	NUM	CD	_	8	dep	_	_
10	,	_	.	,	_	4	punct	_	_
11	2.04	_	NUM	CD	_	12	nummod	_	_
12	1.98	_	NUM	CD	_	4	appos	_	_
13	1.77	_	NUM	CD	_	12	dep	_	_
14	,	_	.	,	_	4	punct	_	_
15	2.23	_	NUM	CD	_	4	appos	_	_
16	2.63	_	NUM	CD	_	15	dep	_	_
17	2.32	_	NUM	CD	_	16	dep	_	_
18	,	_	.	,	_	4	punct	_	_
19	2.97	_	NUM	CD	_	20	compound	_	_
20	No	_	NOUN	NN	_	21	amod	_	_
21	effect	_	NOUN	NN	_	32	nsubjpass	_	_
22	on	_	ADP	IN	_	25	case	_	_
23	the	_	DET	DT	_	25	det	_	_
24	pharmacokinetic	_	ADJ	JJ	_	25	amod	_	_
25	parameters	_	NOUN	NNS	_	21	nmod	_	_
26	of	_	ADP	IN	_	30	case	_	_
27	the	_	DET	DT	_	30	det	_	_
28	following	_	VERB	VBG	_	30	amod	_	_
29	coadministered	_	VERB	VBN	_	30	amod	_	_
30	drugs	_	NOUN	NNS	_	25	nmod	_	_
31	was	_	VERB	VBD	_	32	auxpass	_	_
32	observed	_	VERB	VBN	_	4	acl:relcl	_	_
33	with	_	ADP	IN	_	34	case	_	_
34	DRUG	_	NOUN	NN	_	32	nmod	_	_
35	or	_	CONJ	CC	_	34	cc	_	_
36	DRUG	_	NOUN	NN	_	34	conj	_	_
37	:	_	.	:	_	1	punct	_	_
38	abacavir	_	NOUN	NN	_	1	dep	_	_
39	,	_	.	,	_	38	punct	_	_
40	cyclosporine	_	NOUN	NN	_	38	conj	_	_
41	,	_	.	,	_	38	punct	_	_
42	darunavir	_	NOUN	NN	_	38	conj	_	_
43	/	_	.	:	_	38	punct	_	_
44	ritonavir	_	NOUN	NN	_	38	conj	_	_
45	,	_	.	,	_	38	punct	_	_
46	dolutegravir	_	NOUN	NN	_	38	conj	_	_
47	,	_	.	,	_	38	punct	_	_
48	efavirenz	_	NOUN	NN	_	38	conj	_	_
49	,	_	.	,	_	38	punct	_	_
50	emtricitabine	_	NOUN	NN	_	38	conj	_	_
51	,	_	.	,	_	38	punct	_	_
52	lamivudine	_	NOUN	NN	_	38	conj	_	_
53	,	_	.	,	_	38	punct	_	_
54	methadone	_	NOUN	NN	_	38	conj	_	_
55	,	_	.	,	_	38	punct	_	_
56	or	_	CONJ	CC	_	38	cc	_	_
57	rilpivirine	_	NOUN	NN	_	38	conj	_	_

#	Harvoni	4468
1	Mechanism	_	NOUN	NN	_	7	nsubj	_	_
2	of	_	ADP	IN	_	4	case	_	_
3	Action	_	NOUN	NN	_	4	compound	_	_
4	DRUG	_	NOUN	NN	_	1	nmod	_	_
5	is	_	VERB	VBZ	_	7	cop	_	_
6	an	_	DET	DT	_	7	det	_	_
7	inhibitor	_	NOUN	NN	_	0	root	_	_
8	of	_	ADP	IN	_	12	case	_	_
9	the	_	DET	DT	_	12	det	_	_
10	HCV	_	NOUN	NN	_	12	compound	_	_
11	NS5A	_	NOUN	NN	_	12	compound	_	_
12	protein	_	NOUN	NN	_	7	nmod	_	_
13	,	_	.	,	_	12	punct	_	_
14	which	_	DET	WDT	_	16	nsubjpass	_	_
15	is	_	VERB	VBZ	_	16	auxpass	_	_
16	required	_	VERB	VBN	_	12	acl:relcl	_	_
17	for	_	ADP	IN	_	19	case	_	_
18	viral	_	ADJ	JJ	_	19	amod	_	_
19	replication	_	NOUN	NN	_	16	nmod	_	_

#	Harvoni	4469
1	Resistance	_	NOUN	NN	_	2	compound	_	_
2	selection	_	NOUN	NN	_	10	nsubj	_	_
3	in	_	ADP	IN	_	5	case	_	_
4	cell	_	NOUN	NN	_	5	compound	_	_
5	culture	_	NOUN	NN	_	2	nmod	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	cross	_	ADJ	JJ	_	9	amod	_	_
8	resistance	_	NOUN	NN	_	9	compound	_	_
9	studies	_	NOUN	NNS	_	5	conj	_	_
10	indicate	_	VERB	VBP	_	0	root	_	_
11	DRUG	_	NOUN	NN	_	12	compound	_	_
12	targets	_	NOUN	NNS	_	10	dobj	_	_
13	NS5A	_	NOUN	NN	_	12	dobj	_	_
14	as	_	ADP	IN	_	16	case	_	_
15	its	_	PRON	PRP$	_	16	nmod:poss	_	_
16	mode	_	NOUN	NN	_	10	nmod	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	action	_	NOUN	NN	_	16	nmod	_	_

#	Harvoni	4470
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	is	_	VERB	VBZ	_	4	cop	_	_
3	an	_	DET	DT	_	4	det	_	_
4	inhibitor	_	NOUN	NN	_	0	root	_	_
5	of	_	ADP	IN	_	12	case	_	_
6	the	_	DET	DT	_	12	det	_	_
7	HCV	_	NOUN	NN	_	12	compound	_	_
8	NS5B	_	NOUN	NN	_	12	compound	_	_
9	RNA	_	NOUN	NN	_	12	compound	_	_
10	dependent	_	ADJ	JJ	_	12	amod	_	_
11	RNA	_	NOUN	NN	_	12	compound	_	_
12	polymerase	_	NOUN	NN	_	4	nmod	_	_
13	,	_	.	,	_	12	punct	_	_
14	which	_	DET	WDT	_	16	nsubjpass	_	_
15	is	_	VERB	VBZ	_	16	auxpass	_	_
16	required	_	VERB	VBN	_	12	acl:relcl	_	_
17	for	_	ADP	IN	_	19	case	_	_
18	viral	_	ADJ	JJ	_	19	amod	_	_
19	replication	_	NOUN	NN	_	16	nmod	_	_

#	Harvoni	4471
1	DRUG	_	NOUN	NN	_	5	nsubj	_	_
2	is	_	VERB	VBZ	_	5	cop	_	_
3	a	_	DET	DT	_	5	det	_	_
4	nucleotide	_	NOUN	NN	_	5	compound	_	_
5	prodrug	_	NOUN	NN	_	0	root	_	_
6	that	_	DET	WDT	_	7	nsubj	_	_
7	undergoes	_	VERB	VBZ	_	5	acl:relcl	_	_
8	intracellular	_	ADJ	JJ	_	9	amod	_	_
9	metabolism	_	NOUN	NN	_	7	dobj	_	_
10	to	_	PRT	TO	_	11	mark	_	_
11	form	_	VERB	VB	_	7	xcomp	_	_
12	the	_	DET	DT	_	18	det	_	_
13	pharmacologically	_	ADV	RB	_	14	advmod	_	_
14	active	_	ADJ	JJ	_	18	amod	_	_
15	uridine	_	ADJ	JJ	_	18	compound	_	_
16	analog	_	NOUN	NN	_	18	compound	_	_
17	triphosphate	_	NOUN	NN	_	18	compound	_	_
18	GS	_	NOUN	NN	_	11	dobj	_	_
19	461203	_	NUM	CD	_	18	nummod	_	_
20	,	_	.	,	_	18	punct	_	_
21	which	_	DET	WDT	_	24	nsubjpass	_	_
22	can	_	VERB	MD	_	24	aux	_	_
23	be	_	VERB	VB	_	24	auxpass	_	_
24	incorporated	_	VERB	VBN	_	18	acl:relcl	_	_
25	into	_	ADP	IN	_	27	case	_	_
26	HCV	_	NOUN	NN	_	27	compound	_	_
27	RNA	_	NOUN	NN	_	24	nmod	_	_
28	by	_	ADP	IN	_	31	case	_	_
29	the	_	DET	DT	_	31	det	_	_
30	NS5B	_	NOUN	NN	_	31	compound	_	_
31	polymerase	_	NOUN	NN	_	24	nmod	_	_
32	and	_	CONJ	CC	_	24	cc	_	_
33	acts	_	VERB	VBZ	_	24	conj	_	_
34	as	_	ADP	IN	_	37	case	_	_
35	a	_	DET	DT	_	37	det	_	_
36	chain	_	NOUN	NN	_	37	compound	_	_
37	terminator	_	NOUN	NN	_	33	nmod	_	_

#	Harvoni	4472
1	In	_	ADP	IN	_	4	case	_	_
2	a	_	DET	DT	_	4	det	_	_
3	biochemical	_	ADJ	JJ	_	4	amod	_	_
4	assay	_	NOUN	NN	_	8	nmod	_	_
5	,	_	.	,	_	8	punct	_	_
6	GS	_	NOUN	NN	_	8	nsubj	_	_
7	461203	_	NUM	CD	_	6	nummod	_	_
8	inhibited	_	VERB	VBD	_	0	root	_	_
9	the	_	DET	DT	_	11	det	_	_
10	polymerase	_	NOUN	NN	_	11	compound	_	_
11	activity	_	NOUN	NN	_	8	dobj	_	_
12	of	_	ADP	IN	_	15	case	_	_
13	the	_	DET	DT	_	15	det	_	_
14	recombinant	_	ADJ	JJ	_	15	amod	_	_
15	NS5B	_	NOUN	NN	_	11	nmod	_	_
16	from	_	ADP	IN	_	18	case	_	_
17	HCV	_	NOUN	NN	_	18	compound	_	_
18	genotypes	_	NOUN	NNS	_	11	nmod	_	_
19	1b	_	NOUN	NN	_	18	dep	_	_
20	and	_	CONJ	CC	_	19	cc	_	_
21	4a	_	NOUN	NN	_	19	conj	_	_
22	with	_	ADP	IN	_	24	case	_	_
23	IC50	_	NOUN	NN	_	24	compound	_	_
24	values	_	NOUN	NNS	_	11	nmod	_	_
25	of	_	ADP	IN	_	29	case	_	_
26	3.3	_	NUM	CD	_	29	nummod	_	_
27	and	_	CONJ	CC	_	26	cc	_	_
28	2.7	_	NUM	CD	_	26	conj	_	_
29	microM	_	NOUN	NN	_	24	nmod	_	_
30	,	_	.	,	_	8	punct	_	_
31	respectively	_	ADV	RB	_	8	advmod	_	_

#	Harvoni	4473
1	GS	_	NOUN	NN	_	6	nsubj	_	_
2	461203	_	NUM	CD	_	1	nummod	_	_
3	is	_	VERB	VBZ	_	6	cop	_	_
4	neither	_	CONJ	CC	_	6	cc:preconj	_	_
5	an	_	DET	DT	_	6	det	_	_
6	inhibitor	_	NOUN	NN	_	0	root	_	_
7	of	_	ADP	IN	_	9	case	_	_
8	human	_	ADJ	JJ	_	9	amod	_	_
9	DNA	_	NOUN	NN	_	6	nmod	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	RNA	_	NOUN	NN	_	12	compound	_	_
12	polymerases	_	NOUN	NNS	_	9	conj	_	_
13	nor	_	CONJ	CC	_	9	cc	_	_
14	an	_	DET	DT	_	15	det	_	_
15	inhibitor	_	NOUN	NN	_	9	conj	_	_
16	of	_	ADP	IN	_	19	case	_	_
17	mitochondrial	_	ADJ	JJ	_	19	amod	_	_
18	RNA	_	NOUN	NN	_	19	compound	_	_
19	polymerase	_	NOUN	NN	_	15	nmod	_	_

#	Harvoni	4474
1	Antiviral	_	ADJ	JJ	_	2	amod	_	_
2	Activity	_	NOUN	NN	_	24	nsubj	_	_
3	In	_	ADP	IN	_	6	case	_	_
4	HCV	_	NOUN	NN	_	6	compound	_	_
5	replicon	_	NOUN	NN	_	6	compound	_	_
6	assays	_	NOUN	NNS	_	2	nmod	_	_
7	,	_	.	,	_	2	punct	_	_
8	the	_	DET	DT	_	10	det	_	_
9	EC50	_	NOUN	NN	_	10	compound	_	_
10	values	_	NOUN	NNS	_	2	appos	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_
13	against	_	ADP	IN	_	16	case	_	_
14	full	_	ADJ	JJ	_	16	amod	_	_
15	length	_	NOUN	NN	_	16	compound	_	_
16	replicons	_	NOUN	NNS	_	10	nmod	_	_
17	from	_	ADP	IN	_	18	case	_	_
18	genotypes	_	NOUN	NNS	_	16	nmod	_	_
19	1a	_	NOUN	NN	_	18	dep	_	_
20	and	_	CONJ	CC	_	19	cc	_	_
21	1b	_	NOUN	NN	_	19	conj	_	_
22	were	_	VERB	VBD	_	24	cop	_	_
23	0.031	_	NUM	CD	_	24	nummod	_	_
24	nM	_	NOUN	NN	_	0	root	_	_
25	and	_	CONJ	CC	_	24	cc	_	_
26	0.004	_	NUM	CD	_	27	nummod	_	_
27	nM	_	NOUN	NN	_	24	conj	_	_
28	,	_	.	,	_	24	punct	_	_
29	respectively	_	ADV	RB	_	24	neg	_	_

#	Harvoni	4475
1	The	_	DET	DT	_	4	det	_	_
2	median	_	ADJ	JJ	_	4	amod	_	_
3	EC50	_	NOUN	NN	_	4	compound	_	_
4	values	_	NOUN	NNS	_	25	nsubj	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	against	_	ADP	IN	_	9	case	_	_
8	chimeric	_	ADJ	JJ	_	9	amod	_	_
9	replicons	_	NOUN	NNS	_	4	nmod	_	_
10	encoding	_	VERB	VBG	_	9	acl	_	_
11	NS5A	_	NOUN	NN	_	12	compound	_	_
12	sequences	_	NOUN	NNS	_	10	dobj	_	_
13	from	_	ADP	IN	_	15	case	_	_
14	clinical	_	ADJ	JJ	_	15	amod	_	_
15	isolates	_	NOUN	NNS	_	12	nmod	_	_
16	from	_	ADP	IN	_	21	case	_	_
17	treatment	_	NOUN	NN	_	21	compound	_	_
18	naA*ve	_	ADJ	JJ	_	21	amod	_	_
19	HCV	_	NOUN	NN	_	21	compound	_	_
20	infected	_	ADJ	JJ	_	21	amod	_	_
21	subjects	_	NOUN	NNS	_	15	nmod	_	_
22	were	_	VERB	VBD	_	25	cop	_	_
23	0	_	NUM	CD	_	25	nummod	_	_
24	02	_	NUM	CD	_	25	nummod	_	_
25	nM	_	NOUN	NN	_	0	root	_	_
26	for	_	ADP	IN	_	33	case	_	_
27	genotype	_	NOUN	NN	_	33	compound	_	_
28	1a	_	NOUN	NN	_	33	compound	_	_
29	range	_	NOUN	NN	_	33	compound	_	_
30	0.007	_	NUM	CD	_	33	nummod	_	_
31	1.0	_	NUM	CD	_	33	nummod	_	_
32	nM	_	NOUN	NN	_	33	compound	_	_
33	N=23	_	NOUN	NN	_	25	nmod	_	_
34	and	_	CONJ	CC	_	33	cc	_	_
35	0.006	_	NUM	CD	_	36	nummod	_	_
36	nM	_	NOUN	NN	_	33	conj	_	_
37	for	_	ADP	IN	_	44	case	_	_
38	genotype	_	NOUN	NN	_	44	compound	_	_
39	1b	_	NOUN	NN	_	44	compound	_	_
40	range	_	NOUN	NN	_	44	compound	_	_
41	0.002	_	NUM	CD	_	44	nummod	_	_
42	1.0	_	NUM	CD	_	44	nummod	_	_
43	nM	_	NOUN	NN	_	44	compound	_	_
44	N=34	_	NOUN	NN	_	33	nmod	_	_

#	Harvoni	4476
1	02	_	NUM	CD	_	2	nummod	_	_
2	nM	_	NOUN	NN	_	0	root	_	_
3	for	_	ADP	IN	_	10	case	_	_
4	genotype	_	NOUN	NN	_	10	compound	_	_
5	1a	_	NOUN	NN	_	10	compound	_	_
6	range	_	NOUN	NN	_	10	compound	_	_
7	0.007	_	NUM	CD	_	10	nummod	_	_
8	1.0	_	NUM	CD	_	10	nummod	_	_
9	nM	_	NOUN	NN	_	10	compound	_	_
10	N=23	_	NOUN	NN	_	2	nmod	_	_
11	and	_	CONJ	CC	_	2	cc	_	_
12	0.006	_	NUM	CD	_	13	nummod	_	_
13	nM	_	NOUN	NN	_	2	conj	_	_
14	for	_	ADP	IN	_	21	case	_	_
15	genotype	_	NOUN	NN	_	21	compound	_	_
16	1b	_	NOUN	NN	_	21	compound	_	_
17	range	_	NOUN	NN	_	21	compound	_	_
18	0.002	_	NUM	CD	_	21	nummod	_	_
19	1.0	_	NUM	CD	_	21	nummod	_	_
20	nM	_	NOUN	NN	_	21	compound	_	_
21	N=34	_	NOUN	NN	_	2	nmod	_	_

#	Harvoni	4477
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	had	_	VERB	VBD	_	0	root	_	_
3	median	_	ADJ	JJ	_	5	amod	_	_
4	EC50	_	NOUN	NN	_	5	compound	_	_
5	values	_	NOUN	NNS	_	2	dobj	_	_
6	ranging	_	VERB	VBG	_	5	acl	_	_
7	between	_	ADP	IN	_	9	case	_	_
8	0.002	_	NUM	CD	_	9	nummod	_	_
9	nM	_	NOUN	NN	_	6	nmod	_	_
10	to	_	PRT	TO	_	12	case	_	_
11	0.16	_	NUM	CD	_	12	nummod	_	_
12	nM	_	NOUN	NN	_	6	nmod	_	_
13	against	_	ADP	IN	_	17	case	_	_
14	11	_	NUM	CD	_	17	nummod	_	_
15	genotype	_	NOUN	NN	_	17	compound	_	_
16	4	_	NUM	CD	_	17	nummod	_	_
17	subtypes	_	NOUN	NNS	_	6	nmod	_	_
18	4a	_	NOUN	NN	_	17	dep	_	_
19	,	_	.	,	_	17	punct	_	_
20	4d	_	NOUN	NN	_	17	conj	_	_
21	,	_	.	,	_	17	punct	_	_
22	4n	_	NOUN	NN	_	17	conj	_	_
23	,	_	.	,	_	17	punct	_	_
24	4r	_	NOUN	NN	_	17	conj	_	_
25	,	_	.	,	_	17	punct	_	_
26	4o	_	NOUN	NN	_	17	conj	_	_
27	,	_	.	,	_	17	punct	_	_
28	4c	_	NOUN	NN	_	17	conj	_	_
29	,	_	.	,	_	17	punct	_	_
30	4f	_	NOUN	NN	_	17	conj	_	_
31	,	_	.	,	_	17	punct	_	_
32	4k	_	NOUN	NN	_	17	conj	_	_
33	,	_	.	,	_	17	punct	_	_
34	4l	_	NOUN	NN	_	17	conj	_	_
35	,	_	.	,	_	17	punct	_	_
36	4m	_	NOUN	NN	_	17	appos	_	_
37	and	_	CONJ	CC	_	36	cc	_	_
38	4t	_	ADJ	JJ	_	36	conj	_	_

#	Harvoni	4478
1	The	_	DET	DT	_	4	det	_	_
2	median	_	ADJ	JJ	_	4	amod	_	_
3	EC50	_	NOUN	NN	_	4	compound	_	_
4	value	_	NOUN	NN	_	15	nsubj	_	_
5	for	_	ADP	IN	_	7	case	_	_
6	subtype	_	NOUN	NN	_	7	compound	_	_
7	4b	_	NOUN	NN	_	4	nmod	_	_
8	was	_	VERB	VBD	_	15	cop	_	_
9	199.6	_	NUM	CD	_	15	nummod	_	_
10	nM	_	NOUN	NN	_	15	compound	_	_
11	range	_	NOUN	NN	_	15	compound	_	_
12	0.66	_	NUM	CD	_	15	nummod	_	_
13	1799	_	NUM	CD	_	15	nummod	_	_
14	nM	_	NOUN	NN	_	15	compound	_	_
15	N=3	_	NOUN	NN	_	0	root	_	_
16	the	_	DET	DT	_	19	det	_	_
17	two	_	NUM	CD	_	19	nummod	_	_
18	4b	_	NOUN	NN	_	19	compound	_	_
19	isolates	_	NOUN	NNS	_	15	dobj	_	_
20	with	_	ADP	IN	_	22	case	_	_
21	EC50	_	NOUN	NN	_	22	compound	_	_
22	values	_	NOUN	NNS	_	19	nmod	_	_
23	greater	_	ADJ	JJ	_	25	advmod	_	_
24	than	_	ADP	IN	_	23	mwe	_	_
25	100	_	NUM	CD	_	26	nummod	_	_
26	nM	_	NOUN	NN	_	22	nmod	_	_
27	had	_	VERB	VBD	_	15	dep	_	_
28	NS5A	_	NOUN	NN	_	29	compound	_	_
29	resistance	_	NOUN	NN	_	30	nsubj	_	_
30	associated	_	VERB	VBN	_	31	amod	_	_
31	polymorphisms	_	NOUN	NNS	_	27	nmod	_	_
32	L30S+M31M+P58S+Y93H	_	NOUN	NN	_	31	dep	_	_

#	Harvoni	4479
1	The	_	DET	DT	_	4	det	_	_
2	median	_	ADJ	JJ	_	4	amod	_	_
3	EC50	_	NOUN	NN	_	4	compound	_	_
4	value	_	NOUN	NN	_	9	nsubj	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	was	_	VERB	VBD	_	9	cop	_	_
8	0.03	_	NUM	CD	_	9	nummod	_	_
9	nM	_	NOUN	NN	_	0	root	_	_
10	against	_	ADP	IN	_	13	case	_	_
11	genotype	_	NOUN	NN	_	13	compound	_	_
12	5a	_	NOUN	NN	_	13	compound	_	_
13	isolates	_	NOUN	NNS	_	9	nmod	_	_
14	range	_	NOUN	NN	_	13	dep	_	_
15	0.008	_	NUM	CD	_	18	nummod	_	_
16	0.081	_	NUM	CD	_	18	nummod	_	_
17	nM	_	NOUN	NN	_	18	compound	_	_
18	N=35	_	NOUN	NN	_	14	dobj	_	_

#	Harvoni	4480
1	For	_	ADP	IN	_	2	case	_	_
2	genotype	_	NOUN	NN	_	10	nmod	_	_
3	6	_	NUM	CD	_	2	nummod	_	_
4	,	_	.	,	_	10	punct	_	_
5	the	_	DET	DT	_	7	det	_	_
6	EC50	_	NOUN	NN	_	7	compound	_	_
7	values	_	NOUN	NNS	_	10	nsubj	_	_
8	for	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	varied	_	VERB	VBN	_	0	root	_	_
11	by	_	ADP	IN	_	12	case	_	_
12	subtype	_	NOUN	NN	_	10	nmod	_	_

#	Harvoni	4481
1	Subtypes	_	NOUN	NNS	_	5	nsubj	_	_
2	6a	_	NOUN	NN	_	1	dep	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	6h	_	NOUN	NN	_	2	conj	_	_
5	had	_	VERB	VBD	_	0	root	_	_
6	median	_	ADJ	JJ	_	8	amod	_	_
7	EC50	_	NOUN	NN	_	8	compound	_	_
8	values	_	NOUN	NNS	_	5	dobj	_	_
9	of	_	ADP	IN	_	13	case	_	_
10	0.55	_	NUM	CD	_	13	nummod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	0.17	_	NUM	CD	_	10	conj	_	_
13	nM	_	NOUN	NN	_	8	nmod	_	_
14	,	_	.	,	_	5	punct	_	_
15	respectively	_	ADV	RB	_	5	advmod	_	_

#	Harvoni	4482
1	For	_	ADP	IN	_	2	case	_	_
2	subtypes	_	NOUN	NNS	_	0	root	_	_
3	6e	_	NOUN	NN	_	2	dep	_	_
4	,	_	.	,	_	3	punct	_	_
5	6l	_	NOUN	NN	_	3	conj	_	_
6	,	_	.	,	_	3	punct	_	_
7	6n	_	NOUN	NN	_	3	conj	_	_
8	,	_	.	,	_	3	punct	_	_
9	6q	_	NOUN	NN	_	3	conj	_	_
10	,	_	.	,	_	3	punct	_	_
11	6k	_	NOUN	NN	_	3	conj	_	_
12	and	_	CONJ	CC	_	3	cc	_	_
13	6m	_	NOUN	NN	_	3	conj	_	_
14	,	_	.	,	_	2	punct	_	_
15	the	_	DET	DT	_	18	det	_	_
16	median	_	ADJ	JJ	_	18	amod	_	_
17	EC50	_	NOUN	NN	_	18	compound	_	_
18	values	_	NOUN	NNS	_	14	root	_	_
19	ranged	_	VERB	VBN	_	18	acl	_	_
20	from	_	ADP	IN	_	22	case	_	_
21	60.6	_	NUM	CD	_	22	nummod	_	_
22	nM	_	NOUN	NN	_	19	nmod	_	_
23	to	_	PRT	TO	_	25	case	_	_
24	430.1	_	NUM	CD	_	25	nummod	_	_
25	nM	_	NOUN	NN	_	22	nmod	_	_

#	Harvoni	4483
1	In	_	ADP	IN	_	4	case	_	_
2	HCV	_	NOUN	NN	_	4	compound	_	_
3	replicon	_	NOUN	NN	_	4	compound	_	_
4	assays	_	NOUN	NNS	_	0	root	_	_
5	,	_	.	,	_	4	punct	_	_
6	the	_	DET	DT	_	8	det	_	_
7	EC50	_	NOUN	NN	_	8	compound	_	_
8	values	_	NOUN	NNS	_	5	root	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	against	_	ADP	IN	_	14	case	_	_
12	full	_	ADJ	JJ	_	14	amod	_	_
13	length	_	NOUN	NN	_	14	compound	_	_
14	replicons	_	NOUN	NNS	_	8	nmod	_	_
15	from	_	ADP	IN	_	16	case	_	_
16	genotypes	_	NOUN	NNS	_	14	nmod	_	_
17	1a	_	NOUN	NN	_	16	dep	_	_
18	,	_	.	,	_	17	punct	_	_
19	1b	_	NOUN	NN	_	17	conj	_	_
20	,	_	.	,	_	17	punct	_	_
21	2a	_	NOUN	NN	_	17	conj	_	_
22	,	_	.	,	_	17	punct	_	_
23	3a	_	NOUN	NN	_	17	conj	_	_
24	,	_	.	,	_	17	punct	_	_
25	and	_	CONJ	CC	_	17	cc	_	_
26	4a	_	NOUN	NN	_	17	conj	_	_
27	,	_	.	,	_	16	punct	_	_
28	and	_	CONJ	CC	_	16	cc	_	_
29	chimeric	_	ADJ	JJ	_	31	amod	_	_
30	1b	_	ADJ	JJ	_	31	amod	_	_
31	replicons	_	NOUN	NNS	_	16	conj	_	_
32	encoding	_	VERB	VBG	_	31	acl	_	_
33	NS5B	_	NOUN	NN	_	32	dobj	_	_
34	from	_	ADP	IN	_	35	case	_	_
35	genotypes	_	NOUN	NNS	_	33	nmod	_	_
36	2b	_	NOUN	NN	_	35	dep	_	_
37	,	_	.	,	_	36	punct	_	_
38	5a	_	NOUN	NN	_	36	conj	_	_
39	,	_	.	,	_	36	punct	_	_
40	or	_	CONJ	CC	_	36	cc	_	_
41	6a	_	NOUN	NN	_	36	conj	_	_
42	ranged	_	VERB	VBN	_	35	acl	_	_
43	from	_	ADP	IN	_	46	case	_	_
44	14	_	NUM	CD	_	46	nummod	_	_
45	110	_	NUM	CD	_	46	nummod	_	_
46	nM	_	NOUN	NN	_	42	nmod	_	_

#	Harvoni	4484
1	The	_	DET	DT	_	4	det	_	_
2	median	_	ADJ	JJ	_	4	amod	_	_
3	EC50	_	NOUN	NN	_	4	compound	_	_
4	value	_	NOUN	NN	_	18	nsubj	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	against	_	ADP	IN	_	9	case	_	_
8	chimeric	_	ADJ	JJ	_	9	amod	_	_
9	replicons	_	NOUN	NNS	_	4	nmod	_	_
10	encoding	_	VERB	VBG	_	9	acl	_	_
11	NS5B	_	NOUN	NN	_	12	compound	_	_
12	sequences	_	NOUN	NNS	_	10	dobj	_	_
13	from	_	ADP	IN	_	15	case	_	_
14	clinical	_	ADJ	JJ	_	15	amod	_	_
15	isolates	_	NOUN	NNS	_	12	nmod	_	_
16	was	_	VERB	VBD	_	18	cop	_	_
17	62	_	NUM	CD	_	18	nummod	_	_
18	nM	_	NOUN	NN	_	0	root	_	_
19	for	_	ADP	IN	_	26	case	_	_
20	genotype	_	NOUN	NN	_	26	compound	_	_
21	1a	_	NOUN	NN	_	26	compound	_	_
22	range	_	NOUN	NN	_	26	compound	_	_
23	29	_	NUM	CD	_	26	nummod	_	_
24	128	_	NUM	CD	_	26	nummod	_	_
25	nM	_	NOUN	NN	_	26	amod	_	_
26	N=67	_	NOUN	NN	_	18	nmod	_	_
27	,	_	.	,	_	26	punct	_	_
28	102	_	NUM	CD	_	29	nummod	_	_
29	nM	_	NOUN	NN	_	26	appos	_	_
30	for	_	ADP	IN	_	37	case	_	_
31	genotype	_	NOUN	NN	_	37	compound	_	_
32	1b	_	NOUN	NN	_	37	compound	_	_
33	range	_	NOUN	NN	_	37	compound	_	_
34	45	_	NUM	CD	_	37	nummod	_	_
35	170	_	NUM	CD	_	37	nummod	_	_
36	nM	_	NOUN	NN	_	37	amod	_	_
37	N=29	_	NOUN	NN	_	29	nmod	_	_
38	,	_	.	,	_	26	punct	_	_
39	29	_	NUM	CD	_	40	nummod	_	_
40	nM	_	NOUN	NN	_	26	conj	_	_
41	for	_	ADP	IN	_	48	case	_	_
42	genotype	_	NOUN	NN	_	48	compound	_	_
43	2	_	NUM	CD	_	48	nummod	_	_
44	range	_	NOUN	NN	_	48	compound	_	_
45	14	_	NUM	CD	_	48	nummod	_	_
46	81	_	NUM	CD	_	48	nummod	_	_
47	nM	_	NOUN	NN	_	48	amod	_	_
48	N=15	_	NOUN	NN	_	40	nmod	_	_
49	,	_	.	,	_	26	punct	_	_
50	and	_	CONJ	CC	_	26	cc	_	_
51	81	_	NUM	CD	_	52	nummod	_	_
52	nM	_	NOUN	NN	_	26	conj	_	_
53	for	_	ADP	IN	_	60	case	_	_
54	genotype	_	NOUN	NN	_	60	compound	_	_
55	3a	_	NOUN	NN	_	60	compound	_	_
56	range	_	NOUN	NN	_	60	compound	_	_
57	24	_	NUM	CD	_	60	nummod	_	_
58	181	_	NUM	CD	_	60	nummod	_	_
59	nM	_	NOUN	NN	_	60	compound	_	_
60	N=106	_	NOUN	NN	_	52	nmod	_	_

#	Harvoni	4485
1	In	_	ADP	IN	_	5	case	_	_
2	replication	_	NOUN	NN	_	5	compound	_	_
3	competent	_	ADJ	JJ	_	5	amod	_	_
4	virus	_	NOUN	NN	_	5	compound	_	_
5	assays	_	NOUN	NNS	_	17	nmod	_	_
6	,	_	.	,	_	17	punct	_	_
7	the	_	DET	DT	_	9	det	_	_
8	EC50	_	NOUN	NN	_	9	compound	_	_
9	value	_	NOUN	NN	_	17	nsubj	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_
12	against	_	ADP	IN	_	14	case	_	_
13	genotype	_	NOUN	NN	_	14	compound	_	_
14	1a	_	NOUN	NN	_	9	nmod	_	_
15	was	_	VERB	VBD	_	17	cop	_	_
16	30	_	NUM	CD	_	17	nummod	_	_
17	nM	_	NOUN	NN	_	0	root	_	_

#	Harvoni	4486
1	Evaluation	_	NOUN	NN	_	8	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	in	_	ADP	IN	_	5	case	_	_
5	combination	_	NOUN	NN	_	1	nmod	_	_
6	with	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	showed	_	VERB	VBD	_	0	root	_	_
9	no	_	DET	DT	_	11	neg	_	_
10	antagonistic	_	ADJ	JJ	_	11	amod	_	_
11	effect	_	NOUN	NN	_	8	dobj	_	_
12	in	_	ADP	IN	_	13	mark	_	_
13	reducing	_	VERB	VBG	_	8	advcl	_	_
14	HCV	_	NOUN	NN	_	16	compound	_	_
15	RNA	_	NOUN	NN	_	16	compound	_	_
16	levels	_	NOUN	NNS	_	13	dobj	_	_
17	in	_	ADP	IN	_	19	case	_	_
18	replicon	_	NOUN	NN	_	19	compound	_	_
19	cells	_	NOUN	NNS	_	16	nmod	_	_

#	Harvoni	4487
1	Resistance	_	NOUN	NN	_	14	nsubjpass	_	_
2	In	_	ADP	IN	_	6	case	_	_
3	Cell	_	NOUN	NN	_	6	compound	_	_
4	Culture	_	NOUN	NN	_	6	compound	_	_
5	HCV	_	NOUN	NN	_	6	compound	_	_
6	replicons	_	NOUN	NNS	_	1	nmod	_	_
7	with	_	ADP	IN	_	9	case	_	_
8	reduced	_	VERB	VBN	_	9	amod	_	_
9	susceptibility	_	NOUN	NN	_	1	nmod	_	_
10	to	_	PRT	TO	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_
12	have	_	VERB	VBP	_	14	aux	_	_
13	been	_	VERB	VBN	_	14	auxpass	_	_
14	selected	_	VERB	VBN	_	0	root	_	_
15	in	_	ADP	IN	_	17	case	_	_
16	cell	_	NOUN	NN	_	17	compound	_	_
17	culture	_	NOUN	NN	_	14	nmod	_	_
18	for	_	ADP	IN	_	19	case	_	_
19	genotypes	_	NOUN	NNS	_	17	nmod	_	_
20	1a	_	NOUN	NN	_	19	dep	_	_
21	and	_	CONJ	CC	_	20	cc	_	_
22	1b	_	NOUN	NN	_	20	conj	_	_

#	Harvoni	4488
1	Reduced	_	VERB	VBN	_	2	amod	_	_
2	susceptibility	_	NOUN	NN	_	6	nsubjpass	_	_
3	to	_	PRT	TO	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	was	_	VERB	VBD	_	6	auxpass	_	_
6	associated	_	VERB	VBN	_	0	root	_	_
7	with	_	ADP	IN	_	14	case	_	_
8	the	_	DET	DT	_	14	det	_	_
9	primary	_	ADJ	JJ	_	14	amod	_	_
10	NS5A	_	NOUN	NN	_	14	compound	_	_
11	amino	_	NOUN	NN	_	14	compound	_	_
12	acid	_	NOUN	NN	_	14	compound	_	_
13	substitution	_	NOUN	NN	_	14	compound	_	_
14	Y93H	_	NOUN	NN	_	6	nmod	_	_
15	in	_	ADP	IN	_	17	case	_	_
16	both	_	CONJ	CC	_	17	cc:preconj	_	_
17	genotypes	_	NOUN	NNS	_	6	nmod	_	_
18	1a	_	NOUN	NN	_	17	dep	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	1b	_	NOUN	NN	_	18	conj	_	_

#	Harvoni	4489
1	Additionally	_	ADV	RB	_	0	root	_	_
2	,	_	.	,	_	1	punct	_	_
3	a	_	DET	DT	_	5	det	_	_
4	Q30E	_	NOUN	NN	_	5	compound	_	_
5	substitution	_	NOUN	NN	_	2	root	_	_
6	emerged	_	VERB	VBN	_	5	acl	_	_
7	in	_	ADP	IN	_	10	case	_	_
8	genotype	_	NOUN	NN	_	10	compound	_	_
9	1a	_	NOUN	NN	_	10	compound	_	_
10	replicons	_	NOUN	NNS	_	6	nmod	_	_

#	Harvoni	4490
1	Site	_	NOUN	NN	_	2	nsubj	_	_
2	directed	_	VERB	VBD	_	0	root	_	_
3	mutagenesis	_	NOUN	NN	_	2	dobj	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	the	_	DET	DT	_	6	det	_	_
6	Y93H	_	NOUN	NN	_	3	nmod	_	_
7	in	_	ADP	IN	_	9	case	_	_
8	both	_	CONJ	CC	_	9	det	_	_
9	genotypes	_	NOUN	NNS	_	3	nmod	_	_
10	1a	_	NOUN	NN	_	9	dep	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	1b	_	NOUN	NN	_	10	conj	_	_
13	,	_	.	,	_	9	punct	_	_
14	as	_	ADV	RB	_	9	cc	_	_
15	well	_	ADV	RB	_	14	mwe	_	_
16	as	_	ADP	IN	_	14	mwe	_	_
17	the	_	DET	DT	_	19	det	_	_
18	Q30E	_	NOUN	NN	_	19	compound	_	_
19	substitution	_	NOUN	NN	_	9	conj	_	_
20	in	_	ADP	IN	_	22	case	_	_
21	genotype	_	NOUN	NN	_	22	compound	_	_
22	1a	_	NOUN	NN	_	19	nmod	_	_
23	,	_	.	,	_	2	punct	_	_
24	conferred	_	VERB	VBN	_	2	parataxis	_	_
25	high	_	ADJ	JJ	_	26	amod	_	_
26	levels	_	NOUN	NNS	_	24	dobj	_	_
27	of	_	ADP	IN	_	29	case	_	_
28	reduced	_	VERB	VBN	_	29	amod	_	_
29	susceptibility	_	NOUN	NN	_	26	nmod	_	_
30	to	_	PRT	TO	_	33	case	_	_
31	DRUG	_	NOUN	NN	_	33	compound	_	_
32	fold	_	NOUN	NN	_	33	compound	_	_
33	change	_	NOUN	NN	_	26	nmod	_	_
34	in	_	ADP	IN	_	35	case	_	_
35	EC50	_	NOUN	NN	_	33	nmod	_	_
36	greater	_	ADJ	JJ	_	38	advmod	_	_
37	than	_	ADP	IN	_	36	mwe	_	_
38	1000	_	NUM	CD	_	33	nmod	_	_
39	fold	_	ADV	RB	_	38	dep	_	_

#	Harvoni	4491
1	HCV	_	NOUN	NN	_	2	compound	_	_
2	replicons	_	NOUN	NNS	_	10	nsubjpass	_	_
3	with	_	ADP	IN	_	5	case	_	_
4	reduced	_	VERB	VBN	_	5	amod	_	_
5	susceptibility	_	NOUN	NN	_	2	nmod	_	_
6	to	_	PRT	TO	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	have	_	VERB	VBP	_	10	aux	_	_
9	been	_	VERB	VBN	_	10	auxpass	_	_
10	selected	_	VERB	VBN	_	0	root	_	_
11	in	_	ADP	IN	_	13	case	_	_
12	cell	_	NOUN	NN	_	13	compound	_	_
13	culture	_	NOUN	NN	_	10	nmod	_	_
14	for	_	ADP	IN	_	16	case	_	_
15	multiple	_	ADJ	JJ	_	16	amod	_	_
16	genotypes	_	NOUN	NNS	_	13	nmod	_	_
17	including	_	ADP	IN	_	18	case	_	_
18	1b	_	NOUN	NN	_	16	nmod	_	_
19	,	_	.	,	_	18	punct	_	_
20	4a	_	NOUN	NN	_	18	conj	_	_
21	,	_	.	,	_	18	punct	_	_
22	5a	_	NOUN	NN	_	18	conj	_	_
23	,	_	.	,	_	18	punct	_	_
24	and	_	CONJ	CC	_	18	cc	_	_
25	6a	_	NOUN	NN	_	18	conj	_	_

#	Harvoni	4492
1	Reduced	_	VERB	VBN	_	2	amod	_	_
2	susceptibility	_	NOUN	NN	_	6	nsubjpass	_	_
3	to	_	PRT	TO	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	was	_	VERB	VBD	_	6	auxpass	_	_
6	associated	_	VERB	VBN	_	0	root	_	_
7	with	_	ADP	IN	_	11	case	_	_
8	the	_	DET	DT	_	11	det	_	_
9	NS5B	_	NOUN	NN	_	11	compound	_	_
10	substitution	_	NOUN	NN	_	11	compound	_	_
11	S282T	_	NOUN	NN	_	6	nmod	_	_
12	in	_	ADP	IN	_	15	case	_	_
13	all	_	DET	DT	_	15	det	_	_
14	replicon	_	NOUN	NN	_	15	compound	_	_
15	genotypes	_	NOUN	NNS	_	6	nmod	_	_
16	examined	_	VERB	VBN	_	15	acl	_	_

#	Harvoni	4493
1	An	_	DET	DT	_	3	det	_	_
2	M289L	_	NOUN	NN	_	3	compound	_	_
3	substitution	_	NOUN	NN	_	4	nsubj	_	_
4	developed	_	VERB	VBD	_	0	root	_	_
5	along	_	ADP	IN	_	9	case	_	_
6	with	_	ADP	IN	_	9	case	_	_
7	the	_	DET	DT	_	9	det	_	_
8	S282T	_	NOUN	NN	_	9	compound	_	_
9	substitution	_	NOUN	NN	_	4	nmod	_	_
10	in	_	ADP	IN	_	11	case	_	_
11	genotype	_	NOUN	NN	_	9	nmod	_	_
12	5	_	NUM	CD	_	11	nummod	_	_
13	and	_	CONJ	CC	_	11	cc	_	_
14	6	_	NUM	CD	_	15	nummod	_	_
15	replicons	_	NOUN	NNS	_	11	conj	_	_

#	Harvoni	4494
1	Site	_	NOUN	NN	_	2	nsubj	_	_
2	directed	_	VERB	VBD	_	0	root	_	_
3	mutagenesis	_	NOUN	NN	_	2	dobj	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	the	_	DET	DT	_	7	det	_	_
6	S282T	_	NOUN	NN	_	7	compound	_	_
7	substitution	_	NOUN	NN	_	3	nmod	_	_
8	in	_	ADP	IN	_	9	case	_	_
9	replicons	_	NOUN	NNS	_	3	nmod	_	_
10	of	_	ADP	IN	_	12	case	_	_
11	8	_	NUM	CD	_	12	nummod	_	_
12	genotypes	_	NOUN	NNS	_	9	nmod	_	_
13	conferred	_	VERB	VBD	_	2	xcomp	_	_
14	2	_	NUM	CD	_	16	compound	_	_
15	to	_	PRT	TO	_	16	dep	_	_
16	18	_	NUM	CD	_	19	nummod	_	_
17	fold	_	NOUN	NN	_	19	amod	_	_
18	reduced	_	VERB	VBN	_	19	amod	_	_
19	susceptibility	_	NOUN	NN	_	13	dobj	_	_
20	to	_	PRT	TO	_	21	case	_	_
21	DRUG	_	NOUN	NN	_	19	nmod	_	_

#	Harvoni	4495
1	In	_	ADP	IN	_	3	case	_	_
2	Clinical	_	ADJ	JJ	_	3	amod	_	_
3	Trials	_	NOUN	NNS	_	0	root	_	_
4	In	_	ADP	IN	_	7	case	_	_
5	a	_	DET	DT	_	7	det	_	_
6	pooled	_	VERB	VBN	_	7	amod	_	_
7	analysis	_	NOUN	NN	_	3	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	subjects	_	NOUN	NNS	_	7	nmod	_	_
10	who	_	DET	WDT	_	11	nsubj	_	_
11	received	_	VERB	VBD	_	9	acl:relcl	_	_
12	DRUG	_	NOUN	NN	_	11	dobj	_	_
13	in	_	ADP	IN	_	16	case	_	_
14	Phase	_	NOUN	NN	_	16	compound	_	_
15	3	_	NUM	CD	_	16	nummod	_	_
16	trials	_	NOUN	NNS	_	11	nmod	_	_
17	,	_	.	,	_	3	punct	_	_
18	37	_	NUM	CD	_	19	nummod	_	_
19	subjects	_	NOUN	NNS	_	17	root	_	_
20	29	_	NUM	CD	_	19	nummod	_	_
21	with	_	ADP	IN	_	23	case	_	_
22	genotype	_	NOUN	NN	_	23	compound	_	_
23	1a	_	NOUN	NN	_	19	nmod	_	_
24	and	_	CONJ	CC	_	23	cc	_	_
25	8	_	NUM	CD	_	23	conj	_	_
26	with	_	ADP	IN	_	28	case	_	_
27	genotype	_	NOUN	NN	_	28	compound	_	_
28	1b	_	NOUN	NN	_	19	nmod	_	_
29	qualified	_	VERB	VBN	_	28	acl	_	_
30	for	_	ADP	IN	_	32	case	_	_
31	resistance	_	NOUN	NN	_	32	compound	_	_
32	analysis	_	NOUN	NN	_	29	nmod	_	_
33	due	_	ADJ	JJ	_	36	case	_	_
34	to	_	PRT	TO	_	36	case	_	_
35	virologic	_	ADJ	JJ	_	36	amod	_	_
36	failure	_	NOUN	NN	_	29	nmod	_	_
37	35	_	NUM	CD	_	36	nummod	_	_
38	with	_	ADP	IN	_	40	case	_	_
39	virologic	_	ADJ	JJ	_	40	amod	_	_
40	relapse	_	NOUN	NN	_	29	nmod	_	_
41	,	_	.	,	_	40	punct	_	_
42	2	_	NUM	CD	_	44	nummod	_	_
43	with	_	ADP	IN	_	44	case	_	_
44	breakthrough	_	NOUN	NN	_	40	nmod	_	_
45	on	_	ADP	IN	_	46	case	_	_
46	treatment	_	NOUN	NN	_	44	nmod	_	_
47	due	_	ADJ	JJ	_	51	case	_	_
48	to	_	PRT	TO	_	47	mwe	_	_
49	documented	_	VERB	VBN	_	51	amod	_	_
50	non	_	ADJ	JJ	_	51	amod	_	_
51	adherence	_	NOUN	NN	_	46	nmod	_	_

#	Harvoni	4496
1	Post	_	ADJ	JJ	_	3	amod	_	_
2	baseline	_	NOUN	NN	_	3	compound	_	_
3	NS5A	_	NOUN	NN	_	12	compound	_	_
4	and	_	CONJ	CC	_	3	cc	_	_
5	NS5B	_	NOUN	NN	_	10	compound	_	_
6	deep	_	NOUN	NN	_	10	compound	_	_
7	nucleotide	_	NOUN	NN	_	10	compound	_	_
8	sequence	_	NOUN	NN	_	10	compound	_	_
9	analysis	_	NOUN	NN	_	10	compound	_	_
10	data	_	NOUN	NNS	_	3	conj	_	_
11	assay	_	NOUN	NN	_	12	compound	_	_
12	sensitivity	_	NOUN	NN	_	16	nsubj	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	1%	_	NOUN	NN	_	12	nmod	_	_
15	were	_	VERB	VBD	_	16	cop	_	_
16	available	_	ADJ	JJ	_	0	root	_	_
17	for	_	ADP	IN	_	26	case	_	_
18	37	_	NUM	CD	_	26	nummod	_	_
19	/	_	.	-RRB-	_	26	punct	_	_
20	37	_	NUM	CD	_	26	nummod	_	_
21	and	_	CONJ	CC	_	20	cc	_	_
22	36	_	NUM	CD	_	20	conj	_	_
23	/	_	.	-RRB-	_	26	punct	_	_
24	37	_	NUM	CD	_	26	nummod	_	_
25	subjects'	_	ADJ	JJ	_	26	amod	_	_
26	viruses	_	NOUN	NNS	_	16	nmod	_	_
27	,	_	.	,	_	16	punct	_	_
28	respectively	_	ADV	RB	_	16	advmod	_	_

#	Harvoni	4497
1	Of	_	ADP	IN	_	8	case	_	_
2	the	_	DET	DT	_	8	det	_	_
3	29	_	NUM	CD	_	8	nummod	_	_
4	genotype	_	NOUN	NN	_	8	compound	_	_
5	1a	_	NOUN	NN	_	8	amod	_	_
6	virologic	_	ADJ	JJ	_	8	amod	_	_
7	failure	_	NOUN	NN	_	8	compound	_	_
8	subjects	_	NOUN	NNS	_	16	nmod	_	_
9	,	_	.	,	_	16	punct	_	_
10	55%	_	NOUN	NN	_	16	nsubj	_	_
11	16	_	NUM	CD	_	10	nummod	_	_
12	/	_	.	:	_	10	punct	_	_
13	29	_	NUM	CD	_	10	dep	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	subjects	_	NOUN	NNS	_	13	nmod	_	_
16	had	_	VERB	VBD	_	0	root	_	_
17	virus	_	NOUN	NN	_	16	dobj	_	_
18	with	_	ADP	IN	_	21	case	_	_
19	emergent	_	ADJ	JJ	_	21	amod	_	_
20	NS5A	_	NOUN	NN	_	21	compound	_	_
21	resistance	_	NOUN	NN	_	16	nmod	_	_
22	associated	_	VERB	VBN	_	21	acl	_	_
23	substitutions	_	NOUN	NNS	_	22	dobj	_	_
24	K24R	_	NOUN	NN	_	23	dep	_	_
25	,	_	.	,	_	24	punct	_	_
26	M28T	_	NOUN	NN	_	24	conj	_	_
27	/	_	.	:	_	24	punct	_	_
28	V	_	NOUN	NN	_	24	conj	_	_
29	,	_	.	,	_	24	punct	_	_
30	Q30R	_	NOUN	NN	_	24	conj	_	_
31	/	_	.	:	_	24	punct	_	_
32	H	_	NOUN	NN	_	34	compound	_	_
33	/	_	.	:	_	34	punct	_	_
34	K	_	NOUN	NN	_	24	appos	_	_
35	/	_	.	:	_	34	punct	_	_
36	L	_	NOUN	NN	_	34	conj	_	_
37	,	_	.	,	_	34	punct	_	_
38	L31M	_	NOUN	NN	_	34	conj	_	_
39	,	_	.	,	_	34	punct	_	_
40	or	_	CONJ	CC	_	34	cc	_	_
41	Y93H	_	NOUN	NN	_	34	conj	_	_
42	/	_	.	:	_	24	punct	_	_
43	N	_	NOUN	NN	_	24	dep	_	_
44	at	_	ADP	IN	_	45	case	_	_
45	failure	_	NOUN	NN	_	23	nmod	_	_

#	Harvoni	4498
1	Five	_	NUM	CD	_	8	nsubj	_	_
2	of	_	ADP	IN	_	6	case	_	_
3	these	_	DET	DT	_	6	det	_	_
4	16	_	NUM	CD	_	6	nummod	_	_
5	subjects'	_	ADJ	JJ	_	6	amod	_	_
6	viruses	_	NOUN	NNS	_	1	nmod	_	_
7	also	_	ADV	RB	_	8	advmod	_	_
8	had	_	VERB	VBD	_	0	root	_	_
9	baseline	_	NOUN	NN	_	11	compound	_	_
10	NS5A	_	NOUN	NN	_	11	compound	_	_
11	polymorphisms	_	NOUN	NNS	_	8	dobj	_	_
12	at	_	ADP	IN	_	17	case	_	_
13	resistance	_	NOUN	NN	_	17	compound	_	_
14	associated	_	ADJ	JJ	_	17	amod	_	_
15	amino	_	NOUN	NN	_	17	compound	_	_
16	acid	_	NOUN	NN	_	17	compound	_	_
17	positions	_	NOUN	NNS	_	8	nmod	_	_

#	Harvoni	4499
1	The	_	DET	DT	_	4	det	_	_
2	most	_	ADV	RB	_	3	advmod	_	_
3	common	_	ADJ	JJ	_	4	amod	_	_
4	substitutions	_	NOUN	NNS	_	9	nsubj	_	_
5	detected	_	VERB	VBN	_	4	acl	_	_
6	at	_	ADP	IN	_	7	case	_	_
7	failure	_	NOUN	NN	_	5	nmod	_	_
8	were	_	VERB	VBD	_	9	cop	_	_
9	Q30R	_	NOUN	NN	_	0	root	_	_
10	,	_	.	,	_	9	punct	_	_
11	Y93H	_	NOUN	NN	_	9	conj	_	_
12	or	_	CONJ	CC	_	11	cc	_	_
13	N	_	NOUN	NN	_	11	conj	_	_
14	,	_	.	,	_	9	punct	_	_
15	and	_	CONJ	CC	_	9	cc	_	_
16	L31M	_	NOUN	NN	_	9	conj	_	_

#	Harvoni	4500
1	Of	_	ADP	IN	_	8	case	_	_
2	the	_	DET	DT	_	8	det	_	_
3	8	_	NUM	CD	_	8	nummod	_	_
4	genotype	_	NOUN	NN	_	8	compound	_	_
5	1b	_	NOUN	NN	_	8	amod	_	_
6	virologic	_	ADJ	JJ	_	8	amod	_	_
7	failure	_	NOUN	NN	_	8	compound	_	_
8	subjects	_	NOUN	NNS	_	14	nmod	_	_
9	,	_	.	,	_	14	punct	_	_
10	88%	_	ADJ	JJ	_	13	amod	_	_
11	7	_	NUM	CD	_	13	nummod	_	_
12	/	_	.	:	_	13	punct	_	_
13	8	_	NUM	CD	_	14	nsubj	_	_
14	had	_	VERB	VBD	_	0	root	_	_
15	virus	_	NOUN	NN	_	14	dobj	_	_
16	with	_	ADP	IN	_	21	case	_	_
17	emergent	_	ADJ	JJ	_	21	amod	_	_
18	NS5A	_	NOUN	NN	_	21	compound	_	_
19	resistance	_	NOUN	NN	_	21	compound	_	_
20	associated	_	VERB	VBN	_	21	amod	_	_
21	substitutions	_	NOUN	NNS	_	14	nmod	_	_
22	L31V	_	NOUN	NN	_	21	dep	_	_
23	/	_	.	:	_	22	punct	_	_
24	M	_	NOUN	NN	_	22	dep	_	_
25	/	_	.	-RRB-	_	24	punct	_	_
26	I	_	NOUN	NN	_	24	dep	_	_
27	or	_	CONJ	CC	_	26	cc	_	_
28	Y93H	_	NOUN	NN	_	26	conj	_	_
29	at	_	ADP	IN	_	30	case	_	_
30	failure	_	NOUN	NN	_	26	nmod	_	_

#	Harvoni	4501
1	Virus	_	NOUN	NN	_	9	nsubj	_	_
2	from	_	ADP	IN	_	3	case	_	_
3	three	_	NUM	CD	_	1	nmod	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	these	_	DET	DT	_	7	det	_	_
6	7	_	NUM	CD	_	7	nummod	_	_
7	subjects	_	NOUN	NNS	_	3	nmod	_	_
8	also	_	ADV	RB	_	9	advmod	_	_
9	had	_	VERB	VBD	_	0	root	_	_
10	baseline	_	NOUN	NN	_	12	compound	_	_
11	NS5A	_	NOUN	NN	_	12	compound	_	_
12	polymorphisms	_	NOUN	NNS	_	9	dobj	_	_
13	at	_	ADP	IN	_	16	case	_	_
14	resistance	_	NOUN	NN	_	16	compound	_	_
15	associated	_	ADJ	JJ	_	16	amod	_	_
16	positions	_	NOUN	NNS	_	9	nmod	_	_

#	Harvoni	4502
1	The	_	DET	DT	_	4	det	_	_
2	most	_	ADV	RB	_	3	advmod	_	_
3	common	_	ADJ	JJ	_	4	amod	_	_
4	substitution	_	NOUN	NN	_	9	nsubj	_	_
5	detected	_	VERB	VBN	_	4	acl	_	_
6	at	_	ADP	IN	_	7	case	_	_
7	failure	_	NOUN	NN	_	5	nmod	_	_
8	was	_	VERB	VBD	_	9	cop	_	_
9	Y93H	_	NOUN	NN	_	0	root	_	_

#	Harvoni	4503
1	At	_	ADP	IN	_	2	case	_	_
2	failure	_	NOUN	NN	_	13	nmod	_	_
3	,	_	.	,	_	13	punct	_	_
4	38%	_	NOUN	NN	_	13	nsubj	_	_
5	14	_	NUM	CD	_	4	nummod	_	_
6	/	_	.	-RRB-	_	4	punct	_	_
7	37	_	NUM	CD	_	4	dep	_	_
8	of	_	ADP	IN	_	12	case	_	_
9	virologic	_	ADJ	JJ	_	12	amod	_	_
10	failure	_	NOUN	NN	_	12	compound	_	_
11	subjects'	_	ADJ	JJ	_	12	amod	_	_
12	viruses	_	NOUN	NNS	_	7	nmod	_	_
13	had	_	VERB	VBD	_	0	root	_	_
14	2	_	NUM	CD	_	13	dobj	_	_
15	or	_	CONJ	CC	_	14	cc	_	_
16	more	_	ADV	RB	_	14	conj	_	_
17	NS5A	_	NOUN	NN	_	18	compound	_	_
18	substitutions	_	NOUN	NNS	_	14	dep	_	_
19	at	_	ADP	IN	_	22	case	_	_
20	resistance	_	NOUN	NN	_	22	compound	_	_
21	associated	_	ADJ	JJ	_	22	amod	_	_
22	positions	_	NOUN	NNS	_	13	nmod	_	_

#	Harvoni	4504
1	In	_	ADP	IN	_	3	case	_	_
2	the	_	DET	DT	_	3	det	_	_
3	SOLAR	_	NOUN	NN	_	8	nsubj	_	_
4	1	_	NUM	CD	_	3	nummod	_	_
5	and	_	CONJ	CC	_	3	cc	_	_
6	SOLAR	_	NOUN	NN	_	3	conj	_	_
7	2	_	NUM	CD	_	6	nummod	_	_
8	trials	_	NOUN	NNS	_	20	advcl	_	_
9	liver	_	NOUN	NN	_	11	compound	_	_
10	transplant	_	ADJ	JJ	_	11	amod	_	_
11	recipients	_	NOUN	NNS	_	8	dobj	_	_
12	or	_	CONJ	CC	_	11	cc	_	_
13	subjects	_	NOUN	NNS	_	11	conj	_	_
14	with	_	ADP	IN	_	17	case	_	_
15	decompensated	_	VERB	VBN	_	17	amod	_	_
16	liver	_	NOUN	NN	_	17	compound	_	_
17	disease	_	NOUN	NN	_	11	nmod	_	_
18	,	_	.	,	_	20	punct	_	_
19	there	_	PRON	PRP$	_	20	expl	_	_
20	were	_	VERB	VBD	_	0	root	_	_
21	24	_	NUM	CD	_	23	nummod	_	_
22	virologic	_	ADJ	JJ	_	23	amod	_	_
23	failures	_	NOUN	NNS	_	20	nsubj	_	_
24	with	_	ADP	IN	_	29	case	_	_
25	genotype	_	NOUN	NN	_	29	compound	_	_
26	1	_	NUM	CD	_	29	nummod	_	_
27	infection	_	NOUN	NN	_	29	compound	_	_
28	20	_	NUM	CD	_	29	nummod	_	_
29	relapsers	_	NOUN	NNS	_	23	nmod	_	_
30	and	_	CONJ	CC	_	29	cc	_	_
31	4	_	NUM	CD	_	32	nummod	_	_
32	subjects	_	NOUN	NNS	_	29	conj	_	_
33	who	_	DET	WDT	_	34	nsubj	_	_
34	discontinued	_	VERB	VBD	_	32	acl:relcl	_	_
35	treatment	_	NOUN	NN	_	34	dobj	_	_
36	prior	_	ADJ	JJ	_	35	amod	_	_
37	to	_	PRT	TO	_	38	mark	_	_
38	achieving	_	VERB	VBG	_	36	advcl	_	_
39	HCV	_	NOUN	NN	_	42	compound	_	_
40	RNA	_	NOUN	NN	_	42	compound	_	_
41	<	_	NUM	CD	_	42	nummod	_	_
42	LLOQ	_	NOUN	NN	_	38	dobj	_	_

#	Harvoni	4505
1	Treatment	_	NOUN	NN	_	4	compound	_	_
2	emergent	_	ADJ	JJ	_	4	amod	_	_
3	NS5A	_	NOUN	NN	_	4	compound	_	_
4	resistance	_	NOUN	NN	_	5	nsubj	_	_
5	associated	_	VERB	VBD	_	30	nsubjpass	_	_
6	substitutions	_	NOUN	NNS	_	5	dobj	_	_
7	K24R	_	NOUN	NN	_	28	compound	_	_
8	,	_	.	,	_	7	punct	_	_
9	M28T	_	NOUN	NN	_	7	conj	_	_
10	,	_	.	,	_	7	punct	_	_
11	Q30R	_	NOUN	NN	_	7	conj	_	_
12	/	_	.	:	_	7	punct	_	_
13	H	_	NOUN	NN	_	15	compound	_	_
14	/	_	.	:	_	15	punct	_	_
15	K	_	NOUN	NN	_	7	conj	_	_
16	,	_	.	,	_	7	punct	_	_
17	L31V	_	NOUN	NN	_	7	conj	_	_
18	,	_	.	,	_	7	punct	_	_
19	H58D	_	NOUN	NN	_	7	conj	_	_
20	/	_	.	:	_	7	punct	_	_
21	P	_	NOUN	NN	_	7	conj	_	_
22	,	_	.	,	_	7	punct	_	_
23	and	_	CONJ	CC	_	7	cc	_	_
24	/	_	NOUN	NN	_	7	conj	_	_
25	or	_	CONJ	CC	_	24	cc	_	_
26	Y93H	_	NOUN	NN	_	24	conj	_	_
27	/	_	.	:	_	28	punct	_	_
28	C	_	NOUN	NN	_	6	nmod	_	_
29	were	_	VERB	VBD	_	30	auxpass	_	_
30	detected	_	VERB	VBN	_	0	root	_	_
31	in	_	ADP	IN	_	40	case	_	_
32	14	_	NUM	CD	_	40	nummod	_	_
33	/	_	NUM	CD	_	40	punct	_	_
34	17	_	NUM	CD	_	40	nummod	_	_
35	82%	_	ADJ	JJ	_	40	amod	_	_
36	genotype	_	NOUN	NN	_	40	compound	_	_
37	1a	_	NOUN	NN	_	40	compound	_	_
38	virologic	_	ADJ	JJ	_	40	amod	_	_
39	failure	_	NOUN	NN	_	40	compound	_	_
40	subjects	_	NOUN	NNS	_	30	nmod	_	_
41	,	_	.	,	_	40	punct	_	_
42	and	_	CONJ	CC	_	40	cc	_	_
43	R30Q	_	NOUN	NN	_	52	compound	_	_
44	,	_	.	,	_	43	punct	_	_
45	L31M	_	NOUN	NN	_	43	conj	_	_
46	,	_	.	,	_	43	punct	_	_
47	and	_	CONJ	CC	_	43	cc	_	_
48	/	_	NOUN	NN	_	43	conj	_	_
49	or	_	CONJ	CC	_	43	cc	_	_
50	Y93H	_	NOUN	NN	_	43	conj	_	_
51	/	_	.	:	_	52	punct	_	_
52	N	_	NOUN	NN	_	40	conj	_	_
53	were	_	VERB	VBD	_	54	auxpass	_	_
54	detected	_	VERB	VBN	_	30	parataxis	_	_
55	in	_	ADP	IN	_	64	case	_	_
56	6	_	NUM	CD	_	64	nummod	_	_
57	/	_	NUM	CD	_	64	punct	_	_
58	7	_	NUM	CD	_	64	nummod	_	_
59	86%	_	ADJ	JJ	_	64	amod	_	_
60	genotype	_	NOUN	NN	_	64	compound	_	_
61	1b	_	NOUN	NN	_	64	compound	_	_
62	virologic	_	ADJ	JJ	_	64	amod	_	_
63	failure	_	NOUN	NN	_	64	compound	_	_
64	subjects	_	NOUN	NNS	_	54	nmod	_	_

#	Harvoni	4506
1	In	_	ADP	IN	_	3	case	_	_
2	phenotypic	_	ADJ	JJ	_	3	amod	_	_
3	analyses	_	NOUN	NNS	_	18	nmod	_	_
4	,	_	.	,	_	18	punct	_	_
5	post	_	ADJ	JJ	_	7	amod	_	_
6	baseline	_	NOUN	NN	_	7	compound	_	_
7	isolates	_	NOUN	NNS	_	18	nsubj	_	_
8	from	_	ADP	IN	_	9	case	_	_
9	subjects	_	NOUN	NNS	_	7	nmod	_	_
10	who	_	DET	WDT	_	11	nsubj	_	_
11	harbored	_	VERB	VBD	_	9	acl:relcl	_	_
12	NS5A	_	NOUN	NN	_	15	compound	_	_
13	resistance	_	NOUN	NN	_	15	compound	_	_
14	associated	_	ADJ	JJ	_	15	amod	_	_
15	substitutions	_	NOUN	NNS	_	11	dobj	_	_
16	at	_	ADP	IN	_	17	case	_	_
17	failure	_	NOUN	NN	_	11	nmod	_	_
18	showed	_	VERB	VBD	_	0	root	_	_
19	20	_	NUM	CD	_	21	compound	_	_
20	to	_	PRT	TO	_	21	dep	_	_
21	>243	_	NUM	CD	_	24	nummod	_	_
22	fold	_	NOUN	NN	_	24	amod	_	_
23	reduced	_	VERB	VBN	_	24	amod	_	_
24	susceptibility	_	NOUN	NN	_	18	dobj	_	_
25	to	_	PRT	TO	_	26	case	_	_
26	DRUG	_	NOUN	NN	_	24	nmod	_	_

#	Harvoni	4507
1	Treatment	_	NOUN	NN	_	4	compound	_	_
2	emergent	_	ADJ	JJ	_	4	amod	_	_
3	NS5B	_	NOUN	NN	_	4	compound	_	_
4	substitutions	_	NOUN	NNS	_	16	nsubjpass	_	_
5	L159	_	NOUN	NN	_	6	compound	_	_
6	n=1	_	NOUN	NN	_	4	dep	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	V321	_	NOUN	NN	_	9	compound	_	_
9	n=2	_	NOUN	NN	_	6	conj	_	_
10	previously	_	ADV	RB	_	11	advmod	_	_
11	associated	_	VERB	VBN	_	4	acl	_	_
12	with	_	ADP	IN	_	14	case	_	_
13	DRUG	_	NOUN	NN	_	14	compound	_	_
14	failure	_	NOUN	NN	_	11	nmod	_	_
15	were	_	VERB	VBD	_	16	auxpass	_	_
16	detected	_	VERB	VBN	_	0	root	_	_
17	in	_	ADP	IN	_	21	case	_	_
18	the	_	DET	DT	_	21	det	_	_
19	Phase	_	NOUN	NN	_	21	compound	_	_
20	3	_	NUM	CD	_	21	nummod	_	_
21	trials	_	NOUN	NNS	_	16	nmod	_	_
22	ION	_	NOUN	NN	_	21	dep	_	_
23	3	_	NUM	CD	_	22	nummod	_	_
24	,	_	.	,	_	22	punct	_	_
25	ION	_	NOUN	NN	_	22	conj	_	_
26	1	_	NUM	CD	_	25	nummod	_	_
27	,	_	.	,	_	22	punct	_	_
28	and	_	CONJ	CC	_	22	cc	_	_
29	ION	_	NOUN	NN	_	22	conj	_	_
30	2	_	NUM	CD	_	29	nummod	_	_

#	Harvoni	4508
1	In	_	ADP	IN	_	2	case	_	_
2	addition	_	NOUN	NN	_	23	nmod	_	_
3	,	_	.	,	_	23	punct	_	_
4	NS5B	_	NOUN	NN	_	5	compound	_	_
5	substitutions	_	NOUN	NNS	_	23	nsubjpass	_	_
6	at	_	ADP	IN	_	9	case	_	_
7	highly	_	ADV	RB	_	8	advmod	_	_
8	conserved	_	VERB	VBN	_	9	amod	_	_
9	positions	_	NOUN	NNS	_	5	nmod	_	_
10	D61G	_	NOUN	NN	_	11	compound	_	_
11	n=3	_	NOUN	NN	_	9	dep	_	_
12	,	_	.	,	_	11	punct	_	_
13	A112T	_	NOUN	NN	_	14	compound	_	_
14	n=2	_	NOUN	NN	_	11	conj	_	_
15	,	_	.	,	_	11	punct	_	_
16	E237G	_	NOUN	NN	_	17	compound	_	_
17	n=2	_	NOUN	NN	_	11	conj	_	_
18	,	_	.	,	_	11	punct	_	_
19	and	_	CONJ	CC	_	11	cc	_	_
20	S473T	_	NOUN	NN	_	21	compound	_	_
21	n=1	_	NOUN	NN	_	11	conj	_	_
22	were	_	VERB	VBD	_	23	auxpass	_	_
23	detected	_	VERB	VBN	_	0	root	_	_
24	at	_	ADP	IN	_	26	case	_	_
25	low	_	ADJ	JJ	_	26	amod	_	_
26	frequency	_	NOUN	NN	_	23	nmod	_	_
27	by	_	ADP	IN	_	30	case	_	_
28	next	_	ADV	RB	_	29	advmod	_	_
29	generation	_	NOUN	NN	_	30	compound	_	_
30	sequencing	_	NOUN	NN	_	23	nmod	_	_
31	in	_	ADP	IN	_	34	case	_	_
32	treatment	_	NOUN	NN	_	34	compound	_	_
33	failure	_	NOUN	NN	_	34	compound	_	_
34	subjects	_	NOUN	NNS	_	30	nmod	_	_
35	infected	_	VERB	VBN	_	34	acl	_	_
36	with	_	ADP	IN	_	38	case	_	_
37	HCV	_	NOUN	NN	_	38	compound	_	_
38	GT1a	_	NOUN	NN	_	35	nmod	_	_

#	Harvoni	4509
1	The	_	DET	DT	_	3	det	_	_
2	D61G	_	NOUN	NN	_	3	compound	_	_
3	substitution	_	NOUN	NN	_	6	nsubjpass	_	_
4	was	_	VERB	VBD	_	6	auxpass	_	_
5	previously	_	ADV	RB	_	6	advmod	_	_
6	described	_	VERB	VBN	_	0	root	_	_
7	in	_	ADP	IN	_	8	case	_	_
8	subjects	_	NOUN	NNS	_	6	nmod	_	_
9	infected	_	VERB	VBN	_	8	acl	_	_
10	with	_	ADP	IN	_	13	case	_	_
11	HCV	_	NOUN	NN	_	13	compound	_	_
12	genotype	_	NOUN	NN	_	13	compound	_	_
13	1a	_	NOUN	NN	_	9	nmod	_	_
14	in	_	ADP	IN	_	19	case	_	_
15	a	_	DET	DT	_	19	det	_	_
16	liver	_	NOUN	NN	_	19	compound	_	_
17	pre	_	NOUN	NN	_	19	compound	_	_
18	transplant	_	ADJ	JJ	_	19	amod	_	_
19	trial	_	ADJ	JJ	_	9	nmod	_	_

#	Harvoni	4510
1	The	_	DET	DT	_	3	det	_	_
2	E237G	_	NOUN	NN	_	3	compound	_	_
3	substitution	_	NOUN	NN	_	5	nsubjpass	_	_
4	was	_	VERB	VBD	_	5	auxpass	_	_
5	detected	_	VERB	VBN	_	0	root	_	_
6	in	_	ADP	IN	_	8	case	_	_
7	3	_	NUM	CD	_	8	nummod	_	_
8	subjects	_	NOUN	NNS	_	5	nmod	_	_
9	infected	_	VERB	VBN	_	8	acl	_	_
10	with	_	ADP	IN	_	12	case	_	_
11	HCV	_	NOUN	NN	_	12	compound	_	_
12	GT1a	_	NOUN	NN	_	9	nmod	_	_
13	in	_	ADP	IN	_	20	case	_	_
14	the	_	DET	DT	_	20	det	_	_
15	SOLAR	_	NOUN	NN	_	20	compound	_	_
16	1	_	NUM	CD	_	20	nummod	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	SOLAR	_	NOUN	NN	_	16	conj	_	_
19	2	_	NUM	CD	_	20	nummod	_	_
20	trials	_	NOUN	NNS	_	9	nmod	_	_

#	Harvoni	4511
1	The	_	DET	DT	_	3	det	_	_
2	clinical	_	ADJ	JJ	_	3	amod	_	_
3	significance	_	NOUN	NN	_	9	nsubj	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	these	_	DET	DT	_	6	det	_	_
6	substitutions	_	NOUN	NNS	_	3	nmod	_	_
7	is	_	VERB	VBZ	_	9	auxpass	_	_
8	currently	_	ADV	RB	_	9	advmod	_	_
9	unknown	_	ADJ	JJ	_	0	root	_	_

#	Harvoni	4512
1	The	_	DET	DT	_	5	det	_	_
2	DRUG	_	NOUN	NN	_	5	compound	_	_
3	associated	_	ADJ	JJ	_	5	amod	_	_
4	resistance	_	NOUN	NN	_	5	compound	_	_
5	substitution	_	NOUN	NN	_	11	nsubjpass	_	_
6	S282T	_	NOUN	NN	_	5	dep	_	_
7	in	_	ADP	IN	_	8	case	_	_
8	NS5B	_	NOUN	NN	_	5	nmod	_	_
9	was	_	VERB	VBD	_	11	auxpass	_	_
10	not	_	ADV	RB	_	11	neg	_	_
11	detected	_	VERB	VBN	_	0	root	_	_
12	in	_	ADP	IN	_	15	case	_	_
13	any	_	DET	DT	_	15	det	_	_
14	failure	_	NOUN	NN	_	15	compound	_	_
15	isolate	_	NOUN	NN	_	11	nmod	_	_
16	from	_	ADP	IN	_	20	case	_	_
17	the	_	DET	DT	_	20	det	_	_
18	Phase	_	NOUN	NN	_	20	compound	_	_
19	3	_	NUM	CD	_	20	nummod	_	_
20	trials	_	NOUN	NNS	_	15	nmod	_	_

#	Harvoni	4513
1	NS5B	_	NOUN	NN	_	2	compound	_	_
2	substitutions	_	NOUN	NNS	_	23	nsubjpass	_	_
3	S282T	_	NOUN	NN	_	2	dep	_	_
4	,	_	.	,	_	3	punct	_	_
5	L320V	_	NOUN	NN	_	3	conj	_	_
6	/	_	.	:	_	3	punct	_	_
7	I	_	NUM	CD	_	3	conj	_	_
8	,	_	.	,	_	3	punct	_	_
9	and	_	CONJ	CC	_	3	cc	_	_
10	V321I	_	NOUN	NN	_	3	conj	_	_
11	in	_	ADP	IN	_	12	case	_	_
12	combination	_	NOUN	NN	_	2	nmod	_	_
13	with	_	ADP	IN	_	15	case	_	_
14	NS5A	_	NOUN	NN	_	15	compound	_	_
15	substitutions	_	NOUN	NNS	_	12	nmod	_	_
16	L31M	_	NOUN	NN	_	15	dep	_	_
17	,	_	.	,	_	16	punct	_	_
18	Y93H	_	NOUN	NN	_	16	conj	_	_
19	,	_	.	,	_	16	punct	_	_
20	and	_	CONJ	CC	_	16	cc	_	_
21	Q30L	_	NOUN	NN	_	16	conj	_	_
22	were	_	VERB	VBD	_	23	auxpass	_	_
23	detected	_	VERB	VBN	_	0	root	_	_
24	in	_	ADP	IN	_	26	case	_	_
25	one	_	NUM	CD	_	26	nummod	_	_
26	subject	_	NOUN	NN	_	23	nmod	_	_
27	at	_	ADP	IN	_	28	case	_	_
28	failure	_	NOUN	NN	_	23	nmod	_	_
29	following	_	ADP	IN	_	31	case	_	_
30	8	_	NUM	CD	_	31	nummod	_	_
31	weeks	_	NOUN	NNS	_	23	nmod	_	_
32	of	_	ADP	IN	_	33	case	_	_
33	treatment	_	NOUN	NN	_	31	nmod	_	_
34	with	_	ADP	IN	_	35	case	_	_
35	DRUG	_	NOUN	NN	_	33	nmod	_	_
36	in	_	ADP	IN	_	40	case	_	_
37	a	_	DET	DT	_	40	det	_	_
38	Phase	_	NOUN	NN	_	40	compound	_	_
39	2	_	NUM	CD	_	40	nummod	_	_
40	trial	_	ADJ	JJ	_	33	nmod	_	_

#	Harvoni	4514
1	Genotype	_	NOUN	NN	_	10	nsubjpass	_	_
2	4	_	NUM	CD	_	1	nummod	_	_
3	,	_	.	,	_	1	punct	_	_
4	5	_	NUM	CD	_	8	nummod	_	_
5	or	_	CONJ	CC	_	4	cc	_	_
6	6	_	NUM	CD	_	4	conj	_	_
7	Resistance	_	NOUN	NN	_	8	compound	_	_
8	analysis	_	NOUN	NN	_	1	appos	_	_
9	was	_	VERB	VBD	_	10	auxpass	_	_
10	performed	_	VERB	VBN	_	0	root	_	_
11	for	_	ADP	IN	_	14	case	_	_
12	6	_	NUM	CD	_	14	nummod	_	_
13	relapse	_	NOUN	NN	_	14	compound	_	_
14	subjects	_	NOUN	NNS	_	10	nmod	_	_
15	infected	_	VERB	VBN	_	14	acl	_	_
16	with	_	ADP	IN	_	20	case	_	_
17	HCV	_	NOUN	NN	_	20	compound	_	_
18	genotype	_	NOUN	NN	_	20	compound	_	_
19	4	_	NUM	CD	_	20	nummod	_	_
20	Study	_	NOUN	NN	_	15	nmod	_	_
21	1119	_	NUM	CD	_	20	nummod	_	_
22	and	_	CONJ	CC	_	20	cc	_	_
23	ION	_	NOUN	NN	_	20	conj	_	_
24	4	_	NUM	CD	_	23	nummod	_	_
25	,	_	.	,	_	20	punct	_	_
26	N=3	_	NOUN	NN	_	20	conj	_	_
27	,	_	.	,	_	20	punct	_	_
28	genotype	_	NOUN	NN	_	30	compound	_	_
29	5	_	NUM	CD	_	30	nummod	_	_
30	Study	_	NOUN	NN	_	20	conj	_	_
31	1119	_	NUM	CD	_	30	nummod	_	_
32	,	_	.	,	_	20	punct	_	_
33	N=2	_	NOUN	NN	_	20	conj	_	_
34	or	_	CONJ	CC	_	20	cc	_	_
35	genotype	_	NOUN	NN	_	37	compound	_	_
36	6	_	NUM	CD	_	37	nummod	_	_
37	ELECTRON	_	NOUN	NN	_	20	conj	_	_
38	2	_	NUM	CD	_	37	nummod	_	_
39	,	_	.	,	_	10	punct	_	_
40	N=1	_	NOUN	NN	_	10	dobj	_	_
41	and	_	CONJ	CC	_	40	cc	_	_
42	treated	_	VERB	VBN	_	40	conj	_	_
43	with	_	ADP	IN	_	44	case	_	_
44	DRUG	_	NOUN	NN	_	42	nmod	_	_
45	for	_	ADP	IN	_	47	case	_	_
46	12	_	NUM	CD	_	47	nummod	_	_
47	weeks	_	NOUN	NNS	_	40	nmod	_	_

#	Harvoni	4515
1	All	_	DET	DT	_	4	cc:preconj	_	_
2	the	_	DET	DT	_	4	det	_	_
3	relapse	_	ADJ	JJ	_	4	amod	_	_
4	subjects	_	NOUN	NNS	_	12	nsubj	_	_
5	with	_	ADP	IN	_	8	case	_	_
6	NS5A	_	NOUN	NN	_	8	compound	_	_
7	sequencing	_	NOUN	NN	_	8	compound	_	_
8	data	_	NOUN	NNS	_	4	nmod	_	_
9	5	_	NUM	CD	_	8	nummod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	6	_	NUM	CD	_	8	nmod	_	_
12	had	_	VERB	VBD	_	0	root	_	_
13	pretreatment	_	NOUN	NN	_	15	compound	_	_
14	NS5A	_	NOUN	NN	_	15	compound	_	_
15	resistance	_	NOUN	NN	_	12	dobj	_	_
16	associated	_	VERB	VBD	_	17	amod	_	_
17	polymorphisms	_	NOUN	NNS	_	12	dobj	_	_
18	single	_	ADJ	JJ	_	17	dep	_	_
19	or	_	CONJ	CC	_	18	cc	_	_
20	combinations	_	NOUN	NNS	_	18	conj	_	_
21	at	_	ADP	IN	_	22	case	_	_
22	positions	_	NOUN	NNS	_	18	nmod	_	_
23	24	_	NUM	CD	_	22	nummod	_	_
24	,	_	.	,	_	22	punct	_	_
25	28	_	NUM	CD	_	22	conj	_	_
26	,	_	.	,	_	22	punct	_	_
27	30	_	NUM	CD	_	22	conj	_	_
28	,	_	.	,	_	22	punct	_	_
29	31	_	NUM	CD	_	22	conj	_	_
30	,	_	.	,	_	22	punct	_	_
31	and	_	CONJ	CC	_	22	cc	_	_
32	58	_	NUM	CD	_	22	conj	_	_

#	Harvoni	4516
1	NS5A	_	NOUN	NN	_	3	compound	_	_
2	resistance	_	NOUN	NN	_	3	compound	_	_
3	substitutions	_	NOUN	NNS	_	16	nsubj	_	_
4	Y93C	_	NOUN	NN	_	3	dep	_	_
5	or	_	CONJ	CC	_	4	cc	_	_
6	L28V	_	NOUN	NN	_	4	conj	_	_
7	emerged	_	VERB	VBN	_	3	acl	_	_
8	in	_	ADP	IN	_	9	case	_	_
9	two	_	NUM	CD	_	7	nmod	_	_
10	of	_	ADP	IN	_	15	case	_	_
11	the	_	DET	DT	_	15	det	_	_
12	genotype	_	NOUN	NN	_	15	compound	_	_
13	4	_	NUM	CD	_	15	nummod	_	_
14	relapse	_	NOUN	NN	_	15	compound	_	_
15	subjects	_	NOUN	NNS	_	9	nmod	_	_
16	post	_	VERB	VBP	_	0	root	_	_
17	treatment	_	NOUN	NN	_	16	dobj	_	_
18	who	_	DET	WDT	_	20	nsubj	_	_
19	also	_	ADV	RB	_	20	advmod	_	_
20	had	_	VERB	VBD	_	17	acl:relcl	_	_
21	NS5A	_	NOUN	NN	_	22	compound	_	_
22	polymorphisms	_	NOUN	NNS	_	23	compound	_	_
23	pretreatment	_	NOUN	NN	_	20	dobj	_	_
24	that	_	DET	WDT	_	26	nsubjpass	_	_
25	were	_	VERB	VBD	_	26	auxpass	_	_
26	retained	_	VERB	VBN	_	23	acl:relcl	_	_
27	post	_	ADJ	JJ	_	28	compound	_	_
28	treatment	_	NOUN	NN	_	26	dobj	_	_

#	Harvoni	4517
1	Two	_	NUM	CD	_	10	nsubj	_	_
2	of	_	ADP	IN	_	4	case	_	_
3	the	_	DET	DT	_	4	det	_	_
4	relapsers	_	NOUN	NNS	_	1	nmod	_	_
5	with	_	ADP	IN	_	9	case	_	_
6	genotype	_	NOUN	NN	_	9	compound	_	_
7	4	_	NUM	CD	_	9	nummod	_	_
8	HCV	_	NOUN	NN	_	9	compound	_	_
9	infection	_	NOUN	NN	_	4	nmod	_	_
10	had	_	VERB	VBD	_	0	root	_	_
11	an	_	DET	DT	_	15	det	_	_
12	NS5B	_	NOUN	NN	_	15	compound	_	_
13	V321I	_	NOUN	NN	_	15	compound	_	_
14	substitution	_	NOUN	NN	_	15	compound	_	_
15	pretreatment	_	NOUN	NN	_	10	dobj	_	_
16	,	_	.	,	_	15	punct	_	_
17	which	_	DET	WDT	_	19	nsubjpass	_	_
18	was	_	VERB	VBD	_	19	auxpass	_	_
19	retained	_	VERB	VBN	_	15	acl:relcl	_	_
20	post	_	ADJ	JJ	_	21	compound	_	_
21	treatment	_	NOUN	NN	_	19	dobj	_	_

#	Harvoni	4518
1	Three	_	NUM	CD	_	16	nsubj	_	_
2	of	_	ADP	IN	_	5	case	_	_
3	the	_	DET	DT	_	5	det	_	_
4	relapse	_	NOUN	NN	_	5	compound	_	_
5	subjects	_	NOUN	NNS	_	1	nmod	_	_
6	1	_	NUM	CD	_	7	nummod	_	_
7	each	_	DET	DT	_	5	dep	_	_
8	for	_	ADP	IN	_	9	case	_	_
9	genotype	_	NOUN	NN	_	7	nmod	_	_
10	4	_	NUM	CD	_	9	nummod	_	_
11	,	_	.	,	_	9	punct	_	_
12	5	_	NUM	CD	_	9	conj	_	_
13	,	_	.	,	_	9	punct	_	_
14	and	_	CONJ	CC	_	9	cc	_	_
15	6	_	NUM	CD	_	9	conj	_	_
16	had	_	VERB	VBD	_	0	root	_	_
17	virus	_	NOUN	NN	_	16	dobj	_	_
18	with	_	ADP	IN	_	21	case	_	_
19	emergent	_	ADJ	JJ	_	21	amod	_	_
20	DRUG	_	NOUN	NN	_	21	compound	_	_
21	resistance	_	NOUN	NN	_	16	nmod	_	_
22	associated	_	VERB	VBN	_	24	amod	_	_
23	substitution	_	NOUN	NN	_	24	compound	_	_
24	S282T	_	NOUN	NN	_	16	dobj	_	_
25	at	_	ADP	IN	_	26	case	_	_
26	relapse	_	NOUN	NN	_	16	nmod	_	_
27	the	_	DET	DT	_	31	det	_	_
28	genotype	_	NOUN	NN	_	31	compound	_	_
29	5	_	NUM	CD	_	31	nummod	_	_
30	relapse	_	NOUN	NN	_	31	amod	_	_
31	subject	_	NOUN	NN	_	16	dobj	_	_
32	also	_	ADV	RB	_	33	advmod	_	_
33	had	_	VERB	VBD	_	16	parataxis	_	_
34	emergent	_	ADJ	JJ	_	37	amod	_	_
35	nucleotide	_	NOUN	NN	_	37	compound	_	_
36	inhibitor	_	NOUN	NN	_	37	compound	_	_
37	substitution	_	NOUN	NN	_	33	dobj	_	_
38	M289I	_	NOUN	NN	_	37	dep	_	_

#	Harvoni	4519
1	Persistence	_	NOUN	NN	_	9	nsubj	_	_
2	of	_	ADP	IN	_	5	case	_	_
3	Resistance	_	NOUN	NN	_	5	compound	_	_
4	Associated	_	ADJ	JJ	_	5	amod	_	_
5	Substitutions	_	NOUN	NNS	_	1	nmod	_	_
6	No	_	NOUN	NN	_	7	compound	_	_
7	data	_	NOUN	NNS	_	5	dep	_	_
8	are	_	VERB	VBP	_	9	cop	_	_
9	available	_	ADJ	JJ	_	0	root	_	_
10	on	_	ADP	IN	_	12	case	_	_
11	the	_	DET	DT	_	12	det	_	_
12	persistence	_	NOUN	NN	_	9	nmod	_	_
13	of	_	ADP	IN	_	19	case	_	_
14	DRUG	_	NOUN	NN	_	19	compound	_	_
15	or	_	CONJ	CC	_	14	cc	_	_
16	DRUG	_	NOUN	NN	_	14	conj	_	_
17	resistance	_	NOUN	NN	_	19	compound	_	_
18	associated	_	ADJ	JJ	_	19	amod	_	_
19	substitutions	_	NOUN	NNS	_	12	nmod	_	_

#	Harvoni	4520
1	NS5A	_	NOUN	NN	_	4	compound	_	_
2	resistance	_	NOUN	NN	_	4	compound	_	_
3	associated	_	ADJ	JJ	_	4	amod	_	_
4	substitutions	_	NOUN	NNS	_	11	nsubjpass	_	_
5	for	_	ADP	IN	_	8	case	_	_
6	other	_	ADJ	JJ	_	8	amod	_	_
7	NS5A	_	NOUN	NN	_	8	compound	_	_
8	inhibitors	_	NOUN	NNS	_	4	nmod	_	_
9	have	_	VERB	VBP	_	11	aux	_	_
10	been	_	VERB	VBN	_	11	auxpass	_	_
11	found	_	VERB	VBN	_	0	root	_	_
12	to	_	PRT	TO	_	13	mark	_	_
13	persist	_	VERB	VB	_	11	xcomp	_	_
14	for	_	ADP	IN	_	16	case	_	_
15	>1	_	NUM	CD	_	16	nummod	_	_
16	year	_	NOUN	NN	_	13	nmod	_	_
17	in	_	ADP	IN	_	19	case	_	_
18	some	_	DET	DT	_	19	det	_	_
19	patients	_	NOUN	NNS	_	16	nmod	_	_

#	Harvoni	4521
1	The	_	DET	DT	_	5	det	_	_
2	long	_	ADJ	JJ	_	5	amod	_	_
3	term	_	NOUN	NN	_	5	compound	_	_
4	clinical	_	ADJ	JJ	_	5	amod	_	_
5	impact	_	NOUN	NN	_	21	nsubj	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	the	_	DET	DT	_	8	det	_	_
8	emergence	_	NOUN	NN	_	5	nmod	_	_
9	or	_	CONJ	CC	_	5	cc	_	_
10	persistence	_	NOUN	NN	_	5	conj	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	virus	_	NOUN	NN	_	10	nmod	_	_
13	containing	_	VERB	VBG	_	12	acl	_	_
14	DRUG	_	NOUN	NN	_	13	dobj	_	_
15	or	_	CONJ	CC	_	14	cc	_	_
16	DRUG	_	NOUN	NN	_	14	conj	_	_
17	resistance	_	NOUN	NN	_	19	compound	_	_
18	associated	_	VERB	VBN	_	19	amod	_	_
19	substitutions	_	NOUN	NNS	_	14	dep	_	_
20	is	_	VERB	VBZ	_	21	auxpass	_	_
21	unknown	_	ADJ	JJ	_	0	root	_	_

#	Harvoni	4522
1	Effect	_	NOUN	NN	_	14	nsubjpass	_	_
2	of	_	ADP	IN	_	5	case	_	_
3	Baseline	_	NOUN	NN	_	5	compound	_	_
4	HCV	_	NOUN	NN	_	5	compound	_	_
5	Polymorphisms	_	NOUN	NNS	_	1	nmod	_	_
6	on	_	ADP	IN	_	12	case	_	_
7	Treatment	_	NOUN	NN	_	12	compound	_	_
8	Response	_	NOUN	NN	_	12	compound	_	_
9	Adults	_	NOUN	NNS	_	12	compound	_	_
10	Genotype	_	NOUN	NN	_	12	compound	_	_
11	1	_	NUM	CD	_	12	nummod	_	_
12	Analyses	_	NOUN	NNS	_	1	nmod	_	_
13	were	_	VERB	VBD	_	14	auxpass	_	_
14	conducted	_	VERB	VBN	_	0	root	_	_
15	to	_	PRT	TO	_	16	mark	_	_
16	explore	_	VERB	VB	_	14	xcomp	_	_
17	the	_	DET	DT	_	18	det	_	_
18	association	_	NOUN	NN	_	16	dobj	_	_
19	between	_	ADP	IN	_	24	case	_	_
20	pre	_	NOUN	NN	_	24	compound	_	_
21	existing	_	VERB	VBG	_	24	amod	_	_
22	baseline	_	NOUN	NN	_	24	compound	_	_
23	NS5A	_	NOUN	NN	_	24	compound	_	_
24	polymorphisms	_	NOUN	NNS	_	18	nmod	_	_
25	at	_	ADP	IN	_	28	case	_	_
26	resistance	_	NOUN	NN	_	28	compound	_	_
27	associated	_	ADJ	JJ	_	28	amod	_	_
28	positions	_	NOUN	NNS	_	18	nmod	_	_
29	and	_	CONJ	CC	_	28	cc	_	_
30	relapse	_	ADJ	JJ	_	31	amod	_	_
31	rates	_	NOUN	NNS	_	28	conj	_	_

#	Harvoni	4523
1	In	_	ADP	IN	_	4	case	_	_
2	the	_	DET	DT	_	4	det	_	_
3	pooled	_	VERB	VBN	_	4	amod	_	_
4	analysis	_	NOUN	NN	_	18	nmod	_	_
5	of	_	ADP	IN	_	9	case	_	_
6	the	_	DET	DT	_	9	det	_	_
7	Phase	_	NOUN	NN	_	9	compound	_	_
8	3	_	NUM	CD	_	9	nummod	_	_
9	trials	_	NOUN	NNS	_	4	nmod	_	_
10	,	_	.	,	_	18	punct	_	_
11	23%	_	NOUN	NN	_	18	nsubj	_	_
12	370	_	NUM	CD	_	11	nummod	_	_
13	/	_	.	-RRB-	_	11	punct	_	_
14	1589	_	NUM	CD	_	11	dep	_	_
15	of	_	ADP	IN	_	17	case	_	_
16	subjects'	_	ADJ	JJ	_	17	amod	_	_
17	virus	_	NOUN	NN	_	14	nmod	_	_
18	had	_	VERB	VBD	_	0	root	_	_
19	baseline	_	NOUN	NN	_	21	compound	_	_
20	NS5A	_	NOUN	NN	_	21	compound	_	_
21	polymorphisms	_	NOUN	NNS	_	18	dobj	_	_
22	at	_	ADP	IN	_	23	case	_	_
23	resistance	_	NOUN	NN	_	18	nmod	_	_
24	associated	_	VERB	VBN	_	23	acl	_	_
25	positions	_	VERB	VBZ	_	18	parataxis	_	_
26	any	_	DET	DT	_	27	det	_	_
27	change	_	NOUN	NN	_	25	dobj	_	_
28	from	_	ADP	IN	_	29	case	_	_
29	reference	_	NOUN	NN	_	27	nmod	_	_
30	at	_	ADP	IN	_	34	case	_	_
31	NS5A	_	NOUN	NN	_	34	compound	_	_
32	amino	_	NOUN	NN	_	34	compound	_	_
33	acid	_	NOUN	NN	_	34	compound	_	_
34	positions	_	NOUN	NNS	_	29	nmod	_	_
35	24	_	NUM	CD	_	34	nummod	_	_
36	,	_	.	,	_	34	punct	_	_
37	28	_	NUM	CD	_	34	conj	_	_
38	,	_	.	,	_	34	punct	_	_
39	30	_	NUM	CD	_	34	conj	_	_
40	,	_	.	,	_	34	punct	_	_
41	31	_	NUM	CD	_	34	conj	_	_
42	,	_	.	,	_	34	punct	_	_
43	58	_	NUM	CD	_	34	conj	_	_
44	,	_	.	,	_	34	punct	_	_
45	92	_	NUM	CD	_	34	conj	_	_
46	,	_	.	,	_	34	punct	_	_
47	or	_	CONJ	CC	_	34	cc	_	_
48	93	_	NUM	CD	_	34	conj	_	_
49	identified	_	VERB	VBN	_	48	dep	_	_
50	by	_	ADP	IN	_	51	case	_	_
51	population	_	NOUN	NN	_	49	nmod	_	_
52	or	_	CONJ	CC	_	49	cc	_	_
53	deep	_	NOUN	NN	_	49	conj	_	_
54	sequencing	_	NOUN	NN	_	53	xcomp	_	_

#	Harvoni	4524
1	In	_	ADP	IN	_	4	case	_	_
2	treatment	_	NOUN	NN	_	4	compound	_	_
3	naive	_	ADJ	JJ	_	4	amod	_	_
4	subjects	_	NOUN	NNS	_	26	nmod	_	_
5	whose	_	PRON	PRP$	_	6	nmod:poss	_	_
6	virus	_	NOUN	NN	_	7	nsubj	_	_
7	had	_	VERB	VBD	_	4	acl:relcl	_	_
8	baseline	_	NOUN	NN	_	10	compound	_	_
9	NS5A	_	NOUN	NN	_	10	compound	_	_
10	polymorphisms	_	NOUN	NNS	_	7	dobj	_	_
11	at	_	ADP	IN	_	14	case	_	_
12	resistance	_	NOUN	NN	_	14	compound	_	_
13	associated	_	VERB	VBN	_	14	amod	_	_
14	positions	_	NOUN	NNS	_	7	nmod	_	_
15	in	_	ADP	IN	_	16	case	_	_
16	Studies	_	NOUN	NNS	_	14	nmod	_	_
17	ION	_	NOUN	NN	_	16	dep	_	_
18	1	_	NUM	CD	_	17	nummod	_	_
19	and	_	CONJ	CC	_	17	cc	_	_
20	ION	_	NOUN	NN	_	17	conj	_	_
21	3	_	NUM	CD	_	20	nummod	_	_
22	,	_	.	,	_	26	punct	_	_
23	relapse	_	ADJ	JJ	_	24	amod	_	_
24	rates	_	NOUN	NNS	_	26	nsubj	_	_
25	were	_	VERB	VBD	_	26	cop	_	_
26	6%	_	ADJ	JJ	_	0	root	_	_
27	3	_	NUM	CD	_	26	dobj	_	_
28	/	_	.	:	_	26	punct	_	_
29	48	_	NUM	CD	_	26	dep	_	_
30	after	_	ADP	IN	_	32	case	_	_
31	8	_	NUM	CD	_	32	nummod	_	_
32	weeks	_	NOUN	NNS	_	29	nmod	_	_
33	and	_	CONJ	CC	_	29	cc	_	_
34	1%	_	NOUN	NN	_	29	conj	_	_
35	1	_	NUM	CD	_	34	nummod	_	_
36	/	_	.	-LRB-	_	34	punct	_	_
37	113	_	NUM	CD	_	34	nummod	_	_
38	after	_	ADP	IN	_	40	case	_	_
39	12	_	NUM	CD	_	40	nummod	_	_
40	weeks	_	NOUN	NNS	_	34	nmod	_	_
41	of	_	ADP	IN	_	42	case	_	_
42	treatment	_	NOUN	NN	_	40	nmod	_	_
43	with	_	ADP	IN	_	44	case	_	_
44	DRUG	_	NOUN	NN	_	42	nmod	_	_

#	Harvoni	4525
1	Relapse	_	NOUN	NN	_	2	compound	_	_
2	rates	_	NOUN	NNS	_	14	nsubj	_	_
3	among	_	ADP	IN	_	4	case	_	_
4	subjects	_	NOUN	NNS	_	2	nmod	_	_
5	without	_	ADP	IN	_	8	case	_	_
6	baseline	_	NOUN	NN	_	8	compound	_	_
7	NS5A	_	NOUN	NN	_	8	compound	_	_
8	polymorphisms	_	NOUN	NNS	_	2	nmod	_	_
9	at	_	ADP	IN	_	12	case	_	_
10	resistance	_	NOUN	NN	_	12	compound	_	_
11	associated	_	ADJ	JJ	_	12	amod	_	_
12	positions	_	NOUN	NNS	_	2	nmod	_	_
13	were	_	VERB	VBD	_	14	cop	_	_
14	5%	_	ADJ	JJ	_	0	root	_	_
15	8	_	NUM	CD	_	17	nummod	_	_
16	/	_	.	:	_	17	punct	_	_
17	167	_	NUM	CD	_	14	dobj	_	_
18	after	_	ADP	IN	_	20	case	_	_
19	8	_	NUM	CD	_	20	nummod	_	_
20	weeks	_	NOUN	NNS	_	14	nmod	_	_
21	and	_	CONJ	CC	_	20	cc	_	_
22	1%	_	NOUN	NN	_	20	conj	_	_
23	3	_	NUM	CD	_	22	nummod	_	_
24	/	_	.	-LRB-	_	22	punct	_	_
25	306	_	NUM	CD	_	22	nummod	_	_
26	after	_	ADP	IN	_	29	case	_	_
27	12	_	NUM	CD	_	29	nummod	_	_
28	weeks	_	NOUN	NN	_	29	compound	_	_
29	treatment	_	NOUN	NN	_	14	nmod	_	_
30	with	_	ADP	IN	_	31	case	_	_
31	DRUG	_	NOUN	NN	_	29	nmod	_	_

#	Harvoni	4526
1	In	_	ADP	IN	_	2	case	_	_
2	treatment	_	NOUN	NN	_	11	nmod	_	_
3	experienced	_	VERB	VBN	_	4	amod	_	_
4	subjects	_	NOUN	NNS	_	11	nsubj	_	_
5	in	_	ADP	IN	_	10	case	_	_
6	Study	_	NOUN	NN	_	10	compound	_	_
7	ION	_	NOUN	NN	_	10	compound	_	_
8	2	_	NUM	CD	_	10	nummod	_	_
9	whose	_	PRON	PRP$	_	10	nmod:poss	_	_
10	virus	_	NOUN	NN	_	4	nmod	_	_
11	had	_	VERB	VBD	_	23	advcl	_	_
12	baseline	_	NOUN	NN	_	14	compound	_	_
13	NS5A	_	NOUN	NN	_	14	compound	_	_
14	polymorphisms	_	NOUN	NNS	_	11	dobj	_	_
15	at	_	ADP	IN	_	18	case	_	_
16	resistance	_	NOUN	NN	_	18	compound	_	_
17	associated	_	ADJ	JJ	_	18	amod	_	_
18	positions	_	NOUN	NNS	_	11	nmod	_	_
19	,	_	.	,	_	23	punct	_	_
20	relapse	_	ADJ	JJ	_	21	amod	_	_
21	rates	_	NOUN	NNS	_	23	nsubj	_	_
22	were	_	VERB	VBD	_	23	cop	_	_
23	22%	_	ADJ	JJ	_	0	root	_	_
24	5	_	NUM	CD	_	26	nummod	_	_
25	/	_	.	:	_	26	punct	_	_
26	23	_	NUM	CD	_	23	dobj	_	_
27	after	_	ADP	IN	_	29	case	_	_
28	12	_	NUM	CD	_	29	nummod	_	_
29	weeks	_	NOUN	NNS	_	23	nmod	_	_
30	and	_	CONJ	CC	_	29	cc	_	_
31	0%	_	NOUN	NN	_	29	conj	_	_
32	0	_	NUM	CD	_	31	nummod	_	_
33	/	_	.	:	_	31	punct	_	_
34	19	_	NUM	CD	_	31	nummod	_	_
35	after	_	ADP	IN	_	37	case	_	_
36	24	_	NUM	CD	_	37	nummod	_	_
37	weeks	_	NOUN	NNS	_	23	nmod	_	_
38	of	_	ADP	IN	_	39	case	_	_
39	treatment	_	NOUN	NN	_	37	nmod	_	_
40	with	_	ADP	IN	_	41	case	_	_
41	DRUG	_	NOUN	NN	_	39	nmod	_	_

#	Harvoni	4527
1	In	_	ADP	IN	_	3	case	_	_
2	another	_	DET	DT	_	3	det	_	_
3	study	_	NOUN	NN	_	0	root	_	_
4	in	_	ADP	IN	_	5	case	_	_
5	treatment	_	NOUN	NN	_	3	nmod	_	_
6	experienced	_	VERB	VBN	_	8	amod	_	_
7	subjects	_	NOUN	NNS	_	8	compound	_	_
8	SIRIUS	_	NOUN	NN	_	3	dep	_	_
9	,	_	.	,	_	8	punct	_	_
10	0	_	NUM	CD	_	14	nummod	_	_
11	/	_	NUM	CD	_	14	punct	_	_
12	15	_	NUM	CD	_	14	nummod	_	_
13	0%	_	ADJ	JJ	_	14	amod	_	_
14	subjects	_	NOUN	NNS	_	32	nsubj	_	_
15	with	_	ADP	IN	_	17	case	_	_
16	NS5A	_	NOUN	NN	_	17	compound	_	_
17	polymorphisms	_	NOUN	NNS	_	14	nmod	_	_
18	at	_	ADP	IN	_	21	case	_	_
19	resistance	_	NOUN	NN	_	21	compound	_	_
20	associated	_	ADJ	JJ	_	21	amod	_	_
21	positions	_	NOUN	NNS	_	14	nmod	_	_
22	relapsed	_	VERB	VBN	_	21	acl	_	_
23	after	_	ADP	IN	_	25	case	_	_
24	12	_	NUM	CD	_	25	nummod	_	_
25	weeks	_	NOUN	NNS	_	22	nmod	_	_
26	of	_	ADP	IN	_	27	case	_	_
27	treatment	_	NOUN	NN	_	25	nmod	_	_
28	with	_	ADP	IN	_	29	case	_	_
29	DRUG	_	NOUN	NN	_	27	nmod	_	_
30	+	_	CONJ	CC	_	21	cc	_	_
31	RBV	_	NOUN	NN	_	21	conj	_	_
32	compared	_	VERB	VBD	_	8	dep	_	_
33	to	_	PRT	TO	_	38	case	_	_
34	2	_	NUM	CD	_	38	nummod	_	_
35	/	_	NUM	CD	_	38	punct	_	_
36	15	_	NUM	CD	_	38	nummod	_	_
37	13%	_	ADJ	JJ	_	38	amod	_	_
38	subjects	_	NOUN	NNS	_	32	nmod	_	_
39	treated	_	VERB	VBN	_	38	acl	_	_
40	with	_	ADP	IN	_	42	case	_	_
41	24	_	NUM	CD	_	42	nummod	_	_
42	weeks	_	NOUN	NNS	_	39	nmod	_	_
43	of	_	ADP	IN	_	44	case	_	_
44	DRUG	_	NOUN	NN	_	42	nmod	_	_

#	Harvoni	4528
1	SVR	_	NOUN	NN	_	3	nsubjpass	_	_
2	was	_	VERB	VBD	_	3	auxpass	_	_
3	achieved	_	VERB	VBN	_	0	root	_	_
4	in	_	ADP	IN	_	7	case	_	_
5	all	_	DET	DT	_	7	det	_	_
6	24	_	NUM	CD	_	7	nummod	_	_
7	subjects	_	NOUN	NNS	_	3	nmod	_	_
8	N=20	_	NOUN	NN	_	7	dep	_	_
9	with	_	ADP	IN	_	11	case	_	_
10	L159F+C316N	_	NOUN	NN	_	11	compound	_	_
11	N=1	_	NOUN	NN	_	3	nmod	_	_
12	with	_	ADP	IN	_	13	case	_	_
13	L159F	_	NOUN	NN	_	3	nmod	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	N=3	_	NOUN	NN	_	13	conj	_	_
16	with	_	ADP	IN	_	17	case	_	_
17	N142T	_	NOUN	NN	_	3	nmod	_	_
18	who	_	DET	WDT	_	19	nsubj	_	_
19	had	_	VERB	VBD	_	17	acl:relcl	_	_
20	baseline	_	NOUN	NN	_	21	compound	_	_
21	polymorphisms	_	NOUN	NNS	_	19	dobj	_	_
22	associated	_	VERB	VBN	_	21	acl	_	_
23	with	_	ADP	IN	_	24	case	_	_
24	resistance	_	NOUN	NN	_	22	nmod	_	_
25	to	_	PRT	TO	_	26	case	_	_
26	DRUG	_	NOUN	NN	_	24	nmod	_	_
27	and	_	CONJ	CC	_	26	cc	_	_
28	/	_	NUM	CD	_	26	conj	_	_
29	or	_	CONJ	CC	_	26	cc	_	_
30	other	_	ADJ	JJ	_	33	amod	_	_
31	NS5B	_	NOUN	NN	_	33	compound	_	_
32	nucleoside	_	NOUN	NN	_	33	compound	_	_
33	inhibitors	_	NOUN	NNS	_	26	conj	_	_

#	Harvoni	4529
1	The	_	DET	DT	_	4	det	_	_
2	NS5B	_	NOUN	NN	_	4	compound	_	_
3	S282T	_	NOUN	NN	_	4	compound	_	_
4	substitution	_	NOUN	NN	_	12	nsubjpass	_	_
5	associated	_	VERB	VBN	_	4	acl	_	_
6	with	_	ADP	IN	_	7	case	_	_
7	resistance	_	NOUN	NN	_	5	nmod	_	_
8	to	_	PRT	TO	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	was	_	VERB	VBD	_	12	auxpass	_	_
11	not	_	ADV	RB	_	12	neg	_	_
12	detected	_	VERB	VBN	_	0	root	_	_
13	in	_	ADP	IN	_	17	case	_	_
14	the	_	DET	DT	_	17	det	_	_
15	baseline	_	NOUN	NN	_	17	compound	_	_
16	NS5B	_	NOUN	NN	_	17	compound	_	_
17	sequence	_	NOUN	NN	_	12	nmod	_	_
18	of	_	ADP	IN	_	20	case	_	_
19	any	_	DET	DT	_	20	det	_	_
20	subject	_	NOUN	NN	_	17	nmod	_	_
21	in	_	ADP	IN	_	24	case	_	_
22	Phase	_	NOUN	NN	_	24	compound	_	_
23	3	_	NUM	CD	_	24	nummod	_	_
24	trials	_	NOUN	NNS	_	17	nmod	_	_
25	by	_	ADP	IN	_	26	case	_	_
26	population	_	NOUN	NN	_	12	nmod	_	_
27	or	_	CONJ	CC	_	12	cc	_	_
28	deep	_	VERB	VBP	_	12	conj	_	_
29	nucleotide	_	NOUN	NN	_	31	compound	_	_
30	sequence	_	NOUN	NN	_	31	compound	_	_
31	analysis	_	NOUN	NN	_	28	dobj	_	_

#	Harvoni	4530
1	In	_	ADP	IN	_	3	case	_	_
2	the	_	DET	DT	_	3	det	_	_
3	SOLAR	_	NOUN	NN	_	8	nsubj	_	_
4	1	_	NUM	CD	_	3	nummod	_	_
5	and	_	CONJ	CC	_	3	cc	_	_
6	SOLAR	_	NOUN	NN	_	3	conj	_	_
7	2	_	NUM	CD	_	6	nummod	_	_
8	trials	_	NOUN	NNS	_	32	advcl	_	_
9	liver	_	NOUN	NN	_	11	compound	_	_
10	transplant	_	ADJ	JJ	_	11	amod	_	_
11	recipients	_	NOUN	NNS	_	8	dobj	_	_
12	or	_	CONJ	CC	_	11	cc	_	_
13	subjects	_	NOUN	NNS	_	11	conj	_	_
14	with	_	ADP	IN	_	17	case	_	_
15	decompensated	_	VERB	VBN	_	17	amod	_	_
16	liver	_	NOUN	NN	_	17	compound	_	_
17	disease	_	NOUN	NN	_	11	nmod	_	_
18	,	_	.	,	_	8	punct	_	_
19	after	_	ADP	IN	_	21	case	_	_
20	12	_	NUM	CD	_	21	nummod	_	_
21	weeks	_	NOUN	NNS	_	8	nmod	_	_
22	of	_	ADP	IN	_	23	case	_	_
23	treatment	_	NOUN	NN	_	21	nmod	_	_
24	with	_	ADP	IN	_	25	case	_	_
25	DRUG	_	NOUN	NN	_	23	nmod	_	_
26	and	_	CONJ	CC	_	25	cc	_	_
27	RBV	_	NOUN	NN	_	25	conj	_	_
28	,	_	.	,	_	32	punct	_	_
29	relapse	_	ADJ	JJ	_	30	amod	_	_
30	rates	_	NOUN	NNS	_	32	nsubj	_	_
31	were	_	VERB	VBD	_	32	cop	_	_
32	7%	_	ADJ	JJ	_	0	root	_	_
33	5	_	NUM	CD	_	40	nummod	_	_
34	/	_	.	-LRB-	_	40	punct	_	_
35	71	_	NUM	CD	_	40	nummod	_	_
36	and	_	CONJ	CC	_	35	cc	_	_
37	5%	_	NOUN	NN	_	35	conj	_	_
38	10	_	NUM	CD	_	37	nummod	_	_
39	/	_	.	:	_	40	punct	_	_
40	217	_	NUM	CD	_	32	dobj	_	_
41	in	_	ADP	IN	_	44	case	_	_
42	genotype	_	NOUN	NN	_	44	compound	_	_
43	1	_	NUM	CD	_	44	nummod	_	_
44	subjects	_	NOUN	NNS	_	32	nmod	_	_
45	with	_	ADP	IN	_	54	case	_	_
46	and	_	CONJ	CC	_	45	cc	_	_
47	without	_	ADP	IN	_	45	conj	_	_
48	baseline	_	NOUN	NN	_	50	compound	_	_
49	NS5A	_	NOUN	NN	_	50	compound	_	_
50	polymorphisms	_	NOUN	NNS	_	45	dep	_	_
51	at	_	ADP	IN	_	54	case	_	_
52	resistance	_	NOUN	NN	_	54	compound	_	_
53	associated	_	VERB	VBN	_	54	amod	_	_
54	positions	_	NOUN	NNS	_	44	nmod	_	_
55	,	_	.	,	_	32	punct	_	_
56	respectively	_	ADV	RB	_	32	advmod	_	_

#	Harvoni	4531
1	In	_	ADP	IN	_	5	case	_	_
2	the	_	DET	DT	_	5	det	_	_
3	Phase	_	NOUN	NN	_	5	compound	_	_
4	3	_	NUM	CD	_	5	nummod	_	_
5	trials	_	NOUN	NNS	_	15	nmod	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	SOLAR	_	NOUN	NN	_	8	compound	_	_
8	trials	_	NOUN	NNS	_	5	conj	_	_
9	,	_	.	,	_	15	punct	_	_
10	the	_	DET	DT	_	14	det	_	_
11	specific	_	ADJ	JJ	_	14	amod	_	_
12	baseline	_	NOUN	NN	_	14	compound	_	_
13	NS5A	_	NOUN	NN	_	14	compound	_	_
14	resistance	_	NOUN	NN	_	15	nsubj	_	_
15	associated	_	VERB	VBD	_	0	root	_	_
16	polymorphisms	_	NOUN	NNS	_	15	dobj	_	_
17	observed	_	VERB	VBN	_	16	acl	_	_
18	among	_	ADP	IN	_	19	case	_	_
19	subjects	_	NOUN	NNS	_	17	nmod	_	_
20	who	_	DET	WDT	_	19	root	_	_
21	relapsed	_	VERB	VBN	_	20	acl:relcl	_	_
22	were	_	VERB	VBD	_	23	cop	_	_
23	M28T	_	NOUN	NN	_	21	nmod	_	_
24	/	_	.	:	_	23	punct	_	_
25	V	_	NOUN	NN	_	23	conj	_	_
26	,	_	.	,	_	25	punct	_	_
27	Q30H	_	NOUN	NN	_	25	conj	_	_
28	/	_	.	:	_	25	punct	_	_
29	R	_	NOUN	NN	_	25	conj	_	_
30	,	_	.	,	_	25	punct	_	_
31	L31M	_	NOUN	NN	_	25	conj	_	_
32	,	_	.	,	_	25	punct	_	_
33	H58D	_	NOUN	NN	_	25	conj	_	_
34	/	_	.	:	_	25	punct	_	_
35	P	_	NOUN	NN	_	25	conj	_	_
36	,	_	.	,	_	25	punct	_	_
37	and	_	CONJ	CC	_	25	cc	_	_
38	Y93H	_	NOUN	NN	_	40	compound	_	_
39	/	_	.	:	_	40	punct	_	_
40	N	_	NOUN	NN	_	25	conj	_	_
41	in	_	ADP	IN	_	43	case	_	_
42	genotype	_	NOUN	NN	_	43	compound	_	_
43	1a	_	NOUN	NN	_	25	nmod	_	_
44	,	_	.	,	_	23	punct	_	_
45	and	_	CONJ	CC	_	23	cc	_	_
46	L28M	_	NOUN	NN	_	23	conj	_	_
47	,	_	.	,	_	23	punct	_	_
48	L31M	_	NOUN	NN	_	23	conj	_	_
49	,	_	.	,	_	23	punct	_	_
50	A92T	_	NOUN	NN	_	23	conj	_	_
51	,	_	.	,	_	23	punct	_	_
52	and	_	CONJ	CC	_	23	cc	_	_
53	Y93H	_	NOUN	NN	_	23	conj	_	_
54	in	_	ADP	IN	_	56	case	_	_
55	genotype	_	NOUN	NN	_	56	compound	_	_
56	1b	_	NOUN	NN	_	23	nmod	_	_

#	Harvoni	4532
1	Subjects	_	NOUN	NNS	_	10	nsubj	_	_
2	with	_	ADP	IN	_	5	case	_	_
3	multiple	_	ADJ	JJ	_	5	amod	_	_
4	NS5A	_	NOUN	NN	_	5	compound	_	_
5	polymorphisms	_	NOUN	NNS	_	1	nmod	_	_
6	at	_	ADP	IN	_	9	case	_	_
7	resistance	_	NOUN	NN	_	9	compound	_	_
8	associated	_	ADJ	JJ	_	9	amod	_	_
9	positions	_	NOUN	NNS	_	1	nmod	_	_
10	appeared	_	VERB	VBD	_	0	root	_	_
11	to	_	PRT	TO	_	12	mark	_	_
12	have	_	VERB	VB	_	10	xcomp	_	_
13	higher	_	ADJ	JJ	_	15	amod	_	_
14	relapse	_	NOUN	NN	_	15	compound	_	_
15	rates	_	NOUN	NNS	_	12	dobj	_	_

#	Harvoni	4533
1	Genotype	_	NOUN	NN	_	25	nsubj	_	_
2	4	_	NUM	CD	_	1	nummod	_	_
3	,	_	.	,	_	1	punct	_	_
4	5	_	NUM	CD	_	8	nummod	_	_
5	or	_	CONJ	CC	_	4	cc	_	_
6	6	_	NUM	CD	_	4	conj	_	_
7	Phylogenetic	_	ADJ	JJ	_	8	amod	_	_
8	analysis	_	NOUN	NN	_	1	appos	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	HCV	_	NOUN	NN	_	11	compound	_	_
11	sequences	_	NOUN	NNS	_	8	nmod	_	_
12	from	_	ADP	IN	_	16	case	_	_
13	genotype	_	NOUN	NN	_	16	compound	_	_
14	4	_	NUM	CD	_	16	nummod	_	_
15	infected	_	ADJ	JJ	_	16	amod	_	_
16	subjects	_	NOUN	NNS	_	8	nmod	_	_
17	in	_	ADP	IN	_	20	case	_	_
18	Study	_	NOUN	NN	_	20	compound	_	_
19	1119	_	NUM	CD	_	20	nummod	_	_
20	N=44	_	NOUN	NN	_	16	nmod	_	_
21	and	_	CONJ	CC	_	20	cc	_	_
22	ION	_	NOUN	NN	_	24	compound	_	_
23	4	_	NUM	CD	_	24	nummod	_	_
24	N=8	_	NOUN	NN	_	20	conj	_	_
25	identified	_	VERB	VBD	_	0	root	_	_
26	7	_	NUM	CD	_	30	nummod	_	_
27	HCV	_	NOUN	NN	_	30	compound	_	_
28	genotype	_	NOUN	NN	_	30	compound	_	_
29	4	_	NUM	CD	_	30	nummod	_	_
30	subtypes	_	NOUN	NNS	_	25	dobj	_	_
31	4a	_	NOUN	NN	_	30	dep	_	_
32	,	_	.	,	_	31	punct	_	_
33	4b	_	NOUN	NN	_	31	conj	_	_
34	,	_	.	,	_	31	punct	_	_
35	4d	_	NOUN	NN	_	31	conj	_	_
36	,	_	.	,	_	31	punct	_	_
37	4f	_	NOUN	NN	_	31	conj	_	_
38	,	_	.	,	_	31	punct	_	_
39	4m	_	NOUN	NN	_	31	conj	_	_
40	,	_	.	,	_	31	punct	_	_
41	4o	_	ADJ	JJ	_	31	conj	_	_
42	,	_	.	,	_	31	punct	_	_
43	and	_	CONJ	CC	_	31	cc	_	_
44	4r	_	ADJ	JJ	_	31	conj	_	_

#	Harvoni	4534
1	Most	_	ADJ	JJ	_	2	amod	_	_
2	subjects	_	NOUN	NNS	_	4	nsubjpass	_	_
3	were	_	VERB	VBD	_	4	auxpass	_	_
4	infected	_	VERB	VBN	_	0	root	_	_
5	with	_	ADP	IN	_	9	case	_	_
6	subtype	_	NOUN	NN	_	9	compound	_	_
7	4a	_	NOUN	NN	_	9	compound	_	_
8	N=32	_	NOUN	NN	_	9	compound	_	_
9	62%	_	NOUN	NN	_	4	nmod	_	_
10	or	_	CONJ	CC	_	9	cc	_	_
11	4d	_	ADJ	JJ	_	13	amod	_	_
12	N=11	_	NOUN	NN	_	13	compound	_	_
13	21%	_	ADJ	JJ	_	9	conj	_	_
14	1	_	NUM	CD	_	13	nummod	_	_
15	to	_	PRT	TO	_	17	case	_	_
16	3	_	NUM	CD	_	17	nummod	_	_
17	subjects	_	NOUN	NNS	_	4	nmod	_	_
18	were	_	VERB	VBD	_	19	auxpass	_	_
19	infected	_	VERB	VBN	_	4	parataxis	_	_
20	with	_	ADP	IN	_	21	case	_	_
21	each	_	DET	DT	_	19	nmod	_	_
22	of	_	ADP	IN	_	27	case	_	_
23	the	_	DET	DT	_	27	det	_	_
24	other	_	ADJ	JJ	_	27	amod	_	_
25	genotype	_	NOUN	NN	_	27	compound	_	_
26	4	_	NUM	CD	_	27	nummod	_	_
27	subtypes	_	NOUN	NNS	_	21	nmod	_	_

#	Harvoni	4535
1	There	_	PRON	PRP$	_	2	expl	_	_
2	were	_	VERB	VBD	_	0	root	_	_
3	3	_	NUM	CD	_	4	nummod	_	_
4	subjects	_	NOUN	NNS	_	2	nsubj	_	_
5	with	_	ADP	IN	_	7	case	_	_
6	subtype	_	NOUN	NN	_	7	compound	_	_
7	4r	_	NOUN	NN	_	4	nmod	_	_
8	,	_	.	,	_	4	punct	_	_
9	2	_	NUM	CD	_	4	appos	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	whom	_	DET	WDT	_	12	nmod	_	_
12	experienced	_	VERB	VBD	_	14	amod	_	_
13	virologic	_	ADJ	JJ	_	14	amod	_	_
14	relapse	_	NOUN	NN	_	9	nmod	_	_
15	,	_	.	,	_	2	punct	_	_
16	and	_	CONJ	CC	_	2	cc	_	_
17	both	_	DET	DT	_	18	nsubj	_	_
18	had	_	VERB	VBD	_	2	conj	_	_
19	a	_	DET	DT	_	20	det	_	_
20	combination	_	NOUN	NN	_	18	dobj	_	_
21	of	_	ADP	IN	_	25	case	_	_
22	2	_	NUM	CD	_	25	nummod	_	_
23	pretreatment	_	NOUN	NN	_	25	compound	_	_
24	NS5A	_	NOUN	NN	_	25	compound	_	_
25	resistance	_	NOUN	NN	_	20	nmod	_	_
26	associated	_	VERB	VBN	_	25	acl	_	_
27	polymorphisms	_	NOUN	NNS	_	26	dobj	_	_
28	L28M	_	NOUN	NN	_	27	dep	_	_
29	/	_	.	:	_	27	punct	_	_
30	V+L30R	_	NOUN	NN	_	27	dep	_	_

#	Harvoni	4536
1	Phylogenetic	_	ADJ	JJ	_	2	amod	_	_
2	analysis	_	NOUN	NN	_	14	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	HCV	_	NOUN	NN	_	5	compound	_	_
5	sequences	_	NOUN	NNS	_	2	nmod	_	_
6	from	_	ADP	IN	_	10	case	_	_
7	genotype	_	NOUN	NN	_	10	compound	_	_
8	5	_	NUM	CD	_	10	nummod	_	_
9	infected	_	ADJ	JJ	_	10	amod	_	_
10	subjects	_	NOUN	NNS	_	2	nmod	_	_
11	in	_	ADP	IN	_	12	case	_	_
12	Study	_	NOUN	NN	_	10	nmod	_	_
13	1119	_	NUM	CD	_	12	nummod	_	_
14	showed	_	VERB	VBD	_	0	root	_	_
15	almost	_	ADV	RB	_	14	advmod	_	_
16	all	_	DET	DT	_	20	nsubj	_	_
17	were	_	VERB	VBD	_	20	cop	_	_
18	subtype	_	NOUN	NN	_	20	compound	_	_
19	5a	_	NOUN	NN	_	20	compound	_	_
20	N=39	_	NOUN	NN	_	14	dep	_	_
21	with	_	ADP	IN	_	23	case	_	_
22	one	_	NUM	CD	_	23	nummod	_	_
23	subject	_	NOUN	NN	_	20	nmod	_	_
24	not	_	ADV	RB	_	25	neg	_	_
25	having	_	VERB	VBG	_	23	acl	_	_
26	a	_	DET	DT	_	27	det	_	_
27	subtype	_	NOUN	NN	_	25	dobj	_	_
28	identified	_	VERB	VBN	_	27	acl	_	_
29	at	_	ADP	IN	_	30	case	_	_
30	screening	_	NOUN	NN	_	28	nmod	_	_
31	or	_	CONJ	CC	_	30	cc	_	_
32	by	_	ADP	IN	_	33	case	_	_
33	analysis	_	NOUN	NN	_	30	conj	_	_

#	Harvoni	4537
1	Phylogenetic	_	ADJ	JJ	_	2	amod	_	_
2	analysis	_	NOUN	NN	_	14	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	HCV	_	NOUN	NN	_	5	compound	_	_
5	sequences	_	NOUN	NNS	_	2	nmod	_	_
6	from	_	ADP	IN	_	10	case	_	_
7	genotype	_	NOUN	NN	_	10	compound	_	_
8	6	_	NUM	CD	_	10	nummod	_	_
9	infected	_	ADJ	JJ	_	10	amod	_	_
10	subjects	_	NOUN	NNS	_	2	nmod	_	_
11	in	_	ADP	IN	_	12	case	_	_
12	ELECTRON	_	NOUN	NN	_	10	nmod	_	_
13	2	_	NUM	CD	_	12	nummod	_	_
14	identified	_	VERB	VBD	_	0	root	_	_
15	7	_	NUM	CD	_	19	nummod	_	_
16	HCV	_	NOUN	NN	_	19	compound	_	_
17	genotype	_	NOUN	NN	_	19	compound	_	_
18	6	_	NUM	CD	_	19	nummod	_	_
19	subtypes	_	NOUN	NNS	_	14	dobj	_	_
20	6a	_	NOUN	NN	_	19	dep	_	_
21	,	_	.	,	_	20	punct	_	_
22	6e	_	NOUN	NN	_	20	conj	_	_
23	,	_	.	,	_	20	punct	_	_
24	6l	_	NOUN	NN	_	20	conj	_	_
25	,	_	.	,	_	20	punct	_	_
26	6m	_	NOUN	NN	_	20	conj	_	_
27	,	_	.	,	_	20	punct	_	_
28	6p	_	NOUN	NN	_	20	conj	_	_
29	,	_	.	,	_	20	punct	_	_
30	6q	_	NOUN	NN	_	20	conj	_	_
31	,	_	.	,	_	20	punct	_	_
32	and	_	CONJ	CC	_	20	cc	_	_
33	6r	_	ADJ	JJ	_	20	conj	_	_

#	Harvoni	4538
1	Thirty	_	NUM	CD	_	3	nummod	_	_
2	two	_	NUM	CD	_	3	nummod	_	_
3	percent	_	NOUN	NN	_	7	nsubj	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	the	_	DET	DT	_	6	det	_	_
6	subjects	_	NOUN	NNS	_	3	nmod	_	_
7	had	_	VERB	VBD	_	0	root	_	_
8	subtype	_	NOUN	NN	_	9	compound	_	_
9	6a	_	NOUN	NN	_	7	dobj	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	24%	_	NOUN	NN	_	9	conj	_	_
12	had	_	VERB	VBD	_	7	parataxis	_	_
13	subtype	_	NOUN	NN	_	14	compound	_	_
14	6e	_	ADJ	JJ	_	12	dep	_	_

#	Harvoni	4539
1	One	_	NUM	CD	_	3	compound	_	_
2	to	_	PRT	TO	_	3	dep	_	_
3	three	_	NUM	CD	_	4	nummod	_	_
4	subjects	_	NOUN	NNS	_	6	nsubjpass	_	_
5	were	_	VERB	VBD	_	6	auxpass	_	_
6	infected	_	VERB	VBN	_	0	root	_	_
7	with	_	ADP	IN	_	10	case	_	_
8	the	_	DET	DT	_	10	det	_	_
9	other	_	ADJ	JJ	_	10	amod	_	_
10	subtypes	_	NOUN	NNS	_	6	nmod	_	_
11	6l	_	NOUN	NN	_	10	dep	_	_
12	,	_	.	,	_	11	punct	_	_
13	6m	_	NOUN	NN	_	11	conj	_	_
14	,	_	.	,	_	11	punct	_	_
15	6p	_	NOUN	NN	_	11	conj	_	_
16	,	_	.	,	_	11	punct	_	_
17	6q	_	NOUN	NN	_	11	conj	_	_
18	,	_	.	,	_	11	punct	_	_
19	or	_	CONJ	CC	_	11	cc	_	_
20	6r	_	ADJ	JJ	_	11	conj	_	_

#	Harvoni	4540
1	The	_	DET	DT	_	3	det	_	_
2	one	_	NUM	CD	_	3	nummod	_	_
3	subject	_	NOUN	NN	_	9	nsubj	_	_
4	who	_	DET	WDT	_	7	nsubj	_	_
5	did	_	VERB	VBD	_	7	aux	_	_
6	not	_	ADV	RB	_	7	neg	_	_
7	achieve	_	VERB	VB	_	3	acl:relcl	_	_
8	SVR12	_	NOUN	NN	_	7	dobj	_	_
9	had	_	VERB	VBD	_	0	root	_	_
10	subtype	_	NOUN	NN	_	11	compound	_	_
11	6l	_	NOUN	NN	_	9	dobj	_	_

#	Harvoni	4541
1	Although	_	ADP	IN	_	5	mark	_	_
2	the	_	DET	DT	_	3	det	_	_
3	data	_	NOUN	NNS	_	5	nsubj	_	_
4	are	_	VERB	VBP	_	5	cop	_	_
5	limited	_	ADJ	JJ	_	15	advcl	_	_
6	,	_	.	,	_	15	punct	_	_
7	baseline	_	NOUN	NN	_	12	compound	_	_
8	HCV	_	NOUN	NN	_	12	compound	_	_
9	NS5A	_	NOUN	NN	_	12	compound	_	_
10	resistance	_	NOUN	NN	_	12	compound	_	_
11	associated	_	ADJ	JJ	_	12	amod	_	_
12	polymorphisms	_	NOUN	NNS	_	15	nsubjpass	_	_
13	are	_	VERB	VBP	_	15	auxpass	_	_
14	not	_	ADV	RB	_	15	neg	_	_
15	expected	_	VERB	VBN	_	0	root	_	_
16	to	_	PRT	TO	_	17	mark	_	_
17	impact	_	VERB	VB	_	15	xcomp	_	_
18	the	_	DET	DT	_	19	det	_	_
19	likelihood	_	NOUN	NN	_	17	dobj	_	_
20	of	_	ADP	IN	_	21	mark	_	_
21	achieving	_	VERB	VBG	_	19	acl	_	_
22	SVR	_	NOUN	NN	_	21	dobj	_	_
23	when	_	ADV	WRB	_	26	advmod	_	_
24	DRUG	_	NOUN	NN	_	26	nsubjpass	_	_
25	is	_	VERB	VBZ	_	26	auxpass	_	_
26	used	_	VERB	VBN	_	17	advcl	_	_
27	as	_	ADP	IN	_	28	mark	_	_
28	recommended	_	VERB	VBN	_	26	advcl	_	_
29	to	_	PRT	TO	_	30	mark	_	_
30	treat	_	VERB	VB	_	28	xcomp	_	_
31	HCV	_	NOUN	NN	_	32	compound	_	_
32	genotype	_	NOUN	NN	_	30	dobj	_	_
33	4	_	NUM	CD	_	32	nummod	_	_
34	,	_	.	,	_	32	punct	_	_
35	5	_	NUM	CD	_	32	conj	_	_
36	,	_	.	,	_	32	punct	_	_
37	or	_	CONJ	CC	_	32	cc	_	_
38	6	_	NUM	CD	_	40	nummod	_	_
39	infected	_	ADJ	JJ	_	40	amod	_	_
40	patients	_	NOUN	NNS	_	32	conj	_	_
41	,	_	.	,	_	17	punct	_	_
42	based	_	VERB	VBN	_	17	xcomp	_	_
43	on	_	ADP	IN	_	48	case	_	_
44	the	_	DET	DT	_	48	det	_	_
45	low	_	ADJ	JJ	_	48	amod	_	_
46	virologic	_	ADJ	JJ	_	48	amod	_	_
47	failure	_	NOUN	NN	_	48	compound	_	_
48	rate	_	NOUN	NN	_	42	nmod	_	_
49	observed	_	VERB	VBN	_	48	acl	_	_
50	in	_	ADP	IN	_	51	case	_	_
51	Study	_	NOUN	NN	_	49	nmod	_	_
52	1119	_	NUM	CD	_	51	nummod	_	_
53	and	_	CONJ	CC	_	51	cc	_	_
54	ELECTRON	_	NOUN	NN	_	51	conj	_	_
55	2	_	NUM	CD	_	54	nummod	_	_

#	Harvoni	4542
1	The	_	DET	DT	_	4	det	_	_
2	specific	_	ADJ	JJ	_	4	amod	_	_
3	baseline	_	NOUN	NN	_	4	compound	_	_
4	polymorphisms	_	NOUN	NNS	_	12	nsubj	_	_
5	observed	_	VERB	VBN	_	4	acl	_	_
6	in	_	ADP	IN	_	7	case	_	_
7	subjects	_	NOUN	NNS	_	5	nmod	_	_
8	with	_	ADP	IN	_	10	case	_	_
9	virologic	_	ADJ	JJ	_	10	amod	_	_
10	failure	_	NOUN	NN	_	7	nmod	_	_
11	were	_	VERB	VBD	_	12	cop	_	_
12	L28M	_	NOUN	NN	_	0	root	_	_
13	/	_	.	:	_	12	punct	_	_
14	V	_	NOUN	NN	_	12	dep	_	_
15	,	_	.	,	_	14	punct	_	_
16	L30R	_	NOUN	NN	_	14	conj	_	_
17	,	_	.	,	_	14	punct	_	_
18	and	_	CONJ	CC	_	14	cc	_	_
19	P58T	_	NOUN	NN	_	14	conj	_	_
20	for	_	ADP	IN	_	23	case	_	_
21	genotype	_	NOUN	NN	_	23	compound	_	_
22	4	_	NUM	CD	_	23	nummod	_	_
23	L31M	_	NOUN	NN	_	14	nmod	_	_
24	for	_	ADP	IN	_	25	case	_	_
25	genotype	_	NOUN	NN	_	23	nmod	_	_
26	5	_	NUM	CD	_	25	nummod	_	_
27	and	_	CONJ	CC	_	25	cc	_	_
28	Q24K	_	NOUN	NN	_	25	conj	_	_
29	,	_	.	,	_	25	punct	_	_
30	F28V	_	NOUN	NN	_	25	conj	_	_
31	,	_	.	,	_	25	punct	_	_
32	R30A	_	NOUN	NN	_	25	conj	_	_
33	,	_	.	,	_	25	punct	_	_
34	and	_	CONJ	CC	_	25	cc	_	_
35	T58P	_	NOUN	NN	_	25	conj	_	_
36	for	_	ADP	IN	_	37	case	_	_
37	genotype	_	NOUN	NN	_	23	nmod	_	_
38	6	_	NUM	CD	_	37	nummod	_	_

#	Harvoni	4543
1	Relapse	_	NOUN	NN	_	2	nsubj	_	_
2	occurred	_	VERB	VBD	_	0	root	_	_
3	in	_	ADP	IN	_	9	case	_	_
4	2	_	NUM	CD	_	9	nummod	_	_
5	of	_	ADP	IN	_	9	case	_	_
6	3	_	NUM	CD	_	9	nummod	_	_
7	genotype	_	NOUN	NN	_	9	compound	_	_
8	4	_	NUM	CD	_	9	nummod	_	_
9	subjects	_	NOUN	NNS	_	2	nmod	_	_
10	who	_	DET	WDT	_	11	nsubj	_	_
11	had	_	VERB	VBD	_	9	acl:relcl	_	_
12	baseline	_	NOUN	NN	_	14	compound	_	_
13	NS5B	_	NOUN	NN	_	14	compound	_	_
14	V321I	_	NOUN	NN	_	11	dobj	_	_
15	,	_	.	,	_	2	punct	_	_
16	a	_	DET	DT	_	17	det	_	_
17	polymorphism	_	NOUN	NN	_	35	nsubj	_	_
18	at	_	ADP	IN	_	20	case	_	_
19	a	_	DET	DT	_	20	det	_	_
20	position	_	NOUN	NN	_	17	nmod	_	_
21	associated	_	VERB	VBN	_	20	acl	_	_
22	with	_	ADP	IN	_	24	case	_	_
23	treatment	_	NOUN	NN	_	24	compound	_	_
24	failure	_	NOUN	NN	_	21	nmod	_	_
25	to	_	PRT	TO	_	26	case	_	_
26	DRUG	_	NOUN	NN	_	24	nmod	_	_
27	and	_	CONJ	CC	_	26	cc	_	_
28	other	_	ADJ	JJ	_	30	amod	_	_
29	nucleoside	_	NOUN	NN	_	30	compound	_	_
30	inhibitors	_	NOUN	NNS	_	26	conj	_	_
31	these	_	DET	DT	_	33	det	_	_
32	two	_	NUM	CD	_	33	nummod	_	_
33	subjects	_	NOUN	NNS	_	35	nsubj	_	_
34	also	_	ADV	RB	_	35	advmod	_	_
35	had	_	VERB	VBD	_	2	parataxis	_	_
36	baseline	_	NOUN	NN	_	40	compound	_	_
37	NS5A	_	NOUN	NN	_	40	compound	_	_
38	resistance	_	NOUN	NN	_	40	compound	_	_
39	associated	_	ADJ	JJ	_	40	amod	_	_
40	polymorphisms	_	NOUN	NNS	_	35	dobj	_	_

#	Harvoni	4544
1	For	_	ADP	IN	_	2	case	_	_
2	genotype	_	NOUN	NN	_	9	nmod	_	_
3	5	_	NUM	CD	_	2	nummod	_	_
4	and	_	CONJ	CC	_	2	cc	_	_
5	6	_	NUM	CD	_	2	conj	_	_
6	,	_	.	,	_	9	punct	_	_
7	SVR12	_	NOUN	NN	_	9	nsubjpass	_	_
8	was	_	VERB	VBD	_	9	auxpass	_	_
9	achieved	_	VERB	VBN	_	0	root	_	_
10	in	_	ADP	IN	_	11	case	_	_
11	subjects	_	NOUN	NNS	_	9	nmod	_	_
12	who	_	DET	WDT	_	13	nsubj	_	_
13	had	_	VERB	VBD	_	11	acl:relcl	_	_
14	baseline	_	NOUN	NN	_	16	compound	_	_
15	NS5B	_	NOUN	NN	_	16	compound	_	_
16	polymorphisms	_	NOUN	NNS	_	13	dobj	_	_
17	at	_	ADP	IN	_	18	case	_	_
18	positions	_	NOUN	NNS	_	13	nmod	_	_
19	associated	_	VERB	VBN	_	18	acl	_	_
20	with	_	ADP	IN	_	21	case	_	_
21	resistance	_	NOUN	NN	_	19	nmod	_	_
22	to	_	PRT	TO	_	23	case	_	_
23	DRUG	_	NOUN	NN	_	21	nmod	_	_
24	and	_	CONJ	CC	_	23	cc	_	_
25	other	_	ADJ	JJ	_	27	amod	_	_
26	nucleoside	_	NOUN	NN	_	27	compound	_	_
27	inhibitors	_	NOUN	NNS	_	23	conj	_	_
28	N=1	_	NOUN	NN	_	27	dep	_	_
29	with	_	ADP	IN	_	30	case	_	_
30	N142T	_	NOUN	NN	_	21	nmod	_	_
31	in	_	ADP	IN	_	34	case	_	_
32	genotype	_	NOUN	NN	_	34	compound	_	_
33	5	_	NUM	CD	_	34	nummod	_	_
34	N=1	_	NOUN	NN	_	21	nmod	_	_
35	with	_	ADP	IN	_	36	case	_	_
36	M289I	_	NOUN	NN	_	21	nmod	_	_
37	in	_	ADP	IN	_	40	case	_	_
38	genotype	_	NOUN	NN	_	40	compound	_	_
39	5	_	NUM	CD	_	40	nummod	_	_
40	N=15	_	NOUN	NN	_	21	nmod	_	_
41	with	_	ADP	IN	_	42	case	_	_
42	M289L	_	NOUN	NN	_	21	nmod	_	_
43	/	_	.	-LRB-	_	44	punct	_	_
44	I	_	NUM	CD	_	11	dep	_	_
45	in	_	ADP	IN	_	46	case	_	_
46	genotype	_	NOUN	NN	_	44	nmod	_	_
47	6	_	NUM	CD	_	46	nummod	_	_

#	Harvoni	4545
1	The	_	DET	DT	_	3	det	_	_
2	DRUG	_	NOUN	NN	_	3	compound	_	_
3	resistance	_	NOUN	NN	_	9	nsubjpass	_	_
4	associated	_	VERB	VBN	_	6	amod	_	_
5	substitution	_	NOUN	NN	_	6	compound	_	_
6	S282T	_	NOUN	NN	_	3	dep	_	_
7	was	_	VERB	VBD	_	9	auxpass	_	_
8	not	_	ADV	RB	_	9	neg	_	_
9	detected	_	VERB	VBN	_	0	root	_	_
10	in	_	ADP	IN	_	14	case	_	_
11	the	_	DET	DT	_	14	det	_	_
12	baseline	_	NOUN	NN	_	14	compound	_	_
13	NS5B	_	NOUN	NN	_	14	compound	_	_
14	sequence	_	NOUN	NN	_	9	nmod	_	_
15	of	_	ADP	IN	_	17	case	_	_
16	any	_	DET	DT	_	17	det	_	_
17	subject	_	NOUN	NN	_	14	nmod	_	_
18	with	_	ADP	IN	_	19	case	_	_
19	genotype	_	NOUN	NN	_	17	nmod	_	_
20	4	_	NUM	CD	_	19	nummod	_	_
21	,	_	.	,	_	19	punct	_	_
22	5	_	NUM	CD	_	19	conj	_	_
23	,	_	.	,	_	19	punct	_	_
24	or	_	CONJ	CC	_	19	cc	_	_
25	6	_	NUM	CD	_	26	nummod	_	_
26	HCV	_	NOUN	NN	_	19	conj	_	_
27	in	_	ADP	IN	_	29	case	_	_
28	clinical	_	ADJ	JJ	_	29	amod	_	_
29	trials	_	NOUN	NNS	_	14	nmod	_	_
30	by	_	ADP	IN	_	31	case	_	_
31	population	_	NOUN	NN	_	9	nmod	_	_
32	or	_	CONJ	CC	_	9	cc	_	_
33	deep	_	VERB	VBP	_	9	conj	_	_
34	nucleotide	_	NOUN	NN	_	36	compound	_	_
35	sequence	_	NOUN	NN	_	36	compound	_	_
36	analysis	_	NOUN	NN	_	33	dobj	_	_

#	Harvoni	4546
1	Pediatrics	_	NOUN	NNS	_	0	root	_	_
2	In	_	ADP	IN	_	3	case	_	_
3	Study	_	NOUN	NN	_	1	nmod	_	_
4	1116	_	NUM	CD	_	3	nummod	_	_
5	,	_	.	,	_	1	punct	_	_
6	the	_	DET	DT	_	7	det	_	_
7	presence	_	NOUN	NN	_	17	nsubj	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	NS5A	_	NOUN	NN	_	7	nmod	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	NS5B	_	NOUN	NN	_	12	compound	_	_
12	resistance	_	NOUN	NN	_	9	conj	_	_
13	associated	_	ADJ	JJ	_	14	amod	_	_
14	polymorphisms	_	NOUN	NNS	_	9	dep	_	_
15	did	_	VERB	VBD	_	17	aux	_	_
16	not	_	ADV	RB	_	17	neg	_	_
17	impact	_	VERB	VB	_	1	dep	_	_
18	treatment	_	NOUN	NN	_	19	compound	_	_
19	outcome	_	NOUN	NN	_	17	dobj	_	_
20	all	_	DET	DT	_	22	det	_	_
21	pediatric	_	ADJ	JJ	_	22	amod	_	_
22	subjects	_	NOUN	NNS	_	17	dobj	_	_
23	12	_	NUM	CD	_	24	nummod	_	_
24	years	_	NOUN	NNS	_	22	dep	_	_
25	of	_	ADP	IN	_	26	case	_	_
26	age	_	NOUN	NN	_	24	nmod	_	_
27	and	_	CONJ	CC	_	24	cc	_	_
28	older	_	ADV	RB	_	24	conj	_	_
29	with	_	ADP	IN	_	31	case	_	_
30	baseline	_	NOUN	NN	_	31	compound	_	_
31	NS5A	_	NOUN	NN	_	38	compound	_	_
32	or	_	CONJ	CC	_	31	cc	_	_
33	NS5B	_	NOUN	NN	_	36	compound	_	_
34	nucleoside	_	NOUN	NN	_	36	compound	_	_
35	inhibitor	_	NOUN	NN	_	36	compound	_	_
36	resistance	_	NOUN	NN	_	31	conj	_	_
37	associated	_	VERB	VBN	_	38	amod	_	_
38	polymorphisms	_	NOUN	NNS	_	28	nmod	_	_
39	18%	_	ADJ	JJ	_	38	amod	_	_
40	17	_	NUM	CD	_	39	nummod	_	_
41	/	_	.	:	_	38	punct	_	_
42	96	_	NUM	CD	_	44	nummod	_	_
43	achieved	_	VERB	VBN	_	44	amod	_	_
44	SVR	_	NOUN	NN	_	38	conj	_	_
45	following	_	ADP	IN	_	48	case	_	_
46	12	_	NUM	CD	_	48	nummod	_	_
47	weeks	_	NOUN	NN	_	48	compound	_	_
48	treatment	_	NOUN	NN	_	38	nmod	_	_
49	with	_	ADP	IN	_	50	case	_	_
50	DRUG	_	NOUN	NN	_	48	nmod	_	_

#	Harvoni	4547
1	Cross	_	NOUN	NN	_	2	compound	_	_
2	Resistance	_	NOUN	NN	_	0	root	_	_
3	Based	_	VERB	VBN	_	2	acl	_	_
4	on	_	ADP	IN	_	6	case	_	_
5	resistance	_	NOUN	NN	_	6	compound	_	_
6	patterns	_	NOUN	NNS	_	3	nmod	_	_
7	observed	_	VERB	VBN	_	6	acl	_	_
8	in	_	ADP	IN	_	12	case	_	_
9	cell	_	NOUN	NN	_	12	compound	_	_
10	culture	_	NOUN	NN	_	12	compound	_	_
11	replicon	_	NOUN	NN	_	12	compound	_	_
12	studies	_	NOUN	NNS	_	7	nmod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	HCV	_	NOUN	NN	_	16	compound	_	_
15	infected	_	ADJ	JJ	_	16	amod	_	_
16	subjects	_	NOUN	NNS	_	12	conj	_	_
17	,	_	.	,	_	2	punct	_	_
18	cross	_	ADJ	JJ	_	19	amod	_	_
19	resistance	_	NOUN	NN	_	27	nsubjpass	_	_
20	between	_	ADP	IN	_	21	case	_	_
21	DRUG	_	NOUN	NN	_	19	nmod	_	_
22	and	_	CONJ	CC	_	21	cc	_	_
23	other	_	ADJ	JJ	_	25	amod	_	_
24	NS5A	_	NOUN	NN	_	25	compound	_	_
25	inhibitors	_	NOUN	NNS	_	21	conj	_	_
26	is	_	VERB	VBZ	_	27	auxpass	_	_
27	expected	_	VERB	VBN	_	2	dep	_	_

#	Harvoni	4548
1	Both	_	CONJ	CC	_	2	cc:preconj	_	_
2	DRUG	_	NOUN	NN	_	7	nsubj	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	DRUG	_	NOUN	NN	_	2	conj	_	_
5	were	_	VERB	VBD	_	7	cop	_	_
6	fully	_	ADV	RB	_	7	advmod	_	_
7	active	_	ADJ	JJ	_	0	root	_	_
8	against	_	ADP	IN	_	9	case	_	_
9	substitutions	_	NOUN	NNS	_	7	nmod	_	_
10	associated	_	VERB	VBN	_	9	acl	_	_
11	with	_	ADP	IN	_	12	case	_	_
12	resistance	_	NOUN	NN	_	10	nmod	_	_
13	to	_	PRT	TO	_	15	case	_	_
14	other	_	ADJ	JJ	_	15	amod	_	_
15	classes	_	NOUN	NNS	_	12	nmod	_	_
16	of	_	ADP	IN	_	19	case	_	_
17	direct	_	ADJ	JJ	_	19	amod	_	_
18	acting	_	VERB	VBG	_	19	amod	_	_
19	antivirals	_	NOUN	NNS	_	15	nmod	_	_
20	with	_	ADP	IN	_	22	case	_	_
21	different	_	ADJ	JJ	_	22	amod	_	_
22	mechanisms	_	NOUN	NNS	_	15	nmod	_	_
23	of	_	ADP	IN	_	24	case	_	_
24	action	_	NOUN	NN	_	22	nmod	_	_
25	,	_	.	,	_	7	punct	_	_
26	such	_	ADJ	JJ	_	31	case	_	_
27	as	_	ADP	IN	_	26	mwe	_	_
28	NS5B	_	NOUN	NN	_	31	compound	_	_
29	non	_	ADJ	JJ	_	31	amod	_	_
30	nucleoside	_	NOUN	NN	_	31	compound	_	_
31	inhibitors	_	NOUN	NNS	_	7	nmod	_	_
32	and	_	CONJ	CC	_	31	cc	_	_
33	NS3	_	NOUN	NN	_	35	compound	_	_
34	protease	_	NOUN	NN	_	35	compound	_	_
35	inhibitors	_	NOUN	NNS	_	31	conj	_	_

#	Harvoni	4549
1	The	_	DET	DT	_	2	det	_	_
2	efficacy	_	NOUN	NN	_	10	nsubjpass	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	DRUG	_	NOUN	NN	_	6	compound	_	_
5	/	_	.	:	_	6	punct	_	_
6	DRUG	_	NOUN	NN	_	2	nmod	_	_
7	has	_	VERB	VBZ	_	10	aux	_	_
8	not	_	ADV	RB	_	10	neg	_	_
9	been	_	VERB	VBN	_	10	auxpass	_	_
10	established	_	VERB	VBN	_	0	root	_	_
11	in	_	ADP	IN	_	12	case	_	_
12	patients	_	NOUN	NNS	_	10	nmod	_	_
13	who	_	DET	WDT	_	16	nsubj	_	_
14	have	_	VERB	VBP	_	16	aux	_	_
15	previously	_	ADV	RB	_	16	advmod	_	_
16	failed	_	VERB	VBN	_	12	acl:relcl	_	_
17	treatment	_	NOUN	NN	_	16	dobj	_	_
18	with	_	ADP	IN	_	20	case	_	_
19	other	_	ADJ	JJ	_	20	amod	_	_
20	regimens	_	NOUN	NNS	_	17	nmod	_	_
21	that	_	DET	WDT	_	22	nsubj	_	_
22	include	_	VERB	VBP	_	20	acl:relcl	_	_
23	an	_	DET	DT	_	25	det	_	_
24	NS5A	_	NOUN	NN	_	25	compound	_	_
25	inhibitor	_	NOUN	NN	_	22	dobj	_	_

#	INVEGA	4247
1	Centrally	_	ADV	RB	_	2	advmod	_	_
2	acting	_	VERB	VBG	_	0	root	_	_
3	drugs	_	NOUN	NNS	_	2	dobj	_	_
4	:	_	.	:	_	2	punct	_	_
5	Due	_	NOUN	NN	_	10	nsubj	_	_
6	to	_	PRT	TO	_	8	case	_	_
7	CNS	_	NOUN	NN	_	8	compound	_	_
8	effects	_	NOUN	NNS	_	5	nmod	_	_
9	,	_	.	,	_	5	punct	_	_
10	use	_	VERB	VBP	_	2	parataxis	_	_
11	caution	_	NOUN	NN	_	10	dobj	_	_
12	in	_	ADP	IN	_	13	case	_	_
13	combination	_	NOUN	NN	_	11	nmod	_	_

#	INVEGA	4248
1	Drugs	_	NOUN	NNS	_	0	root	_	_
2	that	_	DET	WDT	_	4	nsubj	_	_
3	may	_	VERB	MD	_	4	aux	_	_
4	cause	_	VERB	VB	_	1	acl:relcl	_	_
5	orthostatic	_	ADJ	JJ	_	6	amod	_	_
6	hypotension	_	NOUN	NN	_	4	dobj	_	_
7	:	_	.	:	_	1	punct	_	_
8	An	_	DET	DT	_	10	det	_	_
9	additive	_	ADJ	JJ	_	10	amod	_	_
10	effect	_	NOUN	NN	_	13	nsubjpass	_	_
11	may	_	VERB	MD	_	13	aux	_	_
12	be	_	VERB	VB	_	13	auxpass	_	_
13	observed	_	VERB	VBN	_	1	dep	_	_
14	when	_	ADV	WRB	_	13	advmod	_	_
15	co	_	PRT	TO	_	14	nmod	_	_
16	administered	_	VERB	VBN	_	15	root	_	_
17	with	_	ADP	IN	_	18	case	_	_
18	DRUG	_	NOUN	NN	_	16	nmod	_	_
19	*	_	NUM	CD	_	18	nummod	_	_

#	INVEGA	4249
1	Strong	_	ADJ	JJ	_	2	amod	_	_
2	CYP3A4	_	NOUN	NN	_	8	compound	_	_
3	/	_	.	:	_	8	punct	_	_
4	P	_	NOUN	NN	_	8	compound	_	_
5	glycoprotein	_	NOUN	NN	_	8	compound	_	_
6	P	_	NOUN	NN	_	8	compound	_	_
7	gp	_	NOUN	NN	_	8	compound	_	_
8	inducers	_	NOUN	NNS	_	0	root	_	_
9	:	_	.	:	_	8	punct	_	_
10	It	_	NOUN	NN	_	13	nsubj	_	_
11	may	_	VERB	MD	_	13	aux	_	_
12	be	_	VERB	VB	_	13	cop	_	_
13	necessary	_	ADJ	JJ	_	8	dep	_	_
14	to	_	PRT	TO	_	15	mark	_	_
15	increase	_	VERB	VB	_	13	xcomp	_	_
16	the	_	DET	DT	_	17	det	_	_
17	dose	_	NOUN	NN	_	15	dobj	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	DRUG	_	NOUN	NN	_	17	nmod	_	_
20	*	_	NUM	CD	_	17	dep	_	_
21	when	_	ADV	WRB	_	20	mwe	_	_
22	a	_	DET	DT	_	24	det	_	_
23	strong	_	ADJ	JJ	_	24	amod	_	_
24	inducer	_	NOUN	NN	_	20	dep	_	_
25	of	_	ADP	IN	_	27	case	_	_
26	both	_	CONJ	CC	_	27	cc:preconj	_	_
27	CYP3A4	_	NOUN	NN	_	24	nmod	_	_
28	and	_	CONJ	CC	_	27	cc	_	_
29	P	_	NOUN	NN	_	31	compound	_	_
30	gp	_	NOUN	NN	_	31	compound	_	_
31	e.g	_	NOUN	NN	_	27	conj	_	_
32	,	_	.	,	_	24	punct	_	_
33	carbamazepine	_	NOUN	NN	_	36	nsubjpass	_	_
34	is	_	VERB	VBZ	_	36	auxpass	_	_
35	co	_	PRT	TO	_	36	mark	_	_
36	administered	_	VERB	VBN	_	24	dep	_	_

#	INVEGA	4250
1	Conversely	_	ADV	RB	_	13	advmod	_	_
2	,	_	.	,	_	13	punct	_	_
3	on	_	ADP	IN	_	4	case	_	_
4	discontinuation	_	NOUN	NN	_	13	nmod	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	the	_	DET	DT	_	8	det	_	_
7	strong	_	ADJ	JJ	_	8	amod	_	_
8	inducer	_	NOUN	NN	_	4	nmod	_	_
9	,	_	.	,	_	13	punct	_	_
10	it	_	PRON	PRP	_	13	nsubj	_	_
11	may	_	VERB	MD	_	13	aux	_	_
12	be	_	VERB	VB	_	13	cop	_	_
13	necessary	_	ADJ	JJ	_	0	root	_	_
14	to	_	PRT	TO	_	15	mark	_	_
15	decrease	_	VERB	VB	_	13	xcomp	_	_
16	the	_	DET	DT	_	17	det	_	_
17	dose	_	NOUN	NN	_	15	dobj	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	DRUG	_	NOUN	NN	_	17	nmod	_	_
20	*	_	NUM	CD	_	19	nummod	_	_

#	INVEGA	4251
1	Co	_	PRT	TO	_	2	case	_	_
2	administration	_	NOUN	NN	_	6	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	divalproex	_	NOUN	NN	_	5	compound	_	_
5	sodium	_	NOUN	NN	_	2	nmod	_	_
6	increased	_	VERB	VBD	_	0	root	_	_
7	Cmax	_	NOUN	NN	_	6	dobj	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	AUC	_	NOUN	NN	_	7	conj	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	7	nmod	_	_
12	by	_	ADP	IN	_	14	case	_	_
13	approximately	_	ADV	RB	_	14	advmod	_	_
14	50%	_	ADJ	JJ	_	6	nmod	_	_

#	INVEGA	4252
1	Adjust	_	ADJ	JJ	_	2	amod	_	_
2	dose	_	NOUN	NN	_	0	root	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	*	_	NUM	CD	_	2	nummod	_	_
6	if	_	ADP	IN	_	8	mark	_	_
7	necessary	_	ADJ	JJ	_	8	advmod	_	_
8	based	_	VERB	VBN	_	2	dep	_	_
9	on	_	ADP	IN	_	11	case	_	_
10	clinical	_	ADJ	JJ	_	11	amod	_	_
11	assessment	_	NOUN	NN	_	8	nmod	_	_

#	INVEGA	4253
1	Given	_	ADP	IN	_	5	case	_	_
2	the	_	DET	DT	_	5	det	_	_
3	primary	_	ADJ	JJ	_	5	amod	_	_
4	CNS	_	NOUN	NN	_	5	compound	_	_
5	effects	_	NOUN	NNS	_	13	nmod	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	,	_	.	,	_	13	punct	_	_
9	DRUG	_	NOUN	NN	_	13	nsubjpass	_	_
10	*	_	NUM	CD	_	9	nummod	_	_
11	should	_	VERB	MD	_	13	aux	_	_
12	be	_	VERB	VB	_	13	auxpass	_	_
13	used	_	VERB	VBN	_	0	root	_	_
14	with	_	ADP	IN	_	15	case	_	_
15	caution	_	NOUN	NN	_	13	nmod	_	_
16	in	_	ADP	IN	_	17	case	_	_
17	combination	_	NOUN	NN	_	15	nmod	_	_
18	with	_	ADP	IN	_	22	case	_	_
19	other	_	ADJ	JJ	_	22	amod	_	_
20	centrally	_	ADV	RB	_	21	advmod	_	_
21	acting	_	VERB	VBG	_	22	amod	_	_
22	drugs	_	NOUN	NNS	_	17	nmod	_	_
23	and	_	CONJ	CC	_	22	cc	_	_
24	alcohol	_	NOUN	NN	_	22	conj	_	_

#	INVEGA	4254
1	DRUG	_	NOUN	NN	_	3	nsubj	_	_
2	may	_	VERB	MD	_	3	aux	_	_
3	antagonize	_	VERB	VB	_	0	root	_	_
4	the	_	DET	DT	_	5	det	_	_
5	effect	_	NOUN	NN	_	3	dobj	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	levodopa	_	NOUN	NN	_	5	nmod	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	other	_	ADJ	JJ	_	11	amod	_	_
10	dopamine	_	NOUN	NN	_	11	compound	_	_
11	agonists	_	NOUN	NNS	_	7	conj	_	_

#	INVEGA	4255
1	Because	_	ADP	IN	_	4	case	_	_
2	of	_	ADP	IN	_	4	case	_	_
3	its	_	PRON	PRP$	_	4	nmod:poss	_	_
4	potential	_	NOUN	NN	_	15	nmod	_	_
5	for	_	ADP	IN	_	6	mark	_	_
6	inducing	_	VERB	VBG	_	4	acl	_	_
7	orthostatic	_	ADJ	JJ	_	8	amod	_	_
8	hypotension	_	NOUN	NN	_	6	dobj	_	_
9	,	_	.	,	_	15	punct	_	_
10	an	_	DET	DT	_	12	det	_	_
11	additive	_	ADJ	JJ	_	12	amod	_	_
12	effect	_	NOUN	NN	_	15	nsubjpass	_	_
13	may	_	VERB	MD	_	15	aux	_	_
14	be	_	VERB	VB	_	15	auxpass	_	_
15	observed	_	VERB	VBN	_	0	root	_	_
16	when	_	ADV	WRB	_	20	advmod	_	_
17	DRUG	_	NOUN	NN	_	20	nsubjpass	_	_
18	*	_	NUM	CD	_	17	nummod	_	_
19	is	_	VERB	VBZ	_	20	auxpass	_	_
20	administered	_	VERB	VBN	_	15	ccomp	_	_
21	with	_	ADP	IN	_	24	case	_	_
22	other	_	ADJ	JJ	_	24	amod	_	_
23	therapeutic	_	ADJ	JJ	_	24	amod	_	_
24	agents	_	NOUN	NNS	_	20	nmod	_	_
25	that	_	DET	WDT	_	26	nsubj	_	_
26	have	_	VERB	VBP	_	24	acl:relcl	_	_
27	this	_	DET	DT	_	28	det	_	_
28	potential	_	ADJ	JJ	_	26	dobj	_	_

#	INVEGA	4256
1	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
2	is	_	VERB	VBZ	_	4	auxpass	_	_
3	not	_	ADV	RB	_	4	neg	_	_
4	expected	_	VERB	VBN	_	0	root	_	_
5	to	_	PRT	TO	_	6	mark	_	_
6	cause	_	VERB	VB	_	4	xcomp	_	_
7	clinically	_	ADV	RB	_	8	advmod	_	_
8	important	_	ADJ	JJ	_	10	amod	_	_
9	pharmacokinetic	_	ADJ	JJ	_	10	amod	_	_
10	interactions	_	NOUN	NNS	_	6	dobj	_	_
11	with	_	ADP	IN	_	12	case	_	_
12	drugs	_	NOUN	NNS	_	10	nmod	_	_
13	that	_	DET	WDT	_	15	nsubjpass	_	_
14	are	_	VERB	VBP	_	15	auxpass	_	_
15	metabolized	_	VERB	VBN	_	12	acl:relcl	_	_
16	by	_	ADP	IN	_	19	case	_	_
17	cytochrome	_	NOUN	NN	_	19	compound	_	_
18	P450	_	NOUN	NN	_	19	compound	_	_
19	isozymes	_	NOUN	NNS	_	15	nmod	_	_

#	INVEGA	4257
1	In	_	X	FW	_	3	amod	_	_
2	vitro	_	X	FW	_	1	dep	_	_
3	studies	_	NOUN	NNS	_	8	nsubj	_	_
4	in	_	ADP	IN	_	7	case	_	_
5	human	_	ADJ	JJ	_	7	amod	_	_
6	liver	_	NOUN	NN	_	7	compound	_	_
7	microsomes	_	NOUN	NNS	_	3	nmod	_	_
8	showed	_	VERB	VBD	_	0	root	_	_
9	that	_	ADP	IN	_	14	mark	_	_
10	DRUG	_	NOUN	NN	_	14	nsubj	_	_
11	does	_	VERB	VBZ	_	14	aux	_	_
12	not	_	ADV	RB	_	14	neg	_	_
13	substantially	_	ADV	RB	_	14	advmod	_	_
14	inhibit	_	VERB	VB	_	8	ccomp	_	_
15	the	_	DET	DT	_	16	det	_	_
16	metabolism	_	NOUN	NN	_	14	dobj	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	drugs	_	NOUN	NNS	_	16	nmod	_	_
19	metabolized	_	VERB	VBN	_	18	acl	_	_
20	by	_	ADP	IN	_	23	case	_	_
21	cytochrome	_	NOUN	NN	_	23	compound	_	_
22	P450	_	NOUN	NN	_	23	compound	_	_
23	isozymes	_	NOUN	NNS	_	19	nmod	_	_
24	,	_	.	,	_	23	punct	_	_
25	including	_	VERB	VBG	_	26	case	_	_
26	CYP1A2	_	NOUN	NN	_	23	nmod	_	_
27	,	_	.	,	_	26	punct	_	_
28	CYP2A6	_	NOUN	NN	_	26	conj	_	_
29	,	_	.	,	_	26	punct	_	_
30	CYP2C8	_	NOUN	NN	_	26	conj	_	_
31	/	_	.	:	_	26	punct	_	_
32	9	_	NUM	CD	_	26	nummod	_	_
33	/	_	.	-RRB-	_	26	punct	_	_
34	10	_	NUM	CD	_	26	nummod	_	_
35	,	_	.	,	_	26	punct	_	_
36	CYP2D6	_	NOUN	NN	_	26	conj	_	_
37	,	_	.	,	_	26	punct	_	_
38	CYP2E1	_	NOUN	NN	_	26	conj	_	_
39	,	_	.	,	_	26	punct	_	_
40	CYP3A4	_	NOUN	NN	_	26	conj	_	_
41	,	_	.	,	_	26	punct	_	_
42	and	_	CONJ	CC	_	26	cc	_	_
43	CYP3A5	_	NOUN	NN	_	26	conj	_	_

#	INVEGA	4258
1	Therefore	_	ADV	RB	_	6	advmod	_	_
2	,	_	.	,	_	6	punct	_	_
3	DRUG	_	NOUN	NN	_	6	nsubjpass	_	_
4	is	_	VERB	VBZ	_	6	auxpass	_	_
5	not	_	ADV	RB	_	6	neg	_	_
6	expected	_	VERB	VBN	_	0	root	_	_
7	to	_	PRT	TO	_	8	mark	_	_
8	inhibit	_	VERB	VB	_	6	xcomp	_	_
9	clearance	_	NOUN	NN	_	8	dobj	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	drugs	_	NOUN	NNS	_	9	nmod	_	_
12	that	_	DET	WDT	_	14	nsubjpass	_	_
13	are	_	VERB	VBP	_	14	auxpass	_	_
14	metabolized	_	VERB	VBN	_	11	acl:relcl	_	_
15	by	_	ADP	IN	_	18	case	_	_
16	these	_	DET	DT	_	18	det	_	_
17	metabolic	_	ADJ	JJ	_	18	amod	_	_
18	pathways	_	NOUN	NNS	_	14	nmod	_	_
19	in	_	ADP	IN	_	23	case	_	_
20	a	_	DET	DT	_	23	det	_	_
21	clinically	_	ADV	RB	_	22	advmod	_	_
22	relevant	_	ADJ	JJ	_	23	amod	_	_
23	manner	_	NOUN	NN	_	18	nmod	_	_

#	INVEGA	4259
1	DRUG	_	NOUN	NN	_	5	nsubjpass	_	_
2	is	_	VERB	VBZ	_	5	auxpass	_	_
3	also	_	ADV	RB	_	5	advmod	_	_
4	not	_	ADV	RB	_	5	neg	_	_
5	expected	_	VERB	VBN	_	0	root	_	_
6	to	_	PRT	TO	_	7	mark	_	_
7	have	_	VERB	VB	_	5	xcomp	_	_
8	enzyme	_	NOUN	NN	_	10	compound	_	_
9	inducing	_	NOUN	NN	_	10	compound	_	_
10	properties	_	NOUN	NNS	_	7	dobj	_	_

#	INVEGA	4260
1	DRUG	_	NOUN	NN	_	5	nsubj	_	_
2	is	_	VERB	VBZ	_	5	cop	_	_
3	a	_	DET	DT	_	5	det	_	_
4	weak	_	ADJ	JJ	_	5	amod	_	_
5	inhibitor	_	NOUN	NN	_	0	root	_	_
6	of	_	ADP	IN	_	10	case	_	_
7	P	_	NOUN	NN	_	10	compound	_	_
8	glycoprotein	_	NOUN	NN	_	10	compound	_	_
9	P	_	NOUN	NN	_	10	compound	_	_
10	gp	_	NOUN	NN	_	5	nmod	_	_
11	at	_	ADP	IN	_	13	case	_	_
12	high	_	ADJ	JJ	_	13	amod	_	_
13	concentrations	_	NOUN	NNS	_	5	nmod	_	_

#	INVEGA	4261
1	No	_	DET	DT	_	4	neg	_	_
2	in	_	X	FW	_	4	amod	_	_
3	vivo	_	X	FW	_	2	dep	_	_
4	data	_	NOUN	NNS	_	6	nsubj	_	_
5	are	_	VERB	VBP	_	6	cop	_	_
6	available	_	ADJ	JJ	_	0	root	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	the	_	DET	DT	_	10	det	_	_
9	clinical	_	ADJ	JJ	_	10	amod	_	_
10	relevance	_	NOUN	NN	_	12	nsubj	_	_
11	is	_	VERB	VBZ	_	12	auxpass	_	_
12	unknown	_	ADJ	JJ	_	6	conj	_	_

#	INVEGA	4262
1	Pharmacokinetic	_	ADJ	JJ	_	2	amod	_	_
2	interaction	_	NOUN	NN	_	9	nsubj	_	_
3	between	_	ADP	IN	_	4	case	_	_
4	lithium	_	NOUN	NN	_	2	nmod	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	DRUG	_	NOUN	NN	_	4	conj	_	_
7	*	_	NUM	CD	_	2	nummod	_	_
8	is	_	VERB	VBZ	_	9	auxpass	_	_
9	unlikely	_	ADV	RB	_	0	root	_	_

#	INVEGA	4263
1	In	_	ADP	IN	_	5	case	_	_
2	a	_	DET	DT	_	5	det	_	_
3	drug	_	NOUN	NN	_	5	compound	_	_
4	interaction	_	NOUN	NN	_	5	compound	_	_
5	study	_	NOUN	NN	_	22	nmod	_	_
6	,	_	.	,	_	22	punct	_	_
7	co	_	PRT	TO	_	8	case	_	_
8	administration	_	NOUN	NN	_	22	nsubj	_	_
9	of	_	ADP	IN	_	13	case	_	_
10	DRUG	_	NOUN	NN	_	13	compound	_	_
11	*	_	CONJ	CC	_	13	punct	_	_
12	12	_	NUM	CD	_	13	nummod	_	_
13	mg	_	NOUN	NN	_	8	nmod	_	_
14	once	_	ADV	RB	_	15	advmod	_	_
15	daily	_	ADV	RB	_	22	advmod	_	_
16	for	_	ADP	IN	_	18	case	_	_
17	5	_	NUM	CD	_	18	nummod	_	_
18	days	_	NOUN	NNS	_	15	nmod	_	_
19	with	_	ADP	IN	_	21	case	_	_
20	divalproex	_	NOUN	NN	_	21	compound	_	_
21	sodium	_	NOUN	NN	_	18	nmod	_	_
22	extended	_	VERB	VBD	_	0	root	_	_
23	release	_	NOUN	NN	_	24	compound	_	_
24	tablets	_	NOUN	NNS	_	22	dobj	_	_
25	500	_	NUM	CD	_	26	nummod	_	_
26	mg	_	NOUN	NN	_	28	advmod	_	_
27	to	_	PRT	TO	_	28	dep	_	_
28	2000	_	NUM	CD	_	29	nummod	_	_
29	mg	_	NOUN	NN	_	24	nmod	_	_
30	once	_	ADV	RB	_	31	advmod	_	_
31	daily	_	ADV	RB	_	29	advmod	_	_
32	did	_	VERB	VBD	_	34	aux	_	_
33	not	_	ADV	RB	_	34	neg	_	_
34	affect	_	VERB	VB	_	22	parataxis	_	_
35	the	_	DET	DT	_	38	det	_	_
36	steady	_	ADJ	JJ	_	38	amod	_	_
37	state	_	NOUN	NN	_	38	compound	_	_
38	pharmacokinetics	_	NOUN	NNS	_	34	dobj	_	_
39	AUC24h	_	NOUN	NN	_	38	dep	_	_
40	and	_	CONJ	CC	_	39	cc	_	_
41	Cmax,ss	_	NOUN	NN	_	39	conj	_	_
42	of	_	ADP	IN	_	43	case	_	_
43	valproate	_	NOUN	NN	_	38	nmod	_	_
44	in	_	ADP	IN	_	46	case	_	_
45	13	_	NUM	CD	_	46	nummod	_	_
46	patients	_	NOUN	NNS	_	38	nmod	_	_
47	stabilized	_	VERB	VBN	_	46	acl	_	_
48	on	_	ADP	IN	_	49	case	_	_
49	valproate	_	NOUN	NN	_	47	nmod	_	_

#	INVEGA	4264
1	In	_	ADP	IN	_	4	case	_	_
2	a	_	DET	DT	_	4	det	_	_
3	clinical	_	ADJ	JJ	_	4	amod	_	_
4	study	_	NOUN	NN	_	12	nmod	_	_
5	,	_	.	,	_	12	punct	_	_
6	subjects	_	NOUN	NNS	_	12	nsubj	_	_
7	on	_	ADP	IN	_	9	case	_	_
8	stable	_	ADJ	JJ	_	9	amod	_	_
9	doses	_	NOUN	NNS	_	6	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	valproate	_	NOUN	NN	_	9	nmod	_	_
12	had	_	VERB	VBD	_	0	root	_	_
13	comparable	_	ADJ	JJ	_	17	amod	_	_
14	valproate	_	NOUN	NN	_	17	compound	_	_
15	average	_	ADJ	JJ	_	17	amod	_	_
16	plasma	_	NOUN	NN	_	17	compound	_	_
17	concentrations	_	NOUN	NNS	_	12	dobj	_	_
18	when	_	ADV	WRB	_	27	advmod	_	_
19	DRUG	_	NOUN	NN	_	25	compound	_	_
20	*	_	CONJ	CC	_	21	advmod	_	_
21	3	_	NUM	CD	_	25	nummod	_	_
22	15	_	NUM	CD	_	23	nummod	_	_
23	mg	_	NOUN	NN	_	21	conj	_	_
24	/	_	.	:	_	21	punct	_	_
25	day	_	NOUN	NN	_	27	nsubjpass	_	_
26	was	_	VERB	VBD	_	27	auxpass	_	_
27	added	_	VERB	VBN	_	12	advcl	_	_
28	to	_	PRT	TO	_	32	case	_	_
29	their	_	PRON	PRP$	_	32	nmod:poss	_	_
30	existing	_	VERB	VBG	_	32	amod	_	_
31	valproate	_	NOUN	NN	_	32	compound	_	_
32	treatment	_	NOUN	NN	_	27	nmod	_	_

#	INVEGA	4265
1	DRUG	_	NOUN	NN	_	5	nsubj	_	_
2	is	_	VERB	VBZ	_	5	cop	_	_
3	not	_	ADV	RB	_	5	neg	_	_
4	a	_	DET	DT	_	5	det	_	_
5	substrate	_	NOUN	NN	_	0	root	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	CYP1A2	_	NOUN	NN	_	5	nmod	_	_
8	,	_	.	,	_	7	punct	_	_
9	CYP2A6	_	NOUN	NN	_	7	conj	_	_
10	,	_	.	,	_	7	punct	_	_
11	CYP2C9	_	NOUN	NN	_	7	conj	_	_
12	,	_	.	,	_	7	punct	_	_
13	and	_	CONJ	CC	_	7	cc	_	_
14	CYP2C19	_	NOUN	NN	_	7	conj	_	_
15	,	_	.	,	_	5	punct	_	_
16	so	_	ADV	RB	_	28	advmod	_	_
17	that	_	ADP	IN	_	28	mark	_	_
18	an	_	DET	DT	_	19	det	_	_
19	interaction	_	NOUN	NN	_	28	nsubj	_	_
20	with	_	ADP	IN	_	21	case	_	_
21	inhibitors	_	NOUN	NNS	_	19	nmod	_	_
22	or	_	CONJ	CC	_	21	cc	_	_
23	inducers	_	NOUN	NNS	_	21	conj	_	_
24	of	_	ADP	IN	_	26	case	_	_
25	these	_	DET	DT	_	26	det	_	_
26	isozymes	_	NOUN	NNS	_	21	nmod	_	_
27	is	_	VERB	VBZ	_	28	auxpass	_	_
28	unlikely	_	ADV	RB	_	5	advmod	_	_

#	INVEGA	4266
1	While	_	ADP	IN	_	5	mark	_	_
2	in	_	X	FW	_	4	amod	_	_
3	vitro	_	X	FW	_	2	dep	_	_
4	studies	_	NOUN	NNS	_	5	nsubj	_	_
5	indicate	_	VERB	VBP	_	23	advcl	_	_
6	that	_	ADP	IN	_	13	mark	_	_
7	CYP2D6	_	NOUN	NN	_	13	nsubjpass	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	CYP3A4	_	NOUN	NN	_	7	conj	_	_
10	may	_	VERB	MD	_	13	aux	_	_
11	be	_	VERB	VB	_	13	auxpass	_	_
12	minimally	_	ADV	RB	_	13	advmod	_	_
13	involved	_	VERB	VBN	_	5	ccomp	_	_
14	in	_	ADP	IN	_	16	case	_	_
15	DRUG	_	NOUN	NN	_	16	compound	_	_
16	metabolism	_	NOUN	NN	_	13	nmod	_	_
17	,	_	.	,	_	23	punct	_	_
18	in	_	X	FW	_	20	amod	_	_
19	vivo	_	X	FW	_	18	dep	_	_
20	studies	_	NOUN	NNS	_	23	nsubj	_	_
21	do	_	VERB	MD	_	23	aux	_	_
22	not	_	ADV	RB	_	23	neg	_	_
23	show	_	VERB	VB	_	0	root	_	_
24	decreased	_	VERB	VBN	_	25	amod	_	_
25	elimination	_	NOUN	NN	_	23	dobj	_	_
26	by	_	ADP	IN	_	28	case	_	_
27	these	_	DET	DT	_	28	det	_	_
28	isozymes	_	NOUN	NNS	_	25	nmod	_	_
29	and	_	CONJ	CC	_	23	cc	_	_
30	they	_	PRON	PRP	_	31	nsubj	_	_
31	contribute	_	VERB	VBP	_	23	conj	_	_
32	to	_	PRT	TO	_	36	case	_	_
33	only	_	ADV	RB	_	36	advmod	_	_
34	a	_	DET	DT	_	36	det	_	_
35	small	_	ADJ	JJ	_	36	amod	_	_
36	fraction	_	NOUN	NN	_	31	nmod	_	_
37	of	_	ADP	IN	_	40	case	_	_
38	total	_	ADJ	JJ	_	40	amod	_	_
39	body	_	NOUN	NN	_	40	compound	_	_
40	clearance	_	NOUN	NN	_	36	nmod	_	_

#	INVEGA	4267
1	In	_	X	FW	_	3	amod	_	_
2	vitro	_	X	FW	_	1	dep	_	_
3	studies	_	NOUN	NNS	_	5	nsubj	_	_
4	have	_	VERB	VBP	_	5	aux	_	_
5	shown	_	VERB	VBN	_	0	root	_	_
6	that	_	ADP	IN	_	12	mark	_	_
7	DRUG	_	NOUN	NN	_	12	nsubj	_	_
8	is	_	VERB	VBZ	_	12	cop	_	_
9	a	_	DET	DT	_	12	det	_	_
10	P	_	NOUN	NN	_	12	compound	_	_
11	gp	_	NOUN	NN	_	12	compound	_	_
12	substrate	_	NOUN	NN	_	5	ccomp	_	_

#	INVEGA	4268
1	Co	_	PRT	TO	_	2	case	_	_
2	administration	_	NOUN	NN	_	30	nmod	_	_
3	of	_	ADP	IN	_	7	case	_	_
4	DRUG	_	NOUN	NN	_	7	compound	_	_
5	*	_	CONJ	CC	_	7	punct	_	_
6	6	_	NUM	CD	_	7	nummod	_	_
7	mg	_	NOUN	NN	_	2	nmod	_	_
8	once	_	ADV	RB	_	9	advmod	_	_
9	daily	_	ADV	RB	_	2	advmod	_	_
10	with	_	ADP	IN	_	11	case	_	_
11	carbamazepine	_	NOUN	NN	_	9	nmod	_	_
12	,	_	.	,	_	30	punct	_	_
13	a	_	DET	DT	_	15	det	_	_
14	strong	_	ADJ	JJ	_	15	amod	_	_
15	inducer	_	NOUN	NN	_	30	nsubj	_	_
16	of	_	ADP	IN	_	18	case	_	_
17	both	_	CONJ	CC	_	18	cc:preconj	_	_
18	CYP3A4	_	NOUN	NN	_	15	nmod	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	P	_	NOUN	NN	_	23	compound	_	_
21	glycoprotein	_	NOUN	NN	_	23	compound	_	_
22	P	_	NOUN	NN	_	23	compound	_	_
23	gp	_	NOUN	NN	_	18	conj	_	_
24	,	_	.	,	_	15	punct	_	_
25	at	_	ADP	IN	_	27	case	_	_
26	200	_	NUM	CD	_	27	nummod	_	_
27	mg	_	NOUN	NN	_	15	nmod	_	_
28	twice	_	ADV	RB	_	30	advmod	_	_
29	daily	_	ADV	RB	_	30	advmod	_	_
30	caused	_	VERB	VBD	_	0	root	_	_
31	a	_	DET	DT	_	32	det	_	_
32	decrease	_	NOUN	NN	_	30	dobj	_	_
33	of	_	ADP	IN	_	35	case	_	_
34	approximately	_	ADV	RB	_	35	advmod	_	_
35	37%	_	NOUN	NN	_	32	nmod	_	_
36	in	_	ADP	IN	_	41	case	_	_
37	the	_	DET	DT	_	41	det	_	_
38	mean	_	NOUN	NN	_	41	compound	_	_
39	steady	_	ADJ	JJ	_	41	amod	_	_
40	state	_	NOUN	NN	_	41	compound	_	_
41	Cmax	_	NOUN	NN	_	32	nmod	_	_
42	and	_	CONJ	CC	_	41	cc	_	_
43	AUC	_	NOUN	NN	_	41	conj	_	_
44	of	_	ADP	IN	_	45	case	_	_
45	DRUG	_	NOUN	NN	_	41	nmod	_	_

#	INVEGA	4269
1	This	_	DET	DT	_	2	det	_	_
2	decrease	_	NOUN	NN	_	4	nsubjpass	_	_
3	is	_	VERB	VBZ	_	4	auxpass	_	_
4	caused	_	VERB	VBN	_	0	root	_	_
5	,	_	.	,	_	4	punct	_	_
6	to	_	PRT	TO	_	9	case	_	_
7	a	_	DET	DT	_	9	det	_	_
8	substantial	_	ADJ	JJ	_	9	amod	_	_
9	degree	_	NOUN	NN	_	4	nmod	_	_
10	,	_	.	,	_	4	punct	_	_
11	by	_	ADP	IN	_	14	case	_	_
12	a	_	DET	DT	_	14	det	_	_
13	35%	_	ADJ	JJ	_	14	amod	_	_
14	increase	_	NOUN	NN	_	4	nmod	_	_
15	in	_	ADP	IN	_	17	case	_	_
16	renal	_	ADJ	JJ	_	17	amod	_	_
17	clearance	_	NOUN	NN	_	14	nmod	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	DRUG	_	NOUN	NN	_	17	nmod	_	_

#	INVEGA	4270
1	A	_	DET	DT	_	3	det	_	_
2	minor	_	ADJ	JJ	_	3	amod	_	_
3	decrease	_	NOUN	NN	_	14	nsubj	_	_
4	in	_	ADP	IN	_	6	case	_	_
5	the	_	DET	DT	_	6	det	_	_
6	amount	_	NOUN	NN	_	3	nmod	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	drug	_	NOUN	NN	_	6	nmod	_	_
9	excreted	_	VERB	VBN	_	8	acl	_	_
10	unchanged	_	ADJ	JJ	_	9	xcomp	_	_
11	in	_	ADP	IN	_	13	case	_	_
12	the	_	DET	DT	_	13	det	_	_
13	urine	_	ADJ	JJ	_	10	nmod	_	_
14	suggests	_	VERB	VBZ	_	0	root	_	_
15	that	_	ADP	IN	_	17	mark	_	_
16	there	_	DET	EX	_	17	expl	_	_
17	was	_	VERB	VBD	_	14	ccomp	_	_
18	little	_	ADJ	JJ	_	19	amod	_	_
19	effect	_	NOUN	NN	_	17	nsubj	_	_
20	on	_	ADP	IN	_	23	case	_	_
21	the	_	DET	DT	_	23	det	_	_
22	CYP	_	NOUN	NN	_	23	compound	_	_
23	metabolism	_	NOUN	NN	_	17	nmod	_	_
24	or	_	CONJ	CC	_	23	cc	_	_
25	bioavailability	_	NOUN	NN	_	23	conj	_	_
26	of	_	ADP	IN	_	27	case	_	_
27	DRUG	_	NOUN	NN	_	23	nmod	_	_
28	during	_	ADP	IN	_	29	case	_	_
29	carbamazepine	_	NOUN	NN	_	17	nmod	_	_
30	co	_	ADP	IN	_	31	case	_	_
31	administration	_	NOUN	NN	_	29	nmod	_	_

#	INVEGA	4271
1	On	_	ADP	IN	_	2	case	_	_
2	initiation	_	NOUN	NN	_	14	nmod	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	carbamazepine	_	NOUN	NN	_	2	nmod	_	_
5	,	_	.	,	_	14	punct	_	_
6	the	_	DET	DT	_	7	det	_	_
7	dose	_	NOUN	NN	_	14	nsubjpass	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	*	_	NUM	CD	_	9	nummod	_	_
11	should	_	VERB	MD	_	14	aux	_	_
12	be	_	VERB	VB	_	14	auxpass	_	_
13	re	_	ADV	RB	_	14	advmod	_	_
14	evaluated	_	VERB	VBN	_	0	root	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	increased	_	VERB	VBD	_	14	conj	_	_
17	if	_	ADP	IN	_	16	root	_	_
18	necessary	_	ADJ	JJ	_	17	root	_	_

#	INVEGA	4272
1	Conversely	_	ADV	RB	_	16	advmod	_	_
2	,	_	.	,	_	16	punct	_	_
3	on	_	ADP	IN	_	4	case	_	_
4	discontinuation	_	NOUN	NN	_	16	nmod	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	carbamazepine	_	NOUN	NN	_	4	nmod	_	_
7	,	_	.	,	_	16	punct	_	_
8	the	_	DET	DT	_	9	det	_	_
9	dose	_	NOUN	NN	_	16	nsubjpass	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_
12	*	_	NUM	CD	_	11	nummod	_	_
13	should	_	VERB	MD	_	16	aux	_	_
14	be	_	VERB	VB	_	16	auxpass	_	_
15	re	_	ADV	RB	_	16	advmod	_	_
16	evaluated	_	VERB	VBN	_	0	root	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	decreased	_	VERB	VBD	_	16	conj	_	_
19	if	_	ADP	IN	_	18	root	_	_
20	necessary	_	ADJ	JJ	_	19	root	_	_

#	INVEGA	4273
1	DRUG	_	NOUN	NN	_	3	nsubjpass	_	_
2	is	_	VERB	VBZ	_	3	auxpass	_	_
3	metabolized	_	VERB	VBN	_	0	root	_	_
4	to	_	PRT	TO	_	7	case	_	_
5	a	_	DET	DT	_	7	det	_	_
6	limited	_	ADJ	JJ	_	7	amod	_	_
7	extent	_	NOUN	NN	_	3	nmod	_	_
8	by	_	ADP	IN	_	9	case	_	_
9	CYP2D6	_	NOUN	NN	_	7	nmod	_	_

#	INVEGA	4274
1	In	_	ADP	IN	_	4	case	_	_
2	an	_	DET	DT	_	4	det	_	_
3	interaction	_	NOUN	NN	_	4	compound	_	_
4	study	_	NOUN	NN	_	40	nmod	_	_
5	in	_	ADP	IN	_	7	case	_	_
6	healthy	_	ADJ	JJ	_	7	amod	_	_
7	subjects	_	NOUN	NNS	_	4	nmod	_	_
8	in	_	ADP	IN	_	9	case	_	_
9	which	_	DET	WDT	_	19	nmod	_	_
10	a	_	DET	DT	_	14	det	_	_
11	single	_	ADJ	JJ	_	14	amod	_	_
12	3	_	NUM	CD	_	14	nummod	_	_
13	mg	_	NOUN	NN	_	14	compound	_	_
14	dose	_	NOUN	NN	_	19	nsubjpass	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	14	nmod	_	_
17	*	_	NUM	CD	_	16	nummod	_	_
18	was	_	VERB	VBD	_	19	auxpass	_	_
19	administered	_	VERB	VBN	_	7	acl:relcl	_	_
20	concomitantly	_	ADV	RB	_	19	advmod	_	_
21	with	_	ADP	IN	_	23	case	_	_
22	20	_	NUM	CD	_	23	nummod	_	_
23	mg	_	NOUN	NN	_	19	nmod	_	_
24	per	_	ADP	IN	_	25	case	_	_
25	day	_	NOUN	NN	_	19	nmod	_	_
26	of	_	ADP	IN	_	27	case	_	_
27	paroxetine	_	NOUN	NN	_	25	nmod	_	_
28	a	_	DET	DT	_	31	det	_	_
29	potent	_	ADJ	JJ	_	31	amod	_	_
30	CYP2D6	_	NOUN	NN	_	31	compound	_	_
31	inhibitor	_	NOUN	NN	_	27	dep	_	_
32	,	_	.	,	_	40	punct	_	_
33	DRUG	_	NOUN	NN	_	34	compound	_	_
34	exposures	_	NOUN	NNS	_	40	nsubj	_	_
35	were	_	VERB	VBD	_	40	cop	_	_
36	on	_	ADP	IN	_	40	case	_	_
37	average	_	ADJ	JJ	_	40	amod	_	_
38	16%	_	ADJ	JJ	_	40	amod	_	_
39	90%	_	ADJ	JJ	_	40	amod	_	_
40	CI	_	NOUN	NN	_	0	root	_	_
41	:	_	.	:	_	40	punct	_	_
42	4	_	NUM	CD	_	40	dep	_	_
43	,	_	.	,	_	42	punct	_	_
44	30	_	NUM	CD	_	45	nummod	_	_
45	higher	_	ADJ	JJ	_	42	dep	_	_
46	in	_	ADP	IN	_	49	case	_	_
47	CYP2D6	_	NOUN	NN	_	49	compound	_	_
48	extensive	_	ADJ	JJ	_	49	amod	_	_
49	metabolizers	_	NOUN	NNS	_	45	nmod	_	_

#	INVEGA	4275
1	Higher	_	ADJ	JJ	_	2	amod	_	_
2	doses	_	NOUN	NNS	_	8	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	paroxetine	_	NOUN	NN	_	2	nmod	_	_
5	have	_	VERB	MD	_	8	aux	_	_
6	not	_	ADV	RB	_	8	neg	_	_
7	been	_	VERB	VBN	_	8	auxpass	_	_
8	studied	_	VERB	VBN	_	0	root	_	_

#	INVEGA	4276
1	Co	_	PRT	TO	_	2	case	_	_
2	administration	_	NOUN	NN	_	15	nsubj	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	a	_	DET	DT	_	6	det	_	_
5	single	_	ADJ	JJ	_	6	amod	_	_
6	dose	_	NOUN	NN	_	2	nmod	_	_
7	of	_	ADP	IN	_	11	case	_	_
8	DRUG	_	NOUN	NN	_	11	compound	_	_
9	*	_	CONJ	CC	_	8	cc	_	_
10	12	_	NUM	CD	_	8	conj	_	_
11	mg	_	NOUN	NN	_	6	nmod	_	_
12	with	_	ADP	IN	_	14	case	_	_
13	divalproex	_	NOUN	NN	_	14	compound	_	_
14	sodium	_	NOUN	NN	_	2	nmod	_	_
15	extended	_	VERB	VBD	_	0	root	_	_
16	release	_	NOUN	NN	_	17	compound	_	_
17	tablets	_	NOUN	NNS	_	15	dobj	_	_
18	two	_	NUM	CD	_	21	nummod	_	_
19	500	_	NUM	CD	_	21	nummod	_	_
20	mg	_	NOUN	NN	_	21	amod	_	_
21	tablets	_	NOUN	NNS	_	24	nsubj	_	_
22	once	_	ADV	RB	_	23	advmod	_	_
23	daily	_	ADV	RB	_	24	advmod	_	_
24	resulted	_	VERB	VBD	_	17	dep	_	_
25	in	_	ADP	IN	_	27	case	_	_
26	an	_	DET	DT	_	27	det	_	_
27	increase	_	NOUN	NN	_	24	nmod	_	_
28	of	_	ADP	IN	_	30	case	_	_
29	approximately	_	ADV	RB	_	30	advmod	_	_
30	50%	_	NOUN	NN	_	27	nmod	_	_
31	in	_	ADP	IN	_	33	case	_	_
32	the	_	DET	DT	_	33	det	_	_
33	Cmax	_	NOUN	NN	_	27	nmod	_	_
34	and	_	CONJ	CC	_	33	cc	_	_
35	AUC	_	NOUN	NN	_	33	conj	_	_
36	of	_	ADP	IN	_	37	case	_	_
37	DRUG	_	NOUN	NN	_	33	nmod	_	_

#	INVEGA	4277
1	Dosage	_	NOUN	NN	_	2	compound	_	_
2	reduction	_	NOUN	NN	_	8	nsubjpass	_	_
3	for	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	*	_	NUM	CD	_	4	nummod	_	_
6	should	_	VERB	MD	_	8	aux	_	_
7	be	_	VERB	VB	_	8	auxpass	_	_
8	considered	_	VERB	VBN	_	0	root	_	_
9	when	_	ADV	WRB	_	14	advmod	_	_
10	DRUG	_	NOUN	NN	_	14	nsubjpass	_	_
11	*	_	NUM	CD	_	10	nummod	_	_
12	is	_	VERB	VBZ	_	14	auxpass	_	_
13	co	_	PRT	TO	_	14	mark	_	_
14	administered	_	VERB	VBN	_	8	advcl	_	_
15	with	_	ADP	IN	_	16	case	_	_
16	valproate	_	NOUN	NN	_	14	nmod	_	_
17	after	_	ADP	IN	_	19	case	_	_
18	clinical	_	ADJ	JJ	_	19	amod	_	_
19	assessment	_	NOUN	NN	_	14	nmod	_	_

#	INVEGA	4279
1	DRUG	_	NOUN	NN	_	6	nsubj	_	_
2	is	_	VERB	VBZ	_	6	cop	_	_
3	the	_	DET	DT	_	6	det	_	_
4	major	_	ADJ	JJ	_	6	amod	_	_
5	active	_	ADJ	JJ	_	6	amod	_	_
6	metabolite	_	NOUN	NN	_	0	root	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	risperidone	_	NOUN	NN	_	6	nmod	_	_

#	INVEGA	4280
1	The	_	DET	DT	_	2	det	_	_
2	mechanism	_	NOUN	NN	_	18	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	action	_	NOUN	NN	_	2	nmod	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	,	_	.	,	_	2	punct	_	_
8	as	_	ADP	IN	_	11	case	_	_
9	with	_	ADP	IN	_	11	case	_	_
10	other	_	ADJ	JJ	_	11	amod	_	_
11	drugs	_	NOUN	NNS	_	2	nmod	_	_
12	having	_	VERB	VBG	_	11	acl	_	_
13	efficacy	_	NOUN	NN	_	12	dobj	_	_
14	in	_	ADP	IN	_	15	case	_	_
15	schizophrenia	_	NOUN	NN	_	13	nmod	_	_
16	,	_	.	,	_	2	punct	_	_
17	is	_	VERB	VBZ	_	18	cop	_	_
18	unknown	_	ADJ	JJ	_	0	root	_	_
19	,	_	.	,	_	18	punct	_	_
20	but	_	CONJ	CC	_	18	cc	_	_
21	it	_	PRON	PRP	_	24	nsubjpass	_	_
22	has	_	VERB	VBZ	_	24	aux	_	_
23	been	_	VERB	VBN	_	24	auxpass	_	_
24	proposed	_	VERB	VBN	_	18	conj	_	_
25	that	_	ADP	IN	_	33	mark	_	_
26	the	_	DET	DT	_	29	det	_	_
27	drug's	_	NOUN	NNS	_	29	compound	_	_
28	therapeutic	_	ADJ	JJ	_	29	amod	_	_
29	activity	_	NOUN	NN	_	33	nsubjpass	_	_
30	in	_	ADP	IN	_	31	case	_	_
31	schizophrenia	_	NOUN	NN	_	29	nmod	_	_
32	is	_	VERB	VBZ	_	33	auxpass	_	_
33	mediated	_	VERB	VBN	_	24	ccomp	_	_
34	through	_	ADP	IN	_	36	case	_	_
35	a	_	DET	DT	_	36	det	_	_
36	combination	_	NOUN	NN	_	33	nmod	_	_
37	of	_	ADP	IN	_	42	case	_	_
38	central	_	ADJ	JJ	_	42	amod	_	_
39	dopamine	_	NOUN	NN	_	42	compound	_	_
40	Type	_	NOUN	NN	_	42	compound	_	_
41	2	_	NUM	CD	_	42	nummod	_	_
42	D2	_	NOUN	NN	_	36	nmod	_	_
43	and	_	CONJ	CC	_	42	cc	_	_
44	serotonin	_	NOUN	NN	_	49	compound	_	_
45	Type	_	NOUN	NN	_	49	compound	_	_
46	2	_	NUM	CD	_	49	nummod	_	_
47	5HT2A	_	NOUN	NN	_	49	compound	_	_
48	receptor	_	NOUN	NN	_	49	compound	_	_
49	antagonism	_	NOUN	NN	_	42	conj	_	_

#	INVEGA	4281
1	DRUG	_	NOUN	NN	_	10	nsubj	_	_
2	is	_	VERB	VBZ	_	10	cop	_	_
3	a	_	DET	DT	_	10	det	_	_
4	centrally	_	ADV	RB	_	5	advmod	_	_
5	active	_	ADJ	JJ	_	10	amod	_	_
6	dopamine	_	NOUN	NN	_	10	compound	_	_
7	Type	_	NOUN	NN	_	10	compound	_	_
8	2	_	NUM	CD	_	10	nummod	_	_
9	D2	_	NOUN	NN	_	10	compound	_	_
10	antagonist	_	NOUN	NN	_	0	root	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	with	_	ADP	IN	_	18	case	_	_
13	predominant	_	ADJ	JJ	_	18	amod	_	_
14	serotonin	_	NOUN	NN	_	18	compound	_	_
15	Type	_	NOUN	NN	_	18	compound	_	_
16	2	_	NUM	CD	_	18	nummod	_	_
17	5HT2A	_	NOUN	NN	_	18	compound	_	_
18	activity	_	NOUN	NN	_	10	conj	_	_

#	INVEGA	4282
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	is	_	VERB	VBZ	_	4	cop	_	_
3	also	_	ADV	RB	_	4	advmod	_	_
4	active	_	ADJ	JJ	_	0	root	_	_
5	as	_	ADP	IN	_	7	case	_	_
6	an	_	DET	DT	_	7	det	_	_
7	antagonist	_	NOUN	NN	_	4	nmod	_	_
8	at	_	ADP	IN	_	9	case	_	_
9	A1	_	NOUN	NN	_	7	nmod	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	A2	_	NOUN	NN	_	13	compound	_	_
12	adrenergic	_	ADJ	JJ	_	13	amod	_	_
13	receptors	_	NOUN	NNS	_	9	conj	_	_
14	and	_	CONJ	CC	_	9	cc	_	_
15	H1	_	NOUN	NN	_	17	compound	_	_
16	histaminergic	_	ADJ	JJ	_	17	amod	_	_
17	receptors	_	NOUN	NNS	_	9	conj	_	_
18	,	_	.	,	_	9	punct	_	_
19	which	_	DET	WDT	_	21	nsubj	_	_
20	may	_	VERB	MD	_	21	aux	_	_
21	explain	_	VERB	VB	_	9	acl:relcl	_	_
22	some	_	DET	DT	_	21	dobj	_	_
23	of	_	ADP	IN	_	26	case	_	_
24	the	_	DET	DT	_	26	det	_	_
25	other	_	ADJ	JJ	_	26	amod	_	_
26	effects	_	NOUN	NNS	_	22	nmod	_	_
27	of	_	ADP	IN	_	29	case	_	_
28	the	_	DET	DT	_	29	det	_	_
29	drug	_	NOUN	NN	_	26	nmod	_	_

#	INVEGA	4283
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	has	_	VERB	VBZ	_	0	root	_	_
3	no	_	DET	DT	_	4	neg	_	_
4	affinity	_	NOUN	NN	_	2	dobj	_	_
5	for	_	ADP	IN	_	7	case	_	_
6	cholinergic	_	ADJ	JJ	_	7	amod	_	_
7	muscarinic	_	ADJ	JJ	_	4	nmod	_	_
8	or	_	CONJ	CC	_	7	cc	_	_
9	B1	_	NOUN	NN	_	7	conj	_	_
10	and	_	CONJ	CC	_	7	cc	_	_
11	B2	_	NOUN	NN	_	13	compound	_	_
12	adrenergic	_	ADJ	JJ	_	13	amod	_	_
13	receptors	_	NOUN	NNS	_	7	conj	_	_

#	INVEGA	4284
1	The	_	DET	DT	_	3	det	_	_
2	pharmacological	_	ADJ	JJ	_	3	amod	_	_
3	activity	_	NOUN	NN	_	14	nsubj	_	_
4	of	_	ADP	IN	_	9	case	_	_
5	the	_	DET	DT	_	9	det	_	_
6	+	_	CONJ	CC	_	9	amod	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	DRUG	_	NOUN	NN	_	6	conj	_	_
9	enantiomers	_	NOUN	NNS	_	3	nmod	_	_
10	is	_	VERB	VBZ	_	14	cop	_	_
11	qualitatively	_	ADV	RB	_	12	advmod	_	_
12	and	_	CONJ	CC	_	14	advmod	_	_
13	quantitatively	_	ADV	RB	_	12	advmod	_	_
14	similar	_	ADJ	JJ	_	0	root	_	_
15	in	_	NOUN	NN	_	16	compound	_	_
16	vitro	_	X	FW	_	14	advmod	_	_

#	INVEGA	4285
1	Following	_	ADP	IN	_	4	case	_	_
2	a	_	DET	DT	_	4	det	_	_
3	single	_	ADJ	JJ	_	4	amod	_	_
4	dose	_	NOUN	NN	_	12	nmod	_	_
5	,	_	.	,	_	12	punct	_	_
6	the	_	DET	DT	_	8	det	_	_
7	plasma	_	NOUN	NN	_	8	compound	_	_
8	concentrations	_	NOUN	NNS	_	12	nsubj	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	gradually	_	ADV	RB	_	12	advmod	_	_
12	rise	_	VERB	VBP	_	0	root	_	_
13	to	_	PRT	TO	_	14	mark	_	_
14	reach	_	VERB	VB	_	12	xcomp	_	_
15	peak	_	ADJ	JJ	_	18	amod	_	_
16	plasma	_	NOUN	NN	_	18	compound	_	_
17	concentration	_	NOUN	NN	_	18	compound	_	_
18	Cmax	_	NOUN	NN	_	14	dobj	_	_
19	approximately	_	ADV	RB	_	20	advmod	_	_
20	24	_	NUM	CD	_	21	nummod	_	_
21	hours	_	NOUN	NNS	_	14	dobj	_	_
22	after	_	ADP	IN	_	23	mark	_	_
23	dosing	_	VERB	VBG	_	14	advcl	_	_

#	INVEGA	4286
1	The	_	DET	DT	_	2	det	_	_
2	pharmacokinetics	_	NOUN	NNS	_	11	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	following	_	ADP	IN	_	8	case	_	_
6	DRUG	_	NOUN	NN	_	8	compound	_	_
7	*	_	NUM	CD	_	8	nummod	_	_
8	administration	_	NOUN	NN	_	2	nmod	_	_
9	are	_	VERB	VBP	_	11	cop	_	_
10	dose	_	NOUN	NN	_	11	nmod:npmod	_	_
11	proportional	_	ADJ	JJ	_	0	root	_	_
12	within	_	ADP	IN	_	16	case	_	_
13	the	_	DET	DT	_	16	det	_	_
14	available	_	ADJ	JJ	_	16	amod	_	_
15	dose	_	NOUN	NN	_	16	compound	_	_
16	range	_	NOUN	NN	_	11	nmod	_	_

#	INVEGA	4287
1	The	_	DET	DT	_	5	det	_	_
2	terminal	_	ADJ	JJ	_	5	amod	_	_
3	elimination	_	NOUN	NN	_	5	compound	_	_
4	half	_	NOUN	NN	_	5	compound	_	_
5	life	_	NOUN	NN	_	11	nsubj	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	is	_	VERB	VBZ	_	11	cop	_	_
9	approximately	_	ADV	RB	_	11	advmod	_	_
10	23	_	NUM	CD	_	11	nummod	_	_
11	hours	_	NOUN	NNS	_	0	root	_	_

#	INVEGA	4288
1	Steady	_	ADJ	JJ	_	3	amod	_	_
2	state	_	NOUN	NN	_	3	compound	_	_
3	concentrations	_	NOUN	NNS	_	7	nsubjpass	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	are	_	VERB	VBP	_	7	auxpass	_	_
7	attained	_	VERB	VBN	_	0	root	_	_
8	within	_	ADP	IN	_	11	case	_	_
9	4	_	NUM	CD	_	11	nummod	_	_
10	5	_	NUM	CD	_	11	nummod	_	_
11	days	_	NOUN	NNS	_	7	nmod	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	dosing	_	NOUN	NN	_	11	acl	_	_
14	with	_	ADP	IN	_	15	case	_	_
15	DRUG	_	NOUN	NN	_	13	nmod	_	_
16	*	_	NUM	CD	_	13	nmod	_	_
17	in	_	ADP	IN	_	19	case	_	_
18	most	_	ADJ	JJ	_	19	amod	_	_
19	subjects	_	NOUN	NNS	_	16	nmod	_	_

#	INVEGA	4289
1	The	_	DET	DT	_	6	det	_	_
2	mean	_	ADJ	JJ	_	6	amod	_	_
3	steady	_	ADJ	JJ	_	6	amod	_	_
4	state	_	NOUN	NN	_	6	compound	_	_
5	peak:trough	_	NOUN	NN	_	6	compound	_	_
6	ratio	_	NOUN	NN	_	16	nsubj	_	_
7	for	_	ADP	IN	_	11	case	_	_
8	an	_	DET	DT	_	11	det	_	_
9	DRUG	_	NOUN	NN	_	11	compound	_	_
10	*	_	NUM	CD	_	11	nummod	_	_
11	dose	_	NOUN	NN	_	6	nmod	_	_
12	of	_	ADP	IN	_	14	case	_	_
13	9	_	NUM	CD	_	14	nummod	_	_
14	mg	_	NOUN	NN	_	11	nmod	_	_
15	was	_	VERB	VBD	_	16	cop	_	_
16	1.7	_	NUM	CD	_	0	root	_	_
17	with	_	ADP	IN	_	19	case	_	_
18	a	_	DET	DT	_	19	det	_	_
19	range	_	NOUN	NN	_	16	nmod	_	_
20	of	_	ADP	IN	_	22	case	_	_
21	1.2	_	NUM	CD	_	22	nummod	_	_
22	3.1	_	NUM	CD	_	19	nmod	_	_

#	INVEGA	4290
1	Following	_	VERB	VBG	_	2	case	_	_
2	administration	_	NOUN	NN	_	0	root	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	*	_	NUM	CD	_	4	nummod	_	_
6	,	_	.	,	_	4	punct	_	_
7	the	_	DET	DT	_	4	appos	_	_
8	+	_	CONJ	CC	_	7	punct	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	enantiomers	_	NOUN	NNS	_	8	conj	_	_
11	of	_	ADP	IN	_	13	case	_	_
12	DRUG	_	NOUN	NN	_	13	compound	_	_
13	interconvert	_	NOUN	NN	_	8	nmod	_	_
14	,	_	.	,	_	8	punct	_	_
15	reaching	_	VERB	VBG	_	8	dep	_	_
16	an	_	DET	DT	_	17	det	_	_
17	AUC	_	NOUN	NN	_	15	dobj	_	_
18	+	_	CONJ	CC	_	15	cc	_	_
19	to	_	PRT	TO	_	20	case	_	_
20	ratio	_	NOUN	NN	_	15	conj	_	_
21	of	_	ADP	IN	_	23	case	_	_
22	approximately	_	ADV	RB	_	23	advmod	_	_
23	1.6	_	NUM	CD	_	20	nmod	_	_
24	at	_	ADP	IN	_	26	case	_	_
25	steady	_	ADJ	JJ	_	26	amod	_	_
26	state	_	NOUN	NN	_	20	nmod	_	_

#	INVEGA	4291
1	Absorption	_	NOUN	NN	_	15	nsubj	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	Distribution	_	NOUN	NN	_	1	conj	_	_
4	The	_	DET	DT	_	7	det	_	_
5	absolute	_	NOUN	NN	_	7	amod	_	_
6	oral	_	ADJ	JJ	_	7	amod	_	_
7	bioavailability	_	NOUN	NN	_	1	dep	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	following	_	ADP	IN	_	13	case	_	_
11	DRUG	_	NOUN	NN	_	13	compound	_	_
12	*	_	NUM	CD	_	13	nummod	_	_
13	administration	_	NOUN	NN	_	7	nmod	_	_
14	is	_	VERB	VBZ	_	15	auxpass	_	_
15	28%	_	ADJ	JJ	_	0	root	_	_

#	INVEGA	4292
1	Administration	_	NOUN	NN	_	7	nsubj	_	_
2	of	_	ADP	IN	_	6	case	_	_
3	a	_	DET	DT	_	6	det	_	_
4	12	_	NUM	CD	_	6	nummod	_	_
5	mg	_	NOUN	NN	_	6	compound	_	_
6	DRUG	_	NOUN	NN	_	1	nmod	_	_
7	extended	_	VERB	VBD	_	0	root	_	_
8	release	_	NOUN	NN	_	9	amod	_	_
9	tablet	_	NOUN	NN	_	7	dobj	_	_
10	to	_	PRT	TO	_	13	case	_	_
11	healthy	_	ADJ	JJ	_	13	amod	_	_
12	ambulatory	_	ADJ	JJ	_	13	amod	_	_
13	subjects	_	NOUN	NNS	_	9	nmod	_	_
14	with	_	ADP	IN	_	18	case	_	_
15	a	_	DET	DT	_	18	det	_	_
16	standard	_	ADJ	JJ	_	18	amod	_	_
17	high	_	ADJ	JJ	_	18	amod	_	_
18	fat	_	NOUN	NN	_	13	nmod	_	_
19	/	_	.	:	_	7	punct	_	_
20	high	_	ADJ	JJ	_	25	amod	_	_
21	caloric	_	ADJ	JJ	_	25	amod	_	_
22	meal	_	ADJ	JJ	_	25	amod	_	_
23	gave	_	NOUN	NN	_	25	compound	_	_
24	mean	_	NOUN	NN	_	25	compound	_	_
25	Cmax	_	NOUN	NN	_	7	parataxis	_	_
26	and	_	CONJ	CC	_	25	cc	_	_
27	AUC	_	NOUN	NN	_	28	compound	_	_
28	values	_	NOUN	NNS	_	25	conj	_	_
29	of	_	ADP	IN	_	30	case	_	_
30	DRUG	_	NOUN	NN	_	25	nmod	_	_
31	that	_	DET	WDT	_	33	nsubjpass	_	_
32	were	_	VERB	VBD	_	33	auxpass	_	_
33	increased	_	VERB	VBN	_	30	acl:relcl	_	_
34	by	_	ADP	IN	_	35	case	_	_
35	60%	_	NOUN	NN	_	33	nmod	_	_
36	and	_	CONJ	CC	_	35	cc	_	_
37	54%	_	NOUN	NN	_	35	conj	_	_
38	,	_	.	,	_	25	punct	_	_
39	respectively	_	ADV	RB	_	25	advmod	_	_
40	,	_	.	,	_	25	punct	_	_
41	compared	_	VERB	VBN	_	25	acl	_	_
42	with	_	ADP	IN	_	43	case	_	_
43	administration	_	NOUN	NN	_	41	nmod	_	_
44	under	_	ADP	IN	_	46	case	_	_
45	fasting	_	VERB	VBG	_	46	amod	_	_
46	conditions	_	NOUN	NNS	_	43	nmod	_	_

#	INVEGA	4293
1	Clinical	_	ADJ	JJ	_	2	amod	_	_
2	trials	_	NOUN	NNS	_	12	nsubjpass	_	_
3	establishing	_	VERB	VBG	_	2	acl	_	_
4	the	_	DET	DT	_	5	det	_	_
5	safety	_	NOUN	NN	_	3	dobj	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	efficacy	_	NOUN	NN	_	5	conj	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	5	nmod	_	_
10	*	_	NUM	CD	_	9	nummod	_	_
11	were	_	VERB	VBD	_	12	auxpass	_	_
12	carried	_	VERB	VBN	_	0	root	_	_
13	out	_	ADV	RB	_	12	advmod	_	_
14	in	_	ADP	IN	_	15	case	_	_
15	subjects	_	NOUN	NNS	_	13	nmod	_	_
16	without	_	ADP	IN	_	17	case	_	_
17	regard	_	NOUN	NN	_	12	nmod	_	_
18	to	_	PRT	TO	_	20	case	_	_
19	the	_	DET	DT	_	20	det	_	_
20	timing	_	NOUN	NN	_	17	nmod	_	_
21	of	_	ADP	IN	_	22	case	_	_
22	meals	_	NOUN	NNS	_	20	nmod	_	_

#	INVEGA	4294
1	While	_	ADP	IN	_	6	mark	_	_
2	DRUG	_	NOUN	NN	_	6	nsubjpass	_	_
3	*	_	NUM	CD	_	2	nummod	_	_
4	can	_	VERB	MD	_	6	aux	_	_
5	be	_	VERB	VB	_	6	auxpass	_	_
6	taken	_	VERB	VBN	_	24	advcl	_	_
7	without	_	ADP	IN	_	8	case	_	_
8	regard	_	NOUN	NN	_	6	nmod	_	_
9	to	_	PRT	TO	_	10	case	_	_
10	food	_	NOUN	NN	_	8	nmod	_	_
11	,	_	.	,	_	24	punct	_	_
12	the	_	DET	DT	_	13	det	_	_
13	presence	_	NOUN	NN	_	24	nsubj	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	food	_	NOUN	NN	_	13	nmod	_	_
16	at	_	ADP	IN	_	18	case	_	_
17	the	_	DET	DT	_	18	det	_	_
18	time	_	NOUN	NN	_	13	nmod	_	_
19	of	_	ADP	IN	_	22	case	_	_
20	DRUG	_	NOUN	NN	_	22	compound	_	_
21	*	_	NUM	CD	_	22	nummod	_	_
22	administration	_	NOUN	NN	_	18	nmod	_	_
23	may	_	VERB	MD	_	24	aux	_	_
24	increase	_	VERB	VB	_	0	root	_	_
25	exposure	_	NOUN	NN	_	24	dobj	_	_
26	to	_	PRT	TO	_	27	case	_	_
27	DRUG	_	NOUN	NN	_	25	nmod	_	_

#	INVEGA	4295
1	Based	_	VERB	VBN	_	16	advcl	_	_
2	on	_	ADP	IN	_	5	case	_	_
3	a	_	DET	DT	_	5	det	_	_
4	population	_	NOUN	NN	_	5	compound	_	_
5	analysis	_	NOUN	NN	_	1	nmod	_	_
6	,	_	.	,	_	16	punct	_	_
7	the	_	DET	DT	_	9	det	_	_
8	apparent	_	ADJ	JJ	_	9	amod	_	_
9	volume	_	NOUN	NN	_	16	nsubj	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	distribution	_	NOUN	NN	_	9	nmod	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	DRUG	_	NOUN	NN	_	11	nmod	_	_
14	is	_	VERB	VBZ	_	16	cop	_	_
15	487	_	NUM	CD	_	16	nummod	_	_
16	L	_	NOUN	NN	_	0	root	_	_
17	The	_	DET	DT	_	20	det	_	_
18	plasma	_	NOUN	NN	_	20	compound	_	_
19	protein	_	NOUN	NN	_	20	compound	_	_
20	binding	_	NOUN	NN	_	25	nsubj	_	_
21	of	_	ADP	IN	_	23	case	_	_
22	racemic	_	ADJ	JJ	_	23	amod	_	_
23	DRUG	_	NOUN	NN	_	20	nmod	_	_
24	is	_	VERB	VBZ	_	25	auxpass	_	_
25	74%	_	ADJ	JJ	_	16	dep	_	_

#	INVEGA	4296
1	Metabolism	_	NOUN	NN	_	24	nsubj	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	Elimination	_	NOUN	NN	_	1	conj	_	_
4	Although	_	ADP	IN	_	8	mark	_	_
5	in	_	X	FW	_	7	amod	_	_
6	vitro	_	X	FW	_	5	dep	_	_
7	studies	_	NOUN	NNS	_	8	nsubj	_	_
8	suggested	_	VERB	VBD	_	1	acl:relcl	_	_
9	a	_	DET	DT	_	10	det	_	_
10	role	_	NOUN	NN	_	8	dobj	_	_
11	for	_	ADP	IN	_	12	case	_	_
12	CYP2D6	_	NOUN	NN	_	10	nmod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	CYP3A4	_	NOUN	NN	_	12	conj	_	_
15	in	_	ADP	IN	_	17	case	_	_
16	the	_	DET	DT	_	17	det	_	_
17	metabolism	_	NOUN	NN	_	10	nmod	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	DRUG	_	NOUN	NN	_	17	nmod	_	_
20	,	_	.	,	_	1	punct	_	_
21	in	_	X	FW	_	23	amod	_	_
22	vivo	_	X	FW	_	21	dep	_	_
23	results	_	NOUN	NNS	_	24	nsubj	_	_
24	indicate	_	VERB	VBP	_	0	root	_	_
25	that	_	ADP	IN	_	28	mark	_	_
26	these	_	DET	DT	_	27	det	_	_
27	isozymes	_	NOUN	NNS	_	28	nsubj	_	_
28	play	_	VERB	VBP	_	24	ccomp	_	_
29	a	_	DET	DT	_	31	det	_	_
30	limited	_	ADJ	JJ	_	31	amod	_	_
31	role	_	NOUN	NN	_	28	dobj	_	_
32	in	_	ADP	IN	_	35	case	_	_
33	the	_	DET	DT	_	35	det	_	_
34	overall	_	ADJ	JJ	_	35	amod	_	_
35	elimination	_	NOUN	NN	_	28	nmod	_	_
36	of	_	ADP	IN	_	37	case	_	_
37	DRUG	_	NOUN	NN	_	35	nmod	_	_

#	INVEGA	4297
1	One	_	NUM	CD	_	2	nummod	_	_
2	week	_	NOUN	NN	_	54	nsubjpass	_	_
3	following	_	VERB	VBG	_	4	case	_	_
4	administration	_	NOUN	NN	_	2	nmod	_	_
5	of	_	ADP	IN	_	9	case	_	_
6	a	_	DET	DT	_	9	det	_	_
7	single	_	ADJ	JJ	_	9	amod	_	_
8	oral	_	ADJ	JJ	_	9	amod	_	_
9	dose	_	NOUN	NN	_	4	nmod	_	_
10	of	_	ADP	IN	_	16	case	_	_
11	1	_	NUM	CD	_	16	nummod	_	_
12	mg	_	NOUN	NN	_	16	compound	_	_
13	immediate	_	ADJ	JJ	_	16	amod	_	_
14	release	_	NOUN	NN	_	16	compound	_	_
15	14C	_	NOUN	NN	_	16	compound	_	_
16	DRUG	_	NOUN	NN	_	9	nmod	_	_
17	to	_	PRT	TO	_	20	case	_	_
18	5	_	NUM	CD	_	20	nummod	_	_
19	healthy	_	ADJ	JJ	_	20	amod	_	_
20	volunteers	_	NOUN	NNS	_	4	nmod	_	_
21	,	_	.	,	_	2	punct	_	_
22	59%	_	ADJ	JJ	_	25	amod	_	_
23	range	_	NOUN	NN	_	25	compound	_	_
24	51%	_	ADJ	JJ	_	25	amod	_	_
25	67%	_	NOUN	NN	_	30	nsubjpass	_	_
26	of	_	ADP	IN	_	28	case	_	_
27	the	_	DET	DT	_	28	det	_	_
28	dose	_	NOUN	NN	_	25	nmod	_	_
29	was	_	VERB	VBD	_	30	auxpass	_	_
30	excreted	_	VERB	VBN	_	2	acl:relcl	_	_
31	unchanged	_	ADJ	JJ	_	30	xcomp	_	_
32	into	_	ADP	IN	_	33	case	_	_
33	urine	_	ADJ	JJ	_	31	nmod	_	_
34	,	_	.	,	_	2	punct	_	_
35	32%	_	ADJ	JJ	_	37	amod	_	_
36	26%	_	ADJ	JJ	_	37	amod	_	_
37	41%	_	NOUN	NN	_	42	nsubjpass	_	_
38	of	_	ADP	IN	_	40	case	_	_
39	the	_	DET	DT	_	40	det	_	_
40	dose	_	NOUN	NN	_	37	nmod	_	_
41	was	_	VERB	VBD	_	42	auxpass	_	_
42	recovered	_	VERB	VBN	_	2	conj	_	_
43	as	_	ADP	IN	_	44	case	_	_
44	metabolites	_	NOUN	NNS	_	42	nmod	_	_
45	,	_	.	,	_	2	punct	_	_
46	and	_	CONJ	CC	_	2	cc	_	_
47	6%	_	ADJ	JJ	_	48	amod	_	_
48	12%	_	NOUN	NN	_	2	conj	_	_
49	of	_	ADP	IN	_	51	case	_	_
50	the	_	DET	DT	_	51	det	_	_
51	dose	_	NOUN	NN	_	48	nmod	_	_
52	was	_	VERB	VBD	_	54	auxpass	_	_
53	not	_	ADV	RB	_	54	neg	_	_
54	recovered	_	VERB	VBN	_	0	root	_	_

#	INVEGA	4298
1	Approximately	_	ADV	RB	_	8	advmod	_	_
2	80%	_	NOUN	NN	_	8	nsubjpass	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	the	_	DET	DT	_	6	det	_	_
5	administered	_	VERB	VBN	_	6	amod	_	_
6	radioactivity	_	NOUN	NN	_	2	nmod	_	_
7	was	_	VERB	VBD	_	8	auxpass	_	_
8	recovered	_	VERB	VBN	_	0	root	_	_
9	in	_	ADP	IN	_	10	case	_	_
10	urine	_	ADJ	JJ	_	8	nmod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	11%	_	NOUN	NN	_	10	conj	_	_
13	in	_	ADP	IN	_	15	case	_	_
14	the	_	DET	DT	_	15	det	_	_
15	feces	_	NOUN	NNS	_	8	nmod	_	_

#	INVEGA	4299
1	Four	_	NUM	CD	_	4	nummod	_	_
2	primary	_	ADJ	JJ	_	4	amod	_	_
3	metabolic	_	ADJ	JJ	_	4	amod	_	_
4	pathways	_	NOUN	NNS	_	7	nsubjpass	_	_
5	have	_	VERB	VBP	_	7	aux	_	_
6	been	_	VERB	VBN	_	7	auxpass	_	_
7	identified	_	VERB	VBN	_	0	root	_	_
8	in	_	X	FW	_	9	compound	_	_
9	vivo	_	X	FW	_	7	advmod	_	_
10	,	_	.	,	_	7	punct	_	_
11	none	_	NOUN	NN	_	16	nsubjpass	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	which	_	DET	WDT	_	11	nmod	_	_
14	could	_	VERB	MD	_	16	aux	_	_
15	be	_	VERB	VB	_	16	auxpass	_	_
16	shown	_	VERB	VBN	_	7	root	_	_
17	to	_	PRT	TO	_	18	mark	_	_
18	account	_	VERB	VB	_	16	xcomp	_	_
19	for	_	ADP	IN	_	22	case	_	_
20	more	_	ADV	RB	_	22	advmod	_	_
21	than	_	ADP	IN	_	22	case	_	_
22	10%	_	NOUN	NN	_	18	nmod	_	_
23	of	_	ADP	IN	_	25	case	_	_
24	the	_	DET	DT	_	25	det	_	_
25	dose	_	NOUN	NN	_	22	nmod	_	_
26	:	_	.	:	_	16	punct	_	_
27	dealkylation	_	NOUN	NN	_	16	dep	_	_
28	,	_	.	,	_	27	punct	_	_
29	hydroxylation	_	NOUN	NN	_	27	conj	_	_
30	,	_	.	,	_	27	punct	_	_
31	dehydrogenation	_	NOUN	NN	_	27	conj	_	_
32	,	_	.	,	_	27	punct	_	_
33	and	_	CONJ	CC	_	27	cc	_	_
34	benzisoxazole	_	NOUN	NN	_	35	compound	_	_
35	scission	_	NOUN	NN	_	27	conj	_	_

#	INVEGA	4300
1	Population	_	NOUN	NN	_	3	compound	_	_
2	pharmacokinetic	_	ADJ	JJ	_	3	amod	_	_
3	analyses	_	NOUN	NNS	_	4	nsubj	_	_
4	found	_	VERB	VBD	_	0	root	_	_
5	no	_	DET	DT	_	6	neg	_	_
6	difference	_	NOUN	NN	_	4	dobj	_	_
7	in	_	ADP	IN	_	8	case	_	_
8	exposure	_	NOUN	NN	_	6	nmod	_	_
9	or	_	CONJ	CC	_	6	cc	_	_
10	clearance	_	NOUN	NN	_	6	conj	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_
13	between	_	ADP	IN	_	15	case	_	_
14	extensive	_	ADJ	JJ	_	15	amod	_	_
15	metabolizers	_	NOUN	NNS	_	10	nmod	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	poor	_	ADJ	JJ	_	18	amod	_	_
18	metabolizers	_	NOUN	NNS	_	15	conj	_	_
19	of	_	ADP	IN	_	21	case	_	_
20	CYP2D6	_	NOUN	NN	_	21	compound	_	_
21	substrates	_	NOUN	NNS	_	18	nmod	_	_

#	INVEGA	4301
1	Special	_	ADJ	JJ	_	2	amod	_	_
2	Populations	_	NOUN	NNS	_	0	root	_	_
3	Renal	_	ADJ	JJ	_	4	amod	_	_
4	Impairment	_	NOUN	NN	_	2	dep	_	_
5	The	_	DET	DT	_	6	det	_	_
6	dose	_	NOUN	NN	_	12	nsubjpass	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	*	_	NUM	CD	_	8	nummod	_	_
10	should	_	VERB	MD	_	12	aux	_	_
11	be	_	VERB	VB	_	12	auxpass	_	_
12	reduced	_	VERB	VBN	_	4	dep	_	_
13	in	_	ADP	IN	_	14	case	_	_
14	patients	_	NOUN	NNS	_	12	nmod	_	_
15	with	_	ADP	IN	_	20	case	_	_
16	moderate	_	ADJ	JJ	_	20	amod	_	_
17	or	_	CONJ	CC	_	16	cc	_	_
18	severe	_	ADJ	JJ	_	16	conj	_	_
19	renal	_	ADJ	JJ	_	20	amod	_	_
20	impairment	_	NOUN	NN	_	14	nmod	_	_

#	INVEGA	4302
1	The	_	DET	DT	_	2	det	_	_
2	disposition	_	NOUN	NN	_	10	nsubj	_	_
3	of	_	ADP	IN	_	9	case	_	_
4	a	_	DET	DT	_	9	det	_	_
5	single	_	ADJ	JJ	_	9	amod	_	_
6	dose	_	NOUN	NN	_	9	compound	_	_
7	DRUG	_	NOUN	NN	_	9	compound	_	_
8	3	_	NUM	CD	_	9	nummod	_	_
9	mg	_	NOUN	NN	_	2	nmod	_	_
10	extended	_	VERB	VBD	_	14	nsubjpass	_	_
11	release	_	NOUN	NN	_	12	compound	_	_
12	tablet	_	NOUN	NN	_	10	dobj	_	_
13	was	_	VERB	VBD	_	14	auxpass	_	_
14	studied	_	VERB	VBN	_	0	root	_	_
15	in	_	ADP	IN	_	17	case	_	_
16	adult	_	ADJ	JJ	_	17	amod	_	_
17	subjects	_	NOUN	NNS	_	14	nmod	_	_
18	with	_	ADP	IN	_	20	case	_	_
19	varying	_	ADJ	JJ	_	20	amod	_	_
20	degrees	_	NOUN	NNS	_	17	nmod	_	_
21	of	_	ADP	IN	_	23	case	_	_
22	renal	_	ADJ	JJ	_	23	amod	_	_
23	function	_	NOUN	NN	_	20	nmod	_	_

#	INVEGA	4303
1	Elimination	_	NOUN	NN	_	4	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	decreased	_	VERB	VBD	_	0	root	_	_
5	with	_	ADP	IN	_	6	mark	_	_
6	decreasing	_	VERB	VBG	_	4	advcl	_	_
7	estimated	_	VERB	VBN	_	9	amod	_	_
8	creatinine	_	NOUN	NN	_	9	compound	_	_
9	clearance	_	NOUN	NN	_	6	dobj	_	_

#	INVEGA	4304
1	Total	_	ADJ	JJ	_	2	amod	_	_
2	clearance	_	NOUN	NN	_	6	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	was	_	VERB	VBD	_	6	auxpass	_	_
6	reduced	_	VERB	VBN	_	0	root	_	_
7	in	_	ADP	IN	_	8	case	_	_
8	subjects	_	NOUN	NNS	_	6	nmod	_	_
9	with	_	ADP	IN	_	12	case	_	_
10	impaired	_	ADJ	JJ	_	12	amod	_	_
11	renal	_	ADJ	JJ	_	12	amod	_	_
12	function	_	NOUN	NN	_	8	nmod	_	_
13	by	_	ADP	IN	_	14	case	_	_
14	32%	_	NOUN	NN	_	8	nmod	_	_
15	on	_	ADP	IN	_	16	case	_	_
16	average	_	NOUN	NN	_	6	nmod	_	_
17	in	_	ADP	IN	_	22	case	_	_
18	mild	_	ADJ	JJ	_	22	amod	_	_
19	CrCl	_	NOUN	NN	_	22	compound	_	_
20	=	_	ADJ	JJ	_	22	amod	_	_
21	50	_	NUM	CD	_	22	nummod	_	_
22	mL	_	NOUN	NN	_	16	nmod	_	_
23	/	_	.	:	_	6	punct	_	_
24	min	_	NOUN	NN	_	6	parataxis	_	_
25	to	_	PRT	TO	_	28	case	_	_
26	<	_	NUM	CD	_	28	nummod	_	_
27	80	_	NUM	CD	_	28	nummod	_	_
28	mL	_	NOUN	NN	_	24	nmod	_	_
29	/	_	.	:	_	24	punct	_	_
30	min	_	NOUN	NN	_	24	dep	_	_
31	,	_	.	,	_	30	punct	_	_
32	64%	_	NOUN	NN	_	30	appos	_	_
33	in	_	ADP	IN	_	38	case	_	_
34	moderate	_	ADJ	JJ	_	38	amod	_	_
35	CrCl	_	NOUN	NN	_	38	compound	_	_
36	=	_	ADJ	JJ	_	38	amod	_	_
37	30	_	NUM	CD	_	38	nummod	_	_
38	mL	_	NOUN	NN	_	32	nmod	_	_
39	/	_	.	:	_	30	punct	_	_
40	min	_	NOUN	NN	_	30	dep	_	_
41	to	_	PRT	TO	_	44	case	_	_
42	<	_	NUM	CD	_	44	nummod	_	_
43	50	_	NUM	CD	_	44	nummod	_	_
44	mL	_	NOUN	NN	_	40	nmod	_	_
45	/	_	.	:	_	24	punct	_	_
46	min	_	NOUN	NN	_	24	dep	_	_
47	,	_	.	,	_	46	punct	_	_
48	and	_	CONJ	CC	_	46	cc	_	_
49	71%	_	NOUN	NN	_	46	conj	_	_
50	in	_	ADP	IN	_	55	case	_	_
51	severe	_	ADJ	JJ	_	55	amod	_	_
52	CrCl	_	NOUN	NN	_	55	compound	_	_
53	=	_	ADJ	JJ	_	55	amod	_	_
54	10	_	NUM	CD	_	55	nummod	_	_
55	mL	_	NOUN	NN	_	46	nmod	_	_
56	/	_	.	:	_	24	punct	_	_
57	min	_	NOUN	NN	_	24	dep	_	_
58	to	_	PRT	TO	_	61	case	_	_
59	<	_	NUM	CD	_	61	nummod	_	_
60	30	_	NUM	CD	_	61	nummod	_	_
61	mL	_	NOUN	NN	_	57	nmod	_	_
62	/	_	.	:	_	24	punct	_	_
63	min	_	NOUN	NN	_	65	compound	_	_
64	renal	_	ADJ	JJ	_	65	amod	_	_
65	impairment	_	NOUN	NN	_	24	dep	_	_
66	,	_	.	,	_	65	punct	_	_
67	corresponding	_	VERB	VBG	_	65	acl	_	_
68	to	_	PRT	TO	_	71	case	_	_
69	an	_	DET	DT	_	71	det	_	_
70	average	_	ADJ	JJ	_	71	amod	_	_
71	increase	_	NOUN	NN	_	67	nmod	_	_
72	in	_	ADP	IN	_	74	case	_	_
73	exposure	_	NOUN	NN	_	74	compound	_	_
74	AUCinf	_	NOUN	NN	_	71	nmod	_	_
75	of	_	ADP	IN	_	77	case	_	_
76	1.5	_	NUM	CD	_	77	nummod	_	_
77	fold	_	NOUN	NN	_	74	nmod	_	_
78	,	_	.	,	_	77	punct	_	_
79	2.6	_	NUM	CD	_	80	nummod	_	_
80	fold	_	NOUN	NN	_	77	conj	_	_
81	,	_	.	,	_	77	punct	_	_
82	and	_	CONJ	CC	_	77	cc	_	_
83	4.8	_	NUM	CD	_	84	nummod	_	_
84	fold	_	NOUN	NN	_	77	conj	_	_
85	,	_	.	,	_	65	punct	_	_
86	respectively	_	ADV	RB	_	65	advmod	_	_
87	,	_	.	,	_	24	punct	_	_
88	compared	_	VERB	VBN	_	24	acl	_	_
89	to	_	PRT	TO	_	91	case	_	_
90	healthy	_	ADJ	JJ	_	91	amod	_	_
91	subjects	_	NOUN	NNS	_	88	nmod	_	_

#	INVEGA	4305
1	The	_	DET	DT	_	6	det	_	_
2	mean	_	ADJ	JJ	_	6	amod	_	_
3	terminal	_	ADJ	JJ	_	6	amod	_	_
4	elimination	_	NOUN	NN	_	6	compound	_	_
5	half	_	NOUN	NN	_	6	compound	_	_
6	life	_	NOUN	NN	_	11	nsubj	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	was	_	VERB	VBD	_	11	cop	_	_
10	24	_	NUM	CD	_	11	nummod	_	_
11	hours	_	NOUN	NNS	_	0	root	_	_
12	,	_	.	,	_	11	punct	_	_
13	40	_	NUM	CD	_	14	nummod	_	_
14	hours	_	NOUN	NNS	_	11	conj	_	_
15	,	_	.	,	_	11	punct	_	_
16	and	_	CONJ	CC	_	11	cc	_	_
17	51	_	NUM	CD	_	18	nummod	_	_
18	hours	_	NOUN	NNS	_	11	conj	_	_
19	in	_	ADP	IN	_	20	case	_	_
20	subjects	_	NOUN	NNS	_	18	nmod	_	_
21	with	_	ADP	IN	_	29	case	_	_
22	mild	_	ADJ	JJ	_	29	amod	_	_
23	,	_	.	,	_	22	punct	_	_
24	moderate	_	ADJ	JJ	_	22	conj	_	_
25	,	_	.	,	_	22	punct	_	_
26	and	_	CONJ	CC	_	22	cc	_	_
27	severe	_	ADJ	JJ	_	22	conj	_	_
28	renal	_	ADJ	JJ	_	29	amod	_	_
29	impairment	_	NOUN	NN	_	20	nmod	_	_
30	,	_	.	,	_	11	punct	_	_
31	respectively	_	ADV	RB	_	11	advmod	_	_
32	,	_	.	,	_	11	punct	_	_
33	compared	_	VERB	VBD	_	11	conj	_	_
34	with	_	ADP	IN	_	36	case	_	_
35	23	_	NUM	CD	_	36	nummod	_	_
36	hours	_	NOUN	NNS	_	33	nmod	_	_
37	in	_	ADP	IN	_	38	case	_	_
38	subjects	_	NOUN	NNS	_	36	nmod	_	_
39	with	_	ADP	IN	_	46	case	_	_
40	normal	_	ADJ	JJ	_	46	amod	_	_
41	renal	_	ADJ	JJ	_	46	amod	_	_
42	function	_	NOUN	NN	_	46	compound	_	_
43	CrCl	_	NOUN	NN	_	46	compound	_	_
44	>	_	NUM	CD	_	46	nummod	_	_
45	80	_	NUM	CD	_	46	nummod	_	_
46	mL	_	NOUN	NN	_	38	nmod	_	_
47	/	_	.	:	_	11	punct	_	_
48	min	_	NOUN	NN	_	11	dep	_	_

#	INVEGA	4306
1	Hepatic	_	ADJ	JJ	_	2	amod	_	_
2	Impairment	_	NOUN	NN	_	0	root	_	_
3	In	_	ADP	IN	_	5	case	_	_
4	a	_	DET	DT	_	5	det	_	_
5	study	_	NOUN	NN	_	2	nmod	_	_
6	in	_	ADP	IN	_	8	case	_	_
7	adult	_	ADJ	JJ	_	8	amod	_	_
8	subjects	_	NOUN	NNS	_	5	nmod	_	_
9	with	_	ADP	IN	_	16	case	_	_
10	moderate	_	ADJ	JJ	_	16	amod	_	_
11	hepatic	_	ADJ	JJ	_	16	amod	_	_
12	impairment	_	NOUN	NN	_	16	compound	_	_
13	Child	_	NOUN	NN	_	16	compound	_	_
14	Pugh	_	NOUN	NN	_	16	compound	_	_
15	class	_	NOUN	NN	_	16	compound	_	_
16	B	_	NOUN	NN	_	8	nmod	_	_
17	,	_	.	,	_	2	punct	_	_
18	the	_	DET	DT	_	20	det	_	_
19	plasma	_	NOUN	NN	_	20	compound	_	_
20	concentrations	_	NOUN	NNS	_	25	nsubj	_	_
21	of	_	ADP	IN	_	23	case	_	_
22	free	_	ADJ	JJ	_	23	amod	_	_
23	DRUG	_	NOUN	NN	_	20	nmod	_	_
24	were	_	VERB	VBD	_	25	cop	_	_
25	similar	_	ADJ	JJ	_	2	acl:relcl	_	_
26	to	_	PRT	TO	_	27	case	_	_
27	those	_	DET	DT	_	25	nmod	_	_
28	of	_	ADP	IN	_	30	case	_	_
29	healthy	_	ADJ	JJ	_	30	amod	_	_
30	subjects	_	NOUN	NNS	_	27	nmod	_	_
31	,	_	.	,	_	2	punct	_	_
32	although	_	ADP	IN	_	36	mark	_	_
33	total	_	ADJ	JJ	_	35	amod	_	_
34	DRUG	_	NOUN	NN	_	35	compound	_	_
35	exposure	_	NOUN	NN	_	36	nsubj	_	_
36	decreased	_	VERB	VBD	_	2	dep	_	_
37	because	_	ADP	IN	_	40	case	_	_
38	of	_	ADP	IN	_	40	case	_	_
39	a	_	DET	DT	_	40	det	_	_
40	decrease	_	NOUN	NN	_	36	nmod	_	_
41	in	_	ADP	IN	_	43	case	_	_
42	protein	_	NOUN	NN	_	43	compound	_	_
43	binding	_	NOUN	NN	_	40	nmod	_	_

#	INVEGA	4307
1	Consequently	_	ADV	RB	_	7	advmod	_	_
2	,	_	.	,	_	7	punct	_	_
3	no	_	DET	DT	_	5	neg	_	_
4	dose	_	NOUN	NN	_	5	compound	_	_
5	adjustment	_	NOUN	NN	_	7	nsubjpass	_	_
6	is	_	VERB	VBZ	_	7	auxpass	_	_
7	required	_	VERB	VBN	_	0	root	_	_
8	in	_	ADP	IN	_	9	case	_	_
9	patients	_	NOUN	NNS	_	7	nmod	_	_
10	with	_	ADP	IN	_	15	case	_	_
11	mild	_	ADJ	JJ	_	15	amod	_	_
12	or	_	CONJ	CC	_	11	cc	_	_
13	moderate	_	ADJ	JJ	_	11	conj	_	_
14	hepatic	_	ADJ	JJ	_	15	amod	_	_
15	impairment	_	NOUN	NN	_	9	nmod	_	_

#	INVEGA	4308
1	DRUG	_	NOUN	NN	_	6	nsubjpass	_	_
2	*	_	NUM	CD	_	1	nummod	_	_
3	has	_	VERB	VBZ	_	6	aux	_	_
4	not	_	ADV	RB	_	6	neg	_	_
5	been	_	VERB	VBN	_	6	auxpass	_	_
6	studied	_	VERB	VBN	_	0	root	_	_
7	in	_	ADP	IN	_	8	case	_	_
8	patients	_	NOUN	NNS	_	6	nmod	_	_
9	with	_	ADP	IN	_	12	case	_	_
10	severe	_	ADJ	JJ	_	12	amod	_	_
11	hepatic	_	ADJ	JJ	_	12	amod	_	_
12	impairment	_	NOUN	NN	_	8	nmod	_	_

#	INVEGA	4309
1	Adolescents	_	NOUN	NNS	_	20	nsubj	_	_
2	12	_	NUM	CD	_	4	nummod	_	_
3	17	_	NUM	CD	_	4	nummod	_	_
4	years	_	NOUN	NNS	_	1	nmod	_	_
5	of	_	ADP	IN	_	9	case	_	_
6	age	_	NOUN	NN	_	9	compound	_	_
7	DRUG	_	NOUN	NN	_	9	compound	_	_
8	systemic	_	ADJ	JJ	_	9	amod	_	_
9	exposure	_	NOUN	NN	_	4	nmod	_	_
10	in	_	ADP	IN	_	11	case	_	_
11	adolescents	_	NOUN	NNS	_	4	nmod	_	_
12	weighing	_	VERB	VBG	_	11	acl	_	_
13	>	_	NUM	CD	_	18	nummod	_	_
14	51	_	NUM	CD	_	18	nummod	_	_
15	kg	_	NOUN	NN	_	18	compound	_	_
16	>	_	NUM	CD	_	18	nummod	_	_
17	112	_	NUM	CD	_	18	nummod	_	_
18	lbs	_	NOUN	NN	_	12	dobj	_	_
19	was	_	VERB	VBD	_	20	cop	_	_
20	similar	_	ADJ	JJ	_	0	root	_	_
21	to	_	PRT	TO	_	22	case	_	_
22	that	_	DET	WDT	_	20	nmod	_	_
23	in	_	ADP	IN	_	24	case	_	_
24	adults	_	NOUN	NNS	_	22	nmod	_	_

#	INVEGA	4310
1	In	_	ADP	IN	_	2	case	_	_
2	adolescents	_	NOUN	NNS	_	16	nmod	_	_
3	weighing	_	VERB	VBG	_	2	acl	_	_
4	<	_	NUM	CD	_	9	nummod	_	_
5	51	_	NUM	CD	_	9	nummod	_	_
6	kg	_	NOUN	NN	_	9	compound	_	_
7	<	_	NUM	CD	_	9	nummod	_	_
8	112	_	NUM	CD	_	9	nummod	_	_
9	lbs	_	NOUN	NN	_	3	dobj	_	_
10	,	_	.	,	_	16	punct	_	_
11	a	_	DET	DT	_	14	det	_	_
12	23%	_	ADJ	JJ	_	14	amod	_	_
13	higher	_	ADJ	JJ	_	14	amod	_	_
14	exposure	_	NOUN	NN	_	16	nsubjpass	_	_
15	was	_	VERB	VBD	_	16	auxpass	_	_
16	observed	_	VERB	VBN	_	0	root	_	_
17	this	_	DET	DT	_	19	nsubjpass	_	_
18	is	_	VERB	VBZ	_	19	auxpass	_	_
19	considered	_	VERB	VBN	_	16	ccomp	_	_
20	not	_	ADV	RB	_	24	neg	_	_
21	to	_	PRT	TO	_	24	mark	_	_
22	be	_	VERB	VB	_	24	cop	_	_
23	clinically	_	ADV	RB	_	24	advmod	_	_
24	significant	_	ADJ	JJ	_	19	xcomp	_	_

#	INVEGA	4311
1	Age	_	NOUN	NN	_	4	nsubj	_	_
2	did	_	VERB	VBD	_	4	aux	_	_
3	not	_	ADV	RB	_	4	neg	_	_
4	influence	_	VERB	VB	_	0	root	_	_
5	the	_	DET	DT	_	7	det	_	_
6	DRUG	_	NOUN	NN	_	7	compound	_	_
7	exposure	_	NOUN	NN	_	4	dobj	_	_

#	INVEGA	4312
1	Elderly	_	ADJ	JJ	_	4	amod	_	_
2	No	_	NOUN	NN	_	4	compound	_	_
3	dosage	_	NOUN	NN	_	4	compound	_	_
4	adjustment	_	NOUN	NN	_	6	nsubjpass	_	_
5	is	_	VERB	VBZ	_	6	auxpass	_	_
6	recommended	_	VERB	VBN	_	0	root	_	_
7	based	_	VERB	VBN	_	6	xcomp	_	_
8	on	_	ADP	IN	_	9	case	_	_
9	age	_	NOUN	NN	_	7	nmod	_	_
10	alone	_	ADV	RB	_	9	advmod	_	_

#	INVEGA	4313
1	However	_	ADV	RB	_	7	advmod	_	_
2	,	_	.	,	_	7	punct	_	_
3	dose	_	NOUN	NN	_	4	compound	_	_
4	adjustment	_	NOUN	NN	_	7	nsubjpass	_	_
5	may	_	VERB	MD	_	7	aux	_	_
6	be	_	VERB	VB	_	7	auxpass	_	_
7	required	_	VERB	VBN	_	0	root	_	_
8	because	_	ADP	IN	_	12	case	_	_
9	of	_	ADP	IN	_	12	case	_	_
10	age	_	NOUN	NN	_	12	compound	_	_
11	related	_	ADJ	JJ	_	12	amod	_	_
12	decreases	_	NOUN	NNS	_	7	nmod	_	_
13	in	_	ADP	IN	_	15	case	_	_
14	creatinine	_	NOUN	NN	_	15	compound	_	_
15	clearance	_	NOUN	NN	_	12	nmod	_	_

#	INVEGA	4314
1	Race	_	ADJ	JJ	_	4	amod	_	_
2	No	_	NOUN	NN	_	4	compound	_	_
3	dosage	_	NOUN	NN	_	4	compound	_	_
4	adjustment	_	NOUN	NN	_	6	nsubjpass	_	_
5	is	_	VERB	VBZ	_	6	auxpass	_	_
6	recommended	_	VERB	VBN	_	0	root	_	_
7	based	_	VERB	VBN	_	6	xcomp	_	_
8	on	_	ADP	IN	_	9	case	_	_
9	race	_	DET	DT	_	7	punct	_	_

#	INVEGA	4315
1	No	_	DET	DT	_	2	neg	_	_
2	differences	_	NOUN	NNS	_	6	nsubjpass	_	_
3	in	_	ADP	IN	_	4	case	_	_
4	pharmacokinetics	_	NOUN	NNS	_	2	nmod	_	_
5	were	_	VERB	VBD	_	6	auxpass	_	_
6	observed	_	VERB	VBN	_	0	root	_	_
7	in	_	ADP	IN	_	10	case	_	_
8	a	_	DET	DT	_	10	det	_	_
9	pharmacokinetic	_	ADJ	JJ	_	10	amod	_	_
10	study	_	NOUN	NN	_	6	nmod	_	_
11	conducted	_	VERB	VBN	_	10	acl	_	_
12	in	_	ADP	IN	_	13	case	_	_
13	Japanese	_	NOUN	NN	_	11	nmod	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	Caucasians	_	NOUN	NNS	_	13	conj	_	_

#	INVEGA	4316
1	Gender	_	NOUN	NN	_	4	compound	_	_
2	No	_	NOUN	NN	_	4	compound	_	_
3	dosage	_	NOUN	NN	_	4	compound	_	_
4	adjustment	_	NOUN	NN	_	6	nsubjpass	_	_
5	is	_	VERB	VBZ	_	6	auxpass	_	_
6	recommended	_	VERB	VBN	_	0	root	_	_
7	based	_	VERB	VBN	_	6	xcomp	_	_
8	on	_	ADP	IN	_	9	case	_	_
9	gender	_	NOUN	NN	_	7	nmod	_	_

#	INVEGA	4317
1	No	_	DET	DT	_	2	neg	_	_
2	differences	_	NOUN	NNS	_	6	nsubjpass	_	_
3	in	_	ADP	IN	_	4	case	_	_
4	pharmacokinetics	_	NOUN	NNS	_	2	nmod	_	_
5	were	_	VERB	VBD	_	6	auxpass	_	_
6	observed	_	VERB	VBN	_	0	root	_	_
7	in	_	ADP	IN	_	10	case	_	_
8	a	_	DET	DT	_	10	det	_	_
9	pharmacokinetic	_	ADJ	JJ	_	10	amod	_	_
10	study	_	NOUN	NN	_	6	nmod	_	_
11	conducted	_	VERB	VBN	_	10	acl	_	_
12	in	_	ADP	IN	_	13	case	_	_
13	men	_	NOUN	NN	_	11	nmod	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	women	_	NOUN	NNS	_	13	conj	_	_

#	INVEGA	4318
1	Smoking	_	VERB	VBG	_	6	nsubjpass	_	_
2	No	_	NOUN	NN	_	4	compound	_	_
3	dosage	_	NOUN	NN	_	4	compound	_	_
4	adjustment	_	NOUN	NN	_	1	dobj	_	_
5	is	_	VERB	VBZ	_	6	auxpass	_	_
6	recommended	_	VERB	VBN	_	0	root	_	_
7	based	_	VERB	VBN	_	6	xcomp	_	_
8	on	_	ADP	IN	_	10	case	_	_
9	smoking	_	VERB	VBG	_	10	amod	_	_
10	status	_	NOUN	NN	_	7	nmod	_	_

#	INVEGA	4319
1	Based	_	VERB	VBN	_	15	advcl	_	_
2	on	_	ADP	IN	_	5	case	_	_
3	in	_	X	FW	_	5	amod	_	_
4	vitro	_	X	FW	_	3	dep	_	_
5	studies	_	NOUN	NNS	_	1	nmod	_	_
6	utilizing	_	VERB	VBG	_	5	acl	_	_
7	human	_	ADJ	JJ	_	9	amod	_	_
8	liver	_	NOUN	NN	_	9	compound	_	_
9	enzymes	_	NOUN	NNS	_	6	dobj	_	_
10	,	_	.	,	_	15	punct	_	_
11	DRUG	_	NOUN	NN	_	15	nsubj	_	_
12	is	_	VERB	VBZ	_	15	cop	_	_
13	not	_	ADV	RB	_	15	neg	_	_
14	a	_	DET	DT	_	15	det	_	_
15	substrate	_	NOUN	NN	_	24	nsubj	_	_
16	for	_	ADP	IN	_	18	case	_	_
17	CYP1A2	_	NOUN	NN	_	18	compound	_	_
18	smoking	_	NOUN	NN	_	15	nmod	_	_
19	should	_	VERB	MD	_	24	aux	_	_
20	,	_	.	,	_	24	punct	_	_
21	therefore	_	ADV	RB	_	24	advmod	_	_
22	,	_	.	,	_	24	punct	_	_
23	not	_	ADV	RB	_	24	neg	_	_
24	have	_	VERB	VB	_	0	root	_	_
25	an	_	DET	DT	_	26	det	_	_
26	effect	_	NOUN	NN	_	24	dobj	_	_
27	on	_	ADP	IN	_	29	case	_	_
28	the	_	DET	DT	_	29	det	_	_
29	pharmacokinetics	_	NOUN	NNS	_	26	nmod	_	_
30	of	_	ADP	IN	_	31	case	_	_
31	DRUG	_	NOUN	NN	_	29	nmod	_	_

#	Iloperidone	662
1	Given	_	ADP	IN	_	5	case	_	_
2	the	_	DET	DT	_	5	det	_	_
3	primary	_	ADJ	JJ	_	5	amod	_	_
4	CNS	_	NOUN	NN	_	5	compound	_	_
5	effects	_	NOUN	NNS	_	12	nmod	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	FANAPT	_	NOUN	NN	_	5	nmod	_	_
8	,	_	.	,	_	12	punct	_	_
9	caution	_	NOUN	NN	_	12	nsubjpass	_	_
10	should	_	VERB	MD	_	12	aux	_	_
11	be	_	VERB	VB	_	12	auxpass	_	_
12	used	_	VERB	VBN	_	0	root	_	_
13	when	_	ADV	WRB	_	16	advmod	_	_
14	it	_	PRON	PRP	_	16	nsubjpass	_	_
15	is	_	VERB	VBZ	_	16	auxpass	_	_
16	taken	_	VERB	VBN	_	12	ccomp	_	_
17	in	_	ADP	IN	_	18	case	_	_
18	combination	_	NOUN	NN	_	16	nmod	_	_
19	with	_	ADP	IN	_	23	case	_	_
20	other	_	ADJ	JJ	_	23	amod	_	_
21	centrally	_	ADV	RB	_	22	advmod	_	_
22	acting	_	VERB	VBG	_	23	amod	_	_
23	drugs	_	NOUN	NNS	_	18	nmod	_	_
24	and	_	CONJ	CC	_	23	cc	_	_
25	alcohol	_	NOUN	NN	_	23	conj	_	_

#	Iloperidone	663
1	Due	_	ADJ	JJ	_	7	case	_	_
2	to	_	PRT	TO	_	1	mwe	_	_
3	its	_	PRON	PRP$	_	7	nmod:poss	_	_
4	alpha1	_	NOUN	NN	_	7	compound	_	_
5	adrenergic	_	ADJ	JJ	_	7	amod	_	_
6	receptor	_	NOUN	NN	_	7	compound	_	_
7	antagonism	_	NOUN	NN	_	10	nmod	_	_
8	,	_	.	,	_	10	punct	_	_
9	FANAPT	_	NOUN	NN	_	10	nsubj	_	_
10	has	_	VERB	VBZ	_	0	root	_	_
11	the	_	DET	DT	_	12	det	_	_
12	potential	_	NOUN	NN	_	10	dobj	_	_
13	to	_	PRT	TO	_	14	mark	_	_
14	enhance	_	VERB	VB	_	10	xcomp	_	_
15	the	_	DET	DT	_	16	det	_	_
16	effect	_	NOUN	NN	_	14	dobj	_	_
17	of	_	ADP	IN	_	20	case	_	_
18	certain	_	ADJ	JJ	_	20	amod	_	_
19	antihypertensive	_	ADJ	JJ	_	20	amod	_	_
20	agents	_	NOUN	NNS	_	16	nmod	_	_

#	Iloperidone	664
1	The	_	DET	DT	_	2	det	_	_
2	dose	_	NOUN	NN	_	7	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	FANAPT	_	NOUN	NN	_	2	nmod	_	_
5	should	_	VERB	MD	_	7	aux	_	_
6	be	_	VERB	VB	_	7	auxpass	_	_
7	reduced	_	VERB	VBN	_	0	root	_	_
8	in	_	ADP	IN	_	9	case	_	_
9	patients	_	NOUN	NNS	_	7	nmod	_	_
10	co	_	PRT	TO	_	11	mark	_	_
11	administered	_	VERB	VBN	_	9	acl	_	_
12	a	_	DET	DT	_	14	det	_	_
13	strong	_	ADJ	JJ	_	14	amod	_	_
14	CYP2D6	_	NOUN	NN	_	11	dobj	_	_
15	or	_	CONJ	CC	_	14	cc	_	_
16	CYP3A4	_	NOUN	NN	_	17	compound	_	_
17	inhibitor	_	NOUN	NN	_	14	conj	_	_

#	Iloperidone	665
1	DRUG	_	NOUN	NN	_	5	nsubj	_	_
2	is	_	VERB	VBZ	_	5	cop	_	_
3	not	_	ADV	RB	_	5	neg	_	_
4	a	_	DET	DT	_	5	det	_	_
5	substrate	_	NOUN	NN	_	0	root	_	_
6	for	_	ADP	IN	_	7	case	_	_
7	CYP1A1	_	NOUN	NN	_	5	nmod	_	_
8	,	_	.	,	_	7	punct	_	_
9	CYP1A2	_	NOUN	NN	_	7	conj	_	_
10	,	_	.	,	_	7	punct	_	_
11	CYP2A6	_	NOUN	NN	_	7	conj	_	_
12	,	_	.	,	_	7	punct	_	_
13	CYP2B6	_	NOUN	NN	_	7	conj	_	_
14	,	_	.	,	_	7	punct	_	_
15	CYP2C8	_	NOUN	NN	_	7	conj	_	_
16	,	_	.	,	_	7	punct	_	_
17	CYP2C9	_	NOUN	NN	_	7	conj	_	_
18	,	_	.	,	_	7	punct	_	_
19	CYP2C19	_	NOUN	NN	_	7	conj	_	_
20	,	_	.	,	_	7	punct	_	_
21	or	_	CONJ	CC	_	7	cc	_	_
22	CYP2E1	_	NOUN	NN	_	23	compound	_	_
23	enzymes	_	NOUN	NNS	_	7	conj	_	_

#	Iloperidone	666
1	This	_	DET	DT	_	2	nsubj	_	_
2	suggests	_	VERB	VBZ	_	0	root	_	_
3	that	_	ADP	IN	_	24	mark	_	_
4	an	_	DET	DT	_	5	det	_	_
5	interaction	_	NOUN	NN	_	24	nsubj	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	with	_	ADP	IN	_	9	case	_	_
9	inhibitors	_	NOUN	NNS	_	5	nmod	_	_
10	or	_	CONJ	CC	_	9	cc	_	_
11	inducers	_	NOUN	NNS	_	9	conj	_	_
12	of	_	ADP	IN	_	14	case	_	_
13	these	_	DET	DT	_	14	det	_	_
14	enzymes	_	NOUN	NNS	_	9	nmod	_	_
15	,	_	.	,	_	14	punct	_	_
16	or	_	CONJ	CC	_	14	cc	_	_
17	other	_	ADJ	JJ	_	18	amod	_	_
18	factors	_	NOUN	NNS	_	14	conj	_	_
19	,	_	.	,	_	5	punct	_	_
20	like	_	ADP	IN	_	21	case	_	_
21	smoking	_	NOUN	NN	_	5	nmod	_	_
22	,	_	.	,	_	5	punct	_	_
23	is	_	VERB	VBZ	_	24	auxpass	_	_
24	unlikely	_	ADV	RB	_	2	ccomp	_	_

#	Iloperidone	667
1	Both	_	CONJ	CC	_	2	cc:preconj	_	_
2	CYP3A4	_	NOUN	NN	_	6	nsubj	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	CYP2D6	_	NOUN	NN	_	2	conj	_	_
5	are	_	VERB	VBP	_	6	cop	_	_
6	responsible	_	ADJ	JJ	_	0	root	_	_
7	for	_	ADP	IN	_	9	case	_	_
8	DRUG	_	NOUN	NN	_	9	compound	_	_
9	metabolism	_	NOUN	NN	_	6	nmod	_	_

#	Iloperidone	668
1	Inhibitors	_	NOUN	NNS	_	15	nsubj	_	_
2	of	_	ADP	IN	_	4	case	_	_
3	CYP3A4	_	NOUN	NN	_	4	compound	_	_
4	e.g	_	NOUN	NN	_	1	nmod	_	_
5	,	_	.	,	_	4	punct	_	_
6	ketoconazole	_	NOUN	NN	_	4	conj	_	_
7	or	_	CONJ	CC	_	4	cc	_	_
8	CYP2D6	_	NOUN	NN	_	9	compound	_	_
9	e.g	_	NOUN	NN	_	4	conj	_	_
10	,	_	.	,	_	4	punct	_	_
11	fluoxetine	_	NOUN	NN	_	4	appos	_	_
12	,	_	.	,	_	4	punct	_	_
13	paroxetine	_	NOUN	NN	_	4	appos	_	_
14	can	_	VERB	MD	_	15	aux	_	_
15	inhibit	_	VERB	VB	_	0	root	_	_
16	DRUG	_	NOUN	NN	_	17	compound	_	_
17	elimination	_	NOUN	NN	_	15	dobj	_	_
18	and	_	CONJ	CC	_	15	cc	_	_
19	cause	_	VERB	VBP	_	15	conj	_	_
20	increased	_	ADJ	JJ	_	22	amod	_	_
21	blood	_	NOUN	NN	_	22	compound	_	_
22	levels	_	NOUN	NNS	_	19	dobj	_	_

#	Iloperidone	669
1	Ketoconazole	_	NOUN	NN	_	40	nsubj	_	_
2	:	_	.	:	_	1	punct	_	_
3	Co	_	NOUN	NN	_	4	compound	_	_
4	administration	_	NOUN	NN	_	34	nsubj	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	ketoconazole	_	NOUN	NN	_	8	compound	_	_
7	200	_	NUM	CD	_	8	nummod	_	_
8	mg	_	NOUN	NN	_	4	nmod	_	_
9	twice	_	ADV	RB	_	10	advmod	_	_
10	daily	_	ADV	RB	_	34	advmod	_	_
11	for	_	ADP	IN	_	13	case	_	_
12	4	_	NUM	CD	_	13	nummod	_	_
13	days	_	NOUN	NNS	_	10	nmod	_	_
14	,	_	.	,	_	34	punct	_	_
15	a	_	DET	DT	_	17	det	_	_
16	potent	_	ADJ	JJ	_	17	amod	_	_
17	inhibitor	_	NOUN	NN	_	34	nsubj	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	CYP3A4	_	NOUN	NN	_	17	nmod	_	_
20	,	_	.	,	_	17	punct	_	_
21	with	_	ADP	IN	_	26	case	_	_
22	a	_	DET	DT	_	26	det	_	_
23	3	_	NUM	CD	_	26	nummod	_	_
24	mg	_	NOUN	NN	_	26	compound	_	_
25	single	_	ADJ	JJ	_	26	amod	_	_
26	dose	_	NOUN	NN	_	17	nmod	_	_
27	of	_	ADP	IN	_	28	case	_	_
28	DRUG	_	NOUN	NN	_	26	nmod	_	_
29	to	_	PRT	TO	_	32	case	_	_
30	19	_	NUM	CD	_	32	nummod	_	_
31	healthy	_	ADJ	JJ	_	32	amod	_	_
32	volunteers	_	NOUN	NNS	_	26	nmod	_	_
33	,	_	.	,	_	17	punct	_	_
34	ages	_	VERB	VBZ	_	1	appos	_	_
35	18	_	NUM	CD	_	37	compound	_	_
36	to	_	PRT	TO	_	37	dep	_	_
37	45	_	NUM	CD	_	38	nummod	_	_
38	years	_	NOUN	NNS	_	34	dobj	_	_
39	,	_	.	,	_	1	punct	_	_
40	increased	_	VERB	VBD	_	0	root	_	_
41	the	_	DET	DT	_	42	det	_	_
42	area	_	NOUN	NN	_	40	dobj	_	_
43	under	_	ADP	IN	_	46	case	_	_
44	the	_	DET	DT	_	46	det	_	_
45	curve	_	ADJ	JJ	_	46	amod	_	_
46	AUC	_	NOUN	NN	_	40	nmod	_	_
47	of	_	ADP	IN	_	48	case	_	_
48	DRUG	_	NOUN	NN	_	46	nmod	_	_
49	and	_	CONJ	CC	_	46	cc	_	_
50	its	_	PRON	PRP$	_	51	nmod:poss	_	_
51	metabolites	_	NOUN	NNS	_	46	conj	_	_
52	P88	_	NOUN	NN	_	51	dep	_	_
53	and	_	CONJ	CC	_	52	cc	_	_
54	P95	_	NOUN	NN	_	52	conj	_	_
55	by	_	ADP	IN	_	56	case	_	_
56	57%	_	NOUN	NN	_	40	nmod	_	_
57	,	_	.	,	_	56	punct	_	_
58	55%	_	NOUN	NN	_	56	conj	_	_
59	and	_	CONJ	CC	_	56	cc	_	_
60	35%	_	NOUN	NN	_	56	conj	_	_
61	,	_	.	,	_	40	punct	_	_
62	respectively	_	ADV	RB	_	40	advmod	_	_

#	Iloperidone	670
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	doses	_	NOUN	NNS	_	5	nsubjpass	_	_
3	should	_	VERB	MD	_	5	aux	_	_
4	be	_	VERB	VB	_	5	auxpass	_	_
5	reduced	_	VERB	VBN	_	0	root	_	_
6	by	_	ADP	IN	_	9	case	_	_
7	about	_	ADV	RB	_	8	advmod	_	_
8	one	_	NUM	CD	_	9	nummod	_	_
9	half	_	NOUN	NN	_	5	nmod	_	_
10	when	_	ADV	WRB	_	11	advmod	_	_
11	administered	_	VERB	VBN	_	5	advcl	_	_
12	with	_	ADP	IN	_	13	case	_	_
13	ketoconazole	_	NOUN	NN	_	11	nmod	_	_
14	or	_	CONJ	CC	_	13	cc	_	_
15	other	_	ADJ	JJ	_	17	amod	_	_
16	strong	_	ADJ	JJ	_	17	amod	_	_
17	inhibitors	_	NOUN	NNS	_	13	conj	_	_
18	of	_	ADP	IN	_	20	case	_	_
19	CYP3A4	_	NOUN	NN	_	20	compound	_	_
20	e.g	_	NOUN	NN	_	13	nmod	_	_
21	,	_	.	,	_	20	punct	_	_
22	itraconazole	_	NOUN	NN	_	20	appos	_	_

#	Iloperidone	671
1	Weaker	_	ADJ	JJ	_	2	amod	_	_
2	inhibitors	_	NOUN	NNS	_	12	nsubjpass	_	_
3	e.g	_	NOUN	NN	_	2	nmod	_	_
4	,	_	.	,	_	3	punct	_	_
5	erythromycin	_	NOUN	NN	_	3	appos	_	_
6	,	_	.	,	_	3	punct	_	_
7	grapefruit	_	ADJ	JJ	_	8	amod	_	_
8	juice	_	NOUN	NN	_	3	appos	_	_
9	have	_	VERB	MD	_	12	aux	_	_
10	not	_	ADV	RB	_	12	neg	_	_
11	been	_	VERB	VBN	_	12	auxpass	_	_
12	studied	_	VERB	VBN	_	0	root	_	_

#	Iloperidone	672
1	When	_	ADV	WRB	_	6	advmod	_	_
2	the	_	DET	DT	_	4	det	_	_
3	CYP3A4	_	NOUN	NN	_	4	compound	_	_
4	inhibitor	_	NOUN	NN	_	6	nsubjpass	_	_
5	is	_	VERB	VBZ	_	6	auxpass	_	_
6	withdrawn	_	ADJ	JJ	_	17	advcl	_	_
7	from	_	ADP	IN	_	10	case	_	_
8	the	_	DET	DT	_	10	det	_	_
9	combination	_	NOUN	NN	_	10	compound	_	_
10	therapy	_	NOUN	NN	_	6	nmod	_	_
11	,	_	.	,	_	17	punct	_	_
12	the	_	DET	DT	_	14	det	_	_
13	DRUG	_	NOUN	NN	_	14	compound	_	_
14	dose	_	NOUN	NN	_	17	nsubjpass	_	_
15	should	_	VERB	MD	_	17	aux	_	_
16	be	_	VERB	VB	_	17	auxpass	_	_
17	returned	_	VERB	VBN	_	0	root	_	_
18	to	_	PRT	TO	_	21	case	_	_
19	the	_	DET	DT	_	21	det	_	_
20	previous	_	ADJ	JJ	_	21	amod	_	_
21	level	_	NOUN	NN	_	17	nmod	_	_

#	Iloperidone	673
1	Fluoxetine	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Co	_	NOUN	NN	_	4	compound	_	_
4	administration	_	NOUN	NN	_	48	nsubj	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	fluoxetine	_	NOUN	NN	_	8	compound	_	_
7	20	_	NUM	CD	_	8	nummod	_	_
8	mg	_	NOUN	NN	_	4	nmod	_	_
9	twice	_	ADV	RB	_	10	advmod	_	_
10	daily	_	ADV	RB	_	4	advmod	_	_
11	for	_	ADP	IN	_	13	case	_	_
12	21	_	NUM	CD	_	13	nummod	_	_
13	days	_	NOUN	NNS	_	10	nmod	_	_
14	,	_	.	,	_	10	punct	_	_
15	a	_	DET	DT	_	17	det	_	_
16	potent	_	ADJ	JJ	_	17	amod	_	_
17	inhibitor	_	NOUN	NN	_	34	nsubj	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	CYP2D6	_	NOUN	NN	_	17	nmod	_	_
20	,	_	.	,	_	17	punct	_	_
21	with	_	ADP	IN	_	26	case	_	_
22	a	_	DET	DT	_	26	det	_	_
23	single	_	ADJ	JJ	_	26	amod	_	_
24	3	_	NUM	CD	_	26	nummod	_	_
25	mg	_	NOUN	NN	_	26	compound	_	_
26	dose	_	NOUN	NN	_	17	nmod	_	_
27	of	_	ADP	IN	_	28	case	_	_
28	DRUG	_	NOUN	NN	_	26	nmod	_	_
29	to	_	PRT	TO	_	32	case	_	_
30	23	_	NUM	CD	_	32	nummod	_	_
31	healthy	_	ADJ	JJ	_	32	amod	_	_
32	volunteers	_	NOUN	NNS	_	26	nmod	_	_
33	,	_	.	,	_	17	punct	_	_
34	ages	_	VERB	VBZ	_	10	dep	_	_
35	29	_	NUM	CD	_	37	compound	_	_
36	to	_	PRT	TO	_	37	dep	_	_
37	44	_	NUM	CD	_	38	nummod	_	_
38	years	_	NOUN	NNS	_	34	dobj	_	_
39	,	_	.	,	_	34	punct	_	_
40	who	_	DET	WDT	_	42	nsubjpass	_	_
41	were	_	VERB	VBD	_	42	auxpass	_	_
42	classified	_	VERB	VBN	_	34	ccomp	_	_
43	as	_	ADP	IN	_	46	case	_	_
44	CYP2D6	_	NOUN	NN	_	46	compound	_	_
45	extensive	_	ADJ	JJ	_	46	amod	_	_
46	metabolizers	_	NOUN	NNS	_	42	nmod	_	_
47	,	_	.	,	_	4	punct	_	_
48	increased	_	VERB	VBD	_	1	dep	_	_
49	the	_	DET	DT	_	50	det	_	_
50	AUC	_	NOUN	NN	_	48	dobj	_	_
51	of	_	ADP	IN	_	52	case	_	_
52	DRUG	_	NOUN	NN	_	50	nmod	_	_
53	and	_	CONJ	CC	_	50	cc	_	_
54	its	_	PRON	PRP$	_	56	nmod:poss	_	_
55	metabolite	_	NOUN	NN	_	56	compound	_	_
56	P88	_	NOUN	NN	_	50	conj	_	_
57	,	_	.	,	_	48	punct	_	_
58	by	_	ADP	IN	_	63	case	_	_
59	about	_	ADV	RB	_	60	advmod	_	_
60	2	_	NUM	CD	_	62	compound	_	_
61	to	_	PRT	TO	_	62	dep	_	_
62	3	_	NUM	CD	_	63	nummod	_	_
63	fold	_	NOUN	NN	_	48	nmod	_	_
64	,	_	.	,	_	48	punct	_	_
65	and	_	CONJ	CC	_	48	cc	_	_
66	decreased	_	VERB	VBD	_	48	conj	_	_
67	the	_	DET	DT	_	68	det	_	_
68	AUC	_	NOUN	NN	_	66	dobj	_	_
69	of	_	ADP	IN	_	72	case	_	_
70	its	_	PRON	PRP$	_	72	nmod:poss	_	_
71	metabolite	_	NOUN	NN	_	72	compound	_	_
72	P95	_	NOUN	NN	_	68	nmod	_	_
73	by	_	ADP	IN	_	74	case	_	_
74	one	_	NUM	CD	_	66	nmod	_	_
75	half	_	VERB	MD	_	48	root	_	_

#	Iloperidone	674
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	doses	_	NOUN	NNS	_	5	nsubjpass	_	_
3	should	_	VERB	MD	_	5	aux	_	_
4	be	_	VERB	VB	_	5	auxpass	_	_
5	reduced	_	VERB	VBN	_	0	root	_	_
6	by	_	ADP	IN	_	8	case	_	_
7	one	_	NUM	CD	_	8	nummod	_	_
8	half	_	NOUN	NN	_	5	nmod	_	_
9	when	_	ADV	WRB	_	10	advmod	_	_
10	administered	_	VERB	VBN	_	5	advcl	_	_
11	with	_	ADP	IN	_	12	case	_	_
12	fluoxetine	_	NOUN	NN	_	10	nmod	_	_

#	Iloperidone	675
1	When	_	ADV	WRB	_	4	advmod	_	_
2	fluoxetine	_	NOUN	NN	_	4	nsubj	_	_
3	is	_	VERB	VBZ	_	4	auxpass	_	_
4	withdrawn	_	ADJ	JJ	_	15	advcl	_	_
5	from	_	ADP	IN	_	8	case	_	_
6	the	_	DET	DT	_	8	det	_	_
7	combination	_	NOUN	NN	_	8	compound	_	_
8	therapy	_	NOUN	NN	_	4	nmod	_	_
9	,	_	.	,	_	15	punct	_	_
10	the	_	DET	DT	_	12	det	_	_
11	DRUG	_	NOUN	NN	_	12	compound	_	_
12	dose	_	NOUN	NN	_	15	nsubjpass	_	_
13	should	_	VERB	MD	_	15	aux	_	_
14	be	_	VERB	VB	_	15	auxpass	_	_
15	returned	_	VERB	VBN	_	0	root	_	_
16	to	_	PRT	TO	_	19	case	_	_
17	the	_	DET	DT	_	19	det	_	_
18	previous	_	ADJ	JJ	_	19	amod	_	_
19	level	_	NOUN	NN	_	15	nmod	_	_

#	Iloperidone	676
1	Other	_	ADJ	JJ	_	3	amod	_	_
2	strong	_	ADJ	JJ	_	3	amod	_	_
3	inhibitors	_	NOUN	NNS	_	8	nsubjpass	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	CYP2D6	_	NOUN	NN	_	3	nmod	_	_
6	would	_	VERB	MD	_	8	aux	_	_
7	be	_	VERB	VB	_	8	auxpass	_	_
8	expected	_	VERB	VBN	_	0	root	_	_
9	to	_	PRT	TO	_	10	mark	_	_
10	have	_	VERB	VB	_	8	xcomp	_	_
11	similar	_	ADJ	JJ	_	12	amod	_	_
12	effects	_	NOUN	NNS	_	10	dobj	_	_
13	and	_	CONJ	CC	_	8	cc	_	_
14	would	_	VERB	MD	_	15	aux	_	_
15	need	_	VERB	VB	_	8	conj	_	_
16	appropriate	_	ADJ	JJ	_	18	amod	_	_
17	dose	_	NOUN	NN	_	18	compound	_	_
18	reductions	_	NOUN	NNS	_	15	dobj	_	_

#	Iloperidone	677
1	When	_	ADV	WRB	_	6	advmod	_	_
2	the	_	DET	DT	_	4	det	_	_
3	CYP2D6	_	NOUN	NN	_	4	compound	_	_
4	inhibitor	_	NOUN	NN	_	6	nsubjpass	_	_
5	is	_	VERB	VBZ	_	6	auxpass	_	_
6	withdrawn	_	ADJ	JJ	_	17	advcl	_	_
7	from	_	ADP	IN	_	10	case	_	_
8	the	_	DET	DT	_	10	det	_	_
9	combination	_	NOUN	NN	_	10	compound	_	_
10	therapy	_	NOUN	NN	_	6	nmod	_	_
11	,	_	.	,	_	17	punct	_	_
12	DRUG	_	NOUN	NN	_	13	compound	_	_
13	dose	_	NOUN	NN	_	17	nsubjpass	_	_
14	could	_	VERB	MD	_	17	aux	_	_
15	then	_	ADV	RB	_	17	advmod	_	_
16	be	_	VERB	VB	_	17	auxpass	_	_
17	increased	_	VERB	VBN	_	0	root	_	_
18	to	_	PRT	TO	_	21	case	_	_
19	the	_	DET	DT	_	21	det	_	_
20	previous	_	ADJ	JJ	_	21	amod	_	_
21	level	_	NOUN	NN	_	17	nmod	_	_

#	Iloperidone	678
1	Paroxetine	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Co	_	NOUN	NN	_	4	compound	_	_
4	administration	_	NOUN	NN	_	76	nsubj	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	paroxetine	_	NOUN	NN	_	8	compound	_	_
7	20	_	NUM	CD	_	8	nummod	_	_
8	mg	_	NOUN	NN	_	4	nmod	_	_
9	/	_	.	:	_	4	punct	_	_
10	day	_	NOUN	NN	_	4	dep	_	_
11	for	_	ADP	IN	_	15	case	_	_
12	5	_	NUM	CD	_	14	compound	_	_
13	to	_	PRT	TO	_	14	dep	_	_
14	8	_	NUM	CD	_	15	nummod	_	_
15	days	_	NOUN	NNS	_	10	nmod	_	_
16	,	_	.	,	_	15	punct	_	_
17	a	_	DET	DT	_	19	det	_	_
18	potent	_	ADJ	JJ	_	19	amod	_	_
19	inhibitor	_	NOUN	NN	_	15	appos	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	CYP2D6	_	NOUN	NN	_	19	nmod	_	_
22	,	_	.	,	_	10	punct	_	_
23	with	_	ADP	IN	_	25	case	_	_
24	multiple	_	ADJ	JJ	_	25	amod	_	_
25	doses	_	NOUN	NNS	_	10	nmod	_	_
26	of	_	ADP	IN	_	27	case	_	_
27	DRUG	_	NOUN	NN	_	25	nmod	_	_
28	8	_	NUM	CD	_	27	nummod	_	_
29	or	_	CONJ	CC	_	27	cc	_	_
30	12	_	NUM	CD	_	31	nummod	_	_
31	mg	_	NOUN	NN	_	27	conj	_	_
32	twice	_	ADV	RB	_	33	advmod	_	_
33	daily	_	ADV	RB	_	10	advmod	_	_
34	to	_	PRT	TO	_	35	case	_	_
35	patients	_	NOUN	NNS	_	33	nmod	_	_
36	with	_	ADP	IN	_	37	case	_	_
37	schizophrenia	_	NOUN	NN	_	35	nmod	_	_
38	ages	_	VERB	VBZ	_	42	case	_	_
39	18	_	NUM	CD	_	41	compound	_	_
40	to	_	PRT	TO	_	41	dep	_	_
41	65	_	NUM	CD	_	42	nummod	_	_
42	years	_	NOUN	NNS	_	35	dep	_	_
43	resulted	_	VERB	VBD	_	42	acl	_	_
44	in	_	ADP	IN	_	50	case	_	_
45	increased	_	VERB	VBN	_	50	amod	_	_
46	mean	_	NOUN	NN	_	50	amod	_	_
47	steady	_	ADJ	JJ	_	50	amod	_	_
48	state	_	NOUN	NN	_	50	compound	_	_
49	peak	_	ADJ	JJ	_	50	amod	_	_
50	concentrations	_	NOUN	NNS	_	43	nmod	_	_
51	of	_	ADP	IN	_	52	case	_	_
52	DRUG	_	NOUN	NN	_	50	nmod	_	_
53	and	_	CONJ	CC	_	50	cc	_	_
54	its	_	PRON	PRP$	_	56	nmod:poss	_	_
55	metabolite	_	NOUN	NN	_	56	compound	_	_
56	P88	_	NOUN	NN	_	50	conj	_	_
57	,	_	.	,	_	10	punct	_	_
58	by	_	ADP	IN	_	61	case	_	_
59	about	_	ADV	RB	_	60	advmod	_	_
60	1.6	_	NUM	CD	_	61	nummod	_	_
61	fold	_	NOUN	NN	_	10	nmod	_	_
62	,	_	.	,	_	4	punct	_	_
63	and	_	CONJ	CC	_	4	cc	_	_
64	decreased	_	VERB	VBN	_	69	amod	_	_
65	mean	_	NOUN	NN	_	69	amod	_	_
66	steady	_	ADJ	JJ	_	69	amod	_	_
67	state	_	NOUN	NN	_	69	compound	_	_
68	peak	_	ADJ	JJ	_	69	amod	_	_
69	concentrations	_	NOUN	NNS	_	4	conj	_	_
70	of	_	ADP	IN	_	73	case	_	_
71	its	_	PRON	PRP$	_	73	nmod:poss	_	_
72	metabolite	_	NOUN	NN	_	73	compound	_	_
73	P95	_	NOUN	NN	_	69	nmod	_	_
74	by	_	ADP	IN	_	75	case	_	_
75	one	_	NUM	CD	_	4	nmod	_	_
76	half	_	VERB	MD	_	1	dep	_	_

#	Iloperidone	679
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	doses	_	NOUN	NNS	_	5	nsubjpass	_	_
3	should	_	VERB	MD	_	5	aux	_	_
4	be	_	VERB	VB	_	5	auxpass	_	_
5	reduced	_	VERB	VBN	_	0	root	_	_
6	by	_	ADP	IN	_	8	case	_	_
7	one	_	NUM	CD	_	8	nummod	_	_
8	half	_	NOUN	NN	_	5	nmod	_	_
9	when	_	ADV	WRB	_	10	advmod	_	_
10	administered	_	VERB	VBN	_	5	advcl	_	_
11	with	_	ADP	IN	_	12	case	_	_
12	paroxetine	_	NOUN	NN	_	10	nmod	_	_

#	Iloperidone	680
1	When	_	ADV	WRB	_	4	advmod	_	_
2	paroxetine	_	NOUN	NN	_	4	nsubj	_	_
3	is	_	VERB	VBZ	_	4	cop	_	_
4	withdrawn	_	ADJ	JJ	_	15	advcl	_	_
5	from	_	ADP	IN	_	8	case	_	_
6	the	_	DET	DT	_	8	det	_	_
7	combination	_	NOUN	NN	_	8	compound	_	_
8	therapy	_	NOUN	NN	_	4	nmod	_	_
9	,	_	.	,	_	15	punct	_	_
10	the	_	DET	DT	_	12	det	_	_
11	DRUG	_	NOUN	NN	_	12	compound	_	_
12	dose	_	NOUN	NN	_	15	nsubjpass	_	_
13	should	_	VERB	MD	_	15	aux	_	_
14	be	_	VERB	VB	_	15	auxpass	_	_
15	returned	_	VERB	VBN	_	0	root	_	_
16	to	_	PRT	TO	_	19	case	_	_
17	the	_	DET	DT	_	19	det	_	_
18	previous	_	ADJ	JJ	_	19	amod	_	_
19	level	_	NOUN	NN	_	15	nmod	_	_

#	Iloperidone	682
1	When	_	ADV	WRB	_	6	advmod	_	_
2	the	_	DET	DT	_	4	det	_	_
3	CYP2D6	_	NOUN	NN	_	4	compound	_	_
4	inhibitor	_	NOUN	NN	_	6	nsubjpass	_	_
5	is	_	VERB	VBZ	_	6	auxpass	_	_
6	withdrawn	_	ADJ	JJ	_	17	advcl	_	_
7	from	_	ADP	IN	_	10	case	_	_
8	the	_	DET	DT	_	10	det	_	_
9	combination	_	NOUN	NN	_	10	compound	_	_
10	therapy	_	NOUN	NN	_	6	nmod	_	_
11	,	_	.	,	_	17	punct	_	_
12	DRUG	_	NOUN	NN	_	13	compound	_	_
13	dose	_	NOUN	NN	_	17	nsubjpass	_	_
14	could	_	VERB	MD	_	17	aux	_	_
15	then	_	ADV	RB	_	17	advmod	_	_
16	be	_	VERB	VB	_	17	auxpass	_	_
17	increased	_	VERB	VBN	_	0	root	_	_
18	to	_	PRT	TO	_	20	case	_	_
19	previous	_	ADJ	JJ	_	20	amod	_	_
20	levels	_	NOUN	NNS	_	17	nmod	_	_

#	Iloperidone	683
1	Paroxetine	_	NOUN	NN	_	0	root	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	Ketoconazole	_	NOUN	NN	_	1	conj	_	_
4	:	_	.	:	_	1	punct	_	_
5	Co	_	NOUN	NN	_	6	compound	_	_
6	administration	_	NOUN	NN	_	47	nsubj	_	_
7	of	_	ADP	IN	_	10	case	_	_
8	paroxetine	_	NOUN	NN	_	10	compound	_	_
9	20	_	NUM	CD	_	10	nummod	_	_
10	mg	_	NOUN	NN	_	6	nmod	_	_
11	once	_	ADV	RB	_	12	advmod	_	_
12	daily	_	ADV	RB	_	26	advmod	_	_
13	for	_	ADP	IN	_	15	case	_	_
14	10	_	NUM	CD	_	15	nummod	_	_
15	days	_	NOUN	NNS	_	12	nmod	_	_
16	,	_	.	,	_	15	punct	_	_
17	a	_	DET	DT	_	19	det	_	_
18	CYP2D6	_	NOUN	NN	_	19	compound	_	_
19	inhibitor	_	NOUN	NN	_	15	conj	_	_
20	,	_	.	,	_	15	punct	_	_
21	and	_	CONJ	CC	_	15	cc	_	_
22	ketoconazole	_	NOUN	NN	_	24	compound	_	_
23	200	_	NUM	CD	_	24	nummod	_	_
24	mg	_	NOUN	NN	_	15	conj	_	_
25	twice	_	ADV	RB	_	26	advmod	_	_
26	daily	_	ADV	RB	_	47	advmod	_	_
27	with	_	ADP	IN	_	29	case	_	_
28	multiple	_	ADJ	JJ	_	29	amod	_	_
29	doses	_	NOUN	NNS	_	26	nmod	_	_
30	of	_	ADP	IN	_	31	case	_	_
31	DRUG	_	NOUN	NN	_	29	nmod	_	_
32	8	_	NUM	CD	_	31	nummod	_	_
33	or	_	CONJ	CC	_	31	cc	_	_
34	12	_	NUM	CD	_	35	nummod	_	_
35	mg	_	NOUN	NN	_	31	conj	_	_
36	twice	_	ADV	RB	_	37	advmod	_	_
37	daily	_	ADV	RB	_	47	advmod	_	_
38	to	_	PRT	TO	_	39	case	_	_
39	patients	_	NOUN	NNS	_	37	nmod	_	_
40	with	_	ADP	IN	_	41	case	_	_
41	schizophrenia	_	NOUN	NN	_	39	nmod	_	_
42	ages	_	VERB	VBZ	_	39	acl	_	_
43	18	_	NUM	CD	_	45	compound	_	_
44	to	_	PRT	TO	_	45	dep	_	_
45	65	_	NUM	CD	_	46	nummod	_	_
46	years	_	NOUN	NNS	_	42	dobj	_	_
47	resulted	_	VERB	VBD	_	1	dep	_	_
48	in	_	ADP	IN	_	52	case	_	_
49	a	_	DET	DT	_	52	det	_	_
50	1.4	_	NUM	CD	_	51	compound	_	_
51	fold	_	NOUN	NN	_	52	amod	_	_
52	increase	_	NOUN	NN	_	47	nmod	_	_
53	in	_	ADP	IN	_	56	case	_	_
54	steady	_	ADJ	JJ	_	56	amod	_	_
55	state	_	NOUN	NN	_	56	compound	_	_
56	concentrations	_	NOUN	NNS	_	52	nmod	_	_
57	of	_	ADP	IN	_	58	case	_	_
58	DRUG	_	NOUN	NN	_	56	nmod	_	_
59	and	_	CONJ	CC	_	52	cc	_	_
60	its	_	PRON	PRP$	_	62	nmod:poss	_	_
61	metabolite	_	NOUN	NN	_	62	compound	_	_
62	P88	_	NOUN	NN	_	52	conj	_	_
63	and	_	CONJ	CC	_	62	cc	_	_
64	a	_	DET	DT	_	67	det	_	_
65	1.4	_	NUM	CD	_	66	compound	_	_
66	fold	_	NOUN	NN	_	67	amod	_	_
67	decrease	_	NOUN	NN	_	62	conj	_	_
68	in	_	ADP	IN	_	70	case	_	_
69	the	_	DET	DT	_	70	det	_	_
70	P95	_	NOUN	NN	_	67	nmod	_	_
71	in	_	ADP	IN	_	73	case	_	_
72	the	_	DET	DT	_	73	det	_	_
73	presence	_	NOUN	NN	_	47	nmod	_	_
74	of	_	ADP	IN	_	75	case	_	_
75	paroxetine	_	NOUN	NN	_	73	nmod	_	_

#	Iloperidone	684
1	So	_	DET	DT	_	2	neg	_	_
2	giving	_	VERB	VBG	_	14	nsubj	_	_
3	DRUG	_	NOUN	NN	_	2	dobj	_	_
4	with	_	ADP	IN	_	5	case	_	_
5	inhibitors	_	NOUN	NNS	_	2	nmod	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	both	_	DET	DT	_	5	nmod	_	_
8	of	_	ADP	IN	_	11	case	_	_
9	its	_	PRON	PRP$	_	11	nmod:poss	_	_
10	metabolic	_	ADJ	JJ	_	11	amod	_	_
11	pathways	_	NOUN	NNS	_	7	nmod	_	_
12	did	_	VERB	VBD	_	14	aux	_	_
13	not	_	ADV	RB	_	14	neg	_	_
14	add	_	VERB	VB	_	0	root	_	_
15	to	_	PRT	TO	_	17	case	_	_
16	the	_	DET	DT	_	17	det	_	_
17	effect	_	NOUN	NN	_	14	nmod	_	_
18	of	_	ADP	IN	_	20	case	_	_
19	either	_	CONJ	CC	_	20	det	_	_
20	inhibitor	_	NOUN	NN	_	17	nmod	_	_
21	given	_	VERB	VBN	_	20	acl	_	_
22	alone	_	ADV	RB	_	21	advmod	_	_

#	Iloperidone	685
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	doses	_	NOUN	NNS	_	6	nsubjpass	_	_
3	should	_	VERB	MD	_	6	aux	_	_
4	therefore	_	ADV	RB	_	6	advmod	_	_
5	be	_	VERB	VB	_	6	auxpass	_	_
6	reduced	_	VERB	VBN	_	0	root	_	_
7	by	_	ADP	IN	_	10	case	_	_
8	about	_	ADV	RB	_	9	advmod	_	_
9	one	_	NUM	CD	_	10	nummod	_	_
10	half	_	NOUN	NN	_	6	nmod	_	_
11	if	_	DET	WDT	_	12	nsubj	_	_
12	administered	_	VERB	VBN	_	10	acl	_	_
13	concomitantly	_	ADV	RB	_	12	advmod	_	_
14	with	_	ADP	IN	_	17	case	_	_
15	both	_	CONJ	CC	_	17	cc:preconj	_	_
16	a	_	DET	DT	_	17	dep	_	_
17	CYP2D6	_	NOUN	NN	_	12	nmod	_	_
18	and	_	CONJ	CC	_	17	cc	_	_
19	CYP3A4	_	NOUN	NN	_	20	compound	_	_
20	inhibitor	_	NOUN	NN	_	17	conj	_	_

#	Iloperidone	686
1	In	_	X	FW	_	3	amod	_	_
2	vitro	_	X	FW	_	1	dep	_	_
3	studies	_	NOUN	NNS	_	8	nsubj	_	_
4	in	_	ADP	IN	_	7	case	_	_
5	human	_	ADJ	JJ	_	7	amod	_	_
6	liver	_	NOUN	NN	_	7	compound	_	_
7	microsomes	_	NOUN	NNS	_	3	nmod	_	_
8	showed	_	VERB	VBD	_	0	root	_	_
9	that	_	ADP	IN	_	14	mark	_	_
10	DRUG	_	NOUN	NN	_	14	nsubj	_	_
11	does	_	VERB	VBZ	_	14	aux	_	_
12	not	_	ADV	RB	_	14	neg	_	_
13	substantially	_	ADV	RB	_	14	advmod	_	_
14	inhibit	_	VERB	VB	_	8	ccomp	_	_
15	the	_	DET	DT	_	16	det	_	_
16	metabolism	_	NOUN	NN	_	14	dobj	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	drugs	_	NOUN	NNS	_	16	nmod	_	_
19	metabolized	_	VERB	VBN	_	18	acl	_	_
20	by	_	ADP	IN	_	25	case	_	_
21	the	_	DET	DT	_	25	det	_	_
22	following	_	VERB	VBG	_	25	amod	_	_
23	cytochrome	_	NOUN	NN	_	25	compound	_	_
24	P450	_	NOUN	NN	_	25	compound	_	_
25	isozymes	_	NOUN	NNS	_	19	nmod	_	_
26	:	_	.	:	_	14	punct	_	_
27	CYP1A1	_	NOUN	NN	_	14	dep	_	_
28	,	_	.	,	_	27	punct	_	_
29	CYP1A2	_	NOUN	NN	_	27	conj	_	_
30	,	_	.	,	_	27	punct	_	_
31	CYP2A6	_	NOUN	NN	_	27	conj	_	_
32	,	_	.	,	_	27	punct	_	_
33	CYP2B6	_	NOUN	NN	_	27	conj	_	_
34	,	_	.	,	_	27	punct	_	_
35	CYP2C8	_	NOUN	NN	_	27	conj	_	_
36	,	_	.	,	_	27	punct	_	_
37	CYP2C9	_	NOUN	NN	_	27	conj	_	_
38	,	_	.	,	_	27	punct	_	_
39	or	_	CONJ	CC	_	27	cc	_	_
40	CYP2E1	_	NOUN	NN	_	27	conj	_	_

#	Iloperidone	687
1	Furthermore	_	ADV	RB	_	10	advmod	_	_
2	,	_	.	,	_	10	punct	_	_
3	in	_	X	FW	_	5	amod	_	_
4	vitro	_	X	FW	_	3	dep	_	_
5	studies	_	NOUN	NNS	_	10	nsubj	_	_
6	in	_	ADP	IN	_	9	case	_	_
7	human	_	ADJ	JJ	_	9	amod	_	_
8	liver	_	NOUN	NN	_	9	compound	_	_
9	microsomes	_	NOUN	NNS	_	5	nmod	_	_
10	showed	_	VERB	VBD	_	0	root	_	_
11	that	_	ADP	IN	_	15	mark	_	_
12	DRUG	_	NOUN	NN	_	15	nsubj	_	_
13	does	_	VERB	VBZ	_	15	aux	_	_
14	not	_	ADV	RB	_	15	neg	_	_
15	have	_	VERB	VB	_	10	ccomp	_	_
16	enzyme	_	NOUN	NN	_	18	compound	_	_
17	inducing	_	VERB	VBG	_	18	compound	_	_
18	properties	_	NOUN	NNS	_	15	dobj	_	_
19	,	_	.	,	_	15	punct	_	_
20	specifically	_	ADV	RB	_	26	advmod	_	_
21	for	_	ADP	IN	_	26	case	_	_
22	the	_	DET	DT	_	26	det	_	_
23	following	_	VERB	VBG	_	26	amod	_	_
24	cytochrome	_	NOUN	NN	_	26	compound	_	_
25	P450	_	NOUN	NN	_	26	compound	_	_
26	isozymes	_	NOUN	NNS	_	15	nmod	_	_
27	:	_	.	:	_	15	punct	_	_
28	CYP1A2	_	NOUN	NN	_	15	dep	_	_
29	,	_	.	,	_	28	punct	_	_
30	CYP2C8	_	NOUN	NN	_	28	conj	_	_
31	,	_	.	,	_	28	punct	_	_
32	CYP2C9	_	NOUN	NN	_	28	conj	_	_
33	,	_	.	,	_	28	punct	_	_
34	CYP2C19	_	NOUN	NN	_	28	conj	_	_
35	,	_	.	,	_	28	punct	_	_
36	CYP3A4	_	NOUN	NN	_	28	conj	_	_
37	and	_	CONJ	CC	_	28	cc	_	_
38	CYP3A5	_	NOUN	NN	_	28	conj	_	_

#	Iloperidone	688
1	Dextromethorphan	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	A	_	PRON	PRP$	_	4	det	_	_
4	study	_	NOUN	NN	_	8	nsubj	_	_
5	in	_	ADP	IN	_	7	case	_	_
6	healthy	_	ADJ	JJ	_	7	amod	_	_
7	volunteers	_	NOUN	NNS	_	4	nmod	_	_
8	showed	_	VERB	VBD	_	1	dep	_	_
9	that	_	ADP	IN	_	29	mark	_	_
10	changes	_	NOUN	NNS	_	29	nsubj	_	_
11	in	_	ADP	IN	_	13	case	_	_
12	the	_	DET	DT	_	13	det	_	_
13	pharmacokinetics	_	NOUN	NNS	_	10	nmod	_	_
14	of	_	ADP	IN	_	18	case	_	_
15	dextromethorphan	_	NOUN	NN	_	18	compound	_	_
16	80	_	NUM	CD	_	18	nummod	_	_
17	mg	_	NOUN	NN	_	18	compound	_	_
18	dose	_	NOUN	NN	_	13	nmod	_	_
19	when	_	ADV	WRB	_	28	advmod	_	_
20	a	_	DET	DT	_	23	det	_	_
21	3	_	NUM	CD	_	23	nummod	_	_
22	mg	_	NOUN	NN	_	23	compound	_	_
23	dose	_	NOUN	NN	_	28	nsubjpass	_	_
24	of	_	ADP	IN	_	25	case	_	_
25	DRUG	_	NOUN	NN	_	23	nmod	_	_
26	was	_	VERB	VBD	_	28	auxpass	_	_
27	co	_	PRT	TO	_	28	mark	_	_
28	administered	_	VERB	VBN	_	10	acl	_	_
29	resulted	_	VERB	VBN	_	8	ccomp	_	_
30	in	_	ADP	IN	_	33	case	_	_
31	a	_	DET	DT	_	33	det	_	_
32	17%	_	ADJ	JJ	_	33	amod	_	_
33	increase	_	NOUN	NN	_	29	nmod	_	_
34	in	_	ADP	IN	_	36	case	_	_
35	total	_	ADJ	JJ	_	36	amod	_	_
36	exposure	_	NOUN	NN	_	33	nmod	_	_
37	and	_	CONJ	CC	_	29	cc	_	_
38	a	_	DET	DT	_	40	det	_	_
39	26%	_	ADJ	JJ	_	40	amod	_	_
40	increase	_	NOUN	NN	_	29	conj	_	_
41	in	_	ADP	IN	_	45	case	_	_
42	the	_	DET	DT	_	45	det	_	_
43	maximum	_	NOUN	NN	_	45	compound	_	_
44	plasma	_	NOUN	NN	_	45	compound	_	_
45	concentrations	_	NOUN	NNS	_	40	nmod	_	_
46	Cmax)of	_	NOUN	NN	_	47	compound	_	_
47	dextromethorphan	_	NOUN	NN	_	45	dep	_	_

#	Iloperidone	689
1	Thus	_	ADV	RB	_	12	advmod	_	_
2	,	_	.	,	_	12	punct	_	_
3	an	_	DET	DT	_	4	det	_	_
4	interaction	_	NOUN	NN	_	12	nsubj	_	_
5	between	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	other	_	ADJ	JJ	_	10	amod	_	_
9	CYP2D6	_	NOUN	NN	_	10	compound	_	_
10	substrates	_	NOUN	NNS	_	6	conj	_	_
11	is	_	VERB	VBZ	_	12	auxpass	_	_
12	unlikely	_	ADV	RB	_	0	root	_	_

#	Iloperidone	690
1	Fluoxetine	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	A	_	PRON	PRP$	_	7	det	_	_
4	single	_	ADJ	JJ	_	7	amod	_	_
5	3	_	NUM	CD	_	7	nummod	_	_
6	mg	_	NOUN	NN	_	7	compound	_	_
7	dose	_	NOUN	NN	_	10	nsubj	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	had	_	VERB	VBD	_	1	dep	_	_
11	no	_	DET	DT	_	12	neg	_	_
12	effect	_	NOUN	NN	_	10	dobj	_	_
13	on	_	ADP	IN	_	15	case	_	_
14	the	_	DET	DT	_	15	det	_	_
15	pharmacokinetics	_	NOUN	NNS	_	12	nmod	_	_
16	of	_	ADP	IN	_	19	case	_	_
17	fluoxetine	_	NOUN	NN	_	19	compound	_	_
18	20	_	NUM	CD	_	19	nummod	_	_
19	mg	_	NOUN	NN	_	15	nmod	_	_
20	twice	_	ADV	RB	_	21	advmod	_	_
21	daily	_	ADV	RB	_	10	advmod	_	_

#	Iloperidone	691
1	Midazolam	_	NOUN	NN	_	12	advmod	_	_
2	a	_	DET	DT	_	7	det	_	_
3	sensitive	_	ADJ	JJ	_	7	amod	_	_
4	CYP	_	NOUN	NN	_	7	compound	_	_
5	3A4	_	NOUN	NN	_	7	compound	_	_
6	substrate):A	_	NOUN	NN	_	7	compound	_	_
7	study	_	NOUN	NN	_	12	nsubj	_	_
8	in	_	ADP	IN	_	9	case	_	_
9	patients	_	NOUN	NNS	_	7	nmod	_	_
10	with	_	ADP	IN	_	11	case	_	_
11	schizophrenia	_	NOUN	NN	_	9	nmod	_	_
12	showed	_	VERB	VBD	_	0	root	_	_
13	a	_	DET	DT	_	17	det	_	_
14	less	_	ADV	RB	_	16	advmod	_	_
15	than	_	ADP	IN	_	14	mwe	_	_
16	50%	_	ADJ	JJ	_	17	amod	_	_
17	increase	_	NOUN	NN	_	12	dobj	_	_
18	in	_	ADP	IN	_	21	case	_	_
19	midazolam	_	NOUN	NN	_	21	compound	_	_
20	total	_	ADJ	JJ	_	21	amod	_	_
21	exposure	_	NOUN	NN	_	17	nmod	_	_
22	at	_	ADP	IN	_	27	case	_	_
23	DRUG	_	NOUN	NN	_	27	compound	_	_
24	steady	_	ADJ	JJ	_	27	amod	_	_
25	state	_	NOUN	NN	_	27	compound	_	_
26	14	_	NUM	CD	_	27	nummod	_	_
27	days	_	NOUN	NNS	_	17	nmod	_	_
28	of	_	ADP	IN	_	30	case	_	_
29	oral	_	ADJ	JJ	_	30	amod	_	_
30	dosing	_	NOUN	NN	_	27	nmod	_	_
31	at	_	ADP	IN	_	36	case	_	_
32	up	_	ADJ	JJ	_	34	advmod	_	_
33	to	_	PRT	TO	_	34	dep	_	_
34	10	_	NUM	CD	_	36	nummod	_	_
35	mg	_	NOUN	NN	_	36	compound	_	_
36	DRUG	_	NOUN	NN	_	17	nmod	_	_
37	twice	_	ADV	RB	_	38	advmod	_	_
38	daily	_	ADV	RB	_	39	advmod	_	_
39	and	_	CONJ	CC	_	12	advmod	_	_
40	no	_	DET	DT	_	41	neg	_	_
41	effect	_	NOUN	NN	_	39	conj	_	_
42	on	_	ADP	IN	_	43	case	_	_
43	midazolam	_	NOUN	NN	_	41	nmod	_	_
44	Cmax	_	NOUN	NN	_	43	dep	_	_

#	Iloperidone	692
1	Thus	_	ADV	RB	_	12	advmod	_	_
2	,	_	.	,	_	12	punct	_	_
3	an	_	DET	DT	_	4	det	_	_
4	interaction	_	NOUN	NN	_	12	nsubj	_	_
5	between	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	other	_	ADJ	JJ	_	10	amod	_	_
9	CYP3A4	_	NOUN	NN	_	10	compound	_	_
10	substrates	_	NOUN	NNS	_	6	conj	_	_
11	is	_	VERB	VBZ	_	12	auxpass	_	_
12	unlikely	_	ADV	RB	_	0	root	_	_

#	Iloperidone	693
1	FANAPT	_	NOUN	NN	_	5	nsubjpass	_	_
2	should	_	VERB	MD	_	5	aux	_	_
3	not	_	ADV	RB	_	5	neg	_	_
4	be	_	VERB	VB	_	5	auxpass	_	_
5	used	_	VERB	VBN	_	0	root	_	_
6	with	_	ADP	IN	_	9	case	_	_
7	any	_	DET	DT	_	9	det	_	_
8	other	_	ADJ	JJ	_	9	amod	_	_
9	drugs	_	NOUN	NNS	_	5	nmod	_	_
10	that	_	DET	WDT	_	11	nsubj	_	_
11	prolong	_	VERB	VBP	_	9	acl:relcl	_	_
12	the	_	DET	DT	_	14	det	_	_
13	QT	_	NOUN	NN	_	14	nmod:npmod	_	_
14	interval	_	ADJ	JJ	_	11	dobj	_	_

#	Iloperidone	694
1	The	_	DET	DT	_	2	det	_	_
2	mechanism	_	NOUN	NN	_	18	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	action	_	NOUN	NN	_	2	nmod	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	FANAPT	_	NOUN	NN	_	4	nmod	_	_
7	,	_	.	,	_	2	punct	_	_
8	as	_	ADP	IN	_	11	case	_	_
9	with	_	ADP	IN	_	11	case	_	_
10	other	_	ADJ	JJ	_	11	amod	_	_
11	drugs	_	NOUN	NNS	_	2	nmod	_	_
12	having	_	VERB	VBG	_	11	acl	_	_
13	efficacy	_	NOUN	NN	_	12	dobj	_	_
14	in	_	ADP	IN	_	15	case	_	_
15	schizophrenia	_	NOUN	NN	_	13	nmod	_	_
16	,	_	.	,	_	2	punct	_	_
17	is	_	VERB	VBZ	_	18	auxpass	_	_
18	unknown	_	ADJ	JJ	_	0	root	_	_

#	Iloperidone	695
1	However	_	ADV	RB	_	4	advmod	_	_
2	it	_	PRON	PRP	_	4	nsubjpass	_	_
3	is	_	VERB	VBZ	_	4	auxpass	_	_
4	proposed	_	VERB	VBN	_	0	root	_	_
5	that	_	ADP	IN	_	4	punct	_	_
6	the	_	DET	DT	_	7	det	_	_
7	efficacy	_	NOUN	NN	_	5	root	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	FANAPTis	_	NOUN	NN	_	7	nmod	_	_
10	mediated	_	VERB	VBN	_	9	acl	_	_
11	through	_	ADP	IN	_	13	case	_	_
12	a	_	DET	DT	_	13	det	_	_
13	combination	_	NOUN	NN	_	10	nmod	_	_
14	of	_	ADP	IN	_	18	case	_	_
15	dopamine	_	NOUN	NN	_	18	compound	_	_
16	type	_	NOUN	NN	_	18	compound	_	_
17	2	_	NUM	CD	_	18	nummod	_	_
18	D2	_	NOUN	NN	_	13	nmod	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	serotonin	_	NOUN	NN	_	25	compound	_	_
21	type	_	NOUN	NN	_	25	compound	_	_
22	2	_	NUM	CD	_	25	nummod	_	_
23	5	_	NUM	CD	_	25	nummod	_	_
24	HT2	_	NOUN	NN	_	25	compound	_	_
25	antagonisms	_	NOUN	NNS	_	18	conj	_	_

#	Iloperidone	696
1	FANAPT	_	NOUN	NN	_	2	nsubj	_	_
2	exhibits	_	VERB	VBZ	_	0	root	_	_
3	high	_	ADJ	JJ	_	5	amod	_	_
4	nM	_	NOUN	NN	_	5	compound	_	_
5	affinity	_	NOUN	NN	_	2	dobj	_	_
6	binding	_	VERB	VBG	_	5	acl	_	_
7	to	_	PRT	TO	_	12	case	_	_
8	serotonin	_	NOUN	NN	_	12	compound	_	_
9	5	_	NUM	CD	_	12	nummod	_	_
10	HT2A	_	NOUN	NN	_	12	compound	_	_
11	dopamine	_	NOUN	NN	_	12	compound	_	_
12	D2	_	NOUN	NN	_	22	compound	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	D3	_	NOUN	NN	_	15	compound	_	_
15	receptors	_	NOUN	NNS	_	12	conj	_	_
16	,	_	.	,	_	12	punct	_	_
17	and	_	CONJ	CC	_	12	cc	_	_
18	norepinephrine	_	NOUN	NN	_	20	compound	_	_
19	NEA1	_	NOUN	NN	_	20	compound	_	_
20	receptors	_	NOUN	NNS	_	12	conj	_	_
21	Ki	_	NOUN	NN	_	22	compound	_	_
22	values	_	NOUN	NNS	_	6	dobj	_	_
23	of	_	ADP	IN	_	24	case	_	_
24	5.6	_	NUM	CD	_	22	nmod	_	_
25	,	_	.	,	_	24	punct	_	_
26	6.3	_	NUM	CD	_	24	conj	_	_
27	,	_	.	,	_	24	punct	_	_
28	7.1	_	NUM	CD	_	24	conj	_	_
29	,	_	.	,	_	24	punct	_	_
30	and	_	CONJ	CC	_	24	cc	_	_
31	0.36	_	NUM	CD	_	24	conj	_	_
32	nM	_	NOUN	NN	_	24	dep	_	_
33	,	_	.	,	_	2	punct	_	_
34	respectively	_	ADV	RB	_	2	advmod	_	_

#	Iloperidone	697
1	FANAPT	_	NOUN	NN	_	2	nsubj	_	_
2	has	_	VERB	VBZ	_	0	root	_	_
3	moderate	_	ADJ	JJ	_	4	amod	_	_
4	affinity	_	NOUN	NN	_	2	dobj	_	_
5	for	_	ADP	IN	_	7	case	_	_
6	dopamine	_	NOUN	NN	_	7	compound	_	_
7	D4	_	NOUN	NN	_	4	nmod	_	_
8	,	_	.	,	_	4	punct	_	_
9	and	_	CONJ	CC	_	4	cc	_	_
10	serotonin	_	NOUN	NN	_	12	compound	_	_
11	5	_	NUM	CD	_	12	nummod	_	_
12	HT6	_	NOUN	NN	_	18	compound	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	5	_	NUM	CD	_	16	nummod	_	_
15	HT7	_	NOUN	NN	_	16	compound	_	_
16	receptors	_	NOUN	NNS	_	12	conj	_	_
17	Ki	_	NOUN	NN	_	18	compound	_	_
18	values	_	NOUN	NNS	_	4	conj	_	_
19	of	_	ADP	IN	_	20	case	_	_
20	25	_	NUM	CD	_	18	nmod	_	_
21	,	_	.	,	_	20	punct	_	_
22	43	_	NUM	CD	_	20	conj	_	_
23	,	_	.	,	_	20	punct	_	_
24	and	_	CONJ	CC	_	20	cc	_	_
25	22	_	NUM	CD	_	20	conj	_	_
26	,	_	.	,	_	20	punct	_	_
27	nM	_	NOUN	NN	_	20	conj	_	_
28	respectively	_	ADV	RB	_	27	advmod	_	_
29	,	_	.	,	_	20	punct	_	_
30	and	_	CONJ	CC	_	20	cc	_	_
31	low	_	ADJ	JJ	_	32	amod	_	_
32	affinity	_	NOUN	NN	_	20	conj	_	_
33	for	_	ADP	IN	_	37	case	_	_
34	the	_	DET	DT	_	37	det	_	_
35	serotonin	_	NOUN	NN	_	37	compound	_	_
36	5	_	NUM	CD	_	37	nummod	_	_
37	HT1A	_	NOUN	NN	_	18	nmod	_	_
38	,	_	.	,	_	37	punct	_	_
39	dopamine	_	NOUN	NN	_	40	compound	_	_
40	D1	_	NOUN	NN	_	37	conj	_	_
41	,	_	.	,	_	37	punct	_	_
42	and	_	CONJ	CC	_	37	cc	_	_
43	histamine	_	NOUN	NN	_	45	compound	_	_
44	H1	_	NOUN	NN	_	45	compound	_	_
45	receptors	_	NOUN	NNS	_	37	conj	_	_
46	Ki	_	NOUN	NN	_	47	compound	_	_
47	values	_	NOUN	NNS	_	37	dep	_	_
48	of	_	ADP	IN	_	49	case	_	_
49	168	_	NUM	CD	_	47	nmod	_	_
50	,	_	.	,	_	49	punct	_	_
51	216	_	NUM	CD	_	49	conj	_	_
52	and	_	CONJ	CC	_	49	cc	_	_
53	437	_	NUM	CD	_	49	conj	_	_
54	nM	_	NOUN	NN	_	49	dep	_	_
55	,	_	.	,	_	4	punct	_	_
56	respectively	_	ADV	RB	_	2	advmod	_	_

#	Iloperidone	698
1	FANAPT	_	NOUN	NN	_	2	nsubj	_	_
2	has	_	VERB	VBZ	_	0	root	_	_
3	no	_	DET	DT	_	8	neg	_	_
4	appreciable	_	ADJ	JJ	_	8	amod	_	_
5	affinity	_	NOUN	NN	_	8	compound	_	_
6	Ki	_	NOUN	NN	_	8	compound	_	_
7	>1000	_	NUM	CD	_	8	nummod	_	_
8	nM	_	NOUN	NN	_	2	dobj	_	_
9	for	_	ADP	IN	_	12	case	_	_
10	cholinergic	_	ADJ	JJ	_	12	amod	_	_
11	muscarinic	_	ADJ	JJ	_	12	amod	_	_
12	receptors	_	NOUN	NNS	_	8	nmod	_	_

#	Iloperidone	699
1	FANAPT	_	NOUN	NN	_	2	nsubj	_	_
2	functions	_	VERB	VBZ	_	0	root	_	_
3	as	_	ADP	IN	_	5	case	_	_
4	an	_	DET	DT	_	5	det	_	_
5	antagonist	_	NOUN	NN	_	2	nmod	_	_
6	at	_	ADP	IN	_	9	case	_	_
7	the	_	DET	DT	_	9	det	_	_
8	dopamine	_	NOUN	NN	_	9	compound	_	_
9	D2	_	NOUN	NN	_	5	nmod	_	_
10	,	_	.	,	_	9	punct	_	_
11	D3	_	NOUN	NN	_	9	conj	_	_
12	,	_	.	,	_	9	punct	_	_
13	serotonin	_	NOUN	NN	_	15	compound	_	_
14	5	_	NUM	CD	_	15	nummod	_	_
15	HT1A	_	NOUN	NN	_	9	conj	_	_
16	and	_	CONJ	CC	_	9	cc	_	_
17	norepinephrine	_	NOUN	NN	_	18	compound	_	_
18	A1	_	NOUN	NN	_	9	conj	_	_
19	/	_	.	:	_	2	punct	_	_
20	A2C	_	NOUN	NN	_	21	compound	_	_
21	receptors	_	NOUN	NNS	_	2	parataxis	_	_

#	Iloperidone	700
1	The	_	DET	DT	_	2	det	_	_
2	affinity	_	NOUN	NN	_	10	nsubj	_	_
3	of	_	ADP	IN	_	7	case	_	_
4	the	_	DET	DT	_	7	det	_	_
5	FANAPT	_	NOUN	NN	_	7	compound	_	_
6	metabolite	_	NOUN	NN	_	7	compound	_	_
7	P88	_	NOUN	NN	_	2	nmod	_	_
8	is	_	VERB	VBZ	_	10	cop	_	_
9	generally	_	ADV	RB	_	10	advmod	_	_
10	equal	_	ADJ	JJ	_	0	root	_	_
11	or	_	CONJ	CC	_	10	cc	_	_
12	less	_	ADV	RB	_	10	conj	_	_
13	than	_	ADP	IN	_	14	case	_	_
14	that	_	DET	DT	_	12	nmod	_	_
15	of	_	ADP	IN	_	18	case	_	_
16	the	_	DET	DT	_	18	det	_	_
17	parent	_	NOUN	NN	_	18	compound	_	_
18	compound	_	NOUN	NN	_	14	nmod	_	_

#	Iloperidone	701
1	In	_	ADP	IN	_	2	case	_	_
2	contrast	_	NOUN	NN	_	8	nmod	_	_
3	,	_	.	,	_	8	punct	_	_
4	the	_	DET	DT	_	6	det	_	_
5	metabolite	_	NOUN	NN	_	6	compound	_	_
6	P95	_	NOUN	NN	_	8	nsubj	_	_
7	only	_	ADV	RB	_	8	advmod	_	_
8	shows	_	VERB	VBZ	_	0	root	_	_
9	affinity	_	NOUN	NN	_	8	dobj	_	_
10	for	_	ADP	IN	_	14	case	_	_
11	5	_	NUM	CD	_	14	nummod	_	_
12	HT2A	_	NOUN	NN	_	14	compound	_	_
13	Ki	_	NOUN	NN	_	14	compound	_	_
14	value	_	NOUN	NN	_	9	nmod	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	3.91	_	NUM	CD	_	30	nummod	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	the	_	DET	DT	_	19	det	_	_
19	NEA1A	_	NOUN	NN	_	16	conj	_	_
20	,	_	.	,	_	16	punct	_	_
21	NEA1B	_	NOUN	NN	_	16	conj	_	_
22	,	_	.	,	_	16	punct	_	_
23	NEA1D	_	NOUN	NN	_	16	conj	_	_
24	,	_	.	,	_	16	punct	_	_
25	and	_	CONJ	CC	_	16	cc	_	_
26	NEA2	_	NOUN	NN	_	28	compound	_	_
27	C	_	NOUN	NN	_	28	compound	_	_
28	receptors	_	NOUN	NNS	_	16	conj	_	_
29	Ki	_	NOUN	NN	_	30	compound	_	_
30	values	_	NOUN	NNS	_	14	nmod	_	_
31	of	_	ADP	IN	_	32	case	_	_
32	4.7	_	NUM	CD	_	30	nmod	_	_
33	,	_	.	,	_	32	punct	_	_
34	2.7	_	NUM	CD	_	32	conj	_	_
35	,	_	.	,	_	32	punct	_	_
36	8.8	_	NUM	CD	_	32	conj	_	_
37	,	_	.	,	_	32	punct	_	_
38	and	_	CONJ	CC	_	32	cc	_	_
39	4.7	_	NUM	CD	_	32	conj	_	_
40	nM	_	NOUN	NN	_	32	dep	_	_
41	respectively	_	ADV	RB	_	8	advmod	_	_

#	Iloperidone	702
1	The	_	DET	DT	_	6	det	_	_
2	observed	_	VERB	VBN	_	6	amod	_	_
3	mean	_	NOUN	NN	_	6	compound	_	_
4	elimination	_	NOUN	NN	_	6	compound	_	_
5	half	_	NOUN	NN	_	6	compound	_	_
6	lives	_	NOUN	NNS	_	0	root	_	_
7	for	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	,	_	.	,	_	8	punct	_	_
10	P88	_	NOUN	NN	_	8	conj	_	_
11	and	_	CONJ	CC	_	8	cc	_	_
12	P95	_	NOUN	NN	_	8	conj	_	_
13	in	_	ADP	IN	_	16	case	_	_
14	CYP2D6	_	NOUN	NN	_	16	compound	_	_
15	extensive	_	ADJ	JJ	_	16	amod	_	_
16	metabolizers	_	NOUN	NNS	_	6	nmod	_	_
17	EM)are	_	NOUN	NN	_	16	dep	_	_
18	18	_	NUM	CD	_	17	nummod	_	_
19	,	_	.	,	_	17	punct	_	_
20	26	_	NUM	CD	_	17	conj	_	_
21	,	_	.	,	_	17	punct	_	_
22	and	_	CONJ	CC	_	17	cc	_	_
23	23	_	NUM	CD	_	24	nummod	_	_
24	hours	_	NOUN	NNS	_	17	conj	_	_
25	,	_	.	,	_	16	punct	_	_
26	respectively	_	ADV	RB	_	16	advmod	_	_
27	,	_	.	,	_	6	punct	_	_
28	and	_	CONJ	CC	_	6	cc	_	_
29	in	_	ADP	IN	_	31	case	_	_
30	poor	_	ADJ	JJ	_	31	amod	_	_
31	metabolizers	_	NOUN	NNS	_	6	conj	_	_
32	PM	_	NOUN	NN	_	34	nsubj	_	_
33	are	_	VERB	VBP	_	34	cop	_	_
34	33	_	NUM	CD	_	40	nummod	_	_
35	,	_	.	,	_	34	punct	_	_
36	37	_	NUM	CD	_	34	conj	_	_
37	,	_	.	,	_	34	punct	_	_
38	and	_	CONJ	CC	_	34	cc	_	_
39	31	_	NUM	CD	_	34	conj	_	_
40	hours	_	NOUN	NNS	_	31	dep	_	_
41	,	_	.	,	_	31	punct	_	_
42	respectively	_	ADV	RB	_	31	advmod	_	_

#	Iloperidone	703
1	Steady	_	ADJ	JJ	_	3	amod	_	_
2	state	_	NOUN	NN	_	3	compound	_	_
3	concentrations	_	NOUN	NNS	_	5	nsubjpass	_	_
4	are	_	VERB	VBP	_	5	auxpass	_	_
5	attained	_	VERB	VBN	_	0	root	_	_
6	within3	_	NUM	CD	_	8	compound	_	_
7	to	_	PRT	TO	_	8	dep	_	_
8	4	_	NUM	CD	_	9	nummod	_	_
9	days	_	NOUN	NNS	_	5	dobj	_	_
10	of	_	ADP	IN	_	11	mark	_	_
11	dosing	_	VERB	VBG	_	9	acl	_	_

#	Iloperidone	704
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	accumulation	_	NOUN	NN	_	4	nsubj	_	_
3	is	_	VERB	VBZ	_	4	cop	_	_
4	predictable	_	ADJ	JJ	_	0	root	_	_
5	from	_	ADP	IN	_	8	case	_	_
6	single	_	ADJ	JJ	_	8	amod	_	_
7	dose	_	NOUN	NN	_	8	compound	_	_
8	pharmacokinetics	_	NOUN	NNS	_	4	nmod	_	_

#	Iloperidone	705
1	The	_	DET	DT	_	2	det	_	_
2	pharmacokinetics	_	NOUN	NNS	_	9	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	is	_	VERB	VBZ	_	9	cop	_	_
6	more	_	ADV	RB	_	9	advmod	_	_
7	than	_	ADP	IN	_	9	case	_	_
8	dose	_	NOUN	NN	_	9	nmod:npmod	_	_
9	proportional	_	ADJ	JJ	_	0	root	_	_

#	Iloperidone	706
1	Elimination	_	NOUN	NN	_	8	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	is	_	VERB	VBZ	_	8	cop	_	_
5	mainly	_	ADV	RB	_	8	advmod	_	_
6	through	_	ADP	IN	_	8	case	_	_
7	hepatic	_	ADJ	JJ	_	8	amod	_	_
8	metabolism	_	NOUN	NN	_	0	root	_	_
9	involving	_	VERB	VBG	_	8	acl	_	_
10	2	_	NUM	CD	_	12	nummod	_	_
11	P450	_	NOUN	NN	_	12	compound	_	_
12	isozymes	_	NOUN	NNS	_	9	dobj	_	_
13	,	_	.	,	_	12	punct	_	_
14	CYP2D6	_	NOUN	NN	_	12	appos	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	CYP3A4	_	NOUN	NN	_	14	conj	_	_

#	Iloperidone	707
1	Absorption	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	DRUG	_	NOUN	NN	_	6	nsubjpass	_	_
4	is	_	VERB	VBZ	_	6	auxpass	_	_
5	well	_	ADV	RB	_	6	advmod	_	_
6	absorbed	_	VERB	VBN	_	1	dep	_	_
7	after	_	ADP	IN	_	8	case	_	_
8	administration	_	NOUN	NN	_	6	nmod	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	the	_	DET	DT	_	11	det	_	_
11	tablet	_	NOUN	NN	_	8	nmod	_	_
12	with	_	ADP	IN	_	15	case	_	_
13	peak	_	ADJ	JJ	_	15	amod	_	_
14	plasma	_	NOUN	NN	_	15	compound	_	_
15	concentrations	_	NOUN	NNS	_	8	nmod	_	_
16	occurring	_	VERB	VBG	_	15	acl	_	_
17	within	_	ADP	IN	_	21	case	_	_
18	2	_	NUM	CD	_	20	compound	_	_
19	to	_	PRT	TO	_	20	dep	_	_
20	4	_	NUM	CD	_	21	nummod	_	_
21	hours	_	NOUN	NNS	_	16	nmod	_	_
22	while	_	ADP	IN	_	30	mark	_	_
23	the	_	DET	DT	_	25	det	_	_
24	relative	_	ADJ	JJ	_	25	amod	_	_
25	bioavailability	_	NOUN	NN	_	30	nsubj	_	_
26	of	_	ADP	IN	_	29	case	_	_
27	the	_	DET	DT	_	29	det	_	_
28	tablet	_	NOUN	NN	_	29	compound	_	_
29	formulation	_	NOUN	NN	_	25	nmod	_	_
30	compared	_	VERB	VBD	_	6	parataxis	_	_
31	to	_	PRT	TO	_	33	case	_	_
32	oral	_	ADJ	JJ	_	33	amod	_	_
33	solution	_	NOUN	NN	_	30	nmod	_	_
34	is	_	VERB	VBZ	_	35	auxpass	_	_
35	96%	_	ADJ	JJ	_	30	parataxis	_	_

#	Iloperidone	708
1	Administration	_	NOUN	NN	_	13	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	with	_	ADP	IN	_	9	case	_	_
5	a	_	DET	DT	_	9	det	_	_
6	standard	_	ADJ	JJ	_	9	amod	_	_
7	high	_	ADJ	JJ	_	9	amod	_	_
8	fat	_	NOUN	NN	_	9	compound	_	_
9	meal	_	NOUN	NN	_	1	nmod	_	_
10	did	_	VERB	VBD	_	13	aux	_	_
11	not	_	ADV	RB	_	13	neg	_	_
12	significantly	_	ADV	RB	_	13	advmod	_	_
13	affect	_	VERB	VB	_	0	root	_	_
14	the	_	DET	DT	_	15	det	_	_
15	Cmax	_	NOUN	NN	_	13	dobj	_	_
16	or	_	CONJ	CC	_	15	cc	_	_
17	AUC	_	NOUN	NN	_	15	conj	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	DRUG	_	NOUN	NN	_	15	nmod	_	_
20	,	_	.	,	_	19	punct	_	_
21	P88	_	NOUN	NN	_	19	conj	_	_
22	,	_	.	,	_	19	punct	_	_
23	or	_	CONJ	CC	_	19	cc	_	_
24	P95	_	NOUN	NN	_	19	conj	_	_
25	,	_	.	,	_	13	punct	_	_
26	but	_	CONJ	CC	_	13	cc	_	_
27	delayed	_	VERB	VBD	_	13	conj	_	_
28	Tmax	_	NOUN	NN	_	27	dobj	_	_
29	by	_	ADP	IN	_	31	case	_	_
30	1	_	NUM	CD	_	31	nummod	_	_
31	hour	_	NOUN	NN	_	27	nmod	_	_
32	for	_	ADP	IN	_	33	case	_	_
33	DRUG	_	NOUN	NN	_	31	nmod	_	_
34	,	_	.	,	_	13	punct	_	_
35	2	_	NUM	CD	_	36	nummod	_	_
36	hours	_	NOUN	NNS	_	13	dobj	_	_
37	for	_	ADP	IN	_	38	case	_	_
38	P88	_	NOUN	NN	_	36	nmod	_	_
39	and	_	CONJ	CC	_	36	cc	_	_
40	6	_	NUM	CD	_	41	nummod	_	_
41	hours	_	NOUN	NNS	_	36	conj	_	_
42	for	_	ADP	IN	_	43	case	_	_
43	P95	_	NOUN	NN	_	41	nmod	_	_

#	Iloperidone	709
1	FANAPT	_	NOUN	NN	_	4	nsubjpass	_	_
2	can	_	VERB	MD	_	4	aux	_	_
3	be	_	VERB	VB	_	4	auxpass	_	_
4	administered	_	VERB	VBN	_	0	root	_	_
5	without	_	ADP	IN	_	6	case	_	_
6	regard	_	NOUN	NN	_	4	nmod	_	_
7	to	_	PRT	TO	_	8	case	_	_
8	meals	_	NOUN	NNS	_	6	nmod	_	_

#	Iloperidone	710
1	Distribution	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	DRUG	_	NOUN	NN	_	4	nsubj	_	_
4	has	_	VERB	VBZ	_	1	dep	_	_
5	an	_	DET	DT	_	8	det	_	_
6	apparent	_	ADJ	JJ	_	8	amod	_	_
7	clearance	_	NOUN	NN	_	8	compound	_	_
8	clearance	_	NOUN	NN	_	4	dobj	_	_
9	/	_	.	:	_	4	punct	_	_
10	bioavailability	_	NOUN	NN	_	4	dep	_	_
11	of	_	ADP	IN	_	15	case	_	_
12	47	_	NUM	CD	_	14	compound	_	_
13	to	_	PRT	TO	_	14	dep	_	_
14	102	_	NUM	CD	_	15	nummod	_	_
15	L	_	NOUN	NN	_	10	nmod	_	_
16	/	_	.	:	_	10	punct	_	_
17	h	_	NOUN	NN	_	52	nsubj	_	_
18	,	_	.	,	_	17	punct	_	_
19	with	_	ADP	IN	_	22	case	_	_
20	an	_	DET	DT	_	22	det	_	_
21	apparent	_	ADJ	JJ	_	22	amod	_	_
22	volume	_	NOUN	NN	_	17	nmod	_	_
23	of	_	ADP	IN	_	24	case	_	_
24	distribution	_	NOUN	NN	_	22	nmod	_	_
25	of	_	ADP	IN	_	32	case	_	_
26	1340	_	NUM	CD	_	28	compound	_	_
27	to	_	PRT	TO	_	28	dep	_	_
28	2800	_	NUM	CD	_	32	nummod	_	_
29	L	_	NOUN	NN	_	32	compound	_	_
30	At	_	NOUN	NN	_	32	compound	_	_
31	therapeutic	_	ADJ	JJ	_	32	amod	_	_
32	concentrations	_	NOUN	NNS	_	24	nmod	_	_
33	,	_	.	,	_	17	punct	_	_
34	the	_	DET	DT	_	36	det	_	_
35	unbound	_	ADJ	JJ	_	36	amod	_	_
36	fraction	_	NOUN	NN	_	42	nsubj	_	_
37	of	_	ADP	IN	_	38	case	_	_
38	DRUG	_	NOUN	NN	_	36	nmod	_	_
39	in	_	ADP	IN	_	40	case	_	_
40	plasma	_	NOUN	NN	_	36	nmod	_	_
41	is	_	VERB	VBZ	_	42	cop	_	_
42	~3%	_	ADJ	JJ	_	17	acl:relcl	_	_
43	and	_	CONJ	CC	_	42	cc	_	_
44	of	_	ADP	IN	_	46	case	_	_
45	each	_	DET	DT	_	46	det	_	_
46	metabolite	_	NOUN	NN	_	42	conj	_	_
47	P88	_	NOUN	NN	_	46	dep	_	_
48	and	_	CONJ	CC	_	47	cc	_	_
49	P95	_	NOUN	NN	_	47	conj	_	_
50	it	_	PRON	PRP	_	52	nsubj	_	_
51	is	_	VERB	VBZ	_	52	auxpass	_	_
52	~8%	_	ADJ	JJ	_	10	dep	_	_

#	Iloperidone	711
1	Metabolism	_	NOUN	NN	_	0	root	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	Elimination	_	NOUN	NN	_	1	conj	_	_
4	:	_	.	:	_	1	punct	_	_
5	DRUG	_	NOUN	NN	_	7	nsubjpass	_	_
6	is	_	VERB	VBZ	_	7	auxpass	_	_
7	metabolized	_	VERB	VBN	_	1	dep	_	_
8	primarily	_	ADV	RB	_	7	advmod	_	_
9	by	_	ADP	IN	_	12	case	_	_
10	3	_	NUM	CD	_	12	nummod	_	_
11	biotransformation	_	NOUN	NN	_	12	compound	_	_
12	pathways	_	NOUN	NNS	_	7	nmod	_	_
13	:	_	.	:	_	7	punct	_	_
14	carbonyl	_	NOUN	NN	_	15	compound	_	_
15	reduction	_	NOUN	NN	_	7	parataxis	_	_
16	,	_	.	,	_	15	punct	_	_
17	hydroxylation	_	NOUN	NN	_	15	appos	_	_
18	mediated	_	VERB	VBN	_	17	acl	_	_
19	by	_	ADP	IN	_	20	case	_	_
20	CYP2D6	_	NOUN	NN	_	18	nmod	_	_
21	and	_	CONJ	CC	_	20	cc	_	_
22	O	_	NOUN	NN	_	23	compound	_	_
23	demethylation	_	NOUN	NN	_	20	conj	_	_
24	mediated	_	VERB	VBN	_	20	acl	_	_
25	by	_	ADP	IN	_	26	case	_	_
26	CYP3A4	_	NOUN	NN	_	24	nmod	_	_

#	Iloperidone	712
1	There	_	DET	EX	_	2	expl	_	_
2	are	_	VERB	VBP	_	0	root	_	_
3	2	_	NUM	CD	_	6	nummod	_	_
4	predominant	_	ADJ	JJ	_	6	amod	_	_
5	DRUG	_	NOUN	NN	_	6	compound	_	_
6	metabolites	_	NOUN	NNS	_	2	nsubj	_	_
7	,	_	.	,	_	6	punct	_	_
8	P95	_	NOUN	NN	_	6	appos	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	P88	_	NOUN	NN	_	8	conj	_	_

#	Iloperidone	713
1	The	_	DET	DT	_	4	det	_	_
2	DRUG	_	NOUN	NN	_	4	compound	_	_
3	metabolite	_	NOUN	NN	_	4	compound	_	_
4	P95	_	NOUN	NN	_	5	nsubj	_	_
5	represents	_	VERB	VBZ	_	0	root	_	_
6	47.9%	_	NOUN	NN	_	5	dobj	_	_
7	of	_	ADP	IN	_	9	case	_	_
8	the	_	DET	DT	_	9	det	_	_
9	AUC	_	NOUN	NN	_	6	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_
12	and	_	CONJ	CC	_	5	cc	_	_
13	its	_	PRON	PRP$	_	14	nmod:poss	_	_
14	metabolites	_	NOUN	NNS	_	5	conj	_	_
15	in	_	ADP	IN	_	16	case	_	_
16	plasma	_	NOUN	NN	_	14	nmod	_	_
17	at	_	ADP	IN	_	19	case	_	_
18	steady	_	ADJ	JJ	_	19	amod	_	_
19	state	_	NOUN	NN	_	14	nmod	_	_
20	for	_	ADP	IN	_	22	case	_	_
21	extensive	_	ADJ	JJ	_	22	amod	_	_
22	metabolizers	_	NOUN	NNS	_	19	nmod	_	_
23	EM	_	NOUN	NN	_	22	dep	_	_
24	and	_	CONJ	CC	_	23	cc	_	_
25	25%	_	NOUN	NN	_	23	conj	_	_
26	for	_	ADP	IN	_	28	case	_	_
27	poor	_	ADJ	JJ	_	28	amod	_	_
28	metabolizers	_	NOUN	NNS	_	22	nmod	_	_
29	PM	_	NOUN	NN	_	28	dep	_	_

#	Iloperidone	714
1	The	_	DET	DT	_	4	det	_	_
2	active	_	ADJ	JJ	_	4	amod	_	_
3	metabolite	_	NOUN	NN	_	4	compound	_	_
4	P88	_	NOUN	NN	_	5	nsubj	_	_
5	accounts	_	VERB	VBZ	_	0	root	_	_
6	for	_	ADP	IN	_	7	case	_	_
7	19.5%	_	ADJ	JJ	_	5	nmod	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	34.0%	_	NOUN	NN	_	7	conj	_	_
10	of	_	ADP	IN	_	13	case	_	_
11	total	_	ADJ	JJ	_	13	amod	_	_
12	plasma	_	NOUN	NN	_	13	compound	_	_
13	exposure	_	NOUN	NN	_	7	nmod	_	_
14	in	_	ADP	IN	_	15	case	_	_
15	EM	_	NOUN	NN	_	13	nmod	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	PM	_	NOUN	NN	_	15	conj	_	_
18	,	_	.	,	_	5	punct	_	_
19	respectively	_	ADV	RB	_	5	advmod	_	_

#	Iloperidone	715
1	Approximately	_	ADV	RB	_	2	advmod	_	_
2	7%	_	ADJ	JJ	_	16	nsubj	_	_
3	to	_	PRT	TO	_	4	case	_	_
4	10%	_	NOUN	NN	_	2	nmod	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	Caucasians	_	NOUN	NNS	_	4	nmod	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	3%	_	NOUN	NN	_	6	conj	_	_
9	to	_	PRT	TO	_	10	case	_	_
10	8%	_	NOUN	NN	_	2	nmod	_	_
11	of	_	ADP	IN	_	15	case	_	_
12	black	_	ADJ	JJ	_	15	amod	_	_
13	/	_	.	:	_	15	punct	_	_
14	African	_	NOUN	NN	_	15	compound	_	_
15	Americans	_	NOUN	NNS	_	10	nmod	_	_
16	lack	_	VERB	VBP	_	0	root	_	_
17	the	_	DET	DT	_	18	det	_	_
18	capacity	_	NOUN	NN	_	16	dobj	_	_
19	to	_	PRT	TO	_	20	mark	_	_
20	metabolize	_	VERB	VB	_	18	acl	_	_
21	CYP2D6	_	NOUN	NN	_	22	compound	_	_
22	substrates	_	NOUN	NNS	_	20	dobj	_	_
23	and	_	CONJ	CC	_	16	cc	_	_
24	are	_	VERB	VBP	_	25	auxpass	_	_
25	classified	_	VERB	VBN	_	16	conj	_	_
26	as	_	ADP	IN	_	29	case	_	_
27	poor	_	ADJ	JJ	_	29	amod	_	_
28	metabolizers	_	NOUN	NNS	_	29	compound	_	_
29	PM	_	NOUN	NN	_	25	nmod	_	_
30	,	_	.	,	_	16	punct	_	_
31	whereas	_	ADP	IN	_	35	mark	_	_
32	the	_	DET	DT	_	33	det	_	_
33	rest	_	NOUN	NN	_	35	nsubj	_	_
34	are	_	VERB	VBP	_	35	cop	_	_
35	intermediate	_	ADJ	JJ	_	16	advcl	_	_
36	,	_	.	,	_	16	punct	_	_
37	extensive	_	ADJ	JJ	_	16	dep	_	_
38	or	_	CONJ	CC	_	37	cc	_	_
39	ultrarapid	_	NOUN	NN	_	37	conj	_	_
40	metabolizers	_	NOUN	NNS	_	37	dep	_	_

#	Iloperidone	716
1	Co	_	PRT	TO	_	2	case	_	_
2	administration	_	NOUN	NN	_	13	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	FANAPT	_	NOUN	NN	_	2	nmod	_	_
5	with	_	ADP	IN	_	8	case	_	_
6	known	_	VERB	VBN	_	8	amod	_	_
7	strong	_	ADJ	JJ	_	8	amod	_	_
8	inhibitors	_	NOUN	NNS	_	2	nmod	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	CYP2D6	_	NOUN	NN	_	8	nmod	_	_
11	like	_	ADP	IN	_	12	case	_	_
12	fluoxetine	_	NOUN	NN	_	8	nmod	_	_
13	results	_	VERB	VBZ	_	33	advcl	_	_
14	in	_	ADP	IN	_	18	case	_	_
15	a	_	DET	DT	_	18	det	_	_
16	2.3	_	NUM	CD	_	17	compound	_	_
17	fold	_	NOUN	NN	_	18	amod	_	_
18	increase	_	NOUN	NN	_	13	nmod	_	_
19	in	_	ADP	IN	_	22	case	_	_
20	DRUG	_	NOUN	NN	_	22	compound	_	_
21	plasma	_	NOUN	NN	_	22	compound	_	_
22	exposure	_	NOUN	NN	_	18	nmod	_	_
23	,	_	.	,	_	33	punct	_	_
24	andtherefore	_	ADV	RB	_	25	advmod	_	_
25	one	_	NUM	CD	_	26	nummod	_	_
26	half	_	NOUN	NN	_	33	nsubjpass	_	_
27	of	_	ADP	IN	_	30	case	_	_
28	the	_	DET	DT	_	30	det	_	_
29	FANAPT	_	NOUN	NN	_	30	compound	_	_
30	dose	_	NOUN	NN	_	26	nmod	_	_
31	should	_	VERB	MD	_	33	aux	_	_
32	be	_	VERB	VB	_	33	auxpass	_	_
33	administered	_	VERB	VBN	_	0	root	_	_

#	Iloperidone	717
1	Similarly	_	ADV	RB	_	6	advmod	_	_
2	,	_	.	,	_	6	punct	_	_
3	PMs	_	NOUN	NN	_	6	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	CYP2D6	_	NOUN	NN	_	3	nmod	_	_
6	have	_	VERB	VBP	_	0	root	_	_
7	higher	_	ADJ	JJ	_	8	amod	_	_
8	exposure	_	NOUN	NN	_	6	dobj	_	_
9	to	_	PRT	TO	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	compared	_	VERB	VBN	_	6	xcomp	_	_
12	with	_	ADP	IN	_	14	case	_	_
13	EMsand	_	NOUN	NN	_	14	compound	_	_
14	PMs	_	NOUN	NNS	_	11	nmod	_	_
15	should	_	VERB	MD	_	16	aux	_	_
16	have	_	VERB	VB	_	6	parataxis	_	_
17	their	_	PRON	PRP$	_	18	nmod:poss	_	_
18	dose	_	NOUN	NN	_	16	dobj	_	_
19	reduced	_	VERB	VBN	_	18	acl	_	_
20	by	_	ADP	IN	_	21	case	_	_
21	one	_	NUM	CD	_	19	nmod	_	_
22	half	_	ADV	RB	_	16	parataxis	_	_

#	Iloperidone	718
1	Laboratory	_	ADJ	JJ	_	2	amod	_	_
2	tests	_	NOUN	NNS	_	4	nsubj	_	_
3	are	_	VERB	VBP	_	4	cop	_	_
4	available	_	ADJ	JJ	_	0	root	_	_
5	to	_	PRT	TO	_	6	mark	_	_
6	identify	_	VERB	VB	_	4	xcomp	_	_
7	CYP2D6	_	NOUN	NN	_	8	compound	_	_
8	PMs	_	NOUN	NNS	_	6	dobj	_	_

#	Iloperidone	719
1	The	_	DET	DT	_	2	det	_	_
2	bulk	_	NOUN	NN	_	8	nsubjpass	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	the	_	DET	DT	_	6	det	_	_
5	radioactive	_	ADJ	JJ	_	6	amod	_	_
6	materials	_	NOUN	NNS	_	2	nmod	_	_
7	were	_	VERB	VBD	_	8	auxpass	_	_
8	recovered	_	VERB	VBN	_	0	root	_	_
9	in	_	ADP	IN	_	13	case	_	_
10	the	_	DET	DT	_	13	det	_	_
11	urine	_	ADJ	JJ	_	13	amod	_	_
12	mean	_	NOUN	NN	_	13	compound	_	_
13	58.2%	_	NOUN	NN	_	8	nmod	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	45.1%	_	NOUN	NN	_	13	conj	_	_
16	in	_	ADP	IN	_	17	case	_	_
17	EM	_	NOUN	NN	_	8	nmod	_	_
18	and	_	CONJ	CC	_	17	cc	_	_
19	PM	_	NOUN	NN	_	17	conj	_	_
20	,	_	.	,	_	8	punct	_	_
21	respectively	_	ADV	RB	_	8	advmod	_	_
22	,	_	.	,	_	8	punct	_	_
23	with	_	ADP	IN	_	24	case	_	_
24	feces	_	NOUN	NNS	_	8	nmod	_	_
25	accounting	_	VERB	VBG	_	24	acl	_	_
26	for	_	ADP	IN	_	28	case	_	_
27	19.9%	_	ADJ	JJ	_	28	amod	_	_
28	EM	_	NOUN	NN	_	25	nmod	_	_
29	to	_	PRT	TO	_	31	case	_	_
30	22.1%	_	ADJ	JJ	_	31	amod	_	_
31	PM	_	NOUN	NN	_	25	nmod	_	_
32	of	_	ADP	IN	_	35	case	_	_
33	the	_	DET	DT	_	35	det	_	_
34	dosed	_	ADJ	JJ	_	35	amod	_	_
35	radioactivity	_	NOUN	NN	_	31	nmod	_	_

#	Iloperidone	720
1	Transporter	_	NOUN	NN	_	2	compound	_	_
2	Interaction	_	NOUN	NN	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	DRUG	_	NOUN	NN	_	9	nsubj	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	P88	_	NOUN	NN	_	4	conj	_	_
7	are	_	VERB	VBP	_	9	cop	_	_
8	not	_	ADV	RB	_	9	neg	_	_
9	substrates	_	NOUN	NNS	_	20	nsubj	_	_
10	of	_	ADP	IN	_	12	case	_	_
11	P	_	NOUN	NN	_	12	compound	_	_
12	gp	_	NOUN	NN	_	9	nmod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	DRUG	_	NOUN	NN	_	12	conj	_	_
15	is	_	VERB	VBZ	_	20	cop	_	_
16	a	_	DET	DT	_	20	det	_	_
17	weak	_	ADJ	JJ	_	20	amod	_	_
18	P	_	NOUN	NN	_	20	compound	_	_
19	gp	_	NOUN	NN	_	20	compound	_	_
20	inhibitor	_	NOUN	NN	_	2	dep	_	_

#	Imipramine	972
1	Drugs	_	NOUN	NNS	_	20	nsubjpass	_	_
2	Metabolized	_	VERB	VBN	_	1	acl	_	_
3	by	_	ADP	IN	_	5	case	_	_
4	P450	_	NOUN	NN	_	5	compound	_	_
5	2D6	_	NOUN	NN	_	2	nmod	_	_
6	The	_	DET	DT	_	8	det	_	_
7	biochemical	_	ADJ	JJ	_	8	amod	_	_
8	activity	_	NOUN	NN	_	1	dep	_	_
9	of	_	ADP	IN	_	18	case	_	_
10	the	_	DET	DT	_	18	det	_	_
11	drug	_	NOUN	NN	_	18	compound	_	_
12	metabolizing	_	NOUN	NN	_	18	compound	_	_
13	isozyme	_	NOUN	NN	_	18	compound	_	_
14	cytochrome	_	NOUN	NN	_	18	compound	_	_
15	P450	_	NOUN	NN	_	18	compound	_	_
16	2D6	_	NOUN	NN	_	18	compound	_	_
17	debrisoquin	_	NOUN	NN	_	18	compound	_	_
18	hydroxylase	_	NOUN	NN	_	8	nmod	_	_
19	is	_	VERB	VBZ	_	20	auxpass	_	_
20	reduced	_	VERB	VBN	_	0	root	_	_
21	in	_	ADP	IN	_	23	case	_	_
22	a	_	DET	DT	_	23	det	_	_
23	subset	_	NOUN	NN	_	20	nmod	_	_
24	of	_	ADP	IN	_	27	case	_	_
25	the	_	DET	DT	_	27	det	_	_
26	Caucasian	_	ADJ	JJ	_	27	amod	_	_
27	population	_	NOUN	NN	_	23	nmod	_	_
28	about	_	ADV	RB	_	29	advmod	_	_
29	7%	_	NOUN	NN	_	23	nmod	_	_
30	to	_	PRT	TO	_	31	case	_	_
31	10%	_	NOUN	NN	_	29	nmod	_	_
32	of	_	ADP	IN	_	33	case	_	_
33	Caucasians	_	NOUN	NNS	_	31	nmod	_	_
34	are	_	VERB	VBP	_	36	auxpass	_	_
35	so	_	ADV	RB	_	36	advmod	_	_
36	called	_	VERB	VBN	_	20	parataxis	_	_
37	"poor	_	ADJ	JJ	_	40	amod	_	_
38	metabolizers"	_	NOUN	NN	_	40	compound	_	_
39	reliable	_	ADJ	JJ	_	40	amod	_	_
40	estimates	_	NOUN	NNS	_	36	dobj	_	_
41	of	_	ADP	IN	_	43	case	_	_
42	the	_	DET	DT	_	43	det	_	_
43	prevalence	_	NOUN	NN	_	40	nmod	_	_
44	of	_	ADP	IN	_	49	case	_	_
45	reduced	_	VERB	VBN	_	49	amod	_	_
46	P450	_	NOUN	NN	_	49	compound	_	_
47	2D6	_	NOUN	NN	_	49	compound	_	_
48	isozyme	_	NOUN	NN	_	49	compound	_	_
49	activity	_	NOUN	NN	_	43	nmod	_	_
50	among	_	ADP	IN	_	51	case	_	_
51	Asian	_	NOUN	NN	_	40	nmod	_	_
52	,	_	.	,	_	51	punct	_	_
53	African	_	NOUN	NN	_	51	conj	_	_
54	and	_	CONJ	CC	_	51	cc	_	_
55	other	_	ADJ	JJ	_	51	conj	_	_
56	populations	_	NOUN	NNS	_	51	dep	_	_
57	are	_	VERB	VBP	_	60	auxpass	_	_
58	not	_	ADV	RB	_	60	neg	_	_
59	yet	_	ADV	RB	_	60	advmod	_	_
60	available	_	ADJ	JJ	_	36	parataxis	_	_

#	Imipramine	973
1	Poor	_	ADJ	JJ	_	2	amod	_	_
2	metabolizers	_	NOUN	NNS	_	4	nsubj	_	_
3	have	_	VERB	VBP	_	4	aux	_	_
4	higher	_	ADJ	JJ	_	0	root	_	_
5	than	_	ADP	IN	_	8	case	_	_
6	expected	_	VERB	VBN	_	8	amod	_	_
7	plasma	_	NOUN	NN	_	8	compound	_	_
8	concentrations	_	NOUN	NNS	_	10	nmod	_	_
9	DRUGS	_	NOUN	NN	_	10	nsubj	_	_
10	antidepressants	_	VERB	VBZ	_	4	ccomp	_	_
11	TCAs	_	NOUN	NNS	_	10	dobj	_	_
12	when	_	ADV	WRB	_	10	advmod	_	_
13	given	_	VERB	VBN	_	15	amod	_	_
14	usual	_	ADJ	JJ	_	15	amod	_	_
15	doses	_	NOUN	NNS	_	12	nmod	_	_

#	Imipramine	974
1	Depending	_	VERB	VBG	_	4	case	_	_
2	on	_	ADP	IN	_	4	case	_	_
3	the	_	DET	DT	_	4	det	_	_
4	fraction	_	NOUN	NN	_	19	nmod	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	drug	_	NOUN	NN	_	4	nmod	_	_
7	metabolized	_	VERB	VBN	_	6	acl	_	_
8	by	_	ADP	IN	_	10	case	_	_
9	P450	_	NOUN	NN	_	10	compound	_	_
10	2D6	_	NOUN	NN	_	7	nmod	_	_
11	,	_	.	,	_	19	punct	_	_
12	the	_	DET	DT	_	13	det	_	_
13	increase	_	NOUN	NN	_	19	nsubj	_	_
14	in	_	ADP	IN	_	16	case	_	_
15	plasma	_	NOUN	NN	_	16	compound	_	_
16	concentration	_	NOUN	NN	_	13	nmod	_	_
17	may	_	VERB	MD	_	19	aux	_	_
18	be	_	VERB	VB	_	19	cop	_	_
19	small	_	ADJ	JJ	_	0	root	_	_
20	,	_	.	,	_	19	punct	_	_
21	or	_	CONJ	CC	_	19	cc	_	_
22	quite	_	ADV	RB	_	23	advmod	_	_
23	large	_	ADJ	JJ	_	26	amod	_	_
24	8	_	NUM	CD	_	26	nummod	_	_
25	fold	_	NOUN	NN	_	26	amod	_	_
26	increase	_	NOUN	NN	_	19	conj	_	_
27	in	_	ADP	IN	_	29	case	_	_
28	plasma	_	NOUN	NN	_	29	compound	_	_
29	AUC	_	NOUN	NN	_	26	nmod	_	_
30	of	_	ADP	IN	_	32	case	_	_
31	the	_	DET	DT	_	32	det	_	_
32	TCA	_	NOUN	NN	_	29	nmod	_	_

#	Imipramine	975
1	In	_	ADP	IN	_	2	case	_	_
2	addition	_	NOUN	NN	_	6	nmod	_	_
3	,	_	.	,	_	6	punct	_	_
4	certain	_	ADJ	JJ	_	5	amod	_	_
5	drugs	_	NOUN	NNS	_	6	nsubj	_	_
6	inhibit	_	VERB	VBP	_	0	root	_	_
7	the	_	DET	DT	_	8	det	_	_
8	activity	_	NOUN	NN	_	6	dobj	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	this	_	DET	DT	_	11	det	_	_
11	isozyme	_	NOUN	NN	_	8	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	make	_	ADJ	JJ	_	15	amod	_	_
14	normal	_	ADJ	JJ	_	15	amod	_	_
15	metabolizers	_	NOUN	NNS	_	11	conj	_	_
16	resemble	_	ADJ	JJ	_	6	xcomp	_	_
17	poor	_	ADJ	JJ	_	18	amod	_	_
18	metabolizers	_	NOUN	NNS	_	16	dobj	_	_

#	Imipramine	976
1	An	_	DET	DT	_	2	det	_	_
2	individual	_	NOUN	NN	_	13	nsubj	_	_
3	who	_	DET	WDT	_	5	nsubj	_	_
4	is	_	VERB	VBZ	_	5	cop	_	_
5	stable	_	ADJ	JJ	_	2	acl:relcl	_	_
6	on	_	ADP	IN	_	9	case	_	_
7	a	_	DET	DT	_	9	det	_	_
8	given	_	VERB	VBN	_	9	amod	_	_
9	dose	_	NOUN	NN	_	5	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	TCA	_	NOUN	NN	_	9	nmod	_	_
12	may	_	VERB	MD	_	13	aux	_	_
13	become	_	VERB	VB	_	0	root	_	_
14	abruptly	_	ADV	RB	_	15	advmod	_	_
15	toxic	_	ADJ	JJ	_	13	xcomp	_	_
16	when	_	ADV	WRB	_	17	advmod	_	_
17	given	_	VERB	VBN	_	15	dep	_	_
18	one	_	NUM	CD	_	17	dobj	_	_
19	of	_	ADP	IN	_	22	case	_	_
20	these	_	DET	DT	_	22	det	_	_
21	inhibiting	_	VERB	VBG	_	22	amod	_	_
22	drugs	_	NOUN	NNS	_	18	nmod	_	_
23	as	_	ADP	IN	_	25	case	_	_
24	concomitant	_	ADJ	JJ	_	25	amod	_	_
25	therapy	_	NOUN	NN	_	17	nmod	_	_

#	Imipramine	977
1	The	_	DET	DT	_	2	det	_	_
2	drugs	_	NOUN	NNS	_	8	nsubj	_	_
3	that	_	DET	WDT	_	4	nsubj	_	_
4	inhibit	_	VERB	VBP	_	2	acl:relcl	_	_
5	cytochrome	_	NOUN	NN	_	7	compound	_	_
6	P450	_	NOUN	NN	_	7	compound	_	_
7	2D6	_	NOUN	NN	_	4	dobj	_	_
8	include	_	VERB	VBP	_	0	root	_	_
9	some	_	DET	DT	_	8	dobj	_	_
10	that	_	DET	WDT	_	13	nsubjpass	_	_
11	are	_	VERB	VBP	_	13	auxpass	_	_
12	not	_	ADV	RB	_	13	neg	_	_
13	metabolized	_	VERB	VBN	_	9	root	_	_
14	by	_	ADP	IN	_	18	case	_	_
15	the	_	DET	DT	_	18	det	_	_
16	enzyme	_	NOUN	NN	_	18	compound	_	_
17	quinidine	_	NOUN	NN	_	18	compound	_	_
18	cimetidine	_	NOUN	NN	_	13	nmod	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	many	_	NOUN	NN	_	18	conj	_	_
21	that	_	DET	WDT	_	23	nsubj	_	_
22	are	_	VERB	VBP	_	23	cop	_	_
23	substrates	_	NOUN	NNS	_	18	acl:relcl	_	_
24	for	_	ADP	IN	_	29	case	_	_
25	P450	_	NOUN	NN	_	29	compound	_	_
26	2D6	_	NOUN	NN	_	29	compound	_	_
27	many	_	ADJ	JJ	_	29	amod	_	_
28	other	_	ADJ	JJ	_	29	amod	_	_
29	antidepressants	_	NOUN	NNS	_	23	nmod	_	_
30	,	_	.	,	_	29	punct	_	_
31	phenothiazines	_	NOUN	NNS	_	29	conj	_	_
32	,	_	.	,	_	29	punct	_	_
33	and	_	CONJ	CC	_	29	cc	_	_
34	the	_	DET	DT	_	37	det	_	_
35	Type	_	NOUN	NN	_	37	compound	_	_
36	1C	_	NOUN	NN	_	37	compound	_	_
37	antiarrhythmics	_	NOUN	NNS	_	29	conj	_	_
38	propafenone	_	NOUN	NN	_	37	dep	_	_
39	and	_	CONJ	CC	_	38	cc	_	_
40	flecainide	_	NOUN	NN	_	38	conj	_	_

#	Imipramine	978
1	While	_	ADP	IN	_	19	mark	_	_
2	all	_	CONJ	CC	_	7	cc:preconj	_	_
3	the	_	DET	DT	_	7	det	_	_
4	selective	_	ADJ	JJ	_	7	amod	_	_
5	serotonin	_	NOUN	NN	_	7	compound	_	_
6	reuptake	_	NOUN	NN	_	7	compound	_	_
7	inhibitors	_	NOUN	NNS	_	19	nsubj	_	_
8	SSRIs	_	NOUN	NNS	_	7	dep	_	_
9	,	_	.	,	_	8	punct	_	_
10	e.g	_	NOUN	NN	_	8	conj	_	_
11	,	_	.	,	_	8	punct	_	_
12	fluoxetine	_	NOUN	NN	_	8	conj	_	_
13	,	_	.	,	_	8	punct	_	_
14	sertraline	_	NOUN	NN	_	8	conj	_	_
15	,	_	.	,	_	8	punct	_	_
16	and	_	CONJ	CC	_	8	cc	_	_
17	paroxetine	_	NOUN	NN	_	8	conj	_	_
18	,	_	.	,	_	7	punct	_	_
19	inhibit	_	VERB	VBP	_	25	advcl	_	_
20	P450	_	NOUN	NN	_	21	compound	_	_
21	2D6	_	NOUN	NN	_	19	dobj	_	_
22	,	_	.	,	_	25	punct	_	_
23	they	_	PRON	PRP	_	25	nsubj	_	_
24	may	_	VERB	MD	_	25	aux	_	_
25	vary	_	VERB	VB	_	0	root	_	_
26	in	_	ADP	IN	_	28	case	_	_
27	the	_	DET	DT	_	28	det	_	_
28	extent	_	NOUN	NN	_	25	nmod	_	_
29	of	_	ADP	IN	_	30	case	_	_
30	inhibition	_	NOUN	NN	_	28	nmod	_	_

#	Imipramine	979
1	The	_	DET	DT	_	2	det	_	_
2	extent	_	NOUN	NN	_	13	nsubj	_	_
3	to	_	PRT	TO	_	4	case	_	_
4	which	_	DET	WDT	_	9	nmod	_	_
5	SSRI	_	NOUN	NN	_	7	compound	_	_
6	TCA	_	NOUN	NN	_	7	compound	_	_
7	interactions	_	NOUN	NNS	_	9	nsubj	_	_
8	may	_	VERB	MD	_	9	aux	_	_
9	pose	_	VERB	VB	_	2	acl:relcl	_	_
10	clinical	_	ADJ	JJ	_	11	amod	_	_
11	problems	_	NOUN	NNS	_	9	dobj	_	_
12	will	_	VERB	MD	_	13	aux	_	_
13	depend	_	VERB	VB	_	0	root	_	_
14	on	_	ADP	IN	_	16	case	_	_
15	the	_	DET	DT	_	16	det	_	_
16	degree	_	NOUN	NN	_	13	nmod	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	inhibition	_	NOUN	NN	_	16	nmod	_	_
19	and	_	CONJ	CC	_	13	cc	_	_
20	the	_	DET	DT	_	21	det	_	_
21	pharmacokinetics	_	NOUN	NNS	_	13	conj	_	_
22	of	_	ADP	IN	_	24	case	_	_
23	the	_	DET	DT	_	24	det	_	_
24	SSRI	_	NOUN	NN	_	21	nmod	_	_
25	involved	_	VERB	VBN	_	24	acl	_	_

#	Imipramine	980
1	Nevertheless	_	ADV	RB	_	5	advmod	_	_
2	,	_	.	,	_	5	punct	_	_
3	caution	_	NOUN	NN	_	5	nsubjpass	_	_
4	is	_	VERB	VBZ	_	5	auxpass	_	_
5	indicated	_	VERB	VBN	_	0	root	_	_
6	in	_	ADP	IN	_	9	case	_	_
7	the	_	DET	DT	_	9	det	_	_
8	co	_	DET	DT	_	9	det	_	_
9	administration	_	NOUN	NN	_	5	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	TCAs	_	NOUN	NNS	_	9	nmod	_	_
12	with	_	ADP	IN	_	13	case	_	_
13	any	_	DET	DT	_	9	nmod	_	_
14	of	_	ADP	IN	_	16	case	_	_
15	the	_	DET	DT	_	16	det	_	_
16	SSRIs	_	NOUN	NNS	_	13	nmod	_	_
17	and	_	CONJ	CC	_	9	cc	_	_
18	also	_	ADV	RB	_	20	advmod	_	_
19	in	_	ADP	IN	_	20	case	_	_
20	switching	_	NOUN	NN	_	9	conj	_	_
21	from	_	ADP	IN	_	23	case	_	_
22	one	_	NUM	CD	_	23	nummod	_	_
23	class	_	NOUN	NN	_	20	nmod	_	_
24	to	_	PRT	TO	_	26	case	_	_
25	the	_	DET	DT	_	26	det	_	_
26	other	_	ADJ	JJ	_	20	nmod	_	_

#	Imipramine	981
1	Of	_	ADP	IN	_	3	case	_	_
2	particular	_	ADJ	JJ	_	3	amod	_	_
3	importance	_	NOUN	NN	_	8	nmod	_	_
4	,	_	.	,	_	8	punct	_	_
5	sufficient	_	ADJ	JJ	_	6	amod	_	_
6	time	_	NOUN	NN	_	8	nsubj	_	_
7	must	_	VERB	MD	_	8	aux	_	_
8	elapse	_	VERB	VB	_	17	aux	_	_
9	before	_	ADP	IN	_	10	mark	_	_
10	initiating	_	VERB	VBG	_	8	advcl	_	_
11	TCA	_	NOUN	NN	_	12	compound	_	_
12	treatment	_	NOUN	NN	_	10	dobj	_	_
13	in	_	ADP	IN	_	15	case	_	_
14	a	_	DET	DT	_	15	det	_	_
15	patient	_	NOUN	NN	_	10	nmod	_	_
16	being	_	VERB	VBD	_	17	cop	_	_
17	withdrawn	_	ADJ	JJ	_	0	root	_	_
18	from	_	ADP	IN	_	19	case	_	_
19	fluoxetine	_	NOUN	NN	_	17	nmod	_	_
20	,	_	.	,	_	17	punct	_	_
21	given	_	VERB	VBN	_	17	parataxis	_	_
22	the	_	DET	DT	_	25	det	_	_
23	long	_	ADJ	JJ	_	25	amod	_	_
24	half	_	NOUN	NN	_	25	amod	_	_
25	life	_	NOUN	NN	_	21	dobj	_	_
26	of	_	ADP	IN	_	28	case	_	_
27	the	_	DET	DT	_	28	det	_	_
28	parent	_	NOUN	NN	_	25	nmod	_	_
29	and	_	CONJ	CC	_	28	cc	_	_
30	active	_	ADJ	JJ	_	31	amod	_	_
31	metabolite	_	NOUN	NN	_	28	conj	_	_
32	at	_	ADP	IN	_	33	case	_	_
33	least	_	ADJ	JJS	_	34	nmod:npmod	_	_
34	5	_	NUM	CD	_	35	nummod	_	_
35	weeks	_	NOUN	NNS	_	25	nmod	_	_
36	may	_	VERB	MD	_	38	aux	_	_
37	be	_	VERB	VB	_	38	auxpass	_	_
38	necessary	_	ADJ	JJ	_	21	dep	_	_

#	Imipramine	982
1	Concomitant	_	ADJ	JJ	_	2	amod	_	_
2	use	_	NOUN	NN	_	4	compound	_	_
3	DRUGS	_	NOUN	NN	_	4	compound	_	_
4	antidepressants	_	NOUN	NNS	_	14	nsubj	_	_
5	with	_	ADP	IN	_	6	case	_	_
6	drugs	_	NOUN	NNS	_	4	nmod	_	_
7	that	_	DET	WDT	_	9	nsubj	_	_
8	can	_	VERB	MD	_	9	aux	_	_
9	inhibit	_	VERB	VB	_	6	acl:relcl	_	_
10	cytochrome	_	NOUN	NN	_	12	compound	_	_
11	P450	_	NOUN	NN	_	12	compound	_	_
12	2D6	_	NOUN	NN	_	9	dobj	_	_
13	may	_	VERB	MD	_	14	aux	_	_
14	require	_	VERB	VB	_	0	root	_	_
15	lower	_	ADJ	JJ	_	16	amod	_	_
16	doses	_	NOUN	NNS	_	14	dobj	_	_
17	than	_	ADP	IN	_	19	mark	_	_
18	usually	_	ADV	RB	_	19	advmod	_	_
19	prescribed	_	VERB	VBN	_	14	advcl	_	_
20	for	_	ADP	IN	_	23	case	_	_
21	either	_	CONJ	CC	_	23	cc:preconj	_	_
22	tGGGGGGGGGGGG	_	NOUN	NN	_	23	compound	_	_
23	antidepressant	_	NOUN	NN	_	19	nmod	_	_
24	or	_	CONJ	CC	_	23	cc	_	_
25	the	_	DET	DT	_	27	det	_	_
26	other	_	ADJ	JJ	_	27	amod	_	_
27	drug	_	NOUN	NN	_	23	conj	_	_

#	Imipramine	983
1	Furthermore	_	ADV	RB	_	22	advmod	_	_
2	,	_	.	,	_	22	punct	_	_
3	whenever	_	ADP	IN	_	10	mark	_	_
4	one	_	NUM	CD	_	10	nsubj	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	these	_	DET	DT	_	8	det	_	_
7	other	_	ADJ	JJ	_	8	amod	_	_
8	drugs	_	NOUN	NNS	_	4	nmod	_	_
9	is	_	VERB	VBZ	_	10	cop	_	_
10	withdrawn	_	ADJ	JJ	_	22	advcl	_	_
11	from	_	ADP	IN	_	13	case	_	_
12	co	_	PRT	TO	_	13	case	_	_
13	therapy	_	NOUN	NN	_	10	nmod	_	_
14	,	_	.	,	_	22	punct	_	_
15	an	_	DET	DT	_	19	det	_	_
16	increased	_	VERB	VBN	_	19	amod	_	_
17	dose	_	NOUN	NN	_	19	compound	_	_
18	DRUGS	_	NOUN	NN	_	19	compound	_	_
19	antidepressant	_	NOUN	NN	_	22	nsubjpass	_	_
20	may	_	VERB	MD	_	22	aux	_	_
21	be	_	VERB	VB	_	22	auxpass	_	_
22	required	_	VERB	VBN	_	0	root	_	_

#	Imipramine	984
1	It	_	PRON	PRP	_	3	nsubj	_	_
2	is	_	VERB	VBZ	_	3	cop	_	_
3	desirable	_	ADJ	JJ	_	0	root	_	_
4	to	_	PRT	TO	_	5	mark	_	_
5	monitor	_	VERB	VB	_	3	xcomp	_	_
6	TCA	_	NOUN	NN	_	8	compound	_	_
7	plasma	_	NOUN	NN	_	8	compound	_	_
8	levels	_	NOUN	NNS	_	5	dobj	_	_
9	whenever	_	ADV	WRB	_	13	advmod	_	_
10	a	_	DET	DT	_	11	det	_	_
11	TCA	_	NOUN	NN	_	13	nsubj	_	_
12	is	_	VERB	VBZ	_	13	cop	_	_
13	going	_	VERB	VBG	_	5	advcl	_	_
14	to	_	PRT	TO	_	17	mark	_	_
15	be	_	VERB	VB	_	17	auxpass	_	_
16	co	_	PRT	TO	_	17	dep	_	_
17	administered	_	VERB	VBN	_	13	xcomp	_	_
18	with	_	ADP	IN	_	20	case	_	_
19	another	_	DET	DT	_	20	det	_	_
20	drug	_	NOUN	NN	_	17	nmod	_	_
21	known	_	VERB	VBN	_	20	acl	_	_
22	to	_	PRT	TO	_	25	mark	_	_
23	be	_	VERB	VB	_	25	cop	_	_
24	an	_	DET	DT	_	25	det	_	_
25	inhibitor	_	NOUN	NN	_	21	xcomp	_	_
26	of	_	ADP	IN	_	28	case	_	_
27	P450	_	NOUN	NN	_	28	compound	_	_
28	2D6	_	NOUN	NN	_	25	nmod	_	_

#	Imipramine	985
1	The	_	DET	DT	_	3	det	_	_
2	plasma	_	NOUN	NN	_	3	compound	_	_
3	concentration	_	NOUN	NN	_	7	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	may	_	VERB	MD	_	7	aux	_	_
7	increase	_	VERB	VB	_	0	root	_	_
8	when	_	ADV	WRB	_	12	advmod	_	_
9	the	_	DET	DT	_	10	det	_	_
10	drug	_	NOUN	NN	_	12	nsubjpass	_	_
11	is	_	VERB	VBZ	_	12	auxpass	_	_
12	given	_	VERB	VBN	_	7	ccomp	_	_
13	concomitantly	_	ADV	RB	_	12	advmod	_	_
14	with	_	ADP	IN	_	17	case	_	_
15	hepatic	_	ADJ	JJ	_	17	amod	_	_
16	enzyme	_	NOUN	NN	_	17	compound	_	_
17	inhibitors	_	NOUN	NNS	_	12	nmod	_	_
18	e.g	_	NOUN	NN	_	17	dep	_	_
19	,	_	.	,	_	18	punct	_	_
20	cimetidine	_	NOUN	NN	_	18	conj	_	_
21	,	_	.	,	_	18	punct	_	_
22	fluoxetine	_	NOUN	NN	_	18	conj	_	_
23	and	_	CONJ	CC	_	18	cc	_	_
24	decrease	_	NOUN	NN	_	18	conj	_	_
25	by	_	ADP	IN	_	27	case	_	_
26	concomitant	_	ADJ	JJ	_	27	amod	_	_
27	administration	_	NOUN	NN	_	12	nmod	_	_
28	with	_	ADP	IN	_	31	case	_	_
29	hepatic	_	ADJ	JJ	_	31	amod	_	_
30	enzyme	_	NOUN	NN	_	31	compound	_	_
31	inducers	_	NOUN	NNS	_	27	nmod	_	_
32	e.g	_	NOUN	NN	_	31	dep	_	_
33	,	_	.	,	_	32	punct	_	_
34	barbiturates	_	VERB	VBZ	_	32	conj	_	_
35	,	_	.	,	_	32	punct	_	_
36	phenytoin	_	NOUN	NN	_	32	conj	_	_
37	,	_	.	,	_	32	punct	_	_
38	and	_	CONJ	CC	_	32	cc	_	_
39	adjustment	_	NOUN	NN	_	32	conj	_	_
40	of	_	ADP	IN	_	42	case	_	_
41	the	_	DET	DT	_	42	det	_	_
42	dosage	_	NOUN	NN	_	31	nmod	_	_
43	of	_	ADP	IN	_	44	case	_	_
44	DRUG	_	NOUN	NN	_	42	nmod	_	_
45	may	_	VERB	MD	_	48	aux	_	_
46	therefore	_	ADV	RB	_	48	advmod	_	_
47	be	_	VERB	VB	_	48	auxpass	_	_
48	necessary	_	ADJ	JJ	_	12	dep	_	_

#	Imipramine	986
1	In	_	ADP	IN	_	4	case	_	_
2	occasional	_	ADJ	JJ	_	4	amod	_	_
3	susceptible	_	ADJ	JJ	_	4	amod	_	_
4	patients	_	NOUN	NNS	_	22	nmod	_	_
5	or	_	CONJ	CC	_	4	cc	_	_
6	in	_	ADP	IN	_	7	case	_	_
7	those	_	DET	DT	_	4	conj	_	_
8	receiving	_	VERB	VBG	_	7	acl	_	_
9	anticholinergic	_	ADJ	JJ	_	10	amod	_	_
10	drugs	_	NOUN	NNS	_	8	dobj	_	_
11	including	_	ADP	IN	_	13	case	_	_
12	antiparkinsonism	_	NOUN	NN	_	13	compound	_	_
13	agents	_	NOUN	NNS	_	10	nmod	_	_
14	in	_	ADP	IN	_	15	case	_	_
15	addition	_	NOUN	NN	_	10	nmod	_	_
16	,	_	.	,	_	22	punct	_	_
17	the	_	DET	DT	_	18	det	_	_
18	atropine	_	NOUN	NN	_	22	nsubj	_	_
19	like	_	ADP	IN	_	20	case	_	_
20	effects	_	NOUN	NNS	_	18	nmod	_	_
21	may	_	VERB	MD	_	22	aux	_	_
22	become	_	VERB	VB	_	0	root	_	_
23	more	_	ADV	RB	_	24	advmod	_	_
24	pronounced	_	ADJ	JJ	_	25	amod	_	_
25	e.g	_	NOUN	NN	_	22	dobj	_	_
26	,	_	.	,	_	25	punct	_	_
27	paralytic	_	ADJ	JJ	_	28	amod	_	_
28	ileus	_	NOUN	NN	_	25	appos	_	_

#	Imipramine	987
1	Close	_	ADJ	JJ	_	2	compound	_	_
2	supervision	_	NOUN	NN	_	9	nsubjpass	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	careful	_	ADJ	JJ	_	5	amod	_	_
5	adjustment	_	NOUN	NN	_	2	conj	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	dosage	_	NOUN	NN	_	2	nmod	_	_
8	is	_	VERB	VBZ	_	9	auxpass	_	_
9	required	_	VERB	VBN	_	0	root	_	_
10	when	_	ADV	WRB	_	14	advmod	_	_
11	DRUG	_	NOUN	NN	_	12	compound	_	_
12	pamoate	_	NOUN	NN	_	14	nsubjpass	_	_
13	is	_	VERB	VBZ	_	14	auxpass	_	_
14	administered	_	VERB	VBN	_	9	ccomp	_	_
15	concomitantly	_	ADV	RB	_	14	advmod	_	_
16	with	_	ADP	IN	_	18	case	_	_
17	anticholinergic	_	ADJ	JJ	_	18	amod	_	_
18	drugs	_	NOUN	NNS	_	14	nmod	_	_

#	Imipramine	988
1	Avoid	_	ADP	IN	_	3	case	_	_
2	the	_	DET	DT	_	3	det	_	_
3	use	_	NOUN	NN	_	33	nmod	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	preparations	_	NOUN	NNS	_	3	nmod	_	_
6	,	_	.	,	_	5	punct	_	_
7	such	_	ADJ	JJ	_	9	case	_	_
8	as	_	ADP	IN	_	7	mwe	_	_
9	decongestants	_	NOUN	NNS	_	5	nmod	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	local	_	ADJ	JJ	_	12	amod	_	_
12	anesthetics	_	NOUN	NNS	_	9	conj	_	_
13	,	_	.	,	_	5	punct	_	_
14	that	_	DET	WDT	_	15	nsubj	_	_
15	contain	_	VERB	VBP	_	5	acl:relcl	_	_
16	any	_	DET	DT	_	19	det	_	_
17	sympathomimetic	_	ADJ	JJ	_	19	amod	_	_
18	amine	_	NOUN	NN	_	19	compound	_	_
19	e.g	_	NOUN	NN	_	15	dobj	_	_
20	,	_	.	,	_	19	punct	_	_
21	epinephrine	_	NOUN	NN	_	19	conj	_	_
22	,	_	.	,	_	19	punct	_	_
23	norepinephrine	_	NOUN	NN	_	19	appos	_	_
24	,	_	.	,	_	33	punct	_	_
25	since	_	ADP	IN	_	29	mark	_	_
26	it	_	PRON	PRP	_	29	nsubjpass	_	_
27	has	_	VERB	VBZ	_	29	aux	_	_
28	been	_	VERB	VBN	_	29	auxpass	_	_
29	reported	_	VERB	VBN	_	33	advcl	_	_
30	thGGGGGGGGGGGG	_	NOUN	NN	_	31	compound	_	_
31	antidepressants	_	NOUN	NNS	_	29	dobj	_	_
32	can	_	VERB	MD	_	33	aux	_	_
33	potentiate	_	VERB	VB	_	0	root	_	_
34	the	_	DET	DT	_	35	det	_	_
35	effects	_	NOUN	NNS	_	33	dobj	_	_
36	of	_	ADP	IN	_	37	case	_	_
37	catecholamines	_	NOUN	NNS	_	35	nmod	_	_

#	Imipramine	989
1	Caution	_	NOUN	NN	_	4	nsubjpass	_	_
2	should	_	VERB	MD	_	4	aux	_	_
3	be	_	VERB	VB	_	4	auxpass	_	_
4	exercised	_	VERB	VBN	_	0	root	_	_
5	when	_	ADV	WRB	_	9	advmod	_	_
6	DRUG	_	NOUN	NN	_	7	compound	_	_
7	pamoate	_	NOUN	NN	_	9	nsubjpass	_	_
8	is	_	VERB	VBZ	_	9	auxpass	_	_
9	used	_	VERB	VBN	_	4	ccomp	_	_
10	with	_	ADP	IN	_	11	case	_	_
11	agents	_	NOUN	NNS	_	9	nmod	_	_
12	that	_	DET	WDT	_	15	mark	_	_
13	lower	_	ADJ	JJ	_	15	amod	_	_
14	blood	_	NOUN	NN	_	15	compound	_	_
15	pressure	_	NOUN	NN	_	11	ccomp	_	_

#	Imipramine	990
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	pamoate	_	NOUN	NN	_	4	nsubj	_	_
3	may	_	VERB	MD	_	4	aux	_	_
4	potentiate	_	VERB	VB	_	0	root	_	_
5	the	_	DET	DT	_	6	det	_	_
6	effects	_	NOUN	NNS	_	4	dobj	_	_
7	of	_	ADP	IN	_	10	case	_	_
8	CNS	_	NOUN	NN	_	10	compound	_	_
9	depressant	_	ADJ	JJ	_	10	amod	_	_
10	drugs	_	NOUN	NNS	_	6	nmod	_	_

#	Imipramine	991
1	Patients	_	NOUN	NNS	_	4	nsubjpass	_	_
2	should	_	VERB	MD	_	4	aux	_	_
3	be	_	VERB	VB	_	4	auxpass	_	_
4	warned	_	VERB	VBN	_	0	root	_	_
5	that	_	ADP	IN	_	9	mark	_	_
6	DRUG	_	NOUN	NN	_	7	compound	_	_
7	pamoate	_	NOUN	NN	_	9	nsubj	_	_
8	may	_	VERB	MD	_	9	aux	_	_
9	enhance	_	VERB	VB	_	4	ccomp	_	_
10	the	_	DET	DT	_	13	det	_	_
11	CNS	_	NOUN	NN	_	13	compound	_	_
12	depressant	_	ADJ	JJ	_	13	amod	_	_
13	effects	_	NOUN	NNS	_	9	dobj	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	alcohol	_	NOUN	NN	_	13	nmod	_	_

#	Imipramine	992
1	Monoamine	_	NOUN	NN	_	3	compound	_	_
2	Oxidase	_	NOUN	NN	_	3	compound	_	_
3	Inhibitors	_	NOUN	NNS	_	0	root	_	_
4	MAOIs	_	NOUN	NNS	_	3	dep	_	_

#	Imipramine	993
1	Serotonergic	_	ADJ	JJ	_	2	amod	_	_
2	Drugs	_	NOUN	NNS	_	0	root	_	_

#	Imipramine	994
1	The	_	DET	DT	_	2	det	_	_
2	mechanism	_	NOUN	NN	_	10	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	action	_	NOUN	NN	_	2	nmod	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	is	_	VERB	VBZ	_	10	auxpass	_	_
8	not	_	ADV	RB	_	10	neg	_	_
9	definitely	_	ADV	RB	_	10	advmod	_	_
10	known	_	VERB	VBN	_	0	root	_	_

#	Imipramine	995
1	However	_	ADV	RB	_	6	advmod	_	_
2	,	_	.	,	_	6	punct	_	_
3	it	_	PRON	PRP	_	6	nsubj	_	_
4	does	_	VERB	VBZ	_	6	aux	_	_
5	not	_	ADV	RB	_	6	neg	_	_
6	act	_	VERB	VB	_	0	root	_	_
7	primarily	_	ADV	RB	_	6	advmod	_	_
8	by	_	ADP	IN	_	9	case	_	_
9	stimulation	_	NOUN	NN	_	6	nmod	_	_
10	of	_	ADP	IN	_	14	case	_	_
11	the	_	DET	DT	_	14	det	_	_
12	central	_	ADJ	JJ	_	14	amod	_	_
13	nervous	_	ADJ	JJ	_	14	amod	_	_
14	system	_	NOUN	NN	_	9	nmod	_	_

#	Imipramine	996
1	The	_	DET	DT	_	3	det	_	_
2	clinical	_	ADJ	JJ	_	3	amod	_	_
3	effect	_	NOUN	NN	_	5	nsubjpass	_	_
4	is	_	VERB	VBZ	_	5	auxpass	_	_
5	hypothesized	_	VERB	VBN	_	0	root	_	_
6	as	_	ADP	IN	_	10	mark	_	_
7	being	_	VERB	VBN	_	10	cop	_	_
8	due	_	ADJ	JJ	_	10	case	_	_
9	to	_	PRT	TO	_	8	mwe	_	_
10	potentiation	_	NOUN	NN	_	5	nmod	_	_
11	of	_	ADP	IN	_	13	case	_	_
12	adrenergic	_	ADJ	JJ	_	13	amod	_	_
13	synapses	_	NOUN	NNS	_	10	nmod	_	_
14	by	_	ADP	IN	_	15	mark	_	_
15	blocking	_	VERB	VBG	_	10	acl	_	_
16	uptake	_	NOUN	NN	_	15	dobj	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	norepinephrine	_	NOUN	NN	_	16	nmod	_	_
19	at	_	ADP	IN	_	21	case	_	_
20	nerve	_	ADJ	JJ	_	21	compound	_	_
21	endings	_	NOUN	NNS	_	15	nmod	_	_

#	Lamisil	5726
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	is	_	VERB	VBZ	_	4	cop	_	_
3	an	_	DET	DT	_	4	det	_	_
4	inhibitor	_	NOUN	NN	_	0	root	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	CYP450	_	NOUN	NN	_	8	compound	_	_
7	2D6	_	NOUN	NN	_	8	compound	_	_
8	isozyme	_	NOUN	NN	_	4	nmod	_	_
9	and	_	CONJ	CC	_	4	cc	_	_
10	has	_	VERB	VBZ	_	4	conj	_	_
11	an	_	DET	DT	_	12	det	_	_
12	effect	_	NOUN	NN	_	10	dobj	_	_
13	on	_	ADP	IN	_	14	case	_	_
14	metabolism	_	NOUN	NN	_	10	nmod	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	desipramine	_	NOUN	NN	_	14	nmod	_	_

#	Lamisil	5727
1	Drug	_	NOUN	NN	_	2	compound	_	_
2	interactions	_	NOUN	NNS	_	6	nsubjpass	_	_
3	have	_	VERB	VBP	_	6	aux	_	_
4	also	_	ADV	RB	_	6	advmod	_	_
5	been	_	VERB	VBN	_	6	auxpass	_	_
6	noted	_	VERB	VBN	_	0	root	_	_
7	with	_	ADP	IN	_	8	case	_	_
8	cimetidine	_	NOUN	NN	_	6	nmod	_	_
9	,	_	.	,	_	8	punct	_	_
10	fluconazole	_	NOUN	NN	_	8	conj	_	_
11	,	_	.	,	_	8	punct	_	_
12	cyclosporine	_	NOUN	NN	_	8	conj	_	_
13	,	_	.	,	_	8	punct	_	_
14	rifampin	_	NOUN	NN	_	8	conj	_	_
15	,	_	.	,	_	8	punct	_	_
16	and	_	CONJ	CC	_	8	cc	_	_
17	caffeine	_	NOUN	NN	_	8	conj	_	_

#	Lamisil	5728
1	In	_	X	FW	_	3	amod	_	_
2	vivo	_	X	FW	_	1	dep	_	_
3	studies	_	NOUN	NNS	_	5	nsubj	_	_
4	have	_	VERB	VBP	_	5	aux	_	_
5	shown	_	VERB	VBN	_	0	root	_	_
6	that	_	ADP	IN	_	10	mark	_	_
7	DRUG	_	NOUN	NN	_	10	nsubj	_	_
8	is	_	VERB	VBZ	_	10	cop	_	_
9	an	_	DET	DT	_	10	det	_	_
10	inhibitor	_	NOUN	NN	_	5	ccomp	_	_
11	of	_	ADP	IN	_	15	case	_	_
12	the	_	DET	DT	_	15	det	_	_
13	CYP450	_	NOUN	NN	_	15	compound	_	_
14	2D6	_	NOUN	NN	_	15	compound	_	_
15	isozyme	_	NOUN	NN	_	10	nmod	_	_

#	Lamisil	5729
1	Drugs	_	NOUN	NNS	_	9	nsubj	_	_
2	predominantly	_	ADV	RB	_	3	advmod	_	_
3	metabolized	_	VERB	VBN	_	1	acl	_	_
4	by	_	ADP	IN	_	8	case	_	_
5	the	_	DET	DT	_	8	det	_	_
6	CYP450	_	NOUN	NN	_	8	compound	_	_
7	2D6	_	NOUN	NN	_	8	compound	_	_
8	isozyme	_	NOUN	NN	_	3	nmod	_	_
9	include	_	VERB	VBP	_	0	root	_	_
10	the	_	DET	DT	_	13	det	_	_
11	following	_	VERB	VBG	_	13	amod	_	_
12	drug	_	NOUN	NN	_	13	compound	_	_
13	classes	_	NOUN	NNS	_	9	dobj	_	_
14	:	_	.	:	_	9	punct	_	_
15	tricyclic	_	ADJ	JJ	_	16	amod	_	_
16	antidepressants	_	NOUN	NNS	_	9	parataxis	_	_
17	,	_	.	,	_	16	punct	_	_
18	selective	_	ADJ	JJ	_	21	amod	_	_
19	serotonin	_	NOUN	NN	_	21	compound	_	_
20	reuptake	_	NOUN	NN	_	21	compound	_	_
21	inhibitors	_	NOUN	NNS	_	16	conj	_	_
22	,	_	.	,	_	16	punct	_	_
23	beta	_	NOUN	NN	_	24	compound	_	_
24	blockers	_	NOUN	NNS	_	16	conj	_	_
25	,	_	.	,	_	16	punct	_	_
26	antiarrhythmics	_	ADJ	JJ	_	29	compound	_	_
27	class	_	NOUN	NN	_	29	compound	_	_
28	1C	_	NOUN	NN	_	29	compound	_	_
29	e.g	_	NOUN	NN	_	16	conj	_	_
30	,	_	.	,	_	16	punct	_	_
31	flecainide	_	NOUN	NN	_	16	conj	_	_
32	and	_	CONJ	CC	_	16	cc	_	_
33	propafenone	_	NOUN	NN	_	37	compound	_	_
34	and	_	CONJ	CC	_	33	cc	_	_
35	monoamine	_	NOUN	NN	_	33	conj	_	_
36	oxidase	_	NOUN	NN	_	37	compound	_	_
37	inhibitors	_	NOUN	NNS	_	16	conj	_	_
38	Type	_	NOUN	NN	_	40	compound	_	_
39	B	_	NOUN	NN	_	40	compound	_	_
40	Coadministration	_	NOUN	NN	_	46	nsubj	_	_
41	of	_	ADP	IN	_	43	case	_	_
42	DRUG	_	NOUN	NN	_	43	compound	_	_
43	Tablets	_	NOUN	NNS	_	40	nmod	_	_
44	should	_	VERB	MD	_	46	aux	_	_
45	be	_	VERB	VB	_	46	auxpass	_	_
46	done	_	ADJ	JJ	_	16	dep	_	_
47	with	_	ADP	IN	_	49	case	_	_
48	careful	_	ADJ	JJ	_	49	amod	_	_
49	monitoring	_	NOUN	NN	_	46	nmod	_	_
50	and	_	CONJ	CC	_	46	cc	_	_
51	may	_	VERB	MD	_	52	aux	_	_
52	require	_	VERB	VB	_	46	conj	_	_
53	a	_	DET	DT	_	54	det	_	_
54	reduction	_	NOUN	NN	_	52	dobj	_	_
55	in	_	ADP	IN	_	56	case	_	_
56	dose	_	NOUN	NN	_	54	nmod	_	_
57	of	_	ADP	IN	_	61	case	_	_
58	the	_	DET	DT	_	61	det	_	_
59	2D6	_	NOUN	NN	_	61	compound	_	_
60	metabolized	_	ADJ	JJ	_	61	amod	_	_
61	drug	_	NOUN	NN	_	56	nmod	_	_

#	Lamisil	5730
1	In	_	ADP	IN	_	3	case	_	_
2	a	_	DET	DT	_	3	det	_	_
3	study	_	NOUN	NN	_	24	nmod	_	_
4	to	_	PRT	TO	_	5	mark	_	_
5	assess	_	VERB	VB	_	3	acl	_	_
6	the	_	DET	DT	_	7	det	_	_
7	effects	_	NOUN	NNS	_	5	dobj	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	on	_	ADP	IN	_	11	case	_	_
11	desipramine	_	NOUN	NN	_	7	nmod	_	_
12	in	_	ADP	IN	_	14	case	_	_
13	healthy	_	ADJ	JJ	_	14	amod	_	_
14	volunteers	_	NOUN	NNS	_	11	nmod	_	_
15	characterized	_	VERB	VBN	_	14	acl	_	_
16	as	_	ADP	IN	_	18	case	_	_
17	normal	_	ADJ	JJ	_	18	amod	_	_
18	metabolizers	_	NOUN	NNS	_	15	nmod	_	_
19	,	_	.	,	_	24	punct	_	_
20	the	_	DET	DT	_	21	det	_	_
21	administration	_	NOUN	NN	_	24	nsubj	_	_
22	of	_	ADP	IN	_	23	case	_	_
23	DRUG	_	NOUN	NN	_	21	nmod	_	_
24	resulted	_	VERB	VBD	_	0	root	_	_
25	in	_	ADP	IN	_	29	case	_	_
26	a	_	DET	DT	_	29	det	_	_
27	2	_	NUM	CD	_	28	compound	_	_
28	fold	_	NOUN	NN	_	29	amod	_	_
29	increase	_	NOUN	NN	_	24	nmod	_	_
30	in	_	ADP	IN	_	31	case	_	_
31	Cmax	_	NOUN	NN	_	29	nmod	_	_
32	and	_	CONJ	CC	_	24	cc	_	_
33	a	_	DET	DT	_	36	det	_	_
34	5	_	NUM	CD	_	35	compound	_	_
35	fold	_	NOUN	NN	_	36	amod	_	_
36	increase	_	NOUN	NN	_	24	conj	_	_
37	in	_	ADP	IN	_	38	case	_	_
38	area	_	NOUN	NN	_	36	nmod	_	_
39	under	_	ADP	IN	_	42	case	_	_
40	the	_	DET	DT	_	42	det	_	_
41	curve	_	ADJ	JJ	_	42	amod	_	_
42	AUC	_	NOUN	NN	_	36	nmod	_	_

#	Lamisil	5731
1	In	_	ADP	IN	_	3	case	_	_
2	this	_	DET	DT	_	3	det	_	_
3	study	_	NOUN	NN	_	8	nmod	_	_
4	,	_	.	,	_	8	punct	_	_
5	these	_	DET	DT	_	6	det	_	_
6	effects	_	NOUN	NNS	_	8	nsubjpass	_	_
7	were	_	VERB	VBD	_	8	auxpass	_	_
8	shown	_	VERB	VBN	_	0	root	_	_
9	to	_	PRT	TO	_	10	mark	_	_
10	persist	_	VERB	VB	_	8	xcomp	_	_
11	at	_	ADP	IN	_	14	case	_	_
12	the	_	DET	DT	_	14	det	_	_
13	last	_	ADJ	JJ	_	14	amod	_	_
14	observation	_	NOUN	NN	_	10	nmod	_	_
15	at	_	ADP	IN	_	17	case	_	_
16	4	_	NUM	CD	_	17	nummod	_	_
17	weeks	_	NOUN	NNS	_	10	nmod	_	_
18	after	_	ADP	IN	_	19	case	_	_
19	discontinuation	_	NOUN	NN	_	10	nmod	_	_
20	of	_	ADP	IN	_	22	case	_	_
21	DRUG	_	NOUN	NN	_	22	compound	_	_
22	Tablets	_	NOUN	NNS	_	19	nmod	_	_

#	Lamisil	5732
1	In	_	ADP	IN	_	2	case	_	_
2	studies	_	NOUN	NNS	_	20	nmod	_	_
3	in	_	ADP	IN	_	5	case	_	_
4	healthy	_	ADJ	JJ	_	5	amod	_	_
5	subjects	_	NOUN	NNS	_	2	nmod	_	_
6	characterized	_	VERB	VBN	_	5	acl	_	_
7	as	_	ADP	IN	_	9	case	_	_
8	extensive	_	ADJ	JJ	_	9	amod	_	_
9	metabolizers	_	NOUN	NNS	_	6	nmod	_	_
10	of	_	ADP	IN	_	13	case	_	_
11	dextromethorphan	_	NOUN	NN	_	13	compound	_	_
12	antitussive	_	ADJ	JJ	_	13	amod	_	_
13	drug	_	NOUN	NN	_	9	nmod	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	CYP2D6	_	NOUN	NN	_	17	compound	_	_
16	probe	_	NOUN	NN	_	17	compound	_	_
17	substrate	_	NOUN	NN	_	13	conj	_	_
18	,	_	.	,	_	20	punct	_	_
19	DRUG	_	NOUN	NN	_	20	nsubj	_	_
20	increases	_	VERB	VBZ	_	0	root	_	_
21	the	_	DET	DT	_	26	det	_	_
22	dextromethorphan	_	NOUN	NN	_	26	compound	_	_
23	/	_	.	:	_	26	punct	_	_
24	dextrorphan	_	NOUN	NN	_	26	compound	_	_
25	metabolite	_	NOUN	NN	_	26	compound	_	_
26	ratio	_	NOUN	NN	_	20	dobj	_	_
27	in	_	ADP	IN	_	28	mark	_	_
28	urine	_	VERB	VBG	_	20	advcl	_	_
29	by	_	ADP	IN	_	33	case	_	_
30	16	_	NUM	CD	_	32	compound	_	_
31	to	_	PRT	TO	_	32	dep	_	_
32	97	_	NUM	CD	_	33	nummod	_	_
33	fold	_	NOUN	NN	_	28	nmod	_	_
34	on	_	ADP	IN	_	35	mark	_	_
35	average	_	ADJ	JJ	_	28	nmod	_	_

#	Lamisil	5733
1	Thus	_	ADV	RB	_	5	advmod	_	_
2	,	_	.	,	_	5	punct	_	_
3	DRUG	_	NOUN	NN	_	5	nsubj	_	_
4	may	_	VERB	MD	_	5	aux	_	_
5	convert	_	VERB	VB	_	0	root	_	_
6	extensive	_	ADJ	JJ	_	8	amod	_	_
7	CYP2D6	_	NOUN	NN	_	8	compound	_	_
8	metabolizers	_	NOUN	NNS	_	5	dobj	_	_
9	to	_	PRT	TO	_	12	case	_	_
10	poor	_	ADJ	JJ	_	12	amod	_	_
11	metabolizer	_	ADJ	JJ	_	12	amod	_	_
12	status	_	NOUN	NN	_	8	nmod	_	_

#	Lamisil	5734
1	In	_	X	FW	_	3	amod	_	_
2	vitro	_	X	FW	_	1	dep	_	_
3	studies	_	NOUN	NNS	_	8	nsubj	_	_
4	with	_	ADP	IN	_	7	case	_	_
5	human	_	ADJ	JJ	_	7	amod	_	_
6	liver	_	NOUN	NN	_	7	compound	_	_
7	microsomes	_	NOUN	NNS	_	3	nmod	_	_
8	showed	_	VERB	VBD	_	0	root	_	_
9	that	_	ADP	IN	_	13	mark	_	_
10	DRUG	_	NOUN	NN	_	13	nsubj	_	_
11	does	_	VERB	VBZ	_	13	aux	_	_
12	not	_	ADV	RB	_	13	neg	_	_
13	inhibit	_	VERB	VB	_	8	ccomp	_	_
14	the	_	DET	DT	_	15	det	_	_
15	metabolism	_	NOUN	NN	_	13	dobj	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	tolbutamide	_	NOUN	NN	_	15	nmod	_	_
18	,	_	.	,	_	17	punct	_	_
19	ethinylestradiol	_	NOUN	NN	_	17	conj	_	_
20	,	_	.	,	_	17	punct	_	_
21	ethoxycoumarin	_	NOUN	NN	_	17	conj	_	_
22	,	_	.	,	_	17	punct	_	_
23	cyclosporine	_	NOUN	NN	_	17	conj	_	_
24	,	_	.	,	_	17	punct	_	_
25	cisapride	_	NOUN	NN	_	17	conj	_	_
26	and	_	CONJ	CC	_	17	cc	_	_
27	fluvastatin	_	NOUN	NN	_	17	conj	_	_

#	Lamisil	5735
1	In	_	X	FW	_	6	amod	_	_
2	vivo	_	X	FW	_	1	dep	_	_
3	drug	_	NOUN	NN	_	6	compound	_	_
4	drug	_	NOUN	NN	_	6	compound	_	_
5	interaction	_	NOUN	NN	_	6	compound	_	_
6	studies	_	NOUN	NNS	_	12	nsubj	_	_
7	conducted	_	VERB	VBN	_	6	acl	_	_
8	in	_	ADP	IN	_	11	case	_	_
9	healthy	_	ADJ	JJ	_	11	amod	_	_
10	volunteer	_	ADJ	JJ	_	11	amod	_	_
11	subjects	_	NOUN	NNS	_	7	nmod	_	_
12	showed	_	VERB	VBD	_	0	root	_	_
13	that	_	ADP	IN	_	17	mark	_	_
14	DRUG	_	NOUN	NN	_	17	nsubj	_	_
15	does	_	VERB	VBZ	_	17	aux	_	_
16	not	_	ADV	RB	_	17	neg	_	_
17	affect	_	VERB	VB	_	12	ccomp	_	_
18	the	_	DET	DT	_	19	det	_	_
19	clearance	_	NOUN	NN	_	17	dobj	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	antipyrine	_	NOUN	NN	_	19	nmod	_	_
22	or	_	CONJ	CC	_	21	cc	_	_
23	digoxin	_	NOUN	NN	_	21	conj	_	_

#	Lamisil	5736
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	decreases	_	VERB	VBZ	_	0	root	_	_
3	the	_	DET	DT	_	4	det	_	_
4	clearance	_	NOUN	NN	_	2	dobj	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	caffeine	_	NOUN	NN	_	4	nmod	_	_
7	by	_	ADP	IN	_	8	case	_	_
8	19%	_	ADJ	JJ	_	6	nmod	_	_

#	Lamisil	5737
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	increases	_	VERB	VBZ	_	0	root	_	_
3	the	_	DET	DT	_	4	det	_	_
4	clearance	_	NOUN	NN	_	2	dobj	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	cyclosporine	_	NOUN	NN	_	4	nmod	_	_
7	by	_	ADP	IN	_	8	case	_	_
8	15%	_	ADJ	JJ	_	4	nmod	_	_

#	Lamisil	5738
1	The	_	DET	DT	_	2	det	_	_
2	influence	_	NOUN	NN	_	21	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	on	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	pharmacokinetics	_	NOUN	NNS	_	2	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	fluconazole	_	NOUN	NN	_	7	nmod	_	_
10	,	_	.	,	_	9	punct	_	_
11	cotrimoxazole	_	NOUN	NN	_	12	compound	_	_
12	trimethoprim	_	NOUN	NN	_	9	conj	_	_
13	and	_	CONJ	CC	_	9	cc	_	_
14	sulfamethoxazole	_	NOUN	NN	_	9	conj	_	_
15	,	_	.	,	_	9	punct	_	_
16	zidovudine	_	NOUN	NN	_	9	conj	_	_
17	or	_	CONJ	CC	_	9	cc	_	_
18	theophylline	_	NOUN	NN	_	9	conj	_	_
19	was	_	VERB	VBD	_	21	auxpass	_	_
20	not	_	ADV	RB	_	21	neg	_	_
21	considered	_	VERB	VBN	_	0	root	_	_
22	to	_	PRT	TO	_	25	mark	_	_
23	be	_	VERB	VB	_	25	cop	_	_
24	clinically	_	ADV	RB	_	25	advmod	_	_
25	significant	_	ADJ	JJ	_	21	xcomp	_	_

#	Lamisil	5739
1	Coadministration	_	NOUN	NN	_	16	nsubj	_	_
2	of	_	ADP	IN	_	5	case	_	_
3	a	_	DET	DT	_	5	det	_	_
4	single	_	ADJ	JJ	_	5	amod	_	_
5	dose	_	NOUN	NN	_	1	nmod	_	_
6	of	_	ADP	IN	_	9	case	_	_
7	fluconazole	_	NOUN	NN	_	9	compound	_	_
8	100	_	NUM	CD	_	9	nummod	_	_
9	mg	_	NOUN	NN	_	5	nmod	_	_
10	with	_	ADP	IN	_	13	case	_	_
11	a	_	DET	DT	_	13	det	_	_
12	single	_	ADJ	JJ	_	13	amod	_	_
13	dose	_	NOUN	NN	_	1	nmod	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	DRUG	_	NOUN	NN	_	13	nmod	_	_
16	resulted	_	VERB	VBD	_	0	root	_	_
17	in	_	ADP	IN	_	22	case	_	_
18	a	_	DET	DT	_	22	det	_	_
19	52%	_	ADJ	JJ	_	22	amod	_	_
20	and	_	CONJ	CC	_	19	cc	_	_
21	69%	_	ADJ	JJ	_	19	conj	_	_
22	increase	_	NOUN	NN	_	16	nmod	_	_
23	in	_	ADP	IN	_	24	case	_	_
24	DRUG	_	NOUN	NN	_	22	nmod	_	_
25	Cmax	_	NOUN	NN	_	24	dep	_	_
26	and	_	CONJ	CC	_	25	cc	_	_
27	AUC	_	NOUN	NN	_	25	conj	_	_
28	,	_	.	,	_	16	punct	_	_
29	respectively	_	ADV	RB	_	16	advmod	_	_

#	Lamisil	5740
1	Fluconazole	_	NOUN	NN	_	4	nsubj	_	_
2	is	_	VERB	VBZ	_	4	cop	_	_
3	an	_	DET	DT	_	4	det	_	_
4	inhibitor	_	NOUN	NN	_	0	root	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	CYP2C9	_	NOUN	NN	_	4	nmod	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	CYP3A	_	NOUN	NN	_	6	conj	_	_
9	enzymes	_	NOUN	NNS	_	6	dep	_	_

#	Lamisil	5741
1	Based	_	VERB	VBN	_	8	advcl	_	_
2	on	_	ADP	IN	_	4	case	_	_
3	this	_	DET	DT	_	4	det	_	_
4	finding	_	NOUN	NN	_	1	nmod	_	_
5	,	_	.	,	_	8	punct	_	_
6	it	_	PRON	PRP	_	8	nsubj	_	_
7	is	_	VERB	VBZ	_	8	cop	_	_
8	likely	_	ADJ	JJ	_	0	root	_	_
9	that	_	ADP	IN	_	24	mark	_	_
10	other	_	ADJ	JJ	_	11	amod	_	_
11	inhibitors	_	NOUN	NNS	_	24	nsubj	_	_
12	of	_	ADP	IN	_	14	case	_	_
13	both	_	CONJ	CC	_	14	cc:preconj	_	_
14	CYP2C9	_	NOUN	NN	_	11	nmod	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	CYP3A4	_	NOUN	NN	_	17	compound	_	_
17	e.g	_	NOUN	NN	_	14	conj	_	_
18	,	_	.	,	_	14	punct	_	_
19	ketoconazole	_	NOUN	NN	_	14	appos	_	_
20	,	_	.	,	_	14	punct	_	_
21	amiodarone	_	NOUN	NN	_	14	appos	_	_
22	may	_	VERB	MD	_	24	aux	_	_
23	also	_	ADV	RB	_	24	advmod	_	_
24	lead	_	VERB	VB	_	8	ccomp	_	_
25	to	_	PRT	TO	_	28	case	_	_
26	a	_	DET	DT	_	28	det	_	_
27	substantial	_	ADJ	JJ	_	28	amod	_	_
28	increase	_	NOUN	NN	_	24	nmod	_	_
29	in	_	ADP	IN	_	33	case	_	_
30	the	_	DET	DT	_	33	det	_	_
31	systemic	_	ADJ	JJ	_	33	amod	_	_
32	exposure	_	NOUN	NN	_	33	compound	_	_
33	Cmax	_	NOUN	NN	_	28	nmod	_	_
34	and	_	CONJ	CC	_	33	cc	_	_
35	AUC	_	NOUN	NN	_	33	conj	_	_
36	of	_	ADP	IN	_	37	case	_	_
37	DRUG	_	NOUN	NN	_	33	nmod	_	_
38	when	_	ADV	WRB	_	40	advmod	_	_
39	concomitantly	_	ADV	RB	_	40	advmod	_	_
40	administered	_	VERB	VBN	_	24	advcl	_	_

#	Lamisil	5742
1	There	_	DET	EX	_	5	nsubj	_	_
2	have	_	VERB	VBP	_	5	aux	_	_
3	been	_	VERB	VBN	_	5	cop	_	_
4	spontaneous	_	ADJ	JJ	_	5	amod	_	_
5	reports	_	NOUN	NNS	_	0	root	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	increase	_	NOUN	NN	_	5	nmod	_	_
8	or	_	CONJ	CC	_	7	cc	_	_
9	decrease	_	NOUN	NN	_	7	conj	_	_
10	in	_	ADP	IN	_	12	case	_	_
11	prothrombin	_	NOUN	NN	_	12	compound	_	_
12	times	_	NOUN	NNS	_	7	nmod	_	_
13	in	_	ADP	IN	_	14	case	_	_
14	patients	_	NOUN	NNS	_	12	nmod	_	_
15	concomitantly	_	ADV	RB	_	16	advmod	_	_
16	taking	_	VERB	VBG	_	14	acl	_	_
17	oral	_	ADJ	JJ	_	18	amod	_	_
18	DRUG	_	NOUN	NN	_	16	dobj	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	warfarin	_	NOUN	NN	_	18	conj	_	_
21	,	_	.	,	_	5	punct	_	_
22	however	_	ADV	RB	_	5	advmod	_	_
23	,	_	.	,	_	5	punct	_	_
24	a	_	DET	DT	_	26	det	_	_
25	causal	_	ADJ	JJ	_	26	amod	_	_
26	relationship	_	NOUN	NN	_	36	nsubjpass	_	_
27	between	_	ADP	IN	_	29	case	_	_
28	DRUG	_	NOUN	NN	_	29	compound	_	_
29	Tablets	_	NOUN	NNS	_	26	nmod	_	_
30	and	_	CONJ	CC	_	26	cc	_	_
31	these	_	DET	DT	_	32	det	_	_
32	changes	_	NOUN	NNS	_	26	conj	_	_
33	has	_	VERB	VBZ	_	36	aux	_	_
34	not	_	ADV	RB	_	36	neg	_	_
35	been	_	VERB	VBN	_	36	auxpass	_	_
36	established	_	VERB	VBN	_	5	root	_	_

#	Lamisil	5743
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	clearance	_	NOUN	NN	_	4	nsubjpass	_	_
3	is	_	VERB	VBZ	_	4	auxpass	_	_
4	increased	_	VERB	VBN	_	0	root	_	_
5	100%	_	NOUN	NN	_	4	dobj	_	_
6	by	_	ADP	IN	_	7	case	_	_
7	rifampin	_	NOUN	NN	_	4	nmod	_	_
8	,	_	.	,	_	7	punct	_	_
9	a	_	DET	DT	_	12	det	_	_
10	CYP450	_	NOUN	NN	_	12	compound	_	_
11	enzyme	_	NOUN	NN	_	12	compound	_	_
12	inducer	_	NOUN	NN	_	7	conj	_	_
13	,	_	.	,	_	7	punct	_	_
14	and	_	CONJ	CC	_	4	cc	_	_
15	decreased	_	VERB	VBD	_	4	conj	_	_
16	33%	_	NOUN	NN	_	15	dobj	_	_
17	by	_	ADP	IN	_	18	case	_	_
18	cimetidine	_	NOUN	NN	_	15	nmod	_	_
19	,	_	.	,	_	15	punct	_	_
20	a	_	DET	DT	_	23	det	_	_
21	CYP450	_	NOUN	NN	_	23	compound	_	_
22	enzyme	_	NOUN	NN	_	23	compound	_	_
23	inhibitor	_	NOUN	NN	_	15	dobj	_	_

#	Lamisil	5744
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	clearance	_	NOUN	NN	_	4	nsubj	_	_
3	is	_	VERB	VBZ	_	4	cop	_	_
4	unaffected	_	ADJ	JJ	_	0	root	_	_
5	by	_	ADP	IN	_	6	case	_	_
6	cyclosporine	_	NOUN	NN	_	4	nmod	_	_

#	Lamisil	5745
1	There	_	DET	EX	_	2	expl	_	_
2	is	_	VERB	VBZ	_	0	root	_	_
3	no	_	DET	DT	_	4	neg	_	_
4	information	_	NOUN	NN	_	2	nsubj	_	_
5	available	_	ADJ	JJ	_	4	amod	_	_
6	from	_	ADP	IN	_	11	case	_	_
7	adequate	_	ADJ	JJ	_	11	amod	_	_
8	drug	_	NOUN	NN	_	11	compound	_	_
9	drug	_	NOUN	NN	_	11	compound	_	_
10	interaction	_	NOUN	NN	_	11	compound	_	_
11	studies	_	NOUN	NNS	_	5	nmod	_	_
12	with	_	ADP	IN	_	15	case	_	_
13	the	_	DET	DT	_	15	det	_	_
14	following	_	VERB	VBG	_	15	amod	_	_
15	classes	_	NOUN	NNS	_	11	nmod	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	drugs	_	NOUN	NNS	_	15	nmod	_	_
18	:	_	.	:	_	2	punct	_	_
19	oral	_	ADJ	JJ	_	20	amod	_	_
20	contraceptives	_	NOUN	NNS	_	2	dep	_	_
21	,	_	.	,	_	20	punct	_	_
22	hormone	_	NOUN	NN	_	24	compound	_	_
23	replacement	_	NOUN	NN	_	24	compound	_	_
24	therapies	_	NOUN	NNS	_	20	conj	_	_
25	,	_	.	,	_	20	punct	_	_
26	hypoglycemics	_	NOUN	NNS	_	20	conj	_	_
27	,	_	.	,	_	20	punct	_	_
28	phenytoins	_	NOUN	NNS	_	20	conj	_	_
29	,	_	.	,	_	20	punct	_	_
30	thiazide	_	NOUN	NN	_	31	compound	_	_
31	diuretics	_	NOUN	NNS	_	20	conj	_	_
32	,	_	.	,	_	20	punct	_	_
33	and	_	CONJ	CC	_	20	cc	_	_
34	calcium	_	NOUN	NN	_	36	compound	_	_
35	channel	_	NOUN	NN	_	36	compound	_	_
36	blockers	_	NOUN	NNS	_	20	conj	_	_

#	Lamisil	5746
1	An	_	DET	DT	_	2	det	_	_
2	evaluation	_	NOUN	NN	_	12	nsubjpass	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	the	_	DET	DT	_	5	det	_	_
5	effect	_	NOUN	NN	_	2	nmod	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	food	_	NOUN	NN	_	5	nmod	_	_
8	on	_	ADP	IN	_	10	case	_	_
9	DRUG	_	NOUN	NN	_	10	compound	_	_
10	Tablets	_	NOUN	NNS	_	5	nmod	_	_
11	was	_	VERB	VBD	_	12	auxpass	_	_
12	conducted	_	VERB	VBN	_	0	root	_	_

#	Lamisil	5747
1	An	_	DET	DT	_	2	det	_	_
2	increase	_	NOUN	NN	_	13	nsubjpass	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	less	_	ADV	RB	_	6	advmod	_	_
5	than	_	ADP	IN	_	4	mwe	_	_
6	20%	_	NOUN	NN	_	2	nmod	_	_
7	of	_	ADP	IN	_	9	case	_	_
8	the	_	DET	DT	_	9	det	_	_
9	AUC	_	NOUN	NN	_	6	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_
12	was	_	VERB	VBD	_	13	auxpass	_	_
13	observed	_	VERB	VBN	_	0	root	_	_
14	when	_	ADV	WRB	_	18	advmod	_	_
15	DRUG	_	NOUN	NN	_	16	compound	_	_
16	Tablets	_	NOUN	NNS	_	18	nsubjpass	_	_
17	were	_	VERB	VBD	_	18	auxpass	_	_
18	administered	_	VERB	VBN	_	13	advcl	_	_
19	with	_	ADP	IN	_	20	case	_	_
20	food	_	NOUN	NN	_	18	nmod	_	_

#	Lamisil	5748
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	Tablets	_	NOUN	NNS	_	5	nsubjpass	_	_
3	can	_	VERB	MD	_	5	aux	_	_
4	be	_	VERB	VB	_	5	auxpass	_	_
5	taken	_	VERB	VBN	_	0	root	_	_
6	with	_	ADP	IN	_	5	nmod	_	_
7	or	_	CONJ	CC	_	6	cc	_	_
8	without	_	ADP	IN	_	6	conj	_	_
9	food	_	NOUN	NN	_	6	dep	_	_

#	Lamisil	5749
1	DRUG	_	NOUN	NN	_	5	nsubj	_	_
2	is	_	VERB	VBZ	_	5	cop	_	_
3	an	_	DET	DT	_	5	det	_	_
4	allylamine	_	NOUN	NN	_	5	nmod:npmod	_	_
5	antifungal	_	ADJ	JJ	_	0	root	_	_

#	Lamisil	5750
1	The	_	DET	DT	_	2	det	_	_
2	pharmacodynamics	_	NOUN	NNS	_	7	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	DRUG	_	NOUN	NN	_	5	compound	_	_
5	Tablets	_	NOUN	NNS	_	2	nmod	_	_
6	is	_	VERB	VBZ	_	7	auxpass	_	_
7	unknown	_	ADJ	JJ	_	0	root	_	_

#	Lamisil	5751
1	Following	_	VERB	VBG	_	3	case	_	_
2	oral	_	ADJ	JJ	_	3	amod	_	_
3	administration	_	NOUN	NN	_	8	nmod	_	_
4	,	_	.	,	_	8	punct	_	_
5	DRUG	_	NOUN	NN	_	8	nsubjpass	_	_
6	is	_	VERB	VBZ	_	8	auxpass	_	_
7	well	_	ADV	RB	_	8	advmod	_	_
8	absorbed	_	VERB	VBN	_	0	root	_	_
9	>70%	_	NOUN	NN	_	8	xcomp	_	_
10	and	_	CONJ	CC	_	8	cc	_	_
11	the	_	DET	DT	_	12	det	_	_
12	bioavailability	_	NOUN	NN	_	25	nsubj	_	_
13	of	_	ADP	IN	_	15	case	_	_
14	DRUG	_	NOUN	NN	_	15	compound	_	_
15	Tablets	_	NOUN	NNS	_	12	nmod	_	_
16	as	_	ADP	IN	_	18	case	_	_
17	a	_	DET	DT	_	18	det	_	_
18	result	_	NOUN	NN	_	12	nmod	_	_
19	of	_	ADP	IN	_	22	case	_	_
20	first	_	ADJ	JJ	_	22	amod	_	_
21	pass	_	NOUN	NN	_	22	compound	_	_
22	metabolism	_	NOUN	NN	_	18	nmod	_	_
23	is	_	VERB	VBZ	_	25	cop	_	_
24	approximately	_	ADV	RB	_	25	advmod	_	_
25	40%	_	ADJ	JJ	_	8	conj	_	_

#	Lamisil	5752
1	Peak	_	ADJ	JJ	_	3	amod	_	_
2	plasma	_	NOUN	NN	_	3	compound	_	_
3	concentrations	_	NOUN	NNS	_	0	root	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	1	_	NUM	CD	_	6	nummod	_	_
6	mcg	_	NOUN	NN	_	3	nmod	_	_
7	/	_	.	:	_	3	punct	_	_
8	mL	_	NOUN	NN	_	9	nsubj	_	_
9	appear	_	VERB	VBD	_	3	dep	_	_
10	within	_	ADP	IN	_	12	case	_	_
11	2	_	NUM	CD	_	12	nummod	_	_
12	hours	_	NOUN	NNS	_	9	nmod	_	_
13	after	_	ADP	IN	_	18	case	_	_
14	a	_	DET	DT	_	18	det	_	_
15	single	_	ADJ	JJ	_	18	amod	_	_
16	250	_	NUM	CD	_	18	nummod	_	_
17	mg	_	NOUN	NN	_	18	compound	_	_
18	dose	_	NOUN	NN	_	9	nmod	_	_
19	the	_	DET	DT	_	20	det	_	_
20	AUC	_	NOUN	NN	_	24	nsubj	_	_
21	is	_	VERB	VBZ	_	24	cop	_	_
22	approximately	_	ADV	RB	_	23	advmod	_	_
23	4.56	_	NUM	CD	_	24	nummod	_	_
24	mcg.h	_	NOUN	NN	_	9	parataxis	_	_
25	/	_	.	:	_	24	punct	_	_
26	mL	_	NOUN	NN	_	24	dep	_	_

#	Lamisil	5753
1	An	_	DET	DT	_	2	det	_	_
2	increase	_	NOUN	NN	_	13	nsubjpass	_	_
3	in	_	ADP	IN	_	5	case	_	_
4	the	_	DET	DT	_	5	det	_	_
5	AUC	_	NOUN	NN	_	2	nmod	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	of	_	ADP	IN	_	11	case	_	_
9	less	_	ADV	RB	_	11	advmod	_	_
10	than	_	ADP	IN	_	9	mwe	_	_
11	20%	_	NOUN	NN	_	7	nmod	_	_
12	is	_	VERB	VBZ	_	13	auxpass	_	_
13	observed	_	VERB	VBN	_	0	root	_	_
14	when	_	ADV	WRB	_	13	advmod	_	_
15	DRUG	_	NOUN	NN	_	16	compound	_	_
16	Tablets	_	NOUN	NNS	_	14	root	_	_
17	areadministered	_	VERB	VBN	_	16	acl	_	_
18	with	_	ADP	IN	_	19	case	_	_
19	food	_	NOUN	NN	_	17	nmod	_	_

#	Lamisil	5754
1	In	_	ADP	IN	_	2	case	_	_
2	plasma	_	NOUN	NN	_	6	nmod	_	_
3	,	_	.	,	_	6	punct	_	_
4	DRUG	_	NOUN	NN	_	6	nsubj	_	_
5	is	_	VERB	VBZ	_	6	cop	_	_
6	greater	_	ADJ	JJ	_	0	root	_	_
7	than	_	ADP	IN	_	8	case	_	_
8	99%	_	NOUN	NN	_	6	nmod	_	_
9	bound	_	VERB	VBN	_	8	acl	_	_
10	to	_	PRT	TO	_	12	case	_	_
11	plasma	_	NOUN	NN	_	12	compound	_	_
12	proteins	_	NOUN	NNS	_	9	nmod	_	_
13	and	_	CONJ	CC	_	6	cc	_	_
14	there	_	PRON	PRP$	_	15	expl	_	_
15	are	_	VERB	VBP	_	6	conj	_	_
16	no	_	DET	DT	_	19	neg	_	_
17	specific	_	ADJ	JJ	_	19	amod	_	_
18	binding	_	NOUN	NN	_	19	compound	_	_
19	sites	_	NOUN	NNS	_	15	nsubj	_	_

#	Lamisil	5755
1	At	_	ADP	IN	_	3	case	_	_
2	steady	_	ADJ	JJ	_	3	amod	_	_
3	state	_	NOUN	NN	_	19	nmod	_	_
4	,	_	.	,	_	19	punct	_	_
5	in	_	ADP	IN	_	6	case	_	_
6	comparison	_	NOUN	NN	_	19	nmod	_	_
7	to	_	PRT	TO	_	10	case	_	_
8	a	_	DET	DT	_	10	det	_	_
9	single	_	ADJ	JJ	_	10	amod	_	_
10	dose	_	NOUN	NN	_	6	nmod	_	_
11	,	_	.	,	_	19	punct	_	_
12	the	_	DET	DT	_	14	det	_	_
13	peak	_	ADJ	JJ	_	14	amod	_	_
14	concentration	_	NOUN	NN	_	19	nsubj	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	14	nmod	_	_
17	is	_	VERB	VBZ	_	19	cop	_	_
18	25%	_	ADJ	JJ	_	19	amod	_	_
19	higher	_	ADJ	JJ	_	35	nsubj	_	_
20	and	_	CONJ	CC	_	19	cc	_	_
21	plasma	_	NOUN	NN	_	22	compound	_	_
22	AUC	_	NOUN	NN	_	19	conj	_	_
23	increases	_	VERB	VBZ	_	19	dep	_	_
24	by	_	ADP	IN	_	26	case	_	_
25	a	_	DET	DT	_	26	det	_	_
26	factor	_	NOUN	NN	_	23	nmod	_	_
27	of	_	ADP	IN	_	30	case	_	_
28	2.5	_	NUM	CD	_	30	nummod	_	_
29	the	_	DET	DT	_	30	det	_	_
30	increase	_	NOUN	NN	_	26	nmod	_	_
31	in	_	ADP	IN	_	33	case	_	_
32	plasma	_	NOUN	NN	_	33	compound	_	_
33	AUC	_	NOUN	NN	_	30	nmod	_	_
34	is	_	VERB	VBZ	_	35	cop	_	_
35	consistent	_	ADJ	JJ	_	0	root	_	_
36	with	_	ADP	IN	_	40	case	_	_
37	an	_	DET	DT	_	40	det	_	_
38	effective	_	ADJ	JJ	_	40	amod	_	_
39	half	_	ADJ	JJ	_	40	amod	_	_
40	life	_	NOUN	NN	_	35	nmod	_	_
41	of	_	ADP	IN	_	43	case	_	_
42	~36	_	NUM	CD	_	43	nummod	_	_
43	hours	_	NOUN	NNS	_	40	nmod	_	_

#	Lamisil	5756
1	DRUG	_	NOUN	NN	_	3	nsubjpass	_	_
2	is	_	VERB	VBZ	_	3	auxpass	_	_
3	distributed	_	VERB	VBN	_	0	root	_	_
4	to	_	PRT	TO	_	6	case	_	_
5	the	_	DET	DT	_	6	det	_	_
6	sebum	_	NOUN	NN	_	3	nmod	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	skin	_	NOUN	NN	_	6	conj	_	_

#	Lamisil	5757
1	A	_	DET	DT	_	4	det	_	_
2	terminal	_	ADJ	JJ	_	4	amod	_	_
3	half	_	ADJ	JJ	_	4	amod	_	_
4	life	_	NOUN	NN	_	10	nsubj	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	200	_	NUM	CD	_	8	nummod	_	_
7	400	_	NUM	CD	_	8	nummod	_	_
8	hours	_	NOUN	NNS	_	4	nmod	_	_
9	may	_	VERB	MD	_	10	aux	_	_
10	represent	_	VERB	VB	_	0	root	_	_
11	the	_	DET	DT	_	13	det	_	_
12	slow	_	NOUN	NN	_	13	amod	_	_
13	elimination	_	NOUN	NN	_	10	dobj	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	DRUG	_	NOUN	NN	_	13	nmod	_	_
16	from	_	ADP	IN	_	17	case	_	_
17	tissues	_	NOUN	NNS	_	13	nmod	_	_
18	such	_	ADJ	JJ	_	20	case	_	_
19	as	_	ADP	IN	_	18	mwe	_	_
20	skin	_	NOUN	NN	_	17	nmod	_	_
21	and	_	CONJ	CC	_	10	cc	_	_
22	adipose	_	VERB	VBP	_	10	conj	_	_

#	Lamisil	5758
1	Prior	_	ADV	RB	_	3	case	_	_
2	to	_	PRT	TO	_	3	case	_	_
3	excretion	_	NOUN	NN	_	8	nmod	_	_
4	,	_	.	,	_	8	punct	_	_
5	DRUG	_	NOUN	NN	_	8	nsubj	_	_
6	is	_	VERB	VBZ	_	8	cop	_	_
7	extensively	_	ADV	RB	_	8	advmod	_	_
8	metabolizedby	_	ADJ	JJ	_	0	root	_	_
9	at	_	ADP	IN	_	10	case	_	_
10	least	_	ADJ	JJS	_	11	nmod:npmod	_	_
11	7	_	NUM	CD	_	13	nummod	_	_
12	CYP	_	NOUN	NN	_	13	compound	_	_
13	isoenzymes	_	NOUN	NNS	_	8	dobj	_	_
14	with	_	ADP	IN	_	16	case	_	_
15	major	_	ADJ	JJ	_	16	amod	_	_
16	contributions	_	NOUN	NNS	_	13	nmod	_	_
17	from	_	ADP	IN	_	18	case	_	_
18	CYP2C9	_	NOUN	NN	_	16	nmod	_	_
19	,	_	.	,	_	18	punct	_	_
20	CYP1A2	_	NOUN	NN	_	18	conj	_	_
21	,	_	.	,	_	18	punct	_	_
22	CYP3A4	_	NOUN	NN	_	18	conj	_	_
23	,	_	.	,	_	18	punct	_	_
24	CYP2C8	_	NOUN	NN	_	18	conj	_	_
25	,	_	.	,	_	18	punct	_	_
26	and	_	CONJ	CC	_	18	cc	_	_
27	CYP2C19	_	NOUN	NN	_	18	conj	_	_

#	Lamisil	5759
1	No	_	DET	DT	_	2	neg	_	_
2	metabolites	_	NOUN	NNS	_	5	nsubjpass	_	_
3	have	_	VERB	VBP	_	5	aux	_	_
4	been	_	VERB	VBN	_	5	auxpass	_	_
5	identified	_	VERB	VBN	_	0	root	_	_
6	that	_	ADP	IN	_	7	nsubj	_	_
7	have	_	VERB	VBP	_	5	ccomp	_	_
8	antifungal	_	ADJ	JJ	_	9	amod	_	_
9	activity	_	NOUN	NN	_	7	dobj	_	_
10	similar	_	ADJ	JJ	_	9	amod	_	_
11	to	_	PRT	TO	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_

#	Lamisil	5760
1	Approximately	_	ADV	RB	_	8	advmod	_	_
2	70%	_	NOUN	NN	_	8	nsubjpass	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	the	_	DET	DT	_	6	det	_	_
5	administered	_	VERB	VBN	_	6	amod	_	_
6	dose	_	NOUN	NN	_	2	nmod	_	_
7	is	_	VERB	VBZ	_	8	auxpass	_	_
8	eliminated	_	VERB	VBN	_	0	root	_	_
9	in	_	ADP	IN	_	11	case	_	_
10	the	_	DET	DT	_	11	det	_	_
11	urine	_	VERB	VBG	_	8	nmod	_	_

#	Lamisil	5761
1	In	_	ADP	IN	_	2	case	_	_
2	patients	_	NOUN	NNS	_	30	nmod	_	_
3	with	_	ADP	IN	_	7	case	_	_
4	renal	_	ADJ	JJ	_	7	amod	_	_
5	impairment	_	NOUN	NN	_	7	compound	_	_
6	creatinine	_	NOUN	NN	_	7	compound	_	_
7	clearance	_	NOUN	NN	_	2	nmod	_	_
8	less	_	ADV	RB	_	11	advmod	_	_
9	than	_	ADP	IN	_	11	case	_	_
10	or	_	CONJ	CC	_	11	cc	_	_
11	equal	_	ADJ	JJ	_	7	amod	_	_
12	to	_	PRT	TO	_	14	case	_	_
13	50	_	NUM	CD	_	14	nummod	_	_
14	mL	_	NOUN	NN	_	11	nmod	_	_
15	/	_	.	:	_	16	punct	_	_
16	min	_	NOUN	NN	_	30	nsubj	_	_
17	or	_	CONJ	CC	_	16	cc	_	_
18	hepatic	_	ADJ	JJ	_	19	amod	_	_
19	cirrhosis	_	NOUN	NN	_	16	conj	_	_
20	,	_	.	,	_	16	punct	_	_
21	the	_	DET	DT	_	22	det	_	_
22	clearance	_	NOUN	NN	_	26	nsubjpass	_	_
23	of	_	ADP	IN	_	24	case	_	_
24	DRUG	_	NOUN	NN	_	22	nmod	_	_
25	is	_	VERB	VBZ	_	26	auxpass	_	_
26	decreased	_	VERB	VBN	_	16	acl:relcl	_	_
27	by	_	ADP	IN	_	29	case	_	_
28	approximately	_	ADV	RB	_	29	advmod	_	_
29	50%	_	NOUN	NN	_	26	nmod	_	_
30	compared	_	VERB	VBN	_	0	root	_	_
31	to	_	PRT	TO	_	33	case	_	_
32	normal	_	ADJ	JJ	_	33	amod	_	_
33	volunteers	_	NOUN	NNS	_	30	nmod	_	_

#	Lamisil	5762
1	No	_	DET	DT	_	2	neg	_	_
2	effect	_	NOUN	NN	_	12	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	gender	_	NOUN	NN	_	2	nmod	_	_
5	on	_	ADP	IN	_	8	case	_	_
6	the	_	DET	DT	_	8	det	_	_
7	blood	_	NOUN	NN	_	8	compound	_	_
8	levels	_	NOUN	NNS	_	2	nmod	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	was	_	VERB	VBD	_	12	auxpass	_	_
12	detected	_	VERB	VBN	_	0	root	_	_
13	in	_	ADP	IN	_	15	case	_	_
14	clinical	_	ADJ	JJ	_	15	amod	_	_
15	trials	_	NOUN	NNS	_	12	nmod	_	_

#	Lamisil	5763
1	No	_	DET	DT	_	6	neg	_	_
2	clinically	_	ADV	RB	_	3	advmod	_	_
3	relevant	_	ADJ	JJ	_	6	amod	_	_
4	age	_	NOUN	NN	_	6	compound	_	_
5	dependent	_	ADJ	JJ	_	6	amod	_	_
6	changes	_	NOUN	NNS	_	16	nsubjpass	_	_
7	in	_	ADP	IN	_	11	case	_	_
8	steady	_	ADJ	JJ	_	11	amod	_	_
9	state	_	NOUN	NN	_	11	compound	_	_
10	plasma	_	NOUN	NN	_	11	compound	_	_
11	concentrations	_	NOUN	NNS	_	6	nmod	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	DRUG	_	NOUN	NN	_	11	nmod	_	_
14	have	_	VERB	VBP	_	16	aux	_	_
15	been	_	VERB	VBN	_	16	auxpass	_	_
16	reported	_	VERB	VBN	_	0	root	_	_

#	Lamisil	5764
1	DRUG	_	NOUN	NN	_	4	compound	_	_
2	,an	_	NOUN	NN	_	4	compound	_	_
3	allylamine	_	NOUN	NN	_	4	compound	_	_
4	antifungal	_	ADJ	JJ	_	6	nsubj	_	_
5	,	_	.	,	_	4	punct	_	_
6	inhibits	_	VERB	VBZ	_	0	root	_	_
7	biosynthesis	_	NOUN	NN	_	6	dobj	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	ergosterol	_	NOUN	NN	_	7	nmod	_	_
10	,	_	.	,	_	9	punct	_	_
11	an	_	DET	DT	_	13	det	_	_
12	essential	_	ADJ	JJ	_	13	amod	_	_
13	component	_	NOUN	NN	_	9	appos	_	_
14	of	_	ADP	IN	_	17	case	_	_
15	fungal	_	ADJ	JJ	_	17	amod	_	_
16	cell	_	NOUN	NN	_	17	compound	_	_
17	membrane	_	NOUN	NN	_	13	nmod	_	_
18	,	_	.	,	_	6	punct	_	_
19	via	_	ADP	IN	_	20	case	_	_
20	inhibition	_	NOUN	NN	_	6	nmod	_	_
21	of	_	ADP	IN	_	22	case	_	_
22	squaleneepoxidaseenzyme	_	NOUN	NN	_	20	nmod	_	_

#	Lamisil	5765
1	This	_	DET	DT	_	2	det	_	_
2	results	_	NOUN	NNS	_	0	root	_	_
3	in	_	ADP	IN	_	6	case	_	_
4	fungal	_	ADJ	JJ	_	6	amod	_	_
5	cell	_	NOUN	NN	_	6	compound	_	_
6	death	_	NOUN	NN	_	2	nmod	_	_
7	primarily	_	ADV	RB	_	8	advmod	_	_
8	due	_	ADP	IN	_	13	case	_	_
9	to	_	PRT	TO	_	8	mwe	_	_
10	the	_	DET	DT	_	13	det	_	_
11	increased	_	VERB	VBN	_	13	amod	_	_
12	membrane	_	NOUN	NN	_	13	compound	_	_
13	permeability	_	NOUN	NN	_	2	nmod	_	_
14	mediated	_	VERB	VBN	_	13	acl	_	_
15	by	_	ADP	IN	_	17	case	_	_
16	the	_	DET	DT	_	17	det	_	_
17	accumulation	_	NOUN	NN	_	14	nmod	_	_
18	of	_	ADP	IN	_	20	case	_	_
19	high	_	ADJ	JJ	_	20	amod	_	_
20	concentrations	_	NOUN	NNS	_	17	nmod	_	_
21	of	_	ADP	IN	_	22	case	_	_
22	squalene	_	NOUN	NN	_	20	nmod	_	_
23	but	_	CONJ	CC	_	17	cc	_	_
24	not	_	ADV	RB	_	25	neg	_	_
25	due	_	ADJ	JJ	_	28	case	_	_
26	to	_	PRT	TO	_	28	case	_	_
27	ergosterol	_	NOUN	NN	_	28	compound	_	_
28	deficiency	_	NOUN	NN	_	17	conj	_	_

#	Lamisil	5766
1	Depending	_	VERB	VBG	_	4	case	_	_
2	on	_	ADP	IN	_	4	case	_	_
3	the	_	DET	DT	_	4	det	_	_
4	concentration	_	NOUN	NN	_	12	nsubj	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	drug	_	NOUN	NN	_	4	nmod	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	the	_	DET	DT	_	11	det	_	_
10	fungal	_	ADJ	JJ	_	11	amod	_	_
11	species	_	NOUN	NNS	_	7	conj	_	_
12	test	_	VERB	VBP	_	20	advcl	_	_
13	in	_	X	FW	_	14	compound	_	_
14	vitro	_	X	FW	_	12	advmod	_	_
15	,	_	.	,	_	20	punct	_	_
16	DRUG	_	NOUN	NN	_	17	compound	_	_
17	hydrochloride	_	NOUN	NN	_	20	nsubj	_	_
18	may	_	VERB	MD	_	20	aux	_	_
19	be	_	VERB	VB	_	20	auxpass	_	_
20	fungicidal	_	ADJ	JJ	_	0	root	_	_

#	Lamisil	5767
1	However	_	ADV	RB	_	11	advmod	_	_
2	,	_	.	,	_	11	punct	_	_
3	the	_	DET	DT	_	5	det	_	_
4	clinical	_	ADJ	JJ	_	5	amod	_	_
5	significance	_	NOUN	NN	_	11	nsubj	_	_
6	of	_	ADP	IN	_	9	case	_	_
7	in	_	X	FW	_	9	amod	_	_
8	vitro	_	X	FW	_	7	dep	_	_
9	data	_	NOUN	NNS	_	5	nmod	_	_
10	is	_	VERB	VBZ	_	11	auxpass	_	_
11	unknown	_	ADJ	JJ	_	0	root	_	_

#	Lamisil	5768
1	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
2	has	_	VERB	VBZ	_	4	aux	_	_
3	been	_	VERB	VBN	_	4	auxpass	_	_
4	shown	_	VERB	VBN	_	0	root	_	_
5	to	_	PRT	TO	_	7	mark	_	_
6	be	_	VERB	VB	_	7	cop	_	_
7	active	_	ADJ	JJ	_	4	xcomp	_	_
8	against	_	ADP	IN	_	10	case	_	_
9	most	_	ADJ	JJ	_	10	amod	_	_
10	strains	_	NOUN	NNS	_	7	nmod	_	_
11	of	_	ADP	IN	_	14	case	_	_
12	the	_	DET	DT	_	14	det	_	_
13	following	_	VERB	VBG	_	14	amod	_	_
14	microorganisms	_	NOUN	NNS	_	10	nmod	_	_
15	both	_	CONJ	CC	_	14	amod	_	_
16	in	_	X	FW	_	17	compound	_	_
17	vitro	_	X	FW	_	15	dep	_	_
18	and	_	CONJ	CC	_	15	cc	_	_
19	in	_	ADP	IN	_	21	case	_	_
20	clinical	_	ADJ	JJ	_	21	amod	_	_
21	infections	_	NOUN	NNS	_	15	conj	_	_
22	:	_	.	:	_	4	punct	_	_
23	Trichophyton	_	NOUN	NN	_	24	compound	_	_
24	mentagrophytes	_	NOUN	NNS	_	4	parataxis	_	_
25	Trichophyton	_	NOUN	NN	_	26	compound	_	_
26	rubrum	_	NOUN	NN	_	24	dep	_	_
27	The	_	DET	DT	_	33	dep	_	_
28	following	_	VERB	VBG	_	31	case	_	_
29	in	_	X	FW	_	31	amod	_	_
30	vitro	_	X	FW	_	29	dep	_	_
31	data	_	NOUN	NNS	_	33	nsubj	_	_
32	are	_	VERB	VBP	_	33	cop	_	_
33	available	_	ADJ	JJ	_	26	acl:relcl	_	_
34	,	_	.	,	_	24	punct	_	_
35	but	_	CONJ	CC	_	24	cc	_	_
36	their	_	PRON	PRP$	_	38	nmod:poss	_	_
37	clinical	_	ADJ	JJ	_	38	amod	_	_
38	significance	_	NOUN	NN	_	40	nsubj	_	_
39	is	_	VERB	VBZ	_	40	auxpass	_	_
40	unknown	_	ADJ	JJ	_	24	conj	_	_

#	Lamisil	5769
1	In	_	X	FW	_	2	compound	_	_
2	vitro	_	X	FW	_	5	advmod	_	_
3	,	_	.	,	_	5	punct	_	_
4	DRUG	_	NOUN	NN	_	5	nsubj	_	_
5	exhibits	_	VERB	VBZ	_	0	root	_	_
6	satisfactory	_	ADJ	JJ	_	7	amod	_	_
7	MIC's	_	NOUN	NNS	_	5	dobj	_	_
8	against	_	ADP	IN	_	10	case	_	_
9	most	_	ADJ	JJ	_	10	amod	_	_
10	strains	_	NOUN	NNS	_	7	nmod	_	_
11	of	_	ADP	IN	_	14	case	_	_
12	the	_	DET	DT	_	14	det	_	_
13	following	_	VERB	VBG	_	14	amod	_	_
14	microorganisms	_	NOUN	NNS	_	10	nmod	_	_
15	however	_	ADV	RB	_	5	advmod	_	_
16	,	_	.	,	_	5	punct	_	_
17	the	_	DET	DT	_	18	det	_	_
18	safety	_	NOUN	NN	_	34	nsubjpass	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	efficacy	_	NOUN	NN	_	18	conj	_	_
21	of	_	ADP	IN	_	22	case	_	_
22	DRUG	_	NOUN	NN	_	18	nmod	_	_
23	in	_	ADP	IN	_	24	mark	_	_
24	treating	_	VERB	VBG	_	18	acl	_	_
25	clinical	_	ADJ	JJ	_	26	amod	_	_
26	infections	_	NOUN	NNS	_	24	dobj	_	_
27	due	_	ADJ	JJ	_	30	case	_	_
28	to	_	PRT	TO	_	27	mwe	_	_
29	these	_	DET	DT	_	30	det	_	_
30	microorganisms	_	NOUN	NNS	_	24	nmod	_	_
31	have	_	VERB	VBP	_	34	aux	_	_
32	not	_	ADV	RB	_	34	neg	_	_
33	been	_	VERB	VBN	_	34	auxpass	_	_
34	established	_	VERB	VBN	_	5	conj	_	_
35	in	_	ADP	IN	_	41	case	_	_
36	adequate	_	ADJ	JJ	_	41	amod	_	_
37	and	_	CONJ	CC	_	36	cc	_	_
38	well	_	ADV	RB	_	36	conj	_	_
39	controlled	_	VERB	VBN	_	41	amod	_	_
40	clinical	_	ADJ	JJ	_	41	amod	_	_
41	trials	_	NOUN	NNS	_	34	nmod	_	_
42	:	_	.	:	_	5	punct	_	_
43	Candida	_	NOUN	NN	_	44	compound	_	_
44	albicans	_	NOUN	NNS	_	5	parataxis	_	_
45	Epidermophyton	_	NOUN	NN	_	48	compound	_	_
46	floccosum	_	NOUN	NN	_	48	compound	_	_
47	Scopulariopsis	_	NOUN	NN	_	48	compound	_	_
48	brevicaulis	_	NOUN	NN	_	44	dep	_	_

#	Latuda	3677
1	Table	_	ADJ	JJ	_	0	root	_	_
2	34	_	NUM	CD	_	1	dep	_	_
3	:	_	.	:	_	1	punct	_	_
4	Clinically	_	ADV	RB	_	7	advmod	_	_
5	Important	_	ADJ	JJ	_	7	amod	_	_
6	Drug	_	NOUN	NN	_	7	compound	_	_
7	Interactions	_	NOUN	NNS	_	1	dep	_	_
8	with	_	ADP	IN	_	12	case	_	_
9	DRUG	_	NOUN	NN	_	12	compound	_	_
10	Strong	_	ADJ	JJ	_	12	amod	_	_
11	CYP3A4	_	NOUN	NN	_	12	compound	_	_
12	Inhibitors	_	NOUN	NNS	_	7	nmod	_	_
13	Clinical	_	ADJ	JJ	_	14	amod	_	_
14	Impact	_	NOUN	NN	_	12	dep	_	_
15	:	_	.	:	_	1	punct	_	_
16	Concomitant	_	ADJ	JJ	_	17	amod	_	_
17	use	_	NOUN	NN	_	24	nsubj	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	DRUG	_	NOUN	NN	_	17	nmod	_	_
20	with	_	ADP	IN	_	23	case	_	_
21	strong	_	ADJ	JJ	_	23	amod	_	_
22	CYP3A4	_	NOUN	NN	_	23	compound	_	_
23	inhibitors	_	NOUN	NNS	_	17	nmod	_	_
24	increased	_	VERB	VBD	_	1	dep	_	_
25	the	_	DET	DT	_	26	det	_	_
26	exposure	_	NOUN	NN	_	24	dobj	_	_
27	of	_	ADP	IN	_	28	case	_	_
28	DRUG	_	NOUN	NN	_	26	nmod	_	_
29	compared	_	VERB	VBD	_	24	xcomp	_	_
30	to	_	PRT	TO	_	32	case	_	_
31	the	_	DET	DT	_	32	det	_	_
32	use	_	NOUN	NN	_	29	nmod	_	_
33	of	_	ADP	IN	_	34	case	_	_
34	DRUG	_	NOUN	NN	_	32	nmod	_	_
35	alone	_	ADV	RB	_	32	advmod	_	_

#	Latuda	3678
1	Intervention	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	DRUG	_	NOUN	NN	_	7	nsubjpass	_	_
4	should	_	VERB	MD	_	7	aux	_	_
5	not	_	ADV	RB	_	7	neg	_	_
6	be	_	VERB	VB	_	7	auxpass	_	_
7	used	_	VERB	VBN	_	1	dep	_	_
8	concomitantly	_	ADV	RB	_	7	advmod	_	_
9	with	_	ADP	IN	_	12	case	_	_
10	strong	_	ADJ	JJ	_	12	amod	_	_
11	CYP3A4	_	NOUN	NN	_	12	compound	_	_
12	inhibitors	_	NOUN	NNS	_	7	nmod	_	_

#	Latuda	3679
1	Examples	_	NOUN	NNS	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Ketoconazole	_	NOUN	NN	_	1	dep	_	_
4	,	_	.	,	_	3	punct	_	_
5	clarithromycin	_	NOUN	NN	_	3	conj	_	_
6	,	_	.	,	_	3	punct	_	_
7	ritonavir	_	NOUN	NN	_	3	conj	_	_
8	,	_	.	,	_	3	punct	_	_
9	voriconazole	_	NOUN	NN	_	3	conj	_	_
10	,	_	.	,	_	3	punct	_	_
11	mibefradil	_	NOUN	NN	_	14	compound	_	_
12	Moderate	_	ADJ	JJ	_	14	amod	_	_
13	CYP3A4	_	NOUN	NN	_	14	compound	_	_
14	Inhibitors	_	NOUN	NNS	_	16	compound	_	_
15	Clinical	_	ADJ	JJ	_	16	amod	_	_
16	Impact	_	NOUN	NN	_	3	appos	_	_
17	:	_	.	:	_	3	punct	_	_
18	Concomitant	_	ADJ	JJ	_	19	amod	_	_
19	use	_	NOUN	NN	_	26	nsubj	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	DRUG	_	NOUN	NN	_	19	nmod	_	_
22	with	_	ADP	IN	_	25	case	_	_
23	moderate	_	ADJ	JJ	_	25	amod	_	_
24	CYP3A4	_	NOUN	NN	_	25	compound	_	_
25	inhibitors	_	NOUN	NNS	_	19	nmod	_	_
26	increased	_	VERB	VBD	_	3	dep	_	_
27	the	_	DET	DT	_	28	det	_	_
28	exposure	_	NOUN	NN	_	26	dobj	_	_
29	of	_	ADP	IN	_	30	case	_	_
30	DRUG	_	NOUN	NN	_	28	nmod	_	_
31	compared	_	VERB	VBD	_	26	parataxis	_	_
32	to	_	PRT	TO	_	34	case	_	_
33	the	_	DET	DT	_	34	det	_	_
34	use	_	NOUN	NN	_	31	nmod	_	_
35	of	_	ADP	IN	_	36	case	_	_
36	DRUG	_	NOUN	NN	_	34	nmod	_	_
37	alone	_	ADV	RB	_	34	advmod	_	_

#	Latuda	3680
1	Intervention	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	DRUG	_	NOUN	NN	_	4	compound	_	_
4	dose	_	NOUN	NN	_	7	nsubjpass	_	_
5	should	_	VERB	MD	_	7	aux	_	_
6	be	_	VERB	VB	_	7	auxpass	_	_
7	reduced	_	VERB	VBN	_	1	dep	_	_
8	to	_	PRT	TO	_	9	case	_	_
9	half	_	NOUN	NN	_	7	nmod	_	_
10	of	_	ADP	IN	_	13	case	_	_
11	the	_	DET	DT	_	13	det	_	_
12	original	_	ADJ	JJ	_	13	amod	_	_
13	level	_	NOUN	NN	_	9	nmod	_	_
14	when	_	ADV	WRB	_	15	advmod	_	_
15	used	_	VERB	VBN	_	7	advcl	_	_
16	concomitantly	_	ADV	RB	_	15	advmod	_	_
17	with	_	ADP	IN	_	19	case	_	_
18	moderate	_	ADJ	JJ	_	19	amod	_	_
19	inhibitors	_	NOUN	NNS	_	15	nmod	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	CYP3A4	_	NOUN	NN	_	19	nmod	_	_

#	Latuda	3681
1	Examples	_	NOUN	NNS	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Diltiazem	_	NOUN	NN	_	14	nsubj	_	_
4	,	_	.	,	_	3	punct	_	_
5	atazanavir	_	NOUN	NN	_	3	conj	_	_
6	,	_	.	,	_	3	punct	_	_
7	erythromycin	_	NOUN	NN	_	3	conj	_	_
8	,	_	.	,	_	3	punct	_	_
9	fluconazole	_	NOUN	NN	_	3	conj	_	_
10	,	_	.	,	_	3	punct	_	_
11	verapamil	_	NOUN	NN	_	13	compound	_	_
12	Strong	_	ADJ	JJ	_	13	amod	_	_
13	CYP3A4	_	NOUN	NN	_	3	conj	_	_
14	Inducers	_	NOUN	NNS	_	1	dep	_	_
15	Clinical	_	ADJ	JJ	_	16	amod	_	_
16	Impact	_	NOUN	NN	_	14	dobj	_	_
17	:	_	.	:	_	1	punct	_	_
18	Concomitant	_	ADJ	JJ	_	19	amod	_	_
19	use	_	NOUN	NN	_	26	nsubj	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	DRUG	_	NOUN	NN	_	19	nmod	_	_
22	with	_	ADP	IN	_	25	case	_	_
23	strong	_	ADJ	JJ	_	25	amod	_	_
24	CYP3A4	_	NOUN	NN	_	25	compound	_	_
25	inducers	_	NOUN	NNS	_	19	nmod	_	_
26	decreased	_	VERB	VBD	_	1	dep	_	_
27	the	_	DET	DT	_	28	det	_	_
28	exposure	_	NOUN	NN	_	26	dobj	_	_
29	of	_	ADP	IN	_	30	case	_	_
30	DRUG	_	NOUN	NN	_	28	nmod	_	_
31	compared	_	VERB	VBD	_	26	parataxis	_	_
32	to	_	PRT	TO	_	34	case	_	_
33	the	_	DET	DT	_	34	det	_	_
34	use	_	NOUN	NN	_	31	nmod	_	_
35	of	_	ADP	IN	_	36	case	_	_
36	DRUG	_	NOUN	NN	_	34	nmod	_	_
37	alone	_	ADV	RB	_	34	advmod	_	_

#	Latuda	3682
1	Intervention	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	DRUG	_	NOUN	NN	_	7	nsubjpass	_	_
4	should	_	VERB	MD	_	7	aux	_	_
5	not	_	ADV	RB	_	7	neg	_	_
6	be	_	VERB	VB	_	7	auxpass	_	_
7	used	_	VERB	VBN	_	1	dep	_	_
8	concomitantly	_	ADV	RB	_	7	advmod	_	_
9	with	_	ADP	IN	_	12	case	_	_
10	strong	_	ADJ	JJ	_	12	amod	_	_
11	CYP3A4	_	NOUN	NN	_	12	compound	_	_
12	inducers	_	NOUN	NNS	_	7	nmod	_	_

#	Latuda	3683
1	Examples	_	NOUN	NNS	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Rifampin	_	NOUN	NN	_	9	nsubj	_	_
4	,	_	.	,	_	3	punct	_	_
5	avasimibe	_	NOUN	NN	_	3	conj	_	_
6	,	_	.	,	_	3	punct	_	_
7	St	_	NOUN	NN	_	8	compound	_	_
8	John's	_	NOUN	NNS	_	3	conj	_	_
9	wort	_	VERB	VBP	_	1	dep	_	_
10	,	_	.	,	_	9	punct	_	_
11	phenytoin	_	NOUN	NN	_	9	conj	_	_
12	,	_	.	,	_	9	punct	_	_
13	carbamazepine	_	NOUN	NN	_	16	compound	_	_
14	Moderate	_	ADJ	JJ	_	16	amod	_	_
15	CYP3A4	_	NOUN	NN	_	16	compound	_	_
16	Inducers	_	NOUN	NNS	_	18	compound	_	_
17	Clinical	_	ADJ	JJ	_	18	amod	_	_
18	Impact	_	NOUN	NN	_	9	dobj	_	_
19	:	_	.	:	_	1	punct	_	_
20	Concomitant	_	ADJ	JJ	_	21	amod	_	_
21	use	_	NOUN	NN	_	28	nsubj	_	_
22	of	_	ADP	IN	_	23	case	_	_
23	DRUG	_	NOUN	NN	_	21	nmod	_	_
24	with	_	ADP	IN	_	27	case	_	_
25	moderate	_	ADJ	JJ	_	27	amod	_	_
26	CYP3A4	_	NOUN	NN	_	27	compound	_	_
27	inducers	_	NOUN	NNS	_	21	nmod	_	_
28	decreased	_	VERB	VBD	_	1	dep	_	_
29	the	_	DET	DT	_	30	det	_	_
30	exposure	_	NOUN	NN	_	28	dobj	_	_
31	of	_	ADP	IN	_	32	case	_	_
32	DRUG	_	NOUN	NN	_	30	nmod	_	_
33	compared	_	VERB	VBD	_	28	parataxis	_	_
34	to	_	PRT	TO	_	36	case	_	_
35	the	_	DET	DT	_	36	det	_	_
36	use	_	NOUN	NN	_	33	nmod	_	_
37	of	_	ADP	IN	_	38	case	_	_
38	DRUG	_	NOUN	NN	_	36	nmod	_	_
39	alone	_	ADV	RB	_	36	advmod	_	_

#	Latuda	3684
1	Intervention	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	DRUG	_	NOUN	NN	_	4	compound	_	_
4	dose	_	NOUN	NN	_	7	nsubjpass	_	_
5	should	_	VERB	MD	_	7	aux	_	_
6	be	_	VERB	VB	_	7	auxpass	_	_
7	increased	_	VERB	VBN	_	1	dep	_	_
8	when	_	ADV	WRB	_	9	advmod	_	_
9	used	_	VERB	VBN	_	7	advcl	_	_
10	concomitantly	_	ADV	RB	_	9	advmod	_	_
11	with	_	ADP	IN	_	13	case	_	_
12	moderate	_	ADJ	JJ	_	13	amod	_	_
13	inducers	_	NOUN	NNS	_	9	nmod	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	CYP3A4	_	NOUN	NN	_	13	nmod	_	_

#	Latuda	3685
1	Examples	_	NOUN	NNS	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Bosentan	_	NOUN	NN	_	12	nsubj	_	_
4	,	_	.	,	_	3	punct	_	_
5	efavirenz	_	ADJ	JJ	_	3	conj	_	_
6	,	_	.	,	_	3	punct	_	_
7	etravirine	_	NOUN	NN	_	3	conj	_	_
8	,	_	.	,	_	3	punct	_	_
9	modafinil	_	NOUN	NN	_	3	conj	_	_
10	,	_	.	,	_	3	punct	_	_
11	nafcillin	_	NOUN	NN	_	3	conj	_	_
12	Based	_	VERB	VBN	_	1	dep	_	_
13	on	_	ADP	IN	_	15	case	_	_
14	pharmacokinetic	_	ADJ	JJ	_	15	amod	_	_
15	studies	_	NOUN	NNS	_	12	nmod	_	_
16	,	_	.	,	_	1	punct	_	_
17	no	_	DET	DT	_	19	neg	_	_
18	dosage	_	ADJ	JJ	_	19	amod	_	_
19	adjustment	_	NOUN	NN	_	23	nsubjpass	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	DRUG	_	NOUN	NN	_	19	nmod	_	_
22	is	_	VERB	VBZ	_	23	auxpass	_	_
23	required	_	VERB	VBN	_	1	dep	_	_
24	when	_	ADV	WRB	_	25	advmod	_	_
25	administered	_	VERB	VBN	_	23	advcl	_	_
26	concomitantly	_	ADV	RB	_	25	advmod	_	_
27	with	_	ADP	IN	_	28	case	_	_
28	lithium	_	NOUN	NN	_	25	nmod	_	_
29	,	_	.	,	_	28	punct	_	_
30	valproate	_	NOUN	NN	_	28	conj	_	_
31	,	_	.	,	_	28	punct	_	_
32	or	_	CONJ	CC	_	28	cc	_	_
33	substrates	_	NOUN	NNS	_	28	conj	_	_
34	of	_	ADP	IN	_	36	case	_	_
35	P	_	NOUN	NN	_	36	compound	_	_
36	gp	_	NOUN	NN	_	28	nmod	_	_
37	or	_	CONJ	CC	_	36	cc	_	_
38	CYP3A4	_	NOUN	NN	_	36	conj	_	_

#	Latuda	3686
1	The	_	DET	DT	_	2	det	_	_
2	mechanism	_	NOUN	NN	_	16	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	action	_	NOUN	NN	_	2	nmod	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	in	_	ADP	IN	_	9	case	_	_
8	the	_	DET	DT	_	9	det	_	_
9	treatment	_	NOUN	NN	_	2	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	schizophrenia	_	NOUN	NN	_	9	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	bipolar	_	ADJ	JJ	_	14	amod	_	_
14	depression	_	NOUN	NN	_	11	conj	_	_
15	is	_	VERB	VBZ	_	16	auxpass	_	_
16	unclear	_	ADJ	JJ	_	0	root	_	_

#	Latuda	3687
1	However	_	ADV	RB	_	12	advmod	_	_
2	,	_	.	,	_	12	punct	_	_
3	its	_	PRON	PRP$	_	4	nmod:poss	_	_
4	efficacy	_	NOUN	NN	_	12	nsubjpass	_	_
5	in	_	ADP	IN	_	6	case	_	_
6	schizophrenia	_	NOUN	NN	_	4	nmod	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	bipolar	_	ADJ	JJ	_	9	amod	_	_
9	depression	_	NOUN	NN	_	6	conj	_	_
10	could	_	VERB	MD	_	12	aux	_	_
11	be	_	VERB	VB	_	12	auxpass	_	_
12	mediated	_	VERB	VBN	_	0	root	_	_
13	through	_	ADP	IN	_	15	case	_	_
14	a	_	DET	DT	_	15	det	_	_
15	combination	_	NOUN	NN	_	12	nmod	_	_
16	of	_	ADP	IN	_	19	case	_	_
17	central	_	ADJ	JJ	_	19	amod	_	_
18	dopamine	_	NOUN	NN	_	19	compound	_	_
19	D2	_	NOUN	NN	_	15	nmod	_	_
20	and	_	CONJ	CC	_	19	cc	_	_
21	serotonin	_	NOUN	NN	_	26	compound	_	_
22	Type	_	NOUN	NN	_	26	compound	_	_
23	2	_	NUM	CD	_	26	nummod	_	_
24	5HT2A	_	NOUN	NN	_	26	compound	_	_
25	receptor	_	NOUN	NN	_	26	compound	_	_
26	antagonism	_	NOUN	NN	_	19	conj	_	_

#	Latuda	3688
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	is	_	VERB	VBZ	_	4	cop	_	_
3	an	_	DET	DT	_	4	det	_	_
4	antagonist	_	NOUN	NN	_	0	root	_	_
5	with	_	ADP	IN	_	8	case	_	_
6	high	_	ADJ	JJ	_	8	amod	_	_
7	affinity	_	NOUN	NN	_	8	compound	_	_
8	binding	_	NOUN	NN	_	4	nmod	_	_
9	at	_	ADP	IN	_	13	case	_	_
10	the	_	DET	DT	_	13	det	_	_
11	dopamine	_	NOUN	NN	_	13	compound	_	_
12	D2	_	NOUN	NN	_	13	compound	_	_
13	receptors	_	NOUN	NNS	_	8	nmod	_	_
14	Ki	_	NOUN	NN	_	13	dep	_	_
15	of	_	ADP	IN	_	17	case	_	_
16	1	_	NUM	CD	_	17	nummod	_	_
17	nM	_	NOUN	NN	_	14	nmod	_	_
18	and	_	CONJ	CC	_	14	cc	_	_
19	the	_	DET	DT	_	23	det	_	_
20	serotonin	_	NOUN	NN	_	23	compound	_	_
21	5	_	NUM	CD	_	23	nummod	_	_
22	HT2A	_	NOUN	NN	_	23	compound	_	_
23	Ki	_	NOUN	NN	_	14	conj	_	_
24	of	_	ADP	IN	_	26	case	_	_
25	0.5	_	NUM	CD	_	26	nummod	_	_
26	nM	_	NOUN	NN	_	23	nmod	_	_
27	and	_	CONJ	CC	_	26	cc	_	_
28	5	_	NUM	CD	_	30	nummod	_	_
29	HT7	_	NOUN	NN	_	30	compound	_	_
30	Ki	_	NOUN	NN	_	26	conj	_	_
31	of	_	ADP	IN	_	34	case	_	_
32	0.5	_	NUM	CD	_	34	nummod	_	_
33	nM	_	NOUN	NN	_	34	compound	_	_
34	receptors	_	NOUN	NNS	_	26	nmod	_	_

#	Latuda	3689
1	It	_	PRON	PRP	_	3	nsubj	_	_
2	also	_	ADV	RB	_	3	advmod	_	_
3	binds	_	VERB	VBZ	_	0	root	_	_
4	with	_	ADP	IN	_	6	case	_	_
5	moderate	_	ADJ	JJ	_	6	amod	_	_
6	affinity	_	NOUN	NN	_	3	nmod	_	_
7	to	_	PRT	TO	_	12	case	_	_
8	the	_	DET	DT	_	12	det	_	_
9	human	_	ADJ	JJ	_	12	amod	_	_
10	A2C	_	NOUN	NN	_	12	compound	_	_
11	adrenergic	_	ADJ	JJ	_	12	amod	_	_
12	receptors	_	NOUN	NNS	_	6	nmod	_	_
13	Ki=11	_	NOUN	NN	_	14	compound	_	_
14	nM	_	NOUN	NN	_	12	dep	_	_
15	,	_	.	,	_	3	punct	_	_
16	is	_	VERB	VBZ	_	19	cop	_	_
17	a	_	DET	DT	_	19	det	_	_
18	partial	_	ADJ	JJ	_	19	amod	_	_
19	agonist	_	NOUN	NN	_	3	conj	_	_
20	at	_	ADP	IN	_	26	case	_	_
21	serotonin	_	NOUN	NN	_	26	compound	_	_
22	5	_	NUM	CD	_	26	nummod	_	_
23	HT1A	_	NOUN	NN	_	26	compound	_	_
24	Ki=6.4	_	NOUN	NN	_	26	compound	_	_
25	nM	_	NOUN	NN	_	26	compound	_	_
26	receptors	_	NOUN	NNS	_	19	nmod	_	_
27	,	_	.	,	_	3	punct	_	_
28	and	_	CONJ	CC	_	3	cc	_	_
29	is	_	VERB	VBZ	_	31	cop	_	_
30	an	_	DET	DT	_	31	det	_	_
31	antagonist	_	NOUN	NN	_	3	conj	_	_
32	at	_	ADP	IN	_	36	case	_	_
33	the	_	DET	DT	_	36	det	_	_
34	A2A	_	NOUN	NN	_	36	compound	_	_
35	adrenergic	_	ADJ	JJ	_	36	amod	_	_
36	receptors	_	NOUN	NNS	_	31	nmod	_	_
37	Ki=41	_	NOUN	NN	_	38	compound	_	_
38	nM	_	NOUN	NN	_	36	dep	_	_

#	Latuda	3690
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	exhibits	_	VERB	VBZ	_	0	root	_	_
3	little	_	ADJ	JJ	_	6	amod	_	_
4	or	_	CONJ	CC	_	3	cc	_	_
5	no	_	DET	DT	_	3	conj	_	_
6	affinity	_	NOUN	NN	_	2	dobj	_	_
7	for	_	ADP	IN	_	9	case	_	_
8	histamine	_	NOUN	NN	_	9	compound	_	_
9	H1	_	NOUN	NN	_	6	nmod	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	muscarinic	_	ADJ	JJ	_	13	amod	_	_
12	M1	_	NOUN	NN	_	13	compound	_	_
13	receptors	_	NOUN	NNS	_	9	conj	_	_
14	IC50	_	NOUN	NN	_	17	compound	_	_
15	>	_	NUM	CD	_	17	nummod	_	_
16	1,000	_	NUM	CD	_	17	nummod	_	_
17	nM	_	NOUN	NN	_	13	dep	_	_

#	Latuda	3691
1	ECG	_	NOUN	NN	_	2	nsubj	_	_
2	Changes	_	VERB	VBZ	_	0	root	_	_
3	The	_	DET	DT	_	4	det	_	_
4	effects	_	NOUN	NNS	_	2	dobj	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	on	_	ADP	IN	_	10	case	_	_
8	the	_	DET	DT	_	10	det	_	_
9	QTc	_	NOUN	NN	_	10	compound	_	_
10	interval	_	NOUN	NN	_	4	nmod	_	_
11	were	_	VERB	VBD	_	12	auxpass	_	_
12	evaluated	_	VERB	VBN	_	2	parataxis	_	_
13	in	_	ADP	IN	_	18	case	_	_
14	a	_	DET	DT	_	18	det	_	_
15	randomized	_	ADJ	JJ	_	18	amod	_	_
16	,	_	.	,	_	15	punct	_	_
17	double	_	ADJ	JJ	_	15	dep	_	_
18	blind	_	NOUN	NN	_	12	nmod	_	_
19	,	_	.	,	_	18	punct	_	_
20	multiple	_	ADJ	JJ	_	21	amod	_	_
21	dose	_	NOUN	NN	_	18	appos	_	_
22	,	_	.	,	_	18	punct	_	_
23	parallel	_	NOUN	NN	_	18	amod	_	_
24	dedicated	_	VERB	VBN	_	18	acl	_	_
25	thorough	_	ADP	IN	_	27	case	_	_
26	QT	_	NOUN	NN	_	27	compound	_	_
27	study	_	NOUN	NN	_	24	nmod	_	_
28	in	_	ADP	IN	_	30	case	_	_
29	43	_	NUM	CD	_	30	nummod	_	_
30	patients	_	NOUN	NNS	_	24	nmod	_	_
31	with	_	ADP	IN	_	32	case	_	_
32	schizophrenia	_	NOUN	NN	_	30	nmod	_	_
33	or	_	CONJ	CC	_	32	cc	_	_
34	schizoaffective	_	ADJ	JJ	_	35	amod	_	_
35	disorder	_	NOUN	NN	_	32	conj	_	_
36	,	_	.	,	_	30	punct	_	_
37	who	_	DET	WDT	_	39	nsubjpass	_	_
38	were	_	VERB	VBD	_	39	auxpass	_	_
39	treated	_	VERB	VBN	_	30	acl:relcl	_	_
40	with	_	ADP	IN	_	42	case	_	_
41	DRUG	_	NOUN	NN	_	42	compound	_	_
42	doses	_	NOUN	NNS	_	39	nmod	_	_
43	of	_	ADP	IN	_	45	case	_	_
44	120	_	NUM	CD	_	45	nummod	_	_
45	mg	_	NOUN	NN	_	42	nmod	_	_
46	daily	_	ADV	RB	_	49	advmod	_	_
47	,	_	.	,	_	49	punct	_	_
48	600	_	NUM	CD	_	49	nummod	_	_
49	mg	_	NOUN	NN	_	39	nmod	_	_
50	daily	_	ADV	RB	_	49	advmod	_	_
51	and	_	CONJ	CC	_	49	cc	_	_
52	completed	_	VERB	VBD	_	49	conj	_	_
53	the	_	DET	DT	_	54	det	_	_
54	study	_	NOUN	NN	_	52	dobj	_	_

#	Latuda	3692
1	The	_	DET	DT	_	3	det	_	_
2	maximum	_	NOUN	NN	_	3	compound	_	_
3	mean	_	NOUN	NN	_	0	root	_	_
4	upper	_	NOUN	NN	_	6	case	_	_
5	1	_	NUM	CD	_	6	nummod	_	_
6	sided	_	ADJ	JJ	_	3	acl	_	_
7	,	_	.	,	_	3	punct	_	_
8	95%	_	ADJ	JJ	_	10	amod	_	_
9	CI	_	NOUN	NN	_	10	compound	_	_
10	increase	_	NOUN	NN	_	25	nsubj	_	_
11	in	_	ADP	IN	_	15	case	_	_
12	baseline	_	NOUN	NN	_	15	compound	_	_
13	adjusted	_	VERB	VBN	_	15	amod	_	_
14	QTc	_	NOUN	NN	_	15	compound	_	_
15	intervals	_	NOUN	NNS	_	10	nmod	_	_
16	based	_	VERB	VBN	_	15	acl	_	_
17	on	_	ADP	IN	_	21	case	_	_
18	individual	_	ADJ	JJ	_	21	amod	_	_
19	correction	_	NOUN	NN	_	21	compound	_	_
20	method	_	NOUN	NN	_	21	compound	_	_
21	QTcI	_	NOUN	NN	_	16	nmod	_	_
22	was	_	VERB	VBD	_	25	cop	_	_
23	7.5	_	NUM	CD	_	25	nummod	_	_
24	11.7	_	NUM	CD	_	25	nummod	_	_
25	ms	_	NOUN	NNS	_	3	appos	_	_
26	and	_	CONJ	CC	_	25	cc	_	_
27	4.6	_	NUM	CD	_	29	nummod	_	_
28	9.5	_	NUM	CD	_	29	nummod	_	_
29	ms	_	NOUN	NNS	_	25	conj	_	_
30	,	_	.	,	_	3	punct	_	_
31	for	_	ADP	IN	_	34	case	_	_
32	the	_	DET	DT	_	34	det	_	_
33	120	_	NUM	CD	_	34	nummod	_	_
34	mg	_	NOUN	NN	_	3	nmod	_	_
35	and	_	CONJ	CC	_	34	cc	_	_
36	600	_	NUM	CD	_	39	nummod	_	_
37	mg	_	NOUN	NN	_	39	compound	_	_
38	dose	_	NOUN	NN	_	39	compound	_	_
39	groups	_	NOUN	NNS	_	34	conj	_	_
40	respectively	_	ADV	RB	_	3	advmod	_	_
41	,	_	.	,	_	3	punct	_	_
42	observed	_	VERB	VBN	_	3	acl	_	_
43	at	_	ADP	IN	_	47	case	_	_
44	2	_	NUM	CD	_	46	compound	_	_
45	to	_	PRT	TO	_	46	dep	_	_
46	4	_	NUM	CD	_	47	nummod	_	_
47	hours	_	NOUN	NNS	_	42	nmod	_	_
48	after	_	ADP	IN	_	49	mark	_	_
49	dosing	_	VERB	VBG	_	42	advcl	_	_

#	Latuda	3693
1	In	_	ADP	IN	_	3	case	_	_
2	this	_	DET	DT	_	3	det	_	_
3	study	_	NOUN	NN	_	6	nmod	_	_
4	,	_	.	,	_	6	punct	_	_
5	there	_	DET	EX	_	6	expl	_	_
6	was	_	VERB	VBD	_	0	root	_	_
7	no	_	DET	DT	_	11	neg	_	_
8	apparent	_	ADJ	JJ	_	11	amod	_	_
9	dose	_	NOUN	NN	_	11	compound	_	_
10	exposure	_	NOUN	NN	_	11	compound	_	_
11	response	_	NOUN	NN	_	6	dobj	_	_
12	relationship	_	NOUN	NN	_	11	dep	_	_

#	Latuda	3694
1	In	_	ADP	IN	_	3	case	_	_
2	short	_	ADJ	JJ	_	3	amod	_	_
3	term	_	NOUN	NN	_	6	nmod	_	_
4	,	_	.	,	_	6	punct	_	_
5	placebo	_	NOUN	NN	_	6	nsubj	_	_
6	controlled	_	VERB	VBD	_	0	root	_	_
7	studies	_	NOUN	NNS	_	6	dobj	_	_
8	in	_	ADP	IN	_	9	case	_	_
9	schizophrenia	_	NOUN	NN	_	7	nmod	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	bipolar	_	ADJ	JJ	_	12	amod	_	_
12	depression	_	NOUN	NN	_	9	conj	_	_
13	,	_	.	,	_	6	punct	_	_
14	no	_	DET	DT	_	18	neg	_	_
15	post	_	ADJ	JJ	_	18	amod	_	_
16	baseline	_	NOUN	NN	_	18	compound	_	_
17	QT	_	NOUN	NN	_	18	compound	_	_
18	prolongations	_	NOUN	NNS	_	23	nsubjpass	_	_
19	exceeding	_	VERB	VBG	_	18	acl	_	_
20	500	_	NUM	CD	_	21	nummod	_	_
21	msec	_	NOUN	NN	_	19	dobj	_	_
22	were	_	VERB	VBD	_	23	auxpass	_	_
23	reported	_	VERB	VBN	_	6	parataxis	_	_
24	in	_	ADP	IN	_	25	case	_	_
25	patients	_	NOUN	NNS	_	23	nmod	_	_
26	treated	_	VERB	VBN	_	25	acl	_	_
27	with	_	ADP	IN	_	28	case	_	_
28	DRUG	_	NOUN	NN	_	26	nmod	_	_
29	or	_	CONJ	CC	_	28	cc	_	_
30	placebo	_	NOUN	NN	_	28	conj	_	_

#	Latuda	3695
1	Adults	_	NOUN	NNS	_	0	root	_	_
2	The	_	DET	DT	_	3	det	_	_
3	activity	_	NOUN	NN	_	8	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	is	_	VERB	VBZ	_	8	cop	_	_
7	primarily	_	ADV	RB	_	8	advmod	_	_
8	due	_	ADJ	JJ	_	1	dep	_	_
9	to	_	PRT	TO	_	12	case	_	_
10	the	_	DET	DT	_	12	det	_	_
11	parent	_	NOUN	NN	_	12	compound	_	_
12	drug	_	NOUN	NN	_	8	nmod	_	_

#	Latuda	3696
1	The	_	DET	DT	_	2	det	_	_
2	pharmacokinetics	_	NOUN	NNS	_	7	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	is	_	VERB	VBZ	_	7	cop	_	_
6	dose	_	NOUN	NN	_	7	nmod:npmod	_	_
7	proportional	_	ADJ	JJ	_	0	root	_	_
8	within	_	ADP	IN	_	13	case	_	_
9	a	_	DET	DT	_	13	det	_	_
10	total	_	ADJ	JJ	_	13	amod	_	_
11	daily	_	ADV	RB	_	13	advmod	_	_
12	dose	_	NOUN	NN	_	13	compound	_	_
13	range	_	NOUN	NN	_	7	nmod	_	_
14	of	_	ADP	IN	_	16	case	_	_
15	20	_	NUM	CD	_	16	nummod	_	_
16	mg	_	NOUN	NN	_	13	nmod	_	_
17	to	_	PRT	TO	_	22	case	_	_
18	160	_	NUM	CD	_	22	nummod	_	_
19	mg	_	NOUN	NN	_	22	amod	_	_
20	Steady	_	NOUN	NN	_	22	amod	_	_
21	state	_	NOUN	NN	_	22	compound	_	_
22	concentrations	_	NOUN	NNS	_	13	nmod	_	_
23	of	_	ADP	IN	_	24	case	_	_
24	DRUG	_	NOUN	NN	_	22	nmod	_	_
25	are	_	VERB	VBP	_	26	auxpass	_	_
26	reached	_	VERB	VBN	_	7	parataxis	_	_
27	within	_	ADP	IN	_	29	case	_	_
28	7	_	NUM	CD	_	29	nummod	_	_
29	days	_	NOUN	NNS	_	26	nmod	_	_
30	of	_	ADP	IN	_	31	mark	_	_
31	starting	_	VERB	VBG	_	29	acl	_	_
32	DRUG	_	NOUN	NN	_	31	dobj	_	_

#	Latuda	3697
1	Following	_	ADP	IN	_	2	case	_	_
2	administration	_	NOUN	NN	_	18	nmod	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	40	_	NUM	CD	_	5	nummod	_	_
5	mg	_	NOUN	NN	_	2	nmod	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	,	_	.	,	_	18	punct	_	_
9	the	_	DET	DT	_	14	det	_	_
10	mean	_	ADJ	JJ	_	14	compound	_	_
11	%CV	_	NOUN	NN	_	14	compound	_	_
12	elimination	_	NOUN	NN	_	14	compound	_	_
13	half	_	NOUN	NN	_	14	compound	_	_
14	life	_	NOUN	NN	_	18	nsubj	_	_
15	was	_	VERB	VBD	_	18	cop	_	_
16	18	_	NUM	CD	_	18	nummod	_	_
17	7	_	NUM	CD	_	18	nummod	_	_
18	hours	_	NOUN	NNS	_	0	root	_	_

#	Latuda	3698
1	Absorption	_	NOUN	NN	_	0	root	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	Distribution	_	NOUN	NN	_	1	conj	_	_
4	:	_	.	:	_	1	punct	_	_
5	DRUG	_	NOUN	NN	_	7	nsubjpass	_	_
6	is	_	VERB	VBZ	_	7	auxpass	_	_
7	absorbed	_	VERB	VBN	_	1	dep	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	reaches	_	VERB	VBZ	_	7	conj	_	_
10	peak	_	ADJ	JJ	_	12	amod	_	_
11	serum	_	NOUN	NN	_	12	compound	_	_
12	concentrations	_	NOUN	NNS	_	9	dobj	_	_
13	in	_	ADP	IN	_	17	case	_	_
14	approximately	_	ADV	RB	_	15	advmod	_	_
15	1	_	NUM	CD	_	17	nummod	_	_
16	3	_	NUM	CD	_	17	nummod	_	_
17	hours	_	NOUN	NNS	_	12	nmod	_	_

#	Latuda	3699
1	It	_	PRON	PRP	_	3	nsubjpass	_	_
2	is	_	VERB	VBZ	_	3	auxpass	_	_
3	estimated	_	VERB	VBN	_	0	root	_	_
4	that	_	ADP	IN	_	12	mark	_	_
5	9	_	NUM	CD	_	6	nummod	_	_
6	19%	_	NOUN	NN	_	12	nsubjpass	_	_
7	of	_	ADP	IN	_	10	case	_	_
8	an	_	DET	DT	_	10	det	_	_
9	administered	_	VERB	VBN	_	10	amod	_	_
10	dose	_	NOUN	NN	_	6	nmod	_	_
11	is	_	VERB	VBZ	_	12	auxpass	_	_
12	absorbed	_	VERB	VBN	_	3	root	_	_

#	Latuda	3700
1	Following	_	ADP	IN	_	2	case	_	_
2	administration	_	NOUN	NN	_	20	nmod	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	40	_	NUM	CD	_	5	nummod	_	_
5	mg	_	NOUN	NN	_	2	nmod	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	,	_	.	,	_	20	punct	_	_
9	the	_	DET	DT	_	13	det	_	_
10	mean	_	NOUN	NN	_	13	compound	_	_
11	%CV	_	NOUN	NN	_	13	compound	_	_
12	apparent	_	ADJ	JJ	_	13	amod	_	_
13	volume	_	NOUN	NN	_	20	nsubj	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	distribution	_	NOUN	NN	_	13	nmod	_	_
16	was	_	VERB	VBD	_	20	cop	_	_
17	6173	_	NUM	CD	_	20	nummod	_	_
18	17.2	_	NUM	CD	_	20	nummod	_	_
19	L	_	NOUN	NN	_	20	compound	_	_
20	DRUG	_	NOUN	NN	_	23	nsubjpass	_	_
21	is	_	VERB	VBZ	_	23	auxpass	_	_
22	highly	_	ADV	RB	_	23	advmod	_	_
23	bound	_	VERB	VBN	_	0	root	_	_
24	~99%	_	NOUN	NN	_	23	xcomp	_	_
25	to	_	PRT	TO	_	27	case	_	_
26	serum	_	NOUN	NN	_	27	compound	_	_
27	proteins	_	NOUN	NNS	_	24	nmod	_	_

#	Latuda	3701
1	In	_	ADP	IN	_	5	case	_	_
2	a	_	DET	DT	_	5	det	_	_
3	food	_	NOUN	NN	_	5	compound	_	_
4	effect	_	NOUN	NN	_	5	compound	_	_
5	study	_	NOUN	NN	_	15	nmod	_	_
6	,	_	.	,	_	15	punct	_	_
7	DRUG	_	NOUN	NN	_	9	compound	_	_
8	mean	_	NOUN	NN	_	9	compound	_	_
9	Cmax	_	NOUN	NN	_	15	nsubj	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	AUC	_	NOUN	NN	_	9	conj	_	_
12	were	_	VERB	VBD	_	15	cop	_	_
13	about	_	ADV	RB	_	14	advmod	_	_
14	3	_	NUM	CD	_	15	nummod	_	_
15	times	_	NOUN	NNS	_	0	root	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	2	_	NUM	CD	_	18	nummod	_	_
18	times	_	NOUN	NNS	_	15	conj	_	_
19	,	_	.	,	_	15	punct	_	_
20	respectively	_	ADV	RB	_	15	advmod	_	_
21	,	_	.	,	_	15	punct	_	_
22	when	_	ADV	RB	_	23	advmod	_	_
23	administered	_	VERB	VBN	_	15	dep	_	_
24	with	_	ADP	IN	_	25	case	_	_
25	food	_	NOUN	NN	_	23	nmod	_	_
26	compared	_	VERB	VBN	_	23	dep	_	_
27	to	_	PRT	TO	_	29	case	_	_
28	the	_	DET	DT	_	29	det	_	_
29	levels	_	NOUN	NNS	_	26	nmod	_	_
30	observed	_	VERB	VBN	_	29	acl	_	_
31	under	_	ADP	IN	_	33	case	_	_
32	fasting	_	VERB	VBG	_	33	amod	_	_
33	conditions	_	NOUN	NNS	_	30	nmod	_	_

#	Latuda	3702
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	exposure	_	NOUN	NN	_	5	nsubjpass	_	_
3	was	_	VERB	VBD	_	5	auxpass	_	_
4	not	_	ADV	RB	_	5	neg	_	_
5	affected	_	VERB	VBN	_	0	root	_	_
6	as	_	ADP	IN	_	8	case	_	_
7	meal	_	ADJ	JJ	_	8	amod	_	_
8	size	_	NOUN	NN	_	5	nmod	_	_
9	was	_	VERB	VBD	_	10	auxpass	_	_
10	increased	_	VERB	VBN	_	5	parataxis	_	_
11	from	_	ADP	IN	_	15	case	_	_
12	350	_	NUM	CD	_	14	compound	_	_
13	to	_	PRT	TO	_	14	dep	_	_
14	1000	_	NUM	CD	_	15	nummod	_	_
15	calories	_	NOUN	NNS	_	10	nmod	_	_
16	and	_	CONJ	CC	_	10	cc	_	_
17	was	_	VERB	VBD	_	18	cop	_	_
18	independent	_	ADJ	JJ	_	10	conj	_	_
19	of	_	ADP	IN	_	22	case	_	_
20	meal	_	ADJ	JJ	_	22	amod	_	_
21	fat	_	NOUN	NN	_	22	compound	_	_
22	content	_	NOUN	NN	_	18	nmod	_	_

#	Latuda	3703
1	In	_	ADP	IN	_	3	case	_	_
2	clinical	_	ADJ	JJ	_	3	amod	_	_
3	studies	_	NOUN	NNS	_	15	nmod	_	_
4	,	_	.	,	_	15	punct	_	_
5	establishing	_	VERB	VBG	_	15	advcl	_	_
6	the	_	DET	DT	_	7	det	_	_
7	safety	_	NOUN	NN	_	5	dobj	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	efficacy	_	NOUN	NN	_	7	conj	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	7	nmod	_	_
12	,	_	.	,	_	15	punct	_	_
13	patients	_	NOUN	NNS	_	15	nsubjpass	_	_
14	were	_	VERB	VBD	_	15	auxpass	_	_
15	instructed	_	VERB	VBN	_	0	root	_	_
16	to	_	PRT	TO	_	17	mark	_	_
17	take	_	VERB	VB	_	15	xcomp	_	_
18	their	_	PRON	PRP$	_	20	nmod:poss	_	_
19	daily	_	ADV	RB	_	20	amod	_	_
20	dose	_	NOUN	NN	_	17	dobj	_	_
21	with	_	ADP	IN	_	22	case	_	_
22	food	_	NOUN	NN	_	20	nmod	_	_

#	Latuda	3704
1	Metabolism	_	NOUN	NN	_	0	root	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	Elimination	_	NOUN	NN	_	1	conj	_	_
4	:	_	.	:	_	1	punct	_	_
5	DRUG	_	NOUN	NN	_	7	nsubjpass	_	_
6	is	_	VERB	VBZ	_	7	auxpass	_	_
7	metabolized	_	VERB	VBN	_	1	dep	_	_
8	mainly	_	ADV	RB	_	7	advmod	_	_
9	via	_	ADP	IN	_	10	case	_	_
10	CYP3A4	_	NOUN	NN	_	7	nmod	_	_

#	Latuda	3705
1	The	_	DET	DT	_	4	det	_	_
2	major	_	ADJ	JJ	_	4	amod	_	_
3	biotransformation	_	NOUN	NN	_	4	compound	_	_
4	pathways	_	NOUN	NNS	_	8	nsubj	_	_
5	are	_	VERB	VBP	_	8	cop	_	_
6	oxidative	_	ADJ	JJ	_	8	amod	_	_
7	N	_	NOUN	NN	_	8	compound	_	_
8	dealkylation	_	NOUN	NN	_	0	root	_	_
9	,	_	.	,	_	8	punct	_	_
10	hydroxylation	_	NOUN	NN	_	8	conj	_	_
11	of	_	ADP	IN	_	13	case	_	_
12	norbornane	_	NOUN	NN	_	13	compound	_	_
13	ring	_	NOUN	NN	_	10	nmod	_	_
14	,	_	.	,	_	8	punct	_	_
15	and	_	CONJ	CC	_	8	cc	_	_
16	S	_	NOUN	NN	_	17	compound	_	_
17	oxidation	_	NOUN	NN	_	8	conj	_	_

#	Latuda	3706
1	DRUG	_	NOUN	NN	_	3	nsubjpass	_	_
2	is	_	VERB	VBZ	_	3	auxpass	_	_
3	metabolized	_	VERB	VBN	_	0	root	_	_
4	into	_	ADP	IN	_	7	case	_	_
5	two	_	NUM	CD	_	7	nummod	_	_
6	active	_	ADJ	JJ	_	7	amod	_	_
7	metabolites	_	NOUN	NNS	_	3	nmod	_	_
8	ID	_	NOUN	NN	_	7	dep	_	_
9	14283	_	NUM	CD	_	8	nummod	_	_
10	and	_	CONJ	CC	_	8	cc	_	_
11	ID	_	NOUN	NN	_	8	conj	_	_
12	14326	_	NUM	CD	_	11	nummod	_	_
13	and	_	CONJ	CC	_	11	cc	_	_
14	two	_	NUM	CD	_	18	nummod	_	_
15	major	_	ADJ	JJ	_	18	amod	_	_
16	non	_	ADJ	JJ	_	18	amod	_	_
17	active	_	ADJ	JJ	_	18	amod	_	_
18	metabolites	_	NOUN	NNS	_	11	conj	_	_
19	ID	_	NOUN	NN	_	18	dep	_	_
20	20219	_	NUM	CD	_	19	nummod	_	_
21	and	_	CONJ	CC	_	19	cc	_	_
22	ID	_	NOUN	NN	_	19	conj	_	_
23	20220	_	NUM	CD	_	22	nummod	_	_

#	Latuda	3707
1	Based	_	VERB	VBN	_	11	advcl	_	_
2	on	_	ADP	IN	_	5	case	_	_
3	in	_	X	FW	_	5	amod	_	_
4	vitro	_	X	FW	_	3	dep	_	_
5	studies	_	NOUN	NNS	_	1	nmod	_	_
6	,	_	.	,	_	11	punct	_	_
7	DRUG	_	NOUN	NN	_	11	nsubj	_	_
8	is	_	VERB	VBZ	_	11	cop	_	_
9	not	_	ADV	RB	_	11	neg	_	_
10	a	_	DET	DT	_	11	det	_	_
11	substrate	_	NOUN	NN	_	0	root	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	CYP1A1	_	NOUN	NN	_	11	nmod	_	_
14	,	_	.	,	_	13	punct	_	_
15	CYP1A2	_	NOUN	NN	_	13	conj	_	_
16	,	_	.	,	_	13	punct	_	_
17	CYP2A6	_	NOUN	NN	_	13	conj	_	_
18	,	_	.	,	_	13	punct	_	_
19	CYP4A11	_	NOUN	NN	_	13	conj	_	_
20	,	_	.	,	_	13	punct	_	_
21	CYP2B6	_	NOUN	NN	_	13	conj	_	_
22	,	_	.	,	_	13	punct	_	_
23	CYP2C8	_	NOUN	NN	_	13	conj	_	_
24	,	_	.	,	_	13	punct	_	_
25	CYP2C9	_	NOUN	NN	_	13	conj	_	_
26	,	_	.	,	_	13	punct	_	_
27	CYP2C19	_	NOUN	NN	_	13	conj	_	_
28	,	_	.	,	_	13	punct	_	_
29	CYP2D6	_	NOUN	NN	_	13	conj	_	_
30	or	_	CONJ	CC	_	13	cc	_	_
31	CYP2E1	_	NOUN	NN	_	13	conj	_	_
32	enzymes	_	NOUN	NNS	_	13	dep	_	_

#	Latuda	3708
1	Because	_	ADP	IN	_	6	mark	_	_
2	DRUG	_	NOUN	NN	_	6	nsubj	_	_
3	is	_	VERB	VBZ	_	6	cop	_	_
4	not	_	ADV	RB	_	6	neg	_	_
5	a	_	DET	DT	_	6	det	_	_
6	substrate	_	NOUN	NN	_	13	advcl	_	_
7	for	_	ADP	IN	_	8	case	_	_
8	CYP1A2	_	NOUN	NN	_	6	nmod	_	_
9	,	_	.	,	_	13	punct	_	_
10	smoking	_	NOUN	NN	_	13	nsubjpass	_	_
11	is	_	VERB	VBZ	_	13	auxpass	_	_
12	not	_	ADV	RB	_	13	neg	_	_
13	expected	_	VERB	VBN	_	0	root	_	_
14	to	_	PRT	TO	_	15	mark	_	_
15	have	_	VERB	VB	_	13	xcomp	_	_
16	an	_	DET	DT	_	17	det	_	_
17	effect	_	NOUN	NN	_	15	dobj	_	_
18	on	_	ADP	IN	_	20	case	_	_
19	the	_	DET	DT	_	20	det	_	_
20	pharmacokinetics	_	NOUN	NNS	_	17	nmod	_	_
21	of	_	ADP	IN	_	22	case	_	_
22	DRUG	_	NOUN	NN	_	20	nmod	_	_

#	Latuda	3709
1	Transporter	_	NOUN	NN	_	2	compound	_	_
2	proteins	_	NOUN	NNS	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	In	_	X	FW	_	6	amod	_	_
5	vitro	_	X	FW	_	4	dep	_	_
6	studies	_	NOUN	NNS	_	7	nsubj	_	_
7	suggest	_	VERB	VBP	_	2	dep	_	_
8	DRUG	_	NOUN	NN	_	7	dobj	_	_
9	is	_	VERB	VBZ	_	12	cop	_	_
10	not	_	ADV	RB	_	12	neg	_	_
11	a	_	DET	DT	_	12	det	_	_
12	substrate	_	NOUN	NN	_	7	advcl	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	OATP1B1	_	NOUN	NN	_	12	nmod	_	_
15	or	_	CONJ	CC	_	14	cc	_	_
16	OATP1B3	_	NOUN	NN	_	14	conj	_	_
17	,	_	.	,	_	7	punct	_	_
18	however	_	ADV	RB	_	7	advmod	_	_
19	,	_	.	,	_	7	punct	_	_
20	is	_	VERB	VBZ	_	23	cop	_	_
21	probably	_	ADV	RB	_	23	advmod	_	_
22	a	_	DET	DT	_	23	det	_	_
23	substrate	_	NOUN	NN	_	7	parataxis	_	_
24	of	_	ADP	IN	_	26	case	_	_
25	P	_	NOUN	NN	_	26	compound	_	_
26	gp	_	NOUN	NN	_	23	nmod	_	_
27	and	_	CONJ	CC	_	26	cc	_	_
28	BCRP	_	NOUN	NN	_	26	conj	_	_

#	Latuda	3710
1	In	_	X	FW	_	3	amod	_	_
2	vitro	_	X	FW	_	1	dep	_	_
3	studies	_	NOUN	NNS	_	4	nsubj	_	_
4	indicate	_	VERB	VBP	_	0	root	_	_
5	that	_	ADP	IN	_	9	mark	_	_
6	DRUG	_	NOUN	NN	_	9	nsubjpass	_	_
7	is	_	VERB	VBZ	_	9	auxpass	_	_
8	not	_	ADV	RB	_	9	neg	_	_
9	expected	_	VERB	VBN	_	4	ccomp	_	_
10	to	_	PRT	TO	_	11	mark	_	_
11	inhibit	_	VERB	VB	_	9	xcomp	_	_
12	transporters	_	NOUN	NNS	_	11	dobj	_	_
13	OATP1B1	_	NOUN	NN	_	12	dep	_	_
14	,	_	.	,	_	13	punct	_	_
15	OATP1B3	_	NOUN	NN	_	13	conj	_	_
16	,	_	.	,	_	13	punct	_	_
17	OCT1	_	NOUN	NN	_	13	conj	_	_
18	,	_	.	,	_	13	punct	_	_
19	OCT2	_	NOUN	NN	_	13	conj	_	_
20	,	_	.	,	_	13	punct	_	_
21	OAT1	_	NOUN	NN	_	13	conj	_	_
22	,	_	.	,	_	13	punct	_	_
23	OAT3	_	NOUN	NN	_	13	conj	_	_
24	,	_	.	,	_	13	punct	_	_
25	MATE1	_	NOUN	NN	_	13	conj	_	_
26	,	_	.	,	_	13	punct	_	_
27	MATE2	_	NOUN	NN	_	28	compound	_	_
28	K	_	NOUN	NN	_	13	conj	_	_
29	and	_	CONJ	CC	_	13	cc	_	_
30	BSEP	_	NOUN	NN	_	13	conj	_	_
31	at	_	ADP	IN	_	34	case	_	_
32	clinically	_	ADV	RB	_	33	advmod	_	_
33	relevant	_	ADJ	JJ	_	34	amod	_	_
34	concentrations	_	NOUN	NNS	_	11	nmod	_	_

#	Latuda	3711
1	DRUG	_	NOUN	NN	_	7	nsubj	_	_
2	is	_	VERB	VBZ	_	7	cop	_	_
3	not	_	ADV	RB	_	7	neg	_	_
4	a	_	DET	DT	_	7	det	_	_
5	clinically	_	ADV	RB	_	6	advmod	_	_
6	significant	_	ADJ	JJ	_	7	amod	_	_
7	inhibitor	_	NOUN	NN	_	0	root	_	_
8	of	_	ADP	IN	_	10	case	_	_
9	P	_	NOUN	NN	_	10	compound	_	_
10	gp	_	NOUN	NN	_	7	nmod	_	_

#	Latuda	3712
1	Total	_	ADJ	JJ	_	2	amod	_	_
2	excretion	_	NOUN	NN	_	12	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	radioactivity	_	NOUN	NN	_	2	nmod	_	_
5	in	_	ADP	IN	_	6	case	_	_
6	urine	_	ADJ	JJ	_	2	nmod	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	feces	_	NOUN	NNS	_	6	conj	_	_
9	combined	_	VERB	VBN	_	6	acl	_	_
10	was	_	VERB	VBD	_	12	cop	_	_
11	approximately	_	ADV	RB	_	12	advmod	_	_
12	89%	_	ADJ	JJ	_	0	root	_	_
13	,	_	.	,	_	12	punct	_	_
14	with	_	ADP	IN	_	16	case	_	_
15	about	_	ADV	RB	_	16	advmod	_	_
16	80%	_	NOUN	NN	_	12	nmod	_	_
17	recovered	_	VERB	VBN	_	16	acl	_	_
18	in	_	ADP	IN	_	19	case	_	_
19	feces	_	NOUN	NNS	_	17	nmod	_	_
20	and	_	CONJ	CC	_	19	cc	_	_
21	9%	_	NOUN	NN	_	19	conj	_	_
22	recovered	_	VERB	VBN	_	19	acl	_	_
23	in	_	ADP	IN	_	24	case	_	_
24	urine	_	ADJ	JJ	_	22	nmod	_	_
25	,	_	.	,	_	12	punct	_	_
26	after	_	ADP	IN	_	29	case	_	_
27	a	_	DET	DT	_	29	det	_	_
28	single	_	ADJ	JJ	_	29	amod	_	_
29	dose	_	NOUN	NN	_	12	nmod	_	_
30	of	_	ADP	IN	_	33	case	_	_
31	14C	_	NOUN	NN	_	33	compound	_	_
32	labeled	_	VERB	VBN	_	33	amod	_	_
33	DRUG	_	NOUN	NN	_	29	nmod	_	_

#	Latuda	3713
1	Following	_	ADP	IN	_	2	case	_	_
2	administration	_	NOUN	NN	_	17	nmod	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	40	_	NUM	CD	_	5	nummod	_	_
5	mg	_	NOUN	NN	_	2	nmod	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	,	_	.	,	_	17	punct	_	_
9	the	_	DET	DT	_	13	det	_	_
10	mean	_	NOUN	NN	_	13	compound	_	_
11	%CV	_	NOUN	NN	_	13	compound	_	_
12	apparent	_	ADJ	JJ	_	13	amod	_	_
13	clearance	_	NOUN	NN	_	17	nsubj	_	_
14	was	_	VERB	VBD	_	17	cop	_	_
15	3902	_	NUM	CD	_	17	nummod	_	_
16	18.0	_	NUM	CD	_	17	nummod	_	_
17	mL	_	NOUN	NN	_	0	root	_	_
18	/	_	.	:	_	17	punct	_	_
19	min	_	NOUN	NN	_	17	dep	_	_

#	Latuda	3714
1	Drug	_	NOUN	NN	_	3	compound	_	_
2	Interaction	_	NOUN	NN	_	3	compound	_	_
3	Studies	_	NOUN	NNS	_	0	root	_	_
4	:	_	.	:	_	3	punct	_	_
5	Effects	_	NOUN	NNS	_	15	nsubjpass	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	other	_	ADJ	JJ	_	8	amod	_	_
8	drugs	_	NOUN	NNS	_	5	nmod	_	_
9	on	_	ADP	IN	_	11	case	_	_
10	the	_	DET	DT	_	11	det	_	_
11	exposure	_	NOUN	NN	_	5	nmod	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	asenapine	_	NOUN	NN	_	11	nmod	_	_
14	are	_	VERB	VBP	_	15	auxpass	_	_
15	summarized	_	VERB	VBN	_	3	dep	_	_
16	in	_	ADP	IN	_	17	case	_	_
17	Figure	_	NOUN	NN	_	15	nmod	_	_
18	1	_	NUM	CD	_	17	nummod	_	_

#	Latuda	3715
1	A	_	DET	DT	_	4	det	_	_
2	population	_	NOUN	NN	_	4	compound	_	_
3	PK	_	NOUN	NN	_	4	compound	_	_
4	analyses	_	NOUN	NNS	_	5	nsubj	_	_
5	concluded	_	VERB	VBD	_	0	root	_	_
6	that	_	ADP	IN	_	5	root	_	_
7	coadministration	_	NOUN	NN	_	6	root	_	_
8	of	_	ADP	IN	_	12	case	_	_
9	lithium	_	NOUN	NN	_	12	compound	_	_
10	300	_	NUM	CD	_	12	nummod	_	_
11	2400	_	NUM	CD	_	12	nummod	_	_
12	mg	_	NOUN	NN	_	7	nmod	_	_
13	/	_	.	:	_	7	punct	_	_
14	day	_	NOUN	NN	_	7	dep	_	_
15	or	_	CONJ	CC	_	14	cc	_	_
16	valproate	_	NOUN	NN	_	19	compound	_	_
17	300	_	NUM	CD	_	19	nummod	_	_
18	2000	_	NUM	CD	_	19	nummod	_	_
19	mg	_	NOUN	NN	_	14	conj	_	_
20	/	_	.	:	_	7	punct	_	_
21	day	_	NOUN	NN	_	29	nsubj	_	_
22	with	_	ADP	IN	_	23	case	_	_
23	DRUG	_	NOUN	NN	_	21	nmod	_	_
24	for	_	ADP	IN	_	28	case	_	_
25	up	_	ADV	RB	_	27	advmod	_	_
26	to	_	PRT	TO	_	27	dep	_	_
27	6	_	NUM	CD	_	28	nummod	_	_
28	weeks	_	NOUN	NNS	_	21	nmod	_	_
29	has	_	VERB	VBZ	_	7	dep	_	_
30	minimal	_	ADJ	JJ	_	31	amod	_	_
31	effect	_	NOUN	NN	_	29	dobj	_	_
32	on	_	ADP	IN	_	34	case	_	_
33	DRUG	_	NOUN	NN	_	34	compound	_	_
34	exposure	_	NOUN	NN	_	31	nmod	_	_

#	Latuda	3716
1	And	_	CONJ	CC	_	13	advmod	_	_
2	the	_	DET	DT	_	3	det	_	_
3	effects	_	NOUN	NNS	_	13	nsubjpass	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	on	_	ADP	IN	_	8	case	_	_
7	the	_	DET	DT	_	8	det	_	_
8	exposures	_	NOUN	NNS	_	3	nmod	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	other	_	ADJ	JJ	_	11	amod	_	_
11	drugs	_	NOUN	NNS	_	8	nmod	_	_
12	are	_	VERB	VBP	_	13	auxpass	_	_
13	summarized	_	VERB	VBN	_	0	root	_	_
14	in	_	ADP	IN	_	15	case	_	_
15	Figure2	_	NOUN	NN	_	13	nmod	_	_

#	Latuda	3717
1	A	_	DET	DT	_	4	det	_	_
2	population	_	NOUN	NN	_	4	compound	_	_
3	PK	_	NOUN	NN	_	4	compound	_	_
4	analyses	_	NOUN	NNS	_	5	nsubj	_	_
5	concluded	_	VERB	VBD	_	0	root	_	_
6	that	_	ADP	IN	_	10	mark	_	_
7	coadministration	_	NOUN	NN	_	10	nsubj	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	has	_	VERB	VBZ	_	5	ccomp	_	_
11	minimal	_	ADJ	JJ	_	12	amod	_	_
12	effect	_	NOUN	NN	_	10	dobj	_	_
13	on	_	ADP	IN	_	14	case	_	_
14	lithium	_	NOUN	NN	_	10	nmod	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	valproate	_	NOUN	NN	_	14	conj	_	_
17	exposure	_	NOUN	NN	_	14	dep	_	_
18	when	_	ADV	WRB	_	21	advmod	_	_
19	it	_	PRON	PRP	_	21	nsubjpass	_	_
20	is	_	VERB	VBZ	_	21	auxpass	_	_
21	coadministered	_	VERB	VBN	_	10	advcl	_	_
22	with	_	ADP	IN	_	28	case	_	_
23	lithium	_	NOUN	NN	_	28	compound	_	_
24	300	_	NUM	CD	_	28	nummod	_	_
25	2400	_	NUM	CD	_	28	nummod	_	_
26	mg	_	NOUN	NN	_	28	compound	_	_
27	/	_	.	:	_	28	punct	_	_
28	day	_	NOUN	NN	_	21	nmod	_	_
29	or	_	CONJ	CC	_	28	cc	_	_
30	valproate	_	NOUN	NN	_	35	compound	_	_
31	300	_	NUM	CD	_	35	nummod	_	_
32	2000	_	NUM	CD	_	35	nummod	_	_
33	mg	_	NOUN	NN	_	35	compound	_	_
34	/	_	.	:	_	35	punct	_	_
35	day	_	NOUN	NN	_	28	conj	_	_

#	Latuda	3718
1	Figure1	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Impact	_	NOUN	NN	_	1	dep	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	Other	_	ADJ	JJ	_	6	amod	_	_
6	Drugs	_	NOUN	NNS	_	3	nmod	_	_
7	on	_	ADP	IN	_	9	case	_	_
8	DRUG	_	NOUN	NN	_	9	compound	_	_
9	Pharmacokinetics	_	NOUN	NNS	_	3	nmod	_	_

#	Latuda	3719
1	Pediatric	_	ADJ	JJ	_	2	amod	_	_
2	Patients	_	NOUN	NNS	_	25	nsubj	_	_
3	DRUG	_	NOUN	NN	_	4	compound	_	_
4	exposure	_	NOUN	NN	_	2	dep	_	_
5	i.e	_	ADJ	JJ	_	4	amod	_	_
6	,	_	.	,	_	4	punct	_	_
7	steady	_	ADJ	JJ	_	9	amod	_	_
8	state	_	NOUN	NN	_	9	compound	_	_
9	Cmax	_	NOUN	NN	_	4	conj	_	_
10	and	_	CONJ	CC	_	4	cc	_	_
11	AUC	_	NOUN	NN	_	4	conj	_	_
12	in	_	ADP	IN	_	13	case	_	_
13	children	_	NOUN	NN	_	4	nmod	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	adolescent	_	ADJ	JJ	_	16	amod	_	_
16	patients	_	NOUN	NNS	_	13	conj	_	_
17	10	_	NUM	CD	_	16	nummod	_	_
18	to	_	PRT	TO	_	20	case	_	_
19	17	_	NUM	CD	_	20	nummod	_	_
20	years	_	NOUN	NNS	_	4	nmod	_	_
21	of	_	ADP	IN	_	22	case	_	_
22	age	_	NOUN	NN	_	20	nmod	_	_
23	was	_	VERB	VBD	_	25	cop	_	_
24	generally	_	ADV	RB	_	25	advmod	_	_
25	similar	_	ADJ	JJ	_	0	root	_	_
26	to	_	PRT	TO	_	27	case	_	_
27	that	_	DET	WDT	_	25	nmod	_	_
28	in	_	ADP	IN	_	29	case	_	_
29	adults	_	NOUN	NNS	_	27	nmod	_	_
30	across	_	ADP	IN	_	33	case	_	_
31	the	_	DET	DT	_	33	det	_	_
32	dose	_	NOUN	NN	_	33	compound	_	_
33	range	_	NOUN	NN	_	29	nmod	_	_
34	from	_	ADP	IN	_	38	case	_	_
35	40	_	NUM	CD	_	37	compound	_	_
36	to	_	PRT	TO	_	37	dep	_	_
37	160	_	NUM	CD	_	38	nummod	_	_
38	mg	_	NOUN	NN	_	29	nmod	_	_
39	,	_	.	,	_	25	punct	_	_
40	without	_	ADP	IN	_	41	mark	_	_
41	adjusting	_	VERB	VBG	_	25	advcl	_	_
42	for	_	ADP	IN	_	44	case	_	_
43	body	_	NOUN	NN	_	44	compound	_	_
44	weight	_	NOUN	NN	_	41	nmod	_	_

#	Latuda	3720
1	Figure	_	NOUN	NN	_	0	root	_	_
2	3	_	NUM	CD	_	1	nummod	_	_
3	:	_	.	:	_	1	punct	_	_
4	Impact	_	NOUN	NN	_	1	dep	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	Other	_	ADJ	JJ	_	8	amod	_	_
7	Patient	_	NOUN	NN	_	8	compound	_	_
8	Factors	_	NOUN	NNS	_	4	nmod	_	_
9	on	_	ADP	IN	_	11	case	_	_
10	DRUG	_	NOUN	NN	_	11	compound	_	_
11	Pharmacokinetics	_	NOUN	NNS	_	4	nmod	_	_

#	Lipitor	3069
1	The	_	DET	DT	_	2	det	_	_
2	risk	_	NOUN	NN	_	10	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	myopathy	_	NOUN	NN	_	2	nmod	_	_
5	during	_	ADP	IN	_	6	case	_	_
6	treatment	_	NOUN	NN	_	2	nmod	_	_
7	with	_	ADP	IN	_	8	case	_	_
8	statins	_	NOUN	NNS	_	6	nmod	_	_
9	is	_	VERB	VBZ	_	10	auxpass	_	_
10	increased	_	VERB	VBN	_	0	root	_	_
11	with	_	ADP	IN	_	13	case	_	_
12	concurrent	_	ADJ	JJ	_	13	amod	_	_
13	administration	_	NOUN	NN	_	10	nmod	_	_
14	of	_	ADP	IN	_	17	case	_	_
15	fibric	_	ADJ	JJ	_	17	amod	_	_
16	acid	_	NOUN	NN	_	17	compound	_	_
17	derivatives	_	NOUN	NNS	_	13	nmod	_	_
18	,	_	.	,	_	17	punct	_	_
19	lipid	_	NOUN	NN	_	21	compound	_	_
20	modifying	_	VERB	VBG	_	21	compound	_	_
21	doses	_	NOUN	NNS	_	17	appos	_	_
22	of	_	ADP	IN	_	23	case	_	_
23	niacin	_	NOUN	NN	_	21	nmod	_	_
24	,	_	.	,	_	23	punct	_	_
25	cyclosporine	_	NOUN	NN	_	23	conj	_	_
26	,	_	.	,	_	23	punct	_	_
27	or	_	CONJ	CC	_	23	cc	_	_
28	strong	_	ADJ	JJ	_	31	amod	_	_
29	CYP	_	NOUN	NN	_	31	compound	_	_
30	3A4	_	NOUN	NN	_	31	compound	_	_
31	inhibitors	_	NOUN	NNS	_	23	conj	_	_
32	e.g	_	NOUN	NN	_	31	dep	_	_
33	,	_	.	,	_	32	punct	_	_
34	clarithromycin	_	NOUN	NN	_	32	conj	_	_
35	,	_	.	,	_	32	punct	_	_
36	HIV	_	NOUN	NN	_	38	compound	_	_
37	protease	_	NOUN	NN	_	38	compound	_	_
38	inhibitors	_	NOUN	NNS	_	32	conj	_	_
39	,	_	.	,	_	32	punct	_	_
40	and	_	CONJ	CC	_	32	cc	_	_
41	itraconazole	_	NOUN	NN	_	32	conj	_	_

#	Lipitor	3070
1	Drug	_	NOUN	NN	_	2	compound	_	_
2	Interactions	_	NOUN	NNS	_	0	root	_	_
3	Associated	_	VERB	VBN	_	2	acl	_	_
4	with	_	ADP	IN	_	6	case	_	_
5	Increased	_	VERB	VBN	_	6	amod	_	_
6	Risk	_	NOUN	NN	_	3	nmod	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	Myopathy	_	NOUN	NN	_	6	nmod	_	_
9	/	_	.	-LRB-	_	10	punct	_	_
10	Rhabdomyolysis	_	NOUN	NN	_	6	acl	_	_
11	2.6	_	NUM	CD	_	10	nummod	_	_
12	,	_	.	,	_	10	punct	_	_
13	5.1	_	NUM	CD	_	10	conj	_	_
14	,	_	.	,	_	10	punct	_	_
15	7	_	NUM	CD	_	10	conj	_	_
16	,	_	.	,	_	10	punct	_	_
17	12.3	_	NUM	CD	_	19	nummod	_	_
18	Interacting	_	VERB	VBG	_	19	amod	_	_
19	Agents	_	NOUN	NNS	_	10	appos	_	_
20	Prescribing	_	VERB	VBG	_	19	acl	_	_
21	Recommendations	_	NOUN	NNS	_	20	dobj	_	_
22	Cyclosporine	_	NOUN	NN	_	21	dep	_	_
23	,	_	.	,	_	22	punct	_	_
24	HIV	_	NOUN	NN	_	26	compound	_	_
25	protease	_	NOUN	NN	_	26	compound	_	_
26	inhibitors	_	NOUN	NNS	_	22	conj	_	_
27	tipranavir	_	NOUN	NN	_	26	dep	_	_
28	plus	_	CONJ	CC	_	27	cc	_	_
29	ritonavir	_	NOUN	NN	_	27	conj	_	_
30	,	_	.	,	_	22	punct	_	_
31	hepatitis	_	NOUN	NN	_	40	compound	_	_
32	C	_	NOUN	NN	_	40	compound	_	_
33	protease	_	NOUN	NN	_	40	compound	_	_
34	inhibitor	_	NOUN	NN	_	40	compound	_	_
35	telaprevir	_	ADJ	JJ	_	40	amod	_	_
36	Avoid	_	ADJ	JJ	_	40	amod	_	_
37	DRUG	_	NOUN	NN	_	40	compound	_	_
38	HIV	_	NOUN	NN	_	40	compound	_	_
39	protease	_	NOUN	NN	_	40	compound	_	_
40	inhibitor	_	NOUN	NN	_	44	compound	_	_
41	lopinavir	_	ADJ	JJ	_	44	amod	_	_
42	plus	_	CONJ	CC	_	41	cc	_	_
43	ritonavir	_	ADJ	JJ	_	41	conj	_	_
44	Use	_	NOUN	NN	_	22	appos	_	_
45	with	_	ADP	IN	_	46	case	_	_
46	caution	_	NOUN	NN	_	44	nmod	_	_
47	and	_	CONJ	CC	_	46	cc	_	_
48	lowest	_	ADJ	JJ	_	51	amod	_	_
49	dose	_	NOUN	NN	_	51	compound	_	_
50	necessary	_	ADJ	JJ	_	51	amod	_	_
51	Clarithromycin	_	NOUN	NN	_	46	conj	_	_
52	,	_	.	,	_	51	punct	_	_
53	itraconazole	_	NOUN	NN	_	51	conj	_	_
54	,	_	.	,	_	51	punct	_	_
55	HIV	_	NOUN	NN	_	57	compound	_	_
56	protease	_	NOUN	NN	_	57	compound	_	_
57	inhibitors	_	NOUN	NNS	_	88	nsubj	_	_
58	saquinavir	_	NOUN	NN	_	57	dep	_	_
59	plus	_	CONJ	CC	_	58	cc	_	_
60	ritonavir	_	NOUN	NN	_	58	conj	_	_
61	,	_	.	,	_	58	punct	_	_
62	darunavir	_	NOUN	NN	_	58	conj	_	_
63	plus	_	CONJ	CC	_	58	cc	_	_
64	ritonavir	_	NOUN	NN	_	58	conj	_	_
65	,	_	.	,	_	58	punct	_	_
66	fosamprenavir	_	NOUN	NN	_	58	conj	_	_
67	,	_	.	,	_	58	punct	_	_
68	fosamprenavir	_	NOUN	NN	_	58	conj	_	_
69	plus	_	CONJ	CC	_	58	cc	_	_
70	ritonavir	_	NOUN	NN	_	71	compound	_	_
71	Do	_	NOUN	NN	_	73	nsubj	_	_
72	not	_	ADV	RB	_	73	neg	_	_
73	exceed	_	VERB	VBD	_	58	conj	_	_
74	20	_	NUM	CD	_	76	nummod	_	_
75	mg	_	NOUN	NN	_	76	compound	_	_
76	DRUG	_	NOUN	NN	_	73	dobj	_	_
77	daily	_	ADV	RB	_	88	advmod	_	_
78	HIV	_	NOUN	NN	_	86	compound	_	_
79	protease	_	NOUN	NN	_	86	compound	_	_
80	inhibitor	_	NOUN	NN	_	86	compound	_	_
81	nelfinavir)Hepatitis	_	NOUN	NN	_	86	compound	_	_
82	C	_	NOUN	NN	_	86	compound	_	_
83	protease	_	NOUN	NN	_	86	compound	_	_
84	inhibitor	_	NOUN	NN	_	86	compound	_	_
85	boceprevir	_	ADJ	JJ	_	86	compound	_	_
86	Do	_	NOUN	NN	_	88	nsubj	_	_
87	not	_	ADV	RB	_	88	neg	_	_
88	exceed	_	VERB	VBD	_	51	acl:relcl	_	_
89	40	_	NUM	CD	_	91	nummod	_	_
90	mg	_	NOUN	NN	_	91	compound	_	_
91	DRUG	_	NOUN	NN	_	88	dobj	_	_
92	daily	_	ADV	RB	_	93	advmod	_	_
93	Other	_	ADJ	JJ	_	88	advcl	_	_
94	Lipid	_	NOUN	NN	_	96	compound	_	_
95	Lowering	_	NOUN	NN	_	96	compound	_	_
96	Medications	_	NOUN	NNS	_	93	dobj	_	_
97	:	_	.	:	_	10	punct	_	_
98	Use	_	NOUN	NN	_	10	dep	_	_
99	with	_	ADP	IN	_	101	case	_	_
100	fibrate	_	ADJ	JJ	_	101	amod	_	_
101	products	_	NOUN	NNS	_	98	nmod	_	_
102	or	_	CONJ	CC	_	101	cc	_	_
103	lipid	_	NOUN	NN	_	104	compound	_	_
104	modifying	_	VERB	VBG	_	101	conj	_	_
105	doses	_	NOUN	NNS	_	107	compound	_	_
106	>1	_	NUM	CD	_	107	nummod	_	_
107	g	_	NOUN	NN	_	104	dobj	_	_
108	/	_	.	:	_	10	punct	_	_
109	day	_	NOUN	NN	_	112	nsubj	_	_
110	of	_	ADP	IN	_	111	case	_	_
111	niacin	_	NOUN	NN	_	109	nmod	_	_
112	increases	_	VERB	VBZ	_	10	dep	_	_
113	the	_	DET	DT	_	114	det	_	_
114	risk	_	NOUN	NN	_	112	dobj	_	_
115	of	_	ADP	IN	_	119	case	_	_
116	adverse	_	ADJ	JJ	_	119	amod	_	_
117	skeletal	_	ADJ	JJ	_	119	amod	_	_
118	muscle	_	NOUN	NN	_	119	compound	_	_
119	effects	_	NOUN	NNS	_	114	nmod	_	_

#	Lipitor	3071
1	Caution	_	NOUN	NN	_	4	nsubjpass	_	_
2	should	_	VERB	MD	_	4	aux	_	_
3	be	_	VERB	VB	_	4	auxpass	_	_
4	used	_	VERB	VBN	_	0	root	_	_
5	when	_	ADV	WRB	_	6	advmod	_	_
6	prescribing	_	VERB	VBG	_	4	advcl	_	_
7	with	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	7	_	NUM	CD	_	8	nummod	_	_

#	Lipitor	3072
1	Digoxin	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Patients	_	NOUN	NNS	_	6	nsubjpass	_	_
4	should	_	VERB	MD	_	6	aux	_	_
5	be	_	VERB	VB	_	6	auxpass	_	_
6	monitored	_	VERB	VBN	_	1	dep	_	_
7	appropriately	_	ADV	RB	_	8	advmod	_	_
8	7.8	_	NUM	CD	_	6	neg	_	_

#	Lipitor	3073
1	Oral	_	ADJ	JJ	_	2	amod	_	_
2	Contraceptives	_	NOUN	NNS	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	Values	_	NOUN	NNS	_	12	nsubjpass	_	_
5	for	_	ADP	IN	_	6	case	_	_
6	norethindrone	_	NOUN	NN	_	4	nmod	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	ethinyl	_	ADJ	JJ	_	9	amod	_	_
9	estradiol	_	NOUN	NN	_	6	conj	_	_
10	may	_	VERB	MD	_	12	aux	_	_
11	be	_	VERB	VB	_	12	auxpass	_	_
12	increased	_	VERB	VBN	_	2	dep	_	_
13	7.9	_	NUM	CD	_	12	neg	_	_

#	Lipitor	3074
1	Rifampin	_	NOUN	NN	_	6	nsubjpass	_	_
2	should	_	VERB	MD	_	6	aux	_	_
3	be	_	VERB	VB	_	6	auxpass	_	_
4	simultaneously	_	ADV	RB	_	6	advmod	_	_
5	co	_	PRT	TO	_	6	punct	_	_
6	administered	_	VERB	VBN	_	0	root	_	_
7	with	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	7.7	_	NUM	CD	_	8	nummod	_	_

#	Lipitor	3075
1	DRUG	_	NOUN	NN	_	3	nsubjpass	_	_
2	is	_	VERB	VBZ	_	3	auxpass	_	_
3	metabolized	_	VERB	VBN	_	0	root	_	_
4	by	_	ADP	IN	_	7	case	_	_
5	cytochrome	_	NOUN	NN	_	7	compound	_	_
6	P450	_	NOUN	NN	_	7	compound	_	_
7	3A4	_	NOUN	NN	_	3	nmod	_	_

#	Lipitor	3076
1	Concomitant	_	ADJ	JJ	_	2	amod	_	_
2	administration	_	NOUN	NN	_	12	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	with	_	ADP	IN	_	7	case	_	_
6	strong	_	ADJ	JJ	_	7	amod	_	_
7	inhibitors	_	NOUN	NNS	_	2	nmod	_	_
8	of	_	ADP	IN	_	10	case	_	_
9	CYP	_	NOUN	NN	_	10	compound	_	_
10	3A4	_	NOUN	NN	_	7	nmod	_	_
11	can	_	VERB	MD	_	12	aux	_	_
12	lead	_	VERB	VB	_	0	root	_	_
13	to	_	PRT	TO	_	14	case	_	_
14	increases	_	NOUN	NNS	_	12	nmod	_	_
15	in	_	ADP	IN	_	17	case	_	_
16	plasma	_	NOUN	NN	_	17	compound	_	_
17	concentrations	_	NOUN	NNS	_	14	nmod	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	DRUG	_	NOUN	NN	_	17	nmod	_	_

#	Lipitor	3077
1	The	_	DET	DT	_	2	det	_	_
2	extent	_	NOUN	NN	_	9	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	interaction	_	NOUN	NN	_	2	nmod	_	_
5	and	_	CONJ	CC	_	2	cc	_	_
6	potentiation	_	NOUN	NN	_	2	conj	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	effects	_	NOUN	NNS	_	6	nmod	_	_
9	depend	_	VERB	VBP	_	0	root	_	_
10	on	_	ADP	IN	_	12	case	_	_
11	the	_	DET	DT	_	12	det	_	_
12	variability	_	NOUN	NN	_	9	nmod	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	effect	_	NOUN	NN	_	12	nmod	_	_
15	on	_	ADP	IN	_	17	case	_	_
16	CYP	_	NOUN	NN	_	17	compound	_	_
17	3A4	_	NOUN	NN	_	14	nmod	_	_

#	Lipitor	3078
1	Clarithromycin	_	NOUN	NN	_	3	compound	_	_
2	DRUG	_	NOUN	NN	_	3	compound	_	_
3	AUC	_	NOUN	NN	_	6	nsubjpass	_	_
4	was	_	VERB	VBD	_	6	auxpass	_	_
5	significantly	_	ADV	RB	_	6	advmod	_	_
6	increased	_	VERB	VBN	_	0	root	_	_
7	with	_	ADP	IN	_	9	case	_	_
8	concomitant	_	ADJ	JJ	_	9	amod	_	_
9	administration	_	NOUN	NN	_	6	nmod	_	_
10	of	_	ADP	IN	_	13	case	_	_
11	DRUG	_	NOUN	NN	_	13	compound	_	_
12	80	_	NUM	CD	_	13	nummod	_	_
13	mg	_	NOUN	NN	_	9	nmod	_	_
14	with	_	ADP	IN	_	17	case	_	_
15	clarithromycin	_	NOUN	NN	_	17	compound	_	_
16	500	_	NUM	CD	_	17	nummod	_	_
17	mg	_	NOUN	NN	_	9	nmod	_	_
18	twice	_	ADV	RB	_	20	advmod	_	_
19	daily	_	ADV	RB	_	20	advmod	_	_
20	compared	_	VERB	VBN	_	6	advcl	_	_
21	to	_	PRT	TO	_	22	case	_	_
22	that	_	DET	DT	_	20	nmod	_	_
23	of	_	ADP	IN	_	24	case	_	_
24	DRUG	_	NOUN	NN	_	22	nmod	_	_
25	alone	_	ADV	RB	_	24	advmod	_	_

#	Lipitor	3079
1	Therefore	_	ADV	RB	_	11	advmod	_	_
2	,	_	.	,	_	11	punct	_	_
3	in	_	ADP	IN	_	4	case	_	_
4	patients	_	NOUN	NNS	_	11	nmod	_	_
5	taking	_	VERB	VBG	_	4	acl	_	_
6	clarithromycin	_	NOUN	NN	_	5	dobj	_	_
7	,	_	.	,	_	11	punct	_	_
8	caution	_	NOUN	NN	_	11	nsubjpass	_	_
9	should	_	VERB	MD	_	11	aux	_	_
10	be	_	VERB	VB	_	11	auxpass	_	_
11	used	_	VERB	VBN	_	0	root	_	_
12	when	_	ADV	WRB	_	16	advmod	_	_
13	the	_	DET	DT	_	15	det	_	_
14	DRUG	_	NOUN	NN	_	15	compound	_	_
15	dose	_	NOUN	NN	_	16	nsubj	_	_
16	exceeds	_	VERB	VBZ	_	11	ccomp	_	_
17	20	_	NUM	CD	_	18	nummod	_	_
18	mg	_	NOUN	NNS	_	16	dobj	_	_

#	Lipitor	3080
1	Combination	_	NOUN	NN	_	0	root	_	_
2	of	_	ADP	IN	_	4	case	_	_
3	Protease	_	NOUN	NN	_	4	compound	_	_
4	Inhibitors	_	NOUN	NNS	_	1	nmod	_	_
5	:	_	.	:	_	1	punct	_	_
6	DRUG	_	NOUN	NN	_	7	compound	_	_
7	AUC	_	NOUN	NN	_	10	nsubjpass	_	_
8	was	_	VERB	VBD	_	10	auxpass	_	_
9	significantly	_	ADV	RB	_	10	advmod	_	_
10	increased	_	VERB	VBN	_	1	dep	_	_
11	with	_	ADP	IN	_	13	case	_	_
12	concomitant	_	ADJ	JJ	_	13	amod	_	_
13	administration	_	NOUN	NN	_	10	nmod	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	DRUG	_	NOUN	NN	_	13	nmod	_	_
16	with	_	ADP	IN	_	18	case	_	_
17	several	_	ADJ	JJ	_	18	amod	_	_
18	combinations	_	NOUN	NNS	_	13	nmod	_	_
19	of	_	ADP	IN	_	22	case	_	_
20	HIV	_	NOUN	NN	_	22	compound	_	_
21	protease	_	NOUN	NN	_	22	compound	_	_
22	inhibitors	_	NOUN	NNS	_	18	nmod	_	_
23	,	_	.	,	_	22	punct	_	_
24	as	_	ADV	RB	_	22	cc	_	_
25	well	_	ADV	RB	_	24	mwe	_	_
26	as	_	ADP	IN	_	24	mwe	_	_
27	with	_	ADP	IN	_	33	case	_	_
28	the	_	DET	DT	_	33	det	_	_
29	hepatitis	_	NOUN	NN	_	33	compound	_	_
30	C	_	NOUN	NN	_	33	compound	_	_
31	protease	_	NOUN	NN	_	33	compound	_	_
32	inhibitor	_	NOUN	NN	_	33	compound	_	_
33	telaprevir	_	NOUN	NN	_	22	conj	_	_
34	,	_	.	,	_	10	punct	_	_
35	compared	_	VERB	VBN	_	10	xcomp	_	_
36	to	_	PRT	TO	_	37	case	_	_
37	that	_	DET	DT	_	35	nmod	_	_
38	of	_	ADP	IN	_	39	case	_	_
39	DRUG	_	NOUN	NN	_	37	nmod	_	_
40	alone	_	ADV	RB	_	39	advmod	_	_

#	Lipitor	3081
1	Therefore	_	ADV	RB	_	28	advmod	_	_
2	,	_	.	,	_	28	punct	_	_
3	in	_	ADP	IN	_	4	case	_	_
4	patients	_	NOUN	NNS	_	28	nmod	_	_
5	taking	_	VERB	VBG	_	4	acl	_	_
6	the	_	DET	DT	_	10	det	_	_
7	HIV	_	NOUN	NN	_	10	compound	_	_
8	protease	_	NOUN	NN	_	10	compound	_	_
9	inhibitor	_	NOUN	NN	_	10	compound	_	_
10	tipranavir	_	NOUN	NN	_	5	dobj	_	_
11	plus	_	CONJ	CC	_	10	cc	_	_
12	ritonavir	_	NOUN	NN	_	10	conj	_	_
13	,	_	.	,	_	4	punct	_	_
14	or	_	CONJ	CC	_	4	cc	_	_
15	the	_	DET	DT	_	20	det	_	_
16	hepatitis	_	NOUN	NN	_	20	compound	_	_
17	C	_	NOUN	NN	_	20	compound	_	_
18	protease	_	NOUN	NN	_	20	compound	_	_
19	inhibitor	_	NOUN	NN	_	20	compound	_	_
20	telaprevir	_	NOUN	NN	_	4	conj	_	_
21	,	_	.	,	_	28	punct	_	_
22	concomitant	_	ADJ	JJ	_	23	amod	_	_
23	use	_	NOUN	NN	_	28	nsubjpass	_	_
24	of	_	ADP	IN	_	25	case	_	_
25	DRUG	_	NOUN	NN	_	23	nmod	_	_
26	should	_	VERB	MD	_	28	aux	_	_
27	be	_	VERB	VB	_	28	auxpass	_	_
28	avoided	_	VERB	VBN	_	0	root	_	_

#	Lipitor	3082
1	In	_	ADP	IN	_	2	case	_	_
2	patients	_	NOUN	NNS	_	15	nmod	_	_
3	taking	_	VERB	VBG	_	2	acl	_	_
4	the	_	DET	DT	_	7	det	_	_
5	HIV	_	NOUN	NN	_	7	compound	_	_
6	protease	_	NOUN	NN	_	7	compound	_	_
7	inhibitor	_	NOUN	NN	_	3	dobj	_	_
8	lopinavir	_	NOUN	NN	_	7	dep	_	_
9	plus	_	CONJ	CC	_	8	cc	_	_
10	ritonavir	_	NOUN	NN	_	8	conj	_	_
11	,	_	.	,	_	15	punct	_	_
12	caution	_	NOUN	NN	_	15	nsubjpass	_	_
13	should	_	VERB	MD	_	15	aux	_	_
14	be	_	VERB	VB	_	15	auxpass	_	_
15	used	_	VERB	VBN	_	0	root	_	_
16	when	_	ADV	WRB	_	17	advmod	_	_
17	prescribing	_	VERB	VBG	_	15	ccomp	_	_
18	DRUG	_	NOUN	NN	_	17	dobj	_	_
19	and	_	CONJ	CC	_	17	cc	_	_
20	the	_	DET	DT	_	23	det	_	_
21	lowest	_	ADJ	JJ	_	23	amod	_	_
22	dose	_	NOUN	NN	_	23	compound	_	_
23	necessary	_	NOUN	NN	_	26	nsubjpass	_	_
24	should	_	VERB	MD	_	26	aux	_	_
25	be	_	VERB	VB	_	26	auxpass	_	_
26	used	_	VERB	VBN	_	17	conj	_	_

#	Lipitor	3083
1	In	_	ADP	IN	_	2	case	_	_
2	patients	_	NOUN	NNS	_	29	nmod	_	_
3	taking	_	VERB	VBG	_	2	acl	_	_
4	the	_	DET	DT	_	7	det	_	_
5	HIV	_	NOUN	NN	_	7	compound	_	_
6	protease	_	NOUN	NN	_	7	compound	_	_
7	inhibitors	_	NOUN	NNS	_	3	dobj	_	_
8	saquinavir	_	NOUN	NN	_	7	dep	_	_
9	plus	_	CONJ	CC	_	8	cc	_	_
10	ritonavir	_	NOUN	NN	_	8	conj	_	_
11	,	_	.	,	_	8	punct	_	_
12	darunavir	_	NOUN	NN	_	8	conj	_	_
13	plus	_	CONJ	CC	_	8	cc	_	_
14	ritonavir	_	NOUN	NN	_	8	conj	_	_
15	,	_	.	,	_	8	punct	_	_
16	fosamprenavir	_	NOUN	NN	_	8	conj	_	_
17	,	_	.	,	_	8	punct	_	_
18	or	_	CONJ	CC	_	8	cc	_	_
19	fosamprenavir	_	NOUN	NN	_	8	conj	_	_
20	plus	_	CONJ	CC	_	8	cc	_	_
21	ritonavir	_	NOUN	NN	_	8	conj	_	_
22	,	_	.	,	_	29	punct	_	_
23	the	_	DET	DT	_	24	det	_	_
24	dose	_	NOUN	NN	_	29	nsubj	_	_
25	of	_	ADP	IN	_	26	case	_	_
26	DRUG	_	NOUN	NN	_	24	nmod	_	_
27	should	_	VERB	MD	_	29	aux	_	_
28	not	_	ADV	RB	_	29	neg	_	_
29	exceed	_	VERB	VB	_	0	root	_	_
30	20	_	NUM	CD	_	31	nummod	_	_
31	mg	_	NOUN	NN	_	29	dobj	_	_
32	and	_	CONJ	CC	_	29	cc	_	_
33	should	_	VERB	MD	_	35	aux	_	_
34	be	_	VERB	VB	_	35	auxpass	_	_
35	used	_	VERB	VBN	_	29	conj	_	_
36	with	_	ADP	IN	_	37	case	_	_
37	caution	_	NOUN	NN	_	35	nmod	_	_

#	Lipitor	3084
1	In	_	ADP	IN	_	2	case	_	_
2	patients	_	NOUN	NNS	_	23	nmod	_	_
3	taking	_	VERB	VBG	_	2	acl	_	_
4	the	_	DET	DT	_	8	det	_	_
5	HIV	_	NOUN	NN	_	8	compound	_	_
6	protease	_	NOUN	NN	_	8	compound	_	_
7	inhibitor	_	NOUN	NN	_	8	compound	_	_
8	nelfinavir	_	NOUN	NN	_	3	dobj	_	_
9	or	_	CONJ	CC	_	8	cc	_	_
10	the	_	DET	DT	_	15	det	_	_
11	hepatitis	_	NOUN	NN	_	15	compound	_	_
12	C	_	NOUN	NN	_	15	compound	_	_
13	protease	_	NOUN	NN	_	15	compound	_	_
14	inhibitor	_	NOUN	NN	_	15	compound	_	_
15	boceprevir	_	NOUN	NN	_	8	conj	_	_
16	,	_	.	,	_	23	punct	_	_
17	the	_	DET	DT	_	18	det	_	_
18	dose	_	NOUN	NN	_	23	nsubj	_	_
19	of	_	ADP	IN	_	20	case	_	_
20	DRUG	_	NOUN	NN	_	18	nmod	_	_
21	should	_	VERB	MD	_	23	aux	_	_
22	not	_	ADV	RB	_	23	neg	_	_
23	exceed	_	VERB	VBN	_	0	root	_	_
24	40	_	NUM	CD	_	25	nummod	_	_
25	mg	_	NOUN	NN	_	23	dobj	_	_
26	and	_	CONJ	CC	_	25	cc	_	_
27	close	_	ADJ	JJ	_	29	amod	_	_
28	clinical	_	ADJ	JJ	_	29	amod	_	_
29	monitoring	_	NOUN	NN	_	25	conj	_	_
30	is	_	VERB	VBZ	_	31	auxpass	_	_
31	recommended	_	VERB	VBN	_	23	parataxis	_	_

#	Lipitor	3085
1	Itraconazole	_	NOUN	NN	_	3	compound	_	_
2	DRUG	_	NOUN	NN	_	3	compound	_	_
3	AUC	_	NOUN	NN	_	6	nsubjpass	_	_
4	was	_	VERB	VBD	_	6	auxpass	_	_
5	significantly	_	ADV	RB	_	6	advmod	_	_
6	increased	_	VERB	VBN	_	0	root	_	_
7	with	_	ADP	IN	_	9	case	_	_
8	concomitant	_	ADJ	JJ	_	9	amod	_	_
9	administration	_	NOUN	NN	_	6	nmod	_	_
10	of	_	ADP	IN	_	13	case	_	_
11	DRUG	_	NOUN	NN	_	13	compound	_	_
12	40	_	NUM	CD	_	13	nummod	_	_
13	mg	_	NOUN	NN	_	9	nmod	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	itraconazole	_	NOUN	NN	_	17	compound	_	_
16	200	_	NUM	CD	_	17	nummod	_	_
17	mg	_	NOUN	NNS	_	13	conj	_	_

#	Lipitor	3086
1	Therefore	_	ADV	RB	_	11	advmod	_	_
2	,	_	.	,	_	11	punct	_	_
3	in	_	ADP	IN	_	4	case	_	_
4	patients	_	NOUN	NNS	_	11	nmod	_	_
5	taking	_	VERB	VBG	_	4	acl	_	_
6	itraconazole	_	NOUN	NN	_	5	dobj	_	_
7	,	_	.	,	_	11	punct	_	_
8	caution	_	NOUN	NN	_	11	nsubjpass	_	_
9	should	_	VERB	MD	_	11	aux	_	_
10	be	_	VERB	VB	_	11	auxpass	_	_
11	used	_	VERB	VBN	_	0	root	_	_
12	when	_	ADV	WRB	_	16	advmod	_	_
13	the	_	DET	DT	_	15	det	_	_
14	DRUG	_	NOUN	NN	_	15	compound	_	_
15	dose	_	NOUN	NN	_	16	nsubj	_	_
16	exceeds	_	VERB	VBZ	_	11	ccomp	_	_
17	20	_	NUM	CD	_	18	nummod	_	_
18	mg	_	NOUN	NNS	_	16	dobj	_	_

#	Lipitor	3087
1	Contains	_	VERB	VBZ	_	5	case	_	_
2	one	_	NUM	CD	_	5	nummod	_	_
3	or	_	CONJ	CC	_	2	cc	_	_
4	more	_	ADV	RB	_	2	conj	_	_
5	components	_	NOUN	NNS	_	0	root	_	_
6	that	_	DET	WDT	_	7	nsubj	_	_
7	inhibit	_	VERB	VBP	_	5	acl:relcl	_	_
8	CYP	_	NOUN	NN	_	9	compound	_	_
9	3A4	_	NOUN	NN	_	7	dobj	_	_
10	and	_	CONJ	CC	_	7	cc	_	_
11	can	_	VERB	MD	_	12	aux	_	_
12	increase	_	VERB	VB	_	7	conj	_	_
13	plasma	_	NOUN	NN	_	14	compound	_	_
14	concentrations	_	NOUN	NNS	_	12	dobj	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	14	nmod	_	_
17	,	_	.	,	_	5	punct	_	_
18	especially	_	ADV	RB	_	25	advmod	_	_
19	with	_	ADP	IN	_	25	case	_	_
20	excessive	_	ADJ	JJ	_	25	amod	_	_
21	grapefruit	_	ADJ	JJ	_	25	amod	_	_
22	juice	_	NOUN	NN	_	25	compound	_	_
23	consumption	_	NOUN	NN	_	25	compound	_	_
24	>1.2	_	NUM	CD	_	25	nummod	_	_
25	liters	_	NOUN	NNS	_	5	nmod	_	_
26	per	_	ADP	IN	_	27	case	_	_
27	day	_	NOUN	NN	_	25	nmod	_	_

#	Lipitor	3088
1	DRUG	_	NOUN	NN	_	4	compound	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	DRUG	_	NOUN	NN	_	1	conj	_	_
4	metabolites	_	NOUN	NNS	_	6	nsubj	_	_
5	are	_	VERB	VBP	_	6	cop	_	_
6	substrates	_	NOUN	NNS	_	0	root	_	_
7	of	_	ADP	IN	_	10	case	_	_
8	the	_	DET	DT	_	10	det	_	_
9	OATP1B1	_	NOUN	NN	_	10	compound	_	_
10	transporter	_	NOUN	NN	_	6	nmod	_	_

#	Lipitor	3089
1	Inhibitors	_	NOUN	NNS	_	9	nsubj	_	_
2	of	_	ADP	IN	_	5	case	_	_
3	the	_	DET	DT	_	5	det	_	_
4	OATP1B1	_	NOUN	NN	_	5	compound	_	_
5	e.g	_	NOUN	NN	_	1	nmod	_	_
6	,	_	.	,	_	1	punct	_	_
7	cyclosporine	_	NOUN	NN	_	1	appos	_	_
8	can	_	VERB	MD	_	9	aux	_	_
9	increase	_	VERB	VB	_	0	root	_	_
10	the	_	DET	DT	_	11	det	_	_
11	bioavailability	_	NOUN	NN	_	9	dobj	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	DRUG	_	NOUN	NN	_	11	nmod	_	_

#	Lipitor	3090
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	AUC	_	NOUN	NN	_	5	nsubjpass	_	_
3	was	_	VERB	VBD	_	5	auxpass	_	_
4	significantly	_	ADV	RB	_	5	advmod	_	_
5	increased	_	VERB	VBN	_	0	root	_	_
6	with	_	ADP	IN	_	8	case	_	_
7	concomitant	_	ADJ	JJ	_	8	amod	_	_
8	administration	_	NOUN	NN	_	5	nmod	_	_
9	of	_	ADP	IN	_	12	case	_	_
10	DRUG	_	NOUN	NN	_	12	compound	_	_
11	10	_	NUM	CD	_	12	nummod	_	_
12	mg	_	NOUN	NN	_	8	nmod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	cyclosporine	_	NOUN	NN	_	16	compound	_	_
15	5.2	_	NUM	CD	_	16	nummod	_	_
16	mg	_	NOUN	NN	_	20	compound	_	_
17	/	_	.	:	_	18	punct	_	_
18	kg	_	NOUN	NN	_	16	appos	_	_
19	/	_	.	:	_	18	punct	_	_
20	day	_	NOUN	NN	_	12	conj	_	_
21	compared	_	VERB	VBD	_	5	xcomp	_	_
22	to	_	PRT	TO	_	23	case	_	_
23	that	_	DET	DT	_	21	nmod	_	_
24	of	_	ADP	IN	_	25	case	_	_
25	DRUG	_	NOUN	NN	_	23	nmod	_	_
26	alone	_	ADV	RB	_	25	advmod	_	_

#	Lipitor	3091
1	The	_	DET	DT	_	3	det	_	_
2	co	_	DET	DT	_	3	det	_	_
3	administration	_	NOUN	NN	_	10	nsubjpass	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	with	_	ADP	IN	_	7	case	_	_
7	cyclosporine	_	NOUN	NN	_	3	nmod	_	_
8	should	_	VERB	MD	_	10	aux	_	_
9	be	_	VERB	VB	_	10	auxpass	_	_
10	avoided	_	VERB	VBN	_	0	root	_	_

#	Lipitor	3092
1	Due	_	ADP	IN	_	5	case	_	_
2	to	_	PRT	TO	_	1	mwe	_	_
3	an	_	DET	DT	_	5	det	_	_
4	increased	_	VERB	VBN	_	5	amod	_	_
5	risk	_	NOUN	NN	_	29	nmod	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	myopathy	_	NOUN	NN	_	5	nmod	_	_
8	/	_	.	:	_	5	punct	_	_
9	rhabdomyolysis	_	NOUN	NN	_	29	nsubjpass	_	_
10	when	_	ADV	WRB	_	17	advmod	_	_
11	HMG	_	NOUN	NN	_	14	compound	_	_
12	CoA	_	NOUN	NN	_	14	compound	_	_
13	reductase	_	NOUN	NN	_	14	compound	_	_
14	inhibitors	_	NOUN	NNS	_	17	nsubjpass	_	_
15	are	_	VERB	VBP	_	17	auxpass	_	_
16	co	_	PRT	TO	_	17	mark	_	_
17	administered	_	VERB	VBN	_	9	acl	_	_
18	with	_	ADP	IN	_	19	case	_	_
19	gemfibrozil	_	NOUN	NN	_	17	nmod	_	_
20	,	_	.	,	_	29	punct	_	_
21	concomitant	_	ADJ	JJ	_	22	amod	_	_
22	administration	_	NOUN	NN	_	29	nsubjpass	_	_
23	of	_	ADP	IN	_	24	case	_	_
24	DRUG	_	NOUN	NN	_	22	nmod	_	_
25	with	_	ADP	IN	_	26	case	_	_
26	gemfibrozil	_	NOUN	NN	_	22	nmod	_	_
27	should	_	VERB	MD	_	29	aux	_	_
28	be	_	VERB	VB	_	29	auxpass	_	_
29	avoided	_	VERB	VBN	_	0	root	_	_

#	Lipitor	3093
1	Because	_	ADP	IN	_	4	mark	_	_
2	it	_	PRON	PRP	_	4	nsubjpass	_	_
3	is	_	VERB	VBZ	_	4	auxpass	_	_
4	known	_	VERB	VBN	_	29	advcl	_	_
5	that	_	ADP	IN	_	18	mark	_	_
6	the	_	DET	DT	_	7	det	_	_
7	risk	_	NOUN	NN	_	18	nsubjpass	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	myopathy	_	NOUN	NN	_	7	nmod	_	_
10	during	_	ADP	IN	_	11	case	_	_
11	treatment	_	NOUN	NN	_	7	nmod	_	_
12	with	_	ADP	IN	_	16	case	_	_
13	HMG	_	NOUN	NN	_	16	compound	_	_
14	CoA	_	NOUN	NN	_	16	compound	_	_
15	reductase	_	NOUN	NN	_	16	compound	_	_
16	inhibitors	_	NOUN	NNS	_	11	nmod	_	_
17	is	_	VERB	VBZ	_	18	auxpass	_	_
18	increased	_	VERB	VBN	_	4	ccomp	_	_
19	with	_	ADP	IN	_	21	case	_	_
20	concurrent	_	ADJ	JJ	_	21	amod	_	_
21	administration	_	NOUN	NN	_	18	nmod	_	_
22	of	_	ADP	IN	_	24	case	_	_
23	other	_	ADJ	JJ	_	24	amod	_	_
24	fibrates	_	NOUN	NNS	_	21	nmod	_	_
25	,	_	.	,	_	29	punct	_	_
26	DRUG	_	NOUN	NN	_	29	nsubjpass	_	_
27	should	_	VERB	MD	_	29	aux	_	_
28	be	_	VERB	VB	_	29	auxpass	_	_
29	administered	_	VERB	VBN	_	0	root	_	_
30	with	_	ADP	IN	_	31	case	_	_
31	caution	_	NOUN	NN	_	29	nmod	_	_
32	when	_	ADV	WRB	_	33	advmod	_	_
33	used	_	VERB	VBN	_	29	advcl	_	_
34	concomitantly	_	ADV	RB	_	33	advmod	_	_
35	with	_	ADP	IN	_	37	case	_	_
36	other	_	ADJ	JJ	_	37	amod	_	_
37	fibrates	_	NOUN	NNS	_	33	nmod	_	_

#	Lipitor	3094
1	The	_	DET	DT	_	2	det	_	_
2	risk	_	NOUN	NN	_	9	nsubjpass	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	skeletal	_	ADJ	JJ	_	6	amod	_	_
5	muscle	_	NOUN	NN	_	6	compound	_	_
6	effects	_	NOUN	NNS	_	2	nmod	_	_
7	may	_	VERB	MD	_	9	aux	_	_
8	be	_	VERB	VB	_	9	auxpass	_	_
9	enhanced	_	VERB	VBN	_	0	root	_	_
10	when	_	ADV	WRB	_	13	advmod	_	_
11	DRUG	_	NOUN	NN	_	13	nsubjpass	_	_
12	is	_	VERB	VBZ	_	13	auxpass	_	_
13	used	_	VERB	VBN	_	25	advcl	_	_
14	in	_	ADP	IN	_	15	case	_	_
15	combination	_	NOUN	NN	_	13	nmod	_	_
16	with	_	ADP	IN	_	17	case	_	_
17	niacin	_	NOUN	NN	_	15	nmod	_	_
18	a	_	DET	DT	_	19	det	_	_
19	reduction	_	NOUN	NN	_	25	nsubjpass	_	_
20	in	_	ADP	IN	_	22	case	_	_
21	DRUG	_	NOUN	NN	_	22	compound	_	_
22	dosage	_	NOUN	NN	_	19	nmod	_	_
23	should	_	VERB	MD	_	25	aux	_	_
24	be	_	VERB	VB	_	25	auxpass	_	_
25	considered	_	VERB	VBN	_	9	ccomp	_	_
26	in	_	ADP	IN	_	28	case	_	_
27	this	_	DET	DT	_	28	det	_	_
28	setting	_	VERB	VBG	_	25	nmod	_	_

#	Lipitor	3095
1	Concomitant	_	ADJ	JJ	_	2	amod	_	_
2	administration	_	NOUN	NN	_	0	root	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	with	_	ADP	IN	_	6	case	_	_
6	inducers	_	NOUN	NNS	_	2	nmod	_	_
7	of	_	ADP	IN	_	11	case	_	_
8	cytochrome	_	NOUN	NN	_	11	compound	_	_
9	P450	_	NOUN	NN	_	11	compound	_	_
10	3A4	_	NOUN	NN	_	11	compound	_	_
11	e.g	_	NOUN	NN	_	6	nmod	_	_
12	,	_	.	,	_	6	punct	_	_
13	efavirenz	_	ADJ	JJ	_	17	advmod	_	_
14	,	_	.	,	_	17	punct	_	_
15	rifampin	_	NOUN	NN	_	17	nsubj	_	_
16	can	_	VERB	MD	_	17	aux	_	_
17	lead	_	VERB	VB	_	6	dep	_	_
18	to	_	PRT	TO	_	20	case	_	_
19	variable	_	ADJ	JJ	_	20	amod	_	_
20	reductions	_	NOUN	NNS	_	17	nmod	_	_
21	in	_	ADP	IN	_	23	case	_	_
22	plasma	_	NOUN	NN	_	23	compound	_	_
23	concentrations	_	NOUN	NNS	_	20	nmod	_	_
24	of	_	ADP	IN	_	25	case	_	_
25	DRUG	_	NOUN	NN	_	23	nmod	_	_

#	Lipitor	3096
1	Due	_	ADP	IN	_	6	case	_	_
2	to	_	PRT	TO	_	1	mwe	_	_
3	the	_	DET	DT	_	6	det	_	_
4	dual	_	ADJ	JJ	_	6	amod	_	_
5	interaction	_	NOUN	NN	_	6	compound	_	_
6	mechanism	_	NOUN	NN	_	18	nmod	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	rifampin	_	NOUN	NN	_	6	nmod	_	_
9	,	_	.	,	_	18	punct	_	_
10	simultaneous	_	ADJ	JJ	_	12	amod	_	_
11	co	_	PRT	TO	_	12	case	_	_
12	administration	_	NOUN	NN	_	18	nsubjpass	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	DRUG	_	NOUN	NN	_	12	nmod	_	_
15	with	_	ADP	IN	_	16	case	_	_
16	rifampin	_	NOUN	NN	_	12	nmod	_	_
17	is	_	VERB	VBZ	_	18	auxpass	_	_
18	recommended	_	VERB	VBN	_	0	root	_	_
19	,	_	.	,	_	18	punct	_	_
20	as	_	ADP	IN	_	31	mark	_	_
21	delayed	_	VERB	VBN	_	22	amod	_	_
22	administration	_	NOUN	NN	_	31	nsubjpass	_	_
23	of	_	ADP	IN	_	24	case	_	_
24	DRUG	_	NOUN	NN	_	22	nmod	_	_
25	after	_	ADP	IN	_	26	case	_	_
26	administration	_	NOUN	NN	_	22	nmod	_	_
27	of	_	ADP	IN	_	28	case	_	_
28	rifampin	_	NOUN	NN	_	26	nmod	_	_
29	has	_	VERB	VBZ	_	31	aux	_	_
30	been	_	VERB	VBN	_	31	auxpass	_	_
31	associated	_	VERB	VBN	_	18	advcl	_	_
32	with	_	ADP	IN	_	35	case	_	_
33	a	_	DET	DT	_	35	det	_	_
34	significant	_	ADJ	JJ	_	35	amod	_	_
35	reduction	_	NOUN	NN	_	31	nmod	_	_
36	in	_	ADP	IN	_	39	case	_	_
37	DRUG	_	NOUN	NN	_	39	compound	_	_
38	plasma	_	NOUN	NN	_	39	compound	_	_
39	concentrations	_	NOUN	NNS	_	35	nmod	_	_

#	Lipitor	3097
1	When	_	ADV	WRB	_	10	advmod	_	_
2	multiple	_	ADJ	JJ	_	3	amod	_	_
3	doses	_	NOUN	NNS	_	10	nsubjpass	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	digoxin	_	NOUN	NN	_	5	conj	_	_
8	were	_	VERB	VBD	_	10	auxpass	_	_
9	co	_	PRT	TO	_	10	mark	_	_
10	administered	_	VERB	VBN	_	17	advcl	_	_
11	,	_	.	,	_	17	punct	_	_
12	steady	_	ADJ	JJ	_	16	amod	_	_
13	state	_	NOUN	NN	_	16	compound	_	_
14	plasma	_	NOUN	NN	_	16	compound	_	_
15	digoxin	_	NOUN	NN	_	16	compound	_	_
16	concentrations	_	NOUN	NNS	_	17	nsubj	_	_
17	increased	_	VERB	VBD	_	0	root	_	_
18	by	_	ADP	IN	_	20	case	_	_
19	approximately	_	ADV	RB	_	20	advmod	_	_
20	20%	_	ADJ	JJ	_	17	nmod	_	_

#	Lipitor	3098
1	Patients	_	NOUN	NNS	_	6	nsubjpass	_	_
2	taking	_	VERB	VBG	_	1	acl	_	_
3	digoxin	_	NOUN	NN	_	2	dobj	_	_
4	should	_	VERB	MD	_	6	aux	_	_
5	be	_	VERB	VB	_	6	auxpass	_	_
6	monitored	_	VERB	VBN	_	0	root	_	_
7	appropriately	_	ADV	RB	_	6	advmod	_	_

#	Lipitor	3099
1	Co	_	PRT	TO	_	2	case	_	_
2	administration	_	NOUN	NN	_	0	root	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	and	_	CONJ	CC	_	2	cc	_	_
6	an	_	DET	DT	_	11	det	_	_
7	oral	_	ADJ	JJ	_	11	amod	_	_
8	contraceptive	_	ADJ	JJ	_	11	amod	_	_
9	increased	_	VERB	VBN	_	11	amod	_	_
10	AUC	_	NOUN	NN	_	11	compound	_	_
11	values	_	NOUN	NNS	_	2	conj	_	_
12	for	_	ADP	IN	_	13	case	_	_
13	norethindrone	_	NOUN	NN	_	11	nmod	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	ethinyl	_	NOUN	NN	_	16	compound	_	_
16	estradiol	_	NOUN	NN	_	13	conj	_	_

#	Lipitor	3100
1	These	_	DET	DT	_	2	det	_	_
2	increases	_	NOUN	NNS	_	5	nsubjpass	_	_
3	should	_	VERB	MD	_	5	aux	_	_
4	be	_	VERB	VB	_	5	auxpass	_	_
5	considered	_	VERB	VBN	_	0	root	_	_
6	when	_	ADV	WRB	_	7	advmod	_	_
7	selecting	_	VERB	VBG	_	5	advcl	_	_
8	an	_	DET	DT	_	10	det	_	_
9	oral	_	ADJ	JJ	_	10	amod	_	_
10	contraceptive	_	NOUN	NN	_	7	dobj	_	_
11	for	_	ADP	IN	_	13	case	_	_
12	a	_	DET	DT	_	13	det	_	_
13	woman	_	NOUN	NNS	_	10	nmod	_	_
14	taking	_	VERB	VBG	_	13	acl	_	_
15	DRUG	_	NOUN	NN	_	14	nmod	_	_

#	Lipitor	3101
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	had	_	VERB	VBD	_	0	root	_	_
3	no	_	DET	DT	_	6	neg	_	_
4	clinically	_	ADV	RB	_	5	advmod	_	_
5	significant	_	ADJ	JJ	_	6	amod	_	_
6	effect	_	NOUN	NN	_	2	dobj	_	_
7	on	_	ADP	IN	_	9	case	_	_
8	prothrombin	_	NOUN	NN	_	9	compound	_	_
9	time	_	NOUN	NN	_	6	nmod	_	_
10	when	_	ADV	WRB	_	11	advmod	_	_
11	administered	_	VERB	VBN	_	2	advcl	_	_
12	to	_	PRT	TO	_	13	case	_	_
13	patients	_	NOUN	NNS	_	11	nmod	_	_
14	receiving	_	VERB	VBG	_	13	acl	_	_
15	chronic	_	ADJ	JJ	_	17	amod	_	_
16	warfarin	_	NOUN	NN	_	17	compound	_	_
17	treatment	_	NOUN	NN	_	14	dobj	_	_

#	Lipitor	3102
1	Cases	_	NOUN	NNS	_	10	nsubjpass	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	myopathy	_	NOUN	NN	_	1	nmod	_	_
4	,	_	.	,	_	3	punct	_	_
5	including	_	VERB	VBG	_	6	case	_	_
6	rhabdomyolysis	_	NOUN	NN	_	3	nmod	_	_
7	,	_	.	,	_	1	punct	_	_
8	have	_	VERB	VBP	_	10	aux	_	_
9	been	_	VERB	VBN	_	10	auxpass	_	_
10	reported	_	VERB	VBN	_	0	root	_	_
11	with	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_
13	co	_	PRT	TO	_	14	mark	_	_
14	administered	_	VERB	VBN	_	10	xcomp	_	_
15	with	_	ADP	IN	_	16	case	_	_
16	colchicine	_	NOUN	NN	_	14	nmod	_	_
17	,	_	.	,	_	10	punct	_	_
18	and	_	CONJ	CC	_	10	cc	_	_
19	caution	_	NOUN	NN	_	22	nsubjpass	_	_
20	should	_	VERB	MD	_	22	aux	_	_
21	be	_	VERB	VB	_	22	auxpass	_	_
22	exercised	_	VERB	VBN	_	10	conj	_	_
23	when	_	ADV	WRB	_	24	advmod	_	_
24	prescribing	_	VERB	VBG	_	22	advcl	_	_
25	DRUG	_	NOUN	NN	_	24	dobj	_	_
26	with	_	ADP	IN	_	27	case	_	_
27	colchicine	_	NOUN	NN	_	24	nmod	_	_

#	Lipitor	3103
1	DRUG	_	NOUN	NN	_	7	nsubj	_	_
2	is	_	VERB	VBZ	_	7	cop	_	_
3	a	_	DET	DT	_	7	det	_	_
4	selective	_	ADJ	JJ	_	7	amod	_	_
5	,	_	.	,	_	4	punct	_	_
6	competitive	_	ADJ	JJ	_	4	dep	_	_
7	inhibitor	_	NOUN	NN	_	0	root	_	_
8	of	_	ADP	IN	_	11	case	_	_
9	HMG	_	NOUN	NN	_	11	compound	_	_
10	CoA	_	NOUN	NN	_	11	compound	_	_
11	reductase	_	NOUN	NN	_	7	nmod	_	_
12	,	_	.	,	_	11	punct	_	_
13	the	_	DET	DT	_	16	det	_	_
14	rate	_	ADJ	JJ	_	16	amod	_	_
15	limiting	_	VERB	VBG	_	16	compound	_	_
16	enzyme	_	NOUN	NN	_	11	appos	_	_
17	that	_	DET	WDT	_	18	nsubj	_	_
18	converts	_	VERB	VBZ	_	16	acl:relcl	_	_
19	3	_	NUM	CD	_	24	nummod	_	_
20	hydroxy	_	NOUN	NN	_	24	compound	_	_
21	3	_	NUM	CD	_	24	nummod	_	_
22	methylglutaryl	_	NOUN	NN	_	24	amod	_	_
23	coenzyme	_	NOUN	NN	_	24	compound	_	_
24	A	_	NOUN	NN	_	18	dobj	_	_
25	to	_	PRT	TO	_	26	mark	_	_
26	mevalonate	_	VERB	VB	_	18	nmod	_	_
27	,	_	.	,	_	26	punct	_	_
28	a	_	DET	DT	_	29	det	_	_
29	precursor	_	NOUN	NN	_	26	dobj	_	_
30	of	_	ADP	IN	_	31	case	_	_
31	sterols	_	NOUN	NNS	_	29	nmod	_	_
32	,	_	.	,	_	31	punct	_	_
33	including	_	VERB	VBG	_	34	case	_	_
34	cholesterol	_	NOUN	NN	_	31	nmod	_	_

#	Lipitor	3104
1	In	_	ADP	IN	_	3	case	_	_
2	animal	_	NOUN	NN	_	3	compound	_	_
3	models	_	NOUN	NNS	_	6	nmod	_	_
4	,	_	.	,	_	6	punct	_	_
5	DRUG	_	NOUN	NN	_	6	nsubj	_	_
6	lowers	_	VERB	VBZ	_	0	root	_	_
7	plasma	_	NOUN	NN	_	8	compound	_	_
8	cholesterol	_	NOUN	NN	_	11	compound	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	lipoprotein	_	NOUN	NN	_	8	conj	_	_
11	levels	_	NOUN	NNS	_	6	dobj	_	_
12	by	_	ADP	IN	_	13	mark	_	_
13	inhibiting	_	VERB	VBG	_	6	advcl	_	_
14	HMG	_	NOUN	NN	_	16	compound	_	_
15	CoA	_	NOUN	NN	_	16	compound	_	_
16	reductase	_	NOUN	NN	_	13	dobj	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	cholesterol	_	NOUN	NN	_	19	compound	_	_
19	synthesis	_	NOUN	NN	_	16	conj	_	_
20	in	_	ADP	IN	_	22	case	_	_
21	the	_	DET	DT	_	22	det	_	_
22	liver	_	NOUN	NN	_	13	nmod	_	_
23	and	_	CONJ	CC	_	13	cc	_	_
24	by	_	ADP	IN	_	25	mark	_	_
25	increasing	_	VERB	VBG	_	13	conj	_	_
26	the	_	DET	DT	_	27	det	_	_
27	number	_	NOUN	NN	_	25	dobj	_	_
28	of	_	ADP	IN	_	31	case	_	_
29	hepatic	_	ADJ	JJ	_	31	amod	_	_
30	LDL	_	NOUN	NN	_	31	compound	_	_
31	receptors	_	NOUN	NNS	_	27	nmod	_	_
32	on	_	ADP	IN	_	35	case	_	_
33	the	_	DET	DT	_	35	det	_	_
34	cell	_	NOUN	NN	_	35	compound	_	_
35	surface	_	NOUN	NN	_	27	nmod	_	_
36	to	_	PRT	TO	_	37	mark	_	_
37	enhance	_	VERB	VB	_	27	acl	_	_
38	uptake	_	NOUN	NN	_	37	dobj	_	_
39	and	_	CONJ	CC	_	37	cc	_	_
40	catabolism	_	NOUN	NN	_	45	nsubj	_	_
41	of	_	ADP	IN	_	43	case	_	_
42	LDL	_	NOUN	NN	_	43	compound	_	_
43	DRUG	_	NOUN	NN	_	40	nmod	_	_
44	also	_	ADV	RB	_	45	advmod	_	_
45	reduces	_	VERB	VBZ	_	37	conj	_	_
46	LDL	_	NOUN	NN	_	47	compound	_	_
47	production	_	NOUN	NN	_	45	dobj	_	_
48	and	_	CONJ	CC	_	45	cc	_	_
49	the	_	DET	DT	_	50	det	_	_
50	number	_	NOUN	NN	_	45	conj	_	_
51	of	_	ADP	IN	_	53	case	_	_
52	LDL	_	NOUN	NN	_	53	compound	_	_
53	particles	_	NOUN	NNS	_	50	nmod	_	_

#	Lipitor	3105
1	DRUG	_	NOUN	NN	_	13	nsubj	_	_
2	,	_	.	,	_	1	punct	_	_
3	as	_	ADV	RB	_	1	cc	_	_
4	well	_	ADV	RB	_	3	mwe	_	_
5	as	_	ADP	IN	_	3	mwe	_	_
6	some	_	DET	DT	_	1	conj	_	_
7	of	_	ADP	IN	_	9	case	_	_
8	its	_	PRON	PRP$	_	9	nmod:poss	_	_
9	metabolites	_	NOUN	NNS	_	6	nmod	_	_
10	,	_	.	,	_	1	punct	_	_
11	are	_	VERB	VBP	_	13	cop	_	_
12	pharmacologically	_	ADV	RB	_	13	advmod	_	_
13	active	_	ADJ	JJ	_	0	root	_	_
14	in	_	ADP	IN	_	15	case	_	_
15	humans	_	NOUN	NNS	_	13	nmod	_	_

#	Lipitor	3106
1	The	_	DET	DT	_	2	det	_	_
2	liver	_	NOUN	NN	_	6	nsubj	_	_
3	is	_	VERB	VBZ	_	6	cop	_	_
4	the	_	DET	DT	_	6	det	_	_
5	primary	_	ADJ	JJ	_	6	amod	_	_
6	site	_	NOUN	NN	_	0	root	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	action	_	NOUN	NN	_	6	nmod	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	the	_	DET	DT	_	12	det	_	_
11	principal	_	ADJ	JJ	_	12	amod	_	_
12	site	_	NOUN	NN	_	8	conj	_	_
13	of	_	ADP	IN	_	15	case	_	_
14	cholesterol	_	NOUN	NN	_	15	compound	_	_
15	synthesis	_	NOUN	NN	_	12	nmod	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	LDL	_	NOUN	NN	_	18	compound	_	_
18	clearance	_	NOUN	NN	_	15	conj	_	_

#	Lipitor	3107
1	Drug	_	NOUN	NN	_	2	compound	_	_
2	dosage	_	NOUN	NN	_	10	nsubj	_	_
3	,	_	.	,	_	2	punct	_	_
4	rather	_	ADV	RB	_	2	cc	_	_
5	than	_	ADP	IN	_	4	mwe	_	_
6	systemic	_	ADJ	JJ	_	8	amod	_	_
7	drug	_	NOUN	NN	_	8	compound	_	_
8	concentration	_	NOUN	NN	_	2	conj	_	_
9	,	_	.	,	_	2	punct	_	_
10	correlates	_	VERB	VBZ	_	0	root	_	_
11	better	_	ADV	RB	_	10	advmod	_	_
12	with	_	ADP	IN	_	15	case	_	_
13	LDL	_	NOUN	NN	_	15	compound	_	_
14	C	_	NOUN	NN	_	15	compound	_	_
15	reduction	_	NOUN	NN	_	10	nmod	_	_

#	Lipitor	3108
1	Individualization	_	NOUN	NN	_	7	nsubjpass	_	_
2	of	_	ADP	IN	_	4	case	_	_
3	drug	_	NOUN	NN	_	4	compound	_	_
4	dosage	_	NOUN	NN	_	1	nmod	_	_
5	should	_	VERB	MD	_	7	aux	_	_
6	be	_	VERB	VB	_	7	auxpass	_	_
7	based	_	VERB	VBN	_	0	root	_	_
8	on	_	ADP	IN	_	10	case	_	_
9	therapeutic	_	ADJ	JJ	_	10	amod	_	_
10	response	_	NOUN	NN	_	7	nmod	_	_

#	Lipitor	3109
1	Absorption	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	DRUG	_	NOUN	NN	_	6	nsubjpass	_	_
4	is	_	VERB	VBZ	_	6	auxpass	_	_
5	rapidly	_	ADV	RB	_	6	advmod	_	_
6	absorbed	_	VERB	VBN	_	1	dep	_	_
7	after	_	ADP	IN	_	12	case	_	_
8	oral	_	ADJ	JJ	_	12	amod	_	_
9	administration	_	NOUN	NN	_	12	compound	_	_
10	maximum	_	NOUN	NN	_	12	compound	_	_
11	plasma	_	NOUN	NN	_	12	compound	_	_
12	concentrations	_	NOUN	NNS	_	6	nmod	_	_
13	occur	_	VERB	VBP	_	6	xcomp	_	_
14	within	_	ADP	IN	_	18	case	_	_
15	1	_	NUM	CD	_	17	compound	_	_
16	to	_	PRT	TO	_	17	dep	_	_
17	2	_	NUM	CD	_	18	nummod	_	_
18	hours	_	NOUN	NNS	_	13	nmod	_	_

#	Lipitor	3110
1	Extent	_	ADV	RB	_	4	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	absorption	_	NOUN	NN	_	1	nmod	_	_
4	increases	_	VERB	VBZ	_	0	root	_	_
5	in	_	ADP	IN	_	6	case	_	_
6	proportion	_	NOUN	NN	_	4	nmod	_	_
7	to	_	PRT	TO	_	9	case	_	_
8	DRUG	_	NOUN	NN	_	9	compound	_	_
9	dose	_	NOUN	NN	_	6	nmod	_	_

#	Lipitor	3111
1	The	_	DET	DT	_	3	det	_	_
2	absolute	_	ADJ	JJ	_	3	amod	_	_
3	bioavailability	_	NOUN	NN	_	10	nsubj	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	DRUG	_	NOUN	NN	_	7	compound	_	_
6	parent	_	NOUN	NN	_	7	compound	_	_
7	drug	_	NOUN	NN	_	3	nmod	_	_
8	is	_	VERB	VBZ	_	10	cop	_	_
9	approximately	_	ADV	RB	_	10	advmod	_	_
10	14%	_	ADJ	JJ	_	0	root	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	the	_	DET	DT	_	14	det	_	_
13	systemic	_	ADJ	JJ	_	14	amod	_	_
14	availability	_	NOUN	NN	_	23	nsubj	_	_
15	of	_	ADP	IN	_	20	case	_	_
16	HMG	_	NOUN	NN	_	20	compound	_	_
17	CoA	_	NOUN	NN	_	20	compound	_	_
18	reductase	_	NOUN	NN	_	20	compound	_	_
19	inhibitory	_	ADJ	JJ	_	20	amod	_	_
20	activity	_	NOUN	NN	_	14	nmod	_	_
21	is	_	VERB	VBZ	_	23	cop	_	_
22	approximately	_	ADV	RB	_	23	advmod	_	_
23	30%	_	ADJ	JJ	_	10	conj	_	_

#	Lipitor	3112
1	The	_	DET	DT	_	4	det	_	_
2	low	_	ADJ	JJ	_	4	amod	_	_
3	systemic	_	ADJ	JJ	_	4	amod	_	_
4	availability	_	NOUN	NN	_	6	nsubjpass	_	_
5	is	_	VERB	VBZ	_	6	auxpass	_	_
6	attributed	_	VERB	VBN	_	0	root	_	_
7	to	_	PRT	TO	_	9	case	_	_
8	presystemic	_	ADJ	JJ	_	9	amod	_	_
9	clearance	_	NOUN	NN	_	6	nmod	_	_
10	in	_	ADP	IN	_	12	case	_	_
11	gastrointestinal	_	ADJ	JJ	_	12	amod	_	_
12	mucosa	_	NOUN	NN	_	9	nmod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	/	_	NUM	CD	_	12	conj	_	_
15	or	_	CONJ	CC	_	14	cc	_	_
16	hepatic	_	ADJ	JJ	_	19	amod	_	_
17	first	_	ADJ	JJ	_	19	amod	_	_
18	pass	_	NOUN	NN	_	19	compound	_	_
19	metabolism	_	NOUN	NN	_	14	conj	_	_

#	Lipitor	3113
1	Although	_	ADP	IN	_	3	mark	_	_
2	food	_	NOUN	NN	_	3	nsubj	_	_
3	decreases	_	VERB	VBZ	_	30	advcl	_	_
4	the	_	DET	DT	_	5	det	_	_
5	rate	_	NOUN	NN	_	3	dobj	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	extent	_	NOUN	NN	_	5	conj	_	_
8	of	_	ADP	IN	_	10	case	_	_
9	drug	_	NOUN	NN	_	10	compound	_	_
10	absorption	_	NOUN	NN	_	5	nmod	_	_
11	by	_	ADP	IN	_	13	case	_	_
12	approximately	_	ADV	RB	_	13	advmod	_	_
13	25%	_	NOUN	NN	_	3	nmod	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	9%	_	NOUN	NN	_	13	conj	_	_
16	,	_	.	,	_	3	punct	_	_
17	respectively	_	ADV	RB	_	3	advmod	_	_
18	,	_	.	,	_	3	punct	_	_
19	as	_	ADP	IN	_	20	mark	_	_
20	assessed	_	VERB	VBN	_	3	advcl	_	_
21	by	_	ADP	IN	_	22	case	_	_
22	Cmax	_	NOUN	NN	_	20	nmod	_	_
23	and	_	CONJ	CC	_	22	cc	_	_
24	AUC	_	NOUN	NN	_	22	conj	_	_
25	,	_	.	,	_	30	punct	_	_
26	LDL	_	NOUN	NN	_	28	compound	_	_
27	C	_	NOUN	NN	_	28	compound	_	_
28	reduction	_	NOUN	NN	_	30	nsubj	_	_
29	is	_	VERB	VBZ	_	30	cop	_	_
30	similar	_	ADJ	JJ	_	0	root	_	_
31	whether	_	ADP	IN	_	34	mark	_	_
32	DRUG	_	NOUN	NN	_	34	nsubjpass	_	_
33	is	_	VERB	VBZ	_	34	auxpass	_	_
34	given	_	VERB	VBN	_	30	ccomp	_	_
35	with	_	ADP	IN	_	34	nmod	_	_
36	or	_	CONJ	CC	_	35	cc	_	_
37	without	_	ADP	IN	_	35	conj	_	_
38	food	_	NOUN	NN	_	35	dep	_	_

#	Lipitor	3114
1	Plasma	_	NOUN	NN	_	3	compound	_	_
2	DRUG	_	NOUN	NN	_	3	compound	_	_
3	concentrations	_	NOUN	NNS	_	5	nsubj	_	_
4	are	_	VERB	VBP	_	5	cop	_	_
5	lower	_	ADJ	JJ	_	0	root	_	_
6	approximately	_	ADV	RB	_	7	advmod	_	_
7	30%	_	ADJ	JJ	_	5	dobj	_	_
8	for	_	ADP	IN	_	9	case	_	_
9	Cmax	_	NOUN	NN	_	7	nmod	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	AUC	_	NOUN	NN	_	9	conj	_	_
12	following	_	VERB	VBG	_	15	case	_	_
13	evening	_	VERB	VBG	_	15	amod	_	_
14	drug	_	NOUN	NN	_	15	compound	_	_
15	administration	_	NOUN	NN	_	7	nmod	_	_
16	compared	_	VERB	VBN	_	15	acl	_	_
17	with	_	ADP	IN	_	18	case	_	_
18	morning	_	NOUN	NN	_	16	nmod	_	_

#	Lipitor	3115
1	However	_	ADV	RB	_	8	advmod	_	_
2	,	_	.	,	_	8	punct	_	_
3	LDL	_	NOUN	NN	_	5	compound	_	_
4	C	_	NOUN	NN	_	5	compound	_	_
5	reduction	_	NOUN	NN	_	8	nsubj	_	_
6	is	_	VERB	VBZ	_	8	cop	_	_
7	the	_	DET	DT	_	8	det	_	_
8	same	_	ADJ	JJ	_	0	root	_	_
9	regardless	_	ADV	RB	_	8	advmod	_	_
10	of	_	ADP	IN	_	12	case	_	_
11	the	_	DET	DT	_	12	det	_	_
12	time	_	NOUN	NN	_	9	nmod	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	day	_	NOUN	NN	_	12	nmod	_	_
15	of	_	ADP	IN	_	17	case	_	_
16	drug	_	NOUN	NN	_	17	compound	_	_
17	administration	_	NOUN	NN	_	14	nmod	_	_

#	Lipitor	3116
1	Distribution	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Mean	_	ADJ	JJ	_	4	amod	_	_
4	volume	_	NOUN	NN	_	12	nsubj	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	distribution	_	NOUN	NN	_	4	nmod	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	is	_	VERB	VBZ	_	12	cop	_	_
10	approximately	_	ADV	RB	_	11	advmod	_	_
11	381	_	NUM	CD	_	12	nummod	_	_
12	liters	_	NOUN	NNS	_	1	dep	_	_

#	Lipitor	3117
1	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
2	is	_	VERB	VBZ	_	4	auxpass	_	_
3	>98%	_	ADJ	JJ	_	4	advmod	_	_
4	bound	_	VERB	VBN	_	0	root	_	_
5	to	_	PRT	TO	_	7	case	_	_
6	plasma	_	NOUN	NN	_	7	compound	_	_
7	proteins	_	NOUN	NNS	_	4	nmod	_	_

#	Lipitor	3118
1	A	_	DET	DT	_	5	det	_	_
2	blood	_	NOUN	NN	_	5	compound	_	_
3	/	_	.	:	_	5	punct	_	_
4	plasma	_	NOUN	NN	_	5	compound	_	_
5	ratio	_	NOUN	NN	_	9	nsubj	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	approximately	_	ADV	RB	_	8	advmod	_	_
8	0.25	_	NUM	CD	_	5	nmod	_	_
9	indicates	_	VERB	VBZ	_	0	root	_	_
10	poor	_	ADJ	JJ	_	12	amod	_	_
11	drug	_	NOUN	NN	_	12	compound	_	_
12	penetration	_	NOUN	NN	_	9	dobj	_	_
13	into	_	ADP	IN	_	16	case	_	_
14	red	_	ADJ	JJ	_	16	amod	_	_
15	blood	_	NOUN	NN	_	16	compound	_	_
16	cells	_	NOUN	NNS	_	12	nmod	_	_

#	Lipitor	3119
1	Based	_	VERB	VBN	_	9	advcl	_	_
2	on	_	ADP	IN	_	3	case	_	_
3	observations	_	NOUN	NNS	_	1	nmod	_	_
4	in	_	ADP	IN	_	5	case	_	_
5	rats	_	NOUN	NNS	_	3	nmod	_	_
6	,	_	.	,	_	9	punct	_	_
7	DRUG	_	NOUN	NN	_	9	nsubj	_	_
8	is	_	VERB	VBZ	_	9	cop	_	_
9	likely	_	ADJ	JJ	_	0	root	_	_
10	to	_	PRT	TO	_	12	mark	_	_
11	be	_	VERB	VB	_	12	auxpass	_	_
12	secreted	_	VERB	VBN	_	9	xcomp	_	_
13	in	_	ADP	IN	_	15	case	_	_
14	human	_	ADJ	JJ	_	15	amod	_	_
15	milk	_	NOUN	NNS	_	12	nmod	_	_

#	Lipitor	3120
1	Metabolism	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	DRUG	_	NOUN	NN	_	6	nsubjpass	_	_
4	is	_	VERB	VBZ	_	6	auxpass	_	_
5	extensively	_	ADV	RB	_	6	advmod	_	_
6	metabolized	_	VERB	VBN	_	1	dep	_	_
7	to	_	PRT	TO	_	8	case	_	_
8	ortho	_	NOUN	NN	_	6	nmod	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	parahydroxylated	_	ADJ	JJ	_	11	amod	_	_
11	derivatives	_	NOUN	NNS	_	8	conj	_	_
12	and	_	CONJ	CC	_	8	cc	_	_
13	various	_	ADJ	JJ	_	16	amod	_	_
14	beta	_	NOUN	NN	_	16	compound	_	_
15	oxidation	_	NOUN	NN	_	16	compound	_	_
16	products	_	NOUN	NNS	_	8	conj	_	_

#	Lipitor	3121
1	In	_	X	FW	_	3	amod	_	_
2	vitro	_	X	FW	_	1	dep	_	_
3	inhibition	_	NOUN	NN	_	14	nsubj	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	HMG	_	NOUN	NN	_	7	compound	_	_
6	CoA	_	NOUN	NN	_	7	compound	_	_
7	reductase	_	NOUN	NN	_	3	nmod	_	_
8	by	_	ADP	IN	_	9	case	_	_
9	ortho	_	NOUN	NN	_	3	nmod	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	parahydroxylated	_	ADJ	JJ	_	9	conj	_	_
12	metabolites	_	NOUN	NNS	_	9	dep	_	_
13	is	_	VERB	VBZ	_	14	cop	_	_
14	equivalent	_	ADJ	JJ	_	0	root	_	_
15	to	_	PRT	TO	_	16	case	_	_
16	that	_	DET	DT	_	14	nmod	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	DRUG	_	NOUN	NN	_	16	nmod	_	_

#	Lipitor	3122
1	Approximately	_	ADV	RB	_	12	advmod	_	_
2	70%	_	NOUN	NN	_	12	nsubjpass	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	circulating	_	ADJ	JJ	_	6	amod	_	_
5	inhibitory	_	ADJ	JJ	_	6	amod	_	_
6	activity	_	NOUN	NN	_	2	nmod	_	_
7	for	_	ADP	IN	_	10	case	_	_
8	HMG	_	NOUN	NN	_	10	compound	_	_
9	CoA	_	NOUN	NN	_	10	compound	_	_
10	reductase	_	NOUN	NN	_	6	nmod	_	_
11	is	_	VERB	VBZ	_	12	auxpass	_	_
12	attributed	_	VERB	VBN	_	0	root	_	_
13	to	_	PRT	TO	_	15	case	_	_
14	active	_	ADJ	JJ	_	15	amod	_	_
15	metabolites	_	NOUN	NNS	_	12	nmod	_	_

#	Lipitor	3123
1	In	_	X	FW	_	3	amod	_	_
2	vitro	_	X	FW	_	1	dep	_	_
3	studies	_	NOUN	NNS	_	4	nsubj	_	_
4	suggest	_	VERB	VBP	_	0	root	_	_
5	the	_	DET	DT	_	6	det	_	_
6	importance	_	NOUN	NN	_	4	dobj	_	_
7	of	_	ADP	IN	_	9	case	_	_
8	DRUG	_	NOUN	NN	_	9	compound	_	_
9	metabolism	_	NOUN	NN	_	6	nmod	_	_
10	by	_	ADP	IN	_	13	case	_	_
11	cytochrome	_	NOUN	NN	_	13	compound	_	_
12	P450	_	NOUN	NN	_	13	compound	_	_
13	3A4	_	NOUN	NN	_	6	nmod	_	_
14	,	_	.	,	_	6	punct	_	_
15	consistent	_	ADJ	JJ	_	6	amod	_	_
16	with	_	ADP	IN	_	19	case	_	_
17	increased	_	VERB	VBN	_	19	amod	_	_
18	plasma	_	NOUN	NN	_	19	compound	_	_
19	concentrations	_	NOUN	NNS	_	15	nmod	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	DRUG	_	NOUN	NN	_	19	nmod	_	_
22	in	_	ADP	IN	_	23	case	_	_
23	humans	_	NOUN	NNS	_	19	nmod	_	_
24	following	_	VERB	VBG	_	26	case	_	_
25	co	_	PRT	TO	_	26	case	_	_
26	administration	_	NOUN	NN	_	15	nmod	_	_
27	with	_	ADP	IN	_	28	case	_	_
28	erythromycin	_	NOUN	NN	_	26	nmod	_	_
29	,	_	.	,	_	4	punct	_	_
30	a	_	DET	DT	_	32	det	_	_
31	known	_	VERB	VBN	_	32	amod	_	_
32	inhibitor	_	NOUN	NN	_	4	dobj	_	_
33	of	_	ADP	IN	_	35	case	_	_
34	this	_	DET	DT	_	35	det	_	_
35	isozyme	_	NOUN	NN	_	32	nmod	_	_

#	Lipitor	3124
1	In	_	ADP	IN	_	2	case	_	_
2	animals	_	NOUN	NNS	_	8	nmod	_	_
3	,	_	.	,	_	8	punct	_	_
4	the	_	DET	DT	_	7	det	_	_
5	ortho	_	NOUN	NN	_	7	compound	_	_
6	hydroxy	_	NOUN	NN	_	7	compound	_	_
7	metabolite	_	NOUN	NN	_	8	nsubj	_	_
8	undergoes	_	VERB	VBZ	_	0	root	_	_
9	further	_	ADJ	JJ	_	10	amod	_	_
10	glucuronidation	_	NOUN	NN	_	8	dobj	_	_

#	Lipitor	3125
1	Excretion	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	DRUG	_	NOUN	NN	_	8	nsubjpass	_	_
4	and	_	CONJ	CC	_	3	cc	_	_
5	its	_	PRON	PRP$	_	6	nmod:poss	_	_
6	metabolites	_	NOUN	NNS	_	3	conj	_	_
7	are	_	VERB	VBP	_	8	auxpass	_	_
8	eliminated	_	VERB	VBN	_	26	advcl	_	_
9	primarily	_	ADV	RB	_	8	advmod	_	_
10	in	_	ADP	IN	_	11	case	_	_
11	bile	_	ADJ	JJ	_	8	advcl	_	_
12	following	_	ADP	IN	_	19	case	_	_
13	hepatic	_	ADJ	JJ	_	19	amod	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	/	_	NUM	CD	_	13	conj	_	_
16	or	_	CONJ	CC	_	13	cc	_	_
17	extra	_	ADJ	JJ	_	13	conj	_	_
18	hepatic	_	ADJ	JJ	_	19	amod	_	_
19	metabolism	_	NOUN	NN	_	11	nmod	_	_
20	however	_	ADV	RB	_	8	advmod	_	_
21	,	_	.	,	_	26	punct	_	_
22	the	_	DET	DT	_	23	det	_	_
23	drug	_	NOUN	NN	_	26	nsubj	_	_
24	does	_	VERB	VBZ	_	26	aux	_	_
25	not	_	ADV	RB	_	26	neg	_	_
26	appear	_	VERB	VB	_	1	dep	_	_
27	to	_	PRT	TO	_	28	mark	_	_
28	undergo	_	VERB	VB	_	26	xcomp	_	_
29	enterohepatic	_	ADJ	JJ	_	30	amod	_	_
30	recirculation	_	NOUN	NN	_	28	dobj	_	_

#	Lipitor	3126
1	Mean	_	NOUN	NN	_	5	compound	_	_
2	plasma	_	NOUN	NN	_	5	compound	_	_
3	elimination	_	NOUN	NN	_	5	compound	_	_
4	half	_	ADJ	JJ	_	5	compound	_	_
5	life	_	NOUN	NN	_	13	nsubj	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	in	_	ADP	IN	_	9	case	_	_
9	humans	_	NOUN	NNS	_	5	nmod	_	_
10	is	_	VERB	VBZ	_	13	cop	_	_
11	approximately	_	ADV	RB	_	12	advmod	_	_
12	14	_	NUM	CD	_	13	nummod	_	_
13	hours	_	NOUN	NNS	_	0	root	_	_
14	,	_	.	,	_	13	punct	_	_
15	but	_	CONJ	CC	_	13	cc	_	_
16	the	_	DET	DT	_	18	det	_	_
17	half	_	ADJ	JJ	_	18	amod	_	_
18	life	_	NOUN	NN	_	30	nsubj	_	_
19	of	_	ADP	IN	_	21	case	_	_
20	inhibitory	_	ADJ	JJ	_	21	amod	_	_
21	activity	_	NOUN	NN	_	18	nmod	_	_
22	for	_	ADP	IN	_	25	case	_	_
23	HMG	_	NOUN	NN	_	25	compound	_	_
24	CoA	_	NOUN	NN	_	25	compound	_	_
25	reductase	_	NOUN	NN	_	21	nmod	_	_
26	is	_	VERB	VBZ	_	30	cop	_	_
27	20	_	NUM	CD	_	29	compound	_	_
28	to	_	PRT	TO	_	29	dep	_	_
29	30	_	NUM	CD	_	30	nummod	_	_
30	hours	_	NOUN	NNS	_	13	conj	_	_
31	due	_	ADJ	JJ	_	34	case	_	_
32	to	_	PRT	TO	_	31	mwe	_	_
33	the	_	DET	DT	_	34	det	_	_
34	contribution	_	NOUN	NN	_	30	nmod	_	_
35	of	_	ADP	IN	_	37	case	_	_
36	active	_	ADJ	JJ	_	37	amod	_	_
37	metabolites	_	NOUN	NNS	_	34	nmod	_	_

#	Lipitor	3127
1	Less	_	ADV	RB	_	3	case	_	_
2	than	_	ADP	IN	_	1	mwe	_	_
3	2%	_	NOUN	NN	_	10	nsubjpass	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	a	_	DET	DT	_	6	det	_	_
6	dose	_	NOUN	NN	_	3	nmod	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	is	_	VERB	VBZ	_	10	auxpass	_	_
10	recovered	_	VERB	VBN	_	0	root	_	_
11	in	_	ADP	IN	_	12	mark	_	_
12	urine	_	VERB	VBG	_	10	nmod	_	_
13	following	_	ADP	IN	_	15	case	_	_
14	oral	_	ADJ	JJ	_	15	amod	_	_
15	administration	_	NOUN	NN	_	12	nmod	_	_

#	Lipitor	3128
1	Specific	_	ADJ	JJ	_	2	amod	_	_
2	Populations	_	NOUN	NNS	_	0	root	_	_
3	Geriatric	_	ADJ	JJ	_	2	amod	_	_
4	:	_	.	:	_	2	punct	_	_
5	Plasma	_	NOUN	NN	_	6	compound	_	_
6	concentrations	_	NOUN	NNS	_	10	nsubj	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	are	_	VERB	VBP	_	10	cop	_	_
10	higher	_	ADJ	JJ	_	2	dep	_	_
11	approximately	_	ADV	RB	_	12	advmod	_	_
12	40%	_	ADJ	JJ	_	10	nmod	_	_
13	for	_	ADP	IN	_	14	case	_	_
14	Cmax	_	NOUN	NN	_	12	nmod	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	30%	_	NOUN	NN	_	14	conj	_	_
17	for	_	ADP	IN	_	18	case	_	_
18	AUC	_	NOUN	NN	_	14	nmod	_	_
19	in	_	ADP	IN	_	22	case	_	_
20	healthy	_	ADJ	JJ	_	22	amod	_	_
21	elderly	_	ADJ	JJ	_	22	amod	_	_
22	subjects	_	NOUN	NNS	_	12	nmod	_	_
23	age	_	VERB	VBP	_	12	dep	_	_
24	>65	_	NUM	CD	_	25	nummod	_	_
25	years	_	NOUN	NNS	_	23	dobj	_	_
26	than	_	ADP	IN	_	29	case	_	_
27	in	_	ADP	IN	_	29	case	_	_
28	young	_	ADJ	JJ	_	29	amod	_	_
29	adults	_	NOUN	NNS	_	23	nmod	_	_

#	Lipitor	3129
1	Clinical	_	ADJ	JJ	_	2	amod	_	_
2	data	_	NOUN	NNS	_	3	nsubj	_	_
3	suggest	_	VERB	VBP	_	0	root	_	_
4	a	_	DET	DT	_	6	det	_	_
5	greater	_	ADJ	JJ	_	6	amod	_	_
6	degree	_	NOUN	NN	_	3	dobj	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	LDL	_	NOUN	NN	_	6	nmod	_	_
9	lowering	_	VERB	VBG	_	8	acl	_	_
10	at	_	ADP	IN	_	12	case	_	_
11	any	_	DET	DT	_	12	det	_	_
12	dose	_	NOUN	NN	_	9	nmod	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	drug	_	NOUN	NN	_	12	nmod	_	_
15	in	_	ADP	IN	_	19	case	_	_
16	the	_	DET	DT	_	19	det	_	_
17	elderly	_	ADJ	JJ	_	19	amod	_	_
18	patient	_	NOUN	NN	_	19	compound	_	_
19	population	_	NOUN	NN	_	12	nmod	_	_
20	compared	_	VERB	VBN	_	23	case	_	_
21	to	_	PRT	TO	_	23	case	_	_
22	younger	_	ADJ	JJ	_	23	amod	_	_
23	adults	_	NOUN	NNS	_	3	nmod	_	_

#	Lipitor	3130
1	Pediatric	_	ADJ	JJ	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Apparent	_	ADJ	JJ	_	5	amod	_	_
4	oral	_	ADJ	JJ	_	5	amod	_	_
5	clearance	_	NOUN	NN	_	11	nsubj	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	in	_	ADP	IN	_	10	case	_	_
9	pediatric	_	ADJ	JJ	_	10	amod	_	_
10	subjects	_	NOUN	NNS	_	5	nmod	_	_
11	appeared	_	VERB	VBD	_	1	dep	_	_
12	similar	_	ADJ	JJ	_	11	xcomp	_	_
13	to	_	PRT	TO	_	14	case	_	_
14	that	_	DET	DT	_	12	nmod	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	adults	_	NOUN	NNS	_	14	nmod	_	_
17	when	_	ADV	WRB	_	18	advmod	_	_
18	scaled	_	VERB	VBN	_	11	advcl	_	_
19	allometrically	_	ADV	RB	_	18	advmod	_	_
20	by	_	ADP	IN	_	22	case	_	_
21	body	_	NOUN	NN	_	22	compound	_	_
22	weight	_	NOUN	NN	_	18	nmod	_	_
23	as	_	ADP	IN	_	26	case	_	_
24	the	_	DET	DT	_	26	det	_	_
25	body	_	NOUN	NN	_	26	compound	_	_
26	weight	_	NOUN	NN	_	18	nmod	_	_
27	was	_	VERB	VBD	_	31	cop	_	_
28	the	_	DET	DT	_	31	det	_	_
29	only	_	ADV	RB	_	30	advmod	_	_
30	significant	_	ADJ	JJ	_	31	amod	_	_
31	covariate	_	NOUN	NN	_	18	parataxis	_	_
32	in	_	ADP	IN	_	36	case	_	_
33	DRUG	_	NOUN	NN	_	36	compound	_	_
34	population	_	NOUN	NN	_	36	compound	_	_
35	PK	_	NOUN	NN	_	36	compound	_	_
36	model	_	NOUN	NN	_	31	nmod	_	_
37	with	_	ADP	IN	_	38	case	_	_
38	data	_	NOUN	NNS	_	36	nmod	_	_
39	including	_	ADP	IN	_	42	case	_	_
40	pediatric	_	ADJ	JJ	_	42	amod	_	_
41	HeFH	_	NOUN	NN	_	42	compound	_	_
42	patients	_	NOUN	NNS	_	38	nmod	_	_
43	ages	_	VERB	VBZ	_	31	dep	_	_
44	10	_	NUM	CD	_	45	nummod	_	_
45	years	_	NOUN	NNS	_	43	nmod	_	_
46	to	_	PRT	TO	_	48	case	_	_
47	17	_	NUM	CD	_	48	nummod	_	_
48	years	_	NOUN	NNS	_	45	nmod	_	_
49	of	_	ADP	IN	_	50	case	_	_
50	age	_	NOUN	NN	_	48	nmod	_	_
51	,	_	.	,	_	45	punct	_	_
52	n=29	_	NOUN	NN	_	45	appos	_	_
53	in	_	ADP	IN	_	56	case	_	_
54	an	_	DET	DT	_	56	det	_	_
55	open	_	ADJ	JJ	_	56	amod	_	_
56	label	_	NOUN	NN	_	52	nmod	_	_
57	,	_	.	,	_	45	punct	_	_
58	8	_	NUM	CD	_	60	nummod	_	_
59	week	_	NOUN	NN	_	60	compound	_	_
60	study	_	NOUN	NN	_	45	appos	_	_

#	Lipitor	3131
1	Gender	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Plasma	_	NOUN	NN	_	4	compound	_	_
4	concentrations	_	NOUN	NNS	_	9	nsubj	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	in	_	ADP	IN	_	8	case	_	_
8	women	_	NOUN	NNS	_	4	nmod	_	_
9	differ	_	VERB	VBP	_	27	advcl	_	_
10	from	_	ADP	IN	_	11	case	_	_
11	those	_	DET	DT	_	9	nmod	_	_
12	in	_	ADP	IN	_	13	case	_	_
13	men	_	NOUN	NN	_	11	nmod	_	_
14	approximately	_	ADV	RB	_	15	advmod	_	_
15	20%	_	ADJ	JJ	_	13	amod	_	_
16	higher	_	ADJ	JJ	_	15	amod	_	_
17	for	_	ADP	IN	_	18	case	_	_
18	Cmax	_	NOUN	NN	_	16	nmod	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	10%	_	NOUN	NN	_	18	conj	_	_
21	lower	_	ADJ	JJ	_	18	amod	_	_
22	for	_	ADP	IN	_	23	case	_	_
23	AUC	_	NOUN	NN	_	21	nmod	_	_
24	however	_	ADV	RB	_	16	advmod	_	_
25	,	_	.	,	_	27	punct	_	_
26	there	_	DET	EX	_	27	expl	_	_
27	is	_	VERB	VBZ	_	1	dep	_	_
28	no	_	DET	DT	_	31	neg	_	_
29	clinically	_	ADV	RB	_	30	advmod	_	_
30	significant	_	ADJ	JJ	_	31	amod	_	_
31	difference	_	NOUN	NN	_	27	nsubj	_	_
32	in	_	ADP	IN	_	35	case	_	_
33	LDL	_	NOUN	NN	_	35	compound	_	_
34	C	_	NOUN	NN	_	35	compound	_	_
35	reduction	_	NOUN	NN	_	31	nmod	_	_
36	with	_	ADP	IN	_	37	case	_	_
37	DRUG	_	NOUN	NN	_	35	nmod	_	_
38	between	_	ADP	IN	_	39	case	_	_
39	men	_	NOUN	NN	_	35	nmod	_	_
40	and	_	CONJ	CC	_	39	cc	_	_
41	women	_	NOUN	NNS	_	39	conj	_	_

#	Lipitor	3132
1	Renal	_	ADJ	JJ	_	2	amod	_	_
2	Impairment	_	NOUN	NN	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	Renal	_	ADJ	JJ	_	5	amod	_	_
5	disease	_	NOUN	NN	_	6	nsubj	_	_
6	has	_	VERB	VBZ	_	2	dep	_	_
7	no	_	DET	DT	_	8	neg	_	_
8	influence	_	VERB	VB	_	6	dobj	_	_
9	on	_	ADP	IN	_	12	case	_	_
10	the	_	DET	DT	_	12	det	_	_
11	plasma	_	NOUN	NN	_	12	compound	_	_
12	concentrations	_	NOUN	NNS	_	8	nmod	_	_
13	or	_	CONJ	CC	_	12	cc	_	_
14	LDL	_	NOUN	NN	_	16	compound	_	_
15	C	_	NOUN	NN	_	16	compound	_	_
16	reduction	_	NOUN	NN	_	12	conj	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	DRUG	_	NOUN	NN	_	12	nmod	_	_
19	thus	_	ADV	RB	_	8	advmod	_	_
20	,	_	.	,	_	6	punct	_	_
21	dose	_	NOUN	NN	_	22	compound	_	_
22	adjustment	_	NOUN	NN	_	30	nsubj	_	_
23	in	_	ADP	IN	_	24	case	_	_
24	patients	_	NOUN	NNS	_	22	nmod	_	_
25	with	_	ADP	IN	_	27	case	_	_
26	renal	_	ADJ	JJ	_	27	amod	_	_
27	dysfunction	_	NOUN	NN	_	24	nmod	_	_
28	is	_	VERB	VBZ	_	30	auxpass	_	_
29	not	_	ADV	RB	_	30	neg	_	_
30	necessary	_	ADJ	JJ	_	6	parataxis	_	_

#	Lipitor	3133
1	Hemodialysis	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	While	_	ADP	IN	_	8	mark	_	_
4	studies	_	NOUN	NNS	_	8	nsubjpass	_	_
5	have	_	VERB	VBP	_	8	aux	_	_
6	not	_	ADV	RB	_	8	neg	_	_
7	been	_	VERB	VBN	_	8	auxpass	_	_
8	conducted	_	VERB	VBN	_	20	advcl	_	_
9	in	_	ADP	IN	_	10	case	_	_
10	patients	_	NOUN	NNS	_	8	nmod	_	_
11	with	_	ADP	IN	_	15	case	_	_
12	end	_	NOUN	NN	_	15	compound	_	_
13	stage	_	NOUN	NN	_	15	compound	_	_
14	renal	_	ADJ	JJ	_	15	amod	_	_
15	disease	_	NOUN	NN	_	10	nmod	_	_
16	,	_	.	,	_	20	punct	_	_
17	hemodialysis	_	NOUN	NN	_	20	nsubjpass	_	_
18	is	_	VERB	VBZ	_	20	auxpass	_	_
19	not	_	ADV	RB	_	20	neg	_	_
20	expected	_	VERB	VBN	_	1	dep	_	_
21	to	_	PRT	TO	_	23	mark	_	_
22	significantly	_	ADV	RB	_	23	advmod	_	_
23	enhance	_	VERB	VB	_	20	xcomp	_	_
24	clearance	_	NOUN	NN	_	23	dobj	_	_
25	of	_	ADP	IN	_	26	case	_	_
26	DRUG	_	NOUN	NN	_	24	nmod	_	_
27	since	_	ADP	IN	_	32	mark	_	_
28	the	_	DET	DT	_	29	det	_	_
29	drug	_	NOUN	NN	_	32	nsubjpass	_	_
30	is	_	VERB	VBZ	_	32	auxpass	_	_
31	extensively	_	ADV	RB	_	32	advmod	_	_
32	bound	_	VERB	VBN	_	23	advcl	_	_
33	to	_	PRT	TO	_	35	case	_	_
34	plasma	_	NOUN	NN	_	35	compound	_	_
35	proteins	_	NOUN	NNS	_	32	nmod	_	_

#	Lipitor	3134
1	Hepatic	_	ADJ	JJ	_	2	amod	_	_
2	Impairment	_	NOUN	NN	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	In	_	ADP	IN	_	5	case	_	_
5	patients	_	NOUN	NNS	_	2	nmod	_	_
6	with	_	ADP	IN	_	10	case	_	_
7	chronic	_	ADJ	JJ	_	10	amod	_	_
8	alcoholic	_	ADJ	JJ	_	10	amod	_	_
9	liver	_	NOUN	NN	_	10	compound	_	_
10	disease	_	NOUN	NN	_	5	nmod	_	_
11	,	_	.	,	_	2	punct	_	_
12	plasma	_	NOUN	NN	_	13	compound	_	_
13	concentrations	_	NOUN	NNS	_	18	nsubjpass	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	DRUG	_	NOUN	NN	_	13	nmod	_	_
16	are	_	VERB	VBP	_	18	auxpass	_	_
17	markedly	_	ADV	RB	_	18	advmod	_	_
18	increased	_	VERB	VBN	_	2	dep	_	_

#	Lipitor	3135
1	Cmax	_	NOUN	NN	_	7	nsubj	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	AUC	_	NOUN	NN	_	1	conj	_	_
4	are	_	VERB	VBP	_	7	cop	_	_
5	each	_	DET	DT	_	7	det	_	_
6	4	_	NUM	CD	_	7	nummod	_	_
7	fold	_	NOUN	NN	_	0	root	_	_
8	greater	_	ADJ	JJ	_	7	amod	_	_
9	in	_	ADP	IN	_	10	case	_	_
10	patients	_	NOUN	NNS	_	8	nmod	_	_
11	with	_	ADP	IN	_	15	case	_	_
12	Childs	_	NOUN	NN	_	15	compound	_	_
13	Pugh	_	NOUN	NN	_	15	compound	_	_
14	A	_	NOUN	NN	_	15	compound	_	_
15	disease	_	NOUN	NN	_	10	nmod	_	_

#	Lipitor	3136
1	Cmax	_	NOUN	NN	_	7	nsubj	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	AUC	_	NOUN	NN	_	1	conj	_	_
4	are	_	VERB	VBP	_	7	cop	_	_
5	approximately	_	ADV	RB	_	6	advmod	_	_
6	16	_	NUM	CD	_	7	nummod	_	_
7	fold	_	NOUN	NN	_	0	root	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	11	_	NUM	CD	_	10	nummod	_	_
10	fold	_	NOUN	NN	_	7	conj	_	_
11	increased	_	VERB	VBN	_	10	acl	_	_
12	,	_	.	,	_	7	punct	_	_
13	respectively	_	ADV	RB	_	7	advmod	_	_
14	,	_	.	,	_	7	punct	_	_
15	in	_	ADP	IN	_	16	case	_	_
16	patients	_	NOUN	NNS	_	7	nmod	_	_
17	with	_	ADP	IN	_	21	case	_	_
18	Childs	_	NOUN	NN	_	21	compound	_	_
19	Pugh	_	NOUN	NN	_	21	compound	_	_
20	B	_	NOUN	NN	_	21	compound	_	_
21	disease	_	NOUN	NN	_	16	nmod	_	_

#	Lipitor	3137
1	Effect	_	NOUN	NN	_	29	nsubj	_	_
2	of	_	ADP	IN	_	5	case	_	_
3	Co	_	NOUN	NN	_	5	compound	_	_
4	administered	_	ADJ	JJ	_	5	amod	_	_
5	Drugs	_	NOUN	NNS	_	1	nmod	_	_
6	on	_	ADP	IN	_	8	case	_	_
7	the	_	DET	DT	_	8	det	_	_
8	Pharmacokinetics	_	NOUN	NNS	_	1	nmod	_	_
9	of	_	ADP	IN	_	13	case	_	_
10	DRUG	_	NOUN	NN	_	13	compound	_	_
11	Co	_	NOUN	NN	_	13	compound	_	_
12	administered	_	ADJ	JJ	_	13	amod	_	_
13	drug	_	NOUN	NN	_	8	nmod	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	dosing	_	VERB	VBG	_	20	amod	_	_
16	regimen	_	NOUN	NN	_	20	compound	_	_
17	DRUG	_	NOUN	NN	_	20	compound	_	_
18	Dose	_	NOUN	NN	_	20	compound	_	_
19	mg	_	NOUN	NN	_	20	compound	_	_
20	Change	_	NOUN	NN	_	13	conj	_	_
21	in	_	ADP	IN	_	23	case	_	_
22	AUC	_	NOUN	NN	_	23	compound	_	_
23	Data	_	NOUN	NN	_	8	nmod	_	_
24	given	_	VERB	VBN	_	23	acl	_	_
25	as	_	ADP	IN	_	28	case	_	_
26	x	_	NOUN	NN	_	28	compound	_	_
27	fold	_	NOUN	NN	_	28	compound	_	_
28	change	_	NOUN	NN	_	24	nmod	_	_
29	represent	_	VERB	VBP	_	0	root	_	_
30	a	_	DET	DT	_	32	det	_	_
31	simple	_	ADJ	JJ	_	32	amod	_	_
32	ratio	_	NOUN	NN	_	29	dobj	_	_
33	between	_	ADP	IN	_	35	case	_	_
34	co	_	PRT	TO	_	35	case	_	_
35	administration	_	NOUN	NN	_	32	nmod	_	_
36	and	_	CONJ	CC	_	35	cc	_	_
37	DRUG	_	NOUN	NN	_	35	conj	_	_
38	alone	_	ADV	RB	_	39	advmod	_	_
39	i.e	_	ADV	RB	_	32	advmod	_	_
40	,	_	.	,	_	32	punct	_	_
41	1	_	NUM	CD	_	42	nummod	_	_
42	fold	_	NOUN	NN	_	32	conj	_	_
43	=	_	ADJ	JJ	_	45	compound	_	_
44	no	_	DET	DT	_	45	neg	_	_
45	change	_	NOUN	NN	_	29	dobj	_	_

#	Lipitor	3138
1	Data	_	NOUN	NN	_	6	nsubj	_	_
2	given	_	VERB	VBN	_	1	acl	_	_
3	as	_	ADP	IN	_	5	case	_	_
4	%	_	NOUN	NN	_	5	compound	_	_
5	change	_	NOUN	NN	_	2	nmod	_	_
6	represent	_	VERB	VBP	_	0	root	_	_
7	%	_	NOUN	NN	_	8	compound	_	_
8	difference	_	NOUN	NN	_	6	dobj	_	_
9	relative	_	ADJ	JJ	_	6	advmod	_	_
10	to	_	PRT	TO	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_
12	alone	_	ADV	RB	_	13	advmod	_	_
13	i.e	_	ADV	RB	_	11	amod	_	_
14	,	_	.	,	_	6	punct	_	_
15	0%	_	ADJ	JJ	_	18	compound	_	_
16	=	_	ADJ	JJ	_	18	compound	_	_
17	no	_	DET	DT	_	18	nummod	_	_
18	change	_	NOUN	NN	_	6	dobj	_	_

#	Lipitor	3139
1	Change	_	NOUN	NN	_	0	root	_	_
2	in	_	ADP	IN	_	5	case	_	_
3	Cmax	_	NOUN	NN	_	5	compound	_	_
4	See	_	NOUN	NN	_	5	compound	_	_
5	Sections	_	NOUN	NNS	_	1	nmod	_	_
6	5.1	_	NUM	CD	_	5	dep	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	7	_	NUM	CD	_	6	conj	_	_
9	for	_	ADP	IN	_	11	case	_	_
10	clinical	_	ADJ	JJ	_	11	amod	_	_
11	significance	_	NOUN	NN	_	1	nmod	_	_

#	Lipitor	3140
1	Cyclosporine	_	NOUN	NN	_	3	compound	_	_
2	5.2	_	NUM	CD	_	3	nummod	_	_
3	mg	_	NOUN	NN	_	7	compound	_	_
4	/	_	.	:	_	5	punct	_	_
5	kg	_	NOUN	NN	_	3	appos	_	_
6	/	_	.	:	_	5	punct	_	_
7	day	_	NOUN	NN	_	21	case	_	_
8	,	_	.	,	_	7	punct	_	_
9	stable	_	ADJ	JJ	_	13	amod	_	_
10	dose	_	NOUN	NN	_	13	compound	_	_
11	10	_	NUM	CD	_	13	nummod	_	_
12	mg	_	NOUN	NN	_	13	compound	_	_
13	QD	_	NOUN	NN	_	7	appos	_	_
14	for	_	ADP	IN	_	16	case	_	_
15	28	_	NUM	CD	_	16	nummod	_	_
16	days	_	NOUN	NNS	_	13	nmod	_	_
17	*	_	CONJ	CC	_	18	advmod	_	_
18	8.7	_	NUM	CD	_	20	compound	_	_
19	fold	_	NOUN	NN	_	20	advmod	_	_
20	10.7	_	NUM	CD	_	13	nummod	_	_
21	fold	_	VERB	VBD	_	0	root	_	_

#	Lipitor	3141
1	The	_	DET	DT	_	2	det	_	_
2	increase	_	NOUN	NN	_	10	nsubj	_	_
3	in	_	ADP	IN	_	5	case	_	_
4	DRUG	_	NOUN	NN	_	5	compound	_	_
5	exposure	_	NOUN	NN	_	2	nmod	_	_
6	when	_	ADV	WRB	_	7	advmod	_	_
7	used	_	VERB	VBN	_	2	acl	_	_
8	clinically	_	ADV	RB	_	7	advmod	_	_
9	is	_	VERB	VBZ	_	10	cop	_	_
10	likely	_	ADJ	JJ	_	0	root	_	_
11	to	_	PRT	TO	_	13	mark	_	_
12	be	_	VERB	VB	_	13	cop	_	_
13	higher	_	ADJ	JJ	_	10	xcomp	_	_
14	than	_	ADP	IN	_	15	case	_	_
15	what	_	DET	DT	_	13	nmod	_	_
16	was	_	VERB	VBD	_	17	auxpass	_	_
17	observed	_	VERB	VBN	_	13	parataxis	_	_
18	in	_	ADP	IN	_	20	case	_	_
19	this	_	DET	DT	_	20	det	_	_
20	study	_	NOUN	NN	_	17	nmod	_	_

#	Lipitor	3142
1	Therefore	_	ADV	RB	_	6	advmod	_	_
2	,	_	.	,	_	6	punct	_	_
3	caution	_	NOUN	NN	_	6	nsubjpass	_	_
4	should	_	VERB	MD	_	6	aux	_	_
5	be	_	VERB	VB	_	6	auxpass	_	_
6	applied	_	VERB	VBN	_	0	root	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	the	_	DET	DT	_	11	det	_	_
9	lowest	_	ADJ	JJ	_	11	amod	_	_
10	dose	_	NOUN	NN	_	11	compound	_	_
11	necessary	_	NOUN	NN	_	17	nsubj	_	_
12	should	_	VERB	MD	_	17	aux	_	_
13	be	_	VERB	VB	_	17	cop	_	_
14	used.Saquinavir	_	ADJ	JJ	_	17	amod	_	_
15	400	_	NUM	CD	_	17	nummod	_	_
16	mg	_	NOUN	NN	_	17	compound	_	_
17	BID	_	NOUN	NN	_	6	conj	_	_
18	/	_	.	:	_	17	punct	_	_
19	ritonavir	_	ADJ	JJ	_	21	amod	_	_
20	400mg	_	ADJ	JJ	_	21	amod	_	_
21	BID	_	NOUN	NN	_	17	dep	_	_
22	,	_	.	,	_	21	punct	_	_
23	15	_	NUM	CD	_	24	nummod	_	_
24	days	_	NOUN	NNS	_	21	appos	_	_
25	40	_	NUM	CD	_	27	nummod	_	_
26	mg	_	NOUN	NN	_	27	compound	_	_
27	QD	_	NOUN	NN	_	24	dep	_	_
28	for	_	ADP	IN	_	30	case	_	_
29	4	_	NUM	CD	_	30	nummod	_	_
30	days	_	NOUN	NNS	_	27	nmod	_	_
31	*	_	CONJ	CC	_	32	advmod	_	_
32	3.9	_	NUM	CD	_	33	nummod	_	_
33	fold	_	NOUN	NN	_	35	advmod	_	_
34	*	_	CONJ	CC	_	35	advmod	_	_
35	4.3	_	NUM	CD	_	40	nummod	_	_
36	fold	_	NOUN	NN	_	40	amod	_	_
37	Clarithromycin	_	NOUN	NN	_	40	compound	_	_
38	500	_	NUM	CD	_	40	nummod	_	_
39	mg	_	NOUN	NN	_	40	compound	_	_
40	BID	_	NOUN	NN	_	27	dep	_	_
41	,	_	.	,	_	21	punct	_	_
42	9	_	NUM	CD	_	43	nummod	_	_
43	days	_	NOUN	NNS	_	21	appos	_	_
44	80	_	NUM	CD	_	46	nummod	_	_
45	mg	_	NOUN	NN	_	46	compound	_	_
46	QD	_	NOUN	NN	_	43	dep	_	_
47	for	_	ADP	IN	_	49	case	_	_
48	8	_	NUM	CD	_	49	nummod	_	_
49	days	_	NOUN	NNS	_	46	nmod	_	_
50	*	_	CONJ	CC	_	51	advmod	_	_
51	4.4	_	NUM	CD	_	52	nummod	_	_
52	fold	_	NOUN	NN	_	54	advmod	_	_
53	*	_	CONJ	CC	_	54	advmod	_	_
54	5.4	_	NUM	CD	_	55	compound	_	_
55	fold	_	NOUN	NN	_	46	dep	_	_
56	Darunavir	_	ADJ	JJ	_	59	amod	_	_
57	300	_	NUM	CD	_	59	nummod	_	_
58	mg	_	NOUN	NN	_	59	compound	_	_
59	BID	_	NOUN	NN	_	55	dep	_	_
60	/	_	.	:	_	21	punct	_	_
61	ritonavir	_	ADJ	JJ	_	62	advmod	_	_
62	100	_	NUM	CD	_	63	compound	_	_
63	mg	_	NOUN	NN	_	102	dep	_	_
64	BID	_	NOUN	NN	_	63	dep	_	_
65	,	_	.	,	_	63	punct	_	_
66	9	_	NUM	CD	_	67	nummod	_	_
67	days	_	NOUN	NNS	_	63	appos	_	_
68	10	_	NUM	CD	_	70	nummod	_	_
69	mg	_	NOUN	NN	_	70	compound	_	_
70	QD	_	NOUN	NN	_	67	dep	_	_
71	for	_	ADP	IN	_	73	case	_	_
72	4	_	NUM	CD	_	73	nummod	_	_
73	days	_	NOUN	NNS	_	67	nmod	_	_
74	*	_	CONJ	CC	_	75	advmod	_	_
75	3.4	_	NUM	CD	_	76	nummod	_	_
76	fold	_	NOUN	NN	_	78	advmod	_	_
77	*	_	CONJ	CC	_	78	advmod	_	_
78	2.25	_	NUM	CD	_	83	nummod	_	_
79	fold	_	NOUN	NN	_	83	compound	_	_
80	Itraconazole	_	NOUN	NN	_	83	compound	_	_
81	200	_	NUM	CD	_	83	nummod	_	_
82	mg	_	NOUN	NN	_	83	compound	_	_
83	QD	_	NOUN	NN	_	73	dep	_	_
84	,	_	.	,	_	63	punct	_	_
85	4	_	NUM	CD	_	86	nummod	_	_
86	days	_	NOUN	NNS	_	63	appos	_	_
87	40	_	NUM	CD	_	89	nummod	_	_
88	mg	_	NOUN	NN	_	89	compound	_	_
89	SD	_	NOUN	NN	_	98	compound	_	_
90	*	_	CONJ	CC	_	91	advmod	_	_
91	3.3	_	NUM	CD	_	92	nummod	_	_
92	fold	_	NOUN	NN	_	98	dep	_	_
93	*	_	CONJ	CC	_	98	nummod	_	_
94	20%	_	ADJ	JJ	_	98	amod	_	_
95	Fosamprenavir	_	ADJ	JJ	_	98	amod	_	_
96	700	_	NUM	CD	_	98	nummod	_	_
97	mg	_	NOUN	NN	_	98	compound	_	_
98	BID	_	NOUN	NN	_	86	dep	_	_
99	/	_	.	:	_	63	punct	_	_
100	ritonavir	_	NOUN	NN	_	101	advmod	_	_
101	100	_	NUM	CD	_	102	compound	_	_
102	mg	_	NOUN	NN	_	103	amod	_	_
103	BID	_	NOUN	NN	_	179	nsubjpass	_	_
104	,	_	.	,	_	103	punct	_	_
105	14	_	NUM	CD	_	106	nummod	_	_
106	days	_	NOUN	NNS	_	103	appos	_	_
107	10	_	NUM	CD	_	109	nummod	_	_
108	mg	_	NOUN	NN	_	109	compound	_	_
109	QD	_	NOUN	NN	_	106	dep	_	_
110	for	_	ADP	IN	_	112	case	_	_
111	4	_	NUM	CD	_	112	nummod	_	_
112	days	_	NOUN	NNS	_	109	nmod	_	_
113	*	_	CONJ	CC	_	114	advmod	_	_
114	2.53	_	NUM	CD	_	115	nummod	_	_
115	fold	_	NOUN	NN	_	117	advmod	_	_
116	*	_	CONJ	CC	_	117	advmod	_	_
117	2.84	_	NUM	CD	_	118	compound	_	_
118	fold	_	NOUN	NN	_	112	nmod	_	_
119	Fosamprenavir	_	ADJ	JJ	_	122	amod	_	_
120	1400	_	NUM	CD	_	122	nummod	_	_
121	mg	_	NOUN	NN	_	122	compound	_	_
122	BID	_	NOUN	NN	_	118	dep	_	_
123	,	_	.	,	_	103	punct	_	_
124	14	_	NUM	CD	_	125	nummod	_	_
125	days	_	NOUN	NNS	_	103	appos	_	_
126	10	_	NUM	CD	_	128	nummod	_	_
127	mg	_	NOUN	NN	_	128	compound	_	_
128	QD	_	NOUN	NN	_	125	dep	_	_
129	for	_	ADP	IN	_	131	case	_	_
130	4	_	NUM	CD	_	131	nummod	_	_
131	days	_	NOUN	NNS	_	128	nmod	_	_
132	*	_	CONJ	CC	_	133	advmod	_	_
133	2.3	_	NUM	CD	_	134	nummod	_	_
134	fold	_	NOUN	NN	_	136	advmod	_	_
135	*	_	ADJ	JJ	_	136	advmod	_	_
136	4.04	_	NUM	CD	_	137	nummod	_	_
137	fold	_	NOUN	NN	_	138	dep	_	_
138	Nelfinavir	_	NOUN	NN	_	131	nmod	_	_
139	1250	_	NUM	CD	_	141	nummod	_	_
140	mg	_	NOUN	NN	_	141	compound	_	_
141	BID	_	NOUN	NN	_	138	dep	_	_
142	,	_	.	,	_	103	punct	_	_
143	14	_	NUM	CD	_	144	nummod	_	_
144	days	_	NOUN	NNS	_	103	appos	_	_
145	10	_	NUM	CD	_	147	nummod	_	_
146	mg	_	NOUN	NN	_	147	compound	_	_
147	QD	_	NOUN	NN	_	144	dep	_	_
148	for	_	ADP	IN	_	150	case	_	_
149	28	_	NUM	CD	_	150	nummod	_	_
150	days	_	NOUN	NNS	_	147	nmod	_	_
151	*	_	CONJ	CC	_	157	case	_	_
152	74%	_	ADJ	JJ	_	157	amod	_	_
153	*	_	CONJ	CC	_	154	advmod	_	_
154	2.2	_	NUM	CD	_	155	compound	_	_
155	fold	_	NOUN	NN	_	157	amod	_	_
156	Grapefruit	_	NOUN	NN	_	157	amod	_	_
157	Juice	_	NOUN	NN	_	147	nmod	_	_
158	,	_	.	,	_	103	punct	_	_
159	240	_	NUM	CD	_	163	nummod	_	_
160	mL	_	NOUN	NN	_	162	nmod:npmod	_	_
161	QD	_	NOUN	NN	_	162	nmod:npmod	_	_
162	Greater	_	ADJ	JJ	_	163	amod	_	_
163	increases	_	NOUN	NNS	_	103	appos	_	_
164	in	_	ADP	IN	_	165	case	_	_
165	AUC	_	NOUN	NN	_	163	nmod	_	_
166	up	_	ADV	RB	_	168	advmod	_	_
167	to	_	PRT	TO	_	166	mwe	_	_
168	2.5	_	NUM	CD	_	169	nummod	_	_
169	fold	_	NOUN	NN	_	163	nmod	_	_
170	and	_	CONJ	CC	_	169	cc	_	_
171	/	_	NOUN	NN	_	169	conj	_	_
172	or	_	CONJ	CC	_	169	cc	_	_
173	Cmax	_	NOUN	NN	_	169	conj	_	_
174	up	_	ADV	RB	_	173	amod	_	_
175	to	_	PRT	TO	_	176	case	_	_
176	71%	_	NOUN	NN	_	174	nmod	_	_
177	have	_	VERB	VBP	_	179	aux	_	_
178	been	_	VERB	VBN	_	179	auxpass	_	_
179	reported	_	VERB	VBN	_	21	parataxis	_	_
180	with	_	ADP	IN	_	188	case	_	_
181	excessive	_	ADJ	JJ	_	188	amod	_	_
182	grapefruit	_	ADJ	JJ	_	188	compound	_	_
183	consumption	_	NOUN	NN	_	188	compound	_	_
184	>	_	NUM	CD	_	188	nummod	_	_
185	750	_	NUM	CD	_	188	nummod	_	_
186	mL	_	NOUN	NN	_	188	compound	_	_
187	1.2	_	NUM	CD	_	188	nummod	_	_
188	liters	_	NOUN	NNS	_	179	nmod	_	_
189	per	_	ADP	IN	_	190	case	_	_
190	day	_	NOUN	NN	_	188	nmod	_	_

#	Lipitor	3143
1	40	_	NUM	CD	_	2	nummod	_	_
2	mg	_	NOUN	NN	_	0	root	_	_
3	,	_	.	,	_	2	punct	_	_
4	SD	_	NOUN	NN	_	12	compound	_	_
5	*	_	CONJ	CC	_	12	nummod	_	_
6	37%	_	ADJ	JJ	_	12	amod	_	_
7	*	_	CONJ	CC	_	12	amod	_	_
8	16%	_	ADJ	JJ	_	12	amod	_	_
9	Diltiazem	_	NOUN	NN	_	12	compound	_	_
10	240	_	NUM	CD	_	12	nummod	_	_
11	mg	_	NOUN	NN	_	12	compound	_	_
12	QD	_	NOUN	NN	_	2	appos	_	_
13	,	_	.	,	_	2	punct	_	_
14	28	_	NUM	CD	_	15	nummod	_	_
15	days	_	NOUN	NNS	_	2	appos	_	_
16	40	_	NUM	CD	_	17	nummod	_	_
17	mg	_	NOUN	NN	_	15	dep	_	_
18	,	_	.	,	_	2	punct	_	_
19	SD	_	NOUN	NN	_	27	compound	_	_
20	*	_	CONJ	CC	_	27	nummod	_	_
21	51%	_	ADJ	JJ	_	27	amod	_	_
22	No	_	NOUN	NN	_	27	compound	_	_
23	change	_	NOUN	NN	_	27	compound	_	_
24	Erythromycin	_	NOUN	NN	_	27	compound	_	_
25	500	_	NUM	CD	_	27	nummod	_	_
26	mg	_	NOUN	NN	_	27	compound	_	_
27	QID	_	NOUN	NN	_	2	appos	_	_
28	,	_	.	,	_	2	punct	_	_
29	7	_	NUM	CD	_	30	nummod	_	_
30	days	_	NOUN	NNS	_	2	appos	_	_
31	10	_	NUM	CD	_	32	nummod	_	_
32	mg	_	NOUN	NN	_	30	dep	_	_
33	,	_	.	,	_	2	punct	_	_
34	SD	_	NOUN	NN	_	41	compound	_	_
35	*	_	CONJ	CC	_	41	nummod	_	_
36	33%	_	ADJ	JJ	_	41	amod	_	_
37	*	_	CONJ	CC	_	41	amod	_	_
38	38%	_	ADJ	JJ	_	41	amod	_	_
39	Amlodipine	_	NOUN	NN	_	41	compound	_	_
40	10	_	NUM	CD	_	41	nummod	_	_
41	mg	_	NOUN	NN	_	2	conj	_	_
42	,	_	.	,	_	2	punct	_	_
43	single	_	ADJ	JJ	_	46	amod	_	_
44	dose	_	NOUN	NN	_	46	compound	_	_
45	80	_	NUM	CD	_	46	nummod	_	_
46	mg	_	NOUN	NN	_	2	appos	_	_
47	,	_	.	,	_	2	punct	_	_
48	SD	_	NOUN	NN	_	2	appos	_	_
49	*	_	CONJ	CC	_	48	nummod	_	_
50	15%	_	NOUN	NN	_	51	dep	_	_
51	*	_	CONJ	CC	_	49	dep	_	_
52	12	_	NUM	CD	_	57	nummod	_	_
53	%	_	NOUN	NN	_	57	compound	_	_
54	Cimetidine	_	NOUN	NN	_	57	compound	_	_
55	300	_	NUM	CD	_	57	nummod	_	_
56	mg	_	NOUN	NN	_	57	compound	_	_
57	QID	_	NOUN	NN	_	51	dep	_	_
58	,	_	.	,	_	2	punct	_	_
59	2	_	NUM	CD	_	60	compound	_	_
60	weeks	_	NOUN	NN	_	2	appos	_	_
61	10	_	NUM	CD	_	63	nummod	_	_
62	mg	_	NOUN	NN	_	63	compound	_	_
63	QD	_	NOUN	NN	_	60	dep	_	_
64	for	_	ADP	IN	_	66	case	_	_
65	2	_	NUM	CD	_	66	nummod	_	_
66	weeks	_	NOUN	NNS	_	60	nmod	_	_
67	*	_	ADP	IN	_	60	cc	_	_
68	Less	_	ADV	RB	_	67	mwe	_	_
69	than	_	ADP	IN	_	67	mwe	_	_
70	1%	_	ADJ	JJ	_	76	amod	_	_
71	*	_	CONJ	CC	_	76	amod	_	_
72	11%	_	ADJ	JJ	_	76	amod	_	_
73	Colestipol	_	NOUN	NN	_	76	compound	_	_
74	10	_	NUM	CD	_	76	nummod	_	_
75	mg	_	NOUN	NN	_	76	compound	_	_
76	BID	_	NOUN	NN	_	60	conj	_	_
77	,	_	.	,	_	2	punct	_	_
78	28	_	NUM	CD	_	79	nummod	_	_
79	weeks	_	NOUN	NN	_	2	appos	_	_
80	40	_	NUM	CD	_	82	nummod	_	_
81	mg	_	NOUN	NN	_	82	compound	_	_
82	QD	_	NOUN	NN	_	79	dep	_	_
83	for	_	ADP	IN	_	85	case	_	_
84	28	_	NUM	CD	_	85	nummod	_	_
85	weeks	_	NOUN	NNS	_	79	nmod	_	_
86	Not	_	ADV	RB	_	87	neg	_	_
87	determined	_	VERB	VBD	_	85	acl	_	_
88	*	_	DET	DT	_	90	det	_	_
89	26%Single	_	ADJ	JJ	_	90	amod	_	_
90	sample	_	NOUN	NN	_	87	dobj	_	_
91	taken	_	VERB	VBN	_	90	acl	_	_
92	8	_	NUM	CD	_	96	nummod	_	_
93	16	_	NUM	CD	_	96	nummod	_	_
94	h	_	NOUN	NN	_	96	compound	_	_
95	post	_	NOUN	NN	_	96	compound	_	_
96	dose	_	NOUN	NN	_	91	nmod	_	_

#	Lipitor	3144
1	Maalox	_	NOUN	NN	_	5	compound	_	_
2	TC*	_	NOUN	NN	_	5	compound	_	_
3	30	_	NUM	CD	_	5	nummod	_	_
4	mL	_	NOUN	NN	_	5	compound	_	_
5	QD	_	NOUN	NN	_	61	nsubjpass	_	_
6	,	_	.	,	_	5	punct	_	_
7	17	_	NUM	CD	_	8	nummod	_	_
8	days	_	NOUN	NNS	_	5	appos	_	_
9	10	_	NUM	CD	_	11	nummod	_	_
10	mg	_	NOUN	NN	_	11	compound	_	_
11	QD	_	NOUN	NN	_	8	dep	_	_
12	for	_	ADP	IN	_	14	case	_	_
13	15	_	NUM	CD	_	14	nummod	_	_
14	days	_	NOUN	NNS	_	8	nmod	_	_
15	*	_	CONJ	CC	_	22	neg	_	_
16	33%	_	ADJ	JJ	_	22	amod	_	_
17	*	_	CONJ	CC	_	22	nummod	_	_
18	34%	_	ADJ	JJ	_	22	amod	_	_
19	Efavirenz	_	NOUN	NN	_	22	compound	_	_
20	600	_	NUM	CD	_	22	nummod	_	_
21	mg	_	NOUN	NN	_	22	compound	_	_
22	QD	_	NOUN	NN	_	8	dep	_	_
23	,	_	.	,	_	5	punct	_	_
24	14	_	NUM	CD	_	25	nummod	_	_
25	days	_	NOUN	NNS	_	27	dep	_	_
26	10	_	NUM	CD	_	27	nummod	_	_
27	mg	_	NOUN	NN	_	5	appos	_	_
28	for	_	ADP	IN	_	30	case	_	_
29	3	_	NUM	CD	_	30	nummod	_	_
30	days	_	NOUN	NNS	_	27	nmod	_	_
31	*	_	CONJ	CC	_	38	neg	_	_
32	41%	_	ADJ	JJ	_	38	amod	_	_
33	*	_	CONJ	CC	_	38	amod	_	_
34	1%	_	ADJ	JJ	_	38	amod	_	_
35	Rifampin	_	NOUN	NN	_	38	compound	_	_
36	600	_	NUM	CD	_	38	nummod	_	_
37	mg	_	NOUN	NN	_	38	compound	_	_
38	QD	_	NOUN	NN	_	27	dep	_	_
39	,	_	.	,	_	5	punct	_	_
40	7	_	NUM	CD	_	41	nummod	_	_
41	days	_	NOUN	NNS	_	5	appos	_	_
42	co	_	PRT	TO	_	44	case	_	_
43	administered	_	VERB	VBN	_	44	amod	_	_
44	Due	_	NOUN	NN	_	41	nmod	_	_
45	to	_	PRT	TO	_	49	case	_	_
46	the	_	DET	DT	_	49	det	_	_
47	dual	_	ADJ	JJ	_	49	amod	_	_
48	interaction	_	NOUN	NN	_	49	compound	_	_
49	mechanism	_	NOUN	NN	_	41	nmod	_	_
50	of	_	ADP	IN	_	51	case	_	_
51	rifampin	_	NOUN	NN	_	49	nmod	_	_
52	,	_	.	,	_	5	punct	_	_
53	simultaneous	_	ADJ	JJ	_	55	amod	_	_
54	co	_	PRT	TO	_	55	case	_	_
55	administration	_	NOUN	NN	_	5	appos	_	_
56	of	_	ADP	IN	_	57	case	_	_
57	DRUG	_	NOUN	NN	_	55	nmod	_	_
58	with	_	ADP	IN	_	59	case	_	_
59	rifampin	_	NOUN	NN	_	55	nmod	_	_
60	is	_	VERB	VBZ	_	61	auxpass	_	_
61	recommended	_	VERB	VBN	_	0	root	_	_
62	,	_	.	,	_	61	punct	_	_
63	as	_	ADP	IN	_	74	mark	_	_
64	delayed	_	VERB	VBN	_	65	amod	_	_
65	administration	_	NOUN	NN	_	74	nsubjpass	_	_
66	of	_	ADP	IN	_	67	case	_	_
67	DRUG	_	NOUN	NN	_	65	nmod	_	_
68	after	_	ADP	IN	_	69	case	_	_
69	administration	_	NOUN	NN	_	65	nmod	_	_
70	of	_	ADP	IN	_	71	case	_	_
71	rifampin	_	NOUN	NN	_	69	nmod	_	_
72	has	_	VERB	VBZ	_	74	aux	_	_
73	been	_	VERB	VBN	_	74	auxpass	_	_
74	associated	_	VERB	VBN	_	61	advcl	_	_
75	with	_	ADP	IN	_	78	case	_	_
76	a	_	DET	DT	_	78	det	_	_
77	significant	_	ADJ	JJ	_	78	amod	_	_
78	reduction	_	NOUN	NN	_	74	nmod	_	_
79	in	_	ADP	IN	_	82	case	_	_
80	DRUG	_	NOUN	NN	_	82	compound	_	_
81	plasma	_	NOUN	NN	_	82	compound	_	_
82	concentrations	_	NOUN	NNS	_	78	nmod	_	_

#	Lipitor	3145
1	40	_	NUM	CD	_	3	nummod	_	_
2	mg	_	NOUN	NN	_	3	compound	_	_
3	SD	_	NOUN	NN	_	0	root	_	_
4	*	_	NUM	CD	_	3	amod	_	_
5	30%	_	NOUN	NN	_	4	dep	_	_
6	*	_	CONJ	CC	_	5	amod	_	_
7	2.7	_	NUM	CD	_	8	nummod	_	_
8	fold	_	NOUN	NN	_	6	dep	_	_
9	Rifampin	_	NOUN	NN	_	12	compound	_	_
10	600	_	NUM	CD	_	12	nummod	_	_
11	mg	_	NOUN	NN	_	12	compound	_	_
12	QD	_	NOUN	NN	_	8	dep	_	_
13	,	_	.	,	_	3	punct	_	_
14	5	_	NUM	CD	_	16	nummod	_	_
15	days	_	NOUN	NNS	_	16	compound	_	_
16	doses	_	NOUN	NNS	_	17	nsubj	_	_
17	separated	_	VERB	VBD	_	3	conj	_	_
18	40	_	NUM	CD	_	20	nummod	_	_
19	mg	_	NOUN	NN	_	20	compound	_	_
20	SD	_	NOUN	NN	_	27	compound	_	_
21	*	_	NUM	CD	_	27	nummod	_	_
22	80%	_	ADJ	JJ	_	27	amod	_	_
23	*	_	NUM	CD	_	27	nummod	_	_
24	40%	_	ADJ	JJ	_	27	amod	_	_
25	Gemfibrozil	_	NOUN	NN	_	27	compound	_	_
26	600mg	_	ADJ	JJ	_	27	amod	_	_
27	BID	_	NOUN	NN	_	17	dobj	_	_
28	,	_	.	,	_	3	punct	_	_
29	7	_	NUM	CD	_	30	nummod	_	_
30	days	_	NOUN	NNS	_	3	appos	_	_
31	40mg	_	ADJ	JJ	_	32	amod	_	_
32	SD	_	NOUN	NN	_	30	dep	_	_
33	*	_	CONJ	CC	_	41	case	_	_
34	35%	_	NOUN	NN	_	41	dep	_	_
35	*	_	ADJ	JJR	_	36	advmod	_	_
36	Less	_	ADV	RB	_	41	case	_	_
37	than	_	ADP	IN	_	36	mwe	_	_
38	1%	_	ADJ	JJ	_	41	amod	_	_
39	Fenofibrate	_	NOUN	NN	_	41	compound	_	_
40	160mg	_	ADJ	JJ	_	41	amod	_	_
41	QD	_	NOUN	NN	_	32	nmod	_	_
42	,	_	.	,	_	3	punct	_	_
43	7	_	NUM	CD	_	44	nummod	_	_
44	days	_	NOUN	NNS	_	3	appos	_	_
45	40mg	_	ADJ	JJ	_	46	amod	_	_
46	SD	_	NOUN	NN	_	54	compound	_	_
47	*	_	NUM	CD	_	54	punct	_	_
48	3%	_	NOUN	NN	_	54	amod	_	_
49	*	_	CONJ	CC	_	54	nummod	_	_
50	2%	_	NOUN	NN	_	54	amod	_	_
51	Boceprevir	_	NOUN	NN	_	54	amod	_	_
52	800	_	NUM	CD	_	54	nummod	_	_
53	mg	_	NOUN	NN	_	54	compound	_	_
54	TID	_	NOUN	NN	_	44	dep	_	_
55	,	_	.	,	_	3	punct	_	_
56	7	_	NUM	CD	_	57	nummod	_	_
57	days	_	NOUN	NNS	_	3	appos	_	_
58	40	_	NUM	CD	_	60	nummod	_	_
59	mg	_	NOUN	NN	_	60	compound	_	_
60	SD	_	NOUN	NN	_	65	compound	_	_
61	2.30	_	NUM	CD	_	60	nummod	_	_
62	fold	_	NOUN	NN	_	64	dep	_	_
63	2.66	_	NUM	CD	_	64	nummod	_	_
64	fold	_	NOUN	NN	_	65	compound	_	_
65	TABLE	_	NOUN	NN	_	57	nmod	_	_
66	4	_	NUM	CD	_	65	nummod	_	_

#	Lipitor	3146
1	Effect	_	NOUN	NN	_	0	root	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	on	_	ADP	IN	_	6	case	_	_
5	the	_	DET	DT	_	6	det	_	_
6	Pharmacokinetics	_	NOUN	NNS	_	1	nmod	_	_
7	of	_	ADP	IN	_	10	case	_	_
8	Co	_	NOUN	NN	_	10	compound	_	_
9	administered	_	ADJ	JJ	_	10	amod	_	_
10	Drugs	_	NOUN	NNS	_	6	nmod	_	_
11	DRUG	_	NOUN	NN	_	14	compound	_	_
12	Co	_	NOUN	NN	_	14	compound	_	_
13	administered	_	VERB	VBD	_	14	amod	_	_
14	drug	_	NOUN	NN	_	10	dep	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	dosing	_	VERB	VBG	_	18	amod	_	_
17	regimen	_	NOUN	NN	_	18	compound	_	_
18	Drug	_	NOUN	NN	_	14	conj	_	_
19	/	_	.	:	_	1	punct	_	_
20	Dose	_	NOUN	NN	_	22	compound	_	_
21	mg	_	NOUN	NN	_	22	compound	_	_
22	Change	_	NOUN	NN	_	1	dep	_	_
23	in	_	ADP	IN	_	25	case	_	_
24	AUC	_	NOUN	NN	_	25	compound	_	_
25	Change	_	NOUN	NN	_	22	nmod	_	_
26	in	_	ADP	IN	_	30	case	_	_
27	Cmax	_	NOUN	NN	_	30	compound	_	_
28	80	_	NUM	CD	_	30	nummod	_	_
29	mg	_	NOUN	NN	_	30	compound	_	_
30	QD	_	NOUN	NN	_	25	nmod	_	_
31	for	_	ADP	IN	_	34	case	_	_
32	15	_	NUM	CD	_	33	nummod	_	_
33	days	_	NOUN	NNS	_	34	compound	_	_
34	Antipyrine	_	NOUN	NN	_	25	nmod	_	_
35	,	_	.	,	_	22	punct	_	_
36	600	_	NUM	CD	_	38	nummod	_	_
37	mg	_	NOUN	NN	_	38	compound	_	_
38	SD	_	NOUN	NN	_	49	nsubj	_	_
39	*	_	NUM	CD	_	40	neg	_	_
40	3%	_	ADJ	JJ	_	38	amod	_	_
41	*	_	CONJ	CC	_	45	nummod	_	_
42	11%	_	ADJ	JJ	_	45	amod	_	_
43	80	_	NUM	CD	_	45	nummod	_	_
44	mg	_	NOUN	NN	_	45	compound	_	_
45	QD	_	NOUN	NN	_	40	dep	_	_
46	for	_	ADP	IN	_	48	case	_	_
47	14	_	NUM	CD	_	48	nummod	_	_
48	days	_	NOUN	NNS	_	38	nmod	_	_
49	See	_	VERB	VBP	_	22	dep	_	_
50	Section	_	NOUN	NN	_	49	dobj	_	_
51	7	_	NUM	CD	_	50	nummod	_	_
52	for	_	ADP	IN	_	54	case	_	_
53	clinical	_	ADJ	JJ	_	54	amod	_	_
54	significance	_	NOUN	NN	_	49	nmod	_	_

#	Lipitor	3147
1	Digoxin	_	NOUN	NN	_	4	compound	_	_
2	0.25	_	NUM	CD	_	4	nummod	_	_
3	mg	_	NOUN	NN	_	4	compound	_	_
4	QD	_	NOUN	NN	_	0	root	_	_
5	,	_	.	,	_	4	punct	_	_
6	20	_	NUM	CD	_	7	nummod	_	_
7	days	_	NOUN	NNS	_	15	nsubj	_	_
8	*	_	CONJ	CC	_	15	neg	_	_
9	15%	_	NOUN	NN	_	15	amod	_	_
10	*	_	CONJ	CC	_	11	dep	_	_
11	20	_	NUM	CD	_	12	compound	_	_
12	%	_	NOUN	NN	_	15	amod	_	_
13	40	_	NUM	CD	_	15	nummod	_	_
14	mg	_	NOUN	NN	_	15	compound	_	_
15	QD	_	NOUN	NN	_	4	appos	_	_
16	for	_	ADP	IN	_	18	case	_	_
17	22	_	NUM	CD	_	18	nummod	_	_
18	days	_	NOUN	NNS	_	15	nmod	_	_
19	Oral	_	ADJ	JJ	_	21	amod	_	_
20	contraceptive	_	ADJ	JJ	_	21	amod	_	_
21	QD	_	NOUN	NN	_	18	dep	_	_
22	,	_	.	,	_	4	punct	_	_
23	2	_	NUM	CD	_	24	nummod	_	_
24	months	_	NOUN	NNS	_	4	appos	_	_
25	norethindrone	_	NOUN	NN	_	39	compound	_	_
26	1mg	_	ADJ	JJ	_	39	amod	_	_
27	ethinyl	_	NOUN	NN	_	39	compound	_	_
28	estradiol	_	NOUN	NN	_	39	compound	_	_
29	35ug	_	ADJ	JJ	_	39	amod	_	_
30	*	_	CONJ	CC	_	39	amod	_	_
31	28%	_	ADJ	JJ	_	39	amod	_	_
32	*	_	CONJ	CC	_	39	amod	_	_
33	19%	_	ADJ	JJ	_	39	amod	_	_
34	*	_	CONJ	CC	_	39	amod	_	_
35	23%	_	ADJ	JJ	_	39	amod	_	_
36	*	_	CONJ	CC	_	39	amod	_	_
37	30%	_	ADJ	JJ	_	39	amod	_	_
38	10	_	NUM	CD	_	39	nummod	_	_
39	mg	_	NOUN	NN	_	24	dep	_	_
40	,	_	.	,	_	4	punct	_	_
41	SD	_	NOUN	NN	_	45	compound	_	_
42	Tipranavir	_	NOUN	NN	_	45	compound	_	_
43	500	_	NUM	CD	_	45	nummod	_	_
44	mg	_	NOUN	NN	_	45	compound	_	_
45	BID	_	NOUN	NN	_	4	appos	_	_
46	/	_	.	:	_	4	punct	_	_
47	ritonavir	_	ADJ	JJ	_	48	dep	_	_
48	200	_	NUM	CD	_	49	compound	_	_
49	mg	_	NOUN	NN	_	4	dep	_	_
50	BID	_	NOUN	NN	_	49	dep	_	_
51	,	_	.	,	_	4	punct	_	_
52	7	_	NUM	CD	_	53	nummod	_	_
53	days	_	NOUN	NNS	_	60	dep	_	_
54	No	_	NOUN	NN	_	60	compound	_	_
55	change	_	NOUN	NN	_	60	compound	_	_
56	No	_	NOUN	NN	_	60	compound	_	_
57	change	_	NOUN	NN	_	60	compound	_	_
58	10	_	NUM	CD	_	60	nummod	_	_
59	mg	_	NOUN	NN	_	60	compound	_	_
60	QD	_	NOUN	NN	_	4	appos	_	_
61	for	_	ADP	IN	_	63	case	_	_
62	4	_	NUM	CD	_	63	nummod	_	_
63	days	_	NOUN	NNS	_	60	nmod	_	_
64	Fosamprenavir	_	ADJ	JJ	_	67	amod	_	_
65	1400	_	NUM	CD	_	67	nummod	_	_
66	mg	_	NOUN	NN	_	67	compound	_	_
67	BID	_	NOUN	NN	_	63	dep	_	_
68	,	_	.	,	_	4	punct	_	_
69	14	_	NUM	CD	_	70	nummod	_	_
70	days	_	NOUN	NNS	_	4	appos	_	_
71	*	_	CONJ	CC	_	70	case	_	_
72	27%	_	ADJ	JJ	_	77	amod	_	_
73	*	_	CONJ	CC	_	77	amod	_	_
74	18%	_	ADJ	JJ	_	77	amod	_	_
75	10	_	NUM	CD	_	77	nummod	_	_
76	mg	_	NOUN	NN	_	77	compound	_	_
77	QD	_	NOUN	NN	_	70	dep	_	_
78	for	_	ADP	IN	_	80	case	_	_
79	4	_	NUM	CD	_	80	nummod	_	_
80	days	_	NOUN	NNS	_	70	nmod	_	_
81	Fosamprenavir	_	ADJ	JJ	_	84	amod	_	_
82	700	_	NUM	CD	_	84	nummod	_	_
83	mg	_	NOUN	NN	_	84	compound	_	_
84	BID	_	NOUN	NN	_	80	dep	_	_
85	/	_	.	:	_	4	punct	_	_
86	ritonavir	_	ADJ	JJ	_	87	advmod	_	_
87	100	_	NUM	CD	_	88	compound	_	_
88	mg	_	NOUN	NN	_	89	amod	_	_
89	BID	_	NOUN	NN	_	4	dep	_	_
90	,	_	.	,	_	89	punct	_	_
91	14	_	NUM	CD	_	92	nummod	_	_
92	days	_	NOUN	NNS	_	96	compound	_	_
93	No	_	NOUN	NN	_	96	compound	_	_
94	change	_	NOUN	NN	_	96	compound	_	_
95	No	_	NOUN	NN	_	96	compound	_	_
96	change	_	NOUN	NN	_	89	appos	_	_

#	Livalo	551
1	Erythromycin	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Combination	_	NOUN	NN	_	4	nsubj	_	_
4	increases	_	VERB	VBZ	_	1	dep	_	_
5	DRUG	_	NOUN	NN	_	6	compound	_	_
6	exposure	_	NOUN	NN	_	4	dobj	_	_

#	Livalo	552
1	Limit	_	NOUN	NN	_	0	root	_	_
2	DRUG	_	NOUN	NN	_	1	dobj	_	_
3	to	_	PRT	TO	_	5	case	_	_
4	1	_	NUM	CD	_	5	nummod	_	_
5	mg	_	NOUN	NN	_	1	nmod	_	_
6	once	_	ADV	RB	_	8	advmod	_	_
7	daily	_	ADV	RB	_	8	advmod	_	_
8	2.3	_	NUM	CD	_	5	dep	_	_
9	,	_	.	,	_	5	punct	_	_
10	7.2	_	NUM	CD	_	11	nummod	_	_
11	Rifampin	_	NOUN	NN	_	5	appos	_	_
12	:	_	.	:	_	1	punct	_	_
13	Combination	_	NOUN	NN	_	14	nsubj	_	_
14	increases	_	VERB	VBZ	_	1	parataxis	_	_
15	DRUG	_	NOUN	NN	_	16	compound	_	_
16	exposure	_	NOUN	NN	_	14	dobj	_	_

#	Livalo	553
1	Limit	_	NOUN	NN	_	0	root	_	_
2	DRUG	_	NOUN	NN	_	1	dobj	_	_
3	to	_	PRT	TO	_	5	case	_	_
4	2	_	NUM	CD	_	5	nummod	_	_
5	mg	_	NOUN	NN	_	1	nmod	_	_
6	once	_	ADV	RB	_	8	advmod	_	_
7	daily	_	ADV	RB	_	8	advmod	_	_
8	2.4	_	NUM	CD	_	5	dep	_	_
9	,	_	.	,	_	5	punct	_	_
10	7.3	_	NUM	CD	_	14	nummod	_	_
11	Concomitant	_	ADJ	JJ	_	14	amod	_	_
12	lipid	_	NOUN	NN	_	14	compound	_	_
13	lowering	_	VERB	VBG	_	14	compound	_	_
14	therapies	_	NOUN	NNS	_	5	appos	_	_
15	:	_	.	:	_	1	punct	_	_
16	Use	_	NOUN	NN	_	1	dep	_	_
17	with	_	ADP	IN	_	18	case	_	_
18	fibrates	_	NOUN	NNS	_	16	nmod	_	_
19	or	_	CONJ	CC	_	18	cc	_	_
20	lipid	_	NOUN	NN	_	21	compound	_	_
21	modifying	_	VERB	VBG	_	18	conj	_	_
22	doses	_	NOUN	NNS	_	24	compound	_	_
23	>1	_	NUM	CD	_	24	nummod	_	_
24	g	_	NOUN	NN	_	21	dobj	_	_
25	/	_	.	:	_	1	punct	_	_
26	day	_	NOUN	NN	_	29	nsubj	_	_
27	of	_	ADP	IN	_	28	case	_	_
28	niacin	_	NOUN	NN	_	26	nmod	_	_
29	increases	_	VERB	VBZ	_	1	parataxis	_	_
30	the	_	DET	DT	_	31	det	_	_
31	risk	_	NOUN	NN	_	29	dobj	_	_
32	of	_	ADP	IN	_	36	case	_	_
33	adverse	_	ADJ	JJ	_	36	amod	_	_
34	skeletal	_	ADJ	JJ	_	36	amod	_	_
35	muscle	_	NOUN	NN	_	36	compound	_	_
36	effects	_	NOUN	NNS	_	31	nmod	_	_

#	Livalo	554
1	Caution	_	NOUN	NN	_	4	nsubjpass	_	_
2	should	_	VERB	MD	_	4	aux	_	_
3	be	_	VERB	VB	_	4	auxpass	_	_
4	used	_	VERB	VBN	_	0	root	_	_
5	when	_	ADV	WRB	_	6	advmod	_	_
6	prescribing	_	VERB	VBG	_	4	advcl	_	_
7	with	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_

#	Livalo	555
1	Cyclosporine	_	NOUN	NN	_	3	nsubj	_	_
2	significantly	_	ADV	RB	_	3	advmod	_	_
3	increased	_	VERB	VBD	_	0	root	_	_
4	DRUG	_	NOUN	NN	_	5	compound	_	_
5	exposure	_	NOUN	NN	_	3	dobj	_	_

#	Livalo	556
1	Co	_	PRT	TO	_	2	case	_	_
2	administration	_	NOUN	NN	_	8	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	cyclosporine	_	NOUN	NN	_	2	nmod	_	_
5	with	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	2	nmod	_	_
7	is	_	VERB	VBZ	_	8	auxpass	_	_
8	contraindicated	_	VERB	VBN	_	0	root	_	_

#	Livalo	557
1	Erythromycin	_	NOUN	NN	_	3	nsubj	_	_
2	significantly	_	ADV	RB	_	3	advmod	_	_
3	increased	_	VERB	VBD	_	0	root	_	_
4	DRUG	_	NOUN	NN	_	5	compound	_	_
5	exposure	_	NOUN	NN	_	3	dobj	_	_

#	Livalo	558
1	In	_	ADP	IN	_	2	case	_	_
2	patients	_	NOUN	NNS	_	17	nmod	_	_
3	taking	_	VERB	VBG	_	2	acl	_	_
4	erythromycin	_	NOUN	NN	_	3	dobj	_	_
5	,	_	.	,	_	17	punct	_	_
6	a	_	DET	DT	_	7	det	_	_
7	dose	_	NOUN	NN	_	17	nsubjpass	_	_
8	of	_	ADP	IN	_	11	case	_	_
9	DRUG	_	NOUN	NN	_	11	compound	_	_
10	1	_	NUM	CD	_	11	nummod	_	_
11	mg	_	NOUN	NN	_	7	nmod	_	_
12	once	_	ADV	RB	_	17	advmod	_	_
13	daily	_	ADV	RB	_	17	advmod	_	_
14	should	_	VERB	MD	_	17	aux	_	_
15	not	_	ADV	RB	_	17	neg	_	_
16	be	_	VERB	VB	_	17	auxpass	_	_
17	exceeded	_	VERB	VBN	_	0	root	_	_

#	Livalo	559
1	Rifampin	_	NOUN	NN	_	3	nsubj	_	_
2	significantly	_	ADV	RB	_	3	advmod	_	_
3	increased	_	VERB	VBD	_	0	root	_	_
4	DRUG	_	NOUN	NN	_	5	compound	_	_
5	exposure	_	NOUN	NN	_	3	dobj	_	_

#	Livalo	560
1	In	_	ADP	IN	_	2	case	_	_
2	patients	_	NOUN	NNS	_	17	nmod	_	_
3	taking	_	VERB	VBG	_	2	acl	_	_
4	rifampin	_	NOUN	NN	_	3	dobj	_	_
5	,	_	.	,	_	17	punct	_	_
6	a	_	DET	DT	_	7	det	_	_
7	dose	_	NOUN	NN	_	17	nsubjpass	_	_
8	of	_	ADP	IN	_	11	case	_	_
9	DRUG	_	NOUN	NN	_	11	compound	_	_
10	2	_	NUM	CD	_	11	nummod	_	_
11	mg	_	NOUN	NN	_	7	nmod	_	_
12	once	_	ADV	RB	_	17	advmod	_	_
13	daily	_	ADV	RB	_	17	advmod	_	_
14	should	_	VERB	MD	_	17	aux	_	_
15	not	_	ADV	RB	_	17	neg	_	_
16	be	_	VERB	VB	_	17	auxpass	_	_
17	exceeded	_	VERB	VBN	_	0	root	_	_

#	Livalo	561
1	Due	_	ADP	IN	_	5	case	_	_
2	to	_	PRT	TO	_	1	mwe	_	_
3	an	_	DET	DT	_	5	det	_	_
4	increased	_	VERB	VBN	_	5	amod	_	_
5	risk	_	NOUN	NN	_	28	nmod	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	myopathy	_	NOUN	NN	_	5	nmod	_	_
8	/	_	.	:	_	5	punct	_	_
9	rhabdomyolysis	_	NOUN	NN	_	28	nsubjpass	_	_
10	when	_	ADV	WRB	_	16	advmod	_	_
11	HMG	_	NOUN	NN	_	14	compound	_	_
12	CoA	_	NOUN	NN	_	14	compound	_	_
13	reductase	_	NOUN	NN	_	14	compound	_	_
14	inhibitors	_	NOUN	NNS	_	16	nsubjpass	_	_
15	are	_	VERB	VBP	_	16	auxpass	_	_
16	coadministered	_	VERB	VBN	_	9	acl:relcl	_	_
17	with	_	ADP	IN	_	18	case	_	_
18	gemfibrozil	_	NOUN	NN	_	16	nmod	_	_
19	,	_	.	,	_	28	punct	_	_
20	concomitant	_	ADJ	JJ	_	21	amod	_	_
21	administration	_	NOUN	NN	_	28	nsubjpass	_	_
22	of	_	ADP	IN	_	23	case	_	_
23	DRUG	_	NOUN	NN	_	21	nmod	_	_
24	with	_	ADP	IN	_	25	case	_	_
25	gemfibrozil	_	NOUN	NN	_	21	nmod	_	_
26	should	_	VERB	MD	_	28	aux	_	_
27	be	_	VERB	VB	_	28	auxpass	_	_
28	avoided	_	VERB	VBN	_	0	root	_	_

#	Livalo	562
1	Because	_	ADP	IN	_	4	mark	_	_
2	it	_	PRON	PRP	_	4	nsubjpass	_	_
3	is	_	VERB	VBZ	_	4	auxpass	_	_
4	known	_	VERB	VBN	_	29	advcl	_	_
5	that	_	ADP	IN	_	18	mark	_	_
6	the	_	DET	DT	_	7	det	_	_
7	risk	_	NOUN	NN	_	18	nsubjpass	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	myopathy	_	NOUN	NN	_	7	nmod	_	_
10	during	_	ADP	IN	_	11	case	_	_
11	treatment	_	NOUN	NN	_	7	nmod	_	_
12	with	_	ADP	IN	_	16	case	_	_
13	HMG	_	NOUN	NN	_	16	compound	_	_
14	CoA	_	NOUN	NN	_	16	compound	_	_
15	reductase	_	NOUN	NN	_	16	compound	_	_
16	inhibitors	_	NOUN	NNS	_	11	nmod	_	_
17	is	_	VERB	VBZ	_	18	auxpass	_	_
18	increased	_	VERB	VBN	_	4	ccomp	_	_
19	with	_	ADP	IN	_	21	case	_	_
20	concurrent	_	ADJ	JJ	_	21	amod	_	_
21	administration	_	NOUN	NN	_	18	nmod	_	_
22	of	_	ADP	IN	_	24	case	_	_
23	other	_	ADJ	JJ	_	24	amod	_	_
24	fibrates	_	NOUN	NNS	_	21	nmod	_	_
25	,	_	.	,	_	29	punct	_	_
26	DRUG	_	NOUN	NN	_	29	nsubjpass	_	_
27	should	_	VERB	MD	_	29	aux	_	_
28	be	_	VERB	VB	_	29	auxpass	_	_
29	administered	_	VERB	VBN	_	0	root	_	_
30	with	_	ADP	IN	_	31	case	_	_
31	caution	_	NOUN	NN	_	29	nmod	_	_
32	when	_	ADV	WRB	_	33	advmod	_	_
33	used	_	VERB	VBN	_	29	advcl	_	_
34	concomitantly	_	ADV	RB	_	33	advmod	_	_
35	with	_	ADP	IN	_	37	case	_	_
36	other	_	ADJ	JJ	_	37	amod	_	_
37	fibrates	_	NOUN	NNS	_	33	nmod	_	_

#	Livalo	563
1	The	_	DET	DT	_	2	det	_	_
2	risk	_	NOUN	NN	_	9	nsubjpass	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	skeletal	_	ADJ	JJ	_	6	amod	_	_
5	muscle	_	NOUN	NN	_	6	compound	_	_
6	effects	_	NOUN	NNS	_	2	nmod	_	_
7	may	_	VERB	MD	_	9	aux	_	_
8	be	_	VERB	VB	_	9	auxpass	_	_
9	enhanced	_	VERB	VBN	_	0	root	_	_
10	when	_	ADV	WRB	_	13	advmod	_	_
11	DRUG	_	NOUN	NN	_	13	nsubjpass	_	_
12	is	_	VERB	VBZ	_	13	auxpass	_	_
13	used	_	VERB	VBN	_	25	advcl	_	_
14	in	_	ADP	IN	_	15	case	_	_
15	combination	_	NOUN	NN	_	13	nmod	_	_
16	with	_	ADP	IN	_	17	case	_	_
17	niacin	_	NOUN	NN	_	15	nmod	_	_
18	a	_	DET	DT	_	19	det	_	_
19	reduction	_	NOUN	NN	_	25	nsubjpass	_	_
20	in	_	ADP	IN	_	22	case	_	_
21	DRUG	_	NOUN	NN	_	22	compound	_	_
22	dosage	_	NOUN	NN	_	19	nmod	_	_
23	should	_	VERB	MD	_	25	aux	_	_
24	be	_	VERB	VB	_	25	auxpass	_	_
25	considered	_	VERB	VBN	_	9	ccomp	_	_
26	in	_	ADP	IN	_	28	case	_	_
27	this	_	DET	DT	_	28	det	_	_
28	setting	_	VERB	VBG	_	25	nmod	_	_

#	Livalo	564
1	Cases	_	NOUN	NNS	_	10	nsubjpass	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	myopathy	_	NOUN	NN	_	1	nmod	_	_
4	,	_	.	,	_	3	punct	_	_
5	including	_	VERB	VBG	_	6	case	_	_
6	rhabdomyolysis	_	NOUN	NN	_	3	nmod	_	_
7	,	_	.	,	_	1	punct	_	_
8	have	_	VERB	VBP	_	10	aux	_	_
9	been	_	VERB	VBN	_	10	auxpass	_	_
10	reported	_	VERB	VBN	_	0	root	_	_
11	with	_	ADP	IN	_	15	case	_	_
12	HMG	_	NOUN	NN	_	15	compound	_	_
13	CoA	_	NOUN	NN	_	15	compound	_	_
14	reductase	_	NOUN	NN	_	15	compound	_	_
15	inhibitors	_	NOUN	NNS	_	10	nmod	_	_
16	coadministered	_	VERB	VBN	_	15	acl	_	_
17	with	_	ADP	IN	_	18	case	_	_
18	colchicine	_	NOUN	NN	_	16	nmod	_	_
19	,	_	.	,	_	10	punct	_	_
20	and	_	CONJ	CC	_	10	cc	_	_
21	caution	_	NOUN	NN	_	24	nsubjpass	_	_
22	should	_	VERB	MD	_	24	aux	_	_
23	be	_	VERB	VB	_	24	auxpass	_	_
24	exercised	_	VERB	VBN	_	10	conj	_	_
25	when	_	ADV	WRB	_	26	advmod	_	_
26	prescribing	_	VERB	VBG	_	24	advcl	_	_
27	DRUG	_	NOUN	NN	_	26	dobj	_	_
28	with	_	ADP	IN	_	29	case	_	_
29	colchicine	_	NOUN	NN	_	26	nmod	_	_

#	Livalo	565
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	had	_	VERB	VBD	_	0	root	_	_
3	no	_	DET	DT	_	6	neg	_	_
4	significant	_	ADJ	JJ	_	6	amod	_	_
5	pharmacokinetic	_	ADJ	JJ	_	6	amod	_	_
6	interaction	_	NOUN	NN	_	2	dobj	_	_
7	with	_	ADP	IN	_	8	case	_	_
8	R	_	NOUN	NN	_	6	nmod	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	S	_	NOUN	NN	_	11	compound	_	_
11	warfarin	_	NOUN	NN	_	8	conj	_	_

#	Livalo	566
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	had	_	VERB	VBD	_	0	root	_	_
3	no	_	DET	DT	_	5	neg	_	_
4	significant	_	ADJ	JJ	_	5	amod	_	_
5	effect	_	NOUN	NN	_	2	dobj	_	_
6	on	_	ADP	IN	_	9	case	_	_
7	prothrombin	_	NOUN	NN	_	9	compound	_	_
8	time	_	NOUN	NN	_	9	compound	_	_
9	PT	_	NOUN	NN	_	5	nmod	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	international	_	ADJ	JJ	_	14	amod	_	_
12	normalized	_	VERB	VBN	_	14	amod	_	_
13	ratio	_	NOUN	NN	_	14	compound	_	_
14	INR	_	NOUN	NN	_	9	conj	_	_
15	when	_	ADV	WRB	_	16	advmod	_	_
16	administered	_	VERB	VBN	_	2	advcl	_	_
17	to	_	PRT	TO	_	18	case	_	_
18	patients	_	NOUN	NNS	_	16	nmod	_	_
19	receiving	_	VERB	VBG	_	18	acl	_	_
20	chronic	_	ADJ	JJ	_	22	amod	_	_
21	warfarin	_	NOUN	NN	_	22	compound	_	_
22	treatment	_	NOUN	NN	_	19	dobj	_	_

#	Livalo	567
1	However	_	ADV	RB	_	7	advmod	_	_
2	,	_	.	,	_	7	punct	_	_
3	patients	_	NOUN	NNS	_	7	nsubj	_	_
4	receiving	_	VERB	VBG	_	3	acl	_	_
5	warfarin	_	NOUN	NN	_	4	dobj	_	_
6	should	_	VERB	MD	_	7	aux	_	_
7	have	_	VERB	VB	_	0	root	_	_
8	their	_	PRON	PRP$	_	9	nmod:poss	_	_
9	PT	_	NOUN	NN	_	7	dobj	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	INR	_	NOUN	NN	_	9	conj	_	_
12	monitored	_	VERB	VBN	_	9	acl	_	_
13	when	_	ADV	WRB	_	16	advmod	_	_
14	DRUG	_	NOUN	NN	_	16	nsubjpass	_	_
15	is	_	VERB	VBZ	_	16	auxpass	_	_
16	added	_	VERB	VBN	_	12	advcl	_	_
17	to	_	PRT	TO	_	19	case	_	_
18	their	_	PRON	PRP$	_	19	nmod:poss	_	_
19	therapy	_	NOUN	NN	_	16	nmod	_	_

#	Livalo	568
1	DRUG	_	NOUN	NN	_	3	nsubj	_	_
2	competitively	_	ADV	RB	_	3	advmod	_	_
3	inhibits	_	VERB	VBZ	_	0	root	_	_
4	HMG	_	NOUN	NN	_	6	compound	_	_
5	CoA	_	NOUN	NN	_	6	compound	_	_
6	reductase	_	NOUN	NN	_	3	dobj	_	_
7	,	_	.	,	_	6	punct	_	_
8	which	_	DET	WDT	_	11	nsubj	_	_
9	is	_	VERB	VBZ	_	11	cop	_	_
10	a	_	DET	DT	_	11	det	_	_
11	rate	_	ADJ	JJ	_	6	acl:relcl	_	_
12	determining	_	VERB	VBG	_	11	acl	_	_
13	enzyme	_	NOUN	NN	_	12	dobj	_	_
14	involved	_	VERB	VBN	_	13	acl	_	_
15	with	_	ADP	IN	_	16	case	_	_
16	biosynthesis	_	NOUN	NN	_	14	nmod	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	cholesterol	_	NOUN	NN	_	16	nmod	_	_
19	,	_	.	,	_	3	punct	_	_
20	in	_	ADP	IN	_	22	case	_	_
21	a	_	DET	DT	_	22	det	_	_
22	manner	_	NOUN	NN	_	3	nmod	_	_
23	of	_	ADP	IN	_	24	case	_	_
24	competition	_	NOUN	NN	_	22	nmod	_	_
25	with	_	ADP	IN	_	27	case	_	_
26	the	_	DET	DT	_	27	det	_	_
27	substrate	_	NOUN	NN	_	24	nmod	_	_
28	so	_	ADV	RB	_	31	advmod	_	_
29	that	_	ADP	IN	_	31	mark	_	_
30	it	_	PRON	PRP	_	31	nsubj	_	_
31	inhibits	_	VERB	VBZ	_	22	acl:relcl	_	_
32	cholesterol	_	NOUN	NN	_	33	compound	_	_
33	synthesis	_	NOUN	NN	_	31	dobj	_	_
34	in	_	ADP	IN	_	36	case	_	_
35	the	_	DET	DT	_	36	det	_	_
36	liver	_	NOUN	NN	_	33	nmod	_	_

#	Livalo	569
1	As	_	ADP	IN	_	3	case	_	_
2	a	_	DET	DT	_	3	det	_	_
3	result	_	NOUN	NN	_	21	nmod	_	_
4	,	_	.	,	_	21	punct	_	_
5	the	_	DET	DT	_	6	det	_	_
6	expression	_	NOUN	NN	_	21	nsubjpass	_	_
7	of	_	ADP	IN	_	9	case	_	_
8	LDL	_	NOUN	NN	_	9	compound	_	_
9	receptors	_	NOUN	NNS	_	6	nmod	_	_
10	followed	_	VERB	VBN	_	9	acl	_	_
11	by	_	ADP	IN	_	13	case	_	_
12	the	_	DET	DT	_	13	det	_	_
13	uptake	_	NOUN	NN	_	10	nmod	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	LDL	_	NOUN	NN	_	13	nmod	_	_
16	from	_	ADP	IN	_	17	case	_	_
17	blood	_	NOUN	NN	_	13	nmod	_	_
18	to	_	PRT	TO	_	19	case	_	_
19	liver	_	NOUN	NN	_	13	nmod	_	_
20	is	_	VERB	VBZ	_	21	auxpass	_	_
21	accelerated	_	VERB	VBN	_	0	root	_	_
22	and	_	CONJ	CC	_	21	cc	_	_
23	then	_	ADV	RB	_	27	advmod	_	_
24	the	_	DET	DT	_	26	det	_	_
25	plasma	_	NOUN	NN	_	26	compound	_	_
26	TC	_	NOUN	NN	_	27	nsubj	_	_
27	decreases	_	VERB	VBZ	_	21	conj	_	_

#	Livalo	570
1	Further	_	ADV	RB	_	12	advmod	_	_
2	,	_	.	,	_	12	punct	_	_
3	the	_	DET	DT	_	5	det	_	_
4	sustained	_	ADJ	JJ	_	5	amod	_	_
5	inhibition	_	NOUN	NN	_	12	nsubj	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	cholesterol	_	NOUN	NN	_	8	compound	_	_
8	synthesis	_	NOUN	NN	_	5	nmod	_	_
9	in	_	ADP	IN	_	11	case	_	_
10	the	_	DET	DT	_	11	det	_	_
11	liver	_	NOUN	NN	_	5	nmod	_	_
12	decreases	_	VERB	VBZ	_	0	root	_	_
13	levels	_	NOUN	NNS	_	12	dobj	_	_
14	of	_	ADP	IN	_	18	case	_	_
15	very	_	ADV	RB	_	16	advmod	_	_
16	low	_	ADJ	JJ	_	18	amod	_	_
17	density	_	NOUN	NN	_	18	compound	_	_
18	lipoproteins	_	NOUN	NNS	_	13	nmod	_	_

#	Livalo	571
1	In	_	ADP	IN	_	6	case	_	_
2	a	_	DET	DT	_	6	det	_	_
3	randomized	_	VERB	VBN	_	6	amod	_	_
4	,	_	.	,	_	3	punct	_	_
5	double	_	ADJ	JJ	_	3	dep	_	_
6	blind	_	NOUN	NN	_	9	nmod	_	_
7	,	_	.	,	_	9	punct	_	_
8	placebo	_	NOUN	NN	_	9	nsubj	_	_
9	controlled	_	VERB	VBD	_	0	root	_	_
10	,	_	.	,	_	9	punct	_	_
11	4	_	NUM	CD	_	17	nummod	_	_
12	way	_	VERB	VBD	_	17	cop	_	_
13	parallel	_	ADJ	JJ	_	17	amod	_	_
14	,	_	.	,	_	17	punct	_	_
15	active	_	ADJ	JJ	_	17	amod	_	_
16	comparator	_	NOUN	NN	_	17	compound	_	_
17	study	_	NOUN	NN	_	9	dobj	_	_
18	with	_	ADP	IN	_	19	case	_	_
19	moxifloxacin	_	NOUN	NN	_	17	nmod	_	_
20	in	_	ADP	IN	_	23	case	_	_
21	174	_	NUM	CD	_	23	nummod	_	_
22	healthy	_	ADJ	JJ	_	23	amod	_	_
23	participants	_	NOUN	NNS	_	17	nmod	_	_
24	,	_	.	,	_	9	punct	_	_
25	DRUG	_	NOUN	NN	_	28	nsubjpass	_	_
26	was	_	VERB	VBD	_	28	auxpass	_	_
27	not	_	ADV	RB	_	28	neg	_	_
28	associated	_	VERB	VBN	_	9	parataxis	_	_
29	with	_	ADP	IN	_	32	case	_	_
30	clinically	_	ADV	RB	_	31	advmod	_	_
31	meaningful	_	ADJ	JJ	_	32	amod	_	_
32	prolongation	_	NOUN	NN	_	28	nmod	_	_
33	of	_	ADP	IN	_	36	case	_	_
34	the	_	DET	DT	_	36	det	_	_
35	QTc	_	NOUN	NN	_	36	compound	_	_
36	interval	_	ADJ	JJ	_	32	nmod	_	_
37	or	_	CONJ	CC	_	36	cc	_	_
38	heart	_	NOUN	NN	_	36	conj	_	_
39	rate	_	NOUN	NN	_	36	dep	_	_
40	at	_	ADP	IN	_	42	case	_	_
41	daily	_	ADV	RB	_	42	advmod	_	_
42	doses	_	NOUN	NNS	_	32	nmod	_	_
43	up	_	ADJ	JJ	_	45	advmod	_	_
44	to	_	PRT	TO	_	43	mwe	_	_
45	16	_	NUM	CD	_	48	nummod	_	_
46	mg	_	NOUN	NN	_	48	compound	_	_
47	4	_	NUM	CD	_	48	nummod	_	_
48	times	_	NOUN	NNS	_	53	compound	_	_
49	the	_	DET	DT	_	53	det	_	_
50	recommended	_	VERB	VBN	_	53	amod	_	_
51	maximum	_	NOUN	NN	_	53	compound	_	_
52	daily	_	ADV	RB	_	53	amod	_	_
53	dose	_	NOUN	NN	_	42	nmod	_	_

#	Livalo	572
1	Absorption	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	DRUG	_	NOUN	NN	_	6	compound	_	_
4	peak	_	ADJ	JJ	_	6	amod	_	_
5	plasma	_	NOUN	NN	_	6	compound	_	_
6	concentrations	_	NOUN	NNS	_	8	nsubjpass	_	_
7	are	_	VERB	VBP	_	8	auxpass	_	_
8	achieved	_	VERB	VBN	_	1	dep	_	_
9	about	_	ADV	RB	_	10	advmod	_	_
10	1	_	NUM	CD	_	11	nummod	_	_
11	hour	_	NUM	CD	_	8	nmod	_	_
12	after	_	ADP	IN	_	14	case	_	_
13	oral	_	ADJ	JJ	_	14	amod	_	_
14	administration	_	NOUN	NN	_	8	nmod	_	_

#	Livalo	573
1	Both	_	CONJ	CC	_	2	cc:preconj	_	_
2	Cmax	_	NOUN	NN	_	6	nsubj	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	AUC0	_	NOUN	NN	_	2	conj	_	_
5	inf	_	NOUN	NN	_	2	dep	_	_
6	increased	_	VERB	VBD	_	0	root	_	_
7	in	_	ADP	IN	_	12	case	_	_
8	an	_	DET	DT	_	12	det	_	_
9	approximately	_	ADV	RB	_	10	advmod	_	_
10	dose	_	NOUN	NN	_	12	compound	_	_
11	proportional	_	ADJ	JJ	_	12	amod	_	_
12	manner	_	NOUN	NN	_	6	nmod	_	_
13	for	_	ADP	IN	_	16	case	_	_
14	single	_	ADJ	JJ	_	16	amod	_	_
15	DRUG	_	NOUN	NN	_	16	compound	_	_
16	doses	_	NOUN	NNS	_	12	nmod	_	_
17	from	_	ADP	IN	_	21	case	_	_
18	1	_	NUM	CD	_	20	compound	_	_
19	to	_	PRT	TO	_	20	dep	_	_
20	24	_	NUM	CD	_	21	nummod	_	_
21	mg	_	NOUN	NN	_	12	nmod	_	_
22	once	_	ADV	RB	_	6	advmod	_	_
23	daily	_	ADV	RB	_	22	dep	_	_

#	Livalo	574
1	The	_	DET	DT	_	3	det	_	_
2	absolute	_	ADJ	JJ	_	3	amod	_	_
3	bioavailability	_	NOUN	NN	_	9	nsubj	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	DRUG	_	NOUN	NN	_	7	compound	_	_
6	oral	_	ADJ	JJ	_	7	amod	_	_
7	solution	_	NOUN	NN	_	3	nmod	_	_
8	is	_	VERB	VBZ	_	9	auxpass	_	_
9	51%	_	ADJ	JJ	_	0	root	_	_

#	Livalo	575
1	Administration	_	NOUN	NN	_	12	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	with	_	ADP	IN	_	11	case	_	_
5	a	_	DET	DT	_	11	det	_	_
6	high	_	ADJ	JJ	_	11	amod	_	_
7	fat	_	NOUN	NN	_	11	compound	_	_
8	meal	_	ADJ	JJ	_	11	amod	_	_
9	50%	_	ADJ	JJ	_	11	amod	_	_
10	fat	_	NOUN	NN	_	11	compound	_	_
11	content	_	NOUN	NN	_	1	nmod	_	_
12	decreases	_	VERB	VBZ	_	0	root	_	_
13	DRUG	_	NOUN	NN	_	14	compound	_	_
14	Cmax	_	NOUN	NN	_	12	dobj	_	_
15	by	_	ADP	IN	_	16	case	_	_
16	43%	_	NOUN	NN	_	12	nmod	_	_
17	but	_	CONJ	CC	_	12	cc	_	_
18	does	_	VERB	MD	_	21	aux	_	_
19	not	_	ADV	RB	_	21	neg	_	_
20	significantly	_	ADV	RB	_	21	advmod	_	_
21	reduce	_	VERB	VB	_	12	conj	_	_
22	DRUG	_	NOUN	NN	_	23	compound	_	_
23	AUC	_	NOUN	NN	_	21	dobj	_	_

#	Livalo	576
1	The	_	DET	DT	_	2	det	_	_
2	Cmax	_	NOUN	NN	_	9	nsubj	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	AUC	_	NOUN	NN	_	2	conj	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	2	nmod	_	_
7	did	_	VERB	VBD	_	9	aux	_	_
8	not	_	ADV	RB	_	9	neg	_	_
9	differ	_	VERB	VB	_	0	root	_	_
10	following	_	ADP	IN	_	11	case	_	_
11	evening	_	NOUN	NN	_	9	nmod	_	_
12	or	_	CONJ	CC	_	11	cc	_	_
13	morning	_	NOUN	NN	_	15	compound	_	_
14	drug	_	NOUN	NN	_	15	compound	_	_
15	administration	_	NOUN	NN	_	11	conj	_	_

#	Livalo	577
1	In	_	ADP	IN	_	3	case	_	_
2	healthy	_	ADJ	JJ	_	3	amod	_	_
3	volunteers	_	NOUN	NNS	_	22	nmod	_	_
4	receiving	_	VERB	VBG	_	3	acl	_	_
5	4	_	NUM	CD	_	7	nummod	_	_
6	mg	_	NOUN	NN	_	7	compound	_	_
7	DRUG	_	NOUN	NN	_	4	dobj	_	_
8	,	_	.	,	_	22	punct	_	_
9	the	_	DET	DT	_	11	det	_	_
10	percent	_	ADJ	JJ	_	11	amod	_	_
11	change	_	NOUN	NN	_	22	nsubj	_	_
12	from	_	ADP	IN	_	13	case	_	_
13	baseline	_	NOUN	NN	_	11	nmod	_	_
14	for	_	ADP	IN	_	16	case	_	_
15	LDL	_	NOUN	NN	_	16	compound	_	_
16	C	_	NOUN	NN	_	13	nmod	_	_
17	following	_	VERB	VBG	_	19	case	_	_
18	evening	_	NOUN	NN	_	19	compound	_	_
19	dosing	_	NOUN	NN	_	11	nmod	_	_
20	was	_	VERB	VBD	_	22	cop	_	_
21	slightly	_	ADV	RB	_	22	advmod	_	_
22	greater	_	ADJ	JJ	_	0	root	_	_
23	than	_	ADP	IN	_	24	case	_	_
24	that	_	DET	WDT	_	22	nmod	_	_
25	following	_	VERB	VBG	_	27	case	_	_
26	morning	_	NOUN	NN	_	27	compound	_	_
27	dosing	_	VERB	VBG	_	24	nmod	_	_

#	Livalo	578
1	DRUG	_	NOUN	NN	_	3	nsubjpass	_	_
2	was	_	VERB	VBD	_	3	auxpass	_	_
3	absorbed	_	VERB	VBN	_	0	root	_	_
4	in	_	ADP	IN	_	7	case	_	_
5	the	_	DET	DT	_	7	det	_	_
6	small	_	ADJ	JJ	_	7	amod	_	_
7	intestine	_	NOUN	NN	_	3	nmod	_	_
8	but	_	CONJ	CC	_	3	cc	_	_
9	very	_	ADV	RB	_	10	advmod	_	_
10	little	_	ADJ	JJ	_	3	conj	_	_
11	in	_	ADP	IN	_	13	case	_	_
12	the	_	DET	DT	_	13	det	_	_
13	colon	_	NOUN	NN	_	10	nmod	_	_

#	Livalo	579
1	Distribution	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	DRUG	_	NOUN	NN	_	8	nsubj	_	_
4	is	_	VERB	VBZ	_	8	cop	_	_
5	more	_	ADV	RB	_	8	advmod	_	_
6	than	_	ADP	IN	_	8	case	_	_
7	99%	_	ADJ	JJ	_	8	amod	_	_
8	protein	_	NOUN	NN	_	46	nsubj	_	_
9	bound	_	VERB	VBN	_	8	acl	_	_
10	in	_	ADP	IN	_	12	case	_	_
11	human	_	ADJ	JJ	_	12	amod	_	_
12	plasma	_	NOUN	NN	_	9	nmod	_	_
13	,	_	.	,	_	8	punct	_	_
14	mainly	_	ADV	RB	_	16	advmod	_	_
15	to	_	PRT	TO	_	16	case	_	_
16	albumin	_	NOUN	NN	_	8	nmod	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	alpha	_	NOUN	NN	_	21	compound	_	_
19	1	_	NUM	CD	_	21	nummod	_	_
20	acid	_	NOUN	NN	_	21	compound	_	_
21	glycoprotein	_	NOUN	NN	_	16	conj	_	_
22	,	_	.	,	_	8	punct	_	_
23	and	_	CONJ	CC	_	8	cc	_	_
24	the	_	DET	DT	_	26	det	_	_
25	mean	_	ADJ	JJ	_	26	amod	_	_
26	volume	_	NOUN	NN	_	33	nsubj	_	_
27	of	_	ADP	IN	_	28	case	_	_
28	distribution	_	NOUN	NN	_	26	nmod	_	_
29	is	_	VERB	VBZ	_	33	cop	_	_
30	approximately	_	ADV	RB	_	31	advmod	_	_
31	148	_	NUM	CD	_	33	nummod	_	_
32	L	_	NOUN	NN	_	33	compound	_	_
33	Association	_	NOUN	NN	_	8	conj	_	_
34	of	_	ADP	IN	_	35	case	_	_
35	DRUG	_	NOUN	NN	_	33	nmod	_	_
36	and	_	CONJ	CC	_	35	cc	_	_
37	/	_	NUM	CD	_	35	conj	_	_
38	or	_	CONJ	CC	_	35	cc	_	_
39	its	_	PRON	PRP$	_	40	nmod:poss	_	_
40	metabolites	_	NOUN	NNS	_	35	conj	_	_
41	with	_	ADP	IN	_	44	case	_	_
42	the	_	DET	DT	_	44	det	_	_
43	blood	_	NOUN	NN	_	44	compound	_	_
44	cells	_	NOUN	NNS	_	40	nmod	_	_
45	is	_	VERB	VBZ	_	46	auxpass	_	_
46	minimal	_	ADJ	JJ	_	1	dep	_	_

#	Livalo	580
1	Metabolism	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	DRUG	_	NOUN	NN	_	6	nsubjpass	_	_
4	is	_	VERB	VBZ	_	6	auxpass	_	_
5	marginally	_	ADV	RB	_	6	advmod	_	_
6	metabolized	_	VERB	VBN	_	1	dep	_	_
7	by	_	ADP	IN	_	8	case	_	_
8	CYP2C9	_	NOUN	NN	_	6	nmod	_	_
9	and	_	CONJ	CC	_	6	cc	_	_
10	to	_	PRT	TO	_	13	case	_	_
11	a	_	DET	DT	_	13	det	_	_
12	lesser	_	ADJ	JJ	_	13	amod	_	_
13	extent	_	NOUN	NN	_	6	conj	_	_
14	by	_	ADP	IN	_	15	case	_	_
15	CYP2C8	_	NOUN	NN	_	13	nmod	_	_

#	Livalo	581
1	The	_	DET	DT	_	3	det	_	_
2	major	_	ADJ	JJ	_	3	amod	_	_
3	metabolite	_	NOUN	NN	_	9	nsubj	_	_
4	in	_	ADP	IN	_	6	case	_	_
5	human	_	ADJ	JJ	_	6	amod	_	_
6	plasma	_	NOUN	NN	_	3	nmod	_	_
7	is	_	VERB	VBZ	_	9	cop	_	_
8	the	_	DET	DT	_	9	det	_	_
9	lactone	_	NOUN	NN	_	0	root	_	_
10	which	_	DET	WDT	_	12	nsubjpass	_	_
11	is	_	VERB	VBZ	_	12	auxpass	_	_
12	formed	_	VERB	VBN	_	9	acl:relcl	_	_
13	via	_	ADP	IN	_	18	case	_	_
14	an	_	DET	DT	_	18	det	_	_
15	ester	_	NOUN	NN	_	18	compound	_	_
16	type	_	NOUN	NN	_	18	compound	_	_
17	DRUG	_	NOUN	NN	_	18	compound	_	_
18	glucuronide	_	NOUN	NN	_	12	nmod	_	_
19	conjugate	_	NOUN	NN	_	18	acl	_	_
20	by	_	ADP	IN	_	25	case	_	_
21	uridine	_	ADJ	JJ	_	25	amod	_	_
22	5'	_	ADJ	JJ	_	25	amod	_	_
23	diphosphate	_	NOUN	NN	_	25	compound	_	_
24	UDP	_	NOUN	NN	_	25	compound	_	_
25	glucuronosyltransferase	_	NOUN	NN	_	19	nmod	_	_
26	UGT1A3	_	NOUN	NN	_	25	dep	_	_
27	and	_	CONJ	CC	_	26	cc	_	_
28	UGT2B7	_	NOUN	NN	_	26	conj	_	_

#	Livalo	582
1	Excretion	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	A	_	PRON	PRP$	_	4	det	_	_
4	mean	_	NOUN	NN	_	21	nsubjpass	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	15%	_	NOUN	NN	_	4	nmod	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	radioactivity	_	NOUN	NN	_	6	nmod	_	_
9	of	_	ADP	IN	_	19	case	_	_
10	orally	_	ADV	RB	_	11	advmod	_	_
11	administered	_	VERB	VBN	_	19	amod	_	_
12	,	_	.	,	_	11	punct	_	_
13	single	_	ADJ	JJ	_	19	amod	_	_
14	32	_	NUM	CD	_	19	nummod	_	_
15	mg	_	NOUN	NN	_	19	compound	_	_
16	14C	_	NOUN	NN	_	19	compound	_	_
17	labeled	_	ADJ	JJ	_	19	amod	_	_
18	DRUG	_	NOUN	NN	_	19	compound	_	_
19	dose	_	NOUN	NN	_	8	nmod	_	_
20	was	_	VERB	VBD	_	21	auxpass	_	_
21	excreted	_	VERB	VBN	_	1	dep	_	_
22	in	_	ADP	IN	_	23	case	_	_
23	urine	_	ADJ	JJ	_	21	nmod	_	_
24	,	_	.	,	_	21	punct	_	_
25	whereas	_	ADP	IN	_	34	mark	_	_
26	a	_	DET	DT	_	27	det	_	_
27	mean	_	NOUN	NN	_	34	nsubjpass	_	_
28	of	_	ADP	IN	_	29	case	_	_
29	79%	_	NOUN	NN	_	27	nmod	_	_
30	of	_	ADP	IN	_	32	case	_	_
31	the	_	DET	DT	_	32	det	_	_
32	dose	_	NOUN	NN	_	29	nmod	_	_
33	was	_	VERB	VBD	_	34	auxpass	_	_
34	excreted	_	VERB	VBN	_	21	advcl	_	_
35	in	_	ADP	IN	_	36	case	_	_
36	feces	_	NOUN	NNS	_	34	nmod	_	_
37	within	_	ADP	IN	_	39	case	_	_
38	7	_	NUM	CD	_	39	nummod	_	_
39	days	_	NOUN	NNS	_	36	nmod	_	_

#	Livalo	583
1	The	_	DET	DT	_	6	det	_	_
2	mean	_	ADJ	JJ	_	6	compound	_	_
3	plasma	_	NOUN	NN	_	6	compound	_	_
4	elimination	_	NOUN	NN	_	6	compound	_	_
5	half	_	NOUN	NN	_	6	compound	_	_
6	life	_	NOUN	NN	_	10	nsubj	_	_
7	is	_	VERB	VBZ	_	10	cop	_	_
8	approximately	_	ADV	RB	_	10	advmod	_	_
9	12	_	NUM	CD	_	10	nummod	_	_
10	hours	_	NOUN	NNS	_	0	root	_	_

#	Livalo	584
1	Race	_	ADV	RB	_	24	nsubj	_	_
2	:	_	.	:	_	1	punct	_	_
3	In	_	ADP	IN	_	5	case	_	_
4	pharmacokinetic	_	ADJ	JJ	_	5	amod	_	_
5	studies	_	NOUN	NNS	_	11	nmod	_	_
6	DRUG	_	NOUN	NN	_	7	compound	_	_
7	Cmax	_	NOUN	NN	_	11	nsubj	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	AUC	_	NOUN	NN	_	7	conj	_	_
10	were	_	VERB	VBD	_	11	cop	_	_
11	21	_	NUM	CD	_	1	dep	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	5%	_	ADJ	JJ	_	14	nmod:npmod	_	_
14	lower	_	ADJ	JJ	_	11	conj	_	_
15	,	_	.	,	_	1	punct	_	_
16	respectively	_	ADV	RB	_	18	advmod	_	_
17	in	_	ADP	IN	_	18	case	_	_
18	Black	_	NOUN	NN	_	1	nmod	_	_
19	or	_	CONJ	CC	_	18	cc	_	_
20	African	_	NOUN	NN	_	23	compound	_	_
21	American	_	NOUN	NN	_	23	compound	_	_
22	healthy	_	ADJ	JJ	_	23	amod	_	_
23	volunteers	_	NOUN	NNS	_	18	conj	_	_
24	compared	_	VERB	VBN	_	0	root	_	_
25	with	_	ADP	IN	_	26	case	_	_
26	those	_	DET	DT	_	24	nmod	_	_
27	of	_	ADP	IN	_	30	case	_	_
28	Caucasian	_	ADJ	JJ	_	30	amod	_	_
29	healthy	_	ADJ	JJ	_	30	amod	_	_
30	volunteers	_	NOUN	NNS	_	26	nmod	_	_

#	Livalo	585
1	In	_	ADP	IN	_	3	case	_	_
2	pharmacokinetic	_	ADJ	JJ	_	3	amod	_	_
3	comparison	_	NOUN	NN	_	12	nmod	_	_
4	between	_	ADP	IN	_	6	case	_	_
5	Caucasian	_	ADJ	JJ	_	6	amod	_	_
6	volunteers	_	NOUN	NNS	_	3	nmod	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	Japanese	_	ADJ	JJ	_	9	amod	_	_
9	volunteers	_	NOUN	NNS	_	6	conj	_	_
10	,	_	.	,	_	12	punct	_	_
11	there	_	DET	EX	_	12	expl	_	_
12	were	_	VERB	VBD	_	0	root	_	_
13	no	_	DET	DT	_	15	neg	_	_
14	significant	_	ADJ	JJ	_	15	amod	_	_
15	differences	_	NOUN	NNS	_	12	nsubj	_	_
16	in	_	ADP	IN	_	17	case	_	_
17	Cmax	_	NOUN	NN	_	15	nmod	_	_
18	and	_	CONJ	CC	_	17	cc	_	_
19	AUC	_	NOUN	NN	_	17	conj	_	_

#	Livalo	586
1	Gender	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	In	_	ADP	IN	_	6	case	_	_
4	a	_	DET	DT	_	6	det	_	_
5	pharmacokinetic	_	ADJ	JJ	_	6	amod	_	_
6	study	_	NOUN	NN	_	20	nmod	_	_
7	which	_	DET	WDT	_	8	nsubj	_	_
8	compared	_	VERB	VBD	_	6	acl:relcl	_	_
9	healthy	_	ADJ	JJ	_	10	amod	_	_
10	male	_	ADJ	JJ	_	8	dobj	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	female	_	ADJ	JJ	_	10	conj	_	_
13	volunteers	_	NOUN	NNS	_	10	dep	_	_
14	,	_	.	,	_	20	punct	_	_
15	DRUG	_	NOUN	NN	_	16	compound	_	_
16	Cmax	_	NOUN	NN	_	20	nsubj	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	AUC	_	NOUN	NN	_	16	conj	_	_
19	were	_	VERB	VBD	_	20	cop	_	_
20	60	_	NUM	CD	_	1	dep	_	_
21	and	_	CONJ	CC	_	20	cc	_	_
22	54%	_	ADJ	JJ	_	23	nmod:npmod	_	_
23	higher	_	ADJ	JJ	_	20	conj	_	_
24	,	_	.	,	_	20	punct	_	_
25	respectively	_	ADV	RB	_	20	advmod	_	_
26	in	_	ADP	IN	_	27	case	_	_
27	females	_	NOUN	NNS	_	25	nmod	_	_

#	Livalo	587
1	This	_	DET	DT	_	2	nsubj	_	_
2	had	_	VERB	VBD	_	0	root	_	_
3	no	_	DET	DT	_	4	neg	_	_
4	effect	_	NOUN	NN	_	2	dobj	_	_
5	on	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	efficacy	_	NOUN	NN	_	2	nmod	_	_
8	or	_	CONJ	CC	_	7	cc	_	_
9	safety	_	NOUN	NN	_	7	conj	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	7	nmod	_	_
12	in	_	ADP	IN	_	13	case	_	_
13	women	_	NOUN	NNS	_	7	nmod	_	_
14	in	_	ADP	IN	_	16	case	_	_
15	clinical	_	ADJ	JJ	_	16	amod	_	_
16	studies	_	NOUN	NNS	_	13	nmod	_	_

#	Livalo	588
1	Geriatric	_	ADJ	JJ	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	In	_	ADP	IN	_	6	case	_	_
4	a	_	DET	DT	_	6	det	_	_
5	pharmacokinetic	_	ADJ	JJ	_	6	amod	_	_
6	study	_	NOUN	NN	_	21	nmod	_	_
7	which	_	DET	WDT	_	8	nsubj	_	_
8	compared	_	VERB	VBD	_	6	acl:relcl	_	_
9	healthy	_	ADJ	JJ	_	10	amod	_	_
10	young	_	ADJ	JJ	_	8	dobj	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	elderly	_	ADJ	JJ	_	10	conj	_	_
13	>65years	_	NOUN	NN	_	14	compound	_	_
14	volunteers	_	NOUN	NNS	_	10	dep	_	_
15	,	_	.	,	_	21	punct	_	_
16	DRUG	_	NOUN	NN	_	17	compound	_	_
17	Cmax	_	NOUN	NN	_	21	nsubj	_	_
18	and	_	CONJ	CC	_	17	cc	_	_
19	AUC	_	NOUN	NN	_	17	conj	_	_
20	were	_	VERB	VBD	_	21	cop	_	_
21	10	_	NUM	CD	_	24	nummod	_	_
22	and	_	CONJ	CC	_	21	cc	_	_
23	30%	_	ADJ	JJ	_	21	conj	_	_
24	higher	_	ADJ	JJ	_	1	parataxis	_	_
25	,	_	.	,	_	24	punct	_	_
26	respectively	_	ADV	RB	_	24	advmod	_	_
27	,	_	.	,	_	24	punct	_	_
28	in	_	ADP	IN	_	30	case	_	_
29	the	_	DET	DT	_	30	det	_	_
30	elderly	_	ADJ	JJ	_	24	dep	_	_

#	Livalo	589
1	This	_	DET	DT	_	2	nsubj	_	_
2	had	_	VERB	VBD	_	0	root	_	_
3	no	_	DET	DT	_	4	neg	_	_
4	effect	_	NOUN	NN	_	2	dobj	_	_
5	on	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	efficacy	_	NOUN	NN	_	2	nmod	_	_
8	or	_	CONJ	CC	_	7	cc	_	_
9	safety	_	NOUN	NN	_	7	conj	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	7	nmod	_	_
12	in	_	ADP	IN	_	14	case	_	_
13	elderly	_	ADJ	JJ	_	14	amod	_	_
14	subjects	_	NOUN	NNS	_	2	nmod	_	_
15	in	_	ADP	IN	_	17	case	_	_
16	clinical	_	ADJ	JJ	_	17	amod	_	_
17	studies	_	NOUN	NNS	_	14	nmod	_	_

#	Livalo	590
1	Renal	_	ADJ	JJ	_	2	amod	_	_
2	Impairment	_	NOUN	NN	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	In	_	ADP	IN	_	5	case	_	_
5	patients	_	NOUN	NNS	_	50	nmod	_	_
6	with	_	ADP	IN	_	12	case	_	_
7	moderate	_	ADJ	JJ	_	12	amod	_	_
8	renal	_	ADJ	JJ	_	12	amod	_	_
9	impairment	_	NOUN	NN	_	12	compound	_	_
10	glomerular	_	ADJ	JJ	_	12	amod	_	_
11	filtration	_	NOUN	NN	_	12	compound	_	_
12	rate	_	NOUN	NN	_	5	nmod	_	_
13	of	_	ADP	IN	_	16	case	_	_
14	30	_	NUM	CD	_	16	nummod	_	_
15	59	_	NUM	CD	_	16	nummod	_	_
16	mL	_	NOUN	NN	_	12	nmod	_	_
17	/	_	.	:	_	18	punct	_	_
18	min	_	NOUN	NN	_	48	compound	_	_
19	/	_	.	:	_	18	punct	_	_
20	1.73	_	NUM	CD	_	21	nummod	_	_
21	m2	_	NOUN	NN	_	18	dep	_	_
22	and	_	CONJ	CC	_	21	cc	_	_
23	end	_	NOUN	NN	_	26	compound	_	_
24	stage	_	NOUN	NN	_	26	compound	_	_
25	renal	_	ADJ	JJ	_	26	amod	_	_
26	disease	_	NOUN	NN	_	21	conj	_	_
27	receiving	_	VERB	VBG	_	21	acl	_	_
28	hemodialysis	_	NOUN	NN	_	27	dobj	_	_
29	,	_	.	,	_	18	punct	_	_
30	DRUG	_	NOUN	NN	_	32	compound	_	_
31	AUC0	_	NOUN	NN	_	32	compound	_	_
32	inf	_	NOUN	NN	_	34	nsubj	_	_
33	is	_	VERB	VBZ	_	34	cop	_	_
34	102	_	NUM	CD	_	18	appos	_	_
35	and	_	CONJ	CC	_	34	cc	_	_
36	86%	_	NOUN	NN	_	34	conj	_	_
37	higher	_	ADJ	JJ	_	34	amod	_	_
38	than	_	ADP	IN	_	39	case	_	_
39	those	_	DET	DT	_	37	nmod	_	_
40	of	_	ADP	IN	_	42	case	_	_
41	healthy	_	ADJ	JJ	_	42	amod	_	_
42	volunteers	_	NOUN	NNS	_	39	nmod	_	_
43	,	_	.	,	_	18	punct	_	_
44	respectively	_	ADV	RB	_	18	advmod	_	_
45	,	_	.	,	_	18	punct	_	_
46	while	_	ADP	IN	_	18	dep	_	_
47	DRUG	_	NOUN	NN	_	48	compound	_	_
48	Cmax	_	NOUN	NN	_	50	nsubj	_	_
49	is	_	VERB	VBZ	_	50	cop	_	_
50	60	_	NUM	CD	_	2	dep	_	_
51	and	_	CONJ	CC	_	50	cc	_	_
52	40%	_	NOUN	NN	_	50	conj	_	_
53	higher	_	ADJ	JJ	_	52	amod	_	_
54	than	_	ADP	IN	_	55	case	_	_
55	those	_	DET	DT	_	53	nmod	_	_
56	of	_	ADP	IN	_	58	case	_	_
57	healthy	_	ADJ	JJ	_	58	amod	_	_
58	volunteers	_	NOUN	NNS	_	55	nmod	_	_
59	,	_	.	,	_	50	punct	_	_
60	respectively	_	ADV	RB	_	50	neg	_	_

#	Livalo	591
1	Patients	_	NOUN	NNS	_	2	nsubj	_	_
2	received	_	VERB	VBD	_	0	root	_	_
3	hemodialysis	_	NOUN	NN	_	2	dobj	_	_
4	immediately	_	ADV	RB	_	2	advmod	_	_
5	before	_	ADP	IN	_	7	case	_	_
6	DRUG	_	NOUN	NN	_	7	compound	_	_
7	dosing	_	NOUN	NN	_	2	nmod	_	_
8	and	_	CONJ	CC	_	2	cc	_	_
9	did	_	VERB	MD	_	11	aux	_	_
10	not	_	ADV	RB	_	11	neg	_	_
11	undergo	_	VERB	VB	_	2	conj	_	_
12	hemodialysis	_	NOUN	NN	_	11	dobj	_	_
13	during	_	ADP	IN	_	16	case	_	_
14	the	_	DET	DT	_	16	det	_	_
15	pharmacokinetic	_	ADJ	JJ	_	16	amod	_	_
16	study	_	NOUN	NN	_	11	nmod	_	_

#	Livalo	592
1	Hemodialysis	_	NOUN	NN	_	2	compound	_	_
2	patients	_	NOUN	NNS	_	3	nsubj	_	_
3	have	_	VERB	VBP	_	0	root	_	_
4	33	_	NUM	CD	_	7	nummod	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	36%	_	NOUN	NN	_	4	conj	_	_
7	increases	_	VERB	VBZ	_	3	dobj	_	_
8	in	_	ADP	IN	_	12	case	_	_
9	the	_	DET	DT	_	12	det	_	_
10	mean	_	ADJ	JJ	_	12	amod	_	_
11	unbound	_	ADJ	JJ	_	12	amod	_	_
12	fraction	_	NOUN	NN	_	7	nmod	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	DRUG	_	NOUN	NN	_	12	nmod	_	_
15	as	_	ADP	IN	_	16	mark	_	_
16	compared	_	VERB	VBN	_	3	advcl	_	_
17	to	_	PRT	TO	_	19	case	_	_
18	healthy	_	ADJ	JJ	_	19	amod	_	_
19	volunteers	_	NOUN	NNS	_	16	nmod	_	_
20	and	_	CONJ	CC	_	19	cc	_	_
21	patients	_	NOUN	NNS	_	19	conj	_	_
22	with	_	ADP	IN	_	25	case	_	_
23	moderate	_	ADJ	JJ	_	25	amod	_	_
24	renal	_	ADJ	JJ	_	25	amod	_	_
25	impairment	_	NOUN	NN	_	19	nmod	_	_
26	,	_	.	,	_	3	punct	_	_
27	respectively	_	ADV	RB	_	3	advmod	_	_

#	Livalo	593
1	In	_	ADP	IN	_	4	case	_	_
2	another	_	DET	DT	_	4	det	_	_
3	pharmacokinetic	_	ADJ	JJ	_	4	amod	_	_
4	study	_	NOUN	NN	_	26	nmod	_	_
5	,	_	.	,	_	26	punct	_	_
6	patients	_	NOUN	NNS	_	26	nsubjpass	_	_
7	with	_	ADP	IN	_	21	case	_	_
8	severe	_	ADJ	JJ	_	21	amod	_	_
9	renal	_	ADJ	JJ	_	21	amod	_	_
10	impairment	_	NOUN	NN	_	21	compound	_	_
11	glomerular	_	ADJ	JJ	_	21	amod	_	_
12	filtration	_	NOUN	NN	_	21	compound	_	_
13	rate	_	NOUN	NN	_	21	compound	_	_
14	15	_	NUM	CD	_	21	nummod	_	_
15	29	_	NUM	CD	_	21	nummod	_	_
16	mL	_	NOUN	NN	_	21	compound	_	_
17	/	_	.	:	_	21	punct	_	_
18	min	_	NOUN	NN	_	21	compound	_	_
19	/	_	.	:	_	21	punct	_	_
20	1.73	_	NUM	CD	_	21	nummod	_	_
21	m2	_	NOUN	NN	_	24	compound	_	_
22	not	_	ADV	RB	_	23	neg	_	_
23	receiving	_	VERB	VBG	_	24	amod	_	_
24	hemodialysis	_	NOUN	NN	_	6	nmod	_	_
25	were	_	VERB	VBD	_	26	auxpass	_	_
26	administered	_	VERB	VBN	_	0	root	_	_
27	a	_	DET	DT	_	29	det	_	_
28	single	_	ADJ	JJ	_	29	amod	_	_
29	dose	_	NOUN	NN	_	26	dobj	_	_
30	of	_	ADP	IN	_	33	case	_	_
31	DRUG	_	NOUN	NN	_	33	compound	_	_
32	4	_	NUM	CD	_	33	nummod	_	_
33	mg	_	NOUN	NN	_	29	nmod	_	_

#	Livalo	594
1	The	_	DET	DT	_	3	det	_	_
2	AUC0	_	NOUN	NN	_	3	compound	_	_
3	inf	_	NOUN	NN	_	8	nsubj	_	_
4	and	_	CONJ	CC	_	3	cc	_	_
5	the	_	DET	DT	_	6	det	_	_
6	Cmax	_	NOUN	NN	_	3	conj	_	_
7	were	_	VERB	VBD	_	8	cop	_	_
8	36	_	NUM	CD	_	0	root	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	18%	_	ADJ	JJ	_	11	nmod:npmod	_	_
11	higher	_	ADJ	JJ	_	8	conj	_	_
12	,	_	.	,	_	8	punct	_	_
13	respectively	_	ADV	RB	_	8	advmod	_	_
14	,	_	.	,	_	8	punct	_	_
15	compared	_	VERB	VBN	_	8	dep	_	_
16	with	_	ADP	IN	_	17	case	_	_
17	those	_	DET	DT	_	15	nmod	_	_
18	of	_	ADP	IN	_	20	case	_	_
19	healthy	_	ADJ	JJ	_	20	amod	_	_
20	volunteers	_	NOUN	NNS	_	17	nmod	_	_

#	Livalo	595
1	For	_	ADP	IN	_	3	case	_	_
2	both	_	DET	DT	_	3	det	_	_
3	patients	_	NOUN	NNS	_	21	nmod	_	_
4	with	_	ADP	IN	_	7	case	_	_
5	severe	_	ADJ	JJ	_	7	amod	_	_
6	renal	_	ADJ	JJ	_	7	amod	_	_
7	impairment	_	NOUN	NN	_	3	nmod	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	healthy	_	ADJ	JJ	_	10	amod	_	_
10	volunteers	_	NOUN	NNS	_	7	conj	_	_
11	,	_	.	,	_	21	punct	_	_
12	the	_	DET	DT	_	14	det	_	_
13	mean	_	ADJ	JJ	_	14	amod	_	_
14	percentage	_	NOUN	NN	_	21	nsubj	_	_
15	of	_	ADP	IN	_	18	case	_	_
16	protein	_	NOUN	NN	_	18	compound	_	_
17	unbound	_	ADJ	JJ	_	18	amod	_	_
18	DRUG	_	NOUN	NN	_	14	nmod	_	_
19	was	_	VERB	VBD	_	21	auxpass	_	_
20	approximately	_	ADV	RB	_	21	advmod	_	_
21	0.6%	_	ADJ	JJ	_	0	root	_	_

#	Livalo	596
1	The	_	DET	DT	_	2	det	_	_
2	effect	_	NOUN	NN	_	13	nsubjpass	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	mild	_	ADJ	JJ	_	6	amod	_	_
5	renal	_	ADJ	JJ	_	6	amod	_	_
6	impairment	_	NOUN	NN	_	2	nmod	_	_
7	on	_	ADP	IN	_	9	case	_	_
8	DRUG	_	NOUN	NN	_	9	compound	_	_
9	exposure	_	NOUN	NN	_	2	nmod	_	_
10	has	_	VERB	VBZ	_	13	aux	_	_
11	not	_	ADV	RB	_	13	neg	_	_
12	been	_	VERB	VBN	_	13	auxpass	_	_
13	studied	_	VERB	VBN	_	0	root	_	_

#	Livalo	597
1	Hepatic	_	ADJ	JJ	_	2	amod	_	_
2	Impairment	_	NOUN	NN	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	The	_	DET	DT	_	5	det	_	_
5	disposition	_	NOUN	NN	_	9	nsubjpass	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	was	_	VERB	VBD	_	9	auxpass	_	_
9	compared	_	VERB	VBN	_	2	dep	_	_
10	in	_	ADP	IN	_	12	case	_	_
11	healthy	_	ADJ	JJ	_	12	amod	_	_
12	volunteers	_	NOUN	NNS	_	9	nmod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	patients	_	NOUN	NNS	_	12	conj	_	_
15	with	_	ADP	IN	_	17	case	_	_
16	various	_	ADJ	JJ	_	17	amod	_	_
17	degrees	_	NOUN	NNS	_	12	nmod	_	_
18	of	_	ADP	IN	_	20	case	_	_
19	hepatic	_	ADJ	JJ	_	20	amod	_	_
20	impairment	_	NOUN	NN	_	17	nmod	_	_

#	Livalo	598
1	The	_	DET	DT	_	2	det	_	_
2	ratio	_	NOUN	NN	_	20	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	DRUG	_	NOUN	NN	_	5	compound	_	_
5	Cmax	_	NOUN	NN	_	2	nmod	_	_
6	between	_	ADP	IN	_	7	case	_	_
7	patients	_	NOUN	NNS	_	2	nmod	_	_
8	with	_	ADP	IN	_	15	case	_	_
9	moderate	_	ADJ	JJ	_	15	amod	_	_
10	hepatic	_	ADJ	JJ	_	15	amod	_	_
11	impairment	_	NOUN	NN	_	15	compound	_	_
12	Child	_	NOUN	NN	_	15	compound	_	_
13	Pugh	_	NOUN	NN	_	15	compound	_	_
14	B	_	NOUN	NN	_	15	compound	_	_
15	disease	_	NOUN	NN	_	7	nmod	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	healthy	_	ADJ	JJ	_	18	amod	_	_
18	volunteers	_	NOUN	NNS	_	15	conj	_	_
19	was	_	VERB	VBD	_	20	cop	_	_
20	2.7	_	NUM	CD	_	0	root	_	_

#	Livalo	599
1	The	_	DET	DT	_	2	det	_	_
2	ratio	_	NOUN	NN	_	16	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	DRUG	_	NOUN	NN	_	5	compound	_	_
5	AUCinf	_	NOUN	NN	_	2	nmod	_	_
6	between	_	ADP	IN	_	7	case	_	_
7	patients	_	NOUN	NNS	_	2	nmod	_	_
8	with	_	ADP	IN	_	11	case	_	_
9	moderate	_	ADJ	JJ	_	11	amod	_	_
10	hepatic	_	ADJ	JJ	_	11	amod	_	_
11	impairment	_	NOUN	NN	_	7	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	healthy	_	ADJ	JJ	_	14	amod	_	_
14	volunteers	_	NOUN	NNS	_	11	conj	_	_
15	was	_	VERB	VBD	_	16	cop	_	_
16	3.8	_	NUM	CD	_	0	root	_	_

#	Livalo	600
1	The	_	DET	DT	_	2	det	_	_
2	ratio	_	NOUN	NN	_	20	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	DRUG	_	NOUN	NN	_	5	compound	_	_
5	Cmax	_	NOUN	NN	_	2	nmod	_	_
6	between	_	ADP	IN	_	7	case	_	_
7	patients	_	NOUN	NNS	_	2	nmod	_	_
8	with	_	ADP	IN	_	15	case	_	_
9	mild	_	ADJ	JJ	_	15	amod	_	_
10	hepatic	_	ADJ	JJ	_	15	amod	_	_
11	impairment	_	NOUN	NN	_	15	compound	_	_
12	Child	_	NOUN	NN	_	15	compound	_	_
13	Pugh	_	NOUN	NN	_	15	compound	_	_
14	A	_	NOUN	NN	_	15	compound	_	_
15	disease	_	NOUN	NN	_	7	nmod	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	healthy	_	ADJ	JJ	_	18	amod	_	_
18	volunteers	_	NOUN	NNS	_	15	conj	_	_
19	was	_	VERB	VBD	_	20	cop	_	_
20	1.3	_	NUM	CD	_	0	root	_	_

#	Livalo	601
1	The	_	DET	DT	_	2	det	_	_
2	ratio	_	NOUN	NN	_	16	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	DRUG	_	NOUN	NN	_	5	compound	_	_
5	AUCinf	_	NOUN	NN	_	2	nmod	_	_
6	between	_	ADP	IN	_	7	case	_	_
7	patients	_	NOUN	NNS	_	2	nmod	_	_
8	with	_	ADP	IN	_	11	case	_	_
9	mild	_	ADJ	JJ	_	11	amod	_	_
10	hepatic	_	ADJ	JJ	_	11	amod	_	_
11	impairment	_	NOUN	NN	_	7	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	healthy	_	ADJ	JJ	_	14	amod	_	_
14	volunteers	_	NOUN	NNS	_	11	conj	_	_
15	was	_	VERB	VBD	_	16	cop	_	_
16	1.6	_	NUM	CD	_	0	root	_	_

#	Livalo	602
1	Mean	_	VERB	VB	_	0	root	_	_
2	DRUG	_	NOUN	NN	_	1	dobj	_	_
3	t%	_	ADP	IN	_	7	case	_	_
4	for	_	ADP	IN	_	7	case	_	_
5	moderate	_	ADJ	JJ	_	7	amod	_	_
6	hepatic	_	ADJ	JJ	_	7	amod	_	_
7	impairment	_	NOUN	NN	_	1	nmod	_	_
8	,	_	.	,	_	7	punct	_	_
9	mild	_	ADJ	JJ	_	11	amod	_	_
10	hepatic	_	ADJ	JJ	_	11	amod	_	_
11	impairment	_	NOUN	NN	_	7	conj	_	_
12	,	_	.	,	_	7	punct	_	_
13	and	_	CONJ	CC	_	7	cc	_	_
14	healthy	_	NOUN	NN	_	7	conj	_	_
15	were	_	VERB	VBD	_	16	cop	_	_
16	15	_	NUM	CD	_	22	nummod	_	_
17	,	_	.	,	_	16	punct	_	_
18	10	_	NUM	CD	_	16	conj	_	_
19	,	_	.	,	_	16	punct	_	_
20	and	_	CONJ	CC	_	16	cc	_	_
21	8	_	NUM	CD	_	16	conj	_	_
22	hours	_	NOUN	NNS	_	1	dobj	_	_
23	,	_	.	,	_	1	punct	_	_
24	respectively	_	ADV	RB	_	1	neg	_	_

#	Livalo	603
1	Drug	_	NOUN	NN	_	3	compound	_	_
2	Drug	_	NOUN	NN	_	3	compound	_	_
3	Interactions	_	NOUN	NNS	_	0	root	_	_
4	:	_	.	:	_	3	punct	_	_
5	The	_	DET	DT	_	7	det	_	_
6	principal	_	ADJ	JJ	_	7	amod	_	_
7	route	_	NOUN	NN	_	12	nsubj	_	_
8	of	_	ADP	IN	_	10	case	_	_
9	DRUG	_	NOUN	NN	_	10	compound	_	_
10	metabolism	_	NOUN	NN	_	7	nmod	_	_
11	is	_	VERB	VBZ	_	12	cop	_	_
12	glucuronidation	_	NOUN	NN	_	3	dep	_	_
13	via	_	ADP	IN	_	15	case	_	_
14	liver	_	NOUN	NN	_	15	compound	_	_
15	UGTs	_	NOUN	NNS	_	12	nmod	_	_
16	with	_	ADP	IN	_	18	case	_	_
17	subsequent	_	ADJ	JJ	_	18	amod	_	_
18	formation	_	NOUN	NN	_	12	nmod	_	_
19	of	_	ADP	IN	_	21	case	_	_
20	DRUG	_	NOUN	NN	_	21	compound	_	_
21	lactone	_	NOUN	NN	_	18	nmod	_	_

#	Livalo	604
1	There	_	DET	EX	_	2	expl	_	_
2	is	_	VERB	VBZ	_	0	root	_	_
3	only	_	ADV	RB	_	4	advmod	_	_
4	minimal	_	ADJ	JJ	_	5	amod	_	_
5	metabolism	_	NOUN	NN	_	2	nsubj	_	_
6	by	_	ADP	IN	_	10	case	_	_
7	the	_	DET	DT	_	10	det	_	_
8	cytochrome	_	NOUN	NN	_	10	compound	_	_
9	P450	_	NOUN	NN	_	10	compound	_	_
10	system	_	NOUN	NN	_	5	nmod	_	_

#	Livalo	605
1	Warfarin	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	The	_	DET	DT	_	6	det	_	_
4	steady	_	ADJ	JJ	_	6	amod	_	_
5	state	_	NOUN	NN	_	6	compound	_	_
6	pharmacodynamics	_	NOUN	NNS	_	23	nsubj	_	_
7	international	_	ADJ	JJ	_	10	amod	_	_
8	normalized	_	VERB	VBN	_	10	amod	_	_
9	ratio	_	NOUN	NN	_	10	compound	_	_
10	INR	_	NOUN	NN	_	6	dep	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	prothrombin	_	NOUN	NN	_	14	compound	_	_
13	time	_	NOUN	NN	_	14	compound	_	_
14	PT	_	NOUN	NN	_	10	conj	_	_
15	and	_	CONJ	CC	_	10	cc	_	_
16	pharmacokinetics	_	NOUN	NNS	_	10	conj	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	warfarin	_	NOUN	NN	_	10	nmod	_	_
19	in	_	ADP	IN	_	21	case	_	_
20	healthy	_	ADJ	JJ	_	21	amod	_	_
21	volunteers	_	NOUN	NNS	_	18	nmod	_	_
22	were	_	VERB	VBD	_	23	cop	_	_
23	unaffected	_	ADJ	JJ	_	1	dep	_	_
24	by	_	ADP	IN	_	27	case	_	_
25	the	_	DET	DT	_	27	det	_	_
26	co	_	DET	DT	_	27	nmod:poss	_	_
27	administration	_	NOUN	NN	_	23	nmod	_	_
28	of	_	ADP	IN	_	31	case	_	_
29	DRUG	_	NOUN	NN	_	31	compound	_	_
30	4	_	NUM	CD	_	31	nummod	_	_
31	mg	_	NOUN	NN	_	27	nmod	_	_
32	daily	_	ADV	RB	_	23	advmod	_	_

#	Livalo	606
1	However	_	ADV	RB	_	7	advmod	_	_
2	,	_	.	,	_	7	punct	_	_
3	patients	_	NOUN	NNS	_	7	nsubj	_	_
4	receiving	_	VERB	VBG	_	3	acl	_	_
5	warfarin	_	NOUN	NN	_	4	dobj	_	_
6	should	_	VERB	MD	_	7	aux	_	_
7	have	_	VERB	VB	_	0	root	_	_
8	their	_	PRON	PRP$	_	10	nmod:poss	_	_
9	PT	_	NOUN	NN	_	10	compound	_	_
10	time	_	NOUN	NN	_	7	dobj	_	_
11	or	_	CONJ	CC	_	10	cc	_	_
12	INR	_	NOUN	NN	_	10	conj	_	_
13	monitored	_	VERB	VBN	_	10	acl	_	_
14	when	_	ADV	WRB	_	17	advmod	_	_
15	DRUG	_	NOUN	NN	_	17	nsubjpass	_	_
16	is	_	VERB	VBZ	_	17	auxpass	_	_
17	added	_	VERB	VBN	_	13	advcl	_	_
18	to	_	PRT	TO	_	20	case	_	_
19	their	_	PRON	PRP$	_	20	nmod:poss	_	_
20	therapy	_	NOUN	NN	_	17	nmod	_	_

#	Livalo	607
1	Effect	_	NOUN	NN	_	17	nsubj	_	_
2	of	_	ADP	IN	_	5	case	_	_
3	Co	_	NOUN	NN	_	5	compound	_	_
4	Administered	_	ADJ	JJ	_	5	amod	_	_
5	Drugs	_	NOUN	NNS	_	1	nmod	_	_
6	on	_	ADP	IN	_	11	case	_	_
7	DRUG	_	NOUN	NN	_	11	compound	_	_
8	Systemic	_	ADJ	JJ	_	11	amod	_	_
9	Exposure	_	NOUN	NN	_	11	compound	_	_
10	*	_	NUM	CD	_	11	nummod	_	_
11	Data	_	NOUN	NN	_	1	nmod	_	_
12	presented	_	VERB	VBN	_	11	acl	_	_
13	as	_	ADP	IN	_	16	case	_	_
14	x	_	NOUN	NN	_	16	compound	_	_
15	fold	_	NOUN	NN	_	16	compound	_	_
16	change	_	NOUN	NN	_	12	nmod	_	_
17	represent	_	VERB	VBP	_	0	root	_	_
18	the	_	DET	DT	_	19	det	_	_
19	ratio	_	NOUN	NN	_	17	dobj	_	_
20	between	_	ADP	IN	_	22	case	_	_
21	co	_	PRT	TO	_	22	case	_	_
22	administration	_	NOUN	NN	_	19	nmod	_	_
23	and	_	CONJ	CC	_	22	cc	_	_
24	DRUG	_	NOUN	NN	_	22	conj	_	_
25	alone	_	ADV	RB	_	26	advmod	_	_
26	i.e	_	ADV	RB	_	19	advmod	_	_
27	,	_	.	,	_	19	punct	_	_
28	1	_	NUM	CD	_	29	nummod	_	_
29	fold	_	NOUN	NN	_	19	conj	_	_
30	=	_	ADJ	JJ	_	32	compound	_	_
31	no	_	DET	DT	_	32	neg	_	_
32	change	_	NOUN	NN	_	17	dobj	_	_

#	Livalo	608
1	Data	_	NOUN	NN	_	6	nsubj	_	_
2	presented	_	VERB	VBN	_	1	acl	_	_
3	as	_	ADP	IN	_	5	case	_	_
4	%	_	NOUN	NN	_	5	compound	_	_
5	change	_	NOUN	NN	_	2	nmod	_	_
6	represent	_	VERB	VBP	_	0	root	_	_
7	%	_	NOUN	NN	_	8	compound	_	_
8	difference	_	NOUN	NN	_	6	dobj	_	_
9	relative	_	ADJ	JJ	_	6	advmod	_	_
10	to	_	PRT	TO	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_
12	alone	_	ADV	RB	_	13	advmod	_	_
13	i.e	_	ADV	RB	_	11	amod	_	_
14	,	_	.	,	_	6	punct	_	_
15	0%	_	ADJ	JJ	_	18	compound	_	_
16	=	_	ADJ	JJ	_	18	compound	_	_
17	no	_	DET	DT	_	18	nummod	_	_
18	change	_	NOUN	NN	_	6	dobj	_	_

#	Livalo	609
1	*	_	NOUN	NN	_	2	nsubj	_	_
2	Considered	_	VERB	VBD	_	0	root	_	_
3	clinically	_	ADV	RB	_	4	advmod	_	_
4	significant	_	ADJ	JJ	_	5	amod	_	_
5	BID	_	NOUN	NN	_	2	dobj	_	_
6	=	_	CONJ	CC	_	10	aux	_	_
7	twice	_	ADV	RB	_	8	advmod	_	_
8	daily	_	ADV	RB	_	10	advmod	_	_
9	QD	_	NOUN	NN	_	10	nsubj	_	_
10	=	_	ADJ	JJ	_	2	parataxis	_	_
11	once	_	ADV	RB	_	12	advmod	_	_
12	daily	_	ADV	RB	_	13	advmod	_	_
13	LA	_	NOUN	NN	_	24	compound	_	_
14	=	_	CONJ	CC	_	24	amod	_	_
15	Long	_	ADJ	JJ	_	17	amod	_	_
16	Acting	_	ADJ	JJ	_	17	amod	_	_
17	Co	_	NOUN	NN	_	18	nmod:npmod	_	_
18	administered	_	VERB	VBN	_	24	amod	_	_
19	drug	_	NOUN	NN	_	24	compound	_	_
20	Dose	_	NOUN	NN	_	24	compound	_	_
21	regimen	_	NOUN	NN	_	24	compound	_	_
22	Change	_	NOUN	NN	_	24	compound	_	_
23	inAUC*	_	NOUN	NN	_	24	compound	_	_
24	Change	_	NOUN	NN	_	10	dobj	_	_
25	in	_	ADP	IN	_	31	case	_	_
26	Cmax*	_	NOUN	NN	_	31	compound	_	_
27	Cyclosporine	_	NOUN	NN	_	31	compound	_	_
28	DRUG	_	NOUN	NN	_	31	compound	_	_
29	2	_	NUM	CD	_	31	nummod	_	_
30	mg	_	NOUN	NN	_	31	compound	_	_
31	QD	_	NOUN	NN	_	24	nmod	_	_
32	for	_	ADP	IN	_	34	case	_	_
33	6	_	NUM	CD	_	34	nummod	_	_
34	days	_	NOUN	NNS	_	24	nmod	_	_
35	+	_	CONJ	CC	_	34	cc	_	_
36	cyclosporine	_	NOUN	NN	_	38	compound	_	_
37	2	_	NUM	CD	_	38	nummod	_	_
38	mg	_	NOUN	NN	_	34	conj	_	_
39	/	_	.	:	_	10	punct	_	_
40	kg	_	NOUN	NN	_	10	dep	_	_
41	on	_	ADP	IN	_	46	case	_	_
42	Day	_	NOUN	NN	_	46	compound	_	_
43	6	_	NUM	CD	_	45	compound	_	_
44	*	_	ADJ	JJ	_	45	advmod	_	_
45	4.6	_	NUM	CD	_	46	nummod	_	_
46	fold*	_	NOUN	NN	_	40	nmod	_	_
47	*	_	ADJ	JJ	_	48	advmod	_	_
48	6.6	_	NUM	CD	_	49	nummod	_	_
49	fold	_	NOUN	NN	_	40	nmod	_	_
50	*	_	CONJ	CC	_	56	nummod	_	_
51	Erythromycin	_	NOUN	NN	_	56	compound	_	_
52	DRUG	_	NOUN	NN	_	56	compound	_	_
53	4	_	NUM	CD	_	56	nummod	_	_
54	mg	_	NOUN	NN	_	56	compound	_	_
55	single	_	ADJ	JJ	_	56	amod	_	_
56	dose	_	NOUN	NN	_	49	dep	_	_
57	on	_	ADP	IN	_	58	case	_	_
58	Day	_	NOUN	NN	_	49	nmod	_	_
59	4	_	NUM	CD	_	58	nummod	_	_
60	+	_	CONJ	CC	_	58	cc	_	_
61	erythromycin	_	NOUN	NN	_	63	compound	_	_
62	500	_	NUM	CD	_	63	nummod	_	_
63	mg	_	NOUN	NN	_	58	conj	_	_
64	4	_	NUM	CD	_	63	nummod	_	_
65	times	_	NOUN	NNS	_	58	dep	_	_
66	daily	_	ADV	RB	_	49	advmod	_	_
67	for	_	ADP	IN	_	69	case	_	_
68	6	_	NUM	CD	_	69	nummod	_	_
69	days	_	NOUN	NNS	_	49	nmod	_	_
70	*	_	CONJ	CC	_	71	advmod	_	_
71	2.8	_	NUM	CD	_	72	nummod	_	_
72	fold	_	NOUN	NN	_	73	dep	_	_
73	*	_	NUM	CD	_	82	dep	_	_
74	*	_	ADJ	JJ	_	82	amod	_	_
75	3.6	_	NUM	CD	_	76	nummod	_	_
76	fold	_	NOUN	NN	_	82	dep	_	_
77	*	_	CONJ	CC	_	82	nummod	_	_
78	Rifampin	_	NOUN	NN	_	82	compound	_	_
79	DRUG	_	NOUN	NN	_	82	compound	_	_
80	4	_	NUM	CD	_	82	nummod	_	_
81	mg	_	NOUN	NN	_	82	compound	_	_
82	QD	_	NOUN	NN	_	69	nmod	_	_
83	+	_	CONJ	CC	_	49	cc	_	_
84	rifampin	_	NOUN	NN	_	87	compound	_	_
85	600	_	NUM	CD	_	87	nummod	_	_
86	mg	_	NOUN	NN	_	87	compound	_	_
87	QD	_	NOUN	NN	_	49	conj	_	_
88	for	_	ADP	IN	_	90	case	_	_
89	5	_	NUM	CD	_	90	nummod	_	_
90	days	_	NOUN	NNS	_	49	nmod	_	_
91	*	_	CONJ	CC	_	100	nummod	_	_
92	29%	_	NOUN	NN	_	100	amod	_	_
93	*	_	CONJ	CC	_	94	dep	_	_
94	2.0	_	NUM	CD	_	95	compound	_	_
95	fold	_	NOUN	NN	_	100	amod	_	_
96	Atazanavir	_	NOUN	NN	_	100	compound	_	_
97	DRUG	_	NOUN	NN	_	100	compound	_	_
98	4	_	NUM	CD	_	100	nummod	_	_
99	mg	_	NOUN	NN	_	100	compound	_	_
100	QD	_	NOUN	NN	_	90	dep	_	_
101	+	_	CONJ	CC	_	49	cc	_	_
102	atazanavir	_	NOUN	NN	_	104	compound	_	_
103	300	_	NUM	CD	_	104	nummod	_	_
104	mg	_	NOUN	NN	_	49	conj	_	_
105	daily	_	ADV	RB	_	108	advmod	_	_
106	for	_	ADP	IN	_	108	case	_	_
107	5	_	NUM	CD	_	108	nummod	_	_
108	days	_	NOUN	NNS	_	40	nmod	_	_
109	*	_	CONJ	CC	_	108	advmod	_	_
110	31%	_	ADJ	JJ	_	113	amod	_	_
111	*	_	CONJ	CC	_	113	nummod	_	_
112	60%	_	ADJ	JJ	_	113	amod	_	_
113	Darunavir	_	NOUN	NN	_	109	dep	_	_
114	/	_	.	:	_	113	punct	_	_
115	Ritonavir	_	ADJ	JJ	_	118	amod	_	_
116	DRUG	_	NOUN	NN	_	118	compound	_	_
117	4mg	_	ADJ	JJ	_	118	amod	_	_
118	QD	_	NOUN	NN	_	113	dep	_	_
119	on	_	ADP	IN	_	120	case	_	_
120	Days	_	NOUN	NN	_	118	nmod	_	_
121	1	_	NUM	CD	_	122	nummod	_	_
122	5	_	NUM	CD	_	120	dep	_	_
123	and	_	CONJ	CC	_	122	cc	_	_
124	12	_	NUM	CD	_	125	nummod	_	_
125	16	_	NUM	CD	_	122	conj	_	_
126	+	_	CONJ	CC	_	122	cc	_	_
127	darunavir	_	NOUN	NN	_	122	conj	_	_
128	/	_	.	:	_	113	punct	_	_
129	ritonavir	_	ADJ	JJ	_	162	dep	_	_
130	800mg	_	ADJ	JJ	_	129	dep	_	_
131	/	_	.	:	_	129	punct	_	_
132	100	_	NUM	CD	_	133	compound	_	_
133	mg	_	NOUN	NN	_	134	amod	_	_
134	QD	_	NOUN	NN	_	129	dep	_	_
135	on	_	ADP	IN	_	149	case	_	_
136	Days	_	NOUN	NN	_	143	compound	_	_
137	6	_	NUM	CD	_	143	nummod	_	_
138	16	_	NUM	CD	_	143	nummod	_	_
139	*	_	CONJ	CC	_	138	cc	_	_
140	26%	_	ADJ	JJ	_	138	conj	_	_
141	*	_	NUM	CD	_	143	nummod	_	_
142	4%	_	ADJ	JJ	_	143	amod	_	_
143	Lopinavir	_	ADJ	JJ	_	149	dep	_	_
144	/	_	.	:	_	143	punct	_	_
145	Ritonavir	_	ADJ	JJ	_	149	amod	_	_
146	DRUG	_	NOUN	NN	_	149	compound	_	_
147	4	_	NUM	CD	_	149	nummod	_	_
148	mg	_	NOUN	NN	_	149	compound	_	_
149	QD	_	NOUN	NN	_	134	nmod	_	_
150	on	_	ADP	IN	_	151	case	_	_
151	Days	_	NOUN	NN	_	134	nmod	_	_
152	1	_	NUM	CD	_	153	nummod	_	_
153	5	_	NUM	CD	_	151	nummod	_	_
154	and	_	CONJ	CC	_	153	cc	_	_
155	20	_	NUM	CD	_	156	nummod	_	_
156	24	_	NUM	CD	_	153	conj	_	_
157	+	_	CONJ	CC	_	153	cc	_	_
158	lopinavir	_	ADJ	JJ	_	153	conj	_	_
159	/	_	.	:	_	129	punct	_	_
160	ritonavir	_	NOUN	NN	_	162	compound	_	_
161	400	_	NUM	CD	_	162	nummod	_	_
162	mg	_	NOUN	NN	_	113	dep	_	_
163	/	_	.	:	_	162	punct	_	_
164	100	_	NUM	CD	_	165	compound	_	_
165	mg	_	NOUN	NN	_	166	amod	_	_
166	BID	_	NOUN	NN	_	162	dep	_	_
167	on	_	ADP	IN	_	179	case	_	_
168	Days	_	NOUN	NN	_	179	compound	_	_
169	9	_	NUM	CD	_	179	nummod	_	_
170	24	_	NUM	CD	_	179	nummod	_	_
171	*	_	CONJ	CC	_	179	amod	_	_
172	20%	_	ADJ	JJ	_	179	amod	_	_
173	4	_	NUM	CD	_	179	nummod	_	_
174	%	_	NOUN	NN	_	179	compound	_	_
175	Gemfibrozil	_	NOUN	NN	_	179	compound	_	_
176	DRUG	_	NOUN	NN	_	179	compound	_	_
177	4	_	NUM	CD	_	179	nummod	_	_
178	mg	_	NOUN	NN	_	179	compound	_	_
179	QD	_	NOUN	NN	_	166	nmod	_	_
180	+	_	CONJ	CC	_	166	cc	_	_
181	gemfibrozil	_	NOUN	NN	_	184	compound	_	_
182	600	_	NUM	CD	_	184	nummod	_	_
183	mg	_	NOUN	NN	_	184	compound	_	_
184	BID	_	NOUN	NN	_	166	conj	_	_
185	for	_	ADP	IN	_	187	case	_	_
186	7	_	NUM	CD	_	187	nummod	_	_
187	days	_	NOUN	NNS	_	192	nmod	_	_
188	*	_	CONJ	CC	_	191	neg	_	_
189	45%	_	ADJ	JJ	_	191	amod	_	_
190	*	_	NUM	CD	_	191	nummod	_	_
191	31%	_	NOUN	NN	_	192	nsubj	_	_
192	Fenofibrate	_	VERB	VBP	_	166	acl	_	_
193	DRUG	_	NOUN	NN	_	196	compound	_	_
194	4	_	NUM	CD	_	196	nummod	_	_
195	mg	_	NOUN	NN	_	196	compound	_	_
196	QD	_	NOUN	NN	_	192	dobj	_	_
197	+	_	CONJ	CC	_	166	cc	_	_
198	fenofibrate	_	NOUN	NN	_	201	compound	_	_
199	160	_	NUM	CD	_	201	nummod	_	_
200	mg	_	NOUN	NN	_	201	compound	_	_
201	QD	_	NOUN	NN	_	166	conj	_	_
202	for	_	ADP	IN	_	204	case	_	_
203	7	_	NUM	CD	_	204	nummod	_	_
204	days	_	NOUN	NNS	_	166	nmod	_	_
205	18%	_	ADJ	JJ	_	204	amod	_	_
206	*	_	CONJ	CC	_	212	nummod	_	_
207	11%	_	ADJ	JJ	_	212	amod	_	_
208	Ezetimibe	_	NOUN	NN	_	212	compound	_	_
209	DRUG	_	NOUN	NN	_	212	compound	_	_
210	2	_	NUM	CD	_	212	nummod	_	_
211	mg	_	NOUN	NN	_	212	compound	_	_
212	QD	_	NOUN	NN	_	205	dep	_	_
213	+	_	CONJ	CC	_	166	cc	_	_
214	ezetimibe	_	VERB	VB	_	216	amod	_	_
215	10	_	NUM	CD	_	216	nummod	_	_
216	mg	_	NOUN	NN	_	166	conj	_	_
217	for	_	ADP	IN	_	219	case	_	_
218	7	_	NUM	CD	_	219	nummod	_	_
219	days	_	NOUN	NNS	_	166	nmod	_	_
220	*	_	NUM	CD	_	227	nummod	_	_
221	2%	_	ADJ	JJ	_	227	amod	_	_
222	0.2%	_	ADJ	JJ	_	227	amod	_	_
223	Enalapril	_	NOUN	NN	_	227	compound	_	_
224	DRUG	_	NOUN	NN	_	227	compound	_	_
225	4	_	NUM	CD	_	227	nummod	_	_
226	mg	_	NOUN	NN	_	227	compound	_	_
227	QD	_	NOUN	NN	_	219	dep	_	_
228	+	_	CONJ	CC	_	219	cc	_	_
229	enalapril	_	NOUN	NN	_	231	compound	_	_
230	20	_	NUM	CD	_	231	nummod	_	_
231	mg	_	NOUN	NN	_	219	conj	_	_
232	daily	_	ADV	RB	_	244	advmod	_	_
233	for	_	ADP	IN	_	235	case	_	_
234	5	_	NUM	CD	_	235	nummod	_	_
235	days	_	NOUN	NNS	_	232	nmod	_	_
236	*	_	NUM	CD	_	244	nummod	_	_
237	6%	_	ADJ	JJ	_	244	amod	_	_
238	*	_	CONJ	CC	_	244	nummod	_	_
239	7%	_	ADJ	JJ	_	244	amod	_	_
240	Digoxin	_	NOUN	NN	_	244	compound	_	_
241	DRUG	_	NOUN	NN	_	244	compound	_	_
242	4	_	NUM	CD	_	244	nummod	_	_
243	mg	_	NOUN	NN	_	244	compound	_	_
244	QD	_	NOUN	NN	_	166	dep	_	_
245	+	_	CONJ	CC	_	244	cc	_	_
246	digoxin	_	NOUN	NN	_	248	compound	_	_
247	0.25	_	NUM	CD	_	248	nummod	_	_
248	mg	_	NOUN	NN	_	244	conj	_	_
249	for	_	ADP	IN	_	251	case	_	_
250	7	_	NUM	CD	_	251	nummod	_	_
251	days	_	NOUN	NNS	_	244	nmod	_	_
252	*	_	NUM	CD	_	261	neg	_	_
253	4%	_	ADJ	JJ	_	261	amod	_	_
254	*	_	CONJ	CC	_	261	nummod	_	_
255	9%	_	ADJ	JJ	_	261	amod	_	_
256	Diltiazem	_	NOUN	NN	_	261	compound	_	_
257	LA	_	NOUN	NN	_	261	compound	_	_
258	DRUG	_	NOUN	NN	_	261	compound	_	_
259	4	_	NUM	CD	_	261	nummod	_	_
260	mg	_	NOUN	NN	_	261	compound	_	_
261	QD	_	NOUN	NN	_	251	dep	_	_
262	on	_	ADP	IN	_	263	case	_	_
263	Days	_	NOUN	NN	_	261	nmod	_	_
264	1	_	NUM	CD	_	265	nummod	_	_
265	5	_	NUM	CD	_	263	dep	_	_
266	and	_	CONJ	CC	_	265	cc	_	_
267	11	_	NUM	CD	_	268	nummod	_	_
268	15	_	NUM	CD	_	265	conj	_	_
269	and	_	CONJ	CC	_	263	cc	_	_
270	diltiazem	_	NOUN	NN	_	273	compound	_	_
271	LA	_	NOUN	NN	_	273	compound	_	_
272	240	_	NUM	CD	_	273	nummod	_	_
273	mg	_	NOUN	NN	_	263	conj	_	_
274	on	_	ADP	IN	_	286	case	_	_
275	Days	_	NOUN	NN	_	286	compound	_	_
276	6	_	NUM	CD	_	286	nummod	_	_
277	15	_	NUM	CD	_	286	nummod	_	_
278	10%	_	ADJ	JJ	_	286	amod	_	_
279	15%	_	ADJ	JJ	_	286	amod	_	_
280	Grapefruit	_	NOUN	NN	_	286	compound	_	_
281	Juice	_	NOUN	NN	_	286	compound	_	_
282	DRUG	_	NOUN	NN	_	286	compound	_	_
283	2	_	NUM	CD	_	286	nummod	_	_
284	mg	_	NOUN	NN	_	286	compound	_	_
285	single	_	ADJ	JJ	_	286	amod	_	_
286	dose	_	NOUN	NN	_	261	nmod	_	_
287	on	_	ADP	IN	_	288	case	_	_
288	Day	_	NOUN	NN	_	261	nmod	_	_
289	3	_	NUM	CD	_	288	nummod	_	_
290	+	_	CONJ	CC	_	288	cc	_	_
291	grapefruit	_	ADJ	JJ	_	292	amod	_	_
292	juice	_	NOUN	NN	_	288	conj	_	_
293	for	_	ADP	IN	_	295	case	_	_
294	4	_	NUM	CD	_	295	nummod	_	_
295	days	_	NOUN	NNS	_	261	nmod	_	_
296	*	_	CONJ	CC	_	305	neg	_	_
297	15%	_	ADJ	JJ	_	305	amod	_	_
298	*	_	CONJ	CC	_	305	amod	_	_
299	12%	_	ADJ	JJ	_	305	amod	_	_
300	Itraconazole	_	NOUN	NN	_	305	compound	_	_
301	DRUG	_	NOUN	NN	_	305	compound	_	_
302	4	_	NUM	CD	_	305	nummod	_	_
303	mg	_	NOUN	NN	_	305	compound	_	_
304	single	_	ADJ	JJ	_	305	amod	_	_
305	dose	_	NOUN	NN	_	295	dep	_	_
306	on	_	ADP	IN	_	307	case	_	_
307	Day	_	NOUN	NN	_	305	nmod	_	_
308	4	_	NUM	CD	_	307	nummod	_	_
309	+	_	CONJ	CC	_	307	cc	_	_
310	itraconazole	_	NOUN	NN	_	312	compound	_	_
311	200	_	NUM	CD	_	312	nummod	_	_
312	mg	_	NOUN	NN	_	307	conj	_	_
313	daily	_	ADV	RB	_	316	advmod	_	_
314	for	_	ADP	IN	_	316	case	_	_
315	5	_	NUM	CD	_	316	nummod	_	_
316	days	_	NOUN	NNS	_	305	nmod	_	_
317	*	_	CONJ	CC	_	316	punct	_	_
318	23%	_	ADJ	JJ	_	317	dep	_	_
319	*	_	CONJ	CC	_	321	compound	_	_
320	22%	_	ADJ	JJ	_	321	compound	_	_
321	Table	_	ADJ	JJ	_	318	conj	_	_
322	3	_	NUM	CD	_	321	nummod	_	_

#	Livalo	610
1	Effect	_	NOUN	NN	_	17	nsubj	_	_
2	of	_	ADP	IN	_	5	case	_	_
3	DRUG	_	NOUN	NN	_	5	compound	_	_
4	Co	_	NOUN	NN	_	5	compound	_	_
5	Administration	_	NOUN	NN	_	1	nmod	_	_
6	on	_	ADP	IN	_	8	case	_	_
7	Systemic	_	ADJ	JJ	_	8	amod	_	_
8	Exposure	_	NOUN	NN	_	1	nmod	_	_
9	to	_	PRT	TO	_	12	case	_	_
10	Other	_	ADJ	JJ	_	12	amod	_	_
11	Drugs	_	NOUN	NNS	_	12	compound	_	_
12	Data	_	NOUN	NN	_	1	nmod	_	_
13	presented	_	VERB	VBN	_	12	acl	_	_
14	as	_	ADP	IN	_	16	case	_	_
15	%	_	NOUN	NN	_	16	compound	_	_
16	change	_	NOUN	NN	_	13	nmod	_	_
17	represent	_	VERB	VBP	_	0	root	_	_
18	%	_	NOUN	NN	_	19	compound	_	_
19	difference	_	NOUN	NN	_	17	dobj	_	_
20	relative	_	ADJ	JJ	_	17	advmod	_	_
21	to	_	PRT	TO	_	24	case	_	_
22	the	_	DET	DT	_	24	det	_	_
23	investigated	_	VERB	VBN	_	24	amod	_	_
24	drug	_	NOUN	NN	_	20	nmod	_	_
25	alone	_	ADV	RB	_	26	advmod	_	_
26	i.e	_	ADV	RB	_	24	amod	_	_
27	,	_	.	,	_	17	punct	_	_
28	0%	_	ADJ	JJ	_	31	compound	_	_
29	=	_	ADJ	JJ	_	31	compound	_	_
30	no	_	DET	DT	_	31	nummod	_	_
31	change	_	NOUN	NN	_	17	dobj	_	_

#	Livalo	611
1	BID	_	NOUN	NN	_	6	nsubj	_	_
2	=	_	VERB	VBD	_	6	aux	_	_
3	twice	_	ADV	RB	_	4	advmod	_	_
4	daily	_	ADV	RB	_	5	advmod	_	_
5	QD	_	NOUN	NN	_	6	nsubj	_	_
6	=	_	ADJ	JJ	_	0	root	_	_
7	once	_	ADV	RB	_	8	advmod	_	_
8	daily	_	ADV	RB	_	9	advmod	_	_
9	LA	_	NOUN	NN	_	20	compound	_	_
10	=	_	CONJ	CC	_	20	amod	_	_
11	Long	_	ADJ	JJ	_	13	amod	_	_
12	Acting	_	ADJ	JJ	_	13	amod	_	_
13	Co	_	NOUN	NN	_	14	nmod:npmod	_	_
14	administered	_	VERB	VBN	_	20	amod	_	_
15	drug	_	NOUN	NN	_	20	compound	_	_
16	Dose	_	NOUN	NN	_	20	compound	_	_
17	regimen	_	NOUN	NN	_	20	compound	_	_
18	Change	_	NOUN	NN	_	20	compound	_	_
19	inAUC*	_	NOUN	NN	_	20	compound	_	_
20	Change	_	NOUN	NN	_	6	dobj	_	_
21	in	_	ADP	IN	_	27	case	_	_
22	Cmax*	_	NOUN	NN	_	27	compound	_	_
23	Atazanavir	_	NOUN	NN	_	27	compound	_	_
24	DRUG	_	NOUN	NN	_	27	compound	_	_
25	4	_	NUM	CD	_	27	nummod	_	_
26	mg	_	NOUN	NN	_	27	compound	_	_
27	QD	_	NOUN	NN	_	20	nmod	_	_
28	+	_	CONJ	CC	_	27	cc	_	_
29	atazanavir	_	NOUN	NN	_	31	compound	_	_
30	300	_	NUM	CD	_	31	nummod	_	_
31	mg	_	NOUN	NN	_	27	conj	_	_
32	daily	_	ADV	RB	_	6	advmod	_	_
33	for	_	ADP	IN	_	35	case	_	_
34	5	_	NUM	CD	_	35	nummod	_	_
35	days	_	NOUN	NNS	_	6	nmod	_	_
36	*	_	NUM	CD	_	43	neg	_	_
37	6%	_	ADJ	JJ	_	43	amod	_	_
38	*	_	CONJ	CC	_	43	nummod	_	_
39	13%	_	ADJ	JJ	_	43	amod	_	_
40	Darunavir	_	ADJ	JJ	_	43	amod	_	_
41	DRUG	_	NOUN	NN	_	43	compound	_	_
42	4mg	_	ADJ	JJ	_	43	amod	_	_
43	QD	_	NOUN	NN	_	35	dep	_	_
44	on	_	ADP	IN	_	45	case	_	_
45	Days	_	NOUN	NN	_	43	nmod	_	_
46	1	_	NUM	CD	_	47	nummod	_	_
47	5	_	NUM	CD	_	45	dep	_	_
48	and	_	CONJ	CC	_	47	cc	_	_
49	12	_	NUM	CD	_	50	nummod	_	_
50	16	_	NUM	CD	_	47	conj	_	_
51	+	_	CONJ	CC	_	47	cc	_	_
52	darunavir	_	NOUN	NN	_	47	conj	_	_
53	/	_	.	:	_	6	punct	_	_
54	ritonavir	_	ADJ	JJ	_	59	amod	_	_
55	800mg	_	ADJ	JJ	_	59	amod	_	_
56	/	_	.	:	_	59	punct	_	_
57	100	_	NUM	CD	_	59	nummod	_	_
58	mg	_	NOUN	NN	_	59	compound	_	_
59	QD	_	NOUN	NN	_	6	parataxis	_	_
60	on	_	ADP	IN	_	72	case	_	_
61	Days	_	NOUN	NN	_	72	compound	_	_
62	6	_	NUM	CD	_	72	nummod	_	_
63	16	_	NUM	CD	_	72	nummod	_	_
64	*	_	CONJ	CC	_	72	amod	_	_
65	3%	_	ADJ	JJ	_	72	amod	_	_
66	*	_	NUM	CD	_	72	nummod	_	_
67	6%	_	ADJ	JJ	_	72	amod	_	_
68	Lopinavir	_	ADJ	JJ	_	72	amod	_	_
69	DRUG	_	NOUN	NN	_	72	compound	_	_
70	4	_	NUM	CD	_	72	nummod	_	_
71	mg	_	NOUN	NN	_	72	compound	_	_
72	QD	_	NOUN	NN	_	59	nmod	_	_
73	on	_	ADP	IN	_	74	case	_	_
74	Days	_	NOUN	NN	_	59	nmod	_	_
75	1	_	NUM	CD	_	76	nummod	_	_
76	5	_	NUM	CD	_	74	dep	_	_
77	and	_	CONJ	CC	_	76	cc	_	_
78	20	_	NUM	CD	_	79	nummod	_	_
79	24	_	NUM	CD	_	76	conj	_	_
80	+	_	CONJ	CC	_	76	cc	_	_
81	lopinavir	_	ADJ	JJ	_	76	conj	_	_
82	/	_	.	:	_	59	punct	_	_
83	ritonavir	_	NOUN	NN	_	85	compound	_	_
84	400	_	NUM	CD	_	85	nummod	_	_
85	mg	_	NOUN	NN	_	59	dep	_	_
86	/	_	.	:	_	85	punct	_	_
87	100	_	NUM	CD	_	88	compound	_	_
88	mg	_	NOUN	NN	_	89	amod	_	_
89	BID	_	NOUN	NN	_	85	dep	_	_
90	on	_	ADP	IN	_	102	case	_	_
91	Days	_	NOUN	NN	_	102	compound	_	_
92	9	_	NUM	CD	_	102	nummod	_	_
93	24	_	NUM	CD	_	102	nummod	_	_
94	*	_	CONJ	CC	_	102	amod	_	_
95	9%	_	NOUN	NN	_	102	nmod:poss	_	_
96	*	_	NUM	CD	_	102	nummod	_	_
97	7%	_	ADJ	JJ	_	102	amod	_	_
98	Ritonavir	_	NOUN	NN	_	102	amod	_	_
99	DRUG	_	NOUN	NN	_	102	compound	_	_
100	4	_	NUM	CD	_	102	nummod	_	_
101	mg	_	NOUN	NN	_	102	compound	_	_
102	QD	_	NOUN	NN	_	89	nmod	_	_
103	on	_	ADP	IN	_	104	case	_	_
104	Days	_	NOUN	NN	_	89	nmod	_	_
105	1	_	NUM	CD	_	106	nummod	_	_
106	5	_	NUM	CD	_	104	dep	_	_
107	and	_	CONJ	CC	_	106	cc	_	_
108	20	_	NUM	CD	_	109	nummod	_	_
109	24	_	NUM	CD	_	106	conj	_	_
110	+	_	CONJ	CC	_	106	cc	_	_
111	lopinavir	_	ADJ	JJ	_	106	conj	_	_
112	/	_	.	:	_	59	punct	_	_
113	ritonavir	_	NOUN	NN	_	115	compound	_	_
114	400	_	NUM	CD	_	115	nummod	_	_
115	mg	_	NOUN	NN	_	59	dep	_	_
116	/	_	.	:	_	115	punct	_	_
117	100	_	NUM	CD	_	118	compound	_	_
118	mg	_	NOUN	NN	_	119	amod	_	_
119	BID	_	NOUN	NN	_	115	dep	_	_
120	on	_	ADP	IN	_	131	case	_	_
121	Days	_	NOUN	NN	_	131	compound	_	_
122	9	_	NUM	CD	_	131	nummod	_	_
123	24	_	NUM	CD	_	131	nummod	_	_
124	*	_	CONJ	CC	_	123	cc	_	_
125	11%	_	ADJ	JJ	_	123	conj	_	_
126	*	_	NUM	CD	_	131	amod	_	_
127	11%	_	ADJ	JJ	_	131	amod	_	_
128	Ritonavir	_	ADJ	JJ	_	131	amod	_	_
129	DRUG	_	NOUN	NN	_	131	compound	_	_
130	4mg	_	ADJ	JJ	_	131	amod	_	_
131	QD	_	NOUN	NN	_	119	nmod	_	_
132	on	_	ADP	IN	_	133	case	_	_
133	Days	_	NOUN	NN	_	119	nmod	_	_
134	1	_	NUM	CD	_	135	nummod	_	_
135	5	_	NUM	CD	_	133	dep	_	_
136	and	_	CONJ	CC	_	135	cc	_	_
137	12	_	NUM	CD	_	138	nummod	_	_
138	16	_	NUM	CD	_	135	conj	_	_
139	+	_	CONJ	CC	_	135	cc	_	_
140	darunavir	_	NOUN	NN	_	135	conj	_	_
141	/	_	.	:	_	59	punct	_	_
142	ritonavir	_	ADJ	JJ	_	143	amod	_	_
143	800mg	_	ADJ	JJ	_	147	amod	_	_
144	/	_	.	:	_	147	punct	_	_
145	100	_	NUM	CD	_	147	nummod	_	_
146	mg	_	NOUN	NN	_	147	compound	_	_
147	QD	_	NOUN	NN	_	179	nsubj	_	_
148	on	_	ADP	IN	_	160	case	_	_
149	Days	_	NOUN	NN	_	160	compound	_	_
150	6	_	NUM	CD	_	160	nummod	_	_
151	16	_	NUM	CD	_	160	nummod	_	_
152	*	_	CONJ	CC	_	160	amod	_	_
153	8%	_	ADJ	JJ	_	160	amod	_	_
154	*	_	NUM	CD	_	160	nummod	_	_
155	2%	_	ADJ	JJ	_	160	amod	_	_
156	Enalapril	_	NOUN	NN	_	160	compound	_	_
157	DRUG	_	NOUN	NN	_	160	compound	_	_
158	4	_	NUM	CD	_	160	nummod	_	_
159	mg	_	NOUN	NN	_	160	compound	_	_
160	QD	_	NOUN	NN	_	147	nmod	_	_
161	+	_	CONJ	CC	_	160	cc	_	_
162	enalapril	_	NOUN	NN	_	160	conj	_	_
163	20	_	NUM	CD	_	162	nummod	_	_
164	mgdaily	_	ADV	RB	_	167	advmod	_	_
165	for	_	ADP	IN	_	167	case	_	_
166	5	_	NUM	CD	_	167	nummod	_	_
167	days	_	NOUN	NNS	_	178	compound	_	_
168	Enalapril	_	NOUN	NN	_	169	dep	_	_
169	*	_	CONJ	CC	_	178	nummod	_	_
170	12%	_	ADJ	JJ	_	178	amod	_	_
171	*	_	NUM	CD	_	178	amod	_	_
172	12%	_	ADJ	JJ	_	178	amod	_	_
173	Enalaprilat	_	ADJ	JJ	_	178	amod	_	_
174	*	_	CONJ	CC	_	178	amod	_	_
175	1%	_	ADJ	JJ	_	178	amod	_	_
176	*	_	CONJ	CC	_	178	amod	_	_
177	1%	_	ADJ	JJ	_	178	amod	_	_
178	Warfarin	_	NOUN	NN	_	147	nmod	_	_
179	Individualized	_	VERB	VBD	_	59	dep	_	_
180	maintenance	_	NOUN	NN	_	181	compound	_	_
181	dose	_	NOUN	NN	_	179	dobj	_	_
182	of	_	ADP	IN	_	186	case	_	_
183	warfarin	_	NOUN	NN	_	186	compound	_	_
184	2	_	NUM	CD	_	186	nummod	_	_
185	7	_	NUM	CD	_	186	nummod	_	_
186	mg	_	NOUN	NN	_	181	nmod	_	_
187	for	_	ADP	IN	_	189	case	_	_
188	8	_	NUM	CD	_	189	nummod	_	_
189	days	_	NOUN	NNS	_	181	nmod	_	_
190	+	_	CONJ	CC	_	189	cc	_	_
191	DRUG	_	NOUN	NN	_	194	compound	_	_
192	4	_	NUM	CD	_	194	nummod	_	_
193	mg	_	NOUN	NN	_	194	compound	_	_
194	QD	_	NOUN	NN	_	189	conj	_	_
195	for	_	ADP	IN	_	205	case	_	_
196	9	_	NUM	CD	_	197	nummod	_	_
197	days	_	NOUN	NNS	_	205	compound	_	_
198	R	_	NOUN	NN	_	205	compound	_	_
199	warfarin	_	NOUN	NN	_	205	compound	_	_
200	*	_	NUM	CD	_	205	amod	_	_
201	7%	_	ADJ	JJ	_	205	amod	_	_
202	*	_	CONJ	CC	_	205	amod	_	_
203	3%	_	ADJ	JJ	_	205	amod	_	_
204	S	_	NOUN	NN	_	205	compound	_	_
205	warfarin	_	NOUN	NN	_	181	nmod	_	_
206	*	_	NUM	CD	_	214	punct	_	_
207	6%	_	ADJ	JJ	_	214	amod	_	_
208	*	_	CONJ	CC	_	214	nummod	_	_
209	3%	_	ADJ	JJ	_	214	amod	_	_
210	Ezetimibe	_	NOUN	NN	_	214	compound	_	_
211	DRUG	_	NOUN	NN	_	214	compound	_	_
212	2	_	NUM	CD	_	214	nummod	_	_
213	mg	_	NOUN	NN	_	214	compound	_	_
214	QD	_	NOUN	NN	_	181	dep	_	_
215	+	_	CONJ	CC	_	179	cc	_	_
216	ezetimibe	_	VERB	VB	_	179	conj	_	_
217	10	_	NUM	CD	_	218	nummod	_	_
218	mg	_	NOUN	NN	_	216	dobj	_	_
219	for	_	ADP	IN	_	221	case	_	_
220	7	_	NUM	CD	_	221	nummod	_	_
221	days	_	NOUN	NNS	_	216	nmod	_	_
222	*	_	NUM	CD	_	230	neg	_	_
223	9%	_	ADJ	JJ	_	230	amod	_	_
224	*	_	CONJ	CC	_	230	nummod	_	_
225	2%	_	ADJ	JJ	_	230	amod	_	_
226	Digoxin	_	NOUN	NN	_	230	compound	_	_
227	DRUG	_	NOUN	NN	_	230	compound	_	_
228	4	_	NUM	CD	_	230	nummod	_	_
229	mg	_	NOUN	NN	_	230	compound	_	_
230	QD	_	NOUN	NN	_	221	dep	_	_
231	+	_	CONJ	CC	_	221	cc	_	_
232	digoxin	_	NOUN	NN	_	234	compound	_	_
233	0.25	_	NUM	CD	_	234	nummod	_	_
234	mg	_	NOUN	NN	_	221	conj	_	_
235	for	_	ADP	IN	_	237	case	_	_
236	7	_	NUM	CD	_	237	nummod	_	_
237	days	_	NOUN	NNS	_	221	nmod	_	_
238	*	_	NUM	CD	_	247	neg	_	_
239	3%	_	ADJ	JJ	_	247	amod	_	_
240	*	_	CONJ	CC	_	247	nummod	_	_
241	4%	_	ADJ	JJ	_	247	amod	_	_
242	Diltiazem	_	NOUN	NN	_	247	compound	_	_
243	LA	_	NOUN	NN	_	247	compound	_	_
244	DRUG	_	NOUN	NN	_	247	compound	_	_
245	4	_	NUM	CD	_	247	nummod	_	_
246	mg	_	NOUN	NN	_	247	compound	_	_
247	QD	_	NOUN	NN	_	237	dep	_	_
248	on	_	ADP	IN	_	249	case	_	_
249	Days	_	NOUN	NN	_	247	nmod	_	_
250	1	_	NUM	CD	_	251	nummod	_	_
251	5	_	NUM	CD	_	249	dep	_	_
252	and	_	CONJ	CC	_	251	cc	_	_
253	11	_	NUM	CD	_	254	nummod	_	_
254	15	_	NUM	CD	_	251	conj	_	_
255	and	_	CONJ	CC	_	249	cc	_	_
256	diltiazem	_	NOUN	NN	_	259	compound	_	_
257	LA	_	NOUN	NN	_	259	compound	_	_
258	240	_	NUM	CD	_	259	nummod	_	_
259	mg	_	NOUN	NN	_	249	conj	_	_
260	on	_	ADP	IN	_	272	case	_	_
261	Days	_	NOUN	NN	_	272	compound	_	_
262	6	_	NUM	CD	_	272	nummod	_	_
263	15	_	NUM	CD	_	272	nummod	_	_
264	*	_	CONJ	CC	_	272	amod	_	_
265	2%	_	ADJ	JJ	_	272	amod	_	_
266	*	_	CONJ	CC	_	272	nummod	_	_
267	7%	_	ADJ	JJ	_	272	amod	_	_
268	Rifampin	_	NOUN	NN	_	272	compound	_	_
269	DRUG	_	NOUN	NN	_	272	compound	_	_
270	4	_	NUM	CD	_	272	nummod	_	_
271	mg	_	NOUN	NN	_	272	compound	_	_
272	QD	_	NOUN	NN	_	247	nmod	_	_
273	+	_	CONJ	CC	_	272	cc	_	_
274	rifampin	_	NOUN	NN	_	277	compound	_	_
275	600	_	NUM	CD	_	277	nummod	_	_
276	mg	_	NOUN	NN	_	277	compound	_	_
277	QD	_	NOUN	NN	_	272	conj	_	_
278	for	_	ADP	IN	_	280	case	_	_
279	5	_	NUM	CD	_	280	nummod	_	_
280	days	_	NOUN	NNS	_	247	nmod	_	_
281	*	_	CONJ	CC	_	280	advmod	_	_
282	15%	_	ADJ	JJ	_	281	dep	_	_
283	*	_	CONJ	CC	_	282	cc	_	_
284	18%	_	ADJ	JJ	_	282	conj	_	_

#	Lovastatin	5187
1	DRUG	_	NOUN	NN	_	3	nsubjpass	_	_
2	is	_	VERB	VBZ	_	3	auxpass	_	_
3	metabolized	_	VERB	VBN	_	0	root	_	_
4	by	_	ADP	IN	_	5	case	_	_
5	CYP3A4	_	NOUN	NN	_	3	nmod	_	_
6	but	_	CONJ	CC	_	3	cc	_	_
7	has	_	VERB	VBZ	_	3	conj	_	_
8	no	_	DET	DT	_	11	neg	_	_
9	CYP3A4	_	NOUN	NN	_	11	compound	_	_
10	inhibitory	_	ADJ	JJ	_	11	amod	_	_
11	activity	_	NOUN	NN	_	7	dobj	_	_
12	therefore	_	ADV	RB	_	7	advmod	_	_
13	it	_	PRON	PRP	_	16	nsubjpass	_	_
14	is	_	VERB	VBZ	_	16	auxpass	_	_
15	not	_	ADV	RB	_	16	neg	_	_
16	expected	_	VERB	VBN	_	7	parataxis	_	_
17	to	_	PRT	TO	_	18	mark	_	_
18	affect	_	VERB	VB	_	16	xcomp	_	_
19	the	_	DET	DT	_	21	det	_	_
20	plasma	_	NOUN	NN	_	21	compound	_	_
21	concentrations	_	NOUN	NNS	_	18	dobj	_	_
22	of	_	ADP	IN	_	24	case	_	_
23	other	_	ADJ	JJ	_	24	amod	_	_
24	drugs	_	NOUN	NNS	_	21	nmod	_	_
25	metabolized	_	VERB	VBN	_	24	acl	_	_
26	by	_	ADP	IN	_	27	case	_	_
27	CYP3A4	_	NOUN	NN	_	25	nmod	_	_

#	Lovastatin	5188
1	Strong	_	ADJ	JJ	_	2	amod	_	_
2	inhibitors	_	NOUN	NNS	_	39	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	CYP3A4	_	NOUN	NN	_	5	compound	_	_
5	e.g	_	NOUN	NN	_	2	nmod	_	_
6	,	_	.	,	_	5	punct	_	_
7	itraconazole	_	NOUN	NN	_	5	conj	_	_
8	,	_	.	,	_	5	punct	_	_
9	ketoconazole	_	NOUN	NN	_	5	conj	_	_
10	,	_	.	,	_	5	punct	_	_
11	posaconazole	_	NOUN	NN	_	5	conj	_	_
12	,	_	.	,	_	5	punct	_	_
13	voriconazole	_	NOUN	NN	_	5	conj	_	_
14	,	_	.	,	_	5	punct	_	_
15	clarithromycin	_	NOUN	NN	_	5	conj	_	_
16	,	_	.	,	_	5	punct	_	_
17	telithromycin	_	NOUN	NN	_	5	conj	_	_
18	,	_	.	,	_	5	punct	_	_
19	HIV	_	NOUN	NN	_	21	compound	_	_
20	protease	_	NOUN	NN	_	21	compound	_	_
21	inhibitors	_	NOUN	NNS	_	5	conj	_	_
22	,	_	.	,	_	5	punct	_	_
23	boceprevir	_	NOUN	NN	_	5	conj	_	_
24	,	_	.	,	_	5	punct	_	_
25	telaprevir	_	NOUN	NN	_	5	conj	_	_
26	,	_	.	,	_	5	punct	_	_
27	nefazodone	_	NOUN	NN	_	5	conj	_	_
28	,	_	.	,	_	5	punct	_	_
29	erythromycin	_	NOUN	NN	_	5	conj	_	_
30	,	_	.	,	_	5	punct	_	_
31	and	_	CONJ	CC	_	5	cc	_	_
32	cobicistat	_	NOUN	NN	_	34	compound	_	_
33	containing	_	VERB	VBG	_	34	amod	_	_
34	products	_	NOUN	NNS	_	5	conj	_	_
35	,	_	.	,	_	2	punct	_	_
36	and	_	CONJ	CC	_	2	cc	_	_
37	grapefruit	_	ADJ	JJ	_	38	amod	_	_
38	juice	_	NOUN	NN	_	2	conj	_	_
39	increase	_	VERB	VBP	_	0	root	_	_
40	the	_	DET	DT	_	41	det	_	_
41	risk	_	NOUN	NN	_	39	dobj	_	_
42	of	_	ADP	IN	_	43	case	_	_
43	myopathy	_	NOUN	NN	_	41	nmod	_	_
44	by	_	ADP	IN	_	45	mark	_	_
45	reducing	_	VERB	VBG	_	39	advcl	_	_
46	the	_	DET	DT	_	47	det	_	_
47	elimination	_	NOUN	NN	_	45	dobj	_	_
48	of	_	ADP	IN	_	49	case	_	_
49	DRUG	_	NOUN	NN	_	47	nmod	_	_

#	Lovastatin	5190
1	The	_	DET	DT	_	2	det	_	_
2	risk	_	NOUN	NN	_	7	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	myopathy	_	NOUN	NN	_	2	nmod	_	_
5	is	_	VERB	VBZ	_	7	auxpass	_	_
6	also	_	ADV	RB	_	7	advmod	_	_
7	increased	_	VERB	VBN	_	0	root	_	_
8	by	_	ADP	IN	_	13	case	_	_
9	the	_	DET	DT	_	13	det	_	_
10	following	_	VERB	VBG	_	13	amod	_	_
11	lipid	_	NOUN	NN	_	13	compound	_	_
12	lowering	_	NOUN	NN	_	13	compound	_	_
13	drugs	_	NOUN	NNS	_	7	nmod	_	_
14	that	_	DET	WDT	_	19	nsubj	_	_
15	are	_	VERB	VBP	_	19	cop	_	_
16	not	_	ADV	RB	_	19	neg	_	_
17	strong	_	ADJ	JJ	_	19	amod	_	_
18	CYP3A4	_	NOUN	NN	_	19	compound	_	_
19	inhibitors	_	NOUN	NNS	_	13	acl:relcl	_	_
20	,	_	.	,	_	7	punct	_	_
21	but	_	CONJ	CC	_	7	cc	_	_
22	which	_	DET	WDT	_	24	nsubj	_	_
23	can	_	VERB	MD	_	24	aux	_	_
24	cause	_	VERB	VB	_	7	conj	_	_
25	myopathy	_	NOUN	NN	_	24	dobj	_	_
26	when	_	ADV	WRB	_	27	advmod	_	_
27	given	_	VERB	VBN	_	24	advcl	_	_
28	alone	_	ADV	RB	_	27	advmod	_	_

#	Lovastatin	5191
1	Gemfibrozil	_	NOUN	NN	_	2	compound	_	_
2	Other	_	NOUN	NN	_	3	nsubj	_	_
3	fibrates	_	VERB	VBZ	_	0	root	_	_
4	Niacin	_	NOUN	NN	_	8	compound	_	_
5	nicotinic	_	ADJ	JJ	_	8	amod	_	_
6	acid	_	NOUN	NN	_	8	compound	_	_
7	>1	_	NUM	CD	_	8	nummod	_	_
8	g	_	NOUN	NN	_	11	compound	_	_
9	/	_	.	:	_	11	punct	_	_
10	day	_	NOUN	NN	_	11	compound	_	_
11	Cyclosporine	_	NOUN	NN	_	3	dobj	_	_
12	:	_	.	:	_	3	punct	_	_
13	The	_	DET	DT	_	14	det	_	_
14	risk	_	NOUN	NN	_	20	nsubjpass	_	_
15	of	_	ADP	IN	_	18	case	_	_
16	myopathy	_	NOUN	NN	_	18	compound	_	_
17	/	_	.	:	_	18	punct	_	_
18	rhabdomyolysis	_	NOUN	NN	_	14	nmod	_	_
19	is	_	VERB	VBZ	_	20	auxpass	_	_
20	increased	_	VERB	VBN	_	3	parataxis	_	_
21	by	_	ADP	IN	_	23	case	_	_
22	concomitant	_	ADJ	JJ	_	23	amod	_	_
23	administration	_	NOUN	NN	_	20	nmod	_	_
24	of	_	ADP	IN	_	25	case	_	_
25	cyclosporine	_	NOUN	NN	_	23	nmod	_	_

#	Lovastatin	5192
1	Danazol	_	NOUN	NN	_	0	root	_	_
2	,	_	.	,	_	1	punct	_	_
3	Diltiazem	_	NOUN	NN	_	1	conj	_	_
4	,	_	.	,	_	1	punct	_	_
5	Dronedarone	_	NOUN	NN	_	1	conj	_	_
6	or	_	CONJ	CC	_	1	cc	_	_
7	Verapamil	_	NOUN	NN	_	1	conj	_	_
8	:	_	.	:	_	1	punct	_	_
9	The	_	DET	DT	_	10	det	_	_
10	risk	_	NOUN	NN	_	16	nsubjpass	_	_
11	of	_	ADP	IN	_	14	case	_	_
12	myopathy	_	NOUN	NN	_	14	compound	_	_
13	/	_	.	:	_	14	punct	_	_
14	rhabdomyolysis	_	NOUN	NN	_	10	nmod	_	_
15	is	_	VERB	VBZ	_	16	auxpass	_	_
16	increased	_	VERB	VBN	_	1	dep	_	_
17	by	_	ADP	IN	_	19	case	_	_
18	concomitant	_	ADJ	JJ	_	19	amod	_	_
19	administration	_	NOUN	NN	_	16	nmod	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	danazol	_	NOUN	NN	_	19	nmod	_	_
22	,	_	.	,	_	21	punct	_	_
23	diltiazem	_	NOUN	NN	_	21	conj	_	_
24	,	_	.	,	_	21	punct	_	_
25	dronedarone	_	NOUN	NN	_	21	conj	_	_
26	or	_	CONJ	CC	_	21	cc	_	_
27	verapamil	_	NOUN	NN	_	21	conj	_	_
28	particularly	_	ADV	RB	_	16	advmod	_	_
29	with	_	ADP	IN	_	31	case	_	_
30	higher	_	ADJ	JJ	_	31	amod	_	_
31	doses	_	NOUN	NNS	_	16	nmod	_	_
32	of	_	ADP	IN	_	33	case	_	_
33	DRUG	_	NOUN	NN	_	31	nmod	_	_

#	Lovastatin	5193
1	Amiodarone	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	The	_	DET	DT	_	4	det	_	_
4	risk	_	NOUN	NN	_	10	nsubjpass	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	myopathy	_	NOUN	NN	_	8	compound	_	_
7	/	_	.	:	_	8	punct	_	_
8	rhabdomyolysis	_	NOUN	NN	_	4	nmod	_	_
9	is	_	VERB	VBZ	_	10	auxpass	_	_
10	increased	_	VERB	VBN	_	1	dep	_	_
11	when	_	ADV	WRB	_	14	advmod	_	_
12	amiodarone	_	NOUN	NN	_	14	nsubjpass	_	_
13	is	_	VERB	VBZ	_	14	auxpass	_	_
14	used	_	VERB	VBN	_	10	ccomp	_	_
15	concomitantly	_	ADV	RB	_	14	advmod	_	_
16	with	_	ADP	IN	_	20	case	_	_
17	a	_	DET	DT	_	20	det	_	_
18	closely	_	ADV	RB	_	19	advmod	_	_
19	related	_	ADJ	JJ	_	20	amod	_	_
20	member	_	NOUN	NN	_	14	nmod	_	_
21	of	_	ADP	IN	_	27	case	_	_
22	the	_	DET	DT	_	27	det	_	_
23	HMG	_	NOUN	NN	_	27	compound	_	_
24	CoA	_	NOUN	NN	_	27	compound	_	_
25	reductase	_	NOUN	NN	_	27	compound	_	_
26	inhibitor	_	NOUN	NN	_	27	compound	_	_
27	class	_	NOUN	NN	_	20	nmod	_	_

#	Lovastatin	5194
1	Coumarin	_	NOUN	NN	_	2	compound	_	_
2	Anticoagulants	_	NOUN	NNS	_	25	nsubjpass	_	_
3	:	_	.	:	_	2	punct	_	_
4	In	_	ADP	IN	_	8	case	_	_
5	a	_	DET	DT	_	8	det	_	_
6	small	_	ADJ	JJ	_	8	amod	_	_
7	clinical	_	ADJ	JJ	_	8	amod	_	_
8	trial	_	NOUN	NN	_	2	nmod	_	_
9	in	_	ADP	IN	_	10	case	_	_
10	which	_	DET	WDT	_	13	nmod	_	_
11	DRUG	_	NOUN	NN	_	13	nsubjpass	_	_
12	was	_	VERB	VBD	_	13	auxpass	_	_
13	administered	_	VERB	VBN	_	8	acl:relcl	_	_
14	to	_	PRT	TO	_	17	case	_	_
15	warfarin	_	NOUN	NN	_	17	compound	_	_
16	treated	_	VERB	VBN	_	17	amod	_	_
17	patients	_	NOUN	NNS	_	13	nmod	_	_
18	,	_	.	,	_	2	punct	_	_
19	no	_	DET	DT	_	20	neg	_	_
20	effect	_	NOUN	NN	_	25	nsubjpass	_	_
21	on	_	ADP	IN	_	23	case	_	_
22	prothrombin	_	NOUN	NN	_	23	compound	_	_
23	time	_	NOUN	NN	_	20	nmod	_	_
24	was	_	VERB	VBD	_	25	auxpass	_	_
25	detected	_	VERB	VBN	_	0	root	_	_

#	Lovastatin	5195
1	However	_	ADV	RB	_	10	advmod	_	_
2	,	_	.	,	_	10	punct	_	_
3	another	_	DET	DT	_	7	det	_	_
4	HMG	_	NOUN	NN	_	7	compound	_	_
5	CoA	_	NOUN	NN	_	7	compound	_	_
6	reductase	_	NOUN	NN	_	7	compound	_	_
7	inhibitor	_	NOUN	NN	_	10	nsubjpass	_	_
8	has	_	VERB	VBZ	_	10	aux	_	_
9	been	_	VERB	VBN	_	10	auxpass	_	_
10	found	_	VERB	VBN	_	0	root	_	_
11	to	_	PRT	TO	_	12	mark	_	_
12	produce	_	VERB	VB	_	10	xcomp	_	_
13	a	_	DET	DT	_	18	det	_	_
14	less	_	ADV	RB	_	16	advmod	_	_
15	than	_	ADP	IN	_	16	advmod	_	_
16	two	_	NUM	CD	_	18	nummod	_	_
17	second	_	ADJ	JJ	_	18	amod	_	_
18	increase	_	NOUN	NN	_	12	dobj	_	_
19	in	_	ADP	IN	_	21	case	_	_
20	prothrombin	_	NOUN	NN	_	21	compound	_	_
21	time	_	NOUN	NN	_	18	nmod	_	_
22	in	_	ADP	IN	_	24	case	_	_
23	healthy	_	ADJ	JJ	_	24	amod	_	_
24	volunteers	_	NOUN	NNS	_	18	nmod	_	_
25	receiving	_	VERB	VBG	_	24	acl	_	_
26	low	_	ADJ	JJ	_	27	amod	_	_
27	doses	_	NOUN	NNS	_	25	dobj	_	_
28	of	_	ADP	IN	_	29	case	_	_
29	warfarin	_	NOUN	NN	_	27	nmod	_	_

#	Lovastatin	5196
1	Also	_	ADV	RB	_	12	advmod	_	_
2	,	_	.	,	_	12	punct	_	_
3	bleeding	_	NOUN	NN	_	12	nsubjpass	_	_
4	and	_	CONJ	CC	_	3	cc	_	_
5	/	_	NOUN	NN	_	3	conj	_	_
6	or	_	CONJ	CC	_	3	cc	_	_
7	increased	_	VERB	VBN	_	9	amod	_	_
8	prothrombin	_	NOUN	NN	_	9	compound	_	_
9	time	_	NOUN	NN	_	3	conj	_	_
10	have	_	VERB	VBP	_	12	aux	_	_
11	been	_	VERB	VBN	_	12	auxpass	_	_
12	reported	_	VERB	VBN	_	0	root	_	_
13	in	_	ADP	IN	_	16	case	_	_
14	a	_	DET	DT	_	16	det	_	_
15	few	_	ADJ	JJ	_	16	amod	_	_
16	patients	_	NOUN	NNS	_	12	nmod	_	_
17	taking	_	VERB	VBG	_	16	acl	_	_
18	coumarin	_	NOUN	NN	_	19	compound	_	_
19	anticoagulants	_	NOUN	NNS	_	17	dobj	_	_
20	concomitantly	_	ADV	RB	_	17	advmod	_	_
21	with	_	ADP	IN	_	22	case	_	_
22	DRUG	_	NOUN	NN	_	17	nmod	_	_

#	Lovastatin	5197
1	It	_	PRON	PRP	_	3	nsubjpass	_	_
2	is	_	VERB	VBZ	_	3	auxpass	_	_
3	recommended	_	VERB	VBN	_	0	root	_	_
4	that	_	ADP	IN	_	13	mark	_	_
5	in	_	ADP	IN	_	6	case	_	_
6	patients	_	NOUN	NNS	_	13	nmod	_	_
7	taking	_	VERB	VBG	_	6	acl	_	_
8	anticoagulants	_	NOUN	NNS	_	7	dobj	_	_
9	,	_	.	,	_	13	punct	_	_
10	prothrombin	_	NOUN	NN	_	11	compound	_	_
11	time	_	NOUN	NN	_	13	nsubjpass	_	_
12	be	_	VERB	VBZ	_	13	auxpass	_	_
13	determined	_	VERB	VBN	_	3	ccomp	_	_
14	before	_	ADP	IN	_	15	mark	_	_
15	starting	_	VERB	VBG	_	13	advcl	_	_
16	DRUG	_	NOUN	NN	_	15	dobj	_	_
17	and	_	CONJ	CC	_	15	cc	_	_
18	frequently	_	ADV	RB	_	19	advmod	_	_
19	enough	_	VERB	VBP	_	15	conj	_	_
20	during	_	ADP	IN	_	22	case	_	_
21	early	_	ADJ	JJ	_	22	amod	_	_
22	therapy	_	NOUN	NN	_	19	nmod	_	_
23	to	_	PRT	TO	_	24	mark	_	_
24	insure	_	VERB	VB	_	19	xcomp	_	_
25	that	_	ADP	IN	_	32	mark	_	_
26	no	_	DET	DT	_	28	neg	_	_
27	significant	_	ADJ	JJ	_	28	amod	_	_
28	alteration	_	NOUN	NN	_	32	nsubj	_	_
29	of	_	ADP	IN	_	31	case	_	_
30	prothrombin	_	NOUN	NN	_	31	compound	_	_
31	time	_	NOUN	NN	_	28	nmod	_	_
32	occurs	_	VERB	VBZ	_	24	root	_	_

#	Lovastatin	5198
1	Once	_	ADP	IN	_	8	mark	_	_
2	a	_	DET	DT	_	5	det	_	_
3	stable	_	ADJ	JJ	_	5	amod	_	_
4	prothrombin	_	NOUN	NN	_	5	compound	_	_
5	time	_	NOUN	NN	_	8	nsubjpass	_	_
6	has	_	VERB	VBZ	_	8	aux	_	_
7	been	_	VERB	VBN	_	8	auxpass	_	_
8	documented	_	VERB	VBN	_	14	advcl	_	_
9	,	_	.	,	_	14	punct	_	_
10	prothrombin	_	NOUN	NN	_	11	compound	_	_
11	times	_	NOUN	NNS	_	14	nsubjpass	_	_
12	can	_	VERB	MD	_	14	aux	_	_
13	be	_	VERB	VB	_	14	auxpass	_	_
14	monitored	_	VERB	VBN	_	0	root	_	_
15	at	_	ADP	IN	_	17	case	_	_
16	the	_	DET	DT	_	17	det	_	_
17	intervals	_	NOUN	NNS	_	14	nmod	_	_
18	usually	_	ADV	RB	_	19	advmod	_	_
19	recommended	_	VERB	VBN	_	14	advcl	_	_
20	for	_	ADP	IN	_	21	case	_	_
21	patients	_	NOUN	NNS	_	19	nmod	_	_
22	on	_	ADP	IN	_	24	case	_	_
23	coumarin	_	NOUN	NN	_	24	compound	_	_
24	anticoagulants	_	NOUN	NNS	_	21	nmod	_	_

#	Lovastatin	5199
1	If	_	ADP	IN	_	3	case	_	_
2	the	_	DET	DT	_	3	det	_	_
3	dose	_	NOUN	NN	_	7	nsubjpass	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	is	_	VERB	VBZ	_	7	auxpass	_	_
7	changed	_	VERB	VBN	_	14	advcl	_	_
8	,	_	.	,	_	14	punct	_	_
9	the	_	DET	DT	_	11	det	_	_
10	same	_	ADJ	JJ	_	11	amod	_	_
11	procedure	_	NOUN	NN	_	14	nsubjpass	_	_
12	should	_	VERB	MD	_	14	aux	_	_
13	be	_	VERB	VB	_	14	auxpass	_	_
14	repeated	_	VERB	VBN	_	0	root	_	_

#	Lovastatin	5200
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	therapy	_	NOUN	NN	_	6	nsubjpass	_	_
3	has	_	VERB	VBZ	_	6	aux	_	_
4	not	_	ADV	RB	_	6	neg	_	_
5	been	_	VERB	VBN	_	6	auxpass	_	_
6	associated	_	VERB	VBN	_	0	root	_	_
7	with	_	ADP	IN	_	8	case	_	_
8	bleeding	_	NOUN	NN	_	6	nmod	_	_
9	or	_	CONJ	CC	_	8	cc	_	_
10	with	_	ADP	IN	_	11	case	_	_
11	changes	_	NOUN	NNS	_	8	conj	_	_
12	in	_	ADP	IN	_	14	case	_	_
13	prothrombin	_	NOUN	NN	_	14	compound	_	_
14	time	_	NOUN	NN	_	11	nmod	_	_
15	in	_	ADP	IN	_	16	case	_	_
16	patients	_	NOUN	NNS	_	11	nmod	_	_
17	not	_	ADV	RB	_	18	neg	_	_
18	taking	_	VERB	VBG	_	16	acl	_	_
19	anticoagulants	_	NOUN	NNS	_	18	dobj	_	_

#	Lovastatin	5201
1	Colchicine	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Cases	_	NOUN	NNS	_	12	nsubjpass	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	myopathy	_	NOUN	NN	_	3	nmod	_	_
6	,	_	.	,	_	5	punct	_	_
7	including	_	VERB	VBG	_	8	case	_	_
8	rhabdomyolysis	_	NOUN	NN	_	5	nmod	_	_
9	,	_	.	,	_	3	punct	_	_
10	have	_	VERB	VBP	_	12	aux	_	_
11	been	_	VERB	VBN	_	12	auxpass	_	_
12	reported	_	VERB	VBN	_	1	dep	_	_
13	with	_	ADP	IN	_	14	case	_	_
14	DRUG	_	NOUN	NN	_	12	nmod	_	_
15	coadministered	_	VERB	VBN	_	14	acl	_	_
16	with	_	ADP	IN	_	17	case	_	_
17	colchicine	_	NOUN	NN	_	15	nmod	_	_

#	Lovastatin	5202
1	Ranolazine	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	The	_	DET	DT	_	4	det	_	_
4	risk	_	NOUN	NN	_	13	nsubjpass	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	myopathy	_	NOUN	NN	_	4	nmod	_	_
7	,	_	.	,	_	6	punct	_	_
8	including	_	VERB	VBG	_	9	case	_	_
9	rhabdomyolysis	_	NOUN	NN	_	6	nmod	_	_
10	,	_	.	,	_	4	punct	_	_
11	may	_	VERB	MD	_	13	aux	_	_
12	be	_	VERB	VB	_	13	auxpass	_	_
13	increased	_	VERB	VBN	_	1	dep	_	_
14	by	_	ADP	IN	_	16	case	_	_
15	concomitant	_	ADJ	JJ	_	16	amod	_	_
16	administration	_	NOUN	NN	_	13	nmod	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	ranolazine	_	NOUN	NN	_	16	nmod	_	_

#	Lovastatin	5203
1	Propranolol	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	In	_	ADP	IN	_	5	case	_	_
4	normal	_	ADJ	JJ	_	5	amod	_	_
5	volunteers	_	NOUN	NNS	_	1	nmod	_	_
6	,	_	.	,	_	1	punct	_	_
7	there	_	DET	EX	_	8	expl	_	_
8	was	_	VERB	VBD	_	1	dep	_	_
9	no	_	DET	DT	_	15	neg	_	_
10	clinically	_	ADV	RB	_	11	advmod	_	_
11	significant	_	ADJ	JJ	_	12	amod	_	_
12	pharmacokinetic	_	ADJ	JJ	_	15	amod	_	_
13	or	_	CONJ	CC	_	12	cc	_	_
14	pharmacodynamic	_	ADJ	JJ	_	12	conj	_	_
15	interaction	_	NOUN	NN	_	8	nsubj	_	_
16	with	_	ADP	IN	_	18	case	_	_
17	concomitant	_	ADJ	JJ	_	18	amod	_	_
18	administration	_	NOUN	NN	_	15	nmod	_	_
19	of	_	ADP	IN	_	21	case	_	_
20	single	_	ADJ	JJ	_	21	amod	_	_
21	doses	_	NOUN	NNS	_	18	nmod	_	_
22	of	_	ADP	IN	_	23	case	_	_
23	DRUG	_	NOUN	NN	_	21	nmod	_	_
24	and	_	CONJ	CC	_	23	cc	_	_
25	propranolol	_	NOUN	NN	_	23	conj	_	_

#	Lovastatin	5204
1	Digoxin	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	In	_	ADP	IN	_	4	case	_	_
4	patients	_	NOUN	NNS	_	1	nmod	_	_
5	with	_	ADP	IN	_	6	case	_	_
6	hypercholesterolemia	_	NOUN	NN	_	4	nmod	_	_
7	,	_	.	,	_	1	punct	_	_
8	concomitant	_	ADJ	JJ	_	9	amod	_	_
9	administration	_	NOUN	NN	_	14	nsubj	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	digoxin	_	NOUN	NN	_	11	conj	_	_
14	resulted	_	VERB	VBD	_	1	dep	_	_
15	in	_	ADP	IN	_	17	case	_	_
16	no	_	DET	DT	_	17	neg	_	_
17	effect	_	NOUN	NN	_	14	nmod	_	_
18	on	_	ADP	IN	_	21	case	_	_
19	digoxin	_	NOUN	NN	_	21	compound	_	_
20	plasma	_	NOUN	NN	_	21	compound	_	_
21	concentrations	_	NOUN	NNS	_	17	nmod	_	_

#	Lovastatin	5205
1	Oral	_	ADJ	JJ	_	3	amod	_	_
2	Hypoglycemic	_	ADJ	JJ	_	3	amod	_	_
3	Agents	_	NOUN	NNS	_	19	nmod	_	_
4	:	_	.	:	_	3	punct	_	_
5	In	_	ADP	IN	_	7	case	_	_
6	pharmacokinetic	_	ADJ	JJ	_	7	amod	_	_
7	studies	_	NOUN	NNS	_	3	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	MEVACOR	_	NOUN	NN	_	7	nmod	_	_
10	in	_	ADP	IN	_	16	case	_	_
11	hypercholesterolemic	_	ADJ	JJ	_	16	amod	_	_
12	non	_	ADJ	JJ	_	16	amod	_	_
13	insulin	_	NOUN	NN	_	16	compound	_	_
14	dependent	_	ADJ	JJ	_	16	amod	_	_
15	diabetic	_	ADJ	JJ	_	16	amod	_	_
16	patients	_	NOUN	NNS	_	7	nmod	_	_
17	,	_	.	,	_	19	punct	_	_
18	there	_	DET	EX	_	19	expl	_	_
19	was	_	VERB	VBD	_	0	root	_	_
20	no	_	DET	DT	_	22	neg	_	_
21	drug	_	NOUN	NN	_	22	compound	_	_
22	interaction	_	NOUN	NN	_	19	nsubj	_	_
23	with	_	ADP	IN	_	24	case	_	_
24	glipizide	_	NOUN	NN	_	22	nmod	_	_
25	or	_	CONJ	CC	_	24	cc	_	_
26	with	_	ADP	IN	_	27	case	_	_
27	chlorpropamide	_	NOUN	NN	_	24	conj	_	_

#	Lovastatin	5206
1	The	_	DET	DT	_	2	det	_	_
2	involvement	_	NOUN	NN	_	15	nsubjpass	_	_
3	of	_	ADP	IN	_	9	case	_	_
4	low	_	ADJ	JJ	_	9	amod	_	_
5	density	_	NOUN	NN	_	9	compound	_	_
6	lipoprotein	_	NOUN	NN	_	9	compound	_	_
7	cholesterol	_	NOUN	NN	_	9	compound	_	_
8	LDL	_	NOUN	NN	_	9	compound	_	_
9	C	_	NOUN	NN	_	2	nmod	_	_
10	in	_	ADP	IN	_	11	case	_	_
11	atherogenesis	_	NOUN	NN	_	2	nmod	_	_
12	has	_	VERB	VBZ	_	15	aux	_	_
13	been	_	VERB	VBN	_	15	auxpass	_	_
14	well	_	ADV	RB	_	15	advmod	_	_
15	documented	_	VERB	VBN	_	0	root	_	_
16	in	_	ADP	IN	_	20	case	_	_
17	clinical	_	ADJ	JJ	_	20	amod	_	_
18	and	_	CONJ	CC	_	17	cc	_	_
19	pathological	_	ADJ	JJ	_	17	conj	_	_
20	studies	_	NOUN	NNS	_	15	nmod	_	_
21	,	_	.	,	_	20	punct	_	_
22	as	_	ADV	RB	_	20	cc	_	_
23	well	_	ADV	RB	_	22	mwe	_	_
24	as	_	ADP	IN	_	22	mwe	_	_
25	in	_	ADP	IN	_	28	case	_	_
26	many	_	ADJ	JJ	_	28	amod	_	_
27	animal	_	NOUN	NN	_	28	compound	_	_
28	experiments	_	NOUN	NNS	_	20	conj	_	_

#	Lovastatin	5207
1	Epidemiological	_	ADJ	JJ	_	6	nsubj	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	clinical	_	ADJ	JJ	_	1	conj	_	_
4	studies	_	NOUN	NNS	_	1	dep	_	_
5	have	_	VERB	VBP	_	6	aux	_	_
6	established	_	VERB	VBN	_	0	root	_	_
7	that	_	ADP	IN	_	21	mark	_	_
8	high	_	ADJ	JJ	_	10	amod	_	_
9	LDL	_	NOUN	NN	_	10	compound	_	_
10	C	_	NOUN	NN	_	21	nsubjpass	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	low	_	ADJ	JJ	_	18	amod	_	_
13	high	_	ADJ	JJ	_	18	amod	_	_
14	density	_	NOUN	NN	_	18	compound	_	_
15	lipoprotein	_	NOUN	NN	_	18	compound	_	_
16	cholesterol	_	NOUN	NN	_	18	compound	_	_
17	HDL	_	NOUN	NN	_	18	compound	_	_
18	C	_	NOUN	NN	_	10	conj	_	_
19	are	_	VERB	VBP	_	21	auxpass	_	_
20	both	_	CONJ	CC	_	21	advmod	_	_
21	associated	_	VERB	VBN	_	6	ccomp	_	_
22	with	_	ADP	IN	_	25	case	_	_
23	coronary	_	ADJ	JJ	_	25	amod	_	_
24	heart	_	NOUN	NN	_	25	compound	_	_
25	disease	_	NOUN	NN	_	21	nmod	_	_

#	Lovastatin	5208
1	However	_	ADV	RB	_	11	advmod	_	_
2	,	_	.	,	_	11	punct	_	_
3	the	_	DET	DT	_	4	det	_	_
4	risk	_	NOUN	NN	_	11	nsubj	_	_
5	of	_	ADP	IN	_	6	mark	_	_
6	developing	_	VERB	VBG	_	4	acl	_	_
7	coronary	_	ADJ	JJ	_	9	amod	_	_
8	heart	_	NOUN	NN	_	9	compound	_	_
9	disease	_	NOUN	NN	_	6	dobj	_	_
10	is	_	VERB	VBZ	_	11	cop	_	_
11	continuous	_	ADJ	JJ	_	0	root	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	graded	_	VERB	VBN	_	11	conj	_	_
14	over	_	ADP	IN	_	16	case	_	_
15	the	_	DET	DT	_	16	det	_	_
16	range	_	NOUN	NN	_	13	nmod	_	_
17	of	_	ADP	IN	_	19	case	_	_
18	cholesterol	_	NOUN	NN	_	19	compound	_	_
19	levels	_	NOUN	NNS	_	16	nmod	_	_
20	and	_	CONJ	CC	_	19	cc	_	_
21	many	_	ADJ	JJ	_	23	amod	_	_
22	coronary	_	ADJ	JJ	_	23	amod	_	_
23	events	_	NOUN	NNS	_	19	conj	_	_
24	do	_	VERB	MD	_	25	aux	_	_
25	occur	_	VERB	VB	_	11	parataxis	_	_
26	in	_	ADP	IN	_	27	case	_	_
27	patients	_	NOUN	NNS	_	25	nmod	_	_
28	with	_	ADP	IN	_	32	case	_	_
29	total	_	ADJ	JJ	_	32	amod	_	_
30	cholesterol	_	NOUN	NN	_	32	compound	_	_
31	total	_	ADJ	JJ	_	32	amod	_	_
32	C	_	NOUN	NN	_	27	nmod	_	_
33	and	_	CONJ	CC	_	32	cc	_	_
34	LDL	_	NOUN	NN	_	35	compound	_	_
35	C	_	NOUN	NN	_	32	conj	_	_
36	in	_	ADP	IN	_	39	case	_	_
37	the	_	DET	DT	_	39	det	_	_
38	lower	_	ADJ	JJ	_	39	amod	_	_
39	end	_	NOUN	NN	_	27	nmod	_	_
40	of	_	ADP	IN	_	42	case	_	_
41	this	_	DET	DT	_	42	det	_	_
42	range	_	NOUN	NN	_	39	nmod	_	_

#	Lovastatin	5209
1	MEVACOR	_	NOUN	NN	_	4	nsubjpass	_	_
2	has	_	VERB	VBZ	_	4	aux	_	_
3	been	_	VERB	VBN	_	4	auxpass	_	_
4	shown	_	VERB	VBN	_	0	root	_	_
5	to	_	PRT	TO	_	6	mark	_	_
6	reduce	_	VERB	VB	_	4	xcomp	_	_
7	elevated	_	ADJ	JJ	_	10	amod	_	_
8	LDL	_	NOUN	NN	_	10	compound	_	_
9	C	_	NOUN	NN	_	10	compound	_	_
10	concentrations	_	NOUN	NNS	_	6	dobj	_	_

#	Lovastatin	5210
1	LDL	_	NOUN	NN	_	3	nsubjpass	_	_
2	is	_	VERB	VBZ	_	3	auxpass	_	_
3	formed	_	VERB	VBN	_	0	root	_	_
4	from	_	ADP	IN	_	9	case	_	_
5	very	_	ADV	RB	_	6	advmod	_	_
6	low	_	ADJ	JJ	_	9	amod	_	_
7	density	_	NOUN	NN	_	9	compound	_	_
8	lipoprotein	_	NOUN	NN	_	9	compound	_	_
9	VLDL	_	NOUN	NN	_	3	nmod	_	_
10	and	_	CONJ	CC	_	3	cc	_	_
11	is	_	VERB	VBZ	_	12	auxpass	_	_
12	catabolized	_	VERB	VBN	_	3	conj	_	_
13	predominantly	_	ADV	RB	_	12	advmod	_	_
14	by	_	ADP	IN	_	19	case	_	_
15	the	_	DET	DT	_	19	det	_	_
16	high	_	ADJ	JJ	_	19	amod	_	_
17	affinity	_	NOUN	NN	_	19	compound	_	_
18	LDL	_	NOUN	NN	_	19	compound	_	_
19	receptor	_	NOUN	NN	_	12	nmod	_	_

#	Lovastatin	5211
1	The	_	DET	DT	_	2	det	_	_
2	mechanism	_	NOUN	NN	_	11	nsubj	_	_
3	of	_	ADP	IN	_	7	case	_	_
4	the	_	DET	DT	_	7	det	_	_
5	LDL	_	NOUN	NN	_	7	compound	_	_
6	lowering	_	NOUN	NN	_	7	compound	_	_
7	effect	_	NOUN	NN	_	2	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	MEVACOR	_	NOUN	NN	_	7	nmod	_	_
10	may	_	VERB	MD	_	11	aux	_	_
11	involve	_	VERB	VB	_	0	root	_	_
12	both	_	CONJ	CC	_	13	cc:preconj	_	_
13	reduction	_	NOUN	NN	_	11	dobj	_	_
14	of	_	ADP	IN	_	17	case	_	_
15	VLDL	_	NOUN	NN	_	17	compound	_	_
16	C	_	NOUN	NN	_	17	compound	_	_
17	concentration	_	NOUN	NN	_	13	nmod	_	_
18	,	_	.	,	_	11	punct	_	_
19	and	_	CONJ	CC	_	11	cc	_	_
20	induction	_	NOUN	NN	_	11	conj	_	_
21	of	_	ADP	IN	_	24	case	_	_
22	the	_	DET	DT	_	24	det	_	_
23	LDL	_	NOUN	NN	_	24	compound	_	_
24	receptor	_	NOUN	NN	_	20	nmod	_	_
25	,	_	.	,	_	20	punct	_	_
26	leading	_	VERB	VBG	_	20	acl	_	_
27	to	_	PRT	TO	_	29	case	_	_
28	reduced	_	VERB	VBN	_	29	amod	_	_
29	production	_	NOUN	NN	_	26	nmod	_	_
30	and	_	CONJ	CC	_	29	cc	_	_
31	/	_	NOUN	NN	_	29	conj	_	_
32	or	_	CONJ	CC	_	26	cc	_	_
33	increased	_	VERB	VBD	_	34	amod	_	_
34	catabolism	_	NOUN	NN	_	26	conj	_	_
35	of	_	ADP	IN	_	37	case	_	_
36	LDL	_	NOUN	NN	_	37	compound	_	_
37	C	_	NOUN	NN	_	34	nmod	_	_

#	Lovastatin	5212
1	ApolipoproteinB	_	NOUN	NN	_	3	nsubj	_	_
2	also	_	ADV	RB	_	3	advmod	_	_
3	falls	_	VERB	VBZ	_	0	root	_	_
4	during	_	ADP	IN	_	5	case	_	_
5	treatment	_	NOUN	NN	_	3	nmod	_	_
6	with	_	ADP	IN	_	7	case	_	_
7	MEVACOR	_	NOUN	NN	_	5	nmod	_	_

#	Lovastatin	5213
1	MEVACOR	_	NOUN	NN	_	5	nsubj	_	_
2	is	_	VERB	VBZ	_	5	cop	_	_
3	a	_	DET	DT	_	5	det	_	_
4	specific	_	ADJ	JJ	_	5	amod	_	_
5	inhibitor	_	NOUN	NN	_	0	root	_	_
6	of	_	ADP	IN	_	9	case	_	_
7	HMG	_	NOUN	NN	_	9	compound	_	_
8	CoA	_	NOUN	NN	_	9	compound	_	_
9	reductase	_	NOUN	NN	_	5	nmod	_	_
10	,	_	.	,	_	9	punct	_	_
11	the	_	DET	DT	_	12	det	_	_
12	enzyme	_	NOUN	NN	_	9	appos	_	_
13	which	_	DET	WDT	_	14	nsubj	_	_
14	catalyzes	_	VERB	VBZ	_	12	acl:relcl	_	_
15	the	_	DET	DT	_	16	det	_	_
16	conversion	_	NOUN	NN	_	14	dobj	_	_
17	of	_	ADP	IN	_	19	case	_	_
18	HMG	_	NOUN	NN	_	19	compound	_	_
19	CoA	_	NOUN	NN	_	16	nmod	_	_
20	to	_	PRT	TO	_	21	mark	_	_
21	mevalonate	_	VERB	VB	_	16	acl	_	_

#	Lovastatin	5214
1	The	_	DET	DT	_	2	det	_	_
2	conversion	_	NOUN	NN	_	11	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	HMG	_	NOUN	NN	_	5	compound	_	_
5	CoA	_	NOUN	NN	_	2	nmod	_	_
6	to	_	PRT	TO	_	7	case	_	_
7	mevalonate	_	NOUN	NN	_	2	nmod	_	_
8	is	_	VERB	VBZ	_	11	cop	_	_
9	an	_	DET	DT	_	11	det	_	_
10	early	_	ADJ	JJ	_	11	amod	_	_
11	step	_	NOUN	NN	_	0	root	_	_
12	in	_	ADP	IN	_	15	case	_	_
13	the	_	DET	DT	_	15	det	_	_
14	biosynthetic	_	ADJ	JJ	_	15	amod	_	_
15	pathway	_	NOUN	NN	_	11	nmod	_	_
16	for	_	ADP	IN	_	17	case	_	_
17	cholesterol	_	NOUN	NN	_	15	nmod	_	_

#	Lovastatin	5215
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	is	_	VERB	VBZ	_	4	cop	_	_
3	a	_	DET	DT	_	4	det	_	_
4	lactone	_	NOUN	NN	_	0	root	_	_
5	which	_	DET	WDT	_	8	nsubjpass	_	_
6	is	_	VERB	VBZ	_	8	auxpass	_	_
7	readily	_	ADV	RB	_	8	advmod	_	_
8	hydrolyzed	_	VERB	VBN	_	4	acl:relcl	_	_
9	in	_	X	FW	_	10	compound	_	_
10	vivo	_	X	FW	_	8	advmod	_	_
11	to	_	PRT	TO	_	15	case	_	_
12	the	_	DET	DT	_	15	det	_	_
13	corresponding	_	VERB	VBG	_	15	amod	_	_
14	B	_	NOUN	NN	_	15	compound	_	_
15	hydroxyacid	_	NOUN	NN	_	8	nmod	_	_
16	,	_	.	,	_	15	punct	_	_
17	a	_	DET	DT	_	19	det	_	_
18	strong	_	ADJ	JJ	_	19	amod	_	_
19	inhibitor	_	NOUN	NN	_	15	appos	_	_
20	of	_	ADP	IN	_	23	case	_	_
21	HMG	_	NOUN	NN	_	23	compound	_	_
22	CoA	_	NOUN	NN	_	23	compound	_	_
23	reductase	_	NOUN	NN	_	19	nmod	_	_

#	Lovastatin	5216
1	Inhibition	_	NOUN	NN	_	8	nsubj	_	_
2	of	_	ADP	IN	_	5	case	_	_
3	HMG	_	NOUN	NN	_	5	compound	_	_
4	CoA	_	NOUN	NN	_	5	compound	_	_
5	reductase	_	NOUN	NN	_	1	nmod	_	_
6	is	_	VERB	VBZ	_	8	cop	_	_
7	the	_	DET	DT	_	8	det	_	_
8	basis	_	NOUN	NN	_	0	root	_	_
9	for	_	ADP	IN	_	11	case	_	_
10	an	_	DET	DT	_	11	det	_	_
11	assay	_	NOUN	NN	_	8	nmod	_	_
12	in	_	ADP	IN	_	14	case	_	_
13	pharmacokinetic	_	ADJ	JJ	_	14	amod	_	_
14	studies	_	NOUN	NNS	_	11	nmod	_	_
15	of	_	ADP	IN	_	19	case	_	_
16	the	_	DET	DT	_	19	det	_	_
17	B	_	NOUN	NN	_	19	compound	_	_
18	hydroxyacid	_	NOUN	NN	_	19	compound	_	_
19	metabolites	_	NOUN	NNS	_	14	nmod	_	_
20	active	_	ADJ	JJ	_	21	amod	_	_
21	inhibitors	_	NOUN	NNS	_	19	dep	_	_
22	and	_	CONJ	CC	_	21	cc	_	_
23	,	_	.	,	_	21	punct	_	_
24	following	_	VERB	VBG	_	26	case	_	_
25	base	_	NOUN	NN	_	26	compound	_	_
26	hydrolysis	_	NOUN	NN	_	21	conj	_	_
27	,	_	.	,	_	26	punct	_	_
28	active	_	ADJ	JJ	_	31	amod	_	_
29	plus	_	CONJ	CC	_	28	cc	_	_
30	latent	_	ADJ	JJ	_	28	conj	_	_
31	inhibitors	_	NOUN	NNS	_	27	root	_	_
32	total	_	ADJ	JJ	_	33	amod	_	_
33	inhibitors	_	NOUN	NNS	_	31	dep	_	_
34	in	_	ADP	IN	_	35	case	_	_
35	plasma	_	NOUN	NN	_	33	nmod	_	_
36	following	_	ADP	IN	_	37	case	_	_
37	administration	_	NOUN	NN	_	33	nmod	_	_
38	of	_	ADP	IN	_	39	case	_	_
39	DRUG	_	NOUN	NN	_	37	nmod	_	_

#	Lovastatin	5217
1	Following	_	ADP	IN	_	4	case	_	_
2	an	_	DET	DT	_	4	det	_	_
3	oral	_	ADJ	JJ	_	4	amod	_	_
4	dose	_	NOUN	NN	_	17	nmod	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	14C	_	NOUN	NN	_	8	compound	_	_
7	labeled	_	VERB	VBN	_	8	amod	_	_
8	DRUG	_	NOUN	NN	_	4	nmod	_	_
9	in	_	ADP	IN	_	10	case	_	_
10	man	_	X	FW	_	4	nmod	_	_
11	,	_	.	,	_	17	punct	_	_
12	10%	_	NOUN	NN	_	17	nsubjpass	_	_
13	of	_	ADP	IN	_	15	case	_	_
14	the	_	DET	DT	_	15	det	_	_
15	dose	_	NOUN	NN	_	12	nmod	_	_
16	was	_	VERB	VBD	_	17	auxpass	_	_
17	excreted	_	VERB	VBN	_	0	root	_	_
18	in	_	ADP	IN	_	19	case	_	_
19	urine	_	ADJ	JJ	_	17	nmod	_	_
20	and	_	CONJ	CC	_	19	cc	_	_
21	83%	_	NOUN	NN	_	19	conj	_	_
22	in	_	ADP	IN	_	23	case	_	_
23	feces	_	NOUN	NNS	_	17	nmod	_	_

#	Lovastatin	5218
1	The	_	DET	DT	_	3	det	_	_
2	latter	_	ADJ	JJ	_	3	amod	_	_
3	represents	_	NOUN	NNS	_	4	nsubj	_	_
4	absorbed	_	VERB	VBD	_	0	root	_	_
5	drug	_	NOUN	NN	_	6	compound	_	_
6	equivalents	_	NOUN	NNS	_	4	dobj	_	_
7	excreted	_	VERB	VBN	_	6	acl	_	_
8	in	_	ADP	IN	_	9	case	_	_
9	bile	_	ADJ	JJ	_	7	nmod	_	_
10	,	_	.	,	_	6	punct	_	_
11	as	_	ADV	RB	_	6	cc	_	_
12	well	_	ADV	RB	_	11	mwe	_	_
13	as	_	ADP	IN	_	11	mwe	_	_
14	any	_	DET	DT	_	16	det	_	_
15	unabsorbed	_	ADJ	JJ	_	16	amod	_	_
16	drug	_	NOUN	NN	_	6	conj	_	_

#	Lovastatin	5219
1	Plasma	_	NOUN	NN	_	2	compound	_	_
2	concentrations	_	NOUN	NNS	_	10	nsubj	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	total	_	ADJ	JJ	_	6	amod	_	_
5	radioactivity	_	NOUN	NN	_	6	compound	_	_
6	DRUG	_	NOUN	NN	_	2	nmod	_	_
7	plus	_	CONJ	CC	_	6	cc	_	_
8	14C	_	NOUN	NN	_	9	compound	_	_
9	metabolites	_	NOUN	NNS	_	6	conj	_	_
10	peaked	_	VERB	VBD	_	0	root	_	_
11	at	_	ADP	IN	_	12	case	_	_
12	2hours	_	NOUN	NNS	_	10	nmod	_	_
13	and	_	CONJ	CC	_	10	cc	_	_
14	declined	_	VERB	VBN	_	10	conj	_	_
15	rapidly	_	ADV	RB	_	14	advmod	_	_
16	to	_	PRT	TO	_	18	case	_	_
17	about	_	ADV	RB	_	18	advmod	_	_
18	10%	_	NOUN	NN	_	14	nmod	_	_
19	of	_	ADP	IN	_	20	case	_	_
20	peak	_	NOUN	NN	_	18	nmod	_	_
21	by	_	ADP	IN	_	23	case	_	_
22	24hours	_	ADJ	JJ	_	23	compound	_	_
23	postdose	_	NOUN	NN	_	14	nmod	_	_

#	Lovastatin	5220
1	Absorption	_	NOUN	NN	_	0	root	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	,	_	.	,	_	1	punct	_	_
5	estimated	_	VERB	VBN	_	1	acl	_	_
6	relative	_	ADJ	JJ	_	5	xcomp	_	_
7	to	_	PRT	TO	_	11	case	_	_
8	an	_	DET	DT	_	11	det	_	_
9	intravenous	_	ADJ	JJ	_	11	amod	_	_
10	reference	_	NOUN	NN	_	11	compound	_	_
11	dose	_	NOUN	NN	_	6	nmod	_	_
12	,	_	.	,	_	1	punct	_	_
13	in	_	ADP	IN	_	14	case	_	_
14	each	_	DET	DT	_	1	nmod	_	_
15	of	_	ADP	IN	_	18	case	_	_
16	four	_	NUM	CD	_	18	nummod	_	_
17	animal	_	NOUN	NN	_	18	compound	_	_
18	species	_	NOUN	NNS	_	14	nmod	_	_
19	tested	_	VERB	VBN	_	18	acl	_	_
20	,	_	.	,	_	1	punct	_	_
21	averaged	_	VERB	VBN	_	1	acl	_	_
22	about	_	ADV	RB	_	23	advmod	_	_
23	30%	_	NOUN	NN	_	21	nmod	_	_
24	of	_	ADP	IN	_	27	case	_	_
25	an	_	DET	DT	_	27	det	_	_
26	oral	_	ADJ	JJ	_	27	amod	_	_
27	dose	_	NOUN	NN	_	23	nmod	_	_

#	Lovastatin	5221
1	In	_	ADP	IN	_	3	case	_	_
2	animal	_	NOUN	NN	_	3	compound	_	_
3	studies	_	NOUN	NNS	_	10	nmod	_	_
4	,	_	.	,	_	10	punct	_	_
5	after	_	ADP	IN	_	7	case	_	_
6	oral	_	ADJ	JJ	_	7	amod	_	_
7	dosing	_	NOUN	NN	_	10	nmod	_	_
8	,	_	.	,	_	10	punct	_	_
9	DRUG	_	NOUN	NN	_	10	nsubj	_	_
10	had	_	VERB	VBD	_	0	root	_	_
11	high	_	ADJ	JJ	_	12	amod	_	_
12	selectivity	_	NOUN	NN	_	10	dobj	_	_
13	for	_	ADP	IN	_	15	case	_	_
14	the	_	DET	DT	_	15	det	_	_
15	liver	_	NOUN	NN	_	12	nmod	_	_
16	,	_	.	,	_	12	punct	_	_
17	where	_	ADV	WRB	_	19	advmod	_	_
18	it	_	PRON	PRP	_	19	nsubj	_	_
19	achieved	_	VERB	VBD	_	12	dep	_	_
20	substantially	_	ADV	RB	_	21	advmod	_	_
21	higher	_	ADJ	JJ	_	22	amod	_	_
22	concentrations	_	NOUN	NNS	_	19	dobj	_	_
23	than	_	ADP	IN	_	27	case	_	_
24	in	_	ADP	IN	_	27	case	_	_
25	non	_	ADJ	JJ	_	27	amod	_	_
26	target	_	NOUN	NN	_	27	compound	_	_
27	tissues	_	NOUN	NNS	_	19	nmod	_	_

#	Lovastatin	5222
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	undergoes	_	VERB	VBZ	_	0	root	_	_
3	extensive	_	ADJ	JJ	_	6	amod	_	_
4	first	_	ADJ	JJ	_	6	amod	_	_
5	pass	_	NOUN	NN	_	6	compound	_	_
6	extraction	_	NOUN	NN	_	2	dobj	_	_
7	in	_	ADP	IN	_	9	case	_	_
8	the	_	DET	DT	_	9	det	_	_
9	liver	_	NOUN	NN	_	6	nmod	_	_
10	,	_	.	,	_	9	punct	_	_
11	its	_	PRON	PRP$	_	13	nmod:poss	_	_
12	primary	_	ADJ	JJ	_	13	amod	_	_
13	site	_	NOUN	NN	_	9	appos	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	action	_	NOUN	NN	_	13	nmod	_	_
16	,	_	.	,	_	2	punct	_	_
17	with	_	ADP	IN	_	19	case	_	_
18	subsequent	_	ADJ	JJ	_	19	amod	_	_
19	excretion	_	NOUN	NN	_	2	nmod	_	_
20	of	_	ADP	IN	_	22	case	_	_
21	drug	_	NOUN	NN	_	22	compound	_	_
22	equivalents	_	NOUN	NNS	_	19	nmod	_	_
23	in	_	ADP	IN	_	25	case	_	_
24	the	_	DET	DT	_	25	det	_	_
25	bile	_	ADJ	JJ	_	19	nmod	_	_

#	Lovastatin	5223
1	As	_	ADP	IN	_	3	case	_	_
2	a	_	DET	DT	_	3	det	_	_
3	consequence	_	NOUN	NN	_	20	nmod	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	extensive	_	ADJ	JJ	_	7	amod	_	_
6	hepatic	_	ADJ	JJ	_	7	amod	_	_
7	extraction	_	NOUN	NN	_	3	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	,	_	.	,	_	20	punct	_	_
11	the	_	DET	DT	_	12	det	_	_
12	availability	_	NOUN	NN	_	20	nsubj	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	drug	_	NOUN	NN	_	12	nmod	_	_
15	to	_	PRT	TO	_	18	case	_	_
16	the	_	DET	DT	_	18	det	_	_
17	general	_	ADJ	JJ	_	18	amod	_	_
18	circulation	_	NOUN	NN	_	12	nmod	_	_
19	is	_	VERB	VBZ	_	20	cop	_	_
20	low	_	ADJ	JJ	_	0	root	_	_
21	and	_	CONJ	CC	_	20	cc	_	_
22	variable	_	ADJ	JJ	_	20	conj	_	_

#	Lovastatin	5224
1	In	_	ADP	IN	_	5	case	_	_
2	a	_	DET	DT	_	5	det	_	_
3	single	_	ADJ	JJ	_	5	amod	_	_
4	dose	_	NOUN	NN	_	5	compound	_	_
5	study	_	NOUN	NN	_	13	nmod	_	_
6	in	_	ADP	IN	_	9	case	_	_
7	four	_	NUM	CD	_	9	nummod	_	_
8	hypercholesterolemic	_	ADJ	JJ	_	9	amod	_	_
9	patients	_	NOUN	NNS	_	5	nmod	_	_
10	,	_	.	,	_	13	punct	_	_
11	it	_	PRON	PRP	_	13	nsubjpass	_	_
12	was	_	VERB	VBD	_	13	auxpass	_	_
13	estimated	_	VERB	VBN	_	0	root	_	_
14	that	_	ADP	IN	_	24	mark	_	_
15	less	_	ADV	RB	_	17	advmod	_	_
16	than	_	ADP	IN	_	15	mwe	_	_
17	5%	_	NOUN	NN	_	24	nsubj	_	_
18	of	_	ADP	IN	_	21	case	_	_
19	an	_	DET	DT	_	21	det	_	_
20	oral	_	ADJ	JJ	_	21	amod	_	_
21	dose	_	NOUN	NN	_	17	nmod	_	_
22	of	_	ADP	IN	_	23	case	_	_
23	DRUG	_	NOUN	NN	_	21	nmod	_	_
24	reaches	_	VERB	VBZ	_	13	ccomp	_	_
25	the	_	DET	DT	_	27	det	_	_
26	general	_	ADJ	JJ	_	27	amod	_	_
27	circulation	_	NOUN	NN	_	24	dobj	_	_
28	as	_	ADP	IN	_	30	case	_	_
29	active	_	ADJ	JJ	_	30	amod	_	_
30	inhibitors	_	NOUN	NNS	_	24	nmod	_	_

#	Lovastatin	5225
1	Following	_	VERB	VBG	_	2	case	_	_
2	administration	_	NOUN	NN	_	5	nmod	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	tablets	_	VERB	VBZ	_	19	aux	_	_
6	the	_	DET	DT	_	7	det	_	_
7	coefficient	_	NOUN	NN	_	5	dobj	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	variation	_	NOUN	NN	_	7	nmod	_	_
10	,	_	.	,	_	5	punct	_	_
11	based	_	VERB	VBN	_	5	advcl	_	_
12	on	_	ADP	IN	_	15	case	_	_
13	between	_	ADP	IN	_	15	case	_	_
14	subject	_	NOUN	NN	_	15	compound	_	_
15	variability	_	NOUN	NN	_	11	nmod	_	_
16	,	_	.	,	_	5	punct	_	_
17	was	_	VERB	VBD	_	19	cop	_	_
18	approximately	_	ADV	RB	_	19	advmod	_	_
19	40%	_	ADJ	JJ	_	0	root	_	_
20	for	_	ADP	IN	_	22	case	_	_
21	the	_	DET	DT	_	22	det	_	_
22	area	_	NOUN	NN	_	19	nmod	_	_
23	under	_	ADP	IN	_	26	case	_	_
24	the	_	DET	DT	_	26	det	_	_
25	curve	_	ADJ	JJ	_	26	amod	_	_
26	AUC	_	NOUN	NN	_	22	nmod	_	_
27	of	_	ADP	IN	_	30	case	_	_
28	total	_	ADJ	JJ	_	30	amod	_	_
29	inhibitory	_	ADJ	JJ	_	30	amod	_	_
30	activity	_	NOUN	NN	_	26	nmod	_	_
31	in	_	ADP	IN	_	34	case	_	_
32	the	_	DET	DT	_	34	det	_	_
33	general	_	ADJ	JJ	_	34	amod	_	_
34	circulation	_	NOUN	NN	_	30	nmod	_	_

#	Lovastatin	5226
1	Both	_	CONJ	CC	_	2	cc:preconj	_	_
2	DRUG	_	NOUN	NN	_	10	nsubjpass	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	its	_	PRON	PRP$	_	7	nmod:poss	_	_
5	B	_	NOUN	NN	_	7	compound	_	_
6	hydroxyacid	_	NOUN	NN	_	7	compound	_	_
7	metabolite	_	NOUN	NN	_	2	conj	_	_
8	are	_	VERB	VBP	_	10	auxpass	_	_
9	highly	_	ADV	RB	_	10	advmod	_	_
10	bound	_	VERB	VBN	_	0	root	_	_
11	>95%	_	NOUN	NN	_	10	dobj	_	_
12	to	_	PRT	TO	_	15	case	_	_
13	human	_	ADJ	JJ	_	15	amod	_	_
14	plasma	_	NOUN	NN	_	15	compound	_	_
15	proteins	_	NOUN	NNS	_	11	nmod	_	_

#	Lovastatin	5227
1	Animal	_	ADJ	JJ	_	2	amod	_	_
2	studies	_	NOUN	NNS	_	3	nsubj	_	_
3	demonstrated	_	VERB	VBD	_	0	root	_	_
4	that	_	ADP	IN	_	6	mark	_	_
5	DRUG	_	NOUN	NN	_	6	nsubj	_	_
6	crosses	_	VERB	VBZ	_	3	ccomp	_	_
7	the	_	DET	DT	_	9	det	_	_
8	blood	_	NOUN	NN	_	9	compound	_	_
9	brain	_	NOUN	NN	_	6	dobj	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	placental	_	ADJ	JJ	_	12	amod	_	_
12	barriers	_	NOUN	NNS	_	9	conj	_	_

#	Lovastatin	5228
1	The	_	DET	DT	_	4	det	_	_
2	major	_	ADJ	JJ	_	4	amod	_	_
3	active	_	ADJ	JJ	_	4	amod	_	_
4	metabolites	_	NOUN	NNS	_	12	nsubj	_	_
5	present	_	ADJ	JJ	_	4	amod	_	_
6	in	_	ADP	IN	_	8	case	_	_
7	human	_	ADJ	JJ	_	8	amod	_	_
8	plasma	_	NOUN	NN	_	5	nmod	_	_
9	are	_	VERB	VBP	_	12	cop	_	_
10	the	_	DET	DT	_	12	det	_	_
11	B	_	NOUN	NN	_	12	compound	_	_
12	hydroxyacid	_	NOUN	NN	_	0	root	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	DRUG	_	NOUN	NN	_	12	nmod	_	_
15	,	_	.	,	_	14	punct	_	_
16	its	_	PRON	PRP$	_	19	nmod:poss	_	_
17	6*	_	ADJ	JJ	_	19	amod	_	_
18	hydroxy	_	NOUN	NN	_	19	compound	_	_
19	derivative	_	ADJ	JJ	_	14	conj	_	_
20	,	_	.	,	_	14	punct	_	_
21	and	_	CONJ	CC	_	14	cc	_	_
22	two	_	NUM	CD	_	24	nummod	_	_
23	additional	_	ADJ	JJ	_	24	amod	_	_
24	metabolites	_	NOUN	NNS	_	14	conj	_	_

#	Lovastatin	5229
1	Peak	_	ADJ	JJ	_	3	amod	_	_
2	plasma	_	NOUN	NN	_	3	compound	_	_
3	concentrations	_	NOUN	NNS	_	11	nsubjpass	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	both	_	CONJ	CC	_	6	cc:preconj	_	_
6	active	_	ADJ	JJ	_	3	nmod	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	total	_	ADJ	JJ	_	6	conj	_	_
9	inhibitors	_	NOUN	NNS	_	6	dep	_	_
10	were	_	VERB	VBD	_	11	auxpass	_	_
11	attained	_	VERB	VBN	_	0	root	_	_
12	within	_	ADP	IN	_	15	case	_	_
13	2	_	NUM	CD	_	15	nummod	_	_
14	to	_	PRT	TO	_	15	case	_	_
15	4hours	_	NOUN	NNS	_	11	nmod	_	_
16	of	_	ADP	IN	_	18	case	_	_
17	dose	_	NOUN	NN	_	18	compound	_	_
18	administration	_	NOUN	NN	_	15	nmod	_	_

#	Lovastatin	5230
1	While	_	ADP	IN	_	12	mark	_	_
2	the	_	DET	DT	_	6	det	_	_
3	recommended	_	VERB	VBN	_	6	amod	_	_
4	therapeutic	_	ADJ	JJ	_	6	amod	_	_
5	dose	_	NOUN	NN	_	6	compound	_	_
6	range	_	NOUN	NN	_	12	nsubj	_	_
7	is	_	VERB	VBZ	_	12	cop	_	_
8	10	_	NUM	CD	_	12	nummod	_	_
9	to	_	PRT	TO	_	12	case	_	_
10	80mg	_	ADJ	JJ	_	12	amod	_	_
11	/	_	.	:	_	12	punct	_	_
12	day	_	NOUN	NN	_	23	nmod	_	_
13	,	_	.	,	_	23	punct	_	_
14	linearity	_	NOUN	NN	_	23	nsubjpass	_	_
15	of	_	ADP	IN	_	17	case	_	_
16	inhibitory	_	ADJ	JJ	_	17	amod	_	_
17	activity	_	NOUN	NN	_	14	nmod	_	_
18	in	_	ADP	IN	_	21	case	_	_
19	the	_	DET	DT	_	21	det	_	_
20	general	_	ADJ	JJ	_	21	amod	_	_
21	circulation	_	NOUN	NN	_	17	nmod	_	_
22	was	_	VERB	VBD	_	23	auxpass	_	_
23	established	_	VERB	VBN	_	0	root	_	_
24	by	_	ADP	IN	_	28	case	_	_
25	a	_	DET	DT	_	28	det	_	_
26	single	_	ADJ	JJ	_	28	amod	_	_
27	dose	_	NOUN	NN	_	28	compound	_	_
28	study	_	NOUN	NN	_	23	nmod	_	_
29	employing	_	VERB	VBG	_	28	acl	_	_
30	DRUG	_	NOUN	NN	_	32	compound	_	_
31	tablet	_	NOUN	NN	_	32	compound	_	_
32	dosages	_	NOUN	NNS	_	29	dobj	_	_
33	from	_	ADP	IN	_	37	case	_	_
34	60	_	NUM	CD	_	36	compound	_	_
35	to	_	PRT	TO	_	36	dep	_	_
36	as	_	ADV	RB	_	37	advmod	_	_
37	high	_	ADJ	JJ	_	29	nmod	_	_
38	as	_	ADP	IN	_	39	case	_	_
39	120mg	_	ADJ	JJ	_	37	nmod	_	_
40	With	_	ADP	IN	_	46	case	_	_
41	a	_	DET	DT	_	46	det	_	_
42	once	_	ADV	RB	_	46	advmod	_	_
43	a	_	DET	DT	_	46	det	_	_
44	day	_	NOUN	NN	_	46	compound	_	_
45	dosing	_	NOUN	NN	_	46	compound	_	_
46	regimen	_	NOUN	NN	_	39	nmod	_	_
47	,	_	.	,	_	23	punct	_	_
48	plasma	_	NOUN	NN	_	49	compound	_	_
49	concentrations	_	NOUN	NNS	_	57	nsubj	_	_
50	of	_	ADP	IN	_	52	case	_	_
51	total	_	ADJ	JJ	_	52	amod	_	_
52	inhibitors	_	NOUN	NNS	_	49	nmod	_	_
53	over	_	ADP	IN	_	56	case	_	_
54	a	_	DET	DT	_	56	det	_	_
55	dosing	_	ADJ	JJ	_	56	amod	_	_
56	interval	_	NOUN	NN	_	49	nmod	_	_
57	achieved	_	VERB	VBD	_	23	parataxis	_	_
58	a	_	DET	DT	_	60	det	_	_
59	steady	_	ADJ	JJ	_	60	amod	_	_
60	state	_	NOUN	NN	_	57	dobj	_	_
61	between	_	ADP	IN	_	66	case	_	_
62	the	_	DET	DT	_	66	det	_	_
63	second	_	ADJ	JJ	_	66	amod	_	_
64	and	_	CONJ	CC	_	63	cc	_	_
65	third	_	ADJ	JJ	_	63	conj	_	_
66	days	_	NOUN	NNS	_	60	nmod	_	_
67	of	_	ADP	IN	_	68	case	_	_
68	therapy	_	NOUN	NN	_	66	nmod	_	_
69	and	_	CONJ	CC	_	57	cc	_	_
70	were	_	VERB	VBD	_	73	cop	_	_
71	about	_	ADV	RB	_	72	advmod	_	_
72	1.5	_	NUM	CD	_	73	nummod	_	_
73	times	_	NOUN	NNS	_	57	conj	_	_
74	those	_	DET	DT	_	73	dep	_	_
75	following	_	ADP	IN	_	78	case	_	_
76	a	_	DET	DT	_	78	det	_	_
77	single	_	ADJ	JJ	_	78	amod	_	_
78	dose	_	NOUN	NN	_	74	nmod	_	_

#	Lovastatin	5231
1	When	_	ADV	WRB	_	4	advmod	_	_
2	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
3	was	_	VERB	VBD	_	4	auxpass	_	_
4	given	_	VERB	VBN	_	16	advcl	_	_
5	under	_	ADP	IN	_	6	mark	_	_
6	fasting	_	VERB	VBG	_	4	advcl	_	_
7	conditions	_	NOUN	NNS	_	6	dobj	_	_
8	,	_	.	,	_	16	punct	_	_
9	plasma	_	NOUN	NN	_	10	compound	_	_
10	concentrations	_	NOUN	NNS	_	16	nsubj	_	_
11	of	_	ADP	IN	_	13	case	_	_
12	total	_	ADJ	JJ	_	13	amod	_	_
13	inhibitors	_	NOUN	NNS	_	10	nmod	_	_
14	were	_	VERB	VBD	_	16	cop	_	_
15	on	_	ADP	IN	_	16	case	_	_
16	average	_	NOUN	NN	_	0	root	_	_
17	about	_	ADP	IN	_	18	advmod	_	_
18	two	_	NUM	CD	_	19	nummod	_	_
19	thirds	_	NOUN	NNS	_	20	dep	_	_
20	those	_	DET	DT	_	16	dobj	_	_
21	found	_	VERB	VBN	_	20	acl	_	_
22	when	_	ADV	WRB	_	25	advmod	_	_
23	DRUG	_	NOUN	NN	_	25	nsubjpass	_	_
24	was	_	VERB	VBD	_	25	auxpass	_	_
25	administered	_	VERB	VBN	_	21	ccomp	_	_
26	immediately	_	ADV	RB	_	25	advmod	_	_
27	after	_	ADP	IN	_	31	case	_	_
28	a	_	DET	DT	_	31	det	_	_
29	standard	_	ADJ	JJ	_	31	amod	_	_
30	test	_	NOUN	NN	_	31	compound	_	_
31	meal	_	ADJ	JJ	_	25	nmod	_	_

#	Lovastatin	5232
1	In	_	ADP	IN	_	3	case	_	_
2	a	_	DET	DT	_	3	det	_	_
3	study	_	NOUN	NN	_	33	nmod	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	patients	_	NOUN	NNS	_	3	nmod	_	_
6	with	_	ADP	IN	_	13	case	_	_
7	severe	_	ADJ	JJ	_	13	amod	_	_
8	renal	_	ADJ	JJ	_	13	amod	_	_
9	insufficiency	_	NOUN	NN	_	13	compound	_	_
10	creatinine	_	NOUN	NN	_	13	compound	_	_
11	clearance	_	NOUN	NN	_	13	compound	_	_
12	10	_	NUM	CD	_	13	nummod	_	_
13	30mL	_	NOUN	NN	_	5	nmod	_	_
14	/	_	.	:	_	33	punct	_	_
15	min	_	NOUN	NN	_	33	nmod	_	_
16	,	_	.	,	_	33	punct	_	_
17	the	_	DET	DT	_	19	det	_	_
18	plasma	_	NOUN	NN	_	19	compound	_	_
19	concentrations	_	NOUN	NNS	_	33	nsubj	_	_
20	of	_	ADP	IN	_	22	case	_	_
21	total	_	ADJ	JJ	_	22	amod	_	_
22	inhibitors	_	NOUN	NNS	_	19	nmod	_	_
23	after	_	ADP	IN	_	26	case	_	_
24	a	_	DET	DT	_	26	det	_	_
25	single	_	ADJ	JJ	_	26	amod	_	_
26	dose	_	NOUN	NN	_	19	nmod	_	_
27	of	_	ADP	IN	_	28	case	_	_
28	DRUG	_	NOUN	NN	_	26	nmod	_	_
29	were	_	VERB	VBD	_	33	cop	_	_
30	approximately	_	ADV	RB	_	31	advmod	_	_
31	two	_	NUM	CD	_	32	nummod	_	_
32	fold	_	NOUN	NN	_	33	nmod:npmod	_	_
33	higher	_	ADJ	JJ	_	0	root	_	_
34	than	_	ADP	IN	_	35	case	_	_
35	those	_	DET	DT	_	33	nmod	_	_
36	in	_	ADP	IN	_	38	case	_	_
37	healthy	_	ADJ	JJ	_	38	amod	_	_
38	volunteers	_	NOUN	NNS	_	35	nmod	_	_

#	Lovastatin	5233
1	In	_	ADP	IN	_	3	case	_	_
2	a	_	DET	DT	_	3	det	_	_
3	study	_	NOUN	NN	_	31	nmod	_	_
4	including	_	ADP	IN	_	7	case	_	_
5	16	_	NUM	CD	_	7	nummod	_	_
6	elderly	_	ADJ	JJ	_	7	amod	_	_
7	patients	_	NOUN	NNS	_	3	nmod	_	_
8	between	_	ADP	IN	_	10	case	_	_
9	70	_	NUM	CD	_	10	nummod	_	_
10	78years	_	NOUN	NNS	_	3	nmod	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	age	_	NOUN	NN	_	10	nmod	_	_
13	who	_	DET	WDT	_	14	nsubj	_	_
14	received	_	VERB	VBD	_	12	acl:relcl	_	_
15	MEVACOR	_	NOUN	NN	_	18	compound	_	_
16	80mg	_	ADJ	JJ	_	18	amod	_	_
17	/	_	.	:	_	18	punct	_	_
18	day	_	NOUN	NN	_	14	dobj	_	_
19	,	_	.	,	_	31	punct	_	_
20	the	_	DET	DT	_	23	det	_	_
21	mean	_	NOUN	NN	_	23	compound	_	_
22	plasma	_	NOUN	NN	_	23	compound	_	_
23	level	_	NOUN	NN	_	31	nsubjpass	_	_
24	of	_	ADP	IN	_	29	case	_	_
25	HMG	_	NOUN	NN	_	29	compound	_	_
26	CoA	_	NOUN	NN	_	29	compound	_	_
27	reductase	_	NOUN	NN	_	29	compound	_	_
28	inhibitory	_	ADJ	JJ	_	29	amod	_	_
29	activity	_	NOUN	NN	_	23	nmod	_	_
30	was	_	VERB	VBD	_	31	auxpass	_	_
31	increased	_	VERB	VBN	_	0	root	_	_
32	approximately	_	ADV	RB	_	33	advmod	_	_
33	45%	_	NOUN	NN	_	31	xcomp	_	_
34	compared	_	VERB	VBN	_	31	xcomp	_	_
35	with	_	ADP	IN	_	37	case	_	_
36	18	_	NUM	CD	_	37	nummod	_	_
37	patients	_	NOUN	NNS	_	34	nmod	_	_
38	between	_	ADP	IN	_	40	case	_	_
39	18	_	NUM	CD	_	40	nummod	_	_
40	30years	_	NOUN	NN	_	34	nmod	_	_
41	of	_	ADP	IN	_	42	case	_	_
42	age	_	NOUN	NN	_	40	nmod	_	_

#	Lovastatin	5234
1	Although	_	ADP	IN	_	7	mark	_	_
2	the	_	DET	DT	_	3	det	_	_
3	mechanism	_	NOUN	NN	_	7	nsubjpass	_	_
4	is	_	VERB	VBZ	_	7	auxpass	_	_
5	not	_	ADV	RB	_	7	neg	_	_
6	fully	_	ADV	RB	_	7	advmod	_	_
7	understood	_	VERB	VBN	_	12	advcl	_	_
8	,	_	.	,	_	12	punct	_	_
9	cyclosporine	_	NOUN	NN	_	12	nsubjpass	_	_
10	has	_	VERB	VBZ	_	12	aux	_	_
11	been	_	VERB	VBN	_	12	auxpass	_	_
12	shown	_	VERB	VBN	_	0	root	_	_
13	to	_	PRT	TO	_	14	mark	_	_
14	increase	_	VERB	VB	_	12	xcomp	_	_
15	the	_	DET	DT	_	16	det	_	_
16	AUC	_	NOUN	NN	_	14	dobj	_	_
17	of	_	ADP	IN	_	21	case	_	_
18	HMG	_	NOUN	NN	_	21	compound	_	_
19	CoA	_	NOUN	NN	_	21	compound	_	_
20	reductase	_	NOUN	NN	_	21	compound	_	_
21	inhibitors	_	NOUN	NNS	_	16	nmod	_	_

#	Lovastatin	5235
1	The	_	DET	DT	_	2	det	_	_
2	increase	_	NOUN	NN	_	12	nsubj	_	_
3	in	_	ADP	IN	_	4	case	_	_
4	AUC	_	NOUN	NN	_	2	nmod	_	_
5	for	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	2	nmod	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	DRUG	_	NOUN	NN	_	9	compound	_	_
9	acid	_	NOUN	NN	_	6	conj	_	_
10	is	_	VERB	VBZ	_	12	cop	_	_
11	presumably	_	ADV	RB	_	12	advmod	_	_
12	due	_	ADJ	JJ	_	0	root	_	_
13	,	_	.	,	_	12	punct	_	_
14	in	_	ADP	IN	_	15	case	_	_
15	part	_	NOUN	NN	_	12	nmod	_	_
16	,	_	.	,	_	12	punct	_	_
17	to	_	PRT	TO	_	18	case	_	_
18	inhibition	_	NOUN	NN	_	12	nmod	_	_
19	of	_	ADP	IN	_	20	case	_	_
20	CYP3A4	_	NOUN	NN	_	18	nmod	_	_

#	Lovastatin	5236
1	The	_	DET	DT	_	2	det	_	_
2	risk	_	NOUN	NN	_	6	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	myopathy	_	NOUN	NN	_	2	nmod	_	_
5	is	_	VERB	VBZ	_	6	auxpass	_	_
6	increased	_	VERB	VBN	_	0	root	_	_
7	by	_	ADP	IN	_	9	case	_	_
8	high	_	ADJ	JJ	_	9	amod	_	_
9	levels	_	NOUN	NNS	_	6	nmod	_	_
10	of	_	ADP	IN	_	15	case	_	_
11	HMG	_	NOUN	NN	_	15	compound	_	_
12	CoA	_	NOUN	NN	_	15	compound	_	_
13	reductase	_	NOUN	NN	_	15	compound	_	_
14	inhibitory	_	ADJ	JJ	_	15	amod	_	_
15	activity	_	NOUN	NN	_	9	nmod	_	_
16	in	_	ADP	IN	_	17	case	_	_
17	plasma	_	NOUN	NN	_	15	nmod	_	_

#	Lovastatin	5237
1	Strong	_	ADJ	JJ	_	2	amod	_	_
2	inhibitors	_	NOUN	NNS	_	6	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	CYP3A4	_	NOUN	NN	_	2	nmod	_	_
5	can	_	VERB	MD	_	6	aux	_	_
6	raise	_	VERB	VB	_	0	root	_	_
7	the	_	DET	DT	_	9	det	_	_
8	plasma	_	NOUN	NN	_	9	compound	_	_
9	levels	_	NOUN	NNS	_	6	dobj	_	_
10	of	_	ADP	IN	_	15	case	_	_
11	HMG	_	NOUN	NN	_	15	compound	_	_
12	CoA	_	NOUN	NN	_	15	compound	_	_
13	reductase	_	NOUN	NN	_	15	compound	_	_
14	inhibitory	_	ADJ	JJ	_	15	amod	_	_
15	activity	_	NOUN	NN	_	9	nmod	_	_
16	and	_	CONJ	CC	_	6	cc	_	_
17	increase	_	VERB	VBP	_	6	conj	_	_
18	the	_	DET	DT	_	19	det	_	_
19	risk	_	NOUN	NN	_	17	dobj	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	myopathy	_	NOUN	NN	_	19	nmod	_	_

#	Lovastatin	5238
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	is	_	VERB	VBZ	_	4	cop	_	_
3	a	_	DET	DT	_	4	det	_	_
4	substrate	_	NOUN	NN	_	0	root	_	_
5	for	_	ADP	IN	_	8	case	_	_
6	cytochrome	_	NOUN	NN	_	8	compound	_	_
7	P450	_	NOUN	NN	_	8	compound	_	_
8	isoform3A4	_	NOUN	NN	_	4	nmod	_	_
9	CYP3A4	_	NOUN	NN	_	8	dep	_	_

#	Lovastatin	5239
1	Grapefruit	_	ADJ	JJ	_	2	amod	_	_
2	juice	_	NOUN	NN	_	3	nsubj	_	_
3	contains	_	VERB	VBZ	_	0	root	_	_
4	one	_	NUM	CD	_	7	nummod	_	_
5	or	_	CONJ	CC	_	4	cc	_	_
6	more	_	ADV	RB	_	4	conj	_	_
7	components	_	NOUN	NNS	_	3	dobj	_	_
8	that	_	DET	WDT	_	9	nsubj	_	_
9	inhibit	_	VERB	VBP	_	7	acl:relcl	_	_
10	CYP3A4	_	NOUN	NN	_	9	dobj	_	_
11	and	_	CONJ	CC	_	9	cc	_	_
12	can	_	VERB	MD	_	13	aux	_	_
13	increase	_	VERB	VB	_	9	conj	_	_
14	the	_	DET	DT	_	16	det	_	_
15	plasma	_	NOUN	NN	_	16	compound	_	_
16	concentrations	_	NOUN	NNS	_	13	dobj	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	drugs	_	NOUN	NNS	_	16	nmod	_	_
19	metabolized	_	VERB	VBN	_	18	acl	_	_
20	by	_	ADP	IN	_	21	case	_	_
21	CYP3A4	_	NOUN	NN	_	19	nmod	_	_

#	Lovastatin	5240
1	In	_	ADP	IN	_	4	case	_	_
2	one	_	NUM	CD	_	4	nummod	_	_
3	study	_	NOUN	NN	_	4	compound	_	_
4	Kantola	_	NOUN	NN	_	12	nmod	_	_
5	,	_	.	,	_	12	punct	_	_
6	T	_	NOUN	NN	_	12	nsubj	_	_
7	,	_	.	,	_	12	punct	_	_
8	et	_	ADP	IN	_	9	case	_	_
9	al	_	DET	DT	_	12	nmod	_	_
10	,	_	.	,	_	12	punct	_	_
11	Clin	_	NOUN	NN	_	12	compound	_	_
12	Pharmacol	_	NOUN	NN	_	0	root	_	_
13	Ther	_	ADP	IN	_	14	compound	_	_
14	1998	_	NUM	CD	_	12	nummod	_	_
15	63(4):397	_	NUM	CD	_	16	nummod	_	_
16	402	_	NUM	CD	_	14	conj	_	_

#	Lovastatin	5241
1	,	_	DET	DT	_	3	case	_	_
2	10	_	NUM	CD	_	3	nummod	_	_
3	subjects	_	NOUN	NNS	_	16	nsubjpass	_	_
4	consumed	_	VERB	VBD	_	3	acl	_	_
5	200mL	_	NOUN	NN	_	4	dobj	_	_
6	of	_	ADP	IN	_	10	case	_	_
7	double	_	ADJ	JJ	_	10	amod	_	_
8	strength	_	NOUN	NN	_	10	compound	_	_
9	grapefruit	_	NOUN	NN	_	10	compound	_	_
10	juice	_	NOUN	NN	_	5	nmod	_	_
11	one	_	NUM	CD	_	10	nummod	_	_
12	can	_	VERB	MD	_	16	aux	_	_
13	of	_	ADP	IN	_	15	case	_	_
14	frozen	_	NOUN	NN	_	15	compound	_	_
15	concentrate	_	NOUN	NN	_	16	nsubj	_	_
16	diluted	_	VERB	VBN	_	0	root	_	_
17	with	_	ADP	IN	_	22	case	_	_
18	one	_	NUM	CD	_	22	nummod	_	_
19	rather	_	CONJ	CC	_	18	cc	_	_
20	than	_	ADP	IN	_	19	mwe	_	_
21	3	_	NUM	CD	_	18	conj	_	_
22	cans	_	NOUN	NN	_	16	nmod	_	_
23	of	_	ADP	IN	_	26	case	_	_
24	water	_	NOUN	NN	_	26	compound	_	_
25	three	_	NUM	CD	_	26	nummod	_	_
26	times	_	NOUN	NNS	_	22	nmod	_	_
27	daily	_	ADV	RB	_	30	advmod	_	_
28	for	_	ADP	IN	_	30	case	_	_
29	2	_	NUM	CD	_	30	nummod	_	_
30	days	_	NOUN	NNS	_	16	nmod	_	_
31	and	_	CONJ	CC	_	30	cc	_	_
32	an	_	DET	DT	_	38	det	_	_
33	additional	_	ADJ	JJ	_	38	amod	_	_
34	200mL	_	ADJ	JJ	_	38	amod	_	_
35	double	_	ADJ	JJ	_	38	amod	_	_
36	strength	_	NOUN	NN	_	38	compound	_	_
37	grapefruit	_	NOUN	NN	_	38	compound	_	_
38	juice	_	NOUN	NN	_	30	conj	_	_
39	together	_	ADV	RB	_	38	advmod	_	_
40	with	_	ADP	IN	_	48	case	_	_
41	and	_	CONJ	CC	_	40	cc	_	_
42	30	_	NUM	CD	_	40	conj	_	_
43	and	_	CONJ	CC	_	40	cc	_	_
44	90minutes	_	NOUN	NNS	_	40	conj	_	_
45	following	_	ADP	IN	_	48	case	_	_
46	a	_	DET	DT	_	48	det	_	_
47	single	_	ADJ	JJ	_	48	amod	_	_
48	dose	_	NOUN	NN	_	16	nmod	_	_
49	of	_	ADP	IN	_	51	case	_	_
50	80mg	_	ADJ	JJ	_	51	amod	_	_
51	DRUG	_	NOUN	NN	_	48	nmod	_	_
52	on	_	ADP	IN	_	55	case	_	_
53	the	_	DET	DT	_	55	det	_	_
54	third	_	ADJ	JJ	_	55	amod	_	_
55	day	_	NOUN	NN	_	48	nmod	_	_

#	Lovastatin	5242
1	This	_	DET	DT	_	2	det	_	_
2	regimen	_	NOUN	NN	_	6	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	grapefruit	_	ADJ	JJ	_	5	amod	_	_
5	juice	_	NOUN	NN	_	2	nmod	_	_
6	resulted	_	VERB	VBD	_	0	root	_	_
7	in	_	ADP	IN	_	10	case	_	_
8	a	_	DET	DT	_	10	det	_	_
9	mean	_	ADJ	JJ	_	10	amod	_	_
10	increase	_	NOUN	NN	_	6	nmod	_	_
11	in	_	ADP	IN	_	14	case	_	_
12	the	_	DET	DT	_	14	det	_	_
13	serum	_	NOUN	NN	_	14	compound	_	_
14	concentration	_	NOUN	NN	_	10	nmod	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	14	nmod	_	_
17	and	_	CONJ	CC	_	14	cc	_	_
18	its	_	PRON	PRP$	_	21	nmod:poss	_	_
19	B	_	NOUN	NN	_	21	compound	_	_
20	hydroxyacid	_	NOUN	NN	_	21	compound	_	_
21	metabolite	_	NOUN	NN	_	14	conj	_	_
22	as	_	ADP	IN	_	23	mark	_	_
23	measured	_	VERB	VBN	_	6	advcl	_	_
24	by	_	ADP	IN	_	26	case	_	_
25	the	_	DET	DT	_	26	det	_	_
26	area	_	NOUN	NN	_	23	nmod	_	_
27	under	_	ADP	IN	_	31	case	_	_
28	the	_	DET	DT	_	31	det	_	_
29	concentration	_	NOUN	NN	_	31	compound	_	_
30	time	_	NOUN	NN	_	31	compound	_	_
31	curve	_	NOUN	NN	_	23	nmod	_	_
32	of	_	ADP	IN	_	34	case	_	_
33	15	_	NUM	CD	_	34	nummod	_	_
34	fold	_	NOUN	NN	_	31	nmod	_	_
35	and	_	CONJ	CC	_	34	cc	_	_
36	5	_	NUM	CD	_	37	nummod	_	_
37	fold	_	NOUN	NN	_	34	conj	_	_
38	,	_	.	,	_	6	punct	_	_
39	respectively	_	ADV	RB	_	41	advmod	_	_
40	as	_	ADP	IN	_	41	mark	_	_
41	measured	_	VERB	VBN	_	6	advcl	_	_
42	using	_	VERB	VBG	_	41	xcomp	_	_
43	a	_	DET	DT	_	47	det	_	_
44	chemical	_	ADJ	JJ	_	47	amod	_	_
45	assay	_	NOUN	NN	_	47	compound	_	_
46	high	_	ADJ	JJ	_	47	amod	_	_
47	performance	_	NOUN	NN	_	42	dobj	_	_
48	liquid	_	ADJ	JJ	_	49	amod	_	_
49	chromatography	_	NOUN	NN	_	47	dep	_	_

#	Lovastatin	5243
1	In	_	ADP	IN	_	4	case	_	_
2	a	_	DET	DT	_	4	det	_	_
3	second	_	ADJ	JJ	_	4	amod	_	_
4	study	_	NOUN	NN	_	8	nmod	_	_
5	,	_	.	,	_	8	punct	_	_
6	15	_	NUM	CD	_	7	nummod	_	_
7	subjects	_	NOUN	NNS	_	8	nsubj	_	_
8	consumed	_	VERB	VBD	_	0	root	_	_
9	one	_	NUM	CD	_	11	nummod	_	_
10	8oz	_	ADJ	JJ	_	11	amod	_	_
11	glass	_	NOUN	NN	_	8	dobj	_	_
12	of	_	ADP	IN	_	16	case	_	_
13	single	_	ADJ	JJ	_	16	amod	_	_
14	strength	_	NOUN	NN	_	16	compound	_	_
15	grapefruit	_	NOUN	NN	_	16	compound	_	_
16	juice	_	NOUN	NN	_	11	nmod	_	_
17	one	_	NUM	CD	_	16	nummod	_	_
18	can	_	VERB	MD	_	8	parataxis	_	_
19	of	_	ADP	IN	_	21	case	_	_
20	frozen	_	NOUN	NN	_	21	compound	_	_
21	concentrate	_	NOUN	NN	_	18	nmod	_	_
22	diluted	_	VERB	VBN	_	21	acl	_	_
23	with	_	ADP	IN	_	24	case	_	_
24	3cans	_	NOUN	NN	_	22	nmod	_	_
25	of	_	ADP	IN	_	26	case	_	_
26	water	_	NOUN	NN	_	24	nmod	_	_
27	with	_	ADP	IN	_	28	case	_	_
28	breakfast	_	NOUN	NN	_	24	nmod	_	_
29	for	_	ADP	IN	_	32	case	_	_
30	3	_	NUM	CD	_	32	nummod	_	_
31	consecutive	_	ADJ	JJ	_	32	amod	_	_
32	days	_	NOUN	NNS	_	28	nmod	_	_
33	and	_	CONJ	CC	_	21	cc	_	_
34	a	_	DET	DT	_	36	det	_	_
35	single	_	ADJ	JJ	_	36	amod	_	_
36	dose	_	NOUN	NN	_	21	conj	_	_
37	of	_	ADP	IN	_	39	case	_	_
38	40mg	_	ADJ	JJ	_	39	amod	_	_
39	DRUG	_	NOUN	NN	_	36	nmod	_	_
40	in	_	ADP	IN	_	42	case	_	_
41	the	_	DET	DT	_	42	det	_	_
42	evening	_	NOUN	NN	_	36	nmod	_	_
43	of	_	ADP	IN	_	46	case	_	_
44	the	_	DET	DT	_	46	det	_	_
45	third	_	ADJ	JJ	_	46	amod	_	_
46	day	_	NOUN	NN	_	42	nmod	_	_

#	Lovastatin	5244
1	This	_	DET	DT	_	2	det	_	_
2	regimen	_	NOUN	NN	_	6	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	grapefruit	_	ADJ	JJ	_	5	amod	_	_
5	juice	_	NOUN	NN	_	2	nmod	_	_
6	resulted	_	VERB	VBD	_	0	root	_	_
7	in	_	ADP	IN	_	10	case	_	_
8	a	_	DET	DT	_	10	det	_	_
9	mean	_	ADJ	JJ	_	10	amod	_	_
10	increase	_	NOUN	NN	_	6	nmod	_	_
11	in	_	ADP	IN	_	14	case	_	_
12	the	_	DET	DT	_	14	det	_	_
13	plasma	_	NOUN	NN	_	14	compound	_	_
14	concentration	_	NOUN	NN	_	10	nmod	_	_
15	as	_	ADP	IN	_	16	mark	_	_
16	measured	_	VERB	VBN	_	6	advcl	_	_
17	by	_	ADP	IN	_	19	case	_	_
18	the	_	DET	DT	_	19	det	_	_
19	area	_	NOUN	NN	_	16	nmod	_	_
20	under	_	ADP	IN	_	24	case	_	_
21	the	_	DET	DT	_	24	det	_	_
22	concentration	_	NOUN	NN	_	24	compound	_	_
23	time	_	NOUN	NN	_	24	compound	_	_
24	curve	_	NOUN	NN	_	16	nmod	_	_
25	of	_	ADP	IN	_	33	case	_	_
26	active	_	ADJ	JJ	_	33	amod	_	_
27	and	_	CONJ	CC	_	26	cc	_	_
28	total	_	ADJ	JJ	_	26	conj	_	_
29	HMG	_	NOUN	NN	_	33	compound	_	_
30	CoA	_	NOUN	NN	_	33	compound	_	_
31	reductase	_	NOUN	NN	_	33	compound	_	_
32	inhibitory	_	ADJ	JJ	_	33	amod	_	_
33	activity	_	NOUN	NN	_	24	nmod	_	_
34	using	_	VERB	VBG	_	16	xcomp	_	_
35	an	_	DET	DT	_	38	det	_	_
36	enzyme	_	NOUN	NN	_	38	compound	_	_
37	inhibition	_	NOUN	NN	_	38	compound	_	_
38	assay	_	NOUN	NN	_	34	dobj	_	_
39	both	_	CONJ	CC	_	43	cc:preconj	_	_
40	before	_	ADP	IN	_	43	case	_	_
41	for	_	ADP	IN	_	43	case	_	_
42	active	_	ADJ	JJ	_	43	amod	_	_
43	inhibitors	_	NOUN	NNS	_	34	nmod	_	_
44	and	_	CONJ	CC	_	43	cc	_	_
45	after	_	ADP	IN	_	48	case	_	_
46	for	_	ADP	IN	_	48	case	_	_
47	total	_	ADJ	JJ	_	48	amod	_	_
48	inhibitors	_	NOUN	NNS	_	43	conj	_	_
49	base	_	NOUN	NN	_	50	compound	_	_
50	hydrolysis	_	NOUN	NN	_	48	dep	_	_
51	of	_	ADP	IN	_	53	case	_	_
52	1.34	_	NUM	CD	_	53	nummod	_	_
53	fold	_	NOUN	NN	_	50	nmod	_	_
54	and	_	CONJ	CC	_	53	cc	_	_
55	1.36	_	NUM	CD	_	56	nummod	_	_
56	fold	_	NOUN	NN	_	53	conj	_	_
57	,	_	.	,	_	50	punct	_	_
58	respectively	_	ADV	RB	_	50	advmod	_	_
59	,	_	.	,	_	50	punct	_	_
60	and	_	CONJ	CC	_	50	cc	_	_
61	of	_	ADP	IN	_	62	case	_	_
62	DRUG	_	NOUN	NN	_	50	conj	_	_
63	and	_	CONJ	CC	_	62	cc	_	_
64	its	_	PRON	PRP$	_	67	nmod:poss	_	_
65	B	_	NOUN	NN	_	67	compound	_	_
66	hydroxyacid	_	NOUN	NN	_	67	compound	_	_
67	metabolite	_	NOUN	NN	_	62	conj	_	_
68	measured	_	VERB	VBN	_	62	acl	_	_
69	using	_	VERB	VBG	_	50	acl	_	_
70	a	_	DET	DT	_	74	det	_	_
71	chemical	_	ADJ	JJ	_	74	amod	_	_
72	assay	_	NOUN	NN	_	74	compound	_	_
73	liquid	_	ADJ	JJ	_	74	amod	_	_
74	chromatography	_	NOUN	NN	_	69	dobj	_	_
75	/	_	.	:	_	50	punct	_	_
76	tandem	_	ADJ	JJ	_	78	amod	_	_
77	mass	_	NOUN	NN	_	78	compound	_	_
78	spectrometry	_	NOUN	NN	_	50	dep	_	_
79	different	_	ADJ	JJ	_	78	amod	_	_
80	from	_	ADP	IN	_	81	case	_	_
81	that	_	DET	WDT	_	79	nmod	_	_
82	used	_	VERB	VBN	_	81	acl	_	_
83	in	_	ADP	IN	_	86	case	_	_
84	the	_	DET	DT	_	86	det	_	_
85	first	_	ADJ	JJ	_	86	amod	_	_
86	study	_	NOUN	NN	_	82	nmod	_	_
87	of	_	ADP	IN	_	89	case	_	_
88	1.94	_	NUM	CD	_	89	nummod	_	_
89	fold	_	NOUN	NN	_	86	nmod	_	_
90	and	_	CONJ	CC	_	89	cc	_	_
91	1.57	_	NUM	CD	_	92	nummod	_	_
92	fold	_	NOUN	NN	_	89	conj	_	_
93	,	_	.	,	_	78	punct	_	_
94	respectively	_	ADV	RB	_	78	advmod	_	_

#	Lovastatin	5245
1	The	_	DET	DT	_	2	det	_	_
2	effect	_	NOUN	NN	_	21	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	amounts	_	NOUN	NNS	_	2	nmod	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	grapefruit	_	ADJ	JJ	_	7	amod	_	_
7	juice	_	NOUN	NN	_	4	nmod	_	_
8	between	_	ADP	IN	_	9	case	_	_
9	those	_	DET	DT	_	2	nmod	_	_
10	used	_	VERB	VBN	_	9	acl	_	_
11	in	_	ADP	IN	_	14	case	_	_
12	these	_	DET	DT	_	14	det	_	_
13	two	_	NUM	CD	_	14	nummod	_	_
14	studies	_	NOUN	NNS	_	10	nmod	_	_
15	on	_	ADP	IN	_	17	case	_	_
16	DRUG	_	NOUN	NN	_	17	compound	_	_
17	pharmacokinetics	_	NOUN	NNS	_	14	nmod	_	_
18	has	_	VERB	VBZ	_	21	aux	_	_
19	not	_	ADV	RB	_	21	neg	_	_
20	been	_	VERB	VBN	_	21	auxpass	_	_
21	studied	_	VERB	VBN	_	0	root	_	_

#	Lovastatin	5246
1	TABLE	_	NOUN	NN	_	0	root	_	_
2	I	_	NUM	CD	_	1	nummod	_	_
3	:	_	.	:	_	1	punct	_	_
4	The	_	DET	DT	_	5	det	_	_
5	Effect	_	NOUN	NN	_	1	dep	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	Other	_	ADJ	JJ	_	8	amod	_	_
8	Drugs	_	NOUN	NNS	_	5	nmod	_	_
9	on	_	ADP	IN	_	11	case	_	_
10	DRUG	_	NOUN	NN	_	11	compound	_	_
11	Exposure	_	NOUN	NN	_	5	nmod	_	_
12	When	_	ADV	WRB	_	14	advmod	_	_
13	Both	_	CONJ	CC	_	14	cc:preconj	_	_
14	Were	_	VERB	VBP	_	5	dep	_	_
15	Co	_	NOUN	NN	_	17	compound	_	_
16	administered	_	VERB	VBN	_	17	amod	_	_
17	Number	_	NOUN	NN	_	14	dobj	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	Subjects	_	NOUN	NNS	_	17	nmod	_	_
20	Dosing	_	NOUN	NN	_	19	acl	_	_
21	of	_	ADP	IN	_	23	case	_	_
22	Coadministered	_	ADJ	JJ	_	23	amod	_	_
23	Drug	_	NOUN	NN	_	20	nmod	_	_
24	or	_	CONJ	CC	_	23	cc	_	_
25	Grapefruit	_	ADJ	JJ	_	26	compound	_	_
26	Juice	_	NOUN	NN	_	23	conj	_	_
27	Dosing	_	NOUN	NN	_	23	dep	_	_
28	of	_	ADP	IN	_	31	case	_	_
29	DRUG	_	NOUN	NN	_	31	compound	_	_
30	AUC	_	NOUN	NN	_	31	compound	_	_
31	RatioResults	_	NOUN	NNS	_	23	nmod	_	_
32	based	_	VERB	VBN	_	31	acl	_	_
33	on	_	ADP	IN	_	36	case	_	_
34	a	_	DET	DT	_	36	det	_	_
35	chemical	_	ADJ	JJ	_	36	amod	_	_
36	assay	_	NOUN	NN	_	32	nmod	_	_

#	Lovastatin	5247
1	with	_	ADP	IN	_	14	mark	_	_
2	/	_	NUM	CD	_	14	punct	_	_
3	without	_	ADP	IN	_	6	case	_	_
4	coadministered	_	VERB	VBN	_	6	amod	_	_
5	drug)No	_	ADJ	JJ	_	6	amod	_	_
6	Effect	_	NOUN	NN	_	14	nmod	_	_
7	=	_	ADJ	JJ	_	13	amod	_	_
8	1.00	_	NUM	CD	_	13	nummod	_	_
9	DRUG	_	NOUN	NN	_	13	compound	_	_
10	DRUG	_	NOUN	NN	_	13	compound	_	_
11	acid	_	NOUN	NN	_	13	compound	_	_
12	DRUG	_	NOUN	NN	_	13	compound	_	_
13	acid	_	NOUN	NN	_	14	nsubj	_	_
14	refers	_	VERB	VBZ	_	0	root	_	_
15	to	_	PRT	TO	_	18	case	_	_
16	the	_	DET	DT	_	18	det	_	_
17	B	_	NOUN	NN	_	18	compound	_	_
18	hydroxyacid	_	NOUN	NN	_	14	nmod	_	_
19	of	_	ADP	IN	_	20	case	_	_
20	DRUG	_	NOUN	NN	_	18	nmod	_	_

#	Lovastatin	5248
1	Gemfibrozil	_	NOUN	NN	_	5	compound	_	_
2	11	_	NUM	CD	_	5	nummod	_	_
3	600	_	NUM	CD	_	5	nummod	_	_
4	mg	_	NOUN	NN	_	5	compound	_	_
5	BID	_	NOUN	NN	_	25	nsubjpass	_	_
6	for	_	ADP	IN	_	8	case	_	_
7	3	_	NUM	CD	_	8	nummod	_	_
8	days	_	NOUN	NNS	_	5	nmod	_	_
9	40	_	NUM	CD	_	16	nummod	_	_
10	mg	_	NOUN	NN	_	16	compound	_	_
11	0.96	_	NUM	CD	_	16	nummod	_	_
12	2.80	_	NUM	CD	_	16	nummod	_	_
13	ItraconazoleThe	_	NOUN	NN	_	16	compound	_	_
14	mean	_	NOUN	NN	_	16	compound	_	_
15	total	_	ADJ	JJ	_	16	amod	_	_
16	AUC	_	NOUN	NN	_	8	dep	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	DRUG	_	NOUN	NN	_	16	nmod	_	_
19	without	_	ADP	IN	_	21	case	_	_
20	itraconazole	_	NOUN	NN	_	21	compound	_	_
21	phase	_	NOUN	NN	_	5	nmod	_	_
22	could	_	VERB	MD	_	25	aux	_	_
23	not	_	ADV	RB	_	25	neg	_	_
24	be	_	VERB	VB	_	25	auxpass	_	_
25	determined	_	VERB	VBN	_	0	root	_	_
26	accurately	_	ADV	RB	_	25	advmod	_	_

#	Lovastatin	5249
1	Results	_	NOUN	NNS	_	4	nsubj	_	_
2	could	_	VERB	MD	_	4	aux	_	_
3	be	_	VERB	VB	_	4	cop	_	_
4	representative	_	ADJ	JJ	_	0	root	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	strong	_	ADJ	JJ	_	8	amod	_	_
7	CYP3A4	_	NOUN	NN	_	8	compound	_	_
8	inhibitors	_	NOUN	NNS	_	4	nmod	_	_
9	such	_	ADJ	JJ	_	11	case	_	_
10	as	_	ADP	IN	_	9	mwe	_	_
11	ketoconazole	_	NOUN	NN	_	8	nmod	_	_
12	,	_	.	,	_	11	punct	_	_
13	posaconazole	_	NOUN	NN	_	11	conj	_	_
14	,	_	.	,	_	11	punct	_	_
15	clarithromycin	_	NOUN	NN	_	11	conj	_	_
16	,	_	.	,	_	11	punct	_	_
17	telithromycin	_	NOUN	NN	_	11	conj	_	_
18	,	_	.	,	_	11	punct	_	_
19	HIV	_	NOUN	NN	_	21	compound	_	_
20	protease	_	NOUN	NN	_	21	compound	_	_
21	inhibitors	_	NOUN	NNS	_	11	conj	_	_
22	,	_	.	,	_	11	punct	_	_
23	and	_	CONJ	CC	_	11	cc	_	_
24	nefazodone	_	NOUN	NN	_	11	conj	_	_

#	Lovastatin	5250
1	12	_	NUM	CD	_	4	nummod	_	_
2	200	_	NUM	CD	_	4	nummod	_	_
3	mg	_	NOUN	NN	_	4	amod	_	_
4	QD	_	NOUN	NN	_	0	root	_	_
5	for	_	ADP	IN	_	7	case	_	_
6	4	_	NUM	CD	_	7	nummod	_	_
7	days	_	NOUN	NNS	_	4	nmod	_	_
8	40	_	NUM	CD	_	9	nummod	_	_
9	mg	_	NOUN	NN	_	7	dep	_	_
10	on	_	ADP	IN	_	16	case	_	_
11	Day	_	NOUN	NN	_	16	compound	_	_
12	4	_	NUM	CD	_	16	nummod	_	_
13	>	_	NUM	CD	_	16	nummod	_	_
14	36Estimated	_	ADJ	JJ	_	16	amod	_	_
15	minimum	_	ADJ	JJ	_	16	amod	_	_
16	change	_	NOUN	NN	_	4	nmod	_	_

#	Lovastatin	5251
1	22	_	NUM	CD	_	5	nummod	_	_
2	10	_	NUM	CD	_	5	nummod	_	_
3	100	_	NUM	CD	_	5	nummod	_	_
4	mg	_	NOUN	NN	_	5	amod	_	_
5	QD	_	NOUN	NN	_	38	nsubjpass	_	_
6	for	_	ADP	IN	_	8	case	_	_
7	4	_	NUM	CD	_	8	nummod	_	_
8	days	_	NOUN	NNS	_	5	nmod	_	_
9	40	_	NUM	CD	_	10	nummod	_	_
10	mg	_	NOUN	NN	_	8	dep	_	_
11	on	_	ADP	IN	_	19	case	_	_
12	Day	_	NOUN	NN	_	19	compound	_	_
13	4	_	NUM	CD	_	19	nummod	_	_
14	>	_	NUM	CD	_	19	nummod	_	_
15	14.8	_	NUM	CD	_	19	nummod	_	_
16	15.4	_	NUM	CD	_	19	nummod	_	_
17	Grapefruit	_	NOUN	NN	_	19	amod	_	_
18	JuiceThe	_	NOUN	NN	_	19	amod	_	_
19	effect	_	NOUN	NN	_	5	nmod	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	amounts	_	NOUN	NNS	_	19	nmod	_	_
22	of	_	ADP	IN	_	24	case	_	_
23	grapefruit	_	ADJ	JJ	_	24	amod	_	_
24	juice	_	NOUN	NN	_	21	nmod	_	_
25	between	_	ADP	IN	_	26	case	_	_
26	those	_	DET	DT	_	21	nmod	_	_
27	used	_	VERB	VBN	_	26	acl	_	_
28	in	_	ADP	IN	_	31	case	_	_
29	these	_	DET	DT	_	31	det	_	_
30	two	_	NUM	CD	_	31	nummod	_	_
31	studies	_	NOUN	NNS	_	27	nmod	_	_
32	on	_	ADP	IN	_	34	case	_	_
33	DRUG	_	NOUN	NN	_	34	compound	_	_
34	pharmacokinetics	_	NOUN	NNS	_	31	nmod	_	_
35	has	_	VERB	VBZ	_	38	aux	_	_
36	not	_	ADV	RB	_	38	neg	_	_
37	been	_	VERB	VBN	_	38	auxpass	_	_
38	studied	_	VERB	VBN	_	0	root	_	_

#	Lovastatin	5252
1	high	_	ADP	IN	_	0	root	_	_
2	dose	_	NOUN	NN	_	5	compound	_	_
3	10	_	NUM	CD	_	5	nummod	_	_
4	200	_	NUM	CD	_	5	nummod	_	_
5	mL	_	NOUN	NN	_	1	root	_	_
6	of	_	ADP	IN	_	10	case	_	_
7	double	_	ADJ	JJ	_	10	amod	_	_
8	strength	_	NOUN	NN	_	10	compound	_	_
9	TIDDouble	_	ADJ	JJ	_	10	amod	_	_
10	strength	_	NOUN	NN	_	5	nmod	_	_
11	:	_	.	:	_	5	punct	_	_
12	one	_	NUM	CD	_	5	dep	_	_
13	can	_	VERB	MD	_	12	dep	_	_
14	of	_	ADP	IN	_	16	case	_	_
15	frozen	_	NOUN	NN	_	16	compound	_	_
16	concentrate	_	NOUN	NN	_	13	nmod	_	_
17	diluted	_	VERB	VBN	_	16	acl	_	_
18	with	_	ADP	IN	_	20	case	_	_
19	one	_	NUM	CD	_	20	nummod	_	_
20	can	_	VERB	MD	_	17	nmod	_	_
21	of	_	ADP	IN	_	22	case	_	_
22	water	_	NOUN	NN	_	20	nmod	_	_

#	Lovastatin	5253
1	Grapefruit	_	ADJ	JJ	_	2	amod	_	_
2	juice	_	NOUN	NN	_	4	nsubjpass	_	_
3	was	_	VERB	VBD	_	4	auxpass	_	_
4	administered	_	VERB	VBN	_	0	root	_	_
5	TID	_	NOUN	NN	_	4	dobj	_	_
6	for	_	ADP	IN	_	8	case	_	_
7	2	_	NUM	CD	_	8	nummod	_	_
8	days	_	NOUN	NNS	_	5	nmod	_	_
9	,	_	.	,	_	5	punct	_	_
10	and	_	CONJ	CC	_	5	cc	_	_
11	200	_	NUM	CD	_	12	nummod	_	_
12	mL	_	NOUN	NN	_	5	conj	_	_
13	together	_	ADV	RB	_	12	advmod	_	_
14	with	_	ADP	IN	_	17	case	_	_
15	single	_	ADJ	JJ	_	17	amod	_	_
16	dose	_	NOUN	NN	_	17	compound	_	_
17	DRUG	_	NOUN	NN	_	4	nmod	_	_
18	and	_	CONJ	CC	_	17	cc	_	_
19	30	_	NUM	CD	_	22	nummod	_	_
20	and	_	CONJ	CC	_	19	cc	_	_
21	90	_	NUM	CD	_	19	conj	_	_
22	minutes	_	NOUN	NNS	_	17	conj	_	_
23	following	_	VERB	VBG	_	26	case	_	_
24	single	_	ADJ	JJ	_	26	amod	_	_
25	dose	_	NOUN	NN	_	26	compound	_	_
26	DRUG	_	NOUN	NN	_	17	nmod	_	_
27	on	_	ADP	IN	_	28	case	_	_
28	Day	_	NOUN	NN	_	17	nmod	_	_
29	3	_	NUM	CD	_	28	nummod	_	_

#	Lovastatin	5254
1	80	_	NUM	CD	_	10	nummod	_	_
2	mg	_	NOUN	NN	_	10	compound	_	_
3	single	_	ADJ	JJ	_	10	amod	_	_
4	dose	_	NOUN	NN	_	10	compound	_	_
5	15.3	_	NUM	CD	_	10	nummod	_	_
6	5.0	_	NUM	CD	_	10	nummod	_	_
7	Grapefruit	_	NOUN	NN	_	10	amod	_	_
8	Juice	_	NOUN	NN	_	10	compound	_	_
9	low	_	ADJ	JJ	_	10	amod	_	_
10	dose	_	NOUN	NN	_	0	root	_	_
11	16	_	NUM	CD	_	12	nummod	_	_
12	8	_	NUM	CD	_	16	nummod	_	_
13	oz	_	CONJ	CC	_	12	cc	_	_
14	about	_	ADV	RB	_	15	advmod	_	_
15	250	_	NUM	CD	_	12	conj	_	_
16	mL	_	NOUN	NN	_	10	dep	_	_
17	of	_	ADP	IN	_	20	case	_	_
18	single	_	ADJ	JJ	_	20	amod	_	_
19	strengthSingle	_	ADJ	JJ	_	20	amod	_	_
20	strength	_	NOUN	NN	_	10	nmod	_	_
21	:	_	.	:	_	10	punct	_	_
22	one	_	NUM	CD	_	10	dep	_	_
23	can	_	VERB	MD	_	22	dep	_	_
24	of	_	ADP	IN	_	26	case	_	_
25	frozen	_	NOUN	NN	_	26	compound	_	_
26	concentrate	_	NOUN	NN	_	23	nmod	_	_
27	diluted	_	VERB	VBN	_	26	acl	_	_
28	with	_	ADP	IN	_	30	case	_	_
29	3	_	NUM	CD	_	30	nummod	_	_
30	cans	_	NOUN	NN	_	27	nmod	_	_
31	of	_	ADP	IN	_	32	case	_	_
32	water	_	NOUN	NN	_	30	nmod	_	_

#	Lovastatin	5255
1	Grapefruit	_	ADJ	JJ	_	2	amod	_	_
2	juice	_	NOUN	NN	_	4	nsubjpass	_	_
3	was	_	VERB	VBD	_	4	auxpass	_	_
4	administered	_	VERB	VBN	_	0	root	_	_
5	with	_	ADP	IN	_	6	case	_	_
6	breakfast	_	NOUN	NN	_	4	nmod	_	_
7	for	_	ADP	IN	_	9	case	_	_
8	3	_	NUM	CD	_	9	nummod	_	_
9	days	_	NOUN	NNS	_	6	nmod	_	_
10	,	_	.	,	_	4	punct	_	_
11	and	_	CONJ	CC	_	4	cc	_	_
12	DRUG	_	NOUN	NN	_	14	nsubjpass	_	_
13	was	_	VERB	VBD	_	14	auxpass	_	_
14	administered	_	VERB	VBN	_	4	conj	_	_
15	in	_	ADP	IN	_	17	case	_	_
16	the	_	DET	DT	_	17	det	_	_
17	evening	_	NOUN	NN	_	14	nmod	_	_
18	on	_	ADP	IN	_	19	case	_	_
19	Day	_	NOUN	NN	_	17	nmod	_	_
20	3	_	NUM	CD	_	19	nummod	_	_
21	for	_	ADP	IN	_	23	case	_	_
22	4	_	NUM	CD	_	23	nummod	_	_
23	days	_	NOUN	NNS	_	17	nmod	_	_
24	40	_	NUM	CD	_	35	nummod	_	_
25	mg	_	NOUN	NN	_	35	amod	_	_
26	single	_	ADJ	JJ	_	35	amod	_	_
27	dose	_	NOUN	NN	_	35	compound	_	_
28	1.94	_	NUM	CD	_	35	nummod	_	_
29	1.57	_	NUM	CD	_	35	nummod	_	_
30	Cyclosporine	_	NOUN	NN	_	35	compound	_	_
31	16	_	NUM	CD	_	35	nummod	_	_
32	Not	_	ADV	RB	_	31	cc	_	_
33	describedCyclosporine	_	NOUN	NN	_	31	conj	_	_
34	treated	_	VERB	VBN	_	35	amod	_	_
35	patients	_	NOUN	NNS	_	23	dep	_	_
36	with	_	ADP	IN	_	37	case	_	_
37	psoriasis	_	NOUN	NN	_	35	nmod	_	_
38	or	_	CONJ	CC	_	37	cc	_	_
39	post	_	ADJ	JJ	_	40	amod	_	_
40	kidney	_	NOUN	NN	_	37	conj	_	_
41	or	_	CONJ	CC	_	37	cc	_	_
42	heart	_	NOUN	NN	_	44	compound	_	_
43	transplant	_	ADJ	JJ	_	44	amod	_	_
44	patients	_	NOUN	NNS	_	37	conj	_	_
45	with	_	ADP	IN	_	48	case	_	_
46	stable	_	ADJ	JJ	_	48	amod	_	_
47	graft	_	NOUN	NN	_	48	compound	_	_
48	function	_	NOUN	NN	_	35	nmod	_	_
49	,	_	.	,	_	4	punct	_	_
50	transplanted	_	VERB	VBN	_	4	xcomp	_	_
51	at	_	ADP	IN	_	52	case	_	_
52	least	_	ADJ	JJS	_	53	nmod:npmod	_	_
53	9	_	NUM	CD	_	54	nummod	_	_
54	months	_	NOUN	NNS	_	50	nmod	_	_
55	prior	_	ADJ	JJ	_	57	case	_	_
56	to	_	PRT	TO	_	55	mwe	_	_
57	study	_	NOUN	NN	_	54	nmod	_	_

#	Lovastatin	5256
1	10	_	NUM	CD	_	3	nummod	_	_
2	mg	_	NOUN	NN	_	3	compound	_	_
3	QD	_	NOUN	NN	_	0	root	_	_
4	for	_	ADP	IN	_	6	case	_	_
5	10	_	NUM	CD	_	6	nummod	_	_
6	days	_	NOUN	NNS	_	3	nmod	_	_
7	5	_	NUM	CD	_	6	nummod	_	_
8	to	_	PRT	TO	_	11	case	_	_
9	8	_	NUM	CD	_	11	nummod	_	_
10	fold	_	NOUN	NN	_	11	compound	_	_
11	NDND	_	NOUN	NN	_	3	nmod	_	_
12	=	_	CONJ	CC	_	3	punct	_	_
13	Analyte	_	NOUN	NN	_	15	nsubj	_	_
14	not	_	ADV	RB	_	15	neg	_	_
15	determined	_	VERB	VBN	_	12	dep	_	_

#	Lovastatin	5257
1	Number	_	NOUN	NN	_	0	root	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	Subjects	_	NOUN	NNS	_	1	nmod	_	_
4	Dosing	_	NOUN	NN	_	3	acl	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	Coadministered	_	ADJ	JJ	_	7	amod	_	_
7	Drug	_	NOUN	NN	_	4	nmod	_	_
8	or	_	CONJ	CC	_	7	cc	_	_
9	Grapefruit	_	NOUN	NN	_	10	compound	_	_
10	Juice	_	NOUN	NN	_	7	conj	_	_
11	Dosing	_	NOUN	NN	_	7	dep	_	_
12	of	_	ADP	IN	_	15	case	_	_
13	DRUG	_	NOUN	NN	_	15	compound	_	_
14	AUC	_	NOUN	NN	_	15	compound	_	_
15	Ratio	_	NOUN	NN	_	7	nmod	_	_
16	with	_	ADP	IN	_	17	case	_	_
17	/	_	.	-LRB-	_	15	nmod	_	_
18	without	_	ADP	IN	_	21	case	_	_
19	coadministered	_	VERB	VBN	_	21	amod	_	_
20	drug)No	_	ADJ	JJ	_	21	amod	_	_
21	Effect	_	NOUN	NN	_	17	nmod	_	_
22	=	_	ADJ	JJ	_	21	amod	_	_
23	1.00	_	NUM	CD	_	26	nummod	_	_
24	Total	_	ADJ	JJ	_	26	amod	_	_
25	DRUG	_	NOUN	NN	_	26	compound	_	_
26	acidLactone	_	NOUN	NN	_	22	dobj	_	_
27	converted	_	VERB	VBN	_	26	acl	_	_
28	to	_	PRT	TO	_	29	case	_	_
29	acid	_	NOUN	NN	_	27	nmod	_	_
30	by	_	ADP	IN	_	31	case	_	_
31	hydrolysis	_	NOUN	NN	_	27	nmod	_	_
32	prior	_	ADJ	JJ	_	31	amod	_	_
33	to	_	PRT	TO	_	34	case	_	_
34	analysis	_	NOUN	NN	_	32	nmod	_	_

#	Lovastatin	5258
1	Figure	_	NOUN	NN	_	2	nsubj	_	_
2	represents	_	VERB	VBZ	_	0	root	_	_
3	total	_	ADJ	JJ	_	5	amod	_	_
4	unmetabolized	_	ADJ	JJ	_	5	amod	_	_
5	acid	_	NOUN	NN	_	2	dobj	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	lactone	_	NOUN	NN	_	5	conj	_	_

#	Lovastatin	5259
1	Diltiazem	_	NOUN	NN	_	5	compound	_	_
2	10	_	NUM	CD	_	5	nummod	_	_
3	120	_	NUM	CD	_	5	nummod	_	_
4	mg	_	NOUN	NN	_	5	compound	_	_
5	BID	_	NOUN	NN	_	15	nsubjpass	_	_
6	for	_	ADP	IN	_	8	case	_	_
7	14	_	NUM	CD	_	8	nummod	_	_
8	days	_	NOUN	NNS	_	5	nmod	_	_
9	20	_	NUM	CD	_	12	nummod	_	_
10	mg	_	NOUN	NN	_	12	compound	_	_
11	3.57	_	NUM	CD	_	12	nummod	_	_
12	MEVACOR	_	NOUN	NN	_	8	dep	_	_
13	has	_	VERB	VBZ	_	15	aux	_	_
14	been	_	VERB	VBN	_	15	auxpass	_	_
15	shown	_	VERB	VBN	_	0	root	_	_
16	to	_	PRT	TO	_	17	mark	_	_
17	reduce	_	VERB	VB	_	15	xcomp	_	_
18	total	_	ADJ	JJ	_	19	amod	_	_
19	C	_	NOUN	NN	_	17	dobj	_	_
20	and	_	CONJ	CC	_	19	cc	_	_
21	LDL	_	NOUN	NN	_	22	compound	_	_
22	C	_	NOUN	NN	_	19	conj	_	_
23	in	_	ADP	IN	_	25	case	_	_
24	heterozygous	_	ADJ	JJ	_	25	amod	_	_
25	familial	_	ADJ	JJ	_	17	nmod	_	_
26	and	_	CONJ	CC	_	25	cc	_	_
27	non	_	ADJ	JJ	_	25	conj	_	_
28	familial	_	ADJ	JJ	_	29	amod	_	_
29	forms	_	NOUN	NNS	_	25	dep	_	_
30	of	_	ADP	IN	_	32	case	_	_
31	primary	_	ADJ	JJ	_	32	amod	_	_
32	hypercholesterolemia	_	NOUN	NN	_	25	nmod	_	_
33	and	_	CONJ	CC	_	32	cc	_	_
34	in	_	ADP	IN	_	36	case	_	_
35	mixed	_	VERB	VBN	_	36	amod	_	_
36	hyperlipidemia	_	NOUN	NN	_	32	conj	_	_

#	Lovastatin	5260
1	A	_	DET	DT	_	3	det	_	_
2	marked	_	ADJ	JJ	_	3	amod	_	_
3	response	_	NOUN	NN	_	5	nsubjpass	_	_
4	was	_	VERB	VBD	_	5	auxpass	_	_
5	seen	_	VERB	VBN	_	0	root	_	_
6	within	_	ADP	IN	_	7	case	_	_
7	2weeks	_	NOUN	NNS	_	5	nmod	_	_
8	,	_	.	,	_	5	punct	_	_
9	and	_	CONJ	CC	_	5	cc	_	_
10	the	_	DET	DT	_	13	det	_	_
11	maximum	_	ADJ	JJ	_	13	amod	_	_
12	therapeutic	_	ADJ	JJ	_	13	amod	_	_
13	response	_	NOUN	NN	_	14	nsubj	_	_
14	occurred	_	VERB	VBN	_	5	conj	_	_
15	within	_	ADP	IN	_	17	case	_	_
16	4	_	NUM	CD	_	17	nummod	_	_
17	6weeks	_	NOUN	NNS	_	14	nmod	_	_

#	Lovastatin	5261
1	The	_	DET	DT	_	2	det	_	_
2	response	_	NOUN	NN	_	4	nsubjpass	_	_
3	was	_	VERB	VBD	_	4	auxpass	_	_
4	maintained	_	VERB	VBN	_	0	root	_	_
5	during	_	ADP	IN	_	6	case	_	_
6	continuation	_	NOUN	NN	_	4	nmod	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	therapy	_	NOUN	NN	_	6	nmod	_	_

#	Lovastatin	5262
1	Single	_	ADJ	JJ	_	3	amod	_	_
2	daily	_	ADV	RB	_	3	amod	_	_
3	doses	_	NOUN	NNS	_	10	nsubj	_	_
4	given	_	VERB	VBN	_	3	acl	_	_
5	in	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	evening	_	NOUN	NN	_	4	nmod	_	_
8	were	_	VERB	VBD	_	10	cop	_	_
9	more	_	ADV	RB	_	10	advmod	_	_
10	effective	_	ADJ	JJ	_	0	root	_	_
11	than	_	ADP	IN	_	14	case	_	_
12	the	_	DET	DT	_	14	det	_	_
13	same	_	ADJ	JJ	_	14	amod	_	_
14	dose	_	NOUN	NN	_	10	nmod	_	_
15	given	_	VERB	VBN	_	14	acl	_	_
16	in	_	ADP	IN	_	18	case	_	_
17	the	_	DET	DT	_	18	det	_	_
18	morning	_	NOUN	NN	_	15	nmod	_	_
19	,	_	.	,	_	10	punct	_	_
20	perhaps	_	ADV	RB	_	24	advmod	_	_
21	because	_	ADP	IN	_	24	mark	_	_
22	cholesterol	_	NOUN	NN	_	24	nsubjpass	_	_
23	is	_	VERB	VBZ	_	24	auxpass	_	_
24	synthesized	_	VERB	VBN	_	10	advcl	_	_
25	mainly	_	ADV	RB	_	24	advmod	_	_
26	at	_	X	FW	_	27	compound	_	_
27	night	_	VERB	MD	_	24	advmod	_	_

#	Lovastatin	5263
1	In	_	ADP	IN	_	2	case	_	_
2	multicenter	_	ADJ	JJ	_	30	nmod	_	_
3	,	_	.	,	_	30	punct	_	_
4	double	_	ADJ	JJ	_	6	amod	_	_
5	blind	_	NOUN	NN	_	6	compound	_	_
6	studies	_	NOUN	NNS	_	30	nsubjpass	_	_
7	in	_	ADP	IN	_	8	case	_	_
8	patients	_	NOUN	NNS	_	6	nmod	_	_
9	with	_	ADP	IN	_	14	case	_	_
10	familial	_	ADJ	JJ	_	14	amod	_	_
11	or	_	CONJ	CC	_	10	cc	_	_
12	non	_	ADJ	JJ	_	10	conj	_	_
13	familial	_	ADJ	JJ	_	14	amod	_	_
14	hypercholesterolemia	_	NOUN	NN	_	8	nmod	_	_
15	,	_	.	,	_	14	punct	_	_
16	MEVACOR	_	NOUN	NN	_	14	appos	_	_
17	,	_	.	,	_	14	punct	_	_
18	administered	_	VERB	VBN	_	14	acl	_	_
19	in	_	ADP	IN	_	20	case	_	_
20	doses	_	NOUN	NNS	_	18	nmod	_	_
21	ranging	_	VERB	VBG	_	20	acl	_	_
22	from	_	ADP	IN	_	24	case	_	_
23	10mg	_	ADJ	JJ	_	24	amod	_	_
24	q.p.m	_	NOUN	NN	_	21	nmod	_	_
25	to	_	PRT	TO	_	27	case	_	_
26	40mg	_	ADJ	JJ	_	27	amod	_	_
27	b.i.d	_	NOUN	NN	_	24	nmod	_	_
28	,	_	.	,	_	6	punct	_	_
29	was	_	VERB	VBD	_	30	auxpass	_	_
30	compared	_	VERB	VBN	_	0	root	_	_
31	to	_	PRT	TO	_	32	case	_	_
32	placebo	_	NOUN	NN	_	30	nmod	_	_

#	Lovastatin	5264
1	MEVACOR	_	NOUN	NN	_	3	nsubj	_	_
2	significantly	_	ADV	RB	_	3	advmod	_	_
3	decreased	_	VERB	VBD	_	0	root	_	_
4	plasma	_	NOUN	NN	_	6	compound	_	_
5	total	_	ADJ	JJ	_	6	amod	_	_
6	C	_	NOUN	NN	_	3	dobj	_	_
7	,	_	.	,	_	6	punct	_	_
8	LDL	_	NOUN	NN	_	9	compound	_	_
9	C	_	NOUN	NN	_	6	conj	_	_
10	,	_	.	,	_	6	punct	_	_
11	total	_	ADJ	JJ	_	12	amod	_	_
12	C	_	NOUN	NN	_	6	conj	_	_
13	/	_	.	:	_	6	punct	_	_
14	HDL	_	NOUN	NN	_	16	compound	_	_
15	C	_	NOUN	NN	_	16	compound	_	_
16	ratio	_	NOUN	NN	_	6	dep	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	LDL	_	NOUN	NN	_	19	compound	_	_
19	C	_	NOUN	NN	_	16	conj	_	_
20	/	_	.	:	_	16	punct	_	_
21	HDL	_	NOUN	NN	_	23	compound	_	_
22	C	_	NOUN	NN	_	23	compound	_	_
23	ratio	_	NOUN	NN	_	16	dep	_	_

#	Lovastatin	5265
1	In	_	ADP	IN	_	2	case	_	_
2	addition	_	NOUN	NN	_	5	nmod	_	_
3	,	_	.	,	_	5	punct	_	_
4	MEVACOR	_	NOUN	NN	_	5	nsubj	_	_
5	produced	_	VERB	VBD	_	0	root	_	_
6	increases	_	NOUN	NNS	_	5	dobj	_	_
7	of	_	ADP	IN	_	9	case	_	_
8	variable	_	ADJ	JJ	_	9	amod	_	_
9	magnitude	_	NOUN	NN	_	6	nmod	_	_
10	in	_	ADP	IN	_	12	case	_	_
11	HDL	_	NOUN	NN	_	12	compound	_	_
12	C	_	NOUN	NN	_	9	nmod	_	_
13	,	_	.	,	_	5	punct	_	_
14	and	_	CONJ	CC	_	5	cc	_	_
15	modestly	_	ADV	RB	_	16	advmod	_	_
16	decreased	_	VERB	VBD	_	5	conj	_	_
17	VLDL	_	NOUN	NN	_	18	compound	_	_
18	C	_	NOUN	NN	_	16	dobj	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	plasma	_	NOUN	NN	_	21	compound	_	_
21	TG	_	NOUN	NN	_	18	conj	_	_

#	Lovastatin	5266
1	The	_	DET	DT	_	2	det	_	_
2	results	_	NOUN	NNS	_	12	nsubjpass	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	a	_	DET	DT	_	5	det	_	_
5	study	_	NOUN	NN	_	2	nmod	_	_
6	in	_	ADP	IN	_	7	case	_	_
7	patients	_	NOUN	NNS	_	5	nmod	_	_
8	with	_	ADP	IN	_	10	case	_	_
9	primary	_	ADJ	JJ	_	10	amod	_	_
10	hypercholesterolemia	_	NOUN	NN	_	7	nmod	_	_
11	are	_	VERB	VBP	_	12	auxpass	_	_
12	presented	_	VERB	VBN	_	0	root	_	_
13	in	_	ADP	IN	_	14	case	_	_
14	TableII	_	NOUN	NN	_	12	nmod	_	_

#	Lovastatin	5267
1	Placebo	_	NOUN	NN	_	4	compound	_	_
2	Mean	_	NOUN	NN	_	4	compound	_	_
3	Percent	_	ADJ	JJ	_	4	amod	_	_
4	Change	_	NOUN	NN	_	8	nsubj	_	_
5	from	_	ADP	IN	_	7	case	_	_
6	Baseline	_	NOUN	NN	_	7	compound	_	_
7	After	_	NOUN	NN	_	4	nmod	_	_
8	6Weeks	_	VERB	VBZ	_	0	root	_	_
9	DOSAGE	_	NOUN	NN	_	18	compound	_	_
10	N	_	NOUN	NN	_	18	compound	_	_
11	TOTAL	_	NOUN	NN	_	18	compound	_	_
12	C	_	NOUN	NN	_	18	compound	_	_
13	LDL	_	NOUN	NN	_	18	compound	_	_
14	C	_	NOUN	NN	_	18	compound	_	_
15	HDL	_	NOUN	NN	_	18	compound	_	_
16	C	_	NOUN	NN	_	18	compound	_	_
17	LDL	_	NOUN	NN	_	18	compound	_	_
18	C	_	NOUN	NN	_	27	compound	_	_
19	/	_	.	:	_	23	punct	_	_
20	HDL	_	NOUN	NN	_	23	compound	_	_
21	C	_	NOUN	NN	_	23	compound	_	_
22	TOTAL	_	NOUN	NN	_	23	compound	_	_
23	C	_	NOUN	NN	_	18	appos	_	_
24	/	_	.	-RRB-	_	23	punct	_	_
25	HDL	_	NOUN	NN	_	27	compound	_	_
26	C	_	NOUN	NN	_	27	compound	_	_
27	TG	_	NOUN	NN	_	8	dobj	_	_

#	Lovastatin	5268
1	Placebo	_	NOUN	NN	_	3	compound	_	_
2	33	_	NUM	CD	_	3	compound	_	_
3	2	_	NUM	CD	_	0	root	_	_
4	1	_	NUM	CD	_	3	conj	_	_
5	1	_	NUM	CD	_	4	dep	_	_
6	0	_	NUM	CD	_	5	conj	_	_
7	+1	_	NUM	CD	_	6	conj	_	_
8	+9	_	NUM	CD	_	12	nummod	_	_
9	MEVACOR	_	NOUN	NN	_	12	compound	_	_
10	10	_	NUM	CD	_	12	nummod	_	_
11	mg	_	NOUN	NN	_	12	compound	_	_
12	q.p.m	_	NOUN	NN	_	7	dep	_	_

#	Lovastatin	5269
1	33	_	NUM	CD	_	0	root	_	_
2	16	_	NUM	CD	_	1	dep	_	_
3	21	_	NUM	CD	_	2	dep	_	_
4	+5	_	NUM	CD	_	3	dep	_	_
5	24	_	NUM	CD	_	4	conj	_	_
6	19	_	NUM	CD	_	5	conj	_	_
7	10	_	NUM	CD	_	10	nummod	_	_
8	20	_	NUM	CD	_	10	nummod	_	_
9	mg	_	NOUN	NN	_	10	compound	_	_
10	q.p.m	_	NOUN	NN	_	6	dep	_	_

#	Lovastatin	5270
1	33	_	NUM	CD	_	0	root	_	_
2	19	_	NUM	CD	_	1	dep	_	_
3	27	_	NUM	CD	_	2	dep	_	_
4	+6	_	NUM	CD	_	3	dep	_	_
5	30	_	NUM	CD	_	4	dep	_	_
6	23	_	NUM	CD	_	5	conj	_	_
7	+9	_	NUM	CD	_	6	dep	_	_
8	10	_	NUM	CD	_	10	nummod	_	_
9	mg	_	NOUN	NN	_	10	compound	_	_
10	b.i.d	_	NOUN	NN	_	7	dep	_	_

#	Lovastatin	5271
1	32	_	NUM	CD	_	0	root	_	_
2	19	_	NUM	CD	_	1	dep	_	_
3	28	_	NUM	CD	_	2	dep	_	_
4	+8	_	NUM	CD	_	3	dep	_	_
5	33	_	NUM	CD	_	4	dep	_	_
6	25	_	NUM	CD	_	5	conj	_	_
7	7	_	NUM	CD	_	10	nummod	_	_
8	40	_	NUM	CD	_	10	nummod	_	_
9	mg	_	NOUN	NN	_	10	compound	_	_
10	q.p.m	_	NOUN	NN	_	6	dep	_	_

#	Lovastatin	5272
1	33	_	NUM	CD	_	0	root	_	_
2	22	_	NUM	CD	_	1	dep	_	_
3	31	_	NUM	CD	_	2	dep	_	_
4	+5	_	NUM	CD	_	3	dep	_	_
5	33	_	NUM	CD	_	4	dep	_	_
6	25	_	NUM	CD	_	5	conj	_	_
7	8	_	NUM	CD	_	6	dep	_	_
8	20	_	NUM	CD	_	10	nummod	_	_
9	mg	_	NOUN	NN	_	10	compound	_	_
10	b.i.d	_	NOUN	NN	_	7	dep	_	_

#	Lovastatin	5273
1	36	_	NUM	CD	_	8	nummod	_	_
2	24	_	NUM	CD	_	8	nummod	_	_
3	32	_	NUM	CD	_	8	nummod	_	_
4	+2	_	NUM	CD	_	8	nummod	_	_
5	32	_	NUM	CD	_	8	nummod	_	_
6	24	_	NUM	CD	_	8	nummod	_	_
7	6	_	NUM	CD	_	8	nummod	_	_
8	MEVACOR	_	NOUN	NN	_	10	nsubjpass	_	_
9	was	_	VERB	VBD	_	10	auxpass	_	_
10	compared	_	VERB	VBN	_	0	root	_	_
11	to	_	PRT	TO	_	12	case	_	_
12	cholestyramine	_	NOUN	NN	_	10	nmod	_	_
13	in	_	ADP	IN	_	18	case	_	_
14	a	_	DET	DT	_	18	det	_	_
15	randomized	_	ADJ	JJ	_	18	amod	_	_
16	open	_	ADJ	JJ	_	18	amod	_	_
17	parallel	_	ADJ	JJ	_	18	amod	_	_
18	study	_	NOUN	NN	_	12	nmod	_	_

#	Lovastatin	5274
1	The	_	DET	DT	_	2	det	_	_
2	study	_	NOUN	NN	_	4	nsubjpass	_	_
3	was	_	VERB	VBD	_	4	auxpass	_	_
4	performed	_	VERB	VBN	_	0	root	_	_
5	with	_	ADP	IN	_	6	case	_	_
6	patients	_	NOUN	NNS	_	4	nmod	_	_
7	with	_	ADP	IN	_	8	case	_	_
8	hypercholesterolemia	_	NOUN	NN	_	6	nmod	_	_
9	who	_	DET	WDT	_	13	nsubj	_	_
10	were	_	VERB	VBD	_	13	cop	_	_
11	at	_	ADP	IN	_	13	case	_	_
12	high	_	ADJ	JJ	_	13	amod	_	_
13	risk	_	NOUN	NN	_	8	acl:relcl	_	_
14	of	_	ADP	IN	_	16	case	_	_
15	myocardial	_	ADJ	JJ	_	16	amod	_	_
16	infarction	_	NOUN	NN	_	13	nmod	_	_

#	Lovastatin	5275
1	Summary	_	ADJ	JJ	_	2	amod	_	_
2	results	_	NOUN	NNS	_	4	nsubjpass	_	_
3	are	_	VERB	VBP	_	4	auxpass	_	_
4	presented	_	VERB	VBN	_	0	root	_	_
5	in	_	ADP	IN	_	6	case	_	_
6	TableIII	_	NOUN	NN	_	4	nmod	_	_

#	Lovastatin	5276
1	TABLE	_	NOUN	NN	_	0	root	_	_
2	III	_	NUM	CD	_	1	nummod	_	_
3	:	_	.	:	_	1	punct	_	_
4	MEVACOR	_	NOUN	NN	_	1	dep	_	_
5	vs	_	CONJ	CC	_	4	cc	_	_
6	Cholestyramine	_	NOUN	NN	_	8	compound	_	_
7	Percent	_	ADJ	JJ	_	8	amod	_	_
8	Change	_	NOUN	NN	_	4	conj	_	_
9	from	_	ADP	IN	_	12	case	_	_
10	Baseline	_	NOUN	NN	_	12	compound	_	_
11	After	_	NOUN	NN	_	12	compound	_	_
12	12Weeks	_	NOUN	NNS	_	4	nmod	_	_
13	TREATMENT	_	NOUN	NN	_	22	compound	_	_
14	N	_	NOUN	NN	_	22	compound	_	_
15	TOTAL	_	NOUN	NN	_	22	compound	_	_
16	C(mean	_	NOUN	NN	_	22	compound	_	_
17	LDL	_	NOUN	NN	_	22	compound	_	_
18	C(mean	_	NOUN	NN	_	22	compound	_	_
19	HDL	_	NOUN	NN	_	22	compound	_	_
20	C(mean	_	NOUN	NN	_	22	compound	_	_
21	LDL	_	NOUN	NN	_	22	compound	_	_
22	C	_	NOUN	NN	_	12	dep	_	_
23	/	_	.	:	_	22	punct	_	_
24	HDL	_	NOUN	NN	_	27	compound	_	_
25	C(mean	_	NOUN	NN	_	27	compound	_	_
26	TOTAL	_	NOUN	NN	_	27	compound	_	_
27	C	_	NOUN	NN	_	22	dep	_	_
28	/	_	.	-RRB-	_	27	punct	_	_
29	HDL	_	NOUN	NN	_	33	compound	_	_
30	C(mean	_	NOUN	NN	_	33	compound	_	_
31	VLDL	_	NOUN	NN	_	33	compound	_	_
32	C(median	_	ADJ	JJ	_	33	compound	_	_
33	TG	_	NOUN	NN	_	27	dep	_	_

#	Lovastatin	5277
1	mean	_	ADJ	JJ	_	5	compound	_	_
2	MEVACOR	_	NOUN	NN	_	5	compound	_	_
3	20	_	NUM	CD	_	5	nummod	_	_
4	mg	_	NOUN	NN	_	5	compound	_	_
5	b.i.d	_	NOUN	NN	_	0	root	_	_

#	Lovastatin	5278
1	85	_	NUM	CD	_	0	root	_	_
2	27	_	NUM	CD	_	1	dep	_	_
3	32	_	NUM	CD	_	2	dep	_	_
4	+9	_	NUM	CD	_	3	dep	_	_
5	36	_	NUM	CD	_	4	dep	_	_
6	31	_	NUM	CD	_	5	dep	_	_
7	34	_	NUM	CD	_	6	dep	_	_
8	21	_	NUM	CD	_	7	dep	_	_
9	40	_	NUM	CD	_	11	nummod	_	_
10	mg	_	NOUN	NN	_	11	compound	_	_
11	b.i.d	_	NOUN	NN	_	8	dep	_	_

#	Lovastatin	5279
1	88	_	NUM	CD	_	0	root	_	_
2	34	_	NUM	CD	_	1	dep	_	_
3	42	_	NUM	CD	_	2	dep	_	_
4	+8	_	NUM	CD	_	3	dep	_	_
5	44	_	NUM	CD	_	4	dep	_	_
6	37	_	NUM	CD	_	5	dep	_	_
7	31	_	NUM	CD	_	6	dep	_	_
8	27	_	NUM	CD	_	7	conj	_	_
9	Cholestyramine	_	NOUN	NN	_	12	compound	_	_
10	12	_	NUM	CD	_	12	nummod	_	_
11	g	_	NOUN	NN	_	12	compound	_	_
12	b.i.d	_	NOUN	NN	_	8	nmod	_	_

#	Lovastatin	5280
1	88	_	NUM	CD	_	9	nummod	_	_
2	17	_	NUM	CD	_	9	nummod	_	_
3	23	_	NUM	CD	_	9	nummod	_	_
4	+8	_	NUM	CD	_	9	nummod	_	_
5	27	_	NUM	CD	_	9	nummod	_	_
6	21	_	NUM	CD	_	9	nummod	_	_
7	+2	_	NUM	CD	_	9	nummod	_	_
8	+11	_	NUM	CD	_	9	nummod	_	_
9	MEVACOR	_	NOUN	NN	_	11	nsubjpass	_	_
10	was	_	VERB	VBD	_	11	auxpass	_	_
11	studied	_	VERB	VBN	_	0	root	_	_
12	in	_	ADP	IN	_	14	case	_	_
13	controlled	_	VERB	VBN	_	14	amod	_	_
14	trials	_	NOUN	NNS	_	11	nmod	_	_
15	in	_	ADP	IN	_	17	case	_	_
16	hypercholesterolemic	_	ADJ	JJ	_	17	amod	_	_
17	patients	_	NOUN	NNS	_	14	nmod	_	_
18	with	_	ADP	IN	_	24	case	_	_
19	well	_	ADV	RB	_	20	advmod	_	_
20	controlled	_	VERB	VBN	_	24	amod	_	_
21	non	_	ADJ	JJ	_	24	amod	_	_
22	insulin	_	NOUN	NN	_	24	compound	_	_
23	dependent	_	ADJ	JJ	_	24	amod	_	_
24	diabetes	_	NOUN	NNS	_	17	nmod	_	_
25	mellitus	_	NOUN	NN	_	24	dep	_	_
26	with	_	ADP	IN	_	29	case	_	_
27	normal	_	ADJ	JJ	_	29	amod	_	_
28	renal	_	ADJ	JJ	_	29	amod	_	_
29	function	_	NOUN	NN	_	25	nmod	_	_

#	Lovastatin	5281
1	The	_	DET	DT	_	2	det	_	_
2	effect	_	NOUN	NN	_	16	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	MEVACOR	_	NOUN	NN	_	2	nmod	_	_
5	on	_	ADP	IN	_	6	case	_	_
6	lipids	_	NOUN	NNS	_	2	nmod	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	lipoproteins	_	NOUN	NNS	_	6	conj	_	_
9	and	_	CONJ	CC	_	2	cc	_	_
10	the	_	DET	DT	_	12	det	_	_
11	safety	_	NOUN	NN	_	12	compound	_	_
12	profile	_	NOUN	NN	_	2	conj	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	MEVACOR	_	NOUN	NN	_	12	nmod	_	_
15	were	_	VERB	VBD	_	16	cop	_	_
16	similar	_	ADJ	JJ	_	0	root	_	_
17	to	_	PRT	TO	_	18	case	_	_
18	that	_	DET	WDT	_	16	nmod	_	_
19	demonstrated	_	VERB	VBN	_	18	acl	_	_
20	in	_	ADP	IN	_	21	case	_	_
21	studies	_	NOUN	NNS	_	19	nmod	_	_
22	in	_	ADP	IN	_	23	case	_	_
23	nondiabetics	_	NOUN	NNS	_	21	nmod	_	_

#	Lovastatin	5282
1	MEVACOR	_	NOUN	NN	_	2	nsubj	_	_
2	had	_	VERB	VBD	_	0	root	_	_
3	no	_	DET	DT	_	6	neg	_	_
4	clinically	_	ADV	RB	_	5	advmod	_	_
5	important	_	ADJ	JJ	_	6	amod	_	_
6	effect	_	NOUN	NN	_	2	dobj	_	_
7	on	_	ADP	IN	_	9	case	_	_
8	glycemic	_	ADJ	JJ	_	9	amod	_	_
9	control	_	NOUN	NN	_	6	nmod	_	_
10	or	_	CONJ	CC	_	9	cc	_	_
11	on	_	ADP	IN	_	14	case	_	_
12	the	_	DET	DT	_	14	det	_	_
13	dose	_	NOUN	NN	_	14	compound	_	_
14	requirement	_	NOUN	NN	_	9	conj	_	_
15	of	_	ADP	IN	_	18	case	_	_
16	oral	_	ADJ	JJ	_	18	amod	_	_
17	hypoglycemic	_	ADJ	JJ	_	18	amod	_	_
18	agents	_	NOUN	NNS	_	14	nmod	_	_

#	Lovastatin	5283
1	MEVACOR	_	NOUN	NN	_	3	nsubjpass	_	_
2	was	_	VERB	VBD	_	3	auxpass	_	_
3	compared	_	VERB	VBN	_	0	root	_	_
4	to	_	PRT	TO	_	5	case	_	_
5	placebo	_	NOUN	NN	_	3	nmod	_	_
6	in	_	ADP	IN	_	8	case	_	_
7	8,245	_	NUM	CD	_	8	nummod	_	_
8	patients	_	NOUN	NNS	_	3	nmod	_	_
9	with	_	ADP	IN	_	26	case	_	_
10	hypercholesterolemia	_	NOUN	NN	_	26	compound	_	_
11	total	_	ADJ	JJ	_	26	amod	_	_
12	C	_	NOUN	NN	_	26	compound	_	_
13	240	_	NUM	CD	_	26	nummod	_	_
14	300mg	_	ADJ	JJ	_	26	amod	_	_
15	/	_	.	-LRB-	_	26	punct	_	_
16	dL	_	NOUN	NN	_	26	compound	_	_
17	6.2mmol	_	NOUN	NN	_	26	compound	_	_
18	/	_	.	-RRB-	_	26	punct	_	_
19	L	_	NOUN	NN	_	20	compound	_	_
20	7.6mmol	_	NOUN	NN	_	26	compound	_	_
21	/	_	.	:	_	26	punct	_	_
22	L	_	NOUN	NN	_	26	compound	_	_
23	,	_	.	,	_	26	punct	_	_
24	LDL	_	NOUN	NN	_	26	compound	_	_
25	C	_	NOUN	NN	_	26	compound	_	_
26	>160mg	_	ADJ	JJ	_	8	nmod	_	_
27	/	_	.	-RRB-	_	8	punct	_	_
28	dL	_	ADP	IN	_	29	compound	_	_
29	4.1mmol	_	NOUN	NN	_	8	dep	_	_
30	/	_	.	:	_	8	punct	_	_
31	L	_	NOUN	NN	_	8	dep	_	_
32	in	_	ADP	IN	_	37	case	_	_
33	the	_	DET	DT	_	37	det	_	_
34	randomized	_	ADJ	JJ	_	37	amod	_	_
35	,	_	.	,	_	34	punct	_	_
36	double	_	ADJ	JJ	_	34	dep	_	_
37	blind	_	NOUN	NN	_	31	nmod	_	_
38	,	_	.	,	_	31	punct	_	_
39	parallel	_	ADJ	JJ	_	31	amod	_	_
40	,	_	.	,	_	31	punct	_	_
41	48	_	NUM	CD	_	44	nummod	_	_
42	week	_	NOUN	NN	_	44	compound	_	_
43	EXCEL	_	NOUN	NN	_	44	compound	_	_
44	study	_	NOUN	NN	_	31	appos	_	_

#	Lovastatin	5284
1	All	_	DET	DT	_	2	det	_	_
2	changes	_	NOUN	NNS	_	14	nsubj	_	_
3	in	_	ADP	IN	_	6	case	_	_
4	the	_	DET	DT	_	6	det	_	_
5	lipid	_	NOUN	NN	_	6	compound	_	_
6	measurements	_	NOUN	NNS	_	2	nmod	_	_
7	TableIV	_	NOUN	NN	_	6	dep	_	_
8	in	_	ADP	IN	_	11	case	_	_
9	MEVACOR	_	NOUN	NN	_	11	compound	_	_
10	treated	_	ADJ	JJ	_	11	amod	_	_
11	patients	_	NOUN	NNS	_	7	nmod	_	_
12	were	_	VERB	VBD	_	14	cop	_	_
13	dose	_	NOUN	NN	_	14	nmod:npmod	_	_
14	related	_	ADJ	JJ	_	0	root	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	significantly	_	ADV	RB	_	17	advmod	_	_
17	different	_	ADJ	JJ	_	14	conj	_	_
18	from	_	ADP	IN	_	20	case	_	_
19	placebo	_	NOUN	NN	_	20	compound	_	_
20	p<0.001	_	NOUN	NN	_	17	nmod	_	_

#	Lovastatin	5285
1	These	_	DET	DT	_	2	det	_	_
2	results	_	NOUN	NNS	_	4	nsubj	_	_
3	were	_	VERB	VBD	_	4	cop	_	_
4	sustained	_	ADJ	JJ	_	0	root	_	_
5	throughout	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	study	_	NOUN	NN	_	4	nmod	_	_

#	Lovastatin	5286
1	Placebo	_	NOUN	NN	_	3	compound	_	_
2	Percent	_	NOUN	NN	_	3	compound	_	_
3	Change	_	NOUN	NN	_	13	nsubj	_	_
4	from	_	ADP	IN	_	7	case	_	_
5	Baseline	_	NOUN	NN	_	7	compound	_	_
6	Average	_	NOUN	NN	_	7	compound	_	_
7	Values	_	NOUN	NNS	_	3	nmod	_	_
8	Between	_	X	FW	_	12	case	_	_
9	Weeks12	_	NOUN	NN	_	12	compound	_	_
10	and48	_	NUM	CD	_	12	nummod	_	_
11	DOSAGE	_	NOUN	NN	_	12	compound	_	_
12	NPatients	_	NOUN	NNS	_	7	nmod	_	_
13	enrolled	_	VERB	VBD	_	0	root	_	_
14	TOTAL	_	NOUN	NN	_	21	compound	_	_
15	C(mean	_	NOUN	NN	_	21	compound	_	_
16	LDL	_	NOUN	NN	_	21	compound	_	_
17	C(mean	_	NOUN	NN	_	21	compound	_	_
18	HDL	_	NOUN	NN	_	21	compound	_	_
19	C(mean	_	NOUN	NN	_	21	compound	_	_
20	LDL	_	NOUN	NN	_	21	compound	_	_
21	C	_	NOUN	NN	_	31	compound	_	_
22	/	_	.	:	_	27	punct	_	_
23	HDL	_	NOUN	NN	_	27	compound	_	_
24	C	_	NOUN	NN	_	27	compound	_	_
25	mean	_	ADJ	JJ	_	27	compound	_	_
26	TOTAL	_	NOUN	NN	_	27	compound	_	_
27	C	_	NOUN	NN	_	21	appos	_	_
28	/	_	.	:	_	27	punct	_	_
29	HDL	_	NOUN	NN	_	31	compound	_	_
30	C(mean	_	NOUN	NN	_	31	compound	_	_
31	TG	_	NOUN	NN	_	13	dobj	_	_

#	Lovastatin	5287
1	median	_	ADJ	JJ	_	0	root	_	_
2	Placebo	_	NOUN	NN	_	7	compound	_	_
3	1663	_	NUM	CD	_	7	compound	_	_
4	+0.7	_	NUM	CD	_	7	compound	_	_
5	+0.4	_	NUM	CD	_	7	compound	_	_
6	+2.0	_	NUM	CD	_	7	compound	_	_
7	+0.2	_	NUM	CD	_	1	dep	_	_
8	+0.6	_	NUM	CD	_	13	nummod	_	_
9	+4	_	NUM	CD	_	13	nummod	_	_
10	MEVACOR	_	NOUN	NN	_	13	compound	_	_
11	20	_	NUM	CD	_	13	nummod	_	_
12	mg	_	NOUN	NN	_	13	compound	_	_
13	q.p.m	_	NOUN	NN	_	7	dep	_	_

#	Lovastatin	5288
1	1642	_	NUM	CD	_	0	root	_	_
2	17	_	NUM	CD	_	1	dep	_	_
3	24	_	NUM	CD	_	2	dep	_	_
4	+6.6	_	NUM	CD	_	3	dep	_	_
5	27	_	NUM	CD	_	4	conj	_	_
6	21	_	NUM	CD	_	5	conj	_	_
7	10	_	NUM	CD	_	10	nummod	_	_
8	40	_	NUM	CD	_	10	nummod	_	_
9	mg	_	NOUN	NN	_	10	compound	_	_
10	q.p.m	_	NOUN	NN	_	6	dep	_	_

#	Lovastatin	5289
1	1645	_	NUM	CD	_	0	root	_	_
2	22	_	NUM	CD	_	1	dep	_	_
3	30	_	NUM	CD	_	2	dep	_	_
4	+7.2	_	NUM	CD	_	3	dep	_	_
5	34	_	NUM	CD	_	4	dep	_	_
6	26	_	NUM	CD	_	5	dep	_	_
7	14	_	NUM	CD	_	6	dep	_	_
8	20	_	NUM	CD	_	10	nummod	_	_
9	mg	_	NOUN	NN	_	10	compound	_	_
10	b.i.d	_	NOUN	NN	_	7	dep	_	_

#	Lovastatin	5290
1	1646	_	NUM	CD	_	0	root	_	_
2	24	_	NUM	CD	_	1	dep	_	_
3	34	_	NUM	CD	_	2	dep	_	_
4	+8.6	_	NUM	CD	_	3	dep	_	_
5	38	_	NUM	CD	_	4	dep	_	_
6	29	_	NUM	CD	_	5	dep	_	_
7	16	_	NUM	CD	_	6	dep	_	_
8	40	_	NUM	CD	_	10	nummod	_	_
9	mg	_	NOUN	NN	_	10	compound	_	_
10	b.i.d	_	NOUN	NN	_	7	dep	_	_

#	Lovastatin	5291
1	1649	_	NUM	CD	_	10	nummod	_	_
2	29	_	NUM	CD	_	10	nummod	_	_
3	40	_	NUM	CD	_	10	nummod	_	_
4	+9.5	_	NUM	CD	_	10	nummod	_	_
5	44	_	NUM	CD	_	10	nummod	_	_
6	34	_	NUM	CD	_	10	nummod	_	_
7	19	_	NUM	CD	_	6	dep	_	_
8	The	_	DET	DT	_	10	det	_	_
9	Air	_	NOUN	NN	_	10	compound	_	_
10	Force	_	NOUN	NN	_	0	root	_	_
11	/	_	.	:	_	10	punct	_	_
12	Texas	_	NOUN	NN	_	17	compound	_	_
13	Coronary	_	ADJ	JJ	_	17	amod	_	_
14	Atherosclerosis	_	NOUN	NN	_	17	compound	_	_
15	Prevention	_	NOUN	NN	_	17	compound	_	_
16	Study	_	NOUN	NN	_	17	compound	_	_
17	AFCAPS	_	NOUN	NN	_	34	nsubj	_	_
18	/	_	.	:	_	19	punct	_	_
19	TexCAPS	_	NOUN	NN	_	34	nsubj	_	_
20	,	_	.	,	_	19	punct	_	_
21	a	_	DET	DT	_	23	det	_	_
22	double	_	ADJ	JJ	_	23	amod	_	_
23	blind	_	NOUN	NN	_	19	appos	_	_
24	,	_	.	,	_	19	punct	_	_
25	randomized	_	VERB	VBN	_	19	acl	_	_
26	,	_	.	,	_	19	punct	_	_
27	placebo	_	NOUN	NN	_	19	conj	_	_
28	controlled	_	VERB	VBD	_	27	amod	_	_
29	,	_	.	,	_	19	punct	_	_
30	primary	_	ADJ	JJ	_	32	amod	_	_
31	prevention	_	NOUN	NN	_	32	compound	_	_
32	study	_	NOUN	NN	_	19	appos	_	_
33	,	_	.	,	_	19	punct	_	_
34	demonstrated	_	VERB	VBD	_	10	dep	_	_
35	that	_	ADP	IN	_	39	mark	_	_
36	treatment	_	NOUN	NN	_	39	nsubj	_	_
37	with	_	ADP	IN	_	38	case	_	_
38	MEVACOR	_	NOUN	NN	_	36	nmod	_	_
39	decreased	_	VERB	VBD	_	34	ccomp	_	_
40	the	_	DET	DT	_	41	det	_	_
41	rate	_	NOUN	NN	_	39	dobj	_	_
42	of	_	ADP	IN	_	46	case	_	_
43	acute	_	ADJ	JJ	_	46	amod	_	_
44	major	_	ADJ	JJ	_	46	amod	_	_
45	coronary	_	ADJ	JJ	_	46	amod	_	_
46	events	_	NOUN	NNS	_	41	nmod	_	_
47	composite	_	ADJ	JJ	_	48	amod	_	_
48	endpoint	_	NOUN	NN	_	60	nsubj	_	_
49	of	_	ADP	IN	_	51	case	_	_
50	myocardial	_	ADJ	JJ	_	51	amod	_	_
51	infarction	_	NOUN	NN	_	48	nmod	_	_
52	,	_	.	,	_	51	punct	_	_
53	unstable	_	ADJ	JJ	_	54	amod	_	_
54	angina	_	NOUN	NN	_	51	conj	_	_
55	,	_	.	,	_	51	punct	_	_
56	and	_	CONJ	CC	_	51	cc	_	_
57	sudden	_	NOUN	NN	_	59	amod	_	_
58	cardiac	_	ADJ	JJ	_	59	amod	_	_
59	death	_	NOUN	NN	_	51	conj	_	_
60	compared	_	VERB	VBN	_	46	acl	_	_
61	with	_	ADP	IN	_	62	case	_	_
62	placebo	_	NOUN	NN	_	60	nmod	_	_
63	during	_	ADP	IN	_	65	case	_	_
64	a	_	DET	DT	_	65	det	_	_
65	median	_	NOUN	NN	_	60	nmod	_	_
66	of	_	ADP	IN	_	67	case	_	_
67	5.1years	_	NOUN	NNS	_	65	nmod	_	_
68	of	_	ADP	IN	_	69	mark	_	_
69	follow	_	NOUN	NN	_	67	acl	_	_
70	up	_	PRON	PRP$	_	69	neg	_	_

#	Lovastatin	5292
1	Participants	_	NOUN	NNS	_	4	nsubj	_	_
2	were	_	VERB	VBD	_	4	cop	_	_
3	middle	_	NOUN	NN	_	4	nmod:npmod	_	_
4	aged	_	ADJ	JJ	_	0	root	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	elderly	_	ADJ	JJ	_	7	amod	_	_
7	men	_	NOUN	NN	_	4	conj	_	_
8	ages	_	NOUN	NNS	_	13	nsubj	_	_
9	45	_	NUM	CD	_	10	nummod	_	_
10	73	_	NUM	CD	_	8	dep	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	women	_	NOUN	NNS	_	10	conj	_	_
13	ages	_	VERB	VBZ	_	7	dep	_	_
14	55	_	NUM	CD	_	15	nummod	_	_
15	73	_	NUM	CD	_	13	dobj	_	_
16	without	_	ADP	IN	_	19	case	_	_
17	symptomatic	_	ADJ	JJ	_	19	amod	_	_
18	cardiovascular	_	ADJ	JJ	_	19	amod	_	_
19	disease	_	NOUN	NN	_	13	nmod	_	_
20	with	_	ADP	IN	_	21	case	_	_
21	average	_	NOUN	NN	_	13	nmod	_	_
22	to	_	PRT	TO	_	26	case	_	_
23	moderately	_	ADV	RB	_	24	advmod	_	_
24	elevated	_	ADJ	JJ	_	26	amod	_	_
25	total	_	ADJ	JJ	_	26	amod	_	_
26	C	_	NOUN	NN	_	21	nmod	_	_
27	and	_	CONJ	CC	_	26	cc	_	_
28	LDL	_	NOUN	NN	_	29	compound	_	_
29	C	_	NOUN	NN	_	26	conj	_	_
30	,	_	.	,	_	4	punct	_	_
31	below	_	VERB	VBP	_	4	conj	_	_
32	average	_	ADJ	JJ	_	34	amod	_	_
33	HDL	_	NOUN	NN	_	34	compound	_	_
34	C	_	NOUN	NN	_	31	dobj	_	_
35	,	_	.	,	_	4	punct	_	_
36	and	_	CONJ	CC	_	4	cc	_	_
37	who	_	DET	WDT	_	41	nsubj	_	_
38	were	_	VERB	VBD	_	41	cop	_	_
39	at	_	ADP	IN	_	41	case	_	_
40	high	_	ADJ	JJ	_	41	amod	_	_
41	risk	_	NOUN	NN	_	4	conj	_	_
42	based	_	VERB	VBN	_	41	acl	_	_
43	on	_	ADP	IN	_	46	case	_	_
44	elevated	_	ADJ	JJ	_	46	amod	_	_
45	total	_	ADJ	JJ	_	46	amod	_	_
46	C	_	NOUN	NN	_	42	nmod	_	_
47	/	_	.	-LRB-	_	49	punct	_	_
48	HDL	_	NOUN	NN	_	49	compound	_	_
49	C	_	NOUN	NN	_	46	acl	_	_

#	Lovastatin	5293
1	In	_	ADP	IN	_	2	case	_	_
2	addition	_	NOUN	NN	_	10	nmod	_	_
3	to	_	PRT	TO	_	4	case	_	_
4	age	_	NOUN	NN	_	2	nmod	_	_
5	,	_	.	,	_	10	punct	_	_
6	63%	_	NOUN	NN	_	10	nsubj	_	_
7	of	_	ADP	IN	_	9	case	_	_
8	the	_	DET	DT	_	9	det	_	_
9	participants	_	NOUN	NNS	_	6	nmod	_	_
10	had	_	VERB	VBD	_	0	root	_	_
11	at	_	ADP	IN	_	12	case	_	_
12	least	_	ADJ	JJS	_	13	nmod:npmod	_	_
13	one	_	NUM	CD	_	20	nummod	_	_
14	other	_	ADJ	JJ	_	20	amod	_	_
15	risk	_	NOUN	NN	_	20	compound	_	_
16	factor	_	NOUN	NN	_	20	compound	_	_
17	baseline	_	NOUN	NN	_	20	compound	_	_
18	HDL	_	NOUN	NN	_	20	compound	_	_
19	C	_	NOUN	NN	_	20	compound	_	_
20	<35mg	_	ADJ	JJ	_	22	amod	_	_
21	/	_	.	:	_	22	punct	_	_
22	dL	_	NOUN	NN	_	10	dobj	_	_
23	,	_	.	,	_	22	punct	_	_
24	hypertension	_	NOUN	NN	_	22	conj	_	_
25	,	_	.	,	_	22	punct	_	_
26	family	_	NOUN	NN	_	27	compound	_	_
27	history	_	NOUN	NN	_	22	conj	_	_
28	,	_	.	,	_	22	punct	_	_
29	smoking	_	NOUN	NN	_	22	conj	_	_
30	and	_	CONJ	CC	_	22	cc	_	_
31	diabetes	_	NOUN	NNS	_	22	conj	_	_

#	Lovastatin	5294
1	AFCAPS	_	NOUN	NN	_	0	root	_	_
2	/	_	.	:	_	1	punct	_	_
3	TexCAPS	_	NOUN	NN	_	4	nsubj	_	_
4	enrolled	_	VERB	VBD	_	1	dep	_	_
5	6,605	_	NUM	CD	_	6	nummod	_	_
6	participants	_	NOUN	NNS	_	4	dobj	_	_
7	5,608	_	NUM	CD	_	8	nummod	_	_
8	men	_	NOUN	NN	_	6	dep	_	_
9	,	_	.	,	_	4	punct	_	_
10	997	_	NUM	CD	_	11	nummod	_	_
11	women	_	NOUN	NNS	_	12	nsubj	_	_
12	based	_	VERB	VBN	_	4	conj	_	_
13	on	_	ADP	IN	_	18	case	_	_
14	the	_	DET	DT	_	18	det	_	_
15	following	_	VERB	VBG	_	18	amod	_	_
16	lipid	_	NOUN	NN	_	18	compound	_	_
17	entry	_	NOUN	NN	_	18	compound	_	_
18	criteria	_	NOUN	NN	_	12	nmod	_	_
19	:	_	.	:	_	4	punct	_	_
20	total	_	ADJ	JJ	_	22	amod	_	_
21	C	_	NOUN	NN	_	22	compound	_	_
22	range	_	NOUN	NN	_	4	dep	_	_
23	of	_	ADP	IN	_	27	case	_	_
24	180	_	NUM	CD	_	25	nummod	_	_
25	264mg	_	ADJ	JJ	_	27	amod	_	_
26	/	_	.	:	_	27	punct	_	_
27	dL	_	NOUN	NN	_	22	dep	_	_
28	,	_	.	,	_	27	punct	_	_
29	LDL	_	NOUN	NN	_	31	compound	_	_
30	C	_	NOUN	NN	_	31	compound	_	_
31	range	_	NOUN	NN	_	27	conj	_	_
32	of	_	ADP	IN	_	36	case	_	_
33	130	_	NUM	CD	_	34	nummod	_	_
34	190mg	_	ADJ	JJ	_	36	amod	_	_
35	/	_	.	:	_	36	punct	_	_
36	dL	_	NOUN	NN	_	31	nmod	_	_
37	,	_	.	,	_	36	punct	_	_
38	HDL	_	NOUN	NN	_	39	compound	_	_
39	C	_	NOUN	NN	_	36	appos	_	_
40	of	_	ADP	IN	_	43	case	_	_
41	<45mg	_	ADJ	JJ	_	43	amod	_	_
42	/	_	.	:	_	43	punct	_	_
43	dL	_	NOUN	NN	_	39	nmod	_	_
44	for	_	ADP	IN	_	45	case	_	_
45	men	_	NOUN	NN	_	43	nmod	_	_
46	and	_	CONJ	CC	_	45	cc	_	_
47	<47mg	_	ADJ	JJ	_	45	conj	_	_
48	/	_	.	:	_	36	punct	_	_
49	dL	_	NOUN	NN	_	36	dep	_	_
50	for	_	ADP	IN	_	51	case	_	_
51	women	_	NOUN	NNS	_	49	nmod	_	_
52	,	_	.	,	_	36	punct	_	_
53	and	_	CONJ	CC	_	36	cc	_	_
54	TG	_	NOUN	NN	_	56	compound	_	_
55	of	_	ADP	IN	_	56	case	_	_
56	<400mg	_	ADJ	JJ	_	36	conj	_	_
57	/	_	.	-RRB-	_	27	punct	_	_
58	dL	_	ADP	IN	_	22	punct	_	_

#	Lovastatin	5295
1	Participants	_	NOUN	NNS	_	3	nsubjpass	_	_
2	were	_	VERB	VBD	_	3	auxpass	_	_
3	treated	_	VERB	VBN	_	0	root	_	_
4	with	_	ADP	IN	_	6	case	_	_
5	standard	_	ADJ	JJ	_	6	amod	_	_
6	care	_	NOUN	NN	_	3	nmod	_	_
7	,	_	.	,	_	6	punct	_	_
8	including	_	VERB	VBG	_	9	case	_	_
9	diet	_	NOUN	NN	_	6	nmod	_	_
10	,	_	.	,	_	3	punct	_	_
11	and	_	CONJ	CC	_	3	cc	_	_
12	either	_	CONJ	CC	_	17	cc:preconj	_	_
13	MEVACOR	_	NOUN	NN	_	17	compound	_	_
14	20	_	NUM	CD	_	17	nummod	_	_
15	40mg	_	ADJ	JJ	_	17	amod	_	_
16	daily	_	ADV	RB	_	17	advmod	_	_
17	n=3,304	_	NOUN	NN	_	3	conj	_	_
18	or	_	CONJ	CC	_	17	cc	_	_
19	placebo	_	NOUN	NN	_	20	compound	_	_
20	n=3,301	_	NOUN	NN	_	17	conj	_	_

#	Lovastatin	5296
1	Approximately	_	ADV	RB	_	10	advmod	_	_
2	50%	_	NOUN	NN	_	10	nsubjpass	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	the	_	DET	DT	_	5	det	_	_
5	participants	_	NOUN	NNS	_	2	nmod	_	_
6	treated	_	VERB	VBN	_	5	acl	_	_
7	with	_	ADP	IN	_	8	case	_	_
8	MEVACOR	_	NOUN	NN	_	6	nmod	_	_
9	were	_	VERB	VBD	_	10	auxpass	_	_
10	titrated	_	VERB	VBN	_	0	root	_	_
11	to	_	PRT	TO	_	12	case	_	_
12	40mg	_	ADJ	JJ	_	10	nmod	_	_
13	daily	_	ADV	RB	_	18	advmod	_	_
14	when	_	ADV	WRB	_	18	advmod	_	_
15	their	_	PRON	PRP$	_	17	nmod:poss	_	_
16	LDL	_	NOUN	NN	_	17	compound	_	_
17	C	_	NOUN	NN	_	18	nsubj	_	_
18	remained	_	VERB	VBD	_	10	advcl	_	_
19	>110mg	_	ADJ	JJ	_	18	dobj	_	_
20	/	_	.	:	_	19	punct	_	_
21	dL	_	NOUN	NN	_	19	dep	_	_
22	at	_	ADP	IN	_	25	case	_	_
23	the	_	DET	DT	_	25	det	_	_
24	20	_	NUM	CD	_	25	nummod	_	_
25	mg	_	NOUN	NN	_	18	nmod	_	_
26	starting	_	VERB	VBG	_	25	acl	_	_
27	dose	_	NOUN	NN	_	26	nmod	_	_

#	Lovastatin	5297
1	MEVACOR	_	NOUN	NN	_	2	nsubj	_	_
2	reduced	_	VERB	VBD	_	0	root	_	_
3	the	_	DET	DT	_	4	det	_	_
4	risk	_	NOUN	NN	_	2	dobj	_	_
5	of	_	ADP	IN	_	11	case	_	_
6	a	_	DET	DT	_	11	det	_	_
7	first	_	ADJ	JJ	_	11	amod	_	_
8	acute	_	ADJ	JJ	_	11	amod	_	_
9	major	_	ADJ	JJ	_	11	amod	_	_
10	coronary	_	ADJ	JJ	_	11	amod	_	_
11	event	_	NOUN	NN	_	4	nmod	_	_
12	,	_	.	,	_	11	punct	_	_
13	the	_	DET	DT	_	16	det	_	_
14	primary	_	ADJ	JJ	_	16	amod	_	_
15	efficacy	_	NOUN	NN	_	16	compound	_	_
16	endpoint	_	NOUN	NN	_	11	appos	_	_
17	,	_	.	,	_	11	punct	_	_
18	by	_	ADP	IN	_	21	case	_	_
19	37%	_	ADJ	JJ	_	21	amod	_	_
20	MEVACOR	_	NOUN	NN	_	21	compound	_	_
21	3.5%	_	NOUN	NN	_	4	nmod	_	_
22	,	_	.	,	_	2	punct	_	_
23	placebo	_	NOUN	NN	_	26	compound	_	_
24	5.5%	_	ADJ	JJ	_	26	compound	_	_
25	p<0.001	_	NOUN	NN	_	26	compound	_	_
26	Figure1	_	NOUN	NN	_	2	dep	_	_

#	Lovastatin	5298
1	A	_	DET	DT	_	6	det	_	_
2	first	_	ADJ	JJ	_	6	amod	_	_
3	acute	_	ADJ	JJ	_	6	amod	_	_
4	major	_	ADJ	JJ	_	6	amod	_	_
5	coronary	_	ADJ	JJ	_	6	amod	_	_
6	event	_	NOUN	NN	_	8	nsubjpass	_	_
7	was	_	VERB	VBD	_	8	auxpass	_	_
8	defined	_	VERB	VBN	_	0	root	_	_
9	as	_	ADP	IN	_	13	case	_	_
10	myocardial	_	ADJ	JJ	_	13	amod	_	_
11	infarction	_	NOUN	NN	_	13	compound	_	_
12	54	_	NUM	CD	_	13	nummod	_	_
13	participants	_	NOUN	NNS	_	8	nmod	_	_
14	on	_	ADP	IN	_	15	case	_	_
15	MEVACOR	_	NOUN	NN	_	13	nmod	_	_
16	,	_	.	,	_	15	punct	_	_
17	94	_	NUM	CD	_	19	nummod	_	_
18	on	_	ADP	IN	_	19	case	_	_
19	placebo	_	NOUN	NN	_	15	nmod	_	_
20	or	_	CONJ	CC	_	19	cc	_	_
21	unstable	_	ADJ	JJ	_	22	amod	_	_
22	angina	_	NOUN	NN	_	19	conj	_	_
23	54	_	NUM	CD	_	22	dep	_	_
24	vs	_	CONJ	CC	_	23	cc	_	_
25	80	_	NUM	CD	_	23	conj	_	_
26	or	_	CONJ	CC	_	23	cc	_	_
27	sudden	_	NOUN	NN	_	23	conj	_	_
28	cardiac	_	ADJ	JJ	_	27	dep	_	_
29	death	_	NOUN	NN	_	30	compound	_	_
30	8	_	NUM	CD	_	28	dep	_	_
31	vs	_	CONJ	CC	_	30	cc	_	_
32	9	_	NUM	CD	_	30	conj	_	_

#	Lovastatin	5299
1	Furthermore	_	ADV	RB	_	9	advmod	_	_
2	,	_	.	,	_	9	punct	_	_
3	among	_	ADP	IN	_	6	case	_	_
4	the	_	DET	DT	_	6	det	_	_
5	secondary	_	ADJ	JJ	_	6	amod	_	_
6	endpoints	_	NOUN	NNS	_	9	nmod	_	_
7	,	_	.	,	_	9	punct	_	_
8	MEVACOR	_	NOUN	NN	_	9	nsubj	_	_
9	reduced	_	VERB	VBD	_	0	root	_	_
10	the	_	DET	DT	_	11	det	_	_
11	risk	_	NOUN	NN	_	9	dobj	_	_
12	of	_	ADP	IN	_	14	case	_	_
13	unstable	_	ADJ	JJ	_	14	amod	_	_
14	angina	_	NOUN	NN	_	11	nmod	_	_
15	by	_	ADP	IN	_	20	case	_	_
16	32%	_	ADJ	JJ	_	20	amod	_	_
17	1.8	_	NUM	CD	_	20	nummod	_	_
18	vs	_	CONJ	CC	_	17	cc	_	_
19	2.6%	_	ADJ	JJ	_	17	conj	_	_
20	p=0.023	_	NOUN	NN	_	11	nmod	_	_
21	,	_	.	,	_	20	punct	_	_
22	of	_	ADP	IN	_	24	case	_	_
23	myocardial	_	ADJ	JJ	_	24	amod	_	_
24	infarction	_	NOUN	NN	_	20	nmod	_	_
25	by	_	ADP	IN	_	30	case	_	_
26	40%	_	ADJ	JJ	_	30	amod	_	_
27	1.7	_	NUM	CD	_	30	nummod	_	_
28	vs	_	CONJ	CC	_	27	cc	_	_
29	2.9%	_	ADJ	JJ	_	27	conj	_	_
30	p=0.002	_	NOUN	NN	_	24	nmod	_	_
31	,	_	.	,	_	20	punct	_	_
32	and	_	CONJ	CC	_	20	cc	_	_
33	of	_	ADP	IN	_	34	mark	_	_
34	undergoing	_	VERB	VBG	_	20	conj	_	_
35	coronary	_	ADJ	JJ	_	37	amod	_	_
36	revascularization	_	NOUN	NN	_	37	compound	_	_
37	procedures	_	NOUN	NNS	_	34	dobj	_	_
38	e.g	_	NOUN	NN	_	37	dep	_	_
39	,	_	.	,	_	9	punct	_	_
40	coronary	_	ADJ	JJ	_	42	amod	_	_
41	artery	_	NOUN	NN	_	42	compound	_	_
42	bypass	_	NOUN	NN	_	9	dobj	_	_
43	grafting	_	VERB	VBG	_	42	acl	_	_
44	or	_	CONJ	CC	_	43	cc	_	_
45	percutaneous	_	ADJ	JJ	_	48	amod	_	_
46	transluminal	_	ADJ	JJ	_	48	amod	_	_
47	coronary	_	ADJ	JJ	_	48	amod	_	_
48	angioplasty	_	NOUN	NN	_	43	conj	_	_
49	by	_	ADP	IN	_	54	case	_	_
50	33%	_	ADJ	JJ	_	54	amod	_	_
51	3.2	_	NUM	CD	_	54	nummod	_	_
52	vs	_	CONJ	CC	_	51	cc	_	_
53	4.8%	_	ADJ	JJ	_	51	conj	_	_
54	p=0.001	_	NOUN	NN	_	43	nmod	_	_

#	Lovastatin	5300
1	Trends	_	NOUN	NNS	_	11	nsubj	_	_
2	in	_	ADP	IN	_	4	case	_	_
3	risk	_	NOUN	NN	_	4	compound	_	_
4	reduction	_	NOUN	NN	_	1	nmod	_	_
5	associated	_	VERB	VBN	_	4	acl	_	_
6	with	_	ADP	IN	_	7	case	_	_
7	treatment	_	NOUN	NN	_	5	nmod	_	_
8	with	_	ADP	IN	_	9	case	_	_
9	MEVACOR	_	NOUN	NN	_	7	nmod	_	_
10	were	_	VERB	VBD	_	11	cop	_	_
11	consistent	_	ADJ	JJ	_	0	root	_	_
12	across	_	ADP	IN	_	13	case	_	_
13	men	_	NOUN	NN	_	11	nmod	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	women	_	NOUN	NNS	_	13	conj	_	_
16	,	_	.	,	_	13	punct	_	_
17	smokers	_	NOUN	NNS	_	13	conj	_	_
18	and	_	CONJ	CC	_	13	cc	_	_
19	non	_	ADJ	JJ	_	20	amod	_	_
20	smokers	_	NOUN	NNS	_	13	conj	_	_
21	,	_	.	,	_	13	punct	_	_
22	hypertensives	_	NOUN	NNS	_	13	conj	_	_
23	and	_	CONJ	CC	_	13	cc	_	_
24	non	_	ADJ	JJ	_	25	amod	_	_
25	hypertensives	_	NOUN	NNS	_	13	conj	_	_
26	,	_	.	,	_	11	punct	_	_
27	and	_	CONJ	CC	_	11	cc	_	_
28	older	_	ADJ	JJ	_	11	conj	_	_
29	and	_	CONJ	CC	_	28	cc	_	_
30	younger	_	ADJ	JJ	_	28	conj	_	_
31	participants	_	NOUN	NNS	_	28	dep	_	_

#	Lovastatin	5301
1	Participants	_	NOUN	NNS	_	6	nsubj	_	_
2	with	_	ADP	IN	_	5	case	_	_
3	>2	_	NUM	CD	_	5	nummod	_	_
4	risk	_	NOUN	NN	_	5	compound	_	_
5	factors	_	NOUN	NNS	_	1	nmod	_	_
6	had	_	VERB	VBD	_	0	root	_	_
7	risk	_	VERB	VB	_	9	amod	_	_
8	reductions	_	NOUN	NNS	_	9	compound	_	_
9	RR	_	NOUN	NN	_	6	dobj	_	_
10	in	_	ADP	IN	_	15	case	_	_
11	both	_	CONJ	CC	_	15	cc:preconj	_	_
12	acute	_	ADJ	JJ	_	15	amod	_	_
13	major	_	ADJ	JJ	_	15	amod	_	_
14	coronary	_	ADJ	JJ	_	15	amod	_	_
15	events	_	NOUN	NNS	_	6	nmod	_	_
16	RR43%	_	NOUN	NN	_	15	dep	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	coronary	_	ADJ	JJ	_	20	amod	_	_
19	revascularization	_	NOUN	NN	_	20	compound	_	_
20	procedures	_	NOUN	NNS	_	16	conj	_	_
21	RR37%	_	NOUN	NN	_	20	dep	_	_

#	Lovastatin	5302
1	Because	_	ADP	IN	_	3	mark	_	_
2	there	_	DET	EX	_	3	expl	_	_
3	were	_	VERB	VBD	_	31	advcl	_	_
4	too	_	ADV	RB	_	6	neg	_	_
5	few	_	ADJ	JJ	_	6	amod	_	_
6	events	_	NOUN	NNS	_	3	nsubj	_	_
7	among	_	ADP	IN	_	9	case	_	_
8	those	_	DET	DT	_	9	det	_	_
9	participants	_	NOUN	NNS	_	6	nmod	_	_
10	with	_	ADP	IN	_	11	case	_	_
11	age	_	NOUN	NN	_	9	nmod	_	_
12	as	_	ADP	IN	_	16	case	_	_
13	their	_	PRON	PRP$	_	16	nmod:poss	_	_
14	only	_	ADV	RB	_	15	advmod	_	_
15	risk	_	NOUN	NN	_	16	compound	_	_
16	factor	_	NOUN	NN	_	6	nmod	_	_
17	in	_	ADP	IN	_	19	case	_	_
18	this	_	DET	DT	_	19	det	_	_
19	study	_	NOUN	NN	_	16	nmod	_	_
20	,	_	.	,	_	31	punct	_	_
21	the	_	DET	DT	_	22	det	_	_
22	effect	_	NOUN	NN	_	31	nsubjpass	_	_
23	of	_	ADP	IN	_	24	case	_	_
24	MEVACOR	_	NOUN	NN	_	22	nmod	_	_
25	on	_	ADP	IN	_	26	case	_	_
26	outcomes	_	NOUN	NNS	_	22	nmod	_	_
27	could	_	VERB	MD	_	31	aux	_	_
28	not	_	ADV	RB	_	31	neg	_	_
29	be	_	VERB	VB	_	31	auxpass	_	_
30	adequately	_	ADV	RB	_	31	advmod	_	_
31	assessed	_	VERB	VBN	_	0	root	_	_
32	in	_	ADP	IN	_	34	case	_	_
33	this	_	DET	DT	_	34	det	_	_
34	subgroup	_	NOUN	NN	_	31	nmod	_	_

#	Lovastatin	5303
1	Figure	_	NOUN	NN	_	0	root	_	_
2	1	_	NUM	CD	_	1	nummod	_	_
3	:	_	.	:	_	1	punct	_	_
4	Acute	_	ADJ	JJ	_	7	amod	_	_
5	Major	_	ADJ	JJ	_	7	amod	_	_
6	Coronary	_	ADJ	JJ	_	7	amod	_	_
7	Events	_	NOUN	NNS	_	1	dep	_	_
8	Primary	_	ADJ	JJ	_	9	amod	_	_
9	Endpoint	_	NOUN	NN	_	7	dep	_	_
10	In	_	ADP	IN	_	17	case	_	_
11	the	_	DET	DT	_	17	det	_	_
12	Canadian	_	ADJ	JJ	_	17	amod	_	_
13	Coronary	_	ADJ	JJ	_	17	amod	_	_
14	Atherosclerosis	_	NOUN	NN	_	17	compound	_	_
15	Intervention	_	NOUN	NN	_	17	compound	_	_
16	Trial	_	ADJ	JJ	_	17	amod	_	_
17	CCAIT	_	NOUN	NN	_	9	nmod	_	_
18	,	_	.	,	_	7	punct	_	_
19	the	_	DET	DT	_	20	det	_	_
20	effect	_	NOUN	NN	_	29	nsubjpass	_	_
21	of	_	ADP	IN	_	22	case	_	_
22	therapy	_	NOUN	NN	_	20	nmod	_	_
23	with	_	ADP	IN	_	24	case	_	_
24	DRUG	_	NOUN	NN	_	20	nmod	_	_
25	on	_	ADP	IN	_	27	case	_	_
26	coronary	_	ADJ	JJ	_	27	amod	_	_
27	atherosclerosis	_	NOUN	NN	_	20	nmod	_	_
28	was	_	VERB	VBD	_	29	auxpass	_	_
29	assessed	_	VERB	VBN	_	7	dep	_	_
30	by	_	ADP	IN	_	32	case	_	_
31	coronary	_	ADJ	JJ	_	32	amod	_	_
32	angiography	_	NOUN	NN	_	29	nmod	_	_
33	in	_	ADP	IN	_	35	case	_	_
34	hyperlipidemic	_	ADJ	JJ	_	35	amod	_	_
35	patients	_	NOUN	NNS	_	32	nmod	_	_

#	Lovastatin	5304
1	In	_	ADP	IN	_	6	case	_	_
2	the	_	DET	DT	_	6	det	_	_
3	randomized	_	ADJ	JJ	_	6	amod	_	_
4	,	_	.	,	_	3	punct	_	_
5	double	_	ADJ	JJ	_	3	dep	_	_
6	blind	_	NOUN	NN	_	14	nmod	_	_
7	,	_	.	,	_	14	punct	_	_
8	controlled	_	VERB	VBD	_	10	amod	_	_
9	clinical	_	ADJ	JJ	_	10	amod	_	_
10	trial	_	ADJ	JJ	_	14	nmod	_	_
11	,	_	.	,	_	14	punct	_	_
12	patients	_	NOUN	NNS	_	14	nsubjpass	_	_
13	were	_	VERB	VBD	_	14	auxpass	_	_
14	treated	_	VERB	VBN	_	0	root	_	_
15	with	_	ADP	IN	_	17	case	_	_
16	conventional	_	ADJ	JJ	_	17	amod	_	_
17	measures	_	NOUN	NNS	_	14	nmod	_	_
18	usually	_	ADV	RB	_	19	advmod	_	_
19	diet	_	NOUN	NN	_	14	dobj	_	_
20	and	_	CONJ	CC	_	19	cc	_	_
21	325mg	_	NOUN	NN	_	19	conj	_	_
22	of	_	ADP	IN	_	26	case	_	_
23	aspirin	_	NOUN	NN	_	26	compound	_	_
24	every	_	ADV	RB	_	26	advmod	_	_
25	other	_	ADJ	JJ	_	26	amod	_	_
26	day	_	NOUN	NN	_	19	nmod	_	_
27	and	_	CONJ	CC	_	26	cc	_	_
28	either	_	CONJ	CC	_	32	cc:preconj	_	_
29	DRUG	_	NOUN	NN	_	32	compound	_	_
30	20	_	NUM	CD	_	32	nummod	_	_
31	80mg	_	ADJ	JJ	_	32	amod	_	_
32	daily	_	ADV	RB	_	26	conj	_	_
33	or	_	CONJ	CC	_	32	cc	_	_
34	placebo	_	NOUN	NN	_	32	conj	_	_

#	Lovastatin	5305
1	Angiograms	_	NOUN	NNS	_	3	nsubjpass	_	_
2	were	_	VERB	VBD	_	3	auxpass	_	_
3	evaluated	_	VERB	VBN	_	0	root	_	_
4	at	_	ADP	IN	_	5	case	_	_
5	baseline	_	NOUN	NN	_	3	nmod	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	at	_	ADP	IN	_	9	case	_	_
8	two	_	NUM	CD	_	9	nummod	_	_
9	years	_	NOUN	NNS	_	5	conj	_	_
10	by	_	ADP	IN	_	15	case	_	_
11	computerized	_	VERB	VBN	_	15	amod	_	_
12	quantitative	_	ADJ	JJ	_	15	amod	_	_
13	coronary	_	ADJ	JJ	_	15	amod	_	_
14	angiography	_	NOUN	NN	_	15	compound	_	_
15	QCA	_	NOUN	NN	_	3	nmod	_	_

#	Lovastatin	5306
1	DRUG	_	NOUN	NN	_	3	nsubj	_	_
2	significantly	_	ADV	RB	_	3	advmod	_	_
3	slowed	_	VERB	VBD	_	0	root	_	_
4	the	_	DET	DT	_	5	det	_	_
5	progression	_	NOUN	NN	_	3	dobj	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	lesions	_	NOUN	NNS	_	5	nmod	_	_
8	as	_	ADP	IN	_	9	mark	_	_
9	measured	_	VERB	VBN	_	3	advcl	_	_
10	by	_	ADP	IN	_	13	case	_	_
11	the	_	DET	DT	_	13	det	_	_
12	mean	_	NOUN	NN	_	13	amod	_	_
13	change	_	NOUN	NN	_	9	nmod	_	_
14	per	_	ADP	IN	_	15	case	_	_
15	patient	_	NOUN	NN	_	13	nmod	_	_
16	in	_	ADP	IN	_	19	case	_	_
17	minimum	_	ADJ	JJ	_	19	amod	_	_
18	lumen	_	NOUN	NN	_	19	compound	_	_
19	diameter	_	NOUN	NN	_	15	nmod	_	_
20	the	_	DET	DT	_	22	det	_	_
21	primary	_	ADJ	JJ	_	22	amod	_	_
22	endpoint	_	NOUN	NN	_	19	dep	_	_
23	and	_	CONJ	CC	_	22	cc	_	_
24	percent	_	NOUN	NN	_	26	compound	_	_
25	diameter	_	NOUN	NN	_	26	compound	_	_
26	stenosis	_	NOUN	NN	_	22	conj	_	_
27	,	_	.	,	_	3	punct	_	_
28	and	_	CONJ	CC	_	3	cc	_	_
29	decreased	_	VERB	VBD	_	3	conj	_	_
30	the	_	DET	DT	_	31	det	_	_
31	proportions	_	NOUN	NNS	_	29	dobj	_	_
32	of	_	ADP	IN	_	33	case	_	_
33	patients	_	NOUN	NNS	_	31	nmod	_	_
34	categorized	_	VERB	VBN	_	33	acl	_	_
35	with	_	ADP	IN	_	38	case	_	_
36	disease	_	NOUN	NN	_	38	compound	_	_
37	progression	_	NOUN	NN	_	38	compound	_	_
38	33%	_	NOUN	NN	_	34	nmod	_	_
39	vs	_	CONJ	CC	_	38	cc	_	_
40	50%	_	NOUN	NN	_	38	conj	_	_
41	and	_	CONJ	CC	_	38	cc	_	_
42	with	_	ADP	IN	_	44	case	_	_
43	new	_	ADJ	JJ	_	44	amod	_	_
44	lesions	_	NOUN	NNS	_	38	conj	_	_
45	16%	_	ADJ	JJ	_	44	dep	_	_
46	vs	_	CONJ	CC	_	45	cc	_	_
47	32%	_	ADJ	JJ	_	45	conj	_	_

#	Lovastatin	5307
1	In	_	ADP	IN	_	5	case	_	_
2	a	_	DET	DT	_	5	det	_	_
3	similarly	_	ADV	RB	_	4	advmod	_	_
4	designed	_	VERB	VBN	_	5	amod	_	_
5	trial	_	ADJ	JJ	_	0	root	_	_
6	,	_	.	,	_	5	punct	_	_
7	the	_	DET	DT	_	12	det	_	_
8	Monitored	_	VERB	VBN	_	12	amod	_	_
9	Atherosclerosis	_	NOUN	NN	_	12	compound	_	_
10	Regression	_	NOUN	NN	_	12	compound	_	_
11	Study	_	NOUN	NN	_	12	compound	_	_
12	MARS	_	NOUN	NN	_	6	root	_	_
13	,	_	.	,	_	12	punct	_	_
14	patients	_	NOUN	NNS	_	16	nsubjpass	_	_
15	were	_	VERB	VBD	_	16	auxpass	_	_
16	treated	_	VERB	VBN	_	12	dep	_	_
17	with	_	ADP	IN	_	18	case	_	_
18	diet	_	NOUN	NN	_	16	nmod	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	either	_	CONJ	CC	_	23	cc:preconj	_	_
21	DRUG	_	NOUN	NN	_	23	compound	_	_
22	80mg	_	ADJ	JJ	_	23	amod	_	_
23	daily	_	ADV	RB	_	18	conj	_	_
24	or	_	CONJ	CC	_	23	cc	_	_
25	placebo	_	NOUN	NN	_	23	conj	_	_

#	Lovastatin	5308
1	No	_	DET	DT	_	4	neg	_	_
2	statistically	_	ADV	RB	_	3	advmod	_	_
3	significant	_	ADJ	JJ	_	4	amod	_	_
4	difference	_	NOUN	NN	_	10	nsubjpass	_	_
5	between	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	placebo	_	NOUN	NN	_	6	conj	_	_
9	was	_	VERB	VBD	_	10	auxpass	_	_
10	seen	_	VERB	VBN	_	0	root	_	_
11	for	_	ADP	IN	_	16	case	_	_
12	the	_	DET	DT	_	16	det	_	_
13	primary	_	ADJ	JJ	_	16	amod	_	_
14	endpoint	_	NOUN	NN	_	16	compound	_	_
15	mean	_	NOUN	NN	_	16	compound	_	_
16	change	_	NOUN	NN	_	10	nmod	_	_
17	per	_	ADP	IN	_	18	case	_	_
18	patient	_	NOUN	NN	_	16	nmod	_	_
19	in	_	ADP	IN	_	22	case	_	_
20	percent	_	NOUN	NN	_	22	amod	_	_
21	diameter	_	NOUN	NN	_	22	compound	_	_
22	stenosis	_	NOUN	NN	_	18	nmod	_	_
23	of	_	ADP	IN	_	25	case	_	_
24	all	_	DET	DT	_	25	det	_	_
25	lesions	_	NOUN	NNS	_	22	nmod	_	_
26	,	_	.	,	_	10	punct	_	_
27	or	_	CONJ	CC	_	10	cc	_	_
28	for	_	ADP	IN	_	32	case	_	_
29	most	_	ADV	RB	_	32	amod	_	_
30	secondary	_	ADJ	JJ	_	32	amod	_	_
31	QCA	_	NOUN	NN	_	32	compound	_	_
32	endpoints	_	NOUN	NNS	_	10	conj	_	_

#	Lovastatin	5309
1	Visual	_	ADJ	JJ	_	2	amod	_	_
2	assessment	_	NOUN	NN	_	21	nsubj	_	_
3	by	_	ADP	IN	_	4	case	_	_
4	angiographers	_	NOUN	NNS	_	2	nmod	_	_
5	who	_	DET	WDT	_	6	nsubj	_	_
6	formed	_	VERB	VBD	_	4	acl:relcl	_	_
7	a	_	DET	DT	_	9	det	_	_
8	consensus	_	NOUN	NN	_	9	compound	_	_
9	opinion	_	NOUN	NN	_	6	dobj	_	_
10	of	_	ADP	IN	_	16	case	_	_
11	overall	_	ADJ	JJ	_	16	amod	_	_
12	angiographic	_	ADJ	JJ	_	16	amod	_	_
13	change	_	NOUN	NN	_	16	compound	_	_
14	Global	_	ADJ	JJ	_	16	amod	_	_
15	Change	_	NOUN	NN	_	16	compound	_	_
16	Score	_	NOUN	NN	_	9	nmod	_	_
17	was	_	VERB	VBD	_	21	cop	_	_
18	also	_	ADV	RB	_	21	advmod	_	_
19	a	_	DET	DT	_	21	det	_	_
20	secondary	_	ADJ	JJ	_	21	amod	_	_
21	endpoint	_	NOUN	NN	_	0	root	_	_

#	Lovastatin	5310
1	By	_	ADP	IN	_	3	case	_	_
2	this	_	DET	DT	_	3	det	_	_
3	endpoint	_	NOUN	NN	_	10	nmod	_	_
4	,	_	.	,	_	10	punct	_	_
5	significant	_	ADJ	JJ	_	6	amod	_	_
6	slowing	_	NOUN	NN	_	10	nsubjpass	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	disease	_	NOUN	NN	_	6	nmod	_	_
9	was	_	VERB	VBD	_	10	auxpass	_	_
10	seen	_	VERB	VBN	_	0	root	_	_
11	,	_	.	,	_	10	punct	_	_
12	with	_	ADP	IN	_	13	case	_	_
13	regression	_	NOUN	NN	_	10	nmod	_	_
14	in	_	ADP	IN	_	15	case	_	_
15	23%	_	NOUN	NN	_	13	nmod	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	patients	_	NOUN	NNS	_	15	nmod	_	_
18	treated	_	VERB	VBN	_	17	acl	_	_
19	with	_	ADP	IN	_	20	case	_	_
20	DRUG	_	NOUN	NN	_	18	nmod	_	_
21	compared	_	VERB	VBN	_	13	acl	_	_
22	to	_	PRT	TO	_	23	case	_	_
23	11%	_	NOUN	NN	_	21	nmod	_	_
24	of	_	ADP	IN	_	26	case	_	_
25	placebo	_	NOUN	NN	_	26	compound	_	_
26	patients	_	NOUN	NNS	_	23	nmod	_	_

#	Lovastatin	5311
1	In	_	ADP	IN	_	7	case	_	_
2	the	_	DET	DT	_	7	det	_	_
3	Familial	_	ADJ	JJ	_	7	amod	_	_
4	Atherosclerosis	_	NOUN	NN	_	7	compound	_	_
5	Treatment	_	NOUN	NN	_	7	compound	_	_
6	Study	_	NOUN	NN	_	7	compound	_	_
7	FATS	_	NOUN	NN	_	26	nmod	_	_
8	,	_	.	,	_	26	punct	_	_
9	either	_	CONJ	CC	_	10	cc:preconj	_	_
10	DRUG	_	NOUN	NN	_	26	nsubj	_	_
11	or	_	CONJ	CC	_	10	cc	_	_
12	niacin	_	NOUN	NN	_	10	conj	_	_
13	in	_	ADP	IN	_	14	case	_	_
14	combination	_	NOUN	NN	_	10	nmod	_	_
15	with	_	ADP	IN	_	19	case	_	_
16	a	_	DET	DT	_	19	det	_	_
17	bile	_	ADJ	JJ	_	19	amod	_	_
18	acid	_	NOUN	NN	_	19	compound	_	_
19	sequestrant	_	NOUN	NN	_	14	nmod	_	_
20	for	_	ADP	IN	_	21	case	_	_
21	2.5years	_	NOUN	NNS	_	19	nmod	_	_
22	in	_	ADP	IN	_	24	case	_	_
23	hyperlipidemic	_	ADJ	JJ	_	24	amod	_	_
24	subjects	_	NOUN	NNS	_	21	nmod	_	_
25	significantly	_	ADV	RB	_	26	advmod	_	_
26	reduced	_	VERB	VBD	_	0	root	_	_
27	the	_	DET	DT	_	28	det	_	_
28	frequency	_	NOUN	NN	_	26	dobj	_	_
29	of	_	ADP	IN	_	30	case	_	_
30	progression	_	NOUN	NN	_	28	nmod	_	_
31	and	_	CONJ	CC	_	26	cc	_	_
32	increased	_	VERB	VBD	_	26	conj	_	_
33	the	_	DET	DT	_	34	det	_	_
34	frequency	_	NOUN	NN	_	32	dobj	_	_
35	of	_	ADP	IN	_	36	case	_	_
36	regression	_	NOUN	NN	_	34	nmod	_	_
37	of	_	ADP	IN	_	40	case	_	_
38	coronary	_	ADJ	JJ	_	40	amod	_	_
39	atherosclerotic	_	ADJ	JJ	_	40	amod	_	_
40	lesions	_	NOUN	NNS	_	36	nmod	_	_
41	by	_	ADP	IN	_	42	case	_	_
42	QCA	_	NOUN	NN	_	34	nmod	_	_
43	compared	_	VERB	VBD	_	32	parataxis	_	_
44	to	_	PRT	TO	_	45	case	_	_
45	diet	_	NOUN	NN	_	43	nmod	_	_
46	and	_	CONJ	CC	_	43	cc	_	_
47	,	_	.	,	_	43	punct	_	_
48	in	_	ADP	IN	_	50	case	_	_
49	some	_	DET	DT	_	50	det	_	_
50	cases	_	NOUN	NNS	_	43	conj	_	_
51	,	_	.	,	_	50	punct	_	_
52	low	_	ADJ	JJ	_	54	amod	_	_
53	dose	_	NOUN	NN	_	54	compound	_	_
54	resin	_	NOUN	NN	_	51	root	_	_

#	Lovastatin	5312
1	The	_	DET	DT	_	2	det	_	_
2	effect	_	NOUN	NN	_	16	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	on	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	progression	_	NOUN	NN	_	2	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	atherosclerosis	_	NOUN	NN	_	7	nmod	_	_
10	in	_	ADP	IN	_	13	case	_	_
11	the	_	DET	DT	_	13	det	_	_
12	coronary	_	ADJ	JJ	_	13	amod	_	_
13	arteries	_	NOUN	NNS	_	7	nmod	_	_
14	has	_	VERB	VBZ	_	16	aux	_	_
15	been	_	VERB	VBN	_	16	auxpass	_	_
16	corroborated	_	VERB	VBN	_	0	root	_	_
17	by	_	ADP	IN	_	19	case	_	_
18	similar	_	ADJ	JJ	_	19	amod	_	_
19	findings	_	NOUN	NNS	_	16	nmod	_	_
20	in	_	ADP	IN	_	22	case	_	_
21	another	_	DET	DT	_	22	det	_	_
22	vasculature	_	ADJ	JJ	_	19	nmod	_	_

#	Lovastatin	5313
1	In	_	ADP	IN	_	8	case	_	_
2	the	_	DET	DT	_	8	det	_	_
3	Asymptomatic	_	ADJ	JJ	_	8	amod	_	_
4	Carotid	_	NOUN	NN	_	8	compound	_	_
5	Artery	_	NOUN	NN	_	8	compound	_	_
6	Progression	_	NOUN	NN	_	8	compound	_	_
7	Study	_	NOUN	NN	_	8	compound	_	_
8	ACAPS	_	NOUN	NN	_	20	nmod	_	_
9	,	_	.	,	_	20	punct	_	_
10	the	_	DET	DT	_	11	det	_	_
11	effect	_	NOUN	NN	_	20	nsubjpass	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	therapy	_	NOUN	NN	_	11	nmod	_	_
14	with	_	ADP	IN	_	15	case	_	_
15	DRUG	_	NOUN	NN	_	11	nmod	_	_
16	on	_	ADP	IN	_	18	case	_	_
17	carotid	_	NOUN	NN	_	18	compound	_	_
18	atherosclerosis	_	NOUN	NN	_	11	nmod	_	_
19	was	_	VERB	VBD	_	20	auxpass	_	_
20	assessed	_	VERB	VBN	_	0	root	_	_
21	by	_	ADP	IN	_	24	case	_	_
22	B	_	NOUN	NN	_	24	compound	_	_
23	mode	_	NOUN	NN	_	24	compound	_	_
24	ultrasonography	_	NOUN	NN	_	20	nmod	_	_
25	in	_	ADP	IN	_	27	case	_	_
26	hyperlipidemic	_	ADJ	JJ	_	27	amod	_	_
27	patients	_	NOUN	NNS	_	20	nmod	_	_
28	with	_	ADP	IN	_	31	case	_	_
29	early	_	ADJ	JJ	_	31	amod	_	_
30	carotid	_	NOUN	NN	_	31	compound	_	_
31	lesions	_	NOUN	NNS	_	27	nmod	_	_
32	and	_	CONJ	CC	_	27	cc	_	_
33	without	_	ADP	IN	_	37	case	_	_
34	known	_	VERB	VBN	_	37	amod	_	_
35	coronary	_	ADJ	JJ	_	37	amod	_	_
36	heart	_	NOUN	NN	_	37	compound	_	_
37	disease	_	NOUN	NN	_	27	conj	_	_
38	at	_	ADP	IN	_	39	case	_	_
39	baseline	_	NOUN	NN	_	37	nmod	_	_

#	Lovastatin	5314
1	In	_	ADP	IN	_	4	case	_	_
2	this	_	DET	DT	_	4	det	_	_
3	double	_	ADJ	JJ	_	4	amod	_	_
4	blind	_	NOUN	NN	_	0	root	_	_
5	,	_	.	,	_	4	punct	_	_
6	controlled	_	VERB	VBN	_	8	amod	_	_
7	clinical	_	ADJ	JJ	_	8	amod	_	_
8	trial	_	ADJ	JJ	_	5	root	_	_
9	,	_	.	,	_	8	punct	_	_
10	919	_	NUM	CD	_	11	nummod	_	_
11	patients	_	NOUN	NNS	_	13	nsubjpass	_	_
12	were	_	VERB	VBD	_	13	auxpass	_	_
13	randomized	_	VERB	VBN	_	8	dep	_	_
14	in	_	ADP	IN	_	18	case	_	_
15	a	_	DET	DT	_	18	det	_	_
16	2x2	_	NUM	CD	_	18	nummod	_	_
17	factorial	_	ADJ	JJ	_	18	amod	_	_
18	design	_	NOUN	NN	_	13	nmod	_	_
19	to	_	PRT	TO	_	20	case	_	_
20	placebo	_	NOUN	NN	_	18	nmod	_	_
21	,	_	.	,	_	20	punct	_	_
22	DRUG	_	NOUN	NN	_	25	compound	_	_
23	10	_	NUM	CD	_	25	nummod	_	_
24	40mg	_	ADJ	JJ	_	25	amod	_	_
25	daily	_	ADV	RB	_	20	conj	_	_
26	and	_	CONJ	CC	_	20	cc	_	_
27	/	_	.	.	_	20	conj	_	_
28	or	_	CONJ	CC	_	27	cc	_	_
29	warfarin	_	NOUN	NN	_	27	root	_	_

#	Lovastatin	5315
1	Ultrasonograms	_	NOUN	NNS	_	7	nsubjpass	_	_
2	of	_	ADP	IN	_	5	case	_	_
3	the	_	DET	DT	_	5	det	_	_
4	carotid	_	NOUN	NN	_	5	compound	_	_
5	walls	_	NOUN	NNS	_	1	nmod	_	_
6	were	_	VERB	VBD	_	7	auxpass	_	_
7	used	_	VERB	VBN	_	0	root	_	_
8	to	_	PRT	TO	_	9	mark	_	_
9	determine	_	VERB	VB	_	7	xcomp	_	_
10	the	_	DET	DT	_	11	det	_	_
11	change	_	NOUN	NN	_	9	dobj	_	_
12	per	_	ADP	IN	_	13	case	_	_
13	patient	_	NOUN	NN	_	11	nmod	_	_
14	from	_	ADP	IN	_	15	case	_	_
15	baseline	_	NOUN	NN	_	13	nmod	_	_
16	to	_	PRT	TO	_	18	case	_	_
17	three	_	NUM	CD	_	18	nummod	_	_
18	years	_	NOUN	NNS	_	13	nmod	_	_
19	in	_	ADP	IN	_	25	case	_	_
20	mean	_	ADJ	JJ	_	25	amod	_	_
21	maximum	_	NOUN	NN	_	25	compound	_	_
22	intimal	_	ADJ	JJ	_	25	amod	_	_
23	medial	_	ADJ	JJ	_	25	amod	_	_
24	thickness	_	NOUN	NN	_	25	amod	_	_
25	IMT	_	NOUN	NN	_	13	nmod	_	_
26	of	_	ADP	IN	_	29	case	_	_
27	12	_	NUM	CD	_	29	nummod	_	_
28	measured	_	ADJ	JJ	_	29	amod	_	_
29	segments	_	NOUN	NNS	_	25	nmod	_	_

#	Lovastatin	5316
1	There	_	DET	EX	_	2	expl	_	_
2	was	_	VERB	VBD	_	0	root	_	_
3	a	_	DET	DT	_	5	det	_	_
4	significant	_	ADJ	JJ	_	5	amod	_	_
5	regression	_	NOUN	NN	_	2	nsubj	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	carotid	_	NOUN	NN	_	8	compound	_	_
8	lesions	_	NOUN	NNS	_	5	nmod	_	_
9	in	_	ADP	IN	_	10	case	_	_
10	patients	_	NOUN	NNS	_	5	nmod	_	_
11	receiving	_	VERB	VBG	_	10	acl	_	_
12	DRUG	_	NOUN	NN	_	11	dobj	_	_
13	alone	_	ADV	RB	_	11	advmod	_	_
14	compared	_	VERB	VBD	_	2	dep	_	_
15	to	_	PRT	TO	_	16	case	_	_
16	those	_	DET	DT	_	14	nmod	_	_
17	receiving	_	VERB	VBG	_	16	acl	_	_
18	placebo	_	NOUN	NN	_	17	dobj	_	_
19	alone	_	ADV	RB	_	20	advmod	_	_
20	p=0.001	_	NOUN	NN	_	18	nmod	_	_

#	Lovastatin	5317
1	The	_	DET	DT	_	3	det	_	_
2	predictive	_	ADJ	JJ	_	3	amod	_	_
3	value	_	NOUN	NN	_	14	nsubjpass	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	changes	_	NOUN	NNS	_	3	nmod	_	_
6	in	_	ADP	IN	_	7	case	_	_
7	IMT	_	NOUN	NN	_	5	nmod	_	_
8	for	_	ADP	IN	_	9	case	_	_
9	stroke	_	NOUN	NN	_	5	nmod	_	_
10	has	_	VERB	VBZ	_	14	aux	_	_
11	not	_	ADV	RB	_	14	neg	_	_
12	yet	_	ADV	RB	_	14	advmod	_	_
13	been	_	VERB	VBN	_	14	auxpass	_	_
14	established	_	VERB	VBN	_	0	root	_	_

#	Lovastatin	5318
1	In	_	ADP	IN	_	4	case	_	_
2	the	_	DET	DT	_	4	det	_	_
3	DRUG	_	NOUN	NN	_	4	compound	_	_
4	group	_	NOUN	NN	_	6	nmod	_	_
5	there	_	DET	EX	_	6	expl	_	_
6	was	_	VERB	VBD	_	0	root	_	_
7	a	_	DET	DT	_	9	det	_	_
8	significant	_	ADJ	JJ	_	9	amod	_	_
9	reduction	_	NOUN	NN	_	6	nsubj	_	_
10	in	_	ADP	IN	_	12	case	_	_
11	the	_	DET	DT	_	12	det	_	_
12	number	_	NOUN	NN	_	9	nmod	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	patients	_	NOUN	NNS	_	12	nmod	_	_
15	with	_	ADP	IN	_	18	case	_	_
16	major	_	ADJ	JJ	_	18	amod	_	_
17	cardiovascular	_	ADJ	JJ	_	18	amod	_	_
18	events	_	NOUN	NNS	_	14	nmod	_	_
19	relative	_	ADJ	JJ	_	12	amod	_	_
20	to	_	PRT	TO	_	23	case	_	_
21	the	_	DET	DT	_	23	det	_	_
22	placebo	_	NOUN	NN	_	23	compound	_	_
23	group	_	NOUN	NN	_	19	nmod	_	_
24	5	_	NUM	CD	_	23	dep	_	_
25	vs	_	CONJ	CC	_	24	cc	_	_
26	14	_	NUM	CD	_	24	conj	_	_
27	and	_	CONJ	CC	_	23	cc	_	_
28	a	_	DET	DT	_	30	det	_	_
29	significant	_	ADJ	JJ	_	30	amod	_	_
30	reduction	_	NOUN	NN	_	23	conj	_	_
31	in	_	ADP	IN	_	34	case	_	_
32	all	_	DET	DT	_	34	det	_	_
33	cause	_	NOUN	NN	_	34	compound	_	_
34	mortality	_	NOUN	NN	_	30	nmod	_	_
35	1	_	NUM	CD	_	34	nummod	_	_
36	vs	_	CONJ	CC	_	35	cc	_	_
37	8	_	NUM	CD	_	35	conj	_	_

#	Lovastatin	5319
1	There	_	DET	EX	_	2	expl	_	_
2	was	_	VERB	VBD	_	0	root	_	_
3	a	_	DET	DT	_	5	det	_	_
4	high	_	ADJ	JJ	_	5	amod	_	_
5	prevalence	_	NOUN	NN	_	2	nsubj	_	_
6	of	_	ADP	IN	_	9	case	_	_
7	baseline	_	NOUN	NN	_	9	compound	_	_
8	lenticular	_	ADJ	JJ	_	9	amod	_	_
9	opacities	_	NOUN	NNS	_	5	nmod	_	_
10	in	_	ADP	IN	_	13	case	_	_
11	the	_	DET	DT	_	13	det	_	_
12	patient	_	NOUN	NN	_	13	compound	_	_
13	population	_	NOUN	NN	_	5	nmod	_	_
14	included	_	VERB	VBN	_	2	dep	_	_
15	in	_	ADP	IN	_	19	case	_	_
16	the	_	DET	DT	_	19	det	_	_
17	early	_	ADJ	JJ	_	19	amod	_	_
18	clinical	_	ADJ	JJ	_	19	amod	_	_
19	trials	_	NOUN	NNS	_	14	nmod	_	_
20	with	_	ADP	IN	_	21	case	_	_
21	DRUG	_	NOUN	NN	_	19	nmod	_	_

#	Lovastatin	5320
1	During	_	ADP	IN	_	3	case	_	_
2	these	_	DET	DT	_	3	det	_	_
3	trials	_	NOUN	NNS	_	10	nmod	_	_
4	the	_	DET	DT	_	5	det	_	_
5	appearance	_	NOUN	NN	_	10	nsubjpass	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	new	_	ADJ	JJ	_	8	amod	_	_
8	opacities	_	NOUN	NNS	_	5	nmod	_	_
9	was	_	VERB	VBD	_	10	auxpass	_	_
10	noted	_	VERB	VBN	_	0	root	_	_
11	in	_	ADP	IN	_	14	case	_	_
12	both	_	CONJ	CC	_	14	cc:preconj	_	_
13	the	_	DET	DT	_	14	dep	_	_
14	DRUG	_	NOUN	NN	_	10	nmod	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	placebo	_	NOUN	NN	_	14	conj	_	_
17	groups	_	NOUN	NNS	_	14	dep	_	_

#	Lovastatin	5321
1	There	_	DET	EX	_	2	expl	_	_
2	was	_	VERB	VBD	_	0	root	_	_
3	no	_	DET	DT	_	6	neg	_	_
4	clinically	_	ADV	RB	_	5	advmod	_	_
5	significant	_	ADJ	JJ	_	6	amod	_	_
6	change	_	NOUN	NN	_	2	nsubj	_	_
7	in	_	ADP	IN	_	9	case	_	_
8	visual	_	ADJ	JJ	_	9	amod	_	_
9	acuity	_	NOUN	NN	_	6	nmod	_	_
10	in	_	ADP	IN	_	12	case	_	_
11	the	_	DET	DT	_	12	det	_	_
12	patients	_	NOUN	NNS	_	9	nmod	_	_
13	who	_	DET	WDT	_	14	nsubj	_	_
14	had	_	VERB	VBD	_	12	acl:relcl	_	_
15	new	_	ADJ	JJ	_	16	amod	_	_
16	opacities	_	NOUN	NNS	_	14	dobj	_	_
17	reported	_	VERB	VBN	_	16	acl	_	_
18	nor	_	CONJ	CC	_	17	cc	_	_
19	was	_	VERB	VBD	_	21	cop	_	_
20	any	_	DET	DT	_	21	det	_	_
21	patient	_	NOUN	NN	_	17	conj	_	_
22	,	_	.	,	_	2	punct	_	_
23	including	_	VERB	VBG	_	24	case	_	_
24	those	_	DET	DT	_	2	nmod	_	_
25	with	_	ADP	IN	_	26	case	_	_
26	opacities	_	NOUN	NNS	_	24	nmod	_	_
27	noted	_	VERB	VBN	_	26	acl	_	_
28	at	_	ADP	IN	_	29	case	_	_
29	baseline	_	NOUN	NN	_	27	nmod	_	_
30	,	_	.	,	_	2	punct	_	_
31	discontinued	_	VERB	VBN	_	2	xcomp	_	_
32	from	_	ADP	IN	_	33	case	_	_
33	therapy	_	NOUN	NN	_	31	nmod	_	_
34	because	_	ADP	IN	_	37	case	_	_
35	of	_	ADP	IN	_	37	case	_	_
36	a	_	DET	DT	_	37	det	_	_
37	decrease	_	NOUN	NN	_	31	nmod	_	_
38	in	_	ADP	IN	_	40	case	_	_
39	visual	_	ADJ	JJ	_	40	amod	_	_
40	acuity	_	NOUN	NN	_	37	nmod	_	_

#	Lovastatin	5322
1	A	_	DET	DT	_	3	det	_	_
2	three	_	NUM	CD	_	3	nummod	_	_
3	year	_	NOUN	NN	_	24	nsubj	_	_
4	,	_	.	,	_	3	punct	_	_
5	double	_	ADJ	JJ	_	6	amod	_	_
6	blind	_	NOUN	NN	_	3	appos	_	_
7	,	_	.	,	_	3	punct	_	_
8	placebo	_	NOUN	NN	_	10	compound	_	_
9	controlled	_	VERB	VBD	_	10	amod	_	_
10	study	_	NOUN	NN	_	3	appos	_	_
11	in	_	ADP	IN	_	13	case	_	_
12	hypercholesterolemic	_	ADJ	JJ	_	13	amod	_	_
13	patients	_	NOUN	NNS	_	10	nmod	_	_
14	to	_	PRT	TO	_	15	mark	_	_
15	assess	_	VERB	VB	_	10	acl	_	_
16	the	_	DET	DT	_	17	det	_	_
17	effect	_	NOUN	NN	_	15	dobj	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	DRUG	_	NOUN	NN	_	17	nmod	_	_
20	on	_	ADP	IN	_	23	case	_	_
21	the	_	DET	DT	_	23	det	_	_
22	human	_	ADJ	JJ	_	23	amod	_	_
23	lens	_	NOUN	NN	_	17	nmod	_	_
24	demonstrated	_	VERB	VBD	_	0	root	_	_
25	that	_	ADP	IN	_	27	mark	_	_
26	there	_	DET	EX	_	27	expl	_	_
27	were	_	VERB	VBD	_	24	ccomp	_	_
28	no	_	DET	DT	_	33	neg	_	_
29	clinically	_	ADV	RB	_	30	advmod	_	_
30	or	_	CONJ	CC	_	33	amod	_	_
31	statistically	_	ADV	RB	_	30	advmod	_	_
32	significant	_	ADJ	JJ	_	33	amod	_	_
33	differences	_	NOUN	NNS	_	27	nsubj	_	_
34	between	_	ADP	IN	_	39	case	_	_
35	the	_	DET	DT	_	39	det	_	_
36	DRUG	_	NOUN	NN	_	39	compound	_	_
37	and	_	CONJ	CC	_	36	cc	_	_
38	placebo	_	NOUN	NN	_	36	conj	_	_
39	groups	_	NOUN	NNS	_	33	nmod	_	_
40	in	_	ADP	IN	_	42	case	_	_
41	the	_	DET	DT	_	42	det	_	_
42	incidence	_	NOUN	NN	_	33	nmod	_	_
43	,	_	.	,	_	42	punct	_	_
44	type	_	NOUN	NN	_	42	conj	_	_
45	or	_	CONJ	CC	_	42	cc	_	_
46	progression	_	NOUN	NN	_	42	conj	_	_
47	of	_	ADP	IN	_	49	case	_	_
48	lenticular	_	ADJ	JJ	_	49	amod	_	_
49	opacities	_	NOUN	NNS	_	42	nmod	_	_

#	Lovastatin	5323
1	There	_	DET	EX	_	2	expl	_	_
2	are	_	VERB	VBP	_	0	root	_	_
3	no	_	DET	DT	_	6	neg	_	_
4	controlled	_	VERB	VBN	_	6	amod	_	_
5	clinical	_	ADJ	JJ	_	6	amod	_	_
6	data	_	NOUN	NNS	_	2	nsubj	_	_
7	assessing	_	VERB	VBG	_	6	acl	_	_
8	the	_	DET	DT	_	9	det	_	_
9	lens	_	NOUN	NN	_	7	dobj	_	_
10	available	_	ADJ	JJ	_	9	amod	_	_
11	for	_	ADP	IN	_	12	case	_	_
12	treatment	_	NOUN	NN	_	10	nmod	_	_
13	beyond	_	ADP	IN	_	15	case	_	_
14	three	_	NUM	CD	_	15	nummod	_	_
15	years	_	NOUN	NNS	_	12	nmod	_	_

#	Lovastatin	5324
1	In	_	ADP	IN	_	4	case	_	_
2	a	_	DET	DT	_	4	det	_	_
3	double	_	ADJ	JJ	_	4	amod	_	_
4	blind	_	NOUN	NN	_	7	nmod	_	_
5	,	_	.	,	_	7	punct	_	_
6	placebo	_	NOUN	NN	_	7	nsubj	_	_
7	controlled	_	VERB	VBD	_	0	root	_	_
8	study	_	NOUN	NN	_	7	dobj	_	_
9	,	_	.	,	_	7	punct	_	_
10	132	_	NUM	CD	_	13	nummod	_	_
11	boys	_	NOUN	NNS	_	13	dep	_	_
12	10	_	NUM	CD	_	13	nummod	_	_
13	17years	_	NOUN	NNS	_	25	nsubjpass	_	_
14	of	_	ADP	IN	_	18	case	_	_
15	age	_	NOUN	NN	_	18	compound	_	_
16	mean	_	NOUN	NN	_	18	compound	_	_
17	age	_	NOUN	NN	_	18	compound	_	_
18	12.7yrs	_	NOUN	NNS	_	13	nmod	_	_
19	with	_	ADP	IN	_	23	case	_	_
20	heterozygous	_	ADJ	JJ	_	23	amod	_	_
21	familial	_	ADJ	JJ	_	23	amod	_	_
22	hypercholesterolemia	_	NOUN	NN	_	23	compound	_	_
23	heFH	_	NOUN	NN	_	13	nmod	_	_
24	were	_	VERB	VBD	_	25	auxpass	_	_
25	randomized	_	VERB	VBN	_	7	parataxis	_	_
26	to	_	PRT	TO	_	28	case	_	_
27	DRUG	_	NOUN	NN	_	28	compound	_	_
28	n=67	_	NOUN	NN	_	25	nmod	_	_
29	or	_	CONJ	CC	_	28	cc	_	_
30	placebo	_	NOUN	NN	_	31	compound	_	_
31	n=65	_	NOUN	NN	_	28	conj	_	_
32	for	_	ADP	IN	_	33	case	_	_
33	48weeks	_	NOUN	NNS	_	28	nmod	_	_

#	Lovastatin	5325
1	Inclusion	_	NOUN	NN	_	5	nsubj	_	_
2	in	_	ADP	IN	_	4	case	_	_
3	the	_	DET	DT	_	4	det	_	_
4	study	_	NOUN	NN	_	1	nmod	_	_
5	required	_	VERB	VBD	_	0	root	_	_
6	a	_	DET	DT	_	10	det	_	_
7	baseline	_	NOUN	NN	_	10	compound	_	_
8	LDL	_	NOUN	NN	_	10	compound	_	_
9	C	_	NOUN	NN	_	10	compound	_	_
10	level	_	NOUN	NN	_	5	dobj	_	_
11	between	_	ADP	IN	_	16	case	_	_
12	189	_	NUM	CD	_	16	nummod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	500mg	_	ADJ	JJ	_	12	conj	_	_
15	/	_	.	:	_	16	punct	_	_
16	dL	_	NOUN	NN	_	10	nmod	_	_
17	and	_	CONJ	CC	_	10	cc	_	_
18	at	_	ADP	IN	_	19	case	_	_
19	least	_	ADJ	JJS	_	20	nmod:npmod	_	_
20	one	_	NUM	CD	_	21	nummod	_	_
21	parent	_	NOUN	NN	_	10	conj	_	_
22	with	_	ADP	IN	_	27	case	_	_
23	an	_	DET	DT	_	27	det	_	_
24	LDL	_	NOUN	NN	_	27	compound	_	_
25	C	_	NOUN	NN	_	27	compound	_	_
26	level	_	NOUN	NN	_	27	compound	_	_
27	>189mg	_	ADJ	JJ	_	21	nmod	_	_
28	/	_	.	-RRB-	_	10	punct	_	_
29	dL	_	ADP	IN	_	10	punct	_	_

#	Lovastatin	5326
1	The	_	DET	DT	_	6	det	_	_
2	mean	_	ADJ	JJ	_	6	compound	_	_
3	baseline	_	NOUN	NN	_	6	compound	_	_
4	LDL	_	NOUN	NN	_	6	compound	_	_
5	C	_	NOUN	NN	_	6	compound	_	_
6	value	_	NOUN	NN	_	8	nsubj	_	_
7	was	_	VERB	VBD	_	8	cop	_	_
8	253.1mg	_	ADJ	JJ	_	0	root	_	_
9	/	_	.	:	_	8	punct	_	_
10	dL	_	NOUN	NN	_	11	compound	_	_
11	range	_	NOUN	NN	_	8	parataxis	_	_
12	:	_	.	:	_	11	punct	_	_
13	171	_	NUM	CD	_	14	nummod	_	_
14	379mg	_	ADJ	JJ	_	11	dep	_	_
15	/	_	.	:	_	11	punct	_	_
16	dL	_	NOUN	NN	_	21	nsubj	_	_
17	in	_	ADP	IN	_	20	case	_	_
18	the	_	DET	DT	_	20	det	_	_
19	MEVACOR	_	NOUN	NN	_	20	compound	_	_
20	group	_	NOUN	NN	_	16	nmod	_	_
21	compared	_	VERB	VBD	_	11	dep	_	_
22	to	_	PRT	TO	_	26	case	_	_
23	248.2mg	_	ADJ	JJ	_	26	amod	_	_
24	/	_	.	:	_	26	punct	_	_
25	dL	_	NOUN	NN	_	26	compound	_	_
26	range	_	NOUN	NN	_	21	nmod	_	_
27	:	_	.	:	_	21	punct	_	_
28	158.5	_	NUM	CD	_	29	nummod	_	_
29	413.5mg	_	ADJ	JJ	_	21	parataxis	_	_
30	/	_	.	:	_	29	punct	_	_
31	dL	_	NOUN	NN	_	29	dep	_	_
32	in	_	ADP	IN	_	35	case	_	_
33	the	_	DET	DT	_	35	det	_	_
34	placebo	_	NOUN	NN	_	35	compound	_	_
35	group	_	NOUN	NN	_	31	nmod	_	_

#	Lovastatin	5327
1	The	_	DET	DT	_	2	det	_	_
2	dosage	_	NOUN	NN	_	11	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	once	_	ADV	RB	_	6	advmod	_	_
6	daily	_	ADV	RB	_	2	advmod	_	_
7	in	_	ADP	IN	_	9	case	_	_
8	the	_	DET	DT	_	9	det	_	_
9	evening	_	NOUN	NN	_	6	nmod	_	_
10	was	_	VERB	VBD	_	11	cop	_	_
11	10mg	_	ADJ	JJ	_	0	root	_	_
12	for	_	ADP	IN	_	15	case	_	_
13	the	_	DET	DT	_	15	det	_	_
14	first	_	ADJ	JJ	_	15	amod	_	_
15	8weeks	_	NOUN	NNS	_	11	nmod	_	_
16	,	_	.	,	_	15	punct	_	_
17	20mg	_	ADJ	JJ	_	15	conj	_	_
18	for	_	ADP	IN	_	21	case	_	_
19	the	_	DET	DT	_	21	det	_	_
20	second	_	ADJ	JJ	_	21	amod	_	_
21	8weeks	_	NOUN	NNS	_	17	nmod	_	_
22	,	_	.	,	_	15	punct	_	_
23	and	_	CONJ	CC	_	15	cc	_	_
24	40mg	_	NOUN	NN	_	15	conj	_	_
25	thereafter	_	ADV	RB	_	11	advmod	_	_

#	Lovastatin	5328
1	MEVACOR	_	NOUN	NN	_	3	nsubj	_	_
2	significantly	_	ADV	RB	_	3	advmod	_	_
3	decreased	_	VERB	VBD	_	0	root	_	_
4	plasma	_	NOUN	NN	_	5	compound	_	_
5	levels	_	NOUN	NNS	_	3	dobj	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	total	_	ADJ	JJ	_	8	amod	_	_
8	C	_	NOUN	NN	_	5	nmod	_	_
9	,	_	.	,	_	8	punct	_	_
10	LDL	_	NOUN	NN	_	11	compound	_	_
11	C	_	NOUN	NN	_	8	conj	_	_
12	and	_	CONJ	CC	_	8	cc	_	_
13	apolipoproteinB	_	NOUN	NN	_	8	conj	_	_

#	Lovastatin	5329
1	TABLE	_	NOUN	NN	_	0	root	_	_
2	V	_	NUM	CD	_	1	nummod	_	_
3	:	_	.	:	_	1	punct	_	_
4	Lipid	_	NOUN	NN	_	6	compound	_	_
5	lowering	_	VERB	VBG	_	6	compound	_	_
6	Effects	_	NOUN	NNS	_	65	nsubj	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	in	_	ADP	IN	_	11	case	_	_
10	Adolescent	_	ADJ	JJ	_	11	amod	_	_
11	Boys	_	NOUN	NN	_	6	nmod	_	_
12	with	_	ADP	IN	_	18	case	_	_
13	Heterozygous	_	ADJ	JJ	_	18	amod	_	_
14	Familial	_	ADJ	JJ	_	18	amod	_	_
15	Hypercholesterolemia	_	NOUN	NN	_	18	compound	_	_
16	Mean	_	NOUN	NN	_	18	compound	_	_
17	Percent	_	ADJ	JJ	_	18	amod	_	_
18	Change	_	NOUN	NN	_	6	nmod	_	_
19	from	_	ADP	IN	_	20	case	_	_
20	Baseline	_	NOUN	NN	_	18	nmod	_	_
21	at	_	ADP	IN	_	22	case	_	_
22	Week48	_	NOUN	NN	_	18	nmod	_	_
23	in	_	ADP	IN	_	24	case	_	_
24	Intention	_	NOUN	NN	_	6	nmod	_	_
25	to	_	PRT	TO	_	36	case	_	_
26	Treat	_	NOUN	NN	_	36	compound	_	_
27	Population	_	NOUN	NN	_	36	compound	_	_
28	DOSAGE	_	NOUN	NN	_	36	compound	_	_
29	N	_	NOUN	NN	_	36	compound	_	_
30	TOTAL	_	NOUN	NN	_	36	compound	_	_
31	C	_	NOUN	NN	_	36	compound	_	_
32	LDL	_	NOUN	NN	_	36	compound	_	_
33	C	_	NOUN	NN	_	36	compound	_	_
34	HDL	_	NOUN	NN	_	36	compound	_	_
35	C	_	NOUN	NN	_	36	compound	_	_
36	TG.data	_	NOUN	NN	_	24	nmod	_	_
37	presented	_	VERB	VBN	_	36	acl	_	_
38	as	_	ADP	IN	_	63	case	_	_
39	median	_	ADJ	JJ	_	63	amod	_	_
40	percent	_	NOUN	NN	_	63	compound	_	_
41	changes	_	NOUN	NNS	_	63	compound	_	_
42	Apolipoprotein	_	NOUN	NN	_	63	compound	_	_
43	B	_	NOUN	NN	_	63	compound	_	_
44	Placebo	_	NOUN	NN	_	63	compound	_	_
45	61	_	NUM	CD	_	63	nummod	_	_
46	1.1	_	NUM	CD	_	63	nummod	_	_
47	1.4	_	NUM	CD	_	63	nummod	_	_
48	2.2	_	NUM	CD	_	63	nummod	_	_
49	1.4	_	NUM	CD	_	63	nummod	_	_
50	4.4	_	NUM	CD	_	63	nummod	_	_
51	MEVACOR	_	NOUN	NN	_	63	compound	_	_
52	64	_	NUM	CD	_	63	nummod	_	_
53	19.3	_	NUM	CD	_	63	nummod	_	_
54	24.2	_	NUM	CD	_	63	nummod	_	_
55	+1.1	_	NUM	CD	_	63	nummod	_	_
56	1.9	_	NUM	CD	_	63	nummod	_	_
57	21	_	NUM	CD	_	56	dep	_	_
58	The	_	DET	DT	_	63	det	_	_
59	mean	_	ADJ	JJ	_	63	amod	_	_
60	achieved	_	VERB	VBN	_	63	amod	_	_
61	LDL	_	NOUN	NN	_	63	compound	_	_
62	C	_	NOUN	NN	_	63	compound	_	_
63	value	_	NOUN	NN	_	37	nmod	_	_
64	was	_	VERB	VBD	_	65	cop	_	_
65	190.9mg	_	ADJ	JJ	_	1	dep	_	_
66	/	_	.	:	_	65	punct	_	_
67	dL	_	NOUN	NN	_	68	compound	_	_
68	range	_	NOUN	NN	_	65	parataxis	_	_
69	:	_	.	:	_	68	punct	_	_
70	108	_	NUM	CD	_	71	nummod	_	_
71	336mg	_	ADJ	JJ	_	68	dep	_	_
72	/	_	.	:	_	68	punct	_	_
73	dL	_	NOUN	NN	_	78	nsubj	_	_
74	in	_	ADP	IN	_	77	case	_	_
75	the	_	DET	DT	_	77	det	_	_
76	MEVACOR	_	NOUN	NN	_	77	compound	_	_
77	group	_	NOUN	NN	_	73	nmod	_	_
78	compared	_	VERB	VBD	_	68	dep	_	_
79	to	_	PRT	TO	_	83	case	_	_
80	244.8mg	_	ADJ	JJ	_	83	amod	_	_
81	/	_	.	:	_	83	punct	_	_
82	dL	_	NOUN	NN	_	83	compound	_	_
83	range	_	NOUN	NN	_	78	nmod	_	_
84	:	_	.	:	_	78	punct	_	_
85	135	_	NUM	CD	_	88	nummod	_	_
86	404mg	_	ADJ	JJ	_	88	amod	_	_
87	/	_	.	:	_	86	punct	_	_
88	dL	_	NOUN	NN	_	78	dobj	_	_
89	in	_	ADP	IN	_	92	case	_	_
90	the	_	DET	DT	_	92	det	_	_
91	placebo	_	NOUN	NN	_	92	compound	_	_
92	group	_	NOUN	NN	_	88	nmod	_	_

#	Lovastatin	5330
1	In	_	ADP	IN	_	4	case	_	_
2	a	_	DET	DT	_	4	det	_	_
3	double	_	ADJ	JJ	_	4	amod	_	_
4	blind	_	NOUN	NN	_	7	nmod	_	_
5	,	_	.	,	_	7	punct	_	_
6	placebo	_	NOUN	NN	_	7	nsubj	_	_
7	controlled	_	VERB	VBD	_	0	root	_	_
8	study	_	NOUN	NN	_	7	dobj	_	_
9	,	_	.	,	_	8	punct	_	_
10	54	_	NUM	CD	_	11	nummod	_	_
11	girls	_	NOUN	NNS	_	26	nsubjpass	_	_
12	10	_	NUM	CD	_	13	nummod	_	_
13	17years	_	NOUN	NNS	_	11	dep	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	age	_	NOUN	NN	_	11	nmod	_	_
16	who	_	DET	WDT	_	22	nsubj	_	_
17	were	_	VERB	VBD	_	22	cop	_	_
18	at	_	ADP	IN	_	22	case	_	_
19	least	_	ADV	RB	_	20	advmod	_	_
20	1year	_	ADJ	JJ	_	22	amod	_	_
21	post	_	ADJ	JJ	_	22	amod	_	_
22	menarche	_	NOUN	NN	_	15	acl:relcl	_	_
23	with	_	ADP	IN	_	24	case	_	_
24	heFH	_	NOUN	NN	_	22	nmod	_	_
25	were	_	VERB	VBD	_	26	auxpass	_	_
26	randomized	_	VERB	VBN	_	8	dep	_	_
27	to	_	PRT	TO	_	29	case	_	_
28	DRUG	_	NOUN	NN	_	29	compound	_	_
29	n=35	_	NOUN	NN	_	26	nmod	_	_
30	or	_	CONJ	CC	_	29	cc	_	_
31	placebo	_	NOUN	NN	_	32	compound	_	_
32	n=19	_	NOUN	NN	_	29	conj	_	_
33	for	_	ADP	IN	_	34	case	_	_
34	24weeks	_	NOUN	NNS	_	29	nmod	_	_

#	Lovastatin	5331
1	Inclusion	_	NOUN	NN	_	5	nsubj	_	_
2	in	_	ADP	IN	_	4	case	_	_
3	the	_	DET	DT	_	4	det	_	_
4	study	_	NOUN	NN	_	1	nmod	_	_
5	required	_	VERB	VBD	_	0	root	_	_
6	a	_	DET	DT	_	10	det	_	_
7	baseline	_	NOUN	NN	_	10	compound	_	_
8	LDL	_	NOUN	NN	_	10	compound	_	_
9	C	_	NOUN	NN	_	10	compound	_	_
10	level	_	NOUN	NN	_	5	dobj	_	_
11	of	_	ADP	IN	_	15	case	_	_
12	160	_	NUM	CD	_	15	nummod	_	_
13	400mg	_	ADJ	JJ	_	15	amod	_	_
14	/	_	.	:	_	15	punct	_	_
15	dL	_	NOUN	NN	_	10	nmod	_	_
16	and	_	CONJ	CC	_	10	cc	_	_
17	a	_	DET	DT	_	19	det	_	_
18	parental	_	ADJ	JJ	_	19	amod	_	_
19	history	_	NOUN	NN	_	10	conj	_	_
20	of	_	ADP	IN	_	22	case	_	_
21	familial	_	ADJ	JJ	_	22	amod	_	_
22	hypercholesterolemia	_	NOUN	NN	_	19	nmod	_	_

#	Lovastatin	5332
1	The	_	DET	DT	_	6	det	_	_
2	mean	_	ADJ	JJ	_	6	compound	_	_
3	baseline	_	NOUN	NN	_	6	compound	_	_
4	LDL	_	NOUN	NN	_	6	compound	_	_
5	C	_	NOUN	NN	_	6	compound	_	_
6	value	_	NOUN	NN	_	8	nsubj	_	_
7	was	_	VERB	VBD	_	8	cop	_	_
8	218.3mg	_	ADJ	JJ	_	0	root	_	_
9	/	_	.	:	_	8	punct	_	_
10	dL	_	NOUN	NN	_	11	compound	_	_
11	range	_	NOUN	NN	_	8	parataxis	_	_
12	:	_	.	:	_	11	punct	_	_
13	136.3	_	NUM	CD	_	14	nummod	_	_
14	363.7mg	_	ADJ	JJ	_	11	dep	_	_
15	/	_	.	:	_	11	punct	_	_
16	dL	_	NOUN	NN	_	21	nsubj	_	_
17	in	_	ADP	IN	_	20	case	_	_
18	the	_	DET	DT	_	20	det	_	_
19	MEVACOR	_	NOUN	NN	_	20	compound	_	_
20	group	_	NOUN	NN	_	16	nmod	_	_
21	compared	_	VERB	VBD	_	11	dep	_	_
22	to	_	PRT	TO	_	26	case	_	_
23	198.8mg	_	ADJ	JJ	_	26	amod	_	_
24	/	_	.	:	_	26	punct	_	_
25	dL	_	NOUN	NN	_	26	compound	_	_
26	range	_	NOUN	NN	_	21	nmod	_	_
27	:	_	.	:	_	21	punct	_	_
28	151.1	_	NUM	CD	_	29	nummod	_	_
29	283.1mg	_	ADJ	JJ	_	21	parataxis	_	_
30	/	_	.	:	_	29	punct	_	_
31	dL	_	NOUN	NN	_	29	dep	_	_
32	in	_	ADP	IN	_	35	case	_	_
33	the	_	DET	DT	_	35	det	_	_
34	placebo	_	NOUN	NN	_	35	compound	_	_
35	group	_	NOUN	NN	_	31	nmod	_	_

#	Lovastatin	5333
1	The	_	DET	DT	_	2	det	_	_
2	dosage	_	NOUN	NN	_	11	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	once	_	ADV	RB	_	6	advmod	_	_
6	daily	_	ADV	RB	_	2	advmod	_	_
7	in	_	ADP	IN	_	9	case	_	_
8	the	_	DET	DT	_	9	det	_	_
9	evening	_	NOUN	NN	_	6	nmod	_	_
10	was	_	VERB	VBD	_	11	cop	_	_
11	20mg	_	ADJ	JJ	_	0	root	_	_
12	for	_	ADP	IN	_	15	case	_	_
13	the	_	DET	DT	_	15	det	_	_
14	first	_	ADJ	JJ	_	15	amod	_	_
15	4weeks	_	NOUN	NNS	_	11	nmod	_	_
16	,	_	.	,	_	15	punct	_	_
17	and	_	CONJ	CC	_	15	cc	_	_
18	40mg	_	NOUN	NN	_	15	conj	_	_
19	thereafter	_	ADV	RB	_	11	advmod	_	_

#	Lovastatin	5335
1	TABLE	_	NOUN	NN	_	0	root	_	_
2	VI	_	NUM	CD	_	1	nummod	_	_
3	:	_	.	:	_	1	punct	_	_
4	Lipid	_	NOUN	NN	_	6	compound	_	_
5	lowering	_	VERB	VBG	_	6	compound	_	_
6	Effects	_	NOUN	NNS	_	1	dep	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	in	_	ADP	IN	_	12	case	_	_
10	Post	_	NOUN	NN	_	12	amod	_	_
11	Menarchal	_	ADJ	JJ	_	12	amod	_	_
12	Girls	_	NOUN	NNS	_	6	nmod	_	_
13	with	_	ADP	IN	_	19	case	_	_
14	Heterozygous	_	ADJ	JJ	_	19	amod	_	_
15	Familial	_	ADJ	JJ	_	19	amod	_	_
16	Hypercholesterolemia	_	NOUN	NN	_	19	compound	_	_
17	Mean	_	NOUN	NN	_	19	compound	_	_
18	Percent	_	ADJ	JJ	_	19	amod	_	_
19	Change	_	NOUN	NN	_	6	nmod	_	_
20	from	_	ADP	IN	_	21	case	_	_
21	Baseline	_	NOUN	NN	_	19	nmod	_	_
22	at	_	ADP	IN	_	23	case	_	_
23	Week24	_	NOUN	NN	_	19	nmod	_	_
24	in	_	ADP	IN	_	25	case	_	_
25	Intention	_	NOUN	NN	_	6	nmod	_	_
26	to	_	PRT	TO	_	37	case	_	_
27	Treat	_	NOUN	NN	_	37	compound	_	_
28	Population	_	NOUN	NN	_	37	compound	_	_
29	DOSAGE	_	NOUN	NN	_	37	compound	_	_
30	N	_	NOUN	NN	_	37	compound	_	_
31	TOTAL	_	NOUN	NN	_	37	compound	_	_
32	C	_	NOUN	NN	_	37	compound	_	_
33	LDL	_	NOUN	NN	_	37	compound	_	_
34	C	_	NOUN	NN	_	37	compound	_	_
35	HDL	_	NOUN	NN	_	37	compound	_	_
36	C	_	NOUN	NN	_	37	compound	_	_
37	TG.data	_	NOUN	NN	_	25	nmod	_	_
38	presented	_	VERB	VBN	_	37	acl	_	_
39	as	_	ADP	IN	_	42	case	_	_
40	median	_	ADJ	JJ	_	42	amod	_	_
41	percent	_	NOUN	NN	_	42	compound	_	_
42	changes	_	NOUN	NNS	_	66	nmod	_	_
43	Apolipoprotein	_	NOUN	NN	_	64	compound	_	_
44	B	_	NOUN	NN	_	64	compound	_	_
45	Placebo	_	NOUN	NN	_	64	compound	_	_
46	18	_	NUM	CD	_	64	nummod	_	_
47	+3.6	_	NUM	CD	_	64	nummod	_	_
48	+2.5	_	NUM	CD	_	64	nummod	_	_
49	+4.8	_	NUM	CD	_	64	nummod	_	_
50	3.0	_	NUM	CD	_	64	nummod	_	_
51	+6.4	_	NUM	CD	_	64	nummod	_	_
52	MEVACOR	_	NOUN	NN	_	64	compound	_	_
53	35	_	NUM	CD	_	64	nummod	_	_
54	22.4	_	NUM	CD	_	64	nummod	_	_
55	29.2	_	NUM	CD	_	64	nummod	_	_
56	+2.4	_	NUM	CD	_	64	nummod	_	_
57	22.7	_	NUM	CD	_	64	nummod	_	_
58	24.4	_	NUM	CD	_	57	dep	_	_
59	The	_	DET	DT	_	64	det	_	_
60	mean	_	ADJ	JJ	_	64	amod	_	_
61	achieved	_	VERB	VBN	_	64	amod	_	_
62	LDL	_	NOUN	NN	_	64	compound	_	_
63	C	_	NOUN	NN	_	64	compound	_	_
64	value	_	NOUN	NN	_	66	nsubj	_	_
65	was	_	VERB	VBD	_	66	cop	_	_
66	154.5mg	_	ADJ	JJ	_	38	ccomp	_	_
67	/	_	.	:	_	66	punct	_	_
68	dL	_	NOUN	NN	_	69	compound	_	_
69	range	_	NOUN	NN	_	66	parataxis	_	_
70	:	_	.	:	_	69	punct	_	_
71	82	_	NUM	CD	_	72	nummod	_	_
72	286mg	_	ADJ	JJ	_	69	dep	_	_
73	/	_	.	:	_	69	punct	_	_
74	dL	_	NOUN	NN	_	79	nsubj	_	_
75	in	_	ADP	IN	_	78	case	_	_
76	the	_	DET	DT	_	78	det	_	_
77	MEVACOR	_	NOUN	NN	_	78	compound	_	_
78	group	_	NOUN	NN	_	74	nmod	_	_
79	compared	_	VERB	VBD	_	69	dep	_	_
80	to	_	PRT	TO	_	84	case	_	_
81	203.5mg	_	ADJ	JJ	_	84	amod	_	_
82	/	_	.	:	_	84	punct	_	_
83	dL	_	NOUN	NN	_	84	compound	_	_
84	range	_	NOUN	NN	_	79	nmod	_	_
85	:	_	.	:	_	79	punct	_	_
86	135	_	NUM	CD	_	89	nummod	_	_
87	304mg	_	ADJ	JJ	_	89	amod	_	_
88	/	_	.	:	_	87	punct	_	_
89	dL	_	NOUN	NN	_	79	dobj	_	_
90	in	_	ADP	IN	_	93	case	_	_
91	the	_	DET	DT	_	93	det	_	_
92	placebo	_	NOUN	NN	_	93	compound	_	_
93	group	_	NOUN	NN	_	89	nmod	_	_

#	Lovastatin	5336
1	The	_	DET	DT	_	2	det	_	_
2	safety	_	NOUN	NN	_	13	nsubjpass	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	efficacy	_	NOUN	NN	_	2	conj	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	doses	_	NOUN	NNS	_	2	nmod	_	_
7	above	_	ADP	IN	_	8	case	_	_
8	40mg	_	NOUN	NN	_	2	nmod	_	_
9	daily	_	ADV	RB	_	13	advmod	_	_
10	have	_	VERB	VBP	_	13	aux	_	_
11	not	_	ADV	RB	_	13	neg	_	_
12	been	_	VERB	VBN	_	13	auxpass	_	_
13	studied	_	VERB	VBN	_	0	root	_	_
14	in	_	ADP	IN	_	15	case	_	_
15	children	_	NOUN	NN	_	13	nmod	_	_

#	Lovastatin	5337
1	The	_	DET	DT	_	4	det	_	_
2	long	_	ADJ	JJ	_	4	amod	_	_
3	term	_	NOUN	NN	_	4	compound	_	_
4	efficacy	_	NOUN	NN	_	20	nsubjpass	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	DRUG	_	NOUN	NN	_	7	compound	_	_
7	therapy	_	NOUN	NN	_	4	nmod	_	_
8	in	_	ADP	IN	_	9	case	_	_
9	childhood	_	NOUN	NN	_	4	nmod	_	_
10	to	_	PRT	TO	_	11	mark	_	_
11	reduce	_	VERB	VB	_	4	acl	_	_
12	morbidity	_	NOUN	NN	_	11	dobj	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	mortality	_	NOUN	NN	_	12	conj	_	_
15	in	_	ADP	IN	_	16	case	_	_
16	adulthood	_	NOUN	NN	_	11	nmod	_	_
17	has	_	VERB	VBZ	_	20	aux	_	_
18	not	_	ADV	RB	_	20	neg	_	_
19	been	_	VERB	VBN	_	20	auxpass	_	_
20	established	_	VERB	VBN	_	0	root	_	_

#	Maprotiline Hydrochloride	4320
1	Close	_	ADJ	JJ	_	2	compound	_	_
2	supervision	_	NOUN	NN	_	9	nsubjpass	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	careful	_	ADJ	JJ	_	5	amod	_	_
5	adjustment	_	NOUN	NN	_	2	conj	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	dosage	_	NOUN	NN	_	2	nmod	_	_
8	are	_	VERB	VBP	_	9	auxpass	_	_
9	required	_	VERB	VBN	_	0	root	_	_
10	when	_	ADV	WRB	_	11	advmod	_	_
11	administering	_	VERB	VBG	_	9	advcl	_	_
12	DRUG	_	NOUN	NN	_	11	dobj	_	_
13	concomitantly	_	ADV	RB	_	11	advmod	_	_
14	with	_	ADP	IN	_	18	case	_	_
15	anticholinergic	_	ADJ	JJ	_	18	amod	_	_
16	or	_	CONJ	CC	_	15	cc	_	_
17	sympathomimetic	_	ADJ	JJ	_	15	conj	_	_
18	drugs	_	NOUN	NNS	_	13	nmod	_	_
19	because	_	ADP	IN	_	22	case	_	_
20	of	_	ADP	IN	_	22	case	_	_
21	the	_	DET	DT	_	22	det	_	_
22	possibility	_	NOUN	NN	_	11	nmod	_	_
23	of	_	ADP	IN	_	25	case	_	_
24	additive	_	ADJ	JJ	_	25	amod	_	_
25	atropine	_	NOUN	NN	_	22	nmod	_	_
26	like	_	ADP	IN	_	27	case	_	_
27	effects	_	NOUN	NNS	_	25	nmod	_	_

#	Maprotiline Hydrochloride	4321
1	Concurrent	_	ADJ	JJ	_	2	amod	_	_
2	administration	_	NOUN	NN	_	10	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	with	_	ADP	IN	_	7	case	_	_
6	electroshock	_	NOUN	NN	_	7	compound	_	_
7	therapy	_	NOUN	NN	_	2	nmod	_	_
8	should	_	VERB	MD	_	10	aux	_	_
9	be	_	VERB	VB	_	10	auxpass	_	_
10	avoided	_	VERB	VBN	_	0	root	_	_
11	because	_	ADP	IN	_	14	case	_	_
12	of	_	ADP	IN	_	14	case	_	_
13	the	_	DET	DT	_	14	det	_	_
14	lack	_	NOUN	NN	_	10	nmod	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	experience	_	NOUN	NN	_	14	nmod	_	_
17	in	_	ADP	IN	_	19	case	_	_
18	this	_	DET	DT	_	19	det	_	_
19	area	_	NOUN	NN	_	16	nmod	_	_

#	Maprotiline Hydrochloride	4322
1	Caution	_	NOUN	NN	_	4	nsubjpass	_	_
2	should	_	VERB	MD	_	4	aux	_	_
3	be	_	VERB	VB	_	4	auxpass	_	_
4	exercised	_	VERB	VBN	_	0	root	_	_
5	when	_	ADV	WRB	_	6	advmod	_	_
6	administering	_	VERB	VBG	_	4	advcl	_	_
7	DRUG	_	NOUN	NN	_	6	dobj	_	_
8	to	_	PRT	TO	_	10	case	_	_
9	hyperthyroid	_	NOUN	NN	_	10	compound	_	_
10	patients	_	NOUN	NNS	_	6	nmod	_	_
11	or	_	CONJ	CC	_	10	cc	_	_
12	those	_	DET	DT	_	10	conj	_	_
13	on	_	ADP	IN	_	15	case	_	_
14	thyroid	_	NOUN	NN	_	15	compound	_	_
15	medication	_	NOUN	NN	_	10	nmod	_	_
16	because	_	ADP	IN	_	19	case	_	_
17	of	_	ADP	IN	_	19	case	_	_
18	the	_	DET	DT	_	19	det	_	_
19	possibility	_	NOUN	NN	_	6	nmod	_	_
20	of	_	ADP	IN	_	22	case	_	_
21	enhanced	_	VERB	VBN	_	22	amod	_	_
22	potential	_	NOUN	NN	_	19	nmod	_	_
23	for	_	ADP	IN	_	25	case	_	_
24	cardiovascular	_	ADJ	JJ	_	25	amod	_	_
25	toxicity	_	NOUN	NN	_	22	nmod	_	_
26	of	_	ADP	IN	_	27	case	_	_
27	DRUG	_	NOUN	NN	_	25	nmod	_	_

#	Maprotiline Hydrochloride	4323
1	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
2	should	_	VERB	MD	_	4	aux	_	_
3	be	_	VERB	VB	_	4	auxpass	_	_
4	used	_	VERB	VBN	_	0	root	_	_
5	with	_	ADP	IN	_	6	case	_	_
6	caution	_	NOUN	NN	_	4	nmod	_	_
7	in	_	ADP	IN	_	8	case	_	_
8	patients	_	NOUN	NNS	_	6	nmod	_	_
9	receiving	_	VERB	VBG	_	8	acl	_	_
10	guanethidine	_	NOUN	NN	_	9	dobj	_	_
11	or	_	CONJ	CC	_	10	cc	_	_
12	similar	_	ADJ	JJ	_	10	conj	_	_
13	agents	_	NOUN	NNS	_	10	dep	_	_
14	since	_	ADP	IN	_	17	mark	_	_
15	it	_	PRON	PRP	_	17	nsubj	_	_
16	may	_	VERB	MD	_	17	aux	_	_
17	block	_	VERB	VB	_	4	advcl	_	_
18	the	_	DET	DT	_	20	det	_	_
19	pharmacologic	_	ADJ	JJ	_	20	amod	_	_
20	effects	_	NOUN	NNS	_	17	dobj	_	_
21	of	_	ADP	IN	_	23	case	_	_
22	these	_	DET	DT	_	23	det	_	_
23	drugs	_	NOUN	NNS	_	20	nmod	_	_

#	Maprotiline Hydrochloride	4324
1	The	_	DET	DT	_	2	det	_	_
2	risk	_	NOUN	NN	_	7	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	seizures	_	NOUN	NNS	_	2	nmod	_	_
5	may	_	VERB	MD	_	7	aux	_	_
6	be	_	VERB	VB	_	7	auxpass	_	_
7	increased	_	VERB	VBN	_	0	root	_	_
8	when	_	ADV	WRB	_	11	advmod	_	_
9	DRUG	_	NOUN	NN	_	11	nsubjpass	_	_
10	is	_	VERB	VBZ	_	11	auxpass	_	_
11	taken	_	VERB	VBN	_	7	ccomp	_	_
12	concomitantly	_	ADV	RB	_	11	advmod	_	_
13	with	_	ADP	IN	_	14	case	_	_
14	phenothiazines	_	NOUN	NNS	_	11	nmod	_	_
15	or	_	CONJ	CC	_	11	cc	_	_
16	when	_	ADV	RB	_	23	advmod	_	_
17	the	_	DET	DT	_	18	det	_	_
18	dosage	_	NOUN	NN	_	23	nsubjpass	_	_
19	of	_	ADP	IN	_	20	case	_	_
20	benzodiazepines	_	NOUN	NNS	_	18	nmod	_	_
21	is	_	VERB	VBZ	_	23	auxpass	_	_
22	rapidly	_	ADV	RB	_	23	advmod	_	_
23	tapered	_	VERB	VBN	_	11	conj	_	_
24	in	_	ADP	IN	_	25	case	_	_
25	patients	_	NOUN	NNS	_	23	nmod	_	_
26	receiving	_	VERB	VBG	_	25	acl	_	_
27	DRUG	_	NOUN	NN	_	26	nmod	_	_

#	Maprotiline Hydrochloride	4325
1	Because	_	ADP	IN	_	5	case	_	_
2	of	_	ADP	IN	_	5	case	_	_
3	the	_	DET	DT	_	5	det	_	_
4	pharmacologic	_	ADJ	JJ	_	5	amod	_	_
5	similarity	_	NOUN	NN	_	20	nmod	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	to	_	PRT	TO	_	11	case	_	_
9	the	_	DET	DT	_	11	det	_	_
10	tricyclic	_	ADJ	JJ	_	11	amod	_	_
11	antidepressants	_	NOUN	NNS	_	5	nmod	_	_
12	,	_	.	,	_	20	punct	_	_
13	the	_	DET	DT	_	15	det	_	_
14	plasma	_	NOUN	NN	_	15	compound	_	_
15	concentration	_	NOUN	NN	_	20	nsubjpass	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	DRUG	_	NOUN	NN	_	15	nmod	_	_
18	may	_	VERB	MD	_	20	aux	_	_
19	be	_	VERB	VB	_	20	auxpass	_	_
20	increased	_	VERB	VBN	_	0	root	_	_
21	when	_	ADV	WRB	_	25	advmod	_	_
22	the	_	DET	DT	_	23	det	_	_
23	drug	_	NOUN	NN	_	25	nsubjpass	_	_
24	is	_	VERB	VBZ	_	25	auxpass	_	_
25	given	_	VERB	VBN	_	20	ccomp	_	_
26	concomitantly	_	ADV	RB	_	25	advmod	_	_
27	with	_	ADP	IN	_	30	case	_	_
28	hepatic	_	ADJ	JJ	_	30	amod	_	_
29	enzyme	_	NOUN	NN	_	30	compound	_	_
30	inhibitors	_	NOUN	NNS	_	25	nmod	_	_
31	e.g	_	NOUN	NN	_	30	dep	_	_
32	,	_	.	,	_	31	punct	_	_
33	cimetidine	_	NOUN	NN	_	31	conj	_	_
34	,	_	.	,	_	31	punct	_	_
35	fluoxetine	_	NOUN	NN	_	31	conj	_	_
36	and	_	CONJ	CC	_	31	cc	_	_
37	decreased	_	VERB	VBD	_	31	conj	_	_
38	by	_	ADP	IN	_	40	case	_	_
39	concomitant	_	ADJ	JJ	_	40	amod	_	_
40	administration	_	NOUN	NN	_	37	nmod	_	_
41	with	_	ADP	IN	_	44	case	_	_
42	hepatic	_	ADJ	JJ	_	44	amod	_	_
43	enzyme	_	NOUN	NN	_	44	compound	_	_
44	inducers	_	NOUN	NNS	_	40	nmod	_	_
45	e.g	_	NOUN	NN	_	44	dep	_	_
46	,	_	.	,	_	25	punct	_	_
47	barbiturates	_	VERB	VBZ	_	25	conj	_	_
48	,	_	.	,	_	47	punct	_	_
49	phenytoin	_	NOUN	NN	_	47	dobj	_	_
50	,	_	.	,	_	49	punct	_	_
51	as	_	ADP	IN	_	53	mark	_	_
52	has	_	VERB	VBZ	_	53	aux	_	_
53	occurred	_	VERB	VBN	_	49	acl	_	_
54	with	_	ADP	IN	_	56	case	_	_
55	tricyclic	_	ADJ	JJ	_	56	amod	_	_
56	antidepressants	_	NOUN	NNS	_	53	nmod	_	_

#	Maprotiline Hydrochloride	4326
1	Adjustment	_	NOUN	NN	_	10	nsubj	_	_
2	of	_	ADP	IN	_	4	case	_	_
3	the	_	DET	DT	_	4	det	_	_
4	dosage	_	NOUN	NN	_	1	nmod	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	may	_	VERB	MD	_	10	aux	_	_
8	therefore	_	ADV	RB	_	10	advmod	_	_
9	be	_	VERB	VB	_	10	cop	_	_
10	necessary	_	ADJ	JJ	_	0	root	_	_
11	in	_	ADP	IN	_	13	case	_	_
12	such	_	ADJ	JJ	_	13	amod	_	_
13	cases	_	NOUN	NNS	_	10	nmod	_	_

#	Maprotiline Hydrochloride	4328
1	The	_	DET	DT	_	2	det	_	_
2	mechanism	_	NOUN	NN	_	10	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	action	_	NOUN	NN	_	2	nmod	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	is	_	VERB	VBZ	_	10	auxpass	_	_
8	not	_	ADV	RB	_	10	neg	_	_
9	precisely	_	ADV	RB	_	10	advmod	_	_
10	known	_	VERB	VBN	_	0	root	_	_

#	Maprotiline Hydrochloride	4329
1	It	_	PRON	PRP	_	4	nsubj	_	_
2	does	_	VERB	VBZ	_	4	aux	_	_
3	not	_	ADV	RB	_	4	neg	_	_
4	act	_	VERB	VB	_	0	root	_	_
5	primarily	_	ADV	RB	_	4	advmod	_	_
6	by	_	ADP	IN	_	7	case	_	_
7	stimulation	_	NOUN	NN	_	4	nmod	_	_
8	of	_	ADP	IN	_	12	case	_	_
9	the	_	DET	DT	_	12	det	_	_
10	central	_	ADJ	JJ	_	12	amod	_	_
11	nervous	_	ADJ	JJ	_	12	amod	_	_
12	system	_	NOUN	NN	_	7	nmod	_	_
13	and	_	CONJ	CC	_	4	cc	_	_
14	is	_	VERB	VBZ	_	19	cop	_	_
15	not	_	ADV	RB	_	19	neg	_	_
16	a	_	DET	DT	_	19	det	_	_
17	monoamine	_	NOUN	NN	_	19	compound	_	_
18	oxidase	_	NOUN	NN	_	19	compound	_	_
19	inhibitor	_	NOUN	NN	_	4	conj	_	_

#	Maprotiline Hydrochloride	4330
1	The	_	DET	DT	_	3	det	_	_
2	postulated	_	ADJ	JJ	_	3	amod	_	_
3	mechanism	_	NOUN	NN	_	6	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	is	_	VERB	VBZ	_	0	root	_	_
7	that	_	ADP	IN	_	9	mark	_	_
8	it	_	PRON	PRP	_	9	nsubj	_	_
9	acts	_	VERB	VBZ	_	6	ccomp	_	_
10	primarily	_	ADV	RB	_	9	advmod	_	_
11	by	_	ADP	IN	_	12	case	_	_
12	potentiation	_	NOUN	NN	_	9	nmod	_	_
13	of	_	ADP	IN	_	16	case	_	_
14	central	_	ADJ	JJ	_	16	amod	_	_
15	adrenergic	_	ADJ	JJ	_	16	amod	_	_
16	synapses	_	NOUN	NNS	_	12	nmod	_	_
17	by	_	ADP	IN	_	18	mark	_	_
18	blocking	_	VERB	VBG	_	9	advcl	_	_
19	reuptake	_	NOUN	NN	_	18	dobj	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	norepinephrine	_	NOUN	NN	_	19	nmod	_	_
22	at	_	ADP	IN	_	24	case	_	_
23	nerve	_	ADJ	JJ	_	24	compound	_	_
24	endings	_	NOUN	NNS	_	18	nmod	_	_

#	Maprotiline Hydrochloride	4331
1	This	_	DET	DT	_	3	det	_	_
2	pharmacologic	_	ADJ	JJ	_	3	amod	_	_
3	action	_	NOUN	NN	_	5	nsubjpass	_	_
4	is	_	VERB	VBZ	_	5	auxpass	_	_
5	thought	_	VERB	VBN	_	0	root	_	_
6	to	_	PRT	TO	_	8	mark	_	_
7	be	_	VERB	VB	_	8	cop	_	_
8	responsible	_	ADJ	JJ	_	5	xcomp	_	_
9	for	_	ADP	IN	_	12	case	_	_
10	the	_	DET	DT	_	12	dep	_	_
11	drug's	_	NOUN	NNS	_	12	amod	_	_
12	antidepressant	_	ADJ	JJ	_	8	nmod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	anxiolytic	_	ADJ	JJ	_	12	conj	_	_
15	effects	_	NOUN	NNS	_	12	dep	_	_

#	Maprotiline Hydrochloride	4332
1	The	_	DET	DT	_	3	det	_	_
2	half	_	ADJ	JJ	_	3	amod	_	_
3	life	_	NOUN	NN	_	6	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	elimination	_	NOUN	NN	_	3	nmod	_	_
6	averages	_	VERB	VBZ	_	0	root	_	_
7	51	_	NUM	CD	_	8	nummod	_	_
8	hours	_	NOUN	NNS	_	6	dobj	_	_

#	Maprotiline Hydrochloride	4333
1	Steady	_	ADJ	JJ	_	3	amod	_	_
2	state	_	NOUN	NN	_	3	compound	_	_
3	levels	_	NOUN	NNS	_	16	nsubjpass	_	_
4	measured	_	VERB	VBN	_	3	acl	_	_
5	prior	_	ADJ	JJ	_	4	xcomp	_	_
6	to	_	PRT	TO	_	9	case	_	_
7	the	_	DET	DT	_	9	det	_	_
8	morning	_	NOUN	NN	_	9	compound	_	_
9	dose	_	NOUN	NN	_	5	nmod	_	_
10	on	_	ADP	IN	_	14	case	_	_
11	a	_	DET	DT	_	14	det	_	_
12	one	_	NUM	CD	_	14	nummod	_	_
13	dosage	_	NOUN	NN	_	14	compound	_	_
14	regimen	_	NOUN	NN	_	9	nmod	_	_
15	are	_	VERB	VBP	_	16	auxpass	_	_
16	summarized	_	VERB	VBN	_	0	root	_	_
17	as	_	ADP	IN	_	18	case	_	_
18	follows	_	NOUN	NNS	_	16	nmod	_	_
19	:	_	.	:	_	16	punct	_	_
20	Average	_	NOUN	NN	_	25	compound	_	_
21	Minimum	_	NOUN	NN	_	25	compound	_	_
22	Concentration	_	NOUN	NN	_	25	compound	_	_
23	95%	_	ADJ	JJ	_	25	amod	_	_
24	Confidence	_	NOUN	NN	_	25	compound	_	_
25	Limits	_	NOUN	NNS	_	16	parataxis	_	_
26	Regimen	_	NOUN	NN	_	27	compound	_	_
27	ng	_	NOUN	NN	_	34	compound	_	_
28	/	_	.	-LRB-	_	30	punct	_	_
29	mL	_	NOUN	NN	_	30	compound	_	_
30	ng	_	NOUN	NN	_	27	appos	_	_
31	/	_	.	-RRB-	_	30	punct	_	_
32	mL	_	NOUN	NN	_	34	compound	_	_
33	50	_	NUM	CD	_	34	nummod	_	_
34	mg	_	NOUN	NN	_	25	nmod	_	_
35	*	_	ADJ	JJ	_	34	amod	_	_
36	3	_	NUM	CD	_	35	neg	_	_
37	daily	_	ADV	RB	_	38	advmod	_	_
38	238	_	NUM	CD	_	36	conj	_	_
39	181	_	NUM	CD	_	38	dep	_	_
40	295	_	NUM	CD	_	39	conj	_	_

#	ONDANSETRON	5522
1	Apomorphine	_	NOUN	NN	_	3	compound	_	_
2	profound	_	ADJ	JJ	_	3	amod	_	_
3	hypotension	_	NOUN	NN	_	0	root	_	_
4	and	_	CONJ	CC	_	3	cc	_	_
5	loss	_	NOUN	NN	_	3	conj	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	consciousness	_	NOUN	NN	_	3	nmod	_	_

#	ONDANSETRON	5523
1	Concomitant	_	ADJ	JJ	_	2	amod	_	_
2	use	_	NOUN	NN	_	6	nsubjpass	_	_
3	with	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	is	_	VERB	VBZ	_	6	auxpass	_	_
6	contraindicated	_	VERB	VBN	_	0	root	_	_

#	ONDANSETRON	5524
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	does	_	VERB	VBZ	_	4	aux	_	_
3	not	_	ADV	RB	_	4	neg	_	_
4	appear	_	VERB	VB	_	0	root	_	_
5	to	_	PRT	TO	_	6	mark	_	_
6	induce	_	VERB	VB	_	4	xcomp	_	_
7	or	_	CONJ	CC	_	6	cc	_	_
8	inhibit	_	VERB	VB	_	6	conj	_	_
9	the	_	DET	DT	_	16	det	_	_
10	cytochrome	_	NOUN	NN	_	16	compound	_	_
11	P	_	NOUN	NN	_	16	compound	_	_
12	450	_	NUM	CD	_	16	nummod	_	_
13	drug	_	NOUN	NN	_	16	compound	_	_
14	metabolizing	_	NOUN	NN	_	16	compound	_	_
15	enzyme	_	NOUN	NN	_	16	compound	_	_
16	system	_	NOUN	NN	_	6	dobj	_	_
17	of	_	ADP	IN	_	19	case	_	_
18	the	_	DET	DT	_	19	det	_	_
19	liver	_	NOUN	NN	_	16	nmod	_	_

#	ONDANSETRON	5525
1	Because	_	ADP	IN	_	4	mark	_	_
2	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
3	is	_	VERB	VBZ	_	4	auxpass	_	_
4	metabolized	_	VERB	VBN	_	26	advcl	_	_
5	by	_	ADP	IN	_	12	case	_	_
6	hepatic	_	ADJ	JJ	_	12	amod	_	_
7	cytochrome	_	NOUN	NN	_	12	compound	_	_
8	P	_	NOUN	NN	_	12	compound	_	_
9	450	_	NUM	CD	_	12	nummod	_	_
10	drug	_	NOUN	NN	_	12	compound	_	_
11	metabolizing	_	NOUN	NN	_	12	compound	_	_
12	enzymes	_	NOUN	NNS	_	4	nmod	_	_
13	CYP3A4	_	NOUN	NN	_	12	dep	_	_
14	,	_	.	,	_	13	punct	_	_
15	CYP2D6	_	NOUN	NN	_	13	conj	_	_
16	,	_	.	,	_	13	punct	_	_
17	CYP1A2	_	NOUN	NN	_	13	conj	_	_
18	,	_	.	,	_	13	punct	_	_
19	inducers	_	NOUN	NNS	_	13	conj	_	_
20	or	_	CONJ	CC	_	13	cc	_	_
21	inhibitors	_	NOUN	NNS	_	13	conj	_	_
22	of	_	ADP	IN	_	24	case	_	_
23	these	_	DET	DT	_	24	det	_	_
24	enzymes	_	NOUN	NNS	_	13	nmod	_	_
25	may	_	VERB	MD	_	26	aux	_	_
26	change	_	VERB	VB	_	0	root	_	_
27	the	_	DET	DT	_	28	det	_	_
28	clearance	_	NOUN	NN	_	26	dobj	_	_
29	and	_	CONJ	CC	_	26	cc	_	_
30	,	_	.	,	_	26	punct	_	_
31	hence	_	ADV	RB	_	26	advmod	_	_
32	,	_	.	,	_	26	punct	_	_
33	the	_	DET	DT	_	35	det	_	_
34	half	_	ADJ	JJ	_	35	amod	_	_
35	life	_	NOUN	NN	_	26	dobj	_	_
36	of	_	ADP	IN	_	37	case	_	_
37	DRUG	_	NOUN	NN	_	35	nmod	_	_

#	ONDANSETRON	5526
1	On	_	ADP	IN	_	3	case	_	_
2	the	_	DET	DT	_	3	det	_	_
3	basis	_	NOUN	NN	_	13	nmod	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	limited	_	ADJ	JJ	_	7	amod	_	_
6	available	_	ADJ	JJ	_	7	amod	_	_
7	data	_	NOUN	NNS	_	3	nmod	_	_
8	,	_	.	,	_	13	punct	_	_
9	no	_	DET	DT	_	11	neg	_	_
10	dosage	_	NOUN	NN	_	11	compound	_	_
11	adjustment	_	NOUN	NN	_	13	nsubjpass	_	_
12	is	_	VERB	VBZ	_	13	auxpass	_	_
13	recommended	_	VERB	VBN	_	0	root	_	_
14	for	_	ADP	IN	_	15	case	_	_
15	patients	_	NOUN	NNS	_	13	nmod	_	_
16	on	_	ADP	IN	_	18	case	_	_
17	these	_	DET	DT	_	18	det	_	_
18	drugs	_	NOUN	NNS	_	15	nmod	_	_

#	ONDANSETRON	5527
1	Based	_	VERB	VBN	_	25	advcl	_	_
2	on	_	ADP	IN	_	3	case	_	_
3	reports	_	NOUN	NNS	_	1	nmod	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	profound	_	ADJ	JJ	_	6	amod	_	_
6	hypotension	_	NOUN	NN	_	3	nmod	_	_
7	and	_	CONJ	CC	_	3	cc	_	_
8	loss	_	NOUN	NN	_	3	conj	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	consciousness	_	NOUN	NN	_	8	nmod	_	_
11	when	_	ADV	WRB	_	14	advmod	_	_
12	apomorphine	_	NOUN	NN	_	14	nsubjpass	_	_
13	was	_	VERB	VBD	_	14	auxpass	_	_
14	administered	_	VERB	VBN	_	1	advcl	_	_
15	with	_	ADP	IN	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	14	nmod	_	_
17	,	_	.	,	_	25	punct	_	_
18	concomitant	_	ADJ	JJ	_	19	amod	_	_
19	use	_	NOUN	NN	_	25	nsubjpass	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	apomorphine	_	NOUN	NN	_	19	nmod	_	_
22	with	_	ADP	IN	_	23	case	_	_
23	DRUG	_	NOUN	NN	_	19	nmod	_	_
24	is	_	VERB	VBZ	_	25	auxpass	_	_
25	contraindicated	_	VERB	VBN	_	0	root	_	_

#	ONDANSETRON	5528
1	In	_	ADP	IN	_	2	case	_	_
2	patients	_	NOUN	NNS	_	24	nmod	_	_
3	treated	_	VERB	VBN	_	2	acl	_	_
4	with	_	ADP	IN	_	6	case	_	_
5	potent	_	ADJ	JJ	_	6	amod	_	_
6	inducers	_	NOUN	NNS	_	3	nmod	_	_
7	of	_	ADP	IN	_	9	case	_	_
8	CYP3A4	_	NOUN	NN	_	9	compound	_	_
9	i.e	_	ADJ	JJ	_	6	nmod	_	_
10	,	_	.	,	_	9	punct	_	_
11	phenytoin	_	NOUN	NN	_	9	conj	_	_
12	,	_	.	,	_	9	punct	_	_
13	carbamazepine	_	NOUN	NN	_	9	conj	_	_
14	,	_	.	,	_	9	punct	_	_
15	and	_	CONJ	CC	_	9	cc	_	_
16	rifampin	_	NOUN	NN	_	9	conj	_	_
17	,	_	.	,	_	24	punct	_	_
18	the	_	DET	DT	_	19	det	_	_
19	clearance	_	NOUN	NN	_	24	nsubjpass	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	DRUG	_	NOUN	NN	_	19	nmod	_	_
22	was	_	VERB	VBD	_	24	auxpass	_	_
23	significantly	_	ADV	RB	_	24	advmod	_	_
24	increased	_	VERB	VBN	_	0	root	_	_
25	and	_	CONJ	CC	_	24	cc	_	_
26	DRUG	_	NOUN	NN	_	28	compound	_	_
27	blood	_	NOUN	NN	_	28	compound	_	_
28	concentrations	_	NOUN	NNS	_	30	nsubjpass	_	_
29	were	_	VERB	VBD	_	30	auxpass	_	_
30	decreased	_	VERB	VBN	_	24	conj	_	_

#	ONDANSETRON	5529
1	However	_	ADV	RB	_	16	advmod	_	_
2	,	_	.	,	_	16	punct	_	_
3	on	_	ADP	IN	_	5	case	_	_
4	the	_	DET	DT	_	5	det	_	_
5	basis	_	NOUN	NN	_	16	nmod	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	available	_	ADJ	JJ	_	8	amod	_	_
8	data	_	NOUN	NNS	_	5	nmod	_	_
9	,	_	.	,	_	16	punct	_	_
10	no	_	DET	DT	_	12	neg	_	_
11	dosage	_	NOUN	NN	_	12	amod	_	_
12	adjustment	_	NOUN	NN	_	16	nsubjpass	_	_
13	for	_	ADP	IN	_	14	case	_	_
14	DRUG	_	NOUN	NN	_	12	nmod	_	_
15	is	_	VERB	VBZ	_	16	auxpass	_	_
16	recommended	_	VERB	VBN	_	0	root	_	_
17	for	_	ADP	IN	_	18	case	_	_
18	patients	_	NOUN	NNS	_	16	nmod	_	_
19	on	_	ADP	IN	_	21	case	_	_
20	these	_	DET	DT	_	21	det	_	_
21	drugs	_	NOUN	NNS	_	18	nmod	_	_

#	ONDANSETRON	5530
1	Although	_	ADP	IN	_	3	mark	_	_
2	there	_	DET	EX	_	3	expl	_	_
3	are	_	VERB	VBP	_	20	advcl	_	_
4	no	_	DET	DT	_	5	neg	_	_
5	data	_	NOUN	NNS	_	3	nsubj	_	_
6	on	_	ADP	IN	_	9	case	_	_
7	pharmacokinetic	_	ADJ	JJ	_	9	amod	_	_
8	drug	_	NOUN	NN	_	9	compound	_	_
9	interactions	_	NOUN	NNS	_	5	nmod	_	_
10	between	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	tramadol	_	NOUN	NN	_	11	conj	_	_
14	,	_	.	,	_	20	punct	_	_
15	data	_	NOUN	NNS	_	20	nsubj	_	_
16	from	_	ADP	IN	_	19	case	_	_
17	two	_	NUM	CD	_	19	nummod	_	_
18	small	_	ADJ	JJ	_	19	amod	_	_
19	studies	_	NOUN	NNS	_	15	nmod	_	_
20	indicate	_	VERB	VBP	_	0	root	_	_
21	that	_	ADP	IN	_	27	mark	_	_
22	concomitant	_	ADJ	JJ	_	23	amod	_	_
23	use	_	NOUN	NN	_	27	nsubj	_	_
24	of	_	ADP	IN	_	25	case	_	_
25	DRUG	_	NOUN	NN	_	23	nmod	_	_
26	may	_	VERB	MD	_	27	aux	_	_
27	result	_	VERB	VB	_	20	ccomp	_	_
28	in	_	ADP	IN	_	31	case	_	_
29	reduced	_	VERB	VBN	_	31	amod	_	_
30	analgesic	_	ADJ	JJ	_	31	amod	_	_
31	activity	_	NOUN	NN	_	27	nmod	_	_
32	of	_	ADP	IN	_	33	case	_	_
33	tramadol	_	NOUN	NN	_	31	nmod	_	_

#	ONDANSETRON	5531
1	Patients	_	NOUN	NNS	_	6	nsubj	_	_
2	on	_	ADP	IN	_	5	case	_	_
3	concomitant	_	ADJ	JJ	_	5	amod	_	_
4	DRUG	_	NOUN	NN	_	5	compound	_	_
5	self	_	NOUN	NN	_	1	nmod	_	_
6	administered	_	VERB	VBD	_	0	root	_	_
7	tramadol	_	NOUN	NN	_	6	dobj	_	_
8	more	_	ADV	RB	_	9	advmod	_	_
9	frequently	_	ADV	RB	_	6	advmod	_	_
10	in	_	ADP	IN	_	12	case	_	_
11	these	_	DET	DT	_	12	det	_	_
12	studies	_	NOUN	NNS	_	9	nmod	_	_
13	,	_	.	,	_	6	punct	_	_
14	leading	_	VERB	VBG	_	6	advcl	_	_
15	to	_	PRT	TO	_	19	case	_	_
16	an	_	DET	DT	_	19	det	_	_
17	increased	_	VERB	VBN	_	19	amod	_	_
18	cumulative	_	ADJ	JJ	_	19	amod	_	_
19	dose	_	NOUN	NN	_	14	nmod	_	_
20	in	_	ADP	IN	_	21	case	_	_
21	patient	_	NOUN	NN	_	19	nmod	_	_
22	controlled	_	VERB	VBN	_	24	amod	_	_
23	administration	_	NOUN	NN	_	24	compound	_	_
24	PCA	_	NOUN	NN	_	14	dobj	_	_
25	of	_	ADP	IN	_	26	case	_	_
26	tramadol	_	NOUN	NN	_	24	nmod	_	_

#	ONDANSETRON	5532
1	Serotonin	_	NOUN	NN	_	2	compound	_	_
2	syndrome	_	NOUN	NN	_	16	nsubjpass	_	_
3	including	_	ADP	IN	_	6	case	_	_
4	altered	_	VERB	VBN	_	6	amod	_	_
5	mental	_	ADJ	JJ	_	6	amod	_	_
6	status	_	NOUN	NN	_	2	nmod	_	_
7	,	_	.	,	_	6	punct	_	_
8	autonomic	_	ADJ	JJ	_	9	amod	_	_
9	instability	_	NOUN	NN	_	6	conj	_	_
10	,	_	.	,	_	6	punct	_	_
11	and	_	CONJ	CC	_	6	cc	_	_
12	neuromuscular	_	ADJ	JJ	_	13	amod	_	_
13	symptoms	_	NOUN	NNS	_	6	conj	_	_
14	has	_	VERB	VBZ	_	16	aux	_	_
15	been	_	VERB	VBN	_	16	auxpass	_	_
16	described	_	VERB	VBN	_	0	root	_	_
17	following	_	ADP	IN	_	20	case	_	_
18	the	_	DET	DT	_	20	det	_	_
19	concomitant	_	ADJ	JJ	_	20	amod	_	_
20	use	_	NOUN	NN	_	16	nmod	_	_
21	of	_	ADP	IN	_	25	case	_	_
22	5	_	NUM	CD	_	25	nummod	_	_
23	HT3	_	NOUN	NN	_	25	compound	_	_
24	receptor	_	NOUN	NN	_	25	compound	_	_
25	antagonists	_	NOUN	NNS	_	20	nmod	_	_
26	and	_	CONJ	CC	_	25	cc	_	_
27	other	_	ADJ	JJ	_	29	amod	_	_
28	serotonergic	_	ADJ	JJ	_	29	amod	_	_
29	drugs	_	NOUN	NNS	_	25	conj	_	_
30	,	_	.	,	_	16	punct	_	_
31	including	_	VERB	VBG	_	35	case	_	_
32	selective	_	ADJ	JJ	_	35	amod	_	_
33	serotonin	_	NOUN	NN	_	35	compound	_	_
34	reuptake	_	NOUN	NN	_	35	compound	_	_
35	inhibitors	_	NOUN	NNS	_	16	nmod	_	_
36	SSRIs	_	NOUN	NNS	_	35	dep	_	_
37	and	_	CONJ	CC	_	36	cc	_	_
38	serotonin	_	NOUN	NN	_	42	compound	_	_
39	and	_	CONJ	CC	_	38	cc	_	_
40	noradrenaline	_	NOUN	NN	_	38	conj	_	_
41	reuptake	_	NOUN	NN	_	42	compound	_	_
42	inhibitors	_	NOUN	NNS	_	36	conj	_	_
43	SNRIs	_	NOUN	NNS	_	36	dep	_	_

#	ONDANSETRON	5533
1	In	_	ADP	IN	_	2	case	_	_
2	humans	_	NOUN	NNS	_	12	nmod	_	_
3	,	_	.	,	_	12	punct	_	_
4	carmustine	_	NOUN	NN	_	12	nsubj	_	_
5	,	_	.	,	_	4	punct	_	_
6	etoposide	_	NOUN	NN	_	4	conj	_	_
7	,	_	.	,	_	4	punct	_	_
8	and	_	CONJ	CC	_	4	cc	_	_
9	cisplatin	_	NOUN	NN	_	4	conj	_	_
10	do	_	VERB	MD	_	12	aux	_	_
11	not	_	ADV	RB	_	12	neg	_	_
12	affect	_	VERB	VB	_	0	root	_	_
13	the	_	DET	DT	_	14	det	_	_
14	pharmacokinetics	_	NOUN	NNS	_	12	dobj	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	14	nmod	_	_

#	ONDANSETRON	5534
1	In	_	ADP	IN	_	4	case	_	_
2	a	_	DET	DT	_	4	det	_	_
3	crossover	_	ADJ	JJ	_	4	amod	_	_
4	study	_	NOUN	NN	_	14	nmod	_	_
5	in	_	ADP	IN	_	8	case	_	_
6	76	_	NUM	CD	_	8	nummod	_	_
7	pediatric	_	ADJ	JJ	_	8	amod	_	_
8	patients	_	NOUN	NNS	_	4	nmod	_	_
9	,	_	.	,	_	14	punct	_	_
10	intravenous	_	ADJ	JJ	_	11	amod	_	_
11	DRUG	_	NOUN	NN	_	14	nsubj	_	_
12	did	_	VERB	VBD	_	14	aux	_	_
13	not	_	ADV	RB	_	14	neg	_	_
14	increase	_	VERB	VB	_	0	root	_	_
15	blood	_	NOUN	NN	_	16	compound	_	_
16	levels	_	NOUN	NNS	_	14	dobj	_	_
17	of	_	ADP	IN	_	20	case	_	_
18	high	_	ADJ	JJ	_	20	amod	_	_
19	dose	_	NOUN	NN	_	20	compound	_	_
20	methotrexate	_	NOUN	NN	_	16	nmod	_	_

#	ONDANSETRON	5535
1	The	_	DET	DT	_	2	det	_	_
2	coadministration	_	NOUN	NN	_	5	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	had	_	VERB	VBD	_	0	root	_	_
6	no	_	DET	DT	_	7	neg	_	_
7	effect	_	NOUN	NN	_	5	dobj	_	_
8	on	_	ADP	IN	_	10	case	_	_
9	the	_	DET	DT	_	10	det	_	_
10	pharmacokinetics	_	NOUN	NNS	_	7	nmod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	pharmacodynamics	_	NOUN	NNS	_	10	conj	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	temazepam	_	NOUN	NN	_	10	nmod	_	_

#	ONDANSETRON	5536
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	does	_	VERB	VBZ	_	4	aux	_	_
3	not	_	ADV	RB	_	4	neg	_	_
4	alter	_	VERB	VB	_	0	root	_	_
5	the	_	DET	DT	_	8	det	_	_
6	respiratory	_	ADJ	JJ	_	8	amod	_	_
7	depressant	_	ADJ	JJ	_	8	amod	_	_
8	effects	_	NOUN	NNS	_	4	dobj	_	_
9	produced	_	VERB	VBN	_	8	acl	_	_
10	by	_	ADP	IN	_	11	case	_	_
11	alfentanil	_	NOUN	NN	_	9	nmod	_	_
12	or	_	CONJ	CC	_	11	cc	_	_
13	the	_	DET	DT	_	14	det	_	_
14	degree	_	NOUN	NN	_	11	conj	_	_
15	of	_	ADP	IN	_	17	case	_	_
16	neuromuscular	_	ADJ	JJ	_	17	amod	_	_
17	blockade	_	NOUN	NN	_	14	nmod	_	_
18	produced	_	VERB	VBN	_	17	acl	_	_
19	by	_	ADP	IN	_	20	case	_	_
20	atracurium	_	NOUN	NN	_	18	nmod	_	_

#	ONDANSETRON	5537
1	Interactions	_	NOUN	NNS	_	10	nsubjpass	_	_
2	with	_	ADP	IN	_	6	case	_	_
3	general	_	ADJ	JJ	_	6	amod	_	_
4	or	_	CONJ	CC	_	3	cc	_	_
5	local	_	ADJ	JJ	_	3	conj	_	_
6	anesthetics	_	NOUN	NNS	_	1	nmod	_	_
7	have	_	VERB	VBP	_	10	aux	_	_
8	not	_	ADV	RB	_	10	neg	_	_
9	been	_	VERB	VBN	_	10	auxpass	_	_
10	studied	_	VERB	VBN	_	0	root	_	_

#	ONDANSETRON	5538
1	DRUG	_	NOUN	NN	_	8	nsubj	_	_
2	is	_	VERB	VBZ	_	8	cop	_	_
3	a	_	DET	DT	_	8	det	_	_
4	selective	_	ADJ	JJ	_	8	amod	_	_
5	5	_	NUM	CD	_	8	nummod	_	_
6	HT3	_	NOUN	NN	_	8	compound	_	_
7	receptor	_	NOUN	NN	_	8	compound	_	_
8	antagonist	_	NOUN	NN	_	0	root	_	_

#	ONDANSETRON	5539
1	While	_	ADP	IN	_	11	mark	_	_
2	DRUG	_	NOUN	NN	_	4	nmod:poss	_	_
3	's	_	PRT	POS	_	2	case	_	_
4	mechanism	_	NOUN	NN	_	11	nsubjpass	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	action	_	NOUN	NN	_	4	nmod	_	_
7	has	_	VERB	VBZ	_	11	aux	_	_
8	not	_	ADV	RB	_	11	neg	_	_
9	been	_	VERB	VBN	_	11	auxpass	_	_
10	fully	_	ADV	RB	_	11	advmod	_	_
11	characterized	_	VERB	VBN	_	19	advcl	_	_
12	,	_	.	,	_	19	punct	_	_
13	it	_	PRON	PRP	_	19	nsubj	_	_
14	is	_	VERB	VBZ	_	19	cop	_	_
15	not	_	ADV	RB	_	19	neg	_	_
16	a	_	DET	DT	_	19	det	_	_
17	dopamine	_	NOUN	NN	_	19	compound	_	_
18	receptor	_	NOUN	NN	_	19	compound	_	_
19	antagonist	_	NOUN	NN	_	0	root	_	_

#	ONDANSETRON	5540
1	QTc	_	NOUN	NN	_	3	compound	_	_
2	interval	_	ADJ	JJ	_	3	amod	_	_
3	prolongation	_	NOUN	NN	_	5	nsubjpass	_	_
4	was	_	VERB	VBD	_	5	auxpass	_	_
5	studied	_	VERB	VBN	_	0	root	_	_
6	in	_	ADP	IN	_	9	case	_	_
7	a	_	DET	DT	_	9	det	_	_
8	double	_	ADJ	JJ	_	9	amod	_	_
9	blind	_	NOUN	NN	_	5	nmod	_	_
10	,	_	.	,	_	9	punct	_	_
11	single	_	ADJ	JJ	_	13	amod	_	_
12	intravenous	_	ADJ	JJ	_	13	amod	_	_
13	dose	_	NOUN	NN	_	9	conj	_	_
14	,	_	.	,	_	9	punct	_	_
15	placebo	_	NOUN	NN	_	9	conj	_	_
16	and	_	CONJ	CC	_	9	cc	_	_
17	positive	_	ADJ	JJ	_	18	amod	_	_
18	controlled	_	VERB	VBN	_	9	conj	_	_
19	,	_	.	,	_	5	punct	_	_
20	crossover	_	ADJ	JJ	_	21	amod	_	_
21	study	_	NOUN	NN	_	5	dobj	_	_
22	in	_	ADP	IN	_	25	case	_	_
23	58	_	NUM	CD	_	25	nummod	_	_
24	healthy	_	ADJ	JJ	_	25	amod	_	_
25	subjects	_	NOUN	NNS	_	21	nmod	_	_

#	ONDANSETRON	5541
1	The	_	DET	DT	_	6	det	_	_
2	maximum	_	NOUN	NN	_	6	compound	_	_
3	mean	_	NOUN	NN	_	6	compound	_	_
4	95%	_	ADJ	JJ	_	6	amod	_	_
5	upper	_	NOUN	NN	_	6	compound	_	_
6	confidence	_	NOUN	NN	_	7	nsubj	_	_
7	bound	_	ADJ	JJ	_	0	root	_	_
8	difference	_	NOUN	NN	_	7	dobj	_	_
9	in	_	ADP	IN	_	10	case	_	_
10	QTcF	_	NOUN	NN	_	8	nmod	_	_
11	from	_	ADP	IN	_	12	case	_	_
12	placebo	_	NOUN	NN	_	8	nmod	_	_
13	after	_	ADP	IN	_	15	case	_	_
14	baseline	_	NOUN	NN	_	15	compound	_	_
15	correction	_	NOUN	NN	_	7	nmod	_	_
16	was	_	VERB	VBD	_	19	cop	_	_
17	19.5	_	NUM	CD	_	19	nummod	_	_
18	21.8	_	NUM	CD	_	19	nummod	_	_
19	ms	_	NOUN	NNS	_	7	parataxis	_	_
20	and	_	CONJ	CC	_	19	cc	_	_
21	5.6	_	NUM	CD	_	23	nummod	_	_
22	7.4	_	NUM	CD	_	23	nummod	_	_
23	ms	_	NOUN	NNS	_	19	conj	_	_
24	after	_	ADP	IN	_	28	case	_	_
25	15	_	NUM	CD	_	28	nummod	_	_
26	minute	_	NOUN	NN	_	28	amod	_	_
27	intravenous	_	ADJ	JJ	_	28	amod	_	_
28	infusions	_	NOUN	NNS	_	19	nmod	_	_
29	of	_	ADP	IN	_	31	case	_	_
30	32	_	NUM	CD	_	31	nummod	_	_
31	mg	_	NOUN	NN	_	28	nmod	_	_
32	and	_	CONJ	CC	_	31	cc	_	_
33	8	_	NUM	CD	_	34	compound	_	_
34	mg	_	NOUN	NN	_	31	conj	_	_
35	DRUG	_	NOUN	NN	_	31	dep	_	_
36	,	_	.	,	_	19	punct	_	_
37	respectively	_	ADV	RB	_	19	advmod	_	_

#	ONDANSETRON	5542
1	A	_	DET	DT	_	5	det	_	_
2	significant	_	ADJ	JJ	_	5	amod	_	_
3	exposure	_	NOUN	NN	_	5	compound	_	_
4	response	_	NOUN	NN	_	5	compound	_	_
5	relationship	_	NOUN	NN	_	7	nsubjpass	_	_
6	was	_	VERB	VBD	_	7	auxpass	_	_
7	identified	_	VERB	VBN	_	0	root	_	_
8	between	_	ADP	IN	_	10	case	_	_
9	DRUG	_	NOUN	NN	_	10	compound	_	_
10	concentration	_	NOUN	NN	_	7	nmod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	DDQTcF	_	NOUN	NN	_	10	conj	_	_

#	ONDANSETRON	5543
1	Using	_	VERB	VBG	_	15	advcl	_	_
2	the	_	DET	DT	_	6	det	_	_
3	established	_	VERB	VBN	_	6	amod	_	_
4	exposure	_	NOUN	NN	_	6	compound	_	_
5	response	_	NOUN	NN	_	6	compound	_	_
6	relationship	_	NOUN	NN	_	1	dobj	_	_
7	,	_	.	,	_	15	punct	_	_
8	24	_	NUM	CD	_	9	nummod	_	_
9	mg	_	NOUN	NN	_	15	nsubj	_	_
10	infused	_	VERB	VBN	_	9	acl	_	_
11	intravenously	_	ADV	RB	_	10	advmod	_	_
12	over	_	ADP	IN	_	14	case	_	_
13	15	_	NUM	CD	_	14	nummod	_	_
14	min	_	NOUN	NN	_	10	nmod	_	_
15	had	_	VERB	VBD	_	0	root	_	_
16	a	_	DET	DT	_	21	det	_	_
17	mean	_	ADJ	JJ	_	21	amod	_	_
18	predicted	_	ADJ	JJ	_	21	amod	_	_
19	95%	_	ADJ	JJ	_	21	amod	_	_
20	upper	_	NOUN	NN	_	21	compound	_	_
21	prediction	_	NOUN	NN	_	15	dobj	_	_
22	interval	_	ADJ	JJ	_	23	amod	_	_
23	DDQTcF	_	NOUN	NN	_	21	dep	_	_
24	of	_	ADP	IN	_	27	case	_	_
25	14.0	_	NUM	CD	_	27	nummod	_	_
26	16.3	_	NUM	CD	_	27	nummod	_	_
27	ms	_	NOUN	NNS	_	23	nmod	_	_

#	ONDANSETRON	5544
1	In	_	ADP	IN	_	2	case	_	_
2	contrast	_	NOUN	NN	_	6	nmod	_	_
3	,	_	.	,	_	6	punct	_	_
4	16	_	NUM	CD	_	5	nummod	_	_
5	mg	_	NOUN	NN	_	6	nsubj	_	_
6	infused	_	VERB	VBD	_	0	root	_	_
7	intravenously	_	ADV	RB	_	6	advmod	_	_
8	over	_	ADP	IN	_	10	case	_	_
9	15	_	NUM	CD	_	10	nummod	_	_
10	min	_	NOUN	NN	_	6	nmod	_	_
11	using	_	VERB	VBG	_	6	xcomp	_	_
12	the	_	DET	DT	_	14	det	_	_
13	same	_	ADJ	JJ	_	14	amod	_	_
14	model	_	NOUN	NN	_	11	dobj	_	_
15	had	_	VERB	VBD	_	6	parataxis	_	_
16	a	_	DET	DT	_	21	det	_	_
17	mean	_	ADJ	JJ	_	21	amod	_	_
18	predicted	_	ADJ	JJ	_	21	amod	_	_
19	95%	_	ADJ	JJ	_	21	amod	_	_
20	upper	_	NOUN	NN	_	21	compound	_	_
21	prediction	_	NOUN	NN	_	15	dobj	_	_
22	interval	_	ADJ	JJ	_	23	amod	_	_
23	DDQTcF	_	NOUN	NN	_	21	dep	_	_
24	of	_	ADP	IN	_	27	case	_	_
25	9.1	_	NUM	CD	_	27	nummod	_	_
26	11.2	_	NUM	CD	_	27	nummod	_	_
27	ms	_	NOUN	NNS	_	23	nmod	_	_

#	ONDANSETRON	5545
1	In	_	ADP	IN	_	3	case	_	_
2	normal	_	ADJ	JJ	_	3	amod	_	_
3	volunteers	_	NOUN	NNS	_	0	root	_	_
4	,	_	.	,	_	3	punct	_	_
5	single	_	ADJ	JJ	_	7	amod	_	_
6	intravenous	_	ADJ	JJ	_	7	amod	_	_
7	doses	_	NOUN	NNS	_	4	root	_	_
8	of	_	ADP	IN	_	10	case	_	_
9	0.15	_	NUM	CD	_	10	nummod	_	_
10	mg	_	NOUN	NN	_	7	nmod	_	_
11	/	_	.	:	_	7	punct	_	_
12	kg	_	NOUN	NN	_	15	nsubj	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	DRUG	_	NOUN	NN	_	12	nmod	_	_
15	had	_	VERB	VBD	_	7	dep	_	_
16	no	_	DET	DT	_	17	neg	_	_
17	effect	_	NOUN	NN	_	15	dobj	_	_
18	on	_	ADP	IN	_	20	case	_	_
19	esophageal	_	ADJ	JJ	_	20	amod	_	_
20	motility	_	NOUN	NN	_	17	nmod	_	_
21	,	_	.	,	_	20	punct	_	_
22	gastric	_	ADJ	JJ	_	23	amod	_	_
23	motility	_	NOUN	NN	_	20	conj	_	_
24	,	_	.	,	_	20	punct	_	_
25	lower	_	ADJ	JJ	_	28	amod	_	_
26	esophageal	_	ADJ	JJ	_	28	amod	_	_
27	sphincter	_	NOUN	NN	_	28	compound	_	_
28	pressure	_	NOUN	NN	_	20	conj	_	_
29	,	_	.	,	_	20	punct	_	_
30	or	_	CONJ	CC	_	20	cc	_	_
31	small	_	ADJ	JJ	_	34	amod	_	_
32	intestinal	_	ADJ	JJ	_	34	amod	_	_
33	transit	_	NOUN	NN	_	34	compound	_	_
34	time	_	NOUN	NN	_	20	conj	_	_

#	ONDANSETRON	5546
1	In	_	ADP	IN	_	3	case	_	_
2	another	_	DET	DT	_	3	det	_	_
3	study	_	NOUN	NN	_	18	nmod	_	_
4	in	_	ADP	IN	_	8	case	_	_
5	six	_	NUM	CD	_	8	nummod	_	_
6	normal	_	ADJ	JJ	_	8	amod	_	_
7	male	_	ADJ	JJ	_	8	amod	_	_
8	volunteers	_	NOUN	NNS	_	3	nmod	_	_
9	,	_	.	,	_	18	punct	_	_
10	a	_	DET	DT	_	13	det	_	_
11	16	_	NUM	CD	_	13	nummod	_	_
12	mg	_	NOUN	NN	_	13	compound	_	_
13	dose	_	NOUN	NN	_	18	nsubj	_	_
14	infused	_	VERB	VBN	_	13	acl	_	_
15	over	_	ADP	IN	_	17	case	_	_
16	5	_	NUM	CD	_	17	nummod	_	_
17	minutes	_	NOUN	NNS	_	14	nmod	_	_
18	showed	_	VERB	VBD	_	0	root	_	_
19	no	_	DET	DT	_	20	neg	_	_
20	effect	_	NOUN	NN	_	18	dobj	_	_
21	of	_	ADP	IN	_	23	case	_	_
22	the	_	DET	DT	_	23	det	_	_
23	drug	_	NOUN	NN	_	20	nmod	_	_
24	on	_	ADP	IN	_	26	case	_	_
25	cardiac	_	ADJ	JJ	_	26	amod	_	_
26	output	_	NOUN	NN	_	20	nmod	_	_
27	,	_	.	,	_	26	punct	_	_
28	heart	_	NOUN	NN	_	29	compound	_	_
29	rate	_	NOUN	NN	_	26	conj	_	_
30	,	_	.	,	_	26	punct	_	_
31	stroke	_	NOUN	NN	_	32	compound	_	_
32	volume	_	NOUN	NN	_	26	conj	_	_
33	,	_	.	,	_	26	punct	_	_
34	blood	_	NOUN	NN	_	35	compound	_	_
35	pressure	_	NOUN	NN	_	26	conj	_	_
36	,	_	.	,	_	26	punct	_	_
37	or	_	CONJ	CC	_	26	cc	_	_
38	electrocardiogram	_	NOUN	NN	_	39	compound	_	_
39	ECG	_	NOUN	NN	_	26	conj	_	_

#	ONDANSETRON	5547
1	Multiday	_	ADJ	JJ	_	2	amod	_	_
2	administration	_	NOUN	NN	_	7	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	has	_	VERB	VBZ	_	7	aux	_	_
6	been	_	VERB	VBN	_	7	auxpass	_	_
7	shown	_	VERB	VBN	_	0	root	_	_
8	to	_	PRT	TO	_	9	mark	_	_
9	slow	_	VERB	VB	_	7	xcomp	_	_
10	colonic	_	ADJ	JJ	_	11	amod	_	_
11	transit	_	NOUN	NN	_	9	dobj	_	_
12	in	_	ADP	IN	_	14	case	_	_
13	normal	_	ADJ	JJ	_	14	amod	_	_
14	volunteers	_	NOUN	NNS	_	11	nmod	_	_

#	ONDANSETRON	5548
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	has	_	VERB	VBZ	_	0	root	_	_
3	no	_	DET	DT	_	4	neg	_	_
4	effect	_	NOUN	NN	_	2	dobj	_	_
5	on	_	ADP	IN	_	8	case	_	_
6	plasma	_	NOUN	NN	_	8	compound	_	_
7	prolactin	_	NOUN	NN	_	8	compound	_	_
8	concentrations	_	NOUN	NNS	_	4	nmod	_	_

#	ONDANSETRON	5549
1	In	_	ADP	IN	_	7	case	_	_
2	a	_	DET	DT	_	7	det	_	_
3	gender	_	NOUN	NN	_	7	compound	_	_
4	balanced	_	ADJ	JJ	_	7	amod	_	_
5	pharmacodynamic	_	ADJ	JJ	_	7	amod	_	_
6	study	_	NOUN	NN	_	7	compound	_	_
7	n	_	NOUN	NN	_	14	nmod	_	_
8	=	_	ADJ	JJ	_	7	amod	_	_
9	56	_	NUM	CD	_	8	dep	_	_
10	,	_	.	,	_	14	punct	_	_
11	DRUG	_	NOUN	NN	_	13	compound	_	_
12	4	_	NUM	CD	_	13	nummod	_	_
13	mg	_	NOUN	NN	_	14	nsubj	_	_
14	administered	_	VERB	VBN	_	0	root	_	_
15	intravenously	_	ADV	RB	_	14	advmod	_	_
16	or	_	CONJ	CC	_	14	cc	_	_
17	intramuscularly	_	ADV	RB	_	20	advmod	_	_
18	was	_	VERB	VBD	_	20	cop	_	_
19	dynamically	_	ADV	RB	_	20	advmod	_	_
20	similar	_	ADJ	JJ	_	14	conj	_	_
21	in	_	ADP	IN	_	23	case	_	_
22	the	_	DET	DT	_	23	det	_	_
23	prevention	_	NOUN	NN	_	20	nmod	_	_
24	of	_	ADP	IN	_	25	case	_	_
25	nausea	_	NOUN	NN	_	23	nmod	_	_
26	and	_	CONJ	CC	_	23	cc	_	_
27	vomiting	_	VERB	VBG	_	23	conj	_	_
28	using	_	VERB	VBG	_	20	xcomp	_	_
29	the	_	DET	DT	_	31	det	_	_
30	ipecacuanha	_	NOUN	NN	_	31	compound	_	_
31	model	_	NOUN	NN	_	28	dobj	_	_
32	of	_	ADP	IN	_	33	case	_	_
33	emesis	_	NOUN	NNS	_	31	nmod	_	_

#	ONDANSETRON	5550
1	In	_	ADP	IN	_	4	case	_	_
2	normal	_	ADJ	JJ	_	4	amod	_	_
3	adult	_	ADJ	JJ	_	4	amod	_	_
4	volunteers	_	NOUN	NNS	_	13	nmod	_	_
5	,	_	.	,	_	13	punct	_	_
6	the	_	DET	DT	_	10	det	_	_
7	following	_	VERB	VBG	_	10	amod	_	_
8	mean	_	ADJ	JJ	_	10	amod	_	_
9	pharmacokinetic	_	ADJ	JJ	_	10	amod	_	_
10	data	_	NOUN	NNS	_	13	nsubjpass	_	_
11	have	_	VERB	VBP	_	13	aux	_	_
12	been	_	VERB	VBN	_	13	auxpass	_	_
13	determined	_	VERB	VBN	_	0	root	_	_
14	following	_	ADP	IN	_	18	case	_	_
15	a	_	DET	DT	_	18	det	_	_
16	single	_	ADJ	JJ	_	18	amod	_	_
17	0.15	_	NUM	CD	_	18	nummod	_	_
18	mg	_	NOUN	NN	_	13	nmod	_	_
19	/	_	.	:	_	18	punct	_	_
20	kg	_	NOUN	NN	_	22	compound	_	_
21	intravenous	_	ADJ	JJ	_	22	amod	_	_
22	dose	_	NOUN	NN	_	18	dep	_	_

#	ONDANSETRON	5551
1	Pharmacokinetics	_	NOUN	NNS	_	0	root	_	_
2	in	_	ADP	IN	_	5	case	_	_
3	Normal	_	ADJ	JJ	_	5	amod	_	_
4	Adult	_	NOUN	NN	_	5	compound	_	_
5	Volunteers	_	NOUN	NNS	_	1	nmod	_	_
6	Age	_	NOUN	NN	_	7	compound	_	_
7	group(years	_	NOUN	NNS	_	1	dep	_	_
8	n	_	.	:	_	7	punct	_	_
9	Peak	_	ADJ	JJ	_	12	amod	_	_
10	Plasma	_	NOUN	NN	_	12	compound	_	_
11	Concentration	_	NOUN	NN	_	12	compound	_	_
12	ng	_	NOUN	NN	_	7	dep	_	_
13	/	_	.	:	_	7	punct	_	_
14	mL	_	NOUN	NN	_	20	compound	_	_
15	Mean	_	VERB	VBP	_	20	amod	_	_
16	EliminationHalf	_	ADJ	JJ	_	20	amod	_	_
17	life	_	NOUN	NN	_	20	compound	_	_
18	h	_	NOUN	NN	_	20	compound	_	_
19	Plasma	_	NOUN	NN	_	20	compound	_	_
20	Clearance(L	_	NOUN	NN	_	7	dep	_	_
21	/	_	.	:	_	7	punct	_	_
22	h	_	NOUN	NN	_	24	compound	_	_
23	/	_	.	-RRB-	_	24	punct	_	_
24	kg	_	NOUN	NN	_	7	dep	_	_
25	19	_	NUM	CD	_	26	nummod	_	_
26	40	_	NUM	CD	_	24	nummod	_	_
27	11	_	NUM	CD	_	26	dep	_	_
28	102	_	NUM	CD	_	27	dep	_	_
29	3.5	_	NUM	CD	_	28	dep	_	_
30	0.381	_	NUM	CD	_	29	dep	_	_
31	61	_	NUM	CD	_	30	dep	_	_
32	74	_	NUM	CD	_	31	dep	_	_
33	12	_	NUM	CD	_	32	dep	_	_
34	106	_	NUM	CD	_	33	dep	_	_
35	4.7	_	NUM	CD	_	34	dep	_	_
36	0.319	_	NUM	CD	_	35	dep	_	_
37	>	_	NUM	CD	_	43	nummod	_	_
38	75	_	NUM	CD	_	43	nummod	_	_
39	11	_	NUM	CD	_	43	nummod	_	_
40	170	_	NUM	CD	_	43	nummod	_	_
41	5.5	_	NUM	CD	_	43	nummod	_	_
42	0.262	_	NUM	CD	_	43	nummod	_	_
43	Absorption	_	NOUN	NN	_	36	dep	_	_
44	:	_	.	:	_	1	punct	_	_
45	A	_	NOUN	NN	_	46	compound	_	_
46	study	_	NOUN	NN	_	48	nsubjpass	_	_
47	was	_	VERB	VBD	_	48	auxpass	_	_
48	performed	_	VERB	VBN	_	1	dep	_	_
49	in	_	ADP	IN	_	51	case	_	_
50	normal	_	ADJ	JJ	_	51	amod	_	_
51	volunteers	_	NOUN	NNS	_	48	nmod	_	_
52	n	_	NOUN	NN	_	53	nsubj	_	_
53	=	_	ADJ	JJ	_	51	amod	_	_
54	56	_	NUM	CD	_	53	dobj	_	_
55	to	_	PRT	TO	_	56	mark	_	_
56	evaluate	_	VERB	VB	_	53	xcomp	_	_
57	the	_	DET	DT	_	58	det	_	_
58	pharmacokinetics	_	NOUN	NNS	_	56	dobj	_	_
59	of	_	ADP	IN	_	64	case	_	_
60	a	_	DET	DT	_	64	det	_	_
61	single	_	ADJ	JJ	_	64	amod	_	_
62	4	_	NUM	CD	_	64	nummod	_	_
63	mg	_	NOUN	NN	_	64	compound	_	_
64	dose	_	NOUN	NN	_	58	nmod	_	_
65	administered	_	VERB	VBN	_	64	acl	_	_
66	as	_	ADP	IN	_	70	case	_	_
67	a	_	DET	DT	_	70	det	_	_
68	5	_	NUM	CD	_	70	nummod	_	_
69	minute	_	NOUN	NN	_	70	amod	_	_
70	infusion	_	NOUN	NN	_	65	nmod	_	_
71	compared	_	VERB	VBD	_	76	case	_	_
72	to	_	PRT	TO	_	76	case	_	_
73	a	_	DET	DT	_	76	det	_	_
74	single	_	ADJ	JJ	_	76	amod	_	_
75	intramuscular	_	ADJ	JJ	_	76	amod	_	_
76	injection	_	NOUN	NN	_	48	nmod	_	_

#	ONDANSETRON	5552
1	Systemic	_	ADJ	JJ	_	2	amod	_	_
2	exposure	_	NOUN	NN	_	9	nsubj	_	_
3	as	_	ADP	IN	_	4	mark	_	_
4	measured	_	VERB	VBN	_	2	acl	_	_
5	by	_	ADP	IN	_	7	case	_	_
6	mean	_	ADJ	JJ	_	7	amod	_	_
7	AUC	_	NOUN	NN	_	4	nmod	_	_
8	were	_	VERB	VBD	_	9	cop	_	_
9	equivalent	_	ADJ	JJ	_	0	root	_	_
10	,	_	.	,	_	9	punct	_	_
11	with	_	ADP	IN	_	12	case	_	_
12	values	_	NOUN	NNS	_	9	nmod	_	_
13	of	_	ADP	IN	_	16	case	_	_
14	156	_	NUM	CD	_	16	nummod	_	_
15	95%	_	ADJ	JJ	_	16	amod	_	_
16	CI	_	NOUN	NN	_	12	nmod	_	_
17	136	_	NUM	CD	_	16	nummod	_	_
18	,	_	.	,	_	16	punct	_	_
19	180	_	NUM	CD	_	23	nummod	_	_
20	and	_	CONJ	CC	_	19	cc	_	_
21	161	_	NUM	CD	_	19	conj	_	_
22	95%	_	ADJ	JJ	_	23	amod	_	_
23	CI	_	NOUN	NN	_	16	conj	_	_
24	137	_	NUM	CD	_	23	nummod	_	_
25	,	_	.	,	_	16	punct	_	_
26	190	_	NUM	CD	_	27	nummod	_	_
27	ng*h	_	NOUN	NN	_	16	appos	_	_
28	/	_	.	:	_	16	punct	_	_
29	mL	_	NOUN	NN	_	16	appos	_	_
30	for	_	ADP	IN	_	34	case	_	_
31	intravenous	_	ADJ	JJ	_	34	amod	_	_
32	and	_	CONJ	CC	_	31	cc	_	_
33	intramuscular	_	ADJ	JJ	_	31	conj	_	_
34	groups	_	NOUN	NNS	_	29	nmod	_	_
35	,	_	.	,	_	9	punct	_	_
36	respectively	_	ADV	RB	_	9	advmod	_	_

#	ONDANSETRON	5553
1	Mean	_	NOUN	NN	_	4	compound	_	_
2	peak	_	ADJ	JJ	_	4	amod	_	_
3	plasma	_	NOUN	NN	_	4	compound	_	_
4	concentrations	_	NOUN	NNS	_	8	nsubj	_	_
5	were	_	VERB	VBD	_	8	cop	_	_
6	42.9	_	NUM	CD	_	8	nummod	_	_
7	95%	_	ADJ	JJ	_	8	amod	_	_
8	CI	_	NOUN	NN	_	0	root	_	_
9	33.8	_	NUM	CD	_	8	nummod	_	_
10	,	_	.	,	_	8	punct	_	_
11	54.4	_	NUM	CD	_	12	nummod	_	_
12	ng	_	NOUN	NN	_	8	appos	_	_
13	/	_	.	:	_	8	punct	_	_
14	mL	_	NOUN	NN	_	8	dep	_	_
15	at	_	ADP	IN	_	17	case	_	_
16	10	_	NUM	CD	_	17	nummod	_	_
17	minutes	_	NOUN	NNS	_	14	nmod	_	_
18	after	_	ADP	IN	_	20	case	_	_
19	intravenous	_	ADJ	JJ	_	20	amod	_	_
20	infusion	_	NOUN	NN	_	14	nmod	_	_
21	and	_	CONJ	CC	_	20	cc	_	_
22	31.9	_	NUM	CD	_	24	nummod	_	_
23	95%	_	ADJ	JJ	_	24	amod	_	_
24	CI	_	NOUN	NN	_	20	conj	_	_
25	26.3	_	NUM	CD	_	24	nummod	_	_
26	,	_	.	,	_	24	punct	_	_
27	38.6	_	NUM	CD	_	28	nummod	_	_
28	ng	_	NOUN	NN	_	24	appos	_	_
29	/	_	.	:	_	24	punct	_	_
30	mL	_	NOUN	NN	_	24	dep	_	_
31	at	_	ADP	IN	_	33	case	_	_
32	41	_	NUM	CD	_	33	nummod	_	_
33	minutes	_	NOUN	NNS	_	14	nmod	_	_
34	after	_	ADP	IN	_	36	case	_	_
35	intramuscular	_	ADJ	JJ	_	36	amod	_	_
36	injection	_	NOUN	NN	_	14	nmod	_	_

#	ONDANSETRON	5554
1	Distribution	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Plasma	_	NOUN	NN	_	5	compound	_	_
4	protein	_	NOUN	NN	_	5	compound	_	_
5	binding	_	NOUN	NN	_	13	nsubj	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	as	_	ADP	IN	_	9	mark	_	_
9	measured	_	VERB	VBN	_	5	acl	_	_
10	in	_	X	FW	_	11	compound	_	_
11	vitro	_	X	FW	_	9	advmod	_	_
12	was	_	VERB	VBD	_	13	cop	_	_
13	70%	_	ADJ	JJ	_	1	dep	_	_
14	to	_	PRT	TO	_	15	case	_	_
15	76%	_	NOUN	NN	_	13	nmod	_	_
16	,	_	.	,	_	13	punct	_	_
17	over	_	ADP	IN	_	21	case	_	_
18	the	_	DET	DT	_	21	det	_	_
19	pharmacologic	_	ADJ	JJ	_	21	amod	_	_
20	concentration	_	NOUN	NN	_	21	compound	_	_
21	range	_	NOUN	NN	_	13	nmod	_	_
22	of	_	ADP	IN	_	26	case	_	_
23	10	_	NUM	CD	_	25	compound	_	_
24	to	_	PRT	TO	_	25	dep	_	_
25	500	_	NUM	CD	_	26	nummod	_	_
26	ng	_	NOUN	NN	_	21	nmod	_	_
27	/	_	.	:	_	26	punct	_	_
28	mL	_	NOUN	NN	_	26	appos	_	_

#	ONDANSETRON	5555
1	Circulating	_	VERB	VBG	_	2	amod	_	_
2	drug	_	NOUN	NN	_	4	nsubj	_	_
3	also	_	ADV	RB	_	4	advmod	_	_
4	distributes	_	VERB	VBZ	_	0	root	_	_
5	into	_	ADP	IN	_	6	case	_	_
6	erythrocytes	_	NOUN	NNS	_	4	nmod	_	_

#	ONDANSETRON	5556
1	Metabolism	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	DRUG	_	NOUN	NN	_	6	nsubjpass	_	_
4	is	_	VERB	VBZ	_	6	auxpass	_	_
5	extensively	_	ADV	RB	_	6	advmod	_	_
6	metabolized	_	VERB	VBN	_	1	dep	_	_
7	in	_	ADP	IN	_	8	case	_	_
8	humans	_	NOUN	NNS	_	6	nmod	_	_
9	,	_	.	,	_	6	punct	_	_
10	with	_	ADP	IN	_	12	case	_	_
11	approximately	_	ADV	RB	_	12	advmod	_	_
12	5%	_	NOUN	NN	_	6	nmod	_	_
13	of	_	ADP	IN	_	16	case	_	_
14	a	_	DET	DT	_	16	det	_	_
15	radiolabeled	_	VERB	VBN	_	16	amod	_	_
16	dose	_	NOUN	NN	_	12	nmod	_	_
17	recovered	_	VERB	VBN	_	16	acl	_	_
18	as	_	ADP	IN	_	21	case	_	_
19	the	_	DET	DT	_	21	det	_	_
20	parent	_	NOUN	NN	_	21	compound	_	_
21	compound	_	NOUN	NN	_	17	nmod	_	_
22	from	_	ADP	IN	_	24	case	_	_
23	the	_	DET	DT	_	24	det	_	_
24	urine	_	VERB	VBG	_	21	nmod	_	_

#	ONDANSETRON	5557
1	The	_	DET	DT	_	4	det	_	_
2	primary	_	ADJ	JJ	_	4	amod	_	_
3	metabolic	_	ADJ	JJ	_	4	amod	_	_
4	pathway	_	NOUN	NN	_	6	nsubj	_	_
5	is	_	VERB	VBZ	_	6	cop	_	_
6	hydroxylation	_	NOUN	NN	_	0	root	_	_
7	on	_	ADP	IN	_	10	case	_	_
8	the	_	DET	DT	_	10	det	_	_
9	indole	_	ADJ	JJ	_	10	amod	_	_
10	ring	_	NOUN	NN	_	6	nmod	_	_
11	followed	_	VERB	VBN	_	10	acl	_	_
12	by	_	ADP	IN	_	14	case	_	_
13	subsequent	_	ADJ	JJ	_	14	amod	_	_
14	glucuronide	_	NOUN	NN	_	11	nmod	_	_
15	or	_	CONJ	CC	_	14	cc	_	_
16	sulfate	_	NOUN	NN	_	17	compound	_	_
17	conjugation	_	NOUN	NN	_	14	conj	_	_

#	ONDANSETRON	5558
1	Although	_	ADP	IN	_	5	mark	_	_
2	some	_	DET	DT	_	4	det	_	_
3	nonconjugated	_	ADJ	JJ	_	4	amod	_	_
4	metabolites	_	NOUN	NNS	_	5	nsubj	_	_
5	have	_	VERB	VBP	_	12	advcl	_	_
6	pharmacologic	_	ADJ	JJ	_	7	amod	_	_
7	activity	_	NOUN	NN	_	5	dobj	_	_
8	,	_	.	,	_	12	punct	_	_
9	these	_	DET	DT	_	12	nsubjpass	_	_
10	are	_	VERB	VBP	_	12	auxpass	_	_
11	not	_	ADV	RB	_	12	neg	_	_
12	found	_	VERB	VBN	_	0	root	_	_
13	in	_	ADP	IN	_	14	case	_	_
14	plasma	_	NOUN	NN	_	12	nmod	_	_
15	at	_	ADP	IN	_	16	case	_	_
16	concentrations	_	NOUN	NNS	_	12	nmod	_	_
17	likely	_	ADJ	JJ	_	16	amod	_	_
18	to	_	PRT	TO	_	20	mark	_	_
19	significantly	_	ADV	RB	_	20	advmod	_	_
20	contribute	_	VERB	VB	_	17	xcomp	_	_
21	to	_	PRT	TO	_	24	case	_	_
22	the	_	DET	DT	_	24	det	_	_
23	biological	_	ADJ	JJ	_	24	amod	_	_
24	activity	_	NOUN	NN	_	20	nmod	_	_
25	of	_	ADP	IN	_	26	case	_	_
26	DRUG	_	NOUN	NN	_	24	nmod	_	_

#	ONDANSETRON	5559
1	The	_	DET	DT	_	2	det	_	_
2	metabolites	_	NOUN	NNS	_	4	nsubjpass	_	_
3	are	_	VERB	VBP	_	4	auxpass	_	_
4	observed	_	VERB	VBN	_	0	root	_	_
5	in	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	urine	_	VERB	VBG	_	4	nmod	_	_

#	ONDANSETRON	5560
1	In	_	X	FW	_	4	amod	_	_
2	vitro	_	X	FW	_	1	dep	_	_
3	metabolism	_	NOUN	NN	_	4	compound	_	_
4	studies	_	NOUN	NNS	_	6	nsubj	_	_
5	have	_	VERB	VBP	_	6	aux	_	_
6	shown	_	VERB	VBN	_	0	root	_	_
7	that	_	ADP	IN	_	11	mark	_	_
8	DRUG	_	NOUN	NN	_	11	nsubj	_	_
9	is	_	VERB	VBZ	_	11	cop	_	_
10	a	_	DET	DT	_	11	det	_	_
11	substrate	_	NOUN	NN	_	6	ccomp	_	_
12	for	_	ADP	IN	_	19	case	_	_
13	multiple	_	ADJ	JJ	_	19	amod	_	_
14	human	_	ADJ	JJ	_	19	amod	_	_
15	hepatic	_	ADJ	JJ	_	19	amod	_	_
16	cytochrome	_	NOUN	NN	_	19	compound	_	_
17	P	_	NOUN	NN	_	19	compound	_	_
18	450	_	NUM	CD	_	19	nummod	_	_
19	enzymes	_	NOUN	NNS	_	11	nmod	_	_
20	,	_	.	,	_	19	punct	_	_
21	including	_	VERB	VBG	_	22	case	_	_
22	CYP1A2	_	NOUN	NN	_	19	nmod	_	_
23	,	_	.	,	_	22	punct	_	_
24	CYP2D6	_	NOUN	NN	_	22	conj	_	_
25	,	_	.	,	_	22	punct	_	_
26	and	_	CONJ	CC	_	22	cc	_	_
27	CYP3A4	_	NOUN	NN	_	22	conj	_	_

#	ONDANSETRON	5561
1	In	_	ADP	IN	_	2	case	_	_
2	terms	_	NOUN	NNS	_	9	nmod	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	overall	_	ADJ	JJ	_	6	amod	_	_
5	DRUG	_	NOUN	NN	_	6	compound	_	_
6	turnover	_	NOUN	NN	_	2	nmod	_	_
7	,	_	.	,	_	9	punct	_	_
8	CYP3A4	_	NOUN	NN	_	9	nsubj	_	_
9	plays	_	VERB	VBZ	_	0	root	_	_
10	a	_	DET	DT	_	12	det	_	_
11	predominant	_	ADJ	JJ	_	12	amod	_	_
12	role	_	NOUN	NN	_	9	dobj	_	_
13	while	_	ADP	IN	_	23	mark	_	_
14	formation	_	NOUN	NN	_	23	nsubjpass	_	_
15	of	_	ADP	IN	_	20	case	_	_
16	the	_	DET	DT	_	20	det	_	_
17	major	_	ADJ	JJ	_	20	amod	_	_
18	in	_	X	FW	_	20	amod	_	_
19	vivo	_	X	FW	_	18	dep	_	_
20	metabolites	_	NOUN	NNS	_	14	nmod	_	_
21	is	_	VERB	VBZ	_	23	auxpass	_	_
22	apparently	_	ADV	RB	_	23	advmod	_	_
23	mediated	_	VERB	VBN	_	9	advcl	_	_
24	by	_	ADP	IN	_	25	case	_	_
25	CYP1A2	_	NOUN	NN	_	23	nmod	_	_

#	ONDANSETRON	5562
1	The	_	DET	DT	_	2	det	_	_
2	role	_	NOUN	NN	_	12	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	CYP2D6	_	NOUN	NN	_	2	nmod	_	_
5	in	_	ADP	IN	_	9	case	_	_
6	DRUG	_	NOUN	NN	_	9	compound	_	_
7	in	_	X	FW	_	9	amod	_	_
8	vivo	_	X	FW	_	7	dep	_	_
9	metabolism	_	NOUN	NN	_	2	nmod	_	_
10	is	_	VERB	VBZ	_	12	auxpass	_	_
11	relatively	_	ADV	RB	_	12	advmod	_	_
12	minor	_	ADJ	JJ	_	0	root	_	_

#	ONDANSETRON	5563
1	The	_	DET	DT	_	2	det	_	_
2	pharmacokinetics	_	NOUN	NNS	_	8	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	intravenous	_	ADJ	JJ	_	5	amod	_	_
5	DRUG	_	NOUN	NN	_	2	nmod	_	_
6	did	_	VERB	VBD	_	8	aux	_	_
7	not	_	ADV	RB	_	8	neg	_	_
8	differ	_	VERB	VB	_	0	root	_	_
9	between	_	ADP	IN	_	10	case	_	_
10	subjects	_	NOUN	NNS	_	8	nmod	_	_
11	who	_	DET	WDT	_	14	nsubj	_	_
12	were	_	VERB	VBD	_	14	cop	_	_
13	poor	_	ADJ	JJ	_	14	amod	_	_
14	metabolisers	_	NOUN	NNS	_	10	acl:relcl	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	CYP2D6	_	NOUN	NN	_	14	nmod	_	_
17	and	_	CONJ	CC	_	14	cc	_	_
18	those	_	DET	DT	_	14	conj	_	_
19	who	_	DET	WDT	_	22	nsubj	_	_
20	were	_	VERB	VBD	_	22	cop	_	_
21	extensive	_	ADJ	JJ	_	22	amod	_	_
22	metabolisers	_	NOUN	NNS	_	18	acl:relcl	_	_
23	of	_	ADP	IN	_	24	case	_	_
24	CYP2D6	_	NOUN	NN	_	22	nmod	_	_
25	,	_	.	,	_	8	punct	_	_
26	further	_	ADV	RB	_	27	advmod	_	_
27	supporting	_	VERB	VBG	_	8	xcomp	_	_
28	the	_	DET	DT	_	30	det	_	_
29	limited	_	ADJ	JJ	_	30	amod	_	_
30	role	_	NOUN	NN	_	27	dobj	_	_
31	of	_	ADP	IN	_	32	case	_	_
32	CYP2D6	_	NOUN	NN	_	30	nmod	_	_
33	in	_	ADP	IN	_	35	case	_	_
34	DRUG	_	NOUN	NN	_	35	compound	_	_
35	disposition	_	NOUN	NN	_	30	nmod	_	_
36	in	_	X	FW	_	37	compound	_	_
37	vivo	_	X	FW	_	27	advmod	_	_

#	ONDANSETRON	5564
1	Elimination	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	In	_	ADP	IN	_	6	case	_	_
4	adult	_	ADJ	JJ	_	6	amod	_	_
5	cancer	_	NOUN	NN	_	6	compound	_	_
6	patients	_	NOUN	NNS	_	1	nmod	_	_
7	,	_	.	,	_	1	punct	_	_
8	the	_	DET	DT	_	13	det	_	_
9	mean	_	ADJ	JJ	_	13	amod	_	_
10	DRUG	_	NOUN	NN	_	13	compound	_	_
11	elimination	_	NOUN	NN	_	13	compound	_	_
12	half	_	NOUN	NN	_	13	compound	_	_
13	life	_	NOUN	NN	_	16	nsubj	_	_
14	was	_	VERB	VBD	_	16	cop	_	_
15	4.0	_	NUM	CD	_	16	nummod	_	_
16	hours	_	NOUN	NNS	_	1	appos	_	_
17	,	_	.	,	_	1	punct	_	_
18	and	_	CONJ	CC	_	1	cc	_	_
19	there	_	PRON	PRP$	_	20	expl	_	_
20	was	_	VERB	VBD	_	1	conj	_	_
21	no	_	DET	DT	_	22	neg	_	_
22	difference	_	NOUN	NN	_	20	nsubj	_	_
23	in	_	ADP	IN	_	26	case	_	_
24	the	_	DET	DT	_	26	det	_	_
25	multidose	_	ADJ	JJ	_	26	amod	_	_
26	pharmacokinetics	_	NOUN	NNS	_	22	nmod	_	_
27	over	_	ADP	IN	_	31	case	_	_
28	a	_	DET	DT	_	31	det	_	_
29	4	_	NUM	CD	_	31	nummod	_	_
30	day	_	NOUN	NN	_	31	compound	_	_
31	period	_	NOUN	NN	_	20	nmod	_	_

#	ONDANSETRON	5565
1	In	_	ADP	IN	_	5	case	_	_
2	a	_	DET	DT	_	5	det	_	_
3	dose	_	NOUN	NN	_	5	compound	_	_
4	proportionality	_	NOUN	NN	_	5	compound	_	_
5	study	_	NOUN	NN	_	16	nmod	_	_
6	,	_	.	,	_	16	punct	_	_
7	systemic	_	ADJ	JJ	_	8	amod	_	_
8	exposure	_	NOUN	NN	_	16	nsubj	_	_
9	to	_	PRT	TO	_	11	case	_	_
10	32	_	NUM	CD	_	11	nummod	_	_
11	mg	_	NOUN	NN	_	8	nmod	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	DRUG	_	NOUN	NN	_	11	nmod	_	_
14	was	_	VERB	VBD	_	16	cop	_	_
15	not	_	ADV	RB	_	16	neg	_	_
16	proportional	_	ADJ	JJ	_	0	root	_	_
17	to	_	PRT	TO	_	18	case	_	_
18	dose	_	NOUN	NN	_	16	nmod	_	_
19	as	_	ADP	IN	_	20	mark	_	_
20	measured	_	VERB	VBN	_	16	advcl	_	_
21	by	_	ADP	IN	_	22	mark	_	_
22	comparing	_	VERB	VBG	_	20	advcl	_	_
23	dose	_	NOUN	NN	_	26	compound	_	_
24	normalized	_	ADJ	JJ	_	26	amod	_	_
25	AUC	_	NOUN	NN	_	26	compound	_	_
26	values	_	NOUN	NNS	_	22	dobj	_	_
27	to	_	PRT	TO	_	31	case	_	_
28	an	_	DET	DT	_	31	det	_	_
29	8	_	NUM	CD	_	31	nummod	_	_
30	mg	_	NOUN	NN	_	31	compound	_	_
31	dose	_	NOUN	NN	_	26	nmod	_	_

#	ONDANSETRON	5566
1	This	_	DET	DT	_	3	nsubj	_	_
2	is	_	VERB	VBZ	_	3	cop	_	_
3	consistent	_	ADJ	JJ	_	0	root	_	_
4	with	_	ADP	IN	_	7	case	_	_
5	a	_	DET	DT	_	7	det	_	_
6	small	_	ADJ	JJ	_	7	amod	_	_
7	decrease	_	NOUN	NN	_	3	nmod	_	_
8	in	_	ADP	IN	_	10	case	_	_
9	systemic	_	ADJ	JJ	_	10	amod	_	_
10	clearance	_	NOUN	NN	_	7	nmod	_	_
11	with	_	ADP	IN	_	12	mark	_	_
12	increasing	_	VERB	VBG	_	10	acl	_	_
13	plasma	_	NOUN	NN	_	14	compound	_	_
14	concentrations	_	NOUN	NNS	_	12	dobj	_	_

#	ONDANSETRON	5567
1	Geriatrics	_	NOUN	NNS	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	A	_	NOUN	NN	_	4	nmod:poss	_	_
4	reduction	_	NOUN	NN	_	14	nsubjpass	_	_
5	in	_	ADP	IN	_	6	case	_	_
6	clearance	_	NOUN	NN	_	4	nmod	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	increase	_	NOUN	NN	_	6	conj	_	_
9	in	_	ADP	IN	_	12	case	_	_
10	elimination	_	NOUN	NN	_	12	compound	_	_
11	half	_	NOUN	NN	_	12	compound	_	_
12	life	_	NOUN	NN	_	4	nmod	_	_
13	are	_	VERB	VBP	_	14	auxpass	_	_
14	seen	_	VERB	VBN	_	1	dep	_	_
15	in	_	ADP	IN	_	16	case	_	_
16	patients	_	NOUN	NNS	_	14	nmod	_	_
17	over	_	ADP	IN	_	19	case	_	_
18	75	_	NUM	CD	_	19	nummod	_	_
19	years	_	NOUN	NNS	_	14	nmod	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	age	_	NOUN	NN	_	19	nmod	_	_

#	ONDANSETRON	5568
1	In	_	ADP	IN	_	3	case	_	_
2	clinical	_	ADJ	JJ	_	3	amod	_	_
3	trials	_	NOUN	NNS	_	12	nmod	_	_
4	with	_	ADP	IN	_	6	case	_	_
5	cancer	_	NOUN	NN	_	6	compound	_	_
6	patients	_	NOUN	NNS	_	3	nmod	_	_
7	,	_	.	,	_	12	punct	_	_
8	safety	_	NOUN	NN	_	12	nsubj	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	efficacy	_	NOUN	NN	_	8	conj	_	_
11	were	_	VERB	VBD	_	12	cop	_	_
12	similar	_	ADJ	JJ	_	0	root	_	_
13	in	_	ADP	IN	_	14	case	_	_
14	patients	_	NOUN	NNS	_	12	nmod	_	_
15	over	_	ADP	IN	_	17	case	_	_
16	65	_	NUM	CD	_	17	nummod	_	_
17	years	_	NOUN	NNS	_	12	nmod	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	age	_	NOUN	NN	_	17	nmod	_	_
20	and	_	CONJ	CC	_	12	cc	_	_
21	those	_	DET	DT	_	31	nsubj	_	_
22	under	_	ADP	IN	_	24	case	_	_
23	65	_	NUM	CD	_	24	nummod	_	_
24	years	_	NOUN	NNS	_	21	nmod	_	_
25	of	_	ADP	IN	_	26	case	_	_
26	age	_	NOUN	NN	_	24	nmod	_	_
27	there	_	DET	EX	_	26	nummod	_	_
28	was	_	VERB	VBD	_	31	cop	_	_
29	an	_	DET	DT	_	31	det	_	_
30	insufficient	_	ADJ	JJ	_	31	amod	_	_
31	number	_	NOUN	NN	_	12	conj	_	_
32	of	_	ADP	IN	_	33	case	_	_
33	patients	_	NOUN	NNS	_	31	nmod	_	_
34	over	_	ADP	IN	_	36	case	_	_
35	75	_	NUM	CD	_	36	nummod	_	_
36	years	_	NOUN	NNS	_	31	nmod	_	_
37	of	_	ADP	IN	_	38	case	_	_
38	age	_	NOUN	NN	_	36	nmod	_	_
39	to	_	PRT	TO	_	41	case	_	_
40	permit	_	ADJ	JJ	_	41	amod	_	_
41	conclusions	_	NOUN	NNS	_	38	nmod	_	_
42	in	_	ADP	IN	_	43	case	_	_
43	that	_	DET	WDT	_	41	nmod	_	_
44	age	_	NOUN	NN	_	45	compound	_	_
45	group	_	NOUN	NN	_	43	root	_	_

#	ONDANSETRON	5569
1	No	_	DET	DT	_	3	neg	_	_
2	dosage	_	NOUN	NN	_	3	compound	_	_
3	adjustment	_	NOUN	NN	_	5	nsubjpass	_	_
4	is	_	VERB	VBZ	_	5	auxpass	_	_
5	recommended	_	VERB	VBN	_	0	root	_	_
6	in	_	ADP	IN	_	8	case	_	_
7	the	_	DET	DT	_	8	det	_	_
8	elderly	_	ADJ	JJ	_	5	nmod	_	_

#	ONDANSETRON	5570
1	Pediatrics	_	NOUN	NNS	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Pharmacokinetic	_	ADJ	JJ	_	4	amod	_	_
4	samples	_	NOUN	NNS	_	6	nsubjpass	_	_
5	were	_	VERB	VBD	_	6	auxpass	_	_
6	collected	_	VERB	VBN	_	1	dep	_	_
7	from	_	ADP	IN	_	10	case	_	_
8	74	_	NUM	CD	_	10	nummod	_	_
9	cancer	_	NOUN	NN	_	10	compound	_	_
10	patients	_	NOUN	NNS	_	6	nmod	_	_
11	6	_	NUM	CD	_	13	compound	_	_
12	to	_	PRT	TO	_	13	dep	_	_
13	48	_	NUM	CD	_	14	nummod	_	_
14	months	_	NOUN	NNS	_	10	dep	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	age	_	NOUN	NN	_	14	nmod	_	_
17	,	_	.	,	_	10	punct	_	_
18	who	_	DET	WDT	_	19	nsubj	_	_
19	received	_	VERB	VBD	_	10	acl:relcl	_	_
20	a	_	DET	DT	_	21	det	_	_
21	dose	_	NOUN	NN	_	19	dobj	_	_
22	of	_	ADP	IN	_	24	case	_	_
23	0.15	_	NUM	CD	_	24	nummod	_	_
24	mg	_	NOUN	NN	_	21	nmod	_	_
25	/	_	.	:	_	6	punct	_	_
26	kg	_	NOUN	NN	_	6	parataxis	_	_
27	of	_	ADP	IN	_	29	case	_	_
28	intravenous	_	ADJ	JJ	_	29	amod	_	_
29	DRUG	_	NOUN	NN	_	26	nmod	_	_
30	every	_	ADV	RB	_	31	advmod	_	_
31	4	_	NUM	CD	_	32	nummod	_	_
32	hours	_	NOUN	NNS	_	26	dep	_	_
33	for	_	ADP	IN	_	35	case	_	_
34	3	_	NUM	CD	_	35	nummod	_	_
35	doses	_	NOUN	NNS	_	32	nmod	_	_
36	during	_	ADP	IN	_	38	case	_	_
37	a	_	DET	DT	_	38	det	_	_
38	safety	_	NOUN	NN	_	32	nmod	_	_
39	and	_	CONJ	CC	_	38	cc	_	_
40	efficacy	_	NOUN	NN	_	41	compound	_	_
41	trial	_	ADJ	JJ	_	38	conj	_	_

#	ONDANSETRON	5571
1	These	_	DET	DT	_	2	det	_	_
2	data	_	NOUN	NNS	_	4	nsubjpass	_	_
3	were	_	VERB	VBD	_	4	auxpass	_	_
4	combined	_	VERB	VBN	_	0	root	_	_
5	with	_	ADP	IN	_	8	case	_	_
6	sequential	_	ADJ	JJ	_	8	amod	_	_
7	pharmacokinetics	_	NOUN	NNS	_	8	compound	_	_
8	data	_	NOUN	NNS	_	4	nmod	_	_
9	from	_	ADP	IN	_	12	case	_	_
10	41	_	NUM	CD	_	12	nummod	_	_
11	surgery	_	NOUN	NN	_	12	compound	_	_
12	patients	_	NOUN	NNS	_	8	nmod	_	_
13	1	_	NUM	CD	_	14	nummod	_	_
14	month	_	NOUN	NN	_	12	dep	_	_
15	to	_	PRT	TO	_	17	case	_	_
16	24	_	NUM	CD	_	17	nummod	_	_
17	months	_	NOUN	NNS	_	8	nmod	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	age	_	NOUN	NN	_	17	nmod	_	_
20	,	_	.	,	_	8	punct	_	_
21	who	_	DET	WDT	_	22	nsubj	_	_
22	received	_	VERB	VBD	_	8	acl:relcl	_	_
23	a	_	DET	DT	_	25	det	_	_
24	single	_	ADJ	JJ	_	25	amod	_	_
25	dose	_	NOUN	NN	_	22	dobj	_	_
26	of	_	ADP	IN	_	28	case	_	_
27	0.1	_	NUM	CD	_	28	nummod	_	_
28	mg	_	NOUN	NN	_	25	nmod	_	_
29	/	_	.	:	_	4	punct	_	_
30	kg	_	NOUN	NN	_	47	nsubjpass	_	_
31	of	_	ADP	IN	_	33	case	_	_
32	intravenous	_	ADJ	JJ	_	33	amod	_	_
33	DRUG	_	NOUN	NN	_	30	nmod	_	_
34	prior	_	ADJ	JJ	_	36	case	_	_
35	to	_	PRT	TO	_	34	mwe	_	_
36	surgery	_	NOUN	NN	_	30	nmod	_	_
37	with	_	ADP	IN	_	39	case	_	_
38	general	_	ADJ	JJ	_	39	amod	_	_
39	anesthesia	_	NOUN	NN	_	36	nmod	_	_
40	,	_	.	,	_	30	punct	_	_
41	and	_	CONJ	CC	_	30	cc	_	_
42	a	_	DET	DT	_	45	det	_	_
43	population	_	NOUN	NN	_	45	compound	_	_
44	pharmacokinetic	_	ADJ	JJ	_	45	amod	_	_
45	analysis	_	NOUN	NN	_	30	conj	_	_
46	was	_	VERB	VBD	_	47	auxpass	_	_
47	performed	_	VERB	VBN	_	4	parataxis	_	_
48	on	_	ADP	IN	_	51	case	_	_
49	the	_	DET	DT	_	51	det	_	_
50	combined	_	ADJ	JJ	_	51	amod	_	_
51	data	_	NOUN	NNS	_	47	nmod	_	_
52	set	_	VERB	VBP	_	47	parataxis	_	_

#	ONDANSETRON	5572
1	The	_	DET	DT	_	2	det	_	_
2	results	_	NOUN	NNS	_	7	nsubjpass	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	this	_	DET	DT	_	5	det	_	_
5	analysis	_	NOUN	NN	_	2	nmod	_	_
6	are	_	VERB	VBP	_	7	auxpass	_	_
7	included	_	VERB	VBN	_	0	root	_	_
8	in	_	ADP	IN	_	9	case	_	_
9	Table	_	ADJ	JJ	_	7	nmod	_	_
10	4	_	NUM	CD	_	9	nummod	_	_
11	and	_	CONJ	CC	_	7	cc	_	_
12	are	_	VERB	VBP	_	13	auxpass	_	_
13	compared	_	VERB	VBN	_	7	conj	_	_
14	to	_	PRT	TO	_	17	case	_	_
15	the	_	DET	DT	_	17	det	_	_
16	pharmacokinetic	_	ADJ	JJ	_	17	amod	_	_
17	results	_	NOUN	NNS	_	13	nmod	_	_
18	in	_	ADP	IN	_	20	case	_	_
19	cancer	_	NOUN	NN	_	20	compound	_	_
20	patients	_	NOUN	NNS	_	17	nmod	_	_
21	4	_	NUM	CD	_	23	compound	_	_
22	to	_	PRT	TO	_	23	dep	_	_
23	18	_	NUM	CD	_	24	nummod	_	_
24	years	_	NOUN	NNS	_	20	dep	_	_
25	of	_	ADP	IN	_	26	case	_	_
26	age	_	NOUN	NN	_	24	nmod	_	_

#	ONDANSETRON	5573
1	Pharmacokinetics	_	NOUN	NNS	_	0	root	_	_
2	in	_	ADP	IN	_	5	case	_	_
3	Pediatric	_	ADJ	JJ	_	5	amod	_	_
4	Cancer	_	NOUN	NN	_	5	compound	_	_
5	Patients	_	NOUN	NNS	_	1	nmod	_	_
6	1	_	NUM	CD	_	7	nummod	_	_
7	Month	_	NOUN	NN	_	5	dep	_	_
8	to	_	PRT	TO	_	10	case	_	_
9	18	_	NUM	CD	_	10	nummod	_	_
10	Years	_	NOUN	NNS	_	1	nmod	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	Age	_	NOUN	NN	_	10	nmod	_	_
13	a	_	DET	DT	_	17	det	_	_
14	Population	_	NOUN	NN	_	17	compound	_	_
15	PK	_	NOUN	NN	_	17	compound	_	_
16	Pharmacokinetic	_	ADJ	JJ	_	17	amod	_	_
17	Patients	_	NOUN	NNS	_	10	dep	_	_
18	:	_	.	:	_	1	punct	_	_
19	64%	_	ADJ	JJ	_	21	amod	_	_
20	cancer	_	NOUN	NN	_	21	compound	_	_
21	patients	_	NOUN	NNS	_	1	dep	_	_
22	and	_	CONJ	CC	_	21	cc	_	_
23	36%	_	ADJ	JJ	_	25	amod	_	_
24	surgery	_	NOUN	NN	_	25	compound	_	_
25	patients	_	NOUN	NNS	_	21	conj	_	_

#	ONDANSETRON	5574
1	Subjects	_	NOUN	NNS	_	0	root	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	Age	_	NOUN	NN	_	6	compound	_	_
4	Group	_	NOUN	NN	_	6	compound	_	_
5	N	_	NOUN	NN	_	6	compound	_	_
6	CL(L	_	NOUN	NN	_	1	conj	_	_
7	/	_	.	:	_	1	punct	_	_
8	h	_	NOUN	NN	_	1	dep	_	_
9	/	_	.	-RRB-	_	8	punct	_	_
10	kg	_	NOUN	NN	_	12	compound	_	_
11	Vdss	_	NOUN	NN	_	12	compound	_	_
12	L	_	NOUN	NN	_	8	dep	_	_
13	/	_	.	:	_	8	punct	_	_
14	kg	_	NOUN	NN	_	18	compound	_	_
15	T%	_	NOUN	NN	_	18	compound	_	_
16	h	_	NOUN	NN	_	18	compound	_	_
17	Geometric	_	ADJ	JJ	_	18	amod	_	_
18	Mean	_	NOUN	NN	_	19	nsubj	_	_
19	Mean	_	VERB	VBP	_	8	dep	_	_
20	Pediatric	_	ADJ	JJ	_	22	amod	_	_
21	Cancer	_	NOUN	NN	_	22	compound	_	_
22	Patients4	_	NOUN	NN	_	19	dobj	_	_
23	to	_	PRT	TO	_	25	case	_	_
24	18	_	NUM	CD	_	25	nummod	_	_
25	years	_	NOUN	NNS	_	19	nmod	_	_
26	of	_	ADP	IN	_	28	case	_	_
27	age	_	NOUN	NN	_	28	compound	_	_
28	N	_	NOUN	NN	_	25	nmod	_	_
29	=	_	ADJ	JJ	_	25	amod	_	_
30	21	_	NUM	CD	_	38	nummod	_	_
31	0.599	_	NUM	CD	_	38	nummod	_	_
32	1.9	_	NUM	CD	_	38	nummod	_	_
33	2.8	_	NUM	CD	_	38	nummod	_	_
34	Population	_	NOUN	NN	_	38	compound	_	_
35	PK	_	NOUN	NN	_	38	compound	_	_
36	Patientsa	_	NOUN	NN	_	38	compound	_	_
37	1	_	NUM	CD	_	38	nummod	_	_
38	month	_	NOUN	NN	_	29	dep	_	_
39	to	_	PRT	TO	_	41	case	_	_
40	48	_	NUM	CD	_	41	nummod	_	_
41	months	_	NOUN	NNS	_	38	nmod	_	_
42	of	_	ADP	IN	_	44	case	_	_
43	age	_	NOUN	NN	_	44	compound	_	_
44	N	_	NOUN	NN	_	41	nmod	_	_
45	=	_	ADJ	JJ	_	44	amod	_	_
46	115	_	NUM	CD	_	47	nummod	_	_
47	0.582	_	NUM	CD	_	50	dep	_	_
48	3.65	_	NUM	CD	_	47	dep	_	_
49	4.9	_	NUM	CD	_	48	dep	_	_
50	Based	_	VERB	VBN	_	45	xcomp	_	_
51	on	_	ADP	IN	_	55	case	_	_
52	the	_	DET	DT	_	55	det	_	_
53	population	_	NOUN	NN	_	55	compound	_	_
54	pharmacokinetic	_	ADJ	JJ	_	55	amod	_	_
55	analysis	_	NOUN	NN	_	50	nmod	_	_
56	,	_	.	,	_	8	punct	_	_
57	cancer	_	NOUN	NN	_	58	compound	_	_
58	patients	_	NOUN	NNS	_	8	appos	_	_
59	6	_	NUM	CD	_	61	compound	_	_
60	to	_	PRT	TO	_	61	dep	_	_
61	48	_	NUM	CD	_	62	nummod	_	_
62	months	_	NOUN	NNS	_	58	dep	_	_
63	of	_	ADP	IN	_	64	case	_	_
64	age	_	NOUN	NN	_	62	nmod	_	_
65	who	_	DET	WDT	_	66	nsubj	_	_
66	receive	_	VERB	VBP	_	64	acl:relcl	_	_
67	a	_	DET	DT	_	68	det	_	_
68	dose	_	NOUN	NN	_	66	dobj	_	_
69	of	_	ADP	IN	_	71	case	_	_
70	0.15	_	NUM	CD	_	71	nummod	_	_
71	mg	_	NOUN	NN	_	68	nmod	_	_
72	/	_	.	:	_	8	punct	_	_
73	kg	_	NOUN	NN	_	85	nsubjpass	_	_
74	of	_	ADP	IN	_	76	case	_	_
75	intravenous	_	ADJ	JJ	_	76	amod	_	_
76	DRUG	_	NOUN	NN	_	73	nmod	_	_
77	every	_	ADV	RB	_	78	advmod	_	_
78	4	_	NUM	CD	_	79	nummod	_	_
79	hours	_	NOUN	NNS	_	85	nsubjpass	_	_
80	for	_	ADP	IN	_	82	case	_	_
81	3	_	NUM	CD	_	82	nummod	_	_
82	doses	_	NOUN	NNS	_	79	nmod	_	_
83	would	_	VERB	MD	_	85	aux	_	_
84	be	_	VERB	VB	_	85	auxpass	_	_
85	expected	_	VERB	VBN	_	8	dep	_	_
86	to	_	PRT	TO	_	87	mark	_	_
87	achieve	_	VERB	VB	_	85	xcomp	_	_
88	a	_	DET	DT	_	91	det	_	_
89	systemic	_	ADJ	JJ	_	91	amod	_	_
90	exposure	_	NOUN	NN	_	91	compound	_	_
91	AUC	_	NOUN	NN	_	87	dobj	_	_
92	consistent	_	ADJ	JJ	_	91	amod	_	_
93	with	_	ADP	IN	_	95	case	_	_
94	the	_	DET	DT	_	95	det	_	_
95	exposure	_	NOUN	NN	_	92	nmod	_	_
96	achieved	_	VERB	VBN	_	95	acl	_	_
97	in	_	ADP	IN	_	100	case	_	_
98	previous	_	ADJ	JJ	_	100	amod	_	_
99	pediatric	_	ADJ	JJ	_	100	amod	_	_
100	studies	_	NOUN	NNS	_	96	nmod	_	_
101	in	_	ADP	IN	_	103	case	_	_
102	cancer	_	NOUN	NN	_	103	compound	_	_
103	patients	_	NOUN	NNS	_	100	nmod	_	_
104	4	_	NUM	CD	_	106	compound	_	_
105	to	_	PRT	TO	_	106	dep	_	_
106	18	_	NUM	CD	_	107	nummod	_	_
107	years	_	NOUN	NNS	_	103	dep	_	_
108	of	_	ADP	IN	_	109	case	_	_
109	age	_	NOUN	NN	_	107	nmod	_	_
110	at	_	ADP	IN	_	112	case	_	_
111	similar	_	ADJ	JJ	_	112	amod	_	_
112	doses	_	NOUN	NNS	_	107	nmod	_	_

#	ONDANSETRON	5575
1	In	_	ADP	IN	_	3	case	_	_
2	a	_	DET	DT	_	3	det	_	_
3	study	_	NOUN	NN	_	52	nmod	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	21	_	NUM	CD	_	7	nummod	_	_
6	pediatric	_	ADJ	JJ	_	7	amod	_	_
7	patients	_	NOUN	NNS	_	3	nmod	_	_
8	3	_	NUM	CD	_	10	compound	_	_
9	to	_	PRT	TO	_	10	dep	_	_
10	12	_	NUM	CD	_	11	nummod	_	_
11	years	_	NOUN	NNS	_	7	dep	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	age	_	NOUN	NN	_	11	nmod	_	_
14	who	_	DET	WDT	_	16	nsubj	_	_
15	were	_	VERB	VBD	_	16	cop	_	_
16	undergoing	_	VERB	VBG	_	13	acl:relcl	_	_
17	surgery	_	NOUN	NN	_	16	dobj	_	_
18	requiring	_	VERB	VBG	_	17	acl	_	_
19	anesthesia	_	NOUN	NN	_	18	dobj	_	_
20	for	_	ADP	IN	_	22	case	_	_
21	a	_	DET	DT	_	22	det	_	_
22	duration	_	NOUN	NN	_	18	nmod	_	_
23	of	_	ADP	IN	_	25	case	_	_
24	45	_	NUM	CD	_	25	nummod	_	_
25	minutes	_	NOUN	NNS	_	22	nmod	_	_
26	to	_	PRT	TO	_	28	case	_	_
27	2	_	NUM	CD	_	28	nummod	_	_
28	hours	_	NOUN	NNS	_	22	nmod	_	_
29	,	_	.	,	_	28	punct	_	_
30	a	_	DET	DT	_	33	det	_	_
31	single	_	ADJ	JJ	_	33	amod	_	_
32	intravenous	_	ADJ	JJ	_	33	amod	_	_
33	dose	_	NOUN	NN	_	28	appos	_	_
34	of	_	ADP	IN	_	35	case	_	_
35	DRUG	_	NOUN	NN	_	33	nmod	_	_
36	,	_	.	,	_	35	punct	_	_
37	2	_	NUM	CD	_	38	nummod	_	_
38	mg	_	NOUN	NN	_	35	appos	_	_
39	3	_	NUM	CD	_	38	nummod	_	_
40	to	_	PRT	TO	_	42	case	_	_
41	7	_	NUM	CD	_	42	nummod	_	_
42	years	_	NOUN	NNS	_	38	nmod	_	_
43	or	_	CONJ	CC	_	42	cc	_	_
44	4	_	NUM	CD	_	45	nummod	_	_
45	mg	_	NOUN	NN	_	42	conj	_	_
46	8	_	NUM	CD	_	45	nummod	_	_
47	to	_	PRT	TO	_	49	case	_	_
48	12	_	NUM	CD	_	49	nummod	_	_
49	years	_	NOUN	NNS	_	45	nmod	_	_
50	,	_	.	,	_	52	punct	_	_
51	was	_	VERB	VBD	_	52	auxpass	_	_
52	administered	_	VERB	VBN	_	0	root	_	_
53	immediately	_	ADV	RB	_	54	advmod	_	_
54	prior	_	ADJ	JJ	_	52	xcomp	_	_
55	to	_	PRT	TO	_	57	case	_	_
56	anesthesia	_	NOUN	NN	_	57	compound	_	_
57	induction	_	NOUN	NN	_	54	nmod	_	_

#	ONDANSETRON	5576
1	Mean	_	NOUN	NN	_	4	compound	_	_
2	weight	_	NOUN	NN	_	4	compound	_	_
3	normalized	_	ADJ	JJ	_	4	amod	_	_
4	clearance	_	NOUN	NN	_	16	nsubj	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	volume	_	NOUN	NN	_	4	conj	_	_
7	of	_	ADP	IN	_	9	case	_	_
8	distribution	_	NOUN	NN	_	9	compound	_	_
9	values	_	NOUN	NNS	_	4	nmod	_	_
10	in	_	ADP	IN	_	14	case	_	_
11	these	_	DET	DT	_	14	det	_	_
12	pediatric	_	ADJ	JJ	_	14	amod	_	_
13	surgical	_	ADJ	JJ	_	14	amod	_	_
14	patients	_	NOUN	NNS	_	9	nmod	_	_
15	were	_	VERB	VBD	_	16	cop	_	_
16	similar	_	ADJ	JJ	_	0	root	_	_
17	to	_	PRT	TO	_	18	case	_	_
18	those	_	DET	DT	_	16	nmod	_	_
19	previously	_	ADV	RB	_	20	advmod	_	_
20	reported	_	VERB	VBN	_	18	acl	_	_
21	for	_	ADP	IN	_	23	case	_	_
22	young	_	ADJ	JJ	_	23	amod	_	_
23	adults	_	NOUN	NNS	_	20	nmod	_	_

#	ONDANSETRON	5577
1	Mean	_	NOUN	NN	_	4	compound	_	_
2	terminal	_	ADJ	JJ	_	4	amod	_	_
3	half	_	NOUN	NN	_	4	compound	_	_
4	life	_	NOUN	NN	_	7	nsubjpass	_	_
5	was	_	VERB	VBD	_	7	auxpass	_	_
6	slightly	_	ADV	RB	_	7	advmod	_	_
7	reduced	_	VERB	VBN	_	0	root	_	_
8	in	_	ADP	IN	_	11	case	_	_
9	pediatric	_	ADJ	JJ	_	11	amod	_	_
10	patients	_	NOUN	NNS	_	11	compound	_	_
11	range	_	NOUN	NN	_	7	nmod	_	_
12	,	_	.	,	_	11	punct	_	_
13	2.5	_	NUM	CD	_	15	compound	_	_
14	to	_	PRT	TO	_	15	dep	_	_
15	3	_	NUM	CD	_	16	nummod	_	_
16	hours	_	NOUN	NNS	_	11	appos	_	_
17	in	_	ADP	IN	_	18	case	_	_
18	comparison	_	NOUN	NN	_	16	nmod	_	_
19	with	_	ADP	IN	_	21	case	_	_
20	adults	_	NOUN	NNS	_	21	compound	_	_
21	range	_	NOUN	NN	_	18	nmod	_	_
22	,	_	.	,	_	11	punct	_	_
23	3	_	NUM	CD	_	25	compound	_	_
24	to	_	PRT	TO	_	25	dep	_	_
25	3.5	_	NUM	CD	_	26	nummod	_	_
26	hours	_	NOUN	NNS	_	11	appos	_	_

#	ONDANSETRON	5578
1	In	_	ADP	IN	_	3	case	_	_
2	a	_	DET	DT	_	3	det	_	_
3	study	_	NOUN	NN	_	38	nmod	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	51	_	NUM	CD	_	7	nummod	_	_
6	pediatric	_	ADJ	JJ	_	7	amod	_	_
7	patients	_	NOUN	NNS	_	3	nmod	_	_
8	1	_	NUM	CD	_	9	nummod	_	_
9	month	_	NOUN	NN	_	7	dep	_	_
10	to	_	PRT	TO	_	12	case	_	_
11	24	_	NUM	CD	_	12	nummod	_	_
12	months	_	NOUN	NNS	_	9	nmod	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	age	_	NOUN	NN	_	12	nmod	_	_
15	who	_	DET	WDT	_	17	nsubj	_	_
16	were	_	VERB	VBD	_	17	aux	_	_
17	undergoing	_	VERB	VBG	_	14	acl:relcl	_	_
18	surgery	_	NOUN	NN	_	17	dobj	_	_
19	requiring	_	VERB	VBG	_	18	acl	_	_
20	general	_	ADJ	JJ	_	21	amod	_	_
21	anesthesia	_	NOUN	NN	_	19	dobj	_	_
22	,	_	.	,	_	21	punct	_	_
23	a	_	DET	DT	_	26	det	_	_
24	single	_	ADJ	JJ	_	26	amod	_	_
25	intravenous	_	ADJ	JJ	_	26	amod	_	_
26	dose	_	NOUN	NN	_	21	appos	_	_
27	of	_	ADP	IN	_	28	case	_	_
28	DRUG	_	NOUN	NN	_	26	nmod	_	_
29	,	_	.	,	_	28	punct	_	_
30	0.1	_	NUM	CD	_	33	nummod	_	_
31	or	_	CONJ	CC	_	30	cc	_	_
32	0.2	_	NUM	CD	_	30	conj	_	_
33	mg	_	NOUN	NN	_	28	appos	_	_
34	/	_	.	:	_	28	punct	_	_
35	kg	_	NOUN	NN	_	28	appos	_	_
36	,	_	.	,	_	38	punct	_	_
37	was	_	VERB	VBD	_	38	auxpass	_	_
38	administered	_	VERB	VBN	_	0	root	_	_
39	prior	_	ADJ	JJ	_	38	advmod	_	_
40	to	_	PRT	TO	_	41	case	_	_
41	surgery	_	NOUN	NN	_	39	nmod	_	_

#	ONDANSETRON	5579
1	As	_	ADP	IN	_	2	mark	_	_
2	shown	_	VERB	VBN	_	14	advcl	_	_
3	in	_	ADP	IN	_	4	case	_	_
4	Table	_	ADJ	JJ	_	2	nmod	_	_
5	5	_	NUM	CD	_	4	nummod	_	_
6	,	_	.	,	_	14	punct	_	_
7	the	_	DET	DT	_	9	det	_	_
8	41	_	NUM	CD	_	9	nummod	_	_
9	patients	_	NOUN	NNS	_	14	nsubjpass	_	_
10	with	_	ADP	IN	_	12	case	_	_
11	pharmacokinetic	_	ADJ	JJ	_	12	amod	_	_
12	data	_	NOUN	NNS	_	9	nmod	_	_
13	were	_	VERB	VBD	_	14	auxpass	_	_
14	divided	_	VERB	VBN	_	0	root	_	_
15	into	_	ADP	IN	_	17	case	_	_
16	2	_	NUM	CD	_	17	nummod	_	_
17	groups	_	NOUN	NNS	_	14	nmod	_	_
18	,	_	.	,	_	17	punct	_	_
19	patients	_	NOUN	NNS	_	21	compound	_	_
20	1	_	NUM	CD	_	21	nummod	_	_
21	month	_	NOUN	NN	_	17	appos	_	_
22	to	_	PRT	TO	_	24	case	_	_
23	4	_	NUM	CD	_	24	nummod	_	_
24	months	_	NOUN	NNS	_	21	nmod	_	_
25	of	_	ADP	IN	_	26	case	_	_
26	age	_	NOUN	NN	_	24	nmod	_	_
27	and	_	CONJ	CC	_	26	cc	_	_
28	patients	_	NOUN	NNS	_	32	compound	_	_
29	5	_	NUM	CD	_	31	compound	_	_
30	to	_	PRT	TO	_	31	dep	_	_
31	24	_	NUM	CD	_	32	nummod	_	_
32	months	_	NOUN	NNS	_	26	conj	_	_
33	of	_	ADP	IN	_	34	case	_	_
34	age	_	NOUN	NN	_	26	nmod	_	_
35	,	_	.	,	_	14	punct	_	_
36	and	_	CONJ	CC	_	14	cc	_	_
37	are	_	VERB	VBP	_	38	auxpass	_	_
38	compared	_	VERB	VBN	_	14	conj	_	_
39	to	_	PRT	TO	_	41	case	_	_
40	pediatric	_	ADJ	JJ	_	41	amod	_	_
41	patients	_	NOUN	NNS	_	38	nmod	_	_
42	3	_	NUM	CD	_	44	compound	_	_
43	to	_	PRT	TO	_	44	dep	_	_
44	12	_	NUM	CD	_	45	nummod	_	_
45	years	_	NOUN	NNS	_	41	dep	_	_
46	of	_	ADP	IN	_	47	case	_	_
47	age	_	NOUN	NN	_	45	nmod	_	_

#	ONDANSETRON	5580
1	Pharmacokinetics	_	NOUN	NNS	_	94	nsubj	_	_
2	in	_	ADP	IN	_	5	case	_	_
3	Pediatric	_	ADJ	JJ	_	5	amod	_	_
4	Surgery	_	NOUN	NN	_	5	compound	_	_
5	Patients	_	NOUN	NNS	_	1	nmod	_	_
6	1	_	NUM	CD	_	7	nummod	_	_
7	Month	_	NOUN	NN	_	5	dep	_	_
8	to	_	PRT	TO	_	10	case	_	_
9	12	_	NUM	CD	_	10	nummod	_	_
10	Years	_	NOUN	NNS	_	1	nmod	_	_
11	of	_	ADP	IN	_	13	case	_	_
12	Age	_	NOUN	NN	_	13	compound	_	_
13	Subjects	_	NOUN	NNS	_	10	nmod	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	Age	_	NOUN	NN	_	18	compound	_	_
16	Group	_	NOUN	NN	_	18	compound	_	_
17	N	_	NOUN	NN	_	18	compound	_	_
18	CL(L	_	NOUN	NN	_	31	dep	_	_
19	/	_	.	:	_	20	punct	_	_
20	h	_	NOUN	NN	_	31	dep	_	_
21	/	_	.	-RRB-	_	20	punct	_	_
22	kg	_	NOUN	NN	_	24	compound	_	_
23	Vdss	_	NOUN	NN	_	24	compound	_	_
24	L	_	NOUN	NN	_	20	dep	_	_
25	/	_	.	:	_	20	punct	_	_
26	kg	_	NOUN	NN	_	30	compound	_	_
27	T%	_	NOUN	NN	_	30	compound	_	_
28	h	_	NOUN	NN	_	30	compound	_	_
29	Geometric	_	ADJ	JJ	_	30	amod	_	_
30	Mean	_	NOUN	NN	_	31	nsubj	_	_
31	Mean	_	VERB	VBP	_	13	conj	_	_
32	Pediatric	_	ADJ	JJ	_	34	amod	_	_
33	Surgery	_	NOUN	NN	_	34	compound	_	_
34	Patients3	_	NOUN	NN	_	31	dobj	_	_
35	to	_	PRT	TO	_	37	case	_	_
36	12	_	NUM	CD	_	37	nummod	_	_
37	years	_	NOUN	NNS	_	31	nmod	_	_
38	of	_	ADP	IN	_	48	case	_	_
39	age	_	NOUN	NN	_	48	compound	_	_
40	N	_	NOUN	NN	_	48	compound	_	_
41	=	_	ADJ	JJ	_	48	amod	_	_
42	21	_	NUM	CD	_	48	nummod	_	_
43	0.439	_	NUM	CD	_	48	nummod	_	_
44	1.65	_	NUM	CD	_	48	nummod	_	_
45	2.9	_	NUM	CD	_	48	nummod	_	_
46	Pediatric	_	ADJ	JJ	_	48	amod	_	_
47	Surgery	_	NOUN	NN	_	48	compound	_	_
48	Patients5	_	NOUN	NN	_	37	nmod	_	_
49	to	_	PRT	TO	_	51	case	_	_
50	24	_	NUM	CD	_	51	nummod	_	_
51	months	_	NOUN	NNS	_	31	nmod	_	_
52	of	_	ADP	IN	_	63	case	_	_
53	age	_	NOUN	NN	_	63	compound	_	_
54	N	_	NOUN	NN	_	63	compound	_	_
55	=	_	ADJ	JJ	_	63	amod	_	_
56	22	_	NUM	CD	_	63	nummod	_	_
57	0.581	_	NUM	CD	_	63	nummod	_	_
58	2.3	_	NUM	CD	_	63	nummod	_	_
59	2.9	_	NUM	CD	_	63	nummod	_	_
60	Pediatric	_	ADJ	JJ	_	63	amod	_	_
61	Surgery	_	NOUN	NN	_	63	compound	_	_
62	Patients1	_	NOUN	NN	_	63	compound	_	_
63	month	_	NOUN	NN	_	51	nmod	_	_
64	to	_	PRT	TO	_	66	case	_	_
65	4	_	NUM	CD	_	66	nummod	_	_
66	months	_	NOUN	NNS	_	31	nmod	_	_
67	of	_	ADP	IN	_	69	case	_	_
68	age	_	NOUN	NN	_	69	compound	_	_
69	N	_	NOUN	NN	_	66	nmod	_	_
70	=	_	ADJ	JJ	_	69	amod	_	_
71	19	_	NUM	CD	_	72	nummod	_	_
72	0.401	_	NUM	CD	_	70	dep	_	_
73	3.5	_	NUM	CD	_	74	nummod	_	_
74	6.7	_	NUM	CD	_	72	dep	_	_
75	In	_	ADP	IN	_	82	case	_	_
76	general	_	ADJ	JJ	_	82	amod	_	_
77	,	_	.	,	_	76	punct	_	_
78	surgical	_	ADJ	JJ	_	76	conj	_	_
79	and	_	CONJ	CC	_	76	cc	_	_
80	cancer	_	NOUN	NN	_	76	conj	_	_
81	pediatric	_	ADJ	JJ	_	82	amod	_	_
82	patients	_	NOUN	NNS	_	70	nmod	_	_
83	younger	_	ADJ	JJ	_	82	amod	_	_
84	than	_	ADP	IN	_	86	case	_	_
85	18	_	NUM	CD	_	86	nummod	_	_
86	years	_	NOUN	NNS	_	83	nmod	_	_
87	tend	_	VERB	VBP	_	86	amod	_	_
88	to	_	PRT	TO	_	89	mark	_	_
89	have	_	VERB	VB	_	87	xcomp	_	_
90	a	_	DET	DT	_	93	det	_	_
91	higher	_	ADJ	JJ	_	93	amod	_	_
92	DRUG	_	NOUN	NN	_	93	compound	_	_
93	clearance	_	NOUN	NN	_	89	dobj	_	_
94	compared	_	VERB	VBN	_	0	root	_	_
95	to	_	PRT	TO	_	96	case	_	_
96	adults	_	NOUN	NNS	_	94	nmod	_	_
97	leading	_	VERB	VBG	_	96	acl	_	_
98	to	_	PRT	TO	_	102	case	_	_
99	a	_	DET	DT	_	102	det	_	_
100	shorter	_	ADJ	JJ	_	102	amod	_	_
101	half	_	ADJ	JJ	_	102	amod	_	_
102	life	_	NOUN	NN	_	97	nmod	_	_
103	in	_	ADP	IN	_	106	case	_	_
104	most	_	ADJ	JJ	_	106	amod	_	_
105	pediatric	_	ADJ	JJ	_	106	amod	_	_
106	patients	_	NOUN	NNS	_	102	nmod	_	_

#	ONDANSETRON	5581
1	In	_	ADP	IN	_	2	case	_	_
2	patients	_	NOUN	NNS	_	16	nmod	_	_
3	1	_	NUM	CD	_	4	nummod	_	_
4	month	_	NOUN	NN	_	2	dep	_	_
5	to	_	PRT	TO	_	7	case	_	_
6	4	_	NUM	CD	_	7	nummod	_	_
7	months	_	NOUN	NNS	_	4	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	age	_	NOUN	NN	_	7	nmod	_	_
10	,	_	.	,	_	16	punct	_	_
11	a	_	DET	DT	_	14	det	_	_
12	longer	_	ADV	RB	_	13	advmod	_	_
13	half	_	ADJ	JJ	_	14	amod	_	_
14	life	_	NOUN	NN	_	16	nsubjpass	_	_
15	was	_	VERB	VBD	_	16	auxpass	_	_
16	observed	_	VERB	VBN	_	0	root	_	_
17	due	_	ADJ	JJ	_	21	case	_	_
18	to	_	PRT	TO	_	17	mwe	_	_
19	the	_	DET	DT	_	21	det	_	_
20	higher	_	ADJ	JJ	_	21	amod	_	_
21	volume	_	NOUN	NN	_	16	nmod	_	_
22	of	_	ADP	IN	_	23	case	_	_
23	distribution	_	NOUN	NN	_	21	nmod	_	_
24	in	_	ADP	IN	_	27	case	_	_
25	this	_	DET	DT	_	27	det	_	_
26	age	_	NOUN	NN	_	27	compound	_	_
27	group	_	NOUN	NN	_	23	nmod	_	_

#	ONDANSETRON	5582
1	In	_	ADP	IN	_	3	case	_	_
2	a	_	DET	DT	_	3	det	_	_
3	study	_	NOUN	NN	_	39	nmod	_	_
4	of	_	ADP	IN	_	8	case	_	_
5	21	_	NUM	CD	_	8	nummod	_	_
6	pediatric	_	ADJ	JJ	_	8	amod	_	_
7	cancer	_	NOUN	NN	_	8	compound	_	_
8	patients	_	NOUN	NNS	_	3	nmod	_	_
9	4	_	NUM	CD	_	11	compound	_	_
10	to	_	PRT	TO	_	11	dep	_	_
11	18	_	NUM	CD	_	12	nummod	_	_
12	years	_	NOUN	NNS	_	8	dep	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	age	_	NOUN	NN	_	12	nmod	_	_
15	who	_	DET	WDT	_	16	nsubj	_	_
16	received	_	VERB	VBD	_	14	acl:relcl	_	_
17	three	_	NUM	CD	_	19	nummod	_	_
18	intravenous	_	ADJ	JJ	_	19	amod	_	_
19	doses	_	NOUN	NNS	_	16	dobj	_	_
20	of	_	ADP	IN	_	22	case	_	_
21	0.15	_	NUM	CD	_	22	nummod	_	_
22	mg	_	NOUN	NN	_	19	nmod	_	_
23	/	_	.	:	_	39	punct	_	_
24	kg	_	NOUN	NN	_	39	nmod	_	_
25	of	_	ADP	IN	_	26	case	_	_
26	DRUG	_	NOUN	NN	_	24	nmod	_	_
27	at	_	ADP	IN	_	30	case	_	_
28	4	_	NUM	CD	_	30	nummod	_	_
29	hour	_	NUM	CD	_	30	nummod	_	_
30	intervals	_	NOUN	NNS	_	24	nmod	_	_
31	,	_	.	,	_	39	punct	_	_
32	patients	_	NOUN	NNS	_	39	nsubj	_	_
33	older	_	ADV	RB	_	32	amod	_	_
34	than	_	ADP	IN	_	36	case	_	_
35	15	_	NUM	CD	_	36	nummod	_	_
36	years	_	NOUN	NNS	_	33	nmod	_	_
37	of	_	ADP	IN	_	38	case	_	_
38	age	_	NOUN	NN	_	36	nmod	_	_
39	exhibited	_	VERB	VBD	_	0	root	_	_
40	DRUG	_	NOUN	NN	_	42	compound	_	_
41	pharmacokinetic	_	ADJ	JJ	_	42	amod	_	_
42	parameters	_	NOUN	NNS	_	39	dobj	_	_
43	similar	_	ADJ	JJ	_	42	amod	_	_
44	to	_	PRT	TO	_	45	case	_	_
45	those	_	DET	DT	_	43	nmod	_	_
46	of	_	ADP	IN	_	47	case	_	_
47	adults	_	NOUN	NNS	_	45	nmod	_	_

#	ONDANSETRON	5583
1	Renal	_	ADJ	JJ	_	2	amod	_	_
2	Impairment	_	NOUN	NN	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	Due	_	NOUN	NN	_	23	nsubjpass	_	_
5	to	_	PRT	TO	_	10	case	_	_
6	the	_	DET	DT	_	10	det	_	_
7	very	_	ADV	RB	_	8	advmod	_	_
8	small	_	ADJ	JJ	_	10	amod	_	_
9	contribution	_	NOUN	NN	_	10	compound	_	_
10	5%	_	NOUN	NN	_	4	nmod	_	_
11	of	_	ADP	IN	_	13	case	_	_
12	renal	_	ADJ	JJ	_	13	amod	_	_
13	clearance	_	NOUN	NN	_	10	nmod	_	_
14	to	_	PRT	TO	_	17	case	_	_
15	the	_	DET	DT	_	17	det	_	_
16	overall	_	ADJ	JJ	_	17	amod	_	_
17	clearance	_	NOUN	NN	_	13	nmod	_	_
18	,	_	.	,	_	23	punct	_	_
19	renal	_	ADJ	JJ	_	20	amod	_	_
20	impairment	_	NOUN	NN	_	23	nsubjpass	_	_
21	was	_	VERB	VBD	_	23	auxpass	_	_
22	not	_	ADV	RB	_	23	neg	_	_
23	expected	_	VERB	VBN	_	2	dep	_	_
24	to	_	PRT	TO	_	26	mark	_	_
25	significantly	_	ADV	RB	_	26	advmod	_	_
26	influence	_	VERB	VB	_	23	xcomp	_	_
27	the	_	DET	DT	_	29	det	_	_
28	total	_	ADJ	JJ	_	29	amod	_	_
29	clearance	_	NOUN	NN	_	26	dobj	_	_
30	of	_	ADP	IN	_	31	case	_	_
31	DRUG	_	NOUN	NN	_	29	nmod	_	_

#	ONDANSETRON	5584
1	However	_	ADV	RB	_	8	advmod	_	_
2	,	_	.	,	_	8	punct	_	_
3	DRUG	_	NOUN	NN	_	6	compound	_	_
4	mean	_	NOUN	NN	_	6	compound	_	_
5	plasma	_	NOUN	NN	_	6	compound	_	_
6	clearance	_	NOUN	NN	_	8	nsubjpass	_	_
7	was	_	VERB	VBD	_	8	auxpass	_	_
8	reduced	_	VERB	VBN	_	0	root	_	_
9	by	_	ADP	IN	_	11	case	_	_
10	about	_	ADV	RB	_	11	advmod	_	_
11	41%	_	NOUN	NN	_	8	nmod	_	_
12	in	_	ADP	IN	_	13	case	_	_
13	patients	_	NOUN	NNS	_	8	nmod	_	_
14	with	_	ADP	IN	_	22	case	_	_
15	severe	_	ADJ	JJ	_	22	amod	_	_
16	renal	_	ADJ	JJ	_	22	amod	_	_
17	impairment	_	NOUN	NN	_	22	compound	_	_
18	creatinine	_	NOUN	NN	_	22	compound	_	_
19	clearance	_	NOUN	NN	_	22	compound	_	_
20	<	_	NUM	CD	_	22	nummod	_	_
21	30	_	NUM	CD	_	22	nummod	_	_
22	mL	_	NOUN	NN	_	13	nmod	_	_
23	/	_	.	:	_	22	punct	_	_
24	min	_	NOUN	NN	_	22	dep	_	_

#	ONDANSETRON	5585
1	This	_	DET	DT	_	2	det	_	_
2	reduction	_	NOUN	NN	_	6	nsubj	_	_
3	in	_	ADP	IN	_	4	case	_	_
4	clearance	_	NOUN	NN	_	2	nmod	_	_
5	is	_	VERB	VBZ	_	6	cop	_	_
6	variable	_	ADJ	JJ	_	0	root	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	was	_	VERB	VBD	_	10	cop	_	_
9	not	_	ADV	RB	_	10	neg	_	_
10	consistent	_	ADJ	JJ	_	6	conj	_	_
11	with	_	ADP	IN	_	13	case	_	_
12	an	_	DET	DT	_	13	det	_	_
13	increase	_	NOUN	NN	_	10	nmod	_	_
14	in	_	ADP	IN	_	16	case	_	_
15	half	_	ADJ	JJ	_	16	amod	_	_
16	life	_	NOUN	NN	_	13	nmod	_	_

#	ONDANSETRON	5586
1	No	_	DET	DT	_	2	neg	_	_
2	reduction	_	NOUN	NN	_	12	nsubjpass	_	_
3	in	_	ADP	IN	_	4	case	_	_
4	dose	_	NOUN	NN	_	2	nmod	_	_
5	or	_	CONJ	CC	_	4	cc	_	_
6	dosing	_	NOUN	NN	_	4	conj	_	_
7	frequency	_	NOUN	NN	_	4	dep	_	_
8	in	_	ADP	IN	_	10	case	_	_
9	these	_	DET	DT	_	10	det	_	_
10	patients	_	NOUN	NNS	_	2	nmod	_	_
11	is	_	VERB	VBZ	_	12	auxpass	_	_
12	warranted	_	VERB	VBN	_	0	root	_	_

#	ONDANSETRON	5587
1	Hepatic	_	ADJ	JJ	_	2	amod	_	_
2	Impairment	_	NOUN	NN	_	23	nsubjpass	_	_
3	:	_	.	:	_	2	punct	_	_
4	In	_	ADP	IN	_	5	case	_	_
5	patients	_	NOUN	NNS	_	2	nmod	_	_
6	with	_	ADP	IN	_	7	case	_	_
7	mild	_	ADJ	JJ	_	5	nmod	_	_
8	to	_	PRT	TO	_	9	mark	_	_
9	moderate	_	ADJ	JJ	_	5	acl	_	_
10	hepatic	_	ADJ	JJ	_	11	amod	_	_
11	impairment	_	NOUN	NN	_	9	dobj	_	_
12	,	_	.	,	_	2	punct	_	_
13	clearance	_	NOUN	NN	_	15	nsubjpass	_	_
14	is	_	VERB	VBZ	_	15	auxpass	_	_
15	reduced	_	VERB	VBN	_	2	acl:relcl	_	_
16	2	_	NUM	CD	_	17	nummod	_	_
17	fold	_	NOUN	NN	_	15	nmod	_	_
18	and	_	CONJ	CC	_	17	cc	_	_
19	mean	_	NOUN	NN	_	21	compound	_	_
20	half	_	ADJ	JJ	_	21	amod	_	_
21	life	_	NOUN	NN	_	17	conj	_	_
22	is	_	VERB	VBZ	_	23	auxpass	_	_
23	increased	_	VERB	VBN	_	0	root	_	_
24	to	_	PRT	TO	_	26	case	_	_
25	11.6	_	NUM	CD	_	26	nummod	_	_
26	hours	_	NOUN	NNS	_	23	nmod	_	_
27	compared	_	VERB	VBD	_	30	case	_	_
28	to	_	PRT	TO	_	30	case	_	_
29	5.7	_	NUM	CD	_	30	nummod	_	_
30	hours	_	NOUN	NNS	_	23	nmod	_	_
31	in	_	ADP	IN	_	32	case	_	_
32	those	_	DET	DT	_	30	nmod	_	_
33	without	_	ADP	IN	_	35	case	_	_
34	hepatic	_	ADJ	JJ	_	35	amod	_	_
35	impairment	_	NOUN	NN	_	32	nmod	_	_

#	ONDANSETRON	5588
1	In	_	ADP	IN	_	2	case	_	_
2	patients	_	NOUN	NNS	_	17	nmod	_	_
3	with	_	ADP	IN	_	9	case	_	_
4	severe	_	ADJ	JJ	_	9	amod	_	_
5	hepatic	_	ADJ	JJ	_	9	amod	_	_
6	impairment	_	NOUN	NN	_	9	compound	_	_
7	Child	_	NOUN	NN	_	9	compound	_	_
8	Pugh	_	NOUN	NN	_	9	compound	_	_
9	score	_	NOUN	NN	_	2	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	10	_	NUM	CD	_	9	nmod	_	_
12	or	_	CONJ	CC	_	11	cc	_	_
13	greater	_	ADJ	JJ	_	11	conj	_	_
14	,	_	.	,	_	17	punct	_	_
15	clearance	_	NOUN	NN	_	17	nsubjpass	_	_
16	is	_	VERB	VBZ	_	17	auxpass	_	_
17	reduced	_	VERB	VBN	_	0	root	_	_
18	2	_	NUM	CD	_	19	nummod	_	_
19	fold	_	NOUN	NN	_	17	dobj	_	_
20	to	_	PRT	TO	_	22	case	_	_
21	3	_	NUM	CD	_	22	nummod	_	_
22	fold	_	NOUN	NN	_	19	nmod	_	_
23	and	_	CONJ	CC	_	19	cc	_	_
24	apparent	_	ADJ	JJ	_	25	amod	_	_
25	volume	_	NOUN	NN	_	19	conj	_	_
26	of	_	ADP	IN	_	27	case	_	_
27	distribution	_	NOUN	NN	_	25	nmod	_	_
28	is	_	VERB	VBZ	_	29	auxpass	_	_
29	increased	_	VERB	VBN	_	17	parataxis	_	_
30	with	_	ADP	IN	_	33	case	_	_
31	a	_	DET	DT	_	33	det	_	_
32	resultant	_	ADJ	JJ	_	33	amod	_	_
33	increase	_	NOUN	NN	_	29	nmod	_	_
34	in	_	ADP	IN	_	36	case	_	_
35	half	_	ADJ	JJ	_	36	amod	_	_
36	life	_	NOUN	NN	_	33	nmod	_	_
37	to	_	PRT	TO	_	39	case	_	_
38	20	_	NUM	CD	_	39	nummod	_	_
39	hours	_	NOUN	NNS	_	33	nmod	_	_

#	ONDANSETRON	5589
1	In	_	ADP	IN	_	2	case	_	_
2	patients	_	NOUN	NNS	_	18	nmod	_	_
3	with	_	ADP	IN	_	6	case	_	_
4	severe	_	ADJ	JJ	_	6	amod	_	_
5	hepatic	_	ADJ	JJ	_	6	amod	_	_
6	impairment	_	NOUN	NN	_	2	nmod	_	_
7	,	_	.	,	_	18	punct	_	_
8	a	_	DET	DT	_	11	det	_	_
9	total	_	ADJ	JJ	_	11	amod	_	_
10	daily	_	ADV	RB	_	11	amod	_	_
11	dose	_	NOUN	NN	_	18	nsubjpass	_	_
12	of	_	ADP	IN	_	14	case	_	_
13	8	_	NUM	CD	_	14	nummod	_	_
14	mg	_	NOUN	NN	_	11	nmod	_	_
15	should	_	VERB	MD	_	18	aux	_	_
16	not	_	ADV	RB	_	18	neg	_	_
17	be	_	VERB	VB	_	18	auxpass	_	_
18	exceeded	_	VERB	VBN	_	0	root	_	_

#	PAMELOR	6132
1	Administration	_	NOUN	NN	_	10	nsubjpass	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	reserpine	_	NOUN	NN	_	1	nmod	_	_
4	during	_	ADP	IN	_	7	case	_	_
5	therapy	_	NOUN	NN	_	7	compound	_	_
6	withGGGGGGGGGGGG	_	NOUN	NN	_	7	compound	_	_
7	antidepressant	_	NOUN	NN	_	1	nmod	_	_
8	has	_	VERB	VBZ	_	10	aux	_	_
9	been	_	VERB	VBN	_	10	auxpass	_	_
10	shown	_	VERB	VBN	_	0	root	_	_
11	to	_	PRT	TO	_	12	mark	_	_
12	produce	_	VERB	VB	_	10	xcomp	_	_
13	a	_	DET	DT	_	15	det	_	_
14	"stimulating"	_	NOUN	NN	_	15	compound	_	_
15	effect	_	NOUN	NN	_	12	dobj	_	_
16	in	_	ADP	IN	_	19	case	_	_
17	some	_	DET	DT	_	19	det	_	_
18	depressed	_	ADJ	JJ	_	19	amod	_	_
19	patients	_	NOUN	NNS	_	15	nmod	_	_

#	PAMELOR	6133
1	Close	_	ADJ	JJ	_	2	compound	_	_
2	supervision	_	NOUN	NN	_	10	nsubjpass	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	careful	_	ADJ	JJ	_	5	amod	_	_
5	adjustment	_	NOUN	NN	_	2	conj	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	the	_	DET	DT	_	8	det	_	_
8	dosage	_	NOUN	NN	_	2	nmod	_	_
9	are	_	VERB	VBP	_	10	auxpass	_	_
10	required	_	VERB	VBN	_	0	root	_	_
11	when	_	ADV	WRB	_	14	advmod	_	_
12	DRUG	_	NOUN	NN	_	14	nsubjpass	_	_
13	is	_	VERB	VBZ	_	14	auxpass	_	_
14	used	_	VERB	VBN	_	10	ccomp	_	_
15	with	_	ADP	IN	_	18	case	_	_
16	other	_	ADJ	JJ	_	18	amod	_	_
17	anticholinergic	_	ADJ	JJ	_	18	amod	_	_
18	drugs	_	NOUN	NNS	_	14	nmod	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	sympathomimetic	_	ADJ	JJ	_	21	amod	_	_
21	drugs	_	NOUN	NNS	_	18	conj	_	_

#	PAMELOR	6134
1	Concurrent	_	ADJ	JJ	_	2	amod	_	_
2	administration	_	NOUN	NN	_	8	nsubj	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	cimetidine	_	VERB	VBG	_	6	amod	_	_
5	aGGGGGGGGGGGG	_	NOUN	NN	_	6	compound	_	_
6	antidepressants	_	NOUN	NNS	_	2	nmod	_	_
7	can	_	VERB	MD	_	8	aux	_	_
8	produce	_	VERB	VB	_	0	root	_	_
9	clinically	_	ADV	RB	_	10	advmod	_	_
10	significant	_	ADJ	JJ	_	11	amod	_	_
11	increases	_	NOUN	NNS	_	8	dobj	_	_
12	in	_	ADP	IN	_	15	case	_	_
13	the	_	DET	DT	_	15	det	_	_
14	plasma	_	NOUN	NN	_	15	compound	_	_
15	concentrations	_	NOUN	NNS	_	11	nmod	_	_
16	of	_	ADP	IN	_	18	case	_	_
17	tGGGGGGGGGGGG	_	NOUN	NN	_	18	nmod:npmod	_	_
18	antidepressant	_	ADJ	JJ	_	15	nmod	_	_

#	PAMELOR	6135
1	The	_	DET	DT	_	2	det	_	_
2	patient	_	NOUN	NN	_	5	nsubjpass	_	_
3	should	_	VERB	MD	_	5	aux	_	_
4	be	_	VERB	VB	_	5	auxpass	_	_
5	informed	_	VERB	VBN	_	0	root	_	_
6	that	_	ADP	IN	_	13	mark	_	_
7	the	_	DET	DT	_	8	det	_	_
8	response	_	NOUN	NN	_	13	nsubjpass	_	_
9	to	_	PRT	TO	_	10	case	_	_
10	alcohol	_	NOUN	NN	_	8	nmod	_	_
11	may	_	VERB	MD	_	13	aux	_	_
12	be	_	VERB	VB	_	13	auxpass	_	_
13	exaggerated	_	VERB	VBN	_	5	root	_	_

#	PAMELOR	6136
1	A	_	DET	DT	_	2	det	_	_
2	case	_	NOUN	NN	_	8	nsubjpass	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	significant	_	ADJ	JJ	_	5	amod	_	_
5	hypoglycemia	_	NOUN	NN	_	2	nmod	_	_
6	has	_	VERB	VBZ	_	8	aux	_	_
7	been	_	VERB	VBN	_	8	auxpass	_	_
8	reported	_	VERB	VBN	_	0	root	_	_
9	in	_	ADP	IN	_	14	case	_	_
10	a	_	DET	DT	_	14	det	_	_
11	type	_	NOUN	NN	_	14	compound	_	_
12	II	_	NUM	CD	_	14	nummod	_	_
13	diabetic	_	ADJ	JJ	_	14	amod	_	_
14	patient	_	NOUN	NN	_	8	nmod	_	_
15	maintained	_	VERB	VBN	_	14	acl	_	_
16	on	_	ADP	IN	_	21	case	_	_
17	chlorpropamide	_	NOUN	NN	_	19	compound	_	_
18	250	_	NUM	CD	_	19	nummod	_	_
19	mg	_	NOUN	NN	_	21	compound	_	_
20	/	_	.	:	_	21	punct	_	_
21	day	_	NOUN	NN	_	15	nmod	_	_
22	,	_	.	,	_	8	punct	_	_
23	after	_	ADP	IN	_	25	case	_	_
24	the	_	DET	DT	_	25	det	_	_
25	addition	_	NOUN	NN	_	8	nmod	_	_
26	of	_	ADP	IN	_	31	case	_	_
27	DRUG	_	NOUN	NN	_	31	compound	_	_
28	125	_	NUM	CD	_	31	nummod	_	_
29	mg	_	NOUN	NN	_	31	compound	_	_
30	/	_	NUM	CD	_	31	compound	_	_
31	day	_	NOUN	NN	_	25	nmod	_	_

#	PAMELOR	6137
1	Drugs	_	NOUN	NNS	_	20	nsubjpass	_	_
2	Metabolized	_	VERB	VBN	_	1	acl	_	_
3	by	_	ADP	IN	_	5	case	_	_
4	P450	_	NOUN	NN	_	5	compound	_	_
5	2D6	_	NOUN	NN	_	2	nmod	_	_
6	The	_	DET	DT	_	8	det	_	_
7	biochemical	_	ADJ	JJ	_	8	amod	_	_
8	activity	_	NOUN	NN	_	1	dep	_	_
9	of	_	ADP	IN	_	18	case	_	_
10	the	_	DET	DT	_	18	det	_	_
11	drug	_	NOUN	NN	_	18	compound	_	_
12	metabolizing	_	NOUN	NN	_	18	compound	_	_
13	isozyme	_	NOUN	NN	_	18	compound	_	_
14	cytochrome	_	NOUN	NN	_	18	compound	_	_
15	P450	_	NOUN	NN	_	18	compound	_	_
16	2D6	_	NOUN	NN	_	18	compound	_	_
17	debrisoquin	_	NOUN	NN	_	18	compound	_	_
18	hydroxylase	_	NOUN	NN	_	8	nmod	_	_
19	is	_	VERB	VBZ	_	20	auxpass	_	_
20	reduced	_	VERB	VBN	_	0	root	_	_
21	in	_	ADP	IN	_	23	case	_	_
22	a	_	DET	DT	_	23	det	_	_
23	subset	_	NOUN	NN	_	20	nmod	_	_
24	of	_	ADP	IN	_	27	case	_	_
25	the	_	DET	DT	_	27	det	_	_
26	Caucasian	_	ADJ	JJ	_	27	amod	_	_
27	population	_	NOUN	NN	_	23	nmod	_	_
28	about	_	ADV	RB	_	29	advmod	_	_
29	7%	_	NOUN	NN	_	23	nmod	_	_
30	to	_	PRT	TO	_	31	case	_	_
31	10%	_	NOUN	NN	_	29	nmod	_	_
32	of	_	ADP	IN	_	33	case	_	_
33	Caucasians	_	NOUN	NNS	_	31	nmod	_	_
34	are	_	VERB	VBP	_	36	auxpass	_	_
35	so	_	ADV	RB	_	36	advmod	_	_
36	called	_	VERB	VBN	_	20	parataxis	_	_
37	"poor	_	ADJ	JJ	_	40	amod	_	_
38	metabolizers"	_	NOUN	NN	_	40	compound	_	_
39	reliable	_	ADJ	JJ	_	40	amod	_	_
40	estimates	_	NOUN	NNS	_	36	dobj	_	_
41	of	_	ADP	IN	_	43	case	_	_
42	the	_	DET	DT	_	43	det	_	_
43	prevalence	_	NOUN	NN	_	40	nmod	_	_
44	of	_	ADP	IN	_	49	case	_	_
45	reduced	_	VERB	VBN	_	49	amod	_	_
46	P450	_	NOUN	NN	_	49	compound	_	_
47	2D6	_	NOUN	NN	_	49	compound	_	_
48	isozyme	_	NOUN	NN	_	49	compound	_	_
49	activity	_	NOUN	NN	_	43	nmod	_	_
50	among	_	ADP	IN	_	51	case	_	_
51	Asian	_	NOUN	NN	_	40	nmod	_	_
52	,	_	.	,	_	51	punct	_	_
53	African	_	NOUN	NN	_	51	conj	_	_
54	and	_	CONJ	CC	_	51	cc	_	_
55	other	_	ADJ	JJ	_	51	conj	_	_
56	populations	_	NOUN	NNS	_	51	dep	_	_
57	are	_	VERB	VBP	_	60	auxpass	_	_
58	not	_	ADV	RB	_	60	neg	_	_
59	yet	_	ADV	RB	_	60	advmod	_	_
60	available	_	ADJ	JJ	_	36	parataxis	_	_

#	PAMELOR	6138
1	Poor	_	ADJ	JJ	_	2	amod	_	_
2	metabolizers	_	NOUN	NNS	_	4	nsubj	_	_
3	have	_	VERB	VBP	_	4	aux	_	_
4	higher	_	ADJ	JJ	_	0	root	_	_
5	than	_	ADP	IN	_	8	case	_	_
6	expected	_	VERB	VBN	_	8	amod	_	_
7	plasma	_	NOUN	NN	_	8	compound	_	_
8	concentrations	_	NOUN	NNS	_	10	nmod	_	_
9	DRUGS	_	NOUN	NN	_	10	nsubj	_	_
10	antidepressants	_	VERB	VBZ	_	4	ccomp	_	_
11	TCAs	_	NOUN	NNS	_	10	dobj	_	_
12	when	_	ADV	WRB	_	10	advmod	_	_
13	given	_	VERB	VBN	_	15	amod	_	_
14	usual	_	ADJ	JJ	_	15	amod	_	_
15	doses	_	NOUN	NNS	_	12	nmod	_	_

#	PAMELOR	6139
1	Depending	_	VERB	VBG	_	4	case	_	_
2	on	_	ADP	IN	_	4	case	_	_
3	the	_	DET	DT	_	4	det	_	_
4	fraction	_	NOUN	NN	_	19	nmod	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	drug	_	NOUN	NN	_	4	nmod	_	_
7	metabolized	_	VERB	VBN	_	6	acl	_	_
8	by	_	ADP	IN	_	10	case	_	_
9	P450	_	NOUN	NN	_	10	compound	_	_
10	2D6	_	NOUN	NN	_	7	nmod	_	_
11	,	_	.	,	_	19	punct	_	_
12	the	_	DET	DT	_	13	det	_	_
13	increase	_	NOUN	NN	_	19	nsubj	_	_
14	in	_	ADP	IN	_	16	case	_	_
15	plasma	_	NOUN	NN	_	16	compound	_	_
16	concentration	_	NOUN	NN	_	13	nmod	_	_
17	may	_	VERB	MD	_	19	aux	_	_
18	be	_	VERB	VB	_	19	cop	_	_
19	small	_	ADJ	JJ	_	0	root	_	_
20	,	_	.	,	_	19	punct	_	_
21	or	_	CONJ	CC	_	19	cc	_	_
22	quite	_	ADV	RB	_	23	advmod	_	_
23	large	_	ADJ	JJ	_	26	amod	_	_
24	8	_	NUM	CD	_	26	nummod	_	_
25	fold	_	NOUN	NN	_	26	amod	_	_
26	increase	_	NOUN	NN	_	19	conj	_	_
27	in	_	ADP	IN	_	29	case	_	_
28	plasma	_	NOUN	NN	_	29	compound	_	_
29	AUC	_	NOUN	NN	_	26	nmod	_	_
30	of	_	ADP	IN	_	32	case	_	_
31	the	_	DET	DT	_	32	det	_	_
32	TCA	_	NOUN	NN	_	29	nmod	_	_

#	PAMELOR	6140
1	In	_	ADP	IN	_	2	case	_	_
2	addition	_	NOUN	NN	_	6	nmod	_	_
3	,	_	.	,	_	6	punct	_	_
4	certain	_	ADJ	JJ	_	5	amod	_	_
5	drugs	_	NOUN	NNS	_	6	nsubj	_	_
6	inhibit	_	VERB	VBP	_	0	root	_	_
7	the	_	DET	DT	_	8	det	_	_
8	activity	_	NOUN	NN	_	6	dobj	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	this	_	DET	DT	_	11	det	_	_
11	isozyme	_	NOUN	NN	_	8	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	make	_	ADJ	JJ	_	15	amod	_	_
14	normal	_	ADJ	JJ	_	15	amod	_	_
15	metabolizers	_	NOUN	NNS	_	11	conj	_	_
16	resemble	_	ADJ	JJ	_	6	xcomp	_	_
17	poor	_	ADJ	JJ	_	18	amod	_	_
18	metabolizers	_	NOUN	NNS	_	16	dobj	_	_

#	PAMELOR	6141
1	An	_	DET	DT	_	2	det	_	_
2	individual	_	NOUN	NN	_	13	nsubj	_	_
3	who	_	DET	WDT	_	5	nsubj	_	_
4	is	_	VERB	VBZ	_	5	cop	_	_
5	stable	_	ADJ	JJ	_	2	acl:relcl	_	_
6	on	_	ADP	IN	_	9	case	_	_
7	a	_	DET	DT	_	9	det	_	_
8	given	_	VERB	VBN	_	9	amod	_	_
9	dose	_	NOUN	NN	_	5	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	TCA	_	NOUN	NN	_	9	nmod	_	_
12	may	_	VERB	MD	_	13	aux	_	_
13	become	_	VERB	VB	_	0	root	_	_
14	abruptly	_	ADV	RB	_	15	advmod	_	_
15	toxic	_	ADJ	JJ	_	13	xcomp	_	_
16	when	_	ADV	WRB	_	17	advmod	_	_
17	given	_	VERB	VBN	_	15	dep	_	_
18	one	_	NUM	CD	_	17	dobj	_	_
19	of	_	ADP	IN	_	22	case	_	_
20	these	_	DET	DT	_	22	det	_	_
21	inhibiting	_	VERB	VBG	_	22	amod	_	_
22	drugs	_	NOUN	NNS	_	18	nmod	_	_
23	as	_	ADP	IN	_	25	case	_	_
24	concomitant	_	ADJ	JJ	_	25	amod	_	_
25	therapy	_	NOUN	NN	_	17	nmod	_	_

#	PAMELOR	6142
1	The	_	DET	DT	_	2	det	_	_
2	drugs	_	NOUN	NNS	_	8	nsubj	_	_
3	that	_	DET	WDT	_	4	nsubj	_	_
4	inhibit	_	VERB	VBP	_	2	acl:relcl	_	_
5	cytochrome	_	NOUN	NN	_	7	compound	_	_
6	P450	_	NOUN	NN	_	7	compound	_	_
7	2D6	_	NOUN	NN	_	4	dobj	_	_
8	include	_	VERB	VBP	_	0	root	_	_
9	some	_	DET	DT	_	8	dobj	_	_
10	that	_	DET	WDT	_	13	nsubjpass	_	_
11	are	_	VERB	VBP	_	13	auxpass	_	_
12	not	_	ADV	RB	_	13	neg	_	_
13	metabolized	_	VERB	VBN	_	9	root	_	_
14	by	_	ADP	IN	_	18	case	_	_
15	the	_	DET	DT	_	18	det	_	_
16	enzyme	_	NOUN	NN	_	18	compound	_	_
17	quinidine	_	NOUN	NN	_	18	compound	_	_
18	cimetidine	_	NOUN	NN	_	13	nmod	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	many	_	NOUN	NN	_	18	conj	_	_
21	that	_	DET	WDT	_	23	nsubj	_	_
22	are	_	VERB	VBP	_	23	cop	_	_
23	substrates	_	NOUN	NNS	_	18	acl:relcl	_	_
24	for	_	ADP	IN	_	29	case	_	_
25	P450	_	NOUN	NN	_	29	compound	_	_
26	2D6	_	NOUN	NN	_	29	compound	_	_
27	many	_	ADJ	JJ	_	29	amod	_	_
28	other	_	ADJ	JJ	_	29	amod	_	_
29	antidepressants	_	NOUN	NNS	_	23	nmod	_	_
30	,	_	.	,	_	29	punct	_	_
31	phenothiazines	_	NOUN	NNS	_	29	conj	_	_
32	,	_	.	,	_	29	punct	_	_
33	and	_	CONJ	CC	_	29	cc	_	_
34	the	_	DET	DT	_	37	det	_	_
35	Type	_	NOUN	NN	_	37	compound	_	_
36	1C	_	NOUN	NN	_	37	compound	_	_
37	antiarrhythmics	_	NOUN	NNS	_	29	conj	_	_
38	propafenone	_	NOUN	NN	_	37	dep	_	_
39	and	_	CONJ	CC	_	38	cc	_	_
40	flecainide	_	NOUN	NN	_	38	conj	_	_

#	PAMELOR	6143
1	While	_	ADP	IN	_	19	mark	_	_
2	all	_	CONJ	CC	_	7	cc:preconj	_	_
3	the	_	DET	DT	_	7	det	_	_
4	selective	_	ADJ	JJ	_	7	amod	_	_
5	serotonin	_	NOUN	NN	_	7	compound	_	_
6	reuptake	_	NOUN	NN	_	7	compound	_	_
7	inhibitors	_	NOUN	NNS	_	19	nsubj	_	_
8	SSRIs	_	NOUN	NNS	_	7	dep	_	_
9	,	_	.	,	_	8	punct	_	_
10	e.g	_	NOUN	NN	_	8	conj	_	_
11	,	_	.	,	_	8	punct	_	_
12	fluoxetine	_	NOUN	NN	_	8	conj	_	_
13	,	_	.	,	_	8	punct	_	_
14	sertraline	_	NOUN	NN	_	8	conj	_	_
15	,	_	.	,	_	8	punct	_	_
16	and	_	CONJ	CC	_	8	cc	_	_
17	paroxetine	_	NOUN	NN	_	8	conj	_	_
18	,	_	.	,	_	7	punct	_	_
19	inhibit	_	VERB	VBP	_	25	advcl	_	_
20	P450	_	NOUN	NN	_	21	compound	_	_
21	2D6	_	NOUN	NN	_	19	dobj	_	_
22	,	_	.	,	_	25	punct	_	_
23	they	_	PRON	PRP	_	25	nsubj	_	_
24	may	_	VERB	MD	_	25	aux	_	_
25	vary	_	VERB	VB	_	0	root	_	_
26	in	_	ADP	IN	_	28	case	_	_
27	the	_	DET	DT	_	28	det	_	_
28	extent	_	NOUN	NN	_	25	nmod	_	_
29	of	_	ADP	IN	_	30	case	_	_
30	inhibition	_	NOUN	NN	_	28	nmod	_	_

#	PAMELOR	6144
1	The	_	DET	DT	_	2	det	_	_
2	extent	_	NOUN	NN	_	13	nsubj	_	_
3	to	_	PRT	TO	_	4	case	_	_
4	which	_	DET	WDT	_	9	nmod	_	_
5	SSRI	_	NOUN	NN	_	7	compound	_	_
6	TCA	_	NOUN	NN	_	7	compound	_	_
7	interactions	_	NOUN	NNS	_	9	nsubj	_	_
8	may	_	VERB	MD	_	9	aux	_	_
9	pose	_	VERB	VB	_	2	acl:relcl	_	_
10	clinical	_	ADJ	JJ	_	11	amod	_	_
11	problems	_	NOUN	NNS	_	9	dobj	_	_
12	will	_	VERB	MD	_	13	aux	_	_
13	depend	_	VERB	VB	_	0	root	_	_
14	on	_	ADP	IN	_	16	case	_	_
15	the	_	DET	DT	_	16	det	_	_
16	degree	_	NOUN	NN	_	13	nmod	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	inhibition	_	NOUN	NN	_	16	nmod	_	_
19	and	_	CONJ	CC	_	13	cc	_	_
20	the	_	DET	DT	_	21	det	_	_
21	pharmacokinetics	_	NOUN	NNS	_	13	conj	_	_
22	of	_	ADP	IN	_	24	case	_	_
23	the	_	DET	DT	_	24	det	_	_
24	SSRI	_	NOUN	NN	_	21	nmod	_	_
25	involved	_	VERB	VBN	_	24	acl	_	_

#	PAMELOR	6145
1	Nevertheless	_	ADV	RB	_	5	advmod	_	_
2	,	_	.	,	_	5	punct	_	_
3	caution	_	NOUN	NN	_	5	nsubjpass	_	_
4	is	_	VERB	VBZ	_	5	auxpass	_	_
5	indicated	_	VERB	VBN	_	0	root	_	_
6	in	_	ADP	IN	_	9	case	_	_
7	the	_	DET	DT	_	9	det	_	_
8	co	_	DET	DT	_	9	det	_	_
9	administration	_	NOUN	NN	_	5	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	TCAs	_	NOUN	NNS	_	9	nmod	_	_
12	with	_	ADP	IN	_	13	case	_	_
13	any	_	DET	DT	_	9	nmod	_	_
14	of	_	ADP	IN	_	16	case	_	_
15	the	_	DET	DT	_	16	det	_	_
16	SSRIs	_	NOUN	NNS	_	13	nmod	_	_
17	and	_	CONJ	CC	_	9	cc	_	_
18	also	_	ADV	RB	_	20	advmod	_	_
19	in	_	ADP	IN	_	20	case	_	_
20	switching	_	NOUN	NN	_	9	conj	_	_
21	from	_	ADP	IN	_	23	case	_	_
22	one	_	NUM	CD	_	23	nummod	_	_
23	class	_	NOUN	NN	_	20	nmod	_	_
24	to	_	PRT	TO	_	26	case	_	_
25	the	_	DET	DT	_	26	det	_	_
26	other	_	ADJ	JJ	_	20	nmod	_	_

#	PAMELOR	6146
1	Of	_	ADP	IN	_	3	case	_	_
2	particular	_	ADJ	JJ	_	3	amod	_	_
3	importance	_	NOUN	NN	_	8	nmod	_	_
4	,	_	.	,	_	8	punct	_	_
5	sufficient	_	ADJ	JJ	_	6	amod	_	_
6	time	_	NOUN	NN	_	8	nsubj	_	_
7	must	_	VERB	MD	_	8	aux	_	_
8	elapse	_	VERB	VB	_	17	aux	_	_
9	before	_	ADP	IN	_	10	mark	_	_
10	initiating	_	VERB	VBG	_	8	advcl	_	_
11	TCA	_	NOUN	NN	_	12	compound	_	_
12	treatment	_	NOUN	NN	_	10	dobj	_	_
13	in	_	ADP	IN	_	15	case	_	_
14	a	_	DET	DT	_	15	det	_	_
15	patient	_	NOUN	NN	_	10	nmod	_	_
16	being	_	VERB	VBD	_	17	cop	_	_
17	withdrawn	_	ADJ	JJ	_	0	root	_	_
18	from	_	ADP	IN	_	19	case	_	_
19	fluoxetine	_	NOUN	NN	_	17	nmod	_	_
20	,	_	.	,	_	17	punct	_	_
21	given	_	VERB	VBN	_	17	parataxis	_	_
22	the	_	DET	DT	_	25	det	_	_
23	long	_	ADJ	JJ	_	25	amod	_	_
24	half	_	NOUN	NN	_	25	amod	_	_
25	life	_	NOUN	NN	_	21	dobj	_	_
26	of	_	ADP	IN	_	28	case	_	_
27	the	_	DET	DT	_	28	det	_	_
28	parent	_	NOUN	NN	_	25	nmod	_	_
29	and	_	CONJ	CC	_	28	cc	_	_
30	active	_	ADJ	JJ	_	31	amod	_	_
31	metabolite	_	NOUN	NN	_	28	conj	_	_
32	at	_	ADP	IN	_	33	case	_	_
33	least	_	ADJ	JJS	_	34	nmod:npmod	_	_
34	5	_	NUM	CD	_	35	nummod	_	_
35	weeks	_	NOUN	NNS	_	25	nmod	_	_
36	may	_	VERB	MD	_	38	aux	_	_
37	be	_	VERB	VB	_	38	auxpass	_	_
38	necessary	_	ADJ	JJ	_	21	dep	_	_

#	PAMELOR	6147
1	Concomitant	_	ADJ	JJ	_	2	amod	_	_
2	use	_	NOUN	NN	_	4	compound	_	_
3	DRUGS	_	NOUN	NN	_	4	compound	_	_
4	antidepressants	_	NOUN	NNS	_	14	nsubj	_	_
5	with	_	ADP	IN	_	6	case	_	_
6	drugs	_	NOUN	NNS	_	4	nmod	_	_
7	that	_	DET	WDT	_	9	nsubj	_	_
8	can	_	VERB	MD	_	9	aux	_	_
9	inhibit	_	VERB	VB	_	6	acl:relcl	_	_
10	cytochrome	_	NOUN	NN	_	12	compound	_	_
11	P450	_	NOUN	NN	_	12	compound	_	_
12	2D6	_	NOUN	NN	_	9	dobj	_	_
13	may	_	VERB	MD	_	14	aux	_	_
14	require	_	VERB	VB	_	0	root	_	_
15	lower	_	ADJ	JJ	_	16	amod	_	_
16	doses	_	NOUN	NNS	_	14	dobj	_	_
17	than	_	ADP	IN	_	19	mark	_	_
18	usually	_	ADV	RB	_	19	advmod	_	_
19	prescribed	_	VERB	VBN	_	14	advcl	_	_
20	for	_	ADP	IN	_	23	case	_	_
21	either	_	CONJ	CC	_	23	cc:preconj	_	_
22	tGGGGGGGGGGGG	_	NOUN	NN	_	23	compound	_	_
23	antidepressant	_	NOUN	NN	_	19	nmod	_	_
24	or	_	CONJ	CC	_	23	cc	_	_
25	the	_	DET	DT	_	27	det	_	_
26	other	_	ADJ	JJ	_	27	amod	_	_
27	drug	_	NOUN	NN	_	23	conj	_	_

#	PAMELOR	6148
1	Furthermore	_	ADV	RB	_	22	advmod	_	_
2	,	_	.	,	_	22	punct	_	_
3	whenever	_	ADP	IN	_	10	mark	_	_
4	one	_	NUM	CD	_	10	nsubj	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	these	_	DET	DT	_	8	det	_	_
7	other	_	ADJ	JJ	_	8	amod	_	_
8	drugs	_	NOUN	NNS	_	4	nmod	_	_
9	is	_	VERB	VBZ	_	10	cop	_	_
10	withdrawn	_	ADJ	JJ	_	22	advcl	_	_
11	from	_	ADP	IN	_	13	case	_	_
12	co	_	PRT	TO	_	13	case	_	_
13	therapy	_	NOUN	NN	_	10	nmod	_	_
14	,	_	.	,	_	22	punct	_	_
15	an	_	DET	DT	_	19	det	_	_
16	increased	_	VERB	VBN	_	19	amod	_	_
17	dose	_	NOUN	NN	_	19	compound	_	_
18	DRUGS	_	NOUN	NN	_	19	compound	_	_
19	antidepressant	_	NOUN	NN	_	22	nsubjpass	_	_
20	may	_	VERB	MD	_	22	aux	_	_
21	be	_	VERB	VB	_	22	auxpass	_	_
22	required	_	VERB	VBN	_	0	root	_	_

#	PAMELOR	6149
1	It	_	PRON	PRP	_	3	nsubj	_	_
2	is	_	VERB	VBZ	_	3	cop	_	_
3	desirable	_	ADJ	JJ	_	0	root	_	_
4	to	_	PRT	TO	_	5	mark	_	_
5	monitor	_	VERB	VB	_	3	xcomp	_	_
6	TCA	_	NOUN	NN	_	8	compound	_	_
7	plasma	_	NOUN	NN	_	8	compound	_	_
8	levels	_	NOUN	NNS	_	5	dobj	_	_
9	whenever	_	ADV	WRB	_	13	advmod	_	_
10	a	_	DET	DT	_	11	det	_	_
11	TCA	_	NOUN	NN	_	13	nsubj	_	_
12	is	_	VERB	VBZ	_	13	cop	_	_
13	going	_	VERB	VBG	_	5	advcl	_	_
14	to	_	PRT	TO	_	17	mark	_	_
15	be	_	VERB	VB	_	17	auxpass	_	_
16	co	_	PRT	TO	_	17	dep	_	_
17	administered	_	VERB	VBN	_	13	xcomp	_	_
18	with	_	ADP	IN	_	20	case	_	_
19	another	_	DET	DT	_	20	det	_	_
20	drug	_	NOUN	NN	_	17	nmod	_	_
21	known	_	VERB	VBN	_	20	acl	_	_
22	to	_	PRT	TO	_	25	mark	_	_
23	be	_	VERB	VB	_	25	cop	_	_
24	an	_	DET	DT	_	25	det	_	_
25	inhibitor	_	NOUN	NN	_	21	xcomp	_	_
26	of	_	ADP	IN	_	28	case	_	_
27	P450	_	NOUN	NN	_	28	compound	_	_
28	2D6	_	NOUN	NN	_	25	nmod	_	_

#	PAMELOR	6150
1	Monoamine	_	NOUN	NN	_	3	compound	_	_
2	Oxidase	_	NOUN	NN	_	3	compound	_	_
3	Inhibitors	_	NOUN	NNS	_	0	root	_	_
4	MAOIs	_	NOUN	NNS	_	3	dep	_	_

#	PAMELOR	6151
1	Serotonergic	_	ADJ	JJ	_	2	amod	_	_
2	Drugs	_	NOUN	NNS	_	0	root	_	_

#	PAMELOR	6152
1	The	_	DET	DT	_	2	det	_	_
2	mechanism	_	NOUN	NN	_	10	nsubj	_	_
3	of	_	ADP	IN	_	7	case	_	_
4	mood	_	NOUN	NN	_	7	compound	_	_
5	elevation	_	NOUN	NN	_	7	compound	_	_
6	DRUGS	_	NOUN	NN	_	7	compound	_	_
7	antidepressants	_	NOUN	NNS	_	2	nmod	_	_
8	is	_	VERB	VBZ	_	10	cop	_	_
9	at	_	ADP	IN	_	10	case	_	_
10	present	_	ADJ	JJ	_	0	root	_	_
11	unknown	_	ADJ	JJ	_	10	dep	_	_

#	PAMELOR	6153
1	DRUG	_	NOUN	NN	_	7	nsubj	_	_
2	is	_	VERB	VBZ	_	7	cop	_	_
3	not	_	ADV	RB	_	7	neg	_	_
4	a	_	DET	DT	_	7	det	_	_
5	monoamine	_	NOUN	NN	_	7	compound	_	_
6	oxidase	_	NOUN	NN	_	7	compound	_	_
7	inhibitor	_	NOUN	NN	_	0	root	_	_

#	PAMELOR	6154
1	It	_	PRON	PRP	_	2	nsubj	_	_
2	inhibits	_	VERB	VBZ	_	0	root	_	_
3	the	_	DET	DT	_	4	det	_	_
4	activity	_	NOUN	NN	_	2	dobj	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	such	_	ADJ	JJ	_	8	amod	_	_
7	diverse	_	ADJ	JJ	_	8	amod	_	_
8	agents	_	NOUN	NNS	_	4	nmod	_	_
9	as	_	ADP	IN	_	10	case	_	_
10	histamine	_	NOUN	NN	_	4	nmod	_	_
11	,	_	.	,	_	10	punct	_	_
12	5	_	NUM	CD	_	13	nummod	_	_
13	hydroxytryptamine	_	NOUN	NN	_	10	conj	_	_
14	,	_	.	,	_	10	punct	_	_
15	and	_	CONJ	CC	_	10	cc	_	_
16	acetylcholine	_	NOUN	NN	_	10	conj	_	_

#	PAMELOR	6155
1	It	_	PRON	PRP	_	2	nsubj	_	_
2	increases	_	VERB	VBZ	_	0	root	_	_
3	the	_	DET	DT	_	5	det	_	_
4	pressor	_	ADJ	JJ	_	5	amod	_	_
5	effect	_	NOUN	NN	_	2	dobj	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	norepinephrine	_	NOUN	NN	_	5	nmod	_	_
8	but	_	CONJ	CC	_	2	cc	_	_
9	blocks	_	VERB	VBZ	_	2	conj	_	_
10	the	_	DET	DT	_	12	det	_	_
11	pressor	_	ADJ	JJ	_	12	amod	_	_
12	response	_	NOUN	NN	_	9	dobj	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	phenethylamine	_	NOUN	NN	_	12	nmod	_	_

#	PAMELOR	6156
1	Studies	_	NOUN	NNS	_	2	nsubj	_	_
2	suggest	_	VERB	VBP	_	0	root	_	_
3	that	_	ADP	IN	_	5	mark	_	_
4	DRUG	_	NOUN	NN	_	5	nsubj	_	_
5	interferes	_	VERB	VBZ	_	2	ccomp	_	_
6	with	_	ADP	IN	_	8	case	_	_
7	the	_	DET	DT	_	8	det	_	_
8	transport	_	NOUN	NN	_	5	nmod	_	_
9	,	_	.	,	_	8	punct	_	_
10	release	_	NOUN	NN	_	8	conj	_	_
11	,	_	.	,	_	8	punct	_	_
12	and	_	CONJ	CC	_	8	cc	_	_
13	storage	_	NOUN	NN	_	8	conj	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	catecholamines	_	NOUN	NNS	_	8	nmod	_	_

#	PAMELOR	6157
1	Operant	_	ADJ	JJ	_	3	amod	_	_
2	conditioning	_	VERB	VBG	_	3	amod	_	_
3	techniques	_	NOUN	NNS	_	8	nsubj	_	_
4	in	_	ADP	IN	_	5	case	_	_
5	rats	_	NOUN	NNS	_	3	nmod	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	pigeons	_	NOUN	NNS	_	5	conj	_	_
8	suggest	_	VERB	VBP	_	0	root	_	_
9	that	_	ADP	IN	_	11	mark	_	_
10	DRUG	_	NOUN	NN	_	11	nsubj	_	_
11	has	_	VERB	VBZ	_	8	ccomp	_	_
12	a	_	DET	DT	_	13	det	_	_
13	combination	_	NOUN	NN	_	11	dobj	_	_
14	of	_	ADP	IN	_	18	case	_	_
15	stimulant	_	ADJ	JJ	_	18	amod	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	depressant	_	ADJ	JJ	_	15	conj	_	_
18	properties	_	NOUN	NNS	_	13	nmod	_	_

#	PAROXETINE	3504
1	As	_	ADP	IN	_	4	case	_	_
2	with	_	ADP	IN	_	4	case	_	_
3	other	_	ADJ	JJ	_	4	amod	_	_
4	DRUGS	_	NOUN	NN	_	13	nmod	_	_
5	,	_	.	,	_	13	punct	_	_
6	an	_	DET	DT	_	7	det	_	_
7	interaction	_	NOUN	NN	_	13	nsubj	_	_
8	between	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	tryptophan	_	NOUN	NN	_	9	conj	_	_
12	may	_	VERB	MD	_	13	aux	_	_
13	occur	_	VERB	VB	_	0	root	_	_
14	when	_	ADV	WRB	_	17	advmod	_	_
15	they	_	PRON	PRP	_	17	nsubjpass	_	_
16	are	_	VERB	VBP	_	17	auxpass	_	_
17	coadministered	_	VERB	VBN	_	13	ccomp	_	_

#	PAROXETINE	3505
1	Adverse	_	ADJ	JJ	_	2	amod	_	_
2	experiences	_	NOUN	NNS	_	18	nsubjpass	_	_
3	,	_	.	,	_	2	punct	_	_
4	consisting	_	VERB	VBG	_	2	acl	_	_
5	primarily	_	ADV	RB	_	7	advmod	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	headache	_	NOUN	NN	_	4	nmod	_	_
8	,	_	.	,	_	7	punct	_	_
9	nausea	_	NOUN	NN	_	7	conj	_	_
10	,	_	.	,	_	7	punct	_	_
11	sweating	_	NOUN	NN	_	7	conj	_	_
12	,	_	.	,	_	7	punct	_	_
13	and	_	CONJ	CC	_	7	cc	_	_
14	dizziness	_	NOUN	NN	_	7	conj	_	_
15	,	_	.	,	_	2	punct	_	_
16	have	_	VERB	VBP	_	18	aux	_	_
17	been	_	VERB	VBN	_	18	auxpass	_	_
18	reported	_	VERB	VBN	_	0	root	_	_
19	when	_	ADV	WRB	_	22	advmod	_	_
20	tryptophan	_	NOUN	NN	_	22	nsubjpass	_	_
21	was	_	VERB	VBD	_	22	auxpass	_	_
22	administered	_	VERB	VBN	_	18	ccomp	_	_
23	to	_	PRT	TO	_	24	case	_	_
24	patients	_	NOUN	NNS	_	22	nmod	_	_
25	taking	_	VERB	VBG	_	24	acl	_	_
26	DRUG	_	NOUN	NN	_	25	nmod	_	_

#	PAROXETINE	3506
1	Consequently	_	ADV	RB	_	11	advmod	_	_
2	,	_	.	,	_	11	punct	_	_
3	concomitant	_	ADJ	JJ	_	4	amod	_	_
4	use	_	NOUN	NN	_	11	nsubjpass	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	with	_	ADP	IN	_	8	case	_	_
8	tryptophan	_	NOUN	NN	_	4	nmod	_	_
9	is	_	VERB	VBZ	_	11	auxpass	_	_
10	not	_	ADV	RB	_	11	neg	_	_
11	recommended	_	VERB	VBN	_	0	root	_	_

#	PAROXETINE	3507
1	See	_	ADJ	JJ	_	2	compound	_	_
2	CONTRAINDICATIONS	_	NOUN	NN	_	0	root	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	WARNINGS	_	NOUN	NNS	_	2	conj	_	_

#	PAROXETINE	3508
1	In	_	ADP	IN	_	4	case	_	_
2	a	_	DET	DT	_	4	det	_	_
3	controlled	_	VERB	VBN	_	4	amod	_	_
4	study	_	NOUN	NN	_	12	nmod	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	healthy	_	ADJ	JJ	_	7	amod	_	_
7	volunteers	_	NOUN	NNS	_	4	nmod	_	_
8	,	_	.	,	_	12	punct	_	_
9	after	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	12	nsubjpass	_	_
11	was	_	VERB	VBD	_	12	auxpass	_	_
12	titrated	_	VERB	VBN	_	29	advcl	_	_
13	to	_	PRT	TO	_	15	case	_	_
14	60	_	NUM	CD	_	15	nummod	_	_
15	mg	_	NOUN	NN	_	12	nmod	_	_
16	daily	_	ADV	RB	_	12	advmod	_	_
17	,	_	.	,	_	29	punct	_	_
18	co	_	PRT	TO	_	19	case	_	_
19	administration	_	NOUN	NN	_	29	nsubjpass	_	_
20	of	_	ADP	IN	_	23	case	_	_
21	a	_	DET	DT	_	23	det	_	_
22	single	_	ADJ	JJ	_	23	amod	_	_
23	dose	_	NOUN	NN	_	19	nmod	_	_
24	of	_	ADP	IN	_	27	case	_	_
25	2	_	NUM	CD	_	27	nummod	_	_
26	mg	_	NOUN	NN	_	27	compound	_	_
27	pimozide	_	NOUN	NN	_	23	nmod	_	_
28	was	_	VERB	VBD	_	29	auxpass	_	_
29	associated	_	VERB	VBN	_	0	root	_	_
30	with	_	ADP	IN	_	32	case	_	_
31	mean	_	NOUN	NN	_	32	amod	_	_
32	increases	_	NOUN	NNS	_	29	nmod	_	_
33	in	_	ADP	IN	_	35	case	_	_
34	pimozide	_	NOUN	NN	_	35	compound	_	_
35	AUC	_	NOUN	NN	_	32	nmod	_	_
36	of	_	ADP	IN	_	37	case	_	_
37	151%	_	NOUN	NN	_	35	nmod	_	_
38	and	_	CONJ	CC	_	37	cc	_	_
39	Cmax	_	NOUN	NN	_	37	conj	_	_
40	of	_	ADP	IN	_	41	case	_	_
41	62%	_	NOUN	NN	_	37	nmod	_	_
42	,	_	.	,	_	29	punct	_	_
43	compared	_	VERB	VBN	_	29	xcomp	_	_
44	to	_	PRT	TO	_	45	case	_	_
45	pimozide	_	NOUN	NN	_	43	nmod	_	_
46	administered	_	VERB	VBN	_	45	acl	_	_
47	alone	_	ADV	RB	_	46	advmod	_	_

#	PAROXETINE	3509
1	The	_	DET	DT	_	2	det	_	_
2	increase	_	NOUN	NN	_	14	nsubj	_	_
3	in	_	ADP	IN	_	5	case	_	_
4	pimozide	_	NOUN	NN	_	5	compound	_	_
5	AUC	_	NOUN	NN	_	2	nmod	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	Cmax	_	NOUN	NN	_	5	conj	_	_
8	is	_	VERB	VBZ	_	14	cop	_	_
9	due	_	ADJ	JJ	_	14	case	_	_
10	to	_	PRT	TO	_	9	mwe	_	_
11	the	_	DET	DT	_	14	det	_	_
12	CYP2D6	_	NOUN	NN	_	14	compound	_	_
13	inhibitory	_	ADJ	JJ	_	14	amod	_	_
14	properties	_	NOUN	NNS	_	0	root	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	14	nmod	_	_

#	PAROXETINE	3510
1	Due	_	ADJ	JJ	_	6	case	_	_
2	to	_	PRT	TO	_	1	mwe	_	_
3	the	_	DET	DT	_	6	det	_	_
4	narrow	_	NOUN	NN	_	6	compound	_	_
5	therapeutic	_	ADJ	JJ	_	6	amod	_	_
6	index	_	NOUN	NN	_	26	nmod	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	pimozide	_	NOUN	NN	_	6	nmod	_	_
9	and	_	CONJ	CC	_	6	cc	_	_
10	its	_	PRON	PRP$	_	12	nmod:poss	_	_
11	known	_	VERB	VBN	_	12	amod	_	_
12	ability	_	NOUN	NN	_	6	conj	_	_
13	to	_	PRT	TO	_	14	mark	_	_
14	prolong	_	VERB	VB	_	12	acl	_	_
15	the	_	DET	DT	_	17	det	_	_
16	QT	_	NOUN	NN	_	17	nmod:npmod	_	_
17	interval	_	ADJ	JJ	_	14	dobj	_	_
18	,	_	.	,	_	26	punct	_	_
19	concomitant	_	ADJ	JJ	_	20	amod	_	_
20	use	_	NOUN	NN	_	26	nsubjpass	_	_
21	of	_	ADP	IN	_	22	case	_	_
22	pimozide	_	NOUN	NN	_	20	nmod	_	_
23	and	_	CONJ	CC	_	22	cc	_	_
24	DRUG	_	NOUN	NN	_	22	conj	_	_
25	is	_	VERB	VBZ	_	26	auxpass	_	_
26	contraindicated	_	VERB	VBN	_	0	root	_	_

#	PAROXETINE	3511
1	Based	_	VERB	VBN	_	0	root	_	_
2	on	_	ADP	IN	_	4	case	_	_
3	the	_	DET	DT	_	4	det	_	_
4	mechanism	_	NOUN	NN	_	1	nmod	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	action	_	NOUN	NN	_	4	nmod	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	SNRIs	_	NOUN	NNS	_	6	nmod	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	SSRIs	_	NOUN	NNS	_	8	conj	_	_
11	,	_	.	,	_	6	punct	_	_
12	including	_	VERB	VBG	_	14	case	_	_
13	DRUG	_	NOUN	NN	_	14	compound	_	_
14	hydrochloride	_	NOUN	NN	_	6	nmod	_	_
15	,	_	.	,	_	1	punct	_	_
16	and	_	CONJ	CC	_	1	cc	_	_
17	the	_	DET	DT	_	18	det	_	_
18	potential	_	NOUN	NN	_	1	conj	_	_
19	for	_	ADP	IN	_	21	case	_	_
20	serotonin	_	NOUN	NN	_	21	compound	_	_
21	syndrome	_	NOUN	NN	_	18	nmod	_	_
22	,	_	.	,	_	1	punct	_	_
23	caution	_	NOUN	NN	_	25	nsubjpass	_	_
24	is	_	VERB	VBZ	_	25	auxpass	_	_
25	advised	_	VERB	VBN	_	1	parataxis	_	_
26	when	_	ADV	WRB	_	29	advmod	_	_
27	DRUG	_	NOUN	NN	_	29	nsubjpass	_	_
28	is	_	VERB	VBZ	_	29	auxpass	_	_
29	coadministered	_	VERB	VBN	_	25	advcl	_	_
30	with	_	ADP	IN	_	32	case	_	_
31	other	_	ADJ	JJ	_	32	amod	_	_
32	drugs	_	NOUN	NNS	_	29	nmod	_	_
33	that	_	DET	WDT	_	35	nsubj	_	_
34	may	_	VERB	MD	_	35	aux	_	_
35	affect	_	VERB	VB	_	32	acl:relcl	_	_
36	the	_	DET	DT	_	39	det	_	_
37	serotonergic	_	ADJ	JJ	_	39	amod	_	_
38	neurotransmitter	_	ADJ	JJ	_	39	amod	_	_
39	systems	_	NOUN	NNS	_	35	dobj	_	_
40	,	_	.	,	_	39	punct	_	_
41	such	_	ADJ	JJ	_	43	case	_	_
42	as	_	ADP	IN	_	41	mwe	_	_
43	triptans	_	NOUN	NNS	_	39	nmod	_	_
44	,	_	.	,	_	43	punct	_	_
45	lithium	_	NOUN	NN	_	43	conj	_	_
46	,	_	.	,	_	43	punct	_	_
47	fentanyl	_	NOUN	NN	_	43	conj	_	_
48	,	_	.	,	_	43	punct	_	_
49	tramadol	_	NOUN	NN	_	43	conj	_	_
50	,	_	.	,	_	43	punct	_	_
51	or	_	CONJ	CC	_	43	cc	_	_
52	St	_	NOUN	NN	_	53	compound	_	_
53	John's	_	NOUN	NNS	_	43	conj	_	_
54	wort	_	VERB	VBZ	_	25	parataxis	_	_

#	PAROXETINE	3512
1	The	_	DET	DT	_	3	det	_	_
2	concomitant	_	ADJ	JJ	_	3	amod	_	_
3	use	_	NOUN	NN	_	15	nsubjpass	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	with	_	ADP	IN	_	7	case	_	_
7	MAOIs	_	NOUN	NNS	_	3	nmod	_	_
8	including	_	ADP	IN	_	13	case	_	_
9	linezolid	_	ADJ	JJ	_	13	amod	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	intravenous	_	ADJ	JJ	_	9	conj	_	_
12	methylene	_	NOUN	NN	_	13	compound	_	_
13	blue	_	NOUN	NN	_	7	nmod	_	_
14	is	_	VERB	VBZ	_	15	auxpass	_	_
15	contraindicated	_	VERB	VBN	_	0	root	_	_

#	PAROXETINE	3513
1	The	_	DET	DT	_	3	det	_	_
2	concomitant	_	ADJ	JJ	_	3	amod	_	_
3	use	_	NOUN	NN	_	15	nsubjpass	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	with	_	ADP	IN	_	8	case	_	_
7	other	_	ADJ	JJ	_	8	amod	_	_
8	SSRIs	_	NOUN	NNS	_	3	nmod	_	_
9	,	_	.	,	_	8	punct	_	_
10	SNRIs	_	NOUN	NNS	_	8	conj	_	_
11	or	_	CONJ	CC	_	8	cc	_	_
12	tryptophan	_	NOUN	NN	_	8	conj	_	_
13	is	_	VERB	VBZ	_	15	auxpass	_	_
14	not	_	ADV	RB	_	15	neg	_	_
15	recommended	_	VERB	VBN	_	0	root	_	_

#	PAROXETINE	3515
1	Preliminary	_	ADJ	JJ	_	2	amod	_	_
2	data	_	NOUN	NNS	_	3	nsubj	_	_
3	suggest	_	VERB	VBP	_	0	root	_	_
4	that	_	ADP	IN	_	10	mark	_	_
5	there	_	DET	EX	_	10	nsubj	_	_
6	may	_	VERB	MD	_	10	aux	_	_
7	be	_	VERB	VB	_	10	cop	_	_
8	a	_	DET	DT	_	10	det	_	_
9	pharmacodynamic	_	ADJ	JJ	_	10	amod	_	_
10	interaction	_	NOUN	NN	_	3	ccomp	_	_
11	that	_	DET	WDT	_	12	nsubj	_	_
12	causes	_	VERB	VBZ	_	10	ccomp	_	_
13	an	_	DET	DT	_	16	det	_	_
14	increased	_	VERB	VBN	_	16	amod	_	_
15	bleeding	_	NOUN	NN	_	16	compound	_	_
16	diathesis	_	NOUN	NN	_	12	dobj	_	_
17	in	_	ADP	IN	_	19	case	_	_
18	the	_	DET	DT	_	19	det	_	_
19	face	_	NOUN	NN	_	16	nmod	_	_
20	of	_	ADP	IN	_	23	case	_	_
21	unaltered	_	ADJ	JJ	_	23	amod	_	_
22	prothrombin	_	NOUN	NN	_	23	compound	_	_
23	time	_	NOUN	NN	_	19	nmod	_	_
24	between	_	ADP	IN	_	25	case	_	_
25	DRUG	_	NOUN	NN	_	19	nmod	_	_
26	and	_	CONJ	CC	_	25	cc	_	_
27	warfarin	_	NOUN	NN	_	25	conj	_	_

#	PAROXETINE	3516
1	Since	_	ADP	IN	_	3	mark	_	_
2	there	_	DET	EX	_	3	expl	_	_
3	is	_	VERB	VBZ	_	17	advcl	_	_
4	little	_	ADJ	JJ	_	6	amod	_	_
5	clinical	_	ADJ	JJ	_	6	amod	_	_
6	experience	_	NOUN	NN	_	3	nsubj	_	_
7	,	_	.	,	_	17	punct	_	_
8	the	_	DET	DT	_	10	det	_	_
9	concomitant	_	ADJ	JJ	_	10	amod	_	_
10	administration	_	NOUN	NN	_	17	nsubjpass	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	warfarin	_	NOUN	NN	_	12	conj	_	_
15	should	_	VERB	MD	_	17	aux	_	_
16	be	_	VERB	VB	_	17	auxpass	_	_
17	undertaken	_	VERB	VBN	_	0	root	_	_
18	with	_	ADP	IN	_	19	case	_	_
19	caution	_	NOUN	NN	_	17	nmod	_	_

#	PAROXETINE	3517
1	There	_	DET	EX	_	6	nmod:poss	_	_
2	have	_	VERB	VBP	_	6	aux	_	_
3	been	_	VERB	VBN	_	6	cop	_	_
4	rare	_	ADJ	JJ	_	6	amod	_	_
5	postmarketing	_	ADJ	JJ	_	6	amod	_	_
6	reports	_	NOUN	NNS	_	0	root	_	_
7	of	_	ADP	IN	_	9	case	_	_
8	serotonin	_	NOUN	NN	_	9	compound	_	_
9	syndrome	_	NOUN	NN	_	6	nmod	_	_
10	with	_	ADP	IN	_	12	case	_	_
11	the	_	DET	DT	_	12	det	_	_
12	use	_	NOUN	NN	_	6	nmod	_	_
13	of	_	ADP	IN	_	15	case	_	_
14	an	_	DET	DT	_	15	det	_	_
15	SSRI	_	NOUN	NN	_	12	nmod	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	a	_	DET	DT	_	18	det	_	_
18	triptan	_	NOUN	NN	_	15	conj	_	_

#	PAROXETINE	3518
1	If	_	ADP	IN	_	3	case	_	_
2	concomitant	_	ADJ	JJ	_	3	amod	_	_
3	use	_	NOUN	NN	_	11	nsubjpass	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	with	_	ADP	IN	_	8	case	_	_
7	a	_	DET	DT	_	8	det	_	_
8	triptan	_	NOUN	NN	_	3	nmod	_	_
9	is	_	VERB	VBZ	_	11	auxpass	_	_
10	clinically	_	ADV	RB	_	11	advmod	_	_
11	warranted	_	VERB	VBN	_	19	advcl	_	_
12	,	_	.	,	_	19	punct	_	_
13	careful	_	ADJ	JJ	_	14	amod	_	_
14	observation	_	NOUN	NN	_	19	nsubjpass	_	_
15	of	_	ADP	IN	_	17	case	_	_
16	the	_	DET	DT	_	17	det	_	_
17	patient	_	NOUN	NN	_	14	nmod	_	_
18	is	_	VERB	VBZ	_	19	auxpass	_	_
19	advised	_	VERB	VBN	_	0	root	_	_
20	,	_	.	,	_	19	punct	_	_
21	particularly	_	ADV	RB	_	23	advmod	_	_
22	during	_	ADP	IN	_	23	case	_	_
23	treatment	_	NOUN	NN	_	19	nmod	_	_
24	initiation	_	NOUN	NN	_	23	dep	_	_
25	and	_	CONJ	CC	_	24	cc	_	_
26	dose	_	NOUN	NN	_	24	conj	_	_
27	increases	_	VERB	VBZ	_	19	root	_	_

#	PAROXETINE	3519
1	The	_	DET	DT	_	2	det	_	_
2	metabolism	_	NOUN	NN	_	9	nsubjpass	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	pharmacokinetics	_	NOUN	NNS	_	2	conj	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	2	nmod	_	_
7	may	_	VERB	MD	_	9	aux	_	_
8	be	_	VERB	VB	_	9	auxpass	_	_
9	affected	_	VERB	VBN	_	0	root	_	_
10	by	_	ADP	IN	_	12	case	_	_
11	the	_	DET	DT	_	12	det	_	_
12	induction	_	NOUN	NN	_	9	nmod	_	_
13	or	_	CONJ	CC	_	12	cc	_	_
14	inhibition	_	NOUN	NN	_	12	conj	_	_
15	of	_	ADP	IN	_	18	case	_	_
16	drug	_	NOUN	NN	_	18	compound	_	_
17	metabolizing	_	NOUN	NN	_	18	compound	_	_
18	enzymes	_	NOUN	NNS	_	12	nmod	_	_

#	PAROXETINE	3520
1	Cimetidine	_	NOUN	NN	_	2	nsubj	_	_
2	inhibits	_	VERB	VBZ	_	0	root	_	_
3	many	_	ADJ	JJ	_	7	amod	_	_
4	cytochrome	_	NOUN	NN	_	7	compound	_	_
5	P450	_	NOUN	NN	_	7	compound	_	_
6	oxidative	_	ADJ	JJ	_	7	amod	_	_
7	enzymes	_	NOUN	NNS	_	2	dobj	_	_

#	PAROXETINE	3521
1	In	_	ADP	IN	_	3	case	_	_
2	a	_	DET	DT	_	3	det	_	_
3	study	_	NOUN	NN	_	24	nmod	_	_
4	where	_	ADV	WRB	_	11	advmod	_	_
5	DRUG	_	NOUN	NN	_	7	compound	_	_
6	30	_	NUM	CD	_	7	nummod	_	_
7	mg	_	NOUN	NN	_	11	nsubjpass	_	_
8	once	_	ADV	RB	_	11	advmod	_	_
9	daily	_	ADV	RB	_	11	advmod	_	_
10	was	_	VERB	VBD	_	11	auxpass	_	_
11	dosed	_	VERB	VBN	_	3	acl:relcl	_	_
12	orally	_	ADV	RB	_	11	advmod	_	_
13	for	_	ADP	IN	_	15	case	_	_
14	4	_	NUM	CD	_	15	nummod	_	_
15	weeks	_	NOUN	NNS	_	11	nmod	_	_
16	,	_	.	,	_	24	punct	_	_
17	steady	_	ADJ	JJ	_	20	amod	_	_
18	state	_	NOUN	NN	_	20	compound	_	_
19	plasma	_	NOUN	NN	_	20	compound	_	_
20	concentrations	_	NOUN	NNS	_	24	nsubjpass	_	_
21	of	_	ADP	IN	_	22	case	_	_
22	DRUG	_	NOUN	NN	_	20	nmod	_	_
23	were	_	VERB	VBD	_	24	auxpass	_	_
24	increased	_	VERB	VBN	_	0	root	_	_
25	by	_	ADP	IN	_	27	case	_	_
26	approximately	_	ADV	RB	_	27	advmod	_	_
27	50%	_	NOUN	NN	_	24	nmod	_	_
28	during	_	ADP	IN	_	29	case	_	_
29	coadministration	_	NOUN	NN	_	24	nmod	_	_
30	with	_	ADP	IN	_	36	case	_	_
31	oral	_	ADJ	JJ	_	36	amod	_	_
32	cimetidine	_	NOUN	NN	_	36	compound	_	_
33	300	_	NUM	CD	_	36	nummod	_	_
34	mg	_	NOUN	NN	_	36	compound	_	_
35	three	_	NUM	CD	_	36	nummod	_	_
36	times	_	NOUN	NNS	_	29	nmod	_	_
37	daily	_	ADV	RB	_	29	advmod	_	_
38	for	_	ADP	IN	_	41	case	_	_
39	the	_	DET	DT	_	41	det	_	_
40	final	_	ADJ	JJ	_	41	amod	_	_
41	week	_	NOUN	NN	_	37	nmod	_	_

#	PAROXETINE	3522
1	Therefore	_	ADV	RB	_	22	advmod	_	_
2	,	_	.	,	_	22	punct	_	_
3	when	_	ADV	WRB	_	7	advmod	_	_
4	these	_	DET	DT	_	5	det	_	_
5	drugs	_	NOUN	NNS	_	7	nsubjpass	_	_
6	are	_	VERB	VBP	_	7	auxpass	_	_
7	administered	_	VERB	VBN	_	22	advcl	_	_
8	concurrently	_	ADV	RB	_	7	advmod	_	_
9	,	_	.	,	_	22	punct	_	_
10	dosage	_	ADJ	JJ	_	11	compound	_	_
11	adjustment	_	NOUN	NN	_	22	nsubjpass	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	DRUG	_	NOUN	NN	_	11	nmod	_	_
14	after	_	ADP	IN	_	19	case	_	_
15	the	_	DET	DT	_	19	det	_	_
16	20	_	NUM	CD	_	19	nummod	_	_
17	mg	_	NOUN	NN	_	19	compound	_	_
18	starting	_	VERB	VBG	_	19	amod	_	_
19	dose	_	NOUN	NN	_	11	nmod	_	_
20	should	_	VERB	MD	_	22	aux	_	_
21	be	_	VERB	VB	_	22	auxpass	_	_
22	guided	_	VERB	VBN	_	0	root	_	_
23	by	_	ADP	IN	_	25	case	_	_
24	clinical	_	ADJ	JJ	_	25	amod	_	_
25	effect	_	NOUN	NN	_	22	nmod	_	_

#	PAROXETINE	3523
1	The	_	DET	DT	_	2	det	_	_
2	effect	_	NOUN	NN	_	10	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	on	_	ADP	IN	_	7	case	_	_
6	cimetidine's	_	NOUN	NNS	_	7	compound	_	_
7	pharmacokinetics	_	NOUN	NNS	_	2	nmod	_	_
8	was	_	VERB	VBD	_	10	auxpass	_	_
9	not	_	ADV	RB	_	10	neg	_	_
10	studied	_	VERB	VBN	_	0	root	_	_

#	PAROXETINE	3524
1	Phenobarbital	_	ADJ	JJ	_	2	nsubj	_	_
2	induces	_	VERB	VBZ	_	0	root	_	_
3	many	_	ADJ	JJ	_	7	amod	_	_
4	cytochrome	_	NOUN	NN	_	7	compound	_	_
5	P450	_	NOUN	NN	_	7	compound	_	_
6	oxidative	_	ADJ	JJ	_	7	amod	_	_
7	enzymes	_	NOUN	NNS	_	2	dobj	_	_

#	PAROXETINE	3525
1	When	_	ADV	WRB	_	11	advmod	_	_
2	a	_	DET	DT	_	7	det	_	_
3	single	_	ADJ	JJ	_	7	amod	_	_
4	oral	_	ADJ	JJ	_	7	amod	_	_
5	30	_	NUM	CD	_	7	nummod	_	_
6	mg	_	NOUN	NN	_	7	compound	_	_
7	dose	_	NOUN	NN	_	11	nsubjpass	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	was	_	VERB	VBD	_	11	auxpass	_	_
11	administered	_	VERB	VBN	_	29	advcl	_	_
12	at	_	ADP	IN	_	17	case	_	_
13	phenobarbital	_	ADJ	JJ	_	17	amod	_	_
14	steady	_	ADJ	JJ	_	17	amod	_	_
15	state	_	NOUN	NN	_	17	compound	_	_
16	100	_	NUM	CD	_	17	nummod	_	_
17	mg	_	NOUN	NN	_	11	nmod	_	_
18	once	_	ADV	RB	_	19	advmod	_	_
19	daily	_	ADV	RB	_	11	advmod	_	_
20	for	_	ADP	IN	_	22	case	_	_
21	14	_	NUM	CD	_	22	nummod	_	_
22	days	_	NOUN	NNS	_	19	nmod	_	_
23	,	_	.	,	_	29	punct	_	_
24	DRUG	_	NOUN	NN	_	25	compound	_	_
25	AUC	_	NOUN	NN	_	29	nsubjpass	_	_
26	and	_	CONJ	CC	_	25	cc	_	_
27	T%	_	NOUN	NN	_	25	conj	_	_
28	were	_	VERB	VBD	_	29	auxpass	_	_
29	reduced	_	VERB	VBN	_	0	root	_	_
30	by	_	ADP	IN	_	32	case	_	_
31	an	_	DET	DT	_	32	det	_	_
32	average	_	NOUN	NN	_	29	nmod	_	_
33	of	_	ADP	IN	_	34	case	_	_
34	25%	_	NOUN	NN	_	32	nmod	_	_
35	and	_	CONJ	CC	_	34	cc	_	_
36	38%	_	NOUN	NN	_	34	conj	_	_
37	,	_	.	,	_	29	punct	_	_
38	respectively	_	ADV	RB	_	39	advmod	_	_
39	compared	_	VERB	VBN	_	29	advcl	_	_
40	to	_	PRT	TO	_	41	case	_	_
41	DRUG	_	NOUN	NN	_	39	nmod	_	_
42	administered	_	VERB	VBN	_	41	acl	_	_
43	alone	_	ADV	RB	_	42	advmod	_	_

#	PAROXETINE	3526
1	The	_	DET	DT	_	2	det	_	_
2	effect	_	NOUN	NN	_	10	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	on	_	ADP	IN	_	7	case	_	_
6	phenobarbital	_	ADJ	JJ	_	7	amod	_	_
7	pharmacokinetics	_	NOUN	NNS	_	2	nmod	_	_
8	was	_	VERB	VBD	_	10	auxpass	_	_
9	not	_	ADV	RB	_	10	neg	_	_
10	studied	_	VERB	VBN	_	0	root	_	_

#	PAROXETINE	3527
1	Since	_	ADP	IN	_	3	mark	_	_
2	DRUG	_	NOUN	NN	_	3	nsubj	_	_
3	exhibits	_	VERB	VBZ	_	14	advcl	_	_
4	nonlinear	_	ADJ	JJ	_	5	amod	_	_
5	pharmacokinetics	_	NOUN	NNS	_	3	dobj	_	_
6	,	_	.	,	_	14	punct	_	_
7	the	_	DET	DT	_	8	det	_	_
8	results	_	NOUN	NNS	_	14	nsubj	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	this	_	DET	DT	_	11	det	_	_
11	study	_	NOUN	NN	_	8	nmod	_	_
12	may	_	VERB	MD	_	14	aux	_	_
13	not	_	ADV	RB	_	14	neg	_	_
14	address	_	VERB	VB	_	0	root	_	_
15	the	_	DET	DT	_	16	det	_	_
16	case	_	NOUN	NN	_	14	dobj	_	_
17	where	_	ADV	WRB	_	25	advmod	_	_
18	the	_	DET	DT	_	20	det	_	_
19	2	_	NUM	CD	_	20	nummod	_	_
20	drugs	_	NOUN	NNS	_	25	nsubjpass	_	_
21	are	_	VERB	VBP	_	25	auxpass	_	_
22	both	_	DET	DT	_	25	advmod	_	_
23	being	_	VERB	VBN	_	25	auxpass	_	_
24	chronically	_	ADV	RB	_	25	advmod	_	_
25	dosed	_	VERB	VBN	_	16	root	_	_

#	PAROXETINE	3528
1	No	_	DET	DT	_	4	neg	_	_
2	initial	_	ADJ	JJ	_	4	amod	_	_
3	dosage	_	NOUN	NN	_	4	compound	_	_
4	adjustment	_	NOUN	NN	_	8	nsubjpass	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	is	_	VERB	VBZ	_	8	auxpass	_	_
8	considered	_	VERB	VBN	_	0	root	_	_
9	necessary	_	ADJ	JJ	_	8	xcomp	_	_
10	when	_	ADV	WRB	_	11	advmod	_	_
11	coadministered	_	VERB	VBN	_	9	advcl	_	_
12	with	_	ADP	IN	_	16	case	_	_
13	phenobarbital	_	ADJ	JJ	_	16	amod	_	_
14	any	_	DET	DT	_	16	det	_	_
15	subsequent	_	ADJ	JJ	_	16	amod	_	_
16	adjustment	_	NOUN	NN	_	11	nmod	_	_
17	should	_	VERB	MD	_	19	aux	_	_
18	be	_	VERB	VB	_	19	auxpass	_	_
19	guided	_	VERB	VBN	_	8	parataxis	_	_
20	by	_	ADP	IN	_	22	case	_	_
21	clinical	_	ADJ	JJ	_	22	amod	_	_
22	effect	_	NOUN	NN	_	19	nmod	_	_

#	PAROXETINE	3529
1	When	_	ADV	WRB	_	11	advmod	_	_
2	a	_	DET	DT	_	7	det	_	_
3	single	_	ADJ	JJ	_	7	amod	_	_
4	oral	_	ADJ	JJ	_	7	amod	_	_
5	30	_	NUM	CD	_	7	nummod	_	_
6	mg	_	NOUN	NN	_	7	compound	_	_
7	dose	_	NOUN	NN	_	11	nsubjpass	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	was	_	VERB	VBD	_	11	auxpass	_	_
11	administered	_	VERB	VBN	_	27	advcl	_	_
12	at	_	ADP	IN	_	15	case	_	_
13	phenytoin	_	NOUN	NN	_	15	compound	_	_
14	steady	_	ADJ	JJ	_	15	amod	_	_
15	state	_	NOUN	NN	_	11	nmod	_	_
16	300mg	_	ADJ	JJ	_	15	amod	_	_
17	once	_	ADV	RB	_	18	advmod	_	_
18	daily	_	ADV	RB	_	16	advmod	_	_
19	for	_	ADP	IN	_	20	case	_	_
20	14days	_	NOUN	NNS	_	18	nmod	_	_
21	,	_	.	,	_	27	punct	_	_
22	DRUG	_	NOUN	NN	_	23	compound	_	_
23	AUC	_	NOUN	NN	_	27	nsubjpass	_	_
24	and	_	CONJ	CC	_	23	cc	_	_
25	T%	_	NOUN	NN	_	23	conj	_	_
26	were	_	VERB	VBD	_	27	auxpass	_	_
27	reduced	_	VERB	VBN	_	0	root	_	_
28	by	_	ADP	IN	_	30	case	_	_
29	an	_	DET	DT	_	30	det	_	_
30	average	_	NOUN	NN	_	27	nmod	_	_
31	of	_	ADP	IN	_	32	case	_	_
32	50%	_	NOUN	NN	_	30	nmod	_	_
33	and	_	CONJ	CC	_	32	cc	_	_
34	35%	_	NOUN	NN	_	32	conj	_	_
35	,	_	.	,	_	27	punct	_	_
36	respectively	_	ADV	RB	_	37	advmod	_	_
37	compared	_	VERB	VBN	_	27	parataxis	_	_
38	to	_	PRT	TO	_	39	case	_	_
39	DRUG	_	NOUN	NN	_	37	nmod	_	_
40	administered	_	VERB	VBN	_	39	acl	_	_
41	alone	_	ADV	RB	_	40	advmod	_	_

#	PAROXETINE	3530
1	In	_	ADP	IN	_	4	case	_	_
2	a	_	DET	DT	_	4	det	_	_
3	separate	_	ADJ	JJ	_	4	amod	_	_
4	study	_	NOUN	NN	_	33	nmod	_	_
5	,	_	.	,	_	33	punct	_	_
6	when	_	ADV	WRB	_	16	advmod	_	_
7	a	_	DET	DT	_	12	det	_	_
8	single	_	ADJ	JJ	_	12	amod	_	_
9	oral	_	ADJ	JJ	_	12	amod	_	_
10	300	_	NUM	CD	_	12	nummod	_	_
11	mg	_	NOUN	NN	_	12	compound	_	_
12	dose	_	NOUN	NN	_	16	nsubjpass	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	phenytoin	_	NOUN	NN	_	12	nmod	_	_
15	was	_	VERB	VBD	_	16	auxpass	_	_
16	administered	_	VERB	VBN	_	33	advcl	_	_
17	at	_	ADP	IN	_	22	case	_	_
18	DRUG	_	NOUN	NN	_	22	compound	_	_
19	steady	_	ADJ	JJ	_	22	amod	_	_
20	state	_	NOUN	NN	_	22	compound	_	_
21	30	_	NUM	CD	_	22	nummod	_	_
22	mg	_	NOUN	NN	_	16	nmod	_	_
23	once	_	ADV	RB	_	24	advmod	_	_
24	daily	_	ADV	RB	_	16	advmod	_	_
25	for	_	ADP	IN	_	27	case	_	_
26	14	_	NUM	CD	_	27	nummod	_	_
27	days	_	NOUN	NNS	_	24	nmod	_	_
28	,	_	.	,	_	33	punct	_	_
29	phenytoin	_	NOUN	NN	_	30	compound	_	_
30	AUC	_	NOUN	NN	_	33	nsubjpass	_	_
31	was	_	VERB	VBD	_	33	auxpass	_	_
32	slightly	_	ADV	RB	_	33	advmod	_	_
33	reduced	_	VERB	VBN	_	0	root	_	_
34	12%	_	NOUN	NN	_	33	xcomp	_	_
35	on	_	ADP	IN	_	37	mark	_	_
36	average	_	NOUN	NN	_	37	amod	_	_
37	compared	_	VERB	VBN	_	33	advcl	_	_
38	to	_	PRT	TO	_	39	case	_	_
39	phenytoin	_	NOUN	NN	_	37	nmod	_	_
40	administered	_	VERB	VBN	_	39	acl	_	_
41	alone	_	ADV	RB	_	40	advmod	_	_

#	PAROXETINE	3531
1	Since	_	ADP	IN	_	4	mark	_	_
2	both	_	DET	DT	_	3	det	_	_
3	drugs	_	NOUN	NNS	_	4	nsubj	_	_
4	exhibit	_	VERB	VBP	_	13	advcl	_	_
5	nonlinear	_	ADJ	JJ	_	6	amod	_	_
6	pharmacokinetics	_	NOUN	NNS	_	4	dobj	_	_
7	,	_	.	,	_	13	punct	_	_
8	the	_	DET	DT	_	10	det	_	_
9	above	_	ADJ	JJ	_	10	amod	_	_
10	studies	_	NOUN	NNS	_	13	nsubj	_	_
11	may	_	VERB	MD	_	13	aux	_	_
12	not	_	ADV	RB	_	13	neg	_	_
13	address	_	VERB	VB	_	0	root	_	_
14	the	_	DET	DT	_	15	det	_	_
15	case	_	NOUN	NN	_	13	dobj	_	_
16	where	_	ADV	WRB	_	24	advmod	_	_
17	the	_	DET	DT	_	19	det	_	_
18	2	_	NUM	CD	_	19	nummod	_	_
19	drugs	_	NOUN	NNS	_	24	nsubjpass	_	_
20	are	_	VERB	VBP	_	24	auxpass	_	_
21	both	_	DET	DT	_	24	advmod	_	_
22	being	_	VERB	VBN	_	24	auxpass	_	_
23	chronically	_	ADV	RB	_	24	advmod	_	_
24	dosed	_	VERB	VBN	_	15	root	_	_

#	PAROXETINE	3532
1	No	_	DET	DT	_	4	neg	_	_
2	initial	_	ADJ	JJ	_	4	amod	_	_
3	dosage	_	NOUN	NN	_	4	compound	_	_
4	adjustments	_	NOUN	NNS	_	6	nsubjpass	_	_
5	are	_	VERB	VBP	_	6	auxpass	_	_
6	considered	_	VERB	VBN	_	0	root	_	_
7	necessary	_	ADJ	JJ	_	6	xcomp	_	_
8	when	_	ADV	WRB	_	12	advmod	_	_
9	these	_	DET	DT	_	10	det	_	_
10	drugs	_	NOUN	NNS	_	12	nsubjpass	_	_
11	are	_	VERB	VBP	_	12	auxpass	_	_
12	coadministered	_	VERB	VBN	_	6	root	_	_
13	any	_	DET	DT	_	15	det	_	_
14	subsequent	_	ADJ	JJ	_	15	amod	_	_
15	adjustments	_	NOUN	NNS	_	12	dobj	_	_
16	should	_	VERB	MD	_	18	aux	_	_
17	be	_	VERB	VB	_	18	auxpass	_	_
18	guided	_	VERB	VBN	_	12	parataxis	_	_
19	by	_	ADP	IN	_	21	case	_	_
20	clinical	_	ADJ	JJ	_	21	amod	_	_
21	effect	_	NOUN	NN	_	18	nmod	_	_

#	PAROXETINE	3533
1	Many	_	ADJ	JJ	_	2	amod	_	_
2	drugs	_	NOUN	NNS	_	24	nsubjpass	_	_
3	,	_	.	,	_	2	punct	_	_
4	including	_	VERB	VBG	_	6	case	_	_
5	most	_	ADJ	JJ	_	6	amod	_	_
6	drugs	_	NOUN	NNS	_	2	nmod	_	_
7	effective	_	ADJ	JJ	_	6	amod	_	_
8	in	_	ADP	IN	_	10	case	_	_
9	the	_	DET	DT	_	10	det	_	_
10	treatment	_	NOUN	NN	_	7	nmod	_	_
11	of	_	ADP	IN	_	15	case	_	_
12	major	_	ADJ	JJ	_	15	amod	_	_
13	depressive	_	ADJ	JJ	_	15	amod	_	_
14	disorder	_	NOUN	NN	_	15	compound	_	_
15	DRUG	_	NOUN	NN	_	10	nmod	_	_
16	,	_	.	,	_	15	punct	_	_
17	other	_	ADJ	JJ	_	18	amod	_	_
18	SSRIs	_	NOUN	NNS	_	15	conj	_	_
19	and	_	CONJ	CC	_	15	cc	_	_
20	many	_	ADJ	JJ	_	21	amod	_	_
21	tricyclics	_	NOUN	NNS	_	15	conj	_	_
22	,	_	.	,	_	2	punct	_	_
23	are	_	VERB	VBP	_	24	auxpass	_	_
24	metabolized	_	VERB	VBN	_	0	root	_	_
25	by	_	ADP	IN	_	29	case	_	_
26	the	_	DET	DT	_	29	det	_	_
27	cytochrome	_	NOUN	NN	_	29	compound	_	_
28	P450	_	NOUN	NN	_	29	compound	_	_
29	isozyme	_	NOUN	NN	_	24	nmod	_	_
30	CYP2D6	_	NOUN	NN	_	29	dep	_	_

#	PAROXETINE	3534
1	Like	_	ADP	IN	_	3	case	_	_
2	other	_	ADJ	JJ	_	3	amod	_	_
3	agents	_	NOUN	NNS	_	13	nmod	_	_
4	that	_	DET	WDT	_	6	nsubjpass	_	_
5	are	_	VERB	VBP	_	6	auxpass	_	_
6	metabolized	_	VERB	VBN	_	3	acl:relcl	_	_
7	by	_	ADP	IN	_	8	case	_	_
8	CYP2D6	_	NOUN	NN	_	6	nmod	_	_
9	,	_	.	,	_	13	punct	_	_
10	DRUG	_	NOUN	NN	_	13	nsubj	_	_
11	may	_	VERB	MD	_	13	aux	_	_
12	significantly	_	ADV	RB	_	13	advmod	_	_
13	inhibit	_	VERB	VB	_	0	root	_	_
14	the	_	DET	DT	_	15	det	_	_
15	activity	_	NOUN	NN	_	13	dobj	_	_
16	of	_	ADP	IN	_	18	case	_	_
17	this	_	DET	DT	_	18	det	_	_
18	isozyme	_	NOUN	NN	_	15	nmod	_	_

#	PAROXETINE	3535
1	In	_	ADP	IN	_	3	case	_	_
2	most	_	ADJ	JJ	_	3	amod	_	_
3	patients	_	NOUN	NNS	_	10	nmod	_	_
4	>90%	_	NOUN	NN	_	3	dep	_	_
5	,	_	.	,	_	10	punct	_	_
6	this	_	DET	DT	_	8	det	_	_
7	CYP2D6	_	NOUN	NN	_	8	compound	_	_
8	isozyme	_	NOUN	NN	_	10	nsubjpass	_	_
9	is	_	VERB	VBZ	_	10	auxpass	_	_
10	saturated	_	VERB	VBN	_	0	root	_	_
11	early	_	ADJ	JJ	_	10	xcomp	_	_
12	during	_	ADP	IN	_	13	mark	_	_
13	dosing	_	VERB	VBG	_	10	advcl	_	_
14	with	_	ADP	IN	_	15	case	_	_
15	DRUG	_	NOUN	NN	_	13	nmod	_	_

#	PAROXETINE	3536
1	In	_	ADP	IN	_	3	case	_	_
2	1	_	NUM	CD	_	3	nummod	_	_
3	study	_	NOUN	NN	_	17	nmod	_	_
4	,	_	.	,	_	17	punct	_	_
5	daily	_	ADV	RB	_	6	advmod	_	_
6	dosing	_	NOUN	NN	_	17	nsubj	_	_
7	of	_	ADP	IN	_	10	case	_	_
8	DRUG	_	NOUN	NN	_	10	compound	_	_
9	20	_	NUM	CD	_	10	nummod	_	_
10	mg	_	NOUN	NN	_	6	nmod	_	_
11	once	_	ADV	RB	_	12	advmod	_	_
12	daily	_	ADV	RB	_	17	advmod	_	_
13	under	_	ADP	IN	_	16	case	_	_
14	steady	_	ADJ	JJ	_	16	amod	_	_
15	state	_	NOUN	NN	_	16	compound	_	_
16	conditions	_	NOUN	NNS	_	12	nmod	_	_
17	increased	_	VERB	VBD	_	0	root	_	_
18	single	_	ADJ	JJ	_	23	amod	_	_
19	dose	_	NOUN	NN	_	23	compound	_	_
20	desipramine	_	NOUN	NN	_	23	compound	_	_
21	100	_	NUM	CD	_	23	nummod	_	_
22	mg	_	NOUN	NN	_	23	compound	_	_
23	Cmax	_	NOUN	NN	_	17	dobj	_	_
24	,	_	.	,	_	23	punct	_	_
25	AUC	_	NOUN	NN	_	23	conj	_	_
26	,	_	.	,	_	23	punct	_	_
27	and	_	CONJ	CC	_	23	cc	_	_
28	T%	_	NOUN	NN	_	23	conj	_	_
29	by	_	ADP	IN	_	31	case	_	_
30	an	_	DET	DT	_	31	det	_	_
31	average	_	NOUN	NN	_	17	nmod	_	_
32	of	_	ADP	IN	_	34	case	_	_
33	approximately	_	ADV	RB	_	34	advmod	_	_
34	2	_	NUM	CD	_	31	nmod	_	_
35	,	_	.	,	_	34	punct	_	_
36	5	_	NUM	CD	_	34	conj	_	_
37	,	_	.	,	_	34	punct	_	_
38	and	_	CONJ	CC	_	34	cc	_	_
39	3	_	NUM	CD	_	34	conj	_	_
40	fold	_	NOUN	NN	_	34	dep	_	_
41	,	_	.	,	_	17	punct	_	_
42	respectively	_	ADV	RB	_	17	advmod	_	_

#	PAROXETINE	3537
1	Concomitant	_	ADJ	JJ	_	2	amod	_	_
2	use	_	NOUN	NN	_	0	root	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	with	_	ADP	IN	_	6	case	_	_
6	risperidone	_	NOUN	NN	_	2	nmod	_	_
7	,	_	.	,	_	2	punct	_	_
8	a	_	DET	DT	_	10	det	_	_
9	CYP2D6	_	NOUN	NN	_	10	compound	_	_
10	substrate	_	NOUN	NN	_	14	nsubjpass	_	_
11	has	_	VERB	VBZ	_	14	aux	_	_
12	also	_	ADV	RB	_	14	advmod	_	_
13	been	_	VERB	VBN	_	14	auxpass	_	_
14	evaluated	_	VERB	VBN	_	2	dep	_	_

#	PAROXETINE	3538
1	In	_	ADP	IN	_	3	case	_	_
2	1	_	NUM	CD	_	3	nummod	_	_
3	study	_	NOUN	NN	_	32	nmod	_	_
4	,	_	.	,	_	32	punct	_	_
5	daily	_	ADV	RB	_	6	advmod	_	_
6	dosing	_	NOUN	NN	_	32	nsubj	_	_
7	of	_	ADP	IN	_	10	case	_	_
8	DRUG	_	NOUN	NN	_	10	compound	_	_
9	20	_	NUM	CD	_	10	nummod	_	_
10	mg	_	NOUN	NN	_	6	nmod	_	_
11	in	_	ADP	IN	_	12	case	_	_
12	patients	_	NOUN	NNS	_	6	nmod	_	_
13	stabilized	_	VERB	VBN	_	12	acl	_	_
14	on	_	ADP	IN	_	15	case	_	_
15	risperidone	_	NOUN	NN	_	13	nmod	_	_
16	4	_	NUM	CD	_	15	nummod	_	_
17	to	_	PRT	TO	_	19	case	_	_
18	8	_	NUM	CD	_	19	nummod	_	_
19	mg	_	NOUN	NN	_	13	nmod	_	_
20	/	_	.	:	_	6	punct	_	_
21	day	_	NOUN	NN	_	22	nsubj	_	_
22	increased	_	VERB	VBD	_	6	dep	_	_
23	mean	_	ADJ	JJ	_	25	amod	_	_
24	plasma	_	NOUN	NN	_	25	compound	_	_
25	concentrations	_	NOUN	NNS	_	22	dobj	_	_
26	of	_	ADP	IN	_	27	case	_	_
27	risperidone	_	NOUN	NN	_	25	nmod	_	_
28	approximately	_	ADV	RB	_	30	advmod	_	_
29	4	_	NUM	CD	_	30	nummod	_	_
30	fold	_	NOUN	NN	_	22	advmod	_	_
31	,	_	.	,	_	6	punct	_	_
32	decreased	_	VERB	VBD	_	0	root	_	_
33	9	_	NUM	CD	_	35	nummod	_	_
34	hydroxyrisperidone	_	NOUN	NN	_	35	compound	_	_
35	concentrations	_	NOUN	NNS	_	32	dobj	_	_
36	approximately	_	ADV	RB	_	37	advmod	_	_
37	10%	_	ADJ	JJ	_	32	xcomp	_	_
38	,	_	.	,	_	32	punct	_	_
39	and	_	CONJ	CC	_	32	cc	_	_
40	increased	_	VERB	VBN	_	41	amod	_	_
41	concentrations	_	NOUN	NNS	_	32	conj	_	_
42	of	_	ADP	IN	_	45	case	_	_
43	the	_	DET	DT	_	45	det	_	_
44	active	_	ADJ	JJ	_	45	amod	_	_
45	moiety	_	NOUN	NN	_	41	nmod	_	_
46	the	_	DET	DT	_	47	det	_	_
47	sum	_	NOUN	NN	_	41	dep	_	_
48	of	_	ADP	IN	_	49	case	_	_
49	risperidone	_	NOUN	NN	_	47	nmod	_	_
50	plus	_	CONJ	CC	_	49	cc	_	_
51	9	_	NUM	CD	_	52	nummod	_	_
52	hydroxyrisperidone	_	NOUN	NN	_	49	conj	_	_
53	approximately	_	ADV	RB	_	54	advmod	_	_
54	1.4	_	NUM	CD	_	47	nmod	_	_
55	fold	_	VERB	VBD	_	54	dep	_	_

#	PAROXETINE	3539
1	The	_	DET	DT	_	2	det	_	_
2	effect	_	NOUN	NN	_	12	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	on	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	pharmacokinetics	_	NOUN	NNS	_	2	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	atomoxetine	_	NOUN	NN	_	7	nmod	_	_
10	has	_	VERB	VBZ	_	12	aux	_	_
11	been	_	VERB	VBN	_	12	auxpass	_	_
12	evaluated	_	VERB	VBN	_	0	root	_	_
13	when	_	ADV	WRB	_	19	advmod	_	_
14	both	_	DET	DT	_	15	det	_	_
15	drugs	_	NOUN	NNS	_	19	nsubj	_	_
16	were	_	VERB	VBD	_	19	cop	_	_
17	at	_	ADP	IN	_	19	case	_	_
18	steady	_	ADJ	JJ	_	19	amod	_	_
19	state	_	NOUN	NN	_	12	ccomp	_	_

#	PAROXETINE	3540
1	In	_	ADP	IN	_	3	case	_	_
2	healthy	_	ADJ	JJ	_	3	amod	_	_
3	volunteers	_	NOUN	NNS	_	16	nmod	_	_
4	who	_	DET	WDT	_	7	nsubj	_	_
5	were	_	VERB	VBD	_	7	cop	_	_
6	extensive	_	ADJ	JJ	_	7	amod	_	_
7	metabolizers	_	NOUN	NNS	_	3	acl:relcl	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	CYP2D6	_	NOUN	NN	_	7	nmod	_	_
10	,	_	.	,	_	16	punct	_	_
11	DRUG	_	NOUN	NN	_	13	compound	_	_
12	20	_	NUM	CD	_	13	nummod	_	_
13	mg	_	NOUN	NN	_	16	nsubjpass	_	_
14	daily	_	ADV	RB	_	16	advmod	_	_
15	was	_	VERB	VBD	_	16	auxpass	_	_
16	given	_	VERB	VBN	_	0	root	_	_
17	in	_	ADP	IN	_	18	case	_	_
18	combination	_	NOUN	NN	_	16	nmod	_	_
19	with	_	ADP	IN	_	25	case	_	_
20	20	_	NUM	CD	_	25	nummod	_	_
21	mg	_	NOUN	NN	_	25	compound	_	_
22	atomoxetine	_	NOUN	NN	_	25	compound	_	_
23	every	_	ADV	RB	_	24	advmod	_	_
24	12	_	NUM	CD	_	25	nummod	_	_
25	hours	_	NOUN	NNS	_	18	nmod	_	_

#	PAROXETINE	3541
1	This	_	DET	DT	_	2	nsubj	_	_
2	resulted	_	VERB	VBD	_	0	root	_	_
3	in	_	ADP	IN	_	4	case	_	_
4	increases	_	NOUN	NNS	_	2	nmod	_	_
5	in	_	ADP	IN	_	10	case	_	_
6	steady	_	ADJ	JJ	_	10	amod	_	_
7	state	_	NOUN	NN	_	10	compound	_	_
8	atomoxetine	_	NOUN	NN	_	10	compound	_	_
9	AUC	_	NOUN	NN	_	10	compound	_	_
10	values	_	NOUN	NNS	_	4	nmod	_	_
11	that	_	DET	WDT	_	17	nsubj	_	_
12	were	_	VERB	VBD	_	17	cop	_	_
13	6	_	NUM	CD	_	15	compound	_	_
14	to	_	PRT	TO	_	15	dep	_	_
15	8	_	NUM	CD	_	16	nummod	_	_
16	fold	_	NOUN	NN	_	17	nmod:npmod	_	_
17	greater	_	ADJ	JJ	_	10	nmod	_	_
18	and	_	CONJ	CC	_	17	cc	_	_
19	in	_	ADP	IN	_	22	case	_	_
20	atomoxetine	_	NOUN	NN	_	22	compound	_	_
21	Cmax	_	NOUN	NN	_	22	compound	_	_
22	values	_	NOUN	NNS	_	17	conj	_	_
23	that	_	DET	WDT	_	28	nsubj	_	_
24	were	_	VERB	VBD	_	28	cop	_	_
25	3	_	NUM	CD	_	27	compound	_	_
26	to	_	PRT	TO	_	27	dep	_	_
27	4	_	NUM	CD	_	28	nummod	_	_
28	fold	_	NOUN	NN	_	34	nsubjpass	_	_
29	greater	_	ADJ	JJ	_	28	amod	_	_
30	than	_	ADP	IN	_	32	case	_	_
31	when	_	ADV	WRB	_	30	mwe	_	_
32	atomoxetine	_	NOUN	NN	_	29	nmod	_	_
33	was	_	VERB	VBD	_	34	auxpass	_	_
34	given	_	VERB	VBN	_	22	acl:relcl	_	_
35	alone	_	ADV	RB	_	34	advmod	_	_

#	PAROXETINE	3542
1	Dosage	_	NOUN	NN	_	2	compound	_	_
2	adjustment	_	NOUN	NN	_	7	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	atomoxetine	_	NOUN	NN	_	2	nmod	_	_
5	may	_	VERB	MD	_	7	aux	_	_
6	be	_	VERB	VB	_	7	cop	_	_
7	necessary	_	ADJ	JJ	_	0	root	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	it	_	PRON	PRP	_	11	nsubjpass	_	_
10	is	_	VERB	VBZ	_	11	auxpass	_	_
11	recommended	_	VERB	VBN	_	7	conj	_	_
12	that	_	ADP	IN	_	15	mark	_	_
13	atomoxetine	_	NOUN	NN	_	15	nsubjpass	_	_
14	be	_	VERB	VBZ	_	15	auxpass	_	_
15	initiated	_	VERB	VBN	_	11	ccomp	_	_
16	at	_	ADP	IN	_	19	case	_	_
17	a	_	DET	DT	_	19	det	_	_
18	reduced	_	VERB	VBN	_	19	amod	_	_
19	dose	_	NOUN	NN	_	15	nmod	_	_
20	when	_	ADV	WRB	_	23	advmod	_	_
21	it	_	PRON	PRP	_	23	nsubjpass	_	_
22	is	_	VERB	VBZ	_	23	auxpass	_	_
23	given	_	VERB	VBN	_	15	advcl	_	_
24	with	_	ADP	IN	_	25	case	_	_
25	DRUG	_	NOUN	NN	_	23	nmod	_	_

#	PAROXETINE	3543
1	Concomitant	_	ADJ	JJ	_	2	amod	_	_
2	use	_	NOUN	NN	_	16	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	with	_	ADP	IN	_	7	case	_	_
6	other	_	ADJ	JJ	_	7	amod	_	_
7	drugs	_	NOUN	NNS	_	2	nmod	_	_
8	metabolized	_	VERB	VBN	_	7	acl	_	_
9	by	_	ADP	IN	_	11	case	_	_
10	cytochrome	_	NOUN	NN	_	11	compound	_	_
11	CYP2D6	_	NOUN	NN	_	8	nmod	_	_
12	has	_	VERB	VBZ	_	16	aux	_	_
13	not	_	ADV	RB	_	16	neg	_	_
14	been	_	VERB	VBN	_	16	auxpass	_	_
15	formally	_	ADV	RB	_	16	advmod	_	_
16	studied	_	VERB	VBN	_	0	root	_	_
17	but	_	CONJ	CC	_	16	cc	_	_
18	may	_	VERB	MD	_	19	aux	_	_
19	require	_	VERB	VB	_	16	conj	_	_
20	lower	_	ADJ	JJ	_	21	amod	_	_
21	doses	_	NOUN	NNS	_	19	dobj	_	_
22	than	_	ADP	IN	_	24	mark	_	_
23	usually	_	ADV	RB	_	24	advmod	_	_
24	prescribed	_	VERB	VBN	_	19	advcl	_	_
25	for	_	ADP	IN	_	27	case	_	_
26	either	_	CONJ	CC	_	27	cc:preconj	_	_
27	DRUG	_	NOUN	NN	_	24	nmod	_	_
28	or	_	CONJ	CC	_	27	cc	_	_
29	the	_	DET	DT	_	31	det	_	_
30	other	_	ADJ	JJ	_	31	amod	_	_
31	drug	_	NOUN	NN	_	27	conj	_	_

#	PAROXETINE	3544
1	Therefore	_	ADV	RB	_	0	root	_	_
2	,	_	.	,	_	1	punct	_	_
3	coadministration	_	NOUN	NN	_	2	root	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	with	_	ADP	IN	_	8	case	_	_
7	other	_	ADJ	JJ	_	8	amod	_	_
8	drugs	_	NOUN	NNS	_	3	nmod	_	_
9	that	_	DET	WDT	_	11	nsubjpass	_	_
10	are	_	VERB	VBP	_	11	auxpass	_	_
11	metabolized	_	VERB	VBN	_	8	acl:relcl	_	_
12	by	_	ADP	IN	_	14	case	_	_
13	this	_	DET	DT	_	14	det	_	_
14	isozyme	_	NOUN	NN	_	11	nmod	_	_
15	,	_	.	,	_	14	punct	_	_
16	including	_	VERB	VBG	_	18	case	_	_
17	certain	_	ADJ	JJ	_	18	amod	_	_
18	drugs	_	NOUN	NNS	_	14	nmod	_	_
19	effective	_	ADJ	JJ	_	18	amod	_	_
20	in	_	ADP	IN	_	22	case	_	_
21	the	_	DET	DT	_	22	det	_	_
22	treatment	_	NOUN	NN	_	19	nmod	_	_
23	of	_	ADP	IN	_	27	case	_	_
24	major	_	ADJ	JJ	_	27	amod	_	_
25	depressive	_	ADJ	JJ	_	27	amod	_	_
26	disorder	_	NOUN	NN	_	27	compound	_	_
27	e.g	_	NOUN	NN	_	22	nmod	_	_
28	,	_	.	,	_	27	punct	_	_
29	nortriptyline	_	NOUN	NN	_	27	conj	_	_
30	,	_	.	,	_	27	punct	_	_
31	amitriptyline	_	NOUN	NN	_	27	conj	_	_
32	,	_	.	,	_	27	punct	_	_
33	imipramine	_	NOUN	NN	_	27	conj	_	_
34	,	_	.	,	_	27	punct	_	_
35	desipramine	_	NOUN	NN	_	27	conj	_	_
36	,	_	.	,	_	27	punct	_	_
37	and	_	CONJ	CC	_	27	cc	_	_
38	fluoxetine	_	NOUN	NN	_	27	conj	_	_
39	,	_	.	,	_	27	punct	_	_
40	phenothiazines	_	NOUN	NNS	_	27	conj	_	_
41	,	_	.	,	_	27	punct	_	_
42	risperidone,and	_	ADJ	JJ	_	45	amod	_	_
43	Type	_	NOUN	NN	_	45	compound	_	_
44	1C	_	NOUN	NN	_	45	compound	_	_
45	antiarrhythmics	_	NOUN	NNS	_	27	conj	_	_
46	e.g	_	NOUN	NN	_	45	dep	_	_
47	,	_	.	,	_	46	punct	_	_
48	propafenone	_	NOUN	NN	_	46	conj	_	_
49	,	_	.	,	_	46	punct	_	_
50	flecainide	_	NOUN	NN	_	46	conj	_	_
51	,	_	.	,	_	46	punct	_	_
52	and	_	CONJ	CC	_	46	cc	_	_
53	encainide	_	NOUN	NN	_	46	conj	_	_
54	,	_	.	,	_	27	punct	_	_
55	or	_	CONJ	CC	_	11	cc	_	_
56	that	_	DET	WDT	_	57	nsubj	_	_
57	inhibit	_	VERB	VBP	_	11	conj	_	_
58	this	_	DET	DT	_	60	det	_	_
59	enzyme	_	NOUN	NN	_	60	compound	_	_
60	e.g	_	NOUN	NN	_	57	dobj	_	_
61	,	_	.	,	_	60	punct	_	_
62	quinidine	_	NOUN	NN	_	60	appos	_	_
63	,	_	.	,	_	57	punct	_	_
64	should	_	VERB	MD	_	66	aux	_	_
65	be	_	VERB	VB	_	66	auxpass	_	_
66	approached	_	VERB	VBN	_	57	parataxis	_	_
67	with	_	ADP	IN	_	68	case	_	_
68	caution	_	NOUN	NN	_	66	nmod	_	_

#	PAROXETINE	3545
1	However	_	ADV	RB	_	29	advmod	_	_
2	,	_	.	,	_	29	punct	_	_
3	due	_	ADJ	JJ	_	6	case	_	_
4	to	_	PRT	TO	_	3	mwe	_	_
5	the	_	DET	DT	_	6	det	_	_
6	risk	_	NOUN	NN	_	29	nmod	_	_
7	of	_	ADP	IN	_	10	case	_	_
8	serious	_	ADJ	JJ	_	10	amod	_	_
9	ventricular	_	ADJ	JJ	_	10	amod	_	_
10	arrhythmias	_	NOUN	NNS	_	6	nmod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	sudden	_	NOUN	NN	_	13	compound	_	_
13	death	_	NOUN	NN	_	10	conj	_	_
14	potentially	_	ADV	RB	_	15	advmod	_	_
15	associated	_	VERB	VBN	_	10	acl	_	_
16	with	_	ADP	IN	_	19	case	_	_
17	elevated	_	ADJ	JJ	_	19	amod	_	_
18	plasma	_	NOUN	NN	_	19	compound	_	_
19	levels	_	NOUN	NNS	_	15	nmod	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	thioridazine	_	NOUN	NN	_	19	nmod	_	_
22	,	_	.	,	_	29	punct	_	_
23	DRUG	_	NOUN	NN	_	29	nsubjpass	_	_
24	and	_	CONJ	CC	_	23	cc	_	_
25	thioridazine	_	NOUN	NN	_	23	conj	_	_
26	should	_	VERB	MD	_	29	aux	_	_
27	not	_	ADV	RB	_	29	neg	_	_
28	be	_	VERB	VB	_	29	auxpass	_	_
29	coadministered	_	VERB	VBN	_	0	root	_	_

#	PAROXETINE	3546
1	Tamoxifen	_	NOUN	NN	_	5	nsubj	_	_
2	is	_	VERB	VBZ	_	5	cop	_	_
3	a	_	DET	DT	_	5	det	_	_
4	pro	_	NOUN	NN	_	5	compound	_	_
5	drug	_	NOUN	NN	_	0	root	_	_
6	requiring	_	VERB	VBG	_	5	acl	_	_
7	metabolic	_	ADJ	JJ	_	8	amod	_	_
8	activation	_	NOUN	NN	_	6	dobj	_	_
9	by	_	ADP	IN	_	10	case	_	_
10	CYP2D6	_	NOUN	NN	_	8	nmod	_	_

#	PAROXETINE	3547
1	Inhibition	_	NOUN	NN	_	7	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	CYP2D6	_	NOUN	NN	_	1	nmod	_	_
4	by	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	1	nmod	_	_
6	may	_	VERB	MD	_	7	aux	_	_
7	lead	_	VERB	VB	_	0	root	_	_
8	to	_	PRT	TO	_	11	case	_	_
9	reduced	_	VERB	VBN	_	11	amod	_	_
10	plasma	_	NOUN	NN	_	11	compound	_	_
11	concentrations	_	NOUN	NNS	_	7	nmod	_	_
12	of	_	ADP	IN	_	16	case	_	_
13	an	_	DET	DT	_	16	det	_	_
14	active	_	ADJ	JJ	_	16	amod	_	_
15	metabolite	_	NOUN	NN	_	16	compound	_	_
16	endoxifen	_	NOUN	NN	_	11	nmod	_	_
17	and	_	CONJ	CC	_	7	cc	_	_
18	hence	_	ADV	RB	_	19	advmod	_	_
19	reduced	_	VERB	VBN	_	20	amod	_	_
20	efficacy	_	NOUN	NN	_	7	conj	_	_
21	of	_	ADP	IN	_	22	case	_	_
22	tamoxifen	_	NOUN	NN	_	20	nmod	_	_

#	PAROXETINE	3548
1	At	_	ADP	IN	_	3	case	_	_
2	steady	_	ADJ	JJ	_	3	amod	_	_
3	state	_	NOUN	NN	_	16	nmod	_	_
4	,	_	.	,	_	16	punct	_	_
5	when	_	ADV	WRB	_	11	advmod	_	_
6	the	_	DET	DT	_	8	det	_	_
7	CYP2D6	_	NOUN	NN	_	8	compound	_	_
8	pathway	_	NOUN	NN	_	11	nsubjpass	_	_
9	is	_	VERB	VBZ	_	11	auxpass	_	_
10	essentially	_	ADV	RB	_	11	advmod	_	_
11	saturated	_	VERB	VBN	_	16	advcl	_	_
12	,	_	.	,	_	16	punct	_	_
13	DRUG	_	NOUN	NN	_	14	compound	_	_
14	clearance	_	NOUN	NN	_	16	nsubjpass	_	_
15	is	_	VERB	VBZ	_	16	auxpass	_	_
16	governed	_	VERB	VBN	_	0	root	_	_
17	by	_	ADP	IN	_	20	case	_	_
18	alternative	_	ADJ	JJ	_	20	amod	_	_
19	P450	_	NOUN	NN	_	20	compound	_	_
20	isozymes	_	NOUN	NNS	_	16	nmod	_	_
21	that	_	DET	WDT	_	26	nsubj	_	_
22	,	_	.	,	_	26	punct	_	_
23	unlike	_	ADP	IN	_	24	case	_	_
24	CYP2D6	_	NOUN	NN	_	26	nmod	_	_
25	,	_	.	,	_	26	punct	_	_
26	show	_	VERB	VBP	_	20	acl:relcl	_	_
27	no	_	DET	DT	_	28	neg	_	_
28	evidence	_	NOUN	NN	_	26	dobj	_	_
29	of	_	ADP	IN	_	30	case	_	_
30	saturation	_	NOUN	NN	_	28	nmod	_	_

#	PAROXETINE	3549
1	An	_	DET	DT	_	5	det	_	_
2	in	_	ADJ	JJ	_	5	amod	_	_
3	vivo	_	X	FW	_	2	dep	_	_
4	interaction	_	NOUN	NN	_	5	compound	_	_
5	study	_	NOUN	NN	_	24	nsubj	_	_
6	involving	_	VERB	VBG	_	5	acl	_	_
7	the	_	DET	DT	_	8	det	_	_
8	coadministration	_	NOUN	NN	_	6	dobj	_	_
9	under	_	ADP	IN	_	12	case	_	_
10	steady	_	ADJ	JJ	_	12	amod	_	_
11	state	_	NOUN	NN	_	12	compound	_	_
12	conditions	_	NOUN	NNS	_	6	nmod	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	DRUG	_	NOUN	NN	_	12	nmod	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	terfenadine	_	NOUN	NN	_	14	conj	_	_
17	,	_	.	,	_	14	punct	_	_
18	a	_	DET	DT	_	19	det	_	_
19	substrate	_	NOUN	NN	_	14	appos	_	_
20	for	_	ADP	IN	_	22	case	_	_
21	cytochrome	_	NOUN	NN	_	22	compound	_	_
22	CYP3A4	_	NOUN	NN	_	19	nmod	_	_
23	,	_	.	,	_	5	punct	_	_
24	revealed	_	VERB	VBD	_	0	root	_	_
25	no	_	DET	DT	_	26	neg	_	_
26	effect	_	NOUN	NN	_	24	dobj	_	_
27	of	_	ADP	IN	_	28	case	_	_
28	DRUG	_	NOUN	NN	_	26	nmod	_	_
29	on	_	ADP	IN	_	31	case	_	_
30	terfenadine	_	NOUN	NN	_	31	compound	_	_
31	pharmacokinetics	_	NOUN	NNS	_	26	nmod	_	_

#	PAROXETINE	3550
1	In	_	ADP	IN	_	2	case	_	_
2	addition	_	NOUN	NN	_	8	nmod	_	_
3	,	_	.	,	_	8	punct	_	_
4	in	_	X	FW	_	6	amod	_	_
5	vitro	_	X	FW	_	4	dep	_	_
6	studies	_	NOUN	NNS	_	8	nsubj	_	_
7	have	_	VERB	VBP	_	8	aux	_	_
8	shown	_	VERB	VBN	_	0	root	_	_
9	ketoconazole	_	NOUN	NN	_	8	dobj	_	_
10	,	_	.	,	_	9	punct	_	_
11	a	_	DET	DT	_	13	det	_	_
12	potent	_	ADJ	JJ	_	13	amod	_	_
13	inhibitor	_	NOUN	NN	_	9	appos	_	_
14	of	_	ADP	IN	_	16	case	_	_
15	CYP3A4	_	NOUN	NN	_	16	compound	_	_
16	activity	_	NOUN	NN	_	13	nmod	_	_
17	,	_	.	,	_	9	punct	_	_
18	to	_	PRT	TO	_	23	mark	_	_
19	be	_	VERB	VB	_	23	cop	_	_
20	at	_	ADP	IN	_	21	case	_	_
21	least	_	ADJ	JJS	_	22	nmod:npmod	_	_
22	100	_	NUM	CD	_	23	nummod	_	_
23	times	_	NOUN	NNS	_	8	nmod	_	_
24	more	_	ADV	RB	_	25	advmod	_	_
25	potent	_	ADJ	JJ	_	23	amod	_	_
26	than	_	ADP	IN	_	27	case	_	_
27	DRUG	_	NOUN	NN	_	25	nmod	_	_
28	as	_	ADP	IN	_	30	case	_	_
29	an	_	DET	DT	_	30	det	_	_
30	inhibitor	_	NOUN	NN	_	25	nmod	_	_
31	of	_	ADP	IN	_	33	case	_	_
32	the	_	DET	DT	_	33	det	_	_
33	metabolism	_	NOUN	NN	_	30	nmod	_	_
34	of	_	ADP	IN	_	36	case	_	_
35	several	_	ADJ	JJ	_	36	amod	_	_
36	substrates	_	NOUN	NNS	_	33	nmod	_	_
37	for	_	ADP	IN	_	39	case	_	_
38	this	_	DET	DT	_	39	det	_	_
39	enzyme	_	NOUN	NN	_	33	nmod	_	_
40	,	_	.	,	_	39	punct	_	_
41	including	_	VERB	VBG	_	42	case	_	_
42	terfenadine	_	NOUN	NN	_	39	nmod	_	_
43	,	_	.	,	_	42	punct	_	_
44	astemizole	_	NOUN	NN	_	42	conj	_	_
45	,	_	.	,	_	42	punct	_	_
46	cisapride	_	NOUN	NN	_	42	conj	_	_
47	,	_	.	,	_	42	punct	_	_
48	triazolam	_	NOUN	NN	_	42	conj	_	_
49	,	_	.	,	_	42	punct	_	_
50	and	_	CONJ	CC	_	42	cc	_	_
51	cyclosporine	_	NOUN	NN	_	42	conj	_	_

#	PAROXETINE	3551
1	Based	_	VERB	VBN	_	4	case	_	_
2	on	_	ADP	IN	_	4	case	_	_
3	the	_	DET	DT	_	4	det	_	_
4	assumption	_	NOUN	NN	_	42	nmod	_	_
5	that	_	ADP	IN	_	24	mark	_	_
6	the	_	DET	DT	_	7	det	_	_
7	relationship	_	NOUN	NN	_	24	nsubj	_	_
8	between	_	ADP	IN	_	13	case	_	_
9	DRUG	_	NOUN	NN	_	13	nmod:poss	_	_
10	's	_	PRT	POS	_	13	case	_	_
11	in	_	X	FW	_	13	amod	_	_
12	vitro	_	X	FW	_	11	dep	_	_
13	Ki	_	NOUN	NN	_	7	nmod	_	_
14	and	_	CONJ	CC	_	7	cc	_	_
15	its	_	PRON	PRP$	_	16	nmod:poss	_	_
16	lack	_	NOUN	NN	_	7	conj	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	effect	_	NOUN	NN	_	16	nmod	_	_
19	on	_	ADP	IN	_	20	case	_	_
20	terfenadine's	_	NOUN	NNS	_	16	nmod	_	_
21	in	_	X	FW	_	23	amod	_	_
22	vivo	_	X	FW	_	21	dep	_	_
23	clearance	_	NOUN	NN	_	20	dep	_	_
24	predicts	_	VERB	VBZ	_	4	ccomp	_	_
25	its	_	PRON	PRP$	_	26	nmod:poss	_	_
26	effect	_	NOUN	NN	_	24	dobj	_	_
27	on	_	ADP	IN	_	30	case	_	_
28	other	_	ADJ	JJ	_	30	amod	_	_
29	CYP3A4	_	NOUN	NN	_	30	compound	_	_
30	substrates	_	NOUN	NNS	_	26	nmod	_	_
31	,	_	.	,	_	42	punct	_	_
32	DRUG	_	NOUN	NN	_	34	nmod:poss	_	_
33	's	_	PRT	POS	_	34	case	_	_
34	extent	_	NOUN	NN	_	42	nsubj	_	_
35	of	_	ADP	IN	_	36	case	_	_
36	inhibition	_	NOUN	NN	_	34	nmod	_	_
37	of	_	ADP	IN	_	39	case	_	_
38	CYP3A4	_	NOUN	NN	_	39	compound	_	_
39	activity	_	NOUN	NN	_	36	nmod	_	_
40	is	_	VERB	VBZ	_	42	cop	_	_
41	not	_	ADV	RB	_	42	neg	_	_
42	likely	_	ADJ	JJ	_	0	root	_	_
43	to	_	PRT	TO	_	47	mark	_	_
44	be	_	VERB	VB	_	47	cop	_	_
45	of	_	ADP	IN	_	47	case	_	_
46	clinical	_	ADJ	JJ	_	47	amod	_	_
47	significance	_	NOUN	NN	_	42	ccomp	_	_

#	PAROXETINE	3552
1	Caution	_	NOUN	NN	_	3	nsubjpass	_	_
2	is	_	VERB	VBZ	_	3	auxpass	_	_
3	indicated	_	VERB	VBN	_	0	root	_	_
4	in	_	ADP	IN	_	6	case	_	_
5	the	_	DET	DT	_	6	det	_	_
6	coadministration	_	NOUN	NN	_	3	nmod	_	_
7	of	_	ADP	IN	_	10	case	_	_
8	tricyclic	_	ADJ	JJ	_	10	amod	_	_
9	antidepressants	_	NOUN	NNS	_	10	compound	_	_
10	TCAs	_	NOUN	NNS	_	6	nmod	_	_
11	with	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	6	nmod	_	_
13	,	_	.	,	_	3	punct	_	_
14	because	_	ADP	IN	_	3	dep	_	_
15	DRUG	_	NOUN	NN	_	17	nsubj	_	_
16	may	_	VERB	MD	_	17	aux	_	_
17	inhibit	_	VERB	VB	_	3	parataxis	_	_
18	TCA	_	NOUN	NN	_	19	compound	_	_
19	metabolism	_	NOUN	NN	_	17	dobj	_	_

#	PAROXETINE	3553
1	Plasma	_	NOUN	NN	_	3	compound	_	_
2	TCA	_	NOUN	NN	_	3	compound	_	_
3	concentrations	_	NOUN	NNS	_	5	nsubj	_	_
4	may	_	VERB	MD	_	5	aux	_	_
5	need	_	VERB	VB	_	0	root	_	_
6	to	_	PRT	TO	_	8	mark	_	_
7	be	_	VERB	VB	_	8	auxpass	_	_
8	monitored	_	VERB	VBN	_	5	xcomp	_	_
9	,	_	.	,	_	5	punct	_	_
10	and	_	CONJ	CC	_	5	cc	_	_
11	the	_	DET	DT	_	12	det	_	_
12	dose	_	NOUN	NN	_	16	nsubj	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	TCA	_	NOUN	NN	_	12	nmod	_	_
15	may	_	VERB	MD	_	16	aux	_	_
16	need	_	VERB	VB	_	5	conj	_	_
17	to	_	PRT	TO	_	19	mark	_	_
18	be	_	VERB	VB	_	19	auxpass	_	_
19	reduced	_	VERB	VBN	_	16	xcomp	_	_
20	,	_	.	,	_	19	punct	_	_
21	if	_	ADP	IN	_	25	mark	_	_
22	a	_	DET	DT	_	23	det	_	_
23	TCA	_	NOUN	NN	_	25	nsubjpass	_	_
24	is	_	VERB	VBZ	_	25	auxpass	_	_
25	coadministered	_	VERB	VBN	_	19	advcl	_	_
26	with	_	ADP	IN	_	27	case	_	_
27	DRUG	_	NOUN	NN	_	25	nmod	_	_

#	PAROXETINE	3554
1	Because	_	ADP	IN	_	5	mark	_	_
2	DRUG	_	NOUN	NN	_	5	nsubjpass	_	_
3	is	_	VERB	VBZ	_	5	auxpass	_	_
4	highly	_	ADV	RB	_	5	advmod	_	_
5	bound	_	VERB	VBN	_	25	advcl	_	_
6	to	_	PRT	TO	_	8	case	_	_
7	plasma	_	NOUN	NN	_	8	compound	_	_
8	protein	_	NOUN	NN	_	5	nmod	_	_
9	,	_	.	,	_	25	punct	_	_
10	administration	_	NOUN	NN	_	25	nsubj	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_
13	to	_	PRT	TO	_	15	case	_	_
14	a	_	DET	DT	_	15	det	_	_
15	patient	_	NOUN	NN	_	10	nmod	_	_
16	taking	_	VERB	VBG	_	15	acl	_	_
17	another	_	DET	DT	_	18	det	_	_
18	drug	_	NOUN	NN	_	16	dobj	_	_
19	that	_	DET	WDT	_	23	nsubjpass	_	_
20	is	_	VERB	VBZ	_	23	auxpass	_	_
21	highly	_	ADV	RB	_	22	advmod	_	_
22	protein	_	NOUN	NN	_	23	nsubjpass	_	_
23	bound	_	VERB	VBN	_	18	acl:relcl	_	_
24	may	_	VERB	MD	_	25	aux	_	_
25	cause	_	VERB	VB	_	0	root	_	_
26	increased	_	VERB	VBN	_	28	amod	_	_
27	free	_	ADJ	JJ	_	28	amod	_	_
28	concentrations	_	NOUN	NNS	_	25	dobj	_	_
29	of	_	ADP	IN	_	32	case	_	_
30	the	_	DET	DT	_	32	det	_	_
31	other	_	ADJ	JJ	_	32	amod	_	_
32	drug	_	NOUN	NN	_	28	nmod	_	_
33	,	_	.	,	_	25	punct	_	_
34	potentially	_	ADV	RB	_	35	advmod	_	_
35	resulting	_	VERB	VBG	_	25	advcl	_	_
36	in	_	ADP	IN	_	38	case	_	_
37	adverse	_	ADJ	JJ	_	38	amod	_	_
38	events	_	NOUN	NNS	_	35	nmod	_	_

#	PAROXETINE	3555
1	Conversely	_	ADV	RB	_	6	advmod	_	_
2	,	_	.	,	_	6	punct	_	_
3	adverse	_	ADJ	JJ	_	4	amod	_	_
4	effects	_	NOUN	NNS	_	6	nsubj	_	_
5	could	_	VERB	MD	_	6	aux	_	_
6	result	_	VERB	VB	_	0	root	_	_
7	from	_	ADP	IN	_	8	case	_	_
8	displacement	_	NOUN	NN	_	6	nmod	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	by	_	ADP	IN	_	15	case	_	_
12	other	_	ADJ	JJ	_	15	amod	_	_
13	highly	_	ADV	RB	_	14	advmod	_	_
14	bound	_	VERB	VBN	_	15	amod	_	_
15	drugs	_	NOUN	NNS	_	8	nmod	_	_

#	PAROXETINE	3556
1	Serotonin	_	NOUN	NN	_	2	compound	_	_
2	release	_	NOUN	NN	_	5	nsubj	_	_
3	by	_	ADP	IN	_	4	case	_	_
4	platelets	_	NOUN	NNS	_	2	nmod	_	_
5	plays	_	VERB	VBZ	_	0	root	_	_
6	an	_	DET	DT	_	8	det	_	_
7	important	_	ADJ	JJ	_	8	amod	_	_
8	role	_	NOUN	NN	_	5	dobj	_	_
9	in	_	ADP	IN	_	10	case	_	_
10	hemostasis	_	NOUN	NN	_	8	nmod	_	_

#	PAROXETINE	3557
1	Epidemiological	_	ADJ	JJ	_	2	amod	_	_
2	studies	_	NOUN	NNS	_	0	root	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	the	_	DET	DT	_	6	det	_	_
5	case	_	NOUN	NN	_	6	compound	_	_
6	control	_	NOUN	NN	_	2	nmod	_	_
7	and	_	CONJ	CC	_	2	cc	_	_
8	cohort	_	NOUN	NN	_	2	conj	_	_
9	design	_	NOUN	NN	_	8	dobj	_	_
10	that	_	DET	WDT	_	12	nsubj	_	_
11	have	_	VERB	VBP	_	12	aux	_	_
12	demonstrated	_	VERB	VBN	_	9	dep	_	_
13	an	_	DET	DT	_	14	det	_	_
14	association	_	NOUN	NN	_	12	dobj	_	_
15	between	_	ADP	IN	_	16	case	_	_
16	use	_	NOUN	NN	_	14	nmod	_	_
17	of	_	ADP	IN	_	19	case	_	_
18	psychotropic	_	ADJ	JJ	_	19	amod	_	_
19	drugs	_	NOUN	NNS	_	16	nmod	_	_
20	that	_	DET	WDT	_	21	nsubj	_	_
21	interfere	_	VERB	VBP	_	19	acl:relcl	_	_
22	with	_	ADP	IN	_	24	case	_	_
23	serotonin	_	NOUN	NN	_	24	compound	_	_
24	reuptake	_	NOUN	NN	_	21	nmod	_	_
25	and	_	CONJ	CC	_	21	cc	_	_
26	the	_	DET	DT	_	27	det	_	_
27	occurrence	_	NOUN	NN	_	34	nsubj	_	_
28	of	_	ADP	IN	_	31	case	_	_
29	upper	_	VERB	VBG	_	31	amod	_	_
30	gastrointestinal	_	ADJ	JJ	_	31	amod	_	_
31	bleeding	_	NOUN	NN	_	27	nmod	_	_
32	have	_	VERB	MD	_	34	aux	_	_
33	also	_	ADV	RB	_	34	advmod	_	_
34	shown	_	VERB	VBN	_	21	conj	_	_
35	that	_	ADP	IN	_	44	mark	_	_
36	concurrent	_	ADJ	JJ	_	37	amod	_	_
37	use	_	NOUN	NN	_	44	nsubj	_	_
38	of	_	ADP	IN	_	40	case	_	_
39	an	_	DET	DT	_	40	det	_	_
40	NSAID	_	NOUN	NN	_	37	nmod	_	_
41	or	_	CONJ	CC	_	40	cc	_	_
42	aspirin	_	NOUN	NN	_	40	conj	_	_
43	may	_	VERB	MD	_	44	aux	_	_
44	potentiate	_	VERB	VB	_	34	ccomp	_	_
45	this	_	DET	DT	_	46	det	_	_
46	risk	_	NOUN	NN	_	44	dobj	_	_
47	of	_	ADP	IN	_	48	mark	_	_
48	bleeding	_	VERB	VBG	_	46	nmod	_	_

#	PAROXETINE	3558
1	Altered	_	VERB	VBN	_	3	amod	_	_
2	anticoagulant	_	ADJ	JJ	_	3	amod	_	_
3	effects	_	NOUN	NNS	_	11	nsubjpass	_	_
4	,	_	.	,	_	3	punct	_	_
5	including	_	VERB	VBG	_	7	case	_	_
6	increased	_	VERB	VBN	_	7	amod	_	_
7	bleeding	_	NOUN	NN	_	3	nmod	_	_
8	,	_	.	,	_	3	punct	_	_
9	have	_	VERB	VBP	_	11	aux	_	_
10	been	_	VERB	VBN	_	11	auxpass	_	_
11	reported	_	VERB	VBN	_	0	root	_	_
12	when	_	ADV	WRB	_	17	advmod	_	_
13	SSRIs	_	NOUN	NNS	_	17	nsubjpass	_	_
14	or	_	CONJ	CC	_	13	cc	_	_
15	SNRIs	_	NOUN	NNS	_	13	conj	_	_
16	are	_	VERB	VBP	_	17	auxpass	_	_
17	coadministered	_	VERB	VBN	_	11	advcl	_	_
18	with	_	ADP	IN	_	19	case	_	_
19	warfarin	_	NOUN	NN	_	17	nmod	_	_

#	PAROXETINE	3559
1	Patients	_	NOUN	NNS	_	8	nsubjpass	_	_
2	receiving	_	VERB	VBG	_	1	acl	_	_
3	warfarin	_	NOUN	NN	_	4	compound	_	_
4	therapy	_	NOUN	NN	_	2	dobj	_	_
5	should	_	VERB	MD	_	8	aux	_	_
6	be	_	VERB	VB	_	8	auxpass	_	_
7	carefully	_	ADV	RB	_	8	advmod	_	_
8	monitored	_	VERB	VBN	_	0	root	_	_
9	when	_	ADV	WRB	_	12	advmod	_	_
10	DRUG	_	NOUN	NN	_	12	nsubjpass	_	_
11	is	_	VERB	VBZ	_	12	auxpass	_	_
12	initiated	_	VERB	VBN	_	8	ccomp	_	_
13	or	_	CONJ	CC	_	12	cc	_	_
14	discontinued	_	VERB	VBN	_	12	conj	_	_

#	PAROXETINE	3560
1	Although	_	ADP	IN	_	5	mark	_	_
2	DRUG	_	NOUN	NN	_	5	nsubj	_	_
3	does	_	VERB	VBZ	_	5	aux	_	_
4	not	_	ADV	RB	_	5	neg	_	_
5	increase	_	VERB	VB	_	20	advcl	_	_
6	the	_	DET	DT	_	7	det	_	_
7	impairment	_	NOUN	NN	_	5	dobj	_	_
8	of	_	ADP	IN	_	12	case	_	_
9	mental	_	ADJ	JJ	_	12	amod	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	motor	_	NOUN	NN	_	9	conj	_	_
12	skills	_	NOUN	NNS	_	7	nmod	_	_
13	caused	_	VERB	VBN	_	12	acl	_	_
14	by	_	ADP	IN	_	15	case	_	_
15	alcohol	_	NOUN	NN	_	13	nmod	_	_
16	,	_	.	,	_	20	punct	_	_
17	patients	_	NOUN	NNS	_	20	nsubjpass	_	_
18	should	_	VERB	MD	_	20	aux	_	_
19	be	_	VERB	VB	_	20	auxpass	_	_
20	advised	_	VERB	VBN	_	0	root	_	_
21	to	_	PRT	TO	_	22	mark	_	_
22	avoid	_	VERB	VB	_	20	xcomp	_	_
23	alcohol	_	NOUN	NN	_	22	dobj	_	_
24	while	_	ADP	IN	_	25	mark	_	_
25	taking	_	VERB	VBG	_	22	advcl	_	_
26	DRUG	_	NOUN	NN	_	25	dobj	_	_

#	PAROXETINE	3561
1	A	_	DET	DT	_	4	det	_	_
2	multiple	_	ADJ	JJ	_	4	amod	_	_
3	dose	_	NOUN	NN	_	4	compound	_	_
4	study	_	NOUN	NN	_	6	nsubj	_	_
5	has	_	VERB	VBZ	_	6	aux	_	_
6	shown	_	VERB	VBN	_	0	root	_	_
7	that	_	ADP	IN	_	9	mark	_	_
8	there	_	DET	EX	_	9	expl	_	_
9	is	_	VERB	VBZ	_	6	ccomp	_	_
10	no	_	DET	DT	_	12	neg	_	_
11	pharmacokinetic	_	ADJ	JJ	_	12	amod	_	_
12	interaction	_	NOUN	NN	_	9	nsubj	_	_
13	between	_	ADP	IN	_	14	case	_	_
14	DRUG	_	NOUN	NN	_	12	nmod	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	lithium	_	NOUN	NN	_	17	compound	_	_
17	carbonate	_	NOUN	NN	_	14	conj	_	_

#	PAROXETINE	3562
1	However	_	ADV	RB	_	13	advmod	_	_
2	,	_	.	,	_	13	punct	_	_
3	due	_	ADJ	JJ	_	6	case	_	_
4	to	_	PRT	TO	_	3	mwe	_	_
5	the	_	DET	DT	_	6	det	_	_
6	potential	_	NOUN	NN	_	13	nmod	_	_
7	for	_	ADP	IN	_	9	case	_	_
8	serotonin	_	NOUN	NN	_	9	compound	_	_
9	syndrome	_	NOUN	NN	_	6	nmod	_	_
10	,	_	.	,	_	13	punct	_	_
11	caution	_	NOUN	NN	_	13	nsubjpass	_	_
12	is	_	VERB	VBZ	_	13	auxpass	_	_
13	advised	_	VERB	VBN	_	0	root	_	_
14	when	_	ADV	WRB	_	17	advmod	_	_
15	DRUG	_	NOUN	NN	_	17	nsubjpass	_	_
16	is	_	VERB	VBZ	_	17	auxpass	_	_
17	coadministered	_	VERB	VBN	_	13	ccomp	_	_
18	with	_	ADP	IN	_	19	case	_	_
19	lithium	_	NOUN	NN	_	17	nmod	_	_

#	PAROXETINE	3563
1	The	_	DET	DT	_	4	det	_	_
2	steady	_	ADJ	JJ	_	4	amod	_	_
3	state	_	NOUN	NN	_	4	compound	_	_
4	pharmacokinetics	_	NOUN	NNS	_	9	nsubjpass	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	was	_	VERB	VBD	_	9	auxpass	_	_
8	not	_	ADV	RB	_	9	neg	_	_
9	altered	_	VERB	VBN	_	0	root	_	_
10	when	_	ADV	WRB	_	11	advmod	_	_
11	administered	_	VERB	VBN	_	9	advcl	_	_
12	with	_	ADP	IN	_	13	case	_	_
13	digoxin	_	NOUN	NN	_	11	nmod	_	_
14	at	_	ADP	IN	_	16	case	_	_
15	steady	_	ADJ	JJ	_	16	amod	_	_
16	state	_	NOUN	NN	_	11	nmod	_	_

#	PAROXETINE	3564
1	Mean	_	NOUN	NN	_	3	compound	_	_
2	digoxin	_	NOUN	NN	_	3	compound	_	_
3	AUC	_	NOUN	NN	_	7	nsubj	_	_
4	at	_	ADP	IN	_	6	case	_	_
5	steady	_	ADJ	JJ	_	6	amod	_	_
6	state	_	NOUN	NN	_	3	nmod	_	_
7	decreased	_	VERB	VBD	_	0	root	_	_
8	by	_	ADP	IN	_	9	case	_	_
9	15%	_	NOUN	NN	_	7	nmod	_	_
10	in	_	ADP	IN	_	12	case	_	_
11	the	_	DET	DT	_	12	det	_	_
12	presence	_	NOUN	NN	_	7	nmod	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	DRUG	_	NOUN	NN	_	12	nmod	_	_

#	PAROXETINE	3565
1	Since	_	ADP	IN	_	3	mark	_	_
2	there	_	DET	EX	_	3	expl	_	_
3	is	_	VERB	VBZ	_	17	advcl	_	_
4	little	_	ADJ	JJ	_	6	amod	_	_
5	clinical	_	ADJ	JJ	_	6	amod	_	_
6	experience	_	NOUN	NN	_	3	nsubj	_	_
7	,	_	.	,	_	17	punct	_	_
8	the	_	DET	DT	_	10	det	_	_
9	concurrent	_	ADJ	JJ	_	10	amod	_	_
10	administration	_	NOUN	NN	_	17	nsubjpass	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	digoxin	_	NOUN	NN	_	12	conj	_	_
15	should	_	VERB	MD	_	17	aux	_	_
16	be	_	VERB	VB	_	17	auxpass	_	_
17	undertaken	_	VERB	VBN	_	0	root	_	_
18	with	_	ADP	IN	_	19	case	_	_
19	caution	_	NOUN	NN	_	17	nmod	_	_

#	PAROXETINE	3566
1	Under	_	ADP	IN	_	4	case	_	_
2	steady	_	ADJ	JJ	_	4	amod	_	_
3	state	_	NOUN	NN	_	4	compound	_	_
4	conditions	_	NOUN	NNS	_	9	nmod	_	_
5	,	_	.	,	_	9	punct	_	_
6	diazepam	_	NOUN	NN	_	9	nsubj	_	_
7	does	_	VERB	VBZ	_	9	aux	_	_
8	not	_	ADV	RB	_	9	neg	_	_
9	appear	_	VERB	VB	_	0	root	_	_
10	to	_	PRT	TO	_	11	mark	_	_
11	affect	_	VERB	VB	_	9	xcomp	_	_
12	DRUG	_	NOUN	NN	_	13	compound	_	_
13	kinetics	_	NOUN	NNS	_	11	dobj	_	_

#	PAROXETINE	3567
1	The	_	DET	DT	_	2	det	_	_
2	effects	_	NOUN	NNS	_	9	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	on	_	ADP	IN	_	6	case	_	_
6	diazepam	_	NOUN	NN	_	2	nmod	_	_
7	were	_	VERB	VBD	_	9	auxpass	_	_
8	not	_	ADV	RB	_	9	neg	_	_
9	evaluated	_	VERB	VBN	_	0	root	_	_

#	PAROXETINE	3568
1	Daily	_	ADJ	JJ	_	3	amod	_	_
2	oral	_	ADJ	JJ	_	3	amod	_	_
3	dosing	_	NOUN	NN	_	9	nsubj	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	DRUG	_	NOUN	NN	_	6	compound	_	_
6	30mg	_	ADJ	JJ	_	3	nmod	_	_
7	once	_	ADV	RB	_	9	advmod	_	_
8	daily	_	ADV	RB	_	9	advmod	_	_
9	increased	_	VERB	VBD	_	0	root	_	_
10	steady	_	ADJ	JJ	_	12	amod	_	_
11	state	_	NOUN	NN	_	12	compound	_	_
12	AUC0	_	NOUN	NN	_	9	dobj	_	_
13	24	_	NUM	CD	_	12	nummod	_	_
14	,	_	.	,	_	12	punct	_	_
15	Cmax	_	NOUN	NN	_	12	conj	_	_
16	,	_	.	,	_	12	punct	_	_
17	and	_	CONJ	CC	_	12	cc	_	_
18	Cmin	_	NOUN	NN	_	19	compound	_	_
19	values	_	NOUN	NNS	_	12	conj	_	_
20	of	_	ADP	IN	_	23	case	_	_
21	procyclidine	_	NOUN	NN	_	23	compound	_	_
22	5mg	_	NOUN	NN	_	23	compound	_	_
23	oral	_	ADJ	JJ	_	12	dep	_	_
24	once	_	ADV	RB	_	25	advmod	_	_
25	daily	_	ADV	RB	_	23	advmod	_	_
26	by	_	ADP	IN	_	27	case	_	_
27	35%	_	NOUN	NN	_	23	nmod	_	_
28	,	_	.	,	_	27	punct	_	_
29	37%	_	NOUN	NN	_	27	conj	_	_
30	and	_	CONJ	CC	_	27	cc	_	_
31	67%	_	NOUN	NN	_	27	conj	_	_
32	,	_	.	,	_	23	punct	_	_
33	respectively	_	ADV	RB	_	23	advmod	_	_
34	,	_	.	,	_	23	punct	_	_
35	compared	_	VERB	VBN	_	23	dep	_	_
36	to	_	PRT	TO	_	37	case	_	_
37	procyclidine	_	NOUN	NN	_	35	nmod	_	_
38	alone	_	ADV	RB	_	35	advmod	_	_
39	at	_	ADP	IN	_	41	case	_	_
40	steady	_	ADJ	JJ	_	41	amod	_	_
41	state	_	NOUN	NN	_	35	nmod	_	_

#	PAROXETINE	3569
1	If	_	ADP	IN	_	3	case	_	_
2	anticholinergic	_	ADJ	JJ	_	3	amod	_	_
3	effects	_	NOUN	NNS	_	5	nsubjpass	_	_
4	are	_	VERB	VBP	_	5	auxpass	_	_
5	seen	_	VERB	VBN	_	13	advcl	_	_
6	,	_	.	,	_	13	punct	_	_
7	the	_	DET	DT	_	8	det	_	_
8	dose	_	NOUN	NN	_	13	nsubjpass	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	procyclidine	_	NOUN	NN	_	8	nmod	_	_
11	should	_	VERB	MD	_	13	aux	_	_
12	be	_	VERB	VB	_	13	auxpass	_	_
13	reduced	_	VERB	VBN	_	0	root	_	_

#	PAROXETINE	3570
1	In	_	ADP	IN	_	3	case	_	_
2	a	_	DET	DT	_	3	det	_	_
3	study	_	NOUN	NN	_	24	nmod	_	_
4	where	_	ADV	WRB	_	10	advmod	_	_
5	propranolol	_	ADJ	JJ	_	6	amod	_	_
6	80mg	_	NOUN	NN	_	10	nsubjpass	_	_
7	twice	_	ADV	RB	_	10	advmod	_	_
8	daily	_	ADV	RB	_	10	advmod	_	_
9	was	_	VERB	VBD	_	10	auxpass	_	_
10	dosed	_	VERB	VBN	_	3	acl:relcl	_	_
11	orally	_	ADV	RB	_	10	advmod	_	_
12	for	_	ADP	IN	_	13	case	_	_
13	18days	_	NOUN	NNS	_	10	nmod	_	_
14	,	_	.	,	_	24	punct	_	_
15	the	_	DET	DT	_	20	det	_	_
16	established	_	VERB	VBN	_	20	amod	_	_
17	steady	_	ADJ	JJ	_	20	amod	_	_
18	state	_	NOUN	NN	_	20	compound	_	_
19	plasma	_	NOUN	NN	_	20	compound	_	_
20	concentrations	_	NOUN	NNS	_	24	nsubj	_	_
21	of	_	ADP	IN	_	22	case	_	_
22	propranolol	_	NOUN	NN	_	20	nmod	_	_
23	were	_	VERB	VBD	_	24	cop	_	_
24	unaltered	_	ADJ	JJ	_	0	root	_	_
25	during	_	ADP	IN	_	26	case	_	_
26	coadministration	_	NOUN	NN	_	24	nmod	_	_
27	with	_	ADP	IN	_	29	case	_	_
28	DRUG	_	NOUN	NN	_	29	compound	_	_
29	30mg	_	ADJ	JJ	_	26	nmod	_	_
30	once	_	ADV	RB	_	31	advmod	_	_
31	daily	_	ADV	RB	_	29	advmod	_	_
32	for	_	ADP	IN	_	35	case	_	_
33	the	_	DET	DT	_	35	det	_	_
34	final	_	ADJ	JJ	_	35	amod	_	_
35	10days	_	NOUN	NNS	_	31	nmod	_	_

#	PAROXETINE	3571
1	The	_	DET	DT	_	2	det	_	_
2	effects	_	NOUN	NNS	_	10	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	propranolol	_	NOUN	NN	_	2	nmod	_	_
5	on	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	2	nmod	_	_
7	have	_	VERB	MD	_	10	aux	_	_
8	not	_	ADV	RB	_	10	neg	_	_
9	been	_	VERB	VBN	_	10	auxpass	_	_
10	evaluated	_	VERB	VBN	_	0	root	_	_

#	PAROXETINE	3572
1	Reports	_	NOUN	NNS	_	13	nsubjpass	_	_
2	of	_	ADP	IN	_	5	case	_	_
3	elevated	_	ADJ	JJ	_	5	amod	_	_
4	theophylline	_	NOUN	NN	_	5	compound	_	_
5	levels	_	NOUN	NNS	_	1	nmod	_	_
6	associated	_	VERB	VBN	_	5	acl	_	_
7	with	_	ADP	IN	_	8	case	_	_
8	treatment	_	NOUN	NN	_	6	nmod	_	_
9	with	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	have	_	VERB	VBP	_	13	aux	_	_
12	been	_	VERB	VBN	_	13	auxpass	_	_
13	reported	_	VERB	VBN	_	0	root	_	_

#	PAROXETINE	3573
1	While	_	ADP	IN	_	8	mark	_	_
2	this	_	DET	DT	_	3	det	_	_
3	interaction	_	NOUN	NN	_	8	nsubjpass	_	_
4	has	_	VERB	VBZ	_	8	aux	_	_
5	not	_	ADV	RB	_	8	neg	_	_
6	been	_	VERB	VBN	_	8	auxpass	_	_
7	formally	_	ADV	RB	_	8	advmod	_	_
8	studied	_	VERB	VBN	_	12	advcl	_	_
9	,	_	.	,	_	12	punct	_	_
10	it	_	PRON	PRP	_	12	nsubjpass	_	_
11	is	_	VERB	VBZ	_	12	auxpass	_	_
12	recommended	_	VERB	VBN	_	0	root	_	_
13	that	_	ADP	IN	_	17	mark	_	_
14	theophylline	_	NOUN	NN	_	15	compound	_	_
15	levels	_	NOUN	NNS	_	17	nsubjpass	_	_
16	be	_	VERB	VBP	_	17	auxpass	_	_
17	monitored	_	VERB	VBN	_	12	ccomp	_	_
18	when	_	ADV	WRB	_	23	advmod	_	_
19	these	_	DET	DT	_	20	det	_	_
20	drugs	_	NOUN	NNS	_	23	nsubjpass	_	_
21	are	_	VERB	VBP	_	23	auxpass	_	_
22	concurrently	_	ADV	RB	_	23	advmod	_	_
23	administered	_	VERB	VBN	_	17	ccomp	_	_

#	PAROXETINE	3574
1	Co	_	PRT	TO	_	2	case	_	_
2	administration	_	NOUN	NN	_	10	nmod	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	fosamprenavir	_	NOUN	NN	_	2	nmod	_	_
5	/	_	.	:	_	10	punct	_	_
6	ritonavir	_	NOUN	NN	_	10	nsubj	_	_
7	with	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	significantly	_	ADV	RB	_	10	advmod	_	_
10	decreased	_	VERB	VBD	_	0	root	_	_
11	plasma	_	NOUN	NN	_	12	compound	_	_
12	levels	_	NOUN	NNS	_	10	dobj	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	DRUG	_	NOUN	NN	_	12	nmod	_	_

#	PAROXETINE	3575
1	Any	_	DET	DT	_	3	det	_	_
2	dose	_	NOUN	NN	_	3	compound	_	_
3	adjustment	_	NOUN	NN	_	6	nsubjpass	_	_
4	should	_	VERB	MD	_	6	aux	_	_
5	be	_	VERB	VB	_	6	auxpass	_	_
6	guided	_	VERB	VBN	_	0	root	_	_
7	by	_	ADP	IN	_	10	case	_	_
8	clinical	_	ADJ	JJ	_	10	amod	_	_
9	effect	_	NOUN	NN	_	10	compound	_	_
10	tolerability	_	NOUN	NN	_	6	nmod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	efficacy	_	NOUN	NN	_	10	conj	_	_

#	PAROXETINE	3576
1	There	_	DET	EX	_	2	expl	_	_
2	are	_	VERB	VBP	_	0	root	_	_
3	no	_	DET	DT	_	5	neg	_	_
4	clinical	_	ADJ	JJ	_	5	amod	_	_
5	studies	_	NOUN	NNS	_	2	nsubj	_	_
6	of	_	ADP	IN	_	9	case	_	_
7	the	_	DET	DT	_	9	det	_	_
8	combined	_	VERB	VBN	_	9	amod	_	_
9	use	_	NOUN	NN	_	5	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	ECT	_	NOUN	NN	_	9	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	DRUG	_	NOUN	NN	_	11	conj	_	_

#	PAROXETINE	3577
1	The	_	DET	DT	_	2	det	_	_
2	efficacy	_	NOUN	NN	_	31	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	in	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	treatment	_	NOUN	NN	_	2	nmod	_	_
8	of	_	ADP	IN	_	11	case	_	_
9	major	_	ADJ	JJ	_	11	amod	_	_
10	depressive	_	ADJ	JJ	_	11	amod	_	_
11	disorder	_	NOUN	NN	_	7	nmod	_	_
12	,	_	.	,	_	11	punct	_	_
13	social	_	ADJ	JJ	_	15	amod	_	_
14	anxiety	_	NOUN	NN	_	15	compound	_	_
15	disorder	_	NOUN	NN	_	11	conj	_	_
16	,	_	.	,	_	11	punct	_	_
17	obsessive	_	ADJ	JJ	_	20	amod	_	_
18	compulsive	_	ADJ	JJ	_	20	amod	_	_
19	disorder	_	NOUN	NN	_	20	compound	_	_
20	OCD	_	NOUN	NN	_	11	conj	_	_
21	,	_	.	,	_	11	punct	_	_
22	panic	_	ADJ	JJ	_	24	amod	_	_
23	disorder	_	NOUN	NN	_	24	compound	_	_
24	PD	_	NOUN	NN	_	11	appos	_	_
25	,	_	.	,	_	11	punct	_	_
26	generalized	_	VERB	VBN	_	29	amod	_	_
27	anxiety	_	NOUN	NN	_	29	compound	_	_
28	disorder	_	NOUN	NN	_	29	compound	_	_
29	GAD	_	NOUN	NN	_	11	appos	_	_
30	is	_	VERB	VBZ	_	31	auxpass	_	_
31	presumed	_	VERB	VBN	_	0	root	_	_
32	to	_	PRT	TO	_	34	mark	_	_
33	be	_	VERB	VB	_	34	auxpass	_	_
34	linked	_	VERB	VBN	_	31	xcomp	_	_
35	to	_	PRT	TO	_	36	case	_	_
36	potentiation	_	NOUN	NN	_	34	nmod	_	_
37	of	_	ADP	IN	_	39	case	_	_
38	serotonergic	_	ADJ	JJ	_	39	amod	_	_
39	activity	_	NOUN	NN	_	36	nmod	_	_
40	in	_	ADP	IN	_	44	case	_	_
41	the	_	DET	DT	_	44	det	_	_
42	central	_	ADJ	JJ	_	44	amod	_	_
43	nervous	_	ADJ	JJ	_	44	amod	_	_
44	system	_	NOUN	NN	_	39	nmod	_	_
45	resulting	_	VERB	VBG	_	44	acl	_	_
46	from	_	ADP	IN	_	47	case	_	_
47	inhibition	_	NOUN	NN	_	45	nmod	_	_
48	of	_	ADP	IN	_	50	case	_	_
49	neuronal	_	ADJ	JJ	_	50	amod	_	_
50	reuptake	_	NOUN	NN	_	47	nmod	_	_
51	of	_	ADP	IN	_	55	case	_	_
52	serotonin	_	NOUN	NN	_	55	compound	_	_
53	5	_	NUM	CD	_	55	nummod	_	_
54	hydroxy	_	NOUN	NN	_	55	compound	_	_
55	tryptamine	_	NOUN	NN	_	50	nmod	_	_
56	,	_	.	,	_	55	punct	_	_
57	5	_	NUM	CD	_	58	nummod	_	_
58	HT	_	NOUN	NN	_	55	appos	_	_

#	PAROXETINE	3578
1	Studies	_	NOUN	NNS	_	9	nsubj	_	_
2	at	_	ADP	IN	_	5	case	_	_
3	clinically	_	ADV	RB	_	4	advmod	_	_
4	relevant	_	ADJ	JJ	_	5	amod	_	_
5	doses	_	NOUN	NNS	_	1	nmod	_	_
6	in	_	ADP	IN	_	7	case	_	_
7	humans	_	NOUN	NNS	_	5	nmod	_	_
8	have	_	VERB	VBP	_	9	aux	_	_
9	demonstrated	_	VERB	VBN	_	0	root	_	_
10	that	_	ADP	IN	_	12	mark	_	_
11	DRUG	_	NOUN	NN	_	12	nsubj	_	_
12	blocks	_	VERB	VBZ	_	9	ccomp	_	_
13	the	_	DET	DT	_	14	det	_	_
14	uptake	_	NOUN	NN	_	12	dobj	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	serotonin	_	NOUN	NN	_	14	nmod	_	_
17	into	_	ADP	IN	_	19	case	_	_
18	human	_	ADJ	JJ	_	19	amod	_	_
19	platelets	_	NOUN	NNS	_	14	nmod	_	_

#	PAROXETINE	3579
1	In	_	X	FW	_	3	amod	_	_
2	vitro	_	X	FW	_	1	dep	_	_
3	studies	_	NOUN	NNS	_	7	nsubj	_	_
4	in	_	ADP	IN	_	5	case	_	_
5	animals	_	NOUN	NNS	_	3	nmod	_	_
6	also	_	ADV	RB	_	7	advmod	_	_
7	suggest	_	VERB	VBP	_	0	root	_	_
8	that	_	ADP	IN	_	16	mark	_	_
9	DRUG	_	NOUN	NN	_	16	nsubj	_	_
10	is	_	VERB	VBZ	_	16	cop	_	_
11	a	_	DET	DT	_	16	det	_	_
12	potent	_	ADJ	JJ	_	16	amod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	highly	_	ADV	RB	_	12	conj	_	_
15	selective	_	ADJ	JJ	_	16	amod	_	_
16	inhibitor	_	NOUN	NN	_	7	ccomp	_	_
17	of	_	ADP	IN	_	20	case	_	_
18	neuronal	_	ADJ	JJ	_	20	amod	_	_
19	serotonin	_	NOUN	NN	_	20	compound	_	_
20	reuptake	_	NOUN	NN	_	16	nmod	_	_
21	and	_	CONJ	CC	_	16	cc	_	_
22	has	_	VERB	VBZ	_	16	conj	_	_
23	only	_	ADV	RB	_	24	advmod	_	_
24	very	_	ADV	RB	_	25	advmod	_	_
25	weak	_	ADJ	JJ	_	26	amod	_	_
26	effects	_	NOUN	NNS	_	22	dobj	_	_
27	on	_	ADP	IN	_	28	case	_	_
28	norepinephrine	_	NOUN	NN	_	26	nmod	_	_
29	and	_	CONJ	CC	_	28	cc	_	_
30	dopamine	_	NOUN	NN	_	32	compound	_	_
31	neuronal	_	ADJ	JJ	_	32	amod	_	_
32	reuptake	_	NOUN	NN	_	28	conj	_	_

#	PAROXETINE	3580
1	In	_	X	FW	_	5	amod	_	_
2	vitro	_	X	FW	_	1	dep	_	_
3	radioligand	_	NOUN	NN	_	5	compound	_	_
4	binding	_	NOUN	NN	_	5	compound	_	_
5	studies	_	NOUN	NNS	_	6	nsubj	_	_
6	indicate	_	VERB	VBP	_	0	root	_	_
7	that	_	ADP	IN	_	9	mark	_	_
8	DRUG	_	NOUN	NN	_	9	nsubj	_	_
9	has	_	VERB	VBZ	_	6	ccomp	_	_
10	little	_	ADJ	JJ	_	11	amod	_	_
11	affinity	_	NOUN	NN	_	9	dobj	_	_
12	for	_	ADP	IN	_	34	case	_	_
13	muscarinic	_	ADJ	JJ	_	34	amod	_	_
14	,	_	.	,	_	13	punct	_	_
15	alpha1	_	NOUN	NN	_	13	conj	_	_
16	,	_	.	,	_	13	punct	_	_
17	alpha2	_	NOUN	NN	_	13	conj	_	_
18	,	_	.	,	_	13	punct	_	_
19	beta	_	NOUN	NN	_	20	nmod:npmod	_	_
20	adrenergic	_	ADJ	JJ	_	13	conj	_	_
21	,	_	.	,	_	13	punct	_	_
22	dopamine	_	NOUN	NN	_	23	compound	_	_
23	D2	_	NOUN	NN	_	13	conj	_	_
24	,	_	.	,	_	13	punct	_	_
25	5	_	NUM	CD	_	26	nummod	_	_
26	HT1	_	NOUN	NN	_	13	conj	_	_
27	,	_	.	,	_	13	punct	_	_
28	5	_	NUM	CD	_	29	nummod	_	_
29	HT2	_	NOUN	NN	_	13	conj	_	_
30	,	_	.	,	_	13	punct	_	_
31	and	_	CONJ	CC	_	13	cc	_	_
32	histamine	_	NOUN	NN	_	13	conj	_	_
33	H1	_	NOUN	NN	_	34	compound	_	_
34	receptors	_	NOUN	NNS	_	11	nmod	_	_
35	antagonism	_	NOUN	NN	_	47	nsubjpass	_	_
36	of	_	ADP	IN	_	44	case	_	_
37	muscarinic	_	ADJ	JJ	_	44	amod	_	_
38	,	_	.	,	_	37	punct	_	_
39	histaminergic	_	ADJ	JJ	_	37	conj	_	_
40	,	_	.	,	_	37	punct	_	_
41	and	_	CONJ	CC	_	37	cc	_	_
42	alpha1	_	NOUN	NN	_	37	conj	_	_
43	adrenergic	_	ADJ	JJ	_	44	amod	_	_
44	receptors	_	NOUN	NNS	_	35	nmod	_	_
45	has	_	VERB	VBZ	_	47	aux	_	_
46	been	_	VERB	VBN	_	47	auxpass	_	_
47	associated	_	VERB	VBN	_	34	dep	_	_
48	with	_	ADP	IN	_	50	case	_	_
49	various	_	ADJ	JJ	_	50	amod	_	_
50	anticholinergic	_	ADJ	JJ	_	47	nmod	_	_
51	,	_	.	,	_	50	punct	_	_
52	sedative	_	ADJ	JJ	_	50	conj	_	_
53	,	_	.	,	_	50	punct	_	_
54	and	_	CONJ	CC	_	50	cc	_	_
55	cardiovascular	_	ADJ	JJ	_	50	conj	_	_
56	effects	_	NOUN	NNS	_	50	dep	_	_
57	for	_	ADP	IN	_	60	case	_	_
58	other	_	ADJ	JJ	_	60	amod	_	_
59	psychotropic	_	ADJ	JJ	_	60	amod	_	_
60	drugs	_	NOUN	NNS	_	50	nmod	_	_

#	PAROXETINE	3581
1	Because	_	ADP	IN	_	15	mark	_	_
2	the	_	DET	DT	_	4	det	_	_
3	relative	_	ADJ	JJ	_	4	amod	_	_
4	potencies	_	NOUN	NNS	_	15	nsubj	_	_
5	of	_	ADP	IN	_	9	case	_	_
6	DRUG	_	NOUN	NN	_	9	nmod:poss	_	_
7	's	_	PRT	POS	_	6	case	_	_
8	major	_	ADJ	JJ	_	9	amod	_	_
9	metabolites	_	NOUN	NNS	_	4	nmod	_	_
10	are	_	VERB	VBP	_	15	cop	_	_
11	at	_	ADP	IN	_	12	case	_	_
12	most	_	ADV	RB	_	13	advmod	_	_
13	1	_	NUM	CD	_	15	nummod	_	_
14	/	_	NUM	CD	_	15	punct	_	_
15	50	_	NUM	CD	_	24	punct	_	_
16	of	_	ADP	IN	_	19	case	_	_
17	the	_	DET	DT	_	19	det	_	_
18	parent	_	NOUN	NN	_	19	compound	_	_
19	compound	_	NOUN	NN	_	15	nmod	_	_
20	,	_	.	,	_	24	punct	_	_
21	they	_	PRON	PRP	_	24	nsubjpass	_	_
22	are	_	VERB	VBP	_	24	auxpass	_	_
23	essentially	_	ADV	RB	_	24	advmod	_	_
24	inactive	_	ADJ	JJ	_	0	root	_	_

#	PAROXETINE	3582
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	hydrochloride	_	NOUN	NN	_	5	nsubjpass	_	_
3	is	_	VERB	VBZ	_	5	auxpass	_	_
4	completely	_	ADV	RB	_	5	advmod	_	_
5	absorbed	_	VERB	VBN	_	0	root	_	_
6	after	_	ADP	IN	_	8	case	_	_
7	oral	_	ADJ	JJ	_	8	amod	_	_
8	dosing	_	NOUN	NN	_	5	nmod	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	a	_	DET	DT	_	11	det	_	_
11	solution	_	NOUN	NN	_	8	nmod	_	_
12	of	_	ADP	IN	_	15	case	_	_
13	the	_	DET	DT	_	15	det	_	_
14	hydrochloride	_	NOUN	NN	_	15	compound	_	_
15	salt	_	NOUN	NN	_	11	nmod	_	_

#	PAROXETINE	3583
1	The	_	DET	DT	_	5	det	_	_
2	mean	_	ADJ	JJ	_	5	compound	_	_
3	elimination	_	NOUN	NN	_	5	compound	_	_
4	half	_	NOUN	NN	_	5	compound	_	_
5	life	_	NOUN	NN	_	9	nsubj	_	_
6	is	_	VERB	VBZ	_	9	cop	_	_
7	approximately	_	ADV	RB	_	9	advmod	_	_
8	21	_	NUM	CD	_	9	nummod	_	_
9	hours	_	NOUN	NNS	_	0	root	_	_
10	CV	_	NOUN	NN	_	11	compound	_	_
11	32%	_	NOUN	NN	_	9	dep	_	_
12	after	_	ADP	IN	_	14	case	_	_
13	oral	_	ADJ	JJ	_	14	amod	_	_
14	dosing	_	NOUN	NN	_	9	nmod	_	_
15	of	_	ADP	IN	_	18	case	_	_
16	30	_	NUM	CD	_	18	nummod	_	_
17	mg	_	NOUN	NN	_	18	compound	_	_
18	tablets	_	NOUN	NNS	_	14	nmod	_	_
19	of	_	ADP	IN	_	20	case	_	_
20	DRUG	_	NOUN	NN	_	18	nmod	_	_
21	daily	_	ADV	RB	_	9	advmod	_	_
22	for	_	ADP	IN	_	24	case	_	_
23	30	_	NUM	CD	_	24	nummod	_	_
24	days	_	NOUN	NNS	_	9	nmod	_	_

#	PAROXETINE	3584
1	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
2	is	_	VERB	VBZ	_	4	auxpass	_	_
3	extensively	_	ADV	RB	_	4	advmod	_	_
4	metabolized	_	VERB	VBN	_	0	root	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	the	_	DET	DT	_	7	det	_	_
7	metabolites	_	NOUN	NNS	_	9	nsubjpass	_	_
8	are	_	VERB	VBP	_	9	auxpass	_	_
9	considered	_	VERB	VBN	_	4	conj	_	_
10	to	_	PRT	TO	_	12	mark	_	_
11	be	_	VERB	VB	_	12	auxpass	_	_
12	inactive	_	ADJ	JJ	_	9	xcomp	_	_

#	PAROXETINE	3585
1	Nonlinearity	_	NOUN	NN	_	5	nsubjpass	_	_
2	in	_	ADP	IN	_	3	case	_	_
3	pharmacokinetics	_	NOUN	NNS	_	1	nmod	_	_
4	is	_	VERB	VBZ	_	5	auxpass	_	_
5	observed	_	VERB	VBN	_	0	root	_	_
6	with	_	ADP	IN	_	8	case	_	_
7	increasing	_	VERB	VBG	_	8	amod	_	_
8	doses	_	NOUN	NNS	_	5	nmod	_	_

#	PAROXETINE	3586
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	metabolism	_	NOUN	NN	_	4	nsubjpass	_	_
3	is	_	VERB	VBZ	_	4	auxpass	_	_
4	mediated	_	VERB	VBN	_	0	root	_	_
5	in	_	ADP	IN	_	6	case	_	_
6	part	_	NOUN	NN	_	4	nmod	_	_
7	by	_	ADP	IN	_	8	case	_	_
8	CYP2D6	_	NOUN	NN	_	4	nmod	_	_
9	,	_	.	,	_	4	punct	_	_
10	and	_	CONJ	CC	_	4	cc	_	_
11	the	_	DET	DT	_	12	det	_	_
12	metabolites	_	NOUN	NNS	_	15	nsubjpass	_	_
13	are	_	VERB	VBP	_	15	auxpass	_	_
14	primarily	_	ADV	RB	_	15	advmod	_	_
15	excreted	_	VERB	VBN	_	4	conj	_	_
16	in	_	ADP	IN	_	18	case	_	_
17	the	_	DET	DT	_	18	det	_	_
18	urine	_	NOUN	NN	_	15	nmod	_	_
19	and	_	CONJ	CC	_	15	cc	_	_
20	to	_	PRT	TO	_	22	case	_	_
21	some	_	DET	DT	_	22	det	_	_
22	extent	_	NOUN	NN	_	15	conj	_	_
23	in	_	ADP	IN	_	25	case	_	_
24	the	_	DET	DT	_	25	det	_	_
25	feces	_	NOUN	NNS	_	22	nmod	_	_

#	PAROXETINE	3587
1	Pharmacokinetic	_	ADJ	JJ	_	2	amod	_	_
2	behavior	_	NOUN	NN	_	8	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	has	_	VERB	VBZ	_	8	aux	_	_
6	not	_	ADV	RB	_	8	neg	_	_
7	been	_	VERB	VBN	_	8	auxpass	_	_
8	evaluated	_	VERB	VBN	_	0	root	_	_
9	in	_	ADP	IN	_	10	case	_	_
10	subjects	_	NOUN	NNS	_	8	nmod	_	_
11	who	_	DET	WDT	_	13	nsubj	_	_
12	are	_	VERB	VBP	_	13	cop	_	_
13	deficient	_	ADJ	JJ	_	10	acl:relcl	_	_
14	in	_	ADP	IN	_	17	case	_	_
15	CYP2D6	_	NOUN	NN	_	17	compound	_	_
16	poor	_	ADJ	JJ	_	17	amod	_	_
17	metabolizers	_	NOUN	NNS	_	13	nmod	_	_

#	PAROXETINE	3588
1	In	_	ADP	IN	_	4	case	_	_
2	a	_	DET	DT	_	4	det	_	_
3	meta	_	NOUN	NN	_	4	compound	_	_
4	analysis	_	NOUN	NN	_	31	nmod	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	from	_	ADP	IN	_	9	case	_	_
8	4	_	NUM	CD	_	9	nummod	_	_
9	studies	_	NOUN	NNS	_	4	nmod	_	_
10	done	_	NOUN	NN	_	4	dep	_	_
11	in	_	ADP	IN	_	13	case	_	_
12	healthy	_	ADJ	JJ	_	13	amod	_	_
13	volunteers	_	NOUN	NNS	_	10	nmod	_	_
14	following	_	VERB	VBG	_	16	case	_	_
15	multiple	_	ADJ	JJ	_	16	amod	_	_
16	dosing	_	NOUN	NN	_	10	nmod	_	_
17	of	_	ADP	IN	_	19	case	_	_
18	20	_	NUM	CD	_	19	nummod	_	_
19	mg	_	NOUN	NN	_	16	nmod	_	_
20	/	_	.	:	_	31	punct	_	_
21	day	_	NOUN	NN	_	26	dep	_	_
22	to	_	PRT	TO	_	26	case	_	_
23	40	_	NUM	CD	_	24	nummod	_	_
24	mg	_	NOUN	NN	_	26	compound	_	_
25	/	_	.	:	_	26	punct	_	_
26	day	_	NOUN	NN	_	31	nmod	_	_
27	,	_	.	,	_	31	punct	_	_
28	males	_	NOUN	NNS	_	31	nsubj	_	_
29	did	_	VERB	VBD	_	31	aux	_	_
30	not	_	ADV	RB	_	31	neg	_	_
31	exhibit	_	VERB	VB	_	0	root	_	_
32	a	_	DET	DT	_	35	det	_	_
33	significantly	_	ADV	RB	_	34	advmod	_	_
34	lower	_	ADJ	JJ	_	35	amod	_	_
35	Cmax	_	NOUN	NN	_	31	dobj	_	_
36	or	_	CONJ	CC	_	35	cc	_	_
37	AUC	_	NOUN	NN	_	35	conj	_	_
38	than	_	ADP	IN	_	39	case	_	_
39	females	_	NOUN	NNS	_	31	nmod	_	_

#	PAROXETINE	3589
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	is	_	VERB	VBZ	_	4	cop	_	_
3	equally	_	ADV	RB	_	4	advmod	_	_
4	bioavailable	_	ADJ	JJ	_	0	root	_	_
5	from	_	ADP	IN	_	8	case	_	_
6	the	_	DET	DT	_	8	det	_	_
7	oral	_	ADJ	JJ	_	8	amod	_	_
8	suspension	_	NOUN	NN	_	4	nmod	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	tablet	_	NOUN	NN	_	8	conj	_	_

#	PAROXETINE	3591
1	In	_	ADP	IN	_	3	case	_	_
2	a	_	DET	DT	_	3	det	_	_
3	study	_	NOUN	NN	_	26	nmod	_	_
4	in	_	ADP	IN	_	5	case	_	_
5	which	_	DET	WDT	_	10	nmod	_	_
6	normal	_	ADJ	JJ	_	8	amod	_	_
7	male	_	ADJ	JJ	_	8	amod	_	_
8	subjects	_	NOUN	NNS	_	10	nsubj	_	_
9	n	_	NOUN	NN	_	10	nsubj	_	_
10	=	_	ADJ	JJ	_	3	acl:relcl	_	_
11	15	_	NUM	CD	_	15	nummod	_	_
12	received	_	VERB	VBD	_	15	amod	_	_
13	30	_	NUM	CD	_	15	nummod	_	_
14	mg	_	NOUN	NN	_	15	compound	_	_
15	tablets	_	NOUN	NNS	_	10	dobj	_	_
16	daily	_	ADV	RB	_	10	advmod	_	_
17	for	_	ADP	IN	_	19	case	_	_
18	30	_	NUM	CD	_	19	nummod	_	_
19	days	_	NOUN	NNS	_	10	nmod	_	_
20	,	_	.	,	_	26	punct	_	_
21	steady	_	ADJ	JJ	_	24	amod	_	_
22	state	_	NOUN	NN	_	24	compound	_	_
23	DRUG	_	NOUN	NN	_	24	compound	_	_
24	concentrations	_	NOUN	NNS	_	26	nsubjpass	_	_
25	were	_	VERB	VBD	_	26	auxpass	_	_
26	achieved	_	VERB	VBN	_	0	root	_	_
27	by	_	ADP	IN	_	30	case	_	_
28	approximately	_	ADV	RB	_	29	advmod	_	_
29	10	_	NUM	CD	_	30	nummod	_	_
30	days	_	NOUN	NNS	_	26	nmod	_	_
31	for	_	ADP	IN	_	33	case	_	_
32	most	_	ADJ	JJ	_	33	amod	_	_
33	subjects	_	NOUN	NNS	_	30	nmod	_	_
34	,	_	.	,	_	26	punct	_	_
35	although	_	ADP	IN	_	38	mark	_	_
36	it	_	PRON	PRP	_	38	nsubj	_	_
37	may	_	VERB	MD	_	38	aux	_	_
38	take	_	VERB	VB	_	26	advcl	_	_
39	substantially	_	ADV	RB	_	40	advmod	_	_
40	longer	_	ADV	RB	_	38	advmod	_	_
41	in	_	ADP	IN	_	44	case	_	_
42	an	_	DET	DT	_	44	det	_	_
43	occasional	_	ADJ	JJ	_	44	amod	_	_
44	patient	_	NOUN	NN	_	38	nmod	_	_

#	PAROXETINE	3592
1	At	_	ADP	IN	_	3	case	_	_
2	steady	_	ADJ	JJ	_	3	amod	_	_
3	state	_	NOUN	NN	_	18	nmod	_	_
4	,	_	.	,	_	18	punct	_	_
5	mean	_	ADJ	JJ	_	6	amod	_	_
6	values	_	NOUN	NNS	_	18	nsubj	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	Cmax	_	NOUN	NN	_	6	nmod	_	_
9	,	_	.	,	_	8	punct	_	_
10	Tmax	_	NOUN	NN	_	8	conj	_	_
11	,	_	.	,	_	8	punct	_	_
12	Cmin	_	NOUN	NN	_	8	conj	_	_
13	,	_	.	,	_	8	punct	_	_
14	and	_	CONJ	CC	_	8	cc	_	_
15	T%	_	NOUN	NN	_	8	conj	_	_
16	were	_	VERB	VBD	_	18	cop	_	_
17	61.7	_	NUM	CD	_	18	nummod	_	_
18	ng	_	NOUN	NN	_	0	root	_	_
19	/	_	.	:	_	18	punct	_	_
20	mL	_	NOUN	NN	_	22	compound	_	_
21	CV	_	NOUN	NN	_	22	compound	_	_
22	45%	_	NOUN	NN	_	18	dep	_	_
23	,	_	.	,	_	18	punct	_	_
24	5.2	_	NUM	CD	_	25	nummod	_	_
25	hr	_	NOUN	NN	_	18	appos	_	_

#	PAROXETINE	3593
1	CV	_	NOUN	NN	_	2	compound	_	_
2	10%	_	NOUN	NN	_	0	root	_	_
3	,	_	.	,	_	2	punct	_	_
4	30.7	_	NUM	CD	_	5	nummod	_	_
5	ng	_	NOUN	NN	_	2	appos	_	_
6	/	_	.	:	_	2	punct	_	_
7	mL	_	NOUN	NN	_	9	compound	_	_
8	CV	_	NOUN	NN	_	9	compound	_	_
9	67%	_	NOUN	NN	_	2	dep	_	_
10	,	_	.	,	_	9	punct	_	_
11	and	_	CONJ	CC	_	9	cc	_	_
12	21	_	NUM	CD	_	13	nummod	_	_
13	hours	_	NOUN	NNS	_	9	conj	_	_
14	CV	_	NOUN	NN	_	15	compound	_	_
15	32%	_	NOUN	NN	_	13	dep	_	_
16	,	_	.	,	_	2	punct	_	_
17	respectively	_	ADV	RB	_	2	neg	_	_

#	PAROXETINE	3594
1	The	_	DET	DT	_	4	det	_	_
2	steady	_	ADJ	JJ	_	4	amod	_	_
3	state	_	NOUN	NN	_	4	compound	_	_
4	Cmax	_	NOUN	NN	_	13	nsubj	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	Cmin	_	NOUN	NN	_	7	compound	_	_
7	values	_	NOUN	NNS	_	4	conj	_	_
8	were	_	VERB	VBD	_	13	cop	_	_
9	about	_	ADV	RB	_	10	advmod	_	_
10	6	_	NUM	CD	_	13	nummod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	14	_	NUM	CD	_	10	conj	_	_
13	times	_	NOUN	NNS	_	0	root	_	_
14	what	_	DET	WDT	_	17	nsubjpass	_	_
15	would	_	VERB	MD	_	17	aux	_	_
16	be	_	VERB	VB	_	17	auxpass	_	_
17	predicted	_	VERB	VBN	_	13	acl:relcl	_	_
18	from	_	ADP	IN	_	21	case	_	_
19	single	_	ADJ	JJ	_	21	amod	_	_
20	dose	_	NOUN	NN	_	21	compound	_	_
21	studies	_	NOUN	NNS	_	17	nmod	_	_

#	PAROXETINE	3595
1	Steady	_	ADJ	JJ	_	4	amod	_	_
2	state	_	NOUN	NN	_	4	compound	_	_
3	drug	_	NOUN	NN	_	4	compound	_	_
4	exposure	_	NOUN	NN	_	12	nsubj	_	_
5	based	_	VERB	VBN	_	4	acl	_	_
6	on	_	ADP	IN	_	7	case	_	_
7	AUC0	_	NOUN	NN	_	5	nmod	_	_
8	24	_	NUM	CD	_	7	nummod	_	_
9	was	_	VERB	VBD	_	12	cop	_	_
10	about	_	ADV	RB	_	11	advmod	_	_
11	8	_	NUM	CD	_	12	nummod	_	_
12	times	_	NOUN	NNS	_	0	root	_	_
13	greater	_	ADJ	JJ	_	12	amod	_	_
14	than	_	ADP	IN	_	18	mark	_	_
15	would	_	VERB	MD	_	18	aux	_	_
16	have	_	VERB	VB	_	18	aux	_	_
17	been	_	VERB	VBN	_	18	auxpass	_	_
18	predicted	_	VERB	VBN	_	13	advcl	_	_
19	from	_	ADP	IN	_	22	case	_	_
20	single	_	ADJ	JJ	_	22	amod	_	_
21	dose	_	NOUN	NN	_	22	compound	_	_
22	data	_	NOUN	NNS	_	18	nmod	_	_
23	in	_	ADP	IN	_	25	case	_	_
24	these	_	DET	DT	_	25	det	_	_
25	subjects	_	NOUN	NNS	_	22	nmod	_	_

#	PAROXETINE	3596
1	The	_	DET	DT	_	3	det	_	_
2	excess	_	NOUN	NN	_	3	amod	_	_
3	accumulation	_	NOUN	NN	_	6	nsubj	_	_
4	is	_	VERB	VBZ	_	6	cop	_	_
5	a	_	DET	DT	_	6	det	_	_
6	consequence	_	NOUN	NN	_	0	root	_	_
7	of	_	ADP	IN	_	9	case	_	_
8	the	_	DET	DT	_	9	det	_	_
9	fact	_	NOUN	NN	_	6	nmod	_	_
10	that	_	ADP	IN	_	20	mark	_	_
11	1	_	NUM	CD	_	20	nsubjpass	_	_
12	of	_	ADP	IN	_	14	case	_	_
13	the	_	DET	DT	_	14	det	_	_
14	enzymes	_	NOUN	NNS	_	11	nmod	_	_
15	that	_	DET	WDT	_	16	nsubj	_	_
16	metabolizes	_	VERB	VBZ	_	14	acl:relcl	_	_
17	DRUG	_	NOUN	NN	_	16	dobj	_	_
18	is	_	VERB	VBZ	_	20	auxpass	_	_
19	readily	_	ADV	RB	_	20	advmod	_	_
20	saturable	_	ADJ	JJ	_	9	ccomp	_	_

#	PAROXETINE	3597
1	The	_	DET	DT	_	2	det	_	_
2	effects	_	NOUN	NNS	_	11	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	food	_	NOUN	NN	_	2	nmod	_	_
5	on	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	bioavailability	_	NOUN	NN	_	2	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	were	_	VERB	VBD	_	11	auxpass	_	_
11	studied	_	VERB	VBN	_	0	root	_	_
12	in	_	ADP	IN	_	13	case	_	_
13	subjects	_	NOUN	NNS	_	11	nmod	_	_
14	administered	_	VERB	VBD	_	11	xcomp	_	_
15	a	_	DET	DT	_	17	det	_	_
16	single	_	ADJ	JJ	_	17	amod	_	_
17	dose	_	NOUN	NN	_	14	dobj	_	_
18	with	_	ADP	IN	_	17	nmod	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	without	_	ADP	IN	_	18	conj	_	_
21	food	_	NOUN	NN	_	18	dep	_	_

#	PAROXETINE	3598
1	AUC	_	NOUN	NN	_	5	nsubjpass	_	_
2	was	_	VERB	VBD	_	5	auxpass	_	_
3	only	_	ADV	RB	_	5	advmod	_	_
4	slightly	_	ADV	RB	_	5	advmod	_	_
5	increased	_	VERB	VBN	_	0	root	_	_
6	6%	_	NOUN	NN	_	5	xcomp	_	_
7	when	_	ADV	WRB	_	10	advmod	_	_
8	drug	_	NOUN	NN	_	10	nsubjpass	_	_
9	was	_	VERB	VBD	_	10	auxpass	_	_
10	administered	_	VERB	VBN	_	5	advcl	_	_
11	with	_	ADP	IN	_	12	case	_	_
12	food	_	NOUN	NN	_	10	nmod	_	_
13	but	_	CONJ	CC	_	10	cc	_	_
14	the	_	DET	DT	_	15	det	_	_
15	Cmax	_	NOUN	NN	_	18	nsubj	_	_
16	was	_	VERB	VBD	_	18	cop	_	_
17	29%	_	ADJ	JJ	_	18	advmod	_	_
18	greater	_	ADJ	JJ	_	10	conj	_	_
19	,	_	.	,	_	5	punct	_	_
20	while	_	ADP	IN	_	28	mark	_	_
21	the	_	DET	DT	_	22	det	_	_
22	time	_	NOUN	NN	_	28	nsubj	_	_
23	to	_	PRT	TO	_	24	mark	_	_
24	reach	_	VERB	VB	_	22	acl	_	_
25	peak	_	ADJ	JJ	_	27	amod	_	_
26	plasma	_	NOUN	NN	_	27	compound	_	_
27	concentration	_	NOUN	NN	_	24	dobj	_	_
28	decreased	_	VERB	VBN	_	5	advcl	_	_
29	from	_	ADP	IN	_	31	case	_	_
30	6.4	_	NUM	CD	_	31	nummod	_	_
31	hours	_	NOUN	NNS	_	28	nmod	_	_
32	post	_	ADJ	JJ	_	28	dobj	_	_
33	dosing	_	VERB	VBG	_	32	dep	_	_
34	to	_	PRT	TO	_	36	case	_	_
35	4.9	_	NUM	CD	_	36	nummod	_	_
36	hours	_	NOUN	NNS	_	33	nmod	_	_

#	PAROXETINE	3599
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	distributes	_	VERB	VBZ	_	0	root	_	_
3	throughout	_	ADP	IN	_	5	case	_	_
4	the	_	DET	DT	_	5	det	_	_
5	body	_	NOUN	NN	_	2	nmod	_	_
6	,	_	.	,	_	5	punct	_	_
7	including	_	VERB	VBG	_	9	case	_	_
8	the	_	DET	DT	_	9	det	_	_
9	CNS	_	NOUN	NN	_	5	nmod	_	_
10	,	_	.	,	_	2	punct	_	_
11	with	_	ADP	IN	_	13	case	_	_
12	only	_	ADV	RB	_	13	advmod	_	_
13	1%	_	ADJ	JJ	_	2	nmod	_	_
14	remaining	_	VERB	VBG	_	13	acl	_	_
15	in	_	ADP	IN	_	17	case	_	_
16	the	_	DET	DT	_	17	det	_	_
17	plasma	_	NOUN	NN	_	14	nmod	_	_

#	PAROXETINE	3600
1	Approximately	_	ADV	RB	_	8	advmod	_	_
2	95%	_	NOUN	NN	_	8	nsubjpass	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	93%	_	NOUN	NN	_	2	conj	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	2	nmod	_	_
7	is	_	VERB	VBZ	_	8	auxpass	_	_
8	bound	_	VERB	VBN	_	0	root	_	_
9	to	_	PRT	TO	_	11	case	_	_
10	plasma	_	NOUN	NN	_	11	compound	_	_
11	protein	_	NOUN	NN	_	8	nmod	_	_
12	at	_	ADP	IN	_	14	case	_	_
13	100	_	NUM	CD	_	14	nummod	_	_
14	ng	_	NOUN	NN	_	8	nmod	_	_
15	/	_	.	:	_	14	punct	_	_
16	mL	_	NOUN	NN	_	14	appos	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	400	_	NUM	CD	_	19	nummod	_	_
19	ng	_	NOUN	NN	_	16	conj	_	_
20	/	_	.	:	_	16	punct	_	_
21	mL	_	NOUN	NN	_	16	appos	_	_
22	,	_	.	,	_	14	punct	_	_
23	respectively	_	ADV	RB	_	14	advmod	_	_

#	PAROXETINE	3601
1	Under	_	ADP	IN	_	3	case	_	_
2	clinical	_	ADJ	JJ	_	3	amod	_	_
3	conditions	_	NOUN	NNS	_	13	nmod	_	_
4	,	_	.	,	_	13	punct	_	_
5	DRUG	_	NOUN	NN	_	6	compound	_	_
6	concentrations	_	NOUN	NNS	_	13	nsubj	_	_
7	would	_	VERB	MD	_	13	aux	_	_
8	normally	_	ADV	RB	_	13	advmod	_	_
9	be	_	VERB	VB	_	13	cop	_	_
10	less	_	ADV	RB	_	12	advmod	_	_
11	than	_	ADP	IN	_	10	mwe	_	_
12	400	_	NUM	CD	_	13	nummod	_	_
13	ng	_	NOUN	NN	_	0	root	_	_
14	/	_	.	:	_	13	punct	_	_
15	mL	_	NOUN	NN	_	13	dep	_	_

#	PAROXETINE	3602
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	does	_	VERB	VBZ	_	4	aux	_	_
3	not	_	ADV	RB	_	4	neg	_	_
4	alter	_	VERB	VB	_	0	root	_	_
5	the	_	DET	DT	_	9	det	_	_
6	in	_	X	FW	_	9	amod	_	_
7	vitro	_	X	FW	_	6	dep	_	_
8	protein	_	NOUN	NN	_	9	compound	_	_
9	binding	_	NOUN	NN	_	4	dobj	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	phenytoin	_	NOUN	NN	_	9	nmod	_	_
12	or	_	CONJ	CC	_	11	cc	_	_
13	warfarin	_	NOUN	NN	_	11	conj	_	_

#	PAROXETINE	3603
1	The	_	DET	DT	_	5	det	_	_
2	mean	_	ADJ	JJ	_	5	compound	_	_
3	elimination	_	NOUN	NN	_	5	compound	_	_
4	half	_	NOUN	NN	_	5	compound	_	_
5	life	_	NOUN	NN	_	8	nsubj	_	_
6	is	_	VERB	VBZ	_	8	cop	_	_
7	approximately	_	ADV	RB	_	8	advmod	_	_
8	21hours	_	ADJ	JJ	_	0	root	_	_
9	CV32%	_	NOUN	NN	_	8	dobj	_	_
10	after	_	ADP	IN	_	12	case	_	_
11	oral	_	ADJ	JJ	_	12	amod	_	_
12	dosing	_	NOUN	NN	_	8	nmod	_	_
13	of	_	ADP	IN	_	15	case	_	_
14	30mg	_	ADJ	JJ	_	15	amod	_	_
15	tablets	_	NOUN	NNS	_	12	nmod	_	_
16	daily	_	ADV	RB	_	18	advmod	_	_
17	for	_	ADP	IN	_	18	case	_	_
18	30days	_	NOUN	NNS	_	12	nmod	_	_
19	of	_	ADP	IN	_	21	case	_	_
20	DRUG	_	NOUN	NN	_	21	compound	_	_
21	hydrochloride	_	NOUN	NN	_	18	nmod	_	_

#	PAROXETINE	3604
1	In	_	ADP	IN	_	6	case	_	_
2	steady	_	ADJ	JJ	_	6	amod	_	_
3	state	_	NOUN	NN	_	6	compound	_	_
4	dose	_	NOUN	NN	_	6	compound	_	_
5	proportionality	_	NOUN	NN	_	6	compound	_	_
6	studies	_	NOUN	NNS	_	39	nmod	_	_
7	involving	_	VERB	VBG	_	6	acl	_	_
8	elderly	_	ADJ	JJ	_	11	amod	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	nonelderly	_	ADJ	JJ	_	8	conj	_	_
11	patients	_	NOUN	NNS	_	7	dobj	_	_
12	,	_	.	,	_	39	punct	_	_
13	at	_	ADP	IN	_	14	case	_	_
14	doses	_	NOUN	NNS	_	39	nmod	_	_
15	of	_	ADP	IN	_	17	case	_	_
16	20	_	NUM	CD	_	17	nummod	_	_
17	mg	_	NOUN	NN	_	14	nmod	_	_
18	to	_	PRT	TO	_	20	case	_	_
19	40	_	NUM	CD	_	20	nummod	_	_
20	mg	_	NOUN	NN	_	14	nmod	_	_
21	daily	_	ADV	RB	_	24	advmod	_	_
22	for	_	ADP	IN	_	24	case	_	_
23	the	_	DET	DT	_	24	det	_	_
24	elderly	_	NOUN	NN	_	14	nmod	_	_
25	and	_	CONJ	CC	_	24	cc	_	_
26	20	_	NUM	CD	_	27	nummod	_	_
27	mg	_	NOUN	NN	_	24	conj	_	_
28	to	_	PRT	TO	_	30	case	_	_
29	50	_	NUM	CD	_	30	nummod	_	_
30	mg	_	NOUN	NN	_	14	nmod	_	_
31	daily	_	ADV	RB	_	34	advmod	_	_
32	for	_	ADP	IN	_	34	case	_	_
33	the	_	DET	DT	_	34	det	_	_
34	nonelderly	_	ADV	RB	_	14	advmod	_	_
35	,	_	.	,	_	39	punct	_	_
36	some	_	DET	DT	_	37	det	_	_
37	nonlinearity	_	NOUN	NN	_	39	nsubjpass	_	_
38	was	_	VERB	VBD	_	39	auxpass	_	_
39	observed	_	VERB	VBN	_	0	root	_	_
40	in	_	ADP	IN	_	42	case	_	_
41	both	_	DET	DT	_	42	det	_	_
42	populations	_	NOUN	NNS	_	39	nmod	_	_
43	,	_	.	,	_	39	punct	_	_
44	again	_	ADV	RB	_	45	advmod	_	_
45	reflecting	_	VERB	VBG	_	39	xcomp	_	_
46	a	_	DET	DT	_	49	det	_	_
47	saturable	_	ADJ	JJ	_	49	amod	_	_
48	metabolic	_	ADJ	JJ	_	49	amod	_	_
49	pathway	_	NOUN	NN	_	45	dobj	_	_

#	PAROXETINE	3605
1	In	_	ADP	IN	_	2	case	_	_
2	comparison	_	NOUN	NN	_	22	nmod	_	_
3	to	_	PRT	TO	_	5	case	_	_
4	Cmin	_	NOUN	NN	_	5	compound	_	_
5	values	_	NOUN	NNS	_	2	nmod	_	_
6	after	_	ADP	IN	_	8	case	_	_
7	20	_	NUM	CD	_	8	nummod	_	_
8	mg	_	NOUN	NN	_	2	nmod	_	_
9	daily	_	ADV	RB	_	2	advmod	_	_
10	,	_	.	,	_	22	punct	_	_
11	values	_	NOUN	NNS	_	22	nsubj	_	_
12	after	_	ADP	IN	_	14	case	_	_
13	40	_	NUM	CD	_	14	nummod	_	_
14	mg	_	NOUN	NN	_	11	nmod	_	_
15	daily	_	ADV	RB	_	22	advmod	_	_
16	were	_	VERB	VBD	_	22	cop	_	_
17	only	_	ADV	RB	_	19	advmod	_	_
18	about	_	ADV	RB	_	19	advmod	_	_
19	2	_	NUM	CD	_	21	compound	_	_
20	to	_	PRT	TO	_	21	dep	_	_
21	3	_	NUM	CD	_	22	nummod	_	_
22	times	_	NOUN	NNS	_	0	root	_	_
23	greater	_	ADJ	JJ	_	22	amod	_	_
24	than	_	ADP	IN	_	25	mark	_	_
25	doubled	_	VERB	VBN	_	23	conj	_	_

#	PAROXETINE	3606
1	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
2	is	_	VERB	VBZ	_	4	auxpass	_	_
3	extensively	_	ADV	RB	_	4	advmod	_	_
4	metabolized	_	VERB	VBN	_	0	root	_	_
5	after	_	ADP	IN	_	7	case	_	_
6	oral	_	ADJ	JJ	_	7	amod	_	_
7	administration	_	NOUN	NN	_	4	nmod	_	_

#	PAROXETINE	3607
1	The	_	DET	DT	_	3	det	_	_
2	principal	_	ADJ	JJ	_	3	amod	_	_
3	metabolites	_	NOUN	NNS	_	5	nsubj	_	_
4	are	_	VERB	VBP	_	5	cop	_	_
5	polar	_	ADJ	JJ	_	0	root	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	conjugated	_	VERB	VBN	_	5	conj	_	_
8	products	_	NOUN	NNS	_	5	dep	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	oxidation	_	NOUN	NN	_	5	nmod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	methylation	_	NOUN	NN	_	10	conj	_	_
13	,	_	.	,	_	10	punct	_	_
14	which	_	DET	WDT	_	17	nsubjpass	_	_
15	are	_	VERB	VBP	_	17	auxpass	_	_
16	readily	_	ADV	RB	_	17	advmod	_	_
17	cleared	_	VERB	VBN	_	10	acl:relcl	_	_

#	PAROXETINE	3608
1	Conjugates	_	VERB	VBZ	_	0	root	_	_
2	with	_	ADP	IN	_	4	case	_	_
3	glucuronic	_	ADJ	JJ	_	4	amod	_	_
4	acid	_	NOUN	NN	_	1	nmod	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	sulfate	_	NOUN	NN	_	7	compound	_	_
7	predominate	_	NOUN	NN	_	4	conj	_	_
8	,	_	.	,	_	1	punct	_	_
9	and	_	CONJ	CC	_	1	cc	_	_
10	major	_	ADJ	JJ	_	11	amod	_	_
11	metabolites	_	NOUN	NNS	_	14	nsubjpass	_	_
12	have	_	VERB	VBP	_	14	aux	_	_
13	been	_	VERB	VBN	_	14	auxpass	_	_
14	isolated	_	VERB	VBN	_	1	conj	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	identified	_	VERB	VBN	_	14	conj	_	_

#	PAROXETINE	3609
1	Data	_	NOUN	NN	_	2	nsubj	_	_
2	indicate	_	VERB	VBP	_	0	root	_	_
3	that	_	ADP	IN	_	6	mark	_	_
4	the	_	DET	DT	_	5	det	_	_
5	metabolites	_	NOUN	NNS	_	6	nsubj	_	_
6	have	_	VERB	VBP	_	2	ccomp	_	_
7	no	_	DET	DT	_	8	neg	_	_
8	more	_	ADV	RB	_	6	advmod	_	_
9	than	_	ADP	IN	_	14	case	_	_
10	1	_	NUM	CD	_	14	nummod	_	_
11	/	_	.	:	_	14	amod	_	_
12	50	_	NUM	CD	_	14	nummod	_	_
13	the	_	DET	DT	_	14	det	_	_
14	potency	_	NOUN	NN	_	8	dep	_	_
15	of	_	ADP	IN	_	18	case	_	_
16	the	_	DET	DT	_	18	det	_	_
17	parent	_	NOUN	NN	_	18	compound	_	_
18	compound	_	NOUN	NN	_	14	nmod	_	_
19	at	_	ADP	IN	_	20	mark	_	_
20	inhibiting	_	VERB	VBG	_	14	acl	_	_
21	serotonin	_	NOUN	NN	_	22	compound	_	_
22	uptake	_	NOUN	NN	_	20	dobj	_	_

#	PAROXETINE	3610
1	The	_	DET	DT	_	2	det	_	_
2	metabolism	_	NOUN	NN	_	6	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	is	_	VERB	VBZ	_	6	auxpass	_	_
6	accomplished	_	VERB	VBN	_	0	root	_	_
7	in	_	ADP	IN	_	8	case	_	_
8	part	_	NOUN	NN	_	6	nmod	_	_
9	by	_	ADP	IN	_	10	case	_	_
10	CYP2D6	_	NOUN	NN	_	6	nmod	_	_

#	PAROXETINE	3611
1	Saturation	_	NOUN	NN	_	8	nsubj	_	_
2	of	_	ADP	IN	_	4	case	_	_
3	this	_	DET	DT	_	4	det	_	_
4	enzyme	_	NOUN	NN	_	1	nmod	_	_
5	at	_	ADP	IN	_	7	case	_	_
6	clinical	_	ADJ	JJ	_	7	amod	_	_
7	doses	_	NOUN	NNS	_	1	nmod	_	_
8	appears	_	VERB	VBZ	_	0	root	_	_
9	to	_	PRT	TO	_	10	mark	_	_
10	account	_	VERB	VB	_	8	xcomp	_	_
11	for	_	ADP	IN	_	13	case	_	_
12	the	_	DET	DT	_	13	det	_	_
13	nonlinearity	_	NOUN	NN	_	10	nmod	_	_
14	of	_	ADP	IN	_	16	case	_	_
15	DRUG	_	NOUN	NN	_	16	compound	_	_
16	kinetics	_	NOUN	NNS	_	13	nmod	_	_
17	with	_	ADP	IN	_	18	mark	_	_
18	increasing	_	VERB	VBG	_	13	acl	_	_
19	dose	_	NOUN	NN	_	22	compound	_	_
20	and	_	CONJ	CC	_	19	cc	_	_
21	increasing	_	VERB	VBG	_	19	conj	_	_
22	duration	_	NOUN	NN	_	18	dobj	_	_
23	of	_	ADP	IN	_	24	case	_	_
24	treatment	_	NOUN	NN	_	22	nmod	_	_

#	PAROXETINE	3612
1	The	_	DET	DT	_	2	det	_	_
2	role	_	NOUN	NN	_	10	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	this	_	DET	DT	_	5	det	_	_
5	enzyme	_	NOUN	NN	_	2	nmod	_	_
6	in	_	ADP	IN	_	8	case	_	_
7	DRUG	_	NOUN	NN	_	8	compound	_	_
8	metabolism	_	NOUN	NN	_	2	nmod	_	_
9	also	_	ADV	RB	_	10	advmod	_	_
10	suggests	_	VERB	VBZ	_	0	root	_	_
11	potential	_	ADJ	JJ	_	14	amod	_	_
12	drug	_	NOUN	NN	_	14	compound	_	_
13	drug	_	NOUN	NN	_	14	compound	_	_
14	interactions	_	NOUN	NNS	_	10	dobj	_	_

#	PAROXETINE	3613
1	Approximately	_	ADV	RB	_	13	advmod	_	_
2	64%	_	NOUN	NN	_	13	nsubjpass	_	_
3	of	_	ADP	IN	_	9	case	_	_
4	a	_	DET	DT	_	9	det	_	_
5	30	_	NUM	CD	_	9	nummod	_	_
6	mg	_	NOUN	NN	_	9	compound	_	_
7	oral	_	ADJ	JJ	_	9	amod	_	_
8	solution	_	NOUN	NN	_	9	compound	_	_
9	dose	_	NOUN	NN	_	2	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_
12	was	_	VERB	VBD	_	13	auxpass	_	_
13	excreted	_	VERB	VBN	_	0	root	_	_
14	in	_	ADP	IN	_	16	case	_	_
15	the	_	DET	DT	_	16	det	_	_
16	urine	_	NOUN	NN	_	13	nmod	_	_
17	with	_	ADP	IN	_	18	case	_	_
18	2%	_	NOUN	NN	_	16	nmod	_	_
19	as	_	ADP	IN	_	22	case	_	_
20	the	_	DET	DT	_	22	det	_	_
21	parent	_	NOUN	NN	_	22	compound	_	_
22	compound	_	NOUN	NN	_	13	nmod	_	_
23	and	_	CONJ	CC	_	22	cc	_	_
24	62%	_	NOUN	NN	_	22	conj	_	_
25	as	_	ADP	IN	_	26	case	_	_
26	metabolites	_	NOUN	NNS	_	13	nmod	_	_
27	over	_	ADP	IN	_	33	case	_	_
28	a	_	DET	DT	_	33	det	_	_
29	10	_	NUM	CD	_	33	nummod	_	_
30	day	_	NOUN	NN	_	33	compound	_	_
31	post	_	NOUN	NN	_	33	compound	_	_
32	dosing	_	NOUN	NN	_	33	compound	_	_
33	period	_	NOUN	NN	_	26	nmod	_	_

#	PAROXETINE	3614
1	About	_	ADV	RB	_	2	advmod	_	_
2	36%	_	NOUN	NN	_	4	nsubjpass	_	_
3	was	_	VERB	VBD	_	4	auxpass	_	_
4	excreted	_	VERB	VBN	_	0	root	_	_
5	in	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	feces	_	NOUN	NNS	_	4	nmod	_	_
8	probably	_	ADV	RB	_	11	advmod	_	_
9	via	_	ADP	IN	_	11	case	_	_
10	the	_	DET	DT	_	11	det	_	_
11	bile	_	ADJ	JJ	_	4	nmod	_	_
12	,	_	.	,	_	4	punct	_	_
13	mostly	_	ADV	RB	_	15	advmod	_	_
14	as	_	ADP	IN	_	15	case	_	_
15	metabolites	_	NOUN	NNS	_	4	nmod	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	less	_	ADV	RB	_	19	advmod	_	_
18	than	_	ADP	IN	_	17	mwe	_	_
19	1%	_	ADJ	JJ	_	15	conj	_	_
20	as	_	ADP	IN	_	23	case	_	_
21	the	_	DET	DT	_	23	det	_	_
22	parent	_	NOUN	NN	_	23	compound	_	_
23	compound	_	NOUN	NN	_	19	nmod	_	_
24	over	_	ADP	IN	_	30	case	_	_
25	the	_	DET	DT	_	30	det	_	_
26	10	_	NUM	CD	_	30	nummod	_	_
27	day	_	NOUN	NN	_	30	compound	_	_
28	post	_	NOUN	NN	_	30	compound	_	_
29	dosing	_	NOUN	NN	_	30	compound	_	_
30	period	_	NOUN	NN	_	23	nmod	_	_

#	PAROXETINE	3615
1	Increased	_	VERB	VBN	_	3	amod	_	_
2	plasma	_	NOUN	NN	_	3	compound	_	_
3	concentrations	_	NOUN	NNS	_	6	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	occur	_	VERB	VBP	_	0	root	_	_
7	in	_	ADP	IN	_	8	case	_	_
8	subjects	_	NOUN	NNS	_	6	nmod	_	_
9	with	_	ADP	IN	_	13	case	_	_
10	renal	_	ADJ	JJ	_	13	amod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	hepatic	_	ADJ	JJ	_	10	conj	_	_
13	impairment	_	NOUN	NN	_	8	nmod	_	_

#	PAROXETINE	3616
1	The	_	DET	DT	_	4	det	_	_
2	mean	_	ADJ	JJ	_	4	amod	_	_
3	plasma	_	NOUN	NN	_	4	compound	_	_
4	concentrations	_	NOUN	NNS	_	10	nsubj	_	_
5	in	_	ADP	IN	_	6	case	_	_
6	patients	_	NOUN	NNS	_	4	nmod	_	_
7	with	_	ADP	IN	_	9	case	_	_
8	creatinine	_	NOUN	NN	_	9	compound	_	_
9	clearance	_	NOUN	NN	_	6	nmod	_	_
10	below	_	VERB	VBP	_	0	root	_	_
11	30	_	NUM	CD	_	12	nummod	_	_
12	mL	_	NOUN	NN	_	10	dobj	_	_
13	/	_	.	:	_	10	punct	_	_
14	min	_	NOUN	NN	_	18	nsubj	_	_
15	were	_	VERB	VBD	_	18	cop	_	_
16	approximately	_	ADV	RB	_	17	advmod	_	_
17	4	_	NUM	CD	_	18	nummod	_	_
18	times	_	NOUN	NNS	_	10	parataxis	_	_
19	greater	_	ADJ	JJ	_	18	amod	_	_
20	than	_	ADP	IN	_	21	mark	_	_
21	seen	_	VERB	VBN	_	19	advcl	_	_
22	in	_	ADP	IN	_	24	case	_	_
23	normal	_	ADJ	JJ	_	24	amod	_	_
24	volunteers	_	NOUN	NNS	_	21	nmod	_	_

#	PAROXETINE	3617
1	Patients	_	NOUN	NNS	_	0	root	_	_
2	with	_	ADP	IN	_	4	case	_	_
3	creatinine	_	NOUN	NN	_	4	compound	_	_
4	clearance	_	NOUN	NN	_	1	nmod	_	_
5	of	_	ADP	IN	_	9	case	_	_
6	30	_	NUM	CD	_	8	compound	_	_
7	to	_	PRT	TO	_	8	dep	_	_
8	60	_	NUM	CD	_	9	nummod	_	_
9	mL	_	NOUN	NN	_	4	nmod	_	_
10	/	_	.	:	_	1	punct	_	_
11	min	_	NOUN	NN	_	18	nsubj	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	patients	_	NOUN	NNS	_	11	conj	_	_
14	with	_	ADP	IN	_	17	case	_	_
15	hepatic	_	ADJ	JJ	_	17	amod	_	_
16	functional	_	ADJ	JJ	_	17	amod	_	_
17	impairment	_	NOUN	NN	_	11	nmod	_	_
18	had	_	VERB	VBD	_	1	dep	_	_
19	about	_	ADV	RB	_	23	case	_	_
20	a	_	DET	DT	_	23	det	_	_
21	2	_	NUM	CD	_	22	compound	_	_
22	fold	_	NOUN	NN	_	23	amod	_	_
23	increase	_	NOUN	NN	_	18	nmod	_	_
24	in	_	ADP	IN	_	26	case	_	_
25	plasma	_	NOUN	NN	_	26	compound	_	_
26	concentrations	_	NOUN	NNS	_	23	nmod	_	_
27	AUC	_	NOUN	NN	_	26	dep	_	_
28	,	_	.	,	_	27	punct	_	_
29	Cmax	_	NOUN	NN	_	27	appos	_	_

#	PAROXETINE	3618
1	The	_	DET	DT	_	3	det	_	_
2	initial	_	ADJ	JJ	_	3	amod	_	_
3	dosage	_	NOUN	NN	_	7	nsubjpass	_	_
4	should	_	VERB	MD	_	7	aux	_	_
5	therefore	_	ADV	RB	_	7	advmod	_	_
6	be	_	VERB	VB	_	7	auxpass	_	_
7	reduced	_	VERB	VBN	_	0	root	_	_
8	in	_	ADP	IN	_	9	case	_	_
9	patients	_	NOUN	NNS	_	7	nmod	_	_
10	with	_	ADP	IN	_	12	case	_	_
11	severe	_	ADJ	JJ	_	12	amod	_	_
12	renal	_	ADJ	JJ	_	9	nmod	_	_
13	or	_	CONJ	CC	_	12	cc	_	_
14	hepatic	_	ADJ	JJ	_	12	conj	_	_
15	impairment	_	NOUN	NN	_	12	dep	_	_
16	,	_	.	,	_	9	punct	_	_
17	and	_	CONJ	CC	_	9	cc	_	_
18	upward	_	NOUN	NN	_	19	compound	_	_
19	titration	_	NOUN	NN	_	9	conj	_	_
20	,	_	.	,	_	9	punct	_	_
21	if	_	ADP	IN	_	22	nsubj	_	_
22	necessary	_	ADJ	JJ	_	9	acl:relcl	_	_
23	,	_	.	,	_	7	punct	_	_
24	should	_	VERB	MD	_	28	aux	_	_
25	be	_	VERB	VB	_	28	cop	_	_
26	at	_	ADP	IN	_	28	case	_	_
27	increased	_	VERB	VBN	_	28	amod	_	_
28	intervals	_	NOUN	NNS	_	7	conj	_	_

#	PAROXETINE	3619
1	In	_	ADP	IN	_	5	case	_	_
2	a	_	DET	DT	_	5	det	_	_
3	multiple	_	ADJ	JJ	_	5	amod	_	_
4	dose	_	NOUN	NN	_	5	compound	_	_
5	study	_	NOUN	NN	_	25	nmod	_	_
6	in	_	ADP	IN	_	8	case	_	_
7	the	_	DET	DT	_	8	det	_	_
8	elderly	_	ADJ	JJ	_	5	nmod	_	_
9	at	_	ADP	IN	_	12	case	_	_
10	daily	_	ADV	RB	_	12	advmod	_	_
11	DRUG	_	NOUN	NN	_	12	compound	_	_
12	doses	_	NOUN	NNS	_	8	nmod	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	20	_	NUM	CD	_	12	nmod	_	_
15	,	_	.	,	_	14	punct	_	_
16	30	_	NUM	CD	_	14	conj	_	_
17	,	_	.	,	_	14	punct	_	_
18	and	_	CONJ	CC	_	14	cc	_	_
19	40mg	_	ADJ	JJ	_	14	conj	_	_
20	,	_	.	,	_	25	punct	_	_
21	Cmin	_	NOUN	NN	_	22	compound	_	_
22	concentrations	_	NOUN	NNS	_	25	nsubj	_	_
23	were	_	VERB	VBD	_	25	cop	_	_
24	about	_	ADV	RB	_	25	advmod	_	_
25	70%	_	ADJ	JJ	_	0	root	_	_
26	to	_	PRT	TO	_	27	case	_	_
27	80%	_	ADJ	JJ	_	25	nmod	_	_
28	greater	_	ADJ	JJ	_	27	amod	_	_
29	than	_	ADP	IN	_	33	case	_	_
30	the	_	DET	DT	_	33	det	_	_
31	respective	_	ADJ	JJ	_	33	amod	_	_
32	Cmin	_	NOUN	NN	_	33	compound	_	_
33	concentrations	_	NOUN	NNS	_	28	nmod	_	_
34	in	_	ADP	IN	_	36	case	_	_
35	nonelderly	_	ADJ	JJ	_	36	amod	_	_
36	subjects	_	NOUN	NNS	_	33	nmod	_	_

#	PAROXETINE	3620
1	Therefore	_	ADV	RB	_	10	advmod	_	_
2	the	_	DET	DT	_	4	det	_	_
3	initial	_	ADJ	JJ	_	4	amod	_	_
4	dosage	_	NOUN	NN	_	10	nsubjpass	_	_
5	in	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	elderly	_	NOUN	NN	_	4	nmod	_	_
8	should	_	VERB	MD	_	10	aux	_	_
9	be	_	VERB	VB	_	10	auxpass	_	_
10	reduced	_	VERB	VBN	_	0	root	_	_

#	PAROXETINE	3621
1	In	_	X	FW	_	5	amod	_	_
2	vitro	_	X	FW	_	1	dep	_	_
3	drug	_	NOUN	NN	_	5	compound	_	_
4	interaction	_	NOUN	NN	_	5	compound	_	_
5	studies	_	NOUN	NNS	_	6	nsubj	_	_
6	reveal	_	VERB	VBP	_	0	root	_	_
7	that	_	ADP	IN	_	9	mark	_	_
8	DRUG	_	NOUN	NN	_	9	nsubj	_	_
9	inhibits	_	VERB	VBZ	_	6	ccomp	_	_
10	CYP2D6	_	NOUN	NN	_	9	dobj	_	_

#	PAROXETINE	3622
1	Clinical	_	ADJ	JJ	_	4	amod	_	_
2	drug	_	NOUN	NN	_	4	compound	_	_
3	interaction	_	NOUN	NN	_	4	compound	_	_
4	studies	_	NOUN	NNS	_	7	nsubjpass	_	_
5	have	_	VERB	VBP	_	7	aux	_	_
6	been	_	VERB	VBN	_	7	auxpass	_	_
7	performed	_	VERB	VBN	_	0	root	_	_
8	with	_	ADP	IN	_	9	case	_	_
9	substrates	_	NOUN	NNS	_	7	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	CYP2D6	_	NOUN	NN	_	9	nmod	_	_
12	and	_	CONJ	CC	_	7	cc	_	_
13	show	_	VERB	VBP	_	7	conj	_	_
14	that	_	ADP	IN	_	17	mark	_	_
15	DRUG	_	NOUN	NN	_	17	nsubj	_	_
16	can	_	VERB	MD	_	17	aux	_	_
17	inhibit	_	VERB	VB	_	13	ccomp	_	_
18	the	_	DET	DT	_	19	det	_	_
19	metabolism	_	NOUN	NN	_	17	dobj	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	drugs	_	NOUN	NNS	_	19	nmod	_	_
22	metabolized	_	VERB	VBN	_	21	acl	_	_
23	by	_	ADP	IN	_	24	case	_	_
24	CYP2D6	_	NOUN	NN	_	22	nmod	_	_
25	including	_	ADP	IN	_	26	case	_	_
26	desipramine	_	NOUN	NN	_	24	nmod	_	_
27	,	_	.	,	_	26	punct	_	_
28	risperidone	_	NOUN	NN	_	26	conj	_	_
29	,	_	.	,	_	26	punct	_	_
30	and	_	CONJ	CC	_	26	cc	_	_
31	atomoxetine	_	NOUN	NN	_	26	conj	_	_

#	PAROXETINE	3623
1	The	_	DET	DT	_	2	det	_	_
2	efficacy	_	NOUN	NN	_	14	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	as	_	ADP	IN	_	7	case	_	_
6	a	_	DET	DT	_	7	det	_	_
7	treatment	_	NOUN	NN	_	2	nmod	_	_
8	for	_	ADP	IN	_	11	case	_	_
9	major	_	ADJ	JJ	_	11	amod	_	_
10	depressive	_	ADJ	JJ	_	11	amod	_	_
11	disorder	_	NOUN	NN	_	7	nmod	_	_
12	has	_	VERB	VBZ	_	14	aux	_	_
13	been	_	VERB	VBN	_	14	auxpass	_	_
14	established	_	VERB	VBN	_	0	root	_	_
15	in	_	ADP	IN	_	19	case	_	_
16	6	_	NUM	CD	_	17	nummod	_	_
17	placebo	_	NOUN	NN	_	19	amod	_	_
18	controlled	_	VERB	VBN	_	19	amod	_	_
19	studies	_	NOUN	NNS	_	14	nmod	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	patients	_	NOUN	NNS	_	19	nmod	_	_
22	with	_	ADP	IN	_	25	case	_	_
23	major	_	ADJ	JJ	_	25	amod	_	_
24	depressive	_	ADJ	JJ	_	25	amod	_	_
25	disorder	_	NOUN	NN	_	21	nmod	_	_
26	aged	_	ADJ	JJ	_	25	amod	_	_
27	18	_	NUM	CD	_	29	compound	_	_
28	to	_	PRT	TO	_	29	dep	_	_
29	73	_	NUM	CD	_	26	nmod	_	_

#	PAROXETINE	3624
1	In	_	ADP	IN	_	3	case	_	_
2	these	_	DET	DT	_	3	det	_	_
3	studies	_	NOUN	NNS	_	7	nmod	_	_
4	,	_	.	,	_	7	punct	_	_
5	DRUG	_	NOUN	NN	_	7	nsubjpass	_	_
6	was	_	VERB	VBD	_	7	auxpass	_	_
7	shown	_	VERB	VBN	_	0	root	_	_
8	to	_	PRT	TO	_	12	mark	_	_
9	be	_	VERB	VB	_	12	cop	_	_
10	significantly	_	ADV	RB	_	12	advmod	_	_
11	more	_	ADV	RB	_	12	advmod	_	_
12	effective	_	ADJ	JJ	_	7	xcomp	_	_
13	than	_	ADP	IN	_	14	case	_	_
14	placebo	_	NOUN	NN	_	12	nmod	_	_
15	in	_	ADP	IN	_	16	mark	_	_
16	treating	_	VERB	VBG	_	12	advcl	_	_
17	major	_	ADJ	JJ	_	19	amod	_	_
18	depressive	_	ADJ	JJ	_	19	amod	_	_
19	disorder	_	NOUN	NN	_	16	dobj	_	_
20	by	_	ADP	IN	_	22	case	_	_
21	at	_	ADP	IN	_	22	case	_	_
22	least	_	ADJ	JJS	_	16	nmod	_	_
23	2	_	NUM	CD	_	22	nummod	_	_
24	of	_	ADP	IN	_	27	case	_	_
25	the	_	DET	DT	_	27	det	_	_
26	following	_	VERB	VBG	_	27	amod	_	_
27	measures	_	NOUN	NNS	_	22	nmod	_	_
28	:	_	.	:	_	7	punct	_	_
29	Hamilton	_	NOUN	NN	_	30	compound	_	_
30	Depression	_	NOUN	NN	_	7	dep	_	_
31	Rating	_	VERB	VBG	_	30	acl	_	_
32	Scale	_	NOUN	NN	_	33	compound	_	_
33	HDRS	_	NOUN	NN	_	31	dobj	_	_
34	,	_	.	,	_	30	punct	_	_
35	the	_	DET	DT	_	36	det	_	_
36	Hamilton	_	NOUN	NN	_	37	nsubj	_	_
37	depressed	_	VERB	VBD	_	30	conj	_	_
38	mood	_	NOUN	NN	_	39	compound	_	_
39	item	_	NOUN	NN	_	37	dobj	_	_
40	,	_	.	,	_	30	punct	_	_
41	and	_	CONJ	CC	_	30	cc	_	_
42	the	_	DET	DT	_	47	det	_	_
43	Clinical	_	ADJ	JJ	_	47	amod	_	_
44	Global	_	ADJ	JJ	_	47	amod	_	_
45	Impression	_	NOUN	NN	_	47	compound	_	_
46	CGI	_	NOUN	NN	_	47	compound	_	_
47	Severity	_	NOUN	NN	_	30	conj	_	_
48	of	_	ADP	IN	_	49	case	_	_
49	Illness	_	NOUN	NN	_	47	nmod	_	_

#	PAROXETINE	3625
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	was	_	VERB	VBD	_	4	cop	_	_
3	significantly	_	ADV	RB	_	4	advmod	_	_
4	better	_	ADV	RB	_	0	root	_	_
5	than	_	ADP	IN	_	6	case	_	_
6	placebo	_	NOUN	NN	_	4	nmod	_	_
7	in	_	ADP	IN	_	8	case	_	_
8	improvement	_	NOUN	NN	_	4	nmod	_	_
9	of	_	ADP	IN	_	14	case	_	_
10	the	_	DET	DT	_	14	det	_	_
11	HDRS	_	NOUN	NN	_	14	compound	_	_
12	sub	_	NOUN	NN	_	14	compound	_	_
13	factor	_	NOUN	NN	_	14	compound	_	_
14	scores	_	NOUN	NNS	_	8	nmod	_	_
15	,	_	.	,	_	14	punct	_	_
16	including	_	VERB	VBG	_	20	case	_	_
17	the	_	DET	DT	_	20	det	_	_
18	depressed	_	VERB	VBN	_	20	amod	_	_
19	mood	_	NOUN	NN	_	20	compound	_	_
20	item	_	NOUN	NN	_	14	nmod	_	_
21	,	_	.	,	_	20	punct	_	_
22	sleep	_	NOUN	NN	_	24	compound	_	_
23	disturbance	_	NOUN	NN	_	24	compound	_	_
24	factor	_	NOUN	NN	_	20	conj	_	_
25	,	_	.	,	_	20	punct	_	_
26	and	_	CONJ	CC	_	20	cc	_	_
27	anxiety	_	NOUN	NN	_	28	compound	_	_
28	factor	_	NOUN	NN	_	20	conj	_	_

#	PAROXETINE	3626
1	A	_	DET	DT	_	2	det	_	_
2	study	_	NOUN	NN	_	39	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	outpatients	_	NOUN	NNS	_	2	nmod	_	_
5	with	_	ADP	IN	_	8	case	_	_
6	major	_	ADJ	JJ	_	8	amod	_	_
7	depressive	_	ADJ	JJ	_	8	amod	_	_
8	disorder	_	NOUN	NN	_	4	nmod	_	_
9	who	_	DET	WDT	_	11	nsubj	_	_
10	had	_	VERB	MD	_	11	aux	_	_
11	responded	_	VERB	VBN	_	8	acl:relcl	_	_
12	to	_	PRT	TO	_	16	case	_	_
13	DRUG	_	NOUN	NN	_	16	compound	_	_
14	HDRS	_	NOUN	NN	_	16	compound	_	_
15	total	_	ADJ	JJ	_	16	amod	_	_
16	score	_	NOUN	NN	_	11	nmod	_	_
17	<8	_	NUM	CD	_	16	nummod	_	_
18	during	_	ADP	IN	_	25	case	_	_
19	an	_	DET	DT	_	25	det	_	_
20	initial	_	ADJ	JJ	_	25	amod	_	_
21	8	_	NUM	CD	_	25	nummod	_	_
22	week	_	NOUN	NN	_	25	compound	_	_
23	open	_	ADJ	JJ	_	25	amod	_	_
24	treatment	_	NOUN	NN	_	25	compound	_	_
25	phase	_	NOUN	NN	_	11	nmod	_	_
26	and	_	CONJ	CC	_	11	cc	_	_
27	were	_	VERB	VBD	_	29	auxpass	_	_
28	then	_	ADV	RB	_	29	advmod	_	_
29	randomized	_	VERB	VBN	_	11	conj	_	_
30	to	_	PRT	TO	_	31	case	_	_
31	continuation	_	NOUN	NN	_	29	nmod	_	_
32	on	_	ADP	IN	_	33	case	_	_
33	DRUG	_	NOUN	NN	_	31	nmod	_	_
34	or	_	CONJ	CC	_	33	cc	_	_
35	placebo	_	NOUN	NN	_	33	conj	_	_
36	for	_	ADP	IN	_	38	case	_	_
37	1	_	NUM	CD	_	38	nummod	_	_
38	year	_	NOUN	NN	_	31	nmod	_	_
39	demonstrated	_	VERB	VBD	_	0	root	_	_
40	a	_	DET	DT	_	44	det	_	_
41	significantly	_	ADV	RB	_	42	advmod	_	_
42	lower	_	ADJ	JJ	_	44	amod	_	_
43	relapse	_	NOUN	NN	_	44	compound	_	_
44	rate	_	NOUN	NN	_	39	dobj	_	_
45	for	_	ADP	IN	_	46	case	_	_
46	patients	_	NOUN	NNS	_	44	nmod	_	_
47	taking	_	VERB	VBG	_	46	acl	_	_
48	DRUG	_	NOUN	NN	_	49	compound	_	_
49	15%	_	NOUN	NN	_	47	dobj	_	_
50	compared	_	VERB	VBN	_	39	xcomp	_	_
51	to	_	PRT	TO	_	52	case	_	_
52	those	_	DET	DT	_	50	nmod	_	_
53	on	_	ADP	IN	_	55	case	_	_
54	placebo	_	NOUN	NN	_	55	compound	_	_
55	39%	_	ADJ	JJ	_	52	nmod	_	_

#	PAROXETINE	3627
1	Effectiveness	_	NOUN	NN	_	3	nsubj	_	_
2	was	_	VERB	VBD	_	3	cop	_	_
3	similar	_	ADJ	JJ	_	0	root	_	_
4	for	_	ADP	IN	_	8	case	_	_
5	male	_	ADJ	JJ	_	8	amod	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	female	_	ADJ	JJ	_	5	conj	_	_
8	patients	_	NOUN	NNS	_	3	nmod	_	_

#	PAROXETINE	3628
1	The	_	DET	DT	_	2	det	_	_
2	effectiveness	_	NOUN	NN	_	14	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	in	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	treatment	_	NOUN	NN	_	2	nmod	_	_
8	of	_	ADP	IN	_	12	case	_	_
9	obsessive	_	ADJ	JJ	_	12	amod	_	_
10	compulsive	_	ADJ	JJ	_	12	amod	_	_
11	disorder	_	NOUN	NN	_	12	compound	_	_
12	OCD	_	NOUN	NN	_	7	nmod	_	_
13	was	_	VERB	VBD	_	14	auxpass	_	_
14	demonstrated	_	VERB	VBN	_	0	root	_	_
15	in	_	ADP	IN	_	20	case	_	_
16	two	_	NUM	CD	_	20	nummod	_	_
17	12	_	NUM	CD	_	20	nummod	_	_
18	week	_	NOUN	NN	_	20	compound	_	_
19	multicenter	_	ADJ	JJ	_	20	amod	_	_
20	placebo	_	NOUN	NN	_	14	nmod	_	_
21	controlled	_	VERB	VBN	_	22	amod	_	_
22	studies	_	NOUN	NNS	_	14	nmod	_	_
23	of	_	ADP	IN	_	25	case	_	_
24	adult	_	ADJ	JJ	_	25	amod	_	_
25	outpatients	_	NOUN	NNS	_	22	nmod	_	_
26	Studies	_	NOUN	NNS	_	25	dep	_	_
27	1	_	NUM	CD	_	26	punct	_	_
28	and	_	CONJ	CC	_	27	cc	_	_
29	2	_	NUM	CD	_	27	conj	_	_

#	PAROXETINE	3629
1	Patients	_	NOUN	NNS	_	6	nsubj	_	_
2	in	_	ADP	IN	_	4	case	_	_
3	all	_	DET	DT	_	4	det	_	_
4	studies	_	NOUN	NNS	_	1	nmod	_	_
5	had	_	VERB	VBD	_	6	aux	_	_
6	moderate	_	ADJ	JJ	_	0	root	_	_
7	to	_	PRT	TO	_	11	case	_	_
8	severe	_	ADJ	JJ	_	11	amod	_	_
9	OCD	_	NOUN	NN	_	11	compound	_	_
10	DSM	_	NOUN	NN	_	11	compound	_	_
11	IIIR	_	NOUN	NN	_	6	nmod	_	_
12	with	_	ADP	IN	_	15	case	_	_
13	mean	_	ADJ	JJ	_	15	amod	_	_
14	baseline	_	NOUN	NN	_	15	compound	_	_
15	ratings	_	NOUN	NNS	_	6	nmod	_	_
16	on	_	ADP	IN	_	25	case	_	_
17	the	_	DET	DT	_	25	det	_	_
18	Yale	_	NOUN	NN	_	25	compound	_	_
19	Brown	_	VERB	VBN	_	25	amod	_	_
20	Obsessive	_	ADJ	JJ	_	25	amod	_	_
21	Compulsive	_	ADJ	JJ	_	25	amod	_	_
22	Scale	_	NOUN	NN	_	25	compound	_	_
23	YBOCS	_	NOUN	NN	_	25	compound	_	_
24	total	_	ADJ	JJ	_	25	amod	_	_
25	score	_	NOUN	NN	_	15	nmod	_	_
26	ranging	_	VERB	VBG	_	25	acl	_	_
27	from	_	ADP	IN	_	30	case	_	_
28	23	_	NUM	CD	_	30	compound	_	_
29	to	_	PRT	TO	_	30	dep	_	_
30	26	_	NUM	CD	_	26	nmod	_	_

#	PAROXETINE	3630
1	Study	_	NOUN	NN	_	0	root	_	_
2	1	_	NUM	CD	_	1	nummod	_	_
3	,	_	.	,	_	1	punct	_	_
4	a	_	DET	DT	_	8	det	_	_
5	dose	_	NOUN	NN	_	8	compound	_	_
6	range	_	NOUN	NN	_	8	compound	_	_
7	finding	_	NOUN	NN	_	8	compound	_	_
8	study	_	NOUN	NN	_	1	appos	_	_
9	where	_	ADV	WRB	_	12	advmod	_	_
10	patients	_	NOUN	NNS	_	12	nsubjpass	_	_
11	were	_	VERB	VBD	_	12	auxpass	_	_
12	treated	_	VERB	VBN	_	8	acl:relcl	_	_
13	with	_	ADP	IN	_	15	case	_	_
14	fixed	_	VERB	VBN	_	15	amod	_	_
15	doses	_	NOUN	NNS	_	12	nmod	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	20	_	NUM	CD	_	15	nmod	_	_
18	,	_	.	,	_	17	punct	_	_
19	40	_	NUM	CD	_	17	conj	_	_
20	,	_	.	,	_	17	punct	_	_
21	or	_	CONJ	CC	_	17	cc	_	_
22	60	_	NUM	CD	_	17	conj	_	_
23	mg	_	NOUN	NN	_	17	dep	_	_
24	of	_	ADP	IN	_	25	case	_	_
25	DRUG	_	NOUN	NN	_	17	nmod	_	_
26	/	_	.	:	_	1	punct	_	_
27	day	_	NOUN	NN	_	28	nsubj	_	_
28	demonstrated	_	VERB	VBD	_	1	dep	_	_
29	that	_	ADP	IN	_	39	mark	_	_
30	daily	_	ADV	RB	_	31	amod	_	_
31	doses	_	NOUN	NNS	_	39	nsubj	_	_
32	of	_	ADP	IN	_	33	case	_	_
33	DRUG	_	NOUN	NN	_	31	nmod	_	_
34	40	_	NUM	CD	_	33	nummod	_	_
35	and	_	CONJ	CC	_	33	cc	_	_
36	60	_	NUM	CD	_	37	nummod	_	_
37	mg	_	NOUN	NN	_	33	conj	_	_
38	are	_	VERB	VBP	_	39	cop	_	_
39	effective	_	ADJ	JJ	_	28	ccomp	_	_
40	in	_	ADP	IN	_	42	case	_	_
41	the	_	DET	DT	_	42	det	_	_
42	treatment	_	NOUN	NN	_	39	nmod	_	_
43	of	_	ADP	IN	_	44	case	_	_
44	OCD	_	NOUN	NN	_	42	nmod	_	_

#	PAROXETINE	3631
1	Patients	_	NOUN	NNS	_	10	nsubj	_	_
2	receiving	_	VERB	VBG	_	1	acl	_	_
3	doses	_	NOUN	NNS	_	2	dobj	_	_
4	of	_	ADP	IN	_	9	case	_	_
5	40	_	NUM	CD	_	9	nummod	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	60	_	NUM	CD	_	5	conj	_	_
8	mg	_	NOUN	NN	_	9	compound	_	_
9	DRUG	_	NOUN	NN	_	3	nmod	_	_
10	experienced	_	VERB	VBD	_	0	root	_	_
11	a	_	DET	DT	_	13	det	_	_
12	mean	_	ADJ	JJ	_	13	amod	_	_
13	reduction	_	NOUN	NN	_	10	dobj	_	_
14	of	_	ADP	IN	_	19	case	_	_
15	approximately	_	ADV	RB	_	16	advmod	_	_
16	6	_	NUM	CD	_	19	nummod	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	7	_	NUM	CD	_	16	conj	_	_
19	points	_	NOUN	NNS	_	13	nmod	_	_
20	,	_	.	,	_	13	punct	_	_
21	respectively	_	ADV	RB	_	13	advmod	_	_
22	,	_	.	,	_	13	punct	_	_
23	on	_	ADP	IN	_	27	case	_	_
24	the	_	DET	DT	_	27	det	_	_
25	YBOCS	_	NOUN	NN	_	27	compound	_	_
26	total	_	ADJ	JJ	_	27	amod	_	_
27	score	_	NOUN	NN	_	13	nmod	_	_
28	which	_	DET	WDT	_	31	nsubj	_	_
29	was	_	VERB	VBD	_	31	cop	_	_
30	significantly	_	ADV	RB	_	31	advmod	_	_
31	greater	_	ADJ	JJ	_	27	acl:relcl	_	_
32	than	_	ADP	IN	_	37	case	_	_
33	the	_	DET	DT	_	37	det	_	_
34	approximate	_	ADJ	JJ	_	37	amod	_	_
35	4	_	NUM	CD	_	37	nummod	_	_
36	point	_	NOUN	NN	_	37	compound	_	_
37	reduction	_	NOUN	NN	_	31	nmod	_	_
38	at	_	ADP	IN	_	40	case	_	_
39	20	_	NUM	CD	_	40	nummod	_	_
40	mg	_	NOUN	NN	_	31	nmod	_	_
41	and	_	CONJ	CC	_	31	cc	_	_
42	a	_	DET	DT	_	45	det	_	_
43	3	_	NUM	CD	_	45	nummod	_	_
44	point	_	NOUN	NN	_	45	compound	_	_
45	reduction	_	NOUN	NN	_	31	conj	_	_
46	in	_	ADP	IN	_	50	case	_	_
47	the	_	DET	DT	_	50	det	_	_
48	placebo	_	NOUN	NN	_	50	compound	_	_
49	treated	_	ADJ	JJ	_	50	amod	_	_
50	patients	_	NOUN	NNS	_	45	nmod	_	_

#	PAROXETINE	3632
1	Study	_	NOUN	NN	_	7	nsubj	_	_
2	2	_	NUM	CD	_	1	nummod	_	_
3	was	_	VERB	VBD	_	7	cop	_	_
4	a	_	DET	DT	_	7	det	_	_
5	flexible	_	ADJ	JJ	_	7	amod	_	_
6	dose	_	NOUN	NN	_	7	compound	_	_
7	study	_	NOUN	NN	_	0	root	_	_
8	comparing	_	VERB	VBG	_	7	acl	_	_
9	DRUG	_	NOUN	NN	_	13	compound	_	_
10	20	_	NUM	CD	_	12	compound	_	_
11	to	_	PRT	TO	_	12	dep	_	_
12	60	_	NUM	CD	_	13	nummod	_	_
13	mg	_	NOUN	NN	_	8	dobj	_	_
14	daily	_	ADV	RB	_	8	advmod	_	_
15	with	_	ADP	IN	_	16	case	_	_
16	clomipramine	_	NOUN	NN	_	8	nmod	_	_
17	25	_	NUM	CD	_	16	nummod	_	_
18	to	_	PRT	TO	_	20	case	_	_
19	250	_	NUM	CD	_	20	nummod	_	_
20	mg	_	NOUN	NN	_	8	nmod	_	_
21	daily	_	ADV	RB	_	7	neg	_	_

#	PAROXETINE	3633
1	In	_	ADP	IN	_	3	case	_	_
2	this	_	DET	DT	_	3	det	_	_
3	study	_	NOUN	NN	_	8	nmod	_	_
4	,	_	.	,	_	8	punct	_	_
5	patients	_	NOUN	NNS	_	8	nsubj	_	_
6	receiving	_	VERB	VBG	_	5	acl	_	_
7	DRUG	_	NOUN	NN	_	6	dobj	_	_
8	experienced	_	VERB	VBD	_	0	root	_	_
9	a	_	DET	DT	_	11	det	_	_
10	mean	_	ADJ	JJ	_	11	amod	_	_
11	reduction	_	NOUN	NN	_	8	dobj	_	_
12	of	_	ADP	IN	_	15	case	_	_
13	approximately	_	ADV	RB	_	14	advmod	_	_
14	7	_	NUM	CD	_	15	nummod	_	_
15	points	_	NOUN	NNS	_	11	nmod	_	_
16	on	_	ADP	IN	_	20	case	_	_
17	the	_	DET	DT	_	20	det	_	_
18	YBOCS	_	NOUN	NN	_	20	compound	_	_
19	total	_	ADJ	JJ	_	20	amod	_	_
20	score	_	NOUN	NN	_	11	nmod	_	_
21	,	_	.	,	_	20	punct	_	_
22	which	_	DET	WDT	_	25	nsubj	_	_
23	was	_	VERB	VBD	_	25	cop	_	_
24	significantly	_	ADV	RB	_	25	advmod	_	_
25	greater	_	ADJ	JJ	_	20	acl:relcl	_	_
26	than	_	ADP	IN	_	29	case	_	_
27	the	_	DET	DT	_	29	det	_	_
28	mean	_	NOUN	NN	_	29	amod	_	_
29	reduction	_	NOUN	NN	_	25	nmod	_	_
30	of	_	ADP	IN	_	33	case	_	_
31	approximately	_	ADV	RB	_	32	advmod	_	_
32	4	_	NUM	CD	_	33	nummod	_	_
33	points	_	NOUN	NNS	_	29	nmod	_	_
34	in	_	ADP	IN	_	37	case	_	_
35	placebo	_	NOUN	NN	_	37	compound	_	_
36	treated	_	ADJ	JJ	_	37	amod	_	_
37	patients	_	NOUN	NNS	_	29	nmod	_	_

#	PAROXETINE	3634
1	The	_	DET	DT	_	3	det	_	_
2	following	_	VERB	VBG	_	3	amod	_	_
3	table	_	ADJ	JJ	_	4	nsubj	_	_
4	provides	_	VERB	VBZ	_	0	root	_	_
5	the	_	DET	DT	_	7	det	_	_
6	outcome	_	NOUN	NN	_	7	compound	_	_
7	classification	_	NOUN	NN	_	4	dobj	_	_
8	by	_	ADP	IN	_	10	case	_	_
9	treatment	_	NOUN	NN	_	10	compound	_	_
10	group	_	NOUN	NN	_	7	nmod	_	_
11	on	_	ADP	IN	_	14	case	_	_
12	Global	_	ADJ	JJ	_	14	amod	_	_
13	Improvement	_	NOUN	NN	_	14	compound	_	_
14	items	_	NOUN	NNS	_	7	nmod	_	_
15	of	_	ADP	IN	_	21	case	_	_
16	the	_	DET	DT	_	21	det	_	_
17	Clinical	_	ADJ	JJ	_	21	amod	_	_
18	Global	_	ADJ	JJ	_	21	amod	_	_
19	Impression	_	NOUN	NN	_	21	compound	_	_
20	CGI	_	NOUN	NN	_	21	compound	_	_
21	scale	_	NOUN	NN	_	14	nmod	_	_
22	for	_	ADP	IN	_	23	case	_	_
23	Study	_	NOUN	NN	_	21	nmod	_	_
24	1	_	NUM	CD	_	23	nummod	_	_

#	PAROXETINE	3635
1	Outcome	_	NOUN	NN	_	3	compound	_	_
2	Classification	_	NOUN	NN	_	3	compound	_	_
3	%	_	NOUN	NN	_	42	nsubj	_	_
4	on	_	ADP	IN	_	8	case	_	_
5	CGI	_	NOUN	NN	_	8	compound	_	_
6	Global	_	ADJ	JJ	_	8	amod	_	_
7	Improvement	_	NOUN	NN	_	8	compound	_	_
8	Item	_	NOUN	NN	_	3	nmod	_	_
9	for	_	ADP	IN	_	10	case	_	_
10	Completers	_	NOUN	NNS	_	8	nmod	_	_
11	in	_	ADP	IN	_	40	case	_	_
12	Study	_	NOUN	NN	_	40	compound	_	_
13	1	_	NUM	CD	_	40	nummod	_	_
14	Outcome	_	NOUN	NN	_	40	compound	_	_
15	Classification	_	NOUN	NN	_	40	compound	_	_
16	Placebo	_	NOUN	NN	_	40	compound	_	_
17	n=74	_	NOUN	NN	_	40	compound	_	_
18	DRUG	_	NOUN	NN	_	40	compound	_	_
19	20	_	NUM	CD	_	40	nummod	_	_
20	mg	_	NOUN	NN	_	40	compound	_	_
21	DRUG	_	NOUN	NN	_	40	compound	_	_
22	40	_	NUM	CD	_	40	nummod	_	_
23	mg	_	NOUN	NN	_	40	compound	_	_
24	DRUG	_	NOUN	NN	_	40	compound	_	_
25	60	_	NUM	CD	_	40	nummod	_	_
26	mg	_	NOUN	NN	_	40	compound	_	_
27	n=75	_	NOUN	NN	_	40	compound	_	_
28	n=66	_	NOUN	NN	_	40	compound	_	_
29	n=66	_	NOUN	NN	_	40	compound	_	_
30	Worse	_	NOUN	NN	_	40	compound	_	_
31	14%	_	ADJ	JJ	_	40	amod	_	_
32	7%	_	ADJ	JJ	_	40	amod	_	_
33	7%	_	ADJ	JJ	_	40	amod	_	_
34	3%	_	ADJ	JJ	_	40	amod	_	_
35	No	_	NOUN	NN	_	40	compound	_	_
36	Change	_	NOUN	NN	_	40	compound	_	_
37	44%	_	ADJ	JJ	_	40	amod	_	_
38	35%	_	ADJ	JJ	_	40	amod	_	_
39	22%	_	ADJ	JJ	_	40	amod	_	_
40	19%	_	ADJ	JJ	_	10	nmod	_	_
41	Minimally	_	ADV	RB	_	42	advmod	_	_
42	Improved	_	VERB	VBN	_	64	advcl	_	_
43	24%	_	ADJ	JJ	_	61	amod	_	_
44	33%	_	ADJ	JJ	_	61	amod	_	_
45	29%	_	ADJ	JJ	_	61	amod	_	_
46	34%	_	ADJ	JJ	_	61	amod	_	_
47	Much	_	ADJ	JJ	_	61	amod	_	_
48	Improved	_	VERB	VBN	_	61	amod	_	_
49	11%	_	ADJ	JJ	_	61	amod	_	_
50	18%	_	ADJ	JJ	_	61	amod	_	_
51	22%	_	ADJ	JJ	_	61	amod	_	_
52	24%	_	ADJ	JJ	_	61	amod	_	_
53	Very	_	NOUN	NN	_	61	compound	_	_
54	Much	_	ADJ	JJ	_	61	amod	_	_
55	Improved	_	VERB	VBN	_	61	amod	_	_
56	7%	_	ADJ	JJ	_	61	amod	_	_
57	7%	_	ADJ	JJ	_	61	amod	_	_
58	20%	_	ADJ	JJ	_	61	amod	_	_
59	20%	_	ADJ	JJ	_	61	amod	_	_
60	Subgroup	_	NOUN	NN	_	61	compound	_	_
61	analyses	_	NOUN	NNS	_	42	dobj	_	_
62	did	_	VERB	MD	_	64	aux	_	_
63	not	_	ADV	RB	_	64	neg	_	_
64	indicate	_	VERB	VB	_	0	root	_	_
65	that	_	ADP	IN	_	67	mark	_	_
66	there	_	DET	EX	_	67	expl	_	_
67	were	_	VERB	VBD	_	64	root	_	_
68	any	_	DET	DT	_	69	det	_	_
69	differences	_	NOUN	NNS	_	67	nsubj	_	_
70	in	_	ADP	IN	_	72	case	_	_
71	treatment	_	NOUN	NN	_	72	compound	_	_
72	outcomes	_	NOUN	NNS	_	69	nmod	_	_
73	as	_	ADP	IN	_	75	case	_	_
74	a	_	DET	DT	_	75	det	_	_
75	function	_	NOUN	NN	_	67	nmod	_	_
76	of	_	ADP	IN	_	77	case	_	_
77	age	_	NOUN	NN	_	75	nmod	_	_
78	or	_	CONJ	CC	_	67	cc	_	_
79	gender	_	NOUN	NN	_	67	conj	_	_

#	PAROXETINE	3636
1	The	_	DET	DT	_	5	det	_	_
2	long	_	ADJ	JJ	_	5	amod	_	_
3	term	_	NOUN	NN	_	5	compound	_	_
4	maintenance	_	NOUN	NN	_	5	compound	_	_
5	effects	_	NOUN	NNS	_	11	nsubjpass	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	in	_	ADP	IN	_	9	case	_	_
9	OCD	_	NOUN	NN	_	5	nmod	_	_
10	were	_	VERB	VBD	_	11	auxpass	_	_
11	demonstrated	_	VERB	VBN	_	0	root	_	_
12	in	_	ADP	IN	_	16	case	_	_
13	a	_	DET	DT	_	16	det	_	_
14	long	_	ADJ	JJ	_	16	amod	_	_
15	term	_	NOUN	NN	_	16	compound	_	_
16	extension	_	NOUN	NN	_	11	nmod	_	_
17	to	_	PRT	TO	_	18	case	_	_
18	Study	_	NOUN	NN	_	16	nmod	_	_
19	1	_	NUM	CD	_	18	nummod	_	_

#	PAROXETINE	3637
1	Patients	_	NOUN	NNS	_	0	root	_	_
2	who	_	DET	WDT	_	4	nsubj	_	_
3	were	_	VERB	VBD	_	4	cop	_	_
4	responders	_	NOUN	NNS	_	1	nmod	_	_
5	on	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	during	_	ADP	IN	_	13	case	_	_
8	the	_	DET	DT	_	13	det	_	_
9	3	_	NUM	CD	_	13	nummod	_	_
10	month	_	NOUN	NN	_	13	compound	_	_
11	double	_	ADJ	JJ	_	13	amod	_	_
12	blind	_	NOUN	NN	_	13	compound	_	_
13	phase	_	NOUN	NN	_	4	nmod	_	_
14	and	_	CONJ	CC	_	4	cc	_	_
15	a	_	DET	DT	_	18	det	_	_
16	6	_	NUM	CD	_	18	nummod	_	_
17	month	_	NOUN	NN	_	18	compound	_	_
18	extension	_	NOUN	NN	_	30	nsubjpass	_	_
19	on	_	ADP	IN	_	22	case	_	_
20	open	_	ADJ	JJ	_	22	amod	_	_
21	label	_	NOUN	NN	_	22	compound	_	_
22	DRUG	_	NOUN	NN	_	18	nmod	_	_
23	20	_	NUM	CD	_	22	nummod	_	_
24	to	_	PRT	TO	_	28	case	_	_
25	60	_	NUM	CD	_	26	nummod	_	_
26	mg	_	NOUN	NN	_	28	amod	_	_
27	/	_	.	:	_	28	punct	_	_
28	day	_	NOUN	NN	_	18	nmod	_	_
29	were	_	VERB	VBD	_	30	auxpass	_	_
30	randomized	_	VERB	VBN	_	4	conj	_	_
31	to	_	PRT	TO	_	33	case	_	_
32	either	_	CONJ	CC	_	33	cc:preconj	_	_
33	DRUG	_	NOUN	NN	_	30	nmod	_	_
34	or	_	CONJ	CC	_	33	cc	_	_
35	placebo	_	NOUN	NN	_	33	conj	_	_
36	in	_	ADP	IN	_	44	case	_	_
37	a	_	DET	DT	_	44	det	_	_
38	6	_	NUM	CD	_	44	nummod	_	_
39	month	_	NOUN	NN	_	44	compound	_	_
40	double	_	ADJ	JJ	_	44	amod	_	_
41	blind	_	NOUN	NN	_	44	compound	_	_
42	relapse	_	NOUN	NN	_	44	compound	_	_
43	prevention	_	NOUN	NN	_	44	compound	_	_
44	phase	_	NOUN	NN	_	30	nmod	_	_

#	PAROXETINE	3638
1	Patients	_	NOUN	NNS	_	8	nsubj	_	_
2	randomized	_	VERB	VBN	_	1	acl	_	_
3	to	_	PRT	TO	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	were	_	VERB	VBD	_	8	cop	_	_
6	significantly	_	ADV	RB	_	8	advmod	_	_
7	less	_	ADV	RB	_	8	advmod	_	_
8	likely	_	ADJ	JJ	_	0	root	_	_
9	to	_	PRT	TO	_	10	mark	_	_
10	relapse	_	ADJ	JJ	_	8	xcomp	_	_
11	than	_	ADP	IN	_	14	case	_	_
12	comparably	_	ADV	RB	_	13	advmod	_	_
13	treated	_	VERB	VBN	_	14	amod	_	_
14	patients	_	NOUN	NNS	_	10	nmod	_	_
15	who	_	DET	WDT	_	17	nsubjpass	_	_
16	were	_	VERB	VBD	_	17	auxpass	_	_
17	randomized	_	VERB	VBN	_	14	acl:relcl	_	_
18	to	_	PRT	TO	_	19	case	_	_
19	placebo	_	NOUN	NN	_	17	nmod	_	_

#	PAROXETINE	3639
1	The	_	DET	DT	_	2	det	_	_
2	effectiveness	_	NOUN	NN	_	12	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	in	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	treatment	_	NOUN	NN	_	2	nmod	_	_
8	of	_	ADP	IN	_	10	case	_	_
9	panic	_	ADJ	JJ	_	10	amod	_	_
10	disorder	_	NOUN	NN	_	7	nmod	_	_
11	was	_	VERB	VBD	_	12	auxpass	_	_
12	demonstrated	_	VERB	VBN	_	0	root	_	_
13	in	_	ADP	IN	_	19	case	_	_
14	three	_	NUM	CD	_	15	nummod	_	_
15	10	_	NUM	CD	_	17	compound	_	_
16	to	_	PRT	TO	_	17	dep	_	_
17	12	_	NUM	CD	_	19	nummod	_	_
18	week	_	NOUN	NN	_	19	compound	_	_
19	multicenter	_	NOUN	NN	_	12	nmod	_	_
20	,	_	.	,	_	12	punct	_	_
21	placebo	_	NOUN	NN	_	22	nsubj	_	_
22	controlled	_	VERB	VBD	_	12	parataxis	_	_
23	studies	_	NOUN	NNS	_	22	dobj	_	_
24	of	_	ADP	IN	_	27	case	_	_
25	adult	_	ADJ	JJ	_	27	amod	_	_
26	outpatients	_	NOUN	NNS	_	27	compound	_	_
27	Studies	_	NOUN	NNS	_	23	nmod	_	_
28	1	_	NUM	CD	_	30	compound	_	_
29	to	_	PRT	TO	_	30	dep	_	_
30	3	_	NUM	CD	_	27	nummod	_	_

#	PAROXETINE	3640
1	Patients	_	NOUN	NNS	_	5	nsubj	_	_
2	in	_	ADP	IN	_	4	case	_	_
3	all	_	DET	DT	_	4	det	_	_
4	studies	_	NOUN	NNS	_	1	nmod	_	_
5	had	_	VERB	VBD	_	0	root	_	_
6	panic	_	ADJ	JJ	_	9	amod	_	_
7	disorder	_	NOUN	NN	_	9	compound	_	_
8	DSM	_	NOUN	NN	_	9	compound	_	_
9	IIIR	_	NOUN	NN	_	5	dobj	_	_
10	,	_	.	,	_	9	punct	_	_
11	with	_	ADP	IN	_	9	dep	_	_
12	or	_	CONJ	CC	_	11	cc	_	_
13	without	_	ADP	IN	_	14	case	_	_
14	agoraphobia	_	NOUN	NN	_	11	conj	_	_

#	PAROXETINE	3641
1	In	_	ADP	IN	_	3	case	_	_
2	these	_	DET	DT	_	3	det	_	_
3	studies	_	NOUN	NNS	_	7	nmod	_	_
4	,	_	.	,	_	7	punct	_	_
5	DRUG	_	NOUN	NN	_	7	nsubjpass	_	_
6	was	_	VERB	VBD	_	7	auxpass	_	_
7	shown	_	VERB	VBN	_	0	root	_	_
8	to	_	PRT	TO	_	12	mark	_	_
9	be	_	VERB	VB	_	12	cop	_	_
10	significantly	_	ADV	RB	_	12	advmod	_	_
11	more	_	ADV	RB	_	12	advmod	_	_
12	effective	_	ADJ	JJ	_	7	xcomp	_	_
13	than	_	ADP	IN	_	14	case	_	_
14	placebo	_	NOUN	NN	_	12	nmod	_	_
15	in	_	ADP	IN	_	16	mark	_	_
16	treating	_	VERB	VBG	_	12	advcl	_	_
17	panic	_	ADJ	JJ	_	18	amod	_	_
18	disorder	_	NOUN	NN	_	16	dobj	_	_
19	by	_	ADP	IN	_	23	case	_	_
20	at	_	ADP	IN	_	21	case	_	_
21	least	_	ADJ	JJS	_	22	nmod:npmod	_	_
22	2	_	NUM	CD	_	23	nummod	_	_
23	out	_	NOUN	NN	_	16	nmod	_	_
24	of	_	ADP	IN	_	26	case	_	_
25	3	_	NUM	CD	_	26	nummod	_	_
26	measures	_	NOUN	NNS	_	23	nmod	_	_
27	of	_	ADP	IN	_	30	case	_	_
28	panic	_	ADJ	JJ	_	30	amod	_	_
29	attack	_	NOUN	NN	_	30	compound	_	_
30	frequency	_	NOUN	NN	_	26	nmod	_	_
31	and	_	CONJ	CC	_	23	cc	_	_
32	on	_	ADP	IN	_	37	case	_	_
33	the	_	DET	DT	_	37	det	_	_
34	Clinical	_	ADJ	JJ	_	37	amod	_	_
35	Global	_	ADJ	JJ	_	37	amod	_	_
36	Impression	_	NOUN	NN	_	37	compound	_	_
37	Severity	_	NOUN	NN	_	23	conj	_	_
38	of	_	ADP	IN	_	40	case	_	_
39	Illness	_	NOUN	NN	_	40	compound	_	_
40	score	_	NOUN	NN	_	37	nmod	_	_

#	PAROXETINE	3642
1	Study	_	NOUN	NN	_	11	nsubj	_	_
2	1	_	NUM	CD	_	1	nummod	_	_
3	was	_	VERB	VBD	_	11	cop	_	_
4	a	_	DET	DT	_	11	det	_	_
5	10	_	NUM	CD	_	11	nummod	_	_
6	week	_	NOUN	NN	_	11	compound	_	_
7	dose	_	NOUN	NN	_	11	compound	_	_
8	range	_	NOUN	NN	_	11	compound	_	_
9	finding	_	NOUN	NN	_	11	compound	_	_
10	study	_	NOUN	NN	_	11	compound	_	_
11	patients	_	NOUN	NNS	_	13	nsubjpass	_	_
12	were	_	VERB	VBD	_	13	auxpass	_	_
13	treated	_	VERB	VBN	_	0	root	_	_
14	with	_	ADP	IN	_	17	case	_	_
15	fixed	_	VERB	VBN	_	17	amod	_	_
16	DRUG	_	NOUN	NN	_	17	compound	_	_
17	doses	_	NOUN	NNS	_	13	nmod	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	10	_	NUM	CD	_	17	nmod	_	_
20	,	_	.	,	_	19	punct	_	_
21	20	_	NUM	CD	_	19	conj	_	_
22	,	_	.	,	_	19	punct	_	_
23	or	_	CONJ	CC	_	19	cc	_	_
24	40	_	NUM	CD	_	19	conj	_	_
25	mg	_	NOUN	NN	_	19	dep	_	_
26	/	_	.	:	_	17	punct	_	_
27	day	_	NOUN	NN	_	17	dep	_	_
28	or	_	CONJ	CC	_	27	cc	_	_
29	placebo	_	NOUN	NN	_	27	conj	_	_

#	PAROXETINE	3643
1	A	_	DET	DT	_	3	det	_	_
2	significant	_	ADJ	JJ	_	3	amod	_	_
3	difference	_	NOUN	NN	_	7	nsubjpass	_	_
4	from	_	ADP	IN	_	5	case	_	_
5	placebo	_	NOUN	NN	_	3	nmod	_	_
6	was	_	VERB	VBD	_	7	auxpass	_	_
7	observed	_	VERB	VBN	_	0	root	_	_
8	only	_	ADV	RB	_	7	advmod	_	_
9	for	_	ADP	IN	_	15	case	_	_
10	the	_	DET	DT	_	15	det	_	_
11	40	_	NUM	CD	_	12	nummod	_	_
12	mg	_	NOUN	NN	_	15	compound	_	_
13	/	_	NUM	CD	_	15	punct	_	_
14	day	_	NOUN	NN	_	15	compound	_	_
15	group	_	NOUN	NN	_	7	nmod	_	_

#	PAROXETINE	3644
1	At	_	ADP	IN	_	2	case	_	_
2	endpoint	_	NOUN	NN	_	19	nmod	_	_
3	,	_	.	,	_	19	punct	_	_
4	76%	_	NOUN	NN	_	19	nsubj	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	patients	_	NOUN	NNS	_	4	nmod	_	_
7	receiving	_	VERB	VBG	_	6	acl	_	_
8	DRUG	_	NOUN	NN	_	10	compound	_	_
9	40	_	NUM	CD	_	10	nummod	_	_
10	mg	_	NOUN	NN	_	7	dobj	_	_
11	/	_	.	:	_	4	punct	_	_
12	day	_	NOUN	NN	_	14	nsubj	_	_
13	were	_	VERB	VBD	_	14	cop	_	_
14	free	_	ADJ	JJ	_	4	acl:relcl	_	_
15	of	_	ADP	IN	_	17	case	_	_
16	panic	_	ADJ	JJ	_	17	amod	_	_
17	attacks	_	NOUN	NNS	_	14	nmod	_	_
18	,	_	.	,	_	4	punct	_	_
19	compared	_	VERB	VBN	_	0	root	_	_
20	to	_	PRT	TO	_	21	case	_	_
21	44%	_	NOUN	NN	_	19	nmod	_	_
22	of	_	ADP	IN	_	25	case	_	_
23	placebo	_	NOUN	NN	_	25	compound	_	_
24	treated	_	ADJ	JJ	_	25	amod	_	_
25	patients	_	NOUN	NNS	_	21	nmod	_	_

#	PAROXETINE	3645
1	Study	_	NOUN	NN	_	9	nsubj	_	_
2	2	_	NUM	CD	_	1	nummod	_	_
3	was	_	VERB	VBD	_	9	cop	_	_
4	a	_	DET	DT	_	9	det	_	_
5	12	_	NUM	CD	_	9	nummod	_	_
6	week	_	NOUN	NN	_	9	compound	_	_
7	flexible	_	ADJ	JJ	_	9	amod	_	_
8	dose	_	NOUN	NN	_	9	compound	_	_
9	study	_	NOUN	NN	_	0	root	_	_
10	comparing	_	VERB	VBG	_	9	acl	_	_
11	DRUG	_	NOUN	NN	_	15	compound	_	_
12	10	_	NUM	CD	_	14	compound	_	_
13	to	_	PRT	TO	_	14	dep	_	_
14	60	_	NUM	CD	_	15	nummod	_	_
15	mg	_	NOUN	NN	_	10	nmod	_	_
16	daily	_	ADV	RB	_	15	advmod	_	_
17	and	_	CONJ	CC	_	15	cc	_	_
18	placebo	_	NOUN	NN	_	15	conj	_	_

#	PAROXETINE	3646
1	At	_	ADP	IN	_	2	case	_	_
2	endpoint	_	NOUN	NN	_	9	nmod	_	_
3	,	_	.	,	_	9	punct	_	_
4	51%	_	NOUN	NN	_	9	nsubj	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	DRUG	_	NOUN	NN	_	7	compound	_	_
7	patients	_	NOUN	NNS	_	4	nmod	_	_
8	were	_	VERB	VBD	_	9	cop	_	_
9	free	_	ADJ	JJ	_	0	root	_	_
10	of	_	ADP	IN	_	12	case	_	_
11	panic	_	ADJ	JJ	_	12	amod	_	_
12	attacks	_	NOUN	NNS	_	9	nmod	_	_
13	compared	_	VERB	VBN	_	9	xcomp	_	_
14	to	_	PRT	TO	_	15	case	_	_
15	32%	_	NOUN	NN	_	13	nmod	_	_
16	of	_	ADP	IN	_	19	case	_	_
17	placebo	_	NOUN	NN	_	19	compound	_	_
18	treated	_	ADJ	JJ	_	19	amod	_	_
19	patients	_	NOUN	NNS	_	15	nmod	_	_

#	PAROXETINE	3647
1	Study	_	NOUN	NN	_	9	nsubj	_	_
2	3	_	NUM	CD	_	1	nummod	_	_
3	was	_	VERB	VBD	_	9	cop	_	_
4	a	_	DET	DT	_	9	det	_	_
5	12	_	NUM	CD	_	9	nummod	_	_
6	week	_	NOUN	NN	_	9	compound	_	_
7	flexible	_	ADJ	JJ	_	9	amod	_	_
8	dose	_	NOUN	NN	_	9	compound	_	_
9	study	_	NOUN	NN	_	0	root	_	_
10	comparing	_	VERB	VBG	_	9	acl	_	_
11	DRUG	_	NOUN	NN	_	15	compound	_	_
12	10	_	NUM	CD	_	14	compound	_	_
13	to	_	PRT	TO	_	14	dep	_	_
14	60	_	NUM	CD	_	15	nummod	_	_
15	mg	_	NOUN	NN	_	10	dobj	_	_
16	daily	_	ADV	RB	_	18	advmod	_	_
17	to	_	PRT	TO	_	18	case	_	_
18	placebo	_	NOUN	NN	_	10	nmod	_	_
19	in	_	ADP	IN	_	20	case	_	_
20	patients	_	NOUN	NNS	_	18	nmod	_	_
21	concurrently	_	ADV	RB	_	22	advmod	_	_
22	receiving	_	VERB	VBG	_	20	acl	_	_
23	standardized	_	VERB	VBN	_	26	amod	_	_
24	cognitive	_	ADJ	JJ	_	26	amod	_	_
25	behavioral	_	ADJ	JJ	_	26	amod	_	_
26	therapy	_	NOUN	NN	_	22	dobj	_	_

#	PAROXETINE	3648
1	At	_	ADP	IN	_	2	case	_	_
2	endpoint	_	NOUN	NN	_	10	nmod	_	_
3	,	_	.	,	_	10	punct	_	_
4	33%	_	NOUN	NN	_	10	nsubj	_	_
5	of	_	ADP	IN	_	9	case	_	_
6	the	_	DET	DT	_	9	det	_	_
7	DRUG	_	NOUN	NN	_	9	compound	_	_
8	treated	_	ADJ	JJ	_	9	amod	_	_
9	patients	_	NOUN	NNS	_	4	nmod	_	_
10	showed	_	VERB	VBD	_	0	root	_	_
11	a	_	DET	DT	_	12	det	_	_
12	reduction	_	NOUN	NN	_	10	dobj	_	_
13	to	_	PRT	TO	_	18	case	_	_
14	0	_	NUM	CD	_	18	nummod	_	_
15	or	_	CONJ	CC	_	14	cc	_	_
16	1	_	NUM	CD	_	14	conj	_	_
17	panic	_	ADJ	JJ	_	18	amod	_	_
18	attacks	_	NOUN	NNS	_	12	nmod	_	_
19	compared	_	VERB	VBN	_	10	xcomp	_	_
20	to	_	PRT	TO	_	21	case	_	_
21	14%	_	NOUN	NN	_	19	nmod	_	_
22	of	_	ADP	IN	_	24	case	_	_
23	placebo	_	NOUN	NN	_	24	compound	_	_
24	patients	_	NOUN	NNS	_	21	nmod	_	_

#	PAROXETINE	3649
1	In	_	ADP	IN	_	3	case	_	_
2	both	_	DET	DT	_	3	det	_	_
3	Studies	_	NOUN	NNS	_	19	nmod	_	_
4	2	_	NUM	CD	_	3	dep	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	3	_	NUM	CD	_	4	conj	_	_
7	,	_	.	,	_	19	punct	_	_
8	the	_	DET	DT	_	11	det	_	_
9	mean	_	ADJ	JJ	_	11	amod	_	_
10	DRUG	_	NOUN	NN	_	11	compound	_	_
11	dose	_	NOUN	NN	_	19	nsubj	_	_
12	for	_	ADP	IN	_	13	case	_	_
13	completers	_	NOUN	NNS	_	11	nmod	_	_
14	at	_	ADP	IN	_	15	case	_	_
15	endpoint	_	NOUN	NN	_	11	nmod	_	_
16	was	_	VERB	VBD	_	19	cop	_	_
17	approximately	_	ADV	RB	_	18	advmod	_	_
18	40	_	NUM	CD	_	19	nummod	_	_
19	mg	_	NOUN	NN	_	0	root	_	_
20	/	_	.	:	_	19	punct	_	_
21	day	_	NOUN	NN	_	19	dep	_	_
22	of	_	ADP	IN	_	23	case	_	_
23	DRUG	_	NOUN	NN	_	21	nmod	_	_

#	PAROXETINE	3650
1	Long	_	DET	DT	_	4	det	_	_
2	term	_	NOUN	NN	_	4	compound	_	_
3	maintenance	_	NOUN	NN	_	4	compound	_	_
4	effects	_	NOUN	NNS	_	11	nsubjpass	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	in	_	ADP	IN	_	9	case	_	_
8	panic	_	ADJ	JJ	_	9	amod	_	_
9	disorder	_	NOUN	NN	_	4	nmod	_	_
10	were	_	VERB	VBD	_	11	auxpass	_	_
11	demonstrated	_	VERB	VBN	_	0	root	_	_
12	in	_	ADP	IN	_	14	case	_	_
13	an	_	DET	DT	_	14	det	_	_
14	extension	_	NOUN	NN	_	11	nmod	_	_
15	to	_	PRT	TO	_	16	case	_	_
16	Study	_	NOUN	NN	_	14	nmod	_	_
17	1	_	NUM	CD	_	16	nummod	_	_

#	PAROXETINE	3651
1	Patients	_	NOUN	NNS	_	22	nsubjpass	_	_
2	who	_	DET	WDT	_	4	nsubj	_	_
3	were	_	VERB	VBD	_	4	cop	_	_
4	responders	_	NOUN	NNS	_	1	acl:relcl	_	_
5	during	_	ADP	IN	_	11	case	_	_
6	the	_	DET	DT	_	11	det	_	_
7	10	_	NUM	CD	_	11	nummod	_	_
8	week	_	NOUN	NN	_	11	compound	_	_
9	double	_	ADJ	JJ	_	11	amod	_	_
10	blind	_	NOUN	NN	_	11	compound	_	_
11	phase	_	NOUN	NN	_	4	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	during	_	ADP	IN	_	20	case	_	_
14	a	_	DET	DT	_	20	det	_	_
15	3	_	NUM	CD	_	20	nummod	_	_
16	month	_	NOUN	NN	_	20	compound	_	_
17	double	_	ADJ	JJ	_	20	amod	_	_
18	blind	_	NOUN	NN	_	20	compound	_	_
19	extension	_	NOUN	NN	_	20	compound	_	_
20	phase	_	NOUN	NN	_	11	conj	_	_
21	were	_	VERB	VBD	_	22	auxpass	_	_
22	randomized	_	VERB	VBN	_	0	root	_	_
23	to	_	PRT	TO	_	25	case	_	_
24	either	_	CONJ	CC	_	25	cc:preconj	_	_
25	DRUG	_	NOUN	NN	_	22	nmod	_	_
26	10	_	NUM	CD	_	25	nummod	_	_
27	,	_	.	,	_	25	punct	_	_
28	20	_	NUM	CD	_	25	conj	_	_
29	,	_	.	,	_	25	punct	_	_
30	or	_	CONJ	CC	_	25	cc	_	_
31	40	_	NUM	CD	_	32	nummod	_	_
32	mg	_	NOUN	NN	_	25	conj	_	_
33	/	_	.	:	_	25	punct	_	_
34	day	_	NOUN	NN	_	25	conj	_	_
35	or	_	CONJ	CC	_	25	cc	_	_
36	placebo	_	NOUN	NN	_	25	conj	_	_
37	in	_	ADP	IN	_	45	case	_	_
38	a	_	DET	DT	_	45	det	_	_
39	3	_	NUM	CD	_	45	nummod	_	_
40	month	_	NOUN	NN	_	45	compound	_	_
41	double	_	ADJ	JJ	_	45	amod	_	_
42	blind	_	NOUN	NN	_	45	compound	_	_
43	relapse	_	NOUN	NN	_	45	compound	_	_
44	prevention	_	NOUN	NN	_	45	compound	_	_
45	phase	_	NOUN	NN	_	22	nmod	_	_

#	PAROXETINE	3653
1	Subgroup	_	ADJ	JJ	_	2	amod	_	_
2	analyses	_	NOUN	NNS	_	5	nsubj	_	_
3	did	_	VERB	MD	_	5	aux	_	_
4	not	_	ADV	RB	_	5	neg	_	_
5	indicate	_	VERB	VB	_	0	root	_	_
6	that	_	ADP	IN	_	8	mark	_	_
7	there	_	DET	EX	_	8	expl	_	_
8	were	_	VERB	VBD	_	5	root	_	_
9	any	_	DET	DT	_	10	det	_	_
10	differences	_	NOUN	NNS	_	8	nsubj	_	_
11	in	_	ADP	IN	_	13	case	_	_
12	treatment	_	NOUN	NN	_	13	compound	_	_
13	outcomes	_	NOUN	NNS	_	10	nmod	_	_
14	as	_	ADP	IN	_	16	case	_	_
15	a	_	DET	DT	_	16	det	_	_
16	function	_	NOUN	NN	_	8	nmod	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	age	_	NOUN	NN	_	16	nmod	_	_
19	or	_	CONJ	CC	_	8	cc	_	_
20	gender	_	NOUN	NN	_	8	conj	_	_

#	PAROXETINE	3654
1	The	_	DET	DT	_	2	det	_	_
2	effectiveness	_	NOUN	NN	_	13	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	in	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	treatment	_	NOUN	NN	_	2	nmod	_	_
8	of	_	ADP	IN	_	11	case	_	_
9	social	_	ADJ	JJ	_	11	amod	_	_
10	anxiety	_	NOUN	NN	_	11	compound	_	_
11	disorder	_	NOUN	NN	_	7	nmod	_	_
12	was	_	VERB	VBD	_	13	auxpass	_	_
13	demonstrated	_	VERB	VBN	_	0	root	_	_
14	in	_	ADP	IN	_	17	case	_	_
15	three	_	NUM	CD	_	17	nummod	_	_
16	12	_	NUM	CD	_	17	nummod	_	_
17	week	_	NOUN	NN	_	13	nmod	_	_
18	,	_	.	,	_	17	punct	_	_
19	multicenter	_	NOUN	NN	_	17	conj	_	_
20	,	_	.	,	_	17	punct	_	_
21	placebo	_	NOUN	NN	_	22	nsubj	_	_
22	controlled	_	VERB	VBD	_	17	acl	_	_
23	studies	_	NOUN	NNS	_	24	compound	_	_
24	Studies	_	NOUN	NNS	_	22	dobj	_	_
25	1	_	NUM	CD	_	24	nummod	_	_
26	,	_	.	,	_	24	punct	_	_
27	2	_	NUM	CD	_	24	conj	_	_
28	,	_	.	,	_	24	punct	_	_
29	and	_	CONJ	CC	_	24	cc	_	_
30	3	_	NUM	CD	_	24	conj	_	_
31	of	_	ADP	IN	_	33	case	_	_
32	adult	_	ADJ	JJ	_	33	amod	_	_
33	outpatients	_	NOUN	NNS	_	24	nmod	_	_
34	with	_	ADP	IN	_	39	case	_	_
35	social	_	ADJ	JJ	_	39	amod	_	_
36	anxiety	_	NOUN	NN	_	39	compound	_	_
37	disorder	_	NOUN	NN	_	39	compound	_	_
38	DSM	_	NOUN	NN	_	39	compound	_	_
39	IV	_	NUM	CD	_	33	nmod	_	_

#	PAROXETINE	3655
1	In	_	ADP	IN	_	3	case	_	_
2	these	_	DET	DT	_	3	det	_	_
3	studies	_	NOUN	NNS	_	9	nmod	_	_
4	,	_	.	,	_	9	punct	_	_
5	the	_	DET	DT	_	6	det	_	_
6	effectiveness	_	NOUN	NN	_	9	nsubj	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	compared	_	VERB	VBD	_	0	root	_	_
10	to	_	PRT	TO	_	11	case	_	_
11	placebo	_	NOUN	NN	_	9	nmod	_	_
12	was	_	VERB	VBD	_	13	auxpass	_	_
13	evaluated	_	VERB	VBN	_	9	parataxis	_	_
14	on	_	ADP	IN	_	16	case	_	_
15	the	_	DET	DT	_	16	det	_	_
16	basis	_	NOUN	NN	_	13	nmod	_	_
17	of	_	ADP	IN	_	20	case	_	_
18	1	_	NUM	CD	_	20	nummod	_	_
19	the	_	DET	DT	_	20	det	_	_
20	proportion	_	NOUN	NN	_	16	nmod	_	_
21	of	_	ADP	IN	_	22	case	_	_
22	responders	_	NOUN	NNS	_	20	nmod	_	_
23	,	_	.	,	_	13	punct	_	_
24	as	_	ADP	IN	_	25	mark	_	_
25	defined	_	VERB	VBN	_	13	advcl	_	_
26	by	_	ADP	IN	_	33	case	_	_
27	a	_	DET	DT	_	33	det	_	_
28	Clinical	_	ADJ	JJ	_	33	amod	_	_
29	Global	_	ADJ	JJ	_	33	amod	_	_
30	Impression	_	NOUN	NN	_	33	compound	_	_
31	CGI	_	NOUN	NN	_	33	compound	_	_
32	Improvement	_	NOUN	NN	_	33	compound	_	_
33	score	_	NOUN	NN	_	25	nmod	_	_
34	of	_	ADP	IN	_	38	case	_	_
35	1	_	NUM	CD	_	38	nummod	_	_
36	very	_	ADV	RB	_	37	advmod	_	_
37	much	_	ADV	RB	_	38	advmod	_	_
38	improved	_	VERB	VBN	_	33	nmod	_	_
39	or	_	CONJ	CC	_	38	cc	_	_
40	2	_	NUM	CD	_	38	conj	_	_
41	much	_	ADV	RB	_	42	advmod	_	_
42	improved	_	VERB	VBN	_	38	dep	_	_
43	,	_	.	,	_	13	punct	_	_
44	and	_	CONJ	CC	_	13	cc	_	_
45	2	_	NUM	CD	_	46	nummod	_	_
46	change	_	NOUN	NN	_	13	conj	_	_
47	from	_	ADP	IN	_	48	case	_	_
48	baseline	_	NOUN	NN	_	46	nmod	_	_
49	in	_	ADP	IN	_	55	case	_	_
50	the	_	DET	DT	_	55	det	_	_
51	Liebowitz	_	ADJ	JJ	_	55	amod	_	_
52	Social	_	ADJ	JJ	_	55	amod	_	_
53	Anxiety	_	NOUN	NN	_	55	compound	_	_
54	Scale	_	NOUN	NN	_	55	compound	_	_
55	LSAS	_	NOUN	NN	_	46	nmod	_	_

#	PAROXETINE	3656
1	Studies	_	NOUN	NNS	_	8	nsubj	_	_
2	1	_	NUM	CD	_	1	nmod	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	2	_	NUM	CD	_	2	conj	_	_
5	were	_	VERB	VBD	_	8	cop	_	_
6	flexible	_	ADJ	JJ	_	8	amod	_	_
7	dose	_	NOUN	NN	_	8	compound	_	_
8	studies	_	NOUN	NNS	_	0	root	_	_
9	comparing	_	VERB	VBG	_	8	acl	_	_
10	DRUG	_	NOUN	NN	_	9	dobj	_	_
11	20	_	NUM	CD	_	10	nummod	_	_
12	to	_	PRT	TO	_	14	case	_	_
13	50mg	_	ADJ	JJ	_	14	amod	_	_
14	daily	_	ADV	RB	_	9	nmod	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	placebo	_	NOUN	NN	_	14	conj	_	_

#	PAROXETINE	3657
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	demonstrated	_	VERB	VBD	_	0	root	_	_
3	statistically	_	ADV	RB	_	4	advmod	_	_
4	significant	_	ADJ	JJ	_	5	amod	_	_
5	superiority	_	NOUN	NN	_	2	dobj	_	_
6	over	_	ADP	IN	_	7	case	_	_
7	placebo	_	NOUN	NN	_	2	nmod	_	_
8	on	_	ADP	IN	_	14	case	_	_
9	both	_	CONJ	CC	_	14	cc:preconj	_	_
10	the	_	DET	DT	_	14	det	_	_
11	CGI	_	NOUN	NN	_	14	compound	_	_
12	Improvement	_	NOUN	NN	_	14	compound	_	_
13	responder	_	NOUN	NN	_	14	compound	_	_
14	criterion	_	NOUN	NN	_	2	nmod	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	the	_	DET	DT	_	21	det	_	_
17	Liebowitz	_	ADJ	JJ	_	21	amod	_	_
18	Social	_	ADJ	JJ	_	21	amod	_	_
19	Anxiety	_	NOUN	NN	_	21	compound	_	_
20	Scale	_	NOUN	NN	_	21	compound	_	_
21	LSAS	_	NOUN	NN	_	14	conj	_	_

#	PAROXETINE	3658
1	In	_	ADP	IN	_	2	case	_	_
2	Study1	_	NOUN	NN	_	16	nmod	_	_
3	,	_	.	,	_	16	punct	_	_
4	for	_	ADP	IN	_	5	case	_	_
5	patients	_	NOUN	NNS	_	16	nmod	_	_
6	who	_	DET	WDT	_	7	nsubj	_	_
7	completed	_	VERB	VBD	_	5	acl:relcl	_	_
8	to	_	PRT	TO	_	9	case	_	_
9	week12	_	NOUN	NN	_	7	nmod	_	_
10	,	_	.	,	_	16	punct	_	_
11	69%	_	NOUN	NN	_	16	nsubj	_	_
12	of	_	ADP	IN	_	15	case	_	_
13	DRUG	_	NOUN	NN	_	15	compound	_	_
14	treated	_	ADJ	JJ	_	15	amod	_	_
15	patients	_	NOUN	NNS	_	11	nmod	_	_
16	compared	_	VERB	VBN	_	0	root	_	_
17	to	_	PRT	TO	_	18	case	_	_
18	29%	_	NOUN	NN	_	16	nmod	_	_
19	of	_	ADP	IN	_	22	case	_	_
20	placebo	_	NOUN	NN	_	22	compound	_	_
21	treated	_	ADJ	JJ	_	22	amod	_	_
22	patients	_	NOUN	NNS	_	18	nmod	_	_
23	were	_	VERB	VBD	_	26	cop	_	_
24	CGI	_	NOUN	NN	_	26	compound	_	_
25	Improvement	_	NOUN	NN	_	26	compound	_	_
26	responders	_	NOUN	NNS	_	16	advcl	_	_

#	PAROXETINE	3659
1	In	_	ADP	IN	_	2	case	_	_
2	Study	_	NOUN	NN	_	9	nmod	_	_
3	2	_	NUM	CD	_	2	nummod	_	_
4	,	_	.	,	_	9	punct	_	_
5	CGI	_	NOUN	NN	_	7	compound	_	_
6	Improvement	_	NOUN	NN	_	7	compound	_	_
7	responders	_	NOUN	NNS	_	9	nsubj	_	_
8	were	_	VERB	VBD	_	9	cop	_	_
9	77%	_	ADJ	JJ	_	0	root	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	42%	_	NOUN	NN	_	9	conj	_	_
12	for	_	ADP	IN	_	18	case	_	_
13	the	_	DET	DT	_	18	det	_	_
14	DRUG	_	NOUN	NN	_	18	compound	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	placebo	_	NOUN	NN	_	14	conj	_	_
17	treated	_	VERB	VBN	_	18	amod	_	_
18	patients	_	NOUN	NNS	_	9	nmod	_	_
19	,	_	.	,	_	9	punct	_	_
20	respectively	_	ADV	RB	_	9	advmod	_	_

#	PAROXETINE	3660
1	Study	_	NOUN	NN	_	7	nsubj	_	_
2	3	_	NUM	CD	_	1	nummod	_	_
3	was	_	VERB	VBD	_	7	cop	_	_
4	a	_	DET	DT	_	7	det	_	_
5	12	_	NUM	CD	_	7	nummod	_	_
6	week	_	NOUN	NN	_	7	compound	_	_
7	study	_	NOUN	NN	_	0	root	_	_
8	comparing	_	VERB	VBG	_	7	acl	_	_
9	fixed	_	VERB	VBN	_	11	amod	_	_
10	DRUG	_	NOUN	NN	_	11	compound	_	_
11	doses	_	NOUN	NNS	_	8	dobj	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	20	_	NUM	CD	_	11	nmod	_	_
14	,	_	.	,	_	13	punct	_	_
15	40	_	NUM	CD	_	13	conj	_	_
16	,	_	.	,	_	13	punct	_	_
17	or	_	CONJ	CC	_	13	cc	_	_
18	60mg	_	ADJ	JJ	_	13	conj	_	_
19	/	_	.	:	_	7	punct	_	_
20	day	_	NOUN	NN	_	7	dep	_	_
21	with	_	ADP	IN	_	22	case	_	_
22	placebo	_	NOUN	NN	_	20	nmod	_	_

#	PAROXETINE	3661
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	20mg	_	NOUN	NN	_	4	nsubjpass	_	_
3	was	_	VERB	VBD	_	4	auxpass	_	_
4	demonstrated	_	VERB	VBN	_	0	root	_	_
5	to	_	PRT	TO	_	8	mark	_	_
6	be	_	VERB	VB	_	8	cop	_	_
7	significantly	_	ADV	RB	_	8	advmod	_	_
8	superior	_	NOUN	NN	_	4	xcomp	_	_
9	to	_	PRT	TO	_	10	case	_	_
10	placebo	_	NOUN	NN	_	8	nmod	_	_
11	on	_	ADP	IN	_	16	case	_	_
12	both	_	CONJ	CC	_	16	cc:preconj	_	_
13	the	_	DET	DT	_	16	det	_	_
14	LSAS	_	NOUN	NN	_	16	compound	_	_
15	Total	_	ADJ	JJ	_	16	amod	_	_
16	Score	_	NOUN	NN	_	8	nmod	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	the	_	DET	DT	_	22	det	_	_
19	CGI	_	NOUN	NN	_	22	compound	_	_
20	Improvement	_	NOUN	NN	_	22	compound	_	_
21	responder	_	NOUN	NN	_	22	compound	_	_
22	criterion	_	NOUN	NN	_	16	conj	_	_
23	there	_	DET	EX	_	24	expl	_	_
24	were	_	VERB	VBD	_	22	dep	_	_
25	trends	_	NOUN	NNS	_	24	dep	_	_
26	for	_	ADP	IN	_	27	case	_	_
27	superiority	_	NOUN	NN	_	25	nmod	_	_
28	over	_	ADP	IN	_	29	case	_	_
29	placebo	_	NOUN	NN	_	27	nmod	_	_
30	for	_	ADP	IN	_	38	case	_	_
31	the	_	DET	DT	_	38	det	_	_
32	40mg	_	ADJ	JJ	_	38	amod	_	_
33	and	_	CONJ	CC	_	32	cc	_	_
34	60mg	_	ADJ	JJ	_	32	conj	_	_
35	/	_	NUM	CD	_	38	punct	_	_
36	day	_	NOUN	NN	_	38	compound	_	_
37	dose	_	NOUN	NN	_	38	compound	_	_
38	groups	_	NOUN	NNS	_	29	nmod	_	_

#	PAROXETINE	3662
1	There	_	DET	EX	_	2	expl	_	_
2	was	_	VERB	VBD	_	0	root	_	_
3	no	_	DET	DT	_	4	neg	_	_
4	indication	_	NOUN	NN	_	2	nsubj	_	_
5	in	_	ADP	IN	_	7	case	_	_
6	this	_	DET	DT	_	7	det	_	_
7	study	_	NOUN	NN	_	4	nmod	_	_
8	of	_	ADP	IN	_	11	case	_	_
9	any	_	DET	DT	_	11	det	_	_
10	additional	_	ADJ	JJ	_	11	amod	_	_
11	benefit	_	NOUN	NN	_	7	nmod	_	_
12	for	_	ADP	IN	_	13	case	_	_
13	doses	_	NOUN	NNS	_	11	nmod	_	_
14	higher	_	ADJ	JJ	_	18	case	_	_
15	than	_	ADP	IN	_	14	mwe	_	_
16	20mg	_	ADJ	JJ	_	18	amod	_	_
17	/	_	NUM	CD	_	18	compound	_	_
18	day	_	NOUN	NN	_	13	nmod	_	_

#	PAROXETINE	3663
1	Subgroup	_	ADJ	JJ	_	2	amod	_	_
2	analyses	_	NOUN	NNS	_	6	nsubj	_	_
3	generally	_	ADV	RB	_	6	advmod	_	_
4	did	_	VERB	VBD	_	6	aux	_	_
5	not	_	ADV	RB	_	6	neg	_	_
6	indicate	_	VERB	VB	_	0	root	_	_
7	differences	_	NOUN	NNS	_	6	dobj	_	_
8	in	_	ADP	IN	_	10	case	_	_
9	treatment	_	NOUN	NN	_	10	compound	_	_
10	outcomes	_	NOUN	NNS	_	7	nmod	_	_
11	as	_	ADP	IN	_	13	case	_	_
12	a	_	DET	DT	_	13	det	_	_
13	function	_	NOUN	NN	_	6	nmod	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	age	_	NOUN	NN	_	13	nmod	_	_
16	,	_	.	,	_	15	punct	_	_
17	race	_	NOUN	NN	_	15	conj	_	_
18	,	_	.	,	_	15	punct	_	_
19	or	_	CONJ	CC	_	15	cc	_	_
20	gender	_	NOUN	NN	_	15	conj	_	_

#	PAROXETINE	3664
1	The	_	DET	DT	_	2	det	_	_
2	effectiveness	_	NOUN	NN	_	14	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	in	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	treatment	_	NOUN	NN	_	2	nmod	_	_
8	of	_	ADP	IN	_	12	case	_	_
9	Generalized	_	ADJ	JJ	_	12	amod	_	_
10	Anxiety	_	NOUN	NN	_	12	compound	_	_
11	Disorder	_	NOUN	NN	_	12	compound	_	_
12	GAD	_	NOUN	NN	_	7	nmod	_	_
13	was	_	VERB	VBD	_	14	auxpass	_	_
14	demonstrated	_	VERB	VBN	_	0	root	_	_
15	in	_	ADP	IN	_	18	case	_	_
16	two	_	NUM	CD	_	18	nummod	_	_
17	8	_	NUM	CD	_	18	nummod	_	_
18	week	_	NOUN	NN	_	14	nmod	_	_
19	,	_	.	,	_	18	punct	_	_
20	multicenter	_	NOUN	NN	_	18	appos	_	_
21	,	_	.	,	_	18	punct	_	_
22	placebo	_	NOUN	NN	_	25	compound	_	_
23	controlled	_	VERB	VBD	_	25	amod	_	_
24	studies	_	NOUN	NNS	_	25	compound	_	_
25	Studies	_	NOUN	NNS	_	18	appos	_	_
26	1	_	NUM	CD	_	25	dep	_	_
27	and	_	CONJ	CC	_	26	cc	_	_
28	2	_	NUM	CD	_	26	conj	_	_
29	of	_	ADP	IN	_	31	case	_	_
30	adult	_	ADJ	JJ	_	31	amod	_	_
31	outpatients	_	NOUN	NNS	_	25	nmod	_	_
32	with	_	ADP	IN	_	37	case	_	_
33	Generalized	_	VERB	VBN	_	37	amod	_	_
34	Anxiety	_	NOUN	NN	_	37	compound	_	_
35	Disorder	_	NOUN	NN	_	37	compound	_	_
36	DSM	_	NOUN	NN	_	37	compound	_	_
37	IV	_	NUM	CD	_	31	nmod	_	_

#	PAROXETINE	3665
1	Study	_	NOUN	NN	_	7	nsubj	_	_
2	1	_	NUM	CD	_	1	nummod	_	_
3	was	_	VERB	VBD	_	7	cop	_	_
4	an	_	DET	DT	_	7	det	_	_
5	8	_	NUM	CD	_	7	nummod	_	_
6	week	_	NOUN	NN	_	7	compound	_	_
7	study	_	NOUN	NN	_	0	root	_	_
8	comparing	_	VERB	VBG	_	7	acl	_	_
9	fixed	_	VERB	VBN	_	11	amod	_	_
10	DRUG	_	NOUN	NN	_	11	compound	_	_
11	doses	_	NOUN	NNS	_	8	dobj	_	_
12	of	_	ADP	IN	_	14	case	_	_
13	20	_	NUM	CD	_	14	nummod	_	_
14	mg	_	NOUN	NN	_	11	nmod	_	_
15	or	_	CONJ	CC	_	14	cc	_	_
16	40	_	NUM	CD	_	17	nummod	_	_
17	mg	_	NOUN	NN	_	14	conj	_	_
18	/	_	.	:	_	7	punct	_	_
19	day	_	NOUN	NN	_	7	dep	_	_
20	with	_	ADP	IN	_	21	case	_	_
21	placebo	_	NOUN	NN	_	19	nmod	_	_

#	PAROXETINE	3666
1	Doses	_	NOUN	NNS	_	12	nsubjpass	_	_
2	of	_	ADP	IN	_	4	case	_	_
3	20	_	NUM	CD	_	4	nummod	_	_
4	mg	_	NOUN	NN	_	1	nmod	_	_
5	or	_	CONJ	CC	_	4	cc	_	_
6	40	_	NUM	CD	_	7	nummod	_	_
7	mg	_	NOUN	NN	_	4	conj	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	4	nmod	_	_
10	were	_	VERB	VBD	_	12	auxpass	_	_
11	both	_	DET	DT	_	12	advmod	_	_
12	demonstrated	_	VERB	VBN	_	0	root	_	_
13	to	_	PRT	TO	_	16	mark	_	_
14	be	_	VERB	VB	_	16	cop	_	_
15	significantly	_	ADV	RB	_	16	advmod	_	_
16	superior	_	NOUN	NN	_	12	xcomp	_	_
17	to	_	PRT	TO	_	18	case	_	_
18	placebo	_	NOUN	NN	_	16	nmod	_	_
19	on	_	ADP	IN	_	23	case	_	_
20	the	_	DET	DT	_	23	det	_	_
21	Hamilton	_	NOUN	NN	_	23	compound	_	_
22	Rating	_	VERB	VBG	_	23	compound	_	_
23	Scale	_	NOUN	NN	_	16	nmod	_	_
24	for	_	ADP	IN	_	29	case	_	_
25	Anxiety	_	NOUN	NN	_	29	compound	_	_
26	HAM	_	NOUN	NN	_	29	compound	_	_
27	A	_	NOUN	NN	_	29	compound	_	_
28	total	_	ADJ	JJ	_	29	amod	_	_
29	score	_	NOUN	NN	_	23	nmod	_	_

#	PAROXETINE	3667
1	There	_	DET	EX	_	2	expl	_	_
2	was	_	VERB	VBD	_	0	root	_	_
3	not	_	ADV	RB	_	5	neg	_	_
4	sufficient	_	ADJ	JJ	_	5	amod	_	_
5	evidence	_	NOUN	NN	_	2	nsubj	_	_
6	in	_	ADP	IN	_	8	case	_	_
7	this	_	DET	DT	_	8	det	_	_
8	study	_	NOUN	NN	_	2	nmod	_	_
9	to	_	PRT	TO	_	10	mark	_	_
10	suggest	_	VERB	VB	_	8	acl	_	_
11	a	_	DET	DT	_	13	det	_	_
12	greater	_	ADJ	JJ	_	13	amod	_	_
13	benefit	_	NOUN	NN	_	10	dobj	_	_
14	for	_	ADP	IN	_	20	case	_	_
15	the	_	DET	DT	_	20	det	_	_
16	40	_	NUM	CD	_	17	nummod	_	_
17	mg	_	NOUN	NN	_	20	amod	_	_
18	/	_	.	:	_	20	punct	_	_
19	day	_	NOUN	NN	_	20	compound	_	_
20	dose	_	NOUN	NN	_	13	nmod	_	_
21	compared	_	VERB	VBN	_	2	dep	_	_
22	to	_	PRT	TO	_	28	case	_	_
23	the	_	DET	DT	_	28	det	_	_
24	20	_	NUM	CD	_	25	nummod	_	_
25	mg	_	NOUN	NN	_	28	compound	_	_
26	/	_	.	:	_	28	punct	_	_
27	day	_	NOUN	NN	_	28	compound	_	_
28	dose	_	NOUN	NN	_	21	nmod	_	_

#	PAROXETINE	3668
1	Study	_	NOUN	NN	_	7	nsubj	_	_
2	2	_	NUM	CD	_	1	nummod	_	_
3	was	_	VERB	VBD	_	7	cop	_	_
4	a	_	DET	DT	_	7	det	_	_
5	flexible	_	ADJ	JJ	_	7	amod	_	_
6	dose	_	NOUN	NN	_	7	compound	_	_
7	study	_	NOUN	NN	_	0	root	_	_
8	comparing	_	VERB	VBG	_	7	acl	_	_
9	DRUG	_	NOUN	NN	_	11	compound	_	_
10	20	_	NUM	CD	_	11	nummod	_	_
11	mg	_	NOUN	NN	_	8	dobj	_	_
12	to	_	PRT	TO	_	14	case	_	_
13	50	_	NUM	CD	_	14	nummod	_	_
14	mg	_	NOUN	NN	_	8	nmod	_	_
15	daily	_	ADV	RB	_	14	advmod	_	_
16	and	_	CONJ	CC	_	14	cc	_	_
17	placebo	_	NOUN	NN	_	14	conj	_	_

#	PAROXETINE	3669
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	demonstrated	_	VERB	VBD	_	0	root	_	_
3	statistically	_	ADV	RB	_	4	advmod	_	_
4	significant	_	ADJ	JJ	_	5	amod	_	_
5	superiority	_	NOUN	NN	_	2	dobj	_	_
6	over	_	ADP	IN	_	7	case	_	_
7	placebo	_	NOUN	NN	_	2	nmod	_	_
8	on	_	ADP	IN	_	12	case	_	_
9	the	_	DET	DT	_	12	det	_	_
10	Hamilton	_	NOUN	NN	_	12	compound	_	_
11	Rating	_	VERB	VBG	_	12	compound	_	_
12	Scale	_	NOUN	NN	_	2	nmod	_	_
13	for	_	ADP	IN	_	18	case	_	_
14	Anxiety	_	NOUN	NN	_	18	compound	_	_
15	HAM	_	NOUN	NN	_	18	compound	_	_
16	A	_	NOUN	NN	_	18	compound	_	_
17	total	_	ADJ	JJ	_	18	amod	_	_
18	score	_	NOUN	NN	_	12	nmod	_	_

#	PAROXETINE	3670
1	A	_	DET	DT	_	3	det	_	_
2	third	_	ADJ	JJ	_	3	amod	_	_
3	study	_	NOUN	NN	_	19	nsubj	_	_
4	,	_	.	,	_	3	punct	_	_
5	also	_	ADV	RB	_	6	advmod	_	_
6	flexible	_	ADJ	JJ	_	7	amod	_	_
7	dose	_	NOUN	NN	_	3	appos	_	_
8	comparing	_	VERB	VBG	_	7	acl	_	_
9	DRUG	_	NOUN	NN	_	11	compound	_	_
10	20	_	NUM	CD	_	11	nummod	_	_
11	mg	_	NOUN	NN	_	8	dobj	_	_
12	to	_	PRT	TO	_	14	case	_	_
13	50	_	NUM	CD	_	14	nummod	_	_
14	mg	_	NOUN	NN	_	8	nmod	_	_
15	daily	_	ADV	RB	_	7	advmod	_	_
16	,	_	.	,	_	3	punct	_	_
17	did	_	VERB	MD	_	19	aux	_	_
18	not	_	ADV	RB	_	19	neg	_	_
19	demonstrate	_	VERB	VB	_	0	root	_	_
20	statistically	_	ADV	RB	_	21	advmod	_	_
21	significant	_	ADJ	JJ	_	22	amod	_	_
22	superiority	_	NOUN	NN	_	19	dobj	_	_
23	of	_	ADP	IN	_	24	case	_	_
24	DRUG	_	NOUN	NN	_	22	nmod	_	_
25	over	_	ADP	IN	_	26	case	_	_
26	placebo	_	NOUN	NN	_	22	nmod	_	_
27	on	_	ADP	IN	_	31	case	_	_
28	the	_	DET	DT	_	31	det	_	_
29	Hamilton	_	NOUN	NN	_	31	compound	_	_
30	Rating	_	VERB	VBG	_	31	compound	_	_
31	Scale	_	NOUN	NN	_	22	nmod	_	_
32	for	_	ADP	IN	_	37	case	_	_
33	Anxiety	_	NOUN	NN	_	37	compound	_	_
34	HAM	_	NOUN	NN	_	37	compound	_	_
35	A	_	NOUN	NN	_	37	compound	_	_
36	total	_	ADJ	JJ	_	37	amod	_	_
37	score	_	NOUN	NN	_	31	nmod	_	_
38	,	_	.	,	_	19	punct	_	_
39	the	_	DET	DT	_	41	det	_	_
40	primary	_	ADJ	JJ	_	41	amod	_	_
41	outcome	_	NOUN	NN	_	19	root	_	_

#	PAROXETINE	3671
1	Subgroup	_	ADJ	JJ	_	2	amod	_	_
2	analyses	_	NOUN	NNS	_	5	nsubj	_	_
3	did	_	VERB	VBD	_	5	aux	_	_
4	not	_	ADV	RB	_	5	neg	_	_
5	indicate	_	VERB	VB	_	0	root	_	_
6	differences	_	NOUN	NNS	_	5	dobj	_	_
7	in	_	ADP	IN	_	9	case	_	_
8	treatment	_	NOUN	NN	_	9	compound	_	_
9	outcomes	_	NOUN	NNS	_	6	nmod	_	_
10	as	_	ADP	IN	_	12	case	_	_
11	a	_	DET	DT	_	12	det	_	_
12	function	_	NOUN	NN	_	5	nmod	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	race	_	ADJ	JJ	_	12	nmod	_	_
15	or	_	CONJ	CC	_	5	cc	_	_
16	gender	_	NOUN	NN	_	5	conj	_	_

#	PAROXETINE	3672
1	There	_	DET	EX	_	2	expl	_	_
2	were	_	VERB	VBD	_	0	root	_	_
3	insufficient	_	ADJ	JJ	_	5	amod	_	_
4	elderly	_	ADJ	JJ	_	5	amod	_	_
5	patients	_	NOUN	NNS	_	2	nsubj	_	_
6	to	_	PRT	TO	_	7	mark	_	_
7	conduct	_	VERB	VB	_	2	xcomp	_	_
8	subgroup	_	NOUN	NN	_	9	compound	_	_
9	analyses	_	NOUN	NNS	_	7	dobj	_	_
10	on	_	ADP	IN	_	14	case	_	_
11	the	_	DET	DT	_	14	dep	_	_
12	basis	_	NOUN	NN	_	14	dep	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	age	_	NOUN	NN	_	7	nmod	_	_

#	PAROXETINE	3673
1	In	_	ADP	IN	_	5	case	_	_
2	a	_	DET	DT	_	5	det	_	_
3	longer	_	ADV	RB	_	5	advmod	_	_
4	term	_	NOUN	NN	_	5	compound	_	_
5	trial	_	ADJ	JJ	_	42	nmod	_	_
6	,	_	.	,	_	42	punct	_	_
7	566	_	NUM	CD	_	8	nummod	_	_
8	patients	_	NOUN	NNS	_	42	nsubjpass	_	_
9	meeting	_	VERB	VBG	_	8	acl	_	_
10	DSM	_	NOUN	NN	_	12	compound	_	_
11	IV	_	NUM	CD	_	12	nummod	_	_
12	criteria	_	NOUN	NN	_	9	dobj	_	_
13	for	_	ADP	IN	_	16	case	_	_
14	Generalized	_	VERB	VBN	_	16	amod	_	_
15	Anxiety	_	NOUN	NN	_	16	compound	_	_
16	Disorder	_	NOUN	NN	_	9	nmod	_	_
17	,	_	.	,	_	16	punct	_	_
18	who	_	DET	WDT	_	20	nsubj	_	_
19	had	_	VERB	MD	_	20	aux	_	_
20	responded	_	VERB	VBN	_	16	acl:relcl	_	_
21	during	_	ADP	IN	_	24	case	_	_
22	a	_	DET	DT	_	24	det	_	_
23	single	_	ADJ	JJ	_	24	amod	_	_
24	blind	_	NOUN	NN	_	20	nmod	_	_
25	,	_	.	,	_	24	punct	_	_
26	8	_	NUM	CD	_	30	nummod	_	_
27	week	_	NOUN	NN	_	30	compound	_	_
28	acute	_	ADJ	JJ	_	30	amod	_	_
29	treatment	_	NOUN	NN	_	30	compound	_	_
30	phase	_	NOUN	NN	_	24	appos	_	_
31	with	_	ADP	IN	_	35	case	_	_
32	20	_	NUM	CD	_	34	compound	_	_
33	to	_	PRT	TO	_	34	dep	_	_
34	50	_	NUM	CD	_	35	nummod	_	_
35	mg	_	NOUN	NN	_	30	nmod	_	_
36	/	_	.	:	_	24	punct	_	_
37	day	_	NOUN	NN	_	24	dep	_	_
38	of	_	ADP	IN	_	39	case	_	_
39	DRUG	_	NOUN	NN	_	37	nmod	_	_
40	,	_	.	,	_	8	punct	_	_
41	were	_	VERB	VBD	_	42	auxpass	_	_
42	randomized	_	VERB	VBN	_	0	root	_	_
43	to	_	PRT	TO	_	44	case	_	_
44	continuation	_	NOUN	NN	_	42	nmod	_	_
45	of	_	ADP	IN	_	46	case	_	_
46	DRUG	_	NOUN	NN	_	44	nmod	_	_
47	at	_	ADP	IN	_	50	case	_	_
48	their	_	PRON	PRP$	_	50	nmod:poss	_	_
49	same	_	ADJ	JJ	_	50	amod	_	_
50	dose	_	NOUN	NN	_	44	nmod	_	_
51	,	_	.	,	_	44	punct	_	_
52	or	_	CONJ	CC	_	44	cc	_	_
53	to	_	PRT	TO	_	54	case	_	_
54	placebo	_	NOUN	NN	_	44	conj	_	_
55	,	_	.	,	_	54	punct	_	_
56	for	_	ADP	IN	_	60	case	_	_
57	up	_	NOUN	NN	_	59	advmod	_	_
58	to	_	PRT	TO	_	59	dep	_	_
59	24	_	NUM	CD	_	60	nummod	_	_
60	weeks	_	NOUN	NNS	_	54	nmod	_	_
61	of	_	ADP	IN	_	62	case	_	_
62	observation	_	NOUN	NN	_	60	nmod	_	_
63	for	_	ADP	IN	_	64	case	_	_
64	relapse	_	ADP	IN	_	62	nmod	_	_

#	PAROXETINE	3674
1	Response	_	NOUN	NN	_	8	nsubjpass	_	_
2	during	_	ADP	IN	_	6	case	_	_
3	the	_	DET	DT	_	6	det	_	_
4	single	_	ADJ	JJ	_	6	amod	_	_
5	blind	_	NOUN	NN	_	6	compound	_	_
6	phase	_	NOUN	NN	_	1	nmod	_	_
7	was	_	VERB	VBD	_	8	auxpass	_	_
8	defined	_	VERB	VBN	_	0	root	_	_
9	by	_	ADP	IN	_	10	mark	_	_
10	having	_	VERB	VBG	_	8	advcl	_	_
11	a	_	DET	DT	_	12	det	_	_
12	decrease	_	NOUN	NN	_	10	dobj	_	_
13	of	_	ADP	IN	_	15	case	_	_
14	>2	_	NUM	CD	_	15	nummod	_	_
15	points	_	NOUN	NNS	_	12	nmod	_	_
16	compared	_	VERB	VBD	_	18	case	_	_
17	to	_	PRT	TO	_	18	case	_	_
18	baseline	_	NOUN	NN	_	8	nmod	_	_
19	on	_	ADP	IN	_	22	case	_	_
20	the	_	DET	DT	_	22	det	_	_
21	CGI	_	NOUN	NN	_	22	compound	_	_
22	Severity	_	NOUN	NN	_	18	nmod	_	_
23	of	_	ADP	IN	_	25	case	_	_
24	Illness	_	NOUN	NN	_	25	compound	_	_
25	scale	_	NOUN	NN	_	22	nmod	_	_
26	,	_	.	,	_	18	punct	_	_
27	to	_	PRT	TO	_	29	case	_	_
28	a	_	DET	DT	_	29	det	_	_
29	score	_	NOUN	NN	_	18	nmod	_	_
30	of	_	ADP	IN	_	31	case	_	_
31	<3	_	NUM	CD	_	29	nmod	_	_

#	PAROXETINE	3675
1	Relapse	_	NOUN	NN	_	8	nsubjpass	_	_
2	during	_	ADP	IN	_	6	case	_	_
3	the	_	DET	DT	_	6	det	_	_
4	double	_	ADJ	JJ	_	6	amod	_	_
5	blind	_	NOUN	NN	_	6	compound	_	_
6	phase	_	NOUN	NN	_	1	nmod	_	_
7	was	_	VERB	VBD	_	8	auxpass	_	_
8	defined	_	VERB	VBN	_	0	root	_	_
9	as	_	ADP	IN	_	11	case	_	_
10	an	_	DET	DT	_	11	det	_	_
11	increase	_	NOUN	NN	_	8	nmod	_	_
12	of	_	ADP	IN	_	15	case	_	_
13	>	_	NUM	CD	_	15	nummod	_	_
14	2	_	NUM	CD	_	15	nummod	_	_
15	points	_	NOUN	NNS	_	11	nmod	_	_
16	compared	_	VERB	VBD	_	18	case	_	_
17	to	_	PRT	TO	_	18	case	_	_
18	baseline	_	NOUN	NN	_	8	nmod	_	_
19	on	_	ADP	IN	_	22	case	_	_
20	the	_	DET	DT	_	22	det	_	_
21	CGI	_	NOUN	NN	_	22	compound	_	_
22	Severity	_	NOUN	NN	_	18	nmod	_	_
23	of	_	ADP	IN	_	25	case	_	_
24	Illness	_	NOUN	NN	_	25	compound	_	_
25	scale	_	NOUN	NN	_	22	nmod	_	_
26	to	_	PRT	TO	_	28	case	_	_
27	a	_	DET	DT	_	28	det	_	_
28	score	_	NOUN	NN	_	22	nmod	_	_
29	of	_	ADP	IN	_	31	case	_	_
30	>	_	NUM	CD	_	31	nummod	_	_
31	4	_	NUM	CD	_	28	nmod	_	_
32	,	_	.	,	_	8	punct	_	_
33	or	_	CONJ	CC	_	8	cc	_	_
34	withdrawal	_	NOUN	NN	_	8	conj	_	_
35	due	_	ADJ	JJ	_	37	case	_	_
36	to	_	PRT	TO	_	35	mwe	_	_
37	lack	_	NOUN	NN	_	34	nmod	_	_
38	of	_	ADP	IN	_	39	case	_	_
39	efficacy	_	NOUN	NN	_	37	nmod	_	_

#	PAROXETINE	3676
1	Patients	_	NOUN	NNS	_	5	nsubj	_	_
2	receiving	_	VERB	VBG	_	1	acl	_	_
3	continued	_	VERB	VBN	_	4	amod	_	_
4	DRUG	_	NOUN	NN	_	2	dobj	_	_
5	experienced	_	VERB	VBD	_	0	root	_	_
6	a	_	DET	DT	_	10	det	_	_
7	significantly	_	ADV	RB	_	8	advmod	_	_
8	lower	_	ADJ	JJ	_	10	amod	_	_
9	relapse	_	NOUN	NN	_	10	compound	_	_
10	rate	_	NOUN	NN	_	5	dobj	_	_
11	over	_	ADP	IN	_	15	case	_	_
12	the	_	DET	DT	_	15	det	_	_
13	subsequent	_	ADJ	JJ	_	15	amod	_	_
14	24	_	NUM	CD	_	15	nummod	_	_
15	weeks	_	NOUN	NNS	_	5	nmod	_	_
16	compared	_	VERB	VBN	_	5	xcomp	_	_
17	to	_	PRT	TO	_	18	case	_	_
18	those	_	DET	DT	_	16	nmod	_	_
19	receiving	_	VERB	VBG	_	18	acl	_	_
20	placebo	_	NOUN	NN	_	19	nmod	_	_

#	Paroxetine	4087
1	As	_	ADP	IN	_	4	case	_	_
2	with	_	ADP	IN	_	4	case	_	_
3	other	_	ADJ	JJ	_	4	amod	_	_
4	DRUGS	_	NOUN	NN	_	13	nmod	_	_
5	,	_	.	,	_	13	punct	_	_
6	an	_	DET	DT	_	7	det	_	_
7	interaction	_	NOUN	NN	_	13	nsubj	_	_
8	between	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	tryptophan	_	NOUN	NN	_	9	conj	_	_
12	may	_	VERB	MD	_	13	aux	_	_
13	occur	_	VERB	VB	_	0	root	_	_
14	when	_	ADV	WRB	_	17	advmod	_	_
15	they	_	PRON	PRP	_	17	nsubjpass	_	_
16	are	_	VERB	VBP	_	17	auxpass	_	_
17	coadministered	_	VERB	VBN	_	13	ccomp	_	_

#	Paroxetine	4088
1	Adverse	_	ADJ	JJ	_	2	amod	_	_
2	experiences	_	NOUN	NNS	_	18	nsubjpass	_	_
3	,	_	.	,	_	2	punct	_	_
4	consisting	_	VERB	VBG	_	2	acl	_	_
5	primarily	_	ADV	RB	_	7	advmod	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	headache	_	NOUN	NN	_	4	nmod	_	_
8	,	_	.	,	_	7	punct	_	_
9	nausea	_	NOUN	NN	_	7	conj	_	_
10	,	_	.	,	_	7	punct	_	_
11	sweating	_	NOUN	NN	_	7	conj	_	_
12	,	_	.	,	_	7	punct	_	_
13	and	_	CONJ	CC	_	7	cc	_	_
14	dizziness	_	NOUN	NN	_	7	conj	_	_
15	,	_	.	,	_	2	punct	_	_
16	have	_	VERB	VBP	_	18	aux	_	_
17	been	_	VERB	VBN	_	18	auxpass	_	_
18	reported	_	VERB	VBN	_	0	root	_	_
19	when	_	ADV	WRB	_	22	advmod	_	_
20	tryptophan	_	NOUN	NN	_	22	nsubjpass	_	_
21	was	_	VERB	VBD	_	22	auxpass	_	_
22	administered	_	VERB	VBN	_	18	ccomp	_	_
23	to	_	PRT	TO	_	24	case	_	_
24	patients	_	NOUN	NNS	_	22	nmod	_	_
25	taking	_	VERB	VBG	_	24	acl	_	_
26	DRUG	_	NOUN	NN	_	25	nmod	_	_

#	Paroxetine	4089
1	Consequently	_	ADV	RB	_	11	advmod	_	_
2	,	_	.	,	_	11	punct	_	_
3	concomitant	_	ADJ	JJ	_	4	amod	_	_
4	use	_	NOUN	NN	_	11	nsubjpass	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	with	_	ADP	IN	_	8	case	_	_
8	tryptophan	_	NOUN	NN	_	4	nmod	_	_
9	is	_	VERB	VBZ	_	11	auxpass	_	_
10	not	_	ADV	RB	_	11	neg	_	_
11	recommended	_	VERB	VBN	_	0	root	_	_

#	Paroxetine	4090
1	Monoamine	_	NOUN	NN	_	3	compound	_	_
2	Oxidase	_	NOUN	NN	_	3	compound	_	_
3	Inhibitors	_	NOUN	NNS	_	4	nsubj	_	_
4	See	_	VERB	VBP	_	0	root	_	_
5	CONTRAINDICATIONS	_	NOUN	NN	_	4	dobj	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	WARNINGS	_	NOUN	NNS	_	5	conj	_	_

#	Paroxetine	4091
1	Pimozide	_	NOUN	NN	_	13	nsubjpass	_	_
2	In	_	ADP	IN	_	5	case	_	_
3	a	_	DET	DT	_	5	det	_	_
4	controlled	_	VERB	VBN	_	5	amod	_	_
5	study	_	NOUN	NN	_	1	nmod	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	healthy	_	ADJ	JJ	_	8	amod	_	_
8	volunteers	_	NOUN	NNS	_	5	nmod	_	_
9	,	_	.	,	_	1	punct	_	_
10	after	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	1	nmod	_	_
12	was	_	VERB	VBD	_	13	auxpass	_	_
13	titrated	_	VERB	VBN	_	0	root	_	_
14	to	_	PRT	TO	_	16	case	_	_
15	60	_	NUM	CD	_	16	nummod	_	_
16	mg	_	NOUN	NN	_	13	nmod	_	_
17	daily	_	ADV	RB	_	13	advmod	_	_
18	,	_	.	,	_	13	punct	_	_
19	coadministration	_	NOUN	NN	_	29	nsubjpass	_	_
20	of	_	ADP	IN	_	23	case	_	_
21	a	_	DET	DT	_	23	det	_	_
22	single	_	ADJ	JJ	_	23	amod	_	_
23	dose	_	NOUN	NN	_	19	nmod	_	_
24	of	_	ADP	IN	_	27	case	_	_
25	2	_	NUM	CD	_	27	nummod	_	_
26	mg	_	NOUN	NN	_	27	compound	_	_
27	pimozide	_	NOUN	NN	_	23	nmod	_	_
28	was	_	VERB	VBD	_	29	auxpass	_	_
29	associated	_	VERB	VBN	_	13	parataxis	_	_
30	with	_	ADP	IN	_	32	case	_	_
31	mean	_	NOUN	NN	_	32	amod	_	_
32	increases	_	NOUN	NNS	_	29	nmod	_	_
33	in	_	ADP	IN	_	35	case	_	_
34	pimozide	_	NOUN	NN	_	35	compound	_	_
35	AUC	_	NOUN	NN	_	32	nmod	_	_
36	of	_	ADP	IN	_	37	case	_	_
37	151%	_	NOUN	NN	_	35	nmod	_	_
38	and	_	CONJ	CC	_	37	cc	_	_
39	Cmax	_	NOUN	NN	_	37	conj	_	_
40	of	_	ADP	IN	_	41	case	_	_
41	62%	_	NOUN	NN	_	37	nmod	_	_
42	,	_	.	,	_	29	punct	_	_
43	compared	_	VERB	VBN	_	29	xcomp	_	_
44	to	_	PRT	TO	_	45	case	_	_
45	pimozide	_	NOUN	NN	_	43	nmod	_	_
46	administered	_	VERB	VBN	_	45	acl	_	_
47	alone	_	ADV	RB	_	46	advmod	_	_

#	Paroxetine	4092
1	The	_	DET	DT	_	2	det	_	_
2	increase	_	NOUN	NN	_	14	nsubj	_	_
3	in	_	ADP	IN	_	5	case	_	_
4	pimozide	_	NOUN	NN	_	5	compound	_	_
5	AUC	_	NOUN	NN	_	2	nmod	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	Cmax	_	NOUN	NN	_	5	conj	_	_
8	is	_	VERB	VBZ	_	14	cop	_	_
9	due	_	ADJ	JJ	_	14	case	_	_
10	to	_	PRT	TO	_	9	mwe	_	_
11	the	_	DET	DT	_	14	det	_	_
12	CYP2D6	_	NOUN	NN	_	14	compound	_	_
13	inhibitory	_	ADJ	JJ	_	14	amod	_	_
14	properties	_	NOUN	NNS	_	0	root	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	14	nmod	_	_

#	Paroxetine	4093
1	Due	_	ADJ	JJ	_	6	case	_	_
2	to	_	PRT	TO	_	1	mwe	_	_
3	the	_	DET	DT	_	6	det	_	_
4	narrow	_	NOUN	NN	_	6	compound	_	_
5	therapeutic	_	ADJ	JJ	_	6	amod	_	_
6	index	_	NOUN	NN	_	26	nmod	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	pimozide	_	NOUN	NN	_	6	nmod	_	_
9	and	_	CONJ	CC	_	6	cc	_	_
10	its	_	PRON	PRP$	_	12	nmod:poss	_	_
11	known	_	VERB	VBN	_	12	amod	_	_
12	ability	_	NOUN	NN	_	6	conj	_	_
13	to	_	PRT	TO	_	14	mark	_	_
14	prolong	_	VERB	VB	_	12	acl	_	_
15	the	_	DET	DT	_	17	det	_	_
16	QT	_	NOUN	NN	_	17	nmod:npmod	_	_
17	interval	_	ADJ	JJ	_	14	dobj	_	_
18	,	_	.	,	_	26	punct	_	_
19	concomitant	_	ADJ	JJ	_	20	amod	_	_
20	use	_	NOUN	NN	_	26	nsubjpass	_	_
21	of	_	ADP	IN	_	22	case	_	_
22	pimozide	_	NOUN	NN	_	20	nmod	_	_
23	and	_	CONJ	CC	_	22	cc	_	_
24	DRUG	_	NOUN	NN	_	22	conj	_	_
25	is	_	VERB	VBZ	_	26	auxpass	_	_
26	contraindicated	_	VERB	VBN	_	0	root	_	_

#	Paroxetine	4094
1	Serotonergic	_	ADJ	JJ	_	2	amod	_	_
2	Drugs	_	NOUN	NNS	_	0	root	_	_
3	Based	_	VERB	VBN	_	2	acl	_	_
4	on	_	ADP	IN	_	6	case	_	_
5	the	_	DET	DT	_	6	det	_	_
6	mechanism	_	NOUN	NN	_	3	nmod	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	action	_	NOUN	NN	_	6	nmod	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	SNRIs	_	NOUN	NNS	_	8	nmod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	SSRIs	_	NOUN	NNS	_	10	conj	_	_
13	,	_	.	,	_	10	punct	_	_
14	including	_	VERB	VBG	_	16	case	_	_
15	DRUG	_	NOUN	NN	_	16	compound	_	_
16	hydrochloride	_	NOUN	NN	_	10	nmod	_	_
17	,	_	.	,	_	2	punct	_	_
18	and	_	CONJ	CC	_	2	cc	_	_
19	the	_	DET	DT	_	20	det	_	_
20	potential	_	NOUN	NN	_	2	conj	_	_
21	for	_	ADP	IN	_	23	case	_	_
22	serotonin	_	NOUN	NN	_	23	compound	_	_
23	syndrome	_	NOUN	NN	_	20	nmod	_	_
24	,	_	.	,	_	2	punct	_	_
25	caution	_	NOUN	NN	_	27	nsubjpass	_	_
26	is	_	VERB	VBZ	_	27	auxpass	_	_
27	advised	_	VERB	VBN	_	2	dep	_	_
28	when	_	ADV	WRB	_	31	advmod	_	_
29	DRUG	_	NOUN	NN	_	31	nsubjpass	_	_
30	is	_	VERB	VBZ	_	31	auxpass	_	_
31	coadministered	_	VERB	VBN	_	27	advcl	_	_
32	with	_	ADP	IN	_	34	case	_	_
33	other	_	ADJ	JJ	_	34	amod	_	_
34	drugs	_	NOUN	NNS	_	31	nmod	_	_
35	that	_	DET	WDT	_	37	nsubj	_	_
36	may	_	VERB	MD	_	37	aux	_	_
37	affect	_	VERB	VB	_	34	acl:relcl	_	_
38	the	_	DET	DT	_	41	det	_	_
39	serotonergic	_	ADJ	JJ	_	41	amod	_	_
40	neurotransmitter	_	ADJ	JJ	_	41	amod	_	_
41	systems	_	NOUN	NNS	_	37	dobj	_	_
42	,	_	.	,	_	41	punct	_	_
43	such	_	ADJ	JJ	_	45	case	_	_
44	as	_	ADP	IN	_	43	mwe	_	_
45	triptans	_	NOUN	NNS	_	41	nmod	_	_
46	,	_	.	,	_	45	punct	_	_
47	lithium	_	NOUN	NN	_	45	conj	_	_
48	,	_	.	,	_	45	punct	_	_
49	fentanyl	_	NOUN	NN	_	45	conj	_	_
50	,	_	.	,	_	45	punct	_	_
51	tramadol	_	NOUN	NN	_	45	conj	_	_
52	,	_	.	,	_	45	punct	_	_
53	or	_	CONJ	CC	_	45	cc	_	_
54	St	_	NOUN	NN	_	55	compound	_	_
55	John's	_	NOUN	NNS	_	45	conj	_	_
56	Wort	_	ADJ	JJ	_	55	dep	_	_

#	Paroxetine	4095
1	The	_	DET	DT	_	3	det	_	_
2	concomitant	_	ADJ	JJ	_	3	amod	_	_
3	use	_	NOUN	NN	_	15	nsubjpass	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	with	_	ADP	IN	_	7	case	_	_
7	MAOIs	_	NOUN	NNS	_	3	nmod	_	_
8	including	_	ADP	IN	_	13	case	_	_
9	linezolid	_	ADJ	JJ	_	13	amod	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	intravenous	_	ADJ	JJ	_	9	conj	_	_
12	methylene	_	NOUN	NN	_	13	compound	_	_
13	blue	_	NOUN	NN	_	7	nmod	_	_
14	is	_	VERB	VBZ	_	15	auxpass	_	_
15	contraindicated	_	VERB	VBN	_	0	root	_	_

#	Paroxetine	4096
1	The	_	DET	DT	_	3	det	_	_
2	concomitant	_	ADJ	JJ	_	3	amod	_	_
3	use	_	NOUN	NN	_	15	nsubjpass	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	with	_	ADP	IN	_	8	case	_	_
7	other	_	ADJ	JJ	_	8	amod	_	_
8	SSRIs	_	NOUN	NNS	_	3	nmod	_	_
9	,	_	.	,	_	8	punct	_	_
10	SNRIs	_	NOUN	NNS	_	8	conj	_	_
11	or	_	CONJ	CC	_	8	cc	_	_
12	tryptophan	_	NOUN	NN	_	8	conj	_	_
13	is	_	VERB	VBZ	_	15	auxpass	_	_
14	not	_	ADV	RB	_	15	neg	_	_
15	recommended	_	VERB	VBN	_	0	root	_	_

#	Paroxetine	4097
1	Thioridazine	_	NOUN	NN	_	3	compound	_	_
2	See	_	NOUN	NN	_	3	compound	_	_
3	CONTRAINDICATIONS	_	NOUN	NN	_	0	root	_	_
4	and	_	CONJ	CC	_	3	cc	_	_
5	WARNINGS	_	NOUN	NNS	_	3	conj	_	_

#	Paroxetine	4098
1	Warfarin	_	NOUN	NN	_	3	compound	_	_
2	Preliminary	_	ADJ	JJ	_	3	amod	_	_
3	data	_	NOUN	NNS	_	4	nsubj	_	_
4	suggest	_	VERB	VBP	_	0	root	_	_
5	that	_	ADP	IN	_	11	mark	_	_
6	there	_	DET	EX	_	11	nsubj	_	_
7	may	_	VERB	MD	_	11	aux	_	_
8	be	_	VERB	VB	_	11	cop	_	_
9	a	_	DET	DT	_	11	det	_	_
10	pharmacodynamic	_	ADJ	JJ	_	11	amod	_	_
11	interaction	_	NOUN	NN	_	4	ccomp	_	_
12	that	_	DET	WDT	_	13	nsubj	_	_
13	causes	_	VERB	VBZ	_	11	ccomp	_	_
14	an	_	DET	DT	_	17	det	_	_
15	increased	_	VERB	VBN	_	17	amod	_	_
16	bleeding	_	NOUN	NN	_	17	compound	_	_
17	diathesis	_	NOUN	NN	_	13	dobj	_	_
18	in	_	ADP	IN	_	20	case	_	_
19	the	_	DET	DT	_	20	det	_	_
20	face	_	NOUN	NN	_	17	nmod	_	_
21	of	_	ADP	IN	_	24	case	_	_
22	unaltered	_	ADJ	JJ	_	24	amod	_	_
23	prothrombin	_	NOUN	NN	_	24	compound	_	_
24	time	_	NOUN	NN	_	20	nmod	_	_
25	between	_	ADP	IN	_	26	case	_	_
26	DRUG	_	NOUN	NN	_	20	nmod	_	_
27	and	_	CONJ	CC	_	26	cc	_	_
28	warfarin	_	NOUN	NN	_	26	conj	_	_

#	Paroxetine	4099
1	Since	_	ADP	IN	_	3	mark	_	_
2	there	_	DET	EX	_	3	expl	_	_
3	is	_	VERB	VBZ	_	17	advcl	_	_
4	little	_	ADJ	JJ	_	6	amod	_	_
5	clinical	_	ADJ	JJ	_	6	amod	_	_
6	experience	_	NOUN	NN	_	3	nsubj	_	_
7	,	_	.	,	_	17	punct	_	_
8	the	_	DET	DT	_	10	det	_	_
9	concomitant	_	ADJ	JJ	_	10	amod	_	_
10	administration	_	NOUN	NN	_	17	nsubjpass	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	warfarin	_	NOUN	NN	_	12	conj	_	_
15	should	_	VERB	MD	_	17	aux	_	_
16	be	_	VERB	VB	_	17	auxpass	_	_
17	undertaken	_	VERB	VBN	_	0	root	_	_
18	with	_	ADP	IN	_	19	case	_	_
19	caution	_	NOUN	NN	_	17	nmod	_	_

#	Paroxetine	4100
1	Triptans	_	NOUN	NNS	_	0	root	_	_
2	There	_	DET	EX	_	7	nsubj	_	_
3	have	_	VERB	VBP	_	7	aux	_	_
4	been	_	VERB	VBN	_	7	cop	_	_
5	rare	_	ADJ	JJ	_	7	amod	_	_
6	postmarketing	_	ADJ	JJ	_	7	amod	_	_
7	reports	_	NOUN	NNS	_	1	nmod	_	_
8	of	_	ADP	IN	_	10	case	_	_
9	serotonin	_	NOUN	NN	_	10	compound	_	_
10	syndrome	_	NOUN	NN	_	7	nmod	_	_
11	with	_	ADP	IN	_	13	case	_	_
12	the	_	DET	DT	_	13	det	_	_
13	use	_	NOUN	NN	_	7	nmod	_	_
14	of	_	ADP	IN	_	16	case	_	_
15	an	_	DET	DT	_	16	det	_	_
16	SSRI	_	NOUN	NN	_	13	nmod	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	a	_	DET	DT	_	19	det	_	_
19	triptan	_	NOUN	NN	_	16	conj	_	_

#	Paroxetine	4101
1	If	_	ADP	IN	_	3	case	_	_
2	concomitant	_	ADJ	JJ	_	3	amod	_	_
3	use	_	NOUN	NN	_	11	nsubjpass	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	with	_	ADP	IN	_	8	case	_	_
7	a	_	DET	DT	_	8	det	_	_
8	triptan	_	NOUN	NN	_	3	nmod	_	_
9	is	_	VERB	VBZ	_	11	auxpass	_	_
10	clinically	_	ADV	RB	_	11	advmod	_	_
11	warranted	_	VERB	VBN	_	19	advcl	_	_
12	,	_	.	,	_	19	punct	_	_
13	careful	_	ADJ	JJ	_	14	amod	_	_
14	observation	_	NOUN	NN	_	19	nsubjpass	_	_
15	of	_	ADP	IN	_	17	case	_	_
16	the	_	DET	DT	_	17	det	_	_
17	patient	_	NOUN	NN	_	14	nmod	_	_
18	is	_	VERB	VBZ	_	19	auxpass	_	_
19	advised	_	VERB	VBN	_	0	root	_	_
20	,	_	.	,	_	19	punct	_	_
21	particularly	_	ADV	RB	_	23	advmod	_	_
22	during	_	ADP	IN	_	23	case	_	_
23	treatment	_	NOUN	NN	_	19	nmod	_	_
24	initiation	_	NOUN	NN	_	23	dep	_	_
25	and	_	CONJ	CC	_	24	cc	_	_
26	dose	_	NOUN	NN	_	24	conj	_	_
27	increases	_	VERB	VBZ	_	19	root	_	_

#	Paroxetine	4102
1	Drugs	_	NOUN	NNS	_	13	nsubjpass	_	_
2	Affecting	_	VERB	VBG	_	1	acl	_	_
3	Hepatic	_	ADJ	JJ	_	4	amod	_	_
4	Metabolism	_	NOUN	NN	_	2	dobj	_	_
5	The	_	DET	DT	_	6	det	_	_
6	metabolism	_	NOUN	NN	_	2	dobj	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	pharmacokinetics	_	NOUN	NNS	_	6	conj	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	6	nmod	_	_
11	may	_	VERB	MD	_	13	aux	_	_
12	be	_	VERB	VB	_	13	auxpass	_	_
13	affected	_	VERB	VBN	_	0	root	_	_
14	by	_	ADP	IN	_	16	case	_	_
15	the	_	DET	DT	_	16	det	_	_
16	induction	_	NOUN	NN	_	13	nmod	_	_
17	or	_	CONJ	CC	_	16	cc	_	_
18	inhibition	_	NOUN	NN	_	16	conj	_	_
19	of	_	ADP	IN	_	22	case	_	_
20	drug	_	NOUN	NN	_	22	compound	_	_
21	metabolizing	_	NOUN	NN	_	22	compound	_	_
22	enzymes	_	NOUN	NNS	_	16	nmod	_	_

#	Paroxetine	4103
1	Cimetidine	_	NOUN	NN	_	2	compound	_	_
2	Cimetidine	_	NOUN	NN	_	3	nsubj	_	_
3	inhibits	_	VERB	VBZ	_	0	root	_	_
4	many	_	ADJ	JJ	_	8	amod	_	_
5	cytochrome	_	NOUN	NN	_	8	compound	_	_
6	P450	_	NOUN	NN	_	8	compound	_	_
7	oxidative	_	ADJ	JJ	_	8	amod	_	_
8	enzymes	_	NOUN	NNS	_	3	dobj	_	_

#	Paroxetine	4104
1	In	_	ADP	IN	_	3	case	_	_
2	a	_	DET	DT	_	3	det	_	_
3	study	_	NOUN	NN	_	24	nmod	_	_
4	where	_	ADV	WRB	_	11	advmod	_	_
5	DRUG	_	NOUN	NN	_	7	compound	_	_
6	30	_	NUM	CD	_	7	nummod	_	_
7	mg	_	NOUN	NN	_	11	nsubjpass	_	_
8	once	_	ADV	RB	_	11	advmod	_	_
9	daily	_	ADV	RB	_	11	advmod	_	_
10	was	_	VERB	VBD	_	11	auxpass	_	_
11	dosed	_	VERB	VBN	_	3	acl:relcl	_	_
12	orally	_	ADV	RB	_	11	advmod	_	_
13	for	_	ADP	IN	_	15	case	_	_
14	4	_	NUM	CD	_	15	nummod	_	_
15	weeks	_	NOUN	NNS	_	11	nmod	_	_
16	,	_	.	,	_	24	punct	_	_
17	steady	_	ADJ	JJ	_	20	amod	_	_
18	state	_	NOUN	NN	_	20	compound	_	_
19	plasma	_	NOUN	NN	_	20	compound	_	_
20	concentrations	_	NOUN	NNS	_	24	nsubjpass	_	_
21	of	_	ADP	IN	_	22	case	_	_
22	DRUG	_	NOUN	NN	_	20	nmod	_	_
23	were	_	VERB	VBD	_	24	auxpass	_	_
24	increased	_	VERB	VBN	_	0	root	_	_
25	by	_	ADP	IN	_	27	case	_	_
26	approximately	_	ADV	RB	_	27	advmod	_	_
27	50%	_	NOUN	NN	_	24	nmod	_	_
28	during	_	ADP	IN	_	29	case	_	_
29	coadministration	_	NOUN	NN	_	24	nmod	_	_
30	with	_	ADP	IN	_	36	case	_	_
31	oral	_	ADJ	JJ	_	36	amod	_	_
32	cimetidine	_	NOUN	NN	_	36	compound	_	_
33	300	_	NUM	CD	_	36	nummod	_	_
34	mg	_	NOUN	NN	_	36	compound	_	_
35	three	_	NUM	CD	_	36	nummod	_	_
36	times	_	NOUN	NNS	_	29	nmod	_	_
37	daily	_	ADV	RB	_	29	advmod	_	_
38	for	_	ADP	IN	_	41	case	_	_
39	the	_	DET	DT	_	41	det	_	_
40	final	_	ADJ	JJ	_	41	amod	_	_
41	week	_	NOUN	NN	_	37	nmod	_	_

#	Paroxetine	4105
1	Therefore	_	ADV	RB	_	22	advmod	_	_
2	,	_	.	,	_	22	punct	_	_
3	when	_	ADV	WRB	_	7	advmod	_	_
4	these	_	DET	DT	_	5	det	_	_
5	drugs	_	NOUN	NNS	_	7	nsubjpass	_	_
6	are	_	VERB	VBP	_	7	auxpass	_	_
7	administered	_	VERB	VBN	_	22	advcl	_	_
8	concurrently	_	ADV	RB	_	7	advmod	_	_
9	,	_	.	,	_	22	punct	_	_
10	dosage	_	ADJ	JJ	_	11	compound	_	_
11	adjustment	_	NOUN	NN	_	22	nsubjpass	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	DRUG	_	NOUN	NN	_	11	nmod	_	_
14	after	_	ADP	IN	_	19	case	_	_
15	the	_	DET	DT	_	19	det	_	_
16	20	_	NUM	CD	_	19	nummod	_	_
17	mg	_	NOUN	NN	_	19	compound	_	_
18	starting	_	VERB	VBG	_	19	amod	_	_
19	dose	_	NOUN	NN	_	11	nmod	_	_
20	should	_	VERB	MD	_	22	aux	_	_
21	be	_	VERB	VB	_	22	auxpass	_	_
22	guided	_	VERB	VBN	_	0	root	_	_
23	by	_	ADP	IN	_	25	case	_	_
24	clinical	_	ADJ	JJ	_	25	amod	_	_
25	effect	_	NOUN	NN	_	22	nmod	_	_

#	Paroxetine	4106
1	The	_	DET	DT	_	2	det	_	_
2	effect	_	NOUN	NN	_	10	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	on	_	ADP	IN	_	7	case	_	_
6	cimetidine's	_	NOUN	NNS	_	7	compound	_	_
7	pharmacokinetics	_	NOUN	NNS	_	2	nmod	_	_
8	was	_	VERB	VBD	_	10	auxpass	_	_
9	not	_	ADV	RB	_	10	neg	_	_
10	studied	_	VERB	VBN	_	0	root	_	_

#	Paroxetine	4107
1	Phenobarbital	_	ADJ	JJ	_	2	amod	_	_
2	Phenobarbital	_	NOUN	NN	_	3	nsubj	_	_
3	induces	_	VERB	VBZ	_	0	root	_	_
4	many	_	ADJ	JJ	_	8	amod	_	_
5	cytochrome	_	NOUN	NN	_	8	compound	_	_
6	P450	_	NOUN	NN	_	8	compound	_	_
7	oxidative	_	ADJ	JJ	_	8	amod	_	_
8	enzymes	_	NOUN	NNS	_	3	dobj	_	_

#	Paroxetine	4108
1	When	_	ADV	WRB	_	11	advmod	_	_
2	a	_	DET	DT	_	7	det	_	_
3	single	_	ADJ	JJ	_	7	amod	_	_
4	oral	_	ADJ	JJ	_	7	amod	_	_
5	30	_	NUM	CD	_	7	nummod	_	_
6	mg	_	NOUN	NN	_	7	compound	_	_
7	dose	_	NOUN	NN	_	11	nsubjpass	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	was	_	VERB	VBD	_	11	auxpass	_	_
11	administered	_	VERB	VBN	_	29	advcl	_	_
12	at	_	ADP	IN	_	17	case	_	_
13	phenobarbital	_	ADJ	JJ	_	17	amod	_	_
14	steady	_	ADJ	JJ	_	17	amod	_	_
15	state	_	NOUN	NN	_	17	compound	_	_
16	100	_	NUM	CD	_	17	nummod	_	_
17	mg	_	NOUN	NN	_	11	nmod	_	_
18	once	_	ADV	RB	_	19	advmod	_	_
19	daily	_	ADV	RB	_	11	advmod	_	_
20	for	_	ADP	IN	_	22	case	_	_
21	14	_	NUM	CD	_	22	nummod	_	_
22	days	_	NOUN	NNS	_	19	nmod	_	_
23	,	_	.	,	_	29	punct	_	_
24	DRUG	_	NOUN	NN	_	25	compound	_	_
25	AUC	_	NOUN	NN	_	29	nsubjpass	_	_
26	and	_	CONJ	CC	_	25	cc	_	_
27	T%	_	NOUN	NN	_	25	conj	_	_
28	were	_	VERB	VBD	_	29	auxpass	_	_
29	reduced	_	VERB	VBN	_	0	root	_	_
30	by	_	ADP	IN	_	32	case	_	_
31	an	_	DET	DT	_	32	det	_	_
32	average	_	NOUN	NN	_	29	nmod	_	_
33	of	_	ADP	IN	_	34	case	_	_
34	25%	_	NOUN	NN	_	32	nmod	_	_
35	and	_	CONJ	CC	_	34	cc	_	_
36	38%	_	NOUN	NN	_	34	conj	_	_
37	,	_	.	,	_	29	punct	_	_
38	respectively	_	ADV	RB	_	39	advmod	_	_
39	compared	_	VERB	VBN	_	29	advcl	_	_
40	to	_	PRT	TO	_	41	case	_	_
41	DRUG	_	NOUN	NN	_	39	nmod	_	_
42	administered	_	VERB	VBN	_	41	acl	_	_
43	alone	_	ADV	RB	_	42	advmod	_	_

#	Paroxetine	4109
1	The	_	DET	DT	_	2	det	_	_
2	effect	_	NOUN	NN	_	10	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	on	_	ADP	IN	_	7	case	_	_
6	phenobarbital	_	ADJ	JJ	_	7	amod	_	_
7	pharmacokinetics	_	NOUN	NNS	_	2	nmod	_	_
8	was	_	VERB	VBD	_	10	auxpass	_	_
9	not	_	ADV	RB	_	10	neg	_	_
10	studied	_	VERB	VBN	_	0	root	_	_

#	Paroxetine	4110
1	Since	_	ADP	IN	_	3	mark	_	_
2	DRUG	_	NOUN	NN	_	3	nsubj	_	_
3	exhibits	_	VERB	VBZ	_	14	advcl	_	_
4	nonlinear	_	ADJ	JJ	_	5	amod	_	_
5	pharmacokinetics	_	NOUN	NNS	_	3	dobj	_	_
6	,	_	.	,	_	14	punct	_	_
7	the	_	DET	DT	_	8	det	_	_
8	results	_	NOUN	NNS	_	14	nsubj	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	this	_	DET	DT	_	11	det	_	_
11	study	_	NOUN	NN	_	8	nmod	_	_
12	may	_	VERB	MD	_	14	aux	_	_
13	not	_	ADV	RB	_	14	neg	_	_
14	address	_	VERB	VB	_	0	root	_	_
15	the	_	DET	DT	_	16	det	_	_
16	case	_	NOUN	NN	_	14	dobj	_	_
17	where	_	ADV	WRB	_	25	advmod	_	_
18	the	_	DET	DT	_	20	det	_	_
19	2	_	NUM	CD	_	20	nummod	_	_
20	drugs	_	NOUN	NNS	_	25	nsubjpass	_	_
21	are	_	VERB	VBP	_	25	auxpass	_	_
22	both	_	DET	DT	_	25	advmod	_	_
23	being	_	VERB	VBN	_	25	auxpass	_	_
24	chronically	_	ADV	RB	_	25	advmod	_	_
25	dosed	_	VERB	VBN	_	16	root	_	_

#	Paroxetine	4111
1	No	_	DET	DT	_	4	neg	_	_
2	initial	_	ADJ	JJ	_	4	amod	_	_
3	dosage	_	NOUN	NN	_	4	compound	_	_
4	adjustment	_	NOUN	NN	_	8	nsubjpass	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	is	_	VERB	VBZ	_	8	auxpass	_	_
8	considered	_	VERB	VBN	_	0	root	_	_
9	necessary	_	ADJ	JJ	_	8	xcomp	_	_
10	when	_	ADV	WRB	_	11	advmod	_	_
11	coadministered	_	VERB	VBN	_	9	advcl	_	_
12	with	_	ADP	IN	_	16	case	_	_
13	phenobarbital	_	ADJ	JJ	_	16	amod	_	_
14	any	_	DET	DT	_	16	det	_	_
15	subsequent	_	ADJ	JJ	_	16	amod	_	_
16	adjustment	_	NOUN	NN	_	11	nmod	_	_
17	should	_	VERB	MD	_	19	aux	_	_
18	be	_	VERB	VB	_	19	auxpass	_	_
19	guided	_	VERB	VBN	_	8	parataxis	_	_
20	by	_	ADP	IN	_	22	case	_	_
21	clinical	_	ADJ	JJ	_	22	amod	_	_
22	effect	_	NOUN	NN	_	19	nmod	_	_

#	Paroxetine	4112
1	Phenytoin	_	NOUN	NN	_	30	nsubjpass	_	_
2	When	_	ADV	WRB	_	12	advmod	_	_
3	a	_	DET	DT	_	8	det	_	_
4	single	_	ADJ	JJ	_	8	amod	_	_
5	oral	_	ADJ	JJ	_	8	amod	_	_
6	30	_	NUM	CD	_	8	nummod	_	_
7	mg	_	NOUN	NN	_	8	compound	_	_
8	dose	_	NOUN	NN	_	12	nsubjpass	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	was	_	VERB	VBD	_	12	auxpass	_	_
12	administered	_	VERB	VBN	_	1	acl:relcl	_	_
13	at	_	ADP	IN	_	18	case	_	_
14	phenytoin	_	NOUN	NN	_	18	compound	_	_
15	steady	_	ADJ	JJ	_	18	amod	_	_
16	state	_	NOUN	NN	_	18	compound	_	_
17	300	_	NUM	CD	_	18	nummod	_	_
18	mg	_	NOUN	NN	_	12	nmod	_	_
19	once	_	ADV	RB	_	20	advmod	_	_
20	daily	_	ADV	RB	_	12	advmod	_	_
21	for	_	ADP	IN	_	23	case	_	_
22	14	_	NUM	CD	_	23	nummod	_	_
23	days	_	NOUN	NNS	_	20	nmod	_	_
24	,	_	.	,	_	1	punct	_	_
25	DRUG	_	NOUN	NN	_	26	compound	_	_
26	AUC	_	NOUN	NN	_	1	conj	_	_
27	and	_	CONJ	CC	_	1	cc	_	_
28	T%	_	NOUN	NN	_	1	conj	_	_
29	were	_	VERB	VBD	_	30	auxpass	_	_
30	reduced	_	VERB	VBN	_	0	root	_	_
31	by	_	ADP	IN	_	33	case	_	_
32	an	_	DET	DT	_	33	det	_	_
33	average	_	NOUN	NN	_	30	nmod	_	_
34	of	_	ADP	IN	_	35	case	_	_
35	50%	_	NOUN	NN	_	33	nmod	_	_
36	and	_	CONJ	CC	_	35	cc	_	_
37	35%	_	NOUN	NN	_	35	conj	_	_
38	,	_	.	,	_	30	punct	_	_
39	respectively	_	ADV	RB	_	40	advmod	_	_
40	compared	_	VERB	VBN	_	30	advcl	_	_
41	to	_	PRT	TO	_	42	case	_	_
42	DRUG	_	NOUN	NN	_	40	nmod	_	_
43	administered	_	VERB	VBN	_	42	acl	_	_
44	alone	_	ADV	RB	_	43	advmod	_	_

#	Paroxetine	4113
1	In	_	ADP	IN	_	4	case	_	_
2	a	_	DET	DT	_	4	det	_	_
3	separate	_	ADJ	JJ	_	4	amod	_	_
4	study	_	NOUN	NN	_	33	nmod	_	_
5	,	_	.	,	_	33	punct	_	_
6	when	_	ADV	WRB	_	16	advmod	_	_
7	a	_	DET	DT	_	12	det	_	_
8	single	_	ADJ	JJ	_	12	amod	_	_
9	oral	_	ADJ	JJ	_	12	amod	_	_
10	300	_	NUM	CD	_	12	nummod	_	_
11	mg	_	NOUN	NN	_	12	compound	_	_
12	dose	_	NOUN	NN	_	16	nsubjpass	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	phenytoin	_	NOUN	NN	_	12	nmod	_	_
15	was	_	VERB	VBD	_	16	auxpass	_	_
16	administered	_	VERB	VBN	_	33	advcl	_	_
17	at	_	ADP	IN	_	22	case	_	_
18	DRUG	_	NOUN	NN	_	22	compound	_	_
19	steady	_	ADJ	JJ	_	22	amod	_	_
20	state	_	NOUN	NN	_	22	compound	_	_
21	30	_	NUM	CD	_	22	nummod	_	_
22	mg	_	NOUN	NN	_	16	nmod	_	_
23	once	_	ADV	RB	_	24	advmod	_	_
24	daily	_	ADV	RB	_	16	advmod	_	_
25	for	_	ADP	IN	_	27	case	_	_
26	14	_	NUM	CD	_	27	nummod	_	_
27	days	_	NOUN	NNS	_	24	nmod	_	_
28	,	_	.	,	_	33	punct	_	_
29	phenytoin	_	NOUN	NN	_	30	compound	_	_
30	AUC	_	NOUN	NN	_	33	nsubjpass	_	_
31	was	_	VERB	VBD	_	33	auxpass	_	_
32	slightly	_	ADV	RB	_	33	advmod	_	_
33	reduced	_	VERB	VBN	_	0	root	_	_
34	12%	_	NOUN	NN	_	33	xcomp	_	_
35	on	_	ADP	IN	_	37	mark	_	_
36	average	_	NOUN	NN	_	37	amod	_	_
37	compared	_	VERB	VBN	_	33	advcl	_	_
38	to	_	PRT	TO	_	39	case	_	_
39	phenytoin	_	NOUN	NN	_	37	nmod	_	_
40	administered	_	VERB	VBN	_	39	acl	_	_
41	alone	_	ADV	RB	_	40	advmod	_	_

#	Paroxetine	4114
1	Since	_	ADP	IN	_	4	mark	_	_
2	both	_	DET	DT	_	3	det	_	_
3	drugs	_	NOUN	NNS	_	4	nsubj	_	_
4	exhibit	_	VERB	VBP	_	13	advcl	_	_
5	nonlinear	_	ADJ	JJ	_	6	amod	_	_
6	pharmacokinetics	_	NOUN	NNS	_	4	dobj	_	_
7	,	_	.	,	_	13	punct	_	_
8	the	_	DET	DT	_	10	det	_	_
9	above	_	ADJ	JJ	_	10	amod	_	_
10	studies	_	NOUN	NNS	_	13	nsubj	_	_
11	may	_	VERB	MD	_	13	aux	_	_
12	not	_	ADV	RB	_	13	neg	_	_
13	address	_	VERB	VB	_	0	root	_	_
14	the	_	DET	DT	_	15	det	_	_
15	case	_	NOUN	NN	_	13	dobj	_	_
16	where	_	ADV	WRB	_	24	advmod	_	_
17	the	_	DET	DT	_	19	det	_	_
18	2	_	NUM	CD	_	19	nummod	_	_
19	drugs	_	NOUN	NNS	_	24	nsubjpass	_	_
20	are	_	VERB	VBP	_	24	auxpass	_	_
21	both	_	DET	DT	_	24	advmod	_	_
22	being	_	VERB	VBN	_	24	auxpass	_	_
23	chronically	_	ADV	RB	_	24	advmod	_	_
24	dosed	_	VERB	VBN	_	15	root	_	_

#	Paroxetine	4115
1	No	_	DET	DT	_	4	neg	_	_
2	initial	_	ADJ	JJ	_	4	amod	_	_
3	dosage	_	NOUN	NN	_	4	compound	_	_
4	adjustments	_	NOUN	NNS	_	6	nsubjpass	_	_
5	are	_	VERB	VBP	_	6	auxpass	_	_
6	considered	_	VERB	VBN	_	0	root	_	_
7	necessary	_	ADJ	JJ	_	6	xcomp	_	_
8	when	_	ADV	WRB	_	12	advmod	_	_
9	these	_	DET	DT	_	10	det	_	_
10	drugs	_	NOUN	NNS	_	12	nsubjpass	_	_
11	are	_	VERB	VBP	_	12	auxpass	_	_
12	coadministered	_	VERB	VBN	_	6	root	_	_
13	any	_	DET	DT	_	15	det	_	_
14	subsequent	_	ADJ	JJ	_	15	amod	_	_
15	adjustments	_	NOUN	NNS	_	12	dobj	_	_
16	should	_	VERB	MD	_	18	aux	_	_
17	be	_	VERB	VB	_	18	auxpass	_	_
18	guided	_	VERB	VBN	_	12	parataxis	_	_
19	by	_	ADP	IN	_	21	case	_	_
20	clinical	_	ADJ	JJ	_	21	amod	_	_
21	effect	_	NOUN	NN	_	18	nmod	_	_

#	Paroxetine	4116
1	Many	_	ADJ	JJ	_	2	amod	_	_
2	drugs	_	NOUN	NNS	_	24	nsubjpass	_	_
3	,	_	.	,	_	2	punct	_	_
4	including	_	VERB	VBG	_	6	case	_	_
5	most	_	ADJ	JJ	_	6	amod	_	_
6	drugs	_	NOUN	NNS	_	2	nmod	_	_
7	effective	_	ADJ	JJ	_	6	amod	_	_
8	in	_	ADP	IN	_	10	case	_	_
9	the	_	DET	DT	_	10	det	_	_
10	treatment	_	NOUN	NN	_	7	nmod	_	_
11	of	_	ADP	IN	_	15	case	_	_
12	major	_	ADJ	JJ	_	15	amod	_	_
13	depressive	_	ADJ	JJ	_	15	amod	_	_
14	disorder	_	NOUN	NN	_	15	compound	_	_
15	DRUG	_	NOUN	NN	_	10	nmod	_	_
16	,	_	.	,	_	15	punct	_	_
17	other	_	ADJ	JJ	_	18	amod	_	_
18	SSRIs	_	NOUN	NNS	_	15	conj	_	_
19	and	_	CONJ	CC	_	15	cc	_	_
20	many	_	ADJ	JJ	_	21	amod	_	_
21	tricyclics	_	NOUN	NNS	_	15	conj	_	_
22	,	_	.	,	_	2	punct	_	_
23	are	_	VERB	VBP	_	24	auxpass	_	_
24	metabolized	_	VERB	VBN	_	0	root	_	_
25	by	_	ADP	IN	_	29	case	_	_
26	the	_	DET	DT	_	29	det	_	_
27	cytochrome	_	NOUN	NN	_	29	compound	_	_
28	P450	_	NOUN	NN	_	29	compound	_	_
29	isozyme	_	NOUN	NN	_	24	nmod	_	_
30	CYP2D6	_	NOUN	NN	_	29	dep	_	_

#	Paroxetine	4117
1	Like	_	ADP	IN	_	3	case	_	_
2	other	_	ADJ	JJ	_	3	amod	_	_
3	agents	_	NOUN	NNS	_	13	nmod	_	_
4	that	_	DET	WDT	_	6	nsubjpass	_	_
5	are	_	VERB	VBP	_	6	auxpass	_	_
6	metabolized	_	VERB	VBN	_	3	acl:relcl	_	_
7	by	_	ADP	IN	_	8	case	_	_
8	CYP2D6	_	NOUN	NN	_	6	nmod	_	_
9	,	_	.	,	_	13	punct	_	_
10	DRUG	_	NOUN	NN	_	13	nsubj	_	_
11	may	_	VERB	MD	_	13	aux	_	_
12	significantly	_	ADV	RB	_	13	advmod	_	_
13	inhibit	_	VERB	VB	_	0	root	_	_
14	the	_	DET	DT	_	15	det	_	_
15	activity	_	NOUN	NN	_	13	dobj	_	_
16	of	_	ADP	IN	_	18	case	_	_
17	this	_	DET	DT	_	18	det	_	_
18	isozyme	_	NOUN	NN	_	15	nmod	_	_

#	Paroxetine	4118
1	In	_	ADP	IN	_	3	case	_	_
2	most	_	ADJ	JJ	_	3	amod	_	_
3	patients	_	NOUN	NNS	_	10	nmod	_	_
4	>90%	_	NOUN	NN	_	3	dep	_	_
5	,	_	.	,	_	10	punct	_	_
6	this	_	DET	DT	_	8	det	_	_
7	CYP2D6	_	NOUN	NN	_	8	compound	_	_
8	isozyme	_	NOUN	NN	_	10	nsubjpass	_	_
9	is	_	VERB	VBZ	_	10	auxpass	_	_
10	saturated	_	VERB	VBN	_	0	root	_	_
11	early	_	ADJ	JJ	_	10	xcomp	_	_
12	during	_	ADP	IN	_	13	mark	_	_
13	dosing	_	VERB	VBG	_	10	advcl	_	_
14	with	_	ADP	IN	_	15	case	_	_
15	DRUG	_	NOUN	NN	_	13	nmod	_	_

#	Paroxetine	4119
1	In	_	ADP	IN	_	3	case	_	_
2	1	_	NUM	CD	_	3	nummod	_	_
3	study	_	NOUN	NN	_	17	nmod	_	_
4	,	_	.	,	_	17	punct	_	_
5	daily	_	ADV	RB	_	6	advmod	_	_
6	dosing	_	NOUN	NN	_	17	nsubj	_	_
7	of	_	ADP	IN	_	10	case	_	_
8	DRUG	_	NOUN	NN	_	10	compound	_	_
9	20	_	NUM	CD	_	10	nummod	_	_
10	mg	_	NOUN	NN	_	6	nmod	_	_
11	once	_	ADV	RB	_	12	advmod	_	_
12	daily	_	ADV	RB	_	17	advmod	_	_
13	under	_	ADP	IN	_	16	case	_	_
14	steady	_	ADJ	JJ	_	16	amod	_	_
15	state	_	NOUN	NN	_	16	compound	_	_
16	conditions	_	NOUN	NNS	_	12	nmod	_	_
17	increased	_	VERB	VBD	_	0	root	_	_
18	single	_	ADJ	JJ	_	23	amod	_	_
19	dose	_	NOUN	NN	_	23	compound	_	_
20	desipramine	_	NOUN	NN	_	23	compound	_	_
21	100	_	NUM	CD	_	23	nummod	_	_
22	mg	_	NOUN	NN	_	23	compound	_	_
23	Cmax	_	NOUN	NN	_	17	dobj	_	_
24	,	_	.	,	_	23	punct	_	_
25	AUC	_	NOUN	NN	_	23	conj	_	_
26	,	_	.	,	_	23	punct	_	_
27	and	_	CONJ	CC	_	23	cc	_	_
28	T%	_	NOUN	NN	_	23	conj	_	_
29	by	_	ADP	IN	_	31	case	_	_
30	an	_	DET	DT	_	31	det	_	_
31	average	_	NOUN	NN	_	17	nmod	_	_
32	of	_	ADP	IN	_	34	case	_	_
33	approximately	_	ADV	RB	_	34	advmod	_	_
34	2	_	NUM	CD	_	31	nmod	_	_
35	,	_	.	,	_	34	punct	_	_
36	5	_	NUM	CD	_	34	conj	_	_
37	,	_	.	,	_	34	punct	_	_
38	and	_	CONJ	CC	_	34	cc	_	_
39	3	_	NUM	CD	_	34	conj	_	_
40	fold	_	NOUN	NN	_	34	dep	_	_
41	,	_	.	,	_	17	punct	_	_
42	respectively	_	ADV	RB	_	17	advmod	_	_

#	Paroxetine	4120
1	Concomitant	_	ADJ	JJ	_	2	amod	_	_
2	use	_	NOUN	NN	_	0	root	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	with	_	ADP	IN	_	6	case	_	_
6	risperidone	_	NOUN	NN	_	2	nmod	_	_
7	,	_	.	,	_	2	punct	_	_
8	a	_	DET	DT	_	10	det	_	_
9	CYP2D6	_	NOUN	NN	_	10	compound	_	_
10	substrate	_	NOUN	NN	_	14	nsubjpass	_	_
11	has	_	VERB	VBZ	_	14	aux	_	_
12	also	_	ADV	RB	_	14	advmod	_	_
13	been	_	VERB	VBN	_	14	auxpass	_	_
14	evaluated	_	VERB	VBN	_	2	dep	_	_

#	Paroxetine	4121
1	In	_	ADP	IN	_	3	case	_	_
2	1	_	NUM	CD	_	3	nummod	_	_
3	study	_	NOUN	NN	_	32	nmod	_	_
4	,	_	.	,	_	32	punct	_	_
5	daily	_	ADV	RB	_	6	advmod	_	_
6	dosing	_	NOUN	NN	_	32	nsubj	_	_
7	of	_	ADP	IN	_	10	case	_	_
8	DRUG	_	NOUN	NN	_	10	compound	_	_
9	20	_	NUM	CD	_	10	nummod	_	_
10	mg	_	NOUN	NN	_	6	nmod	_	_
11	in	_	ADP	IN	_	12	case	_	_
12	patients	_	NOUN	NNS	_	6	nmod	_	_
13	stabilized	_	VERB	VBN	_	12	acl	_	_
14	on	_	ADP	IN	_	15	case	_	_
15	risperidone	_	NOUN	NN	_	13	nmod	_	_
16	4	_	NUM	CD	_	15	nummod	_	_
17	to	_	PRT	TO	_	19	case	_	_
18	8	_	NUM	CD	_	19	nummod	_	_
19	mg	_	NOUN	NN	_	13	nmod	_	_
20	/	_	.	:	_	6	punct	_	_
21	day	_	NOUN	NN	_	22	nsubj	_	_
22	increased	_	VERB	VBD	_	6	dep	_	_
23	mean	_	ADJ	JJ	_	25	amod	_	_
24	plasma	_	NOUN	NN	_	25	compound	_	_
25	concentrations	_	NOUN	NNS	_	22	dobj	_	_
26	of	_	ADP	IN	_	27	case	_	_
27	risperidone	_	NOUN	NN	_	25	nmod	_	_
28	approximately	_	ADV	RB	_	30	advmod	_	_
29	4	_	NUM	CD	_	30	nummod	_	_
30	fold	_	NOUN	NN	_	22	advmod	_	_
31	,	_	.	,	_	6	punct	_	_
32	decreased	_	VERB	VBD	_	0	root	_	_
33	9	_	NUM	CD	_	35	nummod	_	_
34	hydroxyrisperidone	_	NOUN	NN	_	35	compound	_	_
35	concentrations	_	NOUN	NNS	_	32	dobj	_	_
36	approximately	_	ADV	RB	_	37	advmod	_	_
37	10%	_	ADJ	JJ	_	32	xcomp	_	_
38	,	_	.	,	_	32	punct	_	_
39	and	_	CONJ	CC	_	32	cc	_	_
40	increased	_	VERB	VBN	_	41	amod	_	_
41	concentrations	_	NOUN	NNS	_	32	conj	_	_
42	of	_	ADP	IN	_	45	case	_	_
43	the	_	DET	DT	_	45	det	_	_
44	active	_	ADJ	JJ	_	45	amod	_	_
45	moiety	_	NOUN	NN	_	41	nmod	_	_
46	the	_	DET	DT	_	47	det	_	_
47	sum	_	NOUN	NN	_	41	dep	_	_
48	of	_	ADP	IN	_	49	case	_	_
49	risperidone	_	NOUN	NN	_	47	nmod	_	_
50	plus	_	CONJ	CC	_	49	cc	_	_
51	9	_	NUM	CD	_	52	nummod	_	_
52	hydroxyrisperidone	_	NOUN	NN	_	49	conj	_	_
53	approximately	_	ADV	RB	_	54	advmod	_	_
54	1.4	_	NUM	CD	_	47	nmod	_	_
55	fold	_	VERB	VBD	_	54	dep	_	_

#	Paroxetine	4122
1	The	_	DET	DT	_	2	det	_	_
2	effect	_	NOUN	NN	_	12	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	on	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	pharmacokinetics	_	NOUN	NNS	_	2	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	atomoxetine	_	NOUN	NN	_	7	nmod	_	_
10	has	_	VERB	VBZ	_	12	aux	_	_
11	been	_	VERB	VBN	_	12	auxpass	_	_
12	evaluated	_	VERB	VBN	_	0	root	_	_
13	when	_	ADV	WRB	_	19	advmod	_	_
14	both	_	DET	DT	_	15	det	_	_
15	drugs	_	NOUN	NNS	_	19	nsubj	_	_
16	were	_	VERB	VBD	_	19	cop	_	_
17	at	_	ADP	IN	_	19	case	_	_
18	steady	_	ADJ	JJ	_	19	amod	_	_
19	state	_	NOUN	NN	_	12	ccomp	_	_

#	Paroxetine	4123
1	In	_	ADP	IN	_	3	case	_	_
2	healthy	_	ADJ	JJ	_	3	amod	_	_
3	volunteers	_	NOUN	NNS	_	16	nmod	_	_
4	who	_	DET	WDT	_	7	nsubj	_	_
5	were	_	VERB	VBD	_	7	cop	_	_
6	extensive	_	ADJ	JJ	_	7	amod	_	_
7	metabolizers	_	NOUN	NNS	_	3	acl:relcl	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	CYP2D6	_	NOUN	NN	_	7	nmod	_	_
10	,	_	.	,	_	16	punct	_	_
11	DRUG	_	NOUN	NN	_	13	compound	_	_
12	20	_	NUM	CD	_	13	nummod	_	_
13	mg	_	NOUN	NN	_	16	nsubjpass	_	_
14	daily	_	ADV	RB	_	16	advmod	_	_
15	was	_	VERB	VBD	_	16	auxpass	_	_
16	given	_	VERB	VBN	_	0	root	_	_
17	in	_	ADP	IN	_	18	case	_	_
18	combination	_	NOUN	NN	_	16	nmod	_	_
19	with	_	ADP	IN	_	25	case	_	_
20	20	_	NUM	CD	_	25	nummod	_	_
21	mg	_	NOUN	NN	_	25	compound	_	_
22	atomoxetine	_	NOUN	NN	_	25	compound	_	_
23	every	_	ADV	RB	_	24	advmod	_	_
24	12	_	NUM	CD	_	25	nummod	_	_
25	hours	_	NOUN	NNS	_	18	nmod	_	_

#	Paroxetine	4124
1	This	_	DET	DT	_	2	nsubj	_	_
2	resulted	_	VERB	VBD	_	0	root	_	_
3	in	_	ADP	IN	_	4	case	_	_
4	increases	_	NOUN	NNS	_	2	nmod	_	_
5	in	_	ADP	IN	_	10	case	_	_
6	steady	_	ADJ	JJ	_	10	amod	_	_
7	state	_	NOUN	NN	_	10	compound	_	_
8	atomoxetine	_	NOUN	NN	_	10	compound	_	_
9	AUC	_	NOUN	NN	_	10	compound	_	_
10	values	_	NOUN	NNS	_	4	nmod	_	_
11	that	_	DET	WDT	_	17	nsubj	_	_
12	were	_	VERB	VBD	_	17	cop	_	_
13	6	_	NUM	CD	_	15	compound	_	_
14	to	_	PRT	TO	_	15	dep	_	_
15	8	_	NUM	CD	_	16	nummod	_	_
16	fold	_	NOUN	NN	_	17	nmod:npmod	_	_
17	greater	_	ADJ	JJ	_	10	nmod	_	_
18	and	_	CONJ	CC	_	17	cc	_	_
19	in	_	ADP	IN	_	22	case	_	_
20	atomoxetine	_	NOUN	NN	_	22	compound	_	_
21	Cmax	_	NOUN	NN	_	22	compound	_	_
22	values	_	NOUN	NNS	_	17	conj	_	_
23	that	_	DET	WDT	_	28	nsubj	_	_
24	were	_	VERB	VBD	_	28	cop	_	_
25	3	_	NUM	CD	_	27	compound	_	_
26	to	_	PRT	TO	_	27	dep	_	_
27	4	_	NUM	CD	_	28	nummod	_	_
28	fold	_	NOUN	NN	_	34	nsubjpass	_	_
29	greater	_	ADJ	JJ	_	28	amod	_	_
30	than	_	ADP	IN	_	32	case	_	_
31	when	_	ADV	WRB	_	30	mwe	_	_
32	atomoxetine	_	NOUN	NN	_	29	nmod	_	_
33	was	_	VERB	VBD	_	34	auxpass	_	_
34	given	_	VERB	VBN	_	22	acl:relcl	_	_
35	alone	_	ADV	RB	_	34	advmod	_	_

#	Paroxetine	4125
1	Dosage	_	NOUN	NN	_	2	compound	_	_
2	adjustment	_	NOUN	NN	_	7	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	atomoxetine	_	NOUN	NN	_	2	nmod	_	_
5	may	_	VERB	MD	_	7	aux	_	_
6	be	_	VERB	VB	_	7	cop	_	_
7	necessary	_	ADJ	JJ	_	0	root	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	it	_	PRON	PRP	_	11	nsubjpass	_	_
10	is	_	VERB	VBZ	_	11	auxpass	_	_
11	recommended	_	VERB	VBN	_	7	conj	_	_
12	that	_	ADP	IN	_	15	mark	_	_
13	atomoxetine	_	NOUN	NN	_	15	nsubjpass	_	_
14	be	_	VERB	VBZ	_	15	auxpass	_	_
15	initiated	_	VERB	VBN	_	11	ccomp	_	_
16	at	_	ADP	IN	_	19	case	_	_
17	a	_	DET	DT	_	19	det	_	_
18	reduced	_	VERB	VBN	_	19	amod	_	_
19	dose	_	NOUN	NN	_	15	nmod	_	_
20	when	_	ADV	WRB	_	23	advmod	_	_
21	it	_	PRON	PRP	_	23	nsubjpass	_	_
22	is	_	VERB	VBZ	_	23	auxpass	_	_
23	given	_	VERB	VBN	_	15	advcl	_	_
24	with	_	ADP	IN	_	25	case	_	_
25	DRUG	_	NOUN	NN	_	23	nmod	_	_

#	Paroxetine	4126
1	Concomitant	_	ADJ	JJ	_	2	amod	_	_
2	use	_	NOUN	NN	_	16	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	with	_	ADP	IN	_	7	case	_	_
6	other	_	ADJ	JJ	_	7	amod	_	_
7	drugs	_	NOUN	NNS	_	2	nmod	_	_
8	metabolized	_	VERB	VBN	_	7	acl	_	_
9	by	_	ADP	IN	_	11	case	_	_
10	cytochrome	_	NOUN	NN	_	11	compound	_	_
11	CYP2D6	_	NOUN	NN	_	8	nmod	_	_
12	has	_	VERB	VBZ	_	16	aux	_	_
13	not	_	ADV	RB	_	16	neg	_	_
14	been	_	VERB	VBN	_	16	auxpass	_	_
15	formally	_	ADV	RB	_	16	advmod	_	_
16	studied	_	VERB	VBN	_	0	root	_	_
17	but	_	CONJ	CC	_	16	cc	_	_
18	may	_	VERB	MD	_	19	aux	_	_
19	require	_	VERB	VB	_	16	conj	_	_
20	lower	_	ADJ	JJ	_	21	amod	_	_
21	doses	_	NOUN	NNS	_	19	dobj	_	_
22	than	_	ADP	IN	_	24	mark	_	_
23	usually	_	ADV	RB	_	24	advmod	_	_
24	prescribed	_	VERB	VBN	_	19	advcl	_	_
25	for	_	ADP	IN	_	27	case	_	_
26	either	_	CONJ	CC	_	27	cc:preconj	_	_
27	DRUG	_	NOUN	NN	_	24	nmod	_	_
28	or	_	CONJ	CC	_	27	cc	_	_
29	the	_	DET	DT	_	31	det	_	_
30	other	_	ADJ	JJ	_	31	amod	_	_
31	drug	_	NOUN	NN	_	27	conj	_	_

#	Paroxetine	4127
1	Therefore	_	ADV	RB	_	0	root	_	_
2	,	_	.	,	_	1	punct	_	_
3	coadministration	_	NOUN	NN	_	2	root	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	with	_	ADP	IN	_	8	case	_	_
7	other	_	ADJ	JJ	_	8	amod	_	_
8	drugs	_	NOUN	NNS	_	3	nmod	_	_
9	that	_	DET	WDT	_	11	nsubjpass	_	_
10	are	_	VERB	VBP	_	11	auxpass	_	_
11	metabolized	_	VERB	VBN	_	8	acl:relcl	_	_
12	by	_	ADP	IN	_	14	case	_	_
13	this	_	DET	DT	_	14	det	_	_
14	isozyme	_	NOUN	NN	_	11	nmod	_	_
15	,	_	.	,	_	14	punct	_	_
16	including	_	VERB	VBG	_	18	case	_	_
17	certain	_	ADJ	JJ	_	18	amod	_	_
18	drugs	_	NOUN	NNS	_	14	nmod	_	_
19	effective	_	ADJ	JJ	_	18	amod	_	_
20	in	_	ADP	IN	_	22	case	_	_
21	the	_	DET	DT	_	22	det	_	_
22	treatment	_	NOUN	NN	_	19	nmod	_	_
23	of	_	ADP	IN	_	27	case	_	_
24	major	_	ADJ	JJ	_	27	amod	_	_
25	depressive	_	ADJ	JJ	_	27	amod	_	_
26	disorder	_	NOUN	NN	_	27	compound	_	_
27	e.g	_	NOUN	NN	_	22	nmod	_	_
28	,	_	.	,	_	27	punct	_	_
29	nortriptyline	_	NOUN	NN	_	27	conj	_	_
30	,	_	.	,	_	27	punct	_	_
31	amitriptyline	_	NOUN	NN	_	27	conj	_	_
32	,	_	.	,	_	27	punct	_	_
33	imipramine	_	NOUN	NN	_	27	conj	_	_
34	,	_	.	,	_	27	punct	_	_
35	desipramine	_	NOUN	NN	_	27	conj	_	_
36	,	_	.	,	_	27	punct	_	_
37	and	_	CONJ	CC	_	27	cc	_	_
38	fluoxetine	_	NOUN	NN	_	27	conj	_	_
39	,	_	.	,	_	27	punct	_	_
40	phenothiazines	_	NOUN	NNS	_	27	conj	_	_
41	,	_	.	,	_	27	punct	_	_
42	risperidone,and	_	ADJ	JJ	_	45	amod	_	_
43	Type	_	NOUN	NN	_	45	compound	_	_
44	1C	_	NOUN	NN	_	45	compound	_	_
45	antiarrhythmics	_	NOUN	NNS	_	27	conj	_	_
46	e.g	_	NOUN	NN	_	45	dep	_	_
47	,	_	.	,	_	46	punct	_	_
48	propafenone	_	NOUN	NN	_	46	conj	_	_
49	,	_	.	,	_	46	punct	_	_
50	flecainide	_	NOUN	NN	_	46	conj	_	_
51	,	_	.	,	_	46	punct	_	_
52	and	_	CONJ	CC	_	46	cc	_	_
53	encainide	_	NOUN	NN	_	46	conj	_	_
54	,	_	.	,	_	27	punct	_	_
55	or	_	CONJ	CC	_	11	cc	_	_
56	that	_	DET	WDT	_	57	nsubj	_	_
57	inhibit	_	VERB	VBP	_	11	conj	_	_
58	this	_	DET	DT	_	60	det	_	_
59	enzyme	_	NOUN	NN	_	60	compound	_	_
60	e.g	_	NOUN	NN	_	57	dobj	_	_
61	,	_	.	,	_	60	punct	_	_
62	quinidine	_	NOUN	NN	_	60	appos	_	_
63	,	_	.	,	_	57	punct	_	_
64	should	_	VERB	MD	_	66	aux	_	_
65	be	_	VERB	VB	_	66	auxpass	_	_
66	approached	_	VERB	VBN	_	57	parataxis	_	_
67	with	_	ADP	IN	_	68	case	_	_
68	caution	_	NOUN	NN	_	66	nmod	_	_

#	Paroxetine	4128
1	However	_	ADV	RB	_	29	advmod	_	_
2	,	_	.	,	_	29	punct	_	_
3	due	_	ADJ	JJ	_	6	case	_	_
4	to	_	PRT	TO	_	3	mwe	_	_
5	the	_	DET	DT	_	6	det	_	_
6	risk	_	NOUN	NN	_	29	nmod	_	_
7	of	_	ADP	IN	_	10	case	_	_
8	serious	_	ADJ	JJ	_	10	amod	_	_
9	ventricular	_	ADJ	JJ	_	10	amod	_	_
10	arrhythmias	_	NOUN	NNS	_	6	nmod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	sudden	_	NOUN	NN	_	13	compound	_	_
13	death	_	NOUN	NN	_	10	conj	_	_
14	potentially	_	ADV	RB	_	15	advmod	_	_
15	associated	_	VERB	VBN	_	10	acl	_	_
16	with	_	ADP	IN	_	19	case	_	_
17	elevated	_	ADJ	JJ	_	19	amod	_	_
18	plasma	_	NOUN	NN	_	19	compound	_	_
19	levels	_	NOUN	NNS	_	15	nmod	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	thioridazine	_	NOUN	NN	_	19	nmod	_	_
22	,	_	.	,	_	29	punct	_	_
23	DRUG	_	NOUN	NN	_	29	nsubjpass	_	_
24	and	_	CONJ	CC	_	23	cc	_	_
25	thioridazine	_	NOUN	NN	_	23	conj	_	_
26	should	_	VERB	MD	_	29	aux	_	_
27	not	_	ADV	RB	_	29	neg	_	_
28	be	_	VERB	VB	_	29	auxpass	_	_
29	coadministered	_	VERB	VBN	_	0	root	_	_

#	Paroxetine	4129
1	Tamoxifen	_	NOUN	NN	_	5	nsubj	_	_
2	is	_	VERB	VBZ	_	5	cop	_	_
3	a	_	DET	DT	_	5	det	_	_
4	pro	_	NOUN	NN	_	5	compound	_	_
5	drug	_	NOUN	NN	_	0	root	_	_
6	requiring	_	VERB	VBG	_	5	acl	_	_
7	metabolic	_	ADJ	JJ	_	8	amod	_	_
8	activation	_	NOUN	NN	_	6	dobj	_	_
9	by	_	ADP	IN	_	10	case	_	_
10	CYP2D6	_	NOUN	NN	_	8	nmod	_	_

#	Paroxetine	4130
1	Inhibition	_	NOUN	NN	_	7	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	CYP2D6	_	NOUN	NN	_	1	nmod	_	_
4	by	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	1	nmod	_	_
6	may	_	VERB	MD	_	7	aux	_	_
7	lead	_	VERB	VB	_	0	root	_	_
8	to	_	PRT	TO	_	11	case	_	_
9	reduced	_	VERB	VBN	_	11	amod	_	_
10	plasma	_	NOUN	NN	_	11	compound	_	_
11	concentrations	_	NOUN	NNS	_	7	nmod	_	_
12	of	_	ADP	IN	_	16	case	_	_
13	an	_	DET	DT	_	16	det	_	_
14	active	_	ADJ	JJ	_	16	amod	_	_
15	metabolite	_	NOUN	NN	_	16	compound	_	_
16	endoxifen	_	NOUN	NN	_	11	nmod	_	_
17	and	_	CONJ	CC	_	7	cc	_	_
18	hence	_	ADV	RB	_	19	advmod	_	_
19	reduced	_	VERB	VBN	_	20	amod	_	_
20	efficacy	_	NOUN	NN	_	7	conj	_	_
21	of	_	ADP	IN	_	22	case	_	_
22	tamoxifen	_	NOUN	NN	_	20	nmod	_	_

#	Paroxetine	4131
1	At	_	ADP	IN	_	3	case	_	_
2	steady	_	ADJ	JJ	_	3	amod	_	_
3	state	_	NOUN	NN	_	16	nmod	_	_
4	,	_	.	,	_	16	punct	_	_
5	when	_	ADV	WRB	_	11	advmod	_	_
6	the	_	DET	DT	_	8	det	_	_
7	CYP2D6	_	NOUN	NN	_	8	compound	_	_
8	pathway	_	NOUN	NN	_	11	nsubjpass	_	_
9	is	_	VERB	VBZ	_	11	auxpass	_	_
10	essentially	_	ADV	RB	_	11	advmod	_	_
11	saturated	_	VERB	VBN	_	16	advcl	_	_
12	,	_	.	,	_	16	punct	_	_
13	DRUG	_	NOUN	NN	_	14	compound	_	_
14	clearance	_	NOUN	NN	_	16	nsubjpass	_	_
15	is	_	VERB	VBZ	_	16	auxpass	_	_
16	governed	_	VERB	VBN	_	0	root	_	_
17	by	_	ADP	IN	_	20	case	_	_
18	alternative	_	ADJ	JJ	_	20	amod	_	_
19	P450	_	NOUN	NN	_	20	compound	_	_
20	isozymes	_	NOUN	NNS	_	16	nmod	_	_
21	that	_	DET	WDT	_	26	nsubj	_	_
22	,	_	.	,	_	26	punct	_	_
23	unlike	_	ADP	IN	_	24	case	_	_
24	CYP2D6	_	NOUN	NN	_	26	nmod	_	_
25	,	_	.	,	_	26	punct	_	_
26	show	_	VERB	VBP	_	20	acl:relcl	_	_
27	no	_	DET	DT	_	28	neg	_	_
28	evidence	_	NOUN	NN	_	26	dobj	_	_
29	of	_	ADP	IN	_	30	case	_	_
30	saturation	_	NOUN	NN	_	28	nmod	_	_

#	Paroxetine	4132
1	Drugs	_	NOUN	NNS	_	29	nsubj	_	_
2	Metabolized	_	VERB	VBN	_	1	acl	_	_
3	by	_	ADP	IN	_	10	case	_	_
4	Cytochrome	_	NOUN	NN	_	10	compound	_	_
5	CYP3A4	_	NOUN	NN	_	10	compound	_	_
6	An	_	NOUN	NN	_	10	amod	_	_
7	in	_	X	FW	_	10	amod	_	_
8	vivo	_	X	FW	_	7	dep	_	_
9	interaction	_	NOUN	NN	_	10	compound	_	_
10	study	_	NOUN	NN	_	2	nmod	_	_
11	involving	_	VERB	VBG	_	10	acl	_	_
12	the	_	DET	DT	_	13	det	_	_
13	coadministration	_	NOUN	NN	_	11	dobj	_	_
14	under	_	ADP	IN	_	17	case	_	_
15	steady	_	ADJ	JJ	_	17	amod	_	_
16	state	_	NOUN	NN	_	17	compound	_	_
17	conditions	_	NOUN	NNS	_	11	nmod	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	DRUG	_	NOUN	NN	_	17	nmod	_	_
20	and	_	CONJ	CC	_	19	cc	_	_
21	terfenadine	_	NOUN	NN	_	19	conj	_	_
22	,	_	.	,	_	19	punct	_	_
23	a	_	DET	DT	_	24	det	_	_
24	substrate	_	NOUN	NN	_	19	appos	_	_
25	for	_	ADP	IN	_	27	case	_	_
26	cytochrome	_	NOUN	NN	_	27	compound	_	_
27	CYP3A4	_	NOUN	NN	_	24	nmod	_	_
28	,	_	.	,	_	1	punct	_	_
29	revealed	_	VERB	VBD	_	0	root	_	_
30	no	_	DET	DT	_	31	neg	_	_
31	effect	_	NOUN	NN	_	29	dobj	_	_
32	of	_	ADP	IN	_	33	case	_	_
33	DRUG	_	NOUN	NN	_	31	nmod	_	_
34	on	_	ADP	IN	_	36	case	_	_
35	terfenadine	_	NOUN	NN	_	36	compound	_	_
36	pharmacokinetics	_	NOUN	NNS	_	31	nmod	_	_

#	Paroxetine	4133
1	In	_	ADP	IN	_	2	case	_	_
2	addition	_	NOUN	NN	_	8	nmod	_	_
3	,	_	.	,	_	8	punct	_	_
4	in	_	X	FW	_	6	amod	_	_
5	vitro	_	X	FW	_	4	dep	_	_
6	studies	_	NOUN	NNS	_	8	nsubj	_	_
7	have	_	VERB	VBP	_	8	aux	_	_
8	shown	_	VERB	VBN	_	0	root	_	_
9	ketoconazole	_	NOUN	NN	_	8	dobj	_	_
10	,	_	.	,	_	9	punct	_	_
11	a	_	DET	DT	_	13	det	_	_
12	potent	_	ADJ	JJ	_	13	amod	_	_
13	inhibitor	_	NOUN	NN	_	9	appos	_	_
14	of	_	ADP	IN	_	16	case	_	_
15	CYP3A4	_	NOUN	NN	_	16	compound	_	_
16	activity	_	NOUN	NN	_	13	nmod	_	_
17	,	_	.	,	_	9	punct	_	_
18	to	_	PRT	TO	_	23	mark	_	_
19	be	_	VERB	VB	_	23	cop	_	_
20	at	_	ADP	IN	_	21	case	_	_
21	least	_	ADJ	JJS	_	22	nmod:npmod	_	_
22	100	_	NUM	CD	_	23	nummod	_	_
23	times	_	NOUN	NNS	_	8	nmod	_	_
24	more	_	ADV	RB	_	25	advmod	_	_
25	potent	_	ADJ	JJ	_	23	amod	_	_
26	than	_	ADP	IN	_	27	case	_	_
27	DRUG	_	NOUN	NN	_	25	nmod	_	_
28	as	_	ADP	IN	_	30	case	_	_
29	an	_	DET	DT	_	30	det	_	_
30	inhibitor	_	NOUN	NN	_	25	nmod	_	_
31	of	_	ADP	IN	_	33	case	_	_
32	the	_	DET	DT	_	33	det	_	_
33	metabolism	_	NOUN	NN	_	30	nmod	_	_
34	of	_	ADP	IN	_	36	case	_	_
35	several	_	ADJ	JJ	_	36	amod	_	_
36	substrates	_	NOUN	NNS	_	33	nmod	_	_
37	for	_	ADP	IN	_	39	case	_	_
38	this	_	DET	DT	_	39	det	_	_
39	enzyme	_	NOUN	NN	_	33	nmod	_	_
40	,	_	.	,	_	39	punct	_	_
41	including	_	VERB	VBG	_	42	case	_	_
42	terfenadine	_	NOUN	NN	_	39	nmod	_	_
43	,	_	.	,	_	42	punct	_	_
44	astemizole	_	NOUN	NN	_	42	conj	_	_
45	,	_	.	,	_	42	punct	_	_
46	cisapride	_	NOUN	NN	_	42	conj	_	_
47	,	_	.	,	_	42	punct	_	_
48	triazolam	_	NOUN	NN	_	42	conj	_	_
49	,	_	.	,	_	42	punct	_	_
50	and	_	CONJ	CC	_	42	cc	_	_
51	cyclosporine	_	NOUN	NN	_	42	conj	_	_

#	Paroxetine	4134
1	Based	_	VERB	VBN	_	4	case	_	_
2	on	_	ADP	IN	_	4	case	_	_
3	the	_	DET	DT	_	4	det	_	_
4	assumption	_	NOUN	NN	_	42	nmod	_	_
5	that	_	ADP	IN	_	24	mark	_	_
6	the	_	DET	DT	_	7	det	_	_
7	relationship	_	NOUN	NN	_	24	nsubj	_	_
8	between	_	ADP	IN	_	13	case	_	_
9	DRUG	_	NOUN	NN	_	13	nmod:poss	_	_
10	's	_	PRT	POS	_	13	case	_	_
11	in	_	X	FW	_	13	amod	_	_
12	vitro	_	X	FW	_	11	dep	_	_
13	Ki	_	NOUN	NN	_	7	nmod	_	_
14	and	_	CONJ	CC	_	7	cc	_	_
15	its	_	PRON	PRP$	_	16	nmod:poss	_	_
16	lack	_	NOUN	NN	_	7	conj	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	effect	_	NOUN	NN	_	16	nmod	_	_
19	on	_	ADP	IN	_	20	case	_	_
20	terfenadine's	_	NOUN	NNS	_	16	nmod	_	_
21	in	_	X	FW	_	23	amod	_	_
22	vivo	_	X	FW	_	21	dep	_	_
23	clearance	_	NOUN	NN	_	20	dep	_	_
24	predicts	_	VERB	VBZ	_	4	ccomp	_	_
25	its	_	PRON	PRP$	_	26	nmod:poss	_	_
26	effect	_	NOUN	NN	_	24	dobj	_	_
27	on	_	ADP	IN	_	30	case	_	_
28	other	_	ADJ	JJ	_	30	amod	_	_
29	CYP3A4	_	NOUN	NN	_	30	compound	_	_
30	substrates	_	NOUN	NNS	_	26	nmod	_	_
31	,	_	.	,	_	42	punct	_	_
32	DRUG	_	NOUN	NN	_	34	nmod:poss	_	_
33	's	_	PRT	POS	_	34	case	_	_
34	extent	_	NOUN	NN	_	42	nsubj	_	_
35	of	_	ADP	IN	_	36	case	_	_
36	inhibition	_	NOUN	NN	_	34	nmod	_	_
37	of	_	ADP	IN	_	39	case	_	_
38	CYP3A4	_	NOUN	NN	_	39	compound	_	_
39	activity	_	NOUN	NN	_	36	nmod	_	_
40	is	_	VERB	VBZ	_	42	cop	_	_
41	not	_	ADV	RB	_	42	neg	_	_
42	likely	_	ADJ	JJ	_	0	root	_	_
43	to	_	PRT	TO	_	47	mark	_	_
44	be	_	VERB	VB	_	47	cop	_	_
45	of	_	ADP	IN	_	47	case	_	_
46	clinical	_	ADJ	JJ	_	47	amod	_	_
47	significance	_	NOUN	NN	_	42	ccomp	_	_

#	Paroxetine	4135
1	Caution	_	NOUN	NN	_	3	nsubjpass	_	_
2	is	_	VERB	VBZ	_	3	auxpass	_	_
3	indicated	_	VERB	VBN	_	0	root	_	_
4	in	_	ADP	IN	_	6	case	_	_
5	the	_	DET	DT	_	6	det	_	_
6	coadministration	_	NOUN	NN	_	3	nmod	_	_
7	of	_	ADP	IN	_	10	case	_	_
8	tricyclic	_	ADJ	JJ	_	10	amod	_	_
9	antidepressants	_	NOUN	NNS	_	10	compound	_	_
10	TCAs	_	NOUN	NNS	_	6	nmod	_	_
11	with	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	6	nmod	_	_
13	,	_	.	,	_	3	punct	_	_
14	because	_	ADP	IN	_	3	dep	_	_
15	DRUG	_	NOUN	NN	_	17	nsubj	_	_
16	may	_	VERB	MD	_	17	aux	_	_
17	inhibit	_	VERB	VB	_	3	parataxis	_	_
18	TCA	_	NOUN	NN	_	19	compound	_	_
19	metabolism	_	NOUN	NN	_	17	dobj	_	_

#	Paroxetine	4136
1	Plasma	_	NOUN	NN	_	3	compound	_	_
2	TCA	_	NOUN	NN	_	3	compound	_	_
3	concentrations	_	NOUN	NNS	_	5	nsubj	_	_
4	may	_	VERB	MD	_	5	aux	_	_
5	need	_	VERB	VB	_	0	root	_	_
6	to	_	PRT	TO	_	8	mark	_	_
7	be	_	VERB	VB	_	8	auxpass	_	_
8	monitored	_	VERB	VBN	_	5	xcomp	_	_
9	,	_	.	,	_	5	punct	_	_
10	and	_	CONJ	CC	_	5	cc	_	_
11	the	_	DET	DT	_	12	det	_	_
12	dose	_	NOUN	NN	_	16	nsubj	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	TCA	_	NOUN	NN	_	12	nmod	_	_
15	may	_	VERB	MD	_	16	aux	_	_
16	need	_	VERB	VB	_	5	conj	_	_
17	to	_	PRT	TO	_	19	mark	_	_
18	be	_	VERB	VB	_	19	auxpass	_	_
19	reduced	_	VERB	VBN	_	16	xcomp	_	_
20	,	_	.	,	_	19	punct	_	_
21	if	_	ADP	IN	_	25	mark	_	_
22	a	_	DET	DT	_	23	det	_	_
23	TCA	_	NOUN	NN	_	25	nsubjpass	_	_
24	is	_	VERB	VBZ	_	25	auxpass	_	_
25	coadministered	_	VERB	VBN	_	19	advcl	_	_
26	with	_	ADP	IN	_	27	case	_	_
27	DRUG	_	NOUN	NN	_	25	nmod	_	_

#	Paroxetine	4137
1	Drugs	_	NOUN	NNS	_	0	root	_	_
2	Highly	_	ADV	RB	_	3	advmod	_	_
3	Bound	_	VERB	VBD	_	1	acl	_	_
4	to	_	PRT	TO	_	6	case	_	_
5	Plasma	_	NOUN	NN	_	6	compound	_	_
6	Protein	_	NOUN	NN	_	3	nmod	_	_
7	Because	_	ADP	IN	_	11	mark	_	_
8	DRUG	_	NOUN	NN	_	11	nsubjpass	_	_
9	is	_	VERB	VBZ	_	11	auxpass	_	_
10	highly	_	ADV	RB	_	11	advmod	_	_
11	bound	_	VERB	VBN	_	1	acl:relcl	_	_
12	to	_	PRT	TO	_	14	case	_	_
13	plasma	_	NOUN	NN	_	14	compound	_	_
14	protein	_	NOUN	NN	_	11	nmod	_	_
15	,	_	.	,	_	1	punct	_	_
16	administration	_	NOUN	NN	_	31	nsubj	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	DRUG	_	NOUN	NN	_	16	nmod	_	_
19	to	_	PRT	TO	_	21	case	_	_
20	a	_	DET	DT	_	21	det	_	_
21	patient	_	NOUN	NN	_	16	nmod	_	_
22	taking	_	VERB	VBG	_	21	acl	_	_
23	another	_	DET	DT	_	24	det	_	_
24	drug	_	NOUN	NN	_	22	dobj	_	_
25	that	_	DET	WDT	_	29	nsubjpass	_	_
26	is	_	VERB	VBZ	_	29	auxpass	_	_
27	highly	_	ADV	RB	_	28	advmod	_	_
28	protein	_	NOUN	NN	_	29	nsubjpass	_	_
29	bound	_	VERB	VBN	_	24	acl:relcl	_	_
30	may	_	VERB	MD	_	31	aux	_	_
31	cause	_	VERB	VB	_	1	acl:relcl	_	_
32	increased	_	VERB	VBN	_	34	amod	_	_
33	free	_	ADJ	JJ	_	34	amod	_	_
34	concentrations	_	NOUN	NNS	_	31	dobj	_	_
35	of	_	ADP	IN	_	38	case	_	_
36	the	_	DET	DT	_	38	det	_	_
37	other	_	ADJ	JJ	_	38	amod	_	_
38	drug	_	NOUN	NN	_	34	nmod	_	_
39	,	_	.	,	_	1	punct	_	_
40	potentially	_	ADV	RB	_	41	advmod	_	_
41	resulting	_	VERB	VBG	_	1	acl	_	_
42	in	_	ADP	IN	_	44	case	_	_
43	adverse	_	ADJ	JJ	_	44	amod	_	_
44	events	_	NOUN	NNS	_	41	nmod	_	_

#	Paroxetine	4138
1	Conversely	_	ADV	RB	_	6	advmod	_	_
2	,	_	.	,	_	6	punct	_	_
3	adverse	_	ADJ	JJ	_	4	amod	_	_
4	effects	_	NOUN	NNS	_	6	nsubj	_	_
5	could	_	VERB	MD	_	6	aux	_	_
6	result	_	VERB	VB	_	0	root	_	_
7	from	_	ADP	IN	_	8	case	_	_
8	displacement	_	NOUN	NN	_	6	nmod	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	by	_	ADP	IN	_	15	case	_	_
12	other	_	ADJ	JJ	_	15	amod	_	_
13	highly	_	ADV	RB	_	14	advmod	_	_
14	bound	_	VERB	VBN	_	15	amod	_	_
15	drugs	_	NOUN	NNS	_	8	nmod	_	_

#	Paroxetine	4139
1	Drugs	_	NOUN	NNS	_	18	nsubj	_	_
2	That	_	DET	WDT	_	3	nsubj	_	_
3	Interfere	_	VERB	VBP	_	1	acl:relcl	_	_
4	With	_	ADP	IN	_	6	case	_	_
5	Hemostasis	_	NOUN	NN	_	6	compound	_	_
6	e.g	_	NOUN	NN	_	3	nmod	_	_
7	,	_	.	,	_	6	punct	_	_
8	NSAIDs	_	NOUN	NNS	_	6	conj	_	_
9	,	_	.	,	_	6	punct	_	_
10	Aspirin	_	NOUN	NN	_	6	conj	_	_
11	,	_	.	,	_	6	punct	_	_
12	and	_	CONJ	CC	_	6	cc	_	_
13	Warfarin	_	NOUN	NN	_	15	compound	_	_
14	Serotonin	_	NOUN	NN	_	15	compound	_	_
15	release	_	NOUN	NN	_	6	conj	_	_
16	by	_	ADP	IN	_	17	case	_	_
17	platelets	_	NOUN	NNS	_	3	nmod	_	_
18	plays	_	VERB	VBZ	_	0	root	_	_
19	an	_	DET	DT	_	21	det	_	_
20	important	_	ADJ	JJ	_	21	amod	_	_
21	role	_	NOUN	NN	_	18	dobj	_	_
22	in	_	ADP	IN	_	23	case	_	_
23	hemostasis	_	NOUN	NN	_	21	nmod	_	_

#	Paroxetine	4140
1	Epidemiological	_	ADJ	JJ	_	2	amod	_	_
2	studies	_	NOUN	NNS	_	0	root	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	the	_	DET	DT	_	6	det	_	_
5	case	_	NOUN	NN	_	6	compound	_	_
6	control	_	NOUN	NN	_	2	nmod	_	_
7	and	_	CONJ	CC	_	2	cc	_	_
8	cohort	_	NOUN	NN	_	2	conj	_	_
9	design	_	NOUN	NN	_	8	dobj	_	_
10	that	_	DET	WDT	_	12	nsubj	_	_
11	have	_	VERB	VBP	_	12	aux	_	_
12	demonstrated	_	VERB	VBN	_	9	dep	_	_
13	an	_	DET	DT	_	14	det	_	_
14	association	_	NOUN	NN	_	12	dobj	_	_
15	between	_	ADP	IN	_	16	case	_	_
16	use	_	NOUN	NN	_	14	nmod	_	_
17	of	_	ADP	IN	_	19	case	_	_
18	psychotropic	_	ADJ	JJ	_	19	amod	_	_
19	drugs	_	NOUN	NNS	_	16	nmod	_	_
20	that	_	DET	WDT	_	21	nsubj	_	_
21	interfere	_	VERB	VBP	_	19	acl:relcl	_	_
22	with	_	ADP	IN	_	24	case	_	_
23	serotonin	_	NOUN	NN	_	24	compound	_	_
24	reuptake	_	NOUN	NN	_	21	nmod	_	_
25	and	_	CONJ	CC	_	21	cc	_	_
26	the	_	DET	DT	_	27	det	_	_
27	occurrence	_	NOUN	NN	_	34	nsubj	_	_
28	of	_	ADP	IN	_	31	case	_	_
29	upper	_	VERB	VBG	_	31	amod	_	_
30	gastrointestinal	_	ADJ	JJ	_	31	amod	_	_
31	bleeding	_	NOUN	NN	_	27	nmod	_	_
32	have	_	VERB	MD	_	34	aux	_	_
33	also	_	ADV	RB	_	34	advmod	_	_
34	shown	_	VERB	VBN	_	21	conj	_	_
35	that	_	ADP	IN	_	44	mark	_	_
36	concurrent	_	ADJ	JJ	_	37	amod	_	_
37	use	_	NOUN	NN	_	44	nsubj	_	_
38	of	_	ADP	IN	_	40	case	_	_
39	an	_	DET	DT	_	40	det	_	_
40	NSAID	_	NOUN	NN	_	37	nmod	_	_
41	or	_	CONJ	CC	_	40	cc	_	_
42	aspirin	_	NOUN	NN	_	40	conj	_	_
43	may	_	VERB	MD	_	44	aux	_	_
44	potentiate	_	VERB	VB	_	34	ccomp	_	_
45	this	_	DET	DT	_	46	det	_	_
46	risk	_	NOUN	NN	_	44	dobj	_	_
47	of	_	ADP	IN	_	48	mark	_	_
48	bleeding	_	VERB	VBG	_	46	nmod	_	_

#	Paroxetine	4141
1	Altered	_	VERB	VBN	_	3	amod	_	_
2	anticoagulant	_	ADJ	JJ	_	3	amod	_	_
3	effects	_	NOUN	NNS	_	11	nsubjpass	_	_
4	,	_	.	,	_	3	punct	_	_
5	including	_	VERB	VBG	_	7	case	_	_
6	increased	_	VERB	VBN	_	7	amod	_	_
7	bleeding	_	NOUN	NN	_	3	nmod	_	_
8	,	_	.	,	_	3	punct	_	_
9	have	_	VERB	VBP	_	11	aux	_	_
10	been	_	VERB	VBN	_	11	auxpass	_	_
11	reported	_	VERB	VBN	_	0	root	_	_
12	when	_	ADV	WRB	_	17	advmod	_	_
13	SSRIs	_	NOUN	NNS	_	17	nsubjpass	_	_
14	or	_	CONJ	CC	_	13	cc	_	_
15	SNRIs	_	NOUN	NNS	_	13	conj	_	_
16	are	_	VERB	VBP	_	17	auxpass	_	_
17	coadministered	_	VERB	VBN	_	11	advcl	_	_
18	with	_	ADP	IN	_	19	case	_	_
19	warfarin	_	NOUN	NN	_	17	nmod	_	_

#	Paroxetine	4142
1	Patients	_	NOUN	NNS	_	8	nsubjpass	_	_
2	receiving	_	VERB	VBG	_	1	acl	_	_
3	warfarin	_	NOUN	NN	_	4	compound	_	_
4	therapy	_	NOUN	NN	_	2	dobj	_	_
5	should	_	VERB	MD	_	8	aux	_	_
6	be	_	VERB	VB	_	8	auxpass	_	_
7	carefully	_	ADV	RB	_	8	advmod	_	_
8	monitored	_	VERB	VBN	_	0	root	_	_
9	when	_	ADV	WRB	_	12	advmod	_	_
10	DRUG	_	NOUN	NN	_	12	nsubjpass	_	_
11	is	_	VERB	VBZ	_	12	auxpass	_	_
12	initiated	_	VERB	VBN	_	8	ccomp	_	_
13	or	_	CONJ	CC	_	12	cc	_	_
14	discontinued	_	VERB	VBN	_	12	conj	_	_

#	Paroxetine	4143
1	Alcohol	_	NOUN	NN	_	0	root	_	_
2	Although	_	ADP	IN	_	6	mark	_	_
3	DRUG	_	NOUN	NN	_	6	nsubj	_	_
4	does	_	VERB	VBZ	_	6	aux	_	_
5	not	_	ADV	RB	_	6	neg	_	_
6	increase	_	VERB	VB	_	1	acl:relcl	_	_
7	the	_	DET	DT	_	8	det	_	_
8	impairment	_	NOUN	NN	_	6	dobj	_	_
9	of	_	ADP	IN	_	13	case	_	_
10	mental	_	ADJ	JJ	_	13	amod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	motor	_	NOUN	NN	_	10	conj	_	_
13	skills	_	NOUN	NNS	_	8	nmod	_	_
14	caused	_	VERB	VBN	_	13	acl	_	_
15	by	_	ADP	IN	_	16	case	_	_
16	alcohol	_	NOUN	NN	_	14	nmod	_	_
17	,	_	.	,	_	1	punct	_	_
18	patients	_	NOUN	NNS	_	21	nsubjpass	_	_
19	should	_	VERB	MD	_	21	aux	_	_
20	be	_	VERB	VB	_	21	auxpass	_	_
21	advised	_	VERB	VBN	_	1	dep	_	_
22	to	_	PRT	TO	_	23	mark	_	_
23	avoid	_	VERB	VB	_	21	xcomp	_	_
24	alcohol	_	NOUN	NN	_	23	dobj	_	_
25	while	_	ADP	IN	_	26	mark	_	_
26	taking	_	VERB	VBG	_	23	advcl	_	_
27	DRUG	_	NOUN	NN	_	26	dobj	_	_

#	Paroxetine	4144
1	Lithium	_	NOUN	NN	_	5	compound	_	_
2	A	_	NOUN	NN	_	5	compound	_	_
3	multiple	_	ADJ	JJ	_	5	amod	_	_
4	dose	_	NOUN	NN	_	5	compound	_	_
5	study	_	NOUN	NN	_	7	nsubj	_	_
6	has	_	VERB	VBZ	_	7	aux	_	_
7	shown	_	VERB	VBN	_	0	root	_	_
8	that	_	ADP	IN	_	10	mark	_	_
9	there	_	DET	EX	_	10	expl	_	_
10	is	_	VERB	VBZ	_	7	ccomp	_	_
11	no	_	DET	DT	_	13	neg	_	_
12	pharmacokinetic	_	ADJ	JJ	_	13	amod	_	_
13	interaction	_	NOUN	NN	_	10	nsubj	_	_
14	between	_	ADP	IN	_	15	case	_	_
15	DRUG	_	NOUN	NN	_	13	nmod	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	lithium	_	NOUN	NN	_	18	compound	_	_
18	carbonate	_	NOUN	NN	_	15	conj	_	_

#	Paroxetine	4145
1	However	_	ADV	RB	_	13	advmod	_	_
2	,	_	.	,	_	13	punct	_	_
3	due	_	ADJ	JJ	_	6	case	_	_
4	to	_	PRT	TO	_	3	mwe	_	_
5	the	_	DET	DT	_	6	det	_	_
6	potential	_	NOUN	NN	_	13	nmod	_	_
7	for	_	ADP	IN	_	9	case	_	_
8	serotonin	_	NOUN	NN	_	9	compound	_	_
9	syndrome	_	NOUN	NN	_	6	nmod	_	_
10	,	_	.	,	_	13	punct	_	_
11	caution	_	NOUN	NN	_	13	nsubjpass	_	_
12	is	_	VERB	VBZ	_	13	auxpass	_	_
13	advised	_	VERB	VBN	_	0	root	_	_
14	when	_	ADV	WRB	_	17	advmod	_	_
15	DRUG	_	NOUN	NN	_	17	nsubjpass	_	_
16	is	_	VERB	VBZ	_	17	auxpass	_	_
17	coadministered	_	VERB	VBN	_	13	ccomp	_	_
18	with	_	ADP	IN	_	19	case	_	_
19	lithium	_	NOUN	NN	_	17	nmod	_	_

#	Paroxetine	4146
1	Digoxin	_	NOUN	NN	_	10	nsubjpass	_	_
2	The	_	DET	DT	_	5	det	_	_
3	steady	_	ADJ	JJ	_	5	amod	_	_
4	state	_	NOUN	NN	_	5	compound	_	_
5	pharmacokinetics	_	NOUN	NNS	_	1	dep	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	was	_	VERB	VBD	_	10	auxpass	_	_
9	not	_	ADV	RB	_	10	neg	_	_
10	altered	_	VERB	VBN	_	0	root	_	_
11	when	_	ADV	WRB	_	12	advmod	_	_
12	administered	_	VERB	VBN	_	10	advcl	_	_
13	with	_	ADP	IN	_	14	case	_	_
14	digoxin	_	NOUN	NN	_	12	nmod	_	_
15	at	_	ADP	IN	_	17	case	_	_
16	steady	_	ADJ	JJ	_	17	amod	_	_
17	state	_	NOUN	NN	_	12	nmod	_	_

#	Paroxetine	4147
1	Mean	_	NOUN	NN	_	3	compound	_	_
2	digoxin	_	NOUN	NN	_	3	compound	_	_
3	AUC	_	NOUN	NN	_	7	nsubj	_	_
4	at	_	ADP	IN	_	6	case	_	_
5	steady	_	ADJ	JJ	_	6	amod	_	_
6	state	_	NOUN	NN	_	3	nmod	_	_
7	decreased	_	VERB	VBD	_	0	root	_	_
8	by	_	ADP	IN	_	9	case	_	_
9	15%	_	NOUN	NN	_	7	nmod	_	_
10	in	_	ADP	IN	_	12	case	_	_
11	the	_	DET	DT	_	12	det	_	_
12	presence	_	NOUN	NN	_	7	nmod	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	DRUG	_	NOUN	NN	_	12	nmod	_	_

#	Paroxetine	4148
1	Since	_	ADP	IN	_	3	mark	_	_
2	there	_	DET	EX	_	3	expl	_	_
3	is	_	VERB	VBZ	_	17	advcl	_	_
4	little	_	ADJ	JJ	_	6	amod	_	_
5	clinical	_	ADJ	JJ	_	6	amod	_	_
6	experience	_	NOUN	NN	_	3	nsubj	_	_
7	,	_	.	,	_	17	punct	_	_
8	the	_	DET	DT	_	10	det	_	_
9	concurrent	_	ADJ	JJ	_	10	amod	_	_
10	administration	_	NOUN	NN	_	17	nsubjpass	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	digoxin	_	NOUN	NN	_	12	conj	_	_
15	should	_	VERB	MD	_	17	aux	_	_
16	be	_	VERB	VB	_	17	auxpass	_	_
17	undertaken	_	VERB	VBN	_	0	root	_	_
18	with	_	ADP	IN	_	19	case	_	_
19	caution	_	NOUN	NN	_	17	nmod	_	_

#	Paroxetine	4149
1	Diazepam	_	NOUN	NN	_	5	compound	_	_
2	Under	_	NOUN	NN	_	5	compound	_	_
3	steady	_	ADJ	JJ	_	5	amod	_	_
4	state	_	NOUN	NN	_	5	compound	_	_
5	conditions	_	NOUN	NNS	_	0	root	_	_
6	,	_	.	,	_	5	punct	_	_
7	diazepam	_	NOUN	NN	_	10	nsubj	_	_
8	does	_	VERB	VBZ	_	10	aux	_	_
9	not	_	ADV	RB	_	10	neg	_	_
10	appear	_	VERB	VB	_	5	dep	_	_
11	to	_	PRT	TO	_	12	mark	_	_
12	affect	_	VERB	VB	_	10	xcomp	_	_
13	DRUG	_	NOUN	NN	_	14	compound	_	_
14	kinetics	_	NOUN	NNS	_	12	dobj	_	_

#	Paroxetine	4150
1	The	_	DET	DT	_	2	det	_	_
2	effects	_	NOUN	NNS	_	9	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	on	_	ADP	IN	_	6	case	_	_
6	diazepam	_	NOUN	NN	_	2	nmod	_	_
7	were	_	VERB	VBD	_	9	auxpass	_	_
8	not	_	ADV	RB	_	9	neg	_	_
9	evaluated	_	VERB	VBN	_	0	root	_	_

#	Paroxetine	4151
1	Procyclidine	_	NOUN	NN	_	4	compound	_	_
2	Daily	_	NOUN	NN	_	4	compound	_	_
3	oral	_	ADJ	JJ	_	4	amod	_	_
4	dosing	_	NOUN	NN	_	11	nsubj	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	DRUG	_	NOUN	NN	_	8	compound	_	_
7	30	_	NUM	CD	_	8	nummod	_	_
8	mg	_	NOUN	NN	_	4	nmod	_	_
9	once	_	ADV	RB	_	10	advmod	_	_
10	daily	_	ADV	RB	_	11	advmod	_	_
11	increased	_	VERB	VBD	_	0	root	_	_
12	steady	_	ADJ	JJ	_	14	amod	_	_
13	state	_	NOUN	NN	_	14	compound	_	_
14	AUC0	_	NOUN	NN	_	11	dobj	_	_
15	24	_	NUM	CD	_	14	nummod	_	_
16	,	_	.	,	_	14	punct	_	_
17	Cmax	_	NOUN	NN	_	14	conj	_	_
18	,	_	.	,	_	14	punct	_	_
19	and	_	CONJ	CC	_	14	cc	_	_
20	Cmin	_	NOUN	NN	_	21	compound	_	_
21	values	_	NOUN	NNS	_	14	conj	_	_
22	of	_	ADP	IN	_	25	case	_	_
23	procyclidine	_	NOUN	NN	_	25	compound	_	_
24	5	_	NUM	CD	_	25	nummod	_	_
25	mg	_	NOUN	NN	_	14	nmod	_	_
26	oral	_	ADJ	JJ	_	25	amod	_	_
27	once	_	ADV	RB	_	28	advmod	_	_
28	daily	_	ADV	RB	_	26	advmod	_	_
29	by	_	ADP	IN	_	30	case	_	_
30	35%	_	NOUN	NN	_	26	nmod	_	_
31	,	_	.	,	_	30	punct	_	_
32	37%	_	NOUN	NN	_	30	conj	_	_
33	,	_	.	,	_	30	punct	_	_
34	and	_	CONJ	CC	_	30	cc	_	_
35	67%	_	NOUN	NN	_	30	conj	_	_
36	,	_	.	,	_	11	punct	_	_
37	respectively	_	ADV	RB	_	11	advmod	_	_
38	,	_	.	,	_	11	punct	_	_
39	compared	_	VERB	VBN	_	11	parataxis	_	_
40	to	_	PRT	TO	_	41	case	_	_
41	procyclidine	_	NOUN	NN	_	39	nmod	_	_
42	alone	_	ADV	RB	_	39	advmod	_	_
43	at	_	ADP	IN	_	45	case	_	_
44	steady	_	ADJ	JJ	_	45	amod	_	_
45	state	_	NOUN	NN	_	39	nmod	_	_

#	Paroxetine	4152
1	If	_	ADP	IN	_	3	case	_	_
2	anticholinergic	_	ADJ	JJ	_	3	amod	_	_
3	effects	_	NOUN	NNS	_	5	nsubjpass	_	_
4	are	_	VERB	VBP	_	5	auxpass	_	_
5	seen	_	VERB	VBN	_	13	advcl	_	_
6	,	_	.	,	_	13	punct	_	_
7	the	_	DET	DT	_	8	det	_	_
8	dose	_	NOUN	NN	_	13	nsubjpass	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	procyclidine	_	NOUN	NN	_	8	nmod	_	_
11	should	_	VERB	MD	_	13	aux	_	_
12	be	_	VERB	VB	_	13	auxpass	_	_
13	reduced	_	VERB	VBN	_	0	root	_	_

#	Paroxetine	4153
1	Beta	_	NOUN	NN	_	2	compound	_	_
2	Blockers	_	NOUN	NNS	_	0	root	_	_
3	In	_	ADP	IN	_	5	case	_	_
4	a	_	DET	DT	_	5	det	_	_
5	study	_	NOUN	NN	_	2	nmod	_	_
6	where	_	ADV	WRB	_	13	advmod	_	_
7	propranolol	_	NOUN	NN	_	9	compound	_	_
8	80	_	NUM	CD	_	9	nummod	_	_
9	mg	_	NOUN	NN	_	13	nsubjpass	_	_
10	twice	_	ADV	RB	_	13	advmod	_	_
11	daily	_	ADV	RB	_	13	advmod	_	_
12	was	_	VERB	VBD	_	13	auxpass	_	_
13	dosed	_	VERB	VBN	_	5	acl:relcl	_	_
14	orally	_	ADV	RB	_	13	advmod	_	_
15	for	_	ADP	IN	_	17	case	_	_
16	18	_	NUM	CD	_	17	nummod	_	_
17	days	_	NOUN	NNS	_	13	nmod	_	_
18	,	_	.	,	_	2	punct	_	_
19	the	_	DET	DT	_	24	det	_	_
20	established	_	VERB	VBN	_	24	amod	_	_
21	steady	_	ADJ	JJ	_	24	amod	_	_
22	state	_	NOUN	NN	_	24	compound	_	_
23	plasma	_	NOUN	NN	_	24	compound	_	_
24	concentrations	_	NOUN	NNS	_	28	nsubj	_	_
25	of	_	ADP	IN	_	26	case	_	_
26	propranolol	_	NOUN	NN	_	24	nmod	_	_
27	were	_	VERB	VBD	_	28	cop	_	_
28	unaltered	_	ADJ	JJ	_	2	dep	_	_
29	during	_	ADP	IN	_	30	case	_	_
30	coadministration	_	NOUN	NN	_	28	nmod	_	_
31	with	_	ADP	IN	_	34	case	_	_
32	DRUG	_	NOUN	NN	_	34	compound	_	_
33	30	_	NUM	CD	_	34	nummod	_	_
34	mg	_	NOUN	NN	_	30	nmod	_	_
35	once	_	ADV	RB	_	36	advmod	_	_
36	daily	_	ADV	RB	_	30	advmod	_	_
37	for	_	ADP	IN	_	41	case	_	_
38	the	_	DET	DT	_	41	det	_	_
39	final	_	ADJ	JJ	_	41	amod	_	_
40	10	_	NUM	CD	_	41	nummod	_	_
41	days	_	NOUN	NNS	_	36	nmod	_	_

#	Paroxetine	4154
1	The	_	DET	DT	_	2	det	_	_
2	effects	_	NOUN	NNS	_	10	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	propranolol	_	NOUN	NN	_	2	nmod	_	_
5	on	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	2	nmod	_	_
7	have	_	VERB	MD	_	10	aux	_	_
8	not	_	ADV	RB	_	10	neg	_	_
9	been	_	VERB	VBN	_	10	auxpass	_	_
10	evaluated	_	VERB	VBN	_	0	root	_	_

#	Paroxetine	4155
1	Theophylline	_	NOUN	NN	_	2	compound	_	_
2	Reports	_	NOUN	NNS	_	14	nsubjpass	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	elevated	_	ADJ	JJ	_	6	amod	_	_
5	theophylline	_	NOUN	NN	_	6	compound	_	_
6	levels	_	NOUN	NNS	_	2	nmod	_	_
7	associated	_	VERB	VBN	_	6	acl	_	_
8	with	_	ADP	IN	_	9	case	_	_
9	treatment	_	NOUN	NN	_	7	nmod	_	_
10	with	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_
12	have	_	VERB	VBP	_	14	aux	_	_
13	been	_	VERB	VBN	_	14	auxpass	_	_
14	reported	_	VERB	VBN	_	0	root	_	_

#	Paroxetine	4156
1	While	_	ADP	IN	_	8	mark	_	_
2	this	_	DET	DT	_	3	det	_	_
3	interaction	_	NOUN	NN	_	8	nsubjpass	_	_
4	has	_	VERB	VBZ	_	8	aux	_	_
5	not	_	ADV	RB	_	8	neg	_	_
6	been	_	VERB	VBN	_	8	auxpass	_	_
7	formally	_	ADV	RB	_	8	advmod	_	_
8	studied	_	VERB	VBN	_	12	advcl	_	_
9	,	_	.	,	_	12	punct	_	_
10	it	_	PRON	PRP	_	12	nsubjpass	_	_
11	is	_	VERB	VBZ	_	12	auxpass	_	_
12	recommended	_	VERB	VBN	_	0	root	_	_
13	that	_	ADP	IN	_	17	mark	_	_
14	theophylline	_	NOUN	NN	_	15	compound	_	_
15	levels	_	NOUN	NNS	_	17	nsubjpass	_	_
16	be	_	VERB	VBP	_	17	auxpass	_	_
17	monitored	_	VERB	VBN	_	12	ccomp	_	_
18	when	_	ADV	WRB	_	23	advmod	_	_
19	these	_	DET	DT	_	20	det	_	_
20	drugs	_	NOUN	NNS	_	23	nsubjpass	_	_
21	are	_	VERB	VBP	_	23	auxpass	_	_
22	concurrently	_	ADV	RB	_	23	advmod	_	_
23	administered	_	VERB	VBN	_	17	ccomp	_	_

#	Paroxetine	4157
1	Fosamprenavir	_	ADJ	JJ	_	0	root	_	_
2	/	_	.	:	_	1	punct	_	_
3	Ritonavir	_	ADJ	JJ	_	4	amod	_	_
4	Coadministration	_	NOUN	NN	_	1	dep	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	fosamprenavir	_	NOUN	NN	_	4	nmod	_	_
7	/	_	.	:	_	4	punct	_	_
8	ritonavir	_	NOUN	NN	_	12	nsubj	_	_
9	with	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	significantly	_	ADV	RB	_	12	advmod	_	_
12	decreased	_	VERB	VBD	_	4	dep	_	_
13	plasma	_	NOUN	NN	_	14	compound	_	_
14	levels	_	NOUN	NNS	_	12	dobj	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	14	nmod	_	_

#	Paroxetine	4158
1	Any	_	DET	DT	_	3	det	_	_
2	dose	_	NOUN	NN	_	3	compound	_	_
3	adjustment	_	NOUN	NN	_	6	nsubjpass	_	_
4	should	_	VERB	MD	_	6	aux	_	_
5	be	_	VERB	VB	_	6	auxpass	_	_
6	guided	_	VERB	VBN	_	0	root	_	_
7	by	_	ADP	IN	_	10	case	_	_
8	clinical	_	ADJ	JJ	_	10	amod	_	_
9	effect	_	NOUN	NN	_	10	compound	_	_
10	tolerability	_	NOUN	NN	_	6	nmod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	efficacy	_	NOUN	NN	_	10	conj	_	_

#	Paroxetine	4159
1	Electroconvulsive	_	ADJ	JJ	_	3	amod	_	_
2	Therapy	_	NOUN	NN	_	3	compound	_	_
3	ECT	_	NOUN	NN	_	8	nsubj	_	_
4	There	_	DET	EX	_	3	nummod	_	_
5	are	_	VERB	VBP	_	8	cop	_	_
6	no	_	DET	DT	_	8	neg	_	_
7	clinical	_	ADJ	JJ	_	8	amod	_	_
8	studies	_	NOUN	NNS	_	0	root	_	_
9	of	_	ADP	IN	_	12	case	_	_
10	the	_	DET	DT	_	12	det	_	_
11	combined	_	VERB	VBN	_	12	amod	_	_
12	use	_	NOUN	NN	_	8	nmod	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	ECT	_	NOUN	NN	_	12	nmod	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	DRUG	_	NOUN	NN	_	14	conj	_	_

#	Paroxetine	4160
1	The	_	DET	DT	_	2	det	_	_
2	efficacy	_	NOUN	NN	_	28	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	in	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	treatment	_	NOUN	NN	_	2	nmod	_	_
8	of	_	ADP	IN	_	11	case	_	_
9	major	_	ADJ	JJ	_	11	amod	_	_
10	depressive	_	ADJ	JJ	_	11	amod	_	_
11	disorder	_	NOUN	NN	_	7	nmod	_	_
12	,	_	.	,	_	11	punct	_	_
13	obsessive	_	ADJ	JJ	_	16	amod	_	_
14	compulsive	_	ADJ	JJ	_	16	amod	_	_
15	disorder	_	NOUN	NN	_	16	compound	_	_
16	OCD	_	NOUN	NN	_	11	conj	_	_
17	,	_	.	,	_	11	punct	_	_
18	panic	_	ADJ	JJ	_	20	amod	_	_
19	disorder	_	NOUN	NN	_	20	compound	_	_
20	PD	_	NOUN	NN	_	11	conj	_	_
21	,	_	.	,	_	11	punct	_	_
22	and	_	CONJ	CC	_	11	cc	_	_
23	generalized	_	VERB	VBN	_	26	amod	_	_
24	anxiety	_	NOUN	NN	_	26	compound	_	_
25	disorder	_	NOUN	NN	_	26	compound	_	_
26	GAD	_	NOUN	NN	_	11	conj	_	_
27	is	_	VERB	VBZ	_	28	auxpass	_	_
28	presumed	_	VERB	VBN	_	0	root	_	_
29	to	_	PRT	TO	_	31	mark	_	_
30	be	_	VERB	VB	_	31	auxpass	_	_
31	linked	_	VERB	VBN	_	28	xcomp	_	_
32	to	_	PRT	TO	_	33	case	_	_
33	potentiation	_	NOUN	NN	_	31	nmod	_	_
34	of	_	ADP	IN	_	36	case	_	_
35	serotonergic	_	ADJ	JJ	_	36	amod	_	_
36	activity	_	NOUN	NN	_	33	nmod	_	_
37	in	_	ADP	IN	_	41	case	_	_
38	the	_	DET	DT	_	41	det	_	_
39	central	_	ADJ	JJ	_	41	amod	_	_
40	nervous	_	ADJ	JJ	_	41	amod	_	_
41	system	_	NOUN	NN	_	36	nmod	_	_
42	resulting	_	VERB	VBG	_	41	acl	_	_
43	from	_	ADP	IN	_	44	case	_	_
44	inhibition	_	NOUN	NN	_	42	nmod	_	_
45	of	_	ADP	IN	_	47	case	_	_
46	neuronal	_	ADJ	JJ	_	47	amod	_	_
47	reuptake	_	NOUN	NN	_	44	nmod	_	_
48	of	_	ADP	IN	_	52	case	_	_
49	serotonin	_	NOUN	NN	_	52	compound	_	_
50	5	_	NUM	CD	_	52	nummod	_	_
51	hydroxy	_	NOUN	NN	_	52	compound	_	_
52	tryptamine	_	NOUN	NN	_	47	nmod	_	_
53	,	_	.	,	_	52	punct	_	_
54	5	_	NUM	CD	_	55	nummod	_	_
55	HT	_	NOUN	NN	_	52	appos	_	_

#	Paroxetine	4161
1	Studies	_	NOUN	NNS	_	9	nsubj	_	_
2	at	_	ADP	IN	_	5	case	_	_
3	clinically	_	ADV	RB	_	4	advmod	_	_
4	relevant	_	ADJ	JJ	_	5	amod	_	_
5	doses	_	NOUN	NNS	_	1	nmod	_	_
6	in	_	ADP	IN	_	7	case	_	_
7	humans	_	NOUN	NNS	_	5	nmod	_	_
8	have	_	VERB	VBP	_	9	aux	_	_
9	demonstrated	_	VERB	VBN	_	0	root	_	_
10	that	_	ADP	IN	_	12	mark	_	_
11	DRUG	_	NOUN	NN	_	12	nsubj	_	_
12	blocks	_	VERB	VBZ	_	9	ccomp	_	_
13	the	_	DET	DT	_	14	det	_	_
14	uptake	_	NOUN	NN	_	12	dobj	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	serotonin	_	NOUN	NN	_	14	nmod	_	_
17	into	_	ADP	IN	_	19	case	_	_
18	human	_	ADJ	JJ	_	19	amod	_	_
19	platelets	_	NOUN	NNS	_	14	nmod	_	_

#	Paroxetine	4162
1	In	_	X	FW	_	3	amod	_	_
2	vitro	_	X	FW	_	1	dep	_	_
3	studies	_	NOUN	NNS	_	7	nsubj	_	_
4	in	_	ADP	IN	_	5	case	_	_
5	animals	_	NOUN	NNS	_	3	nmod	_	_
6	also	_	ADV	RB	_	7	advmod	_	_
7	suggest	_	VERB	VBP	_	0	root	_	_
8	that	_	ADP	IN	_	16	mark	_	_
9	DRUG	_	NOUN	NN	_	16	nsubj	_	_
10	is	_	VERB	VBZ	_	16	cop	_	_
11	a	_	DET	DT	_	16	det	_	_
12	potent	_	ADJ	JJ	_	16	amod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	highly	_	ADV	RB	_	12	conj	_	_
15	selective	_	ADJ	JJ	_	16	amod	_	_
16	inhibitor	_	NOUN	NN	_	7	ccomp	_	_
17	of	_	ADP	IN	_	20	case	_	_
18	neuronal	_	ADJ	JJ	_	20	amod	_	_
19	serotonin	_	NOUN	NN	_	20	compound	_	_
20	reuptake	_	NOUN	NN	_	16	nmod	_	_
21	and	_	CONJ	CC	_	16	cc	_	_
22	has	_	VERB	VBZ	_	16	conj	_	_
23	only	_	ADV	RB	_	24	advmod	_	_
24	very	_	ADV	RB	_	25	advmod	_	_
25	weak	_	ADJ	JJ	_	26	amod	_	_
26	effects	_	NOUN	NNS	_	22	dobj	_	_
27	on	_	ADP	IN	_	28	case	_	_
28	norepinephrine	_	NOUN	NN	_	26	nmod	_	_
29	and	_	CONJ	CC	_	28	cc	_	_
30	dopamine	_	NOUN	NN	_	32	compound	_	_
31	neuronal	_	ADJ	JJ	_	32	amod	_	_
32	reuptake	_	NOUN	NN	_	28	conj	_	_

#	Paroxetine	4163
1	In	_	X	FW	_	5	amod	_	_
2	vitro	_	X	FW	_	1	dep	_	_
3	radioligand	_	NOUN	NN	_	5	compound	_	_
4	binding	_	NOUN	NN	_	5	compound	_	_
5	studies	_	NOUN	NNS	_	6	nsubj	_	_
6	indicate	_	VERB	VBP	_	0	root	_	_
7	that	_	ADP	IN	_	9	mark	_	_
8	DRUG	_	NOUN	NN	_	9	nsubj	_	_
9	has	_	VERB	VBZ	_	6	ccomp	_	_
10	little	_	ADJ	JJ	_	11	amod	_	_
11	affinity	_	NOUN	NN	_	9	dobj	_	_
12	for	_	ADP	IN	_	34	case	_	_
13	muscarinic	_	ADJ	JJ	_	34	amod	_	_
14	,	_	.	,	_	13	punct	_	_
15	alpha1	_	NOUN	NN	_	13	conj	_	_
16	,	_	.	,	_	13	punct	_	_
17	alpha2	_	NOUN	NN	_	13	conj	_	_
18	,	_	.	,	_	13	punct	_	_
19	beta	_	NOUN	NN	_	20	nmod:npmod	_	_
20	adrenergic	_	ADJ	JJ	_	13	conj	_	_
21	,	_	.	,	_	13	punct	_	_
22	dopamine	_	NOUN	NN	_	23	compound	_	_
23	D2	_	NOUN	NN	_	13	conj	_	_
24	,	_	.	,	_	13	punct	_	_
25	5	_	NUM	CD	_	26	nummod	_	_
26	HT1	_	NOUN	NN	_	13	conj	_	_
27	,	_	.	,	_	13	punct	_	_
28	5	_	NUM	CD	_	29	nummod	_	_
29	HT2	_	NOUN	NN	_	13	conj	_	_
30	,	_	.	,	_	13	punct	_	_
31	and	_	CONJ	CC	_	13	cc	_	_
32	histamine	_	NOUN	NN	_	13	conj	_	_
33	H1	_	NOUN	NN	_	34	compound	_	_
34	receptors	_	NOUN	NNS	_	11	nmod	_	_
35	antagonism	_	NOUN	NN	_	47	nsubjpass	_	_
36	of	_	ADP	IN	_	44	case	_	_
37	muscarinic	_	ADJ	JJ	_	44	amod	_	_
38	,	_	.	,	_	37	punct	_	_
39	histaminergic	_	ADJ	JJ	_	37	conj	_	_
40	,	_	.	,	_	37	punct	_	_
41	and	_	CONJ	CC	_	37	cc	_	_
42	alpha1	_	NOUN	NN	_	37	conj	_	_
43	adrenergic	_	ADJ	JJ	_	44	amod	_	_
44	receptors	_	NOUN	NNS	_	35	nmod	_	_
45	has	_	VERB	VBZ	_	47	aux	_	_
46	been	_	VERB	VBN	_	47	auxpass	_	_
47	associated	_	VERB	VBN	_	34	dep	_	_
48	with	_	ADP	IN	_	50	case	_	_
49	various	_	ADJ	JJ	_	50	amod	_	_
50	anticholinergic	_	ADJ	JJ	_	47	nmod	_	_
51	,	_	.	,	_	50	punct	_	_
52	sedative	_	ADJ	JJ	_	50	conj	_	_
53	,	_	.	,	_	50	punct	_	_
54	and	_	CONJ	CC	_	50	cc	_	_
55	cardiovascular	_	ADJ	JJ	_	50	conj	_	_
56	effects	_	NOUN	NNS	_	50	dep	_	_
57	for	_	ADP	IN	_	60	case	_	_
58	other	_	ADJ	JJ	_	60	amod	_	_
59	psychotropic	_	ADJ	JJ	_	60	amod	_	_
60	drugs	_	NOUN	NNS	_	50	nmod	_	_

#	Paroxetine	4164
1	Because	_	ADP	IN	_	15	mark	_	_
2	the	_	DET	DT	_	4	det	_	_
3	relative	_	ADJ	JJ	_	4	amod	_	_
4	potencies	_	NOUN	NNS	_	15	nsubj	_	_
5	of	_	ADP	IN	_	9	case	_	_
6	DRUG	_	NOUN	NN	_	9	nmod:poss	_	_
7	's	_	PRT	POS	_	6	case	_	_
8	major	_	ADJ	JJ	_	9	amod	_	_
9	metabolites	_	NOUN	NNS	_	4	nmod	_	_
10	are	_	VERB	VBP	_	15	cop	_	_
11	at	_	ADP	IN	_	12	case	_	_
12	most	_	ADV	RB	_	13	advmod	_	_
13	1	_	NUM	CD	_	15	nummod	_	_
14	/	_	NUM	CD	_	15	punct	_	_
15	50	_	NUM	CD	_	24	punct	_	_
16	of	_	ADP	IN	_	19	case	_	_
17	the	_	DET	DT	_	19	det	_	_
18	parent	_	NOUN	NN	_	19	compound	_	_
19	compound	_	NOUN	NN	_	15	nmod	_	_
20	,	_	.	,	_	24	punct	_	_
21	they	_	PRON	PRP	_	24	nsubjpass	_	_
22	are	_	VERB	VBP	_	24	auxpass	_	_
23	essentially	_	ADV	RB	_	24	advmod	_	_
24	inactive	_	ADJ	JJ	_	0	root	_	_

#	Paroxetine	4165
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	hydrochloride	_	NOUN	NN	_	5	nsubjpass	_	_
3	is	_	VERB	VBZ	_	5	auxpass	_	_
4	completely	_	ADV	RB	_	5	advmod	_	_
5	absorbed	_	VERB	VBN	_	0	root	_	_
6	after	_	ADP	IN	_	8	case	_	_
7	oral	_	ADJ	JJ	_	8	amod	_	_
8	dosing	_	NOUN	NN	_	5	nmod	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	a	_	DET	DT	_	11	det	_	_
11	solution	_	NOUN	NN	_	8	nmod	_	_
12	of	_	ADP	IN	_	15	case	_	_
13	the	_	DET	DT	_	15	det	_	_
14	hydrochloride	_	NOUN	NN	_	15	compound	_	_
15	salt	_	NOUN	NN	_	11	nmod	_	_

#	Paroxetine	4166
1	The	_	DET	DT	_	5	det	_	_
2	mean	_	ADJ	JJ	_	5	compound	_	_
3	elimination	_	NOUN	NN	_	5	compound	_	_
4	half	_	NOUN	NN	_	5	compound	_	_
5	life	_	NOUN	NN	_	9	nsubj	_	_
6	is	_	VERB	VBZ	_	9	cop	_	_
7	approximately	_	ADV	RB	_	9	advmod	_	_
8	21	_	NUM	CD	_	9	nummod	_	_
9	hours	_	NOUN	NNS	_	0	root	_	_
10	CV	_	NOUN	NN	_	11	compound	_	_
11	32%	_	NOUN	NN	_	9	dep	_	_
12	after	_	ADP	IN	_	14	case	_	_
13	oral	_	ADJ	JJ	_	14	amod	_	_
14	dosing	_	NOUN	NN	_	9	nmod	_	_
15	of	_	ADP	IN	_	18	case	_	_
16	30	_	NUM	CD	_	18	nummod	_	_
17	mg	_	NOUN	NN	_	18	compound	_	_
18	tablets	_	NOUN	NNS	_	14	nmod	_	_
19	of	_	ADP	IN	_	20	case	_	_
20	DRUG	_	NOUN	NN	_	18	nmod	_	_
21	daily	_	ADV	RB	_	9	advmod	_	_
22	for	_	ADP	IN	_	24	case	_	_
23	30	_	NUM	CD	_	24	nummod	_	_
24	days	_	NOUN	NNS	_	9	nmod	_	_

#	Paroxetine	4167
1	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
2	is	_	VERB	VBZ	_	4	auxpass	_	_
3	extensively	_	ADV	RB	_	4	advmod	_	_
4	metabolized	_	VERB	VBN	_	0	root	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	the	_	DET	DT	_	7	det	_	_
7	metabolites	_	NOUN	NNS	_	9	nsubjpass	_	_
8	are	_	VERB	VBP	_	9	auxpass	_	_
9	considered	_	VERB	VBN	_	4	conj	_	_
10	to	_	PRT	TO	_	12	mark	_	_
11	be	_	VERB	VB	_	12	auxpass	_	_
12	inactive	_	ADJ	JJ	_	9	xcomp	_	_

#	Paroxetine	4168
1	Nonlinearity	_	NOUN	NN	_	5	nsubjpass	_	_
2	in	_	ADP	IN	_	3	case	_	_
3	pharmacokinetics	_	NOUN	NNS	_	1	nmod	_	_
4	is	_	VERB	VBZ	_	5	auxpass	_	_
5	observed	_	VERB	VBN	_	0	root	_	_
6	with	_	ADP	IN	_	8	case	_	_
7	increasing	_	VERB	VBG	_	8	amod	_	_
8	doses	_	NOUN	NNS	_	5	nmod	_	_

#	Paroxetine	4169
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	metabolism	_	NOUN	NN	_	4	nsubjpass	_	_
3	is	_	VERB	VBZ	_	4	auxpass	_	_
4	mediated	_	VERB	VBN	_	0	root	_	_
5	in	_	ADP	IN	_	6	case	_	_
6	part	_	NOUN	NN	_	4	nmod	_	_
7	by	_	ADP	IN	_	8	case	_	_
8	CYP2D6	_	NOUN	NN	_	4	nmod	_	_
9	,	_	.	,	_	4	punct	_	_
10	and	_	CONJ	CC	_	4	cc	_	_
11	the	_	DET	DT	_	12	det	_	_
12	metabolites	_	NOUN	NNS	_	15	nsubjpass	_	_
13	are	_	VERB	VBP	_	15	auxpass	_	_
14	primarily	_	ADV	RB	_	15	advmod	_	_
15	excreted	_	VERB	VBN	_	4	conj	_	_
16	in	_	ADP	IN	_	18	case	_	_
17	the	_	DET	DT	_	18	det	_	_
18	urine	_	NOUN	NN	_	15	nmod	_	_
19	and	_	CONJ	CC	_	15	cc	_	_
20	to	_	PRT	TO	_	22	case	_	_
21	some	_	DET	DT	_	22	det	_	_
22	extent	_	NOUN	NN	_	15	conj	_	_
23	in	_	ADP	IN	_	25	case	_	_
24	the	_	DET	DT	_	25	det	_	_
25	feces	_	NOUN	NNS	_	22	nmod	_	_

#	Paroxetine	4170
1	Pharmacokinetic	_	ADJ	JJ	_	2	amod	_	_
2	behavior	_	NOUN	NN	_	8	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	has	_	VERB	VBZ	_	8	aux	_	_
6	not	_	ADV	RB	_	8	neg	_	_
7	been	_	VERB	VBN	_	8	auxpass	_	_
8	evaluated	_	VERB	VBN	_	0	root	_	_
9	in	_	ADP	IN	_	10	case	_	_
10	subjects	_	NOUN	NNS	_	8	nmod	_	_
11	who	_	DET	WDT	_	13	nsubj	_	_
12	are	_	VERB	VBP	_	13	cop	_	_
13	deficient	_	ADJ	JJ	_	10	acl:relcl	_	_
14	in	_	ADP	IN	_	17	case	_	_
15	CYP2D6	_	NOUN	NN	_	17	compound	_	_
16	poor	_	ADJ	JJ	_	17	amod	_	_
17	metabolizers	_	NOUN	NNS	_	13	nmod	_	_

#	Paroxetine	4171
1	In	_	ADP	IN	_	4	case	_	_
2	a	_	DET	DT	_	4	det	_	_
3	meta	_	NOUN	NN	_	4	compound	_	_
4	analysis	_	NOUN	NN	_	31	nmod	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	from	_	ADP	IN	_	9	case	_	_
8	4	_	NUM	CD	_	9	nummod	_	_
9	studies	_	NOUN	NNS	_	4	nmod	_	_
10	done	_	NOUN	NN	_	4	dep	_	_
11	in	_	ADP	IN	_	13	case	_	_
12	healthy	_	ADJ	JJ	_	13	amod	_	_
13	volunteers	_	NOUN	NNS	_	10	nmod	_	_
14	following	_	VERB	VBG	_	16	case	_	_
15	multiple	_	ADJ	JJ	_	16	amod	_	_
16	dosing	_	NOUN	NN	_	10	nmod	_	_
17	of	_	ADP	IN	_	19	case	_	_
18	20	_	NUM	CD	_	19	nummod	_	_
19	mg	_	NOUN	NN	_	16	nmod	_	_
20	/	_	.	:	_	31	punct	_	_
21	day	_	NOUN	NN	_	26	dep	_	_
22	to	_	PRT	TO	_	26	case	_	_
23	40	_	NUM	CD	_	24	nummod	_	_
24	mg	_	NOUN	NN	_	26	compound	_	_
25	/	_	.	:	_	26	punct	_	_
26	day	_	NOUN	NN	_	31	nmod	_	_
27	,	_	.	,	_	31	punct	_	_
28	males	_	NOUN	NNS	_	31	nsubj	_	_
29	did	_	VERB	VBD	_	31	aux	_	_
30	not	_	ADV	RB	_	31	neg	_	_
31	exhibit	_	VERB	VB	_	0	root	_	_
32	a	_	DET	DT	_	35	det	_	_
33	significantly	_	ADV	RB	_	34	advmod	_	_
34	lower	_	ADJ	JJ	_	35	amod	_	_
35	Cmax	_	NOUN	NN	_	31	dobj	_	_
36	or	_	CONJ	CC	_	35	cc	_	_
37	AUC	_	NOUN	NN	_	35	conj	_	_
38	than	_	ADP	IN	_	39	case	_	_
39	females	_	NOUN	NNS	_	31	nmod	_	_

#	Paroxetine	4172
1	Absorption	_	NOUN	NN	_	8	nsubjpass	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	Distribution	_	NOUN	NN	_	5	compound	_	_
4	DRUG	_	NOUN	NN	_	5	compound	_	_
5	hydrochloride	_	NOUN	NN	_	1	conj	_	_
6	is	_	VERB	VBZ	_	8	auxpass	_	_
7	completely	_	ADV	RB	_	8	advmod	_	_
8	absorbed	_	VERB	VBN	_	0	root	_	_
9	after	_	ADP	IN	_	11	case	_	_
10	oral	_	ADJ	JJ	_	11	amod	_	_
11	dosing	_	NOUN	NN	_	8	nmod	_	_
12	of	_	ADP	IN	_	14	case	_	_
13	a	_	DET	DT	_	14	det	_	_
14	solution	_	NOUN	NN	_	11	nmod	_	_
15	of	_	ADP	IN	_	18	case	_	_
16	the	_	DET	DT	_	18	det	_	_
17	hydrochloride	_	NOUN	NN	_	18	compound	_	_
18	salt	_	NOUN	NN	_	14	nmod	_	_

#	Paroxetine	4173
1	In	_	ADP	IN	_	3	case	_	_
2	a	_	DET	DT	_	3	det	_	_
3	study	_	NOUN	NN	_	26	nmod	_	_
4	in	_	ADP	IN	_	5	case	_	_
5	which	_	DET	WDT	_	10	nmod	_	_
6	normal	_	ADJ	JJ	_	8	amod	_	_
7	male	_	ADJ	JJ	_	8	amod	_	_
8	subjects	_	NOUN	NNS	_	10	nsubj	_	_
9	n	_	NOUN	NN	_	10	nsubj	_	_
10	=	_	ADJ	JJ	_	3	acl:relcl	_	_
11	15	_	NUM	CD	_	15	nummod	_	_
12	received	_	VERB	VBD	_	15	amod	_	_
13	30	_	NUM	CD	_	15	nummod	_	_
14	mg	_	NOUN	NN	_	15	compound	_	_
15	tablets	_	NOUN	NNS	_	10	dobj	_	_
16	daily	_	ADV	RB	_	10	advmod	_	_
17	for	_	ADP	IN	_	19	case	_	_
18	30	_	NUM	CD	_	19	nummod	_	_
19	days	_	NOUN	NNS	_	10	nmod	_	_
20	,	_	.	,	_	26	punct	_	_
21	steady	_	ADJ	JJ	_	24	amod	_	_
22	state	_	NOUN	NN	_	24	compound	_	_
23	DRUG	_	NOUN	NN	_	24	compound	_	_
24	concentrations	_	NOUN	NNS	_	26	nsubjpass	_	_
25	were	_	VERB	VBD	_	26	auxpass	_	_
26	achieved	_	VERB	VBN	_	0	root	_	_
27	by	_	ADP	IN	_	30	case	_	_
28	approximately	_	ADV	RB	_	29	advmod	_	_
29	10	_	NUM	CD	_	30	nummod	_	_
30	days	_	NOUN	NNS	_	26	nmod	_	_
31	for	_	ADP	IN	_	33	case	_	_
32	most	_	ADJ	JJ	_	33	amod	_	_
33	subjects	_	NOUN	NNS	_	30	nmod	_	_
34	,	_	.	,	_	26	punct	_	_
35	although	_	ADP	IN	_	38	mark	_	_
36	it	_	PRON	PRP	_	38	nsubj	_	_
37	may	_	VERB	MD	_	38	aux	_	_
38	take	_	VERB	VB	_	26	advcl	_	_
39	substantially	_	ADV	RB	_	40	advmod	_	_
40	longer	_	ADV	RB	_	38	advmod	_	_
41	in	_	ADP	IN	_	44	case	_	_
42	an	_	DET	DT	_	44	det	_	_
43	occasional	_	ADJ	JJ	_	44	amod	_	_
44	patient	_	NOUN	NN	_	38	nmod	_	_

#	Paroxetine	4174
1	At	_	ADP	IN	_	3	case	_	_
2	steady	_	ADJ	JJ	_	3	amod	_	_
3	state	_	NOUN	NN	_	18	nmod	_	_
4	,	_	.	,	_	18	punct	_	_
5	mean	_	ADJ	JJ	_	6	amod	_	_
6	values	_	NOUN	NNS	_	18	nsubj	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	Cmax	_	NOUN	NN	_	6	nmod	_	_
9	,	_	.	,	_	8	punct	_	_
10	Tmax	_	NOUN	NN	_	8	conj	_	_
11	,	_	.	,	_	8	punct	_	_
12	Cmin	_	NOUN	NN	_	8	conj	_	_
13	,	_	.	,	_	8	punct	_	_
14	and	_	CONJ	CC	_	8	cc	_	_
15	T%	_	NOUN	NN	_	8	conj	_	_
16	were	_	VERB	VBD	_	18	cop	_	_
17	61.7	_	NUM	CD	_	18	nummod	_	_
18	ng	_	NOUN	NN	_	0	root	_	_
19	/	_	.	:	_	18	punct	_	_
20	mL	_	NOUN	NN	_	22	compound	_	_
21	CV	_	NOUN	NN	_	22	compound	_	_
22	45%	_	NOUN	NN	_	18	dep	_	_
23	,	_	.	,	_	18	punct	_	_
24	5.2	_	NUM	CD	_	25	nummod	_	_
25	hr	_	NOUN	NN	_	18	appos	_	_

#	Paroxetine	4175
1	CV	_	NOUN	NN	_	2	compound	_	_
2	10%	_	NOUN	NN	_	0	root	_	_
3	,	_	.	,	_	2	punct	_	_
4	30.7	_	NUM	CD	_	5	nummod	_	_
5	ng	_	NOUN	NN	_	2	appos	_	_
6	/	_	.	:	_	2	punct	_	_
7	mL	_	NOUN	NN	_	9	compound	_	_
8	CV	_	NOUN	NN	_	9	compound	_	_
9	67%	_	NOUN	NN	_	2	dep	_	_
10	,	_	.	,	_	9	punct	_	_
11	and	_	CONJ	CC	_	9	cc	_	_
12	21	_	NUM	CD	_	13	nummod	_	_
13	hours	_	NOUN	NNS	_	9	conj	_	_
14	CV	_	NOUN	NN	_	15	compound	_	_
15	32%	_	NOUN	NN	_	13	dep	_	_
16	,	_	.	,	_	2	punct	_	_
17	respectively	_	ADV	RB	_	2	neg	_	_

#	Paroxetine	4176
1	The	_	DET	DT	_	4	det	_	_
2	steady	_	ADJ	JJ	_	4	amod	_	_
3	state	_	NOUN	NN	_	4	compound	_	_
4	Cmax	_	NOUN	NN	_	13	nsubj	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	Cmin	_	NOUN	NN	_	7	compound	_	_
7	values	_	NOUN	NNS	_	4	conj	_	_
8	were	_	VERB	VBD	_	13	cop	_	_
9	about	_	ADV	RB	_	10	advmod	_	_
10	6	_	NUM	CD	_	13	nummod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	14	_	NUM	CD	_	10	conj	_	_
13	times	_	NOUN	NNS	_	0	root	_	_
14	what	_	DET	WDT	_	17	nsubjpass	_	_
15	would	_	VERB	MD	_	17	aux	_	_
16	be	_	VERB	VB	_	17	auxpass	_	_
17	predicted	_	VERB	VBN	_	13	acl:relcl	_	_
18	from	_	ADP	IN	_	21	case	_	_
19	single	_	ADJ	JJ	_	21	amod	_	_
20	dose	_	NOUN	NN	_	21	compound	_	_
21	studies	_	NOUN	NNS	_	17	nmod	_	_

#	Paroxetine	4177
1	Steady	_	ADJ	JJ	_	4	amod	_	_
2	state	_	NOUN	NN	_	4	compound	_	_
3	drug	_	NOUN	NN	_	4	compound	_	_
4	exposure	_	NOUN	NN	_	12	nsubj	_	_
5	based	_	VERB	VBN	_	4	acl	_	_
6	on	_	ADP	IN	_	7	case	_	_
7	AUC0	_	NOUN	NN	_	5	nmod	_	_
8	24	_	NUM	CD	_	7	nummod	_	_
9	was	_	VERB	VBD	_	12	cop	_	_
10	about	_	ADV	RB	_	11	advmod	_	_
11	8	_	NUM	CD	_	12	nummod	_	_
12	times	_	NOUN	NNS	_	0	root	_	_
13	greater	_	ADJ	JJ	_	12	amod	_	_
14	than	_	ADP	IN	_	18	mark	_	_
15	would	_	VERB	MD	_	18	aux	_	_
16	have	_	VERB	VB	_	18	aux	_	_
17	been	_	VERB	VBN	_	18	auxpass	_	_
18	predicted	_	VERB	VBN	_	13	advcl	_	_
19	from	_	ADP	IN	_	22	case	_	_
20	single	_	ADJ	JJ	_	22	amod	_	_
21	dose	_	NOUN	NN	_	22	compound	_	_
22	data	_	NOUN	NNS	_	18	nmod	_	_
23	in	_	ADP	IN	_	25	case	_	_
24	these	_	DET	DT	_	25	det	_	_
25	subjects	_	NOUN	NNS	_	22	nmod	_	_

#	Paroxetine	4178
1	The	_	DET	DT	_	3	det	_	_
2	excess	_	NOUN	NN	_	3	amod	_	_
3	accumulation	_	NOUN	NN	_	6	nsubj	_	_
4	is	_	VERB	VBZ	_	6	cop	_	_
5	a	_	DET	DT	_	6	det	_	_
6	consequence	_	NOUN	NN	_	0	root	_	_
7	of	_	ADP	IN	_	9	case	_	_
8	the	_	DET	DT	_	9	det	_	_
9	fact	_	NOUN	NN	_	6	nmod	_	_
10	that	_	ADP	IN	_	20	mark	_	_
11	1	_	NUM	CD	_	20	nsubjpass	_	_
12	of	_	ADP	IN	_	14	case	_	_
13	the	_	DET	DT	_	14	det	_	_
14	enzymes	_	NOUN	NNS	_	11	nmod	_	_
15	that	_	DET	WDT	_	16	nsubj	_	_
16	metabolizes	_	VERB	VBZ	_	14	acl:relcl	_	_
17	DRUG	_	NOUN	NN	_	16	dobj	_	_
18	is	_	VERB	VBZ	_	20	auxpass	_	_
19	readily	_	ADV	RB	_	20	advmod	_	_
20	saturable	_	ADJ	JJ	_	9	ccomp	_	_

#	Paroxetine	4179
1	The	_	DET	DT	_	2	det	_	_
2	effects	_	NOUN	NNS	_	11	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	food	_	NOUN	NN	_	2	nmod	_	_
5	on	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	bioavailability	_	NOUN	NN	_	2	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	were	_	VERB	VBD	_	11	auxpass	_	_
11	studied	_	VERB	VBN	_	0	root	_	_
12	in	_	ADP	IN	_	13	case	_	_
13	subjects	_	NOUN	NNS	_	11	nmod	_	_
14	administered	_	VERB	VBD	_	11	xcomp	_	_
15	a	_	DET	DT	_	17	det	_	_
16	single	_	ADJ	JJ	_	17	amod	_	_
17	dose	_	NOUN	NN	_	14	dobj	_	_
18	with	_	ADP	IN	_	17	nmod	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	without	_	ADP	IN	_	18	conj	_	_
21	food	_	NOUN	NN	_	18	dep	_	_

#	Paroxetine	4180
1	AUC	_	NOUN	NN	_	5	nsubjpass	_	_
2	was	_	VERB	VBD	_	5	auxpass	_	_
3	only	_	ADV	RB	_	5	advmod	_	_
4	slightly	_	ADV	RB	_	5	advmod	_	_
5	increased	_	VERB	VBN	_	0	root	_	_
6	6%	_	NOUN	NN	_	5	xcomp	_	_
7	when	_	ADV	WRB	_	10	advmod	_	_
8	drug	_	NOUN	NN	_	10	nsubjpass	_	_
9	was	_	VERB	VBD	_	10	auxpass	_	_
10	administered	_	VERB	VBN	_	5	advcl	_	_
11	with	_	ADP	IN	_	12	case	_	_
12	food	_	NOUN	NN	_	10	nmod	_	_
13	but	_	CONJ	CC	_	10	cc	_	_
14	the	_	DET	DT	_	15	det	_	_
15	Cmax	_	NOUN	NN	_	18	nsubj	_	_
16	was	_	VERB	VBD	_	18	cop	_	_
17	29%	_	ADJ	JJ	_	18	advmod	_	_
18	greater	_	ADJ	JJ	_	10	conj	_	_
19	,	_	.	,	_	5	punct	_	_
20	while	_	ADP	IN	_	28	mark	_	_
21	the	_	DET	DT	_	22	det	_	_
22	time	_	NOUN	NN	_	28	nsubj	_	_
23	to	_	PRT	TO	_	24	mark	_	_
24	reach	_	VERB	VB	_	22	acl	_	_
25	peak	_	ADJ	JJ	_	27	amod	_	_
26	plasma	_	NOUN	NN	_	27	compound	_	_
27	concentration	_	NOUN	NN	_	24	dobj	_	_
28	decreased	_	VERB	VBN	_	5	advcl	_	_
29	from	_	ADP	IN	_	31	case	_	_
30	6.4	_	NUM	CD	_	31	nummod	_	_
31	hours	_	NOUN	NNS	_	28	nmod	_	_
32	post	_	ADJ	JJ	_	28	dobj	_	_
33	dosing	_	VERB	VBG	_	32	dep	_	_
34	to	_	PRT	TO	_	36	case	_	_
35	4.9	_	NUM	CD	_	36	nummod	_	_
36	hours	_	NOUN	NNS	_	33	nmod	_	_

#	Paroxetine	4181
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	distributes	_	VERB	VBZ	_	0	root	_	_
3	throughout	_	ADP	IN	_	5	case	_	_
4	the	_	DET	DT	_	5	det	_	_
5	body	_	NOUN	NN	_	2	nmod	_	_
6	,	_	.	,	_	5	punct	_	_
7	including	_	VERB	VBG	_	9	case	_	_
8	the	_	DET	DT	_	9	det	_	_
9	CNS	_	NOUN	NN	_	5	nmod	_	_
10	,	_	.	,	_	2	punct	_	_
11	with	_	ADP	IN	_	13	case	_	_
12	only	_	ADV	RB	_	13	advmod	_	_
13	1%	_	ADJ	JJ	_	2	nmod	_	_
14	remaining	_	VERB	VBG	_	13	acl	_	_
15	in	_	ADP	IN	_	17	case	_	_
16	the	_	DET	DT	_	17	det	_	_
17	plasma	_	NOUN	NN	_	14	nmod	_	_

#	Paroxetine	4182
1	Approximately	_	ADV	RB	_	8	advmod	_	_
2	95%	_	NOUN	NN	_	8	nsubjpass	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	93%	_	NOUN	NN	_	2	conj	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	2	nmod	_	_
7	is	_	VERB	VBZ	_	8	auxpass	_	_
8	bound	_	VERB	VBN	_	0	root	_	_
9	to	_	PRT	TO	_	11	case	_	_
10	plasma	_	NOUN	NN	_	11	compound	_	_
11	protein	_	NOUN	NN	_	8	nmod	_	_
12	at	_	ADP	IN	_	14	case	_	_
13	100	_	NUM	CD	_	14	nummod	_	_
14	ng	_	NOUN	NN	_	8	nmod	_	_
15	/	_	.	:	_	14	punct	_	_
16	mL	_	NOUN	NN	_	14	appos	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	400	_	NUM	CD	_	19	nummod	_	_
19	ng	_	NOUN	NN	_	16	conj	_	_
20	/	_	.	:	_	16	punct	_	_
21	mL	_	NOUN	NN	_	16	appos	_	_
22	,	_	.	,	_	14	punct	_	_
23	respectively	_	ADV	RB	_	14	advmod	_	_

#	Paroxetine	4183
1	Under	_	ADP	IN	_	3	case	_	_
2	clinical	_	ADJ	JJ	_	3	amod	_	_
3	conditions	_	NOUN	NNS	_	13	nmod	_	_
4	,	_	.	,	_	13	punct	_	_
5	DRUG	_	NOUN	NN	_	6	compound	_	_
6	concentrations	_	NOUN	NNS	_	13	nsubj	_	_
7	would	_	VERB	MD	_	13	aux	_	_
8	normally	_	ADV	RB	_	13	advmod	_	_
9	be	_	VERB	VB	_	13	cop	_	_
10	less	_	ADV	RB	_	12	advmod	_	_
11	than	_	ADP	IN	_	10	mwe	_	_
12	400	_	NUM	CD	_	13	nummod	_	_
13	ng	_	NOUN	NN	_	0	root	_	_
14	/	_	.	:	_	13	punct	_	_
15	mL	_	NOUN	NN	_	13	dep	_	_

#	Paroxetine	4184
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	does	_	VERB	VBZ	_	4	aux	_	_
3	not	_	ADV	RB	_	4	neg	_	_
4	alter	_	VERB	VB	_	0	root	_	_
5	the	_	DET	DT	_	9	det	_	_
6	in	_	X	FW	_	9	amod	_	_
7	vitro	_	X	FW	_	6	dep	_	_
8	protein	_	NOUN	NN	_	9	compound	_	_
9	binding	_	NOUN	NN	_	4	dobj	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	phenytoin	_	NOUN	NN	_	9	nmod	_	_
12	or	_	CONJ	CC	_	11	cc	_	_
13	warfarin	_	NOUN	NN	_	11	conj	_	_

#	Paroxetine	4185
1	Metabolism	_	NOUN	NN	_	12	nsubj	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	Excretion	_	NOUN	NN	_	1	conj	_	_
4	The	_	DET	DT	_	8	det	_	_
5	mean	_	ADJ	JJ	_	8	compound	_	_
6	elimination	_	NOUN	NN	_	8	compound	_	_
7	half	_	NOUN	NN	_	8	compound	_	_
8	life	_	NOUN	NN	_	1	dep	_	_
9	is	_	VERB	VBZ	_	12	cop	_	_
10	approximately	_	ADV	RB	_	11	advmod	_	_
11	21	_	NUM	CD	_	12	nummod	_	_
12	hours	_	NOUN	NNS	_	0	root	_	_
13	CV	_	NOUN	NN	_	14	compound	_	_
14	32%	_	NOUN	NN	_	12	dep	_	_
15	after	_	ADP	IN	_	17	case	_	_
16	oral	_	ADJ	JJ	_	17	amod	_	_
17	dosing	_	NOUN	NN	_	12	nmod	_	_
18	of	_	ADP	IN	_	21	case	_	_
19	30	_	NUM	CD	_	21	nummod	_	_
20	mg	_	NOUN	NN	_	21	compound	_	_
21	tablets	_	NOUN	NNS	_	17	nmod	_	_
22	daily	_	ADV	RB	_	12	advmod	_	_
23	for	_	ADP	IN	_	25	case	_	_
24	30	_	NUM	CD	_	25	nummod	_	_
25	days	_	NOUN	NNS	_	12	nmod	_	_
26	of	_	ADP	IN	_	27	case	_	_
27	DRUG	_	NOUN	NN	_	25	nmod	_	_

#	Paroxetine	4186
1	In	_	ADP	IN	_	6	case	_	_
2	steady	_	ADJ	JJ	_	6	amod	_	_
3	state	_	NOUN	NN	_	6	compound	_	_
4	dose	_	NOUN	NN	_	6	compound	_	_
5	proportionality	_	NOUN	NN	_	6	compound	_	_
6	studies	_	NOUN	NNS	_	39	nmod	_	_
7	involving	_	VERB	VBG	_	6	acl	_	_
8	elderly	_	ADJ	JJ	_	11	amod	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	nonelderly	_	ADJ	JJ	_	8	conj	_	_
11	patients	_	NOUN	NNS	_	7	dobj	_	_
12	,	_	.	,	_	39	punct	_	_
13	at	_	ADP	IN	_	14	case	_	_
14	doses	_	NOUN	NNS	_	39	nmod	_	_
15	of	_	ADP	IN	_	17	case	_	_
16	20	_	NUM	CD	_	17	nummod	_	_
17	mg	_	NOUN	NN	_	14	nmod	_	_
18	to	_	PRT	TO	_	20	case	_	_
19	40	_	NUM	CD	_	20	nummod	_	_
20	mg	_	NOUN	NN	_	14	nmod	_	_
21	daily	_	ADV	RB	_	24	advmod	_	_
22	for	_	ADP	IN	_	24	case	_	_
23	the	_	DET	DT	_	24	det	_	_
24	elderly	_	NOUN	NN	_	14	nmod	_	_
25	and	_	CONJ	CC	_	24	cc	_	_
26	20	_	NUM	CD	_	27	nummod	_	_
27	mg	_	NOUN	NN	_	24	conj	_	_
28	to	_	PRT	TO	_	30	case	_	_
29	50	_	NUM	CD	_	30	nummod	_	_
30	mg	_	NOUN	NN	_	14	nmod	_	_
31	daily	_	ADV	RB	_	34	advmod	_	_
32	for	_	ADP	IN	_	34	case	_	_
33	the	_	DET	DT	_	34	det	_	_
34	nonelderly	_	ADV	RB	_	14	advmod	_	_
35	,	_	.	,	_	39	punct	_	_
36	some	_	DET	DT	_	37	det	_	_
37	nonlinearity	_	NOUN	NN	_	39	nsubjpass	_	_
38	was	_	VERB	VBD	_	39	auxpass	_	_
39	observed	_	VERB	VBN	_	0	root	_	_
40	in	_	ADP	IN	_	42	case	_	_
41	both	_	DET	DT	_	42	det	_	_
42	populations	_	NOUN	NNS	_	39	nmod	_	_
43	,	_	.	,	_	39	punct	_	_
44	again	_	ADV	RB	_	45	advmod	_	_
45	reflecting	_	VERB	VBG	_	39	xcomp	_	_
46	a	_	DET	DT	_	49	det	_	_
47	saturable	_	ADJ	JJ	_	49	amod	_	_
48	metabolic	_	ADJ	JJ	_	49	amod	_	_
49	pathway	_	NOUN	NN	_	45	dobj	_	_

#	Paroxetine	4187
1	In	_	ADP	IN	_	2	case	_	_
2	comparison	_	NOUN	NN	_	22	nmod	_	_
3	to	_	PRT	TO	_	5	case	_	_
4	Cmin	_	NOUN	NN	_	5	compound	_	_
5	values	_	NOUN	NNS	_	2	nmod	_	_
6	after	_	ADP	IN	_	8	case	_	_
7	20	_	NUM	CD	_	8	nummod	_	_
8	mg	_	NOUN	NN	_	2	nmod	_	_
9	daily	_	ADV	RB	_	2	advmod	_	_
10	,	_	.	,	_	22	punct	_	_
11	values	_	NOUN	NNS	_	22	nsubj	_	_
12	after	_	ADP	IN	_	14	case	_	_
13	40	_	NUM	CD	_	14	nummod	_	_
14	mg	_	NOUN	NN	_	11	nmod	_	_
15	daily	_	ADV	RB	_	22	advmod	_	_
16	were	_	VERB	VBD	_	22	cop	_	_
17	only	_	ADV	RB	_	19	advmod	_	_
18	about	_	ADV	RB	_	19	advmod	_	_
19	2	_	NUM	CD	_	21	compound	_	_
20	to	_	PRT	TO	_	21	dep	_	_
21	3	_	NUM	CD	_	22	nummod	_	_
22	times	_	NOUN	NNS	_	0	root	_	_
23	greater	_	ADJ	JJ	_	22	amod	_	_
24	than	_	ADP	IN	_	25	mark	_	_
25	doubled	_	VERB	VBN	_	23	conj	_	_

#	Paroxetine	4188
1	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
2	is	_	VERB	VBZ	_	4	auxpass	_	_
3	extensively	_	ADV	RB	_	4	advmod	_	_
4	metabolized	_	VERB	VBN	_	0	root	_	_
5	after	_	ADP	IN	_	7	case	_	_
6	oral	_	ADJ	JJ	_	7	amod	_	_
7	administration	_	NOUN	NN	_	4	nmod	_	_

#	Paroxetine	4189
1	The	_	DET	DT	_	3	det	_	_
2	principal	_	ADJ	JJ	_	3	amod	_	_
3	metabolites	_	NOUN	NNS	_	5	nsubj	_	_
4	are	_	VERB	VBP	_	5	cop	_	_
5	polar	_	ADJ	JJ	_	0	root	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	conjugated	_	VERB	VBN	_	5	conj	_	_
8	products	_	NOUN	NNS	_	5	dep	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	oxidation	_	NOUN	NN	_	5	nmod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	methylation	_	NOUN	NN	_	10	conj	_	_
13	,	_	.	,	_	10	punct	_	_
14	which	_	DET	WDT	_	17	nsubjpass	_	_
15	are	_	VERB	VBP	_	17	auxpass	_	_
16	readily	_	ADV	RB	_	17	advmod	_	_
17	cleared	_	VERB	VBN	_	10	acl:relcl	_	_

#	Paroxetine	4190
1	Conjugates	_	VERB	VBZ	_	0	root	_	_
2	with	_	ADP	IN	_	4	case	_	_
3	glucuronic	_	ADJ	JJ	_	4	amod	_	_
4	acid	_	NOUN	NN	_	1	nmod	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	sulfate	_	NOUN	NN	_	7	compound	_	_
7	predominate	_	NOUN	NN	_	4	conj	_	_
8	,	_	.	,	_	1	punct	_	_
9	and	_	CONJ	CC	_	1	cc	_	_
10	major	_	ADJ	JJ	_	11	amod	_	_
11	metabolites	_	NOUN	NNS	_	14	nsubjpass	_	_
12	have	_	VERB	VBP	_	14	aux	_	_
13	been	_	VERB	VBN	_	14	auxpass	_	_
14	isolated	_	VERB	VBN	_	1	conj	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	identified	_	VERB	VBN	_	14	conj	_	_

#	Paroxetine	4191
1	Data	_	NOUN	NN	_	2	nsubj	_	_
2	indicate	_	VERB	VBP	_	0	root	_	_
3	that	_	ADP	IN	_	6	mark	_	_
4	the	_	DET	DT	_	5	det	_	_
5	metabolites	_	NOUN	NNS	_	6	nsubj	_	_
6	have	_	VERB	VBP	_	2	ccomp	_	_
7	no	_	DET	DT	_	8	neg	_	_
8	more	_	ADV	RB	_	6	advmod	_	_
9	than	_	ADP	IN	_	14	case	_	_
10	1	_	NUM	CD	_	14	nummod	_	_
11	/	_	.	:	_	14	amod	_	_
12	50	_	NUM	CD	_	14	nummod	_	_
13	the	_	DET	DT	_	14	det	_	_
14	potency	_	NOUN	NN	_	8	dep	_	_
15	of	_	ADP	IN	_	18	case	_	_
16	the	_	DET	DT	_	18	det	_	_
17	parent	_	NOUN	NN	_	18	compound	_	_
18	compound	_	NOUN	NN	_	14	nmod	_	_
19	at	_	ADP	IN	_	20	mark	_	_
20	inhibiting	_	VERB	VBG	_	14	acl	_	_
21	serotonin	_	NOUN	NN	_	22	compound	_	_
22	uptake	_	NOUN	NN	_	20	dobj	_	_

#	Paroxetine	4192
1	The	_	DET	DT	_	2	det	_	_
2	metabolism	_	NOUN	NN	_	6	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	is	_	VERB	VBZ	_	6	auxpass	_	_
6	accomplished	_	VERB	VBN	_	0	root	_	_
7	in	_	ADP	IN	_	8	case	_	_
8	part	_	NOUN	NN	_	6	nmod	_	_
9	by	_	ADP	IN	_	10	case	_	_
10	CYP2D6	_	NOUN	NN	_	6	nmod	_	_

#	Paroxetine	4193
1	Saturation	_	NOUN	NN	_	8	nsubj	_	_
2	of	_	ADP	IN	_	4	case	_	_
3	this	_	DET	DT	_	4	det	_	_
4	enzyme	_	NOUN	NN	_	1	nmod	_	_
5	at	_	ADP	IN	_	7	case	_	_
6	clinical	_	ADJ	JJ	_	7	amod	_	_
7	doses	_	NOUN	NNS	_	1	nmod	_	_
8	appears	_	VERB	VBZ	_	0	root	_	_
9	to	_	PRT	TO	_	10	mark	_	_
10	account	_	VERB	VB	_	8	xcomp	_	_
11	for	_	ADP	IN	_	13	case	_	_
12	the	_	DET	DT	_	13	det	_	_
13	nonlinearity	_	NOUN	NN	_	10	nmod	_	_
14	of	_	ADP	IN	_	16	case	_	_
15	DRUG	_	NOUN	NN	_	16	compound	_	_
16	kinetics	_	NOUN	NNS	_	13	nmod	_	_
17	with	_	ADP	IN	_	18	mark	_	_
18	increasing	_	VERB	VBG	_	13	acl	_	_
19	dose	_	NOUN	NN	_	22	compound	_	_
20	and	_	CONJ	CC	_	19	cc	_	_
21	increasing	_	VERB	VBG	_	19	conj	_	_
22	duration	_	NOUN	NN	_	18	dobj	_	_
23	of	_	ADP	IN	_	24	case	_	_
24	treatment	_	NOUN	NN	_	22	nmod	_	_

#	Paroxetine	4194
1	The	_	DET	DT	_	2	det	_	_
2	role	_	NOUN	NN	_	10	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	this	_	DET	DT	_	5	det	_	_
5	enzyme	_	NOUN	NN	_	2	nmod	_	_
6	in	_	ADP	IN	_	8	case	_	_
7	DRUG	_	NOUN	NN	_	8	compound	_	_
8	metabolism	_	NOUN	NN	_	2	nmod	_	_
9	also	_	ADV	RB	_	10	advmod	_	_
10	suggests	_	VERB	VBZ	_	0	root	_	_
11	potential	_	ADJ	JJ	_	14	amod	_	_
12	drug	_	NOUN	NN	_	14	compound	_	_
13	drug	_	NOUN	NN	_	14	compound	_	_
14	interactions	_	NOUN	NNS	_	10	dobj	_	_

#	Paroxetine	4195
1	Specific	_	ADJ	JJ	_	2	amod	_	_
2	Populations	_	NOUN	NNS	_	0	root	_	_
3	Renal	_	ADJ	JJ	_	2	amod	_	_
4	and	_	CONJ	CC	_	3	cc	_	_
5	Liver	_	NOUN	NN	_	3	conj	_	_
6	Disease	_	NOUN	NN	_	3	dep	_	_
7	:	_	.	:	_	2	punct	_	_
8	Increased	_	VERB	VBN	_	10	amod	_	_
9	plasma	_	NOUN	NN	_	10	compound	_	_
10	concentrations	_	NOUN	NNS	_	13	nsubj	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_
13	occur	_	VERB	VBP	_	2	dep	_	_
14	in	_	ADP	IN	_	15	case	_	_
15	subjects	_	NOUN	NNS	_	13	nmod	_	_
16	with	_	ADP	IN	_	20	case	_	_
17	renal	_	ADJ	JJ	_	20	amod	_	_
18	and	_	CONJ	CC	_	17	cc	_	_
19	hepatic	_	ADJ	JJ	_	17	conj	_	_
20	impairment	_	NOUN	NN	_	15	nmod	_	_

#	Paroxetine	4196
1	The	_	DET	DT	_	4	det	_	_
2	mean	_	ADJ	JJ	_	4	amod	_	_
3	plasma	_	NOUN	NN	_	4	compound	_	_
4	concentrations	_	NOUN	NNS	_	10	nsubj	_	_
5	in	_	ADP	IN	_	6	case	_	_
6	patients	_	NOUN	NNS	_	4	nmod	_	_
7	with	_	ADP	IN	_	9	case	_	_
8	creatinine	_	NOUN	NN	_	9	compound	_	_
9	clearance	_	NOUN	NN	_	6	nmod	_	_
10	below	_	VERB	VBP	_	0	root	_	_
11	30	_	NUM	CD	_	12	nummod	_	_
12	mL	_	NOUN	NN	_	10	dobj	_	_
13	/	_	.	:	_	10	punct	_	_
14	min	_	NOUN	NN	_	18	nsubj	_	_
15	were	_	VERB	VBD	_	18	cop	_	_
16	approximately	_	ADV	RB	_	17	advmod	_	_
17	4	_	NUM	CD	_	18	nummod	_	_
18	times	_	NOUN	NNS	_	10	parataxis	_	_
19	greater	_	ADJ	JJ	_	18	amod	_	_
20	than	_	ADP	IN	_	21	mark	_	_
21	seen	_	VERB	VBN	_	19	advcl	_	_
22	in	_	ADP	IN	_	24	case	_	_
23	normal	_	ADJ	JJ	_	24	amod	_	_
24	volunteers	_	NOUN	NNS	_	21	nmod	_	_

#	Paroxetine	4197
1	Patients	_	NOUN	NNS	_	0	root	_	_
2	with	_	ADP	IN	_	4	case	_	_
3	creatinine	_	NOUN	NN	_	4	compound	_	_
4	clearance	_	NOUN	NN	_	1	nmod	_	_
5	of	_	ADP	IN	_	9	case	_	_
6	30	_	NUM	CD	_	8	compound	_	_
7	to	_	PRT	TO	_	8	dep	_	_
8	60	_	NUM	CD	_	9	nummod	_	_
9	mL	_	NOUN	NN	_	4	nmod	_	_
10	/	_	.	:	_	1	punct	_	_
11	min	_	NOUN	NN	_	18	nsubj	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	patients	_	NOUN	NNS	_	11	conj	_	_
14	with	_	ADP	IN	_	17	case	_	_
15	hepatic	_	ADJ	JJ	_	17	amod	_	_
16	functional	_	ADJ	JJ	_	17	amod	_	_
17	impairment	_	NOUN	NN	_	11	nmod	_	_
18	had	_	VERB	VBD	_	1	dep	_	_
19	about	_	ADV	RB	_	23	case	_	_
20	a	_	DET	DT	_	23	det	_	_
21	2	_	NUM	CD	_	22	compound	_	_
22	fold	_	NOUN	NN	_	23	amod	_	_
23	increase	_	NOUN	NN	_	18	nmod	_	_
24	in	_	ADP	IN	_	26	case	_	_
25	plasma	_	NOUN	NN	_	26	compound	_	_
26	concentrations	_	NOUN	NNS	_	23	nmod	_	_
27	AUC	_	NOUN	NN	_	26	dep	_	_
28	,	_	.	,	_	27	punct	_	_
29	Cmax	_	NOUN	NN	_	27	appos	_	_

#	Paroxetine	4198
1	The	_	DET	DT	_	3	det	_	_
2	initial	_	ADJ	JJ	_	3	amod	_	_
3	dosage	_	NOUN	NN	_	7	nsubjpass	_	_
4	should	_	VERB	MD	_	7	aux	_	_
5	therefore	_	ADV	RB	_	7	advmod	_	_
6	be	_	VERB	VB	_	7	auxpass	_	_
7	reduced	_	VERB	VBN	_	0	root	_	_
8	in	_	ADP	IN	_	9	case	_	_
9	patients	_	NOUN	NNS	_	7	nmod	_	_
10	with	_	ADP	IN	_	12	case	_	_
11	severe	_	ADJ	JJ	_	12	amod	_	_
12	renal	_	ADJ	JJ	_	9	nmod	_	_
13	or	_	CONJ	CC	_	12	cc	_	_
14	hepatic	_	ADJ	JJ	_	12	conj	_	_
15	impairment	_	NOUN	NN	_	12	dep	_	_
16	,	_	.	,	_	9	punct	_	_
17	and	_	CONJ	CC	_	9	cc	_	_
18	upward	_	NOUN	NN	_	19	compound	_	_
19	titration	_	NOUN	NN	_	9	conj	_	_
20	,	_	.	,	_	9	punct	_	_
21	if	_	ADP	IN	_	22	nsubj	_	_
22	necessary	_	ADJ	JJ	_	9	acl:relcl	_	_
23	,	_	.	,	_	7	punct	_	_
24	should	_	VERB	MD	_	28	aux	_	_
25	be	_	VERB	VB	_	28	cop	_	_
26	at	_	ADP	IN	_	28	case	_	_
27	increased	_	VERB	VBN	_	28	amod	_	_
28	intervals	_	NOUN	NNS	_	7	conj	_	_

#	Paroxetine	4199
1	Elderly	_	ADJ	JJ	_	2	amod	_	_
2	Patients	_	NOUN	NNS	_	29	nsubj	_	_
3	:	_	.	:	_	2	punct	_	_
4	In	_	ADP	IN	_	8	case	_	_
5	a	_	DET	DT	_	8	det	_	_
6	multiple	_	ADJ	JJ	_	8	amod	_	_
7	dose	_	NOUN	NN	_	8	compound	_	_
8	study	_	NOUN	NN	_	2	nmod	_	_
9	in	_	ADP	IN	_	11	case	_	_
10	the	_	DET	DT	_	11	det	_	_
11	elderly	_	ADJ	JJ	_	8	nmod	_	_
12	at	_	ADP	IN	_	15	case	_	_
13	daily	_	ADV	RB	_	15	advmod	_	_
14	DRUG	_	NOUN	NN	_	15	compound	_	_
15	doses	_	NOUN	NNS	_	11	nmod	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	20	_	NUM	CD	_	15	nmod	_	_
18	,	_	.	,	_	17	punct	_	_
19	30	_	NUM	CD	_	17	conj	_	_
20	,	_	.	,	_	17	punct	_	_
21	and	_	CONJ	CC	_	17	cc	_	_
22	40	_	NUM	CD	_	17	conj	_	_
23	mg	_	NOUN	NN	_	17	dep	_	_
24	,	_	.	,	_	2	punct	_	_
25	Cmin	_	NOUN	NN	_	26	compound	_	_
26	concentrations	_	NOUN	NNS	_	2	appos	_	_
27	were	_	VERB	VBD	_	29	cop	_	_
28	about	_	ADV	RB	_	29	advmod	_	_
29	70%	_	ADJ	JJ	_	0	root	_	_
30	to	_	PRT	TO	_	31	case	_	_
31	80%	_	ADJ	JJ	_	29	nmod	_	_
32	greater	_	ADJ	JJ	_	31	amod	_	_
33	than	_	ADP	IN	_	37	case	_	_
34	the	_	DET	DT	_	37	det	_	_
35	respective	_	ADJ	JJ	_	37	amod	_	_
36	Cmin	_	NOUN	NN	_	37	compound	_	_
37	concentrations	_	NOUN	NNS	_	32	nmod	_	_
38	in	_	ADP	IN	_	40	case	_	_
39	nonelderly	_	ADJ	JJ	_	40	amod	_	_
40	subjects	_	NOUN	NNS	_	37	nmod	_	_

#	Paroxetine	4200
1	Therefore	_	ADV	RB	_	10	advmod	_	_
2	the	_	DET	DT	_	4	det	_	_
3	initial	_	ADJ	JJ	_	4	amod	_	_
4	dosage	_	NOUN	NN	_	10	nsubjpass	_	_
5	in	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	elderly	_	NOUN	NN	_	4	nmod	_	_
8	should	_	VERB	MD	_	10	aux	_	_
9	be	_	VERB	VB	_	10	auxpass	_	_
10	reduced	_	VERB	VBN	_	0	root	_	_

#	Paroxetine	4201
1	Drug	_	NOUN	NN	_	3	compound	_	_
2	Drug	_	NOUN	NN	_	3	compound	_	_
3	Interactions	_	NOUN	NNS	_	9	nsubj	_	_
4	In	_	X	FW	_	8	amod	_	_
5	vitro	_	X	FW	_	4	dep	_	_
6	drug	_	NOUN	NN	_	8	compound	_	_
7	interaction	_	NOUN	NN	_	8	compound	_	_
8	studies	_	NOUN	NNS	_	3	nmod	_	_
9	reveal	_	VERB	VBP	_	0	root	_	_
10	that	_	ADP	IN	_	12	mark	_	_
11	DRUG	_	NOUN	NN	_	12	nsubj	_	_
12	inhibits	_	VERB	VBZ	_	9	ccomp	_	_
13	CYP2D6	_	NOUN	NN	_	12	dobj	_	_

#	Paroxetine	4202
1	Clinical	_	ADJ	JJ	_	4	amod	_	_
2	drug	_	NOUN	NN	_	4	compound	_	_
3	interaction	_	NOUN	NN	_	4	compound	_	_
4	studies	_	NOUN	NNS	_	7	nsubjpass	_	_
5	have	_	VERB	VBP	_	7	aux	_	_
6	been	_	VERB	VBN	_	7	auxpass	_	_
7	performed	_	VERB	VBN	_	0	root	_	_
8	with	_	ADP	IN	_	9	case	_	_
9	substrates	_	NOUN	NNS	_	7	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	CYP2D6	_	NOUN	NN	_	9	nmod	_	_
12	and	_	CONJ	CC	_	7	cc	_	_
13	show	_	VERB	VBP	_	7	conj	_	_
14	that	_	ADP	IN	_	17	mark	_	_
15	DRUG	_	NOUN	NN	_	17	nsubj	_	_
16	can	_	VERB	MD	_	17	aux	_	_
17	inhibit	_	VERB	VB	_	13	ccomp	_	_
18	the	_	DET	DT	_	19	det	_	_
19	metabolism	_	NOUN	NN	_	17	dobj	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	drugs	_	NOUN	NNS	_	19	nmod	_	_
22	metabolized	_	VERB	VBN	_	21	acl	_	_
23	by	_	ADP	IN	_	24	case	_	_
24	CYP2D6	_	NOUN	NN	_	22	nmod	_	_
25	including	_	ADP	IN	_	26	case	_	_
26	desipramine	_	NOUN	NN	_	24	nmod	_	_
27	,	_	.	,	_	26	punct	_	_
28	risperidone	_	NOUN	NN	_	26	conj	_	_
29	,	_	.	,	_	26	punct	_	_
30	and	_	CONJ	CC	_	26	cc	_	_
31	atomoxetine	_	NOUN	NN	_	26	conj	_	_

#	Paroxetine	4203
1	Major	_	ADJ	JJ	_	3	amod	_	_
2	Depressive	_	ADJ	JJ	_	3	amod	_	_
3	Disorder	_	NOUN	NN	_	17	nsubjpass	_	_
4	The	_	DET	DT	_	5	det	_	_
5	efficacy	_	NOUN	NN	_	3	dep	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	as	_	ADP	IN	_	10	case	_	_
9	a	_	DET	DT	_	10	det	_	_
10	treatment	_	NOUN	NN	_	3	nmod	_	_
11	for	_	ADP	IN	_	14	case	_	_
12	major	_	ADJ	JJ	_	14	amod	_	_
13	depressive	_	ADJ	JJ	_	14	amod	_	_
14	disorder	_	NOUN	NN	_	10	nmod	_	_
15	has	_	VERB	VBZ	_	17	aux	_	_
16	been	_	VERB	VBN	_	17	auxpass	_	_
17	established	_	VERB	VBN	_	0	root	_	_
18	in	_	ADP	IN	_	22	case	_	_
19	6	_	NUM	CD	_	20	nummod	_	_
20	placebo	_	NOUN	NN	_	22	amod	_	_
21	controlled	_	VERB	VBN	_	22	amod	_	_
22	studies	_	NOUN	NNS	_	17	nmod	_	_
23	of	_	ADP	IN	_	24	case	_	_
24	patients	_	NOUN	NNS	_	22	nmod	_	_
25	with	_	ADP	IN	_	28	case	_	_
26	major	_	ADJ	JJ	_	28	amod	_	_
27	depressive	_	ADJ	JJ	_	28	amod	_	_
28	disorder	_	NOUN	NN	_	24	nmod	_	_
29	aged	_	ADJ	JJ	_	28	amod	_	_
30	18	_	NUM	CD	_	32	compound	_	_
31	to	_	PRT	TO	_	32	dep	_	_
32	73	_	NUM	CD	_	29	nmod	_	_

#	Paroxetine	4204
1	In	_	ADP	IN	_	3	case	_	_
2	these	_	DET	DT	_	3	det	_	_
3	studies	_	NOUN	NNS	_	7	nmod	_	_
4	,	_	.	,	_	7	punct	_	_
5	DRUG	_	NOUN	NN	_	7	nsubjpass	_	_
6	was	_	VERB	VBD	_	7	auxpass	_	_
7	shown	_	VERB	VBN	_	0	root	_	_
8	to	_	PRT	TO	_	12	mark	_	_
9	be	_	VERB	VB	_	12	cop	_	_
10	significantly	_	ADV	RB	_	12	advmod	_	_
11	more	_	ADV	RB	_	12	advmod	_	_
12	effective	_	ADJ	JJ	_	7	xcomp	_	_
13	than	_	ADP	IN	_	14	case	_	_
14	placebo	_	NOUN	NN	_	12	nmod	_	_
15	in	_	ADP	IN	_	16	mark	_	_
16	treating	_	VERB	VBG	_	12	advcl	_	_
17	major	_	ADJ	JJ	_	19	amod	_	_
18	depressive	_	ADJ	JJ	_	19	amod	_	_
19	disorder	_	NOUN	NN	_	16	dobj	_	_
20	by	_	ADP	IN	_	22	case	_	_
21	at	_	ADP	IN	_	22	case	_	_
22	least	_	ADJ	JJS	_	16	nmod	_	_
23	2	_	NUM	CD	_	22	nummod	_	_
24	of	_	ADP	IN	_	27	case	_	_
25	the	_	DET	DT	_	27	det	_	_
26	following	_	VERB	VBG	_	27	amod	_	_
27	measures	_	NOUN	NNS	_	22	nmod	_	_
28	:	_	.	:	_	7	punct	_	_
29	Hamilton	_	NOUN	NN	_	30	compound	_	_
30	Depression	_	NOUN	NN	_	7	dep	_	_
31	Rating	_	VERB	VBG	_	30	acl	_	_
32	Scale	_	NOUN	NN	_	33	compound	_	_
33	HDRS	_	NOUN	NN	_	31	dobj	_	_
34	,	_	.	,	_	30	punct	_	_
35	the	_	DET	DT	_	36	det	_	_
36	Hamilton	_	NOUN	NN	_	37	nsubj	_	_
37	depressed	_	VERB	VBD	_	30	conj	_	_
38	mood	_	NOUN	NN	_	39	compound	_	_
39	item	_	NOUN	NN	_	37	dobj	_	_
40	,	_	.	,	_	30	punct	_	_
41	and	_	CONJ	CC	_	30	cc	_	_
42	the	_	DET	DT	_	47	det	_	_
43	Clinical	_	ADJ	JJ	_	47	amod	_	_
44	Global	_	ADJ	JJ	_	47	amod	_	_
45	Impression	_	NOUN	NN	_	47	compound	_	_
46	CGI	_	NOUN	NN	_	47	compound	_	_
47	Severity	_	NOUN	NN	_	30	conj	_	_
48	of	_	ADP	IN	_	49	case	_	_
49	Illness	_	NOUN	NN	_	47	nmod	_	_

#	Paroxetine	4205
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	was	_	VERB	VBD	_	4	cop	_	_
3	significantly	_	ADV	RB	_	4	advmod	_	_
4	better	_	ADV	RB	_	0	root	_	_
5	than	_	ADP	IN	_	6	case	_	_
6	placebo	_	NOUN	NN	_	4	nmod	_	_
7	in	_	ADP	IN	_	8	case	_	_
8	improvement	_	NOUN	NN	_	4	nmod	_	_
9	of	_	ADP	IN	_	14	case	_	_
10	the	_	DET	DT	_	14	det	_	_
11	HDRS	_	NOUN	NN	_	14	compound	_	_
12	sub	_	NOUN	NN	_	14	compound	_	_
13	factor	_	NOUN	NN	_	14	compound	_	_
14	scores	_	NOUN	NNS	_	8	nmod	_	_
15	,	_	.	,	_	14	punct	_	_
16	including	_	VERB	VBG	_	20	case	_	_
17	the	_	DET	DT	_	20	det	_	_
18	depressed	_	VERB	VBN	_	20	amod	_	_
19	mood	_	NOUN	NN	_	20	compound	_	_
20	item	_	NOUN	NN	_	14	nmod	_	_
21	,	_	.	,	_	20	punct	_	_
22	sleep	_	NOUN	NN	_	24	compound	_	_
23	disturbance	_	NOUN	NN	_	24	compound	_	_
24	factor	_	NOUN	NN	_	20	conj	_	_
25	,	_	.	,	_	20	punct	_	_
26	and	_	CONJ	CC	_	20	cc	_	_
27	anxiety	_	NOUN	NN	_	28	compound	_	_
28	factor	_	NOUN	NN	_	20	conj	_	_

#	Paroxetine	4206
1	A	_	DET	DT	_	2	det	_	_
2	study	_	NOUN	NN	_	39	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	outpatients	_	NOUN	NNS	_	2	nmod	_	_
5	with	_	ADP	IN	_	8	case	_	_
6	major	_	ADJ	JJ	_	8	amod	_	_
7	depressive	_	ADJ	JJ	_	8	amod	_	_
8	disorder	_	NOUN	NN	_	4	nmod	_	_
9	who	_	DET	WDT	_	11	nsubj	_	_
10	had	_	VERB	MD	_	11	aux	_	_
11	responded	_	VERB	VBN	_	8	acl:relcl	_	_
12	to	_	PRT	TO	_	16	case	_	_
13	DRUG	_	NOUN	NN	_	16	compound	_	_
14	HDRS	_	NOUN	NN	_	16	compound	_	_
15	total	_	ADJ	JJ	_	16	amod	_	_
16	score	_	NOUN	NN	_	11	nmod	_	_
17	<8	_	NUM	CD	_	16	nummod	_	_
18	during	_	ADP	IN	_	25	case	_	_
19	an	_	DET	DT	_	25	det	_	_
20	initial	_	ADJ	JJ	_	25	amod	_	_
21	8	_	NUM	CD	_	25	nummod	_	_
22	week	_	NOUN	NN	_	25	compound	_	_
23	open	_	ADJ	JJ	_	25	amod	_	_
24	treatment	_	NOUN	NN	_	25	compound	_	_
25	phase	_	NOUN	NN	_	11	nmod	_	_
26	and	_	CONJ	CC	_	11	cc	_	_
27	were	_	VERB	VBD	_	29	auxpass	_	_
28	then	_	ADV	RB	_	29	advmod	_	_
29	randomized	_	VERB	VBN	_	11	conj	_	_
30	to	_	PRT	TO	_	31	case	_	_
31	continuation	_	NOUN	NN	_	29	nmod	_	_
32	on	_	ADP	IN	_	33	case	_	_
33	DRUG	_	NOUN	NN	_	31	nmod	_	_
34	or	_	CONJ	CC	_	33	cc	_	_
35	placebo	_	NOUN	NN	_	33	conj	_	_
36	for	_	ADP	IN	_	38	case	_	_
37	1	_	NUM	CD	_	38	nummod	_	_
38	year	_	NOUN	NN	_	31	nmod	_	_
39	demonstrated	_	VERB	VBD	_	0	root	_	_
40	a	_	DET	DT	_	44	det	_	_
41	significantly	_	ADV	RB	_	42	advmod	_	_
42	lower	_	ADJ	JJ	_	44	amod	_	_
43	relapse	_	NOUN	NN	_	44	compound	_	_
44	rate	_	NOUN	NN	_	39	dobj	_	_
45	for	_	ADP	IN	_	46	case	_	_
46	patients	_	NOUN	NNS	_	44	nmod	_	_
47	taking	_	VERB	VBG	_	46	acl	_	_
48	DRUG	_	NOUN	NN	_	49	compound	_	_
49	15%	_	NOUN	NN	_	47	dobj	_	_
50	compared	_	VERB	VBN	_	39	xcomp	_	_
51	to	_	PRT	TO	_	52	case	_	_
52	those	_	DET	DT	_	50	nmod	_	_
53	on	_	ADP	IN	_	55	case	_	_
54	placebo	_	NOUN	NN	_	55	compound	_	_
55	39%	_	ADJ	JJ	_	52	nmod	_	_

#	Paroxetine	4207
1	Effectiveness	_	NOUN	NN	_	3	nsubj	_	_
2	was	_	VERB	VBD	_	3	cop	_	_
3	similar	_	ADJ	JJ	_	0	root	_	_
4	for	_	ADP	IN	_	8	case	_	_
5	male	_	ADJ	JJ	_	8	amod	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	female	_	ADJ	JJ	_	5	conj	_	_
8	patients	_	NOUN	NNS	_	3	nmod	_	_

#	Paroxetine	4208
1	Obsessive	_	ADJ	JJ	_	3	amod	_	_
2	Compulsive	_	ADJ	JJ	_	3	amod	_	_
3	Disorder	_	NOUN	NN	_	17	nsubjpass	_	_
4	The	_	DET	DT	_	5	det	_	_
5	effectiveness	_	NOUN	NN	_	3	dep	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	in	_	ADP	IN	_	10	case	_	_
9	the	_	DET	DT	_	10	det	_	_
10	treatment	_	NOUN	NN	_	5	nmod	_	_
11	of	_	ADP	IN	_	15	case	_	_
12	obsessive	_	ADJ	JJ	_	15	amod	_	_
13	compulsive	_	ADJ	JJ	_	15	amod	_	_
14	disorder	_	NOUN	NN	_	15	compound	_	_
15	OCD	_	NOUN	NN	_	10	nmod	_	_
16	was	_	VERB	VBD	_	17	auxpass	_	_
17	demonstrated	_	VERB	VBN	_	0	root	_	_
18	in	_	ADP	IN	_	23	case	_	_
19	two	_	NUM	CD	_	23	nummod	_	_
20	12	_	NUM	CD	_	23	nummod	_	_
21	week	_	NOUN	NN	_	23	compound	_	_
22	multicenter	_	ADJ	JJ	_	23	amod	_	_
23	placebo	_	NOUN	NN	_	17	nmod	_	_
24	controlled	_	VERB	VBN	_	25	amod	_	_
25	studies	_	NOUN	NNS	_	17	nmod	_	_
26	of	_	ADP	IN	_	28	case	_	_
27	adult	_	ADJ	JJ	_	28	amod	_	_
28	outpatients	_	NOUN	NNS	_	25	nmod	_	_
29	Studies	_	NOUN	NNS	_	28	dep	_	_
30	1	_	NUM	CD	_	29	punct	_	_
31	and	_	CONJ	CC	_	30	cc	_	_
32	2	_	NUM	CD	_	30	conj	_	_

#	Paroxetine	4209
1	Patients	_	NOUN	NNS	_	6	nsubj	_	_
2	in	_	ADP	IN	_	4	case	_	_
3	all	_	DET	DT	_	4	det	_	_
4	studies	_	NOUN	NNS	_	1	nmod	_	_
5	had	_	VERB	VBD	_	6	aux	_	_
6	moderate	_	ADJ	JJ	_	0	root	_	_
7	to	_	PRT	TO	_	11	case	_	_
8	severe	_	ADJ	JJ	_	11	amod	_	_
9	OCD	_	NOUN	NN	_	11	compound	_	_
10	DSM	_	NOUN	NN	_	11	compound	_	_
11	IIIR	_	NOUN	NN	_	6	nmod	_	_
12	with	_	ADP	IN	_	15	case	_	_
13	mean	_	ADJ	JJ	_	15	amod	_	_
14	baseline	_	NOUN	NN	_	15	compound	_	_
15	ratings	_	NOUN	NNS	_	6	nmod	_	_
16	on	_	ADP	IN	_	25	case	_	_
17	the	_	DET	DT	_	25	det	_	_
18	Yale	_	NOUN	NN	_	25	compound	_	_
19	Brown	_	VERB	VBN	_	25	amod	_	_
20	Obsessive	_	ADJ	JJ	_	25	amod	_	_
21	Compulsive	_	ADJ	JJ	_	25	amod	_	_
22	Scale	_	NOUN	NN	_	25	compound	_	_
23	YBOCS	_	NOUN	NN	_	25	compound	_	_
24	total	_	ADJ	JJ	_	25	amod	_	_
25	score	_	NOUN	NN	_	15	nmod	_	_
26	ranging	_	VERB	VBG	_	25	acl	_	_
27	from	_	ADP	IN	_	30	case	_	_
28	23	_	NUM	CD	_	30	compound	_	_
29	to	_	PRT	TO	_	30	dep	_	_
30	26	_	NUM	CD	_	26	nmod	_	_

#	Paroxetine	4210
1	Study	_	NOUN	NN	_	0	root	_	_
2	1	_	NUM	CD	_	1	nummod	_	_
3	,	_	.	,	_	1	punct	_	_
4	a	_	DET	DT	_	8	det	_	_
5	dose	_	NOUN	NN	_	8	compound	_	_
6	range	_	NOUN	NN	_	8	compound	_	_
7	finding	_	NOUN	NN	_	8	compound	_	_
8	study	_	NOUN	NN	_	1	appos	_	_
9	where	_	ADV	WRB	_	12	advmod	_	_
10	patients	_	NOUN	NNS	_	12	nsubjpass	_	_
11	were	_	VERB	VBD	_	12	auxpass	_	_
12	treated	_	VERB	VBN	_	8	acl:relcl	_	_
13	with	_	ADP	IN	_	15	case	_	_
14	fixed	_	VERB	VBN	_	15	amod	_	_
15	doses	_	NOUN	NNS	_	12	nmod	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	20	_	NUM	CD	_	15	nmod	_	_
18	,	_	.	,	_	17	punct	_	_
19	40	_	NUM	CD	_	17	conj	_	_
20	,	_	.	,	_	17	punct	_	_
21	or	_	CONJ	CC	_	17	cc	_	_
22	60	_	NUM	CD	_	17	conj	_	_
23	mg	_	NOUN	NN	_	17	dep	_	_
24	of	_	ADP	IN	_	25	case	_	_
25	DRUG	_	NOUN	NN	_	17	nmod	_	_
26	/	_	.	:	_	1	punct	_	_
27	day	_	NOUN	NN	_	28	nsubj	_	_
28	demonstrated	_	VERB	VBD	_	1	dep	_	_
29	that	_	ADP	IN	_	39	mark	_	_
30	daily	_	ADV	RB	_	31	amod	_	_
31	doses	_	NOUN	NNS	_	39	nsubj	_	_
32	of	_	ADP	IN	_	33	case	_	_
33	DRUG	_	NOUN	NN	_	31	nmod	_	_
34	40	_	NUM	CD	_	33	nummod	_	_
35	and	_	CONJ	CC	_	33	cc	_	_
36	60	_	NUM	CD	_	37	nummod	_	_
37	mg	_	NOUN	NN	_	33	conj	_	_
38	are	_	VERB	VBP	_	39	cop	_	_
39	effective	_	ADJ	JJ	_	28	ccomp	_	_
40	in	_	ADP	IN	_	42	case	_	_
41	the	_	DET	DT	_	42	det	_	_
42	treatment	_	NOUN	NN	_	39	nmod	_	_
43	of	_	ADP	IN	_	44	case	_	_
44	OCD	_	NOUN	NN	_	42	nmod	_	_

#	Paroxetine	4211
1	Patients	_	NOUN	NNS	_	10	nsubj	_	_
2	receiving	_	VERB	VBG	_	1	acl	_	_
3	doses	_	NOUN	NNS	_	2	dobj	_	_
4	of	_	ADP	IN	_	9	case	_	_
5	40	_	NUM	CD	_	9	nummod	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	60	_	NUM	CD	_	5	conj	_	_
8	mg	_	NOUN	NN	_	9	compound	_	_
9	DRUG	_	NOUN	NN	_	3	nmod	_	_
10	experienced	_	VERB	VBD	_	0	root	_	_
11	a	_	DET	DT	_	13	det	_	_
12	mean	_	ADJ	JJ	_	13	amod	_	_
13	reduction	_	NOUN	NN	_	10	dobj	_	_
14	of	_	ADP	IN	_	19	case	_	_
15	approximately	_	ADV	RB	_	16	advmod	_	_
16	6	_	NUM	CD	_	19	nummod	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	7	_	NUM	CD	_	16	conj	_	_
19	points	_	NOUN	NNS	_	13	nmod	_	_
20	,	_	.	,	_	13	punct	_	_
21	respectively	_	ADV	RB	_	13	advmod	_	_
22	,	_	.	,	_	13	punct	_	_
23	on	_	ADP	IN	_	27	case	_	_
24	the	_	DET	DT	_	27	det	_	_
25	YBOCS	_	NOUN	NN	_	27	compound	_	_
26	total	_	ADJ	JJ	_	27	amod	_	_
27	score	_	NOUN	NN	_	13	nmod	_	_
28	which	_	DET	WDT	_	31	nsubj	_	_
29	was	_	VERB	VBD	_	31	cop	_	_
30	significantly	_	ADV	RB	_	31	advmod	_	_
31	greater	_	ADJ	JJ	_	27	acl:relcl	_	_
32	than	_	ADP	IN	_	37	case	_	_
33	the	_	DET	DT	_	37	det	_	_
34	approximate	_	ADJ	JJ	_	37	amod	_	_
35	4	_	NUM	CD	_	37	nummod	_	_
36	point	_	NOUN	NN	_	37	compound	_	_
37	reduction	_	NOUN	NN	_	31	nmod	_	_
38	at	_	ADP	IN	_	40	case	_	_
39	20	_	NUM	CD	_	40	nummod	_	_
40	mg	_	NOUN	NN	_	31	nmod	_	_
41	and	_	CONJ	CC	_	31	cc	_	_
42	a	_	DET	DT	_	45	det	_	_
43	3	_	NUM	CD	_	45	nummod	_	_
44	point	_	NOUN	NN	_	45	compound	_	_
45	reduction	_	NOUN	NN	_	31	conj	_	_
46	in	_	ADP	IN	_	50	case	_	_
47	the	_	DET	DT	_	50	det	_	_
48	placebo	_	NOUN	NN	_	50	compound	_	_
49	treated	_	ADJ	JJ	_	50	amod	_	_
50	patients	_	NOUN	NNS	_	45	nmod	_	_

#	Paroxetine	4212
1	Study	_	NOUN	NN	_	7	nsubj	_	_
2	2	_	NUM	CD	_	1	nummod	_	_
3	was	_	VERB	VBD	_	7	cop	_	_
4	a	_	DET	DT	_	7	det	_	_
5	flexible	_	ADJ	JJ	_	7	amod	_	_
6	dose	_	NOUN	NN	_	7	compound	_	_
7	study	_	NOUN	NN	_	0	root	_	_
8	comparing	_	VERB	VBG	_	7	acl	_	_
9	DRUG	_	NOUN	NN	_	13	compound	_	_
10	20	_	NUM	CD	_	12	compound	_	_
11	to	_	PRT	TO	_	12	dep	_	_
12	60	_	NUM	CD	_	13	nummod	_	_
13	mg	_	NOUN	NN	_	8	dobj	_	_
14	daily	_	ADV	RB	_	8	advmod	_	_
15	with	_	ADP	IN	_	16	case	_	_
16	clomipramine	_	NOUN	NN	_	8	nmod	_	_
17	25	_	NUM	CD	_	16	nummod	_	_
18	to	_	PRT	TO	_	20	case	_	_
19	250	_	NUM	CD	_	20	nummod	_	_
20	mg	_	NOUN	NN	_	8	nmod	_	_
21	daily	_	ADV	RB	_	7	neg	_	_

#	Paroxetine	4213
1	In	_	ADP	IN	_	3	case	_	_
2	this	_	DET	DT	_	3	det	_	_
3	study	_	NOUN	NN	_	8	nmod	_	_
4	,	_	.	,	_	8	punct	_	_
5	patients	_	NOUN	NNS	_	8	nsubj	_	_
6	receiving	_	VERB	VBG	_	5	acl	_	_
7	DRUG	_	NOUN	NN	_	6	dobj	_	_
8	experienced	_	VERB	VBD	_	0	root	_	_
9	a	_	DET	DT	_	11	det	_	_
10	mean	_	ADJ	JJ	_	11	amod	_	_
11	reduction	_	NOUN	NN	_	8	dobj	_	_
12	of	_	ADP	IN	_	15	case	_	_
13	approximately	_	ADV	RB	_	14	advmod	_	_
14	7	_	NUM	CD	_	15	nummod	_	_
15	points	_	NOUN	NNS	_	11	nmod	_	_
16	on	_	ADP	IN	_	20	case	_	_
17	the	_	DET	DT	_	20	det	_	_
18	YBOCS	_	NOUN	NN	_	20	compound	_	_
19	total	_	ADJ	JJ	_	20	amod	_	_
20	score	_	NOUN	NN	_	11	nmod	_	_
21	,	_	.	,	_	20	punct	_	_
22	which	_	DET	WDT	_	25	nsubj	_	_
23	was	_	VERB	VBD	_	25	cop	_	_
24	significantly	_	ADV	RB	_	25	advmod	_	_
25	greater	_	ADJ	JJ	_	20	acl:relcl	_	_
26	than	_	ADP	IN	_	29	case	_	_
27	the	_	DET	DT	_	29	det	_	_
28	mean	_	NOUN	NN	_	29	amod	_	_
29	reduction	_	NOUN	NN	_	25	nmod	_	_
30	of	_	ADP	IN	_	33	case	_	_
31	approximately	_	ADV	RB	_	32	advmod	_	_
32	4	_	NUM	CD	_	33	nummod	_	_
33	points	_	NOUN	NNS	_	29	nmod	_	_
34	in	_	ADP	IN	_	37	case	_	_
35	placebo	_	NOUN	NN	_	37	compound	_	_
36	treated	_	ADJ	JJ	_	37	amod	_	_
37	patients	_	NOUN	NNS	_	29	nmod	_	_

#	Paroxetine	4214
1	The	_	DET	DT	_	3	det	_	_
2	following	_	VERB	VBG	_	3	amod	_	_
3	table	_	ADJ	JJ	_	4	nsubj	_	_
4	provides	_	VERB	VBZ	_	0	root	_	_
5	the	_	DET	DT	_	7	det	_	_
6	outcome	_	NOUN	NN	_	7	compound	_	_
7	classification	_	NOUN	NN	_	4	dobj	_	_
8	by	_	ADP	IN	_	10	case	_	_
9	treatment	_	NOUN	NN	_	10	compound	_	_
10	group	_	NOUN	NN	_	7	nmod	_	_
11	on	_	ADP	IN	_	14	case	_	_
12	Global	_	ADJ	JJ	_	14	amod	_	_
13	Improvement	_	NOUN	NN	_	14	compound	_	_
14	items	_	NOUN	NNS	_	7	nmod	_	_
15	of	_	ADP	IN	_	21	case	_	_
16	the	_	DET	DT	_	21	det	_	_
17	Clinical	_	ADJ	JJ	_	21	amod	_	_
18	Global	_	ADJ	JJ	_	21	amod	_	_
19	Impression	_	NOUN	NN	_	21	compound	_	_
20	CGI	_	NOUN	NN	_	21	compound	_	_
21	scale	_	NOUN	NN	_	14	nmod	_	_
22	for	_	ADP	IN	_	23	case	_	_
23	Study	_	NOUN	NN	_	21	nmod	_	_
24	1	_	NUM	CD	_	23	nummod	_	_

#	Paroxetine	4215
1	Outcome	_	NOUN	NN	_	3	compound	_	_
2	Classification	_	NOUN	NN	_	3	compound	_	_
3	%	_	NOUN	NN	_	17	nsubj	_	_
4	on	_	ADP	IN	_	8	case	_	_
5	CGI	_	NOUN	NN	_	8	compound	_	_
6	Global	_	ADJ	JJ	_	8	amod	_	_
7	Improvement	_	NOUN	NN	_	8	compound	_	_
8	Item	_	NOUN	NN	_	3	nmod	_	_
9	for	_	ADP	IN	_	10	case	_	_
10	Completers	_	NOUN	NNS	_	8	nmod	_	_
11	in	_	ADP	IN	_	16	case	_	_
12	Study	_	NOUN	NN	_	16	compound	_	_
13	1	_	NUM	CD	_	16	nummod	_	_
14	Outcome	_	NOUN	NN	_	16	compound	_	_
15	Classification	_	NOUN	NN	_	16	compound	_	_
16	Placebo(n	_	NOUN	NN	_	10	nmod	_	_
17	=	_	ADJ	JJ	_	68	aux	_	_
18	74	_	NUM	CD	_	21	nummod	_	_
19	DRUG	_	NOUN	NN	_	21	compound	_	_
20	20	_	NUM	CD	_	21	nummod	_	_
21	mg(n	_	NOUN	NN	_	65	compound	_	_
22	=	_	ADJ	JJ	_	65	amod	_	_
23	75	_	NUM	CD	_	26	nummod	_	_
24	DRUG	_	NOUN	NN	_	26	compound	_	_
25	40	_	NUM	CD	_	26	nummod	_	_
26	mg(n	_	NOUN	NN	_	65	compound	_	_
27	=	_	ADJ	JJ	_	44	amod	_	_
28	66	_	NUM	CD	_	44	nummod	_	_
29	DRUG	_	NOUN	NN	_	44	compound	_	_
30	60	_	NUM	CD	_	44	nummod	_	_
31	mg(n	_	NOUN	NN	_	44	compound	_	_
32	=	_	ADJ	JJ	_	44	amod	_	_
33	66	_	NUM	CD	_	44	nummod	_	_
34	Worse	_	NOUN	NN	_	44	compound	_	_
35	14%	_	ADJ	JJ	_	44	amod	_	_
36	7%	_	ADJ	JJ	_	44	amod	_	_
37	7%	_	ADJ	JJ	_	44	amod	_	_
38	3%	_	ADJ	JJ	_	44	amod	_	_
39	No	_	NOUN	NN	_	44	compound	_	_
40	Change	_	NOUN	NN	_	44	compound	_	_
41	44%	_	ADJ	JJ	_	44	amod	_	_
42	35%	_	ADJ	JJ	_	44	amod	_	_
43	22%	_	ADJ	JJ	_	44	amod	_	_
44	19%	_	ADJ	JJ	_	46	nsubj	_	_
45	Minimally	_	ADV	RB	_	46	advmod	_	_
46	Improved	_	VERB	VBN	_	57	amod	_	_
47	24%	_	ADJ	JJ	_	57	amod	_	_
48	33%	_	ADJ	JJ	_	57	amod	_	_
49	29%	_	ADJ	JJ	_	57	amod	_	_
50	34%	_	ADJ	JJ	_	57	amod	_	_
51	Much	_	ADJ	JJ	_	57	amod	_	_
52	Improved	_	VERB	VBN	_	57	amod	_	_
53	11%	_	ADJ	JJ	_	57	amod	_	_
54	18%	_	ADJ	JJ	_	57	amod	_	_
55	22%	_	ADJ	JJ	_	57	amod	_	_
56	24%	_	ADJ	JJ	_	57	amod	_	_
57	Very	_	NOUN	NN	_	65	compound	_	_
58	Much	_	ADJ	JJ	_	59	advmod	_	_
59	Improved	_	VERB	VBN	_	65	amod	_	_
60	7%	_	ADJ	JJ	_	65	amod	_	_
61	7%	_	ADJ	JJ	_	65	amod	_	_
62	20%	_	ADJ	JJ	_	65	amod	_	_
63	20%	_	ADJ	JJ	_	65	amod	_	_
64	Subgroup	_	NOUN	NN	_	65	compound	_	_
65	analyses	_	NOUN	NNS	_	17	dobj	_	_
66	did	_	VERB	MD	_	68	aux	_	_
67	not	_	ADV	RB	_	68	neg	_	_
68	indicate	_	VERB	VB	_	0	root	_	_
69	that	_	ADP	IN	_	71	mark	_	_
70	there	_	DET	EX	_	71	expl	_	_
71	were	_	VERB	VBD	_	68	root	_	_
72	any	_	DET	DT	_	73	det	_	_
73	differences	_	NOUN	NNS	_	71	nsubj	_	_
74	in	_	ADP	IN	_	76	case	_	_
75	treatment	_	NOUN	NN	_	76	compound	_	_
76	outcomes	_	NOUN	NNS	_	73	nmod	_	_
77	as	_	ADP	IN	_	79	case	_	_
78	a	_	DET	DT	_	79	det	_	_
79	function	_	NOUN	NN	_	71	nmod	_	_
80	of	_	ADP	IN	_	81	case	_	_
81	age	_	NOUN	NN	_	79	nmod	_	_
82	or	_	CONJ	CC	_	71	cc	_	_
83	gender	_	NOUN	NN	_	71	conj	_	_

#	Paroxetine	4216
1	The	_	DET	DT	_	5	det	_	_
2	long	_	ADJ	JJ	_	5	amod	_	_
3	term	_	NOUN	NN	_	5	compound	_	_
4	maintenance	_	NOUN	NN	_	5	compound	_	_
5	effects	_	NOUN	NNS	_	11	nsubjpass	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	in	_	ADP	IN	_	9	case	_	_
9	OCD	_	NOUN	NN	_	5	nmod	_	_
10	were	_	VERB	VBD	_	11	auxpass	_	_
11	demonstrated	_	VERB	VBN	_	0	root	_	_
12	in	_	ADP	IN	_	16	case	_	_
13	a	_	DET	DT	_	16	det	_	_
14	long	_	ADJ	JJ	_	16	amod	_	_
15	term	_	NOUN	NN	_	16	compound	_	_
16	extension	_	NOUN	NN	_	11	nmod	_	_
17	to	_	PRT	TO	_	18	case	_	_
18	Study	_	NOUN	NN	_	16	nmod	_	_
19	1	_	NUM	CD	_	18	nummod	_	_

#	Paroxetine	4217
1	Patients	_	NOUN	NNS	_	0	root	_	_
2	who	_	DET	WDT	_	4	nsubj	_	_
3	were	_	VERB	VBD	_	4	cop	_	_
4	responders	_	NOUN	NNS	_	1	nmod	_	_
5	on	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	during	_	ADP	IN	_	13	case	_	_
8	the	_	DET	DT	_	13	det	_	_
9	3	_	NUM	CD	_	13	nummod	_	_
10	month	_	NOUN	NN	_	13	compound	_	_
11	double	_	ADJ	JJ	_	13	amod	_	_
12	blind	_	NOUN	NN	_	13	compound	_	_
13	phase	_	NOUN	NN	_	4	nmod	_	_
14	and	_	CONJ	CC	_	4	cc	_	_
15	a	_	DET	DT	_	18	det	_	_
16	6	_	NUM	CD	_	18	nummod	_	_
17	month	_	NOUN	NN	_	18	compound	_	_
18	extension	_	NOUN	NN	_	30	nsubjpass	_	_
19	on	_	ADP	IN	_	22	case	_	_
20	open	_	ADJ	JJ	_	22	amod	_	_
21	label	_	NOUN	NN	_	22	compound	_	_
22	DRUG	_	NOUN	NN	_	18	nmod	_	_
23	20	_	NUM	CD	_	22	nummod	_	_
24	to	_	PRT	TO	_	28	case	_	_
25	60	_	NUM	CD	_	26	nummod	_	_
26	mg	_	NOUN	NN	_	28	amod	_	_
27	/	_	.	:	_	28	punct	_	_
28	day	_	NOUN	NN	_	18	nmod	_	_
29	were	_	VERB	VBD	_	30	auxpass	_	_
30	randomized	_	VERB	VBN	_	4	conj	_	_
31	to	_	PRT	TO	_	33	case	_	_
32	either	_	CONJ	CC	_	33	cc:preconj	_	_
33	DRUG	_	NOUN	NN	_	30	nmod	_	_
34	or	_	CONJ	CC	_	33	cc	_	_
35	placebo	_	NOUN	NN	_	33	conj	_	_
36	in	_	ADP	IN	_	44	case	_	_
37	a	_	DET	DT	_	44	det	_	_
38	6	_	NUM	CD	_	44	nummod	_	_
39	month	_	NOUN	NN	_	44	compound	_	_
40	double	_	ADJ	JJ	_	44	amod	_	_
41	blind	_	NOUN	NN	_	44	compound	_	_
42	relapse	_	NOUN	NN	_	44	compound	_	_
43	prevention	_	NOUN	NN	_	44	compound	_	_
44	phase	_	NOUN	NN	_	30	nmod	_	_

#	Paroxetine	4218
1	Patients	_	NOUN	NNS	_	8	nsubj	_	_
2	randomized	_	VERB	VBN	_	1	acl	_	_
3	to	_	PRT	TO	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	were	_	VERB	VBD	_	8	cop	_	_
6	significantly	_	ADV	RB	_	8	advmod	_	_
7	less	_	ADV	RB	_	8	advmod	_	_
8	likely	_	ADJ	JJ	_	0	root	_	_
9	to	_	PRT	TO	_	10	mark	_	_
10	relapse	_	ADJ	JJ	_	8	xcomp	_	_
11	than	_	ADP	IN	_	14	case	_	_
12	comparably	_	ADV	RB	_	13	advmod	_	_
13	treated	_	VERB	VBN	_	14	amod	_	_
14	patients	_	NOUN	NNS	_	10	nmod	_	_
15	who	_	DET	WDT	_	17	nsubjpass	_	_
16	were	_	VERB	VBD	_	17	auxpass	_	_
17	randomized	_	VERB	VBN	_	14	acl:relcl	_	_
18	to	_	PRT	TO	_	19	case	_	_
19	placebo	_	NOUN	NN	_	17	nmod	_	_

#	Paroxetine	4219
1	Panic	_	ADJ	JJ	_	2	amod	_	_
2	Disorder	_	NOUN	NN	_	14	nsubjpass	_	_
3	The	_	DET	DT	_	4	det	_	_
4	effectiveness	_	NOUN	NN	_	2	dep	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	in	_	ADP	IN	_	9	case	_	_
8	the	_	DET	DT	_	9	det	_	_
9	treatment	_	NOUN	NN	_	4	nmod	_	_
10	of	_	ADP	IN	_	12	case	_	_
11	panic	_	ADJ	JJ	_	12	amod	_	_
12	disorder	_	NOUN	NN	_	9	nmod	_	_
13	was	_	VERB	VBD	_	14	auxpass	_	_
14	demonstrated	_	VERB	VBN	_	0	root	_	_
15	in	_	ADP	IN	_	21	case	_	_
16	three	_	NUM	CD	_	17	nummod	_	_
17	10	_	NUM	CD	_	19	compound	_	_
18	to	_	PRT	TO	_	19	dep	_	_
19	12	_	NUM	CD	_	21	nummod	_	_
20	week	_	NOUN	NN	_	21	compound	_	_
21	multicenter	_	NOUN	NN	_	14	nmod	_	_
22	,	_	.	,	_	14	punct	_	_
23	placebo	_	NOUN	NN	_	24	nsubj	_	_
24	controlled	_	VERB	VBD	_	14	parataxis	_	_
25	studies	_	NOUN	NNS	_	24	dobj	_	_
26	of	_	ADP	IN	_	29	case	_	_
27	adult	_	ADJ	JJ	_	29	amod	_	_
28	outpatients	_	NOUN	NNS	_	29	compound	_	_
29	Studies	_	NOUN	NNS	_	25	nmod	_	_
30	1	_	NUM	CD	_	32	compound	_	_
31	to	_	PRT	TO	_	32	dep	_	_
32	3	_	NUM	CD	_	29	nummod	_	_

#	Paroxetine	4220
1	Patients	_	NOUN	NNS	_	5	nsubj	_	_
2	in	_	ADP	IN	_	4	case	_	_
3	all	_	DET	DT	_	4	det	_	_
4	studies	_	NOUN	NNS	_	1	nmod	_	_
5	had	_	VERB	VBD	_	0	root	_	_
6	panic	_	ADJ	JJ	_	9	amod	_	_
7	disorder	_	NOUN	NN	_	9	compound	_	_
8	DSM	_	NOUN	NN	_	9	compound	_	_
9	IIIR	_	NOUN	NN	_	5	dobj	_	_
10	,	_	.	,	_	9	punct	_	_
11	with	_	ADP	IN	_	9	dep	_	_
12	or	_	CONJ	CC	_	11	cc	_	_
13	without	_	ADP	IN	_	14	case	_	_
14	agoraphobia	_	NOUN	NN	_	11	conj	_	_

#	Paroxetine	4221
1	In	_	ADP	IN	_	3	case	_	_
2	these	_	DET	DT	_	3	det	_	_
3	studies	_	NOUN	NNS	_	7	nmod	_	_
4	,	_	.	,	_	7	punct	_	_
5	DRUG	_	NOUN	NN	_	7	nsubjpass	_	_
6	was	_	VERB	VBD	_	7	auxpass	_	_
7	shown	_	VERB	VBN	_	0	root	_	_
8	to	_	PRT	TO	_	12	mark	_	_
9	be	_	VERB	VB	_	12	cop	_	_
10	significantly	_	ADV	RB	_	12	advmod	_	_
11	more	_	ADV	RB	_	12	advmod	_	_
12	effective	_	ADJ	JJ	_	7	xcomp	_	_
13	than	_	ADP	IN	_	14	case	_	_
14	placebo	_	NOUN	NN	_	12	nmod	_	_
15	in	_	ADP	IN	_	16	mark	_	_
16	treating	_	VERB	VBG	_	12	advcl	_	_
17	panic	_	ADJ	JJ	_	18	amod	_	_
18	disorder	_	NOUN	NN	_	16	dobj	_	_
19	by	_	ADP	IN	_	23	case	_	_
20	at	_	ADP	IN	_	21	case	_	_
21	least	_	ADJ	JJS	_	22	nmod:npmod	_	_
22	2	_	NUM	CD	_	23	nummod	_	_
23	out	_	NOUN	NN	_	16	nmod	_	_
24	of	_	ADP	IN	_	26	case	_	_
25	3	_	NUM	CD	_	26	nummod	_	_
26	measures	_	NOUN	NNS	_	23	nmod	_	_
27	of	_	ADP	IN	_	30	case	_	_
28	panic	_	ADJ	JJ	_	30	amod	_	_
29	attack	_	NOUN	NN	_	30	compound	_	_
30	frequency	_	NOUN	NN	_	26	nmod	_	_
31	and	_	CONJ	CC	_	23	cc	_	_
32	on	_	ADP	IN	_	37	case	_	_
33	the	_	DET	DT	_	37	det	_	_
34	Clinical	_	ADJ	JJ	_	37	amod	_	_
35	Global	_	ADJ	JJ	_	37	amod	_	_
36	Impression	_	NOUN	NN	_	37	compound	_	_
37	Severity	_	NOUN	NN	_	23	conj	_	_
38	of	_	ADP	IN	_	40	case	_	_
39	Illness	_	NOUN	NN	_	40	compound	_	_
40	score	_	NOUN	NN	_	37	nmod	_	_

#	Paroxetine	4222
1	Study	_	NOUN	NN	_	11	nsubj	_	_
2	1	_	NUM	CD	_	1	nummod	_	_
3	was	_	VERB	VBD	_	11	cop	_	_
4	a	_	DET	DT	_	11	det	_	_
5	10	_	NUM	CD	_	11	nummod	_	_
6	week	_	NOUN	NN	_	11	compound	_	_
7	dose	_	NOUN	NN	_	11	compound	_	_
8	range	_	NOUN	NN	_	11	compound	_	_
9	finding	_	NOUN	NN	_	11	compound	_	_
10	study	_	NOUN	NN	_	11	compound	_	_
11	patients	_	NOUN	NNS	_	13	nsubjpass	_	_
12	were	_	VERB	VBD	_	13	auxpass	_	_
13	treated	_	VERB	VBN	_	0	root	_	_
14	with	_	ADP	IN	_	17	case	_	_
15	fixed	_	VERB	VBN	_	17	amod	_	_
16	DRUG	_	NOUN	NN	_	17	compound	_	_
17	doses	_	NOUN	NNS	_	13	nmod	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	10	_	NUM	CD	_	17	nmod	_	_
20	,	_	.	,	_	19	punct	_	_
21	20	_	NUM	CD	_	19	conj	_	_
22	,	_	.	,	_	19	punct	_	_
23	or	_	CONJ	CC	_	19	cc	_	_
24	40	_	NUM	CD	_	19	conj	_	_
25	mg	_	NOUN	NN	_	19	dep	_	_
26	/	_	.	:	_	17	punct	_	_
27	day	_	NOUN	NN	_	17	dep	_	_
28	or	_	CONJ	CC	_	27	cc	_	_
29	placebo	_	NOUN	NN	_	27	conj	_	_

#	Paroxetine	4223
1	A	_	DET	DT	_	3	det	_	_
2	significant	_	ADJ	JJ	_	3	amod	_	_
3	difference	_	NOUN	NN	_	7	nsubjpass	_	_
4	from	_	ADP	IN	_	5	case	_	_
5	placebo	_	NOUN	NN	_	3	nmod	_	_
6	was	_	VERB	VBD	_	7	auxpass	_	_
7	observed	_	VERB	VBN	_	0	root	_	_
8	only	_	ADV	RB	_	7	advmod	_	_
9	for	_	ADP	IN	_	15	case	_	_
10	the	_	DET	DT	_	15	det	_	_
11	40	_	NUM	CD	_	12	nummod	_	_
12	mg	_	NOUN	NN	_	15	compound	_	_
13	/	_	NUM	CD	_	15	punct	_	_
14	day	_	NOUN	NN	_	15	compound	_	_
15	group	_	NOUN	NN	_	7	nmod	_	_

#	Paroxetine	4224
1	At	_	ADP	IN	_	2	case	_	_
2	endpoint	_	NOUN	NN	_	19	nmod	_	_
3	,	_	.	,	_	19	punct	_	_
4	76%	_	NOUN	NN	_	19	nsubj	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	patients	_	NOUN	NNS	_	4	nmod	_	_
7	receiving	_	VERB	VBG	_	6	acl	_	_
8	DRUG	_	NOUN	NN	_	10	compound	_	_
9	40	_	NUM	CD	_	10	nummod	_	_
10	mg	_	NOUN	NN	_	7	dobj	_	_
11	/	_	.	:	_	4	punct	_	_
12	day	_	NOUN	NN	_	14	nsubj	_	_
13	were	_	VERB	VBD	_	14	cop	_	_
14	free	_	ADJ	JJ	_	4	acl:relcl	_	_
15	of	_	ADP	IN	_	17	case	_	_
16	panic	_	ADJ	JJ	_	17	amod	_	_
17	attacks	_	NOUN	NNS	_	14	nmod	_	_
18	,	_	.	,	_	4	punct	_	_
19	compared	_	VERB	VBN	_	0	root	_	_
20	to	_	PRT	TO	_	21	case	_	_
21	44%	_	NOUN	NN	_	19	nmod	_	_
22	of	_	ADP	IN	_	25	case	_	_
23	placebo	_	NOUN	NN	_	25	compound	_	_
24	treated	_	ADJ	JJ	_	25	amod	_	_
25	patients	_	NOUN	NNS	_	21	nmod	_	_

#	Paroxetine	4225
1	Study	_	NOUN	NN	_	9	nsubj	_	_
2	2	_	NUM	CD	_	1	nummod	_	_
3	was	_	VERB	VBD	_	9	cop	_	_
4	a	_	DET	DT	_	9	det	_	_
5	12	_	NUM	CD	_	9	nummod	_	_
6	week	_	NOUN	NN	_	9	compound	_	_
7	flexible	_	ADJ	JJ	_	9	amod	_	_
8	dose	_	NOUN	NN	_	9	compound	_	_
9	study	_	NOUN	NN	_	0	root	_	_
10	comparing	_	VERB	VBG	_	9	acl	_	_
11	DRUG	_	NOUN	NN	_	15	compound	_	_
12	10	_	NUM	CD	_	14	compound	_	_
13	to	_	PRT	TO	_	14	dep	_	_
14	60	_	NUM	CD	_	15	nummod	_	_
15	mg	_	NOUN	NN	_	10	nmod	_	_
16	daily	_	ADV	RB	_	15	advmod	_	_
17	and	_	CONJ	CC	_	15	cc	_	_
18	placebo	_	NOUN	NN	_	15	conj	_	_

#	Paroxetine	4226
1	At	_	ADP	IN	_	2	case	_	_
2	endpoint	_	NOUN	NN	_	9	nmod	_	_
3	,	_	.	,	_	9	punct	_	_
4	51%	_	NOUN	NN	_	9	nsubj	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	DRUG	_	NOUN	NN	_	7	compound	_	_
7	patients	_	NOUN	NNS	_	4	nmod	_	_
8	were	_	VERB	VBD	_	9	cop	_	_
9	free	_	ADJ	JJ	_	0	root	_	_
10	of	_	ADP	IN	_	12	case	_	_
11	panic	_	ADJ	JJ	_	12	amod	_	_
12	attacks	_	NOUN	NNS	_	9	nmod	_	_
13	compared	_	VERB	VBN	_	9	xcomp	_	_
14	to	_	PRT	TO	_	15	case	_	_
15	32%	_	NOUN	NN	_	13	nmod	_	_
16	of	_	ADP	IN	_	19	case	_	_
17	placebo	_	NOUN	NN	_	19	compound	_	_
18	treated	_	ADJ	JJ	_	19	amod	_	_
19	patients	_	NOUN	NNS	_	15	nmod	_	_

#	Paroxetine	4227
1	Study	_	NOUN	NN	_	9	nsubj	_	_
2	3	_	NUM	CD	_	1	nummod	_	_
3	was	_	VERB	VBD	_	9	cop	_	_
4	a	_	DET	DT	_	9	det	_	_
5	12	_	NUM	CD	_	9	nummod	_	_
6	week	_	NOUN	NN	_	9	compound	_	_
7	flexible	_	ADJ	JJ	_	9	amod	_	_
8	dose	_	NOUN	NN	_	9	compound	_	_
9	study	_	NOUN	NN	_	0	root	_	_
10	comparing	_	VERB	VBG	_	9	acl	_	_
11	DRUG	_	NOUN	NN	_	15	compound	_	_
12	10	_	NUM	CD	_	14	compound	_	_
13	to	_	PRT	TO	_	14	dep	_	_
14	60	_	NUM	CD	_	15	nummod	_	_
15	mg	_	NOUN	NN	_	10	dobj	_	_
16	daily	_	ADV	RB	_	18	advmod	_	_
17	to	_	PRT	TO	_	18	case	_	_
18	placebo	_	NOUN	NN	_	10	nmod	_	_
19	in	_	ADP	IN	_	20	case	_	_
20	patients	_	NOUN	NNS	_	18	nmod	_	_
21	concurrently	_	ADV	RB	_	22	advmod	_	_
22	receiving	_	VERB	VBG	_	20	acl	_	_
23	standardized	_	VERB	VBN	_	26	amod	_	_
24	cognitive	_	ADJ	JJ	_	26	amod	_	_
25	behavioral	_	ADJ	JJ	_	26	amod	_	_
26	therapy	_	NOUN	NN	_	22	dobj	_	_

#	Paroxetine	4228
1	At	_	ADP	IN	_	2	case	_	_
2	endpoint	_	NOUN	NN	_	10	nmod	_	_
3	,	_	.	,	_	10	punct	_	_
4	33%	_	NOUN	NN	_	10	nsubj	_	_
5	of	_	ADP	IN	_	9	case	_	_
6	the	_	DET	DT	_	9	det	_	_
7	DRUG	_	NOUN	NN	_	9	compound	_	_
8	treated	_	ADJ	JJ	_	9	amod	_	_
9	patients	_	NOUN	NNS	_	4	nmod	_	_
10	showed	_	VERB	VBD	_	0	root	_	_
11	a	_	DET	DT	_	12	det	_	_
12	reduction	_	NOUN	NN	_	10	dobj	_	_
13	to	_	PRT	TO	_	18	case	_	_
14	0	_	NUM	CD	_	18	nummod	_	_
15	or	_	CONJ	CC	_	14	cc	_	_
16	1	_	NUM	CD	_	14	conj	_	_
17	panic	_	ADJ	JJ	_	18	amod	_	_
18	attacks	_	NOUN	NNS	_	12	nmod	_	_
19	compared	_	VERB	VBN	_	10	xcomp	_	_
20	to	_	PRT	TO	_	21	case	_	_
21	14%	_	NOUN	NN	_	19	nmod	_	_
22	of	_	ADP	IN	_	24	case	_	_
23	placebo	_	NOUN	NN	_	24	compound	_	_
24	patients	_	NOUN	NNS	_	21	nmod	_	_

#	Paroxetine	4229
1	In	_	ADP	IN	_	3	case	_	_
2	both	_	DET	DT	_	3	det	_	_
3	Studies	_	NOUN	NNS	_	19	nmod	_	_
4	2	_	NUM	CD	_	3	dep	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	3	_	NUM	CD	_	4	conj	_	_
7	,	_	.	,	_	19	punct	_	_
8	the	_	DET	DT	_	11	det	_	_
9	mean	_	ADJ	JJ	_	11	amod	_	_
10	DRUG	_	NOUN	NN	_	11	compound	_	_
11	dose	_	NOUN	NN	_	19	nsubj	_	_
12	for	_	ADP	IN	_	13	case	_	_
13	completers	_	NOUN	NNS	_	11	nmod	_	_
14	at	_	ADP	IN	_	15	case	_	_
15	endpoint	_	NOUN	NN	_	11	nmod	_	_
16	was	_	VERB	VBD	_	19	cop	_	_
17	approximately	_	ADV	RB	_	18	advmod	_	_
18	40	_	NUM	CD	_	19	nummod	_	_
19	mg	_	NOUN	NN	_	0	root	_	_
20	/	_	.	:	_	19	punct	_	_
21	day	_	NOUN	NN	_	19	dep	_	_
22	of	_	ADP	IN	_	23	case	_	_
23	DRUG	_	NOUN	NN	_	21	nmod	_	_

#	Paroxetine	4230
1	Long	_	DET	DT	_	4	det	_	_
2	term	_	NOUN	NN	_	4	compound	_	_
3	maintenance	_	NOUN	NN	_	4	compound	_	_
4	effects	_	NOUN	NNS	_	11	nsubjpass	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	in	_	ADP	IN	_	9	case	_	_
8	panic	_	ADJ	JJ	_	9	amod	_	_
9	disorder	_	NOUN	NN	_	4	nmod	_	_
10	were	_	VERB	VBD	_	11	auxpass	_	_
11	demonstrated	_	VERB	VBN	_	0	root	_	_
12	in	_	ADP	IN	_	14	case	_	_
13	an	_	DET	DT	_	14	det	_	_
14	extension	_	NOUN	NN	_	11	nmod	_	_
15	to	_	PRT	TO	_	16	case	_	_
16	Study	_	NOUN	NN	_	14	nmod	_	_
17	1	_	NUM	CD	_	16	nummod	_	_

#	Paroxetine	4231
1	Patients	_	NOUN	NNS	_	22	nsubjpass	_	_
2	who	_	DET	WDT	_	4	nsubj	_	_
3	were	_	VERB	VBD	_	4	cop	_	_
4	responders	_	NOUN	NNS	_	1	acl:relcl	_	_
5	during	_	ADP	IN	_	11	case	_	_
6	the	_	DET	DT	_	11	det	_	_
7	10	_	NUM	CD	_	11	nummod	_	_
8	week	_	NOUN	NN	_	11	compound	_	_
9	double	_	ADJ	JJ	_	11	amod	_	_
10	blind	_	NOUN	NN	_	11	compound	_	_
11	phase	_	NOUN	NN	_	4	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	during	_	ADP	IN	_	20	case	_	_
14	a	_	DET	DT	_	20	det	_	_
15	3	_	NUM	CD	_	20	nummod	_	_
16	month	_	NOUN	NN	_	20	compound	_	_
17	double	_	ADJ	JJ	_	20	amod	_	_
18	blind	_	NOUN	NN	_	20	compound	_	_
19	extension	_	NOUN	NN	_	20	compound	_	_
20	phase	_	NOUN	NN	_	11	conj	_	_
21	were	_	VERB	VBD	_	22	auxpass	_	_
22	randomized	_	VERB	VBN	_	0	root	_	_
23	to	_	PRT	TO	_	25	case	_	_
24	either	_	CONJ	CC	_	25	cc:preconj	_	_
25	DRUG	_	NOUN	NN	_	22	nmod	_	_
26	10	_	NUM	CD	_	25	nummod	_	_
27	,	_	.	,	_	25	punct	_	_
28	20	_	NUM	CD	_	25	conj	_	_
29	,	_	.	,	_	25	punct	_	_
30	or	_	CONJ	CC	_	25	cc	_	_
31	40	_	NUM	CD	_	32	nummod	_	_
32	mg	_	NOUN	NN	_	25	conj	_	_
33	/	_	.	:	_	25	punct	_	_
34	day	_	NOUN	NN	_	25	conj	_	_
35	or	_	CONJ	CC	_	25	cc	_	_
36	placebo	_	NOUN	NN	_	25	conj	_	_
37	in	_	ADP	IN	_	45	case	_	_
38	a	_	DET	DT	_	45	det	_	_
39	3	_	NUM	CD	_	45	nummod	_	_
40	month	_	NOUN	NN	_	45	compound	_	_
41	double	_	ADJ	JJ	_	45	amod	_	_
42	blind	_	NOUN	NN	_	45	compound	_	_
43	relapse	_	NOUN	NN	_	45	compound	_	_
44	prevention	_	NOUN	NN	_	45	compound	_	_
45	phase	_	NOUN	NN	_	22	nmod	_	_

#	Paroxetine	4233
1	Subgroup	_	ADJ	JJ	_	2	amod	_	_
2	analyses	_	NOUN	NNS	_	5	nsubj	_	_
3	did	_	VERB	MD	_	5	aux	_	_
4	not	_	ADV	RB	_	5	neg	_	_
5	indicate	_	VERB	VB	_	0	root	_	_
6	that	_	ADP	IN	_	8	mark	_	_
7	there	_	DET	EX	_	8	expl	_	_
8	were	_	VERB	VBD	_	5	root	_	_
9	any	_	DET	DT	_	10	det	_	_
10	differences	_	NOUN	NNS	_	8	nsubj	_	_
11	in	_	ADP	IN	_	13	case	_	_
12	treatment	_	NOUN	NN	_	13	compound	_	_
13	outcomes	_	NOUN	NNS	_	10	nmod	_	_
14	as	_	ADP	IN	_	16	case	_	_
15	a	_	DET	DT	_	16	det	_	_
16	function	_	NOUN	NN	_	8	nmod	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	age	_	NOUN	NN	_	16	nmod	_	_
19	or	_	CONJ	CC	_	8	cc	_	_
20	gender	_	NOUN	NN	_	8	conj	_	_

#	Paroxetine	4234
1	Generalized	_	VERB	VBN	_	3	amod	_	_
2	Anxiety	_	NOUN	NN	_	3	compound	_	_
3	Disorder	_	NOUN	NN	_	0	root	_	_
4	The	_	DET	DT	_	5	det	_	_
5	effectiveness	_	NOUN	NN	_	17	nsubjpass	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	in	_	ADP	IN	_	10	case	_	_
9	the	_	DET	DT	_	10	det	_	_
10	treatment	_	NOUN	NN	_	5	nmod	_	_
11	of	_	ADP	IN	_	15	case	_	_
12	Generalized	_	ADJ	JJ	_	15	amod	_	_
13	Anxiety	_	NOUN	NN	_	15	compound	_	_
14	Disorder	_	NOUN	NN	_	15	compound	_	_
15	GAD	_	NOUN	NN	_	10	nmod	_	_
16	was	_	VERB	VBD	_	17	auxpass	_	_
17	demonstrated	_	VERB	VBN	_	3	dep	_	_
18	in	_	ADP	IN	_	21	case	_	_
19	two	_	NUM	CD	_	21	nummod	_	_
20	8	_	NUM	CD	_	21	nummod	_	_
21	week	_	NOUN	NN	_	17	nmod	_	_
22	,	_	.	,	_	21	punct	_	_
23	multicenter	_	NOUN	NN	_	21	appos	_	_
24	,	_	.	,	_	21	punct	_	_
25	placebo	_	NOUN	NN	_	28	compound	_	_
26	controlled	_	VERB	VBD	_	28	amod	_	_
27	studies	_	NOUN	NNS	_	28	compound	_	_
28	Studies	_	NOUN	NNS	_	21	appos	_	_
29	1	_	NUM	CD	_	28	dep	_	_
30	and	_	CONJ	CC	_	29	cc	_	_
31	2	_	NUM	CD	_	29	conj	_	_
32	of	_	ADP	IN	_	34	case	_	_
33	adult	_	ADJ	JJ	_	34	amod	_	_
34	outpatients	_	NOUN	NNS	_	28	nmod	_	_
35	with	_	ADP	IN	_	40	case	_	_
36	Generalized	_	VERB	VBN	_	40	amod	_	_
37	Anxiety	_	NOUN	NN	_	40	compound	_	_
38	Disorder	_	NOUN	NN	_	40	compound	_	_
39	DSM	_	NOUN	NN	_	40	compound	_	_
40	IV	_	NUM	CD	_	34	nmod	_	_

#	Paroxetine	4235
1	Study	_	NOUN	NN	_	7	nsubj	_	_
2	1	_	NUM	CD	_	1	nummod	_	_
3	was	_	VERB	VBD	_	7	cop	_	_
4	an	_	DET	DT	_	7	det	_	_
5	8	_	NUM	CD	_	7	nummod	_	_
6	week	_	NOUN	NN	_	7	compound	_	_
7	study	_	NOUN	NN	_	0	root	_	_
8	comparing	_	VERB	VBG	_	7	acl	_	_
9	fixed	_	VERB	VBN	_	11	amod	_	_
10	DRUG	_	NOUN	NN	_	11	compound	_	_
11	doses	_	NOUN	NNS	_	8	dobj	_	_
12	of	_	ADP	IN	_	14	case	_	_
13	20	_	NUM	CD	_	14	nummod	_	_
14	mg	_	NOUN	NN	_	11	nmod	_	_
15	or	_	CONJ	CC	_	14	cc	_	_
16	40	_	NUM	CD	_	17	nummod	_	_
17	mg	_	NOUN	NN	_	14	conj	_	_
18	/	_	.	:	_	7	punct	_	_
19	day	_	NOUN	NN	_	7	dep	_	_
20	with	_	ADP	IN	_	21	case	_	_
21	placebo	_	NOUN	NN	_	19	nmod	_	_

#	Paroxetine	4236
1	Doses	_	NOUN	NNS	_	12	nsubjpass	_	_
2	of	_	ADP	IN	_	4	case	_	_
3	20	_	NUM	CD	_	4	nummod	_	_
4	mg	_	NOUN	NN	_	1	nmod	_	_
5	or	_	CONJ	CC	_	4	cc	_	_
6	40	_	NUM	CD	_	7	nummod	_	_
7	mg	_	NOUN	NN	_	4	conj	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	4	nmod	_	_
10	were	_	VERB	VBD	_	12	auxpass	_	_
11	both	_	DET	DT	_	12	advmod	_	_
12	demonstrated	_	VERB	VBN	_	0	root	_	_
13	to	_	PRT	TO	_	16	mark	_	_
14	be	_	VERB	VB	_	16	cop	_	_
15	significantly	_	ADV	RB	_	16	advmod	_	_
16	superior	_	NOUN	NN	_	12	xcomp	_	_
17	to	_	PRT	TO	_	18	case	_	_
18	placebo	_	NOUN	NN	_	16	nmod	_	_
19	on	_	ADP	IN	_	23	case	_	_
20	the	_	DET	DT	_	23	det	_	_
21	Hamilton	_	NOUN	NN	_	23	compound	_	_
22	Rating	_	VERB	VBG	_	23	compound	_	_
23	Scale	_	NOUN	NN	_	16	nmod	_	_
24	for	_	ADP	IN	_	29	case	_	_
25	Anxiety	_	NOUN	NN	_	29	compound	_	_
26	HAM	_	NOUN	NN	_	29	compound	_	_
27	A	_	NOUN	NN	_	29	compound	_	_
28	total	_	ADJ	JJ	_	29	amod	_	_
29	score	_	NOUN	NN	_	23	nmod	_	_

#	Paroxetine	4237
1	There	_	DET	EX	_	2	expl	_	_
2	was	_	VERB	VBD	_	0	root	_	_
3	not	_	ADV	RB	_	5	neg	_	_
4	sufficient	_	ADJ	JJ	_	5	amod	_	_
5	evidence	_	NOUN	NN	_	2	nsubj	_	_
6	in	_	ADP	IN	_	8	case	_	_
7	this	_	DET	DT	_	8	det	_	_
8	study	_	NOUN	NN	_	2	nmod	_	_
9	to	_	PRT	TO	_	10	mark	_	_
10	suggest	_	VERB	VB	_	8	acl	_	_
11	a	_	DET	DT	_	13	det	_	_
12	greater	_	ADJ	JJ	_	13	amod	_	_
13	benefit	_	NOUN	NN	_	10	dobj	_	_
14	for	_	ADP	IN	_	20	case	_	_
15	the	_	DET	DT	_	20	det	_	_
16	40	_	NUM	CD	_	17	nummod	_	_
17	mg	_	NOUN	NN	_	20	amod	_	_
18	/	_	.	:	_	20	punct	_	_
19	day	_	NOUN	NN	_	20	compound	_	_
20	dose	_	NOUN	NN	_	13	nmod	_	_
21	compared	_	VERB	VBN	_	2	dep	_	_
22	to	_	PRT	TO	_	28	case	_	_
23	the	_	DET	DT	_	28	det	_	_
24	20	_	NUM	CD	_	25	nummod	_	_
25	mg	_	NOUN	NN	_	28	compound	_	_
26	/	_	.	:	_	28	punct	_	_
27	day	_	NOUN	NN	_	28	compound	_	_
28	dose	_	NOUN	NN	_	21	nmod	_	_

#	Paroxetine	4238
1	Study	_	NOUN	NN	_	7	nsubj	_	_
2	2	_	NUM	CD	_	1	nummod	_	_
3	was	_	VERB	VBD	_	7	cop	_	_
4	a	_	DET	DT	_	7	det	_	_
5	flexible	_	ADJ	JJ	_	7	amod	_	_
6	dose	_	NOUN	NN	_	7	compound	_	_
7	study	_	NOUN	NN	_	0	root	_	_
8	comparing	_	VERB	VBG	_	7	acl	_	_
9	DRUG	_	NOUN	NN	_	11	compound	_	_
10	20	_	NUM	CD	_	11	nummod	_	_
11	mg	_	NOUN	NN	_	8	dobj	_	_
12	to	_	PRT	TO	_	14	case	_	_
13	50	_	NUM	CD	_	14	nummod	_	_
14	mg	_	NOUN	NN	_	8	nmod	_	_
15	daily	_	ADV	RB	_	14	advmod	_	_
16	and	_	CONJ	CC	_	14	cc	_	_
17	placebo	_	NOUN	NN	_	14	conj	_	_

#	Paroxetine	4239
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	demonstrated	_	VERB	VBD	_	0	root	_	_
3	statistically	_	ADV	RB	_	4	advmod	_	_
4	significant	_	ADJ	JJ	_	5	amod	_	_
5	superiority	_	NOUN	NN	_	2	dobj	_	_
6	over	_	ADP	IN	_	7	case	_	_
7	placebo	_	NOUN	NN	_	2	nmod	_	_
8	on	_	ADP	IN	_	12	case	_	_
9	the	_	DET	DT	_	12	det	_	_
10	Hamilton	_	NOUN	NN	_	12	compound	_	_
11	Rating	_	VERB	VBG	_	12	compound	_	_
12	Scale	_	NOUN	NN	_	2	nmod	_	_
13	for	_	ADP	IN	_	18	case	_	_
14	Anxiety	_	NOUN	NN	_	18	compound	_	_
15	HAM	_	NOUN	NN	_	18	compound	_	_
16	A	_	NOUN	NN	_	18	compound	_	_
17	total	_	ADJ	JJ	_	18	amod	_	_
18	score	_	NOUN	NN	_	12	nmod	_	_

#	Paroxetine	4240
1	A	_	DET	DT	_	3	det	_	_
2	third	_	ADJ	JJ	_	3	amod	_	_
3	study	_	NOUN	NN	_	19	nsubj	_	_
4	,	_	.	,	_	3	punct	_	_
5	also	_	ADV	RB	_	6	advmod	_	_
6	flexible	_	ADJ	JJ	_	7	amod	_	_
7	dose	_	NOUN	NN	_	3	appos	_	_
8	comparing	_	VERB	VBG	_	7	acl	_	_
9	DRUG	_	NOUN	NN	_	11	compound	_	_
10	20	_	NUM	CD	_	11	nummod	_	_
11	mg	_	NOUN	NN	_	8	dobj	_	_
12	to	_	PRT	TO	_	14	case	_	_
13	50	_	NUM	CD	_	14	nummod	_	_
14	mg	_	NOUN	NN	_	8	nmod	_	_
15	daily	_	ADV	RB	_	7	advmod	_	_
16	,	_	.	,	_	3	punct	_	_
17	did	_	VERB	MD	_	19	aux	_	_
18	not	_	ADV	RB	_	19	neg	_	_
19	demonstrate	_	VERB	VB	_	0	root	_	_
20	statistically	_	ADV	RB	_	21	advmod	_	_
21	significant	_	ADJ	JJ	_	22	amod	_	_
22	superiority	_	NOUN	NN	_	19	dobj	_	_
23	of	_	ADP	IN	_	24	case	_	_
24	DRUG	_	NOUN	NN	_	22	nmod	_	_
25	over	_	ADP	IN	_	26	case	_	_
26	placebo	_	NOUN	NN	_	22	nmod	_	_
27	on	_	ADP	IN	_	31	case	_	_
28	the	_	DET	DT	_	31	det	_	_
29	Hamilton	_	NOUN	NN	_	31	compound	_	_
30	Rating	_	VERB	VBG	_	31	compound	_	_
31	Scale	_	NOUN	NN	_	22	nmod	_	_
32	for	_	ADP	IN	_	37	case	_	_
33	Anxiety	_	NOUN	NN	_	37	compound	_	_
34	HAM	_	NOUN	NN	_	37	compound	_	_
35	A	_	NOUN	NN	_	37	compound	_	_
36	total	_	ADJ	JJ	_	37	amod	_	_
37	score	_	NOUN	NN	_	31	nmod	_	_
38	,	_	.	,	_	19	punct	_	_
39	the	_	DET	DT	_	41	det	_	_
40	primary	_	ADJ	JJ	_	41	amod	_	_
41	outcome	_	NOUN	NN	_	19	root	_	_

#	Paroxetine	4241
1	Subgroup	_	ADJ	JJ	_	2	amod	_	_
2	analyses	_	NOUN	NNS	_	5	nsubj	_	_
3	did	_	VERB	VBD	_	5	aux	_	_
4	not	_	ADV	RB	_	5	neg	_	_
5	indicate	_	VERB	VB	_	0	root	_	_
6	differences	_	NOUN	NNS	_	5	dobj	_	_
7	in	_	ADP	IN	_	9	case	_	_
8	treatment	_	NOUN	NN	_	9	compound	_	_
9	outcomes	_	NOUN	NNS	_	6	nmod	_	_
10	as	_	ADP	IN	_	12	case	_	_
11	a	_	DET	DT	_	12	det	_	_
12	function	_	NOUN	NN	_	5	nmod	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	race	_	ADJ	JJ	_	12	nmod	_	_
15	or	_	CONJ	CC	_	5	cc	_	_
16	gender	_	NOUN	NN	_	5	conj	_	_

#	Paroxetine	4242
1	There	_	DET	EX	_	2	expl	_	_
2	were	_	VERB	VBD	_	0	root	_	_
3	insufficient	_	ADJ	JJ	_	5	amod	_	_
4	elderly	_	ADJ	JJ	_	5	amod	_	_
5	patients	_	NOUN	NNS	_	2	nsubj	_	_
6	to	_	PRT	TO	_	7	mark	_	_
7	conduct	_	VERB	VB	_	2	xcomp	_	_
8	subgroup	_	NOUN	NN	_	9	compound	_	_
9	analyses	_	NOUN	NNS	_	7	dobj	_	_
10	on	_	ADP	IN	_	14	case	_	_
11	the	_	DET	DT	_	14	dep	_	_
12	basis	_	NOUN	NN	_	14	dep	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	age	_	NOUN	NN	_	7	nmod	_	_

#	Paroxetine	4243
1	In	_	ADP	IN	_	5	case	_	_
2	a	_	DET	DT	_	5	det	_	_
3	longer	_	ADV	RB	_	5	advmod	_	_
4	term	_	NOUN	NN	_	5	compound	_	_
5	trial	_	ADJ	JJ	_	42	nmod	_	_
6	,	_	.	,	_	42	punct	_	_
7	566	_	NUM	CD	_	8	nummod	_	_
8	patients	_	NOUN	NNS	_	42	nsubjpass	_	_
9	meeting	_	VERB	VBG	_	8	acl	_	_
10	DSM	_	NOUN	NN	_	12	compound	_	_
11	IV	_	NUM	CD	_	12	nummod	_	_
12	criteria	_	NOUN	NN	_	9	dobj	_	_
13	for	_	ADP	IN	_	16	case	_	_
14	Generalized	_	VERB	VBN	_	16	amod	_	_
15	Anxiety	_	NOUN	NN	_	16	compound	_	_
16	Disorder	_	NOUN	NN	_	9	nmod	_	_
17	,	_	.	,	_	16	punct	_	_
18	who	_	DET	WDT	_	20	nsubj	_	_
19	had	_	VERB	MD	_	20	aux	_	_
20	responded	_	VERB	VBN	_	16	acl:relcl	_	_
21	during	_	ADP	IN	_	24	case	_	_
22	a	_	DET	DT	_	24	det	_	_
23	single	_	ADJ	JJ	_	24	amod	_	_
24	blind	_	NOUN	NN	_	20	nmod	_	_
25	,	_	.	,	_	24	punct	_	_
26	8	_	NUM	CD	_	30	nummod	_	_
27	week	_	NOUN	NN	_	30	compound	_	_
28	acute	_	ADJ	JJ	_	30	amod	_	_
29	treatment	_	NOUN	NN	_	30	compound	_	_
30	phase	_	NOUN	NN	_	24	appos	_	_
31	with	_	ADP	IN	_	35	case	_	_
32	20	_	NUM	CD	_	34	compound	_	_
33	to	_	PRT	TO	_	34	dep	_	_
34	50	_	NUM	CD	_	35	nummod	_	_
35	mg	_	NOUN	NN	_	30	nmod	_	_
36	/	_	.	:	_	24	punct	_	_
37	day	_	NOUN	NN	_	24	dep	_	_
38	of	_	ADP	IN	_	39	case	_	_
39	DRUG	_	NOUN	NN	_	37	nmod	_	_
40	,	_	.	,	_	8	punct	_	_
41	were	_	VERB	VBD	_	42	auxpass	_	_
42	randomized	_	VERB	VBN	_	0	root	_	_
43	to	_	PRT	TO	_	44	case	_	_
44	continuation	_	NOUN	NN	_	42	nmod	_	_
45	of	_	ADP	IN	_	46	case	_	_
46	DRUG	_	NOUN	NN	_	44	nmod	_	_
47	at	_	ADP	IN	_	50	case	_	_
48	their	_	PRON	PRP$	_	50	nmod:poss	_	_
49	same	_	ADJ	JJ	_	50	amod	_	_
50	dose	_	NOUN	NN	_	44	nmod	_	_
51	,	_	.	,	_	44	punct	_	_
52	or	_	CONJ	CC	_	44	cc	_	_
53	to	_	PRT	TO	_	54	case	_	_
54	placebo	_	NOUN	NN	_	44	conj	_	_
55	,	_	.	,	_	54	punct	_	_
56	for	_	ADP	IN	_	60	case	_	_
57	up	_	NOUN	NN	_	59	advmod	_	_
58	to	_	PRT	TO	_	59	dep	_	_
59	24	_	NUM	CD	_	60	nummod	_	_
60	weeks	_	NOUN	NNS	_	54	nmod	_	_
61	of	_	ADP	IN	_	62	case	_	_
62	observation	_	NOUN	NN	_	60	nmod	_	_
63	for	_	ADP	IN	_	64	case	_	_
64	relapse	_	ADP	IN	_	62	nmod	_	_

#	Paroxetine	4244
1	Response	_	NOUN	NN	_	8	nsubjpass	_	_
2	during	_	ADP	IN	_	6	case	_	_
3	the	_	DET	DT	_	6	det	_	_
4	single	_	ADJ	JJ	_	6	amod	_	_
5	blind	_	NOUN	NN	_	6	compound	_	_
6	phase	_	NOUN	NN	_	1	nmod	_	_
7	was	_	VERB	VBD	_	8	auxpass	_	_
8	defined	_	VERB	VBN	_	0	root	_	_
9	by	_	ADP	IN	_	10	mark	_	_
10	having	_	VERB	VBG	_	8	advcl	_	_
11	a	_	DET	DT	_	12	det	_	_
12	decrease	_	NOUN	NN	_	10	dobj	_	_
13	of	_	ADP	IN	_	15	case	_	_
14	>2	_	NUM	CD	_	15	nummod	_	_
15	points	_	NOUN	NNS	_	12	nmod	_	_
16	compared	_	VERB	VBD	_	18	case	_	_
17	to	_	PRT	TO	_	18	case	_	_
18	baseline	_	NOUN	NN	_	8	nmod	_	_
19	on	_	ADP	IN	_	22	case	_	_
20	the	_	DET	DT	_	22	det	_	_
21	CGI	_	NOUN	NN	_	22	compound	_	_
22	Severity	_	NOUN	NN	_	18	nmod	_	_
23	of	_	ADP	IN	_	25	case	_	_
24	Illness	_	NOUN	NN	_	25	compound	_	_
25	scale	_	NOUN	NN	_	22	nmod	_	_
26	,	_	.	,	_	18	punct	_	_
27	to	_	PRT	TO	_	29	case	_	_
28	a	_	DET	DT	_	29	det	_	_
29	score	_	NOUN	NN	_	18	nmod	_	_
30	of	_	ADP	IN	_	31	case	_	_
31	<3	_	NUM	CD	_	29	nmod	_	_

#	Paroxetine	4245
1	Relapse	_	NOUN	NN	_	8	nsubjpass	_	_
2	during	_	ADP	IN	_	6	case	_	_
3	the	_	DET	DT	_	6	det	_	_
4	double	_	ADJ	JJ	_	6	amod	_	_
5	blind	_	NOUN	NN	_	6	compound	_	_
6	phase	_	NOUN	NN	_	1	nmod	_	_
7	was	_	VERB	VBD	_	8	auxpass	_	_
8	defined	_	VERB	VBN	_	0	root	_	_
9	as	_	ADP	IN	_	11	case	_	_
10	an	_	DET	DT	_	11	det	_	_
11	increase	_	NOUN	NN	_	8	nmod	_	_
12	of	_	ADP	IN	_	15	case	_	_
13	>	_	NUM	CD	_	15	nummod	_	_
14	2	_	NUM	CD	_	15	nummod	_	_
15	points	_	NOUN	NNS	_	11	nmod	_	_
16	compared	_	VERB	VBD	_	18	case	_	_
17	to	_	PRT	TO	_	18	case	_	_
18	baseline	_	NOUN	NN	_	8	nmod	_	_
19	on	_	ADP	IN	_	22	case	_	_
20	the	_	DET	DT	_	22	det	_	_
21	CGI	_	NOUN	NN	_	22	compound	_	_
22	Severity	_	NOUN	NN	_	18	nmod	_	_
23	of	_	ADP	IN	_	25	case	_	_
24	Illness	_	NOUN	NN	_	25	compound	_	_
25	scale	_	NOUN	NN	_	22	nmod	_	_
26	to	_	PRT	TO	_	28	case	_	_
27	a	_	DET	DT	_	28	det	_	_
28	score	_	NOUN	NN	_	22	nmod	_	_
29	of	_	ADP	IN	_	31	case	_	_
30	>	_	NUM	CD	_	31	nummod	_	_
31	4	_	NUM	CD	_	28	nmod	_	_
32	,	_	.	,	_	8	punct	_	_
33	or	_	CONJ	CC	_	8	cc	_	_
34	withdrawal	_	NOUN	NN	_	8	conj	_	_
35	due	_	ADJ	JJ	_	37	case	_	_
36	to	_	PRT	TO	_	35	mwe	_	_
37	lack	_	NOUN	NN	_	34	nmod	_	_
38	of	_	ADP	IN	_	39	case	_	_
39	efficacy	_	NOUN	NN	_	37	nmod	_	_

#	Paroxetine	4246
1	Patients	_	NOUN	NNS	_	5	nsubj	_	_
2	receiving	_	VERB	VBG	_	1	acl	_	_
3	continued	_	VERB	VBN	_	4	amod	_	_
4	DRUG	_	NOUN	NN	_	2	dobj	_	_
5	experienced	_	VERB	VBD	_	0	root	_	_
6	a	_	DET	DT	_	10	det	_	_
7	significantly	_	ADV	RB	_	8	advmod	_	_
8	lower	_	ADJ	JJ	_	10	amod	_	_
9	relapse	_	NOUN	NN	_	10	compound	_	_
10	rate	_	NOUN	NN	_	5	dobj	_	_
11	over	_	ADP	IN	_	15	case	_	_
12	the	_	DET	DT	_	15	det	_	_
13	subsequent	_	ADJ	JJ	_	15	amod	_	_
14	24	_	NUM	CD	_	15	nummod	_	_
15	weeks	_	NOUN	NNS	_	5	nmod	_	_
16	compared	_	VERB	VBN	_	5	xcomp	_	_
17	to	_	PRT	TO	_	18	case	_	_
18	those	_	DET	DT	_	16	nmod	_	_
19	receiving	_	VERB	VBG	_	18	acl	_	_
20	placebo	_	NOUN	NN	_	19	nmod	_	_

#	Perphenazine	4550
1	Metabolism	_	NOUN	NN	_	19	nsubj	_	_
2	of	_	ADP	IN	_	4	case	_	_
3	a	_	DET	DT	_	4	det	_	_
4	number	_	NOUN	NN	_	1	nmod	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	medications	_	NOUN	NNS	_	4	nmod	_	_
7	,	_	.	,	_	6	punct	_	_
8	including	_	VERB	VBG	_	9	case	_	_
9	antipsychotics	_	NOUN	NNS	_	6	nmod	_	_
10	,	_	.	,	_	9	punct	_	_
11	antidepressants	_	NOUN	NNS	_	9	conj	_	_
12	,	_	.	,	_	9	punct	_	_
13	B	_	NOUN	NN	_	14	compound	_	_
14	blockers	_	NOUN	NNS	_	9	conj	_	_
15	,	_	.	,	_	9	punct	_	_
16	and	_	CONJ	CC	_	9	cc	_	_
17	antiarrhythmics	_	NOUN	NNS	_	9	conj	_	_
18	,	_	.	,	_	1	punct	_	_
19	occurs	_	VERB	VBZ	_	0	root	_	_
20	through	_	ADP	IN	_	27	case	_	_
21	the	_	DET	DT	_	27	det	_	_
22	cytochrome	_	NOUN	NN	_	27	compound	_	_
23	P450	_	NOUN	NN	_	27	compound	_	_
24	2D6	_	NOUN	NN	_	27	compound	_	_
25	isoenzyme	_	NOUN	NN	_	27	compound	_	_
26	debrisoquine	_	NOUN	NN	_	27	compound	_	_
27	hydroxylase	_	NOUN	NN	_	19	nmod	_	_

#	Perphenazine	4551
1	Approximately	_	ADV	RB	_	8	advmod	_	_
2	10%	_	NOUN	NN	_	8	nsubj	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	the	_	DET	DT	_	6	det	_	_
5	Caucasian	_	ADJ	JJ	_	6	amod	_	_
6	population	_	NOUN	NN	_	2	nmod	_	_
7	has	_	VERB	VBZ	_	8	aux	_	_
8	reduced	_	VERB	VBN	_	0	root	_	_
9	activity	_	NOUN	NN	_	8	dobj	_	_
10	of	_	ADP	IN	_	12	case	_	_
11	this	_	DET	DT	_	12	det	_	_
12	enzyme	_	NOUN	NN	_	9	nmod	_	_
13	,	_	.	,	_	8	punct	_	_
14	so	_	ADV	RB	_	15	advmod	_	_
15	called	_	VERB	VBN	_	8	parataxis	_	_
16	"poor"	_	NOUN	NN	_	17	compound	_	_
17	metabolizers	_	NOUN	NNS	_	15	dobj	_	_

#	Perphenazine	4552
1	Among	_	ADP	IN	_	3	case	_	_
2	other	_	ADJ	JJ	_	3	amod	_	_
3	populations	_	NOUN	NNS	_	8	nmod	_	_
4	the	_	DET	DT	_	5	det	_	_
5	prevalence	_	NOUN	NN	_	8	nsubjpass	_	_
6	is	_	VERB	VBZ	_	8	auxpass	_	_
7	not	_	ADV	RB	_	8	neg	_	_
8	known	_	VERB	VBN	_	0	root	_	_

#	Perphenazine	4553
1	Poor	_	ADJ	JJ	_	2	amod	_	_
2	metabolizers	_	NOUN	NNS	_	3	nsubj	_	_
3	demonstrate	_	VERB	VBP	_	0	root	_	_
4	higher	_	ADJ	JJ	_	6	amod	_	_
5	plasma	_	NOUN	NN	_	6	compound	_	_
6	concentrations	_	NOUN	NNS	_	3	dobj	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUGS	_	NOUN	NN	_	6	nmod	_	_
9	at	_	ADP	IN	_	11	case	_	_
10	usual	_	ADJ	JJ	_	11	amod	_	_
11	doses	_	NOUN	NNS	_	6	nmod	_	_
12	,	_	.	,	_	11	punct	_	_
13	which	_	DET	WDT	_	15	nsubj	_	_
14	may	_	VERB	MD	_	15	aux	_	_
15	correlate	_	VERB	VB	_	11	acl:relcl	_	_
16	with	_	ADP	IN	_	17	case	_	_
17	emergence	_	NOUN	NN	_	15	nmod	_	_
18	of	_	ADP	IN	_	20	case	_	_
19	side	_	ADJ	JJ	_	20	amod	_	_
20	effects	_	NOUN	NNS	_	17	nmod	_	_

#	Perphenazine	4554
1	In	_	ADP	IN	_	3	case	_	_
2	one	_	NUM	CD	_	3	nummod	_	_
3	study	_	NOUN	NN	_	28	nmod	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	45	_	NUM	CD	_	7	nummod	_	_
6	elderly	_	ADJ	JJ	_	7	amod	_	_
7	patients	_	NOUN	NNS	_	3	nmod	_	_
8	suffering	_	VERB	VBG	_	7	acl	_	_
9	from	_	ADP	IN	_	10	case	_	_
10	dementia	_	NOUN	NN	_	8	nmod	_	_
11	treated	_	VERB	VBN	_	10	acl	_	_
12	with	_	ADP	IN	_	13	case	_	_
13	DRUG	_	NOUN	NN	_	11	nmod	_	_
14	,	_	.	,	_	28	punct	_	_
15	the	_	DET	DT	_	17	det	_	_
16	5	_	NUM	CD	_	17	nummod	_	_
17	patients	_	NOUN	NNS	_	28	nsubj	_	_
18	who	_	DET	WDT	_	21	nsubjpass	_	_
19	were	_	VERB	VBD	_	21	auxpass	_	_
20	prospectively	_	ADV	RB	_	21	advmod	_	_
21	identified	_	VERB	VBN	_	17	acl:relcl	_	_
22	as	_	ADP	IN	_	26	case	_	_
23	poor	_	ADJ	JJ	_	26	amod	_	_
24	P450	_	NOUN	NN	_	26	compound	_	_
25	2D6	_	NOUN	NN	_	26	compound	_	_
26	metabolizers	_	NOUN	NNS	_	21	nmod	_	_
27	had	_	VERB	MD	_	28	aux	_	_
28	reported	_	VERB	VBN	_	0	root	_	_
29	significantly	_	ADV	RB	_	30	advmod	_	_
30	greater	_	ADJ	JJ	_	32	amod	_	_
31	side	_	ADJ	JJ	_	32	amod	_	_
32	effects	_	NOUN	NNS	_	28	dobj	_	_
33	during	_	ADP	IN	_	37	case	_	_
34	the	_	DET	DT	_	37	det	_	_
35	first	_	ADJ	JJ	_	37	amod	_	_
36	10	_	NUM	CD	_	37	nummod	_	_
37	days	_	NOUN	NNS	_	28	nmod	_	_
38	of	_	ADP	IN	_	39	case	_	_
39	treatment	_	NOUN	NN	_	37	nmod	_	_
40	than	_	ADP	IN	_	44	case	_	_
41	the	_	DET	DT	_	44	det	_	_
42	40	_	NUM	CD	_	44	nummod	_	_
43	extensive	_	ADJ	JJ	_	44	amod	_	_
44	metabolizers	_	NOUN	NNS	_	37	nmod	_	_
45	,	_	.	,	_	28	punct	_	_
46	following	_	ADP	IN	_	47	case	_	_
47	which	_	DET	WDT	_	50	nmod	_	_
48	the	_	DET	DT	_	49	det	_	_
49	groups	_	NOUN	NNS	_	50	nsubj	_	_
50	tended	_	VERB	VBD	_	28	advcl	_	_
51	to	_	PRT	TO	_	52	mark	_	_
52	converge	_	VERB	VB	_	50	xcomp	_	_

#	Perphenazine	4555
1	Prospective	_	ADJ	JJ	_	2	amod	_	_
2	phenotyping	_	NOUN	NN	_	11	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	elderly	_	ADJ	JJ	_	5	amod	_	_
5	patients	_	NOUN	NNS	_	2	nmod	_	_
6	prior	_	ADJ	JJ	_	9	case	_	_
7	to	_	PRT	TO	_	6	mwe	_	_
8	antipsychotic	_	ADJ	JJ	_	9	amod	_	_
9	treatment	_	NOUN	NN	_	5	nmod	_	_
10	may	_	VERB	MD	_	11	aux	_	_
11	identify	_	VERB	VB	_	0	root	_	_
12	those	_	DET	DT	_	11	dobj	_	_
13	at	_	ADP	IN	_	14	case	_	_
14	risk	_	NOUN	NN	_	11	nmod	_	_
15	for	_	ADP	IN	_	17	case	_	_
16	adverse	_	ADJ	JJ	_	17	amod	_	_
17	events	_	NOUN	NNS	_	14	nmod	_	_

#	Perphenazine	4556
1	The	_	DET	DT	_	3	det	_	_
2	concomitant	_	ADJ	JJ	_	3	amod	_	_
3	administration	_	NOUN	NN	_	16	nsubj	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	other	_	ADJ	JJ	_	6	amod	_	_
6	drugs	_	NOUN	NNS	_	3	nmod	_	_
7	that	_	DET	WDT	_	8	nsubj	_	_
8	inhibit	_	VERB	VBP	_	6	acl:relcl	_	_
9	the	_	DET	DT	_	10	det	_	_
10	activity	_	NOUN	NN	_	8	dobj	_	_
11	of	_	ADP	IN	_	13	case	_	_
12	P450	_	NOUN	NN	_	13	compound	_	_
13	2D6	_	NOUN	NN	_	10	nmod	_	_
14	may	_	VERB	MD	_	16	aux	_	_
15	acutely	_	ADV	RB	_	16	advmod	_	_
16	increase	_	VERB	VB	_	0	root	_	_
17	plasma	_	NOUN	NN	_	18	compound	_	_
18	concentrations	_	NOUN	NNS	_	16	dobj	_	_
19	of	_	ADP	IN	_	20	case	_	_
20	antipsychotics	_	NOUN	NNS	_	18	nmod	_	_

#	Perphenazine	4557
1	Among	_	ADP	IN	_	2	case	_	_
2	these	_	DET	DT	_	5	nmod	_	_
3	are	_	VERB	VBP	_	5	cop	_	_
4	tricyclic	_	ADJ	JJ	_	5	amod	_	_
5	antidepressants	_	NOUN	NNS	_	0	root	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	selective	_	ADJ	JJ	_	10	amod	_	_
8	serotonin	_	NOUN	NN	_	10	compound	_	_
9	reuptake	_	NOUN	NN	_	10	compound	_	_
10	inhibitors	_	NOUN	NNS	_	5	conj	_	_
11	,	_	.	,	_	10	punct	_	_
12	e.g	_	NOUN	NN	_	10	conj	_	_
13	,	_	.	,	_	10	punct	_	_
14	fluoxetine	_	NOUN	NN	_	10	conj	_	_
15	,	_	.	,	_	10	punct	_	_
16	sertraline	_	NOUN	NN	_	10	appos	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	paroxetine	_	NOUN	NN	_	16	conj	_	_

#	Perphenazine	4558
1	When	_	ADV	WRB	_	2	advmod	_	_
2	prescribing	_	VERB	VBG	_	15	advcl	_	_
3	these	_	DET	DT	_	4	det	_	_
4	drugs	_	NOUN	NNS	_	2	dobj	_	_
5	to	_	PRT	TO	_	6	case	_	_
6	patients	_	NOUN	NNS	_	4	nmod	_	_
7	already	_	ADV	RB	_	8	advmod	_	_
8	receiving	_	VERB	VBG	_	6	acl	_	_
9	antipsychotic	_	ADJ	JJ	_	10	amod	_	_
10	therapy	_	NOUN	NN	_	8	dobj	_	_
11	,	_	.	,	_	15	punct	_	_
12	close	_	ADJ	JJ	_	13	amod	_	_
13	monitoring	_	NOUN	NN	_	15	nsubj	_	_
14	is	_	VERB	VBZ	_	15	cop	_	_
15	essential	_	ADJ	JJ	_	20	nsubj	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	dose	_	NOUN	NN	_	18	compound	_	_
18	reduction	_	NOUN	NN	_	15	conj	_	_
19	may	_	VERB	MD	_	20	aux	_	_
20	become	_	VERB	VB	_	0	root	_	_
21	necessary	_	ADJ	JJ	_	20	xcomp	_	_
22	to	_	PRT	TO	_	24	case	_	_
23	avoid	_	NOUN	NN	_	24	compound	_	_
24	toxicity	_	NOUN	NN	_	21	nmod	_	_

#	Perphenazine	4559
1	Lower	_	ADJ	JJ	_	2	amod	_	_
2	doses	_	NOUN	NNS	_	16	nsubjpass	_	_
3	than	_	ADP	IN	_	5	mark	_	_
4	usually	_	ADV	RB	_	5	advmod	_	_
5	prescribed	_	VERB	VBN	_	2	acl	_	_
6	for	_	ADP	IN	_	9	case	_	_
7	either	_	CONJ	CC	_	9	cc:preconj	_	_
8	the	_	DET	DT	_	9	det	_	_
9	antipsychotic	_	ADJ	JJ	_	5	nmod	_	_
10	or	_	CONJ	CC	_	9	cc	_	_
11	the	_	DET	DT	_	13	det	_	_
12	other	_	ADJ	JJ	_	13	amod	_	_
13	drug	_	NOUN	NN	_	9	conj	_	_
14	may	_	VERB	MD	_	16	aux	_	_
15	be	_	VERB	VB	_	16	auxpass	_	_
16	required	_	VERB	VBN	_	0	root	_	_

#	Perphenazine	4560
1	Following	_	VERB	VBG	_	3	case	_	_
2	oral	_	ADJ	JJ	_	3	amod	_	_
3	administration	_	NOUN	NN	_	14	nmod	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	DRUG	_	NOUN	NN	_	6	compound	_	_
6	tablets	_	NOUN	NNS	_	3	nmod	_	_
7	,	_	.	,	_	14	punct	_	_
8	mean	_	ADJ	JJ	_	12	amod	_	_
9	peak	_	ADJ	JJ	_	12	amod	_	_
10	plasma	_	NOUN	NN	_	12	compound	_	_
11	DRUG	_	NOUN	NN	_	12	compound	_	_
12	concentrations	_	NOUN	NNS	_	14	nsubjpass	_	_
13	were	_	VERB	VBD	_	14	auxpass	_	_
14	observed	_	VERB	VBN	_	0	root	_	_
15	between	_	ADP	IN	_	19	case	_	_
16	1	_	NUM	CD	_	18	compound	_	_
17	to	_	PRT	TO	_	18	dep	_	_
18	3	_	NUM	CD	_	19	nummod	_	_
19	hours	_	NOUN	NNS	_	14	nmod	_	_

#	Perphenazine	4561
1	The	_	DET	DT	_	5	det	_	_
2	plasma	_	NOUN	NN	_	5	compound	_	_
3	elimination	_	NOUN	NN	_	5	compound	_	_
4	half	_	NOUN	NN	_	5	compound	_	_
5	life	_	NOUN	NN	_	9	nsubj	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	was	_	VERB	VBD	_	9	cop	_	_
9	independent	_	ADJ	JJ	_	0	root	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	dose	_	NOUN	NN	_	9	nmod	_	_
12	and	_	CONJ	CC	_	9	cc	_	_
13	ranged	_	VERB	VBN	_	9	conj	_	_
14	between	_	ADP	IN	_	18	case	_	_
15	9	_	NUM	CD	_	18	nummod	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	12	_	NUM	CD	_	15	conj	_	_
18	hours	_	NOUN	NNS	_	13	nmod	_	_

#	Perphenazine	4562
1	In	_	ADP	IN	_	3	case	_	_
2	a	_	DET	DT	_	3	det	_	_
3	study	_	NOUN	NN	_	24	nmod	_	_
4	in	_	ADP	IN	_	5	case	_	_
5	which	_	DET	WDT	_	9	nmod	_	_
6	normal	_	ADJ	JJ	_	7	amod	_	_
7	volunteers	_	NOUN	NNS	_	9	nsubj	_	_
8	n=12	_	NOUN	NN	_	7	dep	_	_
9	received	_	VERB	VBD	_	3	acl:relcl	_	_
10	DRUG	_	NOUN	NN	_	12	compound	_	_
11	4	_	NUM	CD	_	12	nummod	_	_
12	mg	_	NOUN	NN	_	9	dobj	_	_
13	q8h	_	NOUN	NN	_	12	dep	_	_
14	for	_	ADP	IN	_	16	case	_	_
15	5	_	NUM	CD	_	16	nummod	_	_
16	days	_	NOUN	NNS	_	9	nmod	_	_
17	,	_	.	,	_	24	punct	_	_
18	steady	_	ADJ	JJ	_	20	amod	_	_
19	state	_	NOUN	NN	_	20	compound	_	_
20	concentrations	_	NOUN	NNS	_	24	nsubjpass	_	_
21	of	_	ADP	IN	_	22	case	_	_
22	DRUG	_	NOUN	NN	_	20	nmod	_	_
23	were	_	VERB	VBD	_	24	auxpass	_	_
24	reached	_	VERB	VBN	_	0	root	_	_
25	within	_	ADP	IN	_	27	case	_	_
26	72	_	NUM	CD	_	27	nummod	_	_
27	hours	_	NOUN	NNS	_	24	nmod	_	_

#	Perphenazine	4563
1	Mean	_	NOUN	NN	_	3	compound	_	_
2	%CV	_	NOUN	NN	_	3	compound	_	_
3	Cmax	_	NOUN	NN	_	18	nsubj	_	_
4	and	_	CONJ	CC	_	3	cc	_	_
5	Cmin	_	NOUN	NN	_	6	compound	_	_
6	values	_	NOUN	NNS	_	3	conj	_	_
7	for	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	3	nmod	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	7	_	NUM	CD	_	12	nummod	_	_
11	hydroxy	_	NOUN	NN	_	12	compound	_	_
12	DRUG	_	NOUN	NN	_	8	conj	_	_
13	at	_	ADP	IN	_	15	case	_	_
14	steady	_	ADJ	JJ	_	15	amod	_	_
15	state	_	NOUN	NN	_	3	nmod	_	_
16	are	_	VERB	VBP	_	18	cop	_	_
17	listed	_	ADJ	JJ	_	18	amod	_	_
18	below	_	NOUN	NN	_	0	root	_	_
19	:	_	.	:	_	18	punct	_	_
20	Parameter	_	NOUN	NN	_	26	compound	_	_
21	DRUG	_	NOUN	NN	_	26	compound	_	_
22	7	_	NUM	CD	_	26	nummod	_	_
23	Hydroxy	_	NOUN	NN	_	26	compound	_	_
24	DRUG	_	NOUN	NN	_	26	compound	_	_
25	Cmax	_	NOUN	NN	_	26	compound	_	_
26	pg	_	NOUN	NN	_	45	compound	_	_
27	/	_	.	-LRB-	_	34	punct	_	_
28	mL	_	NOUN	NN	_	34	compound	_	_
29	984	_	NUM	CD	_	34	nummod	_	_
30	43	_	NUM	CD	_	34	nummod	_	_
31	509	_	NUM	CD	_	34	nummod	_	_
32	25	_	NUM	CD	_	34	nummod	_	_
33	Cmin	_	NOUN	NN	_	34	compound	_	_
34	pg	_	NOUN	NN	_	26	appos	_	_
35	/	_	.	-RRB-	_	34	punct	_	_
36	mL	_	NOUN	NN	_	45	compound	_	_
37	442	_	NUM	CD	_	45	nummod	_	_
38	76	_	NUM	CD	_	45	nummod	_	_
39	350	_	NUM	CD	_	45	nummod	_	_
40	56	_	NUM	CD	_	45	nummod	_	_
41	Peak	_	NOUN	NN	_	45	amod	_	_
42	7	_	NUM	CD	_	45	nummod	_	_
43	hydroxy	_	ADJ	JJ	_	45	amod	_	_
44	DRUG	_	NOUN	NN	_	45	compound	_	_
45	concentrations	_	NOUN	NNS	_	47	nsubjpass	_	_
46	were	_	VERB	VBD	_	47	auxpass	_	_
47	observed	_	VERB	VBN	_	18	parataxis	_	_
48	between	_	ADP	IN	_	52	case	_	_
49	2	_	NUM	CD	_	51	compound	_	_
50	to	_	PRT	TO	_	51	dep	_	_
51	4	_	NUM	CD	_	52	nummod	_	_
52	hours	_	NOUN	NNS	_	47	nmod	_	_
53	with	_	ADP	IN	_	58	case	_	_
54	a	_	DET	DT	_	58	det	_	_
55	terminal	_	ADJ	JJ	_	58	amod	_	_
56	phase	_	NOUN	NN	_	58	compound	_	_
57	half	_	NOUN	NN	_	58	compound	_	_
58	life	_	NOUN	NN	_	52	nmod	_	_
59	ranging	_	VERB	VBG	_	58	acl	_	_
60	between	_	ADP	IN	_	64	case	_	_
61	9.9	_	NUM	CD	_	63	compound	_	_
62	to	_	PRT	TO	_	63	dep	_	_
63	18.8	_	NUM	CD	_	64	nummod	_	_
64	hours	_	NOUN	NNS	_	59	nmod	_	_

#	Perphenazine	4564
1	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
2	is	_	VERB	VBZ	_	4	auxpass	_	_
3	extensively	_	ADV	RB	_	4	advmod	_	_
4	metabolized	_	VERB	VBN	_	0	root	_	_
5	in	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	liver	_	NOUN	NN	_	4	nmod	_	_
8	to	_	PRT	TO	_	10	case	_	_
9	a	_	DET	DT	_	10	det	_	_
10	number	_	NOUN	NN	_	4	nmod	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	metabolites	_	NOUN	NNS	_	10	nmod	_	_
13	by	_	ADP	IN	_	14	case	_	_
14	sulfoxidation	_	NOUN	NN	_	10	nmod	_	_
15	,	_	.	,	_	14	punct	_	_
16	hydroxylation	_	NOUN	NN	_	14	conj	_	_
17	,	_	.	,	_	14	punct	_	_
18	dealkylation	_	NOUN	NN	_	14	conj	_	_
19	,	_	.	,	_	14	punct	_	_
20	and	_	CONJ	CC	_	14	cc	_	_
21	glucuronidation	_	NOUN	NN	_	14	conj	_	_

#	Perphenazine	4565
1	The	_	DET	DT	_	2	det	_	_
2	pharmacokinetics	_	NOUN	NNS	_	5	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	covary	_	VERB	VBP	_	0	root	_	_
6	with	_	ADP	IN	_	8	case	_	_
7	the	_	DET	DT	_	8	det	_	_
8	hydroxylation	_	NOUN	NN	_	5	nmod	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	debrisoquine	_	NOUN	NN	_	8	nmod	_	_
11	which	_	DET	WDT	_	13	nsubjpass	_	_
12	is	_	VERB	VBZ	_	13	auxpass	_	_
13	mediated	_	VERB	VBN	_	10	acl:relcl	_	_
14	by	_	ADP	IN	_	19	case	_	_
15	cytochrome	_	NOUN	NN	_	19	compound	_	_
16	P450	_	NOUN	NN	_	19	compound	_	_
17	2D6	_	NOUN	NN	_	19	compound	_	_
18	CYP	_	NOUN	NN	_	19	compound	_	_
19	2D6	_	NOUN	NN	_	13	nmod	_	_
20	and	_	CONJ	CC	_	13	cc	_	_
21	thus	_	ADV	RB	_	23	advmod	_	_
22	is	_	VERB	VBZ	_	23	cop	_	_
23	subject	_	NOUN	NN	_	13	conj	_	_
24	to	_	PRT	TO	_	26	case	_	_
25	genetic	_	ADJ	JJ	_	26	amod	_	_
26	polymorphism	_	NOUN	NN	_	23	nmod	_	_
27	i.e	_	ADV	RB	_	26	advmod	_	_
28	,	_	.	,	_	5	punct	_	_
29	7%	_	NOUN	NN	_	40	nsubj	_	_
30	to	_	PRT	TO	_	31	case	_	_
31	10%	_	NOUN	NN	_	29	nmod	_	_
32	of	_	ADP	IN	_	33	case	_	_
33	Caucasians	_	NOUN	NNS	_	31	nmod	_	_
34	and	_	CONJ	CC	_	29	cc	_	_
35	a	_	DET	DT	_	37	det	_	_
36	low	_	ADJ	JJ	_	37	amod	_	_
37	percentage	_	NOUN	NN	_	29	conj	_	_
38	of	_	ADP	IN	_	39	case	_	_
39	Asians	_	NOUN	NN	_	37	nmod	_	_
40	have	_	VERB	VBP	_	5	parataxis	_	_
41	little	_	ADJ	JJ	_	44	amod	_	_
42	or	_	CONJ	CC	_	41	cc	_	_
43	no	_	DET	DT	_	41	conj	_	_
44	activity	_	NOUN	NN	_	40	dobj	_	_
45	and	_	CONJ	CC	_	40	cc	_	_
46	are	_	VERB	VBP	_	47	auxpass	_	_
47	called	_	VERB	VBN	_	40	conj	_	_
48	"poor	_	ADJ	JJ	_	51	amod	_	_
49	metabolizers."	_	NOUN	NN	_	51	compound	_	_
50	Poor	_	ADJ	JJ	_	51	amod	_	_
51	metabolizers	_	NOUN	NNS	_	47	dobj	_	_
52	of	_	ADP	IN	_	54	case	_	_
53	CYP	_	NOUN	NN	_	54	compound	_	_
54	2D6	_	NOUN	NN	_	51	nmod	_	_
55	will	_	VERB	MD	_	56	aux	_	_
56	metabolize	_	VERB	VB	_	47	parataxis	_	_
57	DRUG	_	NOUN	NN	_	56	dobj	_	_
58	more	_	ADV	RB	_	59	advmod	_	_
59	slowly	_	ADV	RB	_	56	advmod	_	_
60	and	_	CONJ	CC	_	56	cc	_	_
61	will	_	VERB	MD	_	62	aux	_	_
62	experience	_	VERB	VB	_	56	conj	_	_
63	higher	_	ADJ	JJ	_	64	amod	_	_
64	concentrations	_	NOUN	NNS	_	62	dobj	_	_
65	compared	_	VERB	VBN	_	64	acl	_	_
66	with	_	ADP	IN	_	70	case	_	_
67	normal	_	ADJ	JJ	_	70	amod	_	_
68	or	_	CONJ	CC	_	67	cc	_	_
69	"extensive"	_	NOUN	NN	_	67	conj	_	_
70	metabolizers	_	NOUN	NNS	_	65	nmod	_	_

#	Pfizerpen	6476
1	Bacteriostatic	_	ADJ	JJ	_	2	amod	_	_
2	antibacterials	_	NOUN	NNS	_	13	nsubj	_	_
3	i.e	_	ADJ	JJ	_	2	amod	_	_
4	,	_	.	,	_	3	punct	_	_
5	chloramphenicol	_	NOUN	NN	_	3	conj	_	_
6	,	_	.	,	_	3	punct	_	_
7	erythromycins	_	NOUN	NNS	_	3	conj	_	_
8	,	_	.	,	_	3	punct	_	_
9	sulfonamides	_	NOUN	NNS	_	3	conj	_	_
10	or	_	CONJ	CC	_	3	cc	_	_
11	tetracyclines	_	NOUN	NNS	_	3	conj	_	_
12	may	_	VERB	MD	_	13	aux	_	_
13	antagonize	_	VERB	VB	_	0	root	_	_
14	the	_	DET	DT	_	16	det	_	_
15	bactericidal	_	ADJ	JJ	_	16	amod	_	_
16	effect	_	NOUN	NN	_	13	dobj	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	penicillin	_	NOUN	NN	_	16	nmod	_	_
19	,	_	.	,	_	13	punct	_	_
20	and	_	CONJ	CC	_	13	cc	_	_
21	concurrent	_	ADJ	JJ	_	22	amod	_	_
22	use	_	NOUN	NN	_	28	nsubjpass	_	_
23	of	_	ADP	IN	_	25	case	_	_
24	these	_	DET	DT	_	25	det	_	_
25	drugs	_	NOUN	NNS	_	22	nmod	_	_
26	should	_	VERB	MD	_	28	aux	_	_
27	be	_	VERB	VB	_	28	auxpass	_	_
28	avoided	_	VERB	VBN	_	13	conj	_	_

#	Pfizerpen	6477
1	This	_	DET	DT	_	4	nsubjpass	_	_
2	has	_	VERB	VBZ	_	4	aux	_	_
3	been	_	VERB	VBN	_	4	auxpass	_	_
4	documented	_	VERB	VBN	_	18	advcl	_	_
5	in	_	X	FW	_	6	compound	_	_
6	vitro	_	X	FW	_	4	advmod	_	_
7	however	_	ADV	RB	_	4	advmod	_	_
8	,	_	.	,	_	18	punct	_	_
9	the	_	DET	DT	_	11	det	_	_
10	clinical	_	ADJ	JJ	_	11	amod	_	_
11	significance	_	NOUN	NN	_	18	nsubjpass	_	_
12	of	_	ADP	IN	_	14	case	_	_
13	this	_	DET	DT	_	14	det	_	_
14	interaction	_	NOUN	NN	_	11	nmod	_	_
15	is	_	VERB	VBZ	_	18	auxpass	_	_
16	not	_	ADV	RB	_	18	neg	_	_
17	well	_	ADV	RB	_	18	advmod	_	_
18	documented	_	VERB	VBN	_	0	root	_	_

#	Pfizerpen	6478
1	Penicillin	_	NOUN	NN	_	3	compound	_	_
2	blood	_	NOUN	NN	_	3	compound	_	_
3	levels	_	NOUN	NNS	_	6	nsubjpass	_	_
4	may	_	VERB	MD	_	6	aux	_	_
5	be	_	VERB	VB	_	6	auxpass	_	_
6	prolonged	_	VERB	VBN	_	0	root	_	_
7	by	_	ADP	IN	_	9	case	_	_
8	concurrent	_	ADJ	JJ	_	9	amod	_	_
9	administration	_	NOUN	NN	_	6	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	probenecid	_	NOUN	NN	_	9	nmod	_	_
12	which	_	DET	WDT	_	13	nsubj	_	_
13	blocks	_	VERB	VBZ	_	11	acl:relcl	_	_
14	the	_	DET	DT	_	17	det	_	_
15	renal	_	ADJ	JJ	_	17	amod	_	_
16	tubular	_	ADJ	JJ	_	17	amod	_	_
17	secretion	_	NOUN	NN	_	13	dobj	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	penicillins	_	NOUN	NNS	_	17	nmod	_	_

#	Pfizerpen	6479
1	Other	_	ADJ	JJ	_	2	amod	_	_
2	drugs	_	NOUN	NNS	_	4	nsubj	_	_
3	may	_	VERB	MD	_	4	aux	_	_
4	compete	_	VERB	VB	_	0	root	_	_
5	with	_	ADP	IN	_	7	case	_	_
6	penicillin	_	NOUN	NN	_	7	compound	_	_
7	DRUGS	_	NOUN	NN	_	4	nmod	_	_
8	for	_	ADP	IN	_	11	case	_	_
9	renal	_	ADJ	JJ	_	11	amod	_	_
10	tubular	_	ADJ	JJ	_	11	amod	_	_
11	secretion	_	NOUN	NN	_	7	nmod	_	_
12	and	_	CONJ	CC	_	4	cc	_	_
13	thus	_	ADV	RB	_	14	advmod	_	_
14	prolong	_	VERB	VBP	_	4	conj	_	_
15	the	_	DET	DT	_	18	det	_	_
16	serum	_	NOUN	NN	_	18	compound	_	_
17	half	_	NOUN	NN	_	18	compound	_	_
18	life	_	NOUN	NN	_	14	dobj	_	_
19	of	_	ADP	IN	_	20	case	_	_
20	penicillin	_	NOUN	NN	_	18	nmod	_	_

#	Pfizerpen	6480
1	These	_	DET	DT	_	2	det	_	_
2	drugs	_	NOUN	NNS	_	3	nsubj	_	_
3	include	_	VERB	VBP	_	0	root	_	_
4	:	_	.	:	_	3	punct	_	_
5	aspirin	_	NOUN	NN	_	3	dep	_	_
6	,	_	.	,	_	5	punct	_	_
7	phenylbutazone	_	NOUN	NN	_	5	conj	_	_
8	,	_	.	,	_	5	punct	_	_
9	sulfonamides	_	NOUN	NNS	_	5	conj	_	_
10	,	_	.	,	_	5	punct	_	_
11	indomethacin	_	NOUN	NN	_	5	conj	_	_
12	,	_	.	,	_	5	punct	_	_
13	thiazide	_	NOUN	NN	_	14	compound	_	_
14	diuretics	_	NOUN	NNS	_	5	conj	_	_
15	,	_	.	,	_	5	punct	_	_
16	furosemide	_	NOUN	NN	_	5	conj	_	_
17	and	_	CONJ	CC	_	5	cc	_	_
18	ethacrynic	_	ADJ	JJ	_	19	amod	_	_
19	acid	_	NOUN	NN	_	5	conj	_	_

#	Pfizerpen	6481
1	Aqueous	_	ADJ	JJ	_	3	amod	_	_
2	penicillin	_	NOUN	NN	_	3	compound	_	_
3	DRUGS	_	NOUN	NN	_	6	nsubjpass	_	_
4	is	_	VERB	VBZ	_	6	auxpass	_	_
5	rapidly	_	ADV	RB	_	6	advmod	_	_
6	absorbed	_	VERB	VBN	_	0	root	_	_
7	following	_	ADP	IN	_	9	case	_	_
8	both	_	CONJ	CC	_	9	cc:preconj	_	_
9	intramuscular	_	ADJ	JJ	_	6	nmod	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	subcutaneous	_	ADJ	JJ	_	9	conj	_	_
12	injection	_	NOUN	NN	_	9	dep	_	_

#	Pfizerpen	6482
1	Initial	_	ADJ	JJ	_	3	amod	_	_
2	blood	_	NOUN	NN	_	3	compound	_	_
3	levels	_	NOUN	NNS	_	8	nsubj	_	_
4	following	_	VERB	VBG	_	6	case	_	_
5	parenteral	_	ADJ	JJ	_	6	amod	_	_
6	administration	_	NOUN	NN	_	3	nmod	_	_
7	are	_	VERB	VBP	_	8	cop	_	_
8	high	_	ADJ	JJ	_	0	root	_	_
9	but	_	CONJ	CC	_	8	cc	_	_
10	transient	_	ADJ	JJ	_	8	conj	_	_

#	Pfizerpen	6483
1	Penicillins	_	NOUN	NNS	_	2	nsubj	_	_
2	bind	_	VERB	VBP	_	0	root	_	_
3	to	_	PRT	TO	_	5	case	_	_
4	serum	_	NOUN	NN	_	5	compound	_	_
5	proteins	_	NOUN	NNS	_	2	nmod	_	_
6	,	_	.	,	_	5	punct	_	_
7	mainly	_	ADV	RB	_	8	advmod	_	_
8	albumin	_	NOUN	NN	_	5	appos	_	_

#	Pfizerpen	6484
1	Therapeutic	_	ADJ	JJ	_	2	amod	_	_
2	levels	_	NOUN	NNS	_	8	nsubjpass	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	the	_	DET	DT	_	5	det	_	_
5	penicillins	_	NOUN	NNS	_	2	nmod	_	_
6	are	_	VERB	VBP	_	8	auxpass	_	_
7	easily	_	ADV	RB	_	8	advmod	_	_
8	achieved	_	VERB	VBN	_	0	root	_	_
9	under	_	ADP	IN	_	11	case	_	_
10	normal	_	ADJ	JJ	_	11	amod	_	_
11	circumstances	_	NOUN	NNS	_	8	nmod	_	_
12	in	_	ADP	IN	_	14	case	_	_
13	extracellular	_	ADJ	JJ	_	14	amod	_	_
14	fluid	_	NOUN	NN	_	11	nmod	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	most	_	ADV	RB	_	19	amod	_	_
17	other	_	ADJ	JJ	_	19	amod	_	_
18	body	_	NOUN	NN	_	19	compound	_	_
19	tissues	_	NOUN	NNS	_	14	conj	_	_

#	Pfizerpen	6485
1	Penicillins	_	NOUN	NNS	_	3	nsubjpass	_	_
2	are	_	VERB	VBP	_	3	auxpass	_	_
3	distributed	_	VERB	VBN	_	0	root	_	_
4	in	_	ADP	IN	_	6	case	_	_
5	varying	_	ADJ	JJ	_	6	amod	_	_
6	degrees	_	NOUN	NNS	_	3	nmod	_	_
7	into	_	ADP	IN	_	20	case	_	_
8	pleural	_	ADJ	JJ	_	20	amod	_	_
9	,	_	.	,	_	8	punct	_	_
10	pericardial	_	ADJ	JJ	_	8	conj	_	_
11	,	_	.	,	_	8	punct	_	_
12	peritoneal	_	ADJ	JJ	_	8	conj	_	_
13	,	_	.	,	_	8	punct	_	_
14	ascitic	_	ADJ	JJ	_	8	conj	_	_
15	,	_	.	,	_	8	punct	_	_
16	synovial	_	ADJ	JJ	_	8	conj	_	_
17	,	_	.	,	_	8	punct	_	_
18	and	_	CONJ	CC	_	8	cc	_	_
19	interstitial	_	ADJ	JJ	_	8	conj	_	_
20	fluids	_	NOUN	NNS	_	6	nmod	_	_

#	Pfizerpen	6486
1	Penetration	_	NOUN	NN	_	12	nsubj	_	_
2	into	_	ADP	IN	_	5	case	_	_
3	the	_	DET	DT	_	5	det	_	_
4	cerebrospinal	_	ADJ	JJ	_	5	amod	_	_
5	fluid	_	NOUN	NN	_	1	nmod	_	_
6	,	_	.	,	_	5	punct	_	_
7	eyes	_	ADV	RB	_	5	conj	_	_
8	,	_	.	,	_	5	punct	_	_
9	and	_	CONJ	CC	_	5	cc	_	_
10	prostate	_	NOUN	NN	_	5	conj	_	_
11	is	_	VERB	VBZ	_	12	auxpass	_	_
12	poor	_	ADJ	JJ	_	0	root	_	_

#	Pfizerpen	6487
1	Penicillins	_	NOUN	NNS	_	4	nsubjpass	_	_
2	are	_	VERB	VBP	_	4	auxpass	_	_
3	rapidly	_	ADV	RB	_	4	advmod	_	_
4	excreted	_	VERB	VBN	_	0	root	_	_
5	in	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	urine	_	NOUN	NN	_	4	nmod	_	_
8	by	_	ADP	IN	_	10	case	_	_
9	glomerular	_	ADJ	JJ	_	10	amod	_	_
10	filtration	_	NOUN	NN	_	7	nmod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	active	_	ADJ	JJ	_	14	amod	_	_
13	tubular	_	ADJ	JJ	_	14	amod	_	_
14	secretion	_	NOUN	NN	_	10	conj	_	_
15	,	_	.	,	_	4	punct	_	_
16	primarily	_	ADV	RB	_	19	advmod	_	_
17	as	_	ADP	IN	_	19	case	_	_
18	unchanged	_	ADJ	JJ	_	19	amod	_	_
19	drug	_	NOUN	NN	_	4	nmod	_	_

#	Pfizerpen	6488
1	Approximately	_	ADV	RB	_	12	advmod	_	_
2	60	_	NUM	CD	_	3	nummod	_	_
3	percent	_	NOUN	NN	_	12	nsubjpass	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	the	_	DET	DT	_	7	det	_	_
6	total	_	ADJ	JJ	_	7	amod	_	_
7	dose	_	NOUN	NN	_	3	nmod	_	_
8	of	_	ADP	IN	_	10	case	_	_
9	300,000	_	NUM	CD	_	10	nummod	_	_
10	units	_	NOUN	NNS	_	7	nmod	_	_
11	is	_	VERB	VBZ	_	12	auxpass	_	_
12	excreted	_	VERB	VBN	_	0	root	_	_
13	in	_	ADP	IN	_	15	case	_	_
14	the	_	DET	DT	_	15	det	_	_
15	urine	_	NOUN	NN	_	12	nmod	_	_
16	within	_	ADP	IN	_	20	case	_	_
17	this	_	DET	DT	_	20	det	_	_
18	5	_	NUM	CD	_	20	nummod	_	_
19	hour	_	NUM	CD	_	20	nummod	_	_
20	period	_	NOUN	NN	_	15	nmod	_	_

#	Pfizerpen	6489
1	For	_	ADP	IN	_	3	case	_	_
2	this	_	DET	DT	_	3	det	_	_
3	reason	_	NOUN	NN	_	10	nmod	_	_
4	,	_	.	,	_	10	punct	_	_
5	high	_	ADJ	JJ	_	8	amod	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	frequent	_	ADJ	JJ	_	5	conj	_	_
8	doses	_	NOUN	NNS	_	10	nsubjpass	_	_
9	are	_	VERB	VBP	_	10	auxpass	_	_
10	required	_	VERB	VBN	_	0	root	_	_
11	to	_	PRT	TO	_	12	mark	_	_
12	maintain	_	VERB	VB	_	10	xcomp	_	_
13	the	_	DET	DT	_	16	det	_	_
14	elevated	_	ADJ	JJ	_	16	amod	_	_
15	serum	_	NOUN	NN	_	16	compound	_	_
16	levels	_	NOUN	NNS	_	12	dobj	_	_
17	desirable	_	ADJ	JJ	_	16	amod	_	_
18	in	_	ADP	IN	_	19	mark	_	_
19	treating	_	VERB	VBG	_	17	advcl	_	_
20	certain	_	ADJ	JJ	_	22	amod	_	_
21	severe	_	ADJ	JJ	_	22	amod	_	_
22	infections	_	NOUN	NNS	_	19	dobj	_	_
23	in	_	ADP	IN	_	24	case	_	_
24	individuals	_	NOUN	NNS	_	22	nmod	_	_
25	with	_	ADP	IN	_	28	case	_	_
26	normal	_	ADJ	JJ	_	28	amod	_	_
27	kidney	_	NOUN	NN	_	28	compound	_	_
28	function	_	NOUN	NN	_	24	nmod	_	_

#	Pfizerpen	6490
1	In	_	ADP	IN	_	2	case	_	_
2	neonates	_	NOUN	NNS	_	18	nmod	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	young	_	ADJ	JJ	_	5	amod	_	_
5	infants	_	NOUN	NNS	_	2	conj	_	_
6	,	_	.	,	_	2	punct	_	_
7	and	_	CONJ	CC	_	2	cc	_	_
8	in	_	ADP	IN	_	9	case	_	_
9	individuals	_	NOUN	NNS	_	2	conj	_	_
10	with	_	ADP	IN	_	13	case	_	_
11	impaired	_	ADJ	JJ	_	13	amod	_	_
12	kidney	_	NOUN	NN	_	13	compound	_	_
13	function	_	NOUN	NN	_	9	nmod	_	_
14	,	_	.	,	_	18	punct	_	_
15	excretion	_	NOUN	NN	_	18	nsubjpass	_	_
16	is	_	VERB	VBZ	_	18	auxpass	_	_
17	considerably	_	ADV	RB	_	18	advmod	_	_
18	delayed	_	VERB	VBN	_	0	root	_	_

#	Pfizerpen	6491
1	After	_	ADP	IN	_	4	case	_	_
2	an	_	DET	DT	_	4	det	_	_
3	intravenous	_	ADJ	JJ	_	4	amod	_	_
4	infusion	_	NOUN	NN	_	13	nmod	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	penicillin	_	NOUN	NN	_	7	compound	_	_
7	DRUGS	_	NOUN	NN	_	4	nmod	_	_
8	,	_	.	,	_	13	punct	_	_
9	peak	_	ADJ	JJ	_	11	amod	_	_
10	serum	_	NOUN	NN	_	11	compound	_	_
11	concentrations	_	NOUN	NNS	_	13	nsubjpass	_	_
12	are	_	VERB	VBP	_	13	auxpass	_	_
13	attained	_	VERB	VBN	_	0	root	_	_
14	immediately	_	ADV	RB	_	13	advmod	_	_
15	after	_	ADP	IN	_	16	case	_	_
16	completion	_	NOUN	NN	_	13	nmod	_	_
17	of	_	ADP	IN	_	19	case	_	_
18	the	_	DET	DT	_	19	det	_	_
19	infusion	_	NOUN	NN	_	16	nmod	_	_

#	Pfizerpen	6492
1	In	_	ADP	IN	_	3	case	_	_
2	a	_	DET	DT	_	3	det	_	_
3	study	_	NOUN	NN	_	7	nmod	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	ten	_	NUM	CD	_	6	nummod	_	_
6	patients	_	NOUN	NNS	_	3	nmod	_	_
7	administered	_	VERB	VBD	_	29	advcl	_	_
8	a	_	DET	DT	_	13	det	_	_
9	single	_	ADJ	JJ	_	13	amod	_	_
10	5	_	NUM	CD	_	13	nummod	_	_
11	million	_	NOUN	NN	_	13	compound	_	_
12	unit	_	NOUN	NN	_	13	compound	_	_
13	dose	_	NOUN	NN	_	7	dobj	_	_
14	of	_	ADP	IN	_	16	case	_	_
15	penicillin	_	NOUN	NN	_	16	compound	_	_
16	DRUGS	_	NOUN	NN	_	13	nmod	_	_
17	intravenously	_	ADV	RB	_	7	advmod	_	_
18	over	_	ADP	IN	_	21	case	_	_
19	3	_	NUM	CD	_	21	nummod	_	_
20	5	_	NUM	CD	_	21	nummod	_	_
21	minutes	_	NOUN	NNS	_	7	nmod	_	_
22	,	_	.	,	_	29	punct	_	_
23	the	_	DET	DT	_	26	det	_	_
24	mean	_	ADJ	JJ	_	26	compound	_	_
25	serum	_	NOUN	NN	_	26	compound	_	_
26	concentrations	_	NOUN	NNS	_	29	nsubj	_	_
27	were	_	VERB	VBD	_	29	cop	_	_
28	400	_	NUM	CD	_	29	nummod	_	_
29	mcg	_	NOUN	NN	_	0	root	_	_
30	/	_	.	:	_	29	punct	_	_
31	mL	_	NOUN	NN	_	29	dep	_	_
32	,	_	.	,	_	31	punct	_	_
33	273	_	NUM	CD	_	34	nummod	_	_
34	mcg	_	NOUN	NN	_	31	conj	_	_
35	/	_	.	:	_	31	punct	_	_
36	mL	_	NOUN	NN	_	31	dep	_	_
37	and	_	CONJ	CC	_	36	cc	_	_
38	3.0	_	NUM	CD	_	39	nummod	_	_
39	mcg	_	NOUN	NN	_	36	conj	_	_
40	/	_	.	:	_	31	punct	_	_
41	mL	_	NOUN	NN	_	31	dep	_	_
42	at	_	ADP	IN	_	45	case	_	_
43	5	_	NUM	CD	_	45	nummod	_	_
44	6	_	NUM	CD	_	45	nummod	_	_
45	minutes	_	NOUN	NNS	_	41	nmod	_	_
46	,	_	.	,	_	41	punct	_	_
47	10	_	NUM	CD	_	48	nummod	_	_
48	minutes	_	NOUN	NNS	_	41	appos	_	_
49	and	_	CONJ	CC	_	48	cc	_	_
50	4	_	NUM	CD	_	51	nummod	_	_
51	hours	_	NOUN	NNS	_	48	conj	_	_
52	after	_	ADP	IN	_	53	case	_	_
53	completion	_	NOUN	NN	_	48	nmod	_	_
54	of	_	ADP	IN	_	56	case	_	_
55	the	_	DET	DT	_	56	det	_	_
56	injection	_	NOUN	NN	_	53	nmod	_	_
57	,	_	.	,	_	41	punct	_	_
58	respectively	_	ADV	RB	_	41	advmod	_	_

#	Pfizerpen	6493
1	In	_	ADP	IN	_	4	case	_	_
2	a	_	DET	DT	_	4	det	_	_
3	separate	_	ADJ	JJ	_	4	amod	_	_
4	study	_	NOUN	NN	_	10	nmod	_	_
5	,	_	.	,	_	10	punct	_	_
6	five	_	NUM	CD	_	8	nummod	_	_
7	healthy	_	ADJ	JJ	_	8	amod	_	_
8	adults	_	NOUN	NNS	_	10	nsubjpass	_	_
9	were	_	VERB	VBD	_	10	auxpass	_	_
10	administered	_	VERB	VBN	_	0	root	_	_
11	one	_	NUM	CD	_	13	nummod	_	_
12	million	_	NOUN	NN	_	13	compound	_	_
13	units	_	NOUN	NNS	_	10	dobj	_	_
14	of	_	ADP	IN	_	16	case	_	_
15	penicillin	_	NOUN	NN	_	16	compound	_	_
16	DRUGS	_	NOUN	NN	_	13	nmod	_	_
17	intravenously	_	ADV	RB	_	10	advmod	_	_
18	,	_	.	,	_	10	punct	_	_
19	either	_	CONJ	CC	_	22	cc:preconj	_	_
20	as	_	ADP	IN	_	19	mwe	_	_
21	a	_	DET	DT	_	22	det	_	_
22	bolus	_	NOUN	NN	_	10	nmod	_	_
23	over	_	ADP	IN	_	25	case	_	_
24	4	_	NUM	CD	_	25	nummod	_	_
25	minutes	_	NOUN	NNS	_	22	nmod	_	_
26	or	_	CONJ	CC	_	22	cc	_	_
27	as	_	ADP	IN	_	29	case	_	_
28	an	_	DET	DT	_	29	det	_	_
29	infusion	_	NOUN	NN	_	22	conj	_	_
30	over	_	ADP	IN	_	32	case	_	_
31	60	_	NUM	CD	_	32	nummod	_	_
32	minutes	_	NOUN	NNS	_	29	nmod	_	_

#	Pfizerpen	6494
1	The	_	DET	DT	_	4	det	_	_
2	mean	_	ADJ	JJ	_	4	compound	_	_
3	serum	_	NOUN	NN	_	4	compound	_	_
4	concentration	_	NOUN	NN	_	14	nsubj	_	_
5	eight	_	NUM	CD	_	6	nummod	_	_
6	minutes	_	NOUN	NNS	_	4	dep	_	_
7	after	_	ADP	IN	_	8	case	_	_
8	completion	_	NOUN	NN	_	4	nmod	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	the	_	DET	DT	_	11	det	_	_
11	bolus	_	NOUN	NN	_	8	nmod	_	_
12	was	_	VERB	VBD	_	14	cop	_	_
13	45	_	NUM	CD	_	14	nummod	_	_
14	mcg	_	NOUN	NN	_	0	root	_	_
15	/	_	.	:	_	14	punct	_	_
16	mL	_	NOUN	NN	_	27	nsubj	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	eight	_	NUM	CD	_	19	nummod	_	_
19	minutes	_	NOUN	NNS	_	16	conj	_	_
20	after	_	ADP	IN	_	21	case	_	_
21	completion	_	NOUN	NN	_	16	nmod	_	_
22	of	_	ADP	IN	_	24	case	_	_
23	the	_	DET	DT	_	24	det	_	_
24	infusion	_	NOUN	NN	_	21	nmod	_	_
25	was	_	VERB	VBD	_	27	cop	_	_
26	14.4	_	NUM	CD	_	27	nummod	_	_
27	mcg	_	NOUN	NN	_	14	dep	_	_
28	/	_	.	:	_	27	punct	_	_
29	mL	_	NOUN	NN	_	27	dep	_	_

#	Pfizerpen	6495
1	The	_	DET	DT	_	7	det	_	_
2	mean	_	ADJ	JJ	_	7	compound	_	_
3	B	_	NOUN	NN	_	7	compound	_	_
4	phase	_	NOUN	NN	_	7	compound	_	_
5	serum	_	NOUN	NN	_	7	compound	_	_
6	half	_	ADJ	JJ	_	7	compound	_	_
7	life	_	NOUN	NN	_	25	nsubj	_	_
8	of	_	ADP	IN	_	10	case	_	_
9	penicillin	_	NOUN	NN	_	10	compound	_	_
10	DRUGS	_	NOUN	NN	_	7	nmod	_	_
11	administered	_	VERB	VBN	_	10	acl	_	_
12	by	_	ADP	IN	_	15	case	_	_
13	the	_	DET	DT	_	15	det	_	_
14	intravenous	_	ADJ	JJ	_	15	amod	_	_
15	route	_	NOUN	NN	_	11	nmod	_	_
16	in	_	ADP	IN	_	18	case	_	_
17	ten	_	NUM	CD	_	18	nummod	_	_
18	patients	_	NOUN	NNS	_	15	nmod	_	_
19	with	_	ADP	IN	_	22	case	_	_
20	normal	_	ADJ	JJ	_	22	amod	_	_
21	renal	_	ADJ	JJ	_	22	amod	_	_
22	function	_	NOUN	NN	_	18	nmod	_	_
23	was	_	VERB	VBD	_	25	cop	_	_
24	42	_	NUM	CD	_	25	nummod	_	_
25	minutes	_	NOUN	NNS	_	0	root	_	_
26	,	_	.	,	_	25	punct	_	_
27	with	_	ADP	IN	_	29	case	_	_
28	a	_	DET	DT	_	29	det	_	_
29	range	_	NOUN	NN	_	25	nmod	_	_
30	of	_	ADP	IN	_	33	case	_	_
31	31	_	NUM	CD	_	33	nummod	_	_
32	50	_	NUM	CD	_	33	nummod	_	_
33	minutes	_	NOUN	NNS	_	29	nmod	_	_

#	Pfizerpen	6496
1	The	_	DET	DT	_	2	det	_	_
2	clearance	_	NOUN	NN	_	13	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	penicillin	_	NOUN	NN	_	5	compound	_	_
5	DRUGS	_	NOUN	NN	_	2	nmod	_	_
6	in	_	ADP	IN	_	8	case	_	_
7	normal	_	ADJ	JJ	_	8	amod	_	_
8	individuals	_	NOUN	NNS	_	2	nmod	_	_
9	is	_	VERB	VBZ	_	13	cop	_	_
10	predominantly	_	ADV	RB	_	13	advmod	_	_
11	via	_	ADP	IN	_	13	case	_	_
12	the	_	DET	DT	_	13	det	_	_
13	kidney	_	NOUN	NN	_	0	root	_	_

#	Pfizerpen	6497
1	The	_	DET	DT	_	3	det	_	_
2	renal	_	ADJ	JJ	_	3	amod	_	_
3	clearance	_	NOUN	NN	_	12	nsubj	_	_
4	,	_	.	,	_	3	punct	_	_
5	which	_	DET	WDT	_	8	nsubj	_	_
6	is	_	VERB	VBZ	_	8	cop	_	_
7	extremely	_	ADV	RB	_	8	advmod	_	_
8	rapid	_	ADJ	JJ	_	3	acl:relcl	_	_
9	,	_	.	,	_	3	punct	_	_
10	is	_	VERB	VBZ	_	12	cop	_	_
11	the	_	DET	DT	_	12	det	_	_
12	result	_	NOUN	NN	_	0	root	_	_
13	of	_	ADP	IN	_	15	case	_	_
14	glomerular	_	ADJ	JJ	_	15	amod	_	_
15	filtration	_	NOUN	NN	_	12	nmod	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	active	_	ADJ	JJ	_	19	amod	_	_
18	tubular	_	ADJ	JJ	_	19	amod	_	_
19	transport	_	NOUN	NN	_	15	conj	_	_
20	,	_	.	,	_	12	punct	_	_
21	with	_	ADP	IN	_	24	case	_	_
22	the	_	DET	DT	_	24	det	_	_
23	latter	_	ADJ	JJ	_	24	amod	_	_
24	route	_	NOUN	NN	_	12	nmod	_	_
25	predominating	_	VERB	VBG	_	24	acl	_	_

#	Pfizerpen	6498
1	Urinary	_	ADJ	JJ	_	2	amod	_	_
2	recovery	_	NOUN	NN	_	4	nsubjpass	_	_
3	is	_	VERB	VBZ	_	4	auxpass	_	_
4	reported	_	VERB	VBN	_	0	root	_	_
5	to	_	PRT	TO	_	8	mark	_	_
6	be	_	VERB	VB	_	8	cop	_	_
7	58	_	NUM	CD	_	8	nummod	_	_
8	85%	_	NOUN	NN	_	4	nmod	_	_
9	of	_	ADP	IN	_	12	case	_	_
10	the	_	DET	DT	_	12	det	_	_
11	administered	_	VERB	VBN	_	12	amod	_	_
12	dose	_	NOUN	NN	_	8	nmod	_	_

#	Pfizerpen	6499
1	Renal	_	ADJ	JJ	_	2	amod	_	_
2	clearance	_	NOUN	NN	_	6	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	penicillin	_	NOUN	NN	_	2	nmod	_	_
5	is	_	VERB	VBZ	_	6	auxpass	_	_
6	delayed	_	VERB	VBN	_	0	root	_	_
7	in	_	ADP	IN	_	9	case	_	_
8	premature	_	ADJ	JJ	_	9	amod	_	_
9	infants	_	NOUN	NNS	_	6	nmod	_	_
10	,	_	.	,	_	6	punct	_	_
11	neonates	_	VERB	VBZ	_	6	dep	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	in	_	ADP	IN	_	15	case	_	_
14	the	_	DET	DT	_	15	det	_	_
15	elderly	_	ADJ	JJ	_	11	conj	_	_
16	due	_	ADJ	JJ	_	15	nmod	_	_
17	to	_	PRT	TO	_	20	case	_	_
18	decreased	_	VERB	VBN	_	20	amod	_	_
19	renal	_	ADJ	JJ	_	20	amod	_	_
20	function	_	NOUN	NN	_	16	nmod	_	_

#	Pfizerpen	6500
1	The	_	DET	DT	_	4	det	_	_
2	serum	_	NOUN	NN	_	4	compound	_	_
3	half	_	NOUN	NN	_	4	compound	_	_
4	life	_	NOUN	NN	_	8	nsubj	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	penicillin	_	NOUN	NN	_	7	compound	_	_
7	DRUGS	_	NOUN	NN	_	4	nmod	_	_
8	correlates	_	VERB	VBZ	_	0	root	_	_
9	inversely	_	ADV	RB	_	8	advmod	_	_
10	with	_	ADP	IN	_	11	case	_	_
11	age	_	NOUN	NN	_	8	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	clearance	_	NOUN	NN	_	11	conj	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	creatinine	_	NOUN	NN	_	11	nmod	_	_
16	and	_	CONJ	CC	_	8	cc	_	_
17	ranges	_	NOUN	NNS	_	8	conj	_	_
18	from	_	ADP	IN	_	20	case	_	_
19	3.2	_	NUM	CD	_	20	nummod	_	_
20	hours	_	NOUN	NNS	_	17	nmod	_	_
21	in	_	ADP	IN	_	22	case	_	_
22	infants	_	NOUN	NNS	_	17	nmod	_	_
23	0	_	NUM	CD	_	25	compound	_	_
24	to	_	PRT	TO	_	25	dep	_	_
25	6	_	NUM	CD	_	26	nummod	_	_
26	days	_	NOUN	NNS	_	22	dep	_	_
27	of	_	ADP	IN	_	28	case	_	_
28	age	_	NOUN	NN	_	26	nmod	_	_
29	to	_	PRT	TO	_	31	case	_	_
30	1.4	_	NUM	CD	_	31	nummod	_	_
31	hours	_	NOUN	NNS	_	26	nmod	_	_
32	in	_	ADP	IN	_	33	case	_	_
33	infants	_	NOUN	NNS	_	26	nmod	_	_
34	14	_	NUM	CD	_	35	nummod	_	_
35	days	_	NOUN	NNS	_	33	dep	_	_
36	of	_	ADP	IN	_	37	case	_	_
37	age	_	NOUN	NN	_	35	nmod	_	_
38	or	_	CONJ	CC	_	17	cc	_	_
39	older	_	ADV	RB	_	17	advmod	_	_

#	Pfizerpen	6501
1	Nonrenal	_	ADJ	JJ	_	2	amod	_	_
2	clearance	_	NOUN	NN	_	3	nsubj	_	_
3	includes	_	VERB	VBZ	_	0	root	_	_
4	hepatic	_	ADJ	JJ	_	5	amod	_	_
5	metabolism	_	NOUN	NN	_	3	dobj	_	_
6	and	_	CONJ	CC	_	3	cc	_	_
7	,	_	.	,	_	3	punct	_	_
8	to	_	PRT	TO	_	11	case	_	_
9	a	_	DET	DT	_	11	det	_	_
10	lesser	_	ADJ	JJ	_	11	amod	_	_
11	extent	_	NOUN	NN	_	3	conj	_	_
12	,	_	.	,	_	11	punct	_	_
13	biliary	_	ADJ	JJ	_	14	amod	_	_
14	excretion	_	NOUN	NN	_	12	root	_	_

#	Pfizerpen	6502
1	The	_	DET	DT	_	3	det	_	_
2	latter	_	ADJ	JJ	_	3	amod	_	_
3	routes	_	NOUN	NNS	_	4	nsubj	_	_
4	become	_	VERB	VBD	_	0	root	_	_
5	more	_	ADV	RB	_	6	advmod	_	_
6	important	_	ADJ	JJ	_	4	xcomp	_	_
7	with	_	ADP	IN	_	9	case	_	_
8	renal	_	ADJ	JJ	_	9	amod	_	_
9	impairment	_	NOUN	NN	_	6	nmod	_	_

#	Pfizerpen	6503
1	Probenecid	_	NOUN	NN	_	2	nsubj	_	_
2	blocks	_	VERB	VBZ	_	0	root	_	_
3	the	_	DET	DT	_	6	det	_	_
4	renal	_	ADJ	JJ	_	6	amod	_	_
5	tubular	_	ADJ	JJ	_	6	amod	_	_
6	secretion	_	NOUN	NN	_	2	dobj	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	penicillin	_	NOUN	NN	_	6	nmod	_	_

#	Pfizerpen	6504
1	Therefore	_	ADV	RB	_	8	advmod	_	_
2	,	_	.	,	_	8	punct	_	_
3	the	_	DET	DT	_	5	det	_	_
4	concurrent	_	ADJ	JJ	_	5	amod	_	_
5	administration	_	NOUN	NN	_	8	nsubj	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	probenecid	_	NOUN	NN	_	5	nmod	_	_
8	prolongs	_	VERB	VBZ	_	0	root	_	_
9	the	_	DET	DT	_	10	det	_	_
10	elimination	_	NOUN	NN	_	8	dobj	_	_
11	of	_	ADP	IN	_	13	case	_	_
12	penicillin	_	NOUN	NN	_	13	compound	_	_
13	DRUGS	_	NOUN	NN	_	10	nmod	_	_
14	and	_	CONJ	CC	_	8	cc	_	_
15	,	_	.	,	_	8	punct	_	_
16	consequently	_	ADV	RB	_	8	advmod	_	_
17	,	_	.	,	_	8	punct	_	_
18	increases	_	VERB	VBZ	_	8	conj	_	_
19	the	_	DET	DT	_	21	det	_	_
20	serum	_	NOUN	NN	_	21	compound	_	_
21	concentrations	_	NOUN	NNS	_	18	root	_	_

#	Pfizerpen	6505
1	Penicillin	_	NOUN	NN	_	2	compound	_	_
2	DRUGS	_	NOUN	NN	_	4	nsubjpass	_	_
3	is	_	VERB	VBZ	_	4	auxpass	_	_
4	distributed	_	VERB	VBN	_	0	root	_	_
5	to	_	PRT	TO	_	7	case	_	_
6	most	_	ADJ	JJ	_	7	amod	_	_
7	areas	_	NOUN	NN	_	4	nmod	_	_
8	of	_	ADP	IN	_	10	case	_	_
9	the	_	DET	DT	_	10	det	_	_
10	body	_	NOUN	NN	_	7	nmod	_	_
11	including	_	ADP	IN	_	12	case	_	_
12	lung	_	NOUN	NN	_	10	nmod	_	_
13	,	_	.	,	_	12	punct	_	_
14	liver	_	NOUN	NN	_	12	conj	_	_
15	,	_	.	,	_	12	punct	_	_
16	kidney	_	NOUN	NN	_	12	conj	_	_
17	,	_	.	,	_	12	punct	_	_
18	muscle	_	NOUN	NN	_	12	conj	_	_
19	,	_	.	,	_	12	punct	_	_
20	bone	_	NOUN	NN	_	12	conj	_	_
21	and	_	CONJ	CC	_	12	cc	_	_
22	placenta	_	NOUN	NN	_	12	conj	_	_

#	Pfizerpen	6506
1	In	_	ADP	IN	_	3	case	_	_
2	the	_	DET	DT	_	3	det	_	_
3	presence	_	NOUN	NN	_	23	nmod	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	inflammation	_	NOUN	NN	_	3	nmod	_	_
6	,	_	.	,	_	23	punct	_	_
7	levels	_	NOUN	NNS	_	23	nsubj	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	penicillin	_	NOUN	NN	_	7	nmod	_	_
10	in	_	ADP	IN	_	11	case	_	_
11	abscesses	_	NOUN	NNS	_	7	nmod	_	_
12	,	_	.	,	_	11	punct	_	_
13	middle	_	NOUN	NN	_	14	compound	_	_
14	ear	_	NOUN	NN	_	11	conj	_	_
15	,	_	.	,	_	11	punct	_	_
16	pleural	_	ADJ	JJ	_	11	conj	_	_
17	,	_	.	,	_	11	punct	_	_
18	peritoneal	_	ADJ	JJ	_	11	conj	_	_
19	and	_	CONJ	CC	_	11	cc	_	_
20	synovial	_	ADJ	JJ	_	21	amod	_	_
21	fluids	_	NOUN	NNS	_	11	conj	_	_
22	are	_	VERB	VBP	_	23	cop	_	_
23	sufficient	_	ADJ	JJ	_	0	root	_	_
24	to	_	PRT	TO	_	25	mark	_	_
25	inhibit	_	VERB	VB	_	23	xcomp	_	_
26	most	_	ADV	RB	_	27	advmod	_	_
27	susceptible	_	ADJ	JJ	_	25	dobj	_	_
28	bacteria	_	NOUN	NN	_	27	dep	_	_

#	Pfizerpen	6507
1	Penetration	_	NOUN	NN	_	14	nsubj	_	_
2	in	_	ADP	IN	_	4	case	_	_
3	the	_	DET	DT	_	4	det	_	_
4	eye	_	NOUN	NN	_	1	nmod	_	_
5	,	_	.	,	_	4	punct	_	_
6	brain	_	NOUN	NN	_	4	conj	_	_
7	,	_	.	,	_	4	punct	_	_
8	cerebrospinal	_	ADJ	JJ	_	9	amod	_	_
9	fluid	_	NOUN	NN	_	4	appos	_	_
10	CSF	_	NOUN	NN	_	9	dep	_	_
11	or	_	CONJ	CC	_	10	cc	_	_
12	prostate	_	NOUN	NN	_	10	conj	_	_
13	is	_	VERB	VBZ	_	14	cop	_	_
14	poor	_	ADJ	JJ	_	0	root	_	_
15	in	_	ADP	IN	_	17	case	_	_
16	the	_	DET	DT	_	17	det	_	_
17	absence	_	NOUN	NN	_	14	nmod	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	inflammation	_	NOUN	NN	_	17	nmod	_	_

#	Pfizerpen	6508
1	With	_	ADP	IN	_	3	case	_	_
2	inflamed	_	VERB	VBN	_	3	amod	_	_
3	meninges	_	NOUN	NNS	_	13	nmod	_	_
4	,	_	.	,	_	13	punct	_	_
5	the	_	DET	DT	_	6	det	_	_
6	penetration	_	NOUN	NN	_	13	nsubj	_	_
7	of	_	ADP	IN	_	9	case	_	_
8	penicillin	_	NOUN	NN	_	9	compound	_	_
9	DRUGS	_	NOUN	NN	_	6	nmod	_	_
10	into	_	ADP	IN	_	12	case	_	_
11	the	_	DET	DT	_	12	det	_	_
12	CSF	_	NOUN	NN	_	6	nmod	_	_
13	improves	_	VERB	VBZ	_	0	root	_	_
14	,	_	.	,	_	13	punct	_	_
15	such	_	ADJ	JJ	_	24	mark	_	_
16	that	_	ADP	IN	_	24	mark	_	_
17	the	_	DET	DT	_	21	det	_	_
18	CSF	_	NOUN	NN	_	21	compound	_	_
19	/	_	.	:	_	21	punct	_	_
20	serum	_	NOUN	NN	_	21	compound	_	_
21	ratio	_	NOUN	NN	_	24	nsubj	_	_
22	is	_	VERB	VBZ	_	24	cop	_	_
23	2	_	NUM	CD	_	24	neg	_	_
24	6%	_	ADJ	JJ	_	13	advcl	_	_

#	Pfizerpen	6509
1	Inflammation	_	NOUN	NN	_	3	nsubj	_	_
2	also	_	ADV	RB	_	3	advmod	_	_
3	enhances	_	VERB	VBZ	_	0	root	_	_
4	its	_	PRON	PRP$	_	5	nmod:poss	_	_
5	penetration	_	NOUN	NN	_	3	dobj	_	_
6	into	_	ADP	IN	_	9	case	_	_
7	the	_	DET	DT	_	9	det	_	_
8	pericardial	_	ADJ	JJ	_	9	amod	_	_
9	fluid	_	NOUN	NN	_	5	nmod	_	_

#	Pfizerpen	6510
1	Penicillin	_	NOUN	NN	_	2	compound	_	_
2	DRUGS	_	NOUN	NN	_	5	nsubjpass	_	_
3	is	_	VERB	VBZ	_	5	auxpass	_	_
4	actively	_	ADV	RB	_	5	advmod	_	_
5	secreted	_	VERB	VBN	_	0	root	_	_
6	into	_	ADP	IN	_	9	case	_	_
7	the	_	DET	DT	_	9	det	_	_
8	bile	_	ADJ	JJ	_	9	amod	_	_
9	resulting	_	VERB	VBG	_	5	advcl	_	_
10	in	_	ADP	IN	_	11	case	_	_
11	levels	_	NOUN	NNS	_	9	nmod	_	_
12	at	_	ADP	IN	_	13	case	_	_
13	least	_	ADJ	JJS	_	14	nmod:npmod	_	_
14	10	_	NUM	CD	_	15	nummod	_	_
15	times	_	NOUN	NNS	_	9	nmod	_	_
16	those	_	DET	DT	_	15	dep	_	_
17	achieved	_	VERB	VBN	_	16	acl	_	_
18	simultaneously	_	ADV	RB	_	17	advmod	_	_
19	in	_	ADP	IN	_	20	case	_	_
20	serum	_	NOUN	NN	_	17	nmod	_	_

#	Pfizerpen	6511
1	Penicillin	_	NOUN	NN	_	2	compound	_	_
2	DRUGS	_	NOUN	NN	_	3	nsubj	_	_
3	penetrates	_	VERB	VBZ	_	0	root	_	_
4	poorly	_	ADV	RB	_	3	advmod	_	_
5	into	_	ADP	IN	_	8	case	_	_
6	human	_	ADJ	JJ	_	8	amod	_	_
7	polymorphonuclear	_	ADJ	JJ	_	8	amod	_	_
8	leukocytes	_	NOUN	NNS	_	3	nmod	_	_

#	Pfizerpen	6512
1	In	_	ADP	IN	_	3	case	_	_
2	the	_	DET	DT	_	3	det	_	_
3	presence	_	NOUN	NN	_	19	nmod	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	impaired	_	ADJ	JJ	_	7	amod	_	_
6	renal	_	ADJ	JJ	_	7	amod	_	_
7	function	_	NOUN	NN	_	3	nmod	_	_
8	,	_	.	,	_	19	punct	_	_
9	the	_	DET	DT	_	14	det	_	_
10	B	_	NOUN	NN	_	14	compound	_	_
11	phase	_	NOUN	NN	_	14	compound	_	_
12	serum	_	NOUN	NN	_	14	compound	_	_
13	half	_	ADJ	JJ	_	14	compound	_	_
14	life	_	NOUN	NN	_	19	nsubjpass	_	_
15	of	_	ADP	IN	_	17	case	_	_
16	penicillin	_	NOUN	NN	_	17	compound	_	_
17	DRUGS	_	NOUN	NN	_	14	nmod	_	_
18	is	_	VERB	VBZ	_	19	auxpass	_	_
19	prolonged	_	VERB	VBN	_	0	root	_	_

#	Pfizerpen	6513
1	B	_	NOUN	NN	_	5	compound	_	_
2	phase	_	NOUN	NN	_	5	compound	_	_
3	serum	_	NOUN	NN	_	5	compound	_	_
4	half	_	ADJ	JJ	_	5	amod	_	_
5	lives	_	NOUN	NNS	_	12	nsubjpass	_	_
6	of	_	ADP	IN	_	10	case	_	_
7	one	_	NUM	CD	_	9	compound	_	_
8	to	_	PRT	TO	_	9	dep	_	_
9	two	_	NUM	CD	_	10	nummod	_	_
10	hours	_	NOUN	NNS	_	5	nmod	_	_
11	were	_	VERB	VBD	_	12	auxpass	_	_
12	observed	_	VERB	VBN	_	0	root	_	_
13	in	_	ADP	IN	_	15	case	_	_
14	azotemic	_	ADJ	JJ	_	15	amod	_	_
15	patients	_	NOUN	NNS	_	12	nmod	_	_
16	with	_	ADP	IN	_	19	case	_	_
17	serum	_	NOUN	NN	_	19	compound	_	_
18	creatinine	_	NOUN	NN	_	19	compound	_	_
19	concentrations	_	NOUN	NNS	_	15	nmod	_	_
20	<3	_	NUM	CD	_	21	nummod	_	_
21	mg	_	NOUN	NN	_	19	dep	_	_
22	/	_	.	:	_	21	punct	_	_
23	100	_	NUM	CD	_	24	nummod	_	_
24	mL	_	NOUN	NN	_	21	dep	_	_
25	and	_	CONJ	CC	_	12	cc	_	_
26	ranged	_	VERB	VBD	_	12	conj	_	_
27	as	_	ADV	RB	_	28	advmod	_	_
28	high	_	ADJ	JJ	_	26	nmod	_	_
29	as	_	ADP	IN	_	31	case	_	_
30	20	_	NUM	CD	_	31	nummod	_	_
31	hours	_	NOUN	NNS	_	28	nmod	_	_
32	in	_	ADP	IN	_	34	case	_	_
33	anuric	_	ADJ	JJ	_	34	amod	_	_
34	patients	_	NOUN	NNS	_	31	nmod	_	_

#	Pfizerpen	6514
1	A	_	DET	DT	_	3	det	_	_
2	linear	_	ADJ	JJ	_	3	amod	_	_
3	relationship	_	NOUN	NN	_	14	nsubjpass	_	_
4	,	_	.	,	_	3	punct	_	_
5	including	_	VERB	VBG	_	8	case	_	_
6	the	_	DET	DT	_	8	det	_	_
7	lowest	_	ADJ	JJ	_	8	amod	_	_
8	range	_	NOUN	NN	_	3	nmod	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	renal	_	ADJ	JJ	_	11	amod	_	_
11	function	_	NOUN	NN	_	8	nmod	_	_
12	,	_	.	,	_	3	punct	_	_
13	is	_	VERB	VBZ	_	14	auxpass	_	_
14	found	_	VERB	VBN	_	0	root	_	_
15	between	_	ADP	IN	_	20	case	_	_
16	the	_	DET	DT	_	20	dep	_	_
17	serum	_	NOUN	NN	_	20	compound	_	_
18	elimination	_	NOUN	NN	_	20	compound	_	_
19	rate	_	NOUN	NN	_	20	compound	_	_
20	constant	_	ADJ	JJ	_	14	nmod	_	_
21	and	_	CONJ	CC	_	20	cc	_	_
22	renal	_	ADJ	JJ	_	23	amod	_	_
23	function	_	NOUN	NN	_	20	conj	_	_
24	as	_	ADP	IN	_	25	mark	_	_
25	measured	_	VERB	VBN	_	14	advcl	_	_
26	by	_	ADP	IN	_	28	case	_	_
27	creatinine	_	NOUN	NN	_	28	compound	_	_
28	clearance	_	NOUN	NN	_	25	nmod	_	_

#	Pfizerpen	6515
1	In	_	ADP	IN	_	2	case	_	_
2	patients	_	NOUN	NNS	_	14	nmod	_	_
3	with	_	ADP	IN	_	6	case	_	_
4	altered	_	VERB	VBN	_	6	amod	_	_
5	renal	_	ADJ	JJ	_	6	amod	_	_
6	function	_	NOUN	NN	_	2	nmod	_	_
7	,	_	.	,	_	14	punct	_	_
8	the	_	DET	DT	_	9	det	_	_
9	presence	_	NOUN	NN	_	14	nsubj	_	_
10	of	_	ADP	IN	_	12	case	_	_
11	hepatic	_	ADJ	JJ	_	12	amod	_	_
12	insufficiency	_	NOUN	NN	_	9	nmod	_	_
13	further	_	ADV	RB	_	14	advmod	_	_
14	alters	_	VERB	VBZ	_	0	root	_	_
15	the	_	DET	DT	_	16	det	_	_
16	elimination	_	NOUN	NN	_	14	dobj	_	_
17	of	_	ADP	IN	_	19	case	_	_
18	penicillin	_	NOUN	NN	_	19	compound	_	_
19	DRUGS	_	NOUN	NN	_	16	nmod	_	_
20	In	_	ADP	IN	_	22	case	_	_
21	one	_	NUM	CD	_	22	nummod	_	_
22	study	_	NOUN	NN	_	16	nmod	_	_
23	,	_	.	,	_	14	punct	_	_
24	the	_	DET	DT	_	27	det	_	_
25	serum	_	NOUN	NN	_	27	compound	_	_
26	half	_	NOUN	NN	_	27	compound	_	_
27	lives	_	NOUN	NNS	_	14	dep	_	_
28	in	_	ADP	IN	_	31	case	_	_
29	two	_	NUM	CD	_	31	nummod	_	_
30	anuric	_	ADJ	JJ	_	31	amod	_	_
31	patients	_	NOUN	NNS	_	27	nmod	_	_
32	excreting	_	VERB	VBG	_	31	acl	_	_
33	<400	_	NUM	CD	_	35	nummod	_	_
34	mL	_	NOUN	NN	_	35	nmod:npmod	_	_
35	urine	_	ADJ	JJ	_	32	dobj	_	_
36	/	_	.	:	_	27	punct	_	_
37	day	_	NOUN	NN	_	42	nsubj	_	_
38	were	_	VERB	VBD	_	42	cop	_	_
39	7.2	_	NUM	CD	_	42	compound	_	_
40	and	_	CONJ	CC	_	39	cc	_	_
41	10.1	_	NUM	CD	_	39	conj	_	_
42	hours	_	NOUN	NNS	_	27	dep	_	_

#	Pfizerpen	6516
1	A	_	DET	DT	_	4	det	_	_
2	totally	_	ADV	RB	_	3	advmod	_	_
3	anuric	_	ADJ	JJ	_	4	amod	_	_
4	patient	_	NOUN	NN	_	9	nsubj	_	_
5	with	_	ADP	IN	_	8	case	_	_
6	terminal	_	ADJ	JJ	_	8	amod	_	_
7	hepatic	_	ADJ	JJ	_	8	amod	_	_
8	cirrhosis	_	NOUN	NN	_	4	nmod	_	_
9	had	_	VERB	VBD	_	0	root	_	_
10	a	_	DET	DT	_	13	det	_	_
11	penicillin	_	NOUN	NN	_	13	compound	_	_
12	half	_	NOUN	NN	_	13	compound	_	_
13	life	_	NOUN	NN	_	9	dobj	_	_
14	of	_	ADP	IN	_	16	case	_	_
15	30.5	_	NUM	CD	_	16	nummod	_	_
16	hours	_	NOUN	NNS	_	13	nmod	_	_
17	,	_	.	,	_	9	punct	_	_
18	while	_	ADP	IN	_	26	mark	_	_
19	another	_	DET	DT	_	20	det	_	_
20	patient	_	NOUN	NN	_	26	nsubj	_	_
21	with	_	ADP	IN	_	22	case	_	_
22	anuria	_	NOUN	NN	_	20	nmod	_	_
23	and	_	CONJ	CC	_	22	cc	_	_
24	liver	_	NOUN	NN	_	25	compound	_	_
25	disease	_	NOUN	NN	_	22	conj	_	_
26	had	_	VERB	VBD	_	9	advcl	_	_
27	a	_	DET	DT	_	30	det	_	_
28	serum	_	NOUN	NN	_	30	compound	_	_
29	half	_	ADJ	JJ	_	30	amod	_	_
30	life	_	NOUN	NN	_	26	dobj	_	_
31	of	_	ADP	IN	_	33	case	_	_
32	16.4	_	NUM	CD	_	33	nummod	_	_
33	hours	_	NOUN	NNS	_	30	nmod	_	_

#	Pfizerpen	6517
1	The	_	DET	DT	_	2	det	_	_
2	dosage	_	NOUN	NN	_	8	nsubjpass	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	penicillin	_	NOUN	NN	_	5	compound	_	_
5	DRUGS	_	NOUN	NN	_	2	nmod	_	_
6	should	_	VERB	MD	_	8	aux	_	_
7	be	_	VERB	VB	_	8	auxpass	_	_
8	reduced	_	VERB	VBN	_	0	root	_	_
9	in	_	ADP	IN	_	10	case	_	_
10	patients	_	NOUN	NNS	_	8	nmod	_	_
11	with	_	ADP	IN	_	14	case	_	_
12	severe	_	ADJ	JJ	_	14	amod	_	_
13	renal	_	ADJ	JJ	_	14	amod	_	_
14	impairment	_	NOUN	NN	_	10	nmod	_	_
15	,	_	.	,	_	8	punct	_	_
16	with	_	ADP	IN	_	18	case	_	_
17	additional	_	ADJ	JJ	_	18	amod	_	_
18	modifications	_	NOUN	NNS	_	8	nmod	_	_
19	when	_	ADV	WRB	_	22	advmod	_	_
20	hepatic	_	ADJ	JJ	_	21	amod	_	_
21	disease	_	NOUN	NN	_	22	nsubj	_	_
22	accompanies	_	VERB	VBZ	_	18	acl:relcl	_	_
23	the	_	DET	DT	_	25	det	_	_
24	renal	_	ADJ	JJ	_	25	amod	_	_
25	impairment	_	NOUN	NN	_	22	dobj	_	_

#	Pfizerpen	6518
1	Hemodialysis	_	NOUN	NN	_	4	nsubjpass	_	_
2	has	_	VERB	VBZ	_	4	aux	_	_
3	been	_	VERB	VBN	_	4	auxpass	_	_
4	shown	_	VERB	VBN	_	0	root	_	_
5	to	_	PRT	TO	_	6	mark	_	_
6	reduce	_	VERB	VB	_	4	xcomp	_	_
7	penicillin	_	NOUN	NN	_	10	compound	_	_
8	DRUGS	_	NOUN	NN	_	10	compound	_	_
9	serum	_	NOUN	NN	_	10	compound	_	_
10	levels	_	NOUN	NNS	_	6	dobj	_	_

#	Pfizerpen	6519
1	Penicillin	_	NOUN	NN	_	2	compound	_	_
2	DRUGS	_	NOUN	NN	_	3	nsubj	_	_
3	exerts	_	VERB	VBZ	_	0	root	_	_
4	a	_	DET	DT	_	6	det	_	_
5	bactericidal	_	ADJ	JJ	_	6	amod	_	_
6	action	_	NOUN	NN	_	3	dobj	_	_
7	against	_	ADP	IN	_	10	case	_	_
8	penicillin	_	NOUN	NN	_	10	compound	_	_
9	susceptible	_	ADJ	JJ	_	10	amod	_	_
10	microorganisms	_	NOUN	NNS	_	6	nmod	_	_
11	during	_	ADP	IN	_	13	case	_	_
12	the	_	DET	DT	_	13	det	_	_
13	stage	_	NOUN	NN	_	3	nmod	_	_
14	of	_	ADP	IN	_	16	case	_	_
15	active	_	ADJ	JJ	_	16	amod	_	_
16	multiplication	_	NOUN	NN	_	13	nmod	_	_

#	Pfizerpen	6520
1	It	_	PRON	PRP	_	2	nsubj	_	_
2	acts	_	VERB	VBZ	_	0	root	_	_
3	through	_	ADP	IN	_	5	case	_	_
4	the	_	DET	DT	_	5	det	_	_
5	inhibition	_	NOUN	NN	_	2	nmod	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	biosynthesis	_	NOUN	NN	_	5	nmod	_	_
8	of	_	ADP	IN	_	11	case	_	_
9	cell	_	NOUN	NN	_	11	compound	_	_
10	wall	_	NOUN	NN	_	11	compound	_	_
11	peptidoglycan	_	NOUN	NN	_	7	nmod	_	_
12	rendering	_	VERB	VBG	_	11	acl	_	_
13	the	_	DET	DT	_	17	det	_	_
14	cell	_	NOUN	NN	_	17	nmod:npmod	_	_
15	wall	_	NOUN	NN	_	17	compound	_	_
16	osmotically	_	ADV	RB	_	17	advmod	_	_
17	unstable	_	ADJ	JJ	_	12	dobj	_	_

#	Pfizerpen	6521
1	It	_	PRON	PRP	_	4	nsubj	_	_
2	is	_	VERB	VBZ	_	4	cop	_	_
3	not	_	ADV	RB	_	4	neg	_	_
4	active	_	ADJ	JJ	_	0	root	_	_
5	against	_	ADP	IN	_	9	case	_	_
6	the	_	DET	DT	_	9	det	_	_
7	penicillinase	_	NOUN	NN	_	9	compound	_	_
8	producing	_	VERB	VBG	_	9	compound	_	_
9	bacteria	_	NOUN	NN	_	4	nmod	_	_
10	,	_	.	,	_	9	punct	_	_
11	which	_	DET	WDT	_	12	nsubj	_	_
12	include	_	VERB	VBP	_	9	acl:relcl	_	_
13	many	_	ADJ	JJ	_	14	amod	_	_
14	strains	_	NOUN	NNS	_	12	dobj	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	staphylococci	_	NOUN	NN	_	14	nmod	_	_
17	or	_	CONJ	CC	_	14	cc	_	_
18	against	_	ADP	IN	_	19	case	_	_
19	organisms	_	NOUN	NNS	_	14	conj	_	_
20	resistant	_	ADJ	JJ	_	19	amod	_	_
21	to	_	PRT	TO	_	23	case	_	_
22	beta	_	NOUN	NN	_	23	compound	_	_
23	lactams	_	NOUN	NNS	_	20	nmod	_	_
24	because	_	ADP	IN	_	26	case	_	_
25	of	_	ADP	IN	_	26	case	_	_
26	alterations	_	NOUN	NNS	_	12	nmod	_	_
27	in	_	ADP	IN	_	31	case	_	_
28	the	_	DET	DT	_	31	det	_	_
29	penicillin	_	NOUN	NN	_	31	compound	_	_
30	binding	_	NOUN	NN	_	31	compound	_	_
31	proteins	_	NOUN	NNS	_	26	nmod	_	_
32	,	_	.	,	_	31	punct	_	_
33	such	_	ADJ	JJ	_	37	case	_	_
34	as	_	ADP	IN	_	33	mwe	_	_
35	methicillin	_	NOUN	NN	_	37	compound	_	_
36	resistant	_	ADJ	JJ	_	37	amod	_	_
37	staphylococci	_	NOUN	NNS	_	31	nmod	_	_

#	Pfizerpen	6522
1	Penicillin	_	NOUN	NN	_	2	compound	_	_
2	DRUGS	_	NOUN	NN	_	5	nsubj	_	_
3	is	_	VERB	VBZ	_	5	cop	_	_
4	highly	_	ADV	RB	_	5	advmod	_	_
5	active	_	ADJ	JJ	_	0	root	_	_
6	in	_	X	FW	_	7	compound	_	_
7	vitro	_	X	FW	_	5	advmod	_	_
8	against	_	ADP	IN	_	10	case	_	_
9	streptococci	_	NOUN	NN	_	10	compound	_	_
10	groups	_	NOUN	NNS	_	5	nmod	_	_
11	A	_	NOUN	NN	_	10	dep	_	_
12	,	_	.	,	_	11	punct	_	_
13	B	_	NOUN	NN	_	11	conj	_	_
14	,	_	.	,	_	11	punct	_	_
15	C	_	NOUN	NN	_	11	conj	_	_
16	,	_	.	,	_	11	punct	_	_
17	DRUGS	_	NOUN	NN	_	11	conj	_	_
18	,	_	.	,	_	11	punct	_	_
19	H	_	NOUN	NN	_	11	conj	_	_
20	,	_	.	,	_	11	punct	_	_
21	L	_	NOUN	NN	_	11	conj	_	_
22	,	_	.	,	_	11	punct	_	_
23	and	_	CONJ	CC	_	11	cc	_	_
24	M	_	NOUN	NN	_	11	conj	_	_
25	,	_	.	,	_	11	punct	_	_
26	and	_	CONJ	CC	_	11	cc	_	_
27	Neisseria	_	NOUN	NN	_	28	compound	_	_
28	meningitidis	_	NOUN	NN	_	11	conj	_	_

#	Pfizerpen	6523
1	Other	_	ADJ	JJ	_	2	amod	_	_
2	organisms	_	NOUN	NNS	_	9	nsubj	_	_
3	susceptible	_	ADJ	JJ	_	2	amod	_	_
4	to	_	PRT	TO	_	6	case	_	_
5	penicillin	_	NOUN	NN	_	6	compound	_	_
6	DRUGS	_	NOUN	NN	_	3	nmod	_	_
7	are	_	VERB	VBP	_	9	cop	_	_
8	N	_	NOUN	NN	_	9	compound	_	_
9	gonorrhoeae	_	NOUN	NN	_	38	nsubj	_	_
10	,	_	.	,	_	9	punct	_	_
11	Corynebacterium	_	NOUN	NN	_	12	compound	_	_
12	diphtheriae	_	ADJ	JJ	_	9	conj	_	_
13	,	_	.	,	_	9	punct	_	_
14	Bacillus	_	NOUN	NN	_	15	compound	_	_
15	anthracis	_	NOUN	NN	_	9	conj	_	_
16	,	_	.	,	_	9	punct	_	_
17	Clostridium	_	NOUN	NN	_	18	compound	_	_
18	spp	_	NOUN	NN	_	9	conj	_	_
19	,	_	.	,	_	9	punct	_	_
20	Actinomyces	_	NOUN	NNS	_	21	compound	_	_
21	species	_	NOUN	NNS	_	9	conj	_	_
22	,	_	.	,	_	9	punct	_	_
23	"Spirillum	_	NOUN	NN	_	24	compound	_	_
24	minus"	_	NOUN	NN	_	9	conj	_	_
25	,	_	.	,	_	9	punct	_	_
26	Streptobacillus	_	NOUN	NN	_	27	compound	_	_
27	moniliformis	_	NOUN	NN	_	9	conj	_	_
28	,	_	.	,	_	9	punct	_	_
29	Listeria	_	NOUN	NN	_	30	compound	_	_
30	monocytogenes	_	NOUN	NNS	_	9	conj	_	_
31	and	_	CONJ	CC	_	9	cc	_	_
32	Leptospira	_	NOUN	NN	_	35	compound	_	_
33	spp	_	NOUN	NN	_	35	compound	_	_
34	Treponema	_	NOUN	NN	_	35	compound	_	_
35	pallidum	_	NOUN	NN	_	9	conj	_	_
36	is	_	VERB	VBZ	_	38	cop	_	_
37	extremely	_	ADV	RB	_	38	advmod	_	_
38	sensitive	_	ADJ	JJ	_	0	root	_	_
39	to	_	PRT	TO	_	42	case	_	_
40	the	_	DET	DT	_	42	det	_	_
41	bactericidal	_	ADJ	JJ	_	42	amod	_	_
42	action	_	NOUN	NN	_	38	nmod	_	_
43	of	_	ADP	IN	_	45	case	_	_
44	penicillin	_	NOUN	NN	_	45	compound	_	_
45	DRUGS	_	NOUN	NN	_	42	nmod	_	_
46	Some	_	DET	DT	_	47	det	_	_
47	species	_	NOUN	NNS	_	54	nsubjpass	_	_
48	of	_	ADP	IN	_	51	case	_	_
49	gram	_	NOUN	NN	_	51	compound	_	_
50	negative	_	ADJ	JJ	_	51	amod	_	_
51	bacilli	_	NOUN	NNS	_	47	nmod	_	_
52	were	_	VERB	VBD	_	54	auxpass	_	_
53	previously	_	ADV	RB	_	54	advmod	_	_
54	considered	_	VERB	VBN	_	38	parataxis	_	_
55	susceptible	_	ADJ	JJ	_	54	xcomp	_	_
56	to	_	PRT	TO	_	60	case	_	_
57	very	_	ADV	RB	_	58	advmod	_	_
58	high	_	ADJ	JJ	_	60	amod	_	_
59	intravenous	_	ADJ	JJ	_	60	amod	_	_
60	doses	_	NOUN	NNS	_	55	nmod	_	_
61	of	_	ADP	IN	_	63	case	_	_
62	penicillin	_	NOUN	NN	_	63	compound	_	_
63	DRUGS	_	NOUN	NN	_	60	nmod	_	_
64	up	_	ADJ	JJ	_	66	advmod	_	_
65	to	_	PRT	TO	_	64	mwe	_	_
66	80	_	NUM	CD	_	68	nummod	_	_
67	million	_	NOUN	NN	_	68	compound	_	_
68	units	_	NOUN	NNS	_	60	nmod	_	_
69	/	_	.	:	_	54	punct	_	_
70	day	_	NOUN	NN	_	38	dobj	_	_
71	including	_	ADP	IN	_	73	case	_	_
72	some	_	DET	DT	_	73	det	_	_
73	strains	_	NOUN	NNS	_	70	nmod	_	_
74	of	_	ADP	IN	_	76	case	_	_
75	Escherichia	_	NOUN	NN	_	76	compound	_	_
76	coli	_	NOUN	NN	_	73	nmod	_	_
77	,	_	.	,	_	76	punct	_	_
78	Proteus	_	NOUN	NN	_	79	compound	_	_
79	mirabilis	_	NOUN	NN	_	76	conj	_	_
80	,	_	.	,	_	76	punct	_	_
81	Salmonella	_	NOUN	NN	_	82	compound	_	_
82	spp	_	NOUN	NN	_	76	appos	_	_

#	Pfizerpen	6524
1	Enterobacter	_	NOUN	NN	_	2	compound	_	_
2	aerogenes	_	NOUN	NNS	_	0	root	_	_
3	formerly	_	ADV	RB	_	4	advmod	_	_
4	Aerobacter	_	NOUN	NN	_	5	compound	_	_
5	aerogenes	_	NOUN	NNS	_	2	dep	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	Alcaligenes	_	NOUN	NNS	_	8	compound	_	_
8	faecalis	_	NOUN	NN	_	5	conj	_	_

#	Pfizerpen	6525
1	Penicillin	_	NOUN	NN	_	2	compound	_	_
2	DRUGS	_	NOUN	NN	_	6	nsubjpass	_	_
3	is	_	VERB	VBZ	_	6	auxpass	_	_
4	no	_	ADV	RB	_	6	neg	_	_
5	longer	_	ADV	RB	_	6	advmod	_	_
6	considered	_	VERB	VBN	_	0	root	_	_
7	a	_	DET	DT	_	8	det	_	_
8	drug	_	NOUN	NN	_	6	dobj	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	choice	_	NOUN	NN	_	8	nmod	_	_
11	for	_	ADP	IN	_	12	case	_	_
12	infections	_	NOUN	NNS	_	10	nmod	_	_
13	caused	_	VERB	VBN	_	12	acl	_	_
14	by	_	ADP	IN	_	16	case	_	_
15	these	_	DET	DT	_	16	det	_	_
16	organisms	_	NOUN	NNS	_	13	nmod	_	_

#	Pfizerpen	6526
1	When	_	ADV	WRB	_	2	advmod	_	_
2	available	_	ADJ	JJ	_	9	advcl	_	_
3	,	_	.	,	_	9	punct	_	_
4	the	_	DET	DT	_	7	det	_	_
5	clinical	_	ADJ	JJ	_	7	amod	_	_
6	microbiology	_	NOUN	NN	_	7	compound	_	_
7	laboratory	_	NOUN	NN	_	9	nsubj	_	_
8	should	_	VERB	MD	_	9	aux	_	_
9	provide	_	VERB	VB	_	0	root	_	_
10	the	_	DET	DT	_	11	det	_	_
11	results	_	NOUN	NNS	_	9	dobj	_	_
12	of	_	ADP	IN	_	16	case	_	_
13	in	_	X	FW	_	16	amod	_	_
14	vitro	_	X	FW	_	13	dep	_	_
15	susceptibility	_	NOUN	NN	_	16	compound	_	_
16	test	_	NOUN	NN	_	11	nmod	_	_
17	results	_	NOUN	NNS	_	9	parataxis	_	_
18	for	_	ADP	IN	_	20	case	_	_
19	antimicrobial	_	ADJ	JJ	_	20	amod	_	_
20	drugs	_	NOUN	NNS	_	17	nmod	_	_
21	used	_	VERB	VBN	_	20	acl	_	_
22	in	_	ADP	IN	_	24	case	_	_
23	local	_	ADJ	JJ	_	24	amod	_	_
24	hospitals	_	NOUN	NNS	_	21	nmod	_	_
25	and	_	CONJ	CC	_	17	cc	_	_
26	practice	_	VERB	VBP	_	17	conj	_	_
27	areas	_	NOUN	NN	_	26	dobj	_	_
28	to	_	PRT	TO	_	30	case	_	_
29	the	_	DET	DT	_	30	det	_	_
30	physician	_	NOUN	NN	_	27	nmod	_	_
31	as	_	ADP	IN	_	33	case	_	_
32	periodic	_	ADJ	JJ	_	33	amod	_	_
33	reports	_	NOUN	NNS	_	26	nmod	_	_
34	that	_	DET	WDT	_	35	nsubj	_	_
35	describe	_	VERB	VBP	_	33	acl:relcl	_	_
36	the	_	DET	DT	_	38	det	_	_
37	susceptibility	_	NOUN	NN	_	38	compound	_	_
38	profile	_	NOUN	NN	_	35	dobj	_	_
39	of	_	ADP	IN	_	44	case	_	_
40	nosocomial	_	ADJ	JJ	_	44	amod	_	_
41	and	_	CONJ	CC	_	40	cc	_	_
42	community	_	NOUN	NN	_	40	conj	_	_
43	acquired	_	ADJ	JJ	_	44	amod	_	_
44	pathogens	_	NOUN	NNS	_	38	nmod	_	_

#	Pfizerpen	6527
1	These	_	DET	DT	_	2	det	_	_
2	reports	_	NOUN	NNS	_	4	nsubj	_	_
3	should	_	VERB	MD	_	4	aux	_	_
4	aid	_	VERB	VB	_	0	root	_	_
5	the	_	DET	DT	_	6	det	_	_
6	physician	_	NOUN	NN	_	4	dobj	_	_
7	in	_	ADP	IN	_	8	mark	_	_
8	selecting	_	VERB	VBG	_	6	acl	_	_
9	the	_	DET	DT	_	11	det	_	_
10	most	_	ADV	RB	_	11	advmod	_	_
11	effective	_	ADJ	JJ	_	8	dobj	_	_
12	antimicrobial	_	ADJ	JJ	_	11	dep	_	_

#	Pfizerpen	6528
1	Quantitative	_	ADJ	JJ	_	2	amod	_	_
2	methods	_	NOUN	NNS	_	4	nsubjpass	_	_
3	are	_	VERB	VBP	_	4	auxpass	_	_
4	used	_	VERB	VBN	_	0	root	_	_
5	to	_	PRT	TO	_	6	mark	_	_
6	determine	_	VERB	VB	_	4	xcomp	_	_
7	antimicrobial	_	ADJ	JJ	_	10	amod	_	_
8	minimum	_	ADJ	JJ	_	10	amod	_	_
9	inhibitory	_	ADJ	JJ	_	10	amod	_	_
10	concentrations	_	NOUN	NNS	_	6	dobj	_	_
11	MICs	_	NOUN	NNS	_	10	dep	_	_

#	Pfizerpen	6529
1	These	_	DET	DT	_	2	det	_	_
2	MICs	_	NOUN	NNS	_	3	nsubj	_	_
3	provide	_	VERB	VBP	_	0	root	_	_
4	estimates	_	NOUN	NNS	_	3	dobj	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	susceptibility	_	NOUN	NN	_	4	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	bacteria	_	NOUN	NN	_	7	nmod	_	_
10	to	_	PRT	TO	_	12	case	_	_
11	antimicrobial	_	ADJ	JJ	_	12	amod	_	_
12	compounds	_	NOUN	NNS	_	7	nmod	_	_

#	Pfizerpen	6530
1	The	_	DET	DT	_	2	det	_	_
2	MICs	_	NOUN	NNS	_	5	nsubjpass	_	_
3	should	_	VERB	MD	_	5	aux	_	_
4	be	_	VERB	VB	_	5	auxpass	_	_
5	determined	_	VERB	VBN	_	0	root	_	_
6	using	_	VERB	VBG	_	5	xcomp	_	_
7	a	_	DET	DT	_	9	det	_	_
8	standardized	_	ADJ	JJ	_	9	amod	_	_
9	procedure	_	NOUN	NN	_	6	dobj	_	_

#	Pfizerpen	6531
1	Standardized	_	ADJ	JJ	_	2	amod	_	_
2	procedures	_	NOUN	NNS	_	4	nsubjpass	_	_
3	are	_	VERB	VBP	_	4	auxpass	_	_
4	based	_	VERB	VBN	_	0	root	_	_
5	on	_	ADP	IN	_	7	case	_	_
6	dilution	_	NOUN	NN	_	7	compound	_	_
7	method	_	NOUN	NN	_	4	nmod	_	_
8	1	_	NUM	CD	_	7	nummod	_	_
9	,	_	.	,	_	7	punct	_	_
10	2	_	NUM	CD	_	7	conj	_	_
11	,	_	.	,	_	7	punct	_	_
12	3	_	NUM	CD	_	13	nummod	_	_
13	broth	_	NOUN	NN	_	7	conj	_	_
14	or	_	CONJ	CC	_	7	cc	_	_
15	agar	_	NOUN	NN	_	16	compound	_	_
16	dilution	_	NOUN	NN	_	7	conj	_	_
17	or	_	CONJ	CC	_	7	cc	_	_
18	equivalent	_	ADJ	JJ	_	7	conj	_	_
19	using	_	VERB	VBG	_	4	xcomp	_	_
20	standardized	_	ADJ	JJ	_	21	amod	_	_
21	inoculum	_	NOUN	NN	_	19	dobj	_	_
22	and	_	CONJ	CC	_	21	cc	_	_
23	concentrations	_	NOUN	NNS	_	21	conj	_	_
24	of	_	ADP	IN	_	25	case	_	_
25	penicillin	_	NOUN	NN	_	21	nmod	_	_

#	Pfizerpen	6532
1	The	_	DET	DT	_	3	det	_	_
2	MIC	_	NOUN	NN	_	3	compound	_	_
3	values	_	NOUN	NNS	_	6	nsubjpass	_	_
4	should	_	VERB	MD	_	6	aux	_	_
5	be	_	VERB	VB	_	6	auxpass	_	_
6	interpreted	_	VERB	VBN	_	0	root	_	_
7	according	_	VERB	VBG	_	10	case	_	_
8	to	_	PRT	TO	_	10	case	_	_
9	the	_	DET	DT	_	10	det	_	_
10	criteria	_	NOUN	NN	_	6	nmod	_	_
11	in	_	ADP	IN	_	12	case	_	_
12	Table	_	ADJ	JJ	_	10	nmod	_	_
13	1	_	NUM	CD	_	12	dep	_	_

#	Pfizerpen	6533
1	Quantitative	_	ADJ	JJ	_	2	amod	_	_
2	methods	_	NOUN	NNS	_	10	nsubj	_	_
3	that	_	DET	WDT	_	4	nsubj	_	_
4	require	_	VERB	VBP	_	2	acl:relcl	_	_
5	measurement	_	NOUN	NN	_	4	dobj	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	zone	_	NOUN	NN	_	8	compound	_	_
8	diameters	_	NOUN	NNS	_	5	nmod	_	_
9	also	_	ADV	RB	_	10	advmod	_	_
10	provide	_	VERB	VBP	_	0	root	_	_
11	reproducible	_	ADJ	JJ	_	12	amod	_	_
12	estimates	_	NOUN	NNS	_	10	dobj	_	_
13	of	_	ADP	IN	_	15	case	_	_
14	the	_	DET	DT	_	15	det	_	_
15	susceptibility	_	NOUN	NN	_	12	nmod	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	bacteria	_	NOUN	NN	_	15	nmod	_	_
18	to	_	PRT	TO	_	20	case	_	_
19	antimicrobial	_	ADJ	JJ	_	20	amod	_	_
20	compounds	_	NOUN	NNS	_	15	nmod	_	_

#	Pfizerpen	6534
1	One	_	NUM	CD	_	4	nummod	_	_
2	such	_	ADJ	JJ	_	4	amod	_	_
3	standardized	_	ADJ	JJ	_	4	amod	_	_
4	procedure	_	NOUN	NN	_	8	nsubj	_	_
5	2	_	NUM	CD	_	4	nummod	_	_
6	,	_	.	,	_	4	punct	_	_
7	4	_	NUM	CD	_	4	nummod	_	_
8	requires	_	VERB	VBZ	_	0	root	_	_
9	the	_	DET	DT	_	10	det	_	_
10	use	_	NOUN	NN	_	8	dobj	_	_
11	of	_	ADP	IN	_	14	case	_	_
12	standardized	_	ADJ	JJ	_	14	amod	_	_
13	inoculum	_	NOUN	NN	_	14	compound	_	_
14	concentrations	_	NOUN	NNS	_	10	nmod	_	_

#	Pfizerpen	6535
1	This	_	DET	DT	_	2	det	_	_
2	procedure	_	NOUN	NN	_	3	nsubj	_	_
3	uses	_	VERB	VBZ	_	0	root	_	_
4	paper	_	NOUN	NN	_	5	compound	_	_
5	disks	_	NOUN	NNS	_	3	dobj	_	_
6	impregnated	_	VERB	VBN	_	5	acl	_	_
7	with	_	ADP	IN	_	9	case	_	_
8	10	_	NUM	CD	_	9	nummod	_	_
9	units	_	NOUN	NNS	_	6	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	penicillin	_	NOUN	NN	_	9	nmod	_	_
12	to	_	PRT	TO	_	13	mark	_	_
13	test	_	VERB	VB	_	6	xcomp	_	_
14	the	_	DET	DT	_	15	det	_	_
15	susceptibility	_	NOUN	NN	_	13	dobj	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	microorganisms	_	NOUN	NNS	_	15	nmod	_	_
18	to	_	PRT	TO	_	19	case	_	_
19	penicillin	_	NOUN	NN	_	15	nmod	_	_

#	Pfizerpen	6536
1	Interpretation	_	NOUN	NN	_	2	nsubj	_	_
2	involves	_	VERB	VBZ	_	0	root	_	_
3	correlation	_	NOUN	NN	_	2	dobj	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	the	_	DET	DT	_	6	det	_	_
6	diameter	_	NOUN	NN	_	3	nmod	_	_
7	obtained	_	VERB	VBN	_	6	acl	_	_
8	in	_	ADP	IN	_	11	case	_	_
9	the	_	DET	DT	_	11	det	_	_
10	disk	_	NOUN	NN	_	11	compound	_	_
11	test	_	NOUN	NN	_	7	nmod	_	_
12	with	_	ADP	IN	_	14	case	_	_
13	the	_	DET	DT	_	14	det	_	_
14	MIC	_	NOUN	NN	_	11	nmod	_	_
15	for	_	ADP	IN	_	16	case	_	_
16	penicillin	_	NOUN	NN	_	14	nmod	_	_

#	Pfizerpen	6537
1	Reports	_	NOUN	NNS	_	22	nsubjpass	_	_
2	from	_	ADP	IN	_	4	case	_	_
3	the	_	DET	DT	_	4	det	_	_
4	laboratory	_	ADJ	JJ	_	1	nmod	_	_
5	providing	_	VERB	VBG	_	4	acl	_	_
6	results	_	NOUN	NNS	_	5	dobj	_	_
7	of	_	ADP	IN	_	13	case	_	_
8	the	_	DET	DT	_	13	det	_	_
9	standard	_	ADJ	JJ	_	13	amod	_	_
10	single	_	ADJ	JJ	_	13	amod	_	_
11	disk	_	NOUN	NN	_	13	compound	_	_
12	susceptibility	_	NOUN	NN	_	13	compound	_	_
13	test	_	NOUN	NN	_	6	nmod	_	_
14	with	_	ADP	IN	_	19	case	_	_
15	a	_	DET	DT	_	19	det	_	_
16	10	_	NUM	CD	_	19	nummod	_	_
17	unit	_	NOUN	NN	_	19	compound	_	_
18	penicillin	_	NOUN	NN	_	19	compound	_	_
19	disk	_	NOUN	NN	_	5	nmod	_	_
20	should	_	VERB	MD	_	22	aux	_	_
21	be	_	VERB	VB	_	22	auxpass	_	_
22	interpreted	_	VERB	VBN	_	0	root	_	_
23	according	_	VERB	VBG	_	27	case	_	_
24	to	_	PRT	TO	_	27	case	_	_
25	the	_	DET	DT	_	27	det	_	_
26	following	_	VERB	VBG	_	27	amod	_	_
27	criteria	_	NOUN	NN	_	22	nmod	_	_
28	in	_	ADP	IN	_	29	case	_	_
29	Table	_	ADJ	JJ	_	27	nmod	_	_
30	1	_	NUM	CD	_	29	dep	_	_

#	Pfizerpen	6538
1	Table	_	ADJ	JJ	_	0	root	_	_
2	1	_	NUM	CD	_	1	dep	_	_
3	:	_	.	:	_	1	punct	_	_
4	Susceptibility	_	NOUN	NN	_	7	compound	_	_
5	Test	_	NOUN	NN	_	7	compound	_	_
6	Interpretive	_	ADJ	JJ	_	7	amod	_	_
7	Criteria	_	NOUN	NN	_	1	dep	_	_
8	for	_	ADP	IN	_	11	case	_	_
9	Penicillin	_	NOUN	NN	_	11	compound	_	_
10	MIC	_	NOUN	NN	_	11	compound	_	_
11	mcg	_	NOUN	NN	_	7	nmod	_	_
12	/	_	.	:	_	7	punct	_	_
13	mL	_	NOUN	NN	_	17	compound	_	_
14	Disk	_	NOUN	NN	_	17	compound	_	_
15	Diffusion	_	NOUN	NN	_	17	compound	_	_
16	zone	_	NOUN	NN	_	17	compound	_	_
17	diameter	_	NOUN	NN	_	31	nsubjpass	_	_
18	in	_	ADP	IN	_	19	case	_	_
19	mm)Organisms	_	NOUN	NNS	_	17	nmod	_	_
20	for	_	ADP	IN	_	21	case	_	_
21	which	_	DET	WDT	_	27	nmod	_	_
22	no	_	DET	DT	_	23	neg	_	_
23	values	_	NOUN	NNS	_	27	nsubj	_	_
24	for	_	ADP	IN	_	26	case	_	_
25	disk	_	NOUN	NN	_	26	compound	_	_
26	susceptibility	_	NOUN	NN	_	23	nmod	_	_
27	appear	_	VERB	VBP	_	19	acl:relcl	_	_
28	cannot	_	NOUN	NN	_	27	dobj	_	_
29	be	_	VERB	VBZ	_	31	auxpass	_	_
30	reliably	_	ADV	RB	_	31	advmod	_	_
31	tested	_	VERB	VBN	_	7	dep	_	_
32	with	_	ADP	IN	_	34	case	_	_
33	this	_	DET	DT	_	34	det	_	_
34	method	_	NOUN	NN	_	31	nmod	_	_

#	Pfizerpen	6539
1	Pathogen	_	NOUN	NN	_	9	compound	_	_
2	Susceptible(S	_	NOUN	NN	_	9	compound	_	_
3	Intermediate(I	_	NOUN	NN	_	9	compound	_	_
4	Resistant(R	_	NOUN	NN	_	9	compound	_	_
5	Susceptible(S	_	NOUN	NN	_	9	compound	_	_
6	Intermediate(I	_	NOUN	NN	_	9	compound	_	_
7	Resistant(R	_	NOUN	NN	_	9	compound	_	_
8	Staphylococcus	_	NOUN	NN	_	9	compound	_	_
9	spp	_	NOUN	NN	_	0	root	_	_

#	Pfizerpen	6540
1	<0.12Penicillin	_	NOUN	NN	_	3	compound	_	_
2	resistant	_	ADJ	JJ	_	3	amod	_	_
3	strains	_	NOUN	NNS	_	6	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	staphylococci	_	NOUN	NN	_	3	nmod	_	_
6	produce	_	VERB	VBP	_	0	root	_	_
7	B	_	NOUN	NN	_	8	compound	_	_
8	lactamase	_	NOUN	NN	_	6	dobj	_	_

#	Pfizerpen	6541
1	An	_	DET	DT	_	5	det	_	_
2	induced	_	VERB	VBN	_	5	amod	_	_
3	B	_	NOUN	NN	_	5	compound	_	_
4	lactamase	_	NOUN	NN	_	5	compound	_	_
5	test	_	NOUN	NN	_	8	nsubjpass	_	_
6	should	_	VERB	MD	_	8	aux	_	_
7	be	_	VERB	VB	_	8	auxpass	_	_
8	performed	_	VERB	VBN	_	0	root	_	_
9	on	_	ADP	IN	_	13	case	_	_
10	all	_	DET	DT	_	13	det	_	_
11	S	_	NOUN	NN	_	13	compound	_	_
12	aureus	_	NOUN	NN	_	13	compound	_	_
13	isolates	_	NOUN	NNS	_	8	nmod	_	_
14	for	_	ADP	IN	_	15	case	_	_
15	which	_	DET	WDT	_	21	nmod	_	_
16	the	_	DET	DT	_	18	det	_	_
17	penicillin	_	NOUN	NN	_	18	compound	_	_
18	MIC	_	NOUN	NN	_	21	nsubj	_	_
19	is	_	VERB	VBZ	_	21	cop	_	_
20	<0.12	_	NUM	CD	_	21	nummod	_	_
21	mcg	_	NOUN	NN	_	13	acl:relcl	_	_
22	/	_	.	:	_	13	punct	_	_
23	mL	_	NOUN	NN	_	13	appos	_	_
24	or	_	CONJ	CC	_	23	cc	_	_
25	zone	_	NOUN	NN	_	26	compound	_	_
26	diameter	_	NOUN	NN	_	23	conj	_	_
27	is	_	VERB	VBZ	_	29	cop	_	_
28	>29	_	NUM	CD	_	29	nummod	_	_
29	mm	_	NOUN	NN	_	8	nmod	_	_
30	before	_	ADP	IN	_	31	mark	_	_
31	reporting	_	VERB	VBG	_	29	acl	_	_
32	as	_	ADP	IN	_	34	case	_	_
33	penicillin	_	NOUN	NN	_	34	nmod:npmod	_	_
34	susceptible	_	ADJ	JJ	_	31	nmod	_	_

#	Pfizerpen	6542
1	Rare	_	ADJ	JJ	_	2	amod	_	_
2	isolates	_	NOUN	NNS	_	14	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	staphylococci	_	NOUN	NNS	_	2	nmod	_	_
5	that	_	DET	WDT	_	6	nsubj	_	_
6	contains	_	VERB	VBZ	_	4	acl:relcl	_	_
7	genes	_	NOUN	NNS	_	6	dobj	_	_
8	for	_	ADP	IN	_	11	case	_	_
9	B	_	NOUN	NN	_	11	compound	_	_
10	lactamase	_	NOUN	NN	_	11	compound	_	_
11	production	_	NOUN	NN	_	7	nmod	_	_
12	may	_	VERB	MD	_	14	aux	_	_
13	not	_	ADV	RB	_	14	neg	_	_
14	produce	_	VERB	VB	_	0	root	_	_
15	a	_	DET	DT	_	20	det	_	_
16	positive	_	ADJ	JJ	_	20	amod	_	_
17	induced	_	VERB	VBN	_	20	amod	_	_
18	B	_	NOUN	NN	_	20	compound	_	_
19	lactamase	_	NOUN	NN	_	20	compound	_	_
20	test	_	NOUN	NN	_	14	dobj	_	_

#	Pfizerpen	6543
1	For	_	ADP	IN	_	3	case	_	_
2	serious	_	ADJ	JJ	_	3	amod	_	_
3	infections	_	NOUN	NNS	_	10	nmod	_	_
4	requiring	_	VERB	VBG	_	3	acl	_	_
5	penicillin	_	NOUN	NN	_	6	compound	_	_
6	therapy	_	NOUN	NN	_	4	dobj	_	_
7	,	_	.	,	_	10	punct	_	_
8	laboratories	_	NOUN	NNS	_	10	nsubj	_	_
9	should	_	VERB	MD	_	10	aux	_	_
10	perform	_	VERB	VB	_	0	root	_	_
11	MIC	_	NOUN	NN	_	12	compound	_	_
12	tests	_	NOUN	NNS	_	10	dobj	_	_
13	and	_	CONJ	CC	_	10	cc	_	_
14	induced	_	VERB	VBN	_	10	conj	_	_
15	B	_	NOUN	NN	_	16	compound	_	_
16	lactamase	_	NOUN	NN	_	17	compound	_	_
17	testing	_	NOUN	NN	_	14	dobj	_	_
18	on	_	ADP	IN	_	21	case	_	_
19	all	_	DET	DT	_	21	det	_	_
20	subsequent	_	ADJ	JJ	_	21	amod	_	_
21	isolates	_	NOUN	NNS	_	14	nmod	_	_
22	from	_	ADP	IN	_	37	case	_	_
23	the	_	DET	DT	_	37	det	_	_
24	same	_	ADJ	JJ	_	37	amod	_	_
25	patient.2	_	NOUN	NN	_	37	compound	_	_
26	>0.25	_	NUM	CD	_	37	nummod	_	_
27	>29	_	NUM	CD	_	37	nummod	_	_
28	<28	_	NUM	CD	_	37	nummod	_	_
29	Neisseria	_	NOUN	NN	_	37	compound	_	_
30	Gonorrhoeae	_	ADJ	JJ	_	37	amod	_	_
31	A	_	NOUN	NN	_	37	compound	_	_
32	positive	_	ADJ	JJ	_	37	amod	_	_
33	N	_	NOUN	NN	_	37	compound	_	_
34	gonorrhoeae	_	ADJ	JJ	_	37	amod	_	_
35	B	_	NOUN	NN	_	37	compound	_	_
36	lactamase	_	NOUN	NN	_	37	compound	_	_
37	test	_	NOUN	NN	_	21	nmod	_	_
38	predicts	_	VERB	VBZ	_	10	ccomp	_	_
39	one	_	NUM	CD	_	40	nummod	_	_
40	form	_	NOUN	NN	_	38	dobj	_	_
41	of	_	ADP	IN	_	42	case	_	_
42	resistance	_	NOUN	NN	_	40	nmod	_	_
43	to	_	PRT	TO	_	44	case	_	_
44	penicillin	_	NOUN	NN	_	42	nmod	_	_

#	Pfizerpen	6544
1	Strains	_	NOUN	NNS	_	8	nsubjpass	_	_
2	with	_	ADP	IN	_	5	case	_	_
3	chromosomally	_	ADV	RB	_	4	advmod	_	_
4	mediated	_	ADJ	JJ	_	5	amod	_	_
5	resistance	_	NOUN	NN	_	1	nmod	_	_
6	can	_	VERB	MD	_	8	aux	_	_
7	be	_	VERB	VB	_	8	auxpass	_	_
8	detected	_	VERB	VBN	_	0	root	_	_
9	only	_	ADV	RB	_	8	advmod	_	_
10	by	_	ADP	IN	_	12	case	_	_
11	agar	_	NOUN	NN	_	12	compound	_	_
12	dilution	_	NOUN	NN	_	8	nmod	_	_
13	or	_	CONJ	CC	_	12	cc	_	_
14	disk	_	NOUN	NN	_	19	compound	_	_
15	diffusion	_	NOUN	NN	_	19	compound	_	_
16	susceptibility	_	NOUN	NN	_	19	compound	_	_
17	test	_	NOUN	NN	_	19	compound	_	_
18	methods.2	_	NOUN	NN	_	19	compound	_	_
19	Isolates	_	NOUN	NNS	_	12	conj	_	_
20	with	_	ADP	IN	_	22	case	_	_
21	zone	_	NOUN	NN	_	22	compound	_	_
22	diameters	_	NOUN	NNS	_	12	nmod	_	_
23	<19	_	NUM	CD	_	24	nummod	_	_
24	mm	_	NOUN	NN	_	26	nsubj	_	_
25	generally	_	ADV	RB	_	26	advmod	_	_
26	produced	_	VERB	VBD	_	22	dep	_	_
27	B	_	NOUN	NN	_	38	compound	_	_
28	lactamase.2,4	_	NOUN	NN	_	38	compound	_	_
29	<0.06	_	NUM	CD	_	38	nummod	_	_
30	0.12	_	NUM	CD	_	38	nummod	_	_
31	1	_	NUM	CD	_	38	nummod	_	_
32	>2	_	NUM	CD	_	38	nummod	_	_
33	>47	_	NUM	CD	_	38	nummod	_	_
34	27	_	NUM	CD	_	38	nummod	_	_
35	46	_	NUM	CD	_	38	nummod	_	_
36	<26	_	NUM	CD	_	38	nummod	_	_
37	Listeria	_	NOUN	NN	_	38	compound	_	_
38	Monocytogenes	_	NOUN	NNS	_	26	dobj	_	_
39	<2The	_	ADJ	JJ	_	41	amod	_	_
40	current	_	ADJ	JJ	_	41	amod	_	_
41	absence	_	NOUN	NN	_	26	dobj	_	_
42	of	_	ADP	IN	_	44	case	_	_
43	resistant	_	ADJ	JJ	_	44	amod	_	_
44	isolates	_	NOUN	NNS	_	41	nmod	_	_
45	precludes	_	VERB	VBZ	_	26	parataxis	_	_
46	defining	_	VERB	VBG	_	45	xcomp	_	_
47	results	_	NOUN	NNS	_	46	dobj	_	_
48	other	_	ADJ	JJ	_	50	case	_	_
49	than	_	ADP	IN	_	48	mwe	_	_
50	"Susceptible"	_	NOUN	NN	_	47	nmod	_	_

#	Pfizerpen	6545
1	Isolates	_	NOUN	NNS	_	10	nsubjpass	_	_
2	yielding	_	VERB	VBG	_	1	acl	_	_
3	results	_	NOUN	NNS	_	2	dobj	_	_
4	suggestive	_	ADJ	JJ	_	3	amod	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	"Non	_	NOUN	NN	_	7	compound	_	_
7	susceptible"	_	NOUN	NN	_	4	nmod	_	_
8	should	_	VERB	MD	_	10	aux	_	_
9	be	_	VERB	VB	_	10	auxpass	_	_
10	submitted	_	VERB	VBN	_	0	root	_	_
11	to	_	PRT	TO	_	14	case	_	_
12	a	_	DET	DT	_	14	det	_	_
13	reference	_	NOUN	NN	_	14	compound	_	_
14	laboratory	_	NOUN	NN	_	10	nmod	_	_
15	for	_	ADP	IN	_	17	case	_	_
16	further	_	ADJ	JJ	_	17	advmod	_	_
17	testing	_	NOUN	NN	_	14	nmod	_	_

#	Pfizerpen	6546
1	Streptococcus	_	NOUN	NN	_	14	compound	_	_
2	pneumoniae	_	ADJ	JJ	_	14	amod	_	_
3	meningitis	_	NOUN	NN	_	14	compound	_	_
4	<0.06	_	NUM	CD	_	14	nummod	_	_
5	>0.12	_	NUM	CD	_	14	nummod	_	_
6	Streptococcus	_	NOUN	NN	_	14	compound	_	_
7	pneumoniae	_	ADJ	JJ	_	14	amod	_	_
8	non	_	ADJ	JJ	_	14	amod	_	_
9	meningitis	_	NOUN	NN	_	14	compound	_	_
10	<2	_	NUM	CD	_	14	nummod	_	_
11	4	_	NUM	CD	_	14	nummod	_	_
12	>8	_	NUM	CD	_	14	nummod	_	_
13	Streptococcus	_	NOUN	NN	_	14	compound	_	_
14	spp	_	NOUN	NN	_	32	nsubjpass	_	_
15	,	_	.	,	_	14	punct	_	_
16	Beta	_	NOUN	NN	_	19	compound	_	_
17	hemolytic	_	ADJ	JJ	_	19	amod	_	_
18	GroupSusceptibility	_	NOUN	NN	_	19	compound	_	_
19	testing	_	NOUN	NN	_	14	appos	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	penicillins	_	NOUN	NNS	_	19	nmod	_	_
22	for	_	ADP	IN	_	23	case	_	_
23	treatment	_	NOUN	NN	_	19	nmod	_	_
24	of	_	ADP	IN	_	28	case	_	_
25	B	_	NOUN	NN	_	28	compound	_	_
26	hemolytic	_	ADJ	JJ	_	28	amod	_	_
27	streptococcal	_	ADJ	JJ	_	28	amod	_	_
28	infections	_	NOUN	NNS	_	23	nmod	_	_
29	need	_	VERB	VBP	_	32	aux	_	_
30	not	_	ADV	RB	_	32	neg	_	_
31	be	_	VERB	VB	_	32	auxpass	_	_
32	performed	_	VERB	VBN	_	0	root	_	_
33	routinely	_	ADV	RB	_	32	advmod	_	_
34	,	_	.	,	_	32	punct	_	_
35	because	_	ADP	IN	_	41	mark	_	_
36	non	_	ADJ	JJ	_	38	amod	_	_
37	susceptible	_	ADJ	JJ	_	38	amod	_	_
38	isolates	_	NOUN	NNS	_	41	nsubj	_	_
39	are	_	VERB	VBP	_	41	cop	_	_
40	extremely	_	ADV	RB	_	41	advmod	_	_
41	rare	_	ADJ	JJ	_	32	advcl	_	_
42	in	_	ADP	IN	_	46	case	_	_
43	any	_	DET	DT	_	46	det	_	_
44	B	_	NOUN	NN	_	46	compound	_	_
45	hemolytic	_	ADJ	JJ	_	46	amod	_	_
46	streptococcus	_	NOUN	NN	_	41	nmod	_	_
47	and	_	CONJ	CC	_	41	cc	_	_
48	have	_	VERB	MD	_	51	aux	_	_
49	not	_	ADV	RB	_	51	neg	_	_
50	been	_	VERB	VBN	_	51	auxpass	_	_
51	reported	_	VERB	VBN	_	41	conj	_	_
52	from	_	ADP	IN	_	54	case	_	_
53	Streptococcus	_	NOUN	NN	_	54	compound	_	_
54	pyogenes	_	NOUN	NNS	_	51	nmod	_	_

#	Pfizerpen	6547
1	Any	_	DET	DT	_	5	det	_	_
2	B	_	NOUN	NN	_	5	compound	_	_
3	hemolytic	_	ADJ	JJ	_	5	amod	_	_
4	streptococcal	_	ADJ	JJ	_	5	amod	_	_
5	isolate	_	NOUN	NN	_	16	nsubjpass	_	_
6	found	_	VERB	VBN	_	5	acl	_	_
7	to	_	PRT	TO	_	10	mark	_	_
8	be	_	VERB	VB	_	10	cop	_	_
9	non	_	ADV	RB	_	10	advmod	_	_
10	susceptible	_	ADJ	JJ	_	6	xcomp	_	_
11	to	_	PRT	TO	_	12	case	_	_
12	penicillin	_	NOUN	NN	_	10	nmod	_	_
13	should	_	VERB	MD	_	16	aux	_	_
14	be	_	VERB	VB	_	16	auxpass	_	_
15	re	_	ADV	RB	_	16	advmod	_	_
16	identified	_	VERB	VBN	_	0	root	_	_
17	,	_	.	,	_	16	punct	_	_
18	retested	_	VERB	VBN	_	16	conj	_	_
19	,	_	.	,	_	16	punct	_	_
20	and	_	CONJ	CC	_	16	cc	_	_
21	,	_	.	,	_	16	punct	_	_
22	if	_	DET	WDT	_	23	nsubj	_	_
23	confirmed	_	VERB	VBD	_	16	conj	_	_
24	,	_	.	,	_	23	punct	_	_
25	submitted	_	VERB	VBN	_	23	xcomp	_	_
26	to	_	PRT	TO	_	34	case	_	_
27	a	_	DET	DT	_	34	det	_	_
28	public	_	ADJ	JJ	_	34	amod	_	_
29	health	_	NOUN	NN	_	34	compound	_	_
30	authority.2,4	_	NOUN	NN	_	34	compound	_	_
31	<0.12	_	NUM	CD	_	34	nummod	_	_
32	>24	_	NUM	CD	_	34	nummod	_	_
33	Streptococcus	_	NOUN	NN	_	34	compound	_	_
34	spp	_	NOUN	NN	_	25	nmod	_	_
35	,	_	.	,	_	16	punct	_	_
36	Viridans	_	NOUN	NNS	_	46	compound	_	_
37	Group	_	NOUN	NN	_	46	compound	_	_
38	<0.12	_	NUM	CD	_	46	nummod	_	_
39	0.25	_	NUM	CD	_	46	nummod	_	_
40	2	_	NUM	CD	_	46	nummod	_	_
41	>4	_	NUM	CD	_	46	nummod	_	_
42	Bacillus	_	NOUN	NN	_	46	compound	_	_
43	anthracis	_	NOUN	NN	_	46	compound	_	_
44	B	_	NOUN	NN	_	46	compound	_	_
45	anthracis	_	NOUN	NN	_	46	compound	_	_
46	strains	_	NOUN	NNS	_	48	nsubj	_	_
47	may	_	VERB	MD	_	48	aux	_	_
48	contain	_	VERB	VB	_	16	parataxis	_	_
49	inducible	_	ADJ	JJ	_	51	amod	_	_
50	B	_	NOUN	NN	_	51	compound	_	_
51	lactamases	_	NOUN	NNS	_	48	dobj	_	_

#	Pfizerpen	6548
1	In	_	X	FW	_	5	amod	_	_
2	vitro	_	X	FW	_	1	dep	_	_
3	penicillinase	_	NOUN	NN	_	5	compound	_	_
4	induction	_	NOUN	NN	_	5	compound	_	_
5	studies	_	NOUN	NNS	_	6	nsubj	_	_
6	suggest	_	VERB	VBP	_	0	root	_	_
7	that	_	ADP	IN	_	11	mark	_	_
8	penicillin	_	NOUN	NN	_	9	compound	_	_
9	MICs	_	NOUN	NNS	_	11	nsubj	_	_
10	may	_	VERB	MD	_	11	aux	_	_
11	increase	_	VERB	VB	_	6	ccomp	_	_
12	during	_	ADP	IN	_	13	case	_	_
13	therapy	_	NOUN	NN	_	11	nmod	_	_

#	Pfizerpen	6549
1	However	_	ADV	RB	_	13	advmod	_	_
2	,	_	.	,	_	13	punct	_	_
3	B	_	NOUN	NN	_	5	compound	_	_
4	lactamase	_	NOUN	NN	_	5	compound	_	_
5	testing	_	NOUN	NN	_	13	nsubj	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	clinical	_	ADJ	JJ	_	8	amod	_	_
8	isolates	_	NOUN	NNS	_	5	nmod	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	B	_	NOUN	NN	_	11	compound	_	_
11	anthracis	_	NOUN	NN	_	8	nmod	_	_
12	is	_	VERB	VBZ	_	13	cop	_	_
13	unreliable	_	ADJ	JJ	_	0	root	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	should	_	VERB	MD	_	24	aux	_	_
16	not	_	ADV	RB	_	24	neg	_	_
17	be	_	VERB	VB	_	24	cop	_	_
18	performed.3	_	NOUN	NN	_	24	compound	_	_
19	<0.12	_	NUM	CD	_	24	nummod	_	_
20	>0.25	_	NUM	CD	_	24	nummod	_	_
21	Standardized	_	ADJ	JJ	_	24	amod	_	_
22	susceptibility	_	NOUN	NN	_	24	compound	_	_
23	test	_	NOUN	NN	_	24	compound	_	_
24	procedures	_	NOUN	NNS	_	13	conj	_	_
25	require	_	VERB	VBP	_	24	dep	_	_
26	the	_	DET	DT	_	27	det	_	_
27	use	_	NOUN	NN	_	25	dobj	_	_
28	of	_	ADP	IN	_	31	case	_	_
29	laboratory	_	ADJ	JJ	_	31	amod	_	_
30	control	_	NOUN	NN	_	31	compound	_	_
31	microorganisms	_	NOUN	NNS	_	27	nmod	_	_
32	to	_	PRT	TO	_	33	mark	_	_
33	monitor	_	VERB	VB	_	27	acl	_	_
34	and	_	CONJ	CC	_	25	cc	_	_
35	ensure	_	VERB	VB	_	25	conj	_	_
36	the	_	DET	DT	_	37	det	_	_
37	accuracy	_	NOUN	NN	_	35	dobj	_	_
38	and	_	CONJ	CC	_	37	cc	_	_
39	precision	_	NOUN	NN	_	37	conj	_	_
40	of	_	ADP	IN	_	42	case	_	_
41	the	_	DET	DT	_	42	det	_	_
42	supplies	_	NOUN	NNS	_	37	nmod	_	_
43	and	_	CONJ	CC	_	42	cc	_	_
44	reagents	_	NOUN	NNS	_	42	conj	_	_
45	used	_	VERB	VBN	_	42	acl	_	_
46	in	_	ADP	IN	_	48	case	_	_
47	the	_	DET	DT	_	48	det	_	_
48	assay	_	NOUN	NN	_	45	nmod	_	_
49	,	_	.	,	_	13	punct	_	_
50	and	_	CONJ	CC	_	13	cc	_	_
51	the	_	DET	DT	_	52	det	_	_
52	techniques	_	NOUN	NNS	_	13	conj	_	_
53	of	_	ADP	IN	_	55	case	_	_
54	the	_	DET	DT	_	55	det	_	_
55	individuals	_	NOUN	NNS	_	52	nmod	_	_
56	performing	_	VERB	VBG	_	55	acl	_	_
57	the	_	DET	DT	_	58	det	_	_
58	test	_	NOUN	NN	_	56	dobj	_	_

#	Pfizerpen	6550
1	Standard	_	ADJ	JJ	_	3	amod	_	_
2	penicillin	_	NOUN	NN	_	3	compound	_	_
3	powder	_	NOUN	NN	_	5	nsubj	_	_
4	should	_	VERB	MD	_	5	aux	_	_
5	provide	_	VERB	VB	_	0	root	_	_
6	MIC	_	NOUN	NN	_	7	compound	_	_
7	values	_	NOUN	NNS	_	5	dobj	_	_
8	provided	_	VERB	VBN	_	7	acl	_	_
9	below	_	VERB	VBP	_	5	parataxis	_	_

#	Pfizerpen	6551
1	For	_	ADP	IN	_	4	case	_	_
2	the	_	DET	DT	_	4	det	_	_
3	diffusion	_	NOUN	NN	_	4	compound	_	_
4	technique	_	NOUN	NN	_	12	nmod	_	_
5	,	_	.	,	_	12	punct	_	_
6	the	_	DET	DT	_	10	det	_	_
7	10	_	NUM	CD	_	10	nummod	_	_
8	unit	_	NOUN	NN	_	10	compound	_	_
9	penicillin	_	NOUN	NN	_	10	compound	_	_
10	disk	_	NOUN	NN	_	12	nsubj	_	_
11	should	_	VERB	MD	_	12	aux	_	_
12	provide	_	VERB	VB	_	0	root	_	_
13	the	_	DET	DT	_	16	det	_	_
14	following	_	VERB	VBG	_	16	amod	_	_
15	zone	_	NOUN	NN	_	16	compound	_	_
16	diameters	_	NOUN	NNS	_	12	dobj	_	_
17	with	_	ADP	IN	_	21	case	_	_
18	the	_	DET	DT	_	21	det	_	_
19	quality	_	NOUN	NN	_	21	compound	_	_
20	control	_	NOUN	NN	_	21	compound	_	_
21	strains	_	NOUN	NNS	_	16	nmod	_	_
22	:	_	.	:	_	12	punct	_	_
23	Table	_	ADJ	JJ	_	12	parataxis	_	_
24	2	_	NUM	CD	_	23	punct	_	_

#	Pfizerpen	6552
1	In	_	ADP	IN	_	7	case	_	_
2	Vitro	_	NOUN	NN	_	7	compound	_	_
3	Susceptibility	_	NOUN	NN	_	7	compound	_	_
4	Test	_	NOUN	NN	_	7	amod	_	_
5	Quality	_	NOUN	NN	_	7	compound	_	_
6	Control	_	NOUN	NN	_	7	compound	_	_
7	Ranges	_	NOUN	NNS	_	0	root	_	_
8	for	_	ADP	IN	_	14	case	_	_
9	Penicillin	_	NOUN	NN	_	14	compound	_	_
10	Organism(ATTC	_	NOUN	NN	_	14	compound	_	_
11	#	_	NUM	CD	_	14	nummod	_	_
12	MIC	_	NOUN	NN	_	14	compound	_	_
13	range	_	NOUN	NN	_	14	compound	_	_
14	mcg	_	NOUN	NN	_	7	nmod	_	_
15	/	_	.	:	_	7	punct	_	_
16	mL	_	NOUN	NN	_	22	compound	_	_
17	Disk	_	NOUN	NN	_	22	compound	_	_
18	Diffusion	_	NOUN	NN	_	22	compound	_	_
19	range	_	NOUN	NN	_	22	compound	_	_
20	mm	_	NOUN	NN	_	22	compound	_	_
21	Staphylococcus	_	NOUN	NN	_	22	compound	_	_
22	aureus	_	NOUN	NN	_	7	dep	_	_
23	29213	_	NUM	CD	_	29	nummod	_	_
24	0.25	_	NUM	CD	_	29	nummod	_	_
25	2	_	NUM	CD	_	29	nummod	_	_
26	Not	_	CONJ	CC	_	25	cc	_	_
27	applicable	_	ADJ	JJ	_	25	conj	_	_
28	Staphylococcus	_	NOUN	NN	_	29	compound	_	_
29	aureus	_	NOUN	NN	_	22	dep	_	_
30	25923	_	NUM	CD	_	29	nummod	_	_
31	Not	_	ADV	RB	_	29	cc	_	_
32	applicable	_	ADJ	JJ	_	49	amod	_	_
33	26	_	NUM	CD	_	49	nummod	_	_
34	37	_	NUM	CD	_	49	nummod	_	_
35	Streptococcus	_	NOUN	NN	_	49	compound	_	_
36	pneumoniae	_	ADJ	JJ	_	49	amod	_	_
37	49619	_	NUM	CD	_	49	nummod	_	_
38	0.25	_	NUM	CD	_	49	nummod	_	_
39	1	_	NUM	CD	_	49	nummod	_	_
40	24	_	NUM	CD	_	49	nummod	_	_
41	30	_	NUM	CD	_	49	nummod	_	_
42	Neisseria	_	NOUN	NN	_	49	compound	_	_
43	gonorrhoeae	_	ADJ	JJ	_	49	amod	_	_
44	49226	_	NUM	CD	_	49	nummod	_	_
45	0.25	_	NUM	CD	_	49	nummod	_	_
46	1Using	_	ADJ	JJ	_	49	amod	_	_
47	agar	_	NOUN	NN	_	49	compound	_	_
48	dilution	_	NOUN	NN	_	49	compound	_	_
49	method	_	NOUN	NN	_	29	conj	_	_
50	only	_	ADV	RB	_	22	advmod	_	_

#	Pfizerpen	6553
1	No	_	DET	DT	_	2	neg	_	_
2	criteria	_	NOUN	NN	_	6	nsubj	_	_
3	for	_	ADP	IN	_	5	case	_	_
4	broth	_	ADJ	JJ	_	5	amod	_	_
5	microdilution	_	NOUN	NN	_	2	nmod	_	_
6	are	_	VERB	VBP	_	0	root	_	_
7	available.2	_	NOUN	NN	_	9	compound	_	_
8	26	_	NUM	CD	_	9	nummod	_	_
9	34	_	NUM	CD	_	6	neg	_	_

#	Pimozide	2723
1	Because	_	ADP	IN	_	3	mark	_	_
2	DRUG	_	NOUN	NN	_	3	nsubj	_	_
3	prolongs	_	VERB	VBZ	_	19	advcl	_	_
4	the	_	DET	DT	_	5	det	_	_
5	QT	_	NOUN	NN	_	3	dobj	_	_
6	interval	_	ADJ	JJ	_	5	amod	_	_
7	of	_	ADP	IN	_	9	case	_	_
8	the	_	DET	DT	_	9	det	_	_
9	electrocardiogram	_	NOUN	NN	_	6	nmod	_	_
10	,	_	.	,	_	19	punct	_	_
11	an	_	DET	DT	_	13	det	_	_
12	additive	_	ADJ	JJ	_	13	amod	_	_
13	effect	_	NOUN	NN	_	19	nsubjpass	_	_
14	on	_	ADP	IN	_	16	case	_	_
15	QT	_	NOUN	NN	_	16	compound	_	_
16	interval	_	NOUN	NN	_	13	nmod	_	_
17	would	_	VERB	MD	_	19	aux	_	_
18	be	_	VERB	VB	_	19	auxpass	_	_
19	anticipated	_	VERB	VBN	_	0	root	_	_
20	if	_	ADP	IN	_	21	nsubj	_	_
21	administered	_	VERB	VBN	_	19	ccomp	_	_
22	with	_	ADP	IN	_	24	case	_	_
23	other	_	ADJ	JJ	_	24	amod	_	_
24	drugs	_	NOUN	NNS	_	21	nmod	_	_
25	,	_	.	,	_	24	punct	_	_
26	such	_	ADJ	JJ	_	28	case	_	_
27	as	_	ADP	IN	_	26	mwe	_	_
28	phenothiazines	_	NOUN	NNS	_	24	nmod	_	_
29	,	_	.	,	_	28	punct	_	_
30	tricyclic	_	ADJ	JJ	_	31	amod	_	_
31	antidepressants	_	NOUN	NNS	_	28	conj	_	_
32	or	_	CONJ	CC	_	28	cc	_	_
33	antiarrhythmic	_	ADJ	JJ	_	34	amod	_	_
34	agents	_	NOUN	NNS	_	28	conj	_	_
35	,	_	.	,	_	24	punct	_	_
36	which	_	DET	WDT	_	37	nsubj	_	_
37	prolong	_	VERB	VBP	_	24	acl:relcl	_	_
38	the	_	DET	DT	_	40	det	_	_
39	QT	_	NOUN	NN	_	40	nmod:npmod	_	_
40	interval	_	ADJ	JJ	_	37	dobj	_	_

#	Pimozide	2724
1	Accordingly	_	ADV	RB	_	7	advmod	_	_
2	,	_	.	,	_	7	punct	_	_
3	DRUG	_	NOUN	NN	_	7	nsubjpass	_	_
4	should	_	VERB	MD	_	7	aux	_	_
5	not	_	ADV	RB	_	7	neg	_	_
6	be	_	VERB	VB	_	7	auxpass	_	_
7	given	_	VERB	VBN	_	0	root	_	_
8	with	_	ADP	IN	_	9	case	_	_
9	dofetilide	_	NOUN	NN	_	7	nmod	_	_
10	,	_	.	,	_	9	punct	_	_
11	sotalol	_	NOUN	NN	_	9	conj	_	_
12	,	_	.	,	_	9	punct	_	_
13	quinidine	_	NOUN	NN	_	9	conj	_	_
14	,	_	.	,	_	9	punct	_	_
15	other	_	ADJ	JJ	_	17	amod	_	_
16	Class	_	NOUN	NN	_	17	compound	_	_
17	Ia	_	NOUN	NN	_	9	conj	_	_
18	and	_	CONJ	CC	_	9	cc	_	_
19	III	_	NUM	CD	_	21	nummod	_	_
20	anti	_	ADJ	JJ	_	21	amod	_	_
21	arrhythmics	_	NOUN	NNS	_	9	conj	_	_
22	,	_	.	,	_	9	punct	_	_
23	mesoridazine	_	NOUN	NN	_	9	conj	_	_
24	,	_	.	,	_	9	punct	_	_
25	thioridazine	_	NOUN	NN	_	9	conj	_	_
26	,	_	.	,	_	9	punct	_	_
27	chlorpromazine	_	NOUN	NN	_	9	conj	_	_
28	,	_	.	,	_	9	punct	_	_
29	droperidol	_	NOUN	NN	_	9	conj	_	_
30	,	_	.	,	_	9	punct	_	_
31	sparfloxacin	_	NOUN	NN	_	9	conj	_	_
32	,	_	.	,	_	9	punct	_	_
33	gatifloxacin	_	NOUN	NN	_	9	conj	_	_
34	,	_	.	,	_	9	punct	_	_
35	moxifloxacin	_	NOUN	NN	_	9	conj	_	_
36	,	_	.	,	_	9	punct	_	_
37	halofantrine	_	NOUN	NN	_	9	conj	_	_
38	,	_	.	,	_	9	punct	_	_
39	mefloquine	_	NOUN	NN	_	9	conj	_	_
40	,	_	.	,	_	9	punct	_	_
41	pentamidine	_	NOUN	NN	_	9	conj	_	_
42	,	_	.	,	_	9	punct	_	_
43	arsenic	_	ADJ	JJ	_	44	amod	_	_
44	trioxide	_	NOUN	NN	_	9	conj	_	_
45	,	_	.	,	_	9	punct	_	_
46	levomethadyl	_	NOUN	NN	_	47	compound	_	_
47	acetate	_	NOUN	NN	_	9	conj	_	_
48	,	_	.	,	_	9	punct	_	_
49	dolasetron	_	NOUN	NN	_	50	compound	_	_
50	mesylate	_	NOUN	NN	_	9	conj	_	_
51	,	_	.	,	_	9	punct	_	_
52	probucol	_	NOUN	NN	_	9	conj	_	_
53	,	_	.	,	_	9	punct	_	_
54	tacrolimus	_	NOUN	NN	_	9	conj	_	_
55	,	_	.	,	_	9	punct	_	_
56	ziprasidone	_	NOUN	NN	_	9	conj	_	_
57	,	_	.	,	_	9	punct	_	_
58	or	_	CONJ	CC	_	9	cc	_	_
59	other	_	ADJ	JJ	_	60	amod	_	_
60	drugs	_	NOUN	NNS	_	9	conj	_	_
61	that	_	DET	WDT	_	63	nsubj	_	_
62	have	_	VERB	VBP	_	63	aux	_	_
63	demonstrated	_	VERB	VBN	_	9	acl:relcl	_	_
64	QT	_	NOUN	NN	_	65	compound	_	_
65	prolongation	_	NOUN	NN	_	63	dobj	_	_
66	as	_	ADP	IN	_	67	case	_	_
67	one	_	NUM	CD	_	63	nmod	_	_
68	of	_	ADP	IN	_	71	case	_	_
69	their	_	PRON	PRP$	_	71	nmod:poss	_	_
70	pharmacodynamic	_	ADJ	JJ	_	71	amod	_	_
71	effects	_	NOUN	NNS	_	67	nmod	_	_

#	Pimozide	2725
1	Also	_	ADV	RB	_	17	advmod	_	_
2	,	_	.	,	_	17	punct	_	_
3	the	_	DET	DT	_	4	det	_	_
4	use	_	NOUN	NN	_	17	nsubjpass	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	macrolide	_	NOUN	NN	_	7	compound	_	_
7	antibiotics	_	NOUN	NNS	_	4	nmod	_	_
8	in	_	ADP	IN	_	9	case	_	_
9	patients	_	NOUN	NNS	_	4	nmod	_	_
10	with	_	ADP	IN	_	13	case	_	_
11	prolonged	_	ADJ	JJ	_	13	amod	_	_
12	QT	_	NOUN	NN	_	13	compound	_	_
13	intervals	_	NOUN	NNS	_	9	nmod	_	_
14	has	_	VERB	VBZ	_	17	aux	_	_
15	been	_	VERB	VBN	_	17	auxpass	_	_
16	rarely	_	ADV	RB	_	17	advmod	_	_
17	associated	_	VERB	VBN	_	0	root	_	_
18	with	_	ADP	IN	_	20	case	_	_
19	ventricular	_	ADJ	JJ	_	20	amod	_	_
20	arrhythmias	_	NOUN	NNS	_	17	nmod	_	_

#	Pimozide	2726
1	Such	_	ADJ	JJ	_	3	amod	_	_
2	concomitant	_	ADJ	JJ	_	3	amod	_	_
3	administration	_	NOUN	NN	_	7	nsubjpass	_	_
4	should	_	VERB	MD	_	7	aux	_	_
5	not	_	ADV	RB	_	7	neg	_	_
6	be	_	VERB	VB	_	7	auxpass	_	_
7	undertaken	_	VERB	VBN	_	0	root	_	_

#	Pimozide	2727
1	Since	_	ADP	IN	_	5	mark	_	_
2	DRUG	_	NOUN	NN	_	5	nsubjpass	_	_
3	is	_	VERB	VBZ	_	5	auxpass	_	_
4	partly	_	ADV	RB	_	5	advmod	_	_
5	metabolized	_	VERB	VBN	_	14	advcl	_	_
6	via	_	ADP	IN	_	8	case	_	_
7	CYP	_	NOUN	NN	_	8	compound	_	_
8	3A4	_	NOUN	NN	_	5	nmod	_	_
9	,	_	.	,	_	14	punct	_	_
10	it	_	PRON	PRP	_	14	nsubjpass	_	_
11	should	_	VERB	MD	_	14	aux	_	_
12	not	_	ADV	RB	_	14	neg	_	_
13	be	_	VERB	VB	_	14	auxpass	_	_
14	administered	_	VERB	VBN	_	0	root	_	_
15	concomitantly	_	ADV	RB	_	14	advmod	_	_
16	with	_	ADP	IN	_	17	case	_	_
17	inhibitors	_	NOUN	NNS	_	14	nmod	_	_
18	of	_	ADP	IN	_	21	case	_	_
19	this	_	DET	DT	_	21	det	_	_
20	metabolic	_	ADJ	JJ	_	21	amod	_	_
21	system	_	NOUN	NN	_	17	nmod	_	_
22	,	_	.	,	_	17	punct	_	_
23	such	_	ADJ	JJ	_	27	case	_	_
24	as	_	ADP	IN	_	23	mwe	_	_
25	azole	_	NOUN	NN	_	27	amod	_	_
26	antifungal	_	ADJ	JJ	_	27	amod	_	_
27	agents	_	NOUN	NNS	_	17	nmod	_	_
28	and	_	CONJ	CC	_	27	cc	_	_
29	protease	_	NOUN	NN	_	31	compound	_	_
30	inhibitor	_	NOUN	NN	_	31	compound	_	_
31	drugs	_	NOUN	NNS	_	27	conj	_	_

#	Pimozide	2728
1	DRUG	_	NOUN	NN	_	0	root	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	Celexa	_	NOUN	NN	_	1	conj	_	_
4	:	_	.	:	_	1	punct	_	_
5	In	_	ADP	IN	_	8	case	_	_
6	a	_	DET	DT	_	8	det	_	_
7	controlled	_	VERB	VBN	_	8	amod	_	_
8	study	_	NOUN	NN	_	1	nmod	_	_
9	,	_	.	,	_	1	punct	_	_
10	a	_	DET	DT	_	12	det	_	_
11	single	_	ADJ	JJ	_	12	amod	_	_
12	dose	_	NOUN	NN	_	30	nsubjpass	_	_
13	of	_	ADP	IN	_	16	case	_	_
14	DRUG	_	NOUN	NN	_	16	compound	_	_
15	2	_	NUM	CD	_	16	nummod	_	_
16	mg	_	NOUN	NN	_	12	nmod	_	_
17	coadministered	_	VERB	VBN	_	16	acl	_	_
18	with	_	ADP	IN	_	22	case	_	_
19	racemic	_	ADJ	JJ	_	22	amod	_	_
20	citalopram	_	NOUN	NN	_	22	compound	_	_
21	40	_	NUM	CD	_	22	nummod	_	_
22	mg	_	NOUN	NN	_	17	nmod	_	_
23	given	_	VERB	VBN	_	22	acl	_	_
24	once	_	ADV	RB	_	25	advmod	_	_
25	daily	_	ADV	RB	_	23	advmod	_	_
26	for	_	ADP	IN	_	28	case	_	_
27	11	_	NUM	CD	_	28	nummod	_	_
28	days	_	NOUN	NNS	_	23	nmod	_	_
29	was	_	VERB	VBD	_	30	auxpass	_	_
30	associated	_	VERB	VBN	_	1	dep	_	_
31	with	_	ADP	IN	_	34	case	_	_
32	a	_	DET	DT	_	34	det	_	_
33	mean	_	ADJ	JJ	_	34	amod	_	_
34	increase	_	NOUN	NN	_	30	nmod	_	_
35	in	_	ADP	IN	_	37	case	_	_
36	QTc	_	NOUN	NN	_	37	compound	_	_
37	values	_	NOUN	NNS	_	34	nmod	_	_
38	of	_	ADP	IN	_	41	case	_	_
39	approximately	_	ADV	RB	_	40	advmod	_	_
40	10	_	NUM	CD	_	41	nummod	_	_
41	msec	_	NOUN	NN	_	37	nmod	_	_
42	compared	_	VERB	VBN	_	30	xcomp	_	_
43	to	_	PRT	TO	_	44	case	_	_
44	DRUG	_	NOUN	NN	_	42	nmod	_	_
45	given	_	VERB	VBN	_	44	acl	_	_
46	alone	_	ADV	RB	_	45	advmod	_	_

#	Pimozide	2729
1	Racemic	_	ADJ	JJ	_	2	amod	_	_
2	citalopram	_	NOUN	NN	_	5	nsubj	_	_
3	did	_	VERB	VBD	_	5	aux	_	_
4	not	_	ADV	RB	_	5	neg	_	_
5	alter	_	VERB	VB	_	0	root	_	_
6	the	_	DET	DT	_	8	det	_	_
7	mean	_	NOUN	NN	_	8	compound	_	_
8	AUC	_	NOUN	NN	_	5	dobj	_	_
9	or	_	CONJ	CC	_	8	cc	_	_
10	Cmax	_	NOUN	NN	_	8	conj	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	8	nmod	_	_

#	Pimozide	2730
1	The	_	DET	DT	_	2	det	_	_
2	mechanism	_	NOUN	NN	_	9	nsubjpass	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	this	_	DET	DT	_	6	det	_	_
5	pharmacodynamic	_	ADJ	JJ	_	6	amod	_	_
6	interaction	_	NOUN	NN	_	2	nmod	_	_
7	is	_	VERB	VBZ	_	9	auxpass	_	_
8	not	_	ADV	RB	_	9	neg	_	_
9	known	_	VERB	VBN	_	0	root	_	_

#	Pimozide	2731
1	Concomitant	_	ADJ	JJ	_	2	amod	_	_
2	use	_	NOUN	NN	_	10	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	Celexa	_	NOUN	NN	_	4	conj	_	_
7	or	_	CONJ	CC	_	4	cc	_	_
8	Lexapro	_	NOUN	NN	_	4	conj	_	_
9	is	_	VERB	VBZ	_	10	auxpass	_	_
10	contraindicated	_	VERB	VBN	_	0	root	_	_

#	Pimozide	2732
1	CYP	_	NOUN	NN	_	3	compound	_	_
2	2D6	_	NOUN	NN	_	3	compound	_	_
3	inhibitors	_	NOUN	NNS	_	21	nsubj	_	_
4	:	_	.	:	_	3	punct	_	_
5	In	_	ADP	IN	_	7	case	_	_
6	healthy	_	ADJ	JJ	_	7	amod	_	_
7	subjects	_	NOUN	NNS	_	3	nmod	_	_
8	,	_	.	,	_	3	punct	_	_
9	co	_	PRT	TO	_	10	case	_	_
10	administration	_	NOUN	NN	_	3	nmod	_	_
11	of	_	ADP	IN	_	16	case	_	_
12	DRUG	_	NOUN	NN	_	16	compound	_	_
13	2	_	NUM	CD	_	16	nummod	_	_
14	mg	_	NOUN	NN	_	16	compound	_	_
15	single	_	ADJ	JJ	_	16	amod	_	_
16	dose	_	NOUN	NN	_	10	nmod	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	paroxetine	_	NOUN	NN	_	20	compound	_	_
19	60	_	NUM	CD	_	20	nummod	_	_
20	mg	_	NOUN	NN	_	16	conj	_	_
21	resulted	_	VERB	VBD	_	0	root	_	_
22	in	_	ADP	IN	_	25	case	_	_
23	a	_	DET	DT	_	25	det	_	_
24	151%	_	ADJ	JJ	_	25	amod	_	_
25	increase	_	NOUN	NN	_	21	nmod	_	_
26	in	_	ADP	IN	_	28	case	_	_
27	DRUG	_	NOUN	NN	_	28	compound	_	_
28	AUC	_	NOUN	NN	_	25	nmod	_	_
29	and	_	CONJ	CC	_	21	cc	_	_
30	a	_	DET	DT	_	32	det	_	_
31	62%	_	ADJ	JJ	_	32	amod	_	_
32	increase	_	NOUN	NN	_	36	nsubj	_	_
33	in	_	ADP	IN	_	35	case	_	_
34	DRUG	_	NOUN	NN	_	35	compound	_	_
35	Cmax	_	NOUN	NN	_	32	nmod	_	_
36	compared	_	VERB	VBN	_	21	conj	_	_
37	to	_	PRT	TO	_	38	case	_	_
38	DRUG	_	NOUN	NN	_	36	nmod	_	_
39	administered	_	VERB	VBN	_	38	acl	_	_
40	alone	_	ADV	RB	_	39	advmod	_	_

#	Pimozide	2733
1	The	_	DET	DT	_	2	det	_	_
2	increase	_	NOUN	NN	_	9	nsubj	_	_
3	in	_	ADP	IN	_	5	case	_	_
4	DRUG	_	NOUN	NN	_	5	compound	_	_
5	AUC	_	NOUN	NN	_	2	nmod	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	Cmax	_	NOUN	NN	_	5	conj	_	_
8	is	_	VERB	VBZ	_	9	cop	_	_
9	related	_	ADJ	JJ	_	0	root	_	_
10	to	_	PRT	TO	_	15	case	_	_
11	the	_	DET	DT	_	15	det	_	_
12	CYP	_	NOUN	NN	_	15	compound	_	_
13	2D6	_	NOUN	NN	_	15	compound	_	_
14	inhibitory	_	ADJ	JJ	_	15	amod	_	_
15	properties	_	NOUN	NNS	_	9	nmod	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	paroxetine	_	NOUN	NN	_	15	nmod	_	_

#	Pimozide	2734
1	Concomitant	_	ADJ	JJ	_	2	amod	_	_
2	use	_	NOUN	NN	_	14	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	paroxetine	_	NOUN	NN	_	4	conj	_	_
7	or	_	CONJ	CC	_	4	cc	_	_
8	other	_	ADJ	JJ	_	12	amod	_	_
9	strong	_	ADJ	JJ	_	12	amod	_	_
10	CYP	_	NOUN	NN	_	12	compound	_	_
11	2D6	_	NOUN	NN	_	12	compound	_	_
12	inhibitors	_	NOUN	NNS	_	4	conj	_	_
13	are	_	VERB	VBP	_	14	auxpass	_	_
14	contraindicated	_	VERB	VBN	_	0	root	_	_

#	Pimozide	2735
1	As	_	ADP	IN	_	6	mark	_	_
2	CYP	_	NOUN	NN	_	3	compound	_	_
3	1A2	_	NOUN	NN	_	6	nsubj	_	_
4	may	_	VERB	MD	_	6	aux	_	_
5	also	_	ADV	RB	_	6	advmod	_	_
6	contribute	_	VERB	VB	_	16	advcl	_	_
7	to	_	PRT	TO	_	9	case	_	_
8	the	_	DET	DT	_	9	det	_	_
9	metabolism	_	NOUN	NN	_	6	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_
12	,	_	.	,	_	16	punct	_	_
13	prescribers	_	NOUN	NNS	_	16	nsubj	_	_
14	should	_	VERB	MD	_	16	aux	_	_
15	be	_	VERB	VB	_	16	cop	_	_
16	aware	_	ADJ	JJ	_	0	root	_	_
17	of	_	ADP	IN	_	20	case	_	_
18	the	_	DET	DT	_	20	det	_	_
19	theoretical	_	ADJ	JJ	_	20	amod	_	_
20	potential	_	NOUN	NN	_	16	nmod	_	_
21	for	_	ADP	IN	_	23	case	_	_
22	drug	_	NOUN	NN	_	23	compound	_	_
23	interactions	_	NOUN	NNS	_	20	nmod	_	_
24	with	_	ADP	IN	_	25	case	_	_
25	inhibitors	_	NOUN	NNS	_	23	nmod	_	_
26	of	_	ADP	IN	_	29	case	_	_
27	this	_	DET	DT	_	29	det	_	_
28	enzymatic	_	ADJ	JJ	_	29	amod	_	_
29	system	_	NOUN	NN	_	25	nmod	_	_

#	Pimozide	2736
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	may	_	VERB	MD	_	4	aux	_	_
3	be	_	VERB	VB	_	4	cop	_	_
4	capable	_	ADJ	JJ	_	0	root	_	_
5	of	_	ADP	IN	_	6	mark	_	_
6	potentiating	_	VERB	VBG	_	4	advcl	_	_
7	CNS	_	NOUN	NN	_	8	compound	_	_
8	depressants	_	NOUN	NNS	_	6	dobj	_	_
9	,	_	.	,	_	8	punct	_	_
10	including	_	VERB	VBG	_	11	case	_	_
11	analgesics	_	NOUN	NNS	_	8	nmod	_	_
12	,	_	.	,	_	11	punct	_	_
13	sedatives	_	NOUN	NNS	_	11	conj	_	_
14	,	_	.	,	_	11	punct	_	_
15	anxiolytics	_	NOUN	NNS	_	11	conj	_	_
16	,	_	.	,	_	11	punct	_	_
17	and	_	CONJ	CC	_	11	cc	_	_
18	alcohol	_	NOUN	NN	_	11	conj	_	_

#	Pimozide	2737
1	Rare	_	ADJ	JJ	_	3	amod	_	_
2	case	_	NOUN	NN	_	3	compound	_	_
3	reports	_	NOUN	NNS	_	5	nsubj	_	_
4	have	_	VERB	VBP	_	5	aux	_	_
5	suggested	_	VERB	VBN	_	0	root	_	_
6	possible	_	ADJ	JJ	_	8	amod	_	_
7	additive	_	ADJ	JJ	_	8	amod	_	_
8	effects	_	NOUN	NNS	_	5	dobj	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	fluoxetine	_	NOUN	NN	_	10	conj	_	_
13	leading	_	VERB	VBG	_	10	acl	_	_
14	to	_	PRT	TO	_	15	case	_	_
15	bradycardia	_	NOUN	NN	_	13	nmod	_	_

#	Pimozide	2738
1	Concomitant	_	ADJ	JJ	_	2	amod	_	_
2	administration	_	NOUN	NN	_	9	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	sertraline	_	NOUN	NN	_	4	conj	_	_
7	should	_	VERB	MD	_	9	aux	_	_
8	be	_	VERB	VB	_	9	auxpass	_	_
9	contraindicated	_	VERB	VBN	_	0	root	_	_

#	Pimozide	2739
1	Pharmacogenomics	_	NOUN	NNS	_	2	compound	_	_
2	Individuals	_	NOUN	NNS	_	19	nsubj	_	_
3	with	_	ADP	IN	_	5	case	_	_
4	genetic	_	ADJ	JJ	_	5	amod	_	_
5	variations	_	NOUN	NNS	_	2	nmod	_	_
6	resulting	_	VERB	VBG	_	5	acl	_	_
7	in	_	ADP	IN	_	11	case	_	_
8	poor	_	ADJ	JJ	_	11	amod	_	_
9	CYP	_	NOUN	NN	_	11	compound	_	_
10	2D6	_	NOUN	NN	_	11	compound	_	_
11	metabolism	_	NOUN	NN	_	6	nmod	_	_
12	approximately	_	ADV	RB	_	13	advmod	_	_
13	5	_	NUM	CD	_	11	nmod	_	_
14	to	_	PRT	TO	_	13	dep	_	_
15	10%	_	NOUN	NN	_	13	dep	_	_
16	of	_	ADP	IN	_	18	case	_	_
17	the	_	DET	DT	_	18	det	_	_
18	population	_	NOUN	NN	_	13	nmod	_	_
19	exhibit	_	VERB	VBP	_	0	root	_	_
20	higher	_	ADJ	JJ	_	22	amod	_	_
21	DRUG	_	NOUN	NN	_	22	compound	_	_
22	concentrations	_	NOUN	NNS	_	19	dobj	_	_
23	than	_	ADP	IN	_	27	case	_	_
24	extensive	_	ADJ	JJ	_	27	amod	_	_
25	CYP	_	NOUN	NN	_	27	compound	_	_
26	2D6	_	NOUN	NN	_	27	compound	_	_
27	metabolizers	_	NOUN	NNS	_	19	nmod	_	_

#	Pimozide	2740
1	The	_	DET	DT	_	2	det	_	_
2	concentrations	_	NOUN	NNS	_	10	nsubj	_	_
3	observed	_	VERB	VBN	_	2	acl	_	_
4	in	_	ADP	IN	_	8	case	_	_
5	poor	_	ADJ	JJ	_	8	amod	_	_
6	CYP	_	NOUN	NN	_	8	compound	_	_
7	2D6	_	NOUN	NN	_	8	compound	_	_
8	metabolizers	_	NOUN	NNS	_	3	nmod	_	_
9	are	_	VERB	VBP	_	10	cop	_	_
10	similar	_	ADJ	JJ	_	0	root	_	_
11	to	_	PRT	TO	_	12	case	_	_
12	those	_	DET	DT	_	10	nmod	_	_
13	seen	_	VERB	VBN	_	12	acl	_	_
14	with	_	ADP	IN	_	18	case	_	_
15	strong	_	ADJ	JJ	_	18	amod	_	_
16	CYP	_	NOUN	NN	_	18	compound	_	_
17	2D6	_	NOUN	NN	_	18	compound	_	_
18	inhibitors	_	NOUN	NNS	_	13	nmod	_	_
19	such	_	ADJ	JJ	_	21	case	_	_
20	as	_	ADP	IN	_	19	mwe	_	_
21	paroxetine	_	NOUN	NN	_	18	nmod	_	_

#	Pimozide	2741
1	The	_	DET	DT	_	2	det	_	_
2	time	_	NOUN	NN	_	10	nsubjpass	_	_
3	to	_	PRT	TO	_	4	mark	_	_
4	achieve	_	VERB	VB	_	2	acl	_	_
5	steady	_	ADJ	JJ	_	8	amod	_	_
6	state	_	NOUN	NN	_	8	compound	_	_
7	DRUG	_	NOUN	NN	_	8	compound	_	_
8	concentrations	_	NOUN	NNS	_	4	dobj	_	_
9	is	_	VERB	VBZ	_	10	auxpass	_	_
10	expected	_	VERB	VBN	_	0	root	_	_
11	to	_	PRT	TO	_	16	mark	_	_
12	be	_	VERB	VB	_	16	cop	_	_
13	longer	_	ADV	RB	_	15	advmod	_	_
14	approximately	_	ADV	RB	_	15	advmod	_	_
15	2	_	NUM	CD	_	16	nummod	_	_
16	weeks	_	NOUN	NNS	_	10	nmod	_	_
17	in	_	ADP	IN	_	21	case	_	_
18	poor	_	ADJ	JJ	_	21	amod	_	_
19	CYP	_	NOUN	NN	_	21	compound	_	_
20	2D6	_	NOUN	NN	_	21	compound	_	_
21	metabolizers	_	NOUN	NNS	_	16	nmod	_	_
22	because	_	ADP	IN	_	27	case	_	_
23	of	_	ADP	IN	_	27	case	_	_
24	the	_	DET	DT	_	27	det	_	_
25	prolonged	_	ADJ	JJ	_	27	amod	_	_
26	half	_	NOUN	NN	_	27	compound	_	_
27	life	_	NOUN	NN	_	16	nmod	_	_

#	Pimozide	2742
1	Alternative	_	ADJ	JJ	_	3	amod	_	_
2	dosing	_	NOUN	NN	_	3	amod	_	_
3	strategies	_	NOUN	NNS	_	5	nsubjpass	_	_
4	are	_	VERB	VBP	_	5	auxpass	_	_
5	recommended	_	VERB	VBN	_	0	root	_	_
6	in	_	ADP	IN	_	7	case	_	_
7	patients	_	NOUN	NNS	_	5	nmod	_	_
8	who	_	DET	WDT	_	14	nsubj	_	_
9	are	_	VERB	VBP	_	14	cop	_	_
10	genetically	_	ADV	RB	_	11	advmod	_	_
11	poor	_	ADJ	JJ	_	14	amod	_	_
12	CYP	_	NOUN	NN	_	14	compound	_	_
13	2D6	_	NOUN	NN	_	14	compound	_	_
14	metabolizers	_	NOUN	NNS	_	7	root	_	_

#	Pimozide	2743
1	Interaction	_	NOUN	NN	_	6	nsubj	_	_
2	with	_	ADP	IN	_	4	case	_	_
3	Food	_	ADJ	JJ	_	4	amod	_	_
4	Patients	_	NOUN	NNS	_	1	nmod	_	_
5	should	_	VERB	MD	_	6	aux	_	_
6	avoid	_	VERB	VB	_	0	root	_	_
7	grapefruit	_	ADJ	JJ	_	8	amod	_	_
8	juice	_	NOUN	NN	_	6	dobj	_	_
9	because	_	ADP	IN	_	12	mark	_	_
10	it	_	PRON	PRP	_	12	nsubj	_	_
11	may	_	VERB	MD	_	12	aux	_	_
12	inhibit	_	VERB	VB	_	6	advcl	_	_
13	the	_	DET	DT	_	14	det	_	_
14	metabolism	_	NOUN	NN	_	12	dobj	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	14	nmod	_	_
17	by	_	ADP	IN	_	19	case	_	_
18	CYP	_	NOUN	NN	_	19	compound	_	_
19	3A4	_	NOUN	NN	_	14	nmod	_	_

#	Pimozide	2744
1	Pharmacodynamic	_	ADJ	JJ	_	2	amod	_	_
2	Actions	_	NOUN	NNS	_	0	root	_	_
3	DRUG	_	NOUN	NN	_	4	compound	_	_
4	tablets	_	NOUN	NNS	_	2	dep	_	_
5	,	_	.	,	_	2	punct	_	_
6	USP	_	NOUN	NN	_	13	nsubj	_	_
7	is	_	VERB	VBZ	_	13	cop	_	_
8	an	_	DET	DT	_	13	det	_	_
9	orally	_	ADV	RB	_	10	advmod	_	_
10	active	_	ADJ	JJ	_	13	amod	_	_
11	antipsychotic	_	ADJ	JJ	_	13	amod	_	_
12	drug	_	NOUN	NN	_	13	compound	_	_
13	product	_	NOUN	NN	_	2	dep	_	_
14	which	_	DET	WDT	_	15	nsubj	_	_
15	shares	_	VERB	VBZ	_	13	acl:relcl	_	_
16	with	_	ADP	IN	_	18	case	_	_
17	other	_	ADJ	JJ	_	18	amod	_	_
18	antipsychotics	_	NOUN	NNS	_	15	nmod	_	_
19	the	_	DET	DT	_	20	det	_	_
20	ability	_	NOUN	NN	_	15	dobj	_	_
21	to	_	PRT	TO	_	22	mark	_	_
22	blockade	_	VERB	VB	_	20	acl	_	_
23	dopaminergic	_	ADJ	JJ	_	24	amod	_	_
24	receptors	_	NOUN	NNS	_	22	dobj	_	_
25	on	_	ADP	IN	_	26	case	_	_
26	neurons	_	NOUN	NNS	_	22	nmod	_	_
27	in	_	ADP	IN	_	31	case	_	_
28	the	_	DET	DT	_	31	det	_	_
29	central	_	ADJ	JJ	_	31	amod	_	_
30	nervous	_	ADJ	JJ	_	31	amod	_	_
31	system	_	NOUN	NN	_	26	nmod	_	_

#	Pimozide	2745
1	Although	_	ADP	IN	_	10	mark	_	_
2	its	_	PRON	PRP$	_	4	nmod:poss	_	_
3	exact	_	ADJ	JJ	_	4	amod	_	_
4	mode	_	NOUN	NN	_	10	nsubjpass	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	action	_	NOUN	NN	_	4	nmod	_	_
7	has	_	VERB	VBZ	_	10	aux	_	_
8	not	_	ADV	RB	_	10	neg	_	_
9	been	_	VERB	VBN	_	10	auxpass	_	_
10	established	_	VERB	VBN	_	26	advcl	_	_
11	,	_	.	,	_	26	punct	_	_
12	the	_	DET	DT	_	13	det	_	_
13	ability	_	NOUN	NN	_	26	nsubjpass	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	DRUG	_	NOUN	NN	_	13	nmod	_	_
16	to	_	PRT	TO	_	17	mark	_	_
17	suppress	_	VERB	VB	_	13	acl	_	_
18	motor	_	NOUN	NN	_	17	dobj	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	phonic	_	ADJ	JJ	_	18	conj	_	_
21	tics	_	NOUN	NNS	_	18	dep	_	_
22	in	_	ADP	IN	_	24	case	_	_
23	Tourette's	_	NOUN	NNS	_	24	compound	_	_
24	Disorder	_	NOUN	NN	_	17	nmod	_	_
25	is	_	VERB	VBZ	_	26	auxpass	_	_
26	thought	_	VERB	VBN	_	0	root	_	_
27	to	_	PRT	TO	_	30	mark	_	_
28	be	_	VERB	VB	_	30	cop	_	_
29	a	_	DET	DT	_	30	det	_	_
30	function	_	NOUN	NN	_	26	xcomp	_	_
31	of	_	ADP	IN	_	35	case	_	_
32	its	_	PRON	PRP$	_	35	nmod:poss	_	_
33	dopaminergic	_	ADJ	JJ	_	35	amod	_	_
34	blocking	_	NOUN	NN	_	35	compound	_	_
35	activity	_	NOUN	NN	_	30	nmod	_	_

#	Pimozide	2746
1	However	_	ADV	RB	_	7	advmod	_	_
2	,	_	.	,	_	7	punct	_	_
3	receptor	_	NOUN	NN	_	4	compound	_	_
4	blockade	_	NOUN	NN	_	7	nsubjpass	_	_
5	is	_	VERB	VBZ	_	7	auxpass	_	_
6	often	_	ADV	RB	_	7	advmod	_	_
7	accompanied	_	VERB	VBN	_	0	root	_	_
8	by	_	ADP	IN	_	10	case	_	_
9	a	_	DET	DT	_	10	det	_	_
10	series	_	NOUN	NNS	_	7	nmod	_	_
11	of	_	ADP	IN	_	13	case	_	_
12	secondary	_	ADJ	JJ	_	13	amod	_	_
13	alterations	_	NOUN	NNS	_	10	nmod	_	_
14	in	_	ADP	IN	_	17	case	_	_
15	central	_	ADJ	JJ	_	17	amod	_	_
16	dopamine	_	NOUN	NN	_	17	compound	_	_
17	metabolism	_	NOUN	NN	_	13	nmod	_	_
18	and	_	CONJ	CC	_	10	cc	_	_
19	function	_	NOUN	NN	_	10	conj	_	_
20	which	_	DET	WDT	_	22	nsubj	_	_
21	may	_	VERB	MD	_	22	aux	_	_
22	contribute	_	VERB	VB	_	19	acl:relcl	_	_
23	to	_	PRT	TO	_	27	case	_	_
24	both	_	CONJ	CC	_	25	cc:preconj	_	_
25	DRUG	_	NOUN	NN	_	27	nmod:poss	_	_
26	's	_	PRT	POS	_	25	case	_	_
27	therapeutic	_	ADJ	JJ	_	22	nmod	_	_
28	and	_	CONJ	CC	_	27	cc	_	_
29	untoward	_	ADJ	JJ	_	27	conj	_	_
30	effects	_	NOUN	NNS	_	27	dep	_	_

#	Pimozide	2747
1	In	_	ADP	IN	_	2	case	_	_
2	addition	_	NOUN	NN	_	14	nmod	_	_
3	,	_	.	,	_	14	punct	_	_
4	DRUG	_	NOUN	NN	_	5	compound	_	_
5	tablets	_	NOUN	NNS	_	14	nsubj	_	_
6	,	_	.	,	_	5	punct	_	_
7	USP	_	NOUN	NN	_	5	appos	_	_
8	in	_	ADP	IN	_	9	case	_	_
9	common	_	ADJ	JJ	_	7	nmod	_	_
10	with	_	ADP	IN	_	12	case	_	_
11	other	_	ADJ	JJ	_	12	amod	_	_
12	DRUGS	_	NOUN	NN	_	9	nmod	_	_
13	,	_	.	,	_	5	punct	_	_
14	has	_	VERB	VBZ	_	0	root	_	_
15	various	_	ADJ	JJ	_	16	amod	_	_
16	effects	_	NOUN	NNS	_	14	dobj	_	_
17	on	_	ADP	IN	_	23	case	_	_
18	other	_	ADJ	JJ	_	23	amod	_	_
19	central	_	ADJ	JJ	_	23	amod	_	_
20	nervous	_	ADJ	JJ	_	23	amod	_	_
21	system	_	NOUN	NN	_	23	compound	_	_
22	receptor	_	NOUN	NN	_	23	compound	_	_
23	systems	_	NOUN	NNS	_	16	nmod	_	_
24	which	_	DET	WDT	_	28	nsubjpass	_	_
25	are	_	VERB	VBP	_	28	auxpass	_	_
26	not	_	ADV	RB	_	28	neg	_	_
27	fully	_	ADV	RB	_	28	advmod	_	_
28	characterized	_	VERB	VBN	_	23	acl:relcl	_	_

#	Pimozide	2748
1	Metabolism	_	NOUN	NN	_	13	nsubjpass	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	Pharmacokinetics	_	NOUN	NNS	_	1	conj	_	_
4	More	_	NOUN	NN	_	6	advmod	_	_
5	than	_	ADP	IN	_	6	case	_	_
6	50%	_	NOUN	NN	_	1	nmod	_	_
7	of	_	ADP	IN	_	9	case	_	_
8	a	_	DET	DT	_	9	det	_	_
9	dose	_	NOUN	NN	_	6	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_
12	is	_	VERB	VBZ	_	13	auxpass	_	_
13	absorbed	_	VERB	VBN	_	0	root	_	_
14	after	_	ADP	IN	_	16	case	_	_
15	oral	_	ADJ	JJ	_	16	amod	_	_
16	administration	_	NOUN	NN	_	13	nmod	_	_

#	Pimozide	2749
1	Based	_	VERB	VBN	_	10	advcl	_	_
2	on	_	ADP	IN	_	7	case	_	_
3	the	_	DET	DT	_	7	det	_	_
4	pharmacokinetic	_	ADJ	JJ	_	7	amod	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	metabolic	_	ADJ	JJ	_	4	conj	_	_
7	profile	_	NOUN	NN	_	1	nmod	_	_
8	,	_	.	,	_	10	punct	_	_
9	DRUG	_	NOUN	NN	_	10	nsubj	_	_
10	appears	_	VERB	VBZ	_	0	root	_	_
11	to	_	PRT	TO	_	12	mark	_	_
12	undergo	_	VERB	VB	_	10	xcomp	_	_
13	significant	_	ADJ	JJ	_	16	amod	_	_
14	first	_	ADJ	JJ	_	16	amod	_	_
15	pass	_	NOUN	NN	_	16	compound	_	_
16	metabolism	_	NOUN	NN	_	12	dobj	_	_

#	Pimozide	2750
1	Peak	_	ADJ	JJ	_	3	amod	_	_
2	serum	_	NOUN	NN	_	3	compound	_	_
3	levels	_	NOUN	NNS	_	4	nsubj	_	_
4	occur	_	VERB	VBP	_	0	root	_	_
5	generally	_	ADV	RB	_	6	advmod	_	_
6	six	_	NUM	CD	_	8	compound	_	_
7	to	_	PRT	TO	_	8	dep	_	_
8	eight	_	NUM	CD	_	9	nummod	_	_
9	hours	_	NOUN	NNS	_	4	nmod	_	_
10	range	_	NOUN	NN	_	9	dep	_	_
11	4	_	NUM	CD	_	13	compound	_	_
12	to	_	PRT	TO	_	13	dep	_	_
13	12	_	NUM	CD	_	14	nummod	_	_
14	hours	_	NOUN	NNS	_	10	dep	_	_
15	after	_	ADP	IN	_	16	mark	_	_
16	dosing	_	VERB	VBG	_	10	advcl	_	_

#	Pimozide	2751
1	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
2	is	_	VERB	VBZ	_	4	auxpass	_	_
3	extensively	_	ADV	RB	_	4	advmod	_	_
4	metabolized	_	VERB	VBN	_	0	root	_	_
5	,	_	.	,	_	4	punct	_	_
6	primarily	_	ADV	RB	_	9	advmod	_	_
7	by	_	ADP	IN	_	9	case	_	_
8	N	_	NOUN	NN	_	9	compound	_	_
9	dealkylation	_	NOUN	NN	_	4	nmod	_	_
10	in	_	ADP	IN	_	12	case	_	_
11	the	_	DET	DT	_	12	det	_	_
12	liver	_	NOUN	NN	_	9	nmod	_	_

#	Pimozide	2752
1	This	_	DET	DT	_	2	det	_	_
2	metabolism	_	NOUN	NN	_	4	nsubjpass	_	_
3	is	_	VERB	VBZ	_	4	auxpass	_	_
4	catalyzed	_	VERB	VBN	_	0	root	_	_
5	mainly	_	ADV	RB	_	4	advmod	_	_
6	by	_	ADP	IN	_	14	case	_	_
7	the	_	DET	DT	_	14	det	_	_
8	cytochrome	_	NOUN	NN	_	14	compound	_	_
9	P450	_	NOUN	NN	_	14	compound	_	_
10	3A4	_	NOUN	NN	_	14	compound	_	_
11	CYP	_	NOUN	NN	_	14	compound	_	_
12	3A4	_	NOUN	NN	_	14	compound	_	_
13	enzymatic	_	ADJ	JJ	_	14	amod	_	_
14	system	_	NOUN	NN	_	4	nmod	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	to	_	PRT	TO	_	19	case	_	_
17	a	_	DET	DT	_	19	det	_	_
18	lesser	_	ADJ	JJ	_	19	amod	_	_
19	extent	_	NOUN	NN	_	14	conj	_	_
20	,	_	.	,	_	4	punct	_	_
21	by	_	ADP	IN	_	26	case	_	_
22	cytochrome	_	NOUN	NN	_	26	compound	_	_
23	P450	_	NOUN	NN	_	26	compound	_	_
24	1A2	_	NOUN	NN	_	26	compound	_	_
25	CYP	_	NOUN	NN	_	26	compound	_	_
26	1A2	_	NOUN	NN	_	4	nmod	_	_
27	and	_	CONJ	CC	_	26	cc	_	_
28	cytochrome	_	NOUN	NN	_	32	compound	_	_
29	P450	_	NOUN	NN	_	32	compound	_	_
30	2D6	_	NOUN	NN	_	32	compound	_	_
31	CYP	_	NOUN	NN	_	32	compound	_	_
32	2D6	_	NOUN	NN	_	26	conj	_	_

#	Pimozide	2753
1	Two	_	NUM	CD	_	3	nummod	_	_
2	major	_	ADJ	JJ	_	3	amod	_	_
3	metabolites	_	NOUN	NNS	_	6	nsubjpass	_	_
4	have	_	VERB	VBP	_	6	aux	_	_
5	been	_	VERB	VBN	_	6	auxpass	_	_
6	identified	_	VERB	VBN	_	0	root	_	_
7	,	_	.	,	_	6	punct	_	_
8	1	_	NUM	CD	_	12	nummod	_	_
9	4	_	NUM	CD	_	12	nummod	_	_
10	piperidyl	_	NOUN	NN	_	12	compound	_	_
11	2	_	NUM	CD	_	12	nummod	_	_
12	benzimidazolinone	_	NOUN	NN	_	6	dep	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	4,4	_	NUM	CD	_	18	nummod	_	_
15	bis(4	_	NOUN	NN	_	18	compound	_	_
16	fluorophenyl	_	NOUN	NN	_	18	compound	_	_
17	butyric	_	ADJ	JJ	_	18	amod	_	_
18	acid	_	NOUN	NN	_	12	conj	_	_

#	Pimozide	2754
1	The	_	DET	DT	_	3	det	_	_
2	antipsychotic	_	ADJ	JJ	_	3	amod	_	_
3	activity	_	NOUN	NN	_	8	nsubjpass	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	these	_	DET	DT	_	6	det	_	_
6	metabolites	_	NOUN	NNS	_	3	nmod	_	_
7	is	_	VERB	VBZ	_	8	auxpass	_	_
8	undetermined	_	VERB	VBN	_	0	root	_	_

#	Pimozide	2755
1	The	_	DET	DT	_	3	det	_	_
2	major	_	ADJ	JJ	_	3	amod	_	_
3	route	_	NOUN	NN	_	14	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	elimination	_	NOUN	NN	_	3	nmod	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	and	_	CONJ	CC	_	3	cc	_	_
9	its	_	PRON	PRP$	_	10	nmod:poss	_	_
10	metabolites	_	NOUN	NNS	_	3	conj	_	_
11	is	_	VERB	VBZ	_	14	cop	_	_
12	through	_	ADP	IN	_	14	case	_	_
13	the	_	DET	DT	_	14	det	_	_
14	kidney	_	NOUN	NN	_	0	root	_	_

#	Pimozide	2756
1	The	_	DET	DT	_	6	det	_	_
2	mean	_	ADJ	JJ	_	6	compound	_	_
3	serum	_	NOUN	NN	_	6	compound	_	_
4	elimination	_	NOUN	NN	_	6	compound	_	_
5	half	_	NOUN	NN	_	6	compound	_	_
6	life	_	NOUN	NN	_	15	nsubj	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	in	_	ADP	IN	_	11	case	_	_
10	schizophrenic	_	ADJ	JJ	_	11	amod	_	_
11	patients	_	NOUN	NNS	_	6	nmod	_	_
12	was	_	VERB	VBD	_	15	cop	_	_
13	approximately	_	ADV	RB	_	15	advmod	_	_
14	55	_	NUM	CD	_	15	nummod	_	_
15	hours	_	NOUN	NNS	_	0	root	_	_

#	Pimozide	2757
1	There	_	DET	EX	_	2	expl	_	_
2	was	_	VERB	VBD	_	0	root	_	_
3	a	_	DET	DT	_	7	det	_	_
4	13	_	NUM	CD	_	7	nummod	_	_
5	fold	_	NOUN	NN	_	7	amod	_	_
6	interindividual	_	ADJ	JJ	_	7	amod	_	_
7	difference	_	NOUN	NN	_	2	nsubj	_	_
8	in	_	ADP	IN	_	10	case	_	_
9	the	_	DET	DT	_	10	det	_	_
10	area	_	NOUN	NN	_	7	nmod	_	_
11	under	_	ADP	IN	_	17	case	_	_
12	the	_	DET	DT	_	17	det	_	_
13	serum	_	NOUN	NN	_	17	compound	_	_
14	DRUG	_	NOUN	NN	_	17	compound	_	_
15	level	_	NOUN	NN	_	17	compound	_	_
16	time	_	NOUN	NN	_	17	compound	_	_
17	curve	_	NOUN	NN	_	2	nmod	_	_
18	and	_	CONJ	CC	_	2	cc	_	_
19	an	_	DET	DT	_	21	det	_	_
20	equivalent	_	ADJ	JJ	_	21	amod	_	_
21	degree	_	NOUN	NN	_	2	conj	_	_
22	of	_	ADP	IN	_	23	case	_	_
23	variation	_	NOUN	NN	_	21	nmod	_	_
24	in	_	ADP	IN	_	27	case	_	_
25	peak	_	ADJ	JJ	_	27	amod	_	_
26	serum	_	NOUN	NN	_	27	compound	_	_
27	levels	_	NOUN	NNS	_	23	nmod	_	_
28	among	_	ADP	IN	_	29	case	_	_
29	patients	_	NOUN	NNS	_	27	nmod	_	_
30	studied	_	VERB	VBN	_	29	acl	_	_

#	Pimozide	2758
1	The	_	DET	DT	_	2	det	_	_
2	significance	_	NOUN	NN	_	6	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	this	_	DET	DT	_	2	nmod	_	_
5	is	_	VERB	VBZ	_	6	cop	_	_
6	unclear	_	ADJ	JJ	_	0	root	_	_
7	since	_	ADP	IN	_	9	mark	_	_
8	there	_	PRON	PRP$	_	9	expl	_	_
9	are	_	VERB	VBP	_	6	ccomp	_	_
10	few	_	ADJ	JJ	_	11	amod	_	_
11	correlations	_	NOUN	NNS	_	9	nsubj	_	_
12	between	_	ADP	IN	_	14	case	_	_
13	plasma	_	NOUN	NN	_	14	compound	_	_
14	levels	_	NOUN	NNS	_	11	nmod	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	clinical	_	ADJ	JJ	_	17	amod	_	_
17	findings	_	NOUN	NNS	_	14	conj	_	_

#	Pimozide	2759
1	Effects	_	NOUN	NNS	_	19	nsubjpass	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	food	_	NOUN	NN	_	1	nmod	_	_
4	and	_	CONJ	CC	_	3	cc	_	_
5	disease	_	NOUN	NN	_	3	conj	_	_
6	upon	_	ADP	IN	_	8	case	_	_
7	the	_	DET	DT	_	8	det	_	_
8	absorption	_	NOUN	NN	_	1	nmod	_	_
9	,	_	.	,	_	8	punct	_	_
10	distribution	_	NOUN	NN	_	8	conj	_	_
11	,	_	.	,	_	8	punct	_	_
12	metabolism	_	NOUN	NN	_	8	conj	_	_
13	and	_	CONJ	CC	_	8	cc	_	_
14	elimination	_	NOUN	NN	_	8	conj	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	8	nmod	_	_
17	are	_	VERB	VBD	_	19	auxpass	_	_
18	not	_	ADV	RB	_	19	neg	_	_
19	known	_	VERB	VBN	_	0	root	_	_

#	Pimozide	2760
1	Effects	_	NOUN	NNS	_	12	nsubjpass	_	_
2	of	_	ADP	IN	_	4	case	_	_
3	concomitant	_	ADJ	JJ	_	4	amod	_	_
4	medication	_	NOUN	NN	_	1	nmod	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	genetic	_	ADJ	JJ	_	7	amod	_	_
7	variations	_	NOUN	NNS	_	4	conj	_	_
8	on	_	ADP	IN	_	10	case	_	_
9	DRUG	_	NOUN	NN	_	10	compound	_	_
10	metabolism	_	NOUN	NN	_	1	nmod	_	_
11	are	_	VERB	VBP	_	12	auxpass	_	_
12	described	_	VERB	VBN	_	0	root	_	_
13	in	_	ADP	IN	_	15	case	_	_
14	the	_	DET	DT	_	15	dep	_	_
15	CONTRAINDICATIONS	_	NOUN	NN	_	12	nmod	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	PRECAUTIONS	_	NOUN	NN	_	15	conj	_	_
18	sections	_	NOUN	NNS	_	15	dep	_	_

#	Pravastatin Sodium	1976
1	For	_	ADP	IN	_	4	case	_	_
2	the	_	DET	DT	_	4	det	_	_
3	concurrent	_	ADJ	JJ	_	4	amod	_	_
4	therapy	_	NOUN	NN	_	22	nmod	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	either	_	CONJ	CC	_	7	cc:preconj	_	_
7	cyclosporine	_	NOUN	NN	_	4	nmod	_	_
8	,	_	.	,	_	7	punct	_	_
9	fibrates	_	NOUN	NNS	_	7	conj	_	_
10	,	_	.	,	_	7	punct	_	_
11	niacin	_	NOUN	NN	_	13	compound	_	_
12	nicotinic	_	ADJ	JJ	_	13	amod	_	_
13	acid	_	NOUN	NN	_	7	conj	_	_
14	,	_	.	,	_	7	punct	_	_
15	or	_	CONJ	CC	_	7	cc	_	_
16	erythromycin	_	NOUN	NN	_	7	conj	_	_
17	,	_	.	,	_	22	punct	_	_
18	the	_	DET	DT	_	19	det	_	_
19	risk	_	NOUN	NN	_	22	nsubj	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	myopathy	_	NOUN	NN	_	19	nmod	_	_
22	increases	_	NOUN	NNS	_	0	root	_	_

#	Pravastatin Sodium	1977
1	*	_	NOUN	NN	_	5	compound	_	_
2	Concomitant	_	ADJ	JJ	_	5	amod	_	_
3	lipid	_	NOUN	NN	_	5	compound	_	_
4	lowering	_	NOUN	NN	_	5	compound	_	_
5	therapies	_	NOUN	NNS	_	0	root	_	_
6	:	_	.	:	_	5	punct	_	_
7	use	_	VERB	VBP	_	5	dep	_	_
8	with	_	ADP	IN	_	9	case	_	_
9	fibrates	_	NOUN	NNS	_	7	nmod	_	_
10	or	_	CONJ	CC	_	9	cc	_	_
11	lipid	_	NOUN	NN	_	13	compound	_	_
12	modifying	_	VERB	VBG	_	13	compound	_	_
13	doses	_	NOUN	NNS	_	16	compound	_	_
14	>	_	NUM	CD	_	16	nummod	_	_
15	1	_	NUM	CD	_	16	nummod	_	_
16	g	_	NOUN	NN	_	9	conj	_	_
17	/	_	.	:	_	5	punct	_	_
18	day	_	NOUN	NN	_	21	nsubj	_	_
19	of	_	ADP	IN	_	20	case	_	_
20	niacin	_	NOUN	NN	_	18	nmod	_	_
21	increases	_	VERB	VBZ	_	5	dep	_	_
22	the	_	DET	DT	_	23	det	_	_
23	risk	_	NOUN	NN	_	21	dobj	_	_
24	of	_	ADP	IN	_	28	case	_	_
25	adverse	_	ADJ	JJ	_	28	amod	_	_
26	skeletal	_	ADJ	JJ	_	28	amod	_	_
27	muscle	_	NOUN	NN	_	28	compound	_	_
28	effects	_	NOUN	NNS	_	23	nmod	_	_

#	Pravastatin Sodium	1978
1	Caution	_	NOUN	NN	_	4	nsubjpass	_	_
2	should	_	VERB	MD	_	4	aux	_	_
3	be	_	VERB	VB	_	4	auxpass	_	_
4	used	_	VERB	VBN	_	0	root	_	_
5	when	_	ADV	WRB	_	6	advmod	_	_
6	prescribing	_	VERB	VBG	_	4	advcl	_	_
7	with	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_

#	Pravastatin Sodium	1979
1	Cyclosporine	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	combination	_	NOUN	NN	_	4	nsubj	_	_
4	increases	_	VERB	VBZ	_	1	dep	_	_
5	exposure	_	NOUN	NN	_	4	dobj	_	_

#	Pravastatin Sodium	1980
1	Clarithromycin	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	combination	_	NOUN	NN	_	4	nsubj	_	_
4	increases	_	VERB	VBZ	_	1	dep	_	_
5	exposure	_	NOUN	NN	_	4	dobj	_	_

#	Pravastatin Sodium	1981
1	The	_	DET	DT	_	2	det	_	_
2	risk	_	NOUN	NN	_	8	nsubjpass	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	myopathy	_	NOUN	NN	_	6	compound	_	_
5	/	_	.	:	_	6	punct	_	_
6	rhabdomyolysis	_	NOUN	NN	_	2	nmod	_	_
7	is	_	VERB	VBZ	_	8	auxpass	_	_
8	increased	_	VERB	VBN	_	0	root	_	_
9	with	_	ADP	IN	_	11	case	_	_
10	concomitant	_	ADJ	JJ	_	11	amod	_	_
11	administration	_	NOUN	NN	_	8	nmod	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	cyclosporine	_	NOUN	NN	_	11	nmod	_	_

#	Pravastatin Sodium	1982
1	Limit	_	NOUN	NN	_	0	root	_	_
2	DRUG	_	NOUN	NN	_	1	dobj	_	_
3	to	_	PRT	TO	_	5	case	_	_
4	20	_	NUM	CD	_	5	nummod	_	_
5	mg	_	NOUN	NN	_	1	nmod	_	_
6	once	_	ADV	RB	_	7	advmod	_	_
7	daily	_	ADV	RB	_	5	advmod	_	_
8	for	_	ADP	IN	_	10	case	_	_
9	concomitant	_	ADJ	JJ	_	10	amod	_	_
10	use	_	NOUN	NN	_	5	nmod	_	_
11	with	_	ADP	IN	_	12	case	_	_
12	cyclosporine	_	NOUN	NN	_	10	nmod	_	_

#	Pravastatin Sodium	1983
1	The	_	DET	DT	_	2	det	_	_
2	risk	_	NOUN	NN	_	8	nsubjpass	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	myopathy	_	NOUN	NN	_	6	compound	_	_
5	/	_	.	:	_	6	punct	_	_
6	rhabdomyolysis	_	NOUN	NN	_	2	nmod	_	_
7	is	_	VERB	VBZ	_	8	auxpass	_	_
8	increased	_	VERB	VBN	_	0	root	_	_
9	with	_	ADP	IN	_	11	case	_	_
10	concomitant	_	ADJ	JJ	_	11	amod	_	_
11	administration	_	NOUN	NN	_	8	nmod	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	clarithromycin	_	NOUN	NN	_	11	nmod	_	_

#	Pravastatin Sodium	1984
1	Limit	_	NOUN	NN	_	0	root	_	_
2	DRUG	_	NOUN	NN	_	1	dobj	_	_
3	to	_	PRT	TO	_	5	case	_	_
4	40	_	NUM	CD	_	5	nummod	_	_
5	mg	_	NOUN	NN	_	1	nmod	_	_
6	once	_	ADV	RB	_	7	advmod	_	_
7	daily	_	ADV	RB	_	1	advmod	_	_
8	for	_	ADP	IN	_	10	case	_	_
9	concomitant	_	ADJ	JJ	_	10	amod	_	_
10	use	_	NOUN	NN	_	1	nmod	_	_
11	with	_	ADP	IN	_	12	case	_	_
12	clarithromycin	_	NOUN	NN	_	10	nmod	_	_

#	Pravastatin Sodium	1985
1	Other	_	ADJ	JJ	_	2	amod	_	_
2	macrolides	_	NOUN	NNS	_	8	nsubj	_	_
3	e.g	_	NOUN	NN	_	2	dep	_	_
4	,	_	.	,	_	3	punct	_	_
5	erythromycin	_	NOUN	NN	_	3	conj	_	_
6	and	_	CONJ	CC	_	3	cc	_	_
7	azithromycin	_	NOUN	NN	_	3	conj	_	_
8	have	_	VERB	VBP	_	0	root	_	_
9	the	_	DET	DT	_	10	det	_	_
10	potential	_	NOUN	NN	_	8	dobj	_	_
11	to	_	PRT	TO	_	12	mark	_	_
12	increase	_	VERB	VB	_	10	acl	_	_
13	statin	_	NOUN	NN	_	14	compound	_	_
14	exposures	_	NOUN	NNS	_	12	dobj	_	_
15	while	_	ADP	IN	_	16	mark	_	_
16	used	_	VERB	VBN	_	8	advcl	_	_
17	in	_	ADP	IN	_	18	case	_	_
18	combination	_	NOUN	NN	_	16	nmod	_	_

#	Pravastatin Sodium	1986
1	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
2	should	_	VERB	MD	_	4	aux	_	_
3	be	_	VERB	VB	_	4	auxpass	_	_
4	used	_	VERB	VBN	_	0	root	_	_
5	cautiously	_	ADV	RB	_	4	advmod	_	_
6	with	_	ADP	IN	_	8	case	_	_
7	macrolide	_	NOUN	NN	_	8	compound	_	_
8	antibiotics	_	NOUN	NNS	_	4	nmod	_	_
9	due	_	ADJ	JJ	_	14	case	_	_
10	to	_	PRT	TO	_	9	mwe	_	_
11	a	_	DET	DT	_	14	det	_	_
12	potential	_	ADJ	JJ	_	14	amod	_	_
13	increased	_	ADJ	JJ	_	14	amod	_	_
14	risk	_	NOUN	NN	_	4	nmod	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	myopathies	_	NOUN	NNS	_	14	nmod	_	_

#	Pravastatin Sodium	1987
1	The	_	DET	DT	_	2	det	_	_
2	risk	_	NOUN	NN	_	8	nsubjpass	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	myopathy	_	NOUN	NN	_	6	compound	_	_
5	/	_	.	:	_	6	punct	_	_
6	rhabdomyolysis	_	NOUN	NN	_	2	nmod	_	_
7	is	_	VERB	VBZ	_	8	auxpass	_	_
8	increased	_	VERB	VBN	_	0	root	_	_
9	with	_	ADP	IN	_	11	case	_	_
10	concomitant	_	ADJ	JJ	_	11	amod	_	_
11	administration	_	NOUN	NN	_	8	nmod	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	colchicine	_	NOUN	NN	_	11	nmod	_	_

#	Pravastatin Sodium	1988
1	Due	_	ADP	IN	_	5	case	_	_
2	to	_	PRT	TO	_	1	mwe	_	_
3	an	_	DET	DT	_	5	det	_	_
4	increased	_	VERB	VBN	_	5	amod	_	_
5	risk	_	NOUN	NN	_	28	nmod	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	myopathy	_	NOUN	NN	_	5	nmod	_	_
8	/	_	.	:	_	5	punct	_	_
9	rhabdomyolysis	_	NOUN	NN	_	28	nsubjpass	_	_
10	when	_	ADV	WRB	_	16	advmod	_	_
11	HMG	_	NOUN	NN	_	14	compound	_	_
12	CoA	_	NOUN	NN	_	14	compound	_	_
13	reductase	_	NOUN	NN	_	14	compound	_	_
14	inhibitors	_	NOUN	NNS	_	16	nsubjpass	_	_
15	are	_	VERB	VBP	_	16	auxpass	_	_
16	coadministered	_	VERB	VBN	_	9	acl:relcl	_	_
17	with	_	ADP	IN	_	18	case	_	_
18	gemfibrozil	_	NOUN	NN	_	16	nmod	_	_
19	,	_	.	,	_	28	punct	_	_
20	concomitant	_	ADJ	JJ	_	21	amod	_	_
21	administration	_	NOUN	NN	_	28	nsubjpass	_	_
22	of	_	ADP	IN	_	23	case	_	_
23	DRUG	_	NOUN	NN	_	21	nmod	_	_
24	with	_	ADP	IN	_	25	case	_	_
25	gemfibrozil	_	NOUN	NN	_	21	nmod	_	_
26	should	_	VERB	MD	_	28	aux	_	_
27	be	_	VERB	VB	_	28	auxpass	_	_
28	avoided	_	VERB	VBN	_	0	root	_	_

#	Pravastatin Sodium	1989
1	Because	_	ADP	IN	_	4	mark	_	_
2	it	_	PRON	PRP	_	4	nsubjpass	_	_
3	is	_	VERB	VBZ	_	4	auxpass	_	_
4	known	_	VERB	VBN	_	29	advcl	_	_
5	that	_	ADP	IN	_	18	mark	_	_
6	the	_	DET	DT	_	7	det	_	_
7	risk	_	NOUN	NN	_	18	nsubjpass	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	myopathy	_	NOUN	NN	_	7	nmod	_	_
10	during	_	ADP	IN	_	11	case	_	_
11	treatment	_	NOUN	NN	_	7	nmod	_	_
12	with	_	ADP	IN	_	16	case	_	_
13	HMG	_	NOUN	NN	_	16	compound	_	_
14	CoA	_	NOUN	NN	_	16	compound	_	_
15	reductase	_	NOUN	NN	_	16	compound	_	_
16	inhibitors	_	NOUN	NNS	_	11	nmod	_	_
17	is	_	VERB	VBZ	_	18	auxpass	_	_
18	increased	_	VERB	VBN	_	4	ccomp	_	_
19	with	_	ADP	IN	_	21	case	_	_
20	concurrent	_	ADJ	JJ	_	21	amod	_	_
21	administration	_	NOUN	NN	_	18	nmod	_	_
22	of	_	ADP	IN	_	24	case	_	_
23	other	_	ADJ	JJ	_	24	amod	_	_
24	fibrates	_	NOUN	NNS	_	21	nmod	_	_
25	,	_	.	,	_	29	punct	_	_
26	DRUG	_	NOUN	NN	_	29	nsubjpass	_	_
27	should	_	VERB	MD	_	29	aux	_	_
28	be	_	VERB	VB	_	29	auxpass	_	_
29	administered	_	VERB	VBN	_	0	root	_	_
30	with	_	ADP	IN	_	31	case	_	_
31	caution	_	NOUN	NN	_	29	nmod	_	_
32	when	_	ADV	WRB	_	33	advmod	_	_
33	used	_	VERB	VBN	_	29	advcl	_	_
34	concomitantly	_	ADV	RB	_	33	advmod	_	_
35	with	_	ADP	IN	_	37	case	_	_
36	other	_	ADJ	JJ	_	37	amod	_	_
37	fibrates	_	NOUN	NNS	_	33	nmod	_	_

#	Pravastatin Sodium	1990
1	The	_	DET	DT	_	2	det	_	_
2	risk	_	NOUN	NN	_	9	nsubjpass	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	skeletal	_	ADJ	JJ	_	6	amod	_	_
5	muscle	_	NOUN	NN	_	6	compound	_	_
6	effects	_	NOUN	NNS	_	2	nmod	_	_
7	may	_	VERB	MD	_	9	aux	_	_
8	be	_	VERB	VB	_	9	auxpass	_	_
9	enhanced	_	VERB	VBN	_	0	root	_	_
10	when	_	ADV	WRB	_	13	advmod	_	_
11	DRUG	_	NOUN	NN	_	13	nsubjpass	_	_
12	is	_	VERB	VBZ	_	13	auxpass	_	_
13	used	_	VERB	VBN	_	25	advcl	_	_
14	in	_	ADP	IN	_	15	case	_	_
15	combination	_	NOUN	NN	_	13	nmod	_	_
16	with	_	ADP	IN	_	17	case	_	_
17	niacin	_	NOUN	NN	_	15	nmod	_	_
18	a	_	DET	DT	_	19	det	_	_
19	reduction	_	NOUN	NN	_	25	nsubjpass	_	_
20	in	_	ADP	IN	_	22	case	_	_
21	DRUG	_	NOUN	NN	_	22	compound	_	_
22	dosage	_	NOUN	NN	_	19	nmod	_	_
23	should	_	VERB	MD	_	25	aux	_	_
24	be	_	VERB	VB	_	25	auxpass	_	_
25	considered	_	VERB	VBN	_	9	ccomp	_	_
26	in	_	ADP	IN	_	28	case	_	_
27	this	_	DET	DT	_	28	det	_	_
28	setting	_	VERB	VBG	_	25	nmod	_	_

#	Pravastatin Sodium	1991
1	DRUG	_	NOUN	NN	_	5	nsubj	_	_
2	is	_	VERB	VBZ	_	5	cop	_	_
3	a	_	DET	DT	_	5	det	_	_
4	reversible	_	ADJ	JJ	_	5	amod	_	_
5	inhibitor	_	NOUN	NN	_	0	root	_	_
6	of	_	ADP	IN	_	15	case	_	_
7	3	_	NUM	CD	_	15	nummod	_	_
8	hydroxy	_	NOUN	NN	_	15	compound	_	_
9	3	_	NUM	CD	_	15	nummod	_	_
10	methylglutaryl	_	NOUN	NN	_	15	compound	_	_
11	coenzyme	_	NOUN	NN	_	15	compound	_	_
12	A	_	NOUN	NN	_	15	compound	_	_
13	HMG	_	NOUN	NN	_	15	compound	_	_
14	CoA	_	NOUN	NN	_	15	compound	_	_
15	reductase	_	NOUN	NN	_	5	nmod	_	_
16	,	_	.	,	_	15	punct	_	_
17	the	_	DET	DT	_	18	det	_	_
18	enzyme	_	NOUN	NN	_	15	appos	_	_
19	that	_	DET	WDT	_	20	nsubj	_	_
20	catalyzes	_	VERB	VBZ	_	18	acl:relcl	_	_
21	the	_	DET	DT	_	22	det	_	_
22	conversion	_	NOUN	NN	_	20	dobj	_	_
23	of	_	ADP	IN	_	25	case	_	_
24	HMG	_	NOUN	NN	_	25	compound	_	_
25	CoA	_	NOUN	NN	_	22	nmod	_	_
26	to	_	PRT	TO	_	27	mark	_	_
27	mevalonate	_	VERB	VB	_	22	acl	_	_
28	,	_	.	,	_	27	punct	_	_
29	an	_	DET	DT	_	34	det	_	_
30	early	_	ADJ	JJ	_	34	amod	_	_
31	and	_	CONJ	CC	_	30	cc	_	_
32	rate	_	ADJ	JJ	_	30	conj	_	_
33	limiting	_	VERB	VBG	_	34	amod	_	_
34	step	_	NOUN	NN	_	27	dobj	_	_
35	in	_	ADP	IN	_	38	case	_	_
36	the	_	DET	DT	_	38	det	_	_
37	biosynthetic	_	ADJ	JJ	_	38	amod	_	_
38	pathway	_	NOUN	NN	_	34	nmod	_	_
39	for	_	ADP	IN	_	40	case	_	_
40	cholesterol	_	NOUN	NN	_	38	nmod	_	_

#	Pravastatin Sodium	1992
1	In	_	ADP	IN	_	2	case	_	_
2	addition	_	NOUN	NN	_	5	nmod	_	_
3	,	_	.	,	_	5	punct	_	_
4	DRUG	_	NOUN	NN	_	5	nsubj	_	_
5	reduces	_	VERB	VBZ	_	0	root	_	_
6	VLDL	_	NOUN	NN	_	5	dobj	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	TG	_	NOUN	NN	_	6	conj	_	_
9	and	_	CONJ	CC	_	5	cc	_	_
10	increases	_	VERB	VBZ	_	5	conj	_	_
11	HDL	_	NOUN	NN	_	14	compound	_	_
12	C	_	NOUN	NN	_	14	compound	_	_
13	General	_	ADJ	JJ	_	14	amod	_	_
14	Absorption	_	NOUN	NN	_	10	dobj	_	_
15	:	_	.	:	_	5	punct	_	_
16	DRUG	_	NOUN	NN	_	18	nsubjpass	_	_
17	is	_	VERB	VBZ	_	18	auxpass	_	_
18	administered	_	VERB	VBN	_	5	parataxis	_	_
19	orally	_	ADV	RB	_	18	advmod	_	_
20	in	_	ADP	IN	_	23	case	_	_
21	the	_	DET	DT	_	23	det	_	_
22	active	_	ADJ	JJ	_	23	amod	_	_
23	form	_	NOUN	NN	_	18	nmod	_	_

#	Pravastatin Sodium	1993
1	In	_	ADP	IN	_	2	case	_	_
2	studies	_	NOUN	NNS	_	10	nmod	_	_
3	in	_	ADP	IN	_	4	case	_	_
4	man	_	VERB	VBN	_	2	nmod	_	_
5	,	_	.	,	_	10	punct	_	_
6	peak	_	ADJ	JJ	_	9	amod	_	_
7	plasma	_	NOUN	NN	_	9	compound	_	_
8	DRUG	_	NOUN	NN	_	9	compound	_	_
9	concentrations	_	NOUN	NNS	_	10	nsubj	_	_
10	occurred	_	VERB	VBD	_	0	root	_	_
11	1	_	NUM	CD	_	13	compound	_	_
12	to	_	PRT	TO	_	13	dep	_	_
13	1.5	_	NUM	CD	_	14	nummod	_	_
14	hours	_	NOUN	NNS	_	10	dobj	_	_
15	upon	_	ADP	IN	_	17	case	_	_
16	oral	_	ADJ	JJ	_	17	amod	_	_
17	administration	_	NOUN	NN	_	10	nmod	_	_

#	Pravastatin Sodium	1994
1	Based	_	VERB	VBN	_	17	advcl	_	_
2	on	_	ADP	IN	_	4	case	_	_
3	urinary	_	ADJ	JJ	_	4	amod	_	_
4	recovery	_	NOUN	NN	_	1	nmod	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	total	_	ADJ	JJ	_	8	amod	_	_
7	radiolabeled	_	VERB	VBN	_	8	amod	_	_
8	drug	_	NOUN	NN	_	4	nmod	_	_
9	,	_	.	,	_	17	punct	_	_
10	the	_	DET	DT	_	13	det	_	_
11	average	_	ADJ	JJ	_	13	amod	_	_
12	oral	_	ADJ	JJ	_	13	amod	_	_
13	absorption	_	NOUN	NN	_	17	nsubj	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	DRUG	_	NOUN	NN	_	13	nmod	_	_
16	is	_	VERB	VBZ	_	17	cop	_	_
17	34%	_	ADJ	JJ	_	0	root	_	_
18	and	_	CONJ	CC	_	17	cc	_	_
19	absolute	_	VERB	VB	_	17	conj	_	_
20	bioavailability	_	NOUN	NN	_	19	dobj	_	_
21	is	_	VERB	VBZ	_	22	auxpass	_	_
22	17%	_	ADJ	JJ	_	20	dep	_	_

#	Pravastatin Sodium	1995
1	While	_	ADP	IN	_	10	mark	_	_
2	the	_	DET	DT	_	3	det	_	_
3	presence	_	NOUN	NN	_	10	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	food	_	NOUN	NN	_	3	nmod	_	_
6	in	_	ADP	IN	_	9	case	_	_
7	the	_	DET	DT	_	9	det	_	_
8	gastrointestinal	_	ADJ	JJ	_	9	amod	_	_
9	tract	_	NOUN	NN	_	5	nmod	_	_
10	reduces	_	VERB	VBZ	_	22	advcl	_	_
11	systemic	_	ADJ	JJ	_	12	amod	_	_
12	bioavailability	_	NOUN	NN	_	10	dobj	_	_
13	,	_	.	,	_	22	punct	_	_
14	the	_	DET	DT	_	17	det	_	_
15	lipid	_	NOUN	NN	_	17	compound	_	_
16	lowering	_	NOUN	NN	_	17	compound	_	_
17	effects	_	NOUN	NNS	_	22	nsubj	_	_
18	of	_	ADP	IN	_	20	case	_	_
19	the	_	DET	DT	_	20	det	_	_
20	drug	_	NOUN	NN	_	17	nmod	_	_
21	are	_	VERB	VBP	_	22	cop	_	_
22	similar	_	ADJ	JJ	_	0	root	_	_
23	whether	_	ADP	IN	_	22	root	_	_
24	taken	_	VERB	VBN	_	23	root	_	_
25	with	_	ADP	IN	_	24	nmod	_	_
26	or	_	CONJ	CC	_	25	cc	_	_
27	1	_	NUM	CD	_	25	conj	_	_
28	hour	_	NUM	CD	_	25	dep	_	_
29	prior	_	ADJ	JJ	_	25	nmod	_	_
30	to	_	PRT	TO	_	31	case	_	_
31	meals	_	NOUN	NNS	_	29	nmod	_	_

#	Pravastatin Sodium	1996
1	DRUG	_	NOUN	NN	_	3	compound	_	_
2	plasma	_	NOUN	NN	_	3	compound	_	_
3	concentrations	_	NOUN	NNS	_	24	nsubj	_	_
4	,	_	.	,	_	3	punct	_	_
5	including	_	VERB	VBG	_	6	case	_	_
6	area	_	NOUN	NN	_	3	nmod	_	_
7	under	_	ADP	IN	_	12	case	_	_
8	the	_	DET	DT	_	12	det	_	_
9	concentration	_	NOUN	NN	_	12	compound	_	_
10	time	_	NOUN	NN	_	12	compound	_	_
11	curve	_	ADJ	JJ	_	12	amod	_	_
12	AUC	_	NOUN	NN	_	6	nmod	_	_
13	,	_	.	,	_	12	punct	_	_
14	Cmax	_	NOUN	NN	_	12	conj	_	_
15	,	_	.	,	_	12	punct	_	_
16	and	_	CONJ	CC	_	12	cc	_	_
17	steady	_	ADJ	JJ	_	20	amod	_	_
18	state	_	NOUN	NN	_	20	compound	_	_
19	minimum	_	ADJ	JJ	_	20	amod	_	_
20	Cmin	_	NOUN	NN	_	12	conj	_	_
21	,	_	.	,	_	3	punct	_	_
22	are	_	VERB	VBP	_	24	cop	_	_
23	directly	_	ADV	RB	_	24	advmod	_	_
24	proportional	_	ADJ	JJ	_	0	root	_	_
25	to	_	PRT	TO	_	27	case	_	_
26	administered	_	VERB	VBN	_	27	amod	_	_
27	dose	_	NOUN	NN	_	24	nmod	_	_

#	Pravastatin Sodium	1997
1	Systemic	_	ADJ	JJ	_	2	amod	_	_
2	bioavailability	_	NOUN	NN	_	11	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	administered	_	VERB	VBN	_	4	acl	_	_
6	following	_	ADP	IN	_	9	case	_	_
7	a	_	DET	DT	_	9	det	_	_
8	bedtime	_	NOUN	NN	_	9	compound	_	_
9	dose	_	NOUN	NN	_	5	nmod	_	_
10	was	_	VERB	VBD	_	11	auxpass	_	_
11	decreased	_	VERB	VBN	_	0	root	_	_
12	60%	_	NOUN	NN	_	11	xcomp	_	_
13	compared	_	VERB	VBN	_	11	xcomp	_	_
14	to	_	PRT	TO	_	15	case	_	_
15	that	_	DET	WDT	_	13	nmod	_	_
16	following	_	ADP	IN	_	19	case	_	_
17	an	_	DET	DT	_	19	det	_	_
18	AM	_	NOUN	NN	_	19	compound	_	_
19	dose	_	NOUN	NN	_	15	nmod	_	_

#	Pravastatin Sodium	1998
1	Despite	_	ADP	IN	_	3	case	_	_
2	this	_	DET	DT	_	3	det	_	_
3	decrease	_	NOUN	NN	_	12	nmod	_	_
4	in	_	ADP	IN	_	6	case	_	_
5	systemic	_	ADJ	JJ	_	6	amod	_	_
6	bioavailability	_	NOUN	NN	_	3	nmod	_	_
7	,	_	.	,	_	12	punct	_	_
8	the	_	DET	DT	_	9	det	_	_
9	efficacy	_	NOUN	NN	_	12	nsubj	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_
12	administered	_	VERB	VBD	_	0	root	_	_
13	once	_	ADV	RB	_	14	advmod	_	_
14	daily	_	ADV	RB	_	12	advmod	_	_
15	in	_	ADP	IN	_	17	case	_	_
16	the	_	DET	DT	_	17	det	_	_
17	evening	_	NOUN	NN	_	12	nmod	_	_
18	,	_	.	,	_	12	punct	_	_
19	although	_	ADP	IN	_	22	mark	_	_
20	not	_	ADV	RB	_	22	neg	_	_
21	statistically	_	ADV	RB	_	22	advmod	_	_
22	significant	_	ADJ	JJ	_	12	advcl	_	_
23	,	_	.	,	_	12	punct	_	_
24	was	_	VERB	VBD	_	27	cop	_	_
25	marginally	_	ADV	RB	_	27	advmod	_	_
26	more	_	ADV	RB	_	27	advmod	_	_
27	effective	_	ADJ	JJ	_	12	conj	_	_
28	than	_	ADP	IN	_	29	case	_	_
29	that	_	DET	WDT	_	27	nmod	_	_
30	after	_	ADP	IN	_	33	case	_	_
31	a	_	DET	DT	_	33	det	_	_
32	morning	_	NOUN	NN	_	33	compound	_	_
33	dose	_	NOUN	NN	_	29	nmod	_	_

#	Pravastatin Sodium	1999
1	The	_	DET	DT	_	2	det	_	_
2	coefficient	_	NOUN	NN	_	14	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	variation	_	NOUN	NN	_	5	compound	_	_
5	CV	_	NOUN	NN	_	2	nmod	_	_
6	,	_	.	,	_	2	punct	_	_
7	based	_	VERB	VBN	_	2	acl	_	_
8	on	_	ADP	IN	_	11	case	_	_
9	between	_	ADP	IN	_	11	case	_	_
10	subject	_	NOUN	NN	_	11	compound	_	_
11	variability	_	NOUN	NN	_	7	nmod	_	_
12	,	_	.	,	_	2	punct	_	_
13	was	_	VERB	VBD	_	14	cop	_	_
14	50%	_	ADJ	JJ	_	0	root	_	_
15	to	_	PRT	TO	_	16	case	_	_
16	60%	_	NOUN	NN	_	14	nmod	_	_
17	for	_	ADP	IN	_	18	case	_	_
18	AUC	_	NOUN	NN	_	16	nmod	_	_

#	Pravastatin Sodium	2000
1	The	_	DET	DT	_	3	det	_	_
2	geometric	_	ADJ	JJ	_	3	amod	_	_
3	means	_	NOUN	NNS	_	20	nsubj	_	_
4	of	_	ADP	IN	_	8	case	_	_
5	DRUG	_	NOUN	NN	_	8	compound	_	_
6	Cma	_	NOUN	NN	_	8	compound	_	_
7	xand	_	NOUN	NN	_	8	compound	_	_
8	AUC	_	NOUN	NN	_	3	nmod	_	_
9	following	_	ADP	IN	_	13	case	_	_
10	a	_	DET	DT	_	13	det	_	_
11	20	_	NUM	CD	_	13	nummod	_	_
12	mg	_	NOUN	NN	_	13	compound	_	_
13	dose	_	NOUN	NN	_	3	nmod	_	_
14	in	_	ADP	IN	_	17	case	_	_
15	the	_	DET	DT	_	17	det	_	_
16	fasted	_	ADJ	JJ	_	17	amod	_	_
17	state	_	NOUN	NN	_	13	nmod	_	_
18	were	_	VERB	VBD	_	20	cop	_	_
19	26.5	_	NUM	CD	_	20	nummod	_	_
20	ng	_	NOUN	NN	_	0	root	_	_
21	/	_	.	:	_	20	punct	_	_
22	mL	_	NOUN	NN	_	20	dep	_	_
23	and	_	CONJ	CC	_	22	cc	_	_
24	59.8	_	NUM	CD	_	25	nummod	_	_
25	ng*hr	_	NOUN	NN	_	22	conj	_	_
26	/	_	.	:	_	22	punct	_	_
27	mL	_	NOUN	NN	_	22	appos	_	_
28	,	_	.	,	_	20	punct	_	_
29	respectively	_	ADV	RB	_	20	neg	_	_

#	Pravastatin Sodium	2001
1	Steady	_	ADJ	JJ	_	3	amod	_	_
2	state	_	NOUN	NN	_	3	compound	_	_
3	AUCs	_	NOUN	NNS	_	10	nsubj	_	_
4	,	_	.	,	_	3	punct	_	_
5	Cmax	_	NOUN	NN	_	3	conj	_	_
6	,	_	.	,	_	3	punct	_	_
7	and	_	CONJ	CC	_	3	cc	_	_
8	Cminplasma	_	NOUN	NN	_	9	compound	_	_
9	concentrations	_	NOUN	NNS	_	3	conj	_	_
10	showed	_	VERB	VBD	_	0	root	_	_
11	no	_	DET	DT	_	12	neg	_	_
12	evidence	_	NOUN	NN	_	10	dobj	_	_
13	of	_	ADP	IN	_	15	case	_	_
14	DRUG	_	NOUN	NN	_	15	compound	_	_
15	accumulation	_	NOUN	NN	_	12	nmod	_	_
16	following	_	ADP	IN	_	17	case	_	_
17	once	_	ADJ	JJ	_	12	nmod	_	_
18	or	_	CONJ	CC	_	10	cc	_	_
19	twice	_	ADV	RB	_	20	advmod	_	_
20	daily	_	ADV	RB	_	21	advmod	_	_
21	administration	_	NOUN	NN	_	10	conj	_	_
22	of	_	ADP	IN	_	24	case	_	_
23	DRUG	_	NOUN	NN	_	24	compound	_	_
24	tablets	_	NOUN	NNS	_	21	nmod	_	_

#	Pravastatin Sodium	2002
1	Distribution:Approximately	_	ADV	RB	_	2	advmod	_	_
2	50%	_	NOUN	NN	_	8	nsubjpass	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	the	_	DET	DT	_	6	det	_	_
5	circulating	_	ADJ	JJ	_	6	amod	_	_
6	drug	_	NOUN	NN	_	2	nmod	_	_
7	is	_	VERB	VBZ	_	8	auxpass	_	_
8	bound	_	VERB	VBN	_	0	root	_	_
9	to	_	PRT	TO	_	11	case	_	_
10	plasma	_	NOUN	NN	_	11	compound	_	_
11	proteins	_	NOUN	NNS	_	8	nmod	_	_

#	Pravastatin Sodium	2003
1	Metabolism:The	_	ADJ	JJ	_	4	amod	_	_
2	major	_	ADJ	JJ	_	4	amod	_	_
3	biotransformation	_	NOUN	NN	_	4	compound	_	_
4	pathways	_	NOUN	NNS	_	10	nsubj	_	_
5	for	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	are	_	VERB	VBP	_	10	cop	_	_
8	:	_	.	:	_	10	punct	_	_
9	a	_	DET	DT	_	10	det	_	_
10	isomerization	_	NOUN	NN	_	0	root	_	_
11	to	_	PRT	TO	_	14	case	_	_
12	6	_	NUM	CD	_	14	nummod	_	_
13	epi	_	NOUN	NN	_	14	compound	_	_
14	DRUG	_	NOUN	NN	_	10	nmod	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	the	_	DET	DT	_	18	det	_	_
17	3A	_	NOUN	NN	_	18	compound	_	_
18	hydroxyisomer	_	NOUN	NN	_	14	conj	_	_
19	of	_	ADP	IN	_	21	case	_	_
20	DRUG	_	NOUN	NN	_	21	compound	_	_
21	SQ	_	NOUN	NN	_	18	nmod	_	_
22	31,906	_	NUM	CD	_	21	nummod	_	_
23	and	_	CONJ	CC	_	10	cc	_	_
24	b	_	NUM	CD	_	27	nummod	_	_
25	enzymatic	_	ADJ	JJ	_	27	amod	_	_
26	ring	_	NOUN	NN	_	27	compound	_	_
27	hydroxylation	_	NOUN	NN	_	10	conj	_	_
28	to	_	PRT	TO	_	29	case	_	_
29	SQ	_	NOUN	NN	_	27	nmod	_	_
30	31,945	_	NUM	CD	_	29	nummod	_	_

#	Pravastatin Sodium	2004
1	The	_	DET	DT	_	5	det	_	_
2	3A	_	NOUN	NN	_	5	compound	_	_
3	hydroxyisomeric	_	ADJ	JJ	_	5	amod	_	_
4	metabolite	_	NOUN	NN	_	5	compound	_	_
5	SQ	_	NOUN	NN	_	7	nsubj	_	_
6	31,906	_	NUM	CD	_	5	nummod	_	_
7	has	_	VERB	VBZ	_	0	root	_	_
8	1	_	NUM	CD	_	20	nummod	_	_
9	/	_	.	-LRB-	_	20	punct	_	_
10	10	_	NUM	CD	_	12	nummod	_	_
11	to	_	PRT	TO	_	12	dep	_	_
12	1	_	NUM	CD	_	20	nummod	_	_
13	/	_	.	:	_	20	punct	_	_
14	40	_	NUM	CD	_	20	nummod	_	_
15	the	_	DET	DT	_	20	det	_	_
16	HMG	_	NOUN	NN	_	19	nmod:npmod	_	_
17	CoA	_	NOUN	NN	_	19	nmod:npmod	_	_
18	reductase	_	NOUN	NN	_	19	nmod:npmod	_	_
19	inhibitory	_	ADJ	JJ	_	20	amod	_	_
20	activity	_	NOUN	NN	_	7	dobj	_	_
21	of	_	ADP	IN	_	24	case	_	_
22	the	_	DET	DT	_	24	det	_	_
23	parent	_	NOUN	NN	_	24	compound	_	_
24	compound	_	NOUN	NN	_	20	nmod	_	_

#	Pravastatin Sodium	2005
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	undergoes	_	VERB	VBZ	_	0	root	_	_
3	extensive	_	ADJ	JJ	_	6	amod	_	_
4	first	_	ADJ	JJ	_	6	amod	_	_
5	pass	_	NOUN	NN	_	6	compound	_	_
6	extraction	_	NOUN	NN	_	2	dobj	_	_
7	in	_	ADP	IN	_	12	case	_	_
8	the	_	DET	DT	_	12	det	_	_
9	liver	_	NOUN	NN	_	12	compound	_	_
10	extraction	_	NOUN	NN	_	12	compound	_	_
11	ratio	_	NOUN	NN	_	12	compound	_	_
12	0.66	_	NUM	CD	_	6	nmod	_	_

#	Pravastatin Sodium	2006
1	Excretion:Approximately	_	ADV	RB	_	2	advmod	_	_
2	20%	_	NOUN	NN	_	9	nsubjpass	_	_
3	of	_	ADP	IN	_	7	case	_	_
4	a	_	DET	DT	_	7	det	_	_
5	radiolabeled	_	VERB	VBN	_	7	amod	_	_
6	oral	_	ADJ	JJ	_	7	amod	_	_
7	dose	_	NOUN	NN	_	2	nmod	_	_
8	is	_	VERB	VBZ	_	9	auxpass	_	_
9	excreted	_	VERB	VBN	_	0	root	_	_
10	in	_	ADP	IN	_	11	case	_	_
11	urine	_	ADJ	JJ	_	9	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	70%	_	NOUN	NN	_	11	conj	_	_
14	in	_	ADP	IN	_	16	case	_	_
15	the	_	DET	DT	_	16	det	_	_
16	feces	_	NOUN	NNS	_	9	nmod	_	_

#	Pravastatin Sodium	2007
1	After	_	ADP	IN	_	3	case	_	_
2	intravenous	_	ADJ	JJ	_	3	amod	_	_
3	administration	_	NOUN	NN	_	20	nmod	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	radiolabeled	_	VERB	VBN	_	6	amod	_	_
6	DRUG	_	NOUN	NN	_	3	nmod	_	_
7	to	_	PRT	TO	_	9	case	_	_
8	normal	_	ADJ	JJ	_	9	amod	_	_
9	volunteers	_	NOUN	NNS	_	3	nmod	_	_
10	,	_	.	,	_	20	punct	_	_
11	approximately	_	ADV	RB	_	12	advmod	_	_
12	47%	_	NOUN	NN	_	20	nsubj	_	_
13	of	_	ADP	IN	_	16	case	_	_
14	total	_	ADJ	JJ	_	16	amod	_	_
15	body	_	NOUN	NN	_	16	compound	_	_
16	clearance	_	NOUN	NN	_	12	nmod	_	_
17	was	_	VERB	VBD	_	20	cop	_	_
18	via	_	ADP	IN	_	20	case	_	_
19	renal	_	ADJ	JJ	_	20	amod	_	_
20	excretion	_	NOUN	NN	_	0	root	_	_
21	and	_	CONJ	CC	_	20	cc	_	_
22	53%	_	NOUN	NN	_	20	conj	_	_
23	by	_	ADP	IN	_	26	case	_	_
24	non	_	ADJ	JJ	_	26	amod	_	_
25	renal	_	ADJ	JJ	_	26	amod	_	_
26	routes	_	NOUN	NNS	_	20	nmod	_	_
27	i.e	_	ADJ	JJ	_	26	amod	_	_
28	,	_	.	,	_	26	punct	_	_
29	biliary	_	ADJ	JJ	_	30	amod	_	_
30	excretion	_	NOUN	NN	_	26	appos	_	_
31	and	_	CONJ	CC	_	30	cc	_	_
32	biotransformation	_	NOUN	NN	_	30	conj	_	_

#	Pravastatin Sodium	2008
1	Following	_	ADP	IN	_	7	case	_	_
2	single	_	ADJ	JJ	_	7	amod	_	_
3	dose	_	NOUN	NN	_	7	compound	_	_
4	oral	_	ADJ	JJ	_	7	amod	_	_
5	administration	_	NOUN	NN	_	7	compound	_	_
6	of14C	_	NOUN	NN	_	7	compound	_	_
7	DRUG	_	NOUN	NN	_	16	nmod	_	_
8	,	_	.	,	_	16	punct	_	_
9	the	_	DET	DT	_	11	det	_	_
10	radioactive	_	ADJ	JJ	_	11	amod	_	_
11	elimination	_	NOUN	NN	_	16	nsubj	_	_
12	t%for	_	ADP	IN	_	13	case	_	_
13	DRUG	_	NOUN	NN	_	11	nmod	_	_
14	is	_	VERB	VBZ	_	16	cop	_	_
15	1.8	_	NUM	CD	_	16	nummod	_	_
16	hours	_	NOUN	NNS	_	0	root	_	_
17	in	_	ADP	IN	_	18	case	_	_
18	humans	_	NOUN	NNS	_	16	nmod	_	_

#	Pravastatin Sodium	2009
1	Specific	_	ADJ	JJ	_	2	amod	_	_
2	Populations	_	NOUN	NNS	_	13	nsubjpass	_	_
3	Renal	_	ADJ	JJ	_	9	amod	_	_
4	Impairment:A	_	NOUN	NN	_	9	compound	_	_
5	single	_	ADJ	JJ	_	9	amod	_	_
6	20	_	NUM	CD	_	9	nummod	_	_
7	mg	_	NOUN	NN	_	9	compound	_	_
8	oral	_	ADJ	JJ	_	9	amod	_	_
9	dose	_	NOUN	NN	_	2	dep	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_
12	was	_	VERB	VBD	_	13	auxpass	_	_
13	administered	_	VERB	VBN	_	0	root	_	_
14	to	_	PRT	TO	_	16	case	_	_
15	24	_	NUM	CD	_	16	nummod	_	_
16	patients	_	NOUN	NNS	_	13	nmod	_	_
17	with	_	ADP	IN	_	19	case	_	_
18	varying	_	ADJ	JJ	_	19	amod	_	_
19	degrees	_	NOUN	NNS	_	16	nmod	_	_
20	of	_	ADP	IN	_	22	case	_	_
21	renal	_	ADJ	JJ	_	22	amod	_	_
22	impairment	_	NOUN	NN	_	19	nmod	_	_
23	as	_	ADP	IN	_	24	mark	_	_
24	determined	_	VERB	VBN	_	13	advcl	_	_
25	by	_	ADP	IN	_	27	case	_	_
26	creatinine	_	NOUN	NN	_	27	compound	_	_
27	clearance	_	NOUN	NN	_	24	nmod	_	_

#	Pravastatin Sodium	2010
1	No	_	DET	DT	_	2	neg	_	_
2	effect	_	NOUN	NN	_	4	nsubjpass	_	_
3	was	_	VERB	VBD	_	4	auxpass	_	_
4	observed	_	VERB	VBN	_	0	root	_	_
5	on	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	pharmacokinetics	_	NOUN	NNS	_	4	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	or	_	CONJ	CC	_	9	cc	_	_
11	its	_	PRON	PRP$	_	17	nmod:poss	_	_
12	3A	_	NOUN	NN	_	17	compound	_	_
13	hydroxy	_	NOUN	NN	_	17	compound	_	_
14	isomeric	_	ADJ	JJ	_	17	amod	_	_
15	metabolite	_	NOUN	NN	_	17	compound	_	_
16	SQ	_	NOUN	NN	_	17	compound	_	_
17	31,906	_	NUM	CD	_	9	conj	_	_

#	Pravastatin Sodium	2011
1	Compared	_	VERB	VBN	_	4	case	_	_
2	to	_	PRT	TO	_	4	case	_	_
3	healthy	_	ADJ	JJ	_	4	amod	_	_
4	subjects	_	NOUN	NNS	_	15	nmod	_	_
5	with	_	ADP	IN	_	8	case	_	_
6	normal	_	ADJ	JJ	_	8	amod	_	_
7	renal	_	ADJ	JJ	_	8	amod	_	_
8	function	_	NOUN	NN	_	4	nmod	_	_
9	,	_	.	,	_	15	punct	_	_
10	patients	_	NOUN	NNS	_	15	nsubj	_	_
11	with	_	ADP	IN	_	14	case	_	_
12	severe	_	ADJ	JJ	_	14	amod	_	_
13	renal	_	ADJ	JJ	_	14	amod	_	_
14	impairment	_	NOUN	NN	_	10	nmod	_	_
15	had	_	VERB	VBD	_	0	root	_	_
16	69%	_	ADJ	JJ	_	21	amod	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	37%	_	ADJ	JJ	_	16	conj	_	_
19	higher	_	ADJ	JJ	_	21	amod	_	_
20	mean	_	NOUN	NN	_	21	compound	_	_
21	AUC	_	NOUN	NN	_	15	dobj	_	_
22	and	_	CONJ	CC	_	21	cc	_	_
23	Cmaxvalues	_	NOUN	NNS	_	21	conj	_	_
24	,	_	.	,	_	21	punct	_	_
25	respectively	_	ADV	RB	_	21	advmod	_	_
26	,	_	.	,	_	21	punct	_	_
27	and	_	CONJ	CC	_	21	cc	_	_
28	a	_	DET	DT	_	30	det	_	_
29	0.61	_	NUM	CD	_	30	nummod	_	_
30	hour	_	NUM	CD	_	21	conj	_	_
31	shorter	_	ADJ	JJ	_	30	dep	_	_
32	t%for	_	ADP	IN	_	39	case	_	_
33	the	_	DET	DT	_	39	det	_	_
34	inactive	_	ADJ	JJ	_	39	amod	_	_
35	enzymatic	_	ADJ	JJ	_	39	amod	_	_
36	ring	_	NOUN	NN	_	39	compound	_	_
37	hydroxylation	_	NOUN	NN	_	39	compound	_	_
38	metabolite	_	NOUN	NN	_	39	compound	_	_
39	SQ	_	NOUN	NN	_	31	nmod	_	_
40	31,945	_	NUM	CD	_	39	nummod	_	_

#	Pravastatin Sodium	2012
1	Hepatic	_	ADJ	JJ	_	2	amod	_	_
2	Impairment:In	_	NOUN	NN	_	0	root	_	_
3	a	_	DET	DT	_	4	det	_	_
4	study	_	NOUN	NN	_	14	nsubj	_	_
5	comparing	_	VERB	VBG	_	4	acl	_	_
6	the	_	DET	DT	_	7	det	_	_
7	kinetics	_	NOUN	NNS	_	5	dobj	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	in	_	ADP	IN	_	11	case	_	_
11	patients	_	NOUN	NNS	_	7	nmod	_	_
12	with	_	ADP	IN	_	13	case	_	_
13	biopsy	_	NOUN	NN	_	11	nmod	_	_
14	confirmed	_	VERB	VBD	_	2	acl	_	_
15	cirrhosis	_	NOUN	NN	_	16	compound	_	_
16	N	_	NOUN	NN	_	14	dobj	_	_
17	=	_	ADJ	JJ	_	16	amod	_	_
18	7	_	NUM	CD	_	17	dep	_	_
19	and	_	CONJ	CC	_	17	cc	_	_
20	normal	_	ADJ	JJ	_	21	amod	_	_
21	subjects	_	NOUN	NNS	_	17	conj	_	_
22	N	_	NOUN	NN	_	21	dep	_	_
23	=	_	ADJ	JJ	_	21	amod	_	_
24	7	_	NUM	CD	_	23	dep	_	_
25	,	_	.	,	_	2	punct	_	_
26	the	_	DET	DT	_	28	det	_	_
27	mean	_	NOUN	NN	_	28	amod	_	_
28	AUC	_	NOUN	NN	_	29	nsubj	_	_
29	varied	_	VERB	VBD	_	2	dep	_	_
30	18	_	NUM	CD	_	31	nummod	_	_
31	fold	_	NOUN	NN	_	29	dobj	_	_
32	in	_	ADP	IN	_	34	case	_	_
33	cirrhotic	_	ADJ	JJ	_	34	amod	_	_
34	patients	_	NOUN	NNS	_	29	nmod	_	_
35	and	_	CONJ	CC	_	34	cc	_	_
36	5	_	NUM	CD	_	37	nummod	_	_
37	fold	_	NOUN	NN	_	34	conj	_	_
38	in	_	ADP	IN	_	40	case	_	_
39	healthy	_	ADJ	JJ	_	40	amod	_	_
40	subjects	_	NOUN	NNS	_	34	nmod	_	_

#	Pravastatin Sodium	2013
1	Similarly	_	ADV	RB	_	7	advmod	_	_
2	,	_	.	,	_	7	punct	_	_
3	the	_	DET	DT	_	6	det	_	_
4	peak	_	ADJ	JJ	_	6	amod	_	_
5	DRUG	_	NOUN	NN	_	6	compound	_	_
6	values	_	NOUN	NNS	_	7	nsubj	_	_
7	varied	_	VERB	VBD	_	0	root	_	_
8	47	_	NUM	CD	_	9	nummod	_	_
9	fold	_	NOUN	NN	_	7	dobj	_	_
10	for	_	ADP	IN	_	12	case	_	_
11	cirrhotic	_	ADJ	JJ	_	12	amod	_	_
12	patients	_	NOUN	NNS	_	9	nmod	_	_
13	compared	_	VERB	VBN	_	7	xcomp	_	_
14	to	_	PRT	TO	_	16	case	_	_
15	6	_	NUM	CD	_	16	nummod	_	_
16	fold	_	NOUN	NN	_	13	nmod	_	_
17	for	_	ADP	IN	_	19	case	_	_
18	healthy	_	ADJ	JJ	_	19	amod	_	_
19	subjects	_	NOUN	NNS	_	16	nmod	_	_

#	Pravastatin Sodium	2014
1	Geriatric:In	_	X	FW	_	19	advmod	_	_
2	a	_	DET	DT	_	6	det	_	_
3	single	_	ADJ	JJ	_	6	amod	_	_
4	oral	_	ADJ	JJ	_	6	amod	_	_
5	dose	_	NOUN	NN	_	6	compound	_	_
6	study	_	NOUN	NN	_	1	dobj	_	_
7	using	_	VERB	VBG	_	6	acl	_	_
8	DRUG	_	NOUN	NN	_	10	compound	_	_
9	20	_	NUM	CD	_	10	nummod	_	_
10	mg	_	NOUN	NN	_	7	dobj	_	_
11	,	_	.	,	_	19	punct	_	_
12	the	_	DET	DT	_	14	det	_	_
13	mean	_	NOUN	NN	_	14	amod	_	_
14	AUC	_	NOUN	NN	_	19	nsubj	_	_
15	for	_	ADP	IN	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	14	nmod	_	_
17	was	_	VERB	VBD	_	19	cop	_	_
18	approximately	_	ADV	RB	_	19	advmod	_	_
19	27%	_	ADJ	JJ	_	0	root	_	_
20	greater	_	ADJ	JJ	_	19	xcomp	_	_
21	and	_	CONJ	CC	_	19	cc	_	_
22	the	_	DET	DT	_	27	det	_	_
23	mean	_	ADJ	JJ	_	27	amod	_	_
24	cumulative	_	ADJ	JJ	_	27	amod	_	_
25	urinary	_	ADJ	JJ	_	27	amod	_	_
26	excretion	_	NOUN	NN	_	27	compound	_	_
27	CUE	_	NOUN	NN	_	19	conj	_	_
28	approximately	_	ADV	RB	_	29	advmod	_	_
29	19%	_	ADJ	JJ	_	27	amod	_	_
30	lower	_	ADJ	JJ	_	29	amod	_	_
31	in	_	ADP	IN	_	33	case	_	_
32	elderly	_	ADJ	JJ	_	33	amod	_	_
33	men	_	NOUN	NN	_	30	nmod	_	_
34	65	_	NUM	CD	_	33	nummod	_	_
35	to	_	PRT	TO	_	37	case	_	_
36	75	_	NUM	CD	_	37	nummod	_	_
37	years	_	NOUN	NNS	_	30	nmod	_	_
38	old	_	ADV	RB	_	39	advmod	_	_
39	compared	_	VERB	VBN	_	27	dep	_	_
40	with	_	ADP	IN	_	42	case	_	_
41	younger	_	ADJ	JJ	_	42	amod	_	_
42	men	_	NOUN	NN	_	39	nmod	_	_
43	19	_	NUM	CD	_	42	nummod	_	_
44	to	_	PRT	TO	_	46	case	_	_
45	31	_	NUM	CD	_	46	nummod	_	_
46	years	_	VERB	VBZ	_	39	nmod	_	_
47	old	_	ADV	RB	_	39	neg	_	_

#	Pravastatin Sodium	2015
1	In	_	ADP	IN	_	4	case	_	_
2	a	_	DET	DT	_	4	det	_	_
3	similar	_	ADJ	JJ	_	4	amod	_	_
4	study	_	NOUN	NN	_	16	nmod	_	_
5	conducted	_	VERB	VBN	_	4	acl	_	_
6	in	_	ADP	IN	_	7	case	_	_
7	women	_	NOUN	NNS	_	5	nmod	_	_
8	,	_	.	,	_	16	punct	_	_
9	the	_	DET	DT	_	11	det	_	_
10	mean	_	ADJ	JJ	_	11	amod	_	_
11	AUC	_	NOUN	NN	_	16	nsubj	_	_
12	for	_	ADP	IN	_	13	case	_	_
13	DRUG	_	NOUN	NN	_	11	nmod	_	_
14	was	_	VERB	VBD	_	16	cop	_	_
15	approximately	_	ADV	RB	_	16	advmod	_	_
16	46%	_	ADJ	JJ	_	0	root	_	_
17	higher	_	ADJ	JJ	_	16	xcomp	_	_
18	and	_	CONJ	CC	_	17	cc	_	_
19	the	_	DET	DT	_	21	det	_	_
20	mean	_	ADJ	JJ	_	21	amod	_	_
21	CUE	_	NOUN	NN	_	17	conj	_	_
22	approximately	_	ADV	RB	_	23	advmod	_	_
23	18%	_	ADJ	JJ	_	21	amod	_	_
24	lower	_	ADJ	JJ	_	23	amod	_	_
25	in	_	ADP	IN	_	27	case	_	_
26	elderly	_	ADJ	JJ	_	27	amod	_	_
27	women	_	NOUN	NNS	_	24	nmod	_	_
28	65	_	NUM	CD	_	30	compound	_	_
29	to	_	PRT	TO	_	30	dep	_	_
30	78	_	NUM	CD	_	31	nummod	_	_
31	years	_	NOUN	NNS	_	27	dep	_	_
32	old	_	ADV	RB	_	33	advmod	_	_
33	compared	_	VERB	VBN	_	21	dep	_	_
34	with	_	ADP	IN	_	36	case	_	_
35	younger	_	ADJ	JJ	_	36	amod	_	_
36	women	_	NOUN	NNS	_	33	nmod	_	_
37	18	_	NUM	CD	_	36	nummod	_	_
38	to	_	PRT	TO	_	40	case	_	_
39	38	_	NUM	CD	_	40	nummod	_	_
40	years	_	VERB	VBZ	_	33	nmod	_	_
41	old	_	ADV	RB	_	33	neg	_	_

#	Pravastatin Sodium	2016
1	In	_	ADP	IN	_	3	case	_	_
2	both	_	DET	DT	_	3	det	_	_
3	studies	_	NOUN	NNS	_	12	nmod	_	_
4	,	_	.	,	_	12	punct	_	_
5	Cmax	_	NOUN	NN	_	12	nsubj	_	_
6	,	_	.	,	_	5	punct	_	_
7	Tmax	_	NOUN	NN	_	5	conj	_	_
8	,	_	.	,	_	5	punct	_	_
9	and	_	CONJ	CC	_	5	cc	_	_
10	t%values	_	NOUN	NNS	_	5	conj	_	_
11	were	_	VERB	VBD	_	12	cop	_	_
12	similar	_	ADJ	JJ	_	0	root	_	_
13	in	_	ADP	IN	_	17	case	_	_
14	older	_	ADJ	JJ	_	17	amod	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	younger	_	ADJ	JJ	_	14	conj	_	_
17	subjects	_	NOUN	NNS	_	12	nmod	_	_

#	Pravastatin Sodium	2017
1	Pediatric:After	_	NOUN	NN	_	3	compound	_	_
2	2	_	NUM	CD	_	3	nummod	_	_
3	weeks	_	NOUN	NNS	_	21	nsubj	_	_
4	of	_	ADP	IN	_	11	case	_	_
5	once	_	ADV	RB	_	6	advmod	_	_
6	daily	_	ADV	RB	_	7	advmod	_	_
7	20	_	NUM	CD	_	11	nummod	_	_
8	mg	_	NOUN	NN	_	11	compound	_	_
9	oral	_	ADJ	JJ	_	11	amod	_	_
10	DRUG	_	NOUN	NN	_	11	compound	_	_
11	administration	_	NOUN	NN	_	3	nmod	_	_
12	,	_	.	,	_	21	punct	_	_
13	the	_	DET	DT	_	15	det	_	_
14	geometric	_	ADJ	JJ	_	15	amod	_	_
15	means	_	NOUN	NNS	_	21	nsubj	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	AUC	_	NOUN	NN	_	15	nmod	_	_
18	were	_	VERB	VBD	_	21	cop	_	_
19	80.7	_	NUM	CD	_	21	nummod	_	_
20	CV	_	NOUN	NN	_	21	compound	_	_
21	44%	_	NOUN	NN	_	0	root	_	_
22	and	_	CONJ	CC	_	21	cc	_	_
23	44.8	_	NUM	CD	_	26	nummod	_	_
24	CV	_	NOUN	NN	_	26	compound	_	_
25	89%	_	ADJ	JJ	_	26	amod	_	_
26	ng*hr	_	NOUN	NN	_	21	conj	_	_
27	/	_	.	:	_	21	punct	_	_
28	mL	_	NOUN	NN	_	21	dep	_	_
29	for	_	ADP	IN	_	30	case	_	_
30	children	_	NOUN	NN	_	28	nmod	_	_
31	8	_	NUM	CD	_	33	compound	_	_
32	to	_	PRT	TO	_	33	dep	_	_
33	11	_	NUM	CD	_	34	nummod	_	_
34	years	_	NOUN	NNS	_	30	dep	_	_
35	,	_	.	,	_	28	punct	_	_
36	N	_	NOUN	NN	_	37	nsubj	_	_
37	=	_	ADJ	JJ	_	28	dep	_	_
38	14	_	NUM	CD	_	37	dobj	_	_
39	and	_	CONJ	CC	_	37	cc	_	_
40	adolescents	_	NOUN	NNS	_	37	conj	_	_
41	12	_	NUM	CD	_	43	compound	_	_
42	to	_	PRT	TO	_	43	dep	_	_
43	16	_	NUM	CD	_	44	nummod	_	_
44	years	_	NOUN	NNS	_	40	nmod	_	_
45	,	_	.	,	_	44	punct	_	_
46	N	_	NOUN	NN	_	44	appos	_	_
47	=	_	ADJ	JJ	_	46	amod	_	_
48	10	_	NUM	CD	_	47	dep	_	_
49	,	_	.	,	_	44	punct	_	_
50	respectively	_	ADV	RB	_	40	advmod	_	_

#	Pravastatin Sodium	2018
1	The	_	DET	DT	_	3	det	_	_
2	corresponding	_	VERB	VBG	_	3	amod	_	_
3	values	_	NOUN	NNS	_	0	root	_	_
4	for	_	ADP	IN	_	8	case	_	_
5	Cmaxwere	_	NOUN	NN	_	8	compound	_	_
6	42.4	_	NUM	CD	_	8	nummod	_	_
7	CV	_	NOUN	NN	_	8	compound	_	_
8	54%	_	NOUN	NN	_	3	nmod	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	18.6	_	NUM	CD	_	11	nummod	_	_
11	ng	_	NOUN	NN	_	8	conj	_	_
12	/	_	.	:	_	3	punct	_	_
13	mL	_	NOUN	NN	_	15	compound	_	_
14	CV	_	NOUN	NN	_	15	compound	_	_
15	100%	_	NOUN	NN	_	3	dep	_	_
16	for	_	ADP	IN	_	17	case	_	_
17	children	_	NOUN	NN	_	15	nmod	_	_
18	and	_	CONJ	CC	_	17	cc	_	_
19	adolescents	_	NOUN	NNS	_	17	conj	_	_
20	,	_	.	,	_	15	punct	_	_
21	respectively	_	ADV	RB	_	15	advmod	_	_

#	Pravastatin Sodium	2019
1	No	_	DET	DT	_	2	neg	_	_
2	conclusion	_	NOUN	NN	_	5	nsubjpass	_	_
3	can	_	VERB	MD	_	5	aux	_	_
4	be	_	VERB	VB	_	5	auxpass	_	_
5	made	_	VERB	VBN	_	0	root	_	_
6	based	_	VERB	VBN	_	5	dep	_	_
7	on	_	ADP	IN	_	9	case	_	_
8	these	_	DET	DT	_	9	det	_	_
9	findings	_	NOUN	NNS	_	6	nmod	_	_
10	due	_	ADJ	JJ	_	14	case	_	_
11	to	_	PRT	TO	_	10	mwe	_	_
12	the	_	DET	DT	_	14	det	_	_
13	small	_	ADJ	JJ	_	14	amod	_	_
14	number	_	NOUN	NN	_	6	nmod	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	samples	_	NOUN	NNS	_	14	nmod	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	large	_	ADJ	JJ	_	19	amod	_	_
19	variability	_	NOUN	NN	_	16	conj	_	_

#	Pravastatin Sodium	2020
1	Drug	_	NOUN	NN	_	3	compound	_	_
2	Drug	_	NOUN	NN	_	3	compound	_	_
3	Interactions	_	NOUN	NNS	_	4	nsubj	_	_
4	Table	_	ADJ	JJ	_	0	root	_	_
5	3	_	NUM	CD	_	4	dobj	_	_
6	:	_	.	:	_	4	punct	_	_
7	Effect	_	NOUN	NN	_	4	dep	_	_
8	of	_	ADP	IN	_	10	case	_	_
9	Coadministered	_	ADJ	JJ	_	10	amod	_	_
10	Drugs	_	NOUN	NNS	_	7	nmod	_	_
11	on	_	ADP	IN	_	13	case	_	_
12	the	_	DET	DT	_	13	det	_	_
13	Pharmacokinetics	_	NOUN	NNS	_	7	nmod	_	_
14	of	_	ADP	IN	_	17	case	_	_
15	DRUG	_	NOUN	NN	_	17	compound	_	_
16	Coadministered	_	ADJ	JJ	_	17	amod	_	_
17	Drug	_	NOUN	NN	_	13	nmod	_	_
18	and	_	CONJ	CC	_	17	cc	_	_
19	Dosing	_	ADJ	JJ	_	24	amod	_	_
20	Regimen	_	NOUN	NN	_	24	compound	_	_
21	DRUG	_	NOUN	NN	_	24	compound	_	_
22	Dose	_	NOUN	NN	_	24	compound	_	_
23	mg	_	NOUN	NN	_	24	compound	_	_
24	Change	_	NOUN	NN	_	17	conj	_	_
25	in	_	ADP	IN	_	27	case	_	_
26	AUC	_	NOUN	NN	_	27	compound	_	_
27	Change	_	NOUN	NN	_	7	nmod	_	_
28	in	_	ADP	IN	_	32	case	_	_
29	Cmax	_	NOUN	NN	_	32	compound	_	_
30	Cyclosporine	_	NOUN	NN	_	32	compound	_	_
31	5	_	NUM	CD	_	32	nummod	_	_
32	mg	_	NOUN	NN	_	27	nmod	_	_
33	/	_	.	:	_	7	punct	_	_
34	kg	_	NOUN	NN	_	46	compound	_	_
35	single	_	ADJ	JJ	_	46	amod	_	_
36	dose	_	NOUN	NN	_	46	compound	_	_
37	40	_	NUM	CD	_	46	nummod	_	_
38	mg	_	NOUN	NN	_	46	compound	_	_
39	single	_	ADJ	JJ	_	46	amod	_	_
40	dose	_	NOUN	NN	_	46	compound	_	_
41	282%	_	ADJ	JJ	_	46	amod	_	_
42	327%	_	ADJ	JJ	_	46	amod	_	_
43	Clarithromycin	_	NOUN	NN	_	46	compound	_	_
44	500	_	NUM	CD	_	46	nummod	_	_
45	mg	_	NOUN	NN	_	46	compound	_	_
46	BID	_	NOUN	NN	_	7	dep	_	_
47	for	_	ADP	IN	_	49	case	_	_
48	9	_	NUM	CD	_	49	nummod	_	_
49	days	_	NOUN	NNS	_	46	nmod	_	_
50	40	_	NUM	CD	_	52	nummod	_	_
51	mg	_	NOUN	NN	_	52	compound	_	_
52	OD	_	NOUN	NN	_	49	dep	_	_
53	for	_	ADP	IN	_	55	case	_	_
54	8	_	NUM	CD	_	55	nummod	_	_
55	days	_	NOUN	NNS	_	46	nmod	_	_
56	110%	_	ADJ	JJ	_	61	amod	_	_
57	128%	_	NOUN	NN	_	61	amod	_	_
58	Boceprevir	_	NOUN	NN	_	61	compound	_	_
59	800	_	NUM	CD	_	61	nummod	_	_
60	mg	_	NOUN	NN	_	61	compound	_	_
61	TID	_	NOUN	NN	_	55	dep	_	_
62	for	_	ADP	IN	_	64	case	_	_
63	6	_	NUM	CD	_	64	nummod	_	_
64	days	_	NOUN	NNS	_	61	nmod	_	_
65	40	_	NUM	CD	_	74	nummod	_	_
66	mg	_	NOUN	NN	_	74	compound	_	_
67	single	_	ADJ	JJ	_	74	amod	_	_
68	dose	_	NOUN	NN	_	74	compound	_	_
69	63%	_	ADJ	JJ	_	74	amod	_	_
70	49%	_	ADJ	JJ	_	74	amod	_	_
71	Darunavir	_	NOUN	NN	_	74	compound	_	_
72	600	_	NUM	CD	_	74	nummod	_	_
73	mg	_	NOUN	NN	_	74	compound	_	_
74	BID	_	NOUN	NN	_	64	dep	_	_
75	/	_	.	:	_	7	punct	_	_
76	Ritonavir	_	ADJ	JJ	_	77	dep	_	_
77	100	_	NUM	CD	_	79	nummod	_	_
78	mg	_	NOUN	NN	_	79	compound	_	_
79	BID	_	NOUN	NN	_	7	dep	_	_
80	for	_	ADP	IN	_	82	case	_	_
81	7	_	NUM	CD	_	82	nummod	_	_
82	days	_	NOUN	NNS	_	79	nmod	_	_
83	40	_	NUM	CD	_	108	nummod	_	_
84	mg	_	NOUN	NN	_	108	compound	_	_
85	single	_	ADJ	JJ	_	108	amod	_	_
86	dose	_	NOUN	NN	_	108	compound	_	_
87	81%	_	ADJ	JJ	_	108	amod	_	_
88	63%	_	ADJ	JJ	_	108	amod	_	_
89	Colestipol	_	NOUN	NN	_	108	compound	_	_
90	10	_	NUM	CD	_	108	nummod	_	_
91	g	_	NOUN	NN	_	108	compound	_	_
92	single	_	ADJ	JJ	_	108	amod	_	_
93	dose	_	NOUN	NN	_	108	compound	_	_
94	20	_	NUM	CD	_	108	nummod	_	_
95	mg	_	NOUN	NN	_	108	compound	_	_
96	single	_	ADJ	JJ	_	108	amod	_	_
97	dose	_	NOUN	NN	_	108	compound	_	_
98	47%	_	ADJ	JJ	_	108	amod	_	_
99	53%	_	ADJ	JJ	_	108	amod	_	_
100	Cholestyramine	_	NOUN	NN	_	108	compound	_	_
101	4	_	NUM	CD	_	108	nummod	_	_
102	g	_	NOUN	NN	_	108	compound	_	_
103	single	_	ADJ	JJ	_	108	amod	_	_
104	dose	_	NOUN	NN	_	108	compound	_	_
105	20	_	NUM	CD	_	108	nummod	_	_
106	mg	_	NOUN	NN	_	108	compound	_	_
107	single	_	ADJ	JJ	_	108	amod	_	_
108	dose	_	NOUN	NN	_	109	nsubj	_	_
109	Administered	_	VERB	VBN	_	82	dep	_	_
110	simultaneously	_	ADV	RB	_	111	advmod	_	_
111	40%	_	ADJ	JJ	_	119	amod	_	_
112	39%	_	NOUN	NN	_	119	compound	_	_
113	Administered	_	VERB	VBN	_	119	amod	_	_
114	1	_	NUM	CD	_	119	nummod	_	_
115	hour	_	NUM	CD	_	119	nummod	_	_
116	prior	_	ADJ	JJ	_	119	amod	_	_
117	tocholestyramine	_	NOUN	NN	_	119	compound	_	_
118	12%	_	ADJ	JJ	_	119	amod	_	_
119	30%	_	NOUN	NN	_	120	nsubj	_	_
120	Administered	_	VERB	VBN	_	109	xcomp	_	_
121	4	_	NUM	CD	_	122	nummod	_	_
122	hours	_	NOUN	NNS	_	129	dep	_	_
123	aftercholestyramine	_	NOUN	NN	_	129	compound	_	_
124	12%	_	ADJ	JJ	_	129	amod	_	_
125	6.8%	_	ADJ	JJ	_	129	amod	_	_
126	Cholestyramine	_	NOUN	NN	_	129	compound	_	_
127	24	_	NUM	CD	_	129	nummod	_	_
128	g	_	NOUN	NN	_	129	compound	_	_
129	OD	_	NOUN	NN	_	120	dobj	_	_
130	for	_	ADP	IN	_	135	case	_	_
131	4	_	NUM	CD	_	135	nummod	_	_
132	weeks	_	NOUN	NN	_	135	compound	_	_
133	20	_	NUM	CD	_	135	nummod	_	_
134	mg	_	NOUN	NN	_	135	compound	_	_
135	BID	_	NOUN	NN	_	129	nmod	_	_
136	for	_	ADP	IN	_	143	case	_	_
137	8	_	NUM	CD	_	138	nummod	_	_
138	weeks	_	NOUN	NNS	_	143	compound	_	_
139	51%	_	ADJ	JJ	_	143	amod	_	_
140	4.9%	_	ADJ	JJ	_	143	amod	_	_
141	5	_	NUM	CD	_	143	nummod	_	_
142	mg	_	NOUN	NN	_	143	compound	_	_
143	BID	_	NOUN	NN	_	129	nmod	_	_
144	for	_	ADP	IN	_	151	case	_	_
145	8	_	NUM	CD	_	151	nummod	_	_
146	weeks	_	NOUN	NNS	_	151	compound	_	_
147	38%	_	ADJ	JJ	_	151	amod	_	_
148	23%	_	ADJ	JJ	_	151	amod	_	_
149	10	_	NUM	CD	_	151	nummod	_	_
150	mg	_	NOUN	NN	_	151	compound	_	_
151	BID	_	NOUN	NN	_	129	nmod	_	_
152	for	_	ADP	IN	_	159	case	_	_
153	8	_	NUM	CD	_	154	nummod	_	_
154	weeks	_	NOUN	NNS	_	159	compound	_	_
155	18%	_	ADJ	JJ	_	159	amod	_	_
156	33%	_	ADJ	JJ	_	159	amod	_	_
157	Fluconazole	_	NOUN	NN	_	159	compound	_	_
158	200	_	NUM	CD	_	159	nummod	_	_
159	mg	_	NOUN	NN	_	129	nmod	_	_
160	IV	_	NUM	CD	_	159	nummod	_	_
161	for	_	ADP	IN	_	163	case	_	_
162	6	_	NUM	CD	_	163	nummod	_	_
163	days	_	NOUN	NNS	_	129	nmod	_	_
164	20	_	NUM	CD	_	166	nummod	_	_
165	mg	_	NOUN	NN	_	166	compound	_	_
166	PO	_	NOUN	NN	_	163	dep	_	_
167	+	_	CONJ	CC	_	166	cc	_	_
168	10	_	NUM	CD	_	175	nummod	_	_
169	mg	_	NOUN	NN	_	175	compound	_	_
170	IV	_	NUM	CD	_	175	nummod	_	_
171	34%	_	ADJ	JJ	_	175	amod	_	_
172	33%	_	ADJ	JJ	_	175	amod	_	_
173	200	_	NUM	CD	_	175	nummod	_	_
174	mg	_	NOUN	NN	_	175	compound	_	_
175	PO	_	NOUN	NN	_	166	conj	_	_
176	for	_	ADP	IN	_	178	case	_	_
177	6	_	NUM	CD	_	178	nummod	_	_
178	days	_	NOUN	NNS	_	166	nmod	_	_
179	20	_	NUM	CD	_	181	nummod	_	_
180	mg	_	NOUN	NN	_	181	compound	_	_
181	PO	_	NOUN	NN	_	178	dep	_	_
182	+	_	CONJ	CC	_	181	cc	_	_
183	10	_	NUM	CD	_	190	nummod	_	_
184	mg	_	NOUN	NN	_	190	compound	_	_
185	IV	_	NUM	CD	_	190	nummod	_	_
186	16%	_	ADJ	JJ	_	190	amod	_	_
187	16%	_	ADJ	JJ	_	190	amod	_	_
188	Kaletra	_	NOUN	NN	_	190	compound	_	_
189	400	_	NUM	CD	_	190	nummod	_	_
190	mg	_	NOUN	NN	_	181	conj	_	_
191	/	_	.	:	_	120	punct	_	_
192	100	_	NUM	CD	_	194	nummod	_	_
193	mg	_	NOUN	NN	_	194	compound	_	_
194	BID	_	NOUN	NN	_	120	dep	_	_
195	for	_	ADP	IN	_	197	case	_	_
196	14	_	NUM	CD	_	197	nummod	_	_
197	days	_	NOUN	NNS	_	194	nmod	_	_
198	20	_	NUM	CD	_	200	nummod	_	_
199	mg	_	NOUN	NN	_	200	compound	_	_
200	OD	_	NOUN	NN	_	197	dep	_	_
201	for	_	ADP	IN	_	203	case	_	_
202	4	_	NUM	CD	_	203	nummod	_	_
203	days	_	NOUN	NNS	_	194	nmod	_	_
204	33%	_	ADJ	JJ	_	209	amod	_	_
205	26%	_	ADJ	JJ	_	209	amod	_	_
206	Verapamil	_	NOUN	NN	_	209	compound	_	_
207	IR	_	NUM	CD	_	209	nummod	_	_
208	120	_	NUM	CD	_	209	nummod	_	_
209	mg	_	NOUN	NN	_	203	dep	_	_
210	for	_	ADP	IN	_	212	case	_	_
211	1	_	NUM	CD	_	212	nummod	_	_
212	day	_	NOUN	NN	_	194	nmod	_	_
213	and	_	CONJ	CC	_	212	cc	_	_
214	Verapamil	_	NOUN	NN	_	217	compound	_	_
215	ER	_	NOUN	NN	_	217	compound	_	_
216	480	_	NUM	CD	_	217	nummod	_	_
217	mg	_	NOUN	NN	_	212	conj	_	_
218	for	_	ADP	IN	_	220	case	_	_
219	3	_	NUM	CD	_	220	nummod	_	_
220	days	_	NOUN	NNS	_	194	nmod	_	_
221	40	_	NUM	CD	_	230	nummod	_	_
222	mg	_	NOUN	NN	_	230	compound	_	_
223	single	_	ADJ	JJ	_	230	amod	_	_
224	dose	_	NOUN	NN	_	230	compound	_	_
225	31%	_	ADJ	JJ	_	230	amod	_	_
226	42%	_	ADJ	JJ	_	230	amod	_	_
227	Cimetidine	_	NOUN	NN	_	230	compound	_	_
228	300	_	NUM	CD	_	230	nummod	_	_
229	mg	_	NOUN	NN	_	230	compound	_	_
230	QID	_	NOUN	NN	_	220	dep	_	_
231	for	_	ADP	IN	_	233	case	_	_
232	3	_	NUM	CD	_	233	nummod	_	_
233	days	_	NOUN	NNS	_	220	nmod	_	_
234	20	_	NUM	CD	_	240	nummod	_	_
235	mg	_	NOUN	NN	_	240	compound	_	_
236	single	_	ADJ	JJ	_	240	amod	_	_
237	dose	_	NOUN	NN	_	240	compound	_	_
238	30%	_	ADJ	JJ	_	240	amod	_	_
239	9.8%	_	ADJ	JJ	_	240	amod	_	_
240	Antacids	_	NOUN	NNS	_	233	dep	_	_
241	15	_	NUM	CD	_	243	nummod	_	_
242	mL	_	NOUN	NN	_	243	compound	_	_
243	QID	_	NOUN	NN	_	240	dep	_	_
244	for	_	ADP	IN	_	246	case	_	_
245	3	_	NUM	CD	_	246	nummod	_	_
246	days	_	NOUN	NNS	_	240	nmod	_	_
247	20	_	NUM	CD	_	256	nummod	_	_
248	mg	_	NOUN	NN	_	256	compound	_	_
249	single	_	ADJ	JJ	_	256	amod	_	_
250	dose	_	NOUN	NN	_	256	compound	_	_
251	28%	_	ADJ	JJ	_	256	amod	_	_
252	24%	_	ADJ	JJ	_	256	amod	_	_
253	Digoxin	_	NOUN	NN	_	256	compound	_	_
254	0.2	_	NUM	CD	_	256	nummod	_	_
255	mg	_	NOUN	NN	_	256	compound	_	_
256	OD	_	NOUN	NN	_	246	dep	_	_
257	for	_	ADP	IN	_	259	case	_	_
258	9	_	NUM	CD	_	259	nummod	_	_
259	days	_	NOUN	NNS	_	256	nmod	_	_
260	20	_	NUM	CD	_	262	nummod	_	_
261	mg	_	NOUN	NN	_	262	compound	_	_
262	OD	_	NOUN	NN	_	259	dep	_	_
263	for	_	ADP	IN	_	265	case	_	_
264	9	_	NUM	CD	_	265	nummod	_	_
265	days	_	NOUN	NNS	_	262	nmod	_	_
266	23%	_	ADJ	JJ	_	282	amod	_	_
267	26%	_	ADJ	JJ	_	282	amod	_	_
268	Probucol	_	NOUN	NN	_	282	compound	_	_
269	500	_	NUM	CD	_	282	nummod	_	_
270	mg	_	NOUN	NN	_	282	compound	_	_
271	single	_	ADJ	JJ	_	282	amod	_	_
272	dose	_	NOUN	NN	_	282	compound	_	_
273	20	_	NUM	CD	_	282	nummod	_	_
274	mg	_	NOUN	NN	_	282	compound	_	_
275	single	_	ADJ	JJ	_	282	amod	_	_
276	dose	_	NOUN	NN	_	282	compound	_	_
277	14%	_	ADJ	JJ	_	282	amod	_	_
278	24%	_	ADJ	JJ	_	282	amod	_	_
279	Warfarin	_	NOUN	NN	_	282	compound	_	_
280	5	_	NUM	CD	_	282	nummod	_	_
281	mg	_	NOUN	NN	_	282	compound	_	_
282	OD	_	NOUN	NN	_	262	dep	_	_
283	for	_	ADP	IN	_	285	case	_	_
284	6	_	NUM	CD	_	285	nummod	_	_
285	days	_	NOUN	NNS	_	282	nmod	_	_
286	20	_	NUM	CD	_	288	nummod	_	_
287	mg	_	NOUN	NN	_	288	compound	_	_
288	BID	_	NOUN	NN	_	285	dep	_	_
289	for	_	ADP	IN	_	291	case	_	_
290	6	_	NUM	CD	_	291	nummod	_	_
291	days	_	NOUN	NNS	_	288	nmod	_	_
292	13%	_	ADJ	JJ	_	297	amod	_	_
293	6.7%	_	ADJ	JJ	_	297	amod	_	_
294	Itraconazole	_	NOUN	NN	_	297	compound	_	_
295	200	_	NUM	CD	_	297	nummod	_	_
296	mg	_	NOUN	NN	_	297	compound	_	_
297	OD	_	NOUN	NN	_	288	dep	_	_
298	for	_	ADP	IN	_	300	case	_	_
299	30	_	NUM	CD	_	300	nummod	_	_
300	days	_	NOUN	NNS	_	313	nmod	_	_
301	40	_	NUM	CD	_	303	nummod	_	_
302	mg	_	NOUN	NN	_	303	compound	_	_
303	OD	_	NOUN	NN	_	313	nsubj	_	_
304	for	_	ADP	IN	_	306	case	_	_
305	30	_	NUM	CD	_	306	nummod	_	_
306	days	_	NOUN	NNS	_	303	nmod	_	_
307	11%	_	NOUN	NN	_	306	amod	_	_
308	compared	_	VERB	VBN	_	303	acl	_	_
309	to	_	PRT	TO	_	312	case	_	_
310	Day	_	NOUN	NN	_	312	compound	_	_
311	1	_	NUM	CD	_	312	nummod	_	_
312	17%	_	NOUN	NN	_	308	nmod	_	_
313	compared	_	VERB	VBD	_	297	acl	_	_
314	to	_	PRT	TO	_	365	case	_	_
315	Day	_	NOUN	NN	_	365	compound	_	_
316	1	_	NUM	CD	_	365	nummod	_	_
317	Gemfibrozil	_	NOUN	NN	_	365	compound	_	_
318	600	_	NUM	CD	_	365	nummod	_	_
319	mg	_	NOUN	NN	_	365	compound	_	_
320	single	_	ADJ	JJ	_	365	amod	_	_
321	dose	_	NOUN	NN	_	365	compound	_	_
322	20	_	NUM	CD	_	365	nummod	_	_
323	mg	_	NOUN	NN	_	365	compound	_	_
324	single	_	ADJ	JJ	_	365	amod	_	_
325	dose	_	NOUN	NN	_	365	compound	_	_
326	7.0%	_	ADJ	JJ	_	365	amod	_	_
327	20%	_	ADJ	JJ	_	365	amod	_	_
328	Aspirin	_	NOUN	NN	_	365	compound	_	_
329	324	_	NUM	CD	_	365	nummod	_	_
330	mg	_	NOUN	NN	_	365	compound	_	_
331	single	_	ADJ	JJ	_	365	amod	_	_
332	dose	_	NOUN	NN	_	365	compound	_	_
333	20	_	NUM	CD	_	365	nummod	_	_
334	mg	_	NOUN	NN	_	365	compound	_	_
335	single	_	ADJ	JJ	_	365	amod	_	_
336	dose	_	NOUN	NN	_	365	compound	_	_
337	4.7%	_	ADJ	JJ	_	365	amod	_	_
338	8.9%	_	ADJ	JJ	_	365	amod	_	_
339	Niacin	_	NOUN	NN	_	365	compound	_	_
340	1	_	NUM	CD	_	365	nummod	_	_
341	g	_	NOUN	NN	_	365	compound	_	_
342	single	_	ADJ	JJ	_	365	amod	_	_
343	dose	_	NOUN	NN	_	365	compound	_	_
344	20	_	NUM	CD	_	365	nummod	_	_
345	mg	_	NOUN	NN	_	365	compound	_	_
346	single	_	ADJ	JJ	_	365	amod	_	_
347	dose	_	NOUN	NN	_	365	compound	_	_
348	3.6%	_	ADJ	JJ	_	365	amod	_	_
349	8.2%	_	ADJ	JJ	_	365	amod	_	_
350	Diltiazem	_	NOUN	NN	_	365	compound	_	_
351	20	_	NUM	CD	_	365	nummod	_	_
352	mg	_	NOUN	NN	_	365	compound	_	_
353	single	_	ADJ	JJ	_	365	amod	_	_
354	dose	_	NOUN	NN	_	365	compound	_	_
355	2.7%	_	ADJ	JJ	_	365	amod	_	_
356	30%	_	ADJ	JJ	_	365	amod	_	_
357	Grapefruit	_	NOUN	NN	_	365	compound	_	_
358	juice	_	NOUN	NN	_	365	compound	_	_
359	40	_	NUM	CD	_	365	nummod	_	_
360	mg	_	NOUN	NN	_	365	compound	_	_
361	single	_	ADJ	JJ	_	365	amod	_	_
362	dose	_	NOUN	NN	_	365	compound	_	_
363	1.8%	_	ADJ	JJ	_	365	amod	_	_
364	3.7%	_	ADJ	JJ	_	365	amod	_	_
365	BID	_	NOUN	NN	_	313	nmod	_	_
366	=	_	CONJ	CC	_	369	dep	_	_
367	twice	_	ADV	RB	_	368	advmod	_	_
368	daily	_	ADV	RB	_	369	advmod	_	_
369	OD	_	NOUN	NN	_	370	nsubj	_	_
370	=	_	ADJ	JJ	_	288	acl	_	_
371	once	_	ADV	RB	_	372	advmod	_	_
372	daily	_	ADV	RB	_	370	advmod	_	_
373	QID	_	NOUN	NN	_	370	dobj	_	_
374	=	_	ADJ	JJ	_	376	amod	_	_
375	four	_	NUM	CD	_	376	nummod	_	_
376	times	_	NOUN	NNS	_	378	nsubj	_	_
377	daily	_	ADV	RB	_	378	advmod	_	_
378	Table	_	ADJ	JJ	_	373	amod	_	_
379	4	_	NUM	CD	_	378	dobj	_	_
380	:	_	.	:	_	4	punct	_	_
381	Effect	_	NOUN	NN	_	4	dep	_	_
382	of	_	ADP	IN	_	383	case	_	_
383	DRUG	_	NOUN	NN	_	381	nmod	_	_
384	on	_	ADP	IN	_	386	case	_	_
385	the	_	DET	DT	_	386	det	_	_
386	Pharmacokinetics	_	NOUN	NNS	_	381	nmod	_	_
387	of	_	ADP	IN	_	389	case	_	_
388	Coadministered	_	ADJ	JJ	_	389	amod	_	_
389	Drugs	_	NOUN	NNS	_	386	nmod	_	_
390	DRUG	_	NOUN	NN	_	389	dep	_	_
391	Dosing	_	VERB	VBG	_	390	acl	_	_
392	Regimen	_	NOUN	NN	_	393	compound	_	_
393	Name	_	NOUN	NN	_	391	dobj	_	_
394	and	_	CONJ	CC	_	391	cc	_	_
395	Dose	_	NOUN	NN	_	396	compound	_	_
396	Change	_	NOUN	NN	_	391	conj	_	_
397	in	_	ADP	IN	_	399	case	_	_
398	AUC	_	NOUN	NN	_	399	compound	_	_
399	Change	_	NOUN	NN	_	391	nmod	_	_
400	in	_	ADP	IN	_	404	case	_	_
401	Cmax	_	NOUN	NN	_	404	compound	_	_
402	20	_	NUM	CD	_	404	nummod	_	_
403	mg	_	NOUN	NN	_	404	compound	_	_
404	BID	_	NOUN	NN	_	399	nmod	_	_
405	for	_	ADP	IN	_	407	case	_	_
406	6	_	NUM	CD	_	407	nummod	_	_
407	days	_	NOUN	NNS	_	399	nmod	_	_
408	Warfarin	_	NOUN	NN	_	411	compound	_	_
409	5	_	NUM	CD	_	411	nummod	_	_
410	mg	_	NOUN	NN	_	411	compound	_	_
411	OD	_	NOUN	NN	_	407	dep	_	_
412	for	_	ADP	IN	_	414	case	_	_
413	6	_	NUM	CD	_	414	nummod	_	_
414	days	_	NOUN	NNS	_	399	nmod	_	_
415	17%	_	ADJ	JJ	_	417	amod	_	_
416	15%	_	ADJ	JJ	_	417	amod	_	_
417	Change	_	NOUN	NN	_	414	dep	_	_
418	in	_	ADP	IN	_	426	case	_	_
419	mean	_	ADJ	JJ	_	426	amod	_	_
420	prothrombin	_	NOUN	NN	_	426	compound	_	_
421	time	_	NOUN	NN	_	426	compound	_	_
422	0.4	_	NUM	CD	_	426	nummod	_	_
423	sec	_	NOUN	NN	_	426	amod	_	_
424	20	_	NUM	CD	_	426	nummod	_	_
425	mg	_	NOUN	NN	_	426	compound	_	_
426	OD	_	NOUN	NN	_	417	nmod	_	_
427	for	_	ADP	IN	_	429	case	_	_
428	9	_	NUM	CD	_	429	nummod	_	_
429	days	_	NOUN	NNS	_	417	nmod	_	_
430	Digoxin	_	NOUN	NN	_	433	compound	_	_
431	0.2	_	NUM	CD	_	433	nummod	_	_
432	mg	_	NOUN	NN	_	433	compound	_	_
433	OD	_	NOUN	NN	_	429	dep	_	_
434	for	_	ADP	IN	_	436	case	_	_
435	9	_	NUM	CD	_	436	nummod	_	_
436	days	_	NOUN	NNS	_	433	nmod	_	_
437	4.6%	_	ADJ	JJ	_	441	amod	_	_
438	5.3%	_	ADJ	JJ	_	441	amod	_	_
439	20	_	NUM	CD	_	441	nummod	_	_
440	mg	_	NOUN	NN	_	441	compound	_	_
441	BID	_	NOUN	NN	_	436	dep	_	_
442	for	_	ADP	IN	_	450	case	_	_
443	4	_	NUM	CD	_	450	nummod	_	_
444	weeks	_	NOUN	NNS	_	450	compound	_	_
445	Antipyrine	_	NOUN	NN	_	450	compound	_	_
446	1.2	_	NUM	CD	_	450	nummod	_	_
447	g	_	NOUN	NN	_	450	compound	_	_
448	single	_	ADJ	JJ	_	450	amod	_	_
449	dose	_	NOUN	NN	_	450	compound	_	_
450	3.0%	_	ADJ	JJ	_	441	nmod	_	_
451	Not	_	ADV	RB	_	452	neg	_	_
452	Reported	_	VERB	VBN	_	450	acl	_	_
453	10	_	NUM	CD	_	455	nummod	_	_
454	mg	_	NOUN	NN	_	455	compound	_	_
455	BID	_	NOUN	NN	_	452	dobj	_	_
456	for	_	ADP	IN	_	458	case	_	_
457	4	_	NUM	CD	_	458	nummod	_	_
458	weeks	_	NOUN	NNS	_	452	nmod	_	_
459	1.6%	_	ADJ	JJ	_	462	amod	_	_
460	5	_	NUM	CD	_	462	nummod	_	_
461	mg	_	NOUN	NN	_	462	compound	_	_
462	BID	_	NOUN	NN	_	458	dep	_	_
463	for	_	ADP	IN	_	465	case	_	_
464	4	_	NUM	CD	_	465	nummod	_	_
465	weeks	_	NOUN	NNS	_	452	nmod	_	_
466	Less	_	ADJ	JJ	_	470	dep	_	_
467	than1%	_	NOUN	NN	_	470	amod	_	_
468	20	_	NUM	CD	_	470	nummod	_	_
469	mg	_	NOUN	NN	_	470	compound	_	_
470	OD	_	NOUN	NN	_	465	dep	_	_
471	for	_	ADP	IN	_	476	case	_	_
472	4	_	NUM	CD	_	473	nummod	_	_
473	days	_	NOUN	NNS	_	476	compound	_	_
474	Kaletra	_	NOUN	NN	_	476	compound	_	_
475	400	_	NUM	CD	_	476	nummod	_	_
476	mg	_	NOUN	NN	_	470	nmod	_	_
477	/	_	.	:	_	390	punct	_	_
478	100	_	NUM	CD	_	479	compound	_	_
479	mg	_	NOUN	NN	_	480	amod	_	_
480	BID	_	NOUN	NN	_	390	dep	_	_
481	for	_	ADP	IN	_	483	case	_	_
482	14	_	NUM	CD	_	483	nummod	_	_
483	days	_	NOUN	NNS	_	480	nmod	_	_
484	No	_	NOUN	NN	_	488	compound	_	_
485	change	_	NOUN	NN	_	488	compound	_	_
486	No	_	NOUN	NN	_	488	compound	_	_
487	change	_	NOUN	NN	_	488	compound	_	_
488	BID	_	NOUN	NN	_	480	dep	_	_
489	=	_	CONJ	CC	_	492	dep	_	_
490	twice	_	ADV	RB	_	491	advmod	_	_
491	daily	_	ADV	RB	_	492	advmod	_	_
492	OD	_	NOUN	NN	_	480	amod	_	_
493	=	_	DET	DT	_	480	punct	_	_
494	once	_	ADV	RB	_	495	advmod	_	_
495	daily	_	ADV	RB	_	480	advmod	_	_

#	Pristiq	721
1	Do	_	PRT	TO	_	3	mark	_	_
2	not	_	ADV	RB	_	3	neg	_	_
3	use	_	VERB	VB	_	0	root	_	_
4	MAOIs	_	NOUN	NNS	_	3	dobj	_	_
5	intended	_	VERB	VBN	_	3	parataxis	_	_
6	to	_	PRT	TO	_	7	mark	_	_
7	treat	_	VERB	VB	_	5	xcomp	_	_
8	psychiatric	_	ADJ	JJ	_	9	amod	_	_
9	disorders	_	NOUN	NNS	_	7	dobj	_	_
10	with	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_
12	or	_	CONJ	CC	_	9	cc	_	_
13	within	_	ADP	IN	_	15	case	_	_
14	7	_	NUM	CD	_	15	nummod	_	_
15	days	_	NOUN	NNS	_	9	conj	_	_
16	of	_	ADP	IN	_	18	case	_	_
17	stopping	_	NOUN	NN	_	18	amod	_	_
18	treatment	_	NOUN	NN	_	15	nmod	_	_
19	with	_	ADP	IN	_	20	case	_	_
20	DRUG	_	NOUN	NN	_	18	nmod	_	_

#	Pristiq	722
1	Do	_	PRT	TO	_	3	mark	_	_
2	not	_	ADV	RB	_	3	neg	_	_
3	use	_	VERB	VB	_	0	root	_	_
4	DRUG	_	NOUN	NN	_	3	dobj	_	_
5	within	_	ADP	IN	_	7	case	_	_
6	14	_	NUM	CD	_	7	nummod	_	_
7	days	_	NOUN	NNS	_	3	nmod	_	_
8	of	_	ADP	IN	_	9	mark	_	_
9	stopping	_	VERB	VBG	_	7	acl	_	_
10	an	_	DET	DT	_	11	det	_	_
11	MAOI	_	NOUN	NN	_	9	dobj	_	_
12	intended	_	VERB	VBN	_	11	acl	_	_
13	to	_	PRT	TO	_	14	mark	_	_
14	treat	_	VERB	VB	_	12	xcomp	_	_
15	psychiatric	_	ADJ	JJ	_	16	amod	_	_
16	disorders	_	NOUN	NNS	_	14	dobj	_	_

#	Pristiq	723
1	In	_	ADP	IN	_	2	case	_	_
2	addition	_	NOUN	NN	_	6	nmod	_	_
3	,	_	.	,	_	6	punct	_	_
4	do	_	VERB	MD	_	6	aux	_	_
5	not	_	ADV	RB	_	6	neg	_	_
6	start	_	VERB	VB	_	0	root	_	_
7	DRUG	_	NOUN	NN	_	6	dobj	_	_
8	in	_	ADP	IN	_	10	case	_	_
9	a	_	DET	DT	_	10	det	_	_
10	patient	_	NOUN	NN	_	6	nmod	_	_
11	who	_	DET	WDT	_	14	nsubjpass	_	_
12	is	_	VERB	VBZ	_	14	auxpass	_	_
13	being	_	VERB	VBN	_	14	auxpass	_	_
14	treated	_	VERB	VBN	_	10	acl:relcl	_	_
15	with	_	ADP	IN	_	16	case	_	_
16	linezolid	_	ADJ	JJ	_	14	nmod	_	_
17	or	_	CONJ	CC	_	16	cc	_	_
18	intravenous	_	ADJ	JJ	_	16	conj	_	_
19	methylene	_	NOUN	NN	_	16	dep	_	_
20	blue	_	ADJ	JJ	_	14	parataxis	_	_

#	Pristiq	724
1	Based	_	VERB	VBN	_	18	advcl	_	_
2	on	_	ADP	IN	_	4	case	_	_
3	the	_	DET	DT	_	4	det	_	_
4	mechanism	_	NOUN	NN	_	1	nmod	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	action	_	NOUN	NN	_	4	nmod	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	and	_	CONJ	CC	_	4	cc	_	_
10	the	_	DET	DT	_	11	det	_	_
11	potential	_	NOUN	NN	_	4	conj	_	_
12	for	_	ADP	IN	_	14	case	_	_
13	serotonin	_	NOUN	NN	_	14	compound	_	_
14	syndrome	_	NOUN	NN	_	11	nmod	_	_
15	,	_	.	,	_	18	punct	_	_
16	caution	_	NOUN	NN	_	18	nsubjpass	_	_
17	is	_	VERB	VBZ	_	18	auxpass	_	_
18	advised	_	VERB	VBN	_	0	root	_	_
19	when	_	ADV	WRB	_	23	advmod	_	_
20	DRUG	_	NOUN	NN	_	23	nsubjpass	_	_
21	is	_	VERB	VBZ	_	23	auxpass	_	_
22	co	_	PRT	TO	_	23	mark	_	_
23	administered	_	VERB	VBN	_	18	advcl	_	_
24	with	_	ADP	IN	_	26	case	_	_
25	other	_	ADJ	JJ	_	26	amod	_	_
26	drugs	_	NOUN	NNS	_	23	nmod	_	_
27	that	_	DET	WDT	_	29	nsubj	_	_
28	may	_	VERB	MD	_	29	aux	_	_
29	affect	_	VERB	VB	_	26	acl:relcl	_	_
30	the	_	DET	DT	_	33	det	_	_
31	serotonergic	_	ADJ	JJ	_	33	amod	_	_
32	neurotransmitter	_	ADJ	JJ	_	33	amod	_	_
33	systems	_	NOUN	NNS	_	29	dobj	_	_

#	Pristiq	725
1	Serotonin	_	NOUN	NN	_	2	compound	_	_
2	release	_	NOUN	NN	_	5	nsubj	_	_
3	by	_	ADP	IN	_	4	case	_	_
4	platelets	_	NOUN	NNS	_	2	nmod	_	_
5	plays	_	VERB	VBZ	_	0	root	_	_
6	an	_	DET	DT	_	8	det	_	_
7	important	_	ADJ	JJ	_	8	amod	_	_
8	role	_	NOUN	NN	_	5	dobj	_	_
9	in	_	ADP	IN	_	10	case	_	_
10	hemostasis	_	NOUN	NN	_	8	nmod	_	_

#	Pristiq	726
1	Epidemiological	_	ADJ	JJ	_	2	amod	_	_
2	studies	_	NOUN	NNS	_	0	root	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	case	_	NOUN	NN	_	5	compound	_	_
5	control	_	NOUN	NN	_	2	nmod	_	_
6	and	_	CONJ	CC	_	2	cc	_	_
7	cohort	_	NOUN	NN	_	2	conj	_	_
8	design	_	NOUN	NN	_	7	dobj	_	_
9	that	_	DET	WDT	_	11	nsubj	_	_
10	have	_	VERB	VBP	_	11	aux	_	_
11	demonstrated	_	VERB	VBN	_	8	dep	_	_
12	an	_	DET	DT	_	13	det	_	_
13	association	_	NOUN	NN	_	11	dobj	_	_
14	between	_	ADP	IN	_	15	case	_	_
15	use	_	NOUN	NN	_	13	nmod	_	_
16	of	_	ADP	IN	_	18	case	_	_
17	psychotropic	_	ADJ	JJ	_	18	amod	_	_
18	drugs	_	NOUN	NNS	_	15	nmod	_	_
19	that	_	DET	WDT	_	20	nsubj	_	_
20	interfere	_	VERB	VBP	_	18	acl:relcl	_	_
21	with	_	ADP	IN	_	23	case	_	_
22	serotonin	_	NOUN	NN	_	23	compound	_	_
23	reuptake	_	NOUN	NN	_	20	nmod	_	_
24	and	_	CONJ	CC	_	20	cc	_	_
25	the	_	DET	DT	_	26	det	_	_
26	occurrence	_	NOUN	NN	_	20	conj	_	_
27	of	_	ADP	IN	_	28	mark	_	_
28	upper	_	VERB	VBG	_	26	acl	_	_
29	gastrointestinal	_	ADJ	JJ	_	30	amod	_	_
30	bleeding	_	NOUN	NN	_	28	dobj	_	_

#	Pristiq	727
1	These	_	DET	DT	_	2	det	_	_
2	studies	_	NOUN	NNS	_	5	nsubj	_	_
3	have	_	VERB	VBP	_	5	aux	_	_
4	also	_	ADV	RB	_	5	advmod	_	_
5	shown	_	VERB	VBN	_	0	root	_	_
6	that	_	ADP	IN	_	15	mark	_	_
7	concurrent	_	ADJ	JJ	_	8	amod	_	_
8	use	_	NOUN	NN	_	15	nsubj	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	an	_	DET	DT	_	11	det	_	_
11	NSAID	_	NOUN	NN	_	8	nmod	_	_
12	or	_	CONJ	CC	_	11	cc	_	_
13	aspirin	_	NOUN	NN	_	11	conj	_	_
14	may	_	VERB	MD	_	15	aux	_	_
15	potentiate	_	VERB	VB	_	5	ccomp	_	_
16	this	_	DET	DT	_	17	det	_	_
17	risk	_	NOUN	NN	_	15	dobj	_	_
18	of	_	ADP	IN	_	19	mark	_	_
19	bleeding	_	VERB	VBG	_	17	nmod	_	_

#	Pristiq	728
1	Altered	_	VERB	VBN	_	3	amod	_	_
2	anticoagulant	_	ADJ	JJ	_	3	amod	_	_
3	effects	_	NOUN	NNS	_	11	nsubjpass	_	_
4	,	_	.	,	_	3	punct	_	_
5	including	_	VERB	VBG	_	7	case	_	_
6	increased	_	VERB	VBN	_	7	amod	_	_
7	bleeding	_	NOUN	NN	_	3	nmod	_	_
8	,	_	.	,	_	3	punct	_	_
9	have	_	VERB	VBP	_	11	aux	_	_
10	been	_	VERB	VBN	_	11	auxpass	_	_
11	reported	_	VERB	VBN	_	0	root	_	_
12	when	_	ADV	WRB	_	18	advmod	_	_
13	SSRIs	_	NOUN	NNS	_	18	nsubjpass	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	SNRIs	_	NOUN	NNS	_	13	conj	_	_
16	are	_	VERB	VBP	_	18	auxpass	_	_
17	co	_	PRT	TO	_	18	mark	_	_
18	administered	_	VERB	VBN	_	11	advcl	_	_
19	with	_	ADP	IN	_	20	case	_	_
20	warfarin	_	NOUN	NN	_	18	nmod	_	_

#	Pristiq	729
1	Patients	_	NOUN	NNS	_	8	nsubjpass	_	_
2	receiving	_	VERB	VBG	_	1	acl	_	_
3	warfarin	_	NOUN	NN	_	4	compound	_	_
4	therapy	_	NOUN	NN	_	2	dobj	_	_
5	should	_	VERB	MD	_	8	aux	_	_
6	be	_	VERB	VB	_	8	auxpass	_	_
7	carefully	_	ADV	RB	_	8	advmod	_	_
8	monitored	_	VERB	VBN	_	0	root	_	_
9	when	_	ADV	WRB	_	12	advmod	_	_
10	DRUG	_	NOUN	NN	_	12	nsubjpass	_	_
11	is	_	VERB	VBZ	_	12	auxpass	_	_
12	initiated	_	VERB	VBN	_	8	ccomp	_	_
13	or	_	CONJ	CC	_	12	cc	_	_
14	discontinued	_	VERB	VBN	_	12	conj	_	_

#	Pristiq	730
1	Based	_	VERB	VBN	_	11	advcl	_	_
2	on	_	ADP	IN	_	5	case	_	_
3	in	_	X	FW	_	5	amod	_	_
4	vitro	_	X	FW	_	3	dep	_	_
5	data	_	NOUN	NNS	_	1	nmod	_	_
6	,	_	.	,	_	11	punct	_	_
7	no	_	DET	DT	_	9	neg	_	_
8	dose	_	NOUN	NN	_	9	compound	_	_
9	adjustment	_	NOUN	NN	_	11	nsubjpass	_	_
10	is	_	VERB	VBZ	_	11	auxpass	_	_
11	required	_	VERB	VBN	_	0	root	_	_
12	for	_	ADP	IN	_	13	case	_	_
13	DRUG	_	NOUN	NN	_	11	nmod	_	_
14	when	_	ADV	WRB	_	15	advmod	_	_
15	used	_	VERB	VBN	_	11	advcl	_	_
16	concomitantly	_	ADV	RB	_	15	advmod	_	_
17	with	_	ADP	IN	_	18	case	_	_
18	inhibitors	_	NOUN	NNS	_	15	nmod	_	_
19	of	_	ADP	IN	_	20	case	_	_
20	CYP3A4	_	NOUN	NN	_	18	nmod	_	_
21	and	_	CONJ	CC	_	20	cc	_	_
22	CYP1A1	_	NOUN	NN	_	20	conj	_	_
23	,	_	.	,	_	20	punct	_	_
24	1A2	_	NOUN	NN	_	20	conj	_	_
25	,	_	.	,	_	20	punct	_	_
26	2A6	_	NOUN	NN	_	20	conj	_	_
27	,	_	.	,	_	20	punct	_	_
28	2D6	_	NOUN	NN	_	20	conj	_	_
29	,	_	.	,	_	20	punct	_	_
30	2C8	_	NOUN	NN	_	20	conj	_	_
31	,	_	.	,	_	20	punct	_	_
32	2C9	_	NOUN	NN	_	20	conj	_	_
33	,	_	.	,	_	20	punct	_	_
34	2C19	_	NOUN	NN	_	20	conj	_	_
35	,	_	.	,	_	20	punct	_	_
36	2E1	_	NOUN	NN	_	20	conj	_	_
37	,	_	.	,	_	20	punct	_	_
38	and	_	CONJ	CC	_	20	cc	_	_
39	the	_	DET	DT	_	42	det	_	_
40	P	_	NOUN	NN	_	42	compound	_	_
41	glycoprotein	_	NOUN	NN	_	42	compound	_	_
42	transporter	_	NOUN	NN	_	20	conj	_	_

#	Pristiq	731
1	Clinical	_	ADJ	JJ	_	2	amod	_	_
2	studies	_	NOUN	NNS	_	4	nsubj	_	_
3	have	_	VERB	VBP	_	4	aux	_	_
4	demonstrated	_	VERB	VBN	_	0	root	_	_
5	no	_	DET	DT	_	9	neg	_	_
6	clinically	_	ADV	RB	_	7	advmod	_	_
7	significant	_	ADJ	JJ	_	9	amod	_	_
8	pharmacokinetic	_	ADJ	JJ	_	9	amod	_	_
9	interaction	_	NOUN	NN	_	4	dobj	_	_
10	between	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	strong	_	ADJ	JJ	_	16	amod	_	_
14	CYP	_	NOUN	NN	_	16	compound	_	_
15	3A4	_	NOUN	NN	_	16	compound	_	_
16	inhibitors	_	NOUN	NNS	_	11	conj	_	_
17	Figure	_	NOUN	NN	_	16	nmod	_	_
18	1	_	NUM	CD	_	17	nummod	_	_

#	Pristiq	732
1	Figure	_	NOUN	NN	_	4	compound	_	_
2	1	_	NUM	CD	_	4	nummod	_	_
3	Clinical	_	ADJ	JJ	_	4	amod	_	_
4	studies	_	NOUN	NNS	_	6	nsubj	_	_
5	have	_	VERB	VBP	_	6	aux	_	_
6	shown	_	VERB	VBN	_	0	root	_	_
7	that	_	ADP	IN	_	11	mark	_	_
8	DRUG	_	NOUN	NN	_	11	nsubj	_	_
9	does	_	VERB	VBZ	_	11	aux	_	_
10	not	_	ADV	RB	_	11	neg	_	_
11	have	_	VERB	VB	_	6	ccomp	_	_
12	a	_	DET	DT	_	15	det	_	_
13	clinically	_	ADV	RB	_	14	advmod	_	_
14	relevant	_	ADJ	JJ	_	15	amod	_	_
15	effect	_	NOUN	NN	_	11	dobj	_	_
16	on	_	ADP	IN	_	18	case	_	_
17	CYP2D6	_	NOUN	NN	_	18	compound	_	_
18	metabolism	_	NOUN	NN	_	15	nmod	_	_
19	at	_	ADP	IN	_	21	case	_	_
20	the	_	DET	DT	_	21	det	_	_
21	dose	_	NOUN	NN	_	15	nmod	_	_
22	of	_	ADP	IN	_	24	case	_	_
23	100	_	NUM	CD	_	24	nummod	_	_
24	mg	_	NOUN	NN	_	21	nmod	_	_
25	daily	_	ADV	RB	_	11	advmod	_	_
26	Figure	_	NOUN	NN	_	25	nmod	_	_
27	2	_	NUM	CD	_	26	nummod	_	_

#	Pristiq	733
1	Substrates	_	NOUN	NNS	_	23	nsubjpass	_	_
2	primarily	_	ADV	RB	_	3	advmod	_	_
3	metabolized	_	VERB	VBN	_	1	acl	_	_
4	by	_	ADP	IN	_	6	case	_	_
5	CYP2D6	_	NOUN	NN	_	6	compound	_	_
6	e.g	_	NOUN	NN	_	3	nmod	_	_
7	,	_	.	,	_	6	punct	_	_
8	desipramine	_	NOUN	NN	_	6	conj	_	_
9	,	_	.	,	_	6	punct	_	_
10	atomoxetine	_	NOUN	NN	_	6	conj	_	_
11	,	_	.	,	_	6	punct	_	_
12	dextromethorphan	_	NOUN	NN	_	6	conj	_	_
13	,	_	.	,	_	6	punct	_	_
14	metoprolol	_	NOUN	NN	_	6	conj	_	_
15	,	_	.	,	_	6	punct	_	_
16	nebivolol	_	NOUN	NN	_	6	conj	_	_
17	,	_	.	,	_	6	punct	_	_
18	perphenazine	_	NOUN	NN	_	6	appos	_	_
19	,	_	.	,	_	6	punct	_	_
20	tolterodine	_	NOUN	NN	_	6	appos	_	_
21	should	_	VERB	MD	_	23	aux	_	_
22	be	_	VERB	VB	_	23	auxpass	_	_
23	dosed	_	VERB	VBN	_	0	root	_	_
24	at	_	ADP	IN	_	27	case	_	_
25	the	_	DET	DT	_	27	det	_	_
26	original	_	ADJ	JJ	_	27	amod	_	_
27	level	_	NOUN	NN	_	23	nmod	_	_
28	when	_	ADV	WRB	_	23	advmod	_	_
29	co	_	PRT	TO	_	28	punct	_	_
30	administered	_	VERB	VBN	_	29	dep	_	_
31	with	_	ADP	IN	_	34	case	_	_
32	DRUG	_	NOUN	NN	_	34	compound	_	_
33	100	_	NUM	CD	_	34	nummod	_	_
34	mg	_	NOUN	NN	_	30	nmod	_	_
35	or	_	CONJ	CC	_	34	cc	_	_
36	lower	_	ADJ	JJ	_	34	conj	_	_
37	or	_	CONJ	CC	_	30	cc	_	_
38	when	_	ADV	RB	_	41	advmod	_	_
39	DRUG	_	NOUN	NN	_	41	nsubjpass	_	_
40	is	_	VERB	VBZ	_	41	auxpass	_	_
41	discontinued	_	VERB	VBN	_	30	conj	_	_

#	Pristiq	734
1	Reduce	_	VERB	VBP	_	0	root	_	_
2	the	_	DET	DT	_	3	det	_	_
3	dose	_	NOUN	NN	_	1	dobj	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	these	_	DET	DT	_	6	det	_	_
6	substrates	_	NOUN	NNS	_	3	nmod	_	_
7	by	_	ADP	IN	_	11	case	_	_
8	up	_	ADJ	JJ	_	10	advmod	_	_
9	to	_	PRT	TO	_	10	dep	_	_
10	one	_	NUM	CD	_	11	nummod	_	_
11	half	_	NOUN	NN	_	1	nmod	_	_
12	if	_	ADP	IN	_	11	nmod	_	_
13	co	_	.	,	_	12	nmod	_	_
14	administered	_	VERB	VBN	_	13	root	_	_
15	with	_	ADP	IN	_	17	case	_	_
16	400	_	NUM	CD	_	17	nummod	_	_
17	mg	_	NOUN	NN	_	14	nmod	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	DRUG	_	NOUN	NN	_	17	nmod	_	_

#	Pristiq	735
1	No	_	DET	DT	_	4	neg	_	_
2	additional	_	ADJ	JJ	_	4	amod	_	_
3	dose	_	NOUN	NN	_	4	compound	_	_
4	adjustment	_	NOUN	NN	_	6	nsubjpass	_	_
5	is	_	VERB	VBZ	_	6	auxpass	_	_
6	required	_	VERB	VBN	_	0	root	_	_
7	for	_	ADP	IN	_	9	case	_	_
8	concomitant	_	ADJ	JJ	_	9	amod	_	_
9	use	_	NOUN	NN	_	6	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	substrates	_	NOUN	NNS	_	9	nmod	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	CYP3A4	_	NOUN	NN	_	11	nmod	_	_
14	,	_	.	,	_	13	punct	_	_
15	1A2	_	NOUN	NN	_	13	conj	_	_
16	,	_	.	,	_	13	punct	_	_
17	2A6	_	NOUN	NN	_	13	conj	_	_
18	,	_	.	,	_	13	punct	_	_
19	2C8	_	NOUN	NN	_	13	conj	_	_
20	,	_	.	,	_	13	punct	_	_
21	2C9	_	NOUN	NN	_	13	conj	_	_
22	,	_	.	,	_	13	punct	_	_
23	and	_	CONJ	CC	_	13	cc	_	_
24	2C19	_	NOUN	NN	_	25	compound	_	_
25	isozymes	_	NOUN	NNS	_	13	conj	_	_
26	,	_	.	,	_	6	punct	_	_
27	and	_	CONJ	CC	_	6	cc	_	_
28	P	_	NOUN	NN	_	30	compound	_	_
29	glycoprotein	_	NOUN	NN	_	30	compound	_	_
30	transporter	_	NOUN	NN	_	6	conj	_	_

#	Pristiq	736
1	Clinical	_	ADJ	JJ	_	2	amod	_	_
2	studies	_	NOUN	NNS	_	4	nsubj	_	_
3	have	_	VERB	VBP	_	4	aux	_	_
4	demonstrated	_	VERB	VBN	_	0	root	_	_
5	no	_	DET	DT	_	9	neg	_	_
6	clinically	_	ADV	RB	_	7	advmod	_	_
7	significant	_	ADJ	JJ	_	9	amod	_	_
8	pharmacokinetic	_	ADJ	JJ	_	9	amod	_	_
9	interaction	_	NOUN	NN	_	4	dobj	_	_
10	between	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	CYP3A4	_	NOUN	NN	_	14	compound	_	_
14	substrates	_	NOUN	NNS	_	11	conj	_	_
15	Figure	_	NOUN	NN	_	11	dep	_	_
16	2	_	NUM	CD	_	15	nummod	_	_

#	Pristiq	737
1	Clinical	_	ADJ	JJ	_	2	amod	_	_
2	studies	_	NOUN	NNS	_	4	nsubj	_	_
3	have	_	VERB	VBP	_	4	aux	_	_
4	shown	_	VERB	VBN	_	0	root	_	_
5	that	_	ADP	IN	_	12	mark	_	_
6	DRUG	_	NOUN	NN	_	8	compound	_	_
7	100	_	NUM	CD	_	8	nummod	_	_
8	mg	_	NOUN	NN	_	12	nsubj	_	_
9	daily	_	ADV	RB	_	12	advmod	_	_
10	does	_	VERB	VBZ	_	12	aux	_	_
11	not	_	ADV	RB	_	12	neg	_	_
12	have	_	VERB	VB	_	4	ccomp	_	_
13	a	_	DET	DT	_	16	det	_	_
14	clinically	_	ADV	RB	_	15	advmod	_	_
15	relevant	_	ADJ	JJ	_	16	amod	_	_
16	effect	_	NOUN	NN	_	12	dobj	_	_
17	on	_	ADP	IN	_	18	case	_	_
18	tamoxifen	_	NOUN	NN	_	16	nmod	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	aripiprazole	_	NOUN	NN	_	18	conj	_	_
21	,	_	.	,	_	18	punct	_	_
22	compounds	_	NOUN	NNS	_	18	appos	_	_
23	that	_	DET	WDT	_	25	nsubjpass	_	_
24	are	_	VERB	VBP	_	25	auxpass	_	_
25	metabolized	_	VERB	VBN	_	22	acl:relcl	_	_
26	by	_	ADP	IN	_	28	case	_	_
27	a	_	DET	DT	_	28	det	_	_
28	combination	_	NOUN	NN	_	25	nmod	_	_
29	of	_	ADP	IN	_	31	case	_	_
30	both	_	CONJ	CC	_	31	cc:preconj	_	_
31	CYP2D6	_	NOUN	NN	_	28	nmod	_	_
32	and	_	CONJ	CC	_	31	cc	_	_
33	CYP3A4	_	NOUN	NN	_	31	conj	_	_
34	enzymes	_	NOUN	NNS	_	31	dep	_	_
35	Figure	_	NOUN	NN	_	31	dep	_	_
36	2	_	NUM	CD	_	35	nummod	_	_

#	Pristiq	738
1	In	_	X	FW	_	3	amod	_	_
2	vitro	_	X	FW	_	1	dep	_	_
3	studies	_	NOUN	NNS	_	4	nsubj	_	_
4	showed	_	VERB	VBD	_	0	root	_	_
5	minimal	_	ADJ	JJ	_	7	amod	_	_
6	inhibitory	_	ADJ	JJ	_	7	amod	_	_
7	effect	_	NOUN	NN	_	4	dobj	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	on	_	ADP	IN	_	13	case	_	_
11	the	_	DET	DT	_	13	det	_	_
12	CYP2D6	_	NOUN	NN	_	13	compound	_	_
13	isoenzyme	_	NOUN	NN	_	7	nmod	_	_

#	Pristiq	739
1	In	_	X	FW	_	2	compound	_	_
2	vitro	_	X	FW	_	7	advmod	_	_
3	,	_	.	,	_	7	punct	_	_
4	DRUG	_	NOUN	NN	_	7	nsubj	_	_
5	does	_	VERB	VBZ	_	7	aux	_	_
6	not	_	ADV	RB	_	7	neg	_	_
7	inhibit	_	VERB	VB	_	0	root	_	_
8	or	_	CONJ	CC	_	7	cc	_	_
9	induce	_	VERB	VB	_	7	conj	_	_
10	the	_	DET	DT	_	12	det	_	_
11	CYP3A4	_	NOUN	NN	_	12	compound	_	_
12	isozyme	_	NOUN	NN	_	9	dobj	_	_

#	Pristiq	740
1	In	_	X	FW	_	2	compound	_	_
2	vitro	_	X	FW	_	7	advmod	_	_
3	,	_	.	,	_	7	punct	_	_
4	DRUG	_	NOUN	NN	_	7	nsubj	_	_
5	does	_	VERB	VBZ	_	7	aux	_	_
6	not	_	ADV	RB	_	7	neg	_	_
7	inhibit	_	VERB	VB	_	0	root	_	_
8	CYP1A2	_	NOUN	NN	_	7	dobj	_	_
9	,	_	.	,	_	8	punct	_	_
10	2A6	_	NOUN	NN	_	8	conj	_	_
11	,	_	.	,	_	8	punct	_	_
12	2C8	_	NOUN	NN	_	8	conj	_	_
13	,	_	.	,	_	8	punct	_	_
14	2C9	_	NOUN	NN	_	8	conj	_	_
15	,	_	.	,	_	8	punct	_	_
16	and	_	CONJ	CC	_	8	cc	_	_
17	2C19	_	NOUN	NN	_	8	conj	_	_
18	,	_	.	,	_	8	punct	_	_
19	isozymes	_	NOUN	NNS	_	8	conj	_	_
20	,	_	.	,	_	8	punct	_	_
21	and	_	CONJ	CC	_	8	cc	_	_
22	P	_	NOUN	NN	_	24	compound	_	_
23	glycoprotein	_	NOUN	NN	_	24	compound	_	_
24	transporter	_	NOUN	NN	_	8	conj	_	_
25	and	_	CONJ	CC	_	7	cc	_	_
26	would	_	VERB	MD	_	29	aux	_	_
27	not	_	ADV	RB	_	29	neg	_	_
28	be	_	VERB	VB	_	29	auxpass	_	_
29	expected	_	VERB	VBN	_	7	conj	_	_
30	to	_	PRT	TO	_	31	mark	_	_
31	affect	_	VERB	VB	_	29	xcomp	_	_
32	the	_	DET	DT	_	33	det	_	_
33	pharmacokinetics	_	NOUN	NNS	_	31	dobj	_	_
34	of	_	ADP	IN	_	35	case	_	_
35	drugs	_	NOUN	NNS	_	33	nmod	_	_
36	that	_	DET	WDT	_	38	nsubj	_	_
37	are	_	VERB	VBP	_	38	cop	_	_
38	substrates	_	NOUN	NNS	_	35	acl:relcl	_	_
39	of	_	ADP	IN	_	42	case	_	_
40	these	_	DET	DT	_	42	det	_	_
41	CYP	_	NOUN	NN	_	42	compound	_	_
42	isozymes	_	NOUN	NNS	_	38	nmod	_	_
43	and	_	CONJ	CC	_	42	cc	_	_
44	transporter	_	NOUN	NN	_	42	conj	_	_

#	Pristiq	741
1	Figure	_	NOUN	NN	_	4	compound	_	_
2	2	_	NUM	CD	_	4	nummod	_	_
3	Avoid	_	ADJ	JJ	_	4	amod	_	_
4	use	_	NOUN	NN	_	0	root	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	with	_	ADP	IN	_	11	case	_	_
8	other	_	ADJ	JJ	_	11	amod	_	_
9	DRUG	_	NOUN	NN	_	11	compound	_	_
10	containing	_	VERB	VBG	_	11	compound	_	_
11	products	_	NOUN	NNS	_	4	nmod	_	_
12	or	_	CONJ	CC	_	11	cc	_	_
13	venlafaxine	_	NOUN	NN	_	14	compound	_	_
14	products	_	NOUN	NNS	_	11	conj	_	_

#	Pristiq	742
1	The	_	DET	DT	_	3	det	_	_
2	concomitant	_	ADJ	JJ	_	3	amod	_	_
3	use	_	NOUN	NN	_	14	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	with	_	ADP	IN	_	10	case	_	_
7	other	_	ADJ	JJ	_	10	amod	_	_
8	DRUG	_	NOUN	NN	_	10	compound	_	_
9	containing	_	VERB	VBG	_	10	compound	_	_
10	products	_	NOUN	NNS	_	3	nmod	_	_
11	or	_	CONJ	CC	_	10	cc	_	_
12	venlafaxine	_	NOUN	NN	_	10	conj	_	_
13	will	_	VERB	MD	_	14	aux	_	_
14	increase	_	VERB	VB	_	0	root	_	_
15	DRUG	_	NOUN	NN	_	17	compound	_	_
16	blood	_	NOUN	NN	_	17	compound	_	_
17	levels	_	NOUN	NNS	_	14	dobj	_	_
18	and	_	CONJ	CC	_	14	cc	_	_
19	increase	_	VERB	VBP	_	14	conj	_	_
20	dose	_	NOUN	NN	_	23	compound	_	_
21	related	_	ADJ	JJ	_	23	amod	_	_
22	adverse	_	ADJ	JJ	_	23	amod	_	_
23	reactions	_	NOUN	NNS	_	19	dobj	_	_

#	Pristiq	743
1	A	_	DET	DT	_	3	det	_	_
2	clinical	_	ADJ	JJ	_	3	amod	_	_
3	study	_	NOUN	NN	_	5	nsubj	_	_
4	has	_	VERB	VBZ	_	5	aux	_	_
5	shown	_	VERB	VBN	_	0	root	_	_
6	that	_	ADP	IN	_	10	mark	_	_
7	DRUG	_	NOUN	NN	_	10	nsubj	_	_
8	does	_	VERB	VBZ	_	10	aux	_	_
9	not	_	ADV	RB	_	10	neg	_	_
10	increase	_	VERB	VB	_	5	ccomp	_	_
11	the	_	DET	DT	_	12	det	_	_
12	impairment	_	NOUN	NN	_	10	dobj	_	_
13	of	_	ADP	IN	_	17	case	_	_
14	mental	_	ADJ	JJ	_	17	amod	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	motor	_	NOUN	NN	_	14	conj	_	_
17	skills	_	NOUN	NNS	_	12	nmod	_	_
18	caused	_	VERB	VBN	_	17	acl	_	_
19	by	_	ADP	IN	_	20	case	_	_
20	ethanol	_	NOUN	NN	_	18	nmod	_	_

#	Pristiq	744
1	However	_	ADV	RB	_	13	advmod	_	_
2	,	_	.	,	_	13	punct	_	_
3	as	_	ADP	IN	_	8	case	_	_
4	with	_	ADP	IN	_	8	case	_	_
5	all	_	DET	DT	_	8	det	_	_
6	CNS	_	NOUN	NN	_	8	compound	_	_
7	active	_	ADJ	JJ	_	8	amod	_	_
8	drugs	_	NOUN	NNS	_	13	nmod	_	_
9	,	_	.	,	_	13	punct	_	_
10	patients	_	NOUN	NNS	_	13	nsubjpass	_	_
11	should	_	VERB	MD	_	13	aux	_	_
12	be	_	VERB	VB	_	13	auxpass	_	_
13	advised	_	VERB	VBN	_	0	root	_	_
14	to	_	PRT	TO	_	15	mark	_	_
15	avoid	_	VERB	VB	_	13	xcomp	_	_
16	alcohol	_	NOUN	NN	_	17	compound	_	_
17	consumption	_	NOUN	NN	_	15	dobj	_	_
18	while	_	ADP	IN	_	19	mark	_	_
19	taking	_	VERB	VBG	_	15	advcl	_	_
20	DRUG	_	NOUN	NN	_	19	dobj	_	_

#	Pristiq	745
1	False	_	ADJ	JJ	_	6	amod	_	_
2	positive	_	ADJ	JJ	_	6	amod	_	_
3	urine	_	ADJ	JJ	_	6	amod	_	_
4	immunoassay	_	ADJ	JJ	_	6	amod	_	_
5	screening	_	NOUN	NN	_	6	compound	_	_
6	tests	_	NOUN	NNS	_	14	nsubjpass	_	_
7	for	_	ADP	IN	_	8	case	_	_
8	phencyclidine	_	NOUN	NN	_	6	nmod	_	_
9	PCP	_	NOUN	NN	_	8	dep	_	_
10	and	_	CONJ	CC	_	8	cc	_	_
11	amphetamine	_	NOUN	NN	_	8	conj	_	_
12	have	_	VERB	VBP	_	14	aux	_	_
13	been	_	VERB	VBN	_	14	auxpass	_	_
14	reported	_	VERB	VBN	_	0	root	_	_
15	in	_	ADP	IN	_	16	case	_	_
16	patients	_	NOUN	NNS	_	14	nmod	_	_
17	taking	_	VERB	VBG	_	16	acl	_	_
18	DRUG	_	NOUN	NN	_	17	nmod	_	_

#	Pristiq	746
1	This	_	DET	DT	_	5	nsubj	_	_
2	is	_	VERB	VBZ	_	5	cop	_	_
3	due	_	ADJ	JJ	_	5	case	_	_
4	to	_	PRT	TO	_	3	mwe	_	_
5	lack	_	NOUN	NN	_	0	root	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	specificity	_	NOUN	NN	_	5	nmod	_	_
8	of	_	ADP	IN	_	11	case	_	_
9	the	_	DET	DT	_	11	det	_	_
10	screening	_	ADJ	JJ	_	11	amod	_	_
11	tests	_	NOUN	NNS	_	7	nmod	_	_

#	Pristiq	747
1	False	_	ADJ	JJ	_	4	amod	_	_
2	positive	_	ADJ	JJ	_	4	amod	_	_
3	test	_	NOUN	NN	_	4	compound	_	_
4	results	_	NOUN	NNS	_	7	nsubjpass	_	_
5	may	_	VERB	MD	_	7	aux	_	_
6	be	_	VERB	VB	_	7	auxpass	_	_
7	expected	_	VERB	VBN	_	0	root	_	_
8	for	_	ADP	IN	_	10	case	_	_
9	several	_	ADJ	JJ	_	10	amod	_	_
10	days	_	NOUN	NNS	_	7	nmod	_	_
11	following	_	VERB	VBG	_	12	case	_	_
12	discontinuation	_	NOUN	NN	_	7	nmod	_	_
13	of	_	ADP	IN	_	15	case	_	_
14	DRUG	_	NOUN	NN	_	15	compound	_	_
15	therapy	_	NOUN	NN	_	12	nmod	_	_

#	Pristiq	748
1	Confirmatory	_	ADJ	JJ	_	2	amod	_	_
2	tests	_	NOUN	NNS	_	0	root	_	_
3	,	_	.	,	_	2	punct	_	_
4	such	_	ADJ	JJ	_	7	case	_	_
5	as	_	ADP	IN	_	4	mwe	_	_
6	gas	_	NOUN	NN	_	7	compound	_	_
7	chromatography	_	NOUN	NN	_	2	nmod	_	_
8	/	_	.	:	_	2	punct	_	_
9	mass	_	NOUN	NN	_	10	compound	_	_
10	spectrometry	_	NOUN	NN	_	13	nsubj	_	_
11	,	_	.	,	_	10	punct	_	_
12	will	_	VERB	MD	_	13	aux	_	_
13	distinguish	_	VERB	VB	_	2	dep	_	_
14	DRUG	_	NOUN	NN	_	13	dobj	_	_
15	from	_	ADP	IN	_	16	case	_	_
16	PCP	_	NOUN	NN	_	14	nmod	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	amphetamine	_	NOUN	NN	_	16	conj	_	_

#	Pristiq	749
1	The	_	DET	DT	_	3	det	_	_
2	exact	_	ADJ	JJ	_	3	amod	_	_
3	mechanism	_	NOUN	NN	_	11	nsubj	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	the	_	DET	DT	_	7	det	_	_
6	antidepressant	_	ADJ	JJ	_	7	amod	_	_
7	action	_	NOUN	NN	_	3	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	is	_	VERB	VBZ	_	11	cop	_	_
11	unknown	_	ADJ	JJ	_	0	root	_	_
12	,	_	.	,	_	11	punct	_	_
13	but	_	CONJ	CC	_	11	cc	_	_
14	is	_	VERB	VBZ	_	15	auxpass	_	_
15	thought	_	VERB	VBN	_	11	conj	_	_
16	to	_	PRT	TO	_	18	mark	_	_
17	be	_	VERB	VB	_	18	cop	_	_
18	related	_	ADJ	JJ	_	15	xcomp	_	_
19	to	_	PRT	TO	_	21	case	_	_
20	the	_	DET	DT	_	21	det	_	_
21	potentiation	_	NOUN	NN	_	18	nmod	_	_
22	of	_	ADP	IN	_	23	case	_	_
23	serotonin	_	NOUN	NN	_	21	nmod	_	_
24	and	_	CONJ	CC	_	23	cc	_	_
25	norepinephrine	_	NOUN	NN	_	23	conj	_	_
26	in	_	ADP	IN	_	30	case	_	_
27	the	_	DET	DT	_	30	det	_	_
28	central	_	ADJ	JJ	_	30	amod	_	_
29	nervous	_	ADJ	JJ	_	30	amod	_	_
30	system	_	NOUN	NN	_	21	nmod	_	_
31	,	_	.	,	_	11	punct	_	_
32	through	_	ADP	IN	_	33	case	_	_
33	inhibition	_	NOUN	NN	_	11	nmod	_	_
34	of	_	ADP	IN	_	36	case	_	_
35	their	_	PRON	PRP$	_	36	nmod:poss	_	_
36	reuptake	_	NOUN	NN	_	33	nmod	_	_

#	Pristiq	750
1	Non	_	CONJ	CC	_	3	amod	_	_
2	clinical	_	ADJ	JJ	_	3	amod	_	_
3	studies	_	NOUN	NNS	_	5	nsubj	_	_
4	have	_	VERB	VBP	_	5	aux	_	_
5	shown	_	VERB	VBN	_	0	root	_	_
6	that	_	ADP	IN	_	13	mark	_	_
7	DRUG	_	NOUN	NN	_	13	nsubj	_	_
8	is	_	VERB	VBZ	_	13	cop	_	_
9	a	_	DET	DT	_	13	det	_	_
10	potent	_	ADJ	JJ	_	13	amod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	selective	_	ADJ	JJ	_	10	conj	_	_
13	serotonin	_	NOUN	NN	_	5	ccomp	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	norepinephrine	_	NOUN	NN	_	18	compound	_	_
16	reuptake	_	NOUN	NN	_	18	compound	_	_
17	inhibitor	_	NOUN	NN	_	18	compound	_	_
18	SNRI	_	NOUN	NN	_	13	conj	_	_

#	Pristiq	751
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	lacked	_	VERB	VBD	_	0	root	_	_
3	significant	_	ADJ	JJ	_	4	amod	_	_
4	affinity	_	NOUN	NN	_	2	dobj	_	_
5	for	_	ADP	IN	_	7	case	_	_
6	numerous	_	ADJ	JJ	_	7	amod	_	_
7	receptors	_	NOUN	NNS	_	4	nmod	_	_
8	,	_	.	,	_	7	punct	_	_
9	including	_	VERB	VBG	_	11	case	_	_
10	muscarinic	_	ADJ	JJ	_	11	amod	_	_
11	cholinergic	_	ADJ	JJ	_	7	nmod	_	_
12	,	_	.	,	_	11	punct	_	_
13	H1	_	NOUN	NN	_	14	compound	_	_
14	histaminergic	_	ADJ	JJ	_	11	conj	_	_
15	,	_	.	,	_	11	punct	_	_
16	or	_	CONJ	CC	_	11	cc	_	_
17	A1	_	NOUN	NN	_	19	compound	_	_
18	adrenergic	_	ADJ	JJ	_	19	amod	_	_
19	receptors	_	NOUN	NNS	_	11	conj	_	_
20	in	_	X	FW	_	21	compound	_	_
21	vitro	_	X	FW	_	11	advmod	_	_

#	Pristiq	752
1	DRUG	_	NOUN	NN	_	3	nsubj	_	_
2	also	_	ADV	RB	_	3	advmod	_	_
3	lacked	_	VERB	VBD	_	0	root	_	_
4	monoamine	_	NOUN	NN	_	8	compound	_	_
5	oxidase	_	NOUN	NN	_	8	compound	_	_
6	MAO	_	NOUN	NN	_	8	compound	_	_
7	inhibitory	_	ADJ	JJ	_	8	amod	_	_
8	activity	_	NOUN	NN	_	3	dobj	_	_

#	Pristiq	753
1	ECG	_	NOUN	NN	_	3	compound	_	_
2	changes	_	NOUN	NNS	_	3	compound	_	_
3	Electrocardiograms	_	NOUN	NNS	_	5	nsubjpass	_	_
4	were	_	VERB	VBD	_	5	auxpass	_	_
5	obtained	_	VERB	VBN	_	0	root	_	_
6	from	_	ADP	IN	_	10	case	_	_
7	1,492	_	NUM	CD	_	10	nummod	_	_
8	DRUG	_	NOUN	NN	_	10	compound	_	_
9	treated	_	ADJ	JJ	_	10	amod	_	_
10	patients	_	NOUN	NNS	_	5	nmod	_	_
11	with	_	ADP	IN	_	14	case	_	_
12	major	_	ADJ	JJ	_	14	amod	_	_
13	depressive	_	ADJ	JJ	_	14	amod	_	_
14	disorder	_	NOUN	NN	_	10	nmod	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	984	_	NUM	CD	_	19	nummod	_	_
17	placebo	_	NOUN	NN	_	19	compound	_	_
18	treated	_	ADJ	JJ	_	19	amod	_	_
19	patients	_	NOUN	NNS	_	14	conj	_	_
20	in	_	ADP	IN	_	22	case	_	_
21	clinical	_	ADJ	JJ	_	22	amod	_	_
22	studies	_	NOUN	NNS	_	14	nmod	_	_
23	lasting	_	VERB	VBG	_	22	acl	_	_
24	up	_	ADV	RB	_	23	nmod	_	_
25	to	_	PRT	TO	_	27	case	_	_
26	8	_	NUM	CD	_	27	nummod	_	_
27	weeks	_	NOUN	NNS	_	24	nmod	_	_

#	Pristiq	754
1	No	_	DET	DT	_	4	neg	_	_
2	clinically	_	ADV	RB	_	3	advmod	_	_
3	relevant	_	ADJ	JJ	_	4	amod	_	_
4	differences	_	NOUN	NNS	_	6	nsubjpass	_	_
5	were	_	VERB	VBD	_	6	auxpass	_	_
6	observed	_	VERB	VBN	_	0	root	_	_
7	between	_	ADP	IN	_	9	case	_	_
8	DRUG	_	NOUN	NN	_	9	nmod:npmod	_	_
9	treated	_	VERB	VBN	_	6	advcl	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	placebo	_	NOUN	NN	_	13	compound	_	_
12	treated	_	ADJ	JJ	_	13	amod	_	_
13	patients	_	NOUN	NNS	_	9	conj	_	_
14	for	_	ADP	IN	_	15	case	_	_
15	QT	_	NOUN	NN	_	9	nmod	_	_
16	,	_	.	,	_	15	punct	_	_
17	QTc	_	NOUN	NN	_	15	conj	_	_
18	,	_	.	,	_	15	punct	_	_
19	PR	_	NOUN	NN	_	15	conj	_	_
20	,	_	.	,	_	15	punct	_	_
21	and	_	CONJ	CC	_	15	cc	_	_
22	QRS	_	NOUN	NN	_	15	conj	_	_
23	intervals	_	VERB	VBZ	_	6	punct	_	_

#	Pristiq	755
1	In	_	ADP	IN	_	5	case	_	_
2	a	_	DET	DT	_	5	det	_	_
3	thorough	_	ADP	IN	_	5	amod	_	_
4	QTc	_	NOUN	NN	_	5	compound	_	_
5	study	_	NOUN	NN	_	14	nmod	_	_
6	with	_	ADP	IN	_	9	case	_	_
7	prospectively	_	ADV	RB	_	8	advmod	_	_
8	determined	_	VERB	VBN	_	9	amod	_	_
9	criteria	_	NOUN	NN	_	5	nmod	_	_
10	,	_	.	,	_	14	punct	_	_
11	DRUG	_	NOUN	NN	_	14	nsubj	_	_
12	did	_	VERB	VBD	_	14	aux	_	_
13	not	_	ADV	RB	_	14	neg	_	_
14	cause	_	VERB	VB	_	0	root	_	_
15	QT	_	NOUN	NN	_	16	compound	_	_
16	prolongation	_	NOUN	NN	_	14	dobj	_	_

#	Pristiq	756
1	No	_	DET	DT	_	2	neg	_	_
2	difference	_	NOUN	NN	_	4	nsubjpass	_	_
3	was	_	VERB	VBD	_	4	auxpass	_	_
4	observed	_	VERB	VBN	_	0	root	_	_
5	between	_	ADP	IN	_	6	case	_	_
6	placebo	_	NOUN	NN	_	4	nmod	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	DRUG	_	NOUN	NN	_	6	conj	_	_
9	treatments	_	NOUN	NNS	_	6	dep	_	_
10	for	_	ADP	IN	_	13	case	_	_
11	the	_	DET	DT	_	13	det	_	_
12	QRS	_	NOUN	NN	_	13	nmod:npmod	_	_
13	interval	_	ADJ	JJ	_	6	acl	_	_

#	Pristiq	757
1	The	_	DET	DT	_	4	det	_	_
2	single	_	ADJ	JJ	_	4	amod	_	_
3	dose	_	NOUN	NN	_	4	compound	_	_
4	pharmacokinetics	_	NOUN	NNS	_	8	nsubj	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	are	_	VERB	VBP	_	8	cop	_	_
8	linear	_	ADJ	JJ	_	0	root	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	dose	_	NOUN	NN	_	8	conj	_	_
11	proportional	_	ADJ	JJ	_	10	amod	_	_
12	in	_	ADP	IN	_	15	case	_	_
13	a	_	DET	DT	_	15	det	_	_
14	dose	_	NOUN	NN	_	15	compound	_	_
15	range	_	NOUN	NN	_	11	nmod	_	_
16	of	_	ADP	IN	_	20	case	_	_
17	50	_	NUM	CD	_	19	compound	_	_
18	to	_	PRT	TO	_	19	dep	_	_
19	600	_	NUM	CD	_	20	nummod	_	_
20	mg	_	NOUN	NN	_	15	nmod	_	_
21	per	_	ADP	IN	_	22	case	_	_
22	day	_	NOUN	NN	_	20	nmod	_	_

#	Pristiq	758
1	With	_	ADP	IN	_	4	case	_	_
2	once	_	ADV	RB	_	3	advmod	_	_
3	daily	_	ADV	RB	_	4	advmod	_	_
4	dosing	_	NOUN	NN	_	11	nmod	_	_
5	,	_	.	,	_	11	punct	_	_
6	steady	_	ADJ	JJ	_	9	amod	_	_
7	state	_	NOUN	NN	_	9	compound	_	_
8	plasma	_	NOUN	NN	_	9	compound	_	_
9	concentrations	_	NOUN	NNS	_	11	nsubjpass	_	_
10	are	_	VERB	VBP	_	11	auxpass	_	_
11	achieved	_	VERB	VBN	_	0	root	_	_
12	within	_	ADP	IN	_	17	case	_	_
13	approximately	_	ADV	RB	_	14	advmod	_	_
14	4	_	NUM	CD	_	16	compound	_	_
15	to	_	PRT	TO	_	16	dep	_	_
16	5	_	NUM	CD	_	17	nummod	_	_
17	days	_	NOUN	NNS	_	11	nmod	_	_

#	Pristiq	759
1	At	_	ADP	IN	_	3	case	_	_
2	steady	_	ADJ	JJ	_	3	amod	_	_
3	state	_	NOUN	NN	_	11	nmod	_	_
4	,	_	.	,	_	11	punct	_	_
5	multiple	_	ADJ	JJ	_	7	amod	_	_
6	dose	_	NOUN	NN	_	7	compound	_	_
7	accumulation	_	NOUN	NN	_	11	nsubj	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	is	_	VERB	VBZ	_	11	cop	_	_
11	linear	_	ADJ	JJ	_	0	root	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	predictable	_	ADJ	JJ	_	11	conj	_	_
14	from	_	ADP	IN	_	19	case	_	_
15	the	_	DET	DT	_	19	det	_	_
16	single	_	ADJ	JJ	_	19	amod	_	_
17	dose	_	NOUN	NN	_	19	compound	_	_
18	pharmacokinetic	_	ADJ	JJ	_	19	amod	_	_
19	profile	_	NOUN	NN	_	11	nmod	_	_

#	Pristiq	760
1	Absorption	_	NOUN	NN	_	0	root	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	distribution	_	NOUN	NN	_	1	conj	_	_
4	The	_	DET	DT	_	7	det	_	_
5	absolute	_	VERB	VBP	_	7	amod	_	_
6	oral	_	ADJ	JJ	_	7	amod	_	_
7	bioavailability	_	NOUN	NN	_	15	nsubj	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	after	_	ADP	IN	_	12	case	_	_
11	oral	_	ADJ	JJ	_	12	amod	_	_
12	administration	_	NOUN	NN	_	7	nmod	_	_
13	is	_	VERB	VBZ	_	15	auxpass	_	_
14	about	_	ADV	RB	_	15	advmod	_	_
15	80%	_	ADJ	JJ	_	1	dep	_	_

#	Pristiq	761
1	A	_	DET	DT	_	4	det	_	_
2	food	_	NOUN	NN	_	4	compound	_	_
3	effect	_	NOUN	NN	_	4	compound	_	_
4	study	_	NOUN	NN	_	0	root	_	_
5	involving	_	VERB	VBG	_	4	acl	_	_
6	administration	_	NOUN	NN	_	5	dobj	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	to	_	PRT	TO	_	11	case	_	_
10	healthy	_	ADJ	JJ	_	11	amod	_	_
11	subjects	_	NOUN	NNS	_	6	nmod	_	_
12	under	_	ADP	IN	_	13	mark	_	_
13	fasting	_	VERB	VBG	_	5	advcl	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	fed	_	ADJ	JJ	_	13	conj	_	_
16	conditions	_	NOUN	NNS	_	13	dobj	_	_
17	high	_	ADJ	JJ	_	19	amod	_	_
18	fat	_	NOUN	NN	_	19	nmod:npmod	_	_
19	meal	_	ADJ	JJ	_	16	amod	_	_
20	,	_	.	,	_	13	punct	_	_
21	800	_	NUM	CD	_	23	compound	_	_
22	to	_	PRT	TO	_	23	dep	_	_
23	1000	_	NUM	CD	_	24	nummod	_	_
24	calories	_	NOUN	NNS	_	25	nsubj	_	_
25	indicated	_	VERB	VBD	_	13	parataxis	_	_
26	that	_	ADP	IN	_	30	mark	_	_
27	DRUG	_	NOUN	NN	_	28	compound	_	_
28	Cmax	_	NOUN	NN	_	30	nsubjpass	_	_
29	was	_	VERB	VBD	_	30	auxpass	_	_
30	increased	_	VERB	VBN	_	25	ccomp	_	_
31	about	_	ADV	RB	_	32	case	_	_
32	16%	_	ADJ	JJ	_	30	nmod	_	_
33	in	_	ADP	IN	_	36	case	_	_
34	the	_	DET	DT	_	36	det	_	_
35	fed	_	ADJ	JJ	_	36	amod	_	_
36	state	_	NOUN	NN	_	30	nmod	_	_
37	,	_	.	,	_	30	punct	_	_
38	while	_	ADP	IN	_	42	mark	_	_
39	the	_	DET	DT	_	40	det	_	_
40	AUCs	_	NOUN	NNS	_	42	nsubj	_	_
41	were	_	VERB	VBD	_	42	auxpass	_	_
42	similar	_	ADJ	JJ	_	30	advcl	_	_

#	Pristiq	762
1	This	_	DET	DT	_	2	det	_	_
2	difference	_	NOUN	NN	_	5	nsubjpass	_	_
3	is	_	VERB	VBZ	_	5	auxpass	_	_
4	not	_	ADV	RB	_	5	neg	_	_
5	expected	_	VERB	VBN	_	15	advcl	_	_
6	to	_	PRT	TO	_	9	mark	_	_
7	be	_	VERB	VB	_	9	cop	_	_
8	clinically	_	ADV	RB	_	9	advmod	_	_
9	significant	_	ADJ	JJ	_	5	xcomp	_	_
10	therefore	_	ADV	RB	_	9	advmod	_	_
11	,	_	.	,	_	15	punct	_	_
12	DRUG	_	NOUN	NN	_	15	nsubjpass	_	_
13	can	_	VERB	MD	_	15	aux	_	_
14	be	_	VERB	VB	_	15	auxpass	_	_
15	taken	_	VERB	VBN	_	0	root	_	_
16	without	_	ADP	IN	_	17	case	_	_
17	regard	_	NOUN	NN	_	15	nmod	_	_
18	to	_	PRT	TO	_	19	case	_	_
19	meals	_	NOUN	NNS	_	17	nmod	_	_

#	Pristiq	763
1	The	_	DET	DT	_	4	det	_	_
2	plasma	_	NOUN	NN	_	4	compound	_	_
3	protein	_	NOUN	NN	_	4	compound	_	_
4	binding	_	NOUN	NN	_	9	nsubj	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	is	_	VERB	VBZ	_	9	cop	_	_
8	low	_	ADJ	JJ	_	9	amod	_	_
9	30%	_	NOUN	NN	_	0	root	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	is	_	VERB	VBZ	_	12	cop	_	_
12	independent	_	ADJ	JJ	_	9	conj	_	_
13	of	_	ADP	IN	_	15	case	_	_
14	drug	_	NOUN	NN	_	15	compound	_	_
15	concentration	_	NOUN	NN	_	12	nmod	_	_

#	Pristiq	764
1	The	_	DET	DT	_	3	det	_	_
2	DRUG	_	NOUN	NN	_	3	compound	_	_
3	volume	_	NOUN	NN	_	14	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	distribution	_	NOUN	NN	_	3	nmod	_	_
6	at	_	ADP	IN	_	8	case	_	_
7	steady	_	ADJ	JJ	_	8	amod	_	_
8	state	_	NOUN	NN	_	3	nmod	_	_
9	following	_	VERB	VBG	_	11	case	_	_
10	intravenous	_	ADJ	JJ	_	11	amod	_	_
11	administration	_	NOUN	NN	_	3	nmod	_	_
12	is	_	VERB	VBZ	_	14	cop	_	_
13	3.4	_	NUM	CD	_	14	nummod	_	_
14	L	_	NOUN	NN	_	0	root	_	_
15	/	_	.	:	_	14	punct	_	_
16	kg	_	NOUN	NN	_	14	dep	_	_
17	,	_	.	,	_	16	punct	_	_
18	indicating	_	VERB	VBG	_	16	acl	_	_
19	distribution	_	NOUN	NN	_	18	dobj	_	_
20	into	_	ADP	IN	_	22	case	_	_
21	nonvascular	_	ADJ	JJ	_	22	amod	_	_
22	compartments	_	NOUN	NNS	_	19	nmod	_	_

#	Pristiq	765
1	Metabolism	_	NOUN	NN	_	7	nsubjpass	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	elimination	_	NOUN	NN	_	4	compound	_	_
4	DRUG	_	NOUN	NN	_	1	conj	_	_
5	is	_	VERB	VBZ	_	7	auxpass	_	_
6	primarily	_	ADV	RB	_	7	advmod	_	_
7	metabolized	_	VERB	VBN	_	0	root	_	_
8	by	_	ADP	IN	_	9	case	_	_
9	conjugation	_	NOUN	NN	_	7	nmod	_	_
10	mediated	_	VERB	VBN	_	9	acl	_	_
11	by	_	ADP	IN	_	13	case	_	_
12	UGT	_	NOUN	NN	_	13	compound	_	_
13	isoforms	_	NOUN	NNS	_	10	nmod	_	_
14	and	_	CONJ	CC	_	7	cc	_	_
15	,	_	.	,	_	7	punct	_	_
16	to	_	PRT	TO	_	19	case	_	_
17	a	_	DET	DT	_	19	det	_	_
18	minor	_	ADJ	JJ	_	19	amod	_	_
19	extent	_	NOUN	NN	_	7	conj	_	_
20	,	_	.	,	_	19	punct	_	_
21	through	_	ADP	IN	_	23	case	_	_
22	oxidative	_	ADJ	JJ	_	23	amod	_	_
23	metabolism	_	NOUN	NN	_	19	nmod	_	_

#	Pristiq	766
1	CYP3A4	_	NOUN	NN	_	6	nsubj	_	_
2	is	_	VERB	VBZ	_	6	cop	_	_
3	the	_	DET	DT	_	6	det	_	_
4	cytochrome	_	NOUN	NN	_	6	compound	_	_
5	P450	_	NOUN	NN	_	6	compound	_	_
6	isozyme	_	NOUN	NN	_	0	root	_	_
7	mediating	_	VERB	VBG	_	6	acl	_	_
8	the	_	DET	DT	_	12	det	_	_
9	oxidative	_	ADJ	JJ	_	12	amod	_	_
10	metabolism	_	NOUN	NN	_	12	compound	_	_
11	N	_	NOUN	NN	_	12	compound	_	_
12	demethylation	_	NOUN	NN	_	7	dobj	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	DRUG	_	NOUN	NN	_	12	nmod	_	_

#	Pristiq	767
1	The	_	DET	DT	_	4	det	_	_
2	CYP2D6	_	NOUN	NN	_	4	compound	_	_
3	metabolic	_	ADJ	JJ	_	4	amod	_	_
4	pathway	_	NOUN	NN	_	7	nsubjpass	_	_
5	is	_	VERB	VBZ	_	7	auxpass	_	_
6	not	_	ADV	RB	_	7	neg	_	_
7	involved	_	VERB	VBN	_	0	root	_	_
8	,	_	.	,	_	7	punct	_	_
9	and	_	CONJ	CC	_	7	cc	_	_
10	after	_	ADP	IN	_	11	case	_	_
11	administration	_	NOUN	NN	_	21	nmod	_	_
12	of	_	ADP	IN	_	14	case	_	_
13	100	_	NUM	CD	_	14	nummod	_	_
14	mg	_	NOUN	NN	_	11	nmod	_	_
15	,	_	.	,	_	21	punct	_	_
16	the	_	DET	DT	_	17	det	_	_
17	pharmacokinetics	_	NOUN	NNS	_	21	nsubj	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	DRUG	_	NOUN	NN	_	17	nmod	_	_
20	was	_	VERB	VBD	_	21	cop	_	_
21	similar	_	ADJ	JJ	_	7	conj	_	_
22	in	_	ADP	IN	_	23	case	_	_
23	subjects	_	NOUN	NNS	_	21	nmod	_	_
24	with	_	ADP	IN	_	26	case	_	_
25	CYP2D6	_	NOUN	NN	_	26	compound	_	_
26	poor	_	ADJ	JJ	_	23	nmod	_	_
27	and	_	CONJ	CC	_	26	cc	_	_
28	extensive	_	ADJ	JJ	_	30	amod	_	_
29	metabolizer	_	ADJ	JJ	_	30	amod	_	_
30	phenotype	_	NOUN	NN	_	26	conj	_	_

#	Pristiq	768
1	Approximately	_	ADV	RB	_	6	advmod	_	_
2	45%	_	NOUN	NN	_	6	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	is	_	VERB	VBZ	_	6	auxpass	_	_
6	excreted	_	VERB	VBN	_	0	root	_	_
7	unchanged	_	ADJ	JJ	_	6	xcomp	_	_
8	in	_	ADP	IN	_	9	mark	_	_
9	urine	_	VERB	VBG	_	7	nmod	_	_
10	at	_	ADP	IN	_	12	case	_	_
11	72	_	NUM	CD	_	12	nummod	_	_
12	hours	_	NOUN	NNS	_	9	nmod	_	_
13	after	_	ADP	IN	_	15	case	_	_
14	oral	_	ADJ	JJ	_	15	amod	_	_
15	administration	_	NOUN	NN	_	9	nmod	_	_

#	Pristiq	769
1	Approximately	_	ADV	RB	_	8	advmod	_	_
2	19%	_	NOUN	NN	_	8	nsubjpass	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	the	_	DET	DT	_	6	det	_	_
5	administered	_	VERB	VBN	_	6	amod	_	_
6	dose	_	NOUN	NN	_	2	nmod	_	_
7	is	_	VERB	VBZ	_	8	auxpass	_	_
8	excreted	_	VERB	VBN	_	0	root	_	_
9	as	_	ADP	IN	_	12	case	_	_
10	the	_	DET	DT	_	12	det	_	_
11	glucuronide	_	NOUN	NN	_	12	compound	_	_
12	metabolite	_	NOUN	NN	_	8	nmod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	<5%	_	NOUN	NN	_	12	conj	_	_
15	as	_	ADP	IN	_	20	case	_	_
16	the	_	DET	DT	_	20	det	_	_
17	oxidative	_	ADJ	JJ	_	20	amod	_	_
18	metabolite	_	NOUN	NN	_	20	compound	_	_
19	N,O	_	NOUN	NN	_	20	compound	_	_
20	didesmethylvenlafaxine	_	NOUN	NN	_	8	nmod	_	_
21	in	_	ADP	IN	_	22	mark	_	_
22	urine	_	VERB	VBG	_	8	advcl	_	_

#	Pristiq	770
1	Drug	_	NOUN	NN	_	4	compound	_	_
2	interaction	_	NOUN	NN	_	4	compound	_	_
3	studies	_	NOUN	NNS	_	4	compound	_	_
4	Inhibitors	_	NOUN	NNS	_	12	nsubj	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	CYP3A4	_	NOUN	NN	_	8	compound	_	_
7	ketoconazole	_	NOUN	NN	_	8	compound	_	_
8	CYP3A4	_	NOUN	NN	_	4	nmod	_	_
9	is	_	VERB	VBZ	_	12	cop	_	_
10	a	_	DET	DT	_	12	det	_	_
11	minor	_	ADJ	JJ	_	12	amod	_	_
12	pathway	_	NOUN	NN	_	0	root	_	_
13	for	_	ADP	IN	_	15	case	_	_
14	the	_	DET	DT	_	15	det	_	_
15	metabolism	_	NOUN	NN	_	12	nmod	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	DRUG	_	NOUN	NN	_	15	nmod	_	_

#	Pristiq	771
1	In	_	ADP	IN	_	4	case	_	_
2	a	_	DET	DT	_	4	det	_	_
3	clinical	_	ADJ	JJ	_	4	amod	_	_
4	study	_	NOUN	NN	_	10	nmod	_	_
5	,	_	.	,	_	10	punct	_	_
6	ketoconazole	_	NOUN	NN	_	9	compound	_	_
7	200	_	NUM	CD	_	9	nummod	_	_
8	mg	_	NOUN	NN	_	9	compound	_	_
9	BID	_	NOUN	NN	_	10	nsubj	_	_
10	increased	_	VERB	VBD	_	0	root	_	_
11	the	_	DET	DT	_	12	det	_	_
12	area	_	NOUN	NN	_	10	dobj	_	_
13	under	_	ADP	IN	_	15	case	_	_
14	the	_	DET	DT	_	15	det	_	_
15	concentration	_	NOUN	NN	_	10	nmod	_	_
16	vs	_	CONJ	CC	_	15	cc	_	_
17	time	_	NOUN	NN	_	19	compound	_	_
18	curve	_	ADJ	JJ	_	19	amod	_	_
19	AUC	_	NOUN	NN	_	15	conj	_	_
20	of	_	ADP	IN	_	25	case	_	_
21	DRUG	_	NOUN	NN	_	25	compound	_	_
22	400	_	NUM	CD	_	25	nummod	_	_
23	mg	_	NOUN	NN	_	25	compound	_	_
24	single	_	ADJ	JJ	_	25	amod	_	_
25	dose	_	NOUN	NN	_	15	nmod	_	_
26	by	_	ADP	IN	_	28	case	_	_
27	about	_	ADV	RB	_	28	advmod	_	_
28	43%	_	ADJ	JJ	_	10	nmod	_	_
29	and	_	CONJ	CC	_	28	cc	_	_
30	Cmax	_	NOUN	NN	_	28	conj	_	_
31	by	_	ADP	IN	_	33	case	_	_
32	about	_	ADV	RB	_	33	advmod	_	_
33	8%	_	ADJ	JJ	_	10	nmod	_	_

#	Pristiq	772
1	Concomitant	_	ADJ	JJ	_	2	amod	_	_
2	use	_	NOUN	NN	_	11	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	with	_	ADP	IN	_	7	case	_	_
6	potent	_	ADJ	JJ	_	7	amod	_	_
7	inhibitors	_	NOUN	NNS	_	2	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	CYP3A4	_	NOUN	NN	_	7	nmod	_	_
10	may	_	VERB	MD	_	11	aux	_	_
11	result	_	VERB	VB	_	0	root	_	_
12	in	_	ADP	IN	_	14	case	_	_
13	higher	_	ADJ	JJ	_	14	amod	_	_
14	concentrations	_	NOUN	NNS	_	11	nmod	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	14	nmod	_	_

#	Pristiq	773
1	Inhibitors	_	NOUN	NNS	_	6	nsubj	_	_
2	of	_	ADP	IN	_	5	case	_	_
3	other	_	ADJ	JJ	_	5	amod	_	_
4	CYP	_	NOUN	NN	_	5	compound	_	_
5	enzymes	_	NOUN	NNS	_	1	nmod	_	_
6	Based	_	VERB	VBN	_	0	root	_	_
7	on	_	ADP	IN	_	10	case	_	_
8	in	_	X	FW	_	10	amod	_	_
9	vitro	_	X	FW	_	8	dep	_	_
10	data	_	NOUN	NNS	_	6	nmod	_	_
11	,	_	.	,	_	10	punct	_	_
12	drugs	_	NOUN	NNS	_	35	nsubjpass	_	_
13	that	_	DET	WDT	_	14	nsubj	_	_
14	inhibit	_	VERB	VBP	_	12	acl:relcl	_	_
15	CYP	_	NOUN	NN	_	16	compound	_	_
16	isozymes	_	NOUN	NNS	_	14	dobj	_	_
17	1A1	_	NOUN	NN	_	16	dep	_	_
18	,	_	.	,	_	17	punct	_	_
19	1A2	_	NOUN	NN	_	17	conj	_	_
20	,	_	.	,	_	17	punct	_	_
21	2A6	_	NOUN	NN	_	17	conj	_	_
22	,	_	.	,	_	17	punct	_	_
23	2D6	_	NOUN	NN	_	17	conj	_	_
24	,	_	.	,	_	17	punct	_	_
25	2C8	_	NOUN	NN	_	17	conj	_	_
26	,	_	.	,	_	17	punct	_	_
27	2C9	_	NOUN	NN	_	17	conj	_	_
28	,	_	.	,	_	17	punct	_	_
29	2C19	_	NOUN	NN	_	17	conj	_	_
30	,	_	.	,	_	17	punct	_	_
31	and	_	CONJ	CC	_	17	cc	_	_
32	2E1	_	NOUN	NN	_	17	conj	_	_
33	are	_	VERB	VBP	_	35	auxpass	_	_
34	not	_	ADV	RB	_	35	neg	_	_
35	expected	_	VERB	VBN	_	10	acl:relcl	_	_
36	to	_	PRT	TO	_	37	mark	_	_
37	have	_	VERB	VB	_	35	xcomp	_	_
38	significant	_	ADJ	JJ	_	39	amod	_	_
39	impact	_	NOUN	NN	_	37	dobj	_	_
40	on	_	ADP	IN	_	43	case	_	_
41	the	_	DET	DT	_	43	det	_	_
42	pharmacokinetic	_	ADJ	JJ	_	43	amod	_	_
43	profile	_	NOUN	NN	_	37	nmod	_	_
44	of	_	ADP	IN	_	46	case	_	_
45	DRUG	_	NOUN	NN	_	46	compound	_	_
46	desipramine	_	NOUN	NN	_	43	nmod	_	_
47	,	_	.	,	_	46	punct	_	_
48	dextromethorphan	_	NOUN	NN	_	46	conj	_	_
49	,	_	.	,	_	46	punct	_	_
50	metoprolol	_	NOUN	NN	_	46	conj	_	_
51	,	_	.	,	_	46	punct	_	_
52	atomoxetine	_	NOUN	NN	_	55	compound	_	_
53	In	_	X	FW	_	55	amod	_	_
54	vitro	_	X	FW	_	53	dep	_	_
55	studies	_	NOUN	NNS	_	46	appos	_	_
56	showed	_	VERB	VBD	_	6	parataxis	_	_
57	minimal	_	ADJ	JJ	_	59	amod	_	_
58	inhibitory	_	ADJ	JJ	_	59	amod	_	_
59	effect	_	NOUN	NN	_	56	dobj	_	_
60	of	_	ADP	IN	_	61	case	_	_
61	DRUG	_	NOUN	NN	_	59	nmod	_	_
62	on	_	ADP	IN	_	63	case	_	_
63	CYP2D6	_	NOUN	NN	_	59	nmod	_	_

#	Pristiq	774
1	Clinical	_	ADJ	JJ	_	2	amod	_	_
2	studies	_	NOUN	NNS	_	4	nsubj	_	_
3	have	_	VERB	VBP	_	4	aux	_	_
4	shown	_	VERB	VBN	_	0	root	_	_
5	that	_	ADP	IN	_	9	mark	_	_
6	DRUG	_	NOUN	NN	_	9	nsubj	_	_
7	does	_	VERB	VBZ	_	9	aux	_	_
8	not	_	ADV	RB	_	9	neg	_	_
9	have	_	VERB	VB	_	4	root	_	_
10	a	_	DET	DT	_	13	det	_	_
11	clinically	_	ADV	RB	_	12	advmod	_	_
12	relevant	_	ADJ	JJ	_	13	amod	_	_
13	effect	_	NOUN	NN	_	9	dobj	_	_
14	on	_	ADP	IN	_	16	case	_	_
15	CYP2D6	_	NOUN	NN	_	16	compound	_	_
16	metabolism	_	NOUN	NN	_	13	nmod	_	_
17	at	_	ADP	IN	_	19	case	_	_
18	the	_	DET	DT	_	19	det	_	_
19	dose	_	NOUN	NN	_	13	nmod	_	_
20	of	_	ADP	IN	_	22	case	_	_
21	100	_	NUM	CD	_	22	nummod	_	_
22	mg	_	NOUN	NN	_	19	nmod	_	_
23	daily	_	ADV	RB	_	9	advmod	_	_

#	Pristiq	775
1	When	_	ADV	WRB	_	5	advmod	_	_
2	DRUG	_	NOUN	NN	_	3	compound	_	_
3	succinate	_	NOUN	NN	_	5	nsubjpass	_	_
4	was	_	VERB	VBD	_	5	auxpass	_	_
5	administered	_	VERB	VBN	_	34	advcl	_	_
6	at	_	ADP	IN	_	8	case	_	_
7	a	_	DET	DT	_	8	det	_	_
8	dose	_	NOUN	NN	_	5	nmod	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	100	_	NUM	CD	_	11	nummod	_	_
11	mg	_	NOUN	NN	_	8	nmod	_	_
12	daily	_	ADV	RB	_	5	advmod	_	_
13	in	_	ADP	IN	_	14	case	_	_
14	conjunction	_	NOUN	NN	_	5	nmod	_	_
15	with	_	ADP	IN	_	20	case	_	_
16	a	_	DET	DT	_	20	det	_	_
17	single	_	ADJ	JJ	_	20	amod	_	_
18	50	_	NUM	CD	_	20	nummod	_	_
19	mg	_	NOUN	NN	_	20	compound	_	_
20	dose	_	NOUN	NN	_	14	nmod	_	_
21	of	_	ADP	IN	_	22	case	_	_
22	desipramine	_	NOUN	NN	_	20	nmod	_	_
23	,	_	.	,	_	22	punct	_	_
24	a	_	DET	DT	_	26	det	_	_
25	CYP2D6	_	NOUN	NN	_	26	compound	_	_
26	substrate	_	NOUN	NN	_	22	appos	_	_
27	,	_	.	,	_	34	punct	_	_
28	the	_	DET	DT	_	29	det	_	_
29	Cmax	_	NOUN	NN	_	34	nsubj	_	_
30	and	_	CONJ	CC	_	29	cc	_	_
31	AUC	_	NOUN	NN	_	29	conj	_	_
32	of	_	ADP	IN	_	33	case	_	_
33	desipramine	_	NOUN	NN	_	29	nmod	_	_
34	increased	_	VERB	VBD	_	0	root	_	_
35	approximately	_	ADV	RB	_	36	advmod	_	_
36	25%	_	NOUN	NN	_	34	dobj	_	_
37	and	_	CONJ	CC	_	36	cc	_	_
38	17%	_	NOUN	NN	_	36	conj	_	_
39	,	_	.	,	_	34	punct	_	_
40	respectively	_	ADV	RB	_	34	advmod	_	_

#	Pristiq	776
1	When	_	ADV	WRB	_	12	advmod	_	_
2	400	_	NUM	CD	_	5	nummod	_	_
3	mg	_	NOUN	NN	_	5	compound	_	_
4	8	_	NUM	CD	_	5	nummod	_	_
5	times	_	NOUN	NNS	_	12	nsubjpass	_	_
6	the	_	DET	DT	_	10	det	_	_
7	recommended	_	VERB	VBN	_	10	amod	_	_
8	50	_	NUM	CD	_	10	nummod	_	_
9	mg	_	NOUN	NN	_	10	compound	_	_
10	dose	_	NOUN	NN	_	12	nsubjpass	_	_
11	was	_	VERB	VBD	_	12	auxpass	_	_
12	administered	_	VERB	VBN	_	20	advcl	_	_
13	,	_	.	,	_	20	punct	_	_
14	the	_	DET	DT	_	15	det	_	_
15	Cmax	_	NOUN	NN	_	20	nsubj	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	AUC	_	NOUN	NN	_	15	conj	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	desipramine	_	NOUN	NN	_	15	nmod	_	_
20	increased	_	VERB	VBD	_	0	root	_	_
21	approximately	_	ADV	RB	_	22	advmod	_	_
22	50%	_	NOUN	NN	_	20	dobj	_	_
23	and	_	CONJ	CC	_	22	cc	_	_
24	90%	_	NOUN	NN	_	22	conj	_	_
25	,	_	.	,	_	20	punct	_	_
26	respectively	_	ADV	RB	_	20	advmod	_	_

#	Pristiq	777
1	Concomitant	_	ADJ	JJ	_	2	amod	_	_
2	use	_	NOUN	NN	_	12	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	with	_	ADP	IN	_	7	case	_	_
6	a	_	DET	DT	_	7	det	_	_
7	drug	_	NOUN	NN	_	2	nmod	_	_
8	metabolized	_	VERB	VBN	_	7	acl	_	_
9	by	_	ADP	IN	_	10	case	_	_
10	CYP2D6	_	NOUN	NN	_	8	nmod	_	_
11	can	_	VERB	MD	_	12	aux	_	_
12	result	_	VERB	VB	_	0	root	_	_
13	in	_	ADP	IN	_	15	case	_	_
14	higher	_	ADJ	JJ	_	15	amod	_	_
15	concentrations	_	NOUN	NNS	_	12	nmod	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	that	_	DET	WDT	_	15	nmod	_	_
18	drug	_	NOUN	NN	_	17	root	_	_

#	Pristiq	778
1	Drugs	_	NOUN	NNS	_	0	root	_	_
2	metabolized	_	VERB	VBN	_	1	acl	_	_
3	by	_	ADP	IN	_	5	case	_	_
4	CYP3A4	_	NOUN	NN	_	5	compound	_	_
5	midazolam	_	NOUN	NN	_	2	nmod	_	_
6	In	_	X	FW	_	7	compound	_	_
7	vitro	_	X	FW	_	2	advmod	_	_
8	,	_	.	,	_	1	punct	_	_
9	DRUG	_	NOUN	NN	_	12	nsubj	_	_
10	does	_	VERB	VBZ	_	12	aux	_	_
11	not	_	ADV	RB	_	12	neg	_	_
12	inhibit	_	VERB	VB	_	1	dep	_	_
13	or	_	CONJ	CC	_	12	cc	_	_
14	induce	_	VERB	VB	_	12	conj	_	_
15	the	_	DET	DT	_	17	det	_	_
16	CYP3A4	_	NOUN	NN	_	17	compound	_	_
17	isozyme	_	NOUN	NN	_	14	dobj	_	_

#	Pristiq	779
1	In	_	ADP	IN	_	4	case	_	_
2	a	_	DET	DT	_	4	det	_	_
3	clinical	_	ADJ	JJ	_	4	amod	_	_
4	study	_	NOUN	NN	_	19	nmod	_	_
5	,	_	.	,	_	19	punct	_	_
6	DRUG	_	NOUN	NN	_	8	compound	_	_
7	400	_	NUM	CD	_	8	nummod	_	_
8	mg	_	NOUN	NN	_	11	compound	_	_
9	daily	_	ADV	RB	_	10	advmod	_	_
10	8	_	NUM	CD	_	11	nummod	_	_
11	times	_	NOUN	NNS	_	19	nmod	_	_
12	the	_	DET	DT	_	16	det	_	_
13	recommended	_	VERB	VBN	_	16	amod	_	_
14	50	_	NUM	CD	_	16	nummod	_	_
15	mg	_	NOUN	NN	_	16	compound	_	_
16	dose	_	NOUN	NN	_	19	nsubjpass	_	_
17	was	_	VERB	VBD	_	19	auxpass	_	_
18	co	_	PRT	TO	_	19	dep	_	_
19	administered	_	VERB	VBN	_	0	root	_	_
20	with	_	ADP	IN	_	25	case	_	_
21	a	_	DET	DT	_	25	det	_	_
22	single	_	ADJ	JJ	_	25	amod	_	_
23	4	_	NUM	CD	_	25	nummod	_	_
24	mg	_	NOUN	NN	_	25	compound	_	_
25	dose	_	NOUN	NN	_	19	nmod	_	_
26	of	_	ADP	IN	_	27	case	_	_
27	midazolam	_	NOUN	NN	_	25	nmod	_	_
28	a	_	DET	DT	_	30	det	_	_
29	CYP3A4	_	NOUN	NN	_	30	compound	_	_
30	substrate	_	NOUN	NN	_	27	dep	_	_

#	Pristiq	780
1	The	_	DET	DT	_	2	det	_	_
2	AUC	_	NOUN	NN	_	7	nsubj	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	Cmax	_	NOUN	NN	_	2	conj	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	midazolam	_	NOUN	NN	_	2	nmod	_	_
7	decreased	_	VERB	VBD	_	0	root	_	_
8	by	_	ADP	IN	_	10	case	_	_
9	approximately	_	ADV	RB	_	10	advmod	_	_
10	31%	_	NOUN	NN	_	7	nmod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	16%	_	NOUN	NN	_	10	conj	_	_
13	,	_	.	,	_	7	punct	_	_
14	respectively	_	ADV	RB	_	7	advmod	_	_

#	Pristiq	781
1	Concomitant	_	ADJ	JJ	_	2	amod	_	_
2	use	_	NOUN	NN	_	12	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	with	_	ADP	IN	_	7	case	_	_
6	a	_	DET	DT	_	7	det	_	_
7	drug	_	NOUN	NN	_	2	nmod	_	_
8	metabolized	_	VERB	VBN	_	7	acl	_	_
9	by	_	ADP	IN	_	10	case	_	_
10	CYP3A4	_	NOUN	NN	_	8	nmod	_	_
11	can	_	VERB	MD	_	12	aux	_	_
12	result	_	VERB	VB	_	0	root	_	_
13	in	_	ADP	IN	_	15	case	_	_
14	lower	_	ADJ	JJ	_	15	amod	_	_
15	exposures	_	NOUN	NNS	_	12	nmod	_	_
16	to	_	PRT	TO	_	17	case	_	_
17	that	_	ADP	IN	_	15	nmod	_	_
18	drug	_	NOUN	NN	_	17	root	_	_

#	Pristiq	782
1	Drugs	_	NOUN	NNS	_	19	nsubj	_	_
2	metabolized	_	VERB	VBN	_	1	acl	_	_
3	by	_	ADP	IN	_	4	case	_	_
4	CYP1A2	_	NOUN	NN	_	2	nmod	_	_
5	,	_	.	,	_	4	punct	_	_
6	2A6	_	NOUN	NN	_	4	conj	_	_
7	,	_	.	,	_	4	punct	_	_
8	2C8	_	NOUN	NN	_	4	conj	_	_
9	,	_	.	,	_	4	punct	_	_
10	2C9	_	NOUN	NN	_	4	conj	_	_
11	and	_	CONJ	CC	_	4	cc	_	_
12	2C19	_	NOUN	NN	_	4	conj	_	_
13	In	_	X	FW	_	14	compound	_	_
14	vitro	_	X	FW	_	2	advmod	_	_
15	,	_	.	,	_	1	punct	_	_
16	DRUG	_	NOUN	NN	_	1	appos	_	_
17	does	_	VERB	VBZ	_	19	aux	_	_
18	not	_	ADV	RB	_	19	neg	_	_
19	inhibit	_	VERB	VB	_	0	root	_	_
20	CYP1A2	_	NOUN	NN	_	19	dobj	_	_
21	,	_	.	,	_	20	punct	_	_
22	2A6	_	NOUN	NN	_	20	conj	_	_
23	,	_	.	,	_	20	punct	_	_
24	2C8	_	NOUN	NN	_	20	conj	_	_
25	,	_	.	,	_	20	punct	_	_
26	2C9	_	NOUN	NN	_	20	conj	_	_
27	,	_	.	,	_	20	punct	_	_
28	and	_	CONJ	CC	_	20	cc	_	_
29	2C19	_	NOUN	NN	_	20	conj	_	_
30	isozymes	_	NOUN	NNS	_	20	dep	_	_
31	and	_	CONJ	CC	_	19	cc	_	_
32	would	_	VERB	MD	_	35	aux	_	_
33	not	_	ADV	RB	_	35	neg	_	_
34	be	_	VERB	VB	_	35	auxpass	_	_
35	expected	_	VERB	VBN	_	19	conj	_	_
36	to	_	PRT	TO	_	37	mark	_	_
37	affect	_	VERB	VB	_	35	xcomp	_	_
38	the	_	DET	DT	_	39	det	_	_
39	pharmacokinetics	_	NOUN	NNS	_	37	dobj	_	_
40	of	_	ADP	IN	_	41	case	_	_
41	drugs	_	NOUN	NNS	_	39	nmod	_	_
42	that	_	DET	WDT	_	44	nsubjpass	_	_
43	are	_	VERB	VBP	_	44	auxpass	_	_
44	metabolized	_	VERB	VBN	_	41	acl:relcl	_	_
45	by	_	ADP	IN	_	48	case	_	_
46	these	_	DET	DT	_	48	det	_	_
47	CYP	_	NOUN	NN	_	48	compound	_	_
48	isozymes	_	NOUN	NNS	_	44	nmod	_	_

#	Pristiq	783
1	In	_	X	FW	_	2	compound	_	_
2	vitro	_	X	FW	_	8	advmod	_	_
3	,	_	.	,	_	8	punct	_	_
4	DRUG	_	NOUN	NN	_	8	nsubj	_	_
5	is	_	VERB	VBZ	_	8	cop	_	_
6	not	_	ADV	RB	_	8	neg	_	_
7	a	_	DET	DT	_	8	det	_	_
8	substrate	_	NOUN	NN	_	0	root	_	_
9	or	_	CONJ	CC	_	8	cc	_	_
10	an	_	DET	DT	_	11	det	_	_
11	inhibitor	_	NOUN	NN	_	8	conj	_	_
12	for	_	ADP	IN	_	16	case	_	_
13	the	_	DET	DT	_	16	det	_	_
14	P	_	NOUN	NN	_	16	compound	_	_
15	glycoprotein	_	NOUN	NN	_	16	compound	_	_
16	transporter	_	NOUN	NN	_	11	nmod	_	_

#	Pristiq	784
1	The	_	DET	DT	_	2	det	_	_
2	pharmacokinetics	_	NOUN	NNS	_	6	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	are	_	VERB	VBP	_	6	cop	_	_
6	unlikely	_	ADJ	JJ	_	0	root	_	_
7	to	_	PRT	TO	_	9	mark	_	_
8	be	_	VERB	VB	_	9	auxpass	_	_
9	affected	_	VERB	VBN	_	6	xcomp	_	_
10	by	_	ADP	IN	_	11	case	_	_
11	drugs	_	NOUN	NNS	_	9	nmod	_	_
12	that	_	DET	WDT	_	13	nsubj	_	_
13	inhibit	_	VERB	VBP	_	11	acl:relcl	_	_
14	the	_	DET	DT	_	17	det	_	_
15	P	_	NOUN	NN	_	17	compound	_	_
16	glycoprotein	_	NOUN	NN	_	17	compound	_	_
17	transporter	_	NOUN	NN	_	13	dobj	_	_
18	,	_	.	,	_	6	punct	_	_
19	and	_	CONJ	CC	_	6	cc	_	_
20	DRUG	_	NOUN	NN	_	23	nsubj	_	_
21	is	_	VERB	VBZ	_	23	cop	_	_
22	not	_	ADV	RB	_	23	neg	_	_
23	likely	_	ADJ	JJ	_	6	conj	_	_
24	to	_	PRT	TO	_	25	mark	_	_
25	affect	_	VERB	VB	_	23	xcomp	_	_
26	the	_	DET	DT	_	27	det	_	_
27	pharmacokinetics	_	NOUN	NNS	_	25	dobj	_	_
28	of	_	ADP	IN	_	29	case	_	_
29	drugs	_	NOUN	NNS	_	27	nmod	_	_
30	that	_	DET	WDT	_	32	nsubj	_	_
31	are	_	VERB	VBP	_	32	cop	_	_
32	substrates	_	NOUN	NNS	_	29	acl:relcl	_	_
33	of	_	ADP	IN	_	37	case	_	_
34	the	_	DET	DT	_	37	det	_	_
35	P	_	NOUN	NN	_	37	compound	_	_
36	glycoprotein	_	NOUN	NN	_	37	compound	_	_
37	transporter	_	NOUN	NN	_	32	nmod	_	_

#	Pristiq	785
1	Special	_	ADJ	JJ	_	2	amod	_	_
2	populations	_	NOUN	NNS	_	10	nsubj	_	_
3	Age	_	NOUN	NN	_	2	dep	_	_
4	In	_	ADP	IN	_	6	case	_	_
5	a	_	DET	DT	_	6	det	_	_
6	study	_	NOUN	NN	_	2	nmod	_	_
7	of	_	ADP	IN	_	9	case	_	_
8	healthy	_	ADJ	JJ	_	9	amod	_	_
9	subjects	_	NOUN	NNS	_	6	nmod	_	_
10	administered	_	VERB	VBD	_	0	root	_	_
11	doses	_	NOUN	NNS	_	10	dobj	_	_
12	of	_	ADP	IN	_	16	case	_	_
13	up	_	ADJ	JJ	_	15	advmod	_	_
14	to	_	PRT	TO	_	15	dep	_	_
15	300	_	NUM	CD	_	16	nummod	_	_
16	mg	_	NOUN	NN	_	11	nmod	_	_
17	,	_	.	,	_	10	punct	_	_
18	there	_	DET	EX	_	19	expl	_	_
19	was	_	VERB	VBD	_	10	parataxis	_	_
20	an	_	DET	DT	_	23	det	_	_
21	approximate	_	ADJ	JJ	_	23	amod	_	_
22	32%	_	ADJ	JJ	_	23	amod	_	_
23	increase	_	NOUN	NN	_	19	nsubj	_	_
24	in	_	ADP	IN	_	25	case	_	_
25	Cmax	_	NOUN	NN	_	23	nmod	_	_
26	and	_	CONJ	CC	_	23	cc	_	_
27	a	_	DET	DT	_	29	det	_	_
28	55%	_	ADJ	JJ	_	29	amod	_	_
29	increase	_	NOUN	NN	_	23	conj	_	_
30	in	_	ADP	IN	_	31	case	_	_
31	AUC	_	NOUN	NN	_	29	nmod	_	_
32	in	_	ADP	IN	_	33	case	_	_
33	subjects	_	NOUN	NNS	_	29	nmod	_	_
34	older	_	ADV	RB	_	36	advmod	_	_
35	than	_	ADP	IN	_	34	mwe	_	_
36	75	_	NUM	CD	_	37	nummod	_	_
37	years	_	NOUN	NNS	_	29	nmod	_	_
38	of	_	ADP	IN	_	40	case	_	_
39	age	_	NOUN	NN	_	40	compound	_	_
40	n	_	NOUN	NN	_	37	nmod	_	_
41	=	_	ADJ	JJ	_	40	amod	_	_
42	17	_	NUM	CD	_	41	dep	_	_
43	,	_	.	,	_	19	punct	_	_
44	compared	_	VERB	VBN	_	19	xcomp	_	_
45	with	_	ADP	IN	_	46	case	_	_
46	subjects	_	NOUN	NNS	_	44	nmod	_	_
47	18	_	NUM	CD	_	49	compound	_	_
48	to	_	PRT	TO	_	49	dep	_	_
49	45	_	NUM	CD	_	50	nummod	_	_
50	years	_	NOUN	NNS	_	46	nmod	_	_
51	of	_	ADP	IN	_	55	case	_	_
52	age	_	NOUN	NN	_	55	compound	_	_
53	n	_	NOUN	NN	_	55	compound	_	_
54	=	_	DET	DT	_	55	advmod	_	_
55	16	_	NUM	CD	_	50	nmod	_	_

#	Pristiq	786
1	Subjects	_	NOUN	NNS	_	9	nsubj	_	_
2	65	_	NUM	CD	_	4	compound	_	_
3	to	_	PRT	TO	_	4	dep	_	_
4	75	_	NUM	CD	_	5	nummod	_	_
5	years	_	NOUN	NNS	_	1	nmod	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	age	_	NOUN	NN	_	8	compound	_	_
8	n	_	NOUN	NN	_	5	nmod	_	_
9	=	_	ADJ	JJ	_	0	root	_	_
10	15	_	NUM	CD	_	9	dobj	_	_
11	had	_	VERB	VBD	_	9	parataxis	_	_
12	no	_	DET	DT	_	13	neg	_	_
13	change	_	NOUN	NN	_	11	root	_	_
14	in	_	ADP	IN	_	15	case	_	_
15	Cmax	_	NOUN	NN	_	13	nmod	_	_
16	,	_	.	,	_	13	punct	_	_
17	but	_	CONJ	CC	_	13	cc	_	_
18	an	_	DET	DT	_	21	det	_	_
19	approximately	_	ADV	RB	_	20	advmod	_	_
20	32%	_	ADJ	JJ	_	21	amod	_	_
21	increase	_	NOUN	NN	_	13	conj	_	_
22	in	_	ADP	IN	_	23	case	_	_
23	AUC	_	NOUN	NN	_	21	nmod	_	_
24	,	_	.	,	_	13	punct	_	_
25	compared	_	VERB	VBN	_	13	acl	_	_
26	to	_	PRT	TO	_	27	case	_	_
27	subjects	_	NOUN	NNS	_	25	nmod	_	_
28	18	_	NUM	CD	_	30	compound	_	_
29	to	_	PRT	TO	_	30	dep	_	_
30	45	_	NUM	CD	_	31	nummod	_	_
31	years	_	NOUN	NNS	_	27	dep	_	_
32	of	_	ADP	IN	_	33	case	_	_
33	age	_	NOUN	NN	_	31	nmod	_	_

#	Pristiq	787
1	Gender	_	NOUN	NN	_	8	nsubj	_	_
2	In	_	ADP	IN	_	4	case	_	_
3	a	_	DET	DT	_	4	det	_	_
4	study	_	NOUN	NN	_	1	nmod	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	healthy	_	ADJ	JJ	_	7	amod	_	_
7	subjects	_	NOUN	NNS	_	4	nmod	_	_
8	administered	_	VERB	VBD	_	17	advcl	_	_
9	doses	_	NOUN	NNS	_	8	dobj	_	_
10	of	_	ADP	IN	_	14	case	_	_
11	up	_	ADJ	JJ	_	13	advmod	_	_
12	to	_	PRT	TO	_	13	dep	_	_
13	300	_	NUM	CD	_	14	nummod	_	_
14	mg	_	NOUN	NN	_	9	nmod	_	_
15	,	_	.	,	_	17	punct	_	_
16	women	_	NOUN	NNS	_	17	nsubj	_	_
17	had	_	VERB	VBD	_	0	root	_	_
18	an	_	DET	DT	_	22	det	_	_
19	approximately	_	ADV	RB	_	20	advmod	_	_
20	25%	_	ADJ	JJ	_	22	amod	_	_
21	higher	_	ADJ	JJ	_	22	amod	_	_
22	Cmax	_	NOUN	NN	_	17	dobj	_	_
23	and	_	CONJ	CC	_	22	cc	_	_
24	an	_	DET	DT	_	28	det	_	_
25	approximately	_	ADV	RB	_	26	advmod	_	_
26	10%	_	ADJ	JJ	_	28	amod	_	_
27	higher	_	ADJ	JJ	_	28	amod	_	_
28	AUC	_	NOUN	NN	_	22	conj	_	_
29	than	_	ADP	IN	_	32	case	_	_
30	age	_	NOUN	NN	_	32	compound	_	_
31	matched	_	VERB	VBN	_	32	amod	_	_
32	men	_	NOUN	NN	_	17	nmod	_	_

#	Pristiq	788
1	No	_	DET	DT	_	2	neg	_	_
2	adjustment	_	NOUN	NN	_	11	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	dosage	_	NOUN	NN	_	2	nmod	_	_
5	on	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	basis	_	NOUN	NN	_	2	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	gender	_	NOUN	NN	_	7	nmod	_	_
10	is	_	VERB	VBZ	_	11	auxpass	_	_
11	needed	_	VERB	VBN	_	0	root	_	_

#	Pristiq	789
1	Race	_	ADJ	JJ	_	3	amod	_	_
2	Pharmacokinetic	_	ADJ	JJ	_	3	amod	_	_
3	analysis	_	NOUN	NN	_	4	nsubj	_	_
4	showed	_	VERB	VBD	_	0	root	_	_
5	that	_	ADP	IN	_	27	mark	_	_
6	race	_	ADJ	JJ	_	7	amod	_	_
7	White	_	NOUN	NN	_	27	nsubj	_	_
8	,	_	.	,	_	7	punct	_	_
9	n	_	NOUN	NN	_	10	nsubj	_	_
10	=	_	ADJ	JJ	_	7	appos	_	_
11	466	_	NUM	CD	_	12	nummod	_	_
12	Black	_	NOUN	NN	_	10	dobj	_	_
13	,	_	.	,	_	7	punct	_	_
14	n	_	NOUN	NN	_	15	nsubj	_	_
15	=	_	ADJ	JJ	_	7	amod	_	_
16	97	_	NUM	CD	_	17	nummod	_	_
17	Hispanic	_	ADJ	JJ	_	15	dobj	_	_
18	,	_	.	,	_	7	punct	_	_
19	n	_	NOUN	NN	_	20	nsubj	_	_
20	=	_	ADJ	JJ	_	7	amod	_	_
21	39	_	NUM	CD	_	22	nummod	_	_
22	Other	_	NOUN	NN	_	20	dobj	_	_
23	,	_	.	,	_	7	punct	_	_
24	n	_	NOUN	NN	_	25	nsubj	_	_
25	=	_	ADJ	JJ	_	7	amod	_	_
26	33	_	NUM	CD	_	25	dobj	_	_
27	had	_	VERB	VBD	_	4	ccomp	_	_
28	no	_	DET	DT	_	30	neg	_	_
29	apparent	_	ADJ	JJ	_	30	amod	_	_
30	effect	_	NOUN	NN	_	27	dobj	_	_
31	on	_	ADP	IN	_	33	case	_	_
32	the	_	DET	DT	_	33	det	_	_
33	pharmacokinetics	_	NOUN	NNS	_	27	nmod	_	_
34	of	_	ADP	IN	_	35	case	_	_
35	DRUG	_	NOUN	NN	_	33	nmod	_	_

#	Pristiq	790
1	No	_	DET	DT	_	2	neg	_	_
2	adjustment	_	NOUN	NN	_	11	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	dosage	_	NOUN	NN	_	2	nmod	_	_
5	on	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	basis	_	NOUN	NN	_	2	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	race	_	NOUN	NN	_	7	nmod	_	_
10	is	_	VERB	VBZ	_	11	auxpass	_	_
11	needed	_	VERB	VBN	_	0	root	_	_

#	Pristiq	791
1	Hepatic	_	ADJ	JJ	_	2	amod	_	_
2	insufficiency	_	NOUN	NN	_	0	root	_	_
3	The	_	DET	DT	_	4	det	_	_
4	disposition	_	NOUN	NN	_	14	nsubjpass	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	succinate	_	ADJ	JJ	_	6	amod	_	_
8	after	_	ADP	IN	_	9	case	_	_
9	administration	_	NOUN	NN	_	7	nmod	_	_
10	of	_	ADP	IN	_	12	case	_	_
11	100	_	NUM	CD	_	12	nummod	_	_
12	mg	_	NOUN	NN	_	9	nmod	_	_
13	was	_	VERB	VBD	_	14	auxpass	_	_
14	studied	_	VERB	VBN	_	2	acl:relcl	_	_
15	in	_	ADP	IN	_	16	case	_	_
16	subjects	_	NOUN	NNS	_	14	nmod	_	_
17	with	_	ADP	IN	_	21	case	_	_
18	mild	_	ADJ	JJ	_	21	amod	_	_
19	Child	_	NOUN	NN	_	21	compound	_	_
20	Pugh	_	NOUN	NN	_	21	compound	_	_
21	A	_	NOUN	NN	_	16	nmod	_	_
22	,	_	.	,	_	21	punct	_	_
23	n	_	NOUN	NN	_	24	nsubj	_	_
24	=	_	ADJ	JJ	_	21	conj	_	_
25	8	_	NUM	CD	_	24	dobj	_	_
26	,	_	.	,	_	21	punct	_	_
27	moderate	_	ADJ	JJ	_	30	amod	_	_
28	Child	_	NOUN	NN	_	30	compound	_	_
29	Pugh	_	NOUN	NN	_	30	compound	_	_
30	B	_	NOUN	NN	_	21	conj	_	_
31	,	_	.	,	_	21	punct	_	_
32	n	_	NOUN	NN	_	33	nsubj	_	_
33	=	_	ADJ	JJ	_	21	conj	_	_
34	8	_	NUM	CD	_	33	dobj	_	_
35	,	_	.	,	_	21	punct	_	_
36	and	_	CONJ	CC	_	21	cc	_	_
37	severe	_	ADJ	JJ	_	40	amod	_	_
38	Child	_	NOUN	NN	_	40	compound	_	_
39	Pugh	_	NOUN	NN	_	40	compound	_	_
40	C	_	NOUN	NN	_	21	conj	_	_
41	,	_	.	,	_	2	punct	_	_
42	n	_	NOUN	NN	_	43	nsubj	_	_
43	=	_	ADJ	JJ	_	2	dep	_	_
44	8	_	NUM	CD	_	46	nummod	_	_
45	hepatic	_	ADJ	JJ	_	46	amod	_	_
46	impairment	_	NOUN	NN	_	43	dobj	_	_
47	and	_	CONJ	CC	_	43	cc	_	_
48	to	_	PRT	TO	_	50	case	_	_
49	healthy	_	ADJ	JJ	_	50	amod	_	_
50	subjects	_	NOUN	NNS	_	43	conj	_	_
51	n	_	NOUN	NN	_	50	nmod	_	_
52	=	_	DET	DT	_	53	det	_	_
53	12	_	NUM	CD	_	51	nmod	_	_

#	Pristiq	792
1	Average	_	ADJ	JJ	_	2	amod	_	_
2	AUC	_	NOUN	NN	_	4	nsubjpass	_	_
3	was	_	VERB	VBD	_	4	auxpass	_	_
4	increased	_	VERB	VBN	_	0	root	_	_
5	by	_	ADP	IN	_	7	case	_	_
6	approximately	_	ADV	RB	_	7	advmod	_	_
7	31%	_	NOUN	NN	_	4	nmod	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	35%	_	NOUN	NN	_	7	conj	_	_
10	in	_	ADP	IN	_	11	case	_	_
11	patients	_	NOUN	NNS	_	4	nmod	_	_
12	with	_	ADP	IN	_	17	case	_	_
13	moderate	_	ADJ	JJ	_	17	amod	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	severe	_	ADJ	JJ	_	13	conj	_	_
16	hepatic	_	ADJ	JJ	_	17	amod	_	_
17	impairment	_	NOUN	NN	_	11	nmod	_	_
18	,	_	.	,	_	4	punct	_	_
19	respectively	_	ADV	RB	_	4	advmod	_	_
20	,	_	.	,	_	4	punct	_	_
21	as	_	ADP	IN	_	22	mark	_	_
22	compared	_	VERB	VBN	_	4	advcl	_	_
23	to	_	PRT	TO	_	25	case	_	_
24	healthy	_	ADJ	JJ	_	25	amod	_	_
25	subjects	_	NOUN	NNS	_	22	nmod	_	_

#	Pristiq	793
1	Average	_	ADJ	JJ	_	3	amod	_	_
2	AUC	_	NOUN	NN	_	3	compound	_	_
3	values	_	NOUN	NNS	_	5	nsubj	_	_
4	were	_	VERB	VBD	_	5	cop	_	_
5	similar	_	ADJ	JJ	_	0	root	_	_
6	in	_	ADP	IN	_	7	case	_	_
7	subjects	_	NOUN	NNS	_	5	nmod	_	_
8	with	_	ADP	IN	_	11	case	_	_
9	mild	_	ADJ	JJ	_	11	amod	_	_
10	hepatic	_	ADJ	JJ	_	11	amod	_	_
11	impairment	_	NOUN	NN	_	7	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	healthy	_	ADJ	JJ	_	17	amod	_	_
14	subjects	_	NOUN	NNS	_	17	compound	_	_
15	<	_	NUM	CD	_	17	nummod	_	_
16	5%	_	ADJ	JJ	_	17	amod	_	_
17	difference	_	NOUN	NN	_	11	conj	_	_

#	Pristiq	794
1	Systemic	_	ADJ	JJ	_	5	amod	_	_
2	clearance	_	NOUN	NN	_	5	compound	_	_
3	CL	_	NOUN	NN	_	5	compound	_	_
4	/	_	.	:	_	5	punct	_	_
5	F	_	NOUN	NN	_	7	nsubjpass	_	_
6	was	_	VERB	VBD	_	7	auxpass	_	_
7	decreased	_	VERB	VBN	_	0	root	_	_
8	by	_	ADP	IN	_	10	case	_	_
9	approximately	_	ADV	RB	_	10	advmod	_	_
10	20%	_	ADJ	JJ	_	7	nmod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	36%	_	NOUN	NN	_	10	conj	_	_
13	in	_	ADP	IN	_	14	case	_	_
14	patients	_	NOUN	NNS	_	7	nmod	_	_
15	with	_	ADP	IN	_	20	case	_	_
16	moderate	_	ADJ	JJ	_	20	amod	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	severe	_	ADJ	JJ	_	16	conj	_	_
19	hepatic	_	ADJ	JJ	_	20	amod	_	_
20	impairment	_	NOUN	NN	_	14	nmod	_	_
21	,	_	.	,	_	7	punct	_	_
22	respectively	_	ADV	RB	_	7	advmod	_	_
23	,	_	.	,	_	7	punct	_	_
24	as	_	ADP	IN	_	25	mark	_	_
25	compared	_	VERB	VBN	_	7	advcl	_	_
26	to	_	PRT	TO	_	28	case	_	_
27	healthy	_	ADJ	JJ	_	28	amod	_	_
28	subjects	_	NOUN	NNS	_	25	nmod	_	_

#	Pristiq	795
1	CL	_	NOUN	NN	_	4	compound	_	_
2	/	_	.	:	_	1	punct	_	_
3	F	_	NOUN	NN	_	4	compound	_	_
4	values	_	NOUN	NNS	_	6	nsubj	_	_
5	were	_	VERB	VBD	_	6	cop	_	_
6	comparable	_	ADJ	JJ	_	0	root	_	_
7	in	_	ADP	IN	_	10	case	_	_
8	mild	_	ADJ	JJ	_	10	amod	_	_
9	hepatic	_	ADJ	JJ	_	10	amod	_	_
10	impairment	_	NOUN	NN	_	6	nmod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	healthy	_	ADJ	JJ	_	16	amod	_	_
13	subjects	_	NOUN	NNS	_	16	compound	_	_
14	<	_	NUM	CD	_	16	nummod	_	_
15	5%	_	ADJ	JJ	_	16	amod	_	_
16	difference	_	NOUN	NN	_	10	conj	_	_

#	Pristiq	796
1	The	_	DET	DT	_	2	det	_	_
2	mean	_	NOUN	NN	_	6	nsubj	_	_
3	t1	_	NUM	CD	_	2	nummod	_	_
4	/	_	NOUN	NN	_	2	punct	_	_
5	2	_	NUM	CD	_	2	nummod	_	_
6	changed	_	VERB	VBN	_	0	root	_	_
7	from	_	ADP	IN	_	10	case	_	_
8	approximately	_	ADV	RB	_	9	advmod	_	_
9	10	_	NUM	CD	_	10	nummod	_	_
10	hours	_	NOUN	NNS	_	6	nmod	_	_
11	in	_	ADP	IN	_	13	case	_	_
12	healthy	_	ADJ	JJ	_	13	amod	_	_
13	subjects	_	NOUN	NNS	_	10	nmod	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	subjects	_	NOUN	NNS	_	13	conj	_	_
16	with	_	ADP	IN	_	19	case	_	_
17	mild	_	ADJ	JJ	_	19	amod	_	_
18	hepatic	_	ADJ	JJ	_	19	amod	_	_
19	impairment	_	NOUN	NN	_	13	nmod	_	_
20	to	_	PRT	TO	_	24	case	_	_
21	13	_	NUM	CD	_	24	nummod	_	_
22	and	_	CONJ	CC	_	21	cc	_	_
23	14	_	NUM	CD	_	21	conj	_	_
24	hours	_	NOUN	NNS	_	19	nmod	_	_
25	in	_	ADP	IN	_	30	case	_	_
26	moderate	_	ADJ	JJ	_	30	amod	_	_
27	and	_	CONJ	CC	_	26	cc	_	_
28	severe	_	ADJ	JJ	_	26	conj	_	_
29	hepatic	_	ADJ	JJ	_	30	amod	_	_
30	impairment	_	NOUN	NN	_	19	nmod	_	_
31	,	_	.	,	_	6	punct	_	_
32	respectively	_	ADV	RB	_	6	advmod	_	_

#	Pristiq	797
1	The	_	DET	DT	_	3	det	_	_
2	recommended	_	VERB	VBN	_	3	amod	_	_
3	dose	_	NOUN	NN	_	11	nsubj	_	_
4	in	_	ADP	IN	_	5	case	_	_
5	patients	_	NOUN	NNS	_	3	nmod	_	_
6	with	_	ADP	IN	_	8	case	_	_
7	hepatic	_	ADJ	JJ	_	8	amod	_	_
8	impairment	_	NOUN	NN	_	5	nmod	_	_
9	is	_	VERB	VBZ	_	11	cop	_	_
10	50	_	NUM	CD	_	11	nummod	_	_
11	mg	_	NOUN	NN	_	0	root	_	_
12	per	_	ADP	IN	_	13	case	_	_
13	day	_	NOUN	NN	_	11	nmod	_	_

#	Pristiq	798
1	Dose	_	NOUN	NN	_	2	compound	_	_
2	escalation	_	NOUN	NN	_	10	nsubjpass	_	_
3	above	_	ADP	IN	_	5	case	_	_
4	100	_	NUM	CD	_	5	nummod	_	_
5	mg	_	NOUN	NN	_	2	nmod	_	_
6	per	_	ADP	IN	_	7	case	_	_
7	day	_	NOUN	NN	_	2	nmod	_	_
8	is	_	VERB	VBZ	_	10	auxpass	_	_
9	not	_	ADV	RB	_	10	neg	_	_
10	recommended	_	VERB	VBN	_	0	root	_	_

#	Pristiq	799
1	Renal	_	ADJ	JJ	_	2	amod	_	_
2	insufficiency	_	NOUN	NN	_	13	nsubjpass	_	_
3	The	_	DET	DT	_	4	det	_	_
4	disposition	_	NOUN	NN	_	2	dep	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	after	_	ADP	IN	_	8	case	_	_
8	administration	_	NOUN	NN	_	4	nmod	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	100	_	NUM	CD	_	11	nummod	_	_
11	mg	_	NOUN	NN	_	8	nmod	_	_
12	was	_	VERB	VBD	_	13	auxpass	_	_
13	studied	_	VERB	VBN	_	0	root	_	_
14	in	_	ADP	IN	_	15	case	_	_
15	subjects	_	NOUN	NNS	_	13	nmod	_	_
16	with	_	ADP	IN	_	18	case	_	_
17	mild	_	ADJ	JJ	_	18	amod	_	_
18	n	_	NOUN	NN	_	15	nmod	_	_
19	=	_	ADJ	JJ	_	18	amod	_	_
20	9	_	NUM	CD	_	19	dep	_	_
21	,	_	.	,	_	15	punct	_	_
22	moderate	_	ADJ	JJ	_	23	amod	_	_
23	n	_	NOUN	NN	_	15	conj	_	_
24	=	_	ADJ	JJ	_	23	amod	_	_
25	8	_	NUM	CD	_	24	dep	_	_
26	,	_	.	,	_	15	punct	_	_
27	severe	_	ADJ	JJ	_	28	amod	_	_
28	n	_	NOUN	NN	_	15	conj	_	_
29	=	_	ADJ	JJ	_	28	amod	_	_
30	7	_	NUM	CD	_	29	dep	_	_
31	and	_	CONJ	CC	_	29	cc	_	_
32	end	_	NOUN	NN	_	36	compound	_	_
33	stage	_	NOUN	NN	_	36	compound	_	_
34	renal	_	ADJ	JJ	_	36	amod	_	_
35	disease	_	NOUN	NN	_	36	compound	_	_
36	ESRD	_	NOUN	NN	_	29	conj	_	_
37	n	_	NOUN	NN	_	36	dep	_	_
38	=	_	ADJ	JJ	_	37	amod	_	_
39	9	_	NUM	CD	_	41	nummod	_	_
40	requiring	_	VERB	VBG	_	41	amod	_	_
41	dialysis	_	NOUN	NN	_	38	dobj	_	_
42	and	_	CONJ	CC	_	15	cc	_	_
43	in	_	ADP	IN	_	44	case	_	_
44	healthy	_	ADJ	JJ	_	15	conj	_	_
45	,	_	.	,	_	13	punct	_	_
46	age	_	NOUN	NN	_	47	nsubj	_	_
47	matched	_	VERB	VBN	_	13	parataxis	_	_
48	control	_	NOUN	NN	_	49	compound	_	_
49	subjects	_	NOUN	NNS	_	47	dobj	_	_
50	n	_	NOUN	NN	_	49	dep	_	_
51	=	_	DET	DT	_	52	det	_	_
52	8	_	NUM	CD	_	50	nmod	_	_

#	Pristiq	800
1	Elimination	_	NOUN	NN	_	4	nsubjpass	_	_
2	was	_	VERB	VBD	_	4	auxpass	_	_
3	significantly	_	ADV	RB	_	4	advmod	_	_
4	correlated	_	VERB	VBN	_	0	root	_	_
5	with	_	ADP	IN	_	7	case	_	_
6	creatinine	_	NOUN	NN	_	7	compound	_	_
7	clearance	_	NOUN	NN	_	4	nmod	_	_

#	Pristiq	801
1	Increases	_	NOUN	NNS	_	0	root	_	_
2	in	_	ADP	IN	_	3	case	_	_
3	AUCs	_	NOUN	NNS	_	1	nmod	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	about	_	ADV	RB	_	6	advmod	_	_
6	42%	_	NOUN	NN	_	3	nmod	_	_
7	in	_	ADP	IN	_	13	case	_	_
8	mild	_	ADJ	JJ	_	13	amod	_	_
9	renal	_	ADJ	JJ	_	13	amod	_	_
10	impairment	_	NOUN	NN	_	13	compound	_	_
11	24	_	NUM	CD	_	13	nummod	_	_
12	hr	_	NOUN	NN	_	13	compound	_	_
13	CrCl	_	NOUN	NN	_	3	nmod	_	_
14	=	_	ADJ	JJ	_	13	acl	_	_
15	50	_	NUM	CD	_	17	compound	_	_
16	to	_	PRT	TO	_	17	dep	_	_
17	80	_	NUM	CD	_	18	nummod	_	_
18	mL	_	NOUN	NN	_	14	nmod	_	_
19	/	_	.	:	_	18	punct	_	_
20	min	_	NOUN	NN	_	18	dep	_	_
21	,	_	.	,	_	18	punct	_	_
22	Cockcroft	_	NOUN	NN	_	25	compound	_	_
23	Gault	_	NOUN	NN	_	25	compound	_	_
24	C	_	NOUN	NN	_	25	compound	_	_
25	DRUGS	_	NOUN	NN	_	18	appos	_	_
26	,	_	.	,	_	18	punct	_	_
27	about	_	ADV	RB	_	28	advmod	_	_
28	56%	_	NOUN	NN	_	18	nmod	_	_
29	in	_	ADP	IN	_	35	case	_	_
30	moderate	_	ADJ	JJ	_	35	amod	_	_
31	renal	_	ADJ	JJ	_	35	amod	_	_
32	impairment	_	NOUN	NN	_	35	compound	_	_
33	24	_	NUM	CD	_	35	nummod	_	_
34	hr	_	NOUN	NN	_	35	compound	_	_
35	CrCl	_	NOUN	NN	_	28	nmod	_	_
36	=	_	ADJ	JJ	_	35	amod	_	_
37	30	_	NUM	CD	_	39	compound	_	_
38	to	_	PRT	TO	_	39	dep	_	_
39	50	_	NUM	CD	_	40	nummod	_	_
40	mL	_	NOUN	NN	_	36	nmod	_	_
41	/	_	.	:	_	40	punct	_	_
42	min	_	NOUN	NN	_	40	dep	_	_
43	,	_	.	,	_	40	punct	_	_
44	C	_	NOUN	NN	_	45	compound	_	_
45	DRUGS	_	NOUN	NN	_	40	appos	_	_
46	,	_	.	,	_	40	punct	_	_
47	about	_	ADV	RB	_	48	advmod	_	_
48	108%	_	NOUN	NN	_	40	conj	_	_
49	in	_	ADP	IN	_	57	case	_	_
50	severe	_	ADJ	JJ	_	57	amod	_	_
51	renal	_	ADJ	JJ	_	57	amod	_	_
52	impairment	_	NOUN	NN	_	57	compound	_	_
53	24	_	NUM	CD	_	57	nummod	_	_
54	hr	_	NOUN	NN	_	57	compound	_	_
55	CrCl	_	NOUN	NN	_	57	compound	_	_
56	<30	_	NUM	CD	_	57	nummod	_	_
57	mL	_	NOUN	NN	_	48	nmod	_	_
58	/	_	.	:	_	40	punct	_	_
59	min	_	NOUN	NN	_	71	nsubjpass	_	_
60	,	_	.	,	_	59	punct	_	_
61	C	_	NOUN	NN	_	62	compound	_	_
62	DRUGS	_	NOUN	NN	_	59	conj	_	_
63	,	_	.	,	_	59	punct	_	_
64	and	_	CONJ	CC	_	59	cc	_	_
65	about	_	ADV	RB	_	66	advmod	_	_
66	116%	_	NOUN	NN	_	59	conj	_	_
67	in	_	ADP	IN	_	69	case	_	_
68	ESRD	_	NOUN	NN	_	69	compound	_	_
69	subjects	_	NOUN	NNS	_	66	nmod	_	_
70	were	_	VERB	VBD	_	71	auxpass	_	_
71	observed	_	VERB	VBN	_	40	dep	_	_
72	,	_	.	,	_	71	punct	_	_
73	compared	_	VERB	VBN	_	71	xcomp	_	_
74	with	_	ADP	IN	_	80	case	_	_
75	healthy	_	ADJ	JJ	_	80	amod	_	_
76	,	_	.	,	_	75	punct	_	_
77	age	_	NOUN	NN	_	75	dep	_	_
78	matched	_	ADJ	JJ	_	80	amod	_	_
79	control	_	NOUN	NN	_	80	compound	_	_
80	subjects	_	NOUN	NNS	_	73	nmod	_	_

#	Pristiq	802
1	The	_	DET	DT	_	5	det	_	_
2	mean	_	ADJ	JJ	_	5	compound	_	_
3	terminal	_	ADJ	JJ	_	5	amod	_	_
4	half	_	NOUN	NN	_	5	compound	_	_
5	life	_	NOUN	NN	_	10	nsubjpass	_	_
6	t1	_	NUM	CD	_	5	nummod	_	_
7	/	_	.	:	_	5	punct	_	_
8	2	_	NUM	CD	_	5	nummod	_	_
9	was	_	VERB	VBD	_	10	auxpass	_	_
10	prolonged	_	VERB	VBN	_	0	root	_	_
11	from	_	ADP	IN	_	13	case	_	_
12	11.1	_	NUM	CD	_	13	nummod	_	_
13	hours	_	NOUN	NNS	_	10	nmod	_	_
14	in	_	ADP	IN	_	17	case	_	_
15	the	_	DET	DT	_	17	det	_	_
16	control	_	ADJ	JJ	_	17	amod	_	_
17	subjects	_	NOUN	NNS	_	13	nmod	_	_
18	to	_	PRT	TO	_	20	case	_	_
19	approximately	_	ADV	RB	_	20	advmod	_	_
20	13.5	_	NUM	CD	_	28	nummod	_	_
21	,	_	.	,	_	20	punct	_	_
22	15.5	_	NUM	CD	_	20	conj	_	_
23	,	_	.	,	_	20	punct	_	_
24	17.6	_	NUM	CD	_	20	conj	_	_
25	,	_	.	,	_	20	punct	_	_
26	and	_	CONJ	CC	_	20	cc	_	_
27	22.8	_	NUM	CD	_	20	conj	_	_
28	hours	_	NOUN	NNS	_	13	nmod	_	_
29	in	_	ADP	IN	_	36	case	_	_
30	mild	_	ADJ	JJ	_	36	amod	_	_
31	,	_	.	,	_	30	punct	_	_
32	moderate	_	ADJ	JJ	_	30	conj	_	_
33	,	_	.	,	_	30	punct	_	_
34	severe	_	ADJ	JJ	_	30	dep	_	_
35	renal	_	ADJ	JJ	_	36	amod	_	_
36	impairment	_	NOUN	NN	_	13	nmod	_	_
37	and	_	CONJ	CC	_	36	cc	_	_
38	ESRD	_	NOUN	NN	_	39	compound	_	_
39	subjects	_	NOUN	NNS	_	36	conj	_	_
40	,	_	.	,	_	10	punct	_	_
41	respectively	_	ADV	RB	_	10	advmod	_	_

#	Pristiq	803
1	Less	_	ADV	RB	_	3	case	_	_
2	than	_	ADP	IN	_	1	mwe	_	_
3	5%	_	NOUN	NN	_	11	nsubjpass	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	the	_	DET	DT	_	6	det	_	_
6	drug	_	NOUN	NN	_	3	nmod	_	_
7	in	_	ADP	IN	_	9	case	_	_
8	the	_	DET	DT	_	9	det	_	_
9	body	_	NOUN	NN	_	6	nmod	_	_
10	was	_	VERB	VBD	_	11	auxpass	_	_
11	cleared	_	VERB	VBN	_	0	root	_	_
12	during	_	ADP	IN	_	18	case	_	_
13	a	_	DET	DT	_	18	det	_	_
14	standard	_	ADJ	JJ	_	18	amod	_	_
15	4	_	NUM	CD	_	18	nummod	_	_
16	hour	_	NUM	CD	_	18	nummod	_	_
17	hemodialysis	_	NOUN	NN	_	18	compound	_	_
18	procedure	_	NOUN	NN	_	11	nmod	_	_

#	Pristiq	804
1	The	_	DET	DT	_	4	det	_	_
2	maximum	_	NOUN	NN	_	4	compound	_	_
3	recommended	_	ADJ	JJ	_	4	amod	_	_
4	dose	_	NOUN	NN	_	13	nsubj	_	_
5	in	_	ADP	IN	_	6	case	_	_
6	patients	_	NOUN	NNS	_	4	nmod	_	_
7	with	_	ADP	IN	_	10	case	_	_
8	moderate	_	ADJ	JJ	_	10	amod	_	_
9	renal	_	ADJ	JJ	_	10	amod	_	_
10	impairment	_	NOUN	NN	_	6	nmod	_	_
11	is	_	VERB	VBZ	_	13	cop	_	_
12	50	_	NUM	CD	_	13	nummod	_	_
13	mg	_	NOUN	NN	_	0	root	_	_
14	per	_	ADP	IN	_	15	case	_	_
15	day	_	NOUN	NN	_	13	nmod	_	_

#	Pristiq	805
1	Dosage	_	NOUN	NN	_	2	compound	_	_
2	adjustment	_	NOUN	NN	_	10	nsubjpass	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	50	_	NUM	CD	_	5	nummod	_	_
5	mg	_	NOUN	NN	_	2	nmod	_	_
6	every	_	ADV	RB	_	7	advmod	_	_
7	other	_	ADJ	JJ	_	8	amod	_	_
8	day	_	NOUN	NN	_	2	nmod	_	_
9	is	_	VERB	VBZ	_	10	auxpass	_	_
10	recommended	_	VERB	VBN	_	0	root	_	_
11	in	_	ADP	IN	_	12	case	_	_
12	patients	_	NOUN	NNS	_	10	nmod	_	_
13	with	_	ADP	IN	_	16	case	_	_
14	severe	_	ADJ	JJ	_	16	amod	_	_
15	renal	_	ADJ	JJ	_	16	amod	_	_
16	impairment	_	NOUN	NN	_	12	nmod	_	_
17	or	_	CONJ	CC	_	16	cc	_	_
18	ESRD	_	NOUN	NN	_	16	conj	_	_

#	Protriptyline Hydrochloride	903
1	DRUG	_	NOUN	NN	_	5	nsubj	_	_
2	is	_	VERB	VBZ	_	5	cop	_	_
3	an	_	DET	DT	_	5	det	_	_
4	antidepressant	_	ADJ	JJ	_	5	amod	_	_
5	agent	_	NOUN	NN	_	0	root	_	_

#	Protriptyline Hydrochloride	904
1	The	_	DET	DT	_	2	det	_	_
2	mechanism	_	NOUN	NN	_	0	root	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	its	_	PRON	PRP$	_	6	nmod:poss	_	_
5	antidepressant	_	ADJ	JJ	_	6	amod	_	_
6	action	_	NOUN	NN	_	2	nmod	_	_
7	in	_	ADP	IN	_	8	case	_	_
8	man	_	VERB	MD	_	11	aux	_	_
9	is	_	VERB	VB	_	11	auxpass	_	_
10	not	_	ADV	RB	_	11	neg	_	_
11	known	_	VERB	VBN	_	6	acl:relcl	_	_

#	Protriptyline Hydrochloride	905
1	It	_	PRON	PRP	_	7	nsubj	_	_
2	is	_	VERB	VBZ	_	7	cop	_	_
3	not	_	ADV	RB	_	7	neg	_	_
4	a	_	DET	DT	_	7	det	_	_
5	monoamine	_	NOUN	NN	_	7	compound	_	_
6	oxidase	_	NOUN	NN	_	7	compound	_	_
7	inhibitor	_	NOUN	NN	_	0	root	_	_
8	,	_	.	,	_	7	punct	_	_
9	and	_	CONJ	CC	_	7	cc	_	_
10	it	_	PRON	PRP	_	13	nsubj	_	_
11	does	_	VERB	VBZ	_	13	aux	_	_
12	not	_	ADV	RB	_	13	neg	_	_
13	act	_	VERB	VB	_	7	conj	_	_
14	primarily	_	ADV	RB	_	13	advmod	_	_
15	by	_	ADP	IN	_	16	case	_	_
16	stimulation	_	NOUN	NN	_	13	nmod	_	_
17	of	_	ADP	IN	_	21	case	_	_
18	the	_	DET	DT	_	21	det	_	_
19	central	_	ADJ	JJ	_	21	amod	_	_
20	nervous	_	ADJ	JJ	_	21	amod	_	_
21	system	_	NOUN	NN	_	16	nmod	_	_

#	Protriptyline Hydrochloride	906
1	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
2	has	_	VERB	VBZ	_	4	aux	_	_
3	been	_	VERB	VBN	_	4	auxpass	_	_
4	found	_	VERB	VBN	_	0	root	_	_
5	in	_	ADP	IN	_	7	case	_	_
6	some	_	DET	DT	_	7	det	_	_
7	studies	_	NOUN	NNS	_	4	nmod	_	_
8	to	_	PRT	TO	_	9	mark	_	_
9	have	_	VERB	VB	_	4	xcomp	_	_
10	a	_	DET	DT	_	13	det	_	_
11	more	_	ADV	RB	_	12	advmod	_	_
12	rapid	_	ADJ	JJ	_	13	amod	_	_
13	onset	_	NOUN	NN	_	9	dobj	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	action	_	NOUN	NN	_	13	nmod	_	_
16	than	_	ADP	IN	_	17	case	_	_
17	imipramine	_	NOUN	NN	_	13	nmod	_	_
18	or	_	CONJ	CC	_	17	cc	_	_
19	amitriptyline	_	NOUN	NN	_	17	conj	_	_

#	Protriptyline Hydrochloride	907
1	The	_	DET	DT	_	4	det	_	_
2	initial	_	ADJ	JJ	_	4	amod	_	_
3	clinical	_	ADJ	JJ	_	4	amod	_	_
4	effect	_	NOUN	NN	_	6	nsubj	_	_
5	may	_	VERB	MD	_	6	aux	_	_
6	occur	_	VERB	VB	_	0	root	_	_
7	within	_	ADP	IN	_	9	case	_	_
8	one	_	NUM	CD	_	9	nummod	_	_
9	week	_	NOUN	NN	_	6	nmod	_	_

#	Protriptyline Hydrochloride	908
1	Sedative	_	ADJ	JJ	_	4	amod	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	tranquilizing	_	VERB	VBG	_	1	conj	_	_
4	properties	_	NOUN	NNS	_	6	nsubj	_	_
5	are	_	VERB	VBP	_	6	auxpass	_	_
6	lacking	_	VERB	VBG	_	0	root	_	_

#	Prozac	3721
1	As	_	ADP	IN	_	4	case	_	_
2	with	_	ADP	IN	_	4	case	_	_
3	all	_	DET	DT	_	4	det	_	_
4	drugs	_	NOUN	NNS	_	0	root	_	_
5	,	_	.	,	_	4	punct	_	_
6	the	_	DET	DT	_	7	det	_	_
7	potential	_	NOUN	NN	_	5	root	_	_
8	for	_	ADP	IN	_	9	case	_	_
9	interaction	_	NOUN	NN	_	7	nmod	_	_
10	by	_	ADP	IN	_	12	case	_	_
11	a	_	DET	DT	_	12	det	_	_
12	variety	_	NOUN	NN	_	7	nmod	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	mechanisms	_	NOUN	NNS	_	12	nmod	_	_
15	e.g	_	NOUN	NN	_	25	compound	_	_
16	,	_	.	,	_	15	punct	_	_
17	pharmacodynamic	_	ADJ	JJ	_	15	conj	_	_
18	,	_	.	,	_	15	punct	_	_
19	pharmacokinetic	_	ADJ	JJ	_	20	amod	_	_
20	drug	_	NOUN	NN	_	15	appos	_	_
21	inhibition	_	NOUN	NN	_	20	dep	_	_
22	or	_	CONJ	CC	_	21	cc	_	_
23	enhancement	_	NOUN	NN	_	21	conj	_	_
24	,	_	.	,	_	15	punct	_	_
25	etc	_	NOUN	NN	_	14	dep	_	_

#	Prozac	3722
1	Monoamine	_	NOUN	NN	_	3	compound	_	_
2	Oxidase	_	NOUN	NN	_	3	compound	_	_
3	Inhibitors	_	NOUN	NNS	_	0	root	_	_
4	MAOIs	_	NOUN	NNS	_	3	dep	_	_
5	:	_	.	:	_	3	punct	_	_
6	2.9	_	NUM	CD	_	3	dep	_	_
7	,	_	.	,	_	6	punct	_	_
8	2.10	_	NUM	CD	_	6	conj	_	_
9	,	_	.	,	_	6	punct	_	_
10	4.1	_	NUM	CD	_	6	conj	_	_
11	,	_	.	,	_	6	punct	_	_
12	5.2	_	NUM	CD	_	13	nummod	_	_
13	Drugs	_	NOUN	NNS	_	6	appos	_	_
14	Metabolized	_	VERB	VBN	_	13	acl	_	_
15	by	_	ADP	IN	_	16	case	_	_
16	CYP2D6	_	NOUN	NN	_	14	nmod	_	_
17	:	_	.	:	_	3	punct	_	_
18	DRUG	_	NOUN	NN	_	22	nsubj	_	_
19	is	_	VERB	VBZ	_	22	cop	_	_
20	a	_	DET	DT	_	22	det	_	_
21	potent	_	ADJ	JJ	_	22	amod	_	_
22	inhibitor	_	NOUN	NN	_	3	dep	_	_
23	of	_	ADP	IN	_	29	case	_	_
24	CYP2D6	_	NOUN	NN	_	29	compound	_	_
25	enzyme	_	NOUN	NN	_	29	compound	_	_
26	pathway	_	NOUN	NN	_	29	compound	_	_
27	7.7	_	NUM	CD	_	29	nummod	_	_
28	Tricyclic	_	ADJ	JJ	_	29	amod	_	_
29	Antidepressants	_	NOUN	NNS	_	22	nmod	_	_
30	TCAs	_	NOUN	NNS	_	29	dep	_	_
31	:	_	.	:	_	3	punct	_	_
32	Monitor	_	VERB	VBP	_	3	dep	_	_
33	TCA	_	NOUN	NN	_	34	compound	_	_
34	levels	_	NOUN	NNS	_	32	dobj	_	_
35	during	_	ADP	IN	_	36	case	_	_
36	coadministration	_	NOUN	NN	_	32	nmod	_	_
37	with	_	ADP	IN	_	38	case	_	_
38	DRUG	_	NOUN	NN	_	36	nmod	_	_
39	or	_	CONJ	CC	_	32	cc	_	_
40	when	_	ADV	RB	_	45	advmod	_	_
41	DRUG	_	NOUN	NN	_	45	nsubjpass	_	_
42	has	_	VERB	VBZ	_	45	aux	_	_
43	been	_	VERB	VBN	_	45	auxpass	_	_
44	recently	_	ADV	RB	_	45	advmod	_	_
45	discontinued	_	VERB	VBN	_	32	conj	_	_
46	5.2	_	NUM	CD	_	45	dobj	_	_
47	,	_	.	,	_	46	punct	_	_
48	7.7	_	NUM	CD	_	51	nummod	_	_
49	CNS	_	NOUN	NN	_	51	compound	_	_
50	Acting	_	ADJ	JJ	_	51	amod	_	_
51	Drugs	_	NOUN	NNS	_	46	appos	_	_
52	:	_	.	:	_	3	punct	_	_
53	Caution	_	NOUN	NN	_	56	nsubjpass	_	_
54	should	_	VERB	MD	_	56	aux	_	_
55	be	_	VERB	VB	_	56	auxpass	_	_
56	used	_	VERB	VBN	_	3	dep	_	_
57	when	_	ADV	WRB	_	58	advmod	_	_
58	taken	_	VERB	VBN	_	56	advcl	_	_
59	in	_	ADP	IN	_	60	case	_	_
60	combination	_	NOUN	NN	_	58	nmod	_	_
61	with	_	ADP	IN	_	65	case	_	_
62	other	_	ADJ	JJ	_	65	amod	_	_
63	centrally	_	ADV	RB	_	64	advmod	_	_
64	acting	_	VERB	VBG	_	65	amod	_	_
65	drugs	_	NOUN	NNS	_	60	nmod	_	_
66	7.2	_	NUM	CD	_	67	nummod	_	_
67	Benzodiazepines	_	NOUN	NNS	_	65	dep	_	_
68	:	_	.	:	_	3	punct	_	_
69	Diazepam	_	NOUN	NN	_	70	nsubj	_	_
70	increased	_	VERB	VBD	_	3	dep	_	_
71	t%	_	ADV	RB	_	70	advmod	_	_
72	,	_	.	,	_	70	punct	_	_
73	alprazolam	_	NOUN	NN	_	77	compound	_	_
74	further	_	ADJ	JJ	_	77	amod	_	_
75	psychomotor	_	NOUN	NN	_	77	compound	_	_
76	performance	_	NOUN	NN	_	77	compound	_	_
77	decrement	_	NOUN	NN	_	70	dobj	_	_
78	due	_	ADJ	JJ	_	81	case	_	_
79	to	_	PRT	TO	_	78	mwe	_	_
80	increased	_	VERB	VBN	_	81	amod	_	_
81	levels	_	NOUN	NNS	_	77	nmod	_	_
82	7.7	_	NUM	CD	_	83	nummod	_	_
83	Antipsychotics	_	NOUN	NNS	_	81	dep	_	_
84	:	_	.	:	_	70	punct	_	_
85	Potential	_	ADJ	JJ	_	70	dep	_	_
86	for	_	ADP	IN	_	87	case	_	_
87	elevation	_	NOUN	NN	_	85	nmod	_	_
88	of	_	ADP	IN	_	89	case	_	_
89	haloperidol	_	NOUN	NN	_	87	nmod	_	_
90	and	_	CONJ	CC	_	89	cc	_	_
91	clozapine	_	NOUN	NN	_	89	conj	_	_
92	levels	_	NOUN	NNS	_	89	dep	_	_
93	7.7	_	NUM	CD	_	94	nummod	_	_
94	Anticonvulsants	_	NOUN	NNS	_	92	dep	_	_
95	:	_	.	:	_	70	punct	_	_
96	Potential	_	ADJ	JJ	_	70	dep	_	_
97	for	_	ADP	IN	_	99	case	_	_
98	elevated	_	ADJ	JJ	_	99	amod	_	_
99	phenytoin	_	NOUN	NN	_	96	nmod	_	_
100	and	_	CONJ	CC	_	99	cc	_	_
101	carbamazepine	_	NOUN	NN	_	99	conj	_	_
102	levels	_	NOUN	NNS	_	99	dep	_	_
103	and	_	CONJ	CC	_	99	cc	_	_
104	clinical	_	ADJ	JJ	_	109	amod	_	_
105	anticonvulsant	_	ADJ	JJ	_	109	amod	_	_
106	toxicity	_	NOUN	NN	_	109	compound	_	_
107	7.7	_	NUM	CD	_	109	nummod	_	_
108	Serotonergic	_	ADJ	JJ	_	109	amod	_	_
109	Drugs	_	NOUN	NNS	_	99	conj	_	_
110	:	_	.	:	_	70	punct	_	_
111	2.9	_	NUM	CD	_	70	dep	_	_
112	,	_	.	,	_	111	punct	_	_
113	2.10	_	NUM	CD	_	111	conj	_	_
114	,	_	.	,	_	111	punct	_	_
115	4.1	_	NUM	CD	_	111	conj	_	_
116	,	_	.	,	_	111	punct	_	_
117	5.2	_	NUM	CD	_	118	nummod	_	_
118	Drugs	_	NOUN	NNS	_	111	dep	_	_
119	that	_	DET	WDT	_	120	nsubj	_	_
120	Interfere	_	VERB	VBP	_	118	acl:relcl	_	_
121	with	_	ADP	IN	_	122	case	_	_
122	Hemostasis(e.g	_	NOUN	NN	_	120	nmod	_	_

#	Prozac	3723
1	NSAIDs	_	NOUN	NNS	_	0	root	_	_
2	,	_	.	,	_	1	punct	_	_
3	Aspirin	_	NOUN	NN	_	1	appos	_	_
4	,	_	.	,	_	1	punct	_	_
5	Warfarin	_	NOUN	NN	_	1	appos	_	_
6	:	_	.	:	_	1	punct	_	_
7	May	_	NOUN	NN	_	8	nsubj	_	_
8	potentiate	_	VERB	VBP	_	1	dep	_	_
9	the	_	DET	DT	_	10	det	_	_
10	risk	_	NOUN	NN	_	8	dobj	_	_
11	of	_	ADP	IN	_	12	mark	_	_
12	bleeding	_	VERB	VBG	_	10	acl	_	_
13	7.4	_	NUM	CD	_	14	nummod	_	_
14	Drugs	_	NOUN	NNS	_	12	dobj	_	_
15	Tightly	_	ADV	RB	_	16	advmod	_	_
16	Bound	_	VERB	VBN	_	12	advcl	_	_
17	to	_	PRT	TO	_	19	case	_	_
18	Plasma	_	NOUN	NN	_	19	compound	_	_
19	Proteins	_	NOUN	NNS	_	16	nmod	_	_
20	:	_	.	:	_	1	punct	_	_
21	May	_	NOUN	NN	_	22	nsubj	_	_
22	cause	_	VERB	VBP	_	1	dep	_	_
23	a	_	DET	DT	_	24	det	_	_
24	shift	_	NOUN	NN	_	22	dobj	_	_
25	in	_	ADP	IN	_	27	case	_	_
26	plasma	_	NOUN	NN	_	27	compound	_	_
27	concentrations	_	NOUN	NNS	_	24	nmod	_	_
28	7.6	_	NUM	CD	_	27	nummod	_	_
29	,	_	.	,	_	27	punct	_	_
30	7.7	_	NUM	CD	_	31	nummod	_	_
31	Olanzapine	_	NOUN	NN	_	27	appos	_	_
32	:	_	.	:	_	22	punct	_	_
33	When	_	ADV	WRB	_	34	advmod	_	_
34	used	_	VERB	VBN	_	22	advcl	_	_
35	in	_	ADP	IN	_	36	case	_	_
36	combination	_	NOUN	NN	_	34	nmod	_	_
37	with	_	ADP	IN	_	38	case	_	_
38	DRUG	_	NOUN	NN	_	36	nmod	_	_
39	,	_	.	,	_	22	punct	_	_
40	also	_	ADV	RB	_	41	advmod	_	_
41	refer	_	VERB	VBP	_	22	advcl	_	_
42	to	_	PRT	TO	_	45	case	_	_
43	the	_	DET	DT	_	45	det	_	_
44	Drug	_	NOUN	NN	_	45	compound	_	_
45	Interactions	_	NOUN	NNS	_	41	nmod	_	_
46	section	_	NOUN	NN	_	45	dep	_	_
47	of	_	ADP	IN	_	50	case	_	_
48	the	_	DET	DT	_	50	det	_	_
49	package	_	NOUN	NN	_	50	compound	_	_
50	insert	_	NOUN	NN	_	46	nmod	_	_
51	for	_	ADP	IN	_	54	case	_	_
52	Symbyax	_	NOUN	NN	_	54	compound	_	_
53	7.7	_	NUM	CD	_	54	nummod	_	_
54	Drugs	_	NOUN	NNS	_	50	nmod	_	_
55	that	_	DET	WDT	_	56	nsubj	_	_
56	Prolong	_	VERB	VBP	_	54	acl:relcl	_	_
57	the	_	DET	DT	_	59	det	_	_
58	QT	_	NOUN	NN	_	59	compound	_	_
59	Interval	_	ADJ	JJ	_	56	dobj	_	_
60	:	_	.	:	_	22	punct	_	_
61	Do	_	NOUN	NN	_	63	nsubj	_	_
62	not	_	ADV	RB	_	63	neg	_	_
63	use	_	VERB	VB	_	22	parataxis	_	_
64	DRUG	_	NOUN	NN	_	63	dobj	_	_
65	with	_	ADP	IN	_	66	case	_	_
66	thioridazine	_	NOUN	NN	_	63	nmod	_	_
67	or	_	CONJ	CC	_	66	cc	_	_
68	pimozide	_	NOUN	NN	_	66	conj	_	_

#	Prozac	3724
1	Use	_	NOUN	NN	_	0	root	_	_
2	with	_	ADP	IN	_	3	case	_	_
3	caution	_	NOUN	NN	_	1	nmod	_	_
4	in	_	ADP	IN	_	5	case	_	_
5	combination	_	NOUN	NN	_	3	nmod	_	_
6	with	_	ADP	IN	_	8	case	_	_
7	other	_	ADJ	JJ	_	8	amod	_	_
8	drugs	_	NOUN	NNS	_	5	nmod	_	_
9	that	_	DET	WDT	_	10	nsubj	_	_
10	prolong	_	VERB	VBP	_	8	acl:relcl	_	_
11	the	_	DET	DT	_	13	det	_	_
12	QT	_	NOUN	NN	_	13	compound	_	_
13	interval	_	ADJ	JJ	_	10	ccomp	_	_
14	4.2	_	NUM	CD	_	13	nummod	_	_
15	,	_	.	,	_	13	punct	_	_
16	5.11	_	NUM	CD	_	13	conj	_	_
17	,	_	.	,	_	13	punct	_	_
18	7.7	_	NUM	CD	_	13	conj	_	_
19	,	_	.	,	_	13	punct	_	_
20	7.8	_	NUM	CD	_	13	punct	_	_

#	Prozac	3725
1	Caution	_	NOUN	NN	_	3	nsubjpass	_	_
2	is	_	VERB	VBZ	_	3	auxpass	_	_
3	advised	_	VERB	VBN	_	0	root	_	_
4	if	_	ADP	IN	_	14	mark	_	_
5	the	_	DET	DT	_	7	det	_	_
6	concomitant	_	ADJ	JJ	_	7	amod	_	_
7	administration	_	NOUN	NN	_	14	nsubjpass	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	such	_	ADJ	JJ	_	12	amod	_	_
12	drugs	_	NOUN	NNS	_	9	conj	_	_
13	is	_	VERB	VBZ	_	14	auxpass	_	_
14	required	_	VERB	VBN	_	3	root	_	_

#	Prozac	3726
1	In	_	ADP	IN	_	2	mark	_	_
2	evaluating	_	VERB	VBG	_	9	advcl	_	_
3	individual	_	ADJ	JJ	_	4	amod	_	_
4	cases	_	NOUN	NNS	_	2	dobj	_	_
5	,	_	.	,	_	9	punct	_	_
6	consideration	_	NOUN	NN	_	9	nsubjpass	_	_
7	should	_	VERB	MD	_	9	aux	_	_
8	be	_	VERB	VB	_	9	auxpass	_	_
9	given	_	VERB	VBN	_	0	root	_	_
10	to	_	PRT	TO	_	11	mark	_	_
11	using	_	VERB	VBG	_	9	xcomp	_	_
12	lower	_	ADJ	JJ	_	14	amod	_	_
13	initial	_	ADJ	JJ	_	14	amod	_	_
14	doses	_	NOUN	NNS	_	11	dobj	_	_
15	of	_	ADP	IN	_	19	case	_	_
16	the	_	DET	DT	_	19	det	_	_
17	concomitantly	_	ADV	RB	_	18	advmod	_	_
18	administered	_	VERB	VBN	_	19	amod	_	_
19	drugs	_	NOUN	NNS	_	14	nmod	_	_
20	,	_	.	,	_	9	punct	_	_
21	using	_	VERB	VBG	_	9	xcomp	_	_
22	conservative	_	ADJ	JJ	_	24	amod	_	_
23	titration	_	NOUN	NN	_	24	compound	_	_
24	schedules	_	NOUN	NNS	_	21	dobj	_	_
25	,	_	.	,	_	9	punct	_	_
26	and	_	CONJ	CC	_	9	cc	_	_
27	monitoring	_	NOUN	NN	_	9	conj	_	_
28	of	_	ADP	IN	_	30	case	_	_
29	clinical	_	ADJ	JJ	_	30	amod	_	_
30	status	_	NOUN	NN	_	27	nmod	_	_

#	Prozac	3728
1	Serotonin	_	NOUN	NN	_	2	compound	_	_
2	release	_	NOUN	NN	_	5	nsubj	_	_
3	by	_	ADP	IN	_	4	case	_	_
4	platelets	_	NOUN	NNS	_	2	nmod	_	_
5	plays	_	VERB	VBZ	_	0	root	_	_
6	an	_	DET	DT	_	8	det	_	_
7	important	_	ADJ	JJ	_	8	amod	_	_
8	role	_	NOUN	NN	_	5	dobj	_	_
9	in	_	ADP	IN	_	10	case	_	_
10	hemostasis	_	NOUN	NN	_	8	nmod	_	_

#	Prozac	3729
1	Epidemiological	_	ADJ	JJ	_	2	amod	_	_
2	studies	_	NOUN	NNS	_	0	root	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	the	_	DET	DT	_	6	det	_	_
5	case	_	NOUN	NN	_	6	compound	_	_
6	control	_	NOUN	NN	_	2	nmod	_	_
7	and	_	CONJ	CC	_	2	cc	_	_
8	cohort	_	NOUN	NN	_	2	conj	_	_
9	design	_	NOUN	NN	_	8	dobj	_	_
10	that	_	DET	WDT	_	12	nsubj	_	_
11	have	_	VERB	VBP	_	12	aux	_	_
12	demonstrated	_	VERB	VBN	_	9	dep	_	_
13	an	_	DET	DT	_	14	det	_	_
14	association	_	NOUN	NN	_	12	dobj	_	_
15	between	_	ADP	IN	_	16	case	_	_
16	use	_	NOUN	NN	_	14	nmod	_	_
17	of	_	ADP	IN	_	19	case	_	_
18	psychotropic	_	ADJ	JJ	_	19	amod	_	_
19	drugs	_	NOUN	NNS	_	16	nmod	_	_
20	that	_	DET	WDT	_	21	nsubj	_	_
21	interfere	_	VERB	VBP	_	19	acl:relcl	_	_
22	with	_	ADP	IN	_	24	case	_	_
23	serotonin	_	NOUN	NN	_	24	compound	_	_
24	reuptake	_	NOUN	NN	_	21	nmod	_	_
25	and	_	CONJ	CC	_	21	cc	_	_
26	the	_	DET	DT	_	27	det	_	_
27	occurrence	_	NOUN	NN	_	34	nsubj	_	_
28	of	_	ADP	IN	_	31	case	_	_
29	upper	_	VERB	VBG	_	31	amod	_	_
30	gastrointestinal	_	ADJ	JJ	_	31	amod	_	_
31	bleeding	_	NOUN	NN	_	27	nmod	_	_
32	have	_	VERB	MD	_	34	aux	_	_
33	also	_	ADV	RB	_	34	advmod	_	_
34	shown	_	VERB	VBN	_	21	conj	_	_
35	that	_	ADP	IN	_	44	mark	_	_
36	concurrent	_	ADJ	JJ	_	37	amod	_	_
37	use	_	NOUN	NN	_	44	nsubj	_	_
38	of	_	ADP	IN	_	40	case	_	_
39	an	_	DET	DT	_	40	det	_	_
40	NSAID	_	NOUN	NN	_	37	nmod	_	_
41	or	_	CONJ	CC	_	40	cc	_	_
42	aspirin	_	NOUN	NN	_	40	conj	_	_
43	may	_	VERB	MD	_	44	aux	_	_
44	potentiate	_	VERB	VB	_	34	ccomp	_	_
45	this	_	DET	DT	_	46	det	_	_
46	risk	_	NOUN	NN	_	44	dobj	_	_
47	of	_	ADP	IN	_	48	mark	_	_
48	bleeding	_	VERB	VBG	_	46	nmod	_	_

#	Prozac	3730
1	Altered	_	VERB	VBN	_	3	amod	_	_
2	anticoagulant	_	ADJ	JJ	_	3	amod	_	_
3	effects	_	NOUN	NNS	_	11	nsubjpass	_	_
4	,	_	.	,	_	3	punct	_	_
5	including	_	VERB	VBG	_	7	case	_	_
6	increased	_	VERB	VBN	_	7	amod	_	_
7	bleeding	_	NOUN	NN	_	3	nmod	_	_
8	,	_	.	,	_	3	punct	_	_
9	have	_	VERB	VBP	_	11	aux	_	_
10	been	_	VERB	VBN	_	11	auxpass	_	_
11	reported	_	VERB	VBN	_	0	root	_	_
12	when	_	ADV	WRB	_	17	advmod	_	_
13	SNRIs	_	NOUN	NNS	_	17	nsubjpass	_	_
14	or	_	CONJ	CC	_	13	cc	_	_
15	SSRIs	_	NOUN	NNS	_	13	conj	_	_
16	are	_	VERB	VBP	_	17	auxpass	_	_
17	coadministered	_	VERB	VBN	_	11	advcl	_	_
18	with	_	ADP	IN	_	19	case	_	_
19	warfarin	_	NOUN	NN	_	17	nmod	_	_

#	Prozac	3731
1	Patients	_	NOUN	NNS	_	8	nsubjpass	_	_
2	receiving	_	VERB	VBG	_	1	acl	_	_
3	warfarin	_	NOUN	NN	_	4	compound	_	_
4	therapy	_	NOUN	NN	_	2	dobj	_	_
5	should	_	VERB	MD	_	8	aux	_	_
6	be	_	VERB	VB	_	8	auxpass	_	_
7	carefully	_	ADV	RB	_	8	advmod	_	_
8	monitored	_	VERB	VBN	_	0	root	_	_
9	when	_	ADV	WRB	_	12	advmod	_	_
10	DRUG	_	NOUN	NN	_	12	nsubjpass	_	_
11	is	_	VERB	VBZ	_	12	auxpass	_	_
12	initiated	_	VERB	VBN	_	8	ccomp	_	_
13	or	_	CONJ	CC	_	12	cc	_	_
14	discontinued	_	VERB	VBN	_	12	conj	_	_

#	Prozac	3732
1	There	_	DET	EX	_	2	expl	_	_
2	are	_	VERB	VBP	_	0	root	_	_
3	no	_	DET	DT	_	5	neg	_	_
4	clinical	_	ADJ	JJ	_	5	amod	_	_
5	studies	_	NOUN	NNS	_	2	nsubj	_	_
6	establishing	_	VERB	VBG	_	5	acl	_	_
7	the	_	DET	DT	_	8	det	_	_
8	benefit	_	NOUN	NN	_	6	dobj	_	_
9	of	_	ADP	IN	_	12	case	_	_
10	the	_	DET	DT	_	12	det	_	_
11	combined	_	ADJ	JJ	_	12	amod	_	_
12	use	_	NOUN	NN	_	8	nmod	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	ECT	_	NOUN	NN	_	12	nmod	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	DRUG	_	NOUN	NN	_	14	conj	_	_

#	Prozac	3733
1	There	_	DET	EX	_	5	nmod:poss	_	_
2	have	_	VERB	VBP	_	5	aux	_	_
3	been	_	VERB	VBN	_	5	cop	_	_
4	rare	_	ADJ	JJ	_	5	amod	_	_
5	reports	_	NOUN	NNS	_	0	root	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	prolonged	_	ADJ	JJ	_	8	amod	_	_
8	seizures	_	NOUN	NNS	_	5	nmod	_	_
9	in	_	ADP	IN	_	10	case	_	_
10	patients	_	NOUN	NNS	_	8	nmod	_	_
11	on	_	ADP	IN	_	15	case	_	_
12	DRUG	_	NOUN	NN	_	15	compound	_	_
13	receiving	_	VERB	VBG	_	15	compound	_	_
14	ECT	_	NOUN	NN	_	15	compound	_	_
15	treatment	_	NOUN	NN	_	10	nmod	_	_

#	Prozac	3734
1	Drugs	_	NOUN	NNS	_	3	nsubj	_	_
2	Tightly	_	ADV	RB	_	3	advmod	_	_
3	Bound	_	VERB	VBD	_	19	advcl	_	_
4	to	_	PRT	TO	_	6	case	_	_
5	Plasma	_	NOUN	NN	_	6	compound	_	_
6	Proteins	_	NOUN	NNS	_	3	nmod	_	_
7	Because	_	ADP	IN	_	11	mark	_	_
8	DRUG	_	NOUN	NN	_	11	nsubjpass	_	_
9	is	_	VERB	VBZ	_	11	auxpass	_	_
10	tightly	_	ADV	RB	_	11	advmod	_	_
11	bound	_	VERB	VBN	_	3	advcl	_	_
12	to	_	PRT	TO	_	14	case	_	_
13	plasma	_	NOUN	NN	_	14	compound	_	_
14	proteins	_	NOUN	NNS	_	11	nmod	_	_
15	,	_	.	,	_	19	punct	_	_
16	adverse	_	ADJ	JJ	_	17	amod	_	_
17	effects	_	NOUN	NNS	_	19	nsubj	_	_
18	may	_	VERB	MD	_	19	aux	_	_
19	result	_	VERB	VB	_	0	root	_	_
20	from	_	ADP	IN	_	21	case	_	_
21	displacement	_	NOUN	NN	_	19	nmod	_	_
22	of	_	ADP	IN	_	23	case	_	_
23	protein	_	NOUN	NN	_	21	nmod	_	_
24	bound	_	VERB	VBN	_	25	amod	_	_
25	DRUG	_	NOUN	NN	_	23	dep	_	_
26	by	_	ADP	IN	_	30	case	_	_
27	other	_	ADJ	JJ	_	30	amod	_	_
28	tightly	_	ADV	RB	_	29	advmod	_	_
29	bound	_	VERB	VBN	_	30	amod	_	_
30	drugs	_	NOUN	NNS	_	21	nmod	_	_

#	Prozac	3735
1	Pimozide	_	NOUN	NN	_	3	compound	_	_
2	Concomitant	_	ADJ	JJ	_	3	amod	_	_
3	use	_	NOUN	NN	_	9	nsubjpass	_	_
4	in	_	ADP	IN	_	5	case	_	_
5	patients	_	NOUN	NNS	_	3	nmod	_	_
6	taking	_	VERB	VBG	_	5	acl	_	_
7	pimozide	_	NOUN	NN	_	6	dobj	_	_
8	is	_	VERB	VBZ	_	9	auxpass	_	_
9	contraindicated	_	VERB	VBN	_	0	root	_	_

#	Prozac	3736
1	DRUG	_	NOUN	NN	_	3	nsubj	_	_
2	can	_	VERB	MD	_	3	aux	_	_
3	increase	_	VERB	VB	_	0	root	_	_
4	the	_	DET	DT	_	5	det	_	_
5	level	_	NOUN	NN	_	3	dobj	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	pimozide	_	NOUN	NN	_	5	nmod	_	_
8	through	_	ADP	IN	_	9	case	_	_
9	inhibition	_	NOUN	NN	_	3	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	CYP2D6	_	NOUN	NN	_	9	nmod	_	_

#	Prozac	3737
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	can	_	VERB	MD	_	4	aux	_	_
3	also	_	ADV	RB	_	4	advmod	_	_
4	prolong	_	VERB	VB	_	0	root	_	_
5	the	_	DET	DT	_	7	det	_	_
6	QT	_	NOUN	NN	_	7	nmod:npmod	_	_
7	interval	_	ADJ	JJ	_	4	dobj	_	_

#	Prozac	3738
1	Clinical	_	ADJ	JJ	_	2	amod	_	_
2	studies	_	NOUN	NNS	_	8	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	pimozide	_	NOUN	NN	_	2	nmod	_	_
5	with	_	ADP	IN	_	7	case	_	_
6	other	_	ADJ	JJ	_	7	amod	_	_
7	antidepressants	_	NOUN	NNS	_	2	nmod	_	_
8	demonstrate	_	VERB	VBP	_	0	root	_	_
9	an	_	DET	DT	_	10	det	_	_
10	increase	_	NOUN	NN	_	8	dobj	_	_
11	in	_	ADP	IN	_	13	case	_	_
12	drug	_	NOUN	NN	_	13	compound	_	_
13	interaction	_	NOUN	NN	_	10	nmod	_	_
14	or	_	CONJ	CC	_	13	cc	_	_
15	QTprolongation	_	NOUN	NN	_	13	conj	_	_

#	Prozac	3739
1	While	_	ADP	IN	_	12	mark	_	_
2	a	_	DET	DT	_	4	det	_	_
3	specific	_	ADJ	JJ	_	4	amod	_	_
4	study	_	NOUN	NN	_	12	nsubjpass	_	_
5	with	_	ADP	IN	_	6	case	_	_
6	pimozide	_	NOUN	NN	_	4	nmod	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	DRUG	_	NOUN	NN	_	6	conj	_	_
9	has	_	VERB	VBZ	_	12	aux	_	_
10	not	_	ADV	RB	_	12	neg	_	_
11	been	_	VERB	VBN	_	12	auxpass	_	_
12	conducted	_	VERB	VBN	_	0	root	_	_
13	,	_	.	,	_	12	punct	_	_
14	the	_	DET	DT	_	15	det	_	_
15	potential	_	NOUN	NN	_	13	root	_	_
16	for	_	ADP	IN	_	18	case	_	_
17	drug	_	NOUN	NN	_	18	compound	_	_
18	interactions	_	NOUN	NNS	_	15	nmod	_	_
19	or	_	CONJ	CC	_	18	cc	_	_
20	QTprolongation	_	NOUN	NN	_	21	compound	_	_
21	warrants	_	NOUN	NNS	_	18	conj	_	_
22	restricting	_	VERB	VBG	_	18	acl	_	_
23	the	_	DET	DT	_	25	det	_	_
24	concurrent	_	ADJ	JJ	_	25	amod	_	_
25	use	_	NOUN	NN	_	22	dobj	_	_
26	of	_	ADP	IN	_	27	case	_	_
27	pimozide	_	NOUN	NN	_	25	nmod	_	_
28	and	_	CONJ	CC	_	27	cc	_	_
29	DRUG	_	NOUN	NN	_	27	conj	_	_

#	Prozac	3740
1	Thioridazine	_	NOUN	NN	_	2	compound	_	_
2	Thioridazine	_	NOUN	NN	_	6	nsubjpass	_	_
3	should	_	VERB	MD	_	6	aux	_	_
4	not	_	ADV	RB	_	6	neg	_	_
5	be	_	VERB	VB	_	6	auxpass	_	_
6	administered	_	VERB	VBN	_	0	root	_	_
7	with	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	or	_	CONJ	CC	_	8	cc	_	_
10	within	_	ADP	IN	_	12	case	_	_
11	a	_	DET	DT	_	12	det	_	_
12	minimum	_	NOUN	NN	_	8	conj	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	5weeks	_	NOUN	NNS	_	12	nmod	_	_
15	after	_	ADP	IN	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	12	nmod	_	_
17	has	_	VERB	VBZ	_	19	aux	_	_
18	been	_	VERB	VBN	_	19	auxpass	_	_
19	discontinued	_	VERB	VBN	_	6	parataxis	_	_
20	,	_	.	,	_	19	punct	_	_
21	because	_	ADP	IN	_	24	case	_	_
22	of	_	ADP	IN	_	24	case	_	_
23	the	_	DET	DT	_	24	det	_	_
24	risk	_	NOUN	NN	_	19	nmod	_	_
25	of	_	ADP	IN	_	27	case	_	_
26	QT	_	NOUN	NN	_	27	compound	_	_
27	Prolongation	_	NOUN	NN	_	24	nmod	_	_

#	Prozac	3741
1	In	_	ADP	IN	_	3	case	_	_
2	a	_	DET	DT	_	3	det	_	_
3	study	_	NOUN	NN	_	29	nmod	_	_
4	of	_	ADP	IN	_	8	case	_	_
5	19	_	NUM	CD	_	8	nummod	_	_
6	healthy	_	ADJ	JJ	_	8	amod	_	_
7	male	_	ADJ	JJ	_	8	amod	_	_
8	subjects	_	NOUN	NNS	_	3	nmod	_	_
9	,	_	.	,	_	8	punct	_	_
10	which	_	DET	WDT	_	11	nsubj	_	_
11	included	_	VERB	VBD	_	8	acl:relcl	_	_
12	6	_	NUM	CD	_	13	nummod	_	_
13	slow	_	NOUN	NN	_	11	dobj	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	13	_	NUM	CD	_	17	nummod	_	_
16	rapid	_	ADJ	JJ	_	17	amod	_	_
17	hydroxylators	_	NOUN	NNS	_	13	conj	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	debrisoquin	_	NOUN	NN	_	13	nmod	_	_
20	,	_	.	,	_	29	punct	_	_
21	a	_	DET	DT	_	26	det	_	_
22	single	_	ADJ	JJ	_	26	amod	_	_
23	25	_	NUM	CD	_	26	nummod	_	_
24	mg	_	NOUN	NN	_	26	compound	_	_
25	oral	_	ADJ	JJ	_	26	amod	_	_
26	dose	_	NOUN	NN	_	29	nsubj	_	_
27	of	_	ADP	IN	_	28	case	_	_
28	thioridazine	_	NOUN	NN	_	26	nmod	_	_
29	produced	_	VERB	VBD	_	0	root	_	_
30	a	_	DET	DT	_	34	det	_	_
31	2.4	_	NUM	CD	_	34	nummod	_	_
32	fold	_	NOUN	NN	_	34	amod	_	_
33	higher	_	ADJ	JJ	_	34	amod	_	_
34	Cmax	_	NOUN	NN	_	29	dobj	_	_
35	and	_	CONJ	CC	_	34	cc	_	_
36	a	_	DET	DT	_	40	det	_	_
37	4.5	_	NUM	CD	_	40	nummod	_	_
38	fold	_	NOUN	NN	_	40	amod	_	_
39	higher	_	ADJ	JJ	_	40	amod	_	_
40	AUC	_	NOUN	NN	_	34	conj	_	_
41	for	_	ADP	IN	_	42	case	_	_
42	thioridazine	_	NOUN	NN	_	40	nmod	_	_
43	in	_	ADP	IN	_	46	case	_	_
44	the	_	DET	DT	_	46	det	_	_
45	slow	_	NOUN	NN	_	46	compound	_	_
46	hydroxylators	_	NOUN	NNS	_	34	nmod	_	_
47	compared	_	VERB	VBN	_	50	case	_	_
48	to	_	PRT	TO	_	50	case	_	_
49	rapid	_	ADJ	JJ	_	50	amod	_	_
50	hydroxylators	_	NOUN	NNS	_	29	nmod	_	_

#	Prozac	3742
1	The	_	DET	DT	_	2	det	_	_
2	rate	_	NOUN	NN	_	7	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	debrisoquin	_	NOUN	NN	_	5	compound	_	_
5	hydroxylation	_	NOUN	NN	_	2	nmod	_	_
6	is	_	VERB	VBZ	_	7	cop	_	_
7	felt	_	ADJ	JJ	_	0	root	_	_
8	to	_	PRT	TO	_	9	mark	_	_
9	depend	_	VERB	VB	_	7	xcomp	_	_
10	on	_	ADP	IN	_	12	case	_	_
11	the	_	DET	DT	_	12	det	_	_
12	level	_	NOUN	NN	_	9	nmod	_	_
13	of	_	ADP	IN	_	16	case	_	_
14	CYP2D6	_	NOUN	NN	_	16	compound	_	_
15	isozyme	_	NOUN	NN	_	16	compound	_	_
16	activity	_	NOUN	NN	_	12	nmod	_	_

#	Prozac	3743
1	Thus	_	ADV	RB	_	5	advmod	_	_
2	,	_	.	,	_	5	punct	_	_
3	this	_	DET	DT	_	4	det	_	_
4	study	_	NOUN	NN	_	5	nsubj	_	_
5	suggests	_	VERB	VBZ	_	0	root	_	_
6	that	_	ADP	IN	_	21	mark	_	_
7	drugs	_	NOUN	NNS	_	21	nsubj	_	_
8	which	_	DET	WDT	_	9	nsubj	_	_
9	inhibit	_	VERB	VBP	_	7	acl:relcl	_	_
10	CYP2D6	_	NOUN	NN	_	9	dobj	_	_
11	,	_	.	,	_	10	punct	_	_
12	such	_	ADJ	JJ	_	15	case	_	_
13	as	_	ADP	IN	_	12	mwe	_	_
14	certain	_	ADJ	JJ	_	15	amod	_	_
15	SSRIs	_	NOUN	NNS	_	10	nmod	_	_
16	,	_	.	,	_	15	punct	_	_
17	including	_	VERB	VBG	_	18	case	_	_
18	DRUG	_	NOUN	NN	_	15	nmod	_	_
19	,	_	.	,	_	7	punct	_	_
20	will	_	VERB	MD	_	21	aux	_	_
21	produce	_	VERB	VB	_	5	ccomp	_	_
22	elevated	_	ADJ	JJ	_	24	amod	_	_
23	plasma	_	NOUN	NN	_	24	compound	_	_
24	levels	_	NOUN	NNS	_	21	dobj	_	_
25	of	_	ADP	IN	_	26	case	_	_
26	thioridazine	_	NOUN	NN	_	24	nmod	_	_

#	Prozac	3744
1	Thioridazine	_	NOUN	NN	_	2	compound	_	_
2	administration	_	NOUN	NN	_	3	nsubj	_	_
3	produces	_	VERB	VBZ	_	0	root	_	_
4	a	_	DET	DT	_	7	det	_	_
5	dose	_	NOUN	NN	_	7	compound	_	_
6	related	_	ADJ	JJ	_	7	amod	_	_
7	prolongation	_	NOUN	NN	_	3	dobj	_	_
8	of	_	ADP	IN	_	11	case	_	_
9	the	_	DET	DT	_	11	det	_	_
10	QT	_	NOUN	NN	_	11	compound	_	_
11	interval	_	NOUN	NN	_	7	nmod	_	_
12	,	_	.	,	_	11	punct	_	_
13	which	_	DET	WDT	_	15	nsubjpass	_	_
14	is	_	VERB	VBZ	_	15	auxpass	_	_
15	associated	_	VERB	VBN	_	11	acl:relcl	_	_
16	with	_	ADP	IN	_	19	case	_	_
17	serious	_	ADJ	JJ	_	19	amod	_	_
18	ventricular	_	ADJ	JJ	_	19	amod	_	_
19	arrhythmias	_	NOUN	NNS	_	15	nmod	_	_
20	,	_	.	,	_	19	punct	_	_
21	such	_	ADJ	JJ	_	25	case	_	_
22	as	_	ADP	IN	_	21	mwe	_	_
23	TorsadesdePointes	_	NOUN	NNS	_	25	compound	_	_
24	type	_	NOUN	NN	_	25	compound	_	_
25	arrhythmias	_	NOUN	NNS	_	19	nmod	_	_
26	,	_	.	,	_	19	punct	_	_
27	and	_	CONJ	CC	_	19	cc	_	_
28	sudden	_	NOUN	NN	_	29	compound	_	_
29	death	_	NOUN	NN	_	19	conj	_	_

#	Prozac	3745
1	This	_	DET	DT	_	2	det	_	_
2	risk	_	NOUN	NN	_	4	nsubjpass	_	_
3	is	_	VERB	VBZ	_	4	auxpass	_	_
4	expected	_	VERB	VBN	_	0	root	_	_
5	to	_	PRT	TO	_	6	mark	_	_
6	increase	_	VERB	VB	_	4	xcomp	_	_
7	with	_	ADP	IN	_	10	case	_	_
8	DRUG	_	NOUN	NN	_	10	compound	_	_
9	induced	_	VERB	VBN	_	10	amod	_	_
10	inhibition	_	NOUN	NN	_	6	nmod	_	_
11	of	_	ADP	IN	_	13	case	_	_
12	thioridazine	_	NOUN	NN	_	13	compound	_	_
13	metabolism	_	NOUN	NN	_	10	nmod	_	_

#	Prozac	3746
1	Drugs	_	NOUN	NNS	_	6	nsubj	_	_
2	Metabolized	_	VERB	VBN	_	1	acl	_	_
3	by	_	ADP	IN	_	5	case	_	_
4	CYP2D6	_	NOUN	NN	_	5	compound	_	_
5	DRUG	_	NOUN	NN	_	2	nmod	_	_
6	inhibits	_	VERB	VBZ	_	0	root	_	_
7	the	_	DET	DT	_	8	det	_	_
8	activity	_	NOUN	NN	_	6	dobj	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	CYP2D6	_	NOUN	NN	_	8	nmod	_	_
11	,	_	.	,	_	6	punct	_	_
12	and	_	CONJ	CC	_	6	cc	_	_
13	may	_	VERB	MD	_	14	aux	_	_
14	make	_	VERB	VB	_	6	conj	_	_
15	individuals	_	NOUN	NNS	_	14	dobj	_	_
16	with	_	ADP	IN	_	20	case	_	_
17	normal	_	ADJ	JJ	_	20	amod	_	_
18	CYP2D6	_	NOUN	NN	_	20	compound	_	_
19	metabolic	_	ADJ	JJ	_	20	amod	_	_
20	activity	_	NOUN	NN	_	15	nmod	_	_
21	resemble	_	VERB	VBP	_	14	parataxis	_	_
22	a	_	DET	DT	_	23	det	_	_
23	poor	_	ADJ	JJ	_	21	root	_	_
24	metabolizer	_	ADJ	JJ	_	23	dep	_	_

#	Prozac	3747
1	Coadministration	_	NOUN	NN	_	0	root	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	with	_	ADP	IN	_	6	case	_	_
5	other	_	ADJ	JJ	_	6	amod	_	_
6	drugs	_	NOUN	NNS	_	1	nmod	_	_
7	that	_	DET	WDT	_	9	nsubjpass	_	_
8	are	_	VERB	VBP	_	9	auxpass	_	_
9	metabolized	_	VERB	VBN	_	6	acl:relcl	_	_
10	by	_	ADP	IN	_	11	case	_	_
11	CYP2D6	_	NOUN	NN	_	9	nmod	_	_
12	,	_	.	,	_	11	punct	_	_
13	including	_	VERB	VBG	_	15	case	_	_
14	certain	_	ADJ	JJ	_	15	amod	_	_
15	antidepressants	_	NOUN	NNS	_	40	nmod	_	_
16	e.g	_	NOUN	NN	_	40	nsubjpass	_	_
17	,	_	.	,	_	16	punct	_	_
18	TCAs	_	NOUN	NNS	_	16	conj	_	_
19	,	_	.	,	_	16	punct	_	_
20	antipsychotics	_	NOUN	NNS	_	21	compound	_	_
21	e.g	_	NOUN	NN	_	16	conj	_	_
22	,	_	.	,	_	16	punct	_	_
23	phenothiazines	_	NOUN	NNS	_	16	conj	_	_
24	and	_	CONJ	CC	_	16	cc	_	_
25	most	_	ADJ	JJ	_	26	amod	_	_
26	atypicals	_	NOUN	NNS	_	16	conj	_	_
27	,	_	.	,	_	16	punct	_	_
28	and	_	CONJ	CC	_	16	cc	_	_
29	antiarrhythmics	_	NOUN	NNS	_	30	compound	_	_
30	e.g	_	NOUN	NN	_	16	conj	_	_
31	,	_	.	,	_	30	punct	_	_
32	propafenone	_	NOUN	NN	_	30	conj	_	_
33	,	_	.	,	_	30	punct	_	_
34	flecainide	_	NOUN	NN	_	30	conj	_	_
35	,	_	.	,	_	30	punct	_	_
36	and	_	CONJ	CC	_	30	cc	_	_
37	others	_	NOUN	NNS	_	30	conj	_	_
38	should	_	VERB	MD	_	40	aux	_	_
39	be	_	VERB	VB	_	40	auxpass	_	_
40	approached	_	VERB	VBN	_	11	acl:relcl	_	_
41	with	_	ADP	IN	_	42	case	_	_
42	caution	_	NOUN	NN	_	40	nmod	_	_

#	Prozac	3748
1	Therapy	_	NOUN	NN	_	0	root	_	_
2	with	_	ADP	IN	_	3	case	_	_
3	medications	_	NOUN	NNS	_	1	nmod	_	_
4	that	_	DET	WDT	_	7	nsubjpass	_	_
5	are	_	VERB	VBP	_	7	auxpass	_	_
6	predominantly	_	ADV	RB	_	7	advmod	_	_
7	metabolized	_	VERB	VBN	_	3	acl:relcl	_	_
8	by	_	ADP	IN	_	11	case	_	_
9	the	_	DET	DT	_	11	det	_	_
10	CYP2D6	_	NOUN	NN	_	11	compound	_	_
11	system	_	NOUN	NN	_	7	nmod	_	_
12	and	_	CONJ	CC	_	7	cc	_	_
13	that	_	DET	WDT	_	14	nsubj	_	_
14	have	_	VERB	VBP	_	22	aux	_	_
15	a	_	DET	DT	_	19	det	_	_
16	relatively	_	ADV	RB	_	17	advmod	_	_
17	narrow	_	NOUN	NN	_	19	compound	_	_
18	therapeutic	_	ADJ	JJ	_	19	amod	_	_
19	index	_	NOUN	NN	_	14	dobj	_	_
20	should	_	VERB	MD	_	22	aux	_	_
21	be	_	VERB	VB	_	22	auxpass	_	_
22	initiated	_	VERB	VBN	_	7	conj	_	_
23	at	_	ADP	IN	_	26	case	_	_
24	the	_	DET	DT	_	26	det	_	_
25	low	_	ADJ	JJ	_	26	amod	_	_
26	end	_	NOUN	NN	_	22	nmod	_	_
27	of	_	ADP	IN	_	30	case	_	_
28	the	_	DET	DT	_	30	det	_	_
29	dose	_	NOUN	NN	_	30	compound	_	_
30	range	_	NOUN	NN	_	26	nmod	_	_
31	if	_	ADP	IN	_	35	mark	_	_
32	a	_	DET	DT	_	33	det	_	_
33	patient	_	NOUN	NN	_	35	nsubj	_	_
34	is	_	VERB	VBZ	_	35	cop	_	_
35	receiving	_	VERB	VBG	_	22	ccomp	_	_
36	DRUG	_	NOUN	NN	_	35	dobj	_	_
37	concurrently	_	ADV	RB	_	35	advmod	_	_
38	or	_	CONJ	CC	_	35	cc	_	_
39	has	_	VERB	VBZ	_	40	aux	_	_
40	taken	_	VERB	VBN	_	35	conj	_	_
41	it	_	PRON	PRP	_	40	dobj	_	_
42	in	_	ADP	IN	_	45	case	_	_
43	the	_	DET	DT	_	45	det	_	_
44	previous	_	ADJ	JJ	_	45	amod	_	_
45	5weeks	_	NOUN	NNS	_	41	nmod	_	_

#	Prozac	3749
1	Thus	_	ADV	RB	_	0	root	_	_
2	,	_	.	,	_	1	punct	_	_
3	his	_	DET	EX	_	2	root	_	_
4	/	_	.	:	_	3	punct	_	_
5	her	_	PRON	PRP$	_	7	nmod:poss	_	_
6	dosing	_	ADJ	JJ	_	7	amod	_	_
7	requirements	_	NOUN	NNS	_	8	nsubj	_	_
8	resemble	_	VERB	VBP	_	3	dep	_	_
9	those	_	PRON	PRP	_	8	dobj	_	_
10	of	_	ADP	IN	_	12	case	_	_
11	poor	_	ADJ	JJ	_	12	amod	_	_
12	metabolizers	_	NOUN	NNS	_	9	nmod	_	_

#	Prozac	3750
1	If	_	ADP	IN	_	4	mark	_	_
2	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
3	is	_	VERB	VBZ	_	4	auxpass	_	_
4	added	_	VERB	VBN	_	31	advcl	_	_
5	to	_	PRT	TO	_	8	case	_	_
6	the	_	DET	DT	_	8	det	_	_
7	treatment	_	NOUN	NN	_	8	compound	_	_
8	regimen	_	NOUN	NN	_	4	nmod	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	a	_	DET	DT	_	11	det	_	_
11	patient	_	NOUN	NN	_	8	nmod	_	_
12	already	_	ADV	RB	_	13	advmod	_	_
13	receiving	_	VERB	VBG	_	8	acl	_	_
14	a	_	DET	DT	_	15	det	_	_
15	drug	_	NOUN	NN	_	13	dobj	_	_
16	metabolized	_	VERB	VBN	_	15	acl	_	_
17	by	_	ADP	IN	_	18	case	_	_
18	CYP2D6	_	NOUN	NN	_	16	nmod	_	_
19	,	_	.	,	_	31	punct	_	_
20	the	_	DET	DT	_	21	det	_	_
21	need	_	NOUN	NN	_	31	nsubjpass	_	_
22	for	_	ADP	IN	_	24	case	_	_
23	decreased	_	VERB	VBN	_	24	amod	_	_
24	dose	_	NOUN	NN	_	21	nmod	_	_
25	of	_	ADP	IN	_	28	case	_	_
26	the	_	DET	DT	_	28	det	_	_
27	original	_	ADJ	JJ	_	28	amod	_	_
28	medication	_	NOUN	NN	_	24	nmod	_	_
29	should	_	VERB	MD	_	31	aux	_	_
30	be	_	VERB	VB	_	31	auxpass	_	_
31	considered	_	VERB	VBN	_	0	root	_	_

#	Prozac	3751
1	Drugs	_	NOUN	NNS	_	7	nsubj	_	_
2	with	_	ADP	IN	_	6	case	_	_
3	a	_	DET	DT	_	6	det	_	_
4	narrow	_	NOUN	NN	_	6	compound	_	_
5	therapeutic	_	ADJ	JJ	_	6	amod	_	_
6	index	_	NOUN	NN	_	1	nmod	_	_
7	represent	_	VERB	VBP	_	0	root	_	_
8	the	_	DET	DT	_	11	det	_	_
9	greatest	_	ADJ	JJ	_	11	amod	_	_
10	concern	_	NOUN	NN	_	11	compound	_	_
11	e.g	_	NOUN	NN	_	7	dobj	_	_
12	,	_	.	,	_	11	punct	_	_
13	flecainide	_	NOUN	NN	_	11	conj	_	_
14	,	_	.	,	_	11	punct	_	_
15	propafenone	_	NOUN	NN	_	11	conj	_	_
16	,	_	.	,	_	11	punct	_	_
17	vinblastine	_	NOUN	NN	_	11	conj	_	_
18	,	_	.	,	_	11	punct	_	_
19	and	_	CONJ	CC	_	11	cc	_	_
20	TCAs	_	NOUN	NNS	_	11	conj	_	_

#	Prozac	3752
1	Due	_	ADP	IN	_	4	case	_	_
2	to	_	PRT	TO	_	1	mwe	_	_
3	the	_	DET	DT	_	4	det	_	_
4	risk	_	NOUN	NN	_	25	nmod	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	serious	_	ADJ	JJ	_	8	amod	_	_
7	ventricular	_	ADJ	JJ	_	8	amod	_	_
8	arrhythmias	_	NOUN	NNS	_	4	nmod	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	sudden	_	NOUN	NN	_	11	compound	_	_
11	death	_	NOUN	NN	_	8	conj	_	_
12	potentially	_	ADV	RB	_	13	advmod	_	_
13	associated	_	VERB	VBN	_	8	acl	_	_
14	with	_	ADP	IN	_	17	case	_	_
15	elevated	_	ADJ	JJ	_	17	amod	_	_
16	plasma	_	NOUN	NN	_	17	compound	_	_
17	levels	_	NOUN	NNS	_	13	nmod	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	thioridazine	_	NOUN	NN	_	17	nmod	_	_
20	,	_	.	,	_	25	punct	_	_
21	thioridazine	_	NOUN	NN	_	25	nsubjpass	_	_
22	should	_	VERB	MD	_	25	aux	_	_
23	not	_	ADV	RB	_	25	neg	_	_
24	be	_	VERB	VB	_	25	auxpass	_	_
25	administered	_	VERB	VBN	_	38	nsubjpass	_	_
26	with	_	ADP	IN	_	27	case	_	_
27	DRUG	_	NOUN	NN	_	25	nmod	_	_
28	or	_	CONJ	CC	_	27	cc	_	_
29	within	_	ADP	IN	_	31	case	_	_
30	a	_	DET	DT	_	31	det	_	_
31	minimum	_	NOUN	NN	_	27	conj	_	_
32	of	_	ADP	IN	_	33	case	_	_
33	5weeks	_	NOUN	NNS	_	31	nmod	_	_
34	after	_	ADP	IN	_	35	case	_	_
35	DRUG	_	NOUN	NN	_	31	nmod	_	_
36	has	_	VERB	VBZ	_	38	aux	_	_
37	been	_	VERB	VBN	_	38	auxpass	_	_
38	discontinued	_	VERB	VBN	_	0	root	_	_

#	Prozac	3753
1	Tricyclic	_	ADJ	JJ	_	2	amod	_	_
2	Antidepressants	_	NOUN	NNS	_	0	root	_	_
3	TCAs	_	NOUN	NNS	_	2	dep	_	_
4	In	_	ADP	IN	_	5	case	_	_
5	2studies	_	NOUN	NNS	_	3	nmod	_	_
6	,	_	.	,	_	2	punct	_	_
7	previously	_	ADV	RB	_	8	advmod	_	_
8	stable	_	ADJ	JJ	_	10	amod	_	_
9	plasma	_	NOUN	NN	_	10	compound	_	_
10	levels	_	NOUN	NNS	_	16	nsubj	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	imipramine	_	NOUN	NN	_	10	nmod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	desipramine	_	NOUN	NN	_	12	conj	_	_
15	have	_	VERB	MD	_	16	aux	_	_
16	increased	_	VERB	VBN	_	2	dep	_	_
17	greater	_	ADJ	JJ	_	16	xcomp	_	_
18	than	_	ADP	IN	_	22	case	_	_
19	2	_	NUM	CD	_	21	compound	_	_
20	to	_	PRT	TO	_	21	dep	_	_
21	10	_	NUM	CD	_	22	nummod	_	_
22	fold	_	NOUN	NN	_	17	nmod	_	_
23	when	_	ADV	WRB	_	27	advmod	_	_
24	DRUG	_	NOUN	NN	_	27	nsubjpass	_	_
25	has	_	VERB	VBZ	_	27	aux	_	_
26	been	_	VERB	VBN	_	27	auxpass	_	_
27	administered	_	VERB	VBN	_	16	advcl	_	_
28	in	_	ADP	IN	_	29	case	_	_
29	combination	_	NOUN	NN	_	27	nmod	_	_

#	Prozac	3754
1	This	_	DET	DT	_	2	det	_	_
2	influence	_	NOUN	NN	_	4	nsubj	_	_
3	may	_	VERB	MD	_	4	aux	_	_
4	persist	_	VERB	VB	_	12	nsubjpass	_	_
5	for	_	ADP	IN	_	6	case	_	_
6	3weeks	_	NOUN	NNS	_	4	nmod	_	_
7	or	_	CONJ	CC	_	6	cc	_	_
8	longer	_	ADV	RB	_	10	advmod	_	_
9	after	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	6	conj	_	_
11	is	_	VERB	VBZ	_	12	auxpass	_	_
12	discontinued	_	VERB	VBN	_	0	root	_	_

#	Prozac	3755
1	Thus	_	ADV	RB	_	8	advmod	_	_
2	,	_	.	,	_	8	punct	_	_
3	the	_	DET	DT	_	4	det	_	_
4	dose	_	NOUN	NN	_	8	nsubj	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	TCAs	_	NOUN	NNS	_	4	nmod	_	_
7	may	_	VERB	MD	_	8	aux	_	_
8	need	_	VERB	VB	_	0	root	_	_
9	to	_	PRT	TO	_	11	mark	_	_
10	be	_	VERB	VB	_	11	auxpass	_	_
11	reduced	_	VERB	VBN	_	8	xcomp	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	plasma	_	NOUN	NN	_	15	compound	_	_
14	TCA	_	NOUN	NN	_	15	compound	_	_
15	concentrations	_	NOUN	NNS	_	17	nsubj	_	_
16	may	_	VERB	MD	_	17	aux	_	_
17	need	_	VERB	VB	_	11	conj	_	_
18	to	_	PRT	TO	_	20	mark	_	_
19	be	_	VERB	VB	_	20	auxpass	_	_
20	monitored	_	VERB	VBN	_	17	xcomp	_	_
21	temporarily	_	ADV	RB	_	22	advmod	_	_
22	when	_	ADV	WRB	_	25	advmod	_	_
23	DRUG	_	NOUN	NN	_	25	nsubjpass	_	_
24	is	_	VERB	VBZ	_	25	auxpass	_	_
25	coadministered	_	VERB	VBN	_	20	advcl	_	_
26	or	_	CONJ	CC	_	8	cc	_	_
27	has	_	VERB	MD	_	30	aux	_	_
28	been	_	VERB	VBN	_	30	auxpass	_	_
29	recently	_	ADV	RB	_	30	advmod	_	_
30	discontinued	_	VERB	VBN	_	8	conj	_	_

#	Prozac	3756
1	Benzodiazepines	_	NOUN	NNS	_	0	root	_	_
2	The	_	DET	DT	_	4	det	_	_
3	half	_	ADJ	JJ	_	4	amod	_	_
4	life	_	NOUN	NN	_	11	nsubjpass	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	concurrently	_	ADV	RB	_	7	advmod	_	_
7	administered	_	VERB	VBN	_	8	amod	_	_
8	diazepam	_	NOUN	NN	_	4	nmod	_	_
9	may	_	VERB	MD	_	11	aux	_	_
10	be	_	VERB	VB	_	11	auxpass	_	_
11	prolonged	_	VERB	VBN	_	1	acl	_	_
12	in	_	ADP	IN	_	14	case	_	_
13	some	_	DET	DT	_	14	det	_	_
14	patients	_	NOUN	NNS	_	11	nmod	_	_

#	Prozac	3757
1	Coadministration	_	NOUN	NN	_	7	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	alprazolam	_	NOUN	NN	_	1	nmod	_	_
4	and	_	CONJ	CC	_	3	cc	_	_
5	DRUG	_	NOUN	NN	_	3	conj	_	_
6	has	_	VERB	VBZ	_	7	aux	_	_
7	resulted	_	VERB	VBN	_	0	root	_	_
8	in	_	ADP	IN	_	12	case	_	_
9	increased	_	VERB	VBN	_	12	amod	_	_
10	alprazolam	_	NOUN	NN	_	12	compound	_	_
11	plasma	_	NOUN	NN	_	12	compound	_	_
12	concentrations	_	NOUN	NNS	_	7	nmod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	in	_	ADP	IN	_	18	case	_	_
15	further	_	ADJ	JJ	_	18	amod	_	_
16	psychomotor	_	NOUN	NN	_	18	compound	_	_
17	performance	_	NOUN	NN	_	18	compound	_	_
18	decrement	_	NOUN	NN	_	12	conj	_	_
19	due	_	ADJ	JJ	_	23	case	_	_
20	to	_	PRT	TO	_	19	mwe	_	_
21	increased	_	VERB	VBN	_	23	amod	_	_
22	alprazolam	_	NOUN	NN	_	23	compound	_	_
23	levels	_	NOUN	NNS	_	18	nmod	_	_

#	Prozac	3758
1	Antipsychotics	_	NOUN	NNS	_	5	nsubj	_	_
2	Some	_	DET	DT	_	4	det	_	_
3	clinical	_	ADJ	JJ	_	4	amod	_	_
4	data	_	NOUN	NNS	_	5	nsubj	_	_
5	suggests	_	VERB	VBZ	_	0	root	_	_
6	a	_	DET	DT	_	13	det	_	_
7	possible	_	ADJ	JJ	_	8	amod	_	_
8	pharmacodynamic	_	ADJ	JJ	_	13	amod	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	/	_	NUM	CD	_	8	conj	_	_
11	or	_	CONJ	CC	_	8	cc	_	_
12	pharmacokinetic	_	ADJ	JJ	_	8	conj	_	_
13	interaction	_	NOUN	NN	_	5	dobj	_	_
14	between	_	ADP	IN	_	15	case	_	_
15	SSRIs	_	NOUN	NNS	_	13	nmod	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	antipsychotics	_	NOUN	NNS	_	15	conj	_	_

#	Prozac	3759
1	Elevation	_	NOUN	NN	_	11	nsubjpass	_	_
2	of	_	ADP	IN	_	4	case	_	_
3	blood	_	NOUN	NN	_	4	compound	_	_
4	levels	_	NOUN	NNS	_	1	nmod	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	haloperidol	_	NOUN	NN	_	4	nmod	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	clozapine	_	NOUN	NN	_	6	conj	_	_
9	has	_	VERB	VBZ	_	11	aux	_	_
10	been	_	VERB	VBN	_	11	auxpass	_	_
11	observed	_	VERB	VBN	_	0	root	_	_
12	in	_	ADP	IN	_	13	case	_	_
13	patients	_	NOUN	NNS	_	11	nmod	_	_
14	receiving	_	VERB	VBG	_	13	acl	_	_
15	concomitant	_	ADJ	JJ	_	16	amod	_	_
16	DRUG	_	NOUN	NN	_	14	dobj	_	_

#	Prozac	3760
1	Anticonvulsants	_	NOUN	NNS	_	2	compound	_	_
2	Patients	_	NOUN	NNS	_	11	nsubj	_	_
3	on	_	ADP	IN	_	5	case	_	_
4	stable	_	ADJ	JJ	_	5	amod	_	_
5	doses	_	NOUN	NNS	_	2	nmod	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	phenytoin	_	NOUN	NN	_	5	nmod	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	carbamazepine	_	NOUN	NN	_	7	conj	_	_
10	have	_	VERB	MD	_	11	aux	_	_
11	developed	_	VERB	VBN	_	0	root	_	_
12	elevated	_	ADJ	JJ	_	15	amod	_	_
13	plasma	_	NOUN	NN	_	15	compound	_	_
14	anticonvulsant	_	ADJ	JJ	_	15	amod	_	_
15	concentrations	_	NOUN	NNS	_	11	dobj	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	clinical	_	ADJ	JJ	_	19	amod	_	_
18	anticonvulsant	_	ADJ	JJ	_	19	amod	_	_
19	toxicity	_	NOUN	NN	_	15	conj	_	_
20	following	_	ADP	IN	_	21	case	_	_
21	initiation	_	NOUN	NN	_	11	nmod	_	_
22	of	_	ADP	IN	_	25	case	_	_
23	concomitant	_	ADJ	JJ	_	25	amod	_	_
24	DRUG	_	NOUN	NN	_	25	compound	_	_
25	treatment	_	NOUN	NN	_	21	nmod	_	_

#	Prozac	3761
1	Lithium	_	NOUN	NN	_	5	nsubj	_	_
2	There	_	DET	EX	_	5	nsubj	_	_
3	have	_	VERB	VBP	_	5	aux	_	_
4	been	_	VERB	VBN	_	5	cop	_	_
5	reports	_	NOUN	NNS	_	0	root	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	both	_	CONJ	CC	_	8	cc:preconj	_	_
8	increased	_	VERB	VBN	_	5	nmod	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	decreased	_	VERB	VBN	_	8	conj	_	_
11	lithium	_	NOUN	NN	_	12	compound	_	_
12	levels	_	NOUN	NNS	_	8	dep	_	_
13	when	_	ADV	WRB	_	16	advmod	_	_
14	lithium	_	NOUN	NN	_	16	nsubjpass	_	_
15	was	_	VERB	VBD	_	16	auxpass	_	_
16	used	_	VERB	VBN	_	5	ccomp	_	_
17	concomitantly	_	ADV	RB	_	16	advmod	_	_
18	with	_	ADP	IN	_	19	case	_	_
19	DRUG	_	NOUN	NN	_	16	nmod	_	_

#	Prozac	3762
1	Cases	_	NOUN	NNS	_	11	nsubjpass	_	_
2	of	_	ADP	IN	_	4	case	_	_
3	lithium	_	NOUN	NN	_	4	compound	_	_
4	toxicity	_	NOUN	NN	_	1	nmod	_	_
5	and	_	CONJ	CC	_	1	cc	_	_
6	increased	_	VERB	VBN	_	8	amod	_	_
7	serotonergic	_	ADJ	JJ	_	8	amod	_	_
8	effects	_	NOUN	NNS	_	1	conj	_	_
9	have	_	VERB	VBP	_	11	aux	_	_
10	been	_	VERB	VBN	_	11	auxpass	_	_
11	reported	_	VERB	VBN	_	0	root	_	_

#	Prozac	3763
1	Lithium	_	NOUN	NN	_	2	compound	_	_
2	levels	_	NOUN	NNS	_	5	nsubjpass	_	_
3	should	_	VERB	MD	_	5	aux	_	_
4	be	_	VERB	VB	_	5	auxpass	_	_
5	monitored	_	VERB	VBN	_	0	root	_	_
6	when	_	ADV	WRB	_	10	advmod	_	_
7	these	_	DET	DT	_	8	det	_	_
8	drugs	_	NOUN	NNS	_	10	nsubjpass	_	_
9	are	_	VERB	VBP	_	10	auxpass	_	_
10	administered	_	VERB	VBN	_	5	ccomp	_	_
11	concomitantly	_	ADV	RB	_	10	advmod	_	_

#	Prozac	3764
1	Drugs	_	NOUN	NNS	_	3	nsubj	_	_
2	Tightly	_	ADV	RB	_	3	advmod	_	_
3	Bound	_	VERB	VBD	_	0	root	_	_
4	to	_	PRT	TO	_	6	case	_	_
5	Plasma	_	NOUN	NN	_	6	compound	_	_
6	Proteins	_	NOUN	NNS	_	3	nmod	_	_
7	Because	_	ADP	IN	_	11	mark	_	_
8	DRUG	_	NOUN	NN	_	11	nsubjpass	_	_
9	is	_	VERB	VBZ	_	11	auxpass	_	_
10	tightly	_	ADV	RB	_	11	advmod	_	_
11	bound	_	VERB	VBN	_	3	advcl	_	_
12	to	_	PRT	TO	_	14	case	_	_
13	plasma	_	NOUN	NN	_	14	compound	_	_
14	proteins	_	NOUN	NNS	_	11	nmod	_	_
15	,	_	.	,	_	14	punct	_	_
16	the	_	DET	DT	_	17	det	_	_
17	administration	_	NOUN	NN	_	38	nsubj	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	DRUG	_	NOUN	NN	_	17	nmod	_	_
20	to	_	PRT	TO	_	22	case	_	_
21	a	_	DET	DT	_	22	det	_	_
22	patient	_	NOUN	NN	_	17	nmod	_	_
23	taking	_	VERB	VBG	_	22	acl	_	_
24	another	_	DET	DT	_	25	det	_	_
25	drug	_	NOUN	NN	_	23	dobj	_	_
26	that	_	DET	WDT	_	29	nsubjpass	_	_
27	is	_	VERB	VBZ	_	29	auxpass	_	_
28	tightly	_	ADV	RB	_	29	advmod	_	_
29	bound	_	VERB	VBN	_	25	acl:relcl	_	_
30	to	_	PRT	TO	_	32	case	_	_
31	protein	_	NOUN	NN	_	32	compound	_	_
32	e.g	_	NOUN	NN	_	29	nmod	_	_
33	,	_	.	,	_	32	punct	_	_
34	Coumadin	_	NOUN	NN	_	32	appos	_	_
35	,	_	.	,	_	32	punct	_	_
36	digitoxin	_	NOUN	NN	_	32	appos	_	_
37	may	_	VERB	MD	_	38	aux	_	_
38	cause	_	VERB	VB	_	14	acl:relcl	_	_
39	a	_	DET	DT	_	40	det	_	_
40	shift	_	NOUN	NN	_	38	dobj	_	_
41	in	_	ADP	IN	_	43	case	_	_
42	plasma	_	NOUN	NN	_	43	compound	_	_
43	concentrations	_	NOUN	NNS	_	40	nmod	_	_
44	potentially	_	ADV	RB	_	45	advmod	_	_
45	resulting	_	VERB	VBG	_	40	acl	_	_
46	in	_	ADP	IN	_	49	case	_	_
47	an	_	DET	DT	_	49	det	_	_
48	adverse	_	ADJ	JJ	_	49	amod	_	_
49	effect	_	NOUN	NN	_	45	nmod	_	_

#	Prozac	3765
1	Drugs	_	NOUN	NNS	_	0	root	_	_
2	Metabolized	_	VERB	VBN	_	1	acl	_	_
3	by	_	ADP	IN	_	4	case	_	_
4	CYP3A4	_	NOUN	NN	_	2	nmod	_	_
5	In	_	ADP	IN	_	9	case	_	_
6	an	_	DET	DT	_	9	det	_	_
7	invivo	_	ADV	RB	_	9	advmod	_	_
8	interaction	_	NOUN	NN	_	9	compound	_	_
9	study	_	NOUN	NN	_	2	nmod	_	_
10	involving	_	VERB	VBG	_	9	acl	_	_
11	coadministration	_	NOUN	NN	_	10	dobj	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	DRUG	_	NOUN	NN	_	11	nmod	_	_
14	with	_	ADP	IN	_	16	case	_	_
15	single	_	ADJ	JJ	_	16	amod	_	_
16	doses	_	NOUN	NNS	_	11	nmod	_	_
17	of	_	ADP	IN	_	18	mark	_	_
18	terfenadine	_	NOUN	NN	_	16	acl	_	_
19	a	_	DET	DT	_	21	det	_	_
20	CYP3A4	_	NOUN	NN	_	21	compound	_	_
21	substrate	_	NOUN	NN	_	18	dobj	_	_
22	,	_	.	,	_	1	punct	_	_
23	no	_	DET	DT	_	24	neg	_	_
24	increase	_	NOUN	NN	_	29	nsubj	_	_
25	in	_	ADP	IN	_	28	case	_	_
26	plasma	_	NOUN	NN	_	28	compound	_	_
27	terfenadine	_	NOUN	NN	_	28	compound	_	_
28	concentrations	_	NOUN	NNS	_	24	nmod	_	_
29	occurred	_	VERB	VBN	_	1	dep	_	_
30	with	_	ADP	IN	_	32	case	_	_
31	concomitant	_	ADJ	JJ	_	32	amod	_	_
32	DRUG	_	NOUN	NN	_	29	nmod	_	_

#	Prozac	3766
1	Additionally	_	ADV	RB	_	6	advmod	_	_
2	,	_	.	,	_	6	punct	_	_
3	invitro	_	ADV	RB	_	4	amod	_	_
4	studies	_	NOUN	NNS	_	6	nsubj	_	_
5	have	_	VERB	VBP	_	6	aux	_	_
6	shown	_	VERB	VBN	_	0	root	_	_
7	ketoconazole	_	NOUN	NN	_	6	dobj	_	_
8	,	_	.	,	_	7	punct	_	_
9	a	_	DET	DT	_	11	det	_	_
10	potent	_	ADJ	JJ	_	11	amod	_	_
11	inhibitor	_	NOUN	NN	_	7	appos	_	_
12	of	_	ADP	IN	_	14	case	_	_
13	CYP3A4	_	NOUN	NN	_	14	compound	_	_
14	activity	_	NOUN	NN	_	11	nmod	_	_
15	,	_	.	,	_	7	punct	_	_
16	to	_	PRT	TO	_	20	mark	_	_
17	be	_	VERB	VB	_	20	cop	_	_
18	at	_	ADP	IN	_	20	case	_	_
19	least	_	ADV	RB	_	20	advmod	_	_
20	100times	_	NOUN	NNS	_	6	nmod	_	_
21	more	_	ADV	RB	_	22	advmod	_	_
22	potent	_	ADJ	JJ	_	20	dep	_	_
23	than	_	ADP	IN	_	24	case	_	_
24	DRUG	_	NOUN	NN	_	22	nmod	_	_
25	or	_	CONJ	CC	_	24	cc	_	_
26	nor	_	CONJ	CC	_	24	cc	_	_
27	DRUG	_	NOUN	NN	_	24	conj	_	_
28	as	_	ADP	IN	_	30	case	_	_
29	an	_	DET	DT	_	30	det	_	_
30	inhibitor	_	NOUN	NN	_	22	nmod	_	_
31	of	_	ADP	IN	_	33	case	_	_
32	the	_	DET	DT	_	33	det	_	_
33	metabolism	_	NOUN	NN	_	30	nmod	_	_
34	of	_	ADP	IN	_	36	case	_	_
35	several	_	ADJ	JJ	_	36	amod	_	_
36	substrates	_	NOUN	NNS	_	33	nmod	_	_
37	for	_	ADP	IN	_	39	case	_	_
38	this	_	DET	DT	_	39	det	_	_
39	enzyme	_	NOUN	NN	_	33	nmod	_	_
40	,	_	.	,	_	39	punct	_	_
41	including	_	VERB	VBG	_	42	case	_	_
42	astemizole	_	NOUN	NN	_	39	nmod	_	_
43	,	_	.	,	_	42	punct	_	_
44	cisapride	_	NOUN	NN	_	42	conj	_	_
45	,	_	.	,	_	42	punct	_	_
46	and	_	CONJ	CC	_	42	cc	_	_
47	midazolam	_	NOUN	NN	_	42	conj	_	_

#	Prozac	3767
1	These	_	DET	DT	_	2	det	_	_
2	data	_	NOUN	NNS	_	3	nsubj	_	_
3	indicate	_	VERB	VBP	_	0	root	_	_
4	that	_	ADP	IN	_	15	mark	_	_
5	DRUG	_	NOUN	NN	_	7	nmod:poss	_	_
6	's	_	PRT	POS	_	7	case	_	_
7	extent	_	NOUN	NN	_	15	nsubj	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	inhibition	_	NOUN	NN	_	7	nmod	_	_
10	of	_	ADP	IN	_	12	case	_	_
11	CYP3A4	_	NOUN	NN	_	12	compound	_	_
12	activity	_	NOUN	NN	_	9	nmod	_	_
13	is	_	VERB	VBZ	_	15	cop	_	_
14	not	_	ADV	RB	_	15	neg	_	_
15	likely	_	ADJ	JJ	_	3	ccomp	_	_
16	to	_	PRT	TO	_	20	mark	_	_
17	be	_	VERB	VB	_	20	cop	_	_
18	of	_	ADP	IN	_	20	case	_	_
19	clinical	_	ADJ	JJ	_	20	amod	_	_
20	significance	_	NOUN	NN	_	15	ccomp	_	_

#	Prozac	3768
1	Olanzapine	_	NOUN	NN	_	5	compound	_	_
2	DRUG	_	NOUN	NN	_	5	compound	_	_
3	60mg	_	ADJ	JJ	_	5	amod	_	_
4	single	_	ADJ	JJ	_	5	amod	_	_
5	dose	_	NOUN	NN	_	14	nsubj	_	_
6	or	_	CONJ	CC	_	5	cc	_	_
7	60	_	NUM	CD	_	10	nummod	_	_
8	mg	_	NOUN	NN	_	10	compound	_	_
9	daily	_	ADV	RB	_	10	amod	_	_
10	dose	_	NOUN	NN	_	5	conj	_	_
11	for	_	ADP	IN	_	13	case	_	_
12	8	_	NUM	CD	_	13	nummod	_	_
13	days	_	NOUN	NNS	_	5	nmod	_	_
14	causes	_	VERB	VBZ	_	0	root	_	_
15	a	_	DET	DT	_	19	det	_	_
16	small	_	ADJ	JJ	_	19	amod	_	_
17	mean	_	NOUN	NN	_	19	compound	_	_
18	16%	_	ADJ	JJ	_	19	amod	_	_
19	increase	_	NOUN	NN	_	14	dobj	_	_
20	in	_	ADP	IN	_	23	case	_	_
21	the	_	DET	DT	_	23	det	_	_
22	maximum	_	NOUN	NN	_	23	compound	_	_
23	concentration	_	NOUN	NN	_	19	nmod	_	_
24	of	_	ADP	IN	_	25	case	_	_
25	olanzapine	_	NOUN	NN	_	23	nmod	_	_
26	and	_	CONJ	CC	_	19	cc	_	_
27	a	_	DET	DT	_	31	det	_	_
28	small	_	ADJ	JJ	_	31	amod	_	_
29	mean	_	NOUN	NN	_	31	compound	_	_
30	16%	_	ADJ	JJ	_	31	amod	_	_
31	decrease	_	NOUN	NN	_	19	conj	_	_
32	in	_	ADP	IN	_	34	case	_	_
33	olanzapine	_	NOUN	NN	_	34	compound	_	_
34	clearance	_	NOUN	NN	_	31	nmod	_	_

#	Prozac	3769
1	The	_	DET	DT	_	2	det	_	_
2	magnitude	_	NOUN	NN	_	10	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	the	_	DET	DT	_	5	det	_	_
5	impact	_	NOUN	NN	_	2	nmod	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	this	_	DET	DT	_	8	det	_	_
8	factor	_	NOUN	NN	_	5	nmod	_	_
9	is	_	VERB	VBZ	_	10	cop	_	_
10	small	_	ADJ	JJ	_	0	root	_	_
11	in	_	ADP	IN	_	12	case	_	_
12	comparison	_	NOUN	NN	_	10	nmod	_	_
13	to	_	PRT	TO	_	16	case	_	_
14	the	_	DET	DT	_	16	det	_	_
15	overall	_	ADJ	JJ	_	16	amod	_	_
16	variability	_	NOUN	NN	_	12	nmod	_	_
17	between	_	ADP	IN	_	18	case	_	_
18	individuals	_	NOUN	NNS	_	16	nmod	_	_
19	,	_	.	,	_	10	punct	_	_
20	and	_	CONJ	CC	_	10	cc	_	_
21	therefore	_	ADV	RB	_	27	advmod	_	_
22	dose	_	NOUN	NN	_	23	compound	_	_
23	modification	_	NOUN	NN	_	27	nsubjpass	_	_
24	is	_	VERB	VBZ	_	27	auxpass	_	_
25	not	_	ADV	RB	_	27	neg	_	_
26	routinely	_	ADV	RB	_	27	advmod	_	_
27	recommended	_	VERB	VBN	_	10	conj	_	_

#	Prozac	3770
1	When	_	ADV	WRB	_	2	advmod	_	_
2	using	_	VERB	VBG	_	11	advcl	_	_
3	DRUG	_	NOUN	NN	_	2	dobj	_	_
4	and	_	CONJ	CC	_	3	cc	_	_
5	olanzapine	_	NOUN	NN	_	3	conj	_	_
6	and	_	CONJ	CC	_	3	cc	_	_
7	in	_	ADP	IN	_	8	case	_	_
8	combination	_	NOUN	NN	_	3	conj	_	_
9	,	_	.	,	_	11	punct	_	_
10	also	_	ADV	RB	_	11	advmod	_	_
11	refer	_	VERB	VBP	_	0	root	_	_
12	to	_	PRT	TO	_	15	case	_	_
13	the	_	DET	DT	_	15	det	_	_
14	Drug	_	NOUN	NN	_	15	compound	_	_
15	Interactions	_	NOUN	NNS	_	11	nmod	_	_
16	section	_	NOUN	NN	_	15	dep	_	_
17	of	_	ADP	IN	_	20	case	_	_
18	the	_	DET	DT	_	20	det	_	_
19	package	_	NOUN	NN	_	20	compound	_	_
20	insert	_	NOUN	NN	_	16	nmod	_	_
21	for	_	ADP	IN	_	22	case	_	_
22	Symbyax	_	NOUN	NN	_	20	nmod	_	_

#	Prozac	3771
1	Do	_	PRT	TO	_	3	mark	_	_
2	not	_	ADV	RB	_	3	neg	_	_
3	use	_	VERB	VB	_	0	root	_	_
4	DRUG	_	NOUN	NN	_	3	dobj	_	_
5	in	_	ADP	IN	_	6	case	_	_
6	combination	_	NOUN	NN	_	3	nmod	_	_
7	with	_	ADP	IN	_	8	case	_	_
8	thioridazine	_	NOUN	NN	_	6	nmod	_	_
9	or	_	CONJ	CC	_	8	cc	_	_
10	pimozide	_	NOUN	NN	_	8	conj	_	_

#	Prozac	3772
1	Use	_	VERB	VB	_	0	root	_	_
2	DRUG	_	NOUN	NN	_	1	dobj	_	_
3	with	_	ADP	IN	_	4	case	_	_
4	caution	_	NOUN	NN	_	1	nmod	_	_
5	in	_	ADP	IN	_	6	case	_	_
6	combination	_	NOUN	NN	_	4	nmod	_	_
7	with	_	ADP	IN	_	9	case	_	_
8	other	_	ADJ	JJ	_	9	amod	_	_
9	drugs	_	NOUN	NNS	_	6	nmod	_	_
10	that	_	DET	WDT	_	11	nsubj	_	_
11	cause	_	VERB	VBP	_	9	acl:relcl	_	_
12	QT	_	NOUN	NN	_	13	compound	_	_
13	prolongation	_	NOUN	NN	_	11	dobj	_	_

#	Prozac	3773
1	These	_	DET	DT	_	2	nsubj	_	_
2	include	_	VERB	VBP	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	specific	_	ADJ	JJ	_	5	amod	_	_
5	antipsychotics	_	NOUN	NNS	_	2	dep	_	_
6	e.g	_	NOUN	NN	_	5	dep	_	_
7	,	_	.	,	_	6	punct	_	_
8	ziprasidone	_	NOUN	NN	_	6	conj	_	_
9	,	_	.	,	_	6	punct	_	_
10	iloperidone	_	NOUN	NN	_	6	conj	_	_
11	,	_	.	,	_	6	punct	_	_
12	chlorpromazine	_	NOUN	NN	_	6	conj	_	_
13	,	_	.	,	_	6	punct	_	_
14	mesoridazine	_	NOUN	NN	_	6	conj	_	_
15	,	_	.	,	_	6	punct	_	_
16	droperidol	_	NOUN	NN	_	18	compound	_	_
17	specific	_	ADJ	JJ	_	18	amod	_	_
18	antibiotics	_	NOUN	NNS	_	6	appos	_	_
19	e.g	_	NOUN	NN	_	18	dep	_	_
20	,	_	.	,	_	19	punct	_	_
21	erythromycin	_	NOUN	NN	_	19	conj	_	_
22	,	_	.	,	_	19	punct	_	_
23	gatifloxacin	_	NOUN	NN	_	19	conj	_	_
24	,	_	.	,	_	19	punct	_	_
25	moxifloxacin	_	NOUN	NN	_	19	conj	_	_
26	,	_	.	,	_	19	punct	_	_
27	sparfloxacin	_	NOUN	NN	_	31	compound	_	_
28	Class	_	NOUN	NN	_	31	compound	_	_
29	1A	_	NOUN	NN	_	31	compound	_	_
30	antiarrhythmic	_	ADJ	JJ	_	31	amod	_	_
31	medications	_	NOUN	NNS	_	19	appos	_	_
32	e.g	_	NOUN	NN	_	31	dep	_	_
33	,	_	.	,	_	32	punct	_	_
34	quinidine	_	NOUN	NN	_	32	conj	_	_
35	,	_	.	,	_	32	punct	_	_
36	procainamide	_	NOUN	NN	_	39	compound	_	_
37	Class	_	NOUN	NN	_	39	compound	_	_
38	III	_	NUM	CD	_	39	nummod	_	_
39	antiarrhythmics	_	NOUN	NNS	_	32	conj	_	_
40	e.g	_	NOUN	NN	_	39	dep	_	_
41	,	_	.	,	_	40	punct	_	_
42	amiodarone	_	NOUN	NN	_	40	conj	_	_
43	,	_	.	,	_	40	punct	_	_
44	sotalol	_	NOUN	NN	_	40	conj	_	_
45	and	_	CONJ	CC	_	40	cc	_	_
46	others	_	NOUN	NNS	_	40	conj	_	_
47	e.g	_	NOUN	NN	_	46	dep	_	_
48	,	_	.	,	_	47	punct	_	_
49	pentamidine	_	NOUN	NN	_	47	conj	_	_
50	,	_	.	,	_	47	punct	_	_
51	levomethadyl	_	NOUN	NN	_	52	compound	_	_
52	acetate	_	NOUN	NN	_	47	conj	_	_
53	,	_	.	,	_	47	punct	_	_
54	methadone	_	NOUN	NN	_	47	conj	_	_
55	,	_	.	,	_	47	punct	_	_
56	halofantrine	_	NOUN	NN	_	47	conj	_	_
57	,	_	.	,	_	47	punct	_	_
58	mefloquine	_	NOUN	NN	_	47	conj	_	_
59	,	_	.	,	_	47	punct	_	_
60	dolasetron	_	NOUN	NN	_	61	compound	_	_
61	mesylate	_	NOUN	NN	_	47	conj	_	_
62	,	_	.	,	_	47	punct	_	_
63	probucol	_	NOUN	NN	_	47	conj	_	_
64	or	_	CONJ	CC	_	47	cc	_	_
65	tacrolimus	_	NOUN	NN	_	47	conj	_	_

#	Prozac	3774
1	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
2	is	_	VERB	VBZ	_	4	auxpass	_	_
3	primarily	_	ADV	RB	_	4	advmod	_	_
4	metabolized	_	VERB	VBN	_	0	root	_	_
5	by	_	ADP	IN	_	6	case	_	_
6	CYP2D6	_	NOUN	NN	_	4	nmod	_	_

#	Prozac	3775
1	Concomitant	_	ADJ	JJ	_	2	amod	_	_
2	treatment	_	NOUN	NN	_	7	nsubj	_	_
3	with	_	ADP	IN	_	5	case	_	_
4	CYP2D6	_	NOUN	NN	_	5	compound	_	_
5	inhibitors	_	NOUN	NNS	_	2	nmod	_	_
6	can	_	VERB	MD	_	7	aux	_	_
7	increase	_	VERB	VB	_	0	root	_	_
8	the	_	DET	DT	_	9	det	_	_
9	concentration	_	NOUN	NN	_	7	dobj	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_

#	Prozac	3776
1	Concomitant	_	ADJ	JJ	_	2	amod	_	_
2	use	_	NOUN	NN	_	10	nsubj	_	_
3	of	_	ADP	IN	_	8	case	_	_
4	other	_	ADJ	JJ	_	8	amod	_	_
5	highly	_	ADV	RB	_	8	advmod	_	_
6	protein	_	NOUN	NN	_	8	compound	_	_
7	bound	_	ADJ	JJ	_	8	amod	_	_
8	drugs	_	NOUN	NNS	_	2	nmod	_	_
9	can	_	VERB	MD	_	10	aux	_	_
10	increase	_	VERB	VB	_	0	root	_	_
11	the	_	DET	DT	_	12	det	_	_
12	concentration	_	NOUN	NN	_	10	dobj	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	DRUG	_	NOUN	NN	_	12	nmod	_	_

#	Prozac	3777
1	Although	_	ADP	IN	_	8	mark	_	_
2	the	_	DET	DT	_	4	det	_	_
3	exact	_	ADJ	JJ	_	4	amod	_	_
4	mechanism	_	NOUN	NN	_	8	nsubj	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	is	_	VERB	VBZ	_	8	cop	_	_
8	unknown	_	ADJ	JJ	_	12	advcl	_	_
9	,	_	.	,	_	12	punct	_	_
10	it	_	PRON	PRP	_	12	nsubjpass	_	_
11	is	_	VERB	VBZ	_	12	auxpass	_	_
12	presumed	_	VERB	VBN	_	0	root	_	_
13	to	_	PRT	TO	_	15	mark	_	_
14	be	_	VERB	VB	_	15	auxpass	_	_
15	linked	_	VERB	VBN	_	12	xcomp	_	_
16	to	_	PRT	TO	_	18	case	_	_
17	its	_	PRON	PRP$	_	18	nmod:poss	_	_
18	inhibition	_	NOUN	NN	_	15	nmod	_	_
19	of	_	ADP	IN	_	22	case	_	_
20	CNS	_	NOUN	NN	_	22	compound	_	_
21	neuronal	_	ADJ	JJ	_	22	amod	_	_
22	uptake	_	NOUN	NN	_	18	nmod	_	_
23	of	_	ADP	IN	_	24	case	_	_
24	serotonin	_	NOUN	NN	_	22	nmod	_	_

#	Prozac	3778
1	Studies	_	NOUN	NNS	_	9	nsubj	_	_
2	at	_	ADP	IN	_	5	case	_	_
3	clinically	_	ADV	RB	_	4	advmod	_	_
4	relevant	_	ADJ	JJ	_	5	amod	_	_
5	doses	_	NOUN	NNS	_	1	nmod	_	_
6	in	_	ADP	IN	_	7	compound	_	_
7	man	_	VERB	MD	_	9	aux	_	_
8	have	_	VERB	VB	_	9	aux	_	_
9	demonstrated	_	VERB	VBN	_	0	root	_	_
10	that	_	ADP	IN	_	12	mark	_	_
11	DRUG	_	NOUN	NN	_	12	nsubj	_	_
12	blocks	_	VERB	VBZ	_	9	ccomp	_	_
13	the	_	DET	DT	_	14	det	_	_
14	uptake	_	NOUN	NN	_	12	dobj	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	serotonin	_	NOUN	NN	_	14	nmod	_	_
17	into	_	ADP	IN	_	19	case	_	_
18	human	_	ADJ	JJ	_	19	amod	_	_
19	platelets	_	NOUN	NNS	_	14	nmod	_	_

#	Prozac	3779
1	Studies	_	NOUN	NNS	_	5	nsubj	_	_
2	in	_	ADP	IN	_	3	case	_	_
3	animals	_	NOUN	NNS	_	1	nmod	_	_
4	also	_	ADV	RB	_	5	advmod	_	_
5	suggest	_	VERB	VBP	_	0	root	_	_
6	that	_	ADP	IN	_	14	mark	_	_
7	DRUG	_	NOUN	NN	_	14	nsubj	_	_
8	is	_	VERB	VBZ	_	14	cop	_	_
9	a	_	DET	DT	_	14	det	_	_
10	much	_	ADV	RB	_	11	advmod	_	_
11	more	_	ADV	RB	_	12	advmod	_	_
12	potent	_	ADJ	JJ	_	14	amod	_	_
13	uptake	_	NOUN	NN	_	14	compound	_	_
14	inhibitor	_	NOUN	NN	_	5	ccomp	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	serotonin	_	NOUN	NN	_	14	nmod	_	_
17	than	_	ADP	IN	_	19	case	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	norepinephrine	_	NOUN	NN	_	14	nmod	_	_

#	Prozac	3780
1	Antagonism	_	NOUN	NN	_	13	nsubjpass	_	_
2	of	_	ADP	IN	_	10	case	_	_
3	muscarinic	_	ADJ	JJ	_	10	amod	_	_
4	,	_	.	,	_	3	punct	_	_
5	histaminergic	_	ADJ	JJ	_	3	conj	_	_
6	,	_	.	,	_	3	punct	_	_
7	and	_	CONJ	CC	_	3	cc	_	_
8	A1	_	NOUN	NN	_	3	conj	_	_
9	adrenergic	_	ADJ	JJ	_	10	amod	_	_
10	receptors	_	NOUN	NNS	_	1	nmod	_	_
11	has	_	VERB	VBZ	_	13	aux	_	_
12	been	_	VERB	VBN	_	13	auxpass	_	_
13	hypothesized	_	VERB	VBN	_	0	root	_	_
14	to	_	PRT	TO	_	16	mark	_	_
15	be	_	VERB	VB	_	16	auxpass	_	_
16	associated	_	VERB	VBN	_	13	xcomp	_	_
17	with	_	ADP	IN	_	19	case	_	_
18	various	_	ADJ	JJ	_	19	amod	_	_
19	anticholinergic	_	ADJ	JJ	_	16	nmod	_	_
20	,	_	.	,	_	19	punct	_	_
21	sedative	_	ADJ	JJ	_	19	conj	_	_
22	,	_	.	,	_	19	punct	_	_
23	and	_	CONJ	CC	_	19	cc	_	_
24	cardiovascular	_	ADJ	JJ	_	19	conj	_	_
25	effects	_	NOUN	NNS	_	19	dep	_	_
26	of	_	ADP	IN	_	30	case	_	_
27	classical	_	ADJ	JJ	_	30	amod	_	_
28	tricyclic	_	ADJ	JJ	_	30	amod	_	_
29	antidepressant(TCA	_	ADJ	JJ	_	30	amod	_	_
30	drugs	_	NOUN	NNS	_	19	nmod	_	_

#	Prozac	3781
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	binds	_	VERB	VBZ	_	0	root	_	_
3	to	_	PRT	TO	_	8	case	_	_
4	these	_	DET	DT	_	8	amod	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	other	_	ADJ	JJ	_	4	conj	_	_
7	membrane	_	NOUN	NN	_	8	compound	_	_
8	receptors	_	NOUN	NNS	_	2	nmod	_	_
9	from	_	ADP	IN	_	11	case	_	_
10	brain	_	NOUN	NN	_	11	compound	_	_
11	tissue	_	NOUN	NN	_	8	nmod	_	_
12	much	_	ADV	RB	_	14	advmod	_	_
13	less	_	ADV	RB	_	14	advmod	_	_
14	potently	_	ADV	RB	_	15	advmod	_	_
15	invitro	_	VERB	VB	_	2	advcl	_	_
16	than	_	ADP	IN	_	20	case	_	_
17	do	_	VERB	VB	_	20	compound	_	_
18	the	_	DET	DT	_	20	det	_	_
19	tricyclic	_	ADJ	JJ	_	20	amod	_	_
20	drugs	_	NOUN	NNS	_	15	nmod	_	_

#	Prozac	3782
1	Systemic	_	ADJ	JJ	_	2	amod	_	_
2	Bioavailability	_	NOUN	NN	_	24	nsubjpass	_	_
3	In	_	X	FW	_	4	compound	_	_
4	man	_	VERB	MD	_	2	advmod	_	_
5	,	_	.	,	_	2	punct	_	_
6	following	_	VERB	VBG	_	11	case	_	_
7	a	_	DET	DT	_	11	det	_	_
8	single	_	ADJ	JJ	_	11	amod	_	_
9	oral	_	ADJ	JJ	_	11	amod	_	_
10	40	_	NUM	CD	_	11	nummod	_	_
11	mgdose	_	NOUN	NN	_	2	nmod	_	_
12	,	_	.	,	_	2	punct	_	_
13	peak	_	ADJ	JJ	_	15	amod	_	_
14	plasma	_	NOUN	NN	_	15	compound	_	_
15	concentrations	_	NOUN	NNS	_	2	appos	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	DRUG	_	NOUN	NN	_	15	nmod	_	_
18	from	_	ADP	IN	_	22	case	_	_
19	15to	_	ADJ	JJ	_	22	amod	_	_
20	55ng	_	ADJ	JJ	_	22	amod	_	_
21	/	_	.	:	_	22	punct	_	_
22	mL	_	NOUN	NN	_	15	nmod	_	_
23	are	_	VERB	VBP	_	24	auxpass	_	_
24	observed	_	VERB	VBN	_	0	root	_	_
25	after	_	ADP	IN	_	27	case	_	_
26	6to	_	ADJ	JJ	_	27	amod	_	_
27	8hours	_	NOUN	NNS	_	24	nmod	_	_

#	Prozac	3783
1	The	_	DET	DT	_	2	dep	_	_
2	Pulvule	_	NOUN	NN	_	8	compound	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	DRUG	_	NOUN	NN	_	2	conj	_	_
5	Weekly	_	ADV	RB	_	6	advmod	_	_
6	capsule	_	NOUN	NN	_	8	compound	_	_
7	dosage	_	NOUN	NN	_	8	compound	_	_
8	forms	_	NOUN	NNS	_	12	nsubj	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	are	_	VERB	VBP	_	12	auxpass	_	_
12	bioequivalent	_	ADJ	JJ	_	0	root	_	_

#	Prozac	3784
1	Food	_	NOUN	NN	_	4	nsubj	_	_
2	does	_	VERB	VBZ	_	4	aux	_	_
3	not	_	ADV	RB	_	4	neg	_	_
4	appear	_	VERB	VB	_	0	root	_	_
5	to	_	PRT	TO	_	6	mark	_	_
6	affect	_	VERB	VB	_	4	xcomp	_	_
7	the	_	DET	DT	_	9	det	_	_
8	systemic	_	ADJ	JJ	_	9	amod	_	_
9	bioavailability	_	NOUN	NN	_	6	dobj	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_
12	,	_	.	,	_	4	punct	_	_
13	although	_	ADP	IN	_	16	mark	_	_
14	it	_	PRON	PRP	_	16	nsubj	_	_
15	may	_	VERB	MD	_	16	aux	_	_
16	delay	_	VERB	VB	_	4	advcl	_	_
17	its	_	PRON	PRP$	_	18	nmod:poss	_	_
18	absorption	_	NOUN	NN	_	16	dobj	_	_
19	by	_	ADP	IN	_	21	case	_	_
20	1to	_	ADJ	JJ	_	21	amod	_	_
21	2hours	_	NOUN	NNS	_	18	nmod	_	_
22	,	_	.	,	_	21	punct	_	_
23	which	_	DET	WDT	_	28	nsubj	_	_
24	is	_	VERB	VBZ	_	28	auxpass	_	_
25	probably	_	ADV	RB	_	28	advmod	_	_
26	not	_	ADV	RB	_	28	neg	_	_
27	clinically	_	ADV	RB	_	28	advmod	_	_
28	significant	_	ADJ	JJ	_	21	acl:relcl	_	_

#	Prozac	3785
1	Thus	_	ADV	RB	_	6	advmod	_	_
2	,	_	.	,	_	6	punct	_	_
3	DRUG	_	NOUN	NN	_	6	nsubjpass	_	_
4	may	_	VERB	MD	_	6	aux	_	_
5	be	_	VERB	VB	_	6	auxpass	_	_
6	administered	_	VERB	VBN	_	0	root	_	_
7	with	_	ADP	IN	_	6	nmod	_	_
8	or	_	CONJ	CC	_	7	cc	_	_
9	without	_	ADP	IN	_	7	conj	_	_
10	food	_	NOUN	NN	_	7	dep	_	_

#	Prozac	3786
1	DRUG	_	NOUN	NN	_	3	compound	_	_
2	Weekly	_	ADV	RB	_	3	amod	_	_
3	capsules	_	NOUN	NNS	_	10	nsubj	_	_
4	,	_	.	,	_	3	punct	_	_
5	a	_	DET	DT	_	8	det	_	_
6	delayed	_	VERB	VBN	_	8	amod	_	_
7	release	_	NOUN	NN	_	8	compound	_	_
8	formulation	_	NOUN	NN	_	3	appos	_	_
9	,	_	.	,	_	3	punct	_	_
10	contain	_	VERB	VBP	_	0	root	_	_
11	enteric	_	ADJ	JJ	_	13	amod	_	_
12	coated	_	ADJ	JJ	_	13	amod	_	_
13	pellets	_	NOUN	NNS	_	10	dobj	_	_
14	that	_	DET	WDT	_	15	nsubj	_	_
15	resist	_	VERB	VBP	_	13	acl:relcl	_	_
16	dissolution	_	NOUN	NN	_	15	dobj	_	_
17	until	_	ADP	IN	_	18	mark	_	_
18	reaching	_	VERB	VBG	_	15	advcl	_	_
19	a	_	DET	DT	_	20	det	_	_
20	segment	_	NOUN	NN	_	18	dobj	_	_
21	of	_	ADP	IN	_	24	case	_	_
22	the	_	DET	DT	_	24	det	_	_
23	gastrointestinal	_	ADJ	JJ	_	24	amod	_	_
24	tract	_	NOUN	NN	_	20	nmod	_	_
25	where	_	ADV	WRB	_	24	advmod	_	_
26	the	_	DET	DT	_	27	det	_	_
27	pHexceeds5.5	_	NOUN	NN	_	25	nmod	_	_

#	Prozac	3787
1	The	_	DET	DT	_	3	det	_	_
2	enteric	_	ADJ	JJ	_	3	amod	_	_
3	coating	_	NOUN	NN	_	4	nsubj	_	_
4	delays	_	VERB	VBZ	_	0	root	_	_
5	the	_	DET	DT	_	6	det	_	_
6	onset	_	NOUN	NN	_	4	dobj	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	absorption	_	NOUN	NN	_	6	nmod	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	1to	_	PRT	POS	_	12	case	_	_
12	2hours	_	NOUN	NNS	_	4	nmod	_	_
13	relative	_	ADJ	JJ	_	12	amod	_	_
14	to	_	PRT	TO	_	18	case	_	_
15	the	_	DET	DT	_	18	det	_	_
16	immediate	_	ADJ	JJ	_	18	amod	_	_
17	release	_	NOUN	NN	_	18	compound	_	_
18	formulations	_	NOUN	NNS	_	13	nmod	_	_

#	Prozac	3788
1	Protein	_	NOUN	NN	_	3	compound	_	_
2	Binding	_	NOUN	NN	_	3	compound	_	_
3	Over	_	NOUN	NN	_	0	root	_	_
4	the	_	DET	DT	_	6	det	_	_
5	concentration	_	NOUN	NN	_	6	compound	_	_
6	range	_	NOUN	NN	_	3	dep	_	_
7	from	_	ADP	IN	_	11	case	_	_
8	200to	_	ADJ	JJ	_	11	amod	_	_
9	1000ng	_	ADJ	JJ	_	11	amod	_	_
10	/	_	.	:	_	11	punct	_	_
11	mL	_	NOUN	NN	_	6	nmod	_	_
12	,	_	.	,	_	3	punct	_	_
13	approximately94.5%	_	NOUN	NN	_	17	nsubjpass	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	DRUG	_	NOUN	NN	_	13	nmod	_	_
16	is	_	VERB	VBZ	_	17	auxpass	_	_
17	bound	_	VERB	VBN	_	3	acl:relcl	_	_
18	invitro	_	ADV	RB	_	17	advmod	_	_
19	to	_	PRT	TO	_	22	case	_	_
20	human	_	ADJ	JJ	_	22	amod	_	_
21	serum	_	NOUN	NN	_	22	compound	_	_
22	proteins	_	NOUN	NNS	_	18	nmod	_	_
23	,	_	.	,	_	3	punct	_	_
24	including	_	VERB	VBG	_	25	case	_	_
25	albumin	_	NOUN	NN	_	3	nmod	_	_
26	and	_	CONJ	CC	_	25	cc	_	_
27	A1	_	NOUN	NN	_	28	compound	_	_
28	glycoprotein	_	NOUN	NN	_	25	conj	_	_

#	Prozac	3789
1	The	_	DET	DT	_	2	det	_	_
2	interaction	_	NOUN	NN	_	15	nsubjpass	_	_
3	between	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	other	_	ADJ	JJ	_	10	amod	_	_
7	highly	_	ADV	RB	_	10	advmod	_	_
8	protein	_	NOUN	NN	_	10	compound	_	_
9	bound	_	ADJ	JJ	_	10	amod	_	_
10	drugs	_	NOUN	NNS	_	4	conj	_	_
11	has	_	VERB	VBZ	_	15	aux	_	_
12	not	_	ADV	RB	_	15	neg	_	_
13	been	_	VERB	VBN	_	15	auxpass	_	_
14	fully	_	ADV	RB	_	15	advmod	_	_
15	evaluated	_	VERB	VBN	_	0	root	_	_
16	,	_	.	,	_	15	punct	_	_
17	but	_	CONJ	CC	_	15	cc	_	_
18	may	_	VERB	MD	_	20	aux	_	_
19	be	_	VERB	VB	_	20	auxpass	_	_
20	important	_	ADJ	JJ	_	15	conj	_	_

#	Prozac	3790
1	Enantiomers	_	NOUN	NNS	_	2	compound	_	_
2	DRUG	_	NOUN	NN	_	6	nsubj	_	_
3	is	_	VERB	VBZ	_	6	cop	_	_
4	a	_	DET	DT	_	6	det	_	_
5	racemic	_	ADJ	JJ	_	6	amod	_	_
6	mixture(50	_	NOUN	NN	_	0	root	_	_
7	/	_	.	:	_	6	punct	_	_
8	50	_	NUM	CD	_	11	nummod	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	R	_	NOUN	NN	_	11	compound	_	_
11	DRUG	_	NOUN	NN	_	6	dep	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	S	_	NOUN	NN	_	15	compound	_	_
14	DRUG	_	NOUN	NN	_	15	compound	_	_
15	enantiomers	_	NOUN	NNS	_	11	conj	_	_

#	Prozac	3791
1	In	_	ADP	IN	_	3	case	_	_
2	animal	_	NOUN	NN	_	3	compound	_	_
3	models	_	NOUN	NNS	_	8	nmod	_	_
4	,	_	.	,	_	8	punct	_	_
5	both	_	DET	DT	_	6	det	_	_
6	enantiomers	_	NOUN	NNS	_	8	nsubj	_	_
7	are	_	VERB	VBP	_	8	cop	_	_
8	specific	_	ADJ	JJ	_	0	root	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	potent	_	ADJ	JJ	_	8	conj	_	_
11	DRUGS	_	NOUN	NN	_	8	dep	_	_
12	with	_	ADP	IN	_	16	case	_	_
13	essentially	_	ADV	RB	_	14	advmod	_	_
14	equivalent	_	ADJ	JJ	_	16	amod	_	_
15	pharmacologic	_	ADJ	JJ	_	16	amod	_	_
16	activity	_	NOUN	NN	_	8	nmod	_	_

#	Prozac	3792
1	The	_	DET	DT	_	4	det	_	_
2	S	_	NOUN	NN	_	4	compound	_	_
3	DRUG	_	NOUN	NN	_	4	compound	_	_
4	enantiomer	_	NOUN	NN	_	6	nsubjpass	_	_
5	is	_	VERB	VBZ	_	6	auxpass	_	_
6	eliminated	_	VERB	VBN	_	0	root	_	_
7	more	_	ADV	RB	_	8	advmod	_	_
8	slowly	_	ADV	RB	_	6	advmod	_	_
9	and	_	CONJ	CC	_	6	cc	_	_
10	is	_	VERB	VBZ	_	13	cop	_	_
11	the	_	DET	DT	_	13	det	_	_
12	predominant	_	ADJ	JJ	_	13	amod	_	_
13	enantiomer	_	NOUN	NN	_	6	conj	_	_
14	present	_	ADJ	JJ	_	13	amod	_	_
15	in	_	ADP	IN	_	16	case	_	_
16	plasma	_	NOUN	NN	_	14	nmod	_	_
17	at	_	ADP	IN	_	19	case	_	_
18	steady	_	ADJ	JJ	_	19	amod	_	_
19	state	_	NOUN	NN	_	14	nmod	_	_

#	Prozac	3793
1	Metabolism	_	NOUN	NN	_	2	compound	_	_
2	DRUG	_	NOUN	NN	_	5	nsubjpass	_	_
3	is	_	VERB	VBZ	_	5	auxpass	_	_
4	extensively	_	ADV	RB	_	5	advmod	_	_
5	metabolized	_	VERB	VBN	_	0	root	_	_
6	in	_	ADP	IN	_	8	case	_	_
7	the	_	DET	DT	_	8	det	_	_
8	liver	_	NOUN	NN	_	5	nmod	_	_
9	to	_	PRT	TO	_	8	dep	_	_
10	nor	_	CONJ	CC	_	9	cc	_	_
11	DRUG	_	NOUN	NN	_	9	conj	_	_
12	and	_	CONJ	CC	_	5	cc	_	_
13	a	_	DET	DT	_	14	det	_	_
14	number	_	NOUN	NN	_	5	conj	_	_
15	of	_	ADP	IN	_	18	case	_	_
16	other	_	ADJ	JJ	_	18	amod	_	_
17	unidentified	_	ADJ	JJ	_	18	amod	_	_
18	metabolites	_	NOUN	NNS	_	14	nmod	_	_

#	Prozac	3794
1	The	_	DET	DT	_	5	det	_	_
2	only	_	ADV	RB	_	3	advmod	_	_
3	identified	_	VERB	VBN	_	5	amod	_	_
4	active	_	ADJ	JJ	_	5	amod	_	_
5	metabolite	_	NOUN	NN	_	11	nsubjpass	_	_
6	,	_	.	,	_	5	punct	_	_
7	nor	_	CONJ	CC	_	5	cc	_	_
8	DRUG	_	NOUN	NN	_	5	conj	_	_
9	,	_	.	,	_	5	punct	_	_
10	is	_	VERB	VBZ	_	11	auxpass	_	_
11	formed	_	VERB	VBN	_	0	root	_	_
12	by	_	ADP	IN	_	13	case	_	_
13	demethylation	_	NOUN	NN	_	11	nmod	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	DRUG	_	NOUN	NN	_	13	nmod	_	_

#	Prozac	3795
1	In	_	ADP	IN	_	3	case	_	_
2	animal	_	NOUN	NN	_	3	compound	_	_
3	models	_	NOUN	NNS	_	13	nmod	_	_
4	,	_	.	,	_	13	punct	_	_
5	S	_	NOUN	NN	_	13	nsubj	_	_
6	nor	_	CONJ	CC	_	5	cc	_	_
7	DRUG	_	NOUN	NN	_	5	conj	_	_
8	is	_	VERB	VBZ	_	13	cop	_	_
9	a	_	DET	DT	_	13	det	_	_
10	potent	_	ADJ	JJ	_	13	amod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	selective	_	ADJ	JJ	_	10	conj	_	_
13	inhibitor	_	NOUN	NN	_	0	root	_	_
14	of	_	ADP	IN	_	16	case	_	_
15	serotonin	_	NOUN	NN	_	16	compound	_	_
16	uptake	_	NOUN	NN	_	13	nmod	_	_
17	and	_	CONJ	CC	_	13	cc	_	_
18	has	_	VERB	VBZ	_	13	conj	_	_
19	activity	_	NOUN	NN	_	18	dobj	_	_
20	essentially	_	ADV	RB	_	21	advmod	_	_
21	equivalent	_	ADJ	JJ	_	19	amod	_	_
22	to	_	PRT	TO	_	23	case	_	_
23	R	_	NOUN	NN	_	21	nmod	_	_
24	or	_	CONJ	CC	_	23	cc	_	_
25	S	_	NOUN	NN	_	26	compound	_	_
26	DRUG	_	NOUN	NN	_	23	conj	_	_

#	Prozac	3796
1	R	_	NOUN	NN	_	7	nsubj	_	_
2	nor	_	CONJ	CC	_	1	cc	_	_
3	DRUG	_	NOUN	NN	_	1	conj	_	_
4	is	_	VERB	VBZ	_	7	cop	_	_
5	significantly	_	ADV	RB	_	7	advmod	_	_
6	less	_	ADV	RB	_	7	advmod	_	_
7	potent	_	ADJ	JJ	_	0	root	_	_
8	than	_	ADP	IN	_	11	case	_	_
9	the	_	DET	DT	_	11	det	_	_
10	parent	_	NOUN	NN	_	11	compound	_	_
11	drug	_	NOUN	NN	_	7	nmod	_	_
12	in	_	ADP	IN	_	14	case	_	_
13	the	_	DET	DT	_	14	det	_	_
14	inhibition	_	NOUN	NN	_	11	nmod	_	_
15	of	_	ADP	IN	_	17	case	_	_
16	serotonin	_	NOUN	NN	_	17	compound	_	_
17	uptake	_	NOUN	NN	_	14	nmod	_	_

#	Prozac	3797
1	The	_	DET	DT	_	3	det	_	_
2	primary	_	ADJ	JJ	_	3	amod	_	_
3	route	_	NOUN	NN	_	6	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	elimination	_	NOUN	NN	_	3	nmod	_	_
6	appears	_	VERB	VBZ	_	0	root	_	_
7	to	_	PRT	TO	_	10	mark	_	_
8	be	_	VERB	VB	_	10	cop	_	_
9	hepatic	_	ADJ	JJ	_	10	amod	_	_
10	metabolism	_	NOUN	NN	_	6	xcomp	_	_
11	to	_	PRT	TO	_	13	case	_	_
12	inactive	_	ADJ	JJ	_	13	amod	_	_
13	metabolites	_	NOUN	NNS	_	10	nmod	_	_
14	excreted	_	VERB	VBN	_	13	acl	_	_
15	by	_	ADP	IN	_	17	case	_	_
16	the	_	DET	DT	_	17	det	_	_
17	kidney	_	NOUN	NN	_	14	nmod	_	_

#	Prozac	3798
1	Variability	_	NOUN	NN	_	11	nsubj	_	_
2	in	_	ADP	IN	_	6	case	_	_
3	Metabolism	_	NOUN	NN	_	6	compound	_	_
4	A	_	NOUN	NN	_	6	compound	_	_
5	subset	_	NOUN	NN	_	6	compound	_	_
6	about7%	_	NOUN	NN	_	1	nmod	_	_
7	of	_	ADP	IN	_	9	case	_	_
8	the	_	DET	DT	_	9	det	_	_
9	population	_	NOUN	NN	_	6	nmod	_	_
10	has	_	VERB	VBZ	_	11	aux	_	_
11	reduced	_	VERB	VBN	_	0	root	_	_
12	activity	_	NOUN	NN	_	11	dobj	_	_
13	of	_	ADP	IN	_	18	case	_	_
14	the	_	DET	DT	_	18	det	_	_
15	drug	_	NOUN	NN	_	18	compound	_	_
16	metabolizing	_	NOUN	NN	_	18	compound	_	_
17	enzyme	_	NOUN	NN	_	18	compound	_	_
18	cytochrome	_	NOUN	NN	_	12	nmod	_	_
19	P4502D6(CYP2D6	_	NOUN	NN	_	18	dep	_	_

#	Prozac	3799
1	Such	_	ADJ	JJ	_	2	amod	_	_
2	individuals	_	NOUN	NNS	_	4	nsubjpass	_	_
3	are	_	VERB	VBP	_	4	auxpass	_	_
4	referred	_	VERB	VBN	_	0	root	_	_
5	to	_	PRT	TO	_	8	case	_	_
6	as	_	ADP	IN	_	8	case	_	_
7	"poor	_	ADJ	JJ	_	8	amod	_	_
8	metabolizers"	_	NOUN	NN	_	4	nmod	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	drugs	_	NOUN	NNS	_	8	nmod	_	_
11	such	_	ADJ	JJ	_	13	case	_	_
12	as	_	ADP	IN	_	11	mwe	_	_
13	debrisoquin	_	NOUN	NN	_	10	nmod	_	_
14	,	_	.	,	_	13	punct	_	_
15	dextromethorphan	_	NOUN	NN	_	13	conj	_	_
16	,	_	.	,	_	13	punct	_	_
17	and	_	CONJ	CC	_	13	cc	_	_
18	the	_	DET	DT	_	19	det	_	_
19	TCAs	_	NOUN	NNS	_	13	conj	_	_

#	Prozac	3800
1	In	_	ADP	IN	_	3	case	_	_
2	a	_	DET	DT	_	3	det	_	_
3	study	_	NOUN	NN	_	16	nmod	_	_
4	involving	_	VERB	VBG	_	3	acl	_	_
5	labeled	_	ADJ	JJ	_	8	amod	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	unlabeled	_	ADJ	JJ	_	5	conj	_	_
8	enantiomers	_	NOUN	NNS	_	4	dobj	_	_
9	administered	_	VERB	VBN	_	8	acl	_	_
10	as	_	ADP	IN	_	12	case	_	_
11	a	_	DET	DT	_	12	det	_	_
12	racemate	_	NOUN	NN	_	9	nmod	_	_
13	,	_	.	,	_	16	punct	_	_
14	these	_	DET	DT	_	15	det	_	_
15	individuals	_	NOUN	NNS	_	16	nsubj	_	_
16	metabolized	_	VERB	VBD	_	0	root	_	_
17	S	_	NOUN	NN	_	18	compound	_	_
18	DRUG	_	NOUN	NN	_	16	dobj	_	_
19	at	_	ADP	IN	_	22	case	_	_
20	a	_	DET	DT	_	22	det	_	_
21	slower	_	ADJ	JJ	_	22	amod	_	_
22	rate	_	NOUN	NN	_	16	nmod	_	_
23	and	_	CONJ	CC	_	16	cc	_	_
24	thus	_	ADV	RB	_	25	advmod	_	_
25	achieved	_	VERB	VBN	_	16	conj	_	_
26	higher	_	ADJ	JJ	_	27	amod	_	_
27	concentrations	_	NOUN	NNS	_	25	dobj	_	_
28	of	_	ADP	IN	_	30	case	_	_
29	S	_	NOUN	NN	_	30	compound	_	_
30	DRUG	_	NOUN	NN	_	27	nmod	_	_

#	Prozac	3801
1	Consequently	_	ADV	RB	_	12	advmod	_	_
2	,	_	.	,	_	12	punct	_	_
3	concentrations	_	NOUN	NNS	_	12	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	S	_	NOUN	NN	_	3	nmod	_	_
6	nor	_	CONJ	CC	_	5	cc	_	_
7	DRUG	_	NOUN	NN	_	5	conj	_	_
8	at	_	ADP	IN	_	10	case	_	_
9	steady	_	ADJ	JJ	_	10	amod	_	_
10	state	_	NOUN	NN	_	3	nmod	_	_
11	were	_	VERB	VBD	_	12	auxpass	_	_
12	lower	_	ADJ	JJ	_	0	root	_	_

#	Prozac	3802
1	The	_	DET	DT	_	2	det	_	_
2	metabolism	_	NOUN	NN	_	10	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	R	_	NOUN	NN	_	5	compound	_	_
5	DRUG	_	NOUN	NN	_	2	nmod	_	_
6	in	_	ADP	IN	_	9	case	_	_
7	these	_	DET	DT	_	9	det	_	_
8	poor	_	ADJ	JJ	_	9	amod	_	_
9	metabolizers	_	NOUN	NNS	_	2	nmod	_	_
10	appears	_	VERB	VBZ	_	0	root	_	_
11	normal	_	ADJ	JJ	_	10	root	_	_

#	Prozac	3803
1	When	_	ADV	WRB	_	2	advmod	_	_
2	compared	_	VERB	VBN	_	24	advcl	_	_
3	with	_	ADP	IN	_	5	case	_	_
4	normal	_	ADJ	JJ	_	5	amod	_	_
5	metabolizers	_	NOUN	NNS	_	2	nmod	_	_
6	,	_	.	,	_	24	punct	_	_
7	the	_	DET	DT	_	9	det	_	_
8	total	_	ADJ	JJ	_	9	amod	_	_
9	sum	_	NOUN	NN	_	24	nsubj	_	_
10	at	_	ADP	IN	_	12	case	_	_
11	steady	_	ADJ	JJ	_	12	amod	_	_
12	state	_	NOUN	NN	_	9	nmod	_	_
13	of	_	ADP	IN	_	16	case	_	_
14	the	_	DET	DT	_	16	det	_	_
15	plasma	_	NOUN	NN	_	16	compound	_	_
16	concentrations	_	NOUN	NNS	_	12	nmod	_	_
17	of	_	ADP	IN	_	20	case	_	_
18	the	_	DET	DT	_	20	det	_	_
19	4active	_	ADJ	JJ	_	20	amod	_	_
20	enantiomers	_	NOUN	NNS	_	16	nmod	_	_
21	was	_	VERB	VBD	_	24	cop	_	_
22	not	_	ADV	RB	_	24	neg	_	_
23	significantly	_	ADV	RB	_	24	advmod	_	_
24	greater	_	ADJ	JJ	_	0	root	_	_
25	among	_	ADP	IN	_	27	case	_	_
26	poor	_	ADJ	JJ	_	27	amod	_	_
27	metabolizers	_	NOUN	NNS	_	24	nmod	_	_

#	Prozac	3804
1	Thus	_	ADV	RB	_	10	advmod	_	_
2	,	_	.	,	_	10	punct	_	_
3	the	_	DET	DT	_	6	det	_	_
4	net	_	ADV	RB	_	5	advmod	_	_
5	pharmacodynamic	_	ADJ	JJ	_	6	amod	_	_
6	activities	_	NOUN	NNS	_	10	nsubj	_	_
7	were	_	VERB	VBD	_	10	cop	_	_
8	essentially	_	ADV	RB	_	10	advmod	_	_
9	the	_	DET	DT	_	10	det	_	_
10	same	_	ADJ	JJ	_	0	root	_	_

#	Prozac	3805
1	Alternative	_	ADJ	JJ	_	4	amod	_	_
2	,	_	.	,	_	1	punct	_	_
3	nonsaturable	_	ADJ	JJ	_	1	dep	_	_
4	pathways	_	NOUN	NNS	_	8	nsubj	_	_
5	non	_	ADJ	JJ	_	6	amod	_	_
6	2D6	_	NOUN	NN	_	4	nmod	_	_
7	also	_	ADV	RB	_	8	advmod	_	_
8	contribute	_	VERB	VBP	_	0	root	_	_
9	to	_	PRT	TO	_	11	case	_	_
10	the	_	DET	DT	_	11	det	_	_
11	metabolism	_	NOUN	NN	_	8	nmod	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	DRUG	_	NOUN	NN	_	11	nmod	_	_

#	Prozac	3806
1	This	_	DET	DT	_	2	nsubj	_	_
2	explains	_	VERB	VBZ	_	0	root	_	_
3	how	_	ADV	WRB	_	5	advmod	_	_
4	DRUG	_	NOUN	NN	_	5	nsubj	_	_
5	achieves	_	VERB	VBZ	_	2	ccomp	_	_
6	a	_	DET	DT	_	9	det	_	_
7	steady	_	ADJ	JJ	_	9	amod	_	_
8	state	_	NOUN	NN	_	9	compound	_	_
9	concentration	_	NOUN	NN	_	5	dobj	_	_
10	rather	_	ADV	RB	_	5	cc	_	_
11	than	_	ADP	IN	_	10	mwe	_	_
12	increasing	_	VERB	VBG	_	5	conj	_	_
13	without	_	ADP	IN	_	14	mark	_	_
14	limit	_	VERB	VBG	_	12	ccomp	_	_

#	Prozac	3807
1	Because	_	ADP	IN	_	21	mark	_	_
2	DRUG	_	NOUN	NN	_	4	nmod:poss	_	_
3	's	_	PRT	POS	_	2	case	_	_
4	metabolism	_	NOUN	NN	_	21	nsubj	_	_
5	,	_	.	,	_	4	punct	_	_
6	like	_	ADP	IN	_	7	case	_	_
7	that	_	DET	WDT	_	4	nmod	_	_
8	of	_	ADP	IN	_	10	case	_	_
9	a	_	DET	DT	_	10	det	_	_
10	number	_	NOUN	NN	_	7	nmod	_	_
11	of	_	ADP	IN	_	13	case	_	_
12	other	_	ADJ	JJ	_	13	amod	_	_
13	compounds	_	NOUN	NNS	_	10	nmod	_	_
14	including	_	ADP	IN	_	15	case	_	_
15	TCAs	_	NOUN	NNS	_	13	nmod	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	other	_	ADJ	JJ	_	19	amod	_	_
18	selective	_	ADJ	JJ	_	19	amod	_	_
19	GGGGGGGGGGGGGGGGGGGGGGGGGGGGG(SSRIs	_	NOUN	NNS	_	15	conj	_	_
20	,	_	.	,	_	4	punct	_	_
21	involves	_	VERB	VBZ	_	41	advcl	_	_
22	the	_	DET	DT	_	24	det	_	_
23	CYP2D6	_	NOUN	NN	_	24	compound	_	_
24	system	_	NOUN	NN	_	21	dobj	_	_
25	,	_	.	,	_	41	punct	_	_
26	concomitant	_	ADJ	JJ	_	27	amod	_	_
27	therapy	_	NOUN	NN	_	41	nsubj	_	_
28	with	_	ADP	IN	_	29	case	_	_
29	drugs	_	NOUN	NNS	_	27	nmod	_	_
30	also	_	ADV	RB	_	31	advmod	_	_
31	metabolized	_	VERB	VBN	_	29	acl	_	_
32	by	_	ADP	IN	_	35	case	_	_
33	this	_	DET	DT	_	35	det	_	_
34	enzyme	_	NOUN	NN	_	35	compound	_	_
35	system	_	NOUN	NN	_	31	nmod	_	_
36	such	_	ADJ	JJ	_	39	case	_	_
37	as	_	ADP	IN	_	36	mwe	_	_
38	the	_	DET	DT	_	39	det	_	_
39	TCAs	_	NOUN	NNS	_	35	nmod	_	_
40	may	_	VERB	MD	_	41	aux	_	_
41	lead	_	VERB	VB	_	0	root	_	_
42	to	_	PRT	TO	_	44	case	_	_
43	drug	_	NOUN	NN	_	44	compound	_	_
44	interactions	_	NOUN	NNS	_	41	nmod	_	_

#	Prozac	3808
1	Accumulation	_	NOUN	NN	_	45	nsubj	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	Slow	_	NOUN	NN	_	4	compound	_	_
4	Elimination	_	NOUN	NN	_	1	conj	_	_
5	The	_	DET	DT	_	8	det	_	_
6	relatively	_	ADV	RB	_	7	advmod	_	_
7	slow	_	VERB	VBP	_	8	amod	_	_
8	elimination	_	NOUN	NN	_	1	dep	_	_
9	of	_	ADP	IN	_	13	case	_	_
10	DRUG	_	NOUN	NN	_	13	compound	_	_
11	elimination	_	NOUN	NN	_	13	compound	_	_
12	half	_	NOUN	NN	_	13	compound	_	_
13	life	_	NOUN	NN	_	8	nmod	_	_
14	of	_	ADP	IN	_	16	case	_	_
15	1to	_	ADJ	JJ	_	16	amod	_	_
16	3days	_	NOUN	NNS	_	13	nmod	_	_
17	after	_	ADP	IN	_	19	case	_	_
18	acute	_	ADJ	JJ	_	19	amod	_	_
19	administration	_	NOUN	NN	_	8	nmod	_	_
20	and	_	CONJ	CC	_	19	cc	_	_
21	4to	_	ADJ	JJ	_	22	amod	_	_
22	6days	_	NOUN	NNS	_	19	conj	_	_
23	after	_	ADP	IN	_	25	case	_	_
24	chronic	_	ADJ	JJ	_	25	amod	_	_
25	administration	_	NOUN	NN	_	8	nmod	_	_
26	and	_	CONJ	CC	_	25	cc	_	_
27	its	_	PRON	PRP$	_	29	nmod:poss	_	_
28	active	_	ADJ	JJ	_	29	amod	_	_
29	metabolite	_	NOUN	NN	_	25	conj	_	_
30	,	_	.	,	_	25	punct	_	_
31	nor	_	CONJ	CC	_	25	cc	_	_
32	DRUG	_	NOUN	NN	_	35	compound	_	_
33	elimination	_	NOUN	NN	_	35	compound	_	_
34	half	_	NOUN	NN	_	35	compound	_	_
35	life	_	NOUN	NN	_	25	conj	_	_
36	of	_	ADP	IN	_	38	case	_	_
37	4to	_	ADJ	JJ	_	38	amod	_	_
38	16days	_	NOUN	NNS	_	35	nmod	_	_
39	after	_	ADP	IN	_	43	case	_	_
40	acute	_	ADJ	JJ	_	43	amod	_	_
41	and	_	CONJ	CC	_	40	cc	_	_
42	chronic	_	ADJ	JJ	_	40	conj	_	_
43	administration	_	NOUN	NN	_	8	nmod	_	_
44	,	_	.	,	_	1	punct	_	_
45	leads	_	VERB	VBZ	_	0	root	_	_
46	to	_	PRT	TO	_	48	case	_	_
47	significant	_	ADJ	JJ	_	48	amod	_	_
48	accumulation	_	NOUN	NN	_	45	nmod	_	_
49	of	_	ADP	IN	_	52	case	_	_
50	these	_	DET	DT	_	52	det	_	_
51	active	_	ADJ	JJ	_	52	amod	_	_
52	species	_	NOUN	NNS	_	48	nmod	_	_
53	in	_	ADP	IN	_	55	case	_	_
54	chronic	_	ADJ	JJ	_	55	amod	_	_
55	use	_	NOUN	NN	_	48	nmod	_	_
56	and	_	CONJ	CC	_	48	cc	_	_
57	delayed	_	VERB	VBN	_	58	amod	_	_
58	attainment	_	NOUN	NN	_	48	conj	_	_
59	of	_	ADP	IN	_	61	case	_	_
60	steady	_	ADJ	JJ	_	61	amod	_	_
61	state	_	NOUN	NN	_	58	nmod	_	_
62	,	_	.	,	_	45	punct	_	_
63	even	_	ADV	RB	_	69	advmod	_	_
64	when	_	ADV	WRB	_	69	advmod	_	_
65	a	_	DET	DT	_	67	det	_	_
66	fixed	_	ADJ	JJ	_	67	amod	_	_
67	dose	_	NOUN	NN	_	69	nsubjpass	_	_
68	is	_	VERB	VBZ	_	69	auxpass	_	_
69	used	_	VERB	VBN	_	45	parataxis	_	_

#	Prozac	3809
1	After	_	ADP	IN	_	2	case	_	_
2	30days	_	NOUN	NNS	_	35	nmod	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	dosing	_	NOUN	NN	_	2	nmod	_	_
5	at	_	ADP	IN	_	8	case	_	_
6	40mg	_	ADJ	JJ	_	8	amod	_	_
7	/	_	.	:	_	8	punct	_	_
8	day	_	NOUN	NN	_	4	nmod	_	_
9	,	_	.	,	_	35	punct	_	_
10	plasma	_	NOUN	NN	_	11	compound	_	_
11	concentrations	_	NOUN	NNS	_	35	nsubjpass	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	DRUG	_	NOUN	NN	_	11	nmod	_	_
14	in	_	ADP	IN	_	16	case	_	_
15	the	_	DET	DT	_	16	det	_	_
16	range	_	NOUN	NN	_	11	nmod	_	_
17	of	_	ADP	IN	_	19	case	_	_
18	91to	_	ADJ	JJ	_	19	amod	_	_
19	302ng	_	ADJ	JJ	_	16	nmod	_	_
20	/	_	.	:	_	19	punct	_	_
21	mL	_	NOUN	NN	_	19	conj	_	_
22	and	_	CONJ	CC	_	19	cc	_	_
23	nor	_	CONJ	CC	_	24	cc	_	_
24	DRUG	_	NOUN	NN	_	19	conj	_	_
25	in	_	ADP	IN	_	27	case	_	_
26	the	_	DET	DT	_	27	det	_	_
27	range	_	NOUN	NN	_	16	nmod	_	_
28	of	_	ADP	IN	_	32	case	_	_
29	72to	_	ADJ	JJ	_	32	amod	_	_
30	258ng	_	ADJ	JJ	_	32	amod	_	_
31	/	_	.	:	_	32	punct	_	_
32	mL	_	NOUN	NN	_	27	nmod	_	_
33	have	_	VERB	VBP	_	35	aux	_	_
34	been	_	VERB	VBN	_	35	auxpass	_	_
35	observed	_	VERB	VBN	_	0	root	_	_

#	Prozac	3810
1	Plasma	_	NOUN	NN	_	2	compound	_	_
2	concentrations	_	NOUN	NNS	_	6	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	were	_	VERB	VBD	_	6	cop	_	_
6	higher	_	ADJ	JJ	_	0	root	_	_
7	than	_	ADP	IN	_	8	case	_	_
8	those	_	DET	DT	_	6	nmod	_	_
9	predicted	_	VERB	VBN	_	8	acl	_	_
10	by	_	ADP	IN	_	13	case	_	_
11	single	_	ADJ	JJ	_	13	amod	_	_
12	dose	_	NOUN	NN	_	13	compound	_	_
13	studies	_	NOUN	NNS	_	9	nmod	_	_
14	,	_	.	,	_	6	punct	_	_
15	because	_	ADP	IN	_	21	mark	_	_
16	DRUG	_	NOUN	NN	_	18	nmod:poss	_	_
17	's	_	PRT	POS	_	18	case	_	_
18	metabolism	_	NOUN	NN	_	21	nsubj	_	_
19	is	_	VERB	VBZ	_	21	cop	_	_
20	not	_	ADV	RB	_	21	neg	_	_
21	proportional	_	ADJ	JJ	_	6	advcl	_	_
22	to	_	PRT	TO	_	23	case	_	_
23	dose	_	NOUN	NN	_	21	nmod	_	_

#	Prozac	3811
1	Nor	_	CONJ	CC	_	2	advmod	_	_
2	DRUG	_	NOUN	NN	_	6	nmod	_	_
3	,	_	.	,	_	6	punct	_	_
4	however	_	ADV	RB	_	6	advmod	_	_
5	,	_	.	,	_	6	punct	_	_
6	appears	_	VERB	VBZ	_	0	root	_	_
7	to	_	PRT	TO	_	8	mark	_	_
8	have	_	VERB	VB	_	6	xcomp	_	_
9	linear	_	ADJ	JJ	_	10	amod	_	_
10	pharmacokinetics	_	NOUN	NNS	_	8	dobj	_	_

#	Prozac	3812
1	Its	_	PRON	PRP$	_	5	nmod:poss	_	_
2	mean	_	ADJ	JJ	_	5	amod	_	_
3	terminal	_	ADJ	JJ	_	5	amod	_	_
4	half	_	ADJ	JJ	_	5	amod	_	_
5	life	_	NOUN	NN	_	11	nsubj	_	_
6	after	_	ADP	IN	_	9	case	_	_
7	a	_	DET	DT	_	9	det	_	_
8	single	_	ADJ	JJ	_	9	amod	_	_
9	dose	_	NOUN	NN	_	5	nmod	_	_
10	was	_	VERB	VBD	_	11	cop	_	_
11	8.6days	_	NOUN	NNS	_	0	root	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	after	_	ADP	IN	_	15	case	_	_
14	multiple	_	ADJ	JJ	_	15	amod	_	_
15	dosing	_	NOUN	NN	_	17	nmod	_	_
16	was	_	VERB	VBD	_	17	cop	_	_
17	9.3days	_	NOUN	NNS	_	11	conj	_	_

#	Prozac	3813
1	Steady	_	ADJ	JJ	_	3	amod	_	_
2	state	_	NOUN	NN	_	3	compound	_	_
3	levels	_	NOUN	NNS	_	8	nsubj	_	_
4	after	_	ADP	IN	_	6	case	_	_
5	prolonged	_	ADJ	JJ	_	6	amod	_	_
6	dosing	_	NOUN	NN	_	3	nmod	_	_
7	are	_	VERB	VBP	_	8	cop	_	_
8	similar	_	ADJ	JJ	_	0	root	_	_
9	to	_	PRT	TO	_	10	case	_	_
10	levels	_	NOUN	NNS	_	8	nmod	_	_
11	seen	_	VERB	VBN	_	10	acl	_	_
12	at	_	ADP	IN	_	14	case	_	_
13	4to	_	ADJ	JJ	_	14	amod	_	_
14	5weeks	_	NOUN	NNS	_	11	nmod	_	_

#	Prozac	3814
1	The	_	DET	DT	_	3	det	_	_
2	long	_	ADJ	JJ	_	3	amod	_	_
3	elimination	_	NOUN	NN	_	4	nsubj	_	_
4	half	_	VERB	VBP	_	0	root	_	_
5	lives	_	NOUN	NNS	_	4	dobj	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	nor	_	CONJ	CC	_	7	cc	_	_
10	DRUG	_	NOUN	NN	_	7	conj	_	_
11	assure	_	NOUN	NN	_	7	dep	_	_
12	that	_	DET	WDT	_	24	nsubj	_	_
13	,	_	.	,	_	24	punct	_	_
14	even	_	ADV	RB	_	18	advmod	_	_
15	when	_	ADV	RB	_	18	advmod	_	_
16	dosing	_	NOUN	NN	_	18	nsubjpass	_	_
17	is	_	VERB	VBZ	_	18	auxpass	_	_
18	stopped	_	VERB	VBN	_	24	advcl	_	_
19	,	_	.	,	_	24	punct	_	_
20	active	_	ADJ	JJ	_	22	amod	_	_
21	drug	_	NOUN	NN	_	22	compound	_	_
22	substance	_	NOUN	NN	_	24	nsubj	_	_
23	will	_	VERB	MD	_	24	aux	_	_
24	persist	_	VERB	VB	_	5	acl:relcl	_	_
25	in	_	ADP	IN	_	27	case	_	_
26	the	_	DET	DT	_	27	det	_	_
27	body	_	NOUN	NN	_	24	nmod	_	_
28	for	_	ADP	IN	_	29	case	_	_
29	weeks	_	NOUN	NNS	_	27	nmod	_	_
30	primarily	_	ADV	RB	_	31	advmod	_	_
31	depending	_	VERB	VBG	_	35	case	_	_
32	on	_	ADP	IN	_	35	case	_	_
33	individual	_	ADJ	JJ	_	35	amod	_	_
34	patient	_	NOUN	NN	_	35	compound	_	_
35	characteristics	_	NOUN	NNS	_	24	nmod	_	_
36	,	_	.	,	_	35	punct	_	_
37	previous	_	ADJ	JJ	_	39	amod	_	_
38	dosing	_	NOUN	NN	_	39	compound	_	_
39	regimen	_	NOUN	NN	_	35	conj	_	_
40	,	_	.	,	_	35	punct	_	_
41	and	_	CONJ	CC	_	35	cc	_	_
42	length	_	NOUN	NN	_	35	conj	_	_
43	of	_	ADP	IN	_	45	case	_	_
44	previous	_	ADJ	JJ	_	45	amod	_	_
45	therapy	_	NOUN	NN	_	42	nmod	_	_
46	at	_	ADP	IN	_	47	case	_	_
47	discontinuation	_	NOUN	NN	_	42	nmod	_	_

#	Prozac	3815
1	This	_	DET	DT	_	5	nsubj	_	_
2	is	_	VERB	VBZ	_	5	cop	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	potential	_	ADJ	JJ	_	5	amod	_	_
5	consequence	_	NOUN	NN	_	0	root	_	_
6	when	_	ADV	WRB	_	10	advmod	_	_
7	drug	_	NOUN	NN	_	8	compound	_	_
8	discontinuation	_	NOUN	NN	_	10	nsubjpass	_	_
9	is	_	VERB	VBZ	_	10	auxpass	_	_
10	required	_	VERB	VBN	_	5	ccomp	_	_
11	or	_	CONJ	CC	_	10	cc	_	_
12	when	_	ADV	WRB	_	15	advmod	_	_
13	drugs	_	NOUN	NNS	_	15	nsubjpass	_	_
14	are	_	VERB	VBP	_	15	auxpass	_	_
15	prescribed	_	VERB	VBN	_	10	conj	_	_
16	that	_	DET	WDT	_	18	nsubj	_	_
17	might	_	VERB	MD	_	18	aux	_	_
18	interact	_	VERB	VB	_	15	ccomp	_	_
19	with	_	ADP	IN	_	20	case	_	_
20	DRUG	_	NOUN	NN	_	18	nmod	_	_
21	and	_	CONJ	CC	_	20	cc	_	_
22	nor	_	CONJ	CC	_	20	cc	_	_
23	DRUG	_	NOUN	NN	_	20	conj	_	_
24	following	_	ADP	IN	_	26	case	_	_
25	the	_	DET	DT	_	26	det	_	_
26	discontinuation	_	NOUN	NN	_	18	nmod	_	_
27	of	_	ADP	IN	_	28	case	_	_
28	DRUG	_	NOUN	NN	_	26	nmod	_	_

#	Prozac	3816
1	Weekly	_	ADV	RB	_	2	advmod	_	_
2	Dosing	_	ADJ	JJ	_	3	amod	_	_
3	Administration	_	NOUN	NN	_	8	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	Weekly	_	ADV	RB	_	7	advmod	_	_
7	once	_	ADV	RB	_	8	advmod	_	_
8	weekly	_	ADJ	JJ	_	0	root	_	_
9	results	_	NOUN	NNS	_	8	dobj	_	_
10	in	_	ADP	IN	_	12	case	_	_
11	increased	_	VERB	VBN	_	12	amod	_	_
12	fluctuation	_	NOUN	NN	_	9	nmod	_	_
13	between	_	ADP	IN	_	14	case	_	_
14	peak	_	ADJ	JJ	_	12	nmod	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	trough	_	NOUN	NN	_	14	conj	_	_
17	concentrations	_	NOUN	NNS	_	14	dep	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	DRUG	_	NOUN	NN	_	14	nmod	_	_
20	and	_	CONJ	CC	_	21	cc	_	_
21	nor	_	CONJ	CC	_	19	cc	_	_
22	DRUG	_	NOUN	NN	_	19	conj	_	_
23	compared	_	VERB	VBD	_	8	dep	_	_
24	with	_	ADP	IN	_	27	case	_	_
25	once	_	ADV	RB	_	26	advmod	_	_
26	daily	_	ADV	RB	_	27	advmod	_	_
27	dosing	_	VERB	VBG	_	23	conj	_	_
28	for	_	ADP	IN	_	29	case	_	_
29	DRUG	_	NOUN	NN	_	27	nmod	_	_
30	:24%(daily	_	ADV	RB	_	27	nmod	_	_
31	to	_	PRT	TO	_	32	case	_	_
32	164%(weekly	_	ADV	RB	_	30	nmod	_	_
33	and	_	CONJ	CC	_	30	cc	_	_
34	for	_	ADP	IN	_	30	conj	_	_
35	nor	_	CONJ	CC	_	34	cc	_	_
36	DRUG	_	NOUN	NN	_	34	conj	_	_
37	:17%(daily	_	ADV	RB	_	39	compound	_	_
38	to	_	PRT	TO	_	39	case	_	_
39	43%(weekly	_	ADV	RB	_	34	dep	_	_

#	Prozac	3817
1	Plasma	_	NOUN	NN	_	2	compound	_	_
2	concentrations	_	NOUN	NNS	_	7	nsubj	_	_
3	may	_	VERB	MD	_	7	aux	_	_
4	not	_	ADV	RB	_	7	neg	_	_
5	necessarily	_	ADV	RB	_	7	advmod	_	_
6	be	_	VERB	VB	_	7	cop	_	_
7	predictive	_	ADJ	JJ	_	0	root	_	_
8	of	_	ADP	IN	_	10	case	_	_
9	clinical	_	ADJ	JJ	_	10	amod	_	_
10	response	_	NOUN	NN	_	7	nmod	_	_

#	Prozac	3818
1	Peak	_	ADJ	JJ	_	2	amod	_	_
2	concentrations	_	NOUN	NNS	_	16	nsubj	_	_
3	from	_	ADP	IN	_	6	case	_	_
4	once	_	ADV	RB	_	5	advmod	_	_
5	weekly	_	ADJ	JJ	_	6	amod	_	_
6	doses	_	NOUN	NNS	_	2	nmod	_	_
7	of	_	ADP	IN	_	10	case	_	_
8	DRUG	_	NOUN	NN	_	10	compound	_	_
9	Weekly	_	ADJ	JJ	_	10	amod	_	_
10	capsules	_	NOUN	NNS	_	6	nmod	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_
13	are	_	VERB	VBP	_	16	cop	_	_
14	in	_	ADP	IN	_	16	case	_	_
15	the	_	DET	DT	_	16	det	_	_
16	range	_	NOUN	NN	_	0	root	_	_
17	of	_	ADP	IN	_	20	case	_	_
18	the	_	DET	DT	_	20	det	_	_
19	average	_	ADJ	JJ	_	20	amod	_	_
20	concentration	_	NOUN	NN	_	16	nmod	_	_
21	for	_	ADP	IN	_	23	case	_	_
22	20	_	NUM	CD	_	23	nummod	_	_
23	mg	_	NOUN	NN	_	20	nmod	_	_
24	once	_	ADV	RB	_	25	advmod	_	_
25	daily	_	ADV	RB	_	26	advmod	_	_
26	dosing	_	VERB	VBG	_	20	acl	_	_

#	Prozac	3819
1	Average	_	ADJ	JJ	_	3	amod	_	_
2	trough	_	NOUN	NN	_	3	compound	_	_
3	concentrations	_	NOUN	NNS	_	5	nsubj	_	_
4	are	_	VERB	VBP	_	5	cop	_	_
5	76%lower	_	ADJ	JJ	_	0	root	_	_
6	for	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	47%lower	_	ADJ	JJ	_	7	conj	_	_
10	for	_	ADP	IN	_	9	nmod	_	_
11	nor	_	CONJ	CC	_	10	cc	_	_
12	DRUG	_	NOUN	NN	_	10	conj	_	_
13	than	_	ADP	IN	_	15	case	_	_
14	the	_	DET	DT	_	15	det	_	_
15	concentrations	_	NOUN	NNS	_	5	nmod	_	_
16	maintained	_	VERB	VBN	_	15	acl	_	_
17	by	_	ADP	IN	_	19	case	_	_
18	20	_	NUM	CD	_	19	nummod	_	_
19	mg	_	NOUN	NN	_	16	nmod	_	_
20	once	_	ADV	RB	_	21	advmod	_	_
21	daily	_	ADV	RB	_	22	advmod	_	_
22	dosing	_	VERB	VBG	_	16	advcl	_	_

#	Prozac	3820
1	Average	_	ADJ	JJ	_	4	amod	_	_
2	steady	_	ADJ	JJ	_	4	amod	_	_
3	state	_	NOUN	NN	_	4	compound	_	_
4	concentrations	_	NOUN	NNS	_	16	nsubj	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	either	_	CONJ	CC	_	8	cc:preconj	_	_
7	once	_	ADV	RB	_	8	advmod	_	_
8	daily	_	ADV	RB	_	12	advmod	_	_
9	or	_	CONJ	CC	_	8	cc	_	_
10	once	_	ADV	RB	_	8	conj	_	_
11	weekly	_	ADJ	JJ	_	12	amod	_	_
12	dosing	_	NOUN	NN	_	4	nmod	_	_
13	are	_	VERB	VBP	_	16	cop	_	_
14	in	_	ADP	IN	_	16	case	_	_
15	relative	_	ADJ	JJ	_	16	amod	_	_
16	proportion	_	NOUN	NN	_	0	root	_	_
17	to	_	PRT	TO	_	20	case	_	_
18	the	_	DET	DT	_	20	det	_	_
19	total	_	ADJ	JJ	_	20	amod	_	_
20	dose	_	NOUN	NN	_	16	nmod	_	_
21	administered	_	VERB	VBN	_	20	acl	_	_

#	Prozac	3821
1	Average	_	ADJ	JJ	_	5	amod	_	_
2	steady	_	ADJ	JJ	_	5	amod	_	_
3	state	_	NOUN	NN	_	5	compound	_	_
4	DRUG	_	NOUN	NN	_	5	compound	_	_
5	concentrations	_	NOUN	NNS	_	8	nsubj	_	_
6	are	_	VERB	VBP	_	8	cop	_	_
7	approximately	_	ADV	RB	_	8	advmod	_	_
8	50%lower	_	ADJ	JJ	_	0	root	_	_
9	following	_	ADP	IN	_	13	case	_	_
10	the	_	DET	DT	_	13	det	_	_
11	once	_	ADJ	JJ	_	12	advmod	_	_
12	weekly	_	ADJ	JJ	_	13	amod	_	_
13	regimen	_	NOUN	NN	_	8	nmod	_	_
14	compared	_	VERB	VBN	_	19	case	_	_
15	with	_	ADP	IN	_	19	case	_	_
16	the	_	DET	DT	_	19	det	_	_
17	once	_	ADJ	JJ	_	19	amod	_	_
18	daily	_	ADJ	JJ	_	19	amod	_	_
19	regimen	_	NOUN	NNS	_	8	nmod	_	_

#	Prozac	3822
1	Cmax	_	NOUN	NN	_	13	nsubj	_	_
2	for	_	ADP	IN	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	following	_	ADP	IN	_	8	case	_	_
5	the	_	DET	DT	_	8	det	_	_
6	90	_	NUM	CD	_	8	nummod	_	_
7	mg	_	NOUN	NN	_	8	compound	_	_
8	dose	_	NOUN	NN	_	1	nmod	_	_
9	was	_	VERB	VBD	_	13	cop	_	_
10	approximately	_	ADV	RB	_	11	advmod	_	_
11	1.7	_	NUM	CD	_	12	nummod	_	_
12	fold	_	NOUN	NN	_	13	nsubj	_	_
13	higher	_	ADJ	JJ	_	0	root	_	_
14	than	_	ADP	IN	_	17	case	_	_
15	the	_	DET	DT	_	17	det	_	_
16	Cmax	_	NOUN	NN	_	17	compound	_	_
17	value	_	NOUN	NN	_	13	nmod	_	_
18	for	_	ADP	IN	_	22	case	_	_
19	the	_	DET	DT	_	22	det	_	_
20	established	_	VERB	VBN	_	22	amod	_	_
21	20	_	NUM	CD	_	22	nummod	_	_
22	mg	_	NOUN	NN	_	17	nmod	_	_
23	once	_	ADJ	JJR	_	24	advmod	_	_
24	daily	_	ADV	RB	_	25	advmod	_	_
25	regimen	_	NOUN	NN	_	22	dep	_	_
26	following	_	VERB	VBG	_	27	case	_	_
27	transition	_	NOUN	NN	_	17	nmod	_	_
28	the	_	DET	DT	_	30	det	_	_
29	next	_	ADV	RB	_	30	amod	_	_
30	day	_	NOUN	NN	_	13	dobj	_	_
31	to	_	PRT	TO	_	35	case	_	_
32	the	_	DET	DT	_	35	det	_	_
33	once	_	ADJ	JJR	_	35	amod	_	_
34	weekly	_	ADJ	JJ	_	35	amod	_	_
35	regimen	_	NOUN	NNS	_	30	nmod	_	_

#	Prozac	3823
1	In	_	ADP	IN	_	2	case	_	_
2	contrast	_	NOUN	NN	_	25	nmod	_	_
3	,	_	.	,	_	25	punct	_	_
4	when	_	ADV	WRB	_	18	advmod	_	_
5	the	_	DET	DT	_	9	det	_	_
6	first90	_	NOUN	NN	_	9	compound	_	_
7	mgonce	_	NOUN	NN	_	9	compound	_	_
8	weekly	_	ADJ	JJ	_	9	amod	_	_
9	dose	_	NOUN	NN	_	18	nsubjpass	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	the	_	DET	DT	_	14	det	_	_
12	last	_	ADJ	JJ	_	14	amod	_	_
13	20	_	NUM	CD	_	14	nummod	_	_
14	mgonce	_	NOUN	NN	_	9	conj	_	_
15	daily	_	ADV	RB	_	18	advmod	_	_
16	dose	_	NOUN	NN	_	18	nsubjpass	_	_
17	were	_	VERB	VBD	_	18	auxpass	_	_
18	separated	_	VERB	VBN	_	25	advcl	_	_
19	by	_	ADP	IN	_	20	case	_	_
20	1week	_	NOUN	NN	_	18	nmod	_	_
21	,	_	.	,	_	25	punct	_	_
22	Cmax	_	NOUN	NN	_	23	compound	_	_
23	values	_	NOUN	NNS	_	25	nsubj	_	_
24	were	_	VERB	VBD	_	25	auxpass	_	_
25	similar	_	ADJ	JJ	_	0	root	_	_

#	Prozac	3824
1	Also	_	ADV	RB	_	4	advmod	_	_
2	,	_	.	,	_	4	punct	_	_
3	there	_	DET	EX	_	4	expl	_	_
4	was	_	VERB	VBD	_	0	root	_	_
5	a	_	DET	DT	_	7	det	_	_
6	transient	_	ADJ	JJ	_	7	amod	_	_
7	increase	_	NOUN	NN	_	4	dobj	_	_
8	in	_	ADP	IN	_	13	case	_	_
9	the	_	DET	DT	_	13	det	_	_
10	average	_	ADJ	JJ	_	13	amod	_	_
11	steady	_	ADJ	JJ	_	13	amod	_	_
12	state	_	NOUN	NN	_	13	compound	_	_
13	concentrations	_	NOUN	NNS	_	7	nmod	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	DRUG	_	NOUN	NN	_	13	nmod	_	_
16	observed	_	VERB	VBN	_	15	acl	_	_
17	following	_	VERB	VBG	_	18	case	_	_
18	transition	_	NOUN	NN	_	16	nmod	_	_
19	the	_	DET	DT	_	21	det	_	_
20	next	_	ADV	RB	_	21	amod	_	_
21	day	_	NOUN	NN	_	16	dobj	_	_
22	to	_	PRT	TO	_	26	case	_	_
23	the	_	DET	DT	_	26	det	_	_
24	once	_	ADJ	JJ	_	26	amod	_	_
25	weekly	_	ADJ	JJ	_	26	amod	_	_
26	regimen	_	NOUN	NNS	_	21	nmod	_	_

#	Prozac	3825
1	From	_	ADP	IN	_	4	case	_	_
2	a	_	DET	DT	_	4	det	_	_
3	pharmacokinetic	_	ADJ	JJ	_	4	amod	_	_
4	perspective	_	ADJ	JJ	_	9	nmod	_	_
5	,	_	.	,	_	9	punct	_	_
6	it	_	PRON	PRP	_	9	nsubj	_	_
7	may	_	VERB	MD	_	9	aux	_	_
8	be	_	VERB	VB	_	9	cop	_	_
9	better	_	ADJ	JJ	_	0	root	_	_
10	to	_	PRT	TO	_	11	mark	_	_
11	separate	_	VERB	VB	_	9	xcomp	_	_
12	the	_	DET	DT	_	15	det	_	_
13	first90	_	NOUN	NN	_	15	compound	_	_
14	mgweekly	_	ADJ	JJ	_	15	amod	_	_
15	dose	_	NOUN	NN	_	11	dobj	_	_
16	and	_	CONJ	CC	_	11	cc	_	_
17	the	_	DET	DT	_	20	det	_	_
18	last	_	ADJ	JJ	_	20	amod	_	_
19	20	_	NUM	CD	_	20	nummod	_	_
20	mgonce	_	NOUN	NN	_	11	conj	_	_
21	daily	_	ADV	RB	_	22	advmod	_	_
22	dose	_	NOUN	NN	_	20	dep	_	_
23	by	_	ADP	IN	_	24	case	_	_
24	1week	_	ADJ	JJ	_	20	nmod	_	_

#	Prozac	3826
1	Liver	_	NOUN	NN	_	3	compound	_	_
2	Disease	_	NOUN	NN	_	3	compound	_	_
3	As	_	NOUN	NN	_	6	nsubjpass	_	_
4	might	_	VERB	MD	_	6	aux	_	_
5	be	_	VERB	VB	_	6	auxpass	_	_
6	predicted	_	VERB	VBN	_	17	advcl	_	_
7	from	_	ADP	IN	_	10	case	_	_
8	its	_	PRON	PRP$	_	10	nmod:poss	_	_
9	primary	_	ADJ	JJ	_	10	amod	_	_
10	site	_	NOUN	NN	_	6	nmod	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	metabolism	_	NOUN	NN	_	10	nmod	_	_
13	,	_	.	,	_	17	punct	_	_
14	liver	_	NOUN	NN	_	15	compound	_	_
15	impairment	_	NOUN	NN	_	17	nsubj	_	_
16	can	_	VERB	MD	_	17	aux	_	_
17	affect	_	VERB	VB	_	0	root	_	_
18	the	_	DET	DT	_	19	det	_	_
19	elimination	_	NOUN	NN	_	17	dobj	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	DRUG	_	NOUN	NN	_	19	nmod	_	_

#	Prozac	3827
1	The	_	DET	DT	_	4	det	_	_
2	elimination	_	NOUN	NN	_	4	compound	_	_
3	half	_	NOUN	NN	_	4	compound	_	_
4	life	_	NOUN	NN	_	8	nsubjpass	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	was	_	VERB	VBD	_	8	auxpass	_	_
8	prolonged	_	VERB	VBN	_	0	root	_	_
9	in	_	ADP	IN	_	11	case	_	_
10	a	_	DET	DT	_	11	det	_	_
11	study	_	NOUN	NN	_	8	nmod	_	_
12	of	_	ADP	IN	_	14	case	_	_
13	cirrhotic	_	ADJ	JJ	_	14	amod	_	_
14	patients	_	NOUN	NNS	_	11	nmod	_	_
15	,	_	.	,	_	8	punct	_	_
16	with	_	ADP	IN	_	18	case	_	_
17	a	_	DET	DT	_	18	det	_	_
18	mean	_	NOUN	NN	_	39	nsubjpass	_	_
19	of	_	ADP	IN	_	20	case	_	_
20	7.6days	_	NOUN	NNS	_	18	nmod	_	_
21	compared	_	VERB	VBN	_	18	acl	_	_
22	with	_	ADP	IN	_	24	case	_	_
23	the	_	DET	DT	_	24	det	_	_
24	range	_	NOUN	NN	_	21	nmod	_	_
25	of	_	ADP	IN	_	27	case	_	_
26	2to	_	ADJ	JJ	_	27	amod	_	_
27	3days	_	NOUN	NNS	_	24	nmod	_	_
28	seen	_	VERB	VBN	_	27	acl	_	_
29	in	_	ADP	IN	_	30	case	_	_
30	subjects	_	NOUN	NNS	_	28	nmod	_	_
31	without	_	ADP	IN	_	33	case	_	_
32	liver	_	NOUN	NN	_	33	compound	_	_
33	disease	_	NOUN	NN	_	30	nmod	_	_
34	nor	_	CONJ	CC	_	33	cc	_	_
35	DRUG	_	NOUN	NN	_	36	compound	_	_
36	elimination	_	NOUN	NN	_	33	conj	_	_
37	was	_	VERB	VBD	_	39	auxpass	_	_
38	also	_	ADV	RB	_	39	advmod	_	_
39	delayed	_	VERB	VBN	_	8	parataxis	_	_
40	,	_	.	,	_	39	punct	_	_
41	with	_	ADP	IN	_	44	case	_	_
42	a	_	DET	DT	_	44	det	_	_
43	mean	_	ADJ	JJ	_	44	amod	_	_
44	duration	_	NOUN	NN	_	39	nmod	_	_
45	of	_	ADP	IN	_	46	case	_	_
46	12days	_	NOUN	NNS	_	44	nmod	_	_
47	for	_	ADP	IN	_	49	case	_	_
48	cirrhotic	_	ADJ	JJ	_	49	amod	_	_
49	patients	_	NOUN	NNS	_	44	nmod	_	_
50	compared	_	VERB	VBN	_	44	acl	_	_
51	with	_	ADP	IN	_	53	case	_	_
52	the	_	DET	DT	_	53	det	_	_
53	range	_	NOUN	NN	_	50	nmod	_	_
54	of	_	ADP	IN	_	56	case	_	_
55	7to	_	ADJ	JJ	_	56	amod	_	_
56	9days	_	NOUN	NNS	_	53	nmod	_	_
57	in	_	ADP	IN	_	59	case	_	_
58	normal	_	ADJ	JJ	_	59	amod	_	_
59	subjects	_	NOUN	NNS	_	53	nmod	_	_

#	Prozac	3828
1	This	_	DET	DT	_	2	nsubj	_	_
2	suggests	_	VERB	VBZ	_	0	root	_	_
3	that	_	ADP	IN	_	15	mark	_	_
4	the	_	DET	DT	_	5	det	_	_
5	use	_	NOUN	NN	_	15	nsubjpass	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	in	_	ADP	IN	_	9	case	_	_
9	patients	_	NOUN	NNS	_	5	nmod	_	_
10	with	_	ADP	IN	_	12	case	_	_
11	liver	_	NOUN	NN	_	12	compound	_	_
12	disease	_	NOUN	NN	_	9	nmod	_	_
13	must	_	VERB	MD	_	15	aux	_	_
14	be	_	VERB	VB	_	15	auxpass	_	_
15	approached	_	VERB	VBN	_	2	ccomp	_	_
16	with	_	ADP	IN	_	17	case	_	_
17	caution	_	NOUN	NN	_	15	nmod	_	_

#	Prozac	3829
1	If	_	ADP	IN	_	4	mark	_	_
2	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
3	is	_	VERB	VBZ	_	4	auxpass	_	_
4	administered	_	VERB	VBN	_	19	advcl	_	_
5	to	_	PRT	TO	_	6	case	_	_
6	patients	_	NOUN	NNS	_	4	nmod	_	_
7	with	_	ADP	IN	_	9	case	_	_
8	liver	_	NOUN	NN	_	9	compound	_	_
9	disease	_	NOUN	NN	_	6	nmod	_	_
10	,	_	.	,	_	19	punct	_	_
11	a	_	DET	DT	_	16	det	_	_
12	lower	_	ADJ	JJ	_	16	amod	_	_
13	or	_	CONJ	CC	_	12	cc	_	_
14	less	_	ADV	RB	_	15	advmod	_	_
15	frequent	_	ADJ	JJ	_	12	conj	_	_
16	dose	_	NOUN	NN	_	19	nsubjpass	_	_
17	should	_	VERB	MD	_	19	aux	_	_
18	be	_	VERB	VB	_	19	auxpass	_	_
19	used	_	VERB	VBN	_	0	root	_	_

#	Prozac	3830
1	Renal	_	ADJ	JJ	_	2	amod	_	_
2	Disease	_	NOUN	NN	_	0	root	_	_
3	In	_	ADP	IN	_	5	case	_	_
4	depressed	_	VERB	VBN	_	5	amod	_	_
5	patients	_	NOUN	NNS	_	2	nmod	_	_
6	on	_	ADP	IN	_	7	case	_	_
7	dialysis(N=12	_	NOUN	NN	_	2	nmod	_	_
8	,	_	.	,	_	2	punct	_	_
9	DRUG	_	NOUN	NN	_	2	appos	_	_
10	administered	_	VERB	VBN	_	9	acl	_	_
11	as	_	ADP	IN	_	12	case	_	_
12	20mg	_	ADJ	JJ	_	10	nmod	_	_
13	once	_	ADV	RB	_	14	advmod	_	_
14	daily	_	ADV	RB	_	17	advmod	_	_
15	for	_	ADP	IN	_	16	case	_	_
16	2months	_	NOUN	NNS	_	17	nmod	_	_
17	produced	_	VERB	VBD	_	12	acl	_	_
18	steady	_	ADJ	JJ	_	20	amod	_	_
19	state	_	NOUN	NN	_	20	compound	_	_
20	DRUG	_	NOUN	NN	_	17	dobj	_	_
21	and	_	CONJ	CC	_	20	cc	_	_
22	nor	_	CONJ	CC	_	25	cc	_	_
23	DRUG	_	NOUN	NN	_	25	compound	_	_
24	plasma	_	NOUN	NN	_	25	compound	_	_
25	concentrations	_	NOUN	NNS	_	20	conj	_	_
26	comparable	_	ADJ	JJ	_	25	amod	_	_
27	with	_	ADP	IN	_	28	case	_	_
28	those	_	DET	DT	_	26	nmod	_	_
29	seen	_	VERB	VBN	_	28	acl	_	_
30	in	_	ADP	IN	_	31	case	_	_
31	patients	_	NOUN	NNS	_	29	nmod	_	_
32	with	_	ADP	IN	_	35	case	_	_
33	normal	_	ADJ	JJ	_	35	amod	_	_
34	renal	_	ADJ	JJ	_	35	amod	_	_
35	function	_	NOUN	NN	_	31	nmod	_	_

#	Prozac	3831
1	While	_	ADP	IN	_	4	mark	_	_
2	the	_	DET	DT	_	3	det	_	_
3	possibility	_	NOUN	NN	_	4	nsubj	_	_
4	exists	_	VERB	VBZ	_	34	advcl	_	_
5	that	_	ADP	IN	_	12	mark	_	_
6	renally	_	ADV	RB	_	7	advmod	_	_
7	excreted	_	VERB	VBN	_	8	amod	_	_
8	metabolites	_	NOUN	NNS	_	12	nsubj	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	may	_	VERB	MD	_	12	aux	_	_
12	accumulate	_	VERB	VB	_	4	ccomp	_	_
13	to	_	PRT	TO	_	15	case	_	_
14	higher	_	ADJ	JJ	_	15	amod	_	_
15	levels	_	NOUN	NNS	_	12	nmod	_	_
16	in	_	ADP	IN	_	17	case	_	_
17	patients	_	NOUN	NNS	_	15	nmod	_	_
18	with	_	ADP	IN	_	21	case	_	_
19	severe	_	ADJ	JJ	_	21	amod	_	_
20	renal	_	ADJ	JJ	_	21	amod	_	_
21	dysfunction	_	NOUN	NN	_	17	nmod	_	_
22	,	_	.	,	_	34	punct	_	_
23	use	_	NOUN	NN	_	34	nsubj	_	_
24	of	_	ADP	IN	_	30	case	_	_
25	a	_	DET	DT	_	30	det	_	_
26	lower	_	ADJ	JJ	_	30	amod	_	_
27	or	_	CONJ	CC	_	26	cc	_	_
28	less	_	ADV	RB	_	26	conj	_	_
29	frequent	_	ADJ	JJ	_	30	amod	_	_
30	dose	_	NOUN	NN	_	23	nmod	_	_
31	is	_	VERB	VBZ	_	34	cop	_	_
32	not	_	ADV	RB	_	34	neg	_	_
33	routinely	_	ADV	RB	_	34	advmod	_	_
34	necessary	_	ADJ	JJ	_	0	root	_	_
35	in	_	ADP	IN	_	38	case	_	_
36	renally	_	ADV	RB	_	37	advmod	_	_
37	impaired	_	ADJ	JJ	_	38	amod	_	_
38	patients	_	NOUN	NNS	_	34	nmod	_	_

#	Prozac	3832
1	Geriatric	_	ADJ	JJ	_	2	amod	_	_
2	Pharmacokinetics	_	NOUN	NNS	_	0	root	_	_
3	The	_	DET	DT	_	4	det	_	_
4	disposition	_	NOUN	NN	_	2	dep	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	single	_	ADJ	JJ	_	7	amod	_	_
7	doses	_	NOUN	NNS	_	4	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	in	_	ADP	IN	_	13	case	_	_
11	healthy	_	ADJ	JJ	_	13	amod	_	_
12	elderly	_	ADJ	JJ	_	13	amod	_	_
13	subjects	_	NOUN	NNS	_	19	nmod	_	_
14	>65years	_	NOUN	NNS	_	19	nsubj	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	age	_	NOUN	NN	_	14	nmod	_	_
17	did	_	VERB	VBD	_	19	aux	_	_
18	not	_	ADV	RB	_	19	neg	_	_
19	differ	_	VERB	VB	_	4	acl	_	_
20	significantly	_	ADV	RB	_	19	advmod	_	_
21	from	_	ADP	IN	_	22	case	_	_
22	that	_	DET	WDT	_	19	nmod	_	_
23	in	_	ADP	IN	_	26	case	_	_
24	younger	_	ADJ	JJ	_	26	amod	_	_
25	normal	_	ADJ	JJ	_	26	amod	_	_
26	subjects	_	NOUN	NNS	_	22	nmod	_	_

#	Prozac	3833
1	However	_	ADV	RB	_	21	advmod	_	_
2	,	_	.	,	_	21	punct	_	_
3	given	_	VERB	VBD	_	21	advcl	_	_
4	the	_	DET	DT	_	7	det	_	_
5	long	_	ADJ	JJ	_	7	amod	_	_
6	half	_	NOUN	NN	_	7	compound	_	_
7	life	_	NOUN	NN	_	3	dobj	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	nonlinear	_	ADJ	JJ	_	10	amod	_	_
10	disposition	_	NOUN	NN	_	7	conj	_	_
11	of	_	ADP	IN	_	13	case	_	_
12	the	_	DET	DT	_	13	det	_	_
13	drug	_	NOUN	NN	_	7	nmod	_	_
14	,	_	.	,	_	21	punct	_	_
15	a	_	DET	DT	_	18	det	_	_
16	single	_	ADJ	JJ	_	18	amod	_	_
17	dose	_	NOUN	NN	_	18	compound	_	_
18	study	_	NOUN	NN	_	21	nsubj	_	_
19	is	_	VERB	VBZ	_	21	cop	_	_
20	not	_	ADV	RB	_	21	neg	_	_
21	adequate	_	VERB	VB	_	0	root	_	_
22	to	_	PRT	TO	_	23	mark	_	_
23	rule	_	VERB	VB	_	21	xcomp	_	_
24	out	_	ADV	RB	_	26	cc:preconj	_	_
25	the	_	DET	DT	_	26	det	_	_
26	possibility	_	NOUN	NN	_	23	dobj	_	_
27	of	_	ADP	IN	_	29	case	_	_
28	altered	_	VERB	VBN	_	29	amod	_	_
29	pharmacokinetics	_	NOUN	NNS	_	26	nmod	_	_
30	in	_	ADP	IN	_	32	case	_	_
31	the	_	DET	DT	_	32	det	_	_
32	elderly	_	NOUN	NN	_	26	nmod	_	_
33	,	_	.	,	_	21	punct	_	_
34	particularly	_	ADV	RB	_	37	advmod	_	_
35	if	_	ADP	IN	_	37	mark	_	_
36	they	_	PRON	PRP	_	37	nsubj	_	_
37	have	_	VERB	VBP	_	21	parataxis	_	_
38	systemic	_	ADJ	JJ	_	39	amod	_	_
39	illness	_	NOUN	NN	_	37	dobj	_	_
40	or	_	CONJ	CC	_	37	cc	_	_
41	are	_	VERB	VBP	_	42	aux	_	_
42	receiving	_	VERB	VBG	_	37	conj	_	_
43	multiple	_	ADJ	JJ	_	44	amod	_	_
44	drugs	_	NOUN	NNS	_	42	dobj	_	_
45	for	_	ADP	IN	_	47	case	_	_
46	concomitant	_	ADJ	JJ	_	47	amod	_	_
47	diseases	_	NOUN	NNS	_	44	nmod	_	_

#	Prozac	3834
1	The	_	DET	DT	_	2	det	_	_
2	effects	_	NOUN	NNS	_	12	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	age	_	NOUN	NN	_	2	nmod	_	_
5	upon	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	metabolism	_	NOUN	NN	_	2	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	have	_	VERB	VBP	_	12	aux	_	_
11	been	_	VERB	VBN	_	12	auxpass	_	_
12	investigated	_	VERB	VBN	_	0	root	_	_
13	in	_	ADP	IN	_	14	case	_	_
14	260elderly	_	ADJ	JJ	_	12	nmod	_	_
15	but	_	CONJ	CC	_	14	cc	_	_
16	otherwise	_	ADV	RB	_	17	advmod	_	_
17	healthy	_	ADJ	JJ	_	14	conj	_	_
18	depressed	_	VERB	VBN	_	20	amod	_	_
19	patients	_	NOUN	NNS	_	20	compound	_	_
20	>60years	_	NOUN	NNS	_	14	dep	_	_
21	of	_	ADP	IN	_	22	case	_	_
22	age	_	NOUN	NN	_	14	nmod	_	_
23	who	_	DET	WDT	_	24	nsubj	_	_
24	received	_	VERB	VBD	_	22	acl:relcl	_	_
25	20mg	_	ADJ	JJ	_	26	amod	_	_
26	DRUG	_	NOUN	NN	_	24	dobj	_	_
27	for	_	ADP	IN	_	28	case	_	_
28	6weeks	_	NOUN	NNS	_	26	nmod	_	_

#	Prozac	3835
1	Combined	_	ADJ	JJ	_	2	amod	_	_
2	DRUG	_	NOUN	NN	_	9	nsubj	_	_
3	plus	_	CONJ	CC	_	2	cc	_	_
4	nor	_	CONJ	CC	_	7	cc	_	_
5	DRUG	_	NOUN	NN	_	7	compound	_	_
6	plasma	_	NOUN	NN	_	7	compound	_	_
7	concentrations	_	NOUN	NNS	_	2	conj	_	_
8	were	_	VERB	VBD	_	9	cop	_	_
9	209.3*85.7ng	_	ADJ	JJ	_	0	root	_	_
10	/	_	.	:	_	9	punct	_	_
11	mL	_	NOUN	NN	_	9	dep	_	_
12	at	_	ADP	IN	_	14	case	_	_
13	the	_	DET	DT	_	14	det	_	_
14	end	_	NOUN	NN	_	11	nmod	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	6weeks	_	NOUN	NNS	_	14	nmod	_	_

#	Prozac	3836
1	No	_	DET	DT	_	5	neg	_	_
2	unusual	_	ADJ	JJ	_	5	amod	_	_
3	age	_	NOUN	NN	_	5	compound	_	_
4	associated	_	VERB	VBN	_	5	amod	_	_
5	pattern	_	NOUN	NN	_	10	nsubjpass	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	adverse	_	ADJ	JJ	_	8	amod	_	_
8	reactions	_	NOUN	NNS	_	5	nmod	_	_
9	was	_	VERB	VBD	_	10	auxpass	_	_
10	observed	_	VERB	VBN	_	0	root	_	_
11	in	_	ADP	IN	_	14	case	_	_
12	those	_	DET	DT	_	14	det	_	_
13	elderly	_	ADJ	JJ	_	14	amod	_	_
14	patients	_	NOUN	NNS	_	10	nmod	_	_

#	Prozac	3837
1	Pediatric	_	ADJ	JJ	_	2	amod	_	_
2	Pharmacokinetics	_	NOUN	NNS	_	9	nsubjpass	_	_
3	children	_	NOUN	NN	_	7	compound	_	_
4	and	_	CONJ	CC	_	3	cc	_	_
5	adolescents	_	VERB	VBZ	_	3	conj	_	_
6	DRUG	_	NOUN	NN	_	7	compound	_	_
7	pharmacokinetics	_	NOUN	NNS	_	2	dep	_	_
8	were	_	VERB	VBD	_	9	auxpass	_	_
9	evaluated	_	VERB	VBN	_	0	root	_	_
10	in	_	ADP	IN	_	12	case	_	_
11	21pediatric	_	ADJ	JJ	_	12	amod	_	_
12	patients	_	NOUN	NNS	_	9	nmod	_	_
13	10children	_	NOUN	NN	_	14	compound	_	_
14	ages6	_	NOUN	NN	_	12	dep	_	_
15	to	_	PRT	TO	_	14	dep	_	_
16	<13	_	NUM	CD	_	14	nummod	_	_
17	,	_	.	,	_	9	punct	_	_
18	11adolescents	_	NOUN	NNS	_	9	dobj	_	_
19	ages13	_	NOUN	NN	_	18	dep	_	_
20	to	_	PRT	TO	_	21	case	_	_
21	<18	_	NUM	CD	_	19	nmod	_	_
22	diagnosed	_	VERB	VBN	_	19	acl	_	_
23	with	_	ADP	IN	_	26	case	_	_
24	Major	_	ADJ	JJ	_	26	amod	_	_
25	Depressive	_	ADJ	JJ	_	26	amod	_	_
26	Disorder	_	NOUN	NN	_	22	nmod	_	_
27	or	_	CONJ	CC	_	26	cc	_	_
28	Obsessive	_	ADJ	JJ	_	30	amod	_	_
29	Compulsive	_	ADJ	JJ	_	30	amod	_	_
30	Disorder(OCD	_	NOUN	NN	_	26	conj	_	_

#	Prozac	3838
1	DRUG	_	NOUN	NN	_	4	compound	_	_
2	20mg	_	ADJ	JJ	_	4	amod	_	_
3	/	_	.	:	_	4	punct	_	_
4	day	_	NOUN	NN	_	6	nsubjpass	_	_
5	was	_	VERB	VBD	_	6	auxpass	_	_
6	administered	_	VERB	VBN	_	0	root	_	_
7	for	_	ADP	IN	_	10	case	_	_
8	up	_	ADJ	JJ	_	10	advmod	_	_
9	to	_	PRT	TO	_	10	case	_	_
10	62days	_	NOUN	NNS	_	6	nmod	_	_

#	Prozac	3839
1	The	_	DET	DT	_	5	det	_	_
2	average	_	ADJ	JJ	_	5	amod	_	_
3	steady	_	ADJ	JJ	_	5	amod	_	_
4	state	_	NOUN	NN	_	5	compound	_	_
5	concentrations	_	NOUN	NNS	_	14	nsubj	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	in	_	ADP	IN	_	10	case	_	_
9	these	_	DET	DT	_	10	det	_	_
10	children	_	NOUN	NN	_	5	nmod	_	_
11	were	_	VERB	VBD	_	14	cop	_	_
12	2	_	NUM	CD	_	13	nummod	_	_
13	fold	_	NOUN	NN	_	14	nmod:npmod	_	_
14	higher	_	ADJ	JJ	_	0	root	_	_
15	than	_	ADP	IN	_	19	case	_	_
16	in	_	ADP	IN	_	19	case	_	_
17	adolescents	_	NOUN	NNS	_	19	compound	_	_
18	171and	_	ADJ	JJ	_	19	amod	_	_
19	86ng	_	ADJ	JJ	_	14	nmod	_	_
20	/	_	.	:	_	19	punct	_	_
21	mL	_	NOUN	NN	_	19	dep	_	_
22	,	_	.	,	_	19	punct	_	_
23	respectively	_	ADV	RB	_	19	advmod	_	_

#	Prozac	3840
1	The	_	DET	DT	_	2	dep	_	_
2	average	_	NOUN	NN	_	14	nsubj	_	_
3	nor	_	CONJ	CC	_	2	cc	_	_
4	DRUG	_	NOUN	NN	_	7	compound	_	_
5	steady	_	ADJ	JJ	_	7	amod	_	_
6	state	_	NOUN	NN	_	7	compound	_	_
7	concentrations	_	NOUN	NNS	_	2	conj	_	_
8	in	_	ADP	IN	_	10	case	_	_
9	these	_	DET	DT	_	10	det	_	_
10	children	_	NOUN	NN	_	2	nmod	_	_
11	were	_	VERB	VBD	_	14	cop	_	_
12	1.5	_	NUM	CD	_	13	nummod	_	_
13	fold	_	NOUN	NN	_	14	nmod:npmod	_	_
14	higher	_	ADJ	JJ	_	0	root	_	_
15	than	_	ADP	IN	_	19	case	_	_
16	in	_	ADP	IN	_	19	case	_	_
17	adolescents	_	NOUN	NNS	_	19	compound	_	_
18	195and	_	ADJ	JJ	_	19	amod	_	_
19	113ng	_	ADJ	JJ	_	14	nmod	_	_
20	/	_	.	:	_	19	punct	_	_
21	mL	_	NOUN	NN	_	19	dep	_	_
22	,	_	.	,	_	19	punct	_	_
23	respectively	_	ADV	RB	_	19	advmod	_	_

#	Prozac	3841
1	These	_	DET	DT	_	2	det	_	_
2	differences	_	NOUN	NNS	_	7	nsubjpass	_	_
3	can	_	VERB	MD	_	7	aux	_	_
4	be	_	VERB	VB	_	7	auxpass	_	_
5	almost	_	ADV	RB	_	7	advmod	_	_
6	entirely	_	ADV	RB	_	7	advmod	_	_
7	explained	_	VERB	VBN	_	0	root	_	_
8	by	_	ADP	IN	_	9	case	_	_
9	differences	_	NOUN	NNS	_	7	nmod	_	_
10	in	_	ADP	IN	_	11	case	_	_
11	weight	_	NOUN	NN	_	9	nmod	_	_

#	Prozac	3842
1	No	_	DET	DT	_	4	neg	_	_
2	gender	_	ADJ	JJ	_	4	amod	_	_
3	associated	_	VERB	VBN	_	4	amod	_	_
4	difference	_	NOUN	NN	_	9	nsubjpass	_	_
5	in	_	ADP	IN	_	7	case	_	_
6	DRUG	_	NOUN	NN	_	7	compound	_	_
7	pharmacokinetics	_	NOUN	NNS	_	4	nmod	_	_
8	was	_	VERB	VBD	_	9	auxpass	_	_
9	observed	_	VERB	VBN	_	0	root	_	_

#	Prozac	3843
1	Similar	_	ADJ	JJ	_	2	amod	_	_
2	ranges	_	NOUN	NNS	_	11	nsubjpass	_	_
3	of	_	ADP	IN	_	9	case	_	_
4	DRUG	_	NOUN	NN	_	9	compound	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	nor	_	CONJ	CC	_	7	cc	_	_
7	DRUG	_	NOUN	NN	_	4	conj	_	_
8	plasma	_	NOUN	NN	_	7	conj	_	_
9	concentrations	_	NOUN	NNS	_	2	nmod	_	_
10	were	_	VERB	VBD	_	11	auxpass	_	_
11	observed	_	VERB	VBN	_	0	root	_	_
12	in	_	ADP	IN	_	14	case	_	_
13	another	_	DET	DT	_	14	det	_	_
14	study	_	NOUN	NN	_	11	nmod	_	_
15	in	_	ADP	IN	_	17	case	_	_
16	94pediatric	_	ADJ	JJ	_	17	amod	_	_
17	patients	_	NOUN	NNS	_	14	nmod	_	_
18	ages8	_	NOUN	NN	_	17	dep	_	_
19	to<18	_	NUM	CD	_	18	nummod	_	_
20	diagnosed	_	VERB	VBN	_	18	acl	_	_
21	with	_	ADP	IN	_	24	case	_	_
22	Major	_	ADJ	JJ	_	24	amod	_	_
23	Depressive	_	ADJ	JJ	_	24	amod	_	_
24	Disorder	_	NOUN	NN	_	20	nmod	_	_

#	Prozac	3844
1	Higher	_	ADJ	JJ	_	5	amod	_	_
2	average	_	ADJ	JJ	_	5	amod	_	_
3	steady	_	ADJ	JJ	_	5	amod	_	_
4	state	_	NOUN	NN	_	5	compound	_	_
5	DRUG	_	NOUN	NN	_	11	nsubjpass	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	nor	_	CONJ	CC	_	9	cc	_	_
8	DRUG	_	NOUN	NN	_	9	compound	_	_
9	concentrations	_	NOUN	NNS	_	5	conj	_	_
10	were	_	VERB	VBD	_	11	auxpass	_	_
11	observed	_	VERB	VBN	_	24	advcl	_	_
12	in	_	ADP	IN	_	13	case	_	_
13	children	_	NOUN	NN	_	11	nmod	_	_
14	relative	_	ADJ	JJ	_	16	dep	_	_
15	to	_	PRT	TO	_	16	case	_	_
16	adults	_	NOUN	NNS	_	11	nmod	_	_
17	however	_	ADV	RB	_	11	advmod	_	_
18	,	_	.	,	_	24	punct	_	_
19	these	_	DET	DT	_	20	det	_	_
20	concentrations	_	NOUN	NNS	_	24	nsubj	_	_
21	were	_	VERB	VBD	_	24	cop	_	_
22	within	_	ADP	IN	_	24	case	_	_
23	the	_	DET	DT	_	24	det	_	_
24	range	_	NOUN	NN	_	0	root	_	_
25	of	_	ADP	IN	_	26	case	_	_
26	concentrations	_	NOUN	NNS	_	24	nmod	_	_
27	observed	_	VERB	VBN	_	26	acl	_	_
28	in	_	ADP	IN	_	31	case	_	_
29	the	_	DET	DT	_	31	det	_	_
30	adult	_	ADJ	JJ	_	31	amod	_	_
31	population	_	NOUN	NN	_	27	nmod	_	_

#	Prozac	3845
1	As	_	ADP	IN	_	3	case	_	_
2	in	_	ADP	IN	_	3	case	_	_
3	adults	_	NOUN	NNS	_	19	nmod	_	_
4	,	_	.	,	_	19	punct	_	_
5	DRUG	_	NOUN	NN	_	19	nsubjpass	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	nor	_	CONJ	CC	_	8	cc	_	_
8	DRUG	_	NOUN	NN	_	5	conj	_	_
9	accumulated	_	VERB	VBN	_	5	acl	_	_
10	extensively	_	ADV	RB	_	9	advmod	_	_
11	following	_	VERB	VBG	_	17	case	_	_
12	multiple	_	ADJ	JJ	_	17	amod	_	_
13	oral	_	ADJ	JJ	_	17	amod	_	_
14	dosing	_	NOUN	NN	_	17	amod	_	_
15	steady	_	ADJ	JJ	_	17	amod	_	_
16	state	_	NOUN	NN	_	17	compound	_	_
17	concentrations	_	NOUN	NNS	_	9	nmod	_	_
18	were	_	VERB	VBD	_	19	auxpass	_	_
19	achieved	_	VERB	VBN	_	0	root	_	_
20	within	_	ADP	IN	_	21	case	_	_
21	3to4weeks	_	NOUN	NNS	_	19	nmod	_	_
22	of	_	ADP	IN	_	24	mark	_	_
23	daily	_	ADV	RB	_	24	advmod	_	_
24	dosing	_	VERB	VBG	_	21	acl	_	_

#	Quazepam	1
1	Benzodiazepines	_	NOUN	NNS	_	6	nsubj	_	_
2	,	_	.	,	_	1	punct	_	_
3	including	_	VERB	VBG	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	1	nmod	_	_
5	,	_	.	,	_	1	punct	_	_
6	produce	_	VERB	VBP	_	0	root	_	_
7	additive	_	ADJ	JJ	_	10	amod	_	_
8	CNS	_	NOUN	NN	_	10	compound	_	_
9	depressant	_	ADJ	JJ	_	10	amod	_	_
10	effects	_	NOUN	NNS	_	6	dobj	_	_
11	when	_	ADV	WRB	_	6	advmod	_	_
12	co	_	PRT	TO	_	11	nmod	_	_
13	administered	_	VERB	VBN	_	12	dep	_	_
14	with	_	ADP	IN	_	15	case	_	_
15	ethanol	_	NOUN	NN	_	13	nmod	_	_
16	or	_	CONJ	CC	_	15	cc	_	_
17	other	_	ADJ	JJ	_	18	amod	_	_
18	CNS	_	NOUN	NN	_	15	conj	_	_
19	depressants	_	NOUN	NNS	_	13	dobj	_	_
20	e.g	_	NOUN	NN	_	22	compound	_	_
21	psychotropic	_	ADJ	JJ	_	22	amod	_	_
22	medications	_	NOUN	NNS	_	19	dobj	_	_
23	,	_	.	,	_	22	punct	_	_
24	anticonvulsants	_	NOUN	NNS	_	22	appos	_	_
25	,	_	.	,	_	22	punct	_	_
26	antihistamines	_	NOUN	NNS	_	22	appos	_	_

#	Quazepam	2
1	Downward	_	ADP	IN	_	3	case	_	_
2	dose	_	NOUN	NN	_	3	compound	_	_
3	adjustment	_	NOUN	NN	_	14	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	/	_	NUM	CD	_	5	conj	_	_
8	or	_	CONJ	CC	_	5	cc	_	_
9	concomitant	_	ADJ	JJ	_	11	amod	_	_
10	CNS	_	NOUN	NN	_	11	compound	_	_
11	depressants	_	NOUN	NNS	_	5	conj	_	_
12	may	_	VERB	MD	_	14	aux	_	_
13	be	_	VERB	VB	_	14	cop	_	_
14	necessary	_	ADJ	JJ	_	0	root	_	_
15	because	_	ADP	IN	_	18	case	_	_
16	of	_	ADP	IN	_	18	case	_	_
17	additive	_	ADJ	JJ	_	18	amod	_	_
18	effects	_	NOUN	NNS	_	14	nmod	_	_

#	Quazepam	3
1	CNS	_	NOUN	NN	_	2	compound	_	_
2	Depressants	_	NOUN	NNS	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	downward	_	ADJ	JJ	_	6	amod	_	_
5	dose	_	NOUN	NN	_	6	compound	_	_
6	adjustment	_	NOUN	NN	_	9	nsubj	_	_
7	may	_	VERB	MD	_	9	aux	_	_
8	be	_	VERB	VB	_	9	cop	_	_
9	necessary	_	ADJ	JJ	_	2	dep	_	_
10	due	_	ADJ	JJ	_	13	case	_	_
11	to	_	PRT	TO	_	13	case	_	_
12	additive	_	ADJ	JJ	_	13	amod	_	_
13	effects	_	NOUN	NNS	_	9	nmod	_	_
14	7	_	NUM	CD	_	13	nummod	_	_

#	Quazepam	4
1	DRUG	_	NOUN	NN	_	16	nsubj	_	_
2	,	_	.	,	_	1	punct	_	_
3	like	_	ADP	IN	_	8	case	_	_
4	other	_	ADJ	JJ	_	8	amod	_	_
5	central	_	ADJ	JJ	_	8	amod	_	_
6	nervous	_	ADJ	JJ	_	8	amod	_	_
7	system	_	NOUN	NN	_	8	compound	_	_
8	agents	_	NOUN	NNS	_	1	nmod	_	_
9	of	_	ADP	IN	_	13	case	_	_
10	the	_	DET	DT	_	13	det	_	_
11	1,4	_	NUM	CD	_	13	nummod	_	_
12	benzodiazepine	_	NOUN	NN	_	13	compound	_	_
13	class	_	NOUN	NN	_	8	nmod	_	_
14	,	_	.	,	_	1	punct	_	_
15	presumably	_	ADV	RB	_	16	advmod	_	_
16	exerts	_	VERB	VBZ	_	0	root	_	_
17	its	_	PRON	PRP$	_	18	nmod:poss	_	_
18	effects	_	NOUN	NNS	_	16	dobj	_	_
19	by	_	ADP	IN	_	20	mark	_	_
20	binding	_	VERB	VBG	_	16	advcl	_	_
21	to	_	PRT	TO	_	24	case	_	_
22	stereo	_	VERB	VBN	_	24	amod	_	_
23	specific	_	ADJ	JJ	_	24	amod	_	_
24	receptors	_	NOUN	NNS	_	20	nmod	_	_
25	at	_	ADP	IN	_	27	case	_	_
26	several	_	ADJ	JJ	_	27	amod	_	_
27	sites	_	NOUN	NNS	_	20	nmod	_	_
28	within	_	ADP	IN	_	33	case	_	_
29	the	_	DET	DT	_	33	det	_	_
30	central	_	ADJ	JJ	_	33	amod	_	_
31	nervous	_	ADJ	JJ	_	33	amod	_	_
32	system	_	NOUN	NN	_	33	compound	_	_
33	CNS	_	NOUN	NN	_	27	nmod	_	_

#	Quazepam	5
1	The	_	DET	DT	_	3	det	_	_
2	exact	_	ADJ	JJ	_	3	amod	_	_
3	mechanism	_	NOUN	NN	_	7	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	action	_	NOUN	NN	_	3	nmod	_	_
6	is	_	VERB	VBZ	_	7	auxpass	_	_
7	unknown	_	ADJ	JJ	_	0	root	_	_

#	Quazepam	6
1	Absorption	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	DRUG	_	NOUN	NN	_	6	nsubj	_	_
4	is	_	VERB	VBZ	_	6	cop	_	_
5	rapidly	_	ADV	RB	_	6	advmod	_	_
6	absorption	_	NOUN	NN	_	1	dep	_	_
7	half	_	ADJ	JJ	_	8	amod	_	_
8	life	_	NOUN	NN	_	6	dobj	_	_
9	of	_	ADP	IN	_	12	case	_	_
10	about	_	ADV	RB	_	11	advmod	_	_
11	30	_	NUM	CD	_	12	nummod	_	_
12	minutes	_	NOUN	NNS	_	8	nmod	_	_
13	and	_	CONJ	CC	_	6	cc	_	_
14	well	_	ADV	RB	_	15	advmod	_	_
15	absorbed	_	VERB	VBN	_	6	conj	_	_
16	from	_	ADP	IN	_	19	case	_	_
17	the	_	DET	DT	_	19	det	_	_
18	gastrointestinal	_	ADJ	JJ	_	19	amod	_	_
19	tract	_	NOUN	NN	_	15	nmod	_	_

#	Quazepam	7
1	The	_	DET	DT	_	4	det	_	_
2	peak	_	ADJ	JJ	_	4	amod	_	_
3	plasma	_	NOUN	NN	_	4	compound	_	_
4	concentration	_	NOUN	NN	_	10	nsubj	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	is	_	VERB	VBZ	_	10	cop	_	_
8	approximately	_	ADV	RB	_	10	advmod	_	_
9	20	_	NUM	CD	_	10	nummod	_	_
10	ng	_	NOUN	NN	_	0	root	_	_
11	/	_	.	:	_	10	punct	_	_
12	mL	_	NOUN	NN	_	10	dep	_	_
13	after	_	ADP	IN	_	17	case	_	_
14	a	_	DET	DT	_	17	det	_	_
15	15	_	NUM	CD	_	17	nummod	_	_
16	mg	_	NOUN	NN	_	17	compound	_	_
17	dose	_	NOUN	NN	_	12	nmod	_	_
18	and	_	CONJ	CC	_	12	cc	_	_
19	occurs	_	VERB	VBZ	_	12	conj	_	_
20	at	_	ADP	IN	_	23	case	_	_
21	about	_	ADV	RB	_	22	advmod	_	_
22	2	_	NUM	CD	_	23	nummod	_	_
23	hours	_	NOUN	NNS	_	19	nmod	_	_

#	Quazepam	8
1	Metabolism	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	DRUG	_	NOUN	NN	_	12	nsubjpass	_	_
4	,	_	.	,	_	3	punct	_	_
5	the	_	DET	DT	_	8	det	_	_
6	active	_	ADJ	JJ	_	8	amod	_	_
7	parent	_	NOUN	NN	_	8	compound	_	_
8	compound	_	NOUN	NN	_	3	appos	_	_
9	,	_	.	,	_	3	punct	_	_
10	is	_	VERB	VBZ	_	12	auxpass	_	_
11	extensively	_	ADV	RB	_	12	advmod	_	_
12	metabolized	_	VERB	VBN	_	1	dep	_	_
13	in	_	ADP	IN	_	15	case	_	_
14	the	_	DET	DT	_	15	det	_	_
15	liver	_	NOUN	NN	_	12	nmod	_	_
16	two	_	NUM	CD	_	15	nummod	_	_
17	of	_	ADP	IN	_	20	case	_	_
18	the	_	DET	DT	_	20	det	_	_
19	plasma	_	NOUN	NN	_	20	compound	_	_
20	metabolites	_	NOUN	NNS	_	15	nmod	_	_
21	are	_	VERB	VBP	_	24	cop	_	_
22	2	_	NUM	CD	_	24	nummod	_	_
23	oxo	_	ADJ	JJ	_	24	advmod	_	_
24	DRUG	_	NOUN	NN	_	12	parataxis	_	_
25	and	_	CONJ	CC	_	24	cc	_	_
26	N	_	NOUN	NN	_	30	compound	_	_
27	desalkyl	_	NOUN	NN	_	30	compound	_	_
28	2	_	NUM	CD	_	30	nummod	_	_
29	oxo	_	NOUN	NN	_	30	compound	_	_
30	DRUG	_	NOUN	NN	_	24	conj	_	_

#	Quazepam	9
1	All	_	DET	DT	_	3	det	_	_
2	three	_	NUM	CD	_	3	nummod	_	_
3	compounds	_	NOUN	NNS	_	4	nsubj	_	_
4	show	_	VERB	VBP	_	0	root	_	_
5	CNS	_	NOUN	NN	_	7	compound	_	_
6	depressant	_	ADJ	JJ	_	7	amod	_	_
7	activity	_	NOUN	NN	_	4	dobj	_	_

#	Quazepam	10
1	Distribution	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	The	_	DET	DT	_	4	det	_	_
4	degree	_	NOUN	NN	_	17	nsubj	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	plasma	_	NOUN	NN	_	8	compound	_	_
7	protein	_	NOUN	NN	_	8	compound	_	_
8	binding	_	NOUN	NN	_	4	nmod	_	_
9	for	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	and	_	CONJ	CC	_	4	cc	_	_
12	its	_	PRON	PRP$	_	15	nmod:poss	_	_
13	two	_	NUM	CD	_	15	nummod	_	_
14	major	_	ADJ	JJ	_	15	amod	_	_
15	metabolites	_	NOUN	NNS	_	4	conj	_	_
16	is	_	VERB	VBZ	_	17	cop	_	_
17	greater	_	ADJ	JJ	_	1	dep	_	_
18	than	_	ADP	IN	_	19	case	_	_
19	95%	_	ADJ	JJ	_	17	nmod	_	_

#	Quazepam	11
1	Elimination	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Following	_	ADP	IN	_	4	case	_	_
4	administration	_	NOUN	NN	_	1	nmod	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	14C	_	NOUN	NN	_	7	compound	_	_
7	DRUG	_	NOUN	NN	_	4	nmod	_	_
8	,	_	.	,	_	1	punct	_	_
9	31%	_	NOUN	NN	_	13	nsubj	_	_
10	of	_	ADP	IN	_	12	case	_	_
11	the	_	DET	DT	_	12	det	_	_
12	dose	_	NOUN	NN	_	9	nmod	_	_
13	appeared	_	VERB	VBD	_	1	dep	_	_
14	in	_	ADP	IN	_	16	case	_	_
15	the	_	DET	DT	_	16	det	_	_
16	urine	_	ADJ	JJ	_	13	nmod	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	23%	_	NOUN	NN	_	16	conj	_	_
19	in	_	ADP	IN	_	21	case	_	_
20	the	_	DET	DT	_	21	det	_	_
21	feces	_	NOUN	NNS	_	13	nmod	_	_
22	over	_	ADP	IN	_	24	case	_	_
23	five	_	NUM	CD	_	24	nummod	_	_
24	days	_	NOUN	NNS	_	13	nmod	_	_
25	only	_	ADV	RB	_	32	advmod	_	_
26	trace	_	NOUN	NN	_	27	compound	_	_
27	amounts	_	NOUN	NNS	_	32	nsubj	_	_
28	of	_	ADP	IN	_	30	case	_	_
29	unchanged	_	ADJ	JJ	_	30	amod	_	_
30	drug	_	NOUN	NN	_	27	nmod	_	_
31	were	_	VERB	VBD	_	32	cop	_	_
32	present	_	ADJ	JJ	_	13	parataxis	_	_
33	in	_	ADP	IN	_	35	case	_	_
34	the	_	DET	DT	_	35	det	_	_
35	urine	_	VERB	VBG	_	32	advcl	_	_

#	Quazepam	12
1	The	_	DET	DT	_	5	det	_	_
2	mean	_	ADJ	JJ	_	5	compound	_	_
3	elimination	_	NOUN	NN	_	5	compound	_	_
4	half	_	NOUN	NN	_	5	compound	_	_
5	life	_	NOUN	NN	_	14	nsubj	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	2	_	NUM	CD	_	11	nummod	_	_
10	oxo	_	NOUN	NN	_	11	compound	_	_
11	DRUG	_	NOUN	NN	_	7	conj	_	_
12	is	_	VERB	VBZ	_	14	cop	_	_
13	39	_	NUM	CD	_	14	nummod	_	_
14	hours	_	NOUN	NNS	_	0	root	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	that	_	DET	WDT	_	25	nsubj	_	_
17	of	_	ADP	IN	_	22	case	_	_
18	N	_	NOUN	NN	_	22	compound	_	_
19	desalkyl	_	NOUN	NN	_	22	compound	_	_
20	2	_	NUM	CD	_	22	nummod	_	_
21	oxo	_	NOUN	NN	_	22	amod	_	_
22	DRUG	_	NOUN	NN	_	16	nmod	_	_
23	is	_	VERB	VBZ	_	25	cop	_	_
24	73	_	NUM	CD	_	25	nummod	_	_
25	hours	_	NOUN	NNS	_	14	conj	_	_

#	Quazepam	13
1	Steady	_	ADJ	JJ	_	3	amod	_	_
2	state	_	NOUN	NN	_	3	compound	_	_
3	levels	_	NOUN	NNS	_	11	nsubjpass	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	2	_	NUM	CD	_	9	nummod	_	_
8	oxo	_	NOUN	NN	_	9	amod	_	_
9	DRUG	_	NOUN	NN	_	5	conj	_	_
10	are	_	VERB	VBP	_	11	auxpass	_	_
11	attained	_	VERB	VBN	_	0	root	_	_
12	by	_	ADP	IN	_	16	case	_	_
13	the	_	DET	DT	_	16	det	_	_
14	seventh	_	ADJ	JJ	_	16	amod	_	_
15	daily	_	ADV	RB	_	16	advmod	_	_
16	dose	_	NOUN	NN	_	11	nmod	_	_
17	and	_	CONJ	CC	_	11	cc	_	_
18	that	_	DET	WDT	_	11	conj	_	_
19	of	_	ADP	IN	_	24	case	_	_
20	N	_	NOUN	NN	_	24	compound	_	_
21	desalkyl	_	NOUN	NN	_	24	compound	_	_
22	2	_	NUM	CD	_	24	nummod	_	_
23	oxo	_	NOUN	NN	_	24	amod	_	_
24	DRUG	_	NOUN	NN	_	18	nmod	_	_
25	by	_	ADP	IN	_	29	case	_	_
26	the	_	DET	DT	_	29	det	_	_
27	thirteenth	_	ADJ	JJ	_	29	amod	_	_
28	daily	_	ADV	RB	_	27	dep	_	_
29	dose	_	NOUN	NN	_	18	nmod	_	_

#	Quazepam	14
1	Special	_	ADJ	JJ	_	2	amod	_	_
2	Populations	_	NOUN	NNS	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	Geriatrics	_	NOUN	NNS	_	2	dep	_	_
5	:	_	.	:	_	4	punct	_	_
6	The	_	DET	DT	_	7	det	_	_
7	pharmacokinetics	_	NOUN	NNS	_	18	nsubj	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	2	_	NUM	CD	_	13	nummod	_	_
12	oxo	_	NOUN	NN	_	13	amod	_	_
13	DRUG	_	NOUN	NN	_	9	conj	_	_
14	in	_	ADP	IN	_	16	case	_	_
15	geriatric	_	ADJ	JJ	_	16	amod	_	_
16	subjects	_	NOUN	NNS	_	7	nmod	_	_
17	are	_	VERB	VBP	_	18	cop	_	_
18	comparable	_	ADJ	JJ	_	4	acl:relcl	_	_
19	to	_	PRT	TO	_	20	case	_	_
20	those	_	DET	DT	_	18	nmod	_	_
21	seen	_	VERB	VBN	_	20	acl	_	_
22	in	_	ADP	IN	_	24	case	_	_
23	young	_	ADJ	JJ	_	24	amod	_	_
24	adults	_	NOUN	NNS	_	21	nmod	_	_
25	as	_	ADP	IN	_	28	case	_	_
26	with	_	ADP	IN	_	28	case	_	_
27	desalkyl	_	ADJ	JJ	_	28	amod	_	_
28	metabolites	_	NOUN	NNS	_	18	nmod	_	_
29	of	_	ADP	IN	_	31	case	_	_
30	other	_	ADJ	JJ	_	31	amod	_	_
31	benzodiazepines	_	NOUN	NNS	_	28	nmod	_	_
32	,	_	.	,	_	4	punct	_	_
33	the	_	DET	DT	_	36	det	_	_
34	elimination	_	NOUN	NN	_	36	compound	_	_
35	half	_	NOUN	NN	_	36	compound	_	_
36	life	_	NOUN	NN	_	48	nsubj	_	_
37	of	_	ADP	IN	_	42	case	_	_
38	N	_	NOUN	NN	_	42	compound	_	_
39	desalkyl	_	NOUN	NN	_	42	compound	_	_
40	2	_	NUM	CD	_	42	nummod	_	_
41	oxo	_	NOUN	NN	_	42	amod	_	_
42	DRUG	_	NOUN	NN	_	36	nmod	_	_
43	in	_	ADP	IN	_	45	case	_	_
44	geriatric	_	ADJ	JJ	_	45	amod	_	_
45	patients	_	NOUN	NNS	_	36	nmod	_	_
46	is	_	VERB	VBZ	_	48	cop	_	_
47	about	_	ADV	RB	_	48	advmod	_	_
48	twice	_	ADV	RB	_	4	dep	_	_
49	that	_	DET	DT	_	48	dep	_	_
50	of	_	ADP	IN	_	52	case	_	_
51	young	_	ADJ	JJ	_	52	amod	_	_
52	adults	_	NOUN	NNS	_	49	nmod	_	_

#	Quazepam	15
1	Bupropion	_	NOUN	NN	_	0	root	_	_
2	a	_	DET	DT	_	4	det	_	_
3	CYP2B6	_	NOUN	NN	_	4	compound	_	_
4	substrate	_	NOUN	NN	_	1	dobj	_	_
5	:	_	.	:	_	1	punct	_	_
6	Co	_	NOUN	NN	_	7	compound	_	_
7	administration	_	NOUN	NN	_	25	nsubj	_	_
8	of	_	ADP	IN	_	11	case	_	_
9	a	_	DET	DT	_	11	det	_	_
10	single	_	ADJ	JJ	_	11	amod	_	_
11	dose	_	NOUN	NN	_	7	nmod	_	_
12	of	_	ADP	IN	_	17	case	_	_
13	150	_	NUM	CD	_	17	nummod	_	_
14	mg	_	NOUN	NN	_	17	compound	_	_
15	Bupropion	_	NOUN	NN	_	17	compound	_	_
16	Hydrochloride	_	NOUN	NN	_	17	compound	_	_
17	XL	_	NOUN	NN	_	11	nmod	_	_
18	with	_	ADP	IN	_	21	case	_	_
19	steady	_	ADJ	JJ	_	21	amod	_	_
20	state	_	NOUN	NN	_	21	compound	_	_
21	DRUG	_	NOUN	NN	_	7	nmod	_	_
22	did	_	VERB	MD	_	25	aux	_	_
23	not	_	ADV	RB	_	25	neg	_	_
24	significantly	_	ADV	RB	_	25	advmod	_	_
25	affect	_	VERB	VB	_	1	parataxis	_	_
26	the	_	DET	DT	_	27	det	_	_
27	AUC	_	NOUN	NN	_	25	dobj	_	_
28	and	_	CONJ	CC	_	27	cc	_	_
29	Cmax	_	NOUN	NN	_	27	conj	_	_
30	of	_	ADP	IN	_	31	case	_	_
31	bupropion	_	NOUN	NN	_	27	nmod	_	_
32	or	_	CONJ	CC	_	31	cc	_	_
33	its	_	PRON	PRP$	_	35	nmod:poss	_	_
34	primary	_	ADJ	JJ	_	35	amod	_	_
35	metabolite	_	NOUN	NN	_	31	conj	_	_
36	,	_	.	,	_	35	punct	_	_
37	hydroxybupropion	_	NOUN	NN	_	35	appos	_	_

#	Quetiapine fumarate	208
1	Concomitant	_	ADJ	JJ	_	2	amod	_	_
2	use	_	NOUN	NN	_	8	nsubj	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	strong	_	ADJ	JJ	_	6	amod	_	_
5	CYP3A4	_	NOUN	NN	_	6	compound	_	_
6	inhibitors	_	NOUN	NNS	_	2	nmod	_	_
7	:	_	.	:	_	2	punct	_	_
8	Reduce	_	VERB	VBP	_	0	root	_	_
9	DRUG	_	NOUN	NN	_	10	compound	_	_
10	dose	_	NOUN	NN	_	8	dobj	_	_
11	to	_	PRT	TO	_	13	case	_	_
12	one	_	NUM	CD	_	13	nummod	_	_
13	sixth	_	NOUN	NN	_	8	nmod	_	_
14	when	_	ADV	WRB	_	15	advmod	_	_
15	coadministered	_	VERB	VBN	_	8	advcl	_	_
16	with	_	ADP	IN	_	19	case	_	_
17	strong	_	ADJ	JJ	_	19	amod	_	_
18	CYP3A4	_	NOUN	NN	_	19	compound	_	_
19	inhibitors	_	NOUN	NNS	_	15	nmod	_	_
20	e.g	_	NOUN	NN	_	21	compound	_	_
21	ketoconazole	_	NOUN	NN	_	19	dep	_	_
22	,	_	.	,	_	21	punct	_	_
23	ritonavir	_	NOUN	NN	_	21	conj	_	_
24	2.5	_	NUM	CD	_	23	nummod	_	_
25	,	_	.	,	_	21	punct	_	_
26	7.1	_	NUM	CD	_	21	conj	_	_
27	,	_	.	,	_	21	punct	_	_
28	12.3	_	NUM	CD	_	30	nummod	_	_
29	Concomitant	_	ADJ	JJ	_	30	amod	_	_
30	use	_	NOUN	NN	_	21	appos	_	_
31	of	_	ADP	IN	_	34	case	_	_
32	strong	_	ADJ	JJ	_	34	amod	_	_
33	CYP3A4	_	NOUN	NN	_	34	compound	_	_
34	inducers	_	NOUN	NNS	_	30	nmod	_	_
35	:	_	.	:	_	8	punct	_	_
36	Increase	_	VERB	VBP	_	8	parataxis	_	_
37	DRUG	_	NOUN	NN	_	38	compound	_	_
38	dose	_	NOUN	NN	_	36	dobj	_	_
39	up	_	ADV	RB	_	36	advmod	_	_
40	to	_	PRT	TO	_	42	case	_	_
41	5	_	NUM	CD	_	42	nummod	_	_
42	fold	_	NOUN	NN	_	39	nmod	_	_
43	when	_	ADV	WRB	_	44	advmod	_	_
44	used	_	VERB	VBN	_	39	advcl	_	_
45	in	_	ADP	IN	_	46	case	_	_
46	combination	_	NOUN	NN	_	44	nmod	_	_
47	with	_	ADP	IN	_	50	case	_	_
48	a	_	DET	DT	_	50	det	_	_
49	chronic	_	ADJ	JJ	_	50	amod	_	_
50	treatment	_	NOUN	NN	_	46	nmod	_	_
51	more	_	ADV	RB	_	53	advmod	_	_
52	than	_	ADP	IN	_	51	mwe	_	_
53	7	_	NUM	CD	_	55	compound	_	_
54	to	_	PRT	TO	_	55	dep	_	_
55	14	_	NUM	CD	_	56	nummod	_	_
56	days	_	NOUN	NNS	_	46	nmod	_	_
57	of	_	ADP	IN	_	60	case	_	_
58	potent	_	ADJ	JJ	_	60	amod	_	_
59	CYP3A4	_	NOUN	NN	_	60	compound	_	_
60	inducers	_	NOUN	NNS	_	56	nmod	_	_
61	e.g	_	NOUN	NN	_	62	compound	_	_
62	phenytoin	_	NOUN	NN	_	60	dep	_	_
63	,	_	.	,	_	62	punct	_	_
64	rifampin	_	NOUN	NN	_	62	appos	_	_
65	,	_	.	,	_	62	punct	_	_
66	St	_	NOUN	NN	_	67	compound	_	_
67	John's	_	NOUN	NNS	_	62	conj	_	_
68	wort	_	VERB	VBP	_	67	amod	_	_
69	2.6	_	NUM	CD	_	68	dep	_	_
70	,	_	.	,	_	62	punct	_	_
71	7.1	_	NUM	CD	_	62	conj	_	_
72	,	_	.	,	_	62	punct	_	_
73	12.3	_	NUM	CD	_	74	nummod	_	_
74	Discontinuation	_	NOUN	NN	_	62	appos	_	_
75	of	_	ADP	IN	_	78	case	_	_
76	strong	_	ADJ	JJ	_	78	amod	_	_
77	CYP3A4	_	NOUN	NN	_	78	compound	_	_
78	inducers	_	NOUN	NNS	_	74	nmod	_	_
79	:	_	.	:	_	36	punct	_	_
80	Reduce	_	VERB	VBP	_	36	parataxis	_	_
81	DRUG	_	NOUN	NN	_	82	compound	_	_
82	dose	_	NOUN	NN	_	80	dobj	_	_
83	by	_	ADP	IN	_	85	case	_	_
84	5	_	NUM	CD	_	85	nummod	_	_
85	fold	_	NOUN	NN	_	80	nmod	_	_
86	within	_	ADP	IN	_	90	case	_	_
87	7	_	NUM	CD	_	89	compound	_	_
88	to	_	PRT	TO	_	89	dep	_	_
89	14	_	NUM	CD	_	90	nummod	_	_
90	days	_	NOUN	NNS	_	80	nmod	_	_
91	of	_	ADP	IN	_	92	case	_	_
92	discontinuation	_	NOUN	NN	_	90	nmod	_	_
93	of	_	ADP	IN	_	95	case	_	_
94	CYP3A4	_	NOUN	NN	_	95	compound	_	_
95	inducers	_	NOUN	NNS	_	92	nmod	_	_
96	2.6	_	NUM	CD	_	95	nummod	_	_
97	,	_	.	,	_	95	punct	_	_
98	7.1	_	NUM	CD	_	95	appos	_	_
99	,	_	.	,	_	80	punct	_	_
100	12.3	_	NUM	CD	_	102	nummod	_	_
101	The	_	DET	DT	_	102	det	_	_
102	risks	_	NOUN	NNS	_	115	nsubjpass	_	_
103	of	_	ADP	IN	_	104	mark	_	_
104	using	_	VERB	VBG	_	102	acl	_	_
105	DRUG	_	NOUN	NN	_	104	dobj	_	_
106	in	_	ADP	IN	_	107	case	_	_
107	combination	_	NOUN	NN	_	104	nmod	_	_
108	with	_	ADP	IN	_	110	case	_	_
109	other	_	ADJ	JJ	_	110	amod	_	_
110	drugs	_	NOUN	NNS	_	107	nmod	_	_
111	have	_	VERB	VBP	_	115	aux	_	_
112	not	_	ADV	RB	_	115	neg	_	_
113	been	_	VERB	VBN	_	115	auxpass	_	_
114	extensively	_	ADV	RB	_	115	advmod	_	_
115	evaluated	_	VERB	VBN	_	80	parataxis	_	_
116	in	_	ADP	IN	_	118	case	_	_
117	systematic	_	ADJ	JJ	_	118	amod	_	_
118	studies	_	NOUN	NNS	_	115	nmod	_	_

#	Quetiapine fumarate	209
1	Given	_	ADP	IN	_	5	case	_	_
2	the	_	DET	DT	_	5	det	_	_
3	primary	_	ADJ	JJ	_	5	amod	_	_
4	CNS	_	NOUN	NN	_	5	compound	_	_
5	effects	_	NOUN	NNS	_	12	nmod	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	,	_	.	,	_	12	punct	_	_
9	caution	_	NOUN	NN	_	12	nsubjpass	_	_
10	should	_	VERB	MD	_	12	aux	_	_
11	be	_	VERB	VB	_	12	auxpass	_	_
12	used	_	VERB	VBN	_	0	root	_	_
13	when	_	ADV	WRB	_	16	advmod	_	_
14	it	_	PRON	PRP	_	16	nsubjpass	_	_
15	is	_	VERB	VBZ	_	16	auxpass	_	_
16	taken	_	VERB	VBN	_	12	ccomp	_	_
17	in	_	ADP	IN	_	18	case	_	_
18	combination	_	NOUN	NN	_	16	nmod	_	_
19	with	_	ADP	IN	_	23	case	_	_
20	other	_	ADJ	JJ	_	23	amod	_	_
21	centrally	_	ADV	RB	_	22	advmod	_	_
22	acting	_	VERB	VBG	_	23	amod	_	_
23	drugs	_	NOUN	NNS	_	18	nmod	_	_

#	Quetiapine fumarate	210
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	potentiated	_	VERB	VBD	_	0	root	_	_
3	the	_	DET	DT	_	7	det	_	_
4	cognitive	_	ADJ	JJ	_	7	amod	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	motor	_	NOUN	NN	_	4	conj	_	_
7	effects	_	NOUN	NNS	_	2	dobj	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	alcohol	_	NOUN	NN	_	7	nmod	_	_
10	in	_	ADP	IN	_	13	case	_	_
11	a	_	DET	DT	_	13	det	_	_
12	clinical	_	ADJ	JJ	_	13	amod	_	_
13	trial	_	NOUN	NN	_	7	nmod	_	_
14	in	_	ADP	IN	_	15	case	_	_
15	subjects	_	NOUN	NNS	_	13	nmod	_	_
16	with	_	ADP	IN	_	19	case	_	_
17	selected	_	VERB	VBN	_	19	amod	_	_
18	psychotic	_	ADJ	JJ	_	19	amod	_	_
19	disorders	_	NOUN	NNS	_	15	nmod	_	_
20	,	_	.	,	_	2	punct	_	_
21	and	_	CONJ	CC	_	2	cc	_	_
22	alcoholic	_	ADJ	JJ	_	23	amod	_	_
23	beverages	_	NOUN	NNS	_	26	nsubj	_	_
24	should	_	VERB	MD	_	26	aux	_	_
25	be	_	VERB	VB	_	26	cop	_	_
26	limited	_	ADJ	JJ	_	2	conj	_	_
27	while	_	ADP	IN	_	28	mark	_	_
28	taking	_	VERB	VBG	_	26	advcl	_	_
29	DRUG	_	NOUN	NN	_	28	dobj	_	_

#	Quetiapine fumarate	211
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	exposure	_	NOUN	NN	_	4	nsubjpass	_	_
3	is	_	VERB	VBZ	_	4	auxpass	_	_
4	increased	_	VERB	VBN	_	0	root	_	_
5	by	_	ADP	IN	_	9	case	_	_
6	the	_	DET	DT	_	9	det	_	_
7	prototype	_	NOUN	NN	_	9	compound	_	_
8	CYP3A4	_	NOUN	NN	_	9	compound	_	_
9	inhibitors	_	NOUN	NNS	_	4	nmod	_	_
10	e.g	_	NOUN	NN	_	9	dep	_	_
11	,	_	.	,	_	10	punct	_	_
12	ketoconazole	_	NOUN	NN	_	10	conj	_	_
13	,	_	.	,	_	10	punct	_	_
14	itraconazole	_	NOUN	NN	_	10	conj	_	_
15	,	_	.	,	_	10	punct	_	_
16	indinavir	_	NOUN	NN	_	10	conj	_	_
17	,	_	.	,	_	10	punct	_	_
18	ritonavir	_	NOUN	NN	_	10	conj	_	_
19	,	_	.	,	_	10	punct	_	_
20	nefazodone	_	NOUN	NN	_	10	conj	_	_
21	,	_	.	,	_	10	punct	_	_
22	etc	_	NOUN	NN	_	10	conj	_	_
23	and	_	CONJ	CC	_	4	cc	_	_
24	decreased	_	VERB	VBD	_	4	conj	_	_
25	by	_	ADP	IN	_	29	case	_	_
26	the	_	DET	DT	_	29	det	_	_
27	prototype	_	NOUN	NN	_	29	compound	_	_
28	CYP3A4	_	NOUN	NN	_	29	compound	_	_
29	inducers	_	NOUN	NNS	_	24	nmod	_	_
30	e..g	_	NOUN	NN	_	29	dep	_	_
31	,	_	.	,	_	30	punct	_	_
32	phenytoin	_	NOUN	NN	_	30	conj	_	_
33	,	_	.	,	_	30	punct	_	_
34	carbamazepine	_	NOUN	NN	_	30	conj	_	_
35	,	_	.	,	_	30	punct	_	_
36	rifampin	_	NOUN	NN	_	30	conj	_	_
37	,	_	.	,	_	30	punct	_	_
38	avasimibe	_	NOUN	NN	_	30	conj	_	_
39	,	_	.	,	_	30	punct	_	_
40	St	_	NOUN	NN	_	41	compound	_	_
41	John's	_	NOUN	NNS	_	43	compound	_	_
42	wort	_	ADJ	JJR	_	43	compound	_	_
43	etc	_	NOUN	NN	_	30	conj	_	_

#	Quetiapine fumarate	212
1	Dose	_	ADJ	JJ	_	2	amod	_	_
2	adjustment	_	NOUN	NN	_	7	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	will	_	VERB	MD	_	7	aux	_	_
6	be	_	VERB	VB	_	7	cop	_	_
7	necessary	_	ADJ	JJ	_	0	root	_	_
8	if	_	ADP	IN	_	12	mark	_	_
9	it	_	PRON	PRP	_	12	nsubjpass	_	_
10	is	_	VERB	VBZ	_	12	auxpass	_	_
11	co	_	PRT	TO	_	12	dep	_	_
12	administered	_	VERB	VBN	_	7	ccomp	_	_
13	with	_	ADP	IN	_	16	case	_	_
14	potent	_	ADJ	JJ	_	16	amod	_	_
15	CYP3A4	_	NOUN	NN	_	16	compound	_	_
16	inducers	_	NOUN	NNS	_	12	nmod	_	_
17	or	_	CONJ	CC	_	16	cc	_	_
18	inhibitors	_	NOUN	NNS	_	16	conj	_	_

#	Quetiapine fumarate	213
1	CYP3A4	_	NOUN	NN	_	2	compound	_	_
2	inhibitors:Coadministration	_	NOUN	NN	_	13	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	ketoconazole	_	NOUN	NN	_	2	nmod	_	_
5	,	_	.	,	_	4	punct	_	_
6	a	_	DET	DT	_	8	det	_	_
7	potent	_	ADJ	JJ	_	8	amod	_	_
8	inhibitor	_	NOUN	NN	_	4	appos	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	cytochrome	_	NOUN	NN	_	11	compound	_	_
11	CYP3A4	_	NOUN	NN	_	8	nmod	_	_
12	,	_	.	,	_	2	punct	_	_
13	resulted	_	VERB	VBD	_	0	root	_	_
14	in	_	ADP	IN	_	16	case	_	_
15	significant	_	ADJ	JJ	_	16	amod	_	_
16	increase	_	NOUN	NN	_	13	nmod	_	_
17	in	_	ADP	IN	_	19	case	_	_
18	DRUG	_	NOUN	NN	_	19	compound	_	_
19	exposure	_	NOUN	NN	_	16	nmod	_	_

#	Quetiapine fumarate	214
1	The	_	DET	DT	_	2	det	_	_
2	dose	_	NOUN	NN	_	7	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	should	_	VERB	MD	_	7	aux	_	_
6	be	_	VERB	VB	_	7	auxpass	_	_
7	reduced	_	VERB	VBN	_	0	root	_	_
8	to	_	PRT	TO	_	10	case	_	_
9	one	_	NUM	CD	_	10	nummod	_	_
10	sixth	_	NOUN	NN	_	7	nmod	_	_
11	of	_	ADP	IN	_	14	case	_	_
12	the	_	DET	DT	_	14	det	_	_
13	original	_	ADJ	JJ	_	14	amod	_	_
14	dose	_	NOUN	NN	_	10	nmod	_	_
15	if	_	DET	WDT	_	16	nsubj	_	_
16	coadministered	_	VERB	VBN	_	7	dep	_	_
17	with	_	ADP	IN	_	21	case	_	_
18	a	_	DET	DT	_	21	det	_	_
19	strong	_	ADJ	JJ	_	21	amod	_	_
20	CYP3A4	_	NOUN	NN	_	21	compound	_	_
21	inhibitor	_	NOUN	NN	_	16	nmod	_	_

#	Quetiapine fumarate	215
1	CYP3A4	_	NOUN	NN	_	2	compound	_	_
2	inducers:Coadministration	_	NOUN	NN	_	0	root	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	phenytoin	_	NOUN	NN	_	4	conj	_	_
7	,	_	.	,	_	2	punct	_	_
8	a	_	DET	DT	_	10	det	_	_
9	CYP3A4	_	NOUN	NN	_	10	compound	_	_
10	inducer	_	NOUN	NN	_	11	nsubj	_	_
11	increased	_	VERB	VBD	_	2	dep	_	_
12	the	_	DET	DT	_	15	det	_	_
13	mean	_	ADJ	JJ	_	15	amod	_	_
14	oral	_	ADJ	JJ	_	15	amod	_	_
15	clearance	_	NOUN	NN	_	11	dobj	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	DRUG	_	NOUN	NN	_	15	nmod	_	_
18	by	_	ADP	IN	_	20	case	_	_
19	5	_	NUM	CD	_	20	nummod	_	_
20	fold	_	ADV	RB	_	11	nmod	_	_

#	Quetiapine fumarate	216
1	Increased	_	VERB	VBN	_	2	amod	_	_
2	doses	_	NOUN	NNS	_	11	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	up	_	ADV	RB	_	7	advmod	_	_
6	to	_	PRT	TO	_	5	mwe	_	_
7	5	_	NUM	CD	_	8	nummod	_	_
8	fold	_	NOUN	NN	_	2	nmod	_	_
9	may	_	VERB	MD	_	11	aux	_	_
10	be	_	VERB	VB	_	11	auxpass	_	_
11	required	_	VERB	VBN	_	0	root	_	_
12	to	_	PRT	TO	_	13	mark	_	_
13	maintain	_	VERB	VB	_	11	xcomp	_	_
14	control	_	NOUN	NN	_	13	dobj	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	symptoms	_	NOUN	NNS	_	14	nmod	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	schizophrenia	_	NOUN	NN	_	16	nmod	_	_
19	in	_	ADP	IN	_	20	case	_	_
20	patients	_	NOUN	NNS	_	16	nmod	_	_
21	receiving	_	VERB	VBG	_	20	acl	_	_
22	DRUG	_	NOUN	NN	_	21	dobj	_	_
23	and	_	CONJ	CC	_	22	cc	_	_
24	phenytoin	_	NOUN	NN	_	22	conj	_	_
25	,	_	.	,	_	11	punct	_	_
26	or	_	CONJ	CC	_	11	cc	_	_
27	other	_	ADJ	JJ	_	31	amod	_	_
28	known	_	VERB	VBN	_	31	amod	_	_
29	potent	_	ADJ	JJ	_	31	amod	_	_
30	CYP3A4	_	NOUN	NN	_	31	compound	_	_
31	inducers	_	NOUN	NNS	_	11	conj	_	_

#	Quetiapine fumarate	217
1	When	_	ADV	WRB	_	6	advmod	_	_
2	the	_	DET	DT	_	4	det	_	_
3	CYP3A4	_	NOUN	NN	_	4	compound	_	_
4	inducer	_	NOUN	NN	_	6	nsubjpass	_	_
5	is	_	VERB	VBZ	_	6	auxpass	_	_
6	discontinued	_	VERB	VBN	_	14	advcl	_	_
7	,	_	.	,	_	14	punct	_	_
8	the	_	DET	DT	_	9	det	_	_
9	dose	_	NOUN	NN	_	14	nsubjpass	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_
12	should	_	VERB	MD	_	14	aux	_	_
13	be	_	VERB	VB	_	14	auxpass	_	_
14	reduced	_	VERB	VBN	_	0	root	_	_
15	to	_	PRT	TO	_	18	case	_	_
16	the	_	DET	DT	_	18	det	_	_
17	original	_	ADJ	JJ	_	18	amod	_	_
18	level	_	NOUN	NN	_	14	nmod	_	_
19	within	_	ADP	IN	_	23	case	_	_
20	7	_	NUM	CD	_	22	compound	_	_
21	to	_	PRT	TO	_	22	dep	_	_
22	14	_	NUM	CD	_	23	nummod	_	_
23	days	_	NOUN	NNS	_	18	nmod	_	_

#	Quetiapine fumarate	218
1	The	_	DET	DT	_	3	det	_	_
2	potential	_	ADJ	JJ	_	3	amod	_	_
3	effects	_	NOUN	NNS	_	12	nsubjpass	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	several	_	ADJ	JJ	_	7	amod	_	_
6	concomitant	_	ADJ	JJ	_	7	amod	_	_
7	medications	_	NOUN	NNS	_	3	nmod	_	_
8	on	_	ADP	IN	_	10	case	_	_
9	DRUG	_	NOUN	NN	_	10	compound	_	_
10	pharmacokinetics	_	NOUN	NNS	_	3	nmod	_	_
11	were	_	VERB	VBD	_	12	auxpass	_	_
12	studied	_	VERB	VBN	_	23	advcl	_	_
13	Because	_	ADP	IN	_	16	case	_	_
14	of	_	ADP	IN	_	16	case	_	_
15	its	_	PRON	PRP$	_	16	nmod:poss	_	_
16	potential	_	NOUN	NN	_	12	nmod	_	_
17	for	_	ADP	IN	_	18	mark	_	_
18	inducing	_	VERB	VBG	_	16	acl	_	_
19	hypotension	_	NOUN	NN	_	18	dobj	_	_
20	,	_	.	,	_	23	punct	_	_
21	DRUG	_	NOUN	NN	_	23	nsubj	_	_
22	may	_	VERB	MD	_	23	aux	_	_
23	enhance	_	VERB	VB	_	0	root	_	_
24	the	_	DET	DT	_	25	det	_	_
25	effects	_	NOUN	NNS	_	23	dobj	_	_
26	of	_	ADP	IN	_	29	case	_	_
27	certain	_	ADJ	JJ	_	29	amod	_	_
28	antihypertensive	_	ADJ	JJ	_	29	amod	_	_
29	agents	_	NOUN	NNS	_	25	nmod	_	_

#	Quetiapine fumarate	219
1	DRUG	_	NOUN	NN	_	3	nsubj	_	_
2	may	_	VERB	MD	_	3	aux	_	_
3	antagonize	_	VERB	VB	_	0	root	_	_
4	the	_	DET	DT	_	5	det	_	_
5	effects	_	NOUN	NNS	_	3	dobj	_	_
6	of	_	ADP	IN	_	10	case	_	_
7	levodopa	_	NOUN	NN	_	10	compound	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	dopamine	_	NOUN	NN	_	7	conj	_	_
10	agonists	_	NOUN	NNS	_	5	nmod	_	_

#	Quetiapine fumarate	220
1	There	_	DET	EX	_	2	expl	_	_
2	are	_	VERB	VBP	_	0	root	_	_
3	no	_	DET	DT	_	7	neg	_	_
4	clinically	_	ADV	RB	_	5	advmod	_	_
5	relevant	_	ADJ	JJ	_	7	amod	_	_
6	pharmacokinetic	_	ADJ	JJ	_	7	amod	_	_
7	interactions	_	NOUN	NNS	_	2	nsubj	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	on	_	ADP	IN	_	12	case	_	_
11	other	_	ADJ	JJ	_	12	amod	_	_
12	drugs	_	NOUN	NNS	_	2	nmod	_	_
13	based	_	VERB	VBN	_	12	acl	_	_
14	on	_	ADP	IN	_	17	case	_	_
15	the	_	DET	DT	_	17	det	_	_
16	CYP	_	NOUN	NN	_	17	compound	_	_
17	pathway	_	NOUN	NN	_	13	nmod	_	_

#	Quetiapine fumarate	221
1	DRUG	_	NOUN	NN	_	7	nsubj	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	its	_	PRON	PRP$	_	4	nmod:poss	_	_
4	metabolites	_	NOUN	NNS	_	1	conj	_	_
5	are	_	VERB	VBP	_	7	cop	_	_
6	non	_	ADJ	JJ	_	7	amod	_	_
7	inhibitors	_	NOUN	NNS	_	0	root	_	_
8	of	_	ADP	IN	_	11	case	_	_
9	major	_	ADJ	JJ	_	11	amod	_	_
10	metabolizing	_	VERB	VBG	_	11	amod	_	_
11	CYP's	_	NOUN	NNS	_	7	nmod	_	_
12	1A2	_	NOUN	NN	_	11	dep	_	_
13	,	_	.	,	_	12	punct	_	_
14	2C9	_	NOUN	NN	_	12	conj	_	_
15	,	_	.	,	_	12	punct	_	_
16	2C19	_	NOUN	NN	_	12	conj	_	_
17	,	_	.	,	_	12	punct	_	_
18	2D6	_	NOUN	NN	_	12	conj	_	_
19	and	_	CONJ	CC	_	12	cc	_	_
20	3A4	_	NOUN	NN	_	12	conj	_	_

#	Quetiapine fumarate	222
1	The	_	DET	DT	_	2	det	_	_
2	mechanism	_	NOUN	NN	_	8	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	action	_	NOUN	NN	_	2	nmod	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	is	_	VERB	VBZ	_	8	auxpass	_	_
8	unknown	_	ADJ	JJ	_	0	root	_	_

#	Quetiapine fumarate	223
1	However	_	ADV	RB	_	6	advmod	_	_
2	,	_	.	,	_	6	punct	_	_
3	it	_	PRON	PRP	_	6	nsubjpass	_	_
4	has	_	VERB	VBZ	_	6	aux	_	_
5	been	_	VERB	VBN	_	6	auxpass	_	_
6	proposed	_	VERB	VBN	_	0	root	_	_
7	that	_	ADP	IN	_	25	mark	_	_
8	the	_	DET	DT	_	9	det	_	_
9	efficacy	_	NOUN	NN	_	25	nsubjpass	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_
12	in	_	ADP	IN	_	13	case	_	_
13	schizophrenia	_	NOUN	NN	_	9	nmod	_	_
14	and	_	CONJ	CC	_	9	cc	_	_
15	its	_	PRON	PRP$	_	18	nmod:poss	_	_
16	mood	_	NOUN	NN	_	18	amod	_	_
17	stabilizing	_	NOUN	NN	_	18	amod	_	_
18	properties	_	NOUN	NNS	_	9	conj	_	_
19	in	_	ADP	IN	_	21	case	_	_
20	bipolar	_	ADJ	JJ	_	21	amod	_	_
21	depression	_	NOUN	NN	_	18	nmod	_	_
22	and	_	CONJ	CC	_	21	cc	_	_
23	mania	_	NOUN	NN	_	21	conj	_	_
24	are	_	VERB	VBP	_	25	auxpass	_	_
25	mediated	_	VERB	VBN	_	6	ccomp	_	_
26	through	_	ADP	IN	_	28	case	_	_
27	a	_	DET	DT	_	28	det	_	_
28	combination	_	NOUN	NN	_	25	nmod	_	_
29	of	_	ADP	IN	_	33	case	_	_
30	dopamine	_	NOUN	NN	_	33	compound	_	_
31	type	_	NOUN	NN	_	33	compound	_	_
32	2	_	NUM	CD	_	33	nummod	_	_
33	D2	_	NOUN	NN	_	28	nmod	_	_
34	and	_	CONJ	CC	_	33	cc	_	_
35	serotonin	_	NOUN	NN	_	39	compound	_	_
36	type	_	NOUN	NN	_	39	compound	_	_
37	2	_	NUM	CD	_	39	nummod	_	_
38	5HT2	_	NOUN	NN	_	39	compound	_	_
39	antagonism	_	NOUN	NN	_	33	conj	_	_

#	Quetiapine fumarate	224
1	Antagonism	_	NOUN	NN	_	14	nsubj	_	_
2	at	_	ADP	IN	_	3	case	_	_
3	receptors	_	NOUN	NNS	_	1	nmod	_	_
4	other	_	ADJ	JJ	_	6	case	_	_
5	than	_	ADP	IN	_	4	mwe	_	_
6	dopamine	_	NOUN	NN	_	3	nmod	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	5HT2	_	NOUN	NN	_	6	conj	_	_
9	with	_	ADP	IN	_	12	case	_	_
10	similar	_	ADJ	JJ	_	12	amod	_	_
11	receptor	_	NOUN	NN	_	12	compound	_	_
12	affinities	_	NOUN	NNS	_	1	nmod	_	_
13	may	_	VERB	MD	_	14	aux	_	_
14	explain	_	VERB	VB	_	0	root	_	_
15	some	_	DET	DT	_	14	dobj	_	_
16	of	_	ADP	IN	_	19	case	_	_
17	the	_	DET	DT	_	19	det	_	_
18	other	_	ADJ	JJ	_	19	amod	_	_
19	effects	_	NOUN	NNS	_	15	nmod	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	DRUG	_	NOUN	NN	_	19	nmod	_	_

#	Quetiapine fumarate	225
1	DRUG	_	NOUN	NN	_	3	nmod:poss	_	_
2	's	_	PRT	POS	_	1	case	_	_
3	antagonism	_	NOUN	NN	_	9	nsubj	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	histamine	_	NOUN	NN	_	7	compound	_	_
6	H1	_	NOUN	NN	_	7	compound	_	_
7	receptors	_	NOUN	NNS	_	3	nmod	_	_
8	may	_	VERB	MD	_	9	aux	_	_
9	explain	_	VERB	VB	_	0	root	_	_
10	the	_	DET	DT	_	11	det	_	_
11	somnolence	_	NOUN	NN	_	9	dobj	_	_
12	observed	_	VERB	VBN	_	11	acl	_	_
13	with	_	ADP	IN	_	15	case	_	_
14	this	_	DET	DT	_	15	det	_	_
15	drug	_	NOUN	NN	_	12	nmod	_	_

#	Quetiapine fumarate	226
1	DRUG	_	NOUN	NN	_	3	nmod:poss	_	_
2	's	_	PRT	POS	_	1	case	_	_
3	antagonism	_	NOUN	NN	_	9	nsubj	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	adrenergic	_	ADJ	JJ	_	7	amod	_	_
6	A1	_	NOUN	NN	_	7	compound	_	_
7	receptors	_	NOUN	NNS	_	3	nmod	_	_
8	may	_	VERB	MD	_	9	aux	_	_
9	explain	_	VERB	VB	_	0	root	_	_
10	the	_	DET	DT	_	12	det	_	_
11	orthostatic	_	ADJ	JJ	_	12	amod	_	_
12	hypotension	_	NOUN	NN	_	9	dobj	_	_
13	observed	_	VERB	VBN	_	12	acl	_	_
14	with	_	ADP	IN	_	16	case	_	_
15	this	_	DET	DT	_	16	det	_	_
16	drug	_	NOUN	NN	_	13	nmod	_	_

#	Quetiapine fumarate	227
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	is	_	VERB	VBZ	_	4	cop	_	_
3	an	_	DET	DT	_	4	det	_	_
4	antagonist	_	NOUN	NN	_	0	root	_	_
5	at	_	ADP	IN	_	8	case	_	_
6	multiple	_	ADJ	JJ	_	8	amod	_	_
7	neurotransmitter	_	ADJ	JJ	_	8	amod	_	_
8	receptors	_	NOUN	NNS	_	4	nmod	_	_
9	in	_	ADP	IN	_	11	case	_	_
10	the	_	DET	DT	_	11	det	_	_
11	brain	_	NOUN	NN	_	8	nmod	_	_
12	:	_	.	:	_	4	punct	_	_
13	serotonin	_	NOUN	NN	_	14	compound	_	_
14	5HT1A	_	NOUN	NN	_	4	dep	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	5HT2	_	NOUN	NN	_	19	compound	_	_
17	IC50s=717	_	NOUN	NN	_	19	compound	_	_
18	&	_	NOUN	NN	_	19	compound	_	_
19	148nM	_	ADJ	JJ	_	14	conj	_	_
20	,	_	.	,	_	14	punct	_	_
21	respectively	_	ADV	RB	_	24	advmod	_	_
22	,	_	.	,	_	24	punct	_	_
23	dopamine	_	NOUN	NN	_	24	compound	_	_
24	D1	_	NOUN	NN	_	14	nmod	_	_
25	and	_	CONJ	CC	_	24	cc	_	_
26	D2	_	NOUN	NN	_	29	compound	_	_
27	IC50s=1268	_	NOUN	NN	_	29	compound	_	_
28	&	_	NOUN	NN	_	29	compound	_	_
29	329nM	_	NOUN	NN	_	24	conj	_	_
30	,	_	.	,	_	24	punct	_	_
31	respectively	_	ADV	RB	_	24	advmod	_	_
32	,	_	.	,	_	24	punct	_	_
33	histamine	_	NOUN	NN	_	35	compound	_	_
34	H1	_	NOUN	NN	_	35	compound	_	_
35	IC50=30nM	_	NOUN	NN	_	24	conj	_	_
36	,	_	.	,	_	24	punct	_	_
37	and	_	CONJ	CC	_	24	cc	_	_
38	adrenergic	_	ADJ	JJ	_	39	amod	_	_
39	A1	_	NOUN	NN	_	24	conj	_	_
40	and	_	CONJ	CC	_	39	cc	_	_
41	A2receptors	_	NOUN	NNS	_	39	conj	_	_
42	IC50s=94	_	NOUN	NN	_	44	compound	_	_
43	&	_	X	FW	_	44	compound	_	_
44	271nM	_	NOUN	NN	_	39	dep	_	_
45	,	_	.	,	_	24	punct	_	_
46	respectively	_	ADV	RB	_	24	neg	_	_

#	Quetiapine fumarate	228
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	has	_	VERB	VBZ	_	0	root	_	_
3	no	_	DET	DT	_	5	neg	_	_
4	appreciable	_	ADJ	JJ	_	5	amod	_	_
5	affinity	_	NOUN	NN	_	2	dobj	_	_
6	at	_	ADP	IN	_	8	case	_	_
7	cholinergic	_	ADJ	JJ	_	8	amod	_	_
8	muscarinic	_	ADJ	JJ	_	2	nmod	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	benzodiazepine	_	NOUN	NN	_	8	conj	_	_
11	receptors	_	NOUN	NNS	_	12	compound	_	_
12	IC50s	_	NOUN	NN	_	8	dep	_	_
13	>	_	NUM	CD	_	15	nummod	_	_
14	5000	_	NUM	CD	_	15	nummod	_	_
15	nM	_	NOUN	NN	_	12	dep	_	_

#	Quetiapine fumarate	229
1	Effect	_	NOUN	NN	_	11	nsubjpass	_	_
2	on	_	ADP	IN	_	3	case	_	_
3	QT	_	NOUN	NN	_	1	nmod	_	_
4	Interval	_	ADJ	JJ	_	3	amod	_	_
5	In	_	ADP	IN	_	7	case	_	_
6	clinical	_	ADJ	JJ	_	7	amod	_	_
7	trials	_	NOUN	NNS	_	4	nmod	_	_
8	DRUG	_	NOUN	NN	_	7	dep	_	_
9	was	_	VERB	VBD	_	11	auxpass	_	_
10	not	_	ADV	RB	_	11	neg	_	_
11	associated	_	VERB	VBN	_	0	root	_	_
12	with	_	ADP	IN	_	15	case	_	_
13	a	_	DET	DT	_	15	det	_	_
14	persistent	_	ADJ	JJ	_	15	amod	_	_
15	increase	_	NOUN	NN	_	11	nmod	_	_
16	in	_	ADP	IN	_	17	case	_	_
17	QT	_	NOUN	NN	_	15	nmod	_	_
18	intervals	_	NOUN	NNS	_	11	punct	_	_

#	Quetiapine fumarate	230
1	However	_	ADV	RB	_	9	advmod	_	_
2	,	_	.	,	_	9	punct	_	_
3	the	_	DET	DT	_	5	det	_	_
4	QT	_	NOUN	NN	_	5	compound	_	_
5	effect	_	NOUN	NN	_	9	nsubjpass	_	_
6	was	_	VERB	VBD	_	9	auxpass	_	_
7	not	_	ADV	RB	_	9	neg	_	_
8	systematically	_	ADV	RB	_	9	advmod	_	_
9	evaluated	_	VERB	VBN	_	0	root	_	_
10	in	_	ADP	IN	_	14	case	_	_
11	a	_	DET	DT	_	14	det	_	_
12	thorough	_	NOUN	NN	_	14	compound	_	_
13	QT	_	NOUN	NN	_	14	compound	_	_
14	study	_	NOUN	NN	_	9	nmod	_	_

#	Quetiapine fumarate	231
1	In	_	ADP	IN	_	4	case	_	_
2	post	_	ADJ	JJ	_	4	amod	_	_
3	marketing	_	VERB	VBG	_	4	amod	_	_
4	experience	_	NOUN	NN	_	6	nmod	_	_
5	there	_	DET	EX	_	6	expl	_	_
6	were	_	VERB	VBD	_	0	root	_	_
7	cases	_	NOUN	NNS	_	6	nsubj	_	_
8	reported	_	VERB	VBN	_	7	acl	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	QT	_	NOUN	NN	_	11	compound	_	_
11	prolongation	_	NOUN	NN	_	8	nmod	_	_
12	in	_	ADP	IN	_	13	case	_	_
13	patients	_	NOUN	NNS	_	11	nmod	_	_
14	who	_	DET	WDT	_	15	nsubj	_	_
15	overdosed	_	VERB	VBD	_	13	acl:relcl	_	_
16	on	_	ADP	IN	_	17	case	_	_
17	DRUG	_	NOUN	NN	_	15	nmod	_	_
18	,	_	.	,	_	6	punct	_	_
19	in	_	ADP	IN	_	20	case	_	_
20	patients	_	NOUN	NNS	_	6	nmod	_	_
21	with	_	ADP	IN	_	23	case	_	_
22	concomitant	_	ADJ	JJ	_	23	amod	_	_
23	illness	_	NOUN	NN	_	20	nmod	_	_
24	,	_	.	,	_	6	punct	_	_
25	and	_	CONJ	CC	_	6	cc	_	_
26	in	_	ADP	IN	_	27	case	_	_
27	patients	_	NOUN	NNS	_	6	conj	_	_
28	taking	_	VERB	VBG	_	27	acl	_	_
29	medicines	_	NOUN	NNS	_	28	dobj	_	_
30	known	_	VERB	VBN	_	29	acl	_	_
31	to	_	PRT	TO	_	32	mark	_	_
32	cause	_	VERB	VB	_	30	xcomp	_	_
33	electrolyte	_	NOUN	NN	_	34	compound	_	_
34	imbalance	_	NOUN	NN	_	32	dobj	_	_
35	or	_	CONJ	CC	_	32	cc	_	_
36	increase	_	VERB	VBP	_	32	conj	_	_
37	QT	_	NOUN	NN	_	38	compound	_	_
38	interval	_	ADJ	JJ	_	36	dobj	_	_

#	Quetiapine fumarate	232
1	Adults	_	NOUN	NNS	_	3	compound	_	_
2	DRUG	_	NOUN	NN	_	3	compound	_	_
3	activity	_	NOUN	NN	_	6	nsubj	_	_
4	is	_	VERB	VBZ	_	6	cop	_	_
5	primarily	_	ADV	RB	_	6	advmod	_	_
6	due	_	ADJ	JJ	_	0	root	_	_
7	to	_	PRT	TO	_	10	case	_	_
8	the	_	DET	DT	_	10	det	_	_
9	parent	_	NOUN	NN	_	10	compound	_	_
10	drug	_	NOUN	NN	_	6	nmod	_	_

#	Quetiapine fumarate	233
1	The	_	DET	DT	_	4	det	_	_
2	multiple	_	ADJ	JJ	_	4	amod	_	_
3	dose	_	NOUN	NN	_	4	compound	_	_
4	pharmacokinetics	_	NOUN	NNS	_	9	nsubj	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	are	_	VERB	VBP	_	9	cop	_	_
8	dose	_	NOUN	NN	_	9	nmod:npmod	_	_
9	proportional	_	ADJ	JJ	_	0	root	_	_
10	within	_	ADP	IN	_	15	case	_	_
11	the	_	DET	DT	_	15	det	_	_
12	proposed	_	VERB	VBN	_	15	amod	_	_
13	clinical	_	ADJ	JJ	_	15	amod	_	_
14	dose	_	NOUN	NN	_	15	compound	_	_
15	range	_	NOUN	NN	_	9	nmod	_	_
16	,	_	.	,	_	9	punct	_	_
17	and	_	CONJ	CC	_	9	cc	_	_
18	DRUG	_	NOUN	NN	_	19	compound	_	_
19	accumulation	_	NOUN	NN	_	21	nsubj	_	_
20	is	_	VERB	VBZ	_	21	cop	_	_
21	predictable	_	ADJ	JJ	_	9	conj	_	_
22	upon	_	ADP	IN	_	24	case	_	_
23	multiple	_	ADJ	JJ	_	24	amod	_	_
24	dosing	_	VERB	VBG	_	21	nmod	_	_

#	Quetiapine fumarate	234
1	Elimination	_	NOUN	NN	_	8	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	is	_	VERB	VBZ	_	8	cop	_	_
5	mainly	_	ADV	RB	_	8	advmod	_	_
6	via	_	ADP	IN	_	8	case	_	_
7	hepatic	_	ADJ	JJ	_	8	amod	_	_
8	metabolism	_	NOUN	NN	_	0	root	_	_
9	with	_	ADP	IN	_	14	case	_	_
10	a	_	DET	DT	_	14	det	_	_
11	mean	_	ADJ	JJ	_	14	amod	_	_
12	terminal	_	ADJ	JJ	_	14	amod	_	_
13	half	_	ADJ	JJ	_	14	amod	_	_
14	life	_	NOUN	NN	_	8	nmod	_	_
15	of	_	ADP	IN	_	18	case	_	_
16	about	_	ADV	RB	_	17	advmod	_	_
17	6	_	NUM	CD	_	18	nummod	_	_
18	hours	_	NOUN	NNS	_	14	nmod	_	_
19	within	_	ADP	IN	_	24	case	_	_
20	the	_	DET	DT	_	24	det	_	_
21	proposed	_	VERB	VBN	_	24	amod	_	_
22	clinical	_	ADJ	JJ	_	24	amod	_	_
23	dose	_	NOUN	NN	_	24	compound	_	_
24	range	_	NOUN	NN	_	14	nmod	_	_

#	Quetiapine fumarate	235
1	Steady	_	ADJ	JJ	_	3	amod	_	_
2	state	_	NOUN	NN	_	3	compound	_	_
3	concentrations	_	NOUN	NNS	_	5	nsubjpass	_	_
4	are	_	VERB	VBP	_	5	auxpass	_	_
5	expected	_	VERB	VBN	_	0	root	_	_
6	to	_	PRT	TO	_	8	mark	_	_
7	be	_	VERB	VB	_	8	auxpass	_	_
8	achieved	_	VERB	VBN	_	5	xcomp	_	_
9	within	_	ADP	IN	_	11	case	_	_
10	two	_	NUM	CD	_	11	nummod	_	_
11	days	_	NOUN	NNS	_	8	nmod	_	_
12	of	_	ADP	IN	_	13	mark	_	_
13	dosing	_	VERB	VBG	_	11	acl	_	_

#	Quetiapine fumarate	236
1	DRUG	_	NOUN	NN	_	3	nsubj	_	_
2	is	_	VERB	VBZ	_	3	cop	_	_
3	unlikely	_	ADJ	JJ	_	0	root	_	_
4	to	_	PRT	TO	_	5	mark	_	_
5	interfere	_	VERB	VB	_	3	xcomp	_	_
6	with	_	ADP	IN	_	8	case	_	_
7	the	_	DET	DT	_	8	det	_	_
8	metabolism	_	NOUN	NN	_	5	nmod	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	drugs	_	NOUN	NNS	_	8	nmod	_	_
11	metabolized	_	VERB	VBN	_	10	acl	_	_
12	by	_	ADP	IN	_	15	case	_	_
13	cytochrome	_	NOUN	NN	_	15	compound	_	_
14	P450	_	NOUN	NN	_	15	compound	_	_
15	enzymes	_	NOUN	NNS	_	11	nmod	_	_

#	Quetiapine fumarate	237
1	Children	_	NOUN	NN	_	5	compound	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	Adolescents	_	NOUN	NNS	_	1	conj	_	_
4	At	_	NOUN	NN	_	5	nmod:npmod	_	_
5	steady	_	ADJ	JJ	_	6	nsubj	_	_
6	state	_	NOUN	NN	_	26	nsubj	_	_
7	the	_	DET	DT	_	8	det	_	_
8	pharmacokinetics	_	NOUN	NNS	_	6	dobj	_	_
9	of	_	ADP	IN	_	12	case	_	_
10	the	_	DET	DT	_	12	det	_	_
11	parent	_	NOUN	NN	_	12	compound	_	_
12	compound	_	NOUN	NN	_	8	nmod	_	_
13	,	_	.	,	_	6	punct	_	_
14	in	_	ADP	IN	_	15	case	_	_
15	children	_	NOUN	NN	_	6	nmod	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	adolescents	_	NOUN	NNS	_	21	compound	_	_
18	10	_	NUM	CD	_	20	compound	_	_
19	to	_	PRT	TO	_	20	dep	_	_
20	17	_	NUM	CD	_	21	nummod	_	_
21	years	_	NOUN	NNS	_	15	conj	_	_
22	of	_	ADP	IN	_	23	case	_	_
23	age	_	NOUN	NN	_	15	nmod	_	_
24	,	_	.	,	_	6	punct	_	_
25	were	_	VERB	VBD	_	26	cop	_	_
26	similar	_	ADJ	JJ	_	0	root	_	_
27	to	_	PRT	TO	_	28	case	_	_
28	adults	_	NOUN	NNS	_	26	nmod	_	_

#	Quetiapine fumarate	238
1	However	_	ADV	RB	_	18	advmod	_	_
2	,	_	.	,	_	18	punct	_	_
3	when	_	ADV	RB	_	4	advmod	_	_
4	adjusted	_	VERB	VBN	_	18	advcl	_	_
5	for	_	ADP	IN	_	6	case	_	_
6	dose	_	NOUN	NN	_	4	nmod	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	weight	_	NOUN	NN	_	6	conj	_	_
9	,	_	.	,	_	18	punct	_	_
10	AUC	_	NOUN	NN	_	18	nsubj	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	Cmax	_	NOUN	NN	_	10	conj	_	_
13	of	_	ADP	IN	_	16	case	_	_
14	the	_	DET	DT	_	16	det	_	_
15	parent	_	NOUN	NN	_	16	compound	_	_
16	compound	_	NOUN	NN	_	10	nmod	_	_
17	were	_	VERB	VBD	_	18	cop	_	_
18	41%	_	ADJ	JJ	_	0	root	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	39%	_	ADJ	JJ	_	21	nmod:npmod	_	_
21	lower	_	ADJ	JJ	_	18	conj	_	_
22	,	_	.	,	_	18	punct	_	_
23	respectively	_	ADV	RB	_	18	advmod	_	_
24	,	_	.	,	_	18	punct	_	_
25	in	_	ADP	IN	_	26	case	_	_
26	children	_	NOUN	NN	_	18	nmod	_	_
27	and	_	CONJ	CC	_	26	cc	_	_
28	adolescents	_	NOUN	NNS	_	26	conj	_	_
29	than	_	ADP	IN	_	31	case	_	_
30	in	_	ADP	IN	_	31	case	_	_
31	adults	_	NOUN	NNS	_	18	nmod	_	_

#	Quetiapine fumarate	239
1	For	_	ADP	IN	_	4	case	_	_
2	the	_	DET	DT	_	4	det	_	_
3	active	_	ADJ	JJ	_	4	amod	_	_
4	metabolite	_	NOUN	NN	_	13	nmod	_	_
5	,	_	.	,	_	4	punct	_	_
6	nor	_	CONJ	CC	_	4	cc	_	_
7	DRUG	_	NOUN	NN	_	4	conj	_	_
8	,	_	.	,	_	13	punct	_	_
9	AUC	_	NOUN	NN	_	13	nsubj	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	Cmax	_	NOUN	NN	_	9	conj	_	_
12	were	_	VERB	VBD	_	13	cop	_	_
13	45%	_	ADJ	JJ	_	0	root	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	31%	_	ADJ	JJ	_	16	nmod:npmod	_	_
16	higher	_	ADJ	JJ	_	13	conj	_	_
17	,	_	.	,	_	13	punct	_	_
18	respectively	_	ADV	RB	_	13	advmod	_	_
19	,	_	.	,	_	13	punct	_	_
20	in	_	ADP	IN	_	21	case	_	_
21	children	_	NOUN	NN	_	13	nmod	_	_
22	and	_	CONJ	CC	_	21	cc	_	_
23	adolescents	_	NOUN	NNS	_	21	conj	_	_
24	than	_	ADP	IN	_	26	case	_	_
25	in	_	ADP	IN	_	26	case	_	_
26	adults	_	NOUN	NNS	_	13	nmod	_	_

#	Quetiapine fumarate	240
1	When	_	ADV	WRB	_	2	advmod	_	_
2	adjusted	_	VERB	VBN	_	18	advcl	_	_
3	for	_	ADP	IN	_	4	case	_	_
4	dose	_	NOUN	NN	_	2	nmod	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	weight	_	NOUN	NN	_	4	conj	_	_
7	,	_	.	,	_	18	punct	_	_
8	the	_	DET	DT	_	9	det	_	_
9	pharmacokinetics	_	NOUN	NNS	_	18	nsubj	_	_
10	of	_	ADP	IN	_	12	case	_	_
11	the	_	DET	DT	_	12	det	_	_
12	metabolite	_	NOUN	NN	_	9	nmod	_	_
13	,	_	.	,	_	12	punct	_	_
14	nor	_	CONJ	CC	_	12	cc	_	_
15	DRUG	_	NOUN	NN	_	12	conj	_	_
16	,	_	.	,	_	9	punct	_	_
17	was	_	VERB	VBD	_	18	cop	_	_
18	similar	_	ADJ	JJ	_	0	root	_	_
19	between	_	ADP	IN	_	20	case	_	_
20	children	_	NOUN	NN	_	18	nmod	_	_
21	and	_	CONJ	CC	_	20	cc	_	_
22	adolescents	_	NOUN	NNS	_	20	conj	_	_
23	and	_	CONJ	CC	_	20	cc	_	_
24	adults	_	NOUN	NNS	_	20	conj	_	_

#	Quetiapine fumarate	241
1	Absorption	_	NOUN	NN	_	2	compound	_	_
2	DRUG	_	NOUN	NN	_	5	nsubjpass	_	_
3	is	_	VERB	VBZ	_	5	auxpass	_	_
4	rapidly	_	ADV	RB	_	5	advmod	_	_
5	absorbed	_	VERB	VBN	_	0	root	_	_
6	after	_	ADP	IN	_	8	case	_	_
7	oral	_	ADJ	JJ	_	8	amod	_	_
8	administration	_	NOUN	NN	_	5	nmod	_	_
9	,	_	.	,	_	5	punct	_	_
10	reaching	_	VERB	VBG	_	5	advcl	_	_
11	peak	_	ADJ	JJ	_	13	amod	_	_
12	plasma	_	NOUN	NN	_	13	compound	_	_
13	concentrations	_	NOUN	NNS	_	10	dobj	_	_
14	in	_	ADP	IN	_	16	case	_	_
15	1.5	_	NUM	CD	_	16	nummod	_	_
16	hours	_	NOUN	NNS	_	13	nmod	_	_

#	Quetiapine fumarate	242
1	The	_	DET	DT	_	3	det	_	_
2	tablet	_	NOUN	NN	_	3	compound	_	_
3	formulation	_	NOUN	NN	_	6	nsubj	_	_
4	is	_	VERB	VBZ	_	6	cop	_	_
5	100%	_	ADJ	JJ	_	6	advmod	_	_
6	bioavailable	_	ADJ	JJ	_	0	root	_	_
7	relative	_	ADJ	JJ	_	6	xcomp	_	_
8	to	_	PRT	TO	_	9	case	_	_
9	solution	_	NOUN	NN	_	7	nmod	_	_

#	Quetiapine fumarate	243
1	The	_	DET	DT	_	2	det	_	_
2	bioavailability	_	NOUN	NN	_	7	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	is	_	VERB	VBZ	_	7	auxpass	_	_
6	marginally	_	ADV	RB	_	7	advmod	_	_
7	affected	_	VERB	VBN	_	0	root	_	_
8	by	_	ADP	IN	_	9	case	_	_
9	administration	_	NOUN	NN	_	7	nmod	_	_
10	with	_	ADP	IN	_	11	case	_	_
11	food	_	NOUN	NN	_	9	nmod	_	_
12	,	_	.	,	_	7	punct	_	_
13	with	_	ADP	IN	_	17	case	_	_
14	Cmax	_	NOUN	NN	_	17	compound	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	AUC	_	NOUN	NN	_	14	conj	_	_
17	values	_	NOUN	NNS	_	7	nmod	_	_
18	increased	_	VERB	VBN	_	17	acl	_	_
19	by	_	ADP	IN	_	20	case	_	_
20	25%	_	NOUN	NN	_	18	nmod	_	_
21	and	_	CONJ	CC	_	20	cc	_	_
22	15%	_	NOUN	NN	_	20	conj	_	_
23	,	_	.	,	_	7	punct	_	_
24	respectively	_	ADV	RB	_	7	advmod	_	_

#	Quetiapine fumarate	244
1	Distribution	_	NOUN	NN	_	2	compound	_	_
2	DRUG	_	NOUN	NN	_	5	nsubjpass	_	_
3	is	_	VERB	VBZ	_	5	auxpass	_	_
4	widely	_	ADV	RB	_	5	advmod	_	_
5	distributed	_	VERB	VBN	_	0	root	_	_
6	throughout	_	ADP	IN	_	8	case	_	_
7	the	_	DET	DT	_	8	det	_	_
8	body	_	NOUN	NN	_	5	nmod	_	_
9	with	_	ADP	IN	_	12	case	_	_
10	an	_	DET	DT	_	12	det	_	_
11	apparent	_	ADJ	JJ	_	12	amod	_	_
12	volume	_	NOUN	NN	_	8	nmod	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	distribution	_	NOUN	NN	_	12	nmod	_	_
15	of	_	ADP	IN	_	17	case	_	_
16	10*4	_	NUM	CD	_	17	nummod	_	_
17	L	_	NOUN	NN	_	14	nmod	_	_
18	/	_	.	:	_	17	punct	_	_
19	kg	_	NOUN	NN	_	17	dep	_	_

#	Quetiapine fumarate	245
1	It	_	PRON	PRP	_	4	nsubjpass	_	_
2	is	_	VERB	VBZ	_	4	auxpass	_	_
3	83%	_	ADJ	JJ	_	4	advmod	_	_
4	bound	_	VERB	VBN	_	0	root	_	_
5	to	_	PRT	TO	_	7	case	_	_
6	plasma	_	NOUN	NN	_	7	compound	_	_
7	proteins	_	NOUN	NNS	_	4	nmod	_	_
8	at	_	ADP	IN	_	10	case	_	_
9	therapeutic	_	ADJ	JJ	_	10	amod	_	_
10	concentrations	_	NOUN	NNS	_	4	nmod	_	_

#	Quetiapine fumarate	246
1	In	_	X	FW	_	2	compound	_	_
2	vitro	_	X	FW	_	7	advmod	_	_
3	,	_	.	,	_	7	punct	_	_
4	DRUG	_	NOUN	NN	_	7	nsubj	_	_
5	did	_	VERB	VBD	_	7	aux	_	_
6	not	_	ADV	RB	_	7	neg	_	_
7	affect	_	VERB	VB	_	0	root	_	_
8	the	_	DET	DT	_	9	det	_	_
9	binding	_	NOUN	NN	_	7	dobj	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	warfarin	_	NOUN	NN	_	9	nmod	_	_
12	or	_	CONJ	CC	_	11	cc	_	_
13	diazepam	_	NOUN	NN	_	11	conj	_	_
14	to	_	PRT	TO	_	17	case	_	_
15	human	_	ADJ	JJ	_	17	amod	_	_
16	serum	_	NOUN	NN	_	17	compound	_	_
17	albumin	_	NOUN	NN	_	9	nmod	_	_

#	Quetiapine fumarate	247
1	In	_	ADP	IN	_	2	case	_	_
2	turn	_	NOUN	NNS	_	8	nmod	_	_
3	,	_	.	,	_	8	punct	_	_
4	neither	_	CONJ	CC	_	5	cc:preconj	_	_
5	warfarin	_	NOUN	NN	_	8	nsubj	_	_
6	nor	_	CONJ	CC	_	5	cc	_	_
7	diazepam	_	NOUN	NN	_	5	conj	_	_
8	altered	_	VERB	VBD	_	0	root	_	_
9	the	_	DET	DT	_	10	det	_	_
10	binding	_	NOUN	NN	_	8	dobj	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_

#	Quetiapine fumarate	248
1	Metabolism	_	NOUN	NN	_	21	nsubjpass	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	Elimination	_	NOUN	NN	_	1	conj	_	_
4	Following	_	ADP	IN	_	8	case	_	_
5	a	_	DET	DT	_	8	det	_	_
6	single	_	ADJ	JJ	_	8	amod	_	_
7	oral	_	ADJ	JJ	_	8	amod	_	_
8	dose	_	NOUN	NN	_	1	nmod	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	14C	_	NOUN	NN	_	11	compound	_	_
11	DRUG	_	NOUN	NN	_	8	nmod	_	_
12	,	_	.	,	_	1	punct	_	_
13	less	_	ADV	RB	_	15	case	_	_
14	than	_	ADP	IN	_	13	mwe	_	_
15	1%	_	NOUN	NN	_	1	nmod	_	_
16	of	_	ADP	IN	_	19	case	_	_
17	the	_	DET	DT	_	19	det	_	_
18	administered	_	VERB	VBN	_	19	amod	_	_
19	dose	_	NOUN	NN	_	15	nmod	_	_
20	was	_	VERB	VBD	_	21	auxpass	_	_
21	excreted	_	VERB	VBN	_	0	root	_	_
22	as	_	ADP	IN	_	24	case	_	_
23	unchanged	_	ADJ	JJ	_	24	amod	_	_
24	drug	_	NOUN	NN	_	21	nmod	_	_
25	,	_	.	,	_	21	punct	_	_
26	indicating	_	VERB	VBG	_	21	advcl	_	_
27	that	_	ADP	IN	_	31	mark	_	_
28	DRUG	_	NOUN	NN	_	31	nsubjpass	_	_
29	is	_	VERB	VBZ	_	31	auxpass	_	_
30	highly	_	ADV	RB	_	31	advmod	_	_
31	metabolized	_	VERB	VBN	_	26	ccomp	_	_

#	Quetiapine fumarate	249
1	Approximately	_	ADV	RB	_	9	advmod	_	_
2	73%	_	ADJ	JJ	_	9	nsubjpass	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	20%	_	NOUN	NN	_	2	conj	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	dose	_	NOUN	NN	_	2	nmod	_	_
8	was	_	VERB	VBD	_	9	auxpass	_	_
9	recovered	_	VERB	VBN	_	0	root	_	_
10	in	_	ADP	IN	_	12	case	_	_
11	the	_	DET	DT	_	12	det	_	_
12	urine	_	ADJ	JJ	_	9	nmod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	feces	_	NOUN	NNS	_	12	conj	_	_
15	,	_	.	,	_	12	punct	_	_
16	respectively	_	ADV	RB	_	12	advmod	_	_

#	Quetiapine fumarate	250
1	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
2	is	_	VERB	VBZ	_	4	auxpass	_	_
3	extensively	_	ADV	RB	_	4	advmod	_	_
4	metabolized	_	VERB	VBN	_	0	root	_	_
5	by	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	liver	_	NOUN	NN	_	4	nmod	_	_

#	Quetiapine fumarate	251
1	The	_	DET	DT	_	4	det	_	_
2	major	_	ADJ	JJ	_	4	amod	_	_
3	metabolic	_	ADJ	JJ	_	4	amod	_	_
4	pathways	_	NOUN	NNS	_	6	nsubj	_	_
5	are	_	VERB	VBP	_	6	cop	_	_
6	sulfoxidation	_	NOUN	NN	_	0	root	_	_
7	to	_	PRT	TO	_	10	case	_	_
8	the	_	DET	DT	_	10	det	_	_
9	sulfoxide	_	NOUN	NN	_	10	compound	_	_
10	metabolite	_	NOUN	NN	_	6	nmod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	oxidation	_	NOUN	NN	_	10	conj	_	_
13	to	_	PRT	TO	_	17	case	_	_
14	the	_	DET	DT	_	17	det	_	_
15	parent	_	NOUN	NN	_	17	compound	_	_
16	acid	_	NOUN	NN	_	17	compound	_	_
17	metabolite	_	NOUN	NN	_	6	nmod	_	_
18	both	_	CONJ	CC	_	19	det	_	_
19	metabolites	_	NOUN	NNS	_	22	nsubj	_	_
20	are	_	VERB	VBP	_	22	auxpass	_	_
21	pharmacologically	_	ADV	RB	_	22	advmod	_	_
22	inactive	_	ADJ	JJ	_	6	parataxis	_	_

#	Quetiapine fumarate	252
1	In	_	X	FW	_	3	amod	_	_
2	vitro	_	X	FW	_	1	dep	_	_
3	studies	_	NOUN	NNS	_	8	nsubj	_	_
4	using	_	VERB	VBG	_	3	acl	_	_
5	human	_	ADJ	JJ	_	7	amod	_	_
6	liver	_	NOUN	NN	_	7	compound	_	_
7	microsomes	_	NOUN	NNS	_	4	dobj	_	_
8	revealed	_	VERB	VBD	_	0	root	_	_
9	that	_	ADP	IN	_	16	mark	_	_
10	the	_	DET	DT	_	14	det	_	_
11	cytochrome	_	NOUN	NN	_	14	compound	_	_
12	P450	_	NOUN	NN	_	14	compound	_	_
13	3A4	_	NOUN	NN	_	14	compound	_	_
14	isoenzyme	_	NOUN	NN	_	16	nsubjpass	_	_
15	is	_	VERB	VBZ	_	16	auxpass	_	_
16	involved	_	VERB	VBN	_	8	ccomp	_	_
17	in	_	ADP	IN	_	19	case	_	_
18	the	_	DET	DT	_	19	det	_	_
19	metabolism	_	NOUN	NN	_	16	nmod	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	DRUG	_	NOUN	NN	_	19	nmod	_	_
22	to	_	PRT	TO	_	24	case	_	_
23	its	_	PRON	PRP$	_	24	nmod:poss	_	_
24	major	_	ADJ	JJ	_	19	nmod	_	_
25	,	_	.	,	_	24	punct	_	_
26	but	_	CONJ	CC	_	24	cc	_	_
27	inactive	_	ADJ	JJ	_	24	conj	_	_
28	,	_	.	,	_	24	punct	_	_
29	sulfoxide	_	NOUN	NN	_	30	compound	_	_
30	metabolite	_	NOUN	NN	_	24	conj	_	_
31	and	_	CONJ	CC	_	24	cc	_	_
32	in	_	ADP	IN	_	34	case	_	_
33	the	_	DET	DT	_	34	det	_	_
34	metabolism	_	NOUN	NN	_	24	conj	_	_
35	of	_	ADP	IN	_	41	case	_	_
36	its	_	PRON	PRP$	_	41	nmod:poss	_	_
37	active	_	ADJ	JJ	_	41	amod	_	_
38	metabolite	_	NOUN	NN	_	41	compound	_	_
39	N	_	NOUN	NN	_	41	compound	_	_
40	desalkyl	_	NOUN	NN	_	41	compound	_	_
41	DRUG	_	NOUN	NN	_	34	nmod	_	_

#	Quetiapine fumarate	253
1	Age	_	NOUN	NN	_	3	compound	_	_
2	Oral	_	ADJ	JJ	_	3	amod	_	_
3	clearance	_	NOUN	NN	_	7	nsubjpass	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	was	_	VERB	VBD	_	7	auxpass	_	_
7	reduced	_	VERB	VBN	_	18	advcl	_	_
8	by	_	ADP	IN	_	9	case	_	_
9	40%	_	NOUN	NN	_	7	nmod	_	_
10	in	_	ADP	IN	_	12	case	_	_
11	elderly	_	ADJ	JJ	_	12	amod	_	_
12	patients	_	NOUN	NNS	_	7	nmod	_	_
13	>	_	NUM	CD	_	15	nummod	_	_
14	65	_	NUM	CD	_	15	nummod	_	_
15	years	_	NOUN	NNS	_	12	dep	_	_
16	,	_	.	,	_	18	punct	_	_
17	n=9	_	NOUN	NN	_	18	nsubj	_	_
18	compared	_	VERB	VBD	_	0	root	_	_
19	to	_	PRT	TO	_	21	case	_	_
20	young	_	ADJ	JJ	_	21	amod	_	_
21	patients	_	NOUN	NNS	_	18	nmod	_	_
22	n=12	_	NOUN	NN	_	21	dep	_	_
23	,	_	.	,	_	22	punct	_	_
24	and	_	CONJ	CC	_	22	cc	_	_
25	dosing	_	ADJ	JJ	_	26	compound	_	_
26	adjustment	_	NOUN	NN	_	22	conj	_	_
27	may	_	VERB	MD	_	29	aux	_	_
28	be	_	VERB	VB	_	29	auxpass	_	_
29	necessary	_	ADJ	JJ	_	18	dep	_	_

#	Quetiapine fumarate	254
1	Gender	_	NOUN	NN	_	3	advmod	_	_
2	There	_	DET	EX	_	3	expl	_	_
3	is	_	VERB	VBZ	_	0	root	_	_
4	no	_	DET	DT	_	6	neg	_	_
5	gender	_	NOUN	NN	_	6	amod	_	_
6	effect	_	NOUN	NN	_	3	nsubj	_	_
7	on	_	ADP	IN	_	9	case	_	_
8	the	_	DET	DT	_	9	det	_	_
9	pharmacokinetics	_	NOUN	NNS	_	3	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_

#	Quetiapine fumarate	255
1	Race	_	NOUN	NN	_	0	root	_	_
2	There	_	DET	EX	_	3	expl	_	_
3	is	_	VERB	VBZ	_	1	dep	_	_
4	no	_	DET	DT	_	6	neg	_	_
5	race	_	ADJ	JJ	_	6	amod	_	_
6	effect	_	NOUN	NN	_	3	nsubj	_	_
7	on	_	ADP	IN	_	9	case	_	_
8	the	_	DET	DT	_	9	det	_	_
9	pharmacokinetics	_	NOUN	NNS	_	3	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_

#	Quetiapine fumarate	256
1	Smoking	_	VERB	VBG	_	2	amod	_	_
2	Smoking	_	NOUN	NN	_	3	nsubj	_	_
3	has	_	VERB	VBZ	_	0	root	_	_
4	no	_	DET	DT	_	5	neg	_	_
5	effect	_	NOUN	NN	_	3	dobj	_	_
6	on	_	ADP	IN	_	9	case	_	_
7	the	_	DET	DT	_	9	det	_	_
8	oral	_	ADJ	JJ	_	9	amod	_	_
9	clearance	_	NOUN	NN	_	3	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_

#	Quetiapine fumarate	257
1	Renal	_	ADJ	JJ	_	3	amod	_	_
2	Insufficiency	_	NOUN	NN	_	3	compound	_	_
3	Patients	_	NOUN	NNS	_	0	root	_	_
4	with	_	ADP	IN	_	8	case	_	_
5	severe	_	ADJ	JJ	_	8	amod	_	_
6	renal	_	ADJ	JJ	_	8	amod	_	_
7	impairment	_	NOUN	NN	_	8	compound	_	_
8	Clcr=10	_	NOUN	NN	_	3	nmod	_	_
9	to	_	PRT	TO	_	11	case	_	_
10	30	_	NUM	CD	_	11	nummod	_	_
11	mL	_	NOUN	NN	_	3	nmod	_	_
12	/	_	.	:	_	3	punct	_	_
13	min	_	NOUN	NN	_	19	nsubj	_	_
14	/	_	.	:	_	13	punct	_	_
15	1.73	_	NUM	CD	_	16	nummod	_	_
16	m2	_	NOUN	NN	_	13	appos	_	_
17	,	_	.	,	_	13	punct	_	_
18	n=8	_	NOUN	NN	_	13	appos	_	_
19	had	_	VERB	VBD	_	3	dep	_	_
20	a	_	DET	DT	_	25	det	_	_
21	25%	_	ADJ	JJ	_	25	amod	_	_
22	lower	_	ADJ	JJ	_	25	amod	_	_
23	mean	_	NOUN	NN	_	25	compound	_	_
24	oral	_	ADJ	JJ	_	25	amod	_	_
25	clearance	_	NOUN	NN	_	19	dobj	_	_
26	than	_	ADP	IN	_	28	case	_	_
27	normal	_	ADJ	JJ	_	28	amod	_	_
28	subjects	_	NOUN	NNS	_	19	nmod	_	_
29	Clcr	_	NOUN	NN	_	32	compound	_	_
30	>	_	NUM	CD	_	32	nummod	_	_
31	80	_	NUM	CD	_	32	nummod	_	_
32	mL	_	NOUN	NN	_	54	dep	_	_
33	/	_	.	:	_	32	punct	_	_
34	min	_	NOUN	NN	_	54	nsubj	_	_
35	/	_	.	:	_	34	punct	_	_
36	1.73	_	NUM	CD	_	37	nummod	_	_
37	m2	_	NOUN	NN	_	34	conj	_	_
38	,	_	.	,	_	34	punct	_	_
39	n=8	_	NOUN	NN	_	34	conj	_	_
40	,	_	.	,	_	34	punct	_	_
41	but	_	CONJ	CC	_	34	cc	_	_
42	plasma	_	NOUN	NN	_	44	compound	_	_
43	DRUG	_	NOUN	NN	_	44	compound	_	_
44	concentrations	_	NOUN	NNS	_	34	conj	_	_
45	in	_	ADP	IN	_	47	case	_	_
46	the	_	DET	DT	_	47	det	_	_
47	subjects	_	NOUN	NNS	_	34	nmod	_	_
48	with	_	ADP	IN	_	50	case	_	_
49	renal	_	ADJ	JJ	_	50	amod	_	_
50	insufficiency	_	NOUN	NN	_	47	nmod	_	_
51	were	_	VERB	VBD	_	54	cop	_	_
52	within	_	ADP	IN	_	54	case	_	_
53	the	_	DET	DT	_	54	det	_	_
54	range	_	NOUN	NN	_	28	acl	_	_
55	of	_	ADP	IN	_	56	case	_	_
56	concentrations	_	NOUN	NNS	_	54	nmod	_	_
57	seen	_	VERB	VBN	_	56	acl	_	_
58	in	_	ADP	IN	_	60	case	_	_
59	normal	_	ADJ	JJ	_	60	amod	_	_
60	subjects	_	NOUN	NNS	_	57	nmod	_	_
61	receiving	_	VERB	VBG	_	60	acl	_	_
62	the	_	DET	DT	_	64	det	_	_
63	same	_	ADJ	JJ	_	64	amod	_	_
64	dose	_	NOUN	NN	_	61	dobj	_	_

#	Quetiapine fumarate	258
1	Dosage	_	NOUN	NN	_	2	compound	_	_
2	adjustment	_	NOUN	NN	_	6	nsubjpass	_	_
3	is	_	VERB	VBZ	_	6	auxpass	_	_
4	therefore	_	ADV	RB	_	6	advmod	_	_
5	not	_	ADV	RB	_	6	neg	_	_
6	needed	_	VERB	VBN	_	0	root	_	_
7	in	_	ADP	IN	_	9	case	_	_
8	these	_	DET	DT	_	9	det	_	_
9	patients	_	NOUN	NNS	_	6	nmod	_	_

#	Quetiapine fumarate	260
1	Hepatic	_	ADJ	JJ	_	2	amod	_	_
2	Insufficiency	_	NOUN	NN	_	7	nsubj	_	_
3	Hepatically	_	ADV	RB	_	4	advmod	_	_
4	impaired	_	ADJ	JJ	_	5	amod	_	_
5	patients	_	NOUN	NNS	_	6	compound	_	_
6	n=8	_	NOUN	NN	_	2	dep	_	_
7	had	_	VERB	VBD	_	0	root	_	_
8	a	_	DET	DT	_	13	det	_	_
9	30%	_	ADJ	JJ	_	13	amod	_	_
10	lower	_	ADJ	JJ	_	13	amod	_	_
11	mean	_	NOUN	NN	_	13	compound	_	_
12	oral	_	ADJ	JJ	_	13	amod	_	_
13	clearance	_	NOUN	NN	_	7	dobj	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	DRUG	_	NOUN	NN	_	13	nmod	_	_
16	than	_	ADP	IN	_	18	case	_	_
17	normal	_	ADJ	JJ	_	18	amod	_	_
18	subjects	_	NOUN	NNS	_	7	nmod	_	_

#	Quetiapine fumarate	261
1	In	_	ADP	IN	_	2	case	_	_
2	two	_	NUM	CD	_	15	nmod	_	_
3	of	_	ADP	IN	_	8	case	_	_
4	the	_	DET	DT	_	8	det	_	_
5	8	_	NUM	CD	_	8	nummod	_	_
6	hepatically	_	ADV	RB	_	7	advmod	_	_
7	impaired	_	ADJ	JJ	_	8	amod	_	_
8	patients	_	NOUN	NNS	_	2	nmod	_	_
9	,	_	.	,	_	15	punct	_	_
10	AUC	_	NOUN	NN	_	15	nsubj	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	Cmax	_	NOUN	NN	_	10	conj	_	_
13	were	_	VERB	VBD	_	15	cop	_	_
14	3	_	NUM	CD	_	15	nummod	_	_
15	times	_	NOUN	NNS	_	0	root	_	_
16	higher	_	ADJ	JJ	_	15	amod	_	_
17	than	_	ADP	IN	_	18	case	_	_
18	those	_	DET	DT	_	16	nmod	_	_
19	observed	_	VERB	VBN	_	18	acl	_	_
20	typically	_	ADV	RB	_	19	advmod	_	_
21	in	_	ADP	IN	_	23	case	_	_
22	healthy	_	ADJ	JJ	_	23	amod	_	_
23	subjects	_	NOUN	NNS	_	19	nmod	_	_

#	Quetiapine fumarate	262
1	Since	_	ADP	IN	_	5	mark	_	_
2	DRUG	_	NOUN	NN	_	5	nsubjpass	_	_
3	is	_	VERB	VBZ	_	5	auxpass	_	_
4	extensively	_	ADV	RB	_	5	advmod	_	_
5	metabolized	_	VERB	VBN	_	14	advcl	_	_
6	by	_	ADP	IN	_	8	case	_	_
7	the	_	DET	DT	_	8	det	_	_
8	liver	_	NOUN	NN	_	5	nmod	_	_
9	,	_	.	,	_	14	punct	_	_
10	higher	_	ADJ	JJ	_	12	amod	_	_
11	plasma	_	NOUN	NN	_	12	compound	_	_
12	levels	_	NOUN	NNS	_	14	nsubjpass	_	_
13	are	_	VERB	VBP	_	14	auxpass	_	_
14	expected	_	VERB	VBN	_	0	root	_	_
15	in	_	ADP	IN	_	19	case	_	_
16	the	_	DET	DT	_	19	det	_	_
17	hepatically	_	ADV	RB	_	18	advmod	_	_
18	impaired	_	ADJ	JJ	_	19	amod	_	_
19	population	_	NOUN	NN	_	14	nmod	_	_
20	,	_	.	,	_	14	punct	_	_
21	and	_	CONJ	CC	_	14	cc	_	_
22	dosage	_	NOUN	NN	_	23	compound	_	_
23	adjustment	_	NOUN	NN	_	26	nsubjpass	_	_
24	may	_	VERB	MD	_	26	aux	_	_
25	be	_	VERB	VB	_	26	auxpass	_	_
26	needed	_	VERB	VBN	_	14	conj	_	_

#	Quetiapine fumarate	263
1	Drug	_	NOUN	NN	_	4	compound	_	_
2	Drug	_	NOUN	NN	_	4	compound	_	_
3	Interaction	_	NOUN	NN	_	4	compound	_	_
4	Studies	_	NOUN	NNS	_	0	root	_	_
5	The	_	DET	DT	_	8	det	_	_
6	in	_	X	FW	_	8	amod	_	_
7	vivo	_	X	FW	_	6	dep	_	_
8	assessments	_	NOUN	NNS	_	20	nsubjpass	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	effect	_	NOUN	NN	_	8	nmod	_	_
11	of	_	ADP	IN	_	13	case	_	_
12	other	_	ADJ	JJ	_	13	amod	_	_
13	drugs	_	NOUN	NNS	_	10	nmod	_	_
14	on	_	ADP	IN	_	16	case	_	_
15	the	_	DET	DT	_	16	det	_	_
16	pharmacokinetics	_	NOUN	NNS	_	10	nmod	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	DRUG	_	NOUN	NN	_	16	nmod	_	_
19	are	_	VERB	VBP	_	20	auxpass	_	_
20	summarized	_	VERB	VBN	_	4	dep	_	_
21	in	_	ADP	IN	_	22	case	_	_
22	Table	_	ADJ	JJ	_	20	nmod	_	_
23	17	_	NUM	CD	_	22	dep	_	_

#	Quetiapine fumarate	264
1	Table	_	ADJ	JJ	_	0	root	_	_
2	17	_	NUM	CD	_	1	dep	_	_
3	:	_	.	:	_	1	punct	_	_
4	The	_	DET	DT	_	5	det	_	_
5	Effect	_	NOUN	NN	_	1	dep	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	Other	_	ADJ	JJ	_	8	amod	_	_
8	Drugs	_	NOUN	NNS	_	5	nmod	_	_
9	on	_	ADP	IN	_	11	case	_	_
10	the	_	DET	DT	_	11	det	_	_
11	Pharmacokinetics	_	NOUN	NNS	_	5	nmod	_	_
12	of	_	ADP	IN	_	17	case	_	_
13	DRUG	_	NOUN	NN	_	17	compound	_	_
14	Coadministered	_	ADJ	JJ	_	17	amod	_	_
15	drug	_	NOUN	NN	_	17	compound	_	_
16	Dose	_	NOUN	NN	_	17	compound	_	_
17	schedules	_	NOUN	NNS	_	11	nmod	_	_
18	Effect	_	NOUN	NN	_	17	dep	_	_
19	on	_	ADP	IN	_	21	case	_	_
20	DRUG	_	NOUN	NN	_	21	compound	_	_
21	pharmacokinetics	_	NOUN	NNS	_	18	nmod	_	_
22	Coadministered	_	ADJ	JJ	_	29	amod	_	_
23	drug	_	NOUN	NN	_	29	compound	_	_
24	DRUG	_	NOUN	NN	_	29	compound	_	_
25	Phenytoin	_	NOUN	NN	_	29	compound	_	_
26	100	_	NUM	CD	_	29	nummod	_	_
27	mg	_	NOUN	NN	_	29	compound	_	_
28	three	_	NUM	CD	_	29	nummod	_	_
29	times	_	NOUN	NNS	_	21	dep	_	_
30	daily	_	ADV	RB	_	31	advmod	_	_
31	250	_	NUM	CD	_	34	nummod	_	_
32	mg	_	NOUN	NN	_	34	compound	_	_
33	three	_	NUM	CD	_	34	nummod	_	_
34	times	_	NOUN	NNS	_	38	compound	_	_
35	daily	_	ADV	RB	_	36	advmod	_	_
36	5	_	NUM	CD	_	38	nummod	_	_
37	fold	_	NOUN	NN	_	38	amod	_	_
38	Increase	_	NOUN	NN	_	5	dep	_	_
39	in	_	ADP	IN	_	44	case	_	_
40	oral	_	ADJ	JJ	_	44	amod	_	_
41	clearance	_	NOUN	NN	_	44	compound	_	_
42	Divalproex	_	NOUN	NN	_	44	compound	_	_
43	500	_	NUM	CD	_	44	nummod	_	_
44	mg	_	NOUN	NN	_	38	nmod	_	_
45	twice	_	ADV	RB	_	46	advmod	_	_
46	daily	_	ADV	RB	_	47	advmod	_	_
47	150	_	NUM	CD	_	48	nummod	_	_
48	mg	_	NOUN	NN	_	56	dep	_	_
49	twice	_	ADV	RB	_	50	advmod	_	_
50	daily	_	ADV	RB	_	56	advmod	_	_
51	17%	_	ADJ	JJ	_	56	amod	_	_
52	increase	_	NOUN	NN	_	56	compound	_	_
53	mean	_	NOUN	NN	_	56	compound	_	_
54	max	_	NOUN	NN	_	56	compound	_	_
55	plasma	_	NOUN	NN	_	56	compound	_	_
56	concentration	_	NOUN	NN	_	38	nmod	_	_
57	at	_	ADP	IN	_	59	case	_	_
58	steady	_	ADJ	JJ	_	59	amod	_	_
59	state	_	NOUN	NN	_	56	nmod	_	_

#	Quetiapine fumarate	265
1	No	_	DET	DT	_	2	neg	_	_
2	effect	_	NOUN	NN	_	139	nsubj	_	_
3	on	_	ADP	IN	_	4	case	_	_
4	absorption	_	NOUN	NN	_	2	nmod	_	_
5	or	_	CONJ	CC	_	4	cc	_	_
6	mean	_	NOUN	NN	_	11	amod	_	_
7	oral	_	ADJ	JJ	_	11	amod	_	_
8	clearance	_	NOUN	NN	_	11	compound	_	_
9	Thioridazine	_	NOUN	NN	_	11	compound	_	_
10	200	_	NUM	CD	_	11	nummod	_	_
11	mg	_	NOUN	NN	_	4	conj	_	_
12	twice	_	ADV	RB	_	13	advmod	_	_
13	daily	_	ADV	RB	_	14	advmod	_	_
14	300	_	NUM	CD	_	15	nummod	_	_
15	mg	_	NOUN	NN	_	19	compound	_	_
16	twice	_	ADV	RB	_	17	advmod	_	_
17	daily	_	ADV	RB	_	18	advmod	_	_
18	65%	_	ADJ	JJ	_	19	amod	_	_
19	increase	_	NOUN	NN	_	139	nsubj	_	_
20	in	_	ADP	IN	_	27	case	_	_
21	oral	_	ADJ	JJ	_	27	amod	_	_
22	clearance	_	NOUN	NN	_	27	compound	_	_
23	Cimetidine	_	NOUN	NN	_	27	compound	_	_
24	400	_	NUM	CD	_	27	nummod	_	_
25	mg	_	NOUN	NN	_	27	compound	_	_
26	three	_	NUM	CD	_	27	nummod	_	_
27	times	_	NOUN	NNS	_	19	nmod	_	_
28	daily	_	ADV	RB	_	31	advmod	_	_
29	for	_	ADP	IN	_	31	case	_	_
30	4	_	NUM	CD	_	31	nummod	_	_
31	days	_	NOUN	NNS	_	139	nmod	_	_
32	150	_	NUM	CD	_	35	nummod	_	_
33	mg	_	NOUN	NN	_	35	compound	_	_
34	three	_	NUM	CD	_	35	nummod	_	_
35	times	_	NOUN	NNS	_	38	compound	_	_
36	daily	_	ADV	RB	_	37	advmod	_	_
37	20%	_	ADJ	JJ	_	38	amod	_	_
38	decrease	_	NOUN	NN	_	139	nsubj	_	_
39	in	_	ADP	IN	_	49	case	_	_
40	mean	_	ADJ	JJ	_	49	amod	_	_
41	oral	_	ADJ	JJ	_	49	amod	_	_
42	clearance	_	NOUN	NN	_	49	compound	_	_
43	Ketoconazole	_	NOUN	NN	_	49	compound	_	_
44	potent	_	ADJ	JJ	_	49	amod	_	_
45	CYP	_	NOUN	NN	_	49	compound	_	_
46	3A4	_	NOUN	NN	_	49	compound	_	_
47	inhibitor	_	NOUN	NN	_	49	compound	_	_
48	200	_	NUM	CD	_	49	nummod	_	_
49	mg	_	NOUN	NN	_	38	nmod	_	_
50	once	_	ADV	RB	_	51	advmod	_	_
51	daily	_	ADV	RB	_	139	advmod	_	_
52	for	_	ADP	IN	_	54	case	_	_
53	4	_	NUM	CD	_	54	nummod	_	_
54	days	_	NOUN	NNS	_	139	nmod	_	_
55	25	_	NUM	CD	_	60	nummod	_	_
56	mg	_	NOUN	NN	_	60	amod	_	_
57	single	_	ADJ	JJ	_	60	amod	_	_
58	dose	_	NOUN	NN	_	60	compound	_	_
59	84%	_	ADJ	JJ	_	60	amod	_	_
60	decrease	_	NOUN	NN	_	139	nsubj	_	_
61	in	_	ADP	IN	_	63	case	_	_
62	oral	_	ADJ	JJ	_	63	amod	_	_
63	clearance	_	NOUN	NN	_	60	nmod	_	_
64	resulting	_	VERB	VBG	_	63	acl	_	_
65	in	_	ADP	IN	_	69	case	_	_
66	a	_	DET	DT	_	69	det	_	_
67	6.2	_	NUM	CD	_	68	compound	_	_
68	fold	_	NOUN	NN	_	69	amod	_	_
69	increase	_	NOUN	NN	_	64	nmod	_	_
70	in	_	ADP	IN	_	71	case	_	_
71	AUC	_	NOUN	NN	_	69	nmod	_	_
72	of	_	ADP	IN	_	76	case	_	_
73	DRUG	_	NOUN	NN	_	76	compound	_	_
74	Fluoxetine	_	NOUN	NN	_	76	compound	_	_
75	60	_	NUM	CD	_	76	nummod	_	_
76	mg	_	NOUN	NN	_	71	nmod	_	_
77	once	_	ADV	RB	_	79	advmod	_	_
78	daily	_	ADV	RB	_	79	advmod	_	_
79	300	_	NUM	CD	_	80	nummod	_	_
80	mg	_	NOUN	NN	_	64	dobj	_	_
81	twice	_	ADV	RB	_	82	advmod	_	_
82	daily	_	ADV	RB	_	84	advmod	_	_
83	No	_	NOUN	NN	_	84	compound	_	_
84	change	_	NOUN	NN	_	139	nsubj	_	_
85	in	_	ADP	IN	_	91	case	_	_
86	steady	_	ADJ	JJ	_	91	amod	_	_
87	state	_	NOUN	NN	_	91	compound	_	_
88	PK	_	NOUN	NN	_	91	compound	_	_
89	Imipramine	_	NOUN	NN	_	91	compound	_	_
90	75	_	NUM	CD	_	91	nummod	_	_
91	mg	_	NOUN	NN	_	84	nmod	_	_
92	twice	_	ADV	RB	_	93	advmod	_	_
93	daily	_	ADV	RB	_	94	advmod	_	_
94	300	_	NUM	CD	_	95	nummod	_	_
95	mg	_	NOUN	NN	_	99	dep	_	_
96	twice	_	ADV	RB	_	97	advmod	_	_
97	daily	_	ADV	RB	_	99	advmod	_	_
98	No	_	NOUN	NN	_	99	compound	_	_
99	change	_	NOUN	NN	_	84	dep	_	_
100	in	_	ADP	IN	_	106	case	_	_
101	steady	_	ADJ	JJ	_	106	amod	_	_
102	state	_	NOUN	NN	_	106	compound	_	_
103	PK	_	NOUN	NN	_	106	compound	_	_
104	Haloperidol	_	NOUN	NN	_	106	compound	_	_
105	7.5	_	NUM	CD	_	106	nummod	_	_
106	mg	_	NOUN	NN	_	99	nmod	_	_
107	twice	_	ADV	RB	_	108	advmod	_	_
108	daily	_	ADV	RB	_	109	advmod	_	_
109	300	_	NUM	CD	_	110	nummod	_	_
110	mg	_	NOUN	NN	_	114	dep	_	_
111	twice	_	ADV	RB	_	112	advmod	_	_
112	daily	_	ADV	RB	_	114	advmod	_	_
113	No	_	NOUN	NN	_	114	compound	_	_
114	change	_	NOUN	NN	_	99	dep	_	_
115	in	_	ADP	IN	_	121	case	_	_
116	steady	_	ADJ	JJ	_	121	amod	_	_
117	state	_	NOUN	NN	_	121	compound	_	_
118	PK	_	NOUN	NN	_	121	compound	_	_
119	Risperidone	_	NOUN	NN	_	121	compound	_	_
120	3	_	NUM	CD	_	121	nummod	_	_
121	mg	_	NOUN	NN	_	114	nmod	_	_
122	twice	_	ADV	RB	_	123	advmod	_	_
123	daily	_	ADV	RB	_	124	advmod	_	_
124	300	_	NUM	CD	_	125	nummod	_	_
125	mg	_	NOUN	NN	_	129	dep	_	_
126	twice	_	ADV	RB	_	127	advmod	_	_
127	daily	_	ADV	RB	_	129	advmod	_	_
128	No	_	NOUN	NN	_	129	compound	_	_
129	change	_	NOUN	NN	_	114	nmod	_	_
130	in	_	ADP	IN	_	138	case	_	_
131	steady	_	ADJ	JJ	_	138	amod	_	_
132	state	_	NOUN	NN	_	138	compound	_	_
133	PK	_	NOUN	NN	_	138	compound	_	_
134	In	_	X	FW	_	138	amod	_	_
135	vitro	_	X	FW	_	134	dep	_	_
136	enzyme	_	NOUN	NN	_	138	compound	_	_
137	inhibition	_	NOUN	NN	_	138	compound	_	_
138	data	_	NOUN	NNS	_	129	nmod	_	_
139	suggest	_	VERB	VBP	_	0	root	_	_
140	that	_	ADP	IN	_	148	mark	_	_
141	DRUG	_	NOUN	NN	_	148	nsubj	_	_
142	and	_	CONJ	CC	_	141	cc	_	_
143	9	_	NUM	CD	_	141	conj	_	_
144	of	_	ADP	IN	_	146	case	_	_
145	its	_	PRON	PRP$	_	146	nmod:poss	_	_
146	metabolites	_	NOUN	NNS	_	141	nmod	_	_
147	would	_	VERB	MD	_	148	aux	_	_
148	have	_	VERB	VB	_	139	ccomp	_	_
149	little	_	ADJ	JJ	_	151	amod	_	_
150	inhibitory	_	ADJ	JJ	_	151	amod	_	_
151	effect	_	NOUN	NN	_	148	dobj	_	_
152	on	_	ADP	IN	_	155	case	_	_
153	in	_	X	FW	_	155	amod	_	_
154	vivo	_	X	FW	_	153	dep	_	_
155	metabolism	_	NOUN	NN	_	148	nmod	_	_
156	mediated	_	VERB	VBN	_	155	acl	_	_
157	by	_	ADP	IN	_	158	case	_	_
158	cytochromes	_	NOUN	NNS	_	156	nmod	_	_
159	CYP	_	NOUN	NN	_	160	compound	_	_
160	1A2	_	NOUN	NN	_	158	dep	_	_
161	,	_	.	,	_	160	punct	_	_
162	2C9	_	NOUN	NN	_	160	conj	_	_
163	,	_	.	,	_	160	punct	_	_
164	2C19	_	NOUN	NN	_	160	conj	_	_
165	,	_	.	,	_	160	punct	_	_
166	2D6	_	NOUN	NN	_	160	conj	_	_
167	and	_	CONJ	CC	_	160	cc	_	_
168	3A4	_	NOUN	NN	_	160	conj	_	_

#	Quetiapine fumarate	266
1	DRUG	_	NOUN	NN	_	11	nsubj	_	_
2	at	_	ADP	IN	_	3	case	_	_
3	doses	_	NOUN	NNS	_	1	nmod	_	_
4	of	_	ADP	IN	_	8	case	_	_
5	750	_	NUM	CD	_	8	nummod	_	_
6	mg	_	NOUN	NN	_	8	compound	_	_
7	/	_	.	:	_	8	compound	_	_
8	day	_	NOUN	NN	_	3	nmod	_	_
9	did	_	VERB	VBD	_	11	aux	_	_
10	not	_	ADV	RB	_	11	neg	_	_
11	affect	_	VERB	VB	_	0	root	_	_
12	the	_	DET	DT	_	15	det	_	_
13	single	_	ADJ	JJ	_	15	amod	_	_
14	dose	_	NOUN	NN	_	15	compound	_	_
15	pharmacokinetics	_	NOUN	NNS	_	11	dobj	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	antipyrine	_	NOUN	NN	_	15	nmod	_	_
18	,	_	.	,	_	15	punct	_	_
19	lithium	_	NOUN	NN	_	15	appos	_	_
20	or	_	CONJ	CC	_	19	cc	_	_
21	lorazepam	_	NOUN	NN	_	19	conj	_	_
22	Table	_	ADJ	JJ	_	21	dep	_	_
23	18	_	NUM	CD	_	22	neg	_	_

#	Quetiapine fumarate	267
1	Table	_	ADJ	JJ	_	0	root	_	_
2	18	_	NUM	CD	_	1	dep	_	_
3	:	_	.	:	_	1	punct	_	_
4	The	_	DET	DT	_	5	det	_	_
5	Effect	_	NOUN	NN	_	1	dep	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	on	_	ADP	IN	_	10	case	_	_
9	the	_	DET	DT	_	10	det	_	_
10	Pharmacokinetics	_	NOUN	NNS	_	5	nmod	_	_
11	of	_	ADP	IN	_	13	case	_	_
12	Other	_	ADJ	JJ	_	13	amod	_	_
13	Drugs	_	NOUN	NNS	_	22	nmod	_	_
14	Coadministered	_	ADJ	JJ	_	17	amod	_	_
15	drug	_	NOUN	NN	_	17	compound	_	_
16	Dose	_	NOUN	NN	_	17	compound	_	_
17	schedules	_	NOUN	NNS	_	18	nsubj	_	_
18	Effect	_	NOUN	NN	_	22	nsubj	_	_
19	on	_	ADP	IN	_	21	case	_	_
20	other	_	ADJ	JJ	_	21	amod	_	_
21	drugs	_	NOUN	NNS	_	18	nmod	_	_
22	pharmacokinetics	_	VERB	VBZ	_	10	nmod	_	_
23	Coadministered	_	ADJ	JJ	_	28	amod	_	_
24	drug	_	NOUN	NN	_	28	compound	_	_
25	DRUG	_	NOUN	NN	_	28	compound	_	_
26	Lorazepam	_	NOUN	NN	_	28	compound	_	_
27	2	_	NUM	CD	_	28	nummod	_	_
28	mg	_	NOUN	NN	_	22	dobj	_	_
29	,	_	.	,	_	5	punct	_	_
30	single	_	ADJ	JJ	_	35	amod	_	_
31	dose	_	NOUN	NN	_	35	compound	_	_
32	250	_	NUM	CD	_	35	nummod	_	_
33	mg	_	NOUN	NN	_	35	compound	_	_
34	three	_	NUM	CD	_	35	nummod	_	_
35	times	_	NOUN	NNS	_	37	nsubj	_	_
36	daily	_	ADV	RB	_	37	advmod	_	_
37	Oral	_	ADJ	JJ	_	38	amod	_	_
38	clearance	_	NOUN	NN	_	64	nsubjpass	_	_
39	of	_	ADP	IN	_	40	case	_	_
40	lorazepam	_	NOUN	NN	_	38	nmod	_	_
41	reduced	_	VERB	VBN	_	40	acl	_	_
42	by	_	ADP	IN	_	46	case	_	_
43	20%	_	ADJ	JJ	_	46	amod	_	_
44	Divalproex	_	NOUN	NN	_	46	compound	_	_
45	500	_	NUM	CD	_	46	nummod	_	_
46	mg	_	NOUN	NN	_	41	nmod	_	_
47	twice	_	ADV	RB	_	49	advmod	_	_
48	daily	_	ADV	RB	_	49	advmod	_	_
49	150	_	NUM	CD	_	50	nummod	_	_
50	mg	_	NOUN	NN	_	38	nmod	_	_
51	twice	_	ADV	RB	_	52	advmod	_	_
52	daily	_	ADV	RB	_	53	advmod	_	_
53	Cmax	_	NOUN	NN	_	50	dep	_	_
54	and	_	CONJ	CC	_	53	cc	_	_
55	AUC	_	NOUN	NN	_	53	conj	_	_
56	of	_	ADP	IN	_	59	case	_	_
57	free	_	ADJ	JJ	_	59	amod	_	_
58	valproic	_	ADJ	JJ	_	59	amod	_	_
59	acid	_	NOUN	NN	_	50	nmod	_	_
60	at	_	ADP	IN	_	62	case	_	_
61	steady	_	ADJ	JJ	_	62	amod	_	_
62	state	_	NOUN	NN	_	50	nmod	_	_
63	was	_	VERB	VBD	_	64	auxpass	_	_
64	decreased	_	VERB	VBN	_	5	dep	_	_
65	by	_	ADP	IN	_	70	case	_	_
66	10	_	NUM	CD	_	70	nummod	_	_
67	to	_	PRT	TO	_	70	case	_	_
68	12%	_	ADJ	JJ	_	70	amod	_	_
69	Lithium	_	NOUN	NN	_	70	compound	_	_
70	Up	_	NOUN	NN	_	64	nmod	_	_
71	to	_	PRT	TO	_	73	case	_	_
72	2400	_	NUM	CD	_	73	nummod	_	_
73	mg	_	NOUN	NN	_	70	nmod	_	_
74	/	_	.	:	_	64	punct	_	_
75	day	_	NOUN	NN	_	64	nmod	_	_
76	given	_	VERB	VBN	_	75	acl	_	_
77	in	_	ADP	IN	_	80	case	_	_
78	twice	_	ADV	RB	_	79	advmod	_	_
79	daily	_	ADV	RB	_	80	advmod	_	_
80	doses	_	NOUN	NNS	_	76	nmod	_	_
81	250	_	NUM	CD	_	84	nummod	_	_
82	mg	_	NOUN	NN	_	84	compound	_	_
83	three	_	NUM	CD	_	84	nummod	_	_
84	times	_	NOUN	NNS	_	87	nsubj	_	_
85	daily	_	ADV	RB	_	87	advmod	_	_
86	No	_	NOUN	NN	_	87	compound	_	_
87	effect	_	NOUN	NN	_	80	dep	_	_
88	on	_	ADP	IN	_	91	case	_	_
89	steady	_	ADJ	JJ	_	91	amod	_	_
90	state	_	NOUN	NN	_	91	compound	_	_
91	pharmacokinetics	_	NOUN	NNS	_	87	nmod	_	_
92	of	_	ADP	IN	_	96	case	_	_
93	lithium	_	NOUN	NN	_	96	compound	_	_
94	Antipyrine	_	NOUN	NN	_	96	compound	_	_
95	1	_	NUM	CD	_	96	nummod	_	_
96	g	_	NOUN	NN	_	91	nmod	_	_
97	,	_	.	,	_	75	punct	_	_
98	single	_	ADJ	JJ	_	103	amod	_	_
99	dose	_	NOUN	NN	_	103	compound	_	_
100	250	_	NUM	CD	_	103	nummod	_	_
101	mg	_	NOUN	NN	_	103	compound	_	_
102	three	_	NUM	CD	_	103	nummod	_	_
103	times	_	NOUN	NNS	_	75	appos	_	_
104	daily	_	ADV	RB	_	106	advmod	_	_
105	No	_	NOUN	NN	_	106	compound	_	_
106	effect	_	NOUN	NN	_	103	dep	_	_
107	on	_	ADP	IN	_	108	case	_	_
108	clearance	_	NOUN	NN	_	106	nmod	_	_
109	of	_	ADP	IN	_	110	case	_	_
110	antipyrine	_	NOUN	NN	_	108	nmod	_	_
111	or	_	CONJ	CC	_	110	cc	_	_
112	urinary	_	ADJ	JJ	_	110	conj	_	_
113	recovery	_	NOUN	NN	_	110	dep	_	_
114	of	_	ADP	IN	_	116	case	_	_
115	its	_	PRON	PRP$	_	116	nmod:poss	_	_
116	metabolites	_	NOUN	NNS	_	110	nmod	_	_

#	REMERON	3431
1	As	_	ADP	IN	_	4	case	_	_
2	with	_	ADP	IN	_	4	case	_	_
3	other	_	ADJ	JJ	_	4	amod	_	_
4	drugs	_	NOUN	NNS	_	27	nmod	_	_
5	,	_	.	,	_	27	punct	_	_
6	the	_	DET	DT	_	7	det	_	_
7	potential	_	NOUN	NN	_	27	nsubj	_	_
8	for	_	ADP	IN	_	9	case	_	_
9	interaction	_	NOUN	NN	_	7	nmod	_	_
10	by	_	ADP	IN	_	12	case	_	_
11	a	_	DET	DT	_	12	det	_	_
12	variety	_	NOUN	NN	_	9	nmod	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	mechanisms	_	NOUN	NNS	_	12	nmod	_	_
15	e.g	_	NOUN	NN	_	14	dep	_	_
16	,	_	.	,	_	15	punct	_	_
17	pharmacodynamic	_	ADJ	JJ	_	15	conj	_	_
18	,	_	.	,	_	15	punct	_	_
19	pharmacokinetic	_	ADJ	JJ	_	20	amod	_	_
20	inhibition	_	NOUN	NN	_	15	conj	_	_
21	or	_	CONJ	CC	_	15	cc	_	_
22	enhancement	_	NOUN	NN	_	15	conj	_	_
23	,	_	.	,	_	27	punct	_	_
24	etc	_	NOUN	NN	_	27	nsubj	_	_
25	is	_	VERB	VBZ	_	27	cop	_	_
26	a	_	DET	DT	_	27	det	_	_
27	possibility	_	NOUN	NN	_	0	root	_	_

#	REMERON	3433
1	The	_	DET	DT	_	2	det	_	_
2	metabolism	_	NOUN	NN	_	11	nsubjpass	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	pharmacokinetics	_	NOUN	NNS	_	2	conj	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	DRUG	_	NOUN	NN	_	8	compound	_	_
7	DRUG	_	NOUN	NN	_	8	compound	_	_
8	Tablets	_	NOUN	NNS	_	2	nmod	_	_
9	may	_	VERB	MD	_	11	aux	_	_
10	be	_	VERB	VB	_	11	auxpass	_	_
11	affected	_	VERB	VBN	_	0	root	_	_
12	by	_	ADP	IN	_	14	case	_	_
13	the	_	DET	DT	_	14	det	_	_
14	induction	_	NOUN	NN	_	11	nmod	_	_
15	or	_	CONJ	CC	_	14	cc	_	_
16	inhibition	_	NOUN	NN	_	14	conj	_	_
17	of	_	ADP	IN	_	20	case	_	_
18	drug	_	NOUN	NN	_	20	compound	_	_
19	metabolizing	_	NOUN	NN	_	20	compound	_	_
20	enzymes	_	NOUN	NNS	_	14	nmod	_	_

#	REMERON	3434
1	these	_	DET	DT	_	2	det	_	_
2	studies	_	NOUN	NNS	_	3	nsubj	_	_
3	used	_	VERB	VBD	_	0	root	_	_
4	both	_	DET	DT	_	5	det	_	_
5	drugs	_	NOUN	NNS	_	3	dobj	_	_
6	at	_	ADP	IN	_	8	case	_	_
7	steady	_	ADJ	JJ	_	8	amod	_	_
8	state	_	NOUN	NN	_	3	nmod	_	_
9	In	_	ADP	IN	_	12	case	_	_
10	healthy	_	ADJ	JJ	_	12	amod	_	_
11	male	_	ADJ	JJ	_	12	amod	_	_
12	patients	_	NOUN	NNS	_	8	nmod	_	_
13	n=18	_	NOUN	NN	_	12	dep	_	_
14	,	_	.	,	_	13	punct	_	_
15	phenytoin	_	NOUN	NN	_	17	compound	_	_
16	200	_	NUM	CD	_	17	nummod	_	_
17	mg	_	NOUN	NN	_	13	appos	_	_
18	daily	_	ADV	RB	_	19	advmod	_	_
19	increased	_	VERB	VBD	_	3	parataxis	_	_
20	DRUG	_	NOUN	NN	_	22	compound	_	_
21	30	_	NUM	CD	_	22	nummod	_	_
22	mg	_	NOUN	NN	_	19	dobj	_	_
23	daily	_	ADV	RB	_	24	advmod	_	_
24	clearance	_	NOUN	NN	_	19	xcomp	_	_
25	about	_	ADV	RB	_	26	advmod	_	_
26	2	_	NUM	CD	_	27	nummod	_	_
27	fold	_	NOUN	NN	_	24	dobj	_	_
28	,	_	.	,	_	19	punct	_	_
29	resulting	_	VERB	VBG	_	19	advcl	_	_
30	in	_	ADP	IN	_	32	case	_	_
31	a	_	DET	DT	_	32	det	_	_
32	decrease	_	NOUN	NN	_	29	nmod	_	_
33	in	_	ADP	IN	_	37	case	_	_
34	average	_	ADJ	JJ	_	37	amod	_	_
35	plasma	_	NOUN	NN	_	37	compound	_	_
36	DRUG	_	NOUN	NN	_	37	compound	_	_
37	concentrations	_	NOUN	NNS	_	32	nmod	_	_
38	of	_	ADP	IN	_	39	case	_	_
39	45%	_	ADJ	JJ	_	37	nmod	_	_

#	REMERON	3435
1	DRUG	_	NOUN	NN	_	5	nsubj	_	_
2	did	_	VERB	VBD	_	5	aux	_	_
3	not	_	ADV	RB	_	5	neg	_	_
4	significantly	_	ADV	RB	_	5	advmod	_	_
5	affect	_	VERB	VB	_	0	root	_	_
6	the	_	DET	DT	_	7	det	_	_
7	pharmacokinetics	_	NOUN	NNS	_	5	dobj	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	phenytoin	_	NOUN	NN	_	7	nmod	_	_

#	REMERON	3436
1	In	_	ADP	IN	_	4	case	_	_
2	healthy	_	ADJ	JJ	_	4	amod	_	_
3	male	_	ADJ	JJ	_	4	amod	_	_
4	patients	_	NOUN	NNS	_	0	root	_	_
5	n=24	_	NOUN	NN	_	4	dep	_	_
6	,	_	.	,	_	5	punct	_	_
7	carbamazepine	_	NOUN	NN	_	11	compound	_	_
8	400	_	NUM	CD	_	11	nummod	_	_
9	mg	_	NOUN	NN	_	11	compound	_	_
10	b.i.d	_	NOUN	NN	_	11	compound	_	_
11	clearance	_	NOUN	NN	_	14	compound	_	_
12	about	_	ADV	RB	_	13	advmod	_	_
13	2	_	NUM	CD	_	14	nummod	_	_
14	fold	_	NOUN	NN	_	5	appos	_	_
15	,	_	.	,	_	5	punct	_	_
16	resulting	_	VERB	VBG	_	5	acl	_	_
17	in	_	ADP	IN	_	19	case	_	_
18	a	_	DET	DT	_	19	det	_	_
19	decrease	_	NOUN	NN	_	16	nmod	_	_
20	in	_	ADP	IN	_	24	case	_	_
21	average	_	ADJ	JJ	_	24	amod	_	_
22	plasma	_	NOUN	NN	_	24	compound	_	_
23	DRUG	_	NOUN	NN	_	24	compound	_	_
24	concentrations	_	NOUN	NNS	_	19	nmod	_	_
25	of	_	ADP	IN	_	26	case	_	_
26	60%	_	ADJ	JJ	_	24	nmod	_	_

#	REMERON	3437
1	When	_	ADV	WRB	_	16	advmod	_	_
2	phenytoin	_	NOUN	NN	_	16	nsubjpass	_	_
3	,	_	.	,	_	2	punct	_	_
4	carbamazepine	_	NOUN	NN	_	2	conj	_	_
5	,	_	.	,	_	2	punct	_	_
6	or	_	CONJ	CC	_	2	cc	_	_
7	another	_	DET	DT	_	8	det	_	_
8	inducer	_	NOUN	NN	_	2	conj	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	hepatic	_	ADJ	JJ	_	11	amod	_	_
11	metabolism	_	NOUN	NN	_	8	nmod	_	_
12	such	_	ADJ	JJ	_	14	case	_	_
13	as	_	ADP	IN	_	12	mwe	_	_
14	rifampicin	_	NOUN	NN	_	11	nmod	_	_
15	is	_	VERB	VBZ	_	16	auxpass	_	_
16	added	_	VERB	VBN	_	25	advcl	_	_
17	to	_	PRT	TO	_	19	case	_	_
18	DRUG	_	NOUN	NN	_	19	compound	_	_
19	therapy	_	NOUN	NN	_	16	nmod	_	_
20	,	_	.	,	_	25	punct	_	_
21	the	_	DET	DT	_	23	det	_	_
22	DRUG	_	NOUN	NN	_	23	compound	_	_
23	dose	_	NOUN	NN	_	25	nsubj	_	_
24	may	_	VERB	MD	_	25	aux	_	_
25	have	_	VERB	VB	_	0	root	_	_
26	to	_	PRT	TO	_	28	mark	_	_
27	be	_	VERB	VB	_	28	auxpass	_	_
28	increased	_	VERB	VBN	_	25	ccomp	_	_

#	REMERON	3438
1	If	_	ADP	IN	_	2	case	_	_
2	treatment	_	NOUN	NN	_	9	nsubjpass	_	_
3	with	_	ADP	IN	_	7	case	_	_
4	such	_	ADJ	JJ	_	7	amod	_	_
5	a	_	DET	DT	_	7	det	_	_
6	medicinal	_	ADJ	JJ	_	7	amod	_	_
7	product	_	NOUN	NN	_	2	nmod	_	_
8	is	_	VERB	VBZ	_	9	auxpass	_	_
9	discontinued	_	VERB	VBN	_	14	advcl	_	_
10	,	_	.	,	_	14	punct	_	_
11	it	_	PRON	PRP	_	14	nsubj	_	_
12	may	_	VERB	MD	_	14	aux	_	_
13	be	_	VERB	VB	_	14	cop	_	_
14	necessary	_	ADJ	JJ	_	0	root	_	_
15	to	_	PRT	TO	_	16	mark	_	_
16	reduce	_	VERB	VB	_	14	xcomp	_	_
17	the	_	DET	DT	_	19	det	_	_
18	DRUG	_	NOUN	NN	_	19	compound	_	_
19	dose	_	NOUN	NN	_	16	dobj	_	_

#	REMERON	3439
1	In	_	ADP	IN	_	4	case	_	_
2	healthy	_	ADJ	JJ	_	4	amod	_	_
3	male	_	ADJ	JJ	_	4	amod	_	_
4	patients	_	NOUN	NNS	_	48	nmod	_	_
5	n=12	_	NOUN	NN	_	48	nsubj	_	_
6	,	_	.	,	_	5	punct	_	_
7	when	_	ADV	RB	_	30	advmod	_	_
8	cimetidine	_	NOUN	NN	_	30	nsubjpass	_	_
9	,	_	.	,	_	8	punct	_	_
10	a	_	DET	DT	_	12	det	_	_
11	weak	_	ADJ	JJ	_	12	amod	_	_
12	inhibitor	_	NOUN	NN	_	8	appos	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	CYP1A2	_	NOUN	NN	_	12	nmod	_	_
15	,	_	.	,	_	14	punct	_	_
16	CYP2D6	_	NOUN	NN	_	14	conj	_	_
17	,	_	.	,	_	14	punct	_	_
18	and	_	CONJ	CC	_	14	cc	_	_
19	CYP3A4	_	NOUN	NN	_	14	conj	_	_
20	,	_	.	,	_	8	punct	_	_
21	given	_	VERB	VBN	_	8	acl	_	_
22	at	_	ADP	IN	_	25	case	_	_
23	800	_	NUM	CD	_	25	nummod	_	_
24	mg	_	NOUN	NN	_	25	compound	_	_
25	b.i.d	_	NOUN	NN	_	21	nmod	_	_
26	at	_	ADP	IN	_	28	case	_	_
27	steady	_	ADJ	JJ	_	28	amod	_	_
28	state	_	NOUN	NN	_	21	nmod	_	_
29	was	_	VERB	VBD	_	30	auxpass	_	_
30	coadministered	_	VERB	VBN	_	5	acl:relcl	_	_
31	with	_	ADP	IN	_	34	case	_	_
32	DRUG	_	NOUN	NN	_	34	compound	_	_
33	30	_	NUM	CD	_	34	nummod	_	_
34	mg	_	NOUN	NN	_	30	nmod	_	_
35	daily	_	ADV	RB	_	30	advmod	_	_
36	at	_	ADP	IN	_	38	case	_	_
37	steady	_	ADJ	JJ	_	38	amod	_	_
38	state	_	NOUN	NN	_	30	nmod	_	_
39	,	_	.	,	_	5	punct	_	_
40	the	_	DET	DT	_	42	det	_	_
41	Area	_	NOUN	NN	_	42	compound	_	_
42	Under	_	NOUN	NN	_	5	appos	_	_
43	the	_	DET	DT	_	45	det	_	_
44	Curve	_	ADJ	JJ	_	45	amod	_	_
45	AUC	_	NOUN	NN	_	42	dep	_	_
46	of	_	ADP	IN	_	47	case	_	_
47	DRUG	_	NOUN	NN	_	45	nmod	_	_
48	increased	_	VERB	VBD	_	0	root	_	_
49	more	_	ADV	RB	_	48	advmod	_	_
50	than	_	ADP	IN	_	51	case	_	_
51	50%	_	ADJ	JJ	_	49	nmod	_	_

#	REMERON	3440
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	did	_	VERB	VBD	_	4	aux	_	_
3	not	_	ADV	RB	_	4	neg	_	_
4	cause	_	VERB	VB	_	0	root	_	_
5	relevant	_	ADJ	JJ	_	6	amod	_	_
6	changes	_	NOUN	NNS	_	4	dobj	_	_
7	in	_	ADP	IN	_	9	case	_	_
8	the	_	DET	DT	_	9	det	_	_
9	pharmacokinetics	_	NOUN	NNS	_	6	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	cimetidine	_	NOUN	NN	_	9	nmod	_	_

#	REMERON	3441
1	The	_	DET	DT	_	3	det	_	_
2	DRUG	_	NOUN	NN	_	3	compound	_	_
3	dose	_	NOUN	NN	_	5	nsubj	_	_
4	may	_	VERB	MD	_	5	aux	_	_
5	have	_	VERB	VB	_	0	root	_	_
6	to	_	PRT	TO	_	8	mark	_	_
7	be	_	VERB	VB	_	8	auxpass	_	_
8	decreased	_	VERB	VBN	_	5	xcomp	_	_
9	when	_	ADV	WRB	_	15	advmod	_	_
10	concomitant	_	ADJ	JJ	_	11	amod	_	_
11	treatment	_	NOUN	NN	_	15	nsubjpass	_	_
12	with	_	ADP	IN	_	13	case	_	_
13	cimetidine	_	NOUN	NN	_	11	nmod	_	_
14	is	_	VERB	VBZ	_	15	auxpass	_	_
15	started	_	VERB	VBN	_	8	advcl	_	_
16	,	_	.	,	_	5	punct	_	_
17	or	_	CONJ	CC	_	5	cc	_	_
18	increased	_	VERB	VBD	_	5	conj	_	_
19	when	_	ADV	WRB	_	23	advmod	_	_
20	cimetidine	_	NOUN	NN	_	21	compound	_	_
21	treatment	_	NOUN	NN	_	23	nsubjpass	_	_
22	is	_	VERB	VBZ	_	23	auxpass	_	_
23	discontinued	_	VERB	VBN	_	18	ccomp	_	_

#	REMERON	3442
1	In	_	ADP	IN	_	7	case	_	_
2	healthy	_	ADJ	JJ	_	7	amod	_	_
3	,	_	.	,	_	2	punct	_	_
4	male	_	ADJ	JJ	_	2	conj	_	_
5	,	_	.	,	_	2	punct	_	_
6	Caucasian	_	ADJ	JJ	_	2	dep	_	_
7	patients	_	NOUN	NNS	_	23	nmod	_	_
8	n=24	_	NOUN	NN	_	23	nsubj	_	_
9	,	_	.	,	_	8	punct	_	_
10	coadministration	_	NOUN	NN	_	8	appos	_	_
11	of	_	ADP	IN	_	19	case	_	_
12	the	_	DET	DT	_	19	det	_	_
13	potent	_	ADJ	JJ	_	19	amod	_	_
14	CYP3A4	_	NOUN	NN	_	19	compound	_	_
15	inhibitor	_	NOUN	NN	_	19	compound	_	_
16	ketoconazole	_	NOUN	NN	_	19	compound	_	_
17	200	_	NUM	CD	_	19	nummod	_	_
18	mg	_	NOUN	NN	_	19	compound	_	_
19	b.i.d	_	NOUN	NN	_	10	nmod	_	_
20	for	_	ADP	IN	_	22	case	_	_
21	6.5	_	NUM	CD	_	22	nummod	_	_
22	days	_	NOUN	NNS	_	10	nmod	_	_
23	increased	_	VERB	VBD	_	0	root	_	_
24	the	_	DET	DT	_	27	det	_	_
25	peak	_	ADJ	JJ	_	27	amod	_	_
26	plasma	_	NOUN	NN	_	27	compound	_	_
27	levels	_	NOUN	NNS	_	23	dobj	_	_
28	and	_	CONJ	CC	_	27	cc	_	_
29	the	_	DET	DT	_	30	det	_	_
30	AUC	_	NOUN	NN	_	27	conj	_	_
31	of	_	ADP	IN	_	36	case	_	_
32	a	_	DET	DT	_	36	det	_	_
33	single	_	ADJ	JJ	_	36	amod	_	_
34	30	_	NUM	CD	_	36	nummod	_	_
35	mg	_	NOUN	NN	_	36	compound	_	_
36	dose	_	NOUN	NN	_	30	nmod	_	_
37	of	_	ADP	IN	_	38	case	_	_
38	DRUG	_	NOUN	NN	_	36	nmod	_	_
39	by	_	ADP	IN	_	41	case	_	_
40	approximately	_	ADV	RB	_	41	advmod	_	_
41	40%	_	NOUN	NN	_	23	nmod	_	_
42	and	_	CONJ	CC	_	41	cc	_	_
43	50%	_	NOUN	NN	_	41	conj	_	_
44	,	_	.	,	_	23	punct	_	_
45	respectively	_	ADV	RB	_	23	advmod	_	_

#	REMERON	3443
1	Caution	_	NOUN	NN	_	4	nsubjpass	_	_
2	should	_	VERB	MD	_	4	aux	_	_
3	be	_	VERB	VB	_	4	auxpass	_	_
4	exercised	_	VERB	VBN	_	0	root	_	_
5	when	_	ADV	WRB	_	6	advmod	_	_
6	coadministering	_	VERB	VBG	_	4	advcl	_	_
7	DRUG	_	NOUN	NN	_	6	dobj	_	_
8	with	_	ADP	IN	_	11	case	_	_
9	potent	_	ADJ	JJ	_	11	amod	_	_
10	CYP3A4	_	NOUN	NN	_	11	compound	_	_
11	inhibitors	_	NOUN	NNS	_	6	nmod	_	_
12	,	_	.	,	_	11	punct	_	_
13	HIV	_	NOUN	NN	_	15	compound	_	_
14	protease	_	NOUN	NN	_	15	compound	_	_
15	inhibitors	_	NOUN	NNS	_	11	conj	_	_
16	,	_	.	,	_	11	punct	_	_
17	azole	_	NOUN	NN	_	18	compound	_	_
18	antifungals	_	NOUN	NNS	_	11	conj	_	_
19	,	_	.	,	_	11	punct	_	_
20	erythromycin	_	NOUN	NN	_	11	conj	_	_
21	,	_	.	,	_	11	punct	_	_
22	or	_	CONJ	CC	_	11	cc	_	_
23	nefazodone	_	NOUN	NN	_	11	conj	_	_

#	REMERON	3444
1	In	_	ADP	IN	_	6	case	_	_
2	an	_	DET	DT	_	6	det	_	_
3	in	_	ADJ	JJ	_	6	amod	_	_
4	vivo	_	X	FW	_	3	dep	_	_
5	interaction	_	NOUN	NN	_	6	compound	_	_
6	study	_	NOUN	NN	_	28	nsubj	_	_
7	in	_	ADP	IN	_	13	case	_	_
8	healthy	_	ADJ	JJ	_	13	amod	_	_
9	,	_	.	,	_	8	punct	_	_
10	CYP2D6	_	NOUN	NN	_	13	compound	_	_
11	extensive	_	ADJ	JJ	_	13	amod	_	_
12	metabolizer	_	ADJ	JJ	_	13	amod	_	_
13	patients	_	NOUN	NNS	_	6	nmod	_	_
14	n=24	_	NOUN	NN	_	13	dep	_	_
15	,	_	.	,	_	14	punct	_	_
16	DRUG	_	NOUN	NN	_	18	compound	_	_
17	30	_	NUM	CD	_	18	nummod	_	_
18	mg	_	NOUN	NN	_	14	appos	_	_
19	/	_	.	:	_	14	punct	_	_
20	day	_	NOUN	NN	_	14	dep	_	_
21	,	_	.	,	_	6	punct	_	_
22	at	_	ADP	IN	_	24	case	_	_
23	steady	_	ADJ	JJ	_	24	amod	_	_
24	state	_	NOUN	NN	_	6	nmod	_	_
25	,	_	.	,	_	6	punct	_	_
26	did	_	VERB	MD	_	28	aux	_	_
27	not	_	ADV	RB	_	28	neg	_	_
28	cause	_	VERB	VB	_	0	root	_	_
29	relevant	_	ADJ	JJ	_	30	amod	_	_
30	changes	_	NOUN	NNS	_	28	dobj	_	_
31	in	_	ADP	IN	_	33	case	_	_
32	the	_	DET	DT	_	33	det	_	_
33	pharmacokinetics	_	NOUN	NNS	_	30	nmod	_	_
34	of	_	ADP	IN	_	39	case	_	_
35	steady	_	ADJ	JJ	_	39	amod	_	_
36	state	_	NOUN	NN	_	39	compound	_	_
37	paroxetine	_	NOUN	NN	_	39	compound	_	_
38	40	_	NUM	CD	_	39	nummod	_	_
39	mg	_	NOUN	NN	_	33	nmod	_	_
40	/	_	.	:	_	28	punct	_	_
41	day	_	NOUN	NN	_	28	parataxis	_	_
42	,	_	.	,	_	41	punct	_	_
43	a	_	DET	DT	_	45	det	_	_
44	CYP2D6	_	NOUN	NN	_	45	compound	_	_
45	inhibitor	_	NOUN	NN	_	41	appos	_	_

#	REMERON	3445
1	In	_	ADP	IN	_	7	case	_	_
2	healthy	_	ADJ	JJ	_	7	amod	_	_
3	,	_	.	,	_	2	punct	_	_
4	CYP2D6	_	NOUN	NN	_	7	compound	_	_
5	extensive	_	ADJ	JJ	_	7	amod	_	_
6	metabolizer	_	ADJ	JJ	_	7	amod	_	_
7	patients	_	NOUN	NNS	_	21	nsubj	_	_
8	n=32	_	NOUN	NN	_	7	dep	_	_
9	,	_	.	,	_	8	punct	_	_
10	amitriptyline	_	NOUN	NN	_	12	compound	_	_
11	75	_	NUM	CD	_	12	nummod	_	_
12	mg	_	NOUN	NN	_	8	appos	_	_
13	daily	_	ADV	RB	_	7	advmod	_	_
14	,	_	.	,	_	7	punct	_	_
15	at	_	ADP	IN	_	17	case	_	_
16	steady	_	ADJ	JJ	_	17	amod	_	_
17	state	_	NOUN	NN	_	7	nmod	_	_
18	,	_	.	,	_	7	punct	_	_
19	did	_	VERB	MD	_	21	aux	_	_
20	not	_	ADV	RB	_	21	neg	_	_
21	cause	_	VERB	VB	_	0	root	_	_
22	relevant	_	ADJ	JJ	_	23	amod	_	_
23	changes	_	NOUN	NNS	_	21	dobj	_	_
24	in	_	ADP	IN	_	26	case	_	_
25	the	_	DET	DT	_	26	det	_	_
26	pharmacokinetics	_	NOUN	NNS	_	23	nmod	_	_
27	of	_	ADP	IN	_	32	case	_	_
28	steady	_	ADJ	JJ	_	32	amod	_	_
29	state	_	NOUN	NN	_	32	compound	_	_
30	DRUG	_	NOUN	NN	_	32	compound	_	_
31	30	_	NUM	CD	_	32	nummod	_	_
32	mg	_	NOUN	NN	_	26	nmod	_	_
33	daily	_	ADV	RB	_	38	advmod	_	_
34	DRUG	_	NOUN	NN	_	38	nsubj	_	_
35	also	_	ADV	RB	_	38	advmod	_	_
36	did	_	VERB	VBD	_	38	aux	_	_
37	not	_	ADV	RB	_	38	neg	_	_
38	cause	_	VERB	VB	_	21	parataxis	_	_
39	relevant	_	ADJ	JJ	_	40	amod	_	_
40	changes	_	NOUN	NNS	_	38	dobj	_	_
41	to	_	PRT	TO	_	43	case	_	_
42	the	_	DET	DT	_	43	det	_	_
43	pharmacokinetics	_	NOUN	NNS	_	38	nmod	_	_
44	of	_	ADP	IN	_	45	case	_	_
45	amitriptyline	_	NOUN	NN	_	43	nmod	_	_

#	REMERON	3446
1	In	_	ADP	IN	_	4	case	_	_
2	healthy	_	ADJ	JJ	_	4	amod	_	_
3	male	_	ADJ	JJ	_	4	amod	_	_
4	subjects	_	NOUN	NNS	_	16	nmod	_	_
5	n=16	_	NOUN	NN	_	16	nsubj	_	_
6	,	_	.	,	_	5	punct	_	_
7	DRUG	_	NOUN	NN	_	9	compound	_	_
8	30	_	NUM	CD	_	9	nummod	_	_
9	mg	_	NOUN	NN	_	5	appos	_	_
10	daily	_	ADV	RB	_	5	advmod	_	_
11	,	_	.	,	_	5	punct	_	_
12	at	_	ADP	IN	_	14	case	_	_
13	steady	_	ADJ	JJ	_	14	amod	_	_
14	state	_	NOUN	NN	_	5	nmod	_	_
15	,	_	.	,	_	5	punct	_	_
16	caused	_	VERB	VBD	_	0	root	_	_
17	a	_	DET	DT	_	19	det	_	_
18	small	_	ADJ	JJ	_	19	amod	_	_
19	0.2	_	NUM	CD	_	16	dobj	_	_
20	but	_	CONJ	CC	_	19	cc	_	_
21	statistically	_	ADV	RB	_	22	advmod	_	_
22	significant	_	ADJ	JJ	_	19	conj	_	_
23	increase	_	NOUN	NN	_	19	dep	_	_
24	in	_	ADP	IN	_	29	case	_	_
25	the	_	DET	DT	_	29	det	_	_
26	International	_	ADJ	JJ	_	29	amod	_	_
27	Normalized	_	ADJ	JJ	_	29	amod	_	_
28	Ratio	_	NOUN	NN	_	29	compound	_	_
29	INR	_	NOUN	NN	_	19	nmod	_	_
30	in	_	ADP	IN	_	31	case	_	_
31	subjects	_	NOUN	NNS	_	16	nmod	_	_
32	treated	_	VERB	VBN	_	31	acl	_	_
33	with	_	ADP	IN	_	34	case	_	_
34	warfarin	_	NOUN	NN	_	32	nmod	_	_

#	REMERON	3447
1	As	_	ADP	IN	_	5	case	_	_
2	at	_	ADP	IN	_	5	case	_	_
3	a	_	DET	DT	_	5	det	_	_
4	higher	_	ADJ	JJ	_	5	amod	_	_
5	dose	_	NOUN	NN	_	16	nmod	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	,	_	.	,	_	16	punct	_	_
9	a	_	DET	DT	_	12	det	_	_
10	more	_	ADV	RB	_	11	advmod	_	_
11	pronounced	_	ADJ	JJ	_	12	amod	_	_
12	effect	_	NOUN	NN	_	16	nsubjpass	_	_
13	can	_	VERB	MD	_	16	aux	_	_
14	not	_	ADV	RB	_	16	neg	_	_
15	be	_	VERB	VB	_	16	auxpass	_	_
16	excluded	_	VERB	VBN	_	0	root	_	_
17	,	_	.	,	_	16	punct	_	_
18	it	_	PRON	PRP	_	20	nsubj	_	_
19	is	_	VERB	VBZ	_	20	cop	_	_
20	advisable	_	ADJ	JJ	_	16	parataxis	_	_
21	to	_	PRT	TO	_	22	mark	_	_
22	monitor	_	VERB	VB	_	20	xcomp	_	_
23	the	_	DET	DT	_	24	det	_	_
24	INR	_	NOUN	NN	_	22	dobj	_	_
25	in	_	ADP	IN	_	26	case	_	_
26	case	_	NOUN	NN	_	22	nmod	_	_
27	of	_	ADP	IN	_	29	case	_	_
28	concomitant	_	ADJ	JJ	_	29	amod	_	_
29	treatment	_	NOUN	NN	_	26	nmod	_	_
30	of	_	ADP	IN	_	31	case	_	_
31	warfarin	_	NOUN	NN	_	29	nmod	_	_
32	with	_	ADP	IN	_	33	case	_	_
33	DRUG	_	NOUN	NN	_	31	nmod	_	_

#	REMERON	3448
1	No	_	DET	DT	_	4	neg	_	_
2	relevant	_	ADJ	JJ	_	4	amod	_	_
3	clinical	_	ADJ	JJ	_	4	amod	_	_
4	effects	_	NOUN	NNS	_	12	nsubjpass	_	_
5	or	_	CONJ	CC	_	4	cc	_	_
6	significant	_	ADJ	JJ	_	7	amod	_	_
7	changes	_	NOUN	NNS	_	4	conj	_	_
8	in	_	ADP	IN	_	9	case	_	_
9	pharmacokinetics	_	NOUN	NNS	_	4	nmod	_	_
10	have	_	VERB	VBP	_	12	aux	_	_
11	been	_	VERB	VBN	_	12	auxpass	_	_
12	observed	_	VERB	VBN	_	0	root	_	_
13	in	_	ADP	IN	_	16	case	_	_
14	healthy	_	ADJ	JJ	_	16	amod	_	_
15	male	_	ADJ	JJ	_	16	amod	_	_
16	subjects	_	NOUN	NNS	_	12	nmod	_	_
17	on	_	ADP	IN	_	19	case	_	_
18	concurrent	_	ADJ	JJ	_	19	amod	_	_
19	treatment	_	NOUN	NN	_	12	nmod	_	_
20	with	_	ADP	IN	_	22	case	_	_
21	subtherapeutic	_	ADJ	JJ	_	22	amod	_	_
22	levels	_	NOUN	NNS	_	19	nmod	_	_
23	of	_	ADP	IN	_	26	case	_	_
24	lithium	_	NOUN	NN	_	26	compound	_	_
25	600	_	NUM	CD	_	26	nummod	_	_
26	mg	_	NOUN	NN	_	22	nmod	_	_
27	/	_	.	:	_	12	punct	_	_
28	day	_	NOUN	NN	_	12	nmod	_	_
29	for	_	ADP	IN	_	31	case	_	_
30	10	_	NUM	CD	_	31	nummod	_	_
31	days	_	NOUN	NNS	_	28	nmod	_	_
32	at	_	ADP	IN	_	34	case	_	_
33	steady	_	ADJ	JJ	_	34	amod	_	_
34	state	_	NOUN	NN	_	28	nmod	_	_
35	and	_	CONJ	CC	_	28	cc	_	_
36	a	_	DET	DT	_	40	det	_	_
37	single	_	ADJ	JJ	_	40	amod	_	_
38	30	_	NUM	CD	_	40	nummod	_	_
39	mg	_	NOUN	NN	_	40	compound	_	_
40	dose	_	NOUN	NN	_	28	conj	_	_
41	of	_	ADP	IN	_	42	case	_	_
42	DRUG	_	NOUN	NN	_	40	nmod	_	_

#	REMERON	3449
1	The	_	DET	DT	_	2	det	_	_
2	effects	_	NOUN	NNS	_	14	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	higher	_	ADJ	JJ	_	5	amod	_	_
5	doses	_	NOUN	NNS	_	2	nmod	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	lithium	_	NOUN	NN	_	5	nmod	_	_
8	on	_	ADP	IN	_	10	case	_	_
9	the	_	DET	DT	_	10	det	_	_
10	pharmacokinetics	_	NOUN	NNS	_	2	nmod	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_
13	are	_	VERB	VBP	_	14	auxpass	_	_
14	unknown	_	ADJ	JJ	_	0	root	_	_

#	REMERON	3450
1	In	_	ADP	IN	_	11	case	_	_
2	an	_	DET	DT	_	11	det	_	_
3	in	_	ADJ	JJ	_	4	compound	_	_
4	vivo	_	ADV	RB	_	11	advmod	_	_
5	,	_	.	,	_	11	punct	_	_
6	nonrandomized	_	ADJ	JJ	_	9	amod	_	_
7	,	_	.	,	_	6	punct	_	_
8	interaction	_	NOUN	NN	_	9	compound	_	_
9	study	_	NOUN	NN	_	11	nsubj	_	_
10	,	_	.	,	_	9	punct	_	_
11	subjects	_	VERB	VBZ	_	24	nsubj	_	_
12	n=6	_	NOUN	NN	_	11	dep	_	_
13	in	_	ADP	IN	_	14	case	_	_
14	need	_	NOUN	NN	_	11	nmod	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	treatment	_	NOUN	NN	_	14	nmod	_	_
17	with	_	ADP	IN	_	22	case	_	_
18	an	_	DET	DT	_	22	det	_	_
19	antipsychotic	_	ADJ	JJ	_	22	amod	_	_
20	and	_	CONJ	CC	_	19	cc	_	_
21	antidepressant	_	ADJ	JJ	_	19	conj	_	_
22	drug	_	NOUN	NN	_	16	nmod	_	_
23	,	_	.	,	_	11	punct	_	_
24	showed	_	VERB	VBD	_	0	root	_	_
25	that	_	ADP	IN	_	35	mark	_	_
26	DRUG	_	NOUN	NN	_	28	compound	_	_
27	30	_	NUM	CD	_	28	nummod	_	_
28	mg	_	NOUN	NN	_	35	nsubj	_	_
29	daily	_	ADV	RB	_	32	advmod	_	_
30	at	_	ADP	IN	_	32	case	_	_
31	steady	_	ADJ	JJ	_	32	amod	_	_
32	state	_	NOUN	NN	_	28	nmod	_	_
33	did	_	VERB	VBD	_	35	aux	_	_
34	not	_	ADV	RB	_	35	neg	_	_
35	influence	_	VERB	VB	_	24	ccomp	_	_
36	the	_	DET	DT	_	37	det	_	_
37	pharmacokinetics	_	NOUN	NNS	_	35	dobj	_	_
38	of	_	ADP	IN	_	39	case	_	_
39	risperidone	_	NOUN	NN	_	37	nmod	_	_
40	up	_	ADV	RB	_	35	nmod	_	_
41	to	_	PRT	TO	_	44	case	_	_
42	3	_	NUM	CD	_	44	nummod	_	_
43	mg	_	NOUN	NN	_	44	compound	_	_
44	b.i.d	_	NOUN	NN	_	40	nmod	_	_

#	REMERON	3451
1	Concomitant	_	ADJ	JJ	_	2	amod	_	_
2	administration	_	NOUN	NN	_	9	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	alcohol	_	NOUN	NN	_	2	nmod	_	_
5	equivalent	_	ADJ	JJ	_	4	amod	_	_
6	to	_	PRT	TO	_	8	case	_	_
7	60	_	NUM	CD	_	8	nummod	_	_
8	g	_	NOUN	NN	_	5	nmod	_	_
9	had	_	VERB	VBD	_	0	root	_	_
10	a	_	DET	DT	_	12	det	_	_
11	minimal	_	ADJ	JJ	_	12	amod	_	_
12	effect	_	NOUN	NN	_	9	dobj	_	_
13	on	_	ADP	IN	_	15	case	_	_
14	plasma	_	NOUN	NN	_	15	compound	_	_
15	levels	_	NOUN	NNS	_	12	nmod	_	_
16	of	_	ADP	IN	_	19	case	_	_
17	DRUG	_	NOUN	NN	_	19	compound	_	_
18	15	_	NUM	CD	_	19	nummod	_	_
19	mg	_	NOUN	NN	_	15	nmod	_	_
20	in	_	ADP	IN	_	24	case	_	_
21	6	_	NUM	CD	_	24	nummod	_	_
22	healthy	_	ADJ	JJ	_	24	amod	_	_
23	male	_	ADJ	JJ	_	24	amod	_	_
24	subjects	_	NOUN	NNS	_	12	nmod	_	_

#	REMERON	3452
1	However	_	ADV	RB	_	14	advmod	_	_
2	,	_	.	,	_	14	punct	_	_
3	the	_	DET	DT	_	4	det	_	_
4	impairment	_	NOUN	NN	_	14	nsubjpass	_	_
5	of	_	ADP	IN	_	9	case	_	_
6	cognitive	_	ADJ	JJ	_	9	amod	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	motor	_	NOUN	NN	_	6	conj	_	_
9	skills	_	NOUN	NNS	_	4	nmod	_	_
10	produced	_	VERB	VBN	_	9	acl	_	_
11	by	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_
13	were	_	VERB	VBD	_	14	auxpass	_	_
14	shown	_	VERB	VBN	_	0	root	_	_
15	to	_	PRT	TO	_	17	mark	_	_
16	be	_	VERB	VB	_	17	cop	_	_
17	additive	_	ADJ	JJ	_	14	xcomp	_	_
18	with	_	ADP	IN	_	19	case	_	_
19	those	_	DET	DT	_	17	nmod	_	_
20	produced	_	VERB	VBN	_	19	acl	_	_
21	by	_	ADP	IN	_	22	case	_	_
22	alcohol	_	NOUN	NN	_	20	nmod	_	_

#	REMERON	3453
1	Accordingly	_	ADV	RB	_	6	advmod	_	_
2	,	_	.	,	_	6	punct	_	_
3	patients	_	NOUN	NNS	_	6	nsubjpass	_	_
4	should	_	VERB	MD	_	6	aux	_	_
5	be	_	VERB	VB	_	6	auxpass	_	_
6	advised	_	VERB	VBN	_	0	root	_	_
7	to	_	PRT	TO	_	8	mark	_	_
8	avoid	_	VERB	VB	_	6	xcomp	_	_
9	alcohol	_	NOUN	NN	_	8	dobj	_	_
10	while	_	ADP	IN	_	11	mark	_	_
11	taking	_	VERB	VBG	_	8	advcl	_	_
12	DRUG	_	NOUN	NN	_	11	dobj	_	_

#	REMERON	3454
1	Concomitant	_	ADJ	JJ	_	2	amod	_	_
2	administration	_	NOUN	NN	_	7	nsubj	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	diazepam	_	NOUN	NN	_	6	compound	_	_
5	15	_	NUM	CD	_	6	nummod	_	_
6	mg	_	NOUN	NN	_	2	nmod	_	_
7	had	_	VERB	VBD	_	0	root	_	_
8	a	_	DET	DT	_	10	det	_	_
9	minimal	_	ADJ	JJ	_	10	amod	_	_
10	effect	_	NOUN	NN	_	7	dobj	_	_
11	on	_	ADP	IN	_	13	case	_	_
12	plasma	_	NOUN	NN	_	13	compound	_	_
13	levels	_	NOUN	NNS	_	10	nmod	_	_
14	of	_	ADP	IN	_	17	case	_	_
15	DRUG	_	NOUN	NN	_	17	compound	_	_
16	15	_	NUM	CD	_	17	nummod	_	_
17	mg	_	NOUN	NN	_	13	nmod	_	_
18	in	_	ADP	IN	_	21	case	_	_
19	12	_	NUM	CD	_	21	nummod	_	_
20	healthy	_	ADJ	JJ	_	21	amod	_	_
21	subjects	_	NOUN	NNS	_	10	nmod	_	_

#	REMERON	3455
1	However	_	ADV	RB	_	13	advmod	_	_
2	,	_	.	,	_	13	punct	_	_
3	the	_	DET	DT	_	4	det	_	_
4	impairment	_	NOUN	NN	_	13	nsubjpass	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	motor	_	NOUN	NN	_	7	compound	_	_
7	skills	_	NOUN	NNS	_	4	nmod	_	_
8	produced	_	VERB	VBN	_	7	acl	_	_
9	by	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	has	_	VERB	VBZ	_	13	aux	_	_
12	been	_	VERB	VBN	_	13	auxpass	_	_
13	shown	_	VERB	VBN	_	0	root	_	_
14	to	_	PRT	TO	_	16	mark	_	_
15	be	_	VERB	VB	_	16	cop	_	_
16	additive	_	ADJ	JJ	_	13	xcomp	_	_
17	with	_	ADP	IN	_	18	case	_	_
18	those	_	DET	DT	_	16	nmod	_	_
19	caused	_	VERB	VBN	_	18	acl	_	_
20	by	_	ADP	IN	_	21	case	_	_
21	diazepam	_	NOUN	NN	_	19	nmod	_	_

#	REMERON	3456
1	Accordingly	_	ADV	RB	_	6	advmod	_	_
2	,	_	.	,	_	6	punct	_	_
3	patients	_	NOUN	NNS	_	6	nsubjpass	_	_
4	should	_	VERB	MD	_	6	aux	_	_
5	be	_	VERB	VB	_	6	auxpass	_	_
6	advised	_	VERB	VBN	_	0	root	_	_
7	to	_	PRT	TO	_	8	mark	_	_
8	avoid	_	VERB	VB	_	6	xcomp	_	_
9	diazepam	_	NOUN	NN	_	8	dobj	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	other	_	ADJ	JJ	_	13	amod	_	_
12	similar	_	ADJ	JJ	_	13	amod	_	_
13	drugs	_	NOUN	NNS	_	9	conj	_	_
14	while	_	ADP	IN	_	15	mark	_	_
15	taking	_	VERB	VBG	_	8	advcl	_	_
16	DRUG	_	NOUN	NN	_	15	dobj	_	_

#	REMERON	3457
1	The	_	DET	DT	_	2	det	_	_
2	risk	_	NOUN	NN	_	40	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	QT	_	NOUN	NN	_	5	compound	_	_
5	prolongation	_	NOUN	NN	_	2	nmod	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	/	_	NOUN	NN	_	5	conj	_	_
8	or	_	CONJ	CC	_	7	cc	_	_
9	ventricular	_	ADJ	JJ	_	11	amod	_	_
10	arrhythmias	_	NOUN	NNS	_	11	compound	_	_
11	e.g	_	NOUN	NN	_	7	conj	_	_
12	,	_	.	,	_	2	punct	_	_
13	Torsades	_	NOUN	NNS	_	18	nsubjpass	_	_
14	de	_	ADP	IN	_	15	case	_	_
15	Pointes	_	NOUN	NNS	_	13	nmod	_	_
16	may	_	VERB	MD	_	18	aux	_	_
17	be	_	VERB	VB	_	18	auxpass	_	_
18	increased	_	VERB	VBN	_	2	acl:relcl	_	_
19	with	_	ADP	IN	_	21	case	_	_
20	concomitant	_	ADJ	JJ	_	21	amod	_	_
21	use	_	NOUN	NN	_	18	nmod	_	_
22	of	_	ADP	IN	_	23	case	_	_
23	medicines	_	NOUN	NNS	_	21	nmod	_	_
24	which	_	DET	WDT	_	25	nsubj	_	_
25	prolong	_	VERB	VBP	_	23	acl:relcl	_	_
26	the	_	DET	DT	_	29	det	_	_
27	QTc	_	NOUN	NN	_	29	compound	_	_
28	interval	_	ADJ	JJ	_	29	amod	_	_
29	e.g	_	NOUN	NN	_	25	dobj	_	_
30	,	_	.	,	_	2	punct	_	_
31	some	_	DET	DT	_	32	det	_	_
32	antipsychotics	_	NOUN	NNS	_	2	conj	_	_
33	and	_	CONJ	CC	_	32	cc	_	_
34	antibiotics	_	NOUN	NNS	_	32	conj	_	_
35	and	_	CONJ	CC	_	2	cc	_	_
36	in	_	ADP	IN	_	37	case	_	_
37	case	_	NOUN	NN	_	2	conj	_	_
38	of	_	ADP	IN	_	39	case	_	_
39	DRUG	_	NOUN	NN	_	37	nmod	_	_
40	overdose	_	VERB	VBP	_	0	root	_	_

#	REMERON	3458
1	The	_	DET	DT	_	2	det	_	_
2	mechanism	_	NOUN	NN	_	24	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	action	_	NOUN	NN	_	2	nmod	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	DRUG	_	NOUN	NN	_	8	compound	_	_
7	DRUG	_	NOUN	NN	_	8	compound	_	_
8	Tablets	_	NOUN	NNS	_	4	nmod	_	_
9	,	_	.	,	_	2	punct	_	_
10	as	_	ADP	IN	_	13	case	_	_
11	with	_	ADP	IN	_	13	case	_	_
12	other	_	ADJ	JJ	_	13	amod	_	_
13	drugs	_	NOUN	NNS	_	2	nmod	_	_
14	effective	_	ADJ	JJ	_	13	amod	_	_
15	in	_	ADP	IN	_	17	case	_	_
16	the	_	DET	DT	_	17	det	_	_
17	treatment	_	NOUN	NN	_	14	nmod	_	_
18	of	_	ADP	IN	_	21	case	_	_
19	major	_	ADJ	JJ	_	21	amod	_	_
20	depressive	_	ADJ	JJ	_	21	amod	_	_
21	disorder	_	NOUN	NN	_	17	nmod	_	_
22	,	_	.	,	_	2	punct	_	_
23	is	_	VERB	VBZ	_	24	auxpass	_	_
24	unknown	_	ADJ	JJ	_	0	root	_	_

#	REMERON	3459
1	Evidence	_	NOUN	NN	_	6	nsubj	_	_
2	gathered	_	VERB	VBN	_	1	acl	_	_
3	in	_	ADP	IN	_	5	case	_	_
4	preclinical	_	ADJ	JJ	_	5	amod	_	_
5	studies	_	NOUN	NNS	_	2	nmod	_	_
6	suggests	_	VERB	VBZ	_	0	root	_	_
7	that	_	ADP	IN	_	9	mark	_	_
8	DRUG	_	NOUN	NN	_	9	nsubj	_	_
9	enhances	_	VERB	VBZ	_	6	ccomp	_	_
10	central	_	ADJ	JJ	_	11	amod	_	_
11	noradrenergic	_	ADJ	JJ	_	9	dobj	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	serotonergic	_	ADJ	JJ	_	11	conj	_	_
14	activity	_	NOUN	NN	_	11	dep	_	_

#	REMERON	3460
1	These	_	DET	DT	_	2	det	_	_
2	studies	_	NOUN	NNS	_	4	nsubj	_	_
3	have	_	VERB	VBP	_	4	aux	_	_
4	shown	_	VERB	VBN	_	0	root	_	_
5	that	_	ADP	IN	_	7	mark	_	_
6	DRUG	_	NOUN	NN	_	7	nsubj	_	_
7	acts	_	VERB	VBZ	_	4	ccomp	_	_
8	as	_	ADP	IN	_	10	case	_	_
9	an	_	DET	DT	_	10	det	_	_
10	antagonist	_	NOUN	NN	_	7	nmod	_	_
11	at	_	ADP	IN	_	17	case	_	_
12	central	_	ADJ	JJ	_	17	amod	_	_
13	presynaptic	_	ADJ	JJ	_	17	amod	_	_
14	A2	_	NOUN	NN	_	17	compound	_	_
15	adrenergic	_	ADJ	JJ	_	17	amod	_	_
16	inhibitory	_	ADJ	JJ	_	17	amod	_	_
17	autoreceptors	_	NOUN	NNS	_	10	nmod	_	_
18	and	_	CONJ	CC	_	17	cc	_	_
19	heteroreceptors	_	NOUN	NNS	_	17	conj	_	_
20	,	_	.	,	_	17	punct	_	_
21	an	_	DET	DT	_	22	det	_	_
22	action	_	NOUN	NN	_	17	appos	_	_
23	that	_	DET	WDT	_	25	nsubjpass	_	_
24	is	_	VERB	VBZ	_	25	auxpass	_	_
25	postulated	_	VERB	VBN	_	22	acl:relcl	_	_
26	to	_	PRT	TO	_	27	mark	_	_
27	result	_	VERB	VB	_	25	xcomp	_	_
28	in	_	ADP	IN	_	30	case	_	_
29	an	_	DET	DT	_	30	det	_	_
30	increase	_	NOUN	NN	_	27	nmod	_	_
31	in	_	ADP	IN	_	33	case	_	_
32	central	_	ADJ	JJ	_	33	amod	_	_
33	noradrenergic	_	ADJ	JJ	_	30	nmod	_	_
34	and	_	CONJ	CC	_	33	cc	_	_
35	serotonergic	_	ADJ	JJ	_	33	conj	_	_
36	activity	_	NOUN	NN	_	33	dep	_	_

#	REMERON	3461
1	DRUG	_	NOUN	NN	_	5	nsubj	_	_
2	is	_	VERB	VBZ	_	5	cop	_	_
3	a	_	DET	DT	_	5	det	_	_
4	potent	_	ADJ	JJ	_	5	amod	_	_
5	antagonist	_	NOUN	NN	_	0	root	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	5	_	NUM	CD	_	8	nummod	_	_
8	HT2	_	NOUN	NN	_	5	nmod	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	5	_	NUM	CD	_	12	nummod	_	_
11	HT3	_	NOUN	NN	_	12	compound	_	_
12	receptors	_	NOUN	NNS	_	8	conj	_	_

#	REMERON	3462
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	has	_	VERB	VBZ	_	0	root	_	_
3	no	_	DET	DT	_	5	neg	_	_
4	significant	_	ADJ	JJ	_	5	amod	_	_
5	affinity	_	NOUN	NN	_	2	dobj	_	_
6	for	_	ADP	IN	_	9	case	_	_
7	the	_	DET	DT	_	9	det	_	_
8	5	_	NUM	CD	_	9	nummod	_	_
9	HT1A	_	NOUN	NN	_	5	nmod	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	5	_	NUM	CD	_	13	nummod	_	_
12	HT1B	_	NOUN	NN	_	13	compound	_	_
13	receptors	_	NOUN	NNS	_	9	conj	_	_

#	REMERON	3463
1	DRUG	_	NOUN	NN	_	5	nsubj	_	_
2	is	_	VERB	VBZ	_	5	cop	_	_
3	a	_	DET	DT	_	5	det	_	_
4	potent	_	ADJ	JJ	_	5	amod	_	_
5	antagonist	_	NOUN	NN	_	0	root	_	_
6	of	_	ADP	IN	_	9	case	_	_
7	histamine	_	NOUN	NN	_	9	compound	_	_
8	H1	_	NOUN	NN	_	9	compound	_	_
9	receptors	_	NOUN	NNS	_	5	nmod	_	_
10	,	_	.	,	_	9	punct	_	_
11	a	_	DET	DT	_	12	det	_	_
12	property	_	NOUN	NN	_	9	appos	_	_
13	that	_	DET	WDT	_	15	nsubj	_	_
14	may	_	VERB	MD	_	15	aux	_	_
15	explain	_	VERB	VB	_	12	acl:relcl	_	_
16	its	_	PRON	PRP$	_	19	nmod:poss	_	_
17	prominent	_	ADJ	JJ	_	19	amod	_	_
18	sedative	_	ADJ	JJ	_	19	amod	_	_
19	effects	_	NOUN	NNS	_	15	dobj	_	_

#	REMERON	3464
1	DRUG	_	NOUN	NN	_	8	nsubj	_	_
2	is	_	VERB	VBZ	_	8	cop	_	_
3	a	_	DET	DT	_	8	det	_	_
4	moderate	_	ADJ	JJ	_	8	amod	_	_
5	peripheral	_	ADJ	JJ	_	8	amod	_	_
6	A1	_	NOUN	NN	_	8	compound	_	_
7	adrenergic	_	ADJ	JJ	_	8	amod	_	_
8	antagonist	_	NOUN	NN	_	0	root	_	_
9	,	_	.	,	_	8	punct	_	_
10	a	_	DET	DT	_	11	det	_	_
11	property	_	NOUN	NN	_	8	appos	_	_
12	that	_	DET	WDT	_	14	nsubj	_	_
13	may	_	VERB	MD	_	14	aux	_	_
14	explain	_	VERB	VB	_	11	acl:relcl	_	_
15	the	_	DET	DT	_	18	det	_	_
16	occasional	_	ADJ	JJ	_	18	amod	_	_
17	orthostatic	_	ADJ	JJ	_	18	amod	_	_
18	hypotension	_	NOUN	NN	_	14	dobj	_	_
19	reported	_	VERB	VBN	_	18	acl	_	_
20	in	_	ADP	IN	_	21	case	_	_
21	association	_	NOUN	NN	_	19	nmod	_	_
22	with	_	ADP	IN	_	24	case	_	_
23	its	_	PRON	PRP$	_	24	nmod:poss	_	_
24	use	_	NOUN	NN	_	21	nmod	_	_

#	REMERON	3465
1	DRUG	_	NOUN	NN	_	5	nsubj	_	_
2	is	_	VERB	VBZ	_	5	cop	_	_
3	a	_	DET	DT	_	5	det	_	_
4	moderate	_	ADJ	JJ	_	5	amod	_	_
5	antagonist	_	NOUN	NN	_	0	root	_	_
6	at	_	ADP	IN	_	8	case	_	_
7	muscarinic	_	ADJ	JJ	_	8	amod	_	_
8	receptors	_	NOUN	NNS	_	5	nmod	_	_
9	,	_	.	,	_	8	punct	_	_
10	a	_	DET	DT	_	11	det	_	_
11	property	_	NOUN	NN	_	8	appos	_	_
12	that	_	DET	WDT	_	14	nsubj	_	_
13	may	_	VERB	MD	_	14	aux	_	_
14	explain	_	VERB	VB	_	11	acl:relcl	_	_
15	the	_	DET	DT	_	18	det	_	_
16	relatively	_	ADV	RB	_	17	advmod	_	_
17	low	_	ADJ	JJ	_	18	amod	_	_
18	incidence	_	NOUN	NN	_	14	dobj	_	_
19	of	_	ADP	IN	_	22	case	_	_
20	anticholinergic	_	ADJ	JJ	_	22	amod	_	_
21	side	_	ADJ	JJ	_	22	amod	_	_
22	effects	_	NOUN	NNS	_	18	nmod	_	_
23	associated	_	VERB	VBN	_	22	acl	_	_
24	with	_	ADP	IN	_	26	case	_	_
25	its	_	PRON	PRP$	_	26	nmod:poss	_	_
26	use	_	NOUN	NN	_	23	nmod	_	_

#	REMERON	3466
1	DRUG	_	NOUN	NN	_	3	compound	_	_
2	DRUG	_	NOUN	NN	_	3	compound	_	_
3	Tablets	_	NOUN	NNS	_	8	nsubjpass	_	_
4	are	_	VERB	VBP	_	8	auxpass	_	_
5	rapidly	_	ADV	RB	_	6	advmod	_	_
6	and	_	CONJ	CC	_	8	advmod	_	_
7	completely	_	ADV	RB	_	6	advmod	_	_
8	absorbed	_	VERB	VBN	_	0	root	_	_
9	following	_	ADP	IN	_	11	case	_	_
10	oral	_	ADJ	JJ	_	11	amod	_	_
11	administration	_	NOUN	NN	_	8	nmod	_	_
12	and	_	CONJ	CC	_	8	cc	_	_
13	have	_	VERB	VBP	_	8	conj	_	_
14	a	_	DET	DT	_	16	det	_	_
15	half	_	ADJ	JJ	_	16	amod	_	_
16	life	_	NOUN	NN	_	13	dobj	_	_
17	of	_	ADP	IN	_	22	case	_	_
18	about	_	ADV	RB	_	19	advmod	_	_
19	20	_	NUM	CD	_	21	compound	_	_
20	to	_	PRT	TO	_	21	dep	_	_
21	40	_	NUM	CD	_	22	nummod	_	_
22	hours	_	NOUN	NNS	_	16	nmod	_	_

#	REMERON	3467
1	Peak	_	ADJ	JJ	_	3	amod	_	_
2	plasma	_	NOUN	NN	_	3	compound	_	_
3	concentrations	_	NOUN	NNS	_	5	nsubjpass	_	_
4	are	_	VERB	VBP	_	5	auxpass	_	_
5	reached	_	VERB	VBN	_	0	root	_	_
6	within	_	ADP	IN	_	9	case	_	_
7	about	_	ADV	RB	_	8	advmod	_	_
8	2	_	NUM	CD	_	9	nummod	_	_
9	hours	_	NOUN	NNS	_	5	nmod	_	_
10	following	_	ADP	IN	_	13	case	_	_
11	an	_	DET	DT	_	13	det	_	_
12	oral	_	ADJ	JJ	_	13	amod	_	_
13	dose	_	NOUN	NN	_	9	nmod	_	_

#	REMERON	3468
1	The	_	DET	DT	_	2	det	_	_
2	presence	_	NOUN	NN	_	8	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	food	_	NOUN	NN	_	2	nmod	_	_
5	in	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	stomach	_	NOUN	NN	_	2	nmod	_	_
8	has	_	VERB	VBZ	_	0	root	_	_
9	a	_	DET	DT	_	11	det	_	_
10	minimal	_	ADJ	JJ	_	11	amod	_	_
11	effect	_	NOUN	NN	_	8	dobj	_	_
12	on	_	ADP	IN	_	15	case	_	_
13	both	_	CONJ	CC	_	15	cc:preconj	_	_
14	the	_	DET	DT	_	15	det	_	_
15	rate	_	NOUN	NN	_	8	nmod	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	extent	_	NOUN	NN	_	15	conj	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	absorption	_	NOUN	NN	_	15	nmod	_	_
20	and	_	CONJ	CC	_	8	cc	_	_
21	does	_	VERB	VBZ	_	23	aux	_	_
22	not	_	ADV	RB	_	23	neg	_	_
23	require	_	VERB	VB	_	8	conj	_	_
24	a	_	DET	DT	_	26	det	_	_
25	dosage	_	NOUN	NN	_	26	compound	_	_
26	adjustment	_	NOUN	NN	_	23	dobj	_	_

#	REMERON	3469
1	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
2	is	_	VERB	VBZ	_	4	auxpass	_	_
3	extensively	_	ADV	RB	_	4	advmod	_	_
4	metabolized	_	VERB	VBN	_	0	root	_	_
5	after	_	ADP	IN	_	7	case	_	_
6	oral	_	ADJ	JJ	_	7	amod	_	_
7	administration	_	NOUN	NN	_	4	nmod	_	_

#	REMERON	3470
1	Major	_	ADJ	JJ	_	2	amod	_	_
2	pathways	_	NOUN	NNS	_	6	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	biotransformation	_	NOUN	NN	_	2	nmod	_	_
5	are	_	VERB	VBP	_	6	cop	_	_
6	demethylation	_	NOUN	NN	_	0	root	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	hydroxylation	_	NOUN	NN	_	6	conj	_	_
9	followed	_	VERB	VBN	_	8	acl	_	_
10	by	_	ADP	IN	_	12	case	_	_
11	glucuronide	_	NOUN	NN	_	12	compound	_	_
12	conjugation	_	NOUN	NN	_	9	nmod	_	_

#	REMERON	3471
1	In	_	X	FW	_	3	amod	_	_
2	vitro	_	X	FW	_	1	dep	_	_
3	data	_	NOUN	NNS	_	8	nsubj	_	_
4	from	_	ADP	IN	_	7	case	_	_
5	human	_	ADJ	JJ	_	7	amod	_	_
6	liver	_	NOUN	NN	_	7	compound	_	_
7	microsomes	_	NOUN	NNS	_	3	nmod	_	_
8	indicate	_	VERB	VBP	_	0	root	_	_
9	that	_	ADP	IN	_	15	mark	_	_
10	cytochrome	_	NOUN	NN	_	11	compound	_	_
11	2D6	_	NOUN	NN	_	15	nsubjpass	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	1A2	_	NOUN	NN	_	11	conj	_	_
14	are	_	VERB	VBP	_	15	auxpass	_	_
15	involved	_	VERB	VBN	_	8	ccomp	_	_
16	in	_	ADP	IN	_	18	case	_	_
17	the	_	DET	DT	_	18	det	_	_
18	formation	_	NOUN	NN	_	15	nmod	_	_
19	of	_	ADP	IN	_	23	case	_	_
20	the	_	DET	DT	_	23	det	_	_
21	8	_	NUM	CD	_	23	nummod	_	_
22	hydroxy	_	NOUN	NN	_	23	amod	_	_
23	metabolite	_	NOUN	NN	_	18	nmod	_	_
24	of	_	ADP	IN	_	25	case	_	_
25	DRUG	_	NOUN	NN	_	23	nmod	_	_
26	,	_	.	,	_	15	punct	_	_
27	whereas	_	ADP	IN	_	31	mark	_	_
28	cytochrome	_	NOUN	NN	_	29	compound	_	_
29	3A	_	NOUN	NN	_	31	nsubjpass	_	_
30	is	_	VERB	VBZ	_	31	auxpass	_	_
31	considered	_	VERB	VBN	_	15	advcl	_	_
32	to	_	PRT	TO	_	34	mark	_	_
33	be	_	VERB	VB	_	34	cop	_	_
34	responsible	_	ADJ	JJ	_	31	xcomp	_	_
35	for	_	ADP	IN	_	37	case	_	_
36	the	_	DET	DT	_	37	det	_	_
37	formation	_	NOUN	NN	_	34	nmod	_	_
38	of	_	ADP	IN	_	41	case	_	_
39	the	_	DET	DT	_	41	det	_	_
40	N	_	NOUN	NN	_	41	compound	_	_
41	desmethyl	_	NOUN	NN	_	37	nmod	_	_
42	and	_	CONJ	CC	_	41	cc	_	_
43	N	_	NOUN	NN	_	45	compound	_	_
44	oxide	_	NOUN	NN	_	45	compound	_	_
45	metabolite	_	NOUN	NN	_	41	conj	_	_

#	REMERON	3472
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	has	_	VERB	VBZ	_	0	root	_	_
3	an	_	DET	DT	_	5	det	_	_
4	absolute	_	ADJ	JJ	_	5	amod	_	_
5	bioavailability	_	NOUN	NN	_	2	dobj	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	about	_	ADV	RB	_	8	advmod	_	_
8	50%	_	ADJ	JJ	_	5	nmod	_	_

#	REMERON	3473
1	It	_	PRON	PRP	_	3	nsubjpass	_	_
2	is	_	VERB	VBZ	_	3	auxpass	_	_
3	eliminated	_	VERB	VBN	_	0	root	_	_
4	predominantly	_	ADV	RB	_	3	advmod	_	_
5	via	_	ADP	IN	_	6	mark	_	_
6	urine	_	VERB	VBG	_	3	advcl	_	_
7	75%	_	NOUN	NN	_	6	dobj	_	_
8	with	_	ADP	IN	_	9	case	_	_
9	15%	_	NOUN	NN	_	6	nmod	_	_
10	in	_	ADP	IN	_	11	case	_	_
11	feces	_	NOUN	NNS	_	9	nmod	_	_

#	REMERON	3474
1	Several	_	ADJ	JJ	_	3	amod	_	_
2	unconjugated	_	ADJ	JJ	_	3	amod	_	_
3	metabolites	_	NOUN	NNS	_	4	nsubj	_	_
4	possess	_	VERB	VBP	_	0	root	_	_
5	pharmacological	_	ADJ	JJ	_	6	amod	_	_
6	activity	_	NOUN	NN	_	4	dobj	_	_
7	but	_	CONJ	CC	_	4	cc	_	_
8	are	_	VERB	VBP	_	9	cop	_	_
9	present	_	ADJ	JJ	_	4	conj	_	_
10	in	_	ADP	IN	_	12	case	_	_
11	the	_	DET	DT	_	12	det	_	_
12	plasma	_	NOUN	NN	_	9	nmod	_	_
13	at	_	ADP	IN	_	16	case	_	_
14	very	_	ADV	RB	_	15	advmod	_	_
15	low	_	ADJ	JJ	_	16	amod	_	_
16	levels	_	NOUN	NNS	_	12	nmod	_	_

#	REMERON	3475
1	The	_	DET	DT	_	2	det	_	_
2	enantiomer	_	NOUN	NN	_	3	nsubj	_	_
3	has	_	VERB	VBZ	_	0	root	_	_
4	an	_	DET	DT	_	7	det	_	_
5	elimination	_	NOUN	NN	_	7	compound	_	_
6	half	_	NOUN	NN	_	7	compound	_	_
7	life	_	NOUN	NN	_	3	dobj	_	_
8	that	_	DET	WDT	_	11	nsubj	_	_
9	is	_	VERB	VBZ	_	11	cop	_	_
10	approximately	_	ADV	RB	_	11	advmod	_	_
11	twice	_	ADV	RB	_	7	acl:relcl	_	_
12	as	_	ADV	RB	_	13	advmod	_	_
13	long	_	ADJ	JJ	_	11	advcl	_	_
14	as	_	ADP	IN	_	17	case	_	_
15	the	_	DET	DT	_	17	det	_	_
16	+	_	CONJ	CC	_	17	cc	_	_
17	enantiomer	_	NOUN	NN	_	13	nmod	_	_
18	and	_	CONJ	CC	_	11	cc	_	_
19	therefore	_	ADV	RB	_	20	advmod	_	_
20	achieves	_	VERB	VBZ	_	11	conj	_	_
21	plasma	_	NOUN	NN	_	22	compound	_	_
22	levels	_	NOUN	NNS	_	20	dobj	_	_
23	that	_	DET	WDT	_	27	nsubj	_	_
24	are	_	VERB	VBP	_	27	cop	_	_
25	about	_	ADV	RB	_	26	advmod	_	_
26	3	_	NUM	CD	_	27	nummod	_	_
27	times	_	NOUN	NNS	_	22	nmod	_	_
28	as	_	ADV	RB	_	29	advmod	_	_
29	high	_	ADJ	JJ	_	27	nmod	_	_
30	as	_	ADP	IN	_	31	case	_	_
31	that	_	DET	DT	_	29	nmod	_	_
32	of	_	ADP	IN	_	33	case	_	_
33	the	_	DET	DT	_	31	nmod	_	_
34	+	_	CONJ	CC	_	33	cc	_	_
35	enantiomer	_	ADJ	JJ	_	33	conj	_	_

#	REMERON	3476
1	Plasma	_	NOUN	NN	_	2	compound	_	_
2	levels	_	NOUN	NNS	_	5	nsubj	_	_
3	are	_	VERB	VBP	_	5	cop	_	_
4	linearly	_	ADV	RB	_	5	advmod	_	_
5	related	_	ADJ	JJ	_	0	root	_	_
6	to	_	PRT	TO	_	7	case	_	_
7	dose	_	NOUN	NN	_	5	nmod	_	_
8	over	_	ADP	IN	_	11	case	_	_
9	a	_	DET	DT	_	11	det	_	_
10	dose	_	NOUN	NN	_	11	compound	_	_
11	range	_	NOUN	NN	_	5	nmod	_	_
12	of	_	ADP	IN	_	16	case	_	_
13	15	_	NUM	CD	_	15	compound	_	_
14	to	_	PRT	TO	_	15	dep	_	_
15	80	_	NUM	CD	_	16	nummod	_	_
16	mg	_	NOUN	NN	_	11	nmod	_	_

#	REMERON	3477
1	The	_	DET	DT	_	5	det	_	_
2	mean	_	ADJ	JJ	_	5	compound	_	_
3	elimination	_	NOUN	NN	_	5	compound	_	_
4	half	_	NOUN	NN	_	5	compound	_	_
5	life	_	NOUN	NN	_	0	root	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	after	_	ADP	IN	_	11	case	_	_
9	oral	_	ADJ	JJ	_	11	amod	_	_
10	administration	_	NOUN	NN	_	11	compound	_	_
11	ranges	_	NOUN	NNS	_	5	nmod	_	_
12	from	_	ADP	IN	_	17	case	_	_
13	approximately	_	ADV	RB	_	14	advmod	_	_
14	20	_	NUM	CD	_	16	compound	_	_
15	to	_	PRT	TO	_	16	dep	_	_
16	40	_	NUM	CD	_	17	nummod	_	_
17	hours	_	NOUN	NNS	_	11	nmod	_	_
18	across	_	ADP	IN	_	19	case	_	_
19	age	_	NOUN	NN	_	11	nmod	_	_
20	and	_	CONJ	CC	_	19	cc	_	_
21	gender	_	NOUN	NN	_	19	conj	_	_
22	subgroups	_	NOUN	NNS	_	19	dep	_	_
23	,	_	.	,	_	5	punct	_	_
24	with	_	ADP	IN	_	25	case	_	_
25	females	_	NOUN	NNS	_	5	nmod	_	_
26	of	_	ADP	IN	_	28	case	_	_
27	all	_	DET	DT	_	28	det	_	_
28	ages	_	NOUN	NNS	_	25	nmod	_	_
29	exhibiting	_	VERB	VBG	_	28	acl	_	_
30	significantly	_	ADV	RB	_	31	advmod	_	_
31	longer	_	ADV	RB	_	34	amod	_	_
32	elimination	_	NOUN	NN	_	34	compound	_	_
33	half	_	NOUN	NN	_	34	amod	_	_
34	lives	_	NOUN	NNS	_	29	dobj	_	_
35	than	_	ADP	IN	_	36	case	_	_
36	males	_	NOUN	NNS	_	29	nmod	_	_
37	mean	_	ADJ	JJ	_	39	amod	_	_
38	half	_	ADJ	JJ	_	39	amod	_	_
39	life	_	NOUN	NN	_	36	dep	_	_
40	of	_	ADP	IN	_	42	case	_	_
41	37	_	NUM	CD	_	42	nummod	_	_
42	hours	_	NOUN	NNS	_	39	nmod	_	_
43	for	_	ADP	IN	_	44	case	_	_
44	females	_	NOUN	NNS	_	39	nmod	_	_
45	vs	_	CONJ	CC	_	44	cc	_	_
46	26	_	NUM	CD	_	47	nummod	_	_
47	hours	_	NOUN	NNS	_	44	conj	_	_
48	for	_	ADP	IN	_	49	case	_	_
49	males	_	NOUN	NNS	_	44	nmod	_	_

#	REMERON	3478
1	Steady	_	ADJ	JJ	_	4	amod	_	_
2	state	_	NOUN	NN	_	4	compound	_	_
3	plasma	_	NOUN	NN	_	4	compound	_	_
4	levels	_	NOUN	NNS	_	8	nsubjpass	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	are	_	VERB	VBP	_	8	auxpass	_	_
8	attained	_	VERB	VBN	_	0	root	_	_
9	within	_	ADP	IN	_	11	case	_	_
10	5	_	NUM	CD	_	11	nummod	_	_
11	days	_	NOUN	NNS	_	8	nmod	_	_
12	,	_	.	,	_	8	punct	_	_
13	with	_	ADP	IN	_	18	case	_	_
14	about	_	ADV	RB	_	15	advmod	_	_
15	50%	_	ADJ	JJ	_	18	amod	_	_
16	accumulation	_	NOUN	NN	_	18	compound	_	_
17	accumulation	_	NOUN	NN	_	18	compound	_	_
18	ratio	_	NOUN	NN	_	8	nmod	_	_
19	=	_	DET	DT	_	20	det	_	_
20	1.5	_	NUM	CD	_	18	nmod	_	_

#	REMERON	3479
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	is	_	VERB	VBZ	_	4	cop	_	_
3	approximately	_	ADV	RB	_	4	advmod	_	_
4	85%	_	ADJ	JJ	_	0	root	_	_
5	bound	_	VERB	VBN	_	4	acl	_	_
6	to	_	PRT	TO	_	8	case	_	_
7	plasma	_	NOUN	NN	_	8	compound	_	_
8	proteins	_	NOUN	NNS	_	5	nmod	_	_
9	over	_	ADP	IN	_	12	case	_	_
10	a	_	DET	DT	_	12	det	_	_
11	concentration	_	NOUN	NN	_	12	compound	_	_
12	range	_	NOUN	NN	_	5	nmod	_	_
13	of	_	ADP	IN	_	17	case	_	_
14	0.01	_	NUM	CD	_	16	compound	_	_
15	to	_	PRT	TO	_	16	dep	_	_
16	10	_	NUM	CD	_	17	nummod	_	_
17	mcg	_	NOUN	NN	_	12	nmod	_	_
18	/	_	.	:	_	17	punct	_	_
19	mL	_	NOUN	NN	_	17	appos	_	_

#	REMERON	3480
1	Following	_	VERB	VBG	_	3	case	_	_
2	oral	_	ADJ	JJ	_	3	amod	_	_
3	administration	_	NOUN	NN	_	30	nmod	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	DRUG	_	NOUN	NN	_	7	compound	_	_
6	DRUG	_	NOUN	NN	_	7	compound	_	_
7	Tablets	_	NOUN	NNS	_	3	nmod	_	_
8	20	_	NUM	CD	_	9	nummod	_	_
9	mg	_	NOUN	NN	_	7	dep	_	_
10	/	_	.	:	_	11	punct	_	_
11	day	_	NOUN	NN	_	3	dep	_	_
12	for	_	ADP	IN	_	14	case	_	_
13	7	_	NUM	CD	_	14	nummod	_	_
14	days	_	NOUN	NNS	_	11	nmod	_	_
15	to	_	PRT	TO	_	16	case	_	_
16	subjects	_	NOUN	NNS	_	11	nmod	_	_
17	of	_	ADP	IN	_	20	case	_	_
18	varying	_	VERB	VBG	_	20	amod	_	_
19	ages	_	NOUN	NNS	_	20	compound	_	_
20	range	_	NOUN	NN	_	16	nmod	_	_
21	,	_	.	,	_	20	punct	_	_
22	25	_	NUM	CD	_	23	nummod	_	_
23	74	_	NUM	CD	_	20	appos	_	_
24	,	_	.	,	_	30	punct	_	_
25	oral	_	ADJ	JJ	_	26	amod	_	_
26	clearance	_	NOUN	NN	_	30	nsubjpass	_	_
27	of	_	ADP	IN	_	28	case	_	_
28	DRUG	_	NOUN	NN	_	26	nmod	_	_
29	was	_	VERB	VBD	_	30	auxpass	_	_
30	reduced	_	VERB	VBN	_	0	root	_	_
31	in	_	ADP	IN	_	33	case	_	_
32	the	_	DET	DT	_	33	det	_	_
33	elderly	_	NOUN	NN	_	30	nmod	_	_
34	compared	_	VERB	VBN	_	38	case	_	_
35	to	_	PRT	TO	_	38	case	_	_
36	the	_	DET	DT	_	38	det	_	_
37	younger	_	ADJ	JJ	_	38	amod	_	_
38	subjects	_	NOUN	NNS	_	30	nmod	_	_

#	REMERON	3481
1	The	_	DET	DT	_	2	det	_	_
2	differences	_	NOUN	NNS	_	5	nsubj	_	_
3	were	_	VERB	VBD	_	5	cop	_	_
4	most	_	ADV	RB	_	5	advmod	_	_
5	striking	_	NOUN	NN	_	0	root	_	_
6	in	_	ADP	IN	_	7	case	_	_
7	males	_	NOUN	NNS	_	5	nmod	_	_
8	,	_	.	,	_	5	punct	_	_
9	with	_	ADP	IN	_	13	case	_	_
10	a	_	DET	DT	_	13	det	_	_
11	40%	_	ADJ	JJ	_	13	amod	_	_
12	lower	_	ADJ	JJ	_	13	amod	_	_
13	clearance	_	NOUN	NN	_	5	nmod	_	_
14	in	_	ADP	IN	_	16	case	_	_
15	elderly	_	ADJ	JJ	_	16	amod	_	_
16	males	_	NOUN	NNS	_	13	nmod	_	_
17	compared	_	VERB	VBN	_	13	acl	_	_
18	to	_	PRT	TO	_	20	case	_	_
19	younger	_	ADJ	JJ	_	20	amod	_	_
20	males	_	NOUN	NNS	_	17	nmod	_	_
21	,	_	.	,	_	5	punct	_	_
22	while	_	ADP	IN	_	31	mark	_	_
23	the	_	DET	DT	_	24	det	_	_
24	clearance	_	NOUN	NN	_	31	nsubj	_	_
25	in	_	ADP	IN	_	27	case	_	_
26	elderly	_	ADJ	JJ	_	27	amod	_	_
27	females	_	NOUN	NNS	_	24	nmod	_	_
28	was	_	VERB	VBD	_	31	cop	_	_
29	only	_	ADV	RB	_	30	advmod	_	_
30	10%	_	ADJ	JJ	_	31	amod	_	_
31	lower	_	ADJ	JJ	_	5	advcl	_	_
32	compared	_	VERB	VBN	_	31	dep	_	_
33	to	_	PRT	TO	_	35	case	_	_
34	younger	_	ADJ	JJ	_	35	amod	_	_
35	females	_	NOUN	NNS	_	32	nmod	_	_

#	REMERON	3482
1	Caution	_	NOUN	NN	_	3	nsubjpass	_	_
2	is	_	VERB	VBZ	_	3	auxpass	_	_
3	indicated	_	VERB	VBN	_	0	root	_	_
4	in	_	ADP	IN	_	5	mark	_	_
5	administering	_	VERB	VBG	_	3	advcl	_	_
6	DRUG	_	NOUN	NN	_	5	dobj	_	_
7	to	_	PRT	TO	_	9	case	_	_
8	elderly	_	ADJ	JJ	_	9	amod	_	_
9	patients	_	NOUN	NNS	_	5	nmod	_	_

#	REMERON	3483
1	Safety	_	NOUN	NN	_	13	nsubjpass	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	effectiveness	_	NOUN	NN	_	1	conj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	1	nmod	_	_
6	in	_	ADP	IN	_	9	case	_	_
7	the	_	DET	DT	_	9	det	_	_
8	pediatric	_	ADJ	JJ	_	9	amod	_	_
9	population	_	NOUN	NN	_	1	nmod	_	_
10	have	_	VERB	MD	_	13	aux	_	_
11	not	_	ADV	RB	_	13	neg	_	_
12	been	_	VERB	VBN	_	13	auxpass	_	_
13	established	_	VERB	VBN	_	0	root	_	_

#	REMERON	3485
1	There	_	DET	EX	_	6	nsubj	_	_
2	have	_	VERB	VBP	_	6	aux	_	_
3	been	_	VERB	VBN	_	6	cop	_	_
4	no	_	DET	DT	_	6	neg	_	_
5	clinical	_	ADJ	JJ	_	6	amod	_	_
6	studies	_	NOUN	NNS	_	0	root	_	_
7	to	_	PRT	TO	_	8	mark	_	_
8	evaluate	_	VERB	VB	_	6	acl	_	_
9	the	_	DET	DT	_	10	det	_	_
10	effect	_	NOUN	NN	_	8	dobj	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	race	_	NOUN	NN	_	10	nmod	_	_
13	on	_	ADP	IN	_	15	case	_	_
14	the	_	DET	DT	_	15	det	_	_
15	pharmacokinetics	_	NOUN	NNS	_	10	nmod	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	DRUG	_	NOUN	NN	_	15	nmod	_	_

#	REMERON	3486
1	The	_	DET	DT	_	2	det	_	_
2	disposition	_	NOUN	NN	_	6	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	was	_	VERB	VBD	_	6	auxpass	_	_
6	studied	_	VERB	VBN	_	0	root	_	_
7	in	_	ADP	IN	_	8	case	_	_
8	patients	_	NOUN	NNS	_	6	nmod	_	_
9	with	_	ADP	IN	_	11	case	_	_
10	varying	_	ADJ	JJ	_	11	amod	_	_
11	degrees	_	NOUN	NNS	_	8	nmod	_	_
12	of	_	ADP	IN	_	14	case	_	_
13	renal	_	ADJ	JJ	_	14	amod	_	_
14	function	_	NOUN	NN	_	11	nmod	_	_

#	REMERON	3487
1	Elimination	_	NOUN	NN	_	5	nsubjpass	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	is	_	VERB	VBZ	_	5	auxpass	_	_
5	correlated	_	VERB	VBN	_	0	root	_	_
6	with	_	ADP	IN	_	8	case	_	_
7	creatinine	_	NOUN	NN	_	8	compound	_	_
8	clearance	_	NOUN	NN	_	5	nmod	_	_

#	REMERON	3488
1	Total	_	ADJ	JJ	_	3	amod	_	_
2	body	_	NOUN	NN	_	3	compound	_	_
3	clearance	_	NOUN	NN	_	7	nsubjpass	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	was	_	VERB	VBD	_	7	auxpass	_	_
7	reduced	_	VERB	VBN	_	0	root	_	_
8	approximately	_	ADV	RB	_	9	advmod	_	_
9	30%	_	ADJ	JJ	_	7	xcomp	_	_
10	in	_	ADP	IN	_	11	case	_	_
11	patients	_	NOUN	NNS	_	9	nmod	_	_
12	with	_	ADP	IN	_	16	case	_	_
13	moderate	_	ADJ	JJ	_	16	amod	_	_
14	Clcr=11	_	NOUN	NN	_	16	compound	_	_
15	39	_	NUM	CD	_	16	nummod	_	_
16	mL	_	NOUN	NN	_	11	nmod	_	_
17	/	_	.	:	_	7	punct	_	_
18	min	_	NOUN	NN	_	7	dep	_	_
19	/	_	.	:	_	18	punct	_	_
20	1.73	_	NUM	CD	_	21	nummod	_	_
21	m2	_	NOUN	NN	_	18	dep	_	_
22	and	_	CONJ	CC	_	21	cc	_	_
23	approximately	_	ADV	RB	_	24	advmod	_	_
24	50%	_	NOUN	NN	_	21	conj	_	_
25	in	_	ADP	IN	_	26	case	_	_
26	patients	_	NOUN	NNS	_	21	nmod	_	_
27	with	_	ADP	IN	_	37	case	_	_
28	severe	_	ADJ	JJ	_	37	amod	_	_
29	Clcr=<10	_	NOUN	NN	_	37	compound	_	_
30	mL	_	NOUN	NN	_	37	compound	_	_
31	/	_	.	:	_	37	punct	_	_
32	min	_	NOUN	NN	_	37	compound	_	_
33	/	_	.	:	_	37	punct	_	_
34	1.73	_	NUM	CD	_	37	nummod	_	_
35	m2	_	NOUN	NN	_	37	compound	_	_
36	renal	_	ADJ	JJ	_	37	amod	_	_
37	impairment	_	NOUN	NN	_	26	nmod	_	_
38	when	_	ADV	WRB	_	39	advmod	_	_
39	compared	_	VERB	VBN	_	21	acl	_	_
40	to	_	PRT	TO	_	42	case	_	_
41	normal	_	ADJ	JJ	_	42	amod	_	_
42	subjects	_	NOUN	NNS	_	39	nmod	_	_

#	REMERON	3489
1	Caution	_	NOUN	NN	_	3	nsubjpass	_	_
2	is	_	VERB	VBZ	_	3	auxpass	_	_
3	indicated	_	VERB	VBN	_	0	root	_	_
4	in	_	ADP	IN	_	5	mark	_	_
5	administering	_	VERB	VBG	_	3	advcl	_	_
6	DRUG	_	NOUN	NN	_	5	dobj	_	_
7	to	_	PRT	TO	_	8	case	_	_
8	patients	_	NOUN	NNS	_	5	nmod	_	_
9	with	_	ADP	IN	_	12	case	_	_
10	compromised	_	VERB	VBN	_	12	amod	_	_
11	renal	_	ADJ	JJ	_	12	amod	_	_
12	function	_	NOUN	NN	_	8	nmod	_	_

#	REMERON	3490
1	Following	_	ADP	IN	_	7	case	_	_
2	a	_	DET	DT	_	7	det	_	_
3	single	_	ADJ	JJ	_	7	amod	_	_
4	15	_	NUM	CD	_	7	nummod	_	_
5	mg	_	NOUN	NN	_	7	compound	_	_
6	oral	_	ADJ	JJ	_	7	amod	_	_
7	dose	_	NOUN	NN	_	17	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	,	_	.	,	_	17	punct	_	_
11	the	_	DET	DT	_	13	det	_	_
12	oral	_	ADJ	JJ	_	13	amod	_	_
13	clearance	_	NOUN	NN	_	17	nsubjpass	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	DRUG	_	NOUN	NN	_	13	nmod	_	_
16	was	_	VERB	VBD	_	17	auxpass	_	_
17	decreased	_	VERB	VBN	_	0	root	_	_
18	by	_	ADP	IN	_	20	case	_	_
19	approximately	_	ADV	RB	_	20	advmod	_	_
20	30%	_	NOUN	NN	_	17	nmod	_	_
21	in	_	ADP	IN	_	24	case	_	_
22	hepatically	_	ADV	RB	_	23	advmod	_	_
23	impaired	_	ADJ	JJ	_	24	amod	_	_
24	patients	_	NOUN	NNS	_	17	nmod	_	_
25	compared	_	VERB	VBN	_	17	xcomp	_	_
26	to	_	PRT	TO	_	27	case	_	_
27	subjects	_	NOUN	NNS	_	25	nmod	_	_
28	with	_	ADP	IN	_	31	case	_	_
29	normal	_	ADJ	JJ	_	31	amod	_	_
30	hepatic	_	ADJ	JJ	_	31	amod	_	_
31	function	_	NOUN	NN	_	27	nmod	_	_

#	REMERON	3491
1	Caution	_	NOUN	NN	_	3	nsubjpass	_	_
2	is	_	VERB	VBZ	_	3	auxpass	_	_
3	indicated	_	VERB	VBN	_	0	root	_	_
4	in	_	ADP	IN	_	5	mark	_	_
5	administering	_	VERB	VBG	_	3	advcl	_	_
6	DRUG	_	NOUN	NN	_	5	dobj	_	_
7	to	_	PRT	TO	_	8	case	_	_
8	patients	_	NOUN	NNS	_	5	nmod	_	_
9	with	_	ADP	IN	_	12	case	_	_
10	compromised	_	VERB	VBN	_	12	amod	_	_
11	hepatic	_	ADJ	JJ	_	12	amod	_	_
12	function	_	NOUN	NN	_	8	nmod	_	_

#	REMERON	3492
1	The	_	DET	DT	_	2	det	_	_
2	efficacy	_	NOUN	NN	_	15	nsubjpass	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	DRUG	_	NOUN	NN	_	6	compound	_	_
5	DRUG	_	NOUN	NN	_	6	compound	_	_
6	Tablets	_	NOUN	NNS	_	2	nmod	_	_
7	as	_	ADP	IN	_	9	case	_	_
8	a	_	DET	DT	_	9	det	_	_
9	treatment	_	NOUN	NN	_	2	nmod	_	_
10	for	_	ADP	IN	_	13	case	_	_
11	major	_	ADJ	JJ	_	13	amod	_	_
12	depressive	_	ADJ	JJ	_	13	amod	_	_
13	disorder	_	NOUN	NN	_	9	nmod	_	_
14	was	_	VERB	VBD	_	15	auxpass	_	_
15	established	_	VERB	VBN	_	0	root	_	_
16	in	_	ADP	IN	_	18	case	_	_
17	4	_	NUM	CD	_	18	nummod	_	_
18	placebo	_	NOUN	NN	_	15	nmod	_	_
19	controlled	_	VERB	VBN	_	18	acl	_	_
20	,	_	.	,	_	18	punct	_	_
21	6	_	NUM	CD	_	23	nummod	_	_
22	week	_	NOUN	NN	_	23	compound	_	_
23	trials	_	NOUN	NNS	_	18	appos	_	_
24	in	_	ADP	IN	_	26	case	_	_
25	adult	_	ADJ	JJ	_	26	amod	_	_
26	outpatients	_	NOUN	NNS	_	23	nmod	_	_
27	meeting	_	VERB	VBG	_	26	acl	_	_
28	DSM	_	NOUN	NN	_	30	compound	_	_
29	III	_	NUM	CD	_	30	nummod	_	_
30	criteria	_	NOUN	NN	_	27	dobj	_	_
31	for	_	ADP	IN	_	34	case	_	_
32	major	_	ADJ	JJ	_	34	amod	_	_
33	depressive	_	ADJ	JJ	_	34	amod	_	_
34	disorder	_	NOUN	NN	_	30	nmod	_	_

#	REMERON	3493
1	Patients	_	NOUN	NNS	_	3	nsubjpass	_	_
2	were	_	VERB	VBD	_	3	auxpass	_	_
3	titrated	_	VERB	VBN	_	0	root	_	_
4	with	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	from	_	ADP	IN	_	9	case	_	_
7	a	_	DET	DT	_	9	det	_	_
8	dose	_	NOUN	NN	_	9	compound	_	_
9	range	_	NOUN	NN	_	3	nmod	_	_
10	of	_	ADP	IN	_	12	case	_	_
11	5	_	NUM	CD	_	12	nummod	_	_
12	mg	_	NOUN	NN	_	9	nmod	_	_
13	up	_	ADJ	JJ	_	9	advmod	_	_
14	to	_	PRT	TO	_	18	case	_	_
15	35	_	NUM	CD	_	16	nummod	_	_
16	mg	_	NOUN	NN	_	18	compound	_	_
17	/	_	NUM	CD	_	18	punct	_	_
18	day	_	NOUN	NN	_	13	nmod	_	_

#	REMERON	3494
1	Overall	_	ADV	RB	_	5	advmod	_	_
2	,	_	.	,	_	5	punct	_	_
3	these	_	DET	DT	_	4	det	_	_
4	studies	_	NOUN	NNS	_	5	nsubj	_	_
5	demonstrated	_	VERB	VBD	_	0	root	_	_
6	DRUG	_	NOUN	NN	_	5	dobj	_	_
7	to	_	PRT	TO	_	9	mark	_	_
8	be	_	VERB	VB	_	9	cop	_	_
9	superior	_	NOUN	NN	_	5	xcomp	_	_
10	to	_	PRT	TO	_	11	case	_	_
11	placebo	_	NOUN	NN	_	9	nmod	_	_
12	on	_	ADP	IN	_	14	case	_	_
13	at	_	ADP	IN	_	14	case	_	_
14	least	_	ADJ	JJS	_	9	nmod	_	_
15	3	_	NUM	CD	_	14	nummod	_	_
16	of	_	ADP	IN	_	20	case	_	_
17	the	_	DET	DT	_	20	det	_	_
18	following	_	ADP	IN	_	19	advmod	_	_
19	4	_	NUM	CD	_	20	nummod	_	_
20	measures	_	NOUN	NNS	_	14	nmod	_	_
21	:	_	.	:	_	5	punct	_	_
22	21	_	NUM	CD	_	25	nummod	_	_
23	Item	_	NOUN	NN	_	25	compound	_	_
24	Hamilton	_	NOUN	NN	_	25	compound	_	_
25	Depression	_	NOUN	NN	_	32	nsubj	_	_
26	Rating	_	VERB	VBG	_	25	acl	_	_
27	Scale	_	NOUN	NN	_	31	compound	_	_
28	HDRS	_	NOUN	NN	_	31	compound	_	_
29	total	_	ADJ	JJ	_	31	amod	_	_
30	score	_	NOUN	NN	_	31	compound	_	_
31	HDRS	_	NOUN	NN	_	26	dobj	_	_
32	Depressed	_	VERB	VBD	_	5	parataxis	_	_
33	Mood	_	ADJ	JJ	_	37	amod	_	_
34	Item	_	NOUN	NN	_	37	compound	_	_
35	CGI	_	NOUN	NN	_	37	compound	_	_
36	Severity	_	NOUN	NN	_	37	compound	_	_
37	score	_	NOUN	NN	_	32	dobj	_	_
38	and	_	CONJ	CC	_	37	cc	_	_
39	Montgomery	_	NOUN	NN	_	37	conj	_	_
40	and	_	CONJ	CC	_	37	cc	_	_
41	Asberg	_	NOUN	NN	_	42	compound	_	_
42	Depression	_	NOUN	NN	_	37	conj	_	_
43	Rating	_	VERB	VBG	_	42	acl	_	_
44	Scale	_	NOUN	NN	_	45	compound	_	_
45	MADRS	_	NOUN	NN	_	43	dobj	_	_

#	REMERON	3495
1	Superiority	_	NOUN	NN	_	8	nsubjpass	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	over	_	ADP	IN	_	5	case	_	_
5	placebo	_	NOUN	NN	_	1	nmod	_	_
6	was	_	VERB	VBD	_	8	auxpass	_	_
7	also	_	ADV	RB	_	8	advmod	_	_
8	found	_	VERB	VBN	_	0	root	_	_
9	for	_	ADP	IN	_	11	case	_	_
10	certain	_	ADJ	JJ	_	11	amod	_	_
11	factors	_	NOUN	NNS	_	8	nmod	_	_
12	of	_	ADP	IN	_	14	case	_	_
13	the	_	DET	DT	_	14	det	_	_
14	HDRS	_	NOUN	NN	_	11	nmod	_	_
15	,	_	.	,	_	14	punct	_	_
16	including	_	VERB	VBG	_	17	case	_	_
17	anxiety	_	NOUN	NN	_	14	nmod	_	_
18	/	_	.	:	_	17	punct	_	_
19	somatization	_	NOUN	NN	_	20	compound	_	_
20	factor	_	NOUN	NN	_	17	conj	_	_
21	and	_	CONJ	CC	_	17	cc	_	_
22	sleep	_	NOUN	NN	_	24	compound	_	_
23	disturbance	_	NOUN	NN	_	24	compound	_	_
24	factor	_	NOUN	NN	_	17	conj	_	_

#	REMERON	3496
1	The	_	DET	DT	_	4	det	_	_
2	mean	_	ADJ	JJ	_	4	amod	_	_
3	DRUG	_	NOUN	NN	_	4	compound	_	_
4	dose	_	NOUN	NN	_	0	root	_	_
5	for	_	ADP	IN	_	6	case	_	_
6	patients	_	NOUN	NNS	_	4	nmod	_	_
7	who	_	DET	WDT	_	8	nsubj	_	_
8	completed	_	VERB	VBD	_	6	acl:relcl	_	_
9	these	_	DET	DT	_	11	det	_	_
10	4	_	NUM	CD	_	11	nummod	_	_
11	studies	_	NOUN	NNS	_	8	dobj	_	_
12	ranged	_	VERB	VBN	_	11	acl	_	_
13	from	_	ADP	IN	_	19	case	_	_
14	21	_	NUM	CD	_	16	compound	_	_
15	to	_	PRT	TO	_	16	dep	_	_
16	32	_	NUM	CD	_	17	nummod	_	_
17	mg	_	NOUN	NN	_	19	compound	_	_
18	/	_	NUM	CD	_	19	punct	_	_
19	day	_	NOUN	NN	_	12	nmod	_	_

#	REMERON	3497
1	A	_	DET	DT	_	3	det	_	_
2	fifth	_	ADJ	JJ	_	3	amod	_	_
3	study	_	NOUN	NN	_	7	nsubj	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	similar	_	ADJ	JJ	_	6	amod	_	_
6	design	_	NOUN	NN	_	3	nmod	_	_
7	utilized	_	VERB	VBD	_	0	root	_	_
8	a	_	DET	DT	_	10	det	_	_
9	higher	_	ADJ	JJ	_	10	amod	_	_
10	dose	_	NOUN	NN	_	7	dobj	_	_
11	up	_	ADV	RB	_	14	advmod	_	_
12	to	_	PRT	TO	_	14	case	_	_
13	50	_	NUM	CD	_	14	nummod	_	_
14	mg	_	NOUN	NN	_	7	nmod	_	_
15	per	_	ADP	IN	_	16	case	_	_
16	day	_	NOUN	NN	_	14	nmod	_	_
17	and	_	CONJ	CC	_	7	cc	_	_
18	also	_	ADV	RB	_	19	advmod	_	_
19	showed	_	VERB	VBD	_	7	conj	_	_
20	effectiveness	_	NOUN	NN	_	19	dobj	_	_

#	REMERON	3498
1	Examination	_	NOUN	NN	_	12	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	age	_	NOUN	NN	_	1	nmod	_	_
4	and	_	CONJ	CC	_	3	cc	_	_
5	gender	_	NOUN	NN	_	3	conj	_	_
6	subsets	_	NOUN	NNS	_	3	dep	_	_
7	of	_	ADP	IN	_	9	case	_	_
8	the	_	DET	DT	_	9	det	_	_
9	population	_	NOUN	NN	_	3	nmod	_	_
10	did	_	VERB	VBD	_	12	aux	_	_
11	not	_	ADV	RB	_	12	neg	_	_
12	reveal	_	VERB	VB	_	0	root	_	_
13	any	_	DET	DT	_	15	det	_	_
14	differential	_	ADJ	JJ	_	15	amod	_	_
15	responsiveness	_	NOUN	NN	_	12	dobj	_	_
16	on	_	ADP	IN	_	18	case	_	_
17	the	_	DET	DT	_	18	det	_	_
18	basis	_	NOUN	NN	_	12	nmod	_	_
19	of	_	ADP	IN	_	21	case	_	_
20	these	_	DET	DT	_	21	det	_	_
21	subgroupings	_	NOUN	NNS	_	18	nmod	_	_

#	REMERON	3499
1	In	_	ADP	IN	_	5	case	_	_
2	a	_	DET	DT	_	5	det	_	_
3	longer	_	ADJ	JJ	_	5	amod	_	_
4	term	_	NOUN	NN	_	5	compound	_	_
5	study	_	NOUN	NN	_	32	nmod	_	_
6	,	_	.	,	_	32	punct	_	_
7	patients	_	NOUN	NNS	_	32	nsubjpass	_	_
8	meeting	_	VERB	VBG	_	7	acl	_	_
9	DSM	_	NOUN	NN	_	11	compound	_	_
10	IV	_	NUM	CD	_	11	nummod	_	_
11	criteria	_	NOUN	NN	_	8	dobj	_	_
12	for	_	ADP	IN	_	15	case	_	_
13	major	_	ADJ	JJ	_	15	amod	_	_
14	depressive	_	ADJ	JJ	_	15	amod	_	_
15	disorder	_	NOUN	NN	_	8	nmod	_	_
16	who	_	DET	WDT	_	18	nsubj	_	_
17	had	_	VERB	MD	_	18	aux	_	_
18	responded	_	VERB	VBN	_	15	acl:relcl	_	_
19	during	_	ADP	IN	_	25	case	_	_
20	an	_	DET	DT	_	25	det	_	_
21	initial	_	ADJ	JJ	_	25	amod	_	_
22	8	_	NUM	CD	_	24	compound	_	_
23	to	_	PRT	TO	_	24	dep	_	_
24	12	_	NUM	CD	_	25	nummod	_	_
25	weeks	_	NOUN	NNS	_	18	nmod	_	_
26	of	_	ADP	IN	_	28	case	_	_
27	acute	_	ADJ	JJ	_	28	amod	_	_
28	treatment	_	NOUN	NN	_	25	nmod	_	_
29	on	_	ADP	IN	_	30	case	_	_
30	DRUG	_	NOUN	NN	_	25	nmod	_	_
31	were	_	VERB	VBD	_	32	auxpass	_	_
32	randomized	_	VERB	VBN	_	0	root	_	_
33	to	_	PRT	TO	_	34	case	_	_
34	continuation	_	NOUN	NN	_	32	nmod	_	_
35	of	_	ADP	IN	_	36	case	_	_
36	DRUG	_	NOUN	NN	_	34	nmod	_	_
37	or	_	CONJ	CC	_	36	cc	_	_
38	placebo	_	NOUN	NN	_	36	conj	_	_
39	for	_	ADP	IN	_	43	case	_	_
40	up	_	ADJ	JJ	_	42	advmod	_	_
41	to	_	PRT	TO	_	42	dep	_	_
42	40	_	NUM	CD	_	43	nummod	_	_
43	weeks	_	NOUN	NNS	_	34	nmod	_	_
44	of	_	ADP	IN	_	45	case	_	_
45	observation	_	NOUN	NN	_	43	nmod	_	_
46	for	_	ADP	IN	_	47	case	_	_
47	relapse	_	ADP	IN	_	45	nmod	_	_

#	REMERON	3500
1	Response	_	NOUN	NN	_	7	nsubjpass	_	_
2	during	_	ADP	IN	_	5	case	_	_
3	the	_	DET	DT	_	5	det	_	_
4	open	_	ADJ	JJ	_	5	amod	_	_
5	phase	_	NOUN	NN	_	1	nmod	_	_
6	was	_	VERB	VBD	_	7	auxpass	_	_
7	defined	_	VERB	VBN	_	0	root	_	_
8	as	_	ADP	IN	_	9	mark	_	_
9	having	_	VERB	VBG	_	7	advcl	_	_
10	achieved	_	VERB	VBN	_	9	ccomp	_	_
11	a	_	DET	DT	_	16	det	_	_
12	HAM	_	NOUN	NN	_	16	compound	_	_
13	D	_	NOUN	NN	_	16	compound	_	_
14	17	_	NUM	CD	_	16	nummod	_	_
15	total	_	ADJ	JJ	_	16	amod	_	_
16	score	_	NOUN	NN	_	10	dobj	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	<8	_	NUM	CD	_	16	nmod	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	a	_	DET	DT	_	23	det	_	_
21	CGI	_	NOUN	NN	_	23	compound	_	_
22	Improvement	_	NOUN	NN	_	23	compound	_	_
23	score	_	NOUN	NN	_	18	conj	_	_
24	of	_	ADP	IN	_	25	case	_	_
25	1	_	NUM	CD	_	18	nmod	_	_
26	or	_	CONJ	CC	_	18	cc	_	_
27	2	_	NUM	CD	_	18	conj	_	_
28	at	_	ADP	IN	_	31	case	_	_
29	2	_	NUM	CD	_	31	nummod	_	_
30	consecutive	_	ADJ	JJ	_	31	amod	_	_
31	visits	_	NOUN	NNS	_	10	nmod	_	_
32	beginning	_	VERB	VBG	_	31	acl	_	_
33	with	_	ADP	IN	_	34	case	_	_
34	week	_	NOUN	NN	_	32	nmod	_	_
35	6	_	NUM	CD	_	34	nummod	_	_
36	of	_	ADP	IN	_	41	case	_	_
37	the	_	DET	DT	_	41	det	_	_
38	8	_	NUM	CD	_	40	compound	_	_
39	to	_	PRT	TO	_	40	dep	_	_
40	12	_	NUM	CD	_	41	nummod	_	_
41	weeks	_	NOUN	NNS	_	34	nmod	_	_
42	in	_	ADP	IN	_	46	case	_	_
43	the	_	DET	DT	_	46	det	_	_
44	open	_	ADJ	JJ	_	46	amod	_	_
45	label	_	NOUN	NN	_	46	compound	_	_
46	phase	_	NOUN	NN	_	41	nmod	_	_
47	of	_	ADP	IN	_	49	case	_	_
48	the	_	DET	DT	_	49	det	_	_
49	study	_	NOUN	NN	_	46	nmod	_	_

#	REMERON	3501
1	Relapse	_	NOUN	NN	_	8	nsubjpass	_	_
2	during	_	ADP	IN	_	6	case	_	_
3	the	_	DET	DT	_	6	det	_	_
4	double	_	ADJ	JJ	_	6	amod	_	_
5	blind	_	NOUN	NN	_	6	compound	_	_
6	phase	_	NOUN	NN	_	1	nmod	_	_
7	was	_	VERB	VBD	_	8	auxpass	_	_
8	determined	_	VERB	VBN	_	0	root	_	_
9	by	_	ADP	IN	_	12	case	_	_
10	the	_	DET	DT	_	12	det	_	_
11	individual	_	ADJ	JJ	_	12	amod	_	_
12	investigators	_	NOUN	NNS	_	8	nmod	_	_

#	REMERON	3502
1	Patients	_	NOUN	NNS	_	6	nsubj	_	_
2	receiving	_	VERB	VBG	_	1	acl	_	_
3	continued	_	VERB	VBN	_	5	amod	_	_
4	DRUG	_	NOUN	NN	_	5	compound	_	_
5	treatment	_	NOUN	NN	_	2	dobj	_	_
6	experienced	_	VERB	VBN	_	0	root	_	_
7	significantly	_	ADV	RB	_	8	advmod	_	_
8	lower	_	ADJ	JJ	_	10	amod	_	_
9	relapse	_	ADJ	JJ	_	10	amod	_	_
10	rates	_	NOUN	NNS	_	6	dobj	_	_
11	over	_	ADP	IN	_	15	case	_	_
12	the	_	DET	DT	_	15	det	_	_
13	subsequent	_	ADJ	JJ	_	15	amod	_	_
14	40	_	NUM	CD	_	15	nummod	_	_
15	weeks	_	NOUN	NNS	_	6	nmod	_	_
16	compared	_	VERB	VBN	_	6	xcomp	_	_
17	to	_	PRT	TO	_	18	case	_	_
18	those	_	DET	DT	_	16	nmod	_	_
19	receiving	_	VERB	VBG	_	18	acl	_	_
20	placebo	_	NOUN	NN	_	19	nmod	_	_

#	REMERON	3503
1	This	_	DET	DT	_	2	det	_	_
2	pattern	_	NOUN	NN	_	4	nsubjpass	_	_
3	was	_	VERB	VBD	_	4	auxpass	_	_
4	demonstrated	_	VERB	VBN	_	0	root	_	_
5	in	_	ADP	IN	_	7	case	_	_
6	both	_	CONJ	CC	_	7	cc:preconj	_	_
7	male	_	ADJ	JJ	_	4	nmod	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	female	_	ADJ	JJ	_	7	conj	_	_
10	patients	_	NOUN	NNS	_	7	dep	_	_

#	Rifampin	997
1	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
2	is	_	VERB	VBZ	_	4	auxpass	_	_
3	readily	_	ADV	RB	_	4	advmod	_	_
4	absorbed	_	VERB	VBN	_	0	root	_	_
5	from	_	ADP	IN	_	8	case	_	_
6	the	_	DET	DT	_	8	det	_	_
7	gastrointestinal	_	ADJ	JJ	_	8	amod	_	_
8	tract	_	NOUN	NN	_	4	nmod	_	_

#	Rifampin	998
1	Peak	_	ADJ	JJ	_	3	amod	_	_
2	serum	_	NOUN	NN	_	3	compound	_	_
3	concentrations	_	NOUN	NNS	_	10	nsubj	_	_
4	in	_	ADP	IN	_	6	case	_	_
5	healthy	_	ADJ	JJ	_	6	amod	_	_
6	adults	_	NOUN	NNS	_	3	nmod	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	pediatric	_	ADJ	JJ	_	9	amod	_	_
9	populations	_	NOUN	NNS	_	6	conj	_	_
10	vary	_	VERB	VBP	_	0	root	_	_
11	widely	_	ADV	RB	_	10	advmod	_	_
12	from	_	ADP	IN	_	13	case	_	_
13	individual	_	ADJ	JJ	_	10	nmod	_	_
14	to	_	PRT	TO	_	15	case	_	_
15	individual	_	ADJ	JJ	_	13	nmod	_	_

#	Rifampin	999
1	Following	_	ADP	IN	_	7	case	_	_
2	a	_	DET	DT	_	7	det	_	_
3	single	_	ADJ	JJ	_	7	amod	_	_
4	600	_	NUM	CD	_	7	nummod	_	_
5	mg	_	NOUN	NN	_	7	compound	_	_
6	oral	_	ADJ	JJ	_	7	amod	_	_
7	dose	_	NOUN	NN	_	18	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	in	_	ADP	IN	_	12	case	_	_
11	healthy	_	ADJ	JJ	_	12	amod	_	_
12	adults	_	NOUN	NNS	_	7	nmod	_	_
13	,	_	.	,	_	18	punct	_	_
14	the	_	DET	DT	_	17	det	_	_
15	peak	_	ADJ	JJ	_	17	amod	_	_
16	serum	_	NOUN	NN	_	17	compound	_	_
17	concentration	_	NOUN	NN	_	18	nsubj	_	_
18	averages	_	VERB	VBZ	_	0	root	_	_
19	7	_	NUM	CD	_	20	nummod	_	_
20	mcg	_	NOUN	NN	_	18	dobj	_	_
21	/	_	.	:	_	20	punct	_	_
22	mL	_	NOUN	NN	_	20	dep	_	_
23	but	_	CONJ	CC	_	18	cc	_	_
24	may	_	VERB	MD	_	25	aux	_	_
25	vary	_	VERB	VB	_	18	conj	_	_
26	from	_	ADP	IN	_	30	case	_	_
27	4	_	NUM	CD	_	29	compound	_	_
28	to	_	PRT	TO	_	29	dep	_	_
29	32	_	NUM	CD	_	30	nummod	_	_
30	mcg	_	NOUN	NN	_	25	nmod	_	_
31	/	_	.	:	_	30	punct	_	_
32	mL	_	NOUN	NN	_	30	dep	_	_

#	Rifampin	1000
1	Absorption	_	NOUN	NN	_	5	nsubjpass	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	is	_	VERB	VBZ	_	5	auxpass	_	_
5	reduced	_	VERB	VBN	_	0	root	_	_
6	by	_	ADP	IN	_	8	case	_	_
7	about	_	ADV	RB	_	8	advmod	_	_
8	30%	_	NOUN	NN	_	5	nmod	_	_
9	when	_	ADV	WRB	_	13	advmod	_	_
10	the	_	DET	DT	_	11	det	_	_
11	drug	_	NOUN	NN	_	13	nsubjpass	_	_
12	is	_	VERB	VBZ	_	13	auxpass	_	_
13	ingested	_	VERB	VBN	_	5	advcl	_	_
14	with	_	ADP	IN	_	15	case	_	_
15	food	_	NOUN	NN	_	13	nmod	_	_

#	Rifampin	1001
1	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
2	is	_	VERB	VBZ	_	4	auxpass	_	_
3	widely	_	ADV	RB	_	4	advmod	_	_
4	distributed	_	VERB	VBN	_	0	root	_	_
5	throughout	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	body	_	NOUN	NN	_	4	nmod	_	_

#	Rifampin	1002
1	It	_	PRON	PRP	_	3	nsubj	_	_
2	is	_	VERB	VBZ	_	3	cop	_	_
3	present	_	ADJ	JJ	_	0	root	_	_
4	in	_	ADP	IN	_	6	case	_	_
5	effective	_	ADJ	JJ	_	6	amod	_	_
6	concentrations	_	NOUN	NNS	_	3	nmod	_	_
7	in	_	ADP	IN	_	9	case	_	_
8	many	_	ADJ	JJ	_	9	amod	_	_
9	organs	_	NOUN	NNS	_	6	nmod	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	body	_	NOUN	NN	_	12	compound	_	_
12	fluids	_	NOUN	NNS	_	9	conj	_	_
13	,	_	.	,	_	6	punct	_	_
14	including	_	VERB	VBG	_	16	case	_	_
15	cerebrospinal	_	ADJ	JJ	_	16	amod	_	_
16	fluid	_	NOUN	NN	_	6	nmod	_	_

#	Rifampin	1003
1	Most	_	NOUN	NN	_	8	nsubjpass	_	_
2	of	_	ADP	IN	_	5	case	_	_
3	the	_	DET	DT	_	5	det	_	_
4	unbound	_	ADJ	JJ	_	5	amod	_	_
5	fraction	_	NOUN	NN	_	1	nmod	_	_
6	is	_	VERB	VBZ	_	8	auxpass	_	_
7	not	_	ADV	RB	_	8	neg	_	_
8	ionized	_	VERB	VBN	_	0	root	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	,	_	.	,	_	8	punct	_	_
11	therefore	_	ADV	RB	_	8	advmod	_	_
12	,	_	.	,	_	8	punct	_	_
13	diffuses	_	VERB	VBZ	_	8	conj	_	_
14	freely	_	ADV	RB	_	13	advmod	_	_
15	into	_	ADP	IN	_	16	case	_	_
16	tissues	_	NOUN	NNS	_	13	nmod	_	_

#	Rifampin	1004
1	In	_	ADP	IN	_	3	case	_	_
2	healthy	_	ADJ	JJ	_	3	amod	_	_
3	adults	_	NOUN	NNS	_	14	nmod	_	_
4	,	_	.	,	_	14	punct	_	_
5	the	_	DET	DT	_	9	det	_	_
6	mean	_	ADJ	JJ	_	9	amod	_	_
7	biological	_	ADJ	JJ	_	9	amod	_	_
8	half	_	NOUN	NN	_	9	amod	_	_
9	life	_	NOUN	NN	_	14	nsubj	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_
12	in	_	ADP	IN	_	13	case	_	_
13	serum	_	NOUN	NN	_	9	nmod	_	_
14	averages	_	VERB	VBZ	_	0	root	_	_
15	3.35	_	NUM	CD	_	17	compound	_	_
16	*	_	ADJ	JJ	_	17	advmod	_	_
17	0.66	_	NUM	CD	_	18	nummod	_	_
18	hours	_	NOUN	NNS	_	14	dobj	_	_
19	after	_	ADP	IN	_	24	case	_	_
20	a	_	DET	DT	_	24	det	_	_
21	600	_	NUM	CD	_	24	nummod	_	_
22	mg	_	NOUN	NN	_	24	compound	_	_
23	oral	_	ADJ	JJ	_	24	amod	_	_
24	dose	_	NOUN	NN	_	14	nmod	_	_
25	,	_	.	,	_	14	punct	_	_
26	with	_	ADP	IN	_	27	case	_	_
27	increases	_	NOUN	NNS	_	14	nmod	_	_
28	up	_	ADJ	JJ	_	30	advmod	_	_
29	to	_	PRT	TO	_	28	mwe	_	_
30	5.08	_	NUM	CD	_	33	nummod	_	_
31	*	_	ADJ	JJ	_	32	advmod	_	_
32	2.45	_	NUM	CD	_	33	nummod	_	_
33	hours	_	NOUN	NNS	_	27	nmod	_	_
34	reported	_	VERB	VBN	_	33	acl	_	_
35	after	_	ADP	IN	_	39	case	_	_
36	a	_	DET	DT	_	39	det	_	_
37	900	_	NUM	CD	_	39	nummod	_	_
38	mg	_	NOUN	NN	_	39	compound	_	_
39	dose	_	NOUN	NN	_	34	nmod	_	_

#	Rifampin	1005
1	With	_	ADP	IN	_	3	case	_	_
2	repeated	_	VERB	VBN	_	3	amod	_	_
3	administration	_	NOUN	NN	_	0	root	_	_
4	,	_	.	,	_	3	punct	_	_
5	the	_	DET	DT	_	8	det	_	_
6	half	_	ADJ	JJ	_	8	amod	_	_
7	life	_	NOUN	NN	_	8	compound	_	_
8	decreases	_	NOUN	NNS	_	4	root	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	reaches	_	VERB	VBZ	_	8	conj	_	_
11	average	_	ADJ	JJ	_	12	amod	_	_
12	values	_	NOUN	NNS	_	10	dobj	_	_
13	of	_	ADP	IN	_	18	case	_	_
14	approximately	_	ADV	RB	_	15	advmod	_	_
15	2	_	NUM	CD	_	17	compound	_	_
16	to	_	PRT	TO	_	17	dep	_	_
17	3	_	NUM	CD	_	18	nummod	_	_
18	hours	_	NOUN	NNS	_	12	nmod	_	_

#	Rifampin	1006
1	The	_	DET	DT	_	3	det	_	_
2	half	_	ADJ	JJ	_	3	amod	_	_
3	life	_	NOUN	NN	_	6	nsubj	_	_
4	does	_	VERB	VBZ	_	6	aux	_	_
5	not	_	ADV	RB	_	6	neg	_	_
6	differ	_	VERB	VB	_	0	root	_	_
7	in	_	ADP	IN	_	8	case	_	_
8	patients	_	NOUN	NNS	_	6	nmod	_	_
9	with	_	ADP	IN	_	11	case	_	_
10	renal	_	ADJ	JJ	_	11	amod	_	_
11	failure	_	NOUN	NN	_	8	nmod	_	_
12	at	_	ADP	IN	_	13	case	_	_
13	doses	_	NOUN	NNS	_	8	nmod	_	_
14	not	_	ADV	RB	_	15	neg	_	_
15	exceeding	_	VERB	VBG	_	13	acl	_	_
16	600	_	NUM	CD	_	17	nummod	_	_
17	mg	_	NOUN	NN	_	15	dobj	_	_
18	daily	_	ADV	RB	_	15	advmod	_	_
19	,	_	.	,	_	6	punct	_	_
20	and	_	CONJ	CC	_	6	cc	_	_
21	consequently	_	ADV	RB	_	27	advmod	_	_
22	,	_	.	,	_	27	punct	_	_
23	no	_	DET	DT	_	25	neg	_	_
24	dosage	_	NOUN	NN	_	25	compound	_	_
25	adjustment	_	NOUN	NN	_	27	nsubjpass	_	_
26	is	_	VERB	VBZ	_	27	auxpass	_	_
27	required	_	VERB	VBN	_	6	root	_	_

#	Rifampin	1007
1	The	_	DET	DT	_	3	det	_	_
2	half	_	ADJ	JJ	_	3	amod	_	_
3	life	_	NOUN	NN	_	16	nsubjpass	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	at	_	ADP	IN	_	8	case	_	_
7	a	_	DET	DT	_	8	det	_	_
8	dose	_	NOUN	NN	_	3	nmod	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	720	_	NUM	CD	_	11	nummod	_	_
11	mg	_	NOUN	NN	_	8	nmod	_	_
12	daily	_	ADV	RB	_	16	advmod	_	_
13	has	_	VERB	VBZ	_	16	aux	_	_
14	not	_	ADV	RB	_	16	neg	_	_
15	been	_	VERB	VBN	_	16	auxpass	_	_
16	established	_	VERB	VBN	_	0	root	_	_
17	in	_	ADP	IN	_	18	case	_	_
18	patients	_	NOUN	NNS	_	16	nmod	_	_
19	with	_	ADP	IN	_	21	case	_	_
20	renal	_	ADJ	JJ	_	21	amod	_	_
21	failure	_	NOUN	NN	_	18	nmod	_	_

#	Rifampin	1008
1	Following	_	ADP	IN	_	7	case	_	_
2	a	_	DET	DT	_	7	det	_	_
3	single	_	ADJ	JJ	_	7	amod	_	_
4	900	_	NUM	CD	_	7	nummod	_	_
5	mg	_	NOUN	NN	_	7	compound	_	_
6	oral	_	ADJ	JJ	_	7	amod	_	_
7	dose	_	NOUN	NN	_	23	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	in	_	ADP	IN	_	11	case	_	_
11	patients	_	NOUN	NNS	_	7	nmod	_	_
12	with	_	ADP	IN	_	14	case	_	_
13	varying	_	VERB	VBG	_	14	amod	_	_
14	degrees	_	NOUN	NNS	_	11	nmod	_	_
15	of	_	ADP	IN	_	17	case	_	_
16	renal	_	ADJ	JJ	_	17	amod	_	_
17	insufficiency	_	NOUN	NN	_	14	nmod	_	_
18	,	_	.	,	_	23	punct	_	_
19	the	_	DET	DT	_	22	det	_	_
20	mean	_	NOUN	NN	_	22	compound	_	_
21	half	_	NOUN	NN	_	22	compound	_	_
22	life	_	NOUN	NN	_	23	nsubj	_	_
23	increased	_	VERB	VBD	_	0	root	_	_
24	from	_	ADP	IN	_	26	case	_	_
25	3.6	_	NUM	CD	_	26	nummod	_	_
26	hours	_	NOUN	NNS	_	23	nmod	_	_
27	in	_	ADP	IN	_	29	case	_	_
28	healthy	_	ADJ	JJ	_	29	amod	_	_
29	adults	_	NOUN	NNS	_	26	nmod	_	_
30	to	_	PRT	TO	_	31	case	_	_
31	5	_	NUM	CD	_	29	nmod	_	_
32	,	_	.	,	_	31	punct	_	_
33	7.3	_	NUM	CD	_	31	conj	_	_
34	,	_	.	,	_	31	punct	_	_
35	and	_	CONJ	CC	_	31	cc	_	_
36	11	_	NUM	CD	_	31	conj	_	_
37	hours	_	NOUN	NNS	_	31	dep	_	_
38	in	_	ADP	IN	_	39	case	_	_
39	patients	_	NOUN	NNS	_	29	nmod	_	_
40	with	_	ADP	IN	_	43	case	_	_
41	glomerular	_	ADJ	JJ	_	43	amod	_	_
42	filtration	_	NOUN	NN	_	43	compound	_	_
43	rates	_	NOUN	NNS	_	39	nmod	_	_
44	of	_	ADP	IN	_	48	case	_	_
45	30	_	NUM	CD	_	47	compound	_	_
46	to	_	PRT	TO	_	47	dep	_	_
47	50	_	NUM	CD	_	48	nummod	_	_
48	mL	_	NOUN	NN	_	43	nmod	_	_
49	/	_	.	:	_	23	punct	_	_
50	min	_	NOUN	NN	_	23	parataxis	_	_
51	,	_	.	,	_	50	punct	_	_
52	less	_	ADV	RB	_	54	advmod	_	_
53	than	_	ADP	IN	_	52	mwe	_	_
54	30	_	NUM	CD	_	55	nummod	_	_
55	mL	_	NOUN	NN	_	50	nmod	_	_
56	/	_	.	:	_	50	punct	_	_
57	min	_	NOUN	NN	_	50	dep	_	_
58	,	_	.	,	_	57	punct	_	_
59	and	_	CONJ	CC	_	57	cc	_	_
60	in	_	ADP	IN	_	62	case	_	_
61	anuric	_	ADJ	JJ	_	62	amod	_	_
62	patients	_	NOUN	NNS	_	57	conj	_	_
63	,	_	.	,	_	57	punct	_	_
64	respectively	_	ADV	RB	_	57	advmod	_	_

#	Rifampin	1009
1	Refer	_	ADV	RB	_	5	case	_	_
2	to	_	PRT	TO	_	1	mwe	_	_
3	the	_	DET	DT	_	5	det	_	_
4	WARNINGS	_	NOUN	NN	_	5	compound	_	_
5	section	_	NOUN	NN	_	0	root	_	_
6	for	_	ADP	IN	_	7	case	_	_
7	information	_	NOUN	NN	_	5	nmod	_	_
8	regarding	_	VERB	VBG	_	9	case	_	_
9	patients	_	NOUN	NNS	_	7	nmod	_	_
10	with	_	ADP	IN	_	12	case	_	_
11	hepatic	_	ADJ	JJ	_	12	amod	_	_
12	insufficiency	_	NOUN	NN	_	9	nmod	_	_

#	Rifampin	1010
1	After	_	ADP	IN	_	2	case	_	_
2	absorption	_	NOUN	NN	_	7	nmod	_	_
3	,	_	.	,	_	7	punct	_	_
4	DRUG	_	NOUN	NN	_	7	nsubjpass	_	_
5	is	_	VERB	VBZ	_	7	auxpass	_	_
6	rapidly	_	ADV	RB	_	7	advmod	_	_
7	eliminated	_	VERB	VBN	_	0	root	_	_
8	in	_	ADP	IN	_	10	case	_	_
9	the	_	DET	DT	_	10	det	_	_
10	bile	_	ADJ	JJ	_	7	nmod	_	_
11	,	_	.	,	_	7	punct	_	_
12	and	_	CONJ	CC	_	7	cc	_	_
13	an	_	DET	DT	_	16	det	_	_
14	enterohepatic	_	ADJ	JJ	_	16	amod	_	_
15	circulation	_	NOUN	NN	_	16	compound	_	_
16	ensues	_	NOUN	NNS	_	7	conj	_	_

#	Rifampin	1011
1	During	_	ADP	IN	_	3	case	_	_
2	this	_	DET	DT	_	3	det	_	_
3	process	_	NOUN	NN	_	6	nmod	_	_
4	,	_	.	,	_	6	punct	_	_
5	DRUG	_	NOUN	NN	_	6	nsubj	_	_
6	undergoes	_	VERB	VBZ	_	0	root	_	_
7	progressive	_	ADJ	JJ	_	8	amod	_	_
8	deacetylation	_	NOUN	NN	_	6	dobj	_	_
9	so	_	ADV	RB	_	6	advmod	_	_
10	that	_	ADP	IN	_	21	mark	_	_
11	nearly	_	ADV	RB	_	12	advmod	_	_
12	all	_	CONJ	CC	_	14	cc:preconj	_	_
13	the	_	DET	DT	_	14	det	_	_
14	drug	_	NOUN	NN	_	21	nsubj	_	_
15	in	_	ADP	IN	_	17	case	_	_
16	the	_	DET	DT	_	17	det	_	_
17	bile	_	ADJ	JJ	_	14	nmod	_	_
18	is	_	VERB	VBZ	_	21	cop	_	_
19	in	_	ADP	IN	_	21	case	_	_
20	this	_	DET	DT	_	21	det	_	_
21	form	_	NOUN	NN	_	6	ccomp	_	_
22	in	_	ADP	IN	_	25	case	_	_
23	about	_	ADV	RB	_	24	advmod	_	_
24	6	_	NUM	CD	_	25	nummod	_	_
25	hours	_	NOUN	NNS	_	21	nmod	_	_

#	Rifampin	1012
1	This	_	DET	DT	_	2	det	_	_
2	metabolite	_	NOUN	NN	_	3	nsubj	_	_
3	has	_	VERB	VBZ	_	0	root	_	_
4	antibacterial	_	ADJ	JJ	_	5	amod	_	_
5	activity	_	NOUN	NN	_	3	dobj	_	_

#	Rifampin	1013
1	Intestinal	_	ADJ	JJ	_	2	amod	_	_
2	reabsorption	_	NOUN	NN	_	4	nsubjpass	_	_
3	is	_	VERB	VBZ	_	4	auxpass	_	_
4	reduced	_	VERB	VBN	_	0	root	_	_
5	by	_	ADP	IN	_	6	case	_	_
6	deacetylation	_	NOUN	NN	_	4	nmod	_	_
7	,	_	.	,	_	4	punct	_	_
8	and	_	CONJ	CC	_	4	cc	_	_
9	elimination	_	NOUN	NN	_	11	nsubjpass	_	_
10	is	_	VERB	VBZ	_	11	auxpass	_	_
11	facilitated	_	VERB	VBN	_	4	conj	_	_

#	Rifampin	1014
1	Up	_	ADV	RB	_	8	nsubjpass	_	_
2	to	_	PRT	TO	_	3	case	_	_
3	30%	_	NOUN	NN	_	1	nmod	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	a	_	DET	DT	_	6	det	_	_
6	dose	_	NOUN	NN	_	3	nmod	_	_
7	is	_	VERB	VBZ	_	8	auxpass	_	_
8	excreted	_	VERB	VBN	_	0	root	_	_
9	in	_	ADP	IN	_	11	case	_	_
10	the	_	DET	DT	_	11	det	_	_
11	urine	_	ADJ	JJ	_	8	nmod	_	_
12	,	_	.	,	_	8	punct	_	_
13	with	_	ADP	IN	_	15	case	_	_
14	about	_	ADV	RB	_	15	advmod	_	_
15	half	_	NOUN	NN	_	8	nmod	_	_
16	of	_	ADP	IN	_	20	case	_	_
17	this	_	DET	DT	_	20	nsubj	_	_
18	being	_	VERB	VBD	_	20	cop	_	_
19	unchanged	_	ADJ	JJ	_	20	amod	_	_
20	drug	_	NOUN	NN	_	15	nmod	_	_

#	Rifampin	1015
1	In	_	ADP	IN	_	3	case	_	_
2	one	_	NUM	CD	_	3	nummod	_	_
3	study	_	NOUN	NN	_	13	nmod	_	_
4	,	_	.	,	_	13	punct	_	_
5	pediatric	_	ADJ	JJ	_	6	amod	_	_
6	patients	_	NOUN	NNS	_	13	nsubjpass	_	_
7	6	_	NUM	CD	_	9	compound	_	_
8	to	_	PRT	TO	_	9	dep	_	_
9	58	_	NUM	CD	_	10	nummod	_	_
10	months	_	NOUN	NNS	_	6	nmod	_	_
11	old	_	ADV	RB	_	10	advmod	_	_
12	were	_	VERB	VBD	_	13	auxpass	_	_
13	given	_	VERB	VBN	_	0	root	_	_
14	DRUG	_	NOUN	NN	_	13	dobj	_	_
15	suspended	_	VERB	VBD	_	13	parataxis	_	_
16	in	_	ADP	IN	_	18	case	_	_
17	simple	_	ADJ	JJ	_	18	amod	_	_
18	syrup	_	NOUN	NN	_	15	nmod	_	_
19	or	_	CONJ	CC	_	18	cc	_	_
20	as	_	ADP	IN	_	22	case	_	_
21	dry	_	NOUN	NN	_	22	compound	_	_
22	powder	_	NOUN	NN	_	18	conj	_	_
23	mixed	_	VERB	VBN	_	22	acl	_	_
24	with	_	ADP	IN	_	25	case	_	_
25	applesauce	_	NOUN	NN	_	23	nmod	_	_
26	at	_	ADP	IN	_	28	case	_	_
27	a	_	DET	DT	_	28	det	_	_
28	dose	_	NOUN	NN	_	25	nmod	_	_
29	of	_	ADP	IN	_	31	case	_	_
30	10	_	NUM	CD	_	31	nummod	_	_
31	mg	_	NOUN	NN	_	28	nmod	_	_
32	/	_	.	:	_	35	punct	_	_
33	kg	_	NOUN	NN	_	35	compound	_	_
34	body	_	NOUN	NN	_	35	compound	_	_
35	weight	_	NOUN	NN	_	15	nmod	_	_

#	Rifampin	1016
1	Peak	_	ADJ	JJ	_	3	amod	_	_
2	serum	_	NOUN	NN	_	3	compound	_	_
3	concentrations	_	NOUN	NNS	_	0	root	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	10.7	_	NUM	CD	_	7	nummod	_	_
6	*	_	ADJ	JJ	_	7	advmod	_	_
7	3.7	_	NUM	CD	_	3	nmod	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	11.5	_	NUM	CD	_	7	conj	_	_
10	*	_	ADJ	JJ	_	9	cc	_	_
11	5.1	_	NUM	CD	_	9	conj	_	_
12	mcg	_	NOUN	NN	_	7	dep	_	_
13	/	_	.	:	_	3	punct	_	_
14	mL	_	NOUN	NN	_	16	nsubjpass	_	_
15	were	_	VERB	VBD	_	16	auxpass	_	_
16	obtained	_	VERB	VBN	_	3	dep	_	_
17	1	_	NUM	CD	_	18	nummod	_	_
18	hour	_	NUM	CD	_	16	dobj	_	_
19	after	_	ADP	IN	_	21	case	_	_
20	preprandial	_	ADJ	JJ	_	21	amod	_	_
21	ingestion	_	NOUN	NN	_	16	nmod	_	_
22	of	_	ADP	IN	_	25	case	_	_
23	the	_	DET	DT	_	25	det	_	_
24	drug	_	NOUN	NN	_	25	compound	_	_
25	suspension	_	NOUN	NN	_	21	nmod	_	_
26	and	_	CONJ	CC	_	21	cc	_	_
27	the	_	DET	DT	_	29	det	_	_
28	applesauce	_	NOUN	NN	_	29	compound	_	_
29	mixture	_	NOUN	NN	_	21	conj	_	_
30	,	_	.	,	_	16	punct	_	_
31	respectively	_	ADV	RB	_	16	advmod	_	_

#	Rifampin	1017
1	After	_	ADP	IN	_	3	case	_	_
2	the	_	DET	DT	_	3	det	_	_
3	administration	_	NOUN	NN	_	14	nmod	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	either	_	CONJ	CC	_	6	det	_	_
6	preparation	_	NOUN	NN	_	3	nmod	_	_
7	,	_	.	,	_	14	punct	_	_
8	the	_	DET	DT	_	11	det	_	_
9	t1	_	NUM	CD	_	11	nummod	_	_
10	/	_	NUM	CD	_	11	punct	_	_
11	2	_	NUM	CD	_	14	nsubj	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	DRUG	_	NOUN	NN	_	11	nmod	_	_
14	averaged	_	VERB	VBD	_	0	root	_	_
15	2.9	_	NUM	CD	_	16	nummod	_	_
16	hours	_	NOUN	NNS	_	14	dobj	_	_

#	Rifampin	1018
1	It	_	PRON	PRP	_	4	nsubjpass	_	_
2	should	_	VERB	MD	_	4	aux	_	_
3	be	_	VERB	VB	_	4	auxpass	_	_
4	noted	_	VERB	VBN	_	0	root	_	_
5	that	_	ADP	IN	_	4	root	_	_
6	in	_	ADP	IN	_	8	case	_	_
7	other	_	ADJ	JJ	_	8	amod	_	_
8	studies	_	NOUN	NNS	_	5	root	_	_
9	in	_	ADP	IN	_	11	case	_	_
10	pediatric	_	ADJ	JJ	_	11	amod	_	_
11	populations	_	NOUN	NNS	_	8	nmod	_	_
12	,	_	.	,	_	8	punct	_	_
13	at	_	ADP	IN	_	14	case	_	_
14	doses	_	NOUN	NNS	_	12	root	_	_
15	of	_	ADP	IN	_	17	case	_	_
16	10	_	NUM	CD	_	17	nummod	_	_
17	mg	_	NOUN	NN	_	14	nmod	_	_
18	/	_	.	:	_	21	punct	_	_
19	kg	_	NOUN	NN	_	21	compound	_	_
20	body	_	NOUN	NN	_	21	compound	_	_
21	weight	_	NOUN	NN	_	14	punct	_	_
22	,	_	.	,	_	21	punct	_	_
23	mean	_	ADJ	JJ	_	26	compound	_	_
24	peak	_	ADJ	JJ	_	26	amod	_	_
25	serum	_	NOUN	NN	_	26	compound	_	_
26	concentrations	_	NOUN	NNS	_	21	appos	_	_
27	of	_	ADP	IN	_	29	case	_	_
28	3.5	_	NUM	CD	_	29	nummod	_	_
29	mcg	_	NOUN	NN	_	26	nmod	_	_
30	/	_	.	:	_	21	punct	_	_
31	mL	_	NOUN	NN	_	39	nsubjpass	_	_
32	to	_	PRT	TO	_	36	case	_	_
33	15	_	NUM	CD	_	34	nummod	_	_
34	mcg	_	NOUN	NN	_	36	compound	_	_
35	/	_	.	:	_	36	punct	_	_
36	mL	_	NOUN	NN	_	31	nmod	_	_
37	have	_	VERB	VBP	_	39	aux	_	_
38	been	_	VERB	VBN	_	39	auxpass	_	_
39	reported	_	VERB	VBN	_	21	dep	_	_

#	Rifampin	1019
1	Mechanism	_	NOUN	NN	_	5	nsubj	_	_
2	of	_	ADP	IN	_	4	case	_	_
3	Action	_	NOUN	NN	_	4	compound	_	_
4	DRUG	_	NOUN	NN	_	1	nmod	_	_
5	inhibits	_	VERB	VBZ	_	0	root	_	_
6	DNA	_	NOUN	NN	_	10	compound	_	_
7	dependent	_	ADJ	JJ	_	10	amod	_	_
8	RNA	_	NOUN	NN	_	10	compound	_	_
9	polymerase	_	NOUN	NN	_	10	compound	_	_
10	activity	_	NOUN	NN	_	5	dobj	_	_
11	in	_	ADP	IN	_	15	case	_	_
12	susceptible	_	ADJ	JJ	_	15	amod	_	_
13	Mycobacterium	_	NOUN	NN	_	15	compound	_	_
14	tuberculosis	_	NOUN	NN	_	15	compound	_	_
15	organisms	_	NOUN	NNS	_	10	nmod	_	_

#	Rifampin	1020
1	Specifically	_	ADV	RB	_	4	advmod	_	_
2	,	_	.	,	_	4	punct	_	_
3	it	_	PRON	PRP	_	4	nsubj	_	_
4	interacts	_	VERB	VBZ	_	0	root	_	_
5	with	_	ADP	IN	_	8	case	_	_
6	bacterial	_	ADJ	JJ	_	8	amod	_	_
7	RNA	_	NOUN	NN	_	8	compound	_	_
8	polymerase	_	NOUN	NN	_	4	nmod	_	_
9	but	_	CONJ	CC	_	4	cc	_	_
10	does	_	VERB	VBZ	_	12	aux	_	_
11	not	_	ADV	RB	_	12	neg	_	_
12	inhibit	_	VERB	VB	_	4	conj	_	_
13	the	_	DET	DT	_	15	det	_	_
14	mammalian	_	ADJ	JJ	_	15	amod	_	_
15	enzyme	_	NOUN	NN	_	12	dobj	_	_

#	Rifampin	1021
1	Drug	_	NOUN	NN	_	3	compound	_	_
2	Resistance	_	NOUN	NN	_	3	compound	_	_
3	Organisms	_	NOUN	NNS	_	8	nsubj	_	_
4	resistant	_	ADJ	JJ	_	3	amod	_	_
5	to	_	PRT	TO	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	are	_	VERB	VBP	_	8	cop	_	_
8	likely	_	ADJ	JJ	_	0	root	_	_
9	to	_	PRT	TO	_	11	mark	_	_
10	be	_	VERB	VB	_	11	cop	_	_
11	resistant	_	ADJ	JJ	_	8	xcomp	_	_
12	to	_	PRT	TO	_	14	case	_	_
13	other	_	ADJ	JJ	_	14	amod	_	_
14	rifamycins	_	NOUN	NNS	_	11	nmod	_	_

#	Rifampin	1022
1	In	_	ADP	IN	_	3	case	_	_
2	the	_	DET	DT	_	3	det	_	_
3	treatment	_	NOUN	NN	_	28	nmod	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	both	_	CONJ	CC	_	6	cc:preconj	_	_
6	tuberculosis	_	NOUN	NN	_	3	nmod	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	the	_	DET	DT	_	11	det	_	_
9	meningococcal	_	ADJ	JJ	_	11	amod	_	_
10	carrier	_	NOUN	NN	_	11	compound	_	_
11	state	_	NOUN	NN	_	6	conj	_	_
12	,	_	.	,	_	28	punct	_	_
13	the	_	DET	DT	_	15	det	_	_
14	small	_	ADJ	JJ	_	15	amod	_	_
15	number	_	NOUN	NN	_	28	nsubj	_	_
16	of	_	ADP	IN	_	18	case	_	_
17	resistant	_	ADJ	JJ	_	18	amod	_	_
18	cells	_	NOUN	NNS	_	15	nmod	_	_
19	present	_	ADJ	JJ	_	18	amod	_	_
20	within	_	ADP	IN	_	22	case	_	_
21	large	_	ADJ	JJ	_	22	amod	_	_
22	populations	_	NOUN	NNS	_	19	nmod	_	_
23	of	_	ADP	IN	_	25	case	_	_
24	susceptible	_	ADJ	JJ	_	25	amod	_	_
25	cells	_	NOUN	NNS	_	22	nmod	_	_
26	can	_	VERB	MD	_	28	aux	_	_
27	rapidly	_	ADV	RB	_	28	advmod	_	_
28	become	_	VERB	VB	_	0	root	_	_
29	predominant	_	ADJ	JJ	_	28	xcomp	_	_

#	Rifampin	1023
1	In	_	ADP	IN	_	2	case	_	_
2	addition	_	NOUN	NN	_	9	nmod	_	_
3	,	_	.	,	_	9	punct	_	_
4	resistance	_	NOUN	NN	_	9	nsubjpass	_	_
5	to	_	PRT	TO	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	has	_	VERB	VBZ	_	9	aux	_	_
8	been	_	VERB	VBN	_	9	auxpass	_	_
9	determined	_	VERB	VBN	_	0	root	_	_
10	to	_	PRT	TO	_	11	mark	_	_
11	occur	_	VERB	VB	_	9	xcomp	_	_
12	as	_	ADP	IN	_	15	case	_	_
13	single	_	ADJ	JJ	_	15	amod	_	_
14	step	_	NOUN	NN	_	15	compound	_	_
15	mutations	_	NOUN	NNS	_	11	nmod	_	_
16	of	_	ADP	IN	_	21	case	_	_
17	the	_	DET	DT	_	21	det	_	_
18	DNA	_	NOUN	NN	_	21	compound	_	_
19	dependent	_	ADJ	JJ	_	21	amod	_	_
20	RNA	_	NOUN	NN	_	21	compound	_	_
21	polymerase	_	NOUN	NN	_	15	nmod	_	_

#	Rifampin	1024
1	Since	_	ADP	IN	_	4	mark	_	_
2	resistance	_	NOUN	NN	_	4	nsubj	_	_
3	can	_	VERB	MD	_	4	aux	_	_
4	emerge	_	VERB	VB	_	12	advcl	_	_
5	rapidly	_	ADV	RB	_	4	advmod	_	_
6	,	_	.	,	_	12	punct	_	_
7	appropriate	_	ADJ	JJ	_	9	amod	_	_
8	susceptibility	_	NOUN	NN	_	9	compound	_	_
9	tests	_	NOUN	NNS	_	12	nsubjpass	_	_
10	should	_	VERB	MD	_	12	aux	_	_
11	be	_	VERB	VB	_	12	auxpass	_	_
12	performed	_	VERB	VBN	_	0	root	_	_
13	in	_	ADP	IN	_	15	case	_	_
14	the	_	DET	DT	_	15	det	_	_
15	event	_	NOUN	NN	_	12	nmod	_	_
16	of	_	ADP	IN	_	19	case	_	_
17	persistent	_	ADJ	JJ	_	19	amod	_	_
18	positive	_	ADJ	JJ	_	19	amod	_	_
19	cultures	_	NOUN	NNS	_	15	nmod	_	_

#	Rifampin	1025
1	Activity	_	NOUN	NN	_	8	nsubj	_	_
2	in	_	X	FW	_	3	compound	_	_
3	vitro	_	X	FW	_	1	advmod	_	_
4	and	_	CONJ	CC	_	1	cc	_	_
5	in	_	X	FW	_	7	amod	_	_
6	vivo	_	X	FW	_	5	dep	_	_
7	DRUG	_	NOUN	NN	_	1	conj	_	_
8	has	_	VERB	VBZ	_	0	root	_	_
9	bactericidal	_	ADJ	JJ	_	10	amod	_	_
10	activity	_	NOUN	NN	_	8	dobj	_	_
11	in	_	X	FW	_	12	compound	_	_
12	vitro	_	X	FW	_	8	advmod	_	_
13	against	_	ADP	IN	_	14	case	_	_
14	slow	_	NOUN	NN	_	8	nmod	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	intermittently	_	ADV	RB	_	17	advmod	_	_
17	growing	_	VERB	VBG	_	14	conj	_	_
18	M	_	NOUN	NN	_	20	compound	_	_
19	tuberculosis	_	NOUN	NN	_	20	compound	_	_
20	organisms	_	NOUN	NNS	_	17	dobj	_	_

#	Rifampin	1026
1	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
2	has	_	VERB	VBZ	_	4	aux	_	_
3	been	_	VERB	VBN	_	4	auxpass	_	_
4	shown	_	VERB	VBN	_	0	root	_	_
5	to	_	PRT	TO	_	7	mark	_	_
6	be	_	VERB	VB	_	7	cop	_	_
7	active	_	ADJ	JJ	_	4	xcomp	_	_
8	against	_	ADP	IN	_	10	case	_	_
9	most	_	ADJ	JJ	_	10	amod	_	_
10	strains	_	NOUN	NNS	_	7	nmod	_	_
11	of	_	ADP	IN	_	14	case	_	_
12	the	_	DET	DT	_	14	det	_	_
13	following	_	VERB	VBG	_	14	amod	_	_
14	microorganisms	_	NOUN	NNS	_	10	nmod	_	_
15	,	_	.	,	_	14	punct	_	_
16	both	_	CONJ	CC	_	24	advmod	_	_
17	in	_	X	FW	_	18	compound	_	_
18	vitro	_	X	FW	_	16	dep	_	_
19	and	_	CONJ	CC	_	16	cc	_	_
20	in	_	ADP	IN	_	22	case	_	_
21	clinical	_	ADJ	JJ	_	22	amod	_	_
22	infections	_	NOUN	NNS	_	16	conj	_	_
23	as	_	ADP	IN	_	24	mark	_	_
24	described	_	VERB	VBN	_	14	acl	_	_
25	in	_	ADP	IN	_	30	case	_	_
26	the	_	DET	DT	_	30	det	_	_
27	INDICATIONS	_	NOUN	NN	_	30	compound	_	_
28	AND	_	CONJ	CC	_	27	cc	_	_
29	USAGE	_	NOUN	NN	_	27	conj	_	_
30	section	_	NOUN	NN	_	24	nmod	_	_

#	Rifampin	1027
1	Aerobic	_	ADJ	JJ	_	4	amod	_	_
2	Gram	_	NOUN	NN	_	4	compound	_	_
3	Negative	_	ADJ	JJ	_	4	amod	_	_
4	Microorganisms	_	NOUN	NNS	_	0	root	_	_
5	:	_	.	:	_	4	punct	_	_
6	Neisseria	_	NOUN	NN	_	9	compound	_	_
7	meningitidis	_	NOUN	NN	_	9	compound	_	_
8	"Other"	_	NOUN	NN	_	9	compound	_	_
9	Microorganisms	_	NOUN	NNS	_	4	dep	_	_
10	:	_	.	:	_	4	punct	_	_
11	Mycobacterium	_	NOUN	NN	_	12	compound	_	_
12	tuberculosis	_	NOUN	NN	_	19	nsubj	_	_
13	The	_	DET	DT	_	17	det	_	_
14	following	_	VERB	VBG	_	17	case	_	_
15	in	_	X	FW	_	17	amod	_	_
16	vitro	_	X	FW	_	15	dep	_	_
17	data	_	NOUN	NNS	_	19	nsubj	_	_
18	are	_	VERB	VBP	_	19	cop	_	_
19	available	_	ADJ	JJ	_	4	dep	_	_
20	,	_	.	,	_	19	punct	_	_
21	but	_	CONJ	CC	_	19	cc	_	_
22	their	_	PRON	PRP$	_	24	nmod:poss	_	_
23	clinical	_	ADJ	JJ	_	24	amod	_	_
24	significance	_	NOUN	NN	_	26	nsubj	_	_
25	is	_	VERB	VBZ	_	26	auxpass	_	_
26	unknown	_	ADJ	JJ	_	19	conj	_	_

#	Rifampin	1028
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	exhibits	_	VERB	VBZ	_	0	root	_	_
3	in	_	X	FW	_	5	amod	_	_
4	vitro	_	X	FW	_	3	dep	_	_
5	activity	_	NOUN	NN	_	2	dobj	_	_
6	against	_	ADP	IN	_	8	case	_	_
7	most	_	ADJ	JJ	_	8	amod	_	_
8	strains	_	NOUN	NNS	_	5	nmod	_	_
9	of	_	ADP	IN	_	12	case	_	_
10	the	_	DET	DT	_	12	det	_	_
11	following	_	VERB	VBG	_	12	amod	_	_
12	microorganisms	_	NOUN	NNS	_	8	nmod	_	_
13	however	_	ADV	RB	_	2	advmod	_	_
14	,	_	.	,	_	2	punct	_	_
15	the	_	DET	DT	_	16	det	_	_
16	safety	_	NOUN	NN	_	32	nsubjpass	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	effectiveness	_	NOUN	NN	_	16	conj	_	_
19	of	_	ADP	IN	_	20	case	_	_
20	DRUG	_	NOUN	NN	_	16	nmod	_	_
21	in	_	ADP	IN	_	22	mark	_	_
22	treating	_	VERB	VBG	_	16	acl	_	_
23	clinical	_	ADJ	JJ	_	24	amod	_	_
24	infections	_	NOUN	NNS	_	22	dobj	_	_
25	due	_	ADJ	JJ	_	28	case	_	_
26	to	_	PRT	TO	_	25	mwe	_	_
27	these	_	DET	DT	_	28	det	_	_
28	microorganisms	_	NOUN	NNS	_	22	nmod	_	_
29	have	_	VERB	VBP	_	32	aux	_	_
30	not	_	ADV	RB	_	32	neg	_	_
31	been	_	VERB	VBN	_	32	auxpass	_	_
32	established	_	VERB	VBN	_	2	parataxis	_	_
33	in	_	ADP	IN	_	38	case	_	_
34	adequate	_	ADJ	JJ	_	38	compound	_	_
35	and	_	CONJ	CC	_	34	cc	_	_
36	well	_	ADV	RB	_	34	conj	_	_
37	controlled	_	VERB	VBN	_	38	amod	_	_
38	trials	_	NOUN	NNS	_	32	nmod	_	_

#	Rifampin	1029
1	Aerobic	_	ADJ	JJ	_	4	amod	_	_
2	Gram	_	NOUN	NN	_	4	compound	_	_
3	Positive	_	ADJ	JJ	_	4	amod	_	_
4	Microorganisms	_	NOUN	NNS	_	0	root	_	_
5	:	_	.	:	_	4	punct	_	_
6	Staphylococcus	_	NOUN	NN	_	7	compound	_	_
7	aureus	_	NOUN	NN	_	4	dep	_	_
8	including	_	ADP	IN	_	12	case	_	_
9	Methicillin	_	NOUN	NN	_	12	compound	_	_
10	Resistant	_	ADJ	JJ	_	12	amod	_	_
11	S	_	NOUN	NN	_	12	compound	_	_
12	aureus	_	NOUN	NN	_	7	nmod	_	_
13	/	_	.	:	_	7	punct	_	_
14	MRSA	_	NOUN	NN	_	20	compound	_	_
15	Staphylococcus	_	NOUN	NN	_	20	compound	_	_
16	epidermis	_	NOUN	NN	_	20	compound	_	_
17	Aerobic	_	ADJ	JJ	_	20	amod	_	_
18	Gram	_	NOUN	NN	_	20	compound	_	_
19	Negative	_	ADJ	JJ	_	20	amod	_	_
20	Microorganisms	_	NOUN	NNS	_	7	dep	_	_
21	:	_	.	:	_	4	punct	_	_
22	Haemophilus	_	NOUN	NN	_	25	compound	_	_
23	influenzae	_	ADJ	JJ	_	25	amod	_	_
24	"Other"	_	NOUN	NN	_	25	compound	_	_
25	Microorganisms	_	NOUN	NNS	_	4	dep	_	_
26	:	_	.	:	_	4	punct	_	_
27	Mycobacterium	_	NOUN	NN	_	31	compound	_	_
28	leprae	_	NOUN	NN	_	31	compound	_	_
29	*	_	NUM	CD	_	31	nummod	_	_
30	lactamase	_	NOUN	NN	_	31	compound	_	_
31	production	_	NOUN	NN	_	33	nsubj	_	_
32	should	_	VERB	MD	_	33	aux	_	_
33	have	_	VERB	VB	_	4	dep	_	_
34	no	_	DET	DT	_	35	neg	_	_
35	effect	_	NOUN	NN	_	33	dobj	_	_
36	on	_	ADP	IN	_	38	case	_	_
37	DRUG	_	NOUN	NN	_	38	compound	_	_
38	activity	_	NOUN	NN	_	35	nmod	_	_

#	Rifampin	1030
1	Prior	_	ADV	RB	_	3	case	_	_
2	to	_	PRT	TO	_	1	mwe	_	_
3	initiation	_	NOUN	NN	_	11	nmod	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	therapy	_	NOUN	NN	_	3	nmod	_	_
6	,	_	.	,	_	11	punct	_	_
7	appropriate	_	ADJ	JJ	_	8	amod	_	_
8	specimens	_	NOUN	NNS	_	11	nsubjpass	_	_
9	should	_	VERB	MD	_	11	aux	_	_
10	be	_	VERB	VB	_	11	auxpass	_	_
11	collected	_	VERB	VBN	_	0	root	_	_
12	for	_	ADP	IN	_	13	case	_	_
13	identification	_	NOUN	NN	_	11	nmod	_	_
14	of	_	ADP	IN	_	17	case	_	_
15	the	_	DET	DT	_	17	det	_	_
16	infecting	_	VERB	VBG	_	17	amod	_	_
17	organism	_	NOUN	NN	_	13	nmod	_	_
18	and	_	CONJ	CC	_	17	cc	_	_
19	in	_	X	FW	_	22	amod	_	_
20	vitro	_	X	FW	_	19	dep	_	_
21	susceptibility	_	NOUN	NN	_	22	compound	_	_
22	tests	_	NOUN	NNS	_	17	conj	_	_

#	Rifampin	1031
1	In	_	X	FW	_	3	amod	_	_
2	vitro	_	X	FW	_	1	dep	_	_
3	testing	_	VERB	VBG	_	0	root	_	_
4	for	_	ADP	IN	_	7	case	_	_
5	Mycobacterium	_	NOUN	NN	_	7	compound	_	_
6	tuberculosis	_	NOUN	NN	_	7	compound	_	_
7	isolates	_	NOUN	NNS	_	3	nmod	_	_
8	:	_	.	:	_	3	punct	_	_
9	Two	_	NUM	CD	_	14	nummod	_	_
10	standardized	_	VERB	VBN	_	14	amod	_	_
11	in	_	X	FW	_	14	amod	_	_
12	vitro	_	X	FW	_	11	dep	_	_
13	susceptibility	_	NOUN	NN	_	14	compound	_	_
14	methods	_	NOUN	NNS	_	16	nsubj	_	_
15	are	_	VERB	VBP	_	16	cop	_	_
16	available	_	ADJ	JJ	_	3	parataxis	_	_
17	for	_	ADP	IN	_	18	mark	_	_
18	testing	_	VERB	VBG	_	16	advcl	_	_
19	DRUG	_	NOUN	NN	_	18	dobj	_	_
20	against	_	ADP	IN	_	23	case	_	_
21	M	_	NOUN	NN	_	23	compound	_	_
22	tuberculosis	_	NOUN	NN	_	23	compound	_	_
23	organisms	_	NOUN	NNS	_	18	nmod	_	_

#	Rifampin	1032
1	The	_	DET	DT	_	5	det	_	_
2	agar	_	NOUN	NN	_	5	compound	_	_
3	proportion	_	NOUN	NN	_	5	compound	_	_
4	method	_	NOUN	NN	_	5	compound	_	_
5	CDC	_	NOUN	NN	_	10	nsubj	_	_
6	or	_	CONJ	CC	_	5	cc	_	_
7	CLSI(1	_	NOUN	NN	_	9	compound	_	_
8	M24	_	NOUN	NN	_	9	compound	_	_
9	A	_	NOUN	NN	_	5	conj	_	_
10	utilizes	_	VERB	VBZ	_	0	root	_	_
11	Middlebrook	_	NOUN	NN	_	13	compound	_	_
12	7H10	_	NOUN	NN	_	13	compound	_	_
13	medium	_	NOUN	NN	_	10	dobj	_	_
14	impregnated	_	VERB	VBN	_	13	acl	_	_
15	with	_	ADP	IN	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	14	nmod	_	_
17	at	_	ADP	IN	_	20	case	_	_
18	a	_	DET	DT	_	20	det	_	_
19	final	_	ADJ	JJ	_	20	amod	_	_
20	concentration	_	NOUN	NN	_	14	nmod	_	_
21	of	_	ADP	IN	_	23	case	_	_
22	1.0	_	NUM	CD	_	23	nummod	_	_
23	mcg	_	NOUN	NN	_	20	nmod	_	_
24	/	_	.	:	_	10	punct	_	_
25	mL	_	NOUN	NN	_	10	parataxis	_	_
26	to	_	PRT	TO	_	27	mark	_	_
27	determine	_	VERB	VB	_	25	acl	_	_
28	drug	_	NOUN	NN	_	29	compound	_	_
29	resistance	_	NOUN	NN	_	27	dobj	_	_

#	Rifampin	1033
1	After	_	ADP	IN	_	3	case	_	_
2	three	_	NUM	CD	_	3	nummod	_	_
3	weeks	_	NOUN	NNS	_	9	nsubjpass	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	incubation	_	NOUN	NN	_	7	compound	_	_
6	MIC99	_	NOUN	NN	_	7	compound	_	_
7	values	_	NOUN	NNS	_	3	nmod	_	_
8	are	_	VERB	VBP	_	9	auxpass	_	_
9	calculated	_	VERB	VBN	_	0	root	_	_
10	by	_	ADP	IN	_	11	mark	_	_
11	comparing	_	VERB	VBG	_	9	advcl	_	_
12	the	_	DET	DT	_	13	det	_	_
13	quantity	_	NOUN	NN	_	11	dobj	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	organisms	_	NOUN	NNS	_	13	nmod	_	_
16	growing	_	VERB	VBG	_	15	acl	_	_
17	in	_	ADP	IN	_	19	case	_	_
18	the	_	DET	DT	_	19	det	_	_
19	medium	_	NOUN	NN	_	16	nmod	_	_
20	containing	_	VERB	VBG	_	19	acl	_	_
21	drug	_	NOUN	NN	_	20	dobj	_	_
22	to	_	PRT	TO	_	25	case	_	_
23	the	_	DET	DT	_	25	det	_	_
24	control	_	ADJ	JJ	_	25	compound	_	_
25	cultures	_	NOUN	NNS	_	20	nmod	_	_

#	Rifampin	1034
1	Mycobacterial	_	ADJ	JJ	_	2	amod	_	_
2	growth	_	NOUN	NN	_	21	nsubj	_	_
3	in	_	ADP	IN	_	5	case	_	_
4	the	_	DET	DT	_	5	det	_	_
5	presence	_	NOUN	NN	_	2	nmod	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	drug	_	NOUN	NN	_	5	nmod	_	_
8	,	_	.	,	_	2	punct	_	_
9	of	_	ADP	IN	_	12	case	_	_
10	at	_	X	FW	_	12	amod	_	_
11	least	_	X	FW	_	10	dep	_	_
12	1%	_	NOUN	NN	_	2	nmod	_	_
13	of	_	ADP	IN	_	15	case	_	_
14	the	_	DET	DT	_	15	det	_	_
15	growth	_	NOUN	NN	_	12	nmod	_	_
16	in	_	ADP	IN	_	19	case	_	_
17	the	_	DET	DT	_	19	det	_	_
18	control	_	NOUN	NN	_	19	amod	_	_
19	culture	_	NOUN	NN	_	15	nmod	_	_
20	,	_	.	,	_	2	punct	_	_
21	indicates	_	VERB	VBZ	_	0	root	_	_
22	resistance	_	NOUN	NN	_	21	dobj	_	_

#	Rifampin	1035
1	The	_	DET	DT	_	4	det	_	_
2	radiometric	_	ADJ	JJ	_	4	amod	_	_
3	broth	_	NOUN	NN	_	4	compound	_	_
4	method	_	NOUN	NN	_	5	nsubj	_	_
5	employs	_	VERB	VBZ	_	0	root	_	_
6	the	_	DET	DT	_	9	det	_	_
7	BACTEC	_	NOUN	NN	_	9	compound	_	_
8	460	_	NUM	CD	_	9	nummod	_	_
9	machine	_	NOUN	NN	_	5	dobj	_	_
10	to	_	PRT	TO	_	11	mark	_	_
11	compare	_	VERB	VB	_	5	xcomp	_	_
12	the	_	DET	DT	_	14	det	_	_
13	growth	_	NOUN	NN	_	14	compound	_	_
14	index	_	NOUN	NN	_	11	dobj	_	_
15	from	_	ADP	IN	_	18	case	_	_
16	untreated	_	ADJ	JJ	_	18	amod	_	_
17	control	_	NOUN	NN	_	18	compound	_	_
18	cultures	_	NOUN	NNS	_	14	nmod	_	_
19	to	_	PRT	TO	_	20	case	_	_
20	cultures	_	NOUN	NNS	_	14	nmod	_	_
21	grown	_	VERB	VBN	_	20	acl	_	_
22	in	_	ADP	IN	_	24	case	_	_
23	the	_	DET	DT	_	24	det	_	_
24	presence	_	NOUN	NN	_	21	nmod	_	_
25	of	_	ADP	IN	_	27	case	_	_
26	2.0	_	NUM	CD	_	27	nummod	_	_
27	mcg	_	NOUN	NN	_	24	nmod	_	_
28	/	_	.	:	_	5	punct	_	_
29	mL	_	NOUN	NN	_	5	parataxis	_	_
30	of	_	ADP	IN	_	31	case	_	_
31	DRUG	_	NOUN	NN	_	29	nmod	_	_

#	Rifampin	1036
1	Strict	_	ADJ	JJ	_	2	amod	_	_
2	adherence	_	NOUN	NN	_	14	nsubjpass	_	_
3	to	_	PRT	TO	_	6	case	_	_
4	the	_	DET	DT	_	6	det	_	_
5	manufacturer's	_	NOUN	NNS	_	6	compound	_	_
6	instructions	_	NOUN	NNS	_	2	nmod	_	_
7	for	_	ADP	IN	_	9	case	_	_
8	sample	_	ADJ	JJ	_	9	amod	_	_
9	processing	_	NOUN	NN	_	6	nmod	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	data	_	NOUN	NNS	_	9	conj	_	_
12	interpretation	_	NOUN	NN	_	9	dep	_	_
13	is	_	VERB	VBZ	_	14	auxpass	_	_
14	required	_	VERB	VBN	_	0	root	_	_
15	for	_	ADP	IN	_	17	case	_	_
16	this	_	DET	DT	_	17	det	_	_
17	assay	_	NOUN	NN	_	14	nmod	_	_

#	Rifampin	1037
1	Susceptibility	_	NOUN	NN	_	3	compound	_	_
2	test	_	NOUN	NN	_	3	compound	_	_
3	results	_	NOUN	NNS	_	13	nsubjpass	_	_
4	obtained	_	VERB	VBN	_	3	acl	_	_
5	by	_	ADP	IN	_	9	case	_	_
6	the	_	DET	DT	_	9	det	_	_
7	two	_	NUM	CD	_	9	nummod	_	_
8	different	_	ADJ	JJ	_	9	amod	_	_
9	methods	_	NOUN	NNS	_	4	nmod	_	_
10	can	_	VERB	MD	_	13	aux	_	_
11	only	_	ADV	RB	_	13	advmod	_	_
12	be	_	VERB	VB	_	13	auxpass	_	_
13	compared	_	VERB	VBN	_	0	root	_	_
14	if	_	ADP	IN	_	20	mark	_	_
15	the	_	DET	DT	_	18	det	_	_
16	appropriate	_	ADJ	JJ	_	18	amod	_	_
17	DRUG	_	NOUN	NN	_	18	compound	_	_
18	concentration	_	NOUN	NN	_	20	nsubjpass	_	_
19	is	_	VERB	VBZ	_	20	auxpass	_	_
20	used	_	VERB	VBN	_	13	ccomp	_	_
21	for	_	ADP	IN	_	24	case	_	_
22	each	_	DET	DT	_	24	det	_	_
23	test	_	NOUN	NN	_	24	compound	_	_
24	method	_	NOUN	NN	_	20	nmod	_	_
25	as	_	ADP	IN	_	26	mark	_	_
26	indicated	_	VERB	VBN	_	20	advcl	_	_
27	above	_	ADV	RB	_	26	advmod	_	_

#	Rifampin	1038
1	Both	_	DET	DT	_	2	det	_	_
2	procedures	_	NOUN	NNS	_	3	nsubj	_	_
3	require	_	VERB	VBP	_	0	root	_	_
4	the	_	DET	DT	_	5	det	_	_
5	use	_	NOUN	NN	_	3	dobj	_	_
6	of	_	ADP	IN	_	10	case	_	_
7	M	_	NOUN	NN	_	10	compound	_	_
8	tuberculosis	_	NOUN	NN	_	10	compound	_	_
9	H37Rv	_	NOUN	NN	_	10	compound	_	_
10	ATCC	_	NOUN	NN	_	5	nmod	_	_
11	27294	_	NUM	CD	_	10	nummod	_	_
12	as	_	ADP	IN	_	15	case	_	_
13	a	_	DET	DT	_	15	det	_	_
14	control	_	NOUN	NN	_	15	compound	_	_
15	organism	_	NOUN	NN	_	3	nmod	_	_

#	Rifampin	1039
1	The	_	DET	DT	_	3	det	_	_
2	clinical	_	ADJ	JJ	_	3	amod	_	_
3	relevance	_	NOUN	NN	_	9	nsubj	_	_
4	of	_	ADP	IN	_	8	case	_	_
5	in	_	X	FW	_	8	amod	_	_
6	vitro	_	X	FW	_	5	dep	_	_
7	susceptibility	_	NOUN	NN	_	8	compound	_	_
8	test	_	NOUN	NN	_	3	nmod	_	_
9	results	_	NOUN	NNS	_	28	nsubjpass	_	_
10	for	_	ADP	IN	_	12	case	_	_
11	mycobacterial	_	ADJ	JJ	_	12	amod	_	_
12	species	_	NOUN	NNS	_	9	nmod	_	_
13	other	_	ADJ	JJ	_	16	case	_	_
14	than	_	ADP	IN	_	13	mwe	_	_
15	M	_	NOUN	NN	_	16	compound	_	_
16	tuberculosis	_	NOUN	NN	_	12	nmod	_	_
17	using	_	VERB	VBG	_	9	acl	_	_
18	either	_	CONJ	CC	_	20	cc:preconj	_	_
19	the	_	DET	DT	_	20	det	_	_
20	radiometric	_	ADJ	JJ	_	17	dobj	_	_
21	or	_	CONJ	CC	_	20	cc	_	_
22	the	_	DET	DT	_	24	det	_	_
23	proportion	_	NOUN	NN	_	24	compound	_	_
24	method	_	NOUN	NN	_	20	conj	_	_
25	has	_	VERB	VBZ	_	28	aux	_	_
26	not	_	ADV	RB	_	28	neg	_	_
27	been	_	VERB	VBN	_	28	auxpass	_	_
28	determined	_	VERB	VBN	_	0	root	_	_

#	Rifampin	1040
1	In	_	X	FW	_	3	amod	_	_
2	vitro	_	X	FW	_	1	dep	_	_
3	testing	_	VERB	VBG	_	0	root	_	_
4	for	_	ADP	IN	_	7	case	_	_
5	Neisseria	_	NOUN	NN	_	7	compound	_	_
6	meningitidis	_	NOUN	NN	_	7	compound	_	_
7	isolates	_	NOUN	NNS	_	3	nmod	_	_
8	:	_	.	:	_	3	punct	_	_
9	Dilution	_	NOUN	NN	_	10	compound	_	_
10	Techniques	_	NOUN	NNS	_	3	dep	_	_
11	:	_	.	:	_	10	punct	_	_
12	Quantitative	_	ADJ	JJ	_	13	amod	_	_
13	methods	_	NOUN	NNS	_	22	nsubj	_	_
14	that	_	DET	WDT	_	16	nsubjpass	_	_
15	are	_	VERB	VBP	_	16	auxpass	_	_
16	used	_	VERB	VBN	_	13	acl:relcl	_	_
17	to	_	PRT	TO	_	18	mark	_	_
18	determine	_	VERB	VB	_	16	xcomp	_	_
19	minimum	_	ADJ	JJ	_	21	amod	_	_
20	inhibitory	_	ADJ	JJ	_	21	amod	_	_
21	concentrations	_	NOUN	NNS	_	18	dobj	_	_
22	provide	_	VERB	VBP	_	10	dep	_	_
23	reproducible	_	ADJ	JJ	_	24	amod	_	_
24	estimates	_	NOUN	NNS	_	22	dobj	_	_
25	of	_	ADP	IN	_	27	case	_	_
26	the	_	DET	DT	_	27	det	_	_
27	susceptibility	_	NOUN	NN	_	24	nmod	_	_
28	of	_	ADP	IN	_	29	case	_	_
29	bacteria	_	NOUN	NN	_	27	nmod	_	_
30	to	_	PRT	TO	_	32	case	_	_
31	antimicrobial	_	ADJ	JJ	_	32	amod	_	_
32	compounds	_	NOUN	NNS	_	27	nmod	_	_

#	Rifampin	1041
1	One	_	NUM	CD	_	4	nummod	_	_
2	such	_	ADJ	JJ	_	4	amod	_	_
3	standardized	_	ADJ	JJ	_	4	amod	_	_
4	procedure	_	NOUN	NN	_	5	nsubj	_	_
5	uses	_	VERB	VBZ	_	20	nsubj	_	_
6	a	_	DET	DT	_	10	det	_	_
7	standardized	_	ADJ	JJ	_	10	amod	_	_
8	dilution	_	NOUN	NN	_	10	compound	_	_
9	method2,4	_	NOUN	NN	_	10	compound	_	_
10	broth	_	NOUN	NN	_	5	dobj	_	_
11	,	_	.	,	_	10	punct	_	_
12	agar	_	NOUN	NN	_	10	conj	_	_
13	,	_	.	,	_	10	punct	_	_
14	or	_	CONJ	CC	_	10	cc	_	_
15	microdilution	_	NOUN	NN	_	10	conj	_	_
16	or	_	CONJ	CC	_	10	cc	_	_
17	equivalent	_	ADJ	JJ	_	10	conj	_	_
18	with	_	ADP	IN	_	19	case	_	_
19	DRUG	_	NOUN	NN	_	17	nmod	_	_
20	powder	_	VERB	VBP	_	0	root	_	_

#	Rifampin	1042
1	The	_	DET	DT	_	3	det	_	_
2	MIC	_	NOUN	NN	_	3	compound	_	_
3	values	_	NOUN	NNS	_	7	nsubjpass	_	_
4	obtained	_	VERB	VBN	_	3	acl	_	_
5	should	_	VERB	MD	_	7	aux	_	_
6	be	_	VERB	VB	_	7	auxpass	_	_
7	interpreted	_	VERB	VBN	_	0	root	_	_
8	according	_	VERB	VBG	_	12	case	_	_
9	to	_	PRT	TO	_	12	case	_	_
10	the	_	DET	DT	_	12	det	_	_
11	following	_	VERB	VBG	_	12	amod	_	_
12	criteria	_	NOUN	NN	_	7	nmod	_	_
13	for	_	ADP	IN	_	15	case	_	_
14	Neisseria	_	NOUN	NN	_	15	compound	_	_
15	meningitidis	_	NOUN	NN	_	12	nmod	_	_

#	Rifampin	1043
1	A	_	DET	DT	_	2	det	_	_
2	report	_	NOUN	NN	_	5	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	"intermediate"	_	NOUN	NN	_	2	nmod	_	_
5	indicates	_	VERB	VBZ	_	0	root	_	_
6	that	_	ADP	IN	_	11	mark	_	_
7	the	_	DET	DT	_	8	det	_	_
8	result	_	NOUN	NN	_	11	nsubjpass	_	_
9	should	_	VERB	MD	_	11	aux	_	_
10	be	_	VERB	VB	_	11	auxpass	_	_
11	considered	_	VERB	VBN	_	5	ccomp	_	_
12	equivocal	_	ADJ	JJ	_	11	xcomp	_	_
13	,	_	.	,	_	11	punct	_	_
14	and	_	CONJ	CC	_	11	cc	_	_
15	if	_	ADP	IN	_	21	mark	_	_
16	the	_	DET	DT	_	17	det	_	_
17	microorganism	_	NOUN	NN	_	21	nsubj	_	_
18	is	_	VERB	VBZ	_	21	cop	_	_
19	not	_	ADV	RB	_	21	neg	_	_
20	fully	_	ADV	RB	_	21	advmod	_	_
21	susceptible	_	ADJ	JJ	_	11	conj	_	_
22	to	_	PRT	TO	_	27	case	_	_
23	alternative	_	ADJ	JJ	_	27	amod	_	_
24	,	_	.	,	_	23	punct	_	_
25	clinically	_	ADV	RB	_	26	advmod	_	_
26	feasible	_	ADJ	JJ	_	23	dep	_	_
27	drugs	_	NOUN	NNS	_	21	nmod	_	_
28	,	_	.	,	_	11	punct	_	_
29	the	_	DET	DT	_	30	det	_	_
30	test	_	NOUN	NN	_	33	nsubjpass	_	_
31	should	_	VERB	MD	_	33	aux	_	_
32	be	_	VERB	VB	_	33	auxpass	_	_
33	repeated	_	VERB	VBN	_	11	parataxis	_	_

#	Rifampin	1044
1	This	_	DET	DT	_	2	det	_	_
2	category	_	NOUN	NN	_	3	nsubj	_	_
3	implies	_	VERB	VBZ	_	0	root	_	_
4	possible	_	ADJ	JJ	_	6	amod	_	_
5	clinical	_	ADJ	JJ	_	6	amod	_	_
6	applicability	_	NOUN	NN	_	3	dobj	_	_
7	in	_	ADP	IN	_	9	case	_	_
8	body	_	NOUN	NN	_	9	compound	_	_
9	sites	_	NOUN	NNS	_	6	nmod	_	_
10	where	_	ADV	WRB	_	15	advmod	_	_
11	the	_	DET	DT	_	12	det	_	_
12	drug	_	NOUN	NN	_	15	nsubjpass	_	_
13	is	_	VERB	VBZ	_	15	auxpass	_	_
14	physiologically	_	ADV	RB	_	15	advmod	_	_
15	concentrated	_	VERB	VBN	_	6	acl:relcl	_	_
16	or	_	CONJ	CC	_	15	cc	_	_
17	in	_	ADP	IN	_	18	case	_	_
18	situations	_	NOUN	NNS	_	15	conj	_	_
19	where	_	ADV	WRB	_	28	advmod	_	_
20	the	_	DET	DT	_	23	det	_	_
21	maximum	_	NOUN	NN	_	23	compound	_	_
22	acceptable	_	ADJ	JJ	_	23	amod	_	_
23	dose	_	NOUN	NN	_	28	nsubjpass	_	_
24	of	_	ADP	IN	_	25	case	_	_
25	drug	_	NOUN	NN	_	23	nmod	_	_
26	can	_	VERB	MD	_	28	aux	_	_
27	be	_	VERB	VB	_	28	auxpass	_	_
28	used	_	VERB	VBN	_	18	acl:relcl	_	_

#	Rifampin	1045
1	This	_	DET	DT	_	2	det	_	_
2	category	_	NOUN	NN	_	4	nsubj	_	_
3	also	_	ADV	RB	_	4	advmod	_	_
4	provides	_	VERB	VBZ	_	0	root	_	_
5	a	_	DET	DT	_	7	det	_	_
6	buffer	_	ADJ	JJ	_	7	amod	_	_
7	zone	_	NOUN	NN	_	4	dobj	_	_
8	that	_	DET	WDT	_	9	nsubj	_	_
9	prevents	_	VERB	VBZ	_	7	acl:relcl	_	_
10	small	_	ADJ	JJ	_	13	amod	_	_
11	uncontrolled	_	ADJ	JJ	_	13	amod	_	_
12	technical	_	ADJ	JJ	_	13	amod	_	_
13	factors	_	NOUN	NNS	_	9	dobj	_	_
14	from	_	ADP	IN	_	15	mark	_	_
15	causing	_	VERB	VBG	_	9	advcl	_	_
16	major	_	ADJ	JJ	_	17	amod	_	_
17	discrepancies	_	NOUN	NNS	_	15	dobj	_	_
18	in	_	ADP	IN	_	19	case	_	_
19	interpretation	_	NOUN	NN	_	17	nmod	_	_

#	Rifampin	1046
1	A	_	DET	DT	_	2	det	_	_
2	report	_	NOUN	NN	_	5	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	"resistant"	_	NOUN	NN	_	2	nmod	_	_
5	indicates	_	VERB	VBZ	_	0	root	_	_
6	that	_	ADP	IN	_	18	mark	_	_
7	usually	_	ADV	RB	_	8	advmod	_	_
8	achievable	_	ADJ	JJ	_	9	amod	_	_
9	concentrations	_	NOUN	NNS	_	18	nsubj	_	_
10	of	_	ADP	IN	_	13	case	_	_
11	the	_	DET	DT	_	13	det	_	_
12	antimicrobial	_	ADJ	JJ	_	13	amod	_	_
13	compound	_	NOUN	NN	_	9	nmod	_	_
14	in	_	ADP	IN	_	16	case	_	_
15	the	_	DET	DT	_	16	det	_	_
16	blood	_	NOUN	NN	_	9	nmod	_	_
17	are	_	VERB	VBP	_	18	cop	_	_
18	unlikely	_	ADJ	JJ	_	5	ccomp	_	_
19	to	_	PRT	TO	_	21	mark	_	_
20	be	_	VERB	VB	_	21	cop	_	_
21	inhibitory	_	ADJ	JJ	_	18	xcomp	_	_
22	and	_	CONJ	CC	_	21	cc	_	_
23	that	_	ADP	IN	_	28	mark	_	_
24	other	_	ADJ	JJ	_	25	amod	_	_
25	therapy	_	NOUN	NN	_	28	nsubjpass	_	_
26	should	_	VERB	MD	_	28	aux	_	_
27	be	_	VERB	VB	_	28	auxpass	_	_
28	selected	_	VERB	VBN	_	21	conj	_	_

#	Rifampin	1047
1	Measurement	_	NOUN	NN	_	16	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	MIC	_	NOUN	NN	_	1	nmod	_	_
4	or	_	CONJ	CC	_	3	cc	_	_
5	minimum	_	ADJ	JJ	_	7	amod	_	_
6	bactericidal	_	ADJ	JJ	_	7	amod	_	_
7	concentrations	_	NOUN	NNS	_	3	conj	_	_
8	MBC	_	NOUN	NN	_	3	dep	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	achieved	_	VERB	VBN	_	13	amod	_	_
11	antimicrobial	_	ADJ	JJ	_	13	amod	_	_
12	compound	_	NOUN	NN	_	13	compound	_	_
13	concentrations	_	NOUN	NNS	_	8	conj	_	_
14	may	_	VERB	MD	_	16	aux	_	_
15	be	_	VERB	VB	_	16	cop	_	_
16	appropriate	_	ADJ	JJ	_	0	root	_	_
17	to	_	PRT	TO	_	19	case	_	_
18	guide	_	ADJ	JJ	_	19	amod	_	_
19	therapy	_	NOUN	NN	_	16	nmod	_	_
20	in	_	ADP	IN	_	22	case	_	_
21	some	_	DET	DT	_	22	det	_	_
22	infections	_	NOUN	NNS	_	19	nmod	_	_

#	Rifampin	1049
1	Standardized	_	ADJ	JJ	_	4	amod	_	_
2	susceptibility	_	NOUN	NN	_	4	compound	_	_
3	test	_	NOUN	NN	_	4	compound	_	_
4	procedures	_	NOUN	NNS	_	5	nsubj	_	_
5	require	_	VERB	VBP	_	0	root	_	_
6	the	_	DET	DT	_	7	det	_	_
7	use	_	NOUN	NN	_	5	dobj	_	_
8	of	_	ADP	IN	_	11	case	_	_
9	laboratory	_	ADJ	JJ	_	11	amod	_	_
10	control	_	NOUN	NN	_	11	compound	_	_
11	microorganisms	_	NOUN	NNS	_	7	nmod	_	_

#	Rifampin	1050
1	The	_	DET	DT	_	2	det	_	_
2	use	_	NOUN	NN	_	8	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	these	_	DET	DT	_	5	det	_	_
5	microorganisms	_	NOUN	NNS	_	2	nmod	_	_
6	does	_	VERB	VBZ	_	8	aux	_	_
7	not	_	ADV	RB	_	8	neg	_	_
8	imply	_	VERB	VB	_	0	root	_	_
9	clinical	_	ADJ	JJ	_	10	amod	_	_
10	efficacy	_	NOUN	NN	_	8	dobj	_	_
11	they	_	PRON	PRP	_	13	nsubjpass	_	_
12	are	_	VERB	VBP	_	13	auxpass	_	_
13	used	_	VERB	VBN	_	8	parataxis	_	_
14	to	_	PRT	TO	_	15	mark	_	_
15	control	_	VERB	VB	_	13	xcomp	_	_
16	the	_	DET	DT	_	18	det	_	_
17	technical	_	ADJ	JJ	_	18	amod	_	_
18	aspects	_	NOUN	NNS	_	15	dobj	_	_
19	of	_	ADP	IN	_	22	case	_	_
20	the	_	DET	DT	_	22	det	_	_
21	laboratory	_	ADJ	JJ	_	22	amod	_	_
22	procedures	_	NOUN	NNS	_	18	nmod	_	_

#	Rifampin	1051
1	Standard	_	ADJ	JJ	_	3	amod	_	_
2	DRUG	_	NOUN	NN	_	3	compound	_	_
3	powder	_	NOUN	NN	_	5	nsubj	_	_
4	should	_	VERB	MD	_	5	aux	_	_
5	give	_	VERB	VB	_	0	root	_	_
6	the	_	DET	DT	_	9	det	_	_
7	following	_	VERB	VBG	_	9	amod	_	_
8	MIC	_	NOUN	NN	_	9	compound	_	_
9	values	_	NOUN	NNS	_	5	dobj	_	_
10	:	_	.	:	_	5	punct	_	_
11	Microorganism	_	NOUN	NN	_	13	compound	_	_
12	MIC	_	NOUN	NN	_	13	compound	_	_
13	mcg	_	NOUN	NN	_	5	parataxis	_	_
14	/	_	.	:	_	13	punct	_	_
15	mL	_	NOUN	NN	_	47	compound	_	_
16	Staphylococcus	_	NOUN	NN	_	47	compound	_	_
17	aureus	_	NOUN	NN	_	47	compound	_	_
18	ATCC	_	NOUN	NN	_	47	compound	_	_
19	29213	_	NUM	CD	_	47	nummod	_	_
20	0.008	_	NUM	CD	_	47	nummod	_	_
21	0.06	_	NUM	CD	_	47	nummod	_	_
22	Enterococcus	_	NOUN	NN	_	47	compound	_	_
23	faecalis	_	NOUN	NN	_	47	compound	_	_
24	ATCC	_	NOUN	NN	_	47	compound	_	_
25	29212	_	NUM	CD	_	47	nummod	_	_
26	1	_	NUM	CD	_	47	nummod	_	_
27	4	_	NUM	CD	_	47	nummod	_	_
28	Escherichia	_	NOUN	NN	_	47	compound	_	_
29	coli	_	NOUN	NN	_	47	compound	_	_
30	ATCC	_	NOUN	NN	_	47	compound	_	_
31	25922	_	NUM	CD	_	47	nummod	_	_
32	8	_	NUM	CD	_	47	nummod	_	_
33	32	_	NUM	CD	_	47	nummod	_	_
34	Pseudomonas	_	NOUN	NNS	_	47	compound	_	_
35	aeruginosa	_	NOUN	NN	_	47	compound	_	_
36	ATCC	_	NOUN	NN	_	47	compound	_	_
37	27853	_	NUM	CD	_	47	nummod	_	_
38	32	_	NUM	CD	_	47	nummod	_	_
39	64	_	NUM	CD	_	47	nummod	_	_
40	Haemophilus	_	NOUN	NN	_	47	compound	_	_
41	influenzae	_	ADJ	JJ	_	47	amod	_	_
42	ATCC	_	NOUN	NN	_	47	compound	_	_
43	49247	_	NUM	CD	_	47	nummod	_	_
44	0.25	_	NUM	CD	_	47	nummod	_	_
45	1	_	NUM	CD	_	47	nummod	_	_
46	Diffusion	_	NOUN	NN	_	47	compound	_	_
47	Techniques	_	NOUN	NNS	_	13	dep	_	_
48	:	_	.	:	_	13	punct	_	_
49	Quantitative	_	ADJ	JJ	_	50	amod	_	_
50	methods	_	NOUN	NNS	_	57	nsubj	_	_
51	that	_	DET	WDT	_	52	nsubj	_	_
52	require	_	VERB	VBP	_	50	acl:relcl	_	_
53	measurement	_	NOUN	NN	_	52	dobj	_	_
54	of	_	ADP	IN	_	56	case	_	_
55	zone	_	NOUN	NN	_	56	compound	_	_
56	diameters	_	NOUN	NNS	_	53	nmod	_	_
57	provide	_	VERB	VBP	_	13	dep	_	_
58	reproducible	_	ADJ	JJ	_	59	amod	_	_
59	estimates	_	NOUN	NNS	_	57	dobj	_	_
60	of	_	ADP	IN	_	62	case	_	_
61	the	_	DET	DT	_	62	det	_	_
62	susceptibility	_	NOUN	NN	_	59	nmod	_	_
63	of	_	ADP	IN	_	64	case	_	_
64	bacteria	_	NOUN	NN	_	62	nmod	_	_
65	to	_	PRT	TO	_	67	case	_	_
66	antimicrobial	_	ADJ	JJ	_	67	amod	_	_
67	compounds	_	NOUN	NNS	_	62	nmod	_	_

#	Rifampin	1052
1	One	_	NUM	CD	_	4	nummod	_	_
2	such	_	ADJ	JJ	_	4	amod	_	_
3	standardized	_	ADJ	JJ	_	4	amod	_	_
4	procedure3,4	_	NOUN	NN	_	21	nsubj	_	_
5	that	_	DET	WDT	_	8	nsubjpass	_	_
6	has	_	VERB	VBZ	_	8	aux	_	_
7	been	_	VERB	VBN	_	8	auxpass	_	_
8	recommended	_	VERB	VBN	_	4	acl:relcl	_	_
9	for	_	ADP	IN	_	10	case	_	_
10	use	_	NOUN	NN	_	8	nmod	_	_
11	with	_	ADP	IN	_	12	case	_	_
12	disks	_	NOUN	NNS	_	10	nmod	_	_
13	to	_	PRT	TO	_	14	mark	_	_
14	test	_	VERB	VB	_	10	acl	_	_
15	the	_	DET	DT	_	16	det	_	_
16	susceptibility	_	NOUN	NN	_	14	dobj	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	microorganisms	_	NOUN	NNS	_	16	nmod	_	_
19	to	_	PRT	TO	_	20	case	_	_
20	DRUG	_	NOUN	NN	_	16	nmod	_	_
21	uses	_	VERB	VBZ	_	0	root	_	_
22	the	_	DET	DT	_	26	det	_	_
23	5	_	NUM	CD	_	26	nummod	_	_
24	mcg	_	NOUN	NN	_	26	compound	_	_
25	DRUG	_	NOUN	NN	_	26	compound	_	_
26	disk	_	NOUN	NN	_	21	dobj	_	_

#	Rifampin	1053
1	Interpretation	_	NOUN	NN	_	2	nsubj	_	_
2	involves	_	VERB	VBZ	_	0	root	_	_
3	correlation	_	NOUN	NN	_	2	dobj	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	the	_	DET	DT	_	6	det	_	_
6	diameter	_	NOUN	NN	_	3	nmod	_	_
7	obtained	_	VERB	VBN	_	6	acl	_	_
8	in	_	ADP	IN	_	11	case	_	_
9	the	_	DET	DT	_	11	det	_	_
10	disk	_	NOUN	NN	_	11	compound	_	_
11	test	_	NOUN	NN	_	7	nmod	_	_
12	with	_	ADP	IN	_	14	case	_	_
13	the	_	DET	DT	_	14	det	_	_
14	MIC	_	NOUN	NN	_	11	nmod	_	_
15	for	_	ADP	IN	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	14	nmod	_	_

#	Rifampin	1054
1	Reports	_	NOUN	NNS	_	22	nsubjpass	_	_
2	from	_	ADP	IN	_	4	case	_	_
3	the	_	DET	DT	_	4	det	_	_
4	laboratory	_	ADJ	JJ	_	1	nmod	_	_
5	providing	_	VERB	VBG	_	4	acl	_	_
6	results	_	NOUN	NNS	_	5	dobj	_	_
7	of	_	ADP	IN	_	13	case	_	_
8	the	_	DET	DT	_	13	det	_	_
9	standard	_	ADJ	JJ	_	13	amod	_	_
10	single	_	ADJ	JJ	_	13	amod	_	_
11	disk	_	NOUN	NN	_	13	compound	_	_
12	susceptibility	_	NOUN	NN	_	13	compound	_	_
13	test	_	NOUN	NN	_	6	nmod	_	_
14	with	_	ADP	IN	_	19	case	_	_
15	a	_	DET	DT	_	19	det	_	_
16	5	_	NUM	CD	_	19	nummod	_	_
17	mcg	_	NOUN	NN	_	19	compound	_	_
18	DRUG	_	NOUN	NN	_	19	compound	_	_
19	disk	_	NOUN	NN	_	5	nmod	_	_
20	should	_	VERB	MD	_	22	aux	_	_
21	be	_	VERB	VB	_	22	auxpass	_	_
22	interpreted	_	VERB	VBN	_	0	root	_	_
23	according	_	ADP	IN	_	27	case	_	_
24	to	_	PRT	TO	_	27	case	_	_
25	the	_	DET	DT	_	27	det	_	_
26	following	_	VERB	VBG	_	27	amod	_	_
27	criteria	_	NOUN	NN	_	22	nmod	_	_
28	for	_	ADP	IN	_	30	case	_	_
29	Neisseria	_	NOUN	NN	_	30	compound	_	_
30	meningitides	_	NOUN	NNS	_	27	nmod	_	_
31	:	_	.	:	_	22	punct	_	_
32	Zone	_	NOUN	NN	_	48	compound	_	_
33	Diameter	_	NOUN	NN	_	48	compound	_	_
34	mm	_	NOUN	NN	_	48	compound	_	_
35	Interpretation	_	NOUN	NN	_	48	compound	_	_
36	>	_	NUM	CD	_	48	nummod	_	_
37	20	_	NUM	CD	_	48	nummod	_	_
38	S	_	NOUN	NN	_	48	compound	_	_
39	Susceptible	_	ADJ	JJ	_	48	amod	_	_
40	17	_	NUM	CD	_	48	nummod	_	_
41	19	_	NUM	CD	_	48	nummod	_	_
42	I	_	NUM	CD	_	48	nummod	_	_
43	Intermediate	_	ADJ	JJ	_	48	amod	_	_
44	<	_	NUM	CD	_	48	nummod	_	_
45	16	_	NUM	CD	_	48	nummod	_	_
46	R	_	NOUN	NN	_	48	compound	_	_
47	Resistant	_	ADJ	JJ	_	48	amod	_	_
48	Interpretation	_	NOUN	NN	_	52	nsubjpass	_	_
49	should	_	VERB	MD	_	52	aux	_	_
50	be	_	VERB	VB	_	52	auxpass	_	_
51	as	_	ADP	IN	_	52	mark	_	_
52	stated	_	VERB	VBN	_	22	parataxis	_	_
53	above	_	ADP	IN	_	55	case	_	_
54	for	_	ADP	IN	_	55	case	_	_
55	results	_	NOUN	NNS	_	52	nmod	_	_
56	using	_	VERB	VBG	_	55	acl	_	_
57	dilution	_	NOUN	NN	_	58	compound	_	_
58	techniques	_	NOUN	NNS	_	56	dobj	_	_

#	Rifampin	1055
1	As	_	ADP	IN	_	5	case	_	_
2	with	_	ADP	IN	_	5	case	_	_
3	standard	_	ADJ	JJ	_	5	amod	_	_
4	dilution	_	NOUN	NN	_	5	compound	_	_
5	techniques	_	NOUN	NNS	_	9	nmod	_	_
6	,	_	.	,	_	9	punct	_	_
7	diffusion	_	NOUN	NN	_	8	compound	_	_
8	methods	_	NOUN	NNS	_	9	nsubj	_	_
9	require	_	VERB	VBP	_	0	root	_	_
10	the	_	DET	DT	_	11	det	_	_
11	use	_	NOUN	NN	_	9	dobj	_	_
12	of	_	ADP	IN	_	15	case	_	_
13	laboratory	_	ADJ	JJ	_	15	amod	_	_
14	control	_	NOUN	NN	_	15	compound	_	_
15	microorganisms	_	NOUN	NNS	_	11	nmod	_	_

#	Rifampin	1057
1	The	_	DET	DT	_	5	det	_	_
2	5	_	NUM	CD	_	5	nummod	_	_
3	mcg	_	NOUN	NN	_	5	compound	_	_
4	DRUG	_	NOUN	NN	_	5	compound	_	_
5	disk	_	NOUN	NN	_	7	nsubj	_	_
6	should	_	VERB	MD	_	7	aux	_	_
7	provide	_	VERB	VB	_	0	root	_	_
8	the	_	DET	DT	_	11	det	_	_
9	following	_	VERB	VBG	_	11	amod	_	_
10	zone	_	NOUN	NN	_	11	compound	_	_
11	diameters	_	NOUN	NNS	_	7	dobj	_	_
12	in	_	ADP	IN	_	16	case	_	_
13	these	_	DET	DT	_	16	det	_	_
14	quality	_	NOUN	NN	_	16	compound	_	_
15	control	_	NOUN	NN	_	16	compound	_	_
16	strains	_	NOUN	NNS	_	11	nmod	_	_
17	:	_	.	:	_	7	punct	_	_
18	Microorganism	_	NOUN	NN	_	24	compound	_	_
19	Zone	_	NOUN	NN	_	24	compound	_	_
20	Diameter	_	NOUN	NN	_	24	compound	_	_
21	mm	_	NOUN	NN	_	24	compound	_	_
22	S	_	NOUN	NN	_	24	compound	_	_
23	aureus	_	NOUN	NN	_	24	compound	_	_
24	ATCC	_	NOUN	NN	_	7	parataxis	_	_
25	25923	_	NUM	CD	_	30	nummod	_	_
26	26	_	NUM	CD	_	30	nummod	_	_
27	34	_	NUM	CD	_	30	nummod	_	_
28	E	_	NOUN	NN	_	30	compound	_	_
29	coli	_	NOUN	NN	_	30	compound	_	_
30	ATCC	_	NOUN	NN	_	24	dep	_	_
31	25922	_	NUM	CD	_	30	nummod	_	_
32	8	_	NUM	CD	_	31	dep	_	_
33	10	_	NUM	CD	_	36	nummod	_	_
34	H	_	NOUN	NN	_	36	compound	_	_
35	influenzae	_	ADJ	JJ	_	36	amod	_	_
36	ATCC	_	NOUN	NN	_	32	dep	_	_
37	49247	_	NUM	CD	_	36	nummod	_	_
38	22	_	NUM	CD	_	37	dep	_	_
39	30	_	NUM	CD	_	38	nummod	_	_

#	Risperidone	5056
1	Carbamazepine	_	NOUN	NN	_	6	nsubj	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	other	_	ADJ	JJ	_	5	amod	_	_
4	enzyme	_	NOUN	NN	_	5	compound	_	_
5	inducers	_	NOUN	NNS	_	1	conj	_	_
6	decrease	_	VERB	VBP	_	0	root	_	_
7	plasma	_	NOUN	NN	_	8	compound	_	_
8	concentrations	_	NOUN	NNS	_	6	dobj	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_

#	Risperidone	5057
1	Increase	_	VERB	VB	_	0	root	_	_
2	the	_	DET	DT	_	4	det	_	_
3	respiridone	_	NOUN	NN	_	4	compound	_	_
4	dose	_	NOUN	NN	_	1	dobj	_	_
5	up	_	ADV	RB	_	7	advmod	_	_
6	to	_	PRT	TO	_	7	mark	_	_
7	double	_	ADJ	JJ	_	1	advcl	_	_
8	the	_	DET	DT	_	9	det	_	_
9	patient's	_	NOUN	NNS	_	7	dobj	_	_
10	usual	_	ADJ	JJ	_	11	amod	_	_
11	dose	_	NOUN	NN	_	9	dep	_	_

#	Risperidone	5058
1	Fluoxetine	_	NOUN	NN	_	11	nsubj	_	_
2	,	_	.	,	_	1	punct	_	_
3	paroxetine	_	NOUN	NN	_	1	conj	_	_
4	,	_	.	,	_	1	punct	_	_
5	and	_	CONJ	CC	_	1	cc	_	_
6	other	_	ADJ	JJ	_	10	amod	_	_
7	CYP	_	NOUN	NN	_	10	compound	_	_
8	2D6	_	NOUN	NN	_	10	compound	_	_
9	enzyme	_	NOUN	NN	_	10	compound	_	_
10	inhibitors	_	NOUN	NNS	_	1	conj	_	_
11	increase	_	VERB	VBP	_	0	root	_	_
12	plasma	_	NOUN	NN	_	13	compound	_	_
13	concentrations	_	NOUN	NNS	_	11	dobj	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	DRUG	_	NOUN	NN	_	13	nmod	_	_

#	Risperidone	5059
1	Do	_	PRT	TO	_	3	mark	_	_
2	not	_	ADV	RB	_	3	neg	_	_
3	exceed	_	VERB	VB	_	0	root	_	_
4	a	_	DET	DT	_	6	det	_	_
5	final	_	ADJ	JJ	_	6	amod	_	_
6	dose	_	NOUN	NN	_	3	dobj	_	_
7	of	_	ADP	IN	_	9	case	_	_
8	8	_	NUM	CD	_	9	nummod	_	_
9	mg	_	NOUN	NN	_	6	nmod	_	_
10	per	_	ADP	IN	_	11	case	_	_
11	day	_	NOUN	NN	_	6	nmod	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	respiridone	_	NOUN	NN	_	11	nmod	_	_

#	Risperidone	5060
1	The	_	DET	DT	_	2	det	_	_
2	dose	_	NOUN	NN	_	7	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	should	_	VERB	MD	_	7	aux	_	_
6	be	_	VERB	VB	_	7	auxpass	_	_
7	adjusted	_	VERB	VBN	_	0	root	_	_
8	when	_	ADV	WRB	_	9	advmod	_	_
9	used	_	VERB	VBN	_	7	advcl	_	_
10	in	_	ADP	IN	_	11	case	_	_
11	combination	_	NOUN	NN	_	9	nmod	_	_
12	with	_	ADP	IN	_	15	case	_	_
13	CYP2D6	_	NOUN	NN	_	15	compound	_	_
14	enzyme	_	NOUN	NN	_	15	compound	_	_
15	inhibitors	_	NOUN	NNS	_	11	nmod	_	_
16	e.g	_	NOUN	NN	_	15	dep	_	_
17	,	_	.	,	_	16	punct	_	_
18	fluoxetine	_	NOUN	NN	_	16	conj	_	_
19	,	_	.	,	_	16	punct	_	_
20	and	_	CONJ	CC	_	16	cc	_	_
21	paroxetine	_	NOUN	NN	_	16	conj	_	_
22	and	_	CONJ	CC	_	16	cc	_	_
23	enzyme	_	NOUN	NN	_	24	compound	_	_
24	inducers	_	NOUN	NNS	_	16	conj	_	_
25	e.g	_	NOUN	NN	_	24	dep	_	_
26	,	_	.	,	_	16	punct	_	_
27	carbamazepine	_	NOUN	NN	_	16	appos	_	_

#	Risperidone	5061
1	Dose	_	NOUN	NN	_	2	compound	_	_
2	adjustment	_	NOUN	NN	_	5	nsubjpass	_	_
3	is	_	VERB	VBZ	_	5	auxpass	_	_
4	not	_	ADV	RB	_	5	neg	_	_
5	recommended	_	VERB	VBN	_	0	root	_	_
6	for	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	when	_	ADV	WRB	_	10	advmod	_	_
9	co	_	PRT	TO	_	10	mark	_	_
10	administered	_	VERB	VBN	_	5	advcl	_	_
11	with	_	ADP	IN	_	12	case	_	_
12	ranitidine	_	NOUN	NN	_	10	nmod	_	_
13	,	_	.	,	_	12	punct	_	_
14	cimetidine	_	NOUN	NN	_	12	conj	_	_
15	,	_	.	,	_	12	punct	_	_
16	amitriptyline	_	NOUN	NN	_	12	conj	_	_
17	,	_	.	,	_	12	punct	_	_
18	or	_	CONJ	CC	_	12	cc	_	_
19	erythromycin	_	NOUN	NN	_	12	conj	_	_

#	Risperidone	5062
1	Table	_	ADJ	JJ	_	3	amod	_	_
2	18	_	NUM	CD	_	3	nummod	_	_
3	Summary	_	NOUN	NN	_	0	root	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	Effect	_	NOUN	NN	_	3	nmod	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	Coadministered	_	ADJ	JJ	_	8	amod	_	_
8	Drugs	_	NOUN	NNS	_	5	nmod	_	_
9	on	_	ADP	IN	_	10	case	_	_
10	Exposure	_	NOUN	NN	_	3	nmod	_	_
11	to	_	PRT	TO	_	14	case	_	_
12	Active	_	ADJ	JJ	_	14	amod	_	_
13	Moiety	_	NOUN	NN	_	14	compound	_	_
14	DRUG	_	NOUN	NN	_	10	nmod	_	_
15	+	_	CONJ	CC	_	14	cc	_	_
16	9	_	NUM	CD	_	18	nummod	_	_
17	Hydroxy	_	NOUN	NN	_	18	compound	_	_
18	DRUG	_	NOUN	NN	_	14	conj	_	_
19	in	_	ADP	IN	_	21	case	_	_
20	Healthy	_	ADJ	JJ	_	21	amod	_	_
21	Subjects	_	NOUN	NNS	_	10	nmod	_	_
22	or	_	CONJ	CC	_	21	cc	_	_
23	Patients	_	NOUN	NNS	_	21	conj	_	_
24	with	_	ADP	IN	_	40	case	_	_
25	Schizophrenia	_	NOUN	NN	_	40	compound	_	_
26	CoadministeredDrug	_	ADJ	JJ	_	40	amod	_	_
27	DosingSchedule	_	NOUN	NN	_	40	compound	_	_
28	EffectonActiveMoiety	_	NOUN	NN	_	40	compound	_	_
29	DRUG	_	NOUN	NN	_	40	compound	_	_
30	+9	_	NUM	CD	_	40	nummod	_	_
31	Hydroxy	_	NOUN	NN	_	40	compound	_	_
32	DRUG	_	NOUN	NN	_	40	compound	_	_
33	Ratio*	_	NOUN	NN	_	40	compound	_	_
34	DRUG	_	NOUN	NN	_	40	compound	_	_
35	DoseRecommendation	_	NOUN	NN	_	40	compound	_	_
36	CoadministeredDrug	_	ADJ	JJ	_	40	amod	_	_
37	DRUG	_	NOUN	NN	_	40	compound	_	_
38	AUC	_	NOUN	NN	_	40	compound	_	_
39	Cmax	_	NOUN	NN	_	40	compound	_	_
40	Enzyme(CYP2D6)Inhibitors	_	NOUN	NNS	_	21	nmod	_	_
41	Fluoxetine	_	NOUN	NN	_	42	nmod:npmod	_	_
42	20mg	_	ADJ	JJ	_	40	amod	_	_
43	/	_	.	:	_	3	punct	_	_
44	day	_	NOUN	NN	_	46	compound	_	_
45	2or3mgtwicedaily	_	ADV	RB	_	46	advmod	_	_
46	1.4	_	NUM	CD	_	3	dep	_	_
47	1.5	_	NUM	CD	_	49	nummod	_	_
48	Re	_	NOUN	NN	_	49	compound	_	_
49	evaluatedosing	_	VERB	VBG	_	46	dep	_	_

#	Risperidone	5063
1	Donotexceed8mg	_	NOUN	NN	_	0	root	_	_
2	/	_	.	:	_	1	punct	_	_
3	day	_	NOUN	NN	_	5	compound	_	_
4	Paroxetine	_	NOUN	NN	_	5	compound	_	_
5	10mg	_	ADJ	JJ	_	13	compound	_	_
6	/	_	.	-RRB-	_	5	punct	_	_
7	day	_	NOUN	NN	_	8	compound	_	_
8	4mg	_	NOUN	NN	_	5	dep	_	_
9	/	_	.	:	_	13	punct	_	_
10	day	_	NOUN	NN	_	13	compound	_	_
11	1.3	_	NUM	CD	_	13	nummod	_	_
12	Re	_	NOUN	NN	_	13	compound	_	_
13	evaluatedosing	_	VERB	VBG	_	1	dep	_	_

#	Risperidone	5064
1	Do	_	PRT	TO	_	3	mark	_	_
2	not	_	ADV	RB	_	3	neg	_	_
3	exceed	_	VERB	VBN	_	0	root	_	_
4	8	_	NUM	CD	_	5	nummod	_	_
5	mg	_	NOUN	NN	_	3	dobj	_	_
6	/	_	.	:	_	3	punct	_	_
7	day	_	NOUN	NN	_	9	compound	_	_
8	Enzyme	_	NOUN	NN	_	9	compound	_	_
9	CYP3A	_	NOUN	NN	_	3	parataxis	_	_
10	/	_	.	:	_	9	punct	_	_
11	PgP	_	NOUN	NN	_	17	compound	_	_
12	inducers)Inducers	_	NOUN	NNS	_	17	compound	_	_
13	Carbamazepine	_	NOUN	NN	_	17	compound	_	_
14	573	_	NUM	CD	_	17	nummod	_	_
15	*	_	ADJ	JJ	_	16	advmod	_	_
16	168	_	NUM	CD	_	17	nummod	_	_
17	mg	_	NOUN	NN	_	9	dep	_	_
18	/	_	.	:	_	17	punct	_	_
19	day	_	NOUN	NN	_	21	compound	_	_
20	3	_	NUM	CD	_	21	nummod	_	_
21	mg	_	NOUN	NN	_	28	compound	_	_
22	twice	_	ADV	RB	_	23	advmod	_	_
23	daily	_	ADV	RB	_	24	advmod	_	_
24	0.51	_	NUM	CD	_	28	nummod	_	_
25	0.55	_	NUM	CD	_	28	nummod	_	_
26	Titrate	_	NOUN	NN	_	28	compound	_	_
27	dose	_	NOUN	NN	_	28	compound	_	_
28	upwards	_	NOUN	NNS	_	17	dep	_	_

#	Risperidone	5065
1	Dose	_	ADJ	JJ	_	2	compound	_	_
2	adjustment	_	NOUN	NN	_	7	nsubjpass	_	_
3	for	_	ADP	IN	_	4	case	_	_
4	lithium	_	NOUN	NN	_	2	nmod	_	_
5	is	_	VERB	VBZ	_	7	auxpass	_	_
6	not	_	ADV	RB	_	7	neg	_	_
7	recommended	_	VERB	VBN	_	0	root	_	_

#	Risperidone	5066
1	Valproate	_	NOUN	NN	_	4	compound	_	_
2	Repeated	_	ADJ	JJ	_	4	amod	_	_
3	oral	_	ADJ	JJ	_	4	amod	_	_
4	doses	_	NOUN	NNS	_	13	nsubj	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	DRUG	_	NOUN	NN	_	8	compound	_	_
7	4	_	NUM	CD	_	8	nummod	_	_
8	mg	_	NOUN	NN	_	4	nmod	_	_
9	once	_	ADV	RB	_	10	advmod	_	_
10	daily	_	ADV	RB	_	13	advmod	_	_
11	did	_	VERB	VBD	_	13	aux	_	_
12	not	_	ADV	RB	_	13	neg	_	_
13	affect	_	VERB	VB	_	0	root	_	_
14	the	_	DET	DT	_	16	det	_	_
15	pre	_	NOUN	NN	_	16	compound	_	_
16	dose	_	NOUN	NN	_	13	dobj	_	_
17	or	_	CONJ	CC	_	16	cc	_	_
18	average	_	ADJ	JJ	_	20	amod	_	_
19	plasma	_	NOUN	NN	_	20	compound	_	_
20	concentrations	_	NOUN	NNS	_	16	conj	_	_
21	and	_	CONJ	CC	_	16	cc	_	_
22	exposure	_	NOUN	NN	_	23	compound	_	_
23	AUC	_	NOUN	NN	_	16	conj	_	_
24	of	_	ADP	IN	_	27	case	_	_
25	valproate	_	NOUN	NN	_	27	compound	_	_
26	1000	_	NUM	CD	_	27	nummod	_	_
27	mg	_	NOUN	NN	_	16	nmod	_	_
28	/	_	.	:	_	13	punct	_	_
29	day	_	NOUN	NN	_	34	nsubj	_	_
30	in	_	ADP	IN	_	33	case	_	_
31	three	_	NUM	CD	_	33	nummod	_	_
32	divided	_	ADJ	JJ	_	33	amod	_	_
33	doses	_	NOUN	NNS	_	29	nmod	_	_
34	compared	_	VERB	VBN	_	13	parataxis	_	_
35	to	_	PRT	TO	_	37	case	_	_
36	placebo	_	NOUN	NN	_	37	compound	_	_
37	n=21	_	NOUN	NN	_	34	nmod	_	_

#	Risperidone	5067
1	However	_	ADV	RB	_	4	advmod	_	_
2	,	_	.	,	_	4	punct	_	_
3	there	_	DET	EX	_	4	expl	_	_
4	was	_	VERB	VBD	_	0	root	_	_
5	a	_	DET	DT	_	7	det	_	_
6	20%	_	ADJ	JJ	_	7	amod	_	_
7	increase	_	NOUN	NN	_	4	nsubj	_	_
8	in	_	ADP	IN	_	13	case	_	_
9	valproate	_	NOUN	NN	_	13	compound	_	_
10	peak	_	NOUN	NN	_	13	compound	_	_
11	plasma	_	NOUN	NN	_	13	compound	_	_
12	concentration	_	NOUN	NN	_	13	compound	_	_
13	Cmax	_	NOUN	NN	_	7	nmod	_	_
14	after	_	ADP	IN	_	16	case	_	_
15	concomitant	_	ADJ	JJ	_	16	amod	_	_
16	administration	_	NOUN	NN	_	4	nmod	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	DRUG	_	NOUN	NN	_	16	nmod	_	_

#	Risperidone	5068
1	Dose	_	ADJ	JJ	_	2	compound	_	_
2	adjustment	_	NOUN	NN	_	7	nsubjpass	_	_
3	for	_	ADP	IN	_	4	case	_	_
4	valproate	_	NOUN	NN	_	2	nmod	_	_
5	is	_	VERB	VBZ	_	7	auxpass	_	_
6	not	_	ADV	RB	_	7	neg	_	_
7	recommended	_	VERB	VBN	_	0	root	_	_

#	Risperidone	5069
1	Digoxin	_	NOUN	NN	_	4	compound	_	_
2	DRUG	_	NOUN	NN	_	4	compound	_	_
3	0.25	_	NUM	CD	_	4	nummod	_	_
4	mg	_	NOUN	NN	_	9	nsubj	_	_
5	twice	_	ADV	RB	_	9	advmod	_	_
6	daily	_	ADV	RB	_	9	advmod	_	_
7	did	_	VERB	VBD	_	9	aux	_	_
8	not	_	ADV	RB	_	9	neg	_	_
9	show	_	VERB	VB	_	0	root	_	_
10	a	_	DET	DT	_	13	det	_	_
11	clinically	_	ADV	RB	_	12	advmod	_	_
12	relevant	_	ADJ	JJ	_	13	amod	_	_
13	effect	_	NOUN	NN	_	9	dobj	_	_
14	on	_	ADP	IN	_	16	case	_	_
15	the	_	DET	DT	_	16	det	_	_
16	pharmacokinetics	_	NOUN	NNS	_	13	nmod	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	digoxin	_	NOUN	NN	_	16	nmod	_	_

#	Risperidone	5070
1	Dose	_	ADJ	JJ	_	2	compound	_	_
2	adjustment	_	NOUN	NN	_	7	nsubjpass	_	_
3	for	_	ADP	IN	_	4	case	_	_
4	digoxin	_	NOUN	NN	_	2	nmod	_	_
5	is	_	VERB	VBZ	_	7	auxpass	_	_
6	not	_	ADV	RB	_	7	neg	_	_
7	recommended	_	VERB	VBN	_	0	root	_	_

#	Risperidone	5071
1	Centrally	_	ADV	RB	_	2	advmod	_	_
2	Acting	_	ADJ	JJ	_	3	amod	_	_
3	Drugs	_	NOUN	NNS	_	6	nsubj	_	_
4	and	_	CONJ	CC	_	3	cc	_	_
5	Alcohol	_	NOUN	NN	_	3	conj	_	_
6	Given	_	VERB	VBD	_	0	root	_	_
7	the	_	DET	DT	_	10	det	_	_
8	primary	_	ADJ	JJ	_	10	amod	_	_
9	CNS	_	NOUN	NN	_	10	compound	_	_
10	effects	_	NOUN	NNS	_	6	dobj	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_
13	,	_	.	,	_	6	punct	_	_
14	caution	_	NOUN	NN	_	17	nsubjpass	_	_
15	should	_	VERB	MD	_	17	aux	_	_
16	be	_	VERB	VB	_	17	auxpass	_	_
17	used	_	VERB	VBN	_	6	parataxis	_	_
18	when	_	ADV	WRB	_	21	advmod	_	_
19	DRUG	_	NOUN	NN	_	21	nsubjpass	_	_
20	is	_	VERB	VBZ	_	21	auxpass	_	_
21	taken	_	VERB	VBN	_	17	advcl	_	_
22	in	_	ADP	IN	_	23	case	_	_
23	combination	_	NOUN	NN	_	21	nmod	_	_
24	with	_	ADP	IN	_	28	case	_	_
25	other	_	ADJ	JJ	_	28	amod	_	_
26	centrally	_	ADV	RB	_	27	advmod	_	_
27	acting	_	VERB	VBG	_	28	amod	_	_
28	drugs	_	NOUN	NNS	_	23	nmod	_	_
29	and	_	CONJ	CC	_	28	cc	_	_
30	alcohol	_	NOUN	NN	_	28	conj	_	_

#	Risperidone	5072
1	Drugs	_	NOUN	NNS	_	15	nsubj	_	_
2	with	_	ADP	IN	_	4	case	_	_
3	Hypotensive	_	ADJ	JJ	_	4	amod	_	_
4	Effects	_	NOUN	NNS	_	1	nmod	_	_
5	Because	_	ADP	IN	_	8	case	_	_
6	of	_	ADP	IN	_	5	mwe	_	_
7	its	_	PRON	PRP$	_	8	nmod:poss	_	_
8	potential	_	NOUN	NN	_	1	nmod	_	_
9	for	_	ADP	IN	_	10	mark	_	_
10	inducing	_	VERB	VBG	_	8	acl	_	_
11	hypotension	_	NOUN	NN	_	10	dobj	_	_
12	,	_	.	,	_	1	punct	_	_
13	DRUG	_	NOUN	NN	_	1	appos	_	_
14	may	_	VERB	MD	_	15	aux	_	_
15	enhance	_	VERB	VB	_	0	root	_	_
16	the	_	DET	DT	_	18	det	_	_
17	hypotensive	_	ADJ	JJ	_	18	amod	_	_
18	effects	_	NOUN	NNS	_	15	dobj	_	_
19	of	_	ADP	IN	_	22	case	_	_
20	other	_	ADJ	JJ	_	22	amod	_	_
21	therapeutic	_	ADJ	JJ	_	22	amod	_	_
22	agents	_	NOUN	NNS	_	18	nmod	_	_
23	with	_	ADP	IN	_	25	case	_	_
24	this	_	DET	DT	_	25	det	_	_
25	potential	_	ADJ	JJ	_	22	nmod	_	_

#	Risperidone	5073
1	Levodopa	_	NOUN	NN	_	4	nsubj	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	Dopamine	_	NOUN	NN	_	1	conj	_	_
4	Agonists	_	VERB	VBP	_	0	root	_	_
5	DRUG	_	NOUN	NN	_	4	dobj	_	_
6	may	_	VERB	MD	_	7	aux	_	_
7	antagonize	_	VERB	VB	_	4	parataxis	_	_
8	the	_	DET	DT	_	9	det	_	_
9	effects	_	NOUN	NNS	_	7	dobj	_	_
10	of	_	ADP	IN	_	14	case	_	_
11	levodopa	_	NOUN	NN	_	14	compound	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	dopamine	_	NOUN	NN	_	11	conj	_	_
14	agonists	_	NOUN	NNS	_	9	nmod	_	_

#	Risperidone	5074
1	Clozapine	_	NOUN	NN	_	3	compound	_	_
2	Chronic	_	ADJ	JJ	_	3	amod	_	_
3	administration	_	NOUN	NN	_	9	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	clozapine	_	NOUN	NN	_	3	nmod	_	_
6	with	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	3	nmod	_	_
8	may	_	VERB	MD	_	9	aux	_	_
9	decrease	_	VERB	VB	_	0	root	_	_
10	the	_	DET	DT	_	11	det	_	_
11	clearance	_	NOUN	NN	_	9	dobj	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	DRUG	_	NOUN	NN	_	11	nmod	_	_

#	Risperidone	5075
1	The	_	DET	DT	_	2	det	_	_
2	mechanism	_	NOUN	NN	_	12	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	action	_	NOUN	NN	_	2	nmod	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	,	_	.	,	_	4	punct	_	_
8	in	_	ADP	IN	_	9	case	_	_
9	schizophrenia	_	NOUN	NN	_	4	nmod	_	_
10	,	_	.	,	_	2	punct	_	_
11	is	_	VERB	VBZ	_	12	auxpass	_	_
12	unknown	_	ADJ	JJ	_	0	root	_	_

#	Risperidone	5076
1	However	_	ADV	RB	_	6	advmod	_	_
2	,	_	.	,	_	6	punct	_	_
3	it	_	PRON	PRP	_	6	nsubjpass	_	_
4	has	_	VERB	VBZ	_	6	aux	_	_
5	been	_	VERB	VBN	_	6	auxpass	_	_
6	proposed	_	VERB	VBN	_	0	root	_	_
7	that	_	ADP	IN	_	16	mark	_	_
8	the	_	DET	DT	_	11	det	_	_
9	drug's	_	NOUN	NNS	_	11	compound	_	_
10	therapeutic	_	ADJ	JJ	_	11	amod	_	_
11	activity	_	NOUN	NN	_	16	nsubjpass	_	_
12	in	_	ADP	IN	_	13	case	_	_
13	schizophrenia	_	NOUN	NN	_	11	nmod	_	_
14	could	_	VERB	MD	_	16	aux	_	_
15	be	_	VERB	VB	_	16	auxpass	_	_
16	mediated	_	VERB	VBN	_	6	ccomp	_	_
17	through	_	ADP	IN	_	19	case	_	_
18	a	_	DET	DT	_	19	det	_	_
19	combination	_	NOUN	NN	_	16	nmod	_	_
20	of	_	ADP	IN	_	24	case	_	_
21	dopamine	_	NOUN	NN	_	24	compound	_	_
22	Type	_	NOUN	NN	_	24	compound	_	_
23	2	_	NUM	CD	_	24	nummod	_	_
24	D2	_	NOUN	NN	_	19	nmod	_	_
25	and	_	CONJ	CC	_	24	cc	_	_
26	serotonin	_	NOUN	NN	_	31	compound	_	_
27	Type	_	NOUN	NN	_	31	compound	_	_
28	2	_	NUM	CD	_	31	nummod	_	_
29	5HT2	_	NOUN	NN	_	31	compound	_	_
30	receptor	_	NOUN	NN	_	31	compound	_	_
31	antagonism	_	NOUN	NN	_	24	conj	_	_

#	Risperidone	5077
1	The	_	DET	DT	_	3	det	_	_
2	clinical	_	ADJ	JJ	_	3	amod	_	_
3	effect	_	NOUN	NN	_	6	nsubj	_	_
4	from	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	results	_	VERB	VBZ	_	0	root	_	_
7	from	_	ADP	IN	_	10	case	_	_
8	the	_	DET	DT	_	10	det	_	_
9	combined	_	ADJ	JJ	_	10	amod	_	_
10	concentrations	_	NOUN	NNS	_	6	nmod	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	its	_	PRON	PRP$	_	16	nmod:poss	_	_
15	major	_	ADJ	JJ	_	16	amod	_	_
16	metabolite	_	NOUN	NN	_	12	conj	_	_
17	,	_	.	,	_	6	punct	_	_
18	9	_	NUM	CD	_	20	nummod	_	_
19	hydroxy	_	NOUN	NN	_	20	compound	_	_
20	DRUG	_	NOUN	NN	_	6	dobj	_	_

#	Risperidone	5078
1	Antagonism	_	NOUN	NN	_	10	nsubj	_	_
2	at	_	ADP	IN	_	3	case	_	_
3	receptors	_	NOUN	NNS	_	1	nmod	_	_
4	other	_	ADJ	JJ	_	6	case	_	_
5	than	_	ADP	IN	_	4	mwe	_	_
6	D2	_	NOUN	NN	_	3	nmod	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	5HT2	_	NOUN	NN	_	6	conj	_	_
9	may	_	VERB	MD	_	10	aux	_	_
10	explain	_	VERB	VB	_	0	root	_	_
11	some	_	DET	DT	_	10	dobj	_	_
12	of	_	ADP	IN	_	15	case	_	_
13	the	_	DET	DT	_	15	det	_	_
14	other	_	ADJ	JJ	_	15	amod	_	_
15	effects	_	NOUN	NNS	_	11	nmod	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	DRUG	_	NOUN	NN	_	15	nmod	_	_

#	Risperidone	5079
1	DRUG	_	NOUN	NN	_	6	nsubj	_	_
2	is	_	VERB	VBZ	_	6	cop	_	_
3	a	_	DET	DT	_	6	det	_	_
4	selective	_	ADJ	JJ	_	6	amod	_	_
5	monoaminergic	_	ADJ	JJ	_	6	amod	_	_
6	antagonist	_	NOUN	NN	_	0	root	_	_
7	with	_	ADP	IN	_	10	case	_	_
8	high	_	ADJ	JJ	_	10	amod	_	_
9	affinity	_	NOUN	NN	_	10	compound	_	_
10	Ki	_	NOUN	NN	_	6	nmod	_	_
11	of	_	ADP	IN	_	15	case	_	_
12	0.12	_	NUM	CD	_	14	compound	_	_
13	to	_	PRT	TO	_	14	dep	_	_
14	7.3	_	NUM	CD	_	15	nummod	_	_
15	nM	_	NOUN	NN	_	10	nmod	_	_
16	for	_	ADP	IN	_	21	case	_	_
17	the	_	DET	DT	_	21	det	_	_
18	serotonin	_	NOUN	NN	_	21	compound	_	_
19	Type	_	NOUN	NN	_	21	compound	_	_
20	2	_	NUM	CD	_	21	nummod	_	_
21	5HT2	_	NOUN	NN	_	15	nmod	_	_
22	,	_	.	,	_	21	punct	_	_
23	dopamine	_	NOUN	NN	_	26	compound	_	_
24	Type	_	NOUN	NN	_	26	compound	_	_
25	2	_	NUM	CD	_	26	nummod	_	_
26	D2	_	NOUN	NN	_	21	conj	_	_
27	,	_	.	,	_	21	punct	_	_
28	A1	_	NOUN	NN	_	21	conj	_	_
29	and	_	CONJ	CC	_	21	cc	_	_
30	A2	_	NOUN	NN	_	31	compound	_	_
31	adrenergic	_	ADJ	JJ	_	21	conj	_	_
32	,	_	.	,	_	6	punct	_	_
33	and	_	CONJ	CC	_	6	cc	_	_
34	H1	_	NOUN	NN	_	36	compound	_	_
35	histaminergic	_	ADJ	JJ	_	36	amod	_	_
36	receptors	_	NOUN	NNS	_	6	conj	_	_

#	Risperidone	5080
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	acts	_	VERB	VBZ	_	0	root	_	_
3	as	_	ADP	IN	_	5	case	_	_
4	an	_	DET	DT	_	5	det	_	_
5	antagonist	_	NOUN	NN	_	2	nmod	_	_
6	at	_	ADP	IN	_	8	case	_	_
7	other	_	ADJ	JJ	_	8	amod	_	_
8	receptors	_	NOUN	NNS	_	5	nmod	_	_
9	,	_	.	,	_	2	punct	_	_
10	but	_	CONJ	CC	_	2	cc	_	_
11	with	_	ADP	IN	_	13	case	_	_
12	lower	_	ADJ	JJ	_	13	amod	_	_
13	potency	_	NOUN	NN	_	2	conj	_	_

#	Risperidone	5081
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	has	_	VERB	VBZ	_	0	root	_	_
3	low	_	ADJ	JJ	_	2	xcomp	_	_
4	to	_	PRT	TO	_	5	mark	_	_
5	moderate	_	ADJ	JJ	_	3	xcomp	_	_
6	affinity	_	NOUN	NN	_	7	compound	_	_
7	Ki	_	NOUN	NN	_	5	dobj	_	_
8	of	_	ADP	IN	_	12	case	_	_
9	47	_	NUM	CD	_	11	compound	_	_
10	to	_	PRT	TO	_	11	dep	_	_
11	253	_	NUM	CD	_	12	nummod	_	_
12	nM	_	NOUN	NN	_	7	nmod	_	_
13	for	_	ADP	IN	_	16	case	_	_
14	the	_	DET	DT	_	16	det	_	_
15	serotonin	_	NOUN	NN	_	16	compound	_	_
16	5HT1C	_	NOUN	NN	_	7	nmod	_	_
17	,	_	.	,	_	16	punct	_	_
18	5HT1D	_	NOUN	NN	_	16	conj	_	_
19	,	_	.	,	_	16	punct	_	_
20	and	_	CONJ	CC	_	16	cc	_	_
21	5HT1A	_	NOUN	NN	_	22	compound	_	_
22	receptors	_	NOUN	NNS	_	16	conj	_	_
23	,	_	.	,	_	16	punct	_	_
24	weak	_	ADJ	JJ	_	26	amod	_	_
25	affinity	_	NOUN	NN	_	26	compound	_	_
26	Ki	_	NOUN	NN	_	16	conj	_	_
27	of	_	ADP	IN	_	31	case	_	_
28	620	_	NUM	CD	_	30	compound	_	_
29	to	_	PRT	TO	_	30	dep	_	_
30	800	_	NUM	CD	_	31	nummod	_	_
31	nM	_	NOUN	NN	_	26	nmod	_	_
32	for	_	ADP	IN	_	35	case	_	_
33	the	_	DET	DT	_	35	det	_	_
34	dopamine	_	NOUN	NN	_	35	compound	_	_
35	D1	_	NOUN	NN	_	26	nmod	_	_
36	and	_	CONJ	CC	_	35	cc	_	_
37	haloperidol	_	NOUN	NN	_	40	compound	_	_
38	sensitive	_	ADJ	JJ	_	40	amod	_	_
39	sigma	_	NOUN	NN	_	40	compound	_	_
40	site	_	NOUN	NN	_	35	conj	_	_
41	,	_	.	,	_	16	punct	_	_
42	and	_	CONJ	CC	_	16	cc	_	_
43	no	_	DET	DT	_	44	neg	_	_
44	affinity	_	NOUN	NN	_	16	conj	_	_
45	when	_	ADV	WRB	_	46	advmod	_	_
46	tested	_	VERB	VBN	_	5	advcl	_	_
47	at	_	ADP	IN	_	48	case	_	_
48	concentrations	_	NOUN	NNS	_	46	nmod	_	_
49	>10	_	NUM	CD	_	51	nummod	_	_
50	5	_	NUM	CD	_	51	nummod	_	_
51	M	_	NOUN	NN	_	48	dep	_	_
52	for	_	ADP	IN	_	54	case	_	_
53	cholinergic	_	ADJ	JJ	_	54	amod	_	_
54	muscarinic	_	ADJ	JJ	_	48	nmod	_	_
55	or	_	CONJ	CC	_	54	cc	_	_
56	B1	_	NOUN	NN	_	54	conj	_	_
57	and	_	CONJ	CC	_	54	cc	_	_
58	B2	_	NOUN	NN	_	60	compound	_	_
59	adrenergic	_	ADJ	JJ	_	60	amod	_	_
60	receptors	_	NOUN	NNS	_	54	conj	_	_

#	Risperidone	5082
1	Absorption	_	NOUN	NN	_	2	compound	_	_
2	DRUG	_	NOUN	NN	_	5	nsubjpass	_	_
3	is	_	VERB	VBZ	_	5	auxpass	_	_
4	well	_	ADV	RB	_	5	advmod	_	_
5	absorbed	_	VERB	VBN	_	0	root	_	_

#	Risperidone	5083
1	The	_	DET	DT	_	4	det	_	_
2	absolute	_	NOUN	NN	_	4	amod	_	_
3	oral	_	ADJ	JJ	_	4	amod	_	_
4	bioavailability	_	NOUN	NN	_	9	nsubj	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	is	_	VERB	VBZ	_	9	cop	_	_
8	70%	_	ADJ	JJ	_	9	amod	_	_
9	CV=25%	_	NOUN	NN	_	0	root	_	_

#	Risperidone	5084
1	The	_	DET	DT	_	4	det	_	_
2	relative	_	ADJ	JJ	_	4	amod	_	_
3	oral	_	ADJ	JJ	_	4	amod	_	_
4	bioavailability	_	NOUN	NN	_	12	nsubj	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	from	_	ADP	IN	_	9	case	_	_
8	a	_	DET	DT	_	9	det	_	_
9	tablet	_	NOUN	NN	_	4	nmod	_	_
10	is	_	VERB	VBZ	_	12	cop	_	_
11	94%	_	ADJ	JJ	_	12	amod	_	_
12	CV=10%	_	NOUN	NN	_	0	root	_	_
13	when	_	ADV	WRB	_	14	advmod	_	_
14	compared	_	VERB	VBN	_	12	acl	_	_
15	to	_	PRT	TO	_	17	case	_	_
16	a	_	DET	DT	_	17	det	_	_
17	solution	_	NOUN	NN	_	14	nmod	_	_

#	Risperidone	5085
1	Pharmacokinetic	_	ADJ	JJ	_	2	amod	_	_
2	studies	_	NOUN	NNS	_	3	nsubj	_	_
3	showed	_	VERB	VBD	_	0	root	_	_
4	that	_	ADP	IN	_	14	mark	_	_
5	DRUG	_	NOUN	NN	_	8	compound	_	_
6	Orally	_	ADV	RB	_	7	advmod	_	_
7	Disintegrating	_	ADJ	JJ	_	8	amod	_	_
8	Tablets	_	NOUN	NNS	_	14	nsubj	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	DRUG	_	NOUN	NN	_	12	compound	_	_
11	Oral	_	ADJ	JJ	_	12	amod	_	_
12	Solution	_	NOUN	NN	_	8	conj	_	_
13	are	_	VERB	VBP	_	14	cop	_	_
14	bioequivalent	_	ADJ	JJ	_	3	ccomp	_	_
15	to	_	PRT	TO	_	17	case	_	_
16	DRUG	_	NOUN	NN	_	17	compound	_	_
17	Tablets	_	NOUN	NNS	_	14	nmod	_	_

#	Risperidone	5086
1	Plasma	_	NOUN	NN	_	2	compound	_	_
2	concentrations	_	NOUN	NNS	_	22	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	,	_	.	,	_	4	punct	_	_
6	its	_	PRON	PRP$	_	8	nmod:poss	_	_
7	major	_	ADJ	JJ	_	8	amod	_	_
8	metabolite	_	NOUN	NN	_	4	conj	_	_
9	,	_	.	,	_	4	punct	_	_
10	9	_	NUM	CD	_	12	nummod	_	_
11	hydroxy	_	NOUN	NN	_	12	compound	_	_
12	DRUG	_	NOUN	NN	_	4	conj	_	_
13	,	_	.	,	_	4	punct	_	_
14	and	_	CONJ	CC	_	4	cc	_	_
15	DRUG	_	NOUN	NN	_	4	conj	_	_
16	plus	_	CONJ	CC	_	15	cc	_	_
17	9	_	NUM	CD	_	19	nummod	_	_
18	hydroxy	_	NOUN	NN	_	19	compound	_	_
19	DRUG	_	NOUN	NN	_	15	conj	_	_
20	are	_	VERB	VBP	_	22	cop	_	_
21	dose	_	NOUN	NN	_	22	nmod:npmod	_	_
22	proportional	_	ADJ	JJ	_	0	root	_	_
23	over	_	ADP	IN	_	26	case	_	_
24	the	_	DET	DT	_	26	det	_	_
25	dosing	_	ADJ	JJ	_	26	amod	_	_
26	range	_	NOUN	NN	_	22	nmod	_	_
27	of	_	ADP	IN	_	31	case	_	_
28	1	_	NUM	CD	_	30	compound	_	_
29	to	_	PRT	TO	_	30	dep	_	_
30	16	_	NUM	CD	_	31	nummod	_	_
31	mg	_	NOUN	NN	_	26	nmod	_	_
32	daily	_	ADV	RB	_	33	advmod	_	_
33	0.5	_	NUM	CD	_	26	dep	_	_
34	to	_	PRT	TO	_	33	dep	_	_
35	8	_	NUM	CD	_	36	nummod	_	_
36	mg	_	NOUN	NN	_	33	dep	_	_
37	twice	_	ADV	RB	_	38	advmod	_	_
38	daily	_	ADV	RB	_	22	advmod	_	_

#	Risperidone	5087
1	Following	_	VERB	VBG	_	3	case	_	_
2	oral	_	ADJ	JJ	_	3	amod	_	_
3	administration	_	NOUN	NN	_	15	nmod	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	solution	_	NOUN	NN	_	3	nmod	_	_
6	or	_	CONJ	CC	_	5	cc	_	_
7	tablet	_	NOUN	NN	_	5	conj	_	_
8	,	_	.	,	_	15	punct	_	_
9	mean	_	ADJ	JJ	_	12	amod	_	_
10	peak	_	ADJ	JJ	_	12	amod	_	_
11	plasma	_	NOUN	NN	_	12	compound	_	_
12	concentrations	_	NOUN	NNS	_	15	nsubj	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	DRUG	_	NOUN	NN	_	12	nmod	_	_
15	occurred	_	VERB	VBD	_	0	root	_	_
16	at	_	ADP	IN	_	19	case	_	_
17	about	_	ADP	IN	_	18	advmod	_	_
18	1	_	NUM	CD	_	19	nummod	_	_
19	hour	_	NUM	CD	_	15	nmod	_	_

#	Risperidone	5088
1	Peak	_	ADJ	JJ	_	2	amod	_	_
2	concentrations	_	NOUN	NNS	_	7	nsubj	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	9	_	NUM	CD	_	6	nummod	_	_
5	hydroxy	_	NOUN	NN	_	6	compound	_	_
6	DRUG	_	NOUN	NN	_	2	nmod	_	_
7	occurred	_	VERB	VBD	_	0	root	_	_
8	at	_	ADP	IN	_	11	case	_	_
9	about	_	ADV	RB	_	10	advmod	_	_
10	3	_	NUM	CD	_	11	nummod	_	_
11	hours	_	NOUN	NNS	_	7	nmod	_	_
12	in	_	ADP	IN	_	14	case	_	_
13	extensive	_	ADJ	JJ	_	14	amod	_	_
14	metabolizers	_	NOUN	NNS	_	11	nmod	_	_
15	,	_	.	,	_	7	punct	_	_
16	and	_	CONJ	CC	_	7	cc	_	_
17	17	_	NUM	CD	_	18	nummod	_	_
18	hours	_	NOUN	NNS	_	7	conj	_	_
19	in	_	ADP	IN	_	21	case	_	_
20	poor	_	ADJ	JJ	_	21	amod	_	_
21	metabolizers	_	NOUN	NNS	_	18	nmod	_	_

#	Risperidone	5089
1	Steady	_	ADJ	JJ	_	3	amod	_	_
2	state	_	NOUN	NN	_	3	compound	_	_
3	concentrations	_	NOUN	NNS	_	7	nsubjpass	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	are	_	VERB	VBP	_	7	auxpass	_	_
7	reached	_	VERB	VBN	_	0	root	_	_
8	in	_	ADP	IN	_	10	case	_	_
9	1	_	NUM	CD	_	10	nummod	_	_
10	day	_	NOUN	NN	_	7	nmod	_	_
11	in	_	ADP	IN	_	13	case	_	_
12	extensive	_	ADJ	JJ	_	13	amod	_	_
13	metabolizers	_	NOUN	NNS	_	10	nmod	_	_
14	and	_	CONJ	CC	_	7	cc	_	_
15	would	_	VERB	MD	_	17	aux	_	_
16	be	_	VERB	VB	_	17	auxpass	_	_
17	expected	_	VERB	VBN	_	7	conj	_	_
18	to	_	PRT	TO	_	19	mark	_	_
19	reach	_	VERB	VB	_	17	xcomp	_	_
20	steady	_	ADJ	JJ	_	21	amod	_	_
21	state	_	NOUN	NN	_	19	dobj	_	_
22	in	_	ADP	IN	_	25	case	_	_
23	about	_	ADV	RB	_	24	advmod	_	_
24	5	_	NUM	CD	_	25	nummod	_	_
25	days	_	NOUN	NNS	_	19	nmod	_	_
26	in	_	ADP	IN	_	28	case	_	_
27	poor	_	ADJ	JJ	_	28	amod	_	_
28	metabolizers	_	NOUN	NNS	_	25	nmod	_	_

#	Risperidone	5090
1	Steady	_	ADJ	JJ	_	3	amod	_	_
2	state	_	NOUN	NN	_	3	compound	_	_
3	concentrations	_	NOUN	NNS	_	9	nsubjpass	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	9	_	NUM	CD	_	7	nummod	_	_
6	hydroxy	_	NOUN	NN	_	7	compound	_	_
7	DRUG	_	NOUN	NN	_	3	nmod	_	_
8	are	_	VERB	VBP	_	9	auxpass	_	_
9	reached	_	VERB	VBN	_	0	root	_	_
10	in	_	ADP	IN	_	13	case	_	_
11	5	_	NUM	CD	_	13	nummod	_	_
12	6	_	NUM	CD	_	13	nummod	_	_
13	days	_	NOUN	NNS	_	9	nmod	_	_
14	measured	_	VERB	VBN	_	13	acl	_	_
15	in	_	ADP	IN	_	17	case	_	_
16	extensive	_	ADJ	JJ	_	17	amod	_	_
17	metabolizers	_	NOUN	NNS	_	14	nmod	_	_

#	Risperidone	5091
1	Food	_	NOUN	NN	_	3	compound	_	_
2	Effect	_	NOUN	NN	_	3	compound	_	_
3	Food	_	NOUN	NN	_	6	nsubj	_	_
4	does	_	VERB	VBZ	_	6	aux	_	_
5	not	_	ADV	RB	_	6	neg	_	_
6	affect	_	VERB	VB	_	0	root	_	_
7	either	_	CONJ	CC	_	9	cc:preconj	_	_
8	the	_	DET	DT	_	9	det	_	_
9	rate	_	NOUN	NN	_	6	dobj	_	_
10	or	_	CONJ	CC	_	9	cc	_	_
11	extent	_	NOUN	NN	_	9	conj	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	absorption	_	NOUN	NN	_	9	nmod	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	DRUG	_	NOUN	NN	_	13	nmod	_	_

#	Risperidone	5092
1	Thus	_	ADV	RB	_	6	advmod	_	_
2	,	_	.	,	_	6	punct	_	_
3	DRUG	_	NOUN	NN	_	6	nsubjpass	_	_
4	can	_	VERB	MD	_	6	aux	_	_
5	be	_	VERB	VB	_	6	auxpass	_	_
6	given	_	VERB	VBN	_	0	root	_	_
7	with	_	ADP	IN	_	6	nmod	_	_
8	or	_	CONJ	CC	_	7	cc	_	_
9	without	_	ADP	IN	_	7	conj	_	_
10	meals	_	NOUN	NNS	_	7	dep	_	_

#	Risperidone	5093
1	Distribution	_	NOUN	NN	_	2	compound	_	_
2	DRUG	_	NOUN	NN	_	5	nsubjpass	_	_
3	is	_	VERB	VBZ	_	5	auxpass	_	_
4	rapidly	_	ADV	RB	_	5	advmod	_	_
5	distributed	_	VERB	VBN	_	0	root	_	_

#	Risperidone	5094
1	In	_	ADP	IN	_	2	case	_	_
2	plasma	_	NOUN	NN	_	6	nmod	_	_
3	,	_	.	,	_	6	punct	_	_
4	DRUG	_	NOUN	NN	_	6	nsubjpass	_	_
5	is	_	VERB	VBZ	_	6	auxpass	_	_
6	bound	_	VERB	VBN	_	0	root	_	_
7	to	_	PRT	TO	_	8	case	_	_
8	albumin	_	NOUN	NN	_	6	nmod	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	A1	_	NOUN	NN	_	12	compound	_	_
11	acid	_	NOUN	NN	_	12	compound	_	_
12	glycoprotein	_	NOUN	NN	_	8	conj	_	_

#	Risperidone	5095
1	The	_	DET	DT	_	4	det	_	_
2	plasma	_	NOUN	NN	_	4	compound	_	_
3	protein	_	NOUN	NN	_	4	compound	_	_
4	binding	_	NOUN	NN	_	8	nsubj	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	is	_	VERB	VBZ	_	8	cop	_	_
8	90%	_	ADJ	JJ	_	0	root	_	_
9	,	_	.	,	_	8	punct	_	_
10	and	_	CONJ	CC	_	8	cc	_	_
11	that	_	DET	WDT	_	22	mark	_	_
12	of	_	ADP	IN	_	15	case	_	_
13	its	_	PRON	PRP$	_	15	nmod:poss	_	_
14	major	_	ADJ	JJ	_	15	amod	_	_
15	metabolite	_	NOUN	NN	_	22	nsubj	_	_
16	,	_	.	,	_	15	punct	_	_
17	9	_	NUM	CD	_	19	nummod	_	_
18	hydroxy	_	NOUN	NN	_	19	amod	_	_
19	DRUG	_	NOUN	NN	_	15	appos	_	_
20	,	_	.	,	_	15	punct	_	_
21	is	_	VERB	VBZ	_	22	auxpass	_	_
22	77%	_	ADJ	JJ	_	8	conj	_	_

#	Risperidone	5096
1	Neither	_	CONJ	CC	_	2	cc:preconj	_	_
2	DRUG	_	NOUN	NN	_	7	nsubj	_	_
3	nor	_	CONJ	CC	_	2	cc	_	_
4	9	_	NUM	CD	_	2	conj	_	_
5	hydroxy	_	NOUN	NN	_	6	compound	_	_
6	DRUG	_	NOUN	NN	_	2	dep	_	_
7	displaces	_	VERB	VBZ	_	0	root	_	_
8	each	_	DET	DT	_	9	det	_	_
9	other	_	ADJ	JJ	_	7	dobj	_	_
10	from	_	ADP	IN	_	13	case	_	_
11	plasma	_	NOUN	NN	_	13	compound	_	_
12	binding	_	NOUN	NN	_	13	compound	_	_
13	sites	_	NOUN	NNS	_	9	nmod	_	_

#	Risperidone	5097
1	High	_	ADJ	JJ	_	3	amod	_	_
2	therapeutic	_	ADJ	JJ	_	3	amod	_	_
3	concentrations	_	NOUN	NNS	_	0	root	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	sulfamethazine	_	NOUN	NN	_	7	compound	_	_
6	100	_	NUM	CD	_	7	nummod	_	_
7	mcg	_	NOUN	NN	_	3	nmod	_	_
8	/	_	.	:	_	3	punct	_	_
9	mL	_	NOUN	NN	_	3	dep	_	_
10	,	_	.	,	_	9	punct	_	_
11	warfarin	_	NOUN	NN	_	13	compound	_	_
12	10	_	NUM	CD	_	13	nummod	_	_
13	mcg	_	NOUN	NN	_	9	conj	_	_
14	/	_	.	:	_	9	punct	_	_
15	mL	_	NOUN	NN	_	9	conj	_	_
16	,	_	.	,	_	9	punct	_	_
17	and	_	CONJ	CC	_	9	cc	_	_
18	carbamazepine	_	NOUN	NN	_	19	compound	_	_
19	10mcg	_	NOUN	NN	_	9	conj	_	_
20	/	_	.	:	_	9	punct	_	_
21	mL	_	NOUN	NN	_	22	nsubj	_	_
22	caused	_	VERB	VBD	_	9	dep	_	_
23	only	_	ADV	RB	_	22	advmod	_	_
24	a	_	DET	DT	_	26	det	_	_
25	slight	_	ADJ	JJ	_	26	amod	_	_
26	increase	_	NOUN	NN	_	22	dobj	_	_
27	in	_	ADP	IN	_	30	case	_	_
28	the	_	DET	DT	_	30	det	_	_
29	free	_	ADJ	JJ	_	30	amod	_	_
30	fraction	_	NOUN	NN	_	26	nmod	_	_
31	of	_	ADP	IN	_	32	case	_	_
32	DRUG	_	NOUN	NN	_	30	nmod	_	_
33	at	_	ADP	IN	_	35	case	_	_
34	10	_	NUM	CD	_	35	nummod	_	_
35	ng	_	NOUN	NN	_	26	nmod	_	_
36	/	_	.	:	_	35	punct	_	_
37	mL	_	NOUN	NN	_	35	dep	_	_
38	and	_	CONJ	CC	_	37	cc	_	_
39	9	_	NUM	CD	_	41	nummod	_	_
40	hydroxy	_	NOUN	NN	_	41	compound	_	_
41	DRUG	_	NOUN	NN	_	37	conj	_	_
42	at	_	ADP	IN	_	44	case	_	_
43	50	_	NUM	CD	_	44	nummod	_	_
44	ng	_	NOUN	NN	_	37	nmod	_	_
45	/	_	.	:	_	35	punct	_	_
46	mL	_	NOUN	NN	_	35	dep	_	_
47	,	_	.	,	_	35	punct	_	_
48	changes	_	NOUN	NNS	_	35	appos	_	_
49	of	_	ADP	IN	_	52	case	_	_
50	unknown	_	ADJ	JJ	_	52	amod	_	_
51	clinical	_	ADJ	JJ	_	52	amod	_	_
52	significance	_	NOUN	NN	_	48	nmod	_	_

#	Risperidone	5098
1	Metabolism	_	NOUN	NN	_	2	compound	_	_
2	DRUG	_	NOUN	NN	_	5	nsubjpass	_	_
3	is	_	VERB	VBZ	_	5	auxpass	_	_
4	extensively	_	ADV	RB	_	5	advmod	_	_
5	metabolized	_	VERB	VBN	_	0	root	_	_
6	in	_	ADP	IN	_	8	case	_	_
7	the	_	DET	DT	_	8	det	_	_
8	liver	_	NOUN	NN	_	5	nmod	_	_

#	Risperidone	5099
1	The	_	DET	DT	_	4	det	_	_
2	main	_	ADJ	JJ	_	4	amod	_	_
3	metabolic	_	ADJ	JJ	_	4	amod	_	_
4	pathway	_	NOUN	NN	_	7	nsubj	_	_
5	is	_	VERB	VBZ	_	7	cop	_	_
6	through	_	ADP	IN	_	7	case	_	_
7	hydroxylation	_	NOUN	NN	_	0	root	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	to	_	PRT	TO	_	13	case	_	_
11	9	_	NUM	CD	_	12	compound	_	_
12	hydroxy	_	NOUN	NN	_	13	amod	_	_
13	DRUG	_	NOUN	NN	_	7	nmod	_	_
14	by	_	ADP	IN	_	16	case	_	_
15	the	_	DET	DT	_	16	det	_	_
16	enzyme	_	NOUN	NN	_	7	nmod	_	_
17	,	_	.	,	_	7	punct	_	_
18	CYP	_	NOUN	NN	_	19	compound	_	_
19	2D6	_	NOUN	NN	_	17	root	_	_

#	Risperidone	5100
1	A	_	DET	DT	_	4	det	_	_
2	minor	_	ADJ	JJ	_	4	amod	_	_
3	metabolic	_	ADJ	JJ	_	4	amod	_	_
4	pathway	_	NOUN	NN	_	8	nsubj	_	_
5	is	_	VERB	VBZ	_	8	cop	_	_
6	through	_	ADP	IN	_	8	case	_	_
7	N	_	NOUN	NN	_	8	compound	_	_
8	dealkylation	_	NOUN	NN	_	0	root	_	_

#	Risperidone	5101
1	The	_	DET	DT	_	3	det	_	_
2	main	_	ADJ	JJ	_	3	amod	_	_
3	metabolite	_	NOUN	NN	_	9	nsubj	_	_
4	,	_	.	,	_	3	punct	_	_
5	9	_	NUM	CD	_	7	nummod	_	_
6	hydroxy	_	NOUN	NN	_	7	compound	_	_
7	DRUG	_	NOUN	NN	_	3	appos	_	_
8	,	_	.	,	_	3	punct	_	_
9	has	_	VERB	VBZ	_	0	root	_	_
10	similar	_	ADJ	JJ	_	12	amod	_	_
11	pharmacological	_	ADJ	JJ	_	12	amod	_	_
12	activity	_	NOUN	NN	_	9	dobj	_	_
13	as	_	ADP	IN	_	14	case	_	_
14	DRUG	_	NOUN	NN	_	12	nmod	_	_

#	Risperidone	5102
1	Consequently	_	ADV	RB	_	9	advmod	_	_
2	,	_	.	,	_	9	punct	_	_
3	the	_	DET	DT	_	5	det	_	_
4	clinical	_	ADJ	JJ	_	5	amod	_	_
5	effect	_	NOUN	NN	_	9	nsubj	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	the	_	DET	DT	_	8	det	_	_
8	drug	_	NOUN	NN	_	5	nmod	_	_
9	results	_	NOUN	NNS	_	0	root	_	_
10	from	_	ADP	IN	_	13	case	_	_
11	the	_	DET	DT	_	13	det	_	_
12	combined	_	ADJ	JJ	_	13	amod	_	_
13	concentrations	_	NOUN	NNS	_	9	nmod	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	DRUG	_	NOUN	NN	_	13	nmod	_	_
16	plus	_	CONJ	CC	_	15	cc	_	_
17	9	_	NUM	CD	_	19	nummod	_	_
18	hydroxy	_	NOUN	NN	_	19	compound	_	_
19	DRUG	_	NOUN	NN	_	15	conj	_	_

#	Risperidone	5103
1	CYP	_	NOUN	NN	_	2	compound	_	_
2	2D6	_	NOUN	NN	_	11	nsubj	_	_
3	,	_	.	,	_	2	punct	_	_
4	also	_	ADV	RB	_	5	advmod	_	_
5	called	_	VERB	VBN	_	2	acl	_	_
6	debrisoquin	_	NOUN	NN	_	7	compound	_	_
7	hydroxylase	_	NOUN	NN	_	5	dobj	_	_
8	,	_	.	,	_	2	punct	_	_
9	is	_	VERB	VBZ	_	11	cop	_	_
10	the	_	DET	DT	_	11	det	_	_
11	enzyme	_	NOUN	NN	_	0	root	_	_
12	responsible	_	ADJ	JJ	_	11	amod	_	_
13	for	_	ADP	IN	_	14	case	_	_
14	metabolism	_	NOUN	NN	_	12	nmod	_	_
15	of	_	ADP	IN	_	17	case	_	_
16	many	_	ADJ	JJ	_	17	amod	_	_
17	neuroleptics	_	NOUN	NNS	_	14	nmod	_	_
18	,	_	.	,	_	17	punct	_	_
19	antidepressants	_	NOUN	NNS	_	17	conj	_	_
20	,	_	.	,	_	17	punct	_	_
21	antiarrhythmics	_	NOUN	NNS	_	17	conj	_	_
22	,	_	.	,	_	17	punct	_	_
23	and	_	CONJ	CC	_	17	cc	_	_
24	other	_	ADJ	JJ	_	25	amod	_	_
25	drugs	_	NOUN	NNS	_	17	conj	_	_

#	Risperidone	5104
1	CYP	_	NOUN	NN	_	2	compound	_	_
2	2D6	_	NOUN	NN	_	4	nsubj	_	_
3	is	_	VERB	VBZ	_	4	cop	_	_
4	subject	_	NOUN	NN	_	0	root	_	_
5	to	_	PRT	TO	_	7	case	_	_
6	genetic	_	ADJ	JJ	_	7	amod	_	_
7	polymorphism	_	NOUN	NN	_	4	nmod	_	_
8	about	_	ADP	IN	_	10	case	_	_
9	6%	_	ADJ	JJ	_	10	amod	_	_
10	8%	_	NOUN	NN	_	7	nmod	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	Caucasians	_	NOUN	NNS	_	10	nmod	_	_
13	,	_	.	,	_	4	punct	_	_
14	and	_	CONJ	CC	_	4	cc	_	_
15	a	_	DET	DT	_	18	det	_	_
16	very	_	ADV	RB	_	17	advmod	_	_
17	low	_	ADJ	JJ	_	18	amod	_	_
18	percentage	_	NOUN	NN	_	4	conj	_	_
19	of	_	ADP	IN	_	20	case	_	_
20	Asians	_	NOUN	NN	_	18	nmod	_	_
21	,	_	.	,	_	4	punct	_	_
22	have	_	VERB	VBP	_	4	dep	_	_
23	little	_	ADJ	JJ	_	26	amod	_	_
24	or	_	CONJ	CC	_	23	cc	_	_
25	no	_	DET	DT	_	23	conj	_	_
26	activity	_	NOUN	NN	_	22	dobj	_	_
27	and	_	CONJ	CC	_	22	cc	_	_
28	are	_	VERB	VBP	_	30	cop	_	_
29	"poor	_	ADJ	JJ	_	30	amod	_	_
30	metabolizers"	_	NOUN	NN	_	22	conj	_	_
31	and	_	CONJ	CC	_	30	cc	_	_
32	to	_	PRT	TO	_	33	case	_	_
33	inhibition	_	NOUN	NN	_	30	conj	_	_
34	by	_	ADP	IN	_	36	case	_	_
35	a	_	DET	DT	_	36	det	_	_
36	variety	_	NOUN	NN	_	33	nmod	_	_
37	of	_	ADP	IN	_	38	case	_	_
38	substrates	_	NOUN	NNS	_	36	nmod	_	_
39	and	_	CONJ	CC	_	38	cc	_	_
40	some	_	DET	DT	_	42	det	_	_
41	non	_	ADJ	JJ	_	42	amod	_	_
42	substrates	_	NOUN	NNS	_	38	conj	_	_
43	,	_	.	,	_	42	punct	_	_
44	notably	_	ADV	RB	_	45	advmod	_	_
45	quinidine	_	VERB	VBG	_	42	dep	_	_

#	Risperidone	5105
1	Extensive	_	ADJ	JJ	_	4	amod	_	_
2	CYP	_	NOUN	NN	_	4	compound	_	_
3	2D6	_	NOUN	NN	_	4	compound	_	_
4	metabolizers	_	NOUN	NNS	_	5	nsubj	_	_
5	convert	_	VERB	VBP	_	0	root	_	_
6	DRUG	_	NOUN	NN	_	5	dobj	_	_
7	rapidly	_	ADV	RB	_	5	advmod	_	_
8	into	_	ADP	IN	_	11	case	_	_
9	9	_	NUM	CD	_	11	nummod	_	_
10	hydroxy	_	NOUN	NN	_	11	compound	_	_
11	DRUG	_	NOUN	NN	_	5	nmod	_	_
12	,	_	.	,	_	5	punct	_	_
13	whereas	_	ADP	IN	_	18	mark	_	_
14	poor	_	ADJ	JJ	_	17	amod	_	_
15	CYP	_	NOUN	NN	_	17	compound	_	_
16	2D6	_	NOUN	NN	_	17	compound	_	_
17	metabolizers	_	NOUN	NNS	_	18	nsubj	_	_
18	convert	_	VERB	VBP	_	5	advcl	_	_
19	it	_	PRON	PRP	_	18	dobj	_	_
20	much	_	ADV	RB	_	22	advmod	_	_
21	more	_	ADV	RB	_	22	advmod	_	_
22	slowly	_	ADV	RB	_	19	advmod	_	_

#	Risperidone	5106
1	Although	_	ADP	IN	_	4	mark	_	_
2	extensive	_	ADJ	JJ	_	3	amod	_	_
3	metabolizers	_	NOUN	NNS	_	4	nsubj	_	_
4	have	_	VERB	VBP	_	25	advcl	_	_
5	lower	_	ADJ	JJ	_	6	amod	_	_
6	DRUG	_	NOUN	NN	_	4	dobj	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	higher	_	ADJ	JJ	_	12	amod	_	_
9	9	_	NUM	CD	_	12	nummod	_	_
10	hydroxy	_	NOUN	NN	_	12	amod	_	_
11	DRUG	_	NOUN	NN	_	12	compound	_	_
12	concentrations	_	NOUN	NNS	_	6	conj	_	_
13	than	_	ADP	IN	_	15	case	_	_
14	poor	_	ADJ	JJ	_	15	amod	_	_
15	metabolizers	_	NOUN	NNS	_	4	nmod	_	_
16	,	_	.	,	_	25	punct	_	_
17	the	_	DET	DT	_	18	det	_	_
18	pharmacokinetics	_	NOUN	NNS	_	25	nsubj	_	_
19	of	_	ADP	IN	_	20	case	_	_
20	DRUG	_	NOUN	NN	_	18	nmod	_	_
21	and	_	CONJ	CC	_	20	cc	_	_
22	9	_	NUM	CD	_	24	nummod	_	_
23	hydroxy	_	NOUN	NN	_	24	compound	_	_
24	DRUG	_	NOUN	NN	_	20	conj	_	_
25	combined	_	VERB	VBN	_	0	root	_	_
26	,	_	.	,	_	25	punct	_	_
27	after	_	ADP	IN	_	31	case	_	_
28	single	_	ADJ	JJ	_	31	amod	_	_
29	and	_	CONJ	CC	_	28	cc	_	_
30	multiple	_	ADJ	JJ	_	28	conj	_	_
31	doses	_	NOUN	NNS	_	25	nmod	_	_
32	,	_	.	,	_	25	punct	_	_
33	are	_	VERB	VBP	_	34	cop	_	_
34	similar	_	ADJ	JJ	_	25	parataxis	_	_
35	in	_	ADP	IN	_	39	case	_	_
36	extensive	_	ADJ	JJ	_	39	amod	_	_
37	and	_	CONJ	CC	_	36	cc	_	_
38	poor	_	ADJ	JJ	_	36	conj	_	_
39	metabolizers	_	NOUN	NNS	_	34	nmod	_	_

#	Risperidone	5107
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	could	_	VERB	MD	_	4	aux	_	_
3	be	_	VERB	VB	_	4	cop	_	_
4	subject	_	ADJ	JJ	_	0	root	_	_
5	to	_	PRT	TO	_	7	case	_	_
6	two	_	NUM	CD	_	7	nummod	_	_
7	kinds	_	NOUN	NNS	_	4	nmod	_	_
8	of	_	ADP	IN	_	11	case	_	_
9	drug	_	NOUN	NN	_	11	compound	_	_
10	drug	_	NOUN	NN	_	11	compound	_	_
11	interactions	_	NOUN	NNS	_	7	nmod	_	_

#	Risperidone	5108
1	First	_	ADV	RB	_	7	advmod	_	_
2	,	_	.	,	_	7	punct	_	_
3	inhibitors	_	NOUN	NNS	_	7	nsubj	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	CYP	_	NOUN	NN	_	6	compound	_	_
6	2D6	_	NOUN	NN	_	3	nmod	_	_
7	interfere	_	VERB	VBD	_	0	root	_	_
8	with	_	ADP	IN	_	9	case	_	_
9	conversion	_	NOUN	NN	_	7	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_
12	to	_	PRT	TO	_	15	case	_	_
13	9	_	NUM	CD	_	15	nummod	_	_
14	hydroxy	_	NOUN	NN	_	15	compound	_	_
15	DRUG	_	NOUN	NN	_	9	nmod	_	_

#	Risperidone	5109
1	This	_	DET	DT	_	2	nsubj	_	_
2	occurs	_	VERB	VBZ	_	0	root	_	_
3	with	_	ADP	IN	_	4	case	_	_
4	quinidine	_	NOUN	NN	_	2	nmod	_	_
5	,	_	.	,	_	2	punct	_	_
6	giving	_	VERB	VBG	_	2	advcl	_	_
7	essentially	_	ADV	RB	_	6	advmod	_	_
8	all	_	DET	DT	_	9	nsubj	_	_
9	recipients	_	VERB	VBZ	_	6	dobj	_	_
10	a	_	DET	DT	_	13	det	_	_
11	DRUG	_	NOUN	NN	_	13	compound	_	_
12	pharmacokinetic	_	ADJ	JJ	_	13	amod	_	_
13	profile	_	NOUN	NN	_	9	dobj	_	_
14	typical	_	NOUN	NN	_	13	dep	_	_
15	of	_	ADP	IN	_	17	case	_	_
16	poor	_	ADJ	JJ	_	17	amod	_	_
17	metabolizers	_	NOUN	NNS	_	14	nmod	_	_

#	Risperidone	5110
1	The	_	DET	DT	_	3	det	_	_
2	therapeutic	_	ADJ	JJ	_	3	amod	_	_
3	benefits	_	NOUN	NNS	_	16	nsubjpass	_	_
4	and	_	CONJ	CC	_	3	cc	_	_
5	adverse	_	ADJ	JJ	_	6	amod	_	_
6	effects	_	NOUN	NNS	_	3	conj	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	in	_	ADP	IN	_	10	case	_	_
10	patients	_	NOUN	NNS	_	3	nmod	_	_
11	receiving	_	VERB	VBG	_	10	acl	_	_
12	quinidine	_	NOUN	NN	_	11	dobj	_	_
13	have	_	VERB	MD	_	16	aux	_	_
14	not	_	ADV	RB	_	16	neg	_	_
15	been	_	VERB	VBN	_	16	auxpass	_	_
16	evaluated	_	VERB	VBN	_	0	root	_	_
17	,	_	.	,	_	16	punct	_	_
18	but	_	CONJ	CC	_	16	cc	_	_
19	observations	_	NOUN	NNS	_	32	nsubj	_	_
20	in	_	ADP	IN	_	24	case	_	_
21	a	_	DET	DT	_	24	det	_	_
22	modest	_	ADJ	JJ	_	24	amod	_	_
23	number	_	NOUN	NN	_	24	compound	_	_
24	n=70	_	NOUN	NN	_	19	nmod	_	_
25	of	_	ADP	IN	_	27	case	_	_
26	poor	_	ADJ	JJ	_	27	amod	_	_
27	metabolizers	_	NOUN	NNS	_	24	nmod	_	_
28	given	_	VERB	VBN	_	27	acl	_	_
29	DRUG	_	NOUN	NN	_	28	xcomp	_	_
30	do	_	VERB	MD	_	32	aux	_	_
31	not	_	ADV	RB	_	32	neg	_	_
32	suggest	_	VERB	VB	_	16	conj	_	_
33	important	_	ADJ	JJ	_	34	amod	_	_
34	differences	_	NOUN	NNS	_	32	dobj	_	_
35	between	_	ADP	IN	_	39	case	_	_
36	poor	_	ADJ	JJ	_	39	amod	_	_
37	and	_	CONJ	CC	_	36	cc	_	_
38	extensive	_	ADJ	JJ	_	36	conj	_	_
39	metabolizers	_	NOUN	NNS	_	34	nmod	_	_

#	Risperidone	5111
1	Second	_	ADJ	JJ	_	22	advmod	_	_
2	,	_	.	,	_	22	punct	_	_
3	co	_	PRT	TO	_	4	case	_	_
4	administration	_	NOUN	NN	_	22	nsubj	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	known	_	VERB	VBN	_	8	amod	_	_
7	enzyme	_	NOUN	NN	_	8	compound	_	_
8	inducers	_	NOUN	NNS	_	4	nmod	_	_
9	e.g	_	NOUN	NN	_	8	dep	_	_
10	,	_	.	,	_	9	punct	_	_
11	carbamazepine	_	NOUN	NN	_	9	conj	_	_
12	,	_	.	,	_	9	punct	_	_
13	phenytoin	_	NOUN	NN	_	9	conj	_	_
14	,	_	.	,	_	9	punct	_	_
15	rifampin	_	NOUN	NN	_	9	conj	_	_
16	,	_	.	,	_	9	punct	_	_
17	and	_	CONJ	CC	_	9	cc	_	_
18	phenobarbital	_	ADJ	JJ	_	9	conj	_	_
19	with	_	ADP	IN	_	20	case	_	_
20	DRUG	_	NOUN	NN	_	18	nmod	_	_
21	may	_	VERB	MD	_	22	aux	_	_
22	cause	_	VERB	VB	_	0	root	_	_
23	a	_	DET	DT	_	24	det	_	_
24	decrease	_	NOUN	NN	_	22	dobj	_	_
25	in	_	ADP	IN	_	29	case	_	_
26	the	_	DET	DT	_	29	det	_	_
27	combined	_	ADJ	JJ	_	29	amod	_	_
28	plasma	_	NOUN	NN	_	29	compound	_	_
29	concentrations	_	NOUN	NNS	_	24	nmod	_	_
30	of	_	ADP	IN	_	31	case	_	_
31	DRUG	_	NOUN	NN	_	29	nmod	_	_
32	and	_	CONJ	CC	_	31	cc	_	_
33	9	_	NUM	CD	_	35	nummod	_	_
34	hydroxy	_	NOUN	NN	_	35	compound	_	_
35	DRUG	_	NOUN	NN	_	31	conj	_	_

#	Risperidone	5112
1	It	_	PRON	PRP	_	5	nsubj	_	_
2	would	_	VERB	MD	_	5	aux	_	_
3	also	_	ADV	RB	_	5	advmod	_	_
4	be	_	VERB	VB	_	5	cop	_	_
5	possible	_	ADJ	JJ	_	0	root	_	_
6	for	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	to	_	PRT	TO	_	9	mark	_	_
9	interfere	_	VERB	VB	_	5	xcomp	_	_
10	with	_	ADP	IN	_	11	case	_	_
11	metabolism	_	NOUN	NN	_	9	nmod	_	_
12	of	_	ADP	IN	_	14	case	_	_
13	other	_	ADJ	JJ	_	14	amod	_	_
14	drugs	_	NOUN	NNS	_	11	nmod	_	_
15	metabolized	_	VERB	VBN	_	14	acl	_	_
16	by	_	ADP	IN	_	18	case	_	_
17	CYP	_	NOUN	NN	_	18	compound	_	_
18	2D6	_	NOUN	NN	_	15	nmod	_	_

#	Risperidone	5113
1	Relatively	_	ADV	RB	_	9	advmod	_	_
2	weak	_	ADJ	JJ	_	3	amod	_	_
3	binding	_	NOUN	NN	_	9	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	to	_	PRT	TO	_	8	case	_	_
7	the	_	DET	DT	_	8	det	_	_
8	enzyme	_	NOUN	NN	_	3	nmod	_	_
9	suggests	_	VERB	VBZ	_	0	root	_	_
10	this	_	DET	DT	_	9	dobj	_	_
11	is	_	VERB	VBZ	_	12	auxpass	_	_
12	unlikely	_	ADV	RB	_	9	parataxis	_	_

#	Risperidone	5114
1	In	_	X	FW	_	3	amod	_	_
2	vitro	_	X	FW	_	1	dep	_	_
3	studies	_	NOUN	NNS	_	4	nsubj	_	_
4	indicate	_	VERB	VBP	_	0	root	_	_
5	that	_	ADP	IN	_	11	mark	_	_
6	DRUG	_	NOUN	NN	_	11	nsubj	_	_
7	is	_	VERB	VBZ	_	11	cop	_	_
8	a	_	DET	DT	_	11	det	_	_
9	relatively	_	ADV	RB	_	10	advmod	_	_
10	weak	_	ADJ	JJ	_	11	amod	_	_
11	inhibitor	_	NOUN	NN	_	4	ccomp	_	_
12	of	_	ADP	IN	_	14	case	_	_
13	CYP	_	NOUN	NN	_	14	compound	_	_
14	2D6	_	NOUN	NN	_	11	nmod	_	_

#	Risperidone	5115
1	Therefore	_	ADV	RB	_	6	advmod	_	_
2	,	_	.	,	_	6	punct	_	_
3	DRUG	_	NOUN	NN	_	6	nsubjpass	_	_
4	is	_	VERB	VBZ	_	6	auxpass	_	_
5	not	_	ADV	RB	_	6	neg	_	_
6	expected	_	VERB	VBN	_	0	root	_	_
7	to	_	PRT	TO	_	9	mark	_	_
8	substantially	_	ADV	RB	_	9	advmod	_	_
9	inhibit	_	VERB	VB	_	6	xcomp	_	_
10	the	_	DET	DT	_	11	det	_	_
11	clearance	_	NOUN	NN	_	9	dobj	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	drugs	_	NOUN	NNS	_	11	nmod	_	_
14	that	_	DET	WDT	_	16	nsubjpass	_	_
15	are	_	VERB	VBP	_	16	auxpass	_	_
16	metabolized	_	VERB	VBN	_	13	acl:relcl	_	_
17	by	_	ADP	IN	_	20	case	_	_
18	this	_	DET	DT	_	20	det	_	_
19	enzymatic	_	ADJ	JJ	_	20	amod	_	_
20	pathway	_	NOUN	NN	_	16	nmod	_	_

#	Risperidone	5116
1	In	_	ADP	IN	_	4	case	_	_
2	drug	_	NOUN	NN	_	4	compound	_	_
3	interaction	_	NOUN	NN	_	4	compound	_	_
4	studies	_	NOUN	NNS	_	10	nmod	_	_
5	,	_	.	,	_	10	punct	_	_
6	DRUG	_	NOUN	NN	_	10	nsubj	_	_
7	did	_	VERB	MD	_	10	aux	_	_
8	not	_	ADV	RB	_	10	neg	_	_
9	significantly	_	ADV	RB	_	10	advmod	_	_
10	affect	_	VERB	VB	_	0	root	_	_
11	the	_	DET	DT	_	12	det	_	_
12	pharmacokinetics	_	NOUN	NNS	_	10	dobj	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	donepezil	_	NOUN	NN	_	12	nmod	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	galantamine	_	NOUN	NN	_	14	conj	_	_
17	,	_	.	,	_	14	punct	_	_
18	which	_	DET	WDT	_	20	nsubjpass	_	_
19	are	_	VERB	VBP	_	20	auxpass	_	_
20	metabolized	_	VERB	VBN	_	14	acl:relcl	_	_
21	by	_	ADP	IN	_	23	case	_	_
22	CYP	_	NOUN	NN	_	23	compound	_	_
23	2D6	_	NOUN	NN	_	20	nmod	_	_

#	Risperidone	5117
1	In	_	X	FW	_	3	amod	_	_
2	vitro	_	X	FW	_	1	dep	_	_
3	studies	_	NOUN	NNS	_	4	nsubj	_	_
4	demonstrated	_	VERB	VBD	_	0	root	_	_
5	that	_	ADP	IN	_	28	mark	_	_
6	drugs	_	NOUN	NNS	_	28	nsubj	_	_
7	metabolized	_	VERB	VBN	_	6	acl	_	_
8	by	_	ADP	IN	_	11	case	_	_
9	other	_	ADJ	JJ	_	11	amod	_	_
10	CYP	_	NOUN	NN	_	11	compound	_	_
11	isozymes	_	NOUN	NNS	_	7	nmod	_	_
12	,	_	.	,	_	11	punct	_	_
13	including	_	VERB	VBG	_	14	case	_	_
14	1A1	_	NOUN	NN	_	11	nmod	_	_
15	,	_	.	,	_	14	punct	_	_
16	1A2	_	NOUN	NN	_	14	conj	_	_
17	,	_	.	,	_	14	punct	_	_
18	2C9	_	NOUN	NN	_	14	conj	_	_
19	,	_	.	,	_	14	punct	_	_
20	2C19	_	NOUN	NN	_	14	conj	_	_
21	,	_	.	,	_	14	punct	_	_
22	and	_	CONJ	CC	_	14	cc	_	_
23	3A4	_	NOUN	NN	_	14	conj	_	_
24	,	_	.	,	_	6	punct	_	_
25	are	_	VERB	VBP	_	28	cop	_	_
26	only	_	ADV	RB	_	27	advmod	_	_
27	weak	_	ADJ	JJ	_	28	amod	_	_
28	inhibitors	_	NOUN	NNS	_	4	ccomp	_	_
29	of	_	ADP	IN	_	31	case	_	_
30	DRUG	_	NOUN	NN	_	31	compound	_	_
31	metabolism	_	NOUN	NN	_	28	nmod	_	_

#	Risperidone	5118
1	Excretion	_	NOUN	NN	_	2	compound	_	_
2	DRUG	_	NOUN	NN	_	7	nsubjpass	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	its	_	PRON	PRP$	_	5	nmod:poss	_	_
5	metabolites	_	NOUN	NNS	_	2	conj	_	_
6	are	_	VERB	VBP	_	7	auxpass	_	_
7	eliminated	_	VERB	VBN	_	0	root	_	_
8	via	_	ADP	IN	_	10	case	_	_
9	the	_	DET	DT	_	10	det	_	_
10	urine	_	ADJ	JJ	_	7	nmod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	,	_	.	,	_	10	punct	_	_
13	to	_	PRT	TO	_	17	case	_	_
14	a	_	DET	DT	_	17	det	_	_
15	much	_	ADV	RB	_	16	advmod	_	_
16	lesser	_	ADJ	JJ	_	17	amod	_	_
17	extent	_	NOUN	NN	_	10	nmod	_	_
18	,	_	.	,	_	7	punct	_	_
19	via	_	ADP	IN	_	21	case	_	_
20	the	_	DET	DT	_	21	det	_	_
21	feces	_	NOUN	NNS	_	7	nmod	_	_

#	Risperidone	5119
1	As	_	ADP	IN	_	2	mark	_	_
2	illustrated	_	VERB	VBN	_	35	advcl	_	_
3	by	_	ADP	IN	_	7	case	_	_
4	a	_	DET	DT	_	7	det	_	_
5	mass	_	NOUN	NN	_	7	compound	_	_
6	balance	_	NOUN	NN	_	7	compound	_	_
7	study	_	NOUN	NN	_	2	nmod	_	_
8	of	_	ADP	IN	_	14	case	_	_
9	a	_	DET	DT	_	14	det	_	_
10	single	_	ADJ	JJ	_	14	amod	_	_
11	1	_	NUM	CD	_	14	nummod	_	_
12	mg	_	NOUN	NN	_	14	compound	_	_
13	oral	_	ADJ	JJ	_	14	amod	_	_
14	dose	_	NOUN	NN	_	7	nmod	_	_
15	of	_	ADP	IN	_	17	case	_	_
16	14C	_	NOUN	NN	_	17	compound	_	_
17	DRUG	_	NOUN	NN	_	14	nmod	_	_
18	administered	_	VERB	VBN	_	17	acl	_	_
19	as	_	ADP	IN	_	20	case	_	_
20	solution	_	NOUN	NN	_	18	nmod	_	_
21	to	_	PRT	TO	_	25	case	_	_
22	three	_	NUM	CD	_	25	nummod	_	_
23	healthy	_	ADJ	JJ	_	25	amod	_	_
24	male	_	ADJ	JJ	_	25	amod	_	_
25	volunteers	_	NOUN	NNS	_	20	nmod	_	_
26	,	_	.	,	_	35	punct	_	_
27	total	_	ADJ	JJ	_	28	amod	_	_
28	recovery	_	NOUN	NN	_	35	nsubj	_	_
29	of	_	ADP	IN	_	30	case	_	_
30	radioactivity	_	NOUN	NN	_	28	nmod	_	_
31	at	_	ADP	IN	_	33	case	_	_
32	1	_	NUM	CD	_	33	nummod	_	_
33	week	_	NOUN	NN	_	28	nmod	_	_
34	was	_	VERB	VBD	_	35	cop	_	_
35	84%	_	ADJ	JJ	_	0	root	_	_
36	,	_	.	,	_	35	punct	_	_
37	including	_	VERB	VBG	_	38	case	_	_
38	70%	_	NOUN	NN	_	35	nmod	_	_
39	in	_	ADP	IN	_	41	case	_	_
40	the	_	DET	DT	_	41	det	_	_
41	urine	_	NOUN	NN	_	38	nmod	_	_
42	and	_	CONJ	CC	_	41	cc	_	_
43	14%	_	NOUN	NN	_	41	conj	_	_
44	in	_	ADP	IN	_	46	case	_	_
45	the	_	DET	DT	_	46	det	_	_
46	feces	_	NOUN	NNS	_	41	nmod	_	_

#	Risperidone	5120
1	The	_	DET	DT	_	4	det	_	_
2	apparent	_	ADJ	JJ	_	4	amod	_	_
3	half	_	ADJ	JJ	_	4	amod	_	_
4	life	_	NOUN	NN	_	10	nsubj	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	was	_	VERB	VBD	_	10	cop	_	_
8	3	_	NUM	CD	_	9	nummod	_	_
9	hours	_	NOUN	NNS	_	10	compound	_	_
10	CV=30%	_	NOUN	NN	_	0	root	_	_
11	in	_	ADP	IN	_	13	case	_	_
12	extensive	_	ADJ	JJ	_	13	amod	_	_
13	metabolizers	_	NOUN	NNS	_	10	nmod	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	20	_	NUM	CD	_	16	nummod	_	_
16	hours	_	NOUN	NNS	_	13	conj	_	_
17	CV=40%	_	NOUN	NN	_	16	dep	_	_
18	in	_	ADP	IN	_	20	case	_	_
19	poor	_	ADJ	JJ	_	20	amod	_	_
20	metabolizers	_	NOUN	NNS	_	13	nmod	_	_

#	Risperidone	5121
1	The	_	DET	DT	_	4	det	_	_
2	apparent	_	ADJ	JJ	_	4	amod	_	_
3	half	_	ADJ	JJ	_	4	amod	_	_
4	life	_	NOUN	NN	_	13	nsubj	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	9	_	NUM	CD	_	8	nummod	_	_
7	hydroxy	_	NOUN	NN	_	8	compound	_	_
8	DRUG	_	NOUN	NN	_	4	nmod	_	_
9	was	_	VERB	VBD	_	13	cop	_	_
10	about	_	ADV	RB	_	11	advmod	_	_
11	21	_	NUM	CD	_	12	nummod	_	_
12	hours	_	NOUN	NNS	_	13	compound	_	_
13	CV=20%	_	NOUN	NN	_	0	root	_	_
14	in	_	ADP	IN	_	16	case	_	_
15	extensive	_	ADJ	JJ	_	16	amod	_	_
16	metabolizers	_	NOUN	NNS	_	13	nmod	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	30	_	NUM	CD	_	19	nummod	_	_
19	hours	_	NOUN	NNS	_	16	conj	_	_
20	CV=25%	_	NOUN	NN	_	19	dep	_	_
21	in	_	ADP	IN	_	23	case	_	_
22	poor	_	ADJ	JJ	_	23	amod	_	_
23	metabolizers	_	NOUN	NNS	_	16	nmod	_	_

#	Risperidone	5122
1	The	_	DET	DT	_	2	det	_	_
2	pharmacokinetics	_	NOUN	NNS	_	9	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	9	_	NUM	CD	_	8	nummod	_	_
7	hydroxy	_	NOUN	NN	_	8	compound	_	_
8	DRUG	_	NOUN	NN	_	4	conj	_	_
9	combined	_	VERB	VBN	_	0	root	_	_
10	,	_	.	,	_	9	punct	_	_
11	after	_	ADP	IN	_	15	case	_	_
12	single	_	ADJ	JJ	_	15	amod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	multiple	_	ADJ	JJ	_	12	conj	_	_
15	doses	_	NOUN	NNS	_	9	nmod	_	_
16	,	_	.	,	_	9	punct	_	_
17	were	_	VERB	VBD	_	18	cop	_	_
18	similar	_	ADJ	JJ	_	9	conj	_	_
19	in	_	ADP	IN	_	23	case	_	_
20	extensive	_	ADJ	JJ	_	23	amod	_	_
21	and	_	CONJ	CC	_	20	cc	_	_
22	poor	_	ADJ	JJ	_	20	conj	_	_
23	metabolizers	_	NOUN	NNS	_	18	nmod	_	_
24	,	_	.	,	_	9	punct	_	_
25	with	_	ADP	IN	_	31	case	_	_
26	an	_	DET	DT	_	31	det	_	_
27	overall	_	ADJ	JJ	_	31	amod	_	_
28	mean	_	NOUN	NN	_	31	compound	_	_
29	elimination	_	NOUN	NN	_	31	compound	_	_
30	half	_	NOUN	NN	_	31	compound	_	_
31	life	_	NOUN	NN	_	9	nmod	_	_
32	of	_	ADP	IN	_	35	case	_	_
33	about	_	ADV	RB	_	34	advmod	_	_
34	20	_	NUM	CD	_	35	nummod	_	_
35	hours	_	NOUN	NNS	_	31	nmod	_	_

#	Risperidone	5123
1	Drug	_	NOUN	NN	_	4	compound	_	_
2	Drug	_	NOUN	NN	_	4	compound	_	_
3	Interaction	_	NOUN	NN	_	4	compound	_	_
4	Studies	_	NOUN	NNS	_	0	root	_	_

#	Risperidone	5124
1	Specific	_	ADJ	JJ	_	2	amod	_	_
2	Populations	_	NOUN	NNS	_	0	root	_	_
3	Renal	_	ADJ	JJ	_	2	dep	_	_
4	and	_	CONJ	CC	_	3	cc	_	_
5	Hepatic	_	ADJ	JJ	_	3	conj	_	_
6	Impairment	_	NOUN	NN	_	3	dep	_	_

#	Risperidone	5125
1	Elderly	_	ADV	RB	_	17	advmod	_	_
2	In	_	ADP	IN	_	5	case	_	_
3	healthy	_	ADJ	JJ	_	5	amod	_	_
4	elderly	_	ADJ	JJ	_	5	amod	_	_
5	subjects	_	NOUN	NNS	_	1	nmod	_	_
6	,	_	.	,	_	17	punct	_	_
7	renal	_	ADJ	JJ	_	8	amod	_	_
8	clearance	_	NOUN	NN	_	17	nsubjpass	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	both	_	CONJ	CC	_	11	cc:preconj	_	_
11	DRUG	_	NOUN	NN	_	8	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	9	_	NUM	CD	_	15	nummod	_	_
14	hydroxy	_	NOUN	NN	_	15	amod	_	_
15	DRUG	_	NOUN	NN	_	11	conj	_	_
16	was	_	VERB	VBD	_	17	auxpass	_	_
17	decreased	_	VERB	VBN	_	0	root	_	_
18	,	_	.	,	_	17	punct	_	_
19	and	_	CONJ	CC	_	17	cc	_	_
20	elimination	_	NOUN	NN	_	22	compound	_	_
21	half	_	NOUN	NN	_	22	compound	_	_
22	lives	_	NOUN	NNS	_	24	nsubjpass	_	_
23	were	_	VERB	VBD	_	24	auxpass	_	_
24	prolonged	_	ADJ	JJ	_	17	conj	_	_
25	compared	_	VERB	VBN	_	29	case	_	_
26	to	_	PRT	TO	_	29	case	_	_
27	young	_	ADJ	JJ	_	29	amod	_	_
28	healthy	_	ADJ	JJ	_	29	amod	_	_
29	subjects	_	NOUN	NNS	_	24	nmod	_	_

#	Risperidone	5126
1	Dosing	_	NOUN	NN	_	4	nsubjpass	_	_
2	should	_	VERB	MD	_	4	aux	_	_
3	be	_	VERB	VB	_	4	auxpass	_	_
4	modified	_	VERB	VBN	_	0	root	_	_
5	accordingly	_	ADV	RB	_	4	advmod	_	_
6	in	_	ADP	IN	_	9	case	_	_
7	the	_	DET	DT	_	9	det	_	_
8	elderly	_	ADJ	JJ	_	9	amod	_	_
9	patients	_	NOUN	NNS	_	4	nmod	_	_

#	Risperidone	5127
1	Pediatric	_	ADJ	JJ	_	3	amod	_	_
2	The	_	DET	DT	_	3	amod	_	_
3	pharmacokinetics	_	NOUN	NNS	_	13	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	9	_	NUM	CD	_	9	nummod	_	_
8	hydroxy	_	NOUN	NN	_	9	compound	_	_
9	DRUG	_	NOUN	NN	_	5	conj	_	_
10	in	_	ADP	IN	_	11	case	_	_
11	children	_	NOUN	NN	_	3	nmod	_	_
12	were	_	VERB	VBD	_	13	cop	_	_
13	similar	_	ADJ	JJ	_	0	root	_	_
14	to	_	PRT	TO	_	15	case	_	_
15	those	_	DET	DT	_	13	nmod	_	_
16	in	_	ADP	IN	_	17	case	_	_
17	adults	_	NOUN	NNS	_	15	nmod	_	_
18	after	_	ADP	IN	_	19	mark	_	_
19	correcting	_	VERB	VBG	_	13	advcl	_	_
20	for	_	ADP	IN	_	22	case	_	_
21	the	_	DET	DT	_	22	det	_	_
22	difference	_	NOUN	NN	_	19	nmod	_	_
23	in	_	ADP	IN	_	25	case	_	_
24	body	_	NOUN	NN	_	25	compound	_	_
25	weight	_	NOUN	NN	_	22	nmod	_	_

#	Risperidone	5128
1	Race	_	NOUN	NN	_	4	compound	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	Gender	_	NOUN	NN	_	1	conj	_	_
4	Effects	_	NOUN	NNS	_	10	nsubjpass	_	_
5	No	_	X	FW	_	8	compound	_	_
6	specific	_	ADJ	JJ	_	8	amod	_	_
7	pharmacokinetic	_	ADJ	JJ	_	8	amod	_	_
8	study	_	NOUN	NN	_	4	nmod	_	_
9	was	_	VERB	VBD	_	10	auxpass	_	_
10	conducted	_	VERB	VBN	_	0	root	_	_
11	to	_	PRT	TO	_	12	mark	_	_
12	investigate	_	VERB	VB	_	10	xcomp	_	_
13	race	_	NOUN	NN	_	12	dobj	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	gender	_	NOUN	NN	_	13	conj	_	_
16	effects	_	NOUN	NNS	_	13	dep	_	_
17	,	_	.	,	_	10	punct	_	_
18	but	_	CONJ	CC	_	10	cc	_	_
19	a	_	DET	DT	_	22	det	_	_
20	population	_	NOUN	NN	_	22	compound	_	_
21	pharmacokinetic	_	ADJ	JJ	_	22	amod	_	_
22	analysis	_	NOUN	NN	_	25	nsubj	_	_
23	did	_	VERB	VBD	_	25	aux	_	_
24	not	_	ADV	RB	_	25	neg	_	_
25	identify	_	VERB	VB	_	10	conj	_	_
26	important	_	ADJ	JJ	_	27	amod	_	_
27	differences	_	NOUN	NNS	_	25	dobj	_	_
28	in	_	ADP	IN	_	30	case	_	_
29	the	_	DET	DT	_	30	det	_	_
30	disposition	_	NOUN	NN	_	25	nmod	_	_
31	of	_	ADP	IN	_	32	case	_	_
32	DRUG	_	NOUN	NN	_	30	nmod	_	_
33	due	_	ADJ	JJ	_	35	case	_	_
34	to	_	PRT	TO	_	33	mwe	_	_
35	gender	_	NOUN	NN	_	30	nmod	_	_
36	whether	_	DET	WDT	_	37	nsubj	_	_
37	corrected	_	VERB	VBN	_	35	acl:relcl	_	_
38	for	_	ADP	IN	_	40	case	_	_
39	body	_	NOUN	NN	_	40	compound	_	_
40	weight	_	NOUN	NN	_	37	nmod	_	_
41	or	_	CONJ	CC	_	42	cc	_	_
42	not	_	ADV	RB	_	40	cc	_	_
43	or	_	CONJ	CC	_	40	cc	_	_
44	race	_	DET	DT	_	40	root	_	_

#	SAPHRIS	5933
1	Antihypertensive	_	ADJ	JJ	_	2	amod	_	_
2	Drugs	_	NOUN	NNS	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	DRUG	_	NOUN	NN	_	6	nsubj	_	_
5	may	_	VERB	MD	_	6	aux	_	_
6	cause	_	VERB	VB	_	2	dep	_	_
7	hypotension	_	NOUN	NN	_	6	dobj	_	_

#	SAPHRIS	5934
1	Paroxetine	_	NOUN	NN	_	3	compound	_	_
2	CYP2D6	_	NOUN	NN	_	3	compound	_	_
3	substrate	_	NOUN	NN	_	7	nsubj	_	_
4	and	_	CONJ	CC	_	3	cc	_	_
5	inhibitor	_	NOUN	NN	_	3	conj	_	_
6	:	_	.	:	_	3	punct	_	_
7	Reduce	_	VERB	VBP	_	0	root	_	_
8	paroxetine	_	NOUN	NN	_	7	dobj	_	_
9	by	_	ADP	IN	_	10	case	_	_
10	half	_	NOUN	NN	_	7	nmod	_	_
11	when	_	ADV	WRB	_	12	advmod	_	_
12	used	_	VERB	VBN	_	7	advcl	_	_
13	in	_	ADP	IN	_	14	case	_	_
14	combination	_	NOUN	NN	_	12	nmod	_	_
15	with	_	ADP	IN	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	14	nmod	_	_

#	SAPHRIS	5935
1	Table	_	ADJ	JJ	_	0	root	_	_
2	12	_	NUM	CD	_	1	dep	_	_
3	:	_	.	:	_	1	punct	_	_
4	Clinically	_	ADV	RB	_	7	advmod	_	_
5	Important	_	ADJ	JJ	_	7	amod	_	_
6	Drug	_	NOUN	NN	_	7	compound	_	_
7	Interactions	_	NOUN	NNS	_	36	nsubj	_	_
8	with	_	ADP	IN	_	12	case	_	_
9	DRUG	_	NOUN	NN	_	12	compound	_	_
10	Concomitant	_	ADJ	JJ	_	12	amod	_	_
11	Drug	_	NOUN	NN	_	12	compound	_	_
12	Name	_	NOUN	NN	_	7	nmod	_	_
13	or	_	CONJ	CC	_	12	cc	_	_
14	Drug	_	NOUN	NN	_	21	compound	_	_
15	Class	_	NOUN	NN	_	21	compound	_	_
16	Clinical	_	ADJ	JJ	_	21	amod	_	_
17	Rationale	_	ADJ	JJ	_	21	amod	_	_
18	Clinical	_	ADJ	JJ	_	21	amod	_	_
19	Recommendation	_	NOUN	NN	_	21	compound	_	_
20	Antihypertensive	_	ADJ	JJ	_	21	amod	_	_
21	Drugs	_	NOUN	NNS	_	12	conj	_	_
22	Because	_	ADP	IN	_	27	case	_	_
23	of	_	ADP	IN	_	27	case	_	_
24	its	_	PRON	PRP$	_	27	nmod:poss	_	_
25	A1	_	NOUN	NN	_	27	compound	_	_
26	adrenergic	_	ADJ	JJ	_	27	amod	_	_
27	antagonism	_	NOUN	NN	_	7	nmod	_	_
28	with	_	ADP	IN	_	29	case	_	_
29	potential	_	ADJ	JJ	_	27	nmod	_	_
30	for	_	ADP	IN	_	31	mark	_	_
31	inducing	_	VERB	VBG	_	29	acl	_	_
32	hypotension	_	NOUN	NN	_	31	dobj	_	_
33	,	_	.	,	_	36	punct	_	_
34	DRUG	_	NOUN	NN	_	36	nsubj	_	_
35	may	_	VERB	MD	_	36	aux	_	_
36	enhance	_	VERB	VB	_	1	parataxis	_	_
37	the	_	DET	DT	_	38	det	_	_
38	effects	_	NOUN	NNS	_	36	dobj	_	_
39	of	_	ADP	IN	_	42	case	_	_
40	certain	_	ADJ	JJ	_	42	amod	_	_
41	antihypertensive	_	ADJ	JJ	_	42	amod	_	_
42	agents	_	NOUN	NNS	_	38	nmod	_	_

#	SAPHRIS	5936
1	Monitor	_	NOUN	NN	_	3	compound	_	_
2	blood	_	NOUN	NN	_	3	compound	_	_
3	pressure	_	NOUN	NN	_	0	root	_	_
4	and	_	CONJ	CC	_	3	cc	_	_
5	adjust	_	ADJ	JJ	_	6	amod	_	_
6	dosage	_	NOUN	NN	_	3	conj	_	_
7	of	_	ADP	IN	_	9	case	_	_
8	antihypertensive	_	ADJ	JJ	_	9	amod	_	_
9	drug	_	NOUN	NN	_	6	nmod	_	_
10	accordingly	_	ADV	RB	_	3	root	_	_

#	SAPHRIS	5937
1	Strong	_	ADJ	JJ	_	3	amod	_	_
2	CYP1A2	_	NOUN	NN	_	3	compound	_	_
3	Inhibitors	_	NOUN	NNS	_	0	root	_	_
4	e.g	_	NOUN	NN	_	3	amod	_	_
5	,	_	.	,	_	3	punct	_	_
6	Fluvoxamine	_	NOUN	NN	_	7	compound	_	_
7	DRUG	_	NOUN	NN	_	9	nsubjpass	_	_
8	is	_	VERB	VBZ	_	9	auxpass	_	_
9	metabolized	_	VERB	VBN	_	3	dep	_	_
10	by	_	ADP	IN	_	11	case	_	_
11	CYP1A2	_	NOUN	NN	_	9	nmod	_	_

#	SAPHRIS	5938
1	Marginal	_	ADJ	JJ	_	2	amod	_	_
2	increase	_	NOUN	NN	_	7	nsubjpass	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	DRUG	_	NOUN	NN	_	5	compound	_	_
5	exposure	_	NOUN	NN	_	2	nmod	_	_
6	was	_	VERB	VBD	_	7	auxpass	_	_
7	observed	_	VERB	VBN	_	0	root	_	_
8	when	_	ADV	WRB	_	11	advmod	_	_
9	DRUG	_	NOUN	NN	_	11	nsubjpass	_	_
10	is	_	VERB	VBZ	_	11	auxpass	_	_
11	used	_	VERB	VBN	_	7	root	_	_
12	with	_	ADP	IN	_	13	case	_	_
13	fluvoxamine	_	NOUN	NN	_	11	nmod	_	_
14	at	_	ADP	IN	_	16	case	_	_
15	25	_	NUM	CD	_	16	nummod	_	_
16	mg	_	NOUN	NN	_	11	nmod	_	_
17	administered	_	VERB	VBN	_	16	acl	_	_
18	twice	_	ADV	RB	_	17	advmod	_	_
19	daily	_	ADV	RB	_	11	advmod	_	_

#	SAPHRIS	5939
1	However	_	ADV	RB	_	8	advmod	_	_
2	,	_	.	,	_	8	punct	_	_
3	the	_	DET	DT	_	6	det	_	_
4	tested	_	VERB	VBN	_	6	amod	_	_
5	fluvoxamine	_	NOUN	NN	_	6	compound	_	_
6	dose	_	NOUN	NN	_	8	nsubj	_	_
7	was	_	VERB	VBD	_	8	auxpass	_	_
8	suboptimal	_	ADJ	JJ	_	0	root	_	_

#	SAPHRIS	5940
1	Full	_	ADJ	JJ	_	3	amod	_	_
2	therapeutic	_	ADJ	JJ	_	3	amod	_	_
3	dose	_	NOUN	NN	_	7	nsubjpass	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	fluvoxamine	_	NOUN	NN	_	3	nmod	_	_
6	is	_	VERB	VBZ	_	7	auxpass	_	_
7	expected	_	VERB	VBN	_	0	root	_	_
8	to	_	PRT	TO	_	9	mark	_	_
9	cause	_	VERB	VB	_	7	xcomp	_	_
10	a	_	DET	DT	_	12	det	_	_
11	greater	_	ADJ	JJ	_	12	amod	_	_
12	increase	_	NOUN	NN	_	9	dobj	_	_
13	in	_	ADP	IN	_	15	case	_	_
14	DRUG	_	NOUN	NN	_	15	compound	_	_
15	exposure	_	NOUN	NN	_	12	nmod	_	_

#	SAPHRIS	5941
1	Dosage	_	NOUN	NN	_	2	compound	_	_
2	reduction	_	NOUN	NN	_	11	nsubj	_	_
3	for	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	based	_	VERB	VBN	_	4	acl	_	_
6	on	_	ADP	IN	_	8	case	_	_
7	clinical	_	ADJ	JJ	_	8	amod	_	_
8	response	_	NOUN	NN	_	5	nmod	_	_
9	may	_	VERB	MD	_	11	aux	_	_
10	be	_	VERB	VB	_	11	auxpass	_	_
11	necessary	_	ADJ	JJ	_	0	root	_	_

#	SAPHRIS	5942
1	CYP2D6	_	NOUN	NN	_	2	compound	_	_
2	substrates	_	NOUN	NNS	_	10	nsubj	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	inhibitors	_	NOUN	NNS	_	5	compound	_	_
5	e.g	_	NOUN	NN	_	2	conj	_	_
6	,	_	.	,	_	2	punct	_	_
7	paroxetine	_	NOUN	NN	_	8	compound	_	_
8	DRUG	_	NOUN	NN	_	2	appos	_	_
9	may	_	VERB	MD	_	10	aux	_	_
10	enhance	_	VERB	VB	_	0	root	_	_
11	the	_	DET	DT	_	13	det	_	_
12	inhibitory	_	ADJ	JJ	_	13	amod	_	_
13	effects	_	NOUN	NNS	_	10	dobj	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	paroxetine	_	NOUN	NN	_	13	nmod	_	_
16	on	_	ADP	IN	_	19	case	_	_
17	its	_	PRON	PRP$	_	19	nmod:poss	_	_
18	own	_	ADJ	JJ	_	19	amod	_	_
19	metabolism	_	NOUN	NN	_	13	nmod	_	_

#	SAPHRIS	5943
1	Concomitant	_	ADJ	JJ	_	2	amod	_	_
2	use	_	NOUN	NN	_	7	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	paroxetine	_	NOUN	NN	_	2	nmod	_	_
5	with	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	2	nmod	_	_
7	increased	_	VERB	VBD	_	0	root	_	_
8	the	_	DET	DT	_	10	det	_	_
9	paroxetine	_	NOUN	NN	_	10	compound	_	_
10	exposure	_	NOUN	NN	_	7	dobj	_	_
11	by	_	ADP	IN	_	13	case	_	_
12	2	_	NUM	CD	_	13	nummod	_	_
13	fold	_	NOUN	NN	_	7	nmod	_	_
14	as	_	ADP	IN	_	15	mark	_	_
15	compared	_	VERB	VBN	_	7	advcl	_	_
16	to	_	PRT	TO	_	17	mark	_	_
17	use	_	VERB	VB	_	15	xcomp	_	_
18	paroxetine	_	NOUN	NN	_	17	dobj	_	_
19	alone	_	ADV	RB	_	18	advmod	_	_

#	SAPHRIS	5944
1	Reduce	_	VERB	VBP	_	0	root	_	_
2	paroxetine	_	NOUN	NN	_	3	compound	_	_
3	dose	_	NOUN	NN	_	1	dobj	_	_
4	by	_	ADP	IN	_	5	case	_	_
5	half	_	NOUN	NN	_	1	nmod	_	_
6	when	_	ADV	WRB	_	9	advmod	_	_
7	paroxetine	_	NOUN	NN	_	9	nsubjpass	_	_
8	is	_	VERB	VBZ	_	9	auxpass	_	_
9	used	_	VERB	VBN	_	1	advcl	_	_
10	in	_	ADP	IN	_	11	case	_	_
11	combination	_	NOUN	NN	_	9	nmod	_	_
12	with	_	ADP	IN	_	13	case	_	_
13	DRUG	_	NOUN	NN	_	11	nmod	_	_

#	SAPHRIS	5945
1	No	_	DET	DT	_	3	neg	_	_
2	dosage	_	NOUN	NN	_	3	compound	_	_
3	adjustment	_	NOUN	NN	_	7	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	is	_	VERB	VBZ	_	7	cop	_	_
7	necessary	_	ADJ	JJ	_	0	root	_	_
8	when	_	ADV	WRB	_	9	advmod	_	_
9	administered	_	VERB	VBN	_	7	advcl	_	_
10	concomitantly	_	ADV	RB	_	9	advmod	_	_
11	with	_	ADP	IN	_	12	case	_	_
12	paroxetine	_	NOUN	NN	_	9	nmod	_	_

#	SAPHRIS	5946
1	In	_	ADP	IN	_	2	case	_	_
2	addition	_	NOUN	NN	_	19	nmod	_	_
3	,	_	.	,	_	19	punct	_	_
4	valproic	_	ADJ	JJ	_	5	amod	_	_
5	acid	_	NOUN	NN	_	19	nsubj	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	lithium	_	NOUN	NN	_	11	compound	_	_
8	pre	_	NOUN	NN	_	11	compound	_	_
9	dose	_	NOUN	NN	_	11	compound	_	_
10	serum	_	NOUN	NN	_	11	compound	_	_
11	concentrations	_	NOUN	NNS	_	5	conj	_	_
12	collected	_	VERB	VBN	_	5	acl	_	_
13	from	_	ADP	IN	_	17	case	_	_
14	an	_	DET	DT	_	17	det	_	_
15	adjunctive	_	ADJ	JJ	_	17	amod	_	_
16	therapy	_	NOUN	NN	_	17	compound	_	_
17	study	_	NOUN	NN	_	12	nmod	_	_
18	were	_	VERB	VBD	_	19	cop	_	_
19	comparable	_	ADJ	JJ	_	0	root	_	_
20	between	_	ADP	IN	_	23	case	_	_
21	DRUG	_	NOUN	NN	_	23	compound	_	_
22	treated	_	ADJ	JJ	_	23	amod	_	_
23	patients	_	NOUN	NNS	_	19	nmod	_	_
24	and	_	CONJ	CC	_	23	cc	_	_
25	placebo	_	NOUN	NN	_	27	compound	_	_
26	treated	_	ADJ	JJ	_	27	amod	_	_
27	patients	_	NOUN	NNS	_	23	conj	_	_
28	indicating	_	VERB	VBG	_	23	acl	_	_
29	a	_	DET	DT	_	30	det	_	_
30	lack	_	NOUN	NN	_	28	dobj	_	_
31	of	_	ADP	IN	_	32	case	_	_
32	effect	_	NOUN	NN	_	30	nmod	_	_
33	of	_	ADP	IN	_	34	case	_	_
34	DRUG	_	NOUN	NN	_	32	nmod	_	_
35	on	_	ADP	IN	_	40	case	_	_
36	valproic	_	ADJ	JJ	_	40	amod	_	_
37	and	_	CONJ	CC	_	36	cc	_	_
38	lithium	_	NOUN	NN	_	36	conj	_	_
39	plasma	_	NOUN	NN	_	40	compound	_	_
40	levels	_	NOUN	NNS	_	30	nmod	_	_

#	SAPHRIS	5947
1	The	_	DET	DT	_	2	det	_	_
2	mechanism	_	NOUN	NN	_	16	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	action	_	NOUN	NN	_	2	nmod	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	,	_	.	,	_	2	punct	_	_
8	in	_	ADP	IN	_	9	case	_	_
9	schizophrenia	_	NOUN	NN	_	2	nmod	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	bipolar	_	ADJ	JJ	_	13	amod	_	_
12	I	_	NOUN	NN	_	13	compound	_	_
13	disorder	_	NOUN	NN	_	9	conj	_	_
14	,	_	.	,	_	2	punct	_	_
15	is	_	VERB	VBZ	_	16	auxpass	_	_
16	unknown	_	ADJ	JJ	_	0	root	_	_

#	SAPHRIS	5948
1	It	_	PRON	PRP	_	4	nsubjpass	_	_
2	has	_	VERB	VBZ	_	4	aux	_	_
3	been	_	VERB	VBN	_	4	auxpass	_	_
4	suggested	_	VERB	VBN	_	0	root	_	_
5	that	_	ADP	IN	_	14	mark	_	_
6	the	_	DET	DT	_	7	det	_	_
7	efficacy	_	NOUN	NN	_	14	nsubjpass	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	in	_	ADP	IN	_	11	case	_	_
11	schizophrenia	_	NOUN	NN	_	7	nmod	_	_
12	could	_	VERB	MD	_	14	aux	_	_
13	be	_	VERB	VB	_	14	auxpass	_	_
14	mediated	_	VERB	VBN	_	4	ccomp	_	_
15	through	_	ADP	IN	_	17	case	_	_
16	a	_	DET	DT	_	17	det	_	_
17	combination	_	NOUN	NN	_	14	nmod	_	_
18	of	_	ADP	IN	_	20	case	_	_
19	antagonist	_	NOUN	NN	_	20	compound	_	_
20	activity	_	NOUN	NN	_	17	nmod	_	_
21	at	_	ADP	IN	_	26	case	_	_
22	D2	_	NOUN	NN	_	26	compound	_	_
23	and	_	CONJ	CC	_	22	cc	_	_
24	5	_	NUM	CD	_	22	conj	_	_
25	HT2A	_	NOUN	NN	_	26	compound	_	_
26	receptors	_	NOUN	NNS	_	17	nmod	_	_

#	SAPHRIS	5949
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	exhibits	_	VERB	VBZ	_	0	root	_	_
3	high	_	ADJ	JJ	_	4	amod	_	_
4	affinity	_	NOUN	NN	_	2	dobj	_	_
5	for	_	ADP	IN	_	8	case	_	_
6	serotonin	_	NOUN	NN	_	8	compound	_	_
7	5	_	NUM	CD	_	8	nummod	_	_
8	HT1A	_	NOUN	NN	_	4	nmod	_	_
9	,	_	.	,	_	8	punct	_	_
10	5	_	NUM	CD	_	11	nummod	_	_
11	HT1B	_	NOUN	NN	_	8	conj	_	_
12	,	_	.	,	_	8	punct	_	_
13	5	_	NUM	CD	_	14	nummod	_	_
14	HT2A	_	NOUN	NN	_	8	conj	_	_
15	,	_	.	,	_	8	punct	_	_
16	5	_	NUM	CD	_	17	nummod	_	_
17	HT2B	_	NOUN	NN	_	8	conj	_	_
18	,	_	.	,	_	8	punct	_	_
19	5	_	NUM	CD	_	20	nummod	_	_
20	HT2C	_	NOUN	NN	_	8	conj	_	_
21	,	_	.	,	_	8	punct	_	_
22	5	_	NUM	CD	_	23	nummod	_	_
23	HT5A	_	NOUN	NN	_	8	conj	_	_
24	,	_	.	,	_	8	punct	_	_
25	5	_	NUM	CD	_	26	nummod	_	_
26	HT6	_	NOUN	NN	_	8	conj	_	_
27	,	_	.	,	_	8	punct	_	_
28	and	_	CONJ	CC	_	8	cc	_	_
29	5	_	NUM	CD	_	31	nummod	_	_
30	HT7	_	NOUN	NN	_	31	compound	_	_
31	receptors	_	NOUN	NNS	_	8	conj	_	_
32	Ki	_	NOUN	NN	_	33	compound	_	_
33	values	_	NOUN	NNS	_	8	dep	_	_
34	of	_	ADP	IN	_	35	case	_	_
35	2.5	_	NUM	CD	_	33	nmod	_	_
36	,	_	.	,	_	8	punct	_	_
37	2.7	_	NUM	CD	_	8	conj	_	_
38	,	_	.	,	_	8	punct	_	_
39	0.07	_	NUM	CD	_	8	conj	_	_
40	,	_	.	,	_	8	punct	_	_
41	0.18	_	NUM	CD	_	8	conj	_	_
42	,	_	.	,	_	8	punct	_	_
43	0.03	_	NUM	CD	_	8	conj	_	_
44	,	_	.	,	_	8	punct	_	_
45	1.6	_	NUM	CD	_	8	conj	_	_
46	,	_	.	,	_	8	punct	_	_
47	0.25	_	NUM	CD	_	8	conj	_	_
48	,	_	.	,	_	8	punct	_	_
49	and	_	CONJ	CC	_	8	cc	_	_
50	0.11nM	_	ADJ	JJ	_	8	conj	_	_
51	,	_	.	,	_	8	punct	_	_
52	respectively	_	ADV	RB	_	8	advmod	_	_
53	,	_	.	,	_	8	punct	_	_
54	dopamine	_	NOUN	NN	_	55	compound	_	_
55	D2A	_	NOUN	NN	_	8	conj	_	_
56	,	_	.	,	_	8	punct	_	_
57	D2B	_	NOUN	NN	_	8	conj	_	_
58	,	_	.	,	_	8	punct	_	_
59	D3	_	NOUN	NN	_	8	conj	_	_
60	,	_	.	,	_	8	punct	_	_
61	D4	_	NOUN	NN	_	8	conj	_	_
62	,	_	.	,	_	8	punct	_	_
63	and	_	CONJ	CC	_	8	cc	_	_
64	D1	_	NOUN	NN	_	65	compound	_	_
65	receptors	_	NOUN	NNS	_	8	conj	_	_
66	Ki	_	NOUN	NN	_	67	compound	_	_
67	values	_	NOUN	NNS	_	8	dep	_	_
68	of	_	ADP	IN	_	69	case	_	_
69	1.3	_	NUM	CD	_	67	nmod	_	_
70	,	_	.	,	_	69	punct	_	_
71	1.4	_	NUM	CD	_	69	conj	_	_
72	,	_	.	,	_	69	punct	_	_
73	0.42	_	NUM	CD	_	69	conj	_	_
74	,	_	.	,	_	69	punct	_	_
75	1.1	_	NUM	CD	_	69	conj	_	_
76	,	_	.	,	_	69	punct	_	_
77	and	_	CONJ	CC	_	69	cc	_	_
78	1.4	_	NUM	CD	_	69	conj	_	_
79	nM	_	NOUN	NN	_	69	dep	_	_
80	,	_	.	,	_	8	punct	_	_
81	respectively	_	ADV	RB	_	8	advmod	_	_
82	,	_	.	,	_	8	punct	_	_
83	A1A	_	NOUN	NN	_	8	conj	_	_
84	,	_	.	,	_	8	punct	_	_
85	A2A	_	NOUN	NN	_	8	conj	_	_
86	,	_	.	,	_	8	punct	_	_
87	A2B	_	NOUN	NN	_	8	conj	_	_
88	,	_	.	,	_	8	punct	_	_
89	and	_	CONJ	CC	_	8	cc	_	_
90	A2C	_	NOUN	NN	_	92	compound	_	_
91	adrenergic	_	ADJ	JJ	_	92	amod	_	_
92	receptors	_	NOUN	NNS	_	8	conj	_	_
93	Ki	_	NOUN	NN	_	94	compound	_	_
94	values	_	NOUN	NNS	_	8	dep	_	_
95	of	_	ADP	IN	_	96	case	_	_
96	1.2	_	NUM	CD	_	94	nmod	_	_
97	,	_	.	,	_	96	punct	_	_
98	1.2	_	NUM	CD	_	96	conj	_	_
99	,	_	.	,	_	96	punct	_	_
100	0.33	_	NUM	CD	_	96	conj	_	_
101	and	_	CONJ	CC	_	96	cc	_	_
102	1.2	_	NUM	CD	_	96	conj	_	_
103	nM	_	NOUN	NN	_	96	dep	_	_
104	,	_	.	,	_	96	punct	_	_
105	respectively	_	ADV	RB	_	96	advmod	_	_
106	,	_	.	,	_	96	punct	_	_
107	and	_	CONJ	CC	_	96	cc	_	_
108	histamine	_	NOUN	NN	_	110	compound	_	_
109	H1	_	NOUN	NN	_	110	compound	_	_
110	receptors	_	NOUN	NNS	_	96	conj	_	_
111	Ki	_	NOUN	NN	_	114	compound	_	_
112	value	_	NOUN	NN	_	114	compound	_	_
113	1.0	_	NUM	CD	_	114	nummod	_	_
114	nM	_	NOUN	NN	_	96	dep	_	_
115	,	_	.	,	_	2	punct	_	_
116	and	_	CONJ	CC	_	2	cc	_	_
117	moderate	_	ADJ	JJ	_	118	amod	_	_
118	affinity	_	NOUN	NN	_	2	conj	_	_
119	for	_	ADP	IN	_	121	case	_	_
120	H2	_	NOUN	NN	_	121	compound	_	_
121	receptors	_	NOUN	NNS	_	118	nmod	_	_
122	Ki	_	NOUN	NN	_	123	compound	_	_
123	value	_	NOUN	NN	_	121	dep	_	_
124	of	_	ADP	IN	_	126	case	_	_
125	6.2	_	NUM	CD	_	126	nummod	_	_
126	nM	_	NOUN	NN	_	123	nmod	_	_

#	SAPHRIS	5950
1	In	_	ADP	IN	_	4	case	_	_
2	in	_	X	FW	_	4	amod	_	_
3	vitro	_	X	FW	_	2	dep	_	_
4	assays	_	NOUN	NNS	_	6	nmod	_	_
5	DRUG	_	NOUN	NN	_	6	nsubj	_	_
6	acts	_	VERB	VBZ	_	0	root	_	_
7	as	_	ADP	IN	_	9	case	_	_
8	an	_	DET	DT	_	9	det	_	_
9	antagonist	_	NOUN	NN	_	6	nmod	_	_
10	at	_	ADP	IN	_	12	case	_	_
11	these	_	DET	DT	_	12	det	_	_
12	receptors	_	NOUN	NNS	_	9	nmod	_	_

#	SAPHRIS	5951
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	has	_	VERB	VBZ	_	0	root	_	_
3	no	_	DET	DT	_	5	neg	_	_
4	appreciable	_	ADJ	JJ	_	5	amod	_	_
5	affinity	_	NOUN	NN	_	2	dobj	_	_
6	for	_	ADP	IN	_	9	case	_	_
7	muscarinic	_	ADJ	JJ	_	9	amod	_	_
8	cholinergic	_	ADJ	JJ	_	9	amod	_	_
9	receptors	_	NOUN	NNS	_	5	nmod	_	_
10	e.g	_	NOUN	NN	_	9	dep	_	_
11	,	_	.	,	_	10	punct	_	_
12	Ki	_	NOUN	NN	_	13	compound	_	_
13	value	_	NOUN	NN	_	10	appos	_	_
14	of	_	ADP	IN	_	16	case	_	_
15	8128	_	NUM	CD	_	16	nummod	_	_
16	nM	_	NOUN	NN	_	13	nmod	_	_
17	for	_	ADP	IN	_	18	case	_	_
18	M1	_	NOUN	NN	_	13	nmod	_	_

#	SAPHRIS	5952
1	Following	_	ADP	IN	_	6	case	_	_
2	a	_	DET	DT	_	6	det	_	_
3	single	_	ADJ	JJ	_	6	amod	_	_
4	5	_	NUM	CD	_	6	nummod	_	_
5	mg	_	NOUN	NN	_	6	compound	_	_
6	dose	_	NOUN	NN	_	16	nmod	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	,	_	.	,	_	16	punct	_	_
10	the	_	DET	DT	_	12	det	_	_
11	mean	_	NOUN	NN	_	12	compound	_	_
12	Cmax	_	NOUN	NN	_	16	nsubj	_	_
13	was	_	VERB	VBD	_	16	cop	_	_
14	approximately	_	ADV	RB	_	15	advmod	_	_
15	4	_	NUM	CD	_	16	nummod	_	_
16	ng	_	NOUN	NN	_	0	root	_	_
17	/	_	.	:	_	16	punct	_	_
18	mL	_	NOUN	NN	_	16	dep	_	_
19	and	_	CONJ	CC	_	16	cc	_	_
20	was	_	VERB	VBD	_	21	auxpass	_	_
21	observed	_	VERB	VBN	_	16	conj	_	_
22	at	_	ADP	IN	_	25	case	_	_
23	a	_	DET	DT	_	25	det	_	_
24	mean	_	ADJ	JJ	_	25	amod	_	_
25	tmax	_	NOUN	NN	_	21	nmod	_	_
26	of	_	ADP	IN	_	28	case	_	_
27	1	_	NUM	CD	_	28	nummod	_	_
28	hour	_	NUM	CD	_	25	nmod	_	_

#	SAPHRIS	5953
1	Elimination	_	NOUN	NN	_	8	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	is	_	VERB	VBZ	_	8	cop	_	_
5	primarily	_	ADV	RB	_	8	advmod	_	_
6	through	_	ADP	IN	_	8	case	_	_
7	direct	_	ADJ	JJ	_	8	amod	_	_
8	glucuronidation	_	NOUN	NN	_	0	root	_	_
9	by	_	ADP	IN	_	10	case	_	_
10	UGT1A4	_	NOUN	NN	_	8	nmod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	oxidative	_	ADJ	JJ	_	13	amod	_	_
13	metabolism	_	NOUN	NN	_	10	conj	_	_
14	by	_	ADP	IN	_	17	case	_	_
15	cytochrome	_	NOUN	NN	_	17	compound	_	_
16	P450	_	NOUN	NN	_	17	compound	_	_
17	isoenzymes	_	NOUN	NNS	_	8	nmod	_	_
18	predominantly	_	ADV	RB	_	19	advmod	_	_
19	CYP1A2	_	NOUN	NN	_	17	nmod	_	_

#	SAPHRIS	5954
1	Following	_	ADP	IN	_	7	case	_	_
2	an	_	DET	DT	_	7	det	_	_
3	initial	_	ADJ	JJ	_	7	amod	_	_
4	more	_	ADV	RB	_	5	advmod	_	_
5	rapid	_	ADJ	JJ	_	7	amod	_	_
6	distribution	_	NOUN	NN	_	7	compound	_	_
7	phase	_	NOUN	NN	_	17	nmod	_	_
8	,	_	.	,	_	17	punct	_	_
9	the	_	DET	DT	_	13	det	_	_
10	mean	_	ADJ	JJ	_	13	compound	_	_
11	terminal	_	ADJ	JJ	_	13	amod	_	_
12	half	_	NOUN	NN	_	13	compound	_	_
13	life	_	NOUN	NN	_	17	nsubj	_	_
14	is	_	VERB	VBZ	_	17	cop	_	_
15	approximately	_	ADV	RB	_	16	advmod	_	_
16	24	_	NUM	CD	_	17	nummod	_	_
17	hrs	_	PRON	PRP	_	0	root	_	_

#	SAPHRIS	5955
1	With	_	ADP	IN	_	3	case	_	_
2	multiple	_	ADJ	JJ	_	3	amod	_	_
3	dose	_	NOUN	NN	_	6	nmod	_	_
4	twice	_	ADV	RB	_	5	advmod	_	_
5	daily	_	ADV	RB	_	6	advmod	_	_
6	dosing	_	NOUN	NN	_	11	nmod	_	_
7	,	_	.	,	_	11	punct	_	_
8	steady	_	ADJ	JJ	_	9	amod	_	_
9	state	_	NOUN	NN	_	11	nsubjpass	_	_
10	is	_	VERB	VBZ	_	11	auxpass	_	_
11	attained	_	VERB	VBN	_	0	root	_	_
12	within	_	ADP	IN	_	14	case	_	_
13	3	_	NUM	CD	_	14	nummod	_	_
14	days	_	NOUN	NNS	_	11	nmod	_	_

#	SAPHRIS	5956
1	Overall	_	ADJ	JJ	_	8	advmod	_	_
2	,	_	.	,	_	8	punct	_	_
3	steady	_	ADJ	JJ	_	6	amod	_	_
4	state	_	NOUN	NN	_	6	compound	_	_
5	DRUG	_	NOUN	NN	_	6	compound	_	_
6	pharmacokinetics	_	NOUN	NNS	_	8	nsubj	_	_
7	are	_	VERB	VBP	_	8	cop	_	_
8	similar	_	ADJ	JJ	_	0	root	_	_
9	to	_	PRT	TO	_	12	case	_	_
10	single	_	ADJ	JJ	_	12	amod	_	_
11	dose	_	NOUN	NN	_	12	compound	_	_
12	pharmacokinetics	_	NOUN	NNS	_	8	nmod	_	_

#	SAPHRIS	5957
1	Absorption	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Following	_	ADP	IN	_	5	case	_	_
4	sublingual	_	ADJ	JJ	_	5	amod	_	_
5	administration	_	NOUN	NN	_	1	nmod	_	_
6	,	_	.	,	_	1	punct	_	_
7	DRUG	_	NOUN	NN	_	10	nsubjpass	_	_
8	is	_	VERB	VBZ	_	10	auxpass	_	_
9	rapidly	_	ADV	RB	_	10	advmod	_	_
10	absorbed	_	VERB	VBN	_	1	dep	_	_
11	with	_	ADP	IN	_	14	case	_	_
12	peak	_	ADJ	JJ	_	14	amod	_	_
13	plasma	_	NOUN	NN	_	14	compound	_	_
14	concentrations	_	NOUN	NNS	_	10	nmod	_	_
15	occurring	_	VERB	VBG	_	14	acl	_	_
16	within	_	ADP	IN	_	20	case	_	_
17	0.5	_	NUM	CD	_	19	compound	_	_
18	to	_	PRT	TO	_	19	dep	_	_
19	1.5	_	NUM	CD	_	20	nummod	_	_
20	hours	_	NOUN	NNS	_	15	nmod	_	_

#	SAPHRIS	5958
1	The	_	DET	DT	_	3	det	_	_
2	absolute	_	ADJ	JJ	_	3	amod	_	_
3	bioavailability	_	NOUN	NN	_	11	nsubj	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	sublingual	_	ADJ	JJ	_	6	amod	_	_
6	DRUG	_	NOUN	NN	_	3	nmod	_	_
7	at	_	ADP	IN	_	9	case	_	_
8	5	_	NUM	CD	_	9	nummod	_	_
9	mg	_	NOUN	NN	_	3	nmod	_	_
10	is	_	VERB	VBZ	_	11	auxpass	_	_
11	35%	_	ADJ	JJ	_	0	root	_	_

#	SAPHRIS	5959
1	Increasing	_	VERB	VBG	_	0	root	_	_
2	the	_	DET	DT	_	3	det	_	_
3	dose	_	NOUN	NN	_	1	dobj	_	_
4	from	_	ADP	IN	_	6	case	_	_
5	5	_	NUM	CD	_	6	nummod	_	_
6	mg	_	NOUN	NN	_	1	nmod	_	_
7	to	_	PRT	TO	_	9	case	_	_
8	10	_	NUM	CD	_	9	nummod	_	_
9	mg	_	NOUN	NN	_	1	nmod	_	_
10	twice	_	ADV	RB	_	11	advmod	_	_
11	daily	_	ADV	RB	_	16	advmod	_	_
12	a	_	DET	DT	_	15	det	_	_
13	two	_	NUM	CD	_	15	nummod	_	_
14	fold	_	NOUN	NN	_	15	compound	_	_
15	increase	_	NOUN	NN	_	16	nsubj	_	_
16	results	_	NOUN	NNS	_	1	nmod	_	_
17	in	_	ADP	IN	_	16	cc	_	_
18	less	_	ADV	RB	_	17	mwe	_	_
19	than	_	ADP	IN	_	17	mwe	_	_
20	linear	_	ADJ	JJ	_	22	amod	_	_
21	1.7	_	NUM	CD	_	22	nummod	_	_
22	times	_	NOUN	NNS	_	16	conj	_	_
23	increases	_	VERB	VBZ	_	16	dep	_	_
24	in	_	ADP	IN	_	27	case	_	_
25	both	_	CONJ	CC	_	27	cc:preconj	_	_
26	the	_	DET	DT	_	27	det	_	_
27	extent	_	NOUN	NN	_	23	nmod	_	_
28	of	_	ADP	IN	_	29	case	_	_
29	exposure	_	NOUN	NN	_	27	nmod	_	_
30	and	_	CONJ	CC	_	29	cc	_	_
31	maximum	_	NOUN	NN	_	32	compound	_	_
32	concentration	_	NOUN	NN	_	29	conj	_	_

#	SAPHRIS	5960
1	The	_	DET	DT	_	3	det	_	_
2	absolute	_	ADJ	JJ	_	3	amod	_	_
3	bioavailability	_	NOUN	NN	_	0	root	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	when	_	ADV	WRB	_	7	advmod	_	_
7	swallowed	_	VERB	VBN	_	3	acl	_	_
8	is	_	VERB	VBZ	_	10	cop	_	_
9	low	_	ADJ	JJ	_	10	amod	_	_
10	<2%	_	NOUN	NN	_	7	nmod	_	_
11	with	_	ADP	IN	_	15	case	_	_
12	an	_	DET	DT	_	15	det	_	_
13	oral	_	ADJ	JJ	_	15	amod	_	_
14	tablet	_	NOUN	NN	_	15	compound	_	_
15	formulation	_	NOUN	NN	_	10	nmod	_	_

#	SAPHRIS	5961
1	The	_	DET	DT	_	2	det	_	_
2	intake	_	NOUN	NN	_	13	nsubj	_	_
3	of	_	ADP	IN	_	9	case	_	_
4	water	_	NOUN	NN	_	6	compound	_	_
5	several	_	ADJ	JJ	_	6	amod	_	_
6	2	_	NUM	CD	_	9	nummod	_	_
7	or	_	CONJ	CC	_	6	cc	_	_
8	5	_	NUM	CD	_	6	conj	_	_
9	minutes	_	NOUN	NNS	_	2	nmod	_	_
10	after	_	ADP	IN	_	12	case	_	_
11	DRUG	_	NOUN	NN	_	12	compound	_	_
12	administration	_	NOUN	NN	_	2	nmod	_	_
13	resulted	_	VERB	VBD	_	0	root	_	_
14	in	_	ADP	IN	_	17	case	_	_
15	decreased	_	VERB	VBN	_	17	amod	_	_
16	DRUG	_	NOUN	NN	_	17	compound	_	_
17	exposure	_	NOUN	NN	_	13	nmod	_	_

#	SAPHRIS	5962
1	Therefore	_	ADV	RB	_	8	advmod	_	_
2	,	_	.	,	_	8	punct	_	_
3	eating	_	NOUN	NN	_	8	nsubjpass	_	_
4	and	_	CONJ	CC	_	3	cc	_	_
5	drinking	_	NOUN	NN	_	3	conj	_	_
6	should	_	VERB	MD	_	8	aux	_	_
7	be	_	VERB	VB	_	8	auxpass	_	_
8	avoided	_	VERB	VBN	_	0	root	_	_
9	for	_	ADP	IN	_	11	case	_	_
10	10	_	NUM	CD	_	11	nummod	_	_
11	minutes	_	NOUN	NNS	_	8	nmod	_	_
12	after	_	ADP	IN	_	13	case	_	_
13	administration	_	NOUN	NN	_	11	nmod	_	_

#	SAPHRIS	5963
1	Distribution	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	DRUG	_	NOUN	NN	_	6	nsubjpass	_	_
4	is	_	VERB	VBZ	_	6	auxpass	_	_
5	rapidly	_	ADV	RB	_	6	advmod	_	_
6	distributed	_	VERB	VBN	_	1	dep	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	has	_	VERB	VBZ	_	6	conj	_	_
9	a	_	DET	DT	_	11	det	_	_
10	large	_	ADJ	JJ	_	11	amod	_	_
11	volume	_	NOUN	NN	_	8	dobj	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	distribution	_	NOUN	NN	_	11	nmod	_	_
14	approximately	_	ADV	RB	_	17	advmod	_	_
15	20	_	NUM	CD	_	17	nummod	_	_
16	25	_	NUM	CD	_	17	nummod	_	_
17	L	_	NOUN	NN	_	8	nmod	_	_
18	/	_	.	:	_	17	punct	_	_
19	kg	_	NOUN	NN	_	17	appos	_	_
20	,	_	.	,	_	6	punct	_	_
21	indicating	_	VERB	VBG	_	6	xcomp	_	_
22	extensive	_	ADJ	JJ	_	24	amod	_	_
23	extravascular	_	ADJ	JJ	_	24	amod	_	_
24	distribution	_	NOUN	NN	_	21	dobj	_	_

#	SAPHRIS	5964
1	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
2	is	_	VERB	VBZ	_	4	auxpass	_	_
3	highly	_	ADV	RB	_	4	advmod	_	_
4	bound	_	VERB	VBN	_	0	root	_	_
5	95%	_	ADJ	JJ	_	4	xcomp	_	_
6	to	_	PRT	TO	_	8	case	_	_
7	plasma	_	NOUN	NN	_	8	compound	_	_
8	proteins	_	NOUN	NNS	_	5	nmod	_	_
9	,	_	.	,	_	4	punct	_	_
10	including	_	VERB	VBG	_	11	case	_	_
11	albumin	_	NOUN	NN	_	4	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	A1	_	NOUN	NN	_	15	compound	_	_
14	acid	_	NOUN	NN	_	15	compound	_	_
15	glycoprotein	_	NOUN	NN	_	11	conj	_	_

#	SAPHRIS	5965
1	Metabolism	_	NOUN	NN	_	0	root	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	Elimination	_	NOUN	NN	_	1	conj	_	_
4	:	_	.	:	_	1	punct	_	_
5	Direct	_	ADJ	JJ	_	6	amod	_	_
6	glucuronidation	_	NOUN	NN	_	22	nsubj	_	_
7	by	_	ADP	IN	_	8	case	_	_
8	UGT1A4	_	NOUN	NN	_	6	nmod	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	oxidative	_	ADJ	JJ	_	11	amod	_	_
11	metabolism	_	NOUN	NN	_	8	conj	_	_
12	by	_	ADP	IN	_	15	case	_	_
13	cytochrome	_	NOUN	NN	_	15	compound	_	_
14	P450	_	NOUN	NN	_	15	compound	_	_
15	isoenzymes	_	NOUN	NNS	_	6	nmod	_	_
16	predominantly	_	ADV	RB	_	22	advmod	_	_
17	CYP1A2	_	NOUN	NN	_	22	nsubj	_	_
18	are	_	VERB	VBP	_	22	cop	_	_
19	the	_	DET	DT	_	22	det	_	_
20	primary	_	ADJ	JJ	_	22	amod	_	_
21	metabolic	_	ADJ	JJ	_	22	amod	_	_
22	pathways	_	NOUN	NNS	_	1	dep	_	_
23	for	_	ADP	IN	_	24	case	_	_
24	DRUG	_	NOUN	NN	_	22	nmod	_	_

#	SAPHRIS	5966
1	DRUG	_	NOUN	NN	_	6	nsubj	_	_
2	is	_	VERB	VBZ	_	6	cop	_	_
3	a	_	DET	DT	_	6	det	_	_
4	high	_	ADJ	JJ	_	6	amod	_	_
5	clearance	_	NOUN	NN	_	6	compound	_	_
6	drug	_	NOUN	NN	_	0	root	_	_
7	with	_	ADP	IN	_	9	case	_	_
8	a	_	DET	DT	_	9	det	_	_
9	clearance	_	NOUN	NN	_	6	nmod	_	_
10	after	_	ADP	IN	_	12	case	_	_
11	intravenous	_	ADJ	JJ	_	12	amod	_	_
12	administration	_	NOUN	NN	_	6	nmod	_	_
13	of	_	ADP	IN	_	15	case	_	_
14	52	_	NUM	CD	_	15	nummod	_	_
15	L	_	NOUN	NN	_	12	nmod	_	_
16	/	_	.	:	_	6	punct	_	_
17	h	_	NOUN	NN	_	6	punct	_	_

#	SAPHRIS	5967
1	In	_	ADP	IN	_	3	case	_	_
2	this	_	DET	DT	_	3	det	_	_
3	circumstance	_	NOUN	NN	_	8	nmod	_	_
4	,	_	.	,	_	8	punct	_	_
5	hepatic	_	ADJ	JJ	_	6	amod	_	_
6	clearance	_	NOUN	NN	_	8	nsubjpass	_	_
7	is	_	VERB	VBZ	_	8	auxpass	_	_
8	influenced	_	VERB	VBN	_	0	root	_	_
9	primarily	_	ADV	RB	_	8	advmod	_	_
10	by	_	ADP	IN	_	11	case	_	_
11	changes	_	NOUN	NNS	_	8	nmod	_	_
12	in	_	ADP	IN	_	15	case	_	_
13	liver	_	NOUN	NN	_	15	compound	_	_
14	blood	_	NOUN	NN	_	15	compound	_	_
15	flow	_	NOUN	NN	_	11	nmod	_	_
16	rather	_	ADV	RB	_	11	cc	_	_
17	than	_	ADP	IN	_	16	mwe	_	_
18	by	_	ADP	IN	_	19	case	_	_
19	changes	_	NOUN	NNS	_	11	conj	_	_
20	in	_	ADP	IN	_	23	case	_	_
21	the	_	DET	DT	_	23	det	_	_
22	intrinsic	_	ADJ	JJ	_	23	amod	_	_
23	clearance	_	NOUN	NN	_	19	nmod	_	_
24	,	_	.	,	_	11	punct	_	_
25	i.e	_	ADV	RB	_	11	advmod	_	_
26	,	_	.	,	_	11	punct	_	_
27	the	_	DET	DT	_	30	det	_	_
28	metabolizing	_	VERB	VBG	_	30	amod	_	_
29	enzymatic	_	ADJ	JJ	_	30	amod	_	_
30	activity	_	NOUN	NN	_	11	root	_	_

#	SAPHRIS	5968
1	Following	_	ADP	IN	_	7	case	_	_
2	an	_	DET	DT	_	7	det	_	_
3	initial	_	ADJ	JJ	_	7	amod	_	_
4	more	_	ADV	RB	_	5	advmod	_	_
5	rapid	_	ADJ	JJ	_	7	amod	_	_
6	distribution	_	NOUN	NN	_	7	compound	_	_
7	phase	_	NOUN	NN	_	18	nmod	_	_
8	,	_	.	,	_	18	punct	_	_
9	the	_	DET	DT	_	12	det	_	_
10	terminal	_	ADJ	JJ	_	12	amod	_	_
11	half	_	ADJ	JJ	_	12	amod	_	_
12	life	_	NOUN	NN	_	18	nsubj	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	DRUG	_	NOUN	NN	_	12	nmod	_	_
15	is	_	VERB	VBZ	_	18	cop	_	_
16	approximately	_	ADV	RB	_	18	advmod	_	_
17	24	_	NUM	CD	_	18	nummod	_	_
18	hours	_	NOUN	NNS	_	0	root	_	_

#	SAPHRIS	5969
1	Steady	_	ADJ	JJ	_	3	amod	_	_
2	state	_	NOUN	NN	_	3	compound	_	_
3	concentrations	_	NOUN	NNS	_	7	nsubjpass	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	are	_	VERB	VBP	_	7	auxpass	_	_
7	reached	_	VERB	VBN	_	0	root	_	_
8	within	_	ADP	IN	_	10	case	_	_
9	3	_	NUM	CD	_	10	nummod	_	_
10	days	_	NOUN	NNS	_	7	nmod	_	_
11	of	_	ADP	IN	_	14	mark	_	_
12	twice	_	ADV	RB	_	13	advmod	_	_
13	daily	_	ADV	RB	_	14	advmod	_	_
14	dosing	_	VERB	VBG	_	10	acl	_	_

#	SAPHRIS	5970
1	After	_	ADP	IN	_	2	case	_	_
2	administration	_	NOUN	NN	_	18	nmod	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	a	_	DET	DT	_	6	det	_	_
5	single	_	ADJ	JJ	_	6	amod	_	_
6	dose	_	NOUN	NN	_	2	nmod	_	_
7	of	_	ADP	IN	_	10	case	_	_
8	14C	_	NOUN	NN	_	10	compound	_	_
9	labeled	_	VERB	VBN	_	10	amod	_	_
10	DRUG	_	NOUN	NN	_	6	nmod	_	_
11	,	_	.	,	_	18	punct	_	_
12	about	_	ADV	RB	_	13	advmod	_	_
13	90%	_	NOUN	NN	_	18	nsubjpass	_	_
14	of	_	ADP	IN	_	16	case	_	_
15	the	_	DET	DT	_	16	det	_	_
16	dose	_	NOUN	NN	_	13	nmod	_	_
17	was	_	VERB	VBD	_	18	auxpass	_	_
18	recovered	_	VERB	VBN	_	0	root	_	_
19	approximately	_	ADV	RB	_	22	advmod	_	_
20	50%	_	NOUN	NN	_	22	nsubjpass	_	_
21	was	_	VERB	VBD	_	22	auxpass	_	_
22	recovered	_	VERB	VBN	_	18	advcl	_	_
23	in	_	ADP	IN	_	24	case	_	_
24	urine	_	ADJ	JJ	_	22	nmod	_	_
25	,	_	.	,	_	18	punct	_	_
26	and	_	CONJ	CC	_	18	cc	_	_
27	40%	_	NOUN	NN	_	18	conj	_	_
28	recovered	_	VERB	VBN	_	27	acl	_	_
29	in	_	ADP	IN	_	30	case	_	_
30	feces	_	NOUN	NNS	_	28	nmod	_	_

#	SAPHRIS	5971
1	About	_	ADV	RB	_	2	advmod	_	_
2	50%	_	NOUN	NN	_	11	nsubjpass	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	the	_	DET	DT	_	6	det	_	_
5	circulating	_	ADJ	JJ	_	6	amod	_	_
6	species	_	NOUN	NNS	_	2	nmod	_	_
7	in	_	ADP	IN	_	8	case	_	_
8	plasma	_	NOUN	NN	_	6	nmod	_	_
9	have	_	VERB	VBP	_	11	aux	_	_
10	been	_	VERB	VBN	_	11	auxpass	_	_
11	identified	_	VERB	VBN	_	0	root	_	_

#	SAPHRIS	5972
1	The	_	DET	DT	_	3	det	_	_
2	predominant	_	ADJ	JJ	_	3	amod	_	_
3	species	_	NOUN	NNS	_	8	nsubj	_	_
4	was	_	VERB	VBD	_	8	cop	_	_
5	DRUG	_	NOUN	NN	_	8	compound	_	_
6	N+	_	ADJ	JJ	_	8	amod	_	_
7	glucuronide	_	NOUN	NN	_	8	compound	_	_
8	others	_	NOUN	NNS	_	0	root	_	_
9	included	_	VERB	VBD	_	8	acl	_	_
10	N	_	NOUN	NN	_	12	compound	_	_
11	desmethyl	_	NOUN	NN	_	12	compound	_	_
12	DRUG	_	NOUN	NN	_	9	dobj	_	_
13	,	_	.	,	_	12	punct	_	_
14	N	_	NOUN	NN	_	19	compound	_	_
15	desmethyl	_	NOUN	NN	_	19	compound	_	_
16	DRUG	_	NOUN	NN	_	19	compound	_	_
17	N	_	NOUN	NN	_	19	compound	_	_
18	carbamoyl	_	NOUN	NN	_	19	compound	_	_
19	glucuronide	_	NOUN	NN	_	12	conj	_	_
20	,	_	.	,	_	12	punct	_	_
21	and	_	CONJ	CC	_	12	cc	_	_
22	unchanged	_	ADJ	JJ	_	23	amod	_	_
23	DRUG	_	NOUN	NN	_	12	conj	_	_
24	in	_	ADP	IN	_	26	case	_	_
25	smaller	_	ADJ	JJ	_	26	amod	_	_
26	amounts	_	NOUN	NNS	_	12	nmod	_	_

#	SAPHRIS	5973
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	activity	_	NOUN	NN	_	5	nsubj	_	_
3	is	_	VERB	VBZ	_	5	cop	_	_
4	primarily	_	ADV	RB	_	5	advmod	_	_
5	due	_	ADJ	JJ	_	0	root	_	_
6	to	_	PRT	TO	_	9	case	_	_
7	the	_	DET	DT	_	9	det	_	_
8	parent	_	NOUN	NN	_	9	compound	_	_
9	drug	_	NOUN	NN	_	5	nmod	_	_

#	SAPHRIS	5974
1	In	_	X	FW	_	3	amod	_	_
2	vitro	_	X	FW	_	1	dep	_	_
3	studies	_	NOUN	NNS	_	4	nsubj	_	_
4	indicate	_	VERB	VBP	_	0	root	_	_
5	that	_	ADP	IN	_	9	mark	_	_
6	DRUG	_	NOUN	NN	_	9	nsubj	_	_
7	is	_	VERB	VBZ	_	9	cop	_	_
8	a	_	DET	DT	_	9	det	_	_
9	substrate	_	NOUN	NN	_	4	ccomp	_	_
10	for	_	ADP	IN	_	11	case	_	_
11	UGT1A4	_	NOUN	NN	_	9	nmod	_	_
12	,	_	.	,	_	11	punct	_	_
13	CYP1A2	_	NOUN	NN	_	11	conj	_	_
14	and	_	CONJ	CC	_	11	cc	_	_
15	to	_	PRT	TO	_	18	case	_	_
16	a	_	DET	DT	_	18	det	_	_
17	lesser	_	ADJ	JJ	_	18	amod	_	_
18	extent	_	NOUN	NN	_	11	conj	_	_
19	CYP3A4	_	NOUN	NN	_	18	dep	_	_
20	and	_	CONJ	CC	_	19	cc	_	_
21	CYP2D6	_	NOUN	NN	_	19	conj	_	_

#	SAPHRIS	5975
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	does	_	VERB	VBZ	_	4	aux	_	_
3	not	_	ADV	RB	_	4	neg	_	_
4	cause	_	VERB	VB	_	0	root	_	_
5	induction	_	NOUN	NN	_	4	dobj	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	CYP1A2	_	NOUN	NN	_	5	nmod	_	_
8	or	_	CONJ	CC	_	7	cc	_	_
9	CYP3A4	_	NOUN	NN	_	7	conj	_	_
10	activities	_	NOUN	NNS	_	7	dep	_	_
11	in	_	ADP	IN	_	14	case	_	_
12	cultured	_	VERB	VBN	_	14	amod	_	_
13	human	_	ADJ	JJ	_	14	amod	_	_
14	hepatocytes	_	NOUN	NNS	_	5	nmod	_	_

#	SAPHRIS	5976
1	Coadministration	_	NOUN	NN	_	17	nsubjpass	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	with	_	ADP	IN	_	6	case	_	_
5	known	_	VERB	VBN	_	6	amod	_	_
6	inhibitors	_	NOUN	NNS	_	1	nmod	_	_
7	,	_	.	,	_	6	punct	_	_
8	inducers	_	NOUN	NNS	_	6	conj	_	_
9	or	_	CONJ	CC	_	6	cc	_	_
10	substrates	_	NOUN	NNS	_	6	conj	_	_
11	of	_	ADP	IN	_	14	case	_	_
12	these	_	DET	DT	_	14	det	_	_
13	metabolic	_	ADJ	JJ	_	14	amod	_	_
14	pathways	_	NOUN	NNS	_	10	nmod	_	_
15	has	_	VERB	VBZ	_	17	aux	_	_
16	been	_	VERB	VBN	_	17	auxpass	_	_
17	studied	_	VERB	VBN	_	0	root	_	_
18	in	_	ADP	IN	_	20	case	_	_
19	a	_	DET	DT	_	20	det	_	_
20	number	_	NOUN	NN	_	17	nmod	_	_
21	of	_	ADP	IN	_	25	case	_	_
22	drug	_	NOUN	NN	_	25	compound	_	_
23	drug	_	NOUN	NN	_	25	compound	_	_
24	interaction	_	NOUN	NN	_	25	compound	_	_
25	studies	_	NOUN	NNS	_	20	nmod	_	_

#	SAPHRIS	5977
1	Food	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	A	_	PRON	PRP$	_	5	det	_	_
4	crossover	_	ADJ	JJ	_	5	amod	_	_
5	study	_	NOUN	NN	_	13	nsubjpass	_	_
6	in	_	ADP	IN	_	11	case	_	_
7	26	_	NUM	CD	_	11	nummod	_	_
8	healthy	_	ADJ	JJ	_	11	amod	_	_
9	adult	_	ADJ	JJ	_	11	amod	_	_
10	male	_	ADJ	JJ	_	11	amod	_	_
11	subjects	_	NOUN	NNS	_	5	nmod	_	_
12	was	_	VERB	VBD	_	13	auxpass	_	_
13	performed	_	VERB	VBN	_	1	dep	_	_
14	to	_	PRT	TO	_	15	mark	_	_
15	evaluate	_	VERB	VB	_	13	xcomp	_	_
16	the	_	DET	DT	_	17	det	_	_
17	effect	_	NOUN	NN	_	15	dobj	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	food	_	NOUN	NN	_	17	nmod	_	_
20	on	_	ADP	IN	_	22	case	_	_
21	the	_	DET	DT	_	22	det	_	_
22	pharmacokinetics	_	NOUN	NNS	_	17	nmod	_	_
23	of	_	ADP	IN	_	28	case	_	_
24	a	_	DET	DT	_	28	det	_	_
25	single	_	ADJ	JJ	_	28	amod	_	_
26	5	_	NUM	CD	_	28	nummod	_	_
27	mg	_	NOUN	NN	_	28	compound	_	_
28	dose	_	NOUN	NN	_	22	nmod	_	_
29	of	_	ADP	IN	_	30	case	_	_
30	DRUG	_	NOUN	NN	_	28	nmod	_	_

#	SAPHRIS	5978
1	Consumption	_	NOUN	NN	_	9	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	food	_	NOUN	NN	_	1	nmod	_	_
4	immediately	_	ADV	RB	_	5	advmod	_	_
5	prior	_	ADJ	JJ	_	1	amod	_	_
6	to	_	PRT	TO	_	8	case	_	_
7	sublingual	_	ADJ	JJ	_	8	amod	_	_
8	administration	_	NOUN	NN	_	5	nmod	_	_
9	decreased	_	VERB	VBD	_	0	root	_	_
10	DRUG	_	NOUN	NN	_	11	compound	_	_
11	exposure	_	NOUN	NN	_	9	dobj	_	_
12	by	_	ADP	IN	_	14	case	_	_
13	20%	_	ADJ	JJ	_	14	amod	_	_
14	consumption	_	NOUN	NN	_	9	nmod	_	_
15	of	_	ADP	IN	_	18	case	_	_
16	food	_	NOUN	NN	_	18	compound	_	_
17	4	_	NUM	CD	_	18	nummod	_	_
18	hours	_	NOUN	NNS	_	14	nmod	_	_
19	after	_	ADP	IN	_	21	case	_	_
20	sublingual	_	ADJ	JJ	_	21	amod	_	_
21	administration	_	NOUN	NN	_	14	nmod	_	_
22	decreased	_	VERB	VBD	_	24	amod	_	_
23	DRUG	_	NOUN	NN	_	24	compound	_	_
24	exposure	_	NOUN	NN	_	9	dobj	_	_
25	by	_	ADP	IN	_	27	case	_	_
26	about	_	ADV	RB	_	27	advmod	_	_
27	10%	_	ADJ	JJ	_	24	nmod	_	_

#	SAPHRIS	5979
1	These	_	DET	DT	_	2	det	_	_
2	effects	_	NOUN	NNS	_	5	nsubj	_	_
3	are	_	VERB	VBP	_	5	cop	_	_
4	probably	_	ADV	RB	_	5	advmod	_	_
5	due	_	ADJ	JJ	_	0	root	_	_
6	to	_	PRT	TO	_	10	case	_	_
7	increased	_	VERB	VBN	_	10	amod	_	_
8	hepatic	_	ADJ	JJ	_	10	amod	_	_
9	blood	_	NOUN	NN	_	10	compound	_	_
10	flow	_	NOUN	NN	_	5	nmod	_	_

#	SAPHRIS	5980
1	In	_	ADP	IN	_	3	case	_	_
2	clinical	_	ADJ	JJ	_	3	amod	_	_
3	trials	_	NOUN	NNS	_	14	nmod	_	_
4	establishing	_	VERB	VBG	_	3	acl	_	_
5	the	_	DET	DT	_	6	det	_	_
6	efficacy	_	NOUN	NN	_	4	dobj	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	safety	_	NOUN	NN	_	6	conj	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	6	nmod	_	_
11	,	_	.	,	_	14	punct	_	_
12	patients	_	NOUN	NNS	_	14	nsubjpass	_	_
13	were	_	VERB	VBD	_	14	auxpass	_	_
14	instructed	_	VERB	VBN	_	0	root	_	_
15	to	_	PRT	TO	_	16	mark	_	_
16	avoid	_	VERB	VB	_	14	xcomp	_	_
17	eating	_	VERB	VBG	_	16	xcomp	_	_
18	for	_	ADP	IN	_	20	case	_	_
19	10	_	NUM	CD	_	20	nummod	_	_
20	minutes	_	NOUN	NNS	_	17	nmod	_	_
21	following	_	VERB	VBG	_	23	case	_	_
22	sublingual	_	ADJ	JJ	_	23	amod	_	_
23	dosing	_	VERB	VBG	_	17	nmod	_	_

#	SAPHRIS	5981
1	There	_	DET	EX	_	2	expl	_	_
2	were	_	VERB	VBD	_	0	root	_	_
3	no	_	DET	DT	_	5	neg	_	_
4	other	_	ADJ	JJ	_	5	amod	_	_
5	restrictions	_	NOUN	NNS	_	2	nsubj	_	_
6	with	_	ADP	IN	_	7	case	_	_
7	regard	_	NOUN	NN	_	2	nmod	_	_
8	to	_	PRT	TO	_	10	case	_	_
9	the	_	DET	DT	_	10	det	_	_
10	timing	_	NOUN	NN	_	7	nmod	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	meals	_	NOUN	NNS	_	10	nmod	_	_
13	in	_	ADP	IN	_	15	case	_	_
14	these	_	DET	DT	_	15	det	_	_
15	trials	_	NOUN	NNS	_	10	nmod	_	_

#	SAPHRIS	5982
1	Water	_	NOUN	NN	_	16	nsubjpass	_	_
2	:	_	.	:	_	1	punct	_	_
3	In	_	ADP	IN	_	5	case	_	_
4	clinical	_	ADJ	JJ	_	5	amod	_	_
5	trials	_	NOUN	NNS	_	1	nmod	_	_
6	establishing	_	VERB	VBG	_	5	acl	_	_
7	the	_	DET	DT	_	8	det	_	_
8	efficacy	_	NOUN	NN	_	6	dobj	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	safety	_	NOUN	NN	_	8	conj	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	8	nmod	_	_
13	,	_	.	,	_	16	punct	_	_
14	patients	_	NOUN	NNS	_	16	nsubjpass	_	_
15	were	_	VERB	VBD	_	16	auxpass	_	_
16	instructed	_	VERB	VBN	_	0	root	_	_
17	to	_	PRT	TO	_	18	mark	_	_
18	avoid	_	VERB	VB	_	16	xcomp	_	_
19	drinking	_	NOUN	NN	_	18	dobj	_	_
20	for	_	ADP	IN	_	22	case	_	_
21	10	_	NUM	CD	_	22	nummod	_	_
22	minutes	_	NOUN	NNS	_	19	nmod	_	_
23	following	_	VERB	VBG	_	25	case	_	_
24	sublingual	_	ADJ	JJ	_	25	amod	_	_
25	dosing	_	VERB	VBG	_	19	nmod	_	_

#	SAPHRIS	5983
1	The	_	DET	DT	_	2	det	_	_
2	effect	_	NOUN	NN	_	13	nsubjpass	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	water	_	NOUN	NN	_	5	compound	_	_
5	administration	_	NOUN	NN	_	2	nmod	_	_
6	following	_	ADP	IN	_	11	case	_	_
7	10	_	NUM	CD	_	11	nummod	_	_
8	mg	_	NOUN	NN	_	11	compound	_	_
9	sublingual	_	ADJ	JJ	_	11	amod	_	_
10	DRUG	_	NOUN	NN	_	11	compound	_	_
11	dosing	_	NOUN	NN	_	2	nmod	_	_
12	was	_	VERB	VBD	_	13	auxpass	_	_
13	studied	_	VERB	VBN	_	0	root	_	_
14	at	_	ADP	IN	_	17	case	_	_
15	different	_	ADJ	JJ	_	17	amod	_	_
16	time	_	NOUN	NN	_	17	compound	_	_
17	points	_	NOUN	NNS	_	13	nmod	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	2	_	NUM	CD	_	17	nmod	_	_
20	,	_	.	,	_	19	punct	_	_
21	5	_	NUM	CD	_	19	conj	_	_
22	,	_	.	,	_	19	punct	_	_
23	10	_	NUM	CD	_	19	conj	_	_
24	,	_	.	,	_	19	punct	_	_
25	and	_	CONJ	CC	_	19	cc	_	_
26	30	_	NUM	CD	_	19	conj	_	_
27	minutes	_	NOUN	NNS	_	19	dep	_	_
28	in	_	ADP	IN	_	33	case	_	_
29	15	_	NUM	CD	_	33	nummod	_	_
30	healthy	_	ADJ	JJ	_	33	amod	_	_
31	adult	_	ADJ	JJ	_	33	amod	_	_
32	male	_	ADJ	JJ	_	33	amod	_	_
33	subjects	_	NOUN	NNS	_	17	nmod	_	_

#	SAPHRIS	5984
1	The	_	DET	DT	_	2	det	_	_
2	exposure	_	NOUN	NN	_	15	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	following	_	VERB	VBG	_	6	case	_	_
6	administration	_	NOUN	NN	_	2	nmod	_	_
7	of	_	ADP	IN	_	10	case	_	_
8	water	_	NOUN	NN	_	10	compound	_	_
9	10	_	NUM	CD	_	10	nummod	_	_
10	minutes	_	NOUN	NNS	_	6	nmod	_	_
11	after	_	ADP	IN	_	13	case	_	_
12	sublingual	_	ADJ	JJ	_	13	amod	_	_
13	dosing	_	NOUN	NN	_	6	nmod	_	_
14	was	_	VERB	VBD	_	15	cop	_	_
15	equivalent	_	ADJ	JJ	_	0	root	_	_
16	to	_	PRT	TO	_	17	case	_	_
17	that	_	DET	WDT	_	15	nmod	_	_
18	when	_	ADV	WRB	_	21	advmod	_	_
19	water	_	NOUN	NN	_	21	nsubjpass	_	_
20	was	_	VERB	VBD	_	21	auxpass	_	_
21	administered	_	VERB	VBN	_	17	acl:relcl	_	_
22	30	_	NUM	CD	_	23	nummod	_	_
23	minutes	_	NOUN	NNS	_	21	dobj	_	_
24	after	_	ADP	IN	_	25	mark	_	_
25	dosing	_	VERB	VBG	_	21	advcl	_	_

#	SAPHRIS	5985
1	Reduced	_	VERB	VBN	_	2	amod	_	_
2	exposure	_	NOUN	NN	_	6	nsubjpass	_	_
3	to	_	PRT	TO	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	was	_	VERB	VBD	_	6	auxpass	_	_
6	observed	_	VERB	VBN	_	0	root	_	_
7	following	_	VERB	VBG	_	9	case	_	_
8	water	_	NOUN	NN	_	9	compound	_	_
9	administration	_	NOUN	NN	_	6	nmod	_	_
10	at	_	ADP	IN	_	12	case	_	_
11	2	_	NUM	CD	_	12	nummod	_	_
12	minutes	_	NOUN	NNS	_	9	nmod	_	_
13	19%	_	ADJ	JJ	_	14	amod	_	_
14	decrease	_	NOUN	NN	_	12	dep	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	5	_	NUM	CD	_	19	nummod	_	_
17	minutes	_	NOUN	NNS	_	19	compound	_	_
18	10%	_	ADJ	JJ	_	19	amod	_	_
19	decrease	_	NOUN	NN	_	14	conj	_	_

#	SAPHRIS	5986
1	Drug	_	NOUN	NN	_	3	compound	_	_
2	Interaction	_	NOUN	NN	_	3	compound	_	_
3	Studies	_	NOUN	NNS	_	0	root	_	_
4	:	_	.	:	_	3	punct	_	_
5	Effects	_	NOUN	NNS	_	15	nsubjpass	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	other	_	ADJ	JJ	_	8	amod	_	_
8	drugs	_	NOUN	NNS	_	5	nmod	_	_
9	on	_	ADP	IN	_	11	case	_	_
10	the	_	DET	DT	_	11	det	_	_
11	exposure	_	NOUN	NN	_	5	nmod	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	DRUG	_	NOUN	NN	_	11	nmod	_	_
14	are	_	VERB	VBP	_	15	auxpass	_	_
15	summarized	_	VERB	VBN	_	3	dep	_	_
16	in	_	ADP	IN	_	17	case	_	_
17	Figure	_	NOUN	NN	_	15	nmod	_	_
18	1	_	NUM	CD	_	17	nummod	_	_

#	SAPHRIS	5987
1	In	_	ADP	IN	_	2	case	_	_
2	addition	_	NOUN	NN	_	8	nmod	_	_
3	,	_	.	,	_	8	punct	_	_
4	a	_	DET	DT	_	7	det	_	_
5	population	_	NOUN	NN	_	7	compound	_	_
6	pharmacokinetic	_	ADJ	JJ	_	7	amod	_	_
7	analysis	_	NOUN	NN	_	8	nsubj	_	_
8	indicated	_	VERB	VBD	_	0	root	_	_
9	that	_	ADP	IN	_	15	mark	_	_
10	the	_	DET	DT	_	12	det	_	_
11	concomitant	_	ADJ	JJ	_	12	amod	_	_
12	administration	_	NOUN	NN	_	15	nsubj	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	lithium	_	NOUN	NN	_	12	nmod	_	_
15	had	_	VERB	VBD	_	8	ccomp	_	_
16	no	_	DET	DT	_	17	neg	_	_
17	effect	_	NOUN	NN	_	15	dobj	_	_
18	on	_	ADP	IN	_	20	case	_	_
19	the	_	DET	DT	_	20	det	_	_
20	pharmacokinetics	_	NOUN	NNS	_	15	nmod	_	_
21	of	_	ADP	IN	_	22	case	_	_
22	DRUG	_	NOUN	NN	_	20	nmod	_	_

#	SAPHRIS	5988
1	Figure	_	NOUN	NN	_	0	root	_	_
2	1	_	NUM	CD	_	1	nummod	_	_
3	:	_	.	:	_	1	punct	_	_
4	Effect	_	NOUN	NN	_	24	nsubjpass	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	Other	_	ADJ	JJ	_	7	amod	_	_
7	Drugs	_	NOUN	NNS	_	4	nmod	_	_
8	on	_	ADP	IN	_	10	case	_	_
9	DRUG	_	NOUN	NN	_	10	compound	_	_
10	Pharmacokinetics	_	NOUN	NNS	_	4	nmod	_	_
11	The	_	DET	DT	_	12	det	_	_
12	effects	_	NOUN	NNS	_	24	nsubjpass	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	DRUG	_	NOUN	NN	_	12	nmod	_	_
15	on	_	ADP	IN	_	17	case	_	_
16	the	_	DET	DT	_	17	det	_	_
17	pharmacokinetics	_	NOUN	NNS	_	12	nmod	_	_
18	of	_	ADP	IN	_	22	case	_	_
19	other	_	ADJ	JJ	_	22	amod	_	_
20	co	_	PRT	TO	_	22	amod	_	_
21	administered	_	VERB	VBN	_	22	amod	_	_
22	drugs	_	NOUN	NNS	_	17	nmod	_	_
23	are	_	VERB	VBP	_	24	auxpass	_	_
24	summarized	_	VERB	VBN	_	1	dep	_	_
25	in	_	ADP	IN	_	26	case	_	_
26	Figure	_	NOUN	NN	_	24	nmod	_	_
27	2	_	NUM	CD	_	26	nummod	_	_

#	SAPHRIS	5989
1	Coadministration	_	NOUN	NN	_	6	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	paroxetine	_	NOUN	NN	_	1	nmod	_	_
4	with	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	1	nmod	_	_
6	caused	_	VERB	VBD	_	0	root	_	_
7	a	_	DET	DT	_	10	det	_	_
8	two	_	NUM	CD	_	10	nummod	_	_
9	fold	_	NOUN	NN	_	10	amod	_	_
10	increase	_	NOUN	NN	_	6	dobj	_	_
11	in	_	ADP	IN	_	15	case	_	_
12	the	_	DET	DT	_	15	det	_	_
13	maximum	_	NOUN	NN	_	15	compound	_	_
14	plasma	_	NOUN	NN	_	15	compound	_	_
15	concentrations	_	NOUN	NNS	_	10	nmod	_	_
16	and	_	CONJ	CC	_	10	cc	_	_
17	systemic	_	ADJ	JJ	_	18	amod	_	_
18	exposure	_	NOUN	NN	_	10	conj	_	_
19	of	_	ADP	IN	_	20	case	_	_
20	paroxetine	_	NOUN	NN	_	18	nmod	_	_

#	SAPHRIS	5990
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	enhances	_	VERB	VBZ	_	0	root	_	_
3	the	_	DET	DT	_	5	det	_	_
4	inhibitory	_	ADJ	JJ	_	5	amod	_	_
5	effects	_	NOUN	NNS	_	2	dobj	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	paroxetine	_	NOUN	NN	_	5	nmod	_	_
8	on	_	ADP	IN	_	11	case	_	_
9	its	_	PRON	PRP$	_	11	nmod:poss	_	_
10	own	_	ADJ	JJ	_	11	amod	_	_
11	metabolism	_	NOUN	NN	_	5	nmod	_	_
12	by	_	ADP	IN	_	13	case	_	_
13	CYP2D6	_	NOUN	NN	_	11	nmod	_	_

#	SAPHRIS	5991
1	Figure	_	NOUN	NN	_	0	root	_	_
2	2	_	NUM	CD	_	1	nummod	_	_
3	:	_	.	:	_	1	punct	_	_
4	Effect	_	NOUN	NN	_	1	dep	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	on	_	ADP	IN	_	15	case	_	_
8	Other	_	ADJ	JJ	_	15	amod	_	_
9	Drug	_	NOUN	NN	_	15	compound	_	_
10	Pharmacokinetics	_	NOUN	NNS	_	15	compound	_	_
11	Figure	_	NOUN	NN	_	15	compound	_	_
12	1	_	NUM	CD	_	15	nummod	_	_
13	Figure	_	NOUN	NN	_	15	compound	_	_
14	2	_	NUM	CD	_	15	nummod	_	_
15	Studies	_	NOUN	NNS	_	4	nmod	_	_
16	in	_	ADP	IN	_	18	case	_	_
17	Special	_	ADJ	JJ	_	18	amod	_	_
18	Populations	_	NOUN	NNS	_	15	nmod	_	_
19	:	_	.	:	_	1	punct	_	_
20	Exposures	_	NOUN	NNS	_	27	nsubjpass	_	_
21	of	_	ADP	IN	_	22	case	_	_
22	DRUG	_	NOUN	NN	_	20	nmod	_	_
23	in	_	ADP	IN	_	25	case	_	_
24	special	_	ADJ	JJ	_	25	amod	_	_
25	populations	_	NOUN	NNS	_	20	nmod	_	_
26	are	_	VERB	VBP	_	27	auxpass	_	_
27	summarized	_	VERB	VBN	_	1	dep	_	_
28	in	_	ADP	IN	_	29	case	_	_
29	Figure	_	NOUN	NN	_	27	nmod	_	_
30	3	_	NUM	CD	_	29	nummod	_	_

#	SAPHRIS	5992
1	Additionally	_	ADV	RB	_	25	advmod	_	_
2	,	_	.	,	_	25	punct	_	_
3	based	_	VERB	VBN	_	25	advcl	_	_
4	on	_	ADP	IN	_	7	case	_	_
5	population	_	NOUN	NN	_	7	compound	_	_
6	pharmacokinetic	_	ADJ	JJ	_	7	amod	_	_
7	analysis	_	NOUN	NN	_	3	nmod	_	_
8	,	_	.	,	_	25	punct	_	_
9	no	_	DET	DT	_	10	neg	_	_
10	effects	_	NOUN	NNS	_	25	nsubjpass	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	sex	_	NOUN	NN	_	10	nmod	_	_
13	,	_	.	,	_	12	punct	_	_
14	race	_	NOUN	NN	_	12	conj	_	_
15	,	_	.	,	_	12	punct	_	_
16	BMI	_	NOUN	NN	_	12	conj	_	_
17	,	_	.	,	_	12	punct	_	_
18	and	_	CONJ	CC	_	12	cc	_	_
19	smoking	_	VERB	VBG	_	20	amod	_	_
20	status	_	NOUN	NN	_	12	conj	_	_
21	on	_	ADP	IN	_	23	case	_	_
22	DRUG	_	NOUN	NN	_	23	compound	_	_
23	exposure	_	NOUN	NN	_	10	nmod	_	_
24	were	_	VERB	VBD	_	25	auxpass	_	_
25	observed	_	VERB	VBN	_	0	root	_	_

#	SAPHRIS	5993
1	Exposure	_	NOUN	NN	_	8	nsubj	_	_
2	in	_	ADP	IN	_	4	case	_	_
3	elderly	_	ADJ	JJ	_	4	amod	_	_
4	patients	_	NOUN	NNS	_	1	nmod	_	_
5	is	_	VERB	VBZ	_	8	cop	_	_
6	30	_	NUM	CD	_	7	nummod	_	_
7	40%	_	NOUN	NN	_	8	nmod:npmod	_	_
8	higher	_	ADJ	JJ	_	0	root	_	_
9	as	_	ADP	IN	_	10	mark	_	_
10	compared	_	VERB	VBN	_	8	advcl	_	_
11	to	_	PRT	TO	_	12	case	_	_
12	adults	_	NOUN	NNS	_	10	nmod	_	_

#	SAPHRIS	5994
1	Figure	_	NOUN	NN	_	0	root	_	_
2	3	_	NUM	CD	_	1	nummod	_	_
3	:	_	.	:	_	1	punct	_	_
4	Effect	_	NOUN	NN	_	1	dep	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	Intrinsic	_	ADJ	JJ	_	7	amod	_	_
7	Factors	_	NOUN	NNS	_	4	nmod	_	_
8	on	_	ADP	IN	_	10	case	_	_
9	DRUG	_	NOUN	NN	_	10	compound	_	_
10	Pharmacokinetics	_	NOUN	NNS	_	4	nmod	_	_
11	Figure	_	NOUN	NN	_	10	dep	_	_
12	3	_	NUM	CD	_	11	nummod	_	_

#	Sertraline Hydrochloride	1485
1	Potential	_	ADJ	JJ	_	2	amod	_	_
2	Effects	_	NOUN	NNS	_	0	root	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	Coadministration	_	NOUN	NN	_	2	nmod	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	Drugs	_	NOUN	NNS	_	4	nmod	_	_
7	Highly	_	ADV	RB	_	8	advmod	_	_
8	Bound	_	VERB	VBD	_	6	acl	_	_
9	to	_	PRT	TO	_	11	case	_	_
10	Plasma	_	NOUN	NN	_	11	compound	_	_
11	Proteins	_	NOUN	NNS	_	8	nmod	_	_
12	Because	_	ADP	IN	_	16	mark	_	_
13	DRUG	_	NOUN	NN	_	16	nsubjpass	_	_
14	is	_	VERB	VBZ	_	16	auxpass	_	_
15	tightly	_	ADV	RB	_	16	advmod	_	_
16	bound	_	VERB	VBN	_	2	acl:relcl	_	_
17	to	_	PRT	TO	_	19	case	_	_
18	plasma	_	NOUN	NN	_	19	compound	_	_
19	protein	_	NOUN	NN	_	16	nmod	_	_
20	,	_	.	,	_	19	punct	_	_
21	the	_	DET	DT	_	22	det	_	_
22	administration	_	NOUN	NN	_	43	nsubj	_	_
23	of	_	ADP	IN	_	24	case	_	_
24	DRUG	_	NOUN	NN	_	22	nmod	_	_
25	to	_	PRT	TO	_	27	case	_	_
26	a	_	DET	DT	_	27	det	_	_
27	patient	_	NOUN	NN	_	22	nmod	_	_
28	taking	_	VERB	VBG	_	27	acl	_	_
29	another	_	DET	DT	_	30	det	_	_
30	drug	_	NOUN	NN	_	28	dobj	_	_
31	which	_	DET	WDT	_	34	nsubjpass	_	_
32	is	_	VERB	VBZ	_	34	auxpass	_	_
33	tightly	_	ADV	RB	_	34	advmod	_	_
34	bound	_	VERB	VBN	_	30	acl:relcl	_	_
35	to	_	PRT	TO	_	37	case	_	_
36	protein	_	NOUN	NN	_	37	compound	_	_
37	e.g	_	NOUN	NN	_	34	nmod	_	_
38	,	_	.	,	_	37	punct	_	_
39	warfarin	_	NOUN	NN	_	37	appos	_	_
40	,	_	.	,	_	37	punct	_	_
41	digitoxin	_	NOUN	NN	_	37	appos	_	_
42	may	_	VERB	MD	_	43	aux	_	_
43	cause	_	VERB	VB	_	19	acl:relcl	_	_
44	a	_	DET	DT	_	45	det	_	_
45	shift	_	NOUN	NN	_	43	dobj	_	_
46	in	_	ADP	IN	_	48	case	_	_
47	plasma	_	NOUN	NN	_	48	compound	_	_
48	concentrations	_	NOUN	NNS	_	45	nmod	_	_
49	potentially	_	ADV	RB	_	50	advmod	_	_
50	resulting	_	VERB	VBG	_	45	acl	_	_
51	in	_	ADP	IN	_	54	case	_	_
52	an	_	DET	DT	_	54	det	_	_
53	adverse	_	ADJ	JJ	_	54	amod	_	_
54	effect	_	NOUN	NN	_	50	nmod	_	_

#	Sertraline Hydrochloride	1486
1	Conversely	_	ADV	RB	_	6	advmod	_	_
2	,	_	.	,	_	6	punct	_	_
3	adverse	_	ADJ	JJ	_	4	amod	_	_
4	effects	_	NOUN	NNS	_	6	nsubj	_	_
5	may	_	VERB	MD	_	6	aux	_	_
6	result	_	VERB	VB	_	0	root	_	_
7	from	_	ADP	IN	_	8	case	_	_
8	displacement	_	NOUN	NN	_	6	nmod	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	protein	_	NOUN	NN	_	8	nmod	_	_
11	bound	_	VERB	VBN	_	12	amod	_	_
12	DRUG	_	NOUN	NN	_	10	dep	_	_
13	by	_	ADP	IN	_	17	case	_	_
14	other	_	ADJ	JJ	_	17	amod	_	_
15	tightly	_	ADV	RB	_	16	advmod	_	_
16	bound	_	VERB	VBN	_	17	amod	_	_
17	drugs	_	NOUN	NNS	_	8	nmod	_	_

#	Sertraline Hydrochloride	1487
1	In	_	ADP	IN	_	3	case	_	_
2	a	_	DET	DT	_	3	det	_	_
3	study	_	NOUN	NN	_	40	nmod	_	_
4	comparing	_	VERB	VBG	_	3	acl	_	_
5	prothrombin	_	NOUN	NN	_	7	compound	_	_
6	time	_	NOUN	NN	_	7	compound	_	_
7	AUC	_	NOUN	NN	_	4	dobj	_	_
8	0	_	NUM	CD	_	7	nummod	_	_
9	to	_	PRT	TO	_	11	case	_	_
10	120	_	NUM	CD	_	11	nummod	_	_
11	hr	_	NOUN	NN	_	4	nmod	_	_
12	following	_	VERB	VBG	_	13	case	_	_
13	dosing	_	NOUN	NN	_	4	nmod	_	_
14	with	_	ADP	IN	_	17	case	_	_
15	warfarin	_	NOUN	NN	_	17	compound	_	_
16	0.75	_	NUM	CD	_	17	nummod	_	_
17	mg	_	NOUN	NN	_	13	nmod	_	_
18	/	_	.	:	_	19	punct	_	_
19	kg	_	NOUN	NN	_	3	nmod	_	_
20	before	_	ADP	IN	_	19	dep	_	_
21	and	_	CONJ	CC	_	20	cc	_	_
22	after	_	ADP	IN	_	24	case	_	_
23	21	_	NUM	CD	_	24	nummod	_	_
24	days	_	NOUN	NNS	_	20	conj	_	_
25	of	_	ADP	IN	_	26	case	_	_
26	dosing	_	VERB	VBG	_	24	acl	_	_
27	with	_	ADP	IN	_	29	case	_	_
28	either	_	CONJ	CC	_	29	cc:preconj	_	_
29	DRUG	_	NOUN	NN	_	26	nmod	_	_
30	50	_	NUM	CD	_	32	compound	_	_
31	to	_	PRT	TO	_	32	dep	_	_
32	200	_	NUM	CD	_	33	nummod	_	_
33	mg	_	NOUN	NN	_	29	dep	_	_
34	/	_	.	-RRB-	_	29	punct	_	_
35	day	_	NOUN	NN	_	29	conj	_	_
36	or	_	CONJ	CC	_	29	cc	_	_
37	placebo	_	NOUN	NN	_	29	conj	_	_
38	,	_	.	,	_	40	punct	_	_
39	there	_	DET	EX	_	40	expl	_	_
40	was	_	VERB	VBD	_	0	root	_	_
41	a	_	DET	DT	_	43	det	_	_
42	mean	_	ADJ	JJ	_	43	amod	_	_
43	increase	_	NOUN	NN	_	40	nsubj	_	_
44	in	_	ADP	IN	_	46	case	_	_
45	prothrombin	_	NOUN	NN	_	46	compound	_	_
46	time	_	NOUN	NN	_	43	nmod	_	_
47	of	_	ADP	IN	_	48	case	_	_
48	8%	_	NOUN	NN	_	46	nmod	_	_
49	relative	_	ADJ	JJ	_	54	advmod	_	_
50	to	_	PRT	TO	_	51	case	_	_
51	baseline	_	NOUN	NN	_	49	nmod	_	_
52	for	_	ADP	IN	_	53	case	_	_
53	DRUG	_	NOUN	NN	_	51	nmod	_	_
54	compared	_	VERB	VBD	_	40	xcomp	_	_
55	to	_	PRT	TO	_	58	case	_	_
56	a	_	DET	DT	_	58	det	_	_
57	1%	_	ADJ	JJ	_	58	amod	_	_
58	decrease	_	NOUN	NN	_	54	nmod	_	_
59	for	_	ADP	IN	_	63	case	_	_
60	placebo	_	NOUN	NN	_	63	compound	_	_
61	p	_	NOUN	NN	_	63	compound	_	_
62	<	_	NUM	CD	_	63	nummod	_	_
63	0.02	_	NUM	CD	_	58	nmod	_	_

#	Sertraline Hydrochloride	1488
1	The	_	DET	DT	_	2	det	_	_
2	normalization	_	NOUN	NN	_	11	nsubjpass	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	prothrombin	_	NOUN	NN	_	5	compound	_	_
5	time	_	NOUN	NN	_	2	nmod	_	_
6	for	_	ADP	IN	_	9	case	_	_
7	the	_	DET	DT	_	9	det	_	_
8	DRUG	_	NOUN	NN	_	9	compound	_	_
9	group	_	NOUN	NN	_	2	nmod	_	_
10	was	_	VERB	VBD	_	11	auxpass	_	_
11	delayed	_	VERB	VBN	_	0	root	_	_
12	compared	_	VERB	VBN	_	11	xcomp	_	_
13	to	_	PRT	TO	_	16	case	_	_
14	the	_	DET	DT	_	16	det	_	_
15	placebo	_	NOUN	NN	_	16	compound	_	_
16	group	_	NOUN	NN	_	12	nmod	_	_

#	Sertraline Hydrochloride	1489
1	The	_	DET	DT	_	3	det	_	_
2	clinical	_	ADJ	JJ	_	3	amod	_	_
3	significance	_	NOUN	NN	_	8	nsubj	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	this	_	DET	DT	_	6	det	_	_
6	change	_	NOUN	NN	_	3	nmod	_	_
7	is	_	VERB	VBZ	_	8	auxpass	_	_
8	unknown	_	ADJ	JJ	_	0	root	_	_

#	Sertraline Hydrochloride	1490
1	Accordingly	_	ADV	RB	_	8	advmod	_	_
2	,	_	.	,	_	8	punct	_	_
3	prothrombin	_	NOUN	NN	_	4	compound	_	_
4	time	_	NOUN	NN	_	8	nsubjpass	_	_
5	should	_	VERB	MD	_	8	aux	_	_
6	be	_	VERB	VB	_	8	auxpass	_	_
7	carefully	_	ADV	RB	_	8	advmod	_	_
8	monitored	_	VERB	VBN	_	0	root	_	_
9	when	_	ADV	WRB	_	13	advmod	_	_
10	DRUG	_	NOUN	NN	_	11	compound	_	_
11	therapy	_	NOUN	NN	_	13	nsubjpass	_	_
12	is	_	VERB	VBZ	_	13	auxpass	_	_
13	initiated	_	VERB	VBN	_	8	ccomp	_	_
14	or	_	CONJ	CC	_	13	cc	_	_
15	stopped	_	VERB	VBN	_	13	conj	_	_

#	Sertraline Hydrochloride	1491
1	Cimetidine	_	NOUN	NN	_	0	root	_	_
2	In	_	ADP	IN	_	4	case	_	_
3	a	_	DET	DT	_	4	det	_	_
4	study	_	NOUN	NN	_	1	nmod	_	_
5	assessing	_	VERB	VBG	_	4	acl	_	_
6	disposition	_	NOUN	NN	_	5	dobj	_	_
7	of	_	ADP	IN	_	10	case	_	_
8	DRUG	_	NOUN	NN	_	10	compound	_	_
9	100	_	NUM	CD	_	10	nummod	_	_
10	mg	_	NOUN	NN	_	6	nmod	_	_
11	on	_	ADP	IN	_	13	case	_	_
12	the	_	DET	DT	_	13	det	_	_
13	second	_	ADJ	JJ	_	5	nmod	_	_
14	of	_	ADP	IN	_	16	case	_	_
15	8	_	NUM	CD	_	16	nummod	_	_
16	days	_	NOUN	NNS	_	13	nmod	_	_
17	of	_	ADP	IN	_	21	case	_	_
18	cimetidine	_	NOUN	NN	_	21	compound	_	_
19	administration	_	NOUN	NN	_	21	compound	_	_
20	800	_	NUM	CD	_	21	nummod	_	_
21	mg	_	NOUN	NN	_	16	nmod	_	_
22	daily	_	ADV	RB	_	25	advmod	_	_
23	,	_	.	,	_	25	punct	_	_
24	there	_	DET	EX	_	25	expl	_	_
25	were	_	VERB	VBD	_	1	dep	_	_
26	increases	_	NOUN	NNS	_	25	neg	_	_
27	in	_	ADP	IN	_	31	case	_	_
28	DRUG	_	NOUN	NN	_	31	compound	_	_
29	mean	_	NOUN	NN	_	31	compound	_	_
30	AUC	_	NOUN	NN	_	31	compound	_	_
31	50%	_	NOUN	NN	_	26	nmod	_	_
32	,	_	.	,	_	26	punct	_	_
33	Cmax	_	NOUN	NN	_	34	compound	_	_
34	24%	_	ADJ	JJ	_	39	nsubj	_	_
35	and	_	CONJ	CC	_	34	cc	_	_
36	half	_	ADJ	JJ	_	38	amod	_	_
37	life	_	NOUN	NN	_	38	compound	_	_
38	26%	_	NOUN	NN	_	34	conj	_	_
39	compared	_	VERB	VBN	_	26	dep	_	_
40	to	_	PRT	TO	_	43	case	_	_
41	the	_	DET	DT	_	43	det	_	_
42	placebo	_	NOUN	NN	_	43	compound	_	_
43	group	_	NOUN	NN	_	39	nmod	_	_

#	Sertraline Hydrochloride	1492
1	The	_	DET	DT	_	3	det	_	_
2	clinical	_	ADJ	JJ	_	3	amod	_	_
3	significance	_	NOUN	NN	_	8	nsubj	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	these	_	DET	DT	_	6	det	_	_
6	changes	_	NOUN	NNS	_	3	nmod	_	_
7	is	_	VERB	VBZ	_	8	auxpass	_	_
8	unknown	_	ADJ	JJ	_	0	root	_	_

#	Sertraline Hydrochloride	1493
1	CNS	_	NOUN	NN	_	3	compound	_	_
2	Active	_	ADJ	JJ	_	3	amod	_	_
3	Drugs	_	NOUN	NNS	_	0	root	_	_
4	In	_	ADP	IN	_	6	case	_	_
5	a	_	DET	DT	_	6	det	_	_
6	study	_	NOUN	NN	_	3	nmod	_	_
7	comparing	_	VERB	VBG	_	6	acl	_	_
8	the	_	DET	DT	_	9	det	_	_
9	disposition	_	NOUN	NN	_	7	dobj	_	_
10	of	_	ADP	IN	_	13	case	_	_
11	intravenously	_	ADV	RB	_	12	advmod	_	_
12	administered	_	VERB	VBN	_	13	amod	_	_
13	diazepam	_	NOUN	NN	_	9	nmod	_	_
14	before	_	ADP	IN	_	7	nmod	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	after	_	ADP	IN	_	18	case	_	_
17	21	_	NUM	CD	_	18	nummod	_	_
18	days	_	NOUN	NNS	_	14	conj	_	_
19	of	_	ADP	IN	_	20	case	_	_
20	dosing	_	VERB	VBG	_	18	acl	_	_
21	with	_	ADP	IN	_	23	case	_	_
22	either	_	CONJ	CC	_	23	cc:preconj	_	_
23	DRUG	_	NOUN	NN	_	20	nmod	_	_
24	50	_	NUM	CD	_	23	nummod	_	_
25	to	_	PRT	TO	_	27	case	_	_
26	200	_	NUM	CD	_	27	nummod	_	_
27	mg	_	NOUN	NN	_	20	nmod	_	_
28	/	_	.	:	_	3	punct	_	_
29	day	_	NOUN	NN	_	3	dep	_	_
30	escalating	_	VERB	VBG	_	29	acl	_	_
31	dose	_	NOUN	NN	_	30	dobj	_	_
32	or	_	CONJ	CC	_	31	cc	_	_
33	placebo	_	NOUN	NN	_	31	conj	_	_
34	,	_	.	,	_	29	punct	_	_
35	there	_	DET	EX	_	36	expl	_	_
36	was	_	VERB	VBD	_	29	dep	_	_
37	a	_	DET	DT	_	39	det	_	_
38	32%	_	ADJ	JJ	_	39	amod	_	_
39	decrease	_	NOUN	NN	_	36	nsubj	_	_
40	relative	_	ADJ	JJ	_	39	amod	_	_
41	to	_	PRT	TO	_	42	case	_	_
42	baseline	_	NOUN	NN	_	40	nmod	_	_
43	in	_	ADP	IN	_	45	case	_	_
44	diazepam	_	NOUN	NN	_	45	compound	_	_
45	clearance	_	NOUN	NN	_	42	nmod	_	_
46	for	_	ADP	IN	_	49	case	_	_
47	the	_	DET	DT	_	49	det	_	_
48	DRUG	_	NOUN	NN	_	49	compound	_	_
49	group	_	NOUN	NN	_	45	nmod	_	_
50	compared	_	VERB	VBD	_	36	dep	_	_
51	to	_	PRT	TO	_	54	case	_	_
52	a	_	DET	DT	_	54	det	_	_
53	19%	_	ADJ	JJ	_	54	amod	_	_
54	decrease	_	NOUN	NN	_	50	nmod	_	_
55	relative	_	ADJ	JJ	_	54	amod	_	_
56	to	_	PRT	TO	_	57	case	_	_
57	baseline	_	NOUN	NN	_	55	nmod	_	_
58	for	_	ADP	IN	_	64	case	_	_
59	the	_	DET	DT	_	64	det	_	_
60	placebo	_	NOUN	NN	_	64	compound	_	_
61	group	_	NOUN	NN	_	64	compound	_	_
62	p	_	NOUN	NN	_	64	compound	_	_
63	<	_	NUM	CD	_	64	nummod	_	_
64	0.03	_	NUM	CD	_	57	nmod	_	_

#	Sertraline Hydrochloride	1494
1	There	_	DET	EX	_	2	expl	_	_
2	was	_	VERB	VBD	_	0	root	_	_
3	a	_	DET	DT	_	5	det	_	_
4	23%	_	ADJ	JJ	_	5	amod	_	_
5	increase	_	NOUN	NN	_	2	nsubj	_	_
6	in	_	ADP	IN	_	7	case	_	_
7	Tmax	_	NOUN	NN	_	5	nmod	_	_
8	for	_	ADP	IN	_	9	case	_	_
9	desmethyldiazepam	_	NOUN	NN	_	5	nmod	_	_
10	in	_	ADP	IN	_	13	case	_	_
11	the	_	DET	DT	_	13	det	_	_
12	DRUG	_	NOUN	NN	_	13	compound	_	_
13	group	_	NOUN	NN	_	5	nmod	_	_
14	compared	_	VERB	VBD	_	2	dep	_	_
15	to	_	PRT	TO	_	18	case	_	_
16	a	_	DET	DT	_	18	det	_	_
17	20%	_	ADJ	JJ	_	18	amod	_	_
18	decrease	_	NOUN	NN	_	14	nmod	_	_
19	in	_	ADP	IN	_	25	case	_	_
20	the	_	DET	DT	_	25	det	_	_
21	placebo	_	NOUN	NN	_	25	compound	_	_
22	group	_	NOUN	NN	_	25	compound	_	_
23	p	_	NOUN	NN	_	25	compound	_	_
24	<	_	NUM	CD	_	25	nummod	_	_
25	0.03	_	NUM	CD	_	18	nmod	_	_

#	Sertraline Hydrochloride	1496
1	In	_	ADP	IN	_	3	case	_	_
2	a	_	DET	DT	_	3	det	_	_
3	placebo	_	NOUN	NN	_	20	nmod	_	_
4	controlled	_	VERB	VBN	_	3	acl	_	_
5	trial	_	ADJ	JJ	_	4	xcomp	_	_
6	in	_	ADP	IN	_	8	case	_	_
7	normal	_	ADJ	JJ	_	8	amod	_	_
8	volunteers	_	NOUN	NNS	_	5	nmod	_	_
9	,	_	.	,	_	20	punct	_	_
10	the	_	DET	DT	_	11	det	_	_
11	administration	_	NOUN	NN	_	20	nsubj	_	_
12	of	_	ADP	IN	_	14	case	_	_
13	two	_	NUM	CD	_	14	nummod	_	_
14	doses	_	NOUN	NNS	_	11	nmod	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	14	nmod	_	_
17	did	_	VERB	VBD	_	20	aux	_	_
18	not	_	ADV	RB	_	20	neg	_	_
19	significantly	_	ADV	RB	_	20	advmod	_	_
20	alter	_	VERB	VB	_	0	root	_	_
21	steady	_	ADJ	JJ	_	24	amod	_	_
22	state	_	NOUN	NN	_	24	compound	_	_
23	lithium	_	NOUN	NN	_	24	compound	_	_
24	levels	_	NOUN	NNS	_	20	dobj	_	_
25	or	_	CONJ	CC	_	24	cc	_	_
26	the	_	DET	DT	_	28	det	_	_
27	renal	_	ADJ	JJ	_	28	amod	_	_
28	clearance	_	NOUN	NN	_	24	conj	_	_
29	of	_	ADP	IN	_	30	case	_	_
30	lithium	_	NOUN	NN	_	28	nmod	_	_

#	Sertraline Hydrochloride	1497
1	Nonetheless	_	ADV	RB	_	9	advmod	_	_
2	,	_	.	,	_	9	punct	_	_
3	at	_	ADP	IN	_	5	case	_	_
4	this	_	DET	DT	_	5	det	_	_
5	time	_	NOUN	NN	_	9	nmod	_	_
6	,	_	.	,	_	9	punct	_	_
7	it	_	PRON	PRP	_	9	nsubjpass	_	_
8	is	_	VERB	VBZ	_	9	auxpass	_	_
9	recommended	_	VERB	VBN	_	0	root	_	_
10	that	_	ADP	IN	_	15	mark	_	_
11	plasma	_	NOUN	NN	_	13	compound	_	_
12	lithium	_	NOUN	NN	_	13	compound	_	_
13	levels	_	NOUN	NNS	_	15	nsubjpass	_	_
14	be	_	VERB	VBP	_	15	auxpass	_	_
15	monitored	_	VERB	VBN	_	9	ccomp	_	_
16	following	_	ADP	IN	_	17	case	_	_
17	initiation	_	NOUN	NN	_	15	nmod	_	_
18	of	_	ADP	IN	_	20	case	_	_
19	DRUG	_	NOUN	NN	_	20	compound	_	_
20	therapy	_	NOUN	NN	_	17	nmod	_	_
21	with	_	ADP	IN	_	23	case	_	_
22	appropriate	_	ADJ	JJ	_	23	amod	_	_
23	adjustments	_	NOUN	NNS	_	17	nmod	_	_
24	to	_	PRT	TO	_	27	case	_	_
25	the	_	DET	DT	_	27	det	_	_
26	lithium	_	NOUN	NN	_	27	compound	_	_
27	dose	_	NOUN	NN	_	17	nmod	_	_

#	Sertraline Hydrochloride	1498
1	In	_	ADP	IN	_	4	case	_	_
2	a	_	DET	DT	_	4	det	_	_
3	controlled	_	VERB	VBN	_	4	amod	_	_
4	study	_	NOUN	NN	_	24	nmod	_	_
5	of	_	ADP	IN	_	10	case	_	_
6	a	_	DET	DT	_	10	det	_	_
7	single	_	ADJ	JJ	_	10	amod	_	_
8	dose	_	NOUN	NN	_	10	compound	_	_
9	2	_	NUM	CD	_	10	nummod	_	_
10	mg	_	NOUN	NN	_	4	nmod	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	pimozide	_	NOUN	NN	_	10	nmod	_	_
13	,	_	.	,	_	24	punct	_	_
14	200	_	NUM	CD	_	16	nummod	_	_
15	mg	_	NOUN	NN	_	16	compound	_	_
16	DRUG	_	NOUN	NN	_	24	nsubjpass	_	_
17	q.d	_	CONJ	CC	_	16	cc	_	_
18	co	_	PRT	TO	_	19	case	_	_
19	administration	_	NOUN	NN	_	16	conj	_	_
20	to	_	PRT	TO	_	22	case	_	_
21	steady	_	ADJ	JJ	_	22	amod	_	_
22	state	_	NOUN	NN	_	19	nmod	_	_
23	was	_	VERB	VBD	_	24	auxpass	_	_
24	associated	_	VERB	VBN	_	0	root	_	_
25	with	_	ADP	IN	_	28	case	_	_
26	a	_	DET	DT	_	28	det	_	_
27	mean	_	ADJ	JJ	_	28	amod	_	_
28	increase	_	NOUN	NN	_	24	nmod	_	_
29	in	_	ADP	IN	_	31	case	_	_
30	pimozide	_	NOUN	NN	_	31	compound	_	_
31	AUC	_	NOUN	NN	_	28	nmod	_	_
32	and	_	CONJ	CC	_	31	cc	_	_
33	Cmax	_	NOUN	NN	_	31	conj	_	_
34	of	_	ADP	IN	_	36	case	_	_
35	about	_	ADV	RB	_	36	advmod	_	_
36	40%	_	NOUN	NN	_	31	nmod	_	_
37	,	_	.	,	_	24	punct	_	_
38	but	_	CONJ	CC	_	24	cc	_	_
39	was	_	VERB	VBD	_	41	auxpass	_	_
40	not	_	ADV	RB	_	41	neg	_	_
41	associated	_	VERB	VBN	_	24	conj	_	_
42	with	_	ADP	IN	_	44	case	_	_
43	any	_	DET	DT	_	44	det	_	_
44	changes	_	NOUN	NNS	_	41	nmod	_	_
45	in	_	ADP	IN	_	46	case	_	_
46	EKG	_	NOUN	NN	_	44	nmod	_	_

#	Sertraline Hydrochloride	1499
1	Since	_	ADP	IN	_	12	mark	_	_
2	the	_	DET	DT	_	8	det	_	_
3	highest	_	ADJ	JJ	_	8	amod	_	_
4	recommended	_	VERB	VBN	_	8	amod	_	_
5	pimozide	_	NOUN	NN	_	8	compound	_	_
6	dose	_	NOUN	NN	_	8	compound	_	_
7	10	_	NUM	CD	_	8	nummod	_	_
8	mg	_	NOUN	NN	_	12	nsubjpass	_	_
9	has	_	VERB	VBZ	_	12	aux	_	_
10	not	_	ADV	RB	_	12	neg	_	_
11	been	_	VERB	VBN	_	12	auxpass	_	_
12	evaluated	_	VERB	VBN	_	37	advcl	_	_
13	in	_	ADP	IN	_	14	case	_	_
14	combination	_	NOUN	NN	_	12	nmod	_	_
15	with	_	ADP	IN	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	14	nmod	_	_
17	,	_	.	,	_	37	punct	_	_
18	the	_	DET	DT	_	19	det	_	_
19	effect	_	NOUN	NN	_	37	nsubjpass	_	_
20	on	_	ADP	IN	_	22	case	_	_
21	QT	_	NOUN	NN	_	22	compound	_	_
22	interval	_	ADJ	JJ	_	19	nmod	_	_
23	and	_	CONJ	CC	_	22	cc	_	_
24	PK	_	NOUN	NN	_	22	conj	_	_
25	parameters	_	NOUN	NNS	_	22	dep	_	_
26	at	_	ADP	IN	_	27	case	_	_
27	doses	_	NOUN	NNS	_	19	nmod	_	_
28	higher	_	ADJ	JJ	_	30	advmod	_	_
29	than	_	ADP	IN	_	28	mwe	_	_
30	2	_	NUM	CD	_	31	nummod	_	_
31	mg	_	NOUN	NN	_	27	nmod	_	_
32	at	_	ADP	IN	_	34	case	_	_
33	this	_	DET	DT	_	34	det	_	_
34	time	_	NOUN	NN	_	19	nmod	_	_
35	are	_	VERB	VBP	_	37	auxpass	_	_
36	not	_	ADV	RB	_	37	neg	_	_
37	known	_	VERB	VBN	_	0	root	_	_

#	Sertraline Hydrochloride	1500
1	While	_	ADP	IN	_	8	mark	_	_
2	the	_	DET	DT	_	3	det	_	_
3	mechanism	_	NOUN	NN	_	8	nsubj	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	this	_	DET	DT	_	6	det	_	_
6	interaction	_	NOUN	NN	_	3	nmod	_	_
7	is	_	VERB	VBZ	_	8	cop	_	_
8	unknown	_	ADJ	JJ	_	39	advcl	_	_
9	,	_	.	,	_	39	punct	_	_
10	due	_	ADJ	JJ	_	15	case	_	_
11	to	_	PRT	TO	_	10	mwe	_	_
12	the	_	DET	DT	_	15	det	_	_
13	narrow	_	NOUN	NN	_	15	compound	_	_
14	therapeutic	_	ADJ	JJ	_	15	amod	_	_
15	index	_	NOUN	NN	_	39	nmod	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	pimozide	_	NOUN	NN	_	15	nmod	_	_
18	and	_	CONJ	CC	_	15	cc	_	_
19	due	_	ADJ	JJ	_	22	case	_	_
20	to	_	PRT	TO	_	19	mwe	_	_
21	the	_	DET	DT	_	22	det	_	_
22	interaction	_	NOUN	NN	_	15	conj	_	_
23	noted	_	VERB	VBN	_	22	acl	_	_
24	at	_	ADP	IN	_	27	case	_	_
25	a	_	DET	DT	_	27	det	_	_
26	low	_	ADJ	JJ	_	27	amod	_	_
27	dose	_	NOUN	NN	_	23	nmod	_	_
28	of	_	ADP	IN	_	29	case	_	_
29	pimozide	_	NOUN	NN	_	27	nmod	_	_
30	,	_	.	,	_	39	punct	_	_
31	concomitant	_	ADJ	JJ	_	32	amod	_	_
32	administration	_	NOUN	NN	_	39	nsubjpass	_	_
33	of	_	ADP	IN	_	34	case	_	_
34	DRUG	_	NOUN	NN	_	32	nmod	_	_
35	and	_	CONJ	CC	_	34	cc	_	_
36	pimozide	_	NOUN	NN	_	34	conj	_	_
37	should	_	VERB	MD	_	39	aux	_	_
38	be	_	VERB	VB	_	39	auxpass	_	_
39	contraindicated	_	VERB	VBN	_	0	root	_	_

#	Sertraline Hydrochloride	1501
1	Results	_	NOUN	NNS	_	10	nsubj	_	_
2	of	_	ADP	IN	_	4	case	_	_
3	a	_	DET	DT	_	4	det	_	_
4	placebo	_	NOUN	NN	_	1	nmod	_	_
5	controlled	_	VERB	VBN	_	4	acl	_	_
6	trial	_	ADJ	JJ	_	5	xcomp	_	_
7	in	_	ADP	IN	_	9	case	_	_
8	normal	_	ADJ	JJ	_	9	amod	_	_
9	volunteers	_	NOUN	NNS	_	6	nmod	_	_
10	suggest	_	VERB	VBP	_	0	root	_	_
11	that	_	ADP	IN	_	22	mark	_	_
12	chronic	_	ADJ	JJ	_	13	amod	_	_
13	administration	_	NOUN	NN	_	22	nsubj	_	_
14	of	_	ADP	IN	_	19	case	_	_
15	DRUG	_	NOUN	NN	_	19	compound	_	_
16	200	_	NUM	CD	_	19	nummod	_	_
17	mg	_	NOUN	NN	_	19	compound	_	_
18	/	_	.	:	_	19	compound	_	_
19	day	_	NOUN	NN	_	13	nmod	_	_
20	does	_	VERB	VBZ	_	22	aux	_	_
21	not	_	ADV	RB	_	22	neg	_	_
22	produce	_	VERB	VB	_	10	ccomp	_	_
23	clinically	_	ADV	RB	_	24	advmod	_	_
24	important	_	ADJ	JJ	_	25	amod	_	_
25	inhibition	_	NOUN	NN	_	22	dobj	_	_
26	of	_	ADP	IN	_	28	case	_	_
27	phenytoin	_	NOUN	NN	_	28	compound	_	_
28	metabolism	_	NOUN	NN	_	25	nmod	_	_

#	Sertraline Hydrochloride	1502
1	Nonetheless	_	ADV	RB	_	9	advmod	_	_
2	,	_	.	,	_	9	punct	_	_
3	at	_	ADP	IN	_	5	case	_	_
4	this	_	DET	DT	_	5	det	_	_
5	time	_	NOUN	NN	_	9	nmod	_	_
6	,	_	.	,	_	9	punct	_	_
7	it	_	PRON	PRP	_	9	nsubjpass	_	_
8	is	_	VERB	VBZ	_	9	auxpass	_	_
9	recommended	_	VERB	VBN	_	0	root	_	_
10	that	_	ADP	IN	_	15	mark	_	_
11	plasma	_	NOUN	NN	_	13	compound	_	_
12	phenytoin	_	NOUN	NN	_	13	compound	_	_
13	concentrations	_	NOUN	NNS	_	15	nsubjpass	_	_
14	be	_	VERB	VBP	_	15	auxpass	_	_
15	monitored	_	VERB	VBN	_	9	ccomp	_	_
16	following	_	ADP	IN	_	17	case	_	_
17	initiation	_	NOUN	NN	_	15	nmod	_	_
18	of	_	ADP	IN	_	20	case	_	_
19	DRUG	_	NOUN	NN	_	20	compound	_	_
20	therapy	_	NOUN	NN	_	17	nmod	_	_
21	with	_	ADP	IN	_	23	case	_	_
22	appropriate	_	ADJ	JJ	_	23	amod	_	_
23	adjustments	_	NOUN	NNS	_	17	nmod	_	_
24	to	_	PRT	TO	_	27	case	_	_
25	the	_	DET	DT	_	27	det	_	_
26	phenytoin	_	NOUN	NN	_	27	compound	_	_
27	dose	_	NOUN	NN	_	17	nmod	_	_
28	,	_	.	,	_	15	punct	_	_
29	particularly	_	ADV	RB	_	31	advmod	_	_
30	in	_	ADP	IN	_	31	case	_	_
31	patients	_	NOUN	NNS	_	15	nmod	_	_
32	with	_	ADP	IN	_	36	case	_	_
33	multiple	_	ADJ	JJ	_	36	amod	_	_
34	underlying	_	VERB	VBG	_	36	amod	_	_
35	medical	_	ADJ	JJ	_	36	amod	_	_
36	conditions	_	NOUN	NNS	_	31	nmod	_	_
37	and	_	CONJ	CC	_	36	cc	_	_
38	/	_	NOUN	NN	_	36	conj	_	_
39	or	_	CONJ	CC	_	36	cc	_	_
40	those	_	DET	DT	_	36	conj	_	_
41	receiving	_	VERB	VBG	_	40	acl	_	_
42	multiple	_	ADJ	JJ	_	44	amod	_	_
43	concomitant	_	ADJ	JJ	_	44	amod	_	_
44	medications	_	NOUN	NNS	_	41	dobj	_	_

#	Sertraline Hydrochloride	1503
1	The	_	DET	DT	_	2	det	_	_
2	effect	_	NOUN	NN	_	11	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	on	_	ADP	IN	_	7	case	_	_
6	valproate	_	NOUN	NN	_	7	compound	_	_
7	levels	_	NOUN	NNS	_	2	nmod	_	_
8	has	_	VERB	VBZ	_	11	aux	_	_
9	not	_	ADV	RB	_	11	neg	_	_
10	been	_	VERB	VBN	_	11	auxpass	_	_
11	evaluated	_	VERB	VBN	_	0	root	_	_
12	in	_	ADP	IN	_	14	case	_	_
13	clinical	_	ADJ	JJ	_	14	amod	_	_
14	trials	_	NOUN	NNS	_	11	nmod	_	_

#	Sertraline Hydrochloride	1504
1	In	_	ADP	IN	_	3	case	_	_
2	the	_	DET	DT	_	3	det	_	_
3	absence	_	NOUN	NN	_	10	nmod	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	such	_	ADJ	JJ	_	6	amod	_	_
6	data	_	NOUN	NNS	_	3	nmod	_	_
7	,	_	.	,	_	10	punct	_	_
8	it	_	PRON	PRP	_	10	nsubjpass	_	_
9	is	_	VERB	VBZ	_	10	auxpass	_	_
10	recommended	_	VERB	VBN	_	0	root	_	_
11	that	_	ADP	IN	_	16	mark	_	_
12	plasma	_	NOUN	NN	_	14	compound	_	_
13	valproate	_	NOUN	NN	_	14	compound	_	_
14	levels	_	NOUN	NNS	_	16	nsubjpass	_	_
15	be	_	VERB	VBP	_	16	auxpass	_	_
16	monitored	_	VERB	VBN	_	10	ccomp	_	_
17	following	_	ADP	IN	_	18	case	_	_
18	initiation	_	NOUN	NN	_	16	nmod	_	_
19	of	_	ADP	IN	_	21	case	_	_
20	DRUG	_	NOUN	NN	_	21	compound	_	_
21	therapy	_	NOUN	NN	_	18	nmod	_	_
22	with	_	ADP	IN	_	24	case	_	_
23	appropriate	_	ADJ	JJ	_	24	amod	_	_
24	adjustments	_	NOUN	NNS	_	18	nmod	_	_
25	to	_	PRT	TO	_	28	case	_	_
26	the	_	DET	DT	_	28	det	_	_
27	valproate	_	NOUN	NN	_	28	compound	_	_
28	dose	_	NOUN	NN	_	18	nmod	_	_

#	Sertraline Hydrochloride	1505
1	The	_	DET	DT	_	2	det	_	_
2	risk	_	NOUN	NN	_	17	nsubjpass	_	_
3	of	_	ADP	IN	_	4	mark	_	_
4	using	_	VERB	VBG	_	2	acl	_	_
5	DRUG	_	NOUN	NN	_	4	dobj	_	_
6	in	_	ADP	IN	_	7	case	_	_
7	combination	_	NOUN	NN	_	4	nmod	_	_
8	with	_	ADP	IN	_	12	case	_	_
9	other	_	ADJ	JJ	_	12	amod	_	_
10	CNS	_	NOUN	NN	_	12	compound	_	_
11	active	_	ADJ	JJ	_	12	amod	_	_
12	drugs	_	NOUN	NNS	_	7	nmod	_	_
13	has	_	VERB	VBZ	_	17	aux	_	_
14	not	_	ADV	RB	_	17	neg	_	_
15	been	_	VERB	VBN	_	17	auxpass	_	_
16	systematically	_	ADV	RB	_	17	advmod	_	_
17	evaluated	_	VERB	VBN	_	0	root	_	_

#	Sertraline Hydrochloride	1506
1	Consequently	_	ADV	RB	_	5	advmod	_	_
2	,	_	.	,	_	5	punct	_	_
3	caution	_	NOUN	NN	_	5	nsubjpass	_	_
4	is	_	VERB	VBZ	_	5	auxpass	_	_
5	advised	_	VERB	VBN	_	0	root	_	_
6	if	_	ADP	IN	_	16	mark	_	_
7	the	_	DET	DT	_	9	det	_	_
8	concomitant	_	ADJ	JJ	_	9	amod	_	_
9	administration	_	NOUN	NN	_	16	nsubjpass	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	such	_	ADJ	JJ	_	14	amod	_	_
14	drugs	_	NOUN	NNS	_	11	conj	_	_
15	is	_	VERB	VBZ	_	16	auxpass	_	_
16	required	_	VERB	VBN	_	5	ccomp	_	_

#	Sertraline Hydrochloride	1507
1	There	_	DET	EX	_	2	expl	_	_
2	is	_	VERB	VBZ	_	0	root	_	_
3	limited	_	ADJ	JJ	_	5	amod	_	_
4	controlled	_	VERB	VBN	_	5	amod	_	_
5	experience	_	NOUN	NN	_	2	nsubj	_	_
6	regarding	_	ADP	IN	_	9	case	_	_
7	the	_	DET	DT	_	9	det	_	_
8	optimal	_	ADJ	JJ	_	9	amod	_	_
9	timing	_	NOUN	NN	_	2	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	switching	_	NOUN	NN	_	9	nmod	_	_
12	from	_	ADP	IN	_	14	case	_	_
13	other	_	ADJ	JJ	_	14	amod	_	_
14	drugs	_	NOUN	NNS	_	11	nmod	_	_
15	effective	_	ADJ	JJ	_	14	amod	_	_
16	in	_	ADP	IN	_	18	case	_	_
17	the	_	DET	DT	_	18	det	_	_
18	treatment	_	NOUN	NN	_	15	nmod	_	_
19	of	_	ADP	IN	_	22	case	_	_
20	major	_	ADJ	JJ	_	22	amod	_	_
21	depressive	_	ADJ	JJ	_	22	amod	_	_
22	disorder	_	NOUN	NN	_	18	nmod	_	_
23	,	_	.	,	_	22	punct	_	_
24	obsessive	_	ADJ	JJ	_	26	amod	_	_
25	compulsive	_	ADJ	JJ	_	26	amod	_	_
26	disorder	_	NOUN	NN	_	22	conj	_	_
27	,	_	.	,	_	22	punct	_	_
28	panic	_	ADJ	JJ	_	29	amod	_	_
29	disorder	_	NOUN	NN	_	22	conj	_	_
30	,	_	.	,	_	22	punct	_	_
31	posttraumatic	_	ADJ	JJ	_	33	amod	_	_
32	stress	_	NOUN	NN	_	33	compound	_	_
33	disorder	_	NOUN	NN	_	22	conj	_	_
34	,	_	.	,	_	22	punct	_	_
35	premenstrual	_	ADJ	JJ	_	37	amod	_	_
36	dysphoric	_	ADJ	JJ	_	37	amod	_	_
37	disorder	_	NOUN	NN	_	22	conj	_	_
38	and	_	CONJ	CC	_	22	cc	_	_
39	social	_	ADJ	JJ	_	41	amod	_	_
40	anxiety	_	NOUN	NN	_	41	compound	_	_
41	disorder	_	NOUN	NN	_	22	conj	_	_
42	to	_	PRT	TO	_	43	case	_	_
43	DRUG	_	NOUN	NN	_	41	nmod	_	_

#	Sertraline Hydrochloride	1508
1	Care	_	ADJ	JJ	_	8	nsubjpass	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	prudent	_	ADJ	JJ	_	1	conj	_	_
4	medical	_	ADJ	JJ	_	5	amod	_	_
5	judgment	_	NOUN	NN	_	1	dep	_	_
6	should	_	VERB	MD	_	8	aux	_	_
7	be	_	VERB	VB	_	8	auxpass	_	_
8	exercised	_	VERB	VBN	_	0	root	_	_
9	when	_	ADV	WRB	_	8	advmod	_	_
10	switching	_	NOUN	NN	_	9	nmod	_	_
11	,	_	.	,	_	10	punct	_	_
12	particularly	_	ADV	RB	_	10	advmod	_	_
13	from	_	ADP	IN	_	16	case	_	_
14	long	_	ADJ	JJ	_	16	amod	_	_
15	acting	_	VERB	VBG	_	16	compound	_	_
16	agents	_	NOUN	NNS	_	12	nmod	_	_

#	Sertraline Hydrochloride	1509
1	The	_	DET	DT	_	2	det	_	_
2	duration	_	NOUN	NN	_	25	nsubjpass	_	_
3	of	_	ADP	IN	_	7	case	_	_
4	an	_	DET	DT	_	7	det	_	_
5	appropriate	_	ADJ	JJ	_	7	amod	_	_
6	washout	_	NOUN	NN	_	7	compound	_	_
7	period	_	NOUN	NN	_	2	nmod	_	_
8	which	_	DET	WDT	_	10	nsubj	_	_
9	should	_	VERB	MD	_	10	aux	_	_
10	intervene	_	VERB	VB	_	7	acl:relcl	_	_
11	before	_	ADP	IN	_	12	case	_	_
12	switching	_	NOUN	NN	_	10	nmod	_	_
13	from	_	ADP	IN	_	19	case	_	_
14	one	_	NUM	CD	_	19	nummod	_	_
15	selective	_	ADJ	JJ	_	19	amod	_	_
16	serotonin	_	NOUN	NN	_	19	compound	_	_
17	reuptake	_	NOUN	NN	_	19	compound	_	_
18	inhibitor	_	NOUN	NN	_	19	compound	_	_
19	SSRI	_	NOUN	NN	_	12	nmod	_	_
20	to	_	PRT	TO	_	21	case	_	_
21	another	_	DET	DT	_	12	nmod	_	_
22	has	_	VERB	VBZ	_	25	aux	_	_
23	not	_	ADV	RB	_	25	neg	_	_
24	been	_	VERB	VBN	_	25	auxpass	_	_
25	established	_	VERB	VBN	_	0	root	_	_

#	Sertraline Hydrochloride	1510
1	Monoamine	_	NOUN	NN	_	3	compound	_	_
2	Oxidase	_	NOUN	NN	_	3	compound	_	_
3	Inhibitors	_	NOUN	NNS	_	4	nsubj	_	_
4	See	_	VERB	VBP	_	0	root	_	_
5	CONTRAINDICATIONS	_	NOUN	NN	_	4	dobj	_	_
6	,	_	.	,	_	5	punct	_	_
7	WARNINGS	_	NOUN	NN	_	5	conj	_	_
8	,	_	.	,	_	5	punct	_	_
9	andDOSAGE	_	NOUN	NN	_	5	conj	_	_
10	AND	_	CONJ	CC	_	5	cc	_	_
11	ADMINISTRATION	_	NOUN	NN	_	5	conj	_	_

#	Sertraline Hydrochloride	1511
1	Drugs	_	NOUN	NNS	_	0	root	_	_
2	Metabolized	_	VERB	VBN	_	1	acl	_	_
3	by	_	ADP	IN	_	5	case	_	_
4	P450	_	NOUN	NN	_	5	compound	_	_
5	3A4	_	NOUN	NN	_	2	nmod	_	_
6	In	_	ADP	IN	_	12	case	_	_
7	three	_	NUM	CD	_	12	nummod	_	_
8	separate	_	ADJ	JJ	_	12	amod	_	_
9	in	_	X	FW	_	12	amod	_	_
10	vivo	_	X	FW	_	9	dep	_	_
11	interaction	_	NOUN	NN	_	12	compound	_	_
12	studies	_	NOUN	NNS	_	2	nmod	_	_
13	,	_	.	,	_	1	punct	_	_
14	DRUG	_	NOUN	NN	_	17	nsubjpass	_	_
15	was	_	VERB	VBD	_	17	auxpass	_	_
16	co	_	PRT	TO	_	17	dep	_	_
17	administered	_	VERB	VBN	_	1	dep	_	_
18	with	_	ADP	IN	_	22	case	_	_
19	cytochrome	_	NOUN	NN	_	22	compound	_	_
20	P450	_	NOUN	NN	_	22	compound	_	_
21	3A4	_	NOUN	NN	_	22	compound	_	_
22	substrates	_	NOUN	NNS	_	17	nmod	_	_
23	,	_	.	,	_	22	punct	_	_
24	terfenadine	_	NOUN	NN	_	22	appos	_	_
25	,	_	.	,	_	24	punct	_	_
26	carbamazepine	_	NOUN	NN	_	24	conj	_	_
27	,	_	.	,	_	24	punct	_	_
28	or	_	CONJ	CC	_	24	cc	_	_
29	cisapride	_	NOUN	NN	_	24	conj	_	_
30	under	_	ADP	IN	_	33	case	_	_
31	steady	_	ADJ	JJ	_	33	amod	_	_
32	state	_	NOUN	NN	_	33	compound	_	_
33	conditions	_	NOUN	NNS	_	24	nmod	_	_

#	Sertraline Hydrochloride	1512
1	The	_	DET	DT	_	2	det	_	_
2	results	_	NOUN	NNS	_	6	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	these	_	DET	DT	_	5	det	_	_
5	studies	_	NOUN	NNS	_	2	nmod	_	_
6	indicated	_	VERB	VBD	_	0	root	_	_
7	that	_	ADP	IN	_	11	mark	_	_
8	DRUG	_	NOUN	NN	_	11	nsubj	_	_
9	did	_	VERB	MD	_	11	aux	_	_
10	not	_	ADV	RB	_	11	neg	_	_
11	increase	_	VERB	VB	_	6	ccomp	_	_
12	plasma	_	NOUN	NN	_	13	compound	_	_
13	concentrations	_	NOUN	NNS	_	11	dobj	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	terfenadine	_	NOUN	NN	_	13	nmod	_	_
16	,	_	.	,	_	15	punct	_	_
17	carbamazepine	_	NOUN	NN	_	15	conj	_	_
18	,	_	.	,	_	15	punct	_	_
19	or	_	CONJ	CC	_	15	cc	_	_
20	cisapride	_	NOUN	NN	_	15	conj	_	_

#	Sertraline Hydrochloride	1513
1	These	_	DET	DT	_	2	det	_	_
2	data	_	NOUN	NNS	_	3	nsubj	_	_
3	indicate	_	VERB	VBP	_	0	root	_	_
4	that	_	ADP	IN	_	16	mark	_	_
5	DRUG	_	NOUN	NN	_	7	nmod:poss	_	_
6	's	_	PRT	POS	_	7	case	_	_
7	extent	_	NOUN	NN	_	16	nsubj	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	inhibition	_	NOUN	NN	_	7	nmod	_	_
10	of	_	ADP	IN	_	13	case	_	_
11	P450	_	NOUN	NN	_	13	compound	_	_
12	3A4	_	NOUN	NN	_	13	compound	_	_
13	activity	_	NOUN	NN	_	9	nmod	_	_
14	is	_	VERB	VBZ	_	16	cop	_	_
15	not	_	ADV	RB	_	16	neg	_	_
16	likely	_	ADJ	JJ	_	3	ccomp	_	_
17	to	_	PRT	TO	_	21	mark	_	_
18	be	_	VERB	VB	_	21	cop	_	_
19	of	_	ADP	IN	_	21	case	_	_
20	clinical	_	ADJ	JJ	_	21	amod	_	_
21	significance	_	NOUN	NN	_	16	ccomp	_	_

#	Sertraline Hydrochloride	1514
1	Results	_	NOUN	NNS	_	8	nsubj	_	_
2	of	_	ADP	IN	_	5	case	_	_
3	the	_	DET	DT	_	5	det	_	_
4	interaction	_	NOUN	NN	_	5	compound	_	_
5	study	_	NOUN	NN	_	1	nmod	_	_
6	with	_	ADP	IN	_	7	case	_	_
7	cisapride	_	NOUN	NN	_	5	nmod	_	_
8	indicate	_	VERB	VBP	_	0	root	_	_
9	that	_	ADP	IN	_	24	mark	_	_
10	DRUG	_	NOUN	NN	_	12	compound	_	_
11	200	_	NUM	CD	_	12	nummod	_	_
12	mg	_	NOUN	NN	_	24	nsubjpass	_	_
13	q.d	_	CONJ	CC	_	12	cc	_	_
14	induces	_	VERB	VBZ	_	12	conj	_	_
15	the	_	DET	DT	_	16	det	_	_
16	metabolism	_	NOUN	NN	_	14	dobj	_	_
17	of	_	ADP	IN	_	20	case	_	_
18	cisapride	_	NOUN	NN	_	20	compound	_	_
19	cisapride	_	NOUN	NN	_	20	compound	_	_
20	AUC	_	NOUN	NN	_	16	nmod	_	_
21	and	_	CONJ	CC	_	20	cc	_	_
22	Cmax	_	NOUN	NN	_	20	conj	_	_
23	were	_	VERB	VBD	_	24	auxpass	_	_
24	reduced	_	VERB	VBN	_	8	ccomp	_	_
25	by	_	ADP	IN	_	27	case	_	_
26	about	_	ADV	RB	_	27	advmod	_	_
27	35%	_	ADJ	JJ	_	24	nmod	_	_

#	Sertraline Hydrochloride	1515
1	Drugs	_	NOUN	NNS	_	38	nsubj	_	_
2	Metabolized	_	VERB	VBN	_	1	acl	_	_
3	by	_	ADP	IN	_	7	case	_	_
4	P450	_	NOUN	NN	_	7	compound	_	_
5	2D6	_	NOUN	NN	_	7	compound	_	_
6	Many	_	ADJ	JJ	_	7	amod	_	_
7	drugs	_	NOUN	NNS	_	2	nmod	_	_
8	effective	_	ADJ	JJ	_	7	amod	_	_
9	in	_	ADP	IN	_	11	case	_	_
10	the	_	DET	DT	_	11	det	_	_
11	treatment	_	NOUN	NN	_	8	nmod	_	_
12	of	_	ADP	IN	_	15	case	_	_
13	major	_	ADJ	JJ	_	15	amod	_	_
14	depressive	_	ADJ	JJ	_	15	amod	_	_
15	disorder	_	NOUN	NN	_	11	nmod	_	_
16	,	_	.	,	_	15	punct	_	_
17	e.g	_	NOUN	NN	_	15	conj	_	_
18	,	_	.	,	_	15	punct	_	_
19	the	_	DET	DT	_	20	det	_	_
20	SSRIs	_	NOUN	NNS	_	15	conj	_	_
21	,	_	.	,	_	15	punct	_	_
22	including	_	VERB	VBG	_	23	case	_	_
23	DRUG	_	NOUN	NN	_	15	nmod	_	_
24	,	_	.	,	_	1	punct	_	_
25	and	_	CONJ	CC	_	1	cc	_	_
26	most	_	ADV	RB	_	29	advmod	_	_
27	tricyclic	_	ADJ	JJ	_	29	amod	_	_
28	antidepressant	_	ADJ	JJ	_	29	amod	_	_
29	drugs	_	NOUN	NNS	_	1	conj	_	_
30	effective	_	ADJ	JJ	_	29	amod	_	_
31	in	_	ADP	IN	_	33	case	_	_
32	the	_	DET	DT	_	33	det	_	_
33	treatment	_	NOUN	NN	_	30	nmod	_	_
34	of	_	ADP	IN	_	37	case	_	_
35	major	_	ADJ	JJ	_	37	amod	_	_
36	depressive	_	ADJ	JJ	_	37	amod	_	_
37	disorder	_	NOUN	NN	_	33	nmod	_	_
38	inhibit	_	VERB	VBP	_	0	root	_	_
39	the	_	DET	DT	_	41	det	_	_
40	biochemical	_	ADJ	JJ	_	41	amod	_	_
41	activity	_	NOUN	NN	_	38	dobj	_	_
42	of	_	ADP	IN	_	51	case	_	_
43	the	_	DET	DT	_	51	det	_	_
44	drug	_	NOUN	NN	_	51	compound	_	_
45	metabolizing	_	VERB	VBG	_	51	compound	_	_
46	isozyme	_	NOUN	NN	_	51	compound	_	_
47	cytochrome	_	NOUN	NN	_	51	compound	_	_
48	P450	_	NOUN	NN	_	51	compound	_	_
49	2D6	_	NOUN	NN	_	51	compound	_	_
50	debrisoquin	_	NOUN	NN	_	51	compound	_	_
51	hydroxylase	_	NOUN	NN	_	41	nmod	_	_
52	,	_	.	,	_	38	punct	_	_
53	and	_	CONJ	CC	_	38	cc	_	_
54	,	_	.	,	_	38	punct	_	_
55	thus	_	ADV	RB	_	38	advmod	_	_
56	,	_	.	,	_	38	punct	_	_
57	may	_	VERB	MD	_	58	aux	_	_
58	increase	_	VERB	VB	_	38	parataxis	_	_
59	the	_	DET	DT	_	61	det	_	_
60	plasma	_	NOUN	NN	_	61	compound	_	_
61	concentrations	_	NOUN	NNS	_	58	dobj	_	_
62	of	_	ADP	IN	_	65	case	_	_
63	co	_	PRT	TO	_	65	case	_	_
64	administered	_	VERB	VBN	_	65	amod	_	_
65	drugs	_	NOUN	NNS	_	61	nmod	_	_
66	that	_	DET	WDT	_	68	nsubjpass	_	_
67	are	_	VERB	VBP	_	68	auxpass	_	_
68	metabolized	_	VERB	VBN	_	65	acl:relcl	_	_
69	by	_	ADP	IN	_	71	case	_	_
70	P450	_	NOUN	NN	_	71	compound	_	_
71	2D6	_	NOUN	NN	_	68	nmod	_	_

#	Sertraline Hydrochloride	1516
1	The	_	DET	DT	_	2	det	_	_
2	drugs	_	NOUN	NNS	_	13	nsubj	_	_
3	for	_	ADP	IN	_	4	case	_	_
4	which	_	DET	WDT	_	11	nmod	_	_
5	this	_	DET	DT	_	7	det	_	_
6	potential	_	ADJ	JJ	_	7	amod	_	_
7	interaction	_	NOUN	NN	_	11	nsubj	_	_
8	is	_	VERB	VBZ	_	11	cop	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	greatest	_	ADJ	JJ	_	11	amod	_	_
11	concern	_	NOUN	NN	_	2	acl:relcl	_	_
12	are	_	VERB	VBP	_	13	cop	_	_
13	those	_	DET	DT	_	0	root	_	_
14	metabolized	_	VERB	VBN	_	13	acl	_	_
15	primarily	_	ADV	RB	_	14	advmod	_	_
16	by	_	ADP	IN	_	17	case	_	_
17	2D6	_	NOUN	NN	_	14	nmod	_	_
18	and	_	CONJ	CC	_	14	cc	_	_
19	which	_	DET	WDT	_	20	nsubj	_	_
20	have	_	VERB	VBP	_	14	conj	_	_
21	a	_	DET	DT	_	24	det	_	_
22	narrow	_	NOUN	NN	_	24	compound	_	_
23	therapeutic	_	ADJ	JJ	_	24	amod	_	_
24	index	_	NOUN	NN	_	20	dobj	_	_
25	,	_	.	,	_	24	punct	_	_
26	e.g	_	NOUN	NN	_	24	appos	_	_
27	,	_	.	,	_	24	punct	_	_
28	the	_	DET	DT	_	31	det	_	_
29	tricyclic	_	ADJ	JJ	_	31	amod	_	_
30	antidepressant	_	ADJ	JJ	_	31	amod	_	_
31	drugs	_	NOUN	NNS	_	24	appos	_	_
32	effective	_	ADJ	JJ	_	31	amod	_	_
33	in	_	ADP	IN	_	35	case	_	_
34	the	_	DET	DT	_	35	det	_	_
35	treatment	_	NOUN	NN	_	32	nmod	_	_
36	of	_	ADP	IN	_	39	case	_	_
37	major	_	ADJ	JJ	_	39	amod	_	_
38	depressive	_	ADJ	JJ	_	39	amod	_	_
39	disorder	_	NOUN	NN	_	35	nmod	_	_
40	and	_	CONJ	CC	_	39	cc	_	_
41	the	_	DET	DT	_	44	det	_	_
42	Type	_	NOUN	NN	_	44	compound	_	_
43	1C	_	NOUN	NN	_	44	compound	_	_
44	antiarrhythmics	_	NOUN	NNS	_	39	conj	_	_
45	propafenone	_	NOUN	NN	_	44	dep	_	_
46	and	_	CONJ	CC	_	45	cc	_	_
47	flecainide	_	NOUN	NN	_	45	conj	_	_

#	Sertraline Hydrochloride	1517
1	The	_	DET	DT	_	2	det	_	_
2	extent	_	NOUN	NN	_	12	nsubj	_	_
3	to	_	PRT	TO	_	4	case	_	_
4	which	_	DET	WDT	_	11	nmod	_	_
5	this	_	DET	DT	_	6	det	_	_
6	interaction	_	NOUN	NN	_	11	nsubj	_	_
7	is	_	VERB	VBZ	_	11	cop	_	_
8	an	_	DET	DT	_	11	det	_	_
9	important	_	ADJ	JJ	_	11	amod	_	_
10	clinical	_	ADJ	JJ	_	11	amod	_	_
11	problem	_	NOUN	NN	_	2	acl:relcl	_	_
12	depends	_	VERB	VBZ	_	0	root	_	_
13	on	_	ADP	IN	_	15	case	_	_
14	the	_	DET	DT	_	15	det	_	_
15	extent	_	NOUN	NN	_	12	nmod	_	_
16	of	_	ADP	IN	_	18	case	_	_
17	the	_	DET	DT	_	18	det	_	_
18	inhibition	_	NOUN	NN	_	15	nmod	_	_
19	of	_	ADP	IN	_	21	case	_	_
20	P450	_	NOUN	NN	_	21	compound	_	_
21	2D6	_	NOUN	NN	_	18	nmod	_	_
22	by	_	ADP	IN	_	24	case	_	_
23	the	_	DET	DT	_	24	det	_	_
24	antidepressant	_	ADJ	JJ	_	15	nmod	_	_
25	and	_	CONJ	CC	_	24	cc	_	_
26	the	_	DET	DT	_	28	det	_	_
27	therapeutic	_	ADJ	JJ	_	28	amod	_	_
28	index	_	NOUN	NN	_	24	conj	_	_
29	of	_	ADP	IN	_	33	case	_	_
30	the	_	DET	DT	_	33	det	_	_
31	co	_	DET	DT	_	33	dep	_	_
32	administered	_	VERB	VBN	_	33	amod	_	_
33	drug	_	NOUN	NN	_	24	nmod	_	_

#	Sertraline Hydrochloride	1518
1	There	_	DET	EX	_	2	expl	_	_
2	is	_	VERB	VBZ	_	0	root	_	_
3	variability	_	NOUN	NN	_	2	nsubj	_	_
4	among	_	ADP	IN	_	6	case	_	_
5	the	_	DET	DT	_	6	det	_	_
6	drugs	_	NOUN	NNS	_	3	nmod	_	_
7	effective	_	ADJ	JJ	_	6	amod	_	_
8	in	_	ADP	IN	_	10	case	_	_
9	the	_	DET	DT	_	10	det	_	_
10	treatment	_	NOUN	NN	_	7	nmod	_	_
11	of	_	ADP	IN	_	14	case	_	_
12	major	_	ADJ	JJ	_	14	amod	_	_
13	depressive	_	ADJ	JJ	_	14	amod	_	_
14	disorder	_	NOUN	NN	_	10	nmod	_	_
15	in	_	ADP	IN	_	17	case	_	_
16	the	_	DET	DT	_	17	det	_	_
17	extent	_	NOUN	NN	_	10	nmod	_	_
18	of	_	ADP	IN	_	22	case	_	_
19	clinically	_	ADV	RB	_	20	advmod	_	_
20	important	_	ADJ	JJ	_	22	amod	_	_
21	2D6	_	NOUN	NN	_	22	compound	_	_
22	inhibition	_	NOUN	NN	_	17	nmod	_	_
23	,	_	.	,	_	2	punct	_	_
24	and	_	CONJ	CC	_	2	cc	_	_
25	in	_	ADP	IN	_	27	case	_	_
26	fact	_	NOUN	NN	_	27	amod	_	_
27	DRUG	_	NOUN	NN	_	31	nsubj	_	_
28	at	_	ADP	IN	_	30	case	_	_
29	lower	_	ADJ	JJ	_	30	amod	_	_
30	doses	_	NOUN	NNS	_	27	nmod	_	_
31	has	_	VERB	VBZ	_	2	conj	_	_
32	a	_	DET	DT	_	36	det	_	_
33	less	_	ADV	RB	_	34	advmod	_	_
34	prominent	_	ADJ	JJ	_	36	amod	_	_
35	inhibitory	_	ADJ	JJ	_	36	amod	_	_
36	effect	_	NOUN	NN	_	31	dobj	_	_
37	on	_	ADP	IN	_	38	case	_	_
38	2D6	_	NOUN	NN	_	36	nmod	_	_
39	than	_	ADP	IN	_	41	case	_	_
40	some	_	DET	DT	_	41	det	_	_
41	others	_	NOUN	NNS	_	36	nmod	_	_
42	in	_	ADP	IN	_	44	case	_	_
43	the	_	DET	DT	_	44	det	_	_
44	class	_	NOUN	NN	_	41	nmod	_	_

#	Sertraline Hydrochloride	1519
1	Nevertheless	_	ADV	RB	_	5	advmod	_	_
2	,	_	.	,	_	5	punct	_	_
3	even	_	ADV	RB	_	5	advmod	_	_
4	DRUG	_	NOUN	NN	_	5	nsubj	_	_
5	has	_	VERB	VBZ	_	0	root	_	_
6	the	_	DET	DT	_	7	det	_	_
7	potential	_	NOUN	NN	_	5	dobj	_	_
8	for	_	ADP	IN	_	12	case	_	_
9	clinically	_	ADV	RB	_	10	advmod	_	_
10	important	_	ADJ	JJ	_	12	amod	_	_
11	2D6	_	NOUN	NN	_	12	compound	_	_
12	inhibition	_	NOUN	NN	_	7	nmod	_	_

#	Sertraline Hydrochloride	1520
1	Consequently	_	ADV	RB	_	15	advmod	_	_
2	,	_	.	,	_	15	punct	_	_
3	concomitant	_	ADJ	JJ	_	4	amod	_	_
4	use	_	NOUN	NN	_	15	nsubj	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	a	_	DET	DT	_	7	det	_	_
7	drug	_	NOUN	NN	_	4	nmod	_	_
8	metabolized	_	VERB	VBN	_	7	acl	_	_
9	by	_	ADP	IN	_	11	case	_	_
10	P450	_	NOUN	NN	_	11	compound	_	_
11	2D6	_	NOUN	NN	_	8	nmod	_	_
12	with	_	ADP	IN	_	13	case	_	_
13	DRUG	_	NOUN	NN	_	8	nmod	_	_
14	may	_	VERB	MD	_	15	aux	_	_
15	require	_	VERB	VB	_	0	root	_	_
16	lower	_	ADJ	JJ	_	17	amod	_	_
17	doses	_	NOUN	NNS	_	15	dobj	_	_
18	than	_	ADP	IN	_	20	mark	_	_
19	usually	_	ADV	RB	_	20	advmod	_	_
20	prescribed	_	VERB	VBN	_	15	advcl	_	_
21	for	_	ADP	IN	_	24	case	_	_
22	the	_	DET	DT	_	24	det	_	_
23	other	_	ADJ	JJ	_	24	amod	_	_
24	drug	_	NOUN	NN	_	20	nmod	_	_

#	Sertraline Hydrochloride	1521
1	Furthermore	_	ADV	RB	_	21	advmod	_	_
2	,	_	.	,	_	21	punct	_	_
3	whenever	_	ADP	IN	_	6	mark	_	_
4	DRUG	_	NOUN	NN	_	6	nsubjpass	_	_
5	is	_	VERB	VBZ	_	6	auxpass	_	_
6	withdrawn	_	VERB	VBN	_	21	advcl	_	_
7	from	_	ADP	IN	_	9	case	_	_
8	co	_	PRT	TO	_	9	case	_	_
9	therapy	_	NOUN	NN	_	6	nmod	_	_
10	,	_	.	,	_	21	punct	_	_
11	an	_	DET	DT	_	13	det	_	_
12	increased	_	VERB	VBN	_	13	amod	_	_
13	dose	_	NOUN	NN	_	21	nsubjpass	_	_
14	of	_	ADP	IN	_	18	case	_	_
15	the	_	DET	DT	_	18	det	_	_
16	co	_	DET	DT	_	18	det	_	_
17	administered	_	VERB	VBN	_	18	amod	_	_
18	drug	_	NOUN	NN	_	13	nmod	_	_
19	may	_	VERB	MD	_	21	aux	_	_
20	be	_	VERB	VB	_	21	auxpass	_	_
21	required	_	VERB	VBN	_	0	root	_	_

#	Sertraline Hydrochloride	1522
1	Serotonergic	_	ADJ	JJ	_	2	amod	_	_
2	Drugs	_	NOUN	NNS	_	0	root	_	_
3	SeeCONTRAINDICATIONS	_	NOUN	NN	_	2	dep	_	_
4	,	_	.	,	_	3	punct	_	_
5	WARNINGS	_	NOUN	NN	_	3	conj	_	_
6	,	_	.	,	_	3	punct	_	_
7	and	_	CONJ	CC	_	3	cc	_	_
8	DOSAGE	_	NOUN	NN	_	3	conj	_	_
9	AND	_	CONJ	CC	_	8	cc	_	_
10	ADMINISTRATION	_	NOUN	NN	_	8	conj	_	_

#	Sertraline Hydrochloride	1523
1	Triptans	_	NOUN	NNS	_	0	root	_	_
2	There	_	DET	EX	_	8	nsubj	_	_
3	have	_	VERB	VBP	_	8	aux	_	_
4	been	_	VERB	VBN	_	8	cop	_	_
5	rare	_	ADJ	JJ	_	8	amod	_	_
6	post	_	ADJ	JJ	_	8	amod	_	_
7	marketing	_	VERB	VBG	_	8	amod	_	_
8	reports	_	NOUN	NNS	_	1	nmod	_	_
9	of	_	ADP	IN	_	12	case	_	_
10	serotonin	_	NOUN	NN	_	12	compound	_	_
11	hydrochloride	_	NOUN	NN	_	12	compound	_	_
12	syndrome	_	NOUN	NN	_	8	nmod	_	_
13	with	_	ADP	IN	_	14	case	_	_
14	use	_	NOUN	NN	_	8	nmod	_	_
15	of	_	ADP	IN	_	17	case	_	_
16	an	_	DET	DT	_	17	det	_	_
17	SNRI	_	NOUN	NN	_	14	nmod	_	_
18	or	_	CONJ	CC	_	17	cc	_	_
19	an	_	DET	DT	_	20	det	_	_
20	SSRI	_	NOUN	NN	_	17	conj	_	_
21	and	_	CONJ	CC	_	20	cc	_	_
22	a	_	DET	DT	_	23	det	_	_
23	triptan	_	NOUN	NN	_	20	conj	_	_

#	Sertraline Hydrochloride	1524
1	If	_	ADP	IN	_	3	case	_	_
2	concomitant	_	ADJ	JJ	_	3	amod	_	_
3	treatment	_	NOUN	NN	_	17	nmod	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	SNRIs	_	NOUN	NNS	_	3	nmod	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	SSRIs	_	NOUN	NNS	_	5	conj	_	_
8	,	_	.	,	_	17	punct	_	_
9	including	_	VERB	VBG	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	17	nmod	_	_
11	,	_	.	,	_	17	punct	_	_
12	with	_	ADP	IN	_	14	case	_	_
13	a	_	DET	DT	_	14	det	_	_
14	triptan	_	NOUN	NN	_	17	nsubjpass	_	_
15	is	_	VERB	VBZ	_	17	auxpass	_	_
16	clinically	_	ADV	RB	_	17	advmod	_	_
17	warranted	_	VERB	VBN	_	25	advcl	_	_
18	,	_	.	,	_	25	punct	_	_
19	careful	_	ADJ	JJ	_	20	amod	_	_
20	observation	_	NOUN	NN	_	25	nsubjpass	_	_
21	of	_	ADP	IN	_	23	case	_	_
22	the	_	DET	DT	_	23	det	_	_
23	patient	_	NOUN	NN	_	20	nmod	_	_
24	is	_	VERB	VBZ	_	25	auxpass	_	_
25	advised	_	VERB	VBN	_	0	root	_	_
26	,	_	.	,	_	25	punct	_	_
27	particularly	_	ADV	RB	_	29	advmod	_	_
28	during	_	ADP	IN	_	29	case	_	_
29	treatment	_	NOUN	NN	_	25	nmod	_	_
30	initiation	_	NOUN	NN	_	29	dep	_	_
31	and	_	CONJ	CC	_	30	cc	_	_
32	dose	_	NOUN	NN	_	30	conj	_	_
33	increases	_	VERB	VBZ	_	25	root	_	_

#	Sertraline Hydrochloride	1525
1	Sumatriptan	_	NOUN	NN	_	8	nsubj	_	_
2	There	_	NUM	CD	_	1	nummod	_	_
3	have	_	VERB	VBP	_	8	aux	_	_
4	been	_	VERB	VBN	_	8	cop	_	_
5	rare	_	ADJ	JJ	_	8	amod	_	_
6	post	_	ADJ	JJ	_	8	amod	_	_
7	marketing	_	VERB	VBG	_	8	amod	_	_
8	reports	_	NOUN	NNS	_	0	root	_	_
9	describing	_	VERB	VBG	_	8	acl	_	_
10	patients	_	NOUN	NNS	_	9	dobj	_	_
11	with	_	ADP	IN	_	12	case	_	_
12	weakness	_	NOUN	NN	_	10	nmod	_	_
13	,	_	.	,	_	12	punct	_	_
14	hyperreflexia	_	NOUN	NN	_	12	conj	_	_
15	,	_	.	,	_	12	punct	_	_
16	and	_	CONJ	CC	_	12	cc	_	_
17	incoordination	_	NOUN	NN	_	12	conj	_	_
18	following	_	ADP	IN	_	20	case	_	_
19	the	_	DET	DT	_	20	det	_	_
20	use	_	NOUN	NN	_	9	nmod	_	_
21	of	_	ADP	IN	_	26	case	_	_
22	a	_	DET	DT	_	26	det	_	_
23	selective	_	ADJ	JJ	_	26	amod	_	_
24	serotonin	_	NOUN	NN	_	26	compound	_	_
25	reuptake	_	NOUN	NN	_	26	compound	_	_
26	inhibitor	_	NOUN	NN	_	20	nmod	_	_
27	SSRI	_	NOUN	NN	_	26	dep	_	_
28	and	_	CONJ	CC	_	27	cc	_	_
29	sumatriptan	_	NOUN	NN	_	27	conj	_	_

#	Sertraline Hydrochloride	1526
1	If	_	ADP	IN	_	3	case	_	_
2	concomitant	_	ADJ	JJ	_	3	amod	_	_
3	treatment	_	NOUN	NN	_	22	nsubjpass	_	_
4	with	_	ADP	IN	_	5	case	_	_
5	sumatriptan	_	NOUN	NN	_	3	nmod	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	an	_	DET	DT	_	9	det	_	_
8	SSRI	_	NOUN	NN	_	9	compound	_	_
9	e.g	_	NOUN	NN	_	5	conj	_	_
10	,	_	.	,	_	9	punct	_	_
11	citalopram	_	NOUN	NN	_	9	conj	_	_
12	,	_	.	,	_	9	punct	_	_
13	fluoxetine	_	NOUN	NN	_	9	conj	_	_
14	,	_	.	,	_	9	punct	_	_
15	fluvoxamine	_	NOUN	NN	_	9	conj	_	_
16	,	_	.	,	_	9	punct	_	_
17	paroxetine	_	NOUN	NN	_	9	appos	_	_
18	,	_	.	,	_	9	punct	_	_
19	DRUG	_	NOUN	NN	_	9	appos	_	_
20	is	_	VERB	VBZ	_	22	auxpass	_	_
21	clinically	_	ADV	RB	_	22	advmod	_	_
22	warranted	_	VERB	VBN	_	0	root	_	_
23	,	_	.	,	_	22	punct	_	_
24	appropriate	_	ADJ	JJ	_	25	amod	_	_
25	observation	_	NOUN	NN	_	30	nsubjpass	_	_
26	of	_	ADP	IN	_	28	case	_	_
27	the	_	DET	DT	_	28	det	_	_
28	patient	_	NOUN	NN	_	25	nmod	_	_
29	is	_	VERB	VBZ	_	30	auxpass	_	_
30	advised	_	VERB	VBN	_	22	parataxis	_	_

#	Sertraline Hydrochloride	1527
1	Tricyclic	_	ADJ	JJ	_	3	amod	_	_
2	Antidepressant	_	ADJ	JJ	_	3	amod	_	_
3	Drugs	_	NOUN	NNS	_	0	root	_	_
4	Effective	_	ADJ	JJ	_	3	amod	_	_
5	in	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	Treatment	_	NOUN	NN	_	24	nmod	_	_
8	of	_	ADP	IN	_	11	case	_	_
9	Major	_	ADJ	JJ	_	11	amod	_	_
10	Depressive	_	ADJ	JJ	_	11	amod	_	_
11	Disorder(TCAs	_	NOUN	NNS	_	7	nmod	_	_
12	The	_	DET	DT	_	13	det	_	_
13	extent	_	NOUN	NN	_	24	nsubj	_	_
14	to	_	PRT	TO	_	15	case	_	_
15	which	_	DET	WDT	_	20	nmod	_	_
16	SSRI	_	NOUN	NN	_	18	compound	_	_
17	TCA	_	NOUN	NN	_	18	compound	_	_
18	interactions	_	NOUN	NNS	_	20	nsubj	_	_
19	may	_	VERB	MD	_	20	aux	_	_
20	pose	_	VERB	VB	_	13	acl:relcl	_	_
21	clinical	_	ADJ	JJ	_	22	amod	_	_
22	problems	_	NOUN	NNS	_	20	dobj	_	_
23	will	_	VERB	MD	_	24	aux	_	_
24	depend	_	VERB	VB	_	4	ccomp	_	_
25	on	_	ADP	IN	_	27	case	_	_
26	the	_	DET	DT	_	27	det	_	_
27	degree	_	NOUN	NN	_	24	nmod	_	_
28	of	_	ADP	IN	_	29	case	_	_
29	inhibition	_	NOUN	NN	_	27	nmod	_	_
30	and	_	CONJ	CC	_	24	cc	_	_
31	the	_	DET	DT	_	32	det	_	_
32	pharmacokinetics	_	NOUN	NNS	_	24	conj	_	_
33	of	_	ADP	IN	_	35	case	_	_
34	the	_	DET	DT	_	35	det	_	_
35	SSRI	_	NOUN	NN	_	32	nmod	_	_
36	involved	_	VERB	VBN	_	35	acl	_	_

#	Sertraline Hydrochloride	1528
1	Nevertheless	_	ADV	RB	_	5	advmod	_	_
2	,	_	.	,	_	5	punct	_	_
3	caution	_	NOUN	NN	_	5	nsubjpass	_	_
4	is	_	VERB	VBZ	_	5	auxpass	_	_
5	indicated	_	VERB	VBN	_	0	root	_	_
6	in	_	ADP	IN	_	9	case	_	_
7	the	_	DET	DT	_	9	det	_	_
8	co	_	DET	DT	_	9	det	_	_
9	administration	_	NOUN	NN	_	5	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	TCAs	_	NOUN	NNS	_	9	nmod	_	_
12	with	_	ADP	IN	_	13	case	_	_
13	DRUG	_	NOUN	NN	_	9	nmod	_	_
14	,	_	.	,	_	5	punct	_	_
15	because	_	ADP	IN	_	5	dep	_	_
16	DRUG	_	NOUN	NN	_	18	nsubj	_	_
17	may	_	VERB	MD	_	18	aux	_	_
18	inhibit	_	VERB	VB	_	5	parataxis	_	_
19	TCA	_	NOUN	NN	_	20	compound	_	_
20	metabolism	_	NOUN	NN	_	18	dobj	_	_

#	Sertraline Hydrochloride	1529
1	Plasma	_	NOUN	NN	_	3	compound	_	_
2	TCA	_	NOUN	NN	_	3	compound	_	_
3	concentrations	_	NOUN	NNS	_	5	nsubj	_	_
4	may	_	VERB	MD	_	5	aux	_	_
5	need	_	VERB	VB	_	0	root	_	_
6	to	_	PRT	TO	_	8	mark	_	_
7	be	_	VERB	VB	_	8	auxpass	_	_
8	monitored	_	VERB	VBN	_	5	xcomp	_	_
9	,	_	.	,	_	5	punct	_	_
10	and	_	CONJ	CC	_	5	cc	_	_
11	the	_	DET	DT	_	12	det	_	_
12	dose	_	NOUN	NN	_	16	nsubj	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	TCA	_	NOUN	NN	_	12	nmod	_	_
15	may	_	VERB	MD	_	16	aux	_	_
16	need	_	VERB	VB	_	5	conj	_	_
17	to	_	PRT	TO	_	19	mark	_	_
18	be	_	VERB	VB	_	19	auxpass	_	_
19	reduced	_	VERB	VBN	_	16	xcomp	_	_
20	,	_	.	,	_	19	punct	_	_
21	if	_	ADP	IN	_	26	mark	_	_
22	a	_	DET	DT	_	23	det	_	_
23	TCA	_	NOUN	NN	_	26	nsubjpass	_	_
24	is	_	VERB	VBZ	_	26	auxpass	_	_
25	co	_	PRT	TO	_	26	mark	_	_
26	administered	_	VERB	VBN	_	19	advcl	_	_
27	with	_	ADP	IN	_	28	case	_	_
28	DRUG	_	NOUN	NN	_	26	nmod	_	_

#	Sertraline Hydrochloride	1530
1	Hypoglycemic	_	ADJ	JJ	_	2	amod	_	_
2	Drugs	_	NOUN	NNS	_	0	root	_	_
3	In	_	ADP	IN	_	5	case	_	_
4	a	_	DET	DT	_	5	det	_	_
5	placebo	_	NOUN	NN	_	2	nmod	_	_
6	controlled	_	VERB	VBD	_	5	acl	_	_
7	trial	_	ADJ	JJ	_	6	xcomp	_	_
8	in	_	ADP	IN	_	10	case	_	_
9	normal	_	ADJ	JJ	_	10	amod	_	_
10	volunteers	_	NOUN	NNS	_	7	nmod	_	_
11	,	_	.	,	_	2	punct	_	_
12	administration	_	NOUN	NN	_	2	appos	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	DRUG	_	NOUN	NN	_	12	nmod	_	_
15	for	_	ADP	IN	_	17	case	_	_
16	22	_	NUM	CD	_	17	nummod	_	_
17	days	_	NOUN	NNS	_	12	nmod	_	_
18	including	_	ADP	IN	_	20	case	_	_
19	200	_	NUM	CD	_	20	nummod	_	_
20	mg	_	NOUN	NN	_	17	nmod	_	_
21	/	_	.	:	_	2	punct	_	_
22	day	_	NOUN	NN	_	28	nsubj	_	_
23	for	_	ADP	IN	_	27	case	_	_
24	the	_	DET	DT	_	27	det	_	_
25	final	_	ADJ	JJ	_	27	amod	_	_
26	13	_	NUM	CD	_	27	nummod	_	_
27	days	_	NOUN	NNS	_	22	nmod	_	_
28	caused	_	VERB	VBD	_	2	dep	_	_
29	a	_	DET	DT	_	33	det	_	_
30	statistically	_	ADV	RB	_	31	advmod	_	_
31	significant	_	ADJ	JJ	_	33	amod	_	_
32	16%	_	ADJ	JJ	_	33	amod	_	_
33	decrease	_	NOUN	NN	_	28	dobj	_	_
34	from	_	ADP	IN	_	35	case	_	_
35	baseline	_	NOUN	NN	_	33	nmod	_	_
36	in	_	ADP	IN	_	38	case	_	_
37	the	_	DET	DT	_	38	det	_	_
38	clearance	_	NOUN	NN	_	33	nmod	_	_
39	of	_	ADP	IN	_	40	case	_	_
40	tolbutamide	_	NOUN	NN	_	38	nmod	_	_
41	following	_	ADP	IN	_	46	case	_	_
42	an	_	DET	DT	_	46	det	_	_
43	intravenous	_	ADJ	JJ	_	46	amod	_	_
44	1000	_	NUM	CD	_	46	nummod	_	_
45	mg	_	NOUN	NN	_	46	compound	_	_
46	dose	_	NOUN	NN	_	38	nmod	_	_

#	Sertraline Hydrochloride	1531
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	administration	_	NOUN	NN	_	6	nsubj	_	_
3	did	_	VERB	VBD	_	6	aux	_	_
4	not	_	ADV	RB	_	6	neg	_	_
5	noticeably	_	ADV	RB	_	6	advmod	_	_
6	change	_	VERB	VB	_	0	root	_	_
7	either	_	CONJ	CC	_	11	cc:preconj	_	_
8	the	_	DET	DT	_	11	det	_	_
9	plasma	_	NOUN	NN	_	11	compound	_	_
10	protein	_	NOUN	NN	_	11	compound	_	_
11	binding	_	NOUN	NN	_	6	dobj	_	_
12	or	_	CONJ	CC	_	11	cc	_	_
13	the	_	DET	DT	_	15	det	_	_
14	apparent	_	ADJ	JJ	_	15	amod	_	_
15	volume	_	NOUN	NN	_	11	conj	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	distribution	_	NOUN	NN	_	15	nmod	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	tolbutamide	_	NOUN	NN	_	17	nmod	_	_
20	,	_	.	,	_	6	punct	_	_
21	suggesting	_	VERB	VBG	_	6	advcl	_	_
22	that	_	ADP	IN	_	30	mark	_	_
23	the	_	DET	DT	_	25	det	_	_
24	decreased	_	VERB	VBN	_	25	amod	_	_
25	clearance	_	NOUN	NN	_	30	nsubj	_	_
26	was	_	VERB	VBD	_	30	cop	_	_
27	due	_	ADJ	JJ	_	30	case	_	_
28	to	_	PRT	TO	_	27	mwe	_	_
29	a	_	DET	DT	_	30	det	_	_
30	change	_	NOUN	NN	_	21	ccomp	_	_
31	in	_	ADP	IN	_	33	case	_	_
32	the	_	DET	DT	_	33	det	_	_
33	metabolism	_	NOUN	NN	_	30	nmod	_	_
34	of	_	ADP	IN	_	36	case	_	_
35	the	_	DET	DT	_	36	det	_	_
36	drug	_	NOUN	NN	_	33	nmod	_	_

#	Sertraline Hydrochloride	1532
1	The	_	DET	DT	_	3	det	_	_
2	clinical	_	ADJ	JJ	_	3	amod	_	_
3	significance	_	NOUN	NN	_	11	nsubj	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	this	_	DET	DT	_	6	det	_	_
6	decrease	_	NOUN	NN	_	3	nmod	_	_
7	in	_	ADP	IN	_	9	case	_	_
8	tolbutamide	_	NOUN	NN	_	9	compound	_	_
9	clearance	_	NOUN	NN	_	6	nmod	_	_
10	is	_	VERB	VBZ	_	11	auxpass	_	_
11	unknown	_	ADJ	JJ	_	0	root	_	_

#	Sertraline Hydrochloride	1533
1	Atenolol	_	NOUN	NN	_	4	compound	_	_
2	DRUG	_	NOUN	NN	_	4	compound	_	_
3	100	_	NUM	CD	_	4	nummod	_	_
4	mg	_	NOUN	NN	_	12	nsubj	_	_
5	when	_	ADV	WRB	_	6	advmod	_	_
6	administered	_	VERB	VBN	_	4	acl	_	_
7	to	_	PRT	TO	_	11	case	_	_
8	10	_	NUM	CD	_	11	nummod	_	_
9	healthy	_	ADJ	JJ	_	11	amod	_	_
10	male	_	ADJ	JJ	_	11	amod	_	_
11	subjects	_	NOUN	NNS	_	6	nmod	_	_
12	had	_	VERB	VBD	_	0	root	_	_
13	no	_	DET	DT	_	14	neg	_	_
14	effect	_	NOUN	NN	_	12	dobj	_	_
15	on	_	ADP	IN	_	20	case	_	_
16	the	_	DET	DT	_	20	det	_	_
17	beta	_	NOUN	NN	_	20	compound	_	_
18	adrenergic	_	ADJ	JJ	_	20	amod	_	_
19	blocking	_	NOUN	NN	_	20	amod	_	_
20	ability	_	NOUN	NN	_	14	nmod	_	_
21	of	_	ADP	IN	_	22	case	_	_
22	atenolol	_	NOUN	NN	_	20	nmod	_	_

#	Sertraline Hydrochloride	1534
1	Digoxin	_	NOUN	NN	_	0	root	_	_
2	In	_	ADP	IN	_	4	case	_	_
3	a	_	DET	DT	_	4	det	_	_
4	placebo	_	NOUN	NN	_	1	nmod	_	_
5	controlled	_	VERB	VBD	_	4	acl	_	_
6	trial	_	ADJ	JJ	_	5	xcomp	_	_
7	in	_	ADP	IN	_	9	case	_	_
8	normal	_	ADJ	JJ	_	9	amod	_	_
9	volunteers	_	NOUN	NNS	_	6	nmod	_	_
10	,	_	.	,	_	1	punct	_	_
11	administration	_	NOUN	NN	_	1	appos	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	DRUG	_	NOUN	NN	_	11	nmod	_	_
14	for	_	ADP	IN	_	16	case	_	_
15	17	_	NUM	CD	_	16	nummod	_	_
16	days	_	NOUN	NNS	_	11	nmod	_	_
17	including	_	ADP	IN	_	19	case	_	_
18	200	_	NUM	CD	_	19	nummod	_	_
19	mg	_	NOUN	NN	_	16	nmod	_	_
20	/	_	.	:	_	1	punct	_	_
21	day	_	NOUN	NN	_	29	nsubj	_	_
22	for	_	ADP	IN	_	26	case	_	_
23	the	_	DET	DT	_	26	det	_	_
24	last	_	ADJ	JJ	_	26	amod	_	_
25	10	_	NUM	CD	_	26	nummod	_	_
26	days	_	NOUN	NNS	_	21	nmod	_	_
27	did	_	VERB	VBD	_	29	aux	_	_
28	not	_	ADV	RB	_	29	neg	_	_
29	change	_	VERB	VB	_	1	dep	_	_
30	serum	_	NOUN	NN	_	32	compound	_	_
31	digoxin	_	NOUN	NN	_	32	compound	_	_
32	levels	_	NOUN	NNS	_	29	dobj	_	_
33	or	_	CONJ	CC	_	32	cc	_	_
34	digoxin	_	NOUN	NN	_	36	compound	_	_
35	renal	_	ADJ	JJ	_	36	amod	_	_
36	clearance	_	NOUN	NN	_	32	conj	_	_

#	Sertraline Hydrochloride	1535
1	Microsomal	_	ADJ	JJ	_	5	amod	_	_
2	Enzyme	_	NOUN	NN	_	5	compound	_	_
3	Induction	_	NOUN	NN	_	5	compound	_	_
4	Preclinical	_	ADJ	JJ	_	5	amod	_	_
5	studies	_	NOUN	NNS	_	7	nsubj	_	_
6	have	_	VERB	VBP	_	7	aux	_	_
7	shown	_	VERB	VBN	_	0	root	_	_
8	DRUG	_	NOUN	NN	_	7	dobj	_	_
9	to	_	PRT	TO	_	10	mark	_	_
10	induce	_	VERB	VB	_	7	xcomp	_	_
11	hepatic	_	ADJ	JJ	_	13	amod	_	_
12	microsomal	_	ADJ	JJ	_	13	amod	_	_
13	enzymes	_	NOUN	NNS	_	10	dobj	_	_

#	Sertraline Hydrochloride	1536
1	In	_	ADP	IN	_	3	case	_	_
2	clinical	_	ADJ	JJ	_	3	amod	_	_
3	studies	_	NOUN	NNS	_	7	nmod	_	_
4	,	_	.	,	_	7	punct	_	_
5	DRUG	_	NOUN	NN	_	7	nsubjpass	_	_
6	was	_	VERB	VBD	_	7	auxpass	_	_
7	shown	_	VERB	VBN	_	0	root	_	_
8	to	_	PRT	TO	_	9	mark	_	_
9	induce	_	VERB	VB	_	7	xcomp	_	_
10	hepatic	_	ADJ	JJ	_	11	amod	_	_
11	enzymes	_	NOUN	NNS	_	9	dobj	_	_
12	minimally	_	ADV	RB	_	9	advmod	_	_
13	as	_	ADP	IN	_	14	mark	_	_
14	determined	_	VERB	VBN	_	9	advcl	_	_
15	by	_	ADP	IN	_	18	case	_	_
16	a	_	DET	DT	_	18	det	_	_
17	small	_	ADJ	JJ	_	18	amod	_	_
18	5%	_	ADJ	JJ	_	14	nmod	_	_
19	but	_	CONJ	CC	_	14	cc	_	_
20	statistically	_	ADV	RB	_	21	advmod	_	_
21	significant	_	ADJ	JJ	_	22	amod	_	_
22	decrease	_	NOUN	NN	_	14	conj	_	_
23	in	_	ADP	IN	_	26	case	_	_
24	antipyrine	_	NOUN	NN	_	26	compound	_	_
25	half	_	NOUN	NN	_	26	compound	_	_
26	life	_	NOUN	NN	_	22	nmod	_	_
27	following	_	ADP	IN	_	28	case	_	_
28	administration	_	NOUN	NN	_	22	nmod	_	_
29	of	_	ADP	IN	_	31	case	_	_
30	200	_	NUM	CD	_	31	nummod	_	_
31	mg	_	NOUN	NN	_	28	nmod	_	_
32	/	_	.	:	_	14	punct	_	_
33	day	_	NOUN	NN	_	14	dep	_	_
34	for	_	ADP	IN	_	36	case	_	_
35	21	_	NUM	CD	_	36	nummod	_	_
36	days	_	NOUN	NNS	_	33	nmod	_	_

#	Sertraline Hydrochloride	1537
1	This	_	DET	DT	_	3	det	_	_
2	small	_	ADJ	JJ	_	3	amod	_	_
3	change	_	NOUN	NN	_	8	nsubj	_	_
4	in	_	ADP	IN	_	7	case	_	_
5	antipyrine	_	NOUN	NN	_	7	compound	_	_
6	half	_	NOUN	NN	_	7	compound	_	_
7	life	_	NOUN	NN	_	3	nmod	_	_
8	reflects	_	VERB	VBZ	_	0	root	_	_
9	a	_	DET	DT	_	12	det	_	_
10	clinically	_	ADV	RB	_	11	advmod	_	_
11	insignificant	_	ADJ	JJ	_	12	amod	_	_
12	change	_	NOUN	NN	_	8	dobj	_	_
13	in	_	ADP	IN	_	15	case	_	_
14	hepatic	_	ADJ	JJ	_	15	amod	_	_
15	metabolism	_	NOUN	NN	_	12	nmod	_	_

#	Sertraline Hydrochloride	1538
1	Drugs	_	NOUN	NNS	_	0	root	_	_
2	That	_	DET	WDT	_	3	nsubj	_	_
3	Interfere	_	VERB	VBP	_	1	acl:relcl	_	_
4	With	_	ADP	IN	_	8	case	_	_
5	Hemostasis	_	NOUN	NN	_	8	compound	_	_
6	Non	_	NOUN	NN	_	8	compound	_	_
7	selective	_	ADJ	JJ	_	8	amod	_	_
8	NSAIDs	_	NOUN	NNS	_	3	nmod	_	_
9	,	_	.	,	_	8	punct	_	_
10	Aspirin	_	NOUN	NN	_	8	appos	_	_
11	,	_	.	,	_	10	punct	_	_
12	Warfarin	_	NOUN	NN	_	10	conj	_	_
13	,	_	.	,	_	10	punct	_	_
14	etc	_	NOUN	NN	_	10	appos	_	_

#	Sertraline Hydrochloride	1539
1	Serotonin	_	NOUN	NN	_	2	compound	_	_
2	release	_	NOUN	NN	_	5	nsubj	_	_
3	by	_	ADP	IN	_	4	case	_	_
4	platelets	_	NOUN	NNS	_	2	nmod	_	_
5	plays	_	VERB	VBZ	_	0	root	_	_
6	an	_	DET	DT	_	8	det	_	_
7	important	_	ADJ	JJ	_	8	amod	_	_
8	role	_	NOUN	NN	_	5	dobj	_	_
9	in	_	ADP	IN	_	10	case	_	_
10	hemostasis	_	NOUN	NN	_	8	nmod	_	_

#	Sertraline Hydrochloride	1540
1	Epidemiological	_	ADJ	JJ	_	2	amod	_	_
2	studies	_	NOUN	NNS	_	0	root	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	the	_	DET	DT	_	6	det	_	_
5	case	_	NOUN	NN	_	6	compound	_	_
6	control	_	NOUN	NN	_	2	nmod	_	_
7	and	_	CONJ	CC	_	2	cc	_	_
8	cohort	_	NOUN	NN	_	2	conj	_	_
9	design	_	NOUN	NN	_	8	dobj	_	_
10	that	_	DET	WDT	_	12	nsubj	_	_
11	have	_	VERB	VBP	_	12	aux	_	_
12	demonstrated	_	VERB	VBN	_	9	dep	_	_
13	an	_	DET	DT	_	14	det	_	_
14	association	_	NOUN	NN	_	12	dobj	_	_
15	between	_	ADP	IN	_	16	case	_	_
16	use	_	NOUN	NN	_	14	nmod	_	_
17	of	_	ADP	IN	_	19	case	_	_
18	psychotropic	_	ADJ	JJ	_	19	amod	_	_
19	drugs	_	NOUN	NNS	_	16	nmod	_	_
20	that	_	DET	WDT	_	21	nsubj	_	_
21	interfere	_	VERB	VBP	_	19	acl:relcl	_	_
22	with	_	ADP	IN	_	24	case	_	_
23	serotonin	_	NOUN	NN	_	24	compound	_	_
24	reuptake	_	NOUN	NN	_	21	nmod	_	_
25	and	_	CONJ	CC	_	21	cc	_	_
26	the	_	DET	DT	_	27	det	_	_
27	occurrence	_	NOUN	NN	_	34	nsubj	_	_
28	of	_	ADP	IN	_	31	case	_	_
29	upper	_	VERB	VBG	_	31	amod	_	_
30	gastrointestinal	_	ADJ	JJ	_	31	amod	_	_
31	bleeding	_	NOUN	NN	_	27	nmod	_	_
32	have	_	VERB	MD	_	34	aux	_	_
33	also	_	ADV	RB	_	34	advmod	_	_
34	shown	_	VERB	VBN	_	21	conj	_	_
35	that	_	ADP	IN	_	44	mark	_	_
36	concurrent	_	ADJ	JJ	_	37	amod	_	_
37	use	_	NOUN	NN	_	44	nsubj	_	_
38	of	_	ADP	IN	_	40	case	_	_
39	an	_	DET	DT	_	40	det	_	_
40	NSAID	_	NOUN	NN	_	37	nmod	_	_
41	or	_	CONJ	CC	_	40	cc	_	_
42	aspirin	_	NOUN	NN	_	40	conj	_	_
43	may	_	VERB	MD	_	44	aux	_	_
44	potentiate	_	VERB	VB	_	34	ccomp	_	_
45	this	_	DET	DT	_	46	det	_	_
46	risk	_	NOUN	NN	_	44	dobj	_	_
47	of	_	ADP	IN	_	48	mark	_	_
48	bleeding	_	VERB	VBG	_	46	nmod	_	_

#	Sertraline Hydrochloride	1541
1	Altered	_	VERB	VBN	_	3	amod	_	_
2	anticoagulant	_	ADJ	JJ	_	3	amod	_	_
3	effects	_	NOUN	NNS	_	11	nsubjpass	_	_
4	,	_	.	,	_	3	punct	_	_
5	including	_	VERB	VBG	_	7	case	_	_
6	increased	_	VERB	VBN	_	7	amod	_	_
7	bleeding	_	NOUN	NN	_	3	nmod	_	_
8	,	_	.	,	_	3	punct	_	_
9	have	_	VERB	VBP	_	11	aux	_	_
10	been	_	VERB	VBN	_	11	auxpass	_	_
11	reported	_	VERB	VBN	_	0	root	_	_
12	when	_	ADV	WRB	_	17	advmod	_	_
13	SSRIs	_	NOUN	NNS	_	17	nsubjpass	_	_
14	or	_	CONJ	CC	_	13	cc	_	_
15	SNRIs	_	NOUN	NNS	_	13	conj	_	_
16	are	_	VERB	VBP	_	17	auxpass	_	_
17	coadministered	_	VERB	VBN	_	11	advcl	_	_
18	with	_	ADP	IN	_	19	case	_	_
19	warfarin	_	NOUN	NN	_	17	nmod	_	_

#	Sertraline Hydrochloride	1542
1	Patients	_	NOUN	NNS	_	8	nsubjpass	_	_
2	receiving	_	VERB	VBG	_	1	acl	_	_
3	warfarin	_	NOUN	NN	_	4	compound	_	_
4	therapy	_	NOUN	NN	_	2	dobj	_	_
5	should	_	VERB	MD	_	8	aux	_	_
6	be	_	VERB	VB	_	8	auxpass	_	_
7	carefully	_	ADV	RB	_	8	advmod	_	_
8	monitored	_	VERB	VBN	_	0	root	_	_
9	when	_	ADV	WRB	_	12	advmod	_	_
10	DRUG	_	NOUN	NN	_	12	nsubjpass	_	_
11	is	_	VERB	VBZ	_	12	auxpass	_	_
12	initiated	_	VERB	VBN	_	8	ccomp	_	_
13	or	_	CONJ	CC	_	12	cc	_	_
14	discontinued	_	VERB	VBN	_	12	conj	_	_

#	Sertraline Hydrochloride	1543
1	Electroconvulsive	_	ADJ	JJ	_	2	amod	_	_
2	Therapy	_	NOUN	NN	_	7	nsubj	_	_
3	There	_	NUM	CD	_	2	nummod	_	_
4	are	_	VERB	VBP	_	7	cop	_	_
5	no	_	DET	DT	_	7	neg	_	_
6	clinical	_	ADJ	JJ	_	7	amod	_	_
7	studies	_	NOUN	NNS	_	0	root	_	_
8	establishing	_	VERB	VBG	_	7	acl	_	_
9	the	_	DET	DT	_	10	det	_	_
10	risks	_	NOUN	NNS	_	8	dobj	_	_
11	or	_	CONJ	CC	_	8	cc	_	_
12	benefits	_	NOUN	NNS	_	8	conj	_	_
13	of	_	ADP	IN	_	16	case	_	_
14	the	_	DET	DT	_	16	det	_	_
15	combined	_	ADJ	JJ	_	16	amod	_	_
16	use	_	NOUN	NN	_	12	nmod	_	_
17	of	_	ADP	IN	_	20	case	_	_
18	electroconvulsive	_	ADJ	JJ	_	20	amod	_	_
19	therapy	_	NOUN	NN	_	20	compound	_	_
20	ECT	_	NOUN	NN	_	16	nmod	_	_
21	and	_	CONJ	CC	_	20	cc	_	_
22	DRUG	_	NOUN	NN	_	20	conj	_	_

#	Sertraline Hydrochloride	1544
1	Alcohol	_	NOUN	NN	_	29	nsubjpass	_	_
2	Although	_	ADP	IN	_	6	mark	_	_
3	DRUG	_	NOUN	NN	_	6	nsubj	_	_
4	did	_	VERB	VBD	_	6	aux	_	_
5	not	_	ADV	RB	_	6	neg	_	_
6	potentiate	_	VERB	VB	_	1	acl:relcl	_	_
7	the	_	DET	DT	_	11	det	_	_
8	cognitive	_	ADJ	JJ	_	11	amod	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	psychomotor	_	NOUN	NN	_	8	conj	_	_
11	effects	_	NOUN	NNS	_	6	dobj	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	alcohol	_	NOUN	NN	_	11	nmod	_	_
14	in	_	ADP	IN	_	15	case	_	_
15	experiments	_	NOUN	NNS	_	11	nmod	_	_
16	with	_	ADP	IN	_	18	case	_	_
17	normal	_	ADJ	JJ	_	18	amod	_	_
18	subjects	_	NOUN	NNS	_	15	nmod	_	_
19	,	_	.	,	_	29	punct	_	_
20	the	_	DET	DT	_	22	det	_	_
21	concomitant	_	ADJ	JJ	_	22	amod	_	_
22	use	_	NOUN	NN	_	29	nsubjpass	_	_
23	of	_	ADP	IN	_	24	case	_	_
24	DRUG	_	NOUN	NN	_	22	nmod	_	_
25	and	_	CONJ	CC	_	24	cc	_	_
26	alcohol	_	NOUN	NN	_	24	conj	_	_
27	is	_	VERB	VBZ	_	29	auxpass	_	_
28	not	_	ADV	RB	_	29	neg	_	_
29	recommended	_	VERB	VBN	_	0	root	_	_

#	Sertraline Hydrochloride	1545
1	The	_	DET	DT	_	2	det	_	_
2	mechanism	_	NOUN	NN	_	8	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	action	_	NOUN	NN	_	2	nmod	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	is	_	VERB	VBZ	_	8	auxpass	_	_
8	presumed	_	VERB	VBN	_	0	root	_	_
9	to	_	PRT	TO	_	11	mark	_	_
10	be	_	VERB	VB	_	11	auxpass	_	_
11	linked	_	VERB	VBN	_	8	xcomp	_	_
12	to	_	PRT	TO	_	14	case	_	_
13	its	_	PRON	PRP$	_	14	nmod:poss	_	_
14	inhibition	_	NOUN	NN	_	11	nmod	_	_
15	of	_	ADP	IN	_	18	case	_	_
16	CNS	_	NOUN	NN	_	18	compound	_	_
17	neuronal	_	ADJ	JJ	_	18	amod	_	_
18	uptake	_	NOUN	NN	_	14	nmod	_	_
19	of	_	ADP	IN	_	21	case	_	_
20	serotonin	_	NOUN	NN	_	21	compound	_	_
21	5HT	_	NOUN	NN	_	18	nmod	_	_

#	Sertraline Hydrochloride	1546
1	Studies	_	NOUN	NNS	_	9	nsubj	_	_
2	at	_	ADP	IN	_	5	case	_	_
3	clinically	_	ADV	RB	_	4	advmod	_	_
4	relevant	_	ADJ	JJ	_	5	amod	_	_
5	doses	_	NOUN	NNS	_	1	nmod	_	_
6	in	_	ADP	IN	_	7	compound	_	_
7	man	_	VERB	MD	_	9	aux	_	_
8	have	_	VERB	VB	_	9	aux	_	_
9	demonstrated	_	VERB	VBN	_	0	root	_	_
10	that	_	ADP	IN	_	12	mark	_	_
11	DRUG	_	NOUN	NN	_	12	nsubj	_	_
12	blocks	_	VERB	VBZ	_	9	ccomp	_	_
13	the	_	DET	DT	_	14	det	_	_
14	uptake	_	NOUN	NN	_	12	dobj	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	serotonin	_	NOUN	NN	_	14	nmod	_	_
17	into	_	ADP	IN	_	19	case	_	_
18	human	_	ADJ	JJ	_	19	amod	_	_
19	platelets	_	NOUN	NNS	_	14	nmod	_	_

#	Sertraline Hydrochloride	1547
1	In	_	X	FW	_	3	amod	_	_
2	vitro	_	X	FW	_	1	dep	_	_
3	studies	_	NOUN	NNS	_	7	nsubj	_	_
4	in	_	ADP	IN	_	5	case	_	_
5	animals	_	NOUN	NNS	_	3	nmod	_	_
6	also	_	ADV	RB	_	7	advmod	_	_
7	suggest	_	VERB	VBP	_	0	root	_	_
8	that	_	ADP	IN	_	15	mark	_	_
9	DRUG	_	NOUN	NN	_	15	nsubj	_	_
10	is	_	VERB	VBZ	_	15	cop	_	_
11	a	_	DET	DT	_	15	det	_	_
12	potent	_	ADJ	JJ	_	15	amod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	selective	_	ADJ	JJ	_	12	conj	_	_
15	inhibitor	_	NOUN	NN	_	7	ccomp	_	_
16	of	_	ADP	IN	_	19	case	_	_
17	neuronal	_	ADJ	JJ	_	19	amod	_	_
18	serotonin	_	NOUN	NN	_	19	compound	_	_
19	reuptake	_	NOUN	NN	_	15	nmod	_	_
20	and	_	CONJ	CC	_	15	cc	_	_
21	has	_	VERB	VBZ	_	15	conj	_	_
22	only	_	ADV	RB	_	23	advmod	_	_
23	very	_	ADV	RB	_	24	advmod	_	_
24	weak	_	ADJ	JJ	_	25	amod	_	_
25	effects	_	NOUN	NNS	_	21	dobj	_	_
26	on	_	ADP	IN	_	27	case	_	_
27	norepinephrine	_	NOUN	NN	_	25	nmod	_	_
28	and	_	CONJ	CC	_	27	cc	_	_
29	dopamine	_	NOUN	NN	_	31	compound	_	_
30	neuronal	_	ADJ	JJ	_	31	amod	_	_
31	reuptake	_	NOUN	NN	_	27	conj	_	_

#	Sertraline Hydrochloride	1548
1	In	_	X	FW	_	3	amod	_	_
2	vitro	_	X	FW	_	1	dep	_	_
3	studies	_	NOUN	NNS	_	5	nsubj	_	_
4	have	_	VERB	VBP	_	5	aux	_	_
5	shown	_	VERB	VBN	_	0	root	_	_
6	that	_	ADP	IN	_	8	mark	_	_
7	DRUG	_	NOUN	NN	_	8	nsubj	_	_
8	has	_	VERB	VBZ	_	5	ccomp	_	_
9	no	_	DET	DT	_	11	neg	_	_
10	significant	_	ADJ	JJ	_	11	amod	_	_
11	affinity	_	NOUN	NN	_	8	dobj	_	_
12	for	_	ADP	IN	_	14	case	_	_
13	adrenergic	_	ADJ	JJ	_	14	amod	_	_
14	alpha1	_	NOUN	NN	_	11	nmod	_	_
15	,	_	.	,	_	14	punct	_	_
16	alpha2	_	NOUN	NN	_	14	conj	_	_
17	,	_	.	,	_	14	punct	_	_
18	beta	_	NOUN	NN	_	14	conj	_	_
19	,	_	.	,	_	14	punct	_	_
20	cholinergic	_	ADJ	JJ	_	14	conj	_	_
21	,	_	.	,	_	14	punct	_	_
22	GABA	_	NOUN	NN	_	14	conj	_	_
23	,	_	.	,	_	14	punct	_	_
24	dopaminergic	_	ADJ	JJ	_	14	conj	_	_
25	,	_	.	,	_	14	punct	_	_
26	histaminergic	_	ADJ	JJ	_	14	conj	_	_
27	,	_	.	,	_	14	punct	_	_
28	serotonergic	_	ADJ	JJ	_	29	amod	_	_
29	5HT1A	_	NOUN	NN	_	14	conj	_	_
30	,	_	.	,	_	14	punct	_	_
31	5HT1B	_	NOUN	NN	_	14	conj	_	_
32	,	_	.	,	_	14	punct	_	_
33	5HT2	_	NOUN	NN	_	14	conj	_	_
34	,	_	.	,	_	14	punct	_	_
35	or	_	CONJ	CC	_	14	cc	_	_
36	benzodiazepine	_	NOUN	NN	_	37	compound	_	_
37	receptors	_	NOUN	NNS	_	14	conj	_	_
38	antagonism	_	NOUN	NN	_	14	dep	_	_
39	of	_	ADP	IN	_	41	case	_	_
40	such	_	ADJ	JJ	_	41	amod	_	_
41	receptors	_	NOUN	NNS	_	14	nmod	_	_
42	has	_	VERB	VBZ	_	44	aux	_	_
43	been	_	VERB	VBN	_	44	auxpass	_	_
44	hypothesized	_	VERB	VBN	_	8	parataxis	_	_
45	to	_	PRT	TO	_	47	mark	_	_
46	be	_	VERB	VB	_	47	auxpass	_	_
47	associated	_	VERB	VBN	_	44	xcomp	_	_
48	with	_	ADP	IN	_	50	case	_	_
49	various	_	ADJ	JJ	_	50	amod	_	_
50	anticholinergic	_	ADJ	JJ	_	47	nmod	_	_
51	,	_	.	,	_	50	punct	_	_
52	sedative	_	ADJ	JJ	_	50	conj	_	_
53	,	_	.	,	_	50	punct	_	_
54	and	_	CONJ	CC	_	50	cc	_	_
55	cardiovascular	_	ADJ	JJ	_	50	conj	_	_
56	effects	_	NOUN	NNS	_	50	dep	_	_
57	for	_	ADP	IN	_	60	case	_	_
58	other	_	ADJ	JJ	_	60	amod	_	_
59	psychotropic	_	ADJ	JJ	_	60	amod	_	_
60	drugs	_	NOUN	NNS	_	50	nmod	_	_

#	Sertraline Hydrochloride	1549
1	The	_	DET	DT	_	3	det	_	_
2	chronic	_	ADJ	JJ	_	3	amod	_	_
3	administration	_	NOUN	NN	_	7	nsubjpass	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	was	_	VERB	VBD	_	7	auxpass	_	_
7	found	_	VERB	VBN	_	0	root	_	_
8	in	_	ADP	IN	_	9	case	_	_
9	animals	_	NOUN	NNS	_	7	nmod	_	_
10	to	_	PRT	TO	_	12	mark	_	_
11	down	_	ADV	RB	_	12	advmod	_	_
12	regulate	_	VERB	VB	_	7	xcomp	_	_
13	brain	_	NOUN	NN	_	15	compound	_	_
14	norepinephrine	_	NOUN	NN	_	15	compound	_	_
15	receptors	_	NOUN	NNS	_	12	dobj	_	_
16	,	_	.	,	_	7	punct	_	_
17	as	_	ADP	IN	_	20	mark	_	_
18	has	_	VERB	VBZ	_	20	aux	_	_
19	been	_	VERB	VBN	_	20	auxpass	_	_
20	observed	_	VERB	VBN	_	7	advcl	_	_
21	with	_	ADP	IN	_	23	case	_	_
22	other	_	ADJ	JJ	_	23	amod	_	_
23	drugs	_	NOUN	NNS	_	20	nmod	_	_
24	effective	_	ADJ	JJ	_	23	amod	_	_
25	in	_	ADP	IN	_	27	case	_	_
26	the	_	DET	DT	_	27	det	_	_
27	treatment	_	NOUN	NN	_	24	nmod	_	_
28	of	_	ADP	IN	_	31	case	_	_
29	major	_	ADJ	JJ	_	31	amod	_	_
30	depressive	_	ADJ	JJ	_	31	amod	_	_
31	disorder	_	NOUN	NN	_	27	nmod	_	_

#	Sertraline Hydrochloride	1550
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	does	_	VERB	VBZ	_	4	aux	_	_
3	not	_	ADV	RB	_	4	neg	_	_
4	inhibit	_	VERB	VB	_	0	root	_	_
5	monoamine	_	NOUN	NN	_	6	compound	_	_
6	oxidase	_	NOUN	NN	_	4	dobj	_	_

#	Sertraline Hydrochloride	1551
1	Systemic	_	ADJ	JJ	_	2	amod	_	_
2	Bioavailability	_	NOUN	NN	_	0	root	_	_
3	In	_	ADP	IN	_	4	compound	_	_
4	man	_	VERB	MD	_	2	advmod	_	_
5	,	_	.	,	_	2	punct	_	_
6	following	_	VERB	VBG	_	10	mark	_	_
7	oral	_	ADJ	JJ	_	10	amod	_	_
8	once	_	ADV	RB	_	9	advmod	_	_
9	daily	_	ADV	RB	_	10	advmod	_	_
10	dosing	_	VERB	VBG	_	2	acl	_	_
11	over	_	ADP	IN	_	13	case	_	_
12	the	_	DET	DT	_	13	det	_	_
13	range	_	NOUN	NN	_	10	nmod	_	_
14	of	_	ADP	IN	_	18	case	_	_
15	50	_	NUM	CD	_	17	compound	_	_
16	to	_	PRT	TO	_	17	dep	_	_
17	200	_	NUM	CD	_	18	nummod	_	_
18	mg	_	NOUN	NN	_	13	nmod	_	_
19	for	_	ADP	IN	_	21	case	_	_
20	14	_	NUM	CD	_	21	nummod	_	_
21	days	_	NOUN	NNS	_	13	nmod	_	_
22	,	_	.	,	_	2	punct	_	_
23	mean	_	ADJ	JJ	_	26	compound	_	_
24	peak	_	ADJ	JJ	_	26	amod	_	_
25	plasma	_	NOUN	NN	_	26	compound	_	_
26	concentrations	_	NOUN	NNS	_	30	nsubj	_	_
27	Cmax	_	NOUN	NN	_	26	dep	_	_
28	of	_	ADP	IN	_	29	case	_	_
29	DRUG	_	NOUN	NN	_	27	nmod	_	_
30	occurred	_	VERB	VBD	_	2	dep	_	_
31	between	_	ADP	IN	_	35	case	_	_
32	4.5	_	NUM	CD	_	34	compound	_	_
33	to	_	PRT	TO	_	34	dep	_	_
34	8.4	_	NUM	CD	_	35	nummod	_	_
35	hours	_	NOUN	NNS	_	30	nmod	_	_
36	post	_	ADJ	JJ	_	35	acl	_	_
37	dosing	_	VERB	VBG	_	36	advcl	_	_

#	Sertraline Hydrochloride	1552
1	The	_	DET	DT	_	6	det	_	_
2	average	_	ADJ	JJ	_	6	amod	_	_
3	terminal	_	ADJ	JJ	_	6	amod	_	_
4	elimination	_	NOUN	NN	_	6	compound	_	_
5	half	_	NOUN	NN	_	6	compound	_	_
6	life	_	NOUN	NN	_	13	nsubj	_	_
7	of	_	ADP	IN	_	9	case	_	_
8	plasma	_	NOUN	NN	_	9	compound	_	_
9	DRUG	_	NOUN	NN	_	6	nmod	_	_
10	is	_	VERB	VBZ	_	13	cop	_	_
11	about	_	ADV	RB	_	12	advmod	_	_
12	26	_	NUM	CD	_	13	nummod	_	_
13	hours	_	NOUN	NNS	_	0	root	_	_

#	Sertraline Hydrochloride	1553
1	Based	_	VERB	VBN	_	14	advcl	_	_
2	on	_	ADP	IN	_	5	case	_	_
3	this	_	DET	DT	_	5	det	_	_
4	pharmacokinetic	_	ADJ	JJ	_	5	amod	_	_
5	parameter	_	NOUN	NN	_	1	nmod	_	_
6	,	_	.	,	_	14	punct	_	_
7	steady	_	ADJ	JJ	_	11	amod	_	_
8	state	_	NOUN	NN	_	11	compound	_	_
9	DRUG	_	NOUN	NN	_	11	compound	_	_
10	plasma	_	NOUN	NN	_	11	compound	_	_
11	levels	_	NOUN	NNS	_	14	nsubjpass	_	_
12	should	_	VERB	MD	_	14	aux	_	_
13	be	_	VERB	VB	_	14	auxpass	_	_
14	achieved	_	VERB	VBN	_	0	root	_	_
15	after	_	ADP	IN	_	18	case	_	_
16	approximately	_	ADV	RB	_	17	advmod	_	_
17	one	_	NUM	CD	_	18	nummod	_	_
18	week	_	NOUN	NN	_	14	nmod	_	_
19	of	_	ADP	IN	_	22	mark	_	_
20	once	_	ADV	RB	_	21	advmod	_	_
21	daily	_	ADV	RB	_	22	advmod	_	_
22	dosing	_	VERB	VBG	_	18	acl	_	_

#	Sertraline Hydrochloride	1554
1	Linear	_	ADJ	JJ	_	4	amod	_	_
2	dose	_	NOUN	NN	_	4	compound	_	_
3	proportional	_	ADJ	JJ	_	4	amod	_	_
4	pharmacokinetics	_	NOUN	NNS	_	6	nsubjpass	_	_
5	were	_	VERB	VBD	_	6	auxpass	_	_
6	demonstrated	_	VERB	VBN	_	0	root	_	_
7	in	_	ADP	IN	_	11	case	_	_
8	a	_	DET	DT	_	11	det	_	_
9	single	_	ADJ	JJ	_	11	amod	_	_
10	dose	_	NOUN	NN	_	11	compound	_	_
11	study	_	NOUN	NN	_	6	nmod	_	_
12	in	_	ADP	IN	_	13	case	_	_
13	which	_	DET	WDT	_	28	nmod	_	_
14	the	_	DET	DT	_	15	det	_	_
15	Cmax	_	NOUN	NN	_	28	nsubj	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	area	_	NOUN	NN	_	15	conj	_	_
18	under	_	ADP	IN	_	24	case	_	_
19	the	_	DET	DT	_	24	det	_	_
20	plasma	_	NOUN	NN	_	24	compound	_	_
21	concentration	_	NOUN	NN	_	24	compound	_	_
22	time	_	NOUN	NN	_	24	compound	_	_
23	curve	_	ADJ	JJ	_	24	amod	_	_
24	AUC	_	NOUN	NN	_	15	nmod	_	_
25	of	_	ADP	IN	_	26	case	_	_
26	DRUG	_	NOUN	NN	_	24	nmod	_	_
27	were	_	VERB	VBD	_	28	cop	_	_
28	proportional	_	ADJ	JJ	_	11	acl:relcl	_	_
29	to	_	PRT	TO	_	30	case	_	_
30	dose	_	NOUN	NN	_	28	nmod	_	_
31	over	_	ADP	IN	_	33	case	_	_
32	a	_	DET	DT	_	33	det	_	_
33	range	_	NOUN	NN	_	28	nmod	_	_
34	of	_	ADP	IN	_	38	case	_	_
35	50	_	NUM	CD	_	37	compound	_	_
36	to	_	PRT	TO	_	37	dep	_	_
37	200	_	NUM	CD	_	38	nummod	_	_
38	mg	_	NOUN	NNS	_	33	nmod	_	_

#	Sertraline Hydrochloride	1555
1	Consistent	_	ADJ	JJ	_	10	advmod	_	_
2	with	_	ADP	IN	_	7	case	_	_
3	the	_	DET	DT	_	7	det	_	_
4	terminal	_	ADJ	JJ	_	7	amod	_	_
5	elimination	_	NOUN	NN	_	7	compound	_	_
6	half	_	NOUN	NN	_	7	compound	_	_
7	life	_	NOUN	NN	_	1	nmod	_	_
8	,	_	.	,	_	10	punct	_	_
9	there	_	DET	EX	_	10	expl	_	_
10	is	_	VERB	VBZ	_	0	root	_	_
11	an	_	DET	DT	_	15	det	_	_
12	approximately	_	ADV	RB	_	13	advmod	_	_
13	two	_	NUM	CD	_	15	nummod	_	_
14	fold	_	NOUN	NN	_	15	compound	_	_
15	accumulation	_	NOUN	NN	_	10	nsubj	_	_
16	,	_	.	,	_	10	punct	_	_
17	compared	_	VERB	VBN	_	10	conj	_	_
18	to	_	PRT	TO	_	21	case	_	_
19	a	_	DET	DT	_	21	det	_	_
20	single	_	ADJ	JJ	_	21	amod	_	_
21	dose	_	NOUN	NN	_	17	nmod	_	_
22	,	_	.	,	_	10	punct	_	_
23	of	_	ADP	IN	_	24	case	_	_
24	DRUG	_	NOUN	NN	_	10	nmod	_	_
25	with	_	ADP	IN	_	27	case	_	_
26	repeated	_	VERB	VBN	_	27	amod	_	_
27	dosing	_	NOUN	NN	_	24	nmod	_	_
28	over	_	ADP	IN	_	35	case	_	_
29	a	_	DET	DT	_	35	det	_	_
30	50	_	NUM	CD	_	32	compound	_	_
31	to	_	PRT	TO	_	32	dep	_	_
32	200	_	NUM	CD	_	35	nummod	_	_
33	mg	_	NOUN	NN	_	35	compound	_	_
34	dose	_	NOUN	NN	_	35	compound	_	_
35	range	_	NOUN	NN	_	27	nmod	_	_

#	Sertraline Hydrochloride	1556
1	The	_	DET	DT	_	4	det	_	_
2	single	_	ADJ	JJ	_	4	amod	_	_
3	dose	_	NOUN	NN	_	4	compound	_	_
4	bioavailability	_	NOUN	NN	_	10	nsubj	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	DRUG	_	NOUN	NN	_	7	compound	_	_
7	tablets	_	NOUN	NNS	_	4	nmod	_	_
8	is	_	VERB	VBZ	_	10	cop	_	_
9	approximately	_	ADV	RB	_	10	advmod	_	_
10	equal	_	ADJ	JJ	_	0	root	_	_
11	to	_	PRT	TO	_	14	case	_	_
12	an	_	DET	DT	_	14	det	_	_
13	equivalent	_	ADJ	JJ	_	14	amod	_	_
14	dose	_	NOUN	NN	_	10	nmod	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	solution	_	NOUN	NN	_	14	nmod	_	_

#	Sertraline Hydrochloride	1557
1	In	_	ADP	IN	_	5	case	_	_
2	a	_	DET	DT	_	5	det	_	_
3	relative	_	ADJ	JJ	_	5	amod	_	_
4	bioavailability	_	NOUN	NN	_	5	compound	_	_
5	study	_	NOUN	NN	_	41	nmod	_	_
6	comparing	_	VERB	VBG	_	5	acl	_	_
7	the	_	DET	DT	_	8	det	_	_
8	pharmacokinetics	_	NOUN	NNS	_	6	dobj	_	_
9	of	_	ADP	IN	_	12	case	_	_
10	100	_	NUM	CD	_	12	nummod	_	_
11	mg	_	NOUN	NN	_	12	compound	_	_
12	DRUG	_	NOUN	NN	_	8	nmod	_	_
13	as	_	ADP	IN	_	16	case	_	_
14	the	_	DET	DT	_	16	det	_	_
15	oral	_	ADJ	JJ	_	16	amod	_	_
16	solution	_	NOUN	NN	_	6	nmod	_	_
17	to	_	PRT	TO	_	22	case	_	_
18	a	_	DET	DT	_	22	det	_	_
19	100	_	NUM	CD	_	22	nummod	_	_
20	mg	_	NOUN	NN	_	22	compound	_	_
21	DRUG	_	NOUN	NN	_	22	compound	_	_
22	tablet	_	NOUN	NN	_	16	nmod	_	_
23	in	_	ADP	IN	_	26	case	_	_
24	16	_	NUM	CD	_	26	nummod	_	_
25	healthy	_	ADJ	JJ	_	26	amod	_	_
26	adults	_	NOUN	NNS	_	16	nmod	_	_
27	,	_	.	,	_	41	punct	_	_
28	the	_	DET	DT	_	29	det	_	_
29	solution	_	NOUN	NN	_	41	nsubj	_	_
30	to	_	PRT	TO	_	32	case	_	_
31	tablet	_	NOUN	NN	_	32	compound	_	_
32	ratio	_	NOUN	NN	_	29	nmod	_	_
33	of	_	ADP	IN	_	36	case	_	_
34	geometric	_	ADJ	JJ	_	36	amod	_	_
35	mean	_	NOUN	NN	_	36	compound	_	_
36	AUC	_	NOUN	NN	_	32	nmod	_	_
37	and	_	CONJ	CC	_	36	cc	_	_
38	Cmax	_	NOUN	NN	_	39	compound	_	_
39	values	_	NOUN	NNS	_	36	conj	_	_
40	were	_	VERB	VBD	_	41	cop	_	_
41	114.8%	_	ADJ	JJ	_	0	root	_	_
42	and	_	CONJ	CC	_	41	cc	_	_
43	120.6%	_	NOUN	NN	_	41	conj	_	_
44	,	_	.	,	_	41	punct	_	_
45	respectively	_	ADV	RB	_	41	advmod	_	_

#	Sertraline Hydrochloride	1558
1	90%	_	ADJ	JJ	_	2	amod	_	_
2	confidence	_	NOUN	NN	_	3	nsubj	_	_
3	intervals	_	VERB	VBZ	_	0	root	_	_
4	CI	_	NOUN	NN	_	3	dobj	_	_
5	were	_	VERB	VBD	_	8	cop	_	_
6	within	_	ADP	IN	_	8	case	_	_
7	the	_	DET	DT	_	8	det	_	_
8	range	_	NOUN	NN	_	3	advcl	_	_
9	of	_	ADP	IN	_	12	case	_	_
10	80	_	NUM	CD	_	12	nummod	_	_
11	to	_	PRT	TO	_	12	case	_	_
12	125%	_	NOUN	NN	_	8	nmod	_	_
13	with	_	ADP	IN	_	15	case	_	_
14	the	_	DET	DT	_	15	det	_	_
15	exception	_	NOUN	NN	_	8	nmod	_	_
16	of	_	ADP	IN	_	21	case	_	_
17	the	_	DET	DT	_	21	det	_	_
18	upper	_	ADJ	JJ	_	21	amod	_	_
19	90%	_	ADJ	JJ	_	21	amod	_	_
20	CI	_	NOUN	NN	_	21	compound	_	_
21	limit	_	NOUN	NN	_	15	nmod	_	_
22	for	_	ADP	IN	_	23	case	_	_
23	Cmax	_	NOUN	NN	_	21	nmod	_	_
24	which	_	DET	WDT	_	26	nsubj	_	_
25	was	_	VERB	VBD	_	26	auxpass	_	_
26	126.5%	_	ADJ	JJ	_	23	acl:relcl	_	_

#	Sertraline Hydrochloride	1559
1	The	_	DET	DT	_	2	det	_	_
2	effects	_	NOUN	NNS	_	16	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	food	_	NOUN	NN	_	2	nmod	_	_
5	on	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	bioavailability	_	NOUN	NN	_	2	nmod	_	_
8	of	_	ADP	IN	_	11	case	_	_
9	the	_	DET	DT	_	11	det	_	_
10	DRUG	_	NOUN	NN	_	11	compound	_	_
11	tablet	_	NOUN	NN	_	7	nmod	_	_
12	and	_	CONJ	CC	_	7	cc	_	_
13	oral	_	ADJ	JJ	_	14	amod	_	_
14	concentrate	_	NOUN	NN	_	7	conj	_	_
15	were	_	VERB	VBD	_	16	auxpass	_	_
16	studied	_	VERB	VBN	_	0	root	_	_
17	in	_	ADP	IN	_	18	case	_	_
18	subjects	_	NOUN	NNS	_	16	nmod	_	_
19	administered	_	VERB	VBD	_	16	xcomp	_	_
20	a	_	DET	DT	_	22	det	_	_
21	single	_	ADJ	JJ	_	22	amod	_	_
22	dose	_	NOUN	NN	_	19	dobj	_	_
23	with	_	ADP	IN	_	22	nmod	_	_
24	and	_	CONJ	CC	_	23	cc	_	_
25	without	_	ADP	IN	_	23	conj	_	_
26	food	_	NOUN	NN	_	23	dep	_	_

#	Sertraline Hydrochloride	1560
1	For	_	ADP	IN	_	3	case	_	_
2	the	_	DET	DT	_	3	det	_	_
3	tablet	_	NOUN	NN	_	8	nmod	_	_
4	,	_	.	,	_	8	punct	_	_
5	AUC	_	NOUN	NN	_	8	nsubjpass	_	_
6	was	_	VERB	VBD	_	8	auxpass	_	_
7	slightly	_	ADV	RB	_	8	advmod	_	_
8	increased	_	VERB	VBN	_	0	root	_	_
9	when	_	ADV	WRB	_	12	advmod	_	_
10	drug	_	NOUN	NN	_	12	nsubjpass	_	_
11	was	_	VERB	VBD	_	12	auxpass	_	_
12	administered	_	VERB	VBN	_	8	ccomp	_	_
13	with	_	ADP	IN	_	14	case	_	_
14	food	_	NOUN	NN	_	12	nmod	_	_
15	but	_	CONJ	CC	_	12	cc	_	_
16	the	_	DET	DT	_	17	det	_	_
17	Cmax	_	NOUN	NN	_	20	nsubj	_	_
18	was	_	VERB	VBD	_	20	cop	_	_
19	25%	_	ADJ	JJ	_	20	advmod	_	_
20	greater	_	ADJ	JJ	_	12	conj	_	_
21	,	_	.	,	_	12	punct	_	_
22	while	_	ADP	IN	_	31	mark	_	_
23	the	_	DET	DT	_	24	det	_	_
24	time	_	NOUN	NN	_	31	nsubj	_	_
25	to	_	PRT	TO	_	26	mark	_	_
26	reach	_	VERB	VB	_	24	acl	_	_
27	peak	_	ADJ	JJ	_	30	amod	_	_
28	plasma	_	NOUN	NN	_	30	compound	_	_
29	concentration	_	NOUN	NN	_	30	compound	_	_
30	Tmax	_	NOUN	NN	_	26	dobj	_	_
31	decreased	_	VERB	VBN	_	12	advcl	_	_
32	from	_	ADP	IN	_	34	case	_	_
33	8	_	NUM	CD	_	34	nummod	_	_
34	hours	_	NOUN	NNS	_	31	nmod	_	_
35	post	_	ADJ	JJ	_	31	dobj	_	_
36	dosing	_	VERB	VBG	_	35	dep	_	_
37	to	_	PRT	TO	_	39	case	_	_
38	5.5	_	NUM	CD	_	39	nummod	_	_
39	hours	_	NOUN	NNS	_	36	nmod	_	_

#	Sertraline Hydrochloride	1561
1	For	_	ADP	IN	_	4	case	_	_
2	the	_	DET	DT	_	4	det	_	_
3	oral	_	ADJ	JJ	_	4	amod	_	_
4	concentrate	_	NOUN	NN	_	9	nmod	_	_
5	,	_	.	,	_	9	punct	_	_
6	Tmax	_	NOUN	NN	_	9	nsubjpass	_	_
7	was	_	VERB	VBD	_	9	auxpass	_	_
8	slightly	_	ADV	RB	_	9	advmod	_	_
9	prolonged	_	VERB	VBN	_	0	root	_	_
10	from	_	ADP	IN	_	12	case	_	_
11	5.9	_	NUM	CD	_	12	nummod	_	_
12	hours	_	NOUN	NNS	_	9	nmod	_	_
13	to	_	PRT	TO	_	15	case	_	_
14	7	_	NUM	CD	_	15	nummod	_	_
15	hours	_	NOUN	NNS	_	9	nmod	_	_
16	with	_	ADP	IN	_	17	case	_	_
17	food	_	NOUN	NN	_	15	nmod	_	_

#	Sertraline Hydrochloride	1562
1	Metabolism	_	NOUN	NN	_	2	compound	_	_
2	DRUG	_	NOUN	NN	_	3	nsubj	_	_
3	undergoes	_	VERB	VBZ	_	0	root	_	_
4	extensive	_	ADJ	JJ	_	7	amod	_	_
5	first	_	ADJ	JJ	_	7	amod	_	_
6	pass	_	NOUN	NN	_	7	compound	_	_
7	metabolism	_	NOUN	NN	_	3	dobj	_	_

#	Sertraline Hydrochloride	1563
1	The	_	DET	DT	_	4	det	_	_
2	principal	_	ADJ	JJ	_	4	amod	_	_
3	initial	_	ADJ	JJ	_	4	amod	_	_
4	pathway	_	NOUN	NN	_	11	nsubj	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	metabolism	_	NOUN	NN	_	4	nmod	_	_
7	for	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	is	_	VERB	VBZ	_	11	cop	_	_
10	N	_	NOUN	NN	_	11	compound	_	_
11	demethylation	_	NOUN	NN	_	0	root	_	_

#	Sertraline Hydrochloride	1564
1	N	_	NOUN	NN	_	3	compound	_	_
2	desmethyl	_	NOUN	NN	_	3	compound	_	_
3	DRUG	_	NOUN	NN	_	4	nsubj	_	_
4	has	_	VERB	VBZ	_	0	root	_	_
5	a	_	DET	DT	_	10	det	_	_
6	plasma	_	NOUN	NN	_	10	compound	_	_
7	terminal	_	ADJ	JJ	_	10	amod	_	_
8	elimination	_	NOUN	NN	_	10	compound	_	_
9	half	_	NOUN	NN	_	10	compound	_	_
10	life	_	NOUN	NN	_	4	dobj	_	_
11	of	_	ADP	IN	_	15	case	_	_
12	62	_	NUM	CD	_	14	compound	_	_
13	to	_	PRT	TO	_	14	dep	_	_
14	104	_	NUM	CD	_	15	nummod	_	_
15	hours	_	NOUN	NNS	_	10	nmod	_	_

#	Sertraline Hydrochloride	1565
1	Both	_	DET	DT	_	4	cc:preconj	_	_
2	in	_	X	FW	_	4	amod	_	_
3	vitro	_	X	FW	_	2	dep	_	_
4	biochemical	_	ADJ	JJ	_	11	nsubj	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	in	_	X	FW	_	9	amod	_	_
7	vivo	_	X	FW	_	6	dep	_	_
8	pharmacological	_	ADJ	JJ	_	9	amod	_	_
9	testing	_	NOUN	NN	_	4	conj	_	_
10	have	_	VERB	VBP	_	11	aux	_	_
11	shown	_	VERB	VBN	_	0	root	_	_
12	N	_	NOUN	NN	_	14	compound	_	_
13	desmethyl	_	NOUN	NN	_	14	compound	_	_
14	DRUG	_	NOUN	NN	_	11	dobj	_	_
15	to	_	PRT	TO	_	19	mark	_	_
16	be	_	VERB	VB	_	19	cop	_	_
17	substantially	_	ADV	RB	_	19	advmod	_	_
18	less	_	ADV	RB	_	19	advmod	_	_
19	active	_	ADJ	JJ	_	11	xcomp	_	_
20	than	_	ADP	IN	_	21	case	_	_
21	DRUG	_	NOUN	NN	_	19	nmod	_	_

#	Sertraline Hydrochloride	1566
1	Both	_	CONJ	CC	_	2	cc:preconj	_	_
2	DRUG	_	NOUN	NN	_	7	nsubj	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	N	_	NOUN	NN	_	6	compound	_	_
5	desmethyl	_	NOUN	NN	_	6	compound	_	_
6	DRUG	_	NOUN	NN	_	2	conj	_	_
7	undergo	_	VERB	VBP	_	0	root	_	_
8	oxidative	_	ADJ	JJ	_	9	amod	_	_
9	deamination	_	NOUN	NN	_	7	dobj	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	subsequent	_	ADJ	JJ	_	12	amod	_	_
12	reduction	_	NOUN	NN	_	9	conj	_	_
13	,	_	.	,	_	12	punct	_	_
14	hydroxylation	_	NOUN	NN	_	12	conj	_	_
15	,	_	.	,	_	12	punct	_	_
16	and	_	CONJ	CC	_	12	cc	_	_
17	glucuronide	_	NOUN	NN	_	18	compound	_	_
18	conjugation	_	NOUN	NN	_	12	conj	_	_

#	Sertraline Hydrochloride	1567
1	In	_	ADP	IN	_	3	case	_	_
2	a	_	DET	DT	_	3	det	_	_
3	study	_	NOUN	NN	_	14	nmod	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	radiolabeled	_	VERB	VBN	_	6	amod	_	_
6	DRUG	_	NOUN	NN	_	3	nmod	_	_
7	involving	_	VERB	VBG	_	6	acl	_	_
8	two	_	NUM	CD	_	11	nummod	_	_
9	healthy	_	ADJ	JJ	_	11	amod	_	_
10	male	_	ADJ	JJ	_	11	amod	_	_
11	subjects	_	NOUN	NNS	_	7	dobj	_	_
12	,	_	.	,	_	14	punct	_	_
13	DRUG	_	NOUN	NN	_	14	nsubj	_	_
14	accounted	_	VERB	VBD	_	0	root	_	_
15	for	_	ADP	IN	_	18	case	_	_
16	less	_	ADV	RB	_	18	advmod	_	_
17	than	_	ADP	IN	_	16	mwe	_	_
18	5%	_	NOUN	NN	_	14	nmod	_	_
19	of	_	ADP	IN	_	22	case	_	_
20	the	_	DET	DT	_	22	det	_	_
21	plasma	_	NOUN	NN	_	22	compound	_	_
22	radioactivity	_	NOUN	NN	_	18	nmod	_	_

#	Sertraline Hydrochloride	1568
1	About	_	ADV	RB	_	2	advmod	_	_
2	40	_	NUM	CD	_	10	nsubjpass	_	_
3	to	_	PRT	TO	_	4	case	_	_
4	45%	_	NOUN	NN	_	2	nmod	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	the	_	DET	DT	_	8	det	_	_
7	administered	_	VERB	VBN	_	8	amod	_	_
8	radioactivity	_	NOUN	NN	_	4	nmod	_	_
9	was	_	VERB	VBD	_	10	auxpass	_	_
10	recovered	_	VERB	VBN	_	0	root	_	_
11	in	_	ADP	IN	_	12	case	_	_
12	urine	_	ADJ	JJ	_	10	nmod	_	_
13	in	_	ADP	IN	_	15	case	_	_
14	9	_	NUM	CD	_	15	nummod	_	_
15	days	_	NOUN	NNS	_	12	nmod	_	_

#	Sertraline Hydrochloride	1569
1	Unchanged	_	ADJ	JJ	_	2	amod	_	_
2	DRUG	_	NOUN	NN	_	5	nsubj	_	_
3	was	_	VERB	VBD	_	5	cop	_	_
4	not	_	ADV	RB	_	5	neg	_	_
5	detectable	_	ADJ	JJ	_	0	root	_	_
6	in	_	ADP	IN	_	8	case	_	_
7	the	_	DET	DT	_	8	det	_	_
8	urine	_	VERB	VBG	_	5	nmod	_	_

#	Sertraline Hydrochloride	1570
1	For	_	ADP	IN	_	4	case	_	_
2	the	_	DET	DT	_	4	det	_	_
3	same	_	ADJ	JJ	_	4	amod	_	_
4	period	_	NOUN	NN	_	15	nmod	_	_
5	,	_	.	,	_	15	punct	_	_
6	about	_	ADV	RB	_	7	advmod	_	_
7	40	_	NUM	CD	_	15	nsubjpass	_	_
8	to	_	PRT	TO	_	9	case	_	_
9	45%	_	NOUN	NN	_	7	nmod	_	_
10	of	_	ADP	IN	_	13	case	_	_
11	the	_	DET	DT	_	13	det	_	_
12	administered	_	VERB	VBN	_	13	amod	_	_
13	radioactivity	_	NOUN	NN	_	9	nmod	_	_
14	was	_	VERB	VBD	_	15	auxpass	_	_
15	accounted	_	VERB	VBN	_	0	root	_	_
16	for	_	ADP	IN	_	18	case	_	_
17	in	_	ADP	IN	_	18	case	_	_
18	feces	_	NOUN	NNS	_	15	nmod	_	_
19	,	_	.	,	_	18	punct	_	_
20	including	_	VERB	VBG	_	25	case	_	_
21	12	_	NUM	CD	_	25	nummod	_	_
22	to	_	PRT	TO	_	25	dep	_	_
23	14%	_	ADJ	JJ	_	25	amod	_	_
24	unchanged	_	ADJ	JJ	_	25	amod	_	_
25	DRUG	_	NOUN	NN	_	18	nmod	_	_

#	Sertraline Hydrochloride	1571
1	Desmethyl	_	NOUN	NN	_	2	compound	_	_
2	DRUG	_	NOUN	NN	_	3	nsubj	_	_
3	exhibits	_	VERB	VBZ	_	0	root	_	_
4	time	_	NOUN	NN	_	5	nmod:npmod	_	_
5	related	_	ADJ	JJ	_	9	amod	_	_
6	,	_	.	,	_	5	punct	_	_
7	dose	_	NOUN	NN	_	8	nmod:npmod	_	_
8	dependent	_	ADJ	JJ	_	5	dep	_	_
9	increases	_	NOUN	NNS	_	3	dobj	_	_
10	in	_	ADP	IN	_	11	case	_	_
11	AUC	_	NOUN	NN	_	9	nmod	_	_
12	0	_	NUM	CD	_	11	nummod	_	_
13	to	_	PRT	TO	_	15	case	_	_
14	24	_	NUM	CD	_	15	nummod	_	_
15	hour	_	NUM	CD	_	9	nmod	_	_
16	,	_	.	,	_	15	punct	_	_
17	Cmax	_	NOUN	NN	_	15	conj	_	_
18	and	_	CONJ	CC	_	15	cc	_	_
19	Cmin	_	NOUN	NN	_	15	conj	_	_
20	,	_	.	,	_	9	punct	_	_
21	with	_	ADP	IN	_	28	case	_	_
22	about	_	ADV	RB	_	28	advmod	_	_
23	a	_	DET	DT	_	28	det	_	_
24	5	_	NUM	CD	_	26	compound	_	_
25	to	_	PRT	TO	_	26	dep	_	_
26	9	_	NUM	CD	_	28	nummod	_	_
27	fold	_	NOUN	NN	_	28	amod	_	_
28	increase	_	NOUN	NN	_	9	nmod	_	_
29	in	_	ADP	IN	_	32	case	_	_
30	these	_	DET	DT	_	32	det	_	_
31	pharmacokinetic	_	ADJ	JJ	_	32	amod	_	_
32	parameters	_	NOUN	NNS	_	28	nmod	_	_
33	between	_	ADP	IN	_	35	case	_	_
34	day	_	NOUN	NN	_	35	compound	_	_
35	1	_	NUM	CD	_	32	nmod	_	_
36	and	_	CONJ	CC	_	35	cc	_	_
37	day	_	NOUN	NN	_	35	conj	_	_
38	14	_	NUM	CD	_	37	nummod	_	_

#	Sertraline Hydrochloride	1572
1	Protein	_	NOUN	NN	_	7	compound	_	_
2	Binding	_	NOUN	NN	_	7	compound	_	_
3	In	_	X	FW	_	7	amod	_	_
4	vitro	_	X	FW	_	3	dep	_	_
5	protein	_	NOUN	NN	_	7	compound	_	_
6	binding	_	NOUN	NN	_	7	compound	_	_
7	studies	_	NOUN	NNS	_	13	nsubj	_	_
8	performed	_	VERB	VBN	_	7	acl	_	_
9	with	_	ADP	IN	_	12	case	_	_
10	radiolabeled	_	VERB	VBN	_	12	amod	_	_
11	3H	_	NOUN	NN	_	12	compound	_	_
12	DRUG	_	NOUN	NN	_	8	nmod	_	_
13	showed	_	VERB	VBD	_	0	root	_	_
14	that	_	ADP	IN	_	18	mark	_	_
15	DRUG	_	NOUN	NN	_	18	nsubjpass	_	_
16	is	_	VERB	VBZ	_	18	auxpass	_	_
17	highly	_	ADV	RB	_	18	advmod	_	_
18	bound	_	VERB	VBN	_	13	ccomp	_	_
19	to	_	PRT	TO	_	21	case	_	_
20	serum	_	NOUN	NN	_	21	compound	_	_
21	proteins	_	NOUN	NNS	_	18	nmod	_	_
22	98%	_	NOUN	NN	_	21	dep	_	_
23	in	_	ADP	IN	_	25	case	_	_
24	the	_	DET	DT	_	25	det	_	_
25	range	_	NOUN	NN	_	22	nmod	_	_
26	of	_	ADP	IN	_	30	case	_	_
27	20	_	NUM	CD	_	29	compound	_	_
28	to	_	PRT	TO	_	29	dep	_	_
29	500	_	NUM	CD	_	30	nummod	_	_
30	ng	_	NOUN	NN	_	25	nmod	_	_
31	/	_	.	:	_	30	punct	_	_
32	mL	_	NOUN	NN	_	30	dep	_	_

#	Sertraline Hydrochloride	1573
1	However	_	ADV	RB	_	23	advmod	_	_
2	,	_	.	,	_	23	punct	_	_
3	at	_	ADP	IN	_	9	case	_	_
4	up	_	ADJ	JJ	_	6	advmod	_	_
5	to	_	PRT	TO	_	6	dep	_	_
6	300	_	NUM	CD	_	9	nummod	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	200	_	NUM	CD	_	6	conj	_	_
9	ng	_	NOUN	NN	_	12	compound	_	_
10	/	_	.	:	_	12	punct	_	_
11	mL	_	NOUN	NN	_	12	compound	_	_
12	concentrations	_	NOUN	NNS	_	23	nmod	_	_
13	,	_	.	,	_	23	punct	_	_
14	respectively	_	ADV	RB	_	23	advmod	_	_
15	,	_	.	,	_	23	punct	_	_
16	DRUG	_	NOUN	NN	_	23	nsubj	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	N	_	NOUN	NN	_	20	compound	_	_
19	desmethyl	_	NOUN	NN	_	20	compound	_	_
20	DRUG	_	NOUN	NN	_	16	conj	_	_
21	did	_	VERB	VBD	_	23	aux	_	_
22	not	_	ADV	RB	_	23	neg	_	_
23	alter	_	VERB	VB	_	0	root	_	_
24	the	_	DET	DT	_	27	det	_	_
25	plasma	_	NOUN	NN	_	27	compound	_	_
26	protein	_	NOUN	NN	_	27	compound	_	_
27	binding	_	NOUN	NN	_	23	dobj	_	_
28	of	_	ADP	IN	_	34	case	_	_
29	two	_	NUM	CD	_	34	nummod	_	_
30	other	_	ADJ	JJ	_	34	amod	_	_
31	highly	_	ADV	RB	_	34	advmod	_	_
32	protein	_	NOUN	NN	_	34	compound	_	_
33	bound	_	VERB	VBN	_	34	amod	_	_
34	drugs	_	NOUN	NNS	_	27	nmod	_	_
35	,	_	.	,	_	34	punct	_	_
36	viz	_	NOUN	NN	_	34	conj	_	_
37	,	_	.	,	_	34	punct	_	_
38	warfarin	_	NOUN	NN	_	34	appos	_	_
39	and	_	CONJ	CC	_	38	cc	_	_
40	propranolol	_	NOUN	NN	_	38	conj	_	_

#	Sertraline Hydrochloride	1574
1	Pediatric	_	ADJ	JJ	_	2	amod	_	_
2	Pharmacokinetics	_	NOUN	NNS	_	6	nsubjpass	_	_
3	DRUG	_	NOUN	NN	_	4	compound	_	_
4	pharmacokinetics	_	NOUN	NNS	_	2	dep	_	_
5	were	_	VERB	VBD	_	6	auxpass	_	_
6	evaluated	_	VERB	VBN	_	0	root	_	_
7	in	_	ADP	IN	_	9	case	_	_
8	a	_	DET	DT	_	9	det	_	_
9	group	_	NOUN	NN	_	6	nmod	_	_
10	of	_	ADP	IN	_	13	case	_	_
11	61	_	NUM	CD	_	13	nummod	_	_
12	pediatric	_	ADJ	JJ	_	13	amod	_	_
13	patients	_	NOUN	NNS	_	9	nmod	_	_
14	29	_	NUM	CD	_	19	nummod	_	_
15	aged	_	ADJ	JJ	_	19	amod	_	_
16	6	_	NUM	CD	_	18	compound	_	_
17	to	_	PRT	TO	_	18	dep	_	_
18	12	_	NUM	CD	_	19	nummod	_	_
19	years	_	NOUN	NNS	_	13	dep	_	_
20	,	_	.	,	_	19	punct	_	_
21	32	_	NUM	CD	_	26	nummod	_	_
22	aged	_	ADJ	JJ	_	26	amod	_	_
23	13	_	NUM	CD	_	25	compound	_	_
24	to	_	PRT	TO	_	25	dep	_	_
25	17	_	NUM	CD	_	26	nummod	_	_
26	years	_	NOUN	NNS	_	19	appos	_	_
27	with	_	ADP	IN	_	32	case	_	_
28	a	_	DET	DT	_	32	det	_	_
29	DSM	_	NOUN	NN	_	32	compound	_	_
30	III	_	NUM	CD	_	32	nummod	_	_
31	R	_	NOUN	NN	_	32	compound	_	_
32	diagnosis	_	NOUN	NN	_	26	nmod	_	_
33	of	_	ADP	IN	_	36	case	_	_
34	major	_	ADJ	JJ	_	36	amod	_	_
35	depressive	_	ADJ	JJ	_	36	amod	_	_
36	disorder	_	NOUN	NN	_	32	nmod	_	_
37	or	_	CONJ	CC	_	36	cc	_	_
38	obsessive	_	ADJ	JJ	_	40	amod	_	_
39	compulsive	_	ADJ	JJ	_	40	amod	_	_
40	disorder	_	NOUN	NN	_	36	conj	_	_

#	Sertraline Hydrochloride	1575
1	Patients	_	NOUN	NNS	_	2	nsubj	_	_
2	included	_	VERB	VBD	_	0	root	_	_
3	both	_	CONJ	CC	_	4	det	_	_
4	males	_	NOUN	NNS	_	2	dobj	_	_
5	N	_	NOUN	NN	_	4	dep	_	_
6	=	_	ADJ	JJ	_	4	amod	_	_
7	28	_	NUM	CD	_	6	dep	_	_
8	and	_	CONJ	CC	_	2	cc	_	_
9	females	_	NOUN	NNS	_	2	conj	_	_
10	N	_	NOUN	NN	_	9	dobj	_	_
11	=	_	DET	DT	_	10	dep	_	_
12	33	_	NUM	CD	_	11	neg	_	_

#	Sertraline Hydrochloride	1576
1	During	_	ADP	IN	_	3	case	_	_
2	42	_	NUM	CD	_	3	nummod	_	_
3	days	_	NOUN	NNS	_	11	nmod	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	chronic	_	ADJ	JJ	_	7	amod	_	_
6	DRUG	_	NOUN	NN	_	7	compound	_	_
7	dosing	_	NOUN	NN	_	3	nmod	_	_
8	,	_	.	,	_	11	punct	_	_
9	DRUG	_	NOUN	NN	_	11	nsubjpass	_	_
10	was	_	VERB	VBD	_	11	auxpass	_	_
11	titrated	_	VERB	VBN	_	0	root	_	_
12	up	_	ADJ	JJR	_	14	advmod	_	_
13	to	_	PRT	TO	_	14	dep	_	_
14	200	_	NUM	CD	_	15	nummod	_	_
15	mg	_	NOUN	NN	_	11	nmod	_	_
16	/	_	.	:	_	17	punct	_	_
17	day	_	NOUN	NN	_	15	dep	_	_
18	and	_	CONJ	CC	_	11	cc	_	_
19	maintained	_	VERB	VBD	_	11	conj	_	_
20	at	_	ADP	IN	_	21	case	_	_
21	that	_	ADP	IN	_	19	nmod	_	_
22	dose	_	NOUN	NN	_	21	root	_	_
23	for	_	ADP	IN	_	25	case	_	_
24	a	_	DET	DT	_	25	det	_	_
25	minimum	_	NOUN	NN	_	22	nmod	_	_
26	of	_	ADP	IN	_	28	case	_	_
27	11	_	NUM	CD	_	28	nummod	_	_
28	days	_	NOUN	NNS	_	25	nmod	_	_

#	Sertraline Hydrochloride	1577
1	On	_	ADP	IN	_	4	case	_	_
2	the	_	DET	DT	_	4	det	_	_
3	final	_	ADJ	JJ	_	4	amod	_	_
4	day	_	NOUN	NN	_	19	nmod	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	DRUG	_	NOUN	NN	_	8	compound	_	_
7	200	_	NUM	CD	_	8	nummod	_	_
8	mg	_	NOUN	NN	_	4	nmod	_	_
9	/	_	.	:	_	10	punct	_	_
10	day	_	NOUN	NN	_	19	nsubj	_	_
11	,	_	.	,	_	10	punct	_	_
12	the	_	DET	DT	_	18	det	_	_
13	6	_	NUM	CD	_	15	compound	_	_
14	to	_	PRT	TO	_	15	dep	_	_
15	12	_	NUM	CD	_	18	nummod	_	_
16	year	_	NOUN	NN	_	18	compound	_	_
17	old	_	ADJ	JJ	_	18	amod	_	_
18	group	_	NOUN	NN	_	10	appos	_	_
19	exhibited	_	VERB	VBD	_	0	root	_	_
20	a	_	DET	DT	_	23	det	_	_
21	mean	_	ADJ	JJ	_	23	amod	_	_
22	DRUG	_	NOUN	NN	_	23	compound	_	_
23	AUC	_	NOUN	NN	_	19	dobj	_	_
24	0	_	NUM	CD	_	23	nummod	_	_
25	to	_	PRT	TO	_	27	case	_	_
26	24	_	NUM	CD	_	27	nummod	_	_
27	hr	_	NOUN	NN	_	19	nmod	_	_
28	of	_	ADP	IN	_	31	case	_	_
29	3107	_	NUM	CD	_	31	nummod	_	_
30	ng	_	NOUN	NN	_	31	compound	_	_
31	hr	_	NOUN	NN	_	27	nmod	_	_
32	/	_	.	:	_	27	punct	_	_
33	mL	_	NOUN	NN	_	27	dep	_	_
34	,	_	.	,	_	33	punct	_	_
35	mean	_	ADJ	JJ	_	36	compound	_	_
36	Cmax	_	NOUN	NN	_	33	appos	_	_
37	of	_	ADP	IN	_	39	case	_	_
38	165	_	NUM	CD	_	39	nummod	_	_
39	ng	_	NOUN	NN	_	36	nmod	_	_
40	/	_	.	:	_	39	punct	_	_
41	mL	_	NOUN	NN	_	39	conj	_	_
42	,	_	.	,	_	39	punct	_	_
43	and	_	CONJ	CC	_	39	cc	_	_
44	mean	_	NOUN	NN	_	46	compound	_	_
45	half	_	ADJ	JJ	_	46	amod	_	_
46	life	_	NOUN	NN	_	39	conj	_	_
47	of	_	ADP	IN	_	49	case	_	_
48	26.2	_	NUM	CD	_	49	nummod	_	_
49	hr	_	NOUN	NN	_	46	nmod	_	_

#	Sertraline Hydrochloride	1578
1	The	_	DET	DT	_	7	det	_	_
2	13	_	NUM	CD	_	4	compound	_	_
3	to	_	PRT	TO	_	4	dep	_	_
4	17	_	NUM	CD	_	7	nummod	_	_
5	year	_	NOUN	NN	_	7	compound	_	_
6	old	_	ADJ	JJ	_	7	amod	_	_
7	group	_	NOUN	NN	_	8	nsubj	_	_
8	exhibited	_	VERB	VBD	_	0	root	_	_
9	a	_	DET	DT	_	12	det	_	_
10	mean	_	ADJ	JJ	_	12	amod	_	_
11	DRUG	_	NOUN	NN	_	12	compound	_	_
12	AUC	_	NOUN	NN	_	8	dobj	_	_
13	0	_	NUM	CD	_	12	nummod	_	_
14	to	_	PRT	TO	_	16	case	_	_
15	24	_	NUM	CD	_	16	nummod	_	_
16	hr	_	NOUN	NN	_	12	nmod	_	_
17	of	_	ADP	IN	_	20	case	_	_
18	2296	_	NUM	CD	_	20	nummod	_	_
19	ng	_	NOUN	NN	_	20	compound	_	_
20	hr	_	NOUN	NN	_	16	nmod	_	_
21	/	_	.	:	_	12	punct	_	_
22	mL	_	NOUN	NN	_	12	dep	_	_
23	,	_	.	,	_	22	punct	_	_
24	mean	_	ADJ	JJ	_	25	compound	_	_
25	Cmax	_	NOUN	NN	_	22	appos	_	_
26	of	_	ADP	IN	_	28	case	_	_
27	123	_	NUM	CD	_	28	nummod	_	_
28	ng	_	NOUN	NN	_	25	nmod	_	_
29	/	_	.	:	_	28	punct	_	_
30	mL	_	NOUN	NN	_	28	conj	_	_
31	,	_	.	,	_	28	punct	_	_
32	and	_	CONJ	CC	_	28	cc	_	_
33	mean	_	NOUN	NN	_	35	compound	_	_
34	half	_	ADJ	JJ	_	35	amod	_	_
35	life	_	NOUN	NN	_	28	conj	_	_
36	of	_	ADP	IN	_	38	case	_	_
37	27.8	_	NUM	CD	_	38	nummod	_	_
38	hr	_	NOUN	NN	_	35	nmod	_	_

#	Sertraline Hydrochloride	1579
1	Higher	_	ADJ	JJ	_	3	amod	_	_
2	plasma	_	NOUN	NN	_	3	compound	_	_
3	levels	_	NOUN	NNS	_	14	nsubj	_	_
4	in	_	ADP	IN	_	11	case	_	_
5	the	_	DET	DT	_	11	det	_	_
6	6	_	NUM	CD	_	8	compound	_	_
7	to	_	PRT	TO	_	8	dep	_	_
8	12	_	NUM	CD	_	11	nummod	_	_
9	year	_	NOUN	NN	_	11	amod	_	_
10	old	_	ADJ	JJ	_	11	amod	_	_
11	group	_	NOUN	NN	_	3	nmod	_	_
12	were	_	VERB	VBD	_	14	cop	_	_
13	largely	_	ADV	RB	_	14	advmod	_	_
14	attributable	_	ADJ	JJ	_	0	root	_	_
15	to	_	PRT	TO	_	16	case	_	_
16	patients	_	NOUN	NNS	_	14	nmod	_	_
17	with	_	ADP	IN	_	20	case	_	_
18	lower	_	ADJ	JJ	_	20	amod	_	_
19	body	_	NOUN	NN	_	20	compound	_	_
20	weights	_	NOUN	NNS	_	16	nmod	_	_

#	Sertraline Hydrochloride	1580
1	No	_	DET	DT	_	4	neg	_	_
2	gender	_	ADJ	JJ	_	4	amod	_	_
3	associated	_	ADJ	JJ	_	4	amod	_	_
4	differences	_	NOUN	NNS	_	6	nsubjpass	_	_
5	were	_	VERB	VBD	_	6	auxpass	_	_
6	observed	_	VERB	VBN	_	0	root	_	_

#	Sertraline Hydrochloride	1581
1	By	_	ADP	IN	_	2	case	_	_
2	comparison	_	NOUN	NN	_	0	root	_	_
3	,	_	.	,	_	2	punct	_	_
4	a	_	DET	DT	_	5	det	_	_
5	group	_	NOUN	NN	_	3	root	_	_
6	of	_	ADP	IN	_	10	case	_	_
7	22	_	NUM	CD	_	10	nummod	_	_
8	separately	_	ADV	RB	_	9	advmod	_	_
9	studied	_	VERB	VBN	_	10	amod	_	_
10	adults	_	NOUN	NNS	_	5	nmod	_	_
11	between	_	ADP	IN	_	15	case	_	_
12	18	_	NUM	CD	_	15	nummod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	45	_	NUM	CD	_	12	conj	_	_
15	years	_	NOUN	NNS	_	5	nmod	_	_
16	of	_	ADP	IN	_	19	case	_	_
17	age	_	NOUN	NN	_	19	compound	_	_
18	11	_	NUM	CD	_	19	nummod	_	_
19	male	_	ADJ	JJ	_	15	nmod	_	_
20	,	_	.	,	_	5	punct	_	_
21	11	_	NUM	CD	_	22	nummod	_	_
22	female	_	NOUN	NN	_	23	nsubj	_	_
23	received	_	VERB	VBD	_	5	dep	_	_
24	30	_	NUM	CD	_	25	nummod	_	_
25	days	_	NOUN	NNS	_	23	dobj	_	_
26	of	_	ADP	IN	_	28	case	_	_
27	200	_	NUM	CD	_	28	nummod	_	_
28	mg	_	NOUN	NN	_	25	nmod	_	_
29	/	_	.	:	_	23	punct	_	_
30	day	_	NOUN	NN	_	31	compound	_	_
31	DRUG	_	NOUN	NN	_	23	dobj	_	_
32	and	_	CONJ	CC	_	23	cc	_	_
33	exhibited	_	VERB	VBD	_	23	conj	_	_
34	a	_	DET	DT	_	37	det	_	_
35	mean	_	ADJ	JJ	_	37	amod	_	_
36	DRUG	_	NOUN	NN	_	37	compound	_	_
37	AUC	_	NOUN	NN	_	33	dobj	_	_
38	0	_	NUM	CD	_	37	nummod	_	_
39	to	_	PRT	TO	_	41	case	_	_
40	24	_	NUM	CD	_	41	nummod	_	_
41	hr	_	NOUN	NN	_	33	nmod	_	_
42	of	_	ADP	IN	_	45	case	_	_
43	2570	_	NUM	CD	_	45	nummod	_	_
44	ng	_	NOUN	NN	_	45	compound	_	_
45	hr	_	NOUN	NN	_	41	nmod	_	_
46	/	_	.	:	_	41	punct	_	_
47	mL	_	NOUN	NN	_	41	dep	_	_
48	,	_	.	,	_	47	punct	_	_
49	mean	_	ADJ	JJ	_	50	compound	_	_
50	Cmax	_	NOUN	NN	_	47	appos	_	_
51	of	_	ADP	IN	_	53	case	_	_
52	142	_	NUM	CD	_	53	nummod	_	_
53	ng	_	NOUN	NN	_	50	nmod	_	_
54	/	_	.	:	_	53	punct	_	_
55	mL	_	NOUN	NN	_	53	conj	_	_
56	,	_	.	,	_	53	punct	_	_
57	and	_	CONJ	CC	_	53	cc	_	_
58	mean	_	NOUN	NN	_	60	compound	_	_
59	half	_	ADJ	JJ	_	60	amod	_	_
60	life	_	NOUN	NN	_	53	conj	_	_
61	of	_	ADP	IN	_	63	case	_	_
62	27.2	_	NUM	CD	_	63	nummod	_	_
63	hr	_	NOUN	NN	_	60	nmod	_	_

#	Sertraline Hydrochloride	1582
1	Relative	_	ADV	RB	_	20	advmod	_	_
2	to	_	PRT	TO	_	4	case	_	_
3	the	_	DET	DT	_	4	det	_	_
4	adults	_	NOUN	NNS	_	1	nmod	_	_
5	,	_	.	,	_	20	punct	_	_
6	both	_	CONJ	CC	_	12	cc:preconj	_	_
7	the	_	DET	DT	_	12	det	_	_
8	6	_	NUM	CD	_	10	compound	_	_
9	to	_	PRT	TO	_	10	dep	_	_
10	12	_	NUM	CD	_	12	nummod	_	_
11	year	_	NOUN	NN	_	12	compound	_	_
12	olds	_	NOUN	NNS	_	20	nsubj	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	the	_	DET	DT	_	18	det	_	_
15	13	_	NUM	CD	_	17	compound	_	_
16	to	_	PRT	TO	_	17	dep	_	_
17	17	_	NUM	CD	_	18	nummod	_	_
18	year	_	NOUN	NN	_	12	conj	_	_
19	olds	_	NOUN	NNS	_	20	nsubj	_	_
20	showed	_	VERB	VBD	_	0	root	_	_
21	about	_	ADV	RB	_	24	case	_	_
22	22%	_	ADJ	JJ	_	24	amod	_	_
23	lower	_	ADJ	JJ	_	24	amod	_	_
24	AUC	_	NOUN	NN	_	20	nmod	_	_
25	0	_	NUM	CD	_	24	nummod	_	_
26	to	_	PRT	TO	_	28	case	_	_
27	24	_	NUM	CD	_	28	nummod	_	_
28	hr	_	NOUN	NN	_	24	nmod	_	_
29	and	_	CONJ	CC	_	28	cc	_	_
30	Cmax	_	NOUN	NN	_	28	conj	_	_
31	values	_	NOUN	NNS	_	28	dep	_	_
32	when	_	ADV	WRB	_	36	advmod	_	_
33	plasma	_	NOUN	NN	_	34	compound	_	_
34	concentration	_	NOUN	NN	_	36	nsubjpass	_	_
35	was	_	VERB	VBD	_	36	auxpass	_	_
36	adjusted	_	VERB	VBN	_	20	advcl	_	_
37	for	_	ADP	IN	_	38	case	_	_
38	weight	_	NOUN	NN	_	36	nmod	_	_

#	Sertraline Hydrochloride	1583
1	These	_	DET	DT	_	2	det	_	_
2	data	_	NOUN	NNS	_	3	nsubj	_	_
3	suggest	_	VERB	VBP	_	0	root	_	_
4	that	_	ADP	IN	_	7	mark	_	_
5	pediatric	_	ADJ	JJ	_	6	amod	_	_
6	patients	_	NOUN	NNS	_	7	nsubj	_	_
7	metabolize	_	VERB	VBP	_	3	ccomp	_	_
8	DRUG	_	NOUN	NN	_	7	dobj	_	_
9	with	_	ADP	IN	_	12	case	_	_
10	slightly	_	ADV	RB	_	11	advmod	_	_
11	greater	_	ADJ	JJ	_	12	amod	_	_
12	efficiency	_	NOUN	NN	_	7	nmod	_	_
13	than	_	ADP	IN	_	14	case	_	_
14	adults	_	NOUN	NNS	_	12	nmod	_	_

#	Sertraline Hydrochloride	1584
1	Nevertheless	_	ADV	RB	_	7	advmod	_	_
2	,	_	.	,	_	7	punct	_	_
3	lower	_	ADJ	JJ	_	4	amod	_	_
4	doses	_	NOUN	NNS	_	7	nsubj	_	_
5	may	_	VERB	MD	_	7	aux	_	_
6	be	_	VERB	VB	_	7	cop	_	_
7	advisable	_	ADJ	JJ	_	0	root	_	_
8	for	_	ADP	IN	_	10	case	_	_
9	pediatric	_	ADJ	JJ	_	10	amod	_	_
10	patients	_	NOUN	NNS	_	7	nmod	_	_
11	given	_	VERB	VBN	_	10	acl	_	_
12	their	_	PRON	PRP$	_	15	nmod:poss	_	_
13	lower	_	ADJ	JJ	_	15	amod	_	_
14	body	_	NOUN	NN	_	15	compound	_	_
15	weights	_	NOUN	NNS	_	11	dobj	_	_
16	,	_	.	,	_	15	punct	_	_
17	especially	_	ADV	RB	_	21	advmod	_	_
18	in	_	ADP	IN	_	21	case	_	_
19	very	_	ADV	RB	_	20	advmod	_	_
20	young	_	ADJ	JJ	_	21	amod	_	_
21	patients	_	NOUN	NNS	_	15	nmod	_	_
22	,	_	.	,	_	7	punct	_	_
23	in	_	X	FW	_	29	case	_	_
24	order	_	X	FW	_	23	mwe	_	_
25	to	_	PRT	TO	_	29	case	_	_
26	avoid	_	ADJ	JJ	_	29	compound	_	_
27	excessive	_	ADJ	JJ	_	29	amod	_	_
28	plasma	_	NOUN	NN	_	29	compound	_	_
29	levels	_	NOUN	NNS	_	7	nmod	_	_

#	Sertraline Hydrochloride	1585
1	Age	_	VERB	VBG	_	0	root	_	_
2	DRUG	_	NOUN	NN	_	4	compound	_	_
3	plasma	_	NOUN	NN	_	4	compound	_	_
4	clearance	_	NOUN	NN	_	1	dobj	_	_
5	in	_	ADP	IN	_	7	case	_	_
6	a	_	DET	DT	_	7	det	_	_
7	group	_	NOUN	NN	_	1	nmod	_	_
8	of	_	ADP	IN	_	11	case	_	_
9	16	_	NUM	CD	_	11	nummod	_	_
10	8	_	NUM	CD	_	11	nummod	_	_
11	male	_	ADJ	JJ	_	7	nmod	_	_
12	,	_	.	,	_	1	punct	_	_
13	8	_	NUM	CD	_	16	nummod	_	_
14	female	_	ADJ	JJ	_	16	amod	_	_
15	elderly	_	ADJ	JJ	_	16	amod	_	_
16	patients	_	NOUN	NNS	_	31	nsubj	_	_
17	treated	_	VERB	VBN	_	16	acl	_	_
18	for	_	ADP	IN	_	20	case	_	_
19	14	_	NUM	CD	_	20	nummod	_	_
20	days	_	NOUN	NNS	_	17	nmod	_	_
21	at	_	ADP	IN	_	23	case	_	_
22	a	_	DET	DT	_	23	det	_	_
23	dose	_	NOUN	NN	_	17	nmod	_	_
24	of	_	ADP	IN	_	28	case	_	_
25	100	_	NUM	CD	_	26	nummod	_	_
26	mg	_	NOUN	NN	_	28	amod	_	_
27	/	_	.	:	_	28	punct	_	_
28	day	_	NOUN	NN	_	23	nmod	_	_
29	was	_	VERB	VBD	_	31	cop	_	_
30	approximately	_	ADV	RB	_	31	advmod	_	_
31	40%	_	ADJ	JJ	_	1	parataxis	_	_
32	lower	_	ADJ	JJ	_	31	xcomp	_	_
33	than	_	ADP	IN	_	38	case	_	_
34	in	_	ADP	IN	_	38	case	_	_
35	a	_	DET	DT	_	38	det	_	_
36	similarly	_	ADV	RB	_	37	advmod	_	_
37	studied	_	VERB	VBN	_	38	amod	_	_
38	group	_	NOUN	NN	_	32	nmod	_	_
39	of	_	ADP	IN	_	40	case	_	_
40	younger	_	ADJ	JJ	_	38	nmod	_	_
41	25	_	NUM	CD	_	43	compound	_	_
42	to	_	PRT	TO	_	43	dep	_	_
43	32	_	NUM	CD	_	40	dep	_	_
44	y.o	_	ADV	RB	_	43	advmod	_	_

#	Sertraline Hydrochloride	1586
1	Steady	_	ADJ	JJ	_	2	amod	_	_
2	state	_	NOUN	NN	_	8	nsubjpass	_	_
3	,	_	.	,	_	2	punct	_	_
4	therefore	_	ADV	RB	_	8	advmod	_	_
5	,	_	.	,	_	8	punct	_	_
6	should	_	VERB	MD	_	8	aux	_	_
7	be	_	VERB	VB	_	8	auxpass	_	_
8	achieved	_	VERB	VBN	_	0	root	_	_
9	after	_	ADP	IN	_	13	case	_	_
10	2	_	NUM	CD	_	12	compound	_	_
11	to	_	PRT	TO	_	12	dep	_	_
12	3	_	NUM	CD	_	13	nummod	_	_
13	weeks	_	NOUN	NNS	_	8	nmod	_	_
14	in	_	ADP	IN	_	16	case	_	_
15	older	_	ADJ	JJ	_	16	amod	_	_
16	patients	_	NOUN	NNS	_	13	nmod	_	_

#	Sertraline Hydrochloride	1587
1	The	_	DET	DT	_	3	det	_	_
2	same	_	ADJ	JJ	_	3	amod	_	_
3	study	_	NOUN	NN	_	4	nsubj	_	_
4	showed	_	VERB	VBD	_	0	root	_	_
5	a	_	DET	DT	_	7	det	_	_
6	decreased	_	VERB	VBN	_	7	amod	_	_
7	clearance	_	NOUN	NN	_	4	dobj	_	_
8	of	_	ADP	IN	_	10	case	_	_
9	desmethyl	_	ADJ	JJ	_	10	amod	_	_
10	DRUG	_	NOUN	NN	_	7	nmod	_	_
11	in	_	ADP	IN	_	13	case	_	_
12	older	_	ADJ	JJ	_	13	amod	_	_
13	males	_	NOUN	NNS	_	7	nmod	_	_
14	,	_	.	,	_	4	punct	_	_
15	but	_	CONJ	CC	_	16	cc	_	_
16	not	_	ADV	RB	_	4	cc	_	_
17	in	_	ADP	IN	_	19	case	_	_
18	older	_	ADJ	JJ	_	19	amod	_	_
19	females	_	NOUN	NNS	_	4	conj	_	_

#	Sertraline Hydrochloride	1588
1	Liver	_	NOUN	NN	_	3	compound	_	_
2	Disease	_	NOUN	NN	_	3	compound	_	_
3	As	_	NOUN	NN	_	6	nsubjpass	_	_
4	might	_	VERB	MD	_	6	aux	_	_
5	be	_	VERB	VB	_	6	auxpass	_	_
6	predicted	_	VERB	VBN	_	17	advcl	_	_
7	from	_	ADP	IN	_	10	case	_	_
8	its	_	PRON	PRP$	_	10	nmod:poss	_	_
9	primary	_	ADJ	JJ	_	10	amod	_	_
10	site	_	NOUN	NN	_	6	nmod	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	metabolism	_	NOUN	NN	_	10	nmod	_	_
13	,	_	.	,	_	17	punct	_	_
14	liver	_	NOUN	NN	_	15	compound	_	_
15	impairment	_	NOUN	NN	_	17	nsubj	_	_
16	can	_	VERB	MD	_	17	aux	_	_
17	affect	_	VERB	VB	_	0	root	_	_
18	the	_	DET	DT	_	19	det	_	_
19	elimination	_	NOUN	NN	_	17	dobj	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	DRUG	_	NOUN	NN	_	19	nmod	_	_

#	Sertraline Hydrochloride	1589
1	In	_	ADP	IN	_	2	case	_	_
2	patients	_	NOUN	NNS	_	48	nmod	_	_
3	with	_	ADP	IN	_	8	case	_	_
4	chronic	_	ADJ	JJ	_	8	amod	_	_
5	mild	_	ADJ	JJ	_	8	amod	_	_
6	liver	_	NOUN	NN	_	8	compound	_	_
7	impairment	_	NOUN	NN	_	8	compound	_	_
8	N	_	NOUN	NN	_	2	nmod	_	_
9	=	_	ADJ	JJ	_	8	amod	_	_
10	10	_	NUM	CD	_	9	dep	_	_
11	,	_	.	,	_	48	punct	_	_
12	8	_	NUM	CD	_	13	nummod	_	_
13	patients	_	NOUN	NNS	_	48	nsubjpass	_	_
14	with	_	ADP	IN	_	17	case	_	_
15	Child	_	NOUN	NN	_	17	amod	_	_
16	Pugh	_	NOUN	NN	_	17	compound	_	_
17	scores	_	NOUN	NNS	_	13	nmod	_	_
18	of	_	ADP	IN	_	24	case	_	_
19	5	_	NUM	CD	_	21	compound	_	_
20	to	_	PRT	TO	_	21	dep	_	_
21	6	_	NUM	CD	_	24	nummod	_	_
22	and	_	CONJ	CC	_	21	cc	_	_
23	2	_	NUM	CD	_	21	conj	_	_
24	patients	_	NOUN	NNS	_	17	nmod	_	_
25	with	_	ADP	IN	_	28	case	_	_
26	Child	_	NOUN	NN	_	28	amod	_	_
27	Pugh	_	NOUN	NN	_	28	compound	_	_
28	scores	_	NOUN	NNS	_	24	nmod	_	_
29	of	_	ADP	IN	_	32	case	_	_
30	7	_	NUM	CD	_	32	nummod	_	_
31	to	_	PRT	TO	_	32	case	_	_
32	8	_	NUM	CD	_	28	nmod	_	_
33	who	_	DET	WDT	_	34	nsubj	_	_
34	received	_	VERB	VBD	_	32	acl:relcl	_	_
35	50	_	NUM	CD	_	37	nummod	_	_
36	mg	_	NOUN	NN	_	37	compound	_	_
37	DRUG	_	NOUN	NN	_	34	dobj	_	_
38	per	_	ADP	IN	_	39	case	_	_
39	day	_	NOUN	NN	_	34	nmod	_	_
40	maintained	_	VERB	VBN	_	39	acl	_	_
41	for	_	ADP	IN	_	43	case	_	_
42	21	_	NUM	CD	_	43	nummod	_	_
43	days	_	NOUN	NNS	_	40	nmod	_	_
44	,	_	.	,	_	48	punct	_	_
45	DRUG	_	NOUN	NN	_	46	compound	_	_
46	clearance	_	NOUN	NN	_	48	nsubjpass	_	_
47	was	_	VERB	VBD	_	48	auxpass	_	_
48	reduced	_	VERB	VBN	_	0	root	_	_
49	,	_	.	,	_	48	punct	_	_
50	resulting	_	VERB	VBG	_	48	advcl	_	_
51	in	_	ADP	IN	_	56	case	_	_
52	approximately	_	ADV	RB	_	53	advmod	_	_
53	3	_	NUM	CD	_	56	nummod	_	_
54	fold	_	NOUN	NN	_	56	amod	_	_
55	greater	_	ADJ	JJ	_	56	amod	_	_
56	exposure	_	NOUN	NN	_	50	nmod	_	_
57	compared	_	VERB	VBN	_	50	parataxis	_	_
58	to	_	PRT	TO	_	59	mark	_	_
59	age	_	VERB	VB	_	57	xcomp	_	_
60	matched	_	VERB	VBN	_	61	amod	_	_
61	volunteers	_	NOUN	NNS	_	59	dobj	_	_
62	with	_	ADP	IN	_	66	case	_	_
63	no	_	DET	DT	_	66	neg	_	_
64	hepatic	_	ADJ	JJ	_	66	amod	_	_
65	impairment	_	NOUN	NN	_	66	compound	_	_
66	N	_	NOUN	NN	_	61	nmod	_	_
67	=	_	DET	DT	_	66	dep	_	_
68	10	_	NUM	CD	_	67	neg	_	_

#	Sertraline Hydrochloride	1590
1	The	_	DET	DT	_	2	det	_	_
2	exposure	_	NOUN	NN	_	10	nsubj	_	_
3	to	_	PRT	TO	_	4	mark	_	_
4	desmethyl	_	ADJ	JJ	_	2	acl	_	_
5	DRUG	_	NOUN	NN	_	4	dobj	_	_
6	was	_	VERB	VBD	_	10	cop	_	_
7	approximately	_	ADV	RB	_	8	advmod	_	_
8	2	_	NUM	CD	_	9	nummod	_	_
9	fold	_	NOUN	NN	_	10	advmod	_	_
10	greater	_	ADJ	JJ	_	0	root	_	_
11	compared	_	VERB	VBN	_	10	dep	_	_
12	to	_	PRT	TO	_	13	mark	_	_
13	age	_	VERB	VB	_	11	xcomp	_	_
14	matched	_	VERB	VBN	_	15	amod	_	_
15	volunteers	_	NOUN	NNS	_	13	dobj	_	_
16	with	_	ADP	IN	_	19	case	_	_
17	no	_	DET	DT	_	19	neg	_	_
18	hepatic	_	ADJ	JJ	_	19	amod	_	_
19	impairment	_	NOUN	NN	_	15	nmod	_	_

#	Sertraline Hydrochloride	1591
1	There	_	DET	EX	_	2	expl	_	_
2	were	_	VERB	VBD	_	0	root	_	_
3	no	_	DET	DT	_	5	neg	_	_
4	significant	_	ADJ	JJ	_	5	amod	_	_
5	differences	_	NOUN	NNS	_	2	nsubj	_	_
6	in	_	ADP	IN	_	9	case	_	_
7	plasma	_	NOUN	NN	_	9	compound	_	_
8	protein	_	NOUN	NN	_	9	compound	_	_
9	binding	_	NOUN	NN	_	2	nmod	_	_
10	observed	_	VERB	VBN	_	9	acl	_	_
11	between	_	ADP	IN	_	14	case	_	_
12	the	_	DET	DT	_	14	det	_	_
13	two	_	NUM	CD	_	14	nummod	_	_
14	groups	_	NOUN	NNS	_	10	nmod	_	_

#	Sertraline Hydrochloride	1592
1	The	_	DET	DT	_	2	det	_	_
2	effects	_	NOUN	NNS	_	16	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	in	_	ADP	IN	_	6	case	_	_
6	patients	_	NOUN	NNS	_	2	nmod	_	_
7	with	_	ADP	IN	_	12	case	_	_
8	moderate	_	ADJ	JJ	_	12	amod	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	severe	_	ADJ	JJ	_	8	conj	_	_
11	hepatic	_	ADJ	JJ	_	12	amod	_	_
12	impairment	_	NOUN	NN	_	6	nmod	_	_
13	have	_	VERB	MD	_	16	aux	_	_
14	not	_	ADV	RB	_	16	neg	_	_
15	been	_	VERB	VBN	_	16	auxpass	_	_
16	studied	_	VERB	VBN	_	0	root	_	_

#	Sertraline Hydrochloride	1593
1	The	_	DET	DT	_	2	det	_	_
2	results	_	NOUN	NNS	_	3	nsubj	_	_
3	suggest	_	VERB	VBP	_	0	root	_	_
4	that	_	ADP	IN	_	16	mark	_	_
5	the	_	DET	DT	_	6	det	_	_
6	use	_	NOUN	NN	_	16	nsubjpass	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	in	_	ADP	IN	_	10	case	_	_
10	patients	_	NOUN	NNS	_	6	nmod	_	_
11	with	_	ADP	IN	_	13	case	_	_
12	liver	_	NOUN	NN	_	13	compound	_	_
13	disease	_	NOUN	NN	_	10	nmod	_	_
14	must	_	VERB	MD	_	16	aux	_	_
15	be	_	VERB	VB	_	16	auxpass	_	_
16	approached	_	VERB	VBN	_	3	ccomp	_	_
17	with	_	ADP	IN	_	18	case	_	_
18	caution	_	NOUN	NN	_	16	nmod	_	_

#	Sertraline Hydrochloride	1594
1	If	_	ADP	IN	_	4	mark	_	_
2	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
3	is	_	VERB	VBZ	_	4	auxpass	_	_
4	administered	_	VERB	VBN	_	19	advcl	_	_
5	to	_	PRT	TO	_	6	case	_	_
6	patients	_	NOUN	NNS	_	4	nmod	_	_
7	with	_	ADP	IN	_	9	case	_	_
8	liver	_	NOUN	NN	_	9	compound	_	_
9	impairment	_	NOUN	NN	_	6	nmod	_	_
10	,	_	.	,	_	19	punct	_	_
11	a	_	DET	DT	_	16	det	_	_
12	lower	_	ADJ	JJ	_	16	amod	_	_
13	or	_	CONJ	CC	_	12	cc	_	_
14	less	_	ADV	RB	_	15	advmod	_	_
15	frequent	_	ADJ	JJ	_	12	conj	_	_
16	dose	_	NOUN	NN	_	19	nsubjpass	_	_
17	should	_	VERB	MD	_	19	aux	_	_
18	be	_	VERB	VB	_	19	auxpass	_	_
19	used	_	VERB	VBN	_	0	root	_	_

#	Sertraline Hydrochloride	1595
1	Renal	_	ADJ	JJ	_	3	amod	_	_
2	Disease	_	NOUN	NN	_	3	compound	_	_
3	DRUG	_	NOUN	NN	_	6	nsubjpass	_	_
4	is	_	VERB	VBZ	_	6	auxpass	_	_
5	extensively	_	ADV	RB	_	6	advmod	_	_
6	metabolized	_	VERB	VBN	_	0	root	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	excretion	_	NOUN	NN	_	17	nsubj	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	unchanged	_	ADJ	JJ	_	11	amod	_	_
11	drug	_	NOUN	NN	_	8	nmod	_	_
12	in	_	ADP	IN	_	13	case	_	_
13	urine	_	NOUN	NN	_	8	nmod	_	_
14	is	_	VERB	VBZ	_	17	cop	_	_
15	a	_	DET	DT	_	17	det	_	_
16	minor	_	ADJ	JJ	_	17	amod	_	_
17	route	_	NOUN	NN	_	6	conj	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	elimination	_	NOUN	NN	_	17	nmod	_	_

#	Sertraline Hydrochloride	1596
1	In	_	ADP	IN	_	2	case	_	_
2	volunteers	_	NOUN	NNS	_	56	nmod	_	_
3	with	_	ADP	IN	_	4	case	_	_
4	mild	_	ADJ	JJ	_	2	nmod	_	_
5	to	_	PRT	TO	_	6	mark	_	_
6	moderate	_	ADJ	JJ	_	4	acl	_	_
7	CLcr	_	NOUN	NN	_	6	dobj	_	_
8	=	_	ADJ	JJ	_	7	amod	_	_
9	30	_	NUM	CD	_	11	compound	_	_
10	to	_	PRT	TO	_	11	dep	_	_
11	60	_	NUM	CD	_	12	nummod	_	_
12	mL	_	NOUN	NN	_	8	nmod	_	_
13	/	_	.	:	_	12	punct	_	_
14	min	_	NOUN	NN	_	12	dep	_	_
15	,	_	.	,	_	56	punct	_	_
16	moderate	_	ADJ	JJ	_	56	advcl	_	_
17	to	_	PRT	TO	_	19	case	_	_
18	severe	_	ADJ	JJ	_	19	amod	_	_
19	CLcr	_	NOUN	NN	_	16	nmod	_	_
20	=	_	ADJ	JJ	_	19	amod	_	_
21	10	_	NUM	CD	_	23	compound	_	_
22	to	_	PRT	TO	_	23	dep	_	_
23	29	_	NUM	CD	_	24	nummod	_	_
24	mL	_	NOUN	NN	_	20	nmod	_	_
25	/	_	.	:	_	24	punct	_	_
26	min	_	NOUN	NN	_	24	dep	_	_
27	or	_	CONJ	CC	_	26	cc	_	_
28	severe	_	ADJ	JJ	_	33	amod	_	_
29	receiving	_	VERB	VBG	_	33	amod	_	_
30	hemodialysis	_	NOUN	NN	_	33	compound	_	_
31	renal	_	ADJ	JJ	_	33	amod	_	_
32	impairment	_	NOUN	NN	_	33	compound	_	_
33	N	_	NOUN	NN	_	26	conj	_	_
34	=	_	ADJ	JJ	_	33	amod	_	_
35	10	_	NUM	CD	_	37	nummod	_	_
36	each	_	DET	DT	_	37	det	_	_
37	group	_	NOUN	NN	_	34	dobj	_	_
38	,	_	.	,	_	56	punct	_	_
39	the	_	DET	DT	_	40	det	_	_
40	pharmacokinetics	_	NOUN	NNS	_	56	nsubjpass	_	_
41	and	_	CONJ	CC	_	40	cc	_	_
42	protein	_	NOUN	NN	_	43	compound	_	_
43	binding	_	NOUN	NN	_	40	conj	_	_
44	of	_	ADP	IN	_	47	case	_	_
45	200	_	NUM	CD	_	47	nummod	_	_
46	mg	_	NOUN	NN	_	47	compound	_	_
47	DRUG	_	NOUN	NN	_	40	nmod	_	_
48	per	_	ADP	IN	_	49	case	_	_
49	day	_	NOUN	NN	_	40	nmod	_	_
50	maintained	_	VERB	VBN	_	49	acl	_	_
51	for	_	ADP	IN	_	53	case	_	_
52	21	_	NUM	CD	_	53	nummod	_	_
53	days	_	NOUN	NNS	_	50	nmod	_	_
54	were	_	VERB	VBD	_	56	auxpass	_	_
55	not	_	ADV	RB	_	56	neg	_	_
56	altered	_	VERB	VBN	_	0	root	_	_
57	compared	_	VERB	VBN	_	56	xcomp	_	_
58	to	_	PRT	TO	_	59	mark	_	_
59	age	_	VERB	VB	_	57	xcomp	_	_
60	matched	_	VERB	VBN	_	61	amod	_	_
61	volunteers	_	NOUN	NNS	_	59	dobj	_	_
62	N	_	NOUN	NN	_	61	dep	_	_
63	=	_	ADJ	JJ	_	61	acl	_	_
64	12	_	NUM	CD	_	63	dep	_	_
65	with	_	ADP	IN	_	68	case	_	_
66	no	_	DET	DT	_	68	neg	_	_
67	renal	_	ADJ	JJ	_	68	amod	_	_
68	impairment	_	NOUN	NN	_	63	nmod	_	_

#	Sertraline Hydrochloride	1597
1	Thus	_	ADV	RB	_	6	advmod	_	_
2	DRUG	_	NOUN	NN	_	5	compound	_	_
3	multiple	_	ADJ	JJ	_	5	amod	_	_
4	dose	_	NOUN	NN	_	5	compound	_	_
5	pharmacokinetics	_	NOUN	NNS	_	6	nsubj	_	_
6	appear	_	VERB	VBP	_	0	root	_	_
7	to	_	PRT	TO	_	9	mark	_	_
8	be	_	VERB	VB	_	9	cop	_	_
9	unaffected	_	ADJ	JJ	_	6	xcomp	_	_
10	by	_	ADP	IN	_	12	case	_	_
11	renal	_	ADJ	JJ	_	12	amod	_	_
12	impairment	_	NOUN	NN	_	9	nmod	_	_

#	Sertraline Hydrochloride	1598
1	Clinical	_	ADJ	JJ	_	2	amod	_	_
2	Trials	_	NOUN	NNS	_	0	root	_	_
3	Major	_	ADJ	JJ	_	5	amod	_	_
4	Depressive	_	ADJ	JJ	_	5	amod	_	_
5	Disorder	_	NOUN	NN	_	2	dep	_	_
6	The	_	DET	DT	_	7	det	_	_
7	efficacy	_	NOUN	NN	_	18	nsubjpass	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	as	_	ADP	IN	_	12	case	_	_
11	a	_	DET	DT	_	12	det	_	_
12	treatment	_	NOUN	NN	_	7	nmod	_	_
13	for	_	ADP	IN	_	16	case	_	_
14	major	_	ADJ	JJ	_	16	amod	_	_
15	depressive	_	ADJ	JJ	_	16	amod	_	_
16	disorder	_	NOUN	NN	_	12	nmod	_	_
17	was	_	VERB	VBD	_	18	auxpass	_	_
18	established	_	VERB	VBN	_	5	dep	_	_
19	in	_	ADP	IN	_	23	case	_	_
20	two	_	NUM	CD	_	23	nummod	_	_
21	placebo	_	NOUN	NN	_	23	compound	_	_
22	controlled	_	ADJ	JJ	_	23	amod	_	_
23	studies	_	NOUN	NNS	_	18	nmod	_	_
24	in	_	ADP	IN	_	26	case	_	_
25	adult	_	ADJ	JJ	_	26	amod	_	_
26	outpatients	_	NOUN	NNS	_	23	nmod	_	_
27	meeting	_	VERB	VBG	_	26	acl	_	_
28	DSM	_	NOUN	NN	_	30	compound	_	_
29	III	_	NUM	CD	_	30	nummod	_	_
30	criteria	_	NOUN	NN	_	27	dobj	_	_
31	for	_	ADP	IN	_	34	case	_	_
32	major	_	ADJ	JJ	_	34	amod	_	_
33	depressive	_	ADJ	JJ	_	34	amod	_	_
34	disorder	_	NOUN	NN	_	30	nmod	_	_

#	Sertraline Hydrochloride	1599
1	Study	_	NOUN	NN	_	7	nsubj	_	_
2	1	_	NUM	CD	_	1	nummod	_	_
3	was	_	VERB	VBD	_	7	cop	_	_
4	an	_	DET	DT	_	7	det	_	_
5	8	_	NUM	CD	_	7	nummod	_	_
6	week	_	NOUN	NN	_	7	compound	_	_
7	study	_	NOUN	NN	_	0	root	_	_
8	with	_	ADP	IN	_	10	case	_	_
9	flexible	_	ADJ	JJ	_	10	amod	_	_
10	dosing	_	NOUN	NN	_	7	nmod	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_
13	in	_	ADP	IN	_	15	case	_	_
14	a	_	DET	DT	_	15	det	_	_
15	range	_	NOUN	NN	_	10	nmod	_	_
16	of	_	ADP	IN	_	20	case	_	_
17	50	_	NUM	CD	_	19	compound	_	_
18	to	_	PRT	TO	_	19	dep	_	_
19	200	_	NUM	CD	_	20	nummod	_	_
20	mg	_	NOUN	NN	_	15	nmod	_	_
21	/	_	.	:	_	7	punct	_	_
22	day	_	NOUN	NN	_	7	dep	_	_
23	the	_	DET	DT	_	25	det	_	_
24	mean	_	NOUN	NN	_	25	compound	_	_
25	dose	_	NOUN	NN	_	32	nsubj	_	_
26	for	_	ADP	IN	_	27	case	_	_
27	completers	_	NOUN	NNS	_	25	nmod	_	_
28	was	_	VERB	VBD	_	32	cop	_	_
29	145	_	NUM	CD	_	32	nummod	_	_
30	mg	_	NOUN	NN	_	32	compound	_	_
31	/	_	.	:	_	32	compound	_	_
32	day	_	NOUN	NN	_	22	nmod	_	_

#	Sertraline Hydrochloride	1600
1	Study	_	NOUN	NN	_	9	nsubj	_	_
2	2	_	NUM	CD	_	1	nummod	_	_
3	was	_	VERB	VBD	_	9	cop	_	_
4	a	_	DET	DT	_	9	det	_	_
5	6	_	NUM	CD	_	9	nummod	_	_
6	week	_	NOUN	NN	_	9	compound	_	_
7	fixed	_	VERB	VBN	_	9	amod	_	_
8	dose	_	NOUN	NN	_	9	compound	_	_
9	study	_	NOUN	NN	_	0	root	_	_
10	,	_	.	,	_	9	punct	_	_
11	including	_	VERB	VBG	_	13	case	_	_
12	DRUG	_	NOUN	NN	_	13	compound	_	_
13	doses	_	NOUN	NNS	_	9	nmod	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	50	_	NUM	CD	_	23	nummod	_	_
16	,	_	.	,	_	15	punct	_	_
17	100	_	NUM	CD	_	15	conj	_	_
18	,	_	.	,	_	15	punct	_	_
19	and	_	CONJ	CC	_	15	cc	_	_
20	200	_	NUM	CD	_	21	nummod	_	_
21	mg	_	NOUN	NN	_	15	conj	_	_
22	/	_	.	:	_	23	punct	_	_
23	day	_	NOUN	NN	_	13	nmod	_	_

#	Sertraline Hydrochloride	1601
1	Overall	_	ADV	RB	_	5	advmod	_	_
2	,	_	.	,	_	5	punct	_	_
3	these	_	DET	DT	_	4	det	_	_
4	studies	_	NOUN	NNS	_	5	nsubj	_	_
5	demonstrated	_	VERB	VBD	_	0	root	_	_
6	DRUG	_	NOUN	NN	_	5	dobj	_	_
7	to	_	PRT	TO	_	9	mark	_	_
8	be	_	VERB	VB	_	9	cop	_	_
9	superior	_	NOUN	NN	_	5	xcomp	_	_
10	to	_	PRT	TO	_	11	case	_	_
11	placebo	_	NOUN	NN	_	9	nmod	_	_
12	on	_	ADP	IN	_	17	case	_	_
13	the	_	DET	DT	_	17	det	_	_
14	Hamilton	_	NOUN	NN	_	17	compound	_	_
15	Depression	_	NOUN	NN	_	17	compound	_	_
16	Rating	_	VERB	VBG	_	17	compound	_	_
17	Scale	_	NOUN	NN	_	9	nmod	_	_
18	and	_	CONJ	CC	_	9	cc	_	_
19	the	_	DET	DT	_	23	det	_	_
20	Clinical	_	ADJ	JJ	_	23	amod	_	_
21	Global	_	ADJ	JJ	_	23	amod	_	_
22	Impression	_	NOUN	NN	_	23	compound	_	_
23	Severity	_	NOUN	NN	_	9	conj	_	_
24	and	_	CONJ	CC	_	23	cc	_	_
25	Improvement	_	NOUN	NN	_	26	compound	_	_
26	scales	_	NOUN	NNS	_	23	conj	_	_

#	Sertraline Hydrochloride	1602
1	Study	_	NOUN	NN	_	6	nsubj	_	_
2	2	_	NUM	CD	_	1	nummod	_	_
3	was	_	VERB	VBD	_	6	cop	_	_
4	not	_	ADV	RB	_	6	neg	_	_
5	readily	_	ADV	RB	_	6	advmod	_	_
6	interpretable	_	ADJ	JJ	_	0	root	_	_
7	regarding	_	ADP	IN	_	11	case	_	_
8	a	_	DET	DT	_	11	det	_	_
9	dose	_	NOUN	NN	_	11	compound	_	_
10	response	_	NOUN	NN	_	11	compound	_	_
11	relationship	_	NOUN	NN	_	6	nmod	_	_
12	for	_	ADP	IN	_	13	case	_	_
13	effectiveness	_	NOUN	NN	_	11	nmod	_	_

#	Sertraline Hydrochloride	1603
1	Study	_	NOUN	NN	_	3	nsubj	_	_
2	3	_	NUM	CD	_	1	nummod	_	_
3	involved	_	VERB	VBD	_	0	root	_	_
4	depressed	_	VERB	VBN	_	5	amod	_	_
5	outpatients	_	NOUN	NNS	_	3	dobj	_	_
6	who	_	DET	WDT	_	8	nsubj	_	_
7	had	_	VERB	MD	_	8	aux	_	_
8	responded	_	VERB	VBN	_	5	acl:relcl	_	_
9	by	_	ADP	IN	_	11	case	_	_
10	the	_	DET	DT	_	11	det	_	_
11	end	_	NOUN	NN	_	8	nmod	_	_
12	of	_	ADP	IN	_	19	case	_	_
13	an	_	DET	DT	_	19	det	_	_
14	initial	_	ADJ	JJ	_	19	amod	_	_
15	8	_	NUM	CD	_	19	nummod	_	_
16	week	_	NOUN	NN	_	19	compound	_	_
17	open	_	ADJ	JJ	_	19	amod	_	_
18	treatment	_	NOUN	NN	_	19	compound	_	_
19	phase	_	NOUN	NN	_	11	nmod	_	_
20	on	_	ADP	IN	_	21	case	_	_
21	DRUG	_	NOUN	NN	_	11	nmod	_	_
22	50	_	NUM	CD	_	21	nummod	_	_
23	to	_	PRT	TO	_	27	case	_	_
24	200	_	NUM	CD	_	25	nummod	_	_
25	mg	_	NOUN	NN	_	27	compound	_	_
26	/	_	NUM	CD	_	27	punct	_	_
27	day	_	NOUN	NN	_	11	nmod	_	_

#	Sertraline Hydrochloride	1604
1	These	_	DET	DT	_	2	det	_	_
2	patients	_	NOUN	NNS	_	7	nsubjpass	_	_
3	N	_	NOUN	NN	_	4	nsubj	_	_
4	=	_	ADJ	JJ	_	2	amod	_	_
5	295	_	NUM	CD	_	4	dobj	_	_
6	were	_	VERB	VBD	_	7	auxpass	_	_
7	randomized	_	VERB	VBN	_	0	root	_	_
8	to	_	PRT	TO	_	9	case	_	_
9	continuation	_	NOUN	NN	_	7	nmod	_	_
10	for	_	ADP	IN	_	12	case	_	_
11	44	_	NUM	CD	_	12	nummod	_	_
12	weeks	_	NOUN	NNS	_	9	nmod	_	_
13	on	_	ADP	IN	_	16	case	_	_
14	double	_	ADJ	JJ	_	16	amod	_	_
15	blind	_	NOUN	NN	_	16	compound	_	_
16	DRUG	_	NOUN	NN	_	9	nmod	_	_
17	50	_	NUM	CD	_	19	compound	_	_
18	to	_	PRT	TO	_	19	dep	_	_
19	200	_	NUM	CD	_	20	nummod	_	_
20	mg	_	NOUN	NN	_	16	dep	_	_
21	/	_	.	:	_	16	punct	_	_
22	day	_	NOUN	NN	_	16	dep	_	_
23	or	_	CONJ	CC	_	22	cc	_	_
24	placebo	_	NOUN	NN	_	22	conj	_	_

#	Sertraline Hydrochloride	1605
1	A	_	DET	DT	_	6	det	_	_
2	statistically	_	ADV	RB	_	3	advmod	_	_
3	significantly	_	ADV	RB	_	4	advmod	_	_
4	lower	_	ADJ	JJ	_	6	amod	_	_
5	relapse	_	NOUN	NN	_	6	compound	_	_
6	rate	_	NOUN	NN	_	8	nsubjpass	_	_
7	was	_	VERB	VBD	_	8	auxpass	_	_
8	observed	_	VERB	VBN	_	0	root	_	_
9	for	_	ADP	IN	_	10	case	_	_
10	patients	_	NOUN	NNS	_	8	nmod	_	_
11	taking	_	VERB	VBG	_	10	acl	_	_
12	DRUG	_	NOUN	NN	_	11	dobj	_	_
13	compared	_	VERB	VBN	_	8	xcomp	_	_
14	to	_	PRT	TO	_	15	case	_	_
15	those	_	DET	DT	_	13	nmod	_	_
16	on	_	ADP	IN	_	17	case	_	_
17	placebo	_	NOUN	NN	_	15	nmod	_	_

#	Sertraline Hydrochloride	1606
1	The	_	DET	DT	_	3	det	_	_
2	mean	_	ADJ	JJ	_	3	amod	_	_
3	dose	_	NOUN	NN	_	10	nsubj	_	_
4	for	_	ADP	IN	_	5	case	_	_
5	completers	_	NOUN	NNS	_	3	nmod	_	_
6	was	_	VERB	VBD	_	10	cop	_	_
7	70	_	NUM	CD	_	10	nummod	_	_
8	mg	_	NOUN	NN	_	10	compound	_	_
9	/	_	.	:	_	10	compound	_	_
10	day	_	NOUN	NN	_	0	root	_	_

#	Sertraline Hydrochloride	1607
1	Analyses	_	NOUN	NNS	_	9	nsubj	_	_
2	for	_	ADP	IN	_	4	case	_	_
3	gender	_	NOUN	NN	_	4	compound	_	_
4	effects	_	NOUN	NNS	_	1	nmod	_	_
5	on	_	ADP	IN	_	6	case	_	_
6	outcome	_	NOUN	NN	_	1	nmod	_	_
7	did	_	VERB	VBD	_	9	aux	_	_
8	not	_	ADV	RB	_	9	neg	_	_
9	suggest	_	VERB	VB	_	0	root	_	_
10	any	_	DET	DT	_	12	det	_	_
11	differential	_	ADJ	JJ	_	12	amod	_	_
12	responsiveness	_	NOUN	NN	_	9	dobj	_	_
13	on	_	ADP	IN	_	15	case	_	_
14	the	_	DET	DT	_	15	det	_	_
15	basis	_	NOUN	NN	_	9	nmod	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	sex	_	NOUN	NN	_	15	nmod	_	_

#	Sertraline Hydrochloride	1608
1	Obsessive	_	ADJ	JJ	_	4	amod	_	_
2	Compulsive	_	ADJ	JJ	_	4	amod	_	_
3	Disorder	_	NOUN	NN	_	4	compound	_	_
4	OCD	_	NOUN	NN	_	15	nsubjpass	_	_
5	The	_	DET	DT	_	6	det	_	_
6	effectiveness	_	NOUN	NN	_	4	dep	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	in	_	ADP	IN	_	11	case	_	_
10	the	_	DET	DT	_	11	det	_	_
11	treatment	_	NOUN	NN	_	6	nmod	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	OCD	_	NOUN	NN	_	11	nmod	_	_
14	was	_	VERB	VBD	_	15	auxpass	_	_
15	demonstrated	_	VERB	VBN	_	0	root	_	_
16	in	_	ADP	IN	_	21	case	_	_
17	three	_	NUM	CD	_	21	nummod	_	_
18	multicenter	_	ADJ	JJ	_	21	amod	_	_
19	placebo	_	NOUN	NN	_	21	compound	_	_
20	controlled	_	VERB	VBN	_	21	amod	_	_
21	studies	_	NOUN	NNS	_	15	nmod	_	_
22	of	_	ADP	IN	_	25	case	_	_
23	adult	_	ADJ	JJ	_	25	amod	_	_
24	outpatients	_	NOUN	NNS	_	25	compound	_	_
25	Studies	_	NOUN	NNS	_	21	nmod	_	_
26	1	_	NUM	CD	_	28	compound	_	_
27	to	_	PRT	TO	_	28	dep	_	_
28	3	_	NUM	CD	_	25	dep	_	_

#	Sertraline Hydrochloride	1609
1	Patients	_	NOUN	NNS	_	6	nsubj	_	_
2	in	_	ADP	IN	_	4	case	_	_
3	all	_	DET	DT	_	4	det	_	_
4	studies	_	NOUN	NNS	_	1	nmod	_	_
5	had	_	VERB	VBD	_	6	aux	_	_
6	moderate	_	ADJ	JJ	_	0	root	_	_
7	to	_	PRT	TO	_	10	case	_	_
8	severe	_	ADJ	JJ	_	10	amod	_	_
9	OCD	_	NOUN	NN	_	10	compound	_	_
10	DSM	_	NOUN	NN	_	6	nmod	_	_
11	III	_	NUM	CD	_	10	nummod	_	_
12	or	_	CONJ	CC	_	10	cc	_	_
13	DSM	_	NOUN	NN	_	15	compound	_	_
14	III	_	NUM	CD	_	15	nummod	_	_
15	R	_	NOUN	NN	_	10	conj	_	_
16	with	_	ADP	IN	_	19	case	_	_
17	mean	_	NOUN	NN	_	19	amod	_	_
18	baseline	_	NOUN	NN	_	19	compound	_	_
19	ratings	_	NOUN	NNS	_	6	nmod	_	_
20	on	_	ADP	IN	_	29	case	_	_
21	the	_	DET	DT	_	29	det	_	_
22	Yale	_	NOUN	NN	_	29	compound	_	_
23	Brown	_	VERB	VBN	_	29	amod	_	_
24	Obsessive	_	ADJ	JJ	_	29	amod	_	_
25	Compulsive	_	ADJ	JJ	_	29	amod	_	_
26	Scale	_	NOUN	NN	_	29	compound	_	_
27	YBOCS	_	NOUN	NN	_	29	compound	_	_
28	total	_	ADJ	JJ	_	29	amod	_	_
29	score	_	NOUN	NN	_	19	nmod	_	_
30	ranging	_	VERB	VBG	_	29	acl	_	_
31	from	_	ADP	IN	_	34	case	_	_
32	23	_	NUM	CD	_	34	compound	_	_
33	to	_	PRT	TO	_	34	dep	_	_
34	25	_	NUM	CD	_	30	nmod	_	_

#	Sertraline Hydrochloride	1610
1	Study	_	NOUN	NN	_	7	nsubj	_	_
2	1	_	NUM	CD	_	1	nummod	_	_
3	was	_	VERB	VBD	_	7	cop	_	_
4	an	_	DET	DT	_	7	det	_	_
5	8	_	NUM	CD	_	7	nummod	_	_
6	week	_	NOUN	NN	_	7	compound	_	_
7	study	_	NOUN	NN	_	0	root	_	_
8	with	_	ADP	IN	_	10	case	_	_
9	flexible	_	ADJ	JJ	_	10	amod	_	_
10	dosing	_	NOUN	NN	_	7	nmod	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_
13	in	_	ADP	IN	_	15	case	_	_
14	a	_	DET	DT	_	15	det	_	_
15	range	_	NOUN	NN	_	10	nmod	_	_
16	of	_	ADP	IN	_	20	case	_	_
17	50	_	NUM	CD	_	19	compound	_	_
18	to	_	PRT	TO	_	19	dep	_	_
19	200	_	NUM	CD	_	20	nummod	_	_
20	mg	_	NOUN	NN	_	15	nmod	_	_
21	/	_	.	:	_	7	punct	_	_
22	day	_	NOUN	NN	_	7	dep	_	_
23	the	_	DET	DT	_	25	det	_	_
24	mean	_	NOUN	NN	_	25	compound	_	_
25	dose	_	NOUN	NN	_	32	nsubj	_	_
26	for	_	ADP	IN	_	27	case	_	_
27	completers	_	NOUN	NNS	_	25	nmod	_	_
28	was	_	VERB	VBD	_	32	cop	_	_
29	186	_	NUM	CD	_	32	nummod	_	_
30	mg	_	NOUN	NN	_	32	compound	_	_
31	/	_	.	:	_	32	compound	_	_
32	day	_	NOUN	NN	_	22	nmod	_	_

#	Sertraline Hydrochloride	1611
1	Patients	_	NOUN	NNS	_	4	nsubj	_	_
2	receiving	_	VERB	VBG	_	1	acl	_	_
3	DRUG	_	NOUN	NN	_	2	dobj	_	_
4	experienced	_	VERB	VBD	_	0	root	_	_
5	a	_	DET	DT	_	7	det	_	_
6	mean	_	ADJ	JJ	_	7	amod	_	_
7	reduction	_	NOUN	NN	_	4	dobj	_	_
8	of	_	ADP	IN	_	11	case	_	_
9	approximately	_	ADV	RB	_	10	advmod	_	_
10	4	_	NUM	CD	_	11	nummod	_	_
11	points	_	NOUN	NNS	_	7	nmod	_	_
12	on	_	ADP	IN	_	16	case	_	_
13	the	_	DET	DT	_	16	det	_	_
14	YBOCS	_	NOUN	NN	_	16	compound	_	_
15	total	_	ADJ	JJ	_	16	amod	_	_
16	score	_	NOUN	NN	_	7	nmod	_	_
17	which	_	DET	WDT	_	20	nsubj	_	_
18	was	_	VERB	VBD	_	20	cop	_	_
19	significantly	_	ADV	RB	_	20	advmod	_	_
20	greater	_	ADJ	JJ	_	16	acl:relcl	_	_
21	than	_	ADP	IN	_	24	case	_	_
22	the	_	DET	DT	_	24	det	_	_
23	mean	_	NOUN	NN	_	24	amod	_	_
24	reduction	_	NOUN	NN	_	20	nmod	_	_
25	of	_	ADP	IN	_	27	case	_	_
26	2	_	NUM	CD	_	27	nummod	_	_
27	points	_	NOUN	NNS	_	24	nmod	_	_
28	in	_	ADP	IN	_	31	case	_	_
29	placebo	_	NOUN	NN	_	31	compound	_	_
30	treated	_	ADJ	JJ	_	31	amod	_	_
31	patients	_	NOUN	NNS	_	24	nmod	_	_

#	Sertraline Hydrochloride	1612
1	Study	_	NOUN	NN	_	9	nsubj	_	_
2	2	_	NUM	CD	_	1	nummod	_	_
3	was	_	VERB	VBD	_	9	cop	_	_
4	a	_	DET	DT	_	9	det	_	_
5	12	_	NUM	CD	_	9	nummod	_	_
6	week	_	NOUN	NN	_	9	compound	_	_
7	fixed	_	VERB	VBN	_	9	amod	_	_
8	dose	_	NOUN	NN	_	9	compound	_	_
9	study	_	NOUN	NN	_	0	root	_	_
10	,	_	.	,	_	9	punct	_	_
11	including	_	VERB	VBG	_	13	case	_	_
12	DRUG	_	NOUN	NN	_	13	compound	_	_
13	doses	_	NOUN	NNS	_	9	nmod	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	50	_	NUM	CD	_	23	nummod	_	_
16	,	_	.	,	_	15	punct	_	_
17	100	_	NUM	CD	_	15	conj	_	_
18	,	_	.	,	_	15	punct	_	_
19	and	_	CONJ	CC	_	15	cc	_	_
20	200	_	NUM	CD	_	21	nummod	_	_
21	mg	_	NOUN	NN	_	15	conj	_	_
22	/	_	.	:	_	23	punct	_	_
23	day	_	NOUN	NN	_	13	nmod	_	_

#	Sertraline Hydrochloride	1613
1	Patients	_	NOUN	NNS	_	0	root	_	_
2	receiving	_	VERB	VBG	_	1	acl	_	_
3	DRUG	_	NOUN	NN	_	4	compound	_	_
4	doses	_	NOUN	NNS	_	2	dobj	_	_
5	of	_	ADP	IN	_	9	case	_	_
6	50	_	NUM	CD	_	9	nummod	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	200	_	NUM	CD	_	6	conj	_	_
9	mg	_	NOUN	NN	_	4	nmod	_	_
10	/	_	.	:	_	1	punct	_	_
11	day	_	NOUN	NN	_	12	nsubj	_	_
12	experienced	_	VERB	VBD	_	1	dep	_	_
13	mean	_	ADJ	JJ	_	14	amod	_	_
14	reductions	_	NOUN	NNS	_	12	dobj	_	_
15	of	_	ADP	IN	_	18	case	_	_
16	approximately	_	ADV	RB	_	17	advmod	_	_
17	6	_	NUM	CD	_	18	nummod	_	_
18	points	_	NOUN	NNS	_	14	nmod	_	_
19	on	_	ADP	IN	_	23	case	_	_
20	the	_	DET	DT	_	23	det	_	_
21	YBOCS	_	NOUN	NN	_	23	compound	_	_
22	total	_	ADJ	JJ	_	23	amod	_	_
23	score	_	NOUN	NN	_	14	nmod	_	_
24	which	_	DET	WDT	_	27	nsubj	_	_
25	were	_	VERB	VBD	_	27	cop	_	_
26	significantly	_	ADV	RB	_	27	advmod	_	_
27	greater	_	ADJ	JJ	_	23	acl:relcl	_	_
28	than	_	ADP	IN	_	33	case	_	_
29	the	_	DET	DT	_	33	det	_	_
30	approximately	_	ADV	RB	_	31	advmod	_	_
31	3	_	NUM	CD	_	33	nummod	_	_
32	point	_	NOUN	NN	_	33	compound	_	_
33	reduction	_	NOUN	NN	_	27	nmod	_	_
34	in	_	ADP	IN	_	37	case	_	_
35	placebo	_	NOUN	NN	_	37	compound	_	_
36	treated	_	ADJ	JJ	_	37	amod	_	_
37	patients	_	NOUN	NNS	_	33	nmod	_	_

#	Sertraline Hydrochloride	1614
1	Study	_	NOUN	NN	_	7	nsubj	_	_
2	3	_	NUM	CD	_	1	nummod	_	_
3	was	_	VERB	VBD	_	7	cop	_	_
4	a	_	DET	DT	_	7	det	_	_
5	12	_	NUM	CD	_	7	nummod	_	_
6	week	_	NOUN	NN	_	7	compound	_	_
7	study	_	NOUN	NN	_	0	root	_	_
8	with	_	ADP	IN	_	10	case	_	_
9	flexible	_	ADJ	JJ	_	10	amod	_	_
10	dosing	_	NOUN	NN	_	7	nmod	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_
13	in	_	ADP	IN	_	15	case	_	_
14	a	_	DET	DT	_	15	det	_	_
15	range	_	NOUN	NN	_	10	nmod	_	_
16	of	_	ADP	IN	_	20	case	_	_
17	50	_	NUM	CD	_	19	compound	_	_
18	to	_	PRT	TO	_	19	dep	_	_
19	200	_	NUM	CD	_	20	nummod	_	_
20	mg	_	NOUN	NN	_	15	nmod	_	_
21	/	_	.	:	_	7	punct	_	_
22	day	_	NOUN	NN	_	7	dep	_	_
23	the	_	DET	DT	_	25	det	_	_
24	mean	_	NOUN	NN	_	25	compound	_	_
25	dose	_	NOUN	NN	_	32	nsubj	_	_
26	for	_	ADP	IN	_	27	case	_	_
27	completers	_	NOUN	NNS	_	25	nmod	_	_
28	was	_	VERB	VBD	_	32	cop	_	_
29	185	_	NUM	CD	_	32	nummod	_	_
30	mg	_	NOUN	NN	_	32	compound	_	_
31	/	_	.	:	_	32	compound	_	_
32	day	_	NOUN	NN	_	22	nmod	_	_

#	Sertraline Hydrochloride	1615
1	Patients	_	NOUN	NNS	_	4	nsubj	_	_
2	receiving	_	VERB	VBG	_	1	acl	_	_
3	DRUG	_	NOUN	NN	_	2	dobj	_	_
4	experienced	_	VERB	VBD	_	0	root	_	_
5	a	_	DET	DT	_	7	det	_	_
6	mean	_	ADJ	JJ	_	7	amod	_	_
7	reduction	_	NOUN	NN	_	4	dobj	_	_
8	of	_	ADP	IN	_	11	case	_	_
9	approximately	_	ADV	RB	_	10	advmod	_	_
10	7	_	NUM	CD	_	11	nummod	_	_
11	points	_	NOUN	NNS	_	7	nmod	_	_
12	on	_	ADP	IN	_	16	case	_	_
13	the	_	DET	DT	_	16	det	_	_
14	YBOCS	_	NOUN	NN	_	16	compound	_	_
15	total	_	ADJ	JJ	_	16	amod	_	_
16	score	_	NOUN	NN	_	7	nmod	_	_
17	which	_	DET	WDT	_	20	nsubj	_	_
18	was	_	VERB	VBD	_	20	cop	_	_
19	significantly	_	ADV	RB	_	20	advmod	_	_
20	greater	_	ADJ	JJ	_	16	acl:relcl	_	_
21	than	_	ADP	IN	_	24	case	_	_
22	the	_	DET	DT	_	24	det	_	_
23	mean	_	NOUN	NN	_	24	amod	_	_
24	reduction	_	NOUN	NN	_	20	nmod	_	_
25	of	_	ADP	IN	_	28	case	_	_
26	approximately	_	ADV	RB	_	27	advmod	_	_
27	4	_	NUM	CD	_	28	nummod	_	_
28	points	_	NOUN	NNS	_	24	nmod	_	_
29	in	_	ADP	IN	_	32	case	_	_
30	placebo	_	NOUN	NN	_	32	compound	_	_
31	treated	_	ADJ	JJ	_	32	amod	_	_
32	patients	_	NOUN	NNS	_	24	nmod	_	_

#	Sertraline Hydrochloride	1616
1	Analyses	_	NOUN	NNS	_	11	nsubj	_	_
2	for	_	ADP	IN	_	3	case	_	_
3	age	_	NOUN	NN	_	1	nmod	_	_
4	and	_	CONJ	CC	_	3	cc	_	_
5	gender	_	NOUN	NN	_	3	conj	_	_
6	effects	_	NOUN	NNS	_	3	dep	_	_
7	on	_	ADP	IN	_	8	case	_	_
8	outcome	_	NOUN	NN	_	1	nmod	_	_
9	did	_	VERB	VBD	_	11	aux	_	_
10	not	_	ADV	RB	_	11	neg	_	_
11	suggest	_	VERB	VB	_	0	root	_	_
12	any	_	DET	DT	_	14	det	_	_
13	differential	_	ADJ	JJ	_	14	amod	_	_
14	responsiveness	_	NOUN	NN	_	11	dobj	_	_
15	on	_	ADP	IN	_	17	case	_	_
16	the	_	DET	DT	_	17	det	_	_
17	basis	_	NOUN	NN	_	11	nmod	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	age	_	NOUN	NN	_	17	nmod	_	_
20	or	_	CONJ	CC	_	19	cc	_	_
21	sex	_	NOUN	NN	_	19	conj	_	_

#	Sertraline Hydrochloride	1617
1	The	_	DET	DT	_	2	det	_	_
2	effectiveness	_	NOUN	NN	_	12	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	for	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	treatment	_	NOUN	NN	_	2	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	OCD	_	NOUN	NN	_	7	nmod	_	_
10	was	_	VERB	VBD	_	12	auxpass	_	_
11	also	_	ADV	RB	_	12	advmod	_	_
12	demonstrated	_	VERB	VBN	_	0	root	_	_
13	in	_	ADP	IN	_	16	case	_	_
14	a	_	DET	DT	_	16	det	_	_
15	12	_	NUM	CD	_	16	nummod	_	_
16	week	_	NOUN	NN	_	12	nmod	_	_
17	,	_	.	,	_	16	punct	_	_
18	multicenter	_	NOUN	NN	_	16	appos	_	_
19	,	_	.	,	_	16	punct	_	_
20	placebo	_	NOUN	NN	_	21	nsubj	_	_
21	controlled	_	VERB	VBD	_	16	acl	_	_
22	,	_	.	,	_	16	punct	_	_
23	parallel	_	ADJ	JJ	_	25	amod	_	_
24	group	_	NOUN	NN	_	25	compound	_	_
25	study	_	NOUN	NN	_	16	appos	_	_
26	in	_	ADP	IN	_	31	case	_	_
27	a	_	DET	DT	_	31	det	_	_
28	pediatric	_	ADJ	JJ	_	31	amod	_	_
29	outpatient	_	ADJ	JJ	_	31	amod	_	_
30	population	_	NOUN	NN	_	31	compound	_	_
31	children	_	NOUN	NN	_	25	nmod	_	_
32	and	_	CONJ	CC	_	31	cc	_	_
33	adolescents	_	NOUN	NNS	_	31	conj	_	_
34	,	_	.	,	_	16	punct	_	_
35	ages	_	VERB	VBZ	_	16	acl	_	_
36	6	_	NUM	CD	_	38	compound	_	_
37	to	_	PRT	TO	_	38	dep	_	_
38	17	_	NUM	CD	_	35	nmod	_	_

#	Sertraline Hydrochloride	1618
1	Patients	_	NOUN	NNS	_	8	nsubjpass	_	_
2	receiving	_	VERB	VBG	_	1	acl	_	_
3	DRUG	_	NOUN	NN	_	2	dobj	_	_
4	in	_	ADP	IN	_	6	case	_	_
5	this	_	DET	DT	_	6	det	_	_
6	study	_	NOUN	NN	_	2	nmod	_	_
7	were	_	VERB	VBD	_	8	auxpass	_	_
8	initiated	_	VERB	VBN	_	0	root	_	_
9	at	_	ADP	IN	_	10	case	_	_
10	doses	_	NOUN	NNS	_	8	nmod	_	_
11	of	_	ADP	IN	_	14	case	_	_
12	either	_	CONJ	CC	_	14	cc:preconj	_	_
13	25	_	NUM	CD	_	14	nummod	_	_
14	mg	_	NOUN	NN	_	10	nmod	_	_
15	/	_	.	:	_	10	punct	_	_
16	day	_	NOUN	NN	_	17	compound	_	_
17	children	_	NOUN	NN	_	10	conj	_	_
18	,	_	.	,	_	10	punct	_	_
19	ages	_	VERB	VBZ	_	10	appos	_	_
20	6	_	NUM	CD	_	22	compound	_	_
21	to	_	PRT	TO	_	22	dep	_	_
22	12	_	NUM	CD	_	25	nummod	_	_
23	or	_	CONJ	CC	_	22	cc	_	_
24	50	_	NUM	CD	_	22	conj	_	_
25	mg	_	NOUN	NN	_	19	nmod	_	_
26	/	_	.	:	_	25	punct	_	_
27	day	_	NOUN	NN	_	28	compound	_	_
28	adolescents	_	NOUN	NNS	_	25	dep	_	_
29	,	_	.	,	_	10	punct	_	_
30	ages	_	NOUN	NNS	_	10	conj	_	_
31	13	_	NUM	CD	_	33	compound	_	_
32	to	_	PRT	TO	_	33	case	_	_
33	17	_	NUM	CD	_	30	nmod	_	_
34	,	_	.	,	_	8	punct	_	_
35	and	_	CONJ	CC	_	8	cc	_	_
36	then	_	ADV	RB	_	37	advmod	_	_
37	titrated	_	VERB	VBN	_	8	conj	_	_
38	over	_	ADP	IN	_	42	case	_	_
39	the	_	DET	DT	_	42	det	_	_
40	next	_	ADV	RB	_	41	advmod	_	_
41	four	_	NUM	CD	_	42	nummod	_	_
42	weeks	_	NOUN	NNS	_	37	nmod	_	_
43	to	_	PRT	TO	_	46	case	_	_
44	a	_	DET	DT	_	46	det	_	_
45	maximum	_	NOUN	NN	_	46	compound	_	_
46	dose	_	NOUN	NN	_	37	nmod	_	_
47	of	_	ADP	IN	_	51	case	_	_
48	200	_	NUM	CD	_	49	nummod	_	_
49	mg	_	NOUN	NN	_	51	amod	_	_
50	/	_	.	:	_	51	punct	_	_
51	day	_	NOUN	NN	_	46	nmod	_	_
52	,	_	.	,	_	8	punct	_	_
53	as	_	ADP	IN	_	54	mark	_	_
54	tolerated	_	VERB	VBN	_	8	advcl	_	_

#	Sertraline Hydrochloride	1619
1	The	_	DET	DT	_	3	det	_	_
2	mean	_	ADJ	JJ	_	3	amod	_	_
3	dose	_	NOUN	NN	_	10	nsubj	_	_
4	for	_	ADP	IN	_	5	case	_	_
5	completers	_	NOUN	NNS	_	3	nmod	_	_
6	was	_	VERB	VBD	_	10	cop	_	_
7	178	_	NUM	CD	_	10	nummod	_	_
8	mg	_	NOUN	NN	_	10	compound	_	_
9	/	_	.	:	_	10	compound	_	_
10	day	_	NOUN	NN	_	0	root	_	_

#	Sertraline Hydrochloride	1620
1	Dosing	_	NOUN	NN	_	5	nsubj	_	_
2	was	_	VERB	VBD	_	5	cop	_	_
3	once	_	ADV	RB	_	5	advmod	_	_
4	a	_	DET	DT	_	5	det	_	_
5	day	_	NOUN	NN	_	0	root	_	_
6	in	_	ADP	IN	_	8	case	_	_
7	the	_	DET	DT	_	8	det	_	_
8	morning	_	NOUN	NN	_	5	nmod	_	_
9	or	_	CONJ	CC	_	8	cc	_	_
10	evening	_	VERB	VBG	_	8	conj	_	_

#	Sertraline Hydrochloride	1621
1	Patients	_	NOUN	NNS	_	6	nsubj	_	_
2	in	_	ADP	IN	_	4	case	_	_
3	this	_	DET	DT	_	4	det	_	_
4	study	_	NOUN	NN	_	1	nmod	_	_
5	had	_	VERB	VBD	_	6	aux	_	_
6	moderate	_	ADJ	JJ	_	0	root	_	_
7	to	_	PRT	TO	_	12	case	_	_
8	severe	_	ADJ	JJ	_	12	amod	_	_
9	OCD	_	NOUN	NN	_	12	compound	_	_
10	DSM	_	NOUN	NN	_	12	compound	_	_
11	III	_	NUM	CD	_	12	nummod	_	_
12	R	_	NOUN	NN	_	6	nmod	_	_
13	with	_	ADP	IN	_	16	case	_	_
14	mean	_	NOUN	NN	_	16	amod	_	_
15	baseline	_	NOUN	NN	_	16	compound	_	_
16	ratings	_	NOUN	NNS	_	6	nmod	_	_
17	on	_	ADP	IN	_	19	case	_	_
18	the	_	DET	DT	_	19	det	_	_
19	Children's	_	NOUN	NNS	_	16	nmod	_	_
20	Yale	_	NOUN	NN	_	19	acl	_	_
21	Brown	_	VERB	VBN	_	27	amod	_	_
22	Obsessive	_	ADJ	JJ	_	27	amod	_	_
23	Compulsive	_	ADJ	JJ	_	27	amod	_	_
24	Scale	_	NOUN	NN	_	27	compound	_	_
25	CYBOCS	_	NOUN	NN	_	27	compound	_	_
26	total	_	ADJ	JJ	_	27	amod	_	_
27	score	_	NOUN	NN	_	20	nmod	_	_
28	of	_	ADP	IN	_	29	case	_	_
29	22	_	NUM	CD	_	27	nmod	_	_

#	Sertraline Hydrochloride	1622
1	Patients	_	NOUN	NNS	_	4	nsubj	_	_
2	receiving	_	VERB	VBG	_	1	acl	_	_
3	DRUG	_	NOUN	NN	_	2	dobj	_	_
4	experienced	_	VERB	VBD	_	0	root	_	_
5	a	_	DET	DT	_	7	det	_	_
6	mean	_	ADJ	JJ	_	7	amod	_	_
7	reduction	_	NOUN	NN	_	4	dobj	_	_
8	of	_	ADP	IN	_	11	case	_	_
9	approximately	_	ADV	RB	_	10	advmod	_	_
10	7	_	NUM	CD	_	11	nummod	_	_
11	units	_	NOUN	NNS	_	7	nmod	_	_
12	on	_	ADP	IN	_	16	case	_	_
13	the	_	DET	DT	_	16	det	_	_
14	CYBOCS	_	NOUN	NN	_	16	compound	_	_
15	total	_	ADJ	JJ	_	16	amod	_	_
16	score	_	NOUN	NN	_	7	nmod	_	_
17	which	_	DET	WDT	_	20	nsubj	_	_
18	was	_	VERB	VBD	_	20	cop	_	_
19	significantly	_	ADV	RB	_	20	advmod	_	_
20	greater	_	ADJ	JJ	_	16	acl:relcl	_	_
21	than	_	ADP	IN	_	25	case	_	_
22	the	_	DET	DT	_	25	det	_	_
23	3	_	NUM	CD	_	25	nummod	_	_
24	unit	_	NOUN	NN	_	25	compound	_	_
25	reduction	_	NOUN	NN	_	20	nmod	_	_
26	for	_	ADP	IN	_	28	case	_	_
27	placebo	_	NOUN	NN	_	28	compound	_	_
28	patients	_	NOUN	NNS	_	25	nmod	_	_

#	Sertraline Hydrochloride	1624
1	In	_	ADP	IN	_	5	case	_	_
2	a	_	DET	DT	_	5	det	_	_
3	longer	_	ADJ	JJ	_	5	amod	_	_
4	term	_	NOUN	NN	_	5	compound	_	_
5	study	_	NOUN	NN	_	37	nmod	_	_
6	,	_	.	,	_	37	punct	_	_
7	patients	_	NOUN	NNS	_	37	nsubjpass	_	_
8	meeting	_	VERB	VBG	_	7	acl	_	_
9	DSM	_	NOUN	NN	_	12	compound	_	_
10	III	_	NUM	CD	_	12	nummod	_	_
11	R	_	NOUN	NN	_	12	compound	_	_
12	criteria	_	NOUN	NN	_	8	dobj	_	_
13	for	_	ADP	IN	_	14	case	_	_
14	OCD	_	NOUN	NN	_	12	nmod	_	_
15	who	_	DET	WDT	_	17	nsubj	_	_
16	had	_	VERB	MD	_	17	aux	_	_
17	responded	_	VERB	VBN	_	14	acl:relcl	_	_
18	during	_	ADP	IN	_	23	case	_	_
19	a	_	DET	DT	_	23	det	_	_
20	52	_	NUM	CD	_	23	nummod	_	_
21	week	_	NOUN	NN	_	23	compound	_	_
22	single	_	ADJ	JJ	_	23	amod	_	_
23	blind	_	NOUN	NN	_	17	nmod	_	_
24	trial	_	ADJ	JJ	_	23	amod	_	_
25	on	_	ADP	IN	_	26	case	_	_
26	DRUG	_	NOUN	NN	_	24	nmod	_	_
27	50	_	NUM	CD	_	26	nummod	_	_
28	to	_	PRT	TO	_	30	case	_	_
29	200	_	NUM	CD	_	30	nummod	_	_
30	mg	_	NOUN	NN	_	24	nmod	_	_
31	/	_	.	:	_	33	punct	_	_
32	day	_	NOUN	NN	_	33	compound	_	_
33	n	_	NOUN	NN	_	7	nmod	_	_
34	=	_	ADJ	JJ	_	33	amod	_	_
35	224	_	NUM	CD	_	34	dep	_	_
36	were	_	VERB	VBD	_	37	auxpass	_	_
37	randomized	_	VERB	VBN	_	0	root	_	_
38	to	_	PRT	TO	_	39	case	_	_
39	continuation	_	NOUN	NN	_	37	nmod	_	_
40	of	_	ADP	IN	_	41	case	_	_
41	DRUG	_	NOUN	NN	_	39	nmod	_	_
42	or	_	CONJ	CC	_	39	cc	_	_
43	to	_	PRT	TO	_	44	case	_	_
44	substitution	_	NOUN	NN	_	39	conj	_	_
45	of	_	ADP	IN	_	46	case	_	_
46	placebo	_	NOUN	NN	_	44	nmod	_	_
47	for	_	ADP	IN	_	51	case	_	_
48	up	_	ADJ	JJ	_	50	advmod	_	_
49	to	_	PRT	TO	_	50	dep	_	_
50	28	_	NUM	CD	_	51	nummod	_	_
51	weeks	_	NOUN	NNS	_	44	nmod	_	_
52	of	_	ADP	IN	_	53	case	_	_
53	observation	_	NOUN	NN	_	51	nmod	_	_
54	for	_	ADP	IN	_	55	case	_	_
55	discontinuation	_	NOUN	NN	_	53	nmod	_	_
56	due	_	ADJ	JJ	_	58	case	_	_
57	to	_	PRT	TO	_	56	mwe	_	_
58	relapse	_	NOUN	NN	_	55	nmod	_	_
59	or	_	CONJ	CC	_	58	cc	_	_
60	insufficient	_	ADJ	JJ	_	62	amod	_	_
61	clinical	_	ADJ	JJ	_	62	amod	_	_
62	response	_	NOUN	NN	_	58	conj	_	_

#	Sertraline Hydrochloride	1625
1	Response	_	NOUN	NN	_	8	nsubjpass	_	_
2	during	_	ADP	IN	_	6	case	_	_
3	the	_	DET	DT	_	6	det	_	_
4	single	_	ADJ	JJ	_	6	amod	_	_
5	blind	_	NOUN	NN	_	6	compound	_	_
6	phase	_	NOUN	NN	_	1	nmod	_	_
7	was	_	VERB	VBD	_	8	auxpass	_	_
8	defined	_	VERB	VBN	_	0	root	_	_
9	as	_	ADP	IN	_	11	case	_	_
10	a	_	DET	DT	_	11	det	_	_
11	decrease	_	NOUN	NN	_	8	nmod	_	_
12	in	_	ADP	IN	_	15	case	_	_
13	the	_	DET	DT	_	15	det	_	_
14	YBOCS	_	NOUN	NN	_	15	compound	_	_
15	score	_	NOUN	NN	_	11	nmod	_	_
16	of	_	ADP	IN	_	18	case	_	_
17	>	_	NUM	CD	_	18	nummod	_	_
18	25%	_	NOUN	NN	_	15	nmod	_	_
19	compared	_	VERB	VBD	_	21	case	_	_
20	to	_	PRT	TO	_	21	case	_	_
21	baseline	_	NOUN	NN	_	8	nmod	_	_
22	and	_	CONJ	CC	_	21	cc	_	_
23	a	_	DET	DT	_	24	det	_	_
24	CGI	_	NOUN	NN	_	21	conj	_	_
25	I	_	NUM	CD	_	24	nummod	_	_
26	of	_	ADP	IN	_	27	case	_	_
27	1	_	NUM	CD	_	24	nmod	_	_
28	very	_	ADV	RB	_	29	advmod	_	_
29	much	_	ADV	RB	_	30	advmod	_	_
30	improved	_	VERB	VBN	_	8	parataxis	_	_
31	,	_	.	,	_	30	punct	_	_
32	2	_	NUM	CD	_	34	nummod	_	_
33	much	_	ADV	RB	_	34	advmod	_	_
34	improved	_	VERB	VBN	_	30	parataxis	_	_
35	or	_	CONJ	CC	_	34	cc	_	_
36	3	_	NUM	CD	_	34	conj	_	_
37	minimally	_	ADV	RB	_	38	advmod	_	_
38	improved	_	VERB	VBN	_	36	acl	_	_

#	Sertraline Hydrochloride	1626
1	Relapse	_	NOUN	NN	_	8	nsubjpass	_	_
2	during	_	ADP	IN	_	6	case	_	_
3	the	_	DET	DT	_	6	det	_	_
4	double	_	ADJ	JJ	_	6	amod	_	_
5	blind	_	NOUN	NN	_	6	compound	_	_
6	phase	_	NOUN	NN	_	1	nmod	_	_
7	was	_	VERB	VBD	_	8	auxpass	_	_
8	defined	_	VERB	VBN	_	0	root	_	_
9	as	_	ADP	IN	_	12	case	_	_
10	the	_	DET	DT	_	12	det	_	_
11	following	_	VERB	VBG	_	12	amod	_	_
12	conditions	_	NOUN	NNS	_	8	nmod	_	_
13	being	_	VERB	VBD	_	18	cop	_	_
14	met	_	ADV	RB	_	18	neg	_	_
15	on	_	ADP	IN	_	18	case	_	_
16	three	_	NUM	CD	_	18	nummod	_	_
17	consecutive	_	ADJ	JJ	_	18	amod	_	_
18	visits	_	NOUN	NNS	_	8	parataxis	_	_
19	for	_	ADP	IN	_	20	case	_	_
20	1	_	NUM	CD	_	18	nmod	_	_
21	and	_	CONJ	CC	_	20	cc	_	_
22	2	_	NUM	CD	_	20	conj	_	_
23	,	_	.	,	_	18	punct	_	_
24	and	_	CONJ	CC	_	18	cc	_	_
25	for	_	ADP	IN	_	26	case	_	_
26	visit	_	NOUN	NN	_	18	conj	_	_
27	3	_	NUM	CD	_	26	nummod	_	_
28	for	_	ADP	IN	_	29	case	_	_
29	condition	_	NOUN	NN	_	26	nmod	_	_
30	3	_	NUM	CD	_	29	nummod	_	_
31	:	_	.	:	_	18	punct	_	_
32	1	_	NUM	CD	_	34	nummod	_	_
33	YBOCS	_	NOUN	NN	_	34	compound	_	_
34	score	_	NOUN	NN	_	35	nsubj	_	_
35	increased	_	VERB	VBN	_	18	parataxis	_	_
36	by	_	ADP	IN	_	39	case	_	_
37	>	_	NUM	CD	_	39	nummod	_	_
38	5	_	NUM	CD	_	39	nummod	_	_
39	points	_	NOUN	NNS	_	35	nmod	_	_
40	,	_	.	,	_	35	punct	_	_
41	to	_	PRT	TO	_	43	case	_	_
42	a	_	DET	DT	_	43	det	_	_
43	minimum	_	NOUN	NN	_	35	nmod	_	_
44	of	_	ADP	IN	_	45	case	_	_
45	20	_	NUM	CD	_	43	nmod	_	_
46	,	_	.	,	_	35	punct	_	_
47	relative	_	ADJ	JJ	_	53	advmod	_	_
48	to	_	PRT	TO	_	49	case	_	_
49	baseline	_	NOUN	NN	_	47	nmod	_	_
50	2	_	NUM	CD	_	49	nummod	_	_
51	CGI	_	NOUN	NN	_	49	dep	_	_
52	I	_	NUM	CD	_	51	nummod	_	_
53	increased	_	VERB	VBN	_	35	advcl	_	_
54	by	_	ADP	IN	_	57	case	_	_
55	>	_	NUM	CD	_	57	nummod	_	_
56	one	_	NUM	CD	_	57	nummod	_	_
57	point	_	NOUN	NN	_	53	nmod	_	_
58	and	_	CONJ	CC	_	57	cc	_	_
59	3	_	NUM	CD	_	60	nummod	_	_
60	worsening	_	NOUN	NN	_	57	conj	_	_
61	of	_	ADP	IN	_	63	case	_	_
62	the	_	DET	DT	_	63	det	_	_
63	patient's	_	NOUN	NNS	_	57	nmod	_	_
64	condition	_	NOUN	NN	_	63	acl	_	_
65	in	_	ADP	IN	_	68	case	_	_
66	the	_	DET	DT	_	68	det	_	_
67	investigator's	_	NOUN	NNS	_	68	compound	_	_
68	judgment	_	NOUN	NN	_	64	nmod	_	_
69	,	_	.	,	_	35	punct	_	_
70	to	_	PRT	TO	_	71	mark	_	_
71	justify	_	VERB	VB	_	35	advcl	_	_
72	alternative	_	ADJ	JJ	_	73	amod	_	_
73	treatment	_	NOUN	NN	_	71	dobj	_	_

#	Sertraline Hydrochloride	1627
1	Insufficient	_	ADJ	JJ	_	3	amod	_	_
2	clinical	_	ADJ	JJ	_	3	amod	_	_
3	response	_	NOUN	NN	_	4	nsubj	_	_
4	indicated	_	VERB	VBD	_	0	root	_	_
5	a	_	DET	DT	_	6	det	_	_
6	worsening	_	NOUN	NN	_	4	dobj	_	_
7	of	_	ADP	IN	_	10	case	_	_
8	the	_	DET	DT	_	10	det	_	_
9	patient's	_	NOUN	NNS	_	10	compound	_	_
10	condition	_	NOUN	NN	_	6	nmod	_	_
11	that	_	DET	WDT	_	12	nsubj	_	_
12	resulted	_	VERB	VBD	_	10	acl:relcl	_	_
13	in	_	ADP	IN	_	15	case	_	_
14	study	_	NOUN	NN	_	15	compound	_	_
15	discontinuation	_	NOUN	NN	_	12	nmod	_	_
16	,	_	.	,	_	4	punct	_	_
17	as	_	ADP	IN	_	18	mark	_	_
18	assessed	_	VERB	VBN	_	4	advcl	_	_
19	by	_	ADP	IN	_	21	case	_	_
20	the	_	DET	DT	_	21	det	_	_
21	investigator	_	NOUN	NN	_	18	nmod	_	_

#	Sertraline Hydrochloride	1628
1	Patients	_	NOUN	NNS	_	6	nsubj	_	_
2	receiving	_	VERB	VBG	_	1	acl	_	_
3	continued	_	VERB	VBN	_	5	amod	_	_
4	DRUG	_	NOUN	NN	_	5	compound	_	_
5	treatment	_	NOUN	NN	_	2	dobj	_	_
6	experienced	_	VERB	VBD	_	0	root	_	_
7	a	_	DET	DT	_	10	det	_	_
8	significantly	_	ADV	RB	_	9	advmod	_	_
9	lower	_	ADJ	JJ	_	10	amod	_	_
10	rate	_	NOUN	NN	_	6	dobj	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	discontinuation	_	NOUN	NN	_	10	nmod	_	_
13	due	_	ADJ	JJ	_	15	case	_	_
14	to	_	PRT	TO	_	13	mwe	_	_
15	relapse	_	NOUN	NN	_	10	nmod	_	_
16	or	_	CONJ	CC	_	15	cc	_	_
17	insufficient	_	ADJ	JJ	_	19	amod	_	_
18	clinical	_	ADJ	JJ	_	19	amod	_	_
19	response	_	NOUN	NN	_	15	conj	_	_
20	over	_	ADP	IN	_	24	case	_	_
21	the	_	DET	DT	_	24	det	_	_
22	subsequent	_	ADJ	JJ	_	24	amod	_	_
23	28	_	NUM	CD	_	24	nummod	_	_
24	weeks	_	NOUN	NNS	_	10	nmod	_	_
25	compared	_	VERB	VBN	_	6	xcomp	_	_
26	to	_	PRT	TO	_	27	case	_	_
27	those	_	DET	DT	_	25	nmod	_	_
28	receiving	_	VERB	VBG	_	27	acl	_	_
29	placebo	_	NOUN	NN	_	28	nmod	_	_

#	Sertraline Hydrochloride	1629
1	This	_	DET	DT	_	2	det	_	_
2	pattern	_	NOUN	NN	_	4	nsubjpass	_	_
3	was	_	VERB	VBD	_	4	auxpass	_	_
4	demonstrated	_	VERB	VBN	_	0	root	_	_
5	in	_	ADP	IN	_	9	case	_	_
6	male	_	ADJ	JJ	_	9	amod	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	female	_	ADJ	JJ	_	6	conj	_	_
9	subjects	_	NOUN	NNS	_	4	nmod	_	_

#	Sertraline Hydrochloride	1630
1	Panic	_	ADJ	JJ	_	2	amod	_	_
2	Disorder	_	NOUN	NN	_	14	nsubjpass	_	_
3	The	_	DET	DT	_	4	det	_	_
4	effectiveness	_	NOUN	NN	_	2	dep	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	in	_	ADP	IN	_	9	case	_	_
8	the	_	DET	DT	_	9	det	_	_
9	treatment	_	NOUN	NN	_	4	nmod	_	_
10	of	_	ADP	IN	_	12	case	_	_
11	panic	_	ADJ	JJ	_	12	amod	_	_
12	disorder	_	NOUN	NN	_	9	nmod	_	_
13	was	_	VERB	VBD	_	14	auxpass	_	_
14	demonstrated	_	VERB	VBN	_	0	root	_	_
15	in	_	ADP	IN	_	18	case	_	_
16	three	_	NUM	CD	_	18	nummod	_	_
17	double	_	ADJ	JJ	_	18	amod	_	_
18	blind	_	NOUN	NN	_	14	nmod	_	_
19	,	_	.	,	_	14	punct	_	_
20	placebo	_	NOUN	NN	_	21	nsubj	_	_
21	controlled	_	VERB	VBD	_	14	parataxis	_	_
22	studies	_	NOUN	NNS	_	23	compound	_	_
23	Studies	_	NOUN	NNS	_	21	dobj	_	_
24	1	_	NUM	CD	_	26	nummod	_	_
25	to	_	PRT	TO	_	26	dep	_	_
26	3	_	NUM	CD	_	23	nummod	_	_
27	of	_	ADP	IN	_	29	case	_	_
28	adult	_	ADJ	JJ	_	29	amod	_	_
29	outpatients	_	NOUN	NNS	_	23	nmod	_	_
30	who	_	DET	WDT	_	31	nsubj	_	_
31	had	_	VERB	VBD	_	29	acl:relcl	_	_
32	a	_	DET	DT	_	34	det	_	_
33	primary	_	ADJ	JJ	_	34	amod	_	_
34	diagnosis	_	NOUN	NN	_	31	dobj	_	_
35	of	_	ADP	IN	_	40	case	_	_
36	panic	_	ADJ	JJ	_	40	amod	_	_
37	disorder	_	NOUN	NN	_	40	compound	_	_
38	DSM	_	NOUN	NN	_	40	compound	_	_
39	III	_	NUM	CD	_	40	nummod	_	_
40	R	_	NOUN	NN	_	34	nmod	_	_
41	,	_	.	,	_	21	punct	_	_
42	with	_	ADP	IN	_	21	dep	_	_
43	or	_	CONJ	CC	_	42	cc	_	_
44	without	_	ADP	IN	_	45	case	_	_
45	agoraphobia	_	NOUN	NN	_	42	conj	_	_

#	Sertraline Hydrochloride	1631
1	Studies	_	NOUN	NNS	_	10	nsubj	_	_
2	1	_	NUM	CD	_	1	nmod	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	2	_	NUM	CD	_	2	conj	_	_
5	were	_	VERB	VBD	_	10	cop	_	_
6	10	_	NUM	CD	_	10	nummod	_	_
7	week	_	NOUN	NN	_	10	compound	_	_
8	flexible	_	ADJ	JJ	_	10	amod	_	_
9	dose	_	NOUN	NN	_	10	compound	_	_
10	studies	_	NOUN	NNS	_	0	root	_	_

#	Sertraline Hydrochloride	1632
1	DRUG	_	NOUN	NN	_	3	nsubjpass	_	_
2	was	_	VERB	VBD	_	3	auxpass	_	_
3	initiated	_	VERB	VBN	_	0	root	_	_
4	at	_	ADP	IN	_	6	case	_	_
5	25	_	NUM	CD	_	6	nummod	_	_
6	mg	_	NOUN	NN	_	3	nmod	_	_
7	/	_	.	:	_	3	punct	_	_
8	day	_	NOUN	NN	_	3	nmod	_	_
9	for	_	ADP	IN	_	12	case	_	_
10	the	_	DET	DT	_	12	det	_	_
11	first	_	ADJ	JJ	_	12	amod	_	_
12	week	_	NOUN	NN	_	8	nmod	_	_
13	,	_	.	,	_	8	punct	_	_
14	and	_	CONJ	CC	_	8	cc	_	_
15	then	_	ADV	RB	_	16	advmod	_	_
16	patients	_	NOUN	NNS	_	18	nsubjpass	_	_
17	were	_	VERB	VBD	_	18	auxpass	_	_
18	dosed	_	VERB	VBN	_	8	conj	_	_
19	in	_	ADP	IN	_	21	case	_	_
20	a	_	DET	DT	_	21	det	_	_
21	range	_	NOUN	NN	_	18	nmod	_	_
22	of	_	ADP	IN	_	26	case	_	_
23	50	_	NUM	CD	_	25	compound	_	_
24	to	_	PRT	TO	_	25	dep	_	_
25	200	_	NUM	CD	_	26	nummod	_	_
26	mg	_	NOUN	NN	_	21	nmod	_	_
27	/	_	.	:	_	8	punct	_	_
28	day	_	NOUN	NN	_	8	dep	_	_
29	on	_	ADP	IN	_	31	case	_	_
30	the	_	DET	DT	_	31	det	_	_
31	basis	_	NOUN	NN	_	28	nmod	_	_
32	of	_	ADP	IN	_	34	case	_	_
33	clinical	_	ADJ	JJ	_	34	amod	_	_
34	response	_	NOUN	NN	_	31	nmod	_	_
35	and	_	CONJ	CC	_	34	cc	_	_
36	toleration	_	NOUN	NN	_	34	conj	_	_

#	Sertraline Hydrochloride	1633
1	The	_	DET	DT	_	4	det	_	_
2	mean	_	ADJ	JJ	_	4	amod	_	_
3	DRUG	_	NOUN	NN	_	4	compound	_	_
4	doses	_	NOUN	NNS	_	12	nsubj	_	_
5	for	_	ADP	IN	_	6	case	_	_
6	completers	_	NOUN	NNS	_	4	nmod	_	_
7	to	_	PRT	TO	_	9	case	_	_
8	10	_	NUM	CD	_	9	nummod	_	_
9	weeks	_	NOUN	NNS	_	4	nmod	_	_
10	were	_	VERB	VBD	_	12	cop	_	_
11	131	_	NUM	CD	_	12	nummod	_	_
12	mg	_	NOUN	NN	_	0	root	_	_
13	/	_	.	:	_	12	punct	_	_
14	day	_	NOUN	NN	_	12	dep	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	144	_	NUM	CD	_	17	nummod	_	_
17	mg	_	NOUN	NN	_	14	conj	_	_
18	/	_	.	:	_	12	punct	_	_
19	day	_	NOUN	NN	_	12	dep	_	_
20	,	_	.	,	_	19	punct	_	_
21	respectively	_	ADV	RB	_	19	advmod	_	_
22	,	_	.	,	_	19	punct	_	_
23	for	_	ADP	IN	_	24	case	_	_
24	Studies	_	NOUN	NNS	_	19	nmod	_	_
25	1	_	NUM	CD	_	24	nummod	_	_
26	and	_	CONJ	CC	_	25	cc	_	_
27	2	_	NUM	CD	_	25	conj	_	_

#	Sertraline Hydrochloride	1634
1	In	_	ADP	IN	_	3	case	_	_
2	these	_	DET	DT	_	3	det	_	_
3	studies	_	NOUN	NNS	_	7	nmod	_	_
4	,	_	.	,	_	7	punct	_	_
5	DRUG	_	NOUN	NN	_	7	nsubjpass	_	_
6	was	_	VERB	VBD	_	7	auxpass	_	_
7	shown	_	VERB	VBN	_	0	root	_	_
8	to	_	PRT	TO	_	12	mark	_	_
9	be	_	VERB	VB	_	12	cop	_	_
10	significantly	_	ADV	RB	_	12	advmod	_	_
11	more	_	ADV	RB	_	12	advmod	_	_
12	effective	_	ADJ	JJ	_	7	xcomp	_	_
13	than	_	ADP	IN	_	14	case	_	_
14	placebo	_	NOUN	NN	_	12	nmod	_	_
15	on	_	ADP	IN	_	16	case	_	_
16	change	_	NOUN	NN	_	12	nmod	_	_
17	from	_	ADP	IN	_	18	case	_	_
18	baseline	_	NOUN	NN	_	16	nmod	_	_
19	in	_	ADP	IN	_	22	case	_	_
20	panic	_	ADJ	JJ	_	22	amod	_	_
21	attack	_	NOUN	NN	_	22	compound	_	_
22	frequency	_	NOUN	NN	_	16	nmod	_	_
23	and	_	CONJ	CC	_	16	cc	_	_
24	on	_	ADP	IN	_	29	case	_	_
25	the	_	DET	DT	_	29	det	_	_
26	Clinical	_	ADJ	JJ	_	29	amod	_	_
27	Global	_	ADJ	JJ	_	29	amod	_	_
28	Impression	_	NOUN	NN	_	29	compound	_	_
29	Severity	_	NOUN	NN	_	16	conj	_	_
30	of	_	ADP	IN	_	31	case	_	_
31	Illness	_	NOUN	NN	_	29	nmod	_	_
32	and	_	CONJ	CC	_	31	cc	_	_
33	Global	_	ADJ	JJ	_	35	amod	_	_
34	Improvement	_	NOUN	NN	_	35	compound	_	_
35	scores	_	NOUN	NNS	_	31	conj	_	_

#	Sertraline Hydrochloride	1635
1	The	_	DET	DT	_	2	det	_	_
2	difference	_	NOUN	NN	_	22	nsubj	_	_
3	between	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	placebo	_	NOUN	NN	_	4	conj	_	_
7	in	_	ADP	IN	_	8	case	_	_
8	reduction	_	NOUN	NN	_	2	nmod	_	_
9	from	_	ADP	IN	_	10	case	_	_
10	baseline	_	NOUN	NN	_	8	nmod	_	_
11	in	_	ADP	IN	_	13	case	_	_
12	the	_	DET	DT	_	13	det	_	_
13	number	_	NOUN	NN	_	8	nmod	_	_
14	of	_	ADP	IN	_	17	case	_	_
15	full	_	ADJ	JJ	_	17	amod	_	_
16	panic	_	ADJ	JJ	_	17	amod	_	_
17	attacks	_	NOUN	NNS	_	13	nmod	_	_
18	was	_	VERB	VBD	_	22	cop	_	_
19	approximately	_	ADV	RB	_	22	advmod	_	_
20	2	_	NUM	CD	_	22	nummod	_	_
21	panic	_	ADJ	JJ	_	22	amod	_	_
22	attacks	_	NOUN	NNS	_	0	root	_	_
23	per	_	ADP	IN	_	24	case	_	_
24	week	_	NOUN	NN	_	22	nmod	_	_
25	in	_	ADP	IN	_	27	case	_	_
26	both	_	DET	DT	_	27	det	_	_
27	studies	_	NOUN	NNS	_	24	nmod	_	_

#	Sertraline Hydrochloride	1636
1	Study	_	NOUN	NN	_	9	nsubj	_	_
2	3	_	NUM	CD	_	1	nummod	_	_
3	was	_	VERB	VBD	_	9	cop	_	_
4	a	_	DET	DT	_	9	det	_	_
5	12	_	NUM	CD	_	9	nummod	_	_
6	week	_	NOUN	NN	_	9	compound	_	_
7	fixed	_	VERB	VBN	_	9	amod	_	_
8	dose	_	NOUN	NN	_	9	compound	_	_
9	study	_	NOUN	NN	_	0	root	_	_
10	,	_	.	,	_	9	punct	_	_
11	including	_	VERB	VBG	_	13	case	_	_
12	DRUG	_	NOUN	NN	_	13	compound	_	_
13	doses	_	NOUN	NNS	_	9	nmod	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	50	_	NUM	CD	_	23	nummod	_	_
16	,	_	.	,	_	15	punct	_	_
17	100	_	NUM	CD	_	15	conj	_	_
18	,	_	.	,	_	15	punct	_	_
19	and	_	CONJ	CC	_	15	cc	_	_
20	200	_	NUM	CD	_	21	nummod	_	_
21	mg	_	NOUN	NN	_	15	conj	_	_
22	/	_	.	:	_	23	punct	_	_
23	day	_	NOUN	NN	_	13	nmod	_	_

#	Sertraline Hydrochloride	1637
1	Patients	_	NOUN	NNS	_	4	nsubj	_	_
2	receiving	_	VERB	VBG	_	1	acl	_	_
3	DRUG	_	NOUN	NN	_	2	dobj	_	_
4	experienced	_	VERB	VBD	_	0	root	_	_
5	a	_	DET	DT	_	8	det	_	_
6	significantly	_	ADV	RB	_	7	advmod	_	_
7	greater	_	ADJ	JJ	_	8	amod	_	_
8	reduction	_	NOUN	NN	_	4	dobj	_	_
9	in	_	ADP	IN	_	12	case	_	_
10	panic	_	ADJ	JJ	_	12	amod	_	_
11	attack	_	NOUN	NN	_	12	compound	_	_
12	frequency	_	NOUN	NN	_	8	nmod	_	_
13	than	_	ADP	IN	_	14	case	_	_
14	patients	_	NOUN	NNS	_	8	nmod	_	_
15	receiving	_	VERB	VBG	_	14	acl	_	_
16	placebo	_	NOUN	NN	_	15	nmod	_	_

#	Sertraline Hydrochloride	1638
1	Study	_	NOUN	NN	_	6	nsubj	_	_
2	3	_	NUM	CD	_	1	nummod	_	_
3	was	_	VERB	VBD	_	6	cop	_	_
4	not	_	ADV	RB	_	6	neg	_	_
5	readily	_	ADV	RB	_	6	advmod	_	_
6	interpretable	_	ADJ	JJ	_	0	root	_	_
7	regarding	_	ADP	IN	_	11	case	_	_
8	a	_	DET	DT	_	11	det	_	_
9	dose	_	NOUN	NN	_	11	compound	_	_
10	response	_	NOUN	NN	_	11	compound	_	_
11	relationship	_	NOUN	NN	_	6	nmod	_	_
12	for	_	ADP	IN	_	13	case	_	_
13	effectiveness	_	NOUN	NN	_	11	nmod	_	_

#	Sertraline Hydrochloride	1639
1	Subgroup	_	ADJ	JJ	_	2	amod	_	_
2	analyses	_	NOUN	NNS	_	5	nsubj	_	_
3	did	_	VERB	MD	_	5	aux	_	_
4	not	_	ADV	RB	_	5	neg	_	_
5	indicate	_	VERB	VB	_	0	root	_	_
6	that	_	ADP	IN	_	8	mark	_	_
7	there	_	DET	EX	_	8	expl	_	_
8	were	_	VERB	VBD	_	5	ccomp	_	_
9	any	_	DET	DT	_	10	det	_	_
10	differences	_	NOUN	NNS	_	8	nsubj	_	_
11	in	_	ADP	IN	_	13	case	_	_
12	treatment	_	NOUN	NN	_	13	compound	_	_
13	outcomes	_	NOUN	NNS	_	10	nmod	_	_
14	as	_	ADP	IN	_	16	case	_	_
15	a	_	DET	DT	_	16	det	_	_
16	function	_	NOUN	NN	_	8	nmod	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	age	_	NOUN	NN	_	16	nmod	_	_
19	,	_	.	,	_	18	punct	_	_
20	race	_	NOUN	NN	_	18	conj	_	_
21	,	_	.	,	_	18	punct	_	_
22	or	_	CONJ	CC	_	18	cc	_	_
23	gender	_	NOUN	NN	_	18	conj	_	_

#	Sertraline Hydrochloride	1640
1	In	_	ADP	IN	_	5	case	_	_
2	a	_	DET	DT	_	5	det	_	_
3	longer	_	ADJ	JJ	_	5	amod	_	_
4	term	_	NOUN	NN	_	5	compound	_	_
5	study	_	NOUN	NN	_	34	nmod	_	_
6	,	_	.	,	_	34	punct	_	_
7	patients	_	NOUN	NNS	_	34	nsubjpass	_	_
8	meeting	_	VERB	VBG	_	7	acl	_	_
9	DSM	_	NOUN	NN	_	12	compound	_	_
10	III	_	NUM	CD	_	12	nummod	_	_
11	R	_	NOUN	NN	_	12	compound	_	_
12	criteria	_	NOUN	NN	_	8	dobj	_	_
13	for	_	ADP	IN	_	15	case	_	_
14	Panic	_	ADJ	JJ	_	15	amod	_	_
15	Disorder	_	NOUN	NN	_	12	nmod	_	_
16	who	_	DET	WDT	_	18	nsubj	_	_
17	had	_	VERB	MD	_	18	aux	_	_
18	responded	_	VERB	VBN	_	15	acl:relcl	_	_
19	during	_	ADP	IN	_	24	case	_	_
20	a	_	DET	DT	_	24	det	_	_
21	52	_	NUM	CD	_	22	compound	_	_
22	week	_	NOUN	NN	_	24	amod	_	_
23	open	_	ADJ	JJ	_	24	amod	_	_
24	trial	_	NOUN	NN	_	18	nmod	_	_
25	on	_	ADP	IN	_	32	case	_	_
26	DRUG	_	NOUN	NN	_	32	compound	_	_
27	50	_	NUM	CD	_	32	nummod	_	_
28	200	_	NUM	CD	_	32	nummod	_	_
29	mg	_	NOUN	NN	_	32	amod	_	_
30	/	_	.	:	_	32	punct	_	_
31	day	_	NOUN	NN	_	32	compound	_	_
32	n=183	_	NOUN	NN	_	24	nmod	_	_
33	were	_	VERB	VBD	_	34	auxpass	_	_
34	randomized	_	VERB	VBN	_	0	root	_	_
35	to	_	PRT	TO	_	36	case	_	_
36	continuation	_	NOUN	NN	_	34	nmod	_	_
37	of	_	ADP	IN	_	38	case	_	_
38	DRUG	_	NOUN	NN	_	36	nmod	_	_
39	or	_	CONJ	CC	_	36	cc	_	_
40	to	_	PRT	TO	_	41	case	_	_
41	substitution	_	NOUN	NN	_	36	conj	_	_
42	of	_	ADP	IN	_	43	case	_	_
43	placebo	_	NOUN	NN	_	41	nmod	_	_
44	for	_	ADP	IN	_	48	case	_	_
45	up	_	ADJ	JJ	_	47	advmod	_	_
46	to	_	PRT	TO	_	47	dep	_	_
47	28	_	NUM	CD	_	48	nummod	_	_
48	weeks	_	NOUN	NNS	_	41	nmod	_	_
49	of	_	ADP	IN	_	50	case	_	_
50	observation	_	NOUN	NN	_	48	nmod	_	_
51	for	_	ADP	IN	_	52	case	_	_
52	discontinuation	_	NOUN	NN	_	50	nmod	_	_
53	due	_	ADJ	JJ	_	55	case	_	_
54	to	_	PRT	TO	_	53	mwe	_	_
55	relapse	_	NOUN	NN	_	52	nmod	_	_
56	or	_	CONJ	CC	_	55	cc	_	_
57	insufficient	_	ADJ	JJ	_	59	amod	_	_
58	clinical	_	ADJ	JJ	_	59	amod	_	_
59	response	_	NOUN	NN	_	55	conj	_	_

#	Sertraline Hydrochloride	1641
1	Response	_	NOUN	NN	_	7	nsubjpass	_	_
2	during	_	ADP	IN	_	5	case	_	_
3	the	_	DET	DT	_	5	det	_	_
4	open	_	ADJ	JJ	_	5	amod	_	_
5	phase	_	NOUN	NN	_	1	nmod	_	_
6	was	_	VERB	VBD	_	7	auxpass	_	_
7	defined	_	VERB	VBN	_	0	root	_	_
8	as	_	ADP	IN	_	12	case	_	_
9	a	_	DET	DT	_	12	det	_	_
10	CGI	_	NOUN	NN	_	12	compound	_	_
11	I	_	NUM	CD	_	12	nummod	_	_
12	score	_	NOUN	NN	_	7	nmod	_	_
13	of	_	ADP	IN	_	16	case	_	_
14	1(very	_	ADJ	JJ	_	16	advmod	_	_
15	much	_	ADV	RB	_	16	advmod	_	_
16	improved	_	VERB	VBN	_	12	acl	_	_
17	or	_	CONJ	CC	_	16	cc	_	_
18	2	_	NUM	CD	_	16	conj	_	_
19	much	_	ADV	RB	_	18	dep	_	_
20	improved	_	VERB	VBN	_	19	dep	_	_

#	Sertraline Hydrochloride	1642
1	Relapse	_	NOUN	NN	_	8	nsubjpass	_	_
2	during	_	ADP	IN	_	6	case	_	_
3	the	_	DET	DT	_	6	det	_	_
4	double	_	ADJ	JJ	_	6	amod	_	_
5	blind	_	NOUN	NN	_	6	compound	_	_
6	phase	_	NOUN	NN	_	1	nmod	_	_
7	was	_	VERB	VBD	_	8	auxpass	_	_
8	defined	_	VERB	VBN	_	0	root	_	_
9	as	_	ADP	IN	_	12	case	_	_
10	the	_	DET	DT	_	12	det	_	_
11	following	_	VERB	VBG	_	12	amod	_	_
12	conditions	_	NOUN	NNS	_	8	nmod	_	_
13	being	_	VERB	VBD	_	18	cop	_	_
14	met	_	ADV	RB	_	18	neg	_	_
15	on	_	ADP	IN	_	18	case	_	_
16	three	_	NUM	CD	_	18	nummod	_	_
17	consecutive	_	ADJ	JJ	_	18	amod	_	_
18	visits	_	NOUN	NNS	_	8	parataxis	_	_
19	:	_	.	:	_	18	punct	_	_
20	1	_	NUM	CD	_	30	nummod	_	_
21	CGI	_	NOUN	NN	_	30	compound	_	_
22	I	_	NUM	CD	_	30	nummod	_	_
23	>	_	NUM	CD	_	30	nummod	_	_
24	3	_	NUM	CD	_	30	nummod	_	_
25	2	_	NUM	CD	_	24	dep	_	_
26	meets	_	NOUN	NNS	_	30	compound	_	_
27	DSM	_	NOUN	NN	_	30	compound	_	_
28	III	_	NUM	CD	_	30	nummod	_	_
29	R	_	NOUN	NN	_	30	compound	_	_
30	criteria	_	NOUN	NN	_	18	dep	_	_
31	for	_	ADP	IN	_	35	case	_	_
32	Panic	_	ADJ	JJ	_	35	amod	_	_
33	Disorder	_	NOUN	NN	_	35	compound	_	_
34	3	_	NUM	CD	_	35	nummod	_	_
35	number	_	NOUN	NN	_	30	nmod	_	_
36	of	_	ADP	IN	_	38	case	_	_
37	panic	_	ADJ	JJ	_	38	amod	_	_
38	attacks	_	NOUN	NNS	_	35	nmod	_	_
39	greater	_	ADJ	JJ	_	38	amod	_	_
40	than	_	ADP	IN	_	42	case	_	_
41	at	_	ADP	IN	_	42	case	_	_
42	baseline	_	NOUN	NN	_	39	nmod	_	_

#	Sertraline Hydrochloride	1646
1	Posttraumatic	_	ADJ	JJ	_	4	amod	_	_
2	Stress	_	NOUN	NN	_	4	compound	_	_
3	Disorder	_	NOUN	NN	_	4	compound	_	_
4	PTSD	_	NOUN	NN	_	15	nsubjpass	_	_
5	The	_	DET	DT	_	6	det	_	_
6	effectiveness	_	NOUN	NN	_	4	dep	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	in	_	ADP	IN	_	11	case	_	_
10	the	_	DET	DT	_	11	det	_	_
11	treatment	_	NOUN	NN	_	6	nmod	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	PTSD	_	NOUN	NN	_	11	nmod	_	_
14	was	_	VERB	VBD	_	15	auxpass	_	_
15	established	_	VERB	VBN	_	0	root	_	_
16	in	_	ADP	IN	_	19	case	_	_
17	two	_	NUM	CD	_	19	nummod	_	_
18	multicenter	_	ADJ	JJ	_	19	amod	_	_
19	placebo	_	NOUN	NN	_	15	nmod	_	_
20	controlled	_	VERB	VBN	_	22	amod	_	_
21	studies	_	NOUN	NNS	_	22	compound	_	_
22	Studies	_	NOUN	NNS	_	15	nmod	_	_
23	1	_	NUM	CD	_	25	nummod	_	_
24	to	_	PRT	TO	_	25	dep	_	_
25	2	_	NUM	CD	_	22	nummod	_	_
26	of	_	ADP	IN	_	28	case	_	_
27	adult	_	ADJ	JJ	_	28	amod	_	_
28	outpatients	_	NOUN	NNS	_	22	nmod	_	_
29	who	_	DET	WDT	_	28	root	_	_
30	met	_	ADV	RB	_	34	neg	_	_
31	DSM	_	NOUN	NN	_	34	compound	_	_
32	III	_	NUM	CD	_	34	nummod	_	_
33	R	_	NOUN	NN	_	34	compound	_	_
34	criteria	_	NOUN	NN	_	29	nmod	_	_
35	for	_	ADP	IN	_	36	case	_	_
36	PTSD	_	NOUN	NN	_	34	nmod	_	_

#	Sertraline Hydrochloride	1647
1	The	_	DET	DT	_	3	det	_	_
2	mean	_	ADJ	JJ	_	3	amod	_	_
3	duration	_	NOUN	NN	_	12	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	PTSD	_	NOUN	NN	_	3	nmod	_	_
6	for	_	ADP	IN	_	8	case	_	_
7	these	_	DET	DT	_	8	det	_	_
8	patients	_	NOUN	NNS	_	3	nmod	_	_
9	was	_	VERB	VBD	_	12	cop	_	_
10	12	_	NUM	CD	_	12	nummod	_	_
11	years	_	NOUN	NNS	_	12	compound	_	_
12	Studies	_	NOUN	NNS	_	0	root	_	_
13	1	_	NUM	CD	_	16	nummod	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	2	_	NUM	CD	_	13	conj	_	_
16	combined	_	ADJ	JJ	_	12	dep	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	44%	_	NOUN	NN	_	27	nsubj	_	_
19	of	_	ADP	IN	_	20	case	_	_
20	patients	_	NOUN	NNS	_	18	nmod	_	_
21	169	_	NUM	CD	_	20	nummod	_	_
22	of	_	ADP	IN	_	25	case	_	_
23	the	_	DET	DT	_	25	det	_	_
24	385	_	NUM	CD	_	25	nummod	_	_
25	patients	_	NOUN	NNS	_	20	nmod	_	_
26	treated	_	VERB	VBN	_	25	acl	_	_
27	had	_	VERB	VBD	_	16	conj	_	_
28	secondary	_	ADJ	JJ	_	30	amod	_	_
29	depressive	_	ADJ	JJ	_	30	amod	_	_
30	disorder	_	NOUN	NN	_	27	dobj	_	_

#	Sertraline Hydrochloride	1648
1	Studies	_	NOUN	NNS	_	10	nsubj	_	_
2	1	_	NUM	CD	_	1	nmod	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	2	_	NUM	CD	_	2	conj	_	_
5	were	_	VERB	VBD	_	10	cop	_	_
6	12	_	NUM	CD	_	10	nummod	_	_
7	week	_	NOUN	NN	_	10	compound	_	_
8	flexible	_	ADJ	JJ	_	10	amod	_	_
9	dose	_	NOUN	NN	_	10	compound	_	_
10	studies	_	NOUN	NNS	_	0	root	_	_

#	Sertraline Hydrochloride	1649
1	DRUG	_	NOUN	NN	_	3	nsubjpass	_	_
2	was	_	VERB	VBD	_	3	auxpass	_	_
3	initiated	_	VERB	VBN	_	0	root	_	_
4	at	_	ADP	IN	_	6	case	_	_
5	25	_	NUM	CD	_	6	nummod	_	_
6	mg	_	NOUN	NN	_	3	nmod	_	_
7	/	_	.	:	_	3	punct	_	_
8	day	_	NOUN	NN	_	18	nsubjpass	_	_
9	for	_	ADP	IN	_	12	case	_	_
10	the	_	DET	DT	_	12	det	_	_
11	first	_	ADJ	JJ	_	12	amod	_	_
12	week	_	NOUN	NN	_	8	nmod	_	_
13	,	_	.	,	_	8	punct	_	_
14	and	_	CONJ	CC	_	8	cc	_	_
15	patients	_	NOUN	NNS	_	8	conj	_	_
16	were	_	VERB	VBD	_	18	auxpass	_	_
17	then	_	ADV	RB	_	18	advmod	_	_
18	dosed	_	VERB	VBN	_	3	parataxis	_	_
19	in	_	ADP	IN	_	21	case	_	_
20	the	_	DET	DT	_	21	det	_	_
21	range	_	NOUN	NN	_	18	nmod	_	_
22	of	_	ADP	IN	_	26	case	_	_
23	50	_	NUM	CD	_	25	compound	_	_
24	to	_	PRT	TO	_	25	dep	_	_
25	200	_	NUM	CD	_	26	nummod	_	_
26	mg	_	NOUN	NN	_	21	nmod	_	_
27	/	_	.	:	_	18	punct	_	_
28	day	_	NOUN	NN	_	18	parataxis	_	_
29	on	_	ADP	IN	_	31	case	_	_
30	the	_	DET	DT	_	31	det	_	_
31	basis	_	NOUN	NN	_	28	nmod	_	_
32	of	_	ADP	IN	_	34	case	_	_
33	clinical	_	ADJ	JJ	_	34	amod	_	_
34	response	_	NOUN	NN	_	31	nmod	_	_
35	and	_	CONJ	CC	_	34	cc	_	_
36	toleration	_	NOUN	NN	_	34	conj	_	_

#	Sertraline Hydrochloride	1650
1	The	_	DET	DT	_	4	det	_	_
2	mean	_	ADJ	JJ	_	4	amod	_	_
3	DRUG	_	NOUN	NN	_	4	compound	_	_
4	dose	_	NOUN	NN	_	9	nsubj	_	_
5	for	_	ADP	IN	_	6	case	_	_
6	completers	_	NOUN	NNS	_	4	nmod	_	_
7	was	_	VERB	VBD	_	9	cop	_	_
8	146	_	NUM	CD	_	9	nummod	_	_
9	mg	_	NOUN	NN	_	0	root	_	_
10	/	_	.	:	_	9	punct	_	_
11	day	_	NOUN	NN	_	9	dep	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	151	_	NUM	CD	_	14	nummod	_	_
14	mg	_	NOUN	NN	_	11	conj	_	_
15	/	_	.	:	_	9	punct	_	_
16	day	_	NOUN	NN	_	9	dep	_	_
17	,	_	.	,	_	16	punct	_	_
18	respectively	_	ADV	RB	_	20	advmod	_	_
19	for	_	ADP	IN	_	20	case	_	_
20	Studies	_	NOUN	NNS	_	16	nmod	_	_
21	1	_	NUM	CD	_	20	nummod	_	_
22	and	_	CONJ	CC	_	21	cc	_	_
23	2	_	NUM	CD	_	21	conj	_	_

#	Sertraline Hydrochloride	1651
1	Study	_	NOUN	NN	_	2	compound	_	_
2	outcome	_	NOUN	NN	_	4	nsubjpass	_	_
3	was	_	VERB	VBD	_	4	auxpass	_	_
4	assessed	_	VERB	VBN	_	0	root	_	_
5	by	_	ADP	IN	_	13	case	_	_
6	the	_	DET	DT	_	13	det	_	_
7	Clinician	_	ADJ	JJ	_	13	amod	_	_
8	Administered	_	VERB	VBN	_	13	amod	_	_
9	PTSD	_	NOUN	NN	_	13	compound	_	_
10	Scale	_	NOUN	NN	_	13	compound	_	_
11	Part	_	NOUN	NN	_	13	compound	_	_
12	2	_	NUM	CD	_	13	nummod	_	_
13	CAPS	_	NOUN	NN	_	4	nmod	_	_
14	which	_	DET	WDT	_	19	nsubj	_	_
15	is	_	VERB	VBZ	_	19	cop	_	_
16	a	_	DET	DT	_	19	det	_	_
17	multi	_	NOUN	NNS	_	19	amod	_	_
18	item	_	NOUN	NN	_	19	compound	_	_
19	instrument	_	NOUN	NN	_	13	acl:relcl	_	_
20	that	_	DET	WDT	_	21	nsubj	_	_
21	measures	_	VERB	VBZ	_	19	acl:relcl	_	_
22	the	_	DET	DT	_	27	det	_	_
23	three	_	NUM	CD	_	27	nummod	_	_
24	PTSD	_	NOUN	NN	_	27	compound	_	_
25	diagnostic	_	ADJ	JJ	_	27	amod	_	_
26	symptom	_	NOUN	NN	_	27	compound	_	_
27	clusters	_	NOUN	NNS	_	21	dobj	_	_
28	of	_	ADP	IN	_	31	case	_	_
29	reexperiencing	_	NOUN	NN	_	31	compound	_	_
30	/	_	.	:	_	31	punct	_	_
31	intrusion	_	NOUN	NN	_	27	nmod	_	_
32	,	_	.	,	_	31	punct	_	_
33	avoidance	_	NOUN	NN	_	31	conj	_	_
34	/	_	.	:	_	31	punct	_	_
35	numbing	_	NOUN	NN	_	31	conj	_	_
36	,	_	.	,	_	31	punct	_	_
37	and	_	CONJ	CC	_	31	cc	_	_
38	hyperarousal	_	ADJ	JJ	_	31	conj	_	_
39	as	_	ADV	RB	_	38	cc	_	_
40	well	_	ADV	RB	_	39	mwe	_	_
41	as	_	ADP	IN	_	39	mwe	_	_
42	the	_	DET	DT	_	45	det	_	_
43	patient	_	NOUN	NN	_	45	compound	_	_
44	rated	_	ADJ	JJ	_	45	amod	_	_
45	Impact	_	NOUN	NN	_	38	conj	_	_
46	of	_	ADP	IN	_	49	case	_	_
47	Event	_	NOUN	NN	_	49	compound	_	_
48	Scale	_	NOUN	NN	_	49	compound	_	_
49	IES	_	NOUN	NN	_	45	nmod	_	_
50	which	_	DET	WDT	_	51	nsubj	_	_
51	measures	_	VERB	VBZ	_	49	acl:relcl	_	_
52	intrusion	_	NOUN	NN	_	55	compound	_	_
53	and	_	CONJ	CC	_	52	cc	_	_
54	avoidance	_	NOUN	NN	_	52	conj	_	_
55	symptoms	_	NOUN	NNS	_	51	dobj	_	_

#	Sertraline Hydrochloride	1652
1	DRUG	_	NOUN	NN	_	3	nsubjpass	_	_
2	was	_	VERB	VBD	_	3	auxpass	_	_
3	shown	_	VERB	VBN	_	0	root	_	_
4	to	_	PRT	TO	_	8	mark	_	_
5	be	_	VERB	VB	_	8	cop	_	_
6	significantly	_	ADV	RB	_	8	advmod	_	_
7	more	_	ADV	RB	_	8	advmod	_	_
8	effective	_	ADJ	JJ	_	3	xcomp	_	_
9	than	_	ADP	IN	_	10	case	_	_
10	placebo	_	NOUN	NN	_	8	nmod	_	_
11	on	_	ADP	IN	_	12	case	_	_
12	change	_	NOUN	NN	_	8	nmod	_	_
13	from	_	ADP	IN	_	14	case	_	_
14	baseline	_	NOUN	NN	_	12	nmod	_	_
15	to	_	PRT	TO	_	16	case	_	_
16	endpoint	_	NOUN	NN	_	12	nmod	_	_
17	on	_	ADP	IN	_	19	case	_	_
18	the	_	DET	DT	_	19	det	_	_
19	CAPS	_	NOUN	NN	_	16	nmod	_	_
20	,	_	.	,	_	3	punct	_	_
21	IES	_	NOUN	NN	_	3	dep	_	_
22	and	_	CONJ	CC	_	21	cc	_	_
23	on	_	ADP	IN	_	27	case	_	_
24	the	_	DET	DT	_	27	det	_	_
25	Clinical	_	ADJ	JJ	_	27	amod	_	_
26	Global	_	ADJ	JJ	_	27	amod	_	_
27	Impressions	_	NOUN	NNS	_	21	conj	_	_
28	CGI	_	NOUN	NN	_	29	compound	_	_
29	Severity	_	NOUN	NN	_	27	dep	_	_
30	of	_	ADP	IN	_	31	case	_	_
31	Illness	_	NOUN	NN	_	29	nmod	_	_
32	and	_	CONJ	CC	_	31	cc	_	_
33	Global	_	ADJ	JJ	_	35	amod	_	_
34	Improvement	_	NOUN	NN	_	35	compound	_	_
35	scores	_	NOUN	NNS	_	31	conj	_	_

#	Sertraline Hydrochloride	1653
1	In	_	ADP	IN	_	7	case	_	_
2	two	_	NUM	CD	_	7	nummod	_	_
3	additional	_	ADJ	JJ	_	7	amod	_	_
4	placebo	_	NOUN	NN	_	7	compound	_	_
5	controlled	_	VERB	VBD	_	7	amod	_	_
6	PTSD	_	NOUN	NN	_	7	compound	_	_
7	trials	_	NOUN	NNS	_	26	nmod	_	_
8	,	_	.	,	_	26	punct	_	_
9	the	_	DET	DT	_	10	det	_	_
10	difference	_	NOUN	NN	_	26	nsubj	_	_
11	in	_	ADP	IN	_	12	case	_	_
12	response	_	NOUN	NN	_	10	nmod	_	_
13	to	_	PRT	TO	_	14	case	_	_
14	treatment	_	NOUN	NN	_	12	nmod	_	_
15	between	_	ADP	IN	_	16	case	_	_
16	patients	_	NOUN	NNS	_	14	nmod	_	_
17	receiving	_	VERB	VBG	_	16	acl	_	_
18	DRUG	_	NOUN	NN	_	17	dobj	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	patients	_	NOUN	NNS	_	18	conj	_	_
21	receiving	_	VERB	VBG	_	18	acl	_	_
22	placebo	_	NOUN	NN	_	21	dobj	_	_
23	was	_	VERB	VBD	_	26	cop	_	_
24	not	_	ADV	RB	_	26	neg	_	_
25	statistically	_	ADV	RB	_	26	advmod	_	_
26	significant	_	ADJ	JJ	_	0	root	_	_

#	Sertraline Hydrochloride	1654
1	One	_	NUM	CD	_	7	nsubjpass	_	_
2	of	_	ADP	IN	_	5	case	_	_
3	these	_	DET	DT	_	5	det	_	_
4	additional	_	ADJ	JJ	_	5	amod	_	_
5	studies	_	NOUN	NNS	_	1	nmod	_	_
6	was	_	VERB	VBD	_	7	auxpass	_	_
7	conducted	_	VERB	VBN	_	0	root	_	_
8	in	_	ADP	IN	_	9	case	_	_
9	patients	_	NOUN	NNS	_	7	nmod	_	_
10	similar	_	ADJ	JJ	_	9	amod	_	_
11	to	_	PRT	TO	_	12	case	_	_
12	those	_	DET	DT	_	10	nmod	_	_
13	recruited	_	VERB	VBN	_	12	acl	_	_
14	for	_	ADP	IN	_	15	case	_	_
15	Studies	_	NOUN	NNS	_	13	nmod	_	_
16	1	_	NUM	CD	_	15	dep	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	2	_	NUM	CD	_	16	conj	_	_
19	,	_	.	,	_	7	punct	_	_
20	while	_	ADP	IN	_	26	mark	_	_
21	the	_	DET	DT	_	24	det	_	_
22	second	_	ADJ	JJ	_	24	amod	_	_
23	additional	_	ADJ	JJ	_	24	amod	_	_
24	study	_	NOUN	NN	_	26	nsubjpass	_	_
25	was	_	VERB	VBD	_	26	auxpass	_	_
26	conducted	_	VERB	VBN	_	7	advcl	_	_
27	in	_	ADP	IN	_	30	case	_	_
28	predominantly	_	ADV	RB	_	29	advmod	_	_
29	male	_	ADJ	JJ	_	30	amod	_	_
30	veterans	_	NOUN	NNS	_	26	nmod	_	_

#	Sertraline Hydrochloride	1655
1	As	_	ADP	IN	_	7	mark	_	_
2	PTSD	_	NOUN	NN	_	7	nsubj	_	_
3	is	_	VERB	VBZ	_	7	cop	_	_
4	a	_	DET	DT	_	7	det	_	_
5	more	_	ADV	RB	_	6	advmod	_	_
6	common	_	ADJ	JJ	_	7	amod	_	_
7	disorder	_	NOUN	NN	_	22	advcl	_	_
8	in	_	ADP	IN	_	9	case	_	_
9	women	_	NOUN	NNS	_	7	nmod	_	_
10	than	_	ADP	IN	_	11	case	_	_
11	men	_	NOUN	NN	_	7	nmod	_	_
12	,	_	.	,	_	22	punct	_	_
13	the	_	DET	DT	_	15	det	_	_
14	majority	_	NOUN	NN	_	15	compound	_	_
15	76%	_	NOUN	NN	_	22	nsubj	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	patients	_	NOUN	NNS	_	15	nmod	_	_
18	in	_	ADP	IN	_	20	case	_	_
19	these	_	DET	DT	_	20	det	_	_
20	trials	_	NOUN	NNS	_	17	nmod	_	_
21	were	_	VERB	VBD	_	22	cop	_	_
22	women	_	NOUN	NNS	_	0	root	_	_
23	152	_	NUM	CD	_	26	nummod	_	_
24	and	_	CONJ	CC	_	23	cc	_	_
25	139	_	NUM	CD	_	23	conj	_	_
26	women	_	NOUN	NNS	_	22	dobj	_	_
27	on	_	ADP	IN	_	28	case	_	_
28	DRUG	_	NOUN	NN	_	26	nmod	_	_
29	and	_	CONJ	CC	_	28	cc	_	_
30	placebo	_	NOUN	NN	_	28	conj	_	_
31	versus	_	CONJ	CC	_	30	cc	_	_
32	39	_	NUM	CD	_	30	conj	_	_
33	and	_	CONJ	CC	_	30	cc	_	_
34	55	_	NUM	CD	_	35	nummod	_	_
35	men	_	NOUN	NN	_	30	conj	_	_
36	on	_	ADP	IN	_	37	case	_	_
37	DRUG	_	NOUN	NN	_	26	nmod	_	_
38	and	_	CONJ	CC	_	37	cc	_	_
39	placebo	_	NOUN	NN	_	40	compound	_	_
40	Studies	_	NOUN	NNS	_	37	conj	_	_
41	1	_	NUM	CD	_	40	nummod	_	_
42	and	_	CONJ	CC	_	26	cc	_	_
43	2	_	NUM	CD	_	26	conj	_	_
44	combined	_	VERB	VBN	_	43	punct	_	_

#	Sertraline Hydrochloride	1656
1	Post	_	ADV	RB	_	5	advmod	_	_
2	hoc	_	ADP	IN	_	5	mark	_	_
3	exploratory	_	ADJ	JJ	_	4	amod	_	_
4	analyses	_	NOUN	NNS	_	5	nsubj	_	_
5	revealed	_	VERB	VBD	_	0	root	_	_
6	a	_	DET	DT	_	8	det	_	_
7	significant	_	ADJ	JJ	_	8	amod	_	_
8	difference	_	NOUN	NN	_	5	dobj	_	_
9	between	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	placebo	_	NOUN	NN	_	10	conj	_	_
13	on	_	ADP	IN	_	15	case	_	_
14	the	_	DET	DT	_	15	det	_	_
15	CAPS	_	NOUN	NN	_	8	nmod	_	_
16	,	_	.	,	_	15	punct	_	_
17	IES	_	NOUN	NN	_	15	conj	_	_
18	and	_	CONJ	CC	_	15	cc	_	_
19	CGI	_	NOUN	NN	_	15	conj	_	_
20	in	_	ADP	IN	_	21	case	_	_
21	women	_	NOUN	NNS	_	8	nmod	_	_
22	,	_	.	,	_	5	punct	_	_
23	regardless	_	ADV	RB	_	26	advmod	_	_
24	of	_	ADP	IN	_	26	case	_	_
25	baseline	_	NOUN	NN	_	26	compound	_	_
26	diagnosis	_	NOUN	NN	_	5	nmod	_	_
27	of	_	ADP	IN	_	31	case	_	_
28	comorbid	_	ADJ	JJ	_	31	amod	_	_
29	major	_	ADJ	JJ	_	31	amod	_	_
30	depressive	_	ADJ	JJ	_	31	amod	_	_
31	disorder	_	NOUN	NN	_	26	nmod	_	_
32	,	_	.	,	_	5	punct	_	_
33	but	_	CONJ	CC	_	5	cc	_	_
34	essentially	_	ADV	RB	_	35	advmod	_	_
35	no	_	ADV	RB	_	36	neg	_	_
36	effect	_	NOUN	NN	_	5	conj	_	_
37	in	_	ADP	IN	_	41	case	_	_
38	the	_	DET	DT	_	41	det	_	_
39	relatively	_	ADV	RB	_	40	advmod	_	_
40	smaller	_	ADJ	JJ	_	41	amod	_	_
41	number	_	NOUN	NN	_	36	nmod	_	_
42	of	_	ADP	IN	_	43	case	_	_
43	men	_	NOUN	NN	_	41	nmod	_	_
44	in	_	ADP	IN	_	46	case	_	_
45	these	_	DET	DT	_	46	det	_	_
46	studies	_	NOUN	NNS	_	41	nmod	_	_

#	Sertraline Hydrochloride	1657
1	The	_	DET	DT	_	3	det	_	_
2	clinical	_	ADJ	JJ	_	3	amod	_	_
3	significance	_	NOUN	NN	_	10	nsubj	_	_
4	of	_	ADP	IN	_	8	case	_	_
5	this	_	DET	DT	_	8	det	_	_
6	apparent	_	ADJ	JJ	_	8	amod	_	_
7	gender	_	NOUN	NN	_	8	compound	_	_
8	interaction	_	NOUN	NN	_	3	nmod	_	_
9	is	_	VERB	VBZ	_	10	cop	_	_
10	unknown	_	ADJ	JJ	_	0	root	_	_
11	at	_	ADP	IN	_	13	case	_	_
12	this	_	DET	DT	_	13	det	_	_
13	time	_	NOUN	NN	_	10	nmod	_	_

#	Sertraline Hydrochloride	1658
1	There	_	DET	EX	_	2	expl	_	_
2	was	_	VERB	VBD	_	0	root	_	_
3	insufficient	_	ADJ	JJ	_	4	amod	_	_
4	information	_	NOUN	NN	_	2	nsubj	_	_
5	to	_	PRT	TO	_	6	mark	_	_
6	determine	_	VERB	VB	_	2	xcomp	_	_
7	the	_	DET	DT	_	8	det	_	_
8	effect	_	NOUN	NN	_	6	dobj	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	race	_	NOUN	NN	_	8	nmod	_	_
11	or	_	CONJ	CC	_	10	cc	_	_
12	age	_	NOUN	NN	_	10	conj	_	_
13	on	_	ADP	IN	_	14	case	_	_
14	outcome	_	NOUN	NN	_	8	nmod	_	_

#	Sertraline Hydrochloride	1659
1	In	_	ADP	IN	_	5	case	_	_
2	a	_	DET	DT	_	5	det	_	_
3	longer	_	ADJ	JJ	_	5	amod	_	_
4	term	_	NOUN	NN	_	5	compound	_	_
5	study	_	NOUN	NN	_	34	nmod	_	_
6	,	_	.	,	_	34	punct	_	_
7	patients	_	NOUN	NNS	_	34	nsubjpass	_	_
8	meeting	_	VERB	VBG	_	7	acl	_	_
9	DSM	_	NOUN	NN	_	12	compound	_	_
10	III	_	NUM	CD	_	12	nummod	_	_
11	R	_	NOUN	NN	_	12	compound	_	_
12	criteria	_	NOUN	NN	_	8	dobj	_	_
13	for	_	ADP	IN	_	14	case	_	_
14	PTSD	_	NOUN	NN	_	12	nmod	_	_
15	who	_	DET	WDT	_	17	nsubj	_	_
16	had	_	VERB	MD	_	17	aux	_	_
17	responded	_	VERB	VBN	_	14	acl:relcl	_	_
18	during	_	ADP	IN	_	23	case	_	_
19	a	_	DET	DT	_	23	det	_	_
20	24	_	NUM	CD	_	23	nummod	_	_
21	week	_	NOUN	NN	_	23	compound	_	_
22	open	_	ADJ	JJ	_	23	amod	_	_
23	trial	_	NOUN	NN	_	17	nmod	_	_
24	on	_	ADP	IN	_	25	case	_	_
25	DRUG	_	NOUN	NN	_	23	nmod	_	_
26	50	_	NUM	CD	_	25	nummod	_	_
27	to	_	PRT	TO	_	32	case	_	_
28	200	_	NUM	CD	_	29	nummod	_	_
29	mg	_	NOUN	NN	_	32	amod	_	_
30	/	_	.	:	_	32	punct	_	_
31	day	_	NOUN	NN	_	32	compound	_	_
32	N=96	_	NOUN	NN	_	23	nmod	_	_
33	were	_	VERB	VBD	_	34	auxpass	_	_
34	randomized	_	VERB	VBN	_	0	root	_	_
35	to	_	PRT	TO	_	36	case	_	_
36	continuation	_	NOUN	NN	_	34	nmod	_	_
37	of	_	ADP	IN	_	38	case	_	_
38	DRUG	_	NOUN	NN	_	36	nmod	_	_
39	or	_	CONJ	CC	_	36	cc	_	_
40	to	_	PRT	TO	_	41	case	_	_
41	substitution	_	NOUN	NN	_	36	conj	_	_
42	of	_	ADP	IN	_	43	case	_	_
43	placebo	_	NOUN	NN	_	41	nmod	_	_
44	for	_	ADP	IN	_	48	case	_	_
45	up	_	ADJ	JJ	_	47	advmod	_	_
46	to	_	PRT	TO	_	47	dep	_	_
47	28	_	NUM	CD	_	48	nummod	_	_
48	weeks	_	NOUN	NNS	_	41	nmod	_	_
49	of	_	ADP	IN	_	50	case	_	_
50	observation	_	NOUN	NN	_	48	nmod	_	_
51	for	_	ADP	IN	_	52	case	_	_
52	relapse	_	ADP	IN	_	50	nmod	_	_

#	Sertraline Hydrochloride	1660
1	Response	_	NOUN	NN	_	7	nsubjpass	_	_
2	during	_	ADP	IN	_	5	case	_	_
3	the	_	DET	DT	_	5	det	_	_
4	open	_	ADJ	JJ	_	5	amod	_	_
5	phase	_	NOUN	NN	_	1	nmod	_	_
6	was	_	VERB	VBD	_	7	auxpass	_	_
7	defined	_	VERB	VBN	_	0	root	_	_
8	as	_	ADP	IN	_	10	case	_	_
9	a	_	DET	DT	_	10	det	_	_
10	CGI	_	NOUN	NN	_	7	nmod	_	_
11	I	_	NUM	CD	_	10	nummod	_	_
12	of	_	ADP	IN	_	16	mark	_	_
13	1	_	NUM	CD	_	16	nummod	_	_
14	very	_	ADV	RB	_	15	advmod	_	_
15	much	_	ADV	RB	_	16	advmod	_	_
16	improved	_	VERB	VBN	_	10	acl	_	_
17	or	_	CONJ	CC	_	16	cc	_	_
18	2	_	NUM	CD	_	16	conj	_	_
19	much	_	ADV	RB	_	20	advmod	_	_
20	improved	_	VERB	VBN	_	16	dep	_	_
21	,	_	.	,	_	7	punct	_	_
22	and	_	CONJ	CC	_	7	cc	_	_
23	a	_	DET	DT	_	24	det	_	_
24	decrease	_	NOUN	NN	_	33	nsubj	_	_
25	in	_	ADP	IN	_	29	case	_	_
26	the	_	DET	DT	_	29	det	_	_
27	CAPS	_	NOUN	NN	_	29	compound	_	_
28	2	_	NUM	CD	_	29	nummod	_	_
29	score	_	NOUN	NN	_	24	nmod	_	_
30	of	_	ADP	IN	_	32	case	_	_
31	>	_	NUM	CD	_	32	nummod	_	_
32	30%	_	NOUN	NN	_	29	nmod	_	_
33	compared	_	VERB	VBN	_	7	conj	_	_
34	to	_	PRT	TO	_	35	case	_	_
35	baseline	_	NOUN	NN	_	33	nmod	_	_

#	Sertraline Hydrochloride	1661
1	Relapse	_	NOUN	NN	_	8	nsubjpass	_	_
2	during	_	ADP	IN	_	6	case	_	_
3	the	_	DET	DT	_	6	det	_	_
4	double	_	ADJ	JJ	_	6	amod	_	_
5	blind	_	NOUN	NN	_	6	compound	_	_
6	phase	_	NOUN	NN	_	1	nmod	_	_
7	was	_	VERB	VBD	_	8	auxpass	_	_
8	defined	_	VERB	VBN	_	0	root	_	_
9	as	_	ADP	IN	_	12	case	_	_
10	the	_	DET	DT	_	12	det	_	_
11	following	_	VERB	VBG	_	12	amod	_	_
12	conditions	_	NOUN	NNS	_	8	nmod	_	_
13	being	_	VERB	VBD	_	18	cop	_	_
14	met	_	ADV	RB	_	18	neg	_	_
15	on	_	ADP	IN	_	18	case	_	_
16	two	_	NUM	CD	_	18	nummod	_	_
17	consecutive	_	ADJ	JJ	_	18	amod	_	_
18	visits	_	NOUN	NNS	_	8	parataxis	_	_
19	:	_	.	:	_	18	punct	_	_
20	1	_	NUM	CD	_	28	nummod	_	_
21	CGI	_	NOUN	NN	_	28	compound	_	_
22	I	_	NUM	CD	_	28	nummod	_	_
23	>	_	NUM	CD	_	28	nummod	_	_
24	3	_	NUM	CD	_	28	nummod	_	_
25	2	_	NUM	CD	_	28	nummod	_	_
26	CAPS	_	NOUN	NN	_	28	compound	_	_
27	2	_	NUM	CD	_	28	nummod	_	_
28	score	_	NOUN	NN	_	29	nsubj	_	_
29	increased	_	VERB	VBN	_	18	dep	_	_
30	by	_	ADP	IN	_	32	case	_	_
31	>	_	NUM	CD	_	32	nummod	_	_
32	30%	_	NOUN	NN	_	29	nmod	_	_
33	and	_	CONJ	CC	_	29	cc	_	_
34	by	_	ADP	IN	_	37	case	_	_
35	>	_	NUM	CD	_	37	nummod	_	_
36	15	_	NUM	CD	_	37	nummod	_	_
37	points	_	NOUN	NNS	_	29	conj	_	_
38	relative	_	ADJ	JJ	_	37	amod	_	_
39	to	_	PRT	TO	_	40	case	_	_
40	baseline	_	NOUN	NN	_	38	nmod	_	_
41	and	_	CONJ	CC	_	37	cc	_	_
42	3	_	NUM	CD	_	43	nummod	_	_
43	worsening	_	NOUN	NN	_	37	conj	_	_
44	of	_	ADP	IN	_	47	case	_	_
45	the	_	DET	DT	_	47	det	_	_
46	patient's	_	NOUN	NNS	_	47	compound	_	_
47	condition	_	NOUN	NN	_	43	nmod	_	_
48	in	_	ADP	IN	_	51	case	_	_
49	the	_	DET	DT	_	51	det	_	_
50	investigator's	_	NOUN	NNS	_	51	compound	_	_
51	judgment	_	NOUN	NN	_	47	nmod	_	_

#	Sertraline Hydrochloride	1662
1	Patients	_	NOUN	NNS	_	6	nsubj	_	_
2	receiving	_	VERB	VBG	_	1	acl	_	_
3	continued	_	VERB	VBN	_	5	amod	_	_
4	DRUG	_	NOUN	NN	_	5	compound	_	_
5	treatment	_	NOUN	NN	_	2	dobj	_	_
6	experienced	_	VERB	VBN	_	0	root	_	_
7	significantly	_	ADV	RB	_	8	advmod	_	_
8	lower	_	ADJ	JJ	_	10	amod	_	_
9	relapse	_	ADJ	JJ	_	10	amod	_	_
10	rates	_	NOUN	NNS	_	6	dobj	_	_
11	over	_	ADP	IN	_	15	case	_	_
12	the	_	DET	DT	_	15	det	_	_
13	subsequent	_	ADJ	JJ	_	15	amod	_	_
14	28	_	NUM	CD	_	15	nummod	_	_
15	weeks	_	NOUN	NNS	_	6	nmod	_	_
16	compared	_	VERB	VBN	_	6	xcomp	_	_
17	to	_	PRT	TO	_	18	case	_	_
18	those	_	DET	DT	_	16	nmod	_	_
19	receiving	_	VERB	VBG	_	18	acl	_	_
20	placebo	_	NOUN	NN	_	19	nmod	_	_

#	Sertraline Hydrochloride	1664
1	Premenstrual	_	ADJ	JJ	_	4	amod	_	_
2	Dysphoric	_	ADJ	JJ	_	4	amod	_	_
3	Disorder	_	NOUN	NN	_	4	compound	_	_
4	PMDD	_	NOUN	NN	_	15	nsubjpass	_	_
5	The	_	DET	DT	_	6	det	_	_
6	effectiveness	_	NOUN	NN	_	4	dep	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	for	_	ADP	IN	_	11	case	_	_
10	the	_	DET	DT	_	11	det	_	_
11	treatment	_	NOUN	NN	_	6	nmod	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	PMDD	_	NOUN	NN	_	11	nmod	_	_
14	was	_	VERB	VBD	_	15	auxpass	_	_
15	established	_	VERB	VBN	_	0	root	_	_
16	in	_	ADP	IN	_	19	case	_	_
17	two	_	NUM	CD	_	19	nummod	_	_
18	double	_	ADJ	JJ	_	19	amod	_	_
19	blind	_	NOUN	NN	_	15	nmod	_	_
20	,	_	.	,	_	19	punct	_	_
21	parallel	_	ADJ	JJ	_	22	amod	_	_
22	group	_	NOUN	NN	_	19	appos	_	_
23	,	_	.	,	_	19	punct	_	_
24	placebo	_	NOUN	NN	_	25	nmod:npmod	_	_
25	controlled	_	VERB	VBN	_	29	amod	_	_
26	flexible	_	ADJ	JJ	_	29	amod	_	_
27	dose	_	NOUN	NN	_	29	compound	_	_
28	trials	_	NOUN	NNS	_	29	compound	_	_
29	Studies	_	NOUN	NNS	_	19	conj	_	_
30	1	_	NUM	CD	_	29	nummod	_	_
31	and	_	CONJ	CC	_	19	cc	_	_
32	2	_	NUM	CD	_	19	conj	_	_
33	conducted	_	VERB	VBN	_	19	acl	_	_
34	over	_	ADP	IN	_	37	case	_	_
35	3	_	NUM	CD	_	37	nummod	_	_
36	menstrual	_	ADJ	JJ	_	37	amod	_	_
37	cycles	_	NOUN	NNS	_	33	nmod	_	_

#	Sertraline Hydrochloride	1665
1	Patients	_	NOUN	NNS	_	0	root	_	_
2	in	_	ADP	IN	_	4	case	_	_
3	Study	_	NOUN	NN	_	4	compound	_	_
4	1	_	NUM	CD	_	1	nmod	_	_
5	met	_	ADV	RB	_	4	cc	_	_
6	DSM	_	NOUN	NN	_	9	compound	_	_
7	III	_	NUM	CD	_	9	nummod	_	_
8	R	_	NOUN	NN	_	9	compound	_	_
9	criteria	_	NOUN	NN	_	4	conj	_	_
10	for	_	ADP	IN	_	16	case	_	_
11	Late	_	ADJ	JJ	_	16	amod	_	_
12	Luteal	_	NOUN	NN	_	16	compound	_	_
13	Phase	_	NOUN	NN	_	16	compound	_	_
14	Dysphoric	_	ADJ	JJ	_	16	amod	_	_
15	Disorder	_	NOUN	NN	_	16	compound	_	_
16	LLPDD	_	NOUN	NN	_	1	nmod	_	_
17	,	_	.	,	_	16	punct	_	_
18	the	_	DET	DT	_	20	det	_	_
19	clinical	_	ADJ	JJ	_	20	amod	_	_
20	entity	_	NOUN	NN	_	16	appos	_	_
21	now	_	ADV	RB	_	22	advmod	_	_
22	referred	_	VERB	VBN	_	20	acl	_	_
23	to	_	PRT	TO	_	28	case	_	_
24	as	_	ADP	IN	_	28	case	_	_
25	Premenstrual	_	ADJ	JJ	_	28	amod	_	_
26	Dysphoric	_	ADJ	JJ	_	28	amod	_	_
27	Disorder	_	NOUN	NN	_	28	compound	_	_
28	PMDD	_	NOUN	NN	_	22	nmod	_	_
29	in	_	ADP	IN	_	30	case	_	_
30	DSM	_	NOUN	NN	_	28	nmod	_	_
31	IV	_	NUM	CD	_	30	nummod	_	_

#	Sertraline Hydrochloride	1666
1	Patients	_	NOUN	NNS	_	0	root	_	_
2	in	_	ADP	IN	_	4	case	_	_
3	Study	_	NOUN	NN	_	4	compound	_	_
4	2	_	NUM	CD	_	1	nmod	_	_
5	met	_	ADV	RB	_	4	cc	_	_
6	DSM	_	NOUN	NN	_	8	compound	_	_
7	IV	_	NUM	CD	_	8	nummod	_	_
8	criteria	_	NOUN	NN	_	4	conj	_	_
9	for	_	ADP	IN	_	10	case	_	_
10	PMDD	_	NOUN	NN	_	4	nmod	_	_

#	Sertraline Hydrochloride	1667
1	Study	_	NOUN	NN	_	3	nsubj	_	_
2	1	_	NUM	CD	_	1	nummod	_	_
3	utilized	_	VERB	VBD	_	0	root	_	_
4	daily	_	ADV	RB	_	5	advmod	_	_
5	dosing	_	VERB	VBG	_	3	xcomp	_	_
6	throughout	_	ADP	IN	_	8	case	_	_
7	the	_	DET	DT	_	8	det	_	_
8	study	_	NOUN	NN	_	5	nmod	_	_
9	,	_	.	,	_	3	punct	_	_
10	while	_	ADP	IN	_	3	dep	_	_
11	Study	_	NOUN	NN	_	15	compound	_	_
12	2	_	NUM	CD	_	15	nummod	_	_
13	utilized	_	VERB	VBD	_	15	amod	_	_
14	luteal	_	ADJ	JJ	_	15	amod	_	_
15	phase	_	NOUN	NN	_	10	root	_	_
16	dosing	_	VERB	VBG	_	15	acl	_	_
17	for	_	ADP	IN	_	20	case	_	_
18	the	_	DET	DT	_	20	det	_	_
19	2	_	NUM	CD	_	20	nummod	_	_
20	weeks	_	NOUN	NNS	_	16	nmod	_	_
21	prior	_	ADJ	JJ	_	20	amod	_	_
22	to	_	PRT	TO	_	24	case	_	_
23	the	_	DET	DT	_	24	det	_	_
24	onset	_	NOUN	NN	_	21	nmod	_	_
25	of	_	ADP	IN	_	26	case	_	_
26	menses	_	NOUN	NNS	_	24	nmod	_	_

#	Sertraline Hydrochloride	1668
1	The	_	DET	DT	_	3	det	_	_
2	mean	_	ADJ	JJ	_	3	amod	_	_
3	duration	_	NOUN	NN	_	13	nsubj	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	PMDD	_	NOUN	NN	_	6	compound	_	_
6	symptoms	_	NOUN	NNS	_	3	nmod	_	_
7	for	_	ADP	IN	_	9	case	_	_
8	these	_	DET	DT	_	9	det	_	_
9	patients	_	NOUN	NNS	_	3	nmod	_	_
10	was	_	VERB	VBD	_	13	cop	_	_
11	approximately	_	ADV	RB	_	12	advmod	_	_
12	10.5	_	NUM	CD	_	13	nummod	_	_
13	years	_	NOUN	NNS	_	0	root	_	_
14	in	_	ADP	IN	_	16	case	_	_
15	both	_	DET	DT	_	16	det	_	_
16	studies	_	NOUN	NNS	_	13	nmod	_	_

#	Sertraline Hydrochloride	1669
1	Patients	_	NOUN	NNS	_	6	nsubjpass	_	_
2	on	_	ADP	IN	_	4	case	_	_
3	oral	_	ADJ	JJ	_	4	amod	_	_
4	contraceptives	_	NOUN	NNS	_	1	nmod	_	_
5	were	_	VERB	VBD	_	6	auxpass	_	_
6	excluded	_	VERB	VBN	_	0	root	_	_
7	from	_	ADP	IN	_	9	case	_	_
8	these	_	DET	DT	_	9	det	_	_
9	trials	_	NOUN	NNS	_	6	nmod	_	_
10	therefore	_	ADV	RB	_	6	advmod	_	_
11	,	_	.	,	_	6	punct	_	_
12	the	_	DET	DT	_	13	det	_	_
13	efficacy	_	NOUN	NN	_	27	nsubj	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	DRUG	_	NOUN	NN	_	13	nmod	_	_
16	in	_	ADP	IN	_	17	case	_	_
17	combination	_	NOUN	NN	_	13	nmod	_	_
18	with	_	ADP	IN	_	20	case	_	_
19	oral	_	ADJ	JJ	_	20	amod	_	_
20	contraceptives	_	NOUN	NNS	_	17	nmod	_	_
21	for	_	ADP	IN	_	23	case	_	_
22	the	_	DET	DT	_	23	det	_	_
23	treatment	_	NOUN	NN	_	20	nmod	_	_
24	of	_	ADP	IN	_	25	case	_	_
25	PMDD	_	NOUN	NN	_	23	nmod	_	_
26	is	_	VERB	VBZ	_	27	auxpass	_	_
27	unknown	_	ADJ	JJ	_	6	parataxis	_	_

#	Sertraline Hydrochloride	1670
1	Efficacy	_	NOUN	NN	_	3	nsubjpass	_	_
2	was	_	VERB	VBD	_	3	auxpass	_	_
3	assessed	_	VERB	VBN	_	0	root	_	_
4	with	_	ADP	IN	_	7	case	_	_
5	the	_	DET	DT	_	7	det	_	_
6	Daily	_	ADJ	JJ	_	7	amod	_	_
7	Record	_	NOUN	NN	_	3	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	Severity	_	NOUN	NN	_	7	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	Problems	_	NOUN	NNS	_	9	nmod	_	_
12	DRSP	_	NOUN	NN	_	11	dep	_	_
13	,	_	.	,	_	12	punct	_	_
14	a	_	DET	DT	_	17	det	_	_
15	patient	_	NOUN	NN	_	17	compound	_	_
16	rated	_	ADJ	JJ	_	17	amod	_	_
17	instrument	_	NOUN	NN	_	12	appos	_	_
18	that	_	DET	WDT	_	19	nsubj	_	_
19	mirrors	_	VERB	VBZ	_	17	acl:relcl	_	_
20	the	_	DET	DT	_	22	det	_	_
21	diagnostic	_	ADJ	JJ	_	22	amod	_	_
22	criteria	_	NOUN	NN	_	19	dobj	_	_
23	for	_	ADP	IN	_	24	case	_	_
24	PMDD	_	NOUN	NN	_	22	nmod	_	_
25	as	_	ADP	IN	_	26	mark	_	_
26	identified	_	VERB	VBN	_	19	advcl	_	_
27	in	_	ADP	IN	_	29	case	_	_
28	the	_	DET	DT	_	29	det	_	_
29	DSM	_	NOUN	NN	_	26	nmod	_	_
30	IV	_	NUM	CD	_	29	nummod	_	_
31	,	_	.	,	_	12	punct	_	_
32	and	_	CONJ	CC	_	3	cc	_	_
33	includes	_	VERB	VBZ	_	3	conj	_	_
34	assessments	_	NOUN	NNS	_	33	dobj	_	_
35	for	_	ADP	IN	_	36	case	_	_
36	mood	_	NOUN	NN	_	34	nmod	_	_
37	,	_	.	,	_	36	punct	_	_
38	physical	_	ADJ	JJ	_	39	amod	_	_
39	symptoms	_	NOUN	NNS	_	36	conj	_	_
40	,	_	.	,	_	36	punct	_	_
41	and	_	CONJ	CC	_	36	cc	_	_
42	other	_	ADJ	JJ	_	43	amod	_	_
43	symptoms	_	NOUN	NNS	_	36	conj	_	_

#	Sertraline Hydrochloride	1671
1	Other	_	ADJ	JJ	_	3	amod	_	_
2	efficacy	_	NOUN	NN	_	3	compound	_	_
3	assessments	_	NOUN	NNS	_	4	nsubj	_	_
4	included	_	VERB	VBD	_	0	root	_	_
5	the	_	DET	DT	_	7	det	_	_
6	Hamilton	_	NOUN	NN	_	7	compound	_	_
7	Depression	_	NOUN	NN	_	4	dobj	_	_
8	Rating	_	VERB	VBG	_	7	acl	_	_
9	Scale	_	NOUN	NN	_	10	compound	_	_
10	HAMD	_	NOUN	NN	_	8	dobj	_	_
11	17	_	NUM	CD	_	10	nummod	_	_
12	,	_	.	,	_	4	punct	_	_
13	and	_	CONJ	CC	_	4	cc	_	_
14	the	_	DET	DT	_	18	det	_	_
15	Clinical	_	ADJ	JJ	_	18	amod	_	_
16	Global	_	ADJ	JJ	_	18	amod	_	_
17	Impression	_	NOUN	NN	_	18	compound	_	_
18	Severity	_	NOUN	NN	_	4	conj	_	_
19	of	_	ADP	IN	_	22	case	_	_
20	Illness	_	NOUN	NN	_	22	compound	_	_
21	CGI	_	NOUN	NN	_	22	compound	_	_
22	S	_	NOUN	NN	_	18	nmod	_	_
23	and	_	CONJ	CC	_	22	cc	_	_
24	Improvement	_	NOUN	NN	_	27	compound	_	_
25	CGI	_	NOUN	NN	_	27	compound	_	_
26	I	_	NUM	CD	_	27	nummod	_	_
27	scores	_	NOUN	NNS	_	22	conj	_	_

#	Sertraline Hydrochloride	1672
1	In	_	ADP	IN	_	2	case	_	_
2	Study	_	NOUN	NN	_	14	nmod	_	_
3	1	_	NUM	CD	_	2	nummod	_	_
4	,	_	.	,	_	14	punct	_	_
5	involving	_	VERB	VBG	_	14	nsubjpass	_	_
6	n	_	NOUN	NN	_	10	compound	_	_
7	=	_	ADJ	JJ	_	10	amod	_	_
8	251	_	NUM	CD	_	10	nummod	_	_
9	randomized	_	ADJ	JJ	_	10	amod	_	_
10	patients	_	NOUN	NNS	_	12	compound	_	_
11	DRUG	_	NOUN	NN	_	12	compound	_	_
12	treatment	_	NOUN	NN	_	5	dobj	_	_
13	was	_	VERB	VBD	_	14	auxpass	_	_
14	initiated	_	VERB	VBN	_	0	root	_	_
15	at	_	ADP	IN	_	19	case	_	_
16	50	_	NUM	CD	_	17	nummod	_	_
17	mg	_	NOUN	NN	_	19	amod	_	_
18	/	_	.	:	_	19	punct	_	_
19	day	_	NOUN	NN	_	14	nmod	_	_
20	and	_	CONJ	CC	_	14	cc	_	_
21	administered	_	VERB	VBN	_	14	conj	_	_
22	daily	_	ADV	RB	_	21	advmod	_	_
23	throughout	_	ADP	IN	_	26	case	_	_
24	the	_	DET	DT	_	26	det	_	_
25	menstrual	_	ADJ	JJ	_	26	amod	_	_
26	cycle	_	NOUN	NN	_	21	nmod	_	_

#	Sertraline Hydrochloride	1673
1	In	_	ADP	IN	_	3	case	_	_
2	subsequent	_	ADJ	JJ	_	3	amod	_	_
3	cycles	_	NOUN	NNS	_	7	nmod	_	_
4	,	_	.	,	_	7	punct	_	_
5	patients	_	NOUN	NNS	_	7	nsubjpass	_	_
6	were	_	VERB	VBD	_	7	auxpass	_	_
7	dosed	_	VERB	VBN	_	0	root	_	_
8	in	_	ADP	IN	_	10	case	_	_
9	the	_	DET	DT	_	10	det	_	_
10	range	_	NOUN	NN	_	7	nmod	_	_
11	of	_	ADP	IN	_	15	case	_	_
12	50	_	NUM	CD	_	14	compound	_	_
13	to	_	PRT	TO	_	14	dep	_	_
14	150	_	NUM	CD	_	15	nummod	_	_
15	mg	_	NOUN	NN	_	10	nmod	_	_
16	/	_	.	:	_	7	punct	_	_
17	day	_	NOUN	NN	_	7	parataxis	_	_
18	on	_	ADP	IN	_	20	case	_	_
19	the	_	DET	DT	_	20	det	_	_
20	basis	_	NOUN	NN	_	17	nmod	_	_
21	of	_	ADP	IN	_	23	case	_	_
22	clinical	_	ADJ	JJ	_	23	amod	_	_
23	response	_	NOUN	NN	_	20	nmod	_	_
24	and	_	CONJ	CC	_	23	cc	_	_
25	toleration	_	NOUN	NN	_	23	conj	_	_

#	Sertraline Hydrochloride	1674
1	The	_	DET	DT	_	3	det	_	_
2	mean	_	ADJ	JJ	_	3	amod	_	_
3	dose	_	NOUN	NN	_	10	nsubj	_	_
4	for	_	ADP	IN	_	5	case	_	_
5	completers	_	NOUN	NNS	_	3	nmod	_	_
6	was	_	VERB	VBD	_	10	cop	_	_
7	102	_	NUM	CD	_	10	nummod	_	_
8	mg	_	NOUN	NN	_	10	compound	_	_
9	/	_	.	:	_	10	compound	_	_
10	day	_	NOUN	NN	_	0	root	_	_

#	Sertraline Hydrochloride	1675
1	DRUG	_	NOUN	NN	_	11	nsubj	_	_
2	administered	_	VERB	VBN	_	1	acl	_	_
3	daily	_	ADV	RB	_	2	advmod	_	_
4	throughout	_	ADP	IN	_	7	case	_	_
5	the	_	DET	DT	_	7	det	_	_
6	menstrual	_	ADJ	JJ	_	7	amod	_	_
7	cycle	_	NOUN	NN	_	2	nmod	_	_
8	was	_	VERB	VBD	_	11	cop	_	_
9	significantly	_	ADV	RB	_	11	advmod	_	_
10	more	_	ADV	RB	_	11	advmod	_	_
11	effective	_	ADJ	JJ	_	0	root	_	_
12	than	_	ADP	IN	_	13	case	_	_
13	placebo	_	NOUN	NN	_	11	nmod	_	_
14	on	_	ADP	IN	_	15	case	_	_
15	change	_	NOUN	NN	_	11	nmod	_	_
16	from	_	ADP	IN	_	17	case	_	_
17	baseline	_	NOUN	NN	_	15	nmod	_	_
18	to	_	PRT	TO	_	19	case	_	_
19	endpoint	_	NOUN	NN	_	15	nmod	_	_
20	on	_	ADP	IN	_	24	case	_	_
21	the	_	DET	DT	_	24	det	_	_
22	DRSP	_	NOUN	NN	_	24	compound	_	_
23	total	_	ADJ	JJ	_	24	amod	_	_
24	score	_	NOUN	NN	_	19	nmod	_	_
25	,	_	.	,	_	24	punct	_	_
26	the	_	DET	DT	_	30	det	_	_
27	HAMD	_	NOUN	NN	_	30	compound	_	_
28	17	_	NUM	CD	_	30	nummod	_	_
29	total	_	ADJ	JJ	_	30	amod	_	_
30	score	_	NOUN	NN	_	24	conj	_	_
31	,	_	.	,	_	24	punct	_	_
32	and	_	CONJ	CC	_	24	cc	_	_
33	the	_	DET	DT	_	36	det	_	_
34	CGI	_	NOUN	NN	_	36	compound	_	_
35	S	_	NOUN	NN	_	36	compound	_	_
36	score	_	NOUN	NN	_	24	conj	_	_
37	,	_	.	,	_	36	punct	_	_
38	as	_	ADV	RB	_	36	cc	_	_
39	well	_	ADV	RB	_	38	mwe	_	_
40	as	_	ADP	IN	_	38	mwe	_	_
41	the	_	DET	DT	_	44	det	_	_
42	CGI	_	NOUN	NN	_	44	compound	_	_
43	I	_	NUM	CD	_	44	nummod	_	_
44	score	_	NOUN	NN	_	36	conj	_	_
45	at	_	ADP	IN	_	46	case	_	_
46	endpoint	_	NOUN	NN	_	44	nmod	_	_

#	Sertraline Hydrochloride	1676
1	In	_	ADP	IN	_	2	case	_	_
2	Study	_	NOUN	NN	_	15	nmod	_	_
3	2	_	NUM	CD	_	2	nummod	_	_
4	,	_	.	,	_	15	punct	_	_
5	involving	_	VERB	VBG	_	15	advcl	_	_
6	n	_	NOUN	NN	_	10	compound	_	_
7	=	_	ADJ	JJ	_	10	amod	_	_
8	281	_	NUM	CD	_	10	nummod	_	_
9	randomized	_	ADJ	JJ	_	10	amod	_	_
10	patients	_	NOUN	NNS	_	5	dobj	_	_
11	,	_	.	,	_	15	punct	_	_
12	DRUG	_	NOUN	NN	_	13	compound	_	_
13	treatment	_	NOUN	NN	_	15	nsubjpass	_	_
14	was	_	VERB	VBD	_	15	auxpass	_	_
15	initiated	_	VERB	VBN	_	0	root	_	_
16	at	_	ADP	IN	_	20	case	_	_
17	50	_	NUM	CD	_	18	nummod	_	_
18	mg	_	NOUN	NN	_	20	amod	_	_
19	/	_	.	:	_	20	punct	_	_
20	day	_	NOUN	NN	_	15	nmod	_	_
21	in	_	ADP	IN	_	28	case	_	_
22	the	_	DET	DT	_	28	det	_	_
23	late	_	ADJ	JJ	_	28	amod	_	_
24	luteal	_	ADJ	JJ	_	28	amod	_	_
25	phase	_	NOUN	NN	_	28	compound	_	_
26	last	_	NOUN	NN	_	28	compound	_	_
27	2	_	NUM	CD	_	28	nummod	_	_
28	weeks	_	NOUN	NNS	_	20	nmod	_	_
29	of	_	ADP	IN	_	32	case	_	_
30	each	_	DET	DT	_	32	det	_	_
31	menstrual	_	ADJ	JJ	_	32	amod	_	_
32	cycle	_	NOUN	NN	_	28	nmod	_	_
33	and	_	CONJ	CC	_	15	cc	_	_
34	then	_	ADV	RB	_	35	advmod	_	_
35	discontinued	_	VERB	VBN	_	15	conj	_	_
36	at	_	ADP	IN	_	38	case	_	_
37	the	_	DET	DT	_	38	det	_	_
38	onset	_	NOUN	NN	_	35	nmod	_	_
39	of	_	ADP	IN	_	40	case	_	_
40	menses	_	NOUN	NNS	_	38	nmod	_	_

#	Sertraline Hydrochloride	1677
1	In	_	ADP	IN	_	3	case	_	_
2	subsequent	_	ADJ	JJ	_	3	amod	_	_
3	cycles	_	NOUN	NNS	_	7	nmod	_	_
4	,	_	.	,	_	7	punct	_	_
5	patients	_	NOUN	NNS	_	7	nsubjpass	_	_
6	were	_	VERB	VBD	_	7	auxpass	_	_
7	dosed	_	VERB	VBN	_	0	root	_	_
8	in	_	ADP	IN	_	10	case	_	_
9	the	_	DET	DT	_	10	det	_	_
10	range	_	NOUN	NN	_	7	nmod	_	_
11	of	_	ADP	IN	_	17	case	_	_
12	50	_	NUM	CD	_	14	compound	_	_
13	to	_	PRT	TO	_	14	dep	_	_
14	100	_	NUM	CD	_	15	nummod	_	_
15	mg	_	NOUN	NN	_	17	compound	_	_
16	/	_	.	:	_	17	punct	_	_
17	day	_	NOUN	NN	_	10	nmod	_	_
18	in	_	ADP	IN	_	21	case	_	_
19	the	_	DET	DT	_	21	det	_	_
20	luteal	_	ADJ	JJ	_	21	amod	_	_
21	phase	_	NOUN	NN	_	17	nmod	_	_
22	of	_	ADP	IN	_	24	case	_	_
23	each	_	DET	DT	_	24	det	_	_
24	cycle	_	NOUN	NN	_	21	nmod	_	_
25	,	_	.	,	_	7	punct	_	_
26	on	_	ADP	IN	_	28	case	_	_
27	the	_	DET	DT	_	28	det	_	_
28	basis	_	NOUN	NN	_	7	nmod	_	_
29	of	_	ADP	IN	_	31	case	_	_
30	clinical	_	ADJ	JJ	_	31	amod	_	_
31	response	_	NOUN	NN	_	28	nmod	_	_
32	and	_	CONJ	CC	_	31	cc	_	_
33	toleration	_	NOUN	NN	_	31	conj	_	_

#	Sertraline Hydrochloride	1678
1	Patients	_	NOUN	NNS	_	0	root	_	_
2	who	_	DET	WDT	_	4	nsubjpass	_	_
3	were	_	VERB	VBD	_	4	auxpass	_	_
4	titrated	_	VERB	VBN	_	1	acl:relcl	_	_
5	to	_	PRT	TO	_	7	case	_	_
6	100	_	NUM	CD	_	7	nummod	_	_
7	mg	_	NOUN	NN	_	4	nmod	_	_
8	/	_	.	:	_	1	punct	_	_
9	day	_	NOUN	NN	_	10	nsubj	_	_
10	received	_	VERB	VBD	_	1	dep	_	_
11	50	_	NUM	CD	_	12	nummod	_	_
12	mg	_	NOUN	NN	_	10	dobj	_	_
13	/	_	.	:	_	10	punct	_	_
14	day	_	NOUN	NN	_	10	dep	_	_
15	for	_	ADP	IN	_	19	case	_	_
16	the	_	DET	DT	_	19	det	_	_
17	first	_	ADJ	JJ	_	19	amod	_	_
18	3	_	NUM	CD	_	19	nummod	_	_
19	days	_	NOUN	NNS	_	14	nmod	_	_
20	of	_	ADP	IN	_	22	case	_	_
21	the	_	DET	DT	_	22	det	_	_
22	cycle	_	NOUN	NN	_	19	nmod	_	_
23	,	_	.	,	_	14	punct	_	_
24	then	_	ADV	RB	_	25	advmod	_	_
25	100	_	NUM	CD	_	26	nummod	_	_
26	mg	_	NOUN	NN	_	14	appos	_	_
27	/	_	.	:	_	10	punct	_	_
28	day	_	NOUN	NN	_	10	parataxis	_	_
29	for	_	ADP	IN	_	31	case	_	_
30	the	_	DET	DT	_	31	det	_	_
31	remainder	_	NOUN	NN	_	28	nmod	_	_
32	of	_	ADP	IN	_	34	case	_	_
33	the	_	DET	DT	_	34	det	_	_
34	cycle	_	NOUN	NN	_	31	nmod	_	_

#	Sertraline Hydrochloride	1679
1	The	_	DET	DT	_	4	det	_	_
2	mean	_	ADJ	JJ	_	4	amod	_	_
3	DRUG	_	NOUN	NN	_	4	compound	_	_
4	dose	_	NOUN	NN	_	11	nsubj	_	_
5	for	_	ADP	IN	_	6	case	_	_
6	completers	_	NOUN	NNS	_	4	nmod	_	_
7	was	_	VERB	VBD	_	11	cop	_	_
8	74	_	NUM	CD	_	11	nummod	_	_
9	mg	_	NOUN	NN	_	11	compound	_	_
10	/	_	.	:	_	11	compound	_	_
11	day	_	NOUN	NN	_	0	root	_	_

#	Sertraline Hydrochloride	1680
1	DRUG	_	NOUN	NN	_	15	nsubj	_	_
2	administered	_	VERB	VBN	_	1	acl	_	_
3	in	_	ADP	IN	_	7	case	_	_
4	the	_	DET	DT	_	7	det	_	_
5	late	_	ADJ	JJ	_	7	amod	_	_
6	luteal	_	ADJ	JJ	_	7	amod	_	_
7	phase	_	NOUN	NN	_	2	nmod	_	_
8	of	_	ADP	IN	_	11	case	_	_
9	the	_	DET	DT	_	11	det	_	_
10	menstrual	_	ADJ	JJ	_	11	amod	_	_
11	cycle	_	NOUN	NN	_	7	nmod	_	_
12	was	_	VERB	VBD	_	15	cop	_	_
13	significantly	_	ADV	RB	_	15	advmod	_	_
14	more	_	ADV	RB	_	15	advmod	_	_
15	effective	_	ADJ	JJ	_	0	root	_	_
16	than	_	ADP	IN	_	17	case	_	_
17	placebo	_	NOUN	NN	_	15	nmod	_	_
18	on	_	ADP	IN	_	19	case	_	_
19	change	_	NOUN	NN	_	15	nmod	_	_
20	from	_	ADP	IN	_	21	case	_	_
21	baseline	_	NOUN	NN	_	19	nmod	_	_
22	to	_	PRT	TO	_	23	case	_	_
23	endpoint	_	NOUN	NN	_	19	nmod	_	_
24	on	_	ADP	IN	_	28	case	_	_
25	the	_	DET	DT	_	28	det	_	_
26	DRSP	_	NOUN	NN	_	28	compound	_	_
27	total	_	ADJ	JJ	_	28	amod	_	_
28	score	_	NOUN	NN	_	23	nmod	_	_
29	and	_	CONJ	CC	_	28	cc	_	_
30	the	_	DET	DT	_	33	det	_	_
31	CGI	_	NOUN	NN	_	33	compound	_	_
32	S	_	NOUN	NN	_	33	compound	_	_
33	score	_	NOUN	NN	_	28	conj	_	_
34	,	_	.	,	_	28	punct	_	_
35	as	_	ADV	RB	_	28	cc	_	_
36	well	_	ADV	RB	_	35	mwe	_	_
37	as	_	ADP	IN	_	35	mwe	_	_
38	the	_	DET	DT	_	41	det	_	_
39	CGI	_	NOUN	NN	_	41	compound	_	_
40	I	_	NUM	CD	_	41	nummod	_	_
41	score	_	NOUN	NN	_	28	conj	_	_
42	at	_	ADP	IN	_	43	case	_	_
43	endpoint	_	NOUN	NN	_	41	nmod	_	_

#	Sertraline Hydrochloride	1681
1	There	_	DET	EX	_	2	expl	_	_
2	was	_	VERB	VBD	_	0	root	_	_
3	insufficient	_	ADJ	JJ	_	4	amod	_	_
4	information	_	NOUN	NN	_	2	nsubj	_	_
5	to	_	PRT	TO	_	6	mark	_	_
6	determine	_	VERB	VB	_	2	xcomp	_	_
7	the	_	DET	DT	_	8	det	_	_
8	effect	_	NOUN	NN	_	6	dobj	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	race	_	NOUN	NN	_	8	nmod	_	_
11	or	_	CONJ	CC	_	10	cc	_	_
12	age	_	NOUN	NN	_	10	conj	_	_
13	on	_	ADP	IN	_	14	case	_	_
14	outcome	_	NOUN	NN	_	8	nmod	_	_
15	in	_	ADP	IN	_	17	case	_	_
16	these	_	DET	DT	_	17	det	_	_
17	studies	_	NOUN	NNS	_	8	nmod	_	_

#	Sertraline Hydrochloride	1682
1	Social	_	ADJ	JJ	_	3	amod	_	_
2	Anxiety	_	NOUN	NN	_	3	compound	_	_
3	Disorder	_	NOUN	NN	_	21	nsubjpass	_	_
4	The	_	DET	DT	_	5	det	_	_
5	effectiveness	_	NOUN	NN	_	3	dep	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	in	_	ADP	IN	_	10	case	_	_
9	the	_	DET	DT	_	10	det	_	_
10	treatment	_	NOUN	NN	_	5	nmod	_	_
11	of	_	ADP	IN	_	14	case	_	_
12	social	_	ADJ	JJ	_	14	amod	_	_
13	anxiety	_	NOUN	NN	_	14	compound	_	_
14	disorder	_	NOUN	NN	_	10	nmod	_	_
15	also	_	ADV	RB	_	16	advmod	_	_
16	known	_	VERB	VBN	_	14	acl	_	_
17	as	_	ADP	IN	_	19	case	_	_
18	social	_	ADJ	JJ	_	19	amod	_	_
19	phobia	_	NOUN	NN	_	16	nmod	_	_
20	was	_	VERB	VBD	_	21	auxpass	_	_
21	established	_	VERB	VBN	_	0	root	_	_
22	in	_	ADP	IN	_	27	case	_	_
23	two	_	NUM	CD	_	27	nummod	_	_
24	multicenter	_	ADJ	JJ	_	27	amod	_	_
25	placebo	_	NOUN	NN	_	27	compound	_	_
26	controlled	_	VERB	VBN	_	27	amod	_	_
27	studies	_	NOUN	NNS	_	21	nmod	_	_
28	Study	_	NOUN	NN	_	27	dep	_	_
29	1	_	NUM	CD	_	28	nummod	_	_
30	and	_	CONJ	CC	_	28	cc	_	_
31	2	_	NUM	CD	_	28	conj	_	_
32	of	_	ADP	IN	_	34	case	_	_
33	adult	_	ADJ	JJ	_	34	amod	_	_
34	outpatients	_	NOUN	NNS	_	28	nmod	_	_
35	who	_	DET	WDT	_	39	nsubj	_	_
36	met	_	ADV	RB	_	39	neg	_	_
37	DSM	_	NOUN	NN	_	39	compound	_	_
38	IV	_	NUM	CD	_	39	nummod	_	_
39	criteria	_	NOUN	NN	_	34	nmod	_	_
40	for	_	ADP	IN	_	43	case	_	_
41	social	_	ADJ	JJ	_	43	amod	_	_
42	anxiety	_	NOUN	NN	_	43	compound	_	_
43	disorder	_	NOUN	NN	_	39	nmod	_	_

#	Sertraline Hydrochloride	1683
1	Study	_	NOUN	NN	_	6	nsubj	_	_
2	1	_	NUM	CD	_	1	nummod	_	_
3	was	_	VERB	VBD	_	6	cop	_	_
4	a	_	DET	DT	_	6	det	_	_
5	12	_	NUM	CD	_	6	nummod	_	_
6	week	_	NOUN	NN	_	0	root	_	_
7	,	_	.	,	_	6	punct	_	_
8	multicenter	_	ADJ	JJ	_	6	conj	_	_
9	,	_	.	,	_	6	punct	_	_
10	flexible	_	ADJ	JJ	_	12	amod	_	_
11	dose	_	NOUN	NN	_	12	compound	_	_
12	study	_	NOUN	NN	_	6	appos	_	_
13	comparing	_	VERB	VBG	_	12	acl	_	_
14	DRUG	_	NOUN	NN	_	18	compound	_	_
15	50	_	NUM	CD	_	17	compound	_	_
16	to	_	PRT	TO	_	17	dep	_	_
17	200	_	NUM	CD	_	18	nummod	_	_
18	mg	_	NOUN	NN	_	13	dobj	_	_
19	/	_	.	:	_	6	punct	_	_
20	day	_	NOUN	NN	_	6	dep	_	_
21	to	_	PRT	TO	_	22	case	_	_
22	placebo	_	NOUN	NN	_	20	nmod	_	_
23	,	_	.	,	_	6	punct	_	_
24	in	_	ADP	IN	_	25	case	_	_
25	which	_	DET	WDT	_	28	nmod	_	_
26	DRUG	_	NOUN	NN	_	28	nsubjpass	_	_
27	was	_	VERB	VBD	_	28	auxpass	_	_
28	initiated	_	VERB	VBN	_	6	advcl	_	_
29	at	_	ADP	IN	_	31	case	_	_
30	25	_	NUM	CD	_	31	nummod	_	_
31	mg	_	NOUN	NN	_	28	nmod	_	_
32	/	_	.	:	_	6	punct	_	_
33	day	_	NOUN	NN	_	6	dep	_	_
34	for	_	ADP	IN	_	37	case	_	_
35	the	_	DET	DT	_	37	det	_	_
36	first	_	ADJ	JJ	_	37	amod	_	_
37	week	_	NOUN	NN	_	33	nmod	_	_

#	Sertraline Hydrochloride	1684
1	Study	_	NOUN	NN	_	2	compound	_	_
2	outcome	_	NOUN	NN	_	4	nsubjpass	_	_
3	was	_	VERB	VBD	_	4	auxpass	_	_
4	assessed	_	VERB	VBN	_	0	root	_	_
5	by	_	ADP	IN	_	12	case	_	_
6	a	_	DET	DT	_	12	det	_	_
7	the	_	DET	DT	_	12	det	_	_
8	Liebowitz	_	ADJ	JJ	_	12	amod	_	_
9	Social	_	ADJ	JJ	_	12	amod	_	_
10	Anxiety	_	NOUN	NN	_	12	compound	_	_
11	Scale	_	NOUN	NN	_	12	compound	_	_
12	LSAS	_	NOUN	NN	_	4	nmod	_	_
13	,	_	.	,	_	12	punct	_	_
14	a	_	DET	DT	_	17	det	_	_
15	24	_	NUM	CD	_	17	nummod	_	_
16	item	_	NOUN	NN	_	17	compound	_	_
17	clinician	_	NOUN	NN	_	12	appos	_	_
18	administered	_	VERB	VBN	_	17	acl	_	_
19	instrument	_	NOUN	NN	_	18	dobj	_	_
20	that	_	DET	WDT	_	21	nsubj	_	_
21	measures	_	VERB	VBZ	_	19	acl:relcl	_	_
22	fear	_	NOUN	NN	_	21	dobj	_	_
23	,	_	.	,	_	22	punct	_	_
24	anxiety	_	NOUN	NN	_	22	conj	_	_
25	and	_	CONJ	CC	_	22	cc	_	_
26	avoidance	_	NOUN	NN	_	22	conj	_	_
27	of	_	ADP	IN	_	31	case	_	_
28	social	_	ADJ	JJ	_	31	amod	_	_
29	and	_	CONJ	CC	_	28	cc	_	_
30	performance	_	NOUN	NN	_	28	conj	_	_
31	situations	_	NOUN	NNS	_	22	nmod	_	_
32	,	_	.	,	_	12	punct	_	_
33	and	_	CONJ	CC	_	12	cc	_	_
34	by	_	ADP	IN	_	35	case	_	_
35	b	_	NOUN	NN	_	61	nmod	_	_
36	the	_	DET	DT	_	37	det	_	_
37	proportion	_	NOUN	NN	_	61	nsubj	_	_
38	of	_	ADP	IN	_	39	case	_	_
39	responders	_	NOUN	NNS	_	37	nmod	_	_
40	as	_	ADP	IN	_	41	mark	_	_
41	defined	_	VERB	VBN	_	37	acl	_	_
42	by	_	ADP	IN	_	46	case	_	_
43	the	_	DET	DT	_	46	det	_	_
44	Clinical	_	ADJ	JJ	_	46	amod	_	_
45	Global	_	ADJ	JJ	_	46	amod	_	_
46	Impression	_	NOUN	NN	_	41	nmod	_	_
47	of	_	ADP	IN	_	51	case	_	_
48	Improvement	_	NOUN	NN	_	51	compound	_	_
49	CGI	_	NOUN	NN	_	51	compound	_	_
50	I	_	NUM	CD	_	51	nummod	_	_
51	criterion	_	NOUN	NN	_	46	nmod	_	_
52	of	_	ADP	IN	_	56	case	_	_
53	CGI	_	NOUN	NN	_	56	compound	_	_
54	I	_	NUM	CD	_	56	nummod	_	_
55	<	_	NUM	CD	_	56	nummod	_	_
56	2	_	NUM	CD	_	51	nmod	_	_
57	very	_	ADV	RB	_	58	advmod	_	_
58	much	_	ADV	RB	_	59	advmod	_	_
59	or	_	CONJ	CC	_	61	advmod	_	_
60	much	_	ADV	RB	_	59	advmod	_	_
61	improved	_	VERB	VBD	_	12	conj	_	_

#	Sertraline Hydrochloride	1685
1	DRUG	_	NOUN	NN	_	6	nsubj	_	_
2	was	_	VERB	VBD	_	6	cop	_	_
3	statistically	_	ADV	RB	_	6	advmod	_	_
4	significantly	_	ADV	RB	_	6	advmod	_	_
5	more	_	ADV	RB	_	6	advmod	_	_
6	effective	_	ADJ	JJ	_	0	root	_	_
7	than	_	ADP	IN	_	8	case	_	_
8	placebo	_	NOUN	NN	_	6	nmod	_	_
9	as	_	ADP	IN	_	10	mark	_	_
10	measured	_	VERB	VBN	_	6	advcl	_	_
11	by	_	ADP	IN	_	13	case	_	_
12	the	_	DET	DT	_	13	det	_	_
13	LSAS	_	NOUN	NN	_	10	nmod	_	_
14	and	_	CONJ	CC	_	10	cc	_	_
15	the	_	DET	DT	_	16	det	_	_
16	percentage	_	NOUN	NN	_	10	conj	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	responders	_	NOUN	NNS	_	16	nmod	_	_

#	Sertraline Hydrochloride	1686
1	Study	_	NOUN	NN	_	6	nsubj	_	_
2	2	_	NUM	CD	_	1	nummod	_	_
3	was	_	VERB	VBD	_	6	cop	_	_
4	a	_	DET	DT	_	6	det	_	_
5	20	_	NUM	CD	_	6	nummod	_	_
6	week	_	NOUN	NN	_	0	root	_	_
7	,	_	.	,	_	6	punct	_	_
8	multicenter	_	ADJ	JJ	_	6	conj	_	_
9	,	_	.	,	_	6	punct	_	_
10	flexible	_	ADJ	JJ	_	12	amod	_	_
11	dose	_	NOUN	NN	_	12	compound	_	_
12	study	_	NOUN	NN	_	6	appos	_	_
13	that	_	DET	WDT	_	14	nsubj	_	_
14	compared	_	VERB	VBD	_	12	acl:relcl	_	_
15	DRUG	_	NOUN	NN	_	19	compound	_	_
16	50	_	NUM	CD	_	18	compound	_	_
17	to	_	PRT	TO	_	18	dep	_	_
18	200	_	NUM	CD	_	19	nummod	_	_
19	mg	_	NOUN	NN	_	14	dobj	_	_
20	/	_	.	:	_	6	punct	_	_
21	day	_	NOUN	NN	_	6	dep	_	_
22	to	_	PRT	TO	_	23	case	_	_
23	placebo	_	NOUN	NN	_	21	nmod	_	_

#	Sertraline Hydrochloride	1687
1	Study	_	NOUN	NN	_	2	compound	_	_
2	outcome	_	NOUN	NN	_	4	nsubjpass	_	_
3	was	_	VERB	VBD	_	4	auxpass	_	_
4	assessed	_	VERB	VBN	_	0	root	_	_
5	by	_	ADP	IN	_	13	case	_	_
6	the	_	DET	DT	_	13	det	_	_
7	a	_	DET	DT	_	13	det	_	_
8	Duke	_	NOUN	NN	_	13	compound	_	_
9	Brief	_	NOUN	NN	_	13	compound	_	_
10	Social	_	ADJ	JJ	_	13	amod	_	_
11	Phobia	_	NOUN	NN	_	13	compound	_	_
12	Scale	_	NOUN	NN	_	13	compound	_	_
13	BSPS	_	NOUN	NN	_	4	nmod	_	_
14	,	_	.	,	_	4	punct	_	_
15	a	_	DET	DT	_	16	det	_	_
16	multi	_	NOUN	NNS	_	17	nsubj	_	_
17	item	_	VERB	VBP	_	4	parataxis	_	_
18	clinician	_	ADJ	JJ	_	20	amod	_	_
19	rated	_	ADJ	JJ	_	20	amod	_	_
20	instrument	_	NOUN	NN	_	17	dobj	_	_
21	that	_	DET	WDT	_	22	nsubj	_	_
22	measures	_	VERB	VBZ	_	20	acl:relcl	_	_
23	fear	_	NOUN	NN	_	22	dobj	_	_
24	,	_	.	,	_	23	punct	_	_
25	avoidance	_	NOUN	NN	_	23	conj	_	_
26	and	_	CONJ	CC	_	23	cc	_	_
27	physiologic	_	ADJ	JJ	_	28	amod	_	_
28	response	_	NOUN	NN	_	23	conj	_	_
29	to	_	PRT	TO	_	30	case	_	_
30	social	_	ADJ	JJ	_	23	nmod	_	_
31	or	_	CONJ	CC	_	30	cc	_	_
32	performance	_	NOUN	NN	_	30	conj	_	_
33	situations	_	NOUN	NNS	_	30	dep	_	_
34	,	_	.	,	_	17	punct	_	_
35	b	_	ADV	RB	_	38	advmod	_	_
36	the	_	DET	DT	_	37	det	_	_
37	Marks	_	NOUN	NNS	_	38	nsubj	_	_
38	Fear	_	VERB	VBP	_	17	parataxis	_	_
39	Questionnaire	_	ADJ	JJ	_	44	amod	_	_
40	Social	_	ADJ	JJ	_	44	amod	_	_
41	Phobia	_	NOUN	NN	_	44	compound	_	_
42	Subscale	_	NOUN	NN	_	44	compound	_	_
43	FQ	_	NOUN	NN	_	44	compound	_	_
44	SPS	_	NOUN	NN	_	38	dobj	_	_
45	,	_	.	,	_	44	punct	_	_
46	a	_	DET	DT	_	51	det	_	_
47	5	_	NUM	CD	_	51	nummod	_	_
48	item	_	NOUN	NN	_	51	compound	_	_
49	patient	_	NOUN	NN	_	51	compound	_	_
50	rated	_	ADJ	JJ	_	51	amod	_	_
51	instrument	_	NOUN	NN	_	44	appos	_	_
52	that	_	DET	WDT	_	53	nsubj	_	_
53	measures	_	VERB	VBZ	_	51	acl:relcl	_	_
54	change	_	NOUN	NN	_	53	dobj	_	_
55	in	_	ADP	IN	_	57	case	_	_
56	the	_	DET	DT	_	57	det	_	_
57	severity	_	NOUN	NN	_	53	nmod	_	_
58	of	_	ADP	IN	_	60	case	_	_
59	phobic	_	ADJ	JJ	_	60	amod	_	_
60	avoidance	_	NOUN	NN	_	57	nmod	_	_
61	and	_	CONJ	CC	_	60	cc	_	_
62	distress	_	NOUN	NN	_	60	conj	_	_
63	,	_	.	,	_	57	punct	_	_
64	and	_	CONJ	CC	_	57	cc	_	_
65	c	_	NOUN	NN	_	70	compound	_	_
66	the	_	DET	DT	_	70	det	_	_
67	CGI	_	NOUN	NN	_	70	compound	_	_
68	I	_	NUM	CD	_	70	nummod	_	_
69	responder	_	NOUN	NN	_	70	compound	_	_
70	criterion	_	NOUN	NN	_	57	conj	_	_
71	of	_	ADP	IN	_	73	case	_	_
72	<	_	NUM	CD	_	73	nummod	_	_
73	2	_	NUM	CD	_	70	nmod	_	_

#	Sertraline Hydrochloride	1688
1	DRUG	_	NOUN	NN	_	3	nsubjpass	_	_
2	was	_	VERB	VBD	_	3	auxpass	_	_
3	shown	_	VERB	VBN	_	0	root	_	_
4	to	_	PRT	TO	_	9	mark	_	_
5	be	_	VERB	VB	_	9	cop	_	_
6	statistically	_	ADV	RB	_	8	advmod	_	_
7	significantly	_	ADV	RB	_	8	advmod	_	_
8	more	_	ADV	RB	_	9	advmod	_	_
9	effective	_	ADJ	JJ	_	3	xcomp	_	_
10	than	_	ADP	IN	_	11	case	_	_
11	placebo	_	NOUN	NN	_	9	nmod	_	_
12	as	_	ADP	IN	_	13	mark	_	_
13	measured	_	VERB	VBN	_	9	advcl	_	_
14	by	_	ADP	IN	_	18	case	_	_
15	the	_	DET	DT	_	18	det	_	_
16	BSPS	_	NOUN	NN	_	18	compound	_	_
17	total	_	ADJ	JJ	_	18	amod	_	_
18	score	_	NOUN	NN	_	13	nmod	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	fear	_	NOUN	NN	_	18	conj	_	_
21	,	_	.	,	_	20	punct	_	_
22	avoidance	_	NOUN	NN	_	20	conj	_	_
23	and	_	CONJ	CC	_	20	cc	_	_
24	physiologic	_	ADJ	JJ	_	26	amod	_	_
25	factor	_	NOUN	NN	_	26	compound	_	_
26	scores	_	NOUN	NNS	_	20	conj	_	_
27	,	_	.	,	_	18	punct	_	_
28	as	_	ADV	RB	_	18	cc	_	_
29	well	_	ADV	RB	_	28	mwe	_	_
30	as	_	ADP	IN	_	28	mwe	_	_
31	the	_	DET	DT	_	35	det	_	_
32	FQ	_	NOUN	NN	_	35	compound	_	_
33	SPS	_	NOUN	NN	_	35	compound	_	_
34	total	_	ADJ	JJ	_	35	amod	_	_
35	score	_	NOUN	NN	_	18	conj	_	_
36	,	_	.	,	_	3	punct	_	_
37	and	_	CONJ	CC	_	3	cc	_	_
38	to	_	PRT	TO	_	39	mark	_	_
39	have	_	VERB	VB	_	3	conj	_	_
40	significantly	_	ADV	RB	_	41	advmod	_	_
41	more	_	ADV	RB	_	42	advmod	_	_
42	responders	_	NOUN	NNS	_	39	dobj	_	_
43	than	_	ADP	IN	_	44	case	_	_
44	placebo	_	NOUN	NN	_	42	nmod	_	_
45	as	_	ADP	IN	_	46	mark	_	_
46	defined	_	VERB	VBN	_	39	advcl	_	_
47	by	_	ADP	IN	_	49	case	_	_
48	the	_	DET	DT	_	49	det	_	_
49	CGI	_	NOUN	NN	_	46	nmod	_	_
50	I	_	NUM	CD	_	49	nummod	_	_

#	Sertraline Hydrochloride	1689
1	Subgroup	_	ADJ	JJ	_	2	amod	_	_
2	analyses	_	NOUN	NNS	_	5	nsubj	_	_
3	did	_	VERB	VBD	_	5	aux	_	_
4	not	_	ADV	RB	_	5	neg	_	_
5	suggest	_	VERB	VB	_	0	root	_	_
6	differences	_	NOUN	NNS	_	5	dobj	_	_
7	in	_	ADP	IN	_	9	case	_	_
8	treatment	_	NOUN	NN	_	9	compound	_	_
9	outcome	_	NOUN	NN	_	6	nmod	_	_
10	on	_	ADP	IN	_	12	case	_	_
11	the	_	DET	DT	_	12	det	_	_
12	basis	_	NOUN	NN	_	5	nmod	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	gender	_	NOUN	NN	_	12	nmod	_	_

#	Sertraline Hydrochloride	1691
1	In	_	ADP	IN	_	5	case	_	_
2	a	_	DET	DT	_	5	det	_	_
3	longer	_	ADJ	JJ	_	5	amod	_	_
4	term	_	NOUN	NN	_	5	compound	_	_
5	study	_	NOUN	NN	_	45	nmod	_	_
6	,	_	.	,	_	45	punct	_	_
7	patients	_	NOUN	NNS	_	45	nsubjpass	_	_
8	meeting	_	VERB	VBG	_	7	acl	_	_
9	DSM	_	NOUN	NN	_	11	compound	_	_
10	IV	_	NUM	CD	_	11	nummod	_	_
11	criteria	_	NOUN	NN	_	8	dobj	_	_
12	for	_	ADP	IN	_	15	case	_	_
13	social	_	ADJ	JJ	_	15	amod	_	_
14	anxiety	_	NOUN	NN	_	15	compound	_	_
15	disorder	_	NOUN	NN	_	8	nmod	_	_
16	who	_	DET	WDT	_	18	nsubj	_	_
17	had	_	VERB	MD	_	18	aux	_	_
18	responded	_	VERB	VBN	_	15	acl:relcl	_	_
19	while	_	ADP	IN	_	20	mark	_	_
20	assigned	_	VERB	VBN	_	18	advcl	_	_
21	to	_	PRT	TO	_	23	case	_	_
22	DRUG	_	NOUN	NN	_	23	compound	_	_
23	CGI	_	NOUN	NN	_	20	nmod	_	_
24	I	_	NUM	CD	_	23	nummod	_	_
25	of	_	ADP	IN	_	26	case	_	_
26	1	_	NUM	CD	_	23	nmod	_	_
27	or	_	CONJ	CC	_	26	cc	_	_
28	2	_	NUM	CD	_	26	conj	_	_
29	during	_	ADP	IN	_	33	case	_	_
30	a	_	DET	DT	_	33	det	_	_
31	20	_	NUM	CD	_	33	nummod	_	_
32	week	_	NOUN	NN	_	33	compound	_	_
33	placebo	_	NOUN	NN	_	20	nmod	_	_
34	controlled	_	VERB	VBN	_	33	acl	_	_
35	trial	_	ADJ	JJ	_	34	xcomp	_	_
36	on	_	ADP	IN	_	37	case	_	_
37	DRUG	_	NOUN	NN	_	35	nmod	_	_
38	50	_	NUM	CD	_	37	nummod	_	_
39	to	_	PRT	TO	_	43	case	_	_
40	200	_	NUM	CD	_	41	nummod	_	_
41	mg	_	NOUN	NN	_	43	amod	_	_
42	/	_	.	:	_	43	punct	_	_
43	day	_	NOUN	NN	_	35	nmod	_	_
44	were	_	VERB	VBD	_	45	auxpass	_	_
45	randomized	_	VERB	VBN	_	0	root	_	_
46	to	_	PRT	TO	_	47	case	_	_
47	continuation	_	NOUN	NN	_	45	nmod	_	_
48	of	_	ADP	IN	_	49	case	_	_
49	DRUG	_	NOUN	NN	_	47	nmod	_	_
50	or	_	CONJ	CC	_	47	cc	_	_
51	to	_	PRT	TO	_	52	case	_	_
52	substitution	_	NOUN	NN	_	47	conj	_	_
53	of	_	ADP	IN	_	54	case	_	_
54	placebo	_	NOUN	NN	_	52	nmod	_	_
55	for	_	ADP	IN	_	59	case	_	_
56	up	_	ADJ	JJ	_	58	advmod	_	_
57	to	_	PRT	TO	_	58	dep	_	_
58	24	_	NUM	CD	_	59	nummod	_	_
59	weeks	_	NOUN	NNS	_	52	nmod	_	_
60	of	_	ADP	IN	_	61	case	_	_
61	observation	_	NOUN	NN	_	59	nmod	_	_
62	for	_	ADP	IN	_	63	case	_	_
63	relapse	_	ADP	IN	_	61	nmod	_	_

#	Sertraline Hydrochloride	1692
1	Relapse	_	NOUN	NN	_	3	nsubjpass	_	_
2	was	_	VERB	VBD	_	3	auxpass	_	_
3	defined	_	VERB	VBN	_	0	root	_	_
4	as	_	ADP	IN	_	8	case	_	_
5	>	_	NUM	CD	_	8	nummod	_	_
6	2	_	NUM	CD	_	8	nummod	_	_
7	point	_	NOUN	NN	_	8	compound	_	_
8	increase	_	NOUN	NN	_	3	nmod	_	_
9	in	_	ADP	IN	_	14	case	_	_
10	the	_	DET	DT	_	14	det	_	_
11	Clinical	_	ADJ	JJ	_	14	amod	_	_
12	Global	_	ADJ	JJ	_	14	amod	_	_
13	Impression	_	NOUN	NN	_	14	compound	_	_
14	Severity	_	NOUN	NN	_	8	nmod	_	_
15	of	_	ADP	IN	_	19	case	_	_
16	Illness	_	NOUN	NN	_	19	compound	_	_
17	CGI	_	NOUN	NN	_	19	compound	_	_
18	S	_	NOUN	NN	_	19	compound	_	_
19	score	_	NOUN	NN	_	14	nmod	_	_
20	compared	_	VERB	VBN	_	3	xcomp	_	_
21	to	_	PRT	TO	_	22	case	_	_
22	baseline	_	NOUN	NN	_	20	nmod	_	_
23	or	_	CONJ	CC	_	22	cc	_	_
24	study	_	NOUN	NN	_	22	conj	_	_
25	discontinuation	_	NOUN	NN	_	22	dep	_	_
26	due	_	ADJ	JJ	_	28	case	_	_
27	to	_	PRT	TO	_	26	mwe	_	_
28	lack	_	NOUN	NN	_	20	nmod	_	_
29	of	_	ADP	IN	_	30	case	_	_
30	efficacy	_	NOUN	NN	_	28	nmod	_	_

#	Sertraline Hydrochloride	1693
1	Patients	_	NOUN	NNS	_	6	nsubj	_	_
2	receiving	_	VERB	VBG	_	1	acl	_	_
3	DRUG	_	NOUN	NN	_	5	compound	_	_
4	continuation	_	NOUN	NN	_	5	compound	_	_
5	treatment	_	NOUN	NN	_	2	dobj	_	_
6	experienced	_	VERB	VBD	_	0	root	_	_
7	a	_	DET	DT	_	12	det	_	_
8	statistically	_	ADV	RB	_	9	advmod	_	_
9	significantly	_	ADV	RB	_	10	advmod	_	_
10	lower	_	ADJ	JJ	_	12	amod	_	_
11	relapse	_	NOUN	NN	_	12	compound	_	_
12	rate	_	NOUN	NN	_	6	dobj	_	_
13	over	_	ADP	IN	_	17	case	_	_
14	this	_	DET	DT	_	17	det	_	_
15	24	_	NUM	CD	_	17	nummod	_	_
16	week	_	NOUN	NN	_	17	compound	_	_
17	study	_	NOUN	NN	_	6	nmod	_	_
18	than	_	ADP	IN	_	19	case	_	_
19	patients	_	NOUN	NNS	_	17	nmod	_	_
20	randomized	_	VERB	VBN	_	19	acl	_	_
21	to	_	PRT	TO	_	23	case	_	_
22	placebo	_	NOUN	NN	_	23	compound	_	_
23	substitution	_	NOUN	NN	_	20	nmod	_	_

#	Temazepam	1694
1	In	_	ADP	IN	_	7	case	_	_
2	a	_	DET	DT	_	7	det	_	_
3	single	_	ADJ	JJ	_	7	amod	_	_
4	and	_	CONJ	CC	_	3	cc	_	_
5	multiple	_	ADJ	JJ	_	3	conj	_	_
6	dose	_	NOUN	NN	_	7	compound	_	_
7	absorption	_	NOUN	NN	_	26	nmod	_	_
8	,	_	.	,	_	7	punct	_	_
9	distribution	_	NOUN	NN	_	7	conj	_	_
10	,	_	.	,	_	7	punct	_	_
11	metabolism	_	NOUN	NN	_	7	conj	_	_
12	,	_	.	,	_	7	punct	_	_
13	and	_	CONJ	CC	_	7	cc	_	_
14	excretion	_	NOUN	NN	_	16	compound	_	_
15	ADME	_	NOUN	NN	_	16	compound	_	_
16	study	_	NOUN	NN	_	7	conj	_	_
17	,	_	.	,	_	7	punct	_	_
18	using	_	VERB	VBG	_	7	acl	_	_
19	3H	_	NOUN	NN	_	21	compound	_	_
20	labeled	_	ADJ	JJ	_	21	amod	_	_
21	drug	_	NOUN	NN	_	18	dobj	_	_
22	,	_	.	,	_	26	punct	_	_
23	DRUG	_	NOUN	NN	_	26	nsubjpass	_	_
24	was	_	VERB	VBD	_	26	auxpass	_	_
25	well	_	ADV	RB	_	26	advmod	_	_
26	absorbed	_	VERB	VBN	_	0	root	_	_
27	and	_	CONJ	CC	_	26	cc	_	_
28	found	_	VERB	VBN	_	26	conj	_	_
29	to	_	PRT	TO	_	30	mark	_	_
30	have	_	VERB	VB	_	28	xcomp	_	_
31	minimal	_	ADJ	JJ	_	35	amod	_	_
32	8%	_	ADJ	JJ	_	35	amod	_	_
33	first	_	ADJ	JJ	_	35	amod	_	_
34	pass	_	NOUN	NN	_	35	compound	_	_
35	metabolism	_	NOUN	NN	_	30	dobj	_	_

#	Temazepam	1695
1	There	_	DET	EX	_	2	expl	_	_
2	were	_	VERB	VBD	_	18	auxpass	_	_
3	no	_	DET	DT	_	5	neg	_	_
4	active	_	ADJ	JJ	_	5	amod	_	_
5	metabolites	_	NOUN	NNS	_	2	nsubj	_	_
6	formed	_	VERB	VBN	_	5	acl	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	the	_	DET	DT	_	11	det	_	_
9	only	_	ADV	RB	_	10	advmod	_	_
10	significant	_	ADJ	JJ	_	11	amod	_	_
11	metabolite	_	NOUN	NN	_	17	nsubj	_	_
12	present	_	ADJ	JJ	_	11	amod	_	_
13	in	_	ADP	IN	_	14	case	_	_
14	blood	_	NOUN	NN	_	12	nmod	_	_
15	was	_	VERB	VBD	_	17	cop	_	_
16	the	_	DET	DT	_	17	det	_	_
17	O	_	NOUN	NN	_	6	conj	_	_
18	conjugate	_	VERB	VBP	_	0	root	_	_

#	Temazepam	1696
1	The	_	DET	DT	_	3	det	_	_
2	unchanged	_	ADJ	JJ	_	3	amod	_	_
3	drug	_	NOUN	NN	_	6	nsubjpass	_	_
4	was	_	VERB	VBD	_	6	auxpass	_	_
5	96%	_	ADJ	JJ	_	6	advmod	_	_
6	bound	_	VERB	VBN	_	0	root	_	_
7	to	_	PRT	TO	_	9	case	_	_
8	plasma	_	NOUN	NN	_	9	compound	_	_
9	proteins	_	NOUN	NNS	_	6	nmod	_	_

#	Temazepam	1697
1	The	_	DET	DT	_	4	det	_	_
2	blood	_	NOUN	NN	_	4	compound	_	_
3	level	_	NOUN	NN	_	4	compound	_	_
4	decline	_	NOUN	NN	_	10	nsubj	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	the	_	DET	DT	_	8	det	_	_
7	parent	_	NOUN	NN	_	8	compound	_	_
8	drug	_	NOUN	NN	_	4	nmod	_	_
9	was	_	VERB	VBD	_	10	cop	_	_
10	biphasic	_	ADJ	JJ	_	0	root	_	_
11	with	_	ADP	IN	_	15	case	_	_
12	the	_	DET	DT	_	15	det	_	_
13	short	_	ADJ	JJ	_	15	amod	_	_
14	half	_	NOUN	NN	_	15	compound	_	_
15	life	_	NOUN	NN	_	10	nmod	_	_
16	ranging	_	VERB	VBG	_	15	acl	_	_
17	from	_	ADP	IN	_	21	case	_	_
18	0.4	_	NUM	CD	_	20	compound	_	_
19	to	_	PRT	TO	_	20	dep	_	_
20	0.6	_	NUM	CD	_	21	nummod	_	_
21	hours	_	NOUN	NNS	_	16	nmod	_	_
22	and	_	CONJ	CC	_	21	cc	_	_
23	the	_	DET	DT	_	26	det	_	_
24	terminal	_	ADJ	JJ	_	26	amod	_	_
25	half	_	ADJ	JJ	_	26	compound	_	_
26	life	_	NOUN	NN	_	21	conj	_	_
27	from	_	ADP	IN	_	31	case	_	_
28	3.5	_	NUM	CD	_	30	compound	_	_
29	to	_	PRT	TO	_	30	dep	_	_
30	18.4	_	NUM	CD	_	31	nummod	_	_
31	hours	_	NOUN	NNS	_	16	nmod	_	_
32	mean	_	ADJ	JJ	_	31	amod	_	_
33	8.8	_	NUM	CD	_	34	nummod	_	_
34	hours	_	NOUN	NNS	_	32	dobj	_	_
35	,	_	.	,	_	10	punct	_	_
36	depending	_	VERB	VBG	_	40	case	_	_
37	on	_	ADP	IN	_	40	case	_	_
38	the	_	DET	DT	_	40	det	_	_
39	study	_	NOUN	NN	_	40	compound	_	_
40	population	_	NOUN	NN	_	10	nmod	_	_
41	and	_	CONJ	CC	_	40	cc	_	_
42	method	_	NOUN	NN	_	40	conj	_	_
43	of	_	ADP	IN	_	44	case	_	_
44	determination	_	NOUN	NN	_	42	nmod	_	_

#	Temazepam	1698
1	Metabolites	_	NOUN	NNS	_	3	nsubjpass	_	_
2	were	_	VERB	VBD	_	3	auxpass	_	_
3	formed	_	VERB	VBN	_	0	root	_	_
4	with	_	ADP	IN	_	7	case	_	_
5	a	_	DET	DT	_	7	det	_	_
6	half	_	ADJ	JJ	_	7	amod	_	_
7	life	_	NOUN	NN	_	3	nmod	_	_
8	of	_	ADP	IN	_	10	case	_	_
9	10	_	NUM	CD	_	10	nummod	_	_
10	hours	_	NOUN	NNS	_	7	nmod	_	_
11	and	_	CONJ	CC	_	3	cc	_	_
12	excreted	_	VERB	VBN	_	3	conj	_	_
13	with	_	ADP	IN	_	16	case	_	_
14	a	_	DET	DT	_	16	det	_	_
15	half	_	ADJ	JJ	_	16	amod	_	_
16	life	_	NOUN	NN	_	12	nmod	_	_
17	of	_	ADP	IN	_	20	case	_	_
18	approximately	_	ADV	RB	_	19	advmod	_	_
19	2	_	NUM	CD	_	20	nummod	_	_
20	hours	_	NOUN	NNS	_	16	nmod	_	_

#	Temazepam	1699
1	Thus	_	ADV	RB	_	12	advmod	_	_
2	,	_	.	,	_	12	punct	_	_
3	formation	_	NOUN	NN	_	12	nsubj	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	the	_	DET	DT	_	7	det	_	_
6	major	_	ADJ	JJ	_	7	amod	_	_
7	metabolite	_	NOUN	NN	_	3	nmod	_	_
8	is	_	VERB	VBZ	_	12	cop	_	_
9	the	_	DET	DT	_	12	det	_	_
10	rate	_	ADJ	JJ	_	12	amod	_	_
11	limiting	_	VERB	VBG	_	12	amod	_	_
12	step	_	NOUN	NN	_	0	root	_	_
13	in	_	ADP	IN	_	15	case	_	_
14	the	_	DET	DT	_	15	det	_	_
15	biodisposition	_	NOUN	NN	_	12	nmod	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	DRUG	_	NOUN	NN	_	15	nmod	_	_

#	Temazepam	1700
1	A	_	DET	DT	_	4	det	_	_
2	dose	_	NOUN	NN	_	4	compound	_	_
3	proportional	_	ADJ	JJ	_	4	amod	_	_
4	relationship	_	NOUN	NN	_	7	nsubjpass	_	_
5	has	_	VERB	VBZ	_	7	aux	_	_
6	been	_	VERB	VBN	_	7	auxpass	_	_
7	established	_	VERB	VBN	_	0	root	_	_
8	for	_	ADP	IN	_	10	case	_	_
9	the	_	DET	DT	_	10	det	_	_
10	area	_	NOUN	NN	_	7	nmod	_	_
11	under	_	ADP	IN	_	14	case	_	_
12	the	_	DET	DT	_	14	det	_	_
13	plasma	_	NOUN	NN	_	14	compound	_	_
14	concentration	_	NOUN	NN	_	7	nmod	_	_
15	/	_	.	:	_	7	punct	_	_
16	time	_	NOUN	NN	_	17	nsubj	_	_
17	curve	_	VERB	VBN	_	7	parataxis	_	_
18	over	_	ADP	IN	_	21	case	_	_
19	the	_	DET	DT	_	21	det	_	_
20	15	_	NUM	CD	_	21	nummod	_	_
21	mg	_	NOUN	NN	_	17	nmod	_	_
22	to	_	PRT	TO	_	26	case	_	_
23	30	_	NUM	CD	_	26	nummod	_	_
24	mg	_	NOUN	NN	_	26	compound	_	_
25	dose	_	NOUN	NN	_	26	compound	_	_
26	range	_	NOUN	NN	_	17	nmod	_	_

#	Temazepam	1701
1	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
2	was	_	VERB	VBD	_	4	auxpass	_	_
3	completely	_	ADV	RB	_	4	advmod	_	_
4	metabolized	_	VERB	VBN	_	0	root	_	_
5	through	_	ADP	IN	_	6	case	_	_
6	conjugation	_	NOUN	NN	_	4	nmod	_	_
7	prior	_	ADJ	JJ	_	6	amod	_	_
8	to	_	PRT	TO	_	9	case	_	_
9	excretion	_	NOUN	NN	_	7	nmod	_	_
10	80%	_	NOUN	NN	_	9	dep	_	_
11	to	_	PRT	TO	_	12	case	_	_
12	90%	_	NOUN	NN	_	10	nmod	_	_
13	of	_	ADP	IN	_	15	case	_	_
14	the	_	DET	DT	_	15	det	_	_
15	dose	_	NOUN	NN	_	12	nmod	_	_
16	appeared	_	VERB	VBD	_	4	parataxis	_	_
17	in	_	ADP	IN	_	19	case	_	_
18	the	_	DET	DT	_	19	det	_	_
19	urine	_	VERB	VBG	_	16	conj	_	_

#	Temazepam	1702
1	The	_	DET	DT	_	3	det	_	_
2	major	_	ADJ	JJ	_	3	amod	_	_
3	metabolite	_	NOUN	NN	_	7	nsubj	_	_
4	was	_	VERB	VBD	_	7	cop	_	_
5	the	_	DET	DT	_	7	det	_	_
6	O	_	NOUN	NN	_	7	compound	_	_
7	conjugate	_	NOUN	NN	_	0	root	_	_
8	of	_	ADP	IN	_	10	case	_	_
9	DRUG	_	NOUN	NN	_	10	compound	_	_
10	90%	_	NOUN	NN	_	7	nmod	_	_
11	the	_	DET	DT	_	13	det	_	_
12	O	_	NOUN	NN	_	13	compound	_	_
13	conjugate	_	NOUN	NN	_	22	nsubj	_	_
14	of	_	ADP	IN	_	17	case	_	_
15	N	_	NOUN	NN	_	17	compound	_	_
16	desmethyl	_	NOUN	NN	_	17	compound	_	_
17	DRUG	_	NOUN	NN	_	13	nmod	_	_
18	was	_	VERB	VBD	_	22	cop	_	_
19	a	_	DET	DT	_	22	det	_	_
20	minor	_	ADJ	JJ	_	22	amod	_	_
21	metabolite	_	NOUN	NN	_	22	compound	_	_
22	7%	_	ADJ	JJ	_	7	root	_	_

#	Temazepam	1703
1	Following	_	ADP	IN	_	2	case	_	_
2	ingestion	_	NOUN	NN	_	14	nmod	_	_
3	of	_	ADP	IN	_	8	case	_	_
4	a	_	DET	DT	_	8	det	_	_
5	30	_	NUM	CD	_	8	nummod	_	_
6	mg	_	NOUN	NN	_	8	compound	_	_
7	DRUG	_	NOUN	NN	_	8	compound	_	_
8	capsule	_	NOUN	NN	_	2	nmod	_	_
9	,	_	.	,	_	14	punct	_	_
10	measurable	_	ADJ	JJ	_	12	amod	_	_
11	plasma	_	NOUN	NN	_	12	compound	_	_
12	concentrations	_	NOUN	NNS	_	14	nsubjpass	_	_
13	were	_	VERB	VBD	_	14	auxpass	_	_
14	achieved	_	VERB	VBN	_	0	root	_	_
15	10	_	NUM	CD	_	17	compound	_	_
16	to	_	PRT	TO	_	17	dep	_	_
17	20	_	NUM	CD	_	18	nummod	_	_
18	minutes	_	NOUN	NNS	_	14	dobj	_	_
19	after	_	ADP	IN	_	20	mark	_	_
20	dosing	_	VERB	VBG	_	14	advcl	_	_
21	with	_	ADP	IN	_	24	case	_	_
22	peak	_	ADJ	JJ	_	24	amod	_	_
23	plasma	_	NOUN	NN	_	24	compound	_	_
24	levels	_	NOUN	NNS	_	20	nmod	_	_
25	ranging	_	VERB	VBG	_	24	acl	_	_
26	from	_	ADP	IN	_	30	case	_	_
27	666	_	NUM	CD	_	29	compound	_	_
28	to	_	PRT	TO	_	29	dep	_	_
29	982	_	NUM	CD	_	30	nummod	_	_
30	ng	_	NOUN	NN	_	25	nmod	_	_
31	/	_	.	:	_	14	punct	_	_
32	mL	_	NOUN	NN	_	35	compound	_	_
33	mean	_	NOUN	NN	_	35	compound	_	_
34	865	_	NUM	CD	_	35	nummod	_	_
35	ng	_	NOUN	NN	_	14	parataxis	_	_
36	/	_	.	:	_	35	punct	_	_
37	mL	_	NOUN	NN	_	35	dep	_	_
38	occurring	_	VERB	VBG	_	37	acl	_	_
39	approximately	_	ADV	RB	_	40	advmod	_	_
40	1.2	_	NUM	CD	_	42	compound	_	_
41	to	_	PRT	TO	_	42	dep	_	_
42	1.6	_	NUM	CD	_	43	nummod	_	_
43	hours	_	NOUN	NNS	_	38	dobj	_	_
44	mean	_	ADJ	JJ	_	43	amod	_	_
45	1.5	_	NUM	CD	_	46	nummod	_	_
46	hours	_	NOUN	NNS	_	44	dobj	_	_
47	after	_	ADP	IN	_	48	mark	_	_
48	dosing	_	VERB	VBG	_	38	advcl	_	_

#	Temazepam	1704
1	In	_	ADP	IN	_	5	case	_	_
2	a	_	DET	DT	_	5	det	_	_
3	7	_	NUM	CD	_	5	nummod	_	_
4	day	_	NOUN	NN	_	5	compound	_	_
5	study	_	NOUN	NN	_	39	nmod	_	_
6	,	_	.	,	_	5	punct	_	_
7	in	_	ADP	IN	_	8	case	_	_
8	which	_	DET	WDT	_	11	nmod	_	_
9	subjects	_	NOUN	NNS	_	11	nsubjpass	_	_
10	were	_	VERB	VBD	_	11	auxpass	_	_
11	given	_	VERB	VBN	_	5	acl:relcl	_	_
12	a	_	DET	DT	_	15	det	_	_
13	30	_	NUM	CD	_	15	nummod	_	_
14	mg	_	NOUN	NN	_	15	compound	_	_
15	capsule	_	NOUN	NN	_	11	dobj	_	_
16	of	_	ADP	IN	_	21	case	_	_
17	a	_	DET	DT	_	21	det	_	_
18	marketed	_	VERB	VBN	_	21	amod	_	_
19	bioequivalent	_	ADJ	JJ	_	21	amod	_	_
20	DRUG	_	NOUN	NN	_	21	compound	_	_
21	product	_	NOUN	NN	_	15	nmod	_	_
22	one	_	NUM	CD	_	23	nummod	_	_
23	hour	_	NUM	CD	_	21	dep	_	_
24	before	_	ADP	IN	_	25	mark	_	_
25	retiring	_	NOUN	NN	_	11	advcl	_	_
26	,	_	.	,	_	39	punct	_	_
27	steady	_	ADJ	JJ	_	28	amod	_	_
28	state	_	NOUN	NN	_	39	nsubjpass	_	_
29	as	_	ADP	IN	_	30	mark	_	_
30	measured	_	VERB	VBN	_	28	acl	_	_
31	by	_	ADP	IN	_	33	case	_	_
32	the	_	DET	DT	_	33	det	_	_
33	attainment	_	NOUN	NN	_	30	nmod	_	_
34	of	_	ADP	IN	_	37	case	_	_
35	maximal	_	ADJ	JJ	_	37	amod	_	_
36	trough	_	NOUN	NN	_	37	compound	_	_
37	concentrations	_	NOUN	NNS	_	33	nmod	_	_
38	was	_	VERB	VBD	_	39	auxpass	_	_
39	achieved	_	VERB	VBN	_	0	root	_	_
40	by	_	ADP	IN	_	43	case	_	_
41	the	_	DET	DT	_	43	det	_	_
42	third	_	ADJ	JJ	_	43	amod	_	_
43	dose	_	NOUN	NN	_	39	nmod	_	_

#	Temazepam	1705
1	Mean	_	NOUN	NN	_	3	compound	_	_
2	plasma	_	NOUN	NN	_	3	compound	_	_
3	levels	_	NOUN	NNS	_	0	root	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	for	_	ADP	IN	_	7	case	_	_
7	days	_	NOUN	NNS	_	3	nmod	_	_
8	2	_	NUM	CD	_	7	nummod	_	_
9	to	_	PRT	TO	_	15	case	_	_
10	7	_	NUM	CD	_	15	nummod	_	_
11	were	_	VERB	VBD	_	15	cop	_	_
12	260	_	NUM	CD	_	14	compound	_	_
13	*	_	CONJ	CC	_	14	advmod	_	_
14	210	_	NUM	CD	_	15	nummod	_	_
15	ng	_	NOUN	NN	_	3	nmod	_	_
16	/	_	.	:	_	3	punct	_	_
17	mL	_	NOUN	NN	_	3	dep	_	_
18	at	_	ADP	IN	_	20	case	_	_
19	9	_	NUM	CD	_	20	nummod	_	_
20	hours	_	NOUN	NNS	_	17	nmod	_	_
21	and	_	CONJ	CC	_	17	cc	_	_
22	75	_	NUM	CD	_	24	compound	_	_
23	*	_	ADJ	JJ	_	24	advmod	_	_
24	80	_	NUM	CD	_	25	nummod	_	_
25	ng	_	NOUN	NN	_	17	conj	_	_
26	/	_	.	:	_	3	punct	_	_
27	mL	_	NOUN	NN	_	3	dep	_	_
28	at	_	ADP	IN	_	30	case	_	_
29	24	_	NUM	CD	_	30	nummod	_	_
30	hours	_	NOUN	NNS	_	27	nmod	_	_
31	after	_	ADP	IN	_	32	mark	_	_
32	dosing	_	VERB	VBG	_	27	acl	_	_

#	Temazepam	1706
1	A	_	DET	DT	_	3	det	_	_
2	slight	_	ADJ	JJ	_	3	amod	_	_
3	trend	_	NOUN	NN	_	11	nsubjpass	_	_
4	toward	_	ADP	IN	_	5	mark	_	_
5	declining	_	VERB	VBG	_	3	acl	_	_
6	24	_	NUM	CD	_	9	nummod	_	_
7	hour	_	NUM	CD	_	9	nummod	_	_
8	plasma	_	NOUN	NN	_	9	compound	_	_
9	levels	_	NOUN	NNS	_	5	dobj	_	_
10	was	_	VERB	VBD	_	11	auxpass	_	_
11	seen	_	VERB	VBN	_	0	root	_	_
12	after	_	ADP	IN	_	13	case	_	_
13	day	_	NOUN	NN	_	11	nmod	_	_
14	4	_	NUM	CD	_	13	nummod	_	_
15	in	_	ADP	IN	_	17	case	_	_
16	the	_	DET	DT	_	17	det	_	_
17	study	_	NOUN	NN	_	11	nmod	_	_
18	,	_	.	,	_	11	punct	_	_
19	however	_	ADV	RB	_	11	advmod	_	_
20	,	_	.	,	_	11	punct	_	_
21	the	_	DET	DT	_	25	det	_	_
22	24	_	NUM	CD	_	25	nummod	_	_
23	hour	_	NUM	CD	_	25	nummod	_	_
24	plasma	_	NOUN	NN	_	25	compound	_	_
25	levels	_	NOUN	NNS	_	28	nsubj	_	_
26	were	_	VERB	VBD	_	28	auxpass	_	_
27	quite	_	ADV	RB	_	28	advmod	_	_
28	variable	_	ADJ	JJ	_	11	parataxis	_	_

#	Temazepam	1707
1	At	_	ADP	IN	_	3	case	_	_
2	a	_	DET	DT	_	3	det	_	_
3	dose	_	NOUN	NN	_	20	nmod	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	30	_	NUM	CD	_	6	nummod	_	_
6	mg	_	NOUN	NN	_	3	nmod	_	_
7	once	_	ADP	IN	_	9	case	_	_
8	a	_	DET	DT	_	9	det	_	_
9	day	_	NOUN	NN	_	3	nmod	_	_
10	for	_	ADP	IN	_	12	case	_	_
11	8	_	NUM	CD	_	12	nummod	_	_
12	weeks	_	NOUN	NNS	_	9	nmod	_	_
13	,	_	.	,	_	20	punct	_	_
14	no	_	DET	DT	_	15	neg	_	_
15	evidence	_	NOUN	NN	_	20	nsubjpass	_	_
16	of	_	ADP	IN	_	18	case	_	_
17	enzyme	_	NOUN	NN	_	18	compound	_	_
18	induction	_	NOUN	NN	_	15	nmod	_	_
19	was	_	VERB	VBD	_	20	auxpass	_	_
20	found	_	VERB	VBN	_	0	root	_	_
21	in	_	X	FW	_	22	compound	_	_
22	man	_	VERB	MD	_	20	advmod	_	_

#	Temazepam	1708
1	The	_	DET	DT	_	2	det	_	_
2	type	_	NOUN	NN	_	21	nsubjpass	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	duration	_	NOUN	NN	_	2	conj	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	hypnotic	_	ADJ	JJ	_	7	amod	_	_
7	effects	_	NOUN	NNS	_	2	nmod	_	_
8	and	_	CONJ	CC	_	2	cc	_	_
9	the	_	DET	DT	_	10	det	_	_
10	profile	_	NOUN	NN	_	2	conj	_	_
11	of	_	ADP	IN	_	13	case	_	_
12	unwanted	_	ADJ	JJ	_	13	amod	_	_
13	effects	_	NOUN	NNS	_	10	nmod	_	_
14	during	_	ADP	IN	_	15	case	_	_
15	administration	_	NOUN	NN	_	2	nmod	_	_
16	of	_	ADP	IN	_	18	case	_	_
17	benzodiazepine	_	NOUN	NN	_	18	compound	_	_
18	hypnotics	_	NOUN	NNS	_	15	nmod	_	_
19	may	_	VERB	MD	_	21	aux	_	_
20	be	_	VERB	VB	_	21	auxpass	_	_
21	influenced	_	VERB	VBN	_	43	advcl	_	_
22	by	_	ADP	IN	_	26	case	_	_
23	the	_	DET	DT	_	26	det	_	_
24	biologic	_	ADJ	JJ	_	26	amod	_	_
25	half	_	NOUN	NN	_	26	compound	_	_
26	life	_	NOUN	NN	_	21	nmod	_	_
27	of	_	ADP	IN	_	30	case	_	_
28	the	_	DET	DT	_	30	det	_	_
29	administered	_	VERB	VBN	_	30	amod	_	_
30	drug	_	NOUN	NN	_	26	nmod	_	_
31	and	_	CONJ	CC	_	30	cc	_	_
32	for	_	ADP	IN	_	34	case	_	_
33	some	_	DET	DT	_	34	det	_	_
34	hypnotics	_	NOUN	NNS	_	30	conj	_	_
35	,	_	.	,	_	43	punct	_	_
36	the	_	DET	DT	_	38	det	_	_
37	half	_	ADJ	JJ	_	38	amod	_	_
38	life	_	NOUN	NN	_	43	nsubj	_	_
39	of	_	ADP	IN	_	42	case	_	_
40	any	_	DET	DT	_	42	det	_	_
41	active	_	ADJ	JJ	_	42	amod	_	_
42	metabolites	_	NOUN	NNS	_	38	nmod	_	_
43	formed	_	VERB	VBN	_	0	root	_	_

#	Temazepam	1709
1	Benzodiazepine	_	NOUN	NN	_	2	compound	_	_
2	hypnotics	_	NOUN	NNS	_	3	nsubj	_	_
3	have	_	VERB	VBP	_	0	root	_	_
4	a	_	DET	DT	_	5	det	_	_
5	spectrum	_	NOUN	NN	_	3	dobj	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	half	_	ADJ	JJ	_	8	amod	_	_
8	lives	_	NOUN	NNS	_	5	nmod	_	_
9	from	_	ADP	IN	_	13	case	_	_
10	short	_	ADJ	JJ	_	13	amod	_	_
11	<	_	NUM	CD	_	13	nummod	_	_
12	4	_	NUM	CD	_	13	nummod	_	_
13	hours	_	NOUN	NNS	_	5	nmod	_	_
14	to	_	PRT	TO	_	18	case	_	_
15	long	_	ADJ	JJ	_	18	amod	_	_
16	>	_	NUM	CD	_	18	nummod	_	_
17	20	_	NUM	CD	_	18	nummod	_	_
18	hours	_	NOUN	NNS	_	5	nmod	_	_

#	Temazepam	1710
1	When	_	ADV	WRB	_	5	advmod	_	_
2	half	_	ADJ	JJ	_	3	amod	_	_
3	lives	_	NOUN	NNS	_	5	nsubj	_	_
4	are	_	VERB	VBP	_	5	cop	_	_
5	long	_	ADJ	JJ	_	0	root	_	_
6	,	_	.	,	_	5	punct	_	_
7	drug	_	NOUN	NN	_	6	root	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	for	_	ADP	IN	_	11	case	_	_
10	some	_	DET	DT	_	11	det	_	_
11	drugs	_	NOUN	NNS	_	16	nmod	_	_
12	their	_	PRON	PRP$	_	14	nmod:poss	_	_
13	active	_	ADJ	JJ	_	14	amod	_	_
14	metabolites	_	NOUN	NNS	_	16	nsubj	_	_
15	may	_	VERB	MD	_	16	aux	_	_
16	accumulate	_	VERB	VB	_	7	conj	_	_
17	during	_	ADP	IN	_	18	case	_	_
18	periods	_	NOUN	NNS	_	16	nmod	_	_
19	of	_	ADP	IN	_	21	case	_	_
20	nightly	_	ADV	RB	_	21	advmod	_	_
21	administration	_	NOUN	NN	_	18	nmod	_	_
22	and	_	CONJ	CC	_	7	cc	_	_
23	be	_	VERB	VBZ	_	24	auxpass	_	_
24	associated	_	VERB	VBN	_	49	advcl	_	_
25	with	_	ADP	IN	_	26	case	_	_
26	impairments	_	NOUN	NNS	_	24	nmod	_	_
27	of	_	ADP	IN	_	33	case	_	_
28	cognitive	_	ADJ	JJ	_	33	amod	_	_
29	and	_	CONJ	CC	_	28	cc	_	_
30	/	_	NUM	CD	_	28	conj	_	_
31	or	_	CONJ	CC	_	28	cc	_	_
32	motor	_	NOUN	NN	_	28	conj	_	_
33	performance	_	NOUN	NN	_	26	nmod	_	_
34	during	_	ADP	IN	_	36	case	_	_
35	waking	_	VERB	VBG	_	36	amod	_	_
36	hours	_	NOUN	NNS	_	24	nmod	_	_
37	the	_	DET	DT	_	38	det	_	_
38	possibility	_	NOUN	NN	_	49	nsubjpass	_	_
39	of	_	ADP	IN	_	40	case	_	_
40	interaction	_	NOUN	NN	_	38	nmod	_	_
41	with	_	ADP	IN	_	44	case	_	_
42	other	_	ADJ	JJ	_	44	amod	_	_
43	psychoactive	_	ADJ	JJ	_	44	amod	_	_
44	drugs	_	NOUN	NNS	_	40	nmod	_	_
45	or	_	CONJ	CC	_	44	cc	_	_
46	alcohol	_	NOUN	NN	_	44	conj	_	_
47	will	_	VERB	MD	_	49	aux	_	_
48	be	_	VERB	VB	_	49	auxpass	_	_
49	enhanced	_	VERB	VBN	_	7	conj	_	_

#	Temazepam	1711
1	In	_	ADP	IN	_	2	case	_	_
2	contrast	_	NOUN	NN	_	27	nmod	_	_
3	,	_	.	,	_	27	punct	_	_
4	if	_	ADP	IN	_	8	mark	_	_
5	half	_	ADJ	JJ	_	6	amod	_	_
6	lives	_	NOUN	NNS	_	8	nsubj	_	_
7	are	_	VERB	VBP	_	8	cop	_	_
8	shorter	_	ADJ	JJ	_	27	advcl	_	_
9	,	_	.	,	_	27	punct	_	_
10	drug	_	NOUN	NN	_	27	nsubjpass	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	,	_	.	,	_	10	punct	_	_
13	where	_	ADV	RB	_	14	advmod	_	_
14	appropriate	_	ADJ	JJ	_	21	advcl	_	_
15	,	_	.	,	_	21	punct	_	_
16	its	_	PRON	PRP$	_	18	nmod:poss	_	_
17	active	_	ADJ	JJ	_	18	amod	_	_
18	metabolites	_	NOUN	NNS	_	21	nsubjpass	_	_
19	will	_	VERB	MD	_	21	aux	_	_
20	be	_	VERB	VB	_	21	auxpass	_	_
21	cleared	_	VERB	VBN	_	10	acl:relcl	_	_
22	before	_	ADP	IN	_	25	case	_	_
23	the	_	DET	DT	_	25	det	_	_
24	next	_	ADV	RB	_	25	advmod	_	_
25	dose	_	NOUN	NN	_	21	nmod	_	_
26	is	_	VERB	VBZ	_	27	auxpass	_	_
27	ingested	_	VERB	VBN	_	0	root	_	_
28	,	_	.	,	_	27	punct	_	_
29	and	_	CONJ	CC	_	27	cc	_	_
30	carry	_	VERB	VB	_	42	nsubj	_	_
31	over	_	ADP	IN	_	32	case	_	_
32	effects	_	NOUN	NNS	_	30	nmod	_	_
33	related	_	ADJ	JJ	_	32	amod	_	_
34	to	_	PRT	TO	_	36	case	_	_
35	excessive	_	ADJ	JJ	_	36	amod	_	_
36	sedation	_	NOUN	NN	_	33	nmod	_	_
37	or	_	CONJ	CC	_	36	cc	_	_
38	CNS	_	NOUN	NN	_	39	compound	_	_
39	depression	_	NOUN	NN	_	36	conj	_	_
40	should	_	VERB	MD	_	42	aux	_	_
41	be	_	VERB	VB	_	42	cop	_	_
42	minimal	_	ADJ	JJ	_	27	conj	_	_
43	or	_	CONJ	CC	_	42	cc	_	_
44	absent	_	ADJ	JJ	_	42	conj	_	_

#	Temazepam	1712
1	However	_	ADV	RB	_	22	advmod	_	_
2	,	_	.	,	_	22	punct	_	_
3	during	_	ADP	IN	_	5	case	_	_
4	nightly	_	ADV	RB	_	5	advmod	_	_
5	use	_	NOUN	NN	_	22	nmod	_	_
6	for	_	ADP	IN	_	9	case	_	_
7	an	_	DET	DT	_	9	det	_	_
8	extended	_	VERB	VBN	_	9	amod	_	_
9	period	_	NOUN	NN	_	5	nmod	_	_
10	,	_	.	,	_	22	punct	_	_
11	pharmacodynamic	_	ADJ	JJ	_	12	amod	_	_
12	tolerance	_	NOUN	NN	_	22	nsubj	_	_
13	or	_	CONJ	CC	_	12	cc	_	_
14	adaptation	_	NOUN	NN	_	12	conj	_	_
15	to	_	PRT	TO	_	17	case	_	_
16	some	_	DET	DT	_	17	det	_	_
17	effects	_	NOUN	NNS	_	12	nmod	_	_
18	of	_	ADP	IN	_	20	case	_	_
19	benzodiazepine	_	NOUN	NN	_	20	compound	_	_
20	hypnotics	_	NOUN	NNS	_	17	nmod	_	_
21	may	_	VERB	MD	_	22	aux	_	_
22	develop	_	VERB	VB	_	0	root	_	_

#	Temazepam	1713
1	If	_	ADP	IN	_	3	case	_	_
2	the	_	DET	DT	_	3	det	_	_
3	drug	_	NOUN	NN	_	4	nsubj	_	_
4	has	_	VERB	VBZ	_	13	advcl	_	_
5	a	_	DET	DT	_	9	det	_	_
6	short	_	ADJ	JJ	_	9	amod	_	_
7	elimination	_	NOUN	NN	_	9	compound	_	_
8	half	_	NOUN	NN	_	9	compound	_	_
9	life	_	NOUN	NN	_	4	dobj	_	_
10	,	_	.	,	_	13	punct	_	_
11	it	_	PRON	PRP	_	13	nsubj	_	_
12	is	_	VERB	VBZ	_	13	cop	_	_
13	possible	_	ADJ	JJ	_	0	root	_	_
14	that	_	ADP	IN	_	49	mark	_	_
15	a	_	DET	DT	_	17	det	_	_
16	relative	_	ADJ	JJ	_	17	amod	_	_
17	deficiency	_	NOUN	NN	_	49	nsubj	_	_
18	of	_	ADP	IN	_	20	case	_	_
19	the	_	DET	DT	_	20	det	_	_
20	drug	_	NOUN	NN	_	17	nmod	_	_
21	,	_	.	,	_	17	punct	_	_
22	or	_	CONJ	CC	_	17	cc	_	_
23	,	_	.	,	_	17	punct	_	_
24	if	_	DET	WDT	_	25	nsubj	_	_
25	appropriate	_	ADJ	JJ	_	17	acl:relcl	_	_
26	,	_	.	,	_	25	punct	_	_
27	its	_	PRON	PRP$	_	29	nmod:poss	_	_
28	active	_	ADJ	JJ	_	29	amod	_	_
29	metabolites	_	NOUN	NNS	_	39	nsubj	_	_
30	i.e	_	ADJ	JJ	_	29	amod	_	_
31	,	_	.	,	_	29	punct	_	_
32	in	_	ADP	IN	_	33	case	_	_
33	relationship	_	NOUN	NN	_	29	nmod	_	_
34	to	_	PRT	TO	_	37	case	_	_
35	the	_	DET	DT	_	37	det	_	_
36	receptor	_	NOUN	NN	_	37	compound	_	_
37	site	_	NOUN	NN	_	33	nmod	_	_
38	may	_	VERB	MD	_	39	aux	_	_
39	occur	_	VERB	VB	_	25	ccomp	_	_
40	at	_	ADP	IN	_	42	case	_	_
41	some	_	DET	DT	_	42	det	_	_
42	point	_	NOUN	NN	_	39	nmod	_	_
43	in	_	ADP	IN	_	45	case	_	_
44	the	_	DET	DT	_	45	det	_	_
45	interval	_	ADJ	JJ	_	42	nmod	_	_
46	between	_	ADP	IN	_	48	case	_	_
47	each	_	DET	DT	_	48	det	_	_
48	night's	_	NOUN	NNS	_	45	nmod	_	_
49	use	_	VERB	VBP	_	13	ccomp	_	_

#	Temazepam	1714
1	This	_	DET	DT	_	2	det	_	_
2	sequence	_	NOUN	NN	_	6	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	events	_	NOUN	NNS	_	2	nmod	_	_
5	may	_	VERB	MD	_	6	aux	_	_
6	account	_	VERB	VB	_	0	root	_	_
7	for	_	ADP	IN	_	10	case	_	_
8	two	_	NUM	CD	_	10	nummod	_	_
9	clinical	_	ADJ	JJ	_	10	amod	_	_
10	findings	_	NOUN	NNS	_	6	nmod	_	_
11	reported	_	VERB	VBN	_	10	acl	_	_
12	to	_	PRT	TO	_	13	mark	_	_
13	occur	_	VERB	VB	_	11	xcomp	_	_
14	after	_	ADP	IN	_	16	case	_	_
15	several	_	ADJ	JJ	_	16	amod	_	_
16	weeks	_	NOUN	NNS	_	13	nmod	_	_
17	of	_	ADP	IN	_	19	case	_	_
18	nightly	_	ADV	RB	_	19	advmod	_	_
19	use	_	NOUN	NN	_	16	nmod	_	_
20	of	_	ADP	IN	_	24	case	_	_
21	rapidly	_	ADV	RB	_	22	advmod	_	_
22	eliminated	_	VERB	VBN	_	24	amod	_	_
23	benzodiazepine	_	NOUN	NN	_	24	compound	_	_
24	hypnotics	_	NOUN	NNS	_	19	nmod	_	_
25	,	_	.	,	_	6	punct	_	_
26	namely	_	ADV	RB	_	6	advmod	_	_
27	,	_	.	,	_	6	punct	_	_
28	increased	_	VERB	VBD	_	29	amod	_	_
29	wakefulness	_	NOUN	NN	_	6	conj	_	_
30	during	_	ADP	IN	_	33	case	_	_
31	the	_	DET	DT	_	33	det	_	_
32	last	_	ADJ	JJ	_	33	amod	_	_
33	third	_	NOUN	NN	_	29	nmod	_	_
34	of	_	ADP	IN	_	36	case	_	_
35	the	_	DET	DT	_	36	det	_	_
36	night	_	VERB	MD	_	33	nmod	_	_
37	,	_	.	,	_	6	punct	_	_
38	and	_	CONJ	CC	_	6	cc	_	_
39	the	_	DET	DT	_	40	det	_	_
40	appearance	_	NOUN	NN	_	6	conj	_	_
41	of	_	ADP	IN	_	43	case	_	_
42	increased	_	VERB	VBN	_	43	amod	_	_
43	signs	_	NOUN	NNS	_	40	nmod	_	_
44	of	_	ADP	IN	_	46	case	_	_
45	daytime	_	ADJ	JJ	_	46	amod	_	_
46	anxiety	_	NOUN	NN	_	43	nmod	_	_

#	Temazepam	1715
1	DRUG	_	NOUN	NN	_	4	compound	_	_
2	improved	_	ADJ	JJ	_	4	amod	_	_
3	sleep	_	NOUN	NN	_	4	compound	_	_
4	parameters	_	NOUN	NNS	_	0	root	_	_
5	in	_	ADP	IN	_	7	case	_	_
6	clinical	_	ADJ	JJ	_	7	amod	_	_
7	studies	_	NOUN	NNS	_	4	nmod	_	_

#	Temazepam	1716
1	Residual	_	ADJ	JJ	_	3	amod	_	_
2	medication	_	NOUN	NN	_	3	compound	_	_
3	effects	_	NOUN	NNS	_	7	nsubj	_	_
4	"hangover"	_	NOUN	NN	_	3	dep	_	_
5	were	_	VERB	VBD	_	7	cop	_	_
6	essentially	_	ADV	RB	_	7	advmod	_	_
7	absent	_	ADJ	JJ	_	0	root	_	_

#	Temazepam	1717
1	Early	_	ADJ	JJ	_	3	amod	_	_
2	morning	_	NOUN	NN	_	3	compound	_	_
3	awakening	_	NOUN	NN	_	15	nsubjpass	_	_
4	,	_	.	,	_	3	punct	_	_
5	a	_	DET	DT	_	7	det	_	_
6	particular	_	ADJ	JJ	_	7	amod	_	_
7	problem	_	NOUN	NN	_	3	appos	_	_
8	in	_	ADP	IN	_	11	case	_	_
9	the	_	DET	DT	_	11	det	_	_
10	geriatric	_	ADJ	JJ	_	11	amod	_	_
11	patient	_	NOUN	NN	_	7	nmod	_	_
12	,	_	.	,	_	3	punct	_	_
13	was	_	VERB	VBD	_	15	auxpass	_	_
14	significantly	_	ADV	RB	_	15	advmod	_	_
15	reduced	_	VERB	VBN	_	0	root	_	_

#	Temazepam	1718
1	Patients	_	NOUN	NNS	_	6	nsubjpass	_	_
2	with	_	ADP	IN	_	4	case	_	_
3	chronic	_	ADJ	JJ	_	4	amod	_	_
4	insomnia	_	NOUN	NN	_	1	nmod	_	_
5	were	_	VERB	VBD	_	6	auxpass	_	_
6	evaluated	_	VERB	VBN	_	0	root	_	_
7	in	_	ADP	IN	_	9	case	_	_
8	2	_	NUM	CD	_	9	nummod	_	_
9	week	_	NOUN	NN	_	6	nmod	_	_
10	,	_	.	,	_	6	punct	_	_
11	placebo	_	NOUN	NN	_	12	nsubj	_	_
12	controlled	_	VERB	VBD	_	6	conj	_	_
13	sleep	_	NOUN	NN	_	15	amod	_	_
14	laboratory	_	ADJ	JJ	_	15	amod	_	_
15	studies	_	NOUN	NNS	_	12	dobj	_	_
16	with	_	ADP	IN	_	17	case	_	_
17	DRUG	_	NOUN	NN	_	15	nmod	_	_
18	at	_	ADP	IN	_	19	case	_	_
19	doses	_	NOUN	NNS	_	12	nmod	_	_
20	of	_	ADP	IN	_	22	case	_	_
21	7.5	_	NUM	CD	_	22	nummod	_	_
22	mg	_	NOUN	NN	_	19	nmod	_	_
23	,	_	.	,	_	22	punct	_	_
24	15	_	NUM	CD	_	25	nummod	_	_
25	mg	_	NOUN	NN	_	22	conj	_	_
26	and	_	CONJ	CC	_	22	cc	_	_
27	30	_	NUM	CD	_	28	nummod	_	_
28	mg	_	NOUN	NN	_	22	conj	_	_
29	,	_	.	,	_	6	punct	_	_
30	given	_	VERB	VBN	_	6	xcomp	_	_
31	30	_	NUM	CD	_	32	nummod	_	_
32	minutes	_	NOUN	NNS	_	30	dobj	_	_
33	prior	_	ADJ	JJ	_	35	mark	_	_
34	to	_	PRT	TO	_	35	mark	_	_
35	bedtime	_	VERB	VB	_	30	xcomp	_	_

#	Temazepam	1719
1	There	_	DET	EX	_	2	expl	_	_
2	was	_	VERB	VBD	_	0	root	_	_
3	a	_	DET	DT	_	7	det	_	_
4	linear	_	ADJ	JJ	_	7	amod	_	_
5	dose	_	NOUN	NN	_	7	compound	_	_
6	response	_	NOUN	NN	_	7	compound	_	_
7	improvement	_	NOUN	NN	_	2	nsubj	_	_
8	in	_	ADP	IN	_	11	case	_	_
9	total	_	ADJ	JJ	_	11	amod	_	_
10	sleep	_	NOUN	NN	_	11	compound	_	_
11	time	_	NOUN	NN	_	7	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	sleep	_	NOUN	NN	_	14	compound	_	_
14	latency	_	NOUN	NN	_	11	conj	_	_
15	,	_	.	,	_	2	punct	_	_
16	with	_	ADP	IN	_	20	case	_	_
17	significant	_	ADJ	JJ	_	20	amod	_	_
18	drug	_	NOUN	NN	_	20	compound	_	_
19	placebo	_	NOUN	NN	_	20	compound	_	_
20	differences	_	NOUN	NNS	_	2	nmod	_	_
21	at	_	ADP	IN	_	23	case	_	_
22	2	_	NUM	CD	_	23	nummod	_	_
23	weeks	_	NOUN	NNS	_	20	nmod	_	_
24	occurring	_	VERB	VBG	_	23	acl	_	_
25	only	_	ADV	RB	_	24	advmod	_	_
26	for	_	ADP	IN	_	29	case	_	_
27	total	_	ADJ	JJ	_	29	amod	_	_
28	sleep	_	NOUN	NN	_	29	compound	_	_
29	time	_	NOUN	NN	_	24	nmod	_	_
30	at	_	ADP	IN	_	34	case	_	_
31	the	_	DET	DT	_	34	det	_	_
32	two	_	NUM	CD	_	34	nummod	_	_
33	higher	_	ADJ	JJ	_	34	amod	_	_
34	doses	_	NOUN	NNS	_	24	nmod	_	_
35	,	_	.	,	_	2	punct	_	_
36	and	_	CONJ	CC	_	2	cc	_	_
37	for	_	ADP	IN	_	39	case	_	_
38	sleep	_	NOUN	NN	_	39	compound	_	_
39	latency	_	NOUN	NN	_	2	conj	_	_
40	only	_	ADV	RB	_	39	advmod	_	_
41	at	_	ADP	IN	_	44	case	_	_
42	the	_	DET	DT	_	44	det	_	_
43	highest	_	ADJ	JJ	_	44	amod	_	_
44	dose	_	NOUN	NN	_	40	nmod	_	_

#	Temazepam	1720
1	In	_	ADP	IN	_	5	case	_	_
2	these	_	DET	DT	_	5	det	_	_
3	sleep	_	NOUN	NN	_	5	amod	_	_
4	laboratory	_	ADJ	JJ	_	5	amod	_	_
5	studies	_	NOUN	NNS	_	11	nmod	_	_
6	,	_	.	,	_	11	punct	_	_
7	REM	_	NOUN	NN	_	8	compound	_	_
8	sleep	_	NOUN	NN	_	11	nsubj	_	_
9	was	_	VERB	VBD	_	11	cop	_	_
10	essentially	_	ADV	RB	_	11	advmod	_	_
11	unchanged	_	ADJ	JJ	_	0	root	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	slow	_	ADJ	JJ	_	15	amod	_	_
14	wave	_	ADJ	JJ	_	15	amod	_	_
15	sleep	_	NOUN	NN	_	17	nsubjpass	_	_
16	was	_	VERB	VBD	_	17	auxpass	_	_
17	decreased	_	VERB	VBN	_	11	conj	_	_

#	Temazepam	1721
1	No	_	DET	DT	_	3	neg	_	_
2	measurable	_	ADJ	JJ	_	3	amod	_	_
3	effects	_	NOUN	NNS	_	9	nsubj	_	_
4	on	_	ADP	IN	_	6	case	_	_
5	daytime	_	ADJ	JJ	_	6	amod	_	_
6	alertness	_	NOUN	NN	_	3	nmod	_	_
7	or	_	CONJ	CC	_	6	cc	_	_
8	performance	_	NOUN	NN	_	6	conj	_	_
9	occurred	_	VERB	VBD	_	0	root	_	_
10	following	_	ADP	IN	_	12	case	_	_
11	DRUG	_	NOUN	NN	_	12	compound	_	_
12	treatment	_	NOUN	NN	_	9	nmod	_	_
13	or	_	CONJ	CC	_	12	cc	_	_
14	during	_	ADP	IN	_	17	case	_	_
15	the	_	DET	DT	_	17	det	_	_
16	withdrawal	_	NOUN	NN	_	17	compound	_	_
17	period	_	NOUN	NN	_	12	conj	_	_
18	,	_	.	,	_	9	punct	_	_
19	even	_	ADV	RB	_	30	advmod	_	_
20	though	_	ADP	IN	_	30	mark	_	_
21	a	_	DET	DT	_	24	det	_	_
22	transient	_	ADJ	JJ	_	24	amod	_	_
23	sleep	_	NOUN	NN	_	24	compound	_	_
24	disturbance	_	NOUN	NN	_	30	nsubjpass	_	_
25	in	_	ADP	IN	_	28	case	_	_
26	some	_	DET	DT	_	28	det	_	_
27	sleep	_	NOUN	NN	_	28	compound	_	_
28	parameters	_	NOUN	NNS	_	24	nmod	_	_
29	was	_	VERB	VBD	_	30	auxpass	_	_
30	observed	_	VERB	VBN	_	9	advcl	_	_
31	following	_	VERB	VBG	_	32	case	_	_
32	withdrawal	_	NOUN	NN	_	30	nmod	_	_
33	of	_	ADP	IN	_	36	case	_	_
34	the	_	DET	DT	_	36	det	_	_
35	higher	_	ADJ	JJ	_	36	amod	_	_
36	doses	_	NOUN	NNS	_	32	nmod	_	_

#	Temazepam	1722
1	There	_	DET	EX	_	2	expl	_	_
2	was	_	VERB	VBD	_	0	root	_	_
3	no	_	DET	DT	_	4	neg	_	_
4	evidence	_	NOUN	NN	_	2	nsubj	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	tolerance	_	NOUN	NN	_	7	compound	_	_
7	development	_	NOUN	NN	_	4	nmod	_	_
8	in	_	ADP	IN	_	12	case	_	_
9	the	_	DET	DT	_	12	det	_	_
10	sleep	_	ADJ	JJ	_	12	amod	_	_
11	laboratory	_	ADJ	JJ	_	12	amod	_	_
12	parameters	_	NOUN	NNS	_	4	nmod	_	_
13	when	_	ADV	WRB	_	16	advmod	_	_
14	patients	_	NOUN	NNS	_	16	nsubjpass	_	_
15	were	_	VERB	VBD	_	16	auxpass	_	_
16	given	_	VERB	VBN	_	2	advcl	_	_
17	DRUG	_	NOUN	NN	_	16	dobj	_	_
18	nightly	_	ADV	RB	_	16	advmod	_	_
19	for	_	ADP	IN	_	23	case	_	_
20	at	_	ADP	IN	_	21	case	_	_
21	least	_	ADJ	JJS	_	22	nmod:npmod	_	_
22	2	_	NUM	CD	_	23	nummod	_	_
23	weeks	_	NOUN	NNS	_	18	nmod	_	_

#	Temazepam	1723
1	In	_	ADP	IN	_	2	case	_	_
2	addition	_	NOUN	NN	_	19	nmod	_	_
3	,	_	.	,	_	19	punct	_	_
4	normal	_	ADJ	JJ	_	5	amod	_	_
5	subjects	_	NOUN	NNS	_	19	nsubjpass	_	_
6	with	_	ADP	IN	_	8	case	_	_
7	transient	_	ADJ	JJ	_	8	amod	_	_
8	insomnia	_	NOUN	NN	_	5	nmod	_	_
9	associated	_	VERB	VBN	_	8	acl	_	_
10	with	_	ADP	IN	_	13	case	_	_
11	first	_	ADJ	JJ	_	13	amod	_	_
12	night	_	VERB	MD	_	13	advmod	_	_
13	adaptation	_	NOUN	NN	_	9	nmod	_	_
14	to	_	PRT	TO	_	17	case	_	_
15	the	_	DET	DT	_	17	det	_	_
16	sleep	_	NOUN	NN	_	17	compound	_	_
17	laboratory	_	NOUN	NN	_	13	nmod	_	_
18	were	_	VERB	VBD	_	19	auxpass	_	_
19	evaluated	_	VERB	VBN	_	0	root	_	_
20	in	_	ADP	IN	_	22	case	_	_
21	24	_	NUM	CD	_	22	nummod	_	_
22	hour	_	NUM	CD	_	19	nmod	_	_
23	,	_	.	,	_	19	punct	_	_
24	placebo	_	NOUN	NN	_	25	nsubj	_	_
25	controlled	_	VERB	VBD	_	19	conj	_	_
26	sleep	_	NOUN	NN	_	28	amod	_	_
27	laboratory	_	ADJ	JJ	_	28	amod	_	_
28	studies	_	NOUN	NNS	_	25	dobj	_	_
29	with	_	ADP	IN	_	30	case	_	_
30	DRUG	_	NOUN	NN	_	28	nmod	_	_
31	at	_	ADP	IN	_	32	case	_	_
32	doses	_	NOUN	NNS	_	25	nmod	_	_
33	of	_	ADP	IN	_	35	case	_	_
34	7.5	_	NUM	CD	_	35	nummod	_	_
35	mg	_	NOUN	NN	_	32	nmod	_	_
36	,	_	.	,	_	35	punct	_	_
37	15	_	NUM	CD	_	38	nummod	_	_
38	mg	_	NOUN	NN	_	35	conj	_	_
39	and	_	CONJ	CC	_	35	cc	_	_
40	30	_	NUM	CD	_	41	nummod	_	_
41	mg	_	NOUN	NN	_	35	conj	_	_
42	,	_	.	,	_	19	punct	_	_
43	given	_	VERB	VBN	_	19	xcomp	_	_
44	30	_	NUM	CD	_	45	nummod	_	_
45	minutes	_	NOUN	NNS	_	43	dobj	_	_
46	prior	_	ADJ	JJ	_	48	mark	_	_
47	to	_	PRT	TO	_	48	mark	_	_
48	bedtime	_	VERB	VB	_	43	xcomp	_	_

#	Temazepam	1724
1	There	_	DET	EX	_	2	expl	_	_
2	was	_	VERB	VBD	_	0	root	_	_
3	a	_	DET	DT	_	7	det	_	_
4	linear	_	ADJ	JJ	_	7	amod	_	_
5	dose	_	NOUN	NN	_	7	compound	_	_
6	response	_	NOUN	NN	_	7	compound	_	_
7	improvement	_	NOUN	NN	_	2	nsubj	_	_
8	in	_	ADP	IN	_	11	case	_	_
9	total	_	ADJ	JJ	_	11	amod	_	_
10	sleep	_	NOUN	NN	_	11	compound	_	_
11	time	_	NOUN	NN	_	7	nmod	_	_
12	,	_	.	,	_	11	punct	_	_
13	sleep	_	NOUN	NN	_	14	compound	_	_
14	latency	_	NOUN	NN	_	11	conj	_	_
15	and	_	CONJ	CC	_	11	cc	_	_
16	number	_	NOUN	NN	_	11	conj	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	awakenings	_	NOUN	NNS	_	16	nmod	_	_
19	,	_	.	,	_	2	punct	_	_
20	with	_	ADP	IN	_	24	case	_	_
21	significant	_	ADJ	JJ	_	24	amod	_	_
22	drug	_	NOUN	NN	_	24	compound	_	_
23	placebo	_	NOUN	NN	_	24	compound	_	_
24	differences	_	NOUN	NNS	_	2	nmod	_	_
25	occurring	_	VERB	VBG	_	24	acl	_	_
26	for	_	ADP	IN	_	28	case	_	_
27	sleep	_	NOUN	NN	_	28	compound	_	_
28	latency	_	NOUN	NN	_	25	nmod	_	_
29	at	_	ADP	IN	_	31	case	_	_
30	all	_	DET	DT	_	31	det	_	_
31	doses	_	NOUN	NNS	_	25	nmod	_	_
32	,	_	.	,	_	24	punct	_	_
33	for	_	ADP	IN	_	36	case	_	_
34	total	_	ADJ	JJ	_	36	amod	_	_
35	sleep	_	NOUN	NN	_	36	compound	_	_
36	time	_	NOUN	NN	_	24	nmod	_	_
37	at	_	ADP	IN	_	41	case	_	_
38	the	_	DET	DT	_	41	det	_	_
39	two	_	NUM	CD	_	41	nummod	_	_
40	higher	_	ADJ	JJ	_	41	amod	_	_
41	doses	_	NOUN	NNS	_	36	nmod	_	_
42	and	_	CONJ	CC	_	36	cc	_	_
43	for	_	ADP	IN	_	44	case	_	_
44	number	_	NOUN	NN	_	36	conj	_	_
45	of	_	ADP	IN	_	46	case	_	_
46	awakenings	_	NOUN	NNS	_	44	nmod	_	_
47	only	_	ADV	RB	_	44	advmod	_	_
48	at	_	ADP	IN	_	52	case	_	_
49	the	_	DET	DT	_	52	det	_	_
50	30	_	NUM	CD	_	52	nummod	_	_
51	mg	_	NOUN	NN	_	52	compound	_	_
52	dose	_	NOUN	NN	_	47	nmod	_	_

#	Thioridazine Hydrochloride	1725
1	Reduced	_	VERB	VBN	_	6	amod	_	_
2	cytochrome	_	NOUN	NN	_	6	compound	_	_
3	P450	_	NOUN	NN	_	6	compound	_	_
4	2D6	_	NOUN	NN	_	6	compound	_	_
5	isozyme	_	NOUN	NN	_	6	compound	_	_
6	activity	_	NOUN	NN	_	0	root	_	_
7	,	_	.	,	_	6	punct	_	_
8	drugs	_	NOUN	NNS	_	31	nsubj	_	_
9	which	_	DET	WDT	_	10	nsubj	_	_
10	inhibit	_	VERB	VBP	_	8	acl:relcl	_	_
11	this	_	DET	DT	_	13	det	_	_
12	isozyme	_	NOUN	NN	_	13	compound	_	_
13	e.g	_	NOUN	NN	_	10	dobj	_	_
14	,	_	.	,	_	13	punct	_	_
15	fluoxetine	_	NOUN	NN	_	13	conj	_	_
16	and	_	CONJ	CC	_	13	cc	_	_
17	paroxetine	_	NOUN	NN	_	13	conj	_	_
18	,	_	.	,	_	13	punct	_	_
19	and	_	CONJ	CC	_	13	cc	_	_
20	certain	_	ADJ	JJ	_	22	amod	_	_
21	other	_	ADJ	JJ	_	22	amod	_	_
22	drugs	_	NOUN	NNS	_	13	conj	_	_
23	e.g	_	NOUN	NN	_	22	dep	_	_
24	,	_	.	,	_	23	punct	_	_
25	fluvoxamine	_	NOUN	NN	_	23	conj	_	_
26	,	_	.	,	_	23	punct	_	_
27	propranolol	_	NOUN	NN	_	23	conj	_	_
28	,	_	.	,	_	23	punct	_	_
29	and	_	CONJ	CC	_	23	cc	_	_
30	pindolol	_	NOUN	NN	_	23	conj	_	_
31	appear	_	VERB	VBD	_	6	dep	_	_
32	to	_	PRT	TO	_	34	mark	_	_
33	appreciably	_	ADV	RB	_	34	advmod	_	_
34	inhibit	_	VERB	VB	_	31	xcomp	_	_
35	the	_	DET	DT	_	36	det	_	_
36	metabolism	_	NOUN	NN	_	34	dobj	_	_
37	of	_	ADP	IN	_	38	case	_	_
38	DRUG	_	NOUN	NN	_	36	nmod	_	_

#	Thioridazine Hydrochloride	1726
1	The	_	DET	DT	_	4	det	_	_
2	resulting	_	VERB	VBG	_	4	amod	_	_
3	elevated	_	ADJ	JJ	_	4	amod	_	_
4	levels	_	NOUN	NNS	_	9	nsubjpass	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	would	_	VERB	MD	_	9	aux	_	_
8	be	_	VERB	VB	_	9	auxpass	_	_
9	expected	_	VERB	VBN	_	0	root	_	_
10	to	_	PRT	TO	_	11	mark	_	_
11	augment	_	VERB	VB	_	9	xcomp	_	_
12	the	_	DET	DT	_	13	det	_	_
13	prolongation	_	NOUN	NN	_	11	dobj	_	_
14	of	_	ADP	IN	_	17	case	_	_
15	the	_	DET	DT	_	17	det	_	_
16	QTc	_	NOUN	NN	_	17	compound	_	_
17	interval	_	NOUN	NN	_	13	nmod	_	_
18	associated	_	VERB	VBN	_	17	acl	_	_
19	with	_	ADP	IN	_	20	case	_	_
20	DRUG	_	NOUN	NN	_	18	nmod	_	_
21	and	_	CONJ	CC	_	9	cc	_	_
22	may	_	VERB	MD	_	23	aux	_	_
23	increase	_	VERB	VB	_	9	conj	_	_
24	the	_	DET	DT	_	25	det	_	_
25	risk	_	NOUN	NN	_	23	dobj	_	_
26	of	_	ADP	IN	_	33	case	_	_
27	serious	_	ADJ	JJ	_	33	amod	_	_
28	,	_	.	,	_	27	punct	_	_
29	potentially	_	ADV	RB	_	30	advmod	_	_
30	fatal	_	ADJ	JJ	_	27	conj	_	_
31	,	_	.	,	_	27	punct	_	_
32	cardiac	_	ADJ	JJ	_	27	dep	_	_
33	arrhythmias	_	NOUN	NNS	_	25	nmod	_	_
34	,	_	.	,	_	23	punct	_	_
35	such	_	ADJ	JJ	_	37	case	_	_
36	as	_	ADP	IN	_	35	mwe	_	_
37	Torsades	_	NOUN	NNS	_	23	nmod	_	_
38	de	_	ADP	IN	_	41	case	_	_
39	pointes	_	NOUN	NNS	_	41	compound	_	_
40	type	_	NOUN	NN	_	41	compound	_	_
41	arrhythmias	_	NOUN	NNS	_	37	nmod	_	_

#	Thioridazine Hydrochloride	1727
1	Such	_	ADJ	JJ	_	6	advmod	_	_
2	an	_	DET	DT	_	4	det	_	_
3	increased	_	ADJ	JJ	_	4	amod	_	_
4	risk	_	NOUN	NN	_	6	nsubj	_	_
5	may	_	VERB	MD	_	6	aux	_	_
6	result	_	VERB	VB	_	0	root	_	_
7	also	_	ADV	RB	_	6	advmod	_	_
8	from	_	ADP	IN	_	11	case	_	_
9	the	_	DET	DT	_	11	det	_	_
10	additive	_	ADJ	JJ	_	11	amod	_	_
11	effect	_	NOUN	NN	_	6	nmod	_	_
12	of	_	ADP	IN	_	13	mark	_	_
13	coadministering	_	VERB	VBG	_	11	acl	_	_
14	DRUG	_	NOUN	NN	_	13	dobj	_	_
15	with	_	ADP	IN	_	17	case	_	_
16	other	_	ADJ	JJ	_	17	amod	_	_
17	agents	_	NOUN	NNS	_	13	nmod	_	_
18	that	_	DET	WDT	_	19	nsubj	_	_
19	prolong	_	VERB	VBP	_	17	acl:relcl	_	_
20	the	_	DET	DT	_	22	det	_	_
21	QTc	_	NOUN	NN	_	22	nmod:npmod	_	_
22	interval	_	ADJ	JJ	_	19	dobj	_	_

#	Thioridazine Hydrochloride	1728
1	Therefore	_	ADV	RB	_	5	advmod	_	_
2	,	_	.	,	_	5	punct	_	_
3	DRUG	_	NOUN	NN	_	5	nsubjpass	_	_
4	is	_	VERB	VBZ	_	5	auxpass	_	_
5	contraindicated	_	VERB	VBN	_	0	root	_	_
6	with	_	ADP	IN	_	8	case	_	_
7	these	_	DET	DT	_	8	det	_	_
8	drugs	_	NOUN	NNS	_	5	nmod	_	_
9	as	_	ADV	RB	_	8	cc	_	_
10	well	_	ADV	RB	_	9	mwe	_	_
11	as	_	ADP	IN	_	9	mwe	_	_
12	in	_	ADP	IN	_	13	case	_	_
13	patients	_	NOUN	NNS	_	8	conj	_	_
14	,	_	.	,	_	5	punct	_	_
15	comprising	_	VERB	VBG	_	5	xcomp	_	_
16	about	_	ADV	RB	_	17	advmod	_	_
17	7%	_	NOUN	NN	_	15	nmod	_	_
18	of	_	ADP	IN	_	21	case	_	_
19	the	_	DET	DT	_	21	det	_	_
20	normal	_	ADJ	JJ	_	21	amod	_	_
21	population	_	NOUN	NN	_	17	nmod	_	_
22	,	_	.	,	_	17	punct	_	_
23	who	_	DET	WDT	_	25	nsubjpass	_	_
24	are	_	VERB	VBP	_	25	auxpass	_	_
25	known	_	VERB	VBN	_	17	acl:relcl	_	_
26	to	_	PRT	TO	_	27	mark	_	_
27	have	_	VERB	VB	_	25	xcomp	_	_
28	a	_	DET	DT	_	30	det	_	_
29	genetic	_	ADJ	JJ	_	30	amod	_	_
30	defect	_	NOUN	NN	_	27	dobj	_	_
31	leading	_	VERB	VBG	_	30	acl	_	_
32	to	_	PRT	TO	_	34	case	_	_
33	reduced	_	VERB	VBN	_	34	amod	_	_
34	levels	_	NOUN	NNS	_	31	nmod	_	_
35	of	_	ADP	IN	_	36	case	_	_
36	activity	_	NOUN	NN	_	34	nmod	_	_
37	of	_	ADP	IN	_	39	case	_	_
38	P450	_	NOUN	NN	_	39	compound	_	_
39	2D6	_	NOUN	NN	_	36	nmod	_	_

#	Thioridazine Hydrochloride	1729
1	In	_	ADP	IN	_	3	case	_	_
2	a	_	DET	DT	_	3	det	_	_
3	study	_	NOUN	NN	_	29	nmod	_	_
4	of	_	ADP	IN	_	8	case	_	_
5	19	_	NUM	CD	_	8	nummod	_	_
6	healthy	_	ADJ	JJ	_	8	amod	_	_
7	male	_	ADJ	JJ	_	8	amod	_	_
8	subjects	_	NOUN	NNS	_	3	nmod	_	_
9	,	_	.	,	_	8	punct	_	_
10	which	_	DET	WDT	_	11	nsubj	_	_
11	included	_	VERB	VBD	_	8	acl:relcl	_	_
12	6	_	NUM	CD	_	13	nummod	_	_
13	slow	_	NOUN	NN	_	11	dobj	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	13	_	NUM	CD	_	17	nummod	_	_
16	rapid	_	ADJ	JJ	_	17	amod	_	_
17	hydroxylators	_	NOUN	NNS	_	13	conj	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	debrisoquin	_	NOUN	NN	_	13	nmod	_	_
20	,	_	.	,	_	29	punct	_	_
21	a	_	DET	DT	_	26	det	_	_
22	single	_	ADJ	JJ	_	26	amod	_	_
23	25	_	NUM	CD	_	26	nummod	_	_
24	mg	_	NOUN	NN	_	26	compound	_	_
25	oral	_	ADJ	JJ	_	26	amod	_	_
26	dose	_	NOUN	NN	_	29	nsubj	_	_
27	of	_	ADP	IN	_	28	case	_	_
28	DRUG	_	NOUN	NN	_	26	nmod	_	_
29	produced	_	VERB	VBD	_	0	root	_	_
30	a	_	DET	DT	_	34	det	_	_
31	2.4	_	NUM	CD	_	34	nummod	_	_
32	fold	_	NOUN	NN	_	34	amod	_	_
33	higher	_	ADJ	JJ	_	34	amod	_	_
34	Cmax	_	NOUN	NN	_	29	dobj	_	_
35	and	_	CONJ	CC	_	34	cc	_	_
36	a	_	DET	DT	_	40	det	_	_
37	4.5	_	NUM	CD	_	40	nummod	_	_
38	fold	_	NOUN	NN	_	40	amod	_	_
39	higher	_	ADJ	JJ	_	40	amod	_	_
40	AUC	_	NOUN	NN	_	34	conj	_	_
41	for	_	ADP	IN	_	42	case	_	_
42	DRUG	_	NOUN	NN	_	34	nmod	_	_
43	in	_	ADP	IN	_	46	case	_	_
44	the	_	DET	DT	_	46	det	_	_
45	slow	_	NOUN	NN	_	46	compound	_	_
46	hydroxylators	_	NOUN	NNS	_	34	nmod	_	_
47	compared	_	VERB	VBN	_	50	case	_	_
48	to	_	PRT	TO	_	50	case	_	_
49	rapid	_	ADJ	JJ	_	50	amod	_	_
50	hydroxylators	_	NOUN	NNS	_	29	nmod	_	_

#	Thioridazine Hydrochloride	1730
1	The	_	DET	DT	_	2	det	_	_
2	rate	_	NOUN	NN	_	7	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	debrisoquin	_	NOUN	NN	_	5	compound	_	_
5	hydroxylation	_	NOUN	NN	_	2	nmod	_	_
6	is	_	VERB	VBZ	_	7	cop	_	_
7	felt	_	ADJ	JJ	_	0	root	_	_
8	to	_	PRT	TO	_	9	mark	_	_
9	depend	_	VERB	VB	_	7	xcomp	_	_
10	on	_	ADP	IN	_	12	case	_	_
11	the	_	DET	DT	_	12	det	_	_
12	level	_	NOUN	NN	_	9	nmod	_	_
13	of	_	ADP	IN	_	18	case	_	_
14	cytochrome	_	NOUN	NN	_	18	compound	_	_
15	P450	_	NOUN	NN	_	18	compound	_	_
16	2D6	_	NOUN	NN	_	18	compound	_	_
17	isozyme	_	NOUN	NN	_	18	compound	_	_
18	activity	_	NOUN	NN	_	12	nmod	_	_

#	Thioridazine Hydrochloride	1731
1	Thus	_	ADV	RB	_	5	advmod	_	_
2	,	_	.	,	_	5	punct	_	_
3	this	_	DET	DT	_	4	det	_	_
4	study	_	NOUN	NN	_	5	nsubj	_	_
5	suggests	_	VERB	VBZ	_	0	root	_	_
6	that	_	ADP	IN	_	5	root	_	_
7	drugs	_	NOUN	NNS	_	6	root	_	_
8	that	_	DET	WDT	_	9	nsubj	_	_
9	inhibit	_	VERB	VBP	_	7	dep	_	_
10	P450	_	NOUN	NN	_	11	compound	_	_
11	2D6	_	NOUN	NN	_	9	dobj	_	_
12	or	_	CONJ	CC	_	9	cc	_	_
13	the	_	DET	DT	_	14	det	_	_
14	presence	_	NOUN	NN	_	23	nsubj	_	_
15	of	_	ADP	IN	_	18	case	_	_
16	reduced	_	VERB	VBN	_	18	amod	_	_
17	activity	_	NOUN	NN	_	18	compound	_	_
18	levels	_	NOUN	NNS	_	14	nmod	_	_
19	of	_	ADP	IN	_	21	case	_	_
20	this	_	DET	DT	_	21	det	_	_
21	isozyme	_	NOUN	NN	_	18	nmod	_	_
22	will	_	VERB	MD	_	23	aux	_	_
23	produce	_	VERB	VB	_	9	conj	_	_
24	elevated	_	ADJ	JJ	_	26	amod	_	_
25	plasma	_	NOUN	NN	_	26	compound	_	_
26	levels	_	NOUN	NNS	_	23	dobj	_	_
27	of	_	ADP	IN	_	28	case	_	_
28	DRUG	_	NOUN	NN	_	26	nmod	_	_

#	Thioridazine Hydrochloride	1732
1	Therefore	_	ADV	RB	_	39	advmod	_	_
2	,	_	.	,	_	39	punct	_	_
3	the	_	DET	DT	_	4	det	_	_
4	coadministration	_	NOUN	NN	_	39	nsubjpass	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	drugs	_	NOUN	NNS	_	4	nmod	_	_
7	that	_	DET	WDT	_	8	nsubj	_	_
8	inhibit	_	VERB	VBP	_	6	acl:relcl	_	_
9	P450	_	NOUN	NN	_	10	compound	_	_
10	2D6	_	NOUN	NN	_	8	dobj	_	_
11	with	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	8	nmod	_	_
13	and	_	CONJ	CC	_	8	cc	_	_
14	the	_	DET	DT	_	15	det	_	_
15	use	_	NOUN	NN	_	29	nsubjpass	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	DRUG	_	NOUN	NN	_	15	nmod	_	_
18	in	_	ADP	IN	_	19	case	_	_
19	patients	_	NOUN	NNS	_	15	nmod	_	_
20	known	_	VERB	VBN	_	19	acl	_	_
21	to	_	PRT	TO	_	24	case	_	_
22	have	_	VERB	VB	_	23	aux	_	_
23	reduced	_	VERB	VBN	_	24	amod	_	_
24	activity	_	NOUN	NN	_	20	nmod	_	_
25	of	_	ADP	IN	_	27	case	_	_
26	P450	_	NOUN	NN	_	27	compound	_	_
27	2D6	_	NOUN	NN	_	24	nmod	_	_
28	are	_	VERB	VBP	_	29	auxpass	_	_
29	contraindicated	_	VERB	VBN	_	8	conj	_	_
30	for	_	ADP	IN	_	32	case	_	_
31	one	_	NUM	CD	_	32	nummod	_	_
32	week	_	NOUN	NN	_	29	nmod	_	_
33	on	_	ADP	IN	_	37	case	_	_
34	DRUG	_	NOUN	NN	_	37	compound	_	_
35	steady	_	ADJ	JJ	_	37	amod	_	_
36	state	_	NOUN	NN	_	37	compound	_	_
37	concentration	_	NOUN	NN	_	29	nmod	_	_
38	was	_	VERB	VBD	_	39	auxpass	_	_
39	evaluated	_	VERB	VBN	_	0	root	_	_
40	in	_	ADP	IN	_	43	case	_	_
41	ten	_	NUM	CD	_	43	nummod	_	_
42	male	_	ADJ	JJ	_	43	amod	_	_
43	inpatients	_	NOUN	NNS	_	39	nmod	_	_
44	with	_	ADP	IN	_	45	case	_	_
45	schizophrenia	_	NOUN	NN	_	43	nmod	_	_

#	Thioridazine Hydrochloride	1733
1	Concentrations	_	NOUN	NNS	_	14	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	and	_	CONJ	CC	_	1	cc	_	_
5	its	_	PRON	PRP$	_	8	nmod:poss	_	_
6	two	_	NUM	CD	_	8	nummod	_	_
7	active	_	ADJ	JJ	_	8	amod	_	_
8	metabolites	_	NOUN	NNS	_	1	conj	_	_
9	,	_	.	,	_	8	punct	_	_
10	mesoridazine	_	NOUN	NN	_	8	appos	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	sulforidazine	_	NOUN	NN	_	10	conj	_	_
13	,	_	.	,	_	8	punct	_	_
14	increased	_	VERB	VBD	_	0	root	_	_
15	3	_	NUM	CD	_	16	nummod	_	_
16	fold	_	NOUN	NN	_	14	dobj	_	_
17	following	_	ADP	IN	_	18	case	_	_
18	coadministration	_	NOUN	NN	_	14	nmod	_	_
19	of	_	ADP	IN	_	20	case	_	_
20	fluvoxamine	_	NOUN	NN	_	18	nmod	_	_

#	Thioridazine Hydrochloride	1734
1	Fluvoxamine	_	NOUN	NN	_	7	nsubjpass	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	DRUG	_	NOUN	NN	_	1	conj	_	_
4	should	_	VERB	MD	_	7	aux	_	_
5	not	_	ADV	RB	_	7	neg	_	_
6	be	_	VERB	VB	_	7	auxpass	_	_
7	coadministered	_	VERB	VBN	_	0	root	_	_

#	Thioridazine Hydrochloride	1735
1	Concurrent	_	ADJ	JJ	_	2	amod	_	_
2	administration	_	NOUN	NN	_	12	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	propranolol	_	NOUN	NN	_	2	nmod	_	_
5	100	_	NUM	CD	_	4	nummod	_	_
6	to	_	PRT	TO	_	8	case	_	_
7	800	_	NUM	CD	_	8	nummod	_	_
8	mg	_	NOUN	NN	_	2	nmod	_	_
9	daily	_	ADV	RB	_	12	advmod	_	_
10	has	_	VERB	VBZ	_	12	aux	_	_
11	been	_	VERB	VBN	_	12	auxpass	_	_
12	reported	_	VERB	VBN	_	0	root	_	_
13	to	_	PRT	TO	_	14	mark	_	_
14	produce	_	VERB	VB	_	12	xcomp	_	_
15	increases	_	NOUN	NNS	_	14	dobj	_	_
16	in	_	ADP	IN	_	18	case	_	_
17	plasma	_	NOUN	NN	_	18	compound	_	_
18	levels	_	NOUN	NNS	_	15	nmod	_	_
19	of	_	ADP	IN	_	20	case	_	_
20	DRUG	_	NOUN	NN	_	18	nmod	_	_
21	approximately	_	ADV	RB	_	22	advmod	_	_
22	50%	_	ADJ	JJ	_	14	nmod	_	_
23	to	_	PRT	TO	_	24	case	_	_
24	400%	_	NOUN	NN	_	22	nmod	_	_
25	and	_	CONJ	CC	_	22	cc	_	_
26	its	_	PRON	PRP$	_	27	nmod:poss	_	_
27	metabolites	_	NOUN	NNS	_	22	conj	_	_
28	approximately	_	ADV	RB	_	29	advmod	_	_
29	80%	_	ADJ	JJ	_	27	nmod	_	_
30	to	_	PRT	TO	_	31	case	_	_
31	300%	_	ADJ	JJ	_	29	nmod	_	_

#	Thioridazine Hydrochloride	1736
1	Propranolol	_	NOUN	NN	_	7	nsubjpass	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	DRUG	_	NOUN	NN	_	1	conj	_	_
4	should	_	VERB	MD	_	7	aux	_	_
5	not	_	ADV	RB	_	7	neg	_	_
6	be	_	VERB	VB	_	7	auxpass	_	_
7	coadministered	_	VERB	VBN	_	0	root	_	_

#	Thioridazine Hydrochloride	1737
1	Concurrent	_	ADJ	JJ	_	2	amod	_	_
2	administration	_	NOUN	NN	_	8	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	pindolol	_	NOUN	NN	_	2	nmod	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	DRUG	_	NOUN	NN	_	4	conj	_	_
7	have	_	VERB	MD	_	8	aux	_	_
8	resulted	_	VERB	VBN	_	0	root	_	_
9	in	_	ADP	IN	_	14	case	_	_
10	moderate	_	ADJ	JJ	_	14	amod	_	_
11	,	_	.	,	_	10	punct	_	_
12	dose	_	NOUN	NN	_	13	nmod:npmod	_	_
13	related	_	ADJ	JJ	_	10	dep	_	_
14	increases	_	NOUN	NNS	_	8	nmod	_	_
15	in	_	ADP	IN	_	18	case	_	_
16	the	_	DET	DT	_	18	det	_	_
17	serum	_	NOUN	NN	_	18	compound	_	_
18	levels	_	NOUN	NNS	_	14	nmod	_	_
19	of	_	ADP	IN	_	20	case	_	_
20	DRUG	_	NOUN	NN	_	18	nmod	_	_
21	and	_	CONJ	CC	_	20	cc	_	_
22	two	_	NUM	CD	_	20	conj	_	_
23	of	_	ADP	IN	_	25	case	_	_
24	its	_	PRON	PRP$	_	25	nmod:poss	_	_
25	metabolites	_	NOUN	NNS	_	20	nmod	_	_
26	,	_	.	,	_	14	punct	_	_
27	as	_	ADV	RB	_	14	cc	_	_
28	well	_	ADV	RB	_	27	mwe	_	_
29	as	_	ADV	RB	_	27	mwe	_	_
30	higher	_	ADJ	JJ	_	27	mwe	_	_
31	than	_	ADP	IN	_	27	mwe	_	_
32	expected	_	VERB	VBN	_	35	amod	_	_
33	serum	_	NOUN	NN	_	35	compound	_	_
34	pindolol	_	NOUN	NN	_	35	compound	_	_
35	levels	_	NOUN	NNS	_	14	conj	_	_

#	Thioridazine Hydrochloride	1738
1	Pindolol	_	NOUN	NN	_	7	nsubjpass	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	DRUG	_	NOUN	NN	_	1	conj	_	_
4	should	_	VERB	MD	_	7	aux	_	_
5	not	_	ADV	RB	_	7	neg	_	_
6	be	_	VERB	VB	_	7	auxpass	_	_
7	coadministered	_	VERB	VBN	_	0	root	_	_

#	Thioridazine Hydrochloride	1739
1	There	_	DET	EX	_	2	expl	_	_
2	are	_	VERB	VBP	_	0	root	_	_
3	no	_	DET	DT	_	4	neg	_	_
4	studies	_	NOUN	NNS	_	2	nsubj	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	coadministration	_	NOUN	NN	_	4	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	other	_	ADJ	JJ	_	12	amod	_	_
12	drugs	_	NOUN	NNS	_	9	conj	_	_
13	that	_	DET	WDT	_	14	nsubj	_	_
14	prolong	_	VERB	VBP	_	9	acl:relcl	_	_
15	the	_	DET	DT	_	17	det	_	_
16	QTc	_	NOUN	NN	_	17	nmod:npmod	_	_
17	interval	_	ADJ	JJ	_	14	dobj	_	_

#	Thioridazine Hydrochloride	1740
1	However	_	ADV	RB	_	5	advmod	_	_
2	,	_	.	,	_	5	punct	_	_
3	it	_	PRON	PRP	_	5	nsubjpass	_	_
4	is	_	VERB	VBZ	_	5	auxpass	_	_
5	expected	_	VERB	VBN	_	0	root	_	_
6	that	_	ADP	IN	_	10	mark	_	_
7	such	_	ADJ	JJ	_	8	amod	_	_
8	coadministration	_	NOUN	NN	_	10	nsubj	_	_
9	would	_	VERB	MD	_	10	aux	_	_
10	produce	_	VERB	VB	_	5	ccomp	_	_
11	additive	_	ADJ	JJ	_	12	amod	_	_
12	prolongation	_	NOUN	NN	_	10	dobj	_	_
13	of	_	ADP	IN	_	16	case	_	_
14	the	_	DET	DT	_	16	det	_	_
15	QTc	_	NOUN	NN	_	16	compound	_	_
16	interval	_	ADJ	JJ	_	12	nmod	_	_
17	and	_	CONJ	CC	_	10	cc	_	_
18	,	_	.	,	_	10	punct	_	_
19	thus	_	ADV	RB	_	10	advmod	_	_
20	,	_	.	,	_	10	punct	_	_
21	such	_	ADJ	JJ	_	22	amod	_	_
22	use	_	NOUN	NN	_	24	nsubjpass	_	_
23	is	_	VERB	VBZ	_	24	auxpass	_	_
24	contraindicated	_	VERB	VBN	_	10	parataxis	_	_

#	Thioridazine Hydrochloride	1741
1	The	_	DET	DT	_	4	det	_	_
2	basic	_	ADJ	JJ	_	4	amod	_	_
3	pharmacological	_	ADJ	JJ	_	4	amod	_	_
4	activity	_	NOUN	NN	_	8	nsubj	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	is	_	VERB	VBZ	_	8	cop	_	_
8	similar	_	ADJ	JJ	_	0	root	_	_
9	to	_	PRT	TO	_	10	case	_	_
10	that	_	DET	DT	_	8	nmod	_	_
11	of	_	ADP	IN	_	13	case	_	_
12	other	_	ADJ	JJ	_	13	amod	_	_
13	phenothiazines	_	NOUN	NNS	_	10	nmod	_	_
14	,	_	.	,	_	8	punct	_	_
15	but	_	CONJ	CC	_	8	cc	_	_
16	is	_	VERB	VBZ	_	17	auxpass	_	_
17	associated	_	VERB	VBN	_	8	conj	_	_
18	with	_	ADP	IN	_	21	case	_	_
19	minimal	_	ADJ	JJ	_	21	amod	_	_
20	extrapyramidal	_	ADJ	JJ	_	21	amod	_	_
21	stimulation	_	NOUN	NN	_	17	nmod	_	_

#	Thioridazine Hydrochloride	1742
1	However	_	ADV	RB	_	6	advmod	_	_
2	,	_	.	,	_	6	punct	_	_
3	DRUG	_	NOUN	NN	_	6	nsubjpass	_	_
4	has	_	VERB	VBZ	_	6	aux	_	_
5	been	_	VERB	VBN	_	6	auxpass	_	_
6	shown	_	VERB	VBN	_	0	root	_	_
7	to	_	PRT	TO	_	8	mark	_	_
8	prolong	_	VERB	VB	_	6	xcomp	_	_
9	the	_	DET	DT	_	10	det	_	_
10	QTc	_	NOUN	NN	_	8	dobj	_	_
11	interval	_	ADJ	JJ	_	10	amod	_	_
12	in	_	ADP	IN	_	16	case	_	_
13	a	_	DET	DT	_	16	det	_	_
14	dose	_	NOUN	NN	_	16	compound	_	_
15	dependent	_	ADJ	JJ	_	16	amod	_	_
16	fashion	_	NOUN	NN	_	11	nmod	_	_

#	Thioridazine Hydrochloride	1743
1	This	_	DET	DT	_	2	det	_	_
2	effect	_	NOUN	NN	_	4	nsubj	_	_
3	may	_	VERB	MD	_	4	aux	_	_
4	increase	_	VERB	VB	_	0	root	_	_
5	the	_	DET	DT	_	6	det	_	_
6	risk	_	NOUN	NN	_	4	dobj	_	_
7	of	_	ADP	IN	_	14	case	_	_
8	serious	_	ADJ	JJ	_	14	amod	_	_
9	,	_	.	,	_	8	punct	_	_
10	potentially	_	ADV	RB	_	11	advmod	_	_
11	fatal	_	ADJ	JJ	_	8	conj	_	_
12	,	_	.	,	_	8	punct	_	_
13	ventricular	_	ADJ	JJ	_	8	dep	_	_
14	arrhythmias	_	NOUN	NNS	_	6	nmod	_	_
15	,	_	.	,	_	4	punct	_	_
16	such	_	ADJ	JJ	_	18	case	_	_
17	as	_	ADP	IN	_	16	mwe	_	_
18	Torsades	_	NOUN	NNS	_	4	nmod	_	_
19	de	_	ADP	IN	_	22	case	_	_
20	pointes	_	NOUN	NNS	_	22	compound	_	_
21	type	_	NOUN	NN	_	22	compound	_	_
22	arrhythmias	_	NOUN	NNS	_	18	nmod	_	_

#	Thioridazine Hydrochloride	1744
1	Due	_	ADP	IN	_	4	case	_	_
2	to	_	PRT	TO	_	1	mwe	_	_
3	this	_	DET	DT	_	4	det	_	_
4	risk	_	NOUN	NN	_	8	nmod	_	_
5	,	_	.	,	_	8	punct	_	_
6	DRUG	_	NOUN	NN	_	8	nsubjpass	_	_
7	is	_	VERB	VBZ	_	8	auxpass	_	_
8	indicated	_	VERB	VBN	_	0	root	_	_
9	only	_	ADV	RB	_	8	advmod	_	_
10	for	_	ADP	IN	_	12	case	_	_
11	schizophrenic	_	ADJ	JJ	_	12	amod	_	_
12	patients	_	NOUN	NNS	_	8	nmod	_	_
13	who	_	DET	WDT	_	17	nsubj	_	_
14	have	_	VERB	VBP	_	17	aux	_	_
15	not	_	ADV	RB	_	17	neg	_	_
16	been	_	VERB	VBN	_	17	cop	_	_
17	responsive	_	ADJ	JJ	_	12	acl:relcl	_	_
18	to	_	PRT	TO	_	17	nmod	_	_
19	or	_	CONJ	CC	_	18	cc	_	_
20	cannot	_	NOUN	NN	_	18	conj	_	_
21	tolerate	_	VERB	VBP	_	8	xcomp	_	_
22	other	_	ADJ	JJ	_	23	amod	_	_
23	DRUGS	_	NOUN	NN	_	21	dobj	_	_

#	Thioridazine Hydrochloride	1745
1	However	_	ADV	RB	_	7	advmod	_	_
2	,	_	.	,	_	7	punct	_	_
3	the	_	DET	DT	_	4	det	_	_
4	prescriber	_	NOUN	NN	_	7	nsubj	_	_
5	should	_	VERB	MD	_	7	aux	_	_
6	be	_	VERB	VB	_	7	cop	_	_
7	aware	_	ADJ	JJ	_	0	root	_	_
8	that	_	ADP	IN	_	14	mark	_	_
9	DRUG	_	NOUN	NN	_	14	nsubjpass	_	_
10	has	_	VERB	VBZ	_	14	aux	_	_
11	not	_	ADV	RB	_	14	neg	_	_
12	been	_	VERB	VBN	_	14	auxpass	_	_
13	systematically	_	ADV	RB	_	14	advmod	_	_
14	evaluated	_	VERB	VBN	_	7	ccomp	_	_
15	in	_	ADP	IN	_	17	case	_	_
16	controlled	_	VERB	VBN	_	17	amod	_	_
17	trials	_	NOUN	NNS	_	14	nmod	_	_
18	in	_	ADP	IN	_	22	case	_	_
19	treatment	_	NOUN	NN	_	22	compound	_	_
20	refractory	_	ADJ	JJ	_	22	amod	_	_
21	schizophrenic	_	ADJ	JJ	_	22	amod	_	_
22	patients	_	NOUN	NNS	_	17	nmod	_	_
23	and	_	CONJ	CC	_	14	cc	_	_
24	its	_	PRON	PRP$	_	25	nmod:poss	_	_
25	efficacy	_	NOUN	NN	_	30	nsubj	_	_
26	in	_	ADP	IN	_	28	case	_	_
27	such	_	ADJ	JJ	_	28	amod	_	_
28	patients	_	NOUN	NNS	_	25	nmod	_	_
29	is	_	VERB	VBZ	_	30	auxpass	_	_
30	unknown	_	ADJ	JJ	_	14	conj	_	_

#	Thiothixene	3064
1	Hepatic	_	ADJ	JJ	_	3	amod	_	_
2	microsomal	_	ADJ	JJ	_	3	amod	_	_
3	enzyme	_	NOUN	NN	_	12	nsubjpass	_	_
4	inducing	_	VERB	VBG	_	3	acl	_	_
5	agents	_	NOUN	NNS	_	4	dobj	_	_
6	,	_	.	,	_	5	punct	_	_
7	such	_	ADJ	JJ	_	9	case	_	_
8	as	_	ADP	IN	_	7	mwe	_	_
9	carbamazepine	_	NOUN	NN	_	5	nmod	_	_
10	,	_	.	,	_	3	punct	_	_
11	were	_	VERB	VBD	_	12	auxpass	_	_
12	found	_	VERB	VBN	_	0	root	_	_
13	to	_	PRT	TO	_	15	mark	_	_
14	significantly	_	ADV	RB	_	15	advmod	_	_
15	increase	_	VERB	VB	_	12	xcomp	_	_
16	the	_	DET	DT	_	17	det	_	_
17	clearance	_	NOUN	NN	_	15	dobj	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	DRUG	_	NOUN	NN	_	17	nmod	_	_

#	Thiothixene	3065
1	Patients	_	NOUN	NNS	_	7	nsubjpass	_	_
2	receiving	_	VERB	VBG	_	1	acl	_	_
3	these	_	DET	DT	_	4	det	_	_
4	drugs	_	NOUN	NNS	_	2	dobj	_	_
5	should	_	VERB	MD	_	7	aux	_	_
6	be	_	VERB	VB	_	7	auxpass	_	_
7	observed	_	VERB	VBN	_	0	root	_	_
8	for	_	ADP	IN	_	9	case	_	_
9	signs	_	NOUN	NNS	_	7	nmod	_	_
10	of	_	ADP	IN	_	13	case	_	_
11	reduced	_	VERB	VBN	_	13	amod	_	_
12	DRUG	_	NOUN	NN	_	13	compound	_	_
13	effectiveness4,5	_	NOUN	NN	_	9	nmod	_	_

#	Thiothixene	3066
1	Due	_	ADP	IN	_	6	case	_	_
2	to	_	PRT	TO	_	1	mwe	_	_
3	a	_	DET	DT	_	6	det	_	_
4	possible	_	ADJ	JJ	_	6	amod	_	_
5	additive	_	ADJ	JJ	_	6	amod	_	_
6	effect	_	NOUN	NN	_	17	nmod	_	_
7	with	_	ADP	IN	_	9	case	_	_
8	hypotensive	_	ADJ	JJ	_	9	amod	_	_
9	agents	_	NOUN	NNS	_	6	nmod	_	_
10	,	_	.	,	_	17	punct	_	_
11	patients	_	NOUN	NNS	_	17	nsubjpass	_	_
12	receiving	_	VERB	VBG	_	11	acl	_	_
13	these	_	DET	DT	_	14	det	_	_
14	drugs	_	NOUN	NNS	_	12	dobj	_	_
15	should	_	VERB	MD	_	17	aux	_	_
16	be	_	VERB	VB	_	17	auxpass	_	_
17	observed	_	VERB	VBN	_	0	root	_	_
18	closely	_	ADV	RB	_	17	advmod	_	_
19	for	_	ADP	IN	_	20	case	_	_
20	signs	_	NOUN	NNS	_	17	nmod	_	_
21	of	_	ADP	IN	_	23	case	_	_
22	excessive	_	ADJ	JJ	_	23	amod	_	_
23	hypotension	_	NOUN	NN	_	20	nmod	_	_
24	when	_	ADV	WRB	_	27	advmod	_	_
25	DRUG	_	NOUN	NN	_	27	nsubjpass	_	_
26	is	_	VERB	VBZ	_	27	auxpass	_	_
27	added	_	VERB	VBN	_	17	advcl	_	_
28	to	_	PRT	TO	_	31	case	_	_
29	their	_	PRON	PRP$	_	31	nmod:poss	_	_
30	drug	_	NOUN	NN	_	31	compound	_	_
31	regimen6	_	NOUN	NN	_	27	nmod	_	_

#	Thiothixene	3067
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	is	_	VERB	VBZ	_	4	cop	_	_
3	an	_	DET	DT	_	4	det	_	_
4	antipsychotic	_	NOUN	NN	_	0	root	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	the	_	DET	DT	_	8	det	_	_
7	thioxanthene	_	NOUN	NN	_	8	compound	_	_
8	series	_	NOUN	NNS	_	4	nmod	_	_

#	Thiothixene	3068
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	possesses	_	VERB	VBZ	_	0	root	_	_
3	certain	_	ADJ	JJ	_	4	amod	_	_
4	chemical	_	ADJ	JJ	_	2	dobj	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	pharmacological	_	ADJ	JJ	_	4	conj	_	_
7	similarities	_	NOUN	NNS	_	4	dep	_	_
8	to	_	PRT	TO	_	11	case	_	_
9	the	_	DET	DT	_	11	det	_	_
10	piperazine	_	NOUN	NN	_	11	compound	_	_
11	phenothiazines	_	NOUN	NNS	_	2	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	differences	_	NOUN	NNS	_	11	conj	_	_
14	from	_	ADP	IN	_	17	case	_	_
15	the	_	DET	DT	_	17	det	_	_
16	aliphatic	_	ADJ	JJ	_	17	amod	_	_
17	group	_	NOUN	NN	_	11	nmod	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	phenothiazines	_	NOUN	NNS	_	17	nmod	_	_

#	Venlafaxine Hydrochloride	5770
1	Serotonergic	_	ADJ	JJ	_	2	amod	_	_
2	Drugs	_	NOUN	NNS	_	23	nsubj	_	_
3	e.g	_	NOUN	NN	_	2	dep	_	_
4	,	_	.	,	_	3	punct	_	_
5	MAOIs	_	NOUN	NNS	_	3	conj	_	_
6	,	_	.	,	_	3	punct	_	_
7	triptans	_	NOUN	NNS	_	3	conj	_	_
8	,	_	.	,	_	3	punct	_	_
9	SSRIs	_	NOUN	NNS	_	3	conj	_	_
10	,	_	.	,	_	3	punct	_	_
11	other	_	ADJ	JJ	_	12	amod	_	_
12	SNRIs	_	NOUN	NNS	_	3	conj	_	_
13	,	_	.	,	_	3	punct	_	_
14	linezolid	_	NOUN	NN	_	3	conj	_	_
15	,	_	.	,	_	3	punct	_	_
16	lithium	_	NOUN	NN	_	3	conj	_	_
17	,	_	.	,	_	3	punct	_	_
18	tramadol	_	NOUN	NN	_	3	conj	_	_
19	,	_	.	,	_	3	punct	_	_
20	or	_	CONJ	CC	_	3	cc	_	_
21	St	_	NOUN	NN	_	22	compound	_	_
22	John's	_	NOUN	NNS	_	3	conj	_	_
23	wort	_	ADV	RB	_	0	root	_	_
24	:	_	.	:	_	23	punct	_	_
25	Potential	_	ADJ	JJ	_	23	dep	_	_
26	for	_	ADP	IN	_	28	case	_	_
27	serotonin	_	NOUN	NN	_	28	compound	_	_
28	syndrome	_	NOUN	NN	_	25	nmod	_	_

#	Venlafaxine Hydrochloride	5771
1	Careful	_	ADJ	JJ	_	3	amod	_	_
2	patient	_	NOUN	NN	_	3	compound	_	_
3	observation	_	NOUN	NN	_	5	nsubjpass	_	_
4	is	_	VERB	VBZ	_	5	auxpass	_	_
5	advised	_	VERB	VBN	_	0	root	_	_
6	4.2	_	NUM	CD	_	5	neg	_	_
7	,	_	.	,	_	6	punct	_	_
8	5.2	_	NUM	CD	_	6	conj	_	_
9	,	_	.	,	_	6	punct	_	_
10	7.3	_	NUM	CD	_	6	conj	_	_

#	Venlafaxine Hydrochloride	5772
1	The	_	DET	DT	_	2	det	_	_
2	risk	_	NOUN	NN	_	17	nsubjpass	_	_
3	of	_	ADP	IN	_	4	mark	_	_
4	using	_	VERB	VBG	_	2	acl	_	_
5	DRUG	_	NOUN	NN	_	4	dobj	_	_
6	in	_	ADP	IN	_	7	case	_	_
7	combination	_	NOUN	NN	_	4	nmod	_	_
8	with	_	ADP	IN	_	12	case	_	_
9	other	_	ADJ	JJ	_	12	amod	_	_
10	CNS	_	NOUN	NN	_	12	compound	_	_
11	active	_	ADJ	JJ	_	12	amod	_	_
12	drugs	_	NOUN	NNS	_	7	nmod	_	_
13	has	_	VERB	VBZ	_	17	aux	_	_
14	not	_	ADV	RB	_	17	neg	_	_
15	been	_	VERB	VBN	_	17	auxpass	_	_
16	systematically	_	ADV	RB	_	17	advmod	_	_
17	evaluated	_	VERB	VBN	_	0	root	_	_

#	Venlafaxine Hydrochloride	5773
1	Consequently	_	ADV	RB	_	5	advmod	_	_
2	,	_	.	,	_	5	punct	_	_
3	caution	_	NOUN	NN	_	5	nsubjpass	_	_
4	is	_	VERB	VBZ	_	5	auxpass	_	_
5	advised	_	VERB	VBN	_	0	root	_	_
6	when	_	ADV	WRB	_	8	advmod	_	_
7	DRUG	_	NOUN	NN	_	8	nsubj	_	_
8	extended	_	VERB	VBD	_	5	ccomp	_	_
9	release	_	NOUN	NN	_	8	dobj	_	_
10	is	_	VERB	VBZ	_	11	auxpass	_	_
11	taken	_	VERB	VBN	_	8	parataxis	_	_
12	in	_	ADP	IN	_	13	case	_	_
13	combination	_	NOUN	NN	_	11	nmod	_	_
14	with	_	ADP	IN	_	18	case	_	_
15	other	_	ADJ	JJ	_	18	amod	_	_
16	CNS	_	NOUN	NN	_	18	compound	_	_
17	active	_	ADJ	JJ	_	18	amod	_	_
18	drugs	_	NOUN	NNS	_	13	nmod	_	_

#	Venlafaxine Hydrochloride	5774
1	Adverse	_	ADJ	JJ	_	2	amod	_	_
2	reactions	_	NOUN	NNS	_	12	nsubjpass	_	_
3	,	_	.	,	_	2	punct	_	_
4	some	_	DET	DT	_	8	nsubj	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	which	_	DET	WDT	_	4	nmod	_	_
7	were	_	VERB	VBD	_	8	cop	_	_
8	serious	_	ADJ	JJ	_	2	acl:relcl	_	_
9	,	_	.	,	_	2	punct	_	_
10	have	_	VERB	VBP	_	12	aux	_	_
11	been	_	VERB	VBN	_	12	auxpass	_	_
12	reported	_	VERB	VBN	_	0	root	_	_
13	in	_	ADP	IN	_	14	case	_	_
14	patients	_	NOUN	NNS	_	12	nmod	_	_
15	who	_	DET	WDT	_	19	nsubjpass	_	_
16	have	_	VERB	VBP	_	19	aux	_	_
17	recently	_	ADV	RB	_	19	advmod	_	_
18	been	_	VERB	VBN	_	19	auxpass	_	_
19	discontinued	_	VERB	VBN	_	14	acl:relcl	_	_
20	from	_	ADP	IN	_	22	case	_	_
21	an	_	DET	DT	_	22	det	_	_
22	MAOI	_	NOUN	NN	_	19	nmod	_	_
23	and	_	CONJ	CC	_	19	cc	_	_
24	started	_	VERB	VBN	_	19	conj	_	_
25	on	_	ADP	IN	_	26	case	_	_
26	DRUGS	_	NOUN	NN	_	24	nmod	_	_
27	with	_	ADP	IN	_	29	case	_	_
28	pharmacological	_	ADJ	JJ	_	29	amod	_	_
29	properties	_	NOUN	NNS	_	24	nmod	_	_
30	similar	_	ADJ	JJ	_	29	amod	_	_
31	to	_	PRT	TO	_	32	case	_	_
32	DRUG	_	NOUN	NN	_	30	nmod	_	_
33	extended	_	VERB	VBD	_	12	parataxis	_	_
34	release	_	NOUN	NN	_	35	amod	_	_
35	SNRIs	_	NOUN	NNS	_	33	dobj	_	_
36	or	_	CONJ	CC	_	35	cc	_	_
37	SSRIs	_	NOUN	NNS	_	35	conj	_	_
38	,	_	.	,	_	33	punct	_	_
39	or	_	CONJ	CC	_	33	cc	_	_
40	who	_	DET	WDT	_	43	nsubj	_	_
41	have	_	VERB	VBP	_	43	aux	_	_
42	recently	_	ADV	RB	_	43	advmod	_	_
43	had	_	VERB	VB	_	33	conj	_	_
44	SNRI	_	NOUN	NN	_	43	dobj	_	_
45	or	_	CONJ	CC	_	44	cc	_	_
46	SSRI	_	NOUN	NN	_	44	conj	_	_
47	therapy	_	NOUN	NN	_	44	dep	_	_
48	discontinued	_	VERB	VBN	_	44	acl	_	_
49	prior	_	ADJ	JJ	_	48	xcomp	_	_
50	to	_	PRT	TO	_	51	case	_	_
51	initiation	_	NOUN	NN	_	49	nmod	_	_
52	of	_	ADP	IN	_	54	case	_	_
53	an	_	DET	DT	_	54	det	_	_
54	MAOI	_	NOUN	NN	_	51	nmod	_	_

#	Venlafaxine Hydrochloride	5775
1	Based	_	VERB	VBN	_	20	advcl	_	_
2	on	_	ADP	IN	_	4	case	_	_
3	the	_	DET	DT	_	4	det	_	_
4	mechanism	_	NOUN	NN	_	1	nmod	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	action	_	NOUN	NN	_	4	nmod	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	extended	_	VERB	VBD	_	10	amod	_	_
10	release	_	NOUN	NN	_	1	dobj	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	the	_	DET	DT	_	13	det	_	_
13	potential	_	NOUN	NN	_	10	conj	_	_
14	for	_	ADP	IN	_	16	case	_	_
15	serotonin	_	NOUN	NN	_	16	compound	_	_
16	syndrome	_	NOUN	NN	_	13	nmod	_	_
17	,	_	.	,	_	20	punct	_	_
18	caution	_	NOUN	NN	_	20	nsubjpass	_	_
19	is	_	VERB	VBZ	_	20	auxpass	_	_
20	advised	_	VERB	VBN	_	0	root	_	_
21	when	_	ADV	WRB	_	23	advmod	_	_
22	DRUG	_	NOUN	NN	_	23	nsubj	_	_
23	extended	_	VERB	VBD	_	20	ccomp	_	_
24	release	_	NOUN	NN	_	23	dobj	_	_
25	is	_	VERB	VBZ	_	26	auxpass	_	_
26	coadministered	_	VERB	VBN	_	23	parataxis	_	_
27	with	_	ADP	IN	_	29	case	_	_
28	other	_	ADJ	JJ	_	29	amod	_	_
29	drugs	_	NOUN	NNS	_	26	nmod	_	_
30	that	_	DET	WDT	_	32	nsubj	_	_
31	may	_	VERB	MD	_	32	aux	_	_
32	affect	_	VERB	VB	_	29	acl:relcl	_	_
33	the	_	DET	DT	_	36	det	_	_
34	serotonergic	_	ADJ	JJ	_	36	amod	_	_
35	neurotransmitter	_	ADJ	JJ	_	36	amod	_	_
36	systems	_	NOUN	NNS	_	32	dobj	_	_
37	,	_	.	,	_	36	punct	_	_
38	such	_	ADJ	JJ	_	40	case	_	_
39	as	_	ADP	IN	_	38	mwe	_	_
40	triptans	_	NOUN	NNS	_	36	nmod	_	_
41	,	_	.	,	_	40	punct	_	_
42	SSRIs	_	NOUN	NNS	_	40	conj	_	_
43	,	_	.	,	_	40	punct	_	_
44	other	_	ADJ	JJ	_	45	amod	_	_
45	SNRIs	_	NOUN	NNS	_	40	appos	_	_
46	,	_	.	,	_	40	punct	_	_
47	linezolid	_	NOUN	NN	_	49	compound	_	_
48	an	_	DET	DT	_	49	det	_	_
49	antibiotic	_	NOUN	NN	_	40	appos	_	_
50	which	_	DET	WDT	_	56	nsubj	_	_
51	is	_	VERB	VBZ	_	56	cop	_	_
52	a	_	DET	DT	_	56	det	_	_
53	reversible	_	ADJ	JJ	_	56	amod	_	_
54	non	_	ADJ	JJ	_	56	amod	_	_
55	selective	_	ADJ	JJ	_	56	amod	_	_
56	MAOI	_	NOUN	NN	_	49	acl:relcl	_	_
57	,	_	.	,	_	56	punct	_	_
58	lithium	_	NOUN	NN	_	56	conj	_	_
59	,	_	.	,	_	56	punct	_	_
60	tramadol	_	NOUN	NN	_	56	conj	_	_
61	,	_	.	,	_	56	punct	_	_
62	or	_	CONJ	CC	_	56	cc	_	_
63	St	_	NOUN	NN	_	64	compound	_	_
64	John's	_	NOUN	NNS	_	56	conj	_	_
65	wort	_	VERB	VBZ	_	26	parataxis	_	_

#	Venlafaxine Hydrochloride	5776
1	If	_	ADP	IN	_	3	case	_	_
2	concomitant	_	ADJ	JJ	_	3	amod	_	_
3	treatment	_	NOUN	NN	_	6	nsubj	_	_
4	with	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	extended	_	VERB	VBD	_	21	advcl	_	_
7	release	_	NOUN	NN	_	6	dobj	_	_
8	and	_	CONJ	CC	_	6	cc	_	_
9	these	_	DET	DT	_	10	det	_	_
10	drugs	_	NOUN	NNS	_	13	nsubjpass	_	_
11	is	_	VERB	VBZ	_	13	auxpass	_	_
12	clinically	_	ADV	RB	_	13	advmod	_	_
13	warranted	_	VERB	VBN	_	6	conj	_	_
14	,	_	.	,	_	21	punct	_	_
15	careful	_	ADJ	JJ	_	16	amod	_	_
16	observation	_	NOUN	NN	_	21	nsubjpass	_	_
17	of	_	ADP	IN	_	19	case	_	_
18	the	_	DET	DT	_	19	det	_	_
19	patient	_	NOUN	NN	_	16	nmod	_	_
20	is	_	VERB	VBZ	_	21	auxpass	_	_
21	advised	_	VERB	VBN	_	0	root	_	_
22	,	_	.	,	_	21	punct	_	_
23	particularly	_	ADV	RB	_	25	advmod	_	_
24	during	_	ADP	IN	_	25	case	_	_
25	treatment	_	NOUN	NN	_	21	nmod	_	_
26	initiation	_	NOUN	NN	_	25	dep	_	_
27	and	_	CONJ	CC	_	26	cc	_	_
28	dose	_	NOUN	NN	_	26	conj	_	_
29	increases	_	VERB	VBZ	_	21	root	_	_

#	Venlafaxine Hydrochloride	5777
1	The	_	DET	DT	_	3	det	_	_
2	concomitant	_	ADJ	JJ	_	3	amod	_	_
3	use	_	NOUN	NN	_	6	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	extended	_	VERB	VBD	_	13	nsubjpass	_	_
7	release	_	NOUN	NN	_	6	dobj	_	_
8	with	_	ADP	IN	_	10	case	_	_
9	tryptophan	_	NOUN	NN	_	10	compound	_	_
10	supplements	_	NOUN	NNS	_	7	nmod	_	_
11	is	_	VERB	VBZ	_	13	auxpass	_	_
12	not	_	ADV	RB	_	13	neg	_	_
13	recommended	_	VERB	VBN	_	0	root	_	_

#	Venlafaxine Hydrochloride	5778
1	Serotonin	_	NOUN	NN	_	2	compound	_	_
2	release	_	NOUN	NN	_	5	nsubj	_	_
3	by	_	ADP	IN	_	4	case	_	_
4	platelets	_	NOUN	NNS	_	2	nmod	_	_
5	plays	_	VERB	VBZ	_	0	root	_	_
6	an	_	DET	DT	_	8	det	_	_
7	important	_	ADJ	JJ	_	8	amod	_	_
8	role	_	NOUN	NN	_	5	dobj	_	_
9	in	_	ADP	IN	_	10	case	_	_
10	hemostasis	_	NOUN	NN	_	8	nmod	_	_

#	Venlafaxine Hydrochloride	5779
1	The	_	DET	DT	_	2	det	_	_
2	use	_	NOUN	NN	_	12	nsubjpass	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	psychotropic	_	ADJ	JJ	_	5	amod	_	_
5	drugs	_	NOUN	NNS	_	2	nmod	_	_
6	that	_	DET	WDT	_	7	nsubj	_	_
7	interfere	_	VERB	VBP	_	5	acl:relcl	_	_
8	with	_	ADP	IN	_	10	case	_	_
9	serotonin	_	NOUN	NN	_	10	compound	_	_
10	reuptake	_	NOUN	NN	_	7	nmod	_	_
11	is	_	VERB	VBZ	_	12	auxpass	_	_
12	associated	_	VERB	VBN	_	0	root	_	_
13	with	_	ADP	IN	_	15	case	_	_
14	the	_	DET	DT	_	15	det	_	_
15	occurrence	_	NOUN	NN	_	12	nmod	_	_
16	of	_	ADP	IN	_	19	case	_	_
17	upper	_	VERB	VBG	_	19	amod	_	_
18	gastrointestinal	_	ADJ	JJ	_	19	amod	_	_
19	bleeding	_	NOUN	NN	_	15	nmod	_	_
20	and	_	CONJ	CC	_	12	cc	_	_
21	concurrent	_	ADJ	JJ	_	22	amod	_	_
22	use	_	NOUN	NN	_	29	nsubj	_	_
23	of	_	ADP	IN	_	25	case	_	_
24	an	_	DET	DT	_	25	det	_	_
25	NSAID	_	NOUN	NN	_	22	nmod	_	_
26	or	_	CONJ	CC	_	25	cc	_	_
27	aspirin	_	NOUN	NN	_	25	conj	_	_
28	may	_	VERB	MD	_	29	aux	_	_
29	potentiate	_	VERB	VB	_	12	conj	_	_
30	this	_	DET	DT	_	31	det	_	_
31	risk	_	NOUN	NN	_	29	dobj	_	_
32	of	_	ADP	IN	_	33	mark	_	_
33	bleeding	_	VERB	VBG	_	31	nmod	_	_

#	Venlafaxine Hydrochloride	5780
1	Altered	_	VERB	VBN	_	3	amod	_	_
2	anticoagulant	_	ADJ	JJ	_	3	amod	_	_
3	effects	_	NOUN	NNS	_	11	nsubjpass	_	_
4	,	_	.	,	_	3	punct	_	_
5	including	_	VERB	VBG	_	7	case	_	_
6	increased	_	VERB	VBN	_	7	amod	_	_
7	bleeding	_	NOUN	NN	_	3	nmod	_	_
8	,	_	.	,	_	3	punct	_	_
9	have	_	VERB	VBP	_	11	aux	_	_
10	been	_	VERB	VBN	_	11	auxpass	_	_
11	reported	_	VERB	VBN	_	0	root	_	_
12	when	_	ADV	WRB	_	17	advmod	_	_
13	SSRIs	_	NOUN	NNS	_	17	nsubjpass	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	SNRIs	_	NOUN	NNS	_	13	conj	_	_
16	are	_	VERB	VBP	_	17	auxpass	_	_
17	coadministered	_	VERB	VBN	_	11	advcl	_	_
18	with	_	ADP	IN	_	19	case	_	_
19	warfarin	_	NOUN	NN	_	17	nmod	_	_

#	Venlafaxine Hydrochloride	5781
1	Patients	_	NOUN	NNS	_	8	nsubjpass	_	_
2	receiving	_	VERB	VBG	_	1	acl	_	_
3	warfarin	_	NOUN	NN	_	4	compound	_	_
4	therapy	_	NOUN	NN	_	2	dobj	_	_
5	should	_	VERB	MD	_	8	aux	_	_
6	be	_	VERB	VB	_	8	auxpass	_	_
7	carefully	_	ADV	RB	_	8	advmod	_	_
8	monitored	_	VERB	VBN	_	0	root	_	_
9	when	_	ADV	WRB	_	11	advmod	_	_
10	DRUG	_	NOUN	NN	_	11	nsubj	_	_
11	extended	_	VERB	VBD	_	14	nsubjpass	_	_
12	release	_	NOUN	NN	_	11	dobj	_	_
13	is	_	VERB	VBZ	_	14	auxpass	_	_
14	initiated	_	VERB	VBN	_	8	ccomp	_	_
15	or	_	CONJ	CC	_	14	cc	_	_
16	discontinued	_	VERB	VBN	_	14	conj	_	_

#	Venlafaxine Hydrochloride	5782
1	The	_	DET	DT	_	2	det	_	_
2	safety	_	NOUN	NN	_	21	nsubjpass	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	efficacy	_	NOUN	NN	_	2	conj	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	DRUG	_	NOUN	NN	_	7	compound	_	_
7	therapy	_	NOUN	NN	_	2	nmod	_	_
8	in	_	ADP	IN	_	9	case	_	_
9	combination	_	NOUN	NN	_	2	nmod	_	_
10	with	_	ADP	IN	_	13	case	_	_
11	weight	_	NOUN	NN	_	13	compound	_	_
12	loss	_	NOUN	NN	_	13	compound	_	_
13	agents	_	NOUN	NNS	_	9	nmod	_	_
14	,	_	.	,	_	13	punct	_	_
15	including	_	VERB	VBG	_	16	case	_	_
16	phentermine	_	NOUN	NN	_	13	nmod	_	_
17	,	_	.	,	_	2	punct	_	_
18	have	_	VERB	MD	_	21	aux	_	_
19	not	_	ADV	RB	_	21	neg	_	_
20	been	_	VERB	VBN	_	21	auxpass	_	_
21	established	_	VERB	VBN	_	0	root	_	_

#	Venlafaxine Hydrochloride	5783
1	Coadministration	_	NOUN	NN	_	12	nsubjpass	_	_
2	of	_	ADP	IN	_	5	case	_	_
3	DRUG	_	NOUN	NN	_	5	compound	_	_
4	extended	_	VERB	VBD	_	5	amod	_	_
5	release	_	NOUN	NN	_	1	nmod	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	weight	_	NOUN	NN	_	9	compound	_	_
8	loss	_	NOUN	NN	_	9	compound	_	_
9	agents	_	NOUN	NNS	_	5	conj	_	_
10	is	_	VERB	VBZ	_	12	auxpass	_	_
11	not	_	ADV	RB	_	12	neg	_	_
12	recommended	_	VERB	VBN	_	0	root	_	_

#	Venlafaxine Hydrochloride	5784
1	DRUG	_	NOUN	NN	_	3	compound	_	_
2	extended	_	VERB	VBD	_	3	amod	_	_
3	release	_	NOUN	NN	_	6	nsubjpass	_	_
4	is	_	VERB	VBZ	_	6	auxpass	_	_
5	not	_	ADV	RB	_	6	neg	_	_
6	indicated	_	VERB	VBN	_	0	root	_	_
7	for	_	ADP	IN	_	9	case	_	_
8	weight	_	NOUN	NN	_	9	compound	_	_
9	loss	_	NOUN	NN	_	6	nmod	_	_
10	alone	_	ADV	RB	_	11	advmod	_	_
11	or	_	CONJ	CC	_	9	advmod	_	_
12	in	_	ADP	IN	_	13	case	_	_
13	combination	_	NOUN	NN	_	11	conj	_	_
14	with	_	ADP	IN	_	16	case	_	_
15	other	_	ADJ	JJ	_	16	amod	_	_
16	products	_	NOUN	NNS	_	13	nmod	_	_

#	Venlafaxine Hydrochloride	5785
1	Figure	_	NOUN	NN	_	0	root	_	_
2	1	_	NUM	CD	_	1	nummod	_	_
3	:	_	.	:	_	1	punct	_	_
4	Effect	_	NOUN	NN	_	1	dep	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	interacting	_	VERB	VBG	_	7	amod	_	_
7	drugs	_	NOUN	NNS	_	4	nmod	_	_
8	on	_	ADP	IN	_	10	case	_	_
9	the	_	DET	DT	_	10	det	_	_
10	pharmacokinetics	_	NOUN	NNS	_	4	nmod	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	active	_	ADJ	JJ	_	17	amod	_	_
15	metabolite	_	NOUN	NN	_	17	compound	_	_
16	O	_	NOUN	NN	_	17	compound	_	_
17	desmethyl	_	NOUN	NN	_	12	conj	_	_
18	DRUG	_	NOUN	NN	_	19	compound	_	_
19	ODV	_	NOUN	NN	_	17	dep	_	_

#	Venlafaxine Hydrochloride	5786
1	Abbreviations	_	NOUN	NNS	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	ODV	_	NOUN	NN	_	10	nmod:poss	_	_
4	,	_	.	,	_	3	punct	_	_
5	O	_	NOUN	NN	_	8	compound	_	_
6	desmethyl	_	NOUN	NN	_	8	compound	_	_
7	DRUG	_	NOUN	NN	_	8	compound	_	_
8	AUC	_	NOUN	NN	_	3	conj	_	_
9	,	_	.	,	_	3	punct	_	_
10	area	_	NOUN	NN	_	1	dep	_	_
11	under	_	ADP	IN	_	14	case	_	_
12	the	_	DET	DT	_	14	det	_	_
13	curve	_	ADJ	JJ	_	14	amod	_	_
14	Cmax	_	NOUN	NN	_	10	nmod	_	_
15	,	_	.	,	_	14	punct	_	_
16	peak	_	ADJ	JJ	_	18	amod	_	_
17	plasma	_	NOUN	NN	_	18	compound	_	_
18	concentrations	_	NOUN	NNS	_	14	conj	_	_
19	EM's	_	NOUN	NNS	_	14	dep	_	_
20	,	_	.	,	_	19	punct	_	_
21	extensive	_	ADJ	JJ	_	23	amod	_	_
22	metabolizers	_	NOUN	NNS	_	23	compound	_	_
23	PM's	_	NOUN	NNS	_	19	conj	_	_
24	,	_	.	,	_	19	punct	_	_
25	poor	_	ADJ	JJ	_	26	amod	_	_
26	metabolizers	_	NOUN	NNS	_	19	appos	_	_
27	*	_	NUM	CD	_	30	neg	_	_
28	No	_	NOUN	NN	_	30	compound	_	_
29	dose	_	NOUN	NN	_	30	compound	_	_
30	adjustment	_	NOUN	NN	_	26	nmod	_	_
31	on	_	ADP	IN	_	33	case	_	_
32	co	_	PRT	TO	_	33	case	_	_
33	administration	_	NOUN	NN	_	26	nmod	_	_
34	with	_	ADP	IN	_	36	case	_	_
35	CYP2D6	_	NOUN	NN	_	36	compound	_	_
36	inhibitors	_	NOUN	NNS	_	33	nmod	_	_
37	Fig	_	NOUN	NN	_	36	dep	_	_
38	3	_	NUM	CD	_	37	nummod	_	_
39	and	_	CONJ	CC	_	37	cc	_	_
40	Metabolism	_	NOUN	NN	_	45	compound	_	_
41	Section	_	NOUN	NN	_	45	compound	_	_
42	12.3	_	NUM	CD	_	45	nummod	_	_
43	Figure	_	NOUN	NN	_	45	compound	_	_
44	1	_	NUM	CD	_	45	nummod	_	_
45	Figure	_	NOUN	NN	_	37	conj	_	_
46	2	_	NUM	CD	_	45	nummod	_	_
47	:	_	.	:	_	1	punct	_	_
48	Effect	_	NOUN	NN	_	1	dep	_	_
49	of	_	ADP	IN	_	50	case	_	_
50	DRUG	_	NOUN	NN	_	48	nmod	_	_
51	on	_	ADP	IN	_	53	case	_	_
52	the	_	DET	DT	_	53	det	_	_
53	pharmacokinetics	_	NOUN	NNS	_	48	nmod	_	_
54	interacting	_	VERB	VBG	_	53	acl	_	_
55	drugs	_	NOUN	NNS	_	54	dobj	_	_
56	and	_	CONJ	CC	_	55	cc	_	_
57	their	_	PRON	PRP$	_	59	nmod:poss	_	_
58	active	_	ADJ	JJ	_	59	amod	_	_
59	metabolites	_	NOUN	NNS	_	55	conj	_	_

#	Venlafaxine Hydrochloride	5787
1	Abbreviations	_	NOUN	NNS	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	AUC	_	NOUN	NN	_	25	nsubjpass	_	_
4	,	_	.	,	_	3	punct	_	_
5	area	_	NOUN	NN	_	3	conj	_	_
6	under	_	ADP	IN	_	9	case	_	_
7	the	_	DET	DT	_	9	det	_	_
8	curve	_	ADJ	JJ	_	9	amod	_	_
9	Cmax	_	NOUN	NN	_	5	nmod	_	_
10	,	_	.	,	_	3	punct	_	_
11	peak	_	ADJ	JJ	_	13	amod	_	_
12	plasma	_	NOUN	NN	_	13	compound	_	_
13	concentrations	_	NOUN	NNS	_	3	appos	_	_
14	OH	_	NOUN	NN	_	13	dep	_	_
15	,	_	.	,	_	3	punct	_	_
16	hydroxyl	_	NOUN	NN	_	18	compound	_	_
17	*	_	NUM	CD	_	18	nummod	_	_
18	Data	_	NOUN	NN	_	3	appos	_	_
19	for	_	ADP	IN	_	22	case	_	_
20	2	_	NUM	CD	_	22	nummod	_	_
21	OH	_	NOUN	NN	_	22	compound	_	_
22	desipramine	_	NOUN	NN	_	18	nmod	_	_
23	were	_	VERB	VBD	_	25	auxpass	_	_
24	not	_	ADV	RB	_	25	neg	_	_
25	plotted	_	VERB	VBN	_	1	dep	_	_
26	to	_	PRT	TO	_	27	mark	_	_
27	enhance	_	VERB	VB	_	25	xcomp	_	_
28	clarity	_	NOUN	NN	_	27	dobj	_	_
29	the	_	DET	DT	_	31	det	_	_
30	fold	_	NOUN	NN	_	31	compound	_	_
31	change	_	NOUN	NN	_	45	nsubj	_	_
32	and	_	CONJ	CC	_	31	cc	_	_
33	90%	_	ADJ	JJ	_	34	amod	_	_
34	CI	_	NOUN	NN	_	31	conj	_	_
35	for	_	ADP	IN	_	36	case	_	_
36	Cmax	_	NOUN	NN	_	31	nmod	_	_
37	and	_	CONJ	CC	_	36	cc	_	_
38	AUC	_	NOUN	NN	_	36	conj	_	_
39	of	_	ADP	IN	_	42	case	_	_
40	2	_	NUM	CD	_	42	nummod	_	_
41	OH	_	NOUN	NN	_	42	compound	_	_
42	desipramine	_	NOUN	NN	_	36	nmod	_	_
43	were	_	VERB	VBD	_	45	cop	_	_
44	6.6	_	NUM	CD	_	45	nummod	_	_
45	5.5	_	NUM	CD	_	27	punct	_	_
46	,	_	.	,	_	45	punct	_	_
47	7.9	_	NUM	CD	_	45	conj	_	_
48	and	_	CONJ	CC	_	45	cc	_	_
49	4.4	_	NUM	CD	_	45	conj	_	_
50	3.8	_	NUM	CD	_	49	dep	_	_
51	,	_	.	,	_	45	punct	_	_
52	5.0	_	NUM	CD	_	45	appos	_	_
53	,	_	.	,	_	45	punct	_	_
54	respectively	_	ADV	RB	_	45	neg	_	_

#	Venlafaxine Hydrochloride	5788
1	Note	_	ADV	RB	_	14	dep	_	_
2	:	_	.	:	_	1	punct	_	_
3	*	_	DET	EX	_	1	dep	_	_
4	:	_	.	:	_	1	punct	_	_
5	Administration	_	NOUN	NN	_	14	nsubj	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	in	_	ADP	IN	_	11	case	_	_
9	a	_	DET	DT	_	11	det	_	_
10	stable	_	ADJ	JJ	_	11	amod	_	_
11	regimen	_	NOUN	NN	_	5	nmod	_	_
12	did	_	VERB	VBD	_	14	aux	_	_
13	not	_	ADV	RB	_	14	neg	_	_
14	exaggerate	_	VERB	VB	_	0	root	_	_
15	the	_	DET	DT	_	19	det	_	_
16	psychomotor	_	NOUN	NN	_	19	amod	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	psychometric	_	ADJ	JJ	_	16	conj	_	_
19	effects	_	NOUN	NNS	_	14	dobj	_	_
20	induced	_	VERB	VBN	_	19	acl	_	_
21	by	_	ADP	IN	_	22	case	_	_
22	ethanol	_	NOUN	NN	_	20	nmod	_	_
23	in	_	ADP	IN	_	26	case	_	_
24	these	_	DET	DT	_	26	det	_	_
25	same	_	ADJ	JJ	_	26	amod	_	_
26	subjects	_	NOUN	NNS	_	20	nmod	_	_
27	when	_	ADV	WRB	_	31	advmod	_	_
28	they	_	PRON	PRP	_	31	nsubj	_	_
29	were	_	VERB	VBD	_	31	aux	_	_
30	not	_	ADV	RB	_	31	neg	_	_
31	receiving	_	VERB	VBG	_	14	advcl	_	_
32	DRUG	_	NOUN	NN	_	31	dobj	_	_

#	Venlafaxine Hydrochloride	5789
1	Figure	_	NOUN	NN	_	8	compound	_	_
2	2	_	NUM	CD	_	8	nummod	_	_
3	False	_	NOUN	NN	_	8	compound	_	_
4	positive	_	ADJ	JJ	_	8	amod	_	_
5	urine	_	ADJ	JJ	_	8	amod	_	_
6	immunoassay	_	ADJ	JJ	_	8	amod	_	_
7	screening	_	NOUN	NN	_	8	compound	_	_
8	tests	_	NOUN	NNS	_	16	nsubjpass	_	_
9	for	_	ADP	IN	_	10	case	_	_
10	phencyclidine	_	NOUN	NN	_	8	nmod	_	_
11	PCP	_	NOUN	NN	_	10	dep	_	_
12	and	_	CONJ	CC	_	10	cc	_	_
13	amphetamine	_	NOUN	NN	_	10	conj	_	_
14	have	_	VERB	VBP	_	16	aux	_	_
15	been	_	VERB	VBN	_	16	auxpass	_	_
16	reported	_	VERB	VBN	_	0	root	_	_
17	in	_	ADP	IN	_	18	case	_	_
18	patients	_	NOUN	NNS	_	16	nmod	_	_
19	taking	_	VERB	VBG	_	18	acl	_	_
20	DRUG	_	NOUN	NN	_	19	nmod	_	_

#	Venlafaxine Hydrochloride	5790
1	This	_	DET	DT	_	5	nsubj	_	_
2	is	_	VERB	VBZ	_	5	cop	_	_
3	due	_	ADJ	JJ	_	5	case	_	_
4	to	_	PRT	TO	_	3	mwe	_	_
5	lack	_	NOUN	NN	_	0	root	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	specificity	_	NOUN	NN	_	5	nmod	_	_
8	of	_	ADP	IN	_	11	case	_	_
9	the	_	DET	DT	_	11	det	_	_
10	screening	_	ADJ	JJ	_	11	amod	_	_
11	tests	_	NOUN	NNS	_	7	nmod	_	_

#	Venlafaxine Hydrochloride	5791
1	False	_	ADJ	JJ	_	4	amod	_	_
2	positive	_	ADJ	JJ	_	4	amod	_	_
3	test	_	NOUN	NN	_	4	compound	_	_
4	results	_	NOUN	NNS	_	7	nsubjpass	_	_
5	may	_	VERB	MD	_	7	aux	_	_
6	be	_	VERB	VB	_	7	auxpass	_	_
7	expected	_	VERB	VBN	_	0	root	_	_
8	for	_	ADP	IN	_	10	case	_	_
9	several	_	ADJ	JJ	_	10	amod	_	_
10	days	_	NOUN	NNS	_	7	nmod	_	_
11	following	_	VERB	VBG	_	12	case	_	_
12	discontinuation	_	NOUN	NN	_	7	nmod	_	_
13	of	_	ADP	IN	_	15	case	_	_
14	DRUG	_	NOUN	NN	_	15	compound	_	_
15	therapy	_	NOUN	NN	_	12	nmod	_	_

#	Venlafaxine Hydrochloride	5792
1	Confirmatory	_	ADJ	JJ	_	2	amod	_	_
2	tests	_	NOUN	NNS	_	0	root	_	_
3	,	_	.	,	_	2	punct	_	_
4	such	_	ADJ	JJ	_	7	case	_	_
5	as	_	ADP	IN	_	4	mwe	_	_
6	gas	_	NOUN	NN	_	7	compound	_	_
7	chromatography	_	NOUN	NN	_	2	nmod	_	_
8	/	_	.	:	_	2	punct	_	_
9	mass	_	NOUN	NN	_	10	compound	_	_
10	spectrometry	_	NOUN	NN	_	13	nsubj	_	_
11	,	_	.	,	_	10	punct	_	_
12	will	_	VERB	MD	_	13	aux	_	_
13	distinguish	_	VERB	VB	_	2	dep	_	_
14	DRUG	_	NOUN	NN	_	13	dobj	_	_
15	from	_	ADP	IN	_	16	case	_	_
16	PCP	_	NOUN	NN	_	14	nmod	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	amphetamine	_	NOUN	NN	_	16	conj	_	_

#	Venlafaxine Hydrochloride	5793
1	The	_	DET	DT	_	3	det	_	_
2	exact	_	ADJ	JJ	_	3	amod	_	_
3	mechanism	_	NOUN	NN	_	13	nsubj	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	the	_	DET	DT	_	7	det	_	_
6	antidepressant	_	ADJ	JJ	_	7	amod	_	_
7	action	_	NOUN	NN	_	3	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	in	_	ADP	IN	_	11	case	_	_
11	humans	_	NOUN	NNS	_	7	nmod	_	_
12	is	_	VERB	VBZ	_	13	cop	_	_
13	unknown	_	ADJ	JJ	_	0	root	_	_
14	,	_	.	,	_	13	punct	_	_
15	but	_	CONJ	CC	_	13	cc	_	_
16	is	_	VERB	VBZ	_	17	auxpass	_	_
17	thought	_	VERB	VBN	_	13	conj	_	_
18	to	_	PRT	TO	_	20	mark	_	_
19	be	_	VERB	VB	_	20	cop	_	_
20	related	_	ADJ	JJ	_	17	xcomp	_	_
21	to	_	PRT	TO	_	23	case	_	_
22	the	_	DET	DT	_	23	det	_	_
23	potentiation	_	NOUN	NN	_	20	nmod	_	_
24	of	_	ADP	IN	_	25	case	_	_
25	serotonin	_	NOUN	NN	_	23	nmod	_	_
26	and	_	CONJ	CC	_	25	cc	_	_
27	norepinephrine	_	NOUN	NN	_	25	conj	_	_
28	in	_	ADP	IN	_	32	case	_	_
29	the	_	DET	DT	_	32	det	_	_
30	central	_	ADJ	JJ	_	32	amod	_	_
31	nervous	_	ADJ	JJ	_	32	amod	_	_
32	system	_	NOUN	NN	_	23	nmod	_	_
33	,	_	.	,	_	13	punct	_	_
34	through	_	ADP	IN	_	35	case	_	_
35	inhibition	_	NOUN	NN	_	13	nmod	_	_
36	of	_	ADP	IN	_	38	case	_	_
37	their	_	PRON	PRP$	_	38	nmod:poss	_	_
38	reuptake	_	NOUN	NN	_	35	nmod	_	_

#	Venlafaxine Hydrochloride	5794
1	Non	_	CONJ	CC	_	3	amod	_	_
2	clinical	_	ADJ	JJ	_	3	amod	_	_
3	studies	_	NOUN	NNS	_	5	nsubj	_	_
4	have	_	VERB	VBP	_	5	aux	_	_
5	demonstrated	_	VERB	VBN	_	0	root	_	_
6	that	_	ADP	IN	_	16	mark	_	_
7	DRUG	_	NOUN	NN	_	16	nsubj	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	its	_	PRON	PRP$	_	11	nmod:poss	_	_
10	active	_	ADJ	JJ	_	11	amod	_	_
11	metabolite	_	NOUN	NN	_	7	conj	_	_
12	,	_	.	,	_	11	punct	_	_
13	ODV	_	NOUN	NN	_	11	appos	_	_
14	,	_	.	,	_	11	punct	_	_
15	are	_	VERB	VBP	_	16	cop	_	_
16	potent	_	ADJ	JJ	_	5	ccomp	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	selective	_	ADJ	JJ	_	16	conj	_	_
19	inhibitors	_	NOUN	NNS	_	16	dep	_	_
20	of	_	ADP	IN	_	22	case	_	_
21	neuronal	_	ADJ	JJ	_	22	amod	_	_
22	serotonin	_	NOUN	NN	_	16	nmod	_	_
23	and	_	CONJ	CC	_	22	cc	_	_
24	norepinephrine	_	NOUN	NN	_	25	compound	_	_
25	reuptake	_	NOUN	NN	_	22	conj	_	_
26	and	_	CONJ	CC	_	22	cc	_	_
27	weak	_	ADJ	JJ	_	28	amod	_	_
28	inhibitors	_	NOUN	NNS	_	22	conj	_	_
29	of	_	ADP	IN	_	31	case	_	_
30	dopamine	_	NOUN	NN	_	31	compound	_	_
31	reuptake	_	NOUN	NN	_	28	nmod	_	_

#	Venlafaxine Hydrochloride	5795
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	ODV	_	NOUN	NN	_	1	conj	_	_
4	have	_	VERB	VBP	_	0	root	_	_
5	no	_	DET	DT	_	7	neg	_	_
6	significant	_	ADJ	JJ	_	7	amod	_	_
7	affinity	_	NOUN	NN	_	4	dobj	_	_
8	for	_	ADP	IN	_	18	case	_	_
9	muscarinic	_	ADJ	JJ	_	18	amod	_	_
10	cholinergic	_	ADJ	JJ	_	18	amod	_	_
11	,	_	.	,	_	10	punct	_	_
12	H1	_	NOUN	NN	_	13	nmod:npmod	_	_
13	histaminergic	_	ADJ	JJ	_	10	conj	_	_
14	,	_	.	,	_	10	punct	_	_
15	or	_	CONJ	CC	_	10	cc	_	_
16	A1	_	NOUN	NN	_	10	conj	_	_
17	adrenergic	_	ADJ	JJ	_	18	amod	_	_
18	receptors	_	NOUN	NNS	_	7	nmod	_	_
19	in	_	X	FW	_	20	compound	_	_
20	vitro	_	X	FW	_	4	advmod	_	_

#	Venlafaxine Hydrochloride	5796
1	Pharmacologic	_	ADJ	JJ	_	2	amod	_	_
2	activity	_	NOUN	NN	_	7	nsubjpass	_	_
3	at	_	ADP	IN	_	5	case	_	_
4	these	_	DET	DT	_	5	det	_	_
5	receptors	_	NOUN	NNS	_	2	nmod	_	_
6	is	_	VERB	VBZ	_	7	auxpass	_	_
7	hypothesized	_	VERB	VBN	_	0	root	_	_
8	to	_	PRT	TO	_	10	mark	_	_
9	be	_	VERB	VB	_	10	auxpass	_	_
10	associated	_	VERB	VBN	_	7	xcomp	_	_
11	with	_	ADP	IN	_	14	case	_	_
12	the	_	DET	DT	_	14	det	_	_
13	various	_	ADJ	JJ	_	14	amod	_	_
14	anticholinergic	_	ADJ	JJ	_	10	nmod	_	_
15	,	_	.	,	_	14	punct	_	_
16	sedative	_	ADJ	JJ	_	14	conj	_	_
17	,	_	.	,	_	14	punct	_	_
18	and	_	CONJ	CC	_	14	cc	_	_
19	cardiovascular	_	ADJ	JJ	_	14	conj	_	_
20	effects	_	NOUN	NNS	_	14	dep	_	_
21	seen	_	VERB	VBN	_	14	acl	_	_
22	with	_	ADP	IN	_	25	case	_	_
23	other	_	ADJ	JJ	_	25	amod	_	_
24	psychotropic	_	ADJ	JJ	_	25	amod	_	_
25	drugs	_	NOUN	NNS	_	21	nmod	_	_

#	Venlafaxine Hydrochloride	5797
1	DRUG	_	NOUN	NN	_	6	nsubj	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	ODV	_	NOUN	NN	_	1	conj	_	_
4	do	_	VERB	MD	_	6	aux	_	_
5	not	_	ADV	RB	_	6	neg	_	_
6	possess	_	VERB	VB	_	0	root	_	_
7	monoamine	_	NOUN	NN	_	11	compound	_	_
8	oxidase	_	NOUN	NN	_	11	compound	_	_
9	MAO	_	NOUN	NN	_	11	compound	_	_
10	inhibitory	_	ADJ	JJ	_	11	amod	_	_
11	activity	_	NOUN	NN	_	6	dobj	_	_

#	Venlafaxine Hydrochloride	5798
1	Cardiac	_	ADJ	JJ	_	2	amod	_	_
2	Electrophysiology	_	NOUN	NN	_	12	nsubjpass	_	_
3	The	_	DET	DT	_	4	det	_	_
4	effect	_	NOUN	NN	_	2	dep	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	on	_	ADP	IN	_	10	case	_	_
8	the	_	DET	DT	_	10	det	_	_
9	QT	_	NOUN	NN	_	10	compound	_	_
10	interval	_	NOUN	NN	_	4	nmod	_	_
11	was	_	VERB	VBD	_	12	auxpass	_	_
12	evaluated	_	VERB	VBN	_	0	root	_	_
13	in	_	ADP	IN	_	18	case	_	_
14	a	_	DET	DT	_	18	det	_	_
15	randomized	_	ADJ	JJ	_	18	amod	_	_
16	,	_	.	,	_	15	punct	_	_
17	double	_	ADJ	JJ	_	15	dep	_	_
18	blind	_	NOUN	NN	_	12	nmod	_	_
19	,	_	.	,	_	18	punct	_	_
20	placebo	_	NOUN	NN	_	18	conj	_	_
21	and	_	CONJ	CC	_	18	cc	_	_
22	positive	_	ADJ	JJ	_	25	amod	_	_
23	controlled	_	VERB	VBN	_	25	amod	_	_
24	three	_	NUM	CD	_	25	nummod	_	_
25	period	_	NOUN	NN	_	18	conj	_	_
26	crossover	_	ADJ	JJR	_	25	amod	_	_
27	thorough	_	ADP	IN	_	29	case	_	_
28	QT	_	NOUN	NN	_	29	compound	_	_
29	study	_	NOUN	NN	_	12	nmod	_	_
30	in	_	ADP	IN	_	34	case	_	_
31	54	_	NUM	CD	_	34	nummod	_	_
32	healthy	_	ADJ	JJ	_	34	amod	_	_
33	adult	_	ADJ	JJ	_	34	amod	_	_
34	subjects	_	NOUN	NNS	_	29	nmod	_	_

#	Venlafaxine Hydrochloride	5799
1	No	_	DET	DT	_	5	neg	_	_
2	significant	_	ADJ	JJ	_	5	amod	_	_
3	QT	_	NOUN	NN	_	5	compound	_	_
4	prolongation	_	NOUN	NN	_	5	compound	_	_
5	effect	_	NOUN	NN	_	11	nsubjpass	_	_
6	of	_	ADP	IN	_	9	case	_	_
7	DRUG	_	NOUN	NN	_	9	compound	_	_
8	450	_	NUM	CD	_	9	nummod	_	_
9	mg	_	NOUN	NN	_	5	nmod	_	_
10	was	_	VERB	VBD	_	11	auxpass	_	_
11	detected	_	VERB	VBN	_	0	root	_	_

#	Venlafaxine Hydrochloride	5800
1	Steady	_	ADJ	JJ	_	3	amod	_	_
2	state	_	NOUN	NN	_	3	compound	_	_
3	concentrations	_	NOUN	NNS	_	11	nsubjpass	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	ODV	_	NOUN	NN	_	5	conj	_	_
8	in	_	ADP	IN	_	9	case	_	_
9	plasma	_	NOUN	NN	_	3	nmod	_	_
10	are	_	VERB	VBP	_	11	auxpass	_	_
11	attained	_	VERB	VBN	_	0	root	_	_
12	within	_	ADP	IN	_	14	case	_	_
13	3	_	NUM	CD	_	14	nummod	_	_
14	days	_	NOUN	NNS	_	11	nmod	_	_
15	of	_	ADP	IN	_	19	case	_	_
16	oral	_	ADJ	JJ	_	19	amod	_	_
17	multiple	_	ADJ	JJ	_	19	amod	_	_
18	dose	_	NOUN	NN	_	19	compound	_	_
19	therapy	_	NOUN	NN	_	14	nmod	_	_

#	Venlafaxine Hydrochloride	5801
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	ODV	_	NOUN	NN	_	1	conj	_	_
4	exhibited	_	VERB	VBD	_	0	root	_	_
5	linear	_	ADJ	JJ	_	6	amod	_	_
6	kinetics	_	NOUN	NNS	_	4	dobj	_	_
7	over	_	ADP	IN	_	10	case	_	_
8	the	_	DET	DT	_	10	det	_	_
9	dose	_	NOUN	NN	_	10	compound	_	_
10	range	_	NOUN	NN	_	4	nmod	_	_
11	of	_	ADP	IN	_	15	case	_	_
12	75	_	NUM	CD	_	14	compound	_	_
13	to	_	PRT	TO	_	14	dep	_	_
14	450	_	NUM	CD	_	15	nummod	_	_
15	mg	_	NOUN	NN	_	10	nmod	_	_
16	per	_	ADP	IN	_	17	case	_	_
17	day	_	NOUN	NN	_	15	nmod	_	_

#	Venlafaxine Hydrochloride	5802
1	Mean*SD	_	NOUN	NN	_	5	compound	_	_
2	steady	_	ADJ	JJ	_	5	amod	_	_
3	state	_	NOUN	NN	_	5	compound	_	_
4	plasma	_	NOUN	NN	_	5	compound	_	_
5	clearance	_	NOUN	NN	_	14	nsubj	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	ODV	_	NOUN	NN	_	7	conj	_	_
10	is	_	VERB	VBZ	_	14	cop	_	_
11	1.3*0.6	_	NUM	CD	_	14	nummod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	0.4*0.2	_	NUM	CD	_	11	conj	_	_
14	L	_	NOUN	NN	_	0	root	_	_
15	/	_	.	:	_	14	punct	_	_
16	h	_	NOUN	NN	_	18	compound	_	_
17	/	_	.	:	_	18	punct	_	_
18	kg	_	NOUN	NN	_	14	dep	_	_
19	,	_	.	,	_	14	punct	_	_
20	respectively	_	ADV	RB	_	21	advmod	_	_
21	apparent	_	ADJ	JJ	_	24	amod	_	_
22	elimination	_	NOUN	NN	_	24	compound	_	_
23	half	_	NOUN	NN	_	24	compound	_	_
24	life	_	NOUN	NN	_	29	nsubj	_	_
25	is	_	VERB	VBZ	_	29	cop	_	_
26	5*2	_	NUM	CD	_	29	nummod	_	_
27	and	_	CONJ	CC	_	26	cc	_	_
28	11*2	_	NUM	CD	_	26	conj	_	_
29	hours	_	NOUN	NNS	_	14	dep	_	_
30	,	_	.	,	_	14	punct	_	_
31	respectively	_	ADV	RB	_	32	advmod	_	_
32	and	_	CONJ	CC	_	14	advmod	_	_
33	apparent	_	ADJ	JJ	_	36	amod	_	_
34	steady	_	ADJ	JJ	_	36	amod	_	_
35	state	_	NOUN	NN	_	36	compound	_	_
36	volume	_	NOUN	NN	_	43	nsubj	_	_
37	of	_	ADP	IN	_	38	case	_	_
38	distribution	_	NOUN	NN	_	36	nmod	_	_
39	is	_	VERB	VBZ	_	43	cop	_	_
40	7.5*3.7	_	NUM	CD	_	43	nummod	_	_
41	and	_	CONJ	CC	_	40	cc	_	_
42	5.7*1.8	_	NUM	CD	_	40	conj	_	_
43	L	_	NOUN	NN	_	32	conj	_	_
44	/	_	.	:	_	43	punct	_	_
45	kg	_	NOUN	NN	_	43	dep	_	_
46	,	_	.	,	_	14	punct	_	_
47	respectively	_	ADV	RB	_	14	advmod	_	_

#	Venlafaxine Hydrochloride	5803
1	DRUG	_	NOUN	NN	_	6	nsubjpass	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	ODV	_	NOUN	NN	_	1	conj	_	_
4	are	_	VERB	VBP	_	6	auxpass	_	_
5	minimally	_	ADV	RB	_	6	advmod	_	_
6	bound	_	VERB	VBN	_	0	root	_	_
7	at	_	ADP	IN	_	9	case	_	_
8	therapeutic	_	ADJ	JJ	_	9	amod	_	_
9	concentrations	_	NOUN	NNS	_	6	nmod	_	_
10	to	_	PRT	TO	_	12	case	_	_
11	plasma	_	NOUN	NN	_	12	compound	_	_
12	proteins	_	NOUN	NNS	_	9	nmod	_	_
13	27%	_	NOUN	NN	_	12	dep	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	30%	_	NOUN	NN	_	13	conj	_	_
16	,	_	.	,	_	6	punct	_	_
17	respectively	_	ADV	RB	_	6	advmod	_	_

#	Venlafaxine Hydrochloride	5804
1	Absorption	_	NOUN	NN	_	7	nsubjpass	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	Distribution	_	NOUN	NN	_	4	compound	_	_
4	DRUG	_	NOUN	NN	_	1	conj	_	_
5	is	_	VERB	VBZ	_	7	auxpass	_	_
6	well	_	ADV	RB	_	7	advmod	_	_
7	absorbed	_	VERB	VBN	_	0	root	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	extensively	_	ADV	RB	_	10	advmod	_	_
10	metabolized	_	VERB	VBN	_	7	conj	_	_
11	in	_	ADP	IN	_	13	case	_	_
12	the	_	DET	DT	_	13	det	_	_
13	liver	_	NOUN	NN	_	10	nmod	_	_

#	Venlafaxine Hydrochloride	5805
1	On	_	ADP	IN	_	3	case	_	_
2	the	_	DET	DT	_	3	det	_	_
3	basis	_	NOUN	NN	_	20	nmod	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	mass	_	NOUN	NN	_	7	compound	_	_
6	balance	_	NOUN	NN	_	7	compound	_	_
7	studies	_	NOUN	NNS	_	3	nmod	_	_
8	,	_	.	,	_	20	punct	_	_
9	at	_	ADP	IN	_	11	case	_	_
10	least	_	ADV	RB	_	11	advmod	_	_
11	92%	_	NOUN	NN	_	20	nsubjpass	_	_
12	of	_	ADP	IN	_	16	case	_	_
13	a	_	DET	DT	_	16	det	_	_
14	single	_	ADJ	JJ	_	16	amod	_	_
15	oral	_	ADJ	JJ	_	16	amod	_	_
16	dose	_	NOUN	NN	_	11	nmod	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	DRUG	_	NOUN	NN	_	16	nmod	_	_
19	is	_	VERB	VBZ	_	20	auxpass	_	_
20	absorbed	_	VERB	VBN	_	0	root	_	_

#	Venlafaxine Hydrochloride	5806
1	The	_	DET	DT	_	3	det	_	_
2	absolute	_	ADJ	JJ	_	3	amod	_	_
3	bioavailability	_	NOUN	NN	_	8	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	is	_	VERB	VBZ	_	8	auxpass	_	_
7	approximately	_	ADV	RB	_	8	advmod	_	_
8	45%	_	ADJ	JJ	_	0	root	_	_

#	Venlafaxine Hydrochloride	5807
1	Administration	_	NOUN	NN	_	4	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	extended	_	VERB	VBD	_	0	root	_	_
5	release	_	NOUN	NN	_	7	compound	_	_
6	150	_	NUM	CD	_	7	nummod	_	_
7	mg	_	NOUN	NN	_	4	dobj	_	_
8	once	_	ADV	RB	_	11	advmod	_	_
9	daily	_	ADV	RB	_	11	advmod	_	_
10	generally	_	ADV	RB	_	11	advmod	_	_
11	resulted	_	VERB	VBD	_	4	advcl	_	_
12	in	_	ADP	IN	_	14	case	_	_
13	lower	_	ADJ	JJ	_	14	amod	_	_
14	Cmax	_	NOUN	NN	_	11	nmod	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	later	_	ADJ	JJ	_	18	amod	_	_
17	Tmax	_	NOUN	NN	_	18	compound	_	_
18	values	_	NOUN	NNS	_	14	conj	_	_
19	than	_	ADP	IN	_	23	case	_	_
20	for	_	ADP	IN	_	23	case	_	_
21	DRUG	_	NOUN	NN	_	23	compound	_	_
22	immediate	_	ADJ	JJ	_	23	amod	_	_
23	release	_	NOUN	NN	_	11	nmod	_	_
24	administered	_	VERB	VBN	_	23	acl	_	_
25	twice	_	ADV	RB	_	26	advmod	_	_
26	daily	_	ADV	RB	_	27	advmod	_	_
27	Table	_	ADJ	JJ	_	24	dep	_	_
28	16	_	NUM	CD	_	27	neg	_	_

#	Venlafaxine Hydrochloride	5808
1	When	_	ADV	WRB	_	8	advmod	_	_
2	equal	_	ADJ	JJ	_	4	amod	_	_
3	daily	_	ADJ	JJ	_	4	amod	_	_
4	doses	_	NOUN	NNS	_	8	nsubjpass	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	were	_	VERB	VBD	_	8	auxpass	_	_
8	administered	_	VERB	VBN	_	29	advcl	_	_
9	as	_	ADP	IN	_	14	case	_	_
10	either	_	CONJ	CC	_	14	cc:preconj	_	_
11	an	_	DET	DT	_	14	det	_	_
12	immediate	_	ADJ	JJ	_	14	amod	_	_
13	release	_	NOUN	NN	_	14	compound	_	_
14	tablet	_	NOUN	NN	_	8	nmod	_	_
15	or	_	CONJ	CC	_	14	cc	_	_
16	the	_	DET	DT	_	19	det	_	_
17	extended	_	VERB	VBN	_	19	amod	_	_
18	release	_	NOUN	NN	_	19	compound	_	_
19	capsule	_	NOUN	NN	_	14	conj	_	_
20	,	_	.	,	_	29	punct	_	_
21	the	_	DET	DT	_	22	det	_	_
22	exposure	_	NOUN	NN	_	29	nsubj	_	_
23	to	_	PRT	TO	_	25	case	_	_
24	both	_	CONJ	CC	_	25	cc:preconj	_	_
25	DRUG	_	NOUN	NN	_	22	nmod	_	_
26	and	_	CONJ	CC	_	25	cc	_	_
27	ODV	_	NOUN	NN	_	25	conj	_	_
28	was	_	VERB	VBD	_	29	cop	_	_
29	similar	_	ADJ	JJ	_	0	root	_	_
30	for	_	ADP	IN	_	33	case	_	_
31	the	_	DET	DT	_	33	det	_	_
32	two	_	NUM	CD	_	33	nummod	_	_
33	treatments	_	NOUN	NNS	_	29	nmod	_	_
34	,	_	.	,	_	29	punct	_	_
35	and	_	CONJ	CC	_	29	cc	_	_
36	the	_	DET	DT	_	37	det	_	_
37	fluctuation	_	NOUN	NN	_	43	nsubj	_	_
38	in	_	ADP	IN	_	40	case	_	_
39	plasma	_	NOUN	NN	_	40	compound	_	_
40	concentrations	_	NOUN	NNS	_	37	nmod	_	_
41	was	_	VERB	VBD	_	43	cop	_	_
42	slightly	_	ADV	RB	_	43	advmod	_	_
43	lower	_	ADJ	JJ	_	29	conj	_	_
44	with	_	ADP	IN	_	49	case	_	_
45	the	_	DET	DT	_	49	det	_	_
46	DRUG	_	NOUN	NN	_	49	compound	_	_
47	extended	_	ADJ	JJ	_	49	amod	_	_
48	release	_	NOUN	NN	_	49	compound	_	_
49	capsule	_	NOUN	NN	_	43	nmod	_	_

#	Venlafaxine Hydrochloride	5809
1	Therefore	_	ADV	RB	_	4	advmod	_	_
2	,	_	.	,	_	4	punct	_	_
3	DRUG	_	NOUN	NN	_	4	nsubj	_	_
4	extended	_	VERB	VBD	_	0	root	_	_
5	release	_	NOUN	NN	_	4	dobj	_	_
6	provides	_	VERB	VBZ	_	4	xcomp	_	_
7	a	_	DET	DT	_	9	det	_	_
8	slower	_	ADJ	JJ	_	9	amod	_	_
9	rate	_	NOUN	NN	_	6	dobj	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	absorption	_	NOUN	NN	_	9	nmod	_	_
12	,	_	.	,	_	4	punct	_	_
13	but	_	CONJ	CC	_	4	cc	_	_
14	the	_	DET	DT	_	16	det	_	_
15	same	_	ADJ	JJ	_	16	amod	_	_
16	extent	_	NOUN	NN	_	19	nsubj	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	absorption	_	NOUN	NN	_	16	nmod	_	_
19	compared	_	VERB	VBN	_	4	conj	_	_
20	with	_	ADP	IN	_	24	case	_	_
21	the	_	DET	DT	_	24	det	_	_
22	immediate	_	ADJ	JJ	_	24	amod	_	_
23	release	_	NOUN	NN	_	24	compound	_	_
24	tablet	_	NOUN	NN	_	19	nmod	_	_

#	Venlafaxine Hydrochloride	5810
1	Table	_	ADJ	JJ	_	0	root	_	_
2	16	_	NUM	CD	_	1	dep	_	_
3	:	_	.	:	_	1	punct	_	_
4	Comparison	_	NOUN	NN	_	1	dep	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	Cmax	_	NOUN	NN	_	4	nmod	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	Tmax	_	NOUN	NN	_	6	conj	_	_
9	Values	_	NOUN	NNS	_	6	dep	_	_
10	for	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	4	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	ODV	_	NOUN	NN	_	11	conj	_	_
14	Following	_	ADP	IN	_	16	case	_	_
15	Oral	_	ADJ	JJ	_	16	amod	_	_
16	Administration	_	NOUN	NN	_	4	nmod	_	_
17	of	_	ADP	IN	_	20	case	_	_
18	DRUG	_	NOUN	NN	_	20	compound	_	_
19	Extended	_	ADJ	JJ	_	20	amod	_	_
20	Release	_	NOUN	NN	_	16	nmod	_	_
21	and	_	CONJ	CC	_	20	cc	_	_
22	DRUG	_	NOUN	NN	_	28	compound	_	_
23	Immediate	_	ADJ	JJ	_	28	amod	_	_
24	Release	_	NOUN	NN	_	28	compound	_	_
25	DRUG	_	NOUN	NN	_	28	compound	_	_
26	ODV	_	NOUN	NN	_	28	compound	_	_
27	Cmax	_	NOUN	NN	_	28	compound	_	_
28	ng	_	NOUN	NN	_	20	conj	_	_
29	/	_	.	:	_	4	punct	_	_
30	mL	_	NOUN	NN	_	34	compound	_	_
31	Tmax	_	NOUN	NN	_	34	compound	_	_
32	h	_	NOUN	NN	_	34	compound	_	_
33	Cmax	_	NOUN	NN	_	34	compound	_	_
34	ng	_	NOUN	NN	_	4	dep	_	_
35	/	_	.	:	_	4	punct	_	_
36	mL	_	NOUN	NN	_	43	compound	_	_
37	Tmax	_	NOUN	NN	_	43	compound	_	_
38	h	_	NOUN	NN	_	43	compound	_	_
39	DRUG	_	NOUN	NN	_	43	compound	_	_
40	Extended	_	ADJ	JJ	_	43	amod	_	_
41	Release	_	NOUN	NN	_	43	compound	_	_
42	150	_	NUM	CD	_	43	nummod	_	_
43	mg	_	NOUN	NN	_	64	nsubj	_	_
44	once	_	ADV	RB	_	46	advmod	_	_
45	daily	_	ADV	RB	_	46	advmod	_	_
46	150	_	NUM	CD	_	54	nummod	_	_
47	5.5	_	NUM	CD	_	54	nummod	_	_
48	260	_	NUM	CD	_	54	nummod	_	_
49	9	_	NUM	CD	_	54	nummod	_	_
50	DRUG	_	NOUN	NN	_	54	compound	_	_
51	Immediate	_	ADJ	JJ	_	54	amod	_	_
52	Release	_	NOUN	NN	_	54	compound	_	_
53	75	_	NUM	CD	_	54	nummod	_	_
54	mg	_	NOUN	NN	_	43	dep	_	_
55	twice	_	ADV	RB	_	64	advmod	_	_
56	daily	_	ADV	RB	_	64	advmod	_	_
57	225	_	NUM	CD	_	61	nummod	_	_
58	2	_	NUM	CD	_	61	nummod	_	_
59	290	_	NUM	CD	_	61	nummod	_	_
60	3	_	NUM	CD	_	61	nummod	_	_
61	Food	_	NOUN	NN	_	64	nsubj	_	_
62	did	_	VERB	VBD	_	64	aux	_	_
63	not	_	ADV	RB	_	64	neg	_	_
64	affect	_	VERB	VB	_	4	dep	_	_
65	the	_	DET	DT	_	66	det	_	_
66	bioavailability	_	NOUN	NN	_	64	dobj	_	_
67	of	_	ADP	IN	_	68	case	_	_
68	DRUG	_	NOUN	NN	_	66	nmod	_	_
69	or	_	CONJ	CC	_	68	cc	_	_
70	its	_	PRON	PRP$	_	72	nmod:poss	_	_
71	active	_	ADJ	JJ	_	72	amod	_	_
72	metabolite	_	NOUN	NN	_	68	conj	_	_
73	,	_	.	,	_	68	punct	_	_
74	ODV	_	NOUN	NN	_	68	appos	_	_

#	Venlafaxine Hydrochloride	5811
1	Time	_	NOUN	NN	_	9	nsubj	_	_
2	of	_	ADP	IN	_	4	case	_	_
3	administration	_	NOUN	NN	_	4	compound	_	_
4	AM	_	NOUN	NN	_	1	nmod	_	_
5	versus	_	CONJ	CC	_	4	cc	_	_
6	PM	_	NOUN	NN	_	4	conj	_	_
7	did	_	VERB	VBD	_	9	aux	_	_
8	not	_	ADV	RB	_	9	neg	_	_
9	affect	_	VERB	VB	_	0	root	_	_
10	the	_	DET	DT	_	11	det	_	_
11	pharmacokinetics	_	NOUN	NNS	_	9	dobj	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	DRUG	_	NOUN	NN	_	11	nmod	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	ODV	_	NOUN	NN	_	13	conj	_	_
16	from	_	ADP	IN	_	23	case	_	_
17	the	_	DET	DT	_	23	det	_	_
18	75	_	NUM	CD	_	23	nummod	_	_
19	mg	_	NOUN	NN	_	23	compound	_	_
20	DRUG	_	NOUN	NN	_	23	compound	_	_
21	extended	_	ADJ	JJ	_	23	amod	_	_
22	release	_	NOUN	NN	_	23	compound	_	_
23	capsule	_	NOUN	NN	_	11	nmod	_	_

#	Venlafaxine Hydrochloride	5812
1	DRUG	_	NOUN	NN	_	5	nsubjpass	_	_
2	is	_	VERB	VBZ	_	5	auxpass	_	_
3	not	_	ADV	RB	_	5	neg	_	_
4	highly	_	ADV	RB	_	5	advmod	_	_
5	bound	_	VERB	VBN	_	0	root	_	_
6	to	_	PRT	TO	_	8	case	_	_
7	plasma	_	NOUN	NN	_	8	compound	_	_
8	proteins	_	NOUN	NNS	_	5	nmod	_	_
9	therefore	_	ADV	RB	_	5	advmod	_	_
10	,	_	.	,	_	5	punct	_	_
11	administration	_	NOUN	NN	_	14	nsubj	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	DRUG	_	NOUN	NN	_	11	nmod	_	_
14	extended	_	VERB	VBD	_	5	parataxis	_	_
15	release	_	NOUN	NN	_	14	dobj	_	_
16	to	_	PRT	TO	_	18	case	_	_
17	a	_	DET	DT	_	18	det	_	_
18	patient	_	NOUN	NN	_	15	nmod	_	_
19	taking	_	VERB	VBG	_	18	acl	_	_
20	another	_	DET	DT	_	21	det	_	_
21	drug	_	NOUN	NN	_	19	dobj	_	_
22	that	_	DET	WDT	_	26	nsubjpass	_	_
23	is	_	VERB	VBZ	_	26	auxpass	_	_
24	highly	_	ADV	RB	_	25	advmod	_	_
25	protein	_	NOUN	NN	_	26	nsubjpass	_	_
26	bound	_	VERB	VBN	_	21	acl:relcl	_	_
27	should	_	VERB	MD	_	29	aux	_	_
28	not	_	ADV	RB	_	29	neg	_	_
29	cause	_	VERB	VB	_	14	parataxis	_	_
30	increased	_	VERB	VBN	_	32	amod	_	_
31	free	_	ADJ	JJ	_	32	amod	_	_
32	concentrations	_	NOUN	NNS	_	29	dobj	_	_
33	of	_	ADP	IN	_	36	case	_	_
34	the	_	DET	DT	_	36	det	_	_
35	other	_	ADJ	JJ	_	36	amod	_	_
36	drug	_	NOUN	NN	_	32	nmod	_	_

#	Venlafaxine Hydrochloride	5813
1	Metabolism	_	NOUN	NN	_	8	nsubj	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	Elimination	_	NOUN	NN	_	1	conj	_	_
4	Following	_	ADP	IN	_	5	case	_	_
5	absorption	_	NOUN	NN	_	1	nmod	_	_
6	,	_	.	,	_	1	punct	_	_
7	DRUG	_	NOUN	NN	_	1	appos	_	_
8	undergoes	_	VERB	VBZ	_	0	root	_	_
9	extensive	_	ADJ	JJ	_	11	amod	_	_
10	presystemic	_	ADJ	JJ	_	11	amod	_	_
11	metabolism	_	NOUN	NN	_	8	dobj	_	_
12	in	_	ADP	IN	_	14	case	_	_
13	the	_	DET	DT	_	14	det	_	_
14	liver	_	NOUN	NN	_	11	nmod	_	_
15	,	_	.	,	_	11	punct	_	_
16	primarily	_	ADV	RB	_	18	advmod	_	_
17	to	_	PRT	TO	_	18	case	_	_
18	ODV	_	NOUN	NN	_	11	nmod	_	_
19	,	_	.	,	_	11	punct	_	_
20	but	_	CONJ	CC	_	11	cc	_	_
21	also	_	ADV	RB	_	25	advmod	_	_
22	to	_	PRT	TO	_	25	case	_	_
23	N	_	NOUN	NN	_	25	compound	_	_
24	desmethyl	_	NOUN	NN	_	25	compound	_	_
25	DRUG	_	NOUN	NN	_	11	conj	_	_
26	,	_	.	,	_	25	punct	_	_
27	N,O	_	NOUN	NN	_	29	compound	_	_
28	didesmethyl	_	NOUN	NN	_	29	compound	_	_
29	DRUG	_	NOUN	NN	_	25	conj	_	_
30	,	_	.	,	_	25	punct	_	_
31	and	_	CONJ	CC	_	25	cc	_	_
32	other	_	ADJ	JJ	_	34	amod	_	_
33	minor	_	ADJ	JJ	_	34	amod	_	_
34	metabolites	_	NOUN	NNS	_	25	conj	_	_

#	Venlafaxine Hydrochloride	5814
1	In	_	X	FW	_	3	amod	_	_
2	vitro	_	X	FW	_	1	dep	_	_
3	studies	_	NOUN	NNS	_	4	nsubj	_	_
4	indicate	_	VERB	VBP	_	0	root	_	_
5	that	_	ADP	IN	_	11	mark	_	_
6	the	_	DET	DT	_	7	det	_	_
7	formation	_	NOUN	NN	_	11	nsubjpass	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	ODV	_	NOUN	NN	_	7	nmod	_	_
10	is	_	VERB	VBZ	_	11	auxpass	_	_
11	catalyzed	_	VERB	VBN	_	4	ccomp	_	_
12	by	_	ADP	IN	_	13	case	_	_
13	CYP2D6	_	NOUN	NN	_	11	nmod	_	_
14	this	_	DET	DT	_	17	nsubjpass	_	_
15	has	_	VERB	VBZ	_	17	aux	_	_
16	been	_	VERB	VBN	_	17	auxpass	_	_
17	confirmed	_	VERB	VBN	_	11	parataxis	_	_
18	in	_	ADP	IN	_	21	case	_	_
19	a	_	DET	DT	_	21	det	_	_
20	clinical	_	ADJ	JJ	_	21	amod	_	_
21	study	_	NOUN	NN	_	17	nmod	_	_
22	showing	_	VERB	VBG	_	21	acl	_	_
23	that	_	ADP	IN	_	32	mark	_	_
24	patients	_	NOUN	NNS	_	32	nsubj	_	_
25	with	_	ADP	IN	_	28	case	_	_
26	low	_	ADJ	JJ	_	28	amod	_	_
27	CYP2D6	_	NOUN	NN	_	28	compound	_	_
28	levels	_	NOUN	NNS	_	24	nmod	_	_
29	poor	_	ADJ	JJ	_	30	amod	_	_
30	metabolizers	_	NOUN	NNS	_	28	dep	_	_
31	had	_	VERB	MD	_	32	aux	_	_
32	increased	_	VERB	VBN	_	22	ccomp	_	_
33	levels	_	NOUN	NNS	_	32	dobj	_	_
34	of	_	ADP	IN	_	35	case	_	_
35	DRUG	_	NOUN	NN	_	33	nmod	_	_
36	and	_	CONJ	CC	_	32	cc	_	_
37	reduced	_	VERB	VBN	_	38	amod	_	_
38	levels	_	NOUN	NNS	_	41	nsubj	_	_
39	of	_	ADP	IN	_	40	case	_	_
40	ODV	_	NOUN	NN	_	38	nmod	_	_
41	compared	_	VERB	VBN	_	32	conj	_	_
42	to	_	PRT	TO	_	43	mark	_	_
43	people	_	VERB	VB	_	41	nmod	_	_
44	with	_	ADP	IN	_	47	case	_	_
45	normal	_	ADJ	JJ	_	47	amod	_	_
46	CYP2D6	_	NOUN	NN	_	47	compound	_	_
47	levels	_	NOUN	NNS	_	43	nmod	_	_
48	extensive	_	ADJ	JJ	_	49	amod	_	_
49	metabolizers	_	NOUN	NNS	_	47	dep	_	_

#	Venlafaxine Hydrochloride	5815
1	Approximately	_	ADV	RB	_	8	advmod	_	_
2	87%	_	NOUN	NN	_	8	nsubjpass	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	a	_	DET	DT	_	6	det	_	_
5	DRUG	_	NOUN	NN	_	6	compound	_	_
6	dose	_	NOUN	NN	_	2	nmod	_	_
7	is	_	VERB	VBZ	_	8	auxpass	_	_
8	recovered	_	VERB	VBN	_	0	root	_	_
9	in	_	ADP	IN	_	11	case	_	_
10	the	_	DET	DT	_	11	det	_	_
11	urine	_	NOUN	NN	_	8	nmod	_	_
12	within	_	ADP	IN	_	14	case	_	_
13	48	_	NUM	CD	_	14	nummod	_	_
14	hours	_	NOUN	NNS	_	11	nmod	_	_
15	as	_	ADP	IN	_	18	case	_	_
16	unchanged	_	ADJ	JJ	_	18	amod	_	_
17	DRUG	_	NOUN	NN	_	18	compound	_	_
18	5%	_	NOUN	NN	_	8	nmod	_	_
19	,	_	.	,	_	18	punct	_	_
20	unconjugated	_	VERB	VBN	_	22	amod	_	_
21	ODV	_	NOUN	NN	_	22	compound	_	_
22	29%	_	NOUN	NN	_	18	appos	_	_
23	,	_	.	,	_	18	punct	_	_
24	conjugated	_	VERB	VBD	_	18	conj	_	_
25	ODV	_	NOUN	NN	_	26	compound	_	_
26	26%	_	NOUN	NN	_	24	xcomp	_	_
27	,	_	.	,	_	18	punct	_	_
28	or	_	CONJ	CC	_	18	cc	_	_
29	other	_	ADJ	JJ	_	32	amod	_	_
30	minor	_	ADJ	JJ	_	32	amod	_	_
31	inactive	_	ADJ	JJ	_	32	amod	_	_
32	metabolites	_	NOUN	NNS	_	18	conj	_	_
33	27%	_	ADJ	JJ	_	32	dep	_	_

#	Venlafaxine Hydrochloride	5816
1	Renal	_	ADJ	JJ	_	2	amod	_	_
2	elimination	_	NOUN	NN	_	12	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	and	_	CONJ	CC	_	2	cc	_	_
6	its	_	PRON	PRP$	_	7	nmod:poss	_	_
7	metabolites	_	NOUN	NNS	_	2	conj	_	_
8	is	_	VERB	VBZ	_	12	cop	_	_
9	thus	_	ADV	RB	_	12	advmod	_	_
10	the	_	DET	DT	_	12	det	_	_
11	primary	_	ADJ	JJ	_	12	amod	_	_
12	route	_	NOUN	NN	_	0	root	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	excretion	_	NOUN	NN	_	12	nmod	_	_

#	WELLBUTRIN	3846
1	CYP2B6	_	NOUN	NN	_	2	compound	_	_
2	inducers	_	NOUN	NNS	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	Dose	_	NOUN	NN	_	5	compound	_	_
5	increase	_	NOUN	NN	_	8	nsubj	_	_
6	may	_	VERB	MD	_	8	aux	_	_
7	be	_	VERB	VB	_	8	cop	_	_
8	necessary	_	ADJ	JJ	_	2	dep	_	_
9	if	_	ADP	IN	_	10	mark	_	_
10	coadministered	_	VERB	VBN	_	8	advcl	_	_
11	with	_	ADP	IN	_	13	case	_	_
12	CYP2B6	_	NOUN	NN	_	13	compound	_	_
13	inducers	_	NOUN	NNS	_	10	nmod	_	_
14	e.g	_	NOUN	NN	_	13	dep	_	_
15	,	_	.	,	_	14	punct	_	_
16	ritonavir	_	NOUN	NN	_	14	conj	_	_
17	,	_	.	,	_	14	punct	_	_
18	lopinavir	_	ADJ	JJ	_	14	conj	_	_
19	,	_	.	,	_	14	punct	_	_
20	efavirenz	_	NOUN	NN	_	14	conj	_	_
21	,	_	.	,	_	14	punct	_	_
22	carbamazepine	_	NOUN	NN	_	14	conj	_	_
23	,	_	.	,	_	14	punct	_	_
24	phenobarbital	_	ADJ	JJ	_	14	conj	_	_
25	,	_	.	,	_	14	punct	_	_
26	and	_	CONJ	CC	_	14	cc	_	_
27	phenytoin	_	NOUN	NN	_	14	conj	_	_
28	based	_	VERB	VBD	_	13	acl	_	_
29	on	_	ADP	IN	_	31	case	_	_
30	clinical	_	ADJ	JJ	_	31	amod	_	_
31	exposure	_	NOUN	NN	_	28	nmod	_	_
32	,	_	.	,	_	8	punct	_	_
33	but	_	CONJ	CC	_	8	cc	_	_
34	should	_	VERB	MD	_	36	aux	_	_
35	not	_	ADV	RB	_	36	neg	_	_
36	exceed	_	VERB	VB	_	8	conj	_	_
37	the	_	DET	DT	_	40	det	_	_
38	maximum	_	NOUN	NN	_	40	compound	_	_
39	recommended	_	VERB	VBN	_	40	amod	_	_
40	dose	_	NOUN	NN	_	36	dobj	_	_

#	WELLBUTRIN	3847
1	Drugs	_	NOUN	NNS	_	0	root	_	_
2	metabolized	_	VERB	VBN	_	1	acl	_	_
3	by	_	ADP	IN	_	4	case	_	_
4	CYP2D6	_	NOUN	NN	_	2	nmod	_	_
5	:	_	.	:	_	1	punct	_	_
6	DRUG	_	NOUN	NN	_	7	nsubj	_	_
7	inhibits	_	VERB	VBZ	_	1	dep	_	_
8	CYP2D6	_	NOUN	NN	_	7	dobj	_	_
9	and	_	CONJ	CC	_	7	cc	_	_
10	can	_	VERB	MD	_	11	aux	_	_
11	increase	_	VERB	VB	_	7	conj	_	_
12	concentrations	_	NOUN	NNS	_	11	dobj	_	_
13	of	_	ADP	IN	_	15	case	_	_
14	:	_	.	:	_	15	punct	_	_
15	antidepressants	_	NOUN	NNS	_	12	nmod	_	_
16	e.g	_	NOUN	NN	_	15	dep	_	_
17	,	_	.	,	_	16	punct	_	_
18	venlafaxine	_	NOUN	NN	_	16	conj	_	_
19	,	_	.	,	_	16	punct	_	_
20	nortriptyline	_	NOUN	NN	_	16	conj	_	_
21	,	_	.	,	_	16	punct	_	_
22	imipramine	_	NOUN	NN	_	16	conj	_	_
23	,	_	.	,	_	16	punct	_	_
24	desipramine	_	NOUN	NN	_	16	conj	_	_
25	,	_	.	,	_	16	punct	_	_
26	paroxetine	_	NOUN	NN	_	16	conj	_	_
27	,	_	.	,	_	16	punct	_	_
28	fluoxetine	_	NOUN	NN	_	16	conj	_	_
29	,	_	.	,	_	16	punct	_	_
30	sertraline	_	NOUN	NN	_	16	conj	_	_
31	,	_	.	,	_	16	punct	_	_
32	antipsychotics	_	NOUN	NNS	_	33	compound	_	_
33	e.g	_	NOUN	NN	_	16	conj	_	_
34	,	_	.	,	_	16	punct	_	_
35	haloperidol	_	NOUN	NN	_	16	conj	_	_
36	,	_	.	,	_	16	punct	_	_
37	risperidone	_	NOUN	NN	_	16	conj	_	_
38	,	_	.	,	_	16	punct	_	_
39	thioridazine	_	NOUN	NN	_	16	conj	_	_
40	,	_	.	,	_	16	punct	_	_
41	beta	_	NOUN	NN	_	42	compound	_	_
42	blockers	_	NOUN	NNS	_	16	appos	_	_
43	e.g	_	NOUN	NN	_	42	dep	_	_
44	,	_	.	,	_	43	punct	_	_
45	metoprolol	_	NOUN	NN	_	43	conj	_	_
46	,	_	.	,	_	43	punct	_	_
47	and	_	CONJ	CC	_	43	cc	_	_
48	Type	_	NOUN	NN	_	50	compound	_	_
49	1C	_	NOUN	NN	_	50	compound	_	_
50	antiarrhythmics	_	NOUN	NNS	_	43	conj	_	_
51	e.g	_	NOUN	NN	_	50	dep	_	_
52	,	_	.	,	_	43	punct	_	_
53	propafenone	_	NOUN	NN	_	43	conj	_	_
54	,	_	.	,	_	43	punct	_	_
55	flecainide	_	NOUN	NN	_	43	conj	_	_

#	WELLBUTRIN	3848
1	Consider	_	NOUN	NN	_	3	compound	_	_
2	dose	_	NOUN	NN	_	3	compound	_	_
3	reduction	_	NOUN	NN	_	0	root	_	_
4	when	_	ADV	WRB	_	5	advmod	_	_
5	using	_	VERB	VBG	_	3	acl	_	_
6	with	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_

#	WELLBUTRIN	3849
1	Drugs	_	NOUN	NNS	_	0	root	_	_
2	that	_	DET	WDT	_	3	nsubj	_	_
3	lower	_	ADJ	JJ	_	1	acl:relcl	_	_
4	seizure	_	VERB	VBP	_	3	dobj	_	_
5	threshold	_	NOUN	NN	_	4	dobj	_	_
6	:	_	.	:	_	1	punct	_	_
7	Dose	_	VERB	VBP	_	9	amod	_	_
8	DRUG	_	NOUN	NN	_	9	compound	_	_
9	XL	_	NOUN	NN	_	1	dep	_	_
10	with	_	ADP	IN	_	11	case	_	_
11	caution	_	NOUN	NN	_	9	nmod	_	_

#	WELLBUTRIN	3850
1	Dopaminergic	_	ADJ	JJ	_	2	amod	_	_
2	Drugs	_	NOUN	NNS	_	0	root	_	_
3	levodopa	_	NOUN	NN	_	2	dep	_	_
4	and	_	CONJ	CC	_	3	cc	_	_
5	amantadine	_	NOUN	NN	_	3	conj	_	_
6	:	_	.	:	_	2	punct	_	_
7	CNS	_	NOUN	NN	_	8	compound	_	_
8	toxicity	_	NOUN	NN	_	10	nsubj	_	_
9	can	_	VERB	MD	_	10	aux	_	_
10	occur	_	VERB	VB	_	2	dep	_	_
11	when	_	ADV	RB	_	12	advmod	_	_
12	used	_	VERB	VBN	_	10	ccomp	_	_
13	concomitantly	_	ADV	RB	_	12	advmod	_	_
14	with	_	ADP	IN	_	16	case	_	_
15	DRUG	_	NOUN	NN	_	16	compound	_	_
16	XL	_	NOUN	NN	_	12	nmod	_	_

#	WELLBUTRIN	3851
1	MAOIs	_	NOUN	NNS	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Increased	_	VERB	VBN	_	4	amod	_	_
4	risk	_	NOUN	NN	_	9	nsubj	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	hypertensive	_	ADJ	JJ	_	7	amod	_	_
7	reactions	_	NOUN	NNS	_	4	nmod	_	_
8	can	_	VERB	MD	_	9	aux	_	_
9	occur	_	VERB	VB	_	1	dep	_	_
10	when	_	ADV	RB	_	11	advmod	_	_
11	used	_	VERB	VBN	_	9	ccomp	_	_
12	concomitantly	_	ADV	RB	_	11	advmod	_	_
13	with	_	ADP	IN	_	15	case	_	_
14	DRUG	_	NOUN	NN	_	15	compound	_	_
15	XL	_	NOUN	NN	_	11	nmod	_	_

#	WELLBUTRIN	3852
1	Drug	_	NOUN	NN	_	4	compound	_	_
2	laboratory	_	NOUN	NN	_	4	compound	_	_
3	test	_	NOUN	NN	_	4	compound	_	_
4	interactions	_	NOUN	NNS	_	0	root	_	_
5	:	_	.	:	_	4	punct	_	_
6	DRUG	_	NOUN	NN	_	7	compound	_	_
7	XL	_	NOUN	NN	_	9	nsubj	_	_
8	can	_	VERB	MD	_	9	aux	_	_
9	cause	_	VERB	VB	_	4	dep	_	_
10	false	_	ADJ	JJ	_	14	amod	_	_
11	positive	_	ADJ	JJ	_	14	amod	_	_
12	urine	_	ADJ	JJ	_	14	amod	_	_
13	test	_	NOUN	NN	_	14	compound	_	_
14	results	_	NOUN	NNS	_	9	dobj	_	_
15	for	_	ADP	IN	_	16	case	_	_
16	amphetamines	_	NOUN	NNS	_	14	nmod	_	_

#	WELLBUTRIN	3853
1	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
2	is	_	VERB	VBZ	_	4	auxpass	_	_
3	primarily	_	ADV	RB	_	4	advmod	_	_
4	metabolized	_	VERB	VBN	_	0	root	_	_
5	to	_	PRT	TO	_	6	mark	_	_
6	hydroxy	_	VERB	VB	_	4	xcomp	_	_
7	DRUG	_	NOUN	NN	_	6	dobj	_	_
8	by	_	ADP	IN	_	9	case	_	_
9	CYP2B6	_	NOUN	NN	_	6	nmod	_	_

#	WELLBUTRIN	3854
1	Therefore	_	ADV	RB	_	5	advmod	_	_
2	,	_	.	,	_	5	punct	_	_
3	the	_	DET	DT	_	4	det	_	_
4	potential	_	NOUN	NN	_	5	nsubj	_	_
5	exists	_	VERB	VBZ	_	0	root	_	_
6	for	_	ADP	IN	_	8	case	_	_
7	drug	_	NOUN	NN	_	8	compound	_	_
8	interactions	_	NOUN	NNS	_	5	nmod	_	_
9	between	_	ADP	IN	_	11	case	_	_
10	DRUG	_	NOUN	NN	_	11	compound	_	_
11	XL	_	NOUN	NN	_	8	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	drugs	_	NOUN	NNS	_	11	conj	_	_
14	that	_	DET	WDT	_	16	nsubj	_	_
15	are	_	VERB	VBP	_	16	cop	_	_
16	inhibitors	_	NOUN	NNS	_	11	acl:relcl	_	_
17	or	_	CONJ	CC	_	16	cc	_	_
18	inducers	_	NOUN	NNS	_	16	conj	_	_
19	of	_	ADP	IN	_	20	case	_	_
20	CYP2B6	_	NOUN	NN	_	18	nmod	_	_

#	WELLBUTRIN	3855
1	Inhibitors	_	NOUN	NNS	_	0	root	_	_
2	of	_	ADP	IN	_	4	case	_	_
3	CYP2B6	_	NOUN	NN	_	4	compound	_	_
4	Ticlopidine	_	NOUN	NN	_	1	nmod	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	Clopidogrel	_	NOUN	NN	_	4	conj	_	_
7	:	_	.	:	_	1	punct	_	_
8	Concomitant	_	ADJ	JJ	_	9	amod	_	_
9	treatment	_	NOUN	NN	_	14	nsubj	_	_
10	with	_	ADP	IN	_	12	case	_	_
11	these	_	DET	DT	_	12	det	_	_
12	drugs	_	NOUN	NNS	_	9	nmod	_	_
13	can	_	VERB	MD	_	14	aux	_	_
14	increase	_	VERB	VB	_	1	dep	_	_
15	DRUG	_	NOUN	NN	_	16	compound	_	_
16	exposures	_	NOUN	NNS	_	14	dobj	_	_
17	but	_	CONJ	CC	_	14	cc	_	_
18	decrease	_	VERB	VB	_	14	conj	_	_
19	hydroxy	_	ADJ	JJ	_	21	compound	_	_
20	DRUG	_	NOUN	NN	_	21	compound	_	_
21	exposure	_	NOUN	NN	_	18	dobj	_	_

#	WELLBUTRIN	3856
1	Based	_	VERB	VBN	_	13	advcl	_	_
2	on	_	ADP	IN	_	4	case	_	_
3	clinical	_	ADJ	JJ	_	4	amod	_	_
4	response	_	NOUN	NN	_	1	nmod	_	_
5	,	_	.	,	_	13	punct	_	_
6	dosage	_	ADJ	JJ	_	7	compound	_	_
7	adjustment	_	NOUN	NN	_	13	nsubj	_	_
8	of	_	ADP	IN	_	10	case	_	_
9	DRUG	_	NOUN	NN	_	10	compound	_	_
10	XL	_	NOUN	NN	_	7	nmod	_	_
11	may	_	VERB	MD	_	13	aux	_	_
12	be	_	VERB	VB	_	13	cop	_	_
13	necessary	_	ADJ	JJ	_	0	root	_	_
14	when	_	ADV	WRB	_	15	advmod	_	_
15	coadministered	_	VERB	VBN	_	13	advcl	_	_
16	with	_	ADP	IN	_	18	case	_	_
17	CYP2B6	_	NOUN	NN	_	18	compound	_	_
18	inhibitors	_	NOUN	NNS	_	15	nmod	_	_
19	e.g	_	NOUN	NN	_	18	dep	_	_
20	,	_	.	,	_	19	punct	_	_
21	ticlopidine	_	NOUN	NN	_	19	conj	_	_
22	or	_	CONJ	CC	_	19	cc	_	_
23	clopidogrel	_	NOUN	NN	_	19	conj	_	_

#	WELLBUTRIN	3857
1	Inducers	_	NOUN	NNS	_	0	root	_	_
2	of	_	ADP	IN	_	4	case	_	_
3	CYP2B6	_	NOUN	NN	_	4	compound	_	_
4	Ritonavir	_	NOUN	NN	_	1	nmod	_	_
5	,	_	.	,	_	4	punct	_	_
6	Lopinavir	_	ADJ	JJ	_	4	conj	_	_
7	,	_	.	,	_	4	punct	_	_
8	and	_	CONJ	CC	_	4	cc	_	_
9	Efavirenz	_	NOUN	NN	_	4	conj	_	_
10	:	_	.	:	_	1	punct	_	_
11	Concomitant	_	ADJ	JJ	_	12	amod	_	_
12	treatment	_	NOUN	NN	_	17	nsubj	_	_
13	with	_	ADP	IN	_	15	case	_	_
14	these	_	DET	DT	_	15	det	_	_
15	drugs	_	NOUN	NNS	_	12	nmod	_	_
16	can	_	VERB	MD	_	17	aux	_	_
17	decrease	_	VERB	VB	_	1	dep	_	_
18	DRUG	_	NOUN	NN	_	17	dobj	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	hydroxy	_	ADJ	JJ	_	18	conj	_	_
21	DRUG	_	NOUN	NN	_	22	compound	_	_
22	exposure	_	NOUN	NN	_	18	dep	_	_

#	WELLBUTRIN	3858
1	Dosage	_	NOUN	NN	_	2	compound	_	_
2	increase	_	NOUN	NN	_	8	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	DRUG	_	NOUN	NN	_	5	compound	_	_
5	XL	_	NOUN	NN	_	2	nmod	_	_
6	may	_	VERB	MD	_	8	aux	_	_
7	be	_	VERB	VB	_	8	cop	_	_
8	necessary	_	ADJ	JJ	_	0	root	_	_
9	when	_	ADV	WRB	_	10	advmod	_	_
10	coadministered	_	VERB	VBN	_	8	advcl	_	_
11	with	_	ADP	IN	_	12	case	_	_
12	ritonavir	_	NOUN	NN	_	10	nmod	_	_
13	,	_	.	,	_	12	punct	_	_
14	lopinavir	_	ADJ	JJ	_	12	conj	_	_
15	,	_	.	,	_	12	punct	_	_
16	or	_	CONJ	CC	_	12	cc	_	_
17	efavirenz	_	ADJ	JJ	_	12	conj	_	_
18	but	_	CONJ	CC	_	8	cc	_	_
19	should	_	VERB	MD	_	21	aux	_	_
20	not	_	ADV	RB	_	21	neg	_	_
21	exceed	_	VERB	VB	_	8	conj	_	_
22	the	_	DET	DT	_	25	det	_	_
23	maximum	_	NOUN	NN	_	25	compound	_	_
24	recommended	_	VERB	VBN	_	25	amod	_	_
25	dose	_	NOUN	NN	_	21	dobj	_	_

#	WELLBUTRIN	3859
1	Carbamazepine	_	NOUN	NN	_	15	nsubj	_	_
2	,	_	.	,	_	1	punct	_	_
3	Phenobarbital	_	ADJ	JJ	_	1	conj	_	_
4	,	_	.	,	_	1	punct	_	_
5	Phenytoin	_	NOUN	NN	_	1	appos	_	_
6	:	_	.	:	_	1	punct	_	_
7	While	_	ADP	IN	_	10	mark	_	_
8	not	_	ADV	RB	_	10	neg	_	_
9	systemically	_	ADV	RB	_	10	advmod	_	_
10	studied	_	VERB	VBN	_	15	advcl	_	_
11	,	_	.	,	_	15	punct	_	_
12	these	_	DET	DT	_	13	det	_	_
13	drugs	_	NOUN	NNS	_	15	nsubj	_	_
14	may	_	VERB	MD	_	15	aux	_	_
15	induce	_	VERB	VB	_	0	root	_	_
16	metabolism	_	NOUN	NN	_	15	dobj	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	DRUG	_	NOUN	NN	_	16	nmod	_	_
19	and	_	CONJ	CC	_	15	cc	_	_
20	may	_	VERB	MD	_	21	aux	_	_
21	decrease	_	VERB	VB	_	15	conj	_	_
22	DRUG	_	NOUN	NN	_	23	compound	_	_
23	exposure	_	NOUN	NN	_	21	dobj	_	_

#	WELLBUTRIN	3860
1	If	_	ADP	IN	_	4	mark	_	_
2	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
3	is	_	VERB	VBZ	_	4	auxpass	_	_
4	used	_	VERB	VBN	_	14	advcl	_	_
5	concomitantly	_	ADV	RB	_	4	advmod	_	_
6	with	_	ADP	IN	_	9	case	_	_
7	a	_	DET	DT	_	9	det	_	_
8	CYP	_	NOUN	NN	_	9	compound	_	_
9	inducer	_	NOUN	NN	_	4	nmod	_	_
10	,	_	.	,	_	14	punct	_	_
11	it	_	PRON	PRP	_	14	nsubj	_	_
12	may	_	VERB	MD	_	14	aux	_	_
13	be	_	VERB	VB	_	14	cop	_	_
14	necessary	_	ADJ	JJ	_	0	root	_	_
15	to	_	PRT	TO	_	16	mark	_	_
16	increase	_	VERB	VB	_	14	xcomp	_	_
17	the	_	DET	DT	_	18	det	_	_
18	dose	_	NOUN	NN	_	16	dobj	_	_
19	of	_	ADP	IN	_	20	case	_	_
20	DRUG	_	NOUN	NN	_	18	nmod	_	_
21	,	_	.	,	_	14	punct	_	_
22	but	_	CONJ	CC	_	14	cc	_	_
23	the	_	DET	DT	_	26	det	_	_
24	maximum	_	NOUN	NN	_	26	compound	_	_
25	recommended	_	ADJ	JJ	_	26	amod	_	_
26	dose	_	NOUN	NN	_	30	nsubjpass	_	_
27	should	_	VERB	MD	_	30	aux	_	_
28	not	_	ADV	RB	_	30	neg	_	_
29	be	_	VERB	VB	_	30	auxpass	_	_
30	exceeded	_	VERB	VBN	_	14	conj	_	_

#	WELLBUTRIN	3861
1	Drugs	_	NOUN	NNS	_	19	nsubj	_	_
2	Metabolized	_	VERB	VBN	_	1	acl	_	_
3	by	_	ADP	IN	_	5	case	_	_
4	CYP2D6	_	NOUN	NN	_	5	compound	_	_
5	DRUG	_	NOUN	NN	_	2	nmod	_	_
6	and	_	CONJ	CC	_	1	cc	_	_
7	its	_	PRON	PRP$	_	8	nmod:poss	_	_
8	metabolites	_	NOUN	NNS	_	1	conj	_	_
9	erythrohydro	_	VERB	VBP	_	10	compound	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	,	_	.	,	_	10	punct	_	_
12	threohydro	_	ADP	IN	_	13	case	_	_
13	DRUG	_	NOUN	NN	_	10	appos	_	_
14	,	_	.	,	_	10	punct	_	_
15	hydroxy	_	ADJ	JJ	_	16	amod	_	_
16	DRUG	_	NOUN	NN	_	10	appos	_	_
17	are	_	VERB	VBP	_	19	cop	_	_
18	CYP2D6	_	NOUN	NN	_	19	compound	_	_
19	inhibitors	_	NOUN	NNS	_	0	root	_	_

#	WELLBUTRIN	3862
1	Therefore	_	ADV	RB	_	15	advmod	_	_
2	,	_	.	,	_	15	punct	_	_
3	coadministration	_	NOUN	NN	_	15	nsubj	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	DRUG	_	NOUN	NN	_	6	compound	_	_
6	XL	_	NOUN	NN	_	3	nmod	_	_
7	with	_	ADP	IN	_	8	case	_	_
8	drugs	_	NOUN	NNS	_	3	nmod	_	_
9	that	_	DET	WDT	_	11	nsubjpass	_	_
10	are	_	VERB	VBP	_	11	auxpass	_	_
11	metabolized	_	VERB	VBN	_	8	acl:relcl	_	_
12	by	_	ADP	IN	_	13	case	_	_
13	CYP2D6	_	NOUN	NN	_	11	nmod	_	_
14	can	_	VERB	MD	_	15	aux	_	_
15	increase	_	VERB	VB	_	0	root	_	_
16	the	_	DET	DT	_	17	det	_	_
17	exposures	_	NOUN	NNS	_	15	dobj	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	drugs	_	NOUN	NNS	_	17	nmod	_	_
20	that	_	DET	WDT	_	22	nsubj	_	_
21	are	_	VERB	VBP	_	22	cop	_	_
22	substrates	_	NOUN	NNS	_	19	acl:relcl	_	_
23	of	_	ADP	IN	_	24	case	_	_
24	CYP2D6	_	NOUN	NN	_	22	nmod	_	_

#	WELLBUTRIN	3863
1	Such	_	ADJ	JJ	_	2	amod	_	_
2	drugs	_	NOUN	NNS	_	3	nsubj	_	_
3	include	_	VERB	VBP	_	0	root	_	_
4	antidepressants	_	NOUN	NNS	_	3	dobj	_	_
5	e.g	_	NOUN	NN	_	24	compound	_	_
6	,	_	.	,	_	5	punct	_	_
7	venlafaxine	_	NOUN	NN	_	5	conj	_	_
8	,	_	.	,	_	5	punct	_	_
9	nortriptyline	_	NOUN	NN	_	5	conj	_	_
10	,	_	.	,	_	5	punct	_	_
11	imipramine	_	NOUN	NN	_	5	conj	_	_
12	,	_	.	,	_	5	punct	_	_
13	desipramine	_	NOUN	NN	_	5	conj	_	_
14	,	_	.	,	_	5	punct	_	_
15	paroxetine	_	NOUN	NN	_	5	conj	_	_
16	,	_	.	,	_	5	punct	_	_
17	fluoxetine	_	NOUN	NN	_	5	conj	_	_
18	,	_	.	,	_	5	punct	_	_
19	and	_	CONJ	CC	_	5	cc	_	_
20	sertraline	_	NOUN	NN	_	5	conj	_	_
21	,	_	.	,	_	5	punct	_	_
22	antipsychotics	_	NOUN	NNS	_	5	conj	_	_
23	e.g	_	VERB	VBP	_	24	compound	_	_
24	haloperidol	_	NOUN	NN	_	4	dep	_	_
25	,	_	.	,	_	24	punct	_	_
26	risperidone	_	NOUN	NN	_	24	conj	_	_
27	,	_	.	,	_	24	punct	_	_
28	and	_	CONJ	CC	_	24	cc	_	_
29	thioridazine	_	NOUN	NN	_	24	conj	_	_
30	,	_	.	,	_	24	punct	_	_
31	beta	_	NOUN	NN	_	32	compound	_	_
32	blockers	_	NOUN	NNS	_	24	appos	_	_
33	e.g	_	NOUN	NN	_	32	dep	_	_
34	,	_	.	,	_	33	punct	_	_
35	metoprolol	_	NOUN	NN	_	33	conj	_	_
36	,	_	.	,	_	33	punct	_	_
37	and	_	CONJ	CC	_	33	cc	_	_
38	Type	_	NOUN	NN	_	40	compound	_	_
39	1C	_	NOUN	NN	_	40	compound	_	_
40	antiarrhythmics	_	NOUN	NNS	_	33	conj	_	_
41	e.g	_	.	.	_	24	punct	_	_

#	WELLBUTRIN	3864
1	When	_	ADV	WRB	_	2	advmod	_	_
2	used	_	VERB	VBN	_	11	advcl	_	_
3	concomitantly	_	ADV	RB	_	2	advmod	_	_
4	with	_	ADP	IN	_	6	case	_	_
5	DRUG	_	NOUN	NN	_	6	compound	_	_
6	XL	_	NOUN	NN	_	2	nmod	_	_
7	,	_	.	,	_	11	punct	_	_
8	it	_	PRON	PRP	_	11	nsubj	_	_
9	may	_	VERB	MD	_	11	aux	_	_
10	be	_	VERB	VB	_	11	cop	_	_
11	necessary	_	ADJ	JJ	_	0	root	_	_
12	to	_	PRT	TO	_	13	mark	_	_
13	decrease	_	VERB	VB	_	11	xcomp	_	_
14	the	_	DET	DT	_	15	det	_	_
15	dose	_	NOUN	NN	_	13	dobj	_	_
16	of	_	ADP	IN	_	19	case	_	_
17	these	_	DET	DT	_	19	det	_	_
18	CYP2D6	_	NOUN	NN	_	19	compound	_	_
19	substrates	_	NOUN	NNS	_	15	nmod	_	_
20	,	_	.	,	_	13	punct	_	_
21	particularly	_	ADV	RB	_	23	advmod	_	_
22	for	_	ADP	IN	_	23	case	_	_
23	drugs	_	NOUN	NNS	_	13	nmod	_	_
24	with	_	ADP	IN	_	28	case	_	_
25	a	_	DET	DT	_	28	det	_	_
26	narrow	_	NOUN	NN	_	28	compound	_	_
27	therapeutic	_	ADJ	JJ	_	28	amod	_	_
28	index	_	NOUN	NN	_	23	nmod	_	_

#	WELLBUTRIN	3865
1	Drugs	_	NOUN	NNS	_	0	root	_	_
2	that	_	DET	WDT	_	3	nsubj	_	_
3	require	_	VERB	VBP	_	1	acl:relcl	_	_
4	metabolic	_	ADJ	JJ	_	5	amod	_	_
5	activation	_	NOUN	NN	_	3	dobj	_	_
6	by	_	ADP	IN	_	7	case	_	_
7	CYP2D6	_	NOUN	NN	_	5	nmod	_	_
8	to	_	PRT	TO	_	11	mark	_	_
9	be	_	VERB	VB	_	11	cop	_	_
10	effective	_	ADJ	JJ	_	11	amod	_	_
11	e.g	_	NOUN	NN	_	5	nmod	_	_
12	,	_	.	,	_	11	punct	_	_
13	tamoxifen	_	NOUN	NN	_	11	appos	_	_
14	,	_	.	,	_	11	punct	_	_
15	theoretically	_	ADV	RB	_	18	advmod	_	_
16	could	_	VERB	MD	_	18	aux	_	_
17	have	_	VERB	VB	_	18	aux	_	_
18	reduced	_	VERB	VBN	_	19	amod	_	_
19	efficacy	_	NOUN	NN	_	11	appos	_	_
20	when	_	ADV	WRB	_	21	advmod	_	_
21	administered	_	VERB	VBN	_	19	acl	_	_
22	concomitantly	_	ADV	RB	_	21	advmod	_	_
23	with	_	ADP	IN	_	24	case	_	_
24	inhibitors	_	NOUN	NNS	_	21	nmod	_	_
25	of	_	ADP	IN	_	26	case	_	_
26	CYP2D6	_	NOUN	NN	_	24	nmod	_	_
27	such	_	ADJ	JJ	_	29	case	_	_
28	as	_	ADP	IN	_	27	mwe	_	_
29	DRUG	_	NOUN	NN	_	26	nmod	_	_

#	WELLBUTRIN	3866
1	Patients	_	NOUN	NNS	_	11	nsubj	_	_
2	treated	_	VERB	VBN	_	1	acl	_	_
3	concomitantly	_	ADV	RB	_	2	advmod	_	_
4	with	_	ADP	IN	_	6	case	_	_
5	DRUG	_	NOUN	NN	_	6	compound	_	_
6	XL	_	NOUN	NN	_	2	nmod	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	such	_	ADJ	JJ	_	9	amod	_	_
9	drugs	_	NOUN	NNS	_	6	conj	_	_
10	may	_	VERB	MD	_	11	aux	_	_
11	require	_	VERB	VB	_	0	root	_	_
12	increased	_	VERB	VBN	_	13	amod	_	_
13	doses	_	NOUN	NNS	_	11	dobj	_	_
14	of	_	ADP	IN	_	16	case	_	_
15	the	_	DET	DT	_	16	det	_	_
16	drug	_	NOUN	NN	_	13	nmod	_	_

#	WELLBUTRIN	3867
1	Use	_	VERB	VB	_	0	root	_	_
2	extreme	_	ADJ	JJ	_	3	amod	_	_
3	caution	_	NOUN	NN	_	1	dobj	_	_
4	when	_	ADV	WRB	_	5	advmod	_	_
5	coadministering	_	VERB	VBG	_	1	advcl	_	_
6	DRUG	_	NOUN	NN	_	7	compound	_	_
7	XL	_	NOUN	NN	_	5	dobj	_	_
8	with	_	ADP	IN	_	10	case	_	_
9	other	_	ADJ	JJ	_	10	amod	_	_
10	drugs	_	NOUN	NNS	_	5	nmod	_	_
11	that	_	DET	WDT	_	12	nsubj	_	_
12	lower	_	VERB	VBP	_	10	acl:relcl	_	_
13	the	_	DET	DT	_	16	det	_	_
14	seizure	_	NOUN	NN	_	16	amod	_	_
15	threshold	_	NOUN	NN	_	16	compound	_	_
16	e.g	_	NOUN	NN	_	12	dobj	_	_
17	,	_	.	,	_	16	punct	_	_
18	other	_	ADJ	JJ	_	20	amod	_	_
19	DRUG	_	NOUN	NN	_	20	compound	_	_
20	products	_	NOUN	NNS	_	16	conj	_	_
21	,	_	.	,	_	16	punct	_	_
22	antipsychotics	_	NOUN	NNS	_	16	conj	_	_
23	,	_	.	,	_	16	punct	_	_
24	antidepressants	_	NOUN	NNS	_	16	conj	_	_
25	,	_	.	,	_	16	punct	_	_
26	theophylline	_	NOUN	NN	_	16	conj	_	_
27	,	_	.	,	_	16	punct	_	_
28	or	_	CONJ	CC	_	16	cc	_	_
29	systemic	_	ADJ	JJ	_	30	amod	_	_
30	corticosteroids	_	NOUN	NNS	_	16	conj	_	_

#	WELLBUTRIN	3868
1	Use	_	VERB	VB	_	0	root	_	_
2	low	_	ADJ	JJ	_	4	amod	_	_
3	initial	_	ADJ	JJ	_	4	amod	_	_
4	doses	_	NOUN	NNS	_	1	dobj	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	DRUG	_	NOUN	NN	_	7	compound	_	_
7	XL	_	NOUN	NN	_	4	nmod	_	_
8	and	_	CONJ	CC	_	1	cc	_	_
9	increase	_	VERB	VBP	_	1	conj	_	_
10	the	_	DET	DT	_	11	det	_	_
11	dose	_	NOUN	NN	_	9	dobj	_	_
12	gradually	_	ADV	RB	_	9	advmod	_	_

#	WELLBUTRIN	3869
1	DRUG	_	NOUN	NN	_	7	nsubj	_	_
2	,	_	.	,	_	1	punct	_	_
3	levodopa	_	NOUN	NN	_	1	conj	_	_
4	,	_	.	,	_	1	punct	_	_
5	and	_	CONJ	CC	_	1	cc	_	_
6	amantadine	_	NOUN	NN	_	1	conj	_	_
7	have	_	VERB	VBP	_	0	root	_	_
8	dopamine	_	NOUN	NN	_	10	compound	_	_
9	agonist	_	NOUN	NN	_	10	compound	_	_
10	effects	_	NOUN	NNS	_	7	dobj	_	_

#	WELLBUTRIN	3870
1	CNS	_	NOUN	NN	_	2	compound	_	_
2	toxicity	_	NOUN	NN	_	5	nsubjpass	_	_
3	has	_	VERB	VBZ	_	5	aux	_	_
4	been	_	VERB	VBN	_	5	auxpass	_	_
5	reported	_	VERB	VBN	_	0	root	_	_
6	when	_	ADV	WRB	_	9	advmod	_	_
7	DRUG	_	NOUN	NN	_	9	nsubjpass	_	_
8	was	_	VERB	VBD	_	9	auxpass	_	_
9	coadministered	_	VERB	VBN	_	5	ccomp	_	_
10	with	_	ADP	IN	_	11	case	_	_
11	levodopa	_	NOUN	NN	_	9	nmod	_	_
12	or	_	CONJ	CC	_	11	cc	_	_
13	amantadine	_	NOUN	NN	_	11	conj	_	_

#	WELLBUTRIN	3871
1	Adverse	_	ADJ	JJ	_	2	amod	_	_
2	reactions	_	NOUN	NNS	_	4	nsubj	_	_
3	have	_	VERB	VBP	_	4	aux	_	_
4	included	_	VERB	VBN	_	0	root	_	_
5	restlessness	_	NOUN	NN	_	4	dobj	_	_
6	,	_	.	,	_	5	punct	_	_
7	agitation	_	NOUN	NN	_	5	conj	_	_
8	,	_	.	,	_	5	punct	_	_
9	tremor	_	NOUN	NN	_	5	conj	_	_
10	,	_	.	,	_	5	punct	_	_
11	ataxia	_	NOUN	NN	_	5	conj	_	_
12	,	_	.	,	_	5	punct	_	_
13	gait	_	NOUN	NN	_	14	compound	_	_
14	disturbance	_	NOUN	NN	_	5	conj	_	_
15	,	_	.	,	_	5	punct	_	_
16	vertigo	_	ADJ	JJ	_	5	appos	_	_
17	,	_	.	,	_	4	punct	_	_
18	and	_	CONJ	CC	_	4	cc	_	_
19	dizziness	_	VERB	VBP	_	4	root	_	_

#	WELLBUTRIN	3872
1	It	_	PRON	PRP	_	3	nsubjpass	_	_
2	is	_	VERB	VBZ	_	3	auxpass	_	_
3	presumed	_	VERB	VBN	_	0	root	_	_
4	that	_	ADP	IN	_	3	root	_	_
5	the	_	DET	DT	_	7	det	_	_
6	toxicity	_	NOUN	NN	_	7	compound	_	_
7	results	_	NOUN	NNS	_	4	root	_	_
8	from	_	ADP	IN	_	12	case	_	_
9	cumulative	_	ADJ	JJ	_	12	amod	_	_
10	dopamine	_	NOUN	NN	_	12	compound	_	_
11	agonist	_	NOUN	NN	_	12	compound	_	_
12	effects	_	NOUN	NNS	_	7	nmod	_	_

#	WELLBUTRIN	3873
1	Use	_	NOUN	NN	_	2	compound	_	_
2	caution	_	NOUN	NN	_	0	root	_	_
3	when	_	ADV	WRB	_	4	advmod	_	_
4	administering	_	VERB	VBG	_	2	acl	_	_
5	DRUG	_	NOUN	NN	_	6	compound	_	_
6	XL	_	NOUN	NN	_	4	dobj	_	_
7	concomitantly	_	ADV	RB	_	2	advmod	_	_
8	with	_	ADP	IN	_	10	case	_	_
9	these	_	DET	DT	_	10	det	_	_
10	drugs	_	NOUN	NNS	_	7	nmod	_	_

#	WELLBUTRIN	3874
1	In	_	ADP	IN	_	3	case	_	_
2	postmarketing	_	ADJ	JJ	_	3	amod	_	_
3	experience	_	NOUN	NN	_	9	nmod	_	_
4	,	_	.	,	_	9	punct	_	_
5	there	_	DET	EX	_	9	nsubj	_	_
6	have	_	VERB	VBP	_	9	aux	_	_
7	been	_	VERB	VBN	_	9	cop	_	_
8	rare	_	ADJ	JJ	_	9	amod	_	_
9	reports	_	NOUN	NNS	_	0	root	_	_
10	of	_	ADP	IN	_	13	case	_	_
11	adverse	_	ADJ	JJ	_	13	amod	_	_
12	neuropsychiatric	_	ADJ	JJ	_	13	amod	_	_
13	events	_	NOUN	NNS	_	9	nmod	_	_
14	or	_	CONJ	CC	_	13	cc	_	_
15	reduced	_	VERB	VBD	_	17	amod	_	_
16	alcohol	_	NOUN	NN	_	17	compound	_	_
17	tolerance	_	NOUN	NN	_	13	conj	_	_
18	in	_	ADP	IN	_	19	case	_	_
19	patients	_	NOUN	NNS	_	13	nmod	_	_
20	who	_	DET	WDT	_	22	nsubj	_	_
21	were	_	VERB	VBD	_	22	cop	_	_
22	drinking	_	VERB	VBG	_	19	acl:relcl	_	_
23	alcohol	_	NOUN	NN	_	22	dobj	_	_
24	during	_	ADP	IN	_	25	case	_	_
25	treatment	_	NOUN	NN	_	22	nmod	_	_
26	with	_	ADP	IN	_	28	case	_	_
27	DRUG	_	NOUN	NN	_	28	compound	_	_
28	XL	_	NOUN	NN	_	25	nmod	_	_

#	WELLBUTRIN	3875
1	The	_	DET	DT	_	2	det	_	_
2	consumption	_	NOUN	NN	_	12	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	alcohol	_	NOUN	NN	_	2	nmod	_	_
5	during	_	ADP	IN	_	6	case	_	_
6	treatment	_	NOUN	NN	_	2	nmod	_	_
7	with	_	ADP	IN	_	9	case	_	_
8	DRUG	_	NOUN	NN	_	9	compound	_	_
9	XL	_	NOUN	NN	_	6	nmod	_	_
10	should	_	VERB	MD	_	12	aux	_	_
11	be	_	VERB	VB	_	12	auxpass	_	_
12	minimized	_	VERB	VBN	_	0	root	_	_
13	or	_	CONJ	CC	_	12	cc	_	_
14	avoided	_	VERB	VBN	_	12	conj	_	_

#	WELLBUTRIN	3876
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	inhibits	_	VERB	VBZ	_	0	root	_	_
3	the	_	DET	DT	_	4	det	_	_
4	reuptake	_	NOUN	NN	_	2	dobj	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	dopamine	_	NOUN	NN	_	4	nmod	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	norepinephrine	_	NOUN	NN	_	6	conj	_	_

#	WELLBUTRIN	3877
1	Concomitant	_	ADJ	JJ	_	2	amod	_	_
2	use	_	NOUN	NN	_	8	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	MAOIs	_	NOUN	NNS	_	2	nmod	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	DRUG	_	NOUN	NN	_	4	conj	_	_
7	is	_	VERB	VBZ	_	8	auxpass	_	_
8	contraindicated	_	VERB	VBN	_	0	root	_	_
9	because	_	ADP	IN	_	11	mark	_	_
10	there	_	DET	EX	_	11	expl	_	_
11	is	_	VERB	VBZ	_	8	root	_	_
12	an	_	DET	DT	_	14	det	_	_
13	increased	_	VERB	VBN	_	14	amod	_	_
14	risk	_	NOUN	NN	_	11	nsubj	_	_
15	of	_	ADP	IN	_	17	case	_	_
16	hypertensive	_	ADJ	JJ	_	17	amod	_	_
17	reactions	_	NOUN	NNS	_	14	nmod	_	_
18	if	_	ADP	IN	_	21	mark	_	_
19	DRUG	_	NOUN	NN	_	21	nsubjpass	_	_
20	is	_	VERB	VBZ	_	21	auxpass	_	_
21	used	_	VERB	VBN	_	14	ccomp	_	_
22	concomitantly	_	ADV	RB	_	21	advmod	_	_
23	with	_	ADP	IN	_	24	case	_	_
24	MAOIs	_	NOUN	NNS	_	22	nmod	_	_

#	WELLBUTRIN	3878
1	Studies	_	NOUN	NNS	_	4	nsubj	_	_
2	in	_	ADP	IN	_	3	case	_	_
3	animals	_	NOUN	NNS	_	1	nmod	_	_
4	demonstrate	_	VERB	VBP	_	0	root	_	_
5	that	_	ADP	IN	_	12	mark	_	_
6	the	_	DET	DT	_	8	det	_	_
7	acute	_	ADJ	JJ	_	8	amod	_	_
8	toxicity	_	NOUN	NN	_	12	nsubjpass	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	is	_	VERB	VBZ	_	12	auxpass	_	_
12	enhanced	_	VERB	VBN	_	4	ccomp	_	_
13	by	_	ADP	IN	_	16	case	_	_
14	the	_	DET	DT	_	16	det	_	_
15	MAO	_	NOUN	NN	_	16	compound	_	_
16	inhibitor	_	NOUN	NN	_	12	nmod	_	_
17	phenelzine	_	NOUN	NN	_	16	dep	_	_

#	WELLBUTRIN	3879
1	At	_	ADP	IN	_	2	case	_	_
2	least	_	ADJ	JJS	_	3	nmod:npmod	_	_
3	14	_	NUM	CD	_	4	nummod	_	_
4	days	_	NOUN	NNS	_	6	nsubj	_	_
5	should	_	VERB	MD	_	6	aux	_	_
6	elapse	_	VERB	VB	_	0	root	_	_
7	between	_	ADP	IN	_	8	case	_	_
8	discontinuation	_	NOUN	NN	_	6	nmod	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	an	_	DET	DT	_	11	det	_	_
11	MAOI	_	NOUN	NN	_	8	nmod	_	_
12	intended	_	VERB	VBN	_	6	xcomp	_	_
13	to	_	PRT	TO	_	14	mark	_	_
14	treat	_	VERB	VB	_	12	conj	_	_
15	depression	_	NOUN	NN	_	14	dobj	_	_
16	and	_	CONJ	CC	_	14	cc	_	_
17	initiation	_	NOUN	NN	_	14	conj	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	treatment	_	NOUN	NN	_	17	nmod	_	_
20	with	_	ADP	IN	_	22	case	_	_
21	DRUG	_	NOUN	NN	_	22	compound	_	_
22	XL	_	NOUN	NN	_	19	nmod	_	_

#	WELLBUTRIN	3880
1	Conversely	_	ADV	RB	_	9	advmod	_	_
2	,	_	.	,	_	9	punct	_	_
3	at	_	ADP	IN	_	4	case	_	_
4	least	_	ADJ	JJS	_	5	nmod:npmod	_	_
5	14	_	NUM	CD	_	6	nummod	_	_
6	days	_	NOUN	NNS	_	9	nsubjpass	_	_
7	should	_	VERB	MD	_	9	aux	_	_
8	be	_	VERB	VB	_	9	auxpass	_	_
9	allowed	_	VERB	VBN	_	0	root	_	_
10	after	_	ADP	IN	_	11	mark	_	_
11	stopping	_	VERB	VBG	_	9	advcl	_	_
12	DRUG	_	NOUN	NN	_	13	compound	_	_
13	XL	_	NOUN	NN	_	11	dobj	_	_
14	before	_	ADP	IN	_	15	mark	_	_
15	starting	_	VERB	VBG	_	11	advcl	_	_
16	an	_	DET	DT	_	18	det	_	_
17	MAOI	_	NOUN	NN	_	18	compound	_	_
18	antidepressant	_	ADJ	JJ	_	15	dobj	_	_

#	WELLBUTRIN	3881
1	False	_	ADJ	JJ	_	6	amod	_	_
2	positive	_	ADJ	JJ	_	6	amod	_	_
3	urine	_	ADJ	JJ	_	6	amod	_	_
4	immunoassay	_	ADJ	JJ	_	6	amod	_	_
5	screening	_	NOUN	NN	_	6	compound	_	_
6	tests	_	NOUN	NNS	_	11	nsubjpass	_	_
7	for	_	ADP	IN	_	8	case	_	_
8	amphetamines	_	NOUN	NNS	_	6	nmod	_	_
9	have	_	VERB	VBP	_	11	aux	_	_
10	been	_	VERB	VBN	_	11	auxpass	_	_
11	reported	_	VERB	VBN	_	0	root	_	_
12	in	_	ADP	IN	_	13	case	_	_
13	patients	_	NOUN	NNS	_	11	nmod	_	_
14	taking	_	VERB	VBG	_	13	acl	_	_
15	DRUG	_	NOUN	NN	_	14	nmod	_	_

#	WELLBUTRIN	3882
1	This	_	DET	DT	_	5	nsubj	_	_
2	is	_	VERB	VBZ	_	5	cop	_	_
3	due	_	ADJ	JJ	_	5	case	_	_
4	to	_	PRT	TO	_	3	mwe	_	_
5	lack	_	NOUN	NN	_	0	root	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	specificity	_	NOUN	NN	_	5	nmod	_	_
8	of	_	ADP	IN	_	11	case	_	_
9	some	_	DET	DT	_	11	det	_	_
10	screening	_	ADJ	JJ	_	11	amod	_	_
11	tests	_	NOUN	NNS	_	7	nmod	_	_

#	WELLBUTRIN	3883
1	False	_	ADJ	JJ	_	4	amod	_	_
2	positive	_	ADJ	JJ	_	4	amod	_	_
3	test	_	NOUN	NN	_	4	compound	_	_
4	results	_	NOUN	NNS	_	6	nsubj	_	_
5	may	_	VERB	MD	_	6	aux	_	_
6	result	_	VERB	VB	_	0	root	_	_
7	even	_	ADV	RB	_	6	advmod	_	_
8	following	_	VERB	VBG	_	9	case	_	_
9	discontinuation	_	NOUN	NN	_	6	nmod	_	_
10	of	_	ADP	IN	_	12	case	_	_
11	DRUG	_	NOUN	NN	_	12	compound	_	_
12	therapy	_	NOUN	NN	_	9	nmod	_	_

#	WELLBUTRIN	3884
1	Confirmatory	_	ADJ	JJ	_	2	amod	_	_
2	tests	_	NOUN	NNS	_	0	root	_	_
3	,	_	.	,	_	2	punct	_	_
4	such	_	ADJ	JJ	_	7	case	_	_
5	as	_	ADP	IN	_	4	mwe	_	_
6	gas	_	NOUN	NN	_	7	compound	_	_
7	chromatography	_	NOUN	NN	_	2	nmod	_	_
8	/	_	.	:	_	2	punct	_	_
9	mass	_	NOUN	NN	_	10	compound	_	_
10	spectrometry	_	NOUN	NN	_	13	nsubj	_	_
11	,	_	.	,	_	10	punct	_	_
12	will	_	VERB	MD	_	13	aux	_	_
13	distinguish	_	VERB	VB	_	2	dep	_	_
14	DRUG	_	NOUN	NN	_	13	dobj	_	_
15	from	_	ADP	IN	_	16	case	_	_
16	amphetamines	_	NOUN	NNS	_	14	nmod	_	_

#	WELLBUTRIN	3885
1	The	_	DET	DT	_	2	det	_	_
2	mechanism	_	NOUN	NN	_	8	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	action	_	NOUN	NN	_	2	nmod	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	is	_	VERB	VBZ	_	8	cop	_	_
8	unknown	_	ADJ	JJ	_	0	root	_	_
9	,	_	.	,	_	8	punct	_	_
10	as	_	ADP	IN	_	13	mark	_	_
11	is	_	VERB	VBZ	_	13	cop	_	_
12	the	_	DET	DT	_	13	det	_	_
13	case	_	NOUN	NN	_	8	advcl	_	_
14	with	_	ADP	IN	_	16	case	_	_
15	other	_	ADJ	JJ	_	16	amod	_	_
16	antidepressants	_	NOUN	NNS	_	13	nmod	_	_

#	WELLBUTRIN	3886
1	However	_	ADV	RB	_	5	advmod	_	_
2	,	_	.	,	_	5	punct	_	_
3	it	_	PRON	PRP	_	5	nsubjpass	_	_
4	is	_	VERB	VBZ	_	5	auxpass	_	_
5	presumed	_	VERB	VBN	_	0	root	_	_
6	that	_	ADP	IN	_	10	mark	_	_
7	this	_	DET	DT	_	8	det	_	_
8	action	_	NOUN	NN	_	10	nsubjpass	_	_
9	is	_	VERB	VBZ	_	10	auxpass	_	_
10	mediated	_	VERB	VBN	_	5	ccomp	_	_
11	by	_	ADP	IN	_	17	case	_	_
12	noradrenergic	_	ADJ	JJ	_	17	amod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	/	_	NUM	CD	_	12	conj	_	_
15	or	_	CONJ	CC	_	12	cc	_	_
16	dopaminergic	_	ADJ	JJ	_	12	conj	_	_
17	mechanisms	_	NOUN	NNS	_	10	nmod	_	_

#	WELLBUTRIN	3887
1	DRUG	_	NOUN	NN	_	6	nsubj	_	_
2	is	_	VERB	VBZ	_	6	cop	_	_
3	a	_	DET	DT	_	6	det	_	_
4	relatively	_	ADV	RB	_	5	advmod	_	_
5	weak	_	ADJ	JJ	_	6	amod	_	_
6	inhibitor	_	NOUN	NN	_	0	root	_	_
7	of	_	ADP	IN	_	10	case	_	_
8	the	_	DET	DT	_	10	det	_	_
9	neuronal	_	ADJ	JJ	_	10	amod	_	_
10	uptake	_	NOUN	NN	_	6	nmod	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	norepinephrine	_	NOUN	NN	_	10	nmod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	dopamine	_	NOUN	NN	_	12	conj	_	_
15	and	_	CONJ	CC	_	6	cc	_	_
16	does	_	VERB	VBZ	_	18	aux	_	_
17	not	_	ADV	RB	_	18	neg	_	_
18	inhibit	_	VERB	VB	_	6	conj	_	_
19	monoamine	_	NOUN	NN	_	20	compound	_	_
20	oxidase	_	NOUN	NN	_	18	dobj	_	_
21	or	_	CONJ	CC	_	20	cc	_	_
22	the	_	DET	DT	_	23	det	_	_
23	reuptake	_	NOUN	NN	_	20	conj	_	_
24	of	_	ADP	IN	_	25	case	_	_
25	serotonin	_	NOUN	NN	_	23	nmod	_	_

#	WELLBUTRIN	3888
1	The	_	DET	DT	_	3	det	_	_
2	pharmacologic	_	ADJ	JJ	_	3	amod	_	_
3	activity	_	NOUN	NN	_	13	nsubjpass	_	_
4	and	_	CONJ	CC	_	3	cc	_	_
5	pharmacokinetics	_	NOUN	NNS	_	3	conj	_	_
6	of	_	ADP	IN	_	9	case	_	_
7	the	_	DET	DT	_	9	det	_	_
8	individual	_	ADJ	JJ	_	9	amod	_	_
9	enantiomers	_	NOUN	NNS	_	3	nmod	_	_
10	have	_	VERB	VBP	_	13	aux	_	_
11	not	_	ADV	RB	_	13	neg	_	_
12	been	_	VERB	VBN	_	13	auxpass	_	_
13	studied	_	VERB	VBN	_	0	root	_	_

#	WELLBUTRIN	3889
1	Following	_	ADP	IN	_	3	case	_	_
2	chronic	_	ADJ	JJ	_	3	amod	_	_
3	dosing	_	NOUN	NN	_	14	nmod	_	_
4	,	_	.	,	_	14	punct	_	_
5	the	_	DET	DT	_	10	det	_	_
6	mean	_	ADJ	JJ	_	10	compound	_	_
7	steady	_	ADJ	JJ	_	10	amod	_	_
8	state	_	NOUN	NN	_	10	compound	_	_
9	plasma	_	NOUN	NN	_	10	compound	_	_
10	concentration	_	NOUN	NN	_	14	nsubjpass	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_
13	was	_	VERB	VBD	_	14	auxpass	_	_
14	reached	_	VERB	VBN	_	0	root	_	_
15	within	_	ADP	IN	_	17	case	_	_
16	8	_	NUM	CD	_	17	nummod	_	_
17	days	_	NOUN	NNS	_	14	nmod	_	_

#	WELLBUTRIN	3890
1	The	_	DET	DT	_	6	det	_	_
2	mean	_	ADJ	JJ	_	6	compound	_	_
3	elimination	_	NOUN	NN	_	6	compound	_	_
4	half	_	NOUN	NN	_	6	compound	_	_
5	life	_	NOUN	NN	_	6	compound	_	_
6	+SD	_	NOUN	NN	_	0	root	_	_
7	of	_	ADP	IN	_	11	case	_	_
8	DRUG	_	NOUN	NN	_	11	compound	_	_
9	21	_	NUM	CD	_	11	nummod	_	_
10	9	_	NUM	CD	_	11	nummod	_	_
11	hours	_	NOUN	NNS	_	6	nmod	_	_

#	WELLBUTRIN	3891
1	In	_	ADP	IN	_	3	case	_	_
2	a	_	DET	DT	_	3	det	_	_
3	study	_	NOUN	NN	_	32	nmod	_	_
4	comparing	_	VERB	VBG	_	3	acl	_	_
5	14	_	NUM	CD	_	6	nummod	_	_
6	day	_	NOUN	NN	_	7	compound	_	_
7	dosing	_	NOUN	NN	_	4	dobj	_	_
8	with	_	ADP	IN	_	10	case	_	_
9	DRUG	_	NOUN	NN	_	10	compound	_	_
10	XL	_	NOUN	NN	_	7	nmod	_	_
11	,	_	.	,	_	32	punct	_	_
12	300	_	NUM	CD	_	13	nummod	_	_
13	mg	_	NOUN	NN	_	32	nsubjpass	_	_
14	once	_	ADV	RB	_	15	advmod	_	_
15	daily	_	ADV	RB	_	13	advmod	_	_
16	to	_	PRT	TO	_	20	case	_	_
17	the	_	DET	DT	_	20	det	_	_
18	immediate	_	ADJ	JJ	_	20	amod	_	_
19	release	_	NOUN	NN	_	20	compound	_	_
20	formulation	_	NOUN	NN	_	15	nmod	_	_
21	of	_	ADP	IN	_	22	case	_	_
22	DRUG	_	NOUN	NN	_	20	nmod	_	_
23	at	_	ADP	IN	_	27	case	_	_
24	100	_	NUM	CD	_	27	nummod	_	_
25	mg	_	NOUN	NN	_	27	compound	_	_
26	3	_	NUM	CD	_	27	nummod	_	_
27	times	_	NOUN	NNS	_	20	nmod	_	_
28	daily	_	ADV	RB	_	20	advmod	_	_
29	,	_	.	,	_	32	punct	_	_
30	equivalence	_	NOUN	NN	_	32	nsubjpass	_	_
31	was	_	VERB	VBD	_	32	auxpass	_	_
32	demonstrated	_	VERB	VBN	_	0	root	_	_
33	for	_	ADP	IN	_	36	case	_	_
34	peak	_	ADJ	JJ	_	36	amod	_	_
35	plasma	_	NOUN	NN	_	36	compound	_	_
36	concentration	_	NOUN	NN	_	32	nmod	_	_
37	and	_	CONJ	CC	_	36	cc	_	_
38	area	_	NOUN	NN	_	36	conj	_	_
39	under	_	ADP	IN	_	41	case	_	_
40	the	_	DET	DT	_	41	det	_	_
41	curve	_	NOUN	NN	_	32	nmod	_	_
42	for	_	ADP	IN	_	43	case	_	_
43	DRUG	_	NOUN	NN	_	41	nmod	_	_
44	and	_	CONJ	CC	_	43	cc	_	_
45	the	_	DET	DT	_	47	det	_	_
46	three	_	NUM	CD	_	47	nummod	_	_
47	metabolites	_	NOUN	NNS	_	43	conj	_	_
48	hydroxy	_	ADJ	JJ	_	49	compound	_	_
49	DRUG	_	NOUN	NN	_	43	dep	_	_
50	,	_	.	,	_	49	punct	_	_
51	threohydro	_	ADP	IN	_	52	case	_	_
52	DRUG	_	NOUN	NN	_	49	conj	_	_
53	,	_	.	,	_	49	punct	_	_
54	and	_	CONJ	CC	_	49	cc	_	_
55	erythrohydro	_	NOUN	NN	_	56	compound	_	_
56	DRUG	_	NOUN	NN	_	49	conj	_	_

#	WELLBUTRIN	3892
1	Additionally	_	ADV	RB	_	33	advmod	_	_
2	,	_	.	,	_	33	punct	_	_
3	in	_	ADP	IN	_	5	case	_	_
4	a	_	DET	DT	_	5	det	_	_
5	study	_	NOUN	NN	_	33	nmod	_	_
6	comparing	_	VERB	VBG	_	5	acl	_	_
7	14	_	NUM	CD	_	8	nummod	_	_
8	day	_	NOUN	NN	_	9	compound	_	_
9	dosing	_	NOUN	NN	_	6	dobj	_	_
10	with	_	ADP	IN	_	14	case	_	_
11	DRUG	_	NOUN	NN	_	14	compound	_	_
12	XL	_	NOUN	NN	_	14	compound	_	_
13	300	_	NUM	CD	_	14	nummod	_	_
14	mg	_	NOUN	NN	_	9	nmod	_	_
15	once	_	ADV	RB	_	16	advmod	_	_
16	daily	_	ADV	RB	_	9	advmod	_	_
17	to	_	PRT	TO	_	21	case	_	_
18	the	_	DET	DT	_	21	det	_	_
19	sustained	_	ADJ	JJ	_	21	amod	_	_
20	release	_	NOUN	NN	_	21	compound	_	_
21	formulation	_	NOUN	NN	_	16	nmod	_	_
22	of	_	ADP	IN	_	23	case	_	_
23	DRUG	_	NOUN	NN	_	21	nmod	_	_
24	at	_	ADP	IN	_	28	case	_	_
25	150	_	NUM	CD	_	28	nummod	_	_
26	mg	_	NOUN	NN	_	28	compound	_	_
27	2	_	NUM	CD	_	28	nummod	_	_
28	times	_	NOUN	NNS	_	21	nmod	_	_
29	daily	_	ADV	RB	_	21	advmod	_	_
30	,	_	.	,	_	33	punct	_	_
31	equivalence	_	NOUN	NN	_	33	nsubjpass	_	_
32	was	_	VERB	VBD	_	33	auxpass	_	_
33	demonstrated	_	VERB	VBN	_	0	root	_	_
34	for	_	ADP	IN	_	37	case	_	_
35	peak	_	ADJ	JJ	_	37	amod	_	_
36	plasma	_	NOUN	NN	_	37	compound	_	_
37	concentration	_	NOUN	NN	_	33	nmod	_	_
38	and	_	CONJ	CC	_	37	cc	_	_
39	area	_	NOUN	NN	_	37	conj	_	_
40	under	_	ADP	IN	_	42	case	_	_
41	the	_	DET	DT	_	42	det	_	_
42	curve	_	NOUN	NN	_	33	nmod	_	_
43	for	_	ADP	IN	_	44	case	_	_
44	DRUG	_	NOUN	NN	_	42	nmod	_	_
45	and	_	CONJ	CC	_	44	cc	_	_
46	the	_	DET	DT	_	48	det	_	_
47	three	_	NUM	CD	_	48	nummod	_	_
48	metabolites	_	NOUN	NNS	_	44	conj	_	_

#	WELLBUTRIN	3893
1	Absorption	_	NOUN	NN	_	26	nsubj	_	_
2	Following	_	ADP	IN	_	5	case	_	_
3	single	_	ADJ	JJ	_	5	amod	_	_
4	oral	_	ADJ	JJ	_	5	amod	_	_
5	administration	_	NOUN	NN	_	1	nmod	_	_
6	of	_	ADP	IN	_	9	case	_	_
7	DRUG	_	NOUN	NN	_	9	compound	_	_
8	XL	_	NOUN	NN	_	9	compound	_	_
9	tablets	_	NOUN	NNS	_	5	nmod	_	_
10	to	_	PRT	TO	_	12	case	_	_
11	healthy	_	ADJ	JJ	_	12	amod	_	_
12	volunteers	_	NOUN	NNS	_	1	nmod	_	_
13	,	_	.	,	_	1	punct	_	_
14	the	_	DET	DT	_	16	det	_	_
15	median	_	ADJ	JJ	_	16	amod	_	_
16	time	_	NOUN	NN	_	1	appos	_	_
17	to	_	PRT	TO	_	18	mark	_	_
18	peak	_	VERB	VB	_	16	acl	_	_
19	plasma	_	NOUN	NN	_	20	compound	_	_
20	concentrations	_	NOUN	NNS	_	18	dobj	_	_
21	for	_	ADP	IN	_	22	case	_	_
22	DRUG	_	NOUN	NN	_	20	nmod	_	_
23	was	_	VERB	VBD	_	26	cop	_	_
24	approximately	_	ADV	RB	_	26	advmod	_	_
25	5	_	NUM	CD	_	26	nummod	_	_
26	hours	_	NOUN	NNS	_	0	root	_	_

#	WELLBUTRIN	3894
1	The	_	DET	DT	_	2	det	_	_
2	presence	_	NOUN	NN	_	7	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	food	_	NOUN	NN	_	2	nmod	_	_
5	did	_	VERB	VBD	_	7	aux	_	_
6	not	_	ADV	RB	_	7	neg	_	_
7	affect	_	VERB	VB	_	0	root	_	_
8	the	_	DET	DT	_	10	det	_	_
9	peak	_	ADJ	JJ	_	10	amod	_	_
10	concentration	_	NOUN	NN	_	7	dobj	_	_
11	or	_	CONJ	CC	_	10	cc	_	_
12	area	_	NOUN	NN	_	10	conj	_	_
13	under	_	ADP	IN	_	15	case	_	_
14	the	_	DET	DT	_	15	det	_	_
15	curve	_	NOUN	NN	_	7	nmod	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	DRUG	_	NOUN	NN	_	15	nmod	_	_

#	WELLBUTRIN	3895
1	Distribution	_	NOUN	NN	_	4	compound	_	_
2	In	_	X	FW	_	4	amod	_	_
3	vitro	_	X	FW	_	2	dep	_	_
4	tests	_	NOUN	NNS	_	5	nsubj	_	_
5	show	_	VERB	VBP	_	0	root	_	_
6	that	_	ADP	IN	_	10	mark	_	_
7	DRUG	_	NOUN	NN	_	10	nsubjpass	_	_
8	is	_	VERB	VBZ	_	10	auxpass	_	_
9	84%	_	ADJ	JJ	_	10	advmod	_	_
10	bound	_	VERB	VBN	_	5	ccomp	_	_
11	to	_	PRT	TO	_	14	case	_	_
12	human	_	ADJ	JJ	_	14	amod	_	_
13	plasma	_	NOUN	NN	_	14	compound	_	_
14	proteins	_	NOUN	NNS	_	10	nmod	_	_
15	at	_	ADP	IN	_	16	case	_	_
16	concentrations	_	NOUN	NNS	_	14	nmod	_	_
17	up	_	ADV	RB	_	19	advmod	_	_
18	to	_	PRT	TO	_	17	mwe	_	_
19	200	_	NUM	CD	_	20	nummod	_	_
20	mcg	_	NOUN	NN	_	16	nmod	_	_
21	/	_	.	:	_	10	punct	_	_
22	mL	_	NOUN	NN	_	10	parataxis	_	_

#	WELLBUTRIN	3896
1	The	_	DET	DT	_	2	det	_	_
2	extent	_	NOUN	NN	_	12	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	protein	_	NOUN	NN	_	5	compound	_	_
5	binding	_	NOUN	NN	_	2	nmod	_	_
6	of	_	ADP	IN	_	10	case	_	_
7	the	_	DET	DT	_	10	det	_	_
8	hydroxy	_	ADJ	JJ	_	10	amod	_	_
9	DRUG	_	NOUN	NN	_	10	compound	_	_
10	metabolite	_	NOUN	NN	_	5	nmod	_	_
11	is	_	VERB	VBZ	_	12	cop	_	_
12	similar	_	ADJ	JJ	_	0	root	_	_
13	to	_	PRT	TO	_	14	case	_	_
14	that	_	DET	WDT	_	12	nmod	_	_
15	for	_	ADP	IN	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	14	nmod	_	_
17	,	_	.	,	_	12	punct	_	_
18	whereas	_	ADP	IN	_	31	mark	_	_
19	the	_	DET	DT	_	20	det	_	_
20	extent	_	NOUN	NN	_	31	nsubj	_	_
21	of	_	ADP	IN	_	23	case	_	_
22	protein	_	NOUN	NN	_	23	compound	_	_
23	binding	_	NOUN	NN	_	20	nmod	_	_
24	of	_	ADP	IN	_	28	case	_	_
25	the	_	DET	DT	_	28	det	_	_
26	threohydro	_	ADJ	JJ	_	28	amod	_	_
27	DRUG	_	NOUN	NN	_	28	compound	_	_
28	metabolite	_	NOUN	NN	_	23	nmod	_	_
29	is	_	VERB	VBZ	_	31	cop	_	_
30	about	_	ADV	RB	_	31	advmod	_	_
31	half	_	VERB	VB	_	12	advcl	_	_
32	that	_	ADP	IN	_	31	dobj	_	_
33	of	_	ADP	IN	_	34	case	_	_
34	DRUG	_	NOUN	NN	_	32	root	_	_

#	WELLBUTRIN	3897
1	Metabolism	_	NOUN	NN	_	2	compound	_	_
2	DRUG	_	NOUN	NN	_	5	nsubjpass	_	_
3	is	_	VERB	VBZ	_	5	auxpass	_	_
4	extensively	_	ADV	RB	_	5	advmod	_	_
5	metabolized	_	VERB	VBN	_	0	root	_	_
6	in	_	ADP	IN	_	7	case	_	_
7	humans	_	NOUN	NNS	_	5	nmod	_	_

#	WELLBUTRIN	3898
1	Three	_	NUM	CD	_	2	nummod	_	_
2	metabolites	_	NOUN	NNS	_	4	nsubj	_	_
3	are	_	VERB	VBP	_	4	cop	_	_
4	active	_	ADJ	JJ	_	0	root	_	_
5	:	_	.	:	_	4	punct	_	_
6	hydroxy	_	NOUN	NN	_	7	compound	_	_
7	DRUG	_	NOUN	NN	_	4	parataxis	_	_
8	,	_	.	,	_	7	punct	_	_
9	which	_	DET	WDT	_	11	nsubjpass	_	_
10	is	_	VERB	VBZ	_	11	auxpass	_	_
11	formed	_	VERB	VBN	_	7	acl:relcl	_	_
12	via	_	ADP	IN	_	13	case	_	_
13	hydroxylation	_	NOUN	NN	_	11	nmod	_	_
14	of	_	ADP	IN	_	18	case	_	_
15	the	_	DET	DT	_	18	det	_	_
16	tert	_	ADJ	JJ	_	18	amod	_	_
17	butyl	_	NOUN	NN	_	18	compound	_	_
18	group	_	NOUN	NN	_	13	nmod	_	_
19	of	_	ADP	IN	_	20	case	_	_
20	DRUG	_	NOUN	NN	_	18	nmod	_	_
21	,	_	.	,	_	13	punct	_	_
22	and	_	CONJ	CC	_	13	cc	_	_
23	the	_	DET	DT	_	26	det	_	_
24	amino	_	NOUN	NN	_	26	compound	_	_
25	alcohol	_	NOUN	NN	_	26	compound	_	_
26	isomers	_	NOUN	NNS	_	13	conj	_	_
27	threohydro	_	X	FW	_	28	case	_	_
28	DRUG	_	NOUN	NN	_	26	nmod	_	_
29	and	_	CONJ	CC	_	28	cc	_	_
30	erythrohydro	_	NOUN	NN	_	31	compound	_	_
31	DRUG	_	NOUN	NN	_	28	conj	_	_
32	,	_	.	,	_	28	punct	_	_
33	which	_	DET	WDT	_	35	nsubjpass	_	_
34	are	_	VERB	VBP	_	35	auxpass	_	_
35	formed	_	VERB	VBN	_	28	acl:relcl	_	_
36	via	_	ADP	IN	_	37	case	_	_
37	reduction	_	NOUN	NN	_	35	nmod	_	_
38	of	_	ADP	IN	_	41	case	_	_
39	the	_	DET	DT	_	41	det	_	_
40	carbonyl	_	NOUN	NN	_	41	compound	_	_
41	group	_	NOUN	NN	_	37	nmod	_	_

#	WELLBUTRIN	3899
1	In	_	X	FW	_	3	amod	_	_
2	vitro	_	X	FW	_	1	dep	_	_
3	findings	_	NOUN	NNS	_	4	nsubj	_	_
4	suggest	_	VERB	VBP	_	0	root	_	_
5	that	_	ADP	IN	_	10	mark	_	_
6	CYP2B6	_	NOUN	NN	_	10	nsubj	_	_
7	is	_	VERB	VBZ	_	10	cop	_	_
8	the	_	DET	DT	_	10	det	_	_
9	principal	_	ADJ	JJ	_	10	amod	_	_
10	isoenzyme	_	NOUN	NN	_	4	ccomp	_	_
11	involved	_	VERB	VBN	_	10	acl	_	_
12	in	_	ADP	IN	_	14	case	_	_
13	the	_	DET	DT	_	14	det	_	_
14	formation	_	NOUN	NN	_	11	nmod	_	_
15	of	_	ADP	IN	_	17	case	_	_
16	hydroxy	_	NOUN	NN	_	17	compound	_	_
17	DRUG	_	NOUN	NN	_	14	nmod	_	_
18	,	_	.	,	_	10	punct	_	_
19	while	_	ADP	IN	_	25	mark	_	_
20	cytochrome	_	NOUN	NN	_	22	compound	_	_
21	P450	_	NOUN	NN	_	22	compound	_	_
22	enzymes	_	NOUN	NNS	_	25	nsubjpass	_	_
23	are	_	VERB	VBP	_	25	auxpass	_	_
24	not	_	ADV	RB	_	25	neg	_	_
25	involved	_	VERB	VBN	_	10	advcl	_	_
26	in	_	ADP	IN	_	28	case	_	_
27	the	_	DET	DT	_	28	det	_	_
28	formation	_	NOUN	NN	_	25	nmod	_	_
29	of	_	ADP	IN	_	31	case	_	_
30	threohydro	_	NOUN	NN	_	31	det	_	_
31	DRUG	_	NOUN	NN	_	28	nmod	_	_

#	WELLBUTRIN	3900
1	Oxidation	_	NOUN	NN	_	7	nsubj	_	_
2	of	_	ADP	IN	_	6	case	_	_
3	the	_	DET	DT	_	6	det	_	_
4	DRUG	_	NOUN	NN	_	6	compound	_	_
5	side	_	ADJ	JJ	_	6	amod	_	_
6	chain	_	NOUN	NN	_	1	nmod	_	_
7	results	_	VERB	VBZ	_	0	root	_	_
8	in	_	ADP	IN	_	10	case	_	_
9	the	_	DET	DT	_	10	det	_	_
10	formation	_	NOUN	NN	_	7	nmod	_	_
11	of	_	ADP	IN	_	14	case	_	_
12	a	_	DET	DT	_	14	det	_	_
13	glycine	_	NOUN	NN	_	14	compound	_	_
14	conjugate	_	NOUN	NN	_	10	nmod	_	_
15	of	_	ADP	IN	_	18	case	_	_
16	meta	_	NOUN	NN	_	18	compound	_	_
17	chlorobenzoic	_	ADJ	JJ	_	18	amod	_	_
18	acid	_	NOUN	NN	_	14	nmod	_	_
19	,	_	.	,	_	18	punct	_	_
20	which	_	DET	WDT	_	23	nsubjpass	_	_
21	is	_	VERB	VBZ	_	23	auxpass	_	_
22	then	_	ADV	RB	_	23	advmod	_	_
23	excreted	_	VERB	VBN	_	18	acl:relcl	_	_
24	as	_	ADP	IN	_	28	case	_	_
25	the	_	DET	DT	_	28	det	_	_
26	major	_	ADJ	JJ	_	28	amod	_	_
27	urinary	_	ADJ	JJ	_	28	amod	_	_
28	metabolite	_	NOUN	NN	_	23	nmod	_	_

#	WELLBUTRIN	3901
1	The	_	DET	DT	_	2	det	_	_
2	potency	_	NOUN	NN	_	15	nsubjpass	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	toxicity	_	NOUN	NN	_	2	conj	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	metabolites	_	NOUN	NNS	_	2	nmod	_	_
8	relative	_	ADJ	JJ	_	7	amod	_	_
9	to	_	PRT	TO	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	have	_	VERB	MD	_	15	aux	_	_
12	not	_	ADV	RB	_	15	neg	_	_
13	been	_	VERB	VBN	_	15	auxpass	_	_
14	fully	_	ADV	RB	_	15	advmod	_	_
15	characterized	_	VERB	VBN	_	0	root	_	_

#	WELLBUTRIN	3902
1	However	_	ADV	RB	_	6	advmod	_	_
2	,	_	.	,	_	6	punct	_	_
3	it	_	PRON	PRP	_	6	nsubjpass	_	_
4	has	_	VERB	VBZ	_	6	aux	_	_
5	been	_	VERB	VBN	_	6	auxpass	_	_
6	demonstrated	_	VERB	VBN	_	0	root	_	_
7	in	_	ADP	IN	_	11	case	_	_
8	an	_	DET	DT	_	11	det	_	_
9	antidepressant	_	ADJ	JJ	_	11	amod	_	_
10	screening	_	NOUN	NN	_	11	compound	_	_
11	test	_	NOUN	NN	_	6	nmod	_	_
12	in	_	ADP	IN	_	13	case	_	_
13	mice	_	NOUN	NNS	_	11	nmod	_	_
14	that	_	DET	WDT	_	15	nsubj	_	_
15	hydroxy	_	VERB	VBP	_	13	acl:relcl	_	_
16	DRUG	_	NOUN	NN	_	15	dobj	_	_
17	is	_	VERB	VBZ	_	19	cop	_	_
18	one	_	NUM	CD	_	19	nummod	_	_
19	half	_	NOUN	NN	_	6	parataxis	_	_
20	as	_	ADV	RB	_	21	advmod	_	_
21	potent	_	ADJ	JJ	_	19	advmod	_	_
22	as	_	ADP	IN	_	23	case	_	_
23	DRUG	_	NOUN	NN	_	21	nmod	_	_
24	,	_	.	,	_	19	punct	_	_
25	while	_	ADP	IN	_	33	mark	_	_
26	threohydro	_	X	FW	_	27	compound	_	_
27	DRUG	_	NOUN	NN	_	33	nsubj	_	_
28	and	_	CONJ	CC	_	27	cc	_	_
29	erythrohydro	_	NOUN	NN	_	30	compound	_	_
30	DRUG	_	NOUN	NN	_	27	conj	_	_
31	are	_	VERB	VBP	_	33	cop	_	_
32	5	_	NUM	CD	_	33	nummod	_	_
33	fold	_	NOUN	NN	_	19	advcl	_	_
34	less	_	ADV	RB	_	35	advmod	_	_
35	potent	_	ADJ	JJ	_	33	dep	_	_
36	than	_	ADP	IN	_	37	case	_	_
37	DRUG	_	NOUN	NN	_	35	nmod	_	_

#	WELLBUTRIN	3903
1	This	_	DET	DT	_	6	nsubj	_	_
2	may	_	VERB	MD	_	6	aux	_	_
3	be	_	VERB	VB	_	6	cop	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	clinical	_	ADJ	JJ	_	6	amod	_	_
6	importance	_	NOUN	NN	_	0	root	_	_
7	,	_	.	,	_	6	punct	_	_
8	because	_	ADP	IN	_	17	mark	_	_
9	the	_	DET	DT	_	11	det	_	_
10	plasma	_	NOUN	NN	_	11	compound	_	_
11	concentrations	_	NOUN	NNS	_	17	nsubj	_	_
12	of	_	ADP	IN	_	14	case	_	_
13	the	_	DET	DT	_	14	det	_	_
14	metabolites	_	NOUN	NNS	_	11	nmod	_	_
15	are	_	VERB	VBP	_	17	cop	_	_
16	as	_	ADP	IN	_	17	case	_	_
17	high	_	ADJ	JJ	_	6	advcl	_	_
18	or	_	CONJ	CC	_	17	cc	_	_
19	higher	_	ADJ	JJ	_	17	conj	_	_
20	than	_	ADP	IN	_	21	case	_	_
21	those	_	DET	DT	_	19	nmod	_	_
22	of	_	ADP	IN	_	23	case	_	_
23	DRUG	_	NOUN	NN	_	21	nmod	_	_

#	WELLBUTRIN	3904
1	At	_	ADP	IN	_	3	case	_	_
2	steady	_	ADJ	JJ	_	3	amod	_	_
3	state	_	NOUN	NN	_	11	nmod	_	_
4	,	_	.	,	_	11	punct	_	_
5	peak	_	ADJ	JJ	_	7	amod	_	_
6	plasma	_	NOUN	NN	_	7	compound	_	_
7	concentration	_	NOUN	NN	_	11	nsubj	_	_
8	of	_	ADP	IN	_	10	case	_	_
9	hydroxy	_	NOUN	NN	_	10	amod	_	_
10	DRUG	_	NOUN	NN	_	7	nmod	_	_
11	occurred	_	VERB	VBD	_	0	root	_	_
12	approximately	_	ADV	RB	_	13	advmod	_	_
13	7	_	NUM	CD	_	14	nummod	_	_
14	hours	_	NOUN	NNS	_	11	dobj	_	_
15	after	_	ADP	IN	_	16	case	_	_
16	administration	_	NOUN	NN	_	11	nmod	_	_
17	of	_	ADP	IN	_	19	case	_	_
18	DRUG	_	NOUN	NN	_	19	compound	_	_
19	XL	_	NOUN	NN	_	16	nmod	_	_
20	,	_	.	,	_	11	punct	_	_
21	and	_	CONJ	CC	_	11	cc	_	_
22	it	_	PRON	PRP	_	26	nsubj	_	_
23	was	_	VERB	VBD	_	26	cop	_	_
24	approximately	_	ADV	RB	_	25	advmod	_	_
25	7	_	NUM	CD	_	26	nummod	_	_
26	times	_	NOUN	NNS	_	11	conj	_	_
27	the	_	DET	DT	_	29	det	_	_
28	peak	_	ADJ	JJ	_	29	amod	_	_
29	level	_	NOUN	NN	_	26	dobj	_	_
30	of	_	ADP	IN	_	33	case	_	_
31	the	_	DET	DT	_	33	det	_	_
32	parent	_	NOUN	NN	_	33	compound	_	_
33	drug	_	NOUN	NN	_	29	nmod	_	_

#	WELLBUTRIN	3905
1	The	_	DET	DT	_	4	det	_	_
2	elimination	_	NOUN	NN	_	4	compound	_	_
3	half	_	NOUN	NN	_	4	compound	_	_
4	life	_	NOUN	NN	_	12	nsubj	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	hydroxy	_	NOUN	NN	_	7	compound	_	_
7	DRUG	_	NOUN	NN	_	4	nmod	_	_
8	is	_	VERB	VBZ	_	12	cop	_	_
9	approximately	_	ADV	RB	_	12	advmod	_	_
10	20	_	NUM	CD	_	12	nummod	_	_
11	5	_	NUM	CD	_	12	nummod	_	_
12	hours	_	NOUN	NNS	_	0	root	_	_
13	,	_	.	,	_	12	punct	_	_
14	and	_	CONJ	CC	_	12	cc	_	_
15	its	_	PRON	PRP$	_	16	nmod:poss	_	_
16	AUC	_	NOUN	NN	_	23	nsubj	_	_
17	at	_	ADP	IN	_	19	case	_	_
18	steady	_	ADJ	JJ	_	19	amod	_	_
19	state	_	NOUN	NN	_	16	nmod	_	_
20	is	_	VERB	VBZ	_	23	cop	_	_
21	about	_	ADV	RB	_	22	advmod	_	_
22	13	_	NUM	CD	_	23	nummod	_	_
23	times	_	NOUN	NNS	_	12	conj	_	_
24	that	_	DET	WDT	_	23	nmod	_	_
25	of	_	ADP	IN	_	26	case	_	_
26	DRUG	_	NOUN	NN	_	24	nmod	_	_

#	WELLBUTRIN	3906
1	The	_	DET	DT	_	2	det	_	_
2	times	_	NOUN	NNS	_	15	nsubj	_	_
3	to	_	PRT	TO	_	4	mark	_	_
4	peak	_	VERB	VB	_	2	acl	_	_
5	concentrations	_	NOUN	NNS	_	4	dobj	_	_
6	for	_	ADP	IN	_	9	case	_	_
7	the	_	DET	DT	_	9	det	_	_
8	erythrohydro	_	ADJ	JJ	_	9	compound	_	_
9	DRUG	_	NOUN	NN	_	5	nmod	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	threohydro	_	NOUN	NN	_	13	amod	_	_
12	DRUG	_	NOUN	NN	_	13	compound	_	_
13	metabolites	_	NOUN	NNS	_	9	conj	_	_
14	are	_	VERB	VBP	_	15	cop	_	_
15	similar	_	ADJ	JJ	_	0	root	_	_
16	to	_	PRT	TO	_	17	case	_	_
17	that	_	DET	DT	_	15	nmod	_	_
18	of	_	ADP	IN	_	20	case	_	_
19	hydroxy	_	NOUN	NN	_	20	compound	_	_
20	DRUG	_	NOUN	NN	_	17	nmod	_	_

#	WELLBUTRIN	3907
1	However	_	ADV	RB	_	38	advmod	_	_
2	,	_	.	,	_	38	punct	_	_
3	the	_	DET	DT	_	6	det	_	_
4	elimination	_	NOUN	NN	_	6	compound	_	_
5	half	_	ADJ	JJ	_	6	compound	_	_
6	lives	_	NOUN	NNS	_	38	nsubj	_	_
7	of	_	ADP	IN	_	9	case	_	_
8	erythrohydro	_	NOUN	NN	_	9	compound	_	_
9	DRUG	_	NOUN	NN	_	6	nmod	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	threohydro	_	ADV	RB	_	12	amod	_	_
12	DRUG	_	NOUN	NN	_	9	conj	_	_
13	are	_	VERB	VBP	_	38	cop	_	_
14	longer	_	ADV	RB	_	38	advmod	_	_
15	,	_	.	,	_	38	punct	_	_
16	approximately	_	ADV	RB	_	17	advmod	_	_
17	33	_	NUM	CD	_	18	nummod	_	_
18	10	_	NUM	CD	_	38	compound	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	37	_	NUM	CD	_	22	nummod	_	_
21	13	_	NUM	CD	_	22	nummod	_	_
22	hours	_	NOUN	NNS	_	18	conj	_	_
23	,	_	.	,	_	38	punct	_	_
24	respectively	_	ADV	RB	_	25	advmod	_	_
25	and	_	CONJ	CC	_	38	cc	_	_
26	steady	_	ADJ	JJ	_	28	amod	_	_
27	state	_	NOUN	NN	_	28	compound	_	_
28	AUCs	_	NOUN	NNS	_	33	nsubj	_	_
29	were	_	VERB	VBD	_	33	cop	_	_
30	1.4	_	NUM	CD	_	33	nummod	_	_
31	and	_	CONJ	CC	_	30	cc	_	_
32	7	_	NUM	CD	_	30	conj	_	_
33	times	_	NOUN	NNS	_	25	conj	_	_
34	that	_	DET	WDT	_	33	dep	_	_
35	of	_	ADP	IN	_	36	case	_	_
36	DRUG	_	NOUN	NN	_	34	nmod	_	_
37	,	_	.	,	_	38	punct	_	_
38	respectively	_	ADV	RB	_	0	root	_	_

#	WELLBUTRIN	3908
1	DRUG	_	NOUN	NN	_	5	nsubj	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	its	_	PRON	PRP$	_	4	nmod:poss	_	_
4	metabolites	_	NOUN	NNS	_	1	conj	_	_
5	exhibit	_	VERB	VBP	_	0	root	_	_
6	linear	_	ADJ	JJ	_	7	amod	_	_
7	kinetics	_	NOUN	NNS	_	5	dobj	_	_
8	following	_	VERB	VBG	_	10	case	_	_
9	chronic	_	ADJ	JJ	_	10	amod	_	_
10	administration	_	NOUN	NN	_	5	nmod	_	_
11	of	_	ADP	IN	_	17	case	_	_
12	300	_	NUM	CD	_	14	compound	_	_
13	to	_	PRT	TO	_	14	dep	_	_
14	450	_	NUM	CD	_	15	nummod	_	_
15	mg	_	NOUN	NN	_	17	compound	_	_
16	/	_	NUM	CD	_	17	punct	_	_
17	day	_	NOUN	NN	_	10	nmod	_	_

#	WELLBUTRIN	3909
1	Elimination	_	NOUN	NN	_	22	nsubjpass	_	_
2	Following	_	ADP	IN	_	4	case	_	_
3	oral	_	ADJ	JJ	_	4	amod	_	_
4	administration	_	NOUN	NN	_	1	nmod	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	200	_	NUM	CD	_	7	nummod	_	_
7	mg	_	NOUN	NN	_	4	nmod	_	_
8	of	_	ADP	IN	_	10	case	_	_
9	14C	_	NOUN	NN	_	10	compound	_	_
10	DRUG	_	NOUN	NN	_	7	nmod	_	_
11	in	_	ADP	IN	_	12	case	_	_
12	humans	_	NOUN	NNS	_	4	nmod	_	_
13	,	_	.	,	_	4	punct	_	_
14	87%	_	NOUN	NN	_	4	appos	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	10%	_	NOUN	NN	_	14	conj	_	_
17	of	_	ADP	IN	_	20	case	_	_
18	the	_	DET	DT	_	20	det	_	_
19	radioactive	_	ADJ	JJ	_	20	amod	_	_
20	dose	_	NOUN	NN	_	14	nmod	_	_
21	were	_	VERB	VBD	_	22	auxpass	_	_
22	recovered	_	VERB	VBN	_	0	root	_	_
23	in	_	ADP	IN	_	25	case	_	_
24	the	_	DET	DT	_	25	det	_	_
25	urine	_	ADJ	JJ	_	22	nmod	_	_
26	and	_	CONJ	CC	_	25	cc	_	_
27	feces	_	NOUN	NNS	_	25	conj	_	_
28	,	_	.	,	_	25	punct	_	_
29	respectively	_	ADV	RB	_	25	advmod	_	_

#	WELLBUTRIN	3910
1	Only	_	ADV	RB	_	2	advmod	_	_
2	0.5%	_	NOUN	NN	_	8	nsubjpass	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	the	_	DET	DT	_	6	det	_	_
5	oral	_	ADJ	JJ	_	6	amod	_	_
6	dose	_	NOUN	NN	_	2	nmod	_	_
7	was	_	VERB	VBD	_	8	auxpass	_	_
8	excreted	_	VERB	VBN	_	0	root	_	_
9	as	_	ADP	IN	_	11	case	_	_
10	unchanged	_	ADJ	JJ	_	11	amod	_	_
11	DRUG	_	NOUN	NN	_	8	nmod	_	_

#	WELLBUTRIN	3911
1	Population	_	NOUN	NN	_	2	compound	_	_
2	Subgroups	_	NOUN	NNS	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	Factors	_	NOUN	NNS	_	30	nsubjpass	_	_
5	or	_	CONJ	CC	_	4	cc	_	_
6	conditions	_	NOUN	NNS	_	4	conj	_	_
7	altering	_	VERB	VBG	_	4	acl	_	_
8	metabolic	_	ADJ	JJ	_	10	amod	_	_
9	capacity	_	NOUN	NN	_	10	compound	_	_
10	e.g	_	NOUN	NN	_	7	dobj	_	_
11	,	_	.	,	_	10	punct	_	_
12	liver	_	NOUN	NN	_	13	compound	_	_
13	disease	_	NOUN	NN	_	10	conj	_	_
14	,	_	.	,	_	10	punct	_	_
15	congestive	_	ADJ	JJ	_	18	amod	_	_
16	heart	_	NOUN	NN	_	18	compound	_	_
17	failure	_	NOUN	NN	_	18	compound	_	_
18	CHF	_	NOUN	NN	_	10	conj	_	_
19	,	_	.	,	_	10	punct	_	_
20	age	_	NOUN	NN	_	10	conj	_	_
21	,	_	.	,	_	10	punct	_	_
22	concomitant	_	ADJ	JJ	_	23	amod	_	_
23	medications	_	NOUN	NNS	_	10	conj	_	_
24	,	_	.	,	_	10	punct	_	_
25	etc	_	NOUN	NN	_	10	conj	_	_
26	or	_	CONJ	CC	_	10	cc	_	_
27	elimination	_	NOUN	NN	_	10	conj	_	_
28	may	_	VERB	MD	_	30	aux	_	_
29	be	_	VERB	VB	_	30	auxpass	_	_
30	expected	_	VERB	VBN	_	2	dep	_	_
31	to	_	PRT	TO	_	32	mark	_	_
32	influence	_	VERB	VB	_	30	xcomp	_	_
33	the	_	DET	DT	_	34	det	_	_
34	degree	_	NOUN	NN	_	32	dobj	_	_
35	and	_	CONJ	CC	_	34	cc	_	_
36	extent	_	NOUN	NN	_	34	conj	_	_
37	of	_	ADP	IN	_	38	case	_	_
38	accumulation	_	NOUN	NN	_	34	nmod	_	_
39	of	_	ADP	IN	_	42	case	_	_
40	the	_	DET	DT	_	42	det	_	_
41	active	_	ADJ	JJ	_	42	amod	_	_
42	metabolites	_	NOUN	NNS	_	38	nmod	_	_
43	of	_	ADP	IN	_	44	case	_	_
44	DRUG	_	NOUN	NN	_	42	nmod	_	_

#	WELLBUTRIN	3912
1	The	_	DET	DT	_	2	det	_	_
2	elimination	_	NOUN	NN	_	11	nsubjpass	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	the	_	DET	DT	_	6	det	_	_
5	major	_	ADJ	JJ	_	6	amod	_	_
6	metabolites	_	NOUN	NNS	_	2	nmod	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	may	_	VERB	MD	_	11	aux	_	_
10	be	_	VERB	VB	_	11	auxpass	_	_
11	affected	_	VERB	VBN	_	0	root	_	_
12	by	_	ADP	IN	_	14	case	_	_
13	reduced	_	VERB	VBN	_	14	amod	_	_
14	renal	_	ADJ	JJ	_	11	nmod	_	_
15	or	_	CONJ	CC	_	14	cc	_	_
16	hepatic	_	ADJ	JJ	_	14	conj	_	_
17	function	_	NOUN	NN	_	14	dep	_	_
18	,	_	.	,	_	11	punct	_	_
19	because	_	ADP	IN	_	24	mark	_	_
20	they	_	PRON	PRP	_	24	nsubj	_	_
21	are	_	VERB	VBP	_	24	cop	_	_
22	moderately	_	ADV	RB	_	23	advmod	_	_
23	polar	_	ADJ	JJ	_	24	amod	_	_
24	compounds	_	NOUN	NNS	_	11	advcl	_	_
25	and	_	CONJ	CC	_	24	cc	_	_
26	are	_	VERB	VBP	_	27	cop	_	_
27	likely	_	ADJ	JJ	_	24	conj	_	_
28	to	_	PRT	TO	_	29	mark	_	_
29	undergo	_	VERB	VB	_	27	xcomp	_	_
30	further	_	ADV	RB	_	31	amod	_	_
31	metabolism	_	NOUN	NN	_	29	dobj	_	_
32	or	_	CONJ	CC	_	31	cc	_	_
33	conjugation	_	NOUN	NN	_	31	conj	_	_
34	in	_	ADP	IN	_	36	case	_	_
35	the	_	DET	DT	_	36	det	_	_
36	liver	_	NOUN	NN	_	31	nmod	_	_
37	prior	_	ADJ	JJ	_	40	case	_	_
38	to	_	PRT	TO	_	40	case	_	_
39	urinary	_	ADJ	JJ	_	40	amod	_	_
40	excretion	_	NOUN	NN	_	29	nmod	_	_

#	WELLBUTRIN	3913
1	Renal	_	ADJ	JJ	_	2	amod	_	_
2	Impairment	_	NOUN	NN	_	6	nsubj	_	_
3	There	_	DET	EX	_	2	nummod	_	_
4	is	_	VERB	VBZ	_	6	cop	_	_
5	limited	_	ADJ	JJ	_	6	amod	_	_
6	information	_	NOUN	NN	_	0	root	_	_
7	on	_	ADP	IN	_	9	case	_	_
8	the	_	DET	DT	_	9	det	_	_
9	pharmacokinetics	_	NOUN	NNS	_	6	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_
12	in	_	ADP	IN	_	13	case	_	_
13	patients	_	NOUN	NNS	_	9	nmod	_	_
14	with	_	ADP	IN	_	16	case	_	_
15	renal	_	ADJ	JJ	_	16	amod	_	_
16	impairment	_	NOUN	NN	_	13	nmod	_	_

#	WELLBUTRIN	3914
1	An	_	DET	DT	_	4	det	_	_
2	inter	_	ADJ	JJ	_	4	amod	_	_
3	trial	_	ADJ	JJ	_	4	amod	_	_
4	comparison	_	NOUN	NN	_	15	nsubj	_	_
5	between	_	ADP	IN	_	7	case	_	_
6	normal	_	ADJ	JJ	_	7	amod	_	_
7	subjects	_	NOUN	NNS	_	4	nmod	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	patients	_	NOUN	NNS	_	7	conj	_	_
10	with	_	ADP	IN	_	14	case	_	_
11	end	_	NOUN	NN	_	14	compound	_	_
12	stage	_	NOUN	NN	_	14	compound	_	_
13	renal	_	ADJ	JJ	_	14	amod	_	_
14	failure	_	NOUN	NN	_	7	nmod	_	_
15	demonstrated	_	VERB	VBD	_	0	root	_	_
16	that	_	ADP	IN	_	25	mark	_	_
17	the	_	DET	DT	_	20	det	_	_
18	parent	_	NOUN	NN	_	20	compound	_	_
19	drug	_	NOUN	NN	_	20	compound	_	_
20	Cmax	_	NOUN	NN	_	25	nsubj	_	_
21	and	_	CONJ	CC	_	20	cc	_	_
22	AUC	_	NOUN	NN	_	23	compound	_	_
23	values	_	NOUN	NNS	_	20	conj	_	_
24	were	_	VERB	VBD	_	25	cop	_	_
25	comparable	_	ADJ	JJ	_	15	ccomp	_	_
26	in	_	ADP	IN	_	29	case	_	_
27	the	_	DET	DT	_	29	det	_	_
28	2	_	NUM	CD	_	29	nummod	_	_
29	groups	_	NOUN	NNS	_	25	nmod	_	_
30	,	_	.	,	_	25	punct	_	_
31	whereas	_	ADP	IN	_	39	mark	_	_
32	the	_	DET	DT	_	34	det	_	_
33	hydroxy	_	ADJ	JJ	_	34	amod	_	_
34	DRUG	_	NOUN	NN	_	39	nsubj	_	_
35	and	_	CONJ	CC	_	34	cc	_	_
36	threohydro	_	NOUN	NN	_	38	compound	_	_
37	DRUG	_	NOUN	NN	_	38	compound	_	_
38	metabolites	_	NOUN	NNS	_	34	conj	_	_
39	had	_	VERB	VBD	_	25	advcl	_	_
40	a	_	DET	DT	_	45	det	_	_
41	2.3	_	NUM	CD	_	45	nummod	_	_
42	and	_	CONJ	CC	_	41	cc	_	_
43	2.8	_	NUM	CD	_	41	conj	_	_
44	fold	_	NOUN	NN	_	45	amod	_	_
45	increase	_	NOUN	NN	_	39	dobj	_	_
46	,	_	.	,	_	25	punct	_	_
47	respectively	_	ADV	RB	_	25	advmod	_	_
48	,	_	.	,	_	25	punct	_	_
49	in	_	ADP	IN	_	50	case	_	_
50	AUC	_	NOUN	NN	_	25	nmod	_	_
51	for	_	ADP	IN	_	52	case	_	_
52	subjects	_	NOUN	NNS	_	50	nmod	_	_
53	with	_	ADP	IN	_	57	case	_	_
54	end	_	NOUN	NN	_	57	compound	_	_
55	stage	_	NOUN	NN	_	57	compound	_	_
56	renal	_	ADJ	JJ	_	57	amod	_	_
57	failure	_	NOUN	NN	_	52	nmod	_	_

#	WELLBUTRIN	3915
1	A	_	DET	DT	_	3	det	_	_
2	second	_	ADJ	JJ	_	3	amod	_	_
3	study	_	NOUN	NN	_	0	root	_	_
4	,	_	.	,	_	3	punct	_	_
5	comparing	_	VERB	VBG	_	3	acl	_	_
6	normal	_	ADJ	JJ	_	7	amod	_	_
7	subjects	_	NOUN	NNS	_	5	dobj	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	subjects	_	NOUN	NNS	_	7	conj	_	_
10	with	_	ADP	IN	_	11	case	_	_
11	moderate	_	NOUN	NN	_	7	nmod	_	_
12	to	_	PRT	TO	_	20	case	_	_
13	severe	_	ADJ	JJ	_	20	amod	_	_
14	renal	_	ADJ	JJ	_	20	amod	_	_
15	impairment	_	NOUN	NN	_	20	compound	_	_
16	GFR	_	NOUN	NN	_	20	compound	_	_
17	30.9	_	NUM	CD	_	20	nummod	_	_
18	*	_	ADJ	JJ	_	19	advmod	_	_
19	10.8	_	NUM	CD	_	20	nummod	_	_
20	mL	_	NOUN	NN	_	11	nmod	_	_
21	/	_	.	:	_	3	punct	_	_
22	min	_	NOUN	NN	_	23	nsubj	_	_
23	showed	_	VERB	VBD	_	3	dep	_	_
24	that	_	ADP	IN	_	43	mark	_	_
25	after	_	ADP	IN	_	30	case	_	_
26	a	_	DET	DT	_	30	det	_	_
27	single	_	ADJ	JJ	_	30	amod	_	_
28	150	_	NUM	CD	_	30	nummod	_	_
29	mg	_	NOUN	NN	_	30	compound	_	_
30	dose	_	NOUN	NN	_	43	nmod	_	_
31	of	_	ADP	IN	_	34	case	_	_
32	sustained	_	ADJ	JJ	_	34	amod	_	_
33	release	_	NOUN	NN	_	34	compound	_	_
34	DRUG	_	NOUN	NN	_	30	nmod	_	_
35	,	_	.	,	_	43	punct	_	_
36	exposure	_	NOUN	NN	_	43	nsubj	_	_
37	to	_	PRT	TO	_	38	case	_	_
38	DRUG	_	NOUN	NN	_	36	nmod	_	_
39	was	_	VERB	VBD	_	43	cop	_	_
40	approximately	_	ADV	RB	_	41	advmod	_	_
41	2	_	NUM	CD	_	42	nummod	_	_
42	fold	_	NOUN	NN	_	43	nmod:npmod	_	_
43	higher	_	ADJ	JJ	_	23	ccomp	_	_
44	in	_	ADP	IN	_	45	case	_	_
45	subjects	_	NOUN	NNS	_	43	nmod	_	_
46	with	_	ADP	IN	_	49	case	_	_
47	impaired	_	ADJ	JJ	_	49	amod	_	_
48	renal	_	ADJ	JJ	_	49	amod	_	_
49	function	_	NOUN	NN	_	45	nmod	_	_
50	,	_	.	,	_	43	punct	_	_
51	while	_	ADP	IN	_	43	dep	_	_
52	levels	_	NOUN	NNS	_	51	root	_	_
53	of	_	ADP	IN	_	56	case	_	_
54	the	_	DET	DT	_	56	det	_	_
55	hydroxy	_	NOUN	NN	_	56	compound	_	_
56	DRUG	_	NOUN	NN	_	52	nmod	_	_
57	and	_	CONJ	CC	_	56	cc	_	_
58	threo	_	NUM	CD	_	56	conj	_	_
59	/	_	.	:	_	52	punct	_	_
60	erythrohydro	_	NOUN	NN	_	63	compound	_	_
61	DRUG	_	NOUN	NN	_	63	compound	_	_
62	combined	_	ADJ	JJ	_	63	amod	_	_
63	metabolites	_	NOUN	NNS	_	65	nsubj	_	_
64	were	_	VERB	VBD	_	65	cop	_	_
65	similar	_	ADJ	JJ	_	52	dep	_	_
66	in	_	ADP	IN	_	69	case	_	_
67	the	_	DET	DT	_	69	det	_	_
68	2	_	NUM	CD	_	69	nummod	_	_
69	groups	_	NOUN	NNS	_	65	nmod	_	_

#	WELLBUTRIN	3916
1	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
2	is	_	VERB	VBZ	_	4	auxpass	_	_
3	extensively	_	ADV	RB	_	4	advmod	_	_
4	metabolized	_	VERB	VBN	_	0	root	_	_
5	in	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	liver	_	NOUN	NN	_	4	nmod	_	_
8	to	_	PRT	TO	_	10	case	_	_
9	active	_	ADJ	JJ	_	10	amod	_	_
10	metabolites	_	NOUN	NNS	_	7	nmod	_	_
11	,	_	.	,	_	10	punct	_	_
12	which	_	DET	WDT	_	15	nsubjpass	_	_
13	are	_	VERB	VBP	_	15	auxpass	_	_
14	further	_	ADV	RB	_	15	advmod	_	_
15	metabolized	_	VERB	VBN	_	10	acl:relcl	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	subsequently	_	ADV	RB	_	18	advmod	_	_
18	excreted	_	VERB	VBN	_	15	conj	_	_
19	by	_	ADP	IN	_	21	case	_	_
20	the	_	DET	DT	_	21	det	_	_
21	kidneys	_	NOUN	NNS	_	18	nmod	_	_

#	WELLBUTRIN	3917
1	The	_	DET	DT	_	2	det	_	_
2	elimination	_	NOUN	NN	_	11	nsubjpass	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	the	_	DET	DT	_	6	det	_	_
5	major	_	ADJ	JJ	_	6	amod	_	_
6	metabolites	_	NOUN	NNS	_	2	nmod	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	may	_	VERB	MD	_	11	aux	_	_
10	be	_	VERB	VB	_	11	auxpass	_	_
11	reduced	_	VERB	VBN	_	0	root	_	_
12	by	_	ADP	IN	_	15	case	_	_
13	impaired	_	ADJ	JJ	_	15	amod	_	_
14	renal	_	ADJ	JJ	_	15	amod	_	_
15	function	_	NOUN	NN	_	11	nmod	_	_

#	WELLBUTRIN	3918
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	XL	_	NOUN	NN	_	5	nsubjpass	_	_
3	should	_	VERB	MD	_	5	aux	_	_
4	be	_	VERB	VB	_	5	auxpass	_	_
5	used	_	VERB	VBN	_	0	root	_	_
6	with	_	ADP	IN	_	7	case	_	_
7	caution	_	NOUN	NN	_	5	nmod	_	_
8	in	_	ADP	IN	_	9	case	_	_
9	patients	_	NOUN	NNS	_	7	nmod	_	_
10	with	_	ADP	IN	_	12	case	_	_
11	renal	_	ADJ	JJ	_	12	amod	_	_
12	impairment	_	NOUN	NN	_	9	nmod	_	_
13	,	_	.	,	_	5	punct	_	_
14	and	_	CONJ	CC	_	5	cc	_	_
15	a	_	DET	DT	_	17	det	_	_
16	reduced	_	VERB	VBN	_	17	amod	_	_
17	frequency	_	NOUN	NN	_	24	nsubjpass	_	_
18	and	_	CONJ	CC	_	17	cc	_	_
19	/	_	NOUN	NN	_	17	conj	_	_
20	or	_	CONJ	CC	_	19	cc	_	_
21	dose	_	NOUN	NN	_	19	conj	_	_
22	should	_	VERB	MD	_	24	aux	_	_
23	be	_	VERB	VB	_	24	auxpass	_	_
24	considered	_	VERB	VBN	_	5	root	_	_

#	WELLBUTRIN	3919
1	Hepatic	_	ADJ	JJ	_	2	amod	_	_
2	Impairment	_	NOUN	NN	_	14	nsubjpass	_	_
3	The	_	DET	DT	_	4	det	_	_
4	effect	_	NOUN	NN	_	2	dep	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	hepatic	_	ADJ	JJ	_	7	amod	_	_
7	impairment	_	NOUN	NN	_	4	nmod	_	_
8	on	_	ADP	IN	_	10	case	_	_
9	the	_	DET	DT	_	10	det	_	_
10	pharmacokinetics	_	NOUN	NNS	_	4	nmod	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_
13	was	_	VERB	VBD	_	14	auxpass	_	_
14	characterized	_	VERB	VBN	_	0	root	_	_
15	in	_	ADP	IN	_	19	case	_	_
16	2	_	NUM	CD	_	19	nummod	_	_
17	single	_	ADJ	JJ	_	19	amod	_	_
18	dose	_	NOUN	NN	_	19	compound	_	_
19	trials	_	NOUN	NNS	_	14	nmod	_	_
20	,	_	.	,	_	19	punct	_	_
21	one	_	NUM	CD	_	19	appos	_	_
22	in	_	ADP	IN	_	23	case	_	_
23	subjects	_	NOUN	NNS	_	21	nmod	_	_
24	with	_	ADP	IN	_	27	case	_	_
25	alcoholic	_	ADJ	JJ	_	27	amod	_	_
26	liver	_	NOUN	NN	_	27	compound	_	_
27	disease	_	NOUN	NN	_	23	nmod	_	_
28	and	_	CONJ	CC	_	27	cc	_	_
29	one	_	NUM	CD	_	27	conj	_	_
30	in	_	ADP	IN	_	31	case	_	_
31	subjects	_	NOUN	NNS	_	23	nmod	_	_
32	with	_	ADP	IN	_	33	case	_	_
33	mild	_	ADJ	JJ	_	31	nmod	_	_
34	to	_	PRT	TO	_	36	case	_	_
35	severe	_	ADJ	JJ	_	36	amod	_	_
36	cirrhosis	_	NOUN	NN	_	33	nmod	_	_

#	WELLBUTRIN	3920
1	The	_	DET	DT	_	3	det	_	_
2	first	_	ADJ	JJ	_	3	amod	_	_
3	trial	_	NOUN	NN	_	4	nsubj	_	_
4	demonstrated	_	VERB	VBD	_	0	root	_	_
5	that	_	ADP	IN	_	14	mark	_	_
6	the	_	DET	DT	_	8	det	_	_
7	half	_	ADJ	JJ	_	8	amod	_	_
8	life	_	NOUN	NN	_	14	nsubj	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	hydroxy	_	NOUN	NN	_	11	amod	_	_
11	DRUG	_	NOUN	NN	_	8	nmod	_	_
12	was	_	VERB	VBD	_	14	cop	_	_
13	significantly	_	ADV	RB	_	14	advmod	_	_
14	longer	_	ADV	RB	_	4	ccomp	_	_
15	in	_	ADP	IN	_	17	case	_	_
16	8	_	NUM	CD	_	17	nummod	_	_
17	subjects	_	NOUN	NNS	_	14	nmod	_	_
18	with	_	ADP	IN	_	21	case	_	_
19	alcoholic	_	ADJ	JJ	_	21	amod	_	_
20	liver	_	NOUN	NN	_	21	compound	_	_
21	disease	_	NOUN	NN	_	17	nmod	_	_
22	than	_	ADP	IN	_	26	case	_	_
23	in	_	ADP	IN	_	26	case	_	_
24	8	_	NUM	CD	_	26	nummod	_	_
25	healthy	_	ADJ	JJ	_	26	amod	_	_
26	volunteers	_	NOUN	NNS	_	17	nmod	_	_
27	32*14	_	NUM	CD	_	28	nummod	_	_
28	hours	_	NOUN	NNS	_	26	dep	_	_
29	versus	_	CONJ	CC	_	28	cc	_	_
30	21*5	_	NUM	CD	_	31	nummod	_	_
31	hours	_	NOUN	NNS	_	28	conj	_	_
32	,	_	.	,	_	14	punct	_	_
33	respectively	_	ADV	RB	_	14	neg	_	_

#	WELLBUTRIN	3921
1	Although	_	ADP	IN	_	4	mark	_	_
2	not	_	ADV	RB	_	4	neg	_	_
3	statistically	_	ADV	RB	_	4	advmod	_	_
4	significant	_	ADJ	JJ	_	15	advcl	_	_
5	,	_	.	,	_	15	punct	_	_
6	the	_	DET	DT	_	7	det	_	_
7	AUCs	_	NOUN	NNS	_	15	nsubj	_	_
8	for	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	hydroxy	_	NOUN	NN	_	12	compound	_	_
12	DRUG	_	NOUN	NN	_	9	conj	_	_
13	were	_	VERB	VBD	_	15	cop	_	_
14	more	_	ADV	RB	_	15	advmod	_	_
15	variable	_	ADJ	JJ	_	0	root	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	tended	_	VERB	VBN	_	15	conj	_	_
18	to	_	PRT	TO	_	20	mark	_	_
19	be	_	VERB	VB	_	20	cop	_	_
20	greater	_	ADJ	JJ	_	17	xcomp	_	_
21	by	_	ADP	IN	_	22	case	_	_
22	53%	_	NOUN	NN	_	20	nmod	_	_
23	to	_	PRT	TO	_	24	case	_	_
24	57%	_	NOUN	NN	_	22	nmod	_	_
25	in	_	ADP	IN	_	26	case	_	_
26	patients	_	NOUN	NNS	_	22	nmod	_	_
27	with	_	ADP	IN	_	30	case	_	_
28	alcoholic	_	ADJ	JJ	_	30	amod	_	_
29	liver	_	NOUN	NN	_	30	compound	_	_
30	disease	_	NOUN	NN	_	26	nmod	_	_

#	WELLBUTRIN	3922
1	The	_	DET	DT	_	2	det	_	_
2	differences	_	NOUN	NNS	_	17	nsubj	_	_
3	in	_	ADP	IN	_	5	case	_	_
4	half	_	ADJ	JJ	_	5	amod	_	_
5	life	_	NOUN	NN	_	2	nmod	_	_
6	for	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	and	_	CONJ	CC	_	5	cc	_	_
9	the	_	DET	DT	_	11	det	_	_
10	other	_	ADJ	JJ	_	11	amod	_	_
11	metabolites	_	NOUN	NNS	_	5	conj	_	_
12	in	_	ADP	IN	_	15	case	_	_
13	the	_	DET	DT	_	15	det	_	_
14	2	_	NUM	CD	_	15	nummod	_	_
15	groups	_	NOUN	NNS	_	11	nmod	_	_
16	were	_	VERB	VBD	_	17	auxpass	_	_
17	minimal	_	ADJ	JJ	_	0	root	_	_

#	WELLBUTRIN	3923
1	The	_	DET	DT	_	3	det	_	_
2	second	_	ADJ	JJ	_	3	amod	_	_
3	trial	_	ADJ	JJ	_	4	nsubj	_	_
4	demonstrated	_	VERB	VBD	_	0	root	_	_
5	no	_	DET	DT	_	8	neg	_	_
6	statistically	_	ADV	RB	_	7	advmod	_	_
7	significant	_	ADJ	JJ	_	8	amod	_	_
8	differences	_	NOUN	NNS	_	4	dobj	_	_
9	in	_	ADP	IN	_	11	case	_	_
10	the	_	DET	DT	_	11	det	_	_
11	pharmacokinetics	_	NOUN	NNS	_	8	nmod	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	DRUG	_	NOUN	NN	_	11	nmod	_	_
14	and	_	CONJ	CC	_	4	cc	_	_
15	its	_	PRON	PRP$	_	17	nmod:poss	_	_
16	active	_	ADJ	JJ	_	17	amod	_	_
17	metabolites	_	NOUN	NNS	_	27	nsubj	_	_
18	in	_	ADP	IN	_	20	case	_	_
19	9	_	NUM	CD	_	20	nummod	_	_
20	subjects	_	NOUN	NNS	_	17	nmod	_	_
21	with	_	ADP	IN	_	22	case	_	_
22	mild	_	ADJ	JJ	_	17	nmod	_	_
23	to	_	PRT	TO	_	26	case	_	_
24	moderate	_	ADJ	JJ	_	26	amod	_	_
25	hepatic	_	ADJ	JJ	_	26	amod	_	_
26	cirrhosis	_	NOUN	NN	_	22	nmod	_	_
27	compared	_	VERB	VBN	_	4	conj	_	_
28	to	_	PRT	TO	_	31	case	_	_
29	8	_	NUM	CD	_	31	nummod	_	_
30	healthy	_	ADJ	JJ	_	31	amod	_	_
31	volunteers	_	NOUN	NNS	_	27	nmod	_	_

#	WELLBUTRIN	3924
1	However	_	ADV	RB	_	6	advmod	_	_
2	,	_	.	,	_	6	punct	_	_
3	more	_	ADV	RB	_	4	amod	_	_
4	variability	_	NOUN	NN	_	6	nsubjpass	_	_
5	was	_	VERB	VBD	_	6	auxpass	_	_
6	observed	_	VERB	VBN	_	0	root	_	_
7	in	_	ADP	IN	_	8	case	_	_
8	some	_	DET	DT	_	6	nmod	_	_
9	of	_	ADP	IN	_	12	case	_	_
10	the	_	DET	DT	_	12	det	_	_
11	pharmacokinetic	_	ADJ	JJ	_	12	amod	_	_
12	parameters	_	NOUN	NNS	_	8	nmod	_	_
13	for	_	ADP	IN	_	15	case	_	_
14	DRUG	_	NOUN	NN	_	15	compound	_	_
15	AUC	_	NOUN	NN	_	12	nmod	_	_
16	,	_	.	,	_	15	punct	_	_
17	Cmax	_	NOUN	NN	_	15	conj	_	_
18	,	_	.	,	_	15	punct	_	_
19	and	_	CONJ	CC	_	15	cc	_	_
20	Tmax	_	NOUN	NN	_	15	conj	_	_
21	and	_	CONJ	CC	_	8	cc	_	_
22	its	_	PRON	PRP$	_	24	nmod:poss	_	_
23	active	_	ADJ	JJ	_	24	amod	_	_
24	metabolites	_	NOUN	NNS	_	8	conj	_	_
25	t%	_	ADP	IN	_	27	case	_	_
26	in	_	ADP	IN	_	27	case	_	_
27	subjects	_	NOUN	NNS	_	24	nmod	_	_
28	with	_	ADP	IN	_	29	case	_	_
29	mild	_	ADJ	JJ	_	27	nmod	_	_
30	to	_	PRT	TO	_	31	mark	_	_
31	moderate	_	ADJ	JJ	_	29	acl	_	_
32	hepatic	_	ADJ	JJ	_	33	amod	_	_
33	cirrhosis	_	NOUN	NN	_	31	dobj	_	_

#	WELLBUTRIN	3925
1	In	_	ADP	IN	_	2	case	_	_
2	addition	_	NOUN	NN	_	18	nmod	_	_
3	,	_	.	,	_	18	punct	_	_
4	in	_	ADP	IN	_	5	case	_	_
5	patients	_	NOUN	NNS	_	18	nmod	_	_
6	with	_	ADP	IN	_	9	case	_	_
7	severe	_	ADJ	JJ	_	9	amod	_	_
8	hepatic	_	ADJ	JJ	_	9	amod	_	_
9	cirrhosis	_	NOUN	NN	_	5	nmod	_	_
10	,	_	.	,	_	18	punct	_	_
11	the	_	DET	DT	_	13	det	_	_
12	DRUG	_	NOUN	NN	_	13	compound	_	_
13	Cmax	_	NOUN	NN	_	18	nsubjpass	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	AUC	_	NOUN	NN	_	13	conj	_	_
16	were	_	VERB	VBD	_	18	auxpass	_	_
17	substantially	_	ADV	RB	_	18	advmod	_	_
18	increased	_	VERB	VBN	_	0	root	_	_
19	mean	_	ADJ	JJ	_	20	compound	_	_
20	difference	_	NOUN	NN	_	18	dobj	_	_
21	:	_	.	:	_	18	punct	_	_
22	by	_	ADP	IN	_	24	case	_	_
23	approximately	_	ADV	RB	_	24	advmod	_	_
24	70%	_	ADJ	JJ	_	18	parataxis	_	_
25	and	_	CONJ	CC	_	24	cc	_	_
26	3	_	NUM	CD	_	24	conj	_	_
27	fold	_	NOUN	NN	_	24	dep	_	_
28	,	_	.	,	_	24	punct	_	_
29	respectively	_	ADV	RB	_	30	advmod	_	_
30	and	_	CONJ	CC	_	32	advmod	_	_
31	more	_	ADV	RB	_	30	advmod	_	_
32	variable	_	ADJ	JJ	_	24	appos	_	_
33	when	_	ADV	WRB	_	34	advmod	_	_
34	compared	_	VERB	VBN	_	47	advcl	_	_
35	to	_	PRT	TO	_	36	case	_	_
36	values	_	NOUN	NNS	_	34	nmod	_	_
37	in	_	ADP	IN	_	39	case	_	_
38	healthy	_	ADJ	JJ	_	39	amod	_	_
39	volunteers	_	NOUN	NNS	_	36	nmod	_	_
40	the	_	DET	DT	_	44	det	_	_
41	mean	_	ADJ	JJ	_	44	amod	_	_
42	DRUG	_	NOUN	NN	_	44	compound	_	_
43	half	_	NOUN	NN	_	44	compound	_	_
44	life	_	NOUN	NN	_	47	nsubj	_	_
45	was	_	VERB	VBD	_	47	cop	_	_
46	also	_	ADV	RB	_	47	advmod	_	_
47	longer	_	ADV	RB	_	32	ccomp	_	_
48	29	_	NUM	CD	_	49	nummod	_	_
49	hours	_	NOUN	NNS	_	47	dobj	_	_
50	in	_	ADP	IN	_	51	case	_	_
51	patients	_	NOUN	NNS	_	49	nmod	_	_
52	with	_	ADP	IN	_	55	case	_	_
53	severe	_	ADJ	JJ	_	55	amod	_	_
54	hepatic	_	ADJ	JJ	_	55	amod	_	_
55	cirrhosis	_	NOUN	NN	_	51	nmod	_	_
56	vs	_	CONJ	CC	_	55	cc	_	_
57	19	_	NUM	CD	_	58	nummod	_	_
58	hours	_	NOUN	NNS	_	55	conj	_	_
59	in	_	ADP	IN	_	61	case	_	_
60	healthy	_	ADJ	JJ	_	61	amod	_	_
61	subjects	_	NOUN	NNS	_	55	nmod	_	_

#	WELLBUTRIN	3926
1	For	_	ADP	IN	_	5	case	_	_
2	the	_	DET	DT	_	5	det	_	_
3	metabolite	_	NOUN	NN	_	5	compound	_	_
4	hydroxy	_	NOUN	NN	_	5	compound	_	_
5	DRUG	_	NOUN	NN	_	13	nmod	_	_
6	,	_	.	,	_	13	punct	_	_
7	the	_	DET	DT	_	9	det	_	_
8	mean	_	NOUN	NN	_	9	compound	_	_
9	Cmax	_	NOUN	NN	_	13	nsubj	_	_
10	was	_	VERB	VBD	_	13	cop	_	_
11	approximately	_	ADV	RB	_	12	advmod	_	_
12	69%	_	ADJ	JJ	_	13	amod	_	_
13	lower	_	ADJ	JJ	_	0	root	_	_

#	WELLBUTRIN	3927
1	For	_	ADP	IN	_	6	case	_	_
2	the	_	DET	DT	_	6	det	_	_
3	combined	_	VERB	VBN	_	6	amod	_	_
4	amino	_	NOUN	NN	_	6	compound	_	_
5	alcohol	_	NOUN	NN	_	6	compound	_	_
6	isomers	_	NOUN	NNS	_	19	nmod	_	_
7	threohydro	_	X	FW	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	erythrohydro	_	NOUN	NN	_	11	compound	_	_
11	DRUG	_	NOUN	NN	_	8	conj	_	_
12	,	_	.	,	_	19	punct	_	_
13	the	_	DET	DT	_	15	det	_	_
14	mean	_	NOUN	NN	_	15	compound	_	_
15	Cmax	_	NOUN	NN	_	19	nsubj	_	_
16	was	_	VERB	VBD	_	19	cop	_	_
17	approximately	_	ADV	RB	_	18	advmod	_	_
18	31%	_	ADJ	JJ	_	19	amod	_	_
19	lower	_	ADJ	JJ	_	0	root	_	_

#	WELLBUTRIN	3928
1	The	_	DET	DT	_	3	det	_	_
2	mean	_	ADJ	JJ	_	3	amod	_	_
3	AUC	_	NOUN	NN	_	4	nsubj	_	_
4	increased	_	VERB	VBD	_	0	root	_	_
5	by	_	ADP	IN	_	8	case	_	_
6	about	_	ADV	RB	_	7	advmod	_	_
7	1%	_	ADJ	JJ	_	8	amod	_	_
8	fold	_	NOUN	NN	_	4	nmod	_	_
9	for	_	ADP	IN	_	11	case	_	_
10	hydroxy	_	NOUN	NN	_	11	compound	_	_
11	DRUG	_	NOUN	NN	_	8	nmod	_	_
12	and	_	CONJ	CC	_	4	cc	_	_
13	about	_	ADV	RB	_	15	advmod	_	_
14	2%	_	ADJ	JJ	_	15	amod	_	_
15	fold	_	NOUN	NN	_	4	conj	_	_
16	for	_	ADP	IN	_	20	case	_	_
17	threo	_	NUM	CD	_	20	nummod	_	_
18	/	_	.	:	_	20	punct	_	_
19	erythrohydro	_	NOUN	NN	_	20	compound	_	_
20	DRUG	_	NOUN	NN	_	15	nmod	_	_

#	WELLBUTRIN	3929
1	The	_	DET	DT	_	3	det	_	_
2	median	_	ADJ	JJ	_	3	amod	_	_
3	Tmax	_	NOUN	NN	_	5	nsubjpass	_	_
4	was	_	VERB	VBD	_	5	auxpass	_	_
5	observed	_	VERB	VBN	_	0	root	_	_
6	19	_	NUM	CD	_	7	nummod	_	_
7	hours	_	NOUN	NNS	_	5	dobj	_	_
8	later	_	ADJ	JJ	_	7	amod	_	_
9	for	_	ADP	IN	_	11	case	_	_
10	hydroxy	_	NOUN	NN	_	11	compound	_	_
11	DRUG	_	NOUN	NN	_	8	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	31	_	NUM	CD	_	14	nummod	_	_
14	hours	_	NOUN	NNS	_	11	conj	_	_
15	later	_	ADJ	JJ	_	11	amod	_	_
16	for	_	ADP	IN	_	20	case	_	_
17	threo	_	NUM	CD	_	20	nummod	_	_
18	/	_	.	:	_	20	punct	_	_
19	erythrohydro	_	NOUN	NN	_	20	compound	_	_
20	DRUG	_	NOUN	NN	_	15	nmod	_	_

#	WELLBUTRIN	3930
1	The	_	DET	DT	_	4	det	_	_
2	mean	_	ADJ	JJ	_	4	amod	_	_
3	half	_	ADJ	JJ	_	4	amod	_	_
4	lives	_	NOUN	NNS	_	0	root	_	_
5	for	_	ADP	IN	_	7	case	_	_
6	hydroxy	_	NOUN	NN	_	7	compound	_	_
7	DRUG	_	NOUN	NN	_	4	nmod	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	threo	_	NUM	CD	_	7	conj	_	_
10	/	_	.	:	_	4	punct	_	_
11	erythrohydro	_	NOUN	NN	_	12	compound	_	_
12	DRUG	_	NOUN	NN	_	14	nsubjpass	_	_
13	were	_	VERB	VBD	_	14	auxpass	_	_
14	increased	_	VERB	VBN	_	4	dep	_	_
15	5	_	NUM	CD	_	18	nummod	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	2	_	NUM	CD	_	15	conj	_	_
18	fold	_	NOUN	NN	_	14	advmod	_	_
19	,	_	.	,	_	14	punct	_	_
20	respectively	_	ADV	RB	_	14	advmod	_	_
21	,	_	.	,	_	14	punct	_	_
22	in	_	ADP	IN	_	23	case	_	_
23	patients	_	NOUN	NNS	_	14	nmod	_	_
24	with	_	ADP	IN	_	27	case	_	_
25	severe	_	ADJ	JJ	_	27	amod	_	_
26	hepatic	_	ADJ	JJ	_	27	amod	_	_
27	cirrhosis	_	NOUN	NN	_	23	nmod	_	_
28	compared	_	VERB	VBN	_	23	acl	_	_
29	to	_	PRT	TO	_	31	case	_	_
30	healthy	_	ADJ	JJ	_	31	amod	_	_
31	volunteers	_	NOUN	NNS	_	28	nmod	_	_

#	WELLBUTRIN	3931
1	Left	_	NOUN	NN	_	3	compound	_	_
2	Ventricular	_	ADJ	JJ	_	3	amod	_	_
3	Dysfunction	_	NOUN	NN	_	0	root	_	_
4	During	_	VERB	VBG	_	8	case	_	_
5	a	_	DET	DT	_	8	det	_	_
6	chronic	_	ADJ	JJ	_	8	amod	_	_
7	dosing	_	NOUN	NN	_	8	compound	_	_
8	study	_	NOUN	NN	_	3	nmod	_	_
9	with	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	in	_	ADP	IN	_	14	case	_	_
12	14	_	NUM	CD	_	14	nummod	_	_
13	depressed	_	ADJ	JJ	_	14	amod	_	_
14	patients	_	NOUN	NNS	_	3	nmod	_	_
15	with	_	ADP	IN	_	19	case	_	_
16	left	_	ADJ	JJ	_	19	amod	_	_
17	ventricular	_	ADJ	JJ	_	19	amod	_	_
18	dysfunction	_	NOUN	NN	_	19	compound	_	_
19	history	_	NOUN	NN	_	14	nmod	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	CHF	_	NOUN	NN	_	19	nmod	_	_
22	or	_	CONJ	CC	_	21	cc	_	_
23	an	_	DET	DT	_	25	det	_	_
24	enlarged	_	VERB	VBN	_	25	amod	_	_
25	heart	_	NOUN	NN	_	21	conj	_	_
26	on	_	ADP	IN	_	28	case	_	_
27	x	_	NOUN	NN	_	28	compound	_	_
28	ray	_	NOUN	NN	_	14	nmod	_	_
29	,	_	.	,	_	3	punct	_	_
30	there	_	DET	EX	_	31	expl	_	_
31	was	_	VERB	VBD	_	3	acl:relcl	_	_
32	no	_	DET	DT	_	34	neg	_	_
33	apparent	_	ADJ	JJ	_	34	amod	_	_
34	effect	_	NOUN	NN	_	31	nsubj	_	_
35	on	_	ADP	IN	_	37	case	_	_
36	the	_	DET	DT	_	37	det	_	_
37	pharmacokinetics	_	NOUN	NNS	_	31	nmod	_	_
38	of	_	ADP	IN	_	39	case	_	_
39	DRUG	_	NOUN	NN	_	37	nmod	_	_
40	or	_	CONJ	CC	_	39	cc	_	_
41	its	_	PRON	PRP$	_	42	nmod:poss	_	_
42	metabolites	_	NOUN	NNS	_	39	conj	_	_
43	,	_	.	,	_	3	punct	_	_
44	compared	_	VERB	VBN	_	3	acl	_	_
45	to	_	PRT	TO	_	47	case	_	_
46	healthy	_	ADJ	JJ	_	47	amod	_	_
47	volunteers	_	NOUN	NNS	_	44	nmod	_	_

#	WELLBUTRIN	3932
1	Age	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	The	_	DET	DT	_	4	det	_	_
4	effects	_	NOUN	NNS	_	19	nsubjpass	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	age	_	NOUN	NN	_	4	nmod	_	_
7	on	_	ADP	IN	_	9	case	_	_
8	the	_	DET	DT	_	9	det	_	_
9	pharmacokinetics	_	NOUN	NNS	_	4	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_
12	and	_	CONJ	CC	_	4	cc	_	_
13	its	_	PRON	PRP$	_	14	nmod:poss	_	_
14	metabolites	_	NOUN	NNS	_	4	conj	_	_
15	have	_	VERB	VBP	_	19	aux	_	_
16	not	_	ADV	RB	_	19	neg	_	_
17	been	_	VERB	VBN	_	19	auxpass	_	_
18	fully	_	ADV	RB	_	19	advmod	_	_
19	characterized	_	VERB	VBN	_	1	dep	_	_
20	,	_	.	,	_	19	punct	_	_
21	but	_	CONJ	CC	_	19	cc	_	_
22	an	_	DET	DT	_	23	det	_	_
23	exploration	_	NOUN	NN	_	56	nsubj	_	_
24	of	_	ADP	IN	_	28	case	_	_
25	steady	_	ADJ	JJ	_	28	amod	_	_
26	state	_	NOUN	NN	_	28	compound	_	_
27	DRUG	_	NOUN	NN	_	28	compound	_	_
28	concentrations	_	NOUN	NNS	_	23	nmod	_	_
29	from	_	ADP	IN	_	33	case	_	_
30	several	_	ADJ	JJ	_	33	amod	_	_
31	depression	_	NOUN	NN	_	33	compound	_	_
32	efficacy	_	NOUN	NN	_	33	compound	_	_
33	studies	_	NOUN	NNS	_	23	nmod	_	_
34	involving	_	VERB	VBG	_	33	acl	_	_
35	patients	_	NOUN	NNS	_	34	dobj	_	_
36	dosed	_	VERB	VBN	_	35	acl	_	_
37	in	_	ADP	IN	_	39	case	_	_
38	a	_	DET	DT	_	39	det	_	_
39	range	_	NOUN	NN	_	36	nmod	_	_
40	of	_	ADP	IN	_	46	case	_	_
41	300	_	NUM	CD	_	43	compound	_	_
42	to	_	PRT	TO	_	43	dep	_	_
43	750	_	NUM	CD	_	44	nummod	_	_
44	mg	_	NOUN	NN	_	46	compound	_	_
45	/	_	.	:	_	46	punct	_	_
46	day	_	NOUN	NN	_	39	nmod	_	_
47	,	_	.	,	_	23	punct	_	_
48	on	_	ADP	IN	_	51	case	_	_
49	a	_	DET	DT	_	51	det	_	_
50	3	_	NUM	CD	_	51	nummod	_	_
51	times	_	NOUN	NNS	_	23	nmod	_	_
52	a	_	DET	DT	_	54	det	_	_
53	day	_	NOUN	NN	_	54	compound	_	_
54	schedule	_	NOUN	NN	_	51	dep	_	_
55	,	_	.	,	_	23	punct	_	_
56	revealed	_	VERB	VBD	_	19	conj	_	_
57	no	_	DET	DT	_	58	neg	_	_
58	relationship	_	NOUN	NN	_	56	dobj	_	_
59	between	_	ADP	IN	_	60	case	_	_
60	age	_	NOUN	NN	_	58	nmod	_	_
61	18	_	NUM	CD	_	60	nummod	_	_
62	to	_	PRT	TO	_	64	case	_	_
63	83	_	NUM	CD	_	64	nummod	_	_
64	years	_	NOUN	NNS	_	58	nmod	_	_
65	and	_	CONJ	CC	_	64	cc	_	_
66	plasma	_	NOUN	NN	_	67	compound	_	_
67	concentration	_	NOUN	NN	_	64	conj	_	_
68	of	_	ADP	IN	_	69	case	_	_
69	DRUG	_	NOUN	NN	_	67	nmod	_	_

#	WELLBUTRIN	3933
1	A	_	DET	DT	_	5	det	_	_
2	single	_	ADJ	JJ	_	5	amod	_	_
3	dose	_	NOUN	NN	_	5	compound	_	_
4	pharmacokinetic	_	ADJ	JJ	_	5	amod	_	_
5	study	_	NOUN	NN	_	6	nsubj	_	_
6	demonstrated	_	VERB	VBD	_	0	root	_	_
7	that	_	ADP	IN	_	19	mark	_	_
8	the	_	DET	DT	_	9	det	_	_
9	disposition	_	NOUN	NN	_	19	nsubj	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_
12	and	_	CONJ	CC	_	9	cc	_	_
13	its	_	PRON	PRP$	_	14	nmod:poss	_	_
14	metabolites	_	NOUN	NNS	_	9	conj	_	_
15	in	_	ADP	IN	_	17	case	_	_
16	elderly	_	ADJ	JJ	_	17	amod	_	_
17	subjects	_	NOUN	NNS	_	14	nmod	_	_
18	was	_	VERB	VBD	_	19	cop	_	_
19	similar	_	ADJ	JJ	_	6	ccomp	_	_
20	to	_	PRT	TO	_	21	case	_	_
21	that	_	DET	WDT	_	19	nmod	_	_
22	in	_	ADP	IN	_	24	case	_	_
23	younger	_	ADJ	JJ	_	24	amod	_	_
24	subjects	_	NOUN	NNS	_	21	nmod	_	_

#	WELLBUTRIN	3934
1	These	_	DET	DT	_	2	det	_	_
2	data	_	NOUN	NNS	_	3	nsubj	_	_
3	suggest	_	VERB	VBP	_	0	root	_	_
4	that	_	ADP	IN	_	6	mark	_	_
5	there	_	DET	EX	_	6	expl	_	_
6	is	_	VERB	VBZ	_	3	root	_	_
7	no	_	DET	DT	_	9	neg	_	_
8	prominent	_	ADJ	JJ	_	9	amod	_	_
9	effect	_	NOUN	NN	_	6	nsubj	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	age	_	NOUN	NN	_	9	nmod	_	_
12	on	_	ADP	IN	_	14	case	_	_
13	DRUG	_	NOUN	NN	_	14	compound	_	_
14	concentration	_	NOUN	NN	_	9	nmod	_	_
15	however	_	ADV	RB	_	6	advmod	_	_
16	,	_	.	,	_	6	punct	_	_
17	another	_	DET	DT	_	23	det	_	_
18	single	_	ADJ	JJ	_	23	amod	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	multiple	_	ADJ	JJ	_	18	conj	_	_
21	dose	_	NOUN	NN	_	23	compound	_	_
22	pharmacokinetic	_	ADJ	JJ	_	23	amod	_	_
23	study	_	NOUN	NN	_	24	nsubj	_	_
24	suggested	_	VERB	VBD	_	6	parataxis	_	_
25	that	_	ADP	IN	_	31	mark	_	_
26	the	_	DET	DT	_	27	det	_	_
27	elderly	_	NOUN	NN	_	31	nsubj	_	_
28	are	_	VERB	VBP	_	31	cop	_	_
29	at	_	ADP	IN	_	31	case	_	_
30	increased	_	VERB	VBN	_	31	amod	_	_
31	risk	_	NOUN	NN	_	24	ccomp	_	_
32	for	_	ADP	IN	_	33	case	_	_
33	accumulation	_	NOUN	NN	_	31	nmod	_	_
34	of	_	ADP	IN	_	35	case	_	_
35	DRUG	_	NOUN	NN	_	33	nmod	_	_
36	and	_	CONJ	CC	_	35	cc	_	_
37	its	_	PRON	PRP$	_	38	nmod:poss	_	_
38	metabolites	_	NOUN	NNS	_	35	conj	_	_

#	WELLBUTRIN	3935
1	Gender	_	NOUN	NN	_	5	compound	_	_
2	A	_	NOUN	NN	_	5	compound	_	_
3	single	_	ADJ	JJ	_	5	amod	_	_
4	dose	_	NOUN	NN	_	5	compound	_	_
5	study	_	NOUN	NN	_	15	nsubj	_	_
6	involving	_	VERB	VBG	_	5	acl	_	_
7	12	_	NUM	CD	_	9	nummod	_	_
8	healthy	_	ADJ	JJ	_	9	amod	_	_
9	male	_	ADJ	JJ	_	6	dobj	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	12	_	NUM	CD	_	14	nummod	_	_
12	healthy	_	ADJ	JJ	_	14	amod	_	_
13	female	_	ADJ	JJ	_	14	amod	_	_
14	volunteers	_	NOUN	NNS	_	9	conj	_	_
15	revealed	_	VERB	VBD	_	0	root	_	_
16	no	_	DET	DT	_	19	neg	_	_
17	sex	_	NOUN	NN	_	19	compound	_	_
18	related	_	ADJ	JJ	_	19	amod	_	_
19	differences	_	NOUN	NNS	_	15	dobj	_	_
20	in	_	ADP	IN	_	23	case	_	_
21	the	_	DET	DT	_	23	det	_	_
22	pharmacokinetic	_	ADJ	JJ	_	23	amod	_	_
23	parameters	_	NOUN	NNS	_	19	nmod	_	_
24	of	_	ADP	IN	_	25	case	_	_
25	DRUG	_	NOUN	NN	_	23	nmod	_	_

#	WELLBUTRIN	3936
1	In	_	ADP	IN	_	2	case	_	_
2	addition	_	NOUN	NN	_	19	nmod	_	_
3	,	_	.	,	_	19	punct	_	_
4	pooled	_	VERB	VBN	_	5	amod	_	_
5	analysis	_	NOUN	NN	_	19	nsubj	_	_
6	of	_	ADP	IN	_	9	case	_	_
7	DRUG	_	NOUN	NN	_	9	compound	_	_
8	pharmacokinetic	_	ADJ	JJ	_	9	amod	_	_
9	data	_	NOUN	NNS	_	5	nmod	_	_
10	from	_	ADP	IN	_	13	case	_	_
11	90	_	NUM	CD	_	13	nummod	_	_
12	healthy	_	ADJ	JJ	_	13	amod	_	_
13	male	_	ADJ	JJ	_	5	nmod	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	90	_	NUM	CD	_	18	nummod	_	_
16	healthy	_	ADJ	JJ	_	18	amod	_	_
17	female	_	ADJ	JJ	_	18	amod	_	_
18	volunteers	_	NOUN	NNS	_	13	conj	_	_
19	revealed	_	VERB	VBD	_	0	root	_	_
20	no	_	DET	DT	_	23	neg	_	_
21	sex	_	NOUN	NN	_	23	compound	_	_
22	related	_	ADJ	JJ	_	23	amod	_	_
23	differences	_	NOUN	NNS	_	19	dobj	_	_
24	in	_	ADP	IN	_	28	case	_	_
25	the	_	DET	DT	_	28	det	_	_
26	peak	_	ADJ	JJ	_	28	amod	_	_
27	plasma	_	NOUN	NN	_	28	compound	_	_
28	concentrations	_	NOUN	NNS	_	23	nmod	_	_
29	of	_	ADP	IN	_	30	case	_	_
30	DRUG	_	NOUN	NN	_	28	nmod	_	_

#	WELLBUTRIN	3937
1	The	_	DET	DT	_	5	det	_	_
2	mean	_	ADJ	JJ	_	5	amod	_	_
3	systemic	_	ADJ	JJ	_	5	amod	_	_
4	exposure	_	NOUN	NN	_	5	compound	_	_
5	AUC	_	NOUN	NN	_	8	nsubj	_	_
6	was	_	VERB	VBD	_	8	cop	_	_
7	approximately	_	ADV	RB	_	8	advmod	_	_
8	13%	_	ADJ	JJ	_	0	root	_	_
9	higher	_	ADJ	JJ	_	8	xcomp	_	_
10	in	_	ADP	IN	_	12	case	_	_
11	male	_	ADJ	JJ	_	12	amod	_	_
12	volunteers	_	NOUN	NNS	_	9	nmod	_	_
13	compared	_	VERB	VBN	_	16	case	_	_
14	to	_	PRT	TO	_	16	case	_	_
15	female	_	ADJ	JJ	_	16	amod	_	_
16	volunteers	_	NOUN	NNS	_	8	nmod	_	_

#	WELLBUTRIN	3938
1	Smokers	_	NOUN	NNS	_	26	nsubj	_	_
2	The	_	DET	DT	_	3	det	_	_
3	effects	_	NOUN	NNS	_	14	nsubjpass	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	cigarette	_	NOUN	NN	_	6	compound	_	_
6	smoking	_	NOUN	NN	_	3	nmod	_	_
7	on	_	ADP	IN	_	9	case	_	_
8	the	_	DET	DT	_	9	det	_	_
9	pharmacokinetics	_	NOUN	NNS	_	3	nmod	_	_
10	of	_	ADP	IN	_	12	case	_	_
11	DRUG	_	NOUN	NN	_	12	compound	_	_
12	hydrochloride	_	NOUN	NN	_	9	nmod	_	_
13	were	_	VERB	VBD	_	14	auxpass	_	_
14	studied	_	VERB	VBN	_	1	acl:relcl	_	_
15	in	_	ADP	IN	_	18	case	_	_
16	34	_	NUM	CD	_	18	nummod	_	_
17	healthy	_	ADJ	JJ	_	18	amod	_	_
18	male	_	ADJ	JJ	_	14	nmod	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	female	_	ADJ	JJ	_	18	conj	_	_
21	volunteers	_	NOUN	NNS	_	18	dep	_	_
22	17	_	NUM	CD	_	21	nummod	_	_
23	were	_	VERB	VBD	_	26	cop	_	_
24	chronic	_	ADJ	JJ	_	26	amod	_	_
25	cigarette	_	NOUN	NN	_	26	compound	_	_
26	smokers	_	NOUN	NNS	_	0	root	_	_
27	and	_	CONJ	CC	_	26	cc	_	_
28	17	_	NUM	CD	_	30	nummod	_	_
29	were	_	VERB	VBD	_	30	cop	_	_
30	nonsmokers	_	NOUN	NNS	_	26	conj	_	_

#	WELLBUTRIN	3939
1	Following	_	VERB	VBG	_	3	case	_	_
2	oral	_	ADJ	JJ	_	3	amod	_	_
3	administration	_	NOUN	NN	_	14	nmod	_	_
4	of	_	ADP	IN	_	9	case	_	_
5	a	_	DET	DT	_	9	det	_	_
6	single	_	ADJ	JJ	_	9	amod	_	_
7	150	_	NUM	CD	_	9	nummod	_	_
8	mg	_	NOUN	NN	_	9	compound	_	_
9	dose	_	NOUN	NN	_	3	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_
12	,	_	.	,	_	14	punct	_	_
13	there	_	DET	EX	_	14	expl	_	_
14	was	_	VERB	VBD	_	0	root	_	_
15	no	_	DET	DT	_	18	neg	_	_
16	statistically	_	ADV	RB	_	17	advmod	_	_
17	significant	_	ADJ	JJ	_	18	amod	_	_
18	difference	_	NOUN	NN	_	14	nsubj	_	_
19	in	_	ADP	IN	_	20	case	_	_
20	Cmax	_	NOUN	NN	_	18	nmod	_	_
21	,	_	.	,	_	20	punct	_	_
22	half	_	ADJ	JJ	_	23	compound	_	_
23	life	_	NOUN	NN	_	20	conj	_	_
24	,	_	.	,	_	20	punct	_	_
25	Tmax	_	NOUN	NN	_	20	conj	_	_
26	,	_	.	,	_	20	punct	_	_
27	AUC	_	NOUN	NN	_	20	conj	_	_
28	,	_	.	,	_	20	punct	_	_
29	or	_	CONJ	CC	_	20	cc	_	_
30	clearance	_	NOUN	NN	_	20	conj	_	_
31	of	_	ADP	IN	_	32	case	_	_
32	DRUG	_	NOUN	NN	_	20	nmod	_	_
33	or	_	CONJ	CC	_	20	cc	_	_
34	its	_	PRON	PRP$	_	36	nmod:poss	_	_
35	active	_	ADJ	JJ	_	36	amod	_	_
36	metabolites	_	NOUN	NNS	_	20	conj	_	_
37	between	_	ADP	IN	_	38	case	_	_
38	smokers	_	NOUN	NNS	_	36	nmod	_	_
39	and	_	CONJ	CC	_	38	cc	_	_
40	nonsmokers	_	NOUN	NNS	_	38	conj	_	_

#	WELLBUTRIN	3940
1	Drug	_	NOUN	NN	_	2	compound	_	_
2	Interactions	_	NOUN	NNS	_	14	nsubj	_	_
3	Potential	_	ADJ	JJ	_	2	amod	_	_
4	for	_	ADP	IN	_	6	case	_	_
5	Other	_	ADJ	JJ	_	6	amod	_	_
6	Drugs	_	NOUN	NNS	_	3	nmod	_	_
7	to	_	PRT	TO	_	8	mark	_	_
8	Affect	_	NOUN	NN	_	3	acl	_	_
9	DRUG	_	NOUN	NN	_	13	compound	_	_
10	XL	_	NOUN	NN	_	13	compound	_	_
11	In	_	X	FW	_	13	amod	_	_
12	vitro	_	X	FW	_	11	dep	_	_
13	studies	_	NOUN	NNS	_	8	dobj	_	_
14	indicate	_	VERB	VBP	_	0	root	_	_
15	that	_	ADP	IN	_	19	mark	_	_
16	DRUG	_	NOUN	NN	_	19	nsubjpass	_	_
17	is	_	VERB	VBZ	_	19	auxpass	_	_
18	primarily	_	ADV	RB	_	19	advmod	_	_
19	metabolized	_	VERB	VBN	_	14	ccomp	_	_
20	to	_	PRT	TO	_	21	mark	_	_
21	hydroxy	_	VERB	VB	_	19	xcomp	_	_
22	DRUG	_	NOUN	NN	_	21	dobj	_	_
23	by	_	ADP	IN	_	24	case	_	_
24	CYP2B6	_	NOUN	NN	_	21	nmod	_	_

#	WELLBUTRIN	3942
1	In	_	ADP	IN	_	2	case	_	_
2	addition	_	NOUN	NN	_	7	nmod	_	_
3	,	_	.	,	_	7	punct	_	_
4	in	_	X	FW	_	6	amod	_	_
5	vitro	_	X	FW	_	4	dep	_	_
6	studies	_	NOUN	NNS	_	7	nsubj	_	_
7	suggest	_	VERB	VBP	_	0	root	_	_
8	that	_	ADP	IN	_	19	mark	_	_
9	paroxetine	_	NOUN	NN	_	19	nsubj	_	_
10	,	_	.	,	_	9	punct	_	_
11	sertraline	_	NOUN	NN	_	9	conj	_	_
12	,	_	.	,	_	9	punct	_	_
13	norfluoxetine	_	NOUN	NN	_	9	conj	_	_
14	,	_	.	,	_	9	punct	_	_
15	fluvoxamine	_	NOUN	NN	_	9	conj	_	_
16	,	_	.	,	_	9	punct	_	_
17	and	_	CONJ	CC	_	9	cc	_	_
18	nelfinavir	_	NOUN	NN	_	9	conj	_	_
19	inhibit	_	VERB	VBP	_	7	ccomp	_	_
20	the	_	DET	DT	_	21	det	_	_
21	hydroxylation	_	NOUN	NN	_	19	dobj	_	_
22	of	_	ADP	IN	_	23	case	_	_
23	DRUG	_	NOUN	NN	_	21	nmod	_	_

#	WELLBUTRIN	3943
1	Inhibitors	_	NOUN	NNS	_	27	nsubj	_	_
2	of	_	ADP	IN	_	4	case	_	_
3	CYP2B6	_	NOUN	NN	_	4	compound	_	_
4	Ticlopidine	_	NOUN	NN	_	1	nmod	_	_
5	,	_	.	,	_	4	punct	_	_
6	Clopidogrel	_	NOUN	NN	_	4	appos	_	_
7	:	_	.	:	_	1	punct	_	_
8	In	_	ADP	IN	_	10	case	_	_
9	a	_	DET	DT	_	10	det	_	_
10	study	_	NOUN	NN	_	1	nmod	_	_
11	in	_	ADP	IN	_	14	case	_	_
12	healthy	_	ADJ	JJ	_	14	amod	_	_
13	male	_	ADJ	JJ	_	14	amod	_	_
14	volunteers	_	NOUN	NNS	_	10	nmod	_	_
15	,	_	.	,	_	1	punct	_	_
16	clopidogrel	_	NOUN	NN	_	18	compound	_	_
17	75	_	NUM	CD	_	18	nummod	_	_
18	mg	_	NOUN	NN	_	1	appos	_	_
19	once	_	ADV	RB	_	20	advmod	_	_
20	daily	_	ADV	RB	_	18	advmod	_	_
21	or	_	CONJ	CC	_	18	cc	_	_
22	ticlopidine	_	NOUN	NN	_	24	compound	_	_
23	250	_	NUM	CD	_	24	nummod	_	_
24	mg	_	NOUN	NN	_	18	conj	_	_
25	twice	_	ADV	RB	_	27	advmod	_	_
26	daily	_	ADV	RB	_	27	advmod	_	_
27	increased	_	VERB	VBD	_	0	root	_	_
28	exposures	_	NOUN	NNS	_	27	dobj	_	_
29	Cmax	_	NOUN	NN	_	28	dep	_	_
30	and	_	CONJ	CC	_	29	cc	_	_
31	AUC	_	NOUN	NN	_	29	conj	_	_
32	of	_	ADP	IN	_	33	case	_	_
33	DRUG	_	NOUN	NN	_	29	nmod	_	_
34	by	_	ADP	IN	_	35	case	_	_
35	40%	_	NOUN	NN	_	29	nmod	_	_
36	and	_	CONJ	CC	_	35	cc	_	_
37	60%	_	NOUN	NN	_	35	conj	_	_
38	for	_	ADP	IN	_	39	case	_	_
39	clopidogrel	_	NOUN	NN	_	29	nmod	_	_
40	,	_	.	,	_	27	punct	_	_
41	by	_	ADP	IN	_	42	case	_	_
42	38%	_	NOUN	NN	_	27	nmod	_	_
43	and	_	CONJ	CC	_	42	cc	_	_
44	85%	_	NOUN	NN	_	42	conj	_	_
45	for	_	ADP	IN	_	46	case	_	_
46	ticlopidine	_	NOUN	NN	_	42	nmod	_	_
47	,	_	.	,	_	27	punct	_	_
48	respectively	_	ADV	RB	_	27	advmod	_	_

#	WELLBUTRIN	3944
1	The	_	DET	DT	_	2	det	_	_
2	exposures	_	NOUN	NNS	_	7	nsubjpass	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	hydroxy	_	ADJ	JJ	_	5	amod	_	_
5	DRUG	_	NOUN	NN	_	2	nmod	_	_
6	were	_	VERB	VBD	_	7	auxpass	_	_
7	decreased	_	VERB	VBN	_	0	root	_	_

#	WELLBUTRIN	3945
1	Prasugrel	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	In	_	ADP	IN	_	5	case	_	_
4	healthy	_	ADJ	JJ	_	5	amod	_	_
5	subjects	_	NOUN	NNS	_	1	nmod	_	_
6	,	_	.	,	_	1	punct	_	_
7	prasugrel	_	NOUN	NN	_	8	nsubj	_	_
8	increased	_	VERB	VBD	_	1	acl:relcl	_	_
9	DRUG	_	NOUN	NN	_	10	compound	_	_
10	Cmax	_	NOUN	NN	_	8	dobj	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	AUC	_	NOUN	NN	_	13	compound	_	_
13	values	_	NOUN	NNS	_	10	conj	_	_
14	by	_	ADP	IN	_	15	case	_	_
15	14%	_	ADJ	JJ	_	8	nmod	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	18%	_	NOUN	NN	_	15	conj	_	_
18	,	_	.	,	_	1	punct	_	_
19	respectively	_	ADV	RB	_	1	advmod	_	_
20	,	_	.	,	_	1	punct	_	_
21	and	_	CONJ	CC	_	1	cc	_	_
22	decreased	_	VERB	VBD	_	26	amod	_	_
23	Cmax	_	NOUN	NN	_	26	compound	_	_
24	and	_	CONJ	CC	_	23	cc	_	_
25	AUC	_	NOUN	NN	_	23	conj	_	_
26	values	_	NOUN	NNS	_	1	conj	_	_
27	of	_	ADP	IN	_	29	case	_	_
28	hydroxy	_	NOUN	NN	_	29	compound	_	_
29	DRUG	_	NOUN	NN	_	26	nmod	_	_
30	by	_	ADP	IN	_	31	case	_	_
31	32%	_	NOUN	NN	_	1	nmod	_	_
32	and	_	CONJ	CC	_	31	cc	_	_
33	24%	_	NOUN	NN	_	31	conj	_	_
34	,	_	.	,	_	1	punct	_	_
35	respectively	_	ADV	RB	_	1	advmod	_	_

#	WELLBUTRIN	3946
1	Cimetidine	_	NOUN	NN	_	31	nsubj	_	_
2	:	_	.	:	_	1	punct	_	_
3	Following	_	VERB	VBG	_	5	case	_	_
4	oral	_	ADJ	JJ	_	5	amod	_	_
5	administration	_	NOUN	NN	_	1	nmod	_	_
6	of	_	ADP	IN	_	9	case	_	_
7	DRUG	_	NOUN	NN	_	9	compound	_	_
8	300	_	NUM	CD	_	9	nummod	_	_
9	mg	_	NOUN	NN	_	5	nmod	_	_
10	with	_	ADP	IN	_	5	acl	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	without	_	ADP	IN	_	13	mark	_	_
13	cimetidine	_	VERB	VBG	_	10	conj	_	_
14	800	_	NUM	CD	_	15	nummod	_	_
15	mg	_	NOUN	NN	_	13	dobj	_	_
16	in	_	ADP	IN	_	21	case	_	_
17	24	_	NUM	CD	_	21	nummod	_	_
18	healthy	_	ADJ	JJ	_	21	amod	_	_
19	young	_	ADJ	JJ	_	21	amod	_	_
20	male	_	ADJ	JJ	_	21	amod	_	_
21	volunteers	_	NOUN	NNS	_	13	nmod	_	_
22	,	_	.	,	_	31	punct	_	_
23	the	_	DET	DT	_	24	det	_	_
24	pharmacokinetics	_	NOUN	NNS	_	31	nsubj	_	_
25	of	_	ADP	IN	_	26	case	_	_
26	DRUG	_	NOUN	NN	_	24	nmod	_	_
27	and	_	CONJ	CC	_	26	cc	_	_
28	hydroxy	_	ADJ	JJ	_	29	compound	_	_
29	DRUG	_	NOUN	NN	_	26	conj	_	_
30	were	_	VERB	VBD	_	31	auxpass	_	_
31	unaffected	_	ADJ	JJ	_	0	root	_	_

#	WELLBUTRIN	3947
1	However	_	ADV	RB	_	4	advmod	_	_
2	,	_	.	,	_	4	punct	_	_
3	there	_	DET	EX	_	4	expl	_	_
4	were	_	VERB	VBD	_	0	root	_	_
5	16%	_	ADJ	JJ	_	8	amod	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	32%	_	ADJ	JJ	_	5	conj	_	_
8	increases	_	NOUN	NNS	_	4	dobj	_	_
9	in	_	ADP	IN	_	11	case	_	_
10	the	_	DET	DT	_	11	det	_	_
11	AUC	_	NOUN	NN	_	8	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	Cmax	_	NOUN	NN	_	11	conj	_	_
14	,	_	.	,	_	8	punct	_	_
15	respectively	_	ADV	RB	_	8	advmod	_	_
16	,	_	.	,	_	8	punct	_	_
17	of	_	ADP	IN	_	20	case	_	_
18	the	_	DET	DT	_	20	det	_	_
19	combined	_	ADJ	JJ	_	20	amod	_	_
20	moieties	_	NOUN	NNS	_	8	nmod	_	_
21	of	_	ADP	IN	_	23	case	_	_
22	threohydro	_	NOUN	NN	_	23	amod	_	_
23	DRUG	_	NOUN	NN	_	20	nmod	_	_
24	and	_	CONJ	CC	_	23	cc	_	_
25	erythrohydro	_	NOUN	NN	_	26	compound	_	_
26	DRUG	_	NOUN	NN	_	23	conj	_	_

#	WELLBUTRIN	3948
1	Citalopram	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Citalopram	_	NOUN	NN	_	6	nsubj	_	_
4	did	_	VERB	VBD	_	6	aux	_	_
5	not	_	ADV	RB	_	6	neg	_	_
6	affect	_	VERB	VB	_	1	dep	_	_
7	the	_	DET	DT	_	8	det	_	_
8	pharmacokinetics	_	NOUN	NNS	_	6	dobj	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	its	_	PRON	PRP$	_	14	nmod:poss	_	_
13	three	_	NUM	CD	_	14	nummod	_	_
14	metabolites	_	NOUN	NNS	_	10	conj	_	_

#	WELLBUTRIN	3949
1	Inducers	_	NOUN	NNS	_	19	nsubj	_	_
2	of	_	ADP	IN	_	4	case	_	_
3	CYP2B6	_	NOUN	NN	_	4	compound	_	_
4	Ritonavir	_	NOUN	NN	_	1	nmod	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	Lopinavir	_	ADJ	JJ	_	4	conj	_	_
7	:	_	.	:	_	1	punct	_	_
8	In	_	ADP	IN	_	12	case	_	_
9	a	_	DET	DT	_	12	det	_	_
10	healthy	_	ADJ	JJ	_	12	amod	_	_
11	volunteer	_	ADJ	JJ	_	12	amod	_	_
12	study	_	NOUN	NN	_	1	nmod	_	_
13	,	_	.	,	_	1	punct	_	_
14	ritonavir	_	ADJ	JJ	_	15	advmod	_	_
15	100	_	NUM	CD	_	16	nummod	_	_
16	mg	_	NOUN	NN	_	19	nsubj	_	_
17	twice	_	ADV	RB	_	18	advmod	_	_
18	daily	_	ADV	RB	_	19	advmod	_	_
19	reduced	_	VERB	VBD	_	0	root	_	_
20	the	_	DET	DT	_	21	det	_	_
21	AUC	_	NOUN	NN	_	19	dobj	_	_
22	and	_	CONJ	CC	_	21	cc	_	_
23	Cmax	_	NOUN	NN	_	21	conj	_	_
24	of	_	ADP	IN	_	25	case	_	_
25	DRUG	_	NOUN	NN	_	21	nmod	_	_
26	by	_	ADP	IN	_	27	case	_	_
27	22%	_	NOUN	NN	_	19	nmod	_	_
28	and	_	CONJ	CC	_	27	cc	_	_
29	21%	_	NOUN	NN	_	27	conj	_	_
30	,	_	.	,	_	19	punct	_	_
31	respectively	_	ADV	RB	_	19	advmod	_	_

#	WELLBUTRIN	3950
1	The	_	DET	DT	_	2	det	_	_
2	exposure	_	NOUN	NN	_	9	nsubjpass	_	_
3	of	_	ADP	IN	_	7	case	_	_
4	the	_	DET	DT	_	7	det	_	_
5	hydroxy	_	ADJ	JJ	_	7	amod	_	_
6	DRUG	_	NOUN	NN	_	7	compound	_	_
7	metabolite	_	NOUN	NN	_	2	nmod	_	_
8	was	_	VERB	VBD	_	9	auxpass	_	_
9	decreased	_	VERB	VBN	_	0	root	_	_
10	by	_	ADP	IN	_	11	case	_	_
11	23%	_	NOUN	NN	_	9	nmod	_	_
12	,	_	.	,	_	9	punct	_	_
13	the	_	DET	DT	_	15	det	_	_
14	threohydro	_	NOUN	NN	_	15	amod	_	_
15	DRUG	_	NOUN	NN	_	16	nsubj	_	_
16	decreased	_	VERB	VBN	_	9	conj	_	_
17	by	_	ADP	IN	_	18	case	_	_
18	38%	_	NOUN	NN	_	16	nmod	_	_
19	,	_	.	,	_	9	punct	_	_
20	and	_	CONJ	CC	_	9	cc	_	_
21	the	_	DET	DT	_	23	det	_	_
22	erythrohydro	_	NOUN	NN	_	23	amod	_	_
23	DRUG	_	NOUN	NN	_	9	conj	_	_
24	decreased	_	VERB	VBN	_	23	acl	_	_
25	by	_	ADP	IN	_	26	case	_	_
26	48%	_	ADJ	JJ	_	24	nmod	_	_

#	WELLBUTRIN	3951
1	In	_	ADP	IN	_	6	case	_	_
2	a	_	DET	DT	_	6	det	_	_
3	second	_	ADJ	JJ	_	6	amod	_	_
4	healthy	_	ADJ	JJ	_	6	amod	_	_
5	volunteer	_	ADJ	JJ	_	6	amod	_	_
6	study	_	NOUN	NN	_	13	nmod	_	_
7	,	_	.	,	_	13	punct	_	_
8	ritonavir	_	ADJ	JJ	_	10	compound	_	_
9	600	_	NUM	CD	_	10	nummod	_	_
10	mg	_	NOUN	NN	_	13	nsubj	_	_
11	twice	_	ADV	RB	_	13	advmod	_	_
12	daily	_	ADV	RB	_	13	advmod	_	_
13	decreased	_	VERB	VBD	_	0	root	_	_
14	the	_	DET	DT	_	15	det	_	_
15	AUC	_	NOUN	NN	_	13	dobj	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	Cmax	_	NOUN	NN	_	15	conj	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	DRUG	_	NOUN	NN	_	15	nmod	_	_
20	by	_	ADP	IN	_	21	case	_	_
21	66%	_	NOUN	NN	_	13	nmod	_	_
22	and	_	CONJ	CC	_	21	cc	_	_
23	62%	_	NOUN	NN	_	21	conj	_	_
24	,	_	.	,	_	13	punct	_	_
25	respectively	_	ADV	RB	_	13	advmod	_	_

#	WELLBUTRIN	3952
1	The	_	DET	DT	_	2	det	_	_
2	exposure	_	NOUN	NN	_	9	nsubjpass	_	_
3	of	_	ADP	IN	_	7	case	_	_
4	the	_	DET	DT	_	7	det	_	_
5	hydroxy	_	ADJ	JJ	_	7	amod	_	_
6	DRUG	_	NOUN	NN	_	7	compound	_	_
7	metabolite	_	NOUN	NN	_	2	nmod	_	_
8	was	_	VERB	VBD	_	9	auxpass	_	_
9	decreased	_	VERB	VBN	_	0	root	_	_
10	by	_	ADP	IN	_	11	case	_	_
11	78%	_	NOUN	NN	_	9	nmod	_	_
12	,	_	.	,	_	9	punct	_	_
13	the	_	DET	DT	_	15	det	_	_
14	threohydro	_	NOUN	NN	_	15	amod	_	_
15	DRUG	_	NOUN	NN	_	16	nsubj	_	_
16	decreased	_	VERB	VBN	_	9	conj	_	_
17	by	_	ADP	IN	_	18	case	_	_
18	50%	_	NOUN	NN	_	16	nmod	_	_
19	,	_	.	,	_	9	punct	_	_
20	and	_	CONJ	CC	_	9	cc	_	_
21	the	_	DET	DT	_	23	det	_	_
22	erythrohydro	_	NOUN	NN	_	23	amod	_	_
23	DRUG	_	NOUN	NN	_	9	conj	_	_
24	decreased	_	VERB	VBN	_	23	acl	_	_
25	by	_	ADP	IN	_	26	case	_	_
26	68%	_	ADJ	JJ	_	24	nmod	_	_

#	WELLBUTRIN	3953
1	In	_	ADP	IN	_	5	case	_	_
2	another	_	DET	DT	_	5	det	_	_
3	healthy	_	ADJ	JJ	_	5	amod	_	_
4	volunteer	_	ADJ	JJ	_	5	amod	_	_
5	study	_	NOUN	NN	_	0	root	_	_
6	,	_	.	,	_	5	punct	_	_
7	lopinavir	_	ADJ	JJ	_	9	amod	_	_
8	400	_	NUM	CD	_	9	nummod	_	_
9	mg	_	NOUN	NN	_	6	root	_	_
10	/	_	.	:	_	9	punct	_	_
11	ritonavir	_	NOUN	NN	_	13	compound	_	_
12	100	_	NUM	CD	_	13	nummod	_	_
13	mg	_	NOUN	NN	_	16	nsubj	_	_
14	twice	_	ADV	RB	_	16	advmod	_	_
15	daily	_	ADV	RB	_	16	advmod	_	_
16	decreased	_	VERB	VBD	_	9	dep	_	_
17	DRUG	_	NOUN	NN	_	18	compound	_	_
18	AUC	_	NOUN	NN	_	16	dobj	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	Cmax	_	NOUN	NN	_	18	conj	_	_
21	by	_	ADP	IN	_	22	case	_	_
22	57%	_	ADJ	JJ	_	16	nmod	_	_

#	WELLBUTRIN	3954
1	The	_	DET	DT	_	2	det	_	_
2	AUC	_	NOUN	NN	_	10	nsubjpass	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	Cmax	_	NOUN	NN	_	2	conj	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	hydroxy	_	ADJ	JJ	_	8	amod	_	_
7	DRUG	_	NOUN	NN	_	8	compound	_	_
8	metabolite	_	NOUN	NN	_	2	nmod	_	_
9	were	_	VERB	VBD	_	10	auxpass	_	_
10	decreased	_	VERB	VBN	_	0	root	_	_
11	by	_	ADP	IN	_	12	case	_	_
12	50%	_	NOUN	NN	_	10	nmod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	31%	_	NOUN	NN	_	12	conj	_	_
15	,	_	.	,	_	10	punct	_	_
16	respectively	_	ADV	RB	_	10	advmod	_	_

#	WELLBUTRIN	3955
1	Efavirenz	_	ADJ	JJ	_	10	advmod	_	_
2	:	_	.	:	_	1	punct	_	_
3	In	_	ADP	IN	_	5	case	_	_
4	a	_	DET	DT	_	5	det	_	_
5	study	_	NOUN	NN	_	1	nmod	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	healthy	_	ADJ	JJ	_	8	amod	_	_
8	volunteers	_	NOUN	NNS	_	5	nmod	_	_
9	,	_	.	,	_	10	punct	_	_
10	efavirenz	_	ADJ	JJ	_	0	root	_	_
11	600	_	NUM	CD	_	12	nummod	_	_
12	mg	_	NOUN	NN	_	18	nsubj	_	_
13	once	_	ADV	RB	_	14	advmod	_	_
14	daily	_	ADV	RB	_	12	advmod	_	_
15	for	_	ADP	IN	_	17	case	_	_
16	2	_	NUM	CD	_	17	nummod	_	_
17	weeks	_	NOUN	NNS	_	14	nmod	_	_
18	reduced	_	VERB	VBD	_	10	parataxis	_	_
19	the	_	DET	DT	_	20	det	_	_
20	AUC	_	NOUN	NN	_	18	dobj	_	_
21	and	_	CONJ	CC	_	20	cc	_	_
22	Cmax	_	NOUN	NN	_	20	conj	_	_
23	of	_	ADP	IN	_	24	case	_	_
24	DRUG	_	NOUN	NN	_	20	nmod	_	_
25	by	_	ADP	IN	_	27	case	_	_
26	approximately	_	ADV	RB	_	27	advmod	_	_
27	55%	_	NOUN	NN	_	18	nmod	_	_
28	and	_	CONJ	CC	_	27	cc	_	_
29	34%	_	NOUN	NN	_	27	conj	_	_
30	,	_	.	,	_	10	punct	_	_
31	respectively	_	ADV	RB	_	10	advmod	_	_

#	WELLBUTRIN	3956
1	The	_	DET	DT	_	2	det	_	_
2	AUC	_	NOUN	NN	_	7	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	hydroxy	_	NOUN	NN	_	5	compound	_	_
5	DRUG	_	NOUN	NN	_	2	nmod	_	_
6	was	_	VERB	VBD	_	7	cop	_	_
7	unchanged	_	ADJ	JJ	_	0	root	_	_
8	,	_	.	,	_	7	punct	_	_
9	whereas	_	ADP	IN	_	15	mark	_	_
10	Cmax	_	NOUN	NN	_	15	nsubjpass	_	_
11	of	_	ADP	IN	_	13	case	_	_
12	hydroxy	_	NOUN	NN	_	13	compound	_	_
13	DRUG	_	NOUN	NN	_	10	nmod	_	_
14	was	_	VERB	VBD	_	15	auxpass	_	_
15	increased	_	VERB	VBN	_	7	advcl	_	_
16	by	_	ADP	IN	_	17	case	_	_
17	50%	_	ADJ	JJ	_	15	nmod	_	_

#	WELLBUTRIN	3957
1	Carbamazepine	_	NOUN	NN	_	15	nsubj	_	_
2	,	_	.	,	_	1	punct	_	_
3	Phenobarbital	_	ADJ	JJ	_	1	conj	_	_
4	,	_	.	,	_	1	punct	_	_
5	Phenytoin	_	NOUN	NN	_	1	appos	_	_
6	:	_	.	:	_	1	punct	_	_
7	While	_	ADP	IN	_	10	mark	_	_
8	not	_	ADV	RB	_	10	neg	_	_
9	systematically	_	ADV	RB	_	10	advmod	_	_
10	studied	_	VERB	VBN	_	15	advcl	_	_
11	,	_	.	,	_	15	punct	_	_
12	these	_	DET	DT	_	13	det	_	_
13	drugs	_	NOUN	NNS	_	15	nsubj	_	_
14	may	_	VERB	MD	_	15	aux	_	_
15	induce	_	VERB	VB	_	0	root	_	_
16	the	_	DET	DT	_	17	det	_	_
17	metabolism	_	NOUN	NN	_	15	dobj	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	DRUG	_	NOUN	NN	_	17	nmod	_	_

#	WELLBUTRIN	3958
1	Potential	_	ADJ	JJ	_	11	nsubj	_	_
2	for	_	ADP	IN	_	4	case	_	_
3	DRUG	_	NOUN	NN	_	4	compound	_	_
4	XL	_	NOUN	NN	_	1	nmod	_	_
5	to	_	PRT	TO	_	8	case	_	_
6	Affect	_	NOUN	NN	_	8	compound	_	_
7	Other	_	ADJ	JJ	_	8	amod	_	_
8	Drugs	_	NOUN	NNS	_	1	nmod	_	_
9	Animal	_	ADJ	JJ	_	10	amod	_	_
10	data	_	NOUN	NNS	_	8	dep	_	_
11	indicated	_	VERB	VBD	_	0	root	_	_
12	that	_	ADP	IN	_	17	mark	_	_
13	DRUG	_	NOUN	NN	_	17	nsubj	_	_
14	may	_	VERB	MD	_	17	aux	_	_
15	be	_	VERB	VB	_	17	cop	_	_
16	an	_	DET	DT	_	17	det	_	_
17	inducer	_	NOUN	NN	_	11	ccomp	_	_
18	of	_	ADP	IN	_	21	case	_	_
19	drug	_	NOUN	NN	_	21	compound	_	_
20	metabolizing	_	NOUN	NN	_	21	compound	_	_
21	enzymes	_	NOUN	NNS	_	17	nmod	_	_
22	in	_	ADP	IN	_	23	case	_	_
23	humans	_	NOUN	NNS	_	21	nmod	_	_

#	WELLBUTRIN	3959
1	In	_	ADP	IN	_	3	case	_	_
2	a	_	DET	DT	_	3	det	_	_
3	study	_	NOUN	NN	_	25	nmod	_	_
4	of	_	ADP	IN	_	8	case	_	_
5	8	_	NUM	CD	_	8	nummod	_	_
6	healthy	_	ADJ	JJ	_	8	amod	_	_
7	male	_	ADJ	JJ	_	8	amod	_	_
8	volunteers	_	NOUN	NNS	_	3	nmod	_	_
9	,	_	.	,	_	25	punct	_	_
10	following	_	VERB	VBG	_	14	case	_	_
11	a	_	DET	DT	_	14	det	_	_
12	14	_	NUM	CD	_	14	nummod	_	_
13	day	_	NOUN	NN	_	14	compound	_	_
14	administration	_	NOUN	NN	_	25	nmod	_	_
15	of	_	ADP	IN	_	20	case	_	_
16	DRUG	_	NOUN	NN	_	20	compound	_	_
17	100	_	NUM	CD	_	20	nummod	_	_
18	mg	_	NOUN	NN	_	20	compound	_	_
19	three	_	NUM	CD	_	20	nummod	_	_
20	times	_	NOUN	NNS	_	14	nmod	_	_
21	per	_	ADP	IN	_	22	case	_	_
22	day	_	NOUN	NN	_	14	nmod	_	_
23	,	_	.	,	_	25	punct	_	_
24	there	_	DET	EX	_	25	expl	_	_
25	was	_	VERB	VBD	_	0	root	_	_
26	no	_	DET	DT	_	27	neg	_	_
27	evidence	_	NOUN	NN	_	25	nsubj	_	_
28	of	_	ADP	IN	_	29	case	_	_
29	induction	_	NOUN	NN	_	27	nmod	_	_
30	of	_	ADP	IN	_	33	case	_	_
31	its	_	PRON	PRP$	_	33	nmod:poss	_	_
32	own	_	ADJ	JJ	_	33	amod	_	_
33	metabolism	_	NOUN	NN	_	29	nmod	_	_

#	WELLBUTRIN	3960
1	Nevertheless	_	ADV	RB	_	7	advmod	_	_
2	,	_	.	,	_	7	punct	_	_
3	there	_	DET	EX	_	7	nsubj	_	_
4	may	_	VERB	MD	_	7	aux	_	_
5	be	_	VERB	VB	_	7	cop	_	_
6	the	_	DET	DT	_	7	det	_	_
7	potential	_	NOUN	NN	_	0	root	_	_
8	for	_	ADP	IN	_	11	case	_	_
9	clinically	_	ADV	RB	_	10	advmod	_	_
10	important	_	ADJ	JJ	_	11	amod	_	_
11	alterations	_	NOUN	NNS	_	7	nmod	_	_
12	of	_	ADP	IN	_	14	case	_	_
13	blood	_	NOUN	NN	_	14	compound	_	_
14	levels	_	NOUN	NNS	_	11	nmod	_	_
15	of	_	ADP	IN	_	17	case	_	_
16	coadministered	_	VERB	VBN	_	17	amod	_	_
17	drugs	_	NOUN	NNS	_	14	nmod	_	_

#	WELLBUTRIN	3961
1	Drugs	_	NOUN	NNS	_	14	nsubj	_	_
2	Metabolized	_	VERB	VBN	_	1	acl	_	_
3	by	_	ADP	IN	_	4	case	_	_
4	CYP2D6	_	NOUN	NN	_	2	nmod	_	_
5	In	_	X	FW	_	6	compound	_	_
6	vitro	_	X	FW	_	4	advmod	_	_
7	,	_	.	,	_	1	punct	_	_
8	DRUG	_	NOUN	NN	_	1	conj	_	_
9	and	_	CONJ	CC	_	1	cc	_	_
10	hydroxy	_	NOUN	NN	_	11	compound	_	_
11	DRUG	_	NOUN	NN	_	1	conj	_	_
12	are	_	VERB	VBP	_	14	cop	_	_
13	CYP2D6	_	NOUN	NN	_	14	compound	_	_
14	inhibitors	_	NOUN	NNS	_	0	root	_	_

#	WELLBUTRIN	3962
1	In	_	ADP	IN	_	4	case	_	_
2	a	_	DET	DT	_	4	det	_	_
3	clinical	_	ADJ	JJ	_	4	amod	_	_
4	study	_	NOUN	NN	_	9	nsubj	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	15	_	NUM	CD	_	8	nummod	_	_
7	male	_	ADJ	JJ	_	8	amod	_	_
8	subjects	_	NOUN	NNS	_	4	nmod	_	_
9	ages	_	VERB	VBZ	_	0	root	_	_
10	19	_	NUM	CD	_	12	compound	_	_
11	to	_	PRT	TO	_	12	dep	_	_
12	35	_	NUM	CD	_	13	nummod	_	_
13	years	_	NOUN	NNS	_	9	dobj	_	_
14	who	_	DET	WDT	_	17	nsubj	_	_
15	were	_	VERB	VBD	_	17	cop	_	_
16	extensive	_	ADJ	JJ	_	17	amod	_	_
17	metabolizers	_	NOUN	NNS	_	13	acl:relcl	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	CYP2D6	_	NOUN	NN	_	17	nmod	_	_
20	,	_	.	,	_	9	punct	_	_
21	DRUG	_	NOUN	NN	_	22	nsubj	_	_
22	given	_	VERB	VBD	_	9	parataxis	_	_
23	as	_	ADP	IN	_	25	case	_	_
24	150	_	NUM	CD	_	25	nummod	_	_
25	mg	_	NOUN	NN	_	22	nmod	_	_
26	twice	_	ADV	RB	_	27	advmod	_	_
27	daily	_	ADV	RB	_	28	advmod	_	_
28	followed	_	VERB	VBN	_	22	advcl	_	_
29	by	_	ADP	IN	_	32	case	_	_
30	a	_	DET	DT	_	32	det	_	_
31	single	_	ADJ	JJ	_	32	amod	_	_
32	dose	_	NOUN	NN	_	28	nmod	_	_
33	of	_	ADP	IN	_	36	case	_	_
34	50	_	NUM	CD	_	36	nummod	_	_
35	mg	_	NOUN	NN	_	36	compound	_	_
36	desipramine	_	NOUN	NN	_	32	nmod	_	_
37	increased	_	VERB	VBD	_	22	parataxis	_	_
38	the	_	DET	DT	_	39	det	_	_
39	Cmax	_	NOUN	NN	_	37	root	_	_
40	,	_	.	,	_	39	punct	_	_
41	AUC	_	NOUN	NN	_	39	conj	_	_
42	,	_	.	,	_	39	punct	_	_
43	and	_	CONJ	CC	_	39	cc	_	_
44	T1	_	NOUN	NN	_	39	conj	_	_
45	/	_	.	:	_	39	punct	_	_
46	2	_	NUM	CD	_	39	dep	_	_
47	of	_	ADP	IN	_	48	case	_	_
48	desipramine	_	NOUN	NN	_	46	nmod	_	_
49	by	_	ADP	IN	_	51	case	_	_
50	an	_	DET	DT	_	51	det	_	_
51	average	_	NOUN	NN	_	46	nmod	_	_
52	of	_	ADP	IN	_	54	case	_	_
53	approximately	_	ADV	RB	_	54	advmod	_	_
54	2	_	NUM	CD	_	51	nmod	_	_
55	,	_	.	,	_	54	punct	_	_
56	5	_	NUM	CD	_	54	conj	_	_
57	,	_	.	,	_	54	punct	_	_
58	and	_	CONJ	CC	_	54	cc	_	_
59	2	_	NUM	CD	_	54	conj	_	_
60	fold	_	NOUN	NN	_	54	dep	_	_
61	,	_	.	,	_	39	punct	_	_
62	respectively	_	ADV	RB	_	39	advmod	_	_

#	WELLBUTRIN	3963
1	The	_	DET	DT	_	2	det	_	_
2	effect	_	NOUN	NN	_	4	nsubj	_	_
3	was	_	VERB	VBD	_	4	cop	_	_
4	present	_	ADJ	JJ	_	0	root	_	_
5	for	_	ADP	IN	_	9	case	_	_
6	at	_	ADP	IN	_	7	case	_	_
7	least	_	ADJ	JJS	_	8	nmod:npmod	_	_
8	7	_	NUM	CD	_	9	nummod	_	_
9	days	_	NOUN	NNS	_	4	nmod	_	_
10	after	_	ADP	IN	_	13	case	_	_
11	the	_	DET	DT	_	13	det	_	_
12	last	_	ADJ	JJ	_	13	amod	_	_
13	dose	_	NOUN	NN	_	4	nmod	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	DRUG	_	NOUN	NN	_	13	nmod	_	_

#	WELLBUTRIN	3964
1	Concomitant	_	ADJ	JJ	_	2	amod	_	_
2	use	_	NOUN	NN	_	15	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	with	_	ADP	IN	_	7	case	_	_
6	other	_	ADJ	JJ	_	7	amod	_	_
7	drugs	_	NOUN	NNS	_	2	nmod	_	_
8	metabolized	_	VERB	VBN	_	7	acl	_	_
9	by	_	ADP	IN	_	10	case	_	_
10	CYP2D6	_	NOUN	NN	_	8	nmod	_	_
11	has	_	VERB	VBZ	_	15	aux	_	_
12	not	_	ADV	RB	_	15	neg	_	_
13	been	_	VERB	VBN	_	15	auxpass	_	_
14	formally	_	ADV	RB	_	15	advmod	_	_
15	studied	_	VERB	VBN	_	0	root	_	_

#	WELLBUTRIN	3965
1	Citalopram	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Although	_	ADP	IN	_	8	mark	_	_
4	citalopram	_	NOUN	NN	_	8	nsubjpass	_	_
5	is	_	VERB	VBZ	_	8	auxpass	_	_
6	not	_	ADV	RB	_	8	neg	_	_
7	primarily	_	ADV	RB	_	8	advmod	_	_
8	metabolized	_	VERB	VBN	_	16	advcl	_	_
9	by	_	ADP	IN	_	10	case	_	_
10	CYP2D6	_	NOUN	NN	_	8	nmod	_	_
11	,	_	.	,	_	16	punct	_	_
12	in	_	ADP	IN	_	15	case	_	_
13	one	_	NUM	CD	_	15	nummod	_	_
14	study	_	NOUN	NN	_	15	compound	_	_
15	DRUG	_	NOUN	NN	_	16	nsubj	_	_
16	increased	_	VERB	VBD	_	1	dep	_	_
17	the	_	DET	DT	_	18	det	_	_
18	Cmax	_	NOUN	NN	_	16	dobj	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	AUC	_	NOUN	NN	_	18	conj	_	_
21	of	_	ADP	IN	_	22	case	_	_
22	citalopram	_	NOUN	NN	_	18	nmod	_	_
23	by	_	ADP	IN	_	24	case	_	_
24	30%	_	NOUN	NN	_	16	nmod	_	_
25	and	_	CONJ	CC	_	24	cc	_	_
26	40%	_	NOUN	NN	_	24	conj	_	_
27	,	_	.	,	_	16	punct	_	_
28	respectively	_	ADV	RB	_	16	advmod	_	_

#	WELLBUTRIN	3966
1	Lamotrigine	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Multiple	_	ADJ	JJ	_	5	amod	_	_
4	oral	_	ADJ	JJ	_	5	amod	_	_
5	doses	_	NOUN	NNS	_	8	nsubj	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	had	_	VERB	VBD	_	1	dep	_	_
9	no	_	DET	DT	_	12	neg	_	_
10	statistically	_	ADV	RB	_	11	advmod	_	_
11	significant	_	ADJ	JJ	_	12	amod	_	_
12	effects	_	NOUN	NNS	_	8	dobj	_	_
13	on	_	ADP	IN	_	17	case	_	_
14	the	_	DET	DT	_	17	det	_	_
15	single	_	ADJ	JJ	_	17	amod	_	_
16	dose	_	NOUN	NN	_	17	compound	_	_
17	pharmacokinetics	_	NOUN	NNS	_	12	nmod	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	lamotrigine	_	NOUN	NN	_	17	nmod	_	_
20	in	_	ADP	IN	_	23	case	_	_
21	12	_	NUM	CD	_	23	nummod	_	_
22	healthy	_	ADJ	JJ	_	23	amod	_	_
23	volunteers	_	NOUN	NNS	_	12	nmod	_	_

#	ZALEPLON	6344
1	As	_	ADP	IN	_	4	case	_	_
2	with	_	ADP	IN	_	4	case	_	_
3	all	_	DET	DT	_	4	det	_	_
4	drugs	_	NOUN	NNS	_	8	nmod	_	_
5	,	_	.	,	_	8	punct	_	_
6	the	_	DET	DT	_	7	det	_	_
7	potential	_	NOUN	NN	_	8	nsubj	_	_
8	exists	_	VERB	VBZ	_	0	root	_	_
9	for	_	ADP	IN	_	10	case	_	_
10	interaction	_	NOUN	NN	_	8	nmod	_	_
11	with	_	ADP	IN	_	13	case	_	_
12	other	_	ADJ	JJ	_	13	amod	_	_
13	drugs	_	NOUN	NNS	_	10	nmod	_	_
14	by	_	ADP	IN	_	16	case	_	_
15	a	_	DET	DT	_	16	det	_	_
16	variety	_	NOUN	NN	_	10	nmod	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	mechanisms	_	NOUN	NNS	_	16	nmod	_	_

#	ZALEPLON	6345
1	CNS	_	NOUN	NN	_	4	compound	_	_
2	Active	_	ADJ	JJ	_	4	amod	_	_
3	Drugs	_	NOUN	NNS	_	4	compound	_	_
4	Ethanol	_	NOUN	NN	_	0	root	_	_
5	:	_	.	:	_	4	punct	_	_
6	DRUG	_	NOUN	NN	_	8	compound	_	_
7	10	_	NUM	CD	_	8	nummod	_	_
8	mg	_	NOUN	NN	_	9	nsubj	_	_
9	potentiated	_	VERB	VBD	_	4	dep	_	_
10	the	_	DET	DT	_	13	det	_	_
11	CNS	_	NOUN	NN	_	13	compound	_	_
12	impairing	_	VERB	VBG	_	13	compound	_	_
13	effects	_	NOUN	NNS	_	9	dobj	_	_
14	of	_	ADP	IN	_	17	case	_	_
15	ethanol	_	NOUN	NN	_	17	compound	_	_
16	0.75	_	NUM	CD	_	17	nummod	_	_
17	g	_	NOUN	NN	_	13	nmod	_	_
18	/	_	.	:	_	13	punct	_	_
19	kg	_	NOUN	NN	_	13	dep	_	_
20	on	_	ADP	IN	_	22	case	_	_
21	balance	_	NOUN	NN	_	22	compound	_	_
22	testing	_	NOUN	NN	_	19	nmod	_	_
23	and	_	CONJ	CC	_	22	cc	_	_
24	reaction	_	NOUN	NN	_	25	compound	_	_
25	time	_	NOUN	NN	_	22	conj	_	_
26	for	_	ADP	IN	_	28	case	_	_
27	1	_	NUM	CD	_	28	nummod	_	_
28	hour	_	NOUN	NN	_	19	nmod	_	_
29	after	_	ADP	IN	_	31	case	_	_
30	ethanol	_	NOUN	NN	_	31	compound	_	_
31	administration	_	NOUN	NN	_	19	nmod	_	_
32	and	_	CONJ	CC	_	31	cc	_	_
33	on	_	ADP	IN	_	39	case	_	_
34	the	_	DET	DT	_	39	det	_	_
35	digit	_	NOUN	NN	_	39	compound	_	_
36	symbol	_	NOUN	NN	_	39	compound	_	_
37	substitution	_	NOUN	NN	_	39	compound	_	_
38	test	_	NOUN	NN	_	39	compound	_	_
39	DSST	_	NOUN	NN	_	31	conj	_	_
40	,	_	.	,	_	39	punct	_	_
41	symbol	_	NOUN	NN	_	43	compound	_	_
42	copying	_	NOUN	NN	_	43	compound	_	_
43	test	_	NOUN	NN	_	39	conj	_	_
44	,	_	.	,	_	39	punct	_	_
45	and	_	CONJ	CC	_	39	cc	_	_
46	the	_	DET	DT	_	48	det	_	_
47	variability	_	NOUN	NN	_	48	compound	_	_
48	component	_	NOUN	NN	_	39	conj	_	_
49	of	_	ADP	IN	_	53	case	_	_
50	the	_	DET	DT	_	53	det	_	_
51	divided	_	VERB	VBN	_	53	amod	_	_
52	attention	_	NOUN	NN	_	53	compound	_	_
53	test	_	NOUN	NN	_	48	nmod	_	_
54	for	_	ADP	IN	_	56	case	_	_
55	2.5	_	NUM	CD	_	56	nummod	_	_
56	hours	_	NOUN	NNS	_	48	nmod	_	_
57	after	_	ADP	IN	_	59	case	_	_
58	ethanol	_	NOUN	NN	_	59	compound	_	_
59	administration	_	NOUN	NN	_	19	nmod	_	_

#	ZALEPLON	6346
1	The	_	DET	DT	_	2	det	_	_
2	potentiation	_	NOUN	NN	_	3	nsubj	_	_
3	resulted	_	VERB	VBD	_	0	root	_	_
4	from	_	ADP	IN	_	9	case	_	_
5	a	_	DET	DT	_	9	det	_	_
6	CNS	_	NOUN	NN	_	9	compound	_	_
7	pharmacodynamic	_	ADJ	JJ	_	9	amod	_	_
8	interaction	_	NOUN	NN	_	9	compound	_	_
9	DRUG	_	NOUN	NN	_	3	nmod	_	_
10	did	_	VERB	MD	_	12	aux	_	_
11	not	_	ADV	RB	_	12	neg	_	_
12	affect	_	VERB	VB	_	3	parataxis	_	_
13	the	_	DET	DT	_	14	det	_	_
14	pharmacokinetics	_	NOUN	NNS	_	12	dobj	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	ethanol	_	NOUN	NN	_	14	nmod	_	_

#	ZALEPLON	6347
1	Imipramine	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Coadministration	_	NOUN	NN	_	15	nsubj	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	single	_	ADJ	JJ	_	6	amod	_	_
6	doses	_	NOUN	NNS	_	3	nmod	_	_
7	of	_	ADP	IN	_	10	case	_	_
8	DRUG	_	NOUN	NN	_	10	compound	_	_
9	20	_	NUM	CD	_	10	nummod	_	_
10	mg	_	NOUN	NN	_	6	nmod	_	_
11	and	_	CONJ	CC	_	3	cc	_	_
12	imipramine	_	NOUN	NN	_	14	compound	_	_
13	75	_	NUM	CD	_	14	nummod	_	_
14	mg	_	NOUN	NN	_	3	conj	_	_
15	produced	_	VERB	VBD	_	1	dep	_	_
16	additive	_	ADJ	JJ	_	17	amod	_	_
17	effects	_	NOUN	NNS	_	15	dobj	_	_
18	on	_	ADP	IN	_	20	case	_	_
19	decreased	_	VERB	VBN	_	20	amod	_	_
20	alertness	_	NOUN	NN	_	15	nmod	_	_
21	and	_	CONJ	CC	_	20	cc	_	_
22	impaired	_	ADJ	JJ	_	24	amod	_	_
23	psychomotor	_	NOUN	NN	_	24	compound	_	_
24	performance	_	NOUN	NN	_	20	conj	_	_
25	for	_	ADP	IN	_	29	case	_	_
26	2	_	NUM	CD	_	28	compound	_	_
27	to	_	PRT	TO	_	28	dep	_	_
28	4	_	NUM	CD	_	29	nummod	_	_
29	hours	_	NOUN	NNS	_	15	nmod	_	_
30	after	_	ADP	IN	_	31	case	_	_
31	administration	_	NOUN	NN	_	29	nmod	_	_

#	ZALEPLON	6348
1	The	_	DET	DT	_	2	det	_	_
2	interaction	_	NOUN	NN	_	4	nsubj	_	_
3	was	_	VERB	VBD	_	4	cop	_	_
4	pharmacodynamic	_	ADJ	JJ	_	0	root	_	_
5	with	_	ADP	IN	_	7	case	_	_
6	no	_	DET	DT	_	7	neg	_	_
7	alteration	_	NOUN	NN	_	4	nmod	_	_
8	of	_	ADP	IN	_	10	case	_	_
9	the	_	DET	DT	_	10	det	_	_
10	pharmacokinetics	_	NOUN	NNS	_	7	nmod	_	_
11	of	_	ADP	IN	_	13	case	_	_
12	either	_	CONJ	CC	_	13	det	_	_
13	drug	_	NOUN	NN	_	10	nmod	_	_

#	ZALEPLON	6349
1	Paroxetine	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Coadministration	_	NOUN	NN	_	22	nsubj	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	a	_	DET	DT	_	7	det	_	_
6	single	_	ADJ	JJ	_	7	amod	_	_
7	dose	_	NOUN	NN	_	3	nmod	_	_
8	of	_	ADP	IN	_	11	case	_	_
9	DRUG	_	NOUN	NN	_	11	compound	_	_
10	20	_	NUM	CD	_	11	nummod	_	_
11	mg	_	NOUN	NN	_	7	nmod	_	_
12	and	_	CONJ	CC	_	3	cc	_	_
13	paroxetine	_	NOUN	NN	_	15	compound	_	_
14	20	_	NUM	CD	_	15	nummod	_	_
15	mg	_	NOUN	NN	_	3	conj	_	_
16	daily	_	ADV	RB	_	22	advmod	_	_
17	for	_	ADP	IN	_	19	case	_	_
18	7	_	NUM	CD	_	19	nummod	_	_
19	days	_	NOUN	NNS	_	16	nmod	_	_
20	did	_	VERB	VBD	_	22	aux	_	_
21	not	_	ADV	RB	_	22	neg	_	_
22	produce	_	VERB	VB	_	1	dep	_	_
23	any	_	DET	DT	_	24	det	_	_
24	interaction	_	NOUN	NN	_	22	dobj	_	_
25	on	_	ADP	IN	_	27	case	_	_
26	psychomotor	_	NOUN	NN	_	27	compound	_	_
27	performance	_	NOUN	NN	_	24	nmod	_	_

#	ZALEPLON	6350
1	Additionally	_	ADV	RB	_	6	advmod	_	_
2	,	_	.	,	_	6	punct	_	_
3	paroxetine	_	NOUN	NN	_	6	nsubj	_	_
4	did	_	VERB	VBD	_	6	aux	_	_
5	not	_	ADV	RB	_	6	neg	_	_
6	alter	_	VERB	VB	_	0	root	_	_
7	the	_	DET	DT	_	8	det	_	_
8	pharmacokinetics	_	NOUN	NNS	_	6	dobj	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	,	_	.	,	_	6	punct	_	_
12	reflecting	_	VERB	VBG	_	6	advcl	_	_
13	the	_	DET	DT	_	14	det	_	_
14	absence	_	NOUN	NN	_	12	dobj	_	_
15	of	_	ADP	IN	_	17	case	_	_
16	a	_	DET	DT	_	17	det	_	_
17	role	_	NOUN	NN	_	14	nmod	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	CYP2D6	_	NOUN	NN	_	17	nmod	_	_
20	in	_	ADP	IN	_	23	case	_	_
21	DRUG	_	NOUN	NN	_	23	nmod:poss	_	_
22	's	_	PRT	POS	_	21	case	_	_
23	metabolism	_	NOUN	NN	_	14	nmod	_	_

#	ZALEPLON	6351
1	Thioridazine	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Coadministration	_	NOUN	NN	_	15	nsubj	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	single	_	ADJ	JJ	_	6	amod	_	_
6	doses	_	NOUN	NNS	_	3	nmod	_	_
7	of	_	ADP	IN	_	10	case	_	_
8	DRUG	_	NOUN	NN	_	10	compound	_	_
9	20	_	NUM	CD	_	10	nummod	_	_
10	mg	_	NOUN	NN	_	6	nmod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	thioridazine	_	NOUN	NN	_	14	compound	_	_
13	50	_	NUM	CD	_	14	nummod	_	_
14	mg	_	NOUN	NN	_	10	conj	_	_
15	produced	_	VERB	VBD	_	1	dep	_	_
16	additive	_	ADJ	JJ	_	17	amod	_	_
17	effects	_	NOUN	NNS	_	15	dobj	_	_
18	on	_	ADP	IN	_	20	case	_	_
19	decreased	_	VERB	VBN	_	20	amod	_	_
20	alertness	_	NOUN	NN	_	15	nmod	_	_
21	and	_	CONJ	CC	_	20	cc	_	_
22	impaired	_	ADJ	JJ	_	24	amod	_	_
23	psychomotor	_	NOUN	NN	_	24	compound	_	_
24	performance	_	NOUN	NN	_	20	conj	_	_
25	for	_	ADP	IN	_	29	case	_	_
26	2	_	NUM	CD	_	28	compound	_	_
27	to	_	PRT	TO	_	28	dep	_	_
28	4	_	NUM	CD	_	29	nummod	_	_
29	hours	_	NOUN	NNS	_	15	nmod	_	_
30	after	_	ADP	IN	_	31	case	_	_
31	administration	_	NOUN	NN	_	29	nmod	_	_

#	ZALEPLON	6353
1	Venlafaxine	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Coadministration	_	NOUN	NN	_	18	nsubj	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	a	_	DET	DT	_	7	det	_	_
6	single	_	ADJ	JJ	_	7	amod	_	_
7	dose	_	NOUN	NN	_	3	nmod	_	_
8	of	_	ADP	IN	_	11	case	_	_
9	DRUG	_	NOUN	NN	_	11	compound	_	_
10	10	_	NUM	CD	_	11	nummod	_	_
11	mg	_	NOUN	NN	_	7	nmod	_	_
12	and	_	CONJ	CC	_	3	cc	_	_
13	multiple	_	ADJ	JJ	_	14	amod	_	_
14	doses	_	NOUN	NNS	_	3	conj	_	_
15	of	_	ADP	IN	_	17	case	_	_
16	venlafaxine	_	NOUN	NN	_	17	compound	_	_
17	ER	_	NOUN	NN	_	14	nmod	_	_
18	extended	_	VERB	VBD	_	1	dep	_	_
19	release	_	NOUN	NN	_	21	compound	_	_
20	150	_	NUM	CD	_	21	nummod	_	_
21	mg	_	NOUN	NN	_	18	dobj	_	_
22	did	_	VERB	VBD	_	24	aux	_	_
23	not	_	ADV	RB	_	24	neg	_	_
24	result	_	VERB	VB	_	18	parataxis	_	_
25	in	_	ADP	IN	_	28	case	_	_
26	any	_	DET	DT	_	28	det	_	_
27	significant	_	ADJ	JJ	_	28	amod	_	_
28	changes	_	NOUN	NNS	_	24	nmod	_	_
29	in	_	ADP	IN	_	31	case	_	_
30	the	_	DET	DT	_	31	det	_	_
31	pharmacokinetics	_	NOUN	NNS	_	28	nmod	_	_
32	of	_	ADP	IN	_	34	case	_	_
33	either	_	CONJ	CC	_	34	cc:preconj	_	_
34	DRUG	_	NOUN	NN	_	31	nmod	_	_
35	or	_	CONJ	CC	_	34	cc	_	_
36	venlafaxine	_	NOUN	NN	_	34	conj	_	_

#	ZALEPLON	6354
1	In	_	ADP	IN	_	2	case	_	_
2	addition	_	NOUN	NN	_	5	nmod	_	_
3	,	_	.	,	_	5	punct	_	_
4	there	_	DET	EX	_	5	expl	_	_
5	was	_	VERB	VBD	_	0	root	_	_
6	no	_	DET	DT	_	8	neg	_	_
7	pharmacodynamic	_	ADJ	JJ	_	8	amod	_	_
8	interaction	_	NOUN	NN	_	5	nsubj	_	_
9	as	_	ADP	IN	_	11	case	_	_
10	a	_	DET	DT	_	11	det	_	_
11	result	_	NOUN	NN	_	5	nmod	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	coadministration	_	NOUN	NN	_	11	nmod	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	DRUG	_	NOUN	NN	_	13	nmod	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	venlafaxine	_	NOUN	NN	_	18	compound	_	_
18	ER	_	NOUN	NN	_	15	conj	_	_

#	ZALEPLON	6355
1	Promethazine	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Coadministration	_	NOUN	NN	_	18	nsubj	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	a	_	DET	DT	_	7	det	_	_
6	single	_	ADJ	JJ	_	7	amod	_	_
7	dose	_	NOUN	NN	_	3	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	promethazine	_	NOUN	NN	_	9	conj	_	_
12	10	_	NUM	CD	_	11	nummod	_	_
13	and	_	CONJ	CC	_	11	cc	_	_
14	25	_	NUM	CD	_	15	nummod	_	_
15	mg	_	NOUN	NN	_	11	conj	_	_
16	,	_	.	,	_	3	punct	_	_
17	respectively	_	ADV	RB	_	18	advmod	_	_
18	resulted	_	VERB	VBD	_	1	dep	_	_
19	in	_	ADP	IN	_	22	case	_	_
20	a	_	DET	DT	_	22	det	_	_
21	15%	_	ADJ	JJ	_	22	amod	_	_
22	decrease	_	NOUN	NN	_	18	nmod	_	_
23	in	_	ADP	IN	_	26	case	_	_
24	maximal	_	ADJ	JJ	_	26	amod	_	_
25	plasma	_	NOUN	NN	_	26	compound	_	_
26	concentrations	_	NOUN	NNS	_	22	nmod	_	_
27	of	_	ADP	IN	_	28	case	_	_
28	DRUG	_	NOUN	NN	_	26	nmod	_	_
29	,	_	.	,	_	18	punct	_	_
30	but	_	CONJ	CC	_	18	cc	_	_
31	no	_	DET	DT	_	32	neg	_	_
32	change	_	NOUN	NN	_	41	nsubj	_	_
33	in	_	ADP	IN	_	35	case	_	_
34	the	_	DET	DT	_	35	det	_	_
35	area	_	NOUN	NN	_	32	nmod	_	_
36	under	_	ADP	IN	_	40	case	_	_
37	the	_	DET	DT	_	40	det	_	_
38	plasma	_	NOUN	NN	_	40	compound	_	_
39	concentration	_	NOUN	NN	_	40	compound	_	_
40	time	_	NOUN	NN	_	32	nmod	_	_
41	curve	_	VERB	VBD	_	18	conj	_	_

#	ZALEPLON	6356
1	However	_	ADV	RB	_	14	advmod	_	_
2	,	_	.	,	_	14	punct	_	_
3	the	_	DET	DT	_	4	det	_	_
4	pharmacodynamics	_	NOUN	NNS	_	14	nsubjpass	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	coadministration	_	NOUN	NN	_	4	nmod	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	promethazine	_	NOUN	NN	_	8	conj	_	_
11	have	_	VERB	MD	_	14	aux	_	_
12	not	_	ADV	RB	_	14	neg	_	_
13	been	_	VERB	VBN	_	14	auxpass	_	_
14	evaluated	_	VERB	VBN	_	0	root	_	_

#	ZALEPLON	6357
1	Caution	_	NOUN	NN	_	4	nsubjpass	_	_
2	should	_	VERB	MD	_	4	aux	_	_
3	be	_	VERB	VB	_	4	auxpass	_	_
4	exercised	_	VERB	VBN	_	0	root	_	_
5	when	_	ADV	WRB	_	10	advmod	_	_
6	these	_	DET	DT	_	8	det	_	_
7	2	_	NUM	CD	_	8	nummod	_	_
8	agents	_	NOUN	NNS	_	10	nsubjpass	_	_
9	are	_	VERB	VBP	_	10	auxpass	_	_
10	coadministered	_	VERB	VBN	_	4	ccomp	_	_

#	ZALEPLON	6358
1	Drugs	_	NOUN	NNS	_	0	root	_	_
2	That	_	DET	WDT	_	3	nsubj	_	_
3	Induce	_	VERB	VBP	_	1	acl:relcl	_	_
4	CYP3A4	_	NOUN	NN	_	5	compound	_	_
5	Rifampin	_	NOUN	NN	_	3	dobj	_	_
6	:	_	.	:	_	1	punct	_	_
7	CYP3A4	_	NOUN	NN	_	13	nsubj	_	_
8	is	_	VERB	VBZ	_	13	cop	_	_
9	ordinarily	_	ADV	RB	_	13	advmod	_	_
10	a	_	DET	DT	_	13	det	_	_
11	minor	_	ADJ	JJ	_	13	amod	_	_
12	metabolizing	_	NOUN	NN	_	13	amod	_	_
13	enzyme	_	NOUN	NN	_	1	dep	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	DRUG	_	NOUN	NN	_	13	nmod	_	_

#	ZALEPLON	6359
1	Multiple	_	ADJ	JJ	_	3	amod	_	_
2	dose	_	NOUN	NN	_	3	compound	_	_
3	administration	_	NOUN	NN	_	24	nsubj	_	_
4	of	_	ADP	IN	_	11	case	_	_
5	the	_	DET	DT	_	11	det	_	_
6	potent	_	ADJ	JJ	_	11	amod	_	_
7	CYP3A4	_	NOUN	NN	_	11	compound	_	_
8	inducer	_	NOUN	NN	_	11	compound	_	_
9	rifampin	_	NOUN	NN	_	11	compound	_	_
10	600	_	NUM	CD	_	11	nummod	_	_
11	mg	_	NOUN	NN	_	3	nmod	_	_
12	every	_	ADV	RB	_	13	advmod	_	_
13	24	_	NUM	CD	_	14	nummod	_	_
14	hours	_	NOUN	NNS	_	3	nmod	_	_
15	,	_	.	,	_	14	punct	_	_
16	q24h	_	NOUN	NN	_	14	appos	_	_
17	,	_	.	,	_	14	punct	_	_
18	for	_	ADP	IN	_	20	case	_	_
19	14	_	NUM	CD	_	20	nummod	_	_
20	days	_	NOUN	NNS	_	14	nmod	_	_
21	,	_	.	,	_	3	punct	_	_
22	however	_	ADV	RB	_	24	advmod	_	_
23	,	_	.	,	_	24	punct	_	_
24	reduced	_	VERB	VBD	_	0	root	_	_
25	DRUG	_	NOUN	NN	_	26	compound	_	_
26	Cmax	_	NOUN	NN	_	24	dobj	_	_
27	and	_	CONJ	CC	_	26	cc	_	_
28	AUC	_	NOUN	NN	_	26	conj	_	_
29	by	_	ADP	IN	_	31	case	_	_
30	approximately	_	ADV	RB	_	31	advmod	_	_
31	80%	_	ADJ	JJ	_	24	nmod	_	_

#	ZALEPLON	6360
1	The	_	DET	DT	_	2	det	_	_
2	coadministration	_	NOUN	NN	_	19	nsubj	_	_
3	of	_	ADP	IN	_	8	case	_	_
4	a	_	DET	DT	_	8	det	_	_
5	potent	_	ADJ	JJ	_	8	amod	_	_
6	CYP3A4	_	NOUN	NN	_	8	compound	_	_
7	enzyme	_	NOUN	NN	_	8	compound	_	_
8	inducer	_	NOUN	NN	_	2	nmod	_	_
9	,	_	.	,	_	2	punct	_	_
10	although	_	ADP	IN	_	12	mark	_	_
11	not	_	ADV	RB	_	12	neg	_	_
12	posing	_	VERB	VBG	_	19	advcl	_	_
13	a	_	DET	DT	_	15	det	_	_
14	safety	_	NOUN	NN	_	15	compound	_	_
15	concern	_	NOUN	NN	_	12	dobj	_	_
16	,	_	.	,	_	19	punct	_	_
17	thus	_	ADV	RB	_	19	advmod	_	_
18	could	_	VERB	MD	_	19	aux	_	_
19	lead	_	VERB	VB	_	0	root	_	_
20	to	_	PRT	TO	_	21	case	_	_
21	ineffectiveness	_	NOUN	NN	_	19	nmod	_	_
22	of	_	ADP	IN	_	23	case	_	_
23	DRUG	_	NOUN	NN	_	21	nmod	_	_

#	ZALEPLON	6361
1	An	_	DET	DT	_	7	det	_	_
2	alternative	_	ADJ	JJ	_	7	amod	_	_
3	non	_	ADJ	JJ	_	7	amod	_	_
4	CYP3A4	_	NOUN	NN	_	7	compound	_	_
5	substrate	_	NOUN	NN	_	7	compound	_	_
6	hypnotic	_	ADJ	JJ	_	7	amod	_	_
7	agent	_	NOUN	NN	_	10	nsubjpass	_	_
8	may	_	VERB	MD	_	10	aux	_	_
9	be	_	VERB	VB	_	10	auxpass	_	_
10	considered	_	VERB	VBN	_	0	root	_	_
11	in	_	ADP	IN	_	12	case	_	_
12	patients	_	NOUN	NNS	_	10	nmod	_	_
13	taking	_	VERB	VBG	_	12	acl	_	_
14	CYP3A4	_	NOUN	NN	_	15	compound	_	_
15	inducers	_	NOUN	NNS	_	13	dobj	_	_
16	such	_	ADJ	JJ	_	18	case	_	_
17	as	_	ADP	IN	_	16	mwe	_	_
18	rifampin	_	NOUN	NN	_	15	nmod	_	_
19	,	_	.	,	_	18	punct	_	_
20	phenytoin	_	NOUN	NN	_	18	conj	_	_
21	,	_	.	,	_	18	punct	_	_
22	carbamazepine	_	NOUN	NN	_	18	conj	_	_
23	,	_	.	,	_	18	punct	_	_
24	and	_	CONJ	CC	_	18	cc	_	_
25	phenobarbital	_	ADJ	JJ	_	18	conj	_	_

#	ZALEPLON	6362
1	Drugs	_	NOUN	NNS	_	10	nsubj	_	_
2	That	_	DET	WDT	_	3	nsubj	_	_
3	Inhibit	_	VERB	VBP	_	1	acl:relcl	_	_
4	CYP3A4	_	NOUN	NN	_	5	compound	_	_
5	CYP3A4	_	NOUN	NN	_	3	dobj	_	_
6	is	_	VERB	VBZ	_	10	cop	_	_
7	a	_	DET	DT	_	10	det	_	_
8	minor	_	ADJ	JJ	_	10	amod	_	_
9	metabolic	_	ADJ	JJ	_	10	amod	_	_
10	pathway	_	NOUN	NN	_	0	root	_	_
11	for	_	ADP	IN	_	13	case	_	_
12	the	_	DET	DT	_	13	det	_	_
13	elimination	_	NOUN	NN	_	10	nmod	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	DRUG	_	NOUN	NN	_	13	nmod	_	_
16	because	_	ADP	IN	_	42	mark	_	_
17	the	_	DET	DT	_	18	det	_	_
18	sum	_	NOUN	NN	_	42	nsubj	_	_
19	of	_	ADP	IN	_	21	case	_	_
20	desethyl	_	NOUN	NN	_	21	amod	_	_
21	DRUG	_	NOUN	NN	_	18	nmod	_	_
22	formed	_	VERB	VBN	_	21	acl	_	_
23	via	_	ADP	IN	_	24	case	_	_
24	CYP3A4	_	NOUN	NN	_	22	nmod	_	_
25	in	_	X	FW	_	26	compound	_	_
26	vitro	_	X	FW	_	22	advmod	_	_
27	and	_	CONJ	CC	_	18	cc	_	_
28	its	_	PRON	PRP$	_	29	nmod:poss	_	_
29	metabolites	_	NOUN	NNS	_	18	conj	_	_
30	,	_	.	,	_	29	punct	_	_
31	5	_	NUM	CD	_	34	nummod	_	_
32	oxo	_	NOUN	NN	_	33	dep	_	_
33	desethyl	_	NOUN	NN	_	34	compound	_	_
34	DRUG	_	NOUN	NN	_	29	appos	_	_
35	and	_	CONJ	CC	_	34	cc	_	_
36	5	_	NUM	CD	_	40	nummod	_	_
37	oxo	_	NOUN	NN	_	40	compound	_	_
38	desethyl	_	NOUN	NN	_	40	amod	_	_
39	DRUG	_	NOUN	NN	_	40	compound	_	_
40	glucuronide	_	NOUN	NN	_	34	conj	_	_
41	,	_	.	,	_	18	punct	_	_
42	account	_	VERB	VBP	_	10	acl	_	_
43	for	_	ADP	IN	_	45	case	_	_
44	only	_	ADV	RB	_	45	advmod	_	_
45	9%	_	NOUN	NN	_	42	nmod	_	_
46	of	_	ADP	IN	_	49	case	_	_
47	the	_	DET	DT	_	49	det	_	_
48	urinary	_	ADJ	JJ	_	49	amod	_	_
49	recovery	_	NOUN	NN	_	45	nmod	_	_
50	of	_	ADP	IN	_	53	case	_	_
51	a	_	DET	DT	_	53	det	_	_
52	DRUG	_	NOUN	NN	_	53	compound	_	_
53	dose	_	NOUN	NN	_	49	nmod	_	_

#	ZALEPLON	6363
1	Coadministration	_	NOUN	NN	_	26	nsubj	_	_
2	of	_	ADP	IN	_	6	case	_	_
3	single	_	ADJ	JJ	_	6	amod	_	_
4	,	_	.	,	_	3	punct	_	_
5	oral	_	ADJ	JJ	_	3	dep	_	_
6	doses	_	NOUN	NNS	_	1	nmod	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	with	_	ADP	IN	_	12	case	_	_
10	erythromycin	_	NOUN	NN	_	12	compound	_	_
11	10	_	NUM	CD	_	12	nummod	_	_
12	mg	_	NOUN	NN	_	1	nmod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	800	_	NUM	CD	_	15	nummod	_	_
15	mg	_	NOUN	NN	_	12	conj	_	_
16	,	_	.	,	_	12	punct	_	_
17	respectively	_	ADV	RB	_	12	advmod	_	_
18	,	_	.	,	_	12	punct	_	_
19	a	_	DET	DT	_	24	det	_	_
20	strong	_	ADJ	JJ	_	24	amod	_	_
21	,	_	.	,	_	20	punct	_	_
22	selective	_	ADJ	JJ	_	20	dep	_	_
23	CYP3A4	_	NOUN	NN	_	24	compound	_	_
24	inhibitor	_	NOUN	NN	_	12	appos	_	_
25	,	_	.	,	_	1	punct	_	_
26	produced	_	VERB	VBD	_	0	root	_	_
27	a	_	DET	DT	_	29	det	_	_
28	34%	_	ADJ	JJ	_	29	amod	_	_
29	increase	_	NOUN	NN	_	26	dobj	_	_
30	in	_	ADP	IN	_	35	case	_	_
31	DRUG	_	NOUN	NN	_	35	nmod:poss	_	_
32	's	_	PRT	POS	_	35	case	_	_
33	maximal	_	ADJ	JJ	_	35	amod	_	_
34	plasma	_	NOUN	NN	_	35	compound	_	_
35	concentrations	_	NOUN	NNS	_	29	nmod	_	_
36	and	_	CONJ	CC	_	26	cc	_	_
37	a	_	DET	DT	_	39	det	_	_
38	20%	_	ADJ	JJ	_	39	amod	_	_
39	increase	_	NOUN	NN	_	48	nsubj	_	_
40	in	_	ADP	IN	_	42	case	_	_
41	the	_	DET	DT	_	42	det	_	_
42	area	_	NOUN	NN	_	39	nmod	_	_
43	under	_	ADP	IN	_	47	case	_	_
44	the	_	DET	DT	_	47	det	_	_
45	plasma	_	NOUN	NN	_	47	compound	_	_
46	concentration	_	NOUN	NN	_	47	compound	_	_
47	time	_	NOUN	NN	_	39	nmod	_	_
48	curve	_	VERB	VBD	_	26	conj	_	_

#	ZALEPLON	6364
1	The	_	DET	DT	_	2	det	_	_
2	magnitude	_	NOUN	NN	_	11	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	interaction	_	NOUN	NN	_	2	nmod	_	_
5	with	_	ADP	IN	_	7	case	_	_
6	multiple	_	ADJ	JJ	_	7	amod	_	_
7	doses	_	NOUN	NNS	_	4	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	erythromycin	_	NOUN	NN	_	7	nmod	_	_
10	is	_	VERB	VBZ	_	11	auxpass	_	_
11	unknown	_	ADJ	JJ	_	0	root	_	_

#	ZALEPLON	6365
1	Other	_	ADJ	JJ	_	5	amod	_	_
2	strong	_	ADJ	JJ	_	5	amod	_	_
3	selective	_	ADJ	JJ	_	5	amod	_	_
4	CYP3A4	_	NOUN	NN	_	5	compound	_	_
5	inhibitors	_	NOUN	NNS	_	12	nsubjpass	_	_
6	such	_	ADJ	JJ	_	8	case	_	_
7	as	_	ADP	IN	_	6	mwe	_	_
8	ketoconazole	_	NOUN	NN	_	5	nmod	_	_
9	can	_	VERB	MD	_	12	aux	_	_
10	also	_	ADV	RB	_	12	advmod	_	_
11	be	_	VERB	VB	_	12	auxpass	_	_
12	expected	_	VERB	VBN	_	0	root	_	_
13	to	_	PRT	TO	_	14	mark	_	_
14	increase	_	VERB	VB	_	12	xcomp	_	_
15	the	_	DET	DT	_	16	det	_	_
16	exposure	_	NOUN	NN	_	14	dobj	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	DRUG	_	NOUN	NN	_	16	nmod	_	_

#	ZALEPLON	6366
1	A	_	DET	DT	_	4	det	_	_
2	routine	_	ADJ	JJ	_	4	amod	_	_
3	dosage	_	NOUN	NN	_	4	compound	_	_
4	adjustment	_	NOUN	NN	_	9	nsubjpass	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	is	_	VERB	VBZ	_	9	auxpass	_	_
8	not	_	ADV	RB	_	9	neg	_	_
9	considered	_	VERB	VBN	_	0	root	_	_
10	necessary	_	ADJ	JJ	_	9	root	_	_

#	ZALEPLON	6367
1	Drugs	_	NOUN	NNS	_	14	nsubjpass	_	_
2	That	_	DET	WDT	_	3	nsubj	_	_
3	Inhibit	_	VERB	VBP	_	1	acl:relcl	_	_
4	Aldehyde	_	NOUN	NN	_	10	compound	_	_
5	Oxidase	_	NOUN	NN	_	10	compound	_	_
6	The	_	DET	DT	_	10	det	_	_
7	aldehyde	_	NOUN	NN	_	10	compound	_	_
8	oxidase	_	NOUN	NN	_	10	compound	_	_
9	enzyme	_	NOUN	NN	_	10	compound	_	_
10	system	_	NOUN	NN	_	3	dobj	_	_
11	is	_	VERB	VBZ	_	14	auxpass	_	_
12	less	_	ADV	RB	_	14	advmod	_	_
13	well	_	ADV	RB	_	14	advmod	_	_
14	studied	_	VERB	VBN	_	0	root	_	_
15	than	_	ADP	IN	_	20	case	_	_
16	the	_	DET	DT	_	20	det	_	_
17	cytochrome	_	NOUN	NN	_	20	compound	_	_
18	P450	_	NOUN	NN	_	20	compound	_	_
19	enzyme	_	NOUN	NN	_	20	compound	_	_
20	system	_	NOUN	NN	_	14	nmod	_	_

#	ZALEPLON	6368
1	Diphenhydramine	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Diphenhydramine	_	NOUN	NN	_	5	nsubjpass	_	_
4	is	_	VERB	VBZ	_	5	auxpass	_	_
5	reported	_	VERB	VBN	_	1	dep	_	_
6	to	_	PRT	TO	_	10	mark	_	_
7	be	_	VERB	VB	_	10	cop	_	_
8	a	_	DET	DT	_	10	det	_	_
9	weak	_	ADJ	JJ	_	10	amod	_	_
10	inhibitor	_	NOUN	NN	_	5	xcomp	_	_
11	of	_	ADP	IN	_	13	case	_	_
12	aldehyde	_	NOUN	NN	_	13	compound	_	_
13	oxidase	_	NOUN	NN	_	10	nmod	_	_
14	in	_	ADP	IN	_	16	case	_	_
15	rat	_	NOUN	NN	_	16	compound	_	_
16	liver	_	NOUN	NN	_	13	nmod	_	_
17	,	_	.	,	_	5	punct	_	_
18	but	_	CONJ	CC	_	5	cc	_	_
19	its	_	PRON	PRP$	_	21	nmod:poss	_	_
20	inhibitory	_	ADJ	JJ	_	21	amod	_	_
21	effects	_	NOUN	NNS	_	27	nsubjpass	_	_
22	in	_	ADP	IN	_	24	case	_	_
23	human	_	ADJ	JJ	_	24	amod	_	_
24	liver	_	NOUN	NN	_	21	nmod	_	_
25	are	_	VERB	VBP	_	27	auxpass	_	_
26	not	_	ADV	RB	_	27	neg	_	_
27	known	_	VERB	VBN	_	5	root	_	_

#	ZALEPLON	6369
1	There	_	DET	EX	_	2	expl	_	_
2	is	_	VERB	VBZ	_	0	root	_	_
3	no	_	DET	DT	_	5	neg	_	_
4	pharmacokinetic	_	ADJ	JJ	_	5	amod	_	_
5	interaction	_	NOUN	NN	_	2	nsubj	_	_
6	between	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	diphenhydramine	_	NOUN	NN	_	7	conj	_	_
10	following	_	ADP	IN	_	12	case	_	_
11	the	_	DET	DT	_	12	det	_	_
12	administration	_	NOUN	NN	_	2	nmod	_	_
13	of	_	ADP	IN	_	18	case	_	_
14	a	_	DET	DT	_	18	det	_	_
15	single	_	ADJ	JJ	_	18	amod	_	_
16	dose	_	NOUN	NN	_	18	compound	_	_
17	10	_	NUM	CD	_	18	nummod	_	_
18	mg	_	NOUN	NN	_	12	nmod	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	50	_	NUM	CD	_	21	nummod	_	_
21	mg	_	NOUN	NN	_	18	conj	_	_
22	,	_	.	,	_	2	punct	_	_
23	respectively	_	ADV	RB	_	2	advmod	_	_
24	of	_	ADP	IN	_	26	case	_	_
25	each	_	DET	DT	_	26	det	_	_
26	drug	_	NOUN	NN	_	23	nmod	_	_

#	ZALEPLON	6370
1	However	_	ADV	RB	_	17	advmod	_	_
2	,	_	.	,	_	17	punct	_	_
3	because	_	ADP	IN	_	8	mark	_	_
4	both	_	DET	DT	_	8	nsubj	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	these	_	DET	DT	_	7	det	_	_
7	compounds	_	NOUN	NNS	_	4	nmod	_	_
8	have	_	VERB	VBP	_	17	advcl	_	_
9	CNS	_	NOUN	NN	_	10	compound	_	_
10	effects	_	NOUN	NNS	_	8	dobj	_	_
11	,	_	.	,	_	17	punct	_	_
12	an	_	DET	DT	_	15	det	_	_
13	additive	_	ADJ	JJ	_	15	amod	_	_
14	pharmacodynamic	_	ADJ	JJ	_	15	amod	_	_
15	effect	_	NOUN	NN	_	17	nsubj	_	_
16	is	_	VERB	VBZ	_	17	auxpass	_	_
17	possible	_	ADJ	JJ	_	0	root	_	_

#	ZALEPLON	6371
1	Drugs	_	NOUN	NNS	_	0	root	_	_
2	That	_	DET	WDT	_	3	nsubj	_	_
3	Inhibit	_	VERB	VBP	_	1	acl:relcl	_	_
4	Both	_	CONJ	CC	_	6	cc:preconj	_	_
5	Aldehyde	_	NOUN	NN	_	6	compound	_	_
6	Oxidase	_	NOUN	NN	_	3	dobj	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	CYP3A4	_	NOUN	NN	_	9	compound	_	_
9	Cimetidine	_	NOUN	NN	_	6	conj	_	_
10	:	_	.	:	_	1	punct	_	_
11	Cimetidine	_	NOUN	NN	_	12	nsubj	_	_
12	inhibits	_	VERB	VBZ	_	1	dep	_	_
13	both	_	CONJ	CC	_	15	cc:preconj	_	_
14	aldehyde	_	NOUN	NN	_	15	compound	_	_
15	oxidase	_	NOUN	NN	_	12	dobj	_	_
16	in	_	X	FW	_	17	compound	_	_
17	vitro	_	X	FW	_	15	advmod	_	_
18	and	_	CONJ	CC	_	15	cc	_	_
19	CYP3A4	_	NOUN	NN	_	15	conj	_	_
20	in	_	X	FW	_	21	compound	_	_
21	vitro	_	X	FW	_	12	advmod	_	_
22	and	_	CONJ	CC	_	12	cc	_	_
23	in	_	X	FW	_	24	compound	_	_
24	vivo	_	X	FW	_	12	conj	_	_
25	,	_	.	,	_	24	punct	_	_
26	the	_	DET	DT	_	30	det	_	_
27	primary	_	ADJ	JJ	_	30	amod	_	_
28	and	_	CONJ	CC	_	27	cc	_	_
29	secondary	_	ADJ	JJ	_	27	conj	_	_
30	enzymes	_	NOUN	NNS	_	25	root	_	_
31	,	_	.	,	_	30	punct	_	_
32	respectively	_	ADV	RB	_	30	advmod	_	_
33	,	_	.	,	_	30	punct	_	_
34	responsible	_	ADJ	JJ	_	30	amod	_	_
35	for	_	ADP	IN	_	37	case	_	_
36	DRUG	_	NOUN	NN	_	37	compound	_	_
37	metabolism	_	NOUN	NN	_	34	nmod	_	_

#	ZALEPLON	6372
1	Concomitant	_	ADJ	JJ	_	2	amod	_	_
2	administration	_	NOUN	NN	_	11	nsubj	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	DRUG	_	NOUN	NN	_	6	compound	_	_
5	10	_	NUM	CD	_	6	nummod	_	_
6	mg	_	NOUN	NN	_	2	nmod	_	_
7	and	_	CONJ	CC	_	2	cc	_	_
8	cimetidine	_	VERB	VBG	_	2	conj	_	_
9	800	_	NUM	CD	_	10	nummod	_	_
10	mg	_	NOUN	NN	_	8	dobj	_	_
11	produced	_	VERB	VBD	_	0	root	_	_
12	an	_	DET	DT	_	14	det	_	_
13	85%	_	ADJ	JJ	_	14	amod	_	_
14	increase	_	NOUN	NN	_	11	dobj	_	_
15	in	_	ADP	IN	_	18	case	_	_
16	the	_	DET	DT	_	18	det	_	_
17	mean	_	NOUN	NN	_	18	compound	_	_
18	Cmax	_	NOUN	NN	_	14	nmod	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	AUC	_	NOUN	NN	_	18	conj	_	_
21	of	_	ADP	IN	_	22	case	_	_
22	DRUG	_	NOUN	NN	_	18	nmod	_	_

#	ZALEPLON	6373
1	An	_	DET	DT	_	3	det	_	_
2	initial	_	ADJ	JJ	_	3	amod	_	_
3	dose	_	NOUN	NN	_	9	nsubjpass	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	5	_	NUM	CD	_	6	nummod	_	_
6	mg	_	NOUN	NN	_	3	nmod	_	_
7	should	_	VERB	MD	_	9	aux	_	_
8	be	_	VERB	VB	_	9	auxpass	_	_
9	given	_	VERB	VBN	_	0	root	_	_
10	to	_	PRT	TO	_	11	case	_	_
11	patients	_	NOUN	NNS	_	9	nmod	_	_
12	who	_	DET	WDT	_	16	nsubjpass	_	_
13	are	_	VERB	VBP	_	16	auxpass	_	_
14	concomitantly	_	ADV	RB	_	16	advmod	_	_
15	being	_	VERB	VBN	_	16	auxpass	_	_
16	treated	_	VERB	VBN	_	11	acl:relcl	_	_
17	with	_	ADP	IN	_	18	case	_	_
18	cimetidine	_	NOUN	NN	_	16	nmod	_	_

#	ZALEPLON	6374
1	Drugs	_	NOUN	NNS	_	11	nsubjpass	_	_
2	Highly	_	ADV	RB	_	3	advmod	_	_
3	Bound	_	VERB	VBN	_	1	acl	_	_
4	to	_	PRT	TO	_	7	case	_	_
5	Plasma	_	NOUN	NN	_	7	compound	_	_
6	Protein	_	NOUN	NN	_	7	compound	_	_
7	DRUG	_	NOUN	NN	_	3	nmod	_	_
8	is	_	VERB	VBZ	_	11	auxpass	_	_
9	not	_	ADV	RB	_	11	neg	_	_
10	highly	_	ADV	RB	_	11	advmod	_	_
11	bound	_	VERB	VBN	_	0	root	_	_
12	to	_	PRT	TO	_	14	case	_	_
13	plasma	_	NOUN	NN	_	14	compound	_	_
14	proteins	_	NOUN	NNS	_	11	nmod	_	_
15	fraction	_	NOUN	NN	_	16	nsubj	_	_
16	bound	_	VERB	VBN	_	14	acl	_	_
17	60%*15%	_	NOUN	NN	_	16	dobj	_	_
18	therefore	_	ADV	RB	_	16	advmod	_	_
19	,	_	.	,	_	11	punct	_	_
20	the	_	DET	DT	_	21	det	_	_
21	disposition	_	NOUN	NN	_	26	nsubjpass	_	_
22	of	_	ADP	IN	_	23	case	_	_
23	DRUG	_	NOUN	NN	_	21	nmod	_	_
24	is	_	VERB	VBZ	_	26	auxpass	_	_
25	not	_	ADV	RB	_	26	neg	_	_
26	expected	_	VERB	VBN	_	11	parataxis	_	_
27	to	_	PRT	TO	_	29	mark	_	_
28	be	_	VERB	VB	_	29	cop	_	_
29	sensitive	_	ADJ	JJ	_	26	xcomp	_	_
30	to	_	PRT	TO	_	31	case	_	_
31	alterations	_	NOUN	NNS	_	29	nmod	_	_
32	in	_	ADP	IN	_	34	case	_	_
33	protein	_	NOUN	NN	_	34	compound	_	_
34	binding	_	NOUN	NN	_	31	nmod	_	_

#	ZALEPLON	6375
1	In	_	ADP	IN	_	2	case	_	_
2	addition	_	NOUN	NN	_	20	nmod	_	_
3	,	_	.	,	_	20	punct	_	_
4	administration	_	NOUN	NN	_	20	nsubj	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	to	_	PRT	TO	_	9	case	_	_
8	a	_	DET	DT	_	9	det	_	_
9	patient	_	NOUN	NN	_	4	nmod	_	_
10	taking	_	VERB	VBG	_	9	acl	_	_
11	another	_	DET	DT	_	12	det	_	_
12	drug	_	NOUN	NN	_	10	dobj	_	_
13	that	_	DET	WDT	_	17	nsubjpass	_	_
14	is	_	VERB	VBZ	_	17	auxpass	_	_
15	highly	_	ADV	RB	_	16	advmod	_	_
16	protein	_	NOUN	NN	_	17	nsubjpass	_	_
17	bound	_	VERB	VBN	_	12	acl:relcl	_	_
18	should	_	VERB	MD	_	20	aux	_	_
19	not	_	ADV	RB	_	20	neg	_	_
20	cause	_	VERB	VB	_	0	root	_	_
21	transient	_	ADJ	JJ	_	22	amod	_	_
22	increase	_	NOUN	NN	_	20	dobj	_	_
23	in	_	ADP	IN	_	25	case	_	_
24	free	_	ADJ	JJ	_	25	amod	_	_
25	concentrations	_	NOUN	NNS	_	22	nmod	_	_
26	of	_	ADP	IN	_	29	case	_	_
27	the	_	DET	DT	_	29	det	_	_
28	other	_	ADJ	JJ	_	29	amod	_	_
29	drug	_	NOUN	NN	_	25	nmod	_	_

#	ZALEPLON	6376
1	Drugs	_	NOUN	NNS	_	0	root	_	_
2	with	_	ADP	IN	_	7	case	_	_
3	a	_	DET	DT	_	7	det	_	_
4	Narrow	_	NOUN	NN	_	7	compound	_	_
5	Therapeutic	_	ADJ	JJ	_	7	amod	_	_
6	Index	_	NOUN	NN	_	7	compound	_	_
7	Digoxin	_	NOUN	NN	_	1	nmod	_	_
8	:	_	.	:	_	1	punct	_	_
9	DRUG	_	NOUN	NN	_	11	compound	_	_
10	10	_	NUM	CD	_	11	nummod	_	_
11	mg	_	NOUN	NN	_	14	nsubj	_	_
12	did	_	VERB	VBD	_	14	aux	_	_
13	not	_	ADV	RB	_	14	neg	_	_
14	affect	_	VERB	VB	_	1	dep	_	_
15	the	_	DET	DT	_	19	det	_	_
16	pharmacokinetic	_	ADJ	JJ	_	19	amod	_	_
17	or	_	CONJ	CC	_	16	cc	_	_
18	pharmacodynamic	_	ADJ	JJ	_	16	conj	_	_
19	profile	_	NOUN	NN	_	14	dobj	_	_
20	of	_	ADP	IN	_	24	case	_	_
21	digoxin	_	NOUN	NN	_	24	compound	_	_
22	0.375	_	NUM	CD	_	24	nummod	_	_
23	mg	_	NOUN	NN	_	24	compound	_	_
24	q24h	_	NOUN	NN	_	19	nmod	_	_
25	for	_	ADP	IN	_	27	case	_	_
26	8	_	NUM	CD	_	27	nummod	_	_
27	days	_	NOUN	NNS	_	19	nmod	_	_

#	ZALEPLON	6377
1	Warfarin	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Multiple	_	ADJ	JJ	_	5	amod	_	_
4	oral	_	ADJ	JJ	_	5	amod	_	_
5	doses	_	NOUN	NNS	_	16	nsubj	_	_
6	of	_	ADP	IN	_	10	case	_	_
7	DRUG	_	NOUN	NN	_	10	compound	_	_
8	20	_	NUM	CD	_	10	nummod	_	_
9	mg	_	NOUN	NN	_	10	compound	_	_
10	q24h	_	NOUN	NN	_	5	nmod	_	_
11	for	_	ADP	IN	_	13	case	_	_
12	13	_	NUM	CD	_	13	nummod	_	_
13	days	_	NOUN	NNS	_	5	nmod	_	_
14	did	_	VERB	VBD	_	16	aux	_	_
15	not	_	ADV	RB	_	16	neg	_	_
16	affect	_	VERB	VB	_	1	dep	_	_
17	the	_	DET	DT	_	18	det	_	_
18	pharmacokinetics	_	NOUN	NNS	_	16	dobj	_	_
19	of	_	ADP	IN	_	21	case	_	_
20	warfarin	_	NOUN	NN	_	21	compound	_	_
21	R+	_	NOUN	NN	_	18	nmod	_	_
22	or	_	CONJ	CC	_	21	cc	_	_
23	S	_	NOUN	NN	_	24	compound	_	_
24	enantiomers	_	NOUN	NNS	_	21	conj	_	_
25	or	_	CONJ	CC	_	21	cc	_	_
26	the	_	DET	DT	_	27	det	_	_
27	pharmacodynamics	_	NOUN	NNS	_	21	conj	_	_
28	prothrombin	_	NOUN	NN	_	29	compound	_	_
29	time	_	NOUN	NN	_	27	dep	_	_
30	following	_	ADP	IN	_	36	case	_	_
31	a	_	DET	DT	_	36	det	_	_
32	single	_	ADJ	JJ	_	36	amod	_	_
33	25	_	NUM	CD	_	36	nummod	_	_
34	mg	_	NOUN	NN	_	36	compound	_	_
35	oral	_	ADJ	JJ	_	36	amod	_	_
36	dose	_	NOUN	NN	_	18	nmod	_	_
37	of	_	ADP	IN	_	38	case	_	_
38	warfarin	_	NOUN	NN	_	36	nmod	_	_

#	ZALEPLON	6378
1	Drugs	_	NOUN	NNS	_	0	root	_	_
2	That	_	DET	WDT	_	3	nsubj	_	_
3	Alter	_	VERB	VBP	_	1	acl:relcl	_	_
4	Renal	_	ADJ	JJ	_	6	amod	_	_
5	Excretion	_	NOUN	NN	_	6	compound	_	_
6	Ibuprofen	_	NOUN	NN	_	3	dobj	_	_
7	:	_	.	:	_	1	punct	_	_
8	Ibuprofen	_	NOUN	NN	_	10	nsubjpass	_	_
9	is	_	VERB	VBZ	_	10	auxpass	_	_
10	known	_	VERB	VBN	_	1	dep	_	_
11	to	_	PRT	TO	_	12	mark	_	_
12	affect	_	VERB	VB	_	10	xcomp	_	_
13	renal	_	ADJ	JJ	_	14	amod	_	_
14	function	_	NOUN	NN	_	12	dobj	_	_
15	and	_	CONJ	CC	_	12	cc	_	_
16	,	_	.	,	_	12	punct	_	_
17	consequently	_	ADV	RB	_	12	advmod	_	_
18	,	_	.	,	_	10	punct	_	_
19	alter	_	VERB	VBP	_	10	parataxis	_	_
20	the	_	DET	DT	_	22	det	_	_
21	renal	_	ADJ	JJ	_	22	amod	_	_
22	excretion	_	NOUN	NN	_	19	dobj	_	_
23	of	_	ADP	IN	_	25	case	_	_
24	other	_	ADJ	JJ	_	25	amod	_	_
25	drugs	_	NOUN	NNS	_	22	nmod	_	_

#	ZALEPLON	6379
1	There	_	DET	EX	_	2	expl	_	_
2	was	_	VERB	VBD	_	0	root	_	_
3	no	_	DET	DT	_	6	neg	_	_
4	apparent	_	ADJ	JJ	_	6	amod	_	_
5	pharmacokinetic	_	ADJ	JJ	_	6	amod	_	_
6	interaction	_	NOUN	NN	_	2	nsubj	_	_
7	between	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	ibuprofen	_	NOUN	NN	_	8	conj	_	_
11	following	_	ADP	IN	_	16	case	_	_
12	single	_	ADJ	JJ	_	16	amod	_	_
13	dose	_	NOUN	NN	_	16	compound	_	_
14	administration	_	NOUN	NN	_	16	compound	_	_
15	10	_	NUM	CD	_	16	nummod	_	_
16	mg	_	NOUN	NN	_	2	nmod	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	600	_	NUM	CD	_	19	nummod	_	_
19	mg	_	NOUN	NN	_	16	conj	_	_
20	,	_	.	,	_	2	punct	_	_
21	respectively	_	ADV	RB	_	2	advmod	_	_
22	of	_	ADP	IN	_	24	case	_	_
23	each	_	DET	DT	_	24	det	_	_
24	drug	_	NOUN	NN	_	21	nmod	_	_

#	ZALEPLON	6380
1	This	_	DET	DT	_	3	nsubjpass	_	_
2	was	_	VERB	VBD	_	3	auxpass	_	_
3	expected	_	VERB	VBN	_	0	root	_	_
4	because	_	ADP	IN	_	8	mark	_	_
5	DRUG	_	NOUN	NN	_	8	nsubjpass	_	_
6	is	_	VERB	VBZ	_	8	auxpass	_	_
7	primarily	_	ADV	RB	_	8	advmod	_	_
8	metabolized	_	VERB	VBN	_	3	ccomp	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	renal	_	ADJ	JJ	_	11	amod	_	_
11	excretion	_	NOUN	NN	_	15	nsubj	_	_
12	of	_	ADP	IN	_	14	case	_	_
13	unchanged	_	ADJ	JJ	_	14	amod	_	_
14	DRUG	_	NOUN	NN	_	11	nmod	_	_
15	accounts	_	VERB	VBZ	_	8	conj	_	_
16	for	_	ADP	IN	_	19	case	_	_
17	less	_	ADV	RB	_	19	advmod	_	_
18	than	_	ADP	IN	_	17	mwe	_	_
19	1%	_	NOUN	NN	_	15	nmod	_	_
20	of	_	ADP	IN	_	23	case	_	_
21	the	_	DET	DT	_	23	det	_	_
22	administered	_	VERB	VBN	_	23	amod	_	_
23	dose	_	NOUN	NN	_	19	nmod	_	_

#	ZALEPLON	6381
1	Pharmacodynamics	_	NOUN	NNS	_	31	nsubj	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	Mechanism	_	NOUN	NN	_	1	conj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	Action	_	NOUN	NN	_	1	nmod	_	_
6	While	_	ADP	IN	_	11	mark	_	_
7	DRUG	_	NOUN	NN	_	11	nsubj	_	_
8	is	_	VERB	VBZ	_	11	cop	_	_
9	a	_	DET	DT	_	11	det	_	_
10	hypnotic	_	ADJ	JJ	_	11	amod	_	_
11	agent	_	NOUN	NN	_	1	acl	_	_
12	with	_	ADP	IN	_	15	case	_	_
13	a	_	DET	DT	_	15	det	_	_
14	chemical	_	ADJ	JJ	_	15	amod	_	_
15	structure	_	NOUN	NN	_	11	nmod	_	_
16	unrelated	_	ADJ	JJ	_	15	amod	_	_
17	to	_	PRT	TO	_	18	case	_	_
18	benzodiazepines	_	NOUN	NNS	_	16	nmod	_	_
19	,	_	.	,	_	15	punct	_	_
20	barbiturates	_	VERB	VBZ	_	15	conj	_	_
21	,	_	.	,	_	15	punct	_	_
22	or	_	CONJ	CC	_	15	cc	_	_
23	other	_	ADJ	JJ	_	24	amod	_	_
24	drugs	_	NOUN	NNS	_	15	conj	_	_
25	with	_	ADP	IN	_	28	case	_	_
26	known	_	VERB	VBN	_	28	amod	_	_
27	hypnotic	_	ADJ	JJ	_	28	amod	_	_
28	properties	_	NOUN	NNS	_	24	nmod	_	_
29	,	_	.	,	_	31	punct	_	_
30	it	_	PRON	PRP	_	31	nsubj	_	_
31	interacts	_	VERB	VBZ	_	0	root	_	_
32	with	_	ADP	IN	_	41	case	_	_
33	the	_	DET	DT	_	41	det	_	_
34	gamma	_	NOUN	NN	_	41	compound	_	_
35	aminobutyric	_	ADJ	JJ	_	41	amod	_	_
36	acid	_	NOUN	NN	_	41	compound	_	_
37	benzodiazepine	_	NOUN	NN	_	41	compound	_	_
38	GABA	_	NOUN	NN	_	41	compound	_	_
39	BZ	_	NOUN	NN	_	41	compound	_	_
40	receptor	_	NOUN	NN	_	41	compound	_	_
41	complex	_	NOUN	NNS	_	31	nmod	_	_

#	ZALEPLON	6382
1	Subunit	_	NOUN	NN	_	2	compound	_	_
2	modulation	_	NOUN	NN	_	13	nsubjpass	_	_
3	of	_	ADP	IN	_	11	case	_	_
4	the	_	DET	DT	_	11	det	_	_
5	GABA	_	NOUN	NN	_	11	compound	_	_
6	BZ	_	NOUN	NN	_	11	compound	_	_
7	receptor	_	NOUN	NN	_	11	compound	_	_
8	chloride	_	NOUN	NN	_	11	compound	_	_
9	channel	_	NOUN	NN	_	11	compound	_	_
10	macromolecular	_	ADJ	JJ	_	11	amod	_	_
11	complex	_	NOUN	NN	_	2	nmod	_	_
12	is	_	VERB	VBZ	_	13	auxpass	_	_
13	hypothesized	_	VERB	VBN	_	0	root	_	_
14	to	_	PRT	TO	_	16	mark	_	_
15	be	_	VERB	VB	_	16	cop	_	_
16	responsible	_	ADJ	JJ	_	13	xcomp	_	_
17	for	_	ADP	IN	_	18	case	_	_
18	some	_	DET	DT	_	16	nmod	_	_
19	of	_	ADP	IN	_	22	case	_	_
20	the	_	DET	DT	_	22	det	_	_
21	pharmacological	_	ADJ	JJ	_	22	amod	_	_
22	properties	_	NOUN	NNS	_	18	nmod	_	_
23	of	_	ADP	IN	_	24	case	_	_
24	benzodiazepines	_	NOUN	NNS	_	22	nmod	_	_
25	,	_	.	,	_	24	punct	_	_
26	which	_	DET	WDT	_	27	nsubj	_	_
27	include	_	VERB	VBP	_	24	acl:relcl	_	_
28	sedative	_	ADJ	JJ	_	37	amod	_	_
29	,	_	.	,	_	28	punct	_	_
30	anxiolytic	_	ADJ	JJ	_	28	conj	_	_
31	,	_	.	,	_	28	punct	_	_
32	muscle	_	NOUN	NN	_	33	compound	_	_
33	relaxant	_	ADJ	JJ	_	28	conj	_	_
34	,	_	.	,	_	28	punct	_	_
35	and	_	CONJ	CC	_	28	cc	_	_
36	anticonvulsive	_	ADJ	JJ	_	28	conj	_	_
37	effects	_	NOUN	NNS	_	27	dobj	_	_
38	in	_	ADP	IN	_	40	case	_	_
39	animal	_	NOUN	NN	_	40	compound	_	_
40	models	_	NOUN	NNS	_	37	nmod	_	_

#	ZALEPLON	6383
1	Other	_	ADJ	JJ	_	3	amod	_	_
2	nonclinical	_	ADJ	JJ	_	3	amod	_	_
3	studies	_	NOUN	NNS	_	6	nsubj	_	_
4	have	_	VERB	VBP	_	6	aux	_	_
5	also	_	ADV	RB	_	6	advmod	_	_
6	shown	_	VERB	VBN	_	0	root	_	_
7	that	_	ADP	IN	_	9	mark	_	_
8	DRUG	_	NOUN	NN	_	9	nsubj	_	_
9	binds	_	VERB	VBZ	_	6	ccomp	_	_
10	selectively	_	ADV	RB	_	9	advmod	_	_
11	to	_	PRT	TO	_	16	case	_	_
12	the	_	DET	DT	_	16	det	_	_
13	brain	_	NOUN	NN	_	16	compound	_	_
14	omega	_	NOUN	NN	_	16	compound	_	_
15	1	_	NUM	CD	_	16	nummod	_	_
16	receptor	_	NOUN	NN	_	9	nmod	_	_
17	situated	_	VERB	VBN	_	16	acl	_	_
18	on	_	ADP	IN	_	21	case	_	_
19	the	_	DET	DT	_	21	det	_	_
20	alpha	_	NOUN	NN	_	21	compound	_	_
21	subunit	_	NOUN	NN	_	17	nmod	_	_
22	of	_	ADP	IN	_	30	case	_	_
23	the	_	DET	DT	_	30	det	_	_
24	GABAA	_	NOUN	NN	_	30	compound	_	_
25	/	_	.	:	_	30	punct	_	_
26	chloride	_	NOUN	NN	_	30	compound	_	_
27	ion	_	NOUN	NN	_	30	compound	_	_
28	channel	_	NOUN	NN	_	30	compound	_	_
29	receptor	_	NOUN	NN	_	30	compound	_	_
30	complex	_	NOUN	NN	_	21	nmod	_	_
31	and	_	CONJ	CC	_	9	cc	_	_
32	potentiates	_	VERB	VBZ	_	9	conj	_	_
33	t	_	NUM	CD	_	37	case	_	_
34	butyl	_	NOUN	NN	_	37	compound	_	_
35	bicyclophosphorothionate	_	NOUN	NN	_	37	compound	_	_
36	TBPS	_	NOUN	NN	_	37	compound	_	_
37	binding	_	NOUN	NN	_	32	nmod	_	_

#	ZALEPLON	6384
1	Studies	_	NOUN	NNS	_	18	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	binding	_	NOUN	NN	_	1	nmod	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	to	_	PRT	TO	_	9	case	_	_
7	recombinant	_	ADJ	JJ	_	9	amod	_	_
8	GABAA	_	NOUN	NN	_	9	compound	_	_
9	receptors	_	NOUN	NNS	_	1	nmod	_	_
10	A1B1G2	_	NOUN	NN	_	11	compound	_	_
11	omega	_	NOUN	NN	_	9	dep	_	_
12	1	_	NUM	CD	_	11	nummod	_	_
13	and	_	CONJ	CC	_	11	cc	_	_
14	A2B1G2	_	NOUN	NN	_	15	compound	_	_
15	omega	_	NOUN	NN	_	11	conj	_	_
16	2	_	NUM	CD	_	15	nummod	_	_
17	have	_	VERB	VBP	_	18	aux	_	_
18	shown	_	VERB	VBN	_	0	root	_	_
19	that	_	ADP	IN	_	21	mark	_	_
20	DRUG	_	NOUN	NN	_	21	nsubj	_	_
21	has	_	VERB	VBZ	_	18	ccomp	_	_
22	a	_	DET	DT	_	24	det	_	_
23	low	_	ADJ	JJ	_	24	amod	_	_
24	affinity	_	NOUN	NN	_	21	dobj	_	_
25	for	_	ADP	IN	_	27	case	_	_
26	these	_	DET	DT	_	27	det	_	_
27	receptors	_	NOUN	NNS	_	24	nmod	_	_
28	,	_	.	,	_	21	punct	_	_
29	with	_	ADP	IN	_	31	case	_	_
30	preferential	_	ADJ	JJ	_	31	amod	_	_
31	binding	_	NOUN	NN	_	21	nmod	_	_
32	to	_	PRT	TO	_	36	case	_	_
33	the	_	DET	DT	_	36	det	_	_
34	omega	_	NOUN	NN	_	36	compound	_	_
35	1	_	NUM	CD	_	36	nummod	_	_
36	receptor	_	NOUN	NN	_	31	nmod	_	_

#	ZALEPLON	6385
1	Pharmacokinetics	_	NOUN	NNS	_	0	root	_	_
2	The	_	DET	DT	_	3	det	_	_
3	pharmacokinetics	_	NOUN	NNS	_	8	nsubjpass	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	have	_	VERB	VBP	_	8	aux	_	_
7	been	_	VERB	VBN	_	8	auxpass	_	_
8	investigated	_	VERB	VBN	_	1	dep	_	_
9	in	_	ADP	IN	_	14	case	_	_
10	more	_	ADV	RB	_	12	advmod	_	_
11	than	_	ADP	IN	_	10	mwe	_	_
12	500	_	NUM	CD	_	14	nummod	_	_
13	healthy	_	ADJ	JJ	_	14	amod	_	_
14	subjects	_	NOUN	NNS	_	8	nmod	_	_
15	young	_	ADJ	JJ	_	14	dep	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	elderly	_	ADJ	JJ	_	15	conj	_	_
18	,	_	.	,	_	15	punct	_	_
19	nursing	_	VERB	VBG	_	20	amod	_	_
20	mothers	_	NOUN	NNS	_	15	conj	_	_
21	,	_	.	,	_	15	punct	_	_
22	and	_	CONJ	CC	_	15	cc	_	_
23	patients	_	NOUN	NNS	_	15	conj	_	_
24	with	_	ADP	IN	_	26	case	_	_
25	hepatic	_	ADJ	JJ	_	26	amod	_	_
26	disease	_	NOUN	NN	_	23	nmod	_	_
27	or	_	CONJ	CC	_	26	cc	_	_
28	renal	_	ADJ	JJ	_	29	amod	_	_
29	disease	_	NOUN	NN	_	26	conj	_	_

#	ZALEPLON	6386
1	In	_	ADP	IN	_	3	case	_	_
2	healthy	_	ADJ	JJ	_	3	amod	_	_
3	subjects	_	NOUN	NNS	_	10	nmod	_	_
4	,	_	.	,	_	10	punct	_	_
5	the	_	DET	DT	_	7	det	_	_
6	pharmacokinetic	_	ADJ	JJ	_	7	amod	_	_
7	profile	_	NOUN	NN	_	10	nsubjpass	_	_
8	has	_	VERB	VBZ	_	10	aux	_	_
9	been	_	VERB	VBN	_	10	auxpass	_	_
10	examined	_	VERB	VBN	_	0	root	_	_
11	after	_	ADP	IN	_	13	case	_	_
12	single	_	ADJ	JJ	_	13	amod	_	_
13	doses	_	NOUN	NNS	_	10	nmod	_	_
14	of	_	ADP	IN	_	18	case	_	_
15	up	_	ADJ	JJ	_	17	advmod	_	_
16	to	_	PRT	TO	_	17	dep	_	_
17	60	_	NUM	CD	_	18	nummod	_	_
18	mg	_	NOUN	NN	_	13	nmod	_	_
19	and	_	CONJ	CC	_	10	cc	_	_
20	once	_	ADV	RB	_	21	advmod	_	_
21	daily	_	ADV	RB	_	22	advmod	_	_
22	administration	_	NOUN	NN	_	10	conj	_	_
23	at	_	ADP	IN	_	25	case	_	_
24	15	_	NUM	CD	_	25	nummod	_	_
25	mg	_	NOUN	NN	_	22	nmod	_	_
26	and	_	CONJ	CC	_	25	cc	_	_
27	30	_	NUM	CD	_	28	nummod	_	_
28	mg	_	NOUN	NN	_	25	conj	_	_
29	for	_	ADP	IN	_	31	case	_	_
30	10	_	NUM	CD	_	31	nummod	_	_
31	days	_	NOUN	NNS	_	22	nmod	_	_

#	ZALEPLON	6387
1	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
2	was	_	VERB	VBD	_	4	auxpass	_	_
3	rapidly	_	ADV	RB	_	4	advmod	_	_
4	absorbed	_	VERB	VBN	_	0	root	_	_
5	with	_	ADP	IN	_	7	case	_	_
6	a	_	DET	DT	_	7	det	_	_
7	time	_	NOUN	NN	_	4	nmod	_	_
8	to	_	PRT	TO	_	9	mark	_	_
9	peak	_	VERB	VB	_	4	xcomp	_	_
10	concentration	_	NOUN	NN	_	11	compound	_	_
11	tmax	_	NOUN	NN	_	9	dobj	_	_
12	of	_	ADP	IN	_	15	case	_	_
13	approximately	_	ADV	RB	_	14	advmod	_	_
14	1	_	NUM	CD	_	15	nummod	_	_
15	hour	_	NOUN	NN	_	11	nmod	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	a	_	DET	DT	_	22	det	_	_
18	terminal	_	ADJ	JJ	_	22	amod	_	_
19	phase	_	NOUN	NN	_	22	compound	_	_
20	elimination	_	NOUN	NN	_	22	compound	_	_
21	half	_	NOUN	NN	_	22	compound	_	_
22	life	_	NOUN	NN	_	15	conj	_	_
23	t1	_	NUM	CD	_	22	nummod	_	_
24	/	_	.	-LRB-	_	11	punct	_	_
25	2	_	NUM	CD	_	11	dep	_	_
26	of	_	ADP	IN	_	29	case	_	_
27	approximately	_	ADV	RB	_	28	advmod	_	_
28	1	_	NUM	CD	_	29	nummod	_	_
29	hour	_	NUM	CD	_	25	nmod	_	_

#	ZALEPLON	6388
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	does	_	VERB	VBZ	_	4	aux	_	_
3	not	_	ADV	RB	_	4	neg	_	_
4	accumulate	_	VERB	VB	_	0	root	_	_
5	with	_	ADP	IN	_	8	case	_	_
6	once	_	ADV	RB	_	7	advmod	_	_
7	daily	_	ADV	RB	_	8	amod	_	_
8	administration	_	NOUN	NN	_	4	nmod	_	_
9	and	_	CONJ	CC	_	4	cc	_	_
10	its	_	PRON	PRP$	_	11	nmod:poss	_	_
11	pharmacokinetics	_	NOUN	NNS	_	14	nsubj	_	_
12	are	_	VERB	VBP	_	14	cop	_	_
13	dose	_	NOUN	NN	_	14	nmod:npmod	_	_
14	proportional	_	ADJ	JJ	_	4	conj	_	_
15	in	_	ADP	IN	_	18	case	_	_
16	the	_	DET	DT	_	18	det	_	_
17	therapeutic	_	ADJ	JJ	_	18	amod	_	_
18	range	_	NOUN	NN	_	14	nmod	_	_

#	ZALEPLON	6389
1	Absorption	_	NOUN	NN	_	2	compound	_	_
2	DRUG	_	NOUN	NN	_	8	nsubjpass	_	_
3	is	_	VERB	VBZ	_	8	auxpass	_	_
4	rapidly	_	ADV	RB	_	5	advmod	_	_
5	and	_	CONJ	CC	_	7	advmod	_	_
6	almost	_	ADV	RB	_	5	advmod	_	_
7	completely	_	ADV	RB	_	8	advmod	_	_
8	absorbed	_	VERB	VBN	_	0	root	_	_
9	following	_	ADP	IN	_	11	case	_	_
10	oral	_	ADJ	JJ	_	11	amod	_	_
11	administration	_	NOUN	NN	_	8	nmod	_	_

#	ZALEPLON	6390
1	Peak	_	ADJ	JJ	_	3	amod	_	_
2	plasma	_	NOUN	NN	_	3	compound	_	_
3	concentrations	_	NOUN	NNS	_	5	nsubjpass	_	_
4	are	_	VERB	VBP	_	5	auxpass	_	_
5	attained	_	VERB	VBN	_	0	root	_	_
6	within	_	ADP	IN	_	9	case	_	_
7	approximately	_	ADV	RB	_	8	advmod	_	_
8	1	_	NUM	CD	_	9	nummod	_	_
9	hour	_	NOUN	NN	_	5	nmod	_	_
10	after	_	ADP	IN	_	12	case	_	_
11	oral	_	ADJ	JJ	_	12	amod	_	_
12	administration	_	NOUN	NN	_	5	nmod	_	_

#	ZALEPLON	6391
1	Although	_	ADP	IN	_	5	mark	_	_
2	DRUG	_	NOUN	NN	_	5	nsubjpass	_	_
3	is	_	VERB	VBZ	_	5	auxpass	_	_
4	well	_	ADV	RB	_	5	advmod	_	_
5	absorbed	_	VERB	VBN	_	12	advcl	_	_
6	,	_	.	,	_	12	punct	_	_
7	its	_	PRON	PRP$	_	9	nmod:poss	_	_
8	absolute	_	NOUN	NN	_	9	amod	_	_
9	bioavailability	_	NOUN	NN	_	12	nsubj	_	_
10	is	_	VERB	VBZ	_	12	cop	_	_
11	approximately	_	ADV	RB	_	12	advmod	_	_
12	30%	_	ADJ	JJ	_	0	root	_	_
13	because	_	ADP	IN	_	15	mark	_	_
14	it	_	PRON	PRP	_	15	nsubj	_	_
15	undergoes	_	VERB	VBZ	_	12	ccomp	_	_
16	significant	_	ADJ	JJ	_	18	amod	_	_
17	presystemic	_	ADJ	JJ	_	18	amod	_	_
18	metabolism	_	NOUN	NN	_	15	dobj	_	_

#	ZALEPLON	6392
1	Distribution	_	NOUN	NN	_	2	compound	_	_
2	DRUG	_	NOUN	NN	_	6	nsubj	_	_
3	is	_	VERB	VBZ	_	6	cop	_	_
4	a	_	DET	DT	_	6	det	_	_
5	lipophilic	_	ADJ	JJ	_	6	amod	_	_
6	compound	_	NOUN	NN	_	0	root	_	_
7	with	_	ADP	IN	_	9	case	_	_
8	a	_	DET	DT	_	9	det	_	_
9	volume	_	NOUN	NN	_	6	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	distribution	_	NOUN	NN	_	9	nmod	_	_
12	of	_	ADP	IN	_	15	case	_	_
13	approximately	_	ADV	RB	_	14	advmod	_	_
14	1.4	_	NUM	CD	_	15	nummod	_	_
15	L	_	NOUN	NN	_	11	nmod	_	_
16	/	_	.	:	_	6	punct	_	_
17	kg	_	NOUN	NN	_	6	dep	_	_
18	following	_	VERB	VBG	_	21	case	_	_
19	intravenous	_	ADJ	JJ	_	21	amod	_	_
20	IV	_	NUM	CD	_	21	nummod	_	_
21	administration	_	NOUN	NN	_	17	nmod	_	_
22	,	_	.	,	_	17	punct	_	_
23	indicating	_	VERB	VBG	_	17	acl	_	_
24	substantial	_	ADJ	JJ	_	25	amod	_	_
25	distribution	_	NOUN	NN	_	23	dobj	_	_
26	into	_	ADP	IN	_	28	case	_	_
27	extravascular	_	ADJ	JJ	_	28	amod	_	_
28	tissues	_	NOUN	NNS	_	25	nmod	_	_

#	ZALEPLON	6393
1	The	_	DET	DT	_	6	det	_	_
2	in	_	X	FW	_	6	amod	_	_
3	vitro	_	X	FW	_	2	dep	_	_
4	plasma	_	NOUN	NN	_	6	compound	_	_
5	protein	_	NOUN	NN	_	6	compound	_	_
6	binding	_	NOUN	NN	_	9	nsubj	_	_
7	is	_	VERB	VBZ	_	9	cop	_	_
8	approximately	_	ADV	RB	_	9	advmod	_	_
9	60%*15%	_	NOUN	NN	_	0	root	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	is	_	VERB	VBZ	_	12	cop	_	_
12	independent	_	ADJ	JJ	_	9	conj	_	_
13	of	_	ADP	IN	_	15	case	_	_
14	DRUG	_	NOUN	NN	_	15	compound	_	_
15	concentration	_	NOUN	NN	_	12	nmod	_	_
16	over	_	ADP	IN	_	18	case	_	_
17	the	_	DET	DT	_	18	det	_	_
18	range	_	NOUN	NN	_	12	nmod	_	_
19	of	_	ADP	IN	_	21	case	_	_
20	10	_	NUM	CD	_	21	nummod	_	_
21	ng	_	NOUN	NN	_	18	nmod	_	_
22	/	_	.	:	_	9	punct	_	_
23	mL	_	NOUN	NN	_	9	dep	_	_
24	to	_	PRT	TO	_	26	case	_	_
25	1000	_	NUM	CD	_	26	nummod	_	_
26	ng	_	NOUN	NN	_	23	nmod	_	_
27	/	_	.	:	_	23	punct	_	_
28	mL	_	NOUN	NN	_	23	dep	_	_

#	ZALEPLON	6394
1	This	_	DET	DT	_	2	nsubj	_	_
2	suggests	_	VERB	VBZ	_	0	root	_	_
3	that	_	ADP	IN	_	9	mark	_	_
4	DRUG	_	NOUN	NN	_	5	compound	_	_
5	disposition	_	NOUN	NN	_	9	nsubj	_	_
6	should	_	VERB	MD	_	9	aux	_	_
7	not	_	ADV	RB	_	9	neg	_	_
8	be	_	VERB	VB	_	9	cop	_	_
9	sensitive	_	ADJ	JJ	_	2	ccomp	_	_
10	to	_	PRT	TO	_	11	case	_	_
11	alterations	_	NOUN	NNS	_	9	nmod	_	_
12	in	_	ADP	IN	_	14	case	_	_
13	protein	_	NOUN	NN	_	14	compound	_	_
14	binding	_	NOUN	NN	_	11	nmod	_	_

#	ZALEPLON	6395
1	The	_	DET	DT	_	2	det	_	_
2	blood	_	NOUN	NN	_	10	nsubj	_	_
3	to	_	PRT	TO	_	5	case	_	_
4	plasma	_	NOUN	NN	_	5	compound	_	_
5	ratio	_	NOUN	NN	_	2	nmod	_	_
6	for	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	is	_	VERB	VBZ	_	10	cop	_	_
9	approximately	_	ADV	RB	_	10	advmod	_	_
10	1	_	NUM	CD	_	0	root	_	_
11	,	_	.	,	_	10	punct	_	_
12	indicating	_	VERB	VBG	_	10	dep	_	_
13	that	_	ADP	IN	_	17	mark	_	_
14	DRUG	_	NOUN	NN	_	17	nsubjpass	_	_
15	is	_	VERB	VBZ	_	17	auxpass	_	_
16	uniformly	_	ADV	RB	_	17	advmod	_	_
17	distributed	_	VERB	VBN	_	12	ccomp	_	_
18	throughout	_	ADP	IN	_	20	case	_	_
19	the	_	DET	DT	_	20	det	_	_
20	blood	_	NOUN	NN	_	17	nmod	_	_
21	with	_	ADP	IN	_	24	case	_	_
22	no	_	DET	DT	_	24	neg	_	_
23	extensive	_	ADJ	JJ	_	24	amod	_	_
24	distribution	_	NOUN	NN	_	17	nmod	_	_
25	into	_	ADP	IN	_	28	case	_	_
26	red	_	ADJ	JJ	_	28	amod	_	_
27	blood	_	NOUN	NN	_	28	compound	_	_
28	cells	_	NOUN	NNS	_	24	nmod	_	_

#	ZALEPLON	6396
1	Metabolism	_	NOUN	NN	_	4	compound	_	_
2	After	_	NOUN	NN	_	4	compound	_	_
3	oral	_	ADJ	JJ	_	4	amod	_	_
4	administration	_	NOUN	NN	_	9	nsubjpass	_	_
5	,	_	.	,	_	4	punct	_	_
6	DRUG	_	NOUN	NN	_	4	appos	_	_
7	is	_	VERB	VBZ	_	9	auxpass	_	_
8	extensively	_	ADV	RB	_	9	advmod	_	_
9	metabolized	_	VERB	VBN	_	0	root	_	_
10	,	_	.	,	_	9	punct	_	_
11	with	_	ADP	IN	_	14	case	_	_
12	less	_	ADV	RB	_	14	advmod	_	_
13	than	_	ADP	IN	_	12	mwe	_	_
14	1%	_	NOUN	NN	_	9	nmod	_	_
15	of	_	ADP	IN	_	17	case	_	_
16	the	_	DET	DT	_	17	det	_	_
17	dose	_	NOUN	NN	_	14	nmod	_	_
18	excreted	_	VERB	VBN	_	17	acl	_	_
19	unchanged	_	ADJ	JJ	_	18	xcomp	_	_
20	in	_	ADP	IN	_	21	mark	_	_
21	urine	_	VERB	VBG	_	18	advcl	_	_

#	ZALEPLON	6397
1	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
2	is	_	VERB	VBZ	_	4	auxpass	_	_
3	primarily	_	ADV	RB	_	4	advmod	_	_
4	metabolized	_	VERB	VBN	_	0	root	_	_
5	by	_	ADP	IN	_	7	case	_	_
6	aldehyde	_	NOUN	NN	_	7	compound	_	_
7	oxidase	_	NOUN	NN	_	4	nmod	_	_
8	to	_	PRT	TO	_	9	mark	_	_
9	form	_	VERB	VB	_	4	xcomp	_	_
10	5	_	NUM	CD	_	12	nummod	_	_
11	oxo	_	NOUN	NN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	9	dobj	_	_

#	ZALEPLON	6398
1	DRUG	_	NOUN	NN	_	3	nsubjpass	_	_
2	is	_	VERB	VBZ	_	3	auxpass	_	_
3	metabolized	_	VERB	VBN	_	0	root	_	_
4	to	_	PRT	TO	_	7	case	_	_
5	a	_	DET	DT	_	7	det	_	_
6	lesser	_	ADJ	JJ	_	7	amod	_	_
7	extent	_	NOUN	NN	_	3	nmod	_	_
8	by	_	ADP	IN	_	12	case	_	_
9	cytochrome	_	NOUN	NN	_	12	compound	_	_
10	P450	_	NOUN	NN	_	12	compound	_	_
11	CYP	_	NOUN	NN	_	12	compound	_	_
12	3A4	_	NOUN	NN	_	7	nmod	_	_
13	to	_	PRT	TO	_	14	mark	_	_
14	form	_	VERB	VB	_	7	acl	_	_
15	desethyl	_	NOUN	NN	_	16	compound	_	_
16	DRUG	_	NOUN	NN	_	14	dobj	_	_
17	,	_	.	,	_	16	punct	_	_
18	which	_	DET	WDT	_	21	nsubjpass	_	_
19	is	_	VERB	VBZ	_	21	auxpass	_	_
20	quickly	_	ADV	RB	_	21	advmod	_	_
21	converted	_	VERB	VBN	_	16	acl:relcl	_	_
22	,	_	.	,	_	16	punct	_	_
23	presumably	_	ADV	RB	_	14	advmod	_	_
24	by	_	ADP	IN	_	26	case	_	_
25	aldehyde	_	NOUN	NN	_	26	compound	_	_
26	oxidase	_	NOUN	NN	_	14	nmod	_	_
27	,	_	.	,	_	3	punct	_	_
28	to	_	PRT	TO	_	32	case	_	_
29	5	_	NUM	CD	_	30	compound	_	_
30	oxo	_	NOUN	NN	_	32	amod	_	_
31	desethyl	_	NOUN	NN	_	32	compound	_	_
32	DRUG	_	NOUN	NN	_	3	nmod	_	_

#	ZALEPLON	6399
1	These	_	DET	DT	_	3	det	_	_
2	oxidative	_	ADJ	JJ	_	3	amod	_	_
3	metabolites	_	NOUN	NNS	_	6	nsubjpass	_	_
4	are	_	VERB	VBP	_	6	auxpass	_	_
5	then	_	ADV	RB	_	6	advmod	_	_
6	converted	_	VERB	VBN	_	0	root	_	_
7	to	_	PRT	TO	_	8	case	_	_
8	glucuronides	_	NOUN	NNS	_	6	nmod	_	_
9	and	_	CONJ	CC	_	6	cc	_	_
10	eliminated	_	VERB	VBN	_	6	conj	_	_
11	in	_	ADP	IN	_	12	mark	_	_
12	urine	_	VERB	VBG	_	10	advcl	_	_

#	ZALEPLON	6400
1	All	_	DET	DT	_	8	nsubj	_	_
2	of	_	ADP	IN	_	5	case	_	_
3	DRUG	_	NOUN	NN	_	5	nmod:poss	_	_
4	's	_	PRT	POS	_	3	case	_	_
5	metabolites	_	NOUN	NNS	_	1	nmod	_	_
6	are	_	VERB	VBP	_	8	auxpass	_	_
7	pharmacologically	_	ADV	RB	_	8	advmod	_	_
8	inactive	_	ADJ	JJ	_	0	root	_	_

#	ZALEPLON	6401
1	Elimination	_	NOUN	NN	_	2	compound	_	_
2	After	_	NOUN	NN	_	12	nsubjpass	_	_
3	either	_	CONJ	CC	_	4	cc:preconj	_	_
4	oral	_	ADJ	JJ	_	2	dep	_	_
5	or	_	CONJ	CC	_	4	cc	_	_
6	IV	_	NOUN	NN	_	4	conj	_	_
7	administration	_	NOUN	NN	_	4	dep	_	_
8	,	_	.	,	_	2	punct	_	_
9	DRUG	_	NOUN	NN	_	2	appos	_	_
10	is	_	VERB	VBZ	_	12	auxpass	_	_
11	rapidly	_	ADV	RB	_	12	advmod	_	_
12	eliminated	_	VERB	VBN	_	0	root	_	_
13	with	_	ADP	IN	_	15	case	_	_
14	a	_	DET	DT	_	15	det	_	_
15	mean	_	NOUN	NN	_	12	nmod	_	_
16	t1	_	NUM	CD	_	15	nummod	_	_
17	/	_	.	-LRB-	_	15	punct	_	_
18	2	_	NUM	CD	_	15	dep	_	_
19	of	_	ADP	IN	_	22	case	_	_
20	approximately	_	ADV	RB	_	21	advmod	_	_
21	1	_	NUM	CD	_	22	nummod	_	_
22	hour	_	NUM	CD	_	18	nmod	_	_

#	ZALEPLON	6402
1	The	_	DET	DT	_	5	det	_	_
2	oral	_	ADJ	JJ	_	5	amod	_	_
3	dose	_	NOUN	NN	_	5	compound	_	_
4	plasma	_	NOUN	NN	_	5	compound	_	_
5	clearance	_	NOUN	NN	_	11	nsubj	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	is	_	VERB	VBZ	_	11	cop	_	_
9	about	_	ADV	RB	_	11	advmod	_	_
10	3	_	NUM	CD	_	11	nummod	_	_
11	L	_	NOUN	NN	_	0	root	_	_
12	/	_	.	:	_	11	punct	_	_
13	h	_	NOUN	NN	_	15	compound	_	_
14	/	_	.	:	_	15	punct	_	_
15	kg	_	NOUN	NN	_	27	nsubj	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	the	_	DET	DT	_	21	det	_	_
18	IV	_	NOUN	NN	_	21	compound	_	_
19	DRUG	_	NOUN	NN	_	21	compound	_	_
20	plasma	_	NOUN	NN	_	21	compound	_	_
21	clearance	_	NOUN	NN	_	15	conj	_	_
22	is	_	VERB	VBZ	_	27	cop	_	_
23	approximately	_	ADV	RB	_	27	advmod	_	_
24	1	_	NUM	CD	_	27	nummod	_	_
25	L	_	NOUN	NN	_	27	compound	_	_
26	/	_	.	:	_	27	punct	_	_
27	h	_	NOUN	NN	_	11	dep	_	_
28	/	_	.	:	_	29	punct	_	_
29	kg	_	NOUN	NN	_	27	root	_	_

#	ZALEPLON	6403
1	Assuming	_	VERB	VBG	_	22	advcl	_	_
2	normal	_	ADJ	JJ	_	5	amod	_	_
3	hepatic	_	ADJ	JJ	_	5	amod	_	_
4	blood	_	NOUN	NN	_	5	compound	_	_
5	flow	_	NOUN	NN	_	1	dobj	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	negligible	_	ADJ	JJ	_	9	amod	_	_
8	renal	_	ADJ	JJ	_	9	amod	_	_
9	clearance	_	NOUN	NN	_	5	conj	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	5	nmod	_	_
12	,	_	.	,	_	22	punct	_	_
13	the	_	DET	DT	_	17	det	_	_
14	estimated	_	VERB	VBN	_	17	amod	_	_
15	hepatic	_	ADJ	JJ	_	17	amod	_	_
16	extraction	_	NOUN	NN	_	17	compound	_	_
17	ratio	_	NOUN	NN	_	22	nsubj	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	DRUG	_	NOUN	NN	_	17	nmod	_	_
20	is	_	VERB	VBZ	_	22	cop	_	_
21	approximately	_	ADV	RB	_	22	advmod	_	_
22	0.7	_	NUM	CD	_	0	root	_	_
23	,	_	.	,	_	22	punct	_	_
24	indicating	_	VERB	VBG	_	22	dep	_	_
25	that	_	ADP	IN	_	28	mark	_	_
26	DRUG	_	NOUN	NN	_	28	nsubj	_	_
27	is	_	VERB	VBZ	_	28	cop	_	_
28	subject	_	NOUN	NN	_	24	ccomp	_	_
29	to	_	PRT	TO	_	33	case	_	_
30	high	_	ADJ	JJ	_	33	amod	_	_
31	first	_	ADJ	JJ	_	33	amod	_	_
32	pass	_	NOUN	NN	_	33	compound	_	_
33	metabolism	_	NOUN	NN	_	28	nmod	_	_

#	ZALEPLON	6404
1	After	_	ADP	IN	_	2	case	_	_
2	administration	_	NOUN	NN	_	17	nmod	_	_
3	of	_	ADP	IN	_	7	case	_	_
4	a	_	DET	DT	_	7	det	_	_
5	radio	_	ADJ	JJ	_	7	amod	_	_
6	labeled	_	VERB	VBN	_	7	amod	_	_
7	dose	_	NOUN	NN	_	2	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	,	_	.	,	_	17	punct	_	_
11	70%	_	NOUN	NN	_	17	nsubjpass	_	_
12	of	_	ADP	IN	_	15	case	_	_
13	the	_	DET	DT	_	15	det	_	_
14	administered	_	VERB	VBN	_	15	amod	_	_
15	dose	_	NOUN	NN	_	11	nmod	_	_
16	is	_	VERB	VBZ	_	17	auxpass	_	_
17	recovered	_	VERB	VBN	_	0	root	_	_
18	in	_	ADP	IN	_	19	case	_	_
19	urine	_	ADJ	JJ	_	17	advcl	_	_
20	within	_	ADP	IN	_	22	case	_	_
21	48	_	NUM	CD	_	22	nummod	_	_
22	hours	_	NOUN	NNS	_	19	nmod	_	_
23	71%	_	NOUN	NN	_	22	amod	_	_
24	recovered	_	VERB	VBN	_	23	acl	_	_
25	within	_	ADP	IN	_	27	case	_	_
26	6	_	NUM	CD	_	27	nummod	_	_
27	days	_	NOUN	NNS	_	24	nmod	_	_
28	,	_	.	,	_	17	punct	_	_
29	almost	_	ADV	RB	_	30	advmod	_	_
30	all	_	ADV	RB	_	33	case	_	_
31	as	_	ADP	IN	_	30	mwe	_	_
32	DRUG	_	NOUN	NN	_	33	compound	_	_
33	metabolites	_	NOUN	NNS	_	17	nmod	_	_
34	and	_	CONJ	CC	_	33	cc	_	_
35	their	_	PRON	PRP$	_	36	nmod:poss	_	_
36	glucuronides	_	NOUN	NNS	_	33	conj	_	_

#	ZALEPLON	6405
1	An	_	DET	DT	_	3	det	_	_
2	additional	_	ADJ	JJ	_	3	amod	_	_
3	17%	_	NOUN	NN	_	5	nsubjpass	_	_
4	is	_	VERB	VBZ	_	5	auxpass	_	_
5	recovered	_	VERB	VBN	_	0	root	_	_
6	in	_	ADP	IN	_	7	case	_	_
7	feces	_	NOUN	NNS	_	5	nmod	_	_
8	within	_	ADP	IN	_	10	case	_	_
9	6	_	NUM	CD	_	10	nummod	_	_
10	days	_	NOUN	NNS	_	7	nmod	_	_
11	,	_	.	,	_	7	punct	_	_
12	most	_	ADV	RB	_	14	advmod	_	_
13	as	_	ADP	IN	_	12	mwe	_	_
14	5	_	NUM	CD	_	7	nmod	_	_
15	oxo	_	NOUN	NN	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	14	dep	_	_

#	ZALEPLON	6406
1	Effect	_	NOUN	NN	_	0	root	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	Food	_	NOUN	NN	_	1	nmod	_	_
4	In	_	ADP	IN	_	6	case	_	_
5	healthy	_	ADJ	JJ	_	6	amod	_	_
6	adults	_	NOUN	NNS	_	1	nmod	_	_
7	a	_	DET	DT	_	9	det	_	_
8	high	_	ADJ	JJ	_	9	amod	_	_
9	fat	_	NOUN	NN	_	1	dep	_	_
10	/	_	.	:	_	1	punct	_	_
11	heavy	_	ADJ	JJ	_	12	amod	_	_
12	meal	_	ADJ	JJ	_	13	nsubj	_	_
13	prolonged	_	ADJ	JJ	_	1	dep	_	_
14	the	_	DET	DT	_	15	det	_	_
15	absorption	_	NOUN	NN	_	18	nsubj	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	DRUG	_	NOUN	NN	_	15	nmod	_	_
18	compared	_	VERB	VBD	_	13	ccomp	_	_
19	to	_	PRT	TO	_	22	case	_	_
20	the	_	DET	DT	_	22	det	_	_
21	fasted	_	ADJ	JJ	_	22	amod	_	_
22	state	_	NOUN	NN	_	18	nmod	_	_
23	,	_	.	,	_	18	punct	_	_
24	delaying	_	VERB	VBG	_	18	advcl	_	_
25	tmax	_	NOUN	NN	_	24	dobj	_	_
26	by	_	ADP	IN	_	29	case	_	_
27	approximately	_	ADV	RB	_	28	advmod	_	_
28	2	_	NUM	CD	_	29	nummod	_	_
29	hours	_	NOUN	NNS	_	24	nmod	_	_
30	and	_	CONJ	CC	_	24	cc	_	_
31	reducing	_	VERB	VBG	_	24	conj	_	_
32	Cmax	_	NOUN	NN	_	31	dobj	_	_
33	by	_	ADP	IN	_	35	case	_	_
34	approximately	_	ADV	RB	_	35	advmod	_	_
35	35%	_	ADJ	JJ	_	31	nmod	_	_

#	ZALEPLON	6407
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	AUC	_	NOUN	NN	_	10	nsubjpass	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	elimination	_	NOUN	NN	_	6	compound	_	_
5	half	_	NOUN	NN	_	6	compound	_	_
6	life	_	NOUN	NN	_	2	conj	_	_
7	were	_	VERB	VBD	_	10	auxpass	_	_
8	not	_	ADV	RB	_	10	neg	_	_
9	significantly	_	ADV	RB	_	10	advmod	_	_
10	affected	_	VERB	VBN	_	0	root	_	_

#	ZALEPLON	6408
1	These	_	DET	DT	_	2	det	_	_
2	results	_	NOUN	NNS	_	3	nsubj	_	_
3	suggest	_	VERB	VBP	_	0	root	_	_
4	that	_	ADP	IN	_	14	mark	_	_
5	the	_	DET	DT	_	6	det	_	_
6	effects	_	NOUN	NNS	_	14	nsubjpass	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	on	_	ADP	IN	_	11	case	_	_
10	sleep	_	NOUN	NN	_	11	compound	_	_
11	onset	_	NOUN	NN	_	6	nmod	_	_
12	may	_	VERB	MD	_	14	aux	_	_
13	be	_	VERB	VB	_	14	auxpass	_	_
14	reduced	_	VERB	VBN	_	3	ccomp	_	_
15	if	_	ADP	IN	_	18	mark	_	_
16	it	_	PRON	PRP	_	18	nsubjpass	_	_
17	is	_	VERB	VBZ	_	18	auxpass	_	_
18	taken	_	VERB	VBN	_	14	ccomp	_	_
19	with	_	ADP	IN	_	21	case	_	_
20	or	_	CONJ	CC	_	21	cc	_	_
21	immediately	_	ADV	RB	_	18	advmod	_	_
22	after	_	ADP	IN	_	25	case	_	_
23	a	_	DET	DT	_	25	det	_	_
24	high	_	ADJ	JJ	_	25	amod	_	_
25	fat	_	NOUN	NN	_	18	nmod	_	_
26	/	_	.	:	_	28	punct	_	_
27	heavy	_	ADJ	JJ	_	28	amod	_	_
28	meal	_	ADJ	JJ	_	14	parataxis	_	_

#	ZALEPLON	6409
1	Special	_	ADJ	JJ	_	2	amod	_	_
2	Populations	_	NOUN	NNS	_	0	root	_	_
3	Age	_	NOUN	NN	_	2	dep	_	_
4	:	_	.	:	_	2	punct	_	_
5	The	_	DET	DT	_	6	det	_	_
6	pharmacokinetics	_	NOUN	NNS	_	11	nsubjpass	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	have	_	VERB	VBP	_	11	aux	_	_
10	been	_	VERB	VBN	_	11	auxpass	_	_
11	investigated	_	VERB	VBN	_	2	dep	_	_
12	in	_	ADP	IN	_	14	case	_	_
13	three	_	NUM	CD	_	14	nummod	_	_
14	studies	_	NOUN	NNS	_	11	nmod	_	_
15	with	_	ADP	IN	_	17	case	_	_
16	elderly	_	ADJ	JJ	_	17	amod	_	_
17	men	_	NOUN	NN	_	14	nmod	_	_
18	and	_	CONJ	CC	_	17	cc	_	_
19	women	_	NOUN	NNS	_	17	conj	_	_
20	ranging	_	VERB	VBG	_	17	acl	_	_
21	in	_	ADP	IN	_	22	case	_	_
22	age	_	NOUN	NN	_	20	nmod	_	_
23	from	_	ADP	IN	_	27	case	_	_
24	65	_	NUM	CD	_	26	compound	_	_
25	to	_	PRT	TO	_	26	dep	_	_
26	85	_	NUM	CD	_	27	nummod	_	_
27	years	_	NOUN	NNS	_	22	nmod	_	_

#	ZALEPLON	6410
1	The	_	DET	DT	_	2	det	_	_
2	pharmacokinetics	_	NOUN	NNS	_	20	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	in	_	ADP	IN	_	7	case	_	_
6	elderly	_	ADJ	JJ	_	7	amod	_	_
7	subjects	_	NOUN	NNS	_	2	nmod	_	_
8	,	_	.	,	_	7	punct	_	_
9	including	_	VERB	VBG	_	10	case	_	_
10	those	_	DET	DT	_	7	nmod	_	_
11	over	_	ADP	IN	_	13	case	_	_
12	75	_	NUM	CD	_	13	nummod	_	_
13	years	_	NOUN	NNS	_	2	nmod	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	age	_	NOUN	NN	_	13	nmod	_	_
16	,	_	.	,	_	2	punct	_	_
17	are	_	VERB	VBP	_	20	cop	_	_
18	not	_	ADV	RB	_	20	neg	_	_
19	significantly	_	ADV	RB	_	20	advmod	_	_
20	different	_	ADJ	JJ	_	0	root	_	_
21	from	_	ADP	IN	_	22	case	_	_
22	those	_	DET	DT	_	20	nmod	_	_
23	in	_	ADP	IN	_	26	case	_	_
24	young	_	ADJ	JJ	_	26	amod	_	_
25	healthy	_	ADJ	JJ	_	26	amod	_	_
26	subjects	_	NOUN	NNS	_	22	nmod	_	_

#	ZALEPLON	6411
1	Gender	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	There	_	DET	EX	_	4	expl	_	_
4	is	_	VERB	VBZ	_	1	dep	_	_
5	no	_	DET	DT	_	7	neg	_	_
6	significant	_	ADJ	JJ	_	7	amod	_	_
7	difference	_	NOUN	NN	_	4	nsubj	_	_
8	in	_	ADP	IN	_	10	case	_	_
9	the	_	DET	DT	_	10	det	_	_
10	pharmacokinetics	_	NOUN	NNS	_	4	nmod	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	DRUG	_	NOUN	NN	_	10	nmod	_	_
13	in	_	ADP	IN	_	14	case	_	_
14	men	_	NOUN	NN	_	10	nmod	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	women	_	NOUN	NNS	_	14	conj	_	_

#	ZALEPLON	6412
1	Race	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	The	_	DET	DT	_	4	det	_	_
4	pharmacokinetics	_	NOUN	NNS	_	9	nsubjpass	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	have	_	VERB	VBP	_	9	aux	_	_
8	been	_	VERB	VBN	_	9	auxpass	_	_
9	studied	_	VERB	VBN	_	1	dep	_	_
10	in	_	ADP	IN	_	12	case	_	_
11	Japanese	_	ADJ	JJ	_	12	amod	_	_
12	subjects	_	NOUN	NNS	_	9	nmod	_	_
13	as	_	ADP	IN	_	14	case	_	_
14	representative	_	NOUN	NN	_	9	nmod	_	_
15	of	_	ADP	IN	_	17	case	_	_
16	Asian	_	NOUN	NN	_	17	compound	_	_
17	populations	_	NOUN	NNS	_	14	nmod	_	_

#	ZALEPLON	6413
1	For	_	ADP	IN	_	3	case	_	_
2	this	_	DET	DT	_	3	det	_	_
3	group	_	NOUN	NN	_	9	nmod	_	_
4	,	_	.	,	_	9	punct	_	_
5	Cmax	_	NOUN	NN	_	9	nsubjpass	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	AUC	_	NOUN	NN	_	5	conj	_	_
8	were	_	VERB	VBD	_	9	auxpass	_	_
9	increased	_	VERB	VBN	_	0	root	_	_
10	37%	_	NOUN	NN	_	9	xcomp	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	64%	_	NOUN	NN	_	10	conj	_	_
13	,	_	.	,	_	9	punct	_	_
14	respectively	_	ADV	RB	_	9	advmod	_	_

#	ZALEPLON	6414
1	This	_	DET	DT	_	2	det	_	_
2	finding	_	NOUN	NN	_	6	nsubjpass	_	_
3	can	_	VERB	MD	_	6	aux	_	_
4	likely	_	ADV	RB	_	6	advmod	_	_
5	be	_	VERB	VB	_	6	auxpass	_	_
6	attributed	_	VERB	VBN	_	0	root	_	_
7	to	_	PRT	TO	_	8	case	_	_
8	differences	_	NOUN	NNS	_	6	nmod	_	_
9	in	_	ADP	IN	_	11	case	_	_
10	body	_	NOUN	NN	_	11	compound	_	_
11	weight	_	NOUN	NN	_	8	nmod	_	_
12	,	_	.	,	_	6	punct	_	_
13	or	_	CONJ	CC	_	6	cc	_	_
14	alternatively	_	ADV	RB	_	17	advmod	_	_
15	,	_	.	,	_	17	punct	_	_
16	may	_	VERB	MD	_	17	aux	_	_
17	represent	_	VERB	VB	_	6	conj	_	_
18	differences	_	NOUN	NNS	_	17	dobj	_	_
19	in	_	ADP	IN	_	21	case	_	_
20	enzyme	_	NOUN	NN	_	21	compound	_	_
21	activities	_	NOUN	NNS	_	18	nmod	_	_
22	resulting	_	VERB	VBG	_	21	acl	_	_
23	from	_	ADP	IN	_	24	case	_	_
24	differences	_	NOUN	NNS	_	22	nmod	_	_
25	in	_	ADP	IN	_	26	case	_	_
26	diet	_	NOUN	NN	_	24	nmod	_	_
27	,	_	.	,	_	26	punct	_	_
28	environment	_	NOUN	NN	_	26	conj	_	_
29	,	_	.	,	_	26	punct	_	_
30	or	_	CONJ	CC	_	26	cc	_	_
31	other	_	ADJ	JJ	_	32	amod	_	_
32	factors	_	NOUN	NNS	_	26	conj	_	_

#	ZALEPLON	6415
1	The	_	DET	DT	_	2	det	_	_
2	effects	_	NOUN	NNS	_	16	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	race	_	NOUN	NN	_	2	nmod	_	_
5	on	_	ADP	IN	_	7	case	_	_
6	pharmacokinetic	_	ADJ	JJ	_	7	amod	_	_
7	characteristics	_	NOUN	NNS	_	2	nmod	_	_
8	in	_	ADP	IN	_	11	case	_	_
9	other	_	ADJ	JJ	_	11	amod	_	_
10	ethnic	_	ADJ	JJ	_	11	amod	_	_
11	groups	_	NOUN	NNS	_	7	nmod	_	_
12	have	_	VERB	VBP	_	16	aux	_	_
13	not	_	ADV	RB	_	16	neg	_	_
14	been	_	VERB	VBN	_	16	auxpass	_	_
15	well	_	ADV	RB	_	16	advmod	_	_
16	characterized	_	VERB	VBN	_	0	root	_	_

#	ZALEPLON	6416
1	Hepatic	_	ADJ	JJ	_	2	amod	_	_
2	impairment	_	NOUN	NN	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	DRUG	_	NOUN	NN	_	6	nsubjpass	_	_
5	is	_	VERB	VBZ	_	6	auxpass	_	_
6	metabolized	_	VERB	VBN	_	2	dep	_	_
7	primarily	_	ADV	RB	_	6	advmod	_	_
8	by	_	ADP	IN	_	10	case	_	_
9	the	_	DET	DT	_	10	det	_	_
10	liver	_	NOUN	NN	_	6	nmod	_	_
11	and	_	CONJ	CC	_	6	cc	_	_
12	undergoes	_	VERB	VBZ	_	6	conj	_	_
13	significant	_	ADJ	JJ	_	15	amod	_	_
14	presystemic	_	ADJ	JJ	_	15	amod	_	_
15	metabolism	_	NOUN	NN	_	12	dobj	_	_

#	ZALEPLON	6417
1	Consequently	_	ADV	RB	_	9	advmod	_	_
2	,	_	.	,	_	9	punct	_	_
3	the	_	DET	DT	_	5	det	_	_
4	oral	_	ADJ	JJ	_	5	amod	_	_
5	clearance	_	NOUN	NN	_	9	nsubjpass	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	was	_	VERB	VBD	_	9	auxpass	_	_
9	reduced	_	VERB	VBN	_	0	root	_	_
10	by	_	ADP	IN	_	11	case	_	_
11	70%	_	NOUN	NN	_	9	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	87%	_	NOUN	NN	_	11	conj	_	_
14	in	_	ADP	IN	_	19	case	_	_
15	compensated	_	VERB	VBN	_	19	amod	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	decompensated	_	VERB	VBN	_	15	conj	_	_
18	cirrhotic	_	ADJ	JJ	_	19	amod	_	_
19	patients	_	NOUN	NNS	_	9	nmod	_	_
20	,	_	.	,	_	9	punct	_	_
21	respectively	_	ADV	RB	_	9	advmod	_	_
22	,	_	.	,	_	9	punct	_	_
23	leading	_	VERB	VBG	_	9	xcomp	_	_
24	to	_	PRT	TO	_	26	case	_	_
25	marked	_	VERB	VBN	_	26	amod	_	_
26	increases	_	NOUN	NNS	_	23	nmod	_	_
27	in	_	ADP	IN	_	29	case	_	_
28	mean	_	NOUN	NN	_	29	compound	_	_
29	Cmax	_	NOUN	NN	_	26	nmod	_	_
30	and	_	CONJ	CC	_	29	cc	_	_
31	AUC	_	NOUN	NN	_	29	conj	_	_
32	up	_	ADV	RB	_	34	advmod	_	_
33	to	_	PRT	TO	_	32	mwe	_	_
34	4	_	NUM	CD	_	35	nummod	_	_
35	fold	_	NOUN	NN	_	23	nmod	_	_
36	and	_	CONJ	CC	_	35	cc	_	_
37	7	_	NUM	CD	_	38	nummod	_	_
38	fold	_	NOUN	NN	_	35	conj	_	_
39	in	_	ADP	IN	_	43	case	_	_
40	compensated	_	VERB	VBN	_	43	amod	_	_
41	and	_	CONJ	CC	_	40	cc	_	_
42	decompensated	_	VERB	VBN	_	40	conj	_	_
43	patients	_	NOUN	NNS	_	35	nmod	_	_
44	,	_	.	,	_	9	punct	_	_
45	respectively	_	ADV	RB	_	9	advmod	_	_
46	,	_	.	,	_	9	punct	_	_
47	in	_	ADP	IN	_	48	case	_	_
48	comparison	_	NOUN	NN	_	9	nmod	_	_
49	with	_	ADP	IN	_	51	case	_	_
50	healthy	_	ADJ	JJ	_	51	amod	_	_
51	subjects	_	NOUN	NNS	_	48	nmod	_	_

#	ZALEPLON	6418
1	The	_	DET	DT	_	2	det	_	_
2	dose	_	NOUN	NN	_	8	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	should	_	VERB	MD	_	8	aux	_	_
6	therefore	_	ADV	RB	_	8	advmod	_	_
7	be	_	VERB	VB	_	8	auxpass	_	_
8	reduced	_	VERB	VBN	_	0	root	_	_
9	in	_	ADP	IN	_	10	case	_	_
10	patients	_	NOUN	NNS	_	8	nmod	_	_
11	with	_	ADP	IN	_	12	case	_	_
12	mild	_	ADJ	JJ	_	10	nmod	_	_
13	to	_	PRT	TO	_	16	case	_	_
14	moderate	_	ADJ	JJ	_	16	amod	_	_
15	hepatic	_	ADJ	JJ	_	16	amod	_	_
16	impairment	_	NOUN	NN	_	10	nmod	_	_

#	ZALEPLON	6419
1	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
2	is	_	VERB	VBZ	_	4	auxpass	_	_
3	not	_	ADV	RB	_	4	neg	_	_
4	recommended	_	VERB	VBN	_	0	root	_	_
5	for	_	ADP	IN	_	6	case	_	_
6	use	_	NOUN	NN	_	4	nmod	_	_
7	in	_	ADP	IN	_	8	case	_	_
8	patients	_	NOUN	NNS	_	6	nmod	_	_
9	with	_	ADP	IN	_	12	case	_	_
10	severe	_	ADJ	JJ	_	12	amod	_	_
11	hepatic	_	ADJ	JJ	_	12	amod	_	_
12	impairment	_	NOUN	NN	_	8	nmod	_	_

#	ZALEPLON	6420
1	Renal	_	ADJ	JJ	_	2	amod	_	_
2	impairment	_	NOUN	NN	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	Because	_	ADP	IN	_	10	mark	_	_
5	renal	_	ADJ	JJ	_	6	amod	_	_
6	excretion	_	NOUN	NN	_	10	nsubj	_	_
7	of	_	ADP	IN	_	9	case	_	_
8	unchanged	_	ADJ	JJ	_	9	amod	_	_
9	DRUG	_	NOUN	NN	_	6	nmod	_	_
10	accounts	_	VERB	VBZ	_	26	advcl	_	_
11	for	_	ADP	IN	_	14	case	_	_
12	less	_	ADV	RB	_	14	advmod	_	_
13	than	_	ADP	IN	_	12	mwe	_	_
14	1%	_	NOUN	NN	_	10	nmod	_	_
15	of	_	ADP	IN	_	18	case	_	_
16	the	_	DET	DT	_	18	det	_	_
17	administered	_	VERB	VBN	_	18	amod	_	_
18	dose	_	NOUN	NN	_	14	nmod	_	_
19	,	_	.	,	_	26	punct	_	_
20	the	_	DET	DT	_	21	det	_	_
21	pharmacokinetics	_	NOUN	NNS	_	26	nsubjpass	_	_
22	of	_	ADP	IN	_	23	case	_	_
23	DRUG	_	NOUN	NN	_	21	nmod	_	_
24	are	_	VERB	VBP	_	26	auxpass	_	_
25	not	_	ADV	RB	_	26	neg	_	_
26	altered	_	VERB	VBN	_	2	dep	_	_
27	in	_	ADP	IN	_	28	case	_	_
28	patients	_	NOUN	NNS	_	26	nmod	_	_
29	with	_	ADP	IN	_	31	case	_	_
30	renal	_	ADJ	JJ	_	31	amod	_	_
31	insufficiency	_	NOUN	NN	_	28	nmod	_	_

#	ZALEPLON	6421
1	No	_	DET	DT	_	3	neg	_	_
2	dose	_	NOUN	NN	_	3	compound	_	_
3	adjustment	_	NOUN	NN	_	5	nsubj	_	_
4	is	_	VERB	VBZ	_	5	cop	_	_
5	necessary	_	ADJ	JJ	_	0	root	_	_
6	in	_	ADP	IN	_	7	case	_	_
7	patients	_	NOUN	NNS	_	5	nmod	_	_
8	with	_	ADP	IN	_	9	case	_	_
9	mild	_	ADJ	JJ	_	7	nmod	_	_
10	to	_	PRT	TO	_	13	case	_	_
11	moderate	_	ADJ	JJ	_	13	amod	_	_
12	renal	_	ADJ	JJ	_	13	amod	_	_
13	impairment	_	NOUN	NN	_	7	nmod	_	_

#	ZALEPLON	6422
1	DRUG	_	NOUN	NN	_	6	nsubjpass	_	_
2	has	_	VERB	VBZ	_	6	aux	_	_
3	not	_	ADV	RB	_	6	neg	_	_
4	been	_	VERB	VBN	_	6	auxpass	_	_
5	adequately	_	ADV	RB	_	6	advmod	_	_
6	studied	_	VERB	VBN	_	0	root	_	_
7	in	_	ADP	IN	_	8	case	_	_
8	patients	_	NOUN	NNS	_	6	nmod	_	_
9	with	_	ADP	IN	_	12	case	_	_
10	severe	_	ADJ	JJ	_	12	amod	_	_
11	renal	_	ADJ	JJ	_	12	amod	_	_
12	impairment	_	NOUN	NN	_	8	nmod	_	_

#	ZALEPLON	6423
1	Drug	_	NOUN	NN	_	3	compound	_	_
2	Drug	_	NOUN	NN	_	3	compound	_	_
3	Interactions	_	NOUN	NNS	_	27	nsubjpass	_	_
4	Because	_	ADP	IN	_	8	mark	_	_
5	DRUG	_	NOUN	NN	_	8	nsubjpass	_	_
6	is	_	VERB	VBZ	_	8	auxpass	_	_
7	primarily	_	ADV	RB	_	8	advmod	_	_
8	metabolized	_	VERB	VBN	_	3	acl:relcl	_	_
9	by	_	ADP	IN	_	11	case	_	_
10	aldehyde	_	NOUN	NN	_	11	compound	_	_
11	oxidase	_	NOUN	NN	_	8	nmod	_	_
12	,	_	.	,	_	3	punct	_	_
13	and	_	CONJ	CC	_	3	cc	_	_
14	to	_	PRT	TO	_	17	case	_	_
15	a	_	DET	DT	_	17	det	_	_
16	lesser	_	ADJ	JJ	_	17	amod	_	_
17	extent	_	NOUN	NN	_	3	conj	_	_
18	by	_	ADP	IN	_	19	case	_	_
19	CYP3A4	_	NOUN	NN	_	17	nmod	_	_
20	,	_	.	,	_	27	punct	_	_
21	inhibitors	_	NOUN	NNS	_	27	nsubjpass	_	_
22	of	_	ADP	IN	_	24	case	_	_
23	these	_	DET	DT	_	24	det	_	_
24	enzymes	_	NOUN	NNS	_	21	nmod	_	_
25	might	_	VERB	MD	_	27	aux	_	_
26	be	_	VERB	VB	_	27	auxpass	_	_
27	expected	_	VERB	VBN	_	0	root	_	_
28	to	_	PRT	TO	_	29	mark	_	_
29	decrease	_	VERB	VB	_	27	xcomp	_	_
30	DRUG	_	NOUN	NN	_	32	nmod:poss	_	_
31	's	_	PRT	POS	_	32	case	_	_
32	clearance	_	NOUN	NN	_	29	dobj	_	_
33	and	_	CONJ	CC	_	32	cc	_	_
34	inducers	_	NOUN	NNS	_	32	conj	_	_
35	of	_	ADP	IN	_	37	case	_	_
36	these	_	DET	DT	_	37	det	_	_
37	enzymes	_	NOUN	NNS	_	32	nmod	_	_
38	might	_	VERB	MD	_	40	aux	_	_
39	be	_	VERB	VB	_	40	auxpass	_	_
40	expected	_	VERB	VBN	_	27	parataxis	_	_
41	to	_	PRT	TO	_	42	mark	_	_
42	increase	_	VERB	VB	_	40	xcomp	_	_
43	its	_	PRON	PRP$	_	44	nmod:poss	_	_
44	clearance	_	NOUN	NN	_	42	dobj	_	_

#	ZALEPLON	6424
1	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
2	has	_	VERB	VBZ	_	4	aux	_	_
3	been	_	VERB	VBN	_	4	auxpass	_	_
4	shown	_	VERB	VBN	_	0	root	_	_
5	to	_	PRT	TO	_	6	mark	_	_
6	have	_	VERB	VB	_	4	xcomp	_	_
7	minimal	_	ADJ	JJ	_	8	amod	_	_
8	effects	_	NOUN	NNS	_	6	dobj	_	_
9	on	_	ADP	IN	_	11	case	_	_
10	the	_	DET	DT	_	11	det	_	_
11	kinetics	_	NOUN	NNS	_	6	nmod	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	warfarin	_	NOUN	NN	_	11	nmod	_	_
14	both	_	CONJ	CC	_	15	cc:preconj	_	_
15	R	_	NOUN	NN	_	11	dep	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	S	_	NOUN	NN	_	15	conj	_	_
18	forms	_	NOUN	NNS	_	15	dep	_	_
19	,	_	.	,	_	15	punct	_	_
20	imipramine	_	NOUN	NN	_	15	conj	_	_
21	,	_	.	,	_	15	punct	_	_
22	ethanol	_	NOUN	NN	_	15	conj	_	_
23	,	_	.	,	_	15	punct	_	_
24	ibuprofen	_	NOUN	NN	_	15	conj	_	_
25	,	_	.	,	_	15	punct	_	_
26	diphenhydramine	_	NOUN	NN	_	15	conj	_	_
27	,	_	.	,	_	15	punct	_	_
28	thioridazine	_	NOUN	NN	_	15	conj	_	_
29	,	_	.	,	_	15	punct	_	_
30	and	_	CONJ	CC	_	15	cc	_	_
31	digoxin	_	NOUN	NN	_	15	conj	_	_

#	ZALEPLON	6425
1	However	_	ADV	RB	_	21	advmod	_	_
2	,	_	.	,	_	21	punct	_	_
3	the	_	DET	DT	_	4	det	_	_
4	effects	_	NOUN	NNS	_	21	nsubjpass	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	on	_	ADP	IN	_	8	case	_	_
8	inhibition	_	NOUN	NN	_	4	nmod	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	enzymes	_	NOUN	NNS	_	8	nmod	_	_
11	involved	_	VERB	VBN	_	10	acl	_	_
12	in	_	ADP	IN	_	14	case	_	_
13	the	_	DET	DT	_	14	det	_	_
14	metabolism	_	NOUN	NN	_	11	nmod	_	_
15	of	_	ADP	IN	_	17	case	_	_
16	other	_	ADJ	JJ	_	17	amod	_	_
17	drugs	_	NOUN	NNS	_	14	nmod	_	_
18	have	_	VERB	VBP	_	21	aux	_	_
19	not	_	ADV	RB	_	21	neg	_	_
20	been	_	VERB	VBN	_	21	auxpass	_	_
21	studied	_	VERB	VBN	_	0	root	_	_

#	ZALEPLON	6427
1	Clinical	_	ADJ	JJ	_	2	amod	_	_
2	Trials	_	NOUN	NNS	_	3	nsubj	_	_
3	Controlled	_	VERB	VBD	_	0	root	_	_
4	Trials	_	NOUN	NNS	_	3	dobj	_	_
5	Supporting	_	VERB	VBG	_	4	acl	_	_
6	Effectiveness	_	NOUN	NN	_	7	compound	_	_
7	DRUG	_	NOUN	NN	_	5	dobj	_	_
8	typically	_	ADV	RB	_	9	advmod	_	_
9	administered	_	VERB	VBN	_	7	acl	_	_
10	in	_	ADP	IN	_	11	case	_	_
11	doses	_	NOUN	NNS	_	9	nmod	_	_
12	of	_	ADP	IN	_	14	case	_	_
13	5	_	NUM	CD	_	14	nummod	_	_
14	mg	_	NOUN	NN	_	11	nmod	_	_
15	,	_	.	,	_	14	punct	_	_
16	10	_	NUM	CD	_	17	nummod	_	_
17	mg	_	NOUN	NN	_	14	conj	_	_
18	,	_	.	,	_	14	punct	_	_
19	or	_	CONJ	CC	_	14	cc	_	_
20	20	_	NUM	CD	_	21	nummod	_	_
21	mg	_	NOUN	NN	_	14	conj	_	_
22	has	_	VERB	VBZ	_	24	aux	_	_
23	been	_	VERB	VBN	_	24	auxpass	_	_
24	studied	_	VERB	VBN	_	3	parataxis	_	_
25	in	_	ADP	IN	_	26	case	_	_
26	patients	_	NOUN	NNS	_	24	nmod	_	_
27	with	_	ADP	IN	_	30	case	_	_
28	chronic	_	ADJ	JJ	_	30	amod	_	_
29	insomnia	_	NOUN	NN	_	30	compound	_	_
30	n	_	NOUN	NN	_	26	nmod	_	_
31	=	_	ADJ	JJ	_	30	acl	_	_
32	3,435	_	NUM	CD	_	31	dep	_	_
33	in	_	ADP	IN	_	35	case	_	_
34	12	_	NUM	CD	_	35	nummod	_	_
35	placebo	_	NOUN	NN	_	31	nmod	_	_
36	and	_	CONJ	CC	_	35	cc	_	_
37	active	_	ADJ	JJ	_	40	amod	_	_
38	drug	_	NOUN	NN	_	40	compound	_	_
39	controlled	_	ADJ	JJ	_	40	amod	_	_
40	trials	_	NOUN	NNS	_	35	conj	_	_

#	ZALEPLON	6428
1	Three	_	NUM	CD	_	8	nsubj	_	_
2	of	_	ADP	IN	_	4	case	_	_
3	the	_	DET	DT	_	4	det	_	_
4	trials	_	NOUN	NNS	_	1	nmod	_	_
5	were	_	VERB	VBD	_	8	cop	_	_
6	in	_	ADP	IN	_	8	case	_	_
7	elderly	_	ADJ	JJ	_	8	amod	_	_
8	patients	_	NOUN	NNS	_	0	root	_	_
9	n=1,019	_	NOUN	NN	_	8	root	_	_

#	ZALEPLON	6429
1	It	_	PRON	PRP	_	5	nsubjpass	_	_
2	has	_	VERB	VBZ	_	5	aux	_	_
3	also	_	ADV	RB	_	5	advmod	_	_
4	been	_	VERB	VBN	_	5	auxpass	_	_
5	studied	_	VERB	VBN	_	0	root	_	_
6	in	_	ADP	IN	_	9	case	_	_
7	transient	_	ADJ	JJ	_	9	amod	_	_
8	insomnia	_	NOUN	NN	_	9	compound	_	_
9	n=264	_	NOUN	NN	_	5	nmod	_	_

#	ZALEPLON	6430
1	Because	_	ADP	IN	_	7	case	_	_
2	of	_	ADP	IN	_	7	case	_	_
3	its	_	PRON	PRP$	_	7	nmod:poss	_	_
4	very	_	ADV	RB	_	5	advmod	_	_
5	short	_	ADJ	JJ	_	7	amod	_	_
6	half	_	NOUN	NN	_	7	compound	_	_
7	life	_	NOUN	NN	_	10	nmod	_	_
8	,	_	.	,	_	10	punct	_	_
9	studies	_	NOUN	NNS	_	10	nsubj	_	_
10	focused	_	VERB	VBN	_	0	root	_	_
11	on	_	ADP	IN	_	12	mark	_	_
12	decreasing	_	VERB	VBG	_	10	advcl	_	_
13	sleep	_	NOUN	NN	_	14	compound	_	_
14	latency	_	NOUN	NN	_	12	dobj	_	_
15	,	_	.	,	_	10	punct	_	_
16	with	_	ADP	IN	_	18	case	_	_
17	less	_	ADV	RB	_	18	advmod	_	_
18	attention	_	NOUN	NN	_	10	nmod	_	_
19	to	_	PRT	TO	_	20	case	_	_
20	duration	_	NOUN	NN	_	18	nmod	_	_
21	of	_	ADP	IN	_	22	case	_	_
22	sleep	_	NOUN	NN	_	20	nmod	_	_
23	and	_	CONJ	CC	_	22	cc	_	_
24	number	_	NOUN	NN	_	22	conj	_	_
25	of	_	ADP	IN	_	26	case	_	_
26	awakenings	_	NOUN	NNS	_	22	nmod	_	_
27	,	_	.	,	_	10	punct	_	_
28	for	_	ADP	IN	_	29	case	_	_
29	which	_	DET	WDT	_	36	nmod	_	_
30	consistent	_	ADJ	JJ	_	31	amod	_	_
31	differences	_	NOUN	NNS	_	36	nsubjpass	_	_
32	from	_	ADP	IN	_	33	case	_	_
33	placebo	_	NOUN	NN	_	31	nmod	_	_
34	were	_	VERB	VBD	_	36	auxpass	_	_
35	not	_	ADV	RB	_	36	neg	_	_
36	demonstrated	_	VERB	VBN	_	10	root	_	_

#	ZALEPLON	6431
1	Studies	_	NOUN	NNS	_	4	nsubjpass	_	_
2	were	_	VERB	VBD	_	4	auxpass	_	_
3	also	_	ADV	RB	_	4	advmod	_	_
4	carried	_	VERB	VBN	_	0	root	_	_
5	out	_	PRON	PRP$	_	7	advmod	_	_
6	to	_	PRT	TO	_	7	mark	_	_
7	examine	_	VERB	VB	_	4	xcomp	_	_
8	the	_	DET	DT	_	10	det	_	_
9	time	_	NOUN	NN	_	10	compound	_	_
10	course	_	NOUN	NN	_	7	dobj	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	effects	_	NOUN	NNS	_	10	nmod	_	_
13	on	_	ADP	IN	_	14	case	_	_
14	memory	_	NOUN	NN	_	10	nmod	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	psychomotor	_	NOUN	NN	_	17	compound	_	_
17	function	_	NOUN	NN	_	14	conj	_	_
18	,	_	.	,	_	4	punct	_	_
19	and	_	CONJ	CC	_	4	cc	_	_
20	to	_	PRT	TO	_	21	mark	_	_
21	examine	_	VERB	VB	_	4	conj	_	_
22	withdrawal	_	NOUN	NN	_	23	compound	_	_
23	phenomena	_	NOUN	NN	_	21	dobj	_	_

#	ZALEPLON	6432
1	Transient	_	ADJ	JJ	_	4	amod	_	_
2	Insomnia	_	NOUN	NN	_	4	compound	_	_
3	Normal	_	ADJ	JJ	_	4	amod	_	_
4	adults	_	NOUN	NNS	_	17	nsubjpass	_	_
5	experiencing	_	VERB	VBG	_	4	acl	_	_
6	transient	_	ADJ	JJ	_	7	amod	_	_
7	insomnia	_	NOUN	NN	_	5	dobj	_	_
8	during	_	ADP	IN	_	10	case	_	_
9	the	_	DET	DT	_	10	det	_	_
10	first	_	ADJ	JJ	_	5	nmod	_	_
11	night	_	VERB	MD	_	17	aux	_	_
12	in	_	ADP	IN	_	15	case	_	_
13	a	_	DET	DT	_	15	det	_	_
14	sleep	_	NOUN	NN	_	15	compound	_	_
15	laboratory	_	NOUN	NN	_	17	nsubjpass	_	_
16	were	_	VERB	VBD	_	17	auxpass	_	_
17	evaluated	_	VERB	VBN	_	0	root	_	_
18	in	_	ADP	IN	_	21	case	_	_
19	a	_	DET	DT	_	21	det	_	_
20	double	_	ADJ	JJ	_	21	amod	_	_
21	blind	_	NOUN	NN	_	17	nmod	_	_
22	,	_	.	,	_	17	punct	_	_
23	parallel	_	ADJ	JJ	_	25	amod	_	_
24	group	_	NOUN	NN	_	25	compound	_	_
25	trial	_	NOUN	NN	_	17	dobj	_	_
26	comparing	_	VERB	VBG	_	25	acl	_	_
27	the	_	DET	DT	_	28	det	_	_
28	effects	_	NOUN	NNS	_	26	dobj	_	_
29	of	_	ADP	IN	_	31	case	_	_
30	two	_	NUM	CD	_	31	nummod	_	_
31	doses	_	NOUN	NNS	_	28	nmod	_	_
32	of	_	ADP	IN	_	35	case	_	_
33	DRUG	_	NOUN	NN	_	35	compound	_	_
34	5	_	NUM	CD	_	35	nummod	_	_
35	mg	_	NOUN	NN	_	31	nmod	_	_
36	and	_	CONJ	CC	_	31	cc	_	_
37	10	_	NUM	CD	_	38	nummod	_	_
38	mg	_	NOUN	NN	_	31	conj	_	_
39	with	_	ADP	IN	_	40	case	_	_
40	placebo	_	NOUN	NN	_	28	nmod	_	_

#	ZALEPLON	6433
1	DRUG	_	NOUN	NN	_	3	compound	_	_
2	10	_	NUM	CD	_	3	nummod	_	_
3	mg	_	NOUN	NN	_	11	nsubj	_	_
4	,	_	.	,	_	3	punct	_	_
5	but	_	CONJ	CC	_	6	cc	_	_
6	not	_	ADV	RB	_	3	cc	_	_
7	5	_	NUM	CD	_	8	nummod	_	_
8	mg	_	NOUN	NN	_	3	conj	_	_
9	,	_	.	,	_	3	punct	_	_
10	was	_	VERB	VBD	_	11	cop	_	_
11	superior	_	NOUN	NN	_	0	root	_	_
12	to	_	PRT	TO	_	13	case	_	_
13	placebo	_	NOUN	NN	_	11	nmod	_	_
14	in	_	ADP	IN	_	15	mark	_	_
15	decreasing	_	VERB	VBG	_	11	advcl	_	_
16	latency	_	NOUN	NN	_	15	dobj	_	_
17	to	_	PRT	TO	_	20	case	_	_
18	persistent	_	ADJ	JJ	_	20	amod	_	_
19	sleep	_	NOUN	NN	_	20	compound	_	_
20	LPS	_	NOUN	NN	_	15	nmod	_	_
21	,	_	.	,	_	11	punct	_	_
22	a	_	DET	DT	_	24	det	_	_
23	polysomnographic	_	ADJ	JJ	_	24	amod	_	_
24	measure	_	NOUN	NN	_	21	root	_	_
25	of	_	ADP	IN	_	26	case	_	_
26	time	_	NOUN	NN	_	24	nmod	_	_
27	to	_	PRT	TO	_	28	case	_	_
28	onset	_	NOUN	NN	_	24	nmod	_	_
29	of	_	ADP	IN	_	30	case	_	_
30	sleep	_	NOUN	NN	_	28	nmod	_	_

#	ZALEPLON	6434
1	Chronic	_	ADJ	JJ	_	5	amod	_	_
2	Insomnia	_	NOUN	NN	_	5	compound	_	_
3	Non	_	NOUN	NN	_	5	compound	_	_
4	elderly	_	ADJ	JJ	_	5	amod	_	_
5	patients	_	NOUN	NNS	_	0	root	_	_
6	:	_	.	:	_	5	punct	_	_
7	Adult	_	NOUN	NN	_	8	compound	_	_
8	outpatients	_	NOUN	NNS	_	13	nsubjpass	_	_
9	with	_	ADP	IN	_	11	case	_	_
10	chronic	_	ADJ	JJ	_	11	amod	_	_
11	insomnia	_	NOUN	NN	_	8	nmod	_	_
12	were	_	VERB	VBD	_	13	auxpass	_	_
13	evaluated	_	VERB	VBN	_	5	dep	_	_
14	in	_	ADP	IN	_	17	case	_	_
15	three	_	NUM	CD	_	17	nummod	_	_
16	double	_	ADJ	JJ	_	17	amod	_	_
17	blind	_	NOUN	NN	_	13	nmod	_	_
18	,	_	.	,	_	17	punct	_	_
19	parallel	_	ADJ	JJ	_	22	amod	_	_
20	group	_	NOUN	NN	_	22	compound	_	_
21	outpatient	_	ADJ	JJ	_	22	amod	_	_
22	studies	_	NOUN	NNS	_	17	conj	_	_
23	,	_	.	,	_	17	punct	_	_
24	one	_	NUM	CD	_	17	conj	_	_
25	of	_	ADP	IN	_	28	case	_	_
26	2	_	NUM	CD	_	28	nummod	_	_
27	weeks	_	NOUN	NN	_	28	compound	_	_
28	duration	_	NOUN	NN	_	24	nmod	_	_
29	and	_	CONJ	CC	_	17	cc	_	_
30	two	_	NUM	CD	_	32	compound	_	_
31	of	_	ADP	IN	_	32	advmod	_	_
32	4	_	NUM	CD	_	34	nummod	_	_
33	weeks	_	NOUN	NN	_	34	compound	_	_
34	duration	_	NOUN	NN	_	17	conj	_	_
35	,	_	.	,	_	17	punct	_	_
36	that	_	DET	WDT	_	37	nsubj	_	_
37	compared	_	VERB	VBD	_	17	acl:relcl	_	_
38	the	_	DET	DT	_	39	det	_	_
39	effects	_	NOUN	NNS	_	37	dobj	_	_
40	of	_	ADP	IN	_	41	case	_	_
41	DRUG	_	NOUN	NN	_	39	nmod	_	_
42	at	_	ADP	IN	_	43	case	_	_
43	doses	_	NOUN	NNS	_	39	nmod	_	_
44	of	_	ADP	IN	_	46	case	_	_
45	5	_	NUM	CD	_	46	nummod	_	_
46	mg	_	NOUN	NN	_	43	nmod	_	_
47	in	_	ADP	IN	_	49	case	_	_
48	two	_	NUM	CD	_	49	nummod	_	_
49	studies	_	NOUN	NNS	_	43	nmod	_	_
50	,	_	.	,	_	49	punct	_	_
51	10	_	NUM	CD	_	52	nummod	_	_
52	mg	_	NOUN	NN	_	49	conj	_	_
53	,	_	.	,	_	49	punct	_	_
54	and	_	CONJ	CC	_	49	cc	_	_
55	20	_	NUM	CD	_	56	nummod	_	_
56	mg	_	NOUN	NN	_	49	conj	_	_
57	with	_	ADP	IN	_	58	case	_	_
58	placebo	_	NOUN	NN	_	39	nmod	_	_
59	on	_	ADP	IN	_	62	case	_	_
60	a	_	DET	DT	_	62	det	_	_
61	subjective	_	ADJ	JJ	_	62	amod	_	_
62	measure	_	NOUN	NN	_	37	nmod	_	_
63	of	_	ADP	IN	_	64	case	_	_
64	time	_	NOUN	NN	_	62	nmod	_	_
65	to	_	PRT	TO	_	66	mark	_	_
66	sleep	_	VERB	VB	_	62	acl	_	_
67	onset	_	NOUN	NN	_	68	compound	_	_
68	TSO	_	NOUN	NN	_	66	dobj	_	_

#	ZALEPLON	6435
1	DRUG	_	NOUN	NN	_	3	compound	_	_
2	10	_	NUM	CD	_	3	nummod	_	_
3	mg	_	NOUN	NN	_	9	nsubj	_	_
4	and	_	CONJ	CC	_	3	cc	_	_
5	20	_	NUM	CD	_	6	nummod	_	_
6	mg	_	NOUN	NN	_	3	conj	_	_
7	were	_	VERB	VBD	_	9	cop	_	_
8	consistently	_	ADV	RB	_	9	advmod	_	_
9	superior	_	NOUN	NN	_	0	root	_	_
10	to	_	PRT	TO	_	11	case	_	_
11	placebo	_	NOUN	NN	_	9	nmod	_	_
12	for	_	ADP	IN	_	13	case	_	_
13	TSO	_	NOUN	NN	_	11	nmod	_	_
14	,	_	.	,	_	9	punct	_	_
15	generally	_	ADV	RB	_	19	advmod	_	_
16	for	_	ADP	IN	_	19	case	_	_
17	the	_	DET	DT	_	19	det	_	_
18	full	_	ADJ	JJ	_	19	amod	_	_
19	duration	_	NOUN	NN	_	9	nmod	_	_
20	of	_	ADP	IN	_	23	case	_	_
21	all	_	DET	DT	_	23	det	_	_
22	three	_	NUM	CD	_	23	nummod	_	_
23	studies	_	NOUN	NNS	_	19	nmod	_	_

#	ZALEPLON	6436
1	Although	_	ADP	IN	_	5	mark	_	_
2	both	_	DET	DT	_	3	det	_	_
3	doses	_	NOUN	NNS	_	5	nsubj	_	_
4	were	_	VERB	VBD	_	5	cop	_	_
5	effective	_	ADJ	JJ	_	10	advcl	_	_
6	,	_	.	,	_	10	punct	_	_
7	the	_	DET	DT	_	8	det	_	_
8	effect	_	NOUN	NN	_	10	nsubj	_	_
9	was	_	VERB	VBD	_	10	cop	_	_
10	greater	_	ADJ	JJ	_	0	root	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	more	_	ADV	RB	_	13	advmod	_	_
13	consistent	_	ADJ	JJ	_	10	conj	_	_
14	for	_	ADP	IN	_	18	case	_	_
15	the	_	DET	DT	_	18	det	_	_
16	20	_	NUM	CD	_	18	nummod	_	_
17	mg	_	NOUN	NN	_	18	compound	_	_
18	dose	_	NOUN	NN	_	13	nmod	_	_

#	ZALEPLON	6437
1	The	_	DET	DT	_	4	det	_	_
2	5	_	NUM	CD	_	4	nummod	_	_
3	mg	_	NOUN	NN	_	4	compound	_	_
4	dose	_	NOUN	NN	_	8	nsubj	_	_
5	was	_	VERB	VBD	_	8	cop	_	_
6	less	_	ADV	RB	_	8	advmod	_	_
7	consistently	_	ADV	RB	_	8	advmod	_	_
8	effective	_	ADJ	JJ	_	0	root	_	_
9	than	_	ADP	IN	_	13	mark	_	_
10	were	_	VERB	VBN	_	13	cop	_	_
11	the	_	DET	DT	_	13	det	_	_
12	10	_	NUM	CD	_	13	nummod	_	_
13	mg	_	NOUN	NN	_	8	nmod	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	20	_	NUM	CD	_	17	nummod	_	_
16	mg	_	NOUN	NN	_	17	compound	_	_
17	doses	_	NOUN	NNS	_	13	conj	_	_

#	ZALEPLON	6438
1	Sleep	_	NOUN	NN	_	2	compound	_	_
2	latency	_	NOUN	NN	_	13	nsubj	_	_
3	with	_	ADP	IN	_	6	case	_	_
4	DRUG	_	NOUN	NN	_	6	compound	_	_
5	10	_	NUM	CD	_	6	nummod	_	_
6	mg	_	NOUN	NN	_	2	nmod	_	_
7	and	_	CONJ	CC	_	2	cc	_	_
8	20	_	NUM	CD	_	9	nummod	_	_
9	mg	_	NOUN	NN	_	2	conj	_	_
10	was	_	VERB	VBD	_	13	cop	_	_
11	on	_	ADP	IN	_	13	case	_	_
12	the	_	DET	DT	_	13	det	_	_
13	order	_	NOUN	NN	_	0	root	_	_
14	of	_	ADP	IN	_	17	case	_	_
15	10	_	NUM	CD	_	17	nummod	_	_
16	20	_	NUM	CD	_	17	nummod	_	_
17	minutes	_	NOUN	NNS	_	13	nmod	_	_
18	15%	_	ADJ	JJ	_	19	amod	_	_
19	30%	_	NOUN	NN	_	17	dep	_	_
20	less	_	ADV	RB	_	17	advmod	_	_
21	than	_	ADP	IN	_	20	mwe	_	_
22	with	_	ADP	IN	_	23	case	_	_
23	placebo	_	NOUN	NN	_	20	nmod	_	_
24	in	_	ADP	IN	_	26	case	_	_
25	these	_	DET	DT	_	26	det	_	_
26	studies	_	NOUN	NNS	_	23	nmod	_	_

#	ZALEPLON	6439
1	Adult	_	ADJ	JJ	_	2	amod	_	_
2	outpatients	_	NOUN	NNS	_	7	nsubjpass	_	_
3	with	_	ADP	IN	_	5	case	_	_
4	chronic	_	ADJ	JJ	_	5	amod	_	_
5	insomnia	_	NOUN	NN	_	2	nmod	_	_
6	were	_	VERB	VBD	_	7	auxpass	_	_
7	evaluated	_	VERB	VBN	_	0	root	_	_
8	in	_	ADP	IN	_	11	case	_	_
9	six	_	NUM	CD	_	11	nummod	_	_
10	double	_	ADJ	JJ	_	11	amod	_	_
11	blind	_	NOUN	NN	_	7	nmod	_	_
12	,	_	.	,	_	11	punct	_	_
13	parallel	_	ADJ	JJ	_	17	amod	_	_
14	group	_	NOUN	NN	_	17	compound	_	_
15	sleep	_	NOUN	NN	_	17	compound	_	_
16	laboratory	_	ADJ	JJ	_	17	amod	_	_
17	studies	_	NOUN	NNS	_	26	nsubj	_	_
18	that	_	DET	WDT	_	19	nsubj	_	_
19	varied	_	VERB	VBD	_	17	acl:relcl	_	_
20	in	_	ADP	IN	_	21	case	_	_
21	duration	_	NOUN	NN	_	19	nmod	_	_
22	from	_	ADP	IN	_	24	case	_	_
23	a	_	DET	DT	_	24	det	_	_
24	single	_	NOUN	NN	_	21	nmod	_	_
25	night	_	VERB	MD	_	26	aux	_	_
26	up	_	ADV	RB	_	11	appos	_	_
27	to	_	PRT	TO	_	29	case	_	_
28	35	_	NUM	CD	_	29	nummod	_	_
29	nights	_	NOUN	NNS	_	26	nmod	_	_

#	ZALEPLON	6440
1	Overall	_	ADV	RB	_	5	advmod	_	_
2	,	_	.	,	_	5	punct	_	_
3	these	_	DET	DT	_	4	det	_	_
4	studies	_	NOUN	NNS	_	5	nsubj	_	_
5	demonstrated	_	VERB	VBD	_	0	root	_	_
6	a	_	DET	DT	_	7	det	_	_
7	superiority	_	NOUN	NN	_	5	dobj	_	_
8	of	_	ADP	IN	_	11	case	_	_
9	DRUG	_	NOUN	NN	_	11	compound	_	_
10	10	_	NUM	CD	_	11	nummod	_	_
11	mg	_	NOUN	NN	_	7	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	20	_	NUM	CD	_	14	nummod	_	_
14	mg	_	NOUN	NN	_	11	conj	_	_
15	over	_	ADP	IN	_	16	case	_	_
16	placebo	_	NOUN	NN	_	7	nmod	_	_
17	in	_	ADP	IN	_	18	mark	_	_
18	reducing	_	VERB	VBG	_	7	acl	_	_
19	LPS	_	NOUN	NN	_	18	dobj	_	_
20	on	_	ADP	IN	_	24	case	_	_
21	the	_	DET	DT	_	24	det	_	_
22	first	_	ADJ	JJ	_	24	amod	_	_
23	2	_	NUM	CD	_	24	nummod	_	_
24	nights	_	NOUN	NNS	_	18	nmod	_	_
25	of	_	ADP	IN	_	26	case	_	_
26	treatment	_	NOUN	NN	_	24	nmod	_	_

#	ZALEPLON	6441
1	At	_	ADP	IN	_	4	case	_	_
2	later	_	ADJ	JJ	_	4	amod	_	_
3	time	_	NOUN	NN	_	4	compound	_	_
4	points	_	NOUN	NNS	_	13	nmod	_	_
5	in	_	ADP	IN	_	6	case	_	_
6	5	_	NUM	CD	_	4	nmod	_	_
7	,	_	.	,	_	6	punct	_	_
8	14	_	NUM	CD	_	6	conj	_	_
9	,	_	.	,	_	6	punct	_	_
10	and	_	CONJ	CC	_	6	cc	_	_
11	28	_	NUM	CD	_	6	conj	_	_
12	night	_	VERB	VBD	_	13	aux	_	_
13	studies	_	NOUN	NNS	_	22	nmod	_	_
14	,	_	.	,	_	22	punct	_	_
15	a	_	DET	DT	_	16	det	_	_
16	reduction	_	NOUN	NN	_	22	nsubjpass	_	_
17	in	_	ADP	IN	_	18	case	_	_
18	LPS	_	NOUN	NN	_	16	nmod	_	_
19	from	_	ADP	IN	_	20	case	_	_
20	baseline	_	NOUN	NN	_	16	nmod	_	_
21	was	_	VERB	VBD	_	22	auxpass	_	_
22	observed	_	VERB	VBN	_	0	root	_	_
23	for	_	ADP	IN	_	26	case	_	_
24	all	_	DET	DT	_	26	det	_	_
25	treatment	_	NOUN	NN	_	26	compound	_	_
26	groups	_	NOUN	NNS	_	22	nmod	_	_
27	,	_	.	,	_	26	punct	_	_
28	including	_	VERB	VBG	_	31	case	_	_
29	the	_	DET	DT	_	31	det	_	_
30	placebo	_	NOUN	NN	_	31	compound	_	_
31	group	_	NOUN	NN	_	26	nmod	_	_
32	,	_	.	,	_	22	punct	_	_
33	and	_	CONJ	CC	_	22	cc	_	_
34	thus	_	ADV	RB	_	45	advmod	_	_
35	,	_	.	,	_	45	punct	_	_
36	a	_	DET	DT	_	38	det	_	_
37	significant	_	ADJ	JJ	_	38	amod	_	_
38	difference	_	NOUN	NN	_	45	nsubjpass	_	_
39	between	_	ADP	IN	_	40	case	_	_
40	DRUG	_	NOUN	NN	_	38	nmod	_	_
41	and	_	CONJ	CC	_	40	cc	_	_
42	placebo	_	NOUN	NN	_	40	conj	_	_
43	was	_	VERB	VBD	_	45	auxpass	_	_
44	not	_	ADV	RB	_	45	neg	_	_
45	seen	_	VERB	VBN	_	22	conj	_	_
46	beyond	_	ADP	IN	_	48	case	_	_
47	2	_	NUM	CD	_	48	nummod	_	_
48	nights	_	NOUN	NNS	_	45	nmod	_	_

#	ZALEPLON	6442
1	In	_	ADP	IN	_	5	case	_	_
2	a	_	DET	DT	_	5	det	_	_
3	35	_	NUM	CD	_	5	nummod	_	_
4	night	_	VERB	MD	_	5	compound	_	_
5	study	_	NOUN	NN	_	13	nmod	_	_
6	,	_	.	,	_	13	punct	_	_
7	DRUG	_	NOUN	NN	_	9	compound	_	_
8	10	_	NUM	CD	_	9	nummod	_	_
9	mg	_	NOUN	NN	_	13	nsubj	_	_
10	was	_	VERB	VBD	_	13	cop	_	_
11	significantly	_	ADV	RB	_	12	advmod	_	_
12	more	_	ADV	RB	_	13	advmod	_	_
13	effective	_	ADJ	JJ	_	0	root	_	_
14	than	_	ADP	IN	_	15	case	_	_
15	placebo	_	NOUN	NN	_	13	nmod	_	_
16	in	_	ADP	IN	_	17	mark	_	_
17	reducing	_	VERB	VBG	_	13	advcl	_	_
18	LPS	_	NOUN	NN	_	17	dobj	_	_
19	at	_	ADP	IN	_	23	case	_	_
20	the	_	DET	DT	_	23	det	_	_
21	primary	_	ADJ	JJ	_	23	amod	_	_
22	efficacy	_	NOUN	NN	_	23	compound	_	_
23	endpoint	_	NOUN	NN	_	17	nmod	_	_
24	on	_	ADP	IN	_	25	case	_	_
25	nights	_	NOUN	NNS	_	23	nmod	_	_
26	29	_	NUM	CD	_	25	nummod	_	_
27	and	_	CONJ	CC	_	26	cc	_	_
28	30	_	NUM	CD	_	26	conj	_	_

#	ZALEPLON	6443
1	Elderly	_	ADJ	JJ	_	2	amod	_	_
2	patients	_	NOUN	NNS	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	Elderly	_	ADJ	JJ	_	5	amod	_	_
5	outpatients	_	NOUN	NNS	_	10	nsubjpass	_	_
6	with	_	ADP	IN	_	8	case	_	_
7	chronic	_	ADJ	JJ	_	8	amod	_	_
8	insomnia	_	NOUN	NN	_	5	nmod	_	_
9	were	_	VERB	VBD	_	10	auxpass	_	_
10	evaluated	_	VERB	VBN	_	2	dep	_	_
11	in	_	ADP	IN	_	14	case	_	_
12	two	_	NUM	CD	_	14	nummod	_	_
13	2	_	NUM	CD	_	14	nummod	_	_
14	week	_	NOUN	NN	_	10	nmod	_	_
15	,	_	.	,	_	14	punct	_	_
16	double	_	ADJ	JJ	_	17	amod	_	_
17	blind	_	NOUN	NN	_	14	appos	_	_
18	,	_	.	,	_	14	punct	_	_
19	parallel	_	ADJ	JJ	_	22	amod	_	_
20	group	_	NOUN	NN	_	22	compound	_	_
21	outpatient	_	ADJ	JJ	_	22	amod	_	_
22	studies	_	NOUN	NNS	_	14	appos	_	_
23	that	_	DET	WDT	_	24	nsubj	_	_
24	compared	_	VERB	VBD	_	22	acl:relcl	_	_
25	the	_	DET	DT	_	26	det	_	_
26	effects	_	NOUN	NNS	_	24	dobj	_	_
27	of	_	ADP	IN	_	30	case	_	_
28	DRUG	_	NOUN	NN	_	30	compound	_	_
29	5	_	NUM	CD	_	30	nummod	_	_
30	mg	_	NOUN	NN	_	26	nmod	_	_
31	and	_	CONJ	CC	_	30	cc	_	_
32	10	_	NUM	CD	_	33	nummod	_	_
33	mg	_	NOUN	NN	_	30	conj	_	_
34	with	_	ADP	IN	_	35	case	_	_
35	placebo	_	NOUN	NN	_	26	nmod	_	_
36	on	_	ADP	IN	_	39	case	_	_
37	a	_	DET	DT	_	39	det	_	_
38	subjective	_	ADJ	JJ	_	39	amod	_	_
39	measure	_	NOUN	NN	_	24	nmod	_	_
40	of	_	ADP	IN	_	41	case	_	_
41	time	_	NOUN	NN	_	39	nmod	_	_
42	to	_	PRT	TO	_	43	mark	_	_
43	sleep	_	VERB	VB	_	39	acl	_	_
44	onset	_	NOUN	NN	_	45	compound	_	_
45	TSO	_	NOUN	NN	_	43	dobj	_	_

#	ZALEPLON	6444
1	DRUG	_	NOUN	NN	_	6	nsubj	_	_
2	at	_	ADP	IN	_	4	case	_	_
3	both	_	DET	DT	_	4	det	_	_
4	doses	_	NOUN	NNS	_	1	nmod	_	_
5	was	_	VERB	VBD	_	6	cop	_	_
6	superior	_	NOUN	NN	_	0	root	_	_
7	to	_	PRT	TO	_	8	case	_	_
8	placebo	_	NOUN	NN	_	6	nmod	_	_
9	on	_	ADP	IN	_	10	case	_	_
10	TSO	_	NOUN	NN	_	6	nmod	_	_
11	,	_	.	,	_	6	punct	_	_
12	generally	_	ADV	RB	_	16	advmod	_	_
13	for	_	ADP	IN	_	16	case	_	_
14	the	_	DET	DT	_	16	det	_	_
15	full	_	ADJ	JJ	_	16	amod	_	_
16	duration	_	NOUN	NN	_	6	nmod	_	_
17	of	_	ADP	IN	_	19	case	_	_
18	both	_	DET	DT	_	19	det	_	_
19	studies	_	NOUN	NNS	_	16	nmod	_	_
20	,	_	.	,	_	6	punct	_	_
21	with	_	ADP	IN	_	24	case	_	_
22	an	_	DET	DT	_	24	det	_	_
23	effect	_	NOUN	NN	_	24	compound	_	_
24	size	_	NOUN	NN	_	6	nmod	_	_
25	generally	_	ADV	RB	_	26	advmod	_	_
26	similar	_	ADJ	JJ	_	24	amod	_	_
27	to	_	PRT	TO	_	28	case	_	_
28	that	_	DET	WDT	_	26	nmod	_	_
29	seen	_	VERB	VBN	_	28	acl	_	_
30	in	_	ADP	IN	_	32	case	_	_
31	younger	_	ADJ	JJ	_	32	amod	_	_
32	persons	_	NOUN	NNS	_	29	nmod	_	_

#	ZALEPLON	6445
1	The	_	DET	DT	_	4	det	_	_
2	10	_	NUM	CD	_	4	nummod	_	_
3	mg	_	NOUN	NN	_	4	compound	_	_
4	dose	_	NOUN	NN	_	5	nsubj	_	_
5	tended	_	VERB	VBD	_	0	root	_	_
6	to	_	PRT	TO	_	7	mark	_	_
7	have	_	VERB	VB	_	5	xcomp	_	_
8	a	_	DET	DT	_	10	det	_	_
9	greater	_	ADJ	JJ	_	10	amod	_	_
10	effect	_	NOUN	NN	_	7	dobj	_	_
11	in	_	ADP	IN	_	12	mark	_	_
12	reducing	_	VERB	VBG	_	10	acl	_	_
13	TSO	_	NOUN	NN	_	12	dobj	_	_

#	ZALEPLON	6446
1	Elderly	_	ADJ	JJ	_	2	amod	_	_
2	outpatients	_	NOUN	NNS	_	8	nsubjpass	_	_
3	with	_	ADP	IN	_	5	case	_	_
4	chronic	_	ADJ	JJ	_	5	amod	_	_
5	insomnia	_	NOUN	NN	_	2	nmod	_	_
6	were	_	VERB	VBD	_	8	auxpass	_	_
7	also	_	ADV	RB	_	8	advmod	_	_
8	evaluated	_	VERB	VBN	_	0	root	_	_
9	in	_	ADP	IN	_	15	case	_	_
10	a	_	DET	DT	_	15	det	_	_
11	2	_	NUM	CD	_	15	nummod	_	_
12	night	_	VERB	MD	_	13	advmod	_	_
13	sleep	_	ADJ	JJ	_	15	amod	_	_
14	laboratory	_	ADJ	JJ	_	15	amod	_	_
15	study	_	NOUN	NN	_	8	nmod	_	_
16	involving	_	VERB	VBG	_	15	acl	_	_
17	doses	_	NOUN	NNS	_	16	dobj	_	_
18	of	_	ADP	IN	_	20	case	_	_
19	5	_	NUM	CD	_	20	nummod	_	_
20	mg	_	NOUN	NN	_	17	nmod	_	_
21	and	_	CONJ	CC	_	20	cc	_	_
22	10	_	NUM	CD	_	23	nummod	_	_
23	mg	_	NOUN	NN	_	20	conj	_	_

#	ZALEPLON	6447
1	Both	_	CONJ	CC	_	3	cc:preconj	_	_
2	5	_	NUM	CD	_	3	nummod	_	_
3	mg	_	NOUN	NN	_	11	nsubj	_	_
4	and	_	CONJ	CC	_	3	cc	_	_
5	10	_	NUM	CD	_	7	nummod	_	_
6	mg	_	NOUN	NN	_	7	compound	_	_
7	doses	_	NOUN	NNS	_	3	conj	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	3	nmod	_	_
10	were	_	VERB	VBD	_	11	cop	_	_
11	superior	_	NOUN	NN	_	0	root	_	_
12	to	_	PRT	TO	_	13	case	_	_
13	placebo	_	NOUN	NN	_	11	nmod	_	_
14	in	_	ADP	IN	_	15	mark	_	_
15	reducing	_	VERB	VBG	_	11	advcl	_	_
16	latency	_	NOUN	NN	_	15	dobj	_	_
17	to	_	PRT	TO	_	20	case	_	_
18	persistent	_	ADJ	JJ	_	20	amod	_	_
19	sleep	_	NOUN	NN	_	20	compound	_	_
20	LPS	_	NOUN	NN	_	15	nmod	_	_

#	ZALEPLON	6448
1	Generally	_	ADV	RB	_	4	advmod	_	_
2	in	_	ADP	IN	_	4	case	_	_
3	these	_	DET	DT	_	4	det	_	_
4	studies	_	NOUN	NNS	_	7	nmod	_	_
5	,	_	.	,	_	7	punct	_	_
6	there	_	DET	EX	_	7	expl	_	_
7	was	_	VERB	VBD	_	40	auxpass	_	_
8	a	_	DET	DT	_	10	det	_	_
9	slight	_	ADJ	JJ	_	10	amod	_	_
10	increase	_	NOUN	NN	_	7	nsubj	_	_
11	in	_	ADP	IN	_	13	case	_	_
12	sleep	_	NOUN	NN	_	13	compound	_	_
13	duration	_	NOUN	NN	_	10	nmod	_	_
14	,	_	.	,	_	7	punct	_	_
15	compared	_	VERB	VBN	_	7	conj	_	_
16	to	_	PRT	TO	_	17	case	_	_
17	baseline	_	NOUN	NN	_	15	nmod	_	_
18	,	_	.	,	_	7	punct	_	_
19	for	_	ADP	IN	_	22	case	_	_
20	all	_	DET	DT	_	22	det	_	_
21	treatment	_	NOUN	NN	_	22	compound	_	_
22	groups	_	NOUN	NNS	_	7	nmod	_	_
23	,	_	.	,	_	22	punct	_	_
24	including	_	VERB	VBG	_	25	case	_	_
25	placebo	_	NOUN	NN	_	22	nmod	_	_
26	,	_	.	,	_	7	punct	_	_
27	and	_	CONJ	CC	_	7	cc	_	_
28	thus	_	ADV	RB	_	7	advmod	_	_
29	,	_	.	,	_	40	punct	_	_
30	a	_	DET	DT	_	32	det	_	_
31	significant	_	ADJ	JJ	_	32	amod	_	_
32	difference	_	NOUN	NN	_	40	nsubjpass	_	_
33	from	_	ADP	IN	_	34	case	_	_
34	placebo	_	NOUN	NN	_	32	nmod	_	_
35	on	_	ADP	IN	_	37	case	_	_
36	sleep	_	NOUN	NN	_	37	compound	_	_
37	duration	_	NOUN	NN	_	32	nmod	_	_
38	was	_	VERB	VBD	_	40	auxpass	_	_
39	not	_	ADV	RB	_	40	neg	_	_
40	demonstrated	_	VERB	VBN	_	0	root	_	_

#	ZALEPLON	6449
1	Studies	_	NOUN	NNS	_	11	nsubj	_	_
2	Pertinent	_	ADJ	JJ	_	1	amod	_	_
3	to	_	PRT	TO	_	5	case	_	_
4	Safety	_	NOUN	NN	_	5	compound	_	_
5	Concerns	_	NOUN	NNS	_	2	nmod	_	_
6	for	_	ADP	IN	_	10	case	_	_
7	Sedative	_	ADJ	JJ	_	10	amod	_	_
8	/	_	.	:	_	10	punct	_	_
9	Hypnotic	_	ADJ	JJ	_	10	amod	_	_
10	Drugs	_	NOUN	NNS	_	5	nmod	_	_
11	Memory	_	VERB	VBP	_	0	root	_	_
12	Impairment	_	NOUN	NN	_	13	compound	_	_
13	Studies	_	NOUN	NNS	_	11	dobj	_	_
14	involving	_	VERB	VBG	_	13	acl	_	_
15	the	_	DET	DT	_	16	det	_	_
16	exposure	_	NOUN	NN	_	14	dobj	_	_
17	of	_	ADP	IN	_	19	case	_	_
18	normal	_	ADJ	JJ	_	19	amod	_	_
19	subjects	_	NOUN	NNS	_	16	nmod	_	_
20	to	_	PRT	TO	_	23	case	_	_
21	single	_	ADJ	JJ	_	23	amod	_	_
22	fixed	_	VERB	VBN	_	23	amod	_	_
23	doses	_	NOUN	NNS	_	16	nmod	_	_
24	of	_	ADP	IN	_	27	case	_	_
25	DRUG	_	NOUN	NN	_	27	compound	_	_
26	10	_	NUM	CD	_	27	nummod	_	_
27	mg	_	NOUN	NN	_	23	nmod	_	_
28	or	_	CONJ	CC	_	27	cc	_	_
29	20	_	NUM	CD	_	30	nummod	_	_
30	mg	_	NOUN	NN	_	27	conj	_	_
31	with	_	ADP	IN	_	33	case	_	_
32	structured	_	ADJ	JJ	_	33	amod	_	_
33	assessments	_	NOUN	NNS	_	16	nmod	_	_
34	of	_	ADP	IN	_	37	case	_	_
35	short	_	ADJ	JJ	_	37	amod	_	_
36	term	_	NOUN	NN	_	37	compound	_	_
37	memory	_	NOUN	NN	_	33	nmod	_	_
38	at	_	ADP	IN	_	40	case	_	_
39	fixed	_	VERB	VBN	_	40	amod	_	_
40	times	_	NOUN	NNS	_	16	nmod	_	_
41	after	_	ADP	IN	_	42	mark	_	_
42	dosing	_	NOUN	NN	_	14	advcl	_	_
43	eg	_	NOUN	NN	_	42	dobj	_	_
44	,	_	.	,	_	43	punct	_	_
45	1	_	NUM	CD	_	43	conj	_	_
46	,	_	.	,	_	43	punct	_	_
47	2	_	NUM	CD	_	43	conj	_	_
48	,	_	.	,	_	43	punct	_	_
49	3	_	NUM	CD	_	43	conj	_	_
50	,	_	.	,	_	43	punct	_	_
51	4	_	NUM	CD	_	43	conj	_	_
52	,	_	.	,	_	43	punct	_	_
53	5	_	NUM	CD	_	43	conj	_	_
54	,	_	.	,	_	43	punct	_	_
55	8	_	NUM	CD	_	43	conj	_	_
56	,	_	.	,	_	43	punct	_	_
57	and	_	CONJ	CC	_	43	cc	_	_
58	10	_	NUM	CD	_	43	conj	_	_
59	hours	_	NOUN	NNS	_	43	dep	_	_
60	generally	_	ADV	RB	_	61	advmod	_	_
61	revealed	_	VERB	VBD	_	11	advcl	_	_
62	the	_	DET	DT	_	64	det	_	_
63	expected	_	VERB	VBN	_	64	amod	_	_
64	impairment	_	NOUN	NN	_	61	dobj	_	_
65	of	_	ADP	IN	_	68	case	_	_
66	short	_	ADJ	JJ	_	68	amod	_	_
67	term	_	NOUN	NN	_	68	compound	_	_
68	memory	_	NOUN	NN	_	64	nmod	_	_
69	at	_	ADP	IN	_	71	case	_	_
70	1	_	NUM	CD	_	71	nummod	_	_
71	hour	_	NUM	CD	_	64	nmod	_	_
72	,	_	.	,	_	71	punct	_	_
73	the	_	DET	DT	_	74	det	_	_
74	time	_	NOUN	NN	_	71	appos	_	_
75	of	_	ADP	IN	_	77	case	_	_
76	peak	_	ADJ	JJ	_	77	amod	_	_
77	exposure	_	NOUN	NN	_	74	nmod	_	_
78	to	_	PRT	TO	_	79	case	_	_
79	DRUG	_	NOUN	NN	_	74	nmod	_	_
80	,	_	.	,	_	71	punct	_	_
81	for	_	ADP	IN	_	83	case	_	_
82	both	_	DET	DT	_	83	det	_	_
83	doses	_	NOUN	NNS	_	71	nmod	_	_
84	,	_	.	,	_	11	punct	_	_
85	with	_	ADP	IN	_	87	case	_	_
86	a	_	DET	DT	_	87	det	_	_
87	tendency	_	NOUN	NN	_	11	nmod	_	_
88	for	_	ADP	IN	_	90	case	_	_
89	the	_	DET	DT	_	90	det	_	_
90	effect	_	NOUN	NN	_	87	nmod	_	_
91	to	_	PRT	TO	_	93	mark	_	_
92	be	_	VERB	VB	_	93	cop	_	_
93	greater	_	ADJ	JJ	_	90	acl	_	_
94	after	_	ADP	IN	_	96	case	_	_
95	20	_	NUM	CD	_	96	nummod	_	_
96	mg	_	NOUN	NNS	_	93	nmod	_	_

#	ZALEPLON	6450
1	Consistent	_	ADJ	JJ	_	14	advmod	_	_
2	with	_	ADP	IN	_	5	case	_	_
3	the	_	DET	DT	_	5	det	_	_
4	rapid	_	ADJ	JJ	_	5	amod	_	_
5	clearance	_	NOUN	NN	_	1	nmod	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	,	_	.	,	_	14	punct	_	_
9	memory	_	NOUN	NN	_	10	compound	_	_
10	impairment	_	NOUN	NN	_	14	nsubj	_	_
11	was	_	VERB	VBD	_	14	cop	_	_
12	no	_	ADV	RB	_	14	neg	_	_
13	longer	_	ADV	RB	_	14	advmod	_	_
14	present	_	ADJ	JJ	_	0	root	_	_
15	as	_	ADV	RB	_	16	advmod	_	_
16	early	_	ADJ	JJ	_	14	advcl	_	_
17	as	_	ADP	IN	_	19	case	_	_
18	2	_	NUM	CD	_	19	nummod	_	_
19	hours	_	NOUN	NNS	_	16	nmod	_	_
20	post	_	ADJ	JJ	_	19	amod	_	_
21	dosing	_	NOUN	NN	_	20	advcl	_	_
22	in	_	ADP	IN	_	24	case	_	_
23	one	_	NUM	CD	_	24	nummod	_	_
24	study	_	NOUN	NN	_	21	nmod	_	_
25	,	_	.	,	_	14	punct	_	_
26	and	_	CONJ	CC	_	14	cc	_	_
27	in	_	ADP	IN	_	28	case	_	_
28	none	_	NOUN	NN	_	14	conj	_	_
29	of	_	ADP	IN	_	31	case	_	_
30	the	_	DET	DT	_	31	det	_	_
31	studies	_	NOUN	NNS	_	28	nmod	_	_
32	after	_	ADP	IN	_	35	case	_	_
33	3	_	NUM	CD	_	35	nummod	_	_
34	4	_	NUM	CD	_	35	nummod	_	_
35	hours	_	NOUN	NNS	_	28	nmod	_	_

#	ZALEPLON	6451
1	Nevertheless	_	ADV	RB	_	13	advmod	_	_
2	,	_	.	,	_	13	punct	_	_
3	spontaneous	_	ADJ	JJ	_	4	amod	_	_
4	reporting	_	NOUN	NN	_	13	nsubj	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	adverse	_	ADJ	JJ	_	7	amod	_	_
7	events	_	NOUN	NNS	_	4	nmod	_	_
8	in	_	ADP	IN	_	12	case	_	_
9	larger	_	ADJ	JJ	_	12	amod	_	_
10	premarketing	_	VERB	VBG	_	12	amod	_	_
11	clinical	_	ADJ	JJ	_	12	amod	_	_
12	trials	_	NOUN	NNS	_	4	nmod	_	_
13	revealed	_	VERB	VBD	_	0	root	_	_
14	a	_	DET	DT	_	15	det	_	_
15	difference	_	NOUN	NN	_	13	dobj	_	_
16	between	_	ADP	IN	_	17	case	_	_
17	DRUG	_	NOUN	NN	_	15	nmod	_	_
18	and	_	CONJ	CC	_	17	cc	_	_
19	placebo	_	NOUN	NN	_	17	conj	_	_
20	in	_	ADP	IN	_	22	case	_	_
21	the	_	DET	DT	_	22	det	_	_
22	risk	_	NOUN	NN	_	15	nmod	_	_
23	of	_	ADP	IN	_	27	case	_	_
24	next	_	ADV	RB	_	27	advmod	_	_
25	day	_	NOUN	NN	_	27	compound	_	_
26	amnesia	_	NOUN	NN	_	27	compound	_	_
27	3%	_	NOUN	NN	_	22	nmod	_	_
28	vs	_	CONJ	CC	_	27	cc	_	_
29	1%	_	NOUN	NN	_	27	conj	_	_
30	,	_	.	,	_	13	punct	_	_
31	and	_	CONJ	CC	_	13	cc	_	_
32	an	_	DET	DT	_	35	det	_	_
33	apparent	_	ADJ	JJ	_	35	amod	_	_
34	dose	_	NOUN	NN	_	35	compound	_	_
35	dependency	_	NOUN	NN	_	13	conj	_	_
36	for	_	ADP	IN	_	38	case	_	_
37	this	_	DET	DT	_	38	det	_	_
38	event	_	NOUN	NN	_	35	nmod	_	_

#	ZALEPLON	6452
1	Sedative	_	ADJ	JJ	_	5	amod	_	_
2	/	_	.	:	_	1	punct	_	_
3	Psychomotor	_	NOUN	NN	_	5	compound	_	_
4	Effects	_	NOUN	NNS	_	5	compound	_	_
5	Studies	_	NOUN	NNS	_	63	nsubj	_	_
6	involving	_	VERB	VBG	_	5	acl	_	_
7	the	_	DET	DT	_	8	det	_	_
8	exposure	_	NOUN	NN	_	6	dobj	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	normal	_	ADJ	JJ	_	11	amod	_	_
11	subjects	_	NOUN	NNS	_	8	nmod	_	_
12	to	_	PRT	TO	_	15	case	_	_
13	single	_	ADJ	JJ	_	15	amod	_	_
14	fixed	_	ADJ	JJ	_	15	amod	_	_
15	doses	_	NOUN	NNS	_	8	nmod	_	_
16	of	_	ADP	IN	_	19	case	_	_
17	DRUG	_	NOUN	NN	_	19	compound	_	_
18	10	_	NUM	CD	_	19	nummod	_	_
19	mg	_	NOUN	NN	_	15	nmod	_	_
20	or	_	CONJ	CC	_	19	cc	_	_
21	20	_	NUM	CD	_	22	nummod	_	_
22	mg	_	NOUN	NN	_	19	conj	_	_
23	with	_	ADP	IN	_	25	case	_	_
24	structured	_	ADJ	JJ	_	25	amod	_	_
25	assessments	_	NOUN	NNS	_	8	nmod	_	_
26	of	_	ADP	IN	_	27	case	_	_
27	sedation	_	NOUN	NN	_	25	nmod	_	_
28	and	_	CONJ	CC	_	27	cc	_	_
29	psychomotor	_	NOUN	NN	_	30	compound	_	_
30	function	_	NOUN	NN	_	27	conj	_	_
31	eg	_	NOUN	NN	_	30	dep	_	_
32	,	_	.	,	_	27	punct	_	_
33	reaction	_	NOUN	NN	_	34	compound	_	_
34	time	_	NOUN	NN	_	27	conj	_	_
35	and	_	CONJ	CC	_	27	cc	_	_
36	subjective	_	ADJ	JJ	_	37	amod	_	_
37	ratings	_	NOUN	NNS	_	27	conj	_	_
38	of	_	ADP	IN	_	39	case	_	_
39	alertness	_	NOUN	NN	_	37	nmod	_	_
40	at	_	ADP	IN	_	42	case	_	_
41	fixed	_	VERB	VBN	_	42	amod	_	_
42	times	_	NOUN	NNS	_	37	nmod	_	_
43	after	_	ADP	IN	_	44	mark	_	_
44	dosing	_	NOUN	NN	_	6	advcl	_	_
45	eg	_	NOUN	NN	_	44	dobj	_	_
46	,	_	.	,	_	45	punct	_	_
47	1	_	NUM	CD	_	45	conj	_	_
48	,	_	.	,	_	45	punct	_	_
49	2	_	NUM	CD	_	45	conj	_	_
50	,	_	.	,	_	45	punct	_	_
51	3	_	NUM	CD	_	45	conj	_	_
52	,	_	.	,	_	45	punct	_	_
53	4	_	NUM	CD	_	45	conj	_	_
54	,	_	.	,	_	45	punct	_	_
55	5	_	NUM	CD	_	45	conj	_	_
56	,	_	.	,	_	45	punct	_	_
57	8	_	NUM	CD	_	45	conj	_	_
58	,	_	.	,	_	45	punct	_	_
59	and	_	CONJ	CC	_	45	cc	_	_
60	10	_	NUM	CD	_	45	conj	_	_
61	hours	_	NOUN	NNS	_	45	dep	_	_
62	generally	_	ADV	RB	_	63	advmod	_	_
63	revealed	_	VERB	VBD	_	0	root	_	_
64	the	_	DET	DT	_	66	det	_	_
65	expected	_	VERB	VBN	_	66	amod	_	_
66	sedation	_	NOUN	NN	_	63	dobj	_	_
67	and	_	CONJ	CC	_	66	cc	_	_
68	impairment	_	NOUN	NN	_	66	conj	_	_
69	of	_	ADP	IN	_	71	case	_	_
70	psychomotor	_	NOUN	NN	_	71	compound	_	_
71	function	_	NOUN	NN	_	66	nmod	_	_
72	at	_	ADP	IN	_	74	case	_	_
73	1	_	NUM	CD	_	74	nummod	_	_
74	hour	_	NUM	CD	_	66	nmod	_	_
75	,	_	.	,	_	74	punct	_	_
76	the	_	DET	DT	_	77	det	_	_
77	time	_	NOUN	NN	_	74	appos	_	_
78	of	_	ADP	IN	_	80	case	_	_
79	peak	_	ADJ	JJ	_	80	amod	_	_
80	exposure	_	NOUN	NN	_	77	nmod	_	_
81	to	_	PRT	TO	_	82	case	_	_
82	DRUG	_	NOUN	NN	_	80	nmod	_	_
83	,	_	.	,	_	74	punct	_	_
84	for	_	ADP	IN	_	86	case	_	_
85	both	_	DET	DT	_	86	det	_	_
86	doses	_	NOUN	NNS	_	74	nmod	_	_

#	ZALEPLON	6453
1	Consistent	_	ADJ	JJ	_	16	advmod	_	_
2	with	_	ADP	IN	_	5	case	_	_
3	the	_	DET	DT	_	5	det	_	_
4	rapid	_	ADJ	JJ	_	5	amod	_	_
5	clearance	_	NOUN	NN	_	1	nmod	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	,	_	.	,	_	16	punct	_	_
9	impairment	_	NOUN	NN	_	16	nsubj	_	_
10	of	_	ADP	IN	_	12	case	_	_
11	psychomotor	_	NOUN	NN	_	12	compound	_	_
12	function	_	NOUN	NN	_	9	nmod	_	_
13	was	_	VERB	VBD	_	16	cop	_	_
14	no	_	ADV	RB	_	16	neg	_	_
15	longer	_	ADV	RB	_	16	advmod	_	_
16	present	_	ADJ	JJ	_	0	root	_	_
17	as	_	ADV	RB	_	18	advmod	_	_
18	early	_	ADJ	JJ	_	16	advcl	_	_
19	as	_	ADP	IN	_	21	case	_	_
20	2	_	NUM	CD	_	21	nummod	_	_
21	hours	_	NOUN	NNS	_	18	nmod	_	_
22	post	_	ADJ	JJ	_	21	amod	_	_
23	dosing	_	NOUN	NN	_	22	advcl	_	_
24	in	_	ADP	IN	_	26	case	_	_
25	one	_	NUM	CD	_	26	nummod	_	_
26	study	_	NOUN	NN	_	23	nmod	_	_
27	,	_	.	,	_	16	punct	_	_
28	and	_	CONJ	CC	_	16	cc	_	_
29	in	_	ADP	IN	_	30	case	_	_
30	none	_	NOUN	NN	_	16	conj	_	_
31	of	_	ADP	IN	_	33	case	_	_
32	the	_	DET	DT	_	33	det	_	_
33	studies	_	NOUN	NNS	_	30	nmod	_	_
34	after	_	ADP	IN	_	37	case	_	_
35	3	_	NUM	CD	_	37	nummod	_	_
36	4	_	NUM	CD	_	37	nummod	_	_
37	hours	_	NOUN	NNS	_	30	nmod	_	_

#	ZALEPLON	6454
1	Spontaneous	_	ADJ	JJ	_	2	amod	_	_
2	reporting	_	NOUN	NN	_	13	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	adverse	_	ADJ	JJ	_	5	amod	_	_
5	events	_	NOUN	NNS	_	2	nmod	_	_
6	in	_	ADP	IN	_	10	case	_	_
7	larger	_	ADJ	JJ	_	10	amod	_	_
8	premarketing	_	VERB	VBG	_	10	amod	_	_
9	clinical	_	ADJ	JJ	_	10	amod	_	_
10	trials	_	NOUN	NNS	_	2	nmod	_	_
11	did	_	VERB	VBD	_	13	aux	_	_
12	not	_	ADV	RB	_	13	neg	_	_
13	suggest	_	VERB	VB	_	0	root	_	_
14	a	_	DET	DT	_	15	det	_	_
15	difference	_	NOUN	NN	_	13	dobj	_	_
16	between	_	ADP	IN	_	17	case	_	_
17	DRUG	_	NOUN	NN	_	15	nmod	_	_
18	and	_	CONJ	CC	_	17	cc	_	_
19	placebo	_	NOUN	NN	_	17	conj	_	_
20	in	_	ADP	IN	_	22	case	_	_
21	the	_	DET	DT	_	22	det	_	_
22	risk	_	NOUN	NN	_	15	nmod	_	_
23	of	_	ADP	IN	_	26	case	_	_
24	next	_	ADV	RB	_	26	advmod	_	_
25	day	_	NOUN	NN	_	26	compound	_	_
26	somnolence	_	NOUN	NN	_	22	nmod	_	_

#	ZALEPLON	6455
1	Withdrawal	_	NOUN	NN	_	3	compound	_	_
2	Emergent	_	NOUN	NN	_	3	compound	_	_
3	Anxiety	_	NOUN	NN	_	8	nsubj	_	_
4	and	_	CONJ	CC	_	3	cc	_	_
5	Insomnia	_	NOUN	NN	_	6	compound	_	_
6	During	_	NOUN	NN	_	3	conj	_	_
7	nightly	_	ADV	RB	_	8	advmod	_	_
8	use	_	VERB	VBP	_	0	root	_	_
9	for	_	ADP	IN	_	12	case	_	_
10	an	_	DET	DT	_	12	det	_	_
11	extended	_	VERB	VBN	_	12	amod	_	_
12	period	_	NOUN	NN	_	8	nmod	_	_
13	,	_	.	,	_	8	punct	_	_
14	pharmacodynamic	_	ADJ	JJ	_	15	amod	_	_
15	tolerance	_	NOUN	NN	_	24	nsubj	_	_
16	or	_	CONJ	CC	_	15	cc	_	_
17	adaptation	_	NOUN	NN	_	15	conj	_	_
18	to	_	PRT	TO	_	20	case	_	_
19	some	_	DET	DT	_	20	det	_	_
20	effects	_	NOUN	NNS	_	15	nmod	_	_
21	of	_	ADP	IN	_	22	case	_	_
22	hypnotics	_	NOUN	NNS	_	20	nmod	_	_
23	may	_	VERB	MD	_	24	aux	_	_
24	develop	_	VERB	VB	_	8	parataxis	_	_

#	ZALEPLON	6456
1	If	_	ADP	IN	_	3	case	_	_
2	the	_	DET	DT	_	3	det	_	_
3	drug	_	NOUN	NN	_	4	nsubj	_	_
4	has	_	VERB	VBZ	_	13	advcl	_	_
5	a	_	DET	DT	_	9	det	_	_
6	short	_	ADJ	JJ	_	9	amod	_	_
7	elimination	_	NOUN	NN	_	9	compound	_	_
8	half	_	NOUN	NN	_	9	compound	_	_
9	life	_	NOUN	NN	_	4	dobj	_	_
10	,	_	.	,	_	13	punct	_	_
11	it	_	PRON	PRP	_	13	nsubj	_	_
12	is	_	VERB	VBZ	_	13	cop	_	_
13	possible	_	ADJ	JJ	_	0	root	_	_
14	that	_	ADP	IN	_	34	mark	_	_
15	a	_	DET	DT	_	17	det	_	_
16	relative	_	ADJ	JJ	_	17	amod	_	_
17	deficiency	_	NOUN	NN	_	34	nsubj	_	_
18	of	_	ADP	IN	_	20	case	_	_
19	the	_	DET	DT	_	20	det	_	_
20	drug	_	NOUN	NN	_	17	nmod	_	_
21	or	_	CONJ	CC	_	20	cc	_	_
22	its	_	PRON	PRP$	_	24	nmod:poss	_	_
23	active	_	ADJ	JJ	_	24	amod	_	_
24	metabolites	_	NOUN	NNS	_	20	conj	_	_
25	ie	_	ADV	RB	_	34	advmod	_	_
26	,	_	.	,	_	34	punct	_	_
27	in	_	ADP	IN	_	28	case	_	_
28	relationship	_	NOUN	NN	_	34	nmod	_	_
29	to	_	PRT	TO	_	32	case	_	_
30	the	_	DET	DT	_	32	det	_	_
31	receptor	_	NOUN	NN	_	32	compound	_	_
32	site	_	NOUN	NN	_	28	nmod	_	_
33	may	_	VERB	MD	_	34	aux	_	_
34	occur	_	VERB	VB	_	13	ccomp	_	_
35	at	_	ADP	IN	_	37	case	_	_
36	some	_	DET	DT	_	37	det	_	_
37	point	_	NOUN	NN	_	34	nmod	_	_
38	in	_	ADP	IN	_	40	case	_	_
39	the	_	DET	DT	_	40	det	_	_
40	interval	_	ADJ	JJ	_	37	nmod	_	_
41	between	_	ADP	IN	_	43	case	_	_
42	each	_	DET	DT	_	43	det	_	_
43	night's	_	NOUN	NNS	_	40	nmod	_	_
44	use	_	VERB	VBP	_	34	parataxis	_	_

#	ZALEPLON	6457
1	This	_	DET	DT	_	2	det	_	_
2	sequence	_	NOUN	NN	_	6	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	events	_	NOUN	NNS	_	2	nmod	_	_
5	is	_	VERB	VBZ	_	6	auxpass	_	_
6	believed	_	VERB	VBN	_	0	root	_	_
7	to	_	PRT	TO	_	9	mark	_	_
8	be	_	VERB	VB	_	9	cop	_	_
9	responsible	_	ADJ	JJ	_	6	xcomp	_	_
10	for	_	ADP	IN	_	13	case	_	_
11	two	_	NUM	CD	_	13	nummod	_	_
12	clinical	_	ADJ	JJ	_	13	amod	_	_
13	findings	_	NOUN	NNS	_	9	nmod	_	_
14	reported	_	VERB	VBN	_	13	acl	_	_
15	to	_	PRT	TO	_	16	mark	_	_
16	occur	_	VERB	VB	_	14	xcomp	_	_
17	after	_	ADP	IN	_	19	case	_	_
18	several	_	ADJ	JJ	_	19	amod	_	_
19	weeks	_	NOUN	NNS	_	16	nmod	_	_
20	of	_	ADP	IN	_	22	case	_	_
21	nightly	_	ADV	RB	_	22	advmod	_	_
22	use	_	NOUN	NN	_	19	nmod	_	_
23	of	_	ADP	IN	_	27	case	_	_
24	other	_	ADJ	JJ	_	27	amod	_	_
25	rapidly	_	ADV	RB	_	26	advmod	_	_
26	eliminated	_	VERB	VBN	_	27	amod	_	_
27	hypnotics	_	NOUN	NNS	_	22	nmod	_	_
28	:	_	.	:	_	6	punct	_	_
29	increased	_	VERB	VBN	_	30	amod	_	_
30	wakefulness	_	NOUN	NN	_	6	parataxis	_	_
31	during	_	ADP	IN	_	34	case	_	_
32	the	_	DET	DT	_	34	det	_	_
33	last	_	ADJ	JJ	_	34	amod	_	_
34	quarter	_	NOUN	NN	_	30	nmod	_	_
35	of	_	ADP	IN	_	37	case	_	_
36	the	_	DET	DT	_	37	det	_	_
37	night	_	VERB	MD	_	34	nmod	_	_
38	and	_	CONJ	CC	_	30	cc	_	_
39	the	_	DET	DT	_	40	det	_	_
40	appearance	_	NOUN	NN	_	30	conj	_	_
41	of	_	ADP	IN	_	43	case	_	_
42	increased	_	VERB	VBN	_	43	amod	_	_
43	signs	_	NOUN	NNS	_	40	nmod	_	_
44	of	_	ADP	IN	_	46	case	_	_
45	daytime	_	ADJ	JJ	_	46	amod	_	_
46	anxiety	_	NOUN	NN	_	43	nmod	_	_

#	ZALEPLON	6458
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	has	_	VERB	VBZ	_	0	root	_	_
3	a	_	DET	DT	_	6	det	_	_
4	short	_	ADJ	JJ	_	6	amod	_	_
5	half	_	NOUN	NN	_	6	compound	_	_
6	life	_	NOUN	NN	_	2	dobj	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	no	_	DET	DT	_	10	neg	_	_
9	active	_	ADJ	JJ	_	10	amod	_	_
10	metabolites	_	NOUN	NNS	_	6	conj	_	_

#	ZALEPLON	6459
1	At	_	ADP	IN	_	6	case	_	_
2	the	_	DET	DT	_	6	det	_	_
3	primary	_	ADJ	JJ	_	6	amod	_	_
4	efficacy	_	NOUN	NN	_	6	compound	_	_
5	endpoint	_	NOUN	NN	_	6	compound	_	_
6	nights	_	NOUN	NNS	_	14	nsubj	_	_
7	29	_	NUM	CD	_	6	dep	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	30	_	NUM	CD	_	7	conj	_	_
10	in	_	ADP	IN	_	12	case	_	_
11	a	_	DET	DT	_	12	det	_	_
12	35	_	NUM	CD	_	6	nmod	_	_
13	night	_	VERB	MD	_	14	aux	_	_
14	sleep	_	VERB	VB	_	20	advcl	_	_
15	laboratory	_	ADJ	JJ	_	16	amod	_	_
16	study	_	NOUN	NN	_	14	dobj	_	_
17	,	_	.	,	_	20	punct	_	_
18	polysomnographic	_	ADJ	JJ	_	19	amod	_	_
19	recordings	_	NOUN	NNS	_	20	nsubj	_	_
20	showed	_	VERB	VBD	_	0	root	_	_
21	that	_	ADP	IN	_	26	mark	_	_
22	wakefulness	_	NOUN	NN	_	26	nsubj	_	_
23	was	_	VERB	VBD	_	26	cop	_	_
24	not	_	ADV	RB	_	26	neg	_	_
25	significantly	_	ADV	RB	_	26	advmod	_	_
26	longer	_	ADV	RB	_	20	ccomp	_	_
27	with	_	ADP	IN	_	28	case	_	_
28	DRUG	_	NOUN	NN	_	26	nmod	_	_
29	than	_	ADP	IN	_	31	case	_	_
30	with	_	ADP	IN	_	31	case	_	_
31	placebo	_	NOUN	NN	_	38	case	_	_
32	during	_	ADP	IN	_	35	case	_	_
33	the	_	DET	DT	_	35	det	_	_
34	last	_	ADJ	JJ	_	35	amod	_	_
35	quarter	_	NOUN	NN	_	31	nmod	_	_
36	of	_	ADP	IN	_	37	case	_	_
37	the	_	DET	DT	_	35	nmod	_	_
38	night	_	VERB	MD	_	26	dep	_	_

#	ZALEPLON	6460
1	No	_	DET	DT	_	2	neg	_	_
2	increase	_	NOUN	NN	_	10	nsubjpass	_	_
3	in	_	ADP	IN	_	5	case	_	_
4	the	_	DET	DT	_	5	det	_	_
5	signs	_	NOUN	NNS	_	2	nmod	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	daytime	_	ADJ	JJ	_	8	amod	_	_
8	anxiety	_	NOUN	NN	_	5	nmod	_	_
9	was	_	VERB	VBD	_	10	auxpass	_	_
10	observed	_	VERB	VBN	_	0	root	_	_
11	in	_	ADP	IN	_	13	case	_	_
12	clinical	_	ADJ	JJ	_	13	amod	_	_
13	trials	_	NOUN	NNS	_	10	nmod	_	_
14	with	_	ADP	IN	_	15	case	_	_
15	DRUG	_	NOUN	NN	_	13	nmod	_	_

#	ZALEPLON	6461
1	In	_	ADP	IN	_	5	case	_	_
2	two	_	NUM	CD	_	5	nummod	_	_
3	sleep	_	NOUN	NN	_	5	compound	_	_
4	laboratory	_	NOUN	NN	_	5	amod	_	_
5	studies	_	NOUN	NNS	_	44	nmod	_	_
6	involving	_	VERB	VBG	_	5	acl	_	_
7	14	_	NUM	CD	_	11	nummod	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	28	_	NUM	CD	_	7	conj	_	_
10	nightly	_	ADV	RB	_	11	amod	_	_
11	doses	_	NOUN	NNS	_	6	dobj	_	_
12	of	_	ADP	IN	_	15	case	_	_
13	DRUG	_	NOUN	NN	_	15	compound	_	_
14	5	_	NUM	CD	_	15	nummod	_	_
15	mg	_	NOUN	NN	_	11	nmod	_	_
16	and	_	CONJ	CC	_	11	cc	_	_
17	10	_	NUM	CD	_	18	nummod	_	_
18	mg	_	NOUN	NN	_	11	conj	_	_
19	in	_	ADP	IN	_	21	case	_	_
20	one	_	NUM	CD	_	21	nummod	_	_
21	study	_	NOUN	NN	_	6	nmod	_	_
22	and	_	CONJ	CC	_	21	cc	_	_
23	10	_	NUM	CD	_	24	nummod	_	_
24	mg	_	NOUN	NN	_	21	conj	_	_
25	and	_	CONJ	CC	_	24	cc	_	_
26	20	_	NUM	CD	_	27	nummod	_	_
27	mg	_	NOUN	NN	_	24	conj	_	_
28	in	_	ADP	IN	_	33	case	_	_
29	the	_	DET	DT	_	33	det	_	_
30	second	_	ADJ	JJ	_	33	amod	_	_
31	and	_	CONJ	CC	_	30	cc	_	_
32	structured	_	ADJ	JJ	_	30	conj	_	_
33	assessments	_	NOUN	NNS	_	6	nmod	_	_
34	of	_	ADP	IN	_	36	case	_	_
35	daytime	_	ADJ	JJ	_	36	amod	_	_
36	anxiety	_	NOUN	NN	_	33	nmod	_	_
37	,	_	.	,	_	44	punct	_	_
38	no	_	DET	DT	_	39	neg	_	_
39	increases	_	NOUN	NNS	_	44	nsubjpass	_	_
40	in	_	ADP	IN	_	42	case	_	_
41	daytime	_	ADJ	JJ	_	42	amod	_	_
42	anxiety	_	NOUN	NN	_	39	nmod	_	_
43	were	_	VERB	VBD	_	44	auxpass	_	_
44	detected	_	VERB	VBN	_	0	root	_	_

#	ZALEPLON	6462
1	Similarly	_	ADV	RB	_	0	root	_	_
2	,	_	.	,	_	1	punct	_	_
3	in	_	ADP	IN	_	6	case	_	_
4	a	_	DET	DT	_	6	det	_	_
5	pooled	_	VERB	VBN	_	6	amod	_	_
6	analysis	_	NOUN	NN	_	2	root	_	_
7	all	_	CONJ	CC	_	10	cc:preconj	_	_
8	the	_	DET	DT	_	10	det	_	_
9	parallel	_	ADJ	JJ	_	10	amod	_	_
10	group	_	NOUN	NN	_	6	dep	_	_
11	,	_	.	,	_	10	punct	_	_
12	placebo	_	NOUN	NN	_	14	compound	_	_
13	controlled	_	VERB	VBD	_	14	amod	_	_
14	studies	_	NOUN	NNS	_	10	appos	_	_
15	of	_	ADP	IN	_	19	case	_	_
16	spontaneously	_	ADV	RB	_	17	advmod	_	_
17	reported	_	VERB	VBN	_	19	amod	_	_
18	daytime	_	ADJ	JJ	_	19	amod	_	_
19	anxiety	_	NOUN	NN	_	14	nmod	_	_
20	,	_	.	,	_	10	punct	_	_
21	no	_	DET	DT	_	22	neg	_	_
22	difference	_	NOUN	NN	_	24	nsubjpass	_	_
23	was	_	VERB	VBD	_	24	auxpass	_	_
24	observed	_	VERB	VBN	_	10	dep	_	_
25	between	_	ADP	IN	_	26	case	_	_
26	DRUG	_	NOUN	NN	_	24	nmod	_	_
27	and	_	CONJ	CC	_	26	cc	_	_
28	placebo	_	NOUN	NN	_	26	conj	_	_

#	ZALEPLON	6463
1	Rebound	_	ADJ	JJ	_	2	amod	_	_
2	insomnia	_	NOUN	NN	_	24	nsubj	_	_
3	,	_	.	,	_	2	punct	_	_
4	defined	_	VERB	VBN	_	2	acl	_	_
5	as	_	ADP	IN	_	10	case	_	_
6	a	_	DET	DT	_	10	det	_	_
7	dose	_	NOUN	NN	_	10	compound	_	_
8	dependent	_	ADJ	JJ	_	10	amod	_	_
9	temporary	_	ADJ	JJ	_	10	amod	_	_
10	worsening	_	NOUN	NN	_	4	nmod	_	_
11	in	_	ADP	IN	_	13	case	_	_
12	sleep	_	NOUN	NN	_	13	compound	_	_
13	parameters	_	NOUN	NNS	_	10	nmod	_	_
14	latency	_	NOUN	NN	_	13	dep	_	_
15	,	_	.	,	_	14	punct	_	_
16	total	_	ADJ	JJ	_	18	amod	_	_
17	sleep	_	NOUN	NN	_	18	compound	_	_
18	time	_	NOUN	NN	_	14	conj	_	_
19	,	_	.	,	_	14	punct	_	_
20	and	_	CONJ	CC	_	14	cc	_	_
21	number	_	NOUN	NN	_	14	conj	_	_
22	of	_	ADP	IN	_	23	case	_	_
23	awakenings	_	NOUN	NNS	_	21	nmod	_	_
24	compared	_	VERB	VBD	_	0	root	_	_
25	to	_	PRT	TO	_	26	case	_	_
26	baseline	_	NOUN	NN	_	24	nmod	_	_
27	following	_	ADP	IN	_	28	case	_	_
28	discontinuation	_	NOUN	NN	_	24	nmod	_	_
29	of	_	ADP	IN	_	30	case	_	_
30	treatment	_	NOUN	NN	_	28	nmod	_	_
31	,	_	.	,	_	24	punct	_	_
32	is	_	VERB	VBZ	_	33	auxpass	_	_
33	observed	_	VERB	VBN	_	24	parataxis	_	_
34	with	_	ADP	IN	_	39	case	_	_
35	short	_	ADJ	JJ	_	39	amod	_	_
36	and	_	CONJ	CC	_	35	cc	_	_
37	intermediate	_	ADJ	JJ	_	35	conj	_	_
38	acting	_	VERB	VBG	_	39	compound	_	_
39	hypnotics	_	NOUN	NNS	_	33	nmod	_	_

#	ZALEPLON	6464
1	Rebound	_	ADJ	JJ	_	2	amod	_	_
2	insomnia	_	NOUN	NN	_	11	nsubjpass	_	_
3	following	_	VERB	VBG	_	4	case	_	_
4	discontinuation	_	NOUN	NN	_	2	nmod	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	relative	_	ADJ	JJ	_	4	amod	_	_
8	to	_	PRT	TO	_	9	case	_	_
9	baseline	_	NOUN	NN	_	7	nmod	_	_
10	was	_	VERB	VBD	_	11	auxpass	_	_
11	examined	_	VERB	VBN	_	0	root	_	_
12	at	_	ADP	IN	_	14	case	_	_
13	both	_	CONJ	CC	_	14	cc:preconj	_	_
14	nights	_	NOUN	NNS	_	11	nmod	_	_
15	1	_	NUM	CD	_	14	nummod	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	2	_	NUM	CD	_	15	conj	_	_
18	following	_	VERB	VBG	_	19	case	_	_
19	discontinuation	_	NOUN	NN	_	14	nmod	_	_
20	in	_	ADP	IN	_	24	case	_	_
21	three	_	NUM	CD	_	24	nummod	_	_
22	sleep	_	NOUN	NN	_	24	compound	_	_
23	laboratory	_	NOUN	NN	_	24	amod	_	_
24	studies	_	NOUN	NNS	_	19	nmod	_	_
25	14	_	NUM	CD	_	24	nummod	_	_
26	,	_	.	,	_	24	punct	_	_
27	28	_	NUM	CD	_	24	conj	_	_
28	,	_	.	,	_	24	punct	_	_
29	and	_	CONJ	CC	_	24	cc	_	_
30	35	_	NUM	CD	_	31	nummod	_	_
31	nights	_	NOUN	NNS	_	24	conj	_	_
32	and	_	CONJ	CC	_	31	cc	_	_
33	five	_	NUM	CD	_	35	nummod	_	_
34	outpatient	_	ADJ	JJ	_	35	amod	_	_
35	studies	_	NOUN	NNS	_	31	conj	_	_
36	utilizing	_	VERB	VBG	_	35	acl	_	_
37	patient	_	NOUN	NN	_	38	compound	_	_
38	diaries	_	NOUN	NNS	_	36	dobj	_	_
39	14	_	NUM	CD	_	38	nummod	_	_
40	and	_	CONJ	CC	_	38	cc	_	_
41	28	_	NUM	CD	_	42	nummod	_	_
42	nights	_	NOUN	NNS	_	38	conj	_	_

#	ZALEPLON	6465
1	Overall	_	ADV	RB	_	5	advmod	_	_
2	,	_	.	,	_	5	punct	_	_
3	the	_	DET	DT	_	4	det	_	_
4	data	_	NOUN	NNS	_	5	nsubj	_	_
5	suggest	_	VERB	VBP	_	0	root	_	_
6	that	_	ADP	IN	_	12	mark	_	_
7	rebound	_	ADJ	JJ	_	8	amod	_	_
8	insomnia	_	NOUN	NN	_	12	nsubj	_	_
9	may	_	VERB	MD	_	12	aux	_	_
10	be	_	VERB	VB	_	12	cop	_	_
11	dose	_	NOUN	NN	_	12	nmod:npmod	_	_
12	dependent	_	ADJ	JJ	_	5	ccomp	_	_

#	ZALEPLON	6466
1	At	_	ADP	IN	_	3	case	_	_
2	20	_	NUM	CD	_	3	nummod	_	_
3	mg	_	NOUN	NN	_	6	nmod	_	_
4	,	_	.	,	_	6	punct	_	_
5	there	_	DET	EX	_	6	nsubj	_	_
6	appeared	_	VERB	VBD	_	0	root	_	_
7	to	_	PRT	TO	_	11	mark	_	_
8	be	_	VERB	VB	_	11	cop	_	_
9	both	_	CONJ	CC	_	11	cc:preconj	_	_
10	objective	_	ADJ	JJ	_	11	amod	_	_
11	polysomnographic	_	ADJ	JJ	_	6	xcomp	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	subjective	_	ADJ	JJ	_	11	conj	_	_
14	diary	_	ADJ	JJ	_	15	amod	_	_
15	evidence	_	NOUN	NN	_	11	dep	_	_
16	of	_	ADP	IN	_	18	case	_	_
17	rebound	_	ADJ	JJ	_	18	amod	_	_
18	insomnia	_	NOUN	NN	_	11	nmod	_	_
19	on	_	ADP	IN	_	21	case	_	_
20	the	_	DET	DT	_	21	det	_	_
21	first	_	ADJ	JJ	_	11	nmod	_	_
22	night	_	VERB	MD	_	6	dep	_	_
23	after	_	ADP	IN	_	24	case	_	_
24	discontinuation	_	NOUN	NN	_	22	nmod	_	_
25	of	_	ADP	IN	_	26	case	_	_
26	treatment	_	NOUN	NN	_	24	nmod	_	_
27	with	_	ADP	IN	_	28	case	_	_
28	DRUG	_	NOUN	NN	_	26	nmod	_	_

#	ZALEPLON	6467
1	At	_	ADP	IN	_	3	case	_	_
2	5	_	NUM	CD	_	3	nummod	_	_
3	mg	_	NOUN	NN	_	9	nmod	_	_
4	and	_	CONJ	CC	_	3	cc	_	_
5	10	_	NUM	CD	_	6	nummod	_	_
6	mg	_	NOUN	NN	_	3	conj	_	_
7	,	_	.	,	_	9	punct	_	_
8	there	_	DET	EX	_	9	expl	_	_
9	was	_	VERB	VBD	_	0	root	_	_
10	no	_	DET	DT	_	15	neg	_	_
11	objective	_	ADJ	JJ	_	15	amod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	minimal	_	ADJ	JJ	_	11	conj	_	_
14	subjective	_	ADJ	JJ	_	15	amod	_	_
15	evidence	_	NOUN	NN	_	9	nsubj	_	_
16	of	_	ADP	IN	_	18	case	_	_
17	rebound	_	ADJ	JJ	_	18	amod	_	_
18	insomnia	_	NOUN	NN	_	15	nmod	_	_
19	on	_	ADP	IN	_	21	case	_	_
20	the	_	DET	DT	_	21	det	_	_
21	first	_	ADJ	JJ	_	9	nmod	_	_
22	night	_	VERB	MD	_	9	dep	_	_
23	after	_	ADP	IN	_	24	case	_	_
24	discontinuation	_	NOUN	NN	_	22	nmod	_	_
25	of	_	ADP	IN	_	26	case	_	_
26	treatment	_	NOUN	NN	_	24	nmod	_	_
27	with	_	ADP	IN	_	28	case	_	_
28	DRUG	_	NOUN	NN	_	26	nmod	_	_

#	ZALEPLON	6468
1	At	_	ADP	IN	_	3	case	_	_
2	all	_	DET	DT	_	3	det	_	_
3	doses	_	NOUN	NNS	_	8	nmod	_	_
4	,	_	.	,	_	8	punct	_	_
5	the	_	DET	DT	_	7	det	_	_
6	rebound	_	ADJ	JJ	_	7	amod	_	_
7	effect	_	NOUN	NN	_	8	nsubj	_	_
8	appeared	_	VERB	VBD	_	0	root	_	_
9	to	_	PRT	TO	_	10	mark	_	_
10	resolve	_	VERB	VB	_	8	xcomp	_	_
11	by	_	ADP	IN	_	13	case	_	_
12	the	_	DET	DT	_	13	det	_	_
13	second	_	ADJ	JJ	_	10	nmod	_	_
14	night	_	VERB	MD	_	8	dep	_	_
15	following	_	VERB	VBG	_	16	case	_	_
16	withdrawal	_	NOUN	NN	_	14	nmod	_	_

#	ZALEPLON	6469
1	In	_	ADP	IN	_	5	case	_	_
2	the	_	DET	DT	_	5	det	_	_
3	35	_	NUM	CD	_	5	nummod	_	_
4	night	_	VERB	MD	_	5	compound	_	_
5	study	_	NOUN	NN	_	8	nmod	_	_
6	,	_	.	,	_	8	punct	_	_
7	there	_	DET	EX	_	8	expl	_	_
8	was	_	VERB	VBD	_	0	root	_	_
9	a	_	DET	DT	_	10	det	_	_
10	worsening	_	NOUN	NN	_	27	nsubj	_	_
11	in	_	ADP	IN	_	12	case	_	_
12	sleep	_	NOUN	NN	_	10	nmod	_	_
13	on	_	ADP	IN	_	15	case	_	_
14	the	_	DET	DT	_	15	det	_	_
15	first	_	ADJ	JJ	_	10	nmod	_	_
16	night	_	VERB	MD	_	27	aux	_	_
17	off	_	DET	DT	_	27	nsubj	_	_
18	for	_	ADP	IN	_	22	case	_	_
19	both	_	CONJ	CC	_	22	cc:preconj	_	_
20	the	_	DET	DT	_	22	det	_	_
21	10	_	NUM	CD	_	22	nummod	_	_
22	mg	_	NOUN	NN	_	17	nmod	_	_
23	and	_	CONJ	CC	_	22	cc	_	_
24	20	_	NUM	CD	_	26	nummod	_	_
25	mg	_	NOUN	NN	_	26	compound	_	_
26	groups	_	NOUN	NNS	_	22	conj	_	_
27	compared	_	VERB	VBD	_	8	xcomp	_	_
28	to	_	PRT	TO	_	29	case	_	_
29	placebo	_	NOUN	NN	_	27	nmod	_	_
30	,	_	.	,	_	29	punct	_	_
31	but	_	CONJ	CC	_	32	cc	_	_
32	not	_	ADV	RB	_	29	cc	_	_
33	to	_	PRT	TO	_	34	case	_	_
34	baseline	_	NOUN	NN	_	29	conj	_	_

#	ZALEPLON	6470
1	This	_	DET	DT	_	4	det	_	_
2	discontinuation	_	NOUN	NN	_	4	compound	_	_
3	emergent	_	ADJ	JJ	_	4	amod	_	_
4	effect	_	NOUN	NN	_	6	nsubj	_	_
5	was	_	VERB	VBD	_	6	cop	_	_
6	mild	_	ADJ	JJ	_	0	root	_	_
7	,	_	.	,	_	6	punct	_	_
8	had	_	VERB	VBD	_	6	conj	_	_
9	the	_	DET	DT	_	10	det	_	_
10	characteristics	_	NOUN	NNS	_	8	dobj	_	_
11	of	_	ADP	IN	_	13	case	_	_
12	the	_	DET	DT	_	13	det	_	_
13	return	_	NOUN	NN	_	10	nmod	_	_
14	of	_	ADP	IN	_	16	case	_	_
15	the	_	DET	DT	_	16	det	_	_
16	symptoms	_	NOUN	NNS	_	13	nmod	_	_
17	of	_	ADP	IN	_	19	case	_	_
18	chronic	_	ADJ	JJ	_	19	amod	_	_
19	insomnia	_	NOUN	NN	_	16	nmod	_	_
20	,	_	.	,	_	6	punct	_	_
21	and	_	CONJ	CC	_	6	cc	_	_
22	appeared	_	VERB	VBD	_	6	conj	_	_
23	to	_	PRT	TO	_	24	mark	_	_
24	resolve	_	VERB	VB	_	22	xcomp	_	_
25	by	_	ADP	IN	_	27	case	_	_
26	the	_	DET	DT	_	27	det	_	_
27	second	_	NOUN	NN	_	24	nmod	_	_
28	night	_	VERB	MD	_	22	dep	_	_
29	after	_	ADP	IN	_	31	case	_	_
30	DRUG	_	NOUN	NN	_	31	compound	_	_
31	discontinuation	_	NOUN	NN	_	28	nmod	_	_

#	ZALEPLON	6471
1	Other	_	ADJ	JJ	_	4	amod	_	_
2	Withdrawal	_	NOUN	NN	_	4	compound	_	_
3	Emergent	_	NOUN	NN	_	4	compound	_	_
4	Phenomena	_	NOUN	NN	_	13	nsubjpass	_	_
5	The	_	DET	DT	_	6	det	_	_
6	potential	_	NOUN	NN	_	4	dep	_	_
7	for	_	ADP	IN	_	10	case	_	_
8	other	_	ADJ	JJ	_	10	amod	_	_
9	withdrawal	_	NOUN	NN	_	10	compound	_	_
10	phenomena	_	NOUN	NN	_	6	nmod	_	_
11	was	_	VERB	VBD	_	13	auxpass	_	_
12	also	_	ADV	RB	_	13	advmod	_	_
13	assessed	_	VERB	VBN	_	0	root	_	_
14	in	_	ADP	IN	_	19	case	_	_
15	14	_	NUM	CD	_	17	compound	_	_
16	to	_	PRT	TO	_	17	dep	_	_
17	28	_	NUM	CD	_	19	nummod	_	_
18	night	_	VERB	VBD	_	19	compound	_	_
19	studies	_	NOUN	NNS	_	13	nmod	_	_
20	,	_	.	,	_	19	punct	_	_
21	including	_	VERB	VBG	_	26	case	_	_
22	both	_	CONJ	CC	_	26	cc:preconj	_	_
23	the	_	DET	DT	_	26	det	_	_
24	sleep	_	NOUN	NN	_	26	compound	_	_
25	laboratory	_	ADJ	JJ	_	26	amod	_	_
26	studies	_	NOUN	NNS	_	19	nmod	_	_
27	and	_	CONJ	CC	_	26	cc	_	_
28	the	_	DET	DT	_	30	det	_	_
29	outpatient	_	ADJ	JJ	_	30	amod	_	_
30	studies	_	NOUN	NNS	_	26	conj	_	_
31	,	_	.	,	_	13	punct	_	_
32	and	_	CONJ	CC	_	13	cc	_	_
33	in	_	ADP	IN	_	36	case	_	_
34	open	_	ADJ	JJ	_	36	amod	_	_
35	label	_	NOUN	NN	_	36	compound	_	_
36	studies	_	NOUN	NNS	_	13	conj	_	_
37	of	_	ADP	IN	_	42	case	_	_
38	6	_	NUM	CD	_	42	nummod	_	_
39	and	_	CONJ	CC	_	38	cc	_	_
40	12	_	NUM	CD	_	38	conj	_	_
41	month	_	NOUN	NN	_	42	compound	_	_
42	durations	_	NOUN	NNS	_	36	nmod	_	_

#	ZALEPLON	6472
1	The	_	DET	DT	_	5	det	_	_
2	Benzodiazepine	_	NOUN	NN	_	5	compound	_	_
3	Withdrawal	_	NOUN	NN	_	5	compound	_	_
4	Symptom	_	NOUN	NN	_	5	compound	_	_
5	Questionnaire	_	NOUN	NN	_	7	nsubjpass	_	_
6	was	_	VERB	VBD	_	7	auxpass	_	_
7	used	_	VERB	VBN	_	0	root	_	_
8	in	_	ADP	IN	_	9	case	_	_
9	several	_	NOUN	NN	_	7	nmod	_	_
10	of	_	ADP	IN	_	12	case	_	_
11	these	_	DET	DT	_	12	det	_	_
12	studies	_	NOUN	NNS	_	9	nmod	_	_
13	,	_	.	,	_	7	punct	_	_
14	both	_	CONJ	CC	_	16	cc:preconj	_	_
15	at	_	ADP	IN	_	16	case	_	_
16	baseline	_	NOUN	NN	_	7	nmod	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	then	_	ADV	RB	_	20	advmod	_	_
19	during	_	ADP	IN	_	20	case	_	_
20	days	_	NOUN	NNS	_	16	conj	_	_
21	1	_	NUM	CD	_	20	dep	_	_
22	and	_	CONJ	CC	_	21	cc	_	_
23	2	_	NUM	CD	_	21	conj	_	_
24	following	_	ADP	IN	_	25	case	_	_
25	discontinuation	_	NOUN	NN	_	16	nmod	_	_

#	ZALEPLON	6473
1	Withdrawal	_	NOUN	NN	_	4	nsubjpass	_	_
2	was	_	VERB	VBD	_	4	auxpass	_	_
3	operationally	_	ADV	RB	_	4	advmod	_	_
4	defined	_	VERB	VBN	_	0	root	_	_
5	as	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	emergence	_	NOUN	NN	_	4	nmod	_	_
8	of	_	ADP	IN	_	13	case	_	_
9	3	_	NUM	CD	_	13	nummod	_	_
10	or	_	CONJ	CC	_	9	cc	_	_
11	more	_	ADV	RB	_	9	conj	_	_
12	new	_	ADJ	JJ	_	13	amod	_	_
13	symptoms	_	NOUN	NNS	_	7	nmod	_	_
14	after	_	ADP	IN	_	15	case	_	_
15	discontinuation	_	NOUN	NN	_	7	nmod	_	_

#	ZALEPLON	6474
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	was	_	VERB	VBD	_	4	cop	_	_
3	not	_	ADV	RB	_	4	neg	_	_
4	distinguishable	_	ADJ	JJ	_	0	root	_	_
5	from	_	ADP	IN	_	6	case	_	_
6	placebo	_	NOUN	NN	_	4	nmod	_	_
7	at	_	ADP	IN	_	8	case	_	_
8	doses	_	NOUN	NNS	_	4	nmod	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	5	_	NUM	CD	_	11	nummod	_	_
11	mg	_	NOUN	NN	_	8	nmod	_	_
12	,	_	.	,	_	11	punct	_	_
13	10	_	NUM	CD	_	14	nummod	_	_
14	mg	_	NOUN	NN	_	11	conj	_	_
15	,	_	.	,	_	11	punct	_	_
16	or	_	CONJ	CC	_	11	cc	_	_
17	20	_	NUM	CD	_	18	nummod	_	_
18	mg	_	NOUN	NN	_	11	conj	_	_
19	on	_	ADP	IN	_	21	case	_	_
20	this	_	DET	DT	_	21	det	_	_
21	measure	_	NOUN	NN	_	8	nmod	_	_
22	,	_	.	,	_	4	punct	_	_
23	nor	_	CONJ	CC	_	4	cc	_	_
24	was	_	VERB	VBD	_	26	cop	_	_
25	DRUG	_	NOUN	NN	_	26	nsubj	_	_
26	distinguishable	_	ADJ	JJ	_	4	conj	_	_
27	from	_	ADP	IN	_	28	case	_	_
28	placebo	_	NOUN	NN	_	26	nmod	_	_
29	on	_	ADP	IN	_	35	case	_	_
30	spontaneously	_	ADV	RB	_	31	advmod	_	_
31	reported	_	VERB	VBN	_	35	amod	_	_
32	withdrawal	_	NOUN	NN	_	35	compound	_	_
33	emergent	_	ADJ	JJ	_	35	amod	_	_
34	adverse	_	ADJ	JJ	_	35	amod	_	_
35	events	_	NOUN	NNS	_	26	nmod	_	_

#	ZALEPLON	6475
1	There	_	DET	EX	_	2	expl	_	_
2	were	_	VERB	VBD	_	0	root	_	_
3	no	_	DET	DT	_	4	neg	_	_
4	instances	_	NOUN	NNS	_	2	nsubj	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	withdrawal	_	NOUN	NN	_	7	compound	_	_
7	delirium	_	NOUN	NN	_	4	nmod	_	_
8	,	_	.	,	_	7	punct	_	_
9	withdrawal	_	NOUN	NN	_	11	compound	_	_
10	associated	_	VERB	VBN	_	11	amod	_	_
11	hallucinations	_	NOUN	NNS	_	7	conj	_	_
12	,	_	.	,	_	7	punct	_	_
13	or	_	CONJ	CC	_	7	cc	_	_
14	any	_	DET	DT	_	16	det	_	_
15	other	_	ADJ	JJ	_	16	amod	_	_
16	manifestations	_	NOUN	NNS	_	7	conj	_	_
17	of	_	ADP	IN	_	22	case	_	_
18	severe	_	ADJ	JJ	_	22	amod	_	_
19	sedative	_	ADJ	JJ	_	22	amod	_	_
20	/	_	.	:	_	22	punct	_	_
21	hypnotic	_	ADJ	JJ	_	22	amod	_	_
22	withdrawal	_	NOUN	NN	_	16	nmod	_	_

#	Ziprasidone	4566
1	Drug	_	NOUN	NN	_	3	compound	_	_
2	drug	_	NOUN	NN	_	3	compound	_	_
3	interactions	_	NOUN	NNS	_	9	nsubj	_	_
4	can	_	VERB	MD	_	9	aux	_	_
5	be	_	VERB	VB	_	9	cop	_	_
6	pharmacodynamic	_	ADJ	JJ	_	9	amod	_	_
7	combined	_	VERB	VBN	_	9	amod	_	_
8	pharmacologic	_	ADJ	JJ	_	9	amod	_	_
9	effects	_	NOUN	NNS	_	0	root	_	_
10	or	_	CONJ	CC	_	9	cc	_	_
11	pharmacokinetic	_	ADJ	JJ	_	12	amod	_	_
12	alteration	_	NOUN	NN	_	9	conj	_	_
13	of	_	ADP	IN	_	15	case	_	_
14	plasma	_	NOUN	NN	_	15	compound	_	_
15	levels	_	NOUN	NNS	_	12	nmod	_	_

#	Ziprasidone	4567
1	The	_	DET	DT	_	2	det	_	_
2	risks	_	NOUN	NNS	_	13	nsubjpass	_	_
3	of	_	ADP	IN	_	4	mark	_	_
4	using	_	VERB	VBG	_	2	acl	_	_
5	DRUG	_	NOUN	NN	_	4	dobj	_	_
6	in	_	ADP	IN	_	7	case	_	_
7	combination	_	NOUN	NN	_	4	nmod	_	_
8	with	_	ADP	IN	_	10	case	_	_
9	other	_	ADJ	JJ	_	10	amod	_	_
10	drugs	_	NOUN	NNS	_	7	nmod	_	_
11	have	_	VERB	VBP	_	13	aux	_	_
12	been	_	VERB	VBN	_	13	auxpass	_	_
13	evaluated	_	VERB	VBN	_	0	root	_	_
14	as	_	ADP	IN	_	15	mark	_	_
15	described	_	VERB	VBN	_	13	advcl	_	_
16	below	_	VERB	VBP	_	13	xcomp	_	_

#	Ziprasidone	4568
1	All	_	DET	DT	_	3	det	_	_
2	interactions	_	NOUN	NNS	_	3	compound	_	_
3	studies	_	NOUN	NNS	_	6	nsubjpass	_	_
4	have	_	VERB	VBP	_	6	aux	_	_
5	been	_	VERB	VBN	_	6	auxpass	_	_
6	conducted	_	VERB	VBN	_	0	root	_	_
7	with	_	ADP	IN	_	9	case	_	_
8	oral	_	ADJ	JJ	_	9	amod	_	_
9	DRUG	_	NOUN	NN	_	6	nmod	_	_

#	Ziprasidone	4569
1	Based	_	VERB	VBN	_	15	advcl	_	_
2	upon	_	ADP	IN	_	7	case	_	_
3	the	_	DET	DT	_	7	det	_	_
4	pharmacodynamic	_	ADJ	JJ	_	7	amod	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	pharmacokinetic	_	ADJ	JJ	_	4	conj	_	_
7	profile	_	NOUN	NN	_	1	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	,	_	.	,	_	15	punct	_	_
11	possible	_	ADJ	JJ	_	12	amod	_	_
12	interactions	_	NOUN	NNS	_	15	nsubjpass	_	_
13	could	_	VERB	MD	_	15	aux	_	_
14	be	_	VERB	VB	_	15	auxpass	_	_
15	anticipated	_	VERB	VBN	_	0	root	_	_
16	:	_	.	:	_	15	punct	_	_
17	Approximately	_	ADV	RB	_	23	advmod	_	_
18	two	_	NUM	CD	_	19	nummod	_	_
19	thirds	_	NOUN	NNS	_	23	nsubjpass	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	DRUG	_	NOUN	NN	_	19	nmod	_	_
22	is	_	VERB	VBZ	_	23	auxpass	_	_
23	metabolized	_	VERB	VBN	_	15	parataxis	_	_
24	via	_	ADP	IN	_	26	case	_	_
25	a	_	DET	DT	_	26	det	_	_
26	combination	_	NOUN	NN	_	23	nmod	_	_
27	of	_	ADP	IN	_	29	case	_	_
28	chemical	_	ADJ	JJ	_	29	amod	_	_
29	reduction	_	NOUN	NN	_	26	nmod	_	_
30	by	_	ADP	IN	_	31	case	_	_
31	glutathione	_	NOUN	NN	_	26	nmod	_	_
32	and	_	CONJ	CC	_	31	cc	_	_
33	enzymatic	_	ADJ	JJ	_	34	amod	_	_
34	reduction	_	NOUN	NN	_	31	conj	_	_
35	by	_	ADP	IN	_	37	case	_	_
36	aldehyde	_	NOUN	NN	_	37	compound	_	_
37	oxidase	_	NOUN	NN	_	26	nmod	_	_

#	Ziprasidone	4570
1	There	_	DET	EX	_	2	expl	_	_
2	are	_	VERB	VBP	_	0	root	_	_
3	no	_	ADV	RB	_	4	neg	_	_
4	known	_	VERB	VBN	_	7	amod	_	_
5	clinically	_	ADV	RB	_	6	advmod	_	_
6	relevant	_	ADJ	JJ	_	7	amod	_	_
7	inhibitors	_	NOUN	NNS	_	2	dobj	_	_
8	or	_	CONJ	CC	_	7	cc	_	_
9	inducers	_	NOUN	NNS	_	7	conj	_	_
10	of	_	ADP	IN	_	12	case	_	_
11	aldehyde	_	NOUN	NN	_	12	compound	_	_
12	oxidase	_	NOUN	NN	_	9	nmod	_	_

#	Ziprasidone	4571
1	Less	_	ADV	RB	_	3	advmod	_	_
2	than	_	ADP	IN	_	1	mwe	_	_
3	one	_	NUM	CD	_	10	nsubjpass	_	_
4	third	_	NOUN	NN	_	3	dep	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	DRUG	_	NOUN	NN	_	8	compound	_	_
7	metabolic	_	ADJ	JJ	_	8	amod	_	_
8	clearance	_	NOUN	NN	_	3	nmod	_	_
9	is	_	VERB	VBZ	_	10	auxpass	_	_
10	mediated	_	VERB	VBN	_	0	root	_	_
11	by	_	ADP	IN	_	15	case	_	_
12	cytochrome	_	NOUN	NN	_	15	compound	_	_
13	P450	_	NOUN	NN	_	15	compound	_	_
14	catalyzed	_	VERB	VBN	_	15	amod	_	_
15	oxidation	_	NOUN	NN	_	10	nmod	_	_

#	Ziprasidone	4572
1	An	_	DET	DT	_	6	det	_	_
2	in	_	ADJ	JJ	_	6	amod	_	_
3	vitro	_	X	FW	_	2	dep	_	_
4	enzyme	_	NOUN	NN	_	6	compound	_	_
5	inhibition	_	NOUN	NN	_	6	compound	_	_
6	study	_	NOUN	NN	_	11	nsubj	_	_
7	utilizing	_	VERB	VBG	_	6	acl	_	_
8	human	_	ADJ	JJ	_	10	amod	_	_
9	liver	_	NOUN	NN	_	10	compound	_	_
10	microsomes	_	NOUN	NNS	_	7	dobj	_	_
11	showed	_	VERB	VBD	_	0	root	_	_
12	that	_	ADP	IN	_	14	mark	_	_
13	DRUG	_	NOUN	NN	_	14	nsubj	_	_
14	had	_	VERB	VBD	_	11	ccomp	_	_
15	little	_	ADJ	JJ	_	17	amod	_	_
16	inhibitory	_	ADJ	JJ	_	17	amod	_	_
17	effect	_	NOUN	NN	_	14	dobj	_	_
18	on	_	ADP	IN	_	19	case	_	_
19	CYP1A2	_	NOUN	NN	_	14	nmod	_	_
20	,	_	.	,	_	19	punct	_	_
21	CYP2C9	_	NOUN	NN	_	19	conj	_	_
22	,	_	.	,	_	19	punct	_	_
23	CYP2C19	_	NOUN	NN	_	19	conj	_	_
24	,	_	.	,	_	19	punct	_	_
25	CYP2D6	_	NOUN	NN	_	19	conj	_	_
26	and	_	CONJ	CC	_	19	cc	_	_
27	CYP3A4	_	NOUN	NN	_	19	conj	_	_
28	,	_	.	,	_	14	punct	_	_
29	and	_	CONJ	CC	_	14	cc	_	_
30	thus	_	ADV	RB	_	34	advmod	_	_
31	would	_	VERB	MD	_	34	aux	_	_
32	not	_	ADV	RB	_	34	neg	_	_
33	likely	_	ADV	RB	_	34	advmod	_	_
34	interfere	_	VERB	VB	_	14	conj	_	_
35	with	_	ADP	IN	_	37	case	_	_
36	the	_	DET	DT	_	37	det	_	_
37	metabolism	_	NOUN	NN	_	34	nmod	_	_
38	of	_	ADP	IN	_	39	case	_	_
39	drugs	_	NOUN	NNS	_	37	nmod	_	_
40	primarily	_	ADV	RB	_	41	advmod	_	_
41	metabolized	_	VERB	VBN	_	39	acl	_	_
42	by	_	ADP	IN	_	44	case	_	_
43	these	_	DET	DT	_	44	det	_	_
44	enzymes	_	NOUN	NNS	_	41	nmod	_	_

#	Ziprasidone	4573
1	There	_	DET	EX	_	2	expl	_	_
2	is	_	VERB	VBZ	_	0	root	_	_
3	little	_	ADJ	JJ	_	4	amod	_	_
4	potential	_	NOUN	NN	_	2	nsubj	_	_
5	for	_	ADP	IN	_	7	case	_	_
6	drug	_	NOUN	NN	_	7	compound	_	_
7	interactions	_	NOUN	NNS	_	4	nmod	_	_
8	with	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	due	_	ADJ	JJ	_	12	case	_	_
11	to	_	PRT	TO	_	12	case	_	_
12	displacement	_	NOUN	NN	_	2	nmod	_	_

#	Ziprasidone	4574
1	DRUG	_	NOUN	NN	_	5	nsubjpass	_	_
2	should	_	VERB	MD	_	5	aux	_	_
3	not	_	ADV	RB	_	5	neg	_	_
4	be	_	VERB	VB	_	5	auxpass	_	_
5	used	_	VERB	VBN	_	0	root	_	_
6	with	_	ADP	IN	_	8	case	_	_
7	any	_	DET	DT	_	8	det	_	_
8	drug	_	NOUN	NN	_	5	nmod	_	_
9	that	_	DET	WDT	_	10	nsubj	_	_
10	prolongs	_	VERB	VBZ	_	8	acl:relcl	_	_
11	the	_	DET	DT	_	13	det	_	_
12	QT	_	NOUN	NN	_	13	nmod:npmod	_	_
13	interval	_	ADJ	JJ	_	10	dobj	_	_

#	Ziprasidone	4575
1	Given	_	ADP	IN	_	5	case	_	_
2	the	_	DET	DT	_	5	det	_	_
3	primary	_	ADJ	JJ	_	5	amod	_	_
4	CNS	_	NOUN	NN	_	5	compound	_	_
5	effects	_	NOUN	NNS	_	12	nmod	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	,	_	.	,	_	12	punct	_	_
9	caution	_	NOUN	NN	_	12	nsubjpass	_	_
10	should	_	VERB	MD	_	12	aux	_	_
11	be	_	VERB	VB	_	12	auxpass	_	_
12	used	_	VERB	VBN	_	0	root	_	_
13	when	_	ADV	WRB	_	16	advmod	_	_
14	it	_	PRON	PRP	_	16	nsubjpass	_	_
15	is	_	VERB	VBZ	_	16	auxpass	_	_
16	taken	_	VERB	VBN	_	12	ccomp	_	_
17	in	_	ADP	IN	_	18	case	_	_
18	combination	_	NOUN	NN	_	16	nmod	_	_
19	with	_	ADP	IN	_	23	case	_	_
20	other	_	ADJ	JJ	_	23	amod	_	_
21	centrally	_	ADV	RB	_	22	advmod	_	_
22	acting	_	VERB	VBG	_	23	amod	_	_
23	drugs	_	NOUN	NNS	_	18	nmod	_	_

#	Ziprasidone	4576
1	Because	_	ADP	IN	_	4	case	_	_
2	of	_	ADP	IN	_	4	case	_	_
3	its	_	PRON	PRP$	_	4	nmod:poss	_	_
4	potential	_	NOUN	NN	_	11	nmod	_	_
5	for	_	ADP	IN	_	6	mark	_	_
6	inducing	_	VERB	VBG	_	4	acl	_	_
7	hypotension	_	NOUN	NN	_	6	dobj	_	_
8	,	_	.	,	_	11	punct	_	_
9	DRUG	_	NOUN	NN	_	11	nsubj	_	_
10	may	_	VERB	MD	_	11	aux	_	_
11	enhance	_	VERB	VB	_	0	root	_	_
12	the	_	DET	DT	_	13	det	_	_
13	effects	_	NOUN	NNS	_	11	dobj	_	_
14	of	_	ADP	IN	_	17	case	_	_
15	certain	_	ADJ	JJ	_	17	amod	_	_
16	antihypertensive	_	ADJ	JJ	_	17	amod	_	_
17	agents	_	NOUN	NNS	_	13	nmod	_	_

#	Ziprasidone	4577
1	DRUG	_	NOUN	NN	_	3	nsubj	_	_
2	may	_	VERB	MD	_	3	aux	_	_
3	antagonize	_	VERB	VB	_	0	root	_	_
4	the	_	DET	DT	_	5	det	_	_
5	effects	_	NOUN	NNS	_	3	dobj	_	_
6	of	_	ADP	IN	_	10	case	_	_
7	levodopa	_	NOUN	NN	_	10	compound	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	dopamine	_	NOUN	NN	_	7	conj	_	_
10	agonists	_	NOUN	NNS	_	5	nmod	_	_

#	Ziprasidone	4578
1	Carbamazepine	_	NOUN	NN	_	2	compound	_	_
2	Carbamazepine	_	NOUN	NN	_	5	nsubj	_	_
3	is	_	VERB	VBZ	_	5	cop	_	_
4	an	_	DET	DT	_	5	det	_	_
5	inducer	_	NOUN	NN	_	0	root	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	CYP3A4	_	NOUN	NN	_	8	compound	_	_
8	administration	_	NOUN	NN	_	5	nmod	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	200	_	NUM	CD	_	11	nummod	_	_
11	mg	_	NOUN	NN	_	8	nmod	_	_
12	twice	_	ADV	RB	_	13	advmod	_	_
13	daily	_	ADV	RB	_	17	advmod	_	_
14	for	_	ADP	IN	_	16	case	_	_
15	21	_	NUM	CD	_	16	nummod	_	_
16	days	_	NOUN	NNS	_	13	nmod	_	_
17	resulted	_	VERB	VBD	_	5	dep	_	_
18	in	_	ADP	IN	_	20	case	_	_
19	a	_	DET	DT	_	20	det	_	_
20	decrease	_	NOUN	NN	_	17	nmod	_	_
21	of	_	ADP	IN	_	23	case	_	_
22	approximately	_	ADV	RB	_	23	advmod	_	_
23	35%	_	NOUN	NN	_	20	nmod	_	_
24	in	_	ADP	IN	_	26	case	_	_
25	the	_	DET	DT	_	26	det	_	_
26	AUC	_	NOUN	NN	_	20	nmod	_	_
27	of	_	ADP	IN	_	28	case	_	_
28	DRUG	_	NOUN	NN	_	26	nmod	_	_

#	Ziprasidone	4579
1	This	_	DET	DT	_	2	det	_	_
2	effect	_	NOUN	NN	_	5	nsubj	_	_
3	may	_	VERB	MD	_	5	aux	_	_
4	be	_	VERB	VB	_	5	cop	_	_
5	greater	_	ADJ	JJ	_	0	root	_	_
6	when	_	ADV	WRB	_	12	advmod	_	_
7	higher	_	ADJ	JJ	_	8	amod	_	_
8	doses	_	NOUN	NNS	_	12	nsubjpass	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	carbamazepine	_	NOUN	NN	_	8	nmod	_	_
11	are	_	VERB	VBP	_	12	auxpass	_	_
12	administered	_	VERB	VBN	_	5	ccomp	_	_

#	Ziprasidone	4580
1	Ketoconazole	_	NOUN	NN	_	2	compound	_	_
2	Ketoconazole	_	NOUN	NN	_	21	nsubj	_	_
3	,	_	.	,	_	2	punct	_	_
4	a	_	DET	DT	_	6	det	_	_
5	potent	_	ADJ	JJ	_	6	amod	_	_
6	inhibitor	_	NOUN	NN	_	2	appos	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	CYP3A4	_	NOUN	NN	_	6	nmod	_	_
9	,	_	.	,	_	2	punct	_	_
10	at	_	ADP	IN	_	12	case	_	_
11	a	_	DET	DT	_	12	det	_	_
12	dose	_	NOUN	NN	_	2	nmod	_	_
13	of	_	ADP	IN	_	16	case	_	_
14	400	_	NUM	CD	_	16	nummod	_	_
15	mg	_	NOUN	NN	_	16	compound	_	_
16	QD	_	NOUN	NN	_	12	nmod	_	_
17	for	_	ADP	IN	_	19	case	_	_
18	5	_	NUM	CD	_	19	nummod	_	_
19	days	_	NOUN	NNS	_	12	nmod	_	_
20	,	_	.	,	_	2	punct	_	_
21	increased	_	VERB	VBD	_	0	root	_	_
22	the	_	DET	DT	_	23	det	_	_
23	AUC	_	NOUN	NN	_	21	dobj	_	_
24	and	_	CONJ	CC	_	23	cc	_	_
25	Cmax	_	NOUN	NN	_	23	conj	_	_
26	of	_	ADP	IN	_	27	case	_	_
27	DRUG	_	NOUN	NN	_	23	nmod	_	_
28	by	_	ADP	IN	_	31	case	_	_
29	about	_	ADV	RB	_	30	advmod	_	_
30	35	_	NUM	CD	_	31	nummod	_	_
31	40%	_	ADJ	JJ	_	21	nmod	_	_

#	Ziprasidone	4581
1	Other	_	ADJ	JJ	_	2	amod	_	_
2	inhibitors	_	NOUN	NNS	_	7	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	CYP3A4	_	NOUN	NN	_	2	nmod	_	_
5	would	_	VERB	MD	_	7	aux	_	_
6	be	_	VERB	VB	_	7	auxpass	_	_
7	expected	_	VERB	VBN	_	0	root	_	_
8	to	_	PRT	TO	_	9	mark	_	_
9	have	_	VERB	VB	_	7	xcomp	_	_
10	similar	_	ADJ	JJ	_	11	amod	_	_
11	effects	_	NOUN	NNS	_	9	dobj	_	_

#	Ziprasidone	4582
1	Cimetidine	_	NOUN	NN	_	2	compound	_	_
2	Cimetidine	_	NOUN	NN	_	15	nsubj	_	_
3	at	_	ADP	IN	_	5	case	_	_
4	a	_	DET	DT	_	5	det	_	_
5	dose	_	NOUN	NN	_	2	nmod	_	_
6	of	_	ADP	IN	_	9	case	_	_
7	800	_	NUM	CD	_	9	nummod	_	_
8	mg	_	NOUN	NN	_	9	compound	_	_
9	QD	_	NOUN	NN	_	5	nmod	_	_
10	for	_	ADP	IN	_	12	case	_	_
11	2	_	NUM	CD	_	12	nummod	_	_
12	days	_	NOUN	NNS	_	5	nmod	_	_
13	did	_	VERB	VBD	_	15	aux	_	_
14	not	_	ADV	RB	_	15	neg	_	_
15	affect	_	VERB	VB	_	0	root	_	_
16	DRUG	_	NOUN	NN	_	17	compound	_	_
17	pharmacokinetics	_	NOUN	NNS	_	15	dobj	_	_

#	Ziprasidone	4583
1	Antacid	_	NOUN	NN	_	4	compound	_	_
2	The	_	NOUN	NN	_	4	advmod	_	_
3	co	_	PRT	TO	_	4	case	_	_
4	administration	_	NOUN	NN	_	14	nsubj	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	30	_	NUM	CD	_	7	nummod	_	_
7	mL	_	NOUN	NN	_	4	nmod	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	Maalox*	_	NOUN	NN	_	7	nmod	_	_
10	with	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	4	nmod	_	_
12	did	_	VERB	VBD	_	14	aux	_	_
13	not	_	ADV	RB	_	14	neg	_	_
14	affect	_	VERB	VB	_	0	root	_	_
15	the	_	DET	DT	_	16	det	_	_
16	pharmacokinetics	_	NOUN	NNS	_	14	dobj	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	DRUG	_	NOUN	NN	_	16	nmod	_	_

#	Ziprasidone	4584
1	DRUG	_	NOUN	NN	_	10	nsubj	_	_
2	at	_	ADP	IN	_	4	case	_	_
3	a	_	DET	DT	_	4	det	_	_
4	dose	_	NOUN	NN	_	1	nmod	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	40	_	NUM	CD	_	7	nummod	_	_
7	mg	_	NOUN	NN	_	4	nmod	_	_
8	twice	_	ADV	RB	_	9	advmod	_	_
9	daily	_	ADV	RB	_	10	advmod	_	_
10	administered	_	VERB	VBN	_	0	root	_	_
11	concomitantly	_	ADV	RB	_	10	advmod	_	_
12	with	_	ADP	IN	_	13	case	_	_
13	lithium	_	NOUN	NN	_	10	nmod	_	_
14	at	_	ADP	IN	_	16	case	_	_
15	a	_	DET	DT	_	16	det	_	_
16	dose	_	NOUN	NN	_	10	nmod	_	_
17	of	_	ADP	IN	_	19	case	_	_
18	450	_	NUM	CD	_	19	nummod	_	_
19	mg	_	NOUN	NN	_	16	nmod	_	_
20	twice	_	ADV	RB	_	21	advmod	_	_
21	daily	_	ADV	RB	_	10	advmod	_	_
22	for	_	ADP	IN	_	24	case	_	_
23	7	_	NUM	CD	_	24	nummod	_	_
24	days	_	NOUN	NNS	_	21	nmod	_	_
25	did	_	VERB	VBD	_	27	aux	_	_
26	not	_	ADV	RB	_	27	neg	_	_
27	affect	_	VERB	VB	_	10	parataxis	_	_
28	the	_	DET	DT	_	31	det	_	_
29	steady	_	ADJ	JJ	_	31	amod	_	_
30	state	_	NOUN	NN	_	31	compound	_	_
31	level	_	NOUN	NN	_	27	dobj	_	_
32	or	_	CONJ	CC	_	31	cc	_	_
33	renal	_	ADJ	JJ	_	34	amod	_	_
34	clearance	_	NOUN	NN	_	31	conj	_	_
35	of	_	ADP	IN	_	36	case	_	_
36	lithium	_	NOUN	NN	_	34	nmod	_	_

#	Ziprasidone	4585
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	dosed	_	VERB	VBD	_	0	root	_	_
3	adjunctively	_	ADV	RB	_	2	advmod	_	_
4	to	_	PRT	TO	_	5	case	_	_
5	lithium	_	NOUN	NN	_	2	nmod	_	_
6	in	_	ADP	IN	_	9	case	_	_
7	a	_	DET	DT	_	9	det	_	_
8	maintenance	_	NOUN	NN	_	9	compound	_	_
9	trial	_	NOUN	NN	_	2	nmod	_	_
10	of	_	ADP	IN	_	12	case	_	_
11	bipolar	_	ADJ	JJ	_	12	amod	_	_
12	patients	_	NOUN	NNS	_	9	nmod	_	_
13	did	_	VERB	VBD	_	15	aux	_	_
14	not	_	ADV	RB	_	15	neg	_	_
15	affect	_	VERB	VB	_	2	parataxis	_	_
16	mean	_	ADJ	JJ	_	19	compound	_	_
17	therapeutic	_	ADJ	JJ	_	19	amod	_	_
18	lithium	_	NOUN	NN	_	19	compound	_	_
19	levels	_	NOUN	NNS	_	15	dobj	_	_

#	Ziprasidone	4586
1	In	_	X	FW	_	3	amod	_	_
2	vivo	_	X	FW	_	1	dep	_	_
3	studies	_	NOUN	NNS	_	5	nsubj	_	_
4	have	_	VERB	VBP	_	5	aux	_	_
5	revealed	_	VERB	VBN	_	0	root	_	_
6	no	_	DET	DT	_	7	neg	_	_
7	effect	_	NOUN	NN	_	5	dobj	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	on	_	ADP	IN	_	12	case	_	_
11	the	_	DET	DT	_	12	det	_	_
12	pharmacokinetics	_	NOUN	NNS	_	7	nmod	_	_
13	of	_	ADP	IN	_	17	case	_	_
14	estrogen	_	NOUN	NN	_	17	compound	_	_
15	or	_	CONJ	CC	_	14	cc	_	_
16	progesterone	_	NOUN	NN	_	14	conj	_	_
17	components	_	NOUN	NNS	_	12	nmod	_	_

#	Ziprasidone	4587
1	DRUG	_	NOUN	NN	_	12	nsubj	_	_
2	at	_	ADP	IN	_	4	case	_	_
3	a	_	DET	DT	_	4	det	_	_
4	dose	_	NOUN	NN	_	1	nmod	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	20	_	NUM	CD	_	7	nummod	_	_
7	mg	_	NOUN	NN	_	4	nmod	_	_
8	twice	_	ADV	RB	_	12	advmod	_	_
9	daily	_	ADV	RB	_	12	advmod	_	_
10	did	_	VERB	VBD	_	12	aux	_	_
11	not	_	ADV	RB	_	12	neg	_	_
12	affect	_	VERB	VB	_	0	root	_	_
13	the	_	DET	DT	_	14	det	_	_
14	pharmacokinetics	_	NOUN	NNS	_	12	dobj	_	_
15	of	_	ADP	IN	_	19	case	_	_
16	concomitantly	_	ADV	RB	_	17	advmod	_	_
17	administered	_	VERB	VBN	_	19	amod	_	_
18	oral	_	ADJ	JJ	_	19	amod	_	_
19	contraceptives	_	NOUN	NNS	_	14	nmod	_	_
20	,	_	.	,	_	12	punct	_	_
21	ethinyl	_	ADJ	JJ	_	24	compound	_	_
22	estradiol	_	NOUN	NN	_	24	compound	_	_
23	0.03	_	NUM	CD	_	24	nummod	_	_
24	mg	_	NOUN	NN	_	12	dep	_	_
25	and	_	CONJ	CC	_	24	cc	_	_
26	levonorgestrel	_	NOUN	NN	_	28	compound	_	_
27	0.15	_	NUM	CD	_	28	nummod	_	_
28	mg	_	NOUN	NNS	_	24	conj	_	_

#	Ziprasidone	4588
1	Consistent	_	ADJ	JJ	_	13	advcl	_	_
2	with	_	ADP	IN	_	5	case	_	_
3	in	_	X	FW	_	5	amod	_	_
4	vitro	_	X	FW	_	3	dep	_	_
5	results	_	NOUN	NNS	_	1	nmod	_	_
6	,	_	.	,	_	13	punct	_	_
7	a	_	DET	DT	_	8	det	_	_
8	study	_	NOUN	NN	_	13	nsubj	_	_
9	in	_	ADP	IN	_	12	case	_	_
10	normal	_	ADJ	JJ	_	12	amod	_	_
11	healthy	_	ADJ	JJ	_	12	amod	_	_
12	volunteers	_	NOUN	NNS	_	8	nmod	_	_
13	showed	_	VERB	VBD	_	0	root	_	_
14	that	_	ADP	IN	_	18	mark	_	_
15	DRUG	_	NOUN	NN	_	18	nsubj	_	_
16	did	_	VERB	MD	_	18	aux	_	_
17	not	_	ADV	RB	_	18	neg	_	_
18	alter	_	VERB	VB	_	13	ccomp	_	_
19	the	_	DET	DT	_	20	det	_	_
20	metabolism	_	NOUN	NN	_	18	dobj	_	_
21	of	_	ADP	IN	_	22	case	_	_
22	dextromethorphan	_	NOUN	NN	_	20	nmod	_	_
23	,	_	.	,	_	22	punct	_	_
24	a	_	DET	DT	_	27	det	_	_
25	CYP2D6	_	NOUN	NN	_	27	compound	_	_
26	model	_	NOUN	NN	_	27	compound	_	_
27	substrate	_	NOUN	NN	_	22	appos	_	_
28	,	_	.	,	_	22	punct	_	_
29	to	_	PRT	TO	_	32	case	_	_
30	its	_	PRON	PRP$	_	32	nmod:poss	_	_
31	major	_	ADJ	JJ	_	32	amod	_	_
32	metabolite	_	NOUN	NN	_	20	nmod	_	_
33	,	_	.	,	_	32	punct	_	_
34	dextrorphan	_	NOUN	NN	_	32	root	_	_

#	Ziprasidone	4589
1	There	_	DET	EX	_	2	expl	_	_
2	was	_	VERB	VBD	_	0	root	_	_
3	no	_	DET	DT	_	6	neg	_	_
4	statistically	_	ADV	RB	_	5	advmod	_	_
5	significant	_	ADJ	JJ	_	6	amod	_	_
6	change	_	NOUN	NN	_	2	nsubj	_	_
7	in	_	ADP	IN	_	10	case	_	_
8	the	_	DET	DT	_	10	det	_	_
9	urinary	_	ADJ	JJ	_	10	amod	_	_
10	dextromethorphan	_	NOUN	NN	_	6	nmod	_	_
11	/	_	.	:	_	2	punct	_	_
12	dextrorphan	_	NOUN	NN	_	13	compound	_	_
13	ratio	_	NOUN	NN	_	2	dep	_	_

#	Ziprasidone	4590
1	A	_	DET	DT	_	3	det	_	_
2	pharmacokinetic	_	ADJ	JJ	_	3	amod	_	_
3	interaction	_	NOUN	NN	_	9	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	with	_	ADP	IN	_	7	case	_	_
7	valproate	_	NOUN	NN	_	3	nmod	_	_
8	is	_	VERB	VBZ	_	9	cop	_	_
9	unlikely	_	ADJ	JJ	_	0	root	_	_
10	due	_	ADJ	JJ	_	13	case	_	_
11	to	_	PRT	TO	_	13	case	_	_
12	the	_	DET	DT	_	13	det	_	_
13	lack	_	NOUN	NN	_	9	nmod	_	_
14	of	_	ADP	IN	_	17	case	_	_
15	common	_	ADJ	JJ	_	17	amod	_	_
16	metabolic	_	ADJ	JJ	_	17	amod	_	_
17	pathways	_	NOUN	NNS	_	13	nmod	_	_
18	for	_	ADP	IN	_	21	case	_	_
19	the	_	DET	DT	_	21	det	_	_
20	two	_	NUM	CD	_	21	nummod	_	_
21	drugs	_	NOUN	NNS	_	17	nmod	_	_

#	Ziprasidone	4591
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	dosed	_	VERB	VBD	_	0	root	_	_
3	adjunctively	_	ADV	RB	_	2	advmod	_	_
4	to	_	PRT	TO	_	5	case	_	_
5	valproate	_	NOUN	NN	_	2	nmod	_	_
6	in	_	ADP	IN	_	9	case	_	_
7	a	_	DET	DT	_	9	det	_	_
8	maintenance	_	NOUN	NN	_	9	compound	_	_
9	trial	_	NOUN	NN	_	5	nmod	_	_
10	of	_	ADP	IN	_	12	case	_	_
11	bipolar	_	ADJ	JJ	_	12	amod	_	_
12	patients	_	NOUN	NNS	_	9	nmod	_	_
13	did	_	VERB	VBD	_	15	aux	_	_
14	not	_	ADV	RB	_	15	neg	_	_
15	affect	_	VERB	VB	_	2	parataxis	_	_
16	mean	_	ADJ	JJ	_	19	compound	_	_
17	therapeutic	_	ADJ	JJ	_	19	amod	_	_
18	valproate	_	NOUN	NN	_	19	compound	_	_
19	levels	_	NOUN	NNS	_	15	dobj	_	_

#	Ziprasidone	4592
1	Population	_	NOUN	NN	_	3	compound	_	_
2	pharmacokinetic	_	ADJ	JJ	_	3	amod	_	_
3	analysis	_	NOUN	NN	_	14	nsubj	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	schizophrenic	_	ADJ	JJ	_	6	amod	_	_
6	patients	_	NOUN	NNS	_	3	nmod	_	_
7	enrolled	_	VERB	VBN	_	6	acl	_	_
8	in	_	ADP	IN	_	11	case	_	_
9	controlled	_	VERB	VBN	_	11	amod	_	_
10	clinical	_	ADJ	JJ	_	11	amod	_	_
11	trials	_	NOUN	NNS	_	7	nmod	_	_
12	has	_	VERB	VBZ	_	14	aux	_	_
13	not	_	ADV	RB	_	14	neg	_	_
14	revealed	_	VERB	VBN	_	0	root	_	_
15	evidence	_	NOUN	NN	_	14	dobj	_	_
16	of	_	ADP	IN	_	21	case	_	_
17	any	_	DET	DT	_	21	det	_	_
18	clinically	_	ADV	RB	_	19	advmod	_	_
19	significant	_	ADJ	JJ	_	21	amod	_	_
20	pharmacokinetic	_	ADJ	JJ	_	21	amod	_	_
21	interactions	_	NOUN	NNS	_	15	nmod	_	_
22	with	_	ADP	IN	_	23	case	_	_
23	benztropine	_	NOUN	NN	_	21	nmod	_	_
24	,	_	.	,	_	23	punct	_	_
25	propranolol	_	NOUN	NN	_	23	conj	_	_
26	,	_	.	,	_	23	punct	_	_
27	or	_	CONJ	CC	_	23	cc	_	_
28	lorazepam	_	NOUN	NN	_	23	conj	_	_

#	Ziprasidone	4593
1	The	_	DET	DT	_	3	det	_	_
2	absolute	_	ADJ	JJ	_	3	amod	_	_
3	bioavailability	_	NOUN	NN	_	14	nsubj	_	_
4	of	_	ADP	IN	_	8	case	_	_
5	a	_	DET	DT	_	8	det	_	_
6	20	_	NUM	CD	_	8	nummod	_	_
7	mg	_	NOUN	NN	_	8	compound	_	_
8	dose	_	NOUN	NN	_	3	nmod	_	_
9	under	_	ADP	IN	_	11	case	_	_
10	fed	_	ADJ	JJ	_	11	amod	_	_
11	conditions	_	NOUN	NNS	_	3	nmod	_	_
12	is	_	VERB	VBZ	_	14	auxpass	_	_
13	approximately	_	ADV	RB	_	14	advmod	_	_
14	60%	_	ADJ	JJ	_	0	root	_	_

#	Ziprasidone	4594
1	The	_	DET	DT	_	2	det	_	_
2	absorption	_	NOUN	NN	_	6	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	is	_	VERB	VBZ	_	6	auxpass	_	_
6	increased	_	VERB	VBN	_	0	root	_	_
7	up	_	ADJ	JJR	_	10	advmod	_	_
8	to	_	PRT	TO	_	10	case	_	_
9	two	_	NUM	CD	_	10	nummod	_	_
10	fold	_	NOUN	NN	_	6	nmod	_	_
11	in	_	ADP	IN	_	13	case	_	_
12	the	_	DET	DT	_	13	det	_	_
13	presence	_	NOUN	NN	_	10	nmod	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	food	_	NOUN	NN	_	13	nmod	_	_

#	Ziprasidone	4595
1	The	_	DET	DT	_	2	det	_	_
2	mechanism	_	NOUN	NN	_	18	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	action	_	NOUN	NN	_	2	nmod	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	,	_	.	,	_	2	punct	_	_
8	as	_	ADP	IN	_	11	case	_	_
9	with	_	ADP	IN	_	11	case	_	_
10	other	_	ADJ	JJ	_	11	amod	_	_
11	drugs	_	NOUN	NNS	_	2	nmod	_	_
12	having	_	VERB	VBG	_	11	acl	_	_
13	efficacy	_	NOUN	NN	_	12	dobj	_	_
14	in	_	ADP	IN	_	15	case	_	_
15	schizophrenia	_	NOUN	NN	_	13	nmod	_	_
16	,	_	.	,	_	2	punct	_	_
17	is	_	VERB	VBZ	_	18	auxpass	_	_
18	unknown	_	ADJ	JJ	_	0	root	_	_

#	Ziprasidone	4596
1	However	_	ADV	RB	_	6	advmod	_	_
2	,	_	.	,	_	6	punct	_	_
3	it	_	PRON	PRP	_	6	nsubjpass	_	_
4	has	_	VERB	VBZ	_	6	aux	_	_
5	been	_	VERB	VBN	_	6	auxpass	_	_
6	proposed	_	VERB	VBN	_	0	root	_	_
7	that	_	ADP	IN	_	14	mark	_	_
8	this	_	DET	DT	_	10	det	_	_
9	drug's	_	NOUN	NNS	_	10	compound	_	_
10	efficacy	_	NOUN	NN	_	14	nsubjpass	_	_
11	in	_	ADP	IN	_	12	case	_	_
12	schizophrenia	_	NOUN	NN	_	10	nmod	_	_
13	is	_	VERB	VBZ	_	14	auxpass	_	_
14	mediated	_	VERB	VBN	_	6	ccomp	_	_
15	through	_	ADP	IN	_	17	case	_	_
16	a	_	DET	DT	_	17	det	_	_
17	combination	_	NOUN	NN	_	14	nmod	_	_
18	of	_	ADP	IN	_	22	case	_	_
19	dopamine	_	NOUN	NN	_	22	compound	_	_
20	type	_	NOUN	NN	_	22	compound	_	_
21	2	_	NUM	CD	_	22	nummod	_	_
22	D	_	NOUN	NN	_	17	nmod	_	_
23	2	_	NUM	CD	_	22	nummod	_	_
24	and	_	CONJ	CC	_	22	cc	_	_
25	serotonin	_	NOUN	NN	_	30	compound	_	_
26	type	_	NOUN	NN	_	30	compound	_	_
27	2	_	NUM	CD	_	30	nummod	_	_
28	5HT	_	NOUN	NN	_	30	compound	_	_
29	2	_	NUM	CD	_	30	nummod	_	_
30	antagonism	_	NOUN	NN	_	22	conj	_	_

#	Ziprasidone	4597
1	As	_	ADP	IN	_	4	case	_	_
2	with	_	ADP	IN	_	4	case	_	_
3	other	_	ADJ	JJ	_	4	amod	_	_
4	drugs	_	NOUN	NNS	_	21	nmod	_	_
5	having	_	VERB	VBG	_	4	acl	_	_
6	efficacy	_	NOUN	NN	_	5	dobj	_	_
7	in	_	ADP	IN	_	9	case	_	_
8	bipolar	_	ADJ	JJ	_	9	amod	_	_
9	disorder	_	NOUN	NN	_	6	nmod	_	_
10	,	_	.	,	_	21	punct	_	_
11	the	_	DET	DT	_	12	det	_	_
12	mechanism	_	NOUN	NN	_	21	nsubj	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	action	_	NOUN	NN	_	12	nmod	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	14	nmod	_	_
17	in	_	ADP	IN	_	19	case	_	_
18	bipolar	_	ADJ	JJ	_	19	amod	_	_
19	disorder	_	NOUN	NN	_	14	nmod	_	_
20	is	_	VERB	VBZ	_	21	auxpass	_	_
21	unknown	_	ADJ	JJ	_	0	root	_	_

#	Ziprasidone	4598
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	exhibited	_	VERB	VBD	_	0	root	_	_
3	high	_	ADJ	JJ	_	7	amod	_	_
4	in	_	X	FW	_	7	amod	_	_
5	vitro	_	X	FW	_	4	dep	_	_
6	binding	_	NOUN	NN	_	7	compound	_	_
7	affinity	_	NOUN	NN	_	2	dobj	_	_
8	for	_	ADP	IN	_	11	case	_	_
9	the	_	DET	DT	_	11	det	_	_
10	dopamine	_	NOUN	NN	_	11	compound	_	_
11	D2	_	NOUN	NN	_	7	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	D3	_	NOUN	NN	_	11	conj	_	_
14	,	_	.	,	_	11	punct	_	_
15	the	_	DET	DT	_	17	det	_	_
16	serotonin	_	NOUN	NN	_	17	compound	_	_
17	5HT2A	_	NOUN	NN	_	11	conj	_	_
18	,	_	.	,	_	11	punct	_	_
19	5HT2C	_	NOUN	NN	_	11	conj	_	_
20	,	_	.	,	_	11	punct	_	_
21	5HT1A	_	NOUN	NN	_	11	conj	_	_
22	,	_	.	,	_	11	punct	_	_
23	5HT1D	_	NOUN	NN	_	11	conj	_	_
24	,	_	.	,	_	11	punct	_	_
25	and	_	CONJ	CC	_	11	cc	_	_
26	A1	_	NOUN	NN	_	28	compound	_	_
27	adrenergic	_	ADJ	JJ	_	28	amod	_	_
28	receptors	_	NOUN	NNS	_	11	conj	_	_
29	Ki	_	NOUN	NN	_	30	compound	_	_
30	s	_	NOUN	NNS	_	28	dep	_	_
31	of	_	ADP	IN	_	32	case	_	_
32	4.8	_	NUM	CD	_	30	nmod	_	_
33	,	_	.	,	_	32	punct	_	_
34	7.2	_	NUM	CD	_	32	conj	_	_
35	,	_	.	,	_	32	punct	_	_
36	0.4	_	NUM	CD	_	32	conj	_	_
37	,	_	.	,	_	32	punct	_	_
38	1.3	_	NUM	CD	_	32	conj	_	_
39	,	_	.	,	_	32	punct	_	_
40	3.4	_	NUM	CD	_	32	conj	_	_
41	,	_	.	,	_	32	punct	_	_
42	2	_	NUM	CD	_	32	conj	_	_
43	,	_	.	,	_	32	punct	_	_
44	and	_	CONJ	CC	_	32	cc	_	_
45	10	_	NUM	CD	_	32	conj	_	_
46	nM	_	NOUN	NN	_	32	dep	_	_
47	,	_	.	,	_	30	punct	_	_
48	respectively	_	ADV	RB	_	30	advmod	_	_
49	,	_	.	,	_	2	punct	_	_
50	and	_	CONJ	CC	_	2	cc	_	_
51	moderate	_	ADJ	JJ	_	52	amod	_	_
52	affinity	_	NOUN	NN	_	2	conj	_	_
53	for	_	ADP	IN	_	59	case	_	_
54	the	_	DET	DT	_	59	det	_	_
55	histamine	_	NOUN	NN	_	59	compound	_	_
56	H1	_	NOUN	NN	_	59	compound	_	_
57	receptor	_	NOUN	NN	_	59	compound	_	_
58	Ki=47	_	NOUN	NN	_	59	compound	_	_
59	nM	_	NOUN	NN	_	52	nmod	_	_

#	Ziprasidone	4599
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	functioned	_	VERB	VBD	_	0	root	_	_
3	as	_	ADP	IN	_	5	case	_	_
4	an	_	DET	DT	_	5	det	_	_
5	antagonist	_	NOUN	NN	_	2	nmod	_	_
6	at	_	ADP	IN	_	12	case	_	_
7	the	_	DET	DT	_	12	det	_	_
8	D	_	NOUN	NN	_	12	compound	_	_
9	2	_	NUM	CD	_	12	nummod	_	_
10	,	_	.	,	_	12	punct	_	_
11	5HT	_	NOUN	NN	_	12	compound	_	_
12	2A	_	NOUN	NN	_	5	nmod	_	_
13	,	_	.	,	_	12	punct	_	_
14	and	_	CONJ	CC	_	12	cc	_	_
15	5HT	_	NOUN	NN	_	17	compound	_	_
16	1D	_	NOUN	NN	_	17	compound	_	_
17	receptors	_	NOUN	NNS	_	12	conj	_	_
18	,	_	.	,	_	5	punct	_	_
19	and	_	CONJ	CC	_	5	cc	_	_
20	as	_	ADP	IN	_	22	case	_	_
21	an	_	DET	DT	_	22	det	_	_
22	agonist	_	NOUN	NN	_	5	conj	_	_
23	at	_	ADP	IN	_	27	case	_	_
24	the	_	DET	DT	_	27	det	_	_
25	5HT	_	NOUN	NN	_	27	compound	_	_
26	1A	_	NOUN	NN	_	27	compound	_	_
27	receptor	_	NOUN	NN	_	22	nmod	_	_

#	Ziprasidone	4600
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	inhibited	_	VERB	VBD	_	0	root	_	_
3	synaptic	_	ADJ	JJ	_	4	amod	_	_
4	reuptake	_	NOUN	NN	_	2	dobj	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	serotonin	_	NOUN	NN	_	4	nmod	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	norepinephrine	_	NOUN	NN	_	6	conj	_	_

#	Ziprasidone	4601
1	No	_	DET	DT	_	3	neg	_	_
2	appreciable	_	ADJ	JJ	_	3	amod	_	_
3	affinity	_	NOUN	NN	_	5	nsubjpass	_	_
4	was	_	VERB	VBD	_	5	auxpass	_	_
5	exhibited	_	VERB	VBN	_	0	root	_	_
6	for	_	ADP	IN	_	11	case	_	_
7	other	_	ADJ	JJ	_	11	amod	_	_
8	receptor	_	NOUN	NN	_	11	compound	_	_
9	/	_	.	:	_	11	punct	_	_
10	binding	_	NOUN	NN	_	11	compound	_	_
11	sites	_	NOUN	NNS	_	5	nmod	_	_
12	tested	_	VERB	VBN	_	11	acl	_	_
13	,	_	.	,	_	11	punct	_	_
14	including	_	VERB	VBG	_	19	case	_	_
15	the	_	DET	DT	_	19	det	_	_
16	cholinergic	_	ADJ	JJ	_	19	amod	_	_
17	muscarinic	_	ADJ	JJ	_	19	amod	_	_
18	receptor	_	NOUN	NN	_	19	compound	_	_
19	IC50	_	NOUN	NN	_	11	nmod	_	_
20	>1	_	NUM	CD	_	19	nummod	_	_
21	uM	_	ADV	RB	_	5	advmod	_	_

#	Ziprasidone	4602
1	Antagonism	_	NOUN	NN	_	15	nsubj	_	_
2	at	_	ADP	IN	_	3	case	_	_
3	receptors	_	NOUN	NNS	_	1	nmod	_	_
4	other	_	ADJ	JJ	_	6	case	_	_
5	than	_	ADP	IN	_	4	mwe	_	_
6	dopamine	_	NOUN	NN	_	3	nmod	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	5HT	_	NOUN	NN	_	6	conj	_	_
9	2	_	NUM	CD	_	8	nummod	_	_
10	with	_	ADP	IN	_	13	case	_	_
11	similar	_	ADJ	JJ	_	13	amod	_	_
12	receptor	_	NOUN	NN	_	13	compound	_	_
13	affinities	_	NOUN	NNS	_	1	nmod	_	_
14	may	_	VERB	MD	_	15	aux	_	_
15	explain	_	VERB	VB	_	0	root	_	_
16	some	_	DET	DT	_	15	dobj	_	_
17	of	_	ADP	IN	_	20	case	_	_
18	the	_	DET	DT	_	20	det	_	_
19	other	_	ADJ	JJ	_	20	amod	_	_
20	therapeutic	_	ADJ	JJ	_	16	nmod	_	_
21	and	_	CONJ	CC	_	20	cc	_	_
22	side	_	ADJ	JJ	_	20	conj	_	_
23	effects	_	NOUN	NNS	_	20	dep	_	_
24	of	_	ADP	IN	_	25	case	_	_
25	DRUG	_	NOUN	NN	_	20	nmod	_	_

#	Ziprasidone	4603
1	DRUG	_	NOUN	NN	_	3	nmod:poss	_	_
2	's	_	PRT	POS	_	3	case	_	_
3	antagonism	_	NOUN	NN	_	10	nsubj	_	_
4	of	_	ADP	IN	_	8	case	_	_
5	histamine	_	NOUN	NN	_	8	compound	_	_
6	H	_	NOUN	NN	_	8	compound	_	_
7	1	_	NUM	CD	_	8	nummod	_	_
8	receptors	_	NOUN	NNS	_	3	nmod	_	_
9	may	_	VERB	MD	_	10	aux	_	_
10	explain	_	VERB	VB	_	0	root	_	_
11	the	_	DET	DT	_	12	det	_	_
12	somnolence	_	NOUN	NN	_	10	dobj	_	_
13	observed	_	VERB	VBN	_	12	acl	_	_
14	with	_	ADP	IN	_	16	case	_	_
15	this	_	DET	DT	_	16	det	_	_
16	drug	_	NOUN	NN	_	13	nmod	_	_

#	Ziprasidone	4604
1	DRUG	_	NOUN	NN	_	3	nmod:poss	_	_
2	's	_	PRT	POS	_	1	case	_	_
3	antagonism	_	NOUN	NN	_	9	nsubj	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	A1	_	NOUN	NN	_	7	compound	_	_
6	adrenergic	_	ADJ	JJ	_	7	amod	_	_
7	receptors	_	NOUN	NNS	_	3	nmod	_	_
8	may	_	VERB	MD	_	9	aux	_	_
9	explain	_	VERB	VB	_	0	root	_	_
10	the	_	DET	DT	_	12	det	_	_
11	orthostatic	_	ADJ	JJ	_	12	amod	_	_
12	hypotension	_	NOUN	NN	_	9	dobj	_	_
13	observed	_	VERB	VBN	_	12	acl	_	_
14	with	_	ADP	IN	_	16	case	_	_
15	this	_	DET	DT	_	16	det	_	_
16	drug	_	NOUN	NN	_	13	nmod	_	_

#	Ziprasidone	4605
1	Oral	_	ADJ	JJ	_	2	amod	_	_
2	Pharmacokinetics	_	NOUN	NNS	_	8	nsubj	_	_
3	DRUG	_	NOUN	NN	_	5	nmod:poss	_	_
4	's	_	PRT	POS	_	3	case	_	_
5	activity	_	NOUN	NN	_	2	nmod	_	_
6	is	_	VERB	VBZ	_	8	cop	_	_
7	primarily	_	ADV	RB	_	8	advmod	_	_
8	due	_	ADJ	JJ	_	0	root	_	_
9	to	_	PRT	TO	_	12	case	_	_
10	the	_	DET	DT	_	12	det	_	_
11	parent	_	NOUN	NN	_	12	compound	_	_
12	drug	_	NOUN	NN	_	8	nmod	_	_

#	Ziprasidone	4606
1	The	_	DET	DT	_	4	det	_	_
2	multiple	_	ADJ	JJ	_	4	amod	_	_
3	dose	_	NOUN	NN	_	4	compound	_	_
4	pharmacokinetics	_	NOUN	NNS	_	9	nsubj	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	are	_	VERB	VBP	_	9	cop	_	_
8	dose	_	NOUN	NN	_	9	nmod:npmod	_	_
9	proportional	_	ADJ	JJ	_	0	root	_	_
10	within	_	ADP	IN	_	15	case	_	_
11	the	_	DET	DT	_	15	det	_	_
12	proposed	_	VERB	VBN	_	15	amod	_	_
13	clinical	_	ADJ	JJ	_	15	amod	_	_
14	dose	_	NOUN	NN	_	15	compound	_	_
15	range	_	NOUN	NN	_	9	nmod	_	_
16	,	_	.	,	_	9	punct	_	_
17	and	_	CONJ	CC	_	9	cc	_	_
18	DRUG	_	NOUN	NN	_	19	compound	_	_
19	accumulation	_	NOUN	NN	_	21	nsubj	_	_
20	is	_	VERB	VBZ	_	21	cop	_	_
21	predictable	_	ADJ	JJ	_	9	conj	_	_
22	with	_	ADP	IN	_	24	case	_	_
23	multiple	_	ADJ	JJ	_	24	amod	_	_
24	dosing	_	VERB	VBG	_	21	nmod	_	_

#	Ziprasidone	4607
1	Elimination	_	NOUN	NN	_	8	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	is	_	VERB	VBZ	_	8	cop	_	_
5	mainly	_	ADV	RB	_	8	advmod	_	_
6	via	_	ADP	IN	_	8	case	_	_
7	hepatic	_	ADJ	JJ	_	8	amod	_	_
8	metabolism	_	NOUN	NN	_	0	root	_	_
9	with	_	ADP	IN	_	14	case	_	_
10	a	_	DET	DT	_	14	det	_	_
11	mean	_	ADJ	JJ	_	14	amod	_	_
12	terminal	_	ADJ	JJ	_	14	amod	_	_
13	half	_	ADJ	JJ	_	14	amod	_	_
14	life	_	NOUN	NN	_	8	nmod	_	_
15	of	_	ADP	IN	_	18	case	_	_
16	about	_	ADV	RB	_	17	advmod	_	_
17	7	_	NUM	CD	_	18	nummod	_	_
18	hours	_	NOUN	NNS	_	14	nmod	_	_
19	within	_	ADP	IN	_	24	case	_	_
20	the	_	DET	DT	_	24	det	_	_
21	proposed	_	VERB	VBN	_	24	amod	_	_
22	clinical	_	ADJ	JJ	_	24	amod	_	_
23	dose	_	NOUN	NN	_	24	compound	_	_
24	range	_	NOUN	NN	_	14	nmod	_	_

#	Ziprasidone	4608
1	Steady	_	ADJ	JJ	_	3	amod	_	_
2	state	_	NOUN	NN	_	3	compound	_	_
3	concentrations	_	NOUN	NNS	_	5	nsubjpass	_	_
4	are	_	VERB	VBP	_	5	auxpass	_	_
5	achieved	_	VERB	VBN	_	0	root	_	_
6	within	_	ADP	IN	_	10	case	_	_
7	one	_	NUM	CD	_	9	compound	_	_
8	to	_	PRT	TO	_	9	dep	_	_
9	three	_	NUM	CD	_	10	nummod	_	_
10	days	_	NOUN	NNS	_	5	nmod	_	_
11	of	_	ADP	IN	_	12	mark	_	_
12	dosing	_	VERB	VBG	_	10	acl	_	_

#	Ziprasidone	4609
1	The	_	DET	DT	_	5	det	_	_
2	mean	_	ADJ	JJ	_	5	amod	_	_
3	apparent	_	ADJ	JJ	_	5	amod	_	_
4	systemic	_	ADJ	JJ	_	5	amod	_	_
5	clearance	_	NOUN	NN	_	8	nsubj	_	_
6	is	_	VERB	VBZ	_	8	cop	_	_
7	7.5	_	NUM	CD	_	8	nummod	_	_
8	mL	_	NOUN	NN	_	0	root	_	_
9	/	_	.	:	_	8	punct	_	_
10	min	_	NOUN	NN	_	12	compound	_	_
11	/	_	.	:	_	12	punct	_	_
12	kg	_	NOUN	NN	_	8	dep	_	_

#	Ziprasidone	4610
1	DRUG	_	NOUN	NN	_	3	nsubj	_	_
2	is	_	VERB	VBZ	_	3	cop	_	_
3	unlikely	_	ADJ	JJ	_	0	root	_	_
4	to	_	PRT	TO	_	5	mark	_	_
5	interfere	_	VERB	VB	_	3	xcomp	_	_
6	with	_	ADP	IN	_	8	case	_	_
7	the	_	DET	DT	_	8	det	_	_
8	metabolism	_	NOUN	NN	_	5	nmod	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	drugs	_	NOUN	NNS	_	8	nmod	_	_
11	metabolized	_	VERB	VBN	_	10	acl	_	_
12	by	_	ADP	IN	_	15	case	_	_
13	cytochrome	_	NOUN	NN	_	15	compound	_	_
14	P450	_	NOUN	NN	_	15	compound	_	_
15	enzymes	_	NOUN	NNS	_	11	nmod	_	_

#	Ziprasidone	4611
1	Absorption	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	DRUG	_	NOUN	NN	_	6	nsubjpass	_	_
4	is	_	VERB	VBZ	_	6	auxpass	_	_
5	well	_	ADV	RB	_	6	advmod	_	_
6	absorbed	_	VERB	VBN	_	1	dep	_	_
7	after	_	ADP	IN	_	9	case	_	_
8	oral	_	ADJ	JJ	_	9	amod	_	_
9	administration	_	NOUN	NN	_	6	nmod	_	_
10	,	_	.	,	_	6	punct	_	_
11	reaching	_	VERB	VBG	_	6	xcomp	_	_
12	peak	_	ADJ	JJ	_	14	amod	_	_
13	plasma	_	NOUN	NN	_	14	compound	_	_
14	concentrations	_	NOUN	NNS	_	11	dobj	_	_
15	in	_	ADP	IN	_	19	case	_	_
16	6	_	NUM	CD	_	18	compound	_	_
17	to	_	PRT	TO	_	18	dep	_	_
18	8	_	NUM	CD	_	19	nummod	_	_
19	hours	_	NOUN	NNS	_	14	nmod	_	_

#	Ziprasidone	4614
1	Distribution	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	DRUG	_	NOUN	NN	_	4	nsubj	_	_
4	has	_	VERB	VBZ	_	1	dep	_	_
5	a	_	DET	DT	_	8	det	_	_
6	mean	_	ADJ	JJ	_	8	amod	_	_
7	apparent	_	ADJ	JJ	_	8	amod	_	_
8	volume	_	NOUN	NN	_	4	dobj	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	distribution	_	NOUN	NN	_	8	nmod	_	_
11	of	_	ADP	IN	_	13	case	_	_
12	1.5	_	NUM	CD	_	13	nummod	_	_
13	L	_	NOUN	NN	_	10	nmod	_	_
14	/	_	.	:	_	13	punct	_	_
15	kg	_	NOUN	NN	_	13	dep	_	_

#	Ziprasidone	4615
1	It	_	PRON	PRP	_	3	nsubj	_	_
2	is	_	VERB	VBZ	_	3	cop	_	_
3	greater	_	ADJ	JJ	_	0	root	_	_
4	than	_	ADP	IN	_	5	case	_	_
5	99%	_	NOUN	NN	_	3	nmod	_	_
6	bound	_	VERB	VBN	_	5	acl	_	_
7	to	_	PRT	TO	_	9	case	_	_
8	plasma	_	NOUN	NN	_	9	compound	_	_
9	proteins	_	NOUN	NNS	_	6	nmod	_	_
10	,	_	.	,	_	3	punct	_	_
11	binding	_	VERB	VBG	_	3	dep	_	_
12	primarily	_	ADV	RB	_	14	advmod	_	_
13	to	_	PRT	TO	_	14	case	_	_
14	albumin	_	NOUN	NN	_	11	nmod	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	A1	_	NOUN	NN	_	18	compound	_	_
17	acid	_	NOUN	NN	_	18	compound	_	_
18	glycoprotein	_	NOUN	NN	_	14	conj	_	_

#	Ziprasidone	4616
1	The	_	DET	DT	_	6	det	_	_
2	in	_	X	FW	_	6	amod	_	_
3	vitro	_	X	FW	_	2	dep	_	_
4	plasma	_	NOUN	NN	_	6	compound	_	_
5	protein	_	NOUN	NN	_	6	compound	_	_
6	binding	_	NOUN	NN	_	11	nsubjpass	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	was	_	VERB	VBD	_	11	auxpass	_	_
10	not	_	ADV	RB	_	11	neg	_	_
11	altered	_	VERB	VBN	_	0	root	_	_
12	by	_	ADP	IN	_	13	case	_	_
13	warfarin	_	NOUN	NN	_	11	nmod	_	_
14	or	_	CONJ	CC	_	13	cc	_	_
15	propranolol	_	NOUN	NN	_	13	conj	_	_
16	,	_	.	,	_	13	punct	_	_
17	two	_	NUM	CD	_	19	nummod	_	_
18	highly	_	ADV	RB	_	19	advmod	_	_
19	protein	_	NOUN	NN	_	21	compound	_	_
20	bound	_	ADJ	JJ	_	21	amod	_	_
21	drugs	_	NOUN	NNS	_	13	conj	_	_
22	,	_	.	,	_	11	punct	_	_
23	nor	_	CONJ	CC	_	11	cc	_	_
24	did	_	VERB	MD	_	26	aux	_	_
25	DRUG	_	NOUN	NN	_	26	nsubj	_	_
26	alter	_	VERB	VBP	_	11	conj	_	_
27	the	_	DET	DT	_	28	det	_	_
28	binding	_	NOUN	NN	_	26	dobj	_	_
29	of	_	ADP	IN	_	31	case	_	_
30	these	_	DET	DT	_	31	det	_	_
31	drugs	_	NOUN	NNS	_	28	nmod	_	_
32	in	_	ADP	IN	_	34	case	_	_
33	human	_	ADJ	JJ	_	34	amod	_	_
34	plasma	_	NOUN	NN	_	31	nmod	_	_

#	Ziprasidone	4617
1	Thus	_	ADV	RB	_	14	advmod	_	_
2	,	_	.	,	_	14	punct	_	_
3	the	_	DET	DT	_	4	det	_	_
4	potential	_	NOUN	NN	_	14	nsubj	_	_
5	for	_	ADP	IN	_	7	case	_	_
6	drug	_	NOUN	NN	_	7	compound	_	_
7	interactions	_	NOUN	NNS	_	4	nmod	_	_
8	with	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	due	_	ADJ	JJ	_	12	case	_	_
11	to	_	PRT	TO	_	10	mwe	_	_
12	displacement	_	NOUN	NN	_	4	nmod	_	_
13	is	_	VERB	VBZ	_	14	auxpass	_	_
14	minimal	_	ADJ	JJ	_	0	root	_	_

#	Ziprasidone	4618
1	Metabolism	_	NOUN	NN	_	0	root	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	Elimination	_	NOUN	NN	_	1	conj	_	_
4	:	_	.	:	_	1	punct	_	_
5	DRUG	_	NOUN	NN	_	8	nsubjpass	_	_
6	is	_	VERB	VBZ	_	8	auxpass	_	_
7	extensively	_	ADV	RB	_	8	advmod	_	_
8	metabolized	_	VERB	VBN	_	1	dep	_	_
9	after	_	ADP	IN	_	11	case	_	_
10	oral	_	ADJ	JJ	_	11	amod	_	_
11	administration	_	NOUN	NN	_	8	nmod	_	_
12	with	_	ADP	IN	_	16	case	_	_
13	only	_	ADV	RB	_	16	advmod	_	_
14	a	_	DET	DT	_	16	det	_	_
15	small	_	ADJ	JJ	_	16	amod	_	_
16	amount	_	NOUN	NN	_	11	nmod	_	_
17	excreted	_	VERB	VBN	_	16	acl	_	_
18	in	_	ADP	IN	_	21	case	_	_
19	the	_	DET	DT	_	21	det	_	_
20	urine	_	ADJ	JJ	_	21	amod	_	_
21	<1%	_	NOUN	NN	_	17	nmod	_	_
22	or	_	CONJ	CC	_	21	cc	_	_
23	feces	_	NOUN	NNS	_	21	conj	_	_
24	<4%	_	ADJ	JJ	_	21	dep	_	_
25	as	_	ADP	IN	_	27	case	_	_
26	unchanged	_	ADJ	JJ	_	27	amod	_	_
27	drug	_	NOUN	NN	_	24	nmod	_	_

#	Ziprasidone	4619
1	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
2	is	_	VERB	VBZ	_	4	auxpass	_	_
3	primarily	_	ADV	RB	_	4	advmod	_	_
4	cleared	_	VERB	VBN	_	0	root	_	_
5	via	_	ADP	IN	_	8	case	_	_
6	three	_	NUM	CD	_	8	nummod	_	_
7	metabolic	_	ADJ	JJ	_	8	amod	_	_
8	routes	_	NOUN	NNS	_	4	nmod	_	_
9	to	_	PRT	TO	_	10	mark	_	_
10	yield	_	VERB	VB	_	8	acl	_	_
11	four	_	NUM	CD	_	14	nummod	_	_
12	major	_	ADJ	JJ	_	14	amod	_	_
13	circulating	_	ADJ	JJ	_	14	amod	_	_
14	metabolites	_	NOUN	NNS	_	10	dobj	_	_
15	,	_	.	,	_	14	punct	_	_
16	benzisothiazole	_	NOUN	NN	_	18	compound	_	_
17	BITP	_	NOUN	NN	_	18	compound	_	_
18	sulphoxide	_	NOUN	NN	_	14	conj	_	_
19	,	_	.	,	_	14	punct	_	_
20	BITP	_	NOUN	NN	_	21	compound	_	_
21	sulphone	_	NOUN	NN	_	14	conj	_	_
22	,	_	.	,	_	14	punct	_	_
23	DRUG	_	NOUN	NN	_	24	compound	_	_
24	sulphoxide	_	NOUN	NN	_	14	conj	_	_
25	,	_	.	,	_	14	punct	_	_
26	and	_	CONJ	CC	_	14	cc	_	_
27	S	_	NOUN	NN	_	29	compound	_	_
28	methyldihydro	_	NOUN	NN	_	29	compound	_	_
29	DRUG	_	NOUN	NN	_	14	conj	_	_

#	Ziprasidone	4620
1	Approximately	_	ADV	RB	_	7	advmod	_	_
2	20%	_	NOUN	NN	_	7	nsubjpass	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	the	_	DET	DT	_	5	det	_	_
5	dose	_	NOUN	NN	_	2	nmod	_	_
6	is	_	VERB	VBZ	_	7	auxpass	_	_
7	excreted	_	VERB	VBN	_	0	root	_	_
8	in	_	ADP	IN	_	10	case	_	_
9	the	_	DET	DT	_	10	det	_	_
10	urine	_	ADJ	JJ	_	7	nmod	_	_
11	,	_	.	,	_	7	punct	_	_
12	with	_	ADP	IN	_	16	mark	_	_
13	approximately	_	ADV	RB	_	14	advmod	_	_
14	66%	_	NOUN	NN	_	16	nsubjpass	_	_
15	being	_	VERB	VBD	_	16	auxpass	_	_
16	eliminated	_	VERB	VBN	_	7	advcl	_	_
17	in	_	ADP	IN	_	19	case	_	_
18	the	_	DET	DT	_	19	det	_	_
19	feces	_	NOUN	NNS	_	16	nmod	_	_

#	Ziprasidone	4621
1	Unchanged	_	ADJ	JJ	_	2	amod	_	_
2	DRUG	_	NOUN	NN	_	3	nsubj	_	_
3	represents	_	VERB	VBZ	_	0	root	_	_
4	about	_	ADV	RB	_	5	advmod	_	_
5	44%	_	NOUN	NN	_	3	nmod	_	_
6	of	_	ADP	IN	_	10	case	_	_
7	total	_	ADJ	JJ	_	10	amod	_	_
8	drug	_	NOUN	NN	_	10	compound	_	_
9	related	_	ADJ	JJ	_	10	amod	_	_
10	material	_	NOUN	NN	_	5	nmod	_	_
11	in	_	ADP	IN	_	12	case	_	_
12	serum	_	NOUN	NN	_	10	nmod	_	_

#	Ziprasidone	4622
1	In	_	X	FW	_	3	amod	_	_
2	vitro	_	X	FW	_	1	dep	_	_
3	studies	_	NOUN	NNS	_	9	nsubj	_	_
4	using	_	VERB	VBG	_	3	acl	_	_
5	human	_	ADJ	JJ	_	8	amod	_	_
6	liver	_	NOUN	NN	_	8	compound	_	_
7	subcellular	_	ADJ	JJ	_	8	amod	_	_
8	fractions	_	NOUN	NNS	_	4	dobj	_	_
9	indicate	_	VERB	VBP	_	0	root	_	_
10	that	_	ADP	IN	_	15	mark	_	_
11	S	_	NOUN	NN	_	13	compound	_	_
12	methyldihydro	_	NOUN	NN	_	13	compound	_	_
13	DRUG	_	NOUN	NN	_	15	nsubjpass	_	_
14	is	_	VERB	VBZ	_	15	auxpass	_	_
15	generated	_	VERB	VBN	_	9	ccomp	_	_
16	in	_	ADP	IN	_	18	case	_	_
17	two	_	NUM	CD	_	18	nummod	_	_
18	steps	_	NOUN	NNS	_	15	nmod	_	_

#	Ziprasidone	4623
1	These	_	DET	DT	_	2	det	_	_
2	studies	_	NOUN	NNS	_	3	nsubj	_	_
3	indicate	_	VERB	VBP	_	0	root	_	_
4	that	_	ADP	IN	_	9	mark	_	_
5	the	_	DET	DT	_	7	det	_	_
6	reduction	_	NOUN	NN	_	7	compound	_	_
7	reaction	_	NOUN	NN	_	9	nsubjpass	_	_
8	is	_	VERB	VBZ	_	9	auxpass	_	_
9	mediated	_	VERB	VBN	_	3	ccomp	_	_
10	primarily	_	ADV	RB	_	9	advmod	_	_
11	by	_	ADP	IN	_	13	case	_	_
12	chemical	_	ADJ	JJ	_	13	amod	_	_
13	reduction	_	NOUN	NN	_	9	nmod	_	_
14	by	_	ADP	IN	_	15	case	_	_
15	glutathione	_	NOUN	NN	_	13	nmod	_	_
16	as	_	ADV	RB	_	15	cc	_	_
17	well	_	ADV	RB	_	16	mwe	_	_
18	as	_	ADP	IN	_	16	mwe	_	_
19	by	_	ADP	IN	_	21	case	_	_
20	enzymatic	_	ADJ	JJ	_	21	amod	_	_
21	reduction	_	NOUN	NN	_	15	conj	_	_
22	by	_	ADP	IN	_	24	case	_	_
23	aldehyde	_	NOUN	NN	_	24	compound	_	_
24	oxidase	_	NOUN	NN	_	21	nmod	_	_
25	and	_	CONJ	CC	_	9	cc	_	_
26	the	_	DET	DT	_	28	det	_	_
27	subsequent	_	ADJ	JJ	_	28	amod	_	_
28	methylation	_	NOUN	NN	_	30	nsubjpass	_	_
29	is	_	VERB	VBZ	_	30	auxpass	_	_
30	mediated	_	VERB	VBN	_	9	conj	_	_
31	by	_	ADP	IN	_	33	case	_	_
32	thiol	_	NOUN	NN	_	33	compound	_	_
33	methyltransferase	_	NOUN	NN	_	30	nmod	_	_

#	Ziprasidone	4624
1	In	_	X	FW	_	3	amod	_	_
2	vitro	_	X	FW	_	1	dep	_	_
3	studies	_	NOUN	NNS	_	11	nsubj	_	_
4	using	_	VERB	VBG	_	3	acl	_	_
5	human	_	ADJ	JJ	_	7	amod	_	_
6	liver	_	NOUN	NN	_	7	compound	_	_
7	microsomes	_	NOUN	NNS	_	4	dobj	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	recombinant	_	ADJ	JJ	_	10	amod	_	_
10	enzymes	_	NOUN	NNS	_	7	conj	_	_
11	indicate	_	VERB	VBP	_	0	root	_	_
12	that	_	ADP	IN	_	17	mark	_	_
13	CYP3A4	_	NOUN	NN	_	17	nsubj	_	_
14	is	_	VERB	VBZ	_	17	cop	_	_
15	the	_	DET	DT	_	17	det	_	_
16	major	_	ADJ	JJ	_	17	amod	_	_
17	CYP	_	NOUN	NN	_	11	ccomp	_	_
18	contributing	_	VERB	VBG	_	17	acl	_	_
19	to	_	PRT	TO	_	22	case	_	_
20	the	_	DET	DT	_	22	det	_	_
21	oxidative	_	ADJ	JJ	_	22	amod	_	_
22	metabolism	_	NOUN	NN	_	18	nmod	_	_
23	of	_	ADP	IN	_	24	case	_	_
24	DRUG	_	NOUN	NN	_	22	nmod	_	_

#	Ziprasidone	4625
1	CYP1A2	_	NOUN	NN	_	3	nsubj	_	_
2	may	_	VERB	MD	_	3	aux	_	_
3	contribute	_	VERB	VB	_	0	root	_	_
4	to	_	PRT	TO	_	8	case	_	_
5	a	_	DET	DT	_	8	det	_	_
6	much	_	ADV	RB	_	7	advmod	_	_
7	lesser	_	ADJ	JJ	_	8	amod	_	_
8	extent	_	NOUN	NN	_	3	nmod	_	_

#	Ziprasidone	4626
1	Based	_	VERB	VBN	_	19	nsubjpass	_	_
2	on	_	ADP	IN	_	5	case	_	_
3	in	_	X	FW	_	5	amod	_	_
4	vivo	_	X	FW	_	3	dep	_	_
5	abundance	_	NOUN	NN	_	1	nmod	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	excretory	_	ADJ	JJ	_	8	amod	_	_
8	metabolites	_	NOUN	NNS	_	5	nmod	_	_
9	,	_	.	,	_	1	punct	_	_
10	less	_	ADV	RB	_	12	advmod	_	_
11	than	_	ADP	IN	_	10	mwe	_	_
12	one	_	NUM	CD	_	13	nummod	_	_
13	third	_	NOUN	NN	_	1	nmod	_	_
14	of	_	ADP	IN	_	17	case	_	_
15	DRUG	_	NOUN	NN	_	17	compound	_	_
16	metabolic	_	ADJ	JJ	_	17	amod	_	_
17	clearance	_	NOUN	NN	_	13	nmod	_	_
18	is	_	VERB	VBZ	_	19	auxpass	_	_
19	mediated	_	VERB	VBN	_	0	root	_	_
20	by	_	ADP	IN	_	24	case	_	_
21	cytochrome	_	NOUN	NN	_	22	compound	_	_
22	P450	_	NOUN	NN	_	23	nmod:npmod	_	_
23	catalyzed	_	VERB	VBD	_	24	amod	_	_
24	oxidation	_	NOUN	NN	_	19	nmod	_	_
25	and	_	CONJ	CC	_	19	cc	_	_
26	approximately	_	ADV	RB	_	28	advmod	_	_
27	two	_	NUM	CD	_	28	nummod	_	_
28	thirds	_	NOUN	NNS	_	19	conj	_	_
29	via	_	ADP	IN	_	30	case	_	_
30	reduction	_	NOUN	NN	_	28	nmod	_	_

#	Ziprasidone	4628
1	Intramuscular	_	ADJ	JJ	_	2	amod	_	_
2	Pharmacokinetics	_	NOUN	NNS	_	0	root	_	_
3	Systemic	_	ADJ	JJ	_	4	amod	_	_
4	Bioavailability	_	NOUN	NN	_	2	dep	_	_
5	:	_	.	:	_	2	punct	_	_
6	The	_	DET	DT	_	7	det	_	_
7	bioavailability	_	NOUN	NN	_	13	nsubj	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_
10	administered	_	VERB	VBN	_	9	acl	_	_
11	intramuscularly	_	ADV	RB	_	10	advmod	_	_
12	is	_	VERB	VBZ	_	13	auxpass	_	_
13	100%	_	ADJ	JJ	_	2	dep	_	_

#	Ziprasidone	4629
1	After	_	ADP	IN	_	3	case	_	_
2	intramuscular	_	ADJ	JJ	_	3	amod	_	_
3	administration	_	NOUN	NN	_	12	nmod	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	single	_	ADJ	JJ	_	6	amod	_	_
6	doses	_	NOUN	NNS	_	3	nmod	_	_
7	,	_	.	,	_	12	punct	_	_
8	peak	_	ADJ	JJ	_	10	amod	_	_
9	serum	_	NOUN	NN	_	10	compound	_	_
10	concentrations	_	NOUN	NNS	_	12	nsubj	_	_
11	typically	_	ADV	RB	_	12	advmod	_	_
12	occur	_	VERB	VBP	_	0	root	_	_
13	at	_	ADP	IN	_	16	case	_	_
14	approximately	_	ADV	RB	_	15	advmod	_	_
15	60	_	NUM	CD	_	16	nummod	_	_
16	minutes	_	NOUN	NNS	_	12	nmod	_	_
17	post	_	ADJ	JJ	_	18	amod	_	_
18	dose	_	NOUN	NN	_	16	dep	_	_
19	or	_	CONJ	CC	_	18	cc	_	_
20	earlier	_	ADV	RB	_	18	conj	_	_
21	and	_	CONJ	CC	_	20	cc	_	_
22	the	_	DET	DT	_	27	det	_	_
23	mean	_	NOUN	NN	_	27	compound	_	_
24	half	_	ADJ	JJ	_	27	amod	_	_
25	life	_	NOUN	NN	_	27	compound	_	_
26	T%	_	NOUN	NN	_	27	compound	_	_
27	ranges	_	NOUN	NNS	_	20	conj	_	_
28	from	_	ADP	IN	_	32	case	_	_
29	two	_	NUM	CD	_	31	compound	_	_
30	to	_	PRT	TO	_	31	dep	_	_
31	five	_	NUM	CD	_	32	nummod	_	_
32	hours	_	NOUN	NNS	_	27	nmod	_	_

#	Ziprasidone	4630
1	Exposure	_	NOUN	NN	_	2	nsubj	_	_
2	increases	_	VERB	VBZ	_	0	root	_	_
3	in	_	ADP	IN	_	7	case	_	_
4	a	_	DET	DT	_	7	det	_	_
5	dose	_	NOUN	NN	_	7	compound	_	_
6	related	_	ADJ	JJ	_	7	amod	_	_
7	manner	_	NOUN	NN	_	2	nmod	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	following	_	ADP	IN	_	11	case	_	_
10	three	_	NUM	CD	_	11	nummod	_	_
11	days	_	NOUN	NNS	_	7	conj	_	_
12	of	_	ADP	IN	_	14	case	_	_
13	intramuscular	_	ADJ	JJ	_	14	amod	_	_
14	dosing	_	NOUN	NN	_	11	nmod	_	_
15	,	_	.	,	_	2	punct	_	_
16	little	_	ADJ	JJ	_	17	amod	_	_
17	accumulation	_	NOUN	NN	_	19	nsubjpass	_	_
18	is	_	VERB	VBZ	_	19	auxpass	_	_
19	observed	_	VERB	VBN	_	2	parataxis	_	_

#	Ziprasidone	4631
1	Metabolism	_	NOUN	NN	_	0	root	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	Elimination	_	NOUN	NN	_	1	conj	_	_
4	:	_	.	:	_	1	punct	_	_
5	Although	_	ADP	IN	_	17	mark	_	_
6	the	_	DET	DT	_	7	det	_	_
7	metabolism	_	NOUN	NN	_	17	nsubjpass	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	elimination	_	NOUN	NN	_	7	conj	_	_
10	of	_	ADP	IN	_	12	case	_	_
11	IM	_	NOUN	NN	_	12	compound	_	_
12	DRUG	_	NOUN	NN	_	7	nmod	_	_
13	have	_	VERB	VBP	_	17	aux	_	_
14	not	_	ADV	RB	_	17	neg	_	_
15	been	_	VERB	VBN	_	17	auxpass	_	_
16	systematically	_	ADV	RB	_	17	advmod	_	_
17	evaluated	_	VERB	VBN	_	27	advcl	_	_
18	,	_	.	,	_	27	punct	_	_
19	the	_	DET	DT	_	21	det	_	_
20	intramuscular	_	ADJ	JJ	_	21	amod	_	_
21	route	_	NOUN	NN	_	27	nsubjpass	_	_
22	of	_	ADP	IN	_	23	case	_	_
23	administration	_	NOUN	NN	_	21	nmod	_	_
24	would	_	VERB	MD	_	27	aux	_	_
25	not	_	ADV	RB	_	27	neg	_	_
26	be	_	VERB	VB	_	27	auxpass	_	_
27	expected	_	VERB	VBN	_	1	dep	_	_
28	to	_	PRT	TO	_	29	mark	_	_
29	alter	_	VERB	VB	_	27	xcomp	_	_
30	the	_	DET	DT	_	32	det	_	_
31	metabolic	_	ADJ	JJ	_	32	amod	_	_
32	pathways	_	NOUN	NNS	_	29	dobj	_	_

#	Zolpidem	5655
1	CNS	_	NOUN	NN	_	2	compound	_	_
2	depressants	_	NOUN	NNS	_	0	root	_	_
3	,	_	.	,	_	2	punct	_	_
4	including	_	VERB	VBG	_	5	case	_	_
5	alcohol	_	NOUN	NN	_	2	nmod	_	_
6	:	_	.	:	_	2	punct	_	_
7	Possible	_	ADJ	JJ	_	12	amod	_	_
8	adverse	_	ADJ	JJ	_	12	amod	_	_
9	additive	_	ADJ	JJ	_	12	amod	_	_
10	CNS	_	NOUN	NN	_	12	compound	_	_
11	depressant	_	ADJ	JJ	_	12	amod	_	_
12	effects	_	NOUN	NNS	_	2	dep	_	_
13	5.1	_	NUM	CD	_	12	nummod	_	_
14	,	_	.	,	_	12	punct	_	_
15	7.1	_	NUM	CD	_	16	nummod	_	_
16	Imipramine	_	NOUN	NN	_	12	appos	_	_
17	:	_	.	:	_	12	punct	_	_
18	Decreased	_	VERB	VBN	_	19	amod	_	_
19	alertness	_	NOUN	NN	_	20	nsubj	_	_
20	observed	_	VERB	VBN	_	12	dep	_	_
21	7.1	_	NUM	CD	_	22	nummod	_	_
22	Chlorpromazine	_	NOUN	NN	_	20	dobj	_	_
23	:	_	.	:	_	2	punct	_	_
24	Impaired	_	ADJ	JJ	_	25	amod	_	_
25	alertness	_	NOUN	NN	_	29	nsubj	_	_
26	and	_	CONJ	CC	_	25	cc	_	_
27	psychomotor	_	NOUN	NN	_	28	compound	_	_
28	performance	_	NOUN	NN	_	25	conj	_	_
29	observed	_	VERB	VBD	_	2	dep	_	_
30	7.1	_	NUM	CD	_	31	nummod	_	_
31	Rifampin	_	NOUN	NN	_	29	dobj	_	_
32	:	_	.	:	_	2	punct	_	_
33	Combination	_	NOUN	NN	_	34	compound	_	_
34	use	_	NOUN	NN	_	36	nsubj	_	_
35	may	_	VERB	MD	_	36	aux	_	_
36	decrease	_	VERB	VB	_	2	dep	_	_
37	effect	_	NOUN	NN	_	39	compound	_	_
38	7.2	_	NUM	CD	_	39	nummod	_	_
39	Ketoconazole	_	NOUN	NN	_	36	dobj	_	_
40	:	_	.	:	_	36	punct	_	_
41	Combination	_	NOUN	NN	_	42	compound	_	_
42	use	_	NOUN	NN	_	44	nsubj	_	_
43	may	_	VERB	MD	_	44	aux	_	_
44	increase	_	VERB	VB	_	36	parataxis	_	_
45	effect	_	NOUN	NN	_	48	compound	_	_
46	7.2	_	NUM	CD	_	48	nummod	_	_
47	Co	_	NOUN	NN	_	48	compound	_	_
48	administration	_	NOUN	NN	_	44	dobj	_	_
49	of	_	ADP	IN	_	50	case	_	_
50	DRUG	_	NOUN	NN	_	48	nmod	_	_
51	with	_	ADP	IN	_	54	case	_	_
52	other	_	ADJ	JJ	_	54	amod	_	_
53	CNS	_	NOUN	NN	_	54	compound	_	_
54	depressants	_	NOUN	NNS	_	48	nmod	_	_
55	increases	_	VERB	VBZ	_	44	parataxis	_	_
56	the	_	DET	DT	_	57	det	_	_
57	risk	_	NOUN	NN	_	55	root	_	_
58	of	_	ADP	IN	_	60	case	_	_
59	CNS	_	NOUN	NN	_	60	compound	_	_
60	depression	_	NOUN	NN	_	57	nmod	_	_

#	Zolpidem	5656
1	Concomitant	_	ADJ	JJ	_	2	amod	_	_
2	use	_	NOUN	NN	_	9	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	with	_	ADP	IN	_	7	case	_	_
6	these	_	DET	DT	_	7	det	_	_
7	drugs	_	NOUN	NNS	_	2	nmod	_	_
8	may	_	VERB	MD	_	9	aux	_	_
9	increase	_	VERB	VB	_	0	root	_	_
10	drowsiness	_	NOUN	NN	_	9	dobj	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	psychomotor	_	NOUN	NN	_	13	compound	_	_
13	impairment	_	NOUN	NN	_	10	conj	_	_
14	,	_	.	,	_	10	punct	_	_
15	including	_	VERB	VBG	_	18	case	_	_
16	impaired	_	ADJ	JJ	_	18	amod	_	_
17	driving	_	NOUN	NN	_	18	compound	_	_
18	ability	_	NOUN	NN	_	10	nmod	_	_

#	Zolpidem	5657
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	tartrate	_	NOUN	NN	_	4	nsubjpass	_	_
3	was	_	VERB	VBD	_	4	auxpass	_	_
4	evaluated	_	VERB	VBN	_	0	root	_	_
5	in	_	ADP	IN	_	7	case	_	_
6	healthy	_	ADJ	JJ	_	7	amod	_	_
7	volunteers	_	NOUN	NNS	_	4	nmod	_	_
8	in	_	ADP	IN	_	12	case	_	_
9	single	_	ADJ	JJ	_	12	amod	_	_
10	dose	_	NOUN	NN	_	12	compound	_	_
11	interaction	_	NOUN	NN	_	12	compound	_	_
12	studies	_	NOUN	NNS	_	7	nmod	_	_
13	for	_	ADP	IN	_	16	case	_	_
14	several	_	ADJ	JJ	_	16	amod	_	_
15	CNS	_	NOUN	NN	_	16	compound	_	_
16	drugs	_	NOUN	NNS	_	12	nmod	_	_

#	Zolpidem	5658
1	Imipramine	_	NOUN	NN	_	9	nsubj	_	_
2	,	_	.	,	_	1	punct	_	_
3	Chlorpromazine	_	NOUN	NN	_	4	compound	_	_
4	Imipramine	_	NOUN	NN	_	1	appos	_	_
5	in	_	ADP	IN	_	6	case	_	_
6	combination	_	NOUN	NN	_	1	nmod	_	_
7	with	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	produced	_	VERB	VBD	_	0	root	_	_
10	no	_	DET	DT	_	12	neg	_	_
11	pharmacokinetic	_	ADJ	JJ	_	12	amod	_	_
12	interaction	_	NOUN	NN	_	9	dobj	_	_
13	other	_	ADJ	JJ	_	12	amod	_	_
14	than	_	ADP	IN	_	17	case	_	_
15	a	_	DET	DT	_	17	det	_	_
16	20%	_	ADJ	JJ	_	17	amod	_	_
17	decrease	_	NOUN	NN	_	13	nmod	_	_
18	in	_	ADP	IN	_	20	case	_	_
19	peak	_	ADJ	JJ	_	20	amod	_	_
20	levels	_	NOUN	NNS	_	17	nmod	_	_
21	of	_	ADP	IN	_	22	case	_	_
22	imipramine	_	NOUN	NN	_	20	nmod	_	_
23	,	_	.	,	_	9	punct	_	_
24	but	_	CONJ	CC	_	9	cc	_	_
25	there	_	DET	EX	_	26	expl	_	_
26	was	_	VERB	VBD	_	9	conj	_	_
27	an	_	DET	DT	_	29	det	_	_
28	additive	_	ADJ	JJ	_	29	amod	_	_
29	effect	_	NOUN	NN	_	26	nsubj	_	_
30	of	_	ADP	IN	_	32	case	_	_
31	decreased	_	VERB	VBN	_	32	amod	_	_
32	alertness	_	NOUN	NN	_	29	nmod	_	_

#	Zolpidem	5659
1	Similarly	_	ADV	RB	_	8	advmod	_	_
2	,	_	.	,	_	8	punct	_	_
3	chlorpromazine	_	NOUN	NN	_	8	nsubj	_	_
4	in	_	ADP	IN	_	5	case	_	_
5	combination	_	NOUN	NN	_	3	nmod	_	_
6	with	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	produced	_	VERB	VBD	_	0	root	_	_
9	no	_	DET	DT	_	11	neg	_	_
10	pharmacokinetic	_	ADJ	JJ	_	11	amod	_	_
11	interaction	_	NOUN	NN	_	8	dobj	_	_
12	,	_	.	,	_	8	punct	_	_
13	but	_	CONJ	CC	_	8	cc	_	_
14	there	_	DET	EX	_	15	expl	_	_
15	was	_	VERB	VBD	_	8	conj	_	_
16	an	_	DET	DT	_	18	det	_	_
17	additive	_	ADJ	JJ	_	18	amod	_	_
18	effect	_	NOUN	NN	_	15	nsubj	_	_
19	of	_	ADP	IN	_	21	case	_	_
20	decreased	_	VERB	VBN	_	21	amod	_	_
21	alertness	_	NOUN	NN	_	18	nmod	_	_
22	and	_	CONJ	CC	_	21	cc	_	_
23	psychomotor	_	NOUN	NN	_	24	compound	_	_
24	performance	_	NOUN	NN	_	21	conj	_	_

#	Zolpidem	5660
1	Haloperidol	_	NOUN	NN	_	3	compound	_	_
2	A	_	NOUN	NN	_	3	compound	_	_
3	study	_	NOUN	NN	_	8	nsubj	_	_
4	involving	_	VERB	VBG	_	3	acl	_	_
5	haloperidol	_	NOUN	NN	_	4	dobj	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	DRUG	_	NOUN	NN	_	5	conj	_	_
8	revealed	_	VERB	VBD	_	0	root	_	_
9	no	_	DET	DT	_	10	neg	_	_
10	effect	_	NOUN	NN	_	8	dobj	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	haloperidol	_	NOUN	NN	_	10	nmod	_	_
13	on	_	ADP	IN	_	15	case	_	_
14	the	_	DET	DT	_	15	det	_	_
15	pharmacokinetics	_	NOUN	NNS	_	10	nmod	_	_
16	or	_	CONJ	CC	_	15	cc	_	_
17	pharmacodynamics	_	NOUN	NNS	_	15	conj	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	DRUG	_	NOUN	NN	_	15	nmod	_	_

#	Zolpidem	5661
1	The	_	DET	DT	_	2	det	_	_
2	lack	_	NOUN	NN	_	13	nsubj	_	_
3	of	_	ADP	IN	_	6	case	_	_
4	a	_	DET	DT	_	6	det	_	_
5	drug	_	NOUN	NN	_	6	compound	_	_
6	interaction	_	NOUN	NN	_	2	nmod	_	_
7	following	_	VERB	VBG	_	10	case	_	_
8	single	_	ADJ	JJ	_	10	amod	_	_
9	dose	_	NOUN	NN	_	10	compound	_	_
10	administration	_	NOUN	NN	_	2	nmod	_	_
11	does	_	VERB	VBZ	_	13	aux	_	_
12	not	_	ADV	RB	_	13	neg	_	_
13	predict	_	VERB	VB	_	0	root	_	_
14	the	_	DET	DT	_	15	det	_	_
15	absence	_	NOUN	NN	_	13	dobj	_	_
16	of	_	ADP	IN	_	18	case	_	_
17	an	_	DET	DT	_	18	det	_	_
18	effect	_	NOUN	NN	_	15	nmod	_	_
19	following	_	ADP	IN	_	21	case	_	_
20	chronic	_	ADJ	JJ	_	21	amod	_	_
21	administration	_	NOUN	NN	_	15	nmod	_	_

#	Zolpidem	5662
1	Alcohol	_	NOUN	NN	_	5	compound	_	_
2	An	_	NOUN	NN	_	5	compound	_	_
3	additive	_	ADJ	JJ	_	5	amod	_	_
4	adverse	_	ADJ	JJ	_	5	amod	_	_
5	effect	_	NOUN	NN	_	15	nsubjpass	_	_
6	on	_	ADP	IN	_	8	case	_	_
7	psychomotor	_	NOUN	NN	_	8	compound	_	_
8	performance	_	NOUN	NN	_	5	nmod	_	_
9	between	_	ADP	IN	_	10	case	_	_
10	alcohol	_	NOUN	NN	_	8	nmod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	oral	_	ADJ	JJ	_	13	amod	_	_
13	DRUG	_	NOUN	NN	_	10	conj	_	_
14	was	_	VERB	VBD	_	15	auxpass	_	_
15	demonstrated	_	VERB	VBN	_	0	root	_	_

#	Zolpidem	5663
1	Sertraline	_	NOUN	NN	_	3	compound	_	_
2	Concomitant	_	ADJ	JJ	_	3	amod	_	_
3	administration	_	NOUN	NN	_	8	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	sertraline	_	NOUN	NN	_	5	conj	_	_
8	increases	_	VERB	VBZ	_	0	root	_	_
9	exposure	_	NOUN	NN	_	8	dobj	_	_
10	to	_	PRT	TO	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_

#	Zolpidem	5664
1	Fluoxetine	_	NOUN	NN	_	4	compound	_	_
2	After	_	NOUN	NN	_	4	compound	_	_
3	multiple	_	ADJ	JJ	_	4	amod	_	_
4	doses	_	NOUN	NNS	_	19	nsubjpass	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	DRUG	_	NOUN	NN	_	7	compound	_	_
7	tartrate	_	NOUN	NN	_	4	nmod	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	fluoxetine	_	NOUN	NN	_	7	conj	_	_
10	an	_	DET	DT	_	11	det	_	_
11	increase	_	NOUN	NN	_	19	nsubjpass	_	_
12	in	_	ADP	IN	_	17	case	_	_
13	the	_	DET	DT	_	17	det	_	_
14	DRUG	_	NOUN	NN	_	17	compound	_	_
15	half	_	NOUN	NN	_	17	compound	_	_
16	life	_	NOUN	NN	_	17	compound	_	_
17	17%	_	NOUN	NN	_	11	nmod	_	_
18	was	_	VERB	VBD	_	19	auxpass	_	_
19	observed	_	VERB	VBN	_	0	root	_	_

#	Zolpidem	5665
1	There	_	DET	EX	_	2	expl	_	_
2	was	_	VERB	VBD	_	0	root	_	_
3	no	_	DET	DT	_	4	neg	_	_
4	evidence	_	NOUN	NN	_	2	nsubj	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	an	_	DET	DT	_	8	det	_	_
7	additive	_	ADJ	JJ	_	8	amod	_	_
8	effect	_	NOUN	NN	_	4	nmod	_	_
9	in	_	ADP	IN	_	11	case	_	_
10	psychomotor	_	NOUN	NN	_	11	compound	_	_
11	performance	_	NOUN	NN	_	8	nmod	_	_

#	Zolpidem	5666
1	Some	_	DET	DT	_	2	det	_	_
2	compounds	_	NOUN	NNS	_	10	nsubj	_	_
3	known	_	VERB	VBN	_	2	acl	_	_
4	to	_	PRT	TO	_	5	mark	_	_
5	induce	_	VERB	VB	_	3	xcomp	_	_
6	or	_	CONJ	CC	_	3	cc	_	_
7	inhibit	_	VERB	VB	_	3	conj	_	_
8	CYP3A	_	NOUN	NN	_	7	dobj	_	_
9	may	_	VERB	MD	_	10	aux	_	_
10	affect	_	VERB	VB	_	0	root	_	_
11	exposure	_	NOUN	NN	_	10	dobj	_	_
12	to	_	PRT	TO	_	13	case	_	_
13	DRUG	_	NOUN	NN	_	11	nmod	_	_

#	Zolpidem	5667
1	The	_	DET	DT	_	2	det	_	_
2	effect	_	NOUN	NN	_	19	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	drugs	_	NOUN	NNS	_	2	nmod	_	_
5	that	_	DET	WDT	_	6	nsubj	_	_
6	induce	_	VERB	VBP	_	4	acl:relcl	_	_
7	or	_	CONJ	CC	_	6	cc	_	_
8	inhibit	_	VERB	VBP	_	6	conj	_	_
9	other	_	ADJ	JJ	_	11	amod	_	_
10	P450	_	NOUN	NN	_	11	compound	_	_
11	enzymes	_	NOUN	NNS	_	6	dobj	_	_
12	on	_	ADP	IN	_	14	case	_	_
13	the	_	DET	DT	_	14	det	_	_
14	exposure	_	NOUN	NN	_	6	nmod	_	_
15	to	_	PRT	TO	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	14	nmod	_	_
17	is	_	VERB	VBZ	_	19	auxpass	_	_
18	not	_	ADV	RB	_	19	neg	_	_
19	known	_	VERB	VBN	_	0	root	_	_

#	Zolpidem	5668
1	CYP3A4	_	NOUN	NN	_	2	compound	_	_
2	Inducers	_	NOUN	NNS	_	11	nsubj	_	_
3	Rifampin	_	NOUN	NN	_	4	compound	_	_
4	Rifampin	_	NOUN	NN	_	2	dep	_	_
5	,	_	.	,	_	4	punct	_	_
6	a	_	DET	DT	_	8	det	_	_
7	CYP3A4	_	NOUN	NN	_	8	compound	_	_
8	inducer	_	NOUN	NN	_	4	appos	_	_
9	,	_	.	,	_	4	punct	_	_
10	significantly	_	ADV	RB	_	11	advmod	_	_
11	reduced	_	VERB	VBD	_	0	root	_	_
12	the	_	DET	DT	_	13	det	_	_
13	exposure	_	NOUN	NN	_	11	dobj	_	_
14	to	_	PRT	TO	_	13	dep	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	the	_	DET	DT	_	18	det	_	_
17	pharmacodynamic	_	ADJ	JJ	_	18	amod	_	_
18	effects	_	NOUN	NNS	_	14	conj	_	_
19	of	_	ADP	IN	_	20	case	_	_
20	DRUG	_	NOUN	NN	_	18	nmod	_	_

#	Zolpidem	5669
1	Use	_	NOUN	NN	_	9	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	Rifampin	_	NOUN	NN	_	1	nmod	_	_
4	in	_	ADP	IN	_	5	case	_	_
5	combination	_	NOUN	NN	_	1	nmod	_	_
6	with	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	may	_	VERB	MD	_	9	aux	_	_
9	decrease	_	VERB	VB	_	0	root	_	_
10	the	_	DET	DT	_	11	det	_	_
11	efficacy	_	NOUN	NN	_	9	dobj	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	DRUG	_	NOUN	NN	_	11	nmod	_	_
14	and	_	CONJ	CC	_	9	cc	_	_
15	is	_	VERB	VBZ	_	17	auxpass	_	_
16	not	_	ADV	RB	_	17	neg	_	_
17	recommended	_	VERB	VBN	_	9	conj	_	_

#	Zolpidem	5670
1	St	_	NOUN	NN	_	2	compound	_	_
2	John's	_	NOUN	NNS	_	3	nsubj	_	_
3	wort	_	VERB	VBP	_	0	root	_	_
4	Use	_	NOUN	NN	_	3	dobj	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	St	_	NOUN	NN	_	7	compound	_	_
7	John's	_	NOUN	NNS	_	4	nmod	_	_
8	wort	_	VERB	VBP	_	3	parataxis	_	_
9	,	_	.	,	_	8	punct	_	_
10	a	_	DET	DT	_	12	det	_	_
11	CYP3A4	_	NOUN	NN	_	12	compound	_	_
12	inducer	_	NOUN	NN	_	19	nsubj	_	_
13	,	_	.	,	_	12	punct	_	_
14	in	_	ADP	IN	_	15	case	_	_
15	combination	_	NOUN	NN	_	12	nmod	_	_
16	with	_	ADP	IN	_	17	case	_	_
17	DRUG	_	NOUN	NN	_	15	nmod	_	_
18	may	_	VERB	MD	_	19	aux	_	_
19	decrease	_	VERB	VB	_	8	parataxis	_	_
20	blood	_	NOUN	NN	_	21	compound	_	_
21	levels	_	NOUN	NNS	_	19	dobj	_	_
22	of	_	ADP	IN	_	23	case	_	_
23	DRUG	_	NOUN	NN	_	21	nmod	_	_
24	and	_	CONJ	CC	_	19	cc	_	_
25	is	_	VERB	VBZ	_	27	auxpass	_	_
26	not	_	ADV	RB	_	27	neg	_	_
27	recommended	_	VERB	VBN	_	19	conj	_	_

#	Zolpidem	5671
1	CYP3A4	_	NOUN	NN	_	2	compound	_	_
2	Inhibitors	_	NOUN	NNS	_	4	compound	_	_
3	Ketoconazole	_	NOUN	NN	_	4	compound	_	_
4	Ketoconazole	_	NOUN	NN	_	11	nsubj	_	_
5	,	_	.	,	_	4	punct	_	_
6	a	_	DET	DT	_	9	det	_	_
7	potent	_	ADJ	JJ	_	9	amod	_	_
8	CYP3A4	_	NOUN	NN	_	9	compound	_	_
9	inhibitor	_	NOUN	NN	_	4	appos	_	_
10	,	_	.	,	_	4	punct	_	_
11	increased	_	VERB	VBD	_	0	root	_	_
12	the	_	DET	DT	_	13	det	_	_
13	exposure	_	NOUN	NN	_	11	dobj	_	_
14	to	_	PRT	TO	_	13	dep	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	pharmacodynamic	_	ADJ	JJ	_	17	amod	_	_
17	effects	_	NOUN	NNS	_	14	conj	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	DRUG	_	NOUN	NN	_	17	nmod	_	_

#	Zolpidem	5672
1	Consideration	_	NOUN	NN	_	4	nsubjpass	_	_
2	should	_	VERB	MD	_	4	aux	_	_
3	be	_	VERB	VB	_	4	auxpass	_	_
4	given	_	VERB	VBN	_	0	root	_	_
5	to	_	PRT	TO	_	6	mark	_	_
6	using	_	VERB	VBG	_	4	xcomp	_	_
7	a	_	DET	DT	_	9	det	_	_
8	lower	_	ADJ	JJ	_	9	amod	_	_
9	dose	_	NOUN	NN	_	6	dobj	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	DRUG	_	NOUN	NN	_	9	nmod	_	_
12	when	_	ADV	WRB	_	20	advmod	_	_
13	a	_	DET	DT	_	16	det	_	_
14	potent	_	ADJ	JJ	_	16	amod	_	_
15	CYP3A4	_	NOUN	NN	_	16	compound	_	_
16	inhibitor	_	NOUN	NN	_	20	nsubjpass	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	DRUG	_	NOUN	NN	_	16	conj	_	_
19	are	_	VERB	VBP	_	20	auxpass	_	_
20	given	_	VERB	VBN	_	6	parataxis	_	_
21	together	_	ADV	RB	_	20	advmod	_	_

#	Zolpidem	5673
1	DRUG	_	NOUN	NN	_	13	nsubj	_	_
2	,	_	.	,	_	1	punct	_	_
3	the	_	DET	DT	_	5	det	_	_
4	active	_	ADJ	JJ	_	5	amod	_	_
5	moiety	_	NOUN	NN	_	1	appos	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	DRUG	_	NOUN	NN	_	8	compound	_	_
8	tartrate	_	NOUN	NN	_	5	nmod	_	_
9	,	_	.	,	_	1	punct	_	_
10	is	_	VERB	VBZ	_	13	cop	_	_
11	a	_	DET	DT	_	13	det	_	_
12	hypnotic	_	ADJ	JJ	_	13	amod	_	_
13	agent	_	NOUN	NN	_	0	root	_	_
14	with	_	ADP	IN	_	17	case	_	_
15	a	_	DET	DT	_	17	det	_	_
16	chemical	_	ADJ	JJ	_	17	amod	_	_
17	structure	_	NOUN	NN	_	13	nmod	_	_
18	unrelated	_	ADJ	JJ	_	17	amod	_	_
19	to	_	PRT	TO	_	20	case	_	_
20	benzodiazepines	_	NOUN	NNS	_	18	nmod	_	_
21	,	_	.	,	_	20	punct	_	_
22	barbiturates	_	VERB	VBZ	_	20	conj	_	_
23	,	_	.	,	_	13	punct	_	_
24	or	_	CONJ	CC	_	13	cc	_	_
25	other	_	ADJ	JJ	_	26	amod	_	_
26	drugs	_	NOUN	NNS	_	13	conj	_	_
27	with	_	ADP	IN	_	30	case	_	_
28	known	_	VERB	VBN	_	30	amod	_	_
29	hypnotic	_	ADJ	JJ	_	30	amod	_	_
30	properties	_	NOUN	NNS	_	26	nmod	_	_

#	Zolpidem	5674
1	It	_	PRON	PRP	_	2	nsubj	_	_
2	interacts	_	VERB	VBZ	_	0	root	_	_
3	with	_	ADP	IN	_	8	case	_	_
4	a	_	DET	DT	_	8	det	_	_
5	GABA	_	NOUN	NN	_	8	compound	_	_
6	BZ	_	NOUN	NN	_	8	compound	_	_
7	receptor	_	NOUN	NN	_	8	compound	_	_
8	complex	_	NOUN	NN	_	2	nmod	_	_
9	and	_	CONJ	CC	_	2	cc	_	_
10	shares	_	VERB	VBZ	_	2	conj	_	_
11	some	_	DET	DT	_	10	dobj	_	_
12	of	_	ADP	IN	_	15	case	_	_
13	the	_	DET	DT	_	15	det	_	_
14	pharmacological	_	ADJ	JJ	_	15	amod	_	_
15	properties	_	NOUN	NNS	_	11	nmod	_	_
16	of	_	ADP	IN	_	18	case	_	_
17	the	_	DET	DT	_	18	det	_	_
18	benzodiazepines	_	NOUN	NNS	_	15	nmod	_	_

#	Zolpidem	5675
1	In	_	ADP	IN	_	2	case	_	_
2	contrast	_	NOUN	NN	_	10	nmod	_	_
3	to	_	PRT	TO	_	5	case	_	_
4	the	_	DET	DT	_	5	det	_	_
5	benzodiazepines	_	NOUN	NNS	_	2	nmod	_	_
6	,	_	.	,	_	10	punct	_	_
7	which	_	DET	WDT	_	10	nsubj	_	_
8	non	_	VERB	VBP	_	10	advmod	_	_
9	selectively	_	ADV	RB	_	10	advmod	_	_
10	bind	_	VERB	VBP	_	22	advcl	_	_
11	to	_	PRT	TO	_	17	case	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	activate	_	VERB	VB	_	11	conj	_	_
14	all	_	DET	DT	_	17	det	_	_
15	BZ	_	NOUN	NN	_	17	compound	_	_
16	receptor	_	NOUN	NN	_	17	compound	_	_
17	subtypes	_	NOUN	NNS	_	10	nmod	_	_
18	,	_	.	,	_	22	punct	_	_
19	DRUG	_	NOUN	NN	_	22	nsubj	_	_
20	in	_	X	FW	_	21	compound	_	_
21	vitro	_	X	FW	_	19	advmod	_	_
22	binds	_	VERB	VBZ	_	0	root	_	_
23	the	_	DET	DT	_	25	det	_	_
24	BZ1	_	NOUN	NN	_	25	compound	_	_
25	receptor	_	NOUN	NN	_	22	dobj	_	_
26	preferentially	_	ADV	RB	_	22	advmod	_	_
27	with	_	ADP	IN	_	31	case	_	_
28	a	_	DET	DT	_	31	det	_	_
29	high	_	ADJ	JJ	_	31	amod	_	_
30	affinity	_	NOUN	NN	_	31	compound	_	_
31	ratio	_	NOUN	NN	_	22	nmod	_	_
32	of	_	ADP	IN	_	37	case	_	_
33	the	_	DET	DT	_	37	det	_	_
34	A1	_	NOUN	NN	_	37	compound	_	_
35	/	_	.	:	_	37	punct	_	_
36	A5	_	NOUN	NN	_	37	compound	_	_
37	subunits	_	NOUN	NNS	_	31	nmod	_	_

#	Zolpidem	5676
1	This	_	DET	DT	_	3	det	_	_
2	selective	_	ADJ	JJ	_	3	amod	_	_
3	binding	_	NOUN	NN	_	12	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	on	_	ADP	IN	_	9	case	_	_
7	the	_	DET	DT	_	9	det	_	_
8	BZ1	_	NOUN	NN	_	9	compound	_	_
9	receptor	_	NOUN	NN	_	3	nmod	_	_
10	is	_	VERB	VBZ	_	12	cop	_	_
11	not	_	ADV	RB	_	12	neg	_	_
12	absolute	_	VERB	VB	_	0	root	_	_
13	,	_	.	,	_	12	punct	_	_
14	but	_	CONJ	CC	_	12	cc	_	_
15	it	_	PRON	PRP	_	17	nsubj	_	_
16	may	_	VERB	MD	_	17	aux	_	_
17	explain	_	VERB	VB	_	12	conj	_	_
18	the	_	DET	DT	_	20	det	_	_
19	relative	_	ADJ	JJ	_	20	amod	_	_
20	absence	_	NOUN	NN	_	17	dobj	_	_
21	of	_	ADP	IN	_	25	case	_	_
22	myorelaxant	_	ADJ	JJ	_	25	amod	_	_
23	and	_	CONJ	CC	_	22	cc	_	_
24	anticonvulsant	_	ADJ	JJ	_	22	conj	_	_
25	effects	_	NOUN	NNS	_	20	nmod	_	_
26	in	_	ADP	IN	_	28	case	_	_
27	animal	_	NOUN	NN	_	28	compound	_	_
28	studies	_	NOUN	NNS	_	20	nmod	_	_
29	as	_	ADV	RB	_	28	cc	_	_
30	well	_	ADV	RB	_	29	mwe	_	_
31	as	_	ADP	IN	_	29	mwe	_	_
32	the	_	DET	DT	_	33	det	_	_
33	preservation	_	NOUN	NN	_	28	conj	_	_
34	of	_	ADP	IN	_	37	case	_	_
35	deep	_	NOUN	NN	_	37	compound	_	_
36	sleep	_	NOUN	NN	_	37	compound	_	_
37	stages	_	NOUN	NNS	_	33	nmod	_	_
38	3	_	NUM	CD	_	37	dep	_	_
39	and	_	CONJ	CC	_	38	cc	_	_
40	4	_	NUM	CD	_	38	conj	_	_
41	in	_	ADP	IN	_	43	case	_	_
42	human	_	ADJ	JJ	_	43	amod	_	_
43	studies	_	NOUN	NNS	_	33	nmod	_	_
44	of	_	ADP	IN	_	46	case	_	_
45	DRUG	_	NOUN	NN	_	46	compound	_	_
46	tartrate	_	NOUN	NN	_	43	nmod	_	_
47	at	_	ADP	IN	_	49	case	_	_
48	hypnotic	_	ADJ	JJ	_	49	amod	_	_
49	doses	_	NOUN	NNS	_	43	nmod	_	_

#	Zolpidem	5677
1	The	_	DET	DT	_	3	det	_	_
2	pharmacokinetic	_	ADJ	JJ	_	3	amod	_	_
3	profile	_	NOUN	NN	_	7	nsubjpass	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	AMBIEN	_	NOUN	NN	_	3	nmod	_	_
6	is	_	VERB	VBZ	_	7	auxpass	_	_
7	characterized	_	VERB	VBN	_	0	root	_	_
8	by	_	ADP	IN	_	10	case	_	_
9	rapid	_	ADJ	JJ	_	10	amod	_	_
10	absorption	_	NOUN	NN	_	7	nmod	_	_
11	from	_	ADP	IN	_	14	case	_	_
12	the	_	DET	DT	_	14	det	_	_
13	gastrointestinal	_	ADJ	JJ	_	14	amod	_	_
14	tract	_	NOUN	NN	_	10	nmod	_	_
15	and	_	CONJ	CC	_	10	cc	_	_
16	a	_	DET	DT	_	21	det	_	_
17	short	_	ADJ	JJ	_	21	amod	_	_
18	elimination	_	NOUN	NN	_	21	compound	_	_
19	half	_	NOUN	NN	_	21	compound	_	_
20	life	_	NOUN	NN	_	21	compound	_	_
21	T1	_	NOUN	NN	_	10	conj	_	_
22	/	_	.	:	_	21	punct	_	_
23	2	_	NUM	CD	_	21	dep	_	_
24	in	_	ADP	IN	_	26	case	_	_
25	healthy	_	ADJ	JJ	_	26	amod	_	_
26	subjects	_	NOUN	NNS	_	23	nmod	_	_

#	Zolpidem	5678
1	In	_	ADP	IN	_	6	case	_	_
2	a	_	DET	DT	_	6	det	_	_
3	single	_	ADJ	JJ	_	6	amod	_	_
4	dose	_	NOUN	NN	_	6	compound	_	_
5	crossover	_	ADJ	JJ	_	6	amod	_	_
6	study	_	NOUN	NN	_	11	nsubj	_	_
7	in	_	ADP	IN	_	10	case	_	_
8	45	_	NUM	CD	_	10	nummod	_	_
9	healthy	_	ADJ	JJ	_	10	amod	_	_
10	subjects	_	NOUN	NNS	_	6	nmod	_	_
11	administered	_	VERB	VBD	_	28	advcl	_	_
12	5	_	NUM	CD	_	18	nummod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	10	_	NUM	CD	_	12	conj	_	_
15	mg	_	NOUN	NN	_	18	compound	_	_
16	DRUG	_	NOUN	NN	_	18	compound	_	_
17	tartrate	_	NOUN	NN	_	18	compound	_	_
18	tablets	_	NOUN	NNS	_	11	dobj	_	_
19	,	_	.	,	_	28	punct	_	_
20	the	_	DET	DT	_	23	det	_	_
21	mean	_	NOUN	NN	_	23	compound	_	_
22	peak	_	ADJ	JJ	_	23	amod	_	_
23	concentrations	_	NOUN	NNS	_	28	nsubj	_	_
24	Cma	_	NOUN	NN	_	25	compound	_	_
25	x	_	NOUN	NN	_	23	dep	_	_
26	were	_	VERB	VBD	_	28	cop	_	_
27	59	_	NUM	CD	_	28	nummod	_	_
28	range	_	NOUN	NN	_	0	root	_	_
29	:	_	.	:	_	28	punct	_	_
30	29	_	NUM	CD	_	32	compound	_	_
31	to	_	PRT	TO	_	32	dep	_	_
32	113	_	NUM	CD	_	35	nummod	_	_
33	and	_	CONJ	CC	_	32	cc	_	_
34	121	_	NUM	CD	_	32	conj	_	_
35	range	_	NOUN	NN	_	28	dep	_	_
36	:	_	.	:	_	35	punct	_	_
37	58	_	NUM	CD	_	39	compound	_	_
38	to	_	PRT	TO	_	39	dep	_	_
39	272	_	NUM	CD	_	40	nummod	_	_
40	ng	_	NOUN	NN	_	35	dep	_	_
41	/	_	.	:	_	35	punct	_	_
42	mL	_	NOUN	NN	_	35	dep	_	_
43	,	_	.	,	_	42	punct	_	_
44	respectively	_	ADV	RB	_	42	advmod	_	_
45	,	_	.	,	_	42	punct	_	_
46	occurring	_	VERB	VBG	_	42	acl	_	_
47	at	_	ADP	IN	_	52	case	_	_
48	a	_	DET	DT	_	52	det	_	_
49	mean	_	ADJ	JJ	_	52	amod	_	_
50	time	_	NOUN	NN	_	52	compound	_	_
51	Tma	_	NOUN	NN	_	52	compound	_	_
52	x	_	NOUN	NN	_	46	nmod	_	_
53	of	_	ADP	IN	_	55	case	_	_
54	1.6	_	NUM	CD	_	55	nummod	_	_
55	hours	_	NOUN	NNS	_	52	nmod	_	_
56	for	_	ADP	IN	_	57	case	_	_
57	both	_	CONJ	CC	_	46	nmod	_	_

#	Zolpidem	5679
1	The	_	DET	DT	_	6	det	_	_
2	mean	_	ADJ	JJ	_	6	amod	_	_
3	AMBIEN	_	NOUN	NN	_	6	compound	_	_
4	elimination	_	NOUN	NN	_	6	compound	_	_
5	half	_	NOUN	NN	_	6	compound	_	_
6	life	_	NOUN	NN	_	9	nsubj	_	_
7	was	_	VERB	VBD	_	9	cop	_	_
8	2.6	_	NUM	CD	_	9	nummod	_	_
9	range	_	NOUN	NN	_	0	root	_	_
10	:	_	.	:	_	9	punct	_	_
11	1.4	_	NUM	CD	_	13	compound	_	_
12	to	_	PRT	TO	_	13	dep	_	_
13	4.5	_	NUM	CD	_	16	nummod	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	2.5	_	NUM	CD	_	13	conj	_	_
16	range	_	NOUN	NN	_	9	dep	_	_
17	:	_	.	:	_	9	punct	_	_
18	1.4	_	NUM	CD	_	20	compound	_	_
19	to	_	PRT	TO	_	20	dep	_	_
20	3.8	_	NUM	CD	_	21	nummod	_	_
21	hours	_	NOUN	NNS	_	9	dep	_	_
22	,	_	.	,	_	21	punct	_	_
23	for	_	ADP	IN	_	29	case	_	_
24	the	_	DET	DT	_	29	det	_	_
25	5	_	NUM	CD	_	29	nummod	_	_
26	and	_	CONJ	CC	_	25	cc	_	_
27	10	_	NUM	CD	_	25	conj	_	_
28	mg	_	NOUN	NN	_	29	compound	_	_
29	tablets	_	NOUN	NNS	_	21	nmod	_	_
30	,	_	.	,	_	21	punct	_	_
31	respectively	_	ADV	RB	_	21	advmod	_	_

#	Zolpidem	5680
1	AMBIEN	_	NOUN	NN	_	3	nsubjpass	_	_
2	is	_	VERB	VBZ	_	3	auxpass	_	_
3	converted	_	VERB	VBN	_	0	root	_	_
4	to	_	PRT	TO	_	6	case	_	_
5	inactive	_	ADJ	JJ	_	6	amod	_	_
6	metabolites	_	NOUN	NNS	_	3	nmod	_	_
7	that	_	DET	WDT	_	9	nsubjpass	_	_
8	are	_	VERB	VBP	_	9	auxpass	_	_
9	eliminated	_	VERB	VBN	_	6	acl:relcl	_	_
10	primarily	_	ADV	RB	_	9	advmod	_	_
11	by	_	ADP	IN	_	13	case	_	_
12	renal	_	ADJ	JJ	_	13	amod	_	_
13	excretion	_	NOUN	NN	_	9	nmod	_	_

#	Zolpidem	5681
1	AMBIEN	_	NOUN	NN	_	2	nsubj	_	_
2	demonstrated	_	VERB	VBD	_	0	root	_	_
3	linear	_	ADJ	JJ	_	4	amod	_	_
4	kinetics	_	NOUN	NNS	_	2	dobj	_	_
5	in	_	ADP	IN	_	8	case	_	_
6	the	_	DET	DT	_	8	det	_	_
7	dose	_	NOUN	NN	_	8	compound	_	_
8	range	_	NOUN	NN	_	2	nmod	_	_
9	of	_	ADP	IN	_	16	case	_	_
10	5	_	NUM	CD	_	12	compound	_	_
11	to	_	PRT	TO	_	12	dep	_	_
12	20	_	NUM	CD	_	16	nummod	_	_
13	mg	_	NOUN	NN	_	16	amod	_	_
14	Total	_	ADJ	JJ	_	16	amod	_	_
15	protein	_	NOUN	NN	_	16	compound	_	_
16	binding	_	NOUN	NN	_	8	nmod	_	_
17	was	_	VERB	VBD	_	18	auxpass	_	_
18	found	_	VERB	VBN	_	2	parataxis	_	_
19	to	_	PRT	TO	_	23	mark	_	_
20	be	_	VERB	VB	_	23	cop	_	_
21	92.5	_	NUM	CD	_	23	nummod	_	_
22	*	_	CONJ	CC	_	23	advmod	_	_
23	0.1%	_	NOUN	NN	_	18	xcomp	_	_
24	and	_	CONJ	CC	_	18	cc	_	_
25	remained	_	VERB	VBD	_	18	conj	_	_
26	constant	_	NOUN	NN	_	25	xcomp	_	_
27	,	_	.	,	_	25	punct	_	_
28	independent	_	ADJ	JJ	_	25	xcomp	_	_
29	of	_	ADP	IN	_	30	case	_	_
30	concentration	_	NOUN	NN	_	28	nmod	_	_
31	between	_	ADP	IN	_	35	case	_	_
32	40	_	NUM	CD	_	35	nummod	_	_
33	and	_	CONJ	CC	_	32	cc	_	_
34	790	_	NUM	CD	_	32	conj	_	_
35	ng	_	NOUN	NN	_	30	nmod	_	_
36	/	_	.	:	_	35	punct	_	_
37	mL	_	NOUN	NN	_	35	dep	_	_

#	Zolpidem	5682
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	did	_	VERB	VBD	_	4	aux	_	_
3	not	_	ADV	RB	_	4	neg	_	_
4	accumulate	_	VERB	VB	_	0	root	_	_
5	in	_	ADP	IN	_	7	case	_	_
6	young	_	ADJ	JJ	_	7	amod	_	_
7	adults	_	NOUN	NNS	_	4	nmod	_	_
8	following	_	VERB	VBG	_	10	case	_	_
9	nightly	_	ADV	RB	_	10	advmod	_	_
10	dosing	_	VERB	VBG	_	4	nmod	_	_
11	with	_	ADP	IN	_	16	case	_	_
12	20	_	NUM	CD	_	16	nummod	_	_
13	mg	_	NOUN	NN	_	16	amod	_	_
14	DRUG	_	NOUN	NN	_	16	compound	_	_
15	tartrate	_	NOUN	NN	_	16	compound	_	_
16	tablets	_	NOUN	NNS	_	10	nmod	_	_
17	for	_	ADP	IN	_	19	case	_	_
18	2	_	NUM	CD	_	19	nummod	_	_
19	weeks	_	NOUN	NNS	_	16	nmod	_	_

#	Zolpidem	5683
1	A	_	DET	DT	_	4	det	_	_
2	food	_	NOUN	NN	_	4	compound	_	_
3	effect	_	NOUN	NN	_	4	compound	_	_
4	study	_	NOUN	NN	_	10	nsubj	_	_
5	in	_	ADP	IN	_	9	case	_	_
6	30	_	NUM	CD	_	9	nummod	_	_
7	healthy	_	ADJ	JJ	_	9	amod	_	_
8	male	_	ADJ	JJ	_	9	amod	_	_
9	subjects	_	NOUN	NNS	_	4	nmod	_	_
10	compared	_	VERB	VBD	_	0	root	_	_
11	the	_	DET	DT	_	12	det	_	_
12	pharmacokinetics	_	NOUN	NNS	_	10	dobj	_	_
13	of	_	ADP	IN	_	16	case	_	_
14	AMBIEN	_	NOUN	NN	_	16	compound	_	_
15	10	_	NUM	CD	_	16	nummod	_	_
16	mg	_	NOUN	NN	_	12	nmod	_	_
17	when	_	ADV	WRB	_	18	advmod	_	_
18	administered	_	VERB	VBN	_	10	advcl	_	_
19	while	_	ADP	IN	_	18	ccomp	_	_
20	fasting	_	VERB	VBG	_	23	amod	_	_
21	or	_	CONJ	CC	_	20	cc	_	_
22	20	_	NUM	CD	_	20	conj	_	_
23	minutes	_	NOUN	NNS	_	19	root	_	_
24	after	_	ADP	IN	_	26	case	_	_
25	a	_	DET	DT	_	26	det	_	_
26	meal	_	ADJ	JJ	_	23	nmod	_	_

#	Zolpidem	5684
1	Results	_	NOUN	NNS	_	2	nsubj	_	_
2	demonstrated	_	VERB	VBD	_	0	root	_	_
3	that	_	ADP	IN	_	12	mark	_	_
4	with	_	ADP	IN	_	5	case	_	_
5	food	_	NOUN	NN	_	12	nmod	_	_
6	,	_	.	,	_	12	punct	_	_
7	mean	_	NOUN	NN	_	8	compound	_	_
8	AUC	_	NOUN	NN	_	12	nsubjpass	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	Cmax	_	NOUN	NN	_	8	conj	_	_
11	were	_	VERB	VBD	_	12	auxpass	_	_
12	decreased	_	VERB	VBN	_	2	ccomp	_	_
13	by	_	ADP	IN	_	14	case	_	_
14	15%	_	NOUN	NN	_	12	nmod	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	25%	_	NOUN	NN	_	14	conj	_	_
17	,	_	.	,	_	12	punct	_	_
18	respectively	_	ADV	RB	_	12	advmod	_	_
19	,	_	.	,	_	12	punct	_	_
20	while	_	ADP	IN	_	12	dep	_	_
21	mean	_	NOUN	NN	_	22	compound	_	_
22	Tmax	_	NOUN	NN	_	24	nsubjpass	_	_
23	was	_	VERB	VBD	_	24	auxpass	_	_
24	prolonged	_	VERB	VBN	_	12	parataxis	_	_
25	by	_	ADP	IN	_	26	case	_	_
26	60%	_	NOUN	NN	_	24	nmod	_	_
27	from	_	ADP	IN	_	31	case	_	_
28	1.4	_	NUM	CD	_	30	compound	_	_
29	to	_	PRT	TO	_	30	dep	_	_
30	2.2	_	NUM	CD	_	31	nummod	_	_
31	hr	_	NOUN	NN	_	26	nmod	_	_

#	Zolpidem	5685
1	These	_	DET	DT	_	2	det	_	_
2	results	_	NOUN	NNS	_	3	nsubj	_	_
3	suggest	_	VERB	VBP	_	0	root	_	_
4	that	_	ADP	IN	_	15	mark	_	_
5	,	_	.	,	_	15	punct	_	_
6	for	_	ADP	IN	_	9	case	_	_
7	faster	_	NOUN	NN	_	9	amod	_	_
8	sleep	_	NOUN	NN	_	9	compound	_	_
9	onset	_	NOUN	NN	_	15	nmod	_	_
10	,	_	.	,	_	15	punct	_	_
11	AMBIEN	_	NOUN	NN	_	15	nsubjpass	_	_
12	should	_	VERB	MD	_	15	aux	_	_
13	not	_	ADV	RB	_	15	neg	_	_
14	be	_	VERB	VB	_	15	auxpass	_	_
15	administered	_	VERB	VBN	_	3	ccomp	_	_
16	with	_	ADP	IN	_	18	case	_	_
17	or	_	CONJ	CC	_	18	cc	_	_
18	immediately	_	ADV	RB	_	15	advmod	_	_
19	after	_	ADP	IN	_	21	case	_	_
20	a	_	DET	DT	_	21	det	_	_
21	meal	_	ADJ	JJ	_	15	nmod	_	_

#	Zolpidem	5686
1	Special	_	ADJ	JJ	_	2	amod	_	_
2	Populations	_	NOUN	NNS	_	0	root	_	_
3	Elderly	_	ADV	RB	_	2	advmod	_	_
4	:	_	.	:	_	2	punct	_	_
5	In	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	elderly	_	NOUN	NN	_	2	nmod	_	_
8	,	_	.	,	_	2	punct	_	_
9	the	_	DET	DT	_	10	det	_	_
10	dose	_	NOUN	NN	_	16	nsubj	_	_
11	for	_	ADP	IN	_	12	case	_	_
12	AMBIEN	_	NOUN	NN	_	10	nmod	_	_
13	should	_	VERB	MD	_	16	aux	_	_
14	be	_	VERB	VB	_	16	cop	_	_
15	5	_	NUM	CD	_	16	nummod	_	_
16	mg	_	NOUN	NN	_	2	appos	_	_

#	Zolpidem	5687
1	This	_	DET	DT	_	2	det	_	_
2	recommendation	_	NOUN	NN	_	4	nsubjpass	_	_
3	is	_	VERB	VBZ	_	4	auxpass	_	_
4	based	_	VERB	VBN	_	0	root	_	_
5	on	_	ADP	IN	_	7	case	_	_
6	several	_	ADJ	JJ	_	7	amod	_	_
7	studies	_	NOUN	NNS	_	4	nmod	_	_
8	in	_	ADP	IN	_	9	case	_	_
9	which	_	DET	WDT	_	22	nmod	_	_
10	the	_	DET	DT	_	12	det	_	_
11	mean	_	NOUN	NN	_	12	compound	_	_
12	Cmax	_	NOUN	NN	_	22	nsubjpass	_	_
13	,	_	.	,	_	12	punct	_	_
14	T1	_	NOUN	NN	_	12	conj	_	_
15	/	_	.	:	_	12	punct	_	_
16	2	_	NUM	CD	_	12	nummod	_	_
17	,	_	.	,	_	12	punct	_	_
18	and	_	CONJ	CC	_	12	cc	_	_
19	AUC	_	NOUN	NN	_	12	conj	_	_
20	were	_	VERB	VBD	_	22	auxpass	_	_
21	significantly	_	ADV	RB	_	22	advmod	_	_
22	increased	_	VERB	VBN	_	7	acl:relcl	_	_
23	when	_	ADV	WRB	_	24	advmod	_	_
24	compared	_	VERB	VBN	_	22	advcl	_	_
25	to	_	PRT	TO	_	26	case	_	_
26	results	_	NOUN	NNS	_	24	nmod	_	_
27	in	_	ADP	IN	_	29	case	_	_
28	young	_	ADJ	JJ	_	29	amod	_	_
29	adults	_	NOUN	NNS	_	26	nmod	_	_

#	Zolpidem	5688
1	In	_	ADP	IN	_	3	case	_	_
2	one	_	NUM	CD	_	3	nummod	_	_
3	study	_	NOUN	NN	_	24	nmod	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	eight	_	NUM	CD	_	7	nummod	_	_
6	elderly	_	ADJ	JJ	_	7	amod	_	_
7	subjects	_	NOUN	NNS	_	3	nmod	_	_
8	>	_	NUM	CD	_	10	nummod	_	_
9	70	_	NUM	CD	_	10	nummod	_	_
10	years	_	NOUN	NNS	_	7	dep	_	_
11	,	_	.	,	_	24	punct	_	_
12	the	_	DET	DT	_	13	det	_	_
13	means	_	NOUN	NNS	_	24	nsubj	_	_
14	for	_	ADP	IN	_	15	case	_	_
15	Cmax	_	NOUN	NN	_	13	nmod	_	_
16	,	_	.	,	_	15	punct	_	_
17	T1	_	NOUN	NN	_	15	conj	_	_
18	/	_	.	-RRB-	_	15	punct	_	_
19	2	_	NUM	CD	_	15	nummod	_	_
20	,	_	.	,	_	15	punct	_	_
21	and	_	CONJ	CC	_	15	cc	_	_
22	AUC	_	NOUN	NN	_	15	conj	_	_
23	significantly	_	ADV	RB	_	24	advmod	_	_
24	increased	_	VERB	VBD	_	0	root	_	_
25	by	_	ADP	IN	_	30	case	_	_
26	50%	_	ADJ	JJ	_	30	amod	_	_
27	255	_	NUM	CD	_	30	nummod	_	_
28	vs	_	CONJ	CC	_	27	cc	_	_
29	384	_	NUM	CD	_	27	conj	_	_
30	ng	_	NOUN	NN	_	24	nmod	_	_
31	/	_	.	:	_	30	punct	_	_
32	mL	_	NOUN	NN	_	30	appos	_	_
33	,	_	.	,	_	32	punct	_	_
34	32%	_	ADJ	JJ	_	38	amod	_	_
35	2.2	_	NUM	CD	_	38	nummod	_	_
36	vs	_	CONJ	CC	_	35	cc	_	_
37	2.9	_	NUM	CD	_	35	conj	_	_
38	hr	_	NOUN	NN	_	32	conj	_	_
39	,	_	.	,	_	32	punct	_	_
40	and	_	CONJ	CC	_	32	cc	_	_
41	64%	_	ADJ	JJ	_	45	amod	_	_
42	955	_	NUM	CD	_	45	nummod	_	_
43	vs	_	CONJ	CC	_	42	cc	_	_
44	1,562	_	NUM	CD	_	42	conj	_	_
45	ng*hr	_	NOUN	NN	_	32	conj	_	_
46	/	_	.	:	_	32	punct	_	_
47	mL	_	NOUN	NN	_	32	dep	_	_
48	,	_	.	,	_	24	punct	_	_
49	respectively	_	ADV	RB	_	24	advmod	_	_
50	,	_	.	,	_	24	punct	_	_
51	as	_	ADP	IN	_	52	mark	_	_
52	compared	_	VERB	VBN	_	24	advcl	_	_
53	to	_	PRT	TO	_	55	case	_	_
54	younger	_	ADJ	JJ	_	55	amod	_	_
55	adults	_	NOUN	NNS	_	52	nmod	_	_
56	20	_	NUM	CD	_	58	compound	_	_
57	to	_	PRT	TO	_	58	dep	_	_
58	40	_	NUM	CD	_	59	nummod	_	_
59	years	_	NOUN	NNS	_	55	dep	_	_
60	following	_	ADP	IN	_	66	case	_	_
61	a	_	DET	DT	_	66	det	_	_
62	single	_	ADJ	JJ	_	66	amod	_	_
63	20	_	NUM	CD	_	66	nummod	_	_
64	mg	_	NOUN	NN	_	66	compound	_	_
65	oral	_	ADJ	JJ	_	66	amod	_	_
66	dose	_	NOUN	NN	_	55	nmod	_	_

#	Zolpidem	5689
1	AMBIEN	_	NOUN	NN	_	4	nsubj	_	_
2	did	_	VERB	VBD	_	4	aux	_	_
3	not	_	ADV	RB	_	4	neg	_	_
4	accumulate	_	VERB	VB	_	0	root	_	_
5	in	_	ADP	IN	_	7	case	_	_
6	elderly	_	ADJ	JJ	_	7	amod	_	_
7	subjects	_	NOUN	NNS	_	4	nmod	_	_
8	following	_	VERB	VBG	_	11	case	_	_
9	nightly	_	ADV	RB	_	10	advmod	_	_
10	oral	_	ADJ	JJ	_	11	amod	_	_
11	dosing	_	NOUN	NN	_	7	nmod	_	_
12	of	_	ADP	IN	_	14	case	_	_
13	10	_	NUM	CD	_	14	nummod	_	_
14	mg	_	NOUN	NN	_	11	nmod	_	_
15	for	_	ADP	IN	_	17	case	_	_
16	1	_	NUM	CD	_	17	nummod	_	_
17	week	_	NOUN	NN	_	11	nmod	_	_

#	Zolpidem	5690
1	Hepatic	_	ADJ	JJ	_	2	amod	_	_
2	Impairment	_	NOUN	NN	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	The	_	DET	DT	_	5	det	_	_
5	pharmacokinetics	_	NOUN	NNS	_	16	nsubjpass	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	AMBIEN	_	NOUN	NN	_	5	nmod	_	_
8	in	_	ADP	IN	_	10	case	_	_
9	eight	_	NUM	CD	_	10	nummod	_	_
10	patients	_	NOUN	NNS	_	5	nmod	_	_
11	with	_	ADP	IN	_	14	case	_	_
12	chronic	_	ADJ	JJ	_	14	amod	_	_
13	hepatic	_	ADJ	JJ	_	14	amod	_	_
14	insufficiency	_	NOUN	NN	_	10	nmod	_	_
15	were	_	VERB	VBD	_	16	auxpass	_	_
16	compared	_	VERB	VBN	_	2	dep	_	_
17	to	_	PRT	TO	_	18	case	_	_
18	results	_	NOUN	NNS	_	16	nmod	_	_
19	in	_	ADP	IN	_	21	case	_	_
20	healthy	_	ADJ	JJ	_	21	amod	_	_
21	subjects	_	NOUN	NNS	_	18	nmod	_	_

#	Zolpidem	5691
1	Following	_	ADP	IN	_	9	case	_	_
2	a	_	DET	DT	_	9	det	_	_
3	single	_	ADJ	JJ	_	9	amod	_	_
4	20	_	NUM	CD	_	9	nummod	_	_
5	mg	_	NOUN	NN	_	9	compound	_	_
6	oral	_	ADJ	JJ	_	9	amod	_	_
7	DRUG	_	NOUN	NN	_	9	compound	_	_
8	tartrate	_	NOUN	NN	_	9	compound	_	_
9	dose	_	NOUN	NN	_	16	nmod	_	_
10	,	_	.	,	_	16	punct	_	_
11	mean	_	NOUN	NN	_	12	compound	_	_
12	Cmax	_	NOUN	NN	_	16	nsubjpass	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	AUC	_	NOUN	NN	_	12	conj	_	_
15	were	_	VERB	VBD	_	16	auxpass	_	_
16	found	_	VERB	VBN	_	0	root	_	_
17	to	_	PRT	TO	_	20	mark	_	_
18	be	_	VERB	VB	_	20	cop	_	_
19	two	_	NUM	CD	_	20	nummod	_	_
20	times	_	NOUN	NNS	_	16	xcomp	_	_
21	250	_	NUM	CD	_	24	nummod	_	_
22	vs	_	CONJ	CC	_	21	cc	_	_
23	499	_	NUM	CD	_	21	conj	_	_
24	ng	_	NOUN	NN	_	20	dep	_	_
25	/	_	.	:	_	16	punct	_	_
26	mL	_	NOUN	NN	_	16	parataxis	_	_
27	and	_	CONJ	CC	_	26	cc	_	_
28	five	_	NUM	CD	_	29	nummod	_	_
29	times	_	NOUN	NNS	_	33	compound	_	_
30	788	_	NUM	CD	_	33	nummod	_	_
31	vs	_	CONJ	CC	_	30	cc	_	_
32	4,203	_	NUM	CD	_	30	conj	_	_
33	ng*hr	_	NOUN	NN	_	26	conj	_	_
34	/	_	.	:	_	26	punct	_	_
35	mL	_	NOUN	NN	_	36	nmod:npmod	_	_
36	higher	_	ADJ	JJ	_	26	dep	_	_
37	,	_	.	,	_	36	punct	_	_
38	respectively	_	ADV	RB	_	36	advmod	_	_
39	,	_	.	,	_	36	punct	_	_
40	in	_	ADP	IN	_	43	case	_	_
41	hepatically	_	ADV	RB	_	42	advmod	_	_
42	compromised	_	VERB	VBN	_	43	amod	_	_
43	patients	_	NOUN	NNS	_	36	nmod	_	_

#	Zolpidem	5692
1	The	_	DET	DT	_	4	det	_	_
2	mean	_	ADJ	JJ	_	4	compound	_	_
3	half	_	ADJ	JJ	_	4	amod	_	_
4	life	_	NOUN	NN	_	0	root	_	_
5	in	_	ADP	IN	_	7	case	_	_
6	cirrhotic	_	ADJ	JJ	_	7	amod	_	_
7	patients	_	NOUN	NNS	_	4	nmod	_	_
8	of	_	ADP	IN	_	11	case	_	_
9	9.9	_	NUM	CD	_	11	nummod	_	_
10	hr	_	NOUN	NN	_	11	compound	_	_
11	range	_	NOUN	NN	_	7	nmod	_	_
12	:	_	.	:	_	4	punct	_	_
13	4.1	_	NUM	CD	_	15	compound	_	_
14	to	_	PRT	TO	_	15	dep	_	_
15	25.8	_	NUM	CD	_	16	nummod	_	_
16	hr	_	NOUN	NN	_	18	nsubj	_	_
17	was	_	VERB	VBD	_	18	cop	_	_
18	greater	_	ADJ	JJ	_	4	dep	_	_
19	than	_	ADP	IN	_	20	case	_	_
20	that	_	DET	DT	_	18	nmod	_	_
21	observed	_	VERB	VBN	_	20	acl	_	_
22	in	_	ADP	IN	_	24	case	_	_
23	normal	_	ADJ	JJ	_	24	amod	_	_
24	subjects	_	NOUN	NNS	_	21	nmod	_	_
25	of	_	ADP	IN	_	28	case	_	_
26	2.2	_	NUM	CD	_	28	nummod	_	_
27	hr	_	NOUN	NN	_	28	compound	_	_
28	range	_	NOUN	NN	_	24	nmod	_	_
29	:	_	.	:	_	18	punct	_	_
30	1.6	_	NUM	CD	_	32	compound	_	_
31	to	_	PRT	TO	_	32	dep	_	_
32	2.4	_	NUM	CD	_	33	nummod	_	_
33	hr	_	NOUN	NN	_	18	dep	_	_

#	Zolpidem	5693
1	Renal	_	ADJ	JJ	_	2	amod	_	_
2	Impairment	_	NOUN	NN	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	The	_	DET	DT	_	5	det	_	_
5	pharmacokinetics	_	NOUN	NNS	_	10	nsubjpass	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	DRUG	_	NOUN	NN	_	8	compound	_	_
8	tartrate	_	NOUN	NN	_	5	nmod	_	_
9	were	_	VERB	VBD	_	10	auxpass	_	_
10	studied	_	VERB	VBN	_	2	dep	_	_
11	in	_	ADP	IN	_	13	case	_	_
12	11	_	NUM	CD	_	13	nummod	_	_
13	patients	_	NOUN	NNS	_	10	nmod	_	_
14	with	_	ADP	IN	_	20	case	_	_
15	end	_	NOUN	NN	_	20	compound	_	_
16	stage	_	NOUN	NN	_	20	compound	_	_
17	renal	_	ADJ	JJ	_	20	amod	_	_
18	failure	_	NOUN	NN	_	20	compound	_	_
19	mean	_	NOUN	NN	_	20	compound	_	_
20	ClCr	_	NOUN	NN	_	13	nmod	_	_
21	=	_	ADJ	JJ	_	13	amod	_	_
22	6.5	_	NUM	CD	_	24	compound	_	_
23	*	_	ADJ	JJ	_	24	advmod	_	_
24	1.5	_	NUM	CD	_	25	nummod	_	_
25	mL	_	NOUN	NN	_	21	dep	_	_
26	/	_	.	:	_	10	punct	_	_
27	min	_	NOUN	NN	_	10	dep	_	_
28	undergoing	_	VERB	VBG	_	27	acl	_	_
29	hemodialysis	_	NOUN	NN	_	33	compound	_	_
30	three	_	NUM	CD	_	31	nummod	_	_
31	times	_	NOUN	NNS	_	33	dep	_	_
32	a	_	DET	DT	_	33	det	_	_
33	week	_	NOUN	NN	_	28	dobj	_	_
34	,	_	.	,	_	33	punct	_	_
35	who	_	DET	WDT	_	37	nsubjpass	_	_
36	were	_	VERB	VBD	_	37	auxpass	_	_
37	dosed	_	VERB	VBN	_	33	acl:relcl	_	_
38	with	_	ADP	IN	_	42	case	_	_
39	DRUG	_	NOUN	NN	_	42	compound	_	_
40	tartrate	_	NOUN	NN	_	42	compound	_	_
41	10	_	NUM	CD	_	42	nummod	_	_
42	mg	_	NOUN	NN	_	37	nmod	_	_
43	orally	_	ADV	RB	_	37	advmod	_	_
44	each	_	DET	DT	_	45	det	_	_
45	day	_	NOUN	NN	_	43	nmod	_	_
46	for	_	ADP	IN	_	50	case	_	_
47	14	_	NUM	CD	_	50	nummod	_	_
48	or	_	CONJ	CC	_	47	cc	_	_
49	21	_	NUM	CD	_	47	conj	_	_
50	days	_	NOUN	NNS	_	45	nmod	_	_

#	Zolpidem	5694
1	No	_	DET	DT	_	4	neg	_	_
2	statistically	_	ADV	RB	_	3	advmod	_	_
3	significant	_	ADJ	JJ	_	4	amod	_	_
4	differences	_	NOUN	NNS	_	6	nsubjpass	_	_
5	were	_	VERB	VBD	_	6	auxpass	_	_
6	observed	_	VERB	VBN	_	0	root	_	_
7	for	_	ADP	IN	_	8	case	_	_
8	Cmax	_	NOUN	NN	_	6	nmod	_	_
9	,	_	.	,	_	8	punct	_	_
10	Tmax	_	NOUN	NN	_	8	conj	_	_
11	,	_	.	,	_	8	punct	_	_
12	half	_	NOUN	NN	_	13	compound	_	_
13	life	_	NOUN	NN	_	8	conj	_	_
14	,	_	.	,	_	8	punct	_	_
15	and	_	CONJ	CC	_	8	cc	_	_
16	AUC	_	NOUN	NN	_	8	conj	_	_
17	between	_	ADP	IN	_	22	case	_	_
18	the	_	DET	DT	_	22	det	_	_
19	first	_	ADJ	JJ	_	22	amod	_	_
20	and	_	CONJ	CC	_	19	cc	_	_
21	last	_	ADJ	JJ	_	19	conj	_	_
22	day	_	NOUN	NN	_	6	nmod	_	_
23	of	_	ADP	IN	_	25	case	_	_
24	drug	_	NOUN	NN	_	25	compound	_	_
25	administration	_	NOUN	NN	_	22	nmod	_	_
26	when	_	ADV	WRB	_	31	advmod	_	_
27	baseline	_	NOUN	NN	_	29	compound	_	_
28	concentration	_	NOUN	NN	_	29	compound	_	_
29	adjustments	_	NOUN	NNS	_	31	nsubjpass	_	_
30	were	_	VERB	VBD	_	31	auxpass	_	_
31	made	_	VERB	VBN	_	6	advcl	_	_

#	Zolpidem	5695
1	No	_	DET	DT	_	2	neg	_	_
2	accumulation	_	NOUN	NN	_	6	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	unchanged	_	ADJ	JJ	_	5	amod	_	_
5	drug	_	NOUN	NN	_	2	nmod	_	_
6	appeared	_	VERB	VBD	_	0	root	_	_
7	after	_	ADP	IN	_	11	case	_	_
8	14	_	NUM	CD	_	11	nummod	_	_
9	or	_	CONJ	CC	_	8	cc	_	_
10	21	_	NUM	CD	_	8	conj	_	_
11	days	_	NOUN	NNS	_	6	nmod	_	_

#	Zolpidem	5696
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	pharmacokinetics	_	NOUN	NNS	_	6	nsubj	_	_
3	were	_	VERB	VBD	_	6	cop	_	_
4	not	_	ADV	RB	_	6	neg	_	_
5	significantly	_	ADV	RB	_	6	advmod	_	_
6	different	_	ADJ	JJ	_	0	root	_	_
7	in	_	ADP	IN	_	10	case	_	_
8	renally	_	ADV	RB	_	9	advmod	_	_
9	impaired	_	ADJ	JJ	_	10	amod	_	_
10	patients	_	NOUN	NNS	_	6	nmod	_	_

#	Zolpidem	5697
1	No	_	DET	DT	_	3	neg	_	_
2	dosage	_	NOUN	NN	_	3	compound	_	_
3	adjustment	_	NOUN	NN	_	5	nsubj	_	_
4	is	_	VERB	VBZ	_	5	cop	_	_
5	necessary	_	ADJ	JJ	_	0	root	_	_
6	in	_	ADP	IN	_	7	case	_	_
7	patients	_	NOUN	NNS	_	5	nmod	_	_
8	with	_	ADP	IN	_	11	case	_	_
9	compromised	_	VERB	VBN	_	11	amod	_	_
10	renal	_	ADJ	JJ	_	11	amod	_	_
11	function	_	NOUN	NN	_	7	nmod	_	_

#	Zolpidem	5698
1	Drug	_	NOUN	NN	_	2	compound	_	_
2	Interactions	_	NOUN	NNS	_	4	nsubj	_	_
3	CNS	_	NOUN	NN	_	4	nsubj	_	_
4	depressants	_	VERB	VBZ	_	13	nsubj	_	_
5	Co	_	NOUN	NN	_	6	compound	_	_
6	administration	_	NOUN	NN	_	4	dobj	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	with	_	ADP	IN	_	12	case	_	_
10	other	_	ADJ	JJ	_	12	amod	_	_
11	CNS	_	NOUN	NN	_	12	compound	_	_
12	depressants	_	NOUN	NNS	_	4	nmod	_	_
13	increases	_	VERB	VBZ	_	0	root	_	_
14	the	_	DET	DT	_	15	det	_	_
15	risk	_	NOUN	NN	_	13	dobj	_	_
16	of	_	ADP	IN	_	18	case	_	_
17	CNS	_	NOUN	NN	_	18	compound	_	_
18	depression	_	NOUN	NN	_	15	nmod	_	_

#	Zolpidem	5700
1	Imipramine	_	NOUN	NN	_	6	nsubj	_	_
2	in	_	ADP	IN	_	3	case	_	_
3	combination	_	NOUN	NN	_	1	nmod	_	_
4	with	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	produced	_	VERB	VBD	_	0	root	_	_
7	no	_	DET	DT	_	9	neg	_	_
8	pharmacokinetic	_	ADJ	JJ	_	9	amod	_	_
9	interaction	_	NOUN	NN	_	6	dobj	_	_
10	other	_	ADJ	JJ	_	9	amod	_	_
11	than	_	ADP	IN	_	14	case	_	_
12	a	_	DET	DT	_	14	det	_	_
13	20%	_	ADJ	JJ	_	14	amod	_	_
14	decrease	_	NOUN	NN	_	10	nmod	_	_
15	in	_	ADP	IN	_	17	case	_	_
16	peak	_	ADJ	JJ	_	17	amod	_	_
17	levels	_	NOUN	NNS	_	14	nmod	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	imipramine	_	NOUN	NN	_	17	nmod	_	_
20	,	_	.	,	_	6	punct	_	_
21	but	_	CONJ	CC	_	6	cc	_	_
22	there	_	DET	EX	_	23	expl	_	_
23	was	_	VERB	VBD	_	6	conj	_	_
24	an	_	DET	DT	_	26	det	_	_
25	additive	_	ADJ	JJ	_	26	amod	_	_
26	effect	_	NOUN	NN	_	23	nsubj	_	_
27	of	_	ADP	IN	_	29	case	_	_
28	decreased	_	VERB	VBN	_	29	amod	_	_
29	alertness	_	NOUN	NN	_	26	nmod	_	_

#	Zolpidem	5702
1	A	_	DET	DT	_	2	det	_	_
2	study	_	NOUN	NN	_	7	nsubj	_	_
3	involving	_	VERB	VBG	_	2	acl	_	_
4	haloperidol	_	NOUN	NN	_	3	dobj	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	DRUG	_	NOUN	NN	_	4	conj	_	_
7	revealed	_	VERB	VBD	_	0	root	_	_
8	no	_	DET	DT	_	9	neg	_	_
9	effect	_	NOUN	NN	_	7	dobj	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	haloperidol	_	NOUN	NN	_	9	nmod	_	_
12	on	_	ADP	IN	_	14	case	_	_
13	the	_	DET	DT	_	14	det	_	_
14	pharmacokinetics	_	NOUN	NNS	_	9	nmod	_	_
15	or	_	CONJ	CC	_	14	cc	_	_
16	pharmacodynamics	_	NOUN	NNS	_	14	conj	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	DRUG	_	NOUN	NN	_	14	nmod	_	_

#	Zolpidem	5704
1	An	_	DET	DT	_	4	det	_	_
2	additive	_	ADJ	JJ	_	4	amod	_	_
3	adverse	_	ADJ	JJ	_	4	amod	_	_
4	effect	_	NOUN	NN	_	14	nsubjpass	_	_
5	on	_	ADP	IN	_	7	case	_	_
6	psychomotor	_	NOUN	NN	_	7	compound	_	_
7	performance	_	NOUN	NN	_	4	nmod	_	_
8	between	_	ADP	IN	_	9	case	_	_
9	alcohol	_	NOUN	NN	_	7	nmod	_	_
10	and	_	CONJ	CC	_	9	cc	_	_
11	oral	_	ADJ	JJ	_	12	amod	_	_
12	DRUG	_	NOUN	NN	_	9	conj	_	_
13	was	_	VERB	VBD	_	14	auxpass	_	_
14	demonstrated	_	VERB	VBN	_	0	root	_	_

#	Zolpidem	5705
1	Following	_	ADP	IN	_	5	case	_	_
2	five	_	NUM	CD	_	5	nummod	_	_
3	consecutive	_	ADJ	JJ	_	5	amod	_	_
4	nightly	_	ADV	RB	_	5	amod	_	_
5	doses	_	NOUN	NNS	_	39	nmod	_	_
6	at	_	ADP	IN	_	7	case	_	_
7	bedtime	_	NOUN	NN	_	5	nmod	_	_
8	of	_	ADP	IN	_	13	case	_	_
9	oral	_	ADJ	JJ	_	13	amod	_	_
10	DRUG	_	NOUN	NN	_	13	compound	_	_
11	tartrate	_	NOUN	NN	_	13	compound	_	_
12	10	_	NUM	CD	_	13	nummod	_	_
13	mg	_	NOUN	NN	_	7	nmod	_	_
14	in	_	ADP	IN	_	16	case	_	_
15	the	_	DET	DT	_	16	det	_	_
16	presence	_	NOUN	NN	_	7	nmod	_	_
17	of	_	ADP	IN	_	24	case	_	_
18	sertraline	_	NOUN	NN	_	24	compound	_	_
19	50	_	NUM	CD	_	24	nummod	_	_
20	mg	_	NOUN	NN	_	24	compound	_	_
21	17	_	NUM	CD	_	24	nummod	_	_
22	consecutive	_	ADJ	JJ	_	24	amod	_	_
23	daily	_	ADV	RB	_	24	amod	_	_
24	doses	_	NOUN	NNS	_	16	nmod	_	_
25	,	_	.	,	_	39	punct	_	_
26	at	_	ADP	IN	_	28	case	_	_
27	7:00	_	NUM	CD	_	28	nummod	_	_
28	am	_	DET	DT	_	39	nmod	_	_
29	,	_	.	,	_	39	punct	_	_
30	in	_	ADP	IN	_	33	case	_	_
31	healthy	_	ADJ	JJ	_	33	amod	_	_
32	female	_	ADJ	JJ	_	33	amod	_	_
33	volunteers	_	NOUN	NNS	_	39	nmod	_	_
34	,	_	.	,	_	39	punct	_	_
35	DRUG	_	NOUN	NN	_	36	compound	_	_
36	Cmax	_	NOUN	NN	_	39	nsubj	_	_
37	was	_	VERB	VBD	_	39	cop	_	_
38	significantly	_	ADV	RB	_	39	advmod	_	_
39	higher	_	ADJ	JJ	_	0	root	_	_
40	43%	_	NOUN	NN	_	39	xcomp	_	_
41	and	_	CONJ	CC	_	40	cc	_	_
42	Tmax	_	NOUN	NN	_	40	conj	_	_
43	was	_	VERB	VBD	_	45	auxpass	_	_
44	significantly	_	ADV	RB	_	45	advmod	_	_
45	decreased	_	VERB	VBN	_	39	parataxis	_	_
46	53%	_	ADJ	JJ	_	45	xcomp	_	_

#	Zolpidem	5706
1	Pharmacokinetics	_	NOUN	NNS	_	8	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	sertraline	_	NOUN	NN	_	1	nmod	_	_
4	and	_	CONJ	CC	_	3	cc	_	_
5	N	_	NOUN	NN	_	6	compound	_	_
6	desmethylsertraline	_	NOUN	NN	_	3	conj	_	_
7	were	_	VERB	VBD	_	8	cop	_	_
8	unaffected	_	ADJ	JJ	_	0	root	_	_
9	by	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_

#	Zolpidem	5707
1	A	_	DET	DT	_	5	det	_	_
2	single	_	ADJ	JJ	_	5	amod	_	_
3	dose	_	NOUN	NN	_	5	compound	_	_
4	interaction	_	NOUN	NN	_	5	compound	_	_
5	study	_	NOUN	NN	_	24	nsubj	_	_
6	with	_	ADP	IN	_	10	case	_	_
7	DRUG	_	NOUN	NN	_	10	compound	_	_
8	tartrate	_	NOUN	NN	_	10	compound	_	_
9	10	_	NUM	CD	_	10	nummod	_	_
10	mg	_	NOUN	NN	_	5	nmod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	fluoxetine	_	NOUN	NN	_	14	compound	_	_
13	20	_	NUM	CD	_	14	nummod	_	_
14	mg	_	NOUN	NN	_	10	conj	_	_
15	at	_	ADP	IN	_	18	case	_	_
16	steady	_	ADJ	JJ	_	18	amod	_	_
17	state	_	NOUN	NN	_	18	compound	_	_
18	levels	_	NOUN	NNS	_	5	nmod	_	_
19	in	_	ADP	IN	_	21	case	_	_
20	male	_	ADJ	JJ	_	21	amod	_	_
21	volunteers	_	NOUN	NNS	_	18	nmod	_	_
22	did	_	VERB	VBD	_	24	aux	_	_
23	not	_	ADV	RB	_	24	neg	_	_
24	demonstrate	_	VERB	VB	_	0	root	_	_
25	any	_	DET	DT	_	31	det	_	_
26	clinically	_	ADV	RB	_	27	advmod	_	_
27	significant	_	ADJ	JJ	_	28	amod	_	_
28	pharmacokinetic	_	ADJ	JJ	_	31	amod	_	_
29	or	_	CONJ	CC	_	28	cc	_	_
30	pharmacodynamic	_	ADJ	JJ	_	28	conj	_	_
31	interactions	_	NOUN	NNS	_	24	dobj	_	_

#	Zolpidem	5708
1	When	_	ADV	WRB	_	9	advmod	_	_
2	multiple	_	ADJ	JJ	_	3	amod	_	_
3	doses	_	NOUN	NNS	_	9	nsubjpass	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	fluoxetine	_	NOUN	NN	_	5	conj	_	_
8	were	_	VERB	VBD	_	9	auxpass	_	_
9	given	_	VERB	VBN	_	30	advcl	_	_
10	at	_	ADP	IN	_	12	case	_	_
11	steady	_	ADJ	JJ	_	12	amod	_	_
12	state	_	NOUN	NN	_	9	nmod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	the	_	DET	DT	_	15	det	_	_
15	concentrations	_	NOUN	NNS	_	12	conj	_	_
16	evaluated	_	VERB	VBN	_	15	acl	_	_
17	in	_	ADP	IN	_	19	case	_	_
18	healthy	_	ADJ	JJ	_	19	amod	_	_
19	females	_	NOUN	NNS	_	16	nmod	_	_
20	,	_	.	,	_	30	punct	_	_
21	an	_	DET	DT	_	22	det	_	_
22	increase	_	NOUN	NN	_	30	nsubjpass	_	_
23	in	_	ADP	IN	_	28	case	_	_
24	the	_	DET	DT	_	28	det	_	_
25	DRUG	_	NOUN	NN	_	28	compound	_	_
26	half	_	NOUN	NN	_	28	compound	_	_
27	life	_	NOUN	NN	_	28	compound	_	_
28	17%	_	NOUN	NN	_	22	nmod	_	_
29	was	_	VERB	VBD	_	30	auxpass	_	_
30	observed	_	VERB	VBN	_	0	root	_	_

#	Zolpidem	5710
1	Drugs	_	NOUN	NNS	_	16	nsubj	_	_
2	that	_	DET	WDT	_	3	nsubj	_	_
3	Affect	_	NOUN	NN	_	16	advcl	_	_
4	Drug	_	NOUN	NN	_	5	compound	_	_
5	Metabolism	_	NOUN	NN	_	3	dobj	_	_
6	via	_	ADP	IN	_	8	case	_	_
7	Cytochrome	_	NOUN	NN	_	8	compound	_	_
8	P450	_	NOUN	NN	_	3	nmod	_	_
9	Some	_	DET	DT	_	10	det	_	_
10	compounds	_	NOUN	NNS	_	16	nsubj	_	_
11	known	_	VERB	VBN	_	10	acl	_	_
12	to	_	PRT	TO	_	13	mark	_	_
13	inhibit	_	VERB	VB	_	11	xcomp	_	_
14	CYP3A	_	NOUN	NN	_	13	dobj	_	_
15	may	_	VERB	MD	_	16	aux	_	_
16	increase	_	VERB	VB	_	0	root	_	_
17	exposure	_	NOUN	NN	_	16	dobj	_	_
18	to	_	PRT	TO	_	19	case	_	_
19	DRUG	_	NOUN	NN	_	17	nmod	_	_

#	Zolpidem	5711
1	The	_	DET	DT	_	2	det	_	_
2	effect	_	NOUN	NN	_	15	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	inhibitors	_	NOUN	NNS	_	2	nmod	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	other	_	ADJ	JJ	_	8	amod	_	_
7	P450	_	NOUN	NN	_	8	compound	_	_
8	enzymes	_	NOUN	NNS	_	4	nmod	_	_
9	on	_	ADP	IN	_	11	case	_	_
10	the	_	DET	DT	_	11	det	_	_
11	pharmacokinetics	_	NOUN	NNS	_	2	nmod	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	DRUG	_	NOUN	NN	_	11	nmod	_	_
14	is	_	VERB	VBZ	_	15	auxpass	_	_
15	unknown	_	ADJ	JJ	_	0	root	_	_

#	Zolpidem	5712
1	A	_	DET	DT	_	5	det	_	_
2	single	_	ADJ	JJ	_	5	amod	_	_
3	dose	_	NOUN	NN	_	5	compound	_	_
4	interaction	_	NOUN	NN	_	5	compound	_	_
5	study	_	NOUN	NN	_	22	nsubj	_	_
6	with	_	ADP	IN	_	10	case	_	_
7	DRUG	_	NOUN	NN	_	10	compound	_	_
8	tartrate	_	NOUN	NN	_	10	compound	_	_
9	10	_	NUM	CD	_	10	nummod	_	_
10	mg	_	NOUN	NN	_	5	nmod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	itraconazole	_	NOUN	NN	_	14	compound	_	_
13	200	_	NUM	CD	_	14	nummod	_	_
14	mg	_	NOUN	NN	_	10	conj	_	_
15	at	_	ADP	IN	_	18	case	_	_
16	steady	_	ADJ	JJ	_	18	amod	_	_
17	state	_	NOUN	NN	_	18	compound	_	_
18	levels	_	NOUN	NNS	_	5	nmod	_	_
19	in	_	ADP	IN	_	21	case	_	_
20	male	_	ADJ	JJ	_	21	amod	_	_
21	volunteers	_	NOUN	NNS	_	18	nmod	_	_
22	resulted	_	VERB	VBD	_	0	root	_	_
23	in	_	ADP	IN	_	26	case	_	_
24	a	_	DET	DT	_	26	det	_	_
25	34%	_	ADJ	JJ	_	26	amod	_	_
26	increase	_	NOUN	NN	_	22	nmod	_	_
27	in	_	ADP	IN	_	28	case	_	_
28	AUC0	_	NOUN	NN	_	26	nmod	_	_
29	*	_	NUM	CD	_	28	dep	_	_
30	of	_	ADP	IN	_	32	case	_	_
31	DRUG	_	NOUN	NN	_	32	compound	_	_
32	tartrate	_	NOUN	NN	_	28	nmod	_	_

#	Zolpidem	5713
1	There	_	DET	EX	_	2	expl	_	_
2	were	_	VERB	VBD	_	0	root	_	_
3	no	_	DET	DT	_	5	neg	_	_
4	pharmacodynamic	_	ADJ	JJ	_	5	amod	_	_
5	effects	_	NOUN	NNS	_	2	nsubj	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	detected	_	VERB	VBN	_	7	acl	_	_
9	on	_	ADP	IN	_	11	case	_	_
10	subjective	_	ADJ	JJ	_	11	amod	_	_
11	drowsiness	_	NOUN	NN	_	8	nmod	_	_
12	,	_	.	,	_	11	punct	_	_
13	postural	_	ADJ	JJ	_	14	amod	_	_
14	sway	_	NOUN	NN	_	11	conj	_	_
15	,	_	.	,	_	11	punct	_	_
16	or	_	CONJ	CC	_	11	cc	_	_
17	psychomotor	_	NOUN	NN	_	18	compound	_	_
18	performance	_	NOUN	NN	_	11	conj	_	_

#	Zolpidem	5714
1	A	_	DET	DT	_	5	det	_	_
2	single	_	ADJ	JJ	_	5	amod	_	_
3	dose	_	NOUN	NN	_	5	compound	_	_
4	interaction	_	NOUN	NN	_	5	compound	_	_
5	study	_	NOUN	NN	_	22	nsubj	_	_
6	with	_	ADP	IN	_	10	case	_	_
7	DRUG	_	NOUN	NN	_	10	compound	_	_
8	tartrate	_	NOUN	NN	_	10	compound	_	_
9	10	_	NUM	CD	_	10	nummod	_	_
10	mg	_	NOUN	NN	_	5	nmod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	rifampin	_	NOUN	NN	_	14	compound	_	_
13	600	_	NUM	CD	_	14	nummod	_	_
14	mg	_	NOUN	NN	_	10	conj	_	_
15	at	_	ADP	IN	_	18	case	_	_
16	steady	_	ADJ	JJ	_	18	amod	_	_
17	state	_	NOUN	NN	_	18	compound	_	_
18	levels	_	NOUN	NNS	_	5	nmod	_	_
19	in	_	ADP	IN	_	21	case	_	_
20	female	_	ADJ	JJ	_	21	amod	_	_
21	subjects	_	NOUN	NNS	_	18	nmod	_	_
22	showed	_	VERB	VBD	_	0	root	_	_
23	significant	_	ADJ	JJ	_	24	amod	_	_
24	reductions	_	NOUN	NNS	_	22	dobj	_	_
25	of	_	ADP	IN	_	28	case	_	_
26	the	_	DET	DT	_	28	det	_	_
27	AUC	_	NOUN	NN	_	28	compound	_	_
28	73%	_	NOUN	NN	_	24	nmod	_	_
29	,	_	.	,	_	28	punct	_	_
30	Cmax	_	NOUN	NN	_	31	compound	_	_
31	58%	_	NOUN	NN	_	28	conj	_	_
32	,	_	.	,	_	28	punct	_	_
33	and	_	CONJ	CC	_	28	cc	_	_
34	T1	_	NOUN	NN	_	28	conj	_	_
35	/	_	.	:	_	34	punct	_	_
36	2	_	NUM	CD	_	38	nummod	_	_
37	36	_	NUM	CD	_	38	nummod	_	_
38	%	_	NOUN	NN	_	34	appos	_	_
39	of	_	ADP	IN	_	40	case	_	_
40	DRUG	_	NOUN	NN	_	38	nmod	_	_
41	together	_	ADV	RB	_	38	advmod	_	_
42	with	_	ADP	IN	_	44	case	_	_
43	significant	_	ADJ	JJ	_	44	amod	_	_
44	reductions	_	NOUN	NNS	_	38	nmod	_	_
45	in	_	ADP	IN	_	48	case	_	_
46	the	_	DET	DT	_	48	det	_	_
47	pharmacodynamic	_	ADJ	JJ	_	48	amod	_	_
48	effects	_	NOUN	NNS	_	44	nmod	_	_
49	of	_	ADP	IN	_	51	case	_	_
50	DRUG	_	NOUN	NN	_	51	compound	_	_
51	tartrate	_	NOUN	NN	_	48	nmod	_	_

#	Zolpidem	5715
1	Rifampin	_	NOUN	NN	_	8	nsubj	_	_
2	,	_	.	,	_	1	punct	_	_
3	a	_	DET	DT	_	5	det	_	_
4	CYP3A4	_	NOUN	NN	_	5	compound	_	_
5	inducer	_	NOUN	NN	_	1	appos	_	_
6	,	_	.	,	_	1	punct	_	_
7	significantly	_	ADV	RB	_	8	advmod	_	_
8	reduced	_	VERB	VBD	_	0	root	_	_
9	the	_	DET	DT	_	10	det	_	_
10	exposure	_	NOUN	NN	_	8	dobj	_	_
11	to	_	PRT	TO	_	10	dep	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	the	_	DET	DT	_	15	det	_	_
14	pharmacodynamic	_	ADJ	JJ	_	15	amod	_	_
15	effects	_	NOUN	NNS	_	11	conj	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	DRUG	_	NOUN	NN	_	15	nmod	_	_

#	Zolpidem	5716
1	Similarly	_	ADV	RB	_	5	advmod	_	_
2	,	_	.	,	_	5	punct	_	_
3	St	_	NOUN	NN	_	4	compound	_	_
4	John's	_	NOUN	NNS	_	5	nsubj	_	_
5	wort	_	VERB	VBP	_	0	root	_	_
6	,	_	.	,	_	5	punct	_	_
7	a	_	DET	DT	_	9	det	_	_
8	CYP3A4	_	NOUN	NN	_	9	compound	_	_
9	inducer	_	NOUN	NN	_	5	dobj	_	_
10	,	_	.	,	_	5	punct	_	_
11	may	_	VERB	MD	_	13	aux	_	_
12	also	_	ADV	RB	_	13	advmod	_	_
13	decrease	_	VERB	VB	_	5	parataxis	_	_
14	the	_	DET	DT	_	16	det	_	_
15	blood	_	NOUN	NN	_	16	compound	_	_
16	levels	_	NOUN	NNS	_	13	dobj	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	DRUG	_	NOUN	NN	_	16	nmod	_	_

#	Zolpidem	5717
1	A	_	DET	DT	_	5	det	_	_
2	single	_	ADJ	JJ	_	5	amod	_	_
3	dose	_	NOUN	NN	_	5	compound	_	_
4	interaction	_	NOUN	NN	_	5	compound	_	_
5	study	_	NOUN	NN	_	28	nsubj	_	_
6	with	_	ADP	IN	_	10	case	_	_
7	DRUG	_	NOUN	NN	_	10	compound	_	_
8	tartrate	_	NOUN	NN	_	10	compound	_	_
9	5	_	NUM	CD	_	10	nummod	_	_
10	mg	_	NOUN	NN	_	5	nmod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	ketoconazole	_	NOUN	NN	_	10	conj	_	_
13	,	_	.	,	_	10	punct	_	_
14	a	_	DET	DT	_	17	det	_	_
15	potent	_	ADJ	JJ	_	17	amod	_	_
16	CYP3A4	_	NOUN	NN	_	17	compound	_	_
17	inhibitor	_	NOUN	NN	_	10	appos	_	_
18	,	_	.	,	_	10	punct	_	_
19	given	_	VERB	VBN	_	10	acl	_	_
20	as	_	ADP	IN	_	22	case	_	_
21	200	_	NUM	CD	_	22	nummod	_	_
22	mg	_	NOUN	NN	_	19	nmod	_	_
23	twice	_	ADV	RB	_	24	advmod	_	_
24	daily	_	ADV	RB	_	28	advmod	_	_
25	for	_	ADP	IN	_	27	case	_	_
26	2	_	NUM	CD	_	27	nummod	_	_
27	days	_	NOUN	NNS	_	24	nmod	_	_
28	increased	_	VERB	VBD	_	0	root	_	_
29	Cmax	_	NOUN	NN	_	28	dobj	_	_
30	of	_	ADP	IN	_	32	case	_	_
31	DRUG	_	NOUN	NN	_	32	compound	_	_
32	30%	_	NOUN	NN	_	29	nmod	_	_
33	and	_	CONJ	CC	_	28	cc	_	_
34	the	_	DET	DT	_	36	det	_	_
35	total	_	ADJ	JJ	_	36	amod	_	_
36	AUC	_	NOUN	NN	_	40	nsubj	_	_
37	of	_	ADP	IN	_	39	case	_	_
38	DRUG	_	NOUN	NN	_	39	compound	_	_
39	70%	_	NOUN	NN	_	36	nmod	_	_
40	compared	_	VERB	VBD	_	28	conj	_	_
41	to	_	PRT	TO	_	42	case	_	_
42	DRUG	_	NOUN	NN	_	40	nmod	_	_
43	alone	_	ADV	RB	_	40	advmod	_	_
44	and	_	CONJ	CC	_	40	cc	_	_
45	prolonged	_	VERB	VBD	_	40	conj	_	_
46	the	_	DET	DT	_	51	det	_	_
47	elimination	_	NOUN	NN	_	51	compound	_	_
48	half	_	NOUN	NN	_	51	compound	_	_
49	life	_	NOUN	NN	_	51	compound	_	_
50	30	_	NUM	CD	_	51	nummod	_	_
51	%	_	NOUN	NN	_	45	dobj	_	_
52	along	_	ADP	IN	_	55	case	_	_
53	with	_	ADP	IN	_	55	case	_	_
54	an	_	DET	DT	_	55	det	_	_
55	increase	_	NOUN	NN	_	45	nmod	_	_
56	in	_	ADP	IN	_	59	case	_	_
57	the	_	DET	DT	_	59	det	_	_
58	pharmacodynamic	_	ADJ	JJ	_	59	amod	_	_
59	effects	_	NOUN	NNS	_	55	nmod	_	_
60	of	_	ADP	IN	_	61	case	_	_
61	DRUG	_	NOUN	NN	_	59	nmod	_	_

#	Zolpidem	5718
1	Additionally	_	ADV	RB	_	32	advmod	_	_
2	,	_	.	,	_	32	punct	_	_
3	fluvoxamine	_	NOUN	NN	_	32	nsubj	_	_
4	a	_	DET	DT	_	6	det	_	_
5	strong	_	ADJ	JJ	_	6	amod	_	_
6	inhibitor	_	NOUN	NN	_	32	nsubj	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	CYP1A2	_	NOUN	NN	_	6	nmod	_	_
9	and	_	CONJ	CC	_	6	cc	_	_
10	a	_	DET	DT	_	12	det	_	_
11	weak	_	ADJ	JJ	_	12	amod	_	_
12	inhibitor	_	NOUN	NN	_	6	conj	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	CYP3A4	_	NOUN	NN	_	12	nmod	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	CYP2C9	_	NOUN	NN	_	14	conj	_	_
17	and	_	CONJ	CC	_	14	cc	_	_
18	ciprofloxacin	_	NOUN	NN	_	14	conj	_	_
19	a	_	DET	DT	_	21	det	_	_
20	strong	_	ADJ	JJ	_	21	amod	_	_
21	inhibitor	_	NOUN	NN	_	12	dep	_	_
22	of	_	ADP	IN	_	23	case	_	_
23	CYP1A2	_	NOUN	NN	_	21	nmod	_	_
24	and	_	CONJ	CC	_	21	cc	_	_
25	a	_	DET	DT	_	27	det	_	_
26	moderate	_	ADJ	JJ	_	27	amod	_	_
27	inhibitor	_	NOUN	NN	_	21	conj	_	_
28	of	_	ADP	IN	_	29	case	_	_
29	CYP3A4	_	NOUN	NN	_	27	nmod	_	_
30	are	_	VERB	VBP	_	32	cop	_	_
31	also	_	ADV	RB	_	32	advmod	_	_
32	likely	_	ADJ	JJ	_	0	root	_	_
33	to	_	PRT	TO	_	34	mark	_	_
34	inhibit	_	VERB	VB	_	32	xcomp	_	_
35	DRUG	_	NOUN	NN	_	38	nmod:poss	_	_
36	's	_	PRT	POS	_	38	case	_	_
37	metabolic	_	ADJ	JJ	_	38	amod	_	_
38	pathways	_	NOUN	NNS	_	34	dobj	_	_
39	,	_	.	,	_	32	punct	_	_
40	potentially	_	ADV	RB	_	41	advmod	_	_
41	leading	_	VERB	VBG	_	32	advcl	_	_
42	to	_	PRT	TO	_	44	case	_	_
43	an	_	DET	DT	_	44	det	_	_
44	increase	_	NOUN	NN	_	41	nmod	_	_
45	in	_	ADP	IN	_	47	case	_	_
46	DRUG	_	NOUN	NN	_	47	compound	_	_
47	exposure	_	NOUN	NN	_	44	nmod	_	_

#	Zolpidem	5719
1	Other	_	ADJ	JJ	_	2	amod	_	_
2	Drugs	_	NOUN	NNS	_	0	root	_	_
3	with	_	ADP	IN	_	5	case	_	_
4	No	_	NOUN	NN	_	5	compound	_	_
5	Interactions	_	NOUN	NNS	_	2	nmod	_	_
6	with	_	ADP	IN	_	9	case	_	_
7	DRUG	_	NOUN	NN	_	9	compound	_	_
8	A	_	NOUN	NN	_	9	compound	_	_
9	study	_	NOUN	NN	_	5	nmod	_	_
10	involving	_	VERB	VBG	_	9	acl	_	_
11	cimetidine	_	NOUN	NN	_	10	dobj	_	_
12	/	_	.	:	_	11	punct	_	_
13	DRUG	_	NOUN	NN	_	14	compound	_	_
14	tartrate	_	NOUN	NN	_	11	conj	_	_
15	and	_	CONJ	CC	_	11	cc	_	_
16	ranitidine	_	NOUN	NN	_	11	conj	_	_
17	/	_	.	:	_	2	punct	_	_
18	DRUG	_	NOUN	NN	_	20	compound	_	_
19	tartrate	_	NOUN	NN	_	20	compound	_	_
20	combinations	_	NOUN	NNS	_	21	nsubj	_	_
21	revealed	_	VERB	VBD	_	2	dep	_	_
22	no	_	DET	DT	_	23	neg	_	_
23	effect	_	NOUN	NN	_	21	dobj	_	_
24	of	_	ADP	IN	_	26	case	_	_
25	either	_	CONJ	CC	_	26	det	_	_
26	drug	_	NOUN	NN	_	23	nmod	_	_
27	on	_	ADP	IN	_	29	case	_	_
28	the	_	DET	DT	_	29	det	_	_
29	pharmacokinetics	_	NOUN	NNS	_	23	nmod	_	_
30	or	_	CONJ	CC	_	29	cc	_	_
31	pharmacodynamics	_	NOUN	NNS	_	29	conj	_	_
32	of	_	ADP	IN	_	33	case	_	_
33	DRUG	_	NOUN	NN	_	29	nmod	_	_

#	Zolpidem	5720
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	tartrate	_	NOUN	NN	_	3	nsubj	_	_
3	had	_	VERB	VBD	_	0	root	_	_
4	no	_	DET	DT	_	5	neg	_	_
5	effect	_	NOUN	NN	_	3	dobj	_	_
6	on	_	ADP	IN	_	8	case	_	_
7	digoxin	_	NOUN	NN	_	8	compound	_	_
8	pharmacokinetics	_	NOUN	NNS	_	5	nmod	_	_
9	and	_	CONJ	CC	_	3	cc	_	_
10	did	_	VERB	MD	_	12	aux	_	_
11	not	_	ADV	RB	_	12	neg	_	_
12	affect	_	VERB	VB	_	3	conj	_	_
13	prothrombin	_	NOUN	NN	_	14	compound	_	_
14	time	_	NOUN	NN	_	12	dobj	_	_
15	when	_	ADV	WRB	_	16	advmod	_	_
16	given	_	VERB	VBN	_	12	advcl	_	_
17	with	_	ADP	IN	_	18	case	_	_
18	warfarin	_	NOUN	NN	_	16	nmod	_	_
19	in	_	ADP	IN	_	21	case	_	_
20	healthy	_	ADJ	JJ	_	21	amod	_	_
21	subjects	_	NOUN	NNS	_	18	nmod	_	_

#	Zyprexa	1297
1	The	_	DET	DT	_	2	det	_	_
2	risks	_	NOUN	NNS	_	15	nsubjpass	_	_
3	of	_	ADP	IN	_	4	mark	_	_
4	using	_	VERB	VBG	_	2	acl	_	_
5	DRUG	_	NOUN	NN	_	4	dobj	_	_
6	in	_	ADP	IN	_	7	case	_	_
7	combination	_	NOUN	NN	_	4	nmod	_	_
8	with	_	ADP	IN	_	10	case	_	_
9	other	_	ADJ	JJ	_	10	amod	_	_
10	drugs	_	NOUN	NNS	_	7	nmod	_	_
11	have	_	VERB	VBP	_	15	aux	_	_
12	not	_	ADV	RB	_	15	neg	_	_
13	been	_	VERB	VBN	_	15	auxpass	_	_
14	extensively	_	ADV	RB	_	15	advmod	_	_
15	evaluated	_	VERB	VBN	_	0	root	_	_
16	in	_	ADP	IN	_	18	case	_	_
17	systematic	_	ADJ	JJ	_	18	amod	_	_
18	studies	_	NOUN	NNS	_	15	nmod	_	_

#	Zyprexa	1298
1	Diazepam	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	May	_	NOUN	NN	_	4	nsubj	_	_
4	potentiate	_	VERB	VBP	_	1	dep	_	_
5	orthostatic	_	ADJ	JJ	_	6	amod	_	_
6	hypotension	_	NOUN	NN	_	4	dobj	_	_

#	Zyprexa	1299
1	Alcohol	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	May	_	NOUN	NN	_	4	nsubj	_	_
4	potentiate	_	VERB	VBP	_	1	dep	_	_
5	orthostatic	_	ADJ	JJ	_	6	amod	_	_
6	hypotension	_	NOUN	NN	_	4	dobj	_	_

#	Zyprexa	1300
1	Carbamazepine	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	Increased	_	VERB	VBN	_	4	amod	_	_
4	clearance	_	NOUN	NN	_	1	dep	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_

#	Zyprexa	1301
1	Fluvoxamine	_	NOUN	NN	_	0	root	_	_
2	:	_	.	:	_	1	punct	_	_
3	May	_	NOUN	NN	_	6	compound	_	_
4	increase	_	VERB	VBP	_	6	compound	_	_
5	DRUG	_	NOUN	NN	_	6	compound	_	_
6	levels	_	NOUN	NNS	_	1	dep	_	_

#	Zyprexa	1302
1	DRUG	_	NOUN	NN	_	0	root	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	Fluoxetine	_	NOUN	NN	_	1	conj	_	_
4	in	_	ADP	IN	_	5	case	_	_
5	Combination	_	NOUN	NN	_	1	nmod	_	_
6	:	_	.	:	_	1	punct	_	_
7	Also	_	ADV	RB	_	8	advmod	_	_
8	refer	_	VERB	VBP	_	1	dep	_	_
9	to	_	PRT	TO	_	12	case	_	_
10	the	_	DET	DT	_	12	det	_	_
11	Drug	_	NOUN	NN	_	12	compound	_	_
12	Interactions	_	NOUN	NNS	_	8	nmod	_	_
13	section	_	NOUN	NN	_	12	dep	_	_
14	of	_	ADP	IN	_	17	case	_	_
15	the	_	DET	DT	_	17	det	_	_
16	package	_	NOUN	NN	_	17	compound	_	_
17	insert	_	NOUN	NN	_	13	nmod	_	_
18	for	_	ADP	IN	_	19	case	_	_
19	Symbyax	_	NOUN	NN	_	17	nmod	_	_

#	Zyprexa	1303
1	CNS	_	NOUN	NN	_	3	compound	_	_
2	Acting	_	NOUN	NN	_	3	compound	_	_
3	Drugs	_	NOUN	NNS	_	0	root	_	_
4	:	_	.	:	_	3	punct	_	_
5	Caution	_	NOUN	NN	_	8	nsubjpass	_	_
6	should	_	VERB	MD	_	8	aux	_	_
7	be	_	VERB	VB	_	8	auxpass	_	_
8	used	_	VERB	VBN	_	3	dep	_	_
9	when	_	ADV	WRB	_	10	advmod	_	_
10	taken	_	VERB	VBN	_	8	advcl	_	_
11	in	_	ADP	IN	_	12	case	_	_
12	combination	_	NOUN	NN	_	10	nmod	_	_
13	with	_	ADP	IN	_	17	case	_	_
14	other	_	ADJ	JJ	_	17	amod	_	_
15	centrally	_	ADV	RB	_	16	advmod	_	_
16	acting	_	VERB	VBG	_	17	amod	_	_
17	drugs	_	NOUN	NNS	_	12	nmod	_	_
18	and	_	CONJ	CC	_	17	cc	_	_
19	alcohol	_	NOUN	NN	_	17	conj	_	_

#	Zyprexa	1304
1	Antihypertensive	_	ADJ	JJ	_	2	amod	_	_
2	Agents	_	NOUN	NNS	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	Enhanced	_	VERB	VBN	_	6	amod	_	_
5	antihypertensive	_	ADJ	JJ	_	6	amod	_	_
6	effect	_	NOUN	NN	_	2	dep	_	_

#	Zyprexa	1305
1	Levodopa	_	NOUN	NN	_	4	nsubj	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	Dopamine	_	NOUN	NN	_	1	conj	_	_
4	Agonists	_	NOUN	NNS	_	0	root	_	_
5	:	_	.	:	_	4	punct	_	_
6	May	_	NOUN	NN	_	8	compound	_	_
7	antagonize	_	NOUN	NN	_	8	compound	_	_
8	levodopa	_	NOUN	NN	_	4	dep	_	_
9	/	_	.	:	_	8	punct	_	_
10	dopamine	_	NOUN	NN	_	11	compound	_	_
11	agonists	_	NOUN	NNS	_	8	dep	_	_

#	Zyprexa	1306
1	Lorazepam	_	NOUN	NN	_	2	compound	_	_
2	IM	_	NOUN	NN	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	Increased	_	VERB	VBN	_	5	amod	_	_
5	somnolence	_	NOUN	NN	_	2	dep	_	_
6	with	_	ADP	IN	_	8	case	_	_
7	IM	_	NOUN	NN	_	8	compound	_	_
8	DRUG	_	NOUN	NN	_	5	nmod	_	_

#	Zyprexa	1307
1	Other	_	ADJ	JJ	_	4	amod	_	_
2	Concomitant	_	ADJ	JJ	_	4	amod	_	_
3	Drug	_	NOUN	NN	_	4	compound	_	_
4	Therapy	_	NOUN	NN	_	16	nsubj	_	_
5	:	_	.	:	_	4	punct	_	_
6	When	_	ADV	RB	_	7	advmod	_	_
7	using	_	VERB	VBG	_	4	acl	_	_
8	DRUG	_	NOUN	NN	_	7	dobj	_	_
9	in	_	ADP	IN	_	10	case	_	_
10	combination	_	NOUN	NN	_	7	nmod	_	_
11	with	_	ADP	IN	_	12	case	_	_
12	lithium	_	NOUN	NN	_	10	nmod	_	_
13	or	_	CONJ	CC	_	12	cc	_	_
14	valproate	_	NOUN	NN	_	12	conj	_	_
15	,	_	.	,	_	4	punct	_	_
16	refer	_	VERB	VBP	_	0	root	_	_
17	to	_	PRT	TO	_	21	case	_	_
18	the	_	DET	DT	_	21	det	_	_
19	Drug	_	NOUN	NN	_	21	compound	_	_
20	Interactions	_	NOUN	NNS	_	21	compound	_	_
21	sections	_	NOUN	NNS	_	16	nmod	_	_
22	of	_	ADP	IN	_	25	case	_	_
23	the	_	DET	DT	_	25	det	_	_
24	package	_	NOUN	NN	_	25	compound	_	_
25	insert	_	NOUN	NN	_	21	nmod	_	_
26	for	_	ADP	IN	_	28	case	_	_
27	those	_	DET	DT	_	28	det	_	_
28	products	_	NOUN	NNS	_	25	nmod	_	_

#	Zyprexa	1308
1	Diazepam	_	NOUN	NN	_	9	nsubj	_	_
2	The	_	ADV	RB	_	4	advmod	_	_
3	co	_	PRT	TO	_	4	case	_	_
4	administration	_	NOUN	NN	_	1	nmod	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	diazepam	_	NOUN	NN	_	4	nmod	_	_
7	with	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	4	nmod	_	_
9	potentiated	_	VERB	VBD	_	0	root	_	_
10	the	_	DET	DT	_	12	det	_	_
11	orthostatic	_	ADJ	JJ	_	12	amod	_	_
12	hypotension	_	NOUN	NN	_	9	dobj	_	_
13	observed	_	VERB	VBN	_	12	acl	_	_
14	with	_	ADP	IN	_	15	case	_	_
15	DRUG	_	NOUN	NN	_	13	nmod	_	_

#	Zyprexa	1309
1	Cimetidine	_	NOUN	NN	_	5	compound	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	Antacids	_	NOUN	NNS	_	1	conj	_	_
4	Single	_	ADJ	JJ	_	5	amod	_	_
5	doses	_	NOUN	NNS	_	17	nsubj	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	cimetidine	_	VERB	VBG	_	8	amod	_	_
8	800mg	_	ADJ	JJ	_	5	nmod	_	_
9	or	_	CONJ	CC	_	8	cc	_	_
10	aluminum	_	NOUN	NN	_	8	conj	_	_
11	and	_	CONJ	CC	_	8	cc	_	_
12	magnesium	_	NOUN	NN	_	8	conj	_	_
13	containing	_	VERB	VBG	_	14	amod	_	_
14	antacids	_	NOUN	NNS	_	8	dep	_	_
15	did	_	VERB	VBD	_	17	aux	_	_
16	not	_	ADV	RB	_	17	neg	_	_
17	affect	_	VERB	VB	_	0	root	_	_
18	the	_	DET	DT	_	20	det	_	_
19	oral	_	ADJ	JJ	_	20	amod	_	_
20	bioavailability	_	NOUN	NN	_	17	dobj	_	_
21	of	_	ADP	IN	_	22	case	_	_
22	DRUG	_	NOUN	NN	_	20	nmod	_	_

#	Zyprexa	1310
1	Inducers	_	NOUN	NNS	_	7	nsubj	_	_
2	of	_	ADP	IN	_	6	case	_	_
3	CYP1A2	_	NOUN	NN	_	6	compound	_	_
4	Carbamazepine	_	NOUN	NN	_	6	compound	_	_
5	therapy	_	NOUN	NN	_	6	compound	_	_
6	200mgbid	_	NOUN	NN	_	1	nmod	_	_
7	causes	_	VERB	VBZ	_	0	root	_	_
8	an	_	DET	DT	_	11	det	_	_
9	approximately	_	ADV	RB	_	10	advmod	_	_
10	50%	_	ADJ	JJ	_	11	amod	_	_
11	increase	_	NOUN	NN	_	7	dobj	_	_
12	in	_	ADP	IN	_	14	case	_	_
13	the	_	DET	DT	_	14	det	_	_
14	clearance	_	NOUN	NN	_	11	nmod	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	14	nmod	_	_

#	Zyprexa	1311
1	This	_	DET	DT	_	2	det	_	_
2	increase	_	NOUN	NN	_	5	nsubj	_	_
3	is	_	VERB	VBZ	_	5	cop	_	_
4	likely	_	ADV	RB	_	5	advmod	_	_
5	due	_	ADJ	JJ	_	0	root	_	_
6	to	_	PRT	TO	_	8	case	_	_
7	the	_	DET	DT	_	8	det	_	_
8	fact	_	NOUN	NN	_	5	nmod	_	_
9	that	_	ADP	IN	_	14	mark	_	_
10	carbamazepine	_	NOUN	NN	_	14	nsubj	_	_
11	is	_	VERB	VBZ	_	14	cop	_	_
12	a	_	DET	DT	_	14	det	_	_
13	potent	_	ADJ	JJ	_	14	amod	_	_
14	inducer	_	NOUN	NN	_	8	ccomp	_	_
15	of	_	ADP	IN	_	17	case	_	_
16	CYP1A2	_	NOUN	NN	_	17	compound	_	_
17	activity	_	NOUN	NN	_	14	nmod	_	_

#	Zyprexa	1312
1	Higher	_	ADJ	JJ	_	3	amod	_	_
2	daily	_	ADV	RB	_	1	dep	_	_
3	doses	_	NOUN	NNS	_	7	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	carbamazepine	_	NOUN	NN	_	3	nmod	_	_
6	may	_	VERB	MD	_	7	aux	_	_
7	cause	_	VERB	VB	_	0	root	_	_
8	an	_	DET	DT	_	11	det	_	_
9	even	_	ADV	RB	_	10	advmod	_	_
10	greater	_	ADJ	JJ	_	11	amod	_	_
11	increase	_	NOUN	NN	_	7	dobj	_	_
12	in	_	ADP	IN	_	14	case	_	_
13	DRUG	_	NOUN	NN	_	14	compound	_	_
14	clearance	_	NOUN	NN	_	11	nmod	_	_

#	Zyprexa	1313
1	Alcohol	_	NOUN	NN	_	3	compound	_	_
2	Ethanol	_	NOUN	NN	_	3	compound	_	_
3	45mg	_	ADJ	JJ	_	0	root	_	_
4	/	_	.	:	_	3	punct	_	_
5	70kg	_	ADJ	JJ	_	7	amod	_	_
6	single	_	ADJ	JJ	_	7	amod	_	_
7	dose	_	NOUN	NN	_	10	nsubj	_	_
8	did	_	VERB	VBD	_	10	aux	_	_
9	not	_	ADV	RB	_	10	neg	_	_
10	have	_	VERB	VB	_	3	dep	_	_
11	an	_	DET	DT	_	12	det	_	_
12	effect	_	NOUN	NN	_	10	dobj	_	_
13	on	_	ADP	IN	_	15	case	_	_
14	DRUG	_	NOUN	NN	_	15	compound	_	_
15	pharmacokinetics	_	NOUN	NNS	_	12	nmod	_	_

#	Zyprexa	1314
1	The	_	DET	DT	_	3	det	_	_
2	co	_	PRT	TO	_	3	det	_	_
3	administration	_	NOUN	NN	_	0	root	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	alcohol	_	NOUN	NN	_	6	compound	_	_
6	i.e	_	ADV	RB	_	3	nmod	_	_
7	,	_	.	,	_	3	punct	_	_
8	ethanol	_	NOUN	NN	_	11	nsubj	_	_
9	with	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	potentiated	_	VERB	VBD	_	3	dep	_	_
12	the	_	DET	DT	_	14	det	_	_
13	orthostatic	_	ADJ	JJ	_	14	amod	_	_
14	hypotension	_	NOUN	NN	_	11	dobj	_	_
15	observed	_	VERB	VBN	_	14	acl	_	_
16	with	_	ADP	IN	_	17	case	_	_
17	DRUG	_	NOUN	NN	_	15	nmod	_	_

#	Zyprexa	1315
1	Inhibitors	_	NOUN	NNS	_	0	root	_	_
2	of	_	ADP	IN	_	4	case	_	_
3	CYP1A2	_	NOUN	NN	_	4	compound	_	_
4	Fluvoxamine	_	NOUN	NN	_	1	nmod	_	_
5	:	_	.	:	_	1	punct	_	_
6	Fluvoxamine	_	NOUN	NN	_	12	nsubj	_	_
7	,	_	.	,	_	6	punct	_	_
8	a	_	DET	DT	_	10	det	_	_
9	CYP1A2	_	NOUN	NN	_	10	compound	_	_
10	inhibitor	_	NOUN	NN	_	6	appos	_	_
11	,	_	.	,	_	6	punct	_	_
12	decreases	_	VERB	VBZ	_	1	dep	_	_
13	the	_	DET	DT	_	14	det	_	_
14	clearance	_	NOUN	NN	_	12	dobj	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	14	nmod	_	_

#	Zyprexa	1316
1	This	_	DET	DT	_	2	det	_	_
2	results	_	NOUN	NNS	_	0	root	_	_
3	in	_	ADP	IN	_	6	case	_	_
4	a	_	DET	DT	_	6	det	_	_
5	mean	_	ADJ	JJ	_	6	amod	_	_
6	increase	_	NOUN	NN	_	2	nmod	_	_
7	in	_	ADP	IN	_	9	case	_	_
8	DRUG	_	NOUN	NN	_	9	compound	_	_
9	Cmax	_	NOUN	NN	_	6	nmod	_	_
10	following	_	VERB	VBG	_	11	case	_	_
11	fluvoxamine	_	NOUN	NN	_	6	nmod	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	54%	_	NOUN	NN	_	11	nmod	_	_
14	in	_	ADP	IN	_	16	case	_	_
15	female	_	ADJ	JJ	_	16	amod	_	_
16	nonsmokers	_	NOUN	NNS	_	11	nmod	_	_
17	and	_	CONJ	CC	_	16	cc	_	_
18	77%	_	NOUN	NN	_	16	conj	_	_
19	in	_	ADP	IN	_	21	case	_	_
20	male	_	ADJ	JJ	_	21	amod	_	_
21	smokers	_	NOUN	NNS	_	11	nmod	_	_

#	Zyprexa	1317
1	The	_	DET	DT	_	3	det	_	_
2	mean	_	ADJ	JJ	_	3	amod	_	_
3	increase	_	NOUN	NN	_	8	nsubj	_	_
4	in	_	ADP	IN	_	6	case	_	_
5	DRUG	_	NOUN	NN	_	6	compound	_	_
6	AUC	_	NOUN	NN	_	3	nmod	_	_
7	is	_	VERB	VBZ	_	8	cop	_	_
8	52%	_	ADJ	JJ	_	0	root	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	108%	_	NOUN	NN	_	8	conj	_	_
11	,	_	.	,	_	8	punct	_	_
12	respectively	_	ADV	RB	_	8	advmod	_	_

#	Zyprexa	1318
1	Lower	_	ADJ	JJ	_	2	amod	_	_
2	doses	_	NOUN	NNS	_	7	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	should	_	VERB	MD	_	7	aux	_	_
6	be	_	VERB	VB	_	7	auxpass	_	_
7	considered	_	VERB	VBN	_	0	root	_	_
8	in	_	ADP	IN	_	9	case	_	_
9	patients	_	NOUN	NNS	_	7	nmod	_	_
10	receiving	_	VERB	VBG	_	9	acl	_	_
11	concomitant	_	ADJ	JJ	_	12	amod	_	_
12	treatment	_	NOUN	NN	_	10	dobj	_	_
13	with	_	ADP	IN	_	14	case	_	_
14	fluvoxamine	_	NOUN	NN	_	12	nmod	_	_

#	Zyprexa	1319
1	Inhibitors	_	NOUN	NNS	_	0	root	_	_
2	of	_	ADP	IN	_	4	case	_	_
3	CYP2D6	_	NOUN	NN	_	4	compound	_	_
4	Fluoxetine	_	NOUN	NN	_	1	nmod	_	_
5	:	_	.	:	_	1	punct	_	_
6	Fluoxetine	_	NOUN	NN	_	9	compound	_	_
7	60mg	_	ADJ	JJ	_	9	amod	_	_
8	single	_	ADJ	JJ	_	9	amod	_	_
9	dose	_	NOUN	NN	_	17	nsubj	_	_
10	or	_	CONJ	CC	_	9	cc	_	_
11	60mg	_	ADJ	JJ	_	13	amod	_	_
12	daily	_	ADV	RB	_	13	amod	_	_
13	dose	_	NOUN	NN	_	9	conj	_	_
14	for	_	ADP	IN	_	16	case	_	_
15	8	_	NUM	CD	_	16	nummod	_	_
16	days	_	NOUN	NNS	_	9	nmod	_	_
17	causes	_	VERB	VBZ	_	1	dep	_	_
18	a	_	DET	DT	_	22	det	_	_
19	small	_	ADJ	JJ	_	22	amod	_	_
20	mean	_	NOUN	NN	_	22	compound	_	_
21	16%	_	ADJ	JJ	_	22	amod	_	_
22	increase	_	NOUN	NN	_	17	dobj	_	_
23	in	_	ADP	IN	_	26	case	_	_
24	the	_	DET	DT	_	26	det	_	_
25	maximum	_	NOUN	NN	_	26	compound	_	_
26	concentration	_	NOUN	NN	_	22	nmod	_	_
27	of	_	ADP	IN	_	28	case	_	_
28	DRUG	_	NOUN	NN	_	26	nmod	_	_
29	and	_	CONJ	CC	_	22	cc	_	_
30	a	_	DET	DT	_	34	det	_	_
31	small	_	ADJ	JJ	_	34	amod	_	_
32	mean	_	NOUN	NN	_	34	compound	_	_
33	16%	_	ADJ	JJ	_	34	amod	_	_
34	decrease	_	NOUN	NN	_	22	conj	_	_
35	in	_	ADP	IN	_	37	case	_	_
36	DRUG	_	NOUN	NN	_	37	compound	_	_
37	clearance	_	NOUN	NN	_	34	nmod	_	_

#	Zyprexa	1320
1	The	_	DET	DT	_	2	det	_	_
2	magnitude	_	NOUN	NN	_	10	nsubj	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	the	_	DET	DT	_	5	det	_	_
5	impact	_	NOUN	NN	_	2	nmod	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	this	_	DET	DT	_	8	det	_	_
8	factor	_	NOUN	NN	_	5	nmod	_	_
9	is	_	VERB	VBZ	_	10	cop	_	_
10	small	_	ADJ	JJ	_	0	root	_	_
11	in	_	ADP	IN	_	12	case	_	_
12	comparison	_	NOUN	NN	_	10	nmod	_	_
13	to	_	PRT	TO	_	16	case	_	_
14	the	_	DET	DT	_	16	det	_	_
15	overall	_	ADJ	JJ	_	16	amod	_	_
16	variability	_	NOUN	NN	_	12	nmod	_	_
17	between	_	ADP	IN	_	18	case	_	_
18	individuals	_	NOUN	NNS	_	16	nmod	_	_
19	,	_	.	,	_	10	punct	_	_
20	and	_	CONJ	CC	_	10	cc	_	_
21	therefore	_	ADV	RB	_	27	advmod	_	_
22	dose	_	NOUN	NN	_	23	compound	_	_
23	modification	_	NOUN	NN	_	27	nsubjpass	_	_
24	is	_	VERB	VBZ	_	27	auxpass	_	_
25	not	_	ADV	RB	_	27	neg	_	_
26	routinely	_	ADV	RB	_	27	advmod	_	_
27	recommended	_	VERB	VBN	_	10	conj	_	_

#	Zyprexa	1321
1	When	_	ADV	WRB	_	2	advmod	_	_
2	using	_	VERB	VBG	_	10	advcl	_	_
3	DRUG	_	NOUN	NN	_	2	dobj	_	_
4	and	_	CONJ	CC	_	3	cc	_	_
5	fluoxetine	_	NOUN	NN	_	3	conj	_	_
6	in	_	ADP	IN	_	7	case	_	_
7	combination	_	NOUN	NN	_	2	nmod	_	_
8	,	_	.	,	_	10	punct	_	_
9	also	_	ADV	RB	_	10	advmod	_	_
10	refer	_	VERB	VBP	_	0	root	_	_
11	to	_	PRT	TO	_	14	case	_	_
12	the	_	DET	DT	_	14	det	_	_
13	Drug	_	NOUN	NN	_	14	compound	_	_
14	Interactions	_	NOUN	NNS	_	10	nmod	_	_
15	section	_	NOUN	NN	_	14	dep	_	_
16	of	_	ADP	IN	_	19	case	_	_
17	the	_	DET	DT	_	19	det	_	_
18	package	_	NOUN	NN	_	19	compound	_	_
19	insert	_	NOUN	NN	_	15	nmod	_	_
20	for	_	ADP	IN	_	21	case	_	_
21	Symbyax	_	NOUN	NN	_	19	nmod	_	_

#	Zyprexa	1322
1	Warfarin	_	NOUN	NN	_	5	compound	_	_
2	Warfarin	_	NOUN	NN	_	5	compound	_	_
3	20mg	_	ADJ	JJ	_	5	amod	_	_
4	single	_	ADJ	JJ	_	5	amod	_	_
5	dose	_	NOUN	NN	_	8	nsubj	_	_
6	did	_	VERB	VBD	_	8	aux	_	_
7	not	_	ADV	RB	_	8	neg	_	_
8	affect	_	VERB	VB	_	0	root	_	_
9	DRUG	_	NOUN	NN	_	10	compound	_	_
10	pharmacokinetics	_	NOUN	NNS	_	8	dobj	_	_

#	Zyprexa	1323
1	Inducers	_	NOUN	NNS	_	11	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	CYP1A2	_	NOUN	NN	_	1	nmod	_	_
4	or	_	CONJ	CC	_	3	cc	_	_
5	Glucuronyl	_	NOUN	NN	_	7	compound	_	_
6	Transferase	_	NOUN	NN	_	7	compound	_	_
7	Omeprazole	_	NOUN	NN	_	3	conj	_	_
8	and	_	CONJ	CC	_	3	cc	_	_
9	rifampin	_	NOUN	NN	_	3	conj	_	_
10	may	_	VERB	MD	_	11	aux	_	_
11	cause	_	VERB	VB	_	0	root	_	_
12	an	_	DET	DT	_	13	det	_	_
13	increase	_	NOUN	NN	_	11	dobj	_	_
14	in	_	ADP	IN	_	16	case	_	_
15	DRUG	_	NOUN	NN	_	16	compound	_	_
16	clearance	_	NOUN	NN	_	13	nmod	_	_

#	Zyprexa	1324
1	Charcoal	_	ADJ	JJ	_	3	amod	_	_
2	The	_	DET	DT	_	3	det	_	_
3	administration	_	NOUN	NN	_	8	nsubj	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	activated	_	VERB	VBN	_	7	amod	_	_
6	charcoal	_	ADJ	JJ	_	7	amod	_	_
7	1g	_	NOUN	NN	_	3	nmod	_	_
8	reduced	_	VERB	VBD	_	0	root	_	_
9	the	_	DET	DT	_	10	det	_	_
10	Cmax	_	NOUN	NN	_	8	dobj	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	AUC	_	NOUN	NN	_	10	conj	_	_
13	of	_	ADP	IN	_	15	case	_	_
14	oral	_	ADJ	JJ	_	15	amod	_	_
15	DRUG	_	NOUN	NN	_	10	nmod	_	_
16	by	_	ADP	IN	_	18	case	_	_
17	about	_	ADV	RB	_	18	advmod	_	_
18	60%	_	ADJ	JJ	_	8	nmod	_	_

#	Zyprexa	1325
1	As	_	ADP	IN	_	8	mark	_	_
2	peak	_	ADJ	JJ	_	4	amod	_	_
3	DRUG	_	NOUN	NN	_	4	compound	_	_
4	levels	_	NOUN	NNS	_	8	nsubjpass	_	_
5	are	_	VERB	VBP	_	8	auxpass	_	_
6	not	_	ADV	RB	_	8	neg	_	_
7	typically	_	ADV	RB	_	8	advmod	_	_
8	obtained	_	VERB	VBN	_	21	advcl	_	_
9	until	_	ADP	IN	_	12	case	_	_
10	about	_	ADV	RB	_	11	advmod	_	_
11	6	_	NUM	CD	_	12	nummod	_	_
12	hours	_	NOUN	NNS	_	8	nmod	_	_
13	after	_	ADP	IN	_	14	case	_	_
14	dosing	_	NOUN	NN	_	8	nmod	_	_
15	,	_	.	,	_	21	punct	_	_
16	charcoal	_	NOUN	NN	_	21	nsubj	_	_
17	may	_	VERB	MD	_	21	aux	_	_
18	be	_	VERB	VB	_	21	cop	_	_
19	a	_	DET	DT	_	21	det	_	_
20	useful	_	ADJ	JJ	_	21	amod	_	_
21	treatment	_	NOUN	NN	_	24	nsubj	_	_
22	for	_	ADP	IN	_	23	case	_	_
23	DRUG	_	NOUN	NN	_	21	nmod	_	_
24	overdose	_	ADP	IN	_	0	root	_	_

#	Zyprexa	1326
1	CNS	_	NOUN	NN	_	3	compound	_	_
2	Acting	_	NOUN	NN	_	3	compound	_	_
3	Drugs	_	NOUN	NNS	_	4	nsubj	_	_
4	Given	_	VERB	VBP	_	0	root	_	_
5	the	_	DET	DT	_	8	det	_	_
6	primary	_	ADJ	JJ	_	8	amod	_	_
7	CNS	_	NOUN	NN	_	8	compound	_	_
8	effects	_	NOUN	NNS	_	4	dobj	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	,	_	.	,	_	4	punct	_	_
12	caution	_	NOUN	NN	_	15	nsubjpass	_	_
13	should	_	VERB	MD	_	15	aux	_	_
14	be	_	VERB	VB	_	15	auxpass	_	_
15	used	_	VERB	VBN	_	4	parataxis	_	_
16	when	_	ADV	WRB	_	19	advmod	_	_
17	DRUG	_	NOUN	NN	_	19	nsubjpass	_	_
18	is	_	VERB	VBZ	_	19	auxpass	_	_
19	taken	_	VERB	VBN	_	15	advcl	_	_
20	in	_	ADP	IN	_	21	case	_	_
21	combination	_	NOUN	NN	_	19	nmod	_	_
22	with	_	ADP	IN	_	26	case	_	_
23	other	_	ADJ	JJ	_	26	amod	_	_
24	centrally	_	ADV	RB	_	25	advmod	_	_
25	acting	_	VERB	VBG	_	26	amod	_	_
26	drugs	_	NOUN	NNS	_	21	nmod	_	_
27	and	_	CONJ	CC	_	26	cc	_	_
28	alcohol	_	NOUN	NN	_	26	conj	_	_

#	Zyprexa	1327
1	Antihypertensive	_	ADJ	JJ	_	2	amod	_	_
2	Agents	_	NOUN	NNS	_	14	nsubj	_	_
3	DRUG	_	NOUN	NN	_	2	dep	_	_
4	,	_	.	,	_	2	punct	_	_
5	because	_	ADP	IN	_	8	case	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	its	_	PRON	PRP$	_	8	nmod:poss	_	_
8	potential	_	NOUN	NN	_	2	nmod	_	_
9	for	_	ADP	IN	_	10	mark	_	_
10	inducing	_	VERB	VBG	_	8	acl	_	_
11	hypotension	_	NOUN	NN	_	10	dobj	_	_
12	,	_	.	,	_	2	punct	_	_
13	may	_	VERB	MD	_	14	aux	_	_
14	enhance	_	VERB	VB	_	0	root	_	_
15	the	_	DET	DT	_	16	det	_	_
16	effects	_	NOUN	NNS	_	14	dobj	_	_
17	of	_	ADP	IN	_	20	case	_	_
18	certain	_	ADJ	JJ	_	20	amod	_	_
19	antihypertensive	_	ADJ	JJ	_	20	amod	_	_
20	agents	_	NOUN	NNS	_	16	nmod	_	_

#	Zyprexa	1328
1	Levodopa	_	NOUN	NN	_	4	nsubj	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	Dopamine	_	NOUN	NN	_	1	conj	_	_
4	Agonists	_	VERB	VBP	_	0	root	_	_
5	DRUG	_	NOUN	NN	_	4	dobj	_	_
6	may	_	VERB	MD	_	7	aux	_	_
7	antagonize	_	VERB	VB	_	4	parataxis	_	_
8	the	_	DET	DT	_	9	det	_	_
9	effects	_	NOUN	NNS	_	7	dobj	_	_
10	of	_	ADP	IN	_	14	case	_	_
11	levodopa	_	NOUN	NN	_	14	compound	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	dopamine	_	NOUN	NN	_	11	conj	_	_
14	agonists	_	NOUN	NNS	_	9	nmod	_	_

#	Zyprexa	1329
1	Lorazepam	_	NOUN	NN	_	3	compound	_	_
2	IM	_	NOUN	NN	_	3	compound	_	_
3	Administration	_	NOUN	NN	_	19	nsubj	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	intramuscular	_	ADJ	JJ	_	7	amod	_	_
6	lorazepam	_	NOUN	NN	_	7	compound	_	_
7	2mg	_	NOUN	NN	_	3	nmod	_	_
8	1	_	NUM	CD	_	9	nummod	_	_
9	hour	_	NOUN	NN	_	7	dep	_	_
10	after	_	ADP	IN	_	12	case	_	_
11	intramuscular	_	ADJ	JJ	_	12	amod	_	_
12	DRUG	_	NOUN	NN	_	3	nmod	_	_
13	for	_	ADP	IN	_	15	case	_	_
14	injection	_	NOUN	NN	_	15	compound	_	_
15	5mg	_	NOUN	NN	_	12	nmod	_	_
16	did	_	VERB	VBD	_	19	aux	_	_
17	not	_	ADV	RB	_	19	neg	_	_
18	significantly	_	ADV	RB	_	19	advmod	_	_
19	affect	_	VERB	VB	_	0	root	_	_
20	the	_	DET	DT	_	21	det	_	_
21	pharmacokinetics	_	NOUN	NNS	_	19	dobj	_	_
22	of	_	ADP	IN	_	23	case	_	_
23	DRUG	_	NOUN	NN	_	21	nmod	_	_
24	,	_	.	,	_	23	punct	_	_
25	unconjugated	_	VERB	VBN	_	26	amod	_	_
26	lorazepam	_	NOUN	NN	_	23	conj	_	_
27	,	_	.	,	_	23	punct	_	_
28	or	_	CONJ	CC	_	23	cc	_	_
29	total	_	ADJ	JJ	_	30	amod	_	_
30	lorazepam	_	NOUN	NN	_	23	conj	_	_

#	Zyprexa	1330
1	However	_	ADV	RB	_	0	root	_	_
2	,	_	.	,	_	1	punct	_	_
3	this	_	DET	DT	_	5	det	_	_
4	co	_	PRT	TO	_	5	amod	_	_
5	administration	_	NOUN	NN	_	2	root	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	intramuscular	_	ADJ	JJ	_	8	amod	_	_
8	lorazepam	_	NOUN	NN	_	5	nmod	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	intramuscular	_	ADJ	JJ	_	11	amod	_	_
11	DRUG	_	NOUN	NN	_	8	conj	_	_
12	for	_	ADP	IN	_	13	case	_	_
13	injection	_	NOUN	NN	_	5	nmod	_	_
14	added	_	VERB	VBN	_	13	acl	_	_
15	to	_	PRT	TO	_	17	case	_	_
16	the	_	DET	DT	_	17	det	_	_
17	somnolence	_	NOUN	NN	_	14	nmod	_	_
18	observed	_	VERB	VBN	_	17	acl	_	_
19	with	_	ADP	IN	_	21	case	_	_
20	either	_	CONJ	CC	_	21	det	_	_
21	drug	_	NOUN	NN	_	18	nmod	_	_
22	alone	_	ADV	RB	_	21	advmod	_	_

#	Zyprexa	1331
1	Lithium	_	NOUN	NN	_	3	amod	_	_
2	Multiple	_	ADJ	JJ	_	3	amod	_	_
3	doses	_	NOUN	NNS	_	12	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	10mg	_	NOUN	NN	_	5	dep	_	_
7	for	_	ADP	IN	_	9	case	_	_
8	8	_	NUM	CD	_	9	nummod	_	_
9	days	_	NOUN	NNS	_	6	nmod	_	_
10	did	_	VERB	VBD	_	12	aux	_	_
11	not	_	ADV	RB	_	12	neg	_	_
12	influence	_	VERB	VB	_	0	root	_	_
13	the	_	DET	DT	_	14	det	_	_
14	kinetics	_	NOUN	NNS	_	12	dobj	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	lithium	_	NOUN	NN	_	14	nmod	_	_

#	Zyprexa	1332
1	Therefore	_	ADV	RB	_	8	advmod	_	_
2	,	_	.	,	_	8	punct	_	_
3	concomitant	_	ADJ	JJ	_	5	amod	_	_
4	DRUG	_	NOUN	NN	_	5	compound	_	_
5	administration	_	NOUN	NN	_	8	nsubj	_	_
6	does	_	VERB	VBZ	_	8	aux	_	_
7	not	_	ADV	RB	_	8	neg	_	_
8	require	_	VERB	VB	_	0	root	_	_
9	dosage	_	NOUN	NN	_	10	compound	_	_
10	adjustment	_	NOUN	NN	_	8	dobj	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	lithium	_	NOUN	NN	_	10	nmod	_	_

#	Zyprexa	1333
1	Valproate	_	NOUN	NN	_	3	compound	_	_
2	DRUG	_	NOUN	NN	_	3	compound	_	_
3	10mg	_	NOUN	NN	_	10	nsubj	_	_
4	daily	_	ADV	RB	_	3	advmod	_	_
5	for	_	ADP	IN	_	7	case	_	_
6	2	_	NUM	CD	_	7	nummod	_	_
7	weeks	_	NOUN	NNS	_	3	nmod	_	_
8	did	_	VERB	VBD	_	10	aux	_	_
9	not	_	ADV	RB	_	10	neg	_	_
10	affect	_	VERB	VB	_	0	root	_	_
11	the	_	DET	DT	_	15	det	_	_
12	steady	_	ADJ	JJ	_	15	amod	_	_
13	state	_	NOUN	NN	_	15	compound	_	_
14	plasma	_	NOUN	NN	_	15	compound	_	_
15	concentrations	_	NOUN	NNS	_	10	dobj	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	valproate	_	NOUN	NN	_	15	nmod	_	_

#	Zyprexa	1334
1	Therefore	_	ADV	RB	_	8	advmod	_	_
2	,	_	.	,	_	8	punct	_	_
3	concomitant	_	ADJ	JJ	_	5	amod	_	_
4	DRUG	_	NOUN	NN	_	5	compound	_	_
5	administration	_	NOUN	NN	_	8	nsubj	_	_
6	does	_	VERB	VBZ	_	8	aux	_	_
7	not	_	ADV	RB	_	8	neg	_	_
8	require	_	VERB	VB	_	0	root	_	_
9	dosage	_	NOUN	NN	_	10	amod	_	_
10	adjustment	_	NOUN	NN	_	8	dobj	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	valproate	_	NOUN	NN	_	10	nmod	_	_

#	Zyprexa	1335
1	Effect	_	NOUN	NN	_	8	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	on	_	ADP	IN	_	7	case	_	_
5	Drug	_	NOUN	NN	_	7	compound	_	_
6	Metabolizing	_	NOUN	NN	_	7	compound	_	_
7	Enzymes	_	NOUN	NNS	_	1	nmod	_	_
8	Invitro	_	VERB	VBP	_	0	root	_	_
9	studies	_	NOUN	NNS	_	8	dobj	_	_
10	utilizing	_	VERB	VBG	_	9	acl	_	_
11	human	_	ADJ	JJ	_	13	amod	_	_
12	liver	_	NOUN	NN	_	13	compound	_	_
13	microsomes	_	NOUN	NNS	_	10	dobj	_	_
14	suggest	_	VERB	VBP	_	8	parataxis	_	_
15	that	_	ADP	IN	_	17	mark	_	_
16	DRUG	_	NOUN	NN	_	17	nsubj	_	_
17	has	_	VERB	VBZ	_	14	ccomp	_	_
18	little	_	ADJ	JJ	_	19	amod	_	_
19	potential	_	NOUN	NN	_	17	dobj	_	_
20	to	_	PRT	TO	_	21	mark	_	_
21	inhibit	_	VERB	VB	_	17	xcomp	_	_
22	CYP1A2	_	NOUN	NN	_	21	dobj	_	_
23	,	_	.	,	_	22	punct	_	_
24	CYP2C9	_	NOUN	NN	_	22	conj	_	_
25	,	_	.	,	_	22	punct	_	_
26	CYP2C19	_	NOUN	NN	_	22	conj	_	_
27	,	_	.	,	_	22	punct	_	_
28	CYP2D6	_	NOUN	NN	_	22	conj	_	_
29	,	_	.	,	_	22	punct	_	_
30	and	_	CONJ	CC	_	22	cc	_	_
31	CYP3A	_	NOUN	NN	_	22	conj	_	_

#	Zyprexa	1336
1	Thus	_	ADV	RB	_	5	advmod	_	_
2	,	_	.	,	_	5	punct	_	_
3	DRUG	_	NOUN	NN	_	5	nsubj	_	_
4	is	_	VERB	VBZ	_	5	cop	_	_
5	unlikely	_	ADJ	JJ	_	0	root	_	_
6	to	_	PRT	TO	_	7	mark	_	_
7	cause	_	VERB	VB	_	5	xcomp	_	_
8	clinically	_	ADV	RB	_	9	advmod	_	_
9	important	_	ADJ	JJ	_	11	amod	_	_
10	drug	_	NOUN	NN	_	11	compound	_	_
11	interactions	_	NOUN	NNS	_	7	dobj	_	_
12	mediated	_	VERB	VBN	_	11	acl	_	_
13	by	_	ADP	IN	_	15	case	_	_
14	these	_	DET	DT	_	15	det	_	_
15	enzymes	_	NOUN	NNS	_	12	nmod	_	_

#	Zyprexa	1337
1	Imipramine	_	NOUN	NN	_	3	compound	_	_
2	Single	_	ADJ	JJ	_	3	amod	_	_
3	doses	_	NOUN	NNS	_	8	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	did	_	VERB	VBD	_	8	aux	_	_
7	not	_	ADV	RB	_	8	neg	_	_
8	affect	_	VERB	VB	_	0	root	_	_
9	the	_	DET	DT	_	10	det	_	_
10	pharmacokinetics	_	NOUN	NNS	_	8	dobj	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	imipramine	_	NOUN	NN	_	10	nmod	_	_
13	or	_	CONJ	CC	_	12	cc	_	_
14	its	_	PRON	PRP$	_	17	nmod:poss	_	_
15	active	_	ADJ	JJ	_	17	amod	_	_
16	metabolite	_	NOUN	NN	_	17	compound	_	_
17	desipramine	_	NOUN	NN	_	12	conj	_	_

#	Zyprexa	1338
1	Warfarin	_	NOUN	NN	_	3	compound	_	_
2	Single	_	NOUN	NN	_	3	compound	_	_
3	doses	_	NOUN	NNS	_	8	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	did	_	VERB	VBD	_	8	aux	_	_
7	not	_	ADV	RB	_	8	neg	_	_
8	affect	_	VERB	VB	_	0	root	_	_
9	the	_	DET	DT	_	10	det	_	_
10	pharmacokinetics	_	NOUN	NNS	_	8	dobj	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	warfarin	_	NOUN	NN	_	10	nmod	_	_

#	Zyprexa	1339
1	Diazepam	_	NOUN	NN	_	2	compound	_	_
2	DRUG	_	NOUN	NN	_	5	nsubj	_	_
3	did	_	VERB	VBD	_	5	aux	_	_
4	not	_	ADV	RB	_	5	neg	_	_
5	influence	_	VERB	VB	_	0	root	_	_
6	the	_	DET	DT	_	7	det	_	_
7	pharmacokinetics	_	NOUN	NNS	_	5	dobj	_	_
8	of	_	ADP	IN	_	9	case	_	_
9	diazepam	_	NOUN	NN	_	7	nmod	_	_
10	or	_	CONJ	CC	_	9	cc	_	_
11	its	_	PRON	PRP$	_	15	nmod:poss	_	_
12	active	_	ADJ	JJ	_	15	amod	_	_
13	metabolite	_	NOUN	NN	_	15	compound	_	_
14	N	_	NOUN	NN	_	15	compound	_	_
15	desmethyldiazepam	_	NOUN	NN	_	9	conj	_	_

#	Zyprexa	1340
1	However	_	ADV	RB	_	8	advmod	_	_
2	,	_	.	,	_	8	punct	_	_
3	diazepam	_	NOUN	NN	_	8	nsubj	_	_
4	co	_	PRT	TO	_	5	punct	_	_
5	administered	_	VERB	VBN	_	3	acl	_	_
6	with	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	increased	_	VERB	VBD	_	0	root	_	_
9	the	_	DET	DT	_	11	det	_	_
10	orthostatic	_	ADJ	JJ	_	11	amod	_	_
11	hypotension	_	NOUN	NN	_	8	dobj	_	_
12	observed	_	VERB	VBN	_	11	acl	_	_
13	with	_	ADP	IN	_	15	case	_	_
14	either	_	CONJ	CC	_	15	det	_	_
15	drug	_	NOUN	NN	_	12	nmod	_	_
16	given	_	VERB	VBN	_	15	acl	_	_
17	alone	_	ADV	RB	_	16	advmod	_	_

#	Zyprexa	1341
1	Alcohol	_	NOUN	NN	_	3	compound	_	_
2	Multiple	_	ADJ	JJ	_	3	amod	_	_
3	doses	_	NOUN	NNS	_	8	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	did	_	VERB	VBD	_	8	aux	_	_
7	not	_	ADV	RB	_	8	neg	_	_
8	influence	_	VERB	VB	_	0	root	_	_
9	the	_	DET	DT	_	10	det	_	_
10	kinetics	_	NOUN	NNS	_	8	dobj	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	ethanol	_	NOUN	NN	_	10	nmod	_	_

#	Zyprexa	1342
1	Biperiden	_	NOUN	NN	_	3	compound	_	_
2	Multiple	_	ADJ	JJ	_	3	amod	_	_
3	doses	_	NOUN	NNS	_	8	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	did	_	VERB	VBD	_	8	aux	_	_
7	not	_	ADV	RB	_	8	neg	_	_
8	influence	_	VERB	VB	_	0	root	_	_
9	the	_	DET	DT	_	10	det	_	_
10	kinetics	_	NOUN	NNS	_	8	dobj	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	biperiden	_	NOUN	NN	_	10	nmod	_	_

#	Zyprexa	1343
1	Theophylline	_	NOUN	NN	_	3	compound	_	_
2	Multiple	_	ADJ	JJ	_	3	amod	_	_
3	doses	_	NOUN	NNS	_	8	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	did	_	VERB	VBD	_	8	aux	_	_
7	not	_	ADV	RB	_	8	neg	_	_
8	affect	_	VERB	VB	_	0	root	_	_
9	the	_	DET	DT	_	10	det	_	_
10	pharmacokinetics	_	NOUN	NNS	_	8	dobj	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	theophylline	_	NOUN	NN	_	10	nmod	_	_
13	or	_	CONJ	CC	_	12	cc	_	_
14	its	_	PRON	PRP$	_	15	nmod:poss	_	_
15	metabolites	_	NOUN	NNS	_	12	conj	_	_

#	Zyprexa	1344
1	The	_	DET	DT	_	2	det	_	_
2	mechanism	_	NOUN	NN	_	18	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	action	_	NOUN	NN	_	2	nmod	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	,	_	.	,	_	2	punct	_	_
8	as	_	ADP	IN	_	11	case	_	_
9	with	_	ADP	IN	_	11	case	_	_
10	other	_	ADJ	JJ	_	11	amod	_	_
11	drugs	_	NOUN	NNS	_	2	nmod	_	_
12	having	_	VERB	VBG	_	11	acl	_	_
13	efficacy	_	NOUN	NN	_	12	dobj	_	_
14	in	_	ADP	IN	_	15	case	_	_
15	schizophrenia	_	NOUN	NN	_	13	nmod	_	_
16	,	_	.	,	_	2	punct	_	_
17	is	_	VERB	VBZ	_	18	auxpass	_	_
18	unknown	_	ADJ	JJ	_	0	root	_	_

#	Zyprexa	1345
1	However	_	ADV	RB	_	6	advmod	_	_
2	,	_	.	,	_	6	punct	_	_
3	it	_	PRON	PRP	_	6	nsubjpass	_	_
4	has	_	VERB	VBZ	_	6	aux	_	_
5	been	_	VERB	VBN	_	6	auxpass	_	_
6	proposed	_	VERB	VBN	_	0	root	_	_
7	that	_	ADP	IN	_	14	mark	_	_
8	this	_	DET	DT	_	10	det	_	_
9	drug's	_	NOUN	NNS	_	10	compound	_	_
10	efficacy	_	NOUN	NN	_	14	nsubjpass	_	_
11	in	_	ADP	IN	_	12	case	_	_
12	schizophrenia	_	NOUN	NN	_	10	nmod	_	_
13	is	_	VERB	VBZ	_	14	auxpass	_	_
14	mediated	_	VERB	VBN	_	6	ccomp	_	_
15	through	_	ADP	IN	_	17	case	_	_
16	a	_	DET	DT	_	17	det	_	_
17	combination	_	NOUN	NN	_	14	nmod	_	_
18	of	_	ADP	IN	_	19	case	_	_
19	dopamine	_	NOUN	NN	_	17	nmod	_	_
20	and	_	CONJ	CC	_	19	cc	_	_
21	serotonin	_	NOUN	NN	_	23	compound	_	_
22	type2(5HT2	_	NOUN	NN	_	23	compound	_	_
23	antagonism	_	NOUN	NN	_	19	conj	_	_

#	Zyprexa	1346
1	The	_	DET	DT	_	2	det	_	_
2	mechanism	_	NOUN	NN	_	21	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	action	_	NOUN	NN	_	2	nmod	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	in	_	ADP	IN	_	9	case	_	_
8	the	_	DET	DT	_	9	det	_	_
9	treatment	_	NOUN	NN	_	2	nmod	_	_
10	of	_	ADP	IN	_	12	case	_	_
11	acute	_	ADJ	JJ	_	12	amod	_	_
12	manic	_	ADJ	JJ	_	9	nmod	_	_
13	or	_	CONJ	CC	_	12	cc	_	_
14	mixed	_	VERB	VBN	_	12	conj	_	_
15	episodes	_	NOUN	NNS	_	12	dep	_	_
16	associated	_	VERB	VBN	_	12	acl	_	_
17	with	_	ADP	IN	_	19	case	_	_
18	bipolarI	_	ADJ	JJ	_	19	amod	_	_
19	disorder	_	NOUN	NN	_	16	nmod	_	_
20	is	_	VERB	VBZ	_	21	auxpass	_	_
21	unknown	_	ADJ	JJ	_	0	root	_	_

#	Zyprexa	1347
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	binds	_	VERB	VBZ	_	0	root	_	_
3	with	_	ADP	IN	_	5	case	_	_
4	high	_	ADJ	JJ	_	5	amod	_	_
5	affinity	_	NOUN	NN	_	2	nmod	_	_
6	to	_	PRT	TO	_	9	case	_	_
7	the	_	DET	DT	_	9	det	_	_
8	following	_	VERB	VBG	_	9	amod	_	_
9	receptors	_	NOUN	NNS	_	5	nmod	_	_
10	:	_	.	:	_	2	punct	_	_
11	serotonin5HT2A	_	NOUN	NN	_	2	dep	_	_
12	/	_	.	:	_	11	punct	_	_
13	2C	_	NOUN	NN	_	11	conj	_	_
14	,	_	.	,	_	11	punct	_	_
15	5HT6	_	NOUN	NN	_	16	compound	_	_
16	Ki=4	_	NOUN	NN	_	11	conj	_	_
17	,	_	.	,	_	11	punct	_	_
18	11	_	NUM	CD	_	11	conj	_	_
19	,	_	.	,	_	11	punct	_	_
20	and	_	CONJ	CC	_	11	cc	_	_
21	5nM	_	NOUN	NN	_	11	conj	_	_
22	,	_	.	,	_	11	punct	_	_
23	respectively	_	ADV	RB	_	11	advmod	_	_
24	,	_	.	,	_	23	punct	_	_
25	dopamineD1	_	NOUN	NN	_	28	compound	_	_
26	4	_	NUM	CD	_	28	nummod	_	_
27	Ki=11	_	NOUN	NN	_	28	compound	_	_
28	31nM	_	NOUN	NN	_	24	root	_	_
29	,	_	.	,	_	28	punct	_	_
30	histamineH1	_	NOUN	NN	_	31	compound	_	_
31	Ki=7nM	_	NOUN	NN	_	28	conj	_	_
32	,	_	.	,	_	28	punct	_	_
33	and	_	CONJ	CC	_	28	cc	_	_
34	adrenergicA1	_	NOUN	NN	_	35	compound	_	_
35	receptors	_	NOUN	NNS	_	28	conj	_	_
36	Ki=19nM	_	NOUN	NN	_	35	dep	_	_

#	Zyprexa	1348
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	is	_	VERB	VBZ	_	4	cop	_	_
3	an	_	DET	DT	_	4	det	_	_
4	antagonist	_	NOUN	NN	_	0	root	_	_
5	with	_	ADP	IN	_	8	case	_	_
6	moderate	_	ADJ	JJ	_	8	amod	_	_
7	affinity	_	NOUN	NN	_	8	compound	_	_
8	binding	_	NOUN	NN	_	4	nmod	_	_
9	for	_	ADP	IN	_	11	case	_	_
10	serotonin5HT3	_	NOUN	NN	_	11	compound	_	_
11	Ki=57nM	_	NOUN	NN	_	8	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	muscarinicM1	_	NOUN	NN	_	15	compound	_	_
14	5	_	NUM	CD	_	15	nummod	_	_
15	Ki=73	_	NOUN	NN	_	11	conj	_	_
16	,	_	.	,	_	11	punct	_	_
17	96	_	NUM	CD	_	11	conj	_	_
18	,	_	.	,	_	11	punct	_	_
19	132	_	NUM	CD	_	11	conj	_	_
20	,	_	.	,	_	11	punct	_	_
21	32	_	NUM	CD	_	11	conj	_	_
22	,	_	.	,	_	11	punct	_	_
23	and	_	CONJ	CC	_	11	cc	_	_
24	48nM	_	NOUN	NN	_	11	conj	_	_
25	,	_	.	,	_	4	punct	_	_
26	respectively	_	ADV	RB	_	4	advmod	_	_

#	Zyprexa	1349
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	binds	_	VERB	VBZ	_	0	root	_	_
3	weakly	_	ADV	RB	_	2	advmod	_	_
4	to	_	PRT	TO	_	5	case	_	_
5	GABAA	_	NOUN	NN	_	2	nmod	_	_
6	,	_	.	,	_	5	punct	_	_
7	BZD	_	NOUN	NN	_	5	conj	_	_
8	,	_	.	,	_	5	punct	_	_
9	and	_	CONJ	CC	_	5	cc	_	_
10	B	_	NOUN	NN	_	12	compound	_	_
11	adrenergic	_	ADJ	JJ	_	12	amod	_	_
12	receptors	_	NOUN	NNS	_	5	conj	_	_
13	Ki>10MM	_	NOUN	NN	_	12	dep	_	_

#	Zyprexa	1350
1	Antagonism	_	NOUN	NN	_	10	nsubj	_	_
2	at	_	ADP	IN	_	3	case	_	_
3	receptors	_	NOUN	NNS	_	1	nmod	_	_
4	other	_	ADJ	JJ	_	6	case	_	_
5	than	_	ADP	IN	_	4	mwe	_	_
6	dopamine	_	NOUN	NN	_	3	nmod	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	5HT2	_	NOUN	NN	_	6	conj	_	_
9	may	_	VERB	MD	_	10	aux	_	_
10	explain	_	VERB	VB	_	0	root	_	_
11	some	_	DET	DT	_	10	dobj	_	_
12	of	_	ADP	IN	_	15	case	_	_
13	the	_	DET	DT	_	15	det	_	_
14	other	_	ADJ	JJ	_	15	amod	_	_
15	therapeutic	_	ADJ	JJ	_	11	nmod	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	side	_	ADJ	JJ	_	15	conj	_	_
18	effects	_	NOUN	NNS	_	15	dep	_	_
19	of	_	ADP	IN	_	20	case	_	_
20	DRUG	_	NOUN	NN	_	15	nmod	_	_

#	Zyprexa	1351
1	DRUG	_	NOUN	NN	_	3	nmod:poss	_	_
2	's	_	PRT	POS	_	3	case	_	_
3	antagonism	_	NOUN	NN	_	9	nsubj	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	muscarinicM1	_	NOUN	NN	_	7	compound	_	_
6	5	_	NUM	CD	_	7	nummod	_	_
7	receptors	_	NOUN	NNS	_	3	nmod	_	_
8	may	_	VERB	MD	_	9	aux	_	_
9	explain	_	VERB	VB	_	0	root	_	_
10	its	_	PRON	PRP$	_	11	nmod:poss	_	_
11	anticholinergic	_	ADJ	JJ	_	9	dobj	_	_
12	like	_	ADP	IN	_	13	case	_	_
13	effects	_	NOUN	NNS	_	11	nmod	_	_

#	Zyprexa	1352
1	DRUG	_	NOUN	NN	_	3	nmod:poss	_	_
2	's	_	PRT	POS	_	1	case	_	_
3	antagonism	_	NOUN	NN	_	8	nsubj	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	histamineH1	_	NOUN	NN	_	6	compound	_	_
6	receptors	_	NOUN	NNS	_	3	nmod	_	_
7	may	_	VERB	MD	_	8	aux	_	_
8	explain	_	VERB	VB	_	0	root	_	_
9	the	_	DET	DT	_	10	det	_	_
10	somnolence	_	NOUN	NN	_	8	dobj	_	_
11	observed	_	VERB	VBN	_	10	acl	_	_
12	with	_	ADP	IN	_	14	case	_	_
13	this	_	DET	DT	_	14	det	_	_
14	drug	_	NOUN	NN	_	11	nmod	_	_

#	Zyprexa	1353
1	DRUG	_	NOUN	NN	_	3	nmod:poss	_	_
2	's	_	PRT	POS	_	1	case	_	_
3	antagonism	_	NOUN	NN	_	8	nsubj	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	adrenergicA1	_	NOUN	NN	_	6	compound	_	_
6	receptors	_	NOUN	NNS	_	3	nmod	_	_
7	may	_	VERB	MD	_	8	aux	_	_
8	explain	_	VERB	VB	_	0	root	_	_
9	the	_	DET	DT	_	11	det	_	_
10	orthostatic	_	ADJ	JJ	_	11	amod	_	_
11	hypotension	_	NOUN	NN	_	8	dobj	_	_
12	observed	_	VERB	VBN	_	11	acl	_	_
13	with	_	ADP	IN	_	15	case	_	_
14	this	_	DET	DT	_	15	det	_	_
15	drug	_	NOUN	NN	_	12	nmod	_	_

#	Zyprexa	1354
1	Oral	_	ADJ	JJ	_	2	amod	_	_
2	Administration	_	NOUN	NN	_	8	nsubjpass	_	_
3	,	_	.	,	_	2	punct	_	_
4	Monotherapy	_	NOUN	NN	_	5	compound	_	_
5	DRUG	_	NOUN	NN	_	2	appos	_	_
6	is	_	VERB	VBZ	_	8	auxpass	_	_
7	well	_	ADV	RB	_	8	advmod	_	_
8	absorbed	_	VERB	VBN	_	0	root	_	_
9	and	_	CONJ	CC	_	8	cc	_	_
10	reaches	_	VERB	VBZ	_	8	conj	_	_
11	peak	_	ADJ	JJ	_	12	amod	_	_
12	concentrations	_	NOUN	NNS	_	10	dobj	_	_
13	in	_	ADP	IN	_	16	case	_	_
14	approximately	_	ADV	RB	_	15	advmod	_	_
15	6	_	NUM	CD	_	16	nummod	_	_
16	hours	_	NOUN	NNS	_	12	nmod	_	_
17	following	_	ADP	IN	_	20	case	_	_
18	an	_	DET	DT	_	20	det	_	_
19	oral	_	ADJ	JJ	_	20	amod	_	_
20	dose	_	NOUN	NN	_	12	nmod	_	_

#	Zyprexa	1355
1	It	_	PRON	PRP	_	3	nsubjpass	_	_
2	is	_	VERB	VBZ	_	3	auxpass	_	_
3	eliminated	_	VERB	VBN	_	0	root	_	_
4	extensively	_	ADV	RB	_	3	advmod	_	_
5	by	_	ADP	IN	_	8	case	_	_
6	first	_	ADJ	JJ	_	8	amod	_	_
7	pass	_	NOUN	NN	_	8	compound	_	_
8	metabolism	_	NOUN	NN	_	3	nmod	_	_
9	,	_	.	,	_	3	punct	_	_
10	with	_	ADP	IN	_	12	case	_	_
11	approximately	_	ADV	RB	_	12	advmod	_	_
12	40%	_	NOUN	NN	_	3	nmod	_	_
13	of	_	ADP	IN	_	15	case	_	_
14	the	_	DET	DT	_	15	det	_	_
15	dose	_	NOUN	NN	_	12	nmod	_	_
16	metabolized	_	VERB	VBN	_	15	acl	_	_
17	before	_	ADP	IN	_	18	mark	_	_
18	reaching	_	VERB	VBG	_	16	advcl	_	_
19	the	_	DET	DT	_	21	det	_	_
20	systemic	_	ADJ	JJ	_	21	amod	_	_
21	circulation	_	NOUN	NN	_	18	dobj	_	_

#	Zyprexa	1356
1	Food	_	NOUN	NN	_	4	nsubj	_	_
2	does	_	VERB	VBZ	_	4	aux	_	_
3	not	_	ADV	RB	_	4	neg	_	_
4	affect	_	VERB	VB	_	0	root	_	_
5	the	_	DET	DT	_	6	det	_	_
6	rate	_	NOUN	NN	_	4	dobj	_	_
7	or	_	CONJ	CC	_	6	cc	_	_
8	extent	_	NOUN	NN	_	6	conj	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	DRUG	_	NOUN	NN	_	11	compound	_	_
11	absorption	_	NOUN	NN	_	6	nmod	_	_

#	Zyprexa	1357
1	Pharmacokinetic	_	ADJ	JJ	_	2	amod	_	_
2	studies	_	NOUN	NNS	_	3	nsubj	_	_
3	showed	_	VERB	VBD	_	0	root	_	_
4	that	_	ADP	IN	_	12	mark	_	_
5	DRUG	_	NOUN	NN	_	6	compound	_	_
6	tablets	_	NOUN	NNS	_	12	nsubj	_	_
7	and	_	CONJ	CC	_	6	cc	_	_
8	DRUG	_	NOUN	NN	_	10	compound	_	_
9	ZYDIS	_	NOUN	NN	_	10	compound	_	_
10	DRUG	_	NOUN	NN	_	6	conj	_	_
11	orally	_	ADV	RB	_	12	advmod	_	_
12	disintegrating	_	VERB	VBG	_	3	ccomp	_	_
13	tablets	_	NOUN	NNS	_	12	dobj	_	_
14	dosage	_	ADJ	JJ	_	15	amod	_	_
15	forms	_	NOUN	NNS	_	13	nmod	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	DRUG	_	NOUN	NN	_	15	nmod	_	_
18	are	_	VERB	VBP	_	19	auxpass	_	_
19	bioequivalent	_	ADJ	JJ	_	12	parataxis	_	_

#	Zyprexa	1358
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	displays	_	VERB	VBZ	_	0	root	_	_
3	linear	_	ADJ	JJ	_	4	amod	_	_
4	kinetics	_	NOUN	NNS	_	2	dobj	_	_
5	over	_	ADP	IN	_	9	case	_	_
6	the	_	DET	DT	_	9	det	_	_
7	clinical	_	ADJ	JJ	_	9	amod	_	_
8	dosing	_	NOUN	NN	_	9	compound	_	_
9	range	_	NOUN	NN	_	2	nmod	_	_

#	Zyprexa	1359
1	Its	_	PRON	PRP$	_	4	nmod:poss	_	_
2	half	_	ADJ	JJ	_	4	amod	_	_
3	life	_	NOUN	NN	_	4	compound	_	_
4	ranges	_	NOUN	NNS	_	0	root	_	_
5	from	_	ADP	IN	_	9	case	_	_
6	21	_	NUM	CD	_	8	compound	_	_
7	to	_	PRT	TO	_	8	dep	_	_
8	54	_	NUM	CD	_	9	nummod	_	_
9	hours	_	NOUN	NNS	_	4	nmod	_	_
10	5th	_	ADJ	JJ	_	9	amod	_	_
11	to	_	PRT	TO	_	14	case	_	_
12	95th	_	ADJ	JJ	_	14	amod	_	_
13	percentile	_	ADJ	JJ	_	14	amod	_	_
14	mean	_	NOUN	NN	_	10	nmod	_	_
15	of	_	ADP	IN	_	22	case	_	_
16	30hr	_	ADJ	JJ	_	22	amod	_	_
17	,	_	.	,	_	16	punct	_	_
18	and	_	CONJ	CC	_	16	cc	_	_
19	apparent	_	ADJ	JJ	_	16	conj	_	_
20	plasma	_	NOUN	NN	_	22	compound	_	_
21	clearance	_	NOUN	NN	_	22	compound	_	_
22	ranges	_	NOUN	NNS	_	14	nmod	_	_
23	from	_	ADP	IN	_	26	case	_	_
24	12	_	NUM	CD	_	26	nummod	_	_
25	to	_	PRT	TO	_	26	case	_	_
26	47L	_	NOUN	NN	_	22	nmod	_	_
27	/	_	.	:	_	4	punct	_	_
28	hr	_	NOUN	NN	_	4	dep	_	_
29	5th	_	ADJ	JJ	_	28	amod	_	_
30	to	_	PRT	TO	_	33	case	_	_
31	95th	_	ADJ	JJ	_	33	amod	_	_
32	percentile	_	ADJ	JJ	_	33	amod	_	_
33	mean	_	NOUN	NN	_	29	nmod	_	_
34	of	_	ADP	IN	_	37	case	_	_
35	25L	_	NOUN	NN	_	37	compound	_	_
36	/	_	.	:	_	37	punct	_	_
37	hr	_	NOUN	NN	_	33	nmod	_	_

#	Zyprexa	1360
1	Administration	_	NOUN	NN	_	6	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	DRUG	_	NOUN	NN	_	1	nmod	_	_
4	once	_	ADV	RB	_	5	advmod	_	_
5	daily	_	ADV	RB	_	6	advmod	_	_
6	leads	_	VERB	VBZ	_	0	root	_	_
7	to	_	PRT	TO	_	10	case	_	_
8	steady	_	ADJ	JJ	_	10	amod	_	_
9	state	_	NOUN	NN	_	10	compound	_	_
10	concentrations	_	NOUN	NNS	_	6	nmod	_	_
11	in	_	ADP	IN	_	14	case	_	_
12	about	_	ADV	RB	_	13	advmod	_	_
13	1	_	NUM	CD	_	14	nummod	_	_
14	week	_	NOUN	NN	_	6	nmod	_	_
15	that	_	DET	WDT	_	20	nsubj	_	_
16	are	_	VERB	VBP	_	20	cop	_	_
17	approximately	_	ADV	RB	_	18	advmod	_	_
18	twice	_	ADV	RB	_	20	advmod	_	_
19	the	_	DET	DT	_	20	det	_	_
20	concentrations	_	NOUN	NNS	_	14	acl:relcl	_	_
21	after	_	ADP	IN	_	23	case	_	_
22	single	_	ADJ	JJ	_	23	amod	_	_
23	doses	_	NOUN	NNS	_	20	nmod	_	_

#	Zyprexa	1361
1	Plasma	_	NOUN	NN	_	2	compound	_	_
2	concentrations	_	NOUN	NNS	_	12	nsubj	_	_
3	,	_	.	,	_	2	punct	_	_
4	half	_	ADJ	JJ	_	5	compound	_	_
5	life	_	NOUN	NN	_	2	conj	_	_
6	,	_	.	,	_	2	punct	_	_
7	and	_	CONJ	CC	_	2	cc	_	_
8	clearance	_	NOUN	NN	_	2	conj	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	may	_	VERB	MD	_	12	aux	_	_
12	vary	_	VERB	VB	_	0	root	_	_
13	between	_	ADP	IN	_	14	case	_	_
14	individuals	_	NOUN	NNS	_	12	nmod	_	_
15	on	_	ADP	IN	_	17	case	_	_
16	the	_	DET	DT	_	17	det	_	_
17	basis	_	NOUN	NN	_	12	nmod	_	_
18	of	_	ADP	IN	_	19	mark	_	_
19	smoking	_	VERB	VBG	_	17	acl	_	_
20	status	_	NOUN	NN	_	19	dobj	_	_
21	,	_	.	,	_	20	punct	_	_
22	gender	_	NOUN	NN	_	20	conj	_	_
23	,	_	.	,	_	20	punct	_	_
24	and	_	CONJ	CC	_	20	cc	_	_
25	age	_	NOUN	NN	_	20	conj	_	_

#	Zyprexa	1362
1	DRUG	_	NOUN	NN	_	4	nsubjpass	_	_
2	is	_	VERB	VBZ	_	4	auxpass	_	_
3	extensively	_	ADV	RB	_	4	advmod	_	_
4	distributed	_	VERB	VBN	_	0	root	_	_
5	throughout	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	body	_	NOUN	NN	_	4	nmod	_	_
8	,	_	.	,	_	4	punct	_	_
9	with	_	ADP	IN	_	11	case	_	_
10	a	_	DET	DT	_	11	det	_	_
11	volume	_	NOUN	NN	_	20	nsubjpass	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	distribution	_	NOUN	NN	_	11	nmod	_	_
14	of	_	ADP	IN	_	17	case	_	_
15	approximately	_	ADV	RB	_	17	advmod	_	_
16	1000L	_	NOUN	NN	_	17	compound	_	_
17	It	_	NOUN	NN	_	13	nmod	_	_
18	is	_	VERB	VBZ	_	20	auxpass	_	_
19	93%	_	ADJ	JJ	_	20	advmod	_	_
20	bound	_	VERB	VBN	_	4	advcl	_	_
21	to	_	PRT	TO	_	23	case	_	_
22	plasma	_	NOUN	NN	_	23	compound	_	_
23	proteins	_	NOUN	NNS	_	20	nmod	_	_
24	over	_	ADP	IN	_	27	case	_	_
25	the	_	DET	DT	_	27	det	_	_
26	concentration	_	NOUN	NN	_	27	compound	_	_
27	range	_	NOUN	NN	_	20	nmod	_	_
28	of	_	ADP	IN	_	31	case	_	_
29	7	_	NUM	CD	_	31	nummod	_	_
30	to	_	PRT	TO	_	31	case	_	_
31	1100ng	_	ADJ	JJ	_	27	nmod	_	_
32	/	_	.	:	_	27	punct	_	_
33	mL	_	NOUN	NN	_	27	appos	_	_
34	,	_	.	,	_	4	punct	_	_
35	binding	_	VERB	VBG	_	4	dep	_	_
36	primarily	_	ADV	RB	_	38	advmod	_	_
37	to	_	PRT	TO	_	38	case	_	_
38	albumin	_	NOUN	NN	_	35	nmod	_	_
39	and	_	CONJ	CC	_	38	cc	_	_
40	A1	_	NOUN	NN	_	42	compound	_	_
41	acid	_	NOUN	NN	_	42	compound	_	_
42	glycoprotein	_	NOUN	NN	_	38	conj	_	_

#	Zyprexa	1363
1	Metabolism	_	NOUN	NN	_	20	nsubjpass	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	Elimination	_	NOUN	NN	_	1	conj	_	_
4	Following	_	ADP	IN	_	8	case	_	_
5	a	_	DET	DT	_	8	det	_	_
6	single	_	ADJ	JJ	_	8	amod	_	_
7	oral	_	ADJ	JJ	_	8	amod	_	_
8	dose	_	NOUN	NN	_	1	nmod	_	_
9	of	_	ADP	IN	_	11	case	_	_
10	14Clabeled	_	ADJ	JJ	_	11	amod	_	_
11	DRUG	_	NOUN	NN	_	8	nmod	_	_
12	,	_	.	,	_	1	punct	_	_
13	7%	_	NOUN	NN	_	1	appos	_	_
14	of	_	ADP	IN	_	16	case	_	_
15	the	_	DET	DT	_	16	det	_	_
16	dose	_	NOUN	NN	_	13	nmod	_	_
17	of	_	ADP	IN	_	18	case	_	_
18	DRUG	_	NOUN	NN	_	16	nmod	_	_
19	was	_	VERB	VBD	_	20	auxpass	_	_
20	recovered	_	VERB	VBN	_	0	root	_	_
21	in	_	ADP	IN	_	23	case	_	_
22	the	_	DET	DT	_	23	det	_	_
23	urine	_	ADJ	JJ	_	20	nmod	_	_
24	as	_	ADP	IN	_	26	case	_	_
25	unchanged	_	ADJ	JJ	_	26	amod	_	_
26	drug	_	NOUN	NN	_	20	nmod	_	_
27	,	_	.	,	_	20	punct	_	_
28	indicating	_	VERB	VBG	_	20	advcl	_	_
29	that	_	ADP	IN	_	33	mark	_	_
30	DRUG	_	NOUN	NN	_	33	nsubjpass	_	_
31	is	_	VERB	VBZ	_	33	auxpass	_	_
32	highly	_	ADV	RB	_	33	advmod	_	_
33	metabolized	_	VERB	VBN	_	28	ccomp	_	_

#	Zyprexa	1364
1	Approximately	_	ADV	RB	_	9	advmod	_	_
2	57%	_	ADJ	JJ	_	9	nsubjpass	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	30%	_	NOUN	NN	_	2	conj	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	dose	_	NOUN	NN	_	2	nmod	_	_
8	was	_	VERB	VBD	_	9	auxpass	_	_
9	recovered	_	VERB	VBN	_	0	root	_	_
10	in	_	ADP	IN	_	12	case	_	_
11	the	_	DET	DT	_	12	det	_	_
12	urine	_	ADJ	JJ	_	9	nmod	_	_
13	and	_	CONJ	CC	_	12	cc	_	_
14	feces	_	NOUN	NNS	_	12	conj	_	_
15	,	_	.	,	_	12	punct	_	_
16	respectively	_	ADV	RB	_	12	advmod	_	_

#	Zyprexa	1365
1	In	_	ADP	IN	_	3	case	_	_
2	the	_	DET	DT	_	3	det	_	_
3	plasma	_	NOUN	NN	_	6	nmod	_	_
4	,	_	.	,	_	6	punct	_	_
5	DRUG	_	NOUN	NN	_	6	nsubj	_	_
6	accounted	_	VERB	VBD	_	0	root	_	_
7	for	_	ADP	IN	_	9	case	_	_
8	only	_	ADV	RB	_	9	advmod	_	_
9	12%	_	NOUN	NN	_	6	nmod	_	_
10	of	_	ADP	IN	_	12	case	_	_
11	the	_	DET	DT	_	12	det	_	_
12	AUC	_	NOUN	NN	_	9	nmod	_	_
13	for	_	ADP	IN	_	15	case	_	_
14	total	_	ADJ	JJ	_	15	amod	_	_
15	radioactivity	_	NOUN	NN	_	9	nmod	_	_
16	,	_	.	,	_	6	punct	_	_
17	indicating	_	VERB	VBG	_	6	advcl	_	_
18	significant	_	ADJ	JJ	_	19	amod	_	_
19	exposure	_	NOUN	NN	_	17	dobj	_	_
20	to	_	PRT	TO	_	21	case	_	_
21	metabolites	_	NOUN	NNS	_	19	nmod	_	_

#	Zyprexa	1366
1	After	_	ADP	IN	_	3	case	_	_
2	multiple	_	ADJ	JJ	_	3	amod	_	_
3	dosing	_	NOUN	NN	_	13	nmod	_	_
4	,	_	.	,	_	13	punct	_	_
5	the	_	DET	DT	_	8	det	_	_
6	major	_	ADJ	JJ	_	8	amod	_	_
7	circulating	_	ADJ	JJ	_	8	amod	_	_
8	metabolites	_	NOUN	NNS	_	13	nsubj	_	_
9	were	_	VERB	VBD	_	13	cop	_	_
10	the	_	DET	DT	_	13	det	_	_
11	10	_	NUM	CD	_	13	nummod	_	_
12	N	_	NOUN	NN	_	13	compound	_	_
13	glucuronide	_	NOUN	NN	_	0	root	_	_
14	,	_	.	,	_	13	punct	_	_
15	present	_	ADJ	JJ	_	13	amod	_	_
16	at	_	ADP	IN	_	18	case	_	_
17	steady	_	ADJ	JJ	_	18	amod	_	_
18	state	_	NOUN	NN	_	15	nmod	_	_
19	at	_	ADP	IN	_	20	case	_	_
20	44%	_	NOUN	NN	_	18	nmod	_	_
21	of	_	ADP	IN	_	23	case	_	_
22	the	_	DET	DT	_	23	det	_	_
23	concentration	_	NOUN	NN	_	20	nmod	_	_
24	of	_	ADP	IN	_	25	case	_	_
25	DRUG	_	NOUN	NN	_	23	nmod	_	_
26	,	_	.	,	_	13	punct	_	_
27	and	_	CONJ	CC	_	13	cc	_	_
28	4'	_	ADJ	JJ	_	31	amod	_	_
29	N	_	NOUN	NN	_	31	compound	_	_
30	desmethyl	_	NOUN	NN	_	31	compound	_	_
31	DRUG	_	NOUN	NN	_	13	conj	_	_
32	,	_	.	,	_	13	punct	_	_
33	present	_	ADJ	JJ	_	13	amod	_	_
34	at	_	ADP	IN	_	36	case	_	_
35	steady	_	ADJ	JJ	_	36	amod	_	_
36	state	_	NOUN	NN	_	33	nmod	_	_
37	at	_	ADP	IN	_	38	case	_	_
38	31%	_	NOUN	NN	_	33	nmod	_	_
39	of	_	ADP	IN	_	41	case	_	_
40	the	_	DET	DT	_	41	det	_	_
41	concentration	_	NOUN	NN	_	38	nmod	_	_
42	of	_	ADP	IN	_	43	case	_	_
43	DRUG	_	NOUN	NN	_	41	nmod	_	_

#	Zyprexa	1367
1	Both	_	DET	DT	_	2	det	_	_
2	metabolites	_	NOUN	NNS	_	3	nsubj	_	_
3	lack	_	VERB	VBP	_	0	root	_	_
4	pharmacological	_	ADJ	JJ	_	5	amod	_	_
5	activity	_	NOUN	NN	_	3	dobj	_	_
6	at	_	ADP	IN	_	8	case	_	_
7	the	_	DET	DT	_	8	det	_	_
8	concentrations	_	NOUN	NNS	_	5	nmod	_	_
9	observed	_	VERB	VBN	_	8	acl	_	_

#	Zyprexa	1368
1	Direct	_	ADJ	JJ	_	2	amod	_	_
2	glucuronidation	_	NOUN	NN	_	11	nsubj	_	_
3	and	_	CONJ	CC	_	2	cc	_	_
4	cytochromeP450(CYP	_	NOUN	NN	_	6	compound	_	_
5	mediated	_	ADJ	JJ	_	6	amod	_	_
6	oxidation	_	NOUN	NN	_	2	conj	_	_
7	are	_	VERB	VBP	_	11	cop	_	_
8	the	_	DET	DT	_	11	det	_	_
9	primary	_	ADJ	JJ	_	11	amod	_	_
10	metabolic	_	ADJ	JJ	_	11	amod	_	_
11	pathways	_	NOUN	NNS	_	0	root	_	_
12	for	_	ADP	IN	_	13	case	_	_
13	DRUG	_	NOUN	NN	_	11	nmod	_	_

#	Zyprexa	1369
1	Invitro	_	X	FW	_	2	compound	_	_
2	studies	_	NOUN	NNS	_	3	nsubj	_	_
3	suggest	_	VERB	VBP	_	0	root	_	_
4	that	_	ADP	IN	_	16	mark	_	_
5	CYPs1A2	_	NOUN	NN	_	16	nsubjpass	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	2D6	_	NOUN	NN	_	5	conj	_	_
8	,	_	.	,	_	5	punct	_	_
9	and	_	CONJ	CC	_	5	cc	_	_
10	the	_	DET	DT	_	11	det	_	_
11	flavin	_	NOUN	NN	_	5	conj	_	_
12	containing	_	VERB	VBG	_	11	acl	_	_
13	monooxygenase	_	NOUN	NN	_	14	compound	_	_
14	system	_	NOUN	NN	_	12	dobj	_	_
15	are	_	VERB	VBP	_	16	auxpass	_	_
16	involved	_	VERB	VBN	_	3	ccomp	_	_
17	in	_	ADP	IN	_	19	case	_	_
18	DRUG	_	NOUN	NN	_	19	compound	_	_
19	oxidation	_	NOUN	NN	_	16	nmod	_	_

#	Zyprexa	1370
1	CYP2D6	_	NOUN	NN	_	3	compound	_	_
2	mediated	_	ADJ	JJ	_	3	amod	_	_
3	oxidation	_	NOUN	NN	_	4	nsubj	_	_
4	appears	_	VERB	VBZ	_	0	root	_	_
5	to	_	PRT	TO	_	10	mark	_	_
6	be	_	VERB	VB	_	10	cop	_	_
7	a	_	DET	DT	_	10	det	_	_
8	minor	_	ADJ	JJ	_	10	amod	_	_
9	metabolic	_	ADJ	JJ	_	10	amod	_	_
10	pathway	_	NOUN	NN	_	4	xcomp	_	_
11	invivo	_	ADV	RB	_	10	advmod	_	_
12	,	_	.	,	_	4	punct	_	_
13	because	_	ADP	IN	_	20	mark	_	_
14	the	_	DET	DT	_	15	det	_	_
15	clearance	_	NOUN	NN	_	20	nsubjpass	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	DRUG	_	NOUN	NN	_	15	nmod	_	_
18	is	_	VERB	VBZ	_	20	auxpass	_	_
19	not	_	ADV	RB	_	20	neg	_	_
20	reduced	_	VERB	VBN	_	4	advcl	_	_
21	in	_	ADP	IN	_	22	case	_	_
22	subjects	_	NOUN	NNS	_	20	nmod	_	_
23	who	_	DET	WDT	_	25	nsubj	_	_
24	are	_	VERB	VBP	_	25	cop	_	_
25	deficient	_	ADJ	JJ	_	22	acl:relcl	_	_
26	in	_	ADP	IN	_	28	case	_	_
27	this	_	DET	DT	_	28	det	_	_
28	enzyme	_	NOUN	NN	_	25	nmod	_	_

#	Zyprexa	1371
1	Intramuscular	_	ADJ	JJ	_	5	amod	_	_
2	Administration	_	NOUN	NN	_	5	compound	_	_
3	DRUG	_	NOUN	NN	_	5	compound	_	_
4	IntraMuscular	_	ADJ	JJ	_	5	amod	_	_
5	results	_	NOUN	NNS	_	0	root	_	_
6	in	_	ADP	IN	_	8	case	_	_
7	rapid	_	ADJ	JJ	_	8	amod	_	_
8	absorption	_	NOUN	NN	_	5	nmod	_	_
9	with	_	ADP	IN	_	12	case	_	_
10	peak	_	ADJ	JJ	_	12	amod	_	_
11	plasma	_	NOUN	NN	_	12	compound	_	_
12	concentrations	_	NOUN	NNS	_	8	nmod	_	_
13	occurring	_	VERB	VBG	_	12	acl	_	_
14	within	_	ADP	IN	_	18	case	_	_
15	15	_	NUM	CD	_	17	compound	_	_
16	to	_	PRT	TO	_	17	dep	_	_
17	45	_	NUM	CD	_	18	nummod	_	_
18	minutes	_	NOUN	NNS	_	13	nmod	_	_

#	Zyprexa	1372
1	Based	_	VERB	VBN	_	18	advcl	_	_
2	upon	_	ADP	IN	_	5	case	_	_
3	a	_	DET	DT	_	5	det	_	_
4	pharmacokinetic	_	ADJ	JJ	_	5	amod	_	_
5	study	_	NOUN	NN	_	1	nmod	_	_
6	in	_	ADP	IN	_	8	case	_	_
7	healthy	_	ADJ	JJ	_	8	amod	_	_
8	volunteers	_	NOUN	NNS	_	5	nmod	_	_
9	,	_	.	,	_	18	punct	_	_
10	a	_	DET	DT	_	12	det	_	_
11	5mg	_	ADJ	JJ	_	12	amod	_	_
12	dose	_	NOUN	NN	_	18	nsubj	_	_
13	of	_	ADP	IN	_	15	case	_	_
14	intramuscular	_	ADJ	JJ	_	15	amod	_	_
15	DRUG	_	NOUN	NN	_	12	nmod	_	_
16	for	_	ADP	IN	_	17	case	_	_
17	injection	_	NOUN	NN	_	12	nmod	_	_
18	produces	_	VERB	VBZ	_	0	root	_	_
19	,	_	.	,	_	18	punct	_	_
20	on	_	ADP	IN	_	21	case	_	_
21	average	_	NOUN	NN	_	18	nmod	_	_
22	,	_	.	,	_	18	punct	_	_
23	a	_	DET	DT	_	26	det	_	_
24	maximum	_	NOUN	NN	_	26	compound	_	_
25	plasma	_	NOUN	NN	_	26	compound	_	_
26	concentration	_	NOUN	NN	_	18	dobj	_	_
27	approximately	_	ADV	RB	_	28	advmod	_	_
28	5	_	NUM	CD	_	29	nummod	_	_
29	times	_	NOUN	NNS	_	26	dep	_	_
30	higher	_	ADJ	JJ	_	29	amod	_	_
31	than	_	ADP	IN	_	35	case	_	_
32	the	_	DET	DT	_	35	det	_	_
33	maximum	_	NOUN	NN	_	35	compound	_	_
34	plasma	_	NOUN	NN	_	35	compound	_	_
35	concentration	_	NOUN	NN	_	30	nmod	_	_
36	produced	_	VERB	VBN	_	35	acl	_	_
37	by	_	ADP	IN	_	40	case	_	_
38	a	_	DET	DT	_	40	det	_	_
39	5mg	_	ADJ	JJ	_	40	amod	_	_
40	dose	_	NOUN	NN	_	36	nmod	_	_
41	of	_	ADP	IN	_	43	case	_	_
42	oral	_	ADJ	JJ	_	43	amod	_	_
43	DRUG	_	NOUN	NN	_	40	nmod	_	_

#	Zyprexa	1373
1	Area	_	NOUN	NN	_	11	nsubj	_	_
2	under	_	ADP	IN	_	4	case	_	_
3	the	_	DET	DT	_	4	det	_	_
4	curve	_	NOUN	NN	_	1	nmod	_	_
5	achieved	_	VERB	VBN	_	4	acl	_	_
6	after	_	ADP	IN	_	9	case	_	_
7	an	_	DET	DT	_	9	det	_	_
8	intramuscular	_	ADJ	JJ	_	9	amod	_	_
9	dose	_	NOUN	NN	_	5	nmod	_	_
10	is	_	VERB	VBZ	_	11	cop	_	_
11	similar	_	ADJ	JJ	_	0	root	_	_
12	to	_	PRT	TO	_	13	case	_	_
13	that	_	DET	WDT	_	11	nmod	_	_
14	achieved	_	VERB	VBN	_	13	acl	_	_
15	after	_	ADP	IN	_	17	case	_	_
16	oral	_	ADJ	JJ	_	17	amod	_	_
17	administration	_	NOUN	NN	_	14	nmod	_	_
18	of	_	ADP	IN	_	21	case	_	_
19	the	_	DET	DT	_	21	det	_	_
20	same	_	ADJ	JJ	_	21	amod	_	_
21	dose	_	NOUN	NN	_	17	nmod	_	_

#	Zyprexa	1374
1	The	_	DET	DT	_	3	det	_	_
2	half	_	ADJ	JJ	_	3	amod	_	_
3	life	_	NOUN	NN	_	9	nsubj	_	_
4	observed	_	VERB	VBN	_	3	acl	_	_
5	after	_	ADP	IN	_	7	case	_	_
6	intramuscular	_	ADJ	JJ	_	7	amod	_	_
7	administration	_	NOUN	NN	_	4	nmod	_	_
8	is	_	VERB	VBZ	_	9	cop	_	_
9	similar	_	ADJ	JJ	_	0	root	_	_
10	to	_	PRT	TO	_	11	case	_	_
11	that	_	DET	WDT	_	9	nmod	_	_
12	observed	_	VERB	VBN	_	11	acl	_	_
13	after	_	ADP	IN	_	15	case	_	_
14	oral	_	ADJ	JJ	_	15	amod	_	_
15	dosing	_	VERB	VBG	_	12	nmod	_	_

#	Zyprexa	1375
1	The	_	DET	DT	_	2	det	_	_
2	pharmacokinetics	_	NOUN	NNS	_	4	nsubj	_	_
3	are	_	VERB	VBP	_	4	cop	_	_
4	linear	_	ADJ	JJ	_	0	root	_	_
5	over	_	ADP	IN	_	9	case	_	_
6	the	_	DET	DT	_	9	det	_	_
7	clinical	_	ADJ	JJ	_	9	amod	_	_
8	dosing	_	NOUN	NN	_	9	compound	_	_
9	range	_	NOUN	NN	_	4	nmod	_	_

#	Zyprexa	1376
1	Metabolic	_	ADJ	JJ	_	2	amod	_	_
2	profiles	_	NOUN	NNS	_	8	nsubj	_	_
3	after	_	ADP	IN	_	5	case	_	_
4	intramuscular	_	ADJ	JJ	_	5	amod	_	_
5	administration	_	NOUN	NN	_	2	nmod	_	_
6	are	_	VERB	VBP	_	8	cop	_	_
7	qualitatively	_	ADV	RB	_	8	advmod	_	_
8	similar	_	ADJ	JJ	_	0	root	_	_
9	to	_	PRT	TO	_	11	case	_	_
10	metabolic	_	ADJ	JJ	_	11	amod	_	_
11	profiles	_	NOUN	NNS	_	8	nmod	_	_
12	after	_	ADP	IN	_	14	case	_	_
13	oral	_	ADJ	JJ	_	14	amod	_	_
14	administration	_	NOUN	NN	_	11	nmod	_	_

#	Zyprexa	1377
1	Specific	_	ADJ	JJ	_	2	amod	_	_
2	Populations	_	NOUN	NNS	_	0	root	_	_
3	Renal	_	ADJ	JJ	_	4	amod	_	_
4	Impairment	_	NOUN	NN	_	2	dep	_	_
5	Because	_	ADP	IN	_	9	mark	_	_
6	DRUG	_	NOUN	NN	_	9	nsubjpass	_	_
7	is	_	VERB	VBZ	_	9	auxpass	_	_
8	highly	_	ADV	RB	_	9	advmod	_	_
9	metabolized	_	VERB	VBN	_	2	acl:relcl	_	_
10	before	_	ADP	IN	_	11	case	_	_
11	excretion	_	NOUN	NN	_	9	nmod	_	_
12	and	_	CONJ	CC	_	9	cc	_	_
13	only	_	ADV	RB	_	14	advmod	_	_
14	7%	_	NOUN	NN	_	19	nsubjpass	_	_
15	of	_	ADP	IN	_	17	case	_	_
16	the	_	DET	DT	_	17	det	_	_
17	drug	_	NOUN	NN	_	14	nmod	_	_
18	is	_	VERB	VBZ	_	19	auxpass	_	_
19	excreted	_	VERB	VBN	_	9	conj	_	_
20	unchanged	_	ADJ	JJ	_	19	xcomp	_	_
21	,	_	.	,	_	19	punct	_	_
22	renal	_	ADJ	JJ	_	23	amod	_	_
23	dysfunction	_	NOUN	NN	_	26	nsubj	_	_
24	alone	_	ADV	RB	_	23	advmod	_	_
25	is	_	VERB	VBZ	_	26	cop	_	_
26	unlikely	_	ADJ	JJ	_	19	parataxis	_	_
27	to	_	PRT	TO	_	28	mark	_	_
28	have	_	VERB	VB	_	26	xcomp	_	_
29	a	_	DET	DT	_	31	det	_	_
30	major	_	ADJ	JJ	_	31	amod	_	_
31	impact	_	NOUN	NN	_	28	dobj	_	_
32	on	_	ADP	IN	_	34	case	_	_
33	the	_	DET	DT	_	34	det	_	_
34	pharmacokinetics	_	NOUN	NNS	_	31	nmod	_	_
35	of	_	ADP	IN	_	36	case	_	_
36	DRUG	_	NOUN	NN	_	34	nmod	_	_

#	Zyprexa	1378
1	The	_	DET	DT	_	3	det	_	_
2	pharmacokinetic	_	ADJ	JJ	_	3	amod	_	_
3	characteristics	_	NOUN	NNS	_	7	nsubj	_	_
4	of	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	3	nmod	_	_
6	were	_	VERB	VBD	_	7	cop	_	_
7	similar	_	ADJ	JJ	_	0	root	_	_
8	in	_	ADP	IN	_	9	case	_	_
9	patients	_	NOUN	NNS	_	7	nmod	_	_
10	with	_	ADP	IN	_	13	case	_	_
11	severe	_	ADJ	JJ	_	13	amod	_	_
12	renal	_	ADJ	JJ	_	13	amod	_	_
13	impairment	_	NOUN	NN	_	9	nmod	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	normal	_	ADJ	JJ	_	16	amod	_	_
16	subjects	_	NOUN	NNS	_	13	conj	_	_
17	,	_	.	,	_	7	punct	_	_
18	indicating	_	VERB	VBG	_	7	advcl	_	_
19	that	_	ADP	IN	_	31	mark	_	_
20	dosage	_	NOUN	NN	_	21	compound	_	_
21	adjustment	_	NOUN	NN	_	31	nsubjpass	_	_
22	based	_	VERB	VBN	_	21	acl	_	_
23	upon	_	ADP	IN	_	25	case	_	_
24	the	_	DET	DT	_	25	det	_	_
25	degree	_	NOUN	NN	_	22	nmod	_	_
26	of	_	ADP	IN	_	28	case	_	_
27	renal	_	ADJ	JJ	_	28	amod	_	_
28	impairment	_	NOUN	NN	_	25	nmod	_	_
29	is	_	VERB	VBZ	_	31	auxpass	_	_
30	not	_	ADV	RB	_	31	neg	_	_
31	required	_	VERB	VBN	_	18	ccomp	_	_

#	Zyprexa	1379
1	In	_	ADP	IN	_	2	case	_	_
2	addition	_	NOUN	NN	_	7	nmod	_	_
3	,	_	.	,	_	7	punct	_	_
4	DRUG	_	NOUN	NN	_	7	nsubjpass	_	_
5	is	_	VERB	VBZ	_	7	auxpass	_	_
6	not	_	ADV	RB	_	7	neg	_	_
7	removed	_	VERB	VBN	_	0	root	_	_
8	by	_	ADP	IN	_	9	case	_	_
9	dialysis	_	NOUN	NN	_	7	nmod	_	_

#	Zyprexa	1380
1	The	_	DET	DT	_	2	det	_	_
2	effect	_	NOUN	NN	_	12	nsubjpass	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	renal	_	ADJ	JJ	_	5	amod	_	_
5	impairment	_	NOUN	NN	_	2	nmod	_	_
6	on	_	ADP	IN	_	8	case	_	_
7	metabolite	_	NOUN	NN	_	8	compound	_	_
8	elimination	_	NOUN	NN	_	2	nmod	_	_
9	has	_	VERB	VBZ	_	12	aux	_	_
10	not	_	ADV	RB	_	12	neg	_	_
11	been	_	VERB	VBN	_	12	auxpass	_	_
12	studied	_	VERB	VBN	_	0	root	_	_

#	Zyprexa	1381
1	Hepatic	_	ADJ	JJ	_	2	amod	_	_
2	Impairment	_	NOUN	NN	_	0	root	_	_
3	Although	_	ADP	IN	_	11	mark	_	_
4	the	_	DET	DT	_	5	det	_	_
5	presence	_	NOUN	NN	_	11	nsubjpass	_	_
6	of	_	ADP	IN	_	8	case	_	_
7	hepatic	_	ADJ	JJ	_	8	amod	_	_
8	impairment	_	NOUN	NN	_	5	nmod	_	_
9	may	_	VERB	MD	_	11	aux	_	_
10	be	_	VERB	VB	_	11	auxpass	_	_
11	expected	_	VERB	VBN	_	2	acl:relcl	_	_
12	to	_	PRT	TO	_	13	mark	_	_
13	reduce	_	VERB	VB	_	11	xcomp	_	_
14	the	_	DET	DT	_	15	det	_	_
15	clearance	_	NOUN	NN	_	13	dobj	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	DRUG	_	NOUN	NN	_	15	nmod	_	_
18	,	_	.	,	_	2	punct	_	_
19	a	_	DET	DT	_	20	det	_	_
20	study	_	NOUN	NN	_	39	nsubj	_	_
21	of	_	ADP	IN	_	23	case	_	_
22	the	_	DET	DT	_	23	det	_	_
23	effect	_	NOUN	NN	_	20	nmod	_	_
24	of	_	ADP	IN	_	27	case	_	_
25	impaired	_	ADJ	JJ	_	27	amod	_	_
26	liver	_	NOUN	NN	_	27	compound	_	_
27	function	_	NOUN	NN	_	23	nmod	_	_
28	in	_	ADP	IN	_	29	case	_	_
29	subjects	_	NOUN	NNS	_	27	nmod	_	_
30	n=6	_	NOUN	NN	_	29	dep	_	_
31	with	_	ADP	IN	_	38	case	_	_
32	clinically	_	ADV	RB	_	33	advmod	_	_
33	significant	_	ADJ	JJ	_	38	amod	_	_
34	Childs	_	NOUN	NN	_	38	compound	_	_
35	Pugh	_	NOUN	NN	_	38	compound	_	_
36	ClassificationA	_	NOUN	NN	_	38	compound	_	_
37	andB	_	NOUN	NN	_	38	compound	_	_
38	cirrhosis	_	NOUN	NN	_	29	nmod	_	_
39	revealed	_	VERB	VBD	_	2	dep	_	_
40	little	_	ADJ	JJ	_	41	amod	_	_
41	effect	_	NOUN	NN	_	39	dobj	_	_
42	on	_	ADP	IN	_	44	case	_	_
43	the	_	DET	DT	_	44	det	_	_
44	pharmacokinetics	_	NOUN	NNS	_	39	nmod	_	_
45	of	_	ADP	IN	_	46	case	_	_
46	DRUG	_	NOUN	NN	_	44	nmod	_	_

#	Zyprexa	1382
1	Geriatric	_	ADJ	JJ	_	20	advmod	_	_
2	In	_	ADP	IN	_	4	case	_	_
3	a	_	DET	DT	_	4	det	_	_
4	study	_	NOUN	NN	_	1	nmod	_	_
5	involving	_	VERB	VBG	_	4	acl	_	_
6	24	_	NUM	CD	_	8	nummod	_	_
7	healthy	_	ADJ	JJ	_	8	amod	_	_
8	subjects	_	NOUN	NNS	_	5	dobj	_	_
9	,	_	.	,	_	20	punct	_	_
10	the	_	DET	DT	_	14	det	_	_
11	mean	_	NOUN	NN	_	14	compound	_	_
12	elimination	_	NOUN	NN	_	14	compound	_	_
13	half	_	NOUN	NN	_	14	compound	_	_
14	life	_	NOUN	NN	_	20	nsubj	_	_
15	of	_	ADP	IN	_	16	case	_	_
16	DRUG	_	NOUN	NN	_	14	nmod	_	_
17	was	_	VERB	VBD	_	20	cop	_	_
18	about	_	ADV	RB	_	19	advmod	_	_
19	1.5	_	NUM	CD	_	20	nummod	_	_
20	times	_	NOUN	NNS	_	0	root	_	_
21	greater	_	ADJ	JJ	_	20	amod	_	_
22	in	_	ADP	IN	_	25	case	_	_
23	elderly	_	ADJ	JJ	_	25	amod	_	_
24	>65	_	NUM	CD	_	25	nummod	_	_
25	years	_	NOUN	NNS	_	21	nmod	_	_
26	than	_	ADP	IN	_	29	case	_	_
27	in	_	ADP	IN	_	29	case	_	_
28	nonelderly	_	ADJ	JJ	_	29	amod	_	_
29	subjects	_	NOUN	NNS	_	21	nmod	_	_
30	<65	_	NUM	CD	_	31	nummod	_	_
31	years	_	NOUN	NNS	_	29	dep	_	_

#	Zyprexa	1383
1	Caution	_	NOUN	NN	_	4	nsubjpass	_	_
2	should	_	VERB	MD	_	4	aux	_	_
3	be	_	VERB	VB	_	4	auxpass	_	_
4	used	_	VERB	VBN	_	0	root	_	_
5	in	_	ADP	IN	_	6	mark	_	_
6	dosing	_	VERB	VBG	_	4	advcl	_	_
7	the	_	DET	DT	_	8	det	_	_
8	elderly	_	NOUN	NN	_	6	dobj	_	_
9	,	_	.	,	_	4	punct	_	_
10	especially	_	ADV	RB	_	13	advmod	_	_
11	if	_	ADP	IN	_	13	mark	_	_
12	there	_	DET	EX	_	13	expl	_	_
13	are	_	VERB	VBP	_	4	parataxis	_	_
14	other	_	ADJ	JJ	_	15	amod	_	_
15	factors	_	NOUN	NNS	_	13	nsubj	_	_
16	that	_	DET	WDT	_	19	nsubj	_	_
17	might	_	VERB	MD	_	19	aux	_	_
18	additively	_	ADV	RB	_	19	advmod	_	_
19	influence	_	VERB	VB	_	15	acl:relcl	_	_
20	drug	_	NOUN	NN	_	21	compound	_	_
21	metabolism	_	NOUN	NN	_	19	dobj	_	_
22	and	_	CONJ	CC	_	21	cc	_	_
23	/	_	NUM	CD	_	26	compound	_	_
24	or	_	CONJ	CC	_	23	cc	_	_
25	pharmacodynamic	_	ADJ	JJ	_	23	conj	_	_
26	sensitivity	_	NOUN	NN	_	21	conj	_	_

#	Zyprexa	1384
1	Gender	_	NOUN	NN	_	2	compound	_	_
2	Clearance	_	NOUN	NN	_	7	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	is	_	VERB	VBZ	_	7	cop	_	_
6	approximately	_	ADV	RB	_	7	advmod	_	_
7	30%	_	ADJ	JJ	_	0	root	_	_
8	lower	_	ADJ	JJ	_	7	xcomp	_	_
9	in	_	ADP	IN	_	10	case	_	_
10	women	_	NOUN	NNS	_	8	nmod	_	_
11	than	_	ADP	IN	_	13	case	_	_
12	in	_	ADP	IN	_	13	case	_	_
13	men	_	NOUN	NN	_	8	nmod	_	_

#	Zyprexa	1385
1	There	_	DET	EX	_	2	expl	_	_
2	were	_	VERB	VBD	_	0	root	_	_
3	,	_	.	,	_	2	punct	_	_
4	however	_	ADV	RB	_	2	advmod	_	_
5	,	_	.	,	_	2	punct	_	_
6	no	_	DET	DT	_	8	neg	_	_
7	apparent	_	ADJ	JJ	_	8	amod	_	_
8	differences	_	NOUN	NNS	_	2	nsubj	_	_
9	between	_	ADP	IN	_	10	case	_	_
10	men	_	NOUN	NN	_	8	nmod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	women	_	NOUN	NNS	_	10	conj	_	_
13	in	_	ADP	IN	_	14	case	_	_
14	effectiveness	_	NOUN	NN	_	8	nmod	_	_
15	or	_	CONJ	CC	_	14	cc	_	_
16	adverse	_	ADJ	JJ	_	17	amod	_	_
17	effects	_	NOUN	NNS	_	14	conj	_	_

#	Zyprexa	1386
1	Dosage	_	NOUN	NN	_	2	compound	_	_
2	modifications	_	NOUN	NNS	_	9	nsubjpass	_	_
3	based	_	VERB	VBN	_	2	acl	_	_
4	on	_	ADP	IN	_	5	case	_	_
5	gender	_	NOUN	NN	_	3	nmod	_	_
6	should	_	VERB	MD	_	9	aux	_	_
7	not	_	ADV	RB	_	9	neg	_	_
8	be	_	VERB	VB	_	9	auxpass	_	_
9	needed	_	VERB	VBN	_	0	root	_	_

#	Zyprexa	1387
1	Smoking	_	VERB	VBG	_	7	csubj	_	_
2	Status	_	NOUN	NN	_	4	compound	_	_
3	DRUG	_	NOUN	NN	_	4	compound	_	_
4	clearance	_	NOUN	NN	_	1	dobj	_	_
5	is	_	VERB	VBZ	_	7	cop	_	_
6	about	_	ADV	RB	_	7	advmod	_	_
7	40%	_	ADJ	JJ	_	0	root	_	_
8	higher	_	ADJ	JJ	_	7	advmod	_	_
9	in	_	ADP	IN	_	10	case	_	_
10	smokers	_	NOUN	NNS	_	8	nmod	_	_
11	than	_	ADP	IN	_	13	case	_	_
12	in	_	ADP	IN	_	13	case	_	_
13	nonsmokers	_	NOUN	NNS	_	8	nmod	_	_
14	,	_	.	,	_	7	punct	_	_
15	although	_	ADP	IN	_	21	mark	_	_
16	dosage	_	NOUN	NN	_	17	compound	_	_
17	modifications	_	NOUN	NNS	_	21	nsubjpass	_	_
18	are	_	VERB	VBP	_	21	auxpass	_	_
19	not	_	ADV	RB	_	21	neg	_	_
20	routinely	_	ADV	RB	_	21	advmod	_	_
21	recommended	_	VERB	VBN	_	7	advcl	_	_

#	Zyprexa	1388
1	Race	_	ADJ	JJ	_	3	compound	_	_
2	Invivo	_	NOUN	NN	_	3	compound	_	_
3	studies	_	NOUN	NNS	_	5	nsubj	_	_
4	have	_	VERB	VBP	_	5	aux	_	_
5	shown	_	VERB	VBN	_	0	root	_	_
6	that	_	ADP	IN	_	9	mark	_	_
7	exposures	_	NOUN	NNS	_	9	nsubj	_	_
8	are	_	VERB	VBP	_	9	cop	_	_
9	similar	_	ADJ	JJ	_	5	ccomp	_	_
10	among	_	ADP	IN	_	11	case	_	_
11	Japanese	_	NOUN	NN	_	9	nmod	_	_
12	,	_	.	,	_	11	punct	_	_
13	Chinese	_	NOUN	NN	_	11	conj	_	_
14	and	_	CONJ	CC	_	11	cc	_	_
15	Caucasians	_	NOUN	NNS	_	11	conj	_	_
16	,	_	.	,	_	9	punct	_	_
17	especially	_	ADV	RB	_	19	advmod	_	_
18	after	_	ADP	IN	_	19	case	_	_
19	normalization	_	NOUN	NN	_	9	nmod	_	_
20	for	_	ADP	IN	_	23	case	_	_
21	body	_	NOUN	NN	_	23	compound	_	_
22	weight	_	NOUN	NN	_	23	compound	_	_
23	differences	_	NOUN	NNS	_	19	nmod	_	_

#	Zyprexa	1389
1	Dosage	_	NOUN	NN	_	2	compound	_	_
2	modifications	_	NOUN	NNS	_	10	nsubjpass	_	_
3	for	_	ADP	IN	_	4	case	_	_
4	race	_	NOUN	NN	_	2	nmod	_	_
5	are	_	VERB	VBP	_	10	auxpass	_	_
6	,	_	.	,	_	10	punct	_	_
7	therefore	_	ADV	RB	_	10	advmod	_	_
8	,	_	.	,	_	10	punct	_	_
9	not	_	ADV	RB	_	10	neg	_	_
10	recommended	_	VERB	VBN	_	0	root	_	_

#	Zyprexa	1390
1	Combined	_	ADJ	JJ	_	2	amod	_	_
2	Effects	_	NOUN	NNS	_	0	root	_	_
3	The	_	DET	DT	_	5	det	_	_
4	combined	_	VERB	VBN	_	5	amod	_	_
5	effects	_	NOUN	NNS	_	14	nsubj	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	age	_	NOUN	NN	_	5	nmod	_	_
8	,	_	.	,	_	7	punct	_	_
9	smoking	_	NOUN	NN	_	7	conj	_	_
10	,	_	.	,	_	7	punct	_	_
11	and	_	CONJ	CC	_	7	cc	_	_
12	gender	_	NOUN	NN	_	7	conj	_	_
13	could	_	VERB	MD	_	14	aux	_	_
14	lead	_	VERB	VB	_	2	dep	_	_
15	to	_	PRT	TO	_	18	case	_	_
16	substantial	_	ADJ	JJ	_	18	amod	_	_
17	pharmacokinetic	_	ADJ	JJ	_	18	amod	_	_
18	differences	_	NOUN	NNS	_	14	nmod	_	_
19	in	_	ADP	IN	_	20	case	_	_
20	populations	_	NOUN	NNS	_	18	nmod	_	_

#	Zyprexa	1391
1	The	_	DET	DT	_	2	det	_	_
2	clearance	_	NOUN	NN	_	14	nsubj	_	_
3	in	_	ADP	IN	_	6	case	_	_
4	young	_	ADJ	JJ	_	6	amod	_	_
5	smoking	_	NOUN	NN	_	6	compound	_	_
6	males	_	NOUN	NNS	_	2	nmod	_	_
7	,	_	.	,	_	2	punct	_	_
8	for	_	ADP	IN	_	9	case	_	_
9	example	_	NOUN	NN	_	2	nmod	_	_
10	,	_	.	,	_	2	punct	_	_
11	may	_	VERB	MD	_	14	aux	_	_
12	be	_	VERB	VB	_	14	cop	_	_
13	3	_	NUM	CD	_	14	nummod	_	_
14	times	_	NOUN	NNS	_	0	root	_	_
15	higher	_	ADJ	JJ	_	14	amod	_	_
16	than	_	ADP	IN	_	17	case	_	_
17	that	_	DET	WDT	_	15	nmod	_	_
18	in	_	ADP	IN	_	21	case	_	_
19	elderly	_	ADJ	JJ	_	21	amod	_	_
20	nonsmoking	_	ADJ	JJ	_	21	amod	_	_
21	females	_	NOUN	NNS	_	17	nmod	_	_

#	Zyprexa	1392
1	Dosing	_	VERB	VBG	_	2	amod	_	_
2	modification	_	NOUN	NN	_	5	nsubj	_	_
3	may	_	VERB	MD	_	5	aux	_	_
4	be	_	VERB	VB	_	5	cop	_	_
5	necessary	_	ADJ	JJ	_	0	root	_	_
6	in	_	ADP	IN	_	7	case	_	_
7	patients	_	NOUN	NNS	_	5	nmod	_	_
8	who	_	DET	WDT	_	9	nsubj	_	_
9	exhibit	_	VERB	VBP	_	7	acl:relcl	_	_
10	a	_	DET	DT	_	11	det	_	_
11	combination	_	NOUN	NN	_	9	dobj	_	_
12	of	_	ADP	IN	_	13	case	_	_
13	factors	_	NOUN	NNS	_	11	nmod	_	_
14	that	_	DET	WDT	_	16	nsubj	_	_
15	may	_	VERB	MD	_	16	aux	_	_
16	result	_	VERB	VB	_	13	acl:relcl	_	_
17	in	_	ADP	IN	_	19	case	_	_
18	slower	_	ADJ	JJ	_	19	amod	_	_
19	metabolism	_	NOUN	NN	_	16	nmod	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	DRUG	_	NOUN	NN	_	19	nmod	_	_

#	Zyprexa	1393
1	Adolescents	_	NOUN	NNS	_	2	nsubj	_	_
2	ages	_	VERB	VBZ	_	14	advcl	_	_
3	13	_	NUM	CD	_	5	compound	_	_
4	to	_	PRT	TO	_	5	dep	_	_
5	17	_	NUM	CD	_	6	nummod	_	_
6	years	_	NOUN	NNS	_	2	dobj	_	_
7	In	_	ADP	IN	_	9	case	_	_
8	clinical	_	ADJ	JJ	_	9	amod	_	_
9	studies	_	NOUN	NNS	_	2	nmod	_	_
10	,	_	.	,	_	14	punct	_	_
11	most	_	ADJ	JJ	_	12	amod	_	_
12	adolescents	_	NOUN	NNS	_	14	nsubj	_	_
13	were	_	VERB	VBD	_	14	cop	_	_
14	nonsmokers	_	NOUN	NNS	_	0	root	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	this	_	DET	DT	_	17	det	_	_
17	population	_	NOUN	NN	_	18	nsubj	_	_
18	had	_	VERB	VBD	_	14	conj	_	_
19	a	_	DET	DT	_	23	det	_	_
20	lower	_	ADJ	JJ	_	23	amod	_	_
21	average	_	ADJ	JJ	_	23	amod	_	_
22	body	_	NOUN	NN	_	23	compound	_	_
23	weight	_	NOUN	NN	_	18	dobj	_	_
24	,	_	.	,	_	23	punct	_	_
25	which	_	DET	WDT	_	26	nsubj	_	_
26	resulted	_	VERB	VBD	_	23	acl:relcl	_	_
27	in	_	ADP	IN	_	31	case	_	_
28	higher	_	ADJ	JJ	_	31	amod	_	_
29	average	_	ADJ	JJ	_	31	amod	_	_
30	DRUG	_	NOUN	NN	_	31	compound	_	_
31	exposure	_	NOUN	NN	_	26	nmod	_	_
32	compared	_	VERB	VBN	_	34	case	_	_
33	to	_	PRT	TO	_	34	case	_	_
34	adults	_	NOUN	NNS	_	18	nmod	_	_

#	Zytiga	2091
1	CYP3A4	_	NOUN	NN	_	2	compound	_	_
2	Inducers	_	NOUN	NNS	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	Avoid	_	ADJ	JJ	_	8	amod	_	_
5	concomitant	_	ADJ	JJ	_	8	amod	_	_
6	strong	_	ADJ	JJ	_	8	amod	_	_
7	CYP3A4	_	NOUN	NN	_	8	compound	_	_
8	inducers	_	NOUN	NNS	_	2	dep	_	_
9	during	_	ADP	IN	_	11	case	_	_
10	DRUG	_	NOUN	NN	_	11	compound	_	_
11	treatment	_	NOUN	NN	_	8	nmod	_	_

#	Zytiga	2092
1	If	_	ADP	IN	_	5	case	_	_
2	a	_	DET	DT	_	5	det	_	_
3	strong	_	ADJ	JJ	_	5	amod	_	_
4	CYP3A4	_	NOUN	NN	_	5	compound	_	_
5	inducer	_	NOUN	NN	_	9	nsubjpass	_	_
6	must	_	VERB	MD	_	9	aux	_	_
7	be	_	VERB	VB	_	9	auxpass	_	_
8	co	_	PRT	TO	_	9	mark	_	_
9	administered	_	VERB	VBN	_	0	root	_	_
10	,	_	.	,	_	9	punct	_	_
11	increase	_	VERB	VBP	_	9	xcomp	_	_
12	the	_	DET	DT	_	15	det	_	_
13	DRUG	_	NOUN	NN	_	15	compound	_	_
14	dosing	_	NOUN	NN	_	15	compound	_	_
15	frequency	_	NOUN	NN	_	11	dobj	_	_

#	Zytiga	2093
1	CYP2D6	_	NOUN	NN	_	2	compound	_	_
2	Substrates	_	NOUN	NNS	_	0	root	_	_
3	:	_	.	:	_	2	punct	_	_
4	Avoid	_	ADJ	JJ	_	6	case	_	_
5	co	_	PRT	TO	_	4	mwe	_	_
6	administration	_	NOUN	NN	_	2	dep	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	with	_	ADP	IN	_	11	case	_	_
10	CYP2D6	_	NOUN	NN	_	11	compound	_	_
11	substrates	_	NOUN	NNS	_	6	nmod	_	_
12	that	_	DET	WDT	_	13	nsubj	_	_
13	have	_	VERB	VBP	_	11	acl:relcl	_	_
14	a	_	DET	DT	_	17	det	_	_
15	narrow	_	NOUN	NN	_	17	compound	_	_
16	therapeutic	_	ADJ	JJ	_	17	amod	_	_
17	index	_	NOUN	NN	_	13	dobj	_	_

#	Zytiga	2094
1	If	_	ADP	IN	_	7	mark	_	_
2	an	_	DET	DT	_	5	det	_	_
3	alternative	_	ADJ	JJ	_	5	amod	_	_
4	treatment	_	NOUN	NN	_	5	compound	_	_
5	cannot	_	NOUN	NN	_	7	nsubjpass	_	_
6	be	_	VERB	VBZ	_	7	auxpass	_	_
7	used	_	VERB	VBN	_	0	root	_	_
8	,	_	.	,	_	7	punct	_	_
9	exercise	_	VERB	VBP	_	10	amod	_	_
10	caution	_	NOUN	NN	_	8	root	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	consider	_	VERB	VBP	_	10	conj	_	_
13	a	_	DET	DT	_	15	det	_	_
14	dose	_	NOUN	NN	_	15	compound	_	_
15	reduction	_	NOUN	NN	_	12	dobj	_	_
16	of	_	ADP	IN	_	20	case	_	_
17	the	_	DET	DT	_	20	det	_	_
18	concomitant	_	ADJ	JJ	_	20	amod	_	_
19	CYP2D6	_	NOUN	NN	_	20	compound	_	_
20	substrate	_	NOUN	NN	_	15	nmod	_	_

#	Zytiga	2095
1	Based	_	VERB	VBN	_	10	advcl	_	_
2	on	_	ADP	IN	_	5	case	_	_
3	in	_	X	FW	_	5	amod	_	_
4	vitro	_	X	FW	_	3	dep	_	_
5	data	_	NOUN	NNS	_	1	nmod	_	_
6	,	_	.	,	_	10	punct	_	_
7	DRUG	_	NOUN	NN	_	10	nsubj	_	_
8	is	_	VERB	VBZ	_	10	cop	_	_
9	a	_	DET	DT	_	10	det	_	_
10	substrate	_	NOUN	NN	_	0	root	_	_
11	of	_	ADP	IN	_	12	case	_	_
12	CYP3A4	_	NOUN	NN	_	10	nmod	_	_

#	Zytiga	2096
1	In	_	ADP	IN	_	6	case	_	_
2	a	_	DET	DT	_	6	det	_	_
3	dedicated	_	VERB	VBN	_	6	amod	_	_
4	drug	_	NOUN	NN	_	6	compound	_	_
5	interaction	_	NOUN	NN	_	6	compound	_	_
6	trial	_	ADJ	JJ	_	18	nmod	_	_
7	,	_	.	,	_	18	punct	_	_
8	co	_	PRT	TO	_	9	case	_	_
9	administration	_	NOUN	NN	_	18	nsubj	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	rifampin	_	NOUN	NN	_	9	nmod	_	_
12	,	_	.	,	_	11	punct	_	_
13	a	_	DET	DT	_	16	det	_	_
14	strong	_	ADJ	JJ	_	16	amod	_	_
15	CYP3A4	_	NOUN	NN	_	16	compound	_	_
16	inducer	_	NOUN	NN	_	11	appos	_	_
17	,	_	.	,	_	11	punct	_	_
18	decreased	_	VERB	VBD	_	0	root	_	_
19	exposure	_	NOUN	NN	_	18	dobj	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	DRUG	_	NOUN	NN	_	19	nmod	_	_
22	by	_	ADP	IN	_	23	case	_	_
23	55%	_	ADJ	JJ	_	19	nmod	_	_

#	Zytiga	2097
1	Avoid	_	ADP	IN	_	5	case	_	_
2	concomitant	_	ADJ	JJ	_	5	amod	_	_
3	strong	_	ADJ	JJ	_	5	amod	_	_
4	CYP3A4	_	NOUN	NN	_	5	compound	_	_
5	inducers	_	NOUN	NNS	_	0	root	_	_
6	during	_	ADP	IN	_	8	case	_	_
7	DRUG	_	NOUN	NN	_	8	compound	_	_
8	treatment	_	NOUN	NN	_	5	nmod	_	_

#	Zytiga	2099
1	In	_	ADP	IN	_	6	case	_	_
2	a	_	DET	DT	_	6	det	_	_
3	dedicated	_	VERB	VBN	_	6	amod	_	_
4	drug	_	NOUN	NN	_	6	compound	_	_
5	interaction	_	NOUN	NN	_	6	compound	_	_
6	trial	_	ADJ	JJ	_	19	nmod	_	_
7	,	_	.	,	_	19	punct	_	_
8	co	_	PRT	TO	_	9	case	_	_
9	administration	_	NOUN	NN	_	19	nsubj	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	ketoconazole	_	NOUN	NN	_	9	nmod	_	_
12	,	_	.	,	_	11	punct	_	_
13	a	_	DET	DT	_	15	det	_	_
14	strong	_	ADJ	JJ	_	15	amod	_	_
15	inhibitor	_	NOUN	NN	_	11	appos	_	_
16	of	_	ADP	IN	_	17	case	_	_
17	CYP3A4	_	NOUN	NN	_	15	nmod	_	_
18	,	_	.	,	_	9	punct	_	_
19	had	_	VERB	VBD	_	0	root	_	_
20	no	_	DET	DT	_	23	neg	_	_
21	clinically	_	ADV	RB	_	22	advmod	_	_
22	meaningful	_	ADJ	JJ	_	23	amod	_	_
23	effect	_	NOUN	NN	_	19	dobj	_	_
24	on	_	ADP	IN	_	26	case	_	_
25	the	_	DET	DT	_	26	det	_	_
26	pharmacokinetics	_	NOUN	NNS	_	23	nmod	_	_
27	of	_	ADP	IN	_	28	case	_	_
28	DRUG	_	NOUN	NN	_	26	nmod	_	_

#	Zytiga	2100
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	is	_	VERB	VBZ	_	4	cop	_	_
3	an	_	DET	DT	_	4	det	_	_
4	inhibitor	_	NOUN	NN	_	0	root	_	_
5	of	_	ADP	IN	_	10	case	_	_
6	the	_	DET	DT	_	10	det	_	_
7	hepatic	_	ADJ	JJ	_	10	amod	_	_
8	drug	_	NOUN	NN	_	10	compound	_	_
9	metabolizing	_	NOUN	NN	_	10	compound	_	_
10	enzymes	_	NOUN	NNS	_	4	nmod	_	_
11	CYP2D6	_	NOUN	NN	_	10	dep	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	CYP2C8	_	NOUN	NN	_	11	conj	_	_

#	Zytiga	2101
1	In	_	ADP	IN	_	7	case	_	_
2	a	_	DET	DT	_	7	det	_	_
3	CYP2D6	_	NOUN	NN	_	7	compound	_	_
4	drug	_	NOUN	NN	_	7	compound	_	_
5	drug	_	NOUN	NN	_	7	compound	_	_
6	interaction	_	NOUN	NN	_	7	compound	_	_
7	trial	_	ADJ	JJ	_	18	nmod	_	_
8	,	_	.	,	_	18	punct	_	_
9	the	_	DET	DT	_	10	det	_	_
10	Cmax	_	NOUN	NN	_	18	nsubjpass	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	AUC	_	NOUN	NN	_	10	conj	_	_
13	of	_	ADP	IN	_	16	case	_	_
14	dextromethorphan	_	NOUN	NN	_	16	compound	_	_
15	CYP2D6	_	NOUN	NN	_	16	compound	_	_
16	substrate	_	NOUN	NN	_	10	nmod	_	_
17	were	_	VERB	VBD	_	18	auxpass	_	_
18	increased	_	VERB	VBN	_	0	root	_	_
19	2.8	_	NUM	CD	_	22	nummod	_	_
20	and	_	CONJ	CC	_	19	cc	_	_
21	2.9	_	NUM	CD	_	19	conj	_	_
22	fold	_	NOUN	NN	_	18	dobj	_	_
23	,	_	.	,	_	18	punct	_	_
24	respectively	_	ADV	RB	_	18	advmod	_	_
25	,	_	.	,	_	18	punct	_	_
26	when	_	ADV	WRB	_	29	advmod	_	_
27	dextromethorphan	_	NOUN	NN	_	29	nsubjpass	_	_
28	was	_	VERB	VBD	_	29	auxpass	_	_
29	given	_	VERB	VBN	_	18	parataxis	_	_
30	with	_	ADP	IN	_	34	case	_	_
31	DRUG	_	NOUN	NN	_	34	compound	_	_
32	acetate	_	NOUN	NN	_	34	compound	_	_
33	1,000	_	NUM	CD	_	34	nummod	_	_
34	mg	_	NOUN	NN	_	29	nmod	_	_
35	daily	_	ADV	RB	_	36	advmod	_	_
36	and	_	CONJ	CC	_	29	advmod	_	_
37	prednisone	_	NOUN	NN	_	39	compound	_	_
38	5	_	NUM	CD	_	39	nummod	_	_
39	mg	_	NOUN	NN	_	36	conj	_	_
40	twice	_	ADV	RB	_	39	advmod	_	_
41	daily	_	ADV	RB	_	39	advmod	_	_

#	Zytiga	2102
1	Avoid	_	ADV	RB	_	0	root	_	_
2	co	_	PRT	TO	_	1	nmod	_	_
3	administration	_	NOUN	NN	_	2	root	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	DRUG	_	NOUN	NN	_	6	compound	_	_
6	acetate	_	NOUN	NN	_	3	nmod	_	_
7	with	_	ADP	IN	_	8	case	_	_
8	substrates	_	NOUN	NNS	_	3	nmod	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	CYP2D6	_	NOUN	NN	_	8	nmod	_	_
11	with	_	ADP	IN	_	16	case	_	_
12	a	_	DET	DT	_	16	det	_	_
13	narrow	_	NOUN	NN	_	16	compound	_	_
14	therapeutic	_	ADJ	JJ	_	16	amod	_	_
15	index	_	NOUN	NN	_	16	compound	_	_
16	e.g	_	NOUN	NN	_	3	nmod	_	_
17	,	_	.	,	_	16	punct	_	_
18	thioridazine	_	NOUN	NN	_	16	appos	_	_

#	Zytiga	2103
1	If	_	ADP	IN	_	6	mark	_	_
2	alternative	_	ADJ	JJ	_	4	amod	_	_
3	treatments	_	NOUN	NNS	_	4	compound	_	_
4	cannot	_	NOUN	NN	_	6	nsubjpass	_	_
5	be	_	VERB	VBZ	_	6	auxpass	_	_
6	used	_	VERB	VBN	_	8	advcl	_	_
7	,	_	.	,	_	8	punct	_	_
8	consider	_	VERB	VBP	_	0	root	_	_
9	a	_	DET	DT	_	11	det	_	_
10	dose	_	NOUN	NN	_	11	compound	_	_
11	reduction	_	NOUN	NN	_	8	dobj	_	_
12	of	_	ADP	IN	_	17	case	_	_
13	the	_	DET	DT	_	17	det	_	_
14	concomitant	_	ADJ	JJ	_	17	amod	_	_
15	CYP2D6	_	NOUN	NN	_	17	compound	_	_
16	substrate	_	NOUN	NN	_	17	compound	_	_
17	drug	_	NOUN	NN	_	11	nmod	_	_

#	Zytiga	2104
1	In	_	ADP	IN	_	6	case	_	_
2	a	_	DET	DT	_	6	det	_	_
3	CYP2C8	_	NOUN	NN	_	6	compound	_	_
4	drug	_	NOUN	NN	_	6	compound	_	_
5	drug	_	NOUN	NN	_	6	compound	_	_
6	interaction	_	NOUN	NN	_	19	nmod	_	_
7	trial	_	ADJ	JJ	_	6	amod	_	_
8	in	_	ADP	IN	_	10	case	_	_
9	healthy	_	ADJ	JJ	_	10	amod	_	_
10	subjects	_	NOUN	NNS	_	7	nmod	_	_
11	,	_	.	,	_	19	punct	_	_
12	the	_	DET	DT	_	13	det	_	_
13	AUC	_	NOUN	NN	_	19	nsubjpass	_	_
14	of	_	ADP	IN	_	17	case	_	_
15	pioglitazone	_	NOUN	NN	_	17	compound	_	_
16	CYP2C8	_	NOUN	NN	_	17	compound	_	_
17	substrate	_	NOUN	NN	_	13	nmod	_	_
18	was	_	VERB	VBD	_	19	auxpass	_	_
19	increased	_	VERB	VBN	_	0	root	_	_
20	by	_	ADP	IN	_	21	case	_	_
21	46%	_	NOUN	NN	_	19	nmod	_	_
22	when	_	ADV	WRB	_	25	advmod	_	_
23	pioglitazone	_	NOUN	NN	_	25	nsubjpass	_	_
24	was	_	VERB	VBD	_	25	auxpass	_	_
25	given	_	VERB	VBN	_	19	advcl	_	_
26	together	_	ADV	RB	_	25	advmod	_	_
27	with	_	ADP	IN	_	30	case	_	_
28	a	_	DET	DT	_	30	det	_	_
29	single	_	ADJ	JJ	_	30	amod	_	_
30	dose	_	NOUN	NN	_	25	nmod	_	_
31	of	_	ADP	IN	_	35	case	_	_
32	1,000	_	NUM	CD	_	35	nummod	_	_
33	mg	_	NOUN	NN	_	35	compound	_	_
34	DRUG	_	NOUN	NN	_	35	compound	_	_
35	acetate	_	NOUN	NN	_	30	nmod	_	_

#	Zytiga	2105
1	Therefore	_	ADV	RB	_	6	advmod	_	_
2	,	_	.	,	_	6	punct	_	_
3	patients	_	NOUN	NNS	_	6	nsubjpass	_	_
4	should	_	VERB	MD	_	6	aux	_	_
5	be	_	VERB	VB	_	6	auxpass	_	_
6	monitored	_	VERB	VBN	_	0	root	_	_
7	closely	_	ADV	RB	_	6	advmod	_	_
8	for	_	ADP	IN	_	9	case	_	_
9	signs	_	NOUN	NNS	_	6	nmod	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	toxicity	_	NOUN	NN	_	9	nmod	_	_
12	related	_	ADJ	JJ	_	11	amod	_	_
13	to	_	PRT	TO	_	16	case	_	_
14	a	_	DET	DT	_	16	det	_	_
15	CYP2C8	_	NOUN	NN	_	16	compound	_	_
16	substrate	_	NOUN	NN	_	12	nmod	_	_
17	with	_	ADP	IN	_	21	case	_	_
18	a	_	DET	DT	_	21	det	_	_
19	narrow	_	NOUN	NN	_	21	compound	_	_
20	therapeutic	_	ADJ	JJ	_	21	amod	_	_
21	index	_	NOUN	NN	_	16	nmod	_	_
22	if	_	DET	WDT	_	23	nsubj	_	_
23	used	_	VERB	VBN	_	9	acl	_	_
24	concomitantly	_	ADV	RB	_	23	advmod	_	_
25	with	_	ADP	IN	_	26	case	_	_
26	DRUG	_	NOUN	NN	_	23	nmod	_	_

#	Zytiga	2106
1	DRUG	_	NOUN	NN	_	3	compound	_	_
2	acetate	_	NOUN	NN	_	3	compound	_	_
3	DRUG	_	NOUN	NN	_	5	nsubjpass	_	_
4	is	_	VERB	VBZ	_	5	auxpass	_	_
5	converted	_	VERB	VBN	_	0	root	_	_
6	in	_	X	FW	_	7	compound	_	_
7	vivo	_	X	FW	_	5	advmod	_	_
8	to	_	PRT	TO	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	5	nmod	_	_
10	,	_	.	,	_	9	punct	_	_
11	an	_	DET	DT	_	14	det	_	_
12	androgen	_	NOUN	NN	_	14	compound	_	_
13	biosynthesis	_	NOUN	NN	_	14	compound	_	_
14	inhibitor	_	NOUN	NN	_	9	appos	_	_
15	,	_	.	,	_	9	punct	_	_
16	that	_	DET	WDT	_	17	nsubj	_	_
17	inhibits	_	VERB	VBZ	_	9	acl:relcl	_	_
18	17	_	NUM	CD	_	20	nummod	_	_
19	A	_	NOUN	NN	_	20	compound	_	_
20	hydroxylase	_	NOUN	NN	_	17	dobj	_	_
21	/	_	.	:	_	5	punct	_	_
22	C17,20	_	NOUN	NN	_	24	compound	_	_
23	lyase	_	NOUN	NN	_	24	compound	_	_
24	CYP17	_	NOUN	NN	_	5	parataxis	_	_

#	Zytiga	2107
1	This	_	DET	DT	_	2	det	_	_
2	enzyme	_	NOUN	NN	_	4	nsubjpass	_	_
3	is	_	VERB	VBZ	_	4	auxpass	_	_
4	expressed	_	VERB	VBN	_	0	root	_	_
5	in	_	ADP	IN	_	13	case	_	_
6	testicular	_	ADJ	JJ	_	13	amod	_	_
7	,	_	.	,	_	6	punct	_	_
8	adrenal	_	ADJ	JJ	_	6	conj	_	_
9	,	_	.	,	_	6	punct	_	_
10	and	_	CONJ	CC	_	6	cc	_	_
11	prostatic	_	ADJ	JJ	_	6	conj	_	_
12	tumor	_	NOUN	NN	_	13	compound	_	_
13	tissues	_	NOUN	NNS	_	4	nmod	_	_
14	and	_	CONJ	CC	_	4	cc	_	_
15	is	_	VERB	VBZ	_	16	auxpass	_	_
16	required	_	VERB	VBN	_	4	conj	_	_
17	for	_	ADP	IN	_	19	case	_	_
18	androgen	_	NOUN	NN	_	19	compound	_	_
19	biosynthesis	_	NOUN	NN	_	16	nmod	_	_

#	Zytiga	2108
1	CYP17	_	NOUN	NN	_	2	nsubj	_	_
2	catalyzes	_	VERB	VBZ	_	0	root	_	_
3	two	_	NUM	CD	_	5	nummod	_	_
4	sequential	_	ADJ	JJ	_	5	amod	_	_
5	reactions	_	NOUN	NNS	_	2	dobj	_	_
6	:	_	.	:	_	2	punct	_	_
7	1	_	NUM	CD	_	9	nummod	_	_
8	the	_	DET	DT	_	9	det	_	_
9	conversion	_	NOUN	NN	_	2	dep	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	pregnenolone	_	NOUN	NN	_	9	nmod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	progesterone	_	NOUN	NN	_	11	conj	_	_
14	to	_	PRT	TO	_	18	case	_	_
15	their	_	PRON	PRP$	_	18	nmod:poss	_	_
16	17A	_	NOUN	NN	_	18	compound	_	_
17	hydroxy	_	NOUN	NN	_	18	compound	_	_
18	derivatives	_	NOUN	NNS	_	9	nmod	_	_
19	by	_	ADP	IN	_	22	case	_	_
20	17A	_	NOUN	NN	_	22	compound	_	_
21	hydroxylase	_	NOUN	NN	_	22	compound	_	_
22	activity	_	NOUN	NN	_	9	nmod	_	_
23	and	_	CONJ	CC	_	22	cc	_	_
24	2	_	NUM	CD	_	27	nummod	_	_
25	the	_	DET	DT	_	27	det	_	_
26	subsequent	_	ADJ	JJ	_	27	amod	_	_
27	formation	_	NOUN	NN	_	22	conj	_	_
28	of	_	ADP	IN	_	30	case	_	_
29	dehydroepiandrosterone	_	NOUN	NN	_	30	compound	_	_
30	DHEA	_	NOUN	NN	_	27	nmod	_	_
31	and	_	CONJ	CC	_	30	cc	_	_
32	androstenedione	_	NOUN	NN	_	30	conj	_	_
33	,	_	.	,	_	9	punct	_	_
34	respectively	_	ADV	RB	_	41	advmod	_	_
35	,	_	.	,	_	41	punct	_	_
36	by	_	ADP	IN	_	37	case	_	_
37	C17	_	NOUN	NN	_	41	nmod	_	_
38	,	_	.	,	_	41	punct	_	_
39	20	_	NUM	CD	_	41	nummod	_	_
40	lyase	_	NOUN	NN	_	41	compound	_	_
41	activity	_	NOUN	NN	_	9	nmod	_	_

#	Zytiga	2109
1	DHEA	_	NOUN	NN	_	5	nsubj	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	androstenedione	_	NOUN	NN	_	1	conj	_	_
4	are	_	VERB	VBP	_	5	cop	_	_
5	androgens	_	NOUN	NNS	_	0	root	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	are	_	VERB	VBP	_	8	cop	_	_
8	precursors	_	NOUN	NNS	_	5	conj	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	testosterone	_	NOUN	NN	_	8	nmod	_	_

#	Zytiga	2110
1	Inhibition	_	NOUN	NN	_	8	nsubj	_	_
2	of	_	ADP	IN	_	3	case	_	_
3	CYP17	_	NOUN	NN	_	1	nmod	_	_
4	by	_	ADP	IN	_	5	case	_	_
5	DRUG	_	NOUN	NN	_	1	nmod	_	_
6	can	_	VERB	MD	_	8	aux	_	_
7	also	_	ADV	RB	_	8	advmod	_	_
8	result	_	VERB	VB	_	0	root	_	_
9	in	_	ADP	IN	_	12	case	_	_
10	increased	_	VERB	VBN	_	12	amod	_	_
11	mineralocorticoid	_	NOUN	NN	_	12	compound	_	_
12	production	_	NOUN	NN	_	8	nmod	_	_
13	by	_	ADP	IN	_	15	case	_	_
14	the	_	DET	DT	_	15	det	_	_
15	adrenals	_	NOUN	NNS	_	12	nmod	_	_

#	Zytiga	2111
1	Androgen	_	NOUN	NN	_	4	compound	_	_
2	sensitive	_	ADJ	JJ	_	4	amod	_	_
3	prostatic	_	ADJ	JJ	_	4	amod	_	_
4	carcinoma	_	NOUN	NN	_	5	nsubj	_	_
5	responds	_	VERB	VBZ	_	0	root	_	_
6	to	_	PRT	TO	_	7	case	_	_
7	treatment	_	NOUN	NN	_	5	nmod	_	_
8	that	_	DET	WDT	_	9	nsubj	_	_
9	decreases	_	VERB	VBZ	_	7	acl:relcl	_	_
10	androgen	_	NOUN	NN	_	11	compound	_	_
11	levels	_	NOUN	NNS	_	9	dobj	_	_

#	Zytiga	2112
1	Androgen	_	NOUN	NN	_	3	compound	_	_
2	deprivation	_	NOUN	NN	_	3	compound	_	_
3	therapies	_	NOUN	NNS	_	14	nsubj	_	_
4	,	_	.	,	_	3	punct	_	_
5	such	_	ADJ	JJ	_	7	case	_	_
6	as	_	ADP	IN	_	5	mwe	_	_
7	treatment	_	NOUN	NN	_	3	nmod	_	_
8	with	_	ADP	IN	_	10	case	_	_
9	GnRH	_	NOUN	NN	_	10	compound	_	_
10	agonists	_	NOUN	NNS	_	7	nmod	_	_
11	or	_	CONJ	CC	_	10	cc	_	_
12	orchiectomy	_	NOUN	NN	_	10	conj	_	_
13	,	_	.	,	_	3	punct	_	_
14	decrease	_	VERB	VBP	_	0	root	_	_
15	androgen	_	NOUN	NN	_	16	compound	_	_
16	production	_	NOUN	NN	_	14	dobj	_	_
17	in	_	ADP	IN	_	19	case	_	_
18	the	_	DET	DT	_	19	det	_	_
19	testes	_	NOUN	NNS	_	16	nmod	_	_
20	but	_	CONJ	CC	_	14	cc	_	_
21	do	_	VERB	MD	_	23	aux	_	_
22	not	_	ADV	RB	_	23	neg	_	_
23	affect	_	VERB	VB	_	14	conj	_	_
24	androgen	_	NOUN	NN	_	25	compound	_	_
25	production	_	NOUN	NN	_	23	dobj	_	_
26	by	_	ADP	IN	_	28	case	_	_
27	the	_	DET	DT	_	28	det	_	_
28	adrenals	_	NOUN	NNS	_	23	nmod	_	_
29	or	_	CONJ	CC	_	28	cc	_	_
30	in	_	ADP	IN	_	32	case	_	_
31	the	_	DET	DT	_	32	det	_	_
32	tumor	_	NOUN	NN	_	28	conj	_	_

#	Zytiga	2113
1	DRUG	_	NOUN	NN	_	2	nsubj	_	_
2	decreased	_	VERB	VBD	_	0	root	_	_
3	serum	_	NOUN	NN	_	4	compound	_	_
4	testosterone	_	NOUN	NN	_	2	dobj	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	other	_	ADJ	JJ	_	7	amod	_	_
7	androgens	_	NOUN	NNS	_	4	conj	_	_
8	in	_	ADP	IN	_	9	case	_	_
9	patients	_	NOUN	NNS	_	4	nmod	_	_
10	in	_	ADP	IN	_	12	case	_	_
11	the	_	DET	DT	_	12	det	_	_
12	placebo	_	NOUN	NN	_	9	nmod	_	_
13	controlled	_	VERB	VBD	_	2	parataxis	_	_
14	clinical	_	ADJ	JJ	_	13	dep	_	_
15	trial	_	ADJ	JJ	_	14	dep	_	_

#	Zytiga	2114
1	It	_	PRON	PRP	_	4	nsubj	_	_
2	is	_	VERB	VBZ	_	4	cop	_	_
3	not	_	ADV	RB	_	4	neg	_	_
4	necessary	_	ADJ	JJ	_	0	root	_	_
5	to	_	PRT	TO	_	6	mark	_	_
6	monitor	_	VERB	VB	_	4	xcomp	_	_
7	the	_	DET	DT	_	8	det	_	_
8	effect	_	NOUN	NN	_	6	dobj	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	on	_	ADP	IN	_	14	case	_	_
12	serum	_	NOUN	NN	_	14	compound	_	_
13	testosterone	_	NOUN	NN	_	14	compound	_	_
14	levels	_	NOUN	NNS	_	8	nmod	_	_

#	Zytiga	2115
1	Changes	_	NOUN	NNS	_	11	nsubjpass	_	_
2	in	_	ADP	IN	_	8	case	_	_
3	serum	_	NOUN	NN	_	8	compound	_	_
4	prostate	_	NOUN	NN	_	8	compound	_	_
5	specific	_	ADJ	JJ	_	8	amod	_	_
6	antigen	_	NOUN	NN	_	8	compound	_	_
7	PSA	_	NOUN	NN	_	8	compound	_	_
8	levels	_	NOUN	NNS	_	1	nmod	_	_
9	may	_	VERB	MD	_	11	aux	_	_
10	be	_	VERB	VB	_	11	auxpass	_	_
11	observed	_	VERB	VBN	_	0	root	_	_
12	but	_	CONJ	CC	_	11	cc	_	_
13	have	_	VERB	MD	_	16	aux	_	_
14	not	_	ADV	RB	_	16	neg	_	_
15	been	_	VERB	VBN	_	16	auxpass	_	_
16	shown	_	VERB	VBN	_	11	conj	_	_
17	to	_	PRT	TO	_	18	mark	_	_
18	correlate	_	VERB	VB	_	16	xcomp	_	_
19	with	_	ADP	IN	_	21	case	_	_
20	clinical	_	ADJ	JJ	_	21	amod	_	_
21	benefit	_	NOUN	NN	_	18	nmod	_	_
22	in	_	ADP	IN	_	24	case	_	_
23	individual	_	ADJ	JJ	_	24	amod	_	_
24	patients	_	NOUN	NNS	_	21	nmod	_	_

#	Zytiga	2116
1	Following	_	VERB	VBG	_	2	case	_	_
2	administration	_	NOUN	NN	_	16	nmod	_	_
3	of	_	ADP	IN	_	5	case	_	_
4	DRUG	_	NOUN	NN	_	5	compound	_	_
5	acetate	_	NOUN	NN	_	2	nmod	_	_
6	,	_	.	,	_	16	punct	_	_
7	the	_	DET	DT	_	8	det	_	_
8	pharmacokinetics	_	NOUN	NNS	_	16	nsubjpass	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	DRUG	_	NOUN	NN	_	8	nmod	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	DRUG	_	NOUN	NN	_	13	compound	_	_
13	acetate	_	NOUN	NN	_	10	conj	_	_
14	have	_	VERB	VBP	_	16	aux	_	_
15	been	_	VERB	VBN	_	16	auxpass	_	_
16	studied	_	VERB	VBN	_	0	root	_	_
17	in	_	ADP	IN	_	19	case	_	_
18	healthy	_	ADJ	JJ	_	19	amod	_	_
19	subjects	_	NOUN	NNS	_	16	nmod	_	_
20	and	_	CONJ	CC	_	19	cc	_	_
21	in	_	ADP	IN	_	22	case	_	_
22	patients	_	NOUN	NNS	_	19	conj	_	_
23	with	_	ADP	IN	_	25	case	_	_
24	metastatic	_	ADJ	JJ	_	25	amod	_	_
25	CRPC	_	NOUN	NN	_	22	nmod	_	_

#	Zytiga	2117
1	In	_	X	FW	_	2	compound	_	_
2	vivo	_	X	FW	_	7	advmod	_	_
3	,	_	.	,	_	7	punct	_	_
4	DRUG	_	NOUN	NN	_	5	compound	_	_
5	acetate	_	NOUN	NN	_	7	nsubjpass	_	_
6	is	_	VERB	VBZ	_	7	auxpass	_	_
7	converted	_	VERB	VBN	_	0	root	_	_
8	to	_	PRT	TO	_	9	case	_	_
9	DRUG	_	NOUN	NN	_	7	nmod	_	_

#	Zytiga	2118
1	In	_	ADP	IN	_	3	case	_	_
2	clinical	_	ADJ	JJ	_	3	amod	_	_
3	studies	_	NOUN	NNS	_	10	nmod	_	_
4	,	_	.	,	_	10	punct	_	_
5	DRUG	_	NOUN	NN	_	8	compound	_	_
6	acetate	_	NOUN	NN	_	8	compound	_	_
7	plasma	_	NOUN	NN	_	8	compound	_	_
8	concentrations	_	NOUN	NNS	_	10	nsubj	_	_
9	were	_	VERB	VBD	_	10	auxpass	_	_
10	below	_	VERB	VB	_	0	root	_	_
11	detectable	_	ADJ	JJ	_	12	amod	_	_
12	levels	_	NOUN	NNS	_	10	dobj	_	_
13	<0.2	_	NUM	CD	_	14	nummod	_	_
14	ng	_	NOUN	NN	_	12	dep	_	_
15	/	_	.	:	_	10	punct	_	_
16	mL	_	NOUN	NN	_	10	parataxis	_	_
17	in	_	ADP	IN	_	18	case	_	_
18	>99%	_	NOUN	NN	_	16	nmod	_	_
19	of	_	ADP	IN	_	22	case	_	_
20	the	_	DET	DT	_	22	det	_	_
21	analyzed	_	ADJ	JJ	_	22	amod	_	_
22	samples	_	NOUN	NNS	_	18	nmod	_	_

#	Zytiga	2119
1	Absorption	_	NOUN	NN	_	25	nsubj	_	_
2	Following	_	ADP	IN	_	4	case	_	_
3	oral	_	ADJ	JJ	_	4	amod	_	_
4	administration	_	NOUN	NN	_	1	nmod	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	DRUG	_	NOUN	NN	_	7	compound	_	_
7	acetate	_	NOUN	NN	_	4	nmod	_	_
8	to	_	PRT	TO	_	9	case	_	_
9	patients	_	NOUN	NNS	_	1	nmod	_	_
10	with	_	ADP	IN	_	12	case	_	_
11	metastatic	_	ADJ	JJ	_	12	amod	_	_
12	CRPC	_	NOUN	NN	_	9	nmod	_	_
13	,	_	.	,	_	1	punct	_	_
14	the	_	DET	DT	_	16	det	_	_
15	median	_	ADJ	JJ	_	16	amod	_	_
16	time	_	NOUN	NN	_	1	appos	_	_
17	to	_	PRT	TO	_	18	mark	_	_
18	reach	_	VERB	VB	_	16	acl	_	_
19	maximum	_	NOUN	NN	_	22	compound	_	_
20	plasma	_	NOUN	NN	_	22	compound	_	_
21	DRUG	_	NOUN	NN	_	22	compound	_	_
22	concentrations	_	NOUN	NNS	_	18	dobj	_	_
23	is	_	VERB	VBZ	_	25	cop	_	_
24	2	_	NUM	CD	_	25	nummod	_	_
25	hours	_	NOUN	NNS	_	0	root	_	_

#	Zytiga	2120
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	accumulation	_	NOUN	NN	_	4	nsubjpass	_	_
3	is	_	VERB	VBZ	_	4	auxpass	_	_
4	observed	_	VERB	VBN	_	0	root	_	_
5	at	_	ADP	IN	_	7	case	_	_
6	steady	_	ADJ	JJ	_	7	amod	_	_
7	state	_	NOUN	NN	_	4	nmod	_	_
8	,	_	.	,	_	4	punct	_	_
9	with	_	ADP	IN	_	18	mark	_	_
10	a	_	DET	DT	_	17	det	_	_
11	2	_	NUM	CD	_	17	nummod	_	_
12	fold	_	NOUN	NN	_	17	amod	_	_
13	higher	_	ADJ	JJ	_	17	amod	_	_
14	exposure	_	NOUN	NN	_	17	compound	_	_
15	steady	_	ADJ	JJ	_	17	amod	_	_
16	state	_	NOUN	NN	_	17	compound	_	_
17	AUC	_	NOUN	NN	_	18	nsubj	_	_
18	compared	_	VERB	VBN	_	4	advcl	_	_
19	to	_	PRT	TO	_	24	case	_	_
20	a	_	DET	DT	_	24	det	_	_
21	single	_	ADJ	JJ	_	24	amod	_	_
22	1,000	_	NUM	CD	_	24	nummod	_	_
23	mg	_	NOUN	NN	_	24	compound	_	_
24	dose	_	NOUN	NN	_	18	nmod	_	_
25	of	_	ADP	IN	_	27	case	_	_
26	DRUG	_	NOUN	NN	_	27	compound	_	_
27	acetate	_	NOUN	NN	_	24	nmod	_	_

#	Zytiga	2121
1	At	_	ADP	IN	_	3	case	_	_
2	the	_	DET	DT	_	3	det	_	_
3	dose	_	NOUN	NN	_	17	nmod	_	_
4	of	_	ADP	IN	_	6	case	_	_
5	1,000	_	NUM	CD	_	6	nummod	_	_
6	mg	_	NOUN	NN	_	3	nmod	_	_
7	daily	_	ADV	RB	_	9	advmod	_	_
8	in	_	ADP	IN	_	9	case	_	_
9	patients	_	NOUN	NNS	_	3	nmod	_	_
10	with	_	ADP	IN	_	12	case	_	_
11	metastatic	_	ADJ	JJ	_	12	amod	_	_
12	CRPC	_	NOUN	NN	_	9	nmod	_	_
13	,	_	.	,	_	17	punct	_	_
14	steady	_	ADJ	JJ	_	16	amod	_	_
15	state	_	NOUN	NN	_	16	compound	_	_
16	values	_	NOUN	NNS	_	17	nsubj	_	_
17	mean	_	VERB	VBP	_	0	root	_	_
18	*	_	CONJ	CC	_	19	cc:preconj	_	_
19	SD	_	NOUN	NN	_	17	dobj	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	Cmax	_	NOUN	NN	_	19	nmod	_	_
22	were	_	VERB	VBD	_	26	cop	_	_
23	226	_	NUM	CD	_	25	compound	_	_
24	*	_	ADJ	JJ	_	25	advmod	_	_
25	178	_	NUM	CD	_	26	nummod	_	_
26	ng	_	NOUN	NN	_	17	parataxis	_	_
27	/	_	.	:	_	26	punct	_	_
28	mL	_	NOUN	NN	_	36	nsubj	_	_
29	and	_	CONJ	CC	_	28	cc	_	_
30	of	_	ADP	IN	_	31	case	_	_
31	AUC	_	NOUN	NN	_	28	conj	_	_
32	were	_	VERB	VBD	_	36	cop	_	_
33	993	_	NUM	CD	_	35	compound	_	_
34	*	_	ADJ	JJ	_	35	advmod	_	_
35	639	_	NUM	CD	_	36	nummod	_	_
36	ng.hr	_	NOUN	NN	_	26	dep	_	_
37	/	_	.	:	_	36	punct	_	_
38	mL	_	NOUN	NN	_	36	dep	_	_

#	Zytiga	2122
1	No	_	DET	DT	_	3	neg	_	_
2	major	_	ADJ	JJ	_	3	amod	_	_
3	deviation	_	NOUN	NN	_	8	nsubjpass	_	_
4	from	_	ADP	IN	_	6	case	_	_
5	dose	_	NOUN	NN	_	6	compound	_	_
6	proportionality	_	NOUN	NN	_	3	nmod	_	_
7	was	_	VERB	VBD	_	8	auxpass	_	_
8	observed	_	VERB	VBN	_	0	root	_	_
9	in	_	ADP	IN	_	12	case	_	_
10	the	_	DET	DT	_	12	det	_	_
11	dose	_	NOUN	NN	_	12	compound	_	_
12	range	_	NOUN	NN	_	8	nmod	_	_
13	of	_	ADP	IN	_	15	case	_	_
14	250	_	NUM	CD	_	15	nummod	_	_
15	mg	_	NOUN	NN	_	12	nmod	_	_
16	to	_	PRT	TO	_	18	case	_	_
17	1,000	_	NUM	CD	_	18	nummod	_	_
18	mg	_	NOUN	NNS	_	12	nmod	_	_

#	Zytiga	2123
1	However	_	ADV	RB	_	8	advmod	_	_
2	,	_	.	,	_	8	punct	_	_
3	the	_	DET	DT	_	4	det	_	_
4	exposure	_	NOUN	NN	_	8	nsubjpass	_	_
5	was	_	VERB	VBD	_	8	auxpass	_	_
6	not	_	ADV	RB	_	8	neg	_	_
7	significantly	_	ADV	RB	_	8	advmod	_	_
8	increased	_	VERB	VBN	_	0	root	_	_
9	when	_	ADV	WRB	_	13	advmod	_	_
10	the	_	DET	DT	_	11	det	_	_
11	dose	_	NOUN	NN	_	13	nsubjpass	_	_
12	was	_	VERB	VBD	_	13	auxpass	_	_
13	doubled	_	VERB	VBN	_	8	ccomp	_	_
14	from	_	ADP	IN	_	20	case	_	_
15	1,000	_	NUM	CD	_	17	compound	_	_
16	to	_	PRT	TO	_	17	dep	_	_
17	2,000	_	NUM	CD	_	20	nummod	_	_
18	mg	_	NOUN	NN	_	20	amod	_	_
19	8%	_	ADJ	JJ	_	20	amod	_	_
20	increase	_	NOUN	NN	_	13	nmod	_	_
21	in	_	ADP	IN	_	24	case	_	_
22	the	_	DET	DT	_	24	det	_	_
23	mean	_	NOUN	NN	_	24	compound	_	_
24	AUC	_	NOUN	NN	_	20	nmod	_	_

#	Zytiga	2124
1	Systemic	_	ADJ	JJ	_	2	amod	_	_
2	exposure	_	NOUN	NN	_	6	nsubjpass	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	is	_	VERB	VBZ	_	6	auxpass	_	_
6	increased	_	VERB	VBN	_	0	root	_	_
7	when	_	ADV	WRB	_	11	advmod	_	_
8	DRUG	_	NOUN	NN	_	9	compound	_	_
9	acetate	_	NOUN	NN	_	11	nsubjpass	_	_
10	is	_	VERB	VBZ	_	11	auxpass	_	_
11	administered	_	VERB	VBN	_	6	advcl	_	_
12	with	_	ADP	IN	_	13	case	_	_
13	food	_	NOUN	NN	_	11	nmod	_	_

#	Zytiga	2125
1	In	_	ADP	IN	_	3	case	_	_
2	healthy	_	ADJ	JJ	_	3	amod	_	_
3	subjects	_	NOUN	NNS	_	11	nmod	_	_
4	DRUG	_	NOUN	NN	_	5	compound	_	_
5	Cmax	_	NOUN	NN	_	11	nsubj	_	_
6	and	_	CONJ	CC	_	5	cc	_	_
7	AUC0	_	NOUN	NN	_	5	conj	_	_
8	*	_	NUM	CD	_	7	nummod	_	_
9	were	_	VERB	VBD	_	11	cop	_	_
10	approximately	_	ADV	RB	_	11	advmod	_	_
11	7	_	NUM	CD	_	15	nummod	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	5	_	NUM	CD	_	11	conj	_	_
14	fold	_	NOUN	NN	_	15	advmod	_	_
15	higher	_	ADJ	JJ	_	0	root	_	_
16	,	_	.	,	_	15	punct	_	_
17	respectively	_	ADV	RB	_	15	advmod	_	_
18	,	_	.	,	_	15	punct	_	_
19	when	_	ADV	WRB	_	27	advmod	_	_
20	a	_	DET	DT	_	22	det	_	_
21	single	_	ADJ	JJ	_	22	amod	_	_
22	dose	_	NOUN	NN	_	27	nsubjpass	_	_
23	of	_	ADP	IN	_	25	case	_	_
24	DRUG	_	NOUN	NN	_	25	compound	_	_
25	acetate	_	NOUN	NN	_	22	nmod	_	_
26	was	_	VERB	VBD	_	27	auxpass	_	_
27	administered	_	VERB	VBN	_	15	advcl	_	_
28	with	_	ADP	IN	_	34	case	_	_
29	a	_	DET	DT	_	34	det	_	_
30	low	_	ADJ	JJ	_	34	amod	_	_
31	fat	_	NOUN	NN	_	34	compound	_	_
32	meal	_	ADJ	JJ	_	34	amod	_	_
33	7%	_	ADJ	JJ	_	34	amod	_	_
34	fat	_	NOUN	NN	_	27	nmod	_	_
35	,	_	.	,	_	34	punct	_	_
36	300	_	NUM	CD	_	37	nummod	_	_
37	calories	_	NOUN	NNS	_	34	conj	_	_
38	and	_	CONJ	CC	_	34	cc	_	_
39	approximately	_	ADV	RB	_	40	advmod	_	_
40	17	_	NUM	CD	_	43	nummod	_	_
41	and	_	CONJ	CC	_	40	cc	_	_
42	10	_	NUM	CD	_	40	conj	_	_
43	fold	_	NOUN	NN	_	34	conj	_	_
44	higher	_	ADJ	JJ	_	34	amod	_	_
45	,	_	.	,	_	15	punct	_	_
46	respectively	_	ADV	RB	_	15	advmod	_	_
47	,	_	.	,	_	15	punct	_	_
48	when	_	ADV	WRB	_	56	advmod	_	_
49	a	_	DET	DT	_	51	det	_	_
50	single	_	ADJ	JJ	_	51	amod	_	_
51	dose	_	NOUN	NN	_	56	nsubjpass	_	_
52	of	_	ADP	IN	_	54	case	_	_
53	DRUG	_	NOUN	NN	_	54	compound	_	_
54	acetate	_	NOUN	NN	_	51	nmod	_	_
55	was	_	VERB	VBD	_	56	auxpass	_	_
56	administered	_	VERB	VBN	_	15	advcl	_	_
57	with	_	ADP	IN	_	62	case	_	_
58	a	_	DET	DT	_	62	det	_	_
59	high	_	ADJ	JJ	_	62	amod	_	_
60	fat	_	NOUN	NN	_	62	compound	_	_
61	57%	_	ADJ	JJ	_	62	amod	_	_
62	fat	_	NOUN	NN	_	56	nmod	_	_
63	,	_	.	,	_	15	punct	_	_
64	825	_	NUM	CD	_	65	nummod	_	_
65	calories	_	NOUN	NNS	_	67	nsubj	_	_
66	meal	_	ADJ	JJ	_	65	amod	_	_
67	compared	_	VERB	VBD	_	15	parataxis	_	_
68	to	_	PRT	TO	_	69	mark	_	_
69	overnight	_	VERB	VB	_	67	xcomp	_	_
70	fasting	_	VERB	VBG	_	69	ccomp	_	_

#	Zytiga	2126
1	DRUG	_	NOUN	NN	_	2	compound	_	_
2	AUC0	_	NOUN	NN	_	7	nsubj	_	_
3	*	_	NUM	CD	_	2	nummod	_	_
4	was	_	VERB	VBD	_	7	cop	_	_
5	approximately	_	ADV	RB	_	6	advmod	_	_
6	7	_	NUM	CD	_	7	nummod	_	_
7	fold	_	NOUN	NN	_	0	root	_	_
8	or	_	CONJ	CC	_	7	cc	_	_
9	1.6	_	NUM	CD	_	10	nummod	_	_
10	fold	_	NOUN	NN	_	7	conj	_	_
11	higher	_	ADJ	JJ	_	7	amod	_	_
12	,	_	.	,	_	7	punct	_	_
13	respectively	_	ADV	RB	_	7	advmod	_	_
14	,	_	.	,	_	7	punct	_	_
15	when	_	ADV	WRB	_	23	advmod	_	_
16	a	_	DET	DT	_	18	det	_	_
17	single	_	ADJ	JJ	_	18	amod	_	_
18	dose	_	NOUN	NN	_	23	nsubjpass	_	_
19	of	_	ADP	IN	_	21	case	_	_
20	DRUG	_	NOUN	NN	_	21	compound	_	_
21	acetate	_	NOUN	NN	_	18	nmod	_	_
22	was	_	VERB	VBD	_	23	auxpass	_	_
23	administered	_	VERB	VBN	_	7	advcl	_	_
24	2	_	NUM	CD	_	25	nummod	_	_
25	hours	_	NOUN	NNS	_	23	dobj	_	_
26	after	_	ADP	IN	_	36	case	_	_
27	or	_	CONJ	CC	_	26	cc	_	_
28	1	_	NUM	CD	_	29	nummod	_	_
29	hour	_	NUM	CD	_	26	conj	_	_
30	before	_	ADP	IN	_	36	case	_	_
31	a	_	DET	DT	_	36	det	_	_
32	medium	_	NOUN	NN	_	36	compound	_	_
33	fat	_	NOUN	NN	_	36	compound	_	_
34	meal	_	ADJ	JJ	_	36	amod	_	_
35	25%	_	ADJ	JJ	_	36	amod	_	_
36	fat	_	NOUN	NN	_	23	nmod	_	_
37	,	_	.	,	_	7	punct	_	_
38	491	_	NUM	CD	_	39	nummod	_	_
39	calories	_	NOUN	NNS	_	40	nsubj	_	_
40	compared	_	VERB	VBD	_	7	dep	_	_
41	to	_	PRT	TO	_	42	mark	_	_
42	overnight	_	VERB	VB	_	40	xcomp	_	_
43	fasting	_	VERB	VBG	_	42	ccomp	_	_

#	Zytiga	2127
1	Systemic	_	ADJ	JJ	_	2	amod	_	_
2	exposures	_	NOUN	NNS	_	18	nsubj	_	_
3	of	_	ADP	IN	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	in	_	ADP	IN	_	6	case	_	_
6	patients	_	NOUN	NNS	_	2	nmod	_	_
7	with	_	ADP	IN	_	9	case	_	_
8	metastatic	_	ADJ	JJ	_	9	amod	_	_
9	CRPC	_	NOUN	NN	_	6	nmod	_	_
10	,	_	.	,	_	2	punct	_	_
11	after	_	ADP	IN	_	13	case	_	_
12	repeated	_	VERB	VBN	_	13	amod	_	_
13	dosing	_	NOUN	NN	_	2	nmod	_	_
14	of	_	ADP	IN	_	16	case	_	_
15	DRUG	_	NOUN	NN	_	16	compound	_	_
16	acetate	_	NOUN	NN	_	13	nmod	_	_
17	were	_	VERB	VBD	_	18	cop	_	_
18	similar	_	ADJ	JJ	_	0	root	_	_
19	when	_	ADV	WRB	_	23	advmod	_	_
20	DRUG	_	NOUN	NN	_	21	compound	_	_
21	acetate	_	NOUN	NN	_	23	nsubjpass	_	_
22	was	_	VERB	VBD	_	23	auxpass	_	_
23	taken	_	VERB	VBN	_	18	ccomp	_	_
24	with	_	ADP	IN	_	27	case	_	_
25	low	_	ADJ	JJ	_	27	amod	_	_
26	fat	_	NOUN	NN	_	27	compound	_	_
27	meals	_	NOUN	NNS	_	23	nmod	_	_
28	for	_	ADP	IN	_	30	case	_	_
29	7	_	NUM	CD	_	30	nummod	_	_
30	days	_	NOUN	NNS	_	23	nmod	_	_
31	and	_	CONJ	CC	_	23	cc	_	_
32	increased	_	VERB	VBD	_	23	conj	_	_
33	approximately	_	ADV	RB	_	34	advmod	_	_
34	2	_	NUM	CD	_	35	nummod	_	_
35	fold	_	NOUN	NN	_	32	dobj	_	_
36	when	_	ADV	WRB	_	37	advmod	_	_
37	taken	_	VERB	VBN	_	32	advcl	_	_
38	with	_	ADP	IN	_	41	case	_	_
39	high	_	ADJ	JJ	_	41	amod	_	_
40	fat	_	NOUN	NN	_	41	compound	_	_
41	meals	_	NOUN	NNS	_	37	nmod	_	_
42	for	_	ADP	IN	_	44	case	_	_
43	7	_	NUM	CD	_	44	nummod	_	_
44	days	_	NOUN	NNS	_	41	nmod	_	_
45	compared	_	VERB	VBD	_	32	parataxis	_	_
46	to	_	PRT	TO	_	48	mark	_	_
47	when	_	ADV	RB	_	48	advmod	_	_
48	taken	_	VERB	VBN	_	45	conj	_	_
49	at	_	ADP	IN	_	50	case	_	_
50	least	_	ADJ	JJS	_	51	nmod:npmod	_	_
51	2	_	NUM	CD	_	52	nummod	_	_
52	hours	_	NOUN	NNS	_	48	dobj	_	_
53	after	_	ADP	IN	_	55	case	_	_
54	a	_	DET	DT	_	55	det	_	_
55	meal	_	ADJ	JJ	_	48	nmod	_	_
56	and	_	CONJ	CC	_	55	cc	_	_
57	at	_	ADP	IN	_	58	case	_	_
58	least	_	NOUN	NN	_	59	nmod:npmod	_	_
59	1	_	NUM	CD	_	60	nummod	_	_
60	hour	_	NUM	CD	_	55	conj	_	_
61	before	_	ADP	IN	_	63	case	_	_
62	a	_	DET	DT	_	63	det	_	_
63	meal	_	NOUN	NN	_	48	nmod	_	_
64	for	_	ADP	IN	_	66	case	_	_
65	7	_	NUM	CD	_	66	nummod	_	_
66	days	_	NOUN	NNS	_	63	nmod	_	_

#	Zytiga	2128
1	Given	_	ADP	IN	_	4	case	_	_
2	the	_	DET	DT	_	4	det	_	_
3	normal	_	ADJ	JJ	_	4	amod	_	_
4	variation	_	NOUN	NN	_	17	nmod	_	_
5	in	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	content	_	NOUN	NN	_	4	nmod	_	_
8	and	_	CONJ	CC	_	7	cc	_	_
9	composition	_	NOUN	NN	_	7	conj	_	_
10	of	_	ADP	IN	_	11	case	_	_
11	meals	_	NOUN	NNS	_	7	nmod	_	_
12	,	_	.	,	_	17	punct	_	_
13	taking	_	VERB	VBG	_	17	csubj	_	_
14	DRUG	_	NOUN	NN	_	13	dobj	_	_
15	with	_	ADP	IN	_	16	case	_	_
16	meals	_	NOUN	NNS	_	13	nmod	_	_
17	has	_	VERB	VBZ	_	0	root	_	_
18	the	_	DET	DT	_	19	det	_	_
19	potential	_	NOUN	NN	_	17	dobj	_	_
20	to	_	PRT	TO	_	21	mark	_	_
21	result	_	VERB	VB	_	19	acl	_	_
22	in	_	ADP	IN	_	27	case	_	_
23	increased	_	ADJ	JJ	_	27	amod	_	_
24	and	_	CONJ	CC	_	23	cc	_	_
25	highly	_	ADV	RB	_	23	conj	_	_
26	variable	_	ADJ	JJ	_	27	amod	_	_
27	exposures	_	NOUN	NNS	_	21	nmod	_	_

#	Zytiga	2129
1	Therefore	_	ADV	RB	_	6	advmod	_	_
2	,	_	.	,	_	6	punct	_	_
3	DRUG	_	NOUN	NN	_	6	nsubjpass	_	_
4	must	_	VERB	MD	_	6	aux	_	_
5	be	_	VERB	VB	_	6	auxpass	_	_
6	taken	_	VERB	VBN	_	0	root	_	_
7	on	_	ADP	IN	_	10	case	_	_
8	an	_	DET	DT	_	10	det	_	_
9	empty	_	NOUN	NN	_	10	compound	_	_
10	stomach	_	NOUN	NN	_	6	nmod	_	_
11	,	_	.	,	_	10	punct	_	_
12	either	_	CONJ	CC	_	14	cc:preconj	_	_
13	one	_	NUM	CD	_	14	nummod	_	_
14	hour	_	NUM	CD	_	10	appos	_	_
15	before	_	ADP	IN	_	18	case	_	_
16	or	_	CONJ	CC	_	15	cc	_	_
17	two	_	NUM	CD	_	15	conj	_	_
18	hours	_	NOUN	NNS	_	14	nmod	_	_
19	after	_	ADP	IN	_	21	case	_	_
20	a	_	DET	DT	_	21	det	_	_
21	meal	_	ADJ	JJ	_	14	dep	_	_

#	Zytiga	2130
1	The	_	DET	DT	_	2	det	_	_
2	tablets	_	NOUN	NNS	_	5	nsubjpass	_	_
3	should	_	VERB	MD	_	5	aux	_	_
4	be	_	VERB	VB	_	5	auxpass	_	_
5	swallowed	_	VERB	VBN	_	0	root	_	_
6	whole	_	ADJ	JJ	_	5	xcomp	_	_
7	with	_	ADP	IN	_	8	case	_	_
8	water	_	NOUN	NN	_	6	nmod	_	_

#	Zytiga	2131
1	Distribution	_	NOUN	NN	_	8	nsubjpass	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	Protein	_	NOUN	NN	_	5	compound	_	_
4	Binding	_	NOUN	NN	_	5	compound	_	_
5	DRUG	_	NOUN	NN	_	1	conj	_	_
6	is	_	VERB	VBZ	_	8	auxpass	_	_
7	highly	_	ADV	RB	_	8	advmod	_	_
8	bound	_	VERB	VBN	_	0	root	_	_
9	>99%	_	NOUN	NN	_	8	nmod	_	_
10	to	_	PRT	TO	_	14	case	_	_
11	the	_	DET	DT	_	14	det	_	_
12	human	_	ADJ	JJ	_	14	amod	_	_
13	plasma	_	NOUN	NN	_	14	compound	_	_
14	proteins	_	NOUN	NNS	_	9	nmod	_	_
15	,	_	.	,	_	9	punct	_	_
16	albumin	_	NOUN	NN	_	9	conj	_	_
17	and	_	CONJ	CC	_	9	cc	_	_
18	alpha	_	NOUN	NN	_	20	compound	_	_
19	1	_	NUM	CD	_	20	nummod	_	_
20	acid	_	NOUN	NN	_	21	compound	_	_
21	glycoprotein	_	NOUN	NN	_	9	conj	_	_

#	Zytiga	2132
1	The	_	DET	DT	_	5	det	_	_
2	apparent	_	ADJ	JJ	_	5	amod	_	_
3	steady	_	ADJ	JJ	_	5	amod	_	_
4	state	_	NOUN	NN	_	5	compound	_	_
5	volume	_	NOUN	NN	_	18	nsubj	_	_
6	of	_	ADP	IN	_	10	case	_	_
7	distribution	_	NOUN	NN	_	10	compound	_	_
8	mean	_	NOUN	NN	_	10	compound	_	_
9	*	_	CONJ	CC	_	10	amod	_	_
10	SD	_	NOUN	NN	_	5	nmod	_	_
11	is	_	VERB	VBZ	_	18	cop	_	_
12	19,669	_	NUM	CD	_	18	nummod	_	_
13	*	_	ADJ	JJ	_	14	advmod	_	_
14	13,358	_	NUM	CD	_	18	nummod	_	_
15	L	_	NOUN	NN	_	18	compound	_	_
16	In	_	X	FW	_	18	amod	_	_
17	vitro	_	X	FW	_	16	dep	_	_
18	studies	_	NOUN	NNS	_	19	nsubj	_	_
19	show	_	VERB	VBP	_	0	root	_	_
20	that	_	ADP	IN	_	32	mark	_	_
21	at	_	ADP	IN	_	24	case	_	_
22	clinically	_	ADV	RB	_	23	advmod	_	_
23	relevant	_	ADJ	JJ	_	24	amod	_	_
24	concentrations	_	NOUN	NNS	_	32	nmod	_	_
25	,	_	.	,	_	32	punct	_	_
26	DRUG	_	NOUN	NN	_	27	compound	_	_
27	acetate	_	NOUN	NN	_	32	nsubj	_	_
28	and	_	CONJ	CC	_	27	cc	_	_
29	DRUG	_	NOUN	NN	_	27	conj	_	_
30	are	_	VERB	VBP	_	32	cop	_	_
31	not	_	ADV	RB	_	32	neg	_	_
32	substrates	_	NOUN	NNS	_	19	ccomp	_	_
33	of	_	ADP	IN	_	37	case	_	_
34	P	_	NOUN	NN	_	37	compound	_	_
35	glycoprotein	_	NOUN	NN	_	37	compound	_	_
36	P	_	NOUN	NN	_	37	compound	_	_
37	gp	_	NOUN	NN	_	32	nmod	_	_
38	and	_	CONJ	CC	_	32	cc	_	_
39	that	_	ADP	IN	_	44	mark	_	_
40	DRUG	_	NOUN	NN	_	41	compound	_	_
41	acetate	_	NOUN	NN	_	44	nsubj	_	_
42	is	_	VERB	VBZ	_	44	cop	_	_
43	an	_	DET	DT	_	44	det	_	_
44	inhibitor	_	NOUN	NN	_	32	conj	_	_
45	of	_	ADP	IN	_	47	case	_	_
46	P	_	NOUN	NN	_	47	compound	_	_
47	gp	_	NOUN	NN	_	44	nmod	_	_

#	Zytiga	2133
1	Metabolism	_	NOUN	NN	_	15	nsubjpass	_	_
2	Following	_	ADP	IN	_	4	case	_	_
3	oral	_	ADJ	JJ	_	4	amod	_	_
4	administration	_	NOUN	NN	_	1	nmod	_	_
5	of	_	ADP	IN	_	8	case	_	_
6	14C	_	NOUN	NN	_	8	compound	_	_
7	DRUG	_	NOUN	NN	_	8	compound	_	_
8	acetate	_	NOUN	NN	_	4	nmod	_	_
9	as	_	ADP	IN	_	10	case	_	_
10	capsules	_	NOUN	NNS	_	1	nmod	_	_
11	,	_	.	,	_	15	punct	_	_
12	DRUG	_	NOUN	NN	_	13	compound	_	_
13	acetate	_	NOUN	NN	_	15	nsubjpass	_	_
14	is	_	VERB	VBZ	_	15	auxpass	_	_
15	hydrolyzed	_	VERB	VBN	_	0	root	_	_
16	to	_	PRT	TO	_	19	case	_	_
17	DRUG	_	NOUN	NN	_	19	compound	_	_
18	active	_	ADJ	JJ	_	19	amod	_	_
19	metabolite	_	NOUN	NN	_	15	nmod	_	_

#	Zytiga	2134
1	The	_	DET	DT	_	2	det	_	_
2	conversion	_	NOUN	NN	_	4	nsubj	_	_
3	is	_	VERB	VBZ	_	4	cop	_	_
4	likely	_	ADV	RB	_	13	advmod	_	_
5	through	_	ADP	IN	_	7	case	_	_
6	esterase	_	NOUN	NN	_	7	compound	_	_
7	activity	_	NOUN	NN	_	4	nmod	_	_
8	the	_	DET	DT	_	9	det	_	_
9	esterases	_	NOUN	NNS	_	13	nsubjpass	_	_
10	have	_	VERB	VBP	_	13	aux	_	_
11	not	_	ADV	RB	_	13	neg	_	_
12	been	_	VERB	VBN	_	13	auxpass	_	_
13	identified	_	VERB	VBN	_	0	root	_	_
14	and	_	CONJ	CC	_	13	cc	_	_
15	is	_	VERB	VBZ	_	18	auxpass	_	_
16	not	_	ADV	RB	_	17	neg	_	_
17	CYP	_	NOUN	NN	_	18	nsubjpass	_	_
18	mediated	_	VERB	VBN	_	13	conj	_	_

#	Zytiga	2135
1	The	_	DET	DT	_	5	det	_	_
2	two	_	NUM	CD	_	5	nummod	_	_
3	main	_	ADJ	JJ	_	5	amod	_	_
4	circulating	_	ADJ	JJ	_	5	amod	_	_
5	metabolites	_	NOUN	NNS	_	14	nsubj	_	_
6	of	_	ADP	IN	_	7	case	_	_
7	DRUG	_	NOUN	NN	_	5	nmod	_	_
8	in	_	ADP	IN	_	10	case	_	_
9	human	_	ADJ	JJ	_	10	amod	_	_
10	plasma	_	NOUN	NN	_	5	nmod	_	_
11	are	_	VERB	VBP	_	14	cop	_	_
12	DRUG	_	NOUN	NN	_	14	nmod:npmod	_	_
13	sulphate	_	NOUN	NN	_	14	nmod:npmod	_	_
14	inactive	_	ADJ	JJ	_	0	root	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	N	_	NOUN	NN	_	19	compound	_	_
17	oxide	_	NOUN	NN	_	19	compound	_	_
18	DRUG	_	NOUN	NN	_	19	compound	_	_
19	sulphate	_	NOUN	NN	_	14	conj	_	_
20	inactive	_	ADJ	JJ	_	19	amod	_	_
21	,	_	.	,	_	14	punct	_	_
22	which	_	DET	WDT	_	23	nsubj	_	_
23	account	_	VERB	VBP	_	14	root	_	_
24	for	_	ADP	IN	_	26	case	_	_
25	about	_	ADV	RB	_	26	advmod	_	_
26	43%	_	NOUN	NN	_	23	nmod	_	_
27	of	_	ADP	IN	_	28	case	_	_
28	exposure	_	NOUN	NN	_	26	nmod	_	_
29	each	_	DET	DT	_	23	punct	_	_

#	Zytiga	2136
1	CYP3A4	_	NOUN	NN	_	6	nsubj	_	_
2	and	_	CONJ	CC	_	1	cc	_	_
3	SULT2A1	_	NOUN	NN	_	1	conj	_	_
4	are	_	VERB	VBP	_	6	cop	_	_
5	the	_	DET	DT	_	6	det	_	_
6	enzymes	_	NOUN	NNS	_	19	nsubjpass	_	_
7	involved	_	VERB	VBN	_	6	acl	_	_
8	in	_	ADP	IN	_	10	case	_	_
9	the	_	DET	DT	_	10	det	_	_
10	formation	_	NOUN	NN	_	7	nmod	_	_
11	of	_	ADP	IN	_	15	case	_	_
12	N	_	NOUN	NN	_	15	compound	_	_
13	oxide	_	NOUN	NN	_	15	compound	_	_
14	DRUG	_	NOUN	NN	_	15	compound	_	_
15	sulphate	_	NOUN	NN	_	10	nmod	_	_
16	and	_	CONJ	CC	_	15	cc	_	_
17	SULT2A1	_	NOUN	NN	_	15	conj	_	_
18	is	_	VERB	VBZ	_	19	auxpass	_	_
19	involved	_	VERB	VBN	_	0	root	_	_
20	in	_	ADP	IN	_	22	case	_	_
21	the	_	DET	DT	_	22	det	_	_
22	formation	_	NOUN	NN	_	19	nmod	_	_
23	of	_	ADP	IN	_	25	case	_	_
24	DRUG	_	NOUN	NN	_	25	compound	_	_
25	sulphate	_	NOUN	NN	_	22	nmod	_	_

#	Zytiga	2137
1	Excretion	_	NOUN	NN	_	24	nsubj	_	_
2	In	_	ADP	IN	_	3	case	_	_
3	patients	_	NOUN	NNS	_	1	nmod	_	_
4	with	_	ADP	IN	_	6	case	_	_
5	metastatic	_	ADJ	JJ	_	6	amod	_	_
6	CRPC	_	NOUN	NN	_	3	nmod	_	_
7	,	_	.	,	_	1	punct	_	_
8	the	_	DET	DT	_	12	det	_	_
9	mean	_	ADJ	JJ	_	12	amod	_	_
10	terminal	_	ADJ	JJ	_	12	amod	_	_
11	half	_	ADJ	JJ	_	12	amod	_	_
12	life	_	NOUN	NN	_	1	appos	_	_
13	of	_	ADP	IN	_	14	case	_	_
14	DRUG	_	NOUN	NN	_	12	nmod	_	_
15	in	_	ADP	IN	_	19	case	_	_
16	plasma	_	NOUN	NN	_	19	compound	_	_
17	mean	_	NOUN	NN	_	19	compound	_	_
18	*	_	CONJ	CC	_	19	amod	_	_
19	SD	_	NOUN	NN	_	12	nmod	_	_
20	is	_	VERB	VBZ	_	24	cop	_	_
21	12	_	NUM	CD	_	23	compound	_	_
22	*	_	ADJ	JJ	_	23	advmod	_	_
23	5	_	NUM	CD	_	24	nummod	_	_
24	hours	_	NOUN	NNS	_	0	root	_	_

#	Zytiga	2138
1	Following	_	VERB	VBG	_	3	case	_	_
2	oral	_	ADJ	JJ	_	3	amod	_	_
3	administration	_	NOUN	NN	_	16	nmod	_	_
4	of	_	ADP	IN	_	7	case	_	_
5	14C	_	NOUN	NN	_	7	compound	_	_
6	DRUG	_	NOUN	NN	_	7	compound	_	_
7	acetate	_	NOUN	NN	_	3	nmod	_	_
8	,	_	.	,	_	16	punct	_	_
9	approximately	_	ADV	RB	_	10	advmod	_	_
10	88%	_	NOUN	NN	_	16	nsubjpass	_	_
11	of	_	ADP	IN	_	14	case	_	_
12	the	_	DET	DT	_	14	det	_	_
13	radioactive	_	ADJ	JJ	_	14	amod	_	_
14	dose	_	NOUN	NN	_	10	nmod	_	_
15	is	_	VERB	VBZ	_	16	auxpass	_	_
16	recovered	_	VERB	VBN	_	0	root	_	_
17	in	_	ADP	IN	_	18	case	_	_
18	feces	_	NOUN	NNS	_	16	nmod	_	_
19	and	_	CONJ	CC	_	18	cc	_	_
20	approximately	_	ADV	RB	_	21	advmod	_	_
21	5%	_	ADJ	JJ	_	18	conj	_	_
22	in	_	ADP	IN	_	23	mark	_	_
23	urine	_	VERB	VBG	_	16	advcl	_	_

#	Zytiga	2139
1	The	_	DET	DT	_	3	det	_	_
2	major	_	ADJ	JJ	_	3	amod	_	_
3	compounds	_	NOUN	NNS	_	10	nsubj	_	_
4	present	_	ADJ	JJ	_	3	amod	_	_
5	in	_	ADP	IN	_	6	case	_	_
6	feces	_	NOUN	NNS	_	4	nmod	_	_
7	are	_	VERB	VBP	_	10	cop	_	_
8	unchanged	_	ADJ	JJ	_	10	amod	_	_
9	DRUG	_	NOUN	NN	_	10	compound	_	_
10	acetate	_	NOUN	NN	_	0	root	_	_
11	and	_	CONJ	CC	_	10	cc	_	_
12	DRUG	_	NOUN	NN	_	10	conj	_	_
13	approximately	_	ADV	RB	_	14	advmod	_	_
14	55%	_	ADJ	JJ	_	12	amod	_	_
15	and	_	CONJ	CC	_	14	cc	_	_
16	22%	_	NOUN	NN	_	14	conj	_	_
17	of	_	ADP	IN	_	20	case	_	_
18	the	_	DET	DT	_	20	det	_	_
19	administered	_	VERB	VBN	_	20	amod	_	_
20	dose	_	NOUN	NN	_	14	nmod	_	_
21	,	_	.	,	_	10	punct	_	_
22	respectively	_	ADV	RB	_	10	advmod	_	_

#	Zytiga	2140
1	Patients	_	NOUN	NNS	_	0	root	_	_
2	with	_	ADP	IN	_	4	case	_	_
3	Hepatic	_	ADJ	JJ	_	4	amod	_	_
4	Impairment	_	NOUN	NN	_	1	nmod	_	_
5	The	_	DET	DT	_	6	det	_	_
6	pharmacokinetics	_	NOUN	NNS	_	10	nsubjpass	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	was	_	VERB	VBD	_	10	auxpass	_	_
10	examined	_	VERB	VBN	_	1	dep	_	_
11	in	_	ADP	IN	_	12	case	_	_
12	subjects	_	NOUN	NNS	_	10	nmod	_	_
13	with	_	ADP	IN	_	16	case	_	_
14	baseline	_	NOUN	NN	_	16	compound	_	_
15	mild	_	ADJ	JJ	_	16	amod	_	_
16	N=8	_	NOUN	NN	_	12	nmod	_	_
17	or	_	CONJ	CC	_	16	cc	_	_
18	moderate	_	ADJ	JJ	_	25	amod	_	_
19	N=8	_	NOUN	NN	_	25	compound	_	_
20	hepatic	_	ADJ	JJ	_	25	amod	_	_
21	impairment	_	NOUN	NN	_	25	compound	_	_
22	Child	_	NOUN	NN	_	25	compound	_	_
23	Pugh	_	NOUN	NN	_	25	compound	_	_
24	Class	_	NOUN	NN	_	25	compound	_	_
25	A	_	NOUN	NN	_	16	conj	_	_
26	and	_	CONJ	CC	_	25	cc	_	_
27	B	_	NOUN	NN	_	25	conj	_	_
28	,	_	.	,	_	10	punct	_	_
29	respectively	_	ADV	RB	_	30	advmod	_	_
30	and	_	CONJ	CC	_	10	advmod	_	_
31	in	_	ADP	IN	_	35	case	_	_
32	8	_	NUM	CD	_	35	nummod	_	_
33	healthy	_	ADJ	JJ	_	35	amod	_	_
34	control	_	NOUN	NN	_	35	compound	_	_
35	subjects	_	NOUN	NNS	_	30	conj	_	_
36	with	_	ADP	IN	_	39	case	_	_
37	normal	_	ADJ	JJ	_	39	amod	_	_
38	hepatic	_	ADJ	JJ	_	39	amod	_	_
39	function	_	NOUN	NN	_	35	nmod	_	_

#	Zytiga	2141
1	Systemic	_	ADJ	JJ	_	2	amod	_	_
2	exposure	_	NOUN	NN	_	16	nsubj	_	_
3	to	_	PRT	TO	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	after	_	ADP	IN	_	11	case	_	_
6	a	_	DET	DT	_	11	det	_	_
7	single	_	ADJ	JJ	_	11	amod	_	_
8	oral	_	ADJ	JJ	_	11	amod	_	_
9	1,000	_	NUM	CD	_	11	nummod	_	_
10	mg	_	NOUN	NN	_	11	compound	_	_
11	dose	_	NOUN	NN	_	2	nmod	_	_
12	given	_	VERB	VBN	_	11	acl	_	_
13	under	_	ADP	IN	_	15	case	_	_
14	fasting	_	VERB	VBG	_	15	amod	_	_
15	conditions	_	NOUN	NNS	_	12	nmod	_	_
16	increased	_	VERB	VBD	_	0	root	_	_
17	approximately	_	ADV	RB	_	18	advmod	_	_
18	1.1	_	NUM	CD	_	19	nummod	_	_
19	fold	_	NOUN	NN	_	16	dobj	_	_
20	and	_	CONJ	CC	_	19	cc	_	_
21	3.6	_	NUM	CD	_	22	nummod	_	_
22	fold	_	NOUN	NN	_	19	conj	_	_
23	in	_	ADP	IN	_	24	case	_	_
24	subjects	_	NOUN	NNS	_	16	nmod	_	_
25	with	_	ADP	IN	_	31	case	_	_
26	mild	_	ADJ	JJ	_	31	amod	_	_
27	and	_	CONJ	CC	_	26	cc	_	_
28	moderate	_	ADJ	JJ	_	26	conj	_	_
29	baseline	_	NOUN	NN	_	31	compound	_	_
30	hepatic	_	ADJ	JJ	_	31	amod	_	_
31	impairment	_	NOUN	NN	_	24	nmod	_	_
32	,	_	.	,	_	16	punct	_	_
33	respectively	_	ADV	RB	_	16	advmod	_	_

#	Zytiga	2142
1	The	_	DET	DT	_	4	det	_	_
2	mean	_	ADJ	JJ	_	4	amod	_	_
3	half	_	ADJ	JJ	_	4	amod	_	_
4	life	_	NOUN	NN	_	8	nsubjpass	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	is	_	VERB	VBZ	_	8	auxpass	_	_
8	prolonged	_	ADJ	JJ	_	0	root	_	_
9	to	_	PRT	TO	_	12	case	_	_
10	approximately	_	ADV	RB	_	11	advmod	_	_
11	18	_	NUM	CD	_	12	nummod	_	_
12	hours	_	NOUN	NNS	_	8	nmod	_	_
13	in	_	ADP	IN	_	14	case	_	_
14	subjects	_	NOUN	NNS	_	12	nmod	_	_
15	with	_	ADP	IN	_	18	case	_	_
16	mild	_	ADJ	JJ	_	18	amod	_	_
17	hepatic	_	ADJ	JJ	_	18	amod	_	_
18	impairment	_	NOUN	NN	_	14	nmod	_	_
19	and	_	CONJ	CC	_	8	cc	_	_
20	to	_	PRT	TO	_	23	case	_	_
21	approximately	_	ADV	RB	_	22	advmod	_	_
22	19	_	NUM	CD	_	23	nummod	_	_
23	hours	_	NOUN	NNS	_	8	conj	_	_
24	in	_	ADP	IN	_	25	case	_	_
25	subjects	_	NOUN	NNS	_	23	nmod	_	_
26	with	_	ADP	IN	_	29	case	_	_
27	moderate	_	ADJ	JJ	_	29	amod	_	_
28	hepatic	_	ADJ	JJ	_	29	amod	_	_
29	impairment	_	NOUN	NN	_	25	nmod	_	_

#	Zytiga	2143
1	In	_	ADP	IN	_	3	case	_	_
2	another	_	DET	DT	_	3	det	_	_
3	trial	_	ADJ	JJ	_	10	nmod	_	_
4	,	_	.	,	_	10	punct	_	_
5	the	_	DET	DT	_	6	det	_	_
6	pharmacokinetics	_	NOUN	NNS	_	10	nsubjpass	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	were	_	VERB	VBD	_	10	auxpass	_	_
10	examined	_	VERB	VBN	_	0	root	_	_
11	in	_	ADP	IN	_	12	case	_	_
12	subjects	_	NOUN	NNS	_	10	nmod	_	_
13	with	_	ADP	IN	_	22	case	_	_
14	baseline	_	NOUN	NN	_	22	compound	_	_
15	severe	_	ADJ	JJ	_	22	amod	_	_
16	N=8	_	NOUN	NN	_	22	compound	_	_
17	hepatic	_	ADJ	JJ	_	22	amod	_	_
18	impairment	_	NOUN	NN	_	22	compound	_	_
19	Child	_	NOUN	NN	_	22	compound	_	_
20	Pugh	_	NOUN	NN	_	22	compound	_	_
21	Class	_	NOUN	NN	_	22	compound	_	_
22	C	_	NOUN	NN	_	12	nmod	_	_
23	and	_	CONJ	CC	_	12	cc	_	_
24	in	_	ADP	IN	_	28	case	_	_
25	8	_	NUM	CD	_	28	nummod	_	_
26	healthy	_	ADJ	JJ	_	28	amod	_	_
27	control	_	NOUN	NN	_	28	compound	_	_
28	subjects	_	NOUN	NNS	_	12	conj	_	_
29	with	_	ADP	IN	_	32	case	_	_
30	normal	_	ADJ	JJ	_	32	amod	_	_
31	hepatic	_	ADJ	JJ	_	32	amod	_	_
32	function	_	NOUN	NN	_	28	nmod	_	_

#	Zytiga	2144
1	The	_	DET	DT	_	4	det	_	_
2	systemic	_	ADJ	JJ	_	4	amod	_	_
3	exposure	_	NOUN	NN	_	4	compound	_	_
4	AUC	_	NOUN	NN	_	7	nsubj	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	DRUG	_	NOUN	NN	_	4	nmod	_	_
7	increased	_	VERB	VBD	_	0	root	_	_
8	by	_	ADP	IN	_	11	case	_	_
9	approximately	_	ADV	RB	_	10	advmod	_	_
10	7	_	NUM	CD	_	11	nummod	_	_
11	fold	_	NOUN	NN	_	7	nmod	_	_
12	in	_	ADP	IN	_	13	case	_	_
13	subjects	_	NOUN	NNS	_	11	nmod	_	_
14	with	_	ADP	IN	_	18	case	_	_
15	severe	_	ADJ	JJ	_	18	amod	_	_
16	baseline	_	NOUN	NN	_	18	compound	_	_
17	hepatic	_	ADJ	JJ	_	18	amod	_	_
18	impairment	_	NOUN	NN	_	13	nmod	_	_
19	compared	_	VERB	VBN	_	7	xcomp	_	_
20	to	_	PRT	TO	_	21	case	_	_
21	subjects	_	NOUN	NNS	_	19	nmod	_	_
22	with	_	ADP	IN	_	25	case	_	_
23	normal	_	ADJ	JJ	_	25	amod	_	_
24	hepatic	_	ADJ	JJ	_	25	amod	_	_
25	function	_	NOUN	NN	_	21	nmod	_	_

#	Zytiga	2145
1	In	_	ADP	IN	_	2	case	_	_
2	addition	_	NOUN	NN	_	9	nmod	_	_
3	,	_	.	,	_	9	punct	_	_
4	the	_	DET	DT	_	7	det	_	_
5	mean	_	NOUN	NN	_	7	compound	_	_
6	protein	_	NOUN	NN	_	7	compound	_	_
7	binding	_	NOUN	NN	_	9	nsubjpass	_	_
8	was	_	VERB	VBD	_	9	auxpass	_	_
9	found	_	VERB	VBN	_	0	root	_	_
10	to	_	PRT	TO	_	12	mark	_	_
11	be	_	VERB	VB	_	12	cop	_	_
12	lower	_	ADJ	JJ	_	9	xcomp	_	_
13	in	_	ADP	IN	_	18	case	_	_
14	the	_	DET	DT	_	18	det	_	_
15	severe	_	ADJ	JJ	_	18	amod	_	_
16	hepatic	_	ADJ	JJ	_	18	amod	_	_
17	impairment	_	NOUN	NN	_	18	compound	_	_
18	group	_	NOUN	NN	_	12	nmod	_	_
19	compared	_	VERB	VBN	_	9	xcomp	_	_
20	to	_	PRT	TO	_	25	case	_	_
21	the	_	DET	DT	_	25	det	_	_
22	normal	_	ADJ	JJ	_	25	amod	_	_
23	hepatic	_	ADJ	JJ	_	25	amod	_	_
24	function	_	NOUN	NN	_	25	compound	_	_
25	group	_	NOUN	NN	_	19	nmod	_	_
26	,	_	.	,	_	25	punct	_	_
27	which	_	DET	WDT	_	28	nsubj	_	_
28	resulted	_	VERB	VBD	_	25	acl:relcl	_	_
29	in	_	ADP	IN	_	33	case	_	_
30	a	_	DET	DT	_	33	det	_	_
31	two	_	NUM	CD	_	32	compound	_	_
32	fold	_	NOUN	NN	_	33	amod	_	_
33	increase	_	NOUN	NN	_	28	nmod	_	_
34	in	_	ADP	IN	_	36	case	_	_
35	the	_	DET	DT	_	36	det	_	_
36	fraction	_	NOUN	NN	_	33	nmod	_	_
37	of	_	ADP	IN	_	39	case	_	_
38	free	_	ADJ	JJ	_	39	amod	_	_
39	drug	_	NOUN	NN	_	36	nmod	_	_
40	in	_	ADP	IN	_	41	case	_	_
41	patients	_	NOUN	NNS	_	36	nmod	_	_
42	with	_	ADP	IN	_	45	case	_	_
43	severe	_	ADJ	JJ	_	45	amod	_	_
44	hepatic	_	ADJ	JJ	_	45	amod	_	_
45	impairment	_	NOUN	NN	_	41	nmod	_	_

#	Zytiga	2146
1	Patients	_	NOUN	NNS	_	0	root	_	_
2	with	_	ADP	IN	_	4	case	_	_
3	Renal	_	ADJ	JJ	_	4	amod	_	_
4	Impairment	_	NOUN	NN	_	1	nmod	_	_
5	The	_	DET	DT	_	6	det	_	_
6	pharmacokinetics	_	NOUN	NNS	_	10	nsubjpass	_	_
7	of	_	ADP	IN	_	8	case	_	_
8	DRUG	_	NOUN	NN	_	6	nmod	_	_
9	were	_	VERB	VBD	_	10	auxpass	_	_
10	examined	_	VERB	VBN	_	1	dep	_	_
11	in	_	ADP	IN	_	12	case	_	_
12	patients	_	NOUN	NNS	_	10	nmod	_	_
13	with	_	ADP	IN	_	18	case	_	_
14	end	_	NOUN	NN	_	18	compound	_	_
15	stage	_	NOUN	NN	_	18	compound	_	_
16	renal	_	ADJ	JJ	_	18	amod	_	_
17	disease	_	NOUN	NN	_	18	compound	_	_
18	ESRD	_	NOUN	NN	_	12	nmod	_	_
19	on	_	ADP	IN	_	24	case	_	_
20	a	_	DET	DT	_	24	det	_	_
21	stable	_	ADJ	JJ	_	24	amod	_	_
22	hemodialysis	_	NOUN	NN	_	24	compound	_	_
23	schedule	_	NOUN	NN	_	24	compound	_	_
24	N=8	_	NOUN	NN	_	12	nmod	_	_
25	and	_	CONJ	CC	_	12	cc	_	_
26	in	_	ADP	IN	_	29	case	_	_
27	matched	_	VERB	VBN	_	29	amod	_	_
28	control	_	NOUN	NN	_	29	compound	_	_
29	subjects	_	NOUN	NNS	_	12	conj	_	_
30	with	_	ADP	IN	_	33	case	_	_
31	normal	_	ADJ	JJ	_	33	amod	_	_
32	renal	_	ADJ	JJ	_	33	amod	_	_
33	function	_	NOUN	NN	_	29	nmod	_	_
34	N=8	_	NOUN	NN	_	33	dep	_	_

#	Zytiga	2147
1	In	_	ADP	IN	_	4	case	_	_
2	the	_	DET	DT	_	4	det	_	_
3	ESRD	_	NOUN	NN	_	4	compound	_	_
4	cohort	_	NOUN	NN	_	16	nmod	_	_
5	of	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	trial	_	ADJ	JJ	_	4	nmod	_	_
8	,	_	.	,	_	16	punct	_	_
9	a	_	DET	DT	_	14	det	_	_
10	single	_	ADJ	JJ	_	14	amod	_	_
11	1,000	_	NUM	CD	_	14	nummod	_	_
12	mg	_	NOUN	NN	_	14	compound	_	_
13	DRUG	_	NOUN	NN	_	14	compound	_	_
14	dose	_	NOUN	NN	_	16	nsubjpass	_	_
15	was	_	VERB	VBD	_	16	auxpass	_	_
16	given	_	VERB	VBN	_	0	root	_	_
17	under	_	ADP	IN	_	18	mark	_	_
18	fasting	_	VERB	VBG	_	16	advcl	_	_
19	conditions	_	NOUN	NNS	_	18	dobj	_	_
20	1	_	NUM	CD	_	21	nummod	_	_
21	hour	_	NUM	CD	_	19	nmod	_	_
22	after	_	ADP	IN	_	21	case	_	_
23	dialysis	_	NOUN	NN	_	21	dep	_	_
24	,	_	.	,	_	16	punct	_	_
25	and	_	CONJ	CC	_	16	cc	_	_
26	samples	_	NOUN	NNS	_	31	nsubjpass	_	_
27	for	_	ADP	IN	_	29	case	_	_
28	pharmacokinetic	_	ADJ	JJ	_	29	amod	_	_
29	analysis	_	NOUN	NN	_	26	nmod	_	_
30	were	_	VERB	VBD	_	31	auxpass	_	_
31	collected	_	VERB	VBN	_	16	conj	_	_
32	up	_	ADV	RB	_	35	advmod	_	_
33	to	_	PRT	TO	_	35	case	_	_
34	96	_	NUM	CD	_	35	nummod	_	_
35	hours	_	NOUN	NNS	_	31	nmod	_	_
36	post	_	ADJ	JJ	_	35	dep	_	_
37	dose	_	NOUN	NN	_	36	nmod	_	_

#	Zytiga	2148
1	Systemic	_	ADJ	JJ	_	2	amod	_	_
2	exposure	_	NOUN	NN	_	14	nsubj	_	_
3	to	_	PRT	TO	_	4	case	_	_
4	DRUG	_	NOUN	NN	_	2	nmod	_	_
5	after	_	ADP	IN	_	11	case	_	_
6	a	_	DET	DT	_	11	det	_	_
7	single	_	ADJ	JJ	_	11	amod	_	_
8	oral	_	ADJ	JJ	_	11	amod	_	_
9	1,000	_	NUM	CD	_	11	nummod	_	_
10	mg	_	NOUN	NN	_	11	compound	_	_
11	dose	_	NOUN	NN	_	2	nmod	_	_
12	did	_	VERB	VBD	_	14	aux	_	_
13	not	_	ADV	RB	_	14	neg	_	_
14	increase	_	VERB	VB	_	0	root	_	_
15	in	_	ADP	IN	_	16	case	_	_
16	subjects	_	NOUN	NNS	_	14	nmod	_	_
17	with	_	ADP	IN	_	21	case	_	_
18	end	_	NOUN	NN	_	21	compound	_	_
19	stage	_	NOUN	NN	_	21	compound	_	_
20	renal	_	ADJ	JJ	_	21	amod	_	_
21	disease	_	NOUN	NN	_	16	nmod	_	_
22	on	_	ADP	IN	_	23	case	_	_
23	dialysis	_	NOUN	NN	_	16	nmod	_	_
24	,	_	.	,	_	14	punct	_	_
25	compared	_	VERB	VBN	_	14	advcl	_	_
26	to	_	PRT	TO	_	27	case	_	_
27	subjects	_	NOUN	NNS	_	25	nmod	_	_
28	with	_	ADP	IN	_	31	case	_	_
29	normal	_	ADJ	JJ	_	31	amod	_	_
30	renal	_	ADJ	JJ	_	31	amod	_	_
31	function	_	NOUN	NN	_	27	nmod	_	_

#	Zytiga	2149
1	Drug	_	NOUN	NN	_	2	compound	_	_
2	Interactions	_	NOUN	NNS	_	10	nsubj	_	_
3	In	_	X	FW	_	5	amod	_	_
4	vitro	_	X	FW	_	3	dep	_	_
5	studies	_	NOUN	NNS	_	2	nmod	_	_
6	with	_	ADP	IN	_	9	case	_	_
7	human	_	ADJ	JJ	_	9	amod	_	_
8	hepatic	_	ADJ	JJ	_	9	amod	_	_
9	microsomes	_	NOUN	NNS	_	5	nmod	_	_
10	showed	_	VERB	VBD	_	0	root	_	_
11	that	_	ADP	IN	_	13	mark	_	_
12	DRUG	_	NOUN	NN	_	13	nsubj	_	_
13	has	_	VERB	VBZ	_	10	ccomp	_	_
14	the	_	DET	DT	_	15	det	_	_
15	potential	_	NOUN	NN	_	13	dobj	_	_
16	to	_	PRT	TO	_	17	mark	_	_
17	inhibit	_	VERB	VB	_	13	xcomp	_	_
18	CYP1A2	_	NOUN	NN	_	17	dobj	_	_
19	,	_	.	,	_	18	punct	_	_
20	CYP2D6	_	NOUN	NN	_	18	conj	_	_
21	,	_	.	,	_	18	punct	_	_
22	CYP2C8	_	NOUN	NN	_	18	conj	_	_
23	and	_	CONJ	CC	_	18	cc	_	_
24	to	_	PRT	TO	_	27	case	_	_
25	a	_	DET	DT	_	27	det	_	_
26	lesser	_	ADJ	JJ	_	27	amod	_	_
27	extent	_	NOUN	NN	_	18	conj	_	_
28	CYP2C9	_	NOUN	NN	_	27	dep	_	_
29	,	_	.	,	_	27	punct	_	_
30	CYP2C19	_	NOUN	NN	_	27	conj	_	_
31	and	_	CONJ	CC	_	27	cc	_	_
32	CYP3A4	_	NOUN	NN	_	27	conj	_	_
33	/	_	.	,	_	32	punct	_	_
34	5	_	NUM	CD	_	32	nummod	_	_

#	Zytiga	2150
1	In	_	ADP	IN	_	8	case	_	_
2	an	_	DET	DT	_	8	det	_	_
3	in	_	X	FW	_	8	amod	_	_
4	vivo	_	X	FW	_	3	dep	_	_
5	drug	_	NOUN	NN	_	8	compound	_	_
6	drug	_	NOUN	NN	_	8	compound	_	_
7	interaction	_	NOUN	NN	_	8	compound	_	_
8	trial	_	ADJ	JJ	_	19	nmod	_	_
9	,	_	.	,	_	19	punct	_	_
10	the	_	DET	DT	_	11	det	_	_
11	Cmax	_	NOUN	NN	_	19	nsubjpass	_	_
12	and	_	CONJ	CC	_	11	cc	_	_
13	AUC	_	NOUN	NN	_	11	conj	_	_
14	of	_	ADP	IN	_	17	case	_	_
15	dextromethorphan	_	NOUN	NN	_	17	compound	_	_
16	CYP2D6	_	NOUN	NN	_	17	compound	_	_
17	substrate	_	NOUN	NN	_	11	nmod	_	_
18	were	_	VERB	VBD	_	19	auxpass	_	_
19	increased	_	VERB	VBN	_	0	root	_	_
20	2.8	_	NUM	CD	_	23	nummod	_	_
21	and	_	CONJ	CC	_	20	cc	_	_
22	2.9	_	NUM	CD	_	20	conj	_	_
23	fold	_	NOUN	NN	_	19	dobj	_	_
24	,	_	.	,	_	19	punct	_	_
25	respectively	_	ADV	RB	_	31	advmod	_	_
26	when	_	ADV	WRB	_	31	advmod	_	_
27	dextromethorphan	_	NOUN	NN	_	29	compound	_	_
28	30	_	NUM	CD	_	29	nummod	_	_
29	mg	_	NOUN	NN	_	31	nsubjpass	_	_
30	was	_	VERB	VBD	_	31	auxpass	_	_
31	given	_	VERB	VBN	_	19	parataxis	_	_
32	with	_	ADP	IN	_	36	case	_	_
33	DRUG	_	NOUN	NN	_	36	compound	_	_
34	acetate	_	NOUN	NN	_	36	compound	_	_
35	1,000	_	NUM	CD	_	36	nummod	_	_
36	mg	_	NOUN	NN	_	31	nmod	_	_
37	daily	_	ADV	RB	_	38	advmod	_	_
38	plus	_	CONJ	CC	_	31	advmod	_	_
39	prednisone	_	NOUN	NN	_	41	compound	_	_
40	5	_	NUM	CD	_	41	nummod	_	_
41	mg	_	NOUN	NN	_	38	conj	_	_
42	twice	_	ADV	RB	_	41	advmod	_	_
43	daily	_	ADV	RB	_	41	advmod	_	_

#	Zytiga	2151
1	The	_	DET	DT	_	2	det	_	_
2	AUC	_	NOUN	NN	_	12	nsubj	_	_
3	for	_	ADP	IN	_	4	case	_	_
4	dextrorphan	_	NOUN	NN	_	2	nmod	_	_
5	,	_	.	,	_	4	punct	_	_
6	the	_	DET	DT	_	8	det	_	_
7	active	_	ADJ	JJ	_	8	amod	_	_
8	metabolite	_	NOUN	NN	_	4	appos	_	_
9	of	_	ADP	IN	_	10	case	_	_
10	dextromethorphan	_	NOUN	NN	_	8	nmod	_	_
11	,	_	.	,	_	2	punct	_	_
12	increased	_	VERB	VBD	_	0	root	_	_
13	approximately	_	ADV	RB	_	14	advmod	_	_
14	1.3	_	NUM	CD	_	12	neg	_	_
15	fold	_	ADJ	JJR	_	14	dep	_	_

#	Zytiga	2152
1	In	_	ADP	IN	_	4	case	_	_
2	a	_	DET	DT	_	4	det	_	_
3	clinical	_	ADJ	JJ	_	4	amod	_	_
4	study	_	NOUN	NN	_	41	nmod	_	_
5	to	_	PRT	TO	_	6	mark	_	_
6	determine	_	VERB	VB	_	4	acl	_	_
7	the	_	DET	DT	_	8	det	_	_
8	effects	_	NOUN	NNS	_	6	dobj	_	_
9	of	_	ADP	IN	_	13	case	_	_
10	DRUG	_	NOUN	NN	_	13	compound	_	_
11	acetate	_	NOUN	NN	_	13	compound	_	_
12	1,000	_	NUM	CD	_	13	nummod	_	_
13	mg	_	NOUN	NN	_	8	nmod	_	_
14	daily	_	ADV	RB	_	15	advmod	_	_
15	plus	_	CONJ	CC	_	6	advmod	_	_
16	prednisone	_	NOUN	NN	_	18	compound	_	_
17	5	_	NUM	CD	_	18	nummod	_	_
18	mg	_	NOUN	NN	_	15	conj	_	_
19	twice	_	ADV	RB	_	20	advmod	_	_
20	daily	_	ADV	RB	_	18	advmod	_	_
21	on	_	ADP	IN	_	26	case	_	_
22	a	_	DET	DT	_	26	det	_	_
23	single	_	ADJ	JJ	_	26	amod	_	_
24	100	_	NUM	CD	_	26	nummod	_	_
25	mg	_	NOUN	NN	_	26	compound	_	_
26	dose	_	NOUN	NN	_	20	nmod	_	_
27	of	_	ADP	IN	_	31	case	_	_
28	the	_	DET	DT	_	31	det	_	_
29	CYP1A2	_	NOUN	NN	_	31	compound	_	_
30	substrate	_	NOUN	NN	_	31	compound	_	_
31	theophylline	_	NOUN	NN	_	26	nmod	_	_
32	,	_	.	,	_	41	punct	_	_
33	no	_	DET	DT	_	34	neg	_	_
34	increase	_	NOUN	NN	_	41	nsubjpass	_	_
35	in	_	ADP	IN	_	37	case	_	_
36	systemic	_	ADJ	JJ	_	37	amod	_	_
37	exposure	_	NOUN	NN	_	34	nmod	_	_
38	of	_	ADP	IN	_	39	case	_	_
39	theophylline	_	NOUN	NN	_	37	nmod	_	_
40	was	_	VERB	VBD	_	41	auxpass	_	_
41	observed	_	VERB	VBN	_	0	root	_	_

#	Zytiga	2153
1	DRUG	_	NOUN	NN	_	4	nsubj	_	_
2	is	_	VERB	VBZ	_	4	cop	_	_
3	a	_	DET	DT	_	4	det	_	_
4	substrate	_	NOUN	NN	_	0	root	_	_
5	of	_	ADP	IN	_	6	case	_	_
6	CYP3A4	_	NOUN	NN	_	4	nmod	_	_
7	,	_	.	,	_	4	punct	_	_
8	in	_	X	FW	_	9	compound	_	_
9	vitro	_	X	FW	_	4	advmod	_	_

#	Zytiga	2154
1	In	_	ADP	IN	_	6	case	_	_
2	a	_	DET	DT	_	6	det	_	_
3	clinical	_	ADJ	JJ	_	6	amod	_	_
4	pharmacokinetic	_	ADJ	JJ	_	6	amod	_	_
5	interaction	_	NOUN	NN	_	6	compound	_	_
6	study	_	NOUN	NN	_	42	nmod	_	_
7	of	_	ADP	IN	_	9	case	_	_
8	healthy	_	ADJ	JJ	_	9	amod	_	_
9	subjects	_	NOUN	NNS	_	6	nmod	_	_
10	pretreated	_	VERB	VBN	_	9	acl	_	_
11	with	_	ADP	IN	_	16	case	_	_
12	a	_	DET	DT	_	16	det	_	_
13	strong	_	ADJ	JJ	_	16	amod	_	_
14	CYP3A4	_	NOUN	NN	_	16	compound	_	_
15	inducer	_	NOUN	NN	_	16	compound	_	_
16	rifampin	_	NOUN	NN	_	10	nmod	_	_
17	,	_	.	,	_	42	punct	_	_
18	600	_	NUM	CD	_	19	nummod	_	_
19	mg	_	NOUN	NN	_	42	nsubjpass	_	_
20	daily	_	ADV	RB	_	19	advmod	_	_
21	for	_	ADP	IN	_	23	case	_	_
22	6	_	NUM	CD	_	23	nummod	_	_
23	days	_	NOUN	NNS	_	19	nmod	_	_
24	followed	_	VERB	VBN	_	23	acl	_	_
25	by	_	ADP	IN	_	28	case	_	_
26	a	_	DET	DT	_	28	det	_	_
27	single	_	ADJ	JJ	_	28	amod	_	_
28	dose	_	NOUN	NN	_	24	nmod	_	_
29	of	_	ADP	IN	_	33	case	_	_
30	DRUG	_	NOUN	NN	_	33	compound	_	_
31	acetate	_	NOUN	NN	_	33	compound	_	_
32	1,000	_	NUM	CD	_	33	nummod	_	_
33	mg	_	NOUN	NN	_	28	nmod	_	_
34	,	_	.	,	_	42	punct	_	_
35	the	_	DET	DT	_	38	det	_	_
36	mean	_	NOUN	NN	_	38	compound	_	_
37	plasma	_	NOUN	NN	_	38	compound	_	_
38	AUC*	_	NOUN	NN	_	42	nsubjpass	_	_
39	of	_	ADP	IN	_	40	case	_	_
40	DRUG	_	NOUN	NN	_	38	nmod	_	_
41	was	_	VERB	VBD	_	42	auxpass	_	_
42	decreased	_	VERB	VBN	_	0	root	_	_
43	by	_	ADP	IN	_	44	case	_	_
44	55%	_	ADJ	JJ	_	42	nmod	_	_

#	Zytiga	2155
1	In	_	ADP	IN	_	7	case	_	_
2	a	_	DET	DT	_	7	det	_	_
3	separate	_	ADJ	JJ	_	7	amod	_	_
4	clinical	_	ADJ	JJ	_	7	amod	_	_
5	pharmacokinetic	_	ADJ	JJ	_	7	amod	_	_
6	interaction	_	NOUN	NN	_	7	compound	_	_
7	study	_	NOUN	NN	_	23	nmod	_	_
8	of	_	ADP	IN	_	10	case	_	_
9	healthy	_	ADJ	JJ	_	10	amod	_	_
10	subjects	_	NOUN	NNS	_	7	nmod	_	_
11	,	_	.	,	_	23	punct	_	_
12	co	_	PRT	TO	_	13	case	_	_
13	administration	_	NOUN	NN	_	23	nsubj	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	ketoconazole	_	NOUN	NN	_	13	nmod	_	_
16	,	_	.	,	_	15	punct	_	_
17	a	_	DET	DT	_	19	det	_	_
18	strong	_	ADJ	JJ	_	19	amod	_	_
19	inhibitor	_	NOUN	NN	_	15	appos	_	_
20	of	_	ADP	IN	_	21	case	_	_
21	CYP3A4	_	NOUN	NN	_	19	nmod	_	_
22	,	_	.	,	_	13	punct	_	_
23	had	_	VERB	VBD	_	0	root	_	_
24	no	_	DET	DT	_	27	neg	_	_
25	clinically	_	ADV	RB	_	26	advmod	_	_
26	meaningful	_	ADJ	JJ	_	27	amod	_	_
27	effect	_	NOUN	NN	_	23	dobj	_	_
28	on	_	ADP	IN	_	30	case	_	_
29	the	_	DET	DT	_	30	det	_	_
30	pharmacokinetics	_	NOUN	NNS	_	27	nmod	_	_
31	of	_	ADP	IN	_	32	case	_	_
32	DRUG	_	NOUN	NN	_	30	nmod	_	_

#	Zytiga	2156
1	In	_	ADP	IN	_	6	case	_	_
2	a	_	DET	DT	_	6	det	_	_
3	CYP2C8	_	NOUN	NN	_	6	compound	_	_
4	drug	_	NOUN	NN	_	6	compound	_	_
5	drug	_	NOUN	NN	_	6	compound	_	_
6	interaction	_	NOUN	NN	_	17	nmod	_	_
7	trial	_	ADJ	JJ	_	6	amod	_	_
8	in	_	ADP	IN	_	10	case	_	_
9	healthy	_	ADJ	JJ	_	10	amod	_	_
10	subjects	_	NOUN	NNS	_	7	nmod	_	_
11	,	_	.	,	_	17	punct	_	_
12	the	_	DET	DT	_	13	det	_	_
13	AUC	_	NOUN	NN	_	17	nsubjpass	_	_
14	of	_	ADP	IN	_	15	case	_	_
15	pioglitazone	_	NOUN	NN	_	13	nmod	_	_
16	was	_	VERB	VBD	_	17	auxpass	_	_
17	increased	_	VERB	VBN	_	0	root	_	_
18	by	_	ADP	IN	_	19	case	_	_
19	46%	_	NOUN	NN	_	17	nmod	_	_
20	when	_	ADV	WRB	_	23	advmod	_	_
21	pioglitazone	_	NOUN	NN	_	23	nsubjpass	_	_
22	was	_	VERB	VBD	_	23	auxpass	_	_
23	given	_	VERB	VBN	_	17	advcl	_	_
24	together	_	ADV	RB	_	23	advmod	_	_
25	with	_	ADP	IN	_	28	case	_	_
26	a	_	DET	DT	_	28	det	_	_
27	single	_	ADJ	JJ	_	28	amod	_	_
28	dose	_	NOUN	NN	_	23	nmod	_	_
29	of	_	ADP	IN	_	33	case	_	_
30	1,000	_	NUM	CD	_	33	nummod	_	_
31	mg	_	NOUN	NN	_	33	compound	_	_
32	DRUG	_	NOUN	NN	_	33	compound	_	_
33	acetate	_	NOUN	NN	_	28	nmod	_	_

#	Zytiga	2157
1	In	_	X	FW	_	2	compound	_	_
2	vitro	_	X	FW	_	10	advmod	_	_
3	,	_	.	,	_	10	punct	_	_
4	DRUG	_	NOUN	NN	_	10	nsubjpass	_	_
5	and	_	CONJ	CC	_	4	cc	_	_
6	its	_	PRON	PRP$	_	8	nmod:poss	_	_
7	major	_	ADJ	JJ	_	8	amod	_	_
8	metabolites	_	NOUN	NNS	_	4	conj	_	_
9	were	_	VERB	VBD	_	10	auxpass	_	_
10	shown	_	VERB	VBN	_	0	root	_	_
11	to	_	PRT	TO	_	12	mark	_	_
12	inhibit	_	VERB	VB	_	10	xcomp	_	_
13	the	_	DET	DT	_	16	det	_	_
14	hepatic	_	ADJ	JJ	_	16	amod	_	_
15	uptake	_	NOUN	NN	_	16	compound	_	_
16	transporter	_	NOUN	NN	_	12	dobj	_	_
17	OATP1B1	_	NOUN	NN	_	16	dep	_	_

#	Zytiga	2158
1	There	_	DET	EX	_	2	expl	_	_
2	are	_	VERB	VBP	_	0	root	_	_
3	no	_	DET	DT	_	5	neg	_	_
4	clinical	_	ADJ	JJ	_	5	amod	_	_
5	data	_	NOUN	NNS	_	2	nsubj	_	_
6	available	_	ADJ	JJ	_	5	amod	_	_
7	to	_	PRT	TO	_	8	mark	_	_
8	confirm	_	VERB	VB	_	6	xcomp	_	_
9	transporter	_	NOUN	NN	_	11	compound	_	_
10	based	_	ADJ	JJ	_	11	amod	_	_
11	interaction	_	NOUN	NN	_	8	dobj	_	_

#	Zytiga	2159
1	In	_	ADP	IN	_	4	case	_	_
2	a	_	DET	DT	_	4	det	_	_
3	multi	_	NOUN	NN	_	4	compound	_	_
4	center	_	NOUN	NN	_	0	root	_	_
5	,	_	.	,	_	4	punct	_	_
6	open	_	ADJ	JJ	_	7	amod	_	_
7	label	_	NOUN	NN	_	5	root	_	_
8	,	_	.	,	_	7	punct	_	_
9	single	_	ADJ	JJ	_	11	amod	_	_
10	arm	_	NOUN	NN	_	11	compound	_	_
11	trial	_	ADJ	JJ	_	7	conj	_	_
12	,	_	.	,	_	7	punct	_	_
13	33	_	NUM	CD	_	14	nummod	_	_
14	patients	_	NOUN	NNS	_	18	nsubj	_	_
15	with	_	ADP	IN	_	17	case	_	_
16	metastatic	_	ADJ	JJ	_	17	amod	_	_
17	CRPC	_	NOUN	NN	_	14	nmod	_	_
18	received	_	VERB	VBD	_	7	dep	_	_
19	DRUG	_	NOUN	NN	_	18	dobj	_	_
20	orally	_	ADV	RB	_	18	advmod	_	_
21	at	_	ADP	IN	_	23	case	_	_
22	a	_	DET	DT	_	23	det	_	_
23	dose	_	NOUN	NN	_	18	nmod	_	_
24	of	_	ADP	IN	_	26	case	_	_
25	1,000	_	NUM	CD	_	26	nummod	_	_
26	mg	_	NOUN	NN	_	23	nmod	_	_
27	once	_	ADV	RB	_	28	advmod	_	_
28	daily	_	ADV	RB	_	30	advmod	_	_
29	at	_	ADP	IN	_	30	case	_	_
30	least	_	ADJ	JJS	_	31	nmod:npmod	_	_
31	1	_	NUM	CD	_	32	nummod	_	_
32	hour	_	NUM	CD	_	23	dep	_	_
33	before	_	ADP	IN	_	18	nmod	_	_
34	or	_	CONJ	CC	_	33	cc	_	_
35	2	_	NUM	CD	_	33	conj	_	_
36	hours	_	NOUN	NNS	_	33	dep	_	_
37	after	_	ADP	IN	_	39	case	_	_
38	a	_	DET	DT	_	39	det	_	_
39	meal	_	ADJ	JJ	_	18	nmod	_	_
40	in	_	ADP	IN	_	41	case	_	_
41	combination	_	NOUN	NN	_	39	nmod	_	_
42	with	_	ADP	IN	_	45	case	_	_
43	prednisone	_	NOUN	NN	_	45	compound	_	_
44	5	_	NUM	CD	_	45	nummod	_	_
45	mg	_	NOUN	NN	_	41	nmod	_	_
46	orally	_	ADV	RB	_	41	advmod	_	_
47	twice	_	ADV	RB	_	41	advmod	_	_
48	daily	_	ADV	RB	_	18	advmod	_	_

#	Zytiga	2160
1	Assessments	_	NOUN	NNS	_	8	nsubj	_	_
2	up	_	ADV	RB	_	6	case	_	_
3	to	_	PRT	TO	_	2	mwe	_	_
4	Cycle	_	NOUN	NN	_	6	compound	_	_
5	2	_	NUM	CD	_	6	nummod	_	_
6	Day	_	NOUN	NN	_	1	nmod	_	_
7	2	_	NUM	CD	_	6	nummod	_	_
8	showed	_	VERB	VBD	_	0	root	_	_
9	no	_	DET	DT	_	11	neg	_	_
10	large	_	ADJ	JJ	_	11	amod	_	_
11	changes	_	NOUN	NNS	_	8	dobj	_	_
12	in	_	ADP	IN	_	16	case	_	_
13	the	_	DET	DT	_	16	det	_	_
14	QTc	_	NOUN	NN	_	16	compound	_	_
15	interval	_	ADJ	JJ	_	16	amod	_	_
16	i.e	_	ADV	RB	_	11	nmod	_	_
17	,	_	.	,	_	8	punct	_	_
18	>20	_	NUM	CD	_	19	nummod	_	_
19	ms	_	NOUN	NNS	_	8	dobj	_	_
20	from	_	ADP	IN	_	21	case	_	_
21	baseline	_	NOUN	NN	_	19	nmod	_	_

#	Zytiga	2161
1	However	_	ADV	RB	_	19	advmod	_	_
2	,	_	.	,	_	19	punct	_	_
3	small	_	ADJ	JJ	_	4	amod	_	_
4	increases	_	NOUN	NNS	_	19	nsubjpass	_	_
5	in	_	ADP	IN	_	7	case	_	_
6	the	_	DET	DT	_	7	det	_	_
7	QTc	_	NOUN	NN	_	4	nmod	_	_
8	interval	_	ADJ	JJ	_	7	amod	_	_
9	i.e	_	ADV	RB	_	8	advmod	_	_
10	,	_	.	,	_	4	punct	_	_
11	<10	_	NUM	CD	_	12	nummod	_	_
12	ms	_	NOUN	NNS	_	4	appos	_	_
13	due	_	ADJ	JJ	_	17	case	_	_
14	to	_	PRT	TO	_	13	mwe	_	_
15	DRUG	_	NOUN	NN	_	17	compound	_	_
16	acetate	_	NOUN	NN	_	17	compound	_	_
17	cannot	_	NOUN	NN	_	12	nmod	_	_
18	be	_	VERB	VBZ	_	19	auxpass	_	_
19	excluded	_	VERB	VBN	_	0	root	_	_
20	due	_	ADJ	JJ	_	22	mark	_	_
21	to	_	PRT	TO	_	22	mark	_	_
22	study	_	VERB	VB	_	19	xcomp	_	_
23	design	_	ADJ	JJ	_	24	amod	_	_
24	limitations	_	NOUN	NNS	_	22	dobj	_	_

